{"meta":{"query_hash":"f9f3e23ffbb1","filters":{"topic":"Bladder and Urothelial Cancer Treatments"},"cohort_total":3070,"direct_labels_cover":8,"predictions_cover":3070,"exported":3070,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f9f3e23ffbb1","api":"https://metacan.xera.ac/api/v1/cohort?topic=Bladder+and+Urothelial+Cancer+Treatments"},"results":[{"id":"W1145000572","doi":"10.1097/spc.0000000000000158","title":"Options in metastatic urothelial cancer after first-line therapy","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Cabozantinib; Oncology; Disease; Targeted therapy; Internal medicine; Optimism; Urothelial carcinoma; Bladder cancer; Precision medicine; Chemotherapy; Cancer; Pathology","score_opus":0.2667728493851469,"score_gpt":0.4894585351172422,"score_spread":0.2226856857320953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1145000572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001793855,0.9928391,0.000016877993,0.00006593985,0.0017103788,0.0026911863,0.0023868135,0.000017663002,0.00009262836],"genre_scores_gemma":[0.00055258366,0.9938891,0.00003320633,0.000040230447,0.0004925499,0.0034361768,0.0014120752,0.000060812035,0.0000832823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770206,0.00021783564,0.0007450218,0.00065289973,0.00031359715,0.00036856192],"domain_scores_gemma":[0.99891967,0.000087902685,0.00026200523,0.0002493431,0.00026821316,0.00021289174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014238933,0.0005760687,0.0017386993,0.0003751351,0.000037969683,0.0000234407,0.00009494401,0.00016777999,0.0004279521],"category_scores_gemma":[0.000034763016,0.00041878066,0.00029748207,0.00046035537,0.00010962449,0.00008594155,0.000055611017,0.0005606207,0.00003035601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003205086,0.00039327823,0.033648178,0.020481635,0.0002403002,0.00003413881,0.0038595882,0.0000012205754,2.2385425e-8,0.000035903508,0.0005760272,0.9404092],"study_design_scores_gemma":[0.0033767421,0.00042972318,0.008791973,0.028854625,0.00035433637,0.000004016652,0.00027218193,0.00000238286,4.80737e-7,0.00007256301,0.9574615,0.00037947096],"about_ca_topic_score_codex":0.00008536168,"about_ca_topic_score_gemma":0.00013525711,"teacher_disagreement_score":0.95688546,"about_ca_system_score_codex":0.000589908,"about_ca_system_score_gemma":0.0011823159,"threshold_uncertainty_score":0.99982643},"labels":[],"label_agreement":null},{"id":"W1152449573","doi":"","title":"Conservative treatment versus early radical cystectomy for T1G3 bladder cancer: A Meta-analysis","year":2013,"lang":"en","type":"article","venue":"Tumori","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Meta-analysis; Confidence interval; Cochrane Library; Inclusion and exclusion criteria; Odds ratio; Urology; Internal medicine; Oncology; Cancer; Pathology","score_opus":0.12919114569642612,"score_gpt":0.3622308453270772,"score_spread":0.2330396996306511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1152449573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96145946,0.007585976,0.0006917863,0.011519368,0.0005962465,0.0062748054,0.000777615,0.00027661055,0.010818158],"genre_scores_gemma":[0.982819,0.00006321248,0.0011990996,0.0006746808,0.0002563991,0.004379768,0.000070570255,0.000038017686,0.010499212],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99857813,0.00005193991,0.00029158982,0.0004319091,0.0002707093,0.0003757451],"domain_scores_gemma":[0.99885356,0.00019884021,0.000099066005,0.00039203904,0.00019488297,0.00026161686],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006088817,0.00029936017,0.0011513798,0.00013339447,0.00010026268,0.00003582139,0.00008385015,0.000070947804,0.0046705804],"category_scores_gemma":[0.000024943902,0.00019398627,0.0011773118,0.00039602668,0.00009975319,0.00009362112,0.0000154939,0.00007964942,0.00017953957],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043369606,0.0013329777,0.01788517,0.000075885946,0.9535652,0.00014171517,0.002419702,0.000028636912,0.00063371746,0.00057537085,0.013589782,0.005414926],"study_design_scores_gemma":[0.031515736,0.0072826883,0.052589014,0.000010845602,0.8620265,0.000019729412,0.00034891625,0.0004721208,0.009235393,0.0003209056,0.035565495,0.00061264314],"about_ca_topic_score_codex":0.011448874,"about_ca_topic_score_gemma":0.00044607554,"teacher_disagreement_score":0.091538645,"about_ca_system_score_codex":0.00030161976,"about_ca_system_score_gemma":0.00024876135,"threshold_uncertainty_score":0.9962393},"labels":[],"label_agreement":null},{"id":"W118271878","doi":"10.1007/s00345-002-0279-y","title":"Prognostic markers in muscle invasive bladder cancer","year":2002,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Oncology; Angiogenesis; Metastasis; Nephrology; Cancer; Internal medicine; Tissue microarray; Bioinformatics; Biology","score_opus":0.04762702393398093,"score_gpt":0.3355162959535359,"score_spread":0.28788927201955494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W118271878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027382235,0.9926034,0.0000018645763,0.00064619194,0.0009818634,0.00062986417,0.000017584412,0.000007652098,0.005084185],"genre_scores_gemma":[0.0005600928,0.99350154,0.00006668803,0.0007492768,0.0006790238,0.00006927331,0.0000069429825,0.000063699576,0.0043034717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978635,0.0002452971,0.0009862393,0.0002590941,0.00025806593,0.00038781573],"domain_scores_gemma":[0.99835664,0.00036495007,0.0007394381,0.00021862211,0.00012153931,0.0001988047],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020811117,0.00036292284,0.0021131292,0.00093129167,0.000020860649,0.000010292213,0.00019974052,0.00023366782,0.0020004697],"category_scores_gemma":[0.00014401328,0.00025804533,0.0005477215,0.00055291894,0.000103006234,0.00005507067,0.00003908901,0.0010562802,0.00006268604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011594811,0.00024777517,0.0011884292,0.0020665512,0.00094859855,0.0022138727,0.000081446036,0.0000021758237,3.4196876e-7,0.0000057477623,0.01097595,0.9821532],"study_design_scores_gemma":[0.0016642434,0.0007426585,0.0013950123,0.0052484996,0.004085711,0.0013341841,0.0000067785886,0.0000010463662,9.812399e-8,0.000034219225,0.98531836,0.00016919423],"about_ca_topic_score_codex":0.000050088005,"about_ca_topic_score_gemma":0.00043633537,"teacher_disagreement_score":0.98198396,"about_ca_system_score_codex":0.00041661607,"about_ca_system_score_gemma":0.0014237557,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W1200062543","doi":"10.1016/j.euf.2014.11.002","title":"The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer","year":2015,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Human Genome Research Institute","keywords":"Medicine; Bladder cancer; Atlas (anatomy); Somatic cell; Genome; Cohort; Cancer; Oncology; Internal medicine; Genetics; Gene; Anatomy; Biology","score_opus":0.04777724613642292,"score_gpt":0.3122238057488069,"score_spread":0.264446559612384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1200062543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52448416,0.025935277,0.00003518896,0.028078655,0.0026705826,0.0021310397,0.00018306113,0.0003816156,0.4161004],"genre_scores_gemma":[0.98347896,0.0016092068,0.00002838998,0.0050459537,0.0014995355,0.0001828643,0.000013414875,0.00010822931,0.008033457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980736,0.00034319054,0.00025670798,0.00051355315,0.00028798945,0.00052499905],"domain_scores_gemma":[0.99881434,0.00011387481,0.0001104819,0.0005758938,0.00015678168,0.00022865042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030709474,0.0002781899,0.00027866487,0.00007989111,0.00020028508,0.000030481457,0.00027406993,0.00007101229,0.00018838242],"category_scores_gemma":[0.000115165254,0.00017065818,0.000116339346,0.00018843153,0.00022428019,0.00004226361,0.00010327813,0.0003561137,0.0007810179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01373028,0.0020402356,0.061200988,0.00012199618,0.0066607757,0.0071661677,0.018470954,0.00073241326,0.010741482,0.002064761,0.48383504,0.3932349],"study_design_scores_gemma":[0.005556234,0.0030251693,0.10159244,0.000030324294,0.00056270434,0.000095536445,0.00021628334,0.000013118934,0.0010548655,0.00017143978,0.88735235,0.00032956232],"about_ca_topic_score_codex":0.00082871853,"about_ca_topic_score_gemma":0.00063023577,"teacher_disagreement_score":0.4589948,"about_ca_system_score_codex":0.00018293314,"about_ca_system_score_gemma":0.00062357646,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W126050813","doi":"","title":"[Intravesical BCG-therapy: comparison of side effects of Connaught (Toronto) and Pasteur (Paris) strains].","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Discontinuation; Contraindication; Surgery; Malaise; Internal medicine","score_opus":0.019783409061722285,"score_gpt":0.2698640009595913,"score_spread":0.250080591897869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W126050813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712409,0.0067431275,0.000009821794,0.00019650171,0.00008610274,0.0011273954,0.000018132027,0.00002563441,0.020552399],"genre_scores_gemma":[0.9976852,0.0010897677,0.00007597096,0.00014705243,0.00009760727,0.00020676042,0.000008424127,0.000018513616,0.0006706905],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989959,0.00004779215,0.0002941883,0.00019261097,0.00021873199,0.0002507787],"domain_scores_gemma":[0.9994469,0.000074671705,0.000075171156,0.0001954792,0.00003336303,0.00017437492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008421578,0.00014456682,0.0005043768,0.000025022215,0.000021400676,0.0000056643735,0.000051804713,0.00008150172,0.00018347784],"category_scores_gemma":[0.000019592946,0.0001136335,0.00007348989,0.000057094065,0.00012792271,0.00005741237,0.000009139693,0.00008177972,0.0000028344657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083303713,0.00084608566,0.040098317,0.00025849798,0.00034419945,0.000015199387,0.0009653011,8.558121e-7,0.0015359797,0.000116504394,0.0004849408,0.9545011],"study_design_scores_gemma":[0.005515606,0.0005798461,0.939974,0.000043172142,0.00016270872,0.000012609665,0.00006993011,0.000017824692,0.050584845,0.00007327513,0.00286605,0.000100114376],"about_ca_topic_score_codex":0.00042423236,"about_ca_topic_score_gemma":0.000047032427,"teacher_disagreement_score":0.95440096,"about_ca_system_score_codex":0.00003855924,"about_ca_system_score_gemma":0.00003125856,"threshold_uncertainty_score":0.46338394},"labels":[],"label_agreement":null},{"id":"W1271572098","doi":"10.1016/j.eururo.2015.08.037","title":"Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":683,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Incidence (geometry); Oncology; Internal medicine; Disease; Gynecology","score_opus":0.07411168531003823,"score_gpt":0.40867853247551467,"score_spread":0.33456684716547647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1271572098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000114380455,0.9818406,0.0000031107436,0.0004258212,0.00022454433,0.001174028,0.00042331737,0.00003088597,0.015866233],"genre_scores_gemma":[0.000042546173,0.99613565,0.000119621516,0.0029262742,0.00015296035,0.000082554216,0.00015934726,0.00007025569,0.00031076864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997334,0.0011367033,0.00062150724,0.0005579368,0.00008513487,0.000264707],"domain_scores_gemma":[0.9986761,0.00016508186,0.00040529072,0.0003632155,0.00020463331,0.00018566096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050359685,0.0004410468,0.0027819145,0.00014317183,0.000034238667,0.0000041709736,0.00011592788,0.00021385287,0.00017290363],"category_scores_gemma":[0.00017870392,0.0002866722,0.00015731384,0.00019642629,0.0005437047,0.00002068492,0.00018195847,0.0003429947,0.000036625035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006334358,0.000099282566,0.0022224379,0.048939463,0.002595191,0.00012196796,0.00018205657,1.3056844e-8,7.95179e-7,0.00045034508,0.014782976,0.9305421],"study_design_scores_gemma":[0.00095922546,0.0006994726,0.0009619382,0.0043528494,0.0045691854,0.00027559666,0.000009741682,9.910212e-8,1.0737111e-7,0.00004081819,0.98793805,0.00019289617],"about_ca_topic_score_codex":0.000024012214,"about_ca_topic_score_gemma":0.0000038141106,"teacher_disagreement_score":0.9731551,"about_ca_system_score_codex":0.000038594597,"about_ca_system_score_gemma":0.00054372376,"threshold_uncertainty_score":0.9999585},"labels":[],"label_agreement":null},{"id":"W1480201884","doi":"10.1111/bju.12403","title":"Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cystectomy; Hazard ratio; Proportional hazards model; Bladder cancer; Urology; Internal medicine; Carcinoma; Detrusor muscle; Cancer; Survival analysis; Oncology; Confidence interval; Urinary bladder","score_opus":0.01271396518379003,"score_gpt":0.24821132730507942,"score_spread":0.23549736212128938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480201884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505806,0.00092501176,0.000034103738,0.0028904784,0.00016315831,0.00065508386,0.000021755584,0.000025574607,0.00022680033],"genre_scores_gemma":[0.9973276,0.000108591965,0.00055538566,0.0015251952,0.00024999317,0.000050164428,0.0000048439506,0.000039971233,0.00013823941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849695,0.00011905053,0.0003971439,0.00023503152,0.0003823896,0.00036944397],"domain_scores_gemma":[0.99882895,0.00004960174,0.00025684675,0.0001024257,0.00046123692,0.00030094272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018565213,0.00015672775,0.000452268,0.00013124767,0.000113197544,0.00004835102,0.00012443682,0.00012821364,0.00043397312],"category_scores_gemma":[0.0001923117,0.00013288624,0.000105107174,0.0002159647,0.00006255286,0.00014062322,0.000041064533,0.00029155155,0.00003330698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016359738,0.00089206995,0.8731436,0.00005711208,0.00034185476,0.003367516,0.0003478472,0.0000063122748,0.025033897,9.3696116e-7,0.004566946,0.09060591],"study_design_scores_gemma":[0.0055019436,0.00375727,0.97694194,0.000253814,0.00010138548,0.0058111353,0.000029831674,0.000012353567,0.006993814,0.000020562627,0.0004410061,0.00013495352],"about_ca_topic_score_codex":0.00031249627,"about_ca_topic_score_gemma":0.00014437243,"teacher_disagreement_score":0.1037983,"about_ca_system_score_codex":0.00010101893,"about_ca_system_score_gemma":0.00017755404,"threshold_uncertainty_score":0.5418944},"labels":[],"label_agreement":null},{"id":"W1480673074","doi":"10.1016/j.eururo.2015.07.042","title":"Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Taxane; Medicine; Chemotherapy; Oncology; Salvage therapy; Internal medicine; Urothelial carcinoma; Urology; Bladder cancer; Cancer; Breast cancer","score_opus":0.057090370389691066,"score_gpt":0.30394700175432815,"score_spread":0.2468566313646371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480673074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95193684,0.0010040895,0.00058489514,0.0027860908,0.0014353974,0.0013350867,0.000023737584,0.00018782493,0.04070605],"genre_scores_gemma":[0.99129725,0.0000646276,0.0006912301,0.0055712434,0.0006445784,0.00007536259,0.00011421664,0.00013439302,0.0014071228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826163,0.00023551869,0.00031956672,0.00049253297,0.00023998965,0.00045075966],"domain_scores_gemma":[0.99886626,0.000121686004,0.00017471459,0.00039574396,0.00018473646,0.0002568355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033838666,0.00029828484,0.00038792662,0.000116985175,0.00009895427,0.000024437846,0.00017021122,0.000087246124,0.0001441355],"category_scores_gemma":[0.00018528798,0.0002681307,0.00014242866,0.000119805234,0.00010157869,0.000083766674,0.000034603043,0.00017678594,0.00021374885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1849097,0.0039322143,0.01857423,0.00008191553,0.0013024493,0.0012683432,0.009996294,0.0001196492,0.104331754,0.0022526572,0.012292872,0.6609379],"study_design_scores_gemma":[0.19386317,0.08416544,0.025705036,0.00002929159,0.00035927238,0.00029676055,0.0007897924,0.00020617829,0.033479344,0.00048695118,0.6597704,0.0008483375],"about_ca_topic_score_codex":0.000045549925,"about_ca_topic_score_gemma":0.000006853675,"teacher_disagreement_score":0.6600896,"about_ca_system_score_codex":0.0001669001,"about_ca_system_score_gemma":0.00016831305,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null},{"id":"W1484305797","doi":"10.1111/j.1464-410x.2012.11649.x","title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal function; Urology; Cisplatin; Interquartile range; Chemotherapy; Kidney disease; Retrospective cohort study; Urothelial carcinoma; Internal medicine; Oncology; Cancer","score_opus":0.01339146818649941,"score_gpt":0.2930235046255564,"score_spread":0.279632036439057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1484305797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998216,0.00043732242,0.00037353,0.00030856527,0.00010728841,0.00037589908,0.000018965224,0.00000279995,0.00015963384],"genre_scores_gemma":[0.99907726,0.00025405313,0.00009401919,0.0003848905,0.00013679525,0.0000069707075,0.000007328909,0.000011962735,0.000026707012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990689,0.000081547696,0.0003770536,0.00013938032,0.00015680173,0.00017631995],"domain_scores_gemma":[0.99935234,0.000090079586,0.00017888276,0.00007594523,0.00018839538,0.00011433142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018762912,0.00009786263,0.00042712776,0.00009375631,0.00002156998,0.000010043987,0.00004082963,0.000114703595,0.00015109153],"category_scores_gemma":[0.00008881063,0.00008596914,0.00013993848,0.000048588925,0.000093900555,0.000080777885,0.0000074963236,0.00019971738,8.0537416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010904112,0.0010439636,0.8501491,0.000030377965,0.0004259211,0.000026799327,0.00008056155,0.00001650523,0.00043881213,0.000007711459,0.002309887,0.13456623],"study_design_scores_gemma":[0.015437803,0.012668558,0.9704221,0.000057234138,0.00007540462,0.000232909,0.0000069709763,0.00007361734,0.00008227064,0.0006785085,0.00020911895,0.0000555209],"about_ca_topic_score_codex":0.0004450609,"about_ca_topic_score_gemma":0.00005276856,"teacher_disagreement_score":0.13451071,"about_ca_system_score_codex":0.00008388361,"about_ca_system_score_gemma":0.000106792584,"threshold_uncertainty_score":0.350572},"labels":[],"label_agreement":null},{"id":"W1485309517","doi":"10.1111/bju.13018","title":"Fluorescence cystoscopy: the end of biopsies for carcinoma <i>in situ</i> detection?","year":2015,"lang":"en","type":"letter","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Carcinoma in situ; Biopsy; White light; Significant difference; Urology; Radiology; Surgery; Carcinoma; Cancer; Pathology; Internal medicine; Urinary system","score_opus":0.018961086569471968,"score_gpt":0.26658345068336875,"score_spread":0.2476223641138968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485309517","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21118279,0.06876952,0.0003916498,0.70824194,0.005552855,0.0024102705,0.00065923383,0.000029415549,0.0027623049],"genre_scores_gemma":[0.86550623,0.0007201308,0.00025598324,0.12964942,0.0034365398,0.00003262521,0.000024905632,0.00005204342,0.0003221432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984261,0.0001486868,0.0006090668,0.00018663723,0.00032833364,0.00030117267],"domain_scores_gemma":[0.9984981,0.0002014128,0.0004893305,0.0001842053,0.00056196254,0.00006502132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038019635,0.00017671674,0.0007269424,0.00017908611,0.000044416836,0.000015477492,0.00023378727,0.00043502607,0.000035345467],"category_scores_gemma":[0.00021451009,0.00014515774,0.00025165378,0.000117652664,0.00028552779,0.000050424187,0.000027568092,0.0011923511,0.000002346736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016752215,0.00018623234,0.0024040602,0.0003354038,0.00046015324,0.008490392,0.00024763503,0.0000066478206,0.0039632525,0.0000018163945,0.9423074,0.039921768],"study_design_scores_gemma":[0.010771344,0.007541883,0.019821325,0.00048516432,0.0016478639,0.079881266,0.00010603134,0.000015835396,0.0064422362,0.0009917916,0.8719773,0.00031793732],"about_ca_topic_score_codex":0.0004179889,"about_ca_topic_score_gemma":0.00028550407,"teacher_disagreement_score":0.6543234,"about_ca_system_score_codex":0.000099595054,"about_ca_system_score_gemma":0.0005315279,"threshold_uncertainty_score":0.5919361},"labels":[],"label_agreement":null},{"id":"W1487419888","doi":"10.1111/pin.12187","title":"Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal‐like urothelial cells: An immunohistochemical and histopathogenetic study","year":2014,"lang":"en","type":"article","venue":"Pathology International","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pathology; Cytokeratin; Immunohistochemistry; Immunostaining; Basal (medicine); Atypia; CD44; Biology; Medicine; Cell","score_opus":0.008754661260212996,"score_gpt":0.26810709703243096,"score_spread":0.25935243577221795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487419888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742794,0.0006074714,0.0002872904,0.00007898185,0.00048556968,0.00046117877,0.000108312306,0.000017635577,0.0005255985],"genre_scores_gemma":[0.9981033,0.00002319972,0.0012850368,0.00015943854,0.00014498754,0.00004559486,0.00004846744,0.00003190536,0.0001580326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99850416,0.00013549406,0.0004567007,0.00044506148,0.00026404046,0.00019453367],"domain_scores_gemma":[0.9991403,0.000103459846,0.00018391894,0.00030669538,0.00015622533,0.000109384535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020430039,0.00023125233,0.00048268234,0.0001580515,0.000055982284,0.000009253345,0.0001771173,0.0001484191,0.000056836518],"category_scores_gemma":[0.000098246746,0.00021168166,0.00007152828,0.000058991198,0.000377895,0.000053814227,0.00010868952,0.00020313052,0.0000020634573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013468675,0.0006982263,0.0798801,0.000056183148,0.0000937962,0.000061875915,0.0013473028,8.4198075e-7,0.91488236,0.00007264387,0.000033638353,0.0015261777],"study_design_scores_gemma":[0.008908294,0.0025206846,0.8909752,0.00008446279,0.0005102134,0.0010799768,0.00027153268,0.0002519517,0.09480651,0.00019788416,0.00011728053,0.00027601398],"about_ca_topic_score_codex":0.00016805765,"about_ca_topic_score_gemma":0.0000063095463,"teacher_disagreement_score":0.8200758,"about_ca_system_score_codex":0.000077700795,"about_ca_system_score_gemma":0.000085913416,"threshold_uncertainty_score":0.86321276},"labels":[],"label_agreement":null},{"id":"W1488187260","doi":"10.1111/j.1464-410x.2012.11754.x","title":"Bacillus <scp>C</scp> almette‐ <scp>G</scp> uérin immunotherapy for genitourinary cancer","year":2013,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Immunotherapy; Bladder cancer; Medicine; Cancer immunotherapy; Immunology; Cancer; Immune system; BCG vaccine; Oncology; Internal medicine; Cancer research; Vaccination","score_opus":0.040224069592770154,"score_gpt":0.3287263742872817,"score_spread":0.28850230469451155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488187260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010437798,0.99176985,0.00021779945,0.00015012236,0.0024524857,0.0020772251,0.0004815539,0.000042932556,0.0017642478],"genre_scores_gemma":[0.00005563051,0.98266894,0.0009089253,0.0013967352,0.004211705,0.0005717113,0.00009778372,0.0002739483,0.0098146275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956312,0.00039382937,0.0017858688,0.00062245573,0.0005335494,0.0010331072],"domain_scores_gemma":[0.99551415,0.0013054884,0.0016500627,0.00045604663,0.00058298523,0.00049128104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052543194,0.0007847848,0.003918238,0.00048388456,0.00019533988,0.00010557607,0.00064751273,0.00097272417,0.00036673725],"category_scores_gemma":[0.0005441996,0.00072475744,0.0019073674,0.0002992449,0.00022431106,0.00019503073,0.00009428007,0.0015419718,0.00010190699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033855402,0.0003764161,0.00005316296,0.0026598913,0.003194139,0.0022649572,0.00008764689,0.0000019439374,0.000012176874,0.000005699883,0.14765255,0.84365755],"study_design_scores_gemma":[0.004839652,0.00290795,0.0002373351,0.003483734,0.0037443629,0.049602132,0.000047038764,0.000002175269,0.000010014827,0.00015290124,0.9348618,0.00011095179],"about_ca_topic_score_codex":0.0003463347,"about_ca_topic_score_gemma":0.0000366816,"teacher_disagreement_score":0.8435466,"about_ca_system_score_codex":0.0003659516,"about_ca_system_score_gemma":0.0015863327,"threshold_uncertainty_score":0.99952036},"labels":[],"label_agreement":null},{"id":"W1488240986","doi":"10.1002/cncr.23627","title":"Maintenance bacillus Calmette‐Guérin in high‐risk nonmuscle‐invasive bladder cancer","year":2008,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Bladder cancer; Bacillus (shape); Cancer; Urology; Oncology; Internal medicine; Microbiology; Biology","score_opus":0.023974671717895666,"score_gpt":0.27789633538913483,"score_spread":0.25392166367123914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488240986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842265,0.0069260695,0.00006498664,0.0021818317,0.0009342233,0.00074336556,0.00034159343,0.00009072945,0.0044906978],"genre_scores_gemma":[0.96867764,0.017151892,0.00024813818,0.0031704386,0.000731681,0.00071631436,0.000020065962,0.00007322729,0.009210582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979249,0.000056396333,0.00036551376,0.00061240565,0.00038022446,0.0006605406],"domain_scores_gemma":[0.99891776,0.00006383252,0.00013137645,0.00046175838,0.00015845205,0.0002668485],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008321004,0.00034458557,0.0005715644,0.00015201452,0.00013267879,0.0000102972,0.00015066052,0.00016607426,0.0027690968],"category_scores_gemma":[0.0000669781,0.00028381514,0.00015531725,0.00046124274,0.0002080526,0.00012896885,0.000050569855,0.00042027727,0.00015739928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009381545,0.00044698777,0.8833841,0.00015541646,0.00065232045,0.0015181117,0.0022034843,0.00047486098,0.0023567562,0.000092522685,0.05257828,0.055198997],"study_design_scores_gemma":[0.011870975,0.0004019989,0.9362585,0.0005070057,0.0003293465,0.000114654154,0.0001767123,0.000080393715,0.011090619,0.00016326414,0.0384259,0.0005806516],"about_ca_topic_score_codex":0.020186821,"about_ca_topic_score_gemma":0.006832657,"teacher_disagreement_score":0.054618344,"about_ca_system_score_codex":0.0008603028,"about_ca_system_score_gemma":0.0009176476,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W1493373396","doi":"10.1111/j.1464-410x.2011.10482.x","title":"Stage‐specific impact of pelvic lymph node dissection on survival in patients with non‐metastatic bladder cancer treated with radical cystectomy","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Dissection (medical); Bladder cancer; Lymph node; Urology; Stage (stratigraphy); Proportional hazards model; Surgery; Cancer; Internal medicine","score_opus":0.01780853186519079,"score_gpt":0.26585990792259157,"score_spread":0.24805137605740077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493373396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983094,0.00046657442,0.0001075162,0.000025306683,0.000107370695,0.0002888851,0.000066093715,0.000007320368,0.00062153034],"genre_scores_gemma":[0.9994009,0.0002089914,0.00014714341,0.000059968348,0.000064022075,0.000011044699,0.000013072943,0.000038275444,0.000056560333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856526,0.00013533756,0.00044511553,0.00020467004,0.00035809664,0.00029150656],"domain_scores_gemma":[0.99906045,0.000042211555,0.00033361692,0.00013518245,0.00025768927,0.00017083739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012806967,0.0001902103,0.0006279297,0.00020218869,0.000032594813,0.000009269502,0.00008534591,0.00007855874,0.00065691466],"category_scores_gemma":[0.000016275117,0.00013669973,0.0001154662,0.00026437297,0.0001543154,0.000104432576,0.00000851101,0.00029261454,0.000002780483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018266069,0.0017114711,0.97035563,0.00002928385,0.00078184245,0.0017744945,0.00023527151,0.00015147575,0.0000753503,0.0000017557534,0.000063581865,0.0065537915],"study_design_scores_gemma":[0.023078136,0.01045508,0.96430093,0.00023703944,0.00030906458,0.0012569414,0.000045696732,0.000014286473,0.00016017872,0.0000062687814,0.000021976695,0.00011439622],"about_ca_topic_score_codex":0.0027973582,"about_ca_topic_score_gemma":0.0003560211,"teacher_disagreement_score":0.008743609,"about_ca_system_score_codex":0.00021444463,"about_ca_system_score_gemma":0.00030730173,"threshold_uncertainty_score":0.7192755},"labels":[],"label_agreement":null},{"id":"W1500047916","doi":"10.1111/j.1464-410x.2011.010419.x","title":"Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources; Alere","keywords":"Medicine; Cystoscopy; Bladder cancer; Urine cytology; Prospective cohort study; Urinary system; Urology; Cancer; Oncology; Internal medicine","score_opus":0.044913019979311415,"score_gpt":0.3673511149732015,"score_spread":0.3224380949938901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1500047916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372953,0.003923726,0.001289038,0.00008130018,0.00023427357,0.00028081425,0.000039269045,0.0000017011088,0.0004203734],"genre_scores_gemma":[0.99826866,0.0012592868,0.00019224826,0.00011928558,0.0001322518,0.000010230643,0.000002635659,0.000008098868,0.000007318496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974146,0.0004828854,0.0014099998,0.00017233331,0.00037572562,0.00014444347],"domain_scores_gemma":[0.9973226,0.00063093245,0.0012854635,0.00021785671,0.0004958153,0.00004730644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019250059,0.00010118067,0.0011504816,0.0005199523,0.00004252264,0.000008913241,0.00020689484,0.0001434812,0.0003677994],"category_scores_gemma":[0.00036073808,0.00006722953,0.00085874455,0.0014733493,0.00023868355,0.00009743366,0.0000276393,0.000475529,1.9623101e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02134893,0.0015161586,0.7367305,0.000016497295,0.018124748,0.00016198592,0.0014177888,0.00024366584,0.00026342654,0.000013736601,0.0000340594,0.22012846],"study_design_scores_gemma":[0.013484097,0.002692962,0.9643366,0.000039372553,0.017731799,0.0001946362,0.00034867905,0.00019908487,0.00039428307,0.000504092,0.000028215098,0.00004622752],"about_ca_topic_score_codex":0.0028271852,"about_ca_topic_score_gemma":0.00624653,"teacher_disagreement_score":0.22760601,"about_ca_system_score_codex":0.00004242568,"about_ca_system_score_gemma":0.00026052617,"threshold_uncertainty_score":0.4273877},"labels":[],"label_agreement":null},{"id":"W1500536114","doi":"10.1111/j.1464-410x.2012.11448.x","title":"Diagnostic tests in urology: urine cytology","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystoscopy; Urine cytology; Cytology; Urine; Medicine; Urology; Triage; Urothelial carcinoma; Urinary system; Bladder cancer; Internal medicine; Pathology; Cancer; Medical emergency","score_opus":0.015460132206379014,"score_gpt":0.2831113996876309,"score_spread":0.26765126748125184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1500536114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675515,0.026798263,0.00008082763,0.0026607327,0.00080648,0.00015496166,0.0000071299482,0.000012002358,0.0019280653],"genre_scores_gemma":[0.9944996,0.0016306363,0.00022057892,0.0027940604,0.0007323662,0.000008801896,0.0000039506235,0.000020735864,0.00008922858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986794,0.00015179507,0.00045626855,0.000119651304,0.00013179828,0.00046106003],"domain_scores_gemma":[0.9990198,0.00038031532,0.00016875839,0.00010583976,0.000094358715,0.00023089848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032490867,0.00011431622,0.000482319,0.00018629168,0.00002910607,0.0000058973233,0.00010049271,0.00017458068,0.00045351867],"category_scores_gemma":[0.00087051006,0.00011776294,0.00009887318,0.00013090664,0.00012483062,0.00011386668,0.000032897304,0.0004928362,0.000048618913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005229941,0.0010228361,0.95294654,0.00001813297,0.00013560921,0.008650424,0.00012961151,0.000012380882,0.00027045739,0.000067622896,0.0031811898,0.03304219],"study_design_scores_gemma":[0.004175189,0.0017117693,0.8728858,0.000024687213,0.000197725,0.10466546,0.000013092405,0.0000031375016,0.000070540205,0.00036679665,0.015809173,0.00007663587],"about_ca_topic_score_codex":0.00009140069,"about_ca_topic_score_gemma":0.00013037695,"teacher_disagreement_score":0.096015036,"about_ca_system_score_codex":0.00005405959,"about_ca_system_score_gemma":0.0001226693,"threshold_uncertainty_score":0.49657112},"labels":[],"label_agreement":null},{"id":"W1501997055","doi":"10.1002/cncr.28510","title":"Perioperative chemotherapy for muscle‐invasive bladder cancer: A population‐based outcomes study","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Cancer Care Ontario","keywords":"Medicine; Bladder cancer; Cystectomy; Propensity score matching; Perioperative; Internal medicine; Population; Cancer; Cancer registry; Oncology; Proportional hazards model; Stage (stratigraphy); Surgery","score_opus":0.030358135069305087,"score_gpt":0.3528648344628884,"score_spread":0.32250669939358334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501997055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895978,0.0005570059,0.0005421582,0.004654177,0.0005772674,0.0029318717,0.00015207006,0.0001043087,0.00088332186],"genre_scores_gemma":[0.9864555,0.00006629717,0.0003924148,0.007018179,0.00050641317,0.0027402502,0.00003844908,0.00006343041,0.0027190722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881506,0.000041052303,0.0002257189,0.00040499883,0.00023363385,0.00027955932],"domain_scores_gemma":[0.9991805,0.00009317756,0.00008278701,0.00031245523,0.00019855704,0.00013253129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000079561,0.00025217087,0.00047148985,0.000072132134,0.00015548505,0.000027431488,0.000083451916,0.00006919777,0.0012583052],"category_scores_gemma":[0.00005048529,0.0001874694,0.00016120716,0.0001353605,0.000034281966,0.00006958379,0.000010320482,0.00008898364,0.000010183485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045923347,0.0005747554,0.95918137,0.000078052486,0.0006837297,0.0000028904385,0.0022306836,0.00015015264,0.00074289786,0.000056485052,0.0018416354,0.033998117],"study_design_scores_gemma":[0.01481238,0.0010885815,0.96791804,0.00008064794,0.00046273798,6.622903e-7,0.00047778894,0.00036743397,0.0022958284,0.00004607553,0.012178531,0.0002713132],"about_ca_topic_score_codex":0.0022918405,"about_ca_topic_score_gemma":0.001700753,"teacher_disagreement_score":0.0337268,"about_ca_system_score_codex":0.00031646254,"about_ca_system_score_gemma":0.0003514309,"threshold_uncertainty_score":0.99965465},"labels":[],"label_agreement":null},{"id":"W1502810893","doi":"10.1111/bju.12214","title":"In‐hospital mortality and failure‐to‐rescue rates after radical cystectomy","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Odds ratio; Bladder cancer; Odds; Complication; Internal medicine; Medicaid; Logistic regression; Genitourinary system; Surgery; Cancer","score_opus":0.008834705896455564,"score_gpt":0.270147268281634,"score_spread":0.2613125623851784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502810893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897868,0.0027532922,0.000033793152,0.0067638857,0.00022078292,0.0002584329,0.000005966485,0.0000052227456,0.0001718077],"genre_scores_gemma":[0.996684,0.00020332284,0.0003757499,0.0023314832,0.00030040284,0.000025350326,9.045909e-7,0.000013077873,0.00006572261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990857,0.00006628481,0.00033153282,0.00014314393,0.00014950534,0.00022380159],"domain_scores_gemma":[0.99948585,0.000031820604,0.000056306817,0.00007716731,0.000103302096,0.00024554154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012856169,0.000094312185,0.0003456372,0.00009621446,0.00002017909,0.000030012277,0.000059984308,0.00010067202,0.0006854615],"category_scores_gemma":[0.0000907523,0.00008883954,0.000067002446,0.0000806599,0.000103573744,0.00015324175,0.00002930029,0.00028800298,0.00003166146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006867407,0.0008922166,0.9435647,0.00006359034,0.00039398076,0.015619544,0.00048767892,0.0000050664526,0.0008454877,0.000021246646,0.017569754,0.019849958],"study_design_scores_gemma":[0.0037001472,0.0017475572,0.97682655,0.000059113307,0.000089659035,0.011630151,0.000030421987,0.000006926381,0.000117626776,0.00038084472,0.0053275535,0.000083467734],"about_ca_topic_score_codex":0.000923754,"about_ca_topic_score_gemma":0.00032056717,"teacher_disagreement_score":0.033261795,"about_ca_system_score_codex":0.00003193814,"about_ca_system_score_gemma":0.00008026929,"threshold_uncertainty_score":0.75053227},"labels":[],"label_agreement":null},{"id":"W1503887096","doi":"10.1111/bju.13213","title":"Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes","year":2015,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Brigham and Women's Hospital; International Business Machines Corporation","keywords":"Medicine; Dehiscence; Wound dehiscence; Odds ratio; Confidence interval; Current Procedural Terminology; Surgery; Cohort; Cystectomy; Internal medicine; Bladder cancer; Cancer","score_opus":0.03255753619854794,"score_gpt":0.3161440260371211,"score_spread":0.28358648983857315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503887096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935857,0.0023292114,0.002787095,0.0007807279,0.00009887284,0.00023972325,0.00014206058,0.000002361486,0.000034247827],"genre_scores_gemma":[0.99865305,0.00029963817,0.0008983101,0.00006971087,0.00002931426,0.00001259995,0.000005340317,0.0000062892655,0.000025748368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925,0.000031484553,0.00047677258,0.000075684926,0.000082614286,0.00008346048],"domain_scores_gemma":[0.99911577,0.00015482196,0.00030211263,0.00007597675,0.00028517772,0.000066139415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002782457,0.00004557543,0.00028857094,0.00010383311,0.000012599992,0.0000044119097,0.00005767249,0.000051089955,0.000004892666],"category_scores_gemma":[0.00049388903,0.00004520867,0.000050470393,0.00007462874,0.00009046162,0.00006111501,0.000008369728,0.00006555709,1.2874006e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004247837,0.00025357457,0.98683685,0.000067150504,0.000120346944,0.000009083357,0.00051256805,0.000011222317,0.0019803448,0.00011737274,0.00041036576,0.009256314],"study_design_scores_gemma":[0.0038716334,0.00092702423,0.9899045,0.00004055762,0.00014345607,0.00094961,0.00010871494,0.000017106846,0.00041988306,0.0031966565,0.0003901216,0.000030701412],"about_ca_topic_score_codex":0.00030430034,"about_ca_topic_score_gemma":0.00019977786,"teacher_disagreement_score":0.0092256125,"about_ca_system_score_codex":0.000030036415,"about_ca_system_score_gemma":0.00013771461,"threshold_uncertainty_score":0.1843556},"labels":[],"label_agreement":null},{"id":"W1509139787","doi":"10.1111/j.1464-410x.2011.10792.x","title":"Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Lymphovascular invasion; Upper urinary tract; Renal pelvis; Cuff; Bladder cancer; Urology; Carcinoma; Perioperative; Ureter; Surgery; Cancer; Internal medicine; Metastasis; Urinary system","score_opus":0.014895855827921089,"score_gpt":0.25777198566833165,"score_spread":0.24287612984041057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509139787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986264,0.0005956726,0.00006166725,0.00003721994,0.000040950898,0.00044808126,0.00003532925,0.000007248701,0.00014739852],"genre_scores_gemma":[0.99901485,0.00013121462,0.0006467776,0.00007008802,0.00006274375,0.000010180107,0.000010249211,0.000035122437,0.00001878342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987879,0.00014000859,0.00039103036,0.00022291973,0.00022714294,0.00023104441],"domain_scores_gemma":[0.99894243,0.000028984576,0.00026877917,0.000121067336,0.00049485656,0.00014388605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010279794,0.00021484101,0.000588863,0.00013166577,0.000046748333,0.000016795342,0.000069806214,0.000112388494,0.00017187935],"category_scores_gemma":[0.000029225786,0.00015454333,0.00008199418,0.00016174435,0.00025219168,0.00021078812,0.000010328059,0.00025135078,6.002715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059669215,0.0010348571,0.9295992,0.00001789477,0.00045238365,0.0005786279,0.0015802635,0.000011282056,0.00021261147,9.356663e-7,0.000009597153,0.006833132],"study_design_scores_gemma":[0.031186523,0.026355516,0.9369825,0.00009304471,0.00025579354,0.0040722857,0.00012559778,0.00001700667,0.00075831637,0.000006036708,0.000012440669,0.00013493364],"about_ca_topic_score_codex":0.0015978041,"about_ca_topic_score_gemma":0.00027439545,"teacher_disagreement_score":0.028482692,"about_ca_system_score_codex":0.00009474233,"about_ca_system_score_gemma":0.00033768016,"threshold_uncertainty_score":0.63020945},"labels":[],"label_agreement":null},{"id":"W1509566631","doi":"10.1002/jso.23887","title":"Radical cystectomy in patients over 80 years old in Quebec: A population‐based study of outcomes","year":2015,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Cystectomy; Mortality rate; Cohort; Complication; Cohort study; Population; Surgery; Pediatrics; Bladder cancer; Internal medicine; Cancer; Environmental health","score_opus":0.03239200044172426,"score_gpt":0.34955574620273466,"score_spread":0.3171637457610104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509566631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985287,0.00005224259,0.0000016241203,0.00043551094,0.00024448673,0.00029426237,0.0000021995556,0.0000030286249,0.00043793741],"genre_scores_gemma":[0.99951273,0.0000040691716,0.00014910294,0.0001445818,0.000059303846,0.000005008157,0.0000026873909,0.0000091585525,0.00011336656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834156,0.00022165557,0.00073237316,0.00010349223,0.00045163612,0.00014930361],"domain_scores_gemma":[0.9992075,0.00015161747,0.00026794628,0.00009794721,0.000105520354,0.00016944396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003714287,0.00009530307,0.00074662786,0.0003288232,0.0000054325656,0.0000033002823,0.00007267776,0.00012217753,0.00011357569],"category_scores_gemma":[0.000070060174,0.000067674715,0.00010147965,0.00023104134,0.000022780472,0.000072656236,0.000019978841,0.00027334003,0.0000029565902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030752355,0.004836512,0.9851403,0.000008085212,0.00006290942,0.0012275563,0.00047884166,0.00005548701,0.0000018643079,0.000008591305,0.00014355397,0.004961061],"study_design_scores_gemma":[0.050681923,0.005681302,0.94029886,0.00004879278,0.00006384273,0.000020229276,0.00016486985,0.000011128216,0.0000034993245,0.000024542756,0.0029511543,0.000049860082],"about_ca_topic_score_codex":0.006417806,"about_ca_topic_score_gemma":0.0031168154,"teacher_disagreement_score":0.047606684,"about_ca_system_score_codex":0.0006588303,"about_ca_system_score_gemma":0.0003744928,"threshold_uncertainty_score":0.97018456},"labels":[],"label_agreement":null},{"id":"W1510434633","doi":"10.1111/j.1464-410x.2010.09590.x","title":"Radical cystectomy for patients with pT4 urothelial carcinoma in a large population‐based study","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Urinary diversion; Oncology; Cohort; Population; Epidemiology; Retrospective cohort study; Internal medicine; Urinary bladder; Surveillance, Epidemiology, and End Results; Urothelial carcinoma; Stage (stratigraphy); Cancer; Cancer registry","score_opus":0.008403781263572427,"score_gpt":0.2612611355847698,"score_spread":0.2528573543211974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1510434633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981598,0.00009812741,0.00017652422,0.0002486215,0.00032820727,0.0008682283,0.000056786805,0.000007766304,0.00005592611],"genre_scores_gemma":[0.9985333,0.0000015608084,0.0006144528,0.00047762587,0.0002742301,0.00003365528,0.00002022985,0.00002618958,0.000018724333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886906,0.000075512515,0.0003896349,0.00016197926,0.00024940167,0.00025439158],"domain_scores_gemma":[0.9993216,0.000067432156,0.00016473967,0.00010933997,0.00020160842,0.000135288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023545005,0.00010917232,0.00039072213,0.00016349042,0.000057092573,0.000015324407,0.00009100565,0.00010081793,0.00013432323],"category_scores_gemma":[0.00013930853,0.00009723352,0.00008830765,0.00010705244,0.00003120793,0.00006605499,0.000010944863,0.00040399574,0.0000016478152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031730623,0.0025272295,0.98993033,0.000013844868,0.00006575783,0.00066059874,0.00006849288,0.000005298233,0.000027466378,0.000006467623,0.00009190059,0.0034295514],"study_design_scores_gemma":[0.042034123,0.007032028,0.94877106,0.000023227209,0.00017771946,0.00079035125,0.000018951025,0.000043942477,0.000010936698,0.00004144428,0.0009773427,0.0000788499],"about_ca_topic_score_codex":0.00025366165,"about_ca_topic_score_gemma":0.0013086777,"teacher_disagreement_score":0.041159246,"about_ca_system_score_codex":0.00004126058,"about_ca_system_score_gemma":0.00021248234,"threshold_uncertainty_score":0.39650676},"labels":[],"label_agreement":null},{"id":"W1511453483","doi":"10.1111/bju.12913","title":"Pathological factors associated with survival benefit from adjuvant chemotherapy ( <scp>ACT</scp> ): a population‐based study of bladder cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Lymphovascular invasion; Medicine; Hazard ratio; Internal medicine; Cystectomy; Bladder cancer; Population; Proportional hazards model; Confidence interval; Stage (stratigraphy); Oncology; Cancer; Cancer registry; Urology; Metastasis","score_opus":0.024914176222359162,"score_gpt":0.275291169165735,"score_spread":0.25037699294337584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1511453483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808186,0.0008608519,0.00013184086,0.00015401842,0.0002470779,0.00027413564,0.00009667631,0.000018488208,0.00013503748],"genre_scores_gemma":[0.99892896,0.000082684615,0.000077297555,0.0005669085,0.00019928672,0.000008751145,0.000044791817,0.000035016114,0.000056307217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828297,0.00023311489,0.00053400296,0.00023346685,0.00045027593,0.00026614306],"domain_scores_gemma":[0.9984462,0.00036031252,0.00056463026,0.00014670733,0.00032127014,0.00016085408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024503682,0.00018924623,0.0008578596,0.00010152641,0.000063519066,0.000017035938,0.00013347184,0.00017514348,0.00030487397],"category_scores_gemma":[0.0002603718,0.00015131479,0.0001375649,0.00015344648,0.000056824756,0.000062707535,0.000015020004,0.00034751047,0.00000100081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034829238,0.0017685666,0.9891366,0.000004725238,0.0007821015,0.00026156992,0.00031647083,0.00022873095,0.00023687289,0.0000017063857,0.00015288657,0.006761471],"study_design_scores_gemma":[0.012734699,0.006651006,0.97912335,0.000079030484,0.00062590436,0.00009324574,0.0001941475,0.000055107696,0.00014345789,0.000105867395,0.00013200293,0.000062148734],"about_ca_topic_score_codex":0.0020444416,"about_ca_topic_score_gemma":0.0020742156,"teacher_disagreement_score":0.012386407,"about_ca_system_score_codex":0.000078353245,"about_ca_system_score_gemma":0.00011539621,"threshold_uncertainty_score":0.6170438},"labels":[],"label_agreement":null},{"id":"W1512451698","doi":"10.5489/cuaj.2927","title":"Is there a gender effect in bladder cancer? A population-based study of practice and outcomes","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Cystectomy; Bladder cancer; Medicine; Cancer registry; Cohort; Population; Cancer; Internal medicine; Incidence (geometry); Oncology; Urology; Gynecology","score_opus":0.03295579626779525,"score_gpt":0.32379083713394874,"score_spread":0.29083504086615347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512451698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878823,0.0004464551,0.0000029562145,0.010567431,0.00010814706,0.0003565124,0.000018426368,0.0000063119214,0.0006114456],"genre_scores_gemma":[0.99498755,0.000011733792,0.00004291478,0.004784941,0.00006875253,0.000021573149,0.000003303062,0.000008329444,0.0000709079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877316,0.00028786607,0.00024959093,0.00013497104,0.00034183895,0.00021259006],"domain_scores_gemma":[0.99890137,0.00022641452,0.00019775407,0.00007096055,0.00019968567,0.0004037939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005793336,0.000105578074,0.00029566517,0.00014123021,0.00005716021,0.000025275818,0.00004147884,0.000117156655,0.00015941539],"category_scores_gemma":[0.0008245791,0.00007380337,0.000047193396,0.0001587212,0.000007232414,0.00007697159,0.0000054164816,0.00026865202,0.0000031947736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014542918,0.00016529951,0.9970722,0.0000034704865,0.00021185694,0.00006230232,0.0008381506,0.000056709046,0.0000012472691,0.0000036844328,0.0005576425,0.0008819799],"study_design_scores_gemma":[0.0052221497,0.0010923464,0.9921014,0.0000075443727,0.00022214591,0.000012712255,0.0004389313,0.00007056369,0.0000029685561,0.00012692313,0.00063869305,0.00006365346],"about_ca_topic_score_codex":0.033580884,"about_ca_topic_score_gemma":0.008814746,"teacher_disagreement_score":0.024766138,"about_ca_system_score_codex":0.000888941,"about_ca_system_score_gemma":0.00056216563,"threshold_uncertainty_score":0.9728546},"labels":[],"label_agreement":null},{"id":"W1513738801","doi":"10.1111/j.1464-410x.2010.09912.x","title":"Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Western University; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphadenectomy; Proportional hazards model; Multivariate analysis; Stage (stratigraphy); Internal medicine; Oncology; Perioperative; Cancer; Surgery; Urology","score_opus":0.009202427973896782,"score_gpt":0.2491611512424109,"score_spread":0.2399587232685141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1513738801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666643,0.0010080007,0.000008582799,0.00076427293,0.00017768319,0.00035393707,0.000112323025,0.000009159988,0.0008996102],"genre_scores_gemma":[0.99845356,0.00007374167,0.00018820308,0.0009521792,0.00008540904,0.00001548061,0.000010916111,0.000031338244,0.0001891879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987021,0.000057078338,0.00040665336,0.00019565992,0.00031844503,0.0003200684],"domain_scores_gemma":[0.99858063,0.000045162153,0.0002985608,0.00015651596,0.00043227582,0.00048685598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000644859,0.0001774908,0.0006496448,0.00014684873,0.00006752104,0.00001582643,0.00013714879,0.00014759948,0.0005488807],"category_scores_gemma":[0.0000537861,0.00013016516,0.00008505574,0.00012702394,0.00032678625,0.00013311852,0.000011439581,0.00047084785,0.000001770553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016941304,0.00032787124,0.9888559,0.000015715797,0.00058070605,0.0020636981,0.000426854,0.0000029870093,0.00008126101,0.0000021432586,0.001089584,0.004859153],"study_design_scores_gemma":[0.015463049,0.0021729034,0.97421306,0.0001455577,0.0003058545,0.0020700016,0.00013618417,0.000008839993,0.00023231143,0.0000023082318,0.0051120166,0.00013791023],"about_ca_topic_score_codex":0.06787438,"about_ca_topic_score_gemma":0.08745906,"teacher_disagreement_score":0.019584682,"about_ca_system_score_codex":0.00006672705,"about_ca_system_score_gemma":0.0011220198,"threshold_uncertainty_score":0.93833274},"labels":[],"label_agreement":null},{"id":"W1514274784","doi":"10.1111/j.1464-410x.2010.09217.x","title":"International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Western University; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Lymphovascular invasion; Cystectomy; Medicine; Hazard ratio; Bladder cancer; Urology; Proportional hazards model; Lymphadenectomy; Cohort; Lymph node; Oncology; Internal medicine; Stage (stratigraphy); Cancer; Metastasis; Surgery; Confidence interval; Biology","score_opus":0.0065671149833630505,"score_gpt":0.22662614563619535,"score_spread":0.2200590306528323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514274784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902487,0.00010487784,0.000027343955,0.00018058815,0.0002039833,0.00021158364,0.000008173218,0.0000020111086,0.00023657692],"genre_scores_gemma":[0.99961483,0.000045448825,0.00019143967,0.00006557638,0.000054850385,0.000003069172,0.000007755392,0.000008624119,0.000008406135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907726,0.00008963669,0.0003575233,0.00008090111,0.00031060132,0.000084106454],"domain_scores_gemma":[0.99928284,0.000042184998,0.00027477628,0.000087415276,0.00027132602,0.00004146755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017720074,0.000060063398,0.00023740876,0.00009672393,0.000014188636,0.000003995869,0.000113870694,0.00007881961,0.00006620689],"category_scores_gemma":[0.00022247927,0.000042775486,0.00008373154,0.0001222946,0.00011965905,0.00005516988,0.000019198467,0.0002040025,4.559395e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007746785,0.0006325438,0.9885247,0.000017425524,0.00015925459,0.00009352637,0.000050118455,0.00003038342,0.0021997143,0.000012334968,0.000030546664,0.0074748094],"study_design_scores_gemma":[0.009637647,0.0012265511,0.9796348,0.00015703612,0.00018395674,0.0020552024,0.0000056704666,0.00002445155,0.0068050344,0.00004236708,0.00019464924,0.00003260739],"about_ca_topic_score_codex":0.00019575316,"about_ca_topic_score_gemma":0.000030064703,"teacher_disagreement_score":0.008889838,"about_ca_system_score_codex":0.000028814286,"about_ca_system_score_gemma":0.0001447425,"threshold_uncertainty_score":0.17443337},"labels":[],"label_agreement":null},{"id":"W1521389561","doi":"10.1111/bju.12288","title":"Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Regionalisation; Logistic regression; Emergency medicine; Odds ratio; Odds; Bladder cancer; Retrospective cohort study; Observational study; Population; Healthcare Cost and Utilization Project; Adverse effect; Intensive care medicine; Surgery; Internal medicine; Cancer; Health care","score_opus":0.009701376313627486,"score_gpt":0.2446722691542755,"score_spread":0.234970892840648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521389561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979159,0.0006890113,0.0005642649,0.00023055334,0.000030661773,0.0004350959,0.000070289694,0.0000034227837,0.000060803253],"genre_scores_gemma":[0.9983173,0.00009643837,0.001159044,0.00018463511,0.000038761522,0.000037536323,0.0001432227,0.000010152138,0.000012888264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999091,0.00004239737,0.00041734785,0.00011165496,0.00021259057,0.00012499784],"domain_scores_gemma":[0.9986928,0.00011411136,0.00028223786,0.00006633832,0.00077108835,0.00007340459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006261669,0.00007411279,0.000411364,0.00030513032,0.000026015292,0.0000075161065,0.00004945597,0.00007227998,0.000082250386],"category_scores_gemma":[0.00012919687,0.000065847715,0.00012627551,0.0003013456,0.000051962335,0.00008143447,0.0000062022837,0.00009090031,4.718016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011630363,0.00042067692,0.9809976,0.00004789048,0.0005902322,0.000030223884,0.00033689794,0.00021134202,0.000017417793,0.000018736679,0.00011117612,0.016054753],"study_design_scores_gemma":[0.009098913,0.0046746423,0.9841413,0.00008510391,0.00086304283,0.0001711045,0.000077531986,0.00012362546,0.000082594095,0.00020227741,0.00042044252,0.000059457037],"about_ca_topic_score_codex":0.0020507912,"about_ca_topic_score_gemma":0.0011985941,"teacher_disagreement_score":0.015995296,"about_ca_system_score_codex":0.00008892327,"about_ca_system_score_gemma":0.00009181929,"threshold_uncertainty_score":0.31001964},"labels":[],"label_agreement":null},{"id":"W1524280720","doi":"10.1111/bju.12400","title":"Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Association Française d'Urologie","keywords":"Medicine; Urothelial carcinoma; Smoking cessation; Proportional hazards model; Cigarette smoking; Urology; Internal medicine; Surgery; Cancer; Bladder cancer","score_opus":0.013884849292573064,"score_gpt":0.2829796758114781,"score_spread":0.26909482651890504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524280720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963924,0.0027906536,0.000046484616,0.00015875252,0.00012968831,0.00023714252,0.000056515833,0.0000032882992,0.000185075],"genre_scores_gemma":[0.99889684,0.0003987754,0.0002668488,0.00018691704,0.00021208581,0.000006426956,0.0000032024027,0.000018389017,0.000010531319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985755,0.00016136277,0.00054738787,0.00016206918,0.00027091266,0.00028275076],"domain_scores_gemma":[0.9989734,0.00015347287,0.0003009635,0.00010289508,0.00022830152,0.00024091371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001373516,0.0001505598,0.0005913649,0.00013601831,0.00002239891,0.0000137036395,0.000070638445,0.00015249853,0.00061578315],"category_scores_gemma":[0.00014237515,0.00012526654,0.00021881517,0.00008004808,0.00027925253,0.00013014486,0.000020381838,0.00046916323,0.0000015001984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032498331,0.0005845941,0.9158532,0.000038455993,0.0003488969,0.00059100817,0.0006666834,0.0000055984833,0.0011563404,0.000010998714,0.00023131538,0.07726305],"study_design_scores_gemma":[0.0049250047,0.010589559,0.9780763,0.0001580946,0.00020343278,0.005125642,0.000026945683,0.000021574942,0.00041924106,0.00026990453,0.00009960697,0.0000847288],"about_ca_topic_score_codex":0.00069005234,"about_ca_topic_score_gemma":0.0000059073554,"teacher_disagreement_score":0.07717832,"about_ca_system_score_codex":0.0000592076,"about_ca_system_score_gemma":0.00024790104,"threshold_uncertainty_score":0.6742394},"labels":[],"label_agreement":null},{"id":"W1524595415","doi":"10.5489/cuaj.2722","title":"Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over time","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Referral; Confidence interval; Odds ratio; Chemotherapy; Cancer; Internal medicine; Cancer registry; Oncology; Surgery","score_opus":0.025093736701853758,"score_gpt":0.2978920794383193,"score_spread":0.2727983427364655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524595415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91571045,0.0006084781,0.00006740142,0.08112902,0.00033439754,0.001492392,0.00032357042,0.000013902773,0.00032040742],"genre_scores_gemma":[0.98056173,0.00019659197,0.0015166302,0.015747635,0.0010010395,0.00023237645,0.00002461763,0.000030097459,0.0006892525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998824,0.00006955603,0.00026598456,0.0001990978,0.00025821218,0.0003831504],"domain_scores_gemma":[0.9982529,0.0003142303,0.00020755074,0.00006779566,0.0003923268,0.0007651586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005810831,0.00013221269,0.00035033125,0.0001640373,0.00006764215,0.000025333009,0.000063885476,0.00021182703,0.00009419963],"category_scores_gemma":[0.0016802753,0.000103753715,0.000070313545,0.00013544121,0.000027573642,0.00008365299,0.000007789833,0.00019194715,0.000002087734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00731952,0.0005318642,0.817456,0.00007964097,0.0018606853,0.0001038406,0.0062666894,0.000081330734,0.0026096841,0.00012712873,0.118950024,0.044613604],"study_design_scores_gemma":[0.019647302,0.0051043676,0.6267242,0.00009207773,0.00050038064,0.000096030395,0.00033075872,0.00021028428,0.0004842397,0.00031611984,0.3462286,0.00026563313],"about_ca_topic_score_codex":0.0016296034,"about_ca_topic_score_gemma":0.003987998,"teacher_disagreement_score":0.22727859,"about_ca_system_score_codex":0.001101439,"about_ca_system_score_gemma":0.0010960029,"threshold_uncertainty_score":0.42309538},"labels":[],"label_agreement":null},{"id":"W1526147649","doi":"10.1111/j.1464-410x.2012.11133.x","title":"Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Beekeepers' Association; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Western University; Dalhousie University; McGill University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Dissection (medical); Lymph node; Urinary diversion; Cohort; Cancer; Regimen; Disease; Surgery; Urology; Oncology; Internal medicine","score_opus":0.03487971379893586,"score_gpt":0.32931788519050625,"score_spread":0.2944381713915704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526147649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8127996,0.12327355,0.003141646,0.047194593,0.009670685,0.0020544173,0.0010575224,0.000048669142,0.00075934647],"genre_scores_gemma":[0.9744441,0.0020301566,0.00032502957,0.01874312,0.003938238,0.00035241438,0.000009551199,0.000040618736,0.00011675055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777514,0.0001766515,0.0005878956,0.0002497667,0.00037593022,0.0008346102],"domain_scores_gemma":[0.99823177,0.00020160599,0.00026341606,0.00023240449,0.00053244573,0.000538356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005745386,0.00022530984,0.0004829608,0.00008658117,0.00024548767,0.000046768597,0.0002524794,0.00018207305,0.0011367237],"category_scores_gemma":[0.0002229468,0.00017632607,0.00021161005,0.00017170962,0.00020544656,0.000109957364,0.000019465877,0.0004600785,0.0000050819003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019953276,0.00022150457,0.8232058,0.000048786627,0.00046255658,0.0005661404,0.00047028402,0.0011169749,0.000015927753,0.000015654194,0.0777958,0.0940852],"study_design_scores_gemma":[0.005003,0.0010419032,0.6620417,0.00043152983,0.00034648896,0.0027534137,0.00005757837,0.0007756221,0.0000646165,0.000042670134,0.32710075,0.00034073734],"about_ca_topic_score_codex":0.044096105,"about_ca_topic_score_gemma":0.1752647,"teacher_disagreement_score":0.24930495,"about_ca_system_score_codex":0.00024653508,"about_ca_system_score_gemma":0.0011062474,"threshold_uncertainty_score":0.99977636},"labels":[],"label_agreement":null},{"id":"W1529024368","doi":"10.1111/bju.12150","title":"Effect of statin use on outcomes of non‐muscle‐invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Statin; Interquartile range; Bladder cancer; Internal medicine; Clinical endpoint; Retrospective cohort study; Disease; Cancer; Oncology; Surgery; Urology; Clinical trial","score_opus":0.012918895181284236,"score_gpt":0.2922241074202836,"score_spread":0.27930521223899935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1529024368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972406,0.0011465516,0.000027995797,0.0005623272,0.00029339592,0.00032433204,0.000060476992,0.000004032995,0.0003403],"genre_scores_gemma":[0.9975587,0.0009986721,0.00016156853,0.000869517,0.0001010951,0.000016507094,0.0000028312388,0.000022243157,0.00026884663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876136,0.00015085559,0.00050555484,0.000121768106,0.00026118368,0.00019928593],"domain_scores_gemma":[0.9984951,0.00049901474,0.0004244468,0.00012697613,0.00033182238,0.00012262071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001733573,0.00013071236,0.0007224296,0.000120468474,0.000020899693,0.000008899649,0.000094699644,0.00009828991,0.00083883497],"category_scores_gemma":[0.00031009695,0.0001064055,0.00020944208,0.00007827711,0.0001208591,0.000108226544,0.000018688153,0.00024181882,0.000010297803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002345514,0.0010245774,0.62691826,0.0003244766,0.0027538212,0.0013858849,0.000498852,0.00014988649,0.019994723,0.000012358708,0.01859546,0.32599616],"study_design_scores_gemma":[0.006881347,0.010455968,0.9677302,0.00020252993,0.0005846669,0.00079861993,0.000024252977,0.00000863107,0.012811554,0.000049998274,0.00037016158,0.00008202994],"about_ca_topic_score_codex":0.0023666427,"about_ca_topic_score_gemma":0.00013040382,"teacher_disagreement_score":0.34081197,"about_ca_system_score_codex":0.000035534824,"about_ca_system_score_gemma":0.00017174127,"threshold_uncertainty_score":0.9184655},"labels":[],"label_agreement":null},{"id":"W1532789289","doi":"10.5489/cuaj.777","title":"Update on the management of non-muscle invasive bladder cancer","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Urology; General surgery; Internal medicine","score_opus":0.015717069919531985,"score_gpt":0.24589699249198527,"score_spread":0.2301799225724533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1532789289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52223825,0.00806467,0.000035547473,0.42313477,0.0045826174,0.0013640099,0.00032149206,0.000014369613,0.040244244],"genre_scores_gemma":[0.9604715,0.0056692115,0.00007963923,0.022320393,0.0012126275,0.00009569564,0.000009501411,0.000022557935,0.010118871],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978059,0.00022833743,0.00044159274,0.00022577125,0.0005051414,0.0007932848],"domain_scores_gemma":[0.99808174,0.00021482143,0.00038166996,0.00019396549,0.00036683684,0.0007609359],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004728743,0.00022708252,0.00032846865,0.00010891472,0.0003113797,0.000096845186,0.00024372693,0.00027790203,0.028087236],"category_scores_gemma":[0.00010734151,0.00014934334,0.00020429869,0.00027343322,0.00009225847,0.000122017766,0.000026771533,0.00069816655,0.0013427705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008679647,0.00046345577,0.22271655,0.00010090213,0.0058095367,0.00042747494,0.00084945984,0.00035696517,0.00016709174,0.0050882194,0.6081005,0.1558331],"study_design_scores_gemma":[0.0015472701,0.00057799,0.8656786,0.00027957073,0.0006952909,0.000024034402,0.00054004235,0.000108850756,0.00013765995,0.0026430094,0.12757944,0.00018823023],"about_ca_topic_score_codex":0.014254992,"about_ca_topic_score_gemma":0.0017974802,"teacher_disagreement_score":0.64296204,"about_ca_system_score_codex":0.002069281,"about_ca_system_score_gemma":0.00078828033,"threshold_uncertainty_score":0.9994348},"labels":[],"label_agreement":null},{"id":"W1537858404","doi":"10.1111/j.1464-410x.2010.09902.x","title":"Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Western University; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Cystectomy; Lymphovascular invasion; Medicine; Bladder cancer; Proportional hazards model; Hazard ratio; Urology; Internal medicine; Oncology; Stage (stratigraphy); Lymph node; Pathological; Adjuvant therapy; Surgery; Cancer; Confidence interval; Metastasis","score_opus":0.011692470887926009,"score_gpt":0.27737149794255195,"score_spread":0.2656790270546259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1537858404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946037,0.0033220095,0.00036313286,0.0005458292,0.0004319625,0.00025482528,0.000099054894,0.000011053299,0.0003684455],"genre_scores_gemma":[0.9973995,0.0008364736,0.00088679447,0.00029746944,0.00039926582,0.00003006927,0.0000051856287,0.000016529859,0.0001287176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871105,0.00013458915,0.00051588117,0.00017126478,0.00025674526,0.00021047369],"domain_scores_gemma":[0.9989762,0.00008943333,0.00036468977,0.00013562448,0.0002680348,0.00016602663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002961893,0.00011130791,0.00039311405,0.00007866443,0.000038643437,0.000014661179,0.00010317922,0.00021050413,0.0016561897],"category_scores_gemma":[0.0002966215,0.00009690253,0.00014469207,0.00007528691,0.0002771055,0.00007114049,0.000017489208,0.00076913956,0.000006514786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002771171,0.0015885705,0.8285547,0.000095774485,0.0005852956,0.006718723,0.0003422055,0.000018610492,0.022080278,0.00008022801,0.0010392226,0.13612524],"study_design_scores_gemma":[0.0035538734,0.0018001868,0.9798613,0.00005108986,0.0005669039,0.009042713,0.000025631702,0.000027765635,0.00091539655,0.00029098106,0.0037701663,0.000093961266],"about_ca_topic_score_codex":0.0001557062,"about_ca_topic_score_gemma":0.0002380935,"teacher_disagreement_score":0.15130664,"about_ca_system_score_codex":0.000019297097,"about_ca_system_score_gemma":0.0002538907,"threshold_uncertainty_score":0.99925643},"labels":[],"label_agreement":null},{"id":"W1538023901","doi":"10.1111/j.1464-410x.2011.10357.x","title":"Survival after radical cystectomy of non‐bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing‐risks analysis","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Carcinoma; Epidemiology; Carcinoma in situ; Pathological; Urology; Proportional hazards model; Urothelial carcinoma; Biology","score_opus":0.022490568600568858,"score_gpt":0.2600897445501569,"score_spread":0.23759917594958802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1538023901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257445,0.002750053,0.00060166937,0.00010336817,0.0005587163,0.0002677282,0.00009999096,0.000012658797,0.003031337],"genre_scores_gemma":[0.99805695,0.00006353221,0.00074643147,0.0003265393,0.0006417908,0.0000132370515,0.000009286798,0.000045006316,0.00009724053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735546,0.00032467768,0.0010118324,0.00033142482,0.000498853,0.00047776036],"domain_scores_gemma":[0.99830514,0.000119819,0.00053748436,0.00027787487,0.00039067506,0.00036900453],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046082766,0.00025899208,0.0012948468,0.0004239361,0.000066111024,0.000016215414,0.00026892795,0.00026087475,0.0015391088],"category_scores_gemma":[0.00008652103,0.0002584674,0.00077367324,0.00039080463,0.00033750187,0.000084113984,0.000071094466,0.00061465346,0.000015564798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010594286,0.0015036905,0.9685078,0.00011880274,0.00087014976,0.013069698,0.0010725834,0.000011724172,0.00157107,0.0000047614326,0.00023726256,0.002438143],"study_design_scores_gemma":[0.012930572,0.0049103242,0.9667989,0.000024254714,0.0048679854,0.0066840174,0.00011189233,0.00007292415,0.0029038065,0.000028724333,0.0004589841,0.00020762302],"about_ca_topic_score_codex":0.003220987,"about_ca_topic_score_gemma":0.0002465055,"teacher_disagreement_score":0.0063856808,"about_ca_system_score_codex":0.00007327872,"about_ca_system_score_gemma":0.0003946301,"threshold_uncertainty_score":0.99998677},"labels":[],"label_agreement":null},{"id":"W1540985757","doi":"10.1002/cncy.21449","title":"The value of the “suspicious for urothelial carcinoma” cytology category: A correlative study of 4 years including 337 patients","year":2014,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Medical diagnosis; Cytology; Biopsy; Urine cytology; Urothelial carcinoma; Radiology; Carcinoma; Cancer; Bladder cancer; Internal medicine; Pathology","score_opus":0.02381806343040816,"score_gpt":0.3070032535674166,"score_spread":0.28318519013700844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540985757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959245,0.0002744711,0.00016871719,0.00024416327,0.0011178618,0.0016853316,0.00006162372,0.000013242484,0.0005101361],"genre_scores_gemma":[0.99893856,0.000019671506,0.000040313924,0.0002651385,0.0001509498,0.0003766425,0.000004487232,0.000030296615,0.0001739574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985902,0.0002641473,0.00038531693,0.0002849066,0.00019178553,0.00028367783],"domain_scores_gemma":[0.99869347,0.00025874667,0.00031344063,0.0004575758,0.00022746673,0.00004928111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024091743,0.00016442094,0.00049050484,0.000057050423,0.00016406758,0.0000032938078,0.0002083247,0.000107786946,0.000010681895],"category_scores_gemma":[0.00020605681,0.00009841232,0.0001301721,0.00015282109,0.0003258903,0.000021239433,0.00011933142,0.000170632,0.000001919934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011787311,0.00047362133,0.98378295,0.00004549544,0.00012841116,0.000006122873,0.005843956,0.00004679964,0.0014762308,0.0011765352,0.00021575397,0.0056253998],"study_design_scores_gemma":[0.009067321,0.004397518,0.97981286,0.000032757613,0.000496731,0.00001981406,0.00075912103,0.00013445146,0.0032818026,0.0007851439,0.0011028837,0.0001096215],"about_ca_topic_score_codex":0.00072005164,"about_ca_topic_score_gemma":0.00034123333,"teacher_disagreement_score":0.00788859,"about_ca_system_score_codex":0.00012316174,"about_ca_system_score_gemma":0.00022354833,"threshold_uncertainty_score":0.40131378},"labels":[],"label_agreement":null},{"id":"W1543120166","doi":"10.1111/j.1464-410x.2011.10371.x","title":"Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Smoking cessation; Cancer; Internal medicine; Cohort; Oncology; Pathology","score_opus":0.025994782223019427,"score_gpt":0.27593919371191616,"score_spread":0.24994441148889673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543120166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895259,0.0070867045,0.00005224923,0.00059714075,0.0004282506,0.00025608653,0.000023286984,0.000017011696,0.0020133464],"genre_scores_gemma":[0.99302834,0.004287603,0.00026394232,0.001450244,0.00015451315,0.000060256247,0.0000017084394,0.000038415954,0.00071495946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998394,0.00008981949,0.00050349685,0.00026625162,0.00031108706,0.00043532066],"domain_scores_gemma":[0.9990907,0.000050558785,0.00031124378,0.00014002805,0.00018968711,0.00021781008],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013121673,0.00022414612,0.00077687815,0.00017894327,0.000055077468,0.0000170989,0.0001700735,0.0001474613,0.0017979142],"category_scores_gemma":[0.0000333181,0.00017953894,0.00012905299,0.00017642592,0.00026529393,0.00020330156,0.000026471083,0.0005101946,0.0000032192206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008397645,0.00031724662,0.95639646,0.000016137086,0.0008105047,0.002263015,0.00076414016,0.000018215427,0.000041355954,0.000006027999,0.00045311535,0.03807403],"study_design_scores_gemma":[0.0064040693,0.0014018926,0.9888903,0.00014917937,0.00044200427,0.0014809833,0.00029414604,0.00001013379,0.0002187258,0.00013165649,0.0003935693,0.00018332445],"about_ca_topic_score_codex":0.0073191244,"about_ca_topic_score_gemma":0.009344993,"teacher_disagreement_score":0.03789071,"about_ca_system_score_codex":0.00009969631,"about_ca_system_score_gemma":0.000358573,"threshold_uncertainty_score":0.99929124},"labels":[],"label_agreement":null},{"id":"W1543756079","doi":"10.1111/j.1464-410x.2012.10993.x","title":"Marital status: a gender‐independent risk factor for poorer survival after radical cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Proportional hazards model; Oncology; Logistic regression; Marital status; Epidemiology; Prostate cancer; Cancer; Cohort; Internal medicine; Disease; Gynecology; Population","score_opus":0.020243381162019222,"score_gpt":0.27947888629572876,"score_spread":0.2592355051337095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543756079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800754,0.0151803205,0.001544406,0.00026979897,0.001446387,0.00037958106,0.00054949697,0.000016091977,0.0005384736],"genre_scores_gemma":[0.99591017,0.0007397277,0.0010081095,0.0006476608,0.0015056835,0.000023187742,0.000008179319,0.0000397889,0.00011749419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825025,0.00015379935,0.0004606559,0.00016341246,0.00035164403,0.00062026334],"domain_scores_gemma":[0.99885345,0.0001241098,0.00022153142,0.00011473485,0.00017771694,0.0005084345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003351349,0.00015949324,0.00049245416,0.00010315049,0.00006532116,0.000026147034,0.000088895744,0.00019408896,0.0012528554],"category_scores_gemma":[0.00018309226,0.00015009721,0.0003128996,0.000056091572,0.00009829794,0.00016279175,0.00003317017,0.00047657388,0.000018290368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005638847,0.0010302035,0.8822361,0.00007175077,0.0012152266,0.001723517,0.00060536293,0.0000016296381,0.00019470573,0.000024335033,0.0013056844,0.10595262],"study_design_scores_gemma":[0.009448085,0.0014992483,0.94344014,0.000024251045,0.0006104038,0.01430759,0.00007619677,0.0000049075634,0.000068422334,0.00017351493,0.030210033,0.00013721734],"about_ca_topic_score_codex":0.00013433846,"about_ca_topic_score_gemma":0.00004397628,"teacher_disagreement_score":0.1058154,"about_ca_system_score_codex":0.00010741607,"about_ca_system_score_gemma":0.0002054717,"threshold_uncertainty_score":0.99966013},"labels":[],"label_agreement":null},{"id":"W1548161421","doi":"10.1111/j.1464-410x.2012.11325.x","title":"Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"University of Texas MD Anderson Cancer Center","keywords":"Cystectomy; Lymph node; Medicine; Clinical trial; Adjuvant; General surgery; Bladder cancer; Oncology; Internal medicine; Cancer","score_opus":0.06916742383594417,"score_gpt":0.36441092417653986,"score_spread":0.2952435003405957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548161421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92163765,0.05224469,0.024527444,0.0003195197,0.00045671122,0.00074402546,0.000059257207,0.0000056710855,0.0000050001136],"genre_scores_gemma":[0.9829815,0.0035443632,0.01191342,0.0007876115,0.00067160197,0.00007104924,0.000003903872,0.000021345746,0.0000051969496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791914,0.00037041836,0.0011550852,0.00013202315,0.00015608816,0.00026722142],"domain_scores_gemma":[0.99763066,0.0012143767,0.00059895666,0.00006159478,0.00030572026,0.00018868325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029913841,0.000109605746,0.000984648,0.00006028116,0.000054891745,0.000012908374,0.00004534194,0.00016190941,0.000019902283],"category_scores_gemma":[0.0007025669,0.00009273047,0.00035438422,0.000030827392,0.00015552982,0.000076654505,0.000008385029,0.00013743344,2.5211085e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020657752,0.0013814415,0.5590639,0.00031450446,0.0017384811,0.00016735269,0.0012049619,0.000003521808,0.0020720772,0.000021923837,0.0009529777,0.4124211],"study_design_scores_gemma":[0.05755824,0.012947719,0.87631375,0.0012117319,0.005727573,0.015515758,0.00030020074,0.00021202282,0.006212378,0.0012589276,0.022322074,0.0004196444],"about_ca_topic_score_codex":0.000015197046,"about_ca_topic_score_gemma":0.0000031547052,"teacher_disagreement_score":0.4120015,"about_ca_system_score_codex":0.000020621057,"about_ca_system_score_gemma":0.0001153546,"threshold_uncertainty_score":0.37814388},"labels":[],"label_agreement":null},{"id":"W1549792929","doi":"10.1111/j.1464-410x.2009.09100.x","title":"Pathological stage review is indicated in primary pT1 bladder cancer","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Erasmus+","keywords":"Medicine; Stage (stratigraphy); Bladder cancer; Pathological; Carcinoma in situ; Disease; Multivariate analysis; Cancer; Internal medicine; Oncology; Surgery","score_opus":0.01810942963423697,"score_gpt":0.3032593201821607,"score_spread":0.2851498905479237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549792929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.893888,0.093982,0.00001564273,0.008250474,0.0005070875,0.00031969757,0.000056688514,0.000013955469,0.0029664813],"genre_scores_gemma":[0.8732903,0.089951076,0.0003395884,0.035476454,0.00033571132,0.000021103815,0.000010132189,0.000023381715,0.0005522719],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987346,0.00009487108,0.0005175285,0.0001757481,0.00022225543,0.00025500832],"domain_scores_gemma":[0.9992924,0.000037236918,0.0002468619,0.00012478667,0.00013957628,0.00015914622],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037328966,0.00011412761,0.00056111004,0.00009682013,0.000028856246,0.000009947714,0.00013269261,0.00018623084,0.0040982193],"category_scores_gemma":[0.00012837867,0.0001020226,0.00012935603,0.00016171469,0.0001263543,0.000070750815,0.00003204669,0.0009963112,0.000018436955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012041315,0.0019296732,0.37715065,0.0007466948,0.00053635956,0.039966963,0.0002769943,0.0000021836986,0.010684529,0.000030470206,0.07269413,0.49477723],"study_design_scores_gemma":[0.0044904673,0.0009618446,0.8828875,0.00055528514,0.0003177663,0.021650122,0.000007492202,0.0000020299806,0.00018781974,0.00011815316,0.08868841,0.00013311824],"about_ca_topic_score_codex":0.00015773192,"about_ca_topic_score_gemma":0.0001293789,"teacher_disagreement_score":0.5057368,"about_ca_system_score_codex":0.00004671183,"about_ca_system_score_gemma":0.00033176702,"threshold_uncertainty_score":0.99681216},"labels":[],"label_agreement":null},{"id":"W1551078947","doi":"10.1155/2000/409570","title":"Hepatitis in Disseminated Bacillus Calmette-Guérin Infection","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"AstraZeneca Canada","keywords":"Medicine; Lethargy; Surgery; Hepatitis; Internal medicine","score_opus":0.009310134395453248,"score_gpt":0.24321884800604882,"score_spread":0.23390871361059556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551078947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965625,0.00012323713,0.000026565744,0.0014339933,0.00024009332,0.000096161384,0.000014819326,0.0000036982406,0.001498953],"genre_scores_gemma":[0.998123,0.00017145692,0.00007312187,0.001040744,0.00011570344,0.0000035172097,0.000007578965,0.000012146994,0.0004527466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914753,0.000063340536,0.00029821644,0.00009717959,0.00007507558,0.00031862545],"domain_scores_gemma":[0.99932665,0.000008772246,0.00006438804,0.00009125771,0.000063318774,0.0004456463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009632411,0.000099124794,0.00028399122,0.00032611718,0.00003060969,0.000008193473,0.000052317333,0.00006670368,0.0023570682],"category_scores_gemma":[0.000023330744,0.00008927468,0.00008152575,0.00011643592,0.000066822235,0.000067501685,0.0000021259048,0.00023351086,0.000027405973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047734418,0.000038916656,0.9828368,0.0000071522004,0.000056312798,0.0013808258,0.00012110404,0.000019092302,0.000073061114,0.0000030221229,0.0014136039,0.013572798],"study_design_scores_gemma":[0.0029085793,0.0029097733,0.98290634,0.00008083961,0.000057701916,0.0028386076,0.000009306304,0.000014518069,0.000092571325,0.00003500982,0.008107113,0.00003964753],"about_ca_topic_score_codex":0.036978073,"about_ca_topic_score_gemma":0.2599793,"teacher_disagreement_score":0.22300124,"about_ca_system_score_codex":0.00030421317,"about_ca_system_score_gemma":0.00030632218,"threshold_uncertainty_score":0.9985549},"labels":[],"label_agreement":null},{"id":"W1553009243","doi":"10.5489/cuaj.2708","title":"Intravesical bacillus Calmette-Guérin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Propensity score matching; Hazard ratio; Odds ratio; Confidence interval; Internal medicine; Urology; Proportional hazards model; Adjuvant; Retrospective cohort study; Clinical endpoint; Gastroenterology; Cancer; Oncology; Surgery; Randomized controlled trial","score_opus":0.028395882977136366,"score_gpt":0.2692782001644782,"score_spread":0.24088231718734182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553009243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96591455,0.00041495715,0.00022571703,0.028259004,0.0020151846,0.00062880846,0.0004168738,0.000040457762,0.0020844643],"genre_scores_gemma":[0.9909744,0.00017427956,0.00048244538,0.004963674,0.0023887444,0.0000882157,0.000048965157,0.000034189565,0.00084503816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980133,0.00011120972,0.00036656274,0.00031167667,0.0004632418,0.0007339717],"domain_scores_gemma":[0.997037,0.00028671342,0.00026488444,0.00014982355,0.000598593,0.0016630216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047896733,0.00024384528,0.00044739354,0.00013419808,0.00027077566,0.000078620964,0.00014789273,0.00039469104,0.0006707398],"category_scores_gemma":[0.0015346342,0.00018948175,0.00020354698,0.00019703362,0.000050549595,0.00010420621,0.000015632037,0.0006371001,0.00009102555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004159272,0.000488352,0.59344,0.00003133922,0.0036819826,0.0006429485,0.0015939787,0.00036413444,0.000606199,0.00033537665,0.25942016,0.13523631],"study_design_scores_gemma":[0.036084194,0.0059629926,0.79729915,0.00004396054,0.001772082,0.00016677736,0.000483089,0.0004065192,0.000867942,0.0023932932,0.1537726,0.00074737193],"about_ca_topic_score_codex":0.009541287,"about_ca_topic_score_gemma":0.0074892887,"teacher_disagreement_score":0.20385921,"about_ca_system_score_codex":0.003003456,"about_ca_system_score_gemma":0.002594237,"threshold_uncertainty_score":0.9970543},"labels":[],"label_agreement":null},{"id":"W1556453357","doi":"10.1111/j.1464-410x.2010.09212.x","title":"Evaluation of fluorodeoxyglucose positron‐emission tomography with computed tomography for staging of urothelial carcinoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Positron emission tomography; Computed tomography; Nuclear medicine; Medicine; Fluorodeoxyglucose; Positron Emission Tomography-Computed Tomography; Urothelial carcinoma; Radiology; Positron emission; Tomography; Cancer; Bladder cancer; Internal medicine","score_opus":0.01477868094443591,"score_gpt":0.27373437911427284,"score_spread":0.25895569816983693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1556453357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994278,0.0024953599,0.0017901681,0.0002037612,0.00038620192,0.0005390503,0.000067017056,0.000007820337,0.00023260825],"genre_scores_gemma":[0.9953155,0.00003914154,0.0042474256,0.00010700093,0.00023571345,0.000010751968,0.000013520725,0.000024226518,0.0000067409787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838656,0.00012819121,0.00052704726,0.00016302844,0.00059240044,0.00020277008],"domain_scores_gemma":[0.9974638,0.00008001958,0.0004931315,0.00015198858,0.0016754947,0.00013551438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008981927,0.000127643,0.00049266126,0.00031075318,0.000050597115,0.000008769234,0.000120938326,0.00012028283,0.00006961785],"category_scores_gemma":[0.00009146977,0.00011586267,0.00024438894,0.00022224338,0.0001599192,0.00008531824,0.000015716232,0.0002868025,1.4604059e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008910893,0.0020357524,0.34263512,0.00029924233,0.0017091425,0.00022363069,0.00056302216,0.00015011473,0.356924,0.00007262758,0.0010396962,0.28543675],"study_design_scores_gemma":[0.031182695,0.013197253,0.83078414,0.00037773894,0.0045005674,0.005626126,0.00009066719,0.001365177,0.11066958,0.0011488067,0.00081044104,0.00024677764],"about_ca_topic_score_codex":0.00013075657,"about_ca_topic_score_gemma":0.000047205882,"teacher_disagreement_score":0.48814902,"about_ca_system_score_codex":0.000019648287,"about_ca_system_score_gemma":0.0004297064,"threshold_uncertainty_score":0.47247425},"labels":[],"label_agreement":null},{"id":"W1558255535","doi":"10.1158/1538-7445.am2014-3958","title":"Abstract 3958: Investigation of HMGB1 as a potential marker for radiation response in muscle invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Comet assay; Clonogenic assay; Gene knockdown; DNA damage; Cancer research; DNA repair; Bladder cancer; HMGB1; Small hairpin RNA; Cell culture; Medicine; Biology; Cancer; Pathology; Immunology; Internal medicine; DNA; Genetics","score_opus":0.0627725174592787,"score_gpt":0.400404244669854,"score_spread":0.3376317272105753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558255535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935853,0.001124133,0.000042656236,0.0030118013,0.00018203088,0.0013285005,0.00008122352,0.000016239766,0.000628116],"genre_scores_gemma":[0.9964991,0.00054839085,0.00008955815,0.0003490124,0.00035240263,0.0011645219,0.000036145553,0.00003876429,0.00092210644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980804,0.00025823878,0.0003100487,0.00035838102,0.00058342464,0.00040954226],"domain_scores_gemma":[0.9985472,0.0004494444,0.00008920493,0.00028030257,0.00045344763,0.00018038026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013705126,0.00013396137,0.00026960394,0.00036849207,0.00008593486,0.000021406226,0.000115446885,0.00013494627,0.000861922],"category_scores_gemma":[0.0006725472,0.00012104183,0.00008388064,0.0004369072,0.00017728654,0.00013207144,0.000033020606,0.00026613788,0.000021390346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024325814,0.00024937507,0.0653147,0.00076080597,0.00028432766,0.000028099133,0.0027583495,0.00029941034,0.8027664,0.0001409685,0.009766908,0.093304835],"study_design_scores_gemma":[0.005554013,0.0008752021,0.84987336,0.00039081567,0.000058590653,0.0000026123544,0.00022697139,0.0002101698,0.13750683,0.0011611086,0.004001523,0.00013879614],"about_ca_topic_score_codex":0.005571242,"about_ca_topic_score_gemma":0.0008621341,"teacher_disagreement_score":0.78455865,"about_ca_system_score_codex":0.00051859376,"about_ca_system_score_gemma":0.0017195668,"threshold_uncertainty_score":0.9437441},"labels":[],"label_agreement":null},{"id":"W1558486292","doi":"10.1002/cncr.28235","title":"Higher surgeon and hospital volume improves long‐term survival after radical cystectomy","year":2013,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cystectomy; Confidence interval; Proportional hazards model; Bladder cancer; Volume (thermodynamics); Surgery; Hazard ratio; Emergency medicine; Cancer; Internal medicine","score_opus":0.00937691130778203,"score_gpt":0.25620451301397895,"score_spread":0.24682760170619691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558486292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880416,0.0058516874,0.000011303332,0.0020688956,0.0010580394,0.00054684456,0.000024895424,0.000060093924,0.0015740939],"genre_scores_gemma":[0.9846185,0.00026750294,0.00003635659,0.00063211075,0.0006700602,0.00046537528,0.00000994063,0.000036317066,0.013263879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990253,0.000019163665,0.00015229528,0.00030590958,0.00019341896,0.00030394646],"domain_scores_gemma":[0.9994264,0.000014843723,0.000034978337,0.00021028797,0.00006728219,0.00024618115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000032451593,0.00018295713,0.00028448534,0.000038120455,0.000038479855,0.000039469174,0.0000466832,0.00010229669,0.0052780854],"category_scores_gemma":[0.000005832816,0.00013751794,0.000075168646,0.000071133065,0.00013481487,0.00013354805,0.000036748446,0.00013082224,0.0001534764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017515484,0.00010939916,0.9567017,0.00010694209,0.00019058662,0.00007759969,0.0001622042,3.6563637e-8,0.0010063356,0.000007436505,0.0039322344,0.037530355],"study_design_scores_gemma":[0.002291922,0.0002671413,0.98506624,0.00007730405,0.00013507616,0.000009771374,0.0000101315945,0.000004470309,0.00048263423,0.000025920795,0.011456622,0.00017277914],"about_ca_topic_score_codex":0.0010530729,"about_ca_topic_score_gemma":0.00004252029,"teacher_disagreement_score":0.037357576,"about_ca_system_score_codex":0.00010443423,"about_ca_system_score_gemma":0.00009218952,"threshold_uncertainty_score":0.9956312},"labels":[],"label_agreement":null},{"id":"W1560239325","doi":"10.1111/j.1464-410x.2010.09628.x","title":"Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Montréal; McGill University Health Centre; Université Laval","funders":"","keywords":"Cystectomy; Medicine; Stage (stratigraphy); Cohort; Pathological staging; Bladder cancer; Pathological; Lymphadenectomy; Surgery; Retrospective cohort study; Urology; Cancer; Internal medicine","score_opus":0.05609797425825214,"score_gpt":0.36505485841957425,"score_spread":0.3089568841613221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1560239325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988049,0.00019773371,0.00007412463,0.00018070791,0.00018003116,0.00021207002,0.00003392687,0.000003941793,0.00031252363],"genre_scores_gemma":[0.99899286,0.00024184605,0.00038219837,0.00010302526,0.00025097473,0.0000049141986,0.0000040127643,0.000008599736,0.000011581194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985381,0.00034531162,0.00059958495,0.00015447564,0.0002334222,0.00012915849],"domain_scores_gemma":[0.9993305,0.000076857876,0.0002805955,0.000090088375,0.000100648045,0.000121313555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063040113,0.00008608828,0.00037856004,0.00007213806,0.0000225204,0.000011062673,0.00014940024,0.00013014284,0.00018799365],"category_scores_gemma":[0.00019056421,0.000056962563,0.00014975166,0.000058923517,0.00024688878,0.00010903218,0.00003693071,0.0004326642,8.473332e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010327783,0.00062580203,0.9785199,0.0000042208258,0.00011033752,0.00066677114,0.00007412132,0.0000014715608,0.000042905736,0.00001989457,0.000014141944,0.018887613],"study_design_scores_gemma":[0.0032212802,0.0040208423,0.9885334,0.00008285036,0.00012299967,0.0032473232,0.000011554483,0.000010927013,0.00030485264,0.0003765442,0.000023634693,0.00004379486],"about_ca_topic_score_codex":0.00012665828,"about_ca_topic_score_gemma":0.0000088459055,"teacher_disagreement_score":0.018843818,"about_ca_system_score_codex":0.00002790641,"about_ca_system_score_gemma":0.000091206995,"threshold_uncertainty_score":0.23228659},"labels":[],"label_agreement":null},{"id":"W1563710078","doi":"10.1186/1753-6561-9-s1-a37","title":"Comparing extended and standard lymphadenectomy surgeries for bladder cancer (complications, final outcomes and effects of neoadjuvant chemotherapy)","year":2015,"lang":"en","type":"article","venue":"BMC Proceedings","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Lymphadenectomy; Neoadjuvant therapy; Oncology; General surgery; Urology; Internal medicine; Surgery; Cancer; Breast cancer","score_opus":0.05949515888229637,"score_gpt":0.33115199029508685,"score_spread":0.2716568314127905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563710078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917391,0.0054192496,0.00036103214,0.00071015547,0.00007449287,0.00094561244,0.000018596402,0.000052086645,0.0006796502],"genre_scores_gemma":[0.99521255,0.00027308843,0.0034654264,0.00029043655,0.000060050366,0.0002881846,0.0000044338476,0.00002615255,0.00037967874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922055,0.0000034729358,0.0001895594,0.00024017357,0.00016934988,0.00017690517],"domain_scores_gemma":[0.99939394,0.00006679979,0.000094978204,0.00007025795,0.00022866839,0.00014537181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010007375,0.00015804215,0.00043737545,0.000066430664,0.000056185032,0.000026695618,0.000039559443,0.000048987593,0.0000043193318],"category_scores_gemma":[0.00006910611,0.0001224249,0.000047348167,0.0000761339,0.00009884203,0.00010392492,0.00002620949,0.000036375768,3.220447e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010639026,0.00008829677,0.98095053,0.0008872563,0.00019847247,6.8446496e-7,0.0009271025,1.9436374e-7,0.0017289751,0.00044321938,0.001585064,0.012126288],"study_design_scores_gemma":[0.01360912,0.00065525644,0.9491001,0.00030529365,0.00037129456,0.00003320182,0.00034289688,0.00016328794,0.029315608,0.00077569584,0.00512983,0.0001984293],"about_ca_topic_score_codex":0.00009131663,"about_ca_topic_score_gemma":0.0000144916485,"teacher_disagreement_score":0.031850457,"about_ca_system_score_codex":0.00005796637,"about_ca_system_score_gemma":0.00016006053,"threshold_uncertainty_score":0.49923423},"labels":[],"label_agreement":null},{"id":"W1566673280","doi":"10.1002/cncy.21477","title":"Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution","year":2014,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cytology; Medicine; Malignancy; Urine cytology; Concordance; Biopsy; Atypia; Internal medicine; Cancer; Pathology; Bladder cancer","score_opus":0.012271484961973835,"score_gpt":0.29223918154849843,"score_spread":0.2799676965865246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566673280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903187,0.005844182,0.0019586566,0.0004702496,0.00030132968,0.0006285359,0.00016837537,0.000021916865,0.0002880394],"genre_scores_gemma":[0.99467707,0.0038943957,0.00028537173,0.00033407955,0.00013562622,0.0005061961,0.00003358166,0.000016596792,0.00011707362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990173,0.00008625418,0.00026837605,0.00029474605,0.00005677739,0.00027656683],"domain_scores_gemma":[0.99919665,0.0003432753,0.00013065532,0.0002027595,0.00006181351,0.000064874366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016835898,0.00014356614,0.00042644018,0.0001072344,0.000060476883,0.0000023322323,0.000049613685,0.00012597584,0.000054498636],"category_scores_gemma":[0.0005989796,0.00012066529,0.00004988362,0.00008511989,0.00017365975,0.00005376781,0.000055983593,0.00009585284,0.0000036060114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049085444,0.00012436736,0.98504657,0.00020290792,0.000034834015,0.00004960736,0.00047573345,0.000006837331,0.0016849963,0.0013279584,0.00009933432,0.010455988],"study_design_scores_gemma":[0.00651153,0.0007163444,0.9757858,0.00010376561,0.00028904722,0.00019981597,0.00003284184,0.00009255036,0.009013726,0.0015658176,0.005565723,0.00012306105],"about_ca_topic_score_codex":0.0003852427,"about_ca_topic_score_gemma":0.0013836084,"teacher_disagreement_score":0.010332927,"about_ca_system_score_codex":0.00010565675,"about_ca_system_score_gemma":0.00011096001,"threshold_uncertainty_score":0.49205878},"labels":[],"label_agreement":null},{"id":"W1569152004","doi":"10.1111/j.1464-410x.2012.11401.x","title":"Demographic analysis of randomized controlled trials in bladder cancer","year":2012,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; McGill University","funders":"","keywords":"Randomized controlled trial; Medicine; Blinding; Clinical trial; Bladder cancer; MEDLINE; Psychological intervention; Cancer; Internal medicine; Psychiatry","score_opus":0.05710262849381695,"score_gpt":0.3746219536095064,"score_spread":0.3175193251156895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1569152004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000246802,0.9964441,0.0000552677,0.00009309554,0.0006312185,0.002070525,0.00012413334,0.0000046895666,0.00033014122],"genre_scores_gemma":[0.004958025,0.9937975,0.00006612854,0.00017259746,0.0005590422,0.00025002507,0.00003282055,0.000041498395,0.0001224028],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9873006,0.0056003607,0.0060728816,0.0002283092,0.00043242346,0.0003654748],"domain_scores_gemma":[0.9889348,0.004359361,0.0059223035,0.00019538715,0.00038522863,0.00020291693],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.01178772,0.00037759246,0.040423345,0.0025914428,0.000022140717,0.000017145234,0.00019998495,0.0005505366,0.0016411149],"category_scores_gemma":[0.0031619181,0.0002587058,0.012339398,0.0011781327,0.00022061654,0.00005931243,0.00002455115,0.00078015676,0.000002090345],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053954087,0.0005165831,0.0004800521,0.0013834791,0.14216998,0.0006956664,0.00004025267,0.000008408283,4.962159e-7,0.000013226034,0.00022427099,0.8005135],"study_design_scores_gemma":[0.3464757,0.00028049378,0.00044614964,0.004144046,0.5334682,0.0024320479,0.0000055205055,0.000007687429,2.1059627e-7,0.000046670903,0.11250704,0.00018626764],"about_ca_topic_score_codex":0.0005107276,"about_ca_topic_score_gemma":0.0003461166,"teacher_disagreement_score":0.80032724,"about_ca_system_score_codex":0.000085517524,"about_ca_system_score_gemma":0.0008528379,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W1574416649","doi":"10.1002/cncr.27440","title":"Disparities in access to care at high‐volume institutions for uro‐oncologic procedures","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Volume (thermodynamics); Expanded access; Family medicine; Oncology","score_opus":0.07995729014522246,"score_gpt":0.39951229882736444,"score_spread":0.319555008682142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574416649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769728,0.009924633,0.0000948154,0.0046060616,0.0011667368,0.0019320464,0.00031562036,0.000066048306,0.0049212277],"genre_scores_gemma":[0.99109185,0.00016761028,0.00018523492,0.0028968232,0.0005570236,0.0025857228,0.000043822125,0.000015794689,0.0024561493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993129,0.000007740137,0.000114778,0.00016233676,0.00009369818,0.0003085797],"domain_scores_gemma":[0.999615,0.000014930681,0.00002286667,0.00012594528,0.00006865836,0.00015259995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002494129,0.000109864704,0.00019098754,0.00006452039,0.00009936451,0.0000149357475,0.00007782107,0.000063039704,0.00027185876],"category_scores_gemma":[0.00004692017,0.00008723581,0.000043598964,0.0001363651,0.000042231033,0.00015344293,0.00005230844,0.000055193614,0.000026961601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036434073,0.00013434871,0.955576,0.000356123,0.00004302201,0.000003835349,0.0011622779,0.00007648491,0.0002654609,0.00043905652,0.03802012,0.0035589149],"study_design_scores_gemma":[0.0017564875,0.00019605694,0.8185686,0.00013320764,0.000109137705,0.000004810061,0.00013666728,0.0000021483802,0.00258358,0.00004618635,0.17633183,0.00013128569],"about_ca_topic_score_codex":0.0013340526,"about_ca_topic_score_gemma":0.0037808905,"teacher_disagreement_score":0.13831171,"about_ca_system_score_codex":0.00082654203,"about_ca_system_score_gemma":0.00037334854,"threshold_uncertainty_score":0.3557373},"labels":[],"label_agreement":null},{"id":"W1578330188","doi":"10.1111/j.1464-410x.2011.10479.x","title":"Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Hazard ratio; Cohort; Proportional hazards model; Internal medicine; Logistic regression; Performance status; Upper urinary tract; Oncology; Retrospective cohort study; Urinary system; Cancer; Urothelial carcinoma; Urology; Bladder cancer; Confidence interval","score_opus":0.011782075303085431,"score_gpt":0.23166001820689516,"score_spread":0.21987794290380974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578330188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985286,0.00022134128,0.0000011009156,0.000016153046,0.00016666355,0.00037204148,0.000031080952,0.0000018548866,0.00066114677],"genre_scores_gemma":[0.9997364,0.00004326643,0.000079897334,0.00005084515,0.000054060318,0.0000062409185,0.0000027427445,0.000013689508,0.0000128567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898267,0.00008368733,0.00039576835,0.00010643572,0.00027632236,0.00015512317],"domain_scores_gemma":[0.9992674,0.000017082664,0.00028406535,0.000116449715,0.00024940606,0.00006558888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118885706,0.00008321734,0.0002652294,0.000102484475,0.000020499225,0.0000033253868,0.00016634093,0.00004388214,0.00014311307],"category_scores_gemma":[0.000034759767,0.00006186438,0.000053994612,0.0000772441,0.000090758316,0.00015592355,0.000028400125,0.00021632298,6.2174615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028523416,0.0068095094,0.979483,0.000011408723,0.00010055406,0.00014679355,0.0012434482,0.000006259851,0.000025087491,0.0000018731015,0.0000028662032,0.009316821],"study_design_scores_gemma":[0.007352454,0.017598653,0.9733152,0.000060664417,0.00014869135,0.0010761633,0.00020036826,0.000012676025,0.00013641716,0.00001948072,0.00003246822,0.000046802408],"about_ca_topic_score_codex":0.00034735294,"about_ca_topic_score_gemma":0.00004743554,"teacher_disagreement_score":0.010789144,"about_ca_system_score_codex":0.000031562482,"about_ca_system_score_gemma":0.00018568232,"threshold_uncertainty_score":0.25227565},"labels":[],"label_agreement":null},{"id":"W1579561423","doi":"10.1111/j.1464-410x.2012.11455.x","title":"Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage <scp>T</scp> 1 disease and negative lymph nodes after radical cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lymphovascular invasion; Cystectomy; Medicine; Bladder cancer; Stage (stratigraphy); Pathological; Cancer; Urology; Carcinoma; T-stage; Internal medicine; Oncology; Metastasis; Biology","score_opus":0.012460221452580298,"score_gpt":0.2391170994231383,"score_spread":0.226656877970558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1579561423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896449,0.009665162,0.000032807715,0.000110194815,0.00009927612,0.0002690581,0.00012401295,0.000006024382,0.000048585243],"genre_scores_gemma":[0.9981095,0.0010045287,0.00007115563,0.0005872397,0.00008888045,0.000023874954,0.000010380925,0.000025647489,0.00007877891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842095,0.0002095505,0.00029077037,0.00023298296,0.00047017512,0.00037558388],"domain_scores_gemma":[0.99892247,0.00014809587,0.00021882658,0.000088033754,0.00021263336,0.0004099359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002536065,0.00018818067,0.00045759993,0.00012140942,0.000059231214,0.00003174931,0.00006004879,0.00011806615,0.00007014027],"category_scores_gemma":[0.00022784772,0.000152028,0.000048057827,0.00015191126,0.00025397036,0.00029151005,0.000041183626,0.00028497982,8.090809e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018962054,0.0005633215,0.9915054,0.00003452963,0.00047788094,0.00091275165,0.0004899249,0.0000030882882,0.0000029078958,0.0000013449068,0.00006480844,0.0040478692],"study_design_scores_gemma":[0.019558134,0.00084319053,0.97773314,0.00042038126,0.0005190034,0.0005957877,0.000084139705,0.000010318942,0.000018184286,0.000020597667,0.000115330804,0.00008180261],"about_ca_topic_score_codex":0.0004215455,"about_ca_topic_score_gemma":0.00020723649,"teacher_disagreement_score":0.01766193,"about_ca_system_score_codex":0.0001275696,"about_ca_system_score_gemma":0.00030751846,"threshold_uncertainty_score":0.6199522},"labels":[],"label_agreement":null},{"id":"W1581405436","doi":"10.1002/cncr.24463","title":"Key concerns about the current state of bladder cancer","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Key (lock); Current (fluid); Bladder cancer; Cancer; State (computer science); Intensive care medicine; Internal medicine; Computer security; Computer science; Oceanography","score_opus":0.04180249020206766,"score_gpt":0.3673601400137148,"score_spread":0.32555764981164714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581405436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77238184,0.18771115,0.00019281368,0.012393267,0.002586652,0.0017600036,0.00065775285,0.00013111017,0.022185396],"genre_scores_gemma":[0.98401016,0.010272581,0.000018502453,0.0021614674,0.0005816148,0.000127354,0.0000074352733,0.000019256428,0.0028016428],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989945,0.0000219923,0.00023082948,0.00021690823,0.00027045253,0.0002652945],"domain_scores_gemma":[0.999318,0.000019157129,0.00010453819,0.00030139356,0.00014741682,0.00010946917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053251646,0.00016245317,0.00027807095,0.00003285997,0.000058805617,0.000010556981,0.00011359958,0.000024840012,0.0010607487],"category_scores_gemma":[0.000008542098,0.000098183744,0.00011198851,0.00016528799,0.00011130323,0.000049327147,0.000014970661,0.00018736294,0.000026539936],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026470292,0.00013829254,0.010394609,0.000052007526,0.00022625182,0.000006598684,0.0012837653,0.00007458587,0.0012427164,0.000078589066,0.024708489,0.9615294],"study_design_scores_gemma":[0.0039715148,0.00049099425,0.5186322,0.0005714326,0.00065042684,0.0000057677826,0.000040295006,0.00011028949,0.023447443,0.0010003212,0.45078838,0.00029097905],"about_ca_topic_score_codex":0.00043216036,"about_ca_topic_score_gemma":0.0001657213,"teacher_disagreement_score":0.9612384,"about_ca_system_score_codex":0.00015849959,"about_ca_system_score_gemma":0.00047912195,"threshold_uncertainty_score":0.9998524},"labels":[],"label_agreement":null},{"id":"W1581856783","doi":"10.1111/j.1464-410x.2012.11129.x","title":"Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques","year":2012,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Magnetic resonance imaging; Cancer; Radiology; Prospective cohort study; Lymph node; Gold standard (test); Pathology; Internal medicine","score_opus":0.020399054211893558,"score_gpt":0.33110847816646,"score_spread":0.31070942395456647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581856783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029840364,0.99875516,0.0000036845868,0.0000426153,0.00024160257,0.00034946547,0.00006396797,0.0000075928288,0.00023748237],"genre_scores_gemma":[0.002159112,0.99712443,0.00017957125,0.000052534593,0.00037454924,0.000035516732,0.0000063534535,0.000043345597,0.000024554198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981692,0.00016176204,0.0008852844,0.00019748333,0.00019338609,0.00039287138],"domain_scores_gemma":[0.9989747,0.000056676003,0.0005637956,0.00011786655,0.000128601,0.00015835548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026053606,0.00022580147,0.00150123,0.0003261325,0.000023723078,0.000011445078,0.00010885456,0.00013451857,0.00013740668],"category_scores_gemma":[0.00003633417,0.00021945118,0.00020559458,0.0001673481,0.00012615352,0.00008682767,0.000057288384,0.0006892162,9.148991e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038717197,0.00013034345,0.005824272,0.0014063797,0.000045049466,0.00020486035,0.00006284504,4.025389e-8,0.0000032463724,0.0000039797396,0.00014475992,0.9921355],"study_design_scores_gemma":[0.00081911276,0.00027483905,0.008260607,0.009402898,0.0014846307,0.0069461544,0.000014891861,9.564367e-7,0.0000037302766,0.0000769499,0.9725743,0.0001409098],"about_ca_topic_score_codex":0.0004787839,"about_ca_topic_score_gemma":0.000079720434,"teacher_disagreement_score":0.9919946,"about_ca_system_score_codex":0.00011399691,"about_ca_system_score_gemma":0.0005502645,"threshold_uncertainty_score":0.894896},"labels":[],"label_agreement":null},{"id":"W1583672742","doi":"10.1111/j.1464-410x.2009.09190.x","title":"Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Lymphadenectomy; Urothelium; Oncology; Bladder cancer; Hazard ratio; Tissue microarray; Lymph node; Urinary bladder; Urology; Internal medicine; Immunohistochemistry; Pathological; Epidermal growth factor receptor; Metastasis; Stage (stratigraphy); Cancer; Confidence interval; Biology","score_opus":0.0074136335871417495,"score_gpt":0.22782564748589382,"score_spread":0.22041201389875206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1583672742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985454,0.00010333499,0.000012741909,0.00016817075,0.0003292058,0.00060608843,0.00006538076,0.0000054962948,0.00016417279],"genre_scores_gemma":[0.99942887,0.000013785065,0.0001729774,0.00020889542,0.000116445495,0.000013470384,0.000013399629,0.000015664067,0.00001649247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985614,0.00011507149,0.0005566566,0.00010842502,0.00040545542,0.00025301627],"domain_scores_gemma":[0.99888957,0.000038688828,0.0004716079,0.00012719895,0.00035346457,0.000119499215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012240278,0.00012787437,0.00030739114,0.00013750668,0.000068683185,0.000018566067,0.00013912011,0.0001321368,0.00022963357],"category_scores_gemma":[0.00020239115,0.0000902021,0.000081658545,0.000097505945,0.00013327424,0.00035909557,0.000049918937,0.0006145876,0.0000022522686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010946206,0.0006687482,0.9900022,0.000048828617,0.0000523383,0.000063233776,0.0004039988,0.0000038512285,0.0016115993,0.000005748766,0.00020724961,0.0058375434],"study_design_scores_gemma":[0.007467333,0.0031866156,0.98620737,0.00009177302,0.000074946794,0.00065670896,0.000039074064,0.0000024231124,0.0018665858,0.000044162553,0.00028438942,0.00007864138],"about_ca_topic_score_codex":0.00023537957,"about_ca_topic_score_gemma":0.00006970169,"teacher_disagreement_score":0.0063727126,"about_ca_system_score_codex":0.000044887936,"about_ca_system_score_gemma":0.00030657017,"threshold_uncertainty_score":0.3678335},"labels":[],"label_agreement":null},{"id":"W1584434888","doi":"10.1002/cncr.25903","title":"Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle‐invasive bladder cancer and negative cytology","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Cystoscopy; Bladder cancer; Urine cytology; Cytology; Cancer; Urology; Urinary system; False positive paradox; Oncology; Internal medicine; Pathology","score_opus":0.04808570486810508,"score_gpt":0.35157284580685116,"score_spread":0.30348714093874607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584434888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965925,0.0007598298,0.0000035680825,0.0004316456,0.000079214675,0.0009262931,0.00007472675,0.0000061238457,0.0011260901],"genre_scores_gemma":[0.9988106,0.00029405445,0.00020363698,0.00041235372,0.00006353594,0.00013878531,0.0000029995233,0.000021799993,0.000052226445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892586,0.000115331524,0.0003332837,0.00023386168,0.00020756379,0.00018409028],"domain_scores_gemma":[0.9990659,0.0001671286,0.00025772752,0.00026548438,0.00020052952,0.00004324376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020325374,0.00014092092,0.00038641883,0.000036418114,0.000048336842,0.0000072652642,0.00012675549,0.00008061033,0.00026385518],"category_scores_gemma":[0.000057005826,0.00007042662,0.000053517095,0.00018406227,0.00042080128,0.00008338893,0.000034790955,0.0001985026,0.0000010207503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074110297,0.00023955583,0.98879,0.00007790404,0.0002149558,0.0000060649136,0.0030095237,0.0000027051535,0.00010597823,0.00012219988,0.000100145626,0.006589909],"study_design_scores_gemma":[0.0029691935,0.00055557885,0.9943505,0.00020921358,0.00011388473,0.0000017166218,0.00076132227,0.0000072575717,0.00066142186,0.00013693915,0.00015387114,0.00007908547],"about_ca_topic_score_codex":0.0021473903,"about_ca_topic_score_gemma":0.0017009287,"teacher_disagreement_score":0.0065108235,"about_ca_system_score_codex":0.00004647388,"about_ca_system_score_gemma":0.0002360184,"threshold_uncertainty_score":0.3246226},"labels":[],"label_agreement":null},{"id":"W1591494255","doi":"10.1002/cncr.28731","title":"Contemporary cost‐effectiveness analysis comparing sequential bacillus Calmette‐Guerin and electromotive mitomycin versus bacillus Calmette‐Guerin alone for patients with high‐risk non–muscle‐invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network; University of Alberta; McGill University Health Centre","funders":"","keywords":"Medicine; Confidence interval; Cost effectiveness; Randomized controlled trial; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.026288127641958776,"score_gpt":0.2888121031277311,"score_spread":0.26252397548577233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591494255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881676,0.0014157195,0.0045087356,0.00018608326,0.0007959187,0.0030636427,0.0012810321,0.00009279266,0.00048851356],"genre_scores_gemma":[0.99557894,0.00033636196,0.0003993548,0.00028079044,0.00055753865,0.0020233141,0.00052222173,0.00012254562,0.00017892805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668854,0.00026710873,0.00048601764,0.0011758894,0.0005668405,0.00081561314],"domain_scores_gemma":[0.9974772,0.000551489,0.0003677422,0.00055448856,0.00057472795,0.00047438985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026606413,0.0006965114,0.0015688324,0.00033057452,0.00031312907,0.00006566412,0.00017327764,0.00023011278,0.00020268593],"category_scores_gemma":[0.0001232659,0.00057171006,0.00031651562,0.00078587304,0.00028845036,0.0002441752,0.00009024941,0.0004019186,0.000008430402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01934892,0.00076618494,0.92000467,0.0005346493,0.018917734,0.000058191512,0.00085678604,0.0015279533,0.0030516735,0.00002784794,0.0016538455,0.033251572],"study_design_scores_gemma":[0.05309336,0.0045092846,0.9065089,0.00046276278,0.00984689,0.0000039291745,0.0001181198,0.0014019113,0.019638311,0.000024507799,0.0033674878,0.0010245119],"about_ca_topic_score_codex":0.016641498,"about_ca_topic_score_gemma":0.005468059,"teacher_disagreement_score":0.03374444,"about_ca_system_score_codex":0.0010345427,"about_ca_system_score_gemma":0.00058486545,"threshold_uncertainty_score":0.9996734},"labels":[],"label_agreement":null},{"id":"W1593348050","doi":"10.1111/iju.12267","title":"Survival after nephroureterectomy for upper tract urothelial carcinoma: A population‐based competing‐risks analysis","year":2013,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Urology; Epidemiology; Mortality rate; Population; Internal medicine; Stage (stratigraphy); Oncology; Gynecology","score_opus":0.02782118727065367,"score_gpt":0.32833766030725464,"score_spread":0.30051647303660095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593348050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649156,0.00019052252,0.0056206486,0.005703159,0.0012970346,0.00029122952,0.000067472174,0.000011859644,0.0003265172],"genre_scores_gemma":[0.99395823,0.000007220407,0.0022180073,0.0022768932,0.0013074813,0.00004640319,0.00006963214,0.00002143671,0.00009467984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864113,0.00008454824,0.00051597296,0.00016834399,0.00039370824,0.00019627265],"domain_scores_gemma":[0.9984625,0.00021693684,0.0003069505,0.0001239333,0.0007620665,0.00012763236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018005502,0.0001524088,0.00043079382,0.0005306038,0.000030493218,0.0000380621,0.00018186856,0.00010266653,0.0015947262],"category_scores_gemma":[0.000101476486,0.00011944777,0.0005571213,0.00012902159,0.0000375968,0.00012890177,0.000017843071,0.00018755464,0.000019121519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022397572,0.0003151817,0.9923918,0.0000070384253,0.0018283073,0.00009720356,0.000100344674,0.00021059025,0.00035151123,0.000039163722,0.00021156529,0.0022074855],"study_design_scores_gemma":[0.0050784834,0.00079532,0.98704755,0.00000921895,0.0013791864,0.0002041565,0.000021887166,0.0012186684,0.00015460503,0.00025828494,0.00373366,0.00009899478],"about_ca_topic_score_codex":0.00051697163,"about_ca_topic_score_gemma":0.00003616145,"teacher_disagreement_score":0.007466689,"about_ca_system_score_codex":0.000120072815,"about_ca_system_score_gemma":0.0001499272,"threshold_uncertainty_score":0.99931794},"labels":[],"label_agreement":null},{"id":"W1595088044","doi":"10.1111/j.1464-410x.2012.11474.x","title":"Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Western University; Dalhousie University; McGill University; Université Laval; Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Nephrectomy; Cohort; Urothelial carcinoma; Laparoscopy; Upper urinary tract; Cuff; Pathological; Urology; Surgery; Urinary system; Internal medicine; Bladder cancer; Kidney; Cancer","score_opus":0.054666552268005895,"score_gpt":0.37199669710874855,"score_spread":0.3173301448407427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595088044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982537,0.0039906576,0.000023295703,0.011911827,0.00038146874,0.00045838804,0.00027613042,0.0000023725815,0.00041889024],"genre_scores_gemma":[0.9961402,0.00011455997,0.0010251313,0.0023435764,0.00028805912,0.00000871918,0.00003378562,0.0000078485955,0.000038143677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990397,0.00013687368,0.00042047614,0.00009038716,0.00011707087,0.00019548932],"domain_scores_gemma":[0.9989308,0.00041532808,0.00022876375,0.00007560019,0.00013132658,0.00021816794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040013532,0.00007363028,0.00048482433,0.000033117576,0.000109047105,0.000041813462,0.00012981142,0.00014034535,0.000065026936],"category_scores_gemma":[0.00045165993,0.00005261924,0.000058503665,0.00005284228,0.00012328006,0.00011511944,0.000020586442,0.00021031812,8.512113e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015717384,0.00035153335,0.9681017,0.000005089945,0.00020348816,0.000047487218,0.00079523155,0.0000016796411,0.00008186305,0.00005684396,0.016146848,0.012636507],"study_design_scores_gemma":[0.007821003,0.0016016283,0.9435869,0.00002849121,0.0002803069,0.00061186176,0.00016595605,0.000012885902,0.00012319961,0.00015397352,0.045567457,0.00004636107],"about_ca_topic_score_codex":0.022793435,"about_ca_topic_score_gemma":0.052899748,"teacher_disagreement_score":0.030106312,"about_ca_system_score_codex":0.00007936246,"about_ca_system_score_gemma":0.00047609032,"threshold_uncertainty_score":0.98371387},"labels":[],"label_agreement":null},{"id":"W1597122917","doi":"10.1158/1538-7445.am2014-909","title":"Abstract 909: Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cisplatin; Oncology; Internal medicine; Chemotherapy; Cancer; Cohort; Gemcitabine","score_opus":0.02193102164403776,"score_gpt":0.34740595409681296,"score_spread":0.3254749324527752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597122917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654306,0.004341207,0.000015871365,0.006361986,0.00009704111,0.0011056521,0.000965102,0.00002548634,0.0005445732],"genre_scores_gemma":[0.99712133,0.0011699292,0.0002626844,0.00072992756,0.00015843989,0.00041866032,0.000026360736,0.00005908358,0.000053602867],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974828,0.00032767205,0.00037304428,0.00065559556,0.00063810666,0.00052279665],"domain_scores_gemma":[0.9980714,0.000706096,0.00009619273,0.0004067094,0.0003616942,0.0003579243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012250141,0.00025383887,0.00043354885,0.0004774318,0.00010240684,0.000025082967,0.00012695511,0.00019552463,0.00007611252],"category_scores_gemma":[0.00033557726,0.00022156119,0.000046236495,0.0006460226,0.00028684048,0.00007762344,0.000058749843,0.0004340016,0.0000028174545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22488417,0.0005859529,0.06776802,0.0011476794,0.00087320054,0.0005402325,0.012255947,0.00050941313,0.57537633,0.000042344516,0.004901915,0.11111481],"study_design_scores_gemma":[0.014980411,0.004686786,0.83460456,0.0016835269,0.000092479146,0.0000061135943,0.0013913907,0.00021782197,0.13642144,0.000042585747,0.0055535296,0.00031933832],"about_ca_topic_score_codex":0.0018594546,"about_ca_topic_score_gemma":0.00050216133,"teacher_disagreement_score":0.7668366,"about_ca_system_score_codex":0.00030918952,"about_ca_system_score_gemma":0.0013047145,"threshold_uncertainty_score":0.90350026},"labels":[],"label_agreement":null},{"id":"W1598862994","doi":"10.1111/j.1464-410x.2010.09834.x","title":"Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Androgen receptor; Pathological; Bladder cancer; Stage (stratigraphy); Oncology; Androgen; Medicine; Prostate cancer; Outcome (game theory); Internal medicine; Cancer; Biology; Hormone; Mathematics","score_opus":0.05410754638719888,"score_gpt":0.3385855324615048,"score_spread":0.2844779860743059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598862994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793786,0.00058971805,0.00009660971,0.00028985555,0.000304709,0.0003913985,0.0003345565,0.000010071511,0.000045202945],"genre_scores_gemma":[0.9980107,0.00022701538,0.00053071714,0.0008112254,0.00011741746,0.000024061077,0.000011124097,0.000018919623,0.00024880358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827945,0.00016676947,0.00062608515,0.00023437293,0.00039338498,0.00029991486],"domain_scores_gemma":[0.99900484,0.000075329845,0.0003686674,0.00011939969,0.00028121573,0.00015055029],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004445056,0.00016451848,0.00065200956,0.00012792302,0.00007168361,0.000011272508,0.00013292563,0.00021224437,0.0013186296],"category_scores_gemma":[0.00025080817,0.00011394155,0.00010812102,0.00016769629,0.00016411758,0.00010024879,0.000043183984,0.0007315705,0.0000023868438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026001239,0.0045821364,0.980684,0.000016742384,0.00035023357,0.0067230724,0.00057831,0.000015745554,0.0026182022,0.00000467608,0.0004001815,0.0014266],"study_design_scores_gemma":[0.023169255,0.0027566638,0.96781224,0.00007692225,0.0002512136,0.00333022,0.00021423183,0.000020705425,0.00095690414,0.000010664026,0.0012637678,0.00013721918],"about_ca_topic_score_codex":0.00017088825,"about_ca_topic_score_gemma":0.0010746883,"teacher_disagreement_score":0.02056913,"about_ca_system_score_codex":0.00006216705,"about_ca_system_score_gemma":0.00040582463,"threshold_uncertainty_score":0.9995943},"labels":[],"label_agreement":null},{"id":"W1608454431","doi":"10.1111/j.1464-410x.2012.11433.x","title":"Predictors of cancer‐specific mortality after disease recurrence following radical cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Disease; Hazard ratio; Lymphadenectomy; Prognostic variable; Internal medicine; Cancer; Oncology; Chemotherapy; Surgery; Adjuvant therapy; Confidence interval","score_opus":0.01913538300798343,"score_gpt":0.2974115283433214,"score_spread":0.27827614533533795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608454431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91393757,0.083796374,0.000099186924,0.00022608122,0.0015391015,0.00014196844,0.00006211102,0.000008022213,0.00018956854],"genre_scores_gemma":[0.99620515,0.0024312988,0.00009914556,0.00026237272,0.0009319502,0.000016473323,0.0000038488674,0.00001648798,0.00003327299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986321,0.00011208962,0.00048192978,0.00012573408,0.00034583418,0.00030233717],"domain_scores_gemma":[0.9990499,0.000043669916,0.00021459798,0.00013257036,0.000103010694,0.00045624477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027870567,0.00011086003,0.0004314333,0.00007495241,0.0000322133,0.000007817657,0.00009865728,0.00008296589,0.0003920578],"category_scores_gemma":[0.000090218535,0.000107409294,0.00028125691,0.000109164175,0.00014243161,0.00015336528,0.000024885776,0.00029012206,0.0000034498555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009400464,0.00040669952,0.9829731,0.000046097397,0.0004307685,0.0015470259,0.00010762464,0.0000022460977,0.00012179121,0.000006091622,0.0010764459,0.012342053],"study_design_scores_gemma":[0.0027330117,0.00038132325,0.98420393,0.00020751002,0.00075331714,0.0012857763,0.000012453927,0.0000022656573,0.0001187396,0.000047227204,0.010176394,0.00007804938],"about_ca_topic_score_codex":0.0001236506,"about_ca_topic_score_gemma":0.000018247794,"teacher_disagreement_score":0.08226757,"about_ca_system_score_codex":0.00006570311,"about_ca_system_score_gemma":0.00022006348,"threshold_uncertainty_score":0.43800238},"labels":[],"label_agreement":null},{"id":"W1617055729","doi":"10.1016/j.urolonc.2015.06.005","title":"Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: A population-based study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Cystectomy; Medicine; Bladder cancer; Lymph node; Hazard ratio; Proportional hazards model; Population; Cancer registry; Multivariate analysis; Dissection (medical); Multivariate statistics; Surgery; Cancer; Internal medicine; Oncology; Confidence interval; Statistics; Environmental health; Mathematics","score_opus":0.05391834992651538,"score_gpt":0.3802908898054138,"score_spread":0.3263725398788984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1617055729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546576,0.0009825111,6.904893e-7,0.0012587074,0.00012050032,0.0003320448,0.000055953526,0.000009392413,0.0017744519],"genre_scores_gemma":[0.99902576,0.00003397408,0.00040995507,0.00034119803,0.00003104086,0.000056416626,0.000017946615,0.0000053748035,0.00007830286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990955,0.00018384274,0.00027677586,0.00015557258,0.0001851335,0.000103192404],"domain_scores_gemma":[0.9993832,0.00010407892,0.00019518711,0.000151668,0.0000747847,0.000091076414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020902007,0.00009001535,0.00030001623,0.00008950116,0.00004126443,0.0000022298918,0.00006549601,0.00010789043,0.00004846444],"category_scores_gemma":[0.00007525013,0.00006014634,0.00003946003,0.00028349814,0.00020666196,0.000019215136,0.000019959707,0.00011144718,0.0000013765844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012117638,0.00029354377,0.99784017,0.000026588152,0.00003299917,0.000011982818,0.0006750442,0.00009417706,0.000003829208,0.00040697065,0.00017575648,0.00031776345],"study_design_scores_gemma":[0.0032491249,0.0007181843,0.9665021,0.00005400202,0.00021319097,0.000007817767,0.0016412041,0.000032387492,0.000107985376,0.00049538206,0.026900817,0.000077859586],"about_ca_topic_score_codex":0.0012111175,"about_ca_topic_score_gemma":0.00035534558,"teacher_disagreement_score":0.031338125,"about_ca_system_score_codex":0.0001626833,"about_ca_system_score_gemma":0.00072817045,"threshold_uncertainty_score":0.24526966},"labels":[],"label_agreement":null},{"id":"W1617901744","doi":"10.1111/j.1464-410x.2012.11356.x","title":"Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Interquartile range; Lymphadenectomy; Hazard ratio; Bladder cancer; Urology; Internal medicine; Lymph node; Proportional hazards model; Oncology; Stage (stratigraphy); Chemotherapy; Cohort; Cancer; Gastroenterology; Confidence interval","score_opus":0.01178645306483888,"score_gpt":0.23620450024996742,"score_spread":0.22441804718512853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1617901744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764854,0.0018754018,0.000014296849,0.00011442296,0.0000650114,0.00015405867,0.000025223342,0.000003807737,0.00009922942],"genre_scores_gemma":[0.9994555,0.000028654902,0.00027294946,0.0001610844,0.000029074325,0.000002136721,0.0000062389486,0.00001475003,0.000029584971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999095,0.00007934582,0.0003152866,0.00008493481,0.00020743534,0.00021797336],"domain_scores_gemma":[0.9994275,0.0000967542,0.00018228556,0.000058261583,0.000078296136,0.000156903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011551874,0.00009771598,0.00048140602,0.000107783075,0.000020946898,0.000004714967,0.00004213897,0.000065117674,0.00012324819],"category_scores_gemma":[0.0001248895,0.00007526859,0.00006005607,0.00007360757,0.0001157546,0.00009957218,0.000024185652,0.00010894755,0.0000022840545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006885977,0.0008625351,0.99488384,0.000024438577,0.00024060928,0.0001256542,0.00014345202,0.0000011209128,0.00007048277,5.9238295e-7,0.00004954004,0.0029091637],"study_design_scores_gemma":[0.008912141,0.0013296903,0.98729396,0.00006972605,0.00036029358,0.0016335116,0.000012495255,0.0000010617251,0.00016711815,0.000005115193,0.00015717116,0.00005770954],"about_ca_topic_score_codex":0.00006829853,"about_ca_topic_score_gemma":0.000010889244,"teacher_disagreement_score":0.008223544,"about_ca_system_score_codex":0.00006268318,"about_ca_system_score_gemma":0.000047412133,"threshold_uncertainty_score":0.3069364},"labels":[],"label_agreement":null},{"id":"W1621391416","doi":"10.3233/blc-150018","title":"The Role of Population-Based Observational Research in Bladder Cancer","year":2015,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Observational study; Bladder cancer; Psychological intervention; Population; Clinical trial; Clinical Practice; Cancer; Medicine; Translational research; Family medicine; Nursing; Environmental health; Pathology; Internal medicine","score_opus":0.2850106155848942,"score_gpt":0.491273960381424,"score_spread":0.2062633447965298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1621391416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010999139,0.99307495,8.855875e-7,0.0007823991,0.00045883426,0.0021112638,0.00049449666,0.000029560166,0.002937618],"genre_scores_gemma":[0.0009679185,0.99196386,0.00006287206,0.0001789261,0.00089913013,0.003263433,0.00042350532,0.00012782453,0.0021125448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959056,0.0003831121,0.00096933095,0.0006294038,0.0014489488,0.00066362217],"domain_scores_gemma":[0.99737066,0.0005510512,0.00035955067,0.00077236356,0.00072976697,0.0002165961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008672373,0.00047076432,0.0015390079,0.0003916907,0.00016869957,0.000041863303,0.0003876189,0.0004122144,0.00074056286],"category_scores_gemma":[0.00009679214,0.00030283723,0.0004020557,0.0012959338,0.00019418357,0.000081399514,0.00008453814,0.0008389726,0.000041774663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015208863,0.00021235681,0.012917924,0.0027672318,0.0007316535,0.000011722208,0.000097821074,0.00003915119,0.0000010546285,0.00028429658,0.0066156965,0.976169],"study_design_scores_gemma":[0.0011804132,0.00010474709,0.004090201,0.008062308,0.0007924492,0.0000042602937,0.000061000588,0.00006560477,0.000007926053,0.000715437,0.9846436,0.00027207224],"about_ca_topic_score_codex":0.014973501,"about_ca_topic_score_gemma":0.0039062784,"teacher_disagreement_score":0.9780279,"about_ca_system_score_codex":0.0015017664,"about_ca_system_score_gemma":0.0075379,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W1638630979","doi":"10.1111/bju.12564","title":"A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Nomogram; Internal medicine; Hazard ratio; Confidence interval; Oncology; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Progression-free survival; Performance status; Odds ratio; Urology; Surgery; Phases of clinical research","score_opus":0.028838532676684486,"score_gpt":0.32767204376897513,"score_spread":0.2988335110922906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1638630979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229246,0.0013605716,0.0026913125,0.0018026698,0.00031179647,0.0013893058,0.00007893106,0.000012089104,0.000060884537],"genre_scores_gemma":[0.9971066,0.000086350294,0.0015134246,0.0007917808,0.00028634115,0.000088602406,0.000006074584,0.00003338642,0.00008742938],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987804,0.000106768544,0.00044742684,0.00017424002,0.0001894621,0.0003016539],"domain_scores_gemma":[0.9985511,0.00037489654,0.00030678473,0.00014541396,0.00044844387,0.00017337687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000314841,0.00016014543,0.000519703,0.00010079836,0.000097371194,0.000022022194,0.00015122158,0.0000849452,0.0002802623],"category_scores_gemma":[0.00043093826,0.000117619056,0.00021177561,0.00012721815,0.00008832897,0.00011877022,0.000033445336,0.0002526005,0.0000028653928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071094763,0.0016753793,0.12882371,0.00015070438,0.00078011147,0.0002558765,0.0008166224,0.00024522352,0.09547384,0.000015938438,0.0017695385,0.7628836],"study_design_scores_gemma":[0.015782038,0.019813148,0.9264833,0.00015644479,0.00041449402,0.003636118,0.000104042265,0.0006269278,0.02644364,0.0005334706,0.005744353,0.00026207842],"about_ca_topic_score_codex":0.00019272006,"about_ca_topic_score_gemma":0.000102671576,"teacher_disagreement_score":0.7976595,"about_ca_system_score_codex":0.00003932812,"about_ca_system_score_gemma":0.00019887622,"threshold_uncertainty_score":0.4796366},"labels":[],"label_agreement":null},{"id":"W1665876265","doi":"10.1371/journal.pone.0131245","title":"Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma","year":2015,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Flight Attendant Medical Research Institute","keywords":"Cystectomy; Bladder cancer; Medicine; Oncology; Gemcitabine; Cohort; Cisplatin; Internal medicine; Immunohistochemistry; Carboplatin; Tissue microarray; Neoadjuvant therapy; Chemotherapy; Cancer; Breast cancer","score_opus":0.05106682619685078,"score_gpt":0.27207367208659333,"score_spread":0.22100684588974256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1665876265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748796,0.00009128534,0.000022188826,0.0009147292,0.00001333553,0.001306965,0.000033519675,0.000010066867,0.00011992314],"genre_scores_gemma":[0.99863875,0.00000860157,0.000953824,0.00005138462,0.000023635477,0.000086246364,0.000011179589,0.000015609428,0.00021079142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910194,0.00007812125,0.00028001372,0.00016813686,0.00027705837,0.00009471338],"domain_scores_gemma":[0.9994164,0.00003994416,0.000107684114,0.00019302481,0.00015285255,0.00009006531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003054071,0.00008327985,0.00023969037,0.00017093567,0.000009700664,0.0000047362205,0.00004153046,0.000048607602,0.000019093224],"category_scores_gemma":[0.0002788727,0.000077959034,0.0000209567,0.00020131492,0.000039997707,0.000059662114,0.000015046177,0.000039224127,0.00000508508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005758798,0.00075484975,0.04503158,0.00012080099,0.00008194917,0.0000036734737,0.0025907522,9.747991e-7,0.94444346,0.000004463081,0.000015813843,0.0011928538],"study_design_scores_gemma":[0.003783646,0.00082905137,0.22638083,0.00024581613,0.000052980915,9.4478656e-7,0.0002273522,0.000023367362,0.7683247,0.00007591963,0.000005747824,0.00004965606],"about_ca_topic_score_codex":0.0003149429,"about_ca_topic_score_gemma":0.000020521758,"teacher_disagreement_score":0.18134923,"about_ca_system_score_codex":0.000077369456,"about_ca_system_score_gemma":0.00019108386,"threshold_uncertainty_score":0.3179077},"labels":[],"label_agreement":null},{"id":"W167861370","doi":"10.1089/end.2013.0220","title":"Ureteroscopic Biopsy of Upper Tract Urothelial Carcinoma: Comparison of Basket and Forceps","year":2013,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Biopsy; Forceps; Urothelial carcinoma; Punch Biopsy; Carcinoma; Radiology; Urology; Surgery; Cancer; Pathology; Internal medicine","score_opus":0.02238035259257597,"score_gpt":0.3068132037677033,"score_spread":0.28443285117512734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167861370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686086,0.0011560005,0.000095918156,0.0006185025,0.00025702108,0.00019649144,0.000011730504,0.000003052559,0.00080040726],"genre_scores_gemma":[0.99871767,0.000043639906,0.00082119927,0.00014924121,0.00016151229,0.0000035014964,0.0000016006261,0.000013930473,0.00008772347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989795,0.00005925976,0.0005190138,0.00009832993,0.00017637089,0.00016748774],"domain_scores_gemma":[0.9990521,0.00008855829,0.00043248336,0.00012986855,0.00017898713,0.000118008575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099909856,0.00011879997,0.00065630826,0.00015897644,0.00001761388,0.0000039783063,0.000077383804,0.00010594486,0.00047066013],"category_scores_gemma":[0.00004653209,0.00008378688,0.00013299813,0.000057883077,0.00013289883,0.00007553542,0.000018867451,0.0002096738,0.000003366324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006039477,0.00043715158,0.92483926,0.00008164531,0.00015897637,0.000028254213,0.00052286114,0.0000028048944,0.07029767,0.000042476426,0.00076058647,0.0022243583],"study_design_scores_gemma":[0.0067438222,0.0059795836,0.94059676,0.000049013517,0.00037471615,0.0012248824,0.00018059878,0.000064698834,0.04388596,0.00020788406,0.000620016,0.0000720652],"about_ca_topic_score_codex":0.00011921427,"about_ca_topic_score_gemma":0.0000018760396,"teacher_disagreement_score":0.026411708,"about_ca_system_score_codex":0.000017385475,"about_ca_system_score_gemma":0.000103272185,"threshold_uncertainty_score":0.51533985},"labels":[],"label_agreement":null},{"id":"W1682822849","doi":"10.1111/j.1464-410x.2012.10996.x","title":"Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University Health Network","funders":"Erasmus+; KWF Kankerbestrijding","keywords":"Cystectomy; Bladder cancer; Stage (stratigraphy); Medicine; Cancer; Oncology; Internal medicine; Disease; Biology","score_opus":0.03012134662508975,"score_gpt":0.3212389053517005,"score_spread":0.29111755872661077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1682822849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91441214,0.08438396,0.000055128905,0.00039092766,0.00007869872,0.0005160146,0.000075112875,0.0000015718223,0.00008642397],"genre_scores_gemma":[0.9650693,0.034492567,0.00014050156,0.0000780436,0.00013397116,0.000028653103,0.0000029944601,0.000020087478,0.00003385931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989379,0.00025879688,0.00030596924,0.000106269814,0.00017974252,0.00021133316],"domain_scores_gemma":[0.9991904,0.00028557781,0.0002013255,0.00007682731,0.00016496691,0.000080941245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062894524,0.00008112733,0.00028183515,0.0000995759,0.000048851784,0.000008056977,0.000048226968,0.00004613146,0.000039354414],"category_scores_gemma":[0.00009884725,0.000061655686,0.00004312237,0.00007866954,0.00022899086,0.00005675402,0.000022511947,0.0001359734,1.6694415e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014729934,0.00043482948,0.8731103,0.000093293835,0.0004962931,0.000104144296,0.0007263419,0.000024217263,0.007941396,0.000020735653,0.00013023867,0.11544524],"study_design_scores_gemma":[0.004180698,0.0024813644,0.9880225,0.00010099807,0.00047044872,0.00035671063,0.000109353605,0.000022299171,0.0036456445,0.000073539246,0.0004913925,0.0000450551],"about_ca_topic_score_codex":0.002209072,"about_ca_topic_score_gemma":0.00036125843,"teacher_disagreement_score":0.11540018,"about_ca_system_score_codex":0.00008302916,"about_ca_system_score_gemma":0.00018056612,"threshold_uncertainty_score":0.33394706},"labels":[],"label_agreement":null},{"id":"W1684623467","doi":"10.5489/cuaj.483","title":"Invasive bladder cancer: time is of the essence","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.010188480414921434,"score_gpt":0.2282087830465854,"score_spread":0.21802030263166397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1684623467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8718638,0.00035113396,0.00000726315,0.118759416,0.00034956567,0.00038857415,0.00007790428,0.000011024601,0.008191325],"genre_scores_gemma":[0.98085755,0.00008653013,0.00002569869,0.014774237,0.00023431222,0.00001710781,0.0000018889483,0.0000072190956,0.003995463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903584,0.00007351782,0.00021158124,0.00010817395,0.00028833144,0.00028258766],"domain_scores_gemma":[0.9989118,0.00007400635,0.00020564404,0.00010574703,0.00034301533,0.00035980123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011763603,0.00008986865,0.00018782957,0.00005026694,0.00017707943,0.000030726853,0.00012729711,0.00013476357,0.009745327],"category_scores_gemma":[0.00026580264,0.00005343631,0.00012747296,0.0001721411,0.000041683365,0.00007283513,0.00001279076,0.0002962821,0.00020987383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010554797,0.000032393167,0.87857544,0.0000034440384,0.00022243333,0.000008145616,0.0001961158,0.0000063755765,0.0013047484,0.00005382394,0.11780452,0.0017819954],"study_design_scores_gemma":[0.00068405835,0.00015012616,0.9837509,0.000022178247,0.00012001108,0.000056092013,0.00004034942,0.000032815533,0.0009276593,0.0019318684,0.012212336,0.00007160284],"about_ca_topic_score_codex":0.008821374,"about_ca_topic_score_gemma":0.00075310253,"teacher_disagreement_score":0.108993754,"about_ca_system_score_codex":0.0006012175,"about_ca_system_score_gemma":0.0010669789,"threshold_uncertainty_score":0.99777895},"labels":[],"label_agreement":null},{"id":"W1687540477","doi":"10.5489/cuaj.1192","title":"Screening for bladder cancer: the best opportunity to reduce mortality","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Population; Oncology; Cervical cancer; Cancer screening; Internal medicine; Gynecology; Urology; Environmental health","score_opus":0.07306446029940837,"score_gpt":0.324981507996902,"score_spread":0.2519170476974936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1687540477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7681881,0.0002863265,0.00038806777,0.22500221,0.0005721256,0.0013334783,0.00019679128,0.000027260201,0.004005621],"genre_scores_gemma":[0.9619172,0.000055005192,0.00033612968,0.034211516,0.0010157616,0.00021728204,0.000015858037,0.000014025964,0.002217172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871486,0.00008783567,0.00025726907,0.00016953239,0.00027799487,0.0004924784],"domain_scores_gemma":[0.99761045,0.00010844713,0.0001402791,0.00012992474,0.00040464342,0.0016062262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004531368,0.00012566472,0.00021130532,0.00006863714,0.00048044705,0.000115211864,0.00013368213,0.0001425245,0.002565626],"category_scores_gemma":[0.0008522882,0.00007992339,0.00013974146,0.00015168806,0.000024664349,0.000091298716,0.000012130168,0.0003577627,0.000058708476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006600522,0.00007940323,0.7494236,0.0000043768564,0.00063167384,0.000021120153,0.00022130468,0.00006140983,0.00018699458,0.00010156238,0.19126332,0.057939216],"study_design_scores_gemma":[0.0011162523,0.00046455712,0.86541754,0.000016662008,0.0002999329,0.00005476552,0.0002503682,0.00011994479,0.00007263544,0.000746526,0.1312986,0.0001422043],"about_ca_topic_score_codex":0.022378579,"about_ca_topic_score_gemma":0.0036139546,"teacher_disagreement_score":0.19372913,"about_ca_system_score_codex":0.00073723245,"about_ca_system_score_gemma":0.0010652806,"threshold_uncertainty_score":0.99834615},"labels":[],"label_agreement":null},{"id":"W1689640173","doi":"10.5489/cuaj.292","title":"Impact of academic affiliation on radical cystectomy outcomes in","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Cystectomy; Logistic regression; Comorbidity; Odds ratio; Odds; Prospective cohort study; Blood transfusion; Emergency medicine; Internal medicine; Bladder cancer","score_opus":0.01651517998631761,"score_gpt":0.2912493278362286,"score_spread":0.27473414784991096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1689640173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841274,0.00006106961,0.000005000465,0.009355618,0.00009671396,0.00026294173,0.00002042651,0.000009405715,0.0017760879],"genre_scores_gemma":[0.9979821,0.000033076452,0.000036859026,0.0015063307,0.00013284676,0.0000140917255,0.000008658053,0.000007844822,0.00027818035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987792,0.00011312098,0.00034664955,0.000118655735,0.0003040916,0.00033832403],"domain_scores_gemma":[0.99900335,0.00012803439,0.00018752387,0.00007066111,0.00012401436,0.00048640015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025816952,0.00011181861,0.0003107792,0.00025889426,0.000050065773,0.000016897944,0.000072457646,0.00027633613,0.0014584458],"category_scores_gemma":[0.00060666166,0.00007449354,0.00017634456,0.00018154437,0.000020627369,0.00008912036,0.0000045039988,0.00065203843,0.00010888904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046008357,0.000067957284,0.9947917,0.0000014903449,0.000093267096,0.000016296413,0.00005600987,0.00004442129,0.00011961475,0.000030077017,0.0026047581,0.0021284008],"study_design_scores_gemma":[0.0020115287,0.00081374776,0.9959541,0.000014450955,0.000028137418,0.00003376559,0.000012845156,0.00008088794,0.000019699975,0.00054636324,0.000423187,0.00006127071],"about_ca_topic_score_codex":0.005732009,"about_ca_topic_score_gemma":0.00028309293,"teacher_disagreement_score":0.009569375,"about_ca_system_score_codex":0.0020489616,"about_ca_system_score_gemma":0.00056531595,"threshold_uncertainty_score":0.9994544},"labels":[],"label_agreement":null},{"id":"W1690821518","doi":"10.3747/co.22.2277","title":"A Call for Theory-Informed Approaches to Knowledge Translation Studies: An Example of Chemotherapy for Bladder Cancer","year":2015,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Research Chairs","keywords":"Medicine; Bladder cancer; Translation (biology); Cancer chemotherapy; Cancer; Medical education; Bioinformatics; Internal medicine","score_opus":0.7089735225598595,"score_gpt":0.511731336578383,"score_spread":0.19724218598147647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1690821518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7206587,0.08741666,0.13770603,0.008863591,0.007887569,0.027680911,0.00088567956,0.0003053959,0.008595426],"genre_scores_gemma":[0.96540976,0.0012064176,0.017999269,0.00095995725,0.002213492,0.010341205,0.0003732461,0.00012309474,0.001373577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990926,0.000043854623,0.0002750034,0.00025923297,0.0000895069,0.00023982447],"domain_scores_gemma":[0.9989717,0.00029815146,0.00008338426,0.0001778291,0.000284175,0.00018478729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003420732,0.00015268299,0.00047112338,0.000083479325,0.000036918118,0.0000032338205,0.00007507554,0.00009101694,0.000019437017],"category_scores_gemma":[0.00008225217,0.00011616119,0.00010288357,0.00010447362,0.00007392949,0.000056685498,0.000009605164,0.000054162985,0.0000026741825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058375834,0.0015396466,0.0011381421,0.0005560388,0.00058725197,2.293272e-7,0.055088915,0.0000142854815,0.00018166458,0.0014130735,0.011902942,0.92174023],"study_design_scores_gemma":[0.023993524,0.009293731,0.00074613385,0.000118416385,0.00068935676,0.0000041627095,0.0039795754,0.00076398585,0.0041439408,0.0036171067,0.95241255,0.00023751784],"about_ca_topic_score_codex":0.000049460465,"about_ca_topic_score_gemma":0.0005123664,"teacher_disagreement_score":0.9405096,"about_ca_system_score_codex":0.00033127712,"about_ca_system_score_gemma":0.0008070093,"threshold_uncertainty_score":0.47369155},"labels":[],"label_agreement":null},{"id":"W1715061133","doi":"10.1111/j.1464-410x.2009.09072.x","title":"Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Cancer; Oncology; Urology; Internal medicine","score_opus":0.011478130020812953,"score_gpt":0.2570443403222854,"score_spread":0.24556621030147244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1715061133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879268,0.0087210545,0.00007892125,0.0019988113,0.0003669805,0.00021058689,0.0000507104,0.000019861469,0.0006263007],"genre_scores_gemma":[0.9923424,0.0015433057,0.00027545504,0.005413848,0.00027367516,0.000011373372,0.000008839783,0.00002374429,0.00010736189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856305,0.00011200606,0.00042257897,0.0001972625,0.00036275288,0.00034234463],"domain_scores_gemma":[0.9991438,0.000044824043,0.00024811274,0.000111739275,0.00021900085,0.0002325181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103912505,0.00016572585,0.0005785857,0.00008549979,0.00005354262,0.00003045636,0.000086588494,0.00013863083,0.0007117969],"category_scores_gemma":[0.000043534495,0.00014814187,0.0001473878,0.00014975277,0.00011601651,0.00010649488,0.000011999757,0.00045749318,0.0000047881263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0167953,0.0018625945,0.08980756,0.000020734366,0.0013999969,0.07161013,0.001138357,0.000033336062,0.0017179097,0.000012421338,0.009868325,0.8057333],"study_design_scores_gemma":[0.012222438,0.009796552,0.9199027,0.00032161624,0.0003773959,0.009602798,0.000034372082,0.000003638395,0.00029247263,0.0001472877,0.04707626,0.00022247713],"about_ca_topic_score_codex":0.000044749962,"about_ca_topic_score_gemma":0.000109631364,"teacher_disagreement_score":0.8300951,"about_ca_system_score_codex":0.00014477009,"about_ca_system_score_gemma":0.00020519218,"threshold_uncertainty_score":0.7793677},"labels":[],"label_agreement":null},{"id":"W1716164294","doi":"10.5489/cuaj.2692","title":"Bricker versus Wallace anastomosis: A meta-analysis of ureteroenteric stricture rates after ileal conduit urinary diversion","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Anastomosis; Urinary diversion; Cystectomy; Medicine; Surgery; Urology; Odds ratio; Internal medicine; Bladder cancer; Cancer","score_opus":0.06600700513140755,"score_gpt":0.29079906649987225,"score_spread":0.2247920613684647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1716164294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840527,0.0029524905,0.00003333567,0.01109965,0.00037549873,0.00022185012,0.00026009246,0.000018267365,0.0009860763],"genre_scores_gemma":[0.996324,0.000049623126,0.000091117836,0.002590872,0.00012741119,0.000012814245,0.00004609827,0.000009510565,0.0007485507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833924,0.00021510567,0.0003375384,0.00021606572,0.000528471,0.00036358958],"domain_scores_gemma":[0.9981635,0.000080051876,0.00029177166,0.00013769128,0.00045014854,0.00087683613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034295095,0.00017652969,0.00074680673,0.00038165058,0.00008695174,0.00004129989,0.00010981448,0.00021188999,0.0022493456],"category_scores_gemma":[0.0001734664,0.00012321756,0.0007576711,0.0006219299,0.000025826264,0.00010498357,0.000024076338,0.00033013595,0.000025750154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002338634,0.00022676408,0.85674083,0.000006489864,0.115437284,0.0005440105,0.0008128843,0.0001795237,0.000023333367,0.000007930911,0.023369903,0.00031242438],"study_design_scores_gemma":[0.0047248546,0.002877044,0.792628,0.000003862393,0.17628862,0.000083113955,0.00031542676,0.00017591097,0.000030516401,0.00006514455,0.02259402,0.0002135208],"about_ca_topic_score_codex":0.0031681217,"about_ca_topic_score_gemma":0.0011107734,"teacher_disagreement_score":0.06411286,"about_ca_system_score_codex":0.001417852,"about_ca_system_score_gemma":0.00039685846,"threshold_uncertainty_score":0.9986627},"labels":[],"label_agreement":null},{"id":"W1734282631","doi":"10.5489/cuaj.482","title":"An analysis of preoperative delays prior to radical cystectomy forbladder cancer in Quebec","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cystoscopy; Incidence (geometry); Urology; Multivariate analysis; Surgery; Cancer; Internal medicine; Urinary system","score_opus":0.010742636437904827,"score_gpt":0.27242519418939254,"score_spread":0.2616825577514877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1734282631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868902,0.00013249168,0.00012107867,0.011615358,0.000089273206,0.00045492777,0.00008393038,0.000009651743,0.0006030675],"genre_scores_gemma":[0.9946877,0.00002119021,0.00022873312,0.0042298045,0.00014884004,0.00007916036,0.000017379789,0.000009875225,0.000577345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984685,0.00017645561,0.00040400075,0.00021323128,0.00032088038,0.0004168864],"domain_scores_gemma":[0.99837685,0.000068459034,0.00014640897,0.00011798463,0.00034838467,0.0009419298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002630909,0.00013402228,0.00047206302,0.0005587615,0.00009408942,0.00006031796,0.00011371834,0.00020092941,0.0048545874],"category_scores_gemma":[0.00019645595,0.00010084422,0.0001546806,0.0007879725,0.000026889482,0.00017182704,0.000007709274,0.0003282595,0.000028389046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006545112,0.00009880995,0.99055845,0.0000021861126,0.0007579125,0.000029270721,0.0008490184,0.000917802,0.00025109405,0.00003296081,0.0011999578,0.00523708],"study_design_scores_gemma":[0.0011660998,0.00043194348,0.9945193,0.000011927448,0.00054391375,0.0000084836665,0.00019665442,0.0013574745,0.000069765694,0.000047963065,0.0015448126,0.00010165978],"about_ca_topic_score_codex":0.29664895,"about_ca_topic_score_gemma":0.41130427,"teacher_disagreement_score":0.11465529,"about_ca_system_score_codex":0.002012196,"about_ca_system_score_gemma":0.0009939127,"threshold_uncertainty_score":0.9960551},"labels":[],"label_agreement":null},{"id":"W1740468651","doi":"10.5489/cuaj.925","title":"Micropapillary carcinoma of the urinary bladder: a case report and review of the literature","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Pathological; Carcinoma; Pathology; Urinary bladder; Dissection (medical); Magnetic resonance imaging; Metastasis; Biopsy; Lymph node; Radiology; Urology; Bladder cancer; Cancer; Internal medicine","score_opus":0.00890448154932041,"score_gpt":0.22574455136687915,"score_spread":0.21684006981755874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740468651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9332323,0.028797574,2.8354896e-7,0.036126565,0.00017574453,0.0003917666,0.00004192071,0.0000023904615,0.0012314228],"genre_scores_gemma":[0.99045646,0.0016765067,0.0000247344,0.0070778453,0.00011594591,0.000006965213,0.000002620214,0.0000055174896,0.0006334132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990356,0.00016771969,0.00032448766,0.00009885286,0.00020562935,0.00016770801],"domain_scores_gemma":[0.99887633,0.00005253841,0.0003592054,0.0001772116,0.00032439898,0.00021028283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027848786,0.00008614577,0.00022458288,0.000032899006,0.00014310126,0.000016015852,0.00008126579,0.00011326421,0.00030615524],"category_scores_gemma":[0.00055299915,0.000041150302,0.000155628,0.00019369452,0.000053595784,0.000041453193,0.000024675042,0.00034512187,0.0000016883384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000094987745,0.00004249371,0.96843,0.0001812703,0.0001262262,0.0040334687,0.0001821472,1.3824706e-7,0.00013910944,0.000014140605,0.02588683,0.00095471134],"study_design_scores_gemma":[0.00034340037,0.00016511147,0.8842576,0.0005810501,0.00018049721,0.1076844,0.00003241213,0.0000017464305,0.00008112179,0.00016530538,0.0064629354,0.000044428558],"about_ca_topic_score_codex":0.0016578663,"about_ca_topic_score_gemma":0.00012089752,"teacher_disagreement_score":0.103650935,"about_ca_system_score_codex":0.00020673538,"about_ca_system_score_gemma":0.00048322254,"threshold_uncertainty_score":0.33521852},"labels":[],"label_agreement":null},{"id":"W1756869220","doi":"10.5489/cuaj.1025","title":"Synchronous ipsilateral renal cell carcinoma and urothelial carcinoma of the renal pelvis","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Renal pelvis; Urothelium; Medicine; Nephrectomy; Renal cell carcinoma; Urology; Urothelial carcinoma; Upper urinary tract; Lesion; Carcinoma; Pelvis; Urinary system; Radiology; Kidney; Ureter; Urinary bladder; Pathology; Internal medicine; Cancer; Bladder cancer","score_opus":0.008923459787873263,"score_gpt":0.20472242880715097,"score_spread":0.1957989690192777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1756869220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479269,0.007841492,0.00001475683,0.035914756,0.0021850865,0.0005851169,0.0002655688,0.000008449967,0.0052578915],"genre_scores_gemma":[0.98519313,0.00018300844,0.00008930731,0.003653109,0.0022365972,0.000018850043,0.000009335299,0.000031371575,0.008585263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968112,0.0005380206,0.0006758759,0.0003386896,0.0005612949,0.0010749238],"domain_scores_gemma":[0.99736774,0.00017249043,0.00052287476,0.00023650612,0.0004100611,0.0012903155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047090813,0.0003400699,0.00053164194,0.00015357885,0.00049246394,0.00015660441,0.00027447173,0.00054638705,0.004875979],"category_scores_gemma":[0.0002465979,0.000239951,0.00031177606,0.00024333975,0.00023665845,0.0002036685,0.000057407466,0.0010922649,0.00015266285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071030714,0.00012143287,0.9640304,0.00003522211,0.00016721796,0.00013759888,0.0006557581,0.000025010797,0.00097541895,0.00010452191,0.026172627,0.007503762],"study_design_scores_gemma":[0.0029010572,0.0011001437,0.9688113,0.000060046368,0.0004459817,0.00058502844,0.000110642424,0.00027087715,0.000816377,0.00067014014,0.023999294,0.00022915647],"about_ca_topic_score_codex":0.035084475,"about_ca_topic_score_gemma":0.0016318364,"teacher_disagreement_score":0.037266277,"about_ca_system_score_codex":0.0019923253,"about_ca_system_score_gemma":0.0020066975,"threshold_uncertainty_score":0.9960337},"labels":[],"label_agreement":null},{"id":"W1764550786","doi":"10.5489/cuaj.2662","title":"Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case report","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Leiomyosarcoma; Cystectomy; Radiation therapy; Urinary bladder; Malignancy; Urinary system; Cyclophosphamide; Urology; Chemotherapy; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.017663056336003635,"score_gpt":0.24648420929445905,"score_spread":0.22882115295845543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1764550786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865637,0.000526716,0.000025276877,0.008357846,0.00018241524,0.00028875086,0.000016679372,0.000019290947,0.004019327],"genre_scores_gemma":[0.9970257,0.000017257567,0.00015475784,0.0018101461,0.00033152988,0.00002430248,0.000019296413,0.000015470425,0.00060151535],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99844384,0.00010782717,0.00035646025,0.0002094359,0.00039620997,0.00048622023],"domain_scores_gemma":[0.9982485,0.00003664804,0.00021103192,0.00013442102,0.0002923285,0.0010770573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003938191,0.00014945821,0.00027975134,0.00020028869,0.000098615616,0.000047855665,0.000050011186,0.00016633919,0.0002909353],"category_scores_gemma":[0.00023599336,0.000104878214,0.00006542396,0.00028907045,0.000027887001,0.000092130125,0.0000052591918,0.0004837314,0.000033204877],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016562351,0.00012469525,0.5670498,0.0000028349534,0.00016836693,0.42283562,0.0005340463,0.00005622417,0.00000809383,0.000011655424,0.005747912,0.003295128],"study_design_scores_gemma":[0.007890539,0.00391722,0.27181044,0.000039585702,0.0002072101,0.611355,0.00034874727,0.00013988205,0.000037343423,0.00019380054,0.10378411,0.00027610434],"about_ca_topic_score_codex":0.007503575,"about_ca_topic_score_gemma":0.028167281,"teacher_disagreement_score":0.29523933,"about_ca_system_score_codex":0.003746275,"about_ca_system_score_gemma":0.0021378295,"threshold_uncertainty_score":0.9991056},"labels":[],"label_agreement":null},{"id":"W1766945816","doi":"10.18632/oncotarget.1627","title":"Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours","year":2014,"lang":"en","type":"article","venue":"Oncotarget","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Cancer Research UK","keywords":"Bladder cancer; Cystectomy; Medicine; microRNA; Radiation therapy; Cancer; Cancer research; Pathology; Oncology; Internal medicine; Biology; Gene; Genetics","score_opus":0.012281704403950808,"score_gpt":0.26056932978661607,"score_spread":0.24828762538266524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1766945816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903913,0.00021017452,0.0003197141,0.00091493194,0.00018220514,0.00027515565,0.00003344115,0.000026143754,0.007646905],"genre_scores_gemma":[0.99673223,0.000026847778,0.0017331594,0.0004311033,0.00016541373,0.000021180322,0.00012738239,0.00001898375,0.0007436943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99907595,0.000052417756,0.00023577591,0.00020274635,0.00027226505,0.00016086503],"domain_scores_gemma":[0.99950814,0.000046953155,0.00006965408,0.00018610693,0.00010821893,0.00008094996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011450481,0.000117681826,0.00023724399,0.00011150393,0.000026636924,0.0000041193903,0.00004994551,0.00008080114,0.0006571513],"category_scores_gemma":[0.0000572684,0.000098651006,0.00008267389,0.00010734854,0.000042922245,0.00009231277,0.000010968079,0.00009579023,0.0000306795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004099033,0.00041675335,0.18922305,0.000080414604,0.00002782567,0.0000076855285,0.00088986504,0.000049301805,0.8059534,0.00045517873,0.0012156974,0.0012709178],"study_design_scores_gemma":[0.0025705998,0.00043444888,0.92169327,0.00018628126,0.000045621022,0.000006818418,0.00009833638,0.00006809567,0.071284525,0.0007413872,0.0027787497,0.00009184929],"about_ca_topic_score_codex":0.00014167532,"about_ca_topic_score_gemma":0.000083308645,"teacher_disagreement_score":0.73466885,"about_ca_system_score_codex":0.00006574186,"about_ca_system_score_gemma":0.00011584666,"threshold_uncertainty_score":0.7195346},"labels":[],"label_agreement":null},{"id":"W1773860066","doi":"10.5489/cuaj.1200","title":"The case for prostate capsule-sparing radical cystectomy in selected patients","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cystectomy; Capsule; Prostate; Urology; Medicine; General surgery; Internal medicine; Geology","score_opus":0.009711772929168704,"score_gpt":0.2275074764356238,"score_spread":0.2177957035064551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1773860066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985394,0.00012849481,0.00001766449,0.012771363,0.00022351566,0.00092108065,0.000027095113,0.000014878938,0.000501907],"genre_scores_gemma":[0.9974966,0.000023775849,0.00009276786,0.0015818861,0.00019525054,0.00013739687,0.000017421231,0.000012167331,0.00044271935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869716,0.000113892296,0.00031164984,0.00014526042,0.00017434805,0.0005577149],"domain_scores_gemma":[0.99869853,0.00015270968,0.00013671018,0.000071086324,0.00041595494,0.0005249774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033435802,0.000110957335,0.00018645679,0.000091797716,0.0004168556,0.0001194849,0.0000702045,0.0001507372,0.00013104902],"category_scores_gemma":[0.0009720014,0.000069900285,0.00007188007,0.00021659346,0.000025925789,0.00008413809,0.000007326536,0.00040914526,0.000029880683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008097647,0.00007383511,0.97199017,0.0000049644855,0.00010358279,0.00031862574,0.00016415368,0.000008218798,0.000030740164,0.000030748048,0.01378831,0.013405656],"study_design_scores_gemma":[0.00495788,0.00058179005,0.9696103,0.000011849636,0.00005408958,0.000635289,0.00006580263,0.00046574278,0.000027006305,0.0006433815,0.022837793,0.00010909711],"about_ca_topic_score_codex":0.007196081,"about_ca_topic_score_gemma":0.00647733,"teacher_disagreement_score":0.013296559,"about_ca_system_score_codex":0.0013606539,"about_ca_system_score_gemma":0.0004904722,"threshold_uncertainty_score":0.9994151},"labels":[],"label_agreement":null},{"id":"W1773912336","doi":"10.5489/cuaj.2793","title":"Few modifiable factors predict readmission following radical cystectomy","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University; National Institutes of Health","keywords":"Medicine; Cystectomy; Confidence interval; Reimbursement; Healthcare Cost and Utilization Project; Odds ratio; Logistic regression; Bladder cancer; Health care; Hospital readmission; Emergency medicine; Medicaid; Internal medicine; Cancer","score_opus":0.031160787571824628,"score_gpt":0.2642042322983253,"score_spread":0.23304344472650065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1773912336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97306144,0.0005206068,0.00011740221,0.010905477,0.001038837,0.00028417428,0.000033651646,0.00007425198,0.013964141],"genre_scores_gemma":[0.9952315,0.000018689403,0.00019735294,0.001840356,0.0005655717,0.0000072763933,0.000037014357,0.000018206418,0.0020840454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998123,0.00015780484,0.0003133307,0.00021034804,0.00063087133,0.00056467607],"domain_scores_gemma":[0.9969473,0.000074406074,0.00014435455,0.00011620775,0.00016875347,0.0025489815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057788024,0.0001706478,0.0003428066,0.00016024847,0.0002545648,0.00008538642,0.00011073913,0.00032218036,0.00043893867],"category_scores_gemma":[0.0011084991,0.00012180442,0.00021929969,0.00021510215,0.000020473974,0.00013895835,0.000012924681,0.0005789182,0.000074219584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103429906,0.0000722644,0.95585066,0.000003050457,0.00023348468,0.0003762529,0.00021644711,0.000045204906,0.000066854904,0.00003447574,0.042156782,0.00084109936],"study_design_scores_gemma":[0.0101164,0.0020686872,0.5291035,0.00008203937,0.0005814902,0.0006362812,0.000430625,0.00056067645,0.0002272477,0.0020552329,0.45371097,0.00042680986],"about_ca_topic_score_codex":0.0031700227,"about_ca_topic_score_gemma":0.00013354867,"teacher_disagreement_score":0.4267471,"about_ca_system_score_codex":0.002401296,"about_ca_system_score_gemma":0.0017212658,"threshold_uncertainty_score":0.6279306},"labels":[],"label_agreement":null},{"id":"W1776349403","doi":"10.5489/cuaj.1174","title":"NMP22: Does it have a predictive potential for recurrence and progression in non-muscle-invasive bladder cancer?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Medicine; Urology; Oncology; Internal medicine; Cancer","score_opus":0.011144518846038162,"score_gpt":0.27116014601800953,"score_spread":0.26001562717197135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1776349403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9513541,0.0004779042,0.00017169023,0.04524287,0.0005011847,0.0014692817,0.00018554894,0.000014942726,0.00058250857],"genre_scores_gemma":[0.99532855,0.00040134415,0.000254911,0.0028409595,0.0005152928,0.00031255707,0.000018340894,0.000012287602,0.00031577988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986696,0.00007539555,0.00028051,0.0002518559,0.00024535565,0.00047724094],"domain_scores_gemma":[0.99868894,0.000114977665,0.00019177952,0.00006439637,0.00034597982,0.00059392507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023051225,0.00015119527,0.00026485667,0.00014519793,0.000200357,0.00008811764,0.00006918887,0.00023590114,0.0004661913],"category_scores_gemma":[0.0003968094,0.00009959521,0.00008227363,0.00009877462,0.000043369342,0.00016618006,0.000013400776,0.0003845981,0.000008393574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015911387,0.00011178621,0.94460714,0.000021171267,0.00020524712,0.000076092554,0.0009346812,0.0000273236,0.0002712838,0.00000904715,0.01190526,0.041671872],"study_design_scores_gemma":[0.002898381,0.00093451183,0.99009556,0.00012239086,0.00012859046,0.00004711509,0.00054214295,0.0009786093,0.00008615052,0.0014001678,0.0026218125,0.00014455797],"about_ca_topic_score_codex":0.0047951173,"about_ca_topic_score_gemma":0.008221434,"teacher_disagreement_score":0.04548845,"about_ca_system_score_codex":0.00090635,"about_ca_system_score_gemma":0.0006918219,"threshold_uncertainty_score":0.72488153},"labels":[],"label_agreement":null},{"id":"W1778688357","doi":"10.1111/j.1464-410x.2012.11322.x","title":"Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Hazard ratio; Body mass index; Cystectomy; Internal medicine; Bladder cancer; Confidence interval; Urology; Obesity; Retrospective cohort study; Cancer; Surgery; Gastroenterology","score_opus":0.013506724173729332,"score_gpt":0.2570364446076014,"score_spread":0.24352972043387205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1778688357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819076,0.0004770386,0.0000127187695,0.00037166092,0.00007860245,0.00025199872,0.00001715533,0.000014527977,0.0005855172],"genre_scores_gemma":[0.99820423,0.000046763787,0.00014235397,0.0013485118,0.00007820155,0.0000069498587,0.00001051497,0.000018243916,0.00014420957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986027,0.000182055,0.00035967128,0.000134928,0.00032817587,0.00039248867],"domain_scores_gemma":[0.9991166,0.000093669114,0.00023308527,0.00008142727,0.00021284778,0.0002623433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022562238,0.00014788817,0.00067565084,0.00010620106,0.00004455774,0.000010710318,0.00007861425,0.00018281699,0.00025719093],"category_scores_gemma":[0.0001587275,0.00010252,0.00007562938,0.00021809443,0.00014291026,0.00012387914,0.00001653853,0.00046256176,0.000007153263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021574714,0.0032884118,0.9889424,0.0000044666795,0.00037848376,0.0020831472,0.00009590534,0.0000013848751,0.000002744549,0.0000018442817,0.00049058837,0.002553159],"study_design_scores_gemma":[0.019148178,0.006843186,0.9695183,0.0000955116,0.00033388133,0.0034316238,0.00001465135,0.000001741369,0.000021870563,0.000007249854,0.0004845755,0.00009923872],"about_ca_topic_score_codex":0.00014252063,"about_ca_topic_score_gemma":0.00012650818,"teacher_disagreement_score":0.019424101,"about_ca_system_score_codex":0.000187,"about_ca_system_score_gemma":0.00013668243,"threshold_uncertainty_score":0.41806445},"labels":[],"label_agreement":null},{"id":"W1779426963","doi":"","title":"A Comparison of Early Results and Patient Satisfaction Rate between Modified Radical Cystectomy with Mainz II Urinary Diversion and Standard Radical Cystectomy with Continent Ileocecal Urinary Diversion","year":2015,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Surgery; Urinary system; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.15998122178223226,"score_gpt":0.47296251621266194,"score_spread":0.31298129443042966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1779426963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922402,0.004888232,0.00025368028,0.00033013662,0.00011881314,0.0012902925,0.00025339084,0.000036959467,0.00058832986],"genre_scores_gemma":[0.99851906,0.0008345588,0.00035970288,0.000047418438,0.000085246356,0.000024830426,0.000037460555,0.000041861862,0.000049875172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658877,0.0003633969,0.00082594436,0.0006021328,0.0012435562,0.00037622912],"domain_scores_gemma":[0.9974945,0.0002021479,0.0007984307,0.00034867937,0.00040178868,0.0007544623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063092535,0.000422193,0.0013526662,0.0004821125,0.00034251623,0.0001736087,0.00030749338,0.00017442548,0.00014538085],"category_scores_gemma":[0.00007739339,0.00029669958,0.000091474205,0.00043489467,0.00047941515,0.00093109976,0.0006814154,0.00049529894,0.0000012706029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05018798,0.0006649099,0.9303797,0.00018917189,0.00063581485,0.00038026064,0.0017128754,0.000037522044,0.0022213573,0.0000042718866,0.002733261,0.010852893],"study_design_scores_gemma":[0.021035964,0.0056540114,0.961628,0.0015831228,0.0008538829,0.00021537198,0.00058515643,0.000079114354,0.0065172794,0.00009396977,0.0013879775,0.00036610654],"about_ca_topic_score_codex":0.0016841161,"about_ca_topic_score_gemma":0.000019405683,"teacher_disagreement_score":0.031248359,"about_ca_system_score_codex":0.00022579546,"about_ca_system_score_gemma":0.00029483796,"threshold_uncertainty_score":0.9999485},"labels":[],"label_agreement":null},{"id":"W1788729872","doi":"10.1111/j.1464-410x.2012.10939.x","title":"Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cystectomy; Medicine; Lymphovascular invasion; Bladder cancer; Hazard ratio; Urology; Stage (stratigraphy); Pathological; Cancer; Surgery; Oncology; Internal medicine; Confidence interval; Metastasis","score_opus":0.019184835058262358,"score_gpt":0.28416414140141194,"score_spread":0.2649793063431496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1788729872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309886,0.0058143833,0.000009285407,0.00035445206,0.00017742631,0.00023559049,0.00006609394,0.0000071567893,0.00023675102],"genre_scores_gemma":[0.99920136,0.00012839297,0.0000054860643,0.00031286033,0.00013926106,0.0000042003303,0.000002879391,0.00002714449,0.00017840177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863976,0.0002427235,0.0004084795,0.00010875812,0.00031774153,0.00028251673],"domain_scores_gemma":[0.9988281,0.0003980012,0.00043580332,0.00008827079,0.00011063493,0.00013917484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005270368,0.00014433154,0.00063879625,0.000088560766,0.00006872827,0.0000060798548,0.000088649875,0.00009409107,0.00024131534],"category_scores_gemma":[0.00022188264,0.00009218962,0.00012160664,0.00009787946,0.00017243977,0.000068660804,0.000031381598,0.00031877958,0.0000017543015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002013722,0.00027019117,0.9825274,0.00007177798,0.0010102568,0.00015255722,0.00070712,0.0000244218,0.006842106,0.000010411089,0.00016905558,0.006200994],"study_design_scores_gemma":[0.012420049,0.005669302,0.95590025,0.0006115622,0.0014943972,0.0026194,0.00005409361,0.000036782476,0.020264488,0.000014577413,0.00074064214,0.00017446633],"about_ca_topic_score_codex":0.00011271421,"about_ca_topic_score_gemma":0.000025200583,"teacher_disagreement_score":0.026627148,"about_ca_system_score_codex":0.000098830715,"about_ca_system_score_gemma":0.00008685542,"threshold_uncertainty_score":0.37593836},"labels":[],"label_agreement":null},{"id":"W1791564421","doi":"10.6000/1927-7229.2015.04.02.3","title":"Inflammation and Urothelial Bladder Cancer: What we Need to Known? (Review)","year":2015,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Inflammation; Bladder cancer; Medicine; Cancer; Oncology; Tumor progression; Transitional cell carcinoma; Internal medicine","score_opus":0.05222161708056629,"score_gpt":0.37970456615398585,"score_spread":0.32748294907341957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1791564421","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2515103,0.12259855,0.0006015289,0.60827136,0.002242817,0.0012265919,0.000011374841,0.00003280444,0.013504692],"genre_scores_gemma":[0.5299399,0.3938463,0.005422408,0.05255626,0.009730803,0.00007397431,0.000009824572,0.000116289644,0.008304223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871916,0.000085975735,0.0005332495,0.00012965292,0.00033601443,0.00019598076],"domain_scores_gemma":[0.99850154,0.00008291557,0.00019192636,0.000111395144,0.00045990074,0.0006522953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041994266,0.00013123207,0.000654037,0.0001556957,0.000021801052,0.000019551058,0.000073785784,0.00010698316,0.00030431597],"category_scores_gemma":[0.00025908512,0.00008986327,0.00011740808,0.00019813028,0.000066019114,0.00021687346,0.000033934535,0.00023833252,0.000046358786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038056665,0.00059776625,0.0041379547,0.00032609684,0.0012510619,0.00076511316,0.0012596685,0.000055823366,0.0009240755,0.00046102432,0.19602473,0.790391],"study_design_scores_gemma":[0.0076032486,0.009201773,0.0030337574,0.0015221749,0.0021950712,0.0012372344,0.00071271835,0.00030944252,0.0006148421,0.00052094634,0.9728639,0.00018487837],"about_ca_topic_score_codex":0.000031967444,"about_ca_topic_score_gemma":0.000030505553,"teacher_disagreement_score":0.79020613,"about_ca_system_score_codex":0.00034869372,"about_ca_system_score_gemma":0.0009373944,"threshold_uncertainty_score":0.36645177},"labels":[],"label_agreement":null},{"id":"W1794685346","doi":"10.5489/cuaj.879","title":"Using clinical practice guidelines in our own backyard: treating our patients with bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Bladder cancer; Clinical Practice; Medicine; Cancer; Medical physics; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.05928145591891777,"score_gpt":0.3774244963083596,"score_spread":0.31814304038944186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1794685346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9225634,0.00026678827,0.000036754,0.073906995,0.000540491,0.0005450524,0.000037820126,0.000020915322,0.0020818275],"genre_scores_gemma":[0.97328734,0.00010211141,0.004707623,0.019941604,0.0012583862,0.000027541222,0.000013835683,0.000027140326,0.0006343892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975933,0.00026935866,0.00076627114,0.0002790449,0.000503875,0.0005881759],"domain_scores_gemma":[0.99675775,0.000094589544,0.0005037281,0.00011877994,0.0017495224,0.00077563385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068579026,0.00020243802,0.000419067,0.00016084827,0.0001920739,0.00011568682,0.000095642674,0.0002851671,0.0003661812],"category_scores_gemma":[0.0028984642,0.00013728025,0.00011816143,0.0002662629,0.000011098914,0.00034111913,0.000013565037,0.00072407426,0.00006586477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009827474,0.00013081642,0.9697296,0.0000021639523,0.00024055877,0.000063607695,0.000050426104,0.00012114017,0.00000483296,0.000002688558,0.017618533,0.011937359],"study_design_scores_gemma":[0.004269508,0.0005256444,0.9761743,0.000053997,0.00027120096,0.00006756987,0.00051731704,0.0004025616,0.0000021426445,0.000049609593,0.017487828,0.00017833212],"about_ca_topic_score_codex":0.027101854,"about_ca_topic_score_gemma":0.00401136,"teacher_disagreement_score":0.05396539,"about_ca_system_score_codex":0.0015721379,"about_ca_system_score_gemma":0.0013192835,"threshold_uncertainty_score":0.97937673},"labels":[],"label_agreement":null},{"id":"W1795642782","doi":"10.1111/j.1464-410x.2010.09826.x","title":"Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Interquartile range; Lymphovascular invasion; Cohort; Urology; Proportional hazards model; Stage (stratigraphy); Urothelial carcinoma; Concomitant; Retrospective cohort study; Internal medicine; Cancer; Surgery; Bladder cancer; Metastasis","score_opus":0.018433397827157794,"score_gpt":0.32672297515402315,"score_spread":0.30828957732686535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1795642782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217516,0.00024606238,0.000014438382,0.0047515538,0.0010261576,0.00018736006,0.00011592212,0.000008776093,0.0014745628],"genre_scores_gemma":[0.99199086,0.0002893863,0.0021223424,0.0048096427,0.0005955576,0.000009550268,0.000028792112,0.000011761201,0.00014208823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989466,0.000091073955,0.00040008154,0.00021648442,0.00018990388,0.00015582492],"domain_scores_gemma":[0.99926245,0.00011583286,0.00015083422,0.00012513834,0.000103804276,0.0002419244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002841322,0.000100005316,0.0004638176,0.00004958692,0.000039723614,0.00009041718,0.00025110994,0.00018179537,0.0008709608],"category_scores_gemma":[0.00028413816,0.00008506707,0.0000652953,0.000028335695,0.00017678185,0.0002252654,0.00010227195,0.0005679965,0.0000064145765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041924925,0.00041683024,0.96208566,0.0000015389427,0.00035248563,0.0040143225,0.000088121684,2.2902789e-7,0.00038254954,0.000017285227,0.0013473851,0.027101098],"study_design_scores_gemma":[0.010010053,0.0011781271,0.9549931,0.000018881088,0.00018024036,0.0070423824,0.000008048127,0.000009706462,0.00004544355,0.00048426163,0.025960075,0.00006966999],"about_ca_topic_score_codex":0.0005729085,"about_ca_topic_score_gemma":0.00055596593,"teacher_disagreement_score":0.027031427,"about_ca_system_score_codex":0.000026365798,"about_ca_system_score_gemma":0.00014353418,"threshold_uncertainty_score":0.95364106},"labels":[],"label_agreement":null},{"id":"W1822881141","doi":"10.5489/cuaj.119","title":"Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Boniface Hospital; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Western University; McGill University; Dalhousie University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymph node; Chemotherapy; Urology; Dissection (medical); Cohort; Internal medicine; Oncology; Surgery; Cancer","score_opus":0.01818810175208351,"score_gpt":0.2517849503403026,"score_spread":0.2335968485882191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1822881141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936053,0.0023663205,0.000018254927,0.0021842648,0.00020419495,0.00040261613,0.00010752357,0.00001401757,0.0010974767],"genre_scores_gemma":[0.9944399,0.00018334818,0.00029500003,0.004108555,0.0002446387,0.00003142417,0.0000393461,0.0000151815775,0.00064259896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863726,0.00012902313,0.0003144227,0.00018619918,0.00031265678,0.00042041205],"domain_scores_gemma":[0.9987298,0.000080188,0.00026565892,0.00006690537,0.00023098873,0.0006264248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002055846,0.00019518446,0.00048600908,0.00017220767,0.00007857935,0.000010760355,0.000056368834,0.00011608256,0.00023517519],"category_scores_gemma":[0.00011314126,0.0001205085,0.00007158699,0.00019936441,0.00022921135,0.00013935282,0.0000062930158,0.000485543,0.0000044798435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012778906,0.00018522578,0.99422073,0.0000051435236,0.00044840085,0.00013344479,0.00035375057,0.0000045047886,0.00009308213,0.0000046177083,0.001987001,0.0012861777],"study_design_scores_gemma":[0.005906053,0.00055194856,0.98214203,0.000034687782,0.00011054348,0.00027794353,0.000036788333,0.00012404127,0.000024205307,6.1354234e-7,0.010651559,0.00013959323],"about_ca_topic_score_codex":0.018855497,"about_ca_topic_score_gemma":0.007526951,"teacher_disagreement_score":0.012078737,"about_ca_system_score_codex":0.0037349642,"about_ca_system_score_gemma":0.0021871405,"threshold_uncertainty_score":0.98767805},"labels":[],"label_agreement":null},{"id":"W1826289243","doi":"10.5489/cuaj.1173","title":"NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cytology; Urine cytology; Urine; Urology; Proportional hazards model; Bladder cancer; Cancer; Internal medicine; Pathology","score_opus":0.009347732336283695,"score_gpt":0.23270420190969296,"score_spread":0.22335646957340927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1826289243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311775,0.00019967898,0.0000070170113,0.0047311718,0.00040739644,0.00035331462,0.0003324472,0.0000072695752,0.0008439358],"genre_scores_gemma":[0.99700946,0.00029191287,0.000046850353,0.0021305406,0.00027822613,0.000039793274,0.000018009332,0.00000991311,0.00017532715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985266,0.00013383209,0.00038100232,0.00018431824,0.00037194564,0.00040234101],"domain_scores_gemma":[0.998647,0.00007144057,0.00025937136,0.00007682902,0.0004962855,0.0004490846],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018948312,0.00013035398,0.0002991443,0.000176019,0.0001005002,0.000026095226,0.00009264349,0.00021771407,0.0035717848],"category_scores_gemma":[0.0003790085,0.000102408274,0.00009013041,0.00024641043,0.000035446308,0.0001347069,0.000010710393,0.00052457716,0.000051460782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057619916,0.00012412595,0.98262286,0.0000024943106,0.00012050262,0.0000058087085,0.00042230388,0.000013538964,0.000009478202,0.0000097592265,0.009979684,0.0066318484],"study_design_scores_gemma":[0.0020338916,0.00072266906,0.99453497,0.0000225657,0.00009607144,0.0000034858515,0.000061581006,0.00008016923,0.000065292086,0.00073819014,0.0015530824,0.00008803869],"about_ca_topic_score_codex":0.05757558,"about_ca_topic_score_gemma":0.0048774523,"teacher_disagreement_score":0.052698128,"about_ca_system_score_codex":0.0011966996,"about_ca_system_score_gemma":0.00067624246,"threshold_uncertainty_score":0.99733907},"labels":[],"label_agreement":null},{"id":"W1828332964","doi":"10.5489/cuaj.1201","title":"Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Urology; Medicine; Prostate cancer; Prostate; Bladder cancer; Cancer; Internal medicine","score_opus":0.024397555049527824,"score_gpt":0.2647974585296815,"score_spread":0.2403999034801537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1828332964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87132424,0.0010966314,0.000069490045,0.12311774,0.0005555842,0.0026068892,0.00020164376,0.00004979299,0.0009780164],"genre_scores_gemma":[0.97578555,0.00014882065,0.000109837994,0.02125496,0.0007346967,0.00056038896,0.000013691707,0.000036330457,0.0013557122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761504,0.00022016076,0.0005233345,0.0003343164,0.00038049524,0.0009266476],"domain_scores_gemma":[0.9976644,0.00044051686,0.00036160892,0.00023665185,0.0005395027,0.00075731875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069698034,0.0002780595,0.000394967,0.00010441361,0.0010008602,0.0003472201,0.0001878646,0.00024374056,0.00075809134],"category_scores_gemma":[0.0006194723,0.00014805216,0.00023927886,0.00023849239,0.00013323779,0.00016380246,0.000032114367,0.0008798048,0.000055873083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004903949,0.00017257176,0.8208736,0.00007476131,0.0026960322,0.0023341703,0.005676212,0.00037165245,0.0006623087,0.00017259622,0.13395424,0.032521468],"study_design_scores_gemma":[0.019720651,0.0014847677,0.5509122,0.00021354115,0.0016715233,0.010253556,0.002807819,0.00800278,0.0006420583,0.0034844712,0.3997287,0.0010779547],"about_ca_topic_score_codex":0.013286118,"about_ca_topic_score_gemma":0.007268848,"teacher_disagreement_score":0.2699614,"about_ca_system_score_codex":0.0012900117,"about_ca_system_score_gemma":0.0011232988,"threshold_uncertainty_score":0.9932845},"labels":[],"label_agreement":null},{"id":"W1831939955","doi":"10.1002/9781118674826.ch3","title":"Utility of urine biomarkers","year":2015,"lang":"en","type":"other","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Cystoscopy; Bladder cancer; Urine cytology; Medicine; Urine; Cytology; Urinary system; Urology; Cancer; Urinary bladder; Internal medicine; Pathology","score_opus":0.035585582907429025,"score_gpt":0.32316588186901146,"score_spread":0.28758029896158244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831939955","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014026614,0.027086742,0.0000105250865,0.00025995597,0.00070180447,0.00069322594,0.0011560458,0.00015274645,0.9697987],"genre_scores_gemma":[0.008268342,0.001714331,0.00031941748,0.00035997047,0.0009205927,0.00009594948,0.0001991,0.0005156492,0.98760664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863976,0.000027509304,0.0002574213,0.00038981263,0.00042433242,0.00026118796],"domain_scores_gemma":[0.998905,0.000008648122,0.00018659329,0.00057253457,0.00011115009,0.00021608273],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006421997,0.00031819535,0.0006710063,0.00018459214,0.0000121310795,0.000004361856,0.00011012708,0.0002860463,0.038904928],"category_scores_gemma":[0.00001695067,0.00025500567,0.00015549442,0.00021997753,0.00015597057,0.000017196737,0.000045331693,0.00014420104,0.00011366902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024394233,0.00018838838,0.005867542,0.00036053115,0.0016711787,0.00002333042,0.000054178796,4.511082e-8,0.000043409345,0.000005872952,0.9831314,0.008410175],"study_design_scores_gemma":[0.0026564393,0.00014991488,0.0041581644,0.0005629128,0.00077306945,0.000010808002,0.000028390605,0.000004664706,0.00062785996,0.000032472173,0.99078196,0.00021331753],"about_ca_topic_score_codex":0.0045226365,"about_ca_topic_score_gemma":0.0010064521,"teacher_disagreement_score":0.038791258,"about_ca_system_score_codex":0.00006455756,"about_ca_system_score_gemma":0.00095029443,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W1836073398","doi":"10.5489/cuaj.2790","title":"Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Ketamine; Cystectomy; Analgesic; Surgery; Anesthesia; Morphine; Opioid; Retrospective cohort study; Internal medicine; Bladder cancer","score_opus":0.01836166424044635,"score_gpt":0.24184988050867023,"score_spread":0.22348821626822388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1836073398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563825,0.00006746595,0.00012249594,0.0030013777,0.00010502798,0.00016634178,0.000005986682,0.00001071258,0.00088236935],"genre_scores_gemma":[0.9976357,0.0000065159106,0.00018813428,0.002010368,0.00009298458,0.000005188521,0.000014993641,0.0000075170724,0.0000385629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988465,0.00011780122,0.0001838953,0.00016268424,0.00037430853,0.00031483002],"domain_scores_gemma":[0.9988207,0.0000674872,0.00010078739,0.000055644803,0.00014447478,0.0008108762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019370757,0.0001110004,0.00020885647,0.00016913992,0.00011334877,0.00004543164,0.000051100258,0.00013008241,0.00007231583],"category_scores_gemma":[0.00031317037,0.00008121877,0.000031401185,0.00018811034,0.00004667524,0.0001020191,0.000008579761,0.00029041801,0.0000056627537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002917374,0.00006271331,0.99808276,0.0000028083346,0.000025584553,0.00018631537,0.00021260731,0.00008349731,0.0000012251498,0.000009629319,0.00029986925,0.0007412713],"study_design_scores_gemma":[0.008913424,0.0015653083,0.9882393,0.000033910765,0.000053074207,0.000053909433,0.00013435338,0.00021684715,0.000008381125,0.00005995713,0.00062495196,0.00009657705],"about_ca_topic_score_codex":0.0010374656,"about_ca_topic_score_gemma":0.0011489709,"teacher_disagreement_score":0.009843435,"about_ca_system_score_codex":0.0012972187,"about_ca_system_score_gemma":0.0008118749,"threshold_uncertainty_score":0.33921817},"labels":[],"label_agreement":null},{"id":"W1836508011","doi":"10.1016/j.humpath.2015.06.010","title":"Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant","year":2015,"lang":"en","type":"article","venue":"Human Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"","keywords":"Desmoplasia; Pathology; Biology; Carcinoma; Squamous carcinoma; Nuclear atypia; Stroma; Medicine; Immunohistochemistry","score_opus":0.04258106611150062,"score_gpt":0.26378848993267245,"score_spread":0.22120742382117184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1836508011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942174,0.00022008401,0.00030830203,0.0011087187,0.00006148777,0.0006255039,0.000058811787,0.000070337854,0.0033293457],"genre_scores_gemma":[0.9974359,0.000005245495,0.00020804345,0.0011005331,0.00011399684,0.00007320616,0.00004170083,0.00003673895,0.0009846331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987185,0.00014727702,0.00021183456,0.00032536854,0.00022506915,0.00037194128],"domain_scores_gemma":[0.99913037,0.000050412484,0.00014531746,0.00045502055,0.000098329816,0.00012055066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017264926,0.00023688877,0.00047559303,0.0000917905,0.00012746398,0.00001122806,0.00011638702,0.00009541983,0.00011625404],"category_scores_gemma":[0.000038376576,0.0001262785,0.00005246799,0.00017731778,0.00038095462,0.000072969786,0.000053180036,0.00019416661,0.000012411064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013745719,0.0017181933,0.8670511,0.00021672616,0.0007502398,0.06365389,0.01477751,0.0000333036,0.02538677,0.006455824,0.006093401,0.00011728844],"study_design_scores_gemma":[0.027028194,0.024464535,0.8847689,0.00018203405,0.0012934781,0.04696474,0.004396709,0.00003483507,0.0067039845,0.00095966586,0.002630382,0.00057255203],"about_ca_topic_score_codex":0.0005745642,"about_ca_topic_score_gemma":0.0020366,"teacher_disagreement_score":0.022746341,"about_ca_system_score_codex":0.00006399923,"about_ca_system_score_gemma":0.00027898635,"threshold_uncertainty_score":0.5149487},"labels":[],"label_agreement":null},{"id":"W1837119561","doi":"10.3109/0886022x.2015.1103638","title":"Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy","year":2015,"lang":"en","type":"article","venue":"Renal Failure","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Urology; Hazard ratio; Renal function; Nephrectomy; Proportional hazards model; Kidney disease; Dialysis; Renal cell carcinoma; Internal medicine; Surgery; Kidney; Confidence interval","score_opus":0.014865755628603924,"score_gpt":0.27961351442110144,"score_spread":0.2647477587924975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1837119561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997382,0.00012314423,0.000010575774,0.001023099,0.0001764051,0.00077287963,0.000053257856,0.00002945404,0.00042921727],"genre_scores_gemma":[0.9984419,0.0000021032222,0.0006352791,0.0003161585,0.00017341408,0.000045567667,0.00018935165,0.000031402426,0.00016487094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985316,0.00008121452,0.00029650345,0.0002730034,0.00051894825,0.00029877588],"domain_scores_gemma":[0.99890727,0.000013184368,0.00006674891,0.00022677984,0.00006564172,0.0007204068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010029269,0.00019925956,0.00034925726,0.00012833302,0.000027174401,0.00001311963,0.00008838074,0.000107328546,0.000071754584],"category_scores_gemma":[0.00009402435,0.00014604357,0.00018999462,0.0001798404,0.00005012057,0.00013388369,0.00003494648,0.00020068522,0.0000128453985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020617924,0.0007502941,0.99143654,0.000058921203,0.000049570408,0.00021615259,0.00036901285,0.000002424484,0.0004158196,0.00000947414,0.0018786346,0.0027513506],"study_design_scores_gemma":[0.019703677,0.0011032429,0.9570358,0.0007175659,0.00023212911,0.0000129079735,0.000029567967,0.00008684743,0.002248828,0.000072171715,0.018539315,0.00021793903],"about_ca_topic_score_codex":0.00007487153,"about_ca_topic_score_gemma":0.000002978067,"teacher_disagreement_score":0.034400746,"about_ca_system_score_codex":0.00015208656,"about_ca_system_score_gemma":0.00055523997,"threshold_uncertainty_score":0.59554845},"labels":[],"label_agreement":null},{"id":"W1839861539","doi":"10.1111/iju.12611","title":"Reporting trends and prognostic significance of lymphovascular invasion in muscle‐invasive urothelial carcinoma: A population‐based study","year":2014,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Lymphovascular invasion; Medicine; Oncology; Hazard ratio; Internal medicine; Population; Pathological; Cancer; Metastasis; Confidence interval","score_opus":0.02449434780726755,"score_gpt":0.30274419246533457,"score_spread":0.278249844658067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1839861539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981083,0.00015350994,0.0002989979,0.00080491405,0.000292317,0.00018120144,0.0000037819445,0.000004505993,0.0001524591],"genre_scores_gemma":[0.99912477,0.000008317404,0.00037565222,0.00023973447,0.00020786512,0.000010155689,0.0000065976424,0.000012251968,0.000014634732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998176,0.00014437377,0.0010084206,0.0001663496,0.00039424578,0.00011062512],"domain_scores_gemma":[0.9982219,0.00019746985,0.0010790492,0.0001123339,0.00032503778,0.00006420978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006015941,0.0001052736,0.00038674797,0.00048030322,0.000016622827,0.00000794484,0.00010694927,0.00005611819,0.00003941797],"category_scores_gemma":[0.0011936331,0.00008622072,0.0001057364,0.00012376023,0.00003491252,0.000066642344,0.000025964931,0.00012796646,5.83991e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066605303,0.0005529564,0.9817262,0.000015491214,0.00014188097,0.00038643336,0.00030321802,0.00022189153,0.0028342218,0.000021153799,0.0000063894267,0.0131240925],"study_design_scores_gemma":[0.0064959065,0.00199872,0.98965746,0.000050769755,0.00016776774,0.0003172444,0.00006302892,0.0002642211,0.0006864424,0.00018468204,0.00005737421,0.00005635247],"about_ca_topic_score_codex":0.00043297917,"about_ca_topic_score_gemma":0.00015423869,"teacher_disagreement_score":0.01306774,"about_ca_system_score_codex":0.000090065754,"about_ca_system_score_gemma":0.00020158892,"threshold_uncertainty_score":0.3515979},"labels":[],"label_agreement":null},{"id":"W1841258306","doi":"10.25011/cim.v38i4.24262","title":"Sensitivity and Specificity of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Bladder Cancers","year":2015,"lang":"en","type":"review","venue":"Clinical and investigative medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diagnostic odds ratio; Likelihood ratios in diagnostic testing; Medicine; Meta-analysis; Bladder cancer; Magnetic resonance imaging; Odds ratio; Diffusion MRI; Confidence interval; Area under the curve; Internal medicine; Nuclear medicine; Radiology; Cancer","score_opus":0.16974423843613629,"score_gpt":0.38989129019608737,"score_spread":0.22014705175995108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1841258306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012040682,0.9851375,0.0000017166351,0.0008974174,0.00021712236,0.0009175546,0.00012027299,0.000010554117,0.00065717613],"genre_scores_gemma":[0.007609807,0.9913321,0.00018521273,0.0002885695,0.00031260517,0.0000542738,0.00004639417,0.000031421867,0.00013961174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685204,0.0005065571,0.0014566488,0.0006041239,0.00035416178,0.0002264553],"domain_scores_gemma":[0.9977146,0.0008104528,0.0005030098,0.00031399456,0.00022542273,0.00043251435],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0009517582,0.00040898577,0.003493394,0.00019297143,0.000025404679,0.0000026739388,0.00006675641,0.00021945145,0.00009657924],"category_scores_gemma":[0.0011387088,0.00025746255,0.00015510537,0.00042373352,0.009148971,0.000052637315,0.000113442504,0.00053534296,0.0000016893312],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008046966,0.0001581669,0.14102702,0.0034295183,0.0000632471,0.000084731924,0.0002635124,9.734888e-9,0.0000036520285,0.00008320105,0.0011095951,0.8536969],"study_design_scores_gemma":[0.009200537,0.003056006,0.19950208,0.08404819,0.0036100284,0.00009566684,0.0002951874,0.000065686116,0.00003950178,0.0031078015,0.6964423,0.00053702656],"about_ca_topic_score_codex":0.0014255645,"about_ca_topic_score_gemma":0.00016657596,"teacher_disagreement_score":0.85315984,"about_ca_system_score_codex":0.00008559333,"about_ca_system_score_gemma":0.00059437804,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W1844666291","doi":"10.1111/j.1464-410x.2012.10930.x","title":"International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Renal pelvis; Urothelial carcinoma; Stage (stratigraphy); Medicine; Upper urinary tract; Pelvis; Urology; Carcinoma; Urothelium; Oncology; Internal medicine; Radiology; Ureter; Urinary system; Cancer; Urinary bladder; Geology; Bladder cancer","score_opus":0.024210614290211797,"score_gpt":0.2834191170802782,"score_spread":0.2592085027900664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1844666291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958194,0.00064599246,0.0006111034,0.0011427689,0.00075576844,0.00042926538,0.00016323273,0.0000018650035,0.0004306099],"genre_scores_gemma":[0.99903303,0.000071880706,0.0002517487,0.000102172,0.00035077287,0.000010170984,0.000009697229,0.000013749977,0.00015675034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987691,0.00014492752,0.0005452944,0.000079183905,0.00032444426,0.00013704489],"domain_scores_gemma":[0.9985364,0.0001395298,0.00073570193,0.00013615451,0.00040587067,0.000046356952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039754916,0.00007669022,0.00025432685,0.00006411645,0.00003807139,0.000005071021,0.0002004512,0.00008053692,0.00010215854],"category_scores_gemma":[0.00039316594,0.00005350245,0.00025132034,0.000084982894,0.00014422736,0.000103350525,0.000024679648,0.00016072007,3.8069993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010203002,0.0010307833,0.9447112,0.00009608689,0.00029251433,0.0000056970916,0.000563688,0.00006623225,0.042143624,0.0005488518,0.0005058743,0.009015123],"study_design_scores_gemma":[0.002659811,0.0006618315,0.9461959,0.00008797122,0.0004091934,0.0009963121,0.000054598182,0.00006469093,0.04648291,0.00014601635,0.002200268,0.000040486557],"about_ca_topic_score_codex":0.000084190164,"about_ca_topic_score_gemma":0.0000043525633,"teacher_disagreement_score":0.008974637,"about_ca_system_score_codex":0.000043411128,"about_ca_system_score_gemma":0.00021927484,"threshold_uncertainty_score":0.21817665},"labels":[],"label_agreement":null},{"id":"W1847493486","doi":"10.5489/cuaj.1195","title":"Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"Bladder cancer; Cancer; Urothelial cancer; Urothelial Cell; Urothelial carcinoma; Histology; Pathology; Adenocarcinoma; Medicine; Oncology; Cancer research; Biology; Internal medicine","score_opus":0.01427132968854184,"score_gpt":0.254080808540475,"score_spread":0.23980947885193316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1847493486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602867,0.0029763512,0.000019829651,0.031541307,0.00085975346,0.0006339045,0.00014100451,0.000021127933,0.0035200366],"genre_scores_gemma":[0.99018425,0.0010505597,0.00015603716,0.0062672985,0.00046353176,0.00013415345,0.000006843332,0.00002468558,0.001712622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979015,0.00017862546,0.0005744928,0.00033371823,0.00032573557,0.0006859149],"domain_scores_gemma":[0.99843895,0.00011532197,0.00034437177,0.00013201867,0.00032660973,0.00064269884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029686987,0.0002433475,0.0006052979,0.0003298842,0.00014299921,0.00003708795,0.00013827543,0.00043972887,0.006940012],"category_scores_gemma":[0.0002902497,0.00019316017,0.00012293222,0.00024322822,0.00013105321,0.00014314445,0.000022018148,0.0006420448,0.00004552635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015905905,0.00014347456,0.97349226,0.0000131310635,0.00033014396,0.00011597909,0.00035985158,0.00002647492,0.0013829808,0.00015113615,0.011183472,0.012642014],"study_design_scores_gemma":[0.003507938,0.00046698397,0.97482765,0.000029301033,0.00019971041,0.00019194081,0.0000610603,0.00013112187,0.00007843058,0.0011600718,0.0191353,0.00021050834],"about_ca_topic_score_codex":0.05312311,"about_ca_topic_score_gemma":0.011968941,"teacher_disagreement_score":0.041154165,"about_ca_system_score_codex":0.0016547184,"about_ca_system_score_gemma":0.001311575,"threshold_uncertainty_score":0.9939678},"labels":[],"label_agreement":null},{"id":"W1850568951","doi":"10.5489/cuaj.907","title":"Functional outcomes after urinary diversion: The importance of long-term assessment","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Urinary diversion; Term (time); Intensive care medicine; Medicine; Internal medicine; Cystectomy","score_opus":0.01697059416285724,"score_gpt":0.2576225574503073,"score_spread":0.2406519632874501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1850568951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575882,0.00023034103,0.000032857763,0.039520327,0.00032567623,0.00022782006,0.000021876935,0.000008170341,0.002044715],"genre_scores_gemma":[0.9904301,0.00003563691,0.00005986557,0.00764621,0.0002320659,0.00002917246,0.00001278104,0.000006070437,0.0015480963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893373,0.00007400754,0.00024482215,0.00011491842,0.0003730546,0.0002594484],"domain_scores_gemma":[0.9990578,0.00008427967,0.00018060557,0.00010617171,0.00023106603,0.00034007354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002034204,0.00010135006,0.00019247163,0.00006099998,0.00017579981,0.0000353476,0.00007909142,0.0001087501,0.009771875],"category_scores_gemma":[0.00006894294,0.000057436464,0.00015702356,0.00008810279,0.00003744892,0.00010112898,0.000017433516,0.00032759868,0.00008246884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028413795,0.0000676048,0.9902199,0.0000025674196,0.00016113506,0.00008690829,0.000026299047,0.0000017550282,0.0000061071473,0.000025718253,0.008543952,0.00082966185],"study_design_scores_gemma":[0.0008453023,0.00021445609,0.99725676,0.0000066053453,0.00009863738,0.00014682014,0.000027451466,0.0000057807497,0.0000032827274,0.00030962634,0.001029128,0.000056182358],"about_ca_topic_score_codex":0.00038553186,"about_ca_topic_score_gemma":0.00018660582,"teacher_disagreement_score":0.032841887,"about_ca_system_score_codex":0.0007076705,"about_ca_system_score_gemma":0.00040479028,"threshold_uncertainty_score":0.99113333},"labels":[],"label_agreement":null},{"id":"W1853376568","doi":"","title":"Le BCG en instillation intravésicale : complications et interactions","year":2002,"lang":"fr","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Humanities; Art","score_opus":0.040391071477431394,"score_gpt":0.3237008285249444,"score_spread":0.28330975704751304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1853376568","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038010275,0.003941268,0.011455226,0.12961924,0.0016933816,0.0005432945,0.000084807805,0.00012748044,0.84873426],"genre_scores_gemma":[0.89109135,0.0010931944,0.001638936,0.00260526,0.0005965444,0.00005579933,0.000057056604,0.000024035913,0.1028378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902827,0.00009205169,0.00025401154,0.0002442025,0.00013798359,0.00024345821],"domain_scores_gemma":[0.9992282,0.00015951447,0.00004891577,0.00029870166,0.000083322244,0.00018136107],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060617902,0.00015002789,0.00018285868,0.0000826069,0.00014637798,0.000034145967,0.000068091074,0.00008627448,0.0100616235],"category_scores_gemma":[0.00004993575,0.00014874054,0.00008873517,0.00021422823,0.000094026764,0.0002461428,0.000029731293,0.0002455809,0.0036168606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047353544,0.004098664,0.006780974,0.00012763111,0.0006017343,0.000026175387,0.0060975044,0.0001938009,0.0027084537,0.38110983,0.16902758,0.42918032],"study_design_scores_gemma":[0.001737559,0.00023419879,0.056908734,0.00019074917,0.00024313906,0.00012742572,0.00053877645,0.008300781,0.0006704665,0.0009935609,0.9298662,0.0001884084],"about_ca_topic_score_codex":0.0013449375,"about_ca_topic_score_gemma":0.0006874731,"teacher_disagreement_score":0.88729036,"about_ca_system_score_codex":0.00017563632,"about_ca_system_score_gemma":0.00011431803,"threshold_uncertainty_score":0.99715894},"labels":[],"label_agreement":null},{"id":"W1854770270","doi":"10.5489/cuaj.2063","title":"Feasibility and safety of radical cystectomy under combined spinal and epidural anesthesia in octogenarian patients with ASA score ≥3: A case series","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Ileus; Perioperative; Surgery; Hydronephrosis; Urinary diversion; Bladder cancer; Urinary system; Medical record; Anesthesia; Cancer; Internal medicine","score_opus":0.02663437486742435,"score_gpt":0.2480568669078565,"score_spread":0.22142249204043216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1854770270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923067,0.00021357773,0.000007824283,0.006973208,0.000031153402,0.0003271422,0.000023308563,0.000006467135,0.00011060687],"genre_scores_gemma":[0.99896413,0.000013961847,0.00013441028,0.00079379923,0.000044050907,0.0000043330683,0.000011430381,0.0000075742014,0.000026322421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882054,0.0001887225,0.00029076196,0.00017310196,0.0002522739,0.00027462153],"domain_scores_gemma":[0.99873686,0.000039464543,0.00014947519,0.000073145544,0.00021000802,0.00079107156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043333854,0.00012829178,0.00033245242,0.00010659086,0.00010058488,0.000028113855,0.000033971082,0.0001533461,0.000044414868],"category_scores_gemma":[0.00020814434,0.00008968722,0.000032245553,0.0001451493,0.00011731098,0.00011432503,0.000008803837,0.0002903833,9.836971e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022887236,0.00009347102,0.99527,0.000008698563,0.00005829423,0.00153029,0.00016802453,0.0000035777596,0.0000012768991,0.000067082176,0.00007845773,0.0004320688],"study_design_scores_gemma":[0.009368149,0.0022929828,0.9792093,0.000030042775,0.00007658335,0.007954571,0.00017653001,0.000012310311,0.0000024304231,0.00047650162,0.0003122169,0.000088407105],"about_ca_topic_score_codex":0.0019941214,"about_ca_topic_score_gemma":0.0042650704,"teacher_disagreement_score":0.01606076,"about_ca_system_score_codex":0.0007741212,"about_ca_system_score_gemma":0.0005773697,"threshold_uncertainty_score":0.36573386},"labels":[],"label_agreement":null},{"id":"W1859196561","doi":"10.1200/jco.2015.33.7_suppl.374","title":"Frailty as a marker of adverse outcomes during cystectomy for urothelial cancer.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Logistic regression; Frailty Index; Adverse effect; Lung cancer; Univariate analysis; Population; Internal medicine; Quality of life (healthcare); Surgery; Cancer; Multivariate analysis","score_opus":0.20843508561351248,"score_gpt":0.5160904572270377,"score_spread":0.30765537161352524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859196561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707676,0.0003800483,0.00007337052,0.0039917547,0.0018826782,0.00041381558,0.000028324876,0.000008628036,0.006144647],"genre_scores_gemma":[0.99244726,0.00017101744,0.0023727692,0.0014688023,0.001314835,0.000021702732,0.0000010371199,0.000022724822,0.0021798357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738,0.00016121537,0.0017372663,0.00015001213,0.00036374616,0.00020775205],"domain_scores_gemma":[0.99665207,0.00079196057,0.001267596,0.0001674973,0.00066047854,0.0004603888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013267803,0.00013688757,0.0015378336,0.000091335016,0.000022913397,0.0000017451159,0.00013421618,0.00027688296,0.00021989048],"category_scores_gemma":[0.002952823,0.00008918772,0.00070384995,0.000076726814,0.00013428045,0.00008295027,0.000034968147,0.00038727585,0.000012751331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045605514,0.0022831797,0.9110131,0.00014863827,0.0021577857,0.00048158952,0.00032006632,0.000023732902,0.000562145,0.0000822527,0.0042176573,0.033104334],"study_design_scores_gemma":[0.073432416,0.023007832,0.7919584,0.00020857266,0.0014847594,0.00039758126,0.00030515197,0.000021819276,0.0013844229,0.0009720141,0.10667303,0.00015401818],"about_ca_topic_score_codex":0.0001382859,"about_ca_topic_score_gemma":0.000050026974,"teacher_disagreement_score":0.11905473,"about_ca_system_score_codex":0.00020785477,"about_ca_system_score_gemma":0.003457437,"threshold_uncertainty_score":0.6133345},"labels":[],"label_agreement":null},{"id":"W1862358273","doi":"10.5489/cuaj.433","title":"Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; Western University; McGill University","funders":"","keywords":"Cystectomy; Urology; General surgery; Medicine; Bladder cancer; Internal medicine","score_opus":0.013722851824871958,"score_gpt":0.2374516322033439,"score_spread":0.22372878037847194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1862358273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8229731,0.00031583916,0.0000044213016,0.15840435,0.0004543835,0.00049218826,0.0000655803,0.000017183243,0.017273005],"genre_scores_gemma":[0.9796355,0.000022385566,0.000057412704,0.016576339,0.00025762364,0.00002251281,0.000012036021,0.000013542239,0.0034026525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983299,0.00014486957,0.00034824022,0.0001503676,0.0004312783,0.0005953669],"domain_scores_gemma":[0.99783546,0.00014479923,0.00018526916,0.00016058268,0.0003078576,0.0013660272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036185014,0.00014962126,0.00033033142,0.00016225326,0.00051199674,0.00006705198,0.00016720475,0.0003714836,0.006924883],"category_scores_gemma":[0.00048746183,0.0000866386,0.0001972323,0.00018065862,0.00009154031,0.00007074492,0.000013884888,0.0006777806,0.00036956876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012628842,0.00002173383,0.94707125,0.0000016602746,0.0003164684,0.000043713862,0.00012783878,0.0000034955156,0.000032164968,0.00012234687,0.050992817,0.0012538696],"study_design_scores_gemma":[0.001055398,0.0001711864,0.9126099,0.0000043132636,0.00011813732,0.00017542741,0.000038568436,0.000023690096,0.000026780035,0.00056184817,0.08513217,0.000082630955],"about_ca_topic_score_codex":0.39106128,"about_ca_topic_score_gemma":0.48585603,"teacher_disagreement_score":0.15666243,"about_ca_system_score_codex":0.002863763,"about_ca_system_score_gemma":0.0017481163,"threshold_uncertainty_score":0.9939829},"labels":[],"label_agreement":null},{"id":"W1863833365","doi":"10.5489/cuaj.1196","title":"The management of BCG failure in non-muscle-invasive bladder cancer: an update","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Carcinoma in situ; Gold standard (test); Oncology; Internal medicine; Urology; Cancer","score_opus":0.009273859502669027,"score_gpt":0.24205260584367452,"score_spread":0.23277874634100548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1863833365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94888806,0.00034614978,0.00001075983,0.047338672,0.0002492906,0.0005023724,0.000030276853,0.000009364592,0.0026250347],"genre_scores_gemma":[0.9952842,0.00088987366,0.00016000257,0.0029025355,0.00018491854,0.00006375636,0.000009415718,0.000010656822,0.0004946376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987343,0.000090414214,0.00031016144,0.0001504522,0.00028525034,0.00042941186],"domain_scores_gemma":[0.9989682,0.00005284973,0.00018904972,0.00012978335,0.00021207565,0.00044808607],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002871442,0.000117268246,0.00020569544,0.00009220805,0.0001859721,0.00006500803,0.00014888763,0.00013383818,0.001067155],"category_scores_gemma":[0.00003790172,0.00007513301,0.00008247109,0.00019551897,0.000033491295,0.00012431563,0.000013278392,0.0003433442,0.000055245728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009623637,0.00017307243,0.8884995,0.000022444716,0.00095503236,0.00022926531,0.00046590046,0.00010872775,0.00020418125,0.00036980884,0.030844247,0.07803157],"study_design_scores_gemma":[0.0013044791,0.00024403953,0.9797972,0.00002997536,0.00010230847,0.000018349794,0.00042415658,0.00005435714,0.000035863584,0.0011797502,0.01672606,0.00008348834],"about_ca_topic_score_codex":0.0075500184,"about_ca_topic_score_gemma":0.019139687,"teacher_disagreement_score":0.09129766,"about_ca_system_score_codex":0.0008203803,"about_ca_system_score_gemma":0.00035010494,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W1864669210","doi":"10.5489/cuaj.781","title":"Bladder perforation after immediate postoperative intravesical instillation of mitomycin C","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"South Bruce Grey Health Centre; Western University","funders":"","keywords":"Medicine; Mitomycin C; Perforation; Complication; Surgery; Resection; Chemotherapy; Bladder cancer; Urology; Carcinoma; Cancer; Internal medicine","score_opus":0.007996514282782611,"score_gpt":0.2237708182159002,"score_spread":0.21577430393311758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1864669210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748996,0.00015430016,0.00007089772,0.021977525,0.00023606372,0.0003281216,0.000024424937,0.000010973843,0.002298131],"genre_scores_gemma":[0.9944913,0.000036583646,0.00026907603,0.00437956,0.00038648263,0.00002741008,0.000026107722,0.00001001973,0.0003734831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881417,0.000105646825,0.00034352794,0.00014104422,0.00029995985,0.0002956416],"domain_scores_gemma":[0.9987056,0.000054358145,0.00017297138,0.00007463063,0.00051392644,0.00047846718],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018705736,0.00012204091,0.00023733325,0.00014907452,0.000106234336,0.000052724303,0.000047271245,0.00021514205,0.002802519],"category_scores_gemma":[0.0002696047,0.000090438625,0.0001003906,0.00015477826,0.000035262674,0.00020836008,0.0000067919004,0.00034287194,0.00015791495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014097909,0.000081705024,0.9824053,0.0000046620007,0.00020966952,0.000032465214,0.00062160834,0.000022064372,0.0010953989,0.00009074527,0.0064946674,0.008800759],"study_design_scores_gemma":[0.0011486287,0.0005478306,0.9934959,0.000010121626,0.00008357054,0.000072292576,0.00008220391,0.00028213087,0.00030599348,0.00047278646,0.0034082988,0.00009027933],"about_ca_topic_score_codex":0.00201875,"about_ca_topic_score_gemma":0.00046850578,"teacher_disagreement_score":0.019591715,"about_ca_system_score_codex":0.0006561997,"about_ca_system_score_gemma":0.00050953845,"threshold_uncertainty_score":0.99810904},"labels":[],"label_agreement":null},{"id":"W1864803600","doi":"10.3390/ijerph121113739","title":"Arsenic in Drinking Water, Transition Cell Cancer and Chronic Cystitis in Rural Bangladesh","year":2015,"lang":"en","type":"article","venue":"International Journal of Environmental Research and Public Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Arsenic; Medicine; Bladder cancer; Arsenic contamination of groundwater; Cancer; Odds ratio; Confounding; Internal medicine; Chemistry","score_opus":0.0582187682897927,"score_gpt":0.37034194753554533,"score_spread":0.3121231792457526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1864803600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795555,0.005593696,0.000018645249,0.014338036,0.00011341113,0.00015096834,0.000018359266,0.0000015150232,0.00020989367],"genre_scores_gemma":[0.98915297,0.010176023,0.00005639098,0.0002853052,0.00021052035,0.000008565874,0.000018457724,0.000007929611,0.000083864215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998587,0.000097127435,0.00028022443,0.000102415324,0.00063267595,0.00030053867],"domain_scores_gemma":[0.9994803,0.000028821827,0.0000451651,0.000040205327,0.000037684986,0.00036783837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084950984,0.000067614616,0.0001549313,0.00036546224,0.000027714299,0.000037914346,0.00006967479,0.000037375663,0.000119761506],"category_scores_gemma":[0.0000133646045,0.000051233168,0.000020838526,0.000057645015,0.00009613521,0.00023435535,0.000036401474,0.0003336269,0.0000032408498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001685796,0.0026820193,0.5823071,0.00013869673,0.00017289788,0.0011881506,0.012080537,0.00003852333,0.014155779,0.00009160688,0.00050869345,0.3849502],"study_design_scores_gemma":[0.03800861,0.008911035,0.91155046,0.001322008,0.000015817412,0.0020416344,0.008915545,0.0006908068,0.0044090543,0.0022780485,0.021547167,0.0003097956],"about_ca_topic_score_codex":0.0011726279,"about_ca_topic_score_gemma":0.00064182497,"teacher_disagreement_score":0.3846404,"about_ca_system_score_codex":0.0015472748,"about_ca_system_score_gemma":0.00049518945,"threshold_uncertainty_score":0.40460697},"labels":[],"label_agreement":null},{"id":"W1866436638","doi":"10.5489/cuaj.1157","title":"In favour of bladder preservation using combined modality treatment","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Modality (human–computer interaction); Treatment modality; Medicine; Urology; Psychology; Computer science; Surgery; Artificial intelligence","score_opus":0.03258409730009011,"score_gpt":0.2737602944697595,"score_spread":0.24117619716966943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1866436638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814793,0.00007806099,0.00003363596,0.016472107,0.00012511217,0.00034414668,0.00001739943,0.0000062178383,0.0014440252],"genre_scores_gemma":[0.9975314,0.000019198358,0.00026261,0.0013551499,0.00011368856,0.000014751906,0.000009690145,0.0000071533227,0.00068631716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895155,0.000113807466,0.0003260482,0.000115441675,0.00020883256,0.0002842927],"domain_scores_gemma":[0.99914026,0.000049225862,0.0001825205,0.00008231748,0.00022223283,0.00032343695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018602626,0.00010030537,0.00025642107,0.00014009389,0.00006902102,0.000026485399,0.000049613755,0.00015260413,0.0017402404],"category_scores_gemma":[0.0001503399,0.00007573378,0.00008929656,0.00016754064,0.000016446136,0.00019666742,0.000004994483,0.00016886412,0.000027253474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039933715,0.00015656924,0.99705076,0.0000028853146,0.0001260717,0.000019553858,0.00012949946,0.0001042718,0.00047956858,0.000091277274,0.0010534836,0.00074612704],"study_design_scores_gemma":[0.0025320076,0.0005874397,0.9898881,0.000008614421,0.00007101944,0.00002174757,0.00004504164,0.0012068885,0.00019795011,0.0041830167,0.0011905415,0.000067660636],"about_ca_topic_score_codex":0.037402328,"about_ca_topic_score_gemma":0.002122178,"teacher_disagreement_score":0.035280153,"about_ca_system_score_codex":0.0018650412,"about_ca_system_score_gemma":0.0005704458,"threshold_uncertainty_score":0.99917233},"labels":[],"label_agreement":null},{"id":"W1872552157","doi":"10.5489/cuaj.1204","title":"Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Urothelial carcinoma; Bladder cancer; Medicine; Urothelial cancer; Cancer; Profiling (computer programming); Precision medicine; Personalized medicine; Bioinformatics; Internal medicine; Pathology; Computer science; Biology","score_opus":0.014426925564623747,"score_gpt":0.26102814597382246,"score_spread":0.2466012204091987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1872552157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7151856,0.0005059222,0.00004011533,0.27879387,0.00016274587,0.0010603652,0.00011269199,0.000025768764,0.0041129175],"genre_scores_gemma":[0.9354186,0.0002931817,0.00044343935,0.03942739,0.0010788616,0.0003299426,0.000016223375,0.000041745865,0.02295064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977138,0.00016524285,0.00036992962,0.00046287928,0.00046771383,0.00082040986],"domain_scores_gemma":[0.99663067,0.00013515465,0.000116955984,0.0001617669,0.0002784171,0.0026770392],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027667158,0.00032311393,0.0007092724,0.00048479563,0.00020652855,0.00011010976,0.00014735901,0.00022848633,0.0028549377],"category_scores_gemma":[0.0006881262,0.00023561857,0.00009753968,0.0004076243,0.000038411268,0.00015369541,0.000023015613,0.0003687144,0.000111866626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012343526,0.00012717185,0.66560787,0.000026861815,0.00012361653,0.00029099948,0.006113686,0.00005972951,0.004705398,0.000079113364,0.20872189,0.1129093],"study_design_scores_gemma":[0.011997306,0.004360048,0.84642214,0.00018735256,0.00029307962,0.00016284958,0.0007139953,0.000032755575,0.00030385377,0.0005950969,0.1344412,0.0004903339],"about_ca_topic_score_codex":0.035017595,"about_ca_topic_score_gemma":0.011919822,"teacher_disagreement_score":0.23936649,"about_ca_system_score_codex":0.0027243635,"about_ca_system_score_gemma":0.00045234468,"threshold_uncertainty_score":0.9980566},"labels":[],"label_agreement":null},{"id":"W1874355756","doi":"10.5489/cuaj.1045","title":"Impact of treatment delay in patients with bladder cancer managed with partial cystectomy in Quebec: a population-based study","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Bladder cancer; Population; Urology; Oncology; Medicine; Internal medicine; Cancer; Environmental health","score_opus":0.008916197726224463,"score_gpt":0.2501906200093373,"score_spread":0.24127442228311283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874355756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980184,0.000022732576,0.0000068781255,0.0006941821,0.000031726937,0.0010988503,0.000032599226,0.0000069905736,0.000087629065],"genre_scores_gemma":[0.99941444,0.0000017222472,0.000053057924,0.00020676981,0.000045599103,0.00013981591,0.000028774864,0.000014281971,0.00009552795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863386,0.00017009207,0.0003291345,0.00018776426,0.00029925205,0.00037989914],"domain_scores_gemma":[0.9990955,0.000048860325,0.00021953919,0.000101313264,0.00019813023,0.00033668167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011106108,0.00017667584,0.00037843685,0.00028874178,0.00006031488,0.000037910602,0.00005201136,0.00010181051,0.0008612547],"category_scores_gemma":[0.000031887583,0.00010173003,0.00007171013,0.0003315075,0.0000106576035,0.00011902646,0.000002802757,0.00021789559,0.0000052256205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005574292,0.00059516495,0.9943885,0.0000018531792,0.0003359756,0.000051719304,0.00023077909,0.0020641945,9.1946043e-7,6.592553e-7,0.00005749173,0.0017152756],"study_design_scores_gemma":[0.013221743,0.0054229074,0.9808666,0.000024780975,0.00012966766,0.0000021822468,0.0000606294,0.00013014671,0.0000012517338,0.0000063565367,0.000029504998,0.00010423802],"about_ca_topic_score_codex":0.678627,"about_ca_topic_score_gemma":0.5927627,"teacher_disagreement_score":0.08586432,"about_ca_system_score_codex":0.0057133655,"about_ca_system_score_gemma":0.0011641862,"threshold_uncertainty_score":0.9981035},"labels":[],"label_agreement":null},{"id":"W1875297014","doi":"10.5489/cuaj.395","title":"Radiation treatment of bladder squamous cell carcinoma in a patient","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Basal cell; Bladder cancer; Urinary system; Oncology; Urology; Radiation therapy; Urinary bladder; Cancer; Transitional cell carcinoma; Internal medicine","score_opus":0.010701248735694686,"score_gpt":0.2182802896944388,"score_spread":0.2075790409587441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875297014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030703,0.000627646,0.000003675529,0.0039036449,0.00014898548,0.0003925388,0.00002052071,0.0000064532564,0.0045895036],"genre_scores_gemma":[0.99837166,0.000052593146,0.00005118743,0.0010044663,0.0001379779,0.00003656834,0.000015703836,0.000009181501,0.00032066237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889123,0.00009370917,0.00033416314,0.0001318831,0.0002164388,0.0003325961],"domain_scores_gemma":[0.9990841,0.000063880005,0.00018935298,0.00008190144,0.00015131583,0.00042944017],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007445623,0.00011704713,0.000252135,0.0001965389,0.00006137585,0.000022497543,0.000038379516,0.00015588189,0.0017893008],"category_scores_gemma":[0.00007645274,0.00008774629,0.00011169378,0.00015715705,0.000013695906,0.00007137046,0.0000031017535,0.00014029456,0.00009122898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037435333,0.00029339685,0.9775379,0.0000028432512,0.000029626945,0.000077417324,0.00051029684,0.00003697056,0.0001725235,0.000006814704,0.002644212,0.018650584],"study_design_scores_gemma":[0.0029877226,0.002212462,0.9864688,0.0000024637668,0.00006247865,0.00005591707,0.00011804836,0.00011085656,0.0007127819,0.0001796803,0.0070101703,0.00007862129],"about_ca_topic_score_codex":0.016895428,"about_ca_topic_score_gemma":0.0009468883,"teacher_disagreement_score":0.018571964,"about_ca_system_score_codex":0.0020756405,"about_ca_system_score_gemma":0.00048433273,"threshold_uncertainty_score":0.9991232},"labels":[],"label_agreement":null},{"id":"W1875592320","doi":"10.5489/cuaj.2818","title":"The role of single instillation chemotherapy in patients who receive subsequent bacillus Calmette-Guérin: A retrospective single centre study, and systematic review of the literature","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Bladder cancer; Retrospective cohort study; Hazard ratio; Internal medicine; Multivariate analysis; Chemotherapy; Surgery; Oncology; Urology; Gastroenterology; Cancer; Confidence interval; Cyclophosphamide","score_opus":0.010050597150687042,"score_gpt":0.22010950590860998,"score_spread":0.21005890875792294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875592320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98197633,0.01113657,3.7674099e-7,0.0046928017,0.00012539038,0.0013281883,0.000041789004,0.0000033425104,0.00069523335],"genre_scores_gemma":[0.99864084,0.00038056096,0.000006341208,0.0008274515,0.000043182496,0.000008307284,0.0000043837717,0.0000069951943,0.00008196612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983641,0.00042228453,0.00046114123,0.00012028756,0.00044402148,0.00018816757],"domain_scores_gemma":[0.99842066,0.00008283475,0.00051516993,0.00013315403,0.00065764185,0.00019055165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006784257,0.00010952768,0.00042633698,0.000057840356,0.000089301495,0.000030956067,0.00008818653,0.00009801491,0.000013247056],"category_scores_gemma":[0.0016864626,0.00005727902,0.000081009115,0.00031492292,0.000033646975,0.00005637029,0.000012185173,0.0002497403,7.162653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076006465,0.00019279694,0.99635124,0.0005857327,0.00012689982,0.000003603219,0.001819439,0.0000012593631,0.000011163196,0.000014040336,0.00021666977,0.0006011705],"study_design_scores_gemma":[0.0022965267,0.0012040853,0.98715633,0.007713075,0.00019699663,0.000013798691,0.0005951848,0.000010324482,0.000056772147,0.00033119813,0.0003522992,0.00007342628],"about_ca_topic_score_codex":0.00036825595,"about_ca_topic_score_gemma":0.0009881384,"teacher_disagreement_score":0.016664503,"about_ca_system_score_codex":0.0015610226,"about_ca_system_score_gemma":0.00020189615,"threshold_uncertainty_score":0.408202},"labels":[],"label_agreement":null},{"id":"W1881188679","doi":"10.5489/cuaj.12146","title":"Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada.","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lymphadenectomy; Ureter; Proportional hazards model; Pathological; Urology; Ureteroscopy; Internal medicine; Cancer","score_opus":0.043977361016865404,"score_gpt":0.2697446247047131,"score_spread":0.22576726368784772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1881188679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934268,0.0003083996,0.0000021460964,0.004496545,0.00019235261,0.0010172514,0.000090647125,0.000007647223,0.0004582256],"genre_scores_gemma":[0.9966533,0.000038172013,0.000020119694,0.0015886825,0.00009022494,0.0012549395,0.000024312669,0.0000143361485,0.0003158655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898875,0.000051131203,0.00018553567,0.00015335213,0.00019513493,0.00042608238],"domain_scores_gemma":[0.9993804,0.0002963972,0.00005999115,0.000082346574,0.00002765926,0.00015320268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000190902,0.000120258075,0.00026924428,0.000069401234,0.000022535607,0.0000090950725,0.00003815339,0.000052426607,0.000011338119],"category_scores_gemma":[0.00027374655,0.00009274831,0.000032439784,0.000068739755,0.000013774348,0.00014079218,0.000010746522,0.00011005574,3.6937615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016930948,0.00026910924,0.9921775,0.000016660193,0.000050280447,0.000014179186,0.00029163054,5.745334e-8,0.0000010314695,0.00001712475,0.0001929666,0.006800185],"study_design_scores_gemma":[0.0034565812,0.0000271409,0.9946327,0.000013193259,0.00008144957,0.000014900409,0.00033553227,0.000007293611,0.000027351305,0.000011808234,0.001299034,0.00009298791],"about_ca_topic_score_codex":0.56073725,"about_ca_topic_score_gemma":0.5638327,"teacher_disagreement_score":0.006707197,"about_ca_system_score_codex":0.00049434905,"about_ca_system_score_gemma":0.0002841611,"threshold_uncertainty_score":0.44412622},"labels":[],"label_agreement":null},{"id":"W1882655166","doi":"10.5489/cuaj.1193","title":"Chemoprevention in bladder cancer: What’s new?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Medicine; Disease; Cancer; Randomized controlled trial; Intensive care medicine; Surgery; Internal medicine","score_opus":0.014659425033286114,"score_gpt":0.25327516138432443,"score_spread":0.23861573635103833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1882655166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8611305,0.0021197896,0.000027478907,0.1309511,0.00093126897,0.00048123772,0.0000075469893,0.00002614027,0.0043249656],"genre_scores_gemma":[0.982505,0.00082950917,0.00011015044,0.009733755,0.0007170668,0.000032707405,0.000010671586,0.000011529497,0.0060496135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886495,0.000063737876,0.0002599476,0.0001506755,0.00023883843,0.00042184073],"domain_scores_gemma":[0.99890393,0.000029553454,0.00012007138,0.000070873495,0.0001374766,0.000738107],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001850113,0.00010993434,0.00020679538,0.00015297865,0.00008807476,0.00015620065,0.00006839694,0.00019955331,0.008613946],"category_scores_gemma":[0.00012396523,0.000089244764,0.00009986757,0.00019577239,0.000011214903,0.00035915108,0.000006364307,0.00041291193,0.00025839522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002341477,0.000059841794,0.8643337,0.0000023933894,0.0001206682,0.000043062875,0.00016405579,0.00001709299,0.00014185336,0.00003389842,0.06846782,0.066592194],"study_design_scores_gemma":[0.0017694345,0.00015659252,0.9524283,0.000029653029,0.00005392134,0.00006636004,0.00010610703,0.00005454037,0.0000526166,0.002384212,0.042798836,0.00009945857],"about_ca_topic_score_codex":0.02625528,"about_ca_topic_score_gemma":0.0066964435,"teacher_disagreement_score":0.121374525,"about_ca_system_score_codex":0.0016896445,"about_ca_system_score_gemma":0.0009066164,"threshold_uncertainty_score":0.99229234},"labels":[],"label_agreement":null},{"id":"W1884456768","doi":"10.1111/bju.12014","title":"Gender‐specific effect of smoking on upper tract urothelial carcinoma outcomes","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital; Université de Montréal","funders":"","keywords":"Urothelial carcinoma; Medicine; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.018345785319606882,"score_gpt":0.2696629057248976,"score_spread":0.2513171204052907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1884456768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923888,0.0031603703,0.00003907347,0.0005246493,0.0006085316,0.0003077744,0.000014600213,0.000010008304,0.0029462343],"genre_scores_gemma":[0.9983159,0.00029568866,0.00009885577,0.0007535244,0.00036952057,0.000009703966,0.0000031215927,0.00003168368,0.000122060344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985606,0.00017183437,0.00050807296,0.00016381501,0.00032275124,0.00027289992],"domain_scores_gemma":[0.99907017,0.00021141474,0.00026054148,0.0001527919,0.00014932877,0.00015573823],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024667545,0.00016346184,0.00068520574,0.00016128132,0.000046971127,0.000020097981,0.00012726385,0.00013827471,0.0010329295],"category_scores_gemma":[0.000094132876,0.00013521586,0.00033471524,0.000070909824,0.00008977605,0.000093268245,0.000016715621,0.0004107688,0.00003080163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010340732,0.0005031221,0.8525799,0.00006188306,0.00041912997,0.0019507468,0.00015096669,0.000010431555,0.002093538,0.00003202809,0.0039074887,0.13725668],"study_design_scores_gemma":[0.0073535307,0.006018898,0.97077036,0.0000557247,0.00027322542,0.010446665,0.000016045522,0.0000052093455,0.002287614,0.0001447956,0.0025300619,0.000097872],"about_ca_topic_score_codex":0.00018023633,"about_ca_topic_score_gemma":0.0000023906903,"teacher_disagreement_score":0.13715881,"about_ca_system_score_codex":0.000054636654,"about_ca_system_score_gemma":0.00008878822,"threshold_uncertainty_score":0.99988025},"labels":[],"label_agreement":null},{"id":"W1886389877","doi":"10.5489/cuaj.831","title":"Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Island Health; University of British Columbia Hospital; BC Cancer Agency","funders":"","keywords":"Capecitabine; Gemcitabine; Medicine; Carboplatin; Chemotherapy; Oncology; Malignancy; Bladder cancer; Internal medicine; Cancer; Signet ring cell; Signet ring cell carcinoma; Disease; Cisplatin; Adenocarcinoma","score_opus":0.010404996197399034,"score_gpt":0.2562712921198177,"score_spread":0.24586629592241865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886389877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564143,0.013184263,0.000023227116,0.028349565,0.00009545784,0.00069830887,0.000047593338,0.0000047437225,0.0011825829],"genre_scores_gemma":[0.98834187,0.0015016104,0.00044947636,0.008105855,0.00009075142,0.000028356259,0.0000024220465,0.000011666622,0.0014680095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899244,0.00010082882,0.00032185245,0.00012881751,0.000250249,0.0002057993],"domain_scores_gemma":[0.998734,0.00007596131,0.00032803114,0.00011847279,0.0004164112,0.00032711428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034361513,0.00010599399,0.00030104828,0.00012848833,0.000089975394,0.000024997149,0.000054055297,0.000060151026,0.0007265247],"category_scores_gemma":[0.00028081724,0.000057698995,0.00007074267,0.0004664129,0.000023507107,0.00006268022,0.000007946391,0.00023950382,0.0000012630795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003671799,0.000246307,0.9163712,0.001684027,0.0016151415,0.014170022,0.0034621092,0.000055537897,0.0057988316,0.00008586557,0.037933286,0.018210454],"study_design_scores_gemma":[0.0062643853,0.0024761276,0.86857533,0.009107877,0.0018349421,0.06822677,0.00055437785,0.000065930195,0.003584314,0.00032611398,0.038395237,0.0005886082],"about_ca_topic_score_codex":0.0021042076,"about_ca_topic_score_gemma":0.0004228277,"teacher_disagreement_score":0.054056745,"about_ca_system_score_codex":0.00029238,"about_ca_system_score_gemma":0.0004399898,"threshold_uncertainty_score":0.7954936},"labels":[],"label_agreement":null},{"id":"W1893557581","doi":"10.1111/bju.12829","title":"Adjuvant cisplatin‐based combined chemotherapy for lymph node ( <scp>LN</scp> )‐positive urothelial carcinoma of the bladder ( <scp>UCB</scp> ) after radical cystectomy ( <scp>RC</scp> ): a retrospective international study of &gt;1500 patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Urology; Cisplatin; Lymph node; Chemotherapy; Retrospective cohort study; Dissection (medical); Bladder cancer; Internal medicine; Surgery; Oncology; Metastasis; Cancer","score_opus":0.0064892399979120125,"score_gpt":0.2359982427058038,"score_spread":0.2295090027078918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893557581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932043,0.00056977203,0.0011200196,0.00023271874,0.0011453616,0.0018525061,0.0005370183,0.000022613498,0.0013157072],"genre_scores_gemma":[0.99655956,0.00005530163,0.0004370677,0.0017033052,0.0006408617,0.00013656131,0.000040932315,0.00011322756,0.00031315492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955852,0.00053114584,0.001434767,0.0005879115,0.0012065485,0.0006544461],"domain_scores_gemma":[0.99502575,0.0012543934,0.0014197193,0.00043892485,0.0015522677,0.00030895768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006301031,0.00048194863,0.0014392622,0.00033837665,0.00015679488,0.00004536449,0.0006170403,0.00035904438,0.000055015083],"category_scores_gemma":[0.0017925901,0.00041579903,0.00066897017,0.0003213941,0.00047974908,0.00016802954,0.00012234293,0.00062181114,0.000004697306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018657345,0.007174099,0.9736114,0.00011060522,0.0025869836,0.00031612712,0.0034964916,0.00007693647,0.0021298374,0.000044615812,0.004379214,0.0042079496],"study_design_scores_gemma":[0.056584485,0.011123815,0.9223902,0.0002611204,0.0010136059,0.00076343643,0.00046619875,0.0005182278,0.0047852737,0.00029545822,0.0017307615,0.00006740099],"about_ca_topic_score_codex":0.00021186301,"about_ca_topic_score_gemma":0.00005029428,"teacher_disagreement_score":0.05471875,"about_ca_system_score_codex":0.0002796191,"about_ca_system_score_gemma":0.00044110283,"threshold_uncertainty_score":0.9998294},"labels":[],"label_agreement":null},{"id":"W1895441594","doi":"10.5489/cuaj.1198","title":"Management of the urethra in urothelial bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Urothelial cancer; Urethra; Urology; Bladder cancer; Medicine; Cancer; Internal medicine","score_opus":0.012458597294727319,"score_gpt":0.24668302506011203,"score_spread":0.2342244277653847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895441594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367253,0.00046211973,0.0000075506837,0.047844503,0.0005239607,0.000568932,0.000027605805,0.0000082693105,0.013831731],"genre_scores_gemma":[0.9936454,0.0001721339,0.00006897972,0.0037406492,0.00017308703,0.000043716933,0.0000013105649,0.00000821031,0.0021465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989381,0.000083481966,0.00025731968,0.00011197405,0.00029226666,0.00031687666],"domain_scores_gemma":[0.9993598,0.000025030897,0.00013925158,0.00010007256,0.0001266717,0.00024916884],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018393411,0.000091638234,0.00017720425,0.00007787304,0.00008556609,0.000024419638,0.00011829944,0.0001246432,0.003051395],"category_scores_gemma":[0.000043496824,0.00005604023,0.000109109336,0.00021422199,0.000028908356,0.00005503649,0.0000145990725,0.0003394665,0.000043194224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002202332,0.000055896588,0.9834153,0.000006696645,0.00020671413,0.000031589054,0.000116984345,0.00003046681,0.0000731743,0.0001980065,0.0072700083,0.008573121],"study_design_scores_gemma":[0.0012426826,0.000076276534,0.98439735,0.00003141677,0.0000790949,0.000021631935,0.0000673076,0.000026256193,0.00006556236,0.0010973917,0.012838353,0.00005668008],"about_ca_topic_score_codex":0.008760217,"about_ca_topic_score_gemma":0.0016131846,"teacher_disagreement_score":0.056920085,"about_ca_system_score_codex":0.00083637325,"about_ca_system_score_gemma":0.00032819045,"threshold_uncertainty_score":0.99785995},"labels":[],"label_agreement":null},{"id":"W1895605570","doi":"10.1111/bju.12121","title":"Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes","year":2013,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cystectomy; Urinary diversion; Medicine; Bladder cancer; Context (archaeology); Urinary system; Surgery; Stoma (medicine); General surgery; Urology; Cancer; Internal medicine","score_opus":0.0215026174737906,"score_gpt":0.3124257923146673,"score_spread":0.2909231748408767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895605570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016825127,0.9962144,0.000053768694,0.00031347226,0.00056635274,0.0009966997,0.00012934826,0.0000109592,0.00003249315],"genre_scores_gemma":[0.0011431001,0.9969082,0.0005201524,0.0004083235,0.0004292726,0.00026768714,0.000019853753,0.00004211471,0.00026131724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852365,0.0001401026,0.00064727437,0.00024278779,0.00019282088,0.0002533679],"domain_scores_gemma":[0.9989262,0.00011252866,0.00042345127,0.00008387328,0.00024097749,0.00021296734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001089542,0.0002444483,0.0014318732,0.00019309268,0.0000974207,0.000029386712,0.00007858058,0.00032358937,0.0004830231],"category_scores_gemma":[0.000052842926,0.0002016176,0.0004735973,0.00008478697,0.00008796667,0.00008794538,0.000048168225,0.00046171507,0.000007819481],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020964416,0.00026169998,0.0010038823,0.0017999805,0.0011986253,0.00064526114,0.000023031014,3.8506386e-7,2.2684772e-7,0.0000022764345,0.008238669,0.9866163],"study_design_scores_gemma":[0.002403703,0.0025717444,0.0019026228,0.0021539358,0.0040458455,0.039904207,0.000006937391,0.000001691775,3.3348013e-7,0.00003067392,0.9468219,0.0001563621],"about_ca_topic_score_codex":0.00010509939,"about_ca_topic_score_gemma":0.000012973146,"teacher_disagreement_score":0.98646,"about_ca_system_score_codex":0.00014534371,"about_ca_system_score_gemma":0.00039718486,"threshold_uncertainty_score":0.8221727},"labels":[],"label_agreement":null},{"id":"W1900598203","doi":"10.5489/cuaj.3049","title":"Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Pathological; Stage (stratigraphy); Cancer; Internal medicine; Urology; Carcinoma in situ; Carcinoma; Disease","score_opus":0.03198381587876195,"score_gpt":0.31679049907106027,"score_spread":0.2848066831922983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1900598203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812419,0.0014240225,0.0000028240863,0.014757973,0.0007034642,0.00036055196,0.00013712833,0.000018171078,0.0013539868],"genre_scores_gemma":[0.9939905,0.0023018613,0.00006129687,0.0020767523,0.00090740353,0.00008021471,0.00001279313,0.000016824084,0.0005523848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835294,0.00020158998,0.00045184753,0.00026665712,0.00025720464,0.0004697546],"domain_scores_gemma":[0.99810535,0.00009035755,0.00015948602,0.00009230454,0.00019390274,0.001358581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048154488,0.0001784817,0.00038418552,0.00014627422,0.00010000022,0.00006210735,0.00006358978,0.00030084886,0.00048388765],"category_scores_gemma":[0.00039012346,0.00013278116,0.00012576689,0.00014098405,0.00004322009,0.00009155657,0.00001082563,0.00043220076,0.00003045088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020563559,0.00021181142,0.9834477,0.0000010449492,0.00014546221,0.00017019693,0.00025828817,0.0000039633255,7.535349e-7,0.000009820794,0.0027523644,0.012792991],"study_design_scores_gemma":[0.007061931,0.0015122072,0.9777725,0.000024496932,0.0002264187,0.0001590467,0.0001533323,0.00003986163,0.0000063779185,0.00012991152,0.012784689,0.00012925835],"about_ca_topic_score_codex":0.03577902,"about_ca_topic_score_gemma":0.071004346,"teacher_disagreement_score":0.035225324,"about_ca_system_score_codex":0.0026070317,"about_ca_system_score_gemma":0.001321487,"threshold_uncertainty_score":0.9706418},"labels":[],"label_agreement":null},{"id":"W1901042803","doi":"10.5489/cuaj.2621","title":"Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better?","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Perioperative; Cystectomy; Logistic regression; Confounding; Bladder cancer; Odds ratio; Odds; Blood transfusion; Teaching hospital; Internal medicine; Family medicine; Emergency medicine; Cancer; Surgery","score_opus":0.019312207055214824,"score_gpt":0.2479643353454771,"score_spread":0.22865212829026227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1901042803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477888,0.00050577126,0.00001845644,0.04789408,0.00043068916,0.00033621833,0.00012409089,0.000045694745,0.0028562462],"genre_scores_gemma":[0.98189247,0.000024574529,0.00011722744,0.015143454,0.0004487164,0.000029145569,0.000024122337,0.000020889818,0.002299397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792206,0.00030630094,0.00033998326,0.00025270876,0.0005559688,0.00062297523],"domain_scores_gemma":[0.9975318,0.000084827334,0.00019475332,0.00012793264,0.00035836053,0.0017023275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037982146,0.00022696974,0.00044353813,0.00013942181,0.00024799226,0.00009476007,0.00011245322,0.00030245,0.0015053713],"category_scores_gemma":[0.00058145734,0.00015366511,0.00018678156,0.00012812224,0.000047898,0.00011040316,0.00002181556,0.00053763576,0.00027174075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026935383,0.00006410315,0.9874364,0.0000023461607,0.0002625208,0.00080745044,0.0006573454,0.0000070663104,0.00003056328,0.000010833747,0.009997278,0.00045470145],"study_design_scores_gemma":[0.004007101,0.0004019669,0.9298139,0.000020950725,0.00016205366,0.0002991929,0.00021680811,0.000035120556,0.000038598155,0.00019517688,0.064627446,0.0001816367],"about_ca_topic_score_codex":0.0015010072,"about_ca_topic_score_gemma":0.0041445545,"teacher_disagreement_score":0.057622492,"about_ca_system_score_codex":0.004071536,"about_ca_system_score_gemma":0.0008233463,"threshold_uncertainty_score":0.9997516},"labels":[],"label_agreement":null},{"id":"W1901250674","doi":"10.5489/cuaj.842","title":"Laser photoablation of renal pelvic tumours","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto","funders":"","keywords":"Medicine; Cystoscopy; Renal pelvis; Transitional cell carcinoma; Surgery; Urology; Photoablation; Percutaneous; Pyelogram; Radiology; Urinary system; Laser; Ureter; Internal medicine; Excimer laser","score_opus":0.01125865031765543,"score_gpt":0.22858940634800923,"score_spread":0.2173307560303538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1901250674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764776,0.0001127324,0.00005770017,0.011387806,0.00019772815,0.000244546,0.000021945183,0.000014720649,0.011485214],"genre_scores_gemma":[0.99569553,0.000023574345,0.00016004588,0.0024735858,0.00027331387,0.000009670638,0.000014358175,0.0000079873835,0.0013419589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999028,0.000069441216,0.0002515424,0.00010243052,0.0002682695,0.0002802673],"domain_scores_gemma":[0.99890506,0.000049274906,0.00018629272,0.00006728186,0.00030511033,0.0004869536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019798624,0.00008591408,0.00019288293,0.00012390524,0.00009688755,0.000031635,0.00005423142,0.00013854573,0.004316293],"category_scores_gemma":[0.00018778573,0.000065584834,0.0001050673,0.00013887066,0.000019715351,0.00010124671,0.000004484981,0.00026618832,0.00016216695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029364845,0.00006158329,0.9677439,0.0000031453399,0.00012096933,0.000028534974,0.00009301778,0.000026932701,0.0007406817,0.000038279108,0.025328148,0.005785449],"study_design_scores_gemma":[0.0011977658,0.00035172698,0.98875123,0.0000112761645,0.00008696549,0.00009819903,0.00003753519,0.00017711685,0.0005739913,0.0009206464,0.007722715,0.0000708153],"about_ca_topic_score_codex":0.0031956697,"about_ca_topic_score_gemma":0.00037126144,"teacher_disagreement_score":0.021007353,"about_ca_system_score_codex":0.0005892921,"about_ca_system_score_gemma":0.00041036264,"threshold_uncertainty_score":0.9965939},"labels":[],"label_agreement":null},{"id":"W1901797386","doi":"10.5489/cuaj.1197","title":"Role of lymphadenectomy for invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Dissection (medical); Inferior mesenteric artery; Lymphadenectomy; Bladder cancer; Cystectomy; Lymph node; Aortic bifurcation; Levator ani; Anatomy; Surgery; Cancer; Pathology; Aorta; Internal medicine","score_opus":0.013140471745471527,"score_gpt":0.2490792129974339,"score_spread":0.23593874125196238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1901797386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97327036,0.0012665777,0.000026209402,0.019811338,0.0002488759,0.0006754781,0.00011814168,0.00001534774,0.004567686],"genre_scores_gemma":[0.99387246,0.00013280858,0.00022008904,0.0043193414,0.0004387455,0.00011097098,0.000011560873,0.000011757955,0.0008822322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906343,0.000039722185,0.00023966674,0.000120030956,0.00019430206,0.00034287246],"domain_scores_gemma":[0.99862057,0.00012026057,0.0001871346,0.00006480005,0.0005125062,0.0004947008],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012401374,0.00009831889,0.00024131127,0.000101940524,0.00011218977,0.000030575517,0.00007194662,0.00016440169,0.0023888696],"category_scores_gemma":[0.00033435435,0.00007464668,0.00014357838,0.00010481999,0.000020668787,0.00008415644,0.0000054494926,0.00013705327,0.000039338294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004824071,0.000058644284,0.96202576,0.000007853077,0.00044058054,0.000005202611,0.0001742669,0.0000125180295,0.0024163018,0.00012135982,0.024618072,0.01007117],"study_design_scores_gemma":[0.002356505,0.00047876875,0.9599135,0.000017149294,0.00020558055,0.00004945869,0.0001461346,0.00005671037,0.001429453,0.0039738417,0.031263717,0.000109216904],"about_ca_topic_score_codex":0.009541076,"about_ca_topic_score_gemma":0.0020447767,"teacher_disagreement_score":0.020602148,"about_ca_system_score_codex":0.0007870479,"about_ca_system_score_gemma":0.0010903336,"threshold_uncertainty_score":0.99852306},"labels":[],"label_agreement":null},{"id":"W1902398596","doi":"10.1111/j.1464-410x.2010.09572.x","title":"Long‐term follow‐up of T1 high‐grade bladder cancer after intravesical bacille Calmette‐Guérin treatment","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Proportional hazards model; Pathological; Cohort; Cancer; Internal medicine; Carcinoma in situ; Tumor progression; Urology; Stage (stratigraphy); Disease; Urinary system; Surgery","score_opus":0.013210248509247425,"score_gpt":0.27736524811111024,"score_spread":0.26415499960186284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1902398596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105,0.004740921,0.000082303624,0.0019093506,0.0015645897,0.00024640467,0.00010081789,0.00001159393,0.00029402424],"genre_scores_gemma":[0.9951212,0.0017739199,0.00037567914,0.0008299288,0.0010060125,0.00003445407,0.000009442885,0.00003834627,0.0008110374],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99837625,0.00008122243,0.00060569064,0.00024067164,0.00031303387,0.00038311043],"domain_scores_gemma":[0.99891776,0.00006644536,0.00026340774,0.00021608848,0.00022053954,0.00031576527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013004363,0.00021816818,0.0007442545,0.00013939253,0.00004629971,0.000018895575,0.00013978741,0.00024235256,0.0027691668],"category_scores_gemma":[0.00004827947,0.00019021655,0.00032216322,0.0001104345,0.00023155785,0.000092039445,0.000030994284,0.0005266612,0.000014296153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00788198,0.0039573945,0.4245713,0.00011848402,0.004245469,0.019212851,0.0008944917,0.0000130873095,0.026415851,0.00008881273,0.0065040383,0.50609624],"study_design_scores_gemma":[0.017483708,0.004901196,0.9437914,0.00009178376,0.001397867,0.016726363,0.000018261393,0.000005564702,0.008574528,0.0001808313,0.0066141994,0.00021431092],"about_ca_topic_score_codex":0.0010032343,"about_ca_topic_score_gemma":0.001910488,"teacher_disagreement_score":0.51922005,"about_ca_system_score_codex":0.00009224238,"about_ca_system_score_gemma":0.00035238825,"threshold_uncertainty_score":0.9981424},"labels":[],"label_agreement":null},{"id":"W1904725475","doi":"10.5489/cuaj.1202","title":"Perioperative chemotherapy for muscle-invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Perioperative; Chemotherapy; Adjuvant chemotherapy; Adjuvant; Surgery; Cancer; General surgery; Oncology; Internal medicine","score_opus":0.016756542372638964,"score_gpt":0.2669260303074105,"score_spread":0.25016948793477156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1904725475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8281472,0.0007872725,0.00018496312,0.16141848,0.00071188225,0.0015151766,0.00015870659,0.000044170585,0.0070321593],"genre_scores_gemma":[0.96343374,0.00029372168,0.0004133886,0.030628495,0.0010502146,0.00026509474,0.000018585048,0.000022269023,0.0038744977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988617,0.000052787575,0.00022184187,0.00018622598,0.00020479919,0.00047266937],"domain_scores_gemma":[0.9984669,0.000102630926,0.00012956896,0.00007559897,0.0005594021,0.00066587015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014168343,0.00014817227,0.00025631595,0.000086512286,0.00029590534,0.00010788455,0.000075294614,0.00019878337,0.008034195],"category_scores_gemma":[0.00025046943,0.000108396925,0.00016538294,0.00010654402,0.000027459248,0.00012405912,0.0000041879402,0.00028144667,0.000102726066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016975212,0.00020768525,0.7032799,0.000016841388,0.0014936397,0.000049399383,0.0018401534,0.00003834618,0.002908084,0.00030530317,0.2329067,0.05678418],"study_design_scores_gemma":[0.004073165,0.00075332844,0.83564633,0.00001643674,0.00014617645,0.000052672374,0.00028586327,0.00009424778,0.00035320595,0.0008348272,0.15754998,0.0001937757],"about_ca_topic_score_codex":0.004284796,"about_ca_topic_score_gemma":0.0016877531,"teacher_disagreement_score":0.13528654,"about_ca_system_score_codex":0.0012952663,"about_ca_system_score_gemma":0.0010979575,"threshold_uncertainty_score":0.9928726},"labels":[],"label_agreement":null},{"id":"W1905059247","doi":"10.1111/iju.12232","title":"Standardized assessment of complications in a contemporary series of <scp>E</scp>uropean patients undergoing radical cystectomy","year":2013,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Odds ratio; Comorbidity; American society of anesthesiologists; Body mass index; Urinary diversion; Odds; Bladder cancer; Surgery; Internal medicine; Logistic regression; Cancer","score_opus":0.025102130171426144,"score_gpt":0.320800957523857,"score_spread":0.29569882735243086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905059247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542994,0.00027459743,0.0012881109,0.0016797372,0.0003016326,0.00024662452,0.000041967116,0.0000046059376,0.010732811],"genre_scores_gemma":[0.99794954,0.00007439038,0.0015383017,0.00028664278,0.000060806564,0.00000794112,0.00001685798,0.000010636375,0.000054901036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986036,0.000108871274,0.00069473434,0.00009149685,0.00040612204,0.00009517636],"domain_scores_gemma":[0.9982674,0.0002591487,0.0005240213,0.00009506004,0.0007844284,0.000069917936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016754316,0.00008660465,0.0003524548,0.0002623551,0.000011629727,0.000007028381,0.00017086792,0.000049233444,0.00007335139],"category_scores_gemma":[0.00022163686,0.0000698542,0.00010735921,0.000073740965,0.00013055291,0.00014840864,0.000041685318,0.00016725533,0.0000028494933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046279535,0.0011467021,0.9881034,0.000040594594,0.00088868826,0.00007385546,0.0004879872,0.000066865345,0.0036701614,0.0014628988,0.001988886,0.0016071969],"study_design_scores_gemma":[0.0123219015,0.002338289,0.9780801,0.00013821025,0.00006358814,0.00020387437,0.00019699235,0.00007075188,0.0010075028,0.0013281977,0.004217868,0.000032701173],"about_ca_topic_score_codex":0.00006416413,"about_ca_topic_score_gemma":0.000010267533,"teacher_disagreement_score":0.012519609,"about_ca_system_score_codex":0.00010658469,"about_ca_system_score_gemma":0.00045219436,"threshold_uncertainty_score":0.28485715},"labels":[],"label_agreement":null},{"id":"W1917995928","doi":"10.5489/cuaj.83","title":"Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Medicine; Mycobacterium bovis; Bladder cancer; Tuberculosis; Complication; BCG vaccine; Biopsy; Cancer; Mycobacterium tuberculosis; Surgery; Dermatology; Pathology; Internal medicine","score_opus":0.019922063191315214,"score_gpt":0.27686569490714263,"score_spread":0.2569436317158274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1917995928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98583823,0.0008807587,0.00038878704,0.009425433,0.0004638554,0.00060804776,0.00014851779,0.000021505648,0.002224871],"genre_scores_gemma":[0.99607956,0.00016764789,0.0010413346,0.0017507122,0.00069471827,0.000080636084,0.00002260409,0.000017302207,0.00014548913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985331,0.00006565518,0.0003825939,0.0001385909,0.00029479634,0.0005852277],"domain_scores_gemma":[0.9987848,0.00009694986,0.00017871652,0.00009351954,0.00019857555,0.0006474344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037063519,0.00014046574,0.00032859365,0.00009836143,0.00020666354,0.000023503815,0.0000872398,0.00015767918,0.00051037606],"category_scores_gemma":[0.00008028521,0.0001125077,0.00017972579,0.0001515218,0.00003058289,0.00007671245,0.000011275796,0.00023155336,0.0000148629715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119977514,0.0002290446,0.9732076,0.00005298822,0.0009155364,0.000015540103,0.00030993755,0.000010228521,0.00018711571,0.0010291346,0.0036981,0.020224782],"study_design_scores_gemma":[0.0019004574,0.00034218584,0.9842941,0.000045555396,0.0007666181,0.000093367256,0.00014976689,0.00016175328,0.00030160722,0.00058582035,0.011201788,0.00015694322],"about_ca_topic_score_codex":0.0012823917,"about_ca_topic_score_gemma":0.0002240176,"teacher_disagreement_score":0.020067839,"about_ca_system_score_codex":0.0008710322,"about_ca_system_score_gemma":0.00018747018,"threshold_uncertainty_score":0.558826},"labels":[],"label_agreement":null},{"id":"W193019112","doi":"","title":"Association between urinary diversion and quality of life after radical cystectomy.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Bladder cancer; Urology; Quality of life (healthcare); Urinary system; Ureterostomy; Surgery; Internal medicine; Cancer","score_opus":0.03222044109960909,"score_gpt":0.2589625919798843,"score_spread":0.22674215088027522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W193019112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609214,0.0003711812,0.000007198595,0.0012922239,0.00005066775,0.0006195872,0.000020585572,0.0000196988,0.0015267129],"genre_scores_gemma":[0.9980909,0.000031969066,0.000038866427,0.00021940588,0.00012588273,0.00036144943,0.00000895335,0.000005919612,0.001116646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931115,0.000053121577,0.00015902096,0.00011509735,0.00021395658,0.00014764682],"domain_scores_gemma":[0.99955916,0.000067763074,0.0000702672,0.000092004615,0.000045195604,0.00016560989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016994384,0.000061468454,0.00020557306,0.000033378015,0.000019880657,0.0000064873566,0.000022808808,0.00007380343,0.00012191108],"category_scores_gemma":[0.00011694376,0.000048543494,0.000043079708,0.000051029467,0.000027429876,0.00007228405,0.0000320509,0.00006271983,0.000015591064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012674679,0.000070210896,0.9825331,0.00006494204,0.00015033098,0.0000012088589,0.000068985246,7.655754e-9,0.00002127495,0.000001979122,0.0006514544,0.016309733],"study_design_scores_gemma":[0.0020119282,0.00007019063,0.9967061,0.000008537712,0.0001200127,7.007555e-7,0.000016916798,5.522797e-7,0.00027130882,0.00004609778,0.00070345565,0.000044188633],"about_ca_topic_score_codex":0.00042088685,"about_ca_topic_score_gemma":0.0000020219238,"teacher_disagreement_score":0.016265545,"about_ca_system_score_codex":0.00008902535,"about_ca_system_score_gemma":0.0000179223,"threshold_uncertainty_score":0.19795462},"labels":[],"label_agreement":null},{"id":"W1934556839","doi":"10.5489/cuaj.51","title":"Confirming routine stentograms after cystectomy is unnecessary","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Cystectomy; Anastomosis; Extravasation; Percutaneous nephrostomy; Surgery; Urinary diversion; Bladder cancer; Percutaneous; General surgery; Radiology; Cancer; Internal medicine","score_opus":0.01558402968564792,"score_gpt":0.25177336799513317,"score_spread":0.23618933830948524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934556839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664547,0.001834148,0.000059127426,0.020303478,0.0007742059,0.0002517481,0.00006084144,0.000039322287,0.010222421],"genre_scores_gemma":[0.9814591,0.000042967407,0.00011649133,0.01567072,0.0011546145,0.000017674236,0.000013475983,0.00001504511,0.0015099008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998469,0.00009400393,0.00026757986,0.00013449704,0.00033791485,0.00069699774],"domain_scores_gemma":[0.99834555,0.000047929,0.00014412389,0.00009822732,0.00016668768,0.0011974887],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004130888,0.00014625168,0.00025140538,0.00011774412,0.00017732,0.0000631136,0.00006834393,0.00022058163,0.003572813],"category_scores_gemma":[0.00013142741,0.00011126548,0.00015889139,0.00016666879,0.000021254122,0.00015281005,0.000011064642,0.0004478975,0.00021960936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006897584,0.0000615012,0.99081755,0.000003711375,0.00016102305,0.00007264937,0.000275304,3.7224086e-7,0.000018230972,0.000024575153,0.0052590575,0.003237044],"study_design_scores_gemma":[0.0014910251,0.00020358076,0.8280499,0.000014923587,0.00016853769,0.0003722124,0.00008804129,0.0000105610525,0.000048649046,0.00008479931,0.16934983,0.000117928364],"about_ca_topic_score_codex":0.0015015942,"about_ca_topic_score_gemma":0.00023239657,"teacher_disagreement_score":0.16409077,"about_ca_system_score_codex":0.00094869494,"about_ca_system_score_gemma":0.00027106304,"threshold_uncertainty_score":0.99733806},"labels":[],"label_agreement":null},{"id":"W1936302718","doi":"10.5489/cuaj.10070","title":"A smoking cessation program as a resource for bladder cancer","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Smoking cessation; Pathology","score_opus":0.026739871193071557,"score_gpt":0.30603152285068985,"score_spread":0.27929165165761827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1936302718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9097194,0.0027493467,0.00019764148,0.06362533,0.0012180146,0.0017607441,0.00014314677,0.0001412169,0.020445168],"genre_scores_gemma":[0.9875368,0.00004764328,0.00032805695,0.008579397,0.0018479499,0.00020186653,0.00003480704,0.000018330626,0.0014051464],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998674,0.00007042465,0.0002200611,0.00013012435,0.00028215823,0.00062325975],"domain_scores_gemma":[0.99866146,0.00007928621,0.00017552037,0.00006836923,0.0002036109,0.0008117631],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046651202,0.00011917944,0.00019149727,0.0001107816,0.00029476246,0.00006891723,0.000060088292,0.00021753281,0.00095527375],"category_scores_gemma":[0.0003716073,0.00009390013,0.00013600595,0.00014978118,0.000016485632,0.00012751078,0.0000057913785,0.00030611237,0.00002138907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011416316,0.0001364654,0.9164823,0.000006572374,0.00034731647,0.000008935758,0.00039543628,0.0000081073595,0.000029297327,0.0001975824,0.03164318,0.050630607],"study_design_scores_gemma":[0.0016269059,0.00042110987,0.41146147,0.000012867453,0.0002576924,0.000093681316,0.000084477055,0.00003757768,0.000049425,0.00037494965,0.58547765,0.00010218628],"about_ca_topic_score_codex":0.001657665,"about_ca_topic_score_gemma":0.00043753063,"teacher_disagreement_score":0.5538345,"about_ca_system_score_codex":0.0015102199,"about_ca_system_score_gemma":0.0005354887,"threshold_uncertainty_score":0.999958},"labels":[],"label_agreement":null},{"id":"W1938769679","doi":"10.1111/j.1464-410x.2011.10462.x","title":"Prognostic factors and outcome in patients with T1 high‐grade bladder cancer: can we identify patients for early cystectomy?","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Outcome (game theory); Oncology; Urothelial cancer; Internal medicine; Cancer","score_opus":0.022640744980437565,"score_gpt":0.26396572469937557,"score_spread":0.24132497971893802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1938769679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976041,0.0008836274,0.000022449642,0.00016145797,0.00039317374,0.0007357806,0.00015487226,0.000009751986,0.0000348035],"genre_scores_gemma":[0.99920654,0.0001700887,0.00017547158,0.00024614227,0.00007344525,0.00003570888,0.000017025932,0.000037966383,0.00003758139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986199,0.000059880127,0.00050403975,0.00022094142,0.0002515858,0.00034365893],"domain_scores_gemma":[0.9990583,0.000057503657,0.00030531484,0.00009220773,0.0002882824,0.00019839531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008183167,0.00018283838,0.00053292484,0.00017685413,0.000056165038,0.000021506277,0.00009999761,0.0001216753,0.00006108222],"category_scores_gemma":[0.00007877842,0.00015120568,0.00007857023,0.00010819219,0.00009898301,0.0001331027,0.000023512135,0.00027590466,8.638811e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010468764,0.00062201294,0.9906019,0.000047268542,0.00026952807,0.00013070746,0.000512512,6.1515055e-7,0.0000028364227,0.0000027722156,0.00011616822,0.00664679],"study_design_scores_gemma":[0.015951779,0.0052639553,0.9775779,0.0001351489,0.00044762067,0.00013599153,0.000030380867,7.6905803e-7,0.000039842696,0.00014169207,0.00014292607,0.00013195952],"about_ca_topic_score_codex":0.0027516938,"about_ca_topic_score_gemma":0.0012480955,"teacher_disagreement_score":0.014904903,"about_ca_system_score_codex":0.000080556165,"about_ca_system_score_gemma":0.00011135247,"threshold_uncertainty_score":0.61659884},"labels":[],"label_agreement":null},{"id":"W1939717483","doi":"10.1111/bju.12742","title":"Predictors of preoperative delays before radical cystectomy for bladder cancer in <scp>Q</scp> uebec, <scp>C</scp> anada: a population‐based study","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; Bladder Cancer Canada","keywords":"Medicine; Bladder cancer; Cystectomy; Cohort; Logistic regression; Referral; Retrospective cohort study; Odds ratio; Urology; Population; Cancer; Surgery; Demography; Gynecology; Internal medicine; Family medicine","score_opus":0.011874400174667602,"score_gpt":0.2722099712774464,"score_spread":0.2603355711027788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939717483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452233,0.002305893,0.00072344946,0.00029274792,0.00047205124,0.001218302,0.00016172175,0.00001713957,0.00028635605],"genre_scores_gemma":[0.99789304,0.000084650346,0.00031168858,0.0006520783,0.00060237903,0.00012348646,0.0000255708,0.000050161485,0.00025692416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747676,0.00034619903,0.0009373388,0.00032972696,0.00046444454,0.0004455091],"domain_scores_gemma":[0.99794894,0.0007493018,0.00048411117,0.0001775937,0.00037799726,0.00026204923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047825783,0.00024110748,0.0009307633,0.00031200063,0.00009216605,0.000022170736,0.00019837052,0.00022724265,0.000051582898],"category_scores_gemma":[0.0016643812,0.00023023193,0.00021919748,0.0002717713,0.00011553345,0.00014113505,0.000031432057,0.00045875504,0.0000012276269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029987903,0.0016911562,0.9813939,0.000103779916,0.0009278533,0.00050688005,0.0020447962,0.0010348102,0.00019259132,0.000028461964,0.0055525736,0.0062233717],"study_design_scores_gemma":[0.019066088,0.008120594,0.9651989,0.00018267935,0.00082338206,0.0009931333,0.0005402777,0.00082714995,0.0003211518,0.00020623395,0.0036698738,0.00005059025],"about_ca_topic_score_codex":0.0019362132,"about_ca_topic_score_gemma":0.009067717,"teacher_disagreement_score":0.018766208,"about_ca_system_score_codex":0.00018646724,"about_ca_system_score_gemma":0.00057784637,"threshold_uncertainty_score":0.9388586},"labels":[],"label_agreement":null},{"id":"W1942258069","doi":"10.1111/j.1464-410x.2011.10075.x","title":"Upper urinary tract urothelial carcinoma with loco‐regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universitätsmedizin Mannheim; Clínica Alemana de Santiago; Universität Wien; Keio University","keywords":"Medicine; Urology; Stage (stratigraphy); Lymph node; Concomitant; Cohort; Urothelial carcinoma; Carcinoma; Chemotherapy; Pathological; Dissection (medical); Cancer; Internal medicine; Oncology; Surgery; Bladder cancer","score_opus":0.022420158914534808,"score_gpt":0.24759142392680955,"score_spread":0.22517126501227475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1942258069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867888,0.008185256,0.00026701414,0.0016911541,0.0006274175,0.0006798429,0.00034272592,0.000026196332,0.0013915882],"genre_scores_gemma":[0.99357194,0.0003363556,0.00080707145,0.0031847993,0.0017255251,0.00003788344,0.00007464244,0.00008163055,0.00018017094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971997,0.00044821523,0.0007793171,0.00043923498,0.00066854694,0.0004649712],"domain_scores_gemma":[0.9981231,0.00016641436,0.0004917672,0.00034550964,0.00053866435,0.00033453415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002323815,0.0003813565,0.00076352997,0.0001733246,0.00026680116,0.000073679876,0.0003550343,0.00024953048,0.0011571237],"category_scores_gemma":[0.00006814667,0.0002768527,0.00033246167,0.00026068257,0.0003884963,0.00042697377,0.00004022141,0.00080328126,0.00003834304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03540775,0.011245018,0.85088104,0.00007114842,0.00245934,0.0537882,0.012237855,0.000045372555,0.0045249113,0.00047475987,0.012301286,0.016563302],"study_design_scores_gemma":[0.01256258,0.009951985,0.8891577,0.000088416586,0.0014940184,0.06291705,0.000904509,0.000026436745,0.0010539389,0.00047322072,0.0210425,0.00032760753],"about_ca_topic_score_codex":0.0019751824,"about_ca_topic_score_gemma":0.00019450233,"teacher_disagreement_score":0.03827668,"about_ca_system_score_codex":0.00012484108,"about_ca_system_score_gemma":0.0012204678,"threshold_uncertainty_score":0.99996835},"labels":[],"label_agreement":null},{"id":"W1942424277","doi":"10.1111/j.1464-410x.2012.11180.x","title":"Does patient age affect survival after radical cystectomy?","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Comorbidity; Genitourinary system; Pathological; Affect (linguistics); Population; Scrutiny; Intensive care medicine; Internal medicine; Cancer; Psychology","score_opus":0.010760803060036359,"score_gpt":0.26050400144929353,"score_spread":0.24974319838925718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1942424277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870698,0.008700423,0.00010873651,0.00062032766,0.002006122,0.00015356494,0.000018726781,0.000013158715,0.0013091753],"genre_scores_gemma":[0.9968796,0.00037133283,0.00023702276,0.0011495845,0.0011396789,0.000008805863,0.0000026631362,0.000021169804,0.00019017603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998797,0.00017316673,0.00032348267,0.00010162216,0.00026236396,0.0003423881],"domain_scores_gemma":[0.9993391,0.000067002016,0.00012482965,0.00009669884,0.00007201075,0.0003003601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023531368,0.00010881123,0.0003938362,0.00007131523,0.00003558399,0.000014726271,0.0000631687,0.000114882365,0.0007963052],"category_scores_gemma":[0.000085861284,0.00007490442,0.00018467555,0.00006049303,0.00010868988,0.00010370203,0.000027199554,0.0003326739,0.000026170725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007033756,0.0029965083,0.64091706,0.00016133378,0.001408679,0.04711023,0.0012651046,0.000003242762,0.0017132604,0.000051025705,0.0075235614,0.28981623],"study_design_scores_gemma":[0.006467226,0.0032984975,0.82561886,0.00011589695,0.0004951397,0.040538248,0.000059024587,0.0000012500294,0.00058607897,0.00013131773,0.12251794,0.00017050932],"about_ca_topic_score_codex":0.000060837407,"about_ca_topic_score_gemma":0.00003370034,"teacher_disagreement_score":0.28964573,"about_ca_system_score_codex":0.000050718212,"about_ca_system_score_gemma":0.000067639136,"threshold_uncertainty_score":0.87189835},"labels":[],"label_agreement":null},{"id":"W1948071987","doi":"10.5489/cuaj.600","title":"Biomarkers for detection and surveillance of bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Cytology; Urine cytology; Dipstick; Urology; Carcinoma in situ; Urinary system; Cancer; Urine; Biomarker; Gynecology; Oncology; Internal medicine; Pathology","score_opus":0.012703730937013089,"score_gpt":0.2467841464700741,"score_spread":0.23408041553306103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948071987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842559,0.0007340721,0.00018544716,0.013168658,0.00028177776,0.00041933302,0.00006463492,0.000010280918,0.0008799117],"genre_scores_gemma":[0.99798554,0.00014377078,0.00012360429,0.0012316497,0.00018261431,0.00004191283,0.0000033838878,0.0000066923,0.0002808494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937505,0.000037019076,0.00016652742,0.000096412856,0.00011161922,0.00021338511],"domain_scores_gemma":[0.9991826,0.00007527743,0.0001284732,0.00003872133,0.0002706788,0.0003042701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017371718,0.00006797007,0.00016090412,0.00007659182,0.00009910743,0.000023566248,0.000026560821,0.00011546149,0.0006219325],"category_scores_gemma":[0.00018994029,0.000051923107,0.00006171745,0.000081057784,0.000022451157,0.00005447901,0.0000029739408,0.00010518906,0.000005948248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065062275,0.000018647113,0.96166176,0.000008290653,0.00031269906,0.0000020089337,0.000039347553,0.0000026767107,0.0020555644,0.00000970296,0.005665211,0.030159054],"study_design_scores_gemma":[0.0011918138,0.00031091098,0.9859785,0.000004897623,0.00004860483,0.00003235997,0.000029208994,0.0001571808,0.00029865743,0.0004819534,0.011409436,0.000056520057],"about_ca_topic_score_codex":0.0056558135,"about_ca_topic_score_gemma":0.0022574798,"teacher_disagreement_score":0.030102534,"about_ca_system_score_codex":0.0003469429,"about_ca_system_score_gemma":0.00020484853,"threshold_uncertainty_score":0.8549936},"labels":[],"label_agreement":null},{"id":"W1948420521","doi":"10.1016/j.urolonc.2015.06.011","title":"Outcomes of squamous histology in bladder cancer: A population-based study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of California, San Diego; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Bladder cancer; Internal medicine; Hazard ratio; Cystectomy; Population; Cancer; Proportional hazards model; Histology; Oncology; Basal cell; Gastroenterology; Confidence interval","score_opus":0.05390703792996499,"score_gpt":0.3624586836176842,"score_spread":0.3085516456877192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948420521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215376,0.00094064086,0.000009333635,0.005175518,0.00019259406,0.0005856049,0.000016671964,0.000032131047,0.00089374534],"genre_scores_gemma":[0.99353504,0.00002086812,0.0041829115,0.001684881,0.00003468465,0.00019886487,0.000029479508,0.000010537927,0.00030273834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887764,0.00014038793,0.00035307102,0.0002773729,0.00014731771,0.00020423024],"domain_scores_gemma":[0.99921393,0.00019821925,0.00013906705,0.00017282601,0.00007626747,0.00019969973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020560743,0.00015811411,0.0005167104,0.00021500631,0.00005440062,0.000003756989,0.00006458206,0.00015663248,0.000073538016],"category_scores_gemma":[0.00019814298,0.00012486128,0.000040954244,0.00024531852,0.0002108473,0.000046485064,0.000021231735,0.00018767086,0.0000042853385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019648099,0.0009232839,0.9960452,0.000011475518,0.000059215512,0.00009687777,0.00071536313,0.0002198213,0.000015995674,0.00047907652,0.0004595306,0.00077772967],"study_design_scores_gemma":[0.005842256,0.0057779974,0.9559442,0.000015657382,0.00045424642,0.000036225003,0.0006430842,0.0003139188,0.000050058647,0.0026924685,0.028084978,0.0001449218],"about_ca_topic_score_codex":0.0034595036,"about_ca_topic_score_gemma":0.0019535688,"teacher_disagreement_score":0.040100962,"about_ca_system_score_codex":0.00025845427,"about_ca_system_score_gemma":0.0007332234,"threshold_uncertainty_score":0.52297574},"labels":[],"label_agreement":null},{"id":"W1950295975","doi":"10.5489/cuaj.2559","title":"Clinical benefits of tubeless umbilical cutaneous ureterostomy","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ureterostomy; Urinary diversion; Cystectomy; Surgery; Hydronephrosis; Stoma (medicine); Urinary system; Laparotomy; Upper urinary tract; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.04261237558319383,"score_gpt":0.30038685839885165,"score_spread":0.25777448281565785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950295975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850646,0.00044222016,0.000014974178,0.008424763,0.0008934658,0.00017145445,0.000058874743,0.000020051648,0.0049095843],"genre_scores_gemma":[0.99465984,0.00006922767,0.00020716616,0.0036476152,0.00073618017,0.0000038001456,0.000012862411,0.000012446187,0.00065088336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825615,0.00018163986,0.00053582597,0.00018330131,0.0004523772,0.00039069797],"domain_scores_gemma":[0.99745184,0.00013979219,0.00023231473,0.00012510644,0.0005052127,0.0015457382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000657096,0.0001229231,0.0004247222,0.00009795106,0.000077120894,0.000027555265,0.00011366899,0.00034093752,0.00028992025],"category_scores_gemma":[0.0010946583,0.00009534617,0.00020117889,0.00015123001,0.000054454984,0.00005198631,0.000013938013,0.00056179974,0.00006766385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017280433,0.00010851337,0.9774915,0.0000024145875,0.0001389685,0.0001261165,0.00007087637,0.000019609919,0.000007790743,0.0001042235,0.013453696,0.00830349],"study_design_scores_gemma":[0.0035799162,0.0023031265,0.92102635,0.00002195951,0.00022034805,0.0016215311,0.00005694595,0.00006163723,0.00004604182,0.00077083486,0.07014068,0.00015065545],"about_ca_topic_score_codex":0.0008641205,"about_ca_topic_score_gemma":0.00051169004,"teacher_disagreement_score":0.056686986,"about_ca_system_score_codex":0.0007425402,"about_ca_system_score_gemma":0.0011413922,"threshold_uncertainty_score":0.3888104},"labels":[],"label_agreement":null},{"id":"W1950479518","doi":"10.5430/jst.v5n2p59","title":"Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinoma","year":2015,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Urology; Cystoscopy; Chemotherapy; Stage (stratigraphy); Cystectomy; Radiation therapy; Oncology; Radiology; Internal medicine; Surgery; Cancer; Urinary system","score_opus":0.02806202553741014,"score_gpt":0.2989121036173282,"score_spread":0.270850078079918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950479518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414265,0.00019603707,0.000060619917,0.004232313,0.0004513629,0.00074909575,0.000024808987,0.00001816609,0.00012495635],"genre_scores_gemma":[0.9962284,0.000007718425,0.0010653584,0.0020158954,0.00029496694,0.000022021002,0.000002850492,0.00004724814,0.00031554015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981328,0.00011883996,0.000735135,0.00020840474,0.0004651272,0.00033965427],"domain_scores_gemma":[0.998617,0.00012865198,0.00035959607,0.00021567992,0.0002528315,0.00042623095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072593987,0.00023866919,0.00089460827,0.00034863225,0.000041375253,0.000033151042,0.00015619582,0.00006892631,0.000017413518],"category_scores_gemma":[0.0007240166,0.00018498198,0.00026634664,0.00024109961,0.000032664873,0.00020602148,0.000028348917,0.00024476726,0.000015510976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024445664,0.0010380358,0.6014764,0.00008087308,0.00044993288,0.0032333818,0.015338223,0.00011717364,0.34197268,0.0000045120046,0.0015824353,0.01026069],"study_design_scores_gemma":[0.029477473,0.006073704,0.922871,0.00034247636,0.00018939322,0.0004031444,0.002427945,0.00016305728,0.035990123,0.00015894308,0.0015716399,0.0003311143],"about_ca_topic_score_codex":0.0002815993,"about_ca_topic_score_gemma":0.00005593279,"teacher_disagreement_score":0.3213946,"about_ca_system_score_codex":0.0005356073,"about_ca_system_score_gemma":0.001086733,"threshold_uncertainty_score":0.7543346},"labels":[],"label_agreement":null},{"id":"W1953763800","doi":"10.1111/j.1464-410x.2011.10188.x","title":"Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Proportional hazards model; Lymphovascular invasion; Hazard ratio; Internal medicine; Cohort; Pathological; Stage (stratigraphy); Lymph node; Oncology; Concomitant; Cancer; Upper urinary tract; Urinary system; Urology; Metastasis; Confidence interval","score_opus":0.03326676206184197,"score_gpt":0.2752628777204022,"score_spread":0.24199611565856022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953763800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986251,0.000101614074,0.0000041812264,0.000114182985,0.00028566364,0.00030173716,0.000033838474,0.0000012008616,0.0005324561],"genre_scores_gemma":[0.9996283,0.000013771452,0.00003327657,0.00019116745,0.00010328216,0.0000051691695,0.0000014175791,0.000008101486,0.000015535385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988054,0.0001956998,0.00044288774,0.0000936926,0.00035438398,0.000107941385],"domain_scores_gemma":[0.99931985,0.000036993762,0.0003091134,0.0001275179,0.00017132434,0.00003521339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021099528,0.00008109046,0.00029890978,0.00007614822,0.000028345163,0.0000051526454,0.0003193935,0.00004461917,0.00016123553],"category_scores_gemma":[0.000045553075,0.000045602177,0.000084274325,0.00007198865,0.00013559767,0.000099711986,0.00002636247,0.00024465463,3.6015766e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018117196,0.0057363533,0.9859959,0.000005377813,0.0000904193,0.00028039404,0.0032324994,3.8683916e-7,0.0000065111644,0.0000101025225,0.0000058690384,0.0028245018],"study_design_scores_gemma":[0.005369167,0.009935482,0.98285913,0.000019746936,0.00016053468,0.0010488643,0.0004648121,0.0000013043699,0.000021056978,0.00005832366,0.000024294752,0.00003729886],"about_ca_topic_score_codex":0.00044034826,"about_ca_topic_score_gemma":0.00012035973,"teacher_disagreement_score":0.0041991286,"about_ca_system_score_codex":0.000015195941,"about_ca_system_score_gemma":0.00008018778,"threshold_uncertainty_score":0.18596028},"labels":[],"label_agreement":null},{"id":"W1963692202","doi":"10.1371/journal.pone.0111281","title":"Peri-Operative Morbidity Associated with Radical Cystectomy in a Multicenter Database of Community and Academic Hospitals","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"American College of Surgeons","keywords":"Medicine; Cystectomy; Complication; Perioperative; Surgery; Urinary diversion; Sepsis; Incidence (geometry); Blood transfusion; Medical record; Urinary system; Cohort; Thrombosis; Database; Bladder cancer; Internal medicine; Cancer","score_opus":0.06089261987095564,"score_gpt":0.30599826289803256,"score_spread":0.2451056430270769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963692202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847853,0.00015713528,0.000015679012,0.0003205815,0.00000626444,0.00048071865,0.00007925687,0.000019878691,0.00044195564],"genre_scores_gemma":[0.99907714,0.00007120129,0.0003650925,0.00028605058,0.000022639513,0.000040384242,0.00006473246,0.000013970031,0.000058786904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991112,0.00024465765,0.00016766471,0.00011199392,0.00022384916,0.00014064259],"domain_scores_gemma":[0.99942887,0.00014629196,0.000059054186,0.00020675601,0.00006567704,0.00009336612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024912474,0.00010850403,0.000367149,0.000047941357,0.000044735763,0.0000039896554,0.000057795238,0.000074818236,0.000044539538],"category_scores_gemma":[0.00032089336,0.00008017214,0.000016346617,0.00009437448,0.00015476113,0.00007651131,0.00004635164,0.00048393515,0.0000031431653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064851233,0.003767711,0.95523745,0.00023597105,0.0005153745,0.000011750131,0.0036861289,3.2796464e-7,0.03560671,0.000014721765,0.000040082905,0.0002352532],"study_design_scores_gemma":[0.011295787,0.0015054415,0.9286343,0.0015878084,0.0004277322,0.0000031612274,0.0003489695,0.00041056925,0.05564053,0.000015320973,0.00000798592,0.0001223792],"about_ca_topic_score_codex":0.00067585113,"about_ca_topic_score_gemma":0.00020792313,"teacher_disagreement_score":0.026603146,"about_ca_system_score_codex":0.00006314135,"about_ca_system_score_gemma":0.000040296993,"threshold_uncertainty_score":0.3269325},"labels":[],"label_agreement":null},{"id":"W1964568636","doi":"10.3892/ijo.2011.1023","title":"Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL","year":2011,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Fondation pour la Recherche Médicale; National Cancer Institute; Emory University","keywords":"Gemcitabine; Apoptosis; Wortmannin; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; Biology; Cancer; Cancer cell; Pharmacology; Chemistry; Medicine; Internal medicine; Biochemistry","score_opus":0.04892284557164812,"score_gpt":0.3592266507968386,"score_spread":0.31030380522519047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964568636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909977,0.00057273876,0.00015448367,0.0032413837,0.00075929007,0.00013818957,0.00001930989,0.000003389008,0.004113562],"genre_scores_gemma":[0.99628276,0.0009987152,0.0011638689,0.0009575692,0.00018714568,0.0000072178077,9.148996e-7,0.000009427726,0.00039239813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99924797,0.00006610607,0.0003037077,0.000074383606,0.00023396732,0.00007386008],"domain_scores_gemma":[0.99906594,0.000068903704,0.0002112061,0.00005037629,0.0005147483,0.00008883519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002425396,0.0000695623,0.00021567814,0.00013920269,0.000010730816,0.0000033731071,0.00010534305,0.00005354111,0.0006518294],"category_scores_gemma":[0.00004398729,0.00005327336,0.00006209604,0.000041370382,0.000045626446,0.000075075935,0.000016557997,0.00008211633,0.0000029554194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119559124,0.004214501,0.06314767,0.000020144373,0.0012757989,0.00055694726,0.014123234,0.000006867762,0.43501887,0.00061514176,0.002361769,0.35909992],"study_design_scores_gemma":[0.029948164,0.02303602,0.6777523,0.00012927278,0.00014470672,0.0008857469,0.00045475888,0.000014370423,0.19059716,0.0009593312,0.07592565,0.0001525086],"about_ca_topic_score_codex":0.00023728932,"about_ca_topic_score_gemma":0.00003431406,"teacher_disagreement_score":0.61460465,"about_ca_system_score_codex":0.00019569726,"about_ca_system_score_gemma":0.00034957033,"threshold_uncertainty_score":0.7137075},"labels":[],"label_agreement":null},{"id":"W1965322951","doi":"10.1016/j.clgc.2014.06.004","title":"Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Medicine; Perioperative; Urothelial carcinoma; Salvage therapy; Oncology; Chemotherapy; Internal medicine; Urology; Surgery; Bladder cancer; Cancer","score_opus":0.0770716121855227,"score_gpt":0.4207425315289896,"score_spread":0.3436709193434669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965322951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227893,0.00057860446,0.00032877133,0.00037269492,0.00027501304,0.0059097307,0.00020416596,0.000008141982,0.00004395722],"genre_scores_gemma":[0.99393415,0.0013766206,0.0029793745,0.0001891522,0.0004263513,0.0009461035,0.000009662957,0.00004914474,0.00008945702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823874,0.0001863655,0.00086395175,0.0003517633,0.00013805907,0.00022114564],"domain_scores_gemma":[0.9978792,0.0007944732,0.00044931323,0.00039309502,0.0004041589,0.0000797335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003940233,0.0002260906,0.0007853176,0.000046082274,0.0000711247,0.00000531333,0.0001616221,0.0001474369,0.000035084402],"category_scores_gemma":[0.0002588408,0.00013922506,0.0004665486,0.0001569056,0.00022277738,0.0000633518,0.000023751454,0.0001250265,1.3863192e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12699795,0.0016963251,0.661353,0.00006190278,0.0002485287,6.250284e-8,0.00047600808,0.000019367344,0.0048779394,0.0000084949,0.00007989347,0.20418054],"study_design_scores_gemma":[0.120267995,0.010522221,0.8610246,0.00009120577,0.00006631179,6.3580205e-7,0.00001946623,0.000059320482,0.007482773,0.00012987637,0.00021777558,0.000117786076],"about_ca_topic_score_codex":0.000082782564,"about_ca_topic_score_gemma":0.000007509478,"teacher_disagreement_score":0.20406274,"about_ca_system_score_codex":0.00007262229,"about_ca_system_score_gemma":0.00054160185,"threshold_uncertainty_score":0.5677433},"labels":[],"label_agreement":null},{"id":"W1966023125","doi":"10.3747/co.v18i1.695","title":"First- and Second-Line Therapy for Metastatic Urothelial Carcinoma of the Bladder","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; McGill University","funders":"","keywords":"Gemcitabine; Medicine; Cisplatin; Carboplatin; Vinblastine; Oncology; Internal medicine; Metastatic Urothelial Carcinoma; Bladder cancer; Chemotherapy; Malignancy; Paclitaxel; Urothelial cancer; Cancer; Urothelial carcinoma","score_opus":0.1820476308868427,"score_gpt":0.385044516217123,"score_spread":0.2029968853302803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966023125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893694,0.0050929314,0.00023288756,0.00059507374,0.0010872079,0.001466223,0.00012372974,0.00001483911,0.002017732],"genre_scores_gemma":[0.9982186,0.00027963062,0.0005163522,0.0003114464,0.00015576309,0.00017775132,0.0000069420335,0.000018079425,0.00031545953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999308,0.00004486575,0.00021132683,0.0001823012,0.00008255163,0.0001709614],"domain_scores_gemma":[0.99946064,0.00008199615,0.0000967868,0.00020811119,0.000084401,0.00006804276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096078635,0.0001238741,0.00031024942,0.000039618524,0.000056355075,0.0000020326522,0.00008231796,0.000047822727,0.0005732953],"category_scores_gemma":[0.000028243972,0.00007314903,0.00011137969,0.00006251032,0.0001566327,0.000023901934,0.000030370757,0.000095949275,0.0000037195969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010557373,0.008617881,0.4827384,0.0013726039,0.0019408286,0.00003110001,0.019763468,0.0000010504663,0.0038570967,0.0037856507,0.014849976,0.45248458],"study_design_scores_gemma":[0.03175643,0.011635495,0.5232644,0.000102273516,0.0010994799,0.00016244469,0.00040357263,0.00021509339,0.038244102,0.0045225783,0.3882881,0.00030601604],"about_ca_topic_score_codex":0.0000324086,"about_ca_topic_score_gemma":0.00007075641,"teacher_disagreement_score":0.45217854,"about_ca_system_score_codex":0.00003939089,"about_ca_system_score_gemma":0.00021578098,"threshold_uncertainty_score":0.6277181},"labels":[],"label_agreement":null},{"id":"W1966195994","doi":"10.1016/j.ijrobp.2013.11.005","title":"Hypofractionated Intensity Modulated Radiation Therapy in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Genitourinary system; Radiation therapy; Concomitant; Chemotherapy; Cancer; Internal medicine; Urology; Oncology; Surgery","score_opus":0.02879207947708372,"score_gpt":0.32817094049774687,"score_spread":0.29937886102066313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966195994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146795,0.00014881509,0.0024964516,0.0036869417,0.00091219926,0.0010906506,0.00009224357,0.000023986755,0.000080784666],"genre_scores_gemma":[0.9964437,0.0006039205,0.0004912877,0.0010959995,0.00058704405,0.00014748986,0.00055848376,0.00003298341,0.000039097933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982271,0.00021557068,0.0007317334,0.00030476082,0.0002822466,0.00023857123],"domain_scores_gemma":[0.9971286,0.00037027363,0.00084202917,0.0001498561,0.001413337,0.0000958808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000301067,0.00025449725,0.00058336975,0.00027588537,0.000052294108,0.000021462143,0.00015879085,0.00024429327,0.000044470577],"category_scores_gemma":[0.00022874157,0.00019891733,0.00014045583,0.00025213812,0.00008167618,0.0005673016,0.0000146499815,0.0002636284,0.000003047227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006417512,0.0019840505,0.8137282,0.0000057876277,0.0009224946,0.0000048622114,0.00053882145,0.0029534008,0.00076856645,0.00029988133,0.00013898271,0.1722374],"study_design_scores_gemma":[0.047474887,0.00877427,0.92321765,0.000067401226,0.00014041876,0.000008389988,0.000036356378,0.0073985555,0.0036260404,0.0066505163,0.00240016,0.00020535065],"about_ca_topic_score_codex":0.00065910607,"about_ca_topic_score_gemma":0.00023850291,"teacher_disagreement_score":0.17203204,"about_ca_system_score_codex":0.0018957846,"about_ca_system_score_gemma":0.00070320984,"threshold_uncertainty_score":0.81116134},"labels":[],"label_agreement":null},{"id":"W1966197897","doi":"10.1016/j.humpath.2012.11.026","title":"Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non–muscle invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Human Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Bladder cancer; Cancer research; Clinical significance; Cancer; Medicine; Oncology; Internal medicine; Pathology; Biology","score_opus":0.01168101064072627,"score_gpt":0.2386133467575075,"score_spread":0.22693233611678124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966197897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974002,0.00019039417,0.0000048112583,0.00026910772,0.00007513441,0.0013854211,0.00015732234,0.0000053553354,0.00051224517],"genre_scores_gemma":[0.99888384,0.00004403371,0.00023267789,0.00029775468,0.000032612792,0.0003461203,0.000019315708,0.000022334583,0.00012128456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986972,0.0001913226,0.0003888524,0.00023557588,0.00026735803,0.00021968115],"domain_scores_gemma":[0.9987808,0.00008297371,0.00039718705,0.0004729392,0.000233377,0.000032712698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013152417,0.00016117789,0.0004188617,0.00007369054,0.000049430822,0.0000025910413,0.00021816477,0.00009226023,0.0003245546],"category_scores_gemma":[0.00005068469,0.00008206449,0.00008174248,0.00023215378,0.00035898853,0.00005337905,0.000046569017,0.00018742145,0.00000401569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011506185,0.0006528022,0.9872495,0.000119946206,0.00007614038,0.000008672798,0.0035961154,0.000011525556,0.0061717955,0.000073971656,0.00037300665,0.001551445],"study_design_scores_gemma":[0.0029924181,0.0012458022,0.9536365,0.00013168553,0.00010544368,0.0000022207983,0.00029965167,9.2821915e-7,0.040987253,0.00043523294,0.000088330125,0.00007450557],"about_ca_topic_score_codex":0.002020854,"about_ca_topic_score_gemma":0.00093166134,"teacher_disagreement_score":0.03481546,"about_ca_system_score_codex":0.000031552554,"about_ca_system_score_gemma":0.00012516402,"threshold_uncertainty_score":0.3553645},"labels":[],"label_agreement":null},{"id":"W1966304386","doi":"10.1016/j.urology.2010.07.537","title":"Perioperative Mortality Is Significantly Greater in Septuagenarian and Octogenarian Patients Treated With Radical Cystectomy for Urothelial Carcinoma of the Bladder","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Bladder cancer; Odds ratio; Epidemiology; Logistic regression; Population; Surgery; Urology; Internal medicine; Cancer","score_opus":0.03121223329119596,"score_gpt":0.2494618401664371,"score_spread":0.21824960687524114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966304386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643826,0.000050597784,0.000039913288,0.00023153063,0.000059240527,0.0014484515,0.00012437797,0.000011019142,0.0015966335],"genre_scores_gemma":[0.9985309,0.0000029236164,0.000066081724,0.0009349489,0.000035052828,0.00015136148,0.000012765326,0.000025513185,0.00024045334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989218,0.00010269382,0.00024772892,0.0003434298,0.00012577593,0.00025858506],"domain_scores_gemma":[0.999445,0.000026172169,0.00007415762,0.0002747535,0.00008922374,0.00009067374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058201633,0.00019110204,0.00036355676,0.000069507914,0.000059332488,0.0000042913684,0.00008327076,0.00013477461,0.00025684325],"category_scores_gemma":[0.00002020299,0.00010818441,0.000071399365,0.00011597876,0.00035167817,0.000036896578,0.000028940214,0.00011735411,0.0000022167803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024071638,0.00032331693,0.9886745,0.00003196839,0.00026576666,0.000035748828,0.0072043575,3.403343e-7,0.00074256264,0.00005808609,0.000042089538,0.00021404953],"study_design_scores_gemma":[0.012157591,0.0036894367,0.9647021,0.000012341694,0.00044766397,0.000031349933,0.00013433021,0.000051334562,0.018293053,0.000029345993,0.0003307943,0.0001206071],"about_ca_topic_score_codex":0.00095660763,"about_ca_topic_score_gemma":0.00025467726,"teacher_disagreement_score":0.023972398,"about_ca_system_score_codex":0.00003083797,"about_ca_system_score_gemma":0.0001229257,"threshold_uncertainty_score":0.4411632},"labels":[],"label_agreement":null},{"id":"W1966345283","doi":"10.1016/j.eururo.2009.07.002","title":"Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Upper urinary tract; Carcinoma; Ureteral neoplasm; Oncology; Internal medicine; Urinary system; Transitional cell carcinoma; Cancer; Bladder cancer","score_opus":0.009835714756104225,"score_gpt":0.25616525607675317,"score_spread":0.24632954132064894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966345283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948684,0.000062653206,0.00020156136,0.0004715388,0.00005422861,0.0011292107,0.00008094323,0.000042917665,0.0030885546],"genre_scores_gemma":[0.99772507,0.000002844405,0.00023866788,0.0015513485,0.00013795757,0.000023441042,0.00016897549,0.000046916513,0.00010477744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988601,0.00014869701,0.00023095842,0.00031516145,0.00016660607,0.0002784602],"domain_scores_gemma":[0.9993829,0.000052026448,0.00011344402,0.00022698683,0.0001003475,0.0001242825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090689806,0.0002037089,0.0002972453,0.00009505584,0.00004695757,0.000007732628,0.000093351664,0.000040576182,0.0000713421],"category_scores_gemma":[0.000048025813,0.00013884479,0.00012614629,0.00011215827,0.00007685469,0.000043171854,0.000007708713,0.00013575632,0.000022895012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01409232,0.0036539186,0.95319706,0.000041385134,0.000266544,0.00006849674,0.00029117873,0.0000127976655,0.0010351393,0.000035559,0.00794368,0.019361917],"study_design_scores_gemma":[0.00901749,0.030890029,0.9564656,0.000016765545,0.00022342004,0.000022521022,0.0000029306327,0.000028068189,0.00046187695,0.000011430427,0.0027410106,0.00011886279],"about_ca_topic_score_codex":0.0000196534,"about_ca_topic_score_gemma":4.764593e-7,"teacher_disagreement_score":0.027236111,"about_ca_system_score_codex":0.000061357074,"about_ca_system_score_gemma":0.000070360584,"threshold_uncertainty_score":0.5661926},"labels":[],"label_agreement":null},{"id":"W1966858061","doi":"10.1016/j.humpath.2012.04.020","title":"Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion","year":2012,"lang":"en","type":"article","venue":"Human Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Lymphovascular invasion; Concomitant; Muscularis mucosae; Medicine; Pathology; Carcinoma in situ; Carcinoma; Urology; Internal medicine; Metastasis; Cancer","score_opus":0.03896808478487069,"score_gpt":0.2793575192847287,"score_spread":0.240389434499858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966858061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962497,0.0021667466,0.00004816084,0.0000388496,0.00016779668,0.0009235481,0.000033735738,0.000008943657,0.00036256216],"genre_scores_gemma":[0.9992832,0.000101776335,0.0003270146,0.00007795813,0.00007483001,0.000044776123,0.000028424023,0.000035589404,0.000026432876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812245,0.0003424296,0.0006185616,0.00030727414,0.00025068835,0.0003586037],"domain_scores_gemma":[0.9985531,0.0004684933,0.0003171061,0.00042670895,0.00012394636,0.00011067471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043191205,0.00024418437,0.0007104587,0.00050628884,0.00006301827,0.0000033801527,0.00013599904,0.00019269779,0.00007297022],"category_scores_gemma":[0.00046859318,0.00016392078,0.00015560728,0.00042037378,0.00036398825,0.000088881534,0.00013165484,0.00022896887,0.0000020740936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099337914,0.00035647672,0.9349151,0.0002350449,0.00007083983,0.000029911556,0.0047404645,8.0154405e-7,0.058721993,0.00012395495,0.000028546116,0.0006775216],"study_design_scores_gemma":[0.002249331,0.0009951722,0.8902206,0.000096035124,0.00036882507,0.00006850075,0.00069506094,0.0000033420718,0.10498689,0.00019162186,0.000009338424,0.00011531599],"about_ca_topic_score_codex":0.0016476966,"about_ca_topic_score_gemma":0.00026721548,"teacher_disagreement_score":0.046264898,"about_ca_system_score_codex":0.000056214347,"about_ca_system_score_gemma":0.00012611668,"threshold_uncertainty_score":0.6684496},"labels":[],"label_agreement":null},{"id":"W1967090328","doi":"10.1111/j.1464-410x.2008.08323.x","title":"Non‐muscle‐invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost‐effective alternative?","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Cystoscopy; Bladder cancer; Urine; Urology; Microsatellite; Medicine; Cancer; Urinary system; Internal medicine; Biology; Genetics; Gene","score_opus":0.013964563054053674,"score_gpt":0.29283135815775635,"score_spread":0.27886679510370266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967090328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818601,0.013210661,0.0013064393,0.0008449023,0.00032580897,0.0010331813,0.0012026706,0.000009101071,0.00020713502],"genre_scores_gemma":[0.9846582,0.012910809,0.00027623592,0.0012872606,0.0002692464,0.00014297197,0.00005637067,0.000037388996,0.00036151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981054,0.0001390041,0.00070973195,0.00036463692,0.00030258734,0.00037865463],"domain_scores_gemma":[0.9972981,0.0003385989,0.00072346925,0.00020802936,0.0012318144,0.00019996021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003108105,0.00021986067,0.0011742838,0.00026685625,0.00010056203,0.000012706367,0.00016668772,0.00015711566,0.00024268196],"category_scores_gemma":[0.00020223127,0.00022422151,0.0004462164,0.000597426,0.00018892418,0.00009855882,0.000026412317,0.0002914586,0.0000021559913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017354224,0.0027387212,0.6386018,0.00036586725,0.050191466,0.0033513864,0.004390258,0.0014637953,0.10849766,0.0000060636535,0.12052288,0.052515905],"study_design_scores_gemma":[0.029269956,0.009375203,0.7961561,0.00032339332,0.009074741,0.0071628434,0.00016137934,0.0007365935,0.11280163,0.000095932846,0.03415909,0.0006831112],"about_ca_topic_score_codex":0.0012504209,"about_ca_topic_score_gemma":0.0009840544,"teacher_disagreement_score":0.15755436,"about_ca_system_score_codex":0.0001254395,"about_ca_system_score_gemma":0.00038648737,"threshold_uncertainty_score":0.9143488},"labels":[],"label_agreement":null},{"id":"W1967513395","doi":"10.1093/jnci/93.8.597","title":"Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial","year":2001,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Dysuria; Mitomycin C; Confidence interval; Urology; Randomized controlled trial; Urine; Bladder cancer; Pharmacokinetics; Surgery; Chemotherapy; Regimen; Internal medicine; Urinary system; Cancer","score_opus":0.06299626001064262,"score_gpt":0.4401814813643143,"score_spread":0.37718522135367166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967513395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770632,0.00079859147,0.003854054,0.006428779,0.005328356,0.00220793,0.00020565459,0.0000082854895,0.0041051595],"genre_scores_gemma":[0.98693293,0.00018545629,0.00928013,0.00062607974,0.0023923528,0.00003816675,0.0000039911565,0.0000130812905,0.00052783353],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971331,0.0002220656,0.0013487631,0.00014731173,0.0010014285,0.00014736918],"domain_scores_gemma":[0.99713963,0.0004618424,0.0009876281,0.00015719314,0.0011003248,0.0001533884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018499226,0.00015159498,0.0010013575,0.00022102689,0.0000481937,0.000008281651,0.0002388845,0.000080842285,0.00006364152],"category_scores_gemma":[0.003040161,0.00008741611,0.00061607355,0.0004137141,0.00019370025,0.00012722093,0.0000400551,0.00025796815,0.0000010317273],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94710463,0.00093827734,0.000023427623,0.000025613363,0.0010240917,0.000010889831,0.0005029973,0.00031327878,0.02482397,0.00027250682,0.0021277599,0.022832528],"study_design_scores_gemma":[0.9042462,0.0012149791,0.00053524296,0.00028142126,0.00090929115,0.000094423995,0.000016094986,0.00009918278,0.0795519,0.00050945865,0.012455051,0.00008672568],"about_ca_topic_score_codex":0.0003094073,"about_ca_topic_score_gemma":0.000023721273,"teacher_disagreement_score":0.05472793,"about_ca_system_score_codex":0.00029995193,"about_ca_system_score_gemma":0.0014979916,"threshold_uncertainty_score":0.3639576},"labels":[],"label_agreement":null},{"id":"W1967744362","doi":"10.3941/jrcr.v6i11.1100","title":"\"BCGitis\": A rare case of tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guérin therapy","year":2012,"lang":"en","type":"article","venue":"Journal of Radiology Case Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Orchitis; Bladder cancer; Complication; Rare disease; Urology; Surgery; Gynecology; Disease; Internal medicine; Cancer","score_opus":0.02357184571305291,"score_gpt":0.3065949893513808,"score_spread":0.28302314363832787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967744362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842915,0.01239701,0.0001939331,0.00045839127,0.0015861463,0.0003087282,0.000014709553,0.000016607682,0.0007330099],"genre_scores_gemma":[0.99682665,0.0004339507,0.0011357031,0.00039534396,0.0010702227,0.000009183786,0.000006292724,0.000038523096,0.00008416061],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99752045,0.00024028984,0.0012491671,0.0002185338,0.00028111244,0.0004904544],"domain_scores_gemma":[0.99793375,0.00021584985,0.0007654911,0.0003788503,0.00017787481,0.00052818283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009358335,0.0002692152,0.0011213444,0.00023792291,0.000097117285,0.000007977995,0.000040460152,0.00024174548,0.00020758943],"category_scores_gemma":[0.00030904927,0.00019554557,0.00063737365,0.00017252959,0.00014895617,0.00018094244,0.000025348041,0.00048692187,0.000002688804],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034984274,0.00039531014,0.053682443,0.000035380497,0.001180309,0.91349375,0.001017702,0.000004480108,0.0022495268,0.000019246701,0.0011095391,0.026462466],"study_design_scores_gemma":[0.0029579038,0.0017151115,0.007876112,0.000094630166,0.00059299584,0.9797557,0.0003192526,0.0000049304363,0.004318626,0.00010971489,0.0020987215,0.00015629729],"about_ca_topic_score_codex":0.00042488266,"about_ca_topic_score_gemma":0.00001835204,"teacher_disagreement_score":0.066261955,"about_ca_system_score_codex":0.0002003501,"about_ca_system_score_gemma":0.00034818705,"threshold_uncertainty_score":0.7974117},"labels":[],"label_agreement":null},{"id":"W1968784805","doi":"10.1093/jnci/djn451","title":"Multi-Institutional Validation of the Predictive Value of Ki-67 Labeling Index in Patients With Urinary Bladder Cancer","year":2009,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Oncology; Urology; Biomarker; Lymphovascular invasion; Concordance; Lymphadenectomy; Internal medicine; Cancer; Urinary bladder; Carcinoma; Bladder Neoplasm; Metastasis","score_opus":0.027615958752828587,"score_gpt":0.3138484880868198,"score_spread":0.28623252933399124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968784805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959389,0.0004783214,0.00018689649,0.0013040466,0.0010035149,0.00048420942,0.00020651064,0.0000038225053,0.00039379095],"genre_scores_gemma":[0.9984428,0.00006895866,0.00047970595,0.0005803269,0.00031613195,0.0000147720075,0.0000065362065,0.000008875599,0.00008188929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977966,0.00005668156,0.00054844917,0.00013587692,0.0013265908,0.00013580533],"domain_scores_gemma":[0.9978967,0.000028148343,0.00066176534,0.00012214722,0.0012359776,0.000055294324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021977955,0.00015624466,0.00029871764,0.0001628256,0.000101433034,0.0000067024926,0.0002352612,0.000076301105,0.00003750804],"category_scores_gemma":[0.00012843787,0.00008125441,0.00015480779,0.00044904315,0.00019446474,0.0003367826,0.00003363754,0.00031755195,3.1133715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002399282,0.0011877544,0.8758277,0.00005289964,0.0005044123,0.0000037835484,0.00044722322,0.116613954,0.0010480749,0.00027415823,0.00024865265,0.001392066],"study_design_scores_gemma":[0.0069178925,0.00045444592,0.9832974,0.0009123582,0.00023985884,0.000020145058,0.000015356067,0.0004170121,0.0070763365,0.00024514826,0.00032458483,0.00007947798],"about_ca_topic_score_codex":0.0002527918,"about_ca_topic_score_gemma":0.00006898176,"teacher_disagreement_score":0.11619694,"about_ca_system_score_codex":0.00075476227,"about_ca_system_score_gemma":0.0021713774,"threshold_uncertainty_score":0.38519305},"labels":[],"label_agreement":null},{"id":"W1969024200","doi":"10.1038/nrurol.2011.96","title":"Prognostic factors for upper urinary tract urothelial carcinoma","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Medicine; Lymphadenectomy; Stage (stratigraphy); Lymphovascular invasion; Hydronephrosis; Oncology; Disease; Internal medicine; Upper urinary tract; Ureteral neoplasm; Urothelial carcinoma; Pathological; Lymph node; Cancer; Urinary system; Urology; Bladder cancer; Transitional cell carcinoma; Metastasis","score_opus":0.07437759691816079,"score_gpt":0.370998403451031,"score_spread":0.29662080653287026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969024200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018094132,0.98486775,0.000022727878,0.00007864125,0.0015154715,0.010614952,0.00037748663,0.00009021091,0.0024146936],"genre_scores_gemma":[0.00021660325,0.99248284,0.00034865414,0.0008498151,0.0013928026,0.002353219,0.0008673369,0.00022540068,0.0012633033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996385,0.0004091528,0.0011572046,0.0010915397,0.00019192169,0.00076519814],"domain_scores_gemma":[0.99751467,0.00048327932,0.0006239811,0.000939853,0.0001184989,0.00031972892],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00033233137,0.0011165375,0.005116529,0.00035573117,0.00010716962,0.000014225752,0.00040974465,0.0025155698,0.00062377437],"category_scores_gemma":[0.0005996606,0.0006841025,0.0025851594,0.00030020718,0.00011707093,0.000059996306,0.00007314207,0.0020851959,0.0003257544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015247517,0.00092999614,0.0017751715,0.03748771,0.00050227554,0.00014134603,0.00007323617,2.544209e-9,2.1435484e-7,0.00024308982,0.004227397,0.95446706],"study_design_scores_gemma":[0.0009180944,0.0029750587,0.00062766613,0.0031739075,0.011919151,0.002089077,0.0000015906182,2.0027184e-7,6.6120674e-7,0.000061059836,0.9777553,0.00047824538],"about_ca_topic_score_codex":0.000011118289,"about_ca_topic_score_gemma":0.0000013739411,"teacher_disagreement_score":0.9735279,"about_ca_system_score_codex":0.00017182228,"about_ca_system_score_gemma":0.0007951962,"threshold_uncertainty_score":0.999561},"labels":[],"label_agreement":null},{"id":"W1969447092","doi":"10.1016/j.juro.2015.02.2495","title":"MP67-12 THE MODIFIED FRAILTY INDEX AS A MARKER OF ADVERSE OUTCOMES DURING CYSTECTOMY FOR UROTHELIAL CANCER","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urothelial cancer; Index (typography); Lung cancer; Population; Frailty Index; Adverse effect; Gerontology; Cancer; Internal medicine","score_opus":0.049112700749903086,"score_gpt":0.33288088615520306,"score_spread":0.28376818540529997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969447092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891909,0.0009158177,0.00036265023,0.00694078,0.00056176644,0.0005061916,0.000023083348,0.000007801932,0.0014910535],"genre_scores_gemma":[0.9967249,0.00010091639,0.00003533095,0.0014262926,0.00036935444,0.000024100033,5.2268445e-7,0.000022730877,0.0012958647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988154,0.00015749263,0.00041344453,0.00008726057,0.00029760695,0.00022877363],"domain_scores_gemma":[0.9987811,0.0002247577,0.0003749563,0.00025571004,0.00024807494,0.00011541789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057608756,0.00014401317,0.00043621103,0.000081484,0.00006667253,0.000002508807,0.00023501838,0.00009300444,0.000111576184],"category_scores_gemma":[0.00018342349,0.00006671623,0.00019960392,0.00007816809,0.00015333534,0.00005373094,0.00004370541,0.0002746672,0.000005368096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19209397,0.0016444392,0.7263024,0.00037625965,0.010201989,0.00035962038,0.019768551,0.0067024906,0.022903182,0.0007751409,0.009081738,0.009790232],"study_design_scores_gemma":[0.06491559,0.0072692274,0.8832036,0.00011660655,0.0043508853,0.0030377563,0.0017858858,0.0006963804,0.0075960155,0.004916411,0.021753835,0.00035777112],"about_ca_topic_score_codex":0.00036944286,"about_ca_topic_score_gemma":0.00008728841,"teacher_disagreement_score":0.15690126,"about_ca_system_score_codex":0.00007388742,"about_ca_system_score_gemma":0.00040798014,"threshold_uncertainty_score":0.2720609},"labels":[],"label_agreement":null},{"id":"W1969840730","doi":"10.1046/j.1464-410x.2002.03036.x","title":"Treating neuropathic incontinence in children with seromuscular colocystoplasty and an artificial urinary sphincter","year":2002,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Urology; Urinary incontinence; Artificial urinary sphincter; Surgery; Complication; Urinary system; Sphincter; Deformity; Internal medicine","score_opus":0.011694425840151046,"score_gpt":0.23703446516042548,"score_spread":0.22534003932027444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969840730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713355,0.0021305166,0.000039825078,0.0003322468,0.000049386188,0.00014199506,0.000004765682,0.000008601418,0.0001591247],"genre_scores_gemma":[0.99860317,0.00037863347,0.0002604155,0.000472768,0.00023463428,0.0000032910027,0.0000020091543,0.000017268516,0.00002781339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905807,0.00014924101,0.00029281896,0.00017053014,0.00013980363,0.00018951761],"domain_scores_gemma":[0.9995745,0.000024809866,0.00012904673,0.000080135505,0.00006521042,0.00012629357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019038614,0.00010294579,0.00030636144,0.00009610356,0.000052701416,0.000022824297,0.000055586537,0.00007272301,0.00009251285],"category_scores_gemma":[0.00004582439,0.00009477667,0.00003637901,0.00009579668,0.000097814984,0.00014642996,0.00001773,0.0003413502,0.000002251881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006172151,0.0006780909,0.92685807,0.0000109197745,0.00008821315,0.00829698,0.00026623494,0.000024791245,0.00055792497,0.0000054248962,0.00003411142,0.06256204],"study_design_scores_gemma":[0.003163636,0.0051113926,0.87700206,0.000065591325,0.00013008495,0.11403977,0.00002348751,0.00021193954,0.000049777052,0.00004353281,0.000080458965,0.00007827135],"about_ca_topic_score_codex":0.00013310919,"about_ca_topic_score_gemma":0.00012412373,"teacher_disagreement_score":0.1057428,"about_ca_system_score_codex":0.000020043559,"about_ca_system_score_gemma":0.000035009805,"threshold_uncertainty_score":0.38648805},"labels":[],"label_agreement":null},{"id":"W1969979201","doi":"10.1016/j.eururo.2015.01.032","title":"Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Predictive modelling; Disease; Risk assessment; MEDLINE; Intensive care medicine; Oncology; Cancer; Internal medicine; Machine learning; Computer science","score_opus":0.06722718343894528,"score_gpt":0.3468141931814235,"score_spread":0.2795870097424782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969979201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030879164,0.993279,3.1103875e-7,0.0003335351,0.0003174989,0.0020239486,0.0004156674,0.000019051362,0.0035801434],"genre_scores_gemma":[0.000049847218,0.99752814,0.000010198835,0.0015836888,0.00023710207,0.000101492325,0.00017330248,0.000052150317,0.00026409223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790215,0.0008834324,0.0005199188,0.00035069862,0.00016101352,0.00018276523],"domain_scores_gemma":[0.9990008,0.000100063735,0.0002726385,0.0003924992,0.00015504366,0.00007894626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020727498,0.0002880565,0.0013247213,0.00009258315,0.000020462807,0.000008681246,0.00013946014,0.00012544743,0.00004442324],"category_scores_gemma":[0.00016063581,0.00016340357,0.00018554265,0.0003580412,0.000120798184,0.00003125306,0.000121555895,0.0005188605,0.000016205926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039699953,0.00008375355,0.0006122014,0.101208426,0.00032695394,0.00016216312,0.00020493731,1.6318404e-7,4.272609e-7,0.000011211218,0.007503872,0.8898462],"study_design_scores_gemma":[0.00056565914,0.00032076097,0.00305473,0.08424429,0.0022558318,0.00044397023,0.000002309799,3.6775322e-7,8.631744e-8,0.0000051725915,0.90902,0.00008683098],"about_ca_topic_score_codex":0.000007536657,"about_ca_topic_score_gemma":0.0000025323673,"teacher_disagreement_score":0.90151614,"about_ca_system_score_codex":0.000058818256,"about_ca_system_score_gemma":0.0003322492,"threshold_uncertainty_score":0.6663404},"labels":[],"label_agreement":null},{"id":"W1970399747","doi":"10.1016/j.ijrobp.2013.06.1049","title":"Hypofractionation IMRT in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer","year":2013,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Treatment modality; Modality (human–computer interaction); Urology; Cancer; Radiology; Surgery; Internal medicine","score_opus":0.02786705623608525,"score_gpt":0.3346737637406552,"score_spread":0.30680670750456995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970399747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900521,0.00014323635,0.0017738728,0.005460012,0.00080065074,0.0013961437,0.0001005175,0.000016107411,0.00025735606],"genre_scores_gemma":[0.9962984,0.00030105497,0.001123666,0.0007212447,0.0006440295,0.00041559065,0.00036124175,0.000028313152,0.00010648574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841166,0.00012835968,0.00069390424,0.0002567967,0.00028492857,0.0002243751],"domain_scores_gemma":[0.9973894,0.0003553003,0.0007232865,0.000120383505,0.0013197663,0.00009187367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017646266,0.00021607998,0.0004491798,0.00025261697,0.00004241296,0.000026571226,0.00015100536,0.00020406062,0.00013984327],"category_scores_gemma":[0.00016150619,0.00016846006,0.00012461339,0.00019583972,0.00007253419,0.0007372299,0.00001628164,0.00023124932,0.000009224568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016858714,0.0018702573,0.8959482,0.000008817723,0.0007040277,0.00000534887,0.00056189456,0.0010993953,0.00048258156,0.00063680316,0.0004030491,0.0965938],"study_design_scores_gemma":[0.03367466,0.0052737873,0.94318134,0.000081741244,0.00016713295,0.000008910193,0.0000940832,0.0017314468,0.0016072465,0.011918792,0.002072649,0.00018820503],"about_ca_topic_score_codex":0.0009394688,"about_ca_topic_score_gemma":0.00039734997,"teacher_disagreement_score":0.09640559,"about_ca_system_score_codex":0.0021439237,"about_ca_system_score_gemma":0.0009124743,"threshold_uncertainty_score":0.68696016},"labels":[],"label_agreement":null},{"id":"W1970401271","doi":"10.1016/j.urolonc.2005.07.001","title":"Active surveillance for genitourinary cancer: An overview","year":2006,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Genitourinary system; Cancer; Medicine; Internal medicine","score_opus":0.0602360152438203,"score_gpt":0.37243952861038976,"score_spread":0.3122035133665695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970401271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761764,0.0104560265,0.000077399825,0.008385327,0.0002616565,0.0007966631,0.00024811638,0.00009535994,0.0035030744],"genre_scores_gemma":[0.8699899,0.009328961,0.098851375,0.010637166,0.0023848934,0.002120779,0.0009032519,0.00007999558,0.0057036974],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990049,0.00007068422,0.0002022563,0.00035378963,0.000091719114,0.00027667067],"domain_scores_gemma":[0.9993377,0.00013887546,0.00009857844,0.00016148473,0.00008317789,0.0001802091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012131478,0.00017617075,0.00033375842,0.00007027169,0.0002448934,0.000013231069,0.00006347319,0.00017062027,0.000101314305],"category_scores_gemma":[0.000026878393,0.00014554389,0.000062466854,0.00014272035,0.00031432763,0.00010623746,0.000019325034,0.00015009186,0.0000058938003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009661587,0.0009221985,0.93071264,0.00012979534,0.00017740703,0.00014692052,0.00027846234,0.00008401527,0.0016226263,0.016130252,0.01968873,0.029140808],"study_design_scores_gemma":[0.0017972891,0.0037693137,0.060057104,0.000027783934,0.00025920957,0.00023569704,0.000071817674,0.00028434463,0.00076922704,0.015793972,0.91675895,0.00017531346],"about_ca_topic_score_codex":0.00068601925,"about_ca_topic_score_gemma":0.00040558426,"teacher_disagreement_score":0.89707017,"about_ca_system_score_codex":0.00014126202,"about_ca_system_score_gemma":0.00039376595,"threshold_uncertainty_score":0.5935108},"labels":[],"label_agreement":null},{"id":"W1970534185","doi":"10.1002/path.2507","title":"The development of multiple bladder tumour recurrences in relation to the <i>FGFR3</i> mutation status of the primary tumour","year":2008,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cystoscopy; Mutation; Stage (stratigraphy); Disease; Urinary bladder; Urinary system; Internal medicine; Oncology; Gastroenterology; Biology; Gene","score_opus":0.028640353909450612,"score_gpt":0.2828662339478266,"score_spread":0.254225880038376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970534185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456495,0.001489855,0.0003052837,0.0024653776,0.0003127229,0.00036693225,0.0000059083745,0.000002361984,0.0004866342],"genre_scores_gemma":[0.99836403,0.00044251577,0.0007460356,0.00026225107,0.00007284421,0.000007843099,0.0000015978769,0.000008150311,0.00009472726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839956,0.00037858213,0.00062034145,0.00007129836,0.00034057724,0.00018965434],"domain_scores_gemma":[0.99870974,0.000367996,0.0005097825,0.00017837193,0.00019220937,0.000041908264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096840726,0.000094662406,0.0002319357,0.000062353785,0.0001782883,0.000002655709,0.00021770691,0.000041923133,0.000009203299],"category_scores_gemma":[0.00029709944,0.00003632184,0.00007145414,0.00023150825,0.00017161727,0.000045730012,0.00004736066,0.00026629702,0.0000036551094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070909183,0.0012377783,0.50186306,0.00012475459,0.0005714903,0.00029944407,0.19610117,0.0025245207,0.20036569,0.00016810108,0.00439287,0.0852602],"study_design_scores_gemma":[0.0014258075,0.00041657852,0.9770723,0.00009176498,0.000096712756,0.00079044676,0.0015829952,0.00002014398,0.017208736,0.00021186477,0.0010391396,0.000043513362],"about_ca_topic_score_codex":0.00004652829,"about_ca_topic_score_gemma":0.0002551975,"teacher_disagreement_score":0.47520924,"about_ca_system_score_codex":0.00009680953,"about_ca_system_score_gemma":0.00057195895,"threshold_uncertainty_score":0.14811616},"labels":[],"label_agreement":null},{"id":"W1970979192","doi":"10.1111/j.1464-410x.2009.08742.x","title":"p53 expression in patients with advanced urothelial cancer of the urinary bladder","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Bladder cancer; Cystectomy; Hazard ratio; Lymphadenectomy; Urology; Oncology; Internal medicine; Cohort; Proportional hazards model; Cancer; Concordance; Lymph node; Perineural invasion; Stage (stratigraphy); Metastasis; Confidence interval","score_opus":0.006423613414711085,"score_gpt":0.2476329979527333,"score_spread":0.2412093845380222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970979192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566597,0.0025650435,0.000018043324,0.00072572025,0.00020666662,0.00023653438,0.000016991242,0.0000035152723,0.00056153495],"genre_scores_gemma":[0.99823195,0.00039350998,0.00025634057,0.0009163881,0.00010693571,0.0000039609436,0.000001271641,0.00001184185,0.000077822006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906474,0.00006050599,0.00032764112,0.000112793394,0.0002600049,0.00017428919],"domain_scores_gemma":[0.9993925,0.000018213674,0.00024587128,0.00011617709,0.00016090677,0.00006631198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006951811,0.00009325956,0.0003079672,0.000065955646,0.000031695923,0.000004233139,0.00011738623,0.000070975744,0.00013249287],"category_scores_gemma":[0.000032694184,0.00006432199,0.00008068264,0.000119313925,0.000073078045,0.00008589677,0.000016798602,0.00027675502,6.491968e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010214967,0.0038769525,0.78335476,0.000032221462,0.00018250578,0.00085117173,0.00040875177,0.00032946494,0.005457198,0.000009144809,0.0013183159,0.19396457],"study_design_scores_gemma":[0.010031217,0.004246008,0.9819959,0.0002714933,0.00009519434,0.00073891104,0.000015526308,0.0000019932847,0.0014629018,0.00009265835,0.0009887952,0.000059410428],"about_ca_topic_score_codex":0.00004425012,"about_ca_topic_score_gemma":0.000027689402,"teacher_disagreement_score":0.19864115,"about_ca_system_score_codex":0.000043001928,"about_ca_system_score_gemma":0.00017059944,"threshold_uncertainty_score":0.26229745},"labels":[],"label_agreement":null},{"id":"W1971099042","doi":"10.1016/j.urolonc.2015.02.011","title":"Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Gemcitabine; Cystectomy; Cisplatin; Dosing; Cohort; Urology; Internal medicine; Chemotherapy; Cancer; Neoadjuvant therapy; Oncology; Surgery","score_opus":0.05169494951561104,"score_gpt":0.3480347767821162,"score_spread":0.29633982726650515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971099042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98125106,0.0014376739,0.00019606801,0.015663521,0.00017114413,0.00075044145,0.000054944416,0.00006148246,0.00041365044],"genre_scores_gemma":[0.94286317,0.00020114836,0.052162696,0.003818954,0.00019115346,0.00017205144,0.000032001954,0.000028129572,0.0005307212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987267,0.0001338682,0.00028609493,0.0004219239,0.00013152987,0.00029988197],"domain_scores_gemma":[0.9983865,0.00081979454,0.00013898713,0.00014750713,0.000102973085,0.00040425922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054181734,0.00023896595,0.00046067178,0.00012452653,0.00028164923,0.00004733042,0.000047156613,0.00021117285,0.000010677808],"category_scores_gemma":[0.00070683355,0.00018601381,0.000044020802,0.0001077771,0.00054925826,0.00015558969,0.000042741904,0.00020393965,0.0000013643086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011319878,0.00012399744,0.98594904,0.000045384997,0.00008298418,0.0000842661,0.001961338,0.0000045571182,0.0022598829,0.00041984158,0.0008968504,0.0070398957],"study_design_scores_gemma":[0.021773724,0.013503079,0.72167265,0.00014827131,0.0011255511,0.001320526,0.002939203,0.002216998,0.0016425512,0.010017301,0.22310066,0.0005394898],"about_ca_topic_score_codex":0.00009659354,"about_ca_topic_score_gemma":0.000029719798,"teacher_disagreement_score":0.2642764,"about_ca_system_score_codex":0.00010766128,"about_ca_system_score_gemma":0.0006381561,"threshold_uncertainty_score":0.7585423},"labels":[],"label_agreement":null},{"id":"W1971189047","doi":"10.1016/j.eururo.2013.04.036","title":"Lymphadenectomy for Bladder Cancer at the Time of Radical Cystectomy","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Lymphadenectomy; Cystectomy; Medicine; Bladder cancer; Lymph node; Dissection (medical); Urology; General surgery; Oncology; Surgery; Cancer; Internal medicine","score_opus":0.04329181635981125,"score_gpt":0.33696965689818237,"score_spread":0.2936778405383711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971189047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056835685,0.98155254,0.000019237556,0.00040819796,0.00036457807,0.0024964781,0.00022643163,0.00005296179,0.014822743],"genre_scores_gemma":[0.00004813559,0.97387344,0.000059440517,0.0011915491,0.0009847432,0.0005356199,0.00018596032,0.00019571927,0.022925394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976865,0.0005451086,0.00063045556,0.0005209866,0.00019456714,0.00042237985],"domain_scores_gemma":[0.9983082,0.00040802787,0.00037144197,0.00067568047,0.00009000947,0.00014668006],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025714433,0.00044975043,0.0016997474,0.000111942754,0.00008995163,0.0000090904305,0.00034748786,0.00020907981,0.0032720014],"category_scores_gemma":[0.00007575414,0.00024767988,0.0006993276,0.00015357949,0.00033758095,0.000019727191,0.00017758996,0.00024068142,0.0018858043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016723755,0.00012920254,0.000027391428,0.003943784,0.002122847,0.00008012171,0.00009249055,5.4600014e-7,0.00001485227,0.0000287588,0.08008626,0.91330653],"study_design_scores_gemma":[0.0018875393,0.00055614446,0.00004649575,0.000562478,0.0044238525,0.00040053236,0.0000014383428,0.0000036436372,0.0000096149215,0.0000056714252,0.99191564,0.00018696753],"about_ca_topic_score_codex":0.000048213773,"about_ca_topic_score_gemma":0.000004964167,"teacher_disagreement_score":0.91311955,"about_ca_system_score_codex":0.00014666743,"about_ca_system_score_gemma":0.0003786975,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W1972210762","doi":"10.1093/cid/cis1036","title":"Reply to Mandorfer et al","year":2012,"lang":"fr","type":"letter","venue":"Clinical Infectious Diseases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; AIDS Vancouver","funders":"","keywords":"Medicine","score_opus":0.05381170030873176,"score_gpt":0.39882981335853307,"score_spread":0.3450181130498013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972210762","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018121142,0.019815732,0.00038305705,0.88440955,0.034593184,0.0032865978,0.0020112153,0.0006666515,0.03671285],"genre_scores_gemma":[0.060356513,0.0023750528,0.000028014963,0.895787,0.022102512,0.00041725463,0.00068345625,0.00021249891,0.018037714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942544,0.00090501143,0.0014754673,0.0013325128,0.00067484233,0.0013577577],"domain_scores_gemma":[0.99415183,0.0018876841,0.00032974294,0.0013753409,0.0002599348,0.001995492],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005814069,0.0008917345,0.0017717931,0.0002008959,0.00019866799,0.000116912866,0.0002822455,0.00075478764,0.008270338],"category_scores_gemma":[0.0017182154,0.00076818984,0.001443115,0.0003184441,0.00044526404,0.000190597,0.0002712302,0.0021196434,0.0141714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021812409,0.0019232344,0.37847167,0.00018477895,0.00097149774,0.00047159434,0.000037865488,0.000002351706,0.000001314829,0.000058762274,0.6048469,0.012811907],"study_design_scores_gemma":[0.0034374187,0.0018883226,0.2911857,0.00063639344,0.002897547,0.000043994743,0.000007341379,0.0000023040443,0.000004764319,0.00021957603,0.6991429,0.0005337325],"about_ca_topic_score_codex":0.00052363647,"about_ca_topic_score_gemma":0.00003326198,"teacher_disagreement_score":0.094296,"about_ca_system_score_codex":0.0004429488,"about_ca_system_score_gemma":0.00079200324,"threshold_uncertainty_score":0.9994769},"labels":[],"label_agreement":null},{"id":"W1972240152","doi":"10.1016/j.eururo.2012.02.018","title":"Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Cystectomy; Urology; Stage (stratigraphy); Upper urinary tract; Lymphadenectomy; Ureteroscopy; Ureteral neoplasm; Lymph node; Metastasis; Ureter; Surgery; Urinary system; Bladder cancer; Transitional cell carcinoma; Internal medicine; Cancer","score_opus":0.021069980951452377,"score_gpt":0.26982252813135094,"score_spread":0.24875254717989856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972240152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972099,0.00022695842,0.000010522403,0.00011568792,0.00023092993,0.00036544204,0.00001454053,0.000020475543,0.0018055094],"genre_scores_gemma":[0.99916506,0.0000072345333,0.00003946302,0.0005449751,0.000099911835,0.0000066408766,0.000020998199,0.000041429652,0.00007431633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868226,0.00027606337,0.00028499498,0.00023801115,0.00018126656,0.00033741936],"domain_scores_gemma":[0.9993107,0.00019461167,0.00010058738,0.00021659606,0.000031515112,0.00014599763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029037354,0.0001935399,0.00044776616,0.00014523516,0.000030043455,0.000005363148,0.000049938168,0.000045455396,0.0001380075],"category_scores_gemma":[0.00007505542,0.00012482547,0.00012254814,0.00011948891,0.00009485969,0.00008248682,0.00002567784,0.00018085507,0.00003734645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022491976,0.0013509785,0.9941001,0.000010696782,0.000074916636,0.00013853969,0.00021906177,0.000007931391,0.00005829565,0.000010207127,0.0001292534,0.0016508306],"study_design_scores_gemma":[0.0043787034,0.0036054498,0.99112767,0.000015505593,0.00006342589,0.000013796677,0.000011755128,0.0000024146354,0.00003923111,0.0000017089908,0.0006347584,0.0001055792],"about_ca_topic_score_codex":0.00004640305,"about_ca_topic_score_gemma":0.0000018173879,"teacher_disagreement_score":0.0029724198,"about_ca_system_score_codex":0.000104575076,"about_ca_system_score_gemma":0.00008284665,"threshold_uncertainty_score":0.5090235},"labels":[],"label_agreement":null},{"id":"W1972540549","doi":"10.1111/j.1464-4096.2004.04923.x","title":"Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low‐grade urothelial carcinoma","year":2004,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Urothelium; Cytokeratin; Medicine; Pathology; Cystectomy; Urinary bladder; Immunohistochemistry; Bladder cancer; Transitional cell carcinoma; Carcinoma; Adenocarcinoma; Cancer; Urology; Internal medicine","score_opus":0.010323824457031623,"score_gpt":0.23042877067465112,"score_spread":0.2201049462176195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972540549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431384,0.004523104,0.00005309217,0.00026609443,0.00017157948,0.00056591677,0.00007079286,0.000009468288,0.000026142869],"genre_scores_gemma":[0.99865055,0.00069978234,0.00018659211,0.00026683512,0.0001275552,0.000009764204,0.000007919221,0.000033382017,0.000017606017],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797386,0.00020673423,0.00075785513,0.00032582355,0.00042347115,0.00031226483],"domain_scores_gemma":[0.998511,0.00011296486,0.0006130398,0.0001529195,0.00040659372,0.00020346358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021919665,0.00024410605,0.0010181412,0.0001496911,0.00008115164,0.00001258491,0.00012549134,0.0002255013,0.000022775166],"category_scores_gemma":[0.00026433487,0.00021136474,0.00013402724,0.0001239435,0.00063853135,0.00007863918,0.00007088312,0.00046481076,3.8925043e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022489186,0.015672846,0.21475619,0.0004154392,0.002504653,0.08948209,0.0061665718,0.00023954269,0.64237654,0.0000625777,0.00022683317,0.0056075547],"study_design_scores_gemma":[0.045868874,0.036746696,0.81121945,0.0006100657,0.0017213739,0.08389414,0.00095358014,0.000008987908,0.018084675,0.0005393272,0.000012379719,0.00034042116],"about_ca_topic_score_codex":0.00040848297,"about_ca_topic_score_gemma":0.0000806021,"teacher_disagreement_score":0.62429184,"about_ca_system_score_codex":0.00009882421,"about_ca_system_score_gemma":0.00039504195,"threshold_uncertainty_score":0.86192036},"labels":[],"label_agreement":null},{"id":"W1972649200","doi":"10.1016/j.urology.2009.10.004","title":"A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Perioperative; Logistic regression; Cohort; Population; Internal medicine; Epidemiology; Urology; Oncology; Surgery","score_opus":0.020096783313899722,"score_gpt":0.34229326394140075,"score_spread":0.322196480627501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972649200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939075,0.00010805481,0.002044057,0.0013051168,0.0001720001,0.0009063367,0.00012794364,0.000027056538,0.0014019175],"genre_scores_gemma":[0.9944845,0.000001836551,0.0015309129,0.0033502248,0.00022817799,0.00016679533,0.00012274882,0.000015491596,0.000099350524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906135,0.000061024264,0.00025565337,0.0002619897,0.0001400196,0.00021998594],"domain_scores_gemma":[0.999451,0.000058105925,0.00007331955,0.00023967298,0.000099776014,0.000078145225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007927219,0.00015709882,0.0003735002,0.00007866152,0.000041900596,0.0000065824115,0.000049612845,0.000112549635,0.00033420767],"category_scores_gemma":[0.000024583554,0.00012755871,0.00016709635,0.00006405803,0.000041057112,0.00003992325,0.0000057409507,0.00010218163,0.0000022379822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012125319,0.00046172243,0.9945226,0.00003289568,0.000080718644,0.000027368207,0.00017146392,0.00005021567,0.0018557769,0.0003456207,0.000035423513,0.0012037021],"study_design_scores_gemma":[0.0040694415,0.0035773604,0.98803395,0.000007101678,0.00027493061,0.00001567388,0.000010006437,0.0014868788,0.001040033,0.00011638878,0.0012688666,0.000099390585],"about_ca_topic_score_codex":0.0002225235,"about_ca_topic_score_gemma":0.000036674584,"teacher_disagreement_score":0.0064886324,"about_ca_system_score_codex":0.00007371006,"about_ca_system_score_gemma":0.00026351085,"threshold_uncertainty_score":0.5201693},"labels":[],"label_agreement":null},{"id":"W1972705109","doi":"10.1016/s1078-1439(02)00182-5","title":"Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer","year":2002,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Gemcitabine; Cisplatin; Oncology; Term (time); Cancer; Medicine; Internal medicine; Chemotherapy; Physics","score_opus":0.08471538991158399,"score_gpt":0.3853444164681769,"score_spread":0.3006290265565929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972705109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874784,0.0041268053,0.00032489866,0.0052744644,0.00023896023,0.0010224781,0.00043334428,0.000022450224,0.0010782281],"genre_scores_gemma":[0.9777535,0.001805346,0.016962677,0.0010201939,0.00020145273,0.00060363073,0.00020993045,0.00001882047,0.001424429],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985838,0.00012220327,0.00060235965,0.00030600734,0.00013085692,0.00025479423],"domain_scores_gemma":[0.99895537,0.00045993563,0.0002285024,0.00011827628,0.000076459866,0.00016146076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041262628,0.00018364948,0.00077240786,0.00015068724,0.00013353767,0.000004727351,0.000059076323,0.00018351566,0.00067884976],"category_scores_gemma":[0.00013692041,0.00015090154,0.000114503426,0.00019693849,0.00032225897,0.000081033635,0.0000141339315,0.00017329573,0.0000022336244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013939084,0.013422336,0.7527873,0.0012162401,0.00087391917,0.0005613441,0.010026356,0.0017775282,0.06836521,0.006977963,0.009156733,0.12089599],"study_design_scores_gemma":[0.28087112,0.095973104,0.06437309,0.0012355826,0.007359104,0.0006128795,0.0009682686,0.012792335,0.0460238,0.016172325,0.47153115,0.0020872445],"about_ca_topic_score_codex":0.000054507786,"about_ca_topic_score_gemma":0.00012892268,"teacher_disagreement_score":0.6884142,"about_ca_system_score_codex":0.0001352311,"about_ca_system_score_gemma":0.0002691408,"threshold_uncertainty_score":0.74329287},"labels":[],"label_agreement":null},{"id":"W1972968831","doi":"10.1016/j.urology.2006.03.033","title":"Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphovascular invasion; Urology; Carcinoma in situ; Lymphadenectomy; Confidence interval; Univariate analysis; Carcinoma; Stage (stratigraphy); Metastasis; Transitional cell carcinoma; Proportional hazards model; Surgery; Cancer; Internal medicine; Multivariate analysis","score_opus":0.005867410933853399,"score_gpt":0.2244550585606075,"score_spread":0.2185876476267541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972968831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814945,0.00008366974,0.000006858402,0.00026284074,0.000038974238,0.00018801588,0.00002492479,0.000007958084,0.001237308],"genre_scores_gemma":[0.9993894,0.0000030447527,0.000039301776,0.00031024174,0.000023493962,0.000006420371,0.000050270064,0.000009515793,0.00016828602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994864,0.000019970683,0.00014559158,0.0001323757,0.00008440103,0.00013130087],"domain_scores_gemma":[0.99976224,0.000030908555,0.000043845794,0.000102068916,0.000023094,0.000037822505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000019246056,0.000082634964,0.0002711426,0.00005873374,0.000012555313,0.0000011354326,0.000021799788,0.00006274547,0.000039578383],"category_scores_gemma":[0.000008923749,0.00005750883,0.000017222872,0.000041893436,0.00009741863,0.000012573848,0.0000199621,0.000060546194,0.000004180222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073624443,0.00021290773,0.9982163,0.000018660894,0.00002209915,0.000053342897,0.000052453448,2.5283964e-7,0.00009976679,0.00004708018,0.00003915261,0.0005017397],"study_design_scores_gemma":[0.005540165,0.0009009574,0.9923669,0.0000031521972,0.00007366695,0.00002268633,0.0000017933933,0.000005211283,0.00015881115,0.00002050653,0.00086104724,0.000045088265],"about_ca_topic_score_codex":0.00017832674,"about_ca_topic_score_gemma":0.00026507274,"teacher_disagreement_score":0.005849385,"about_ca_system_score_codex":0.00003068907,"about_ca_system_score_gemma":0.00003673268,"threshold_uncertainty_score":0.2345142},"labels":[],"label_agreement":null},{"id":"W1973278919","doi":"10.1016/j.urolonc.2014.12.005","title":"Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Chemotherapy; Lymph node; Oncology; Lymphadenectomy; Cancer; Urothelium; Primary tumor; Internal medicine; Stage (stratigraphy); Urology; Urinary bladder; Metastasis; Biology","score_opus":0.03753704234868138,"score_gpt":0.3315459649183967,"score_spread":0.29400892256971534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973278919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077774,0.0016055322,0.000013495879,0.016298497,0.000106462365,0.00050773367,0.00021311341,0.000014283687,0.00046311785],"genre_scores_gemma":[0.9846892,0.00057124335,0.006778787,0.007281921,0.000059490532,0.00012323711,0.000005662459,0.000015371825,0.00047510033],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887806,0.00018644628,0.00030462444,0.00025660472,0.00018593759,0.00018834938],"domain_scores_gemma":[0.9991567,0.00018402765,0.00013935479,0.00021655308,0.00008874497,0.00021458085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034037372,0.00015619435,0.00040362735,0.00011852681,0.000049140446,0.0000052599444,0.00009146646,0.00013323645,0.00005274365],"category_scores_gemma":[0.0002127009,0.000102764,0.000043509444,0.00026834576,0.0005500676,0.000051149626,0.00005309563,0.00012254392,0.0000012703014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004550942,0.00046814783,0.95318943,0.000055032193,0.0001855334,0.000024274368,0.005209378,0.00013296508,0.024987603,0.00035568787,0.008594198,0.0022467906],"study_design_scores_gemma":[0.018586688,0.006801299,0.3488485,0.00050004665,0.0009293685,0.00024432692,0.0012453033,0.0006811729,0.07655032,0.004282828,0.5409431,0.00038708549],"about_ca_topic_score_codex":0.0007070893,"about_ca_topic_score_gemma":0.00005468039,"teacher_disagreement_score":0.604341,"about_ca_system_score_codex":0.00009068926,"about_ca_system_score_gemma":0.0008566057,"threshold_uncertainty_score":0.41905943},"labels":[],"label_agreement":null},{"id":"W1974528687","doi":"10.1097/rct.0b013e31818d8de6","title":"Fat Within the Wall of the Urinary Bladder","year":2009,"lang":"en","type":"article","venue":"Journal of Computer Assisted Tomography","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sept Iles","funders":"","keywords":"Medicine; Urinary system; Urinary bladder; Computed tomographic; Urology; Computed tomography; Radiology; Anatomy","score_opus":0.015152821676013258,"score_gpt":0.2605513948067338,"score_spread":0.24539857313072053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974528687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760614,0.0028374223,0.0017930885,0.013616088,0.0014883985,0.0004877238,0.000008536321,0.000026993106,0.0036803198],"genre_scores_gemma":[0.9943029,0.00003077529,0.0023460123,0.0028182426,0.0004043411,0.0000011326424,8.0914737e-7,0.000010563567,0.000085189655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986228,0.00010278594,0.00051722146,0.000105003244,0.00050359446,0.00014860043],"domain_scores_gemma":[0.99878615,0.000053960128,0.00047993838,0.00034966948,0.0002332099,0.000097083954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019233406,0.00015302918,0.00034300308,0.00016655188,0.0000848243,0.000023051276,0.000306995,0.00006329626,0.00003068502],"category_scores_gemma":[0.0000068255144,0.0000690083,0.0006334863,0.0004994147,0.00010880601,0.0000781707,0.000029968316,0.00034663107,0.0000013002051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065774745,0.013030309,0.56654155,0.000313721,0.012657294,0.0013728674,0.012326745,0.0005716101,0.012959652,0.002058626,0.117455594,0.25413457],"study_design_scores_gemma":[0.0025773363,0.0026683195,0.9841384,0.00030045517,0.0005973923,0.0015703342,0.00004816472,0.00012232909,0.0022825045,0.00081873516,0.004780494,0.000095501775],"about_ca_topic_score_codex":0.000008367923,"about_ca_topic_score_gemma":0.0000014574692,"teacher_disagreement_score":0.4175969,"about_ca_system_score_codex":0.000025077416,"about_ca_system_score_gemma":0.00009943029,"threshold_uncertainty_score":0.28140768},"labels":[],"label_agreement":null},{"id":"W1974549193","doi":"10.1007/s12032-010-9704-z","title":"Squamous cell carcinoma of the renal pelvis associated with kidney stones: a case report","year":2010,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grace (Canada)","funders":"","keywords":"Medicine; Squamous metaplasia; Nephrectomy; Differential diagnosis; Renal cell carcinoma; Kidney; Malignancy; Kidney stones; Renal pelvis; Urology; Abdominal mass; Kidney disease; Hematology; Pathology; Radiology; Internal medicine; Epithelium","score_opus":0.03463733054188251,"score_gpt":0.34983016842503917,"score_spread":0.31519283788315666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974549193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029460976,0.97228366,0.000010718543,0.0011836168,0.0014526643,0.002137261,0.0002042607,0.00005390884,0.019727796],"genre_scores_gemma":[0.048712775,0.9267027,0.00022400988,0.0035062481,0.0020491823,0.00084613176,0.0008631275,0.00031885318,0.016776975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668103,0.00045949407,0.00100545,0.0005237647,0.0009052607,0.00042499538],"domain_scores_gemma":[0.996695,0.00059418904,0.00094954995,0.00080602156,0.00018908935,0.00076617545],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067575584,0.00044003548,0.0026902368,0.00011066641,0.00009165687,0.000004444054,0.00029591602,0.0015194804,0.0010413218],"category_scores_gemma":[0.0023860375,0.00021577452,0.0005725735,0.00039052079,0.0006141347,0.000015394073,0.0001318894,0.0018718223,0.000020770824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013773321,0.0020213083,0.0012695588,0.0053574736,0.0004633087,0.44892612,0.00025334395,1.5641419e-8,0.0000010556338,0.00000880722,0.012238717,0.52932256],"study_design_scores_gemma":[0.0028266408,0.0016742039,0.00012727919,0.0025564726,0.0047132033,0.18710564,0.000018001523,0.0000012596022,0.000006278308,0.0000029707392,0.80080426,0.00016377926],"about_ca_topic_score_codex":0.0006970226,"about_ca_topic_score_gemma":0.00040396614,"teacher_disagreement_score":0.7885656,"about_ca_system_score_codex":0.0005081627,"about_ca_system_score_gemma":0.0147153465,"threshold_uncertainty_score":0.99987185},"labels":[],"label_agreement":null},{"id":"W1975246874","doi":"10.1016/j.eururo.2012.01.049","title":"Lymph Node–Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy: Effect of the Level of Node Positivity","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Lymphadenectomy; Lymph node; Bladder cancer; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Urology; Dissection (medical); Lymph; Internal medicine; Perioperative; Oncology; Cancer; Confidence interval; Surgery; Pathology","score_opus":0.019608506078240183,"score_gpt":0.2696612730785929,"score_spread":0.2500527670003527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975246874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880637,0.0014521915,0.00008137052,0.00043848762,0.000094646646,0.00041548128,0.00012327352,0.00002476848,0.009306103],"genre_scores_gemma":[0.998771,0.000036691705,0.000054953296,0.00066889165,0.00013523223,0.000016598775,0.000008821884,0.00004815375,0.00025964482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830437,0.0007338045,0.00021064433,0.00024541013,0.00018796687,0.00031783522],"domain_scores_gemma":[0.9991627,0.00019462775,0.0001399761,0.00030182773,0.00006380756,0.00013707667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023982381,0.00022786566,0.0004873615,0.00006342691,0.000060518938,0.000003364104,0.00009806427,0.000069807305,0.00007025836],"category_scores_gemma":[0.00004078594,0.00012611228,0.00008983581,0.00016943712,0.0004670616,0.000051398216,0.00007962482,0.000116368305,0.000008739439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030589004,0.00025108148,0.9719167,0.00008799235,0.00075592083,0.000057408764,0.0005272366,0.000006772787,0.019529458,0.000030498028,0.00009951631,0.0036785456],"study_design_scores_gemma":[0.0075501455,0.0010588998,0.924743,0.00007121085,0.0010214135,0.00036104908,0.000007778394,0.000017524057,0.06481798,0.000001085555,0.00024262824,0.00010726891],"about_ca_topic_score_codex":0.00056351157,"about_ca_topic_score_gemma":0.000011080233,"teacher_disagreement_score":0.04717365,"about_ca_system_score_codex":0.000056558005,"about_ca_system_score_gemma":0.000082393286,"threshold_uncertainty_score":0.51427096},"labels":[],"label_agreement":null},{"id":"W1975514736","doi":"10.1007/s11136-014-0685-9","title":"Conceptualizing global health-related quality of life in bladder cancer","year":2014,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario; University of Toronto; University Health Network; York University; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Quality of Life Research; Public health; Quality of life (healthcare); Bladder cancer; Cancer; Medicine; Health related quality of life; Quality (philosophy); Environmental health; Gerontology; Nursing; Internal medicine; Disease","score_opus":0.31806874814329184,"score_gpt":0.525489197240259,"score_spread":0.20742044909696716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975514736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97900677,0.0062184925,0.00007450236,0.0074119633,0.0001251228,0.00075290503,0.00016675035,0.00003237128,0.0062111444],"genre_scores_gemma":[0.998066,0.00039438272,0.0001686778,0.0008549077,0.00013705376,0.00005026663,0.00002579784,0.00002068735,0.00028221853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923369,0.003101099,0.0018230239,0.00046209872,0.0015993034,0.0006775162],"domain_scores_gemma":[0.9969382,0.00086549186,0.00042109273,0.00062177534,0.00059235946,0.0005610389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008912117,0.00018594743,0.001308079,0.00016415691,0.00008707741,0.000010880249,0.00023952618,0.00019675195,0.0006575978],"category_scores_gemma":[0.003384545,0.0001655842,0.00017897543,0.0008727188,0.0006321792,0.0000794216,0.00011446327,0.0004806887,0.000029051203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025010693,0.0010691985,0.9618604,0.0018725847,0.00044736778,0.0000020630937,0.0034777059,0.000029552395,0.0010511597,0.013078672,0.00341897,0.011191244],"study_design_scores_gemma":[0.009037679,0.00088192115,0.98245245,0.0004667671,0.00001928744,0.0000010750911,0.0025846562,0.00010511613,0.000574038,0.0027738826,0.0009057034,0.00019741489],"about_ca_topic_score_codex":0.14569992,"about_ca_topic_score_gemma":0.004985375,"teacher_disagreement_score":0.14071454,"about_ca_system_score_codex":0.0004641483,"about_ca_system_score_gemma":0.0026264004,"threshold_uncertainty_score":0.8599889},"labels":[],"label_agreement":null},{"id":"W1975604525","doi":"10.12968/bjon.2006.15.11.21226","title":"Fluorescence diagnosis of bladder cancer","year":2006,"lang":"en","type":"review","venue":"British Journal of Nursing","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Bladder cancer; Photodynamic therapy; Clinical trial; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.06761391965023839,"score_gpt":0.38871217657367113,"score_spread":0.32109825692343275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975604525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006237595,0.99695903,0.000013689873,0.00005823771,0.0007834147,0.00032812337,0.00012153665,0.0000075409334,0.0016660428],"genre_scores_gemma":[0.00018523833,0.9977035,0.00060758705,0.00002807165,0.0010771691,0.000019616818,0.00001481103,0.000063660926,0.00030035534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979728,0.000084946965,0.001020997,0.00018627792,0.00048133315,0.0002536305],"domain_scores_gemma":[0.99836594,0.000074486205,0.0009597625,0.00014521705,0.00029902256,0.00015558979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001401751,0.0002506748,0.0019600105,0.00020028678,0.000051453873,0.00003437762,0.00016552892,0.00020449498,0.00031395658],"category_scores_gemma":[0.000049211303,0.00023468447,0.00082534953,0.00026994015,0.00013301315,0.00009531846,0.000011227795,0.0005150738,0.0000042659444],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002035455,0.000449946,0.00013972046,0.0032092135,0.00044430126,0.0008032203,0.00002691524,4.6045915e-7,8.5912217e-7,0.0000011355039,0.02543084,0.969473],"study_design_scores_gemma":[0.001078991,0.00032041618,0.00079612737,0.34408545,0.007598156,0.0141472975,0.000018083265,4.238069e-7,0.00003711415,0.00003661202,0.6316718,0.00020951267],"about_ca_topic_score_codex":0.0003443862,"about_ca_topic_score_gemma":0.000011941253,"teacher_disagreement_score":0.9692635,"about_ca_system_score_codex":0.00042542216,"about_ca_system_score_gemma":0.00083950616,"threshold_uncertainty_score":0.95701545},"labels":[],"label_agreement":null},{"id":"W1975677927","doi":"10.1016/j.eururo.2011.09.017","title":"The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Lymphovascular invasion; Interquartile range; Renal pelvis; Urology; Hazard ratio; Ureter; Tumor progression; Cancer; Ureteral neoplasm; Internal medicine; Oncology; Bladder cancer; Metastasis; Transitional cell carcinoma; Confidence interval","score_opus":0.023668713601147664,"score_gpt":0.27423576392268906,"score_spread":0.2505670503215414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975677927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816404,0.000016432632,0.0000027078045,0.00006366004,0.0000328878,0.00031053956,0.000013722712,0.000023180686,0.01789649],"genre_scores_gemma":[0.99944323,0.0000030934402,0.000034368244,0.0003678851,0.000018276623,0.000005811989,0.00000804782,0.000025999954,0.00009327637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989364,0.0003252973,0.00021492786,0.00018911419,0.00011000068,0.00022424465],"domain_scores_gemma":[0.999431,0.00007781746,0.00007891138,0.00029195764,0.0000370183,0.00008330144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001280879,0.00014715026,0.00027041647,0.000054678174,0.000032350214,0.0000027498481,0.000097596545,0.000024527315,0.00009785723],"category_scores_gemma":[0.00006122618,0.00006851247,0.00008609631,0.000085782645,0.00018239408,0.000017511065,0.000022877675,0.00016072937,0.00005000897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055313203,0.00073639036,0.9911418,0.0000025617207,0.0001648269,0.00012373652,0.00025057886,0.0000012053348,0.000020741878,0.000011917019,0.0001128237,0.0019021223],"study_design_scores_gemma":[0.0062782085,0.007944583,0.9852666,0.0000072664047,0.000051544626,0.000010410183,0.0000054220454,0.000009024771,0.00017160777,0.000008374474,0.00018794439,0.000059009217],"about_ca_topic_score_codex":0.0004904733,"about_ca_topic_score_gemma":0.000022497306,"teacher_disagreement_score":0.017803213,"about_ca_system_score_codex":0.00004445508,"about_ca_system_score_gemma":0.000037270718,"threshold_uncertainty_score":0.27938575},"labels":[],"label_agreement":null},{"id":"W1975848770","doi":"10.1016/j.eururo.2014.02.038","title":"Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":358,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Urology; Radiation therapy; Cystoscopy; Chemotherapy; Multimodal therapy; Surgery; Oncology; Cancer; Internal medicine; Urinary system","score_opus":0.04263597856081241,"score_gpt":0.35430476559137764,"score_spread":0.3116687870305652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975848770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040096467,0.9916018,0.000055569155,0.00019650199,0.00011073457,0.0026043495,0.00006276857,0.000043517695,0.0052846423],"genre_scores_gemma":[0.0026562759,0.9943056,0.00004502521,0.0019947558,0.00016884657,0.00039186404,0.00010594421,0.00015443026,0.00017725512],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99454045,0.0021702175,0.0015887219,0.0008250367,0.00036975904,0.00050581916],"domain_scores_gemma":[0.9970351,0.00084055925,0.0006746397,0.001056052,0.00020146766,0.00019219508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078307197,0.00067702704,0.007627784,0.0007919168,0.00003752852,0.000014397714,0.00035640245,0.0001858961,0.00059616205],"category_scores_gemma":[0.00050671713,0.00042513505,0.000995825,0.0013483199,0.00022093985,0.000040348506,0.00007708641,0.00063776557,0.0001031396],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013975315,0.00044095467,0.00023119588,0.9131034,0.020023596,0.00088929513,0.0001822479,0.0000075163025,9.836525e-7,0.00007872053,0.00030373523,0.064598575],"study_design_scores_gemma":[0.0036628272,0.0036015867,0.0013231491,0.559666,0.2731777,0.00038732437,0.000022199301,0.000026259067,0.0000016285798,0.000007062305,0.15708376,0.0010405154],"about_ca_topic_score_codex":0.00014142973,"about_ca_topic_score_gemma":0.00013536998,"teacher_disagreement_score":0.35343745,"about_ca_system_score_codex":0.00012147555,"about_ca_system_score_gemma":0.00055751967,"threshold_uncertainty_score":0.99982005},"labels":[],"label_agreement":null},{"id":"W1976411264","doi":"10.1159/000354085","title":"Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)","year":2013,"lang":"en","type":"article","venue":"Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Sanofi","keywords":"Gemcitabine; Cisplatin; Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Bladder cancer; Urology; Oncology; Confidence interval; Metastatic Urothelial Carcinoma; Phases of clinical research; Randomized controlled trial; Chemotherapy; Cancer; Urothelial carcinoma","score_opus":0.032120190926865404,"score_gpt":0.3576284512148955,"score_spread":0.3255082602880301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976411264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605514,0.0013476112,0.00053110614,0.0072662896,0.0004019955,0.023459494,0.00014573245,0.000040838244,0.00625558],"genre_scores_gemma":[0.978967,0.0014842311,0.0010011289,0.0014394234,0.00040929433,0.014365485,0.000033046595,0.000050391438,0.0022500018],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975031,0.0004270504,0.00085309404,0.00041474268,0.00035575815,0.00044624347],"domain_scores_gemma":[0.9975189,0.0013782257,0.00043975998,0.00037940298,0.00015510287,0.00012861779],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034886558,0.00040330677,0.002318517,0.00015828451,0.00008095865,0.00001538624,0.00014817913,0.00013473586,0.0021655827],"category_scores_gemma":[0.00013611969,0.00018380744,0.00031797664,0.00028149717,0.00029994475,0.00012108427,0.000012866814,0.00020420158,0.000030254247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8522519,0.010618374,0.0000632179,0.00003132841,0.0010570115,0.00027761614,0.0016205563,0.000086550775,0.0002000409,0.000025344827,0.00023442549,0.13353364],"study_design_scores_gemma":[0.94151497,0.04657027,0.00011499076,0.000087882945,0.0017605623,0.00014078312,0.00043540885,0.0004959531,0.0005858076,0.00011424489,0.008006306,0.00017284453],"about_ca_topic_score_codex":0.0026755012,"about_ca_topic_score_gemma":0.0030834044,"teacher_disagreement_score":0.13336079,"about_ca_system_score_codex":0.00041432292,"about_ca_system_score_gemma":0.0013487164,"threshold_uncertainty_score":0.9987466},"labels":[],"label_agreement":null},{"id":"W1976799753","doi":"10.1016/j.urology.2009.03.052","title":"Partial Cystectomy Does Not Undermine Cancer Control in Appropriately Selected Patients With Urothelial Carcinoma of the Bladder: A Population-based Matched Analysist","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urology; Bladder cancer; Cohort; Urothelial carcinoma; Stage (stratigraphy); Population; Cancer; Internal medicine; Oncology; Surgery","score_opus":0.006804154475413333,"score_gpt":0.23619987235855144,"score_spread":0.22939571788313812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976799753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584323,0.000044329947,0.00019911693,0.0027279996,0.000095082054,0.00089153554,0.00009821665,0.000026927686,0.000073543924],"genre_scores_gemma":[0.9974212,0.0000012843211,0.000031329677,0.0022452525,0.00009263783,0.00008070389,0.00005250777,0.000019495628,0.00005556091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985943,0.00014550639,0.0003651878,0.00031388746,0.00028252092,0.00029860783],"domain_scores_gemma":[0.9991992,0.000053530905,0.0001873445,0.00031578902,0.00017483877,0.000069279246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060437626,0.00020225538,0.0005223501,0.00013375627,0.000050983428,0.00000609987,0.000109178,0.00012670158,0.00012728911],"category_scores_gemma":[0.00003880013,0.00010943751,0.00009140775,0.00046044373,0.000074119074,0.000029535659,0.000008378998,0.00016943301,0.0000019677348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004817138,0.00047948177,0.99095833,0.000016985343,0.00017063523,0.000011424981,0.00011269349,0.0008512427,0.0018740928,0.000015300207,0.000010454026,0.0006822454],"study_design_scores_gemma":[0.017274866,0.0011217024,0.9751966,0.000013966832,0.0005820748,0.000002809107,0.0000068436925,0.0023380828,0.00327169,0.000039202852,0.000037010985,0.00011514197],"about_ca_topic_score_codex":0.0027236,"about_ca_topic_score_gemma":0.0024353864,"teacher_disagreement_score":0.015761698,"about_ca_system_score_codex":0.00010407309,"about_ca_system_score_gemma":0.0003197223,"threshold_uncertainty_score":0.44627324},"labels":[],"label_agreement":null},{"id":"W1977557805","doi":"10.1038/modpathol.3880300","title":"Comparison of the WHO/ISUP Classification and Cytokeratin 20 Expression in Predicting the Behavior of Low-Grade Papillary Urothelial Tumors","year":2001,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Cytokeratin; Medicine; Pathology; Immunostaining; Papillary tumor; Transitional cell carcinoma; Papilloma; Transitional Cell; Carcinoma; Keratin 7; Papillary carcinoma; Surgical pathology; Immunohistochemistry; Cancer; Bladder cancer; Internal medicine","score_opus":0.0413407852651731,"score_gpt":0.327754110377223,"score_spread":0.2864133251120499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977557805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974791,0.0005909022,0.00028933588,0.0004921117,0.00007991407,0.0007032328,0.000026030899,0.000011600215,0.00032776548],"genre_scores_gemma":[0.99940294,0.00007335768,0.0001258694,0.00010012299,0.000051705665,0.000120634366,0.000009837291,0.000014794787,0.00010075103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989417,0.00016834382,0.0003654993,0.00020140842,0.00017334498,0.0001496933],"domain_scores_gemma":[0.9993948,0.000055158664,0.00017184044,0.00030870718,0.000037679943,0.00003182352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014755668,0.00011222676,0.00030404492,0.00004805691,0.00006931837,0.000003852896,0.00009787035,0.000100116966,0.000015850645],"category_scores_gemma":[0.00003549189,0.00006469716,0.000050210976,0.000097017386,0.00019110406,0.000033933447,0.000054511776,0.00019342815,6.855615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013246818,0.00024285432,0.7104565,0.00002925779,0.0000053585213,0.000014349221,0.0025553259,0.000033001634,0.28411028,0.000011150815,0.000028784494,0.0023806416],"study_design_scores_gemma":[0.0015274897,0.000255421,0.9156981,0.00017335908,0.00007480232,0.00010269326,0.0004878328,0.0046289484,0.07685409,0.000108737135,0.00003275296,0.00005575908],"about_ca_topic_score_codex":0.00004510094,"about_ca_topic_score_gemma":0.000055081775,"teacher_disagreement_score":0.2072562,"about_ca_system_score_codex":0.000026794409,"about_ca_system_score_gemma":0.00005618452,"threshold_uncertainty_score":0.26382735},"labels":[],"label_agreement":null},{"id":"W1977580610","doi":"10.1016/s1470-2045(10)70296-5","title":"A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Bladder cancer; NODAL; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.09256945034448312,"score_gpt":0.3755695150153489,"score_spread":0.2830000646708658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977580610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94441277,0.001361794,0.0315826,0.0022985681,0.00016407993,0.0018906731,0.00009558097,0.000045868346,0.018148089],"genre_scores_gemma":[0.952891,0.0001427023,0.04495557,0.00090256834,0.00009096606,0.0005745331,0.000008095097,0.000018772285,0.000415777],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926263,0.000030281994,0.000175075,0.00019172183,0.00010549606,0.00023477788],"domain_scores_gemma":[0.99956095,0.000029520521,0.00008812655,0.00017357481,0.00009404086,0.000053814478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020016232,0.000115139934,0.00039601282,0.000030898,0.00005885305,0.000002727326,0.000077737306,0.000056014906,0.00004151064],"category_scores_gemma":[0.0000069058588,0.00007569247,0.00003655365,0.000040765586,0.00009103272,0.000022064529,0.000046357294,0.00009844599,0.0000010904234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018201007,0.004495846,0.41425875,0.0014427733,0.009928405,0.0003077342,0.11069667,0.0006415731,0.13900512,0.02308647,0.0042853,0.27365035],"study_design_scores_gemma":[0.05176034,0.0064827474,0.29794288,0.00028829352,0.0027949258,0.00014415849,0.001946476,0.027213933,0.56709,0.01920627,0.024187753,0.000942241],"about_ca_topic_score_codex":0.000106938816,"about_ca_topic_score_gemma":0.00010207904,"teacher_disagreement_score":0.42808485,"about_ca_system_score_codex":0.00020060783,"about_ca_system_score_gemma":0.000670166,"threshold_uncertainty_score":0.30866495},"labels":[],"label_agreement":null},{"id":"W1978075170","doi":"10.1016/j.juro.2011.03.031","title":"Obesity Adversely Impacts Disease Specific Outcomes in Patients With Upper Tract Urothelial Carcinoma","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Urothelial carcinoma; Obesity; Disease; Oncology; Internal medicine; Carcinoma; Urology; Bladder cancer; Cancer","score_opus":0.02179482405656766,"score_gpt":0.2399166919709078,"score_spread":0.21812186791434016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978075170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978938,0.00033058744,0.000018384724,0.000551835,0.00020715097,0.00026891183,0.000014946313,0.000005611314,0.00070873636],"genre_scores_gemma":[0.99893045,0.00006354771,0.00006489021,0.00075337786,0.0000975749,0.0000016178711,0.00000198125,0.000019166313,0.00006737929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897385,0.00013276757,0.0002950189,0.00009825736,0.0002513314,0.00024880446],"domain_scores_gemma":[0.9992064,0.000055478155,0.00019196155,0.00022706087,0.00010279034,0.00021628792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019366886,0.00015229429,0.00035413346,0.00013048768,0.000039519142,0.0000033679598,0.00014418381,0.00005084986,0.00032999105],"category_scores_gemma":[0.000030661875,0.00007597822,0.000104291605,0.000082930084,0.00010344861,0.000102623664,0.000018395149,0.00029414467,0.000021244949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011977558,0.0012245927,0.98501456,0.000006549472,0.00009657098,0.00024275028,0.00094402046,0.0000026471812,0.000019434437,0.000014436237,0.00011574102,0.000341142],"study_design_scores_gemma":[0.0076560313,0.0032193477,0.988034,0.00001227465,0.00033552636,0.00009341406,0.000047285834,0.0000011464782,0.00006546641,0.00013175272,0.00033387737,0.000069864895],"about_ca_topic_score_codex":0.00008146242,"about_ca_topic_score_gemma":0.000012864304,"teacher_disagreement_score":0.0043215267,"about_ca_system_score_codex":0.000070469956,"about_ca_system_score_gemma":0.00018534006,"threshold_uncertainty_score":0.36131707},"labels":[],"label_agreement":null},{"id":"W1978335007","doi":"10.1016/j.clinbiochem.2007.04.006","title":"Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis","year":2007,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sanofi (Canada); Lakeridge Health; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Tuberculin; Tuberculosis; Bladder cancer; Internal medicine; Interferon gamma release assay; Skin test; Gastroenterology; Immunology; Cancer; Mycobacterium tuberculosis; Pathology; Latent tuberculosis","score_opus":0.07030458125213983,"score_gpt":0.36851460549185433,"score_spread":0.2982100242397145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978335007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984063,0.000021384847,0.00025267588,0.00037332223,0.000067819994,0.00048850774,0.00012486872,0.000039295533,0.00022580856],"genre_scores_gemma":[0.9950262,0.000009091965,0.0024195607,0.0019816393,0.00017444833,0.0000381697,0.00010012971,0.000037456437,0.00021330635],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981141,0.000051714036,0.00060632627,0.0005999772,0.00030766721,0.00032022342],"domain_scores_gemma":[0.9979956,0.00031012582,0.00009782984,0.00044744698,0.00027749434,0.00087146234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002918072,0.00025568594,0.0005290238,0.0000614002,0.00003236152,0.00002407251,0.000102770595,0.0002466846,0.00013593445],"category_scores_gemma":[0.0003536899,0.0001894452,0.00009359649,0.00022947657,0.00014784951,0.00005754903,0.000050435843,0.00022197407,0.0000060405805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008634602,0.0028312611,0.85630995,0.00012598732,0.00041612223,0.000056586934,0.00009040994,0.0000027059011,0.08809953,7.263388e-7,0.0009926133,0.04243949],"study_design_scores_gemma":[0.0031910855,0.00382084,0.34728166,0.0002423217,0.00028783508,0.0000036199792,0.000035939316,0.00003379787,0.6446411,7.8741294e-7,0.00025521152,0.00020579532],"about_ca_topic_score_codex":0.00012729282,"about_ca_topic_score_gemma":0.000048776405,"teacher_disagreement_score":0.55654156,"about_ca_system_score_codex":0.000102536535,"about_ca_system_score_gemma":0.00016455105,"threshold_uncertainty_score":0.7725351},"labels":[],"label_agreement":null},{"id":"W1978773345","doi":"10.1038/nrurol.2014.52","title":"Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Mitomycin C; Urology; Cancer therapy; Oncology; Cancer; Internal medicine; Surgery","score_opus":0.03546547438956338,"score_gpt":0.3793203269205808,"score_spread":0.34385485253101744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978773345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012375173,0.9916692,0.000025376397,0.00060522923,0.0011301369,0.0044657732,0.000036676996,0.00004675467,0.002008513],"genre_scores_gemma":[0.00007819894,0.9894178,0.00054243335,0.0056102844,0.001993242,0.001738428,0.00016320935,0.00016751901,0.00028889262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955502,0.00076600007,0.0013937654,0.0011845265,0.00030586822,0.0007996352],"domain_scores_gemma":[0.9975944,0.00042215965,0.00063597097,0.00096791686,0.0001021009,0.0002774103],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005673004,0.0010599573,0.0063312417,0.000470545,0.000058542373,0.000021450294,0.0004339535,0.0026567932,0.00063414196],"category_scores_gemma":[0.00025447112,0.00068178924,0.0012586579,0.0006953755,0.00013334704,0.00005522322,0.00008772921,0.0037642387,0.00028904874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056413555,0.00016931433,0.00003466094,0.009038974,0.00044772125,0.00015999468,0.00008136862,3.782772e-7,0.0000028133215,0.000026450783,0.004144387,0.9858375],"study_design_scores_gemma":[0.0016390288,0.0006648741,0.000100268204,0.010580639,0.0020403352,0.00023143442,0.0000018229075,0.0000027855076,0.000003369584,0.000022226775,0.98422974,0.00048345627],"about_ca_topic_score_codex":0.00007639166,"about_ca_topic_score_gemma":0.00015491035,"teacher_disagreement_score":0.98535407,"about_ca_system_score_codex":0.0003546806,"about_ca_system_score_gemma":0.0009055554,"threshold_uncertainty_score":0.99956334},"labels":[],"label_agreement":null},{"id":"W1978777152","doi":"10.3747/co.v17i3.544","title":"Balancing Potential Quality-of-Life Benefits Against the Risk of Lethal Late Recurrence with Bladder-Preserving Surgery","year":2010,"lang":"en","type":"letter","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Intensive care medicine; General surgery; Surgery; Urology; Nursing","score_opus":0.10106406910749183,"score_gpt":0.3635077410960904,"score_spread":0.2624436719885986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978777152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8530262,0.011901866,0.00020473004,0.119811855,0.009078534,0.001731699,0.0012209194,0.00009262487,0.0029315525],"genre_scores_gemma":[0.8971008,0.011896249,0.00063041213,0.072570324,0.014297233,0.00040518722,0.0022788653,0.00032101554,0.0004999259],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960297,0.00075490447,0.0011282774,0.000648006,0.0008123474,0.0006268192],"domain_scores_gemma":[0.9952152,0.0015253865,0.001599068,0.0009985231,0.00050719175,0.00015466024],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00098721,0.0005197533,0.0017895929,0.00024591896,0.00014273296,0.000015183499,0.00046806977,0.0011942427,0.00021350247],"category_scores_gemma":[0.00069474557,0.00033010656,0.00049829244,0.0002864525,0.00051709625,0.000072794224,0.00020572772,0.004888877,0.000014958472],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002125404,0.0011582628,0.26290107,0.004060458,0.0031944683,0.00036031843,0.0012605384,0.000119741075,0.0004734829,0.0000251115,0.5653859,0.15893531],"study_design_scores_gemma":[0.008789431,0.0020374295,0.13626179,0.004168215,0.0048906454,0.00018473824,0.00020777907,0.0002548071,0.0010534739,0.0002856272,0.8404429,0.0014231949],"about_ca_topic_score_codex":0.0005192265,"about_ca_topic_score_gemma":0.0002146066,"teacher_disagreement_score":0.27505702,"about_ca_system_score_codex":0.00013410134,"about_ca_system_score_gemma":0.0018313719,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W1978809339","doi":"10.1016/j.juro.2010.01.025","title":"Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical Cystectomy: An International Study of 243 Patients","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Lymphovascular invasion; Bladder cancer; Carcinoma in situ; Urology; Carcinoma; Metastasis; Cancer; Internal medicine; Oncology; Surgery","score_opus":0.015092189198889359,"score_gpt":0.30055399659497484,"score_spread":0.28546180739608545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978809339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993757,0.0000066283937,0.0000028634345,0.00012475255,0.00013233641,0.00028502053,0.000020347019,0.0000018962076,0.000050461666],"genre_scores_gemma":[0.999757,0.000009198034,0.000051691033,0.00010884217,0.0000462622,0.0000012359508,0.000009070367,0.000010999263,0.000005734593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988201,0.00017154995,0.00054745947,0.00009181604,0.00027081955,0.000098217475],"domain_scores_gemma":[0.9988589,0.00013631511,0.00046977986,0.0001615223,0.00029026315,0.00008316641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002665056,0.00010427119,0.000498844,0.0001146704,0.000015039411,0.000002403672,0.00012627862,0.00006621879,0.000020686379],"category_scores_gemma":[0.00007761977,0.000050527207,0.000029087341,0.000061581784,0.00019398399,0.00006116158,0.000024411444,0.00034219187,2.3936025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011185531,0.004027287,0.98166156,0.000005586509,0.00030917418,0.000031062882,0.0006939844,6.40368e-7,0.000056380417,0.0000029437956,0.0000024167844,0.002023435],"study_design_scores_gemma":[0.019403463,0.02306199,0.9568832,0.0000091819375,0.00042072267,0.000050360322,0.00007171016,0.0000068783675,0.000027708105,0.000004331918,0.000021051574,0.000039397823],"about_ca_topic_score_codex":0.00008441386,"about_ca_topic_score_gemma":0.00025764172,"teacher_disagreement_score":0.024778355,"about_ca_system_score_codex":0.000013614495,"about_ca_system_score_gemma":0.00010169642,"threshold_uncertainty_score":0.20604397},"labels":[],"label_agreement":null},{"id":"W1979333574","doi":"10.1016/j.clgc.2013.04.025","title":"Impact of Response to Prior Chemotherapy in Patients With Advanced Urothelial Carcinoma Receiving Second-Line Therapy: Implications for Trial Design","year":2013,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Pazopanib; Docetaxel; Oncology; Chemotherapy; Metastatic Urothelial Carcinoma; Response Evaluation Criteria in Solid Tumors; Context (archaeology); Cyclophosphamide; Gemcitabine; Progressive disease; Cancer; Bladder cancer; Sunitinib; Urothelial carcinoma","score_opus":0.06850117939776647,"score_gpt":0.40310533449699604,"score_spread":0.3346041550992296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979333574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895731,0.00020598422,0.0002995578,0.0012923247,0.00022304033,0.008151122,0.0001865901,0.000030448015,0.00003783118],"genre_scores_gemma":[0.99141663,0.00012002988,0.0040631616,0.00089366134,0.00046461198,0.0025232385,0.000019463003,0.00007786453,0.00042132253],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979548,0.00020207273,0.0007683108,0.00051005365,0.0001758982,0.00038890785],"domain_scores_gemma":[0.9979451,0.0006228615,0.00022404146,0.0005305638,0.00038735254,0.0002901275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003701682,0.00027840675,0.00069136254,0.0001433529,0.000060657243,0.000013647215,0.00016973782,0.0001484306,0.0005492959],"category_scores_gemma":[0.00018580774,0.0001955927,0.0003007175,0.00030251208,0.00007987015,0.00011915345,0.000025098927,0.00019193791,0.0000093541985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48761746,0.0018166179,0.40940684,0.000016947735,0.00020304606,0.0000013470352,0.00013766643,0.00005228169,0.0025292353,2.2334709e-7,0.00088261295,0.09733571],"study_design_scores_gemma":[0.12769412,0.039374616,0.83132434,0.000067001296,0.000046055262,9.913953e-7,0.000008544874,0.000013461948,0.00084061414,0.000034506746,0.0004168029,0.00017895714],"about_ca_topic_score_codex":0.00011454824,"about_ca_topic_score_gemma":0.000012297691,"teacher_disagreement_score":0.4219175,"about_ca_system_score_codex":0.00028237712,"about_ca_system_score_gemma":0.0010216356,"threshold_uncertainty_score":0.79760385},"labels":[],"label_agreement":null},{"id":"W1979753022","doi":"10.1016/j.urolonc.2013.10.003","title":"Assessing the quality of studies on the diagnostic accuracy of tumor markers","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Quality (philosophy); Medical physics; Relevance (law); Medicine; Quality assessment; Meta-analysis; Systematic review; Scale (ratio); Data science; Computer science; External quality assessment; MEDLINE; Pathology","score_opus":0.1817403107201343,"score_gpt":0.47916022913372835,"score_spread":0.29741991841359405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979753022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014571565,0.9788075,0.0000047832846,0.0034530368,0.00028805688,0.001195023,0.000041892978,0.000016687982,0.0016214247],"genre_scores_gemma":[0.0035328972,0.9930085,0.0012070618,0.0015950153,0.00014637833,0.00033834105,0.000025614368,0.000018759698,0.00012744144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973466,0.0010558919,0.00087311293,0.00030968586,0.0002178443,0.00019691231],"domain_scores_gemma":[0.9784244,0.019735144,0.0012029376,0.00043300542,0.00011778128,0.00008678893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014658064,0.00030874394,0.0016976466,0.000093166724,0.00023781977,0.000013961075,0.0002024614,0.0001945366,0.000033125263],"category_scores_gemma":[0.0072095077,0.00013698396,0.0002628327,0.0002746481,0.0018804907,0.00004281617,0.00007452155,0.0005184498,0.0000068452096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003018829,0.0017104854,0.050075028,0.046491336,0.007217847,0.00019602766,0.0027269942,0.000026221613,0.00001691334,0.08049765,0.029379388,0.7813602],"study_design_scores_gemma":[0.00030516542,0.0015248683,0.00049454236,0.004670306,0.0032246974,0.000103465616,0.00049832725,0.0000048884435,0.000011375727,0.0024550648,0.98658514,0.0001221661],"about_ca_topic_score_codex":0.000051328356,"about_ca_topic_score_gemma":0.00001046088,"teacher_disagreement_score":0.9572058,"about_ca_system_score_codex":0.000107394124,"about_ca_system_score_gemma":0.0008713859,"threshold_uncertainty_score":0.8630975},"labels":[],"label_agreement":null},{"id":"W1980437435","doi":"10.1097/01.ju.0000154354.06892.ba","title":"BACILLUS CALMETTE-GUERIN TOKYO172 SUBSTRAIN FOR SUPERFICIAL BLADDER CANCER: CHARACTERIZATION AND ANTITUMOR EFFECT","year":2005,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bacilli; Medicine; Human bladder; Bacillus (shape); Bladder cancer; Cancer; Bladder tumor; BCG vaccine; Pathology; Microbiology; Internal medicine; Vaccination; Biology; Bacteria","score_opus":0.014350875849959007,"score_gpt":0.2862172756503531,"score_spread":0.27186639980039407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980437435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871575,0.0012743752,0.0009797643,0.009817024,0.00031279767,0.0003473066,0.00003885062,0.000007719518,0.00006466025],"genre_scores_gemma":[0.99611753,0.000678167,0.000088492634,0.0016278673,0.0012792449,0.000011107468,0.000007661699,0.00001752917,0.00017237183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992445,0.000098565644,0.00026070612,0.00008653841,0.0001184703,0.00019119775],"domain_scores_gemma":[0.99947006,0.00013213091,0.00013745084,0.00009259332,0.00008756089,0.00008023571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038324684,0.000117681644,0.00031617025,0.00007087393,0.000073962015,0.000007637907,0.00007011205,0.000069775204,0.00013289606],"category_scores_gemma":[0.000046899077,0.00007014807,0.000072164876,0.00006003841,0.000086143984,0.00007129395,0.000012634045,0.0001641633,0.0000041035073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01559881,0.00034525956,0.038650446,0.00013079615,0.001178894,0.00009838787,0.0021711164,0.000113271206,0.5265575,0.00013416466,0.0016476783,0.41337368],"study_design_scores_gemma":[0.03414579,0.025530063,0.6494953,0.000102935854,0.005309036,0.007193767,0.00013279413,0.001648362,0.09762258,0.00016738543,0.17810942,0.00054256595],"about_ca_topic_score_codex":0.000028676479,"about_ca_topic_score_gemma":0.00004281212,"teacher_disagreement_score":0.61084485,"about_ca_system_score_codex":0.000041167477,"about_ca_system_score_gemma":0.00009687665,"threshold_uncertainty_score":0.2860555},"labels":[],"label_agreement":null},{"id":"W1980536257","doi":"10.1016/j.eururo.2011.12.026","title":"Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Perioperative; Odds ratio; Logistic regression; Cohort; Blood transfusion; Population; Urology; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.14568261030978968,"score_gpt":0.3435386316819542,"score_spread":0.19785602137216451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980536257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205687,0.00011044895,0.000022229771,0.0005378844,0.00006882902,0.00050530036,0.000026312397,0.000027265798,0.07813304],"genre_scores_gemma":[0.99712175,0.000008251584,0.0008494657,0.00083480135,0.00005695842,0.000012595442,0.000023714148,0.00002524411,0.0010672241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895424,0.00023894352,0.0002728254,0.00025499891,0.0001222351,0.00015678044],"domain_scores_gemma":[0.99949545,0.000036849033,0.000104995706,0.00016182683,0.00011686939,0.0000840192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017050214,0.0001530553,0.00057927193,0.00005665116,0.00007067375,0.000017771605,0.0001508615,0.00004094386,0.00021205592],"category_scores_gemma":[0.000060358056,0.00011382758,0.000036641242,0.000065479464,0.00021540943,0.000119763725,0.00021323294,0.00013654177,0.000041998526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005210741,0.00013220505,0.99188346,0.000021337795,0.00024224345,0.000024484472,0.005303518,1.8720719e-7,0.0005963428,0.00052031054,0.00015442005,0.0006004289],"study_design_scores_gemma":[0.002747173,0.0019210016,0.988533,0.000012867993,0.00014769145,0.000030121142,0.00012238504,0.0000020822854,0.0032517991,0.00009474394,0.003040581,0.000096531556],"about_ca_topic_score_codex":0.0001243687,"about_ca_topic_score_gemma":0.000041994674,"teacher_disagreement_score":0.07706582,"about_ca_system_score_codex":0.000018384799,"about_ca_system_score_gemma":0.00009575288,"threshold_uncertainty_score":0.4641754},"labels":[],"label_agreement":null},{"id":"W1980666888","doi":"10.1016/j.eururo.2010.09.022","title":"Re: A Sequence Variant at 4p16.3 Confers Susceptibility to Urinary Bladder Cancer","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Urinary system; Sequence (biology); Urinary bladder; Urothelial cancer; Internal medicine; Cancer; Oncology; Urology; Genetics","score_opus":0.04304983162542378,"score_gpt":0.30730577106967893,"score_spread":0.2642559394442552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980666888","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02296529,0.0005799284,0.00004827752,0.88519806,0.0030035998,0.0016086003,0.0006280079,0.0003232882,0.085644975],"genre_scores_gemma":[0.08667981,0.0001280289,0.00023814879,0.8753633,0.0063914405,0.000110015484,0.00044733923,0.00027298316,0.030368967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959631,0.0006537805,0.0005403235,0.0014651854,0.00042464674,0.0009529744],"domain_scores_gemma":[0.99753463,0.00014452441,0.0002001985,0.0015687254,0.00018414795,0.00036776558],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000348725,0.00067875104,0.00087489514,0.00020525644,0.00016058674,0.000028355922,0.000474991,0.0010123206,0.008591575],"category_scores_gemma":[0.00013715078,0.00058411236,0.00026818374,0.00018237544,0.00037975752,0.00004336569,0.00042460326,0.0038707312,0.0032397108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069945847,0.00013536311,0.0027913132,0.00012303745,0.00043869432,0.024556339,0.00043083655,0.0000025144761,0.001994377,0.00000543558,0.96752393,0.0012986788],"study_design_scores_gemma":[0.0015966783,0.0020123278,0.011097354,0.000041381903,0.00070066965,0.0011329032,0.000007991382,0.000004613739,0.00012518877,0.000027604363,0.9827694,0.00048382767],"about_ca_topic_score_codex":0.00050443364,"about_ca_topic_score_gemma":0.0003308917,"teacher_disagreement_score":0.06371452,"about_ca_system_score_codex":0.00036289004,"about_ca_system_score_gemma":0.00046609147,"threshold_uncertainty_score":0.999661},"labels":[],"label_agreement":null},{"id":"W1981072999","doi":"10.1016/j.juro.2012.02.1370","title":"1597 GENDER DIFFERENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY A POPULATION-BASED ANALYSIS","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Context (archaeology); Population; Demography; Cancer; History; Internal medicine; Archaeology; Sociology","score_opus":0.017803439508833507,"score_gpt":0.2647090452244409,"score_spread":0.24690560571560738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981072999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833494,0.00058756804,0.00025296168,0.0004878165,0.000038740953,0.00017904238,0.000006781718,0.000005719999,0.00010645225],"genre_scores_gemma":[0.9991808,0.000016813523,0.00008300127,0.0005679249,0.000094645126,0.000007774716,0.000008609844,0.000012939427,0.000027473263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989258,0.00018314853,0.0002587254,0.00008153216,0.00030644322,0.00024436376],"domain_scores_gemma":[0.999308,0.00009560869,0.00022110628,0.00014130304,0.000111357396,0.00012263571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016237938,0.00013527145,0.00043491126,0.00025956435,0.000041054664,0.000004318425,0.00007930547,0.00006412541,0.0003439437],"category_scores_gemma":[0.000011222145,0.000059055423,0.00006784167,0.00044683283,0.00008005562,0.000064666776,0.000006138758,0.0002168015,0.0000017269274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049685696,0.00039792806,0.99198663,0.000005350107,0.0016942753,0.000010744153,0.0002927186,0.0003054605,0.0000072304388,0.0000031559248,0.000019809559,0.00030812903],"study_design_scores_gemma":[0.006505295,0.0014913752,0.98755956,0.000011964768,0.004140109,0.000027675973,0.000027960114,0.000100520796,0.000024642715,0.0000060495036,0.00003895151,0.000065869186],"about_ca_topic_score_codex":0.00064381486,"about_ca_topic_score_gemma":0.0002458328,"teacher_disagreement_score":0.0044270423,"about_ca_system_score_codex":0.00008295163,"about_ca_system_score_gemma":0.00011137453,"threshold_uncertainty_score":0.37659425},"labels":[],"label_agreement":null},{"id":"W1981266090","doi":"10.1016/j.eururo.2013.06.009","title":"Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; University Health Network; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Urology; Meta-analysis; Chemotherapy; Resection; Surgery; Cancer; Internal medicine","score_opus":0.20667770559402393,"score_gpt":0.41737984948953066,"score_spread":0.21070214389550673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981266090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004593747,0.9906325,0.000015624102,0.00040392418,0.00024912294,0.0030996285,0.0006352307,0.000032753018,0.0003375186],"genre_scores_gemma":[0.0073001264,0.98886263,0.0000947808,0.002143454,0.00016532179,0.00022879786,0.0008508316,0.00012473608,0.00022929144],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9919526,0.0036174052,0.0020461304,0.0012199339,0.00068579265,0.00047815542],"domain_scores_gemma":[0.9958811,0.00044705518,0.0017324494,0.0010093242,0.00061119004,0.00031889885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012083824,0.00083860965,0.0058448855,0.000482624,0.000065751316,0.000016647396,0.00044481526,0.00024917454,0.0026937018],"category_scores_gemma":[0.00031979394,0.0005182303,0.0017533449,0.00090973853,0.0003753888,0.00017155318,0.00008340025,0.0007361291,0.000061822546],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015877312,0.0027113874,0.0011333998,0.045382377,0.25710028,0.00007664226,0.0009681756,0.000003603757,0.00008807118,0.00002015287,0.0028867242,0.68804145],"study_design_scores_gemma":[0.004653146,0.016200734,0.017894065,0.009474308,0.8158144,0.00003530207,0.00002795349,0.0000050226486,0.00016146804,0.000022703289,0.13424468,0.0014662186],"about_ca_topic_score_codex":0.00043360508,"about_ca_topic_score_gemma":0.00008870896,"teacher_disagreement_score":0.68657523,"about_ca_system_score_codex":0.000073165465,"about_ca_system_score_gemma":0.00038739474,"threshold_uncertainty_score":0.99972695},"labels":[],"label_agreement":null},{"id":"W1981484372","doi":"10.1155/2013/685327","title":"Gross Hematuria in Patients with Prostate Cancer: Etiology and Management","year":2013,"lang":"en","type":"article","venue":"ISRN Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Etiology; Prostatectomy; Prostate cancer; Radiation therapy; Gross hematuria; Surgery; Urology; Prostate; Urinary system; Cancer; Internal medicine","score_opus":0.00829701097931189,"score_gpt":0.23295663369330827,"score_spread":0.22465962271399637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981484372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973068,0.00031991804,0.0000011810796,0.0006050795,0.0001296215,0.0007174523,0.000010666527,0.00002324551,0.0008859939],"genre_scores_gemma":[0.9975757,0.000639338,0.00008243308,0.0005943586,0.000029736946,0.000303511,0.000027261694,0.000016462647,0.0007311737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930316,0.000018724311,0.00014181898,0.0001996798,0.00011089415,0.00022572541],"domain_scores_gemma":[0.9996962,0.000030667845,0.00003736348,0.00012702626,0.000038977352,0.000069779315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050501403,0.00010814807,0.00023942397,0.00008838478,0.00002282267,0.000011505513,0.000017860903,0.00003694964,0.00013883231],"category_scores_gemma":[0.000003798236,0.00007472437,0.000021936086,0.00010375326,0.000044065288,0.00007245719,0.000019967218,0.00006187538,0.000028702587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038182462,0.00012689762,0.9754444,0.0001115935,0.00007221722,0.000025503308,0.000102936494,4.5689063e-7,0.0000050216363,0.000011228202,0.0028644276,0.020853532],"study_design_scores_gemma":[0.0018125924,0.000087604916,0.99592733,0.00014939497,0.000032810458,0.0000030563535,0.00002676077,0.0000016745628,0.00005550716,0.00007154343,0.0017493906,0.00008231633],"about_ca_topic_score_codex":0.0005828778,"about_ca_topic_score_gemma":0.000110046996,"teacher_disagreement_score":0.020771217,"about_ca_system_score_codex":0.000049408714,"about_ca_system_score_gemma":0.00003061412,"threshold_uncertainty_score":0.30471712},"labels":[],"label_agreement":null},{"id":"W1981793288","doi":"10.1016/j.bbrc.2007.08.092","title":"Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clamping","year":2007,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Promotion of Cancer Research; Université Laval","keywords":"Peptide nucleic acid; Molecular biology; DNA; Nucleic acid; genomic DNA; Biology; Urine; Somatic cell; Mutation; Chemistry; Gene; Biochemistry","score_opus":0.03961319512576911,"score_gpt":0.36825599447810087,"score_spread":0.32864279935233176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981793288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591154,0.000548678,0.000018503271,0.0020635794,0.000007553066,0.0003971729,0.00010055524,0.00002314299,0.000929306],"genre_scores_gemma":[0.9970151,0.002091172,0.00036135185,0.00008106287,0.00004127922,0.00005443011,0.00015839285,0.000014538671,0.00018263177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987878,0.000092422975,0.00025451047,0.00024432963,0.00032774336,0.00029319813],"domain_scores_gemma":[0.99865836,0.00045821533,0.00004679391,0.0003697652,0.00024817683,0.00021870772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003110261,0.00011666211,0.00022480694,0.00014787205,0.00014841635,0.0000134571565,0.00010974922,0.000106260515,0.000013184288],"category_scores_gemma":[0.0001883198,0.000100270256,0.00003924968,0.00055474346,0.0007195521,0.00006006561,0.00017268544,0.0003693919,0.000009407592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022791683,0.000499039,0.0009708192,0.000033658594,0.00006722554,0.000002687945,0.00025833407,3.4849663e-8,0.99428,0.000027288132,0.00019127516,0.0034417668],"study_design_scores_gemma":[0.0016314285,0.0003249221,0.05653213,0.0001580385,0.000063375526,0.000005841588,0.00028007262,0.00060894026,0.93970144,0.00012527712,0.00044732812,0.00012122772],"about_ca_topic_score_codex":0.0012592212,"about_ca_topic_score_gemma":0.00008354287,"teacher_disagreement_score":0.055561308,"about_ca_system_score_codex":0.00012762134,"about_ca_system_score_gemma":0.00008291204,"threshold_uncertainty_score":0.40889025},"labels":[],"label_agreement":null},{"id":"W1981945039","doi":"10.1016/j.mpdhp.2013.08.005","title":"Variants of urothelial carcinoma apart from those with glandular, squamous or neuroendocrine differentiation: key morphologic features, differential diagnoses and prognostic significance","year":2013,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pathology; Neuroendocrine differentiation; Differential diagnosis; Neuroendocrine carcinoma; Carcinoma; Medical diagnosis; Urothelial carcinoma; Biology; Medicine; Bladder cancer; Internal medicine; Cancer","score_opus":0.014525557767414743,"score_gpt":0.23770729229403298,"score_spread":0.22318173452661824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981945039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419594,0.0017380246,0.00043308086,0.0005640819,0.00047993977,0.0018630342,0.00031336636,0.00008978992,0.00032275997],"genre_scores_gemma":[0.99665856,0.00033266563,0.00061924144,0.0005280433,0.00027408774,0.00081864797,0.00025884103,0.0000624702,0.0004474445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997752,0.00021909329,0.00046599316,0.0007496988,0.00031645532,0.0004967469],"domain_scores_gemma":[0.9972398,0.001584917,0.00023189123,0.0005233055,0.00015627772,0.00026375885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000038436476,0.00044393586,0.0008557492,0.00014221993,0.00012150182,0.00003084058,0.00016938479,0.00012562575,0.0013120401],"category_scores_gemma":[0.0011762211,0.00029723713,0.00008662835,0.00016917595,0.00041780111,0.00010294761,0.000087235174,0.00029141371,0.000040037583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013744901,0.0013190047,0.9754164,0.00015657484,0.00007609196,0.0049371705,0.00068530167,0.0000029314726,0.011372624,0.00009092772,0.001137182,0.0034312997],"study_design_scores_gemma":[0.0062085604,0.0033014514,0.98469406,0.00012256656,0.000750227,0.0012997763,0.00006782216,0.00002900558,0.0028531114,0.00017611717,0.0002082939,0.000288997],"about_ca_topic_score_codex":0.0018808761,"about_ca_topic_score_gemma":0.0002221482,"teacher_disagreement_score":0.009277671,"about_ca_system_score_codex":0.000056990477,"about_ca_system_score_gemma":0.00018368548,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W1982303017","doi":"10.5489/cuaj.580","title":"Partial cystectomy: Is it a reliable option for the treatment of bladder","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Leiomyosarcoma; Medicine; Stage (stratigraphy); Bladder cancer; Quality of life (healthcare); Surgery; Urology; Internal medicine; Cancer; Nursing","score_opus":0.02632373961054982,"score_gpt":0.26933123836744904,"score_spread":0.24300749875689923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982303017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72282547,0.001918737,0.00086266815,0.2657734,0.0011403152,0.0028124682,0.0001997939,0.00003258106,0.004434558],"genre_scores_gemma":[0.98904353,0.00035815095,0.00019664779,0.00582358,0.0006091945,0.00015830646,0.000010930575,0.000010449706,0.003789178],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990526,0.00003673686,0.00026375838,0.00012277043,0.00019692839,0.00032719877],"domain_scores_gemma":[0.99895716,0.00013546723,0.00017364472,0.00010641455,0.0003110765,0.0003162123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001550728,0.000107652355,0.0002219958,0.000059304522,0.0002202252,0.0000468428,0.00005994558,0.00019613159,0.0028122629],"category_scores_gemma":[0.000094015995,0.000061031045,0.00019643026,0.000095795454,0.000024028306,0.00006257727,0.0000024316034,0.0001452223,0.000102246435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005834347,0.0008259893,0.5098684,0.000019477113,0.002793978,0.000030508565,0.002496794,0.00016347709,0.00063401146,0.0003419666,0.4383316,0.04391035],"study_design_scores_gemma":[0.0053388136,0.0039183497,0.26201963,0.000013203499,0.0006504056,0.00007808209,0.0002650464,0.0013929164,0.00070573855,0.0012495163,0.72423255,0.00013575694],"about_ca_topic_score_codex":0.0045366213,"about_ca_topic_score_gemma":0.00034832046,"teacher_disagreement_score":0.28590092,"about_ca_system_score_codex":0.00087261514,"about_ca_system_score_gemma":0.0003995659,"threshold_uncertainty_score":0.9980993},"labels":[],"label_agreement":null},{"id":"W1982703074","doi":"10.1016/s0022-5347(05)00995-x","title":"Cancer Specific Outcomes in Patients With PT0 Disease Following Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Cancer; Disease; Urology; Internal medicine","score_opus":0.00842669361292868,"score_gpt":0.2548890818768952,"score_spread":0.2464623882639665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982703074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942304,0.0016006752,0.000046665118,0.0034262098,0.00024930295,0.0001759488,0.0000049500572,0.0000049566333,0.0002609118],"genre_scores_gemma":[0.9989371,0.000045992907,0.000042068477,0.0006468785,0.00017308653,0.0000037033828,0.0000015434823,0.000013984373,0.00013567584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991435,0.000086299166,0.0002583402,0.00007297469,0.00025841832,0.0001805018],"domain_scores_gemma":[0.9995515,0.00006904392,0.00011979648,0.00012821655,0.00004463509,0.00008683521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013346871,0.00010158851,0.00030083585,0.00009055637,0.000033260883,0.0000040775926,0.00009008882,0.00003429448,0.000089664136],"category_scores_gemma":[0.000012568181,0.000049740935,0.000090998445,0.000093855284,0.00006588704,0.000045810866,0.000012109713,0.00021224213,0.0000048121155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036926353,0.00028895808,0.99440956,0.0000043523337,0.00013107988,0.00026460623,0.000054856642,0.00008607025,0.000029792964,0.000012177441,0.0004291798,0.00059670093],"study_design_scores_gemma":[0.009189611,0.0007588185,0.9869677,0.000023490675,0.00032669422,0.000032931854,0.000007429089,0.0000035622634,0.000017181277,0.00015203787,0.0024723453,0.000048217848],"about_ca_topic_score_codex":0.000109378,"about_ca_topic_score_gemma":0.00004366878,"teacher_disagreement_score":0.00744191,"about_ca_system_score_codex":0.00007903301,"about_ca_system_score_gemma":0.00011653633,"threshold_uncertainty_score":0.20283765},"labels":[],"label_agreement":null},{"id":"W1982719862","doi":"10.1111/j.1464-410x.2009.09076.x","title":"The effect of age and gender on bladder cancer: a critical review of the literature","year":2009,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Referral; Disease; Epidemiology; Bladder cancer; Incidence (geometry); MEDLINE; Cancer; Gerontology; Family medicine; Internal medicine","score_opus":0.02755185034392202,"score_gpt":0.35605244918748574,"score_spread":0.32850059884356375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982719862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048545862,0.9974003,8.15269e-7,0.00087517704,0.0003870473,0.00061200926,0.000085935426,0.0000021896817,0.0005880127],"genre_scores_gemma":[0.0005357712,0.9976878,0.000010139908,0.0012611053,0.0003644435,0.000018528695,0.000004217859,0.000024766581,0.00009322848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976278,0.00082305196,0.00083532545,0.00017120602,0.00033278557,0.00020984364],"domain_scores_gemma":[0.9981544,0.0007048143,0.000588236,0.00025132185,0.00020154145,0.00009967382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059866766,0.00024150172,0.0020694418,0.000059839258,0.00006650083,0.000017605185,0.00023480789,0.0002570236,0.000056212626],"category_scores_gemma":[0.0006823829,0.00012079979,0.0007606368,0.00018833485,0.0002944493,0.000024479636,0.00003724275,0.000985032,6.8401e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013222196,0.00005707667,0.000015976842,0.040719155,0.0006270966,0.001071536,0.000018910634,4.3838135e-8,4.490931e-7,0.000028910346,0.0071406104,0.95018804],"study_design_scores_gemma":[0.0010876633,0.0030219497,0.00056282175,0.17112176,0.0075844578,0.026256954,9.4786526e-7,7.227768e-8,0.0000029486566,0.00012259363,0.79014385,0.000094011404],"about_ca_topic_score_codex":0.000011459546,"about_ca_topic_score_gemma":0.0000054158336,"teacher_disagreement_score":0.950094,"about_ca_system_score_codex":0.000039912557,"about_ca_system_score_gemma":0.00030093698,"threshold_uncertainty_score":0.49260724},"labels":[],"label_agreement":null},{"id":"W1983105682","doi":"10.5489/cuaj.363","title":"Transurethral resection and degeneration of bladder tumour","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Stage (stratigraphy); Surgery; Degeneration (medical); Urology; Resection; Complication; Cancer; Internal medicine; Pathology","score_opus":0.013762043991361297,"score_gpt":0.23334984504262807,"score_spread":0.21958780105126677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983105682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98361135,0.0002950053,0.000083115156,0.012747437,0.00014893526,0.00018218592,0.000010598903,0.000008472831,0.0029129328],"genre_scores_gemma":[0.9978455,0.00007762059,0.00017916808,0.0011704629,0.00025840383,0.0000085798065,0.000007883729,0.0000060055595,0.00044639086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925405,0.000075403055,0.00019851128,0.00009372104,0.00018323006,0.00019509306],"domain_scores_gemma":[0.999251,0.00003075233,0.00009826101,0.00003803259,0.00023408166,0.00034789142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019230421,0.00007002527,0.00014966854,0.00009668984,0.00011385845,0.000035162277,0.000025240986,0.00013931858,0.0011910386],"category_scores_gemma":[0.00012082177,0.000053981756,0.000054998072,0.00008958639,0.00002043177,0.000102549115,0.0000022578095,0.0002183467,0.00002233041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008604578,0.00005854687,0.96850866,0.000008672884,0.00019169941,0.000015881535,0.00024940816,0.000013412488,0.010194678,0.00020956607,0.013056853,0.0074065696],"study_design_scores_gemma":[0.0011788985,0.0005629211,0.9928445,0.0000067940555,0.0000810632,0.00014277811,0.000048681326,0.00010832374,0.0010636208,0.0010420777,0.0028601608,0.000060144226],"about_ca_topic_score_codex":0.0026029826,"about_ca_topic_score_gemma":0.0009941306,"teacher_disagreement_score":0.024335869,"about_ca_system_score_codex":0.00026925383,"about_ca_system_score_gemma":0.00021805917,"threshold_uncertainty_score":0.999722},"labels":[],"label_agreement":null},{"id":"W1983692792","doi":"10.1002/dc.20886","title":"Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder","year":2008,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Immunostaining; Atypia; Pathology; Urinary bladder; Urology; Immunocytochemistry; Cytology; Urine cytology; Urinary system; Carcinoma; Cytokeratin; Adenocarcinoma; Immunohistochemistry; Internal medicine; Cancer; Cystoscopy","score_opus":0.033093573913853744,"score_gpt":0.2885953770577885,"score_spread":0.2555018031439347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983692792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235386,0.00463123,0.00004007083,0.00040472712,0.00015766933,0.0015538067,0.00007407243,0.00006400965,0.00072056404],"genre_scores_gemma":[0.9980965,0.00024307621,0.0002865637,0.0004392449,0.00016468091,0.000504376,0.00011501627,0.000026459229,0.00012407202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828625,0.0002184118,0.0005146846,0.0004581329,0.00021820811,0.00030433544],"domain_scores_gemma":[0.9975424,0.0014621081,0.00013569117,0.0006519282,0.00010622665,0.00010168656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105999025,0.00024048261,0.0005616785,0.00007591664,0.00020628859,0.000006799602,0.00019457008,0.00013102675,0.00053876854],"category_scores_gemma":[0.0007891612,0.00016280808,0.000110035646,0.0001854258,0.00041677128,0.000058656955,0.0001690089,0.0003790035,0.000051884224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064673054,0.0049000867,0.97180265,0.00003259952,0.00028881323,0.004709677,0.009825608,0.000006457042,0.006301163,0.000076912016,0.0010179551,0.00039131814],"study_design_scores_gemma":[0.004169634,0.005063472,0.98267347,0.000038474573,0.00047986765,0.0025885827,0.0015457368,0.000028635082,0.002807657,0.00038624022,0.000070642884,0.00014758932],"about_ca_topic_score_codex":0.0002792094,"about_ca_topic_score_gemma":0.0000351285,"teacher_disagreement_score":0.010870788,"about_ca_system_score_codex":0.000062012456,"about_ca_system_score_gemma":0.00023972051,"threshold_uncertainty_score":0.6639121},"labels":[],"label_agreement":null},{"id":"W1983950941","doi":"10.1016/j.urology.2008.07.035","title":"Outcome of Patients With Bladder Cancer With pN+ Disease After Preoperative Chemotherapy and Radical Cystectomy","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Chemotherapy; Bladder cancer; Proportional hazards model; Surgery; Internal medicine; Oncology; Survival analysis; Retrospective cohort study; Cancer; Metastasis","score_opus":0.009332431858852573,"score_gpt":0.252218261087022,"score_spread":0.24288582922816943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983950941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977448,0.00059559837,0.00009016635,0.00072370534,0.000028004313,0.0005104445,0.00006868041,0.0000163581,0.00022225089],"genre_scores_gemma":[0.99675107,0.000058741076,0.00013670558,0.0023614638,0.00004553863,0.0001436854,0.000011915901,0.000024160463,0.00046673644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992716,0.0000279378,0.000132152,0.00023782333,0.00015903934,0.00017145993],"domain_scores_gemma":[0.99954164,0.000018268873,0.000041778323,0.00016182364,0.00007933113,0.00015716635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000137262095,0.0001478759,0.00029273427,0.000044307704,0.000032793407,0.0000018713696,0.000030073803,0.00005203297,0.0004547226],"category_scores_gemma":[0.000005134586,0.00008550086,0.000025685395,0.00006794847,0.0003588807,0.000040128554,0.000011413675,0.00009479865,0.0000031938555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01055117,0.00029440125,0.98771006,0.000027614,0.00026250086,0.00010314664,0.0006348431,0.000004639424,0.0000074344102,0.000005069569,0.00008314049,0.00031600572],"study_design_scores_gemma":[0.010142203,0.0021263303,0.98612523,0.000012146735,0.0002384676,0.000023562456,0.000006700528,0.000014599895,0.00011585003,0.000006929117,0.0010935704,0.0000943788],"about_ca_topic_score_codex":0.00009893522,"about_ca_topic_score_gemma":0.000049396738,"teacher_disagreement_score":0.001831929,"about_ca_system_score_codex":0.000022612623,"about_ca_system_score_gemma":0.00011704115,"threshold_uncertainty_score":0.49788937},"labels":[],"label_agreement":null},{"id":"W1984309641","doi":"10.1016/s0002-9440(10)63118-5","title":"Defining a 0.5-Mb Region of Genomic Gain on Chromosome 6p22 in Bladder Cancer by Quantitative-Multiplex Polymerase Chain Reaction","year":2004,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Université Laval; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"University Health Network","keywords":"Comparative genomic hybridization; Biology; Multiplex; Multiplex polymerase chain reaction; Metaphase; Bladder cancer; Molecular biology; Polymerase chain reaction; Locus (genetics); Multiplex ligation-dependent probe amplification; genomic DNA; Fluorescence in situ hybridization; Genetics; Chromosome; Cancer; DNA; Gene","score_opus":0.019922795728594383,"score_gpt":0.315035524069571,"score_spread":0.2951127283409766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984309641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953384,0.0021698815,0.0003821785,0.0015478855,0.00014666942,0.00014648297,0.000025297972,0.0000075398966,0.00023567496],"genre_scores_gemma":[0.9969369,0.00092261494,0.0010386027,0.00093689776,0.00008213753,0.000012970035,0.000007108107,0.000028981514,0.000033789853],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869215,0.00015897065,0.0005153218,0.00020022357,0.0001843334,0.00024901677],"domain_scores_gemma":[0.99887925,0.0000886592,0.00068149134,0.00015082447,0.00008586188,0.00011392598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018919482,0.00016733275,0.0006191934,0.00032414892,0.000029051094,0.000003050177,0.000077486744,0.000060498558,0.000027797912],"category_scores_gemma":[0.00006890753,0.00014042719,0.000121888406,0.00025155288,0.00026638372,0.000066231776,0.0000118284515,0.00031121404,0.000007815287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060371524,0.0013498373,0.03437811,0.00003800638,0.00038760935,0.0041751424,0.006098718,0.00057106285,0.88424385,0.00053692365,0.0002950264,0.061888576],"study_design_scores_gemma":[0.06844997,0.09262807,0.56486756,0.0029384468,0.0014575626,0.02267092,0.017548375,0.00018973832,0.22447214,0.0013717898,0.0018773695,0.0015280531],"about_ca_topic_score_codex":0.001369181,"about_ca_topic_score_gemma":0.00008399267,"teacher_disagreement_score":0.6597717,"about_ca_system_score_codex":0.0003541502,"about_ca_system_score_gemma":0.00032392697,"threshold_uncertainty_score":0.5726454},"labels":[],"label_agreement":null},{"id":"W1984429541","doi":"10.1016/j.urolonc.2004.12.012","title":"A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hamilton Regional Laboratory Medicine Program; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Cancer; Chemotherapy; Internal medicine; Nausea; Farnesyltransferase; Phases of clinical research; Clinical trial; Oncology; Gastroenterology; Pharmacology; Prenylation; Biology","score_opus":0.02361446967630437,"score_gpt":0.3333784436525646,"score_spread":0.3097639739762602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984429541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652296,0.0003084968,0.000004024396,0.0012354109,0.00009431942,0.001063297,0.00005810006,0.000028551829,0.0006848255],"genre_scores_gemma":[0.9939683,0.000085996246,0.0044236197,0.00079939095,0.00015241181,0.00019618629,0.000035486282,0.000016957909,0.00032162672],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998683,0.000100162,0.00037531037,0.00037281442,0.00020229719,0.0002664308],"domain_scores_gemma":[0.9992637,0.00007843277,0.00018582339,0.00019050589,0.00009324403,0.00018828438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013340892,0.0002119232,0.00046217316,0.00018294064,0.00015552048,0.0000057393763,0.000080261656,0.00015513685,0.00015702288],"category_scores_gemma":[0.000045980298,0.00015767298,0.000032597814,0.00023724596,0.0003566909,0.00011358724,0.00004147008,0.00032190228,0.000004628788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028500047,0.010107048,0.96424454,0.000016266094,0.00010893073,0.00004405526,0.0024583717,0.00009894756,0.00015770645,0.0000549896,0.00039324406,0.019465914],"study_design_scores_gemma":[0.075762264,0.13623019,0.36552265,0.00013646252,0.001041706,0.000045932942,0.00092195394,0.0003835425,0.00057282374,0.00014932157,0.4187725,0.00046066413],"about_ca_topic_score_codex":0.000578424,"about_ca_topic_score_gemma":0.0008140476,"teacher_disagreement_score":0.59872186,"about_ca_system_score_codex":0.00020355392,"about_ca_system_score_gemma":0.00047427,"threshold_uncertainty_score":0.64297175},"labels":[],"label_agreement":null},{"id":"W1984836574","doi":"10.1016/j.eururo.2009.03.072","title":"Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Hazard ratio; Stage (stratigraphy); Urology; Internal medicine; Urothelial carcinoma; Cancer; Concomitant; Ureter; Oncology; Bladder cancer; Gastroenterology; Gynecology; Surgery; Confidence interval; Metastasis","score_opus":0.10324741687264638,"score_gpt":0.41502763658185116,"score_spread":0.3117802197092048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984836574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946214,0.0005250235,0.00062833476,0.0006306833,0.00006534328,0.0004899306,0.00008796248,0.000015438287,0.0029358957],"genre_scores_gemma":[0.99588746,0.00001595509,0.0025530148,0.0012977998,0.000021235317,0.0000071057666,0.000050695202,0.000006746563,0.0001599771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999195,0.000108716,0.00029996186,0.0002027937,0.00006710737,0.00012645664],"domain_scores_gemma":[0.99942464,0.000150735,0.00014111944,0.00016618294,0.00006150305,0.000055823526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013854724,0.00011275456,0.00075940485,0.00014506264,0.000043971533,0.000005680028,0.000113633934,0.00003774312,0.000057280376],"category_scores_gemma":[0.0001251697,0.00007987535,0.00011159159,0.00015631254,0.00012370186,0.00003114049,0.00005047809,0.000058348698,0.0000023832379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009524353,0.0008202551,0.9887698,0.000025458785,0.0012676897,0.000050969276,0.0003948461,0.00008041717,0.0014469159,0.00041195552,0.0002881219,0.0054911156],"study_design_scores_gemma":[0.0047383364,0.0036783703,0.9862894,0.000006794633,0.0021489542,0.000016839967,0.000031048185,0.00044659013,0.0005601056,0.000024179919,0.0019977505,0.00006166564],"about_ca_topic_score_codex":0.00006722483,"about_ca_topic_score_gemma":0.000067526395,"teacher_disagreement_score":0.00542945,"about_ca_system_score_codex":0.000018136509,"about_ca_system_score_gemma":0.0000592354,"threshold_uncertainty_score":0.32572225},"labels":[],"label_agreement":null},{"id":"W1985060557","doi":"10.1046/j.1523-5394.2002.106011.x","title":"Bladder Cancer","year":2002,"lang":"en","type":"review","venue":"Cancer Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Internal medicine","score_opus":0.12857603582291505,"score_gpt":0.4535409379707624,"score_spread":0.32496490214784735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985060557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.4367016e-7,0.933412,0.0000075701887,0.0012483825,0.0014663679,0.0014121223,0.00025727163,0.0001221318,0.062073983],"genre_scores_gemma":[0.0000010673712,0.9601608,0.00021511003,0.0026362862,0.0024407392,0.0020771187,0.000059903756,0.00019177717,0.0322172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974673,0.00017469304,0.0005741219,0.00076577556,0.00050194346,0.0005162045],"domain_scores_gemma":[0.99781615,0.00031167007,0.0005565334,0.00074532046,0.0002476313,0.0003226796],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013433505,0.0006591145,0.0019768334,0.00016151064,0.00011235889,0.00005976326,0.00021226557,0.0004557125,0.010271997],"category_scores_gemma":[0.0001868745,0.00049698725,0.0006004884,0.000529096,0.00008014093,0.00029494538,0.000066998444,0.0009319758,0.0011362976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046811703,0.00020399872,0.0000050160816,0.007365762,0.0023205422,0.00022219088,0.00007936585,2.6423217e-7,1.3112928e-7,0.000022550708,0.059389405,0.930344],"study_design_scores_gemma":[0.0008380872,0.00012522057,0.000003037828,0.010739468,0.020152263,0.00043993356,0.00002138389,0.0000015190926,0.0000018903066,0.000003554924,0.96723866,0.00043498384],"about_ca_topic_score_codex":0.0009954486,"about_ca_topic_score_gemma":0.000032057196,"teacher_disagreement_score":0.929909,"about_ca_system_score_codex":0.0010065684,"about_ca_system_score_gemma":0.0017472836,"threshold_uncertainty_score":0.9997482},"labels":[],"label_agreement":null},{"id":"W1985574844","doi":"10.1016/j.juro.2010.02.1766","title":"1828 SURVIVAL AFTER RADICAL CYSTECTOMY OF NON-BILHARZIAL SQUAMOUS CELL CARCINOMA VS. UROTHELIAL CARCINOMA: A NORTH-AMERICAN POPULATION-BASED STUDY","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Population; Stage (stratigraphy); Oncology; Carcinoma; Epidemiology; Urothelial carcinoma; Cancer; Gynecology; Internal medicine","score_opus":0.008577640023433804,"score_gpt":0.2566859439958084,"score_spread":0.2481083039723746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985574844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973541,0.00010155349,0.00008625652,0.0007910761,0.0008603812,0.0006267973,0.00003268741,0.00001028344,0.00013686025],"genre_scores_gemma":[0.99838644,0.0000018598221,0.00011929741,0.00048276572,0.0009080853,0.000016500722,0.000005046045,0.000044489396,0.00003551408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977609,0.00038249098,0.0007442147,0.00020171437,0.0005520277,0.0003586678],"domain_scores_gemma":[0.998135,0.00034489995,0.0005649814,0.00046674273,0.0002567038,0.00023168311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050992897,0.00026156902,0.00081270863,0.00022622371,0.00008327526,0.000008159621,0.00031028088,0.00009940539,0.00021249629],"category_scores_gemma":[0.0000893661,0.00016594019,0.0002469098,0.00026498552,0.0002785521,0.000047327365,0.000045550467,0.00083536585,0.00001072398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012566535,0.0012364715,0.98121107,0.000028264438,0.000083588966,0.00032544418,0.0007815573,0.000040391635,0.0032795034,8.747367e-7,0.00004823886,0.00039808083],"study_design_scores_gemma":[0.011151864,0.010619343,0.9753724,0.0000026756397,0.0010484628,0.00028498436,0.00011746857,0.000100070516,0.0010316358,0.000007522203,0.0001382807,0.00012533908],"about_ca_topic_score_codex":0.0024633254,"about_ca_topic_score_gemma":0.001350952,"teacher_disagreement_score":0.009382872,"about_ca_system_score_codex":0.00005962525,"about_ca_system_score_gemma":0.0005348938,"threshold_uncertainty_score":0.6766845},"labels":[],"label_agreement":null},{"id":"W1985605203","doi":"10.1016/j.clgc.2014.10.005","title":"Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Docetaxel; Medicine; Taxane; Paclitaxel; Oncology; Internal medicine; Clinical endpoint; Clinical trial; Chemotherapy; Salvage therapy; Cancer; Breast cancer","score_opus":0.2056236045651798,"score_gpt":0.5066562109203223,"score_spread":0.3010326063551425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985605203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87734824,0.00573439,0.07751198,0.017616708,0.0039769365,0.014360239,0.0017287241,0.00024357869,0.0014792064],"genre_scores_gemma":[0.8947084,0.0014275217,0.078053646,0.0035438163,0.014866034,0.004575061,0.0001146182,0.00013387475,0.0025770497],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965035,0.00035887063,0.0014528765,0.00097100146,0.00020518617,0.0005086186],"domain_scores_gemma":[0.98994905,0.007836021,0.000524386,0.0006405724,0.00057281624,0.0004771865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017351568,0.00033847484,0.001023151,0.000055170905,0.0003629002,0.000056639077,0.00022805537,0.00033734125,0.000021495023],"category_scores_gemma":[0.0036365318,0.00029451487,0.0005051198,0.00012512879,0.0004122035,0.00019781137,0.00007815518,0.00034422093,0.000008644203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37655523,0.0021033008,0.31356537,0.000514252,0.00114888,0.0000130119115,0.00008853995,0.00001872657,0.00023981048,0.00045673508,0.028431768,0.27686438],"study_design_scores_gemma":[0.14257382,0.012194663,0.32425463,0.00008601786,0.0016093757,0.000013188202,0.00002069643,0.00007497018,0.00018643473,0.0026241567,0.5158929,0.00046911862],"about_ca_topic_score_codex":0.000022794286,"about_ca_topic_score_gemma":0.000011289851,"teacher_disagreement_score":0.48746118,"about_ca_system_score_codex":0.00009443983,"about_ca_system_score_gemma":0.0006248746,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W1986277796","doi":"10.1016/j.eururo.2012.06.008","title":"Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Lymphovascular invasion; Dissection (medical); Stage (stratigraphy); Urology; Neoadjuvant therapy; Metastasis; Radiology; Surgery; Cancer; Internal medicine","score_opus":0.03386154086211229,"score_gpt":0.31167138229151675,"score_spread":0.27780984142940446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986277796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968646,0.008652118,0.017154967,0.0010337108,0.0010456791,0.0019878752,0.00017035441,0.00012705348,0.0011822444],"genre_scores_gemma":[0.9868358,0.00026292528,0.0031124344,0.0072903824,0.0014426014,0.00056117534,0.00004086012,0.00009633885,0.0003574852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983677,0.00014328411,0.0003038796,0.00039739767,0.00014634435,0.0006413683],"domain_scores_gemma":[0.9991212,0.00021694301,0.00008000843,0.0003206878,0.00008232768,0.0001788681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004214692,0.0002495053,0.00038667314,0.00009052846,0.00010351166,0.000014482452,0.00012107627,0.00009048405,0.0003780243],"category_scores_gemma":[0.00010068811,0.00017814121,0.0002020923,0.00007530781,0.000108540866,0.000078370475,0.00005073912,0.00016078666,0.00006949145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026306877,0.0010909577,0.3158116,0.00012309565,0.0005848257,0.00046476032,0.0026424446,0.000011146516,0.006025012,0.00016514414,0.011740931,0.6350332],"study_design_scores_gemma":[0.024130194,0.004976933,0.42558858,0.000061348175,0.0004992065,0.00037569078,0.000049891572,0.00011884824,0.0012492025,0.00024506982,0.54222625,0.0004787927],"about_ca_topic_score_codex":0.000008256174,"about_ca_topic_score_gemma":0.0000023828115,"teacher_disagreement_score":0.63455445,"about_ca_system_score_codex":0.000057845173,"about_ca_system_score_gemma":0.00007430234,"threshold_uncertainty_score":0.72643876},"labels":[],"label_agreement":null},{"id":"W1987048421","doi":"10.5489/cuaj.361","title":"Impact of provider volume on operative mortality after radical cystectomy in a publicly funded healthcare system","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Public Health Ontario; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Astellas Pharma; Prostate Cancer Canada; Institute for Clinical Evaluative Sciences; Heart and Stroke Foundation of Canada; Amgen","keywords":"Cystectomy; Medicine; Bladder cancer; Odds ratio; Confidence interval; Logistic regression; Healthcare Cost and Utilization Project; Odds; Emergency medicine; Health care; Cancer; Internal medicine","score_opus":0.020032406584903767,"score_gpt":0.2960851645715976,"score_spread":0.2760527579866938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987048421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863212,0.00014016833,0.0000066563543,0.011524258,0.00012367031,0.000682655,0.00009013295,0.000016206997,0.0010950598],"genre_scores_gemma":[0.9976528,0.0000062683544,0.000030563693,0.0017614987,0.00020556108,0.00010039827,0.000014030176,0.000012204346,0.00021667371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980558,0.00035175783,0.00046860252,0.00021932148,0.00040227044,0.000502213],"domain_scores_gemma":[0.9983276,0.000054881624,0.0002061437,0.00013387184,0.00038457476,0.0008929169],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004031709,0.00016434133,0.00044065175,0.00021748286,0.00008355757,0.00007561522,0.0000847205,0.00026889445,0.0012373363],"category_scores_gemma":[0.00028342704,0.00011098097,0.00020249146,0.00025463483,0.000035908866,0.00015764301,0.00000872015,0.0005924226,0.00007569331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013876517,0.0000986735,0.9966317,0.000017545872,0.0001929162,0.00011781093,0.00016497115,0.000010230122,0.000008487139,0.00004379124,0.0017005607,0.0008745825],"study_design_scores_gemma":[0.001964471,0.0014109283,0.9956048,0.000056962475,0.00003908761,0.000096743504,0.000105545885,0.00020489367,0.00000454671,0.00007549779,0.0003454054,0.0000911158],"about_ca_topic_score_codex":0.096596986,"about_ca_topic_score_gemma":0.012155172,"teacher_disagreement_score":0.08444182,"about_ca_system_score_codex":0.004792222,"about_ca_system_score_gemma":0.0011621477,"threshold_uncertainty_score":0.9996757},"labels":[],"label_agreement":null},{"id":"W1988243620","doi":"10.2478/raon-2013-0052","title":"Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma","year":2013,"lang":"en","type":"article","venue":"Radiology and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministrstvo za visoko šolstvo, znanost in tehnologijo; School of Medicine, New York University; York University","keywords":"Urothelium; Pathology; Urothelial Cell; Medicine; Immunohistochemistry; Papilloma; Urinary bladder; Biology; Urology","score_opus":0.015076796417740889,"score_gpt":0.2852570980725966,"score_spread":0.2701803016548557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988243620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952427,0.0019465693,0.000057621917,0.00040238185,0.00006923788,0.00036112763,0.000005077302,0.000011800148,0.0019034857],"genre_scores_gemma":[0.9984211,0.00038253865,0.000113455026,0.0008950393,0.00006249999,0.000041227802,0.000018966228,0.000009748634,0.000055464094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991785,0.00014451706,0.00023920414,0.00021140587,0.00004082447,0.00018553028],"domain_scores_gemma":[0.99964815,0.000057197278,0.00006370523,0.000113217495,0.000034219865,0.00008351519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097111275,0.00011180699,0.00038545052,0.00009502905,0.000050542225,0.0000022264187,0.00003141761,0.00021766916,0.00012755262],"category_scores_gemma":[0.000016256197,0.000091964386,0.000026104191,0.00006238681,0.0002853476,0.000046020483,0.00003245457,0.0001108705,0.0000044913595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017344538,0.00012506974,0.97950506,0.0000625167,0.00004864421,0.000076641496,0.0003348886,0.0000037987152,0.012320137,0.00037401088,0.0002605358,0.0067152213],"study_design_scores_gemma":[0.003537878,0.002595384,0.9862636,0.000015308438,0.00006397918,0.0007720624,0.00007120076,0.00016820343,0.004169547,0.0003850061,0.001867902,0.00008997513],"about_ca_topic_score_codex":0.00055283477,"about_ca_topic_score_gemma":0.00018520834,"teacher_disagreement_score":0.00815059,"about_ca_system_score_codex":0.000050263116,"about_ca_system_score_gemma":0.0000643855,"threshold_uncertainty_score":0.37501988},"labels":[],"label_agreement":null},{"id":"W1988375013","doi":"10.5489/cuaj.204","title":"Retubularization of the ileocystoplasty patch for conversion into an ileal conduit","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Surgery; Urinary diversion; Complication; Urinary system; Bladder augmentation; Cystectomy; Urinary bladder; Internal medicine; Bladder cancer","score_opus":0.011683674208335212,"score_gpt":0.23292344877052448,"score_spread":0.22123977456218927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988375013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850047,0.000050214123,0.00022636006,0.01316704,0.00042186017,0.0005440919,0.000032884847,0.000009988316,0.0005428604],"genre_scores_gemma":[0.9958267,0.000012960441,0.00021502415,0.0031495085,0.00022246833,0.000019603225,0.000027839596,0.000008064632,0.0005178049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991229,0.0000980209,0.00022457814,0.00011385834,0.00022052959,0.00022008455],"domain_scores_gemma":[0.9988645,0.000063529435,0.00020562134,0.00009697996,0.00042890856,0.00034049066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022956217,0.00008059416,0.00016767086,0.000053045187,0.00022743024,0.000023488656,0.00008755645,0.00018413542,0.00070958136],"category_scores_gemma":[0.00025741887,0.000051401315,0.000104868705,0.000106134634,0.000029903042,0.000116493095,0.000007689536,0.00020495332,0.000015417863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057853413,0.00005268252,0.98397535,0.000009628922,0.000078787256,0.0000024615824,0.00033647165,0.000010409068,0.0010579702,0.00014993046,0.011602084,0.0026663933],"study_design_scores_gemma":[0.0024286436,0.00093721837,0.96167225,0.000016004999,0.00014081695,0.00004658721,0.00017362332,0.00067969924,0.00086379924,0.002668961,0.030274652,0.00009772311],"about_ca_topic_score_codex":0.008184563,"about_ca_topic_score_gemma":0.0011905296,"teacher_disagreement_score":0.022303056,"about_ca_system_score_codex":0.0005845856,"about_ca_system_score_gemma":0.00054498663,"threshold_uncertainty_score":0.99842},"labels":[],"label_agreement":null},{"id":"W1988460002","doi":"10.1016/j.eururo.2008.01.043","title":"Considerations on the Use of Urine Markers for Bladder Cancer","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Urine; Bladder cancer; Urine cytology; Urinary system; Urology; Gold standard (test); Cancer; Internal medicine","score_opus":0.10792495287673107,"score_gpt":0.29287376769328916,"score_spread":0.1849488148165581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988460002","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019234644,0.00047781246,0.000060835573,0.97664225,0.000763235,0.0014965466,0.00072028406,0.00005729558,0.017858295],"genre_scores_gemma":[0.011993814,0.00040259634,0.00022896483,0.9697988,0.0027295747,0.00013575485,0.00023571681,0.00013473052,0.014340063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851966,0.00033314858,0.00031902367,0.00036273163,0.00017066977,0.00029474017],"domain_scores_gemma":[0.99815804,0.0009371449,0.00017288342,0.0005463875,0.00014136697,0.000044194552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008372326,0.00026915612,0.0004130377,0.00010551745,0.0001130853,0.000010427549,0.00009634489,0.00017773648,0.0013638044],"category_scores_gemma":[0.0002309001,0.00017478301,0.00020870578,0.000055880617,0.00026796633,0.00002001525,0.00003539565,0.0006894028,0.00008474409],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030345205,0.00005551216,0.00017660463,0.00003496152,0.00065486546,0.0005663583,0.00008575884,0.000020310172,0.00003140593,0.00005753893,0.9976608,0.00035239136],"study_design_scores_gemma":[0.0012990898,0.0010076415,0.002247467,0.0000275361,0.00054241496,0.00016672985,0.0000019238562,0.000015231464,0.0000746532,0.000037007336,0.9944505,0.00012981614],"about_ca_topic_score_codex":0.00007682993,"about_ca_topic_score_gemma":0.0000125185925,"teacher_disagreement_score":0.01007035,"about_ca_system_score_codex":0.000037145615,"about_ca_system_score_gemma":0.0001900033,"threshold_uncertainty_score":0.9995491},"labels":[],"label_agreement":null},{"id":"W1988746030","doi":"10.3747/co.v16i4.411","title":"Conservative Treatment of Invasive Bladder Cancer","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Massachusetts General Hospital","keywords":"Cystectomy; Medicine; Bladder cancer; Concomitant; Urology; Resection; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.1825322818921252,"score_gpt":0.456462936718831,"score_spread":0.27393065482670576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988746030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666337,0.012209517,0.00003084366,0.0045470004,0.0008602487,0.00085758773,0.00008267536,0.00004280727,0.014735615],"genre_scores_gemma":[0.99380195,0.0044254786,0.00014914494,0.0005763679,0.00027095331,0.0001047449,0.000034694596,0.000009502482,0.00062713324],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992298,0.000043322943,0.00021728057,0.00020650998,0.000108934095,0.00019415579],"domain_scores_gemma":[0.9993961,0.00007369453,0.000105468986,0.000164597,0.00014915764,0.000110975634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023517456,0.00014863607,0.0004454193,0.00006596867,0.000029125098,0.0000020328782,0.000041194497,0.00007417557,0.0005067001],"category_scores_gemma":[0.00002174548,0.00010845755,0.00010870074,0.000119542354,0.00009834415,0.000029347633,0.0000068182107,0.000063407424,0.00002586916],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001171451,0.0060891407,0.15335846,0.00005616117,0.0005864105,0.00008487359,0.0035764703,0.0000026340297,0.0037891218,0.00048384533,0.009797845,0.8210036],"study_design_scores_gemma":[0.018971914,0.025950497,0.49516705,0.00021971944,0.0013042948,0.00007425769,0.00047339793,0.000025627292,0.05684114,0.0011342763,0.39954305,0.0002947777],"about_ca_topic_score_codex":0.00012459978,"about_ca_topic_score_gemma":0.000111894806,"teacher_disagreement_score":0.8207088,"about_ca_system_score_codex":0.00043355147,"about_ca_system_score_gemma":0.0007791699,"threshold_uncertainty_score":0.55480105},"labels":[],"label_agreement":null},{"id":"W1988974660","doi":"10.1016/j.carj.2013.08.001","title":"Diagnostic Performance of Ultrasound for Macroscopic Hematuria in the Era of Multidetector Computed Tomography Urography","year":2013,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cystoscopy; Radiology; Ultrasound; Confidence interval; Pyelogram; Urinary system; Malignancy; Microscopic hematuria; Retrospective cohort study; Upper urinary tract; Positive predicative value; Urology; Surgery; Pathology; Kidney; Internal medicine; Predictive value; Proteinuria","score_opus":0.009532613143104466,"score_gpt":0.24758100384676934,"score_spread":0.23804839070366487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988974660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768656,0.00063227536,0.000043587435,0.0005716439,0.00019643412,0.00065963104,0.00010805079,0.0000034477248,0.00009834936],"genre_scores_gemma":[0.998462,0.00020002353,0.000989046,0.00018843844,0.00008343259,0.00003476412,0.000019340367,0.000008019843,0.000014921073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895734,0.00009465062,0.0004297226,0.00009034297,0.00018304917,0.00024490902],"domain_scores_gemma":[0.99814016,0.00083821005,0.000462719,0.000120274126,0.0003156199,0.00012303804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004151536,0.000099899305,0.00034547795,0.0002334716,0.000058579466,0.0000122693355,0.00013653502,0.000104122795,0.000045464447],"category_scores_gemma":[0.0006840019,0.000071058166,0.00017306017,0.00031587237,0.00008639045,0.0000652586,0.0000027025233,0.00022432159,7.916777e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037819278,0.00006809134,0.9938252,0.00008743893,0.00018773397,0.0000027604008,0.00052060565,0.00003891595,0.0009361529,0.000019194113,0.0029041902,0.001371914],"study_design_scores_gemma":[0.0020434072,0.0006830316,0.99494064,0.00015473619,0.00007991761,0.00004509769,0.00011878134,0.000077977806,0.0014872865,0.00010613577,0.00020588198,0.0000571056],"about_ca_topic_score_codex":0.0060078218,"about_ca_topic_score_gemma":0.002978998,"teacher_disagreement_score":0.0030288238,"about_ca_system_score_codex":0.0002204874,"about_ca_system_score_gemma":0.00030359926,"threshold_uncertainty_score":0.90820694},"labels":[],"label_agreement":null},{"id":"W1989110054","doi":"10.1586/14737140.4.6.1017","title":"Management of muscle-invasive bladder cancer in the elderly","year":2004,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Radiation therapy; Perioperative; Chemotherapy; Concomitant; Urinary diversion; Adverse effect; Oncology; Cancer; Intensive care medicine; Internal medicine; Surgery","score_opus":0.05084976177873675,"score_gpt":0.40777757041458856,"score_spread":0.35692780863585183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989110054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007533751,0.9923957,0.0000073493666,0.0007185709,0.00027679466,0.0042982376,0.000076923774,0.000014042238,0.0022048394],"genre_scores_gemma":[0.00005106372,0.996338,0.0002770946,0.0013954772,0.00022281372,0.001459698,0.00003991982,0.00007826859,0.0001376274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695086,0.00021979149,0.0012449365,0.00051360537,0.0007151024,0.00035572477],"domain_scores_gemma":[0.99803144,0.00011989853,0.00062841136,0.001022614,0.0001268487,0.00007079865],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034901768,0.0005870032,0.003134282,0.00014561799,0.000031871394,0.000007969477,0.0005273227,0.00016207703,0.001132136],"category_scores_gemma":[0.0000103285865,0.00031617173,0.0010690187,0.00078601344,0.00018622208,0.000050710292,0.000038172588,0.00030918934,0.000013233813],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027904962,0.00036824477,0.000004345823,0.14619304,0.0011654003,0.000070192305,0.00029222496,6.987073e-8,0.0000017867304,0.00012104802,0.0006258265,0.8511299],"study_design_scores_gemma":[0.0010294926,0.00044776738,0.000054145836,0.35980168,0.000942185,0.000017490636,0.000059102957,2.33197e-8,0.000027077424,0.000023531333,0.6374093,0.00018821444],"about_ca_topic_score_codex":0.00044612505,"about_ca_topic_score_gemma":0.000016912223,"teacher_disagreement_score":0.8509417,"about_ca_system_score_codex":0.00025139566,"about_ca_system_score_gemma":0.0009658668,"threshold_uncertainty_score":0.999929},"labels":[],"label_agreement":null},{"id":"W1989399572","doi":"10.1038/bjc.2012.464","title":"Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Université de Montréal","funders":"","keywords":"Nomogram; Lymphovascular invasion; Cystectomy; Medicine; Cohort; Bladder cancer; Concordance; Internal medicine; Oncology; Cancer; Surgery","score_opus":0.01130117259524235,"score_gpt":0.28863928669110867,"score_spread":0.27733811409586634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989399572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966455,0.030188784,0.0021229254,0.00008690528,0.0004666722,0.00041449728,0.00016108339,0.0000056959884,0.00009845346],"genre_scores_gemma":[0.9893418,0.00852583,0.0010475733,0.00019950068,0.0007211714,0.00004547668,0.000008021422,0.000025663061,0.000084940126],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99890614,0.000031403146,0.00044119539,0.00008963204,0.0003351812,0.00019647265],"domain_scores_gemma":[0.9989392,0.000035938774,0.00038960436,0.00008101669,0.00040388564,0.0001503399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021979651,0.00009548508,0.00032590603,0.00004772933,0.00003912848,0.000014319009,0.00005529858,0.00006823765,0.00026388397],"category_scores_gemma":[0.000025741037,0.00008860682,0.00016799761,0.000070493836,0.00005017354,0.00015594198,0.0000020548591,0.00014713136,0.0000012826862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003194232,0.000986821,0.4784063,0.00020849223,0.00059636816,0.000014617958,0.0008126738,0.000009911214,0.000983855,0.0000066007783,0.0024041755,0.51237595],"study_design_scores_gemma":[0.014042765,0.0009785783,0.93653905,0.001100513,0.00073538907,0.00018126323,0.000055815657,0.000030052754,0.015081304,0.00016504277,0.030919487,0.00017075642],"about_ca_topic_score_codex":0.00016528864,"about_ca_topic_score_gemma":0.000045795685,"teacher_disagreement_score":0.5122052,"about_ca_system_score_codex":0.00010048953,"about_ca_system_score_gemma":0.00014113402,"threshold_uncertainty_score":0.36132815},"labels":[],"label_agreement":null},{"id":"W1989400803","doi":"10.5489/cuaj.2440","title":"Microscopic hematuria and urothelial malignancy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Malignancy; Microscopic hematuria; Urothelium; Medicine; Urothelial cancer; Pathology; Urology; Urinary bladder; Bladder cancer; Internal medicine; Cancer; Kidney","score_opus":0.008220512151565038,"score_gpt":0.22940272957284583,"score_spread":0.2211822174212808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989400803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527112,0.0006579649,0.00012829274,0.033441402,0.0005946126,0.00023571572,0.000031719515,0.000035037963,0.012164002],"genre_scores_gemma":[0.9870489,0.0000732622,0.000337439,0.0105237365,0.00065396243,0.000005353134,0.000005783502,0.000010899212,0.0013406351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990661,0.00008674292,0.00018573375,0.00014780046,0.00017421454,0.00033937933],"domain_scores_gemma":[0.9990566,0.000053781805,0.00009623384,0.00007218955,0.00009470039,0.0006265029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027514945,0.00010764125,0.00021209761,0.000083823405,0.00020006951,0.000071133305,0.00004981705,0.00017087272,0.00050396577],"category_scores_gemma":[0.00027522753,0.00008251761,0.0000652953,0.00007340995,0.000024239149,0.00004942631,0.0000075578237,0.00029292537,0.000069104964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061017763,0.0000411557,0.97842234,0.000009257022,0.00010884744,0.000056705332,0.00010802759,9.1814917e-7,0.00070933386,0.0007635359,0.012477015,0.007241866],"study_design_scores_gemma":[0.002189805,0.00052717474,0.8000481,0.000021707492,0.00010257786,0.0004603889,0.000013674411,0.000024233866,0.00020090932,0.0025752264,0.19371842,0.000117753356],"about_ca_topic_score_codex":0.0004984253,"about_ca_topic_score_gemma":0.00025488474,"teacher_disagreement_score":0.18124141,"about_ca_system_score_codex":0.0003504522,"about_ca_system_score_gemma":0.00024267977,"threshold_uncertainty_score":0.55180717},"labels":[],"label_agreement":null},{"id":"W1989826190","doi":"10.1111/j.1464-410x.2007.07352.x","title":"Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytology; Medicine; Urology; Urinary system; Transitional cell carcinoma; Context (archaeology); Urinary bladder; Bladder cancer; Urine cytology; Cancer; Internal medicine; Pathology; Biology","score_opus":0.015253266229153867,"score_gpt":0.2548056767847013,"score_spread":0.2395524105555474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989826190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876827,0.01074039,0.00006849289,0.0007514671,0.00008259463,0.00020873046,0.00001969316,0.0000028336428,0.00044308676],"genre_scores_gemma":[0.9984014,0.0009231351,0.000090461,0.00038053756,0.00013639715,0.000011297996,8.3750825e-7,0.000012298641,0.000043626093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991542,0.00015948362,0.00028013295,0.00011303545,0.00014816203,0.00014498224],"domain_scores_gemma":[0.9996345,0.000031607782,0.00014299295,0.0000626114,0.000081759805,0.00004649815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013908395,0.000079027355,0.00024736277,0.000089905974,0.000055344764,0.0000035740197,0.000071741975,0.000095328214,0.00022580892],"category_scores_gemma":[0.000011850679,0.00006802416,0.00006757727,0.00008975645,0.00018815098,0.000056597728,0.000008310714,0.00030527328,0.0000016633171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022727255,0.007914707,0.6769034,0.00068607274,0.00086636026,0.03979261,0.014020089,0.00013360963,0.16493395,0.00020891601,0.0038223444,0.067990676],"study_design_scores_gemma":[0.004847971,0.0042419815,0.8888048,0.00006781238,0.0001463102,0.098238744,0.00017766908,0.000036921305,0.0012995556,0.0002337311,0.0018133922,0.000091111295],"about_ca_topic_score_codex":0.0005734606,"about_ca_topic_score_gemma":0.00014498144,"teacher_disagreement_score":0.2119014,"about_ca_system_score_codex":0.000024155448,"about_ca_system_score_gemma":0.00011567895,"threshold_uncertainty_score":0.27739447},"labels":[],"label_agreement":null},{"id":"W1989955619","doi":"10.1016/j.clgc.2014.09.004","title":"Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Salvage therapy; Urothelial carcinoma; Systemic therapy; End point; Oncology; Internal medicine; Urology; Cancer; Bladder cancer; Chemotherapy","score_opus":0.051355639782387635,"score_gpt":0.3699060234366396,"score_spread":0.3185503836542519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989955619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480665,0.00042882908,0.000049349786,0.0005303077,0.0016621238,0.0018172086,0.00017855687,0.00007121401,0.00045574695],"genre_scores_gemma":[0.9934671,0.00032276026,0.00020758373,0.003042888,0.0018021573,0.0004999836,0.00008189914,0.00009205166,0.00048359553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683034,0.00071682944,0.00092141586,0.0007135903,0.0003140997,0.0005037086],"domain_scores_gemma":[0.99788755,0.0007390732,0.00021670666,0.000606837,0.00017621253,0.000373627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011382184,0.00032445125,0.0007547658,0.0001457426,0.00009454666,0.000026978716,0.00023847984,0.00021958821,0.0002347163],"category_scores_gemma":[0.00043579025,0.00027056577,0.00029496805,0.00013664705,0.00014610062,0.00013173909,0.000066686785,0.00036808208,0.000055357443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061507735,0.0014532739,0.80329794,0.00013975789,0.00014309259,0.000065084976,0.0006213927,0.000007029986,0.0018045168,0.0000071664767,0.00094554055,0.13000748],"study_design_scores_gemma":[0.023207802,0.013104041,0.9557191,0.00029783844,0.00010381447,0.000017162905,0.00007984071,0.00022295958,0.00038324625,0.00016062074,0.0063970326,0.00030651223],"about_ca_topic_score_codex":0.00022469359,"about_ca_topic_score_gemma":0.000049049737,"teacher_disagreement_score":0.1524212,"about_ca_system_score_codex":0.00029251652,"about_ca_system_score_gemma":0.00040268645,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W1990042561","doi":"10.5489/cuaj.417","title":"Canada’s First Robotic Assisted Totally Intracorporeal Orthotopic Ileal Neobladder","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Urinary diversion; Medicine; Blood loss; Robotic surgery; Bladder cancer; Prostatectomy; Surgery; Cystectomy; Urology; Prostate cancer; Cancer; Internal medicine","score_opus":0.011438742031779867,"score_gpt":0.2089620308671626,"score_spread":0.19752328883538275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990042561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68348783,0.00038496047,0.00012866202,0.2416229,0.0020517684,0.0012602695,0.00011002039,0.00009154823,0.070862025],"genre_scores_gemma":[0.9815739,0.000028143482,0.00021226404,0.014294775,0.0006781066,0.000028755378,0.000041175375,0.000018325403,0.0031246012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981272,0.0000904111,0.0004018651,0.00022007253,0.0004861342,0.00067428645],"domain_scores_gemma":[0.9978717,0.0000932473,0.00021950464,0.00013458129,0.0003361742,0.0013447665],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016354145,0.00019539335,0.0003446513,0.000108812885,0.00035477304,0.00012188099,0.00012531095,0.00024331312,0.005946065],"category_scores_gemma":[0.00023322768,0.00015313554,0.00012713653,0.00017311735,0.00002712885,0.00012218574,0.000012467919,0.0006122182,0.0001362967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031495118,0.00008147965,0.7443658,0.000008430465,0.00035336093,0.0005164222,0.000059344737,0.000094568146,0.000029862045,0.00010641595,0.2447681,0.00958474],"study_design_scores_gemma":[0.0010783704,0.00025535963,0.91239965,0.000012108856,0.00011334602,0.00056316017,0.000030006911,0.00013703565,0.0000054883176,0.00027053166,0.08498908,0.00014588913],"about_ca_topic_score_codex":0.80796236,"about_ca_topic_score_gemma":0.8858593,"teacher_disagreement_score":0.298086,"about_ca_system_score_codex":0.003175206,"about_ca_system_score_gemma":0.0050210897,"threshold_uncertainty_score":0.99496263},"labels":[],"label_agreement":null},{"id":"W1990481620","doi":"10.1097/01.mou.0000175572.46986.2c","title":"Antisense oligonucleotide therapy in the management of bladder cancer","year":2005,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Antisense therapy; Bladder cancer; Oligonucleotide; Cancer; In vivo; Genetic enhancement; Cancer research; Urinary system; Internal medicine; Biology; Locked nucleic acid; Gene; Biotechnology","score_opus":0.14479295016625388,"score_gpt":0.44946255958878945,"score_spread":0.30466960942253557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990481620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008334836,0.99420685,0.0000031141592,0.00033157092,0.0025005373,0.0018259763,0.00004527809,0.000012735277,0.0009906213],"genre_scores_gemma":[0.00036164396,0.99815077,0.000020526524,0.00013277956,0.00052891363,0.00062308996,0.00010367633,0.000038834878,0.00003975383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980381,0.00026531352,0.00070741423,0.00042205252,0.0002264978,0.00034063743],"domain_scores_gemma":[0.9991424,0.000077306744,0.00023441312,0.0004751827,0.000026361893,0.00004433685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022187272,0.00035206528,0.0012149955,0.00031825734,0.000018701372,0.0000056971703,0.00025826076,0.00019343842,0.00032708907],"category_scores_gemma":[0.0000035258001,0.00022019139,0.00027404624,0.0004432465,0.000100557176,0.000025131048,0.000053025546,0.0005056868,0.000043301487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000731788,0.0005307257,0.00040649655,0.0059940726,0.00027547593,0.000016447519,0.0001500935,0.0000026036928,4.1055713e-8,0.0002145421,0.0017323856,0.9906039],"study_design_scores_gemma":[0.001911129,0.0002450834,0.0026753433,0.005397663,0.00034280308,0.00004523628,0.000017545655,0.0000032353973,1.9784096e-7,0.000031762538,0.98917913,0.00015087058],"about_ca_topic_score_codex":0.000060458242,"about_ca_topic_score_gemma":0.000011588291,"teacher_disagreement_score":0.99045306,"about_ca_system_score_codex":0.00011024765,"about_ca_system_score_gemma":0.0001799654,"threshold_uncertainty_score":0.8979144},"labels":[],"label_agreement":null},{"id":"W1991064094","doi":"10.1007/s10637-010-9408-4","title":"A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium","year":2010,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Sorafenib; Response Evaluation Criteria in Solid Tumors; Adverse effect; Progressive disease; Clinical endpoint; Internal medicine; Oncology; Surgery; Phases of clinical research; Clinical trial; Chemotherapy; Hepatocellular carcinoma","score_opus":0.04450204486330388,"score_gpt":0.35368284050258053,"score_spread":0.30918079563927664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991064094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167126,0.00008820234,0.000007797281,0.0046091718,0.0006034026,0.0024612816,0.00028706656,0.000018356825,0.0002534576],"genre_scores_gemma":[0.9975341,0.000011793361,0.00034009866,0.0004917294,0.00039882175,0.0002405837,0.00003071304,0.0000256488,0.0009265093],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979746,0.000085597094,0.00076586386,0.00029817826,0.0006693095,0.00020649067],"domain_scores_gemma":[0.9987739,0.00014110256,0.0003512115,0.00036565022,0.00016534804,0.00020279572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025069807,0.00021911428,0.0005312125,0.00014445983,0.00014009976,0.000006745116,0.00019664818,0.000063531945,0.0004282535],"category_scores_gemma":[0.00031039794,0.00015568882,0.00014039001,0.0004538572,0.0003135396,0.00008999289,0.00008162531,0.00030641697,0.0000029818932],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21542081,0.25830486,0.025237737,0.0007695388,0.003967792,0.00014447316,0.10063451,0.0010467721,0.3162251,0.0056765648,0.012551556,0.060020264],"study_design_scores_gemma":[0.87671846,0.027040599,0.002101446,0.00030520925,0.0013071755,0.000023786653,0.00064163125,0.00069493114,0.07976052,0.0060784006,0.004984427,0.00034343931],"about_ca_topic_score_codex":0.0044785333,"about_ca_topic_score_gemma":0.0022849746,"teacher_disagreement_score":0.6612976,"about_ca_system_score_codex":0.00005389652,"about_ca_system_score_gemma":0.0019639325,"threshold_uncertainty_score":0.67702323},"labels":[],"label_agreement":null},{"id":"W1991403331","doi":"10.1016/s0959-8049(03)00358-7","title":"Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract","year":2003,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Doxorubicin; Metastatic Urothelial Carcinoma; Transitional cell carcinoma; Oncology; Chemotherapy; Urology; Internal medicine; Urothelial carcinoma; Cancer; Bladder cancer","score_opus":0.032301144339876756,"score_gpt":0.3161568543341923,"score_spread":0.2838557099943156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991403331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192375,0.00313002,0.00007111977,0.00032833434,0.00033137994,0.00080807525,0.00012822688,0.000001800731,0.0032773076],"genre_scores_gemma":[0.99846417,0.00050063874,0.00023613841,0.00009859554,0.0001627722,0.000011007071,0.0000019284257,0.000030740586,0.00049400877],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99739176,0.0007020456,0.0009474443,0.0001393551,0.0006149509,0.00020445706],"domain_scores_gemma":[0.998678,0.00012379845,0.00063374994,0.00025177584,0.0002331366,0.00007950851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005117862,0.0002033785,0.0006062252,0.000118153315,0.00005299433,0.000005075005,0.00019550502,0.000022511358,0.0004435774],"category_scores_gemma":[0.000042542695,0.00009742483,0.00037343745,0.0003090705,0.00013560528,0.000078851146,0.0000061240553,0.0001790797,9.318839e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51800704,0.07062119,0.006769623,0.00064842653,0.0018221668,0.002044135,0.030167013,0.003623775,0.26393655,0.00016835202,0.0005811063,0.10161061],"study_design_scores_gemma":[0.4738279,0.09489501,0.011571352,0.00057969254,0.0020091573,0.00030230422,0.0012264224,0.000030935276,0.40728018,0.000048470105,0.008013758,0.0002148137],"about_ca_topic_score_codex":0.00009444365,"about_ca_topic_score_gemma":0.000050812752,"teacher_disagreement_score":0.14334361,"about_ca_system_score_codex":0.00011224402,"about_ca_system_score_gemma":0.00088798057,"threshold_uncertainty_score":0.48568612},"labels":[],"label_agreement":null},{"id":"W1991464658","doi":"10.1186/1471-2490-13-23","title":"The natural history of secondary muscle-invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"BMC Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Natural history; Disease; Biopsy; Cancer; Internal medicine; Urology","score_opus":0.018077997588269,"score_gpt":0.2584348436929765,"score_spread":0.24035684610470748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991464658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8818877,0.06236312,0.000024040737,0.0048061456,0.0038853514,0.0010074168,0.000020785244,0.00007335524,0.045932114],"genre_scores_gemma":[0.98335934,0.00014326064,0.00008275707,0.0027917237,0.00022463754,0.00015873702,0.000006410636,0.000018200504,0.013214962],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99924904,0.000055851535,0.00017536442,0.00017773097,0.000111223286,0.00023078895],"domain_scores_gemma":[0.9992913,0.00017993648,0.00007942354,0.00026886727,0.000114242765,0.00006620106],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004692234,0.00011254517,0.00019850003,0.00003727141,0.000038551705,0.0000027968017,0.00009809341,0.0000840159,0.002337235],"category_scores_gemma":[0.000049212693,0.00007011354,0.00009135338,0.000040076895,0.00024497233,0.00004371793,0.000032721608,0.00018867893,0.00010638344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015981597,0.0005950338,0.12576486,0.00039889725,0.0010875731,0.00007357506,0.0045021535,0.0000151009335,0.047685627,0.001710771,0.6990894,0.11747884],"study_design_scores_gemma":[0.003217624,0.0007276361,0.633555,0.000006718935,0.000369877,0.000059424223,0.00019232952,0.000085494205,0.0013635313,0.0005924454,0.35966635,0.00016359556],"about_ca_topic_score_codex":0.001142874,"about_ca_topic_score_gemma":0.000987943,"teacher_disagreement_score":0.50779015,"about_ca_system_score_codex":0.00015787598,"about_ca_system_score_gemma":0.00090990646,"threshold_uncertainty_score":0.9985748},"labels":[],"label_agreement":null},{"id":"W1991574256","doi":"10.5489/cuaj.08107","title":"Ureteral frozen sections at the time of radical cystectomy: reliability and clinical implications","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cystectomy; Medicine; Urology; Ureter; Urothelial carcinoma; Frozen section procedure; Bladder cancer; Carcinoma in situ; Incidence (geometry); Urinary diversion; Carcinoma; Urethra; Stage (stratigraphy); Surgery; Internal medicine; Cancer","score_opus":0.01339313291040281,"score_gpt":0.2814214935572475,"score_spread":0.26802836064684465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991574256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93124086,0.000060907274,0.000013711234,0.066085234,0.00029253535,0.00022096909,0.00010118425,0.00001419317,0.001970422],"genre_scores_gemma":[0.995796,0.000033591856,0.00015039559,0.0025674968,0.00047900234,0.000009657523,0.000015392652,0.000007620447,0.0009408132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875134,0.00023754657,0.0003980933,0.00017654366,0.00018561856,0.00025086853],"domain_scores_gemma":[0.99837416,0.00043927488,0.00019369375,0.00018711554,0.00021348639,0.0005922501],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000987121,0.000093135954,0.0002464442,0.000053900716,0.00042969533,0.000028524773,0.00009204426,0.00028151664,0.0010664865],"category_scores_gemma":[0.0013246323,0.00005792938,0.00016779396,0.00012539227,0.00019927278,0.000043494816,0.000022037762,0.0009965278,0.00004392386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005760554,0.000060206243,0.9882199,0.0000014777113,0.0001120756,0.0000045205925,0.000052486474,0.0000013682957,0.00033833418,0.00010199895,0.009738655,0.0013113302],"study_design_scores_gemma":[0.0010182281,0.00029157975,0.9552435,0.0000027267515,0.00016178908,0.00033245832,0.0000070964215,0.00004902357,0.000026678434,0.001474837,0.041337684,0.000054363805],"about_ca_topic_score_codex":0.000970225,"about_ca_topic_score_gemma":0.0022090685,"teacher_disagreement_score":0.06455518,"about_ca_system_score_codex":0.00036011334,"about_ca_system_score_gemma":0.0004883227,"threshold_uncertainty_score":0.9998467},"labels":[],"label_agreement":null},{"id":"W1991786253","doi":"10.5489/cuaj.10051","title":"Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravescal therapy","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia Hospital; University of Alberta; Dalhousie University; University of Toronto; Hôtel-Dieu de Québec; McGill University","funders":"","keywords":"Bladder cancer; Focus (optics); Cancer; Medicine; Intensive care medicine; Internal medicine","score_opus":0.03808126819203896,"score_gpt":0.31274290278717903,"score_spread":0.2746616345951401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991786253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8949132,0.00038061792,0.000018593042,0.100194015,0.000914212,0.0008581049,0.000554182,0.000013297345,0.0021538036],"genre_scores_gemma":[0.9892718,0.0007121282,0.0004021493,0.0074723596,0.0014150237,0.00010846446,0.000029400851,0.000023735396,0.0005649406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985379,0.00004104394,0.00038937962,0.00022339862,0.00024505463,0.0005632317],"domain_scores_gemma":[0.9974788,0.00015321655,0.00021184428,0.00014373171,0.00079741643,0.0012150224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021219505,0.00020447712,0.00040544168,0.000245993,0.00024023757,0.000040565003,0.00010476876,0.00031714336,0.001002109],"category_scores_gemma":[0.00044378222,0.00014456463,0.00023736533,0.00014314728,0.000033049473,0.00004548056,0.0000025065406,0.00022756937,0.000015229816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000672678,0.0004992091,0.59055185,0.000008930667,0.0015380628,0.00016619949,0.000929259,0.00005592695,0.0066431225,0.00032294448,0.06231818,0.33629364],"study_design_scores_gemma":[0.008778566,0.0066635557,0.74247336,0.000029926408,0.0002843447,0.00008977565,0.00011554829,0.00013180859,0.004481262,0.0018882887,0.23475115,0.00031239472],"about_ca_topic_score_codex":0.3130143,"about_ca_topic_score_gemma":0.6809916,"teacher_disagreement_score":0.3679773,"about_ca_system_score_codex":0.0019415381,"about_ca_system_score_gemma":0.004383439,"threshold_uncertainty_score":0.9999111},"labels":[],"label_agreement":null},{"id":"W1991834121","doi":"10.1016/j.urology.2005.08.066","title":"Management of stage T1 tumors of the bladder: International Consensus Panel","year":2005,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Stage (stratigraphy); Consensus conference; Adjuvant chemotherapy; Chemotherapy; General surgery; Surgery; Intensive care medicine; Oncology; Cancer; Internal medicine","score_opus":0.024216460364885173,"score_gpt":0.2832439187222267,"score_spread":0.25902745835734153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991834121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9135472,0.0003447932,0.000062239764,0.009757975,0.00033366316,0.0003329407,0.000061367864,0.000016644577,0.07554319],"genre_scores_gemma":[0.99428016,0.000035496854,0.00027519694,0.0007058637,0.000055842265,0.000007395127,0.0000044549734,0.00000673674,0.004628882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994827,0.000021213069,0.00017225454,0.000101298596,0.00012875779,0.00009379696],"domain_scores_gemma":[0.9996526,0.000020477048,0.00007776179,0.0001875903,0.000038124468,0.000023420247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045045897,0.000059491587,0.00013300408,0.000034690944,0.000012215987,7.860736e-7,0.00009358905,0.000032232583,0.00064082874],"category_scores_gemma":[0.00000719241,0.00004009791,0.00005818494,0.00004677517,0.00011740671,0.000006653761,0.000048758335,0.000057124736,0.000014987503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010417601,0.006949953,0.50782764,0.00096623844,0.013507036,0.0011714383,0.006004214,0.003762349,0.028831847,0.10209217,0.037799243,0.28067026],"study_design_scores_gemma":[0.016494393,0.0018461937,0.63045996,0.0000983018,0.0011979153,0.0003320847,0.00083851704,0.0013085493,0.046912402,0.0011289411,0.29910666,0.0002760762],"about_ca_topic_score_codex":0.000037887443,"about_ca_topic_score_gemma":0.000012018352,"teacher_disagreement_score":0.28039417,"about_ca_system_score_codex":0.000019440631,"about_ca_system_score_gemma":0.000031695792,"threshold_uncertainty_score":0.70166254},"labels":[],"label_agreement":null},{"id":"W1991885067","doi":"","title":"Squamous Cell Carcinoma of the Urinary Bladder: A Clinicopathological Study of Four Cases and a Review of the Literature","year":2014,"lang":"en","type":"review","venue":"World Journal of Nephrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Adjuvant therapy; Stage (stratigraphy); Basal cell; Urinary bladder; Urinary system; Carcinoma; Surgery; Urology; Internal medicine; Chemotherapy","score_opus":0.03890275331040895,"score_gpt":0.32893623696876684,"score_spread":0.2900334836583579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991885067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08195915,0.91597605,3.5930108e-7,0.000681098,0.00024961296,0.00093859603,0.00002930486,0.0000017915302,0.00016401304],"genre_scores_gemma":[0.36503989,0.63317233,0.000011848143,0.0015028811,0.0001345796,0.000010827345,0.0000012304203,0.000013788282,0.00011265457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959641,0.0018452079,0.0014969152,0.00027283625,0.0002105037,0.00021043685],"domain_scores_gemma":[0.9958681,0.001108621,0.0022051656,0.0005136384,0.00021654964,0.0000879136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000765857,0.00034394427,0.003176004,0.00020708729,0.0000659761,0.0000026424411,0.00032790957,0.00035230452,0.000050851253],"category_scores_gemma":[0.00027136964,0.00015424684,0.00064311863,0.0003463736,0.00059733714,0.000022174883,0.00023203899,0.001126509,3.3489243e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009289812,0.014734726,0.2109588,0.3330216,0.0040129884,0.0104732765,0.003276769,0.0000015385284,0.000046910587,0.00033575227,0.014990289,0.39885753],"study_design_scores_gemma":[0.007930179,0.042043127,0.09561987,0.021681774,0.028712638,0.090102196,0.00007285394,7.18509e-7,0.000004883373,0.00025715848,0.71326673,0.00030788552],"about_ca_topic_score_codex":0.000008396662,"about_ca_topic_score_gemma":0.000018748045,"teacher_disagreement_score":0.6982764,"about_ca_system_score_codex":0.000014402366,"about_ca_system_score_gemma":0.0003195831,"threshold_uncertainty_score":0.62900037},"labels":[],"label_agreement":null},{"id":"W1991929500","doi":"10.1111/j.1464-410x.2009.08821.x","title":"A delay in radical nephroureterectomy can lead to upstaging","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Interquartile range; Stage (stratigraphy); Pathological; Disease; Cancer; Retrospective cohort study; Internal medicine; Oncology; Surgery; Metastasis","score_opus":0.013928804624530082,"score_gpt":0.2811271700374429,"score_spread":0.26719836541291286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991929500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98134446,0.0024432493,0.0004224219,0.014077344,0.00018124198,0.00014633233,0.0000047099948,0.00001018957,0.0013700591],"genre_scores_gemma":[0.98513734,0.00019775087,0.0010428973,0.013237305,0.0002877712,0.00000182568,0.0000012809151,0.000010723946,0.000083096544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999042,0.000071915885,0.00033342198,0.00012296223,0.0001622804,0.0002674367],"domain_scores_gemma":[0.9995617,0.000027860053,0.00007444863,0.00007289819,0.00006508789,0.00019799989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018158475,0.00008573209,0.000343662,0.00017138572,0.000026191366,0.000015841262,0.0000902607,0.000078557525,0.00010475401],"category_scores_gemma":[0.00008196208,0.000088825946,0.00008821923,0.00014715333,0.000034547033,0.000044892957,0.00001008171,0.00036735213,0.0000071437303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028218292,0.0008079464,0.07326032,0.000016074762,0.00019821021,0.048881765,0.0010828616,0.00008290395,0.0032481137,0.00006340215,0.015082106,0.85445446],"study_design_scores_gemma":[0.013360205,0.00796761,0.7788246,0.00029962964,0.00022887495,0.14224914,0.000085790685,0.000050367224,0.0005337983,0.0013646167,0.05479099,0.00024434092],"about_ca_topic_score_codex":0.0002522768,"about_ca_topic_score_gemma":0.00032212003,"teacher_disagreement_score":0.85421014,"about_ca_system_score_codex":0.00008519185,"about_ca_system_score_gemma":0.00016435118,"threshold_uncertainty_score":0.36222172},"labels":[],"label_agreement":null},{"id":"W1992117873","doi":"10.5489/cuaj.2193","title":"Robotic radical cystectomy with intracorporeal neobladder: Initial experience and outcomes","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Surgery; Bladder cancer; Complication; Body mass index; Lymphadenectomy; Blood loss; Urology; Cancer; Internal medicine","score_opus":0.02368258799803402,"score_gpt":0.27044874339016045,"score_spread":0.24676615539212643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992117873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709807,0.00017451642,0.000271618,0.021480242,0.0003191889,0.0002665786,0.000018486302,0.000040558076,0.0064481334],"genre_scores_gemma":[0.9938067,0.000016800726,0.0005562776,0.0050276443,0.00034946165,0.000013769765,0.000010025997,0.000012254544,0.00020706763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986329,0.000100556616,0.00023971184,0.00018656718,0.00042385468,0.00041639022],"domain_scores_gemma":[0.9979737,0.00006545478,0.00013422796,0.00008319436,0.00017526258,0.0015681589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025068957,0.00015331189,0.00032297111,0.00011163427,0.00016052234,0.000086812106,0.00007189424,0.00017691204,0.00020574662],"category_scores_gemma":[0.0002866902,0.00009989023,0.000054631688,0.00013400044,0.000094975985,0.00012596018,0.00001121786,0.00044432128,0.0000177413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015872161,0.00004565765,0.9929173,0.0000020150715,0.00012905017,0.0005962567,0.00046276595,0.000016276208,0.000004221994,0.00008938591,0.0020793371,0.0034990222],"study_design_scores_gemma":[0.0054318965,0.0015421249,0.97581947,0.000016541917,0.00017507742,0.0027295076,0.00030254165,0.00010365624,0.00001743741,0.0008046818,0.012867581,0.00018949599],"about_ca_topic_score_codex":0.002054538,"about_ca_topic_score_gemma":0.00085703615,"teacher_disagreement_score":0.02282602,"about_ca_system_score_codex":0.0007206819,"about_ca_system_score_gemma":0.00092608226,"threshold_uncertainty_score":0.40734056},"labels":[],"label_agreement":null},{"id":"W1992197403","doi":"10.1007/s00345-012-0939-5","title":"Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Distributed File System; Clinical endpoint; Hazard ratio; Oncology; Surrogate endpoint; Lymph node; Perioperative; Urothelial carcinoma; Stage (stratigraphy); Urology; Clinical trial; Bladder cancer; Surgery; Cancer; Confidence interval","score_opus":0.026918737884291492,"score_gpt":0.2999329716248077,"score_spread":0.2730142337405162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992197403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781922,0.0058205146,0.00009513937,0.008232899,0.002749567,0.0005105057,0.00007065232,0.000015455085,0.0043130363],"genre_scores_gemma":[0.99498594,0.00015312516,0.00020795483,0.0013784568,0.0017892661,0.000019207288,0.0000086173395,0.000046597663,0.0014108622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814147,0.00018403435,0.0005497437,0.00018001387,0.00034656076,0.000598163],"domain_scores_gemma":[0.9985564,0.00030755796,0.00022653372,0.00028618056,0.00013397417,0.0004893808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065612176,0.00022637151,0.0006311631,0.00036418985,0.000047606743,0.000011695056,0.00020379596,0.00008512146,0.00043330065],"category_scores_gemma":[0.0002560303,0.00018097996,0.0003418237,0.00015040202,0.000078470075,0.00018385239,0.000040622977,0.0003712966,0.00002186415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011058641,0.0011326992,0.98087525,0.000045441957,0.00019159363,0.00041619007,0.00033452015,0.000013005931,0.00044443543,0.0015856699,0.0012905949,0.0026119517],"study_design_scores_gemma":[0.015818954,0.0014825002,0.9115901,0.00003245595,0.00048478955,0.00040747147,0.0000367437,0.000018494653,0.000110144145,0.0020877654,0.06775558,0.00017499225],"about_ca_topic_score_codex":0.00011581452,"about_ca_topic_score_gemma":0.00014751995,"teacher_disagreement_score":0.06928515,"about_ca_system_score_codex":0.00012847272,"about_ca_system_score_gemma":0.00038257762,"threshold_uncertainty_score":0.7380148},"labels":[],"label_agreement":null},{"id":"W1992312512","doi":"10.1016/j.eururo.2006.11.004","title":"Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Urothelial cancer; Oncology; Cancer; Internal medicine","score_opus":0.01021228672030671,"score_gpt":0.2268626580059223,"score_spread":0.2166503712856156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992312512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96572226,0.0002879485,0.000014787764,0.00042321475,0.00009718003,0.00056020153,0.0000616014,0.00012223529,0.03271058],"genre_scores_gemma":[0.9967656,0.000027802507,0.000054499837,0.0011043153,0.00013430245,0.00003273398,0.0002417951,0.00011044342,0.0015284729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997959,0.00031606588,0.00031485668,0.0005609411,0.00032266628,0.00052642997],"domain_scores_gemma":[0.99927574,0.00005203987,0.00012384406,0.0003123472,0.00010645471,0.00012955916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010905402,0.00032329638,0.000511614,0.00014791517,0.00006383257,0.000014933209,0.00011592158,0.00008752692,0.0003959274],"category_scores_gemma":[0.000013689883,0.00022577241,0.000054948927,0.00040350904,0.00021724505,0.00005733505,0.000029284338,0.00030902782,0.00007590375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004341832,0.0009701583,0.98774475,0.000008043475,0.00027787036,0.0024084444,0.00019374276,0.00005039839,0.00021988041,0.000023626804,0.0016248834,0.0021363646],"study_design_scores_gemma":[0.022268768,0.0030141172,0.9617378,0.000046042052,0.00016425866,0.00002161036,0.000011292363,0.0000073774995,0.00018621043,0.0000058598253,0.012296963,0.00023966709],"about_ca_topic_score_codex":0.00042501316,"about_ca_topic_score_gemma":0.0004622211,"teacher_disagreement_score":0.031182105,"about_ca_system_score_codex":0.00017111844,"about_ca_system_score_gemma":0.00007242639,"threshold_uncertainty_score":0.9206732},"labels":[],"label_agreement":null},{"id":"W1992328908","doi":"10.1016/j.eururo.2015.03.030","title":"Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Oncology; Carcinoma; Internal medicine; Bladder cancer; Cancer","score_opus":0.043720574068286895,"score_gpt":0.25224740001852924,"score_spread":0.20852682595024236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992328908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45301208,0.0024508273,0.000055151326,0.41669136,0.003808233,0.004182542,0.0016671885,0.00013563246,0.11799698],"genre_scores_gemma":[0.9226776,0.000031167838,0.00008900042,0.07309748,0.0022387165,0.000036225072,0.00014149096,0.000119799784,0.0015685456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762785,0.00061828655,0.00059553044,0.00041843244,0.0004069004,0.0003330017],"domain_scores_gemma":[0.9988966,0.00005180814,0.0003076021,0.00051767327,0.00017058112,0.000055765544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027992664,0.0002959826,0.0006313729,0.00019838157,0.000018612032,0.0000040680065,0.00031764433,0.00034234428,0.0001653786],"category_scores_gemma":[0.00009411959,0.00020579071,0.00022443564,0.0001969989,0.0002997782,0.000027762733,0.00015558345,0.0010460854,0.000037499296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009307428,0.0003852027,0.11574247,0.00038727224,0.00049894856,0.001242956,0.0017978224,0.000029037923,0.00056380493,0.000009264028,0.8769919,0.0014205441],"study_design_scores_gemma":[0.0077684084,0.0051272963,0.30613887,0.00015659594,0.0014482121,0.00057143567,0.00005035334,0.000060643197,0.0019650257,0.000041806965,0.6763692,0.00030213114],"about_ca_topic_score_codex":0.00012923463,"about_ca_topic_score_gemma":0.000004098775,"teacher_disagreement_score":0.4696655,"about_ca_system_score_codex":0.0000712541,"about_ca_system_score_gemma":0.00034976963,"threshold_uncertainty_score":0.8391901},"labels":[],"label_agreement":null},{"id":"W1992683686","doi":"10.1046/j.1464-4096.2001.01517.x","title":"A single-centre long-term outcome analysis of artificial urinary sphincter placement in children","year":2002,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Bladder augmentation; Surgery; Urinary incontinence; Artificial urinary sphincter; Hydronephrosis; Bladder exstrophy; Urinary diversion; Clean Intermittent Catheterization; Urinary system; Urinary bladder; Cystectomy; Internal medicine; Bladder cancer","score_opus":0.027240912955264707,"score_gpt":0.2733359189172559,"score_spread":0.2460950059619912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992683686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961892,0.0025689022,0.000050640978,0.0006067661,0.00011910388,0.00016466934,0.000027188842,0.000004951928,0.00026861604],"genre_scores_gemma":[0.9988965,0.00022122345,0.00008668909,0.0004312509,0.00015109216,0.0000016985227,0.000012697556,0.000012794458,0.00018608513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856216,0.00008341957,0.0007369952,0.00015266333,0.00023657204,0.00022819485],"domain_scores_gemma":[0.99935913,0.00003126056,0.000289969,0.00011783591,0.00009213418,0.000109650544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014691103,0.00011028225,0.0006424046,0.00042018868,0.000022319504,0.000011434347,0.00009411681,0.00009442609,0.0023353356],"category_scores_gemma":[0.000039965522,0.00011340477,0.00027810718,0.0003328504,0.00006837963,0.00006061799,0.0000274302,0.0002376507,0.000007991209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004844837,0.002265385,0.96976364,0.000011827046,0.0016590741,0.002486278,0.000132718,0.00006636208,0.00022775328,0.0000019695071,0.00022262378,0.02267791],"study_design_scores_gemma":[0.0032287217,0.0014801522,0.9881742,0.00004079465,0.0022184518,0.004549312,0.000012783808,0.000084017905,0.00006567391,0.000012802409,0.00005633062,0.000076760385],"about_ca_topic_score_codex":0.000059924932,"about_ca_topic_score_gemma":0.00018974616,"teacher_disagreement_score":0.022601148,"about_ca_system_score_codex":0.00008074331,"about_ca_system_score_gemma":0.00002614826,"threshold_uncertainty_score":0.99857664},"labels":[],"label_agreement":null},{"id":"W1992945401","doi":"10.1016/j.juro.2010.02.1759","title":"1821 ADVANCED AGE IS AN INDEPENDENT PREDICTOR OF CANCER-SPECIFIC MORTALITY AFTER RADICAL CYSTECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; Internal medicine","score_opus":0.01893634075256448,"score_gpt":0.28613986874928904,"score_spread":0.26720352799672453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992945401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954147,0.0016662558,0.00015396046,0.0014008255,0.00055939995,0.000442511,0.00022137404,0.000003090747,0.00013792874],"genre_scores_gemma":[0.99869686,0.00009988073,0.00016163912,0.00053751556,0.00039910097,0.000023808418,0.0000033199724,0.000018394823,0.000059460937],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99871355,0.00012985269,0.00048215687,0.00012353978,0.0003649879,0.00018592362],"domain_scores_gemma":[0.99893475,0.00009300486,0.00033414824,0.0003308173,0.00019865193,0.000108618406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030502523,0.00013519383,0.0003837591,0.000058015954,0.00004807193,0.0000023420303,0.00024326434,0.00013159195,0.0005638685],"category_scores_gemma":[0.000009833404,0.00007316312,0.00023400939,0.00007386699,0.00036191204,0.00005943436,0.000023974217,0.0004515354,5.260876e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047087584,0.0044781966,0.45380357,0.00042915452,0.0015214445,0.00033915215,0.010046087,0.00015618611,0.47710207,0.00016265444,0.0015021226,0.0033717807],"study_design_scores_gemma":[0.0071117706,0.0031446905,0.95198274,0.000020067084,0.0008788778,0.0005304712,0.00010162773,0.000030787633,0.03352202,0.0005402776,0.002063706,0.00007299108],"about_ca_topic_score_codex":0.000057518686,"about_ca_topic_score_gemma":0.00007390123,"teacher_disagreement_score":0.49817914,"about_ca_system_score_codex":0.000029135163,"about_ca_system_score_gemma":0.00029312394,"threshold_uncertainty_score":0.6173965},"labels":[],"label_agreement":null},{"id":"W1992984639","doi":"10.5489/cuaj.1213","title":"Effect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: A systematic review","year":2013,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Warfarin; Bladder cancer; Anticoagulant; Drug; Multivariate analysis; Internal medicine; Bladder tumor; Cancer; Intensive care medicine; Oncology; Pharmacology; Atrial fibrillation","score_opus":0.03916967001545549,"score_gpt":0.33148610928101957,"score_spread":0.29231643926556405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992984639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00927133,0.9862149,3.1736425e-7,0.00061529374,0.00013031551,0.0034159708,0.00020463957,0.0000042391684,0.00014301478],"genre_scores_gemma":[0.018672764,0.98066527,0.0000040124182,0.0002667652,0.000115141695,0.00012290155,0.00002395907,0.000022317994,0.00010687728],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99687356,0.0009389885,0.0011841077,0.00021823449,0.00046079076,0.00032434287],"domain_scores_gemma":[0.99628097,0.0012683372,0.001651865,0.0002504345,0.00018058535,0.0003678213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072201935,0.00037252106,0.004002716,0.00017450361,0.00007228003,0.000016222153,0.000155267,0.00033017332,0.00045400378],"category_scores_gemma":[0.00085358554,0.00016862858,0.00065361214,0.0002339838,0.0000768791,0.000023279528,0.000011544916,0.0003303779,0.000016011083],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020829665,0.00074157777,0.01007996,0.6168315,0.014513542,0.0001984509,0.00018458982,0.0000010071136,0.0000039583124,0.000060038918,0.0049938434,0.35218322],"study_design_scores_gemma":[0.008769662,0.023993302,0.013880081,0.7811929,0.08496191,0.0013060528,0.00002063704,0.00002377482,0.00011440195,0.000037656246,0.084880196,0.0008194038],"about_ca_topic_score_codex":0.00074762874,"about_ca_topic_score_gemma":0.000026480733,"teacher_disagreement_score":0.3513638,"about_ca_system_score_codex":0.0007048342,"about_ca_system_score_gemma":0.0006467155,"threshold_uncertainty_score":0.6876474},"labels":[],"label_agreement":null},{"id":"W1993222946","doi":"10.1016/j.eururo.2012.06.029","title":"Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Urothelial carcinoma; Smoking cessation; Logistic regression; Retrospective cohort study; Risk factor; Lymph node; Internal medicine; Odds ratio; Cancer; Urology; Surgery; Bladder cancer; Pathology","score_opus":0.02577046879959099,"score_gpt":0.3120124866048538,"score_spread":0.2862420178052628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993222946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785183,0.00036864294,0.000019014902,0.0002144836,0.0002921917,0.0002719905,0.0000414758,0.0000299991,0.020243898],"genre_scores_gemma":[0.9980669,0.000011630955,0.00012742881,0.001212796,0.00035360453,0.000009087802,0.0000108790055,0.000049713333,0.00015795654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984505,0.00036779206,0.00036408025,0.00021583537,0.00019542372,0.00040637143],"domain_scores_gemma":[0.99914557,0.00015041353,0.00014426968,0.00033815095,0.000039348954,0.0001822357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002546126,0.00022646057,0.00054934603,0.00014458636,0.000022643715,0.0000028331515,0.00011323844,0.00009558498,0.0011451915],"category_scores_gemma":[0.00009079275,0.0001490406,0.00036246586,0.000087054854,0.00018117984,0.00005136479,0.0000468932,0.0002541512,0.00007664992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019597684,0.000910087,0.99161017,0.00001645209,0.0002753515,0.00012333078,0.0005490469,0.0000019418032,0.0012378581,0.000034492987,0.00025034836,0.0030311807],"study_design_scores_gemma":[0.0034563178,0.005196026,0.98743546,0.0000098210485,0.0002928134,0.00014415577,0.000008783438,0.0000023006232,0.0005976947,0.000010269471,0.002740467,0.00010591944],"about_ca_topic_score_codex":0.000066646964,"about_ca_topic_score_gemma":6.7090326e-7,"teacher_disagreement_score":0.020085942,"about_ca_system_score_codex":0.00007607953,"about_ca_system_score_gemma":0.000082001614,"threshold_uncertainty_score":0.9997679},"labels":[],"label_agreement":null},{"id":"W1993248759","doi":"10.4021/jcgo.v1i1.11","title":"A Case of Muscle Invasive Bladder Cancer Treated With Systemic Chemotherapy During Pregnancy","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Pregnancy; Carboplatin; Chemotherapy; Caesarean section; Cancer; Radiation therapy; Urology; Surgery; Cisplatin; Internal medicine","score_opus":0.0509501110248648,"score_gpt":0.3541619106463671,"score_spread":0.3032117996215023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993248759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831735,0.015633585,0.000012878065,0.00013043104,0.00052539894,0.00025420234,0.000008698491,0.0000064684364,0.00025483494],"genre_scores_gemma":[0.99040216,0.0086528035,0.00024683538,0.00018264803,0.00024001961,0.000007950986,6.379131e-7,0.000018696579,0.00024824133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984884,0.0001192209,0.0008801859,0.00012848944,0.00014977019,0.00023389336],"domain_scores_gemma":[0.99632025,0.0021891352,0.0007419842,0.00014065678,0.00032263913,0.00028535997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024014371,0.00014255644,0.0007975694,0.00014186087,0.00004943798,0.0000042059582,0.000052549218,0.00023216977,0.00012900942],"category_scores_gemma":[0.0013516849,0.000089383466,0.00015558237,0.00025168975,0.00014529585,0.0001209609,0.00001651118,0.0003492245,0.0000015472925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007818806,0.00085039483,0.9624666,0.00025738962,0.00093544717,0.0032162254,0.0005188424,0.0000031075938,0.0002457732,0.000009278446,0.00004973195,0.030665318],"study_design_scores_gemma":[0.021220947,0.004484411,0.95023257,0.0008976157,0.0016106814,0.01742182,0.0005902497,0.000006443269,0.0030295567,0.00001626374,0.00032002275,0.00016943587],"about_ca_topic_score_codex":0.000023648492,"about_ca_topic_score_gemma":0.000016810585,"teacher_disagreement_score":0.03049588,"about_ca_system_score_codex":0.000063958134,"about_ca_system_score_gemma":0.00028963288,"threshold_uncertainty_score":0.3644952},"labels":[],"label_agreement":null},{"id":"W1993710010","doi":"10.1016/j.urology.2009.04.084","title":"Assessment of the Minimum Number of Lymph Nodes Needed to Detect Lymph Node Invasion at Radical Nephroureterectomy in Patients With Upper Tract Urothelial Cancer","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Lymph; Lymphadenectomy; Lymph node; Urology; Receiver operating characteristic; Stage (stratigraphy); Nomogram; Surgery; Oncology; Pathology; Internal medicine","score_opus":0.010556083988951947,"score_gpt":0.28554974275935335,"score_spread":0.2749936587704014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993710010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607027,0.000048307393,0.00005056681,0.0016943847,0.00014693447,0.00059871754,0.000046154415,0.000012652448,0.0013319886],"genre_scores_gemma":[0.9944167,0.000013969532,0.00048127692,0.0048577306,0.000059541235,0.0000462306,0.000010431208,0.000023173301,0.00009094273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857223,0.000121474426,0.00034980304,0.0002992124,0.00034964035,0.00030766227],"domain_scores_gemma":[0.99927324,0.00006631134,0.00013292763,0.00034320838,0.00007733289,0.00010697326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008265349,0.00020312646,0.00047703044,0.00009534366,0.0000377065,0.0000032861217,0.00014786687,0.0001521085,0.00038294337],"category_scores_gemma":[0.000029856816,0.00012458548,0.00010472427,0.00023434992,0.00011625331,0.000037316684,0.000048041504,0.000116694326,0.0000060669267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029893487,0.0005549127,0.98527414,0.000023012906,0.00007587081,0.00000832092,0.00025620701,0.00007666406,0.007366666,0.000011759118,0.00010623096,0.0032568816],"study_design_scores_gemma":[0.010386152,0.00087413145,0.9809586,0.00006800865,0.0001649458,0.000022307662,0.000013681246,0.000053361222,0.00696404,0.000039542385,0.00034376024,0.00011145956],"about_ca_topic_score_codex":0.0007256796,"about_ca_topic_score_gemma":0.000054411896,"teacher_disagreement_score":0.0073968032,"about_ca_system_score_codex":0.0002476218,"about_ca_system_score_gemma":0.00030736462,"threshold_uncertainty_score":0.50804484},"labels":[],"label_agreement":null},{"id":"W1993927422","doi":"10.1016/j.ijrobp.2015.09.030","title":"Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Urology; Oncology; Modality (human–computer interaction); Term (time); Induction therapy; Treatment modality; Internal medicine; Surgery; Cancer; Chemotherapy","score_opus":0.07820243303442015,"score_gpt":0.4002394833205314,"score_spread":0.32203705028611124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993927422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922182,0.00044086788,0.0013540622,0.0031397855,0.00087691506,0.00083986466,0.001074333,0.000013475387,0.00004249397],"genre_scores_gemma":[0.997096,0.00066144357,0.00044469337,0.0009821131,0.000417791,0.000103569146,0.00022413344,0.000029531451,0.00004069769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973576,0.0005577589,0.0011061771,0.0003109224,0.00042025404,0.00024726772],"domain_scores_gemma":[0.99441445,0.0012377094,0.0018879148,0.000270305,0.00202174,0.00016786595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000721218,0.00028629284,0.0011386985,0.00029414374,0.00010128463,0.000028068569,0.0003670523,0.00024276048,0.00009382744],"category_scores_gemma":[0.00053680886,0.00018912228,0.0004337786,0.0003488402,0.00056601886,0.00029856278,0.00009389873,0.00033105043,0.0000010451477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02152803,0.0015119587,0.9176333,0.000019802077,0.011489636,0.000013546627,0.002340584,0.00024365305,0.0009915787,0.0000857215,0.0002217185,0.043920502],"study_design_scores_gemma":[0.025571376,0.0070071244,0.96018213,0.00007027839,0.002757974,0.000013610879,0.00021442163,0.0014930442,0.00067308184,0.0013141193,0.0005386338,0.0001641854],"about_ca_topic_score_codex":0.00036730422,"about_ca_topic_score_gemma":0.00030868952,"teacher_disagreement_score":0.043756317,"about_ca_system_score_codex":0.0005716189,"about_ca_system_score_gemma":0.0010979418,"threshold_uncertainty_score":0.77121824},"labels":[],"label_agreement":null},{"id":"W1994430004","doi":"10.1089/end.2005.19.658","title":"Percutaneous Management of Upper-Tract Transitional Cell Carcinoma","year":2005,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Transitional cell carcinoma; Percutaneous; Upper urinary tract; Urothelial cancer; Surgery; Urology; Cancer; Bladder cancer; Internal medicine; Urinary system","score_opus":0.03560607783005305,"score_gpt":0.3315981620520528,"score_spread":0.29599208422199974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994430004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054960814,0.9904309,0.000025220535,0.00018452387,0.00038628228,0.00036503858,0.00006944524,0.0000052035193,0.007983803],"genre_scores_gemma":[0.012331051,0.9847872,0.001283602,0.00016117343,0.00070261967,0.0000052175096,0.00003236066,0.000047123845,0.00064964214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806803,0.00011605293,0.0010109635,0.00019099363,0.00035752944,0.0002564315],"domain_scores_gemma":[0.9986583,0.000095055926,0.00073020055,0.00021329013,0.00014298638,0.00016017693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015462504,0.0003128861,0.0019279423,0.00033060685,0.000024898067,0.0000044988815,0.0001820158,0.00026909588,0.00096380216],"category_scores_gemma":[0.0000045577044,0.00022305286,0.0011041667,0.0001088301,0.000065441076,0.000034224886,0.000019274637,0.0005947476,0.00002702284],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005358522,0.0013564933,0.00011786693,0.01246649,0.0015648826,0.014961403,0.0001122869,0.00000618575,0.000012651169,0.00008774099,0.0012795764,0.96749854],"study_design_scores_gemma":[0.0016610282,0.0018436832,0.00021362546,0.0016213506,0.007959289,0.06677835,0.000021229695,5.691379e-7,0.0000073071865,0.00002230255,0.91973716,0.00013413516],"about_ca_topic_score_codex":0.0000039243128,"about_ca_topic_score_gemma":4.843e-7,"teacher_disagreement_score":0.96736443,"about_ca_system_score_codex":0.00014990778,"about_ca_system_score_gemma":0.000424553,"threshold_uncertainty_score":0.99994946},"labels":[],"label_agreement":null},{"id":"W1994688487","doi":"10.1016/j.mpdhp.2013.08.004","title":"Pathological staging of bladder cancer","year":2013,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bladder cancer; Pathological; Medicine; Surgical pathology; Pathological staging; Cancer; Radiology; Bladder Neoplasm; Carcinoma; Pathology; Internal medicine","score_opus":0.017208626884528355,"score_gpt":0.28582942087382146,"score_spread":0.2686207939892931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994688487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822253,0.0022559199,0.00031027192,0.0013868003,0.00041178628,0.0005459076,0.00003130103,0.00006651088,0.012766205],"genre_scores_gemma":[0.9957548,0.0003193982,0.0007468504,0.0014896378,0.000114624614,0.00035520416,0.000015950534,0.000021450618,0.001182097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896663,0.000058065794,0.00027322266,0.00027811897,0.00014202402,0.00028195058],"domain_scores_gemma":[0.9991159,0.0002783435,0.000082483115,0.0002695282,0.00013043378,0.0001233299],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000068099085,0.00014928837,0.00039300375,0.00008748429,0.000040924897,0.0000039525576,0.0000771698,0.00011525812,0.0062600216],"category_scores_gemma":[0.00042005006,0.0001167079,0.00009071602,0.00010967301,0.00022340499,0.0000454292,0.000037994523,0.00014476392,0.0003401603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006180853,0.0006452651,0.9279504,0.000091170616,0.000050820945,0.0008544825,0.0010355349,0.0000073270644,0.02089023,0.0005129918,0.014337599,0.0335624],"study_design_scores_gemma":[0.0014452793,0.0005877348,0.99003947,0.00006378855,0.00020988836,0.00019687458,0.00011267907,0.000016514517,0.002625103,0.0006246986,0.0039325496,0.00014541725],"about_ca_topic_score_codex":0.0004189152,"about_ca_topic_score_gemma":0.000008223761,"teacher_disagreement_score":0.0620891,"about_ca_system_score_codex":0.000065688386,"about_ca_system_score_gemma":0.00010469661,"threshold_uncertainty_score":0.9946484},"labels":[],"label_agreement":null},{"id":"W1994756642","doi":"10.1007/s10552-005-0389-0","title":"A Pooled Analysis of Bladder Cancer Case–Control Studies Evaluating Smoking in Men and Women","year":2006,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Innovative Research Group Project of the National Natural Science Foundation of China","keywords":"Medicine; Odds ratio; Bladder cancer; Confidence interval; Epidemiology; Demography; Case-control study; Cancer; Gynecology; Internal medicine","score_opus":0.03469231034762905,"score_gpt":0.366559306318266,"score_spread":0.33186699597063696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994756642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93929875,0.058317058,0.00006879642,0.0005152315,0.00010977317,0.0008719966,0.00031838298,0.00003467371,0.00046533745],"genre_scores_gemma":[0.9963648,0.0008485167,0.0000243451,0.00086134486,0.00024258916,0.0012841424,0.0000053416493,0.00003391921,0.00033500037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796623,0.00013146241,0.0005895719,0.00046313624,0.0003527636,0.0004968078],"domain_scores_gemma":[0.99880373,0.0002704242,0.00024657534,0.00027235644,0.00029311757,0.00011378311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003848419,0.0002951011,0.0012936252,0.0004314329,0.00008738677,0.000020512774,0.000059998085,0.00009122681,0.00043986907],"category_scores_gemma":[0.00008118508,0.00024137848,0.00015995225,0.00071911246,0.00012959745,0.00010306985,0.000023852637,0.00015469389,7.888752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017022161,0.00022777329,0.917646,0.00022500304,0.04124707,0.00069239986,0.0045316797,0.0050008832,0.0074845557,0.000047414724,0.0002782344,0.020916766],"study_design_scores_gemma":[0.04432909,0.00073477207,0.87311655,0.00046094353,0.060435105,0.00007879764,0.004563622,0.014068015,0.001122753,0.00029759022,0.00021066035,0.0005821287],"about_ca_topic_score_codex":0.011172867,"about_ca_topic_score_gemma":0.0067324396,"teacher_disagreement_score":0.05746854,"about_ca_system_score_codex":0.0007768964,"about_ca_system_score_gemma":0.00029583272,"threshold_uncertainty_score":0.9954118},"labels":[],"label_agreement":null},{"id":"W1994831943","doi":"10.5489/cuaj.1668","title":"Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Diagnostic odds ratio; Cytology; Urine cytology; Urine; Receiver operating characteristic; Meta-analysis; Confidence interval; Odds ratio; Urology; Internal medicine; Cochrane Library; Cancer; Oncology; Gastroenterology; Pathology","score_opus":0.046730401881884744,"score_gpt":0.29819730981340115,"score_spread":0.2514669079315164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994831943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67271554,0.0019736672,0.00016049147,0.32118618,0.00020250281,0.00088432746,0.00052604685,0.000017255035,0.0023339808],"genre_scores_gemma":[0.97854894,0.00017356734,0.00006692897,0.020551505,0.000266521,0.00014455951,0.000025077003,0.000011223176,0.00021165048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975454,0.00062731595,0.00054811983,0.00024996116,0.0005037334,0.000525456],"domain_scores_gemma":[0.9978397,0.0008716197,0.00033233265,0.0002567533,0.0002978952,0.00040168822],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013156194,0.00019655151,0.0008959638,0.0003126319,0.00022282085,0.000058289108,0.00034559553,0.0001406953,0.0028006355],"category_scores_gemma":[0.00096661336,0.00009995708,0.0005727201,0.00096444803,0.000052447744,0.000045363802,0.000021632482,0.0004966635,0.000033097826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041134746,0.0001505748,0.9599225,0.000001992121,0.016179265,0.000037109246,0.00057165895,0.0007358687,0.000014567236,0.000047663747,0.021935107,0.00036254112],"study_design_scores_gemma":[0.0008274699,0.00037021472,0.92164695,0.0000019589563,0.023519862,0.000035290857,0.00015985701,0.0001867481,0.000037558155,0.00020178918,0.052904855,0.00010747189],"about_ca_topic_score_codex":0.018704355,"about_ca_topic_score_gemma":0.07979449,"teacher_disagreement_score":0.30583343,"about_ca_system_score_codex":0.00041892764,"about_ca_system_score_gemma":0.00039831953,"threshold_uncertainty_score":0.99811095},"labels":[],"label_agreement":null},{"id":"W1994867502","doi":"10.5489/cuaj.09118","title":"Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Tongji University","keywords":"Suppression subtractive hybridization; Bladder cancer; Telomerase reverse transcriptase; Biology; Complementary DNA; Microarray; Molecular biology; Carcinoma; Cancer research; Cancer; Gene; Oncology; Medicine; cDNA library; Gene expression; Telomerase; Genetics","score_opus":0.014008918041208535,"score_gpt":0.2002422668154226,"score_spread":0.18623334877421405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994867502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220395,0.00027992352,0.004836428,0.00097341574,0.00009577674,0.00044307616,0.000782115,0.0000068350855,0.00037849564],"genre_scores_gemma":[0.99705446,0.00007183691,0.0021715101,0.00027983822,0.00018395507,0.000015463278,0.00010436413,0.000015654043,0.00010292128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990066,0.00007470562,0.00028440956,0.00022723863,0.00018747931,0.00021953663],"domain_scores_gemma":[0.9989669,0.00010724756,0.00029332365,0.00006349156,0.00026086392,0.000308188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001926599,0.00013057979,0.0002174452,0.000116844756,0.00016241294,0.000035545494,0.000041552554,0.00012132788,0.00026584428],"category_scores_gemma":[0.00002944926,0.00010765177,0.000057836303,0.000070878836,0.00006486382,0.00013056592,0.000003880066,0.00017969869,0.0000012308628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004762003,0.0002982522,0.89643145,0.00003893771,0.000636598,0.00009762201,0.0030076865,0.000028585095,0.08856017,0.00009529642,0.0021412296,0.00390218],"study_design_scores_gemma":[0.0038184496,0.0006170833,0.95763993,0.000014069755,0.000305285,0.00006500222,0.00029917486,0.00009831375,0.035998654,0.0002714121,0.000745001,0.00012762018],"about_ca_topic_score_codex":0.0010396698,"about_ca_topic_score_gemma":0.00018004206,"teacher_disagreement_score":0.061208498,"about_ca_system_score_codex":0.00012969792,"about_ca_system_score_gemma":0.00019649972,"threshold_uncertainty_score":0.4389912},"labels":[],"label_agreement":null},{"id":"W199598731","doi":"","title":"Is simpler better? Quality of life based on type of urinary diversion.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urinary diversion; Medicine; Cystectomy; Urinary system; Quality of life (healthcare); Bladder cancer; Surgery; Urology; Cancer; Internal medicine","score_opus":0.08506545016219405,"score_gpt":0.3082863567023503,"score_spread":0.22322090654015622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W199598731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903891,0.00008329786,0.0000064832957,0.0023257358,0.000096247124,0.000592828,0.000035089826,0.000014660466,0.006456572],"genre_scores_gemma":[0.9956436,0.000007896065,0.00007399061,0.0035910984,0.000047707224,0.000116606105,0.000010717472,0.000008699468,0.0004996937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928415,0.000032758016,0.00018697431,0.00012314643,0.00023001191,0.00014293219],"domain_scores_gemma":[0.99939454,0.000057110643,0.00007823757,0.00024749376,0.000097699914,0.00012495088],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000086034765,0.0000752732,0.0002259934,0.000051932548,0.00001615881,0.0000021175467,0.00005311572,0.00004368106,0.00093816215],"category_scores_gemma":[0.000070632545,0.000056854347,0.0000756733,0.00009937777,0.000043612614,0.0000340015,0.000021301745,0.000049122933,0.000038994687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001186065,0.0010208333,0.9222653,0.00027166167,0.00018100224,0.000003898842,0.00016147028,0.0000029130877,0.00042495472,0.000015071985,0.03191877,0.042548086],"study_design_scores_gemma":[0.001887726,0.00026391068,0.99228823,0.000011294606,0.000048972735,3.14725e-7,0.000023601693,0.000018668889,0.004337062,0.00004754822,0.0010236677,0.0000490096],"about_ca_topic_score_codex":0.0004577816,"about_ca_topic_score_gemma":7.1776606e-7,"teacher_disagreement_score":0.07002295,"about_ca_system_score_codex":0.00002880018,"about_ca_system_score_gemma":0.000044146902,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W1996199735","doi":"10.1016/j.eururo.2011.10.011","title":"Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université de Montréal; McGill University Health Centre; Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Risk assessment; General surgery; Urology; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.06342455850407365,"score_gpt":0.3796507864853996,"score_spread":0.316226227981326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996199735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79003966,0.0014144912,0.09621772,0.005570103,0.003979784,0.011761495,0.0013632535,0.00050615345,0.08914732],"genre_scores_gemma":[0.9651648,0.0001587691,0.029295627,0.0023818344,0.0010628067,0.00044486808,0.00005168631,0.00009604634,0.0013435952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819446,0.0003557295,0.0004206748,0.0005246983,0.000105950436,0.00039847786],"domain_scores_gemma":[0.99901575,0.00017921106,0.00015915194,0.00028354404,0.00019986992,0.00016244603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059235905,0.00021220156,0.00039337305,0.000058690457,0.00015510633,0.00001430411,0.00013206166,0.00006589154,0.0002822909],"category_scores_gemma":[0.00014527637,0.00016152218,0.00019878158,0.00005133808,0.0001748496,0.000063022424,0.00006117002,0.00024629635,0.00003248264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056794095,0.0011776184,0.9112597,0.00009978518,0.0015911983,0.00009699948,0.0023533076,0.0000078709045,0.00020930248,0.0024095653,0.012194344,0.06292087],"study_design_scores_gemma":[0.016196748,0.015809586,0.9131316,0.00003666596,0.0019399677,0.00003437585,0.00015073463,0.0010324419,0.00066945085,0.0013859321,0.049218077,0.00039439928],"about_ca_topic_score_codex":0.00009733124,"about_ca_topic_score_gemma":0.00006241769,"teacher_disagreement_score":0.17512509,"about_ca_system_score_codex":0.00004619864,"about_ca_system_score_gemma":0.00048190268,"threshold_uncertainty_score":0.65866834},"labels":[],"label_agreement":null},{"id":"W1996405529","doi":"10.1016/j.jpedsurg.2011.11.053","title":"Button cystostomy for bladder drainage: which children can benefit from this device?","year":2012,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute of Steel Construction","keywords":"Cystostomy; Medicine; Suprapubic cystostomy; Surgery; Urethra","score_opus":0.02442779791767525,"score_gpt":0.2761377990900158,"score_spread":0.25171000117234055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996405529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438334,0.010874775,0.00008434539,0.0012427496,0.0019109136,0.00033365338,0.00015949836,0.000024888248,0.0009858438],"genre_scores_gemma":[0.97631997,0.00078303256,0.00079319143,0.00068723777,0.02083214,0.00001637867,0.00006229983,0.000054524957,0.00045124223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813294,0.000043384192,0.0006664801,0.00017033769,0.0004944217,0.00049241085],"domain_scores_gemma":[0.9976712,0.0006807258,0.0005328938,0.00022946706,0.00043186673,0.0004538803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061557925,0.00023824036,0.0006654489,0.00036935435,0.00009840856,0.000025966745,0.00010832782,0.00015836053,0.00058412633],"category_scores_gemma":[0.00032719903,0.00018423908,0.0004439658,0.0003988157,0.000016820626,0.0002499878,0.00002508455,0.0002816253,0.00003017213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004182819,0.0003978822,0.9103517,0.000039078626,0.000618234,0.000026157957,0.00040786117,0.0000015460889,0.000077163,0.000009822395,0.08019991,0.0074523496],"study_design_scores_gemma":[0.0038271945,0.00035203635,0.9747472,0.000063398955,0.004041133,0.00030307,0.000108993896,0.0000035903279,0.0011480511,0.0002720498,0.014755997,0.00037727522],"about_ca_topic_score_codex":0.00032840765,"about_ca_topic_score_gemma":0.000024080293,"teacher_disagreement_score":0.06544392,"about_ca_system_score_codex":0.00017144761,"about_ca_system_score_gemma":0.0005441236,"threshold_uncertainty_score":0.75130516},"labels":[],"label_agreement":null},{"id":"W1997006799","doi":"10.1586/era.10.194","title":"Management of upper urinary tract urothelial carcinoma","year":2010,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Upper urinary tract; Transitional cell carcinoma; Urology; Dissection (medical); Lymph node; Cuff; Urinary system; Urothelial carcinoma; Gold standard (test); Modalities; Oncology; Internal medicine; Surgery; Bladder cancer; Cancer","score_opus":0.04613362445903069,"score_gpt":0.39523410760499883,"score_spread":0.34910048314596814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997006799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027536806,0.9895417,0.00000875743,0.00019635816,0.00061075727,0.0035089953,0.00010351018,0.000029116889,0.0059732366],"genre_scores_gemma":[0.00005686795,0.99601805,0.0012181833,0.0007524841,0.00054410665,0.00052218075,0.000082588864,0.00013519742,0.00067036203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694544,0.0001368121,0.0013223776,0.0005861638,0.0006485773,0.0003606098],"domain_scores_gemma":[0.9977168,0.00006164016,0.00067791133,0.0012410929,0.0001440127,0.00015857084],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026627124,0.0006871422,0.0040820283,0.00015713014,0.000038228744,0.0000063335065,0.00041530604,0.00027248714,0.002096483],"category_scores_gemma":[0.00000795953,0.00044422748,0.0017289429,0.00037127608,0.00020655926,0.00005655293,0.0000580544,0.0004318261,0.000042377666],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008841611,0.001075046,0.000053007087,0.13126433,0.00077180425,0.000095858144,0.000050761548,1.0828699e-9,0.000010083776,0.00007414388,0.0006554076,0.8658611],"study_design_scores_gemma":[0.0011254468,0.00085059874,0.0001807637,0.16891755,0.0013039082,0.00020824367,0.0000071890236,7.441437e-8,0.00011803941,0.0000068702593,0.8269994,0.00028187505],"about_ca_topic_score_codex":0.000055791865,"about_ca_topic_score_gemma":1.1792484e-7,"teacher_disagreement_score":0.86557925,"about_ca_system_score_codex":0.000099864235,"about_ca_system_score_gemma":0.0005318201,"threshold_uncertainty_score":0.9998009},"labels":[],"label_agreement":null},{"id":"W1997023740","doi":"10.1159/000273466","title":"Outcome of Surgical Treatment of Patients with Upper versus Lower Urinary Tract Urothelial Carcinoma: Stage-by-Stage Comparison","year":2010,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Urology; Stage (stratigraphy); Urothelial carcinoma; Upper urinary tract; Carcinoma; Internal medicine; Urinary system; Surgery; Bladder cancer; Cancer","score_opus":0.02769458725167572,"score_gpt":0.315638764575077,"score_spread":0.2879441773234013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997023740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374884,0.00008103377,0.000018843482,0.00022760278,0.0006819156,0.0004566399,0.0012620243,0.000025090472,0.0034979894],"genre_scores_gemma":[0.99690294,0.000009292035,0.00021177757,0.000044826655,0.00009749123,0.000038824383,0.0003402722,0.000025455722,0.0023291153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998588,0.000032503558,0.00043573932,0.00028094498,0.00047500676,0.00018779855],"domain_scores_gemma":[0.9990415,0.00013439715,0.00021644744,0.00029211427,0.00021416637,0.00010136411],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000054313026,0.00022151673,0.0004546302,0.0001022972,0.000027327784,0.0000071250547,0.00012571072,0.000120779136,0.002272302],"category_scores_gemma":[0.000024385603,0.00014978161,0.00016819983,0.00007587219,0.00016358915,0.00007087691,0.000024567787,0.00015581114,0.000017423414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008999296,0.0065212026,0.9829664,0.000021125119,0.00028133538,0.00008782933,0.00013896155,0.000008629434,0.00020054291,0.00021951165,0.00019915705,0.00035600347],"study_design_scores_gemma":[0.024011299,0.01580893,0.90452003,0.000008697693,0.00025939234,0.000012835385,0.0000302019,0.00006369905,0.004722027,0.000004600095,0.05038588,0.00017239613],"about_ca_topic_score_codex":0.0007090703,"about_ca_topic_score_gemma":0.000025516763,"teacher_disagreement_score":0.078446366,"about_ca_system_score_codex":0.00009267514,"about_ca_system_score_gemma":0.00007507838,"threshold_uncertainty_score":0.99863976},"labels":[],"label_agreement":null},{"id":"W1997135816","doi":"10.1111/his.12214","title":"An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps","year":2013,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Kappa; Medicine; Bladder cancer; Cohen's kappa; Reproducibility; Telepathology; Medical physics; Virtual microscopy; Standardization; Genitourinary system; Radiology; Pathology; Cancer; Internal medicine; Statistics; Computer science","score_opus":0.054670319794025785,"score_gpt":0.35744750034028594,"score_spread":0.3027771805462601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997135816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813753,0.00040680956,0.000047799196,0.000116314186,0.00034463784,0.0007892117,0.000016601061,0.000023455206,0.00011763976],"genre_scores_gemma":[0.99884725,0.000015790058,0.00027954817,0.0004459253,0.000079533456,0.00008227112,0.0000055906794,0.000022519149,0.00022158955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985266,0.00016324985,0.00026164885,0.00076744263,0.000107428146,0.00017368502],"domain_scores_gemma":[0.99873435,0.00002158187,0.00008062266,0.0009437959,0.00012536344,0.00009426497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023249941,0.00015731475,0.0004077268,0.00007566955,0.00005491078,0.000006236453,0.00006816112,0.000077182754,0.00033082985],"category_scores_gemma":[0.000043195494,0.00012924148,0.00004030846,0.000077482204,0.00019672155,0.00008380151,0.00004102255,0.00011810573,0.00001278876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027460384,0.0012641299,0.6942991,0.000026921407,0.00002438268,0.000044902874,0.002230412,0.0000050043677,0.29912055,0.000006128819,0.00008943287,0.0026144013],"study_design_scores_gemma":[0.0019957393,0.004007765,0.969494,0.00004281822,0.00016358496,0.00006487294,0.000560003,0.000024646537,0.023444274,0.00003594728,0.00006122399,0.00010511486],"about_ca_topic_score_codex":0.002649142,"about_ca_topic_score_gemma":0.00014415076,"teacher_disagreement_score":0.27567628,"about_ca_system_score_codex":0.00013866882,"about_ca_system_score_gemma":0.000108413326,"threshold_uncertainty_score":0.5270315},"labels":[],"label_agreement":null},{"id":"W1997581961","doi":"10.1016/j.urology.2009.07.1148","title":"POD-07.09: Incidental Adenocarcinoma of the Prostate Discovered at the Time of Radical Cystectomy: Analysis of the Canadian Bladder Cancer Network Database","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Beekeepers' Association; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University; Western University","funders":"","keywords":"Medicine; Cystectomy; Cystoprostatectomy; Urology; Bladder cancer; Prostate cancer; Prostate; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.009562105086452721,"score_gpt":0.256378036866178,"score_spread":0.24681593177972527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997581961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712194,0.0023200142,0.0000029201408,0.007600048,0.00016369288,0.0006515247,0.00096882024,0.0000050188787,0.0011660246],"genre_scores_gemma":[0.9963487,0.000035468776,0.0000066038488,0.0025051807,0.00009200342,0.00001871142,0.00007295517,0.000012748646,0.00090765377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985604,0.00020969096,0.00035455517,0.00023623413,0.00030938073,0.00032973217],"domain_scores_gemma":[0.9987389,0.00007805403,0.00023787579,0.0007681213,0.00006802087,0.00010903395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016892453,0.0001553268,0.00047910976,0.00008586606,0.0001461222,0.0000037582133,0.0003191574,0.0001016838,0.00089707697],"category_scores_gemma":[0.000044338474,0.00007416329,0.00027073515,0.0006995923,0.000532135,0.000028875455,0.00010954314,0.00020052359,0.000006837365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013332742,0.00018702648,0.9796775,0.000025751959,0.0034514123,0.00003126298,0.0016960014,0.0019782775,0.003642039,0.0001559312,0.006670803,0.0011507078],"study_design_scores_gemma":[0.0016529355,0.00037057456,0.9883863,0.000024866702,0.004273212,0.00003618903,0.000036910063,0.0006204009,0.003018809,0.00007821634,0.001421508,0.00008013101],"about_ca_topic_score_codex":0.09438426,"about_ca_topic_score_gemma":0.2648634,"teacher_disagreement_score":0.17047915,"about_ca_system_score_codex":0.00017889784,"about_ca_system_score_gemma":0.0007268143,"threshold_uncertainty_score":0.9822364},"labels":[],"label_agreement":null},{"id":"W1998283156","doi":"10.1016/j.urolonc.2010.07.010","title":"Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Hazard ratio; Lymphovascular invasion; Proportional hazards model; Cancer; Oncology; Stage (stratigraphy); Medicine; Cohort; Internal medicine; Confidence interval; Metastasis; Biology","score_opus":0.016191666841893222,"score_gpt":0.304917685033329,"score_spread":0.2887260181914358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998283156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98560125,0.001121244,0.00002026386,0.007012523,0.00033859644,0.00060392683,0.00027702036,0.000067779685,0.004957379],"genre_scores_gemma":[0.9562309,0.00015423018,0.03571816,0.006424365,0.00026674292,0.00013686749,0.00008177332,0.000020410309,0.0009665512],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984431,0.000120033204,0.0003231215,0.0005454429,0.00017007808,0.00039822416],"domain_scores_gemma":[0.99870884,0.00020831465,0.0003389088,0.00032704102,0.00010794115,0.00030896204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017295238,0.00032111866,0.0006278785,0.00014842185,0.0002250873,0.000017860051,0.00016248133,0.0004937518,0.00046222995],"category_scores_gemma":[0.000215264,0.00021402545,0.00014372302,0.0002384918,0.0013145796,0.000058371148,0.00006365453,0.00092237495,0.000016216249],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003831241,0.0006354433,0.93668234,0.00007033019,0.00008136728,0.0012846646,0.001005342,0.0000055404657,0.052088127,0.0010223262,0.0034047368,0.0033366338],"study_design_scores_gemma":[0.005217814,0.0148470905,0.20435452,0.00015079851,0.0010185012,0.009289053,0.00042066688,0.0000961775,0.03011274,0.012822351,0.7210466,0.00062364136],"about_ca_topic_score_codex":0.00006302284,"about_ca_topic_score_gemma":0.000022343353,"teacher_disagreement_score":0.7323278,"about_ca_system_score_codex":0.000040555973,"about_ca_system_score_gemma":0.0005351975,"threshold_uncertainty_score":0.8727705},"labels":[],"label_agreement":null},{"id":"W1998311214","doi":"10.1016/j.urolonc.2004.11.008","title":"A Phase II study of oxaliplatin in urothelial cancer","year":2005,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Oxaliplatin; Medicine; Cisplatin; Nausea; Internal medicine; Chemotherapy; Phases of clinical research; Oncology; Toxicity; Clinical endpoint; Urology; Cancer; Surgery; Clinical trial; Colorectal cancer","score_opus":0.04288365957811869,"score_gpt":0.3768328459018545,"score_spread":0.3339491863237358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998311214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915558,0.0008109859,0.0000054633,0.0045976276,0.000085910615,0.00066590024,0.00003087954,0.000026017986,0.002221379],"genre_scores_gemma":[0.9914272,0.00023853457,0.005890269,0.0013216938,0.00016065306,0.00022439261,0.000010942856,0.000010556478,0.0007157967],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896896,0.000080774254,0.0003409297,0.0002735628,0.00012773141,0.00020805928],"domain_scores_gemma":[0.99948335,0.00007457463,0.00011210586,0.00014575839,0.00004065424,0.00014353442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016053864,0.00014889403,0.00037799595,0.00016142323,0.000118367505,0.0000042329993,0.000060489107,0.00012703819,0.0002493148],"category_scores_gemma":[0.000046715668,0.00012048569,0.00003334035,0.00024938877,0.00025258528,0.000071163944,0.000037297294,0.00022429373,0.00000527966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00117453,0.014636069,0.9203199,0.000032815948,0.00016779102,0.00015440099,0.0088084815,0.00020727454,0.0033414937,0.00112882,0.0020816543,0.04794676],"study_design_scores_gemma":[0.038574718,0.074238256,0.01869448,0.00011745571,0.00088965497,0.00021876166,0.002038073,0.0014712467,0.0028171926,0.0017344414,0.85885537,0.00035038483],"about_ca_topic_score_codex":0.0006401998,"about_ca_topic_score_gemma":0.0010154833,"teacher_disagreement_score":0.90162545,"about_ca_system_score_codex":0.00011441056,"about_ca_system_score_gemma":0.00034242938,"threshold_uncertainty_score":0.4913264},"labels":[],"label_agreement":null},{"id":"W1998316942","doi":"10.1590/s1677-55382010000500025","title":"Prevention and management of complications following radical cystectomy for bladder cancer","year":2010,"lang":"en","type":"article","venue":"International braz j urol","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; General surgery; Urology; Surgery; Cancer; Internal medicine","score_opus":0.020240335826462962,"score_gpt":0.35500512314535165,"score_spread":0.3347647873188887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998316942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96677005,0.00035354996,0.008141274,0.006389137,0.0011220854,0.0014413041,0.00012585091,0.000048137703,0.015608635],"genre_scores_gemma":[0.99301857,0.000046895886,0.0046501886,0.00024508123,0.0001144492,0.00033005487,0.000044202778,0.000011116416,0.0015394232],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994717,0.0000043847667,0.00014406217,0.00014597457,0.00016098331,0.000072859046],"domain_scores_gemma":[0.99972004,0.000026328007,0.000046411493,0.00009950171,0.000061801176,0.00004591768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047836427,0.00006355813,0.0000974299,0.000051511346,0.000032607208,0.000008903267,0.000062289495,0.000033822795,0.00014973215],"category_scores_gemma":[0.000008841061,0.000056843634,0.00008223057,0.000037147805,0.000033079978,0.000048553153,0.000021397016,0.00005733495,0.0000037631391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018261985,0.0035808785,0.27255768,0.000950455,0.012988266,0.000065157554,0.0008067533,0.000029852867,0.19360836,0.07795306,0.011701774,0.42393157],"study_design_scores_gemma":[0.018162793,0.00051480235,0.7657823,0.0004342453,0.0013521442,0.00007977074,0.000086080494,0.001978009,0.019066721,0.00556247,0.18667315,0.00030751276],"about_ca_topic_score_codex":0.000036114387,"about_ca_topic_score_gemma":0.000022162645,"teacher_disagreement_score":0.49322462,"about_ca_system_score_codex":0.00002092613,"about_ca_system_score_gemma":0.000029589177,"threshold_uncertainty_score":0.23180161},"labels":[],"label_agreement":null},{"id":"W1998641052","doi":"10.1007/s00345-012-0910-5","title":"Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; McGill University Health Centre; Université de Montréal","funders":"New York Community Trust","keywords":"Medicine; Cystectomy; Urology; Lymphadenectomy; Internal medicine; Nephrology; Metastasis; Interquartile range; Bladder cancer; Lymph node; NODAL; Oncology; Cancer","score_opus":0.013792912249153142,"score_gpt":0.27390663196732273,"score_spread":0.2601137197181696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998641052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915517,0.00081541395,0.000018964814,0.005226184,0.0013128223,0.0002506994,0.000013454353,0.000008850857,0.00080190273],"genre_scores_gemma":[0.99615556,0.00003616535,0.0003058419,0.0024344272,0.00047434124,0.000007128071,0.000002005386,0.000024041365,0.0005605172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982758,0.00024360638,0.0005510302,0.0001357733,0.0003565313,0.0004372134],"domain_scores_gemma":[0.9988294,0.00034992569,0.0003058858,0.00021133275,0.000084056286,0.00021935141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064001896,0.00019282279,0.00060586864,0.00025012548,0.00008275256,0.000010307314,0.0001516562,0.00008222979,0.0003270978],"category_scores_gemma":[0.00023244868,0.00008538717,0.00020485454,0.00015569043,0.00014720784,0.00013627023,0.00007919482,0.00051196665,0.000019429439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029304055,0.00047786173,0.98974293,0.000010770037,0.00034896555,0.000042018113,0.00030778506,0.0000011975152,0.00055616786,0.000023358532,0.00018086853,0.0053776396],"study_design_scores_gemma":[0.006609753,0.00086359266,0.9788512,0.000026187587,0.000586228,0.00028900863,0.000048604652,0.000004399849,0.000705678,0.00004824772,0.011857841,0.00010924257],"about_ca_topic_score_codex":0.00016191174,"about_ca_topic_score_gemma":0.0002526596,"teacher_disagreement_score":0.011676973,"about_ca_system_score_codex":0.00017953829,"about_ca_system_score_gemma":0.000083104016,"threshold_uncertainty_score":0.35814917},"labels":[],"label_agreement":null},{"id":"W1998810794","doi":"10.4137/cmo.s7658","title":"Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Bladder cancer; Urology; Combination therapy; Internal medicine; Cancer; Oncology","score_opus":0.1626714718544074,"score_gpt":0.4567886025966603,"score_spread":0.29411713074225293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998810794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253094,0.00050160923,0.0005061002,0.0015840641,0.0007077173,0.0017244967,0.000011555547,0.000038429436,0.0023950576],"genre_scores_gemma":[0.9928727,0.0011777814,0.001426221,0.0033443507,0.00045025555,0.0002824294,0.000022114054,0.000044196273,0.00037995516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973558,0.00017945032,0.0013258525,0.0006150778,0.00019224657,0.00033155095],"domain_scores_gemma":[0.9978305,0.00084284303,0.0003014322,0.00037836912,0.0002824223,0.00036439957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038401104,0.00030161111,0.0013561024,0.00025687844,0.000044087967,0.000004385828,0.00019895058,0.0002773619,0.00066486764],"category_scores_gemma":[0.000566018,0.00018752925,0.00011521672,0.00019678666,0.00087615324,0.00012951964,0.00005390843,0.00042732165,0.000004511135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13136002,0.03442682,0.2355123,0.00074646366,0.0020468694,0.0015307408,0.030409874,0.000014495201,0.008134935,0.017590525,0.0027014108,0.53552556],"study_design_scores_gemma":[0.14544645,0.198083,0.6101454,0.0012833559,0.0012263606,0.0003037019,0.0013728056,0.010798427,0.007591217,0.016239922,0.0066232653,0.0008860771],"about_ca_topic_score_codex":0.00045614684,"about_ca_topic_score_gemma":0.00093735504,"teacher_disagreement_score":0.5346395,"about_ca_system_score_codex":0.00012100195,"about_ca_system_score_gemma":0.0007864176,"threshold_uncertainty_score":0.76472205},"labels":[],"label_agreement":null},{"id":"W1999136570","doi":"10.3747/co.v17i2.570","title":"Lymphovascular Invasion as a Predictive Factor for Muscle-Invasive Bladder Cancer and Its Importance in a Bladder-Conservation Treatment Group","year":2010,"lang":"en","type":"letter","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lymphovascular invasion; Medicine; Bladder cancer; Cancer; Oncology; Urology; Internal medicine; Metastasis","score_opus":0.09105662174979925,"score_gpt":0.3753435317260304,"score_spread":0.2842869099762312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999136570","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7294743,0.030453144,0.0000601352,0.22031736,0.004803625,0.01160648,0.0026779096,0.00016315546,0.0004438578],"genre_scores_gemma":[0.25345674,0.096161954,0.0008813904,0.55907345,0.027003616,0.04528949,0.013277731,0.0010095634,0.003846062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968538,0.00013713754,0.0006719986,0.0012326108,0.00038424606,0.0007202045],"domain_scores_gemma":[0.9981343,0.00043534394,0.00043999523,0.0004684121,0.00031088467,0.00021102354],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0001241667,0.0007536334,0.0013288481,0.00037033856,0.000120112556,0.000026993017,0.00015555421,0.0019700585,0.00034864224],"category_scores_gemma":[0.00019242088,0.00062000874,0.00035292053,0.00020930608,0.00014887008,0.00014705614,0.00006964987,0.0014263578,0.000020040432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005464952,0.005653098,0.09019915,0.004298868,0.006617738,0.0026340513,0.009227444,0.0000032261846,0.0045543634,0.00007953728,0.37988263,0.49138495],"study_design_scores_gemma":[0.01818295,0.0064593744,0.030630823,0.0006688905,0.0020400712,0.00014191588,0.00010817113,0.00014522867,0.0009237629,0.0003320013,0.93973625,0.0006305915],"about_ca_topic_score_codex":0.00072582817,"about_ca_topic_score_gemma":0.003846472,"teacher_disagreement_score":0.5598536,"about_ca_system_score_codex":0.0021013368,"about_ca_system_score_gemma":0.0022957297,"threshold_uncertainty_score":0.99962515},"labels":[],"label_agreement":null},{"id":"W1999162450","doi":"10.5489/cuaj.787","title":"Age-stratified distribution of metastatic sites in bladder cancer: A population-based analysis","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Concomitant; Lymph node; Lung; Malignancy; Urinary system; Radiology; Internal medicine; Urology; Oncology","score_opus":0.01834250217125433,"score_gpt":0.27261449213001976,"score_spread":0.25427198995876543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999162450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274343,0.00011607647,0.00086721306,0.005554567,0.00007021159,0.00015750219,0.00017774249,0.000009958093,0.00030331974],"genre_scores_gemma":[0.99798673,0.000014327689,0.00018106516,0.0011185224,0.00008745915,0.000013943949,0.0005100176,0.0000057557836,0.000082200095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986905,0.0002014083,0.00039532565,0.00014596833,0.00029048143,0.00027631686],"domain_scores_gemma":[0.9990205,0.00014909648,0.0002604583,0.0000871863,0.00017031078,0.00031244493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044865155,0.000107169086,0.000393719,0.00027430916,0.00008374288,0.000026169526,0.000052773685,0.000108245826,0.000555378],"category_scores_gemma":[0.0004934269,0.00008684116,0.00018572656,0.0006698267,0.000016565711,0.000048800335,0.000002678877,0.00023365811,0.0000036241836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044778983,0.000060987222,0.99557227,0.0000050272465,0.00043907357,0.000017927867,0.00003304685,0.002237229,0.00004175147,0.00011833285,0.0002932017,0.0011363579],"study_design_scores_gemma":[0.0012188696,0.00017593871,0.99265474,0.000008845519,0.00089067756,0.0000035231676,0.000014137308,0.0035284678,0.00003631279,0.00044787748,0.00094564667,0.00007493978],"about_ca_topic_score_codex":0.016753128,"about_ca_topic_score_gemma":0.033569004,"teacher_disagreement_score":0.016815878,"about_ca_system_score_codex":0.0009876947,"about_ca_system_score_gemma":0.00038368898,"threshold_uncertainty_score":0.9897944},"labels":[],"label_agreement":null},{"id":"W2000011746","doi":"10.1016/j.urology.2013.06.040","title":"Long-term Clinical Outcome of Inverted Urothelial Papilloma Including Cases With Focal Papillary Pattern: Is Continuous Surveillance Necessary?","year":2013,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Cystoscopy; Inverted papilloma; Papillary tumor; Urothelial carcinoma; Papilloma; Carcinoma; Urinary bladder; Urinary system; Surgery; Radiology; Internal medicine; Pathology; Cancer; Bladder cancer","score_opus":0.05267420589895214,"score_gpt":0.34122628150281886,"score_spread":0.28855207560386675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000011746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486405,0.0005593168,0.0005115713,0.0020460295,0.00036936076,0.0007481735,0.00006577332,0.00007889115,0.0007568202],"genre_scores_gemma":[0.9909974,0.00016062513,0.00006361135,0.007988912,0.00033222625,0.00005717215,0.000046797344,0.00005207252,0.00030120244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978357,0.00020082183,0.0007448474,0.00049819564,0.00027269495,0.0004477229],"domain_scores_gemma":[0.99846596,0.0003660898,0.00025147526,0.00050069776,0.0001908359,0.0002249393],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001792349,0.00029782462,0.0009658667,0.00009669119,0.00006584779,0.000012665144,0.00016974499,0.00026572676,0.0013081392],"category_scores_gemma":[0.00011735727,0.00021355684,0.00017295919,0.00014283234,0.0004098224,0.000087177374,0.00010802322,0.0003129014,0.00014310468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008092635,0.0003143798,0.9781643,0.000070120186,0.00036166172,0.0006134558,0.00011419003,7.426539e-7,0.00031860787,0.0000041488424,0.0014602914,0.017768795],"study_design_scores_gemma":[0.006212141,0.004818241,0.98663163,0.000032170974,0.00020025973,0.00069893134,0.0000254526,0.00007601646,0.000661621,0.000033733428,0.000389603,0.0002202185],"about_ca_topic_score_codex":0.0011854221,"about_ca_topic_score_gemma":0.00034687182,"teacher_disagreement_score":0.017548576,"about_ca_system_score_codex":0.00003477832,"about_ca_system_score_gemma":0.00011260856,"threshold_uncertainty_score":0.9996048},"labels":[],"label_agreement":null},{"id":"W2000254207","doi":"10.5430/jst.v2n3p59","title":"Cervical lymph node metastasis from transitional cell carcinoma of urinary bladder: Case report and review of literature","year":2012,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastasis; Lymph; Cervical lymph nodes; Bladder cancer; Lymph node; Transitional cell carcinoma; Lymph node metastasis; Urinary bladder; Carcinoma; Neck of urinary bladder; Head and neck; Cervical cancer; Pathology; Cancer; Urology; Internal medicine; Surgery","score_opus":0.017980480234490406,"score_gpt":0.28731964977765134,"score_spread":0.26933916954316095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000254207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.864608,0.13377042,0.00003805257,0.00056827423,0.00012335817,0.00012404704,0.0003179012,0.0000032176856,0.00044676353],"genre_scores_gemma":[0.99358106,0.0038783238,0.0016309262,0.00046083485,0.000362417,0.0000024460776,0.000029404444,0.00001714014,0.000037423044],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99844635,0.00006940191,0.0008225796,0.00011193334,0.00038751523,0.0001622458],"domain_scores_gemma":[0.9986559,0.000052492836,0.0005524558,0.00018178906,0.00028846238,0.00026887955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030458864,0.00015445854,0.00073408487,0.00010457168,0.000026423015,0.0000037474442,0.000050404557,0.000060641134,0.0002601834],"category_scores_gemma":[0.00003262399,0.00011065987,0.00027923452,0.00013940001,0.000065803695,0.00016265319,0.000017521068,0.00018520538,0.000001059535],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003692924,0.007816896,0.43094474,0.028077522,0.002789594,0.4948573,0.007452975,0.0000083488085,0.010583513,0.000046380785,0.008827531,0.004902269],"study_design_scores_gemma":[0.0049679982,0.0010162952,0.2979566,0.009556756,0.0036646742,0.653037,0.00040874872,0.000010692955,0.02850507,0.00007192903,0.0005888072,0.00021542943],"about_ca_topic_score_codex":0.000056332152,"about_ca_topic_score_gemma":4.0876714e-7,"teacher_disagreement_score":0.15817972,"about_ca_system_score_codex":0.000046584064,"about_ca_system_score_gemma":0.00021492588,"threshold_uncertainty_score":0.45125785},"labels":[],"label_agreement":null},{"id":"W2000458264","doi":"10.1016/j.urology.2008.08.165","title":"POD-7.12: Impact of Age on the Ability of Mycobacterial Cell Wall-DNA Complex (MCC) to Induce Urinary Biological Response Markers in Patients with Non-muscle Invasive Bladder Cancer","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Chemokine; Urinary system; Adjuvant; Innate immune system; Apoptosis; Immune system; Cancer; Urinary bladder; Immunology; Cancer research; Urology; Internal medicine; Biology","score_opus":0.035026362413928966,"score_gpt":0.2796954586141531,"score_spread":0.24466909620022415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000458264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748564,0.00001169517,8.7571544e-7,0.0005300366,0.000066533255,0.0009839331,0.00016136037,0.000009150447,0.00075079524],"genre_scores_gemma":[0.9988068,0.000014644235,0.00003162439,0.00097504206,0.00003737974,0.000065676366,0.000028945313,0.000017000422,0.000022895945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985176,0.00036260198,0.00030852118,0.0003294414,0.00018090353,0.0003009347],"domain_scores_gemma":[0.998912,0.00040972207,0.00012885564,0.0003437568,0.00009240456,0.00011330551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001772282,0.00020504238,0.00047696894,0.00011279031,0.000040426567,0.0000016647325,0.00014359235,0.00014923068,0.0006338694],"category_scores_gemma":[0.00014099196,0.00011454197,0.0001020145,0.00018349313,0.00031420533,0.000024146168,0.000063242594,0.00018906647,0.00000885672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10169826,0.0022759584,0.78175855,0.00002040632,0.00020141056,0.00011275734,0.0016188589,0.000041094157,0.11114439,0.0000017241715,0.0007995793,0.00032702982],"study_design_scores_gemma":[0.005137025,0.021858761,0.9701027,0.000018510866,0.000044440545,0.0000068468435,0.000030650626,0.000002354719,0.0025903801,0.000009376791,0.00010193063,0.000096976735],"about_ca_topic_score_codex":0.0010642981,"about_ca_topic_score_gemma":0.00007597251,"teacher_disagreement_score":0.18834421,"about_ca_system_score_codex":0.00016758406,"about_ca_system_score_gemma":0.0003476254,"threshold_uncertainty_score":0.6940425},"labels":[],"label_agreement":null},{"id":"W2000539831","doi":"10.5489/cuaj.2069","title":"Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"American College of Surgeons; Brigham and Women's Hospital","keywords":"Medicine; Cystectomy; Perioperative; Bladder cancer; Blood transfusion; Comorbidity; Odds ratio; Database; Prospective cohort study; Surgery; Multivariate analysis; Odds; Intensive care medicine; Cancer; Internal medicine; Logistic regression","score_opus":0.028790072205099465,"score_gpt":0.3312656823449059,"score_spread":0.3024756101398064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000539831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156827,0.000029939518,0.000022573187,0.0060128034,0.00006172976,0.0012572464,0.00047658937,0.000012025025,0.0005588154],"genre_scores_gemma":[0.9966998,0.000012647686,0.00014916329,0.0022635353,0.0001864568,0.00037721873,0.00021752712,0.000011667831,0.00008198193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978332,0.00031099698,0.00050365407,0.0002333583,0.00072681083,0.00039195854],"domain_scores_gemma":[0.99849105,0.00030449187,0.00021531987,0.000092899405,0.0005849194,0.00031130825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009578408,0.00018168429,0.0004338167,0.00011564419,0.0001952065,0.000049850656,0.00013518173,0.00015062623,0.0001544138],"category_scores_gemma":[0.00041143585,0.00009809336,0.00013033082,0.00019113848,0.0000770284,0.000088393004,0.00001220436,0.00035213257,0.0000012811183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043518288,0.000520804,0.99186605,0.000009296335,0.00028056724,0.000010455732,0.00021728463,0.000007271227,0.000022879538,0.00011925676,0.00038435508,0.006126582],"study_design_scores_gemma":[0.0070456252,0.0017390511,0.98064643,0.000014878574,0.00012865914,0.000011656211,0.000050831306,0.000082709375,0.000044600492,0.00003125992,0.010086405,0.000117912554],"about_ca_topic_score_codex":0.0013445003,"about_ca_topic_score_gemma":0.003093277,"teacher_disagreement_score":0.011219653,"about_ca_system_score_codex":0.0010407805,"about_ca_system_score_gemma":0.0005464436,"threshold_uncertainty_score":0.40001312},"labels":[],"label_agreement":null},{"id":"W2000774400","doi":"10.1159/000020364","title":"p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer","year":2000,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Confusion; Clinical trial; Cancer; Oncology; MEDLINE; Internal medicine; Immunohistochemistry","score_opus":0.028662969122277226,"score_gpt":0.3457627609918029,"score_spread":0.3170997918695257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000774400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011947936,0.7825521,4.0369588e-7,0.000082164785,0.00023204448,0.0008656552,0.00004432939,0.00006741319,0.21603638],"genre_scores_gemma":[0.00029806653,0.9817941,0.000019220439,0.0013539362,0.00049748673,0.0002852838,0.00021000125,0.00020772118,0.015334171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741477,0.00045464758,0.00066683127,0.0007461212,0.00018069676,0.0005369458],"domain_scores_gemma":[0.99886864,0.000106748754,0.00018645015,0.0006380208,0.00003275805,0.00016735312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001746482,0.0005744362,0.0015549639,0.00019922627,0.000042458272,0.000014771092,0.0002716482,0.00027814653,0.005137204],"category_scores_gemma":[0.000078541496,0.00046540968,0.00039041665,0.00027843876,0.00014455196,0.000024171533,0.00008975966,0.00087234535,0.0024440386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021089215,0.0002628565,0.00022834245,0.0030707077,0.00061856816,0.0032249307,0.000080198355,3.762326e-7,0.0000036792314,0.000004009667,0.0060208905,0.98627454],"study_design_scores_gemma":[0.001149615,0.00031513674,0.00057078275,0.0023781054,0.002140426,0.0010670566,0.0000023467398,4.4179137e-7,5.223141e-7,0.000010273513,0.9920381,0.00032724324],"about_ca_topic_score_codex":0.00010349538,"about_ca_topic_score_gemma":0.000005251223,"teacher_disagreement_score":0.98601717,"about_ca_system_score_codex":0.0002227075,"about_ca_system_score_gemma":0.0007393409,"threshold_uncertainty_score":0.99977976},"labels":[],"label_agreement":null},{"id":"W2000803692","doi":"10.1038/nrclinonc.2011.5","title":"Hypoxia modification with radiotherapy for bladder cancer","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Hypoxia (environmental); Context (archaeology); Oncology; Cancer; Cancer therapy; Internal medicine","score_opus":0.30217606434239314,"score_gpt":0.5572233347455076,"score_spread":0.2550472704031144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000803692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.2390505e-7,0.9851236,0.00029623287,0.0005376533,0.0014338981,0.009435823,0.00012601673,0.00006364691,0.0029827314],"genre_scores_gemma":[5.502262e-7,0.9737203,0.010464133,0.0038931097,0.0030511136,0.0053879553,0.00030735062,0.00016350539,0.003011962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953198,0.00071621937,0.0021881827,0.0011081009,0.00019426052,0.0004734674],"domain_scores_gemma":[0.9957833,0.0009982587,0.0016139569,0.00096912263,0.00026289068,0.0003724216],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013111448,0.0007495284,0.007526949,0.00014020714,0.000072824674,0.000011396095,0.00035295982,0.0033839687,0.0005734996],"category_scores_gemma":[0.00042176328,0.00040471146,0.002017359,0.00035689137,0.00022635369,0.000051404888,0.00002815637,0.0023855227,0.000114639086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004317741,0.0006687257,0.000024398012,0.009190242,0.0017788989,0.000014108855,0.000015209947,1.2407085e-8,9.281655e-8,0.0002236578,0.026083367,0.9615695],"study_design_scores_gemma":[0.0031130102,0.0036402761,0.000051125557,0.009252479,0.011832877,0.000121384386,0.0000011130079,0.0000011595199,2.0634175e-7,0.00003736787,0.9715643,0.0003847218],"about_ca_topic_score_codex":0.000021870337,"about_ca_topic_score_gemma":0.00004948775,"teacher_disagreement_score":0.9611848,"about_ca_system_score_codex":0.00062078907,"about_ca_system_score_gemma":0.002984232,"threshold_uncertainty_score":0.999916},"labels":[],"label_agreement":null},{"id":"W2000837090","doi":"10.1016/j.eururo.2009.09.022","title":"The Pathologist’s Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Value (mathematics); Oncology; Gynecology; Internal medicine; Cancer; Statistics","score_opus":0.028125011249887234,"score_gpt":0.2955603973532535,"score_spread":0.26743538610336626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000837090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9275812,0.018039482,0.000057269932,0.029228596,0.0003165844,0.0008017269,0.000069314796,0.000073514035,0.023832351],"genre_scores_gemma":[0.99103844,0.0014329422,0.000050181523,0.0070508993,0.00012114572,0.000010508504,0.000003978914,0.000019527837,0.00027235126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987335,0.00036416546,0.00024053302,0.00023908995,0.00015337794,0.00026931174],"domain_scores_gemma":[0.9992584,0.00022813088,0.00011373881,0.00028909036,0.00004304845,0.00006762179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036799844,0.00015185181,0.00021384722,0.000035403562,0.00019947147,0.000018638633,0.00014971054,0.000036704616,0.000054215227],"category_scores_gemma":[0.00009758004,0.00007626835,0.000058585487,0.00010201397,0.00052302424,0.000021104344,0.00004992945,0.00019511343,0.000014162879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015642986,0.00093272026,0.6915073,0.000096032076,0.0020971238,0.0014126472,0.028558688,0.00002254502,0.009538774,0.04018892,0.042266794,0.18181416],"study_design_scores_gemma":[0.002558557,0.0022646957,0.94979477,0.000041599127,0.00085659424,0.0004540837,0.00037997338,0.00005342911,0.0010681624,0.0032250977,0.03912294,0.00018008245],"about_ca_topic_score_codex":0.000041938536,"about_ca_topic_score_gemma":0.000012162293,"teacher_disagreement_score":0.2582875,"about_ca_system_score_codex":0.000013234446,"about_ca_system_score_gemma":0.00005407972,"threshold_uncertainty_score":0.3110133},"labels":[],"label_agreement":null},{"id":"W2001142641","doi":"10.5489/cuaj.12032","title":"Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Cystectomy; Comorbidity; Logistic regression; Odds ratio; Odds; Emergency medicine; Internal medicine; Bladder cancer","score_opus":0.021091759866413994,"score_gpt":0.30742199903436634,"score_spread":0.28633023916795236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001142641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745995,0.00005346413,0.0000097186185,0.0017531822,0.00012277432,0.0003969244,0.0000523024,0.000012080374,0.00013958919],"genre_scores_gemma":[0.9986486,0.000004721438,0.000034931323,0.0010152247,0.00019357969,0.00001724638,0.000041313564,0.000010511824,0.00003390683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983535,0.00024152636,0.0004232117,0.00012592865,0.00042860574,0.0004272625],"domain_scores_gemma":[0.99875355,0.00018690985,0.00029472946,0.00009197639,0.00009013786,0.000582687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035264745,0.00014215267,0.00039222877,0.00033726907,0.000079849626,0.000011298685,0.00007176001,0.00017223398,0.0003254671],"category_scores_gemma":[0.00069693767,0.00009961217,0.0001752555,0.000367266,0.000011807629,0.0000930585,0.0000042407473,0.0006112522,0.000023219503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014803442,0.00047331656,0.99735606,0.0000015926743,0.00013127715,0.00001305458,0.0002095802,0.00042806403,0.0000044743865,0.0000028853622,0.00016144708,0.0010702153],"study_design_scores_gemma":[0.002854643,0.0014082551,0.9952741,0.00000702198,0.000082491235,0.0000067583946,0.000046534253,0.00008190412,0.0000014439371,0.000013618471,0.00014259774,0.00008063479],"about_ca_topic_score_codex":0.0067732283,"about_ca_topic_score_gemma":0.0022448688,"teacher_disagreement_score":0.00452836,"about_ca_system_score_codex":0.0027630418,"about_ca_system_score_gemma":0.00049742195,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W2001241431","doi":"10.1016/j.urolonc.2013.11.003","title":"Why is perioperative chemotherapy for bladder cancer underutilized?","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Perioperative; Bladder cancer; Medicine; Intensive care medicine; Chemotherapy; Disease; Clinical Practice; Cancer; Oncology; Internal medicine; Surgery; Physical therapy","score_opus":0.07735356287464201,"score_gpt":0.4121752811838386,"score_spread":0.3348217183091966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001241431","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008081148,0.98233324,0.00020678001,0.011481789,0.000369095,0.0023334138,0.00032339038,0.00007507539,0.0027964197],"genre_scores_gemma":[0.00000261502,0.94903415,0.013830871,0.03008769,0.0005539158,0.0021749123,0.00024994902,0.00006855121,0.0039973618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795353,0.00015634263,0.0005365382,0.0007639077,0.00015050176,0.00043920364],"domain_scores_gemma":[0.9985176,0.00038501646,0.00031427198,0.0003227743,0.00012386884,0.00033651298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019579867,0.0005858457,0.0020730137,0.00017778683,0.0003409587,0.000039411883,0.0001453294,0.00079115044,0.0008555224],"category_scores_gemma":[0.00006548482,0.00041336069,0.0003947193,0.00024736603,0.0007337207,0.000062052204,0.00003618586,0.00048743666,0.000026159396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019515344,0.00039474465,0.0010112999,0.0051203524,0.0020872033,0.000041517636,0.0009407384,0.0000011766326,0.0000033745532,0.003750393,0.24003161,0.7464224],"study_design_scores_gemma":[0.0016858218,0.002357388,0.0000044373924,0.001320065,0.0042788624,0.00023404197,0.000053212814,0.00004478166,0.000009431305,0.0010405603,0.9886214,0.00034997278],"about_ca_topic_score_codex":0.00011461182,"about_ca_topic_score_gemma":0.000055526307,"teacher_disagreement_score":0.7485898,"about_ca_system_score_codex":0.00031980753,"about_ca_system_score_gemma":0.0016179241,"threshold_uncertainty_score":0.9998318},"labels":[],"label_agreement":null},{"id":"W2001387602","doi":"10.1097/00042307-200205000-00011","title":"New diagnostic and prognostic tools in bladder cancer","year":2002,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Cystoscopy; Medicine; Urine cytology; Bladder cancer; Gold standard (test); Cytology; Urine; Urology; Cancer; Endoscopy; Oncology; Radiology; Urinary system; Pathology; Internal medicine","score_opus":0.16134983555066656,"score_gpt":0.42501586703692434,"score_spread":0.2636660314862578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001387602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001691415,0.9931903,0.000014344395,0.0002743736,0.004132779,0.002042854,0.00006666649,0.000028300825,0.0002334681],"genre_scores_gemma":[0.00007857286,0.99752146,0.000022651164,0.00006152508,0.0009611682,0.0010031064,0.00018358944,0.000053787568,0.00011412149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979212,0.00016616381,0.0006563809,0.0006414119,0.00015875894,0.00045605132],"domain_scores_gemma":[0.9986281,0.0007175127,0.0001600302,0.0002756404,0.000023515066,0.00019519411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008450614,0.00044462262,0.0015579535,0.00042313582,0.000019911111,0.000018827903,0.000120240846,0.00037068842,0.00066581037],"category_scores_gemma":[0.000350312,0.00036121294,0.0001468102,0.0003867013,0.00007110034,0.00005675817,0.000080683,0.00073769386,0.00009061326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017941904,0.00019892189,0.009394612,0.007635812,0.000074922,0.00002198107,0.000080334525,7.0220534e-7,7.5543864e-9,0.00005409049,0.0050266995,0.977494],"study_design_scores_gemma":[0.0018318242,0.00031911227,0.0059463717,0.011641706,0.0005357056,0.00011377243,0.0000021898147,0.000007239911,2.4210285e-8,0.00007314041,0.9792698,0.0002591342],"about_ca_topic_score_codex":0.00012369067,"about_ca_topic_score_gemma":0.000037990583,"teacher_disagreement_score":0.97723484,"about_ca_system_score_codex":0.0001787984,"about_ca_system_score_gemma":0.0005544104,"threshold_uncertainty_score":0.999884},"labels":[],"label_agreement":null},{"id":"W2001494890","doi":"10.5489/cuaj.2077","title":"Uptake of neoadjuvant chemotherapy for invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Chemotherapy; Bladder cancer; Medicine; Oncology; Urology; Cancer; Internal medicine","score_opus":0.017526372347505353,"score_gpt":0.2651408632987277,"score_spread":0.24761449095122237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001494890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218413,0.0007991554,0.00078325294,0.068517126,0.0008716025,0.00076167256,0.00022039439,0.000029355971,0.006176126],"genre_scores_gemma":[0.98598814,0.00020874196,0.00047989414,0.011640356,0.00072499574,0.000031337764,0.0000132061805,0.000015387217,0.0008979155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989935,0.000045163764,0.00028458636,0.00013514984,0.00020703698,0.00033457344],"domain_scores_gemma":[0.9987896,0.00012303195,0.00022777489,0.00007988639,0.00034519433,0.0004344959],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032142267,0.00010931133,0.00029539684,0.00008985886,0.000117759526,0.000020236486,0.00007482619,0.00017058504,0.00091387756],"category_scores_gemma":[0.00043950984,0.00008265877,0.00016518954,0.00009571787,0.000023375123,0.00004138083,0.0000034738823,0.00019187258,0.000009363241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004599415,0.00016842788,0.82703733,0.000027659034,0.0010560835,0.00001530532,0.0005150415,0.000066423694,0.0017310773,0.00070313195,0.06551794,0.10270163],"study_design_scores_gemma":[0.005060871,0.0011804685,0.7433254,0.000028012751,0.00022464138,0.000043802025,0.000048413396,0.00012690265,0.0010240735,0.0023429655,0.2464592,0.00013525113],"about_ca_topic_score_codex":0.0012040463,"about_ca_topic_score_gemma":0.001502859,"teacher_disagreement_score":0.18094125,"about_ca_system_score_codex":0.00055178493,"about_ca_system_score_gemma":0.0007894648,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2001890904","doi":"10.1016/j.jasc.2015.01.003","title":"Urine cytology: does the number of atypical urothelial cells matter? A qualitative and quantitative study of 112 cases","year":2015,"lang":"en","type":"article","venue":"Journal of the American Society of Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Urine cytology; Cytology; Medicine; Pathology; Urothelial carcinoma; Nucleolus; Biopsy; Cytopathology; Urine; Bladder cancer; Cancer; Internal medicine; Nucleus","score_opus":0.05253220329355187,"score_gpt":0.3954930880461999,"score_spread":0.3429608847526481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001890904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996409,0.00019546451,0.00009724239,0.002714653,0.00014716302,0.00028567488,0.00004611082,0.0000024244573,0.00010225282],"genre_scores_gemma":[0.99597764,0.00008092096,0.0029248404,0.0008339708,0.00007447573,0.000005075221,3.068897e-7,0.00001427901,0.00008849222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797064,0.0007741638,0.0006312685,0.00013284294,0.00033873957,0.00015233483],"domain_scores_gemma":[0.9972402,0.0005994126,0.0014037633,0.00025030546,0.00042813775,0.00007818503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069712056,0.00014752608,0.0009425599,0.000032694028,0.000042041378,0.000002764183,0.00020041512,0.00004456677,0.000022106693],"category_scores_gemma":[0.0001367084,0.00006822413,0.0002957688,0.0001953477,0.0018677262,0.000044731092,0.00010522446,0.00025887645,0.0000017207253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009389522,0.0026725505,0.7799455,0.00013101012,0.0014929357,0.000100946316,0.16645676,0.00001317969,0.034173094,0.0001184562,0.004704717,0.00080135855],"study_design_scores_gemma":[0.009156932,0.016148364,0.5704702,0.00013987534,0.0015294101,0.002802552,0.37921923,0.000011127922,0.018642757,0.001423472,0.00028696464,0.00016911962],"about_ca_topic_score_codex":0.0003981548,"about_ca_topic_score_gemma":0.000017234745,"teacher_disagreement_score":0.21276248,"about_ca_system_score_codex":0.000041930223,"about_ca_system_score_gemma":0.00020228523,"threshold_uncertainty_score":0.6881715},"labels":[],"label_agreement":null},{"id":"W2002566754","doi":"10.1016/s1470-2045(07)70002-5","title":"Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy","year":2007,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources; National Institutes of Health","keywords":"Medicine; Cystectomy; Survivin; Bladder cancer; Hazard ratio; Oncology; Internal medicine; Apoptosis; Cancer; Univariate analysis; Urology; Gastroenterology; Pathology; Multivariate analysis; Confidence interval; Biology","score_opus":0.08985829872637918,"score_gpt":0.37150324276310487,"score_spread":0.2816449440367257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002566754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961552,0.00051941304,0.00045207416,0.0010248328,0.00029092445,0.00074800244,0.00040005377,0.00001679203,0.0003927242],"genre_scores_gemma":[0.9980321,0.0003592003,0.00080447615,0.00039387212,0.00018801852,0.00014209321,0.000018393554,0.000009548135,0.000052278407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918944,0.00006306191,0.00027353194,0.00015619925,0.00012102591,0.00019674742],"domain_scores_gemma":[0.99923915,0.0002626814,0.00012807762,0.00021587488,0.0000935345,0.000060670765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000431639,0.000093565315,0.00042892166,0.00004412894,0.000026717667,0.0000022818247,0.00005454283,0.000106952415,0.00006964534],"category_scores_gemma":[0.00006322156,0.000060697643,0.00006083153,0.00010976953,0.00033158137,0.000037756552,0.00002354787,0.00008534335,4.5399597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01848095,0.0004409981,0.94292104,0.00041086078,0.001242684,0.000005715119,0.0006709688,0.0000012208636,0.008913778,0.00014626326,0.004624727,0.022140795],"study_design_scores_gemma":[0.0065381816,0.002083648,0.9658893,0.00010057189,0.00068371923,0.000015933205,0.000054569507,0.000081972685,0.01786519,0.0001805647,0.006444975,0.00006138659],"about_ca_topic_score_codex":0.0005026084,"about_ca_topic_score_gemma":0.00018910797,"teacher_disagreement_score":0.02296825,"about_ca_system_score_codex":0.000073757015,"about_ca_system_score_gemma":0.00011833759,"threshold_uncertainty_score":0.2475178},"labels":[],"label_agreement":null},{"id":"W2002781120","doi":"10.1016/j.ejso.2014.10.061","title":"Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Urology; Lymph node; Dissection (medical); Bladder cancer; Surgery; Cancer; Internal medicine","score_opus":0.021404090524432134,"score_gpt":0.30586180765061155,"score_spread":0.2844577171261794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002781120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845435,0.00016821962,0.00040319434,0.0009715525,0.0014691295,0.00030202098,0.000018860586,0.000014656721,0.012108876],"genre_scores_gemma":[0.99740016,0.00022976045,0.00008495432,0.00016871361,0.001674974,0.000009998211,0.000010290034,0.00004769534,0.0003734531],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974942,0.0010184426,0.00062366616,0.0002298181,0.00035488047,0.00027894223],"domain_scores_gemma":[0.9978822,0.0010503394,0.00043414513,0.00016124168,0.00018454509,0.00028752122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066032173,0.00021450191,0.00085074065,0.00013323152,0.00007924771,0.000007453405,0.00013261256,0.000088420165,0.00067542586],"category_scores_gemma":[0.00014117373,0.0001419347,0.0004277364,0.00009864854,0.00016681146,0.00004030934,0.000045806464,0.0002567004,0.000026192465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11743049,0.0063075544,0.09714975,0.0012205297,0.0045770383,0.006739951,0.0014556762,0.0003302859,0.14460061,0.0005535901,0.0071319058,0.61250263],"study_design_scores_gemma":[0.11376715,0.06414585,0.41905913,0.0010003619,0.002550405,0.0029317206,0.00008064471,0.00015820756,0.038331453,0.000055383734,0.35734403,0.000575665],"about_ca_topic_score_codex":0.000013173947,"about_ca_topic_score_gemma":0.000010070934,"teacher_disagreement_score":0.611927,"about_ca_system_score_codex":0.000338064,"about_ca_system_score_gemma":0.00017663342,"threshold_uncertainty_score":0.7395439},"labels":[],"label_agreement":null},{"id":"W2003123210","doi":"10.1016/j.urolonc.2012.11.014","title":"Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Western University; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Renal function; Urology; Proportional hazards model; Perioperative; Chemotherapy; Retrospective cohort study; Kidney disease; Nephrectomy; Internal medicine; Surgery; Kidney","score_opus":0.027546134111403348,"score_gpt":0.3241128512845948,"score_spread":0.2965667171731915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003123210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405813,0.00018820488,0.00022830979,0.0036193198,0.000050802333,0.0011471251,0.000040185903,0.000035922923,0.00063200947],"genre_scores_gemma":[0.98021847,0.00007026891,0.01597825,0.002782552,0.00007105328,0.0004392016,0.000050535324,0.000018494378,0.0003711966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989467,0.00005922065,0.00028749855,0.00034185505,0.00012688164,0.00023781044],"domain_scores_gemma":[0.999174,0.00018752868,0.00017049609,0.00016094054,0.00011697747,0.00019003836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011645179,0.00021884976,0.00042183156,0.000118641045,0.0001377806,0.000018493187,0.000045607205,0.00016359195,0.00009183879],"category_scores_gemma":[0.000027993348,0.00014647674,0.000050987775,0.000120987475,0.0004086563,0.000119434204,0.000011081353,0.00019387984,0.0000030341134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006919784,0.0002785103,0.9889108,0.00003634185,0.00012089838,0.000013548087,0.00014308075,0.000021263586,0.0027707627,0.001295044,0.00026384788,0.0054539214],"study_design_scores_gemma":[0.0054972754,0.023804974,0.9408076,0.000060584483,0.0005282019,0.00015742658,0.00009641469,0.00062271656,0.0009787907,0.0015801108,0.025691796,0.0001741432],"about_ca_topic_score_codex":0.00030564933,"about_ca_topic_score_gemma":0.000010653843,"teacher_disagreement_score":0.048103236,"about_ca_system_score_codex":0.00009117954,"about_ca_system_score_gemma":0.0002448182,"threshold_uncertainty_score":0.5973148},"labels":[],"label_agreement":null},{"id":"W2003657718","doi":"10.1007/s00345-012-0996-9","title":"Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrology; Urothelial carcinoma; Internal medicine; Oncology; Carcinoma; Disease; Urology; Bladder cancer; Cancer","score_opus":0.015015185411554593,"score_gpt":0.2368236503680999,"score_spread":0.22180846495654533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003657718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718565,0.0012583551,0.0000094041925,0.000431756,0.00030063014,0.00029716347,0.00008960226,0.0000030636263,0.00042437905],"genre_scores_gemma":[0.9987938,0.00004203598,0.000102880615,0.00068228407,0.00012044732,0.0000053877293,0.0000056772856,0.000024464905,0.00022302577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842215,0.00023487938,0.00044362125,0.00013511747,0.00047095033,0.0002932661],"domain_scores_gemma":[0.99851394,0.00009516659,0.00073592574,0.00025637195,0.00022544495,0.00017316842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021138418,0.00017296345,0.00050262146,0.00018116267,0.000032885375,0.0000024839374,0.00014858578,0.000059643313,0.00021339294],"category_scores_gemma":[0.000041843563,0.00009355641,0.00011071881,0.00034579058,0.0002080931,0.00009854328,0.000034088738,0.0003745758,0.0000013839242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048384615,0.0013604716,0.9918848,0.000027018843,0.0004813811,0.000016522405,0.00052565354,0.000016644966,0.000033438162,0.000028722156,0.00032523676,0.00046161178],"study_design_scores_gemma":[0.008839204,0.0013896379,0.98792887,0.00007624479,0.0010092368,0.000008103046,0.00001285734,0.0000011627068,0.00020060907,0.00006286602,0.00038539292,0.00008580433],"about_ca_topic_score_codex":0.000070824615,"about_ca_topic_score_gemma":0.000035964964,"teacher_disagreement_score":0.004000742,"about_ca_system_score_codex":0.000097034266,"about_ca_system_score_gemma":0.00029702598,"threshold_uncertainty_score":0.381512},"labels":[],"label_agreement":null},{"id":"W2003992719","doi":"10.1016/s0022-5347(08)61698-5","title":"COMBINATION OF CELL CYCLE REGULATING BIO-MARKERS IMPROVES PROGNOSIS IN PATIENTS WITH ORGAN CONFINED UROTHELIAL CANCER AT RADICAL CYSTECTOMY","year":2008,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Cystectomy; George (robot); Medicine; Psychoanalysis; Bladder cancer; Classics; Cancer; Art history; History; Internal medicine; Psychology","score_opus":0.007688145756528609,"score_gpt":0.2278046367181956,"score_spread":0.220116490961667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003992719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998095,0.00023126678,0.000014575307,0.0008936129,0.00010637908,0.00038189345,0.0000062156264,0.000005380167,0.0002657061],"genre_scores_gemma":[0.9994702,0.000075773714,0.000103867416,0.00019086515,0.000058429556,0.0000062830795,0.0000027587012,0.000018411998,0.000073424686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989173,0.00014162363,0.0003963209,0.000091095586,0.00027840302,0.00017526333],"domain_scores_gemma":[0.9991334,0.00009710225,0.00041167976,0.000106750536,0.00018396013,0.000067073415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020060418,0.000114879556,0.0003430832,0.0001197409,0.00006185232,0.0000016407347,0.00009620057,0.00007469588,0.0000956821],"category_scores_gemma":[0.000035680736,0.00006646628,0.000052854328,0.00016057692,0.0002455424,0.000047658217,0.000023294133,0.00019499833,0.0000013588209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015979707,0.0008359036,0.95388734,0.000048612463,0.00021932209,0.00003493145,0.0013352414,0.0000571248,0.025515622,0.0000052453242,0.00015627385,0.0019246594],"study_design_scores_gemma":[0.020712022,0.0069428743,0.94206375,0.000054041626,0.00033068802,0.00018695545,0.00004736459,0.00009967476,0.029327638,0.000028133134,0.00012614865,0.00008068945],"about_ca_topic_score_codex":0.00015875895,"about_ca_topic_score_gemma":0.00003327639,"teacher_disagreement_score":0.011823586,"about_ca_system_score_codex":0.000102406935,"about_ca_system_score_gemma":0.00019451445,"threshold_uncertainty_score":0.27104163},"labels":[],"label_agreement":null},{"id":"W2004038019","doi":"10.5489/cuaj.2577","title":"Author response: Microscopic hematuria and urothelial malignancy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Malignancy; Urology; Medicine; Microscopic hematuria; Pathology; Internal medicine; Kidney","score_opus":0.013468138149211727,"score_gpt":0.26280704688239603,"score_spread":0.24933890873318432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004038019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91405356,0.00039683812,0.00009172111,0.082903184,0.00047547062,0.00019743486,0.0000348455,0.000029711633,0.0018172064],"genre_scores_gemma":[0.9847615,0.00001793244,0.00041148468,0.008816633,0.0005511545,0.000007770978,0.000004395851,0.000014167547,0.0054149707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870396,0.00026102958,0.00023327195,0.00018169028,0.0002216271,0.00039840734],"domain_scores_gemma":[0.99876577,0.00013986863,0.00012271242,0.00009534334,0.00011866688,0.0007576611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073672173,0.000129593,0.00024797668,0.00012232517,0.00025957482,0.00008802505,0.00006342638,0.00022640309,0.0005149672],"category_scores_gemma":[0.0008474374,0.000100791825,0.000076983866,0.00010096684,0.00003189826,0.00005542053,0.00000977013,0.00036341083,0.00007430523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090755016,0.00007256163,0.9414821,0.000013573479,0.00018234989,0.00014800805,0.00029693003,0.0000016067876,0.0030992827,0.0006527872,0.045995444,0.0071477913],"study_design_scores_gemma":[0.0017557802,0.00063739216,0.7476155,0.000019983096,0.00008005575,0.00039005038,0.000015642232,0.000018582048,0.00020763806,0.0012325932,0.24792603,0.00010072127],"about_ca_topic_score_codex":0.00033542508,"about_ca_topic_score_gemma":0.0001710938,"teacher_disagreement_score":0.20193058,"about_ca_system_score_codex":0.00050332455,"about_ca_system_score_gemma":0.00042339735,"threshold_uncertainty_score":0.56385297},"labels":[],"label_agreement":null},{"id":"W2004102863","doi":"10.1016/j.eururo.2012.08.025","title":"Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder Cancer","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Smoking cessation; Bladder cancer; Logistic regression; Cumulative incidence; Internal medicine; Risk factor; Retrospective cohort study; Cancer; Incidence (geometry); Cohort; Pathology","score_opus":0.03007639531880168,"score_gpt":0.3217532945338444,"score_spread":0.2916768992150427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004102863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747628,0.000596856,0.000009467309,0.00028452027,0.00022021249,0.00025100325,0.000014947851,0.000022376098,0.02383785],"genre_scores_gemma":[0.9978402,0.00018598433,0.000030430512,0.0016084748,0.00017730433,0.000013415331,0.000013919213,0.000032106323,0.0000981259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989135,0.00018889619,0.0002447496,0.00021353783,0.00012896681,0.00031031668],"domain_scores_gemma":[0.999407,0.00015937767,0.00013088703,0.00017466824,0.000032973752,0.00009512841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002556857,0.00016847893,0.0003549752,0.00016047407,0.00003315058,0.0000046399537,0.00005801535,0.00006955227,0.0001685395],"category_scores_gemma":[0.000072771014,0.00012263985,0.00007690936,0.00010429303,0.00007469275,0.00007978011,0.000052383646,0.00020642902,0.000009449972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021188178,0.00028298644,0.9839336,0.000024079653,0.0002114869,0.000047044396,0.0009835183,0.000040495815,0.0015361232,0.000012594876,0.00012221118,0.012593939],"study_design_scores_gemma":[0.002754393,0.0013865746,0.9950929,0.00002984442,0.00016715251,0.000017342418,0.000028310553,0.00000499673,0.00019655113,0.000013184626,0.0002146555,0.00009405222],"about_ca_topic_score_codex":0.00026417617,"about_ca_topic_score_gemma":0.000027281161,"teacher_disagreement_score":0.023739723,"about_ca_system_score_codex":0.00019128405,"about_ca_system_score_gemma":0.00009189553,"threshold_uncertainty_score":0.5001108},"labels":[],"label_agreement":null},{"id":"W2004335572","doi":"10.5489/cuaj.1997","title":"Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Complication; Multivariate analysis; Mortality rate; Health care; Population; Surgery; Cancer; Emergency medicine; Database; General surgery; Internal medicine; Environmental health","score_opus":0.012427100960366266,"score_gpt":0.274195257715493,"score_spread":0.26176815675512677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004335572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820432,0.00020368212,0.00036762035,0.01668872,0.000051791925,0.000356306,0.00018915872,0.000008846126,0.000090649206],"genre_scores_gemma":[0.9953124,0.00000951823,0.00012488589,0.0039856094,0.00014584503,0.00013531916,0.000031299573,0.000007484259,0.00024762287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989575,0.00016119573,0.00024976305,0.00017821834,0.00018530137,0.0002680261],"domain_scores_gemma":[0.99923146,0.00014985725,0.000110406865,0.00010006369,0.00012532667,0.0002828856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030294183,0.00010105507,0.00024176507,0.00018116785,0.00020395668,0.000071353155,0.000055974102,0.00012131025,0.00036349182],"category_scores_gemma":[0.000170618,0.00007115185,0.00012190431,0.00031030085,0.000028599412,0.000054453085,0.0000046824484,0.00024215056,0.0000024651304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057732686,0.000022605618,0.9979436,0.0000027504254,0.00031223838,0.0000059499716,0.00014494537,0.00041880267,0.00001007366,0.000033168842,0.00011699167,0.0009311569],"study_design_scores_gemma":[0.0013754495,0.00006329202,0.994055,0.00000804372,0.00041337236,0.0000059716995,0.000019835432,0.0016680331,0.0000029365876,0.00010074158,0.002210964,0.00007637149],"about_ca_topic_score_codex":0.098308146,"about_ca_topic_score_gemma":0.3475346,"teacher_disagreement_score":0.24922647,"about_ca_system_score_codex":0.0012274643,"about_ca_system_score_gemma":0.00041181198,"threshold_uncertainty_score":0.9076963},"labels":[],"label_agreement":null},{"id":"W2004457875","doi":"10.1016/j.eururo.2011.10.026","title":"A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interquartile range; Stage (stratigraphy); Bladder cancer; Cystectomy; Cancer; Carcinoma in situ; Prostatectomy; Urology; Internal medicine; Prostate cancer; Oncology; Surgery; Biology","score_opus":0.027397002619967803,"score_gpt":0.25572363752729904,"score_spread":0.22832663490733124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004457875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8262411,0.0022543923,0.0008525958,0.002222444,0.00072873064,0.0010592,0.000036079095,0.00031918648,0.16628627],"genre_scores_gemma":[0.99192935,0.00004525309,0.00047881706,0.001935392,0.00037783652,0.000024547391,0.000005454755,0.00006436669,0.0051389975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989167,0.00011415776,0.00018492722,0.0003707836,0.00010370549,0.0003097615],"domain_scores_gemma":[0.99927586,0.000022259397,0.00004420147,0.00026589457,0.00003461271,0.00035714204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008282582,0.00017907692,0.0002476514,0.00007790018,0.00005067831,0.000010767935,0.000093245384,0.000039814542,0.00043078794],"category_scores_gemma":[0.00002236345,0.00013874237,0.000041176856,0.00010228764,0.00004627271,0.000032244847,0.0000756402,0.00011458235,0.0005585854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005205765,0.00071610475,0.7779342,0.0005261595,0.0018935085,0.007862777,0.025313923,0.000007766818,0.005510101,0.006600085,0.0497545,0.11867514],"study_design_scores_gemma":[0.0034256892,0.0024675059,0.91988415,0.000073383395,0.00070781546,0.0003843101,0.00015744647,0.000016068823,0.0005530582,0.000021796719,0.0720242,0.00028459704],"about_ca_topic_score_codex":0.0005983999,"about_ca_topic_score_gemma":0.00010387633,"teacher_disagreement_score":0.16568825,"about_ca_system_score_codex":0.00003603138,"about_ca_system_score_gemma":0.000074588395,"threshold_uncertainty_score":0.71796715},"labels":[],"label_agreement":null},{"id":"W2004563844","doi":"10.1016/j.urolonc.2014.06.017","title":"Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Medicine; Context (archaeology); Disease; Intensive care medicine; Cancer; Oncology; Internal medicine; Biology","score_opus":0.06858611587628025,"score_gpt":0.33241921388961726,"score_spread":0.263833098013337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004563844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19839472,0.76593864,0.000031848154,0.016215025,0.00061060354,0.014015165,0.0014374193,0.00005304431,0.0033035465],"genre_scores_gemma":[0.006262289,0.9834464,0.0058002854,0.0027845702,0.00006583896,0.001161366,0.0002194167,0.00003080811,0.00022903143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998291,0.0003491134,0.0005383072,0.00034785326,0.00025305268,0.00022066393],"domain_scores_gemma":[0.9975423,0.0013938564,0.00048413343,0.0004104346,0.000089843896,0.00007941353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023077294,0.00032487352,0.0010064763,0.00016510513,0.00013747792,0.000013772075,0.0001338959,0.00021247224,0.00011814125],"category_scores_gemma":[0.00006522088,0.00015423003,0.00011961905,0.00033784736,0.0008170013,0.00004353255,0.000040652714,0.00040963103,0.000003345012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015923374,0.011624311,0.20981331,0.035639357,0.01762766,0.001198794,0.004623293,0.00088229973,0.0000040312025,0.13377343,0.105958246,0.47726294],"study_design_scores_gemma":[0.0012731646,0.0027374104,0.008099432,0.0034496428,0.0042847283,0.000023355611,0.000084796666,0.0000062439553,0.0000030853264,0.00062545785,0.979253,0.0001596714],"about_ca_topic_score_codex":0.00023652664,"about_ca_topic_score_gemma":0.00016492844,"teacher_disagreement_score":0.8732948,"about_ca_system_score_codex":0.00010989516,"about_ca_system_score_gemma":0.00050673506,"threshold_uncertainty_score":0.62893176},"labels":[],"label_agreement":null},{"id":"W2004990944","doi":"10.1016/s0022-5347(05)00070-4","title":"Effect of Preoperative Delay on Survival in Patients With Bladder Cancer Undergoing Cystectomy in Quebec: A Population Based Study","year":2005,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Population; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.008326611493248263,"score_gpt":0.28406270164713776,"score_spread":0.2757360901538895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004990944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869967,0.00010511367,0.00003403365,0.00038954656,0.000069695,0.00061231054,0.0000022569895,0.0000023042949,0.000085085994],"genre_scores_gemma":[0.9997117,0.0000049234777,0.000020329982,0.00016289178,0.000053222673,0.000010422944,0.0000014852387,0.000012011553,0.000023040713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855655,0.0006814264,0.00031187467,0.00008198359,0.00024038448,0.00012779055],"domain_scores_gemma":[0.9992444,0.00034816802,0.00019519927,0.000106253225,0.00007517302,0.000030796436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047363545,0.000111953006,0.00036205555,0.00017390025,0.00001888579,0.0000026308448,0.00006171885,0.000042496205,0.00005255144],"category_scores_gemma":[0.000040771767,0.000057407346,0.00003189166,0.0001496138,0.000017827611,0.00006494457,0.000007955186,0.00022953768,9.568668e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017175583,0.0006021485,0.9674062,0.000013081037,0.00014831006,0.000016086606,0.0010314685,0.011102643,0.000021778476,0.0000016518069,0.0000044197077,0.0024766289],"study_design_scores_gemma":[0.019400598,0.018104225,0.96169394,0.00007352028,0.000252131,0.0000045295465,0.00006997749,0.00012781292,0.00022370051,0.0000022154193,0.000004096029,0.00004327754],"about_ca_topic_score_codex":0.0046837456,"about_ca_topic_score_gemma":0.05191098,"teacher_disagreement_score":0.047227237,"about_ca_system_score_codex":0.00020302898,"about_ca_system_score_gemma":0.00015625518,"threshold_uncertainty_score":0.9653892},"labels":[],"label_agreement":null},{"id":"W2005370593","doi":"10.1517/13543784.2012.646081","title":"Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Urothelial carcinoma; Bladder cancer; Mitomycin C; Medicine; Urothelial cancer; Urology; Cancer; Cancer research; Urothelium; Cytotoxic T cell; Urinary bladder; Oncology; Internal medicine; Biology; Surgery; In vitro","score_opus":0.11641905106193319,"score_gpt":0.4085934940975326,"score_spread":0.2921744430355994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005370593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033885553,0.98817223,0.0001351327,0.0011628837,0.0024977745,0.004452755,0.0006522949,0.00012960522,0.0027634266],"genre_scores_gemma":[0.0000790867,0.9754831,0.00092870684,0.008919803,0.004790031,0.0057632755,0.0021567845,0.0002431231,0.0016360759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965942,0.0001918237,0.0008618969,0.0010996083,0.00069584453,0.0005566448],"domain_scores_gemma":[0.99771965,0.00034562172,0.00038850083,0.0006669468,0.00025318415,0.000626074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019261814,0.0008935282,0.0015891608,0.00029948074,0.00024329234,0.00005735604,0.0003524519,0.0005848862,0.0011404948],"category_scores_gemma":[0.00009965266,0.0006824022,0.0007481881,0.0002528081,0.00033556705,0.00015702611,0.00005235823,0.0005168484,0.0003846923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000320853,0.0008566932,0.0000041191893,0.0026913383,0.0013915594,0.000008985083,0.0025656435,0.0000013410943,0.000036035,0.010454796,0.016781608,0.964887],"study_design_scores_gemma":[0.0020227549,0.0015540012,0.000058152957,0.008069192,0.0003430067,0.000037064194,0.000075523705,0.000017656814,0.00025342783,0.0021561438,0.9847498,0.0006633039],"about_ca_topic_score_codex":0.00032340825,"about_ca_topic_score_gemma":0.0000069118128,"teacher_disagreement_score":0.96796817,"about_ca_system_score_codex":0.00055132696,"about_ca_system_score_gemma":0.0042285617,"threshold_uncertainty_score":0.9997726},"labels":[],"label_agreement":null},{"id":"W2006475855","doi":"10.1016/j.urology.2009.09.091","title":"Utility of Urine Cytology in the Workup of Asymptomatic Microscopic Hematuria in Low-risk Patients","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cytology; Urine cytology; Cystoscopy; Asymptomatic; Urinary system; Urology; Malignancy; Microscopic hematuria; Work-up; Gynecology; Internal medicine; Pathology; Kidney","score_opus":0.006583658432411353,"score_gpt":0.2628557261241905,"score_spread":0.2562720676917791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006475855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773055,0.0001244883,0.00000804298,0.00026732925,0.00021316548,0.00040681846,0.000016415916,0.000005502926,0.0012277082],"genre_scores_gemma":[0.9995089,0.000015099591,0.00010756058,0.00029001795,0.000021102072,0.000021055905,0.000011516492,0.0000072612443,0.000017491988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990588,0.00013600128,0.00036105403,0.00016209848,0.00009395351,0.00018813927],"domain_scores_gemma":[0.9993026,0.00016165114,0.00012816556,0.00034419697,0.000037237744,0.000026116008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017935336,0.0000975463,0.00037154913,0.00011125981,0.000010357227,9.49739e-7,0.00012441528,0.00014994403,0.00020537643],"category_scores_gemma":[0.00015775528,0.00006559159,0.000046062698,0.0001613905,0.00017482809,0.000016194606,0.000030616087,0.00031559414,0.000008315618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038933952,0.00085958047,0.99556535,0.00008192223,0.000024463292,0.000009601152,0.00064824836,9.290546e-7,0.0012881806,0.00007355699,0.00004364242,0.0010151794],"study_design_scores_gemma":[0.0038461455,0.00059531524,0.9907984,0.00001874839,0.00005355082,0.00001157624,0.000024089974,0.000058716207,0.003480293,0.000989663,0.00008608162,0.00003741671],"about_ca_topic_score_codex":0.00032623103,"about_ca_topic_score_gemma":0.0011329125,"teacher_disagreement_score":0.004766953,"about_ca_system_score_codex":0.000006603097,"about_ca_system_score_gemma":0.000059884736,"threshold_uncertainty_score":0.26747474},"labels":[],"label_agreement":null},{"id":"W2006521013","doi":"10.1097/mou.0b013e32832eb45f","title":"Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Carcinogenesis; Bladder cancer; Epigenetics; Cancer research; microRNA; DNA methylation; Urothelium; Gene expression profiling; Biology; Gene; Gene expression; Genome instability; Medicine; Cancer; Genetics; Urinary bladder; DNA damage; Internal medicine; DNA","score_opus":0.0906964834752376,"score_gpt":0.3734223491039441,"score_spread":0.2827258656287065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006521013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012024557,0.99485177,0.000028697075,0.0000308893,0.0014912272,0.0020976986,0.00012275623,0.000035725207,0.00013881038],"genre_scores_gemma":[0.0032801763,0.99484926,0.00031135598,0.000010595799,0.0007656455,0.00035643796,0.00036327657,0.000049606468,0.00001365011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771255,0.00020278567,0.0008542361,0.00062790327,0.00021221039,0.00039032812],"domain_scores_gemma":[0.99901605,0.00008672861,0.00040238083,0.00029958616,0.00006290043,0.00013238392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020470607,0.00041147627,0.0017208088,0.0003833047,0.000050341474,0.000008844173,0.00013536587,0.00036715588,0.000026378219],"category_scores_gemma":[0.0000591305,0.00032512844,0.00022043103,0.0002376562,0.00009130615,0.0000491033,0.00009711425,0.0005676122,0.0000054512047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028445147,0.0009229686,0.035451297,0.05191423,0.00015946329,0.000015850126,0.00030474376,0.0000031567024,0.0001947251,0.000047789217,0.00008451844,0.9106168],"study_design_scores_gemma":[0.0060660904,0.0029520844,0.0050119213,0.020190611,0.0017517386,0.0005124343,0.000025221305,0.00005583425,0.00025533637,0.00011564039,0.9623201,0.0007430158],"about_ca_topic_score_codex":0.000016300251,"about_ca_topic_score_gemma":4.2571273e-7,"teacher_disagreement_score":0.96223557,"about_ca_system_score_codex":0.00009925694,"about_ca_system_score_gemma":0.00042157524,"threshold_uncertainty_score":0.99992007},"labels":[],"label_agreement":null},{"id":"W2006549427","doi":"10.1016/j.urology.2012.04.010","title":"Clinicopathologic Characteristics of 23 Cases of Invasive Low-grade Papillary Urothelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cytokeratin; Pathology; Immunohistochemistry; Stage (stratigraphy); Stain; Carcinoma; Oncology; Staining","score_opus":0.03752504263668183,"score_gpt":0.29902737310961075,"score_spread":0.2615023304729289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006549427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964117,0.0014127545,0.000021262531,0.00020171596,0.000494991,0.00029490519,0.00015210315,0.000019527135,0.0009910685],"genre_scores_gemma":[0.9981031,0.0002419479,0.00009782059,0.0009489332,0.00038575323,0.00001919922,0.000052006184,0.000021441678,0.00012982736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888647,0.00010490086,0.00041400697,0.00016932047,0.00012705813,0.00029822966],"domain_scores_gemma":[0.99902266,0.00025235597,0.00021880398,0.00030097849,0.000084797044,0.00012040188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013017752,0.00014958388,0.0005407713,0.00008923919,0.000022682187,0.0000010971063,0.00008064625,0.00017336212,0.00024152658],"category_scores_gemma":[0.00027828926,0.000120002434,0.00012574322,0.00008522901,0.00023087644,0.000036675738,0.00005021694,0.00013624289,0.000049360333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008939563,0.0007304783,0.97357947,0.0001739834,0.000084282256,0.00024991852,0.0005140714,3.7980013e-7,0.021718306,0.0001615498,0.00022998992,0.0016636453],"study_design_scores_gemma":[0.0025762238,0.0039606956,0.9488966,0.000024060337,0.0004770802,0.00081185723,0.0000742842,0.0000044738936,0.04178763,0.000096355725,0.0011626887,0.00012808698],"about_ca_topic_score_codex":0.000060180144,"about_ca_topic_score_gemma":0.000005300093,"teacher_disagreement_score":0.024682876,"about_ca_system_score_codex":0.00001940046,"about_ca_system_score_gemma":0.00015540601,"threshold_uncertainty_score":0.4893557},"labels":[],"label_agreement":null},{"id":"W2007084442","doi":"10.2147/dddt.s14071","title":"A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients","year":2010,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Tolerability; Refractory (planetary science); Adverse effect; Bladder cancer; Urology; Toxicity; Pharmacokinetics; Internal medicine; Maximum tolerated dose; Clinical endpoint; Gastroenterology; Surgery; Clinical trial; Cancer","score_opus":0.031168867441170423,"score_gpt":0.31676000066883975,"score_spread":0.2855911332276693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007084442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951558,0.0013675137,0.000064556756,0.00006684577,0.00012584792,0.0031738938,0.000022933225,0.000009776753,0.000012791401],"genre_scores_gemma":[0.9962613,0.0013690523,0.0014769385,0.00006685591,0.00004612296,0.0006826164,0.000021104066,0.000028391109,0.00004761114],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987538,0.000070421906,0.0004609244,0.0003002549,0.00019956935,0.00021505938],"domain_scores_gemma":[0.99918324,0.00023275017,0.0001749596,0.00019257341,0.00012358796,0.00009288238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022053083,0.00024684996,0.000441879,0.000099679964,0.00010613414,0.000016028165,0.00007864922,0.000060853898,0.00004168862],"category_scores_gemma":[0.000013981615,0.00015108613,0.00004213485,0.00009124906,0.00008170124,0.00007458591,0.0000111293675,0.000087347464,2.4343666e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008878768,0.021728404,0.03727768,0.00006254874,0.0011978686,0.000011652901,0.09580312,0.0000030909698,0.07179661,0.000003977026,0.000018607558,0.7632177],"study_design_scores_gemma":[0.105874725,0.026347844,0.39700404,0.00016068501,0.0003113608,0.000004064525,0.0062715802,0.00021513403,0.4614384,0.00005083389,0.0018284249,0.0004929246],"about_ca_topic_score_codex":0.00020270713,"about_ca_topic_score_gemma":0.00026614306,"teacher_disagreement_score":0.76272476,"about_ca_system_score_codex":0.000046269404,"about_ca_system_score_gemma":0.00029297508,"threshold_uncertainty_score":0.6161114},"labels":[],"label_agreement":null},{"id":"W2007231551","doi":"10.2217/cer.13.92","title":"Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors","year":2014,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Fulguration; Medicine; Resection; Bladder tumor; Surgery; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.13018667208462448,"score_gpt":0.4399852707932906,"score_spread":0.3097985987086661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007231551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692832,0.005031181,0.009636593,0.0043695737,0.00088859553,0.008838762,0.00031665977,0.000023725264,0.0016116786],"genre_scores_gemma":[0.99731445,0.00012166131,0.00023665224,0.00035982465,0.0012888311,0.00035990032,0.00014953275,0.000080819525,0.000088320994],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9875697,0.007415586,0.0014823895,0.00071012013,0.002137575,0.0006846283],"domain_scores_gemma":[0.9820213,0.009868073,0.0013429027,0.0004435997,0.006093242,0.00023092135],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0061624013,0.0006889191,0.003847621,0.001427657,0.00023444105,0.000054686738,0.0003544196,0.000615013,0.000056304856],"category_scores_gemma":[0.00036736712,0.0005368596,0.00070309517,0.00085538597,0.0010850633,0.0003146515,0.00006520355,0.003072578,0.0000051540837],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49669242,0.0070964675,0.011521636,0.07298248,0.029368006,0.00071065634,0.014505279,0.0018523771,0.21559185,0.00084389054,0.14433937,0.0044955816],"study_design_scores_gemma":[0.0348975,0.09962492,0.19898438,0.024743216,0.0028522813,0.00091704255,0.0012853763,0.0010168961,0.6182525,0.0027957547,0.013346149,0.0012839438],"about_ca_topic_score_codex":0.00011161213,"about_ca_topic_score_gemma":0.000025680567,"teacher_disagreement_score":0.4617949,"about_ca_system_score_codex":0.00060225173,"about_ca_system_score_gemma":0.0013667728,"threshold_uncertainty_score":0.9997083},"labels":[],"label_agreement":null},{"id":"W2007278030","doi":"10.5489/cuaj.2374","title":"Bilateral ovarian metastases from ureteric urothelial cancer: Initial case report and distinguishing role of immunohistochemistry","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Immunohistochemistry; Medicine; Urothelial carcinoma; Urothelial cancer; Pathology; Ovarian cancer; Cancer; Oncology; Internal medicine; Bladder cancer","score_opus":0.022880529070876586,"score_gpt":0.28752041754183694,"score_spread":0.26463988847096037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007278030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942683,0.0012056546,0.000030121615,0.0018768952,0.0003568882,0.0001270283,0.0005221159,0.000016050995,0.0015969325],"genre_scores_gemma":[0.99795943,0.000018559705,0.0005082144,0.00062596524,0.0006931574,0.000010576574,0.00006636726,0.0000134784395,0.000104224666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987242,0.000099186866,0.00040556423,0.00019734514,0.00028217246,0.0002915373],"domain_scores_gemma":[0.99842566,0.00006506341,0.00035282492,0.00011027063,0.0002867076,0.00075949944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036687957,0.00014346789,0.00033934135,0.000072658266,0.00014849065,0.0000656289,0.00006126712,0.00016894913,0.000258389],"category_scores_gemma":[0.0008664655,0.00011832037,0.00009033203,0.00009863858,0.000048391295,0.000083579376,0.00001876858,0.00035012572,0.0000022900022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005818191,0.0001067048,0.9190607,0.000011271896,0.00079261273,0.064017035,0.0011515052,0.0000150562755,0.004835089,0.000036837202,0.0021886951,0.0072026434],"study_design_scores_gemma":[0.017377954,0.0022781852,0.6521113,0.0001951384,0.0029793303,0.26441333,0.0019311069,0.00041496285,0.005410655,0.011607938,0.040152542,0.001127599],"about_ca_topic_score_codex":0.057313073,"about_ca_topic_score_gemma":0.0009018219,"teacher_disagreement_score":0.26694947,"about_ca_system_score_codex":0.0008082957,"about_ca_system_score_gemma":0.0010949407,"threshold_uncertainty_score":0.94896436},"labels":[],"label_agreement":null},{"id":"W2007279769","doi":"10.1007/s13629-012-0015-3","title":"De FGFR3-mutatie identificeert patiënten met een relatief gunstige prognose na radicale cystectomie voor blaascarcinoom","year":2012,"lang":"nl","type":"article","venue":"Tijdschrift voor Urologie","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Gynecology","score_opus":0.03401655699711715,"score_gpt":0.29726417030169056,"score_spread":0.2632476133045734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007279769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87142676,0.06712708,0.0010967007,0.0033278759,0.0061322865,0.005677958,0.001140228,0.0012091064,0.042862],"genre_scores_gemma":[0.9711409,0.0006930374,0.0016022837,0.002748562,0.0023703754,0.00055841624,0.0003632014,0.00031335923,0.020209862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99091697,0.000995959,0.0016817934,0.0015002027,0.0014844752,0.0034205846],"domain_scores_gemma":[0.99433804,0.0008981228,0.0007062312,0.0018111177,0.0003430891,0.0019034265],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0019296474,0.0014109003,0.0018719238,0.00049637444,0.00057940005,0.00023090583,0.0009777253,0.001299533,0.0074952682],"category_scores_gemma":[0.001540206,0.0012226474,0.00080223026,0.0008902528,0.0008065959,0.00087635586,0.00046895788,0.0018706577,0.01261772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038292997,0.00479227,0.8646265,0.0010801264,0.00410564,0.0014181768,0.005671516,0.00003792002,0.004695966,0.00092766504,0.066822015,0.041992873],"study_design_scores_gemma":[0.031024843,0.011928493,0.6979989,0.0010227838,0.012789167,0.0009306104,0.0023209315,0.0013224852,0.021772688,0.0008823257,0.21430756,0.0036992251],"about_ca_topic_score_codex":0.0013158219,"about_ca_topic_score_gemma":0.000044888602,"teacher_disagreement_score":0.16662765,"about_ca_system_score_codex":0.0005865449,"about_ca_system_score_gemma":0.0013551275,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W2007985468","doi":"10.1097/00008469-200204000-00005","title":"Coffee and tea consumption and cancers of the bladder, colon and rectum","year":2002,"lang":"en","type":"article","venue":"European Journal of Cancer Prevention","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Queen's University; University of Calgary","funders":"","keywords":"Medicine; Colorectal cancer; Rectum; Bladder cancer; Odds ratio; Cancer; Case-control study; Internal medicine; Risk factor; Population; Gynecology; Gastroenterology; Environmental health","score_opus":0.03261592900416906,"score_gpt":0.2894174781115207,"score_spread":0.25680154910735165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007985468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759536,0.021267459,0.000050095085,0.00072565244,0.00022809887,0.00019990483,0.0000069560547,0.0000040467876,0.0015642166],"genre_scores_gemma":[0.9855338,0.013176579,0.000112612855,0.00011856325,0.00011739149,0.0000017303631,3.4425955e-7,0.000012563323,0.0009264658],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992563,0.00017342444,0.00024828338,0.00009345292,0.00015066289,0.00007788051],"domain_scores_gemma":[0.999486,0.000017898927,0.00027616596,0.00007514251,0.00007246818,0.000072266645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024592763,0.000081130645,0.0001740824,0.00004557937,0.00005547259,0.0000122708025,0.00003377205,0.00001681096,0.0001399992],"category_scores_gemma":[0.000020675974,0.00005457086,0.0000456795,0.000051432333,0.000121427474,0.00007965266,0.00002251412,0.000120585035,7.5963567e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011314052,0.00020387936,0.29585257,0.0005094123,0.0009287606,0.000065813096,0.0031119233,0.000016645785,0.021497462,0.00005591392,0.0072124717,0.66941375],"study_design_scores_gemma":[0.0069323773,0.0015764439,0.97361636,0.0012205718,0.00090861117,0.00048199604,0.00011776658,0.00008680561,0.004468939,0.000113549046,0.010362472,0.00011413237],"about_ca_topic_score_codex":0.000030440795,"about_ca_topic_score_gemma":0.000034726178,"teacher_disagreement_score":0.67776376,"about_ca_system_score_codex":0.00005557604,"about_ca_system_score_gemma":0.00003882775,"threshold_uncertainty_score":0.22253352},"labels":[],"label_agreement":null},{"id":"W2008042604","doi":"10.1016/j.bcp.2009.07.018","title":"Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: Role of thymidine kinase 2","year":2009,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Cancer Society Research Institute; Bladder Cancer Canada; University of California, Santa Cruz; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Gemcitabine; Cytotoxic T cell; Thymidine kinase; Cell culture; Kinase; Cancer cell lines; Cancer research; Chemistry; Thymidine; Biology; Cancer; Molecular biology; Cell biology; Cancer cell; In vitro; Biochemistry; Immunology; Genetics","score_opus":0.014674181224356295,"score_gpt":0.2971960938243041,"score_spread":0.2825219125999478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008042604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988419,0.010171763,0.000009240796,0.0005139934,0.00009986277,0.000363283,0.00013165918,0.000015810618,0.00027536333],"genre_scores_gemma":[0.99835443,0.0009879059,0.00020062125,0.0002229296,0.00011396367,0.000029468298,0.000039485163,0.000009398618,0.000041804553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989844,0.000055111628,0.00035721296,0.0002638041,0.00014251926,0.00019694761],"domain_scores_gemma":[0.999399,0.00006577076,0.000196709,0.00013737814,0.000103183695,0.00009792955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029569366,0.0001861744,0.00068337074,0.000068889014,0.000009245884,7.44683e-7,0.00011755839,0.00018653729,0.00068731734],"category_scores_gemma":[0.000023939223,0.0001360622,0.00012158912,0.00013745586,0.00015080682,0.000019451185,0.00003792076,0.00015815032,0.0000014700516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028990428,0.0024080656,0.0055869236,0.000064537504,0.00013541353,0.000010383263,0.00010817763,0.0000041532435,0.9861829,0.0000029101445,0.0017859297,0.00081155647],"study_design_scores_gemma":[0.004259725,0.00068028324,0.07156476,0.000037661608,0.00031266434,0.0000012512658,0.000013844727,0.00005558849,0.9227723,0.00010500618,0.00010244613,0.00009448541],"about_ca_topic_score_codex":0.00037925038,"about_ca_topic_score_gemma":0.000007173254,"teacher_disagreement_score":0.06597783,"about_ca_system_score_codex":0.00008811219,"about_ca_system_score_gemma":0.0000975834,"threshold_uncertainty_score":0.7525643},"labels":[],"label_agreement":null},{"id":"W2008291064","doi":"10.1371/journal.ppat.1004818","title":"Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection","year":2015,"lang":"en","type":"article","venue":"PLoS Pathogens","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; American Association of Anatomists; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Innate immune system; Inflammation; Urinary system; Escherichia coli; Cathelicidin; Microbiology; Biology; Hypoxia-inducible factors; Immunology; Immune system; Endocrinology","score_opus":0.04072582991086957,"score_gpt":0.2678496363886583,"score_spread":0.2271238064777887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008291064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908944,0.0008356254,0.00001419298,0.00004896448,0.00017822426,0.00068114296,0.00014499601,0.00009418519,0.0071082814],"genre_scores_gemma":[0.99866736,0.00016396695,0.00039922295,0.00024324637,0.00014292261,0.00008486582,0.000058590136,0.00006472172,0.0001750886],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816495,0.00014254381,0.00045157922,0.00041646158,0.0004250803,0.00039938084],"domain_scores_gemma":[0.99880815,0.0000326996,0.000160195,0.00046307337,0.0002277223,0.00030816207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019193291,0.0002820735,0.0005223946,0.00026675404,0.000046976525,0.000014348078,0.0000894342,0.00020213259,0.000067579225],"category_scores_gemma":[0.00021261426,0.00025794658,0.00014530316,0.0006805291,0.00006186572,0.00012392105,0.00006525852,0.00029060393,0.00012229265],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030528952,0.0008988219,0.26572633,0.00006427504,0.00013287067,0.00008184118,0.0014517629,0.000026071397,0.727047,0.000023050849,0.000047995407,0.0041946582],"study_design_scores_gemma":[0.005957781,0.0013127952,0.67456883,0.00021187347,0.00036868462,0.000028986691,0.00038555003,0.00043004885,0.31423306,0.00037054624,0.0016950842,0.00043678278],"about_ca_topic_score_codex":0.00041424573,"about_ca_topic_score_gemma":0.0001725501,"teacher_disagreement_score":0.412814,"about_ca_system_score_codex":0.00026969478,"about_ca_system_score_gemma":0.00042660572,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W2008957050","doi":"10.1016/j.jpedsurg.2006.02.006","title":"The challenge of pediatric continent urinary diversion","year":2006,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Surgery; Urinary diversion; Concomitant; Urinary incontinence; Minor surgery; Perioperative; General surgery; Cystectomy; Bladder cancer","score_opus":0.02300447385085526,"score_gpt":0.25764254220785027,"score_spread":0.23463806835699502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008957050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96036696,0.034574203,0.000017306447,0.0017534638,0.0014489997,0.0001287548,0.0000069443804,0.00001065789,0.0016926872],"genre_scores_gemma":[0.9632034,0.026123997,0.000043523207,0.000033451633,0.010193009,0.0000019611741,0.0000024429871,0.000015444812,0.000382815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833554,0.00006369076,0.0007107685,0.00010526077,0.0005639932,0.00022072639],"domain_scores_gemma":[0.99806947,0.0006539258,0.0007088479,0.00017119318,0.00028938535,0.000107196676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060191535,0.00013297473,0.00042032826,0.00029152457,0.0000925974,0.000009722035,0.00009645341,0.00007105394,0.000083137005],"category_scores_gemma":[0.00011501909,0.00008006537,0.00042552277,0.00031212962,0.000031531305,0.00008962038,0.000033996414,0.00019647127,0.000010523022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000680158,0.000834481,0.85744995,0.00010436252,0.000101553014,0.0004232246,0.000059891947,0.0000042393604,0.000022717128,0.000020710335,0.13734719,0.0029515456],"study_design_scores_gemma":[0.004281286,0.0016729344,0.9654552,0.000052105686,0.0028944623,0.0002946941,0.00017050873,0.0000068246577,0.0003768841,0.0006752305,0.023842845,0.00027705348],"about_ca_topic_score_codex":0.000045221568,"about_ca_topic_score_gemma":0.0000011232446,"teacher_disagreement_score":0.11350434,"about_ca_system_score_codex":0.00006693176,"about_ca_system_score_gemma":0.0003213175,"threshold_uncertainty_score":0.3264971},"labels":[],"label_agreement":null},{"id":"W2009203203","doi":"10.1007/s00345-011-0772-2","title":"Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy","year":2011,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Internal medicine; Stage (stratigraphy); Lymphadenectomy; Nephrology; Lymphovascular invasion; Prognostic variable; Chemotherapy; Surgery; Cancer; Oncology; Urology; Metastasis","score_opus":0.012418777641108688,"score_gpt":0.23493070791714946,"score_spread":0.22251193027604077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009203203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869555,0.00010334233,0.000010970866,0.0000978087,0.00009840604,0.00034390375,0.0000030437272,0.0000019964866,0.0006449529],"genre_scores_gemma":[0.9995784,0.000007259132,0.00023342691,0.00012443698,0.00001687326,0.0000042414667,0.0000019482277,0.000009750611,0.000023653805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989999,0.00014592422,0.00044348277,0.00007714702,0.00021689372,0.00011664774],"domain_scores_gemma":[0.9992389,0.000045111028,0.00040188982,0.000121791425,0.00014200882,0.000050318915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008636219,0.000086062086,0.00029955216,0.00017634426,0.000010951806,9.955924e-7,0.00007616789,0.000038243063,0.000064700565],"category_scores_gemma":[0.00005127046,0.00004618888,0.00007453636,0.0001960379,0.000118443415,0.000034392935,0.000016734468,0.00016004605,8.1819195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036211687,0.001143024,0.9927474,0.000024088798,0.00014185038,0.000057590474,0.0008559208,0.000016318334,0.00023423154,0.000020397547,0.000021240558,0.0011167276],"study_design_scores_gemma":[0.00798211,0.0043921554,0.97938883,0.00013076623,0.00032975996,0.000038310667,0.000019246158,0.000007679816,0.0074927574,0.00003447895,0.00014735131,0.00003656943],"about_ca_topic_score_codex":0.00006124774,"about_ca_topic_score_gemma":0.000033296237,"teacher_disagreement_score":0.013358626,"about_ca_system_score_codex":0.00003773167,"about_ca_system_score_gemma":0.000066089924,"threshold_uncertainty_score":0.1883528},"labels":[],"label_agreement":null},{"id":"W2010071068","doi":"10.5489/cuaj.1637","title":"Squamous cell carcinoma of the suprapubic tract: A rare presentation in patients with chronic indwelling urinary catheters","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Medicine; Basal cell; Indwelling catheter; Urinary system; Catheter; Presentation (obstetrics); Surgery; Pathology; Internal medicine","score_opus":0.007253856398171138,"score_gpt":0.20279222428144997,"score_spread":0.19553836788327883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010071068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968248,0.00009889728,0.000011800381,0.0018667416,0.00011816918,0.0002896596,0.000017218976,0.0000040846685,0.0007686455],"genre_scores_gemma":[0.99902576,0.0000035597477,0.000021354894,0.0006913264,0.00011874872,0.000007938715,0.000014197564,0.000010487439,0.00010661589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988771,0.00016408756,0.00023617204,0.0001268849,0.00031069745,0.0002850725],"domain_scores_gemma":[0.9992535,0.00007555011,0.00022879853,0.00010086887,0.00012442862,0.00021682374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019740315,0.000101538935,0.00017998235,0.00011286665,0.00011003053,0.00001873715,0.000093785755,0.00011989369,0.00010670875],"category_scores_gemma":[0.00009330823,0.00006350711,0.00007951261,0.00017929875,0.000025805124,0.000072061106,0.000006997761,0.00036329133,0.0000039643137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009020656,0.0001694126,0.9984506,0.000009285492,0.000011593275,0.000009093889,0.00022300454,0.0001458987,0.000012086872,0.0000039775655,0.00016237168,0.0007125207],"study_design_scores_gemma":[0.0035992744,0.0014854348,0.99369687,0.000012970597,0.00006354997,0.000017783204,0.00002640631,0.00008648862,0.000115421164,0.00005358079,0.000777844,0.00006439501],"about_ca_topic_score_codex":0.0016484413,"about_ca_topic_score_gemma":0.0008326646,"teacher_disagreement_score":0.004753697,"about_ca_system_score_codex":0.0010885055,"about_ca_system_score_gemma":0.0004777131,"threshold_uncertainty_score":0.2846404},"labels":[],"label_agreement":null},{"id":"W2010684169","doi":"10.1016/s1569-9056(04)90151-0","title":"150 Bothersomeness of lower urinary tract symptoms differs in Europe, Middle-East, Latin America, Asia and Canada","year":2004,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Latin Americans; Middle East; Lower urinary tract symptoms; East Asia; Urinary system; Demography; Traditional medicine; Internal medicine; Geography; China; Archaeology; Political science","score_opus":0.015946851130123372,"score_gpt":0.23439616555291276,"score_spread":0.2184493144227894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010684169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855144,0.00027835873,0.00002107779,0.0010701191,0.00018840402,0.00039853793,0.00016361024,0.00002183588,0.009306622],"genre_scores_gemma":[0.99749273,0.00006263903,0.00013364403,0.0016153747,0.00006159662,0.000011228099,0.000091503636,0.000064133834,0.00046717562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838763,0.00018451123,0.00039262773,0.0003948091,0.0002368617,0.00040356824],"domain_scores_gemma":[0.9993366,0.000028296221,0.00012190768,0.00029585438,0.000047240545,0.00017011972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010210482,0.00024992522,0.000382681,0.00012450076,0.00004515765,0.0000062851077,0.00013192049,0.000035079378,0.00037058975],"category_scores_gemma":[0.00002551652,0.00022388862,0.000038266637,0.00022079947,0.00014386245,0.00005312069,0.000081910795,0.00018997713,0.00002050641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015436414,0.0021740284,0.98222625,0.00009998802,0.000360473,0.006917269,0.0010428939,0.00008050018,0.0013751914,0.000049028185,0.0010744467,0.0030563106],"study_design_scores_gemma":[0.009816164,0.0035007256,0.96035033,0.000061972445,0.00015224506,0.00030489103,0.00020286282,0.0000115779885,0.00015724558,0.000013988919,0.025195433,0.00023254444],"about_ca_topic_score_codex":0.048253447,"about_ca_topic_score_gemma":0.008711099,"teacher_disagreement_score":0.03954235,"about_ca_system_score_codex":0.00010743707,"about_ca_system_score_gemma":0.00027179896,"threshold_uncertainty_score":0.9580843},"labels":[],"label_agreement":null},{"id":"W2011175592","doi":"10.1158/1538-7445.am2011-4187","title":"Abstract 4187: Phospho-Akt status as a predictor of disease free interval in patients with muscle invasive transitional cell carcinoma of the bladder","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Cystectomy; Protein kinase B; Medicine; Bladder cancer; Transitional cell carcinoma; Metastasis; Biomarker; Cancer; Immunohistochemistry; PI3K/AKT/mTOR pathway; Cancer research; Oncology; Pathology; Internal medicine; Biology; Signal transduction","score_opus":0.04321877947979669,"score_gpt":0.30171003302532173,"score_spread":0.25849125354552505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011175592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424726,0.000513401,0.000001056474,0.00012439207,0.00007135917,0.001006071,0.0009119625,0.0000055206856,0.0031189844],"genre_scores_gemma":[0.9994151,0.000047975584,0.000026037758,0.00006778694,0.000039254148,0.00017270018,0.00002688088,0.000028197926,0.00017604326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810284,0.00007544688,0.0002570793,0.00027117424,0.00091651274,0.00037694062],"domain_scores_gemma":[0.9986941,0.000063533415,0.00007353568,0.00047739362,0.00044840938,0.00024303258],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013003004,0.00013434011,0.00023694185,0.0001284052,0.000043723692,0.000004788187,0.000238424,0.000053567608,0.0018669371],"category_scores_gemma":[0.000059028633,0.00008631332,0.00009164602,0.0003272847,0.00036978157,0.000085283165,0.00007696195,0.0003125242,0.0000059670356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008460876,0.0015910832,0.98222816,0.00042271146,0.00010321747,0.000028856555,0.0043660374,0.000003931867,0.0015038691,0.000027421564,0.00067984086,0.00058399583],"study_design_scores_gemma":[0.007152115,0.0010136968,0.9481415,0.00031299342,0.00006993209,2.294796e-7,0.00033662043,0.0000012254959,0.042648245,0.00020319299,0.000048067417,0.000072177325],"about_ca_topic_score_codex":0.007963514,"about_ca_topic_score_gemma":0.0007509454,"teacher_disagreement_score":0.041144375,"about_ca_system_score_codex":0.00022760867,"about_ca_system_score_gemma":0.0018329546,"threshold_uncertainty_score":0.9990455},"labels":[],"label_agreement":null},{"id":"W2011340898","doi":"10.1016/j.urology.2009.07.1357","title":"MP-13.17: The Incidence of Prostate Cancer and Urothelial Cancer in the Prostate In Cystoprostatectomy Specimens","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cystoprostatectomy; Cystectomy; Prostate cancer; Urology; Prostate; Neurovascular bundle; Bladder cancer; Prostatectomy; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.011497143266815687,"score_gpt":0.29153660536731785,"score_spread":0.2800394621005022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011340898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96622115,0.0041788104,0.000002431796,0.026274115,0.00011474319,0.0014842122,0.00007916329,0.000014431408,0.0016309258],"genre_scores_gemma":[0.9900875,0.0018690553,0.00001337107,0.007079595,0.000106345484,0.00028849288,0.0000041644066,0.0000145857075,0.0005368923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986317,0.00011809357,0.00033327617,0.00031843618,0.00021083774,0.00038763104],"domain_scores_gemma":[0.99941194,0.00009199939,0.00010666464,0.00028781194,0.00005343888,0.000048172573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029653218,0.00018755774,0.0003366701,0.000111121444,0.000051611263,0.0000115193325,0.00015218498,0.00008294894,0.0001224984],"category_scores_gemma":[0.000029978863,0.00010386376,0.000039745075,0.00033002917,0.00024194908,0.00006243411,0.00003167903,0.0003399449,0.0000039876204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006580596,0.00065093214,0.8825577,0.00011038611,0.00012139729,0.0006294906,0.035278443,0.00080781005,0.01054813,0.0005413327,0.0018747995,0.060299005],"study_design_scores_gemma":[0.0060832356,0.0016403346,0.97644186,0.00008316229,0.000117870964,0.00013414682,0.00033698627,0.00019845589,0.0018800212,0.001998026,0.010919398,0.00016650763],"about_ca_topic_score_codex":0.0037578542,"about_ca_topic_score_gemma":0.007045035,"teacher_disagreement_score":0.09388418,"about_ca_system_score_codex":0.00007652097,"about_ca_system_score_gemma":0.00024126632,"threshold_uncertainty_score":0.5680777},"labels":[],"label_agreement":null},{"id":"W2011457998","doi":"10.1038/ki.2012.405","title":"Tadpole cells in an unstained urine sediment","year":2013,"lang":"en","type":"article","venue":"Kidney International","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Urine cytology; Medicine; Cystectomy; Urology; Pathology; Cystoscopy; Bladder cancer; Urinary bladder; Urinary system; Cancer; Internal medicine","score_opus":0.012446967148147444,"score_gpt":0.28181047733322684,"score_spread":0.26936351018507937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011457998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9106795,0.000031508676,0.00012037025,0.022347024,0.0011556025,0.00066568,0.00009783715,0.0000751367,0.064827345],"genre_scores_gemma":[0.9857125,0.000010155623,0.0010265426,0.0048116846,0.00030072266,0.00008536493,0.0001802818,0.0000135767,0.00785914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992964,0.000012399898,0.00015472707,0.00016772514,0.0002291508,0.00013954793],"domain_scores_gemma":[0.9995165,0.0000076085603,0.00002708352,0.0001307041,0.00008614115,0.00023195175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000037500096,0.00008999412,0.00010407108,0.00010304374,0.000014992994,0.000024117911,0.000087656765,0.000035594163,0.007076693],"category_scores_gemma":[0.000019137948,0.00007613423,0.00003583546,0.000058800095,0.000020564721,0.00014718008,0.000024351148,0.00007728009,0.00044888628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006573966,0.0048226956,0.46141005,0.00008642165,0.00068290875,0.0002789997,0.002111089,0.00005335257,0.18467648,0.0033788,0.31741536,0.024426423],"study_design_scores_gemma":[0.022507668,0.0015623735,0.48361006,0.00028311554,0.000119684955,0.0000836445,0.00047778324,0.007128842,0.13639462,0.0031990907,0.3440249,0.0006082401],"about_ca_topic_score_codex":0.0006474271,"about_ca_topic_score_gemma":0.000016714794,"teacher_disagreement_score":0.07503304,"about_ca_system_score_codex":0.00016433798,"about_ca_system_score_gemma":0.00012970819,"threshold_uncertainty_score":0.993831},"labels":[],"label_agreement":null},{"id":"W2011502763","doi":"10.1016/j.ejca.2009.06.016","title":"Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients","year":2009,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Proportional hazards model; Urothelial carcinoma; Cohort; Internal medicine; Population; Stage (stratigraphy); Overall survival; Epidemiology; Gastroenterology; Cancer; Oncology; Surgery; Bladder cancer","score_opus":0.019357697360852136,"score_gpt":0.2859462039685234,"score_spread":0.26658850660767125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011502763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772507,0.0009320283,0.0000023463847,0.00019890834,0.000104737876,0.0006527386,0.000028621733,0.000002641519,0.00035289425],"genre_scores_gemma":[0.999392,0.000087002714,0.00007082688,0.00025159158,0.00015365986,0.000005349598,0.0000058509663,0.000017778344,0.000015985865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847263,0.0003216363,0.0005510306,0.00013372146,0.0003878965,0.00013310555],"domain_scores_gemma":[0.9991854,0.000063607346,0.00039087763,0.0001525285,0.00013598983,0.00007161602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016527307,0.00017066712,0.00041041136,0.00015954727,0.000030354997,0.000010671429,0.00009279716,0.000018452032,0.00004877045],"category_scores_gemma":[0.000017033517,0.00010120617,0.00012734892,0.00013750716,0.000025711208,0.000073060735,0.0000046082364,0.000105796535,4.4506942e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015592095,0.0033199536,0.9653493,0.00001858646,0.000119809396,0.0001326403,0.007207271,0.000023761522,0.00050594815,5.6608553e-7,0.000031553293,0.021731375],"study_design_scores_gemma":[0.01856026,0.017950812,0.96064985,0.00013584456,0.00034592807,0.000019240353,0.000579058,0.0000041357894,0.0014978581,0.0000040352147,0.00017856661,0.00007439137],"about_ca_topic_score_codex":0.0002837967,"about_ca_topic_score_gemma":0.00006800487,"teacher_disagreement_score":0.021656983,"about_ca_system_score_codex":0.00014840356,"about_ca_system_score_gemma":0.000126735,"threshold_uncertainty_score":0.4127068},"labels":[],"label_agreement":null},{"id":"W2011595291","doi":"10.1371/journal.pone.0013821","title":"FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy","year":2010,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"HRAS; Neuroblastoma RAS viral oncogene homolog; KRAS; Medicine; Cancer research; Bladder cancer; Mutation; Cancer; Cystoscopy; Targeted therapy; Oncology; Cystectomy; Internal medicine; Gene; Biology; Urinary system; Colorectal cancer; Genetics","score_opus":0.028306578578386678,"score_gpt":0.2781354505364668,"score_spread":0.24982887195808015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011595291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116755,0.0051553734,0.000013463839,0.0023570156,0.000064285436,0.00081752404,0.00013497585,0.000026416996,0.00026342177],"genre_scores_gemma":[0.994497,0.0039137667,0.0005310245,0.00039497073,0.00013767096,0.00019324964,0.00003223519,0.000026995569,0.0002730666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992762,0.000018444769,0.00013611521,0.00027238537,0.00010665665,0.00019017217],"domain_scores_gemma":[0.9995696,0.00008219841,0.000039103263,0.00012821319,0.000064949825,0.00011596621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000955733,0.00014914336,0.00026074596,0.000075866374,0.00008369218,0.00002848437,0.000029458433,0.00008465086,0.000092320566],"category_scores_gemma":[0.000033544857,0.000114252805,0.000023170585,0.00008327321,0.00013702453,0.000065814966,0.000015549278,0.00011457644,0.0000013084816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016828739,0.0015188728,0.5692682,0.00022944507,0.0019277906,0.000015484411,0.0021243128,3.9809828e-7,0.35497937,0.00007496637,0.00029797477,0.06788031],"study_design_scores_gemma":[0.0140051795,0.00094770704,0.9367205,0.00015902803,0.00025505436,0.00003518599,0.00036691784,0.0005093751,0.044090685,0.0013725841,0.0011820253,0.00035576496],"about_ca_topic_score_codex":0.0008192073,"about_ca_topic_score_gemma":0.0010674164,"teacher_disagreement_score":0.3674523,"about_ca_system_score_codex":0.000014407345,"about_ca_system_score_gemma":0.00008102114,"threshold_uncertainty_score":0.46590942},"labels":[],"label_agreement":null},{"id":"W2011599032","doi":"10.1046/j.1464-410x.2003.04125.x","title":"Laparoscopically assisted ureterocystoplasty","year":2003,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Surgery; Laparoscopy; Ureter","score_opus":0.015777388570635393,"score_gpt":0.2684687793026876,"score_spread":0.2526913907320522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011599032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786168,0.005286365,0.0008481087,0.0007057965,0.0008333366,0.00012221934,0.000007860945,0.000016169037,0.013563374],"genre_scores_gemma":[0.9960511,0.0002839756,0.0013828303,0.0016236735,0.00014616201,0.0000019934182,0.0000013695523,0.000013083198,0.00049586373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914944,0.00009957904,0.00030806623,0.00009889773,0.00016292138,0.00018107914],"domain_scores_gemma":[0.99945164,0.00003665428,0.0001308483,0.0000771912,0.00014610635,0.00015756467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013823966,0.00007552515,0.00031028318,0.0000550755,0.00004073226,0.000014994343,0.000054855296,0.000096993026,0.0005015549],"category_scores_gemma":[0.00019313011,0.000074194424,0.00011691634,0.00006840353,0.000059386788,0.000048367554,0.000006635984,0.0002685549,0.000017291377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005560914,0.0046212343,0.4712002,0.00022466191,0.0030214721,0.06451173,0.00043499435,0.000040668543,0.029019734,0.0018941876,0.071192265,0.34827796],"study_design_scores_gemma":[0.011532543,0.0047074747,0.51087713,0.000114439295,0.0005394609,0.27097008,0.000029019642,0.0000036515373,0.0017801685,0.00074776,0.19853047,0.00016781208],"about_ca_topic_score_codex":0.000011591132,"about_ca_topic_score_gemma":0.00001605243,"teacher_disagreement_score":0.34811014,"about_ca_system_score_codex":0.000034639306,"about_ca_system_score_gemma":0.00017516623,"threshold_uncertainty_score":0.54916745},"labels":[],"label_agreement":null},{"id":"W2011714290","doi":"10.1016/j.eururo.2009.01.040","title":"Bladder Tumor Infiltrating Mature Dendritic Cells and Macrophages as Predictors of Response to Bacillus Calmette-Guérin Immunotherapy","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Medicine; CD68; Immunotherapy; Infiltration (HVAC); Immune system; Bladder cancer; Dendritic cell; Hazard ratio; Immunohistochemistry; Population; Pathology; Internal medicine; Immunology; Cancer","score_opus":0.007782394543545465,"score_gpt":0.2525258158049442,"score_spread":0.24474342126139875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011714290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898226,0.0012354144,0.00004528108,0.0021343401,0.0002035997,0.00038632652,0.00003792588,0.00006730583,0.0069075315],"genre_scores_gemma":[0.9879056,0.00005024893,0.00057622074,0.009931566,0.00017380915,0.000004614783,0.0000056963554,0.000044548768,0.0013076735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844867,0.00042589352,0.00031420143,0.0003377827,0.0001630586,0.00031040568],"domain_scores_gemma":[0.999232,0.00012421297,0.00007808479,0.00033071486,0.000057217778,0.0001777685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029192446,0.00021415559,0.00034296873,0.00014713402,0.000060898506,0.000014483937,0.000112968584,0.000055780194,0.00024036852],"category_scores_gemma":[0.00012292608,0.00018172164,0.00006647139,0.0001551773,0.000102177844,0.000037420898,0.000035751596,0.00022439455,0.00010932009],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093965875,0.00028657247,0.00681155,0.000036408463,0.00026926934,0.002112737,0.0023940767,0.000025279229,0.96364546,0.00004469523,0.0033158248,0.01166153],"study_design_scores_gemma":[0.009081795,0.019154891,0.8231383,0.00008047064,0.00032147483,0.0016570783,0.00020262582,0.000017195678,0.09460506,0.00008274543,0.05121277,0.00044559335],"about_ca_topic_score_codex":0.00002252416,"about_ca_topic_score_gemma":0.0000022868874,"teacher_disagreement_score":0.8690404,"about_ca_system_score_codex":0.000023376922,"about_ca_system_score_gemma":0.000063121086,"threshold_uncertainty_score":0.74103934},"labels":[],"label_agreement":null},{"id":"W2011804899","doi":"10.1016/j.urolonc.2007.05.002","title":"Difficult decisions in urologic oncology: Management of high-grade T1 transitional cell carcinoma of the bladder","year":2007,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Urothelium; Bladder cancer; Transitional cell carcinoma; Urology; Urothelial carcinoma; Oncology; Carcinoma in situ; Carcinoma; Internal medicine; General surgery; Cancer; Urinary bladder","score_opus":0.06669640328523355,"score_gpt":0.3575625180258078,"score_spread":0.2908661147405742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011804899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06273584,0.9270043,0.000043179993,0.0014473026,0.0004422082,0.0022511433,0.00034004598,0.000027029113,0.0057089473],"genre_scores_gemma":[0.01408373,0.9655864,0.01826135,0.0007781882,0.00010490614,0.0003026611,0.0002456148,0.000035241294,0.0006018988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997068,0.00039625444,0.0011424744,0.0006126745,0.0003450956,0.0004355257],"domain_scores_gemma":[0.99778825,0.00079513097,0.00063651975,0.00046044093,0.00010077926,0.00021888812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047038787,0.00048435197,0.0018952377,0.00039138523,0.00015155245,0.0000058018763,0.00032397214,0.00090516615,0.00011683181],"category_scores_gemma":[0.000051884545,0.00030355513,0.00038245364,0.0009546396,0.0013024656,0.000042262378,0.00012403578,0.0008698198,0.000009794286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084227836,0.01121517,0.058968067,0.010903111,0.0022554211,0.0030657148,0.001672778,0.00016516588,0.000052080482,0.028170662,0.010127517,0.87256205],"study_design_scores_gemma":[0.002081937,0.0022862798,0.004120816,0.001342332,0.004084255,0.00046124368,0.00015964669,0.000007869983,0.000037551254,0.00211916,0.9830643,0.00023460465],"about_ca_topic_score_codex":0.00012646781,"about_ca_topic_score_gemma":0.000072553376,"teacher_disagreement_score":0.9729368,"about_ca_system_score_codex":0.00035315633,"about_ca_system_score_gemma":0.0011946163,"threshold_uncertainty_score":0.99994165},"labels":[],"label_agreement":null},{"id":"W2012099714","doi":"10.1111/j.1464-410x.2007.07213.x","title":"Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival","year":2007,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Bladder cancer; Lymph node; Lymphovascular invasion; Urology; Medicine; Lymphadenectomy; Urinary diversion; Cancer; Pathology; Internal medicine; Metastasis","score_opus":0.01988876379321612,"score_gpt":0.28798709895221936,"score_spread":0.2680983351590032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012099714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956505,0.00276456,0.000276773,0.0003136444,0.00054126163,0.00018840235,0.0000804869,0.000009331373,0.00017509244],"genre_scores_gemma":[0.99681795,0.00116302,0.00081901817,0.00066771806,0.00038121952,0.000001568608,0.0000073763135,0.000018607208,0.0001235334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984259,0.000114029746,0.00057749863,0.00024923525,0.0003302548,0.00030309733],"domain_scores_gemma":[0.99895895,0.0001044291,0.00025062665,0.00014406559,0.00017395317,0.0003679544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035615126,0.00014301401,0.0005489512,0.00009980735,0.00007907116,0.00000992694,0.00012318061,0.0001965675,0.0002738673],"category_scores_gemma":[0.000107218315,0.00014109048,0.000110275476,0.00007763123,0.00045318945,0.000112528105,0.00006751964,0.00036351132,0.0000039969723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014882181,0.0016938347,0.56144893,0.0003669396,0.0005197759,0.009543868,0.0020851532,0.0000017762985,0.34794876,0.000036294252,0.002268513,0.05920397],"study_design_scores_gemma":[0.014324531,0.007666721,0.86070234,0.00034433202,0.00039054718,0.025220312,0.00019625343,0.000014142201,0.086102456,0.00007147833,0.0047710384,0.00019586652],"about_ca_topic_score_codex":0.00017214651,"about_ca_topic_score_gemma":0.00014192332,"teacher_disagreement_score":0.29925337,"about_ca_system_score_codex":0.00006973051,"about_ca_system_score_gemma":0.00013740938,"threshold_uncertainty_score":0.5753503},"labels":[],"label_agreement":null},{"id":"W2012763778","doi":"10.1089/end.2010.0396","title":"The Impact of Previous Ureteroscopic Tumor Ablation on Oncologic Outcomes After Radical Nephrouretectomy for Upper Urinary Tract Urothelial Carcinoma","year":2011,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Texas Southwestern Medical Center","keywords":"Medicine; Upper urinary tract; Urothelial carcinoma; Urology; Ureteroscopy; Ablation; Urinary system; Nephrology; Ureteral neoplasm; Carcinoma; Ureter; Internal medicine; Transitional cell carcinoma; Cancer; Bladder cancer","score_opus":0.03334149097245511,"score_gpt":0.3253381734758833,"score_spread":0.2919966825034282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012763778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715567,0.00075811316,0.00008551874,0.00044846,0.00040256564,0.00062361435,0.000022928807,0.00000817842,0.0004949627],"genre_scores_gemma":[0.99845546,0.000045002645,0.0004672034,0.00053713395,0.00034453298,0.000047398502,0.0000014118559,0.000025057485,0.00007681145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986374,0.00014964474,0.0005635866,0.00014493939,0.00020430266,0.00030014882],"domain_scores_gemma":[0.9986976,0.00036219394,0.0004523832,0.00021177673,0.00013915644,0.00013690816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029141968,0.00019827684,0.0005815219,0.00013798765,0.0000637352,0.000007052851,0.00014934676,0.00012435131,0.00026870403],"category_scores_gemma":[0.00017364234,0.000099807294,0.0005939584,0.000056996047,0.00014706775,0.00006792639,0.00001706509,0.00032501604,0.000005015925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023936527,0.0013431093,0.9693492,0.000030478097,0.000584189,0.00051478617,0.0005468851,0.000007043604,0.0014893071,0.000032772576,0.00047804616,0.0016876482],"study_design_scores_gemma":[0.0075060125,0.03691239,0.95041174,0.000027135005,0.00038597052,0.0019458011,0.000018308308,0.000020495538,0.0015881461,0.00050505536,0.00060302205,0.00007590773],"about_ca_topic_score_codex":0.000039494094,"about_ca_topic_score_gemma":0.000001942326,"teacher_disagreement_score":0.03556928,"about_ca_system_score_codex":0.00012970161,"about_ca_system_score_gemma":0.0003201236,"threshold_uncertainty_score":0.40700233},"labels":[],"label_agreement":null},{"id":"W2013016441","doi":"10.1503/cmaj.101853","title":"Attenuated but live: a pelvic abscess caused by bacille Calmette-Guerin","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Abscess; Resection; Surgery; Transitional cell carcinoma; Stage (stratigraphy); General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.017416891504798138,"score_gpt":0.24998002431676677,"score_spread":0.23256313281196864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013016441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423866,0.00094941707,0.00009888822,0.022901585,0.0015084869,0.0004067166,0.00027255248,0.00007414233,0.031401567],"genre_scores_gemma":[0.9773659,0.00020053895,0.00007810183,0.01444978,0.0009556945,0.000017653105,0.000047319507,0.000038022612,0.006846991],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756324,0.00011711655,0.00040063902,0.00020287855,0.0011220244,0.000594121],"domain_scores_gemma":[0.9967804,0.000051346742,0.00016657654,0.00013371819,0.00035603612,0.0025119043],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053941214,0.00017433923,0.0003240373,0.00014715586,0.00022182161,0.000039017712,0.00016086691,0.00038079903,0.023283485],"category_scores_gemma":[0.0004978539,0.0001496631,0.0001260258,0.00021676073,0.00004608791,0.000098617675,0.000011540611,0.00080910395,0.00076961576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009932604,0.00026108368,0.2885066,0.000026697491,0.0009309896,0.0032664118,0.0021352004,1.8199432e-7,0.00028172592,0.000027004482,0.6764385,0.028026259],"study_design_scores_gemma":[0.013410448,0.0007295073,0.4521739,0.000281889,0.00052896794,0.0015438794,0.0016745166,0.00013951359,0.001028236,0.00014607125,0.52769303,0.0006500821],"about_ca_topic_score_codex":0.025671812,"about_ca_topic_score_gemma":0.020486334,"teacher_disagreement_score":0.16366729,"about_ca_system_score_codex":0.0013606057,"about_ca_system_score_gemma":0.002858159,"threshold_uncertainty_score":0.99738723},"labels":[],"label_agreement":null},{"id":"W2013372693","doi":"10.5489/cuaj.11236","title":"Preoperative hydronephrosis and diabetes mellitus predict poor prognosis in upper urinary tract urothelial carcinoma","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Medicine; Hydronephrosis; Urology; Diabetes mellitus; Upper urinary tract; Urinary system; Internal medicine; Oncology; Bladder cancer; Cancer; Endocrinology","score_opus":0.013012999572887181,"score_gpt":0.23245310608097858,"score_spread":0.2194401065080914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013372693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864467,0.0035750293,0.0000020701686,0.008081857,0.00021692617,0.0004396649,0.000082462175,0.0000180331,0.0011372512],"genre_scores_gemma":[0.99615514,0.0002691529,0.00011837039,0.0024891035,0.0006796904,0.00006636718,0.000016537539,0.00001885583,0.00018677983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982135,0.00021722124,0.00031957997,0.00020436813,0.0002923005,0.00075301697],"domain_scores_gemma":[0.99864656,0.00010747538,0.00012088228,0.00006273768,0.00009126264,0.00097106793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047467914,0.00019441676,0.00033714538,0.00019634055,0.00019908424,0.00006456673,0.000066666136,0.00025459327,0.0004819612],"category_scores_gemma":[0.00022300733,0.00015025331,0.00010408132,0.0001685385,0.0000465913,0.00026543482,0.000014509436,0.0005262919,0.000027973849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006462541,0.00036213727,0.99673223,0.0000072390603,0.00009524774,0.00005309247,0.0004030093,0.0000014435975,0.000110957604,0.00002491389,0.0006351888,0.0015098823],"study_design_scores_gemma":[0.0017939493,0.001196598,0.9917119,0.000023069726,0.00015981945,0.00024461767,0.00008031825,0.00007114384,0.0002976558,0.000093785864,0.0041842735,0.00014287498],"about_ca_topic_score_codex":0.00089897576,"about_ca_topic_score_gemma":0.00011571905,"teacher_disagreement_score":0.009708436,"about_ca_system_score_codex":0.00101997,"about_ca_system_score_gemma":0.0003889694,"threshold_uncertainty_score":0.61271524},"labels":[],"label_agreement":null},{"id":"W2013573526","doi":"10.1016/j.urolonc.2013.10.016","title":"Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia; McMaster University; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; Western University; McGill University","funders":"","keywords":"Medicine; Cystectomy; Body mass index; Urology; Multivariate analysis; Internal medicine; Stage (stratigraphy); Bladder cancer; Urinary system; Radical surgery; Gastroenterology; Surgery; Cancer","score_opus":0.008405531065648298,"score_gpt":0.2640104945111685,"score_spread":0.2556049634455202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013573526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427974,0.00009427157,0.0000024432873,0.0039309934,0.00007506184,0.0005260361,0.00055172516,0.000009480804,0.00053023413],"genre_scores_gemma":[0.99824715,0.00005831273,0.00023493514,0.0010294454,0.000020044594,0.000050787967,0.00026914617,0.000009924415,0.000080267935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893135,0.0002562756,0.0002510053,0.00024464028,0.00014373146,0.00017297838],"domain_scores_gemma":[0.99816835,0.0012339897,0.00016519193,0.00015760848,0.00006614324,0.00020873189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024016442,0.00016661469,0.00041455435,0.0000985082,0.00010678111,0.000007502924,0.000041477844,0.0001546022,0.00003471447],"category_scores_gemma":[0.00026688303,0.00009221248,0.00003425622,0.00014757414,0.0005343031,0.00004879707,0.000008424542,0.00015334295,0.0000010893989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024450598,0.00022837515,0.9942437,0.000010732197,0.00014396806,0.000015834186,0.00015562293,0.000005929016,0.00006620423,0.000041295625,0.0020478715,0.00059542275],"study_design_scores_gemma":[0.006883438,0.017269837,0.91566026,0.00009202952,0.0006871162,0.000008496719,0.00006112645,0.000415165,0.0012320047,0.00010945261,0.05742699,0.00015406034],"about_ca_topic_score_codex":0.015009374,"about_ca_topic_score_gemma":0.0015076933,"teacher_disagreement_score":0.0785834,"about_ca_system_score_codex":0.00013912075,"about_ca_system_score_gemma":0.00033596766,"threshold_uncertainty_score":0.9915498},"labels":[],"label_agreement":null},{"id":"W2013942008","doi":"10.1016/j.juro.2010.02.2062","title":"1027 A POPULATION-BASED COMPETING-RISKS ANALYSIS OF THE SURVIVAL OF PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR BLADDER CANCER","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Population; Bladder cancer; Gerontology; Cancer; Internal medicine","score_opus":0.019883346346775455,"score_gpt":0.30296681250763724,"score_spread":0.2830834661608618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013942008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982091,0.00007599489,0.00018407857,0.00095447566,0.00015728749,0.0002888981,0.00006866062,0.000002960377,0.000058546026],"genre_scores_gemma":[0.99953943,0.0000074017407,0.00009640107,0.00023188126,0.00007641573,0.00000622094,0.000011214673,0.000012705177,0.000018324105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893665,0.00016327208,0.0004101892,0.000075690106,0.0002805496,0.00013364376],"domain_scores_gemma":[0.998348,0.00035771469,0.00061816646,0.0002206198,0.00040072363,0.00005478679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031536218,0.000104540806,0.00051690923,0.00014677303,0.00005302178,0.0000018968972,0.00015536115,0.00007712277,0.00016329257],"category_scores_gemma":[0.0000914635,0.000046373312,0.00022149626,0.0003518288,0.0001706202,0.000017250688,0.000011352703,0.00022898144,1.5973323e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004497715,0.00026764633,0.9900861,0.000015264757,0.0022825284,0.0000012683759,0.00015425471,0.0010555079,0.0011595853,0.000013059577,0.000027092095,0.00044002332],"study_design_scores_gemma":[0.0056912336,0.0014660073,0.9821929,0.000014613497,0.00820856,0.000009020905,0.000021639635,0.0009104572,0.0012763416,0.000016591768,0.000150449,0.000042205553],"about_ca_topic_score_codex":0.00094353635,"about_ca_topic_score_gemma":0.001203297,"teacher_disagreement_score":0.007893174,"about_ca_system_score_codex":0.000023926808,"about_ca_system_score_gemma":0.00017993932,"threshold_uncertainty_score":0.18910487},"labels":[],"label_agreement":null},{"id":"W2014370222","doi":"10.1111/bju.12801","title":"The role of adjuvant chemotherapy for lymph node‐positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; Western University; Dalhousie University; Université de Montréal; University of Alberta; McMaster University; McGill University","funders":"","keywords":"Medicine; Urology; Lymph node; Retrospective cohort study; Urothelial carcinoma; Lymph; Population; Adjuvant therapy; Internal medicine; Chemotherapy; Oncology; Cancer; Bladder cancer; Pathology","score_opus":0.007140154382953496,"score_gpt":0.2586852124946209,"score_spread":0.2515450581116674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014370222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927824,0.0039125397,0.00062842696,0.0009268075,0.00042351137,0.00072812266,0.000036032307,0.000010343159,0.0005518318],"genre_scores_gemma":[0.99790835,0.00014051188,0.00034107594,0.00078385696,0.00069497613,0.00003000049,0.0000033563933,0.000045500296,0.000052361636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982483,0.00025260248,0.0005741215,0.00023151668,0.00034760113,0.00034585566],"domain_scores_gemma":[0.99880654,0.00026186806,0.00034431968,0.00017396657,0.0002686982,0.00014463464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006639663,0.00017961016,0.0007490914,0.00007954124,0.00017880925,0.00003113071,0.0001955283,0.00012682487,0.000032457716],"category_scores_gemma":[0.00024428972,0.00014187931,0.0004982985,0.00009413305,0.00015172461,0.00007895774,0.000020753425,0.0003058638,0.0000012955205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009244822,0.002216754,0.7931773,0.000016979317,0.0019535683,0.0006182711,0.00197975,0.0000045463216,0.004357135,0.00010594944,0.0003667853,0.18595812],"study_design_scores_gemma":[0.022627167,0.009110075,0.95517814,0.00006792865,0.00084096193,0.004684585,0.00045559488,0.00014221601,0.0015633499,0.0013269103,0.0038584005,0.0001446859],"about_ca_topic_score_codex":0.0002118772,"about_ca_topic_score_gemma":0.000022577256,"teacher_disagreement_score":0.18581343,"about_ca_system_score_codex":0.00012444545,"about_ca_system_score_gemma":0.0002562823,"threshold_uncertainty_score":0.5785671},"labels":[],"label_agreement":null},{"id":"W2014485217","doi":"10.1016/s0360-3016(02)03519-8","title":"Radiotherapy for muscle-invasive urinary bladder cancer in elderly patients","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Radiation therapy; Cohort; Urology; Urinary system; Toxicity; Internal medicine; Surgery; Dose fractionation; Bladder cancer; Retrospective cohort study; Oncology; Cancer","score_opus":0.02661126284639768,"score_gpt":0.33966492285812383,"score_spread":0.31305366001172613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014485217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97993755,0.0032551682,0.0030034091,0.008107009,0.0037425011,0.0007947145,0.00025925273,0.00003096419,0.0008694352],"genre_scores_gemma":[0.9894818,0.003939573,0.0016972366,0.0020834357,0.0024581098,0.000072185496,0.00005615771,0.000037845595,0.0001736241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986172,0.00009601229,0.0005995652,0.00022073298,0.00022864278,0.0002378732],"domain_scores_gemma":[0.99829584,0.0002796802,0.0005801855,0.0001123857,0.0006194545,0.000112461756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001539899,0.00019153606,0.00043889126,0.0001892633,0.00004632184,0.000015017836,0.00022454289,0.00020015967,0.00037965915],"category_scores_gemma":[0.00012388836,0.00016589428,0.00023583593,0.00013044053,0.00009067629,0.00022328645,0.000017874865,0.00027958673,0.000011991709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077681016,0.0019592342,0.49683082,0.0000130633825,0.001024129,0.00005379745,0.0009918829,0.00022914556,0.0010931217,0.0005705949,0.0034468763,0.49301052],"study_design_scores_gemma":[0.093874514,0.023174737,0.67500645,0.00038757615,0.00068772933,0.00030353598,0.00021432889,0.0045908075,0.0042185155,0.013589986,0.18313779,0.0008140491],"about_ca_topic_score_codex":0.0000351342,"about_ca_topic_score_gemma":0.000013923453,"teacher_disagreement_score":0.49219647,"about_ca_system_score_codex":0.0010755439,"about_ca_system_score_gemma":0.000328466,"threshold_uncertainty_score":0.6764972},"labels":[],"label_agreement":null},{"id":"W2014671958","doi":"10.1097/01.ju.0000095804.33714.ea","title":"The Prognostic Significance of Metastatic Perivesical Lymph Nodes Identified in Radical Cystectomy Specimens for Transitional Cell Carcinoma of the Bladder","year":2003,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cystectomy; Stage (stratigraphy); Transitional cell carcinoma; Urology; Lymph node; Lymph; Proportional hazards model; Pathological; Carcinoma; Oncology; Survival analysis; Internal medicine; Urinary bladder; Bladder cancer; Pathology; Cancer","score_opus":0.019126200643632532,"score_gpt":0.2657018048022796,"score_spread":0.2465756041586471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014671958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355525,0.0019674075,0.0010232442,0.0023649503,0.00018871263,0.00055753207,0.000020187656,0.000001405719,0.00032132876],"genre_scores_gemma":[0.9992855,0.00005167283,0.00026873942,0.00020821656,0.00006413425,0.000016147942,6.994712e-7,0.000012530557,0.00009231009],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984041,0.000498809,0.00053104927,0.00008677884,0.00028185232,0.00019742311],"domain_scores_gemma":[0.99820673,0.0011038715,0.00030521472,0.00018411328,0.00015020368,0.000049839364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071604864,0.000109960536,0.00035824915,0.00005357132,0.00007425877,0.00000377205,0.00019986293,0.000045370096,0.000061493316],"category_scores_gemma":[0.00018661685,0.000049600854,0.00019614652,0.00013464491,0.00050193875,0.000026049029,0.000010234698,0.00019676398,9.79173e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03898669,0.0075440197,0.25689122,0.001062765,0.0037207901,0.00039403644,0.017873425,0.002873802,0.6548228,0.011390823,0.0022160828,0.0022235103],"study_design_scores_gemma":[0.020506302,0.0030433722,0.8370313,0.00008097387,0.0031990411,0.0020283698,0.0014542204,0.00028952767,0.12315739,0.007910848,0.0011227956,0.00017584782],"about_ca_topic_score_codex":0.000016124051,"about_ca_topic_score_gemma":0.000011215844,"teacher_disagreement_score":0.58014005,"about_ca_system_score_codex":0.000036894704,"about_ca_system_score_gemma":0.00040005252,"threshold_uncertainty_score":0.20226641},"labels":[],"label_agreement":null},{"id":"W2014803533","doi":"10.1016/j.eururo.2013.11.040","title":"Gender-specific Differences in Clinicopathologic Outcomes Following Radical Cystectomy: An International Multi-institutional Study of More Than 8000 Patients","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University; Dalhousie University; Université Laval; McGill University","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Stage (stratigraphy); Internal medicine; Oncology; Male gender; Disease; Bladder cancer; Gynecology; Urology; Cancer; Metastasis","score_opus":0.07302302400206007,"score_gpt":0.3270469623309494,"score_spread":0.2540239383288893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014803533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996359,0.000069574635,0.000074547985,0.00013740304,0.000721896,0.0006571477,0.000012984728,0.00004462268,0.0019228306],"genre_scores_gemma":[0.99905986,0.000011993912,0.0002928123,0.0003936102,0.0000747772,0.000033335877,0.000047698908,0.000021277236,0.00006461563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982127,0.00040174337,0.00047942554,0.00040696547,0.00027855686,0.00022060641],"domain_scores_gemma":[0.99938875,0.00006501679,0.00010738033,0.00027207815,0.00006265514,0.000104126775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019528743,0.0001927006,0.00042146727,0.0001784295,0.000051877854,0.000012810829,0.00024563746,0.00005758353,0.00021062096],"category_scores_gemma":[0.000091376955,0.0001332774,0.00010689317,0.00009115599,0.00013243541,0.00012632152,0.00009566062,0.00021643705,0.000098575474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001286082,0.003392014,0.992009,0.0000040330374,0.00010781212,0.00025697434,0.0015269048,0.000007485509,0.00006483571,0.000022535822,0.000013175833,0.0024666155],"study_design_scores_gemma":[0.009426737,0.001911316,0.9879524,0.0000072232997,0.000048282523,0.000010905151,0.00032556025,0.00007156571,0.0000055304695,0.000018124581,0.00012279548,0.00009954395],"about_ca_topic_score_codex":0.00009226505,"about_ca_topic_score_gemma":0.000022140206,"teacher_disagreement_score":0.009298129,"about_ca_system_score_codex":0.000045844226,"about_ca_system_score_gemma":0.000040761406,"threshold_uncertainty_score":0.54348946},"labels":[],"label_agreement":null},{"id":"W2015354352","doi":"10.1586/14737140.5.6.1001","title":"Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects","year":2005,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Antisense therapy; Genetic enhancement; Cancer research; Cancer; Radiation therapy; Cancer therapy; Targeted therapy; Chemotherapeutic drugs; Internal medicine; Gene; Biology; Oligonucleotide","score_opus":0.04421512318308846,"score_gpt":0.41612942200361197,"score_spread":0.3719142988205235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015354352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004274224,0.98652285,0.000008135443,0.003376516,0.0008951128,0.008239635,0.0002635671,0.00007336798,0.0006165283],"genre_scores_gemma":[7.843056e-7,0.98470443,0.0014555523,0.006294875,0.0045340233,0.002431299,0.00011985134,0.0002181272,0.00024108074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965176,0.0001403809,0.0012178511,0.0009940933,0.0005434299,0.00058661797],"domain_scores_gemma":[0.9976318,0.00012326927,0.00078023225,0.000846995,0.00036198812,0.00025573853],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027511577,0.0010092563,0.0046063904,0.00014801556,0.00012192972,0.000027914266,0.0002735838,0.00029428897,0.0010814514],"category_scores_gemma":[0.000022080518,0.00063626847,0.001019409,0.00047332604,0.00022970488,0.00015500354,0.00003342306,0.00028887833,0.0000065563836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024046353,0.00031701353,0.000015613803,0.045169704,0.0012167427,0.000008471058,0.00010855773,8.602919e-9,0.000008754468,0.000047639904,0.008012547,0.9448545],"study_design_scores_gemma":[0.0026298368,0.0008578109,0.000021545115,0.07382209,0.0007874293,0.00007471948,0.000015863932,5.9329e-7,0.00009653801,0.000015215908,0.92113,0.00054837746],"about_ca_topic_score_codex":0.000025729418,"about_ca_topic_score_gemma":0.000008724046,"teacher_disagreement_score":0.9443061,"about_ca_system_score_codex":0.00021609233,"about_ca_system_score_gemma":0.00095188513,"threshold_uncertainty_score":0.9998317},"labels":[],"label_agreement":null},{"id":"W2015598557","doi":"10.1016/j.prp.2012.06.003","title":"Plasmacytoid variant of urothelial carcinoma: A report of a rare case","year":2012,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences North; NOSM University","funders":"","keywords":"Urothelial carcinoma; Cystectomy; Medicine; Cystoscopy; Hydronephrosis; Gross hematuria; Pathology; Carcinoma; Urinary bladder; Urology; Radiology; Urinary system; Bladder cancer; Internal medicine; Cancer","score_opus":0.12021841615677324,"score_gpt":0.43114845187987577,"score_spread":0.3109300357231025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015598557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681287,0.0024963638,0.000075921926,0.0016250141,0.0001546791,0.0005374784,0.000084377134,0.000010851619,0.02688661],"genre_scores_gemma":[0.9964102,0.00025215157,0.0021619769,0.00008257747,0.00018603618,0.000046783432,0.000011151782,0.000015601938,0.00083350914],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981731,0.0005780896,0.0002976907,0.0002201366,0.00033921635,0.00039172795],"domain_scores_gemma":[0.9975257,0.0012802392,0.00014265355,0.00036852364,0.00044495173,0.00023794541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025149498,0.00010012418,0.0003062808,0.00015788109,0.0000918509,0.000005316489,0.000049563878,0.00011410263,0.00016173963],"category_scores_gemma":[0.0035698588,0.00007089383,0.00004372895,0.00020096668,0.00035855584,0.00019549101,0.00009113578,0.0003592805,0.00001153059],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024973858,0.006281804,0.30205733,0.0012405077,0.0007475403,0.5512872,0.014194737,2.3881407e-7,0.08087512,0.00282539,0.003054232,0.012462093],"study_design_scores_gemma":[0.0051113376,0.0039288644,0.02508823,0.00005850924,0.00040062907,0.9074186,0.0035341617,0.0000075067555,0.03321683,0.00033739296,0.020754633,0.00014328568],"about_ca_topic_score_codex":0.0010688524,"about_ca_topic_score_gemma":0.000019191817,"teacher_disagreement_score":0.35613146,"about_ca_system_score_codex":0.000029999463,"about_ca_system_score_gemma":0.000324816,"threshold_uncertainty_score":0.42737123},"labels":[],"label_agreement":null},{"id":"W2016537592","doi":"10.1002/cncr.21953","title":"Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma","year":2006,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Urothelial carcinoma; Relevance (law); Carcinoma; Prospective cohort study; Oncology; Clinical significance; Urothelial cancer; Internal medicine; Cancer; Bladder cancer","score_opus":0.022999342715268902,"score_gpt":0.3144425650318104,"score_spread":0.2914432223165415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016537592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266267,0.0025193263,0.00031561343,0.00021517168,0.00017469274,0.0021694337,0.00009158185,0.000008415049,0.0018430948],"genre_scores_gemma":[0.9986974,0.000008054649,0.00024469287,0.00005667428,0.00011984553,0.0005894568,0.0000045987026,0.000017424083,0.00026184335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992025,0.000027160744,0.00016811225,0.0001506093,0.00033851352,0.000113123046],"domain_scores_gemma":[0.99919415,0.00003146682,0.0001102585,0.00018511397,0.00046190253,0.000017090799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012104531,0.00008056392,0.00016292994,0.000024306333,0.000027939454,0.0000022138977,0.000051107,0.000029784062,0.00003711549],"category_scores_gemma":[0.00009300488,0.000055122324,0.00008913704,0.00012389464,0.000066757566,0.000023853529,0.000010611699,0.000041973217,3.993567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041897927,0.00017915663,0.8771298,0.0002984878,0.00011587049,0.000001018781,0.00032025354,0.00067258335,0.10930178,0.00076468615,0.0002840178,0.010513364],"study_design_scores_gemma":[0.0032658898,0.00016976494,0.5483029,0.0001567633,0.00061007624,0.0000012947643,0.000025995383,0.00059206947,0.4443222,0.0023362194,0.00016307297,0.000053736272],"about_ca_topic_score_codex":0.00038829105,"about_ca_topic_score_gemma":0.00003709743,"teacher_disagreement_score":0.33502042,"about_ca_system_score_codex":0.00017453328,"about_ca_system_score_gemma":0.00046801774,"threshold_uncertainty_score":0.2247823},"labels":[],"label_agreement":null},{"id":"W2016651596","doi":"10.1007/s00280-010-1499-2","title":"The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Docetaxel; Paclitaxel; Ex vivo; In vivo; Micelle; Pharmacology; Chemistry; Pharmacokinetics; Cancer research; Chemotherapy; Medicine; Internal medicine; Biology; Biotechnology","score_opus":0.01197922883307866,"score_gpt":0.3274978254427914,"score_spread":0.3155185966097127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016651596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744426,0.01714009,0.00005798685,0.006154137,0.0006145563,0.00042468848,0.000070462025,0.000021474698,0.0010739792],"genre_scores_gemma":[0.98520947,0.00903765,0.00052360696,0.0029149326,0.000562302,0.00007379906,0.00001152357,0.000026764268,0.001639938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992219,0.000018922208,0.00023332587,0.00023715156,0.000088230096,0.00020047366],"domain_scores_gemma":[0.99945223,0.00010628922,0.00009607691,0.00015543263,0.000056913243,0.00013302767],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000067566965,0.0001642916,0.0002778057,0.000037462418,0.0001614218,0.000010386244,0.00006902509,0.00010446429,0.0025090124],"category_scores_gemma":[0.0000044216204,0.000112640984,0.00004123612,0.000100652105,0.00027450157,0.000052117255,0.00002139376,0.00019078053,0.000002444493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006758059,0.00010107187,0.0055287452,0.000030530555,0.00042630557,0.0000033906326,0.0014024113,3.5541848e-7,0.86156493,0.00007328178,0.003431407,0.1267618],"study_design_scores_gemma":[0.0077990065,0.00037816862,0.025394646,0.000016238686,0.00042540408,0.00002029864,0.00014823524,0.00014279726,0.67985976,0.0011221503,0.28453118,0.00016215864],"about_ca_topic_score_codex":0.0009543549,"about_ca_topic_score_gemma":0.00020266356,"teacher_disagreement_score":0.28109977,"about_ca_system_score_codex":0.000017591343,"about_ca_system_score_gemma":0.000109546374,"threshold_uncertainty_score":0.99840283},"labels":[],"label_agreement":null},{"id":"W2017206432","doi":"10.1002/cncr.24339","title":"Carcinoma of the upper urinary tract","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Proportional hazards model; Urinary system; Upper urinary tract; Cohort; Cancer; Internal medicine; Carcinoma; Retrospective cohort study; Surgery; Urology; Oncology","score_opus":0.022445250757277196,"score_gpt":0.3010299074641196,"score_spread":0.2785846567068424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017206432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712391,0.004130017,0.0000020129387,0.0029157219,0.0002005295,0.00018433157,0.000014675617,0.000011257896,0.02130237],"genre_scores_gemma":[0.9947246,0.00007790738,0.000022333727,0.0016999708,0.00016972366,0.00001178943,0.0000010462926,0.000006359232,0.0032862772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996108,0.000008338452,0.00008084811,0.00009122484,0.00010989468,0.00009889881],"domain_scores_gemma":[0.99969995,0.000005030053,0.000027138982,0.00019937225,0.000028744338,0.00003979098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015848362,0.00006254485,0.00011520311,0.000014864647,0.000025280779,0.0000017589374,0.000052732037,0.000030391591,0.00045993092],"category_scores_gemma":[0.0000039832,0.000036074664,0.00008444782,0.000078617944,0.00002866811,0.000021792504,0.0000065333707,0.000064294814,0.0000072038633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024651014,0.0006610635,0.941043,0.000042646556,0.00006429062,0.00003250077,0.0005700983,0.0000039552297,0.007176188,0.00017253954,0.0067229816,0.043264203],"study_design_scores_gemma":[0.0008497689,0.00033552083,0.972285,0.000050479193,0.00010333598,0.000038539034,0.000018982091,0.000004398666,0.017040996,0.000104914456,0.009130416,0.000037674177],"about_ca_topic_score_codex":0.00008234691,"about_ca_topic_score_gemma":0.0000011842936,"teacher_disagreement_score":0.04322653,"about_ca_system_score_codex":0.00005011155,"about_ca_system_score_gemma":0.00012872263,"threshold_uncertainty_score":0.50359213},"labels":[],"label_agreement":null},{"id":"W2017531207","doi":"10.1016/j.urology.2006.08.125","title":"PD-11.06","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Occult; Bladder cancer; Urothelial cancer; Incidence (geometry); Disease; Oncology; Urology; Internal medicine; Cancer; Pathology","score_opus":0.011032751554344066,"score_gpt":0.26356601838840477,"score_spread":0.2525332668340607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017531207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912801,0.0011795802,0.0006040755,0.008418044,0.00035986825,0.000278452,0.000012659781,0.00015517809,0.19771208],"genre_scores_gemma":[0.98820275,0.0000064483133,0.00009869918,0.002725495,0.00034315395,0.000012879633,0.000026070147,0.000010596212,0.008573919],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957013,0.000012419882,0.00007994024,0.00012539838,0.00005722502,0.00015487922],"domain_scores_gemma":[0.9997836,0.000014083626,0.000014881478,0.00013358757,0.000017328071,0.000036545258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020340574,0.000062312276,0.000117623036,0.000034784895,0.000022987311,0.0000022611891,0.000027321672,0.000063096486,0.0005942265],"category_scores_gemma":[0.000005548342,0.000050132858,0.000037707214,0.000046456313,0.000038168924,0.000012186976,0.000009985366,0.000051861403,0.0004529253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055324973,0.0008283768,0.7731806,0.000035370034,0.00014761984,0.0006848612,0.00012955655,0.000047080615,0.0073559666,0.012326436,0.19835708,0.0063537904],"study_design_scores_gemma":[0.0030242228,0.000619272,0.23521101,0.0000022000434,0.00015833009,0.00025180125,0.0000060011057,0.000058469937,0.0017984124,0.0028947233,0.7558843,0.000091238115],"about_ca_topic_score_codex":0.00027223802,"about_ca_topic_score_gemma":0.00008210827,"teacher_disagreement_score":0.55752724,"about_ca_system_score_codex":0.000016431317,"about_ca_system_score_gemma":0.000034307006,"threshold_uncertainty_score":0.6506364},"labels":[],"label_agreement":null},{"id":"W2017980244","doi":"10.1111/j.1464-410x.2008.08333.x","title":"Sexual function of patients under surveillance for bladder cancer","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Sexual function; Sexual dysfunction; Outpatient clinic; Population; Libido; Gynecology; Internal medicine; Physical therapy","score_opus":0.016494022980088032,"score_gpt":0.2799583214596231,"score_spread":0.2634642984795351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017980244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910725,0.004573727,0.0019516443,0.0011529713,0.00061197014,0.00022709188,0.00008048654,0.000007093504,0.00032253706],"genre_scores_gemma":[0.99703956,0.00035958804,0.00013317382,0.0019147159,0.0003381059,0.0000040957075,0.000012938198,0.000010895406,0.00018694543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992051,0.000035877958,0.00033415403,0.00010490009,0.00015844915,0.00016152851],"domain_scores_gemma":[0.99915975,0.000038921033,0.00023409934,0.0000634243,0.0004282179,0.00007560934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011643014,0.00007581544,0.00031279272,0.00005928729,0.00003120991,0.0000056202553,0.00004980973,0.000083228966,0.00015784043],"category_scores_gemma":[0.000047056164,0.00007512166,0.00008977545,0.00006536218,0.00004053521,0.000058330297,0.0000048730485,0.00012257344,0.0000010270087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008687428,0.001838965,0.22724654,0.00007336025,0.0010679116,0.00011551881,0.00011761727,0.00026161823,0.001976183,0.00009578953,0.03240274,0.72611636],"study_design_scores_gemma":[0.0065883147,0.006523272,0.97981435,0.000021582911,0.00022523342,0.00033243862,0.000018723911,0.000011984608,0.00012451055,0.0006741321,0.0056003397,0.000065087355],"about_ca_topic_score_codex":0.000059396774,"about_ca_topic_score_gemma":0.00007094131,"teacher_disagreement_score":0.7525678,"about_ca_system_score_codex":0.000037393787,"about_ca_system_score_gemma":0.00013066894,"threshold_uncertainty_score":0.30633724},"labels":[],"label_agreement":null},{"id":"W2019758549","doi":"10.1016/j.urolonc.2013.06.001","title":"Urine markers for detection and surveillance of bladder cancer","year":2013,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystoscopy; Urine cytology; Bladder cancer; Medicine; Cytology; Urinary system; Urine; Cancer; Urothelial carcinoma; Biomarker; Oncology; Carcinoma; Urology; Internal medicine; Pathology","score_opus":0.05582923249804399,"score_gpt":0.3699685646288457,"score_spread":0.3141393321308017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019758549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025537312,0.99395055,0.000045587978,0.00052434474,0.0002502486,0.0017786024,0.00020315639,0.0000308894,0.00066288107],"genre_scores_gemma":[0.00012021613,0.98982215,0.006946603,0.000265386,0.00018864118,0.0012949306,0.00008850793,0.000029296129,0.0012442829],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987125,0.00010529558,0.0004332856,0.00041810566,0.000089406094,0.0002414097],"domain_scores_gemma":[0.9988117,0.00038118963,0.00034216457,0.0001733376,0.000096086515,0.00019552771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018507193,0.00031193884,0.0012699049,0.00015882269,0.00012239226,0.000011026053,0.00006047722,0.00043916667,0.00013725192],"category_scores_gemma":[0.0000952239,0.00022646438,0.00014491861,0.00018021151,0.0005472428,0.000049127524,0.00003521707,0.00026022413,0.0000049111304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010045833,0.00011384586,0.0064266287,0.005116856,0.00065203547,0.000011742532,0.000050261235,7.000619e-7,0.000017042179,0.00020300322,0.0032343965,0.98407304],"study_design_scores_gemma":[0.0007603989,0.0020144973,0.0002050168,0.000687421,0.0017724534,0.00024576377,0.00001804403,0.000035480112,0.000013918772,0.00047787352,0.99359417,0.00017498036],"about_ca_topic_score_codex":0.00017869481,"about_ca_topic_score_gemma":0.00007271945,"teacher_disagreement_score":0.9903598,"about_ca_system_score_codex":0.00012085153,"about_ca_system_score_gemma":0.0005510427,"threshold_uncertainty_score":0.923495},"labels":[],"label_agreement":null},{"id":"W2019812794","doi":"10.1111/j.1464-410x.2008.08212.x","title":"Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Lymphadenectomy; Lymph node; Lymph; Medicine; Bladder cancer; Dissection (medical); Urology; Surgery; Cancer; Internal medicine; Pathology","score_opus":0.015185115144544034,"score_gpt":0.286194044797416,"score_spread":0.271008929652872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019812794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638593,0.0017404169,0.000023110173,0.00066725945,0.00016649997,0.00013915666,0.000010850565,0.000004270145,0.0008625241],"genre_scores_gemma":[0.99820006,0.00034327732,0.00018903098,0.0009807555,0.00014432953,0.0000065785052,0.0000030970389,0.000020886548,0.000112001835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876106,0.000122027515,0.00042641276,0.00012527933,0.0003353146,0.00022989286],"domain_scores_gemma":[0.9992387,0.00008577936,0.00027235423,0.00010171952,0.00020670361,0.00009474189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012729081,0.00011061262,0.000428491,0.000064283704,0.000078517514,0.000010253051,0.00010385171,0.00009727661,0.0003902612],"category_scores_gemma":[0.000049201604,0.00007855893,0.00008928115,0.00014941511,0.00030848297,0.000117483396,0.000027094196,0.00023660959,0.0000032503783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011137413,0.00042029735,0.9906608,0.000015613972,0.00024762246,0.0010943256,0.00024032852,0.000019832787,0.00008467647,0.0000012701911,0.0009208089,0.005180709],"study_design_scores_gemma":[0.012514069,0.000359541,0.9749837,0.00013822423,0.00019060413,0.010994285,0.0000695255,0.000011083121,0.00014450222,0.000015190145,0.0005078519,0.00007142108],"about_ca_topic_score_codex":0.00072444347,"about_ca_topic_score_gemma":0.00006885652,"teacher_disagreement_score":0.01567707,"about_ca_system_score_codex":0.00011102093,"about_ca_system_score_gemma":0.00031491256,"threshold_uncertainty_score":0.42730865},"labels":[],"label_agreement":null},{"id":"W2020201687","doi":"10.1016/j.eururo.2012.12.062","title":"Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Bladder cancer; Population; Cancer; Urinary system; Randomized controlled trial; Gynecology; Oncology; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.16120086828201,"score_gpt":0.36172099932560897,"score_spread":0.20052013104359898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020201687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070145634,0.986299,0.0016660112,0.0018926306,0.00017900199,0.0025574253,0.00018407051,0.00005776814,0.0071571064],"genre_scores_gemma":[0.000041662843,0.9825134,0.007587569,0.0014443533,0.0009812375,0.00072153326,0.00022392294,0.00012614999,0.006360165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850726,0.00022805206,0.00033409157,0.0005508874,0.00010376388,0.00027597224],"domain_scores_gemma":[0.99907386,0.00027732202,0.0001340425,0.00023551367,0.00009117348,0.00018807055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013667697,0.00032564282,0.0008689194,0.0001938185,0.00015729695,0.00004279126,0.00010336322,0.0000962229,0.00021365542],"category_scores_gemma":[0.00016784489,0.00025859533,0.0001987192,0.00012500766,0.00009662254,0.00004782344,0.000065947635,0.00020679417,0.00013838799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050336548,0.000058776386,0.000020988247,0.0009190285,0.0007088138,0.000030931427,0.0006955149,0.0000027820288,0.0000014830732,0.00040968822,0.017457709,0.97964394],"study_design_scores_gemma":[0.0006962208,0.0006006546,0.0003469929,0.0003912037,0.0013475224,0.00011643045,0.00007295095,0.000006429041,3.7178708e-7,0.000022518032,0.9961958,0.00020292385],"about_ca_topic_score_codex":0.000019542324,"about_ca_topic_score_gemma":0.0000071553204,"teacher_disagreement_score":0.97944105,"about_ca_system_score_codex":0.00005428524,"about_ca_system_score_gemma":0.00024112343,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2020245988","doi":"10.1111/j.1464-410x.2009.08818.x","title":"Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Quartile; Stage (stratigraphy); Proportional hazards model; Epidemiology; Cohort; Population; Surgery; Cancer; Internal medicine; Confidence interval","score_opus":0.00957786222513143,"score_gpt":0.23960648935012122,"score_spread":0.23002862712498978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020245988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762297,0.00091075257,0.000016187607,0.0009367377,0.00004419995,0.00021484705,0.000023878902,0.0000066579582,0.00022376492],"genre_scores_gemma":[0.99884206,0.00020861671,0.00014508831,0.0005792706,0.00008513207,0.0000019321012,0.0000232831,0.000011750873,0.00010288647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907655,0.00008215673,0.00032965513,0.00013912536,0.00018645864,0.00018603822],"domain_scores_gemma":[0.99954176,0.00002337518,0.00014232425,0.000058135807,0.00010804861,0.00012632705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010239692,0.00010962028,0.00033495182,0.00012574943,0.00003107069,0.000020187976,0.000040755665,0.00009065416,0.00006226633],"category_scores_gemma":[0.000022600603,0.00009260057,0.00005429822,0.00009408277,0.000051874547,0.00012315485,0.0000040204177,0.00023851499,8.3761023e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018970065,0.00078985194,0.97826785,0.000005673953,0.00003105157,0.0027176167,0.00009867739,0.0000041894846,0.000100831225,0.0000048359766,0.00010468138,0.015977709],"study_design_scores_gemma":[0.011877713,0.0059464863,0.9772143,0.00003833839,0.00008913685,0.0033268007,0.000014109932,0.000012536534,0.00006643735,0.0000403203,0.0012971289,0.00007669655],"about_ca_topic_score_codex":0.00043896344,"about_ca_topic_score_gemma":0.00025739954,"teacher_disagreement_score":0.01590101,"about_ca_system_score_codex":0.000039888073,"about_ca_system_score_gemma":0.00009770442,"threshold_uncertainty_score":0.37761417},"labels":[],"label_agreement":null},{"id":"W2020503254","doi":"10.1159/000182109","title":"Urinary Tract Carcinoma in Patients with Analgesic Nephropathy","year":2008,"lang":"en","type":"article","venue":"˜The œNephron journals/Nephron journals","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Medicine; Analgesic; Urinary system; Incidence (geometry); Bladder cancer; Carcinoma; Population; Internal medicine; Cancer; Nephropathy; Surgery; Anesthesia; Diabetes mellitus; Endocrinology","score_opus":0.02569856458224908,"score_gpt":0.26864516094298246,"score_spread":0.24294659636073337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020503254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983186,0.010173648,0.0001427599,0.002455206,0.0003806992,0.001238524,0.000044183114,0.00007724782,0.0023017453],"genre_scores_gemma":[0.99207866,0.0020043864,0.00031383682,0.0032411008,0.0010893444,0.000063807885,0.000024498193,0.00017478272,0.0010095619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938767,0.0005262143,0.0015159786,0.00072282023,0.001978748,0.0013795212],"domain_scores_gemma":[0.9965308,0.00016131408,0.0008509805,0.0010156622,0.0005090082,0.00093228114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095817115,0.00085518666,0.0012842627,0.0008344554,0.0008469078,0.00015893552,0.00059814483,0.00028902205,0.0027139555],"category_scores_gemma":[0.000042179734,0.0005433712,0.0005075496,0.0012446647,0.00039713137,0.0007894489,0.000101938844,0.0018919257,0.00021415812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034750935,0.0038372304,0.96923715,0.00005531225,0.0004859275,0.0041200547,0.0019606983,0.00012130791,0.00039827236,0.000004774175,0.0068806894,0.0094235],"study_design_scores_gemma":[0.015282909,0.0046008667,0.95893013,0.0005822753,0.00047242708,0.009238186,0.00040784944,0.00006543459,0.00021831554,0.00012380243,0.00947508,0.000602721],"about_ca_topic_score_codex":0.00017599325,"about_ca_topic_score_gemma":0.000050792383,"teacher_disagreement_score":0.011807816,"about_ca_system_score_codex":0.00081762497,"about_ca_system_score_gemma":0.0009384539,"threshold_uncertainty_score":0.9997018},"labels":[],"label_agreement":null},{"id":"W2020780443","doi":"10.1016/j.eururo.2006.08.037","title":"Concomitant Carcinoma In Situ Is a Feature of Aggressive Disease in Patients With Organ-Confined TCC at Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Concomitant; Medicine; Bladder cancer; Carcinoma in situ; Transitional cell carcinoma; Urology; Carcinoma; Urethra; Surgery; Cancer; Internal medicine","score_opus":0.004920991018149207,"score_gpt":0.20763285885152905,"score_spread":0.20271186783337983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020780443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899808,0.00073858286,0.0000022795862,0.0009582192,0.000056643665,0.00048268627,0.000056299257,0.000018595172,0.007705886],"genre_scores_gemma":[0.9982953,0.000005942486,0.000030392965,0.0010112652,0.00006822182,0.000008639479,0.00009324804,0.00004068896,0.00044630878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874,0.00021167699,0.00025696668,0.00033818607,0.00017647717,0.00027669873],"domain_scores_gemma":[0.9993148,0.000042139323,0.0001847427,0.0002786694,0.000054488006,0.00012516712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059999104,0.00018743248,0.00037631983,0.00014406443,0.000021188807,0.0000030888036,0.00009139115,0.00005747593,0.00015424007],"category_scores_gemma":[0.000050344446,0.00013891596,0.000048874062,0.00019233547,0.00016253344,0.000023220153,0.000055691857,0.00019840793,0.000039920895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006033155,0.00046840595,0.98825556,0.00003066637,0.000032878677,0.0029110431,0.0003102272,0.0000064574656,0.0004392955,0.000015292557,0.0012557182,0.00024130305],"study_design_scores_gemma":[0.018281097,0.0012254834,0.9777884,0.00005156131,0.00009840148,0.00002244626,0.0000069549355,0.000009859109,0.0005808681,0.000010522117,0.0018104288,0.00011401681],"about_ca_topic_score_codex":0.00015092289,"about_ca_topic_score_gemma":0.00017507693,"teacher_disagreement_score":0.012247942,"about_ca_system_score_codex":0.00009604344,"about_ca_system_score_gemma":0.000097261836,"threshold_uncertainty_score":0.56648284},"labels":[],"label_agreement":null},{"id":"W2020780903","doi":"10.1007/s00345-011-0677-0","title":"Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy","year":2011,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Internal medicine; Stage (stratigraphy); Cancer; Cohort; Performance status; T-stage; Adjuvant therapy; Nephrology; Surgery; Oncology; Urology; Metastasis","score_opus":0.07436897637369806,"score_gpt":0.3521864511179794,"score_spread":0.27781747474428137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020780903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948239,0.00046943573,0.00013530934,0.0017295512,0.0007775226,0.00017536058,0.0000147166265,0.000014676313,0.001859552],"genre_scores_gemma":[0.9912046,0.00014190459,0.001979067,0.0057253167,0.000525807,0.000006268765,0.0000017119895,0.000019521742,0.0003957629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776775,0.00025065325,0.001122943,0.00022856388,0.00035250557,0.00027759655],"domain_scores_gemma":[0.99866045,0.00011303832,0.0004490394,0.0002860254,0.00012960171,0.0003618676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048130358,0.00018445702,0.0009731008,0.0002219776,0.00002035516,0.000004893569,0.00021578057,0.00023638422,0.004264576],"category_scores_gemma":[0.00009440492,0.000118587355,0.00044645095,0.00009611438,0.00038198175,0.00009591798,0.000058703765,0.00071305456,0.000025238558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010283385,0.0013255245,0.9734106,0.000014318993,0.0007430289,0.0020593274,0.00065498246,1.7298274e-7,0.0001227682,0.00006366044,0.0010278168,0.010294403],"study_design_scores_gemma":[0.0065585286,0.005826471,0.9704844,0.000018026294,0.00054806424,0.0005644282,0.000017534632,0.00000537514,0.00023132036,0.000449796,0.015207139,0.00008892016],"about_ca_topic_score_codex":0.000028032307,"about_ca_topic_score_gemma":0.00006391554,"teacher_disagreement_score":0.014179322,"about_ca_system_score_codex":0.000034621735,"about_ca_system_score_gemma":0.00020667438,"threshold_uncertainty_score":0.9966457},"labels":[],"label_agreement":null},{"id":"W2021659358","doi":"10.1016/j.juro.2010.02.1181","title":"1466 INCIDENCE OF HEMATURIA FOLLOWING TUR-BT AMONG 1315 PATIENTS RECEIVING ANTI-PLATELET THERAPY","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Incidence (geometry); Exact test; Confidence interval; Aspirin; Relative risk; Surgery; Randomization; Clopidogrel; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.010513488826045872,"score_gpt":0.2697039506412945,"score_spread":0.25919046181524863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021659358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969095,0.0005805622,0.000032383356,0.0006561612,0.0010882261,0.00018241341,0.0000019612905,0.0000075140883,0.0005412759],"genre_scores_gemma":[0.99865305,0.0003246379,0.00017250274,0.0005230781,0.0002529436,0.0000013716468,0.0000012090394,0.000019471265,0.00005173177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988447,0.00012148374,0.0004402446,0.00009103834,0.00029430157,0.00020822872],"domain_scores_gemma":[0.9988298,0.00021700449,0.00044160377,0.0002446418,0.00017690755,0.00009008015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006055458,0.00013225102,0.00043256072,0.00010126632,0.00006457424,0.0000060485418,0.00022653848,0.00012383863,0.00012254059],"category_scores_gemma":[0.00018552269,0.00007555527,0.00016729273,0.000110515655,0.00010283892,0.000118816235,0.00003201276,0.0005765422,0.0000056275317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001857445,0.00041604126,0.88780016,0.000019711748,0.0006372029,0.0001321508,0.0023389857,0.000017019382,0.093986,0.000019247742,0.0006544622,0.012121573],"study_design_scores_gemma":[0.0049982993,0.002106531,0.96668535,0.00005793645,0.0002714466,0.0004532368,0.000061183666,0.000013870959,0.02362943,0.0004868254,0.0011447232,0.000091158356],"about_ca_topic_score_codex":0.00006641778,"about_ca_topic_score_gemma":0.00002839788,"teacher_disagreement_score":0.07888519,"about_ca_system_score_codex":0.000018036799,"about_ca_system_score_gemma":0.000101921134,"threshold_uncertainty_score":0.30810544},"labels":[],"label_agreement":null},{"id":"W2021777962","doi":"10.5489/cuaj.1836","title":"Concurrent upper and lower urinary tract robotic surgery: A case series","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Upper urinary tract; Cystectomy; Robotic surgery; Urinary system; Surgery; Da Vinci Surgical System; Prostatectomy; Urinary diversion; Blood loss; Urology; Internal medicine; Bladder cancer; Prostate; Cancer","score_opus":0.017691948485106634,"score_gpt":0.24523952519691242,"score_spread":0.22754757671180578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021777962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683616,0.00072979147,0.00007633287,0.027483163,0.0008441826,0.0001634786,0.000024876563,0.00002682204,0.0022897583],"genre_scores_gemma":[0.99522907,0.00010291635,0.00004507507,0.0033833103,0.00046370825,0.0000060064594,0.000008277081,0.000010508487,0.000751143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989578,0.00014389085,0.0002175743,0.00015190257,0.00017335343,0.00035544496],"domain_scores_gemma":[0.9987703,0.00016794223,0.000111017245,0.000066028646,0.00010962771,0.0007750903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003905653,0.00012365887,0.00028476407,0.000105101906,0.00023776275,0.000067316585,0.00002732763,0.00014791233,0.0006165073],"category_scores_gemma":[0.0004076062,0.00009391063,0.000110257926,0.00008127974,0.00003496877,0.000103010934,0.000009211497,0.00033522688,0.000030109422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048627702,0.00017865251,0.9666451,0.000009077625,0.00013007186,0.007054578,0.000120692464,0.0000063909997,0.000005979084,0.00016120265,0.007818595,0.017821018],"study_design_scores_gemma":[0.0013913761,0.0016014457,0.78616554,0.000027461509,0.0002660963,0.11894515,0.00007860243,0.00012007876,0.0000044639582,0.0007185321,0.09047315,0.00020807148],"about_ca_topic_score_codex":0.0007471269,"about_ca_topic_score_gemma":0.00026699825,"teacher_disagreement_score":0.18047956,"about_ca_system_score_codex":0.00043066143,"about_ca_system_score_gemma":0.00031267264,"threshold_uncertainty_score":0.67503226},"labels":[],"label_agreement":null},{"id":"W2021883996","doi":"10.5489/cuaj.11057","title":"Radiation treatment of bladder squamous cell carcinoma in a patient with spina bifida: A case report","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Spina bifida; Basal cell; Bladder cancer; Urinary bladder; Urinary system; Cancer; Carcinoma; Oncology; Radiation therapy; Urology; Internal medicine; Surgery","score_opus":0.014342820806064568,"score_gpt":0.23680768839926572,"score_spread":0.22246486759320117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021883996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398816,0.0009844408,0.00000957742,0.0013231067,0.00016433463,0.00035105637,0.00002930035,0.0000076203683,0.0031424037],"genre_scores_gemma":[0.99897206,0.000021776681,0.00008484038,0.0004114621,0.0002486625,0.00002802499,0.000020952464,0.000013302039,0.00019890371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863684,0.00010554508,0.0003902814,0.00014721112,0.0002587608,0.00046135794],"domain_scores_gemma":[0.9987131,0.0000536711,0.00033306715,0.00011829248,0.00014130883,0.0006405548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019408029,0.00014966239,0.00030228437,0.0002157991,0.00009275696,0.000014906794,0.000026338566,0.00015557231,0.00031093898],"category_scores_gemma":[0.00008865366,0.00010359113,0.000096257805,0.00021772807,0.000019153227,0.000093659495,0.0000026815121,0.00016860348,0.000012422513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015706121,0.000500866,0.96403813,0.000004479244,0.000053847933,0.029137675,0.00092329655,0.000024392672,0.00002880238,0.00000540674,0.00041853887,0.0047074966],"study_design_scores_gemma":[0.004284072,0.003937514,0.9271525,0.0000054895236,0.00023953605,0.055885255,0.0002999878,0.000024380626,0.0006853101,0.000017503582,0.0073346854,0.00013377295],"about_ca_topic_score_codex":0.012812411,"about_ca_topic_score_gemma":0.00238767,"teacher_disagreement_score":0.036885645,"about_ca_system_score_codex":0.0024619766,"about_ca_system_score_gemma":0.00065907906,"threshold_uncertainty_score":0.99376136},"labels":[],"label_agreement":null},{"id":"W2023068267","doi":"10.1097/pai.0b013e3182351ed3","title":"Utility of Cytokeratin 5/6, Cytokeratin 20, and p16 in the Diagnosis of Reactive Urothelial Atypia and Noninvasive Component of Urothelial Neoplasia","year":2012,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cytokeratin; Urothelium; Atypia; Pathology; Immunostaining; Medicine; Urothelial carcinoma; Staining; Reactivity (psychology); Immunohistochemistry; Urinary bladder; Urology; Cancer; Internal medicine; Bladder cancer","score_opus":0.011915970365438086,"score_gpt":0.2679578049216085,"score_spread":0.2560418345561704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023068267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338865,0.002378417,0.00010848069,0.00014578362,0.00005358604,0.0008697891,0.00015546351,0.000008113872,0.0028916935],"genre_scores_gemma":[0.99863875,0.00013038004,0.00066373876,0.00020401072,0.00003767671,0.00021265553,0.00006698461,0.000027197964,0.000018622846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983851,0.00011035615,0.00060196745,0.00033152636,0.00025898273,0.0003120676],"domain_scores_gemma":[0.99879277,0.00018521717,0.00033292474,0.000511921,0.00009037228,0.000086815664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026519914,0.00028724747,0.0007158492,0.00006899409,0.000047649606,0.000004309453,0.00015087132,0.00020579889,0.00009928248],"category_scores_gemma":[0.000059810507,0.00023906492,0.0001063349,0.0001434259,0.0007168809,0.000035956025,0.00009700767,0.0002984399,0.0000016622331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013233674,0.00070814625,0.023850331,0.00019748029,0.00018118821,0.000030040312,0.0020252422,9.742892e-7,0.9708045,0.00026591407,0.00007691319,0.0005359096],"study_design_scores_gemma":[0.0034779385,0.0002970108,0.052998424,0.00006616068,0.0002723606,0.00029165813,0.0005821327,0.0000053708113,0.94171077,0.00008234454,0.00006636794,0.0001494442],"about_ca_topic_score_codex":0.00042100382,"about_ca_topic_score_gemma":0.0000014875671,"teacher_disagreement_score":0.02914809,"about_ca_system_score_codex":0.000045417135,"about_ca_system_score_gemma":0.00014151681,"threshold_uncertainty_score":0.97487843},"labels":[],"label_agreement":null},{"id":"W2023747560","doi":"10.1111/j.1464-410x.2007.07287.x","title":"Immunocytology in the assessment of patients with painless gross haematuria","year":2007,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urine cytology; Urinary system; Cytology; Urine; Endoscopy; Transitional cell carcinoma; Pathology; Urology; Prospective cohort study; Population; Urinary bladder; Gross examination; Carcinoma; Cancer; Surgery; Internal medicine","score_opus":0.010884276509725474,"score_gpt":0.2905299622114256,"score_spread":0.2796456857017001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023747560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620193,0.0011844685,0.00067635096,0.00044618573,0.00018220572,0.00020241662,0.000009044522,0.0000023860257,0.0010950203],"genre_scores_gemma":[0.9983107,0.00013147958,0.000595432,0.00085594784,0.000076207325,0.0000026266798,0.0000060876564,0.000010127062,0.000011383038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988391,0.00013990999,0.0004569893,0.00008986354,0.00025831407,0.00021581538],"domain_scores_gemma":[0.9992138,0.00013840418,0.00028372387,0.00011186328,0.00020520293,0.00004701413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007546057,0.000081159626,0.00038307416,0.00010265539,0.000030173567,0.0000071669774,0.00013790902,0.00008532966,0.00005232077],"category_scores_gemma":[0.00004189888,0.000056568242,0.00006967581,0.000129001,0.00013472066,0.0000498288,0.000015038431,0.00035804926,5.848276e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017241713,0.0011827196,0.9673337,0.00003446868,0.00021426809,0.0038836156,0.00030071766,0.0000087240915,0.00006262987,0.00015013617,0.00034632618,0.024758575],"study_design_scores_gemma":[0.0064505762,0.002726692,0.9834105,0.00005698703,0.00011844736,0.0058753095,0.00011089199,0.0000019614502,0.000037323673,0.0001537926,0.0010130558,0.000044478096],"about_ca_topic_score_codex":0.0000939081,"about_ca_topic_score_gemma":0.00019701303,"teacher_disagreement_score":0.024714097,"about_ca_system_score_codex":0.000043777985,"about_ca_system_score_gemma":0.00013521568,"threshold_uncertainty_score":0.2306786},"labels":[],"label_agreement":null},{"id":"W2023981892","doi":"10.1016/j.urology.2008.07.042","title":"Evidence-based Sex-related Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results of Large Multicenter Study","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Multicenter study; Oncology; Internal medicine; Cancer; Bladder cancer; Randomized controlled trial","score_opus":0.037880242779949544,"score_gpt":0.31456175221761623,"score_spread":0.2766815094376667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023981892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412143,0.0005814127,0.00016135676,0.002187281,0.0004267183,0.002094501,0.00021315485,0.00005487176,0.00015927927],"genre_scores_gemma":[0.9958931,0.000015317573,0.00023305946,0.0025714554,0.00017051975,0.0003001689,0.00003931717,0.00004403472,0.00073300855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980045,0.00020171255,0.0005895981,0.0004789171,0.0002730645,0.00045219113],"domain_scores_gemma":[0.99867946,0.00048584907,0.00013005912,0.00044186352,0.00011106488,0.00015172323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002531675,0.00026595048,0.00066948956,0.00016350114,0.00007596168,0.0000040219975,0.00012227024,0.00021390397,0.0003081208],"category_scores_gemma":[0.00027209925,0.0001962213,0.0003048712,0.00010515038,0.00016897303,0.00007562872,0.00003095241,0.00023416827,0.000028300863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017458495,0.0031548026,0.9752671,0.00003709451,0.00030712044,0.00041402888,0.0020139208,0.000005632768,0.00028097874,0.0000028412364,0.0007638532,0.00029413385],"study_design_scores_gemma":[0.052192017,0.006520835,0.93343925,0.000028646955,0.0007102723,0.00006838462,0.00007534366,0.0003982871,0.0012497066,0.000008578513,0.0051262314,0.00018242568],"about_ca_topic_score_codex":0.00014621411,"about_ca_topic_score_gemma":0.000028011813,"teacher_disagreement_score":0.041827828,"about_ca_system_score_codex":0.000057320656,"about_ca_system_score_gemma":0.0002284842,"threshold_uncertainty_score":0.80016726},"labels":[],"label_agreement":null},{"id":"W2024104894","doi":"10.14740/jmc.v5i8.1865","title":"An Asymptomatic Small-Cell Bladder Cancer Until Bilateral Ureteral Obstruction Happened","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Percutaneous nephrostomy; Gross hematuria; Asymptomatic; Hydronephrosis; Urology; Surgery; Biopsy; Microscopic hematuria; Radiology; Cancer; Kidney; Percutaneous; Urinary system; Internal medicine","score_opus":0.023273913087266698,"score_gpt":0.3107119978438762,"score_spread":0.28743808475660954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024104894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423164,0.00074369437,0.00057810574,0.0028422957,0.0010360086,0.0001287419,0.000006361933,0.000026274714,0.00040685356],"genre_scores_gemma":[0.99474347,0.00022972975,0.0007235626,0.002113018,0.0019292589,0.000006867525,0.000006585353,0.000027807091,0.00021967711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99784523,0.00012307771,0.0005555072,0.0001662576,0.0010490605,0.0002608648],"domain_scores_gemma":[0.99861234,0.00008796415,0.0002660654,0.0001948756,0.00017672416,0.0006620195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040762924,0.00018456267,0.00046166524,0.00013654,0.00006747061,0.00004056621,0.00017464737,0.00018004877,0.0023408586],"category_scores_gemma":[0.0001876879,0.00012173323,0.00018178916,0.00011614274,0.00008809588,0.0001643877,0.000019949297,0.00037237882,0.000016648128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064889984,0.00528573,0.3572378,0.0015506359,0.0026116609,0.01048592,0.0037005374,0.00024438085,0.02636182,0.00025218655,0.026730547,0.5590498],"study_design_scores_gemma":[0.09350467,0.044352144,0.56423706,0.0068124225,0.009373258,0.08049325,0.0020678896,0.019354992,0.09650873,0.0027229253,0.07809378,0.0024788855],"about_ca_topic_score_codex":0.00025898707,"about_ca_topic_score_gemma":0.00007647866,"teacher_disagreement_score":0.5565709,"about_ca_system_score_codex":0.00010543199,"about_ca_system_score_gemma":0.00041115916,"threshold_uncertainty_score":0.99857116},"labels":[],"label_agreement":null},{"id":"W2024247307","doi":"10.1002/cncr.23665","title":"Reply to Is There an Optimal Comorbidity Index for Prostate Cancer?","year":2008,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Comorbidity; Medicine; Disease; Prostate cancer; Bladder cancer; Cancer; Genitourinary system; Cystectomy; Internal medicine; Diabetes mellitus; Kidney cancer; Oncology; Prostate; Intensive care medicine; Gynecology","score_opus":0.05484302846256963,"score_gpt":0.35149154237882413,"score_spread":0.2966485139162545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024247307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855122,0.0030117456,0.00026116273,0.006948962,0.0004826406,0.0015393347,0.0006573051,0.00009593008,0.0014907442],"genre_scores_gemma":[0.97125053,0.0011927901,0.00053783203,0.016138757,0.0007302256,0.0013998816,0.000025242112,0.000053954063,0.008670805],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989535,0.000012212697,0.000159275,0.00037404933,0.00018856984,0.00031235948],"domain_scores_gemma":[0.9991728,0.000011215819,0.000047405505,0.00033518753,0.0001650529,0.00026832477],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044950637,0.00017023816,0.00027083274,0.00004203962,0.00013914338,0.000010696247,0.00008805292,0.000057927184,0.0010440565],"category_scores_gemma":[0.0000092595465,0.0001381573,0.000081724254,0.00013721829,0.00005479392,0.00008727141,0.000020663232,0.00009809763,0.000021943339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006940493,0.0005401189,0.51755524,0.00027374827,0.000553906,0.00014036316,0.010827142,0.00036497752,0.0017950321,0.000021029651,0.34082222,0.12016572],"study_design_scores_gemma":[0.0057319584,0.0014999169,0.25545773,0.00017672623,0.00018915076,0.000040475825,0.00018913821,0.000352528,0.030371884,0.000049380767,0.70557874,0.00036237936],"about_ca_topic_score_codex":0.0038951205,"about_ca_topic_score_gemma":0.00022409609,"teacher_disagreement_score":0.36475652,"about_ca_system_score_codex":0.00026382066,"about_ca_system_score_gemma":0.000517384,"threshold_uncertainty_score":0.9998691},"labels":[],"label_agreement":null},{"id":"W2024400031","doi":"10.1016/j.humpath.2013.01.014","title":"High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer","year":2013,"lang":"en","type":"article","venue":"Human Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"CD68; Bladder cancer; Immunohistochemistry; Medicine; Hazard ratio; Proportional hazards model; Cancer; Pathology; Tumor progression; Oncology; Stroma; Internal medicine; Confidence interval","score_opus":0.05378597756423603,"score_gpt":0.32481538618629313,"score_spread":0.2710294086220571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024400031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726605,0.000249904,0.000029632387,0.00043191834,0.00023345176,0.00095481856,0.000045800873,0.000035276615,0.0007531178],"genre_scores_gemma":[0.99584347,0.000015806638,0.0021281056,0.0010388122,0.00014985335,0.00033343319,0.000024311672,0.00003076871,0.00043542957],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987511,0.00007024377,0.00033586347,0.000332193,0.00019128883,0.00031929734],"domain_scores_gemma":[0.9993841,0.000026274145,0.00009307056,0.0002698517,0.00009886767,0.0001278486],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008918028,0.00016965847,0.00036795216,0.00015738182,0.000054556294,0.00000916138,0.00009081031,0.00013128566,0.0009760656],"category_scores_gemma":[0.000027209282,0.00013665302,0.00004804716,0.00015677317,0.000071440394,0.000072406896,0.00005921584,0.00021231615,0.000060091406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007277747,0.000420018,0.047844745,0.00022704771,0.000028506047,0.00036963448,0.0019108341,0.000019194498,0.93654495,0.000112674665,0.004130446,0.00831917],"study_design_scores_gemma":[0.002674734,0.0010202357,0.81179255,0.00064434286,0.0000697398,0.000074784686,0.00022767491,0.000014159202,0.18275562,0.00039894946,0.00016016573,0.00016702808],"about_ca_topic_score_codex":0.0009296425,"about_ca_topic_score_gemma":0.0003761094,"teacher_disagreement_score":0.76394784,"about_ca_system_score_codex":0.00007393978,"about_ca_system_score_gemma":0.000086304266,"threshold_uncertainty_score":0.9999372},"labels":[],"label_agreement":null},{"id":"W2024606186","doi":"10.1016/j.juro.2010.02.1185","title":"1470 PROGRESSION TO MUSCLE INVASION DURING SURVEILLANCE OF UROTHELIAL CARCINOMA IS ASSOCIATED WITH POOR PROGNOSIS","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; General surgery; Internal medicine","score_opus":0.013916024579443598,"score_gpt":0.26806856050289635,"score_spread":0.25415253592345277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024606186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441546,0.00015021894,0.000015314135,0.004657008,0.00019651864,0.00035634148,0.00001151132,0.000009434807,0.00018820696],"genre_scores_gemma":[0.99896234,0.000028149572,0.00017556005,0.000554087,0.00018960686,0.000006594958,0.0000011434269,0.00002179719,0.00006068932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989256,0.00012553658,0.0003188525,0.00010633079,0.00031185526,0.00021179883],"domain_scores_gemma":[0.9989653,0.00010022051,0.00034698792,0.00016874101,0.00029498147,0.00012375023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044591396,0.0001229343,0.0003564951,0.000104131155,0.00006999852,0.0000047056487,0.00015611536,0.000095642055,0.00010939418],"category_scores_gemma":[0.00015084371,0.00006481831,0.000073785784,0.00017788779,0.000099970835,0.000043363034,0.000039254548,0.00035793154,0.0000047706935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060335356,0.0005009635,0.5542778,0.000032105883,0.00024202059,0.00011296522,0.0014047052,0.0000074791005,0.43294218,0.0000042055985,0.0004003162,0.004041776],"study_design_scores_gemma":[0.003829048,0.005125045,0.88789123,0.00006229392,0.00022121414,0.0005820875,0.00004366405,0.000011579027,0.101809576,0.00002642832,0.0003260731,0.0000717834],"about_ca_topic_score_codex":0.00005020554,"about_ca_topic_score_gemma":0.000100713674,"teacher_disagreement_score":0.33361346,"about_ca_system_score_codex":0.000028688995,"about_ca_system_score_gemma":0.00016992785,"threshold_uncertainty_score":0.26432142},"labels":[],"label_agreement":null},{"id":"W2024618780","doi":"10.1186/2193-1801-2-412","title":"Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder","year":2013,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Loss of heterozygosity; Carcinogenesis; Urinary system; Medicine; Field cancerization; Urothelial carcinoma; Urinary bladder; Upper urinary tract; Carcinoma in situ; Pathology; Oncology; Carcinoma; Bladder cancer; Urology; Biology; Internal medicine; Cancer; Genetics; Gene","score_opus":0.0558679820806107,"score_gpt":0.3427103606936319,"score_spread":0.2868423786130212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024618780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924051,0.001473107,0.000031402444,0.0033902451,0.0000970256,0.00094433915,0.0000052071914,0.0000061946844,0.0016473917],"genre_scores_gemma":[0.9984879,0.00006359665,0.0005038244,0.00075850525,0.00006279859,0.00007834099,0.0000016874668,0.000013355357,0.000030020577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985714,0.00021025618,0.00043525794,0.0002027744,0.00034197693,0.00023836692],"domain_scores_gemma":[0.9992304,0.00019014355,0.00012764604,0.00037134645,0.000055401077,0.000025066538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045757918,0.00016346743,0.00034304152,0.000069521564,0.00007366697,0.000016608681,0.0002770816,0.00007401222,0.000030420431],"category_scores_gemma":[0.00006169,0.0000802126,0.000077901845,0.00029298384,0.00015124332,0.000071681716,0.00008489517,0.00028495325,0.0000036890303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008070024,0.00028887048,0.98285997,0.000121279794,0.00003111428,0.000010000505,0.011595213,0.00000305444,0.00068344106,0.00070322223,0.00005196569,0.0035711522],"study_design_scores_gemma":[0.0011961432,0.00013377896,0.9912859,0.00022244094,0.00004515519,0.000049514183,0.0022434243,0.00005208463,0.0037640661,0.00039591573,0.00052014535,0.00009142955],"about_ca_topic_score_codex":0.0019728935,"about_ca_topic_score_gemma":0.0001283113,"teacher_disagreement_score":0.009351788,"about_ca_system_score_codex":0.000079557736,"about_ca_system_score_gemma":0.00028457967,"threshold_uncertainty_score":0.3270975},"labels":[],"label_agreement":null},{"id":"W2024809433","doi":"10.1007/s00345-011-0645-8","title":"Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients","year":2011,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Concomitant; Medicine; Lymphovascular invasion; Proportional hazards model; Hazard ratio; Internal medicine; Stage (stratigraphy); Oncology; Urology; Nephrology; Carcinoma; Urothelial carcinoma; Carcinoma in situ; Bladder cancer; Cancer; Metastasis","score_opus":0.030243079100302838,"score_gpt":0.2907591367459789,"score_spread":0.2605160576456761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024809433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983713,0.00044331752,0.000029952625,0.00009871077,0.00023689328,0.0005468722,0.000030608164,0.000002162425,0.00024017642],"genre_scores_gemma":[0.9993105,0.000033947123,0.000338331,0.00021220696,0.000042328964,0.000021994405,0.000010819708,0.000015741483,0.000014161963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983356,0.00020013106,0.00072904216,0.00024348353,0.00021310983,0.00027865515],"domain_scores_gemma":[0.9988987,0.00025745976,0.0003406108,0.00015699284,0.00019127488,0.00015499078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036754427,0.00017180764,0.0007645722,0.0009363044,0.000016570524,0.000005822498,0.00011316504,0.00008974784,0.00007905048],"category_scores_gemma":[0.00018696065,0.00013504493,0.0001708551,0.00033272206,0.00009617946,0.00011495633,0.000024894394,0.00028601155,7.2321444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049361484,0.0016595774,0.98762643,0.000027244223,0.00030163472,0.00017997655,0.0022743363,0.0000047247686,0.0002088735,0.000025148334,0.0000037293325,0.002752157],"study_design_scores_gemma":[0.0108716665,0.0043577645,0.9823363,0.000029372823,0.0013826528,0.00003844092,0.00014659295,0.00024482651,0.00031719232,0.00012364124,0.000052614447,0.00009897266],"about_ca_topic_score_codex":0.00049539545,"about_ca_topic_score_gemma":0.0023154898,"teacher_disagreement_score":0.0059355185,"about_ca_system_score_codex":0.00007603306,"about_ca_system_score_gemma":0.00014475256,"threshold_uncertainty_score":0.5506972},"labels":[],"label_agreement":null},{"id":"W2024892961","doi":"10.1016/j.eururo.2011.07.066","title":"External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Bladder cancer; Receiver operating characteristic; Urology; Cystectomy; Cohort; Area under the curve; Retrospective cohort study; Surgery; Cancer; Oncology; Internal medicine","score_opus":0.08385544484308506,"score_gpt":0.2941928179687829,"score_spread":0.21033737312569784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024892961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735886,0.00013952874,0.000138166,0.00003753523,0.0001696392,0.0008519724,0.00039684988,0.0000053840745,0.00090204057],"genre_scores_gemma":[0.9996412,0.000049120074,0.00011535735,0.00007129408,0.00003474644,0.000023443956,0.00002832378,0.000019850608,0.000016691445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989339,0.00018009575,0.00035679358,0.000226848,0.00017083132,0.00013152494],"domain_scores_gemma":[0.9992701,0.00002387587,0.00023087037,0.00025085118,0.0001846961,0.000039607454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001599836,0.00012280895,0.00024910117,0.00006105918,0.000019872403,0.0000021261044,0.000097603865,0.000037436253,0.00004403778],"category_scores_gemma":[0.000019684961,0.00008235116,0.000046149387,0.00009850845,0.00024658142,0.000055739176,0.000048809008,0.000088112865,4.6140252e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011478029,0.0004036825,0.9940274,0.000037771744,0.00024053972,0.000003226165,0.0017107162,0.0000064671494,0.001344002,0.000113918846,0.000021604199,0.0009429001],"study_design_scores_gemma":[0.0038367512,0.0026411423,0.9820273,0.00004519885,0.0003568662,0.0000037134414,0.00002825938,0.000013801661,0.0108933095,0.00004997323,0.000050326344,0.000053363197],"about_ca_topic_score_codex":0.00045507585,"about_ca_topic_score_gemma":0.00009130984,"teacher_disagreement_score":0.012000074,"about_ca_system_score_codex":0.00001979087,"about_ca_system_score_gemma":0.00005851187,"threshold_uncertainty_score":0.3358183},"labels":[],"label_agreement":null},{"id":"W2025426616","doi":"10.1007/s00428-014-1596-4","title":"FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"KWF Kankerbestrijding; University of Toronto","keywords":"Fibroblast growth factor receptor 3; Biology; Exon; Point mutation; Mutation; Receptor tyrosine kinase; Molecular biology; Mutant; Cancer research; Gene; Receptor; Fibroblast growth factor; Genetics","score_opus":0.02603199013602683,"score_gpt":0.3335202744823073,"score_spread":0.3074882843462805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025426616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98370713,0.0013227311,0.0027614918,0.002429563,0.000386619,0.0015206774,0.000377512,0.00034189492,0.0071523935],"genre_scores_gemma":[0.9871269,0.0016527645,0.0042243735,0.0042556524,0.0004637789,0.00043962314,0.0006865522,0.00011952656,0.0010308302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529064,0.00072139624,0.0008447774,0.0013544724,0.00075023895,0.0010384592],"domain_scores_gemma":[0.9954361,0.0019681535,0.0007283408,0.0009407311,0.0003670381,0.00055967725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080611184,0.0008283063,0.0014050256,0.00024915484,0.00069216744,0.00007726476,0.0004045878,0.0004907375,0.00033429646],"category_scores_gemma":[0.001885747,0.00057564554,0.00021830379,0.0005469083,0.0010167267,0.00030673973,0.00026699243,0.0011186885,0.000101226455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045984834,0.0042768586,0.5581295,0.0008856363,0.00545854,0.0011326203,0.009248172,0.0011434718,0.3605829,0.0019196139,0.02002504,0.032599203],"study_design_scores_gemma":[0.019089501,0.0035747085,0.88146436,0.0020989028,0.003480901,0.00006989518,0.0033380126,0.0020932697,0.07481271,0.0050136424,0.0032951902,0.001668895],"about_ca_topic_score_codex":0.0009325831,"about_ca_topic_score_gemma":0.0002953016,"teacher_disagreement_score":0.3233349,"about_ca_system_score_codex":0.0001547639,"about_ca_system_score_gemma":0.0007245904,"threshold_uncertainty_score":0.9996695},"labels":[],"label_agreement":null},{"id":"W2026073085","doi":"10.5489/cuaj.1223","title":"A case of isolated rectal recurrence of muscle invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Colorectal cancer; Chemotherapy; Adjuvant chemotherapy; Surgery; Urology; Cancer; Internal medicine","score_opus":0.019814948953668525,"score_gpt":0.2578379890652857,"score_spread":0.23802304011161718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026073085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335784,0.0004042996,0.0000138021915,0.0040512555,0.00021302071,0.0002525966,0.00009357557,0.0000071790478,0.0016064292],"genre_scores_gemma":[0.99832577,0.00016957532,0.00010243018,0.0010010801,0.00013433825,0.00001846645,0.000005946753,0.000008069489,0.00023435231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989538,0.000098562974,0.0003503008,0.00012637951,0.00018478377,0.0002861277],"domain_scores_gemma":[0.99840355,0.0001124315,0.00033283635,0.00008326842,0.0006140918,0.0004537973],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016707454,0.00010212357,0.00028363688,0.00012576998,0.000083268365,0.000015345751,0.00006400335,0.00017261095,0.0036192113],"category_scores_gemma":[0.0004691782,0.000078977566,0.0001148585,0.00022643588,0.000042446674,0.00009231455,0.0000086211085,0.00030674052,0.000022242672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012911441,0.0002342639,0.9314301,0.00003330544,0.0008232726,0.0011853225,0.0012863026,0.000028501172,0.003959826,0.00005820696,0.022105368,0.03872639],"study_design_scores_gemma":[0.0031602741,0.001983524,0.9848143,0.000101421894,0.0004247007,0.0030689798,0.00042645223,0.00024083394,0.001405099,0.00114606,0.0029867915,0.00024155765],"about_ca_topic_score_codex":0.027855674,"about_ca_topic_score_gemma":0.004804587,"teacher_disagreement_score":0.053384177,"about_ca_system_score_codex":0.00048214858,"about_ca_system_score_gemma":0.00095077965,"threshold_uncertainty_score":0.9972916},"labels":[],"label_agreement":null},{"id":"W2026246384","doi":"10.1016/j.eururo.2015.02.007","title":"Corrigendum to “Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort” [Eur Urol 2010;57:300–9]","year":2015,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Urology; Cohort; Carcinoma; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.03272047341148435,"score_gpt":0.294395894857815,"score_spread":0.2616754214463306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026246384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596305,0.000098909426,0.000046849942,0.00076918694,0.014873244,0.0017894121,0.010027997,0.00013663103,0.012627283],"genre_scores_gemma":[0.94980115,0.000073950505,0.00042195196,0.0027282515,0.0028618504,0.00003414855,0.012707191,0.0003264249,0.031045068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953102,0.00085180195,0.0012279026,0.0013238561,0.0007938871,0.00049239444],"domain_scores_gemma":[0.9967599,0.00013067853,0.0007499922,0.0010272601,0.0005324804,0.00079972646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041856692,0.0007268616,0.0016743832,0.00028778802,0.00006726362,0.00003623167,0.0004733167,0.000434577,0.000114567425],"category_scores_gemma":[0.00040901016,0.000500975,0.00013605777,0.00014691391,0.0005000508,0.000090138354,0.00019309993,0.0011438653,0.00007175803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0176754,0.0009136229,0.83878267,0.000017751192,0.0011814999,0.00090811664,0.0002473832,3.979309e-7,0.0000034025388,0.0000023654454,0.1391018,0.0011655755],"study_design_scores_gemma":[0.016531125,0.009691127,0.8244328,0.00005355467,0.0013544661,0.0000391356,0.000010681405,0.000028813412,0.0000035607056,0.0000024952562,0.14748214,0.00037008894],"about_ca_topic_score_codex":0.0009164457,"about_ca_topic_score_gemma":0.00025954432,"teacher_disagreement_score":0.018417787,"about_ca_system_score_codex":0.00010189977,"about_ca_system_score_gemma":0.00051153277,"threshold_uncertainty_score":0.9997442},"labels":[],"label_agreement":null},{"id":"W2027705083","doi":"10.1038/ncpuro1106","title":"Can patients with low-grade papillary bladder tumors be followed up with a cystoscopy interval of 6 months?","year":2008,"lang":"en","type":"letter","venue":"Nature Clinical Practice Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Urology; Papillary tumor; Interval (graph theory); Surgery; Internal medicine; Radiology; Urinary system","score_opus":0.018501659437962288,"score_gpt":0.33700305466111824,"score_spread":0.31850139522315596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027705083","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10370428,0.0027560217,0.000028256976,0.8811805,0.0031851314,0.0031749667,0.0005390426,0.00016999786,0.005261782],"genre_scores_gemma":[0.25788853,0.00040378442,0.001472377,0.73512733,0.0025499524,0.0000947506,0.0011405128,0.00022352014,0.0010992397],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941473,0.0009246693,0.0013876621,0.0013883155,0.001327794,0.0008242829],"domain_scores_gemma":[0.9921169,0.003291912,0.002045498,0.0012632959,0.0009576245,0.00032473254],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00037756536,0.00088192226,0.0022790504,0.00025692763,0.00010541591,0.000017373133,0.0004393034,0.0042149895,0.0001919548],"category_scores_gemma":[0.003173438,0.0005823597,0.0004901645,0.000376061,0.00091999606,0.00019705083,0.0001265059,0.01220668,0.000023395201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028374076,0.0025927264,0.052955613,0.00030093614,0.005841466,0.013904997,0.00028853797,0.0000021839394,0.0000028180802,0.0000067480737,0.89495707,0.0007728369],"study_design_scores_gemma":[0.023630327,0.031071067,0.043747824,0.00038934738,0.0076655936,0.0017600259,0.00006483691,0.000006478897,0.000031948322,0.000033327437,0.89073884,0.00086038327],"about_ca_topic_score_codex":0.00026371688,"about_ca_topic_score_gemma":0.00011119102,"teacher_disagreement_score":0.15418424,"about_ca_system_score_codex":0.00013740757,"about_ca_system_score_gemma":0.0014122268,"threshold_uncertainty_score":0.99966276},"labels":[],"label_agreement":null},{"id":"W2028739944","doi":"10.1007/s13629-011-0018-5","title":"3 Een nieuw systeem voor het substadiëren van T1-urotheelcelcarcinoom van de blaas: een prognostische analyse","year":2011,"lang":"nl","type":"article","venue":"Tijdschrift voor Urologie","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Philosophy; Humanities","score_opus":0.05918568892765182,"score_gpt":0.28513544511814787,"score_spread":0.22594975619049606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028739944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72158116,0.028802248,0.0012597333,0.0021708165,0.002480053,0.0076845856,0.0015686944,0.00174525,0.23270749],"genre_scores_gemma":[0.97649616,0.0011856136,0.0012760684,0.00308151,0.001628127,0.0005265283,0.00025072115,0.00038716232,0.01516813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99054337,0.0011220195,0.0016992361,0.0022471095,0.0012205146,0.0031677734],"domain_scores_gemma":[0.9939376,0.0005055765,0.0007566132,0.002633861,0.0005887266,0.0015776331],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0014337377,0.0017444951,0.0023048457,0.00069655495,0.00051182817,0.00018317664,0.0015232563,0.001255263,0.014219585],"category_scores_gemma":[0.000957573,0.0014925073,0.0009547437,0.0011600698,0.00072801736,0.00049199705,0.0004871015,0.001771643,0.013519928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054695457,0.0035609398,0.9292028,0.0010826493,0.0059818677,0.0045575593,0.0060479534,0.00003968347,0.0023869614,0.00065066066,0.02529724,0.01572213],"study_design_scores_gemma":[0.027370129,0.020892788,0.78192574,0.0013644589,0.01946114,0.0009134396,0.004369831,0.001231656,0.0430431,0.0018527731,0.09291136,0.0046635843],"about_ca_topic_score_codex":0.005626928,"about_ca_topic_score_gemma":0.00056938326,"teacher_disagreement_score":0.254915,"about_ca_system_score_codex":0.0004544248,"about_ca_system_score_gemma":0.0018750954,"threshold_uncertainty_score":0.9995301},"labels":[],"label_agreement":null},{"id":"W2028807911","doi":"10.1016/j.eururo.2012.11.039","title":"Impact of Smoking and Smoking Cessation on Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Smoking cessation; Internal medicine; Cumulative incidence; Cancer; Disease; Risk factor; Logistic regression; Incidence (geometry); Oncology; Surgery; Cohort; Pathology","score_opus":0.01815115193923157,"score_gpt":0.29360139824940223,"score_spread":0.2754502463101707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028807911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994565,0.00019369445,0.000004510333,0.000080748825,0.00006072855,0.00022342373,0.0000151720415,0.000021774593,0.004834915],"genre_scores_gemma":[0.99950707,0.000021086376,0.000010584484,0.00029008134,0.000063802516,0.000009096651,0.000018387356,0.00003266668,0.000047240253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990806,0.00016499846,0.00018775693,0.00017445187,0.0001396392,0.00025255527],"domain_scores_gemma":[0.99960077,0.00005339373,0.000089508496,0.00012681428,0.000032263026,0.00009722727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011184029,0.00014908706,0.00027644745,0.00014263099,0.000025088675,0.0000039366005,0.000036143567,0.000046014156,0.00011114536],"category_scores_gemma":[0.000029703584,0.00009503232,0.000040506377,0.00011096706,0.00007412624,0.000060743932,0.000019724837,0.00014718513,0.0000036806225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006426524,0.0003747191,0.99471074,0.000009928283,0.00026651155,0.000020477704,0.00050523377,0.000013114586,0.00008604109,0.000007920578,0.00003165446,0.0033309867],"study_design_scores_gemma":[0.0063034096,0.0020067631,0.9911025,0.000029118304,0.00017293119,0.000011987046,0.00000774672,0.000008478561,0.00013959885,0.0000014585778,0.00013690237,0.00007911247],"about_ca_topic_score_codex":0.00040586176,"about_ca_topic_score_gemma":0.000017560627,"teacher_disagreement_score":0.005660757,"about_ca_system_score_codex":0.00008352301,"about_ca_system_score_gemma":0.000027717015,"threshold_uncertainty_score":0.38753057},"labels":[],"label_agreement":null},{"id":"W2029168581","doi":"10.1016/j.clgc.2013.09.002","title":"Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma","year":2013,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical endpoint; Oncology; Urothelial carcinoma; Internal medicine; Overall survival; Primary (astronomy); Urothelial cancer; Carcinoma; Second line; First line; Cancer; Clinical trial; Bladder cancer","score_opus":0.1740494188975193,"score_gpt":0.4790419817274608,"score_spread":0.3049925628299415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029168581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034207214,0.93851817,0.000018747129,0.0030751538,0.0037136532,0.017547484,0.0009011645,0.000070121605,0.0019482689],"genre_scores_gemma":[0.0016463047,0.96916366,0.00040096045,0.0027650537,0.0060040723,0.006134432,0.00012812042,0.00025913387,0.013498257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99419904,0.000904976,0.0017485458,0.001241086,0.0011227474,0.0007836062],"domain_scores_gemma":[0.9937988,0.0018147747,0.00088710565,0.0024311205,0.00040888385,0.0006593063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013039083,0.001017358,0.00336084,0.00010774004,0.00027236663,0.00004973504,0.0013803667,0.0005624021,0.0020459222],"category_scores_gemma":[0.00059024576,0.0004944724,0.0021574742,0.00038773683,0.0003375541,0.00011556341,0.00054790615,0.0011417232,0.00014779223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067218407,0.0008983829,0.00017277582,0.0023865413,0.0014026146,0.000039562277,0.00013319177,0.0000018622744,0.000025873034,0.0000054538955,0.017475924,0.97073597],"study_design_scores_gemma":[0.009012163,0.008136624,0.0036863831,0.002850068,0.0024841405,0.000038958467,0.00002608805,0.0000048807765,0.00025083817,0.00024250061,0.9727343,0.000533077],"about_ca_topic_score_codex":0.00036570913,"about_ca_topic_score_gemma":0.000061705025,"teacher_disagreement_score":0.9702029,"about_ca_system_score_codex":0.0004093046,"about_ca_system_score_gemma":0.0059670825,"threshold_uncertainty_score":0.9997507},"labels":[],"label_agreement":null},{"id":"W2029301141","doi":"10.1097/01.ju.0000140456.42509.b6","title":"EFFECTIVE BLADDER SPARING THERAPY WITH INTRA-ARTERIAL CISPLATIN AND RADIOTHERAPY FOR LOCALIZED BLADDER CANCER","year":2004,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Cystectomy; Cisplatin; Radiation therapy; Bladder cancer; Urology; Regimen; Chemotherapy; Urinary bladder; Oncology; Surgery; Internal medicine; Cancer","score_opus":0.013661753896083297,"score_gpt":0.2917516768274892,"score_spread":0.2780899229314059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029301141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713835,0.0074263876,0.013733385,0.00613018,0.00032640639,0.0008926475,0.0000067017327,0.000010857413,0.00008992021],"genre_scores_gemma":[0.99264354,0.0025039467,0.0009831052,0.0029474497,0.0008120766,0.000043901182,9.3838736e-7,0.00003406203,0.000030988354],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991834,0.00009107919,0.00023733207,0.00011910194,0.00014361157,0.00022545963],"domain_scores_gemma":[0.9992944,0.0001739347,0.00019378746,0.00012649401,0.00012039422,0.00009101705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026526867,0.00016646164,0.00041916434,0.00006971804,0.00008611064,0.000011949888,0.00008011575,0.000083896135,0.000108978136],"category_scores_gemma":[0.000014630077,0.00008479603,0.00007177207,0.00007266429,0.00018610572,0.00006126969,0.0000075867993,0.00020978914,7.4318007e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37646094,0.0017825129,0.020671546,0.00012849488,0.02049663,0.00035169284,0.022845246,0.0055840444,0.24181035,0.00070521625,0.0024058267,0.30675748],"study_design_scores_gemma":[0.44291794,0.12993456,0.19682677,0.00042477006,0.008413027,0.016728416,0.0009813205,0.0007408965,0.12865645,0.0123837665,0.06065385,0.0013382214],"about_ca_topic_score_codex":0.00010889425,"about_ca_topic_score_gemma":0.000052105366,"teacher_disagreement_score":0.30541927,"about_ca_system_score_codex":0.000073250776,"about_ca_system_score_gemma":0.00018517615,"threshold_uncertainty_score":0.34578818},"labels":[],"label_agreement":null},{"id":"W2029497465","doi":"10.1097/01.mp.0000068237.38715.d9","title":"Leiomyosarcoma of Urinary Bladder Following Cyclophosphamide Therapy: Report of Two Cases","year":2003,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Cyclophosphamide; Medicine; Leiomyosarcoma; Cystoprostatectomy; Urinary bladder; Cystectomy; Pathology; Urinary system; Bladder cancer; Urology; Chemotherapy; Cancer; Internal medicine","score_opus":0.03199609241141147,"score_gpt":0.3170615016649194,"score_spread":0.28506540925350793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029497465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588705,0.005084491,0.000915718,0.00009208846,0.00024759906,0.00031070376,0.00001301429,0.00003145362,0.0074178544],"genre_scores_gemma":[0.9966674,0.0001240162,0.0020728267,0.00021284609,0.0000327407,0.000032220116,0.000015765612,0.000033667446,0.00080850883],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998736,0.00009150012,0.00042189512,0.00031218442,0.00019568068,0.00024273926],"domain_scores_gemma":[0.9991279,0.000062421794,0.00016363253,0.0005039068,0.00007049753,0.00007162527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019540304,0.00017092016,0.00053060707,0.00009469278,0.000035059427,0.000001794065,0.000063728316,0.00009680297,0.00012831116],"category_scores_gemma":[0.00007872848,0.00014240034,0.00022154066,0.00011873453,0.0001096324,0.000041080442,0.000022872198,0.00010235957,0.0000047554518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072858547,0.0020216827,0.78769267,0.000092149836,0.0007680197,0.062343765,0.0016664476,0.000038412283,0.13135146,0.00051391486,0.00019851317,0.012584414],"study_design_scores_gemma":[0.023936944,0.0071959267,0.31031692,0.00022531045,0.001068405,0.08148795,0.00033251426,0.00009401802,0.5571043,0.012935015,0.004580883,0.0007218624],"about_ca_topic_score_codex":0.00012088036,"about_ca_topic_score_gemma":0.00000680914,"teacher_disagreement_score":0.47737575,"about_ca_system_score_codex":0.000029189927,"about_ca_system_score_gemma":0.00017776321,"threshold_uncertainty_score":0.58069175},"labels":[],"label_agreement":null},{"id":"W2030602247","doi":"10.1097/pat.0000000000000029","title":"Long term outcome of primary urothelial papilloma: a single institution cohort","year":2013,"lang":"en","type":"article","venue":"Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"Medicine; Papilloma; Cohort; Resection; Surgery; Internal medicine; Pathology","score_opus":0.02799879431454858,"score_gpt":0.2802919458284333,"score_spread":0.2522931515138847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030602247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774808,0.0002735085,0.000430576,0.00024412396,0.00031505447,0.0006611225,0.0000140483935,0.000050190072,0.020530552],"genre_scores_gemma":[0.9976372,0.000031301493,0.00055427395,0.00071069726,0.000127791,0.00009718555,0.00003405356,0.000015984071,0.0007914943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915135,0.0000376628,0.0002779737,0.00020836608,0.00013104598,0.00019360072],"domain_scores_gemma":[0.99950963,0.00001817141,0.000077590914,0.00024684813,0.00007403324,0.00007370668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000718763,0.000119817145,0.00035810005,0.00007487477,0.000032384854,0.000004798115,0.0000562494,0.000107148626,0.00040450276],"category_scores_gemma":[0.000036063186,0.000094499206,0.00008100449,0.000073170566,0.00015665848,0.000070399336,0.000034511762,0.000095044765,0.00020457437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000736876,0.0003252874,0.923409,0.00007141611,0.000049156995,0.00013645511,0.00010044393,2.568994e-7,0.06272144,0.000071992334,0.00009060989,0.012950251],"study_design_scores_gemma":[0.0018146303,0.00054452545,0.9889016,0.000024079158,0.00013062746,0.00031396103,0.0000073008837,0.000001462447,0.007879968,0.00009681061,0.0002067561,0.00007824581],"about_ca_topic_score_codex":0.00013693885,"about_ca_topic_score_gemma":0.00001027671,"teacher_disagreement_score":0.06549263,"about_ca_system_score_codex":0.0000963649,"about_ca_system_score_gemma":0.000067393616,"threshold_uncertainty_score":0.44290215},"labels":[],"label_agreement":null},{"id":"W2030720027","doi":"10.1016/j.eururo.2013.09.050","title":"Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University; Dalhousie University; Université Laval; University of Alberta; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Bladder cancer; Proportional hazards model; Urology; Lymph node; Stage (stratigraphy); Hazard ratio; Surgery; Cancer; Internal medicine; Gynecology; Oncology; Confidence interval; Metastasis","score_opus":0.022408714139041122,"score_gpt":0.2921674649161132,"score_spread":0.26975875077707206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030720027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788342,0.0023954886,0.0048736106,0.0031475886,0.0008548144,0.0052995,0.0011858111,0.00016774242,0.0032412126],"genre_scores_gemma":[0.99040496,0.000038484817,0.0008334442,0.0034215744,0.0009447591,0.0020775641,0.00013543334,0.000074712,0.002069067],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985487,0.00017987231,0.00025018613,0.00040333773,0.00016297933,0.00045495006],"domain_scores_gemma":[0.99907166,0.00032226788,0.00010402663,0.00020916811,0.00013964457,0.00015321733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019769001,0.00019098244,0.0002813286,0.00009549676,0.00010960735,0.000017685901,0.0000819549,0.000060076534,0.0041977162],"category_scores_gemma":[0.00016442678,0.0001544685,0.00015418821,0.00007785552,0.00011023454,0.000090972375,0.000054406515,0.00012849225,0.000538568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04134901,0.0033649304,0.25767595,0.0014652979,0.0076210625,0.0007973786,0.009856744,0.00021852335,0.023653883,0.0011368117,0.46324784,0.18961258],"study_design_scores_gemma":[0.027298924,0.01287016,0.58132446,0.0002752492,0.0023399703,0.00020848468,0.000088303386,0.006985491,0.0022080715,0.0008837691,0.3643955,0.0011216499],"about_ca_topic_score_codex":0.000057185538,"about_ca_topic_score_gemma":0.000004747829,"teacher_disagreement_score":0.3236485,"about_ca_system_score_codex":0.000063026084,"about_ca_system_score_gemma":0.00009550724,"threshold_uncertainty_score":0.99671257},"labels":[],"label_agreement":null},{"id":"W2030831457","doi":"10.5489/cuaj.1985","title":"The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; McGill University; University of British Columbia; Western University; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McMaster University","funders":"","keywords":"Medicine; Ureter; Cuff; Urology; Surgery; Nephrectomy; Kidney; Internal medicine","score_opus":0.011537138947669086,"score_gpt":0.2833069409150463,"score_spread":0.2717698019673772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030831457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880604,0.00008787816,0.00050978514,0.004138561,0.00019860969,0.0002446414,0.00004365577,0.000008829625,0.006707628],"genre_scores_gemma":[0.9988546,0.00004856758,0.00041402175,0.00026570624,0.00019115848,0.0000056092276,0.0000040403197,0.00000783761,0.00020849404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861723,0.00027775424,0.0003178926,0.00012727671,0.0003346778,0.00032518493],"domain_scores_gemma":[0.9989234,0.00020854584,0.00027558982,0.00011430088,0.000111988316,0.00036613378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006599053,0.000116001545,0.00026088255,0.00009300576,0.00016714825,0.000025153602,0.00012352632,0.000099518016,0.0002259313],"category_scores_gemma":[0.00030781265,0.00006555248,0.00024748617,0.00012894835,0.000044144206,0.000031815885,0.000012122347,0.0003481074,0.0000064340193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012363996,0.00019452118,0.94317,0.00002960253,0.0012670588,0.000081868944,0.00025105692,0.0001508058,0.0014642319,0.001075229,0.0054605408,0.045618646],"study_design_scores_gemma":[0.0015625395,0.0010555042,0.99259144,0.000033702247,0.0001024393,0.00009555676,0.000018633502,0.00012725704,0.00042870094,0.0008457511,0.0030700497,0.00006843871],"about_ca_topic_score_codex":0.00057683437,"about_ca_topic_score_gemma":0.0000675154,"teacher_disagreement_score":0.04942139,"about_ca_system_score_codex":0.00068436237,"about_ca_system_score_gemma":0.00018159859,"threshold_uncertainty_score":0.26731524},"labels":[],"label_agreement":null},{"id":"W2031146512","doi":"10.1016/j.juro.2013.03.009","title":"Hiding in Plain View: Genetic Profiling Reveals Decades Old Cross Contamination of Bladder Cancer Cell Line KU7 with HeLa","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"HeLa; Comparative genomic hybridization; Prostate cancer; Medicine; genomic DNA; Biology; Cancer; Genetics; Cell culture; DNA; Genome; Gene","score_opus":0.015697215945401063,"score_gpt":0.2972538498786592,"score_spread":0.28155663393325814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031146512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854786,0.009189725,0.0003098006,0.0011638482,0.00009532518,0.00037994777,0.000003993438,0.000003297651,0.00030619052],"genre_scores_gemma":[0.9963594,0.0018101044,0.0004632777,0.0007677728,0.00016003127,0.000016367832,0.0000011322832,0.000017398785,0.00040448722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893516,0.0001506936,0.00045761766,0.000086125576,0.00018059164,0.00018979849],"domain_scores_gemma":[0.99904525,0.00014551125,0.00038282873,0.00012180589,0.0002458471,0.00005875507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037286466,0.00011163471,0.00034815742,0.000084573454,0.000032252046,0.000006187448,0.000106846106,0.00007948013,0.0002840779],"category_scores_gemma":[0.000032143656,0.00006254998,0.00004300973,0.0001067385,0.00008015722,0.00008752362,0.000017136177,0.00023283895,0.000004586426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043902975,0.0006690797,0.7059436,0.00033055397,0.0005989875,0.00014318491,0.0039120154,0.0033899553,0.26855975,0.00005516015,0.0007307081,0.011276733],"study_design_scores_gemma":[0.012796969,0.0072731953,0.81079626,0.00037513147,0.0010185306,0.0010600508,0.0006798653,0.000990535,0.1636119,0.0007119208,0.00046634738,0.00021925336],"about_ca_topic_score_codex":0.0004120887,"about_ca_topic_score_gemma":0.0001259224,"teacher_disagreement_score":0.10494785,"about_ca_system_score_codex":0.000077608325,"about_ca_system_score_gemma":0.00012226879,"threshold_uncertainty_score":0.31104538},"labels":[],"label_agreement":null},{"id":"W2031233702","doi":"10.1002/cncr.23212","title":"Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Regione Marche; Associazione Italiana per la Ricerca sul Cancro","keywords":"Cytokeratin; Urothelium; Medicine; Immunohistochemistry; Pathology; Staining; Carcinoma; Urinary bladder; Urology","score_opus":0.019258778789187702,"score_gpt":0.28298161316325643,"score_spread":0.26372283437406874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031233702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957314,0.0006459824,0.0014124912,0.000074725765,0.00021407248,0.00073235057,0.0010893329,0.000016818272,0.000082796556],"genre_scores_gemma":[0.99885184,0.0002536993,0.00040950126,0.000042249645,0.00026830347,0.000040814994,0.00004159453,0.00004310344,0.00004890736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825466,0.000075030504,0.00047546334,0.0003889013,0.00047007028,0.00033585043],"domain_scores_gemma":[0.9989619,0.000077660065,0.00032755526,0.00024143489,0.0002469963,0.00014445218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014788048,0.00029586628,0.00066677446,0.000099390054,0.00006566563,0.0000100186,0.00009362016,0.00018827607,0.00031985476],"category_scores_gemma":[0.00004389616,0.00023517656,0.0001391969,0.000109949964,0.00022321958,0.00014549923,0.000081133716,0.0002406648,8.839518e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059067975,0.0003266429,0.022657398,0.000586297,0.00012786296,0.000011325978,0.0022490039,0.0000085229885,0.96001226,0.0000062952226,0.00009257572,0.00801502],"study_design_scores_gemma":[0.0036169353,0.0009808118,0.016680902,0.0017116322,0.00008967259,0.000008275263,0.00036534344,0.000048462356,0.9762912,0.0000059468684,0.0000134314505,0.00018738437],"about_ca_topic_score_codex":0.00036936637,"about_ca_topic_score_gemma":0.000032713626,"teacher_disagreement_score":0.016278943,"about_ca_system_score_codex":0.00016208566,"about_ca_system_score_gemma":0.00036073464,"threshold_uncertainty_score":0.95902216},"labels":[],"label_agreement":null},{"id":"W2031571951","doi":"10.1016/j.juro.2009.06.041","title":"Longer Wait Times Increase Overall Mortality in Patients With Bladder Cancer","year":2009,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Urology; Hazard ratio; Stage (stratigraphy); Population; Surgery; Survival analysis; Cancer; Oncology; Internal medicine; Confidence interval","score_opus":0.011380678810077068,"score_gpt":0.27442340926175507,"score_spread":0.263042730451678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031571951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953943,0.00070646085,0.000009573356,0.0023365633,0.000078570374,0.00016045583,0.000005829259,0.0000045446754,0.0013037174],"genre_scores_gemma":[0.9949229,0.0001427417,0.00002478843,0.0045927824,0.00014128475,0.0000015078896,0.0000021003746,0.000008868421,0.00016303836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991615,0.00010289305,0.000247706,0.00007680603,0.00022692226,0.00018420945],"domain_scores_gemma":[0.9994339,0.00003739595,0.00016118844,0.0001595697,0.00011912914,0.00008883284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001931887,0.000109530985,0.00028173305,0.00007231862,0.00002528191,0.0000037606683,0.0000936096,0.000054841345,0.00050841185],"category_scores_gemma":[0.000019046951,0.000055709657,0.000047855367,0.00007959138,0.000059844893,0.00007076891,0.000010227478,0.00025864615,0.0000064431997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007840708,0.000775401,0.9846826,0.000005545654,0.00040510742,0.00016945812,0.00055741996,0.00011375736,0.000092692295,0.00004605325,0.002045709,0.003265546],"study_design_scores_gemma":[0.005490497,0.0027736772,0.9901843,0.000016970334,0.0004679236,0.00008645235,0.000011334865,0.000013269893,0.000064404485,0.0003771897,0.00045890236,0.0000550783],"about_ca_topic_score_codex":0.0002542871,"about_ca_topic_score_gemma":0.0000746548,"teacher_disagreement_score":0.005501698,"about_ca_system_score_codex":0.00006018755,"about_ca_system_score_gemma":0.00015091633,"threshold_uncertainty_score":0.5566753},"labels":[],"label_agreement":null},{"id":"W2031934435","doi":"10.1016/j.eururo.2011.05.053","title":"Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urine cytology; Cytology; Urine; Urology; Urinary system; Cancer; Pathology; Internal medicine","score_opus":0.038766942888470185,"score_gpt":0.31326516179748,"score_spread":0.27449821890900983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031934435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021955787,0.98972374,0.00013816879,0.000031968015,0.00048521513,0.001369747,0.0001987498,0.000034304703,0.0077985562],"genre_scores_gemma":[0.004127335,0.9939302,0.000092011636,0.00019224931,0.00042249853,0.00014760744,0.00005402165,0.00012679347,0.00090724864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846506,0.00025334794,0.0004461324,0.00048700557,0.00007224575,0.00027619046],"domain_scores_gemma":[0.99892354,0.00018415268,0.0003366123,0.00033984554,0.00010303749,0.00011282059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022788228,0.00034663884,0.0012544707,0.00015179547,0.00004296922,0.0000043350833,0.000108443484,0.0001491913,0.00017026984],"category_scores_gemma":[0.000086512984,0.00027072834,0.0002766589,0.00011338172,0.00014140793,0.00002098585,0.00006705308,0.00021220847,0.000028286158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025891233,0.000058941816,0.00015411846,0.005916298,0.0007809303,0.000035729543,0.000057801688,1.02401124e-7,0.000020374686,0.000004538525,0.00052895845,0.99218327],"study_design_scores_gemma":[0.0014902925,0.0016068771,0.0055538304,0.0006288706,0.001663369,0.00012699676,0.000003887348,0.0000017589981,0.000013701057,0.000006758043,0.988695,0.00020862363],"about_ca_topic_score_codex":0.00008482416,"about_ca_topic_score_gemma":0.00009127423,"teacher_disagreement_score":0.99197465,"about_ca_system_score_codex":0.00004340005,"about_ca_system_score_gemma":0.00018320557,"threshold_uncertainty_score":0.9999745},"labels":[],"label_agreement":null},{"id":"W2032005128","doi":"10.1016/j.eururo.2010.05.043","title":"Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Interquartile range; Oncology; Internal medicine; Bladder cancer; Population; Biomarker; Cancer; Pathology","score_opus":0.00811141273050086,"score_gpt":0.24415827334260845,"score_spread":0.23604686061210758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032005128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807242,0.0014304876,0.00006413245,0.0011194664,0.00041659878,0.00057198404,0.00010141742,0.00007004422,0.015501633],"genre_scores_gemma":[0.99467516,0.00078967056,0.00015193733,0.003662737,0.0003532151,0.000056384164,0.000028353777,0.000082243845,0.00020028875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982986,0.0002446787,0.00027581205,0.0005886378,0.0001813801,0.00041088177],"domain_scores_gemma":[0.9990781,0.000094312025,0.00014928363,0.00039601515,0.000069650836,0.00021265796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018828218,0.00027734737,0.00039574326,0.00016826186,0.00007481856,0.000015331038,0.00013445177,0.00011877521,0.00015663648],"category_scores_gemma":[0.00013119123,0.0002390326,0.00007707677,0.00015546022,0.00029573622,0.00006902738,0.00012661579,0.00072682765,0.00005678886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007921593,0.00044123834,0.9408237,0.00008108449,0.00042924704,0.0032061683,0.0015642938,0.000068118796,0.039728943,0.00005194705,0.0015768268,0.011236286],"study_design_scores_gemma":[0.0036997157,0.00083879667,0.9897249,0.00003610331,0.00033269593,0.000104549086,0.000051442898,0.00005113181,0.0018415359,0.00012806126,0.0029959418,0.00019516694],"about_ca_topic_score_codex":0.0003333693,"about_ca_topic_score_gemma":0.0005324473,"teacher_disagreement_score":0.048901174,"about_ca_system_score_codex":0.000045134,"about_ca_system_score_gemma":0.00015387972,"threshold_uncertainty_score":0.97474664},"labels":[],"label_agreement":null},{"id":"W2032071883","doi":"10.1016/j.ijrobp.2014.05.581","title":"The Initial Report of RTOG 0524: Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Paclitaxel; Trastuzumab; Cystectomy; Oncology; Irradiation; Internal medicine; Chemotherapy; Bladder cancer; Cancer; Breast cancer","score_opus":0.025983082124421804,"score_gpt":0.34876890544438577,"score_spread":0.32278582331996397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032071883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98481894,0.0002732646,0.011345514,0.0013919678,0.0007314696,0.0011196134,0.00022894972,0.000012103484,0.000078173434],"genre_scores_gemma":[0.99722314,0.00035211578,0.0012231147,0.00010852181,0.0006838912,0.00012854407,0.00021691316,0.000040371044,0.00002339483],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974993,0.00023141032,0.0012041695,0.00028440886,0.0005467932,0.00023395696],"domain_scores_gemma":[0.99409586,0.0015873318,0.0026458374,0.00018766122,0.0013724966,0.000110822606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000985586,0.00027448847,0.0009645584,0.00022776276,0.00013924713,0.000018537998,0.00015790306,0.00018745322,0.000008853954],"category_scores_gemma":[0.0004148666,0.00016803989,0.00022902241,0.00024966802,0.00034386362,0.0003689005,0.000013724901,0.00023337506,1.4157219e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3300302,0.0067459363,0.34943053,0.00038652925,0.013403513,0.00015862646,0.009561989,0.0007205058,0.015262776,0.0012712261,0.00056533545,0.27246284],"study_design_scores_gemma":[0.61179763,0.13320169,0.20117305,0.0017765616,0.006306484,0.000982411,0.0018795456,0.0052317414,0.03138125,0.003082647,0.0022526665,0.0009343252],"about_ca_topic_score_codex":0.00027538356,"about_ca_topic_score_gemma":0.000308004,"teacher_disagreement_score":0.28176743,"about_ca_system_score_codex":0.0003363182,"about_ca_system_score_gemma":0.0020605007,"threshold_uncertainty_score":0.68524677},"labels":[],"label_agreement":null},{"id":"W2032579945","doi":"10.1016/j.urolonc.2009.06.018","title":"BCAN Think Tank session 3: Prevention of bladder cancer","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Cancer prevention; Cancer; Smoking cessation; Disease; Oncology; Clinical trial; Intensive care medicine; Internal medicine; Pathology","score_opus":0.030077364267431204,"score_gpt":0.35255365909833025,"score_spread":0.32247629483089907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032579945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846599,0.00076735433,0.000046607332,0.0066545634,0.0004217425,0.00036487594,0.000027140764,0.00004694061,0.00701088],"genre_scores_gemma":[0.95141643,0.00094560394,0.040095367,0.0026896398,0.00033041168,0.00014043068,0.00006606707,0.000020412941,0.004295605],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991138,0.00005496278,0.00024667894,0.00025992127,0.0001333164,0.00019130234],"domain_scores_gemma":[0.9993123,0.0000789227,0.00015108884,0.00018169987,0.00008380333,0.00019218872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001642586,0.00014484175,0.00029334423,0.000094845804,0.00014158343,0.0000073407673,0.00006381219,0.00025224366,0.0008996685],"category_scores_gemma":[0.00006940355,0.00010932311,0.00006110205,0.000171155,0.0005080046,0.00010698731,0.000030158903,0.00036708877,0.0000121308185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034180487,0.0008305378,0.8836601,0.00008917227,0.00028041878,0.00007069976,0.0010761066,0.00001528673,0.053612754,0.0129323965,0.013059995,0.03403077],"study_design_scores_gemma":[0.0025327643,0.0038376655,0.05103527,0.000107429914,0.00094922795,0.0003428933,0.00025689614,0.00029046935,0.013435376,0.020544415,0.9064401,0.00022748634],"about_ca_topic_score_codex":0.00020795371,"about_ca_topic_score_gemma":0.00016340622,"teacher_disagreement_score":0.8933801,"about_ca_system_score_codex":0.00004352118,"about_ca_system_score_gemma":0.0005549959,"threshold_uncertainty_score":0.9850739},"labels":[],"label_agreement":null},{"id":"W2032898069","doi":"10.1016/j.clgc.2014.03.016","title":"Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma","year":2014,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Accrual; Oncology; Salvage therapy; Metastatic Urothelial Carcinoma; Internal medicine; Urothelial carcinoma; Disease; Intensive care medicine; Chemotherapy; Cancer; Bladder cancer","score_opus":0.1872850933706951,"score_gpt":0.47635958257400335,"score_spread":0.28907448920330825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032898069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034070401,0.98284245,0.00018782819,0.00012315923,0.002107217,0.01088814,0.0003143793,0.00003123084,0.00009856498],"genre_scores_gemma":[0.0019306717,0.9903871,0.0006119541,0.0004004105,0.0030077328,0.003284843,0.00003130039,0.00010609348,0.00023990274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962497,0.0005806787,0.0016648489,0.00081587234,0.00031811107,0.0003707904],"domain_scores_gemma":[0.9948084,0.0030960247,0.00075165747,0.00093569705,0.00018000667,0.00022822809],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083678064,0.0005517175,0.0029140506,0.000063575935,0.00012641991,0.00001568307,0.00024371798,0.0004570643,0.000085412554],"category_scores_gemma":[0.00030901926,0.00030598155,0.001418136,0.00014421975,0.00036612063,0.000033891807,0.00009162995,0.00051134324,0.0000056202757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038771532,0.0005082739,0.00007802631,0.0026590142,0.0007032274,0.000009156049,0.000035868226,0.0000016820171,0.0000011156073,0.0000026570563,0.0015373142,0.9556921],"study_design_scores_gemma":[0.036138523,0.013497051,0.00021694899,0.0017287038,0.0021270593,0.000015035293,0.000011490685,0.000010688429,0.000021017395,0.000060787126,0.9458752,0.00029747383],"about_ca_topic_score_codex":0.00005032815,"about_ca_topic_score_gemma":0.0000031881175,"teacher_disagreement_score":0.9553947,"about_ca_system_score_codex":0.000118800075,"about_ca_system_score_gemma":0.0013559563,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W2033189824","doi":"10.1155/2013/831871","title":"Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis","year":2013,"lang":"en","type":"article","venue":"Case Reports in Pulmonology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Malignancy; Bladder cancer; Cystic fibrosis; Disease; Cancer; Internal medicine; Gastroenterology; Population; Pathology; Dermatology","score_opus":0.017688121367241228,"score_gpt":0.27650527598455166,"score_spread":0.2588171546173104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033189824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942027,0.001212343,0.000027108028,0.0005467571,0.00014068786,0.0011729489,0.000004201739,0.000038633916,0.0026546675],"genre_scores_gemma":[0.9962704,0.000036420915,0.0014943562,0.00012348164,0.00004709858,0.0008522211,0.000015641688,0.00004392723,0.0011164172],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982763,0.00006228751,0.0004596539,0.0005296206,0.00018746065,0.00048466033],"domain_scores_gemma":[0.99909437,0.0000486408,0.00019322026,0.00043975457,0.00009471558,0.00012930328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011466588,0.00024989547,0.0005160544,0.00023385894,0.000050368657,0.00002486585,0.000033767854,0.000092081624,0.0004572252],"category_scores_gemma":[0.00003879632,0.00017084512,0.00006374248,0.00029827043,0.0001294655,0.0001335514,0.00003589643,0.0002622717,0.000009255885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037913816,0.00041926414,0.6907381,0.00026036298,0.00058238563,0.3040715,0.0013889453,0.00026811042,0.00044316976,0.000011401571,0.00020964144,0.001228019],"study_design_scores_gemma":[0.004911495,0.0013966514,0.31366575,0.00069247663,0.0013198538,0.6708818,0.0034924347,0.0009713692,0.0014405925,0.0002588952,0.00035653383,0.0006121575],"about_ca_topic_score_codex":0.011202769,"about_ca_topic_score_gemma":0.00556776,"teacher_disagreement_score":0.37707233,"about_ca_system_score_codex":0.00025702902,"about_ca_system_score_gemma":0.00022292686,"threshold_uncertainty_score":0.9953817},"labels":[],"label_agreement":null},{"id":"W2033402770","doi":"10.1016/j.urolonc.2014.05.012","title":"Patterns of referral for perioperative chemotherapy among patients with muscle-invasive bladder cancer: A population-based study","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Cancer Care Ontario","keywords":"Medicine; Cystectomy; Bladder cancer; Referral; Chemotherapy; Cancer; Cancer registry; Perioperative; Population; Internal medicine; General surgery; Oncology; Surgery; Family medicine","score_opus":0.02195259523182697,"score_gpt":0.3102125310334676,"score_spread":0.2882599358016406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033402770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996668,0.000048724374,0.00019064307,0.0011986212,0.0000767742,0.0015375741,0.00009615171,0.000028754832,0.00015475311],"genre_scores_gemma":[0.9916455,0.000019651412,0.0056563783,0.001657743,0.000079275975,0.000599462,0.00016761143,0.000020723644,0.00015362592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989569,0.00009539301,0.00025479522,0.00033995995,0.00014972464,0.00020321904],"domain_scores_gemma":[0.99910504,0.00020612187,0.0001818485,0.00016938102,0.0001912415,0.00014637719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011143598,0.00019870569,0.0004138257,0.00009423572,0.00018174597,0.000010798916,0.000058835,0.00011879164,0.000098598444],"category_scores_gemma":[0.000067038825,0.00013986495,0.0000496358,0.00011782354,0.00015767687,0.000071656206,0.000010332399,0.00012838177,6.3535265e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040272748,0.0007398127,0.9957967,0.000034990913,0.00016126707,0.000002715678,0.0009949849,0.00010561264,0.000027396223,0.00019944279,0.00007566187,0.001458733],"study_design_scores_gemma":[0.007281218,0.013774794,0.9697821,0.00006149689,0.0005437476,0.000001712522,0.00041129984,0.00027586118,0.0002095473,0.000178673,0.0073290914,0.00015042862],"about_ca_topic_score_codex":0.00084375654,"about_ca_topic_score_gemma":0.0010797033,"teacher_disagreement_score":0.026014525,"about_ca_system_score_codex":0.00010519713,"about_ca_system_score_gemma":0.0002933889,"threshold_uncertainty_score":0.57035273},"labels":[],"label_agreement":null},{"id":"W2033406969","doi":"10.1007/s13277-013-1216-y","title":"Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis","year":2013,"lang":"en","type":"review","venue":"Tumor Biology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"China Scholarship Council","keywords":"Medicine; Bladder cancer; Meta-analysis; Hazard ratio; Publication bias; Survivin; Internal medicine; Confidence interval; Odds ratio; Oncology; Funnel plot; Stage (stratigraphy); Cancer","score_opus":0.1460666644764017,"score_gpt":0.4075139927484597,"score_spread":0.26144732827205797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033406969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035387792,0.9935897,0.000009574417,0.000025508441,0.00008299046,0.0021430352,0.00047000314,0.000017104607,0.00012329551],"genre_scores_gemma":[0.012075272,0.98476744,0.00023869539,0.000111913854,0.000053348504,0.002259234,0.000292908,0.000030922016,0.00017026287],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99719465,0.0006583898,0.0009930279,0.0007159749,0.00012976644,0.00030821102],"domain_scores_gemma":[0.99836975,0.000459171,0.0005718636,0.00037018166,0.0001147958,0.00011420701],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000270824,0.00043200538,0.005231954,0.0003358559,0.000020034287,0.0000058026553,0.00013914864,0.00030384935,0.0012980682],"category_scores_gemma":[0.00020230755,0.00023456542,0.0010261332,0.00051837176,0.00022784801,0.000025107985,0.00009841247,0.0003201231,0.000017838616],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002697287,0.0036019513,0.37730533,0.015939953,0.08874204,0.00013460527,0.00021497109,0.0000012035779,0.00004928192,0.000052714302,0.0004477674,0.51324046],"study_design_scores_gemma":[0.002296891,0.0027294043,0.037401136,0.0016601959,0.8202836,0.00002935735,0.00002478826,0.000005492606,0.00004370804,0.00013601137,0.13453844,0.00085099833],"about_ca_topic_score_codex":0.00040103353,"about_ca_topic_score_gemma":0.0000846339,"teacher_disagreement_score":0.7315415,"about_ca_system_score_codex":0.00005758242,"about_ca_system_score_gemma":0.00021710014,"threshold_uncertainty_score":0.9996149},"labels":[],"label_agreement":null},{"id":"W2033992620","doi":"10.1016/j.eururo.2008.04.083","title":"Carcinoma in situ of the Upper Urinary Tract Treated with Radical Nephroureterectomy – Results from a Multicenter Study","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Upper urinary tract; Urology; Carcinoma in situ; Multicenter study; Urinary system; Urothelial carcinoma; Carcinoma; Surgery; Internal medicine; Cancer; Randomized controlled trial; Bladder cancer","score_opus":0.0216286178633254,"score_gpt":0.2465053683037416,"score_spread":0.2248767504404162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033992620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335928,0.00030398445,5.8424024e-7,0.052700542,0.00017955712,0.0013351694,0.00020423507,0.00004093121,0.011642171],"genre_scores_gemma":[0.88767135,0.000020391903,0.000030928055,0.109849855,0.0010466126,0.000021182697,0.00027656424,0.00012119331,0.0009619468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634564,0.0014884018,0.00060401525,0.00076783885,0.00036285465,0.00043126766],"domain_scores_gemma":[0.9984093,0.00022627314,0.0002623577,0.000972981,0.000053441086,0.00007567603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121555226,0.00046441174,0.0008091904,0.00018202157,0.000051337298,0.000007330071,0.00034475597,0.00027903393,0.000097430304],"category_scores_gemma":[0.00005098862,0.00027236206,0.00019227424,0.0001861854,0.0003035174,0.000030733296,0.00011689306,0.001766723,0.00006381847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010759851,0.0032186147,0.7831773,0.000032305375,0.00076607446,0.06352252,0.0037127228,0.0000028965349,0.00015820777,5.884746e-8,0.1343511,0.0002983409],"study_design_scores_gemma":[0.01895786,0.005324126,0.8555168,0.0000638939,0.0007793944,0.0006653233,0.000036725294,0.000005110096,0.00007346956,5.0364065e-7,0.11837716,0.00019962613],"about_ca_topic_score_codex":0.0009870991,"about_ca_topic_score_gemma":0.00004117466,"teacher_disagreement_score":0.072339505,"about_ca_system_score_codex":0.00007697086,"about_ca_system_score_gemma":0.00013389946,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W2034249431","doi":"10.1007/s00428-013-1456-7","title":"Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance","year":2013,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Urothelial carcinoma; Clinical significance; Papillary carcinoma; Medicine; Pathology; Carcinoma; Oncology; Internal medicine; Cancer; Thyroid carcinoma; Bladder cancer; Thyroid","score_opus":0.03831139583549489,"score_gpt":0.33742916381355015,"score_spread":0.2991177679780553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034249431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98095334,0.011833082,0.0003240285,0.0024103126,0.00069145195,0.0018329832,0.000089881556,0.00022259317,0.0016423516],"genre_scores_gemma":[0.98344016,0.0063504525,0.005546163,0.0029886167,0.0008537048,0.00021673633,0.0001359462,0.00009643064,0.0003717812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995042,0.000773877,0.0011455499,0.0015498463,0.00048138777,0.0010072916],"domain_scores_gemma":[0.9965172,0.001124139,0.00035262317,0.0010313,0.00013795361,0.00083678943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007587694,0.00078254926,0.0015052083,0.00022266604,0.00032696791,0.000056629546,0.00038693898,0.00049113884,0.00013322003],"category_scores_gemma":[0.0006803712,0.0005660156,0.00028848805,0.0002836024,0.0024058814,0.00016287311,0.00040084557,0.0011338142,0.0001272762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026644142,0.0034254822,0.59390503,0.0012351762,0.001871443,0.0023719822,0.0019256293,0.000020076071,0.20321488,0.0047707786,0.00784005,0.17675507],"study_design_scores_gemma":[0.009255038,0.004188808,0.9658168,0.00024788035,0.0012982371,0.00014385759,0.00054317544,0.00058548944,0.006816235,0.008104726,0.0021738096,0.0008259458],"about_ca_topic_score_codex":0.0010222968,"about_ca_topic_score_gemma":0.00003874346,"teacher_disagreement_score":0.3719118,"about_ca_system_score_codex":0.000070081674,"about_ca_system_score_gemma":0.00045388492,"threshold_uncertainty_score":0.99967915},"labels":[],"label_agreement":null},{"id":"W2034906030","doi":"10.1007/s10552-004-1448-7","title":"A case?control study of occupational risk factors for bladder cancer in Canada","year":2004,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Workplace Safety & Insurance Board","funders":"","keywords":"Medicine; Bladder cancer; Odds ratio; Demography; Logistic regression; Epidemiology; Population; Case-control study; Occupational medicine; Asbestos; Public health; Cancer; Internal medicine; Environmental health; Pathology","score_opus":0.0338124215367091,"score_gpt":0.32414583317050527,"score_spread":0.29033341163379617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034906030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838633,0.0019327366,0.00034749444,0.00022092025,0.0004994023,0.0030399752,0.0055230414,0.000019839978,0.00003028016],"genre_scores_gemma":[0.9972464,0.00009061853,0.000016158063,0.00063414936,0.00024025796,0.0016675645,0.000009364069,0.000042410527,0.00005310476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982873,0.00005503533,0.00048756239,0.000398025,0.00036131262,0.00041076975],"domain_scores_gemma":[0.9988311,0.00022758596,0.00022466287,0.00028008877,0.0002563807,0.00018018918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008341631,0.0002864147,0.00070398126,0.000117575604,0.00009020179,0.000009646511,0.00008915046,0.00006721809,0.00037453088],"category_scores_gemma":[0.000078341414,0.0002327728,0.000119769895,0.00020360576,0.00003837386,0.00008073492,0.0000091649035,0.00017045533,7.4293996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027506987,0.0005016487,0.97889704,0.000051731156,0.001633243,0.00037341553,0.0012920565,0.011350191,0.00018459007,0.000012747913,0.00016553493,0.002787081],"study_design_scores_gemma":[0.061406203,0.0010955433,0.9312604,0.000094628136,0.0021490694,0.00004275277,0.0023303772,0.00034181427,0.00068052893,0.0000368304,0.00026542897,0.0002964355],"about_ca_topic_score_codex":0.9662852,"about_ca_topic_score_gemma":0.9878551,"teacher_disagreement_score":0.058655504,"about_ca_system_score_codex":0.0019213591,"about_ca_system_score_gemma":0.0057739904,"threshold_uncertainty_score":0.9998624},"labels":[],"label_agreement":null},{"id":"W2035062922","doi":"10.1016/j.eururo.2006.05.021","title":"Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Stage (stratigraphy); Bladder cancer; Lymphadenectomy; Carcinoma in situ; Transitional cell carcinoma; Surgery; Radical surgery; Carcinoma; Urology; Cancer; Pathology; Internal medicine","score_opus":0.02579578882443177,"score_gpt":0.3319970850088622,"score_spread":0.3062012961844304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035062922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929907,0.00054863037,0.000047543093,0.0011660368,0.000102356425,0.00038329125,0.00006428293,0.00010897899,0.018279787],"genre_scores_gemma":[0.9966124,0.000036978618,0.00021083246,0.001312782,0.00088028307,0.000020724727,0.000040654882,0.000046271263,0.0008390441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981211,0.00056467496,0.00037451737,0.000471437,0.00013431883,0.000333982],"domain_scores_gemma":[0.9993061,0.00013363718,0.00007083307,0.00028206012,0.000022784798,0.0001845877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003416643,0.00021877697,0.00041960855,0.000072368566,0.000048651284,0.00001560054,0.00007229935,0.00010009745,0.00025185975],"category_scores_gemma":[0.000060087823,0.00014067495,0.00015956178,0.00007877657,0.00032178953,0.000029316938,0.00006764868,0.000342237,0.0002559627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009536234,0.0002788555,0.98793405,0.00001253489,0.00008397271,0.0022426425,0.000030408039,5.122267e-7,0.00001835804,0.00004513822,0.0007899353,0.0076099746],"study_design_scores_gemma":[0.003222468,0.0044924812,0.97593576,0.000011538585,0.00021257435,0.00013954661,0.0000027557844,0.0000037711695,0.000025866364,0.00008819659,0.015745295,0.000119760836],"about_ca_topic_score_codex":0.00003730296,"about_ca_topic_score_gemma":0.000003160315,"teacher_disagreement_score":0.017440744,"about_ca_system_score_codex":0.00001984676,"about_ca_system_score_gemma":0.00003665133,"threshold_uncertainty_score":0.5736558},"labels":[],"label_agreement":null},{"id":"W2035660473","doi":"10.1002/cncr.22588","title":"PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":441,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Richard M. Schulze Family Foundation; Commonwealth Foundation","keywords":"Medicine; Bladder cancer; Odds ratio; Oncology; Carcinoma; Immunohistochemistry; Stage (stratigraphy); Cohort; Tissue microarray; Internal medicine; Carcinoma in situ; Cancer; Pathology","score_opus":0.0186577435477403,"score_gpt":0.2914737862695429,"score_spread":0.2728160427218026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035660473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989938,0.003241796,0.00003382348,0.0005104453,0.00039060993,0.00048408948,0.00011008239,0.000023584878,0.0052675693],"genre_scores_gemma":[0.9967148,0.0001404013,0.000037144517,0.000795329,0.00028495715,0.000037100184,0.000007491015,0.000030934552,0.0019518586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989462,0.000025163225,0.00022291759,0.00026025242,0.0002834477,0.00026205077],"domain_scores_gemma":[0.99931276,0.00003376757,0.00008750522,0.00036346738,0.000066532506,0.00013597932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010233459,0.00016944564,0.0002497567,0.000039030838,0.00009037338,0.000008395428,0.000109901855,0.00010497349,0.00036567793],"category_scores_gemma":[0.000017808163,0.000105210966,0.00008046369,0.00013299234,0.000110786656,0.00005536074,0.00004562245,0.00014301298,0.0000053675412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010494407,0.00020760001,0.19637345,0.00014965131,0.00014244857,0.00002118106,0.0012601161,6.6072704e-7,0.7531075,0.000045767443,0.023293082,0.024349121],"study_design_scores_gemma":[0.0033048694,0.00019405049,0.23952499,0.0001678634,0.00017206284,0.0000205543,0.00014213155,0.000006532638,0.74367595,0.00006561642,0.012589075,0.00013632522],"about_ca_topic_score_codex":0.00084145693,"about_ca_topic_score_gemma":0.000066001216,"teacher_disagreement_score":0.043151546,"about_ca_system_score_codex":0.00007982114,"about_ca_system_score_gemma":0.00012820362,"threshold_uncertainty_score":0.42903787},"labels":[],"label_agreement":null},{"id":"W2035716465","doi":"10.5489/cuaj.2408","title":"Oncologic outcomes and prognostic impact of urothelial recurrences in patients undergoing segmental and total ureterectomy for upper tract urothelial carcinoma","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Proportional hazards model; Urothelial cancer; Cohort; Retrospective cohort study; Internal medicine; Carcinoma; Overall survival; Cancer; Gastroenterology; Bladder cancer","score_opus":0.02332635585787853,"score_gpt":0.28382918379821986,"score_spread":0.26050282794034135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035716465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973326,0.00020540744,0.0000058766113,0.0011322192,0.00021867345,0.000652646,0.00019745706,0.0000067059054,0.0002484705],"genre_scores_gemma":[0.99925643,0.000020001311,0.00018331772,0.00030161405,0.00012968703,0.000022772176,0.000025394562,0.0000108829645,0.000049921884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986967,0.0001243531,0.00034877128,0.00019952288,0.000249244,0.00038140503],"domain_scores_gemma":[0.9987125,0.0002730948,0.00021143431,0.000049089922,0.0001689717,0.0005849244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003736387,0.00017161174,0.0004031214,0.0001843937,0.0000894858,0.000047869824,0.00004974818,0.00018275114,0.000051196097],"category_scores_gemma":[0.0010159843,0.000119111755,0.00013004676,0.0000949719,0.000049417522,0.000121704325,0.0000130894205,0.0002495501,0.0000014265185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036218244,0.00015487667,0.995986,0.000008459268,0.00009093704,0.000014354052,0.00029493432,0.0000051326647,0.000009328898,0.000007825553,0.00023175703,0.0028342418],"study_design_scores_gemma":[0.008590399,0.005660452,0.98480433,0.00002178917,0.00010683428,0.00007695145,0.00009853662,0.000059989477,0.000008188738,0.0003676516,0.00009180445,0.00011304825],"about_ca_topic_score_codex":0.0013968336,"about_ca_topic_score_gemma":0.000516612,"teacher_disagreement_score":0.011181616,"about_ca_system_score_codex":0.0011194361,"about_ca_system_score_gemma":0.0011044225,"threshold_uncertainty_score":0.48572364},"labels":[],"label_agreement":null},{"id":"W2035993858","doi":"10.1016/j.urolonc.2011.07.014","title":"Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: Results from the Canadian Bladder Cancer Network Database","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Winnipeg; Dalhousie University; Université de Montréal; University of Alberta; Université Laval; Western University; McGill University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphovascular invasion; Proportional hazards model; Urinary diversion; Logistic regression; Internal medicine; Stage (stratigraphy); Multivariate analysis; Cancer; Database; Oncology; Urology; Metastasis","score_opus":0.05213891928180047,"score_gpt":0.30125694764124605,"score_spread":0.24911802835944558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035993858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820121,0.0010027607,0.000006232418,0.010310608,0.00037754173,0.0005317158,0.0013695784,0.000054820237,0.0043346556],"genre_scores_gemma":[0.9745805,0.00020534739,0.0045378515,0.01830352,0.00027162998,0.00020909951,0.000436682,0.000028735321,0.0014266061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983327,0.00019615056,0.00028522508,0.00045656651,0.00025149595,0.0004778772],"domain_scores_gemma":[0.9986469,0.00032485888,0.0001341624,0.0003386406,0.00006155973,0.00049388484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032183508,0.00024371562,0.00041747064,0.00006519092,0.0003271756,0.000030264313,0.00015210579,0.00030257227,0.00062165136],"category_scores_gemma":[0.00014067844,0.00015271688,0.00005919702,0.00026033056,0.00085578626,0.000085800806,0.000047155354,0.0005331101,0.000025163394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068995875,0.000112412235,0.98125476,0.000002203565,0.0005337084,0.0013857981,0.002078964,0.000004423767,0.000003215762,0.0002485954,0.0133018745,0.00038408375],"study_design_scores_gemma":[0.0034346217,0.00093267084,0.7437796,0.00007775472,0.0009789352,0.000044395616,0.00015489833,0.000030332452,0.000018907445,0.0012245638,0.2491161,0.00020725033],"about_ca_topic_score_codex":0.15836978,"about_ca_topic_score_gemma":0.5108649,"teacher_disagreement_score":0.35249513,"about_ca_system_score_codex":0.00028189798,"about_ca_system_score_gemma":0.0013675139,"threshold_uncertainty_score":0.8472347},"labels":[],"label_agreement":null},{"id":"W2036026013","doi":"10.1016/j.urology.2006.08.131","title":"PD-11.12","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Medicine; Ofloxacin; Bladder cancer; Dermatology; Urology; Internal medicine; Cancer; Antibiotics; Ciprofloxacin","score_opus":0.01208811264205981,"score_gpt":0.2615063693031368,"score_spread":0.249418256661077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036026013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66162926,0.0010688225,0.0007054177,0.009458395,0.0005516349,0.000313696,0.000012144003,0.00017007811,0.32609057],"genre_scores_gemma":[0.9893611,0.000006625201,0.00010312583,0.0028320772,0.00034963345,0.000012708243,0.000018238727,0.000010436703,0.0073060608],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995759,0.000012481736,0.00007840835,0.00012250418,0.00005651444,0.00015419317],"domain_scores_gemma":[0.99978805,0.000014189546,0.000015088107,0.00013164959,0.000014237152,0.00003678948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020499032,0.00006126373,0.000115412586,0.000033617012,0.000022503198,0.0000021614326,0.00002647732,0.0000626198,0.0007304702],"category_scores_gemma":[0.0000056696217,0.00004922248,0.000036852092,0.000034037483,0.000037618396,0.000012377346,0.000009855631,0.000051055675,0.0002853058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009748934,0.00097270234,0.80504245,0.00004016003,0.00017725471,0.00084560894,0.00016695319,0.000050131046,0.008144643,0.013680678,0.15783477,0.012069733],"study_design_scores_gemma":[0.0032552346,0.0008363961,0.26550722,0.000002275202,0.00017072214,0.00028344916,0.0000064880396,0.000056701818,0.0019459596,0.0028921824,0.724948,0.000095352836],"about_ca_topic_score_codex":0.00034369458,"about_ca_topic_score_gemma":0.00017046026,"teacher_disagreement_score":0.5671132,"about_ca_system_score_codex":0.00001631713,"about_ca_system_score_gemma":0.000033649732,"threshold_uncertainty_score":0.7998136},"labels":[],"label_agreement":null},{"id":"W2036288386","doi":"10.1016/j.eururo.2013.08.016","title":"Re: Günter Niegisch, Anja Lorch, Michael J. Droller, Hugh J. Lavery, Kristian D. Stensland, Peter Albers. Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit? Eur Urol 2013;64:355–7","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Regimen; Cystectomy; Oncology; Internal medicine; Immunotherapy; Radiation therapy; Chemotherapy; Cisplatin; Cancer; Urology","score_opus":0.007929733551989795,"score_gpt":0.2160725467014248,"score_spread":0.208142813149435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036288386","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5825831,0.0029311457,0.000024520381,0.3619845,0.0046305857,0.009408445,0.0022855338,0.00046370542,0.03568842],"genre_scores_gemma":[0.33782497,0.0014301183,0.00017132582,0.640751,0.003927012,0.00027462718,0.004421999,0.0011275557,0.010071401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927293,0.00073813414,0.0012945508,0.0022736427,0.0010927152,0.001871665],"domain_scores_gemma":[0.9958504,0.00022366292,0.000855634,0.0017734715,0.0008618062,0.0004350167],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0001996345,0.0016912089,0.0019769804,0.0006851174,0.0001920655,0.000105587445,0.00083462807,0.0009889755,0.0025688906],"category_scores_gemma":[0.00007874843,0.0013364619,0.00037950237,0.00048010895,0.0003510539,0.00025947054,0.0003092029,0.0030420145,0.0013521026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023506875,0.00084114494,0.19565175,0.00017721986,0.0013262229,0.0011120422,0.0013356146,0.000023243583,0.0000075947605,4.0197756e-7,0.7918825,0.0052915826],"study_design_scores_gemma":[0.026486857,0.0047578523,0.4001264,0.00026503598,0.00079855503,0.000025296864,0.000024988169,0.0000138222495,0.000015516072,0.000011561376,0.56635123,0.0011229056],"about_ca_topic_score_codex":0.0020372355,"about_ca_topic_score_gemma":0.0017220333,"teacher_disagreement_score":0.27876648,"about_ca_system_score_codex":0.00033424332,"about_ca_system_score_gemma":0.0003029907,"threshold_uncertainty_score":0.9995834},"labels":[],"label_agreement":null},{"id":"W2036310262","doi":"10.1016/j.eururo.2012.09.031","title":"Oncologic Outcomes and Survival in pT0 Tumors After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results from of a Large Multicenter International Collaborative Study","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Multicenter study; Carcinoma; Oncology; Internal medicine; Cancer; Bladder cancer; Randomized controlled trial","score_opus":0.022847343265809523,"score_gpt":0.3045794465530424,"score_spread":0.2817321032872329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036310262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90826374,0.00040698992,0.000018211627,0.07794814,0.0020348292,0.0027263411,0.0056890035,0.000036877092,0.0028758796],"genre_scores_gemma":[0.90317446,0.000014417496,0.00024944995,0.092362456,0.0025776548,0.0001537198,0.0009250385,0.00009954166,0.00044325355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964672,0.0011167254,0.0008181952,0.00074315805,0.00032799513,0.0005267365],"domain_scores_gemma":[0.99826,0.00079200993,0.00032714766,0.00037170688,0.00014076286,0.00010837063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053040363,0.0004722912,0.0010664705,0.0002771933,0.000035339872,0.000019121067,0.00023221858,0.00032408902,0.0002137159],"category_scores_gemma":[0.00032016364,0.0003612394,0.00018940319,0.000087500805,0.00018399947,0.00007279927,0.00016001696,0.0009782831,0.000027269047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012709188,0.0020417767,0.94398594,0.000041867028,0.00077297253,0.0036060691,0.0050938674,2.4645018e-7,0.00003958902,0.0000019705872,0.031336516,0.0003700207],"study_design_scores_gemma":[0.027016928,0.0020373676,0.73310614,0.000025730245,0.0004486719,0.000021584146,0.00016827685,0.0000070879682,0.0000108582735,0.000004966656,0.23694032,0.0002120674],"about_ca_topic_score_codex":0.00020913479,"about_ca_topic_score_gemma":0.000113563394,"teacher_disagreement_score":0.21087977,"about_ca_system_score_codex":0.00011793003,"about_ca_system_score_gemma":0.00014777738,"threshold_uncertainty_score":0.99988395},"labels":[],"label_agreement":null},{"id":"W2036447354","doi":"10.1016/j.urolonc.2009.07.026","title":"BCAN Think Tank session 2: Molecular detection of bladder cancer: The path to progress","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Session (web analytics); Bladder cancer; Cancer; Medicine; Cancer detection; Oncology; Internal medicine; Intensive care medicine; Computer science; World Wide Web","score_opus":0.015796232377940974,"score_gpt":0.3214644424881337,"score_spread":0.30566821011019274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036447354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97946024,0.0010099872,0.00011095931,0.017143514,0.00037925865,0.0006302657,0.00002400358,0.000044916003,0.0011968508],"genre_scores_gemma":[0.9847151,0.00019436274,0.010384812,0.004008153,0.0001529708,0.0002385376,0.0000115246685,0.0000141660685,0.00028034142],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990693,0.000073321164,0.00021275163,0.00027001955,0.00016047893,0.00021414462],"domain_scores_gemma":[0.99925476,0.00007931935,0.00011617356,0.00023652242,0.00010050812,0.00021273569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019156173,0.00015329843,0.00024617647,0.00008043971,0.00021469692,0.000012265261,0.00009657527,0.00019506342,0.0001207391],"category_scores_gemma":[0.000079347825,0.000095265255,0.00005200176,0.00026404814,0.00057264674,0.000059728744,0.000042500087,0.00038519042,0.000008528521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006900524,0.0007888785,0.5076278,0.00011512227,0.00041849577,0.0002079553,0.003015052,0.000048087906,0.36054888,0.010164926,0.0048487526,0.11152598],"study_design_scores_gemma":[0.0018246348,0.005886184,0.03805999,0.00010838645,0.0009983177,0.000490925,0.0005440973,0.00047735876,0.09449914,0.007114808,0.8497032,0.0002929731],"about_ca_topic_score_codex":0.00024918347,"about_ca_topic_score_gemma":0.00016017303,"teacher_disagreement_score":0.8448544,"about_ca_system_score_codex":0.000056681012,"about_ca_system_score_gemma":0.00034667173,"threshold_uncertainty_score":0.38848042},"labels":[],"label_agreement":null},{"id":"W2036580658","doi":"10.1111/j.1464-410x.2007.07165.x","title":"A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging","year":2007,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Ex vivo; Bioluminescence imaging; In vivo; Medicine; Bladder cancer; Magnetic resonance imaging; Pathology; Submucosa; Luciferase; Preclinical imaging; Cancer; Cancer research; Urology; Radiology; Biology; Cell culture; Internal medicine","score_opus":0.03237870875520974,"score_gpt":0.3185828912368354,"score_spread":0.28620418248162566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036580658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89885515,0.0035692288,0.096847236,0.00033245576,0.00012550552,0.00021222136,0.00002358143,0.000009143776,0.000025449843],"genre_scores_gemma":[0.9949935,0.00036213797,0.0037400417,0.00059418945,0.00021153565,0.0000034425661,0.0000047499,0.000019980636,0.0000704265],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99915504,0.00002352487,0.00034137265,0.00013550527,0.00011602933,0.00022852115],"domain_scores_gemma":[0.9994262,0.000028433338,0.00014841305,0.000045843026,0.0002372132,0.00011391079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026256498,0.000093342926,0.0002596347,0.00009801842,0.00006963421,0.000018597071,0.000040614304,0.00006991494,0.000018294479],"category_scores_gemma":[0.00003395043,0.00009773778,0.00007917852,0.000068538866,0.00006936653,0.000121611534,0.000007211583,0.00015557223,1.1891584e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043707523,0.0005611994,0.36379287,0.00023239762,0.00076804525,0.0016680118,0.0013997273,0.003296492,0.44371393,0.00005908162,0.00032766614,0.17980984],"study_design_scores_gemma":[0.041437086,0.0019502233,0.42852473,0.00059079326,0.0035331813,0.050130773,0.00027881918,0.42940122,0.04105897,0.0013125682,0.0009091623,0.0008724581],"about_ca_topic_score_codex":0.0002919234,"about_ca_topic_score_gemma":0.00017896881,"teacher_disagreement_score":0.42610472,"about_ca_system_score_codex":0.000044988294,"about_ca_system_score_gemma":0.00014555351,"threshold_uncertainty_score":0.39856312},"labels":[],"label_agreement":null},{"id":"W2036602244","doi":"10.1016/j.urolonc.2014.07.009","title":"Radical trimodality therapy for patients with locally advanced bladder cancer: The British Columbia Cancer Agency experience","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Ottawa Hospital; University of Ottawa; BC Cancer Agency","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; Cystoscopy; Univariate analysis; Radiation therapy; Chemotherapy; Urology; Surgery; Oncology; Internal medicine; Multivariate analysis; Urinary system","score_opus":0.034465502855273396,"score_gpt":0.329311269825086,"score_spread":0.29484576696981263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036602244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988984,0.0038086614,0.00015809409,0.004360965,0.0002920321,0.0016507948,0.00013521442,0.00005312163,0.0005571268],"genre_scores_gemma":[0.9677654,0.0035762107,0.010715735,0.010818999,0.00031036517,0.0041522663,0.00010845062,0.000037245154,0.0025153563],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865043,0.00009252493,0.00025230102,0.00042757255,0.00023243313,0.00034473848],"domain_scores_gemma":[0.99892235,0.00013607394,0.00013590771,0.00020029147,0.0002454391,0.00035991386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016303784,0.00016786122,0.00034894026,0.000018960249,0.0005978881,0.00010142682,0.0001292834,0.00016150241,0.00015787591],"category_scores_gemma":[0.00009770969,0.00013397324,0.000053691143,0.00020598139,0.0011037947,0.000120824116,0.000024673645,0.00021661482,0.0000017361092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081921514,0.00049098075,0.93513536,0.000010330873,0.00013713364,0.000022887447,0.0009721951,0.000025544727,0.000023207644,0.00010978375,0.016068932,0.046184443],"study_design_scores_gemma":[0.0100441985,0.007358054,0.13996938,0.00006384656,0.0003064206,0.00006285758,0.00028460016,0.0001357455,0.0000631985,0.0030907446,0.8383778,0.00024318157],"about_ca_topic_score_codex":0.0084069865,"about_ca_topic_score_gemma":0.0068873256,"teacher_disagreement_score":0.82230884,"about_ca_system_score_codex":0.00019895508,"about_ca_system_score_gemma":0.0015356389,"threshold_uncertainty_score":0.9981961},"labels":[],"label_agreement":null},{"id":"W2037217444","doi":"10.1002/cncr.22853","title":"Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Radiation therapy; Surgery; Chemotherapy; Carcinoma; Basal cell; Bladder cancer; Internal medicine; Cancer","score_opus":0.025223971835027125,"score_gpt":0.3031468231203503,"score_spread":0.2779228512853232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037217444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957492,0.001850656,0.0000406792,0.00010825017,0.000280477,0.0002739924,0.00014616022,0.000003441295,0.001547154],"genre_scores_gemma":[0.99923146,0.00005044677,0.00003044538,0.00013032701,0.00009067414,0.000008234515,0.0000018691869,0.000011273708,0.0004452669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992418,0.000013082635,0.00027993793,0.00013445044,0.00019581323,0.00013489713],"domain_scores_gemma":[0.9994185,0.00003712422,0.00014622591,0.00024066554,0.00010208486,0.000055381883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007904347,0.00009652678,0.0002609933,0.000035379864,0.000015989744,0.0000011789614,0.00007972126,0.000057414283,0.0002005317],"category_scores_gemma":[0.00001552358,0.00006154613,0.00007957154,0.00009890269,0.00010045746,0.00002103196,0.000034479846,0.00009069198,5.5390103e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016750606,0.000098328375,0.9871065,0.00032572707,0.00002197866,0.0000033685328,0.0005869135,0.0000010927796,0.0074997125,0.000017836774,0.00013379692,0.0040372517],"study_design_scores_gemma":[0.0016922029,0.00022018932,0.8064325,0.000063919935,0.00015739522,0.0000039850993,0.00012486735,0.0000028288343,0.19096069,0.000011996045,0.00027884336,0.00005062161],"about_ca_topic_score_codex":0.00074148265,"about_ca_topic_score_gemma":0.00018761895,"teacher_disagreement_score":0.18346097,"about_ca_system_score_codex":0.000035759313,"about_ca_system_score_gemma":0.00010754166,"threshold_uncertainty_score":0.25097784},"labels":[],"label_agreement":null},{"id":"W2037730446","doi":"10.1007/s11864-000-0070-5","title":"Localized bladder cancer","year":2000,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Royal College of Physicians and Surgeons of Canada","keywords":"Medicine; Bladder cancer; Cancer; Urology; Oncology; Internal medicine","score_opus":0.16678015950950023,"score_gpt":0.49227819900583614,"score_spread":0.32549803949633593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037730446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015833308,0.9870973,0.0000063342513,0.00014916771,0.0015017178,0.002939972,0.00038360892,0.00010317138,0.007802885],"genre_scores_gemma":[0.0000060408165,0.988282,0.00021577149,0.000052263487,0.00061706174,0.0063138516,0.0010200233,0.00009377006,0.0033991714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723965,0.00027770165,0.00087538233,0.00082547497,0.00020118931,0.0005806094],"domain_scores_gemma":[0.9987314,0.00015360511,0.0002086969,0.00061546336,0.000045986235,0.00024485597],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000725922,0.000765621,0.0029869503,0.00059092796,0.00008971183,0.000017531325,0.0001536437,0.00055790297,0.0043086563],"category_scores_gemma":[0.000010346691,0.0005395225,0.0008345346,0.0006010844,0.00015796718,0.000049460414,0.000037429618,0.00049320963,0.00082876586],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008719363,0.003572135,0.00007496894,0.0014386028,0.0009035114,0.00015942263,0.00008253217,0.0000038682106,2.4511724e-8,0.00007441857,0.0016226899,0.9919806],"study_design_scores_gemma":[0.0046910956,0.0012434808,0.000023464265,0.005922433,0.006137218,0.00018935298,0.000010003354,0.0000058907863,2.9734227e-7,0.00003614252,0.98139066,0.0003499679],"about_ca_topic_score_codex":0.00020777903,"about_ca_topic_score_gemma":0.00020815525,"teacher_disagreement_score":0.9916307,"about_ca_system_score_codex":0.0052769314,"about_ca_system_score_gemma":0.003309289,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W2037761551","doi":"10.1007/s00383-014-3510-1","title":"Sub-urothelial polyp enucleation resection and urothelial auto-augmentation cystoplasty: a simple method for bladder exstrophy–epispadias complex reconstruction in bladder plate polyposis","year":2014,"lang":"en","type":"article","venue":"Pediatric Surgery International","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; University of British Columbia; Faculty of Medicine, University of British Columbia","keywords":"Medicine; Enucleation; Epispadias; Resection; Bladder augmentation; Urology; Surgery; Bladder exstrophy; Urinary bladder; Pediatric surgery","score_opus":0.026311140866584586,"score_gpt":0.3023393746430638,"score_spread":0.2760282337764792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037761551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95285845,0.000098624616,0.040844064,0.0017909269,0.002226664,0.0010671886,0.00033905104,0.00012187935,0.0006531433],"genre_scores_gemma":[0.98820204,0.00034688355,0.006137732,0.000823213,0.0032767525,0.0003116729,0.00060579035,0.000070957496,0.00022497367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778914,0.00017596319,0.00064955105,0.00056685833,0.00045744661,0.00036106101],"domain_scores_gemma":[0.9983823,0.00074693334,0.00028445586,0.00017661863,0.00025526423,0.00015447424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005750808,0.00028560942,0.00042310928,0.0008327507,0.0001503371,0.00006506952,0.00007647138,0.00017448931,0.00037556398],"category_scores_gemma":[0.00042957612,0.00029254166,0.00019750877,0.00030566545,0.00005162696,0.00033171815,0.000031869215,0.00018746874,0.00002344235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009529266,0.0007570744,0.6056623,0.0002277766,0.0008300898,0.000023398601,0.00091606565,0.0003218198,0.029446865,0.00057044893,0.015320838,0.33639407],"study_design_scores_gemma":[0.019867048,0.0015122199,0.85883445,0.00010917579,0.0011751489,0.00070501125,0.00038371197,0.08536303,0.012029547,0.002937073,0.01587383,0.001209749],"about_ca_topic_score_codex":0.0008612043,"about_ca_topic_score_gemma":0.0001903399,"teacher_disagreement_score":0.3351843,"about_ca_system_score_codex":0.00030932704,"about_ca_system_score_gemma":0.00017883962,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W2037798739","doi":"10.1002/cncr.22521","title":"Survivin expression is associated with bladder cancer presence, stage, progression, and mortality","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Survivin; Cystectomy; Medicine; Bladder cancer; Lymph node; Lymphadenectomy; Immunohistochemistry; Stage (stratigraphy); Cancer; Lymph; Oncology; Urinary bladder; Pathology; Transitional cell carcinoma; Urology; Internal medicine; Biology","score_opus":0.034658551825159964,"score_gpt":0.3678451822768657,"score_spread":0.3331866304517057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037798739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888812,0.004877706,0.000094669085,0.00040569287,0.0002487846,0.000708162,0.00018115233,0.00009053761,0.0045121494],"genre_scores_gemma":[0.9885733,0.0007303918,0.00010464701,0.00096827367,0.00022831335,0.00021099164,0.000022589897,0.00004258142,0.009118902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841505,0.000034407476,0.00021837537,0.00043234992,0.00048900873,0.00041080252],"domain_scores_gemma":[0.9990627,0.000053745753,0.00012741057,0.00028119006,0.00020550037,0.00026945447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022000333,0.0002278572,0.00032901767,0.000060260318,0.00012477195,0.000024574367,0.000066049644,0.00013259111,0.0015070558],"category_scores_gemma":[0.000032762597,0.00015008604,0.00004351554,0.00025937156,0.00015529686,0.00012721831,0.00004099448,0.00018905393,0.0000035129228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000514851,0.00021374415,0.97421527,0.000077218036,0.00042072128,0.00006921437,0.00082230516,0.0000033598583,0.003396007,0.000010032903,0.0074194083,0.012837884],"study_design_scores_gemma":[0.0034196784,0.00028117048,0.91758436,0.00086688943,0.00032550175,0.0000056397193,0.00015498536,0.00003387672,0.066301234,0.000029581704,0.01073301,0.00026410355],"about_ca_topic_score_codex":0.0010607436,"about_ca_topic_score_gemma":0.0017924157,"teacher_disagreement_score":0.06290522,"about_ca_system_score_codex":0.00018080119,"about_ca_system_score_gemma":0.00030825305,"threshold_uncertainty_score":0.9994057},"labels":[],"label_agreement":null},{"id":"W2037907483","doi":"10.1016/j.eururo.2006.05.046","title":"Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature","year":2006,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Occult; Stage (stratigraphy); Surgery; Cancer; Internal medicine; Pathology","score_opus":0.034311922410683336,"score_gpt":0.3364971222671261,"score_spread":0.30218519985644277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037907483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039014667,0.9901233,1.68923e-7,0.00030930614,0.00014970632,0.0025083604,0.0001244833,0.0000067096707,0.0067389854],"genre_scores_gemma":[0.0003252161,0.9981715,0.0000026288155,0.00035428326,0.00013976179,0.00014824771,0.000056284345,0.000045508994,0.00075653475],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960946,0.0023324022,0.00088895386,0.00029000329,0.0002104037,0.0001836409],"domain_scores_gemma":[0.9984059,0.000336333,0.00048117625,0.0006822529,0.000059731385,0.00003465164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047264626,0.00034479017,0.0025062084,0.00007511851,0.000023617007,0.000006047379,0.00022621691,0.0001109652,0.00004209187],"category_scores_gemma":[0.000047882317,0.00013372181,0.00047988165,0.00035441038,0.00013767468,0.000010940393,0.000044644235,0.00022730714,0.000007680352],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028194358,0.0003171979,0.00015546687,0.9719909,0.00073542295,0.0005364164,0.00030661834,1.6191456e-7,7.041858e-8,0.000078507546,0.0007820219,0.025069062],"study_design_scores_gemma":[0.0008674484,0.0004742484,0.00025130002,0.29819804,0.008383409,0.0008734468,0.000005102703,1.9394214e-7,1.96243e-7,0.0000030050633,0.6908385,0.0001051085],"about_ca_topic_score_codex":0.00007026199,"about_ca_topic_score_gemma":0.00002971079,"teacher_disagreement_score":0.69005644,"about_ca_system_score_codex":0.000050497936,"about_ca_system_score_gemma":0.00013714773,"threshold_uncertainty_score":0.54530174},"labels":[],"label_agreement":null},{"id":"W2038111129","doi":"10.1016/j.eururo.2012.01.021","title":"Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Lymphovascular invasion; Hazard ratio; Concomitant; Stage (stratigraphy); Internal medicine; Oncology; Cancer; Proportional hazards model; Lymph node; Urology; Carcinoma; Cohort; Metastasis; Confidence interval","score_opus":0.0390510178101316,"score_gpt":0.3309146278737073,"score_spread":0.2918636100635757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038111129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98309106,0.00058842957,0.0003935475,0.0016028787,0.0020483087,0.00072936894,0.000058650552,0.000132528,0.011355207],"genre_scores_gemma":[0.9833607,0.000014831173,0.0010472643,0.009721356,0.0046881684,0.000068606736,0.000034696728,0.00010240937,0.0009619586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978621,0.0004222312,0.00051720795,0.0003795777,0.0001638542,0.0006550378],"domain_scores_gemma":[0.99872893,0.00037648797,0.00009502154,0.0003630384,0.000043901833,0.00039263858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065452117,0.00025608967,0.0004882771,0.00007920298,0.000078998746,0.000012982715,0.00012413025,0.00013626332,0.0004952096],"category_scores_gemma":[0.00031254513,0.00019299581,0.00042575318,0.00005385447,0.00017552928,0.000095487696,0.00006461755,0.00036445312,0.00032743995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015136998,0.0004726448,0.99017644,0.000018230636,0.00017099219,0.00010685172,0.00033197337,1.2669084e-7,0.00004651142,0.00003570491,0.0020984926,0.0050283205],"study_design_scores_gemma":[0.0049615023,0.0011199134,0.8176385,0.0000054221186,0.00039417803,0.00023953756,0.0000124754715,0.000015903324,0.000034862947,0.000009785745,0.17543244,0.00013543134],"about_ca_topic_score_codex":0.000014348475,"about_ca_topic_score_gemma":0.0000018066738,"teacher_disagreement_score":0.17333394,"about_ca_system_score_codex":0.000033744094,"about_ca_system_score_gemma":0.00007055076,"threshold_uncertainty_score":0.78701407},"labels":[],"label_agreement":null},{"id":"W2038186287","doi":"10.1111/j.1464-410x.2009.08650.x","title":"The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cystoscopy; Medicine; Urine cytology; Cytology; Genitourinary system; Incidence (geometry); Bladder cancer; Urothelial carcinoma; Malignancy; Urinary system; Urology; Cancer; Carcinoma; Bladder Neoplasm; Oncology; Internal medicine; Pathology","score_opus":0.006773168379071766,"score_gpt":0.22789567777910327,"score_spread":0.2211225094000315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038186287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758476,0.0009989409,0.00003475289,0.00042521887,0.00017327962,0.00020886098,0.000034474782,0.000008126018,0.00053159817],"genre_scores_gemma":[0.99889123,0.0001748935,0.0001425807,0.00050373067,0.00019475017,0.0000022194754,0.0000067941623,0.000017565126,0.00006620828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987734,0.000111401845,0.0004513139,0.00014227598,0.0002558362,0.0002657503],"domain_scores_gemma":[0.9988598,0.000108191314,0.0003572894,0.00016920638,0.00034250776,0.00016298052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015021973,0.00012852845,0.00041116017,0.00007655951,0.00009460274,0.000013966098,0.0001553074,0.00009754307,0.00006476353],"category_scores_gemma":[0.000110865425,0.00009229681,0.00008764789,0.0000855145,0.000276575,0.00011091825,0.000012682889,0.0003147961,0.0000017668905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017600196,0.0006800011,0.92295843,0.000007626866,0.00012633334,0.0013325729,0.00008981234,0.000008742108,0.0002499487,0.000017602093,0.0002587564,0.07251012],"study_design_scores_gemma":[0.0065944945,0.013392109,0.974407,0.000028966413,0.00021010642,0.0041296873,0.00001694384,0.0000073552706,0.0003222524,0.00017862488,0.0006380701,0.0000743692],"about_ca_topic_score_codex":0.00020366505,"about_ca_topic_score_gemma":0.00024186744,"teacher_disagreement_score":0.07243575,"about_ca_system_score_codex":0.00003444706,"about_ca_system_score_gemma":0.00018177507,"threshold_uncertainty_score":0.37637547},"labels":[],"label_agreement":null},{"id":"W2038313713","doi":"10.1016/j.eururo.2007.09.033","title":"When and How to Treat Superficial and Muscle-Invasive Bladder Cancer","year":2007,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.015955093815904476,"score_gpt":0.2783630909787044,"score_spread":0.2624079971627999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038313713","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103724085,0.012232386,0.000079237376,0.0128784105,0.8170825,0.0021203612,0.0013429816,0.00030432656,0.050235685],"genre_scores_gemma":[0.035538208,0.0033559757,0.00019993143,0.0043785376,0.9421614,0.00004690228,0.00028457315,0.00029220394,0.013742278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976952,0.000225499,0.00023187796,0.00090502953,0.0003968313,0.0005455795],"domain_scores_gemma":[0.9984538,0.00043414359,0.000090372494,0.00037809534,0.0002036508,0.00043993333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002683356,0.00050144974,0.00071062206,0.00025117563,0.00010902946,0.000054291882,0.00013537228,0.00044201815,0.00026515676],"category_scores_gemma":[0.00047600278,0.00042765768,0.00008296526,0.00008975605,0.00020742824,0.000046680947,0.0001906989,0.00073816156,0.00008418351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007278015,0.00006020317,0.00053079246,0.00010237464,0.00023625,0.0009940206,0.0012669233,2.626506e-7,0.00030078867,0.0000045637016,0.97467273,0.021103293],"study_design_scores_gemma":[0.0030391354,0.002211202,0.007108264,0.00005693309,0.0009922425,0.000049827788,0.00006454033,5.3966585e-7,0.00008727021,0.000013520227,0.98603225,0.00034425818],"about_ca_topic_score_codex":0.00035776428,"about_ca_topic_score_gemma":0.00043974695,"teacher_disagreement_score":0.12507886,"about_ca_system_score_codex":0.0000906888,"about_ca_system_score_gemma":0.00031245916,"threshold_uncertainty_score":0.99981755},"labels":[],"label_agreement":null},{"id":"W2038876912","doi":"10.1038/modpathol.2014.154","title":"Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications","year":2014,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"University of Toronto; KWF Kankerbestrijding; Ministerio de Economía y Competitividad; University Health Network","keywords":"Grading (engineering); Bladder cancer; Medicine; Pathology; Internal medicine; Oncology; Tumor grade; Immunohistochemistry; Cancer; Biology","score_opus":0.06104371313168939,"score_gpt":0.34162799383051523,"score_spread":0.28058428069882585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038876912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5003179,0.0006379001,0.47802803,0.014511774,0.00048247105,0.0036065893,0.00039252345,0.00010077918,0.0019220692],"genre_scores_gemma":[0.9948781,0.000020500467,0.0012258486,0.0024101916,0.00014186744,0.00093128625,0.000025825513,0.000033573408,0.0003327732],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989796,0.000097825316,0.00023782592,0.0003760916,0.00008270545,0.0002259001],"domain_scores_gemma":[0.99909115,0.0003498059,0.000078663485,0.00029985164,0.00007743293,0.00010309728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037672624,0.00013971946,0.00032669262,0.00004754061,0.00014338402,0.000015037062,0.00005354986,0.00013475066,0.0000081077715],"category_scores_gemma":[0.00011903371,0.000094856114,0.00009606855,0.00003419073,0.00012981101,0.000016531343,0.0000129989885,0.00009802761,0.0000014574379],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013116377,0.0028425863,0.37674022,0.00394958,0.0037843997,0.00041555255,0.004538556,0.00089874986,0.04818285,0.07863657,0.034880456,0.4320141],"study_design_scores_gemma":[0.035729546,0.009239612,0.090815954,0.0005365601,0.004035197,0.00040703907,0.00036158002,0.81440383,0.006071288,0.008300234,0.02921316,0.00088598003],"about_ca_topic_score_codex":0.000014052542,"about_ca_topic_score_gemma":0.000020142697,"teacher_disagreement_score":0.8135051,"about_ca_system_score_codex":0.000043575095,"about_ca_system_score_gemma":0.000100016536,"threshold_uncertainty_score":0.386812},"labels":[],"label_agreement":null},{"id":"W2038973683","doi":"10.1016/j.ejso.2014.10.004","title":"Contemporary 90-day mortality rates after radical cystectomy in the elderly","year":2014,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Epidemiology; Logistic regression; Mortality rate; Demography; Comorbidity; Bladder cancer; Internal medicine; Surgery; Cancer","score_opus":0.039527127543710384,"score_gpt":0.32828704412500015,"score_spread":0.28875991658128974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038973683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81405926,0.0016066665,0.00011184223,0.0074521233,0.0003653411,0.00020133928,0.0000030167366,0.000010705367,0.17618969],"genre_scores_gemma":[0.99707353,0.00015150745,0.00008595149,0.0016109193,0.00086916523,0.0000040250866,0.0000023639423,0.000018770465,0.00018379014],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604654,0.0025920917,0.0006798009,0.00015194294,0.00031333207,0.00021629815],"domain_scores_gemma":[0.998843,0.0004643309,0.00022408823,0.00019166248,0.00008260621,0.00019427305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031796973,0.00014755053,0.0005342847,0.00009084867,0.000033071003,0.000017123048,0.000196896,0.00005749734,0.00034574632],"category_scores_gemma":[0.00007888668,0.00007928661,0.00021064254,0.00013818603,0.00020841826,0.000073080744,0.000029431465,0.0005887505,0.000060861825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012181283,0.004594328,0.39424983,0.00012253554,0.0009839135,0.19834556,0.003980729,0.000011294298,0.00046538073,0.00034682092,0.042633865,0.34208447],"study_design_scores_gemma":[0.009492642,0.0065474166,0.22713512,0.00009038691,0.00009720506,0.0023883032,0.00010163948,0.0000081811,0.000047659618,0.000053862874,0.7539522,0.00008537398],"about_ca_topic_score_codex":0.000011603216,"about_ca_topic_score_gemma":0.0000038696444,"teacher_disagreement_score":0.7113184,"about_ca_system_score_codex":0.0000710723,"about_ca_system_score_gemma":0.00021138902,"threshold_uncertainty_score":0.378568},"labels":[],"label_agreement":null},{"id":"W2040184473","doi":"10.1038/modpathol.3800262","title":"ImmunoCyt/uCyt+™ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma","year":2004,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Cytology; Cystoscopy; Medicine; Urine cytology; Malignancy; Bladder cancer; Urology; Urine; Carcinoma; Urinary system; Pathology; Urothelial carcinoma; Cancer; Internal medicine","score_opus":0.013702840373091751,"score_gpt":0.26085405272069184,"score_spread":0.2471512123476001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040184473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430215,0.0002115397,0.0028556085,0.0007679553,0.00028107816,0.0011706848,0.00009686645,0.000022619539,0.00029150528],"genre_scores_gemma":[0.998553,0.00001149274,0.0005187675,0.00053636136,0.000073093135,0.0001325928,0.000043335647,0.000030990283,0.00010039376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875814,0.000119609846,0.000322697,0.00032988138,0.00012273743,0.00034695322],"domain_scores_gemma":[0.99925065,0.00009508492,0.00010537449,0.00039896782,0.000103380225,0.000046518668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024457046,0.00018498552,0.00048789274,0.000096666794,0.00005725998,0.0000032733642,0.00008404601,0.00015513942,0.0000074295126],"category_scores_gemma":[0.000103083024,0.00013074483,0.00015001369,0.000088359266,0.00018267488,0.000037267208,0.000058355698,0.0001541961,0.0000058107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011683118,0.0033024738,0.6560906,0.0002521771,0.00030983254,0.00065950566,0.005842774,0.00018061335,0.27508244,0.0011045985,0.00006225363,0.04542958],"study_design_scores_gemma":[0.021903466,0.0027424407,0.93527716,0.00002629197,0.00017254316,0.0001500926,0.000049853654,0.00024071633,0.035269685,0.0038994567,0.00010548829,0.00016277793],"about_ca_topic_score_codex":0.00047889224,"about_ca_topic_score_gemma":0.00025833162,"teacher_disagreement_score":0.27918655,"about_ca_system_score_codex":0.00012365234,"about_ca_system_score_gemma":0.00018031344,"threshold_uncertainty_score":0.53316194},"labels":[],"label_agreement":null},{"id":"W2040879241","doi":"10.1111/j.1464-410x.2007.07132.x","title":"A delay in radical cystectomy of &gt;3 months is not associated with a worse clinical outcome","year":2007,"lang":"en","type":"letter","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Logistic regression; Pathological; Prostate cancer; Urology; Cancer; Internal medicine; Surgery","score_opus":0.0370860772242409,"score_gpt":0.330971650641748,"score_spread":0.2938855734175071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040879241","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68380123,0.008881447,0.00023123562,0.30214393,0.001513977,0.0011555013,0.00035121624,0.00003650731,0.0018849692],"genre_scores_gemma":[0.4884498,0.0006387217,0.00038120736,0.50763,0.002055537,0.000009335156,0.000044812725,0.0000926752,0.00069792825],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9956799,0.00046712687,0.0021530592,0.00035923725,0.00077315525,0.0005675305],"domain_scores_gemma":[0.9972468,0.00060186535,0.0013086726,0.00023540152,0.00039952577,0.00020775579],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012060611,0.0003129986,0.0021834904,0.0004478774,0.000027556474,0.0000146532075,0.0002709666,0.0016394637,0.00033816486],"category_scores_gemma":[0.0006348945,0.00028250774,0.0005593412,0.0002788245,0.00042497698,0.0000576291,0.00004048577,0.0045424188,0.000008223112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004692219,0.0010901315,0.28919578,0.00011676958,0.0022650547,0.2201182,0.00011245125,0.0000030519936,0.0000057536963,7.8493565e-7,0.46993783,0.01246199],"study_design_scores_gemma":[0.039074376,0.010792508,0.5293266,0.0016963632,0.0027959335,0.072407514,0.000014805329,0.000017253818,0.00001743292,0.000056148656,0.34332243,0.00047865126],"about_ca_topic_score_codex":0.00038399204,"about_ca_topic_score_gemma":0.000429458,"teacher_disagreement_score":0.24013083,"about_ca_system_score_codex":0.00017948296,"about_ca_system_score_gemma":0.00063076837,"threshold_uncertainty_score":0.9999627},"labels":[],"label_agreement":null},{"id":"W2042134048","doi":"10.1007/s00345-011-0709-9","title":"Impact of gender on bladder cancer incidence, staging, and prognosis","year":2011,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrology; Incidence (geometry); Internal medicine; Bladder cancer; Oncology; Cancer; Hepatology; Urology; Gynecology","score_opus":0.08057512370437199,"score_gpt":0.39520176615535846,"score_spread":0.3146266424509865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042134048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007451957,0.99527,0.0000033004997,0.00006406727,0.0002597305,0.000402422,0.000037229605,0.000005692413,0.0032123562],"genre_scores_gemma":[0.010988177,0.9877253,0.000083197665,0.00022069331,0.0003803587,0.000024333374,0.0000040305717,0.00005109888,0.00052278215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983284,0.00015267453,0.00079310103,0.00022804958,0.00021956241,0.00027822828],"domain_scores_gemma":[0.99818873,0.000111867594,0.0010635522,0.00021588754,0.00020187402,0.00021807603],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021678106,0.00035429173,0.0020390828,0.0007536504,0.000026907308,0.000006533309,0.00015140399,0.0001836892,0.0018139808],"category_scores_gemma":[0.00003554343,0.00021153121,0.0006676199,0.0002688738,0.000144658,0.00005111982,0.00004316158,0.00067821937,0.000008066856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052743056,0.0004063121,0.045996238,0.0022497172,0.005183013,0.00024848105,0.00021684967,9.580459e-7,0.0000010672002,0.00006345127,0.005613937,0.9394925],"study_design_scores_gemma":[0.0018096183,0.0044427738,0.023666618,0.0031258976,0.0095786145,0.0013079693,0.0000051656793,5.092931e-7,0.000001762332,0.000115998824,0.9557145,0.00023057795],"about_ca_topic_score_codex":0.00010679324,"about_ca_topic_score_gemma":0.000029175691,"teacher_disagreement_score":0.95010054,"about_ca_system_score_codex":0.00017306907,"about_ca_system_score_gemma":0.0010721568,"threshold_uncertainty_score":0.9990985},"labels":[],"label_agreement":null},{"id":"W2042209869","doi":"10.5737/1181912x204177181","title":"Radical cystectomy for bladder cancer: A qualitative study of patient experiences and implications for practice","year":2010,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Sexual function; Qualitative research; Focus group; Cancer; Family medicine; General surgery; Internal medicine","score_opus":0.03896550265698579,"score_gpt":0.4433169555729509,"score_spread":0.40435145291596514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042209869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739571,0.0009933048,0.00039946145,0.021716675,0.0008138275,0.0014532016,0.00007461664,0.0000059760773,0.0005858101],"genre_scores_gemma":[0.99405456,0.000030854833,0.004281027,0.00071767817,0.0002520891,0.0006142635,0.000004013598,0.000014256967,0.000031245385],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99914473,0.00008684773,0.0002676939,0.00016615455,0.00007937975,0.00025522022],"domain_scores_gemma":[0.9984534,0.00039697142,0.00018847284,0.0000996792,0.0003755385,0.00048593758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025597806,0.00009480681,0.0002641896,0.00014869493,0.00032828958,0.000016635655,0.000057905003,0.000098610755,0.000039203635],"category_scores_gemma":[0.00033083512,0.00007952185,0.000049126178,0.00008439927,0.00023982275,0.00008217579,0.0000028582908,0.0002234322,1.8116319e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014604956,0.0015942896,0.002123812,0.000024425073,0.0006305787,0.000025560243,0.72869235,0.0000012454067,0.0012159061,0.0006952355,0.014258997,0.24927711],"study_design_scores_gemma":[0.013782145,0.018079534,0.005858647,0.00020343204,0.0013576994,0.0020613475,0.85046566,0.000045880824,0.00043216476,0.0015932932,0.10589265,0.0002275497],"about_ca_topic_score_codex":0.0036610847,"about_ca_topic_score_gemma":0.018792251,"teacher_disagreement_score":0.24904957,"about_ca_system_score_codex":0.0005840998,"about_ca_system_score_gemma":0.0034051838,"threshold_uncertainty_score":0.99911225},"labels":[],"label_agreement":null},{"id":"W2042400776","doi":"10.3892/ijmm.19.2.285","title":"Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma","year":2007,"lang":"en","type":"article","venue":"International Journal of Molecular Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds Québécois de la Recherche sur la Nature et les Technologies; Cancerfonden","keywords":"Biodistribution; DOTA; Chemistry; Radionuclide therapy; Conjugate; Cancer research; Pharmacology; Medicine; Biochemistry; Chelation; Internal medicine; In vitro","score_opus":0.0167930334316362,"score_gpt":0.3036192269015012,"score_spread":0.28682619346986504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042400776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98183197,0.0020796633,0.013862194,0.0013536843,0.00028643128,0.00031856398,0.000049461694,0.000004743739,0.00021328028],"genre_scores_gemma":[0.9974263,0.00062754686,0.0008660891,0.00026541206,0.000494311,0.000008097526,0.00014557457,0.000026202148,0.00014050757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827397,0.0000194689,0.00073337555,0.00017368805,0.0006361154,0.00016339874],"domain_scores_gemma":[0.9982844,0.00006179384,0.000603533,0.00013215072,0.0007651174,0.00015299932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000224805,0.00019181296,0.00046953722,0.00016989221,0.000020754653,0.000005358095,0.000115969735,0.00007593597,0.00008633394],"category_scores_gemma":[0.000044208602,0.00014504133,0.0001663893,0.000092627815,0.00013959745,0.00006292219,0.000020031148,0.000080106416,3.1975657e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029353371,0.00076998153,0.008753843,0.00013025051,0.0013558049,0.0009973957,0.0007350027,0.000011790378,0.9753768,0.00004501552,0.000045796507,0.008843011],"study_design_scores_gemma":[0.015926516,0.0051953713,0.06968288,0.00071829825,0.0009981261,0.002473559,0.00031405344,0.0002648619,0.90224856,0.000090542024,0.0019195342,0.00016767184],"about_ca_topic_score_codex":0.000062761166,"about_ca_topic_score_gemma":0.0000015942794,"teacher_disagreement_score":0.073128186,"about_ca_system_score_codex":0.00016530698,"about_ca_system_score_gemma":0.00018490404,"threshold_uncertainty_score":0.59146136},"labels":[],"label_agreement":null},{"id":"W2042593936","doi":"10.1016/j.juro.2011.02.1292","title":"1401 THE <i>FGFR3</i> MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"KWF Kankerbestrijding; University of Toronto","keywords":"Cystectomy; Medicine; Bladder cancer; Library science; Cancer; Internal medicine","score_opus":0.019911612935796907,"score_gpt":0.2605120188055681,"score_spread":0.24060040586977122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042593936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923802,0.0020174982,0.00050663337,0.0037184244,0.00037913493,0.0005750252,0.000029299248,0.0000086225655,0.0003851522],"genre_scores_gemma":[0.99716866,0.00016198975,0.0000605553,0.0019095616,0.000202635,0.00003396159,0.0000051444804,0.000020015523,0.00043748957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912447,0.000110928995,0.00024185207,0.000088791385,0.00023666568,0.00019728701],"domain_scores_gemma":[0.99910134,0.00012878519,0.00024211791,0.00017991326,0.00023208692,0.00011574368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022210184,0.00011305956,0.00020812938,0.00004369786,0.00016208763,0.0000063278685,0.00014198001,0.000040233263,0.0002863499],"category_scores_gemma":[0.000044450022,0.00004817352,0.0000874479,0.0000718546,0.00020804175,0.000089353154,0.000023016097,0.00015240448,0.000008956214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16548105,0.0029080713,0.7411493,0.00028691092,0.0063011036,0.00044338527,0.017046226,0.0004184892,0.0014051809,0.0004879938,0.051603843,0.012468455],"study_design_scores_gemma":[0.023733681,0.0073317066,0.92936313,0.000084341074,0.007185451,0.00058158743,0.00027078082,0.00010811345,0.0027345426,0.0025021785,0.025856474,0.00024800195],"about_ca_topic_score_codex":0.00010972275,"about_ca_topic_score_gemma":0.00007937756,"teacher_disagreement_score":0.18821386,"about_ca_system_score_codex":0.00005838506,"about_ca_system_score_gemma":0.00017247065,"threshold_uncertainty_score":0.31353307},"labels":[],"label_agreement":null},{"id":"W2044157449","doi":"10.1016/s0360-3016(01)02328-8","title":"Efficacy of concurrent intra-arterial cisplatin and radiation in the treatment of bladder cancer presenting with hydronephrosis","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Hydronephrosis; Bladder cancer; Cystectomy; Urology; Surgery; Percutaneous nephrostomy; Radiology; Urinary system; Cancer; Internal medicine; Percutaneous","score_opus":0.025621607461746822,"score_gpt":0.3468332652883112,"score_spread":0.3212116578265644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044157449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955598,0.0013533797,0.0005579852,0.0013297906,0.00059632515,0.00035657885,0.000043297536,0.00000474338,0.00019806747],"genre_scores_gemma":[0.9939455,0.004544189,0.00022147853,0.00015067539,0.0010517488,0.00002353194,0.00003884548,0.000011738132,0.000012329272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987913,0.00014536841,0.0005667333,0.00013858818,0.00022768063,0.00013034012],"domain_scores_gemma":[0.99852574,0.00030337326,0.0007841592,0.000090314155,0.00024895233,0.000047461584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001706614,0.00014041088,0.0004056613,0.00011511778,0.000027983937,0.000009916272,0.000118153366,0.000092505565,0.000060854243],"category_scores_gemma":[0.00004141822,0.00008999447,0.0001000699,0.0001365272,0.0001671234,0.00012038793,0.000009622267,0.00012361884,9.850459e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020451131,0.0017601611,0.6612034,0.000010313937,0.0010835858,0.00002676517,0.0037818335,0.00044986227,0.004989355,0.0005170754,0.00013632837,0.32399625],"study_design_scores_gemma":[0.04773915,0.009287891,0.9050344,0.00018169748,0.0010038357,0.00029374508,0.00039686428,0.0021162613,0.01711051,0.0009693241,0.015644489,0.00022180643],"about_ca_topic_score_codex":0.00013895477,"about_ca_topic_score_gemma":0.00003094908,"teacher_disagreement_score":0.32377443,"about_ca_system_score_codex":0.0003085451,"about_ca_system_score_gemma":0.00029387654,"threshold_uncertainty_score":0.3669868},"labels":[],"label_agreement":null},{"id":"W2044247582","doi":"10.1002/ijc.11049","title":"Ki‐67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification","year":2003,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Oncology; Ki-67; Multivariate analysis; Proportional hazards model; Carcinoma; Overall survival; Urology; Pathology; Immunohistochemistry","score_opus":0.02130233538273899,"score_gpt":0.3174248221502224,"score_spread":0.2961224867674834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044247582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903282,0.0018217213,0.0004918336,0.0031344527,0.002565796,0.00034987586,0.00005711935,0.0000052615355,0.0012457431],"genre_scores_gemma":[0.9975418,0.0006281945,0.00005909643,0.00041745012,0.0011317579,0.000030179637,0.0000018243416,0.000017496317,0.0001722437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981986,0.00014554731,0.00050564593,0.00013028432,0.0008774081,0.00014248597],"domain_scores_gemma":[0.9983046,0.00020314335,0.0006464137,0.00018081865,0.0006045824,0.000060443173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027248095,0.00013708964,0.00020281802,0.00008534231,0.0000837025,0.000033255674,0.0003805743,0.0000628108,0.0004732791],"category_scores_gemma":[0.00045120058,0.00007114519,0.00023302506,0.00013935412,0.00015464067,0.00014917868,0.000025288404,0.00032524267,0.000004695321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010014164,0.0003273454,0.9684642,0.00001459017,0.0010457142,0.000014903091,0.0008183555,0.00007593856,0.012111172,0.0014460061,0.00086743775,0.013812951],"study_design_scores_gemma":[0.002834052,0.00024987277,0.95905316,0.00015863097,0.0005033044,0.00013121717,0.0002860215,0.00008879469,0.02543663,0.0011519942,0.0100171445,0.00008917003],"about_ca_topic_score_codex":0.00034161922,"about_ca_topic_score_gemma":0.0001678503,"teacher_disagreement_score":0.01372378,"about_ca_system_score_codex":0.00018648893,"about_ca_system_score_gemma":0.0006810651,"threshold_uncertainty_score":0.51820743},"labels":[],"label_agreement":null},{"id":"W2044545297","doi":"10.1016/j.urology.2013.10.060","title":"Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis","year":2014,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université de Montréal; McGill University Health Centre; Université Laval","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Hazard ratio; Confounding; Internal medicine; Confidence interval; Proportional hazards model; Cohort study; Cohort; Cancer; Oncology; Gynecology; Surgery","score_opus":0.015028373605744359,"score_gpt":0.2512805007498246,"score_spread":0.23625212714408025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044545297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942327,0.00013301124,0.0034014692,0.00036694828,0.00012008538,0.0005819689,0.00016314392,0.000027110576,0.0009735612],"genre_scores_gemma":[0.99813867,0.0000030857007,0.00017868297,0.0011327893,0.00015793655,0.000119998,0.000019102794,0.00003079302,0.00021897041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984602,0.0003218777,0.00027893335,0.00034519692,0.00025190483,0.00034194265],"domain_scores_gemma":[0.99885595,0.00031705256,0.00019795234,0.0004065225,0.0001265762,0.00009597666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033140884,0.00018835388,0.0006027158,0.00011864413,0.000095431045,0.00000675375,0.00012251142,0.00015429144,0.0002933695],"category_scores_gemma":[0.00018540832,0.00011518872,0.00032936267,0.00038765362,0.00022285055,0.00001754109,0.000043178083,0.00019817505,0.0000058328183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002581317,0.00022815267,0.99187165,0.00002396755,0.0031551914,0.000012858718,0.0014231292,0.00005883685,0.000112309055,0.000038579674,0.000049931637,0.00044404232],"study_design_scores_gemma":[0.0098886825,0.0015187607,0.97264934,0.000012395224,0.009086855,0.000025511836,0.00012645598,0.003795461,0.00063667,0.000084531,0.0019989437,0.00017637832],"about_ca_topic_score_codex":0.00025330123,"about_ca_topic_score_gemma":0.0004117459,"teacher_disagreement_score":0.019222328,"about_ca_system_score_codex":0.000039992112,"about_ca_system_score_gemma":0.00011724926,"threshold_uncertainty_score":0.46972597},"labels":[],"label_agreement":null},{"id":"W2044941273","doi":"10.1016/j.urology.2014.12.027","title":"Radical Cystectomy and Adjuvant Chemotherapy for Bladder Cancer in the Elderly: A Population-based Study","year":2015,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Canada Foundation for Innovation; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Cystectomy; Bladder cancer; Adjuvant; Urothelial cancer; Adjuvant chemotherapy; Chemotherapy; Oncology; Urology; Internal medicine; Cancer","score_opus":0.030514313100645535,"score_gpt":0.3348145326842145,"score_spread":0.304300219583569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044941273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881099,0.0009956853,0.00021048992,0.008952108,0.00011119925,0.0014264398,0.000010317542,0.000019712223,0.00016418997],"genre_scores_gemma":[0.9950228,0.000006674594,0.000063299514,0.004242862,0.0001404795,0.00043816867,0.000011179469,0.000014543481,0.000060024304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931467,0.00007622609,0.00013315026,0.00019217767,0.000117628275,0.00016613932],"domain_scores_gemma":[0.9996306,0.00009203083,0.000028915234,0.00015303242,0.000031709915,0.00006372205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017229891,0.00009731838,0.0002139347,0.00005612811,0.000030185458,0.0000065587105,0.00005131843,0.00006602012,0.00005890292],"category_scores_gemma":[0.00003170587,0.00006021696,0.000028352139,0.00008104047,0.000032095024,0.000016203607,0.0000054200045,0.00009086006,0.0000020419347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024869184,0.000822203,0.96713704,0.0000151700115,0.00014507993,0.00004411177,0.0026213413,0.00007458439,0.000036736066,0.000051221108,0.0012053942,0.025360217],"study_design_scores_gemma":[0.047603916,0.01179421,0.91824454,0.000011026167,0.00037791452,0.000048380556,0.0007124037,0.0022081742,0.00004829287,0.0008099029,0.01796169,0.00017955607],"about_ca_topic_score_codex":0.0008678128,"about_ca_topic_score_gemma":0.001015922,"teacher_disagreement_score":0.048892494,"about_ca_system_score_codex":0.0000399581,"about_ca_system_score_gemma":0.00013277831,"threshold_uncertainty_score":0.24555764},"labels":[],"label_agreement":null},{"id":"W2045154422","doi":"10.1016/j.urolonc.2012.09.011","title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cytology; Urine cytology; Medicine; Urine; Urinary system; Bladder cancer; Urology; Cancer; Pathology; Internal medicine","score_opus":0.03111572843048829,"score_gpt":0.31079118991719906,"score_spread":0.2796754614867108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045154422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841298,0.003441145,0.0000075532885,0.010517137,0.000068523455,0.00045749548,0.000008892397,0.000009656787,0.0013597975],"genre_scores_gemma":[0.99513763,0.0015201491,0.0004441129,0.0023293816,0.00003196197,0.00020457128,0.000010442523,0.0000053206013,0.00031643108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989096,0.00018809325,0.00038001177,0.00024358631,0.00013387717,0.00014483577],"domain_scores_gemma":[0.9990161,0.00030013846,0.0002811265,0.00023040065,0.000107121625,0.00006509568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029867378,0.00012880434,0.00041205296,0.0001469077,0.00011216991,0.000005133233,0.000082515035,0.00015017486,0.000169123],"category_scores_gemma":[0.000082454244,0.00007385535,0.000056972545,0.0005488571,0.0007640938,0.000066760214,0.000026318547,0.00021887415,0.0000030401823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015428942,0.00017133192,0.9953802,0.000023622944,0.000382957,0.000033085667,0.0009631626,0.000016945793,0.0008578099,0.0001910846,0.0006467919,0.0011787037],"study_design_scores_gemma":[0.0011577271,0.0054768673,0.94378155,0.000021140051,0.0008310806,0.00053874607,0.00041916195,0.0009784546,0.00089978124,0.0021523384,0.043628037,0.00011513658],"about_ca_topic_score_codex":0.005917885,"about_ca_topic_score_gemma":0.00021912063,"teacher_disagreement_score":0.051598687,"about_ca_system_score_codex":0.00006303875,"about_ca_system_score_gemma":0.00029687802,"threshold_uncertainty_score":0.8946111},"labels":[],"label_agreement":null},{"id":"W2045179755","doi":"10.1007/s11934-014-0450-1","title":"Optimal Treatment of Non-Muscle Invasive Urothelial Carcinoma Including Perioperative Management Revisited","year":2014,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Cystectomy; Disease; Perioperative; Nephrology; Intensive care medicine; Urothelial carcinoma; General surgery; Internal medicine; Surgery; Bladder cancer; Cancer","score_opus":0.06485204144596025,"score_gpt":0.37398328479870174,"score_spread":0.3091312433527415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045179755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018443394,0.98862374,0.00009543293,0.00003357959,0.0013175202,0.004207377,0.00008336048,0.000057543977,0.003737079],"genre_scores_gemma":[0.008524316,0.9880642,0.00023671998,0.00004368271,0.0006954396,0.0010006782,0.00072646514,0.00011815939,0.00059033005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960506,0.00023834078,0.001590809,0.0011995197,0.0003721724,0.0005485693],"domain_scores_gemma":[0.9971326,0.00011179017,0.0011749408,0.0011330816,0.00018172953,0.00026586515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020940973,0.000909345,0.003866624,0.0004513485,0.000138362,0.000019392133,0.000148726,0.00038065205,0.0002292803],"category_scores_gemma":[0.000052896998,0.00066404685,0.0010846494,0.00032226733,0.0002120472,0.000051098672,0.0001707342,0.00032696972,0.00005734024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011794609,0.0009852515,0.001344586,0.016081002,0.0017766511,0.0031781166,0.0004458322,0.000003405631,0.0000054676084,0.000027186255,0.00043749588,0.9755971],"study_design_scores_gemma":[0.0017631094,0.002710549,0.0006220927,0.0042340527,0.010121311,0.0017848859,0.000017814247,0.00000729924,0.000030687333,0.0000076290416,0.97825927,0.0004412866],"about_ca_topic_score_codex":0.000028985263,"about_ca_topic_score_gemma":0.0000028854467,"teacher_disagreement_score":0.97782177,"about_ca_system_score_codex":0.0005033376,"about_ca_system_score_gemma":0.00079478783,"threshold_uncertainty_score":0.9995811},"labels":[],"label_agreement":null},{"id":"W2045376922","doi":"10.1002/jso.21253","title":"Lymph node assessment and lymphadenectomy in bladder cancer","year":2009,"lang":"en","type":"review","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Humber River Regional Hospital; University of Toronto","funders":"","keywords":"Medicine; Lymphadenectomy; Bladder cancer; Lymph node; Urology; Cancer; General surgery; Oncology; Internal medicine","score_opus":0.06062447816278191,"score_gpt":0.43981535086650136,"score_spread":0.37919087270371943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045376922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015285781,0.98690194,0.0000030852311,0.0015272981,0.0004326019,0.0003482625,0.000012351906,0.000006778681,0.0106148],"genre_scores_gemma":[0.00014937334,0.9974266,0.0004298606,0.0003617408,0.0011871032,0.00003216917,0.0000067135948,0.00003407966,0.0003723471],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975164,0.00029451377,0.0012185879,0.00027107703,0.00036102918,0.0003383695],"domain_scores_gemma":[0.99831337,0.00033841017,0.00074630853,0.00015121915,0.00012236682,0.0003283309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043315708,0.00036476625,0.0035454328,0.00040439088,0.00002758995,0.000015833444,0.00013149821,0.00057523156,0.00047172094],"category_scores_gemma":[0.000011419842,0.0002303256,0.0005352902,0.00027196336,0.0000905737,0.000068176,0.000042109798,0.0006462295,0.00000740378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017802241,0.0006037409,0.00060243777,0.0014181278,0.0005878787,0.007811911,0.000024853529,0.0000012265604,2.8676783e-7,0.000027470918,0.000807473,0.98793656],"study_design_scores_gemma":[0.0063212914,0.000943777,0.0010034598,0.007588447,0.0023177767,0.011147404,0.000011793115,0.0000022269687,2.9569006e-7,0.000040323728,0.97044814,0.00017507923],"about_ca_topic_score_codex":0.000069077294,"about_ca_topic_score_gemma":0.0000067478777,"teacher_disagreement_score":0.9877615,"about_ca_system_score_codex":0.0020610872,"about_ca_system_score_gemma":0.0044685206,"threshold_uncertainty_score":0.9392406},"labels":[],"label_agreement":null},{"id":"W2046284618","doi":"10.1586/era.09.42","title":"Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?","year":2009,"lang":"en","type":"letter","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gemcitabine; Bladder cancer; Cisplatin; Neoadjuvant therapy; Cystectomy; Oncology; Chemotherapy; Vinblastine; Regimen; Internal medicine; Urology; Doxorubicin; Cancer; Breast cancer","score_opus":0.016971295446451394,"score_gpt":0.3053958378885686,"score_spread":0.28842454244211724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046284618","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034725185,0.4176194,0.00003740825,0.53667766,0.0004966352,0.008409693,0.00048623563,0.000111957685,0.0014358059],"genre_scores_gemma":[0.003459782,0.39779863,0.00062462763,0.59529746,0.0016322101,0.0003890635,0.00032795477,0.00018685537,0.00028344282],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956107,0.00010514093,0.0009736581,0.0010738857,0.0014487472,0.000787867],"domain_scores_gemma":[0.9974947,0.00007736055,0.00068782386,0.0010680852,0.0005279629,0.00014406165],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012234297,0.001066547,0.0027225057,0.0002492574,0.00006844586,0.000024249,0.00037036103,0.00045792133,0.0022677002],"category_scores_gemma":[0.000010753442,0.0006632239,0.00037049304,0.00065667543,0.00022848054,0.0001347932,0.000021635102,0.001005226,0.0000109678585],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066252043,0.001409864,0.018831214,0.006678528,0.0028256779,0.00044200613,0.0021095036,0.0000033331637,0.000114089795,0.000003741682,0.60580873,0.3551481],"study_design_scores_gemma":[0.035288848,0.008462476,0.08538204,0.06368153,0.00071510044,0.00002108347,0.000034063007,0.0000049974583,0.0019310388,0.00002120036,0.802857,0.0016006622],"about_ca_topic_score_codex":0.0011968758,"about_ca_topic_score_gemma":0.000095627416,"teacher_disagreement_score":0.35354742,"about_ca_system_score_codex":0.00055007276,"about_ca_system_score_gemma":0.0013478968,"threshold_uncertainty_score":0.9995819},"labels":[],"label_agreement":null},{"id":"W2046507158","doi":"10.1089/end.2006.20.1068","title":"BCG for Upper-Tract Transitional-Cell Carcinoma: Is It Safe in Patients with Renal Compromise?","year":2006,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Transitional cell carcinoma; Upper urinary tract; Hemodialysis; Urology; Urinary system; Renal function; Carcinoma; Surgery; Kidney; Renal cell carcinoma; Internal medicine; Cancer","score_opus":0.011452395091818033,"score_gpt":0.25024339658323924,"score_spread":0.2387910014914212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046507158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301606,0.00025322277,0.0003127307,0.00338368,0.000121416226,0.0003399849,0.00006200898,0.0000027583899,0.002508107],"genre_scores_gemma":[0.9962854,0.0000061274727,0.0014822496,0.0015270609,0.00027492654,0.000009478835,0.00003731748,0.000018579076,0.00035885544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989734,0.000034639528,0.00040250854,0.0001367826,0.00021942303,0.00023320972],"domain_scores_gemma":[0.9993733,0.000073326446,0.00019799845,0.00009117482,0.000180307,0.00008386314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010085932,0.00013464472,0.00038283336,0.00017302985,0.00003406068,0.0000055065884,0.000060984792,0.0000859289,0.00029597836],"category_scores_gemma":[0.000006555941,0.00009611668,0.00014534623,0.000069078895,0.00004346541,0.000066922206,0.0000043169407,0.00021921094,0.000005057826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01232131,0.0028934851,0.9679004,0.00005536764,0.00010216643,0.0003276406,0.00025881093,0.00013641697,0.0010732433,0.000033070923,0.014424887,0.00047323032],"study_design_scores_gemma":[0.038541738,0.006576024,0.94214684,0.00003486116,0.000295461,0.00038105805,0.000022649478,0.000028193288,0.002184418,0.0002547063,0.009422871,0.00011116322],"about_ca_topic_score_codex":0.00005032657,"about_ca_topic_score_gemma":0.000021868176,"teacher_disagreement_score":0.026220428,"about_ca_system_score_codex":0.000077066245,"about_ca_system_score_gemma":0.00016306339,"threshold_uncertainty_score":0.39195246},"labels":[],"label_agreement":null},{"id":"W2046821528","doi":"10.1007/s11934-012-0237-1","title":"Biomolecular Predictors of Urothelial Cancer Behavior and Treatment Outcomes","year":2012,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"New York Community Trust","keywords":"Medicine; Malignancy; Bladder cancer; Pathological; Stage (stratigraphy); Intensive care medicine; Internal medicine; Cancer; Nephrology; Oncology; Urothelial carcinoma; Biomarker; Bioinformatics","score_opus":0.078584780604241,"score_gpt":0.39593218439303307,"score_spread":0.31734740378879206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046821528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024772163,0.9915812,0.000004375643,0.00002911963,0.0032209398,0.0022702618,0.00022955392,0.000052165433,0.00013515714],"genre_scores_gemma":[0.0032561654,0.994146,0.000014013358,0.000021324333,0.00044681694,0.001457399,0.0002462796,0.000084618594,0.00032739496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761033,0.000103004095,0.0009765445,0.0006316236,0.0002559637,0.00042253823],"domain_scores_gemma":[0.9982026,0.00004534198,0.000735831,0.0006501506,0.00006805789,0.00029799063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010488731,0.0006346987,0.0025791267,0.00024626707,0.000046411475,0.0000064401233,0.00006322736,0.00039208043,0.00020141904],"category_scores_gemma":[0.000021689373,0.0004125239,0.00066608936,0.00013555044,0.00022749345,0.000036019625,0.00006788951,0.00024099092,0.000008451935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022146463,0.00085133937,0.16159278,0.0023745198,0.0012044809,0.0004694751,0.000055062443,1.5049006e-8,0.0000026382554,0.0000037062712,0.00007426807,0.8333496],"study_design_scores_gemma":[0.000735662,0.0006197572,0.007125818,0.00076138414,0.028723704,0.0018509661,0.0000011707683,6.680549e-8,0.0000131900915,0.0000035587434,0.9599149,0.00024980117],"about_ca_topic_score_codex":0.00009568052,"about_ca_topic_score_gemma":0.000009797099,"teacher_disagreement_score":0.95984066,"about_ca_system_score_codex":0.00018110471,"about_ca_system_score_gemma":0.0006960218,"threshold_uncertainty_score":0.9998327},"labels":[],"label_agreement":null},{"id":"W2047644674","doi":"10.1016/j.juro.2009.04.058","title":"High Risk Populations and Cystectomy Outcomes","year":2009,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Perioperative; Urology; Comorbidity; Population; General surgery; Cancer; Surgery; Internal medicine","score_opus":0.023659635836594355,"score_gpt":0.2926506032007544,"score_spread":0.26899096736416006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047644674","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06840717,0.0030118758,0.00010008677,0.92712796,0.00070116814,0.0002059558,0.000029659457,0.0000111047875,0.00040501897],"genre_scores_gemma":[0.33217984,0.0010516157,0.00036770105,0.6616107,0.0033428487,0.000001943254,0.000015031446,0.00003240438,0.0013979069],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989452,0.00022845056,0.00035665568,0.00008465658,0.00020792853,0.00017711359],"domain_scores_gemma":[0.99900055,0.00017765438,0.00046467825,0.00021971414,0.00008859352,0.000048818853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002107856,0.00017147826,0.00057121756,0.00014646919,0.00007473371,0.000006964113,0.00011631577,0.00030783226,0.00009727664],"category_scores_gemma":[0.000059340346,0.00008801227,0.00013476882,0.000051006427,0.00008340225,0.000027301603,0.000017869372,0.0015309418,0.000011204623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005728769,0.000070008515,0.042051118,0.00002936063,0.0011197831,0.0010762754,0.00024606034,0.00001779315,0.000013889277,0.000026437068,0.9481329,0.0066434992],"study_design_scores_gemma":[0.0049032057,0.0036615147,0.42819846,0.00003736728,0.006754627,0.008444512,0.000013207064,0.000004332595,0.000010186906,0.0075347926,0.5402735,0.00016428683],"about_ca_topic_score_codex":0.00018256373,"about_ca_topic_score_gemma":0.000013980478,"teacher_disagreement_score":0.40785939,"about_ca_system_score_codex":0.000034486053,"about_ca_system_score_gemma":0.00007965092,"threshold_uncertainty_score":0.6651265},"labels":[],"label_agreement":null},{"id":"W2047780250","doi":"10.1111/j.1464-410x.2009.08360.x","title":"Impact of clinical factors, including a point‐of‐care nuclear matrix protein‐22 assay and cytology, on bladder cancer detection","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"U.S. Food and Drug Administration","keywords":"Nomogram; Medicine; Cytology; Bladder cancer; Urinary system; Urology; Cancer; Urinary bladder; Oncology; Internal medicine; Pathology","score_opus":0.030637006201330013,"score_gpt":0.37883048138814934,"score_spread":0.3481934751868193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047780250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499977,0.0038959603,0.000043776934,0.00034276623,0.00017149995,0.00023184136,0.000037286463,0.0000086279315,0.00026847664],"genre_scores_gemma":[0.9983441,0.0010544991,0.00015749494,0.00016869108,0.00024081563,0.0000015439607,0.000002019272,0.00001741203,0.00001340274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99855644,0.00020786365,0.0006964015,0.00016408923,0.00018234886,0.00019285773],"domain_scores_gemma":[0.99884284,0.0000955077,0.0005548552,0.00009717346,0.0002622441,0.00014740646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030300976,0.00012842329,0.0007256441,0.00014211048,0.00005025273,0.000008000982,0.000072911644,0.00022929457,0.00019722985],"category_scores_gemma":[0.00029931052,0.00011107389,0.00029445556,0.0000912586,0.00013260424,0.000078237696,0.00002028709,0.00048731,8.6770683e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015050372,0.0016408055,0.45404074,0.00015417294,0.002187953,0.0014416481,0.00093838846,0.00005747399,0.028306294,0.000046962203,0.0011497235,0.49498546],"study_design_scores_gemma":[0.0052082622,0.021971254,0.96625966,0.00022546765,0.00040808984,0.0037522924,0.00010919736,0.000019499787,0.0014640673,0.00020153211,0.0002842621,0.00009640844],"about_ca_topic_score_codex":0.0003604803,"about_ca_topic_score_gemma":0.00006984597,"teacher_disagreement_score":0.51221895,"about_ca_system_score_codex":0.00007159406,"about_ca_system_score_gemma":0.00018661682,"threshold_uncertainty_score":0.45294616},"labels":[],"label_agreement":null},{"id":"W2047905289","doi":"10.1016/j.eururo.2014.01.014","title":"The Effect of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients Who Have Bladder Cancer Treated with Radical Cystectomy: A Population-based Study","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Perioperative; Propensity score matching; Chemotherapy; Neoadjuvant therapy; Internal medicine; Complication; Oncology; Confounding; Population; Surgery; Cancer; Breast cancer","score_opus":0.0062215926033548224,"score_gpt":0.2635213291937909,"score_spread":0.2572997365904361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047905289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574316,0.00003832465,0.000008194317,0.000563859,0.000051709085,0.0013299674,0.000009733813,0.000025230627,0.0022298237],"genre_scores_gemma":[0.9984285,0.0000026812163,0.0000059088497,0.0009903274,0.000043965778,0.0000770992,0.000016798502,0.000050948114,0.0003837652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793214,0.0010253093,0.00027208525,0.00031385894,0.000225513,0.00023110326],"domain_scores_gemma":[0.99916804,0.00028142595,0.000103876584,0.00032686393,0.00005189367,0.00006788091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002466301,0.00023731965,0.0005163862,0.000088077526,0.00008500447,0.000009892228,0.000099910656,0.000038568778,0.000056202218],"category_scores_gemma":[0.00007663851,0.00011701372,0.00006258084,0.00010461182,0.00009036305,0.00001760141,0.000013279251,0.00018312964,0.000011272089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064124777,0.00047138293,0.9853565,0.0000069796897,0.00024149437,0.000022528482,0.0004965724,0.00015674155,0.000012603714,0.000004029268,0.000025767848,0.006792925],"study_design_scores_gemma":[0.025701527,0.025502145,0.94751465,0.000024346087,0.00013359239,9.3093087e-7,0.000018814024,0.00026225677,0.00027926583,4.2214637e-7,0.00046522784,0.00009682686],"about_ca_topic_score_codex":0.00049829483,"about_ca_topic_score_gemma":0.00030499545,"teacher_disagreement_score":0.037841853,"about_ca_system_score_codex":0.00007427588,"about_ca_system_score_gemma":0.000034030407,"threshold_uncertainty_score":0.4771681},"labels":[],"label_agreement":null},{"id":"W2048024682","doi":"10.5858/arpa.2011-0187-ra","title":"Selected Common Diagnostic Problems in Urologic Pathology: Perspectives From a Large Consult Service in Genitourinary Pathology","year":2012,"lang":"en","type":"review","venue":"Archives of Pathology & Laboratory Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Pathology; Genitourinary system; Anatomical pathology; Differential diagnosis; Surgical pathology; Urothelium; Medical diagnosis; Carcinoma; Atypia; Malakoplakia; Immunohistochemistry; Urinary bladder; Internal medicine","score_opus":0.03202010942928726,"score_gpt":0.32158710186453654,"score_spread":0.2895669924352493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048024682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.088382326,0.9063045,0.000014041126,0.00048360124,0.00040477523,0.0024380235,0.0013404504,0.00009559084,0.0005367138],"genre_scores_gemma":[0.08449781,0.9109878,0.00040380989,0.0008467793,0.0005165823,0.0008497812,0.0017257737,0.0001413253,0.0000303189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924183,0.0030214558,0.0017819974,0.0013143263,0.0003092025,0.0011547025],"domain_scores_gemma":[0.993976,0.003518659,0.0008702648,0.0010893508,0.00022448886,0.00032124246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007775929,0.0010401079,0.0052651437,0.0013441934,0.000074741554,0.000003521334,0.0005112148,0.0010152737,0.00026928008],"category_scores_gemma":[0.0011883822,0.00079909933,0.00022584276,0.0015968864,0.0015089886,0.00009097641,0.00029050588,0.00208492,0.00005570429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018692032,0.013407504,0.5399193,0.033394597,0.0020560352,0.10116235,0.11598207,0.0000048999827,0.002629362,0.0006398001,0.00038657227,0.18854825],"study_design_scores_gemma":[0.038012654,0.011164807,0.6316127,0.04409648,0.013985589,0.0075636194,0.006394026,0.000015486708,0.000048368864,0.0023448393,0.24209559,0.0026658545],"about_ca_topic_score_codex":0.00028774777,"about_ca_topic_score_gemma":0.00095537055,"teacher_disagreement_score":0.24170901,"about_ca_system_score_codex":0.00019462903,"about_ca_system_score_gemma":0.0011080058,"threshold_uncertainty_score":0.999446},"labels":[],"label_agreement":null},{"id":"W2048275270","doi":"10.1016/j.eururo.2013.08.034","title":"Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Proportional hazards model; Bladder cancer; Internal medicine; Urology; Cancer; Cystectomy; Carcinoma; Retrospective cohort study; Oncology; Surgery; Gastroenterology","score_opus":0.02164739504468382,"score_gpt":0.2634388568208737,"score_spread":0.24179146177618988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048275270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760054,0.0013464299,0.000023141045,0.0017955574,0.0005678576,0.0005371182,0.000036775855,0.000023290944,0.019664468],"genre_scores_gemma":[0.99649495,0.00009793887,0.000035390807,0.0012623279,0.00020775545,0.000020893596,0.0000045888346,0.000048042955,0.0018280911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873346,0.00020158813,0.00036597357,0.00025155034,0.00019499758,0.00025245477],"domain_scores_gemma":[0.9989969,0.000053381882,0.00017431923,0.00057511684,0.00011801536,0.00008225104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000084396066,0.00017985418,0.000391096,0.00006409844,0.000041569478,0.0000050131885,0.00025821093,0.00005125523,0.002013481],"category_scores_gemma":[0.00002532574,0.00010934112,0.00018447111,0.00011751516,0.00028832696,0.00003596204,0.000111278976,0.00016386934,0.00017144869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012342012,0.00018305205,0.9817637,0.000029238288,0.00028324046,0.000027157366,0.00036295448,0.0000031673046,0.008252336,0.0000987928,0.0021793721,0.006693557],"study_design_scores_gemma":[0.0020691312,0.0004374591,0.9896882,0.000010685139,0.00020092425,0.000030634186,0.000013043528,0.0000027266515,0.004817393,0.000023496345,0.0026242742,0.00008201941],"about_ca_topic_score_codex":0.00029487195,"about_ca_topic_score_gemma":0.000022173353,"teacher_disagreement_score":0.020489609,"about_ca_system_score_codex":0.000022045853,"about_ca_system_score_gemma":0.00008268312,"threshold_uncertainty_score":0.9988988},"labels":[],"label_agreement":null},{"id":"W2048624682","doi":"10.1177/1756287209103921","title":"Review: Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cystectomy; Medicine; Cystoprostatectomy; Urology; Prostate; Prostate cancer; Prostatectomy; Bladder cancer; Urinary diversion; Cancer; Internal medicine","score_opus":0.03919003386742824,"score_gpt":0.4041269195165172,"score_spread":0.36493688564908894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048624682","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10133384,0.8561397,0.001209495,0.023627527,0.00081662956,0.0026947085,0.000012191162,0.0002149803,0.0139508955],"genre_scores_gemma":[0.792611,0.17374626,0.0005093724,0.032810643,0.00011688568,0.000021736776,0.0000068134414,0.000013913255,0.00016340631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825853,0.00020805294,0.0006536957,0.00040268886,0.00011379262,0.00036321665],"domain_scores_gemma":[0.999325,0.00014178574,0.0001195495,0.00026621154,0.000025801108,0.00012167868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004988962,0.00019464447,0.0007726924,0.000059077578,0.000048080266,0.000003775553,0.00009471206,0.0001434927,0.000081752645],"category_scores_gemma":[0.00008330619,0.00014238877,0.00008224512,0.00014549111,0.00025844807,0.00008491202,0.000029002325,0.00042132413,0.00002170939],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00247906,0.0005274166,0.22308162,0.00023427971,0.00008849106,0.00023190836,0.00010254112,0.000011416309,0.00006692817,0.0005971068,0.000050973897,0.7725283],"study_design_scores_gemma":[0.012789001,0.008024888,0.44609663,0.00033076928,0.0005688504,0.00049174705,0.000024796422,0.00017195485,0.00003520815,0.0068082623,0.5242972,0.00036074308],"about_ca_topic_score_codex":0.000008014975,"about_ca_topic_score_gemma":0.000019479894,"teacher_disagreement_score":0.7721675,"about_ca_system_score_codex":0.00008008226,"about_ca_system_score_gemma":0.000072997456,"threshold_uncertainty_score":0.58064455},"labels":[],"label_agreement":null},{"id":"W2048758300","doi":"10.1097/00129039-200209000-00008","title":"Prostatic Adenocarcinoma with Urothelial (Transitional Cell) Carcinoma Features","year":2002,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adenocarcinoma; Carcinoma; Transitional cell carcinoma; Pathology; Prostate; Prostatectomy; Urology; Cancer; Bladder cancer; Internal medicine","score_opus":0.006991437117107784,"score_gpt":0.21740253469566484,"score_spread":0.21041109757855705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048758300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526392,0.0043908074,0.0005123181,0.0006593124,0.00007843249,0.0008464725,0.00005800656,0.0001060438,0.040709373],"genre_scores_gemma":[0.99246645,0.000018447474,0.0021880157,0.0017406751,0.00009998139,0.00042740122,0.0002242587,0.00009571921,0.00273904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980747,0.000024985791,0.0003038404,0.000677406,0.00038604098,0.0005329923],"domain_scores_gemma":[0.9988843,0.000021853491,0.00011028573,0.0006919144,0.00009386974,0.00019774791],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000041708012,0.000433665,0.00047641798,0.000076640856,0.0001484227,0.000020818728,0.00019022757,0.00023741985,0.0015867685],"category_scores_gemma":[0.0000060470147,0.00039023458,0.00015372851,0.00019822517,0.00034748932,0.000030035771,0.000038336388,0.00044890176,0.00016237139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008471119,0.00045051475,0.00060866715,0.00013643259,0.0001383214,0.0014726031,0.00029077296,0.000006740278,0.9936861,0.00012304964,0.001902884,0.00033683525],"study_design_scores_gemma":[0.008659553,0.00076754787,0.007767314,0.00003153289,0.0005790526,0.004234342,0.00013175781,0.000010346835,0.97689795,0.00011398041,0.00028493788,0.0005216583],"about_ca_topic_score_codex":0.000054965156,"about_ca_topic_score_gemma":9.229436e-8,"teacher_disagreement_score":0.039827228,"about_ca_system_score_codex":0.00021981375,"about_ca_system_score_gemma":0.00014114757,"threshold_uncertainty_score":0.999855},"labels":[],"label_agreement":null},{"id":"W2048932561","doi":"10.1016/j.urology.2010.04.020","title":"Troubling Outcomes From Population-level Analysis of Surgery for Upper Tract Urothelial Carcinoma","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Urothelial carcinoma; Carcinoma; Urology; Population; General surgery; Oncology; Surgery; Internal medicine; Bladder cancer; Cancer; Environmental health","score_opus":0.06337584714348125,"score_gpt":0.32141778860177284,"score_spread":0.25804194145829157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048932561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604,0.00006343636,0.0010856893,0.0012893858,0.00055170903,0.00023750789,0.00052684016,0.000023452421,0.00018199299],"genre_scores_gemma":[0.99748045,0.0000029563641,0.0007758203,0.0007241284,0.00021021454,0.000039479688,0.0005847501,0.000020801115,0.00016140356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908036,0.000025374835,0.0003269986,0.00024580583,0.00012183494,0.00019963393],"domain_scores_gemma":[0.9988928,0.0005596598,0.00011093897,0.0002847748,0.00007609448,0.00007572898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111658126,0.00012830511,0.00065345276,0.00036291828,0.000039977003,0.0000050096955,0.000058613143,0.00015767578,0.0007304356],"category_scores_gemma":[0.00017988012,0.00010259531,0.00045779502,0.00019429461,0.000039629136,0.00004023911,0.000010400879,0.00012228433,0.0000051062348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003906684,0.0001684836,0.99331594,0.00000697096,0.0010228056,0.0000053376402,0.000101803314,0.00001716858,0.0019410381,0.00013544963,0.000080663616,0.0028136957],"study_design_scores_gemma":[0.001419759,0.00011488587,0.99289006,0.0000011004843,0.002998318,0.000003838565,0.000009854884,0.0009289123,0.00059765344,0.0002958816,0.0006619839,0.00007774729],"about_ca_topic_score_codex":0.0021113635,"about_ca_topic_score_gemma":0.00039120243,"teacher_disagreement_score":0.0027359484,"about_ca_system_score_codex":0.0000140844195,"about_ca_system_score_gemma":0.00008178859,"threshold_uncertainty_score":0.7997758},"labels":[],"label_agreement":null},{"id":"W2048993988","doi":"10.1245/s10434-012-2708-5","title":"Predictors of Survival in Patients With Soft Tissue Surgical Margin Involvement at Radical Cystectomy","year":2012,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Surgical oncology; Cystectomy; Medicine; Surgical margin; Soft tissue; Margin (machine learning); General surgery; Surgery; Urology; Internal medicine; Resection; Bladder cancer; Cancer","score_opus":0.03933104687647639,"score_gpt":0.3302025524219345,"score_spread":0.29087150554545815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048993988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875794,0.000719406,0.0000028889438,0.0012854829,0.0002610166,0.0006048961,0.00005416556,0.000018858427,0.009473868],"genre_scores_gemma":[0.99868,0.00040540769,0.00007877552,0.00012571042,0.00019656162,0.000039532126,0.00008795496,0.000024114926,0.00036195325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774873,0.0002265674,0.000629672,0.00026244353,0.00058681075,0.0005458012],"domain_scores_gemma":[0.9987025,0.00030489982,0.0001986194,0.00024061822,0.00016568847,0.00038765938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004829481,0.00021908281,0.0010048402,0.00014947758,0.000025262168,0.0000016401208,0.00010446971,0.00025408797,0.0008650113],"category_scores_gemma":[0.000017170229,0.0001523514,0.00012652794,0.00026224594,0.00035534587,0.000082023835,0.00009858935,0.0002042325,0.000021622522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008000571,0.0041854796,0.97967374,0.000108062086,0.00026149873,0.00020864286,0.00030020444,0.0000029890946,0.000031541236,0.00017321901,0.0011064993,0.0059475466],"study_design_scores_gemma":[0.017011905,0.006325863,0.5446289,0.00010780389,0.0001121419,0.00004093567,0.00004249194,0.0000019167555,0.0026927094,0.000012404888,0.4288652,0.00015771665],"about_ca_topic_score_codex":0.00018597802,"about_ca_topic_score_gemma":0.000042585,"teacher_disagreement_score":0.43504483,"about_ca_system_score_codex":0.00014009362,"about_ca_system_score_gemma":0.00017860097,"threshold_uncertainty_score":0.9471267},"labels":[],"label_agreement":null},{"id":"W2049112672","doi":"10.1590/s1677-55382011000500031","title":"Diminished efficacy of bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer","year":2011,"lang":"en","type":"article","venue":"International braz j urol","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine; Oncology; Urology","score_opus":0.018521147314140538,"score_gpt":0.2549153416330156,"score_spread":0.23639419431887507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049112672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97651666,0.000049063867,0.00006494252,0.00019551058,0.00038957805,0.0005006719,0.00013977262,0.000033266166,0.022110514],"genre_scores_gemma":[0.99766743,0.000018032384,0.0003489051,0.0004769712,0.0001259091,0.000091685295,0.00007279566,0.00003491722,0.0011633445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987101,0.000020077105,0.0002770993,0.00030106827,0.0004987292,0.00019294125],"domain_scores_gemma":[0.9990754,0.00006472532,0.00015107209,0.00023414646,0.0003478251,0.00012683206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000036335874,0.00018375966,0.0002483254,0.00012009294,0.000034740937,0.000010591898,0.00017985037,0.000069306756,0.003070685],"category_scores_gemma":[0.000060730672,0.00014007029,0.00009747979,0.00011743013,0.000119069686,0.0001560136,0.000045849487,0.00012824892,0.000047003206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013306797,0.0013364095,0.98399353,0.000022397542,0.0009804745,0.00003802212,0.0010730977,0.0000085155225,0.00038782318,0.0000489109,0.0013719874,0.009408149],"study_design_scores_gemma":[0.0077619394,0.0010517772,0.9782652,0.00010405489,0.00019533122,0.000003501949,0.000045692785,0.000015023394,0.0114774825,0.000029408957,0.00090381264,0.00014674447],"about_ca_topic_score_codex":0.0013319203,"about_ca_topic_score_gemma":0.00025296508,"teacher_disagreement_score":0.02115076,"about_ca_system_score_codex":0.000082118386,"about_ca_system_score_gemma":0.00015148205,"threshold_uncertainty_score":0.99784064},"labels":[],"label_agreement":null},{"id":"W2049306725","doi":"10.1158/1538-7445.am2014-987","title":"Abstract 987: Comprehensive characterization of urothelial bladder cancer: a TCGA Project update","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Cancer research; ARID1A; CDKN2A; Epigenetics; DNA methylation; Exome sequencing; Cancer; Gene; Genetics; Gene expression; Mutation","score_opus":0.09173370945119375,"score_gpt":0.41718682064677737,"score_spread":0.3254531111955836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049306725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921737,0.00056245306,0.000054539243,0.0017565866,0.00032631605,0.0014188242,0.0003348214,0.000055249453,0.0033175405],"genre_scores_gemma":[0.99379283,0.0026014165,0.000053750628,0.000502054,0.0008767857,0.0006542346,0.00010442333,0.00006268219,0.0013518503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769735,0.00014434064,0.00033884696,0.00044596178,0.00083232706,0.0005411486],"domain_scores_gemma":[0.9983947,0.00007692559,0.000112416994,0.00044045754,0.0008054773,0.0001700077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029613287,0.00020402063,0.00044000323,0.00028913282,0.00013598062,0.000032443382,0.0001909285,0.00012431155,0.0014620527],"category_scores_gemma":[0.00004689717,0.0001679105,0.00010889593,0.0005259333,0.00025956746,0.000121098856,0.000073674804,0.0004123308,0.00008335734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018065987,0.00032699306,0.011086888,0.0006226317,0.00040162093,0.000019361572,0.00078101514,0.0000071199215,0.91788745,0.00021473653,0.0037504805,0.063095085],"study_design_scores_gemma":[0.007656385,0.0011829259,0.30240318,0.00089231296,0.0002167033,0.000014177864,0.00018613569,0.00016528656,0.4611756,0.00018863565,0.22548562,0.00043304503],"about_ca_topic_score_codex":0.0035816303,"about_ca_topic_score_gemma":0.00010440183,"teacher_disagreement_score":0.4567119,"about_ca_system_score_codex":0.00025447703,"about_ca_system_score_gemma":0.0010457579,"threshold_uncertainty_score":0.99945074},"labels":[],"label_agreement":null},{"id":"W2049579216","doi":"10.1007/s00345-014-1363-9","title":"Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study","year":2014,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Lymphovascular invasion; Interquartile range; Urology; Proportional hazards model; Hazard ratio; Bladder cancer; Retrospective cohort study; Concomitant; Internal medicine; Oncology; Cancer; Metastasis; Confidence interval","score_opus":0.00916764492626968,"score_gpt":0.22715674725661975,"score_spread":0.21798910233035007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049579216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967082,0.000447079,0.00000977851,0.00025946152,0.0005972893,0.0011635596,0.00010421963,0.0000038942394,0.00070647954],"genre_scores_gemma":[0.9992148,0.000005628715,0.00017235028,0.00015818748,0.00019248507,0.0000114863105,0.000003900583,0.000039898594,0.00020122391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711794,0.00050311914,0.0011623562,0.0003090163,0.0006337926,0.0002738032],"domain_scores_gemma":[0.99745303,0.00028906323,0.0012119239,0.00047290293,0.00046850977,0.000104572304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040400974,0.00026177752,0.0009633796,0.0003764309,0.000025413383,0.0000022417137,0.00028144076,0.000095300704,0.00008282765],"category_scores_gemma":[0.00031601163,0.00016391605,0.00023050666,0.0002192137,0.0003261821,0.00008186841,0.00006752583,0.00051926513,0.0000013141814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024034265,0.0073019415,0.96247375,0.000031588366,0.0003537468,0.00006171528,0.0047593745,0.00002905798,0.0004704885,0.000012005332,0.00010106173,0.00037101647],"study_design_scores_gemma":[0.03372078,0.015759094,0.94854134,0.000107829874,0.0009357246,0.000026272244,0.000119836666,0.000042418764,0.00034200656,0.000036851296,0.00025849612,0.00010935201],"about_ca_topic_score_codex":0.0007772298,"about_ca_topic_score_gemma":0.00013863857,"teacher_disagreement_score":0.013932398,"about_ca_system_score_codex":0.0003242489,"about_ca_system_score_gemma":0.00056405965,"threshold_uncertainty_score":0.6684302},"labels":[],"label_agreement":null},{"id":"W2049818323","doi":"10.1111/bju.13034","title":"Utilisation of preoperative imaging for muscle‐invasive bladder cancer: a population‐based study","year":2015,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Ottawa Hospital; University of Ottawa","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Bladder cancer; Cystectomy; Pelvis; Quartile; Magnetic resonance imaging; Abdomen; Radiology; Stage (stratigraphy); Population; Odds ratio; Nuclear medicine; Cancer; Internal medicine; Confidence interval","score_opus":0.037949121410235716,"score_gpt":0.32312703150171335,"score_spread":0.28517791009147764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049818323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943416,0.0026226891,0.00095107354,0.0008908076,0.00033037245,0.00067184266,0.00005159053,0.000007433501,0.00013257537],"genre_scores_gemma":[0.99846554,0.00004455542,0.00059597916,0.0005325603,0.0002504351,0.0000372453,0.000013817792,0.000017015831,0.000042865973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899966,0.00011036019,0.00041172496,0.00012616614,0.00021438015,0.00013772945],"domain_scores_gemma":[0.9986104,0.000087377644,0.00030085281,0.00007896003,0.00080956664,0.00011286301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026418202,0.000087467706,0.0003525772,0.00010981292,0.00004115025,0.000011858454,0.00006269927,0.000041221083,0.0000702196],"category_scores_gemma":[0.00029682866,0.00008712982,0.00009931408,0.00008904224,0.00003434587,0.000116070325,0.000010244358,0.00011610967,5.874466e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014823399,0.0010844223,0.9611042,0.000038126527,0.00043710676,0.00026315896,0.0016141569,0.00069270557,0.0002724859,0.000010689277,0.0019171073,0.03108346],"study_design_scores_gemma":[0.013871812,0.004184092,0.9778354,0.00008737245,0.00079873635,0.0006176715,0.0011244767,0.00037496648,0.00037685267,0.00031670745,0.0003208375,0.00009105633],"about_ca_topic_score_codex":0.0010139049,"about_ca_topic_score_gemma":0.00056589063,"teacher_disagreement_score":0.030992404,"about_ca_system_score_codex":0.00009598586,"about_ca_system_score_gemma":0.0005624314,"threshold_uncertainty_score":0.35530508},"labels":[],"label_agreement":null},{"id":"W2049879694","doi":"10.1016/j.juro.2007.08.087","title":"Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer","year":2007,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Receptor; ErbB; Expression (computer science); Oncology; Cancer; Internal medicine; Cancer research","score_opus":0.021499370411285912,"score_gpt":0.3093356853949598,"score_spread":0.2878363149836739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049879694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920323,0.0026725333,0.0034838074,0.00042246087,0.000475106,0.00015963297,0.000020744445,0.000004212724,0.0007292102],"genre_scores_gemma":[0.9985256,0.0005896476,0.00010812314,0.0003924251,0.0002976558,0.0000013282155,0.0000018430845,0.000015821362,0.0000675588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879557,0.0001761105,0.0004919697,0.000090369154,0.00026366473,0.00018231818],"domain_scores_gemma":[0.9982078,0.0002324145,0.0009504231,0.00018498598,0.00032860364,0.00009576959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048324448,0.0001237951,0.00041152525,0.0001057633,0.000037623464,0.0000016145027,0.00015377936,0.00009523974,0.0003520646],"category_scores_gemma":[0.000063620035,0.00006778162,0.00009407227,0.000092640876,0.0002145754,0.000063818086,0.000031649783,0.00024481287,0.0000017571466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02731972,0.0018301698,0.061356068,0.00013732487,0.0021672207,0.00061008544,0.023820441,0.00033472345,0.75782835,0.00003532358,0.0037612983,0.12079926],"study_design_scores_gemma":[0.009632304,0.01686377,0.5486231,0.0004992776,0.0027586306,0.0012326725,0.0059511857,0.000060296596,0.41117468,0.0011745709,0.001752283,0.0002772095],"about_ca_topic_score_codex":0.0003417367,"about_ca_topic_score_gemma":0.000046913166,"teacher_disagreement_score":0.48726705,"about_ca_system_score_codex":0.000035856174,"about_ca_system_score_gemma":0.00014628064,"threshold_uncertainty_score":0.38548607},"labels":[],"label_agreement":null},{"id":"W2050099732","doi":"10.1016/j.eururo.2014.07.045","title":"Next-generation RNA Sequencing of Archival Formalin-fixed Paraffin-embedded Urothelial Bladder Cancer","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Transcriptome; Bladder cancer; Concordance; Medicine; RNA; Computational biology; RNA-Seq; Gene; Biology; Cancer; Gene expression; Genetics; Internal medicine","score_opus":0.0750362743545373,"score_gpt":0.293023078256618,"score_spread":0.2179868039020807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050099732","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.089494534,0.003252108,0.0059548533,0.6849866,0.008771548,0.004415215,0.0008164618,0.0008080643,0.20150062],"genre_scores_gemma":[0.35157084,0.00025513113,0.0007727675,0.6224156,0.019360833,0.0000783928,0.000987799,0.0003281863,0.0042304588],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962632,0.0008574874,0.0008485161,0.00080270076,0.00048524907,0.000742817],"domain_scores_gemma":[0.9982159,0.00012456666,0.0005154042,0.0008160907,0.000176656,0.00015138216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033559516,0.000620919,0.0010335175,0.00029878132,0.00011095477,0.000033827644,0.00035140343,0.00039075036,0.0006606531],"category_scores_gemma":[0.000079713,0.000538362,0.0003709432,0.00013791438,0.00025924406,0.00008774775,0.0001123006,0.0015185914,0.00033253137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007350176,0.00011472419,0.00021401429,0.00039073257,0.0013685278,0.0018656737,0.0010535938,0.00022475958,0.08204008,0.00014219274,0.9008707,0.010979975],"study_design_scores_gemma":[0.006339519,0.0028027263,0.0008039519,0.00015157215,0.0023732816,0.0006115577,0.000015223148,0.0013643388,0.016171763,0.00013846505,0.9682838,0.00094383623],"about_ca_topic_score_codex":0.00020722458,"about_ca_topic_score_gemma":0.000020433215,"teacher_disagreement_score":0.2620763,"about_ca_system_score_codex":0.00014386234,"about_ca_system_score_gemma":0.0005087325,"threshold_uncertainty_score":0.9997068},"labels":[],"label_agreement":null},{"id":"W2050117238","doi":"10.1016/j.anndiagpath.2013.10.006","title":"The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu","year":2013,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Urothelium; Immunohistochemistry; Atypia; Pathology; Tissue microarray; Medicine; Urothelial carcinoma; HER2/neu; Staining; Cancer; Bladder cancer; Internal medicine; Urinary bladder; Breast cancer","score_opus":0.041807660005015373,"score_gpt":0.3437940362551847,"score_spread":0.30198637625016933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050117238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864627,0.011237587,0.0000040330056,0.00073026976,0.000059325972,0.0010986642,0.000039430994,0.000005476958,0.00036249938],"genre_scores_gemma":[0.9964965,0.0028087648,0.00006359561,0.00024699655,0.00004310817,0.0003051872,0.0000037305404,0.00001603601,0.00001610124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985616,0.0002283331,0.0005203479,0.00021917652,0.00022395366,0.00024656503],"domain_scores_gemma":[0.9967315,0.0023379417,0.0002387263,0.000473136,0.00016977041,0.000048891456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004005417,0.00016646326,0.0004719504,0.0000702576,0.00007160926,0.0000068707222,0.00020149865,0.000098888224,0.00004959593],"category_scores_gemma":[0.0015799985,0.00010058918,0.000098202494,0.00016610704,0.00037903854,0.000047402933,0.00008045322,0.00015967111,0.0000031144366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029087273,0.0022469286,0.90359914,0.00012979894,0.00024074753,0.00012408454,0.00621857,0.000006228339,0.061156824,0.00015580562,0.0003092005,0.025521822],"study_design_scores_gemma":[0.0030839774,0.0028998458,0.8610929,0.00042081546,0.00039822544,0.00014835206,0.008222734,0.000025967896,0.119691566,0.0036470501,0.00018838697,0.00018015083],"about_ca_topic_score_codex":0.0017297483,"about_ca_topic_score_gemma":0.00003412739,"teacher_disagreement_score":0.05853474,"about_ca_system_score_codex":0.000012033521,"about_ca_system_score_gemma":0.00010066251,"threshold_uncertainty_score":0.4101908},"labels":[],"label_agreement":null},{"id":"W2050256434","doi":"10.1371/journal.pmed.0040284","title":"Optimal Management of High-Risk T1G3 Bladder Cancer: A Decision Analysis","year":2007,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Cystectomy; Bladder cancer; Medicine; Life expectancy; Comorbidity; Quality of life (healthcare); Decision analysis; Surgery; Intensive care medicine; Urology; Cancer; Internal medicine; Population; Statistics","score_opus":0.019251241913865114,"score_gpt":0.3129487628133887,"score_spread":0.29369752089952356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050256434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97928834,0.0030787787,0.009921242,0.00072450255,0.00023362378,0.000548376,0.000036342077,0.00006109658,0.0061077042],"genre_scores_gemma":[0.98874074,0.0024925251,0.006867024,0.00028966714,0.00034276838,0.000032537377,0.000045449975,0.000028256483,0.0011610516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978996,0.000021288271,0.0005436733,0.0003734536,0.000827439,0.00033455604],"domain_scores_gemma":[0.99877393,0.00011770094,0.00019265639,0.0004984737,0.0001641916,0.00025307154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035830375,0.0002190591,0.0007441653,0.0004560495,0.000057225094,0.000002912424,0.00012150214,0.00008244315,0.0022906165],"category_scores_gemma":[0.000038443013,0.0001501285,0.00016134673,0.0011724274,0.0001308227,0.000039755938,0.00004747716,0.00015912778,0.000023675604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064537176,0.0024080633,0.5462843,0.00064166274,0.047708623,0.0012078823,0.0023170135,0.0007350057,0.002169293,0.00053820934,0.0074478625,0.38208833],"study_design_scores_gemma":[0.014519153,0.0020675622,0.923284,0.0010980046,0.043042943,0.000016597334,0.0009637814,0.0005716813,0.011465345,0.0002575694,0.0024182168,0.0002951697],"about_ca_topic_score_codex":0.0021113246,"about_ca_topic_score_gemma":0.00022660258,"teacher_disagreement_score":0.38179317,"about_ca_system_score_codex":0.00013115692,"about_ca_system_score_gemma":0.000040035557,"threshold_uncertainty_score":0.9986214},"labels":[],"label_agreement":null},{"id":"W2050858827","doi":"10.1016/j.eururo.2009.12.001","title":"Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis? A Population-based Study","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal pelvis; Cuff; Urothelial carcinoma; Urology; Pelvis; Standard of care; Urothelium; Carcinoma; Population; Urinary bladder; Surgery; Ureter; Bladder cancer; Internal medicine; Cancer","score_opus":0.012353235833613765,"score_gpt":0.2539879939506797,"score_spread":0.24163475811706597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050858827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963221,0.00011303241,0.0000127376115,0.0005551892,0.00007758798,0.0012560665,0.000049281432,0.0000134279135,0.0016005563],"genre_scores_gemma":[0.9988777,8.8419625e-7,0.00003892525,0.00090375316,0.00006331653,0.0000063418424,0.000024872603,0.00003113068,0.000053050433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799883,0.00068514055,0.0003790383,0.0002854766,0.00044125112,0.00021028332],"domain_scores_gemma":[0.99896073,0.00007647339,0.00019403484,0.00057402404,0.00014715125,0.00004756409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021272815,0.00018839417,0.00035929662,0.00009235807,0.00008068431,0.0000049335677,0.00019554007,0.0000443655,0.00007834386],"category_scores_gemma":[0.000060733393,0.00009641699,0.000092624396,0.00022575326,0.00008123692,0.000024431305,0.00005608855,0.00020724405,0.0000034043087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008891835,0.00037050704,0.9864666,0.00001141373,0.00004834395,0.000030269004,0.0019694518,0.00015760321,0.00008881563,0.000010691279,0.000104387946,0.001850088],"study_design_scores_gemma":[0.010016137,0.010370316,0.9785148,0.0000308425,0.00018880708,0.0000034190566,0.000120608354,0.0000127519415,0.00028138884,0.000014961855,0.00036382998,0.00008217224],"about_ca_topic_score_codex":0.00011760237,"about_ca_topic_score_gemma":0.0002907034,"teacher_disagreement_score":0.009999809,"about_ca_system_score_codex":0.00009979778,"about_ca_system_score_gemma":0.00010367013,"threshold_uncertainty_score":0.3931771},"labels":[],"label_agreement":null},{"id":"W2051224092","doi":"10.1148/radiol.12111623","title":"Detection of Urothelial Tumors: Comparison of Urothelial Phase with Excretory Phase CT Urography—A Prospective Study","year":2012,"lang":"en","type":"article","venue":"Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pyelogram; Urothelial carcinoma; Urothelial cancer; Urology; Radiology; Prospective cohort study; Pathology; Internal medicine; Bladder cancer; Cancer","score_opus":0.025733248866246453,"score_gpt":0.3493425990272046,"score_spread":0.32360935016095815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051224092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994799,0.00091815344,0.0010662271,0.000015765352,0.00029884058,0.0019267608,0.0000794349,0.00005871834,0.0008370604],"genre_scores_gemma":[0.9989696,0.000011260667,0.00022435008,0.000032248383,0.00047055603,0.00018559718,0.000015200099,0.000042248917,0.00004893847],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983289,0.00020272426,0.0005012979,0.0003179151,0.00026576198,0.00038337932],"domain_scores_gemma":[0.99895954,0.00007385331,0.00029765838,0.0003632463,0.0001295008,0.00017622365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021771545,0.00026398164,0.00089809066,0.00023746418,0.00006415977,0.0000030643828,0.00009812529,0.000070698465,0.00013229145],"category_scores_gemma":[0.000040228602,0.00019809383,0.00014687827,0.0002962615,0.0003414585,0.00009857935,0.000020297968,0.00022914466,0.000008568491],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01735901,0.02038284,0.81857234,0.00011247016,0.0013090055,0.00005389718,0.0055731195,0.000006428691,0.12355352,0.00008215245,0.00007528593,0.012919931],"study_design_scores_gemma":[0.10145498,0.10751001,0.2620498,0.0001370961,0.0023997684,0.00093651604,0.003924974,0.000120980156,0.51945096,0.00006538414,0.0013981224,0.0005514344],"about_ca_topic_score_codex":0.00022738008,"about_ca_topic_score_gemma":0.000027876467,"teacher_disagreement_score":0.55652255,"about_ca_system_score_codex":0.00009052113,"about_ca_system_score_gemma":0.00013888955,"threshold_uncertainty_score":0.80780315},"labels":[],"label_agreement":null},{"id":"W2051313689","doi":"10.5489/cuaj.11128","title":"Long-term results of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma in China","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urology; Upper urinary tract; Transitional cell carcinoma; Medicine; Term (time); Ureteral neoplasm; Carcinoma; Urinary system; China; Internal medicine; Cancer; Political science; Physics","score_opus":0.015866633087749868,"score_gpt":0.2531779453094918,"score_spread":0.2373113122217419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051313689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234074,0.00057505904,0.000020361149,0.003404989,0.00031158747,0.00030161464,0.0006943098,0.000006453741,0.0023448842],"genre_scores_gemma":[0.9975415,0.000030254356,0.00031623995,0.00077708694,0.0007969333,0.000021803397,0.00018625782,0.0000132762825,0.00031667386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867266,0.00010514621,0.00037879782,0.00013665853,0.0002245088,0.00048222224],"domain_scores_gemma":[0.99904585,0.00010452325,0.00017259995,0.00007808176,0.00010091858,0.000498024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003443973,0.00012866277,0.00028464134,0.00017430988,0.0000937445,0.000015545236,0.000067914036,0.00021394328,0.000915968],"category_scores_gemma":[0.00013437215,0.00010443206,0.00017393856,0.00012283408,0.0000225632,0.00012278136,0.00000390882,0.00035687018,0.000008168681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049711065,0.0004051159,0.99456304,0.000018963863,0.00003324917,0.000056956946,0.00035170943,0.000002823184,0.00014787429,0.0000064632004,0.0032923408,0.000624367],"study_design_scores_gemma":[0.0043516965,0.0013466021,0.9888435,0.000023608263,0.00007781318,0.00027932535,0.000018812842,0.000009884145,0.0001821266,0.00003443813,0.004739469,0.00009275253],"about_ca_topic_score_codex":0.0006231083,"about_ca_topic_score_gemma":0.00012298817,"teacher_disagreement_score":0.005719554,"about_ca_system_score_codex":0.0008443177,"about_ca_system_score_gemma":0.0004344926,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W2051436631","doi":"10.5489/cuaj.11050","title":"The Canadian Bladder Cancer Network: efforts to improve patient care","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Bladder cancer; Medicine; Internal medicine","score_opus":0.015404807875305982,"score_gpt":0.23625972760825772,"score_spread":0.22085491973295174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051436631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7944339,0.0064655812,0.000024626508,0.067343965,0.00803624,0.0025545652,0.0004940474,0.0000915045,0.120555565],"genre_scores_gemma":[0.9800238,0.00009102158,0.000105664665,0.017994612,0.00088615814,0.00007507708,0.000010160651,0.00001989327,0.00079358387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980738,0.00008581059,0.00028957118,0.00021200678,0.00033769387,0.0010010937],"domain_scores_gemma":[0.99697274,0.000040350824,0.00013847968,0.00015916675,0.00045500844,0.0022342259],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002507585,0.00016930222,0.00020967322,0.000098970886,0.0011837141,0.00010843558,0.00014267497,0.00022970694,0.001108711],"category_scores_gemma":[0.00016309213,0.00010990174,0.00013291766,0.0002097962,0.000029394096,0.000051761428,0.000014687833,0.00050170213,0.00009711996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013234907,0.000023963414,0.82927835,0.0000028797108,0.00045165248,0.00027633196,0.0023485352,0.000055033226,0.000005954824,0.00027870218,0.08457479,0.08257147],"study_design_scores_gemma":[0.0005762128,0.00080615195,0.5345757,0.0000120463,0.00014328815,0.00005338411,0.00020763131,0.000009106352,0.000031800435,0.00037952908,0.4630521,0.00015303916],"about_ca_topic_score_codex":0.48821622,"about_ca_topic_score_gemma":0.898411,"teacher_disagreement_score":0.41019472,"about_ca_system_score_codex":0.0043301904,"about_ca_system_score_gemma":0.003013375,"threshold_uncertainty_score":0.99980444},"labels":[],"label_agreement":null},{"id":"W2051659258","doi":"10.1016/j.urolonc.2009.11.007","title":"Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Proportional hazards model; Hazard ratio; Urothelial carcinoma; Cancer; Internal medicine; Lymph node; Multivariate analysis; T-stage; Urology; Carcinoma; Disease; Oncology; Gastroenterology; Bladder cancer; Confidence interval","score_opus":0.01465563431599275,"score_gpt":0.30871165730842504,"score_spread":0.2940560229924323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051659258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931293,0.000055929544,0.00003653376,0.0043071583,0.00018543776,0.00139869,0.00011354091,0.00006377198,0.0007096408],"genre_scores_gemma":[0.9837081,0.00006262083,0.01378075,0.0014352691,0.000119197925,0.00032781743,0.0003292684,0.00002696671,0.00021000882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805,0.00023728838,0.0004852664,0.00059169665,0.00024241427,0.00039334863],"domain_scores_gemma":[0.9987871,0.00027826856,0.00019518484,0.00024408699,0.00010974039,0.0003855846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028894056,0.0003181669,0.0005288921,0.00014859045,0.00019722364,0.000042930853,0.00012554794,0.00041867874,0.00021392468],"category_scores_gemma":[0.00016849213,0.00017456478,0.00008506825,0.00027243607,0.0009979183,0.00018016312,0.00003056322,0.0008395882,0.000011771497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017502381,0.0012627996,0.99253523,0.000016582786,0.000097292905,0.000044335025,0.00038183227,0.0000017046854,0.00056633726,0.00020318801,0.0009780724,0.0021624027],"study_design_scores_gemma":[0.00722615,0.010762048,0.9369666,0.00004097321,0.00037055823,0.000048466336,0.00008517594,0.00032454415,0.00030365773,0.00042895615,0.04319106,0.00025178737],"about_ca_topic_score_codex":0.00018266171,"about_ca_topic_score_gemma":0.00006930226,"teacher_disagreement_score":0.05556859,"about_ca_system_score_codex":0.0001637632,"about_ca_system_score_gemma":0.00058714993,"threshold_uncertainty_score":0.71185446},"labels":[],"label_agreement":null},{"id":"W2051922168","doi":"10.1016/j.carpath.2008.09.003","title":"Mycobacterium bovis abdominal aortic and femoral artery aneurysms following intravesical bacillus Calmette–Guérin therapy for bladder cancer","year":2008,"lang":"en","type":"article","venue":"Cardiovascular Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Mycobacterium bovis; Abdominal aortic aneurysm; Bladder cancer; Femoral artery; Surgery; Aneurysm; Radiology; Cancer; Tuberculosis; Pathology; Internal medicine; Mycobacterium tuberculosis","score_opus":0.02943099732409858,"score_gpt":0.27529273727478426,"score_spread":0.24586173995068566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051922168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97999096,0.014435495,0.0030872333,0.00037180402,0.0008161343,0.0010019791,0.000051704606,0.00007403876,0.00017065946],"genre_scores_gemma":[0.9936352,0.002320862,0.0011974003,0.0012075166,0.0008347432,0.00044293163,0.000043561256,0.000070643975,0.0002471912],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980227,0.00014473706,0.0003132605,0.0006650983,0.00029172326,0.0005625283],"domain_scores_gemma":[0.99902713,0.000052473148,0.000047951286,0.0005480264,0.0000883871,0.00023602799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000253023,0.00033837082,0.000992477,0.00010876291,0.0001872476,0.000017037719,0.00008606659,0.0002201251,0.00005067734],"category_scores_gemma":[0.00004278721,0.00025523503,0.0010475024,0.0001260701,0.0002457399,0.00008621764,0.000040635085,0.00022164472,0.000013436119],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048229373,0.00094906514,0.18074341,0.00041953553,0.019456817,0.034246787,0.004435997,0.000048591315,0.05528178,0.000028125756,0.0034261723,0.69614077],"study_design_scores_gemma":[0.04034112,0.004271127,0.8668845,0.00010287292,0.005252619,0.031626496,0.0002543959,0.00028213015,0.01702771,0.00016955567,0.032491267,0.0012961709],"about_ca_topic_score_codex":0.00006083888,"about_ca_topic_score_gemma":0.0000044218677,"teacher_disagreement_score":0.6948446,"about_ca_system_score_codex":0.000090549576,"about_ca_system_score_gemma":0.00017789337,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W2051979916","doi":"10.5489/cuaj.221","title":"Updated assessment of neoblader utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Propensity score matching; Odds; Cohort; Odds ratio; Cohort study; Urinary system; Population; Urology; Surgery; Logistic regression; Internal medicine; Bladder cancer; Environmental health; Cancer","score_opus":0.023909133725405454,"score_gpt":0.2766079226482044,"score_spread":0.25269878892279896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051979916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200404,0.00010257044,0.00019360155,0.0062392056,0.00012068195,0.00062161154,0.000045107405,0.000018778393,0.00065438705],"genre_scores_gemma":[0.9956802,0.000012968452,0.00038251356,0.0036053027,0.00011150183,0.00003633252,0.00009711099,0.0000108383965,0.00006323205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867046,0.00016724538,0.0003387277,0.00019644818,0.00037358477,0.00025351913],"domain_scores_gemma":[0.9987176,0.00006825443,0.00018865486,0.00009146098,0.0002691049,0.0006649381],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026319994,0.00013201167,0.00030651022,0.00020657908,0.00015540674,0.000052965817,0.000055613316,0.00019033755,0.0011441755],"category_scores_gemma":[0.00014631776,0.00010711315,0.000076498145,0.0001965167,0.000022420856,0.00015634374,0.000017820872,0.00026872556,0.000012106661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000793571,0.00008274341,0.99716383,0.00000878121,0.000106617896,0.000040006107,0.000023418079,0.000033229957,0.00007934211,0.000005497219,0.0018928823,0.00048428628],"study_design_scores_gemma":[0.0014058118,0.0005034723,0.9946952,0.00003500575,0.0001011612,0.000029668683,0.000035576042,0.001705861,0.000023256267,0.000059246948,0.0013088092,0.0000969286],"about_ca_topic_score_codex":0.006541047,"about_ca_topic_score_gemma":0.00011488686,"teacher_disagreement_score":0.0064261598,"about_ca_system_score_codex":0.0009560605,"about_ca_system_score_gemma":0.00056470477,"threshold_uncertainty_score":0.9997689},"labels":[],"label_agreement":null},{"id":"W2052244071","doi":"10.5430/jst.v4n2p25","title":"Systemic therapy for bladder cancer – a medical oncologist’s perspective","year":2014,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Gemcitabine; Oncology; Bladder cancer; Tolerability; Cisplatin; Cystectomy; Vinblastine; Chemotherapy; Internal medicine; Systemic therapy; Cancer; Adverse effect","score_opus":0.027847759231399982,"score_gpt":0.36613816845468744,"score_spread":0.33829040922328746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052244071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536144,0.011294005,0.0040594907,0.020873442,0.00228089,0.0013235684,0.000053604927,0.00005484406,0.0064457105],"genre_scores_gemma":[0.9940732,0.0009138507,0.00026985144,0.002159293,0.0019783864,0.000046344685,8.863464e-7,0.000027649063,0.00053054607],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99864167,0.000054899836,0.0004294877,0.00014219945,0.0005025799,0.00022914074],"domain_scores_gemma":[0.9986022,0.00012508915,0.0003201281,0.00012250098,0.0005527209,0.00027733858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046051768,0.00014488348,0.0005723198,0.000104923194,0.000058366146,0.0000101601645,0.00013170813,0.000098085126,0.00034415003],"category_scores_gemma":[0.00028987322,0.00009182933,0.0002610465,0.00008831614,0.000084793006,0.00006223912,0.000011125244,0.00024590944,0.000007016927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05101125,0.010979668,0.1750659,0.0015705852,0.019980172,0.004225083,0.032421708,0.0005682035,0.028007409,0.011929921,0.31134757,0.35289252],"study_design_scores_gemma":[0.23825803,0.10297776,0.24153852,0.013569939,0.0062384508,0.0541422,0.028927637,0.0049157375,0.066429175,0.02214111,0.21778627,0.0030751512],"about_ca_topic_score_codex":0.00010521515,"about_ca_topic_score_gemma":0.000018886876,"teacher_disagreement_score":0.34981737,"about_ca_system_score_codex":0.00040090448,"about_ca_system_score_gemma":0.0009880465,"threshold_uncertainty_score":0.37682015},"labels":[],"label_agreement":null},{"id":"W2052562958","doi":"10.1038/bjc.2013.372","title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Concordance; Medicine; Proportional hazards model; Oncology; Disease; Internal medicine; Bladder cancer; Hazard ratio; Cohort; Retrospective cohort study; Cancer; Confidence interval","score_opus":0.013127931856085167,"score_gpt":0.2676740225934418,"score_spread":0.2545460907373566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052562958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940425,0.003388402,0.000024620796,0.00082560687,0.00033476023,0.0008329737,0.00026136715,0.0000015989274,0.0002881776],"genre_scores_gemma":[0.9972831,0.0018240375,0.000106769665,0.00032632664,0.00012504755,0.0000353085,1.8126374e-7,0.00002272651,0.00027649815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841595,0.00008432152,0.0006326827,0.00013873448,0.00052701606,0.0002013134],"domain_scores_gemma":[0.9984918,0.000119351134,0.00065755495,0.00029546252,0.00035244907,0.00008333639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019186115,0.00014373854,0.00049811084,0.000059289796,0.00007220762,0.000017851058,0.0003384055,0.0000627765,0.00006490749],"category_scores_gemma":[0.00031951175,0.000079255646,0.00025018604,0.00021760284,0.00017948201,0.00015628837,0.00013891209,0.00030073352,2.617664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013128183,0.00014474991,0.9607615,0.00011915337,0.00025867118,0.000007141177,0.0011455765,0.0013408327,0.008766248,0.000004249308,0.00089257304,0.026428018],"study_design_scores_gemma":[0.002717781,0.00014216865,0.96406966,0.0019543506,0.00031797265,0.000080746024,0.00027885,0.00018247339,0.029896013,0.00022631578,0.00006236999,0.000071269955],"about_ca_topic_score_codex":0.017000234,"about_ca_topic_score_gemma":0.0043280064,"teacher_disagreement_score":0.026356747,"about_ca_system_score_codex":0.000089604975,"about_ca_system_score_gemma":0.00075085287,"threshold_uncertainty_score":0.98954564},"labels":[],"label_agreement":null},{"id":"W2052644271","doi":"10.1016/j.clon.2014.05.007","title":"Curative Therapy for Bladder Cancer in Routine Clinical Practice: A Population-based Outcomes Study","year":2014,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Bladder cancer; Cancer; Clinical Practice; Population; Intensive care medicine; Oncology; Internal medicine; Family medicine","score_opus":0.15971817761417698,"score_gpt":0.5682178982976902,"score_spread":0.40849972068351326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052644271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96094155,0.00020509283,0.00050605554,0.030502055,0.0019514129,0.0035665631,0.000027864153,0.00006544504,0.0022339812],"genre_scores_gemma":[0.9710566,0.00011766136,0.0023068346,0.024475425,0.00088977016,0.00069660344,0.000031457927,0.00003484507,0.00039080938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99619156,0.0011398923,0.0015417199,0.00059917587,0.0002175881,0.00031005696],"domain_scores_gemma":[0.9894436,0.009248675,0.0004410765,0.000387568,0.00026843624,0.00021065047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027690234,0.00021791607,0.0013003027,0.00007271059,0.00006257496,0.0000098085375,0.00011832063,0.00036177586,0.00025669034],"category_scores_gemma":[0.0060076094,0.00015086558,0.00034301262,0.00015273051,0.00012077946,0.00007652216,0.00002606052,0.0005031798,0.000027646287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004747422,0.008879408,0.8455262,0.0000052829146,0.00042616588,0.000019379166,0.00012901583,0.000011494088,6.538385e-7,0.00007617354,0.00087657495,0.1393022],"study_design_scores_gemma":[0.038463455,0.017851874,0.9021417,0.000017683264,0.00033985233,0.0000018054953,0.00021010514,0.00055696594,0.0000031164407,0.00021797325,0.04005822,0.00013725372],"about_ca_topic_score_codex":0.0009845358,"about_ca_topic_score_gemma":0.0017149287,"teacher_disagreement_score":0.13916494,"about_ca_system_score_codex":0.0001977496,"about_ca_system_score_gemma":0.0008577995,"threshold_uncertainty_score":0.7192104},"labels":[],"label_agreement":null},{"id":"W2052722839","doi":"10.1111/j.1464-410x.2007.07164.x","title":"Severe bladder trabeculation obviates the need for bladder outlet procedures during augmentation cystoplasty in incontinent patients with neurogenic bladder","year":2007,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Urology; Hydronephrosis; Neck of urinary bladder; Reflux; Concomitant; Urinary bladder; Surgery; Urinary system; Internal medicine","score_opus":0.006591852014538658,"score_gpt":0.23887697899738408,"score_spread":0.23228512698284542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052722839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661094,0.00069670053,0.00047504497,0.00097628246,0.00022365194,0.00085853034,0.000024119732,0.000013170039,0.000121543875],"genre_scores_gemma":[0.99803376,0.00008139117,0.00026387398,0.0011504899,0.00024557926,0.000026702583,0.0000378082,0.000037674152,0.00012272572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984512,0.00006933535,0.0005929158,0.00021094193,0.00031984603,0.0003558007],"domain_scores_gemma":[0.9989073,0.00011452746,0.00036078613,0.000101906575,0.00040869557,0.00010677752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029233817,0.0001738202,0.00032763262,0.00016680146,0.00011829694,0.00003251569,0.00009648615,0.00011146659,0.000057308705],"category_scores_gemma":[0.00015869485,0.00013466095,0.00012008985,0.00017423822,0.000077894685,0.00017550927,0.00001747609,0.0002909256,0.0000018914665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018585298,0.002128668,0.9390555,0.00014796476,0.0022719593,0.0010221798,0.0021277445,0.0014465103,0.0022731042,0.000026008034,0.002487921,0.028427139],"study_design_scores_gemma":[0.016805867,0.0014632213,0.97702146,0.000059080783,0.00046615224,0.0027395943,0.00022951243,0.00003779425,0.0005279341,0.00009311685,0.0004196632,0.000136636],"about_ca_topic_score_codex":0.000072317016,"about_ca_topic_score_gemma":0.00079148746,"teacher_disagreement_score":0.037965924,"about_ca_system_score_codex":0.00009072266,"about_ca_system_score_gemma":0.00015651254,"threshold_uncertainty_score":0.54913145},"labels":[],"label_agreement":null},{"id":"W2053203680","doi":"10.1007/s00345-012-0905-2","title":"Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Retrospective cohort study; Risk factor; Nephrology; Cohort; Urinary system; Univariate analysis; Urinary diversion; Internal medicine; Surgery; Cancer; Multivariate analysis","score_opus":0.028198933410558093,"score_gpt":0.32674976629458835,"score_spread":0.2985508328840303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053203680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95297706,0.04388608,0.000018129927,0.0010449156,0.00017262605,0.0017954138,0.000016645905,0.00000653629,0.000082575294],"genre_scores_gemma":[0.9962967,0.0030889988,0.00017363214,0.0001716662,0.00015191523,0.00006198851,0.0000034457223,0.000014868459,0.00003675306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859387,0.00022093905,0.00049389596,0.00013461987,0.00028439288,0.0002722972],"domain_scores_gemma":[0.9988075,0.00033820941,0.000416237,0.00011832137,0.000045787398,0.00027393206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030889965,0.0002118163,0.0010217378,0.0001581836,0.00005318068,0.0000066319453,0.0000724691,0.000063250714,0.00007714472],"category_scores_gemma":[0.0001244191,0.00010978532,0.00019664902,0.00009685129,0.0001364329,0.0001271287,0.000028415105,0.00037331413,3.6639025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005180781,0.00028442804,0.9914886,0.00043045075,0.0005340899,0.00003726457,0.00038623615,3.034529e-8,0.000010343093,0.000009122498,0.00008792783,0.006213478],"study_design_scores_gemma":[0.0045914617,0.0026773526,0.9834831,0.0016142646,0.0015277247,0.00031125903,0.00004198364,2.2533968e-7,0.00007632515,0.000049036986,0.005530171,0.00009713468],"about_ca_topic_score_codex":0.000022152273,"about_ca_topic_score_gemma":0.000005896786,"teacher_disagreement_score":0.043319657,"about_ca_system_score_codex":0.000026729274,"about_ca_system_score_gemma":0.00006498732,"threshold_uncertainty_score":0.44769153},"labels":[],"label_agreement":null},{"id":"W2053563036","doi":"10.5489/cuaj.11276","title":"Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Proportional hazards model; Hazard ratio; Stage (stratigraphy); Urology; Survival analysis; Oncology; Population; Internal medicine; Surgery; Cancer; Confidence interval","score_opus":0.022572652668025456,"score_gpt":0.2783525191170212,"score_spread":0.25577986644899575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053563036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429394,0.0025945853,0.000007599559,0.04576585,0.0013870056,0.00035408666,0.00008519879,0.000017487077,0.0068487963],"genre_scores_gemma":[0.9841033,0.000092092414,0.00005571819,0.013065676,0.0010910815,0.000036154714,0.000007981442,0.00001519309,0.0015328038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790233,0.00016854484,0.00034830393,0.00014193798,0.00046249098,0.0009763828],"domain_scores_gemma":[0.9975936,0.00014169102,0.00022115852,0.00015799515,0.00017866408,0.0017069],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005453717,0.00016730152,0.00035146272,0.000095351796,0.00069161766,0.00003736873,0.00017151856,0.00026696533,0.0035709192],"category_scores_gemma":[0.00031354444,0.00010120332,0.00018001204,0.00024729234,0.00011078049,0.00009517096,0.000017949586,0.0004954603,0.000056446224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028176364,0.000022476694,0.97694814,0.0000014902636,0.0002562532,0.000020892727,0.00060442125,0.00002263693,0.000010700367,0.0001387221,0.02118817,0.000757922],"study_design_scores_gemma":[0.00068810734,0.00007713085,0.82589644,0.000007161443,0.00013334675,0.00010962114,0.000059125705,0.000011918171,0.000022360644,0.000075373144,0.17282917,0.0000902774],"about_ca_topic_score_codex":0.24157849,"about_ca_topic_score_gemma":0.48231214,"teacher_disagreement_score":0.24073365,"about_ca_system_score_codex":0.0036127192,"about_ca_system_score_gemma":0.0015819279,"threshold_uncertainty_score":0.99733996},"labels":[],"label_agreement":null},{"id":"W2053638441","doi":"10.5489/cuaj.1746","title":"High-grade microscopic hematuria in adult men can predict urothelial malignancy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Malignancy; Microscopic hematuria; Urology; Urothelial cancer; Medicine; Urothelial carcinoma; Internal medicine; Bladder cancer; Kidney; Cancer","score_opus":0.007402872537844591,"score_gpt":0.22454285969371293,"score_spread":0.21713998715586835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053638441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518779,0.00015325003,0.000041181807,0.041346163,0.00073693454,0.0004362753,0.00013262764,0.000044029868,0.005231615],"genre_scores_gemma":[0.9900844,0.00007395526,0.00028303923,0.007521757,0.0009191048,0.000023661738,0.000032070013,0.000021249532,0.0010407385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981432,0.00021055293,0.00040857182,0.00024959596,0.00035377976,0.0006342911],"domain_scores_gemma":[0.9986894,0.00007607134,0.0001868063,0.00013535227,0.00015909079,0.0007532479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038551018,0.00019034024,0.00039060978,0.00020369471,0.00016683275,0.000069877446,0.00013395697,0.0003047259,0.0005230618],"category_scores_gemma":[0.0004834466,0.0001527098,0.00011490659,0.00020123538,0.000029283307,0.000062814324,0.000011076344,0.00059855264,0.00006026837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103123675,0.00012382635,0.982383,0.00001206071,0.00012318802,0.00015628357,0.00021633814,0.000017660213,0.00065280136,0.00079264,0.01370741,0.0017116304],"study_design_scores_gemma":[0.0059159365,0.00074117025,0.97292095,0.00006718523,0.00011509999,0.00019175472,0.000040875686,0.00007763506,0.0005004795,0.002648452,0.016578665,0.0002017762],"about_ca_topic_score_codex":0.009144009,"about_ca_topic_score_gemma":0.0070413314,"teacher_disagreement_score":0.038206503,"about_ca_system_score_codex":0.0014615069,"about_ca_system_score_gemma":0.0006138516,"threshold_uncertainty_score":0.99745417},"labels":[],"label_agreement":null},{"id":"W2053963400","doi":"10.1016/j.juro.2011.02.581","title":"486 LYMPH NODE DENSITY: UTILITY IN STRATIFYING PATIENTS FOR ADJUVANT THERAPY AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Grossman; Bladder cancer; Lymph node; Cancer; Oncology; Proportional hazards model; Internal medicine; Urology","score_opus":0.04923869074127669,"score_gpt":0.3073733994885482,"score_spread":0.2581347087472715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053963400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431723,0.0022369514,0.0012557484,0.00091157947,0.00037197754,0.00072196656,0.000029051445,0.0000056719864,0.0001497975],"genre_scores_gemma":[0.99644715,0.0003128571,0.0004970006,0.0024058672,0.00021016008,0.00007639163,0.0000023687426,0.000020804038,0.000027394844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894524,0.000110003304,0.00039748487,0.00012354631,0.00014926502,0.0002744623],"domain_scores_gemma":[0.99920875,0.00014446254,0.00019107568,0.00016332329,0.00020367886,0.00008870413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040458768,0.0001383324,0.00039306722,0.000079168945,0.00004874339,0.000003808314,0.00011843655,0.00010869716,0.00017421377],"category_scores_gemma":[0.000039443497,0.00007961919,0.00014525006,0.000057812187,0.00010669393,0.00005768066,0.000015108816,0.00016986078,0.0000014671806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08506143,0.0015671646,0.84170526,0.0000941432,0.0010590155,0.000053760425,0.0058684004,0.000007318234,0.0010736891,0.000032095788,0.0009941192,0.062483594],"study_design_scores_gemma":[0.023106284,0.0030828193,0.9655461,0.000044454177,0.0005568099,0.00014055084,0.000121213234,0.00017160503,0.0025884893,0.0013818748,0.0031353566,0.00012448063],"about_ca_topic_score_codex":0.00017812982,"about_ca_topic_score_gemma":0.00010708985,"teacher_disagreement_score":0.123840794,"about_ca_system_score_codex":0.00006774202,"about_ca_system_score_gemma":0.00021958354,"threshold_uncertainty_score":0.32467765},"labels":[],"label_agreement":null},{"id":"W2054379162","doi":"10.1016/j.clgc.2012.12.007","title":"Pooled Analysis of Phase II Trials Evaluating Weekly or Conventional Cisplatin as First-Line Therapy for Advanced Urothelial Carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Oncology; Cisplatin; Urothelial cancer; Pooled analysis; Internal medicine; Metastatic Urothelial Carcinoma; Carcinoma; Bladder cancer; Cancer; Chemotherapy; Meta-analysis","score_opus":0.20872856748471622,"score_gpt":0.5079691153930224,"score_spread":0.2992405479083061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054379162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989268,0.0023685023,0.000388868,0.002295799,0.0010077162,0.0035915433,0.00064668345,0.000046957804,0.0003859293],"genre_scores_gemma":[0.97960603,0.0011559656,0.0022562714,0.0013643614,0.0017572546,0.0020075275,0.00026299345,0.000059410413,0.011530169],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99602693,0.00032484654,0.0020589356,0.0006622451,0.00052508863,0.00040192343],"domain_scores_gemma":[0.99586856,0.0018227266,0.00079813966,0.0005017058,0.00068976136,0.00031911867],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013067378,0.0003488386,0.00191987,0.00023131832,0.00018159786,0.000018389186,0.0001906381,0.00022485323,0.0102331955],"category_scores_gemma":[0.0013036758,0.00024382945,0.00148746,0.00055625814,0.0001690904,0.00012918968,0.00006324659,0.00022917005,0.000029116161],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10077761,0.010308095,0.04314208,0.0002547468,0.021066895,0.000058512753,0.00042321617,0.00051893445,0.020954408,0.00002497614,0.009297425,0.7931731],"study_design_scores_gemma":[0.41303918,0.1938029,0.23459679,0.0007540936,0.056593798,0.000042219246,0.00050263735,0.039498482,0.02239716,0.0019403261,0.034973815,0.0018585998],"about_ca_topic_score_codex":0.00030592,"about_ca_topic_score_gemma":0.000035664594,"teacher_disagreement_score":0.7913145,"about_ca_system_score_codex":0.00014399922,"about_ca_system_score_gemma":0.0012684915,"threshold_uncertainty_score":0.99430764},"labels":[],"label_agreement":null},{"id":"W2054399970","doi":"10.5489/cuaj09134","title":"Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Queen's University","funders":"","keywords":"Medicine; Guideline; Bladder cancer; Internal medicine; Oncology; Chemotherapy; Neoadjuvant therapy; Referral; Cancer; Retrospective cohort study; Breast cancer; Pathology; Family medicine","score_opus":0.029676489269348846,"score_gpt":0.35586293959236986,"score_spread":0.326186450323021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054399970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485286,0.00036732716,0.0000032827356,0.05022324,0.00013591505,0.0002413824,0.0000617948,0.0000035861694,0.00043488923],"genre_scores_gemma":[0.99254614,0.0010917688,0.0011055892,0.0047971117,0.00028980683,0.000024750854,0.00001498263,0.000009144425,0.00012068082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986636,0.00010766443,0.0006658567,0.00017650524,0.00018075932,0.00020559209],"domain_scores_gemma":[0.99836534,0.00018300262,0.00045696608,0.00009045411,0.00054740807,0.00035684256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006490422,0.00011369922,0.0003754129,0.00012610546,0.000038805636,0.00002033821,0.000037602204,0.00023880682,0.00038330903],"category_scores_gemma":[0.0013232183,0.0000796292,0.00007095478,0.00011823304,0.000068183435,0.00012528537,0.000007108052,0.0003344315,9.1271124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003201913,0.00016218092,0.9326313,0.000003924869,0.00017656383,0.000022237147,0.0003853968,5.8485256e-7,0.00019381683,0.000035089928,0.00074571086,0.06532298],"study_design_scores_gemma":[0.0034550028,0.0010246667,0.96599084,0.000014872247,0.0001328681,0.00005702456,0.00009727782,0.000047213387,0.00008955956,0.00018039069,0.028851978,0.000058278536],"about_ca_topic_score_codex":0.0064931223,"about_ca_topic_score_gemma":0.032451913,"teacher_disagreement_score":0.0652647,"about_ca_system_score_codex":0.00021672007,"about_ca_system_score_gemma":0.00081294007,"threshold_uncertainty_score":0.9852033},"labels":[],"label_agreement":null},{"id":"W2054442907","doi":"10.5489/cuaj.2664","title":"BCG-Related Renal Granulomas Managed Conservatively","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Renal pelvis; Cystoprostatectomy; Nephrectomy; Surgery; Carcinoma in situ; Urology; Biopsy; Radiology; Kidney; Ureter; Carcinoma; Cystectomy; Internal medicine; Bladder cancer; Cancer","score_opus":0.02936890377126795,"score_gpt":0.2538613302430371,"score_spread":0.22449242647176915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054442907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8239722,0.0007051008,0.000079826175,0.10497818,0.0008816357,0.00042512108,0.00007002219,0.0000960252,0.06879187],"genre_scores_gemma":[0.9859603,0.000029222036,0.00021647765,0.008359244,0.00028491323,0.000007469229,0.000029164517,0.000013714531,0.0050994633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848163,0.00019553445,0.0003098843,0.00016972926,0.00039990677,0.00044328827],"domain_scores_gemma":[0.9979327,0.00006324799,0.00018502926,0.000088991736,0.00037125818,0.0013588124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006178945,0.0001393844,0.00026981664,0.00015068849,0.00019863601,0.00006223333,0.000091217094,0.00023672095,0.000752185],"category_scores_gemma":[0.0005555119,0.00010846945,0.0001234301,0.00025229793,0.000039844334,0.000098308024,0.000009460316,0.0005634146,0.0002608995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022117687,0.0000875047,0.8740264,0.000002648754,0.0004758427,0.00083797745,0.00041509126,0.000017758026,0.00007243401,0.00078050105,0.120450236,0.0026124096],"study_design_scores_gemma":[0.0045888443,0.0007126115,0.8097828,0.000014190514,0.00018548887,0.00060049805,0.000114143695,0.00006494424,0.000032628213,0.005307014,0.17844218,0.00015466413],"about_ca_topic_score_codex":0.0018898835,"about_ca_topic_score_gemma":0.00072539493,"teacher_disagreement_score":0.16198811,"about_ca_system_score_codex":0.0015240825,"about_ca_system_score_gemma":0.0011023683,"threshold_uncertainty_score":0.82358986},"labels":[],"label_agreement":null},{"id":"W2055493195","doi":"10.5489/cuaj.1506","title":"Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; Hôpital Notre-Dame; University of British Columbia; Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Medicine; Genitourinary system; Urothelial cancer; Chemotherapy; Oncology; Cisplatin; Internal medicine; Neoadjuvant therapy; Cancer; Gynecology; Urology; Breast cancer","score_opus":0.02962295210518577,"score_gpt":0.2856279935096261,"score_spread":0.2560050414044403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055493195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9307917,0.000078339595,0.000026939992,0.06559845,0.00018698734,0.0023425173,0.0008680061,0.0000121861685,0.00009489576],"genre_scores_gemma":[0.9864303,0.00007511118,0.00041964045,0.011767,0.00021708025,0.0003441115,0.000030370322,0.00003514371,0.00068127597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979191,0.000110097586,0.000493678,0.0003244851,0.0005432029,0.00060945976],"domain_scores_gemma":[0.99738723,0.00016389042,0.0004160039,0.00016841473,0.0010840067,0.00078046665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020346852,0.0002553991,0.00043126478,0.000107445965,0.00026964326,0.000085570304,0.00015487336,0.00019656168,0.00053810445],"category_scores_gemma":[0.00037876348,0.0001549998,0.00011549829,0.00017904582,0.00006604004,0.00008148681,0.000019705014,0.00030353354,0.0000030610056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022545834,0.0005500591,0.9140991,0.00007309158,0.0012035194,0.000032573873,0.0025947492,0.00034988413,0.00044982674,0.000011261256,0.068296805,0.010084554],"study_design_scores_gemma":[0.015014577,0.0034939917,0.9655252,0.00011530024,0.00034860978,0.000016330907,0.00036055222,0.00009267971,0.0002850961,0.00013690602,0.014335625,0.0002751045],"about_ca_topic_score_codex":0.019902611,"about_ca_topic_score_gemma":0.03316085,"teacher_disagreement_score":0.05563859,"about_ca_system_score_codex":0.0006972119,"about_ca_system_score_gemma":0.0017781197,"threshold_uncertainty_score":0.98662394},"labels":[],"label_agreement":null},{"id":"W2055636200","doi":"10.1016/j.eururo.2014.08.003","title":"Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Dalhousie University; McMaster University; University of British Columbia; St. Joseph’s Healthcare Hamilton; McGill University Health Centre; Université Laval; University of Alberta; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Proportional hazards model; Urology; Hazard ratio; Stage (stratigraphy); Bladder cancer; Carcinoma in situ; Survivorship curve; Retrospective cohort study; Survival analysis; Cancer; Internal medicine; Oncology; Surgery; Confidence interval","score_opus":0.01702750205646411,"score_gpt":0.2646262123393232,"score_spread":0.2475987102828591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055636200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314439,0.0002579173,0.0050647985,0.0040178094,0.0009409565,0.00051425706,0.000111826455,0.00010382875,0.05754467],"genre_scores_gemma":[0.9888499,0.0000032579385,0.00047979326,0.007676673,0.0017521608,0.00004170426,0.00018586511,0.000051597333,0.00095909525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888355,0.00023984176,0.00017889278,0.0002941722,0.00011884299,0.00028470668],"domain_scores_gemma":[0.99940896,0.00015388137,0.000036044952,0.00020511865,0.0000440944,0.00015187095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020135424,0.00015027195,0.00023997114,0.00005887225,0.000052667623,0.000009677508,0.00007311821,0.000057641402,0.00092675776],"category_scores_gemma":[0.000071309914,0.00012348873,0.00014638426,0.000035924168,0.00012592824,0.000031744887,0.000023277484,0.00014583916,0.0003149066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010819701,0.0014725485,0.9017688,0.00016050659,0.00067354174,0.0012215715,0.00087216916,0.000008308622,0.0030948971,0.0064130104,0.050062306,0.023432642],"study_design_scores_gemma":[0.0036604465,0.0012251247,0.5904016,0.000002691535,0.00013309035,0.00019736258,0.0000033560787,0.000043226493,0.000095501084,0.0001897589,0.40395635,0.00009151251],"about_ca_topic_score_codex":0.000005735243,"about_ca_topic_score_gemma":0.0000018111165,"teacher_disagreement_score":0.35389403,"about_ca_system_score_codex":0.000022049338,"about_ca_system_score_gemma":0.00004246496,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2056065461","doi":"10.1016/j.urolonc.2011.12.017","title":"Summary of the 6th annual bladder cancer think tank: New directions in urologic research","year":2012,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health","keywords":"Bladder cancer; Medicine; Survivorship curve; Standardization; Clinical trial; Multidisciplinary approach; Cancer; Family medicine; Internal medicine; Political science","score_opus":0.12808407301072058,"score_gpt":0.42648679359404085,"score_spread":0.2984027205833203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056065461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001098997,0.9860231,0.0000018251579,0.003692904,0.00066296075,0.0015906616,0.0002562088,0.000041956217,0.0066313664],"genre_scores_gemma":[0.00013190883,0.9888531,0.0016028433,0.00076955155,0.0005793301,0.00045642708,0.00007373826,0.00004021355,0.0074928817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967186,0.0009208114,0.00071988866,0.00059445394,0.0003741542,0.00067211065],"domain_scores_gemma":[0.9978029,0.000792382,0.0003593547,0.00052192446,0.00014026783,0.0003831753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086713734,0.000437221,0.0015019177,0.0004645862,0.00033548492,0.000014962628,0.00033133433,0.00092544657,0.00034824523],"category_scores_gemma":[0.0002527382,0.00026542382,0.00028237057,0.0013387154,0.001484127,0.00011309818,0.00021401678,0.0018450808,0.000026013116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017153595,0.0013057917,0.09905094,0.0027250522,0.0010220656,0.00015833425,0.0024310853,0.000015956632,0.000004417153,0.0034848663,0.07250841,0.81712157],"study_design_scores_gemma":[0.0005593116,0.0009830396,0.00069692265,0.0013995956,0.0022851531,0.0003068924,0.00012408836,0.000003874354,0.0000031887505,0.0019803436,0.9914568,0.00020078014],"about_ca_topic_score_codex":0.0017070267,"about_ca_topic_score_gemma":0.0007692605,"teacher_disagreement_score":0.9189484,"about_ca_system_score_codex":0.00048212407,"about_ca_system_score_gemma":0.004143774,"threshold_uncertainty_score":0.9999798},"labels":[],"label_agreement":null},{"id":"W2056153069","doi":"10.1016/j.ijrobp.2014.05.2043","title":"Hemostatic Radiation Therapy in Advanced Bladder Cancer: A Single-Institution Review","year":2014,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Bladder cancer; Radiation therapy; Medical physics; Radiology; Cancer; Oncology; Internal medicine","score_opus":0.050625360742779554,"score_gpt":0.41038320162794434,"score_spread":0.35975784088516477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056153069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002315495,0.9913586,0.0012541892,0.0017291135,0.003411825,0.0013296119,0.0001114164,0.000035925197,0.00053781975],"genre_scores_gemma":[0.0014815344,0.99171245,0.00054840505,0.0030084837,0.002457745,0.0001800012,0.00048005866,0.000071551374,0.000059757447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642015,0.0005579194,0.0018494312,0.00042106587,0.00043306226,0.00031839256],"domain_scores_gemma":[0.9956586,0.00039411095,0.0028395373,0.00026326635,0.00068103103,0.0001634543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063379976,0.0005125377,0.0024867202,0.00037834037,0.000054381584,0.000026089412,0.0004298407,0.00047926497,0.00014913351],"category_scores_gemma":[0.00035261345,0.00040393893,0.0007596225,0.00042411292,0.00013944453,0.00029593852,0.000037562677,0.00083467265,0.000050564544],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017665233,0.00053521886,0.0015255227,0.001222521,0.0011793097,0.000045474855,0.00008056545,0.000032673226,0.000012784859,0.0004533083,0.0011841841,0.9935518],"study_design_scores_gemma":[0.00610549,0.0016505999,0.00020859134,0.013240282,0.0010809011,0.00030788264,0.0000056369354,0.000050663075,0.00003311791,0.00074781256,0.97626126,0.00030775316],"about_ca_topic_score_codex":0.00003985669,"about_ca_topic_score_gemma":0.00001057462,"teacher_disagreement_score":0.99324405,"about_ca_system_score_codex":0.003043996,"about_ca_system_score_gemma":0.0025561794,"threshold_uncertainty_score":0.9998413},"labels":[],"label_agreement":null},{"id":"W2056303227","doi":"10.4021//jmc.v1i3.42","title":"Fatal Outcome Due to Sepsis by Mycobacterium Bovis Six Years After BCG Intravesical Instillations","year":2010,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Genitourinary system; Mycobacterium bovis; Sepsis; Surgery; Disease; Pneumonitis; Internal medicine; Tuberculosis; Pathology; Lung; Mycobacterium tuberculosis","score_opus":0.01860729735932966,"score_gpt":0.32235979633959166,"score_spread":0.303752498980262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056303227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556393,0.00014402735,0.00017469595,0.012582846,0.0010821983,0.00013090388,0.00008555327,0.000014895446,0.00022094723],"genre_scores_gemma":[0.99365294,0.000040220588,0.00071979774,0.0038702183,0.001433445,0.0000072307907,0.000009262696,0.000021749585,0.000245119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979652,0.00003256782,0.00053982047,0.00014445832,0.0010813059,0.0002366036],"domain_scores_gemma":[0.9984191,0.00016270283,0.00011181276,0.00017607555,0.00012622707,0.001004078],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002699354,0.00014659003,0.00042587987,0.00013119366,0.00003565235,0.00003209292,0.00014202662,0.0001917163,0.0034057936],"category_scores_gemma":[0.0011324715,0.000094374576,0.00018393359,0.00014875366,0.00009944015,0.00010746834,0.00005254939,0.00068571756,0.00008805773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048093223,0.002884006,0.44531158,0.00023578985,0.0010855454,0.06263284,0.0021334335,0.0000016286739,0.014022151,0.000101958925,0.26662096,0.20016077],"study_design_scores_gemma":[0.0054134377,0.0028112466,0.631084,0.000288743,0.00062175293,0.020881016,0.00019741517,0.000019925967,0.002578351,0.000048991682,0.3357235,0.0003315782],"about_ca_topic_score_codex":0.000089636844,"about_ca_topic_score_gemma":0.00008280173,"teacher_disagreement_score":0.19982919,"about_ca_system_score_codex":0.000058257323,"about_ca_system_score_gemma":0.00030721238,"threshold_uncertainty_score":0.99750525},"labels":[],"label_agreement":null},{"id":"W2056361868","doi":"10.1245/s10434-011-1852-7","title":"Development and Validation of a Reference Table for Prediction of Postoperative Mortality Rate in Patients Treated with Radical Cystectomy: A Population-based Study","year":2011,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Cystectomy; Logistic regression; Stepwise regression; Charlson comorbidity index; Population; Prognostic variable; Comorbidity; Cohort; Mortality rate; Surgery; Internal medicine; Bladder cancer; Multivariate analysis; Cancer","score_opus":0.1293255077884252,"score_gpt":0.3613523567229273,"score_spread":0.23202684893450212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056361868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984096,0.00001340584,0.000015330785,0.00005297914,0.000010105374,0.0009892667,0.00007844704,0.0000051697084,0.00042566916],"genre_scores_gemma":[0.9993519,0.00000901798,0.00034533325,0.000024894776,0.000002960936,0.00009291137,0.00015515056,0.000005320101,0.000012475284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910444,0.00011157083,0.00040933414,0.00015596447,0.00012390593,0.00009479339],"domain_scores_gemma":[0.99931985,0.0000747744,0.00017904861,0.00007831705,0.00029979437,0.00004821401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025236062,0.00008265151,0.00041989656,0.00008529927,0.000016207867,7.802244e-7,0.000022869071,0.000071554605,0.000027049713],"category_scores_gemma":[0.000017867344,0.000057888,0.000020101807,0.00013682658,0.000049428443,0.000043783304,0.000007727913,0.000043331995,1.1201279e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006011974,0.0030319393,0.9882138,0.00005301559,0.00014502148,0.000007252895,0.0007748927,0.0000057060497,0.00008710456,0.00003408645,0.000004554119,0.0016306781],"study_design_scores_gemma":[0.010128286,0.010317023,0.95745933,0.00006740896,0.000082295184,6.1399084e-7,0.00008431011,0.000026851156,0.021579558,0.000013347307,0.00020068228,0.000040296658],"about_ca_topic_score_codex":0.0007985553,"about_ca_topic_score_gemma":0.00012220386,"teacher_disagreement_score":0.030754447,"about_ca_system_score_codex":0.000037802547,"about_ca_system_score_gemma":0.00021728616,"threshold_uncertainty_score":0.23606041},"labels":[],"label_agreement":null},{"id":"W2056472977","doi":"10.1016/j.urolonc.2013.07.001","title":"Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nomogram; Medicine; Proportional hazards model; Oncology; Internal medicine; Concordance; Chemotherapy; Confidence interval; Cisplatin; Urothelial cancer; Prognostic variable; Metastatic Urothelial Carcinoma; Cancer; Bladder cancer; Urothelial carcinoma","score_opus":0.02992241614387561,"score_gpt":0.31270409111499575,"score_spread":0.28278167497112017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056472977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825543,0.0003602572,0.0007279514,0.012128664,0.00010904608,0.0035726367,0.0001787275,0.00008060125,0.00028782367],"genre_scores_gemma":[0.84495455,0.00012027916,0.14304224,0.006974199,0.00015105994,0.0038789518,0.00044278125,0.000051360403,0.00038457647],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986655,0.00005098244,0.00030491556,0.00041766226,0.00017107879,0.00038986874],"domain_scores_gemma":[0.9987253,0.00043431367,0.00018156192,0.0001717371,0.00021600435,0.00027111373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008784638,0.00029825914,0.00045808667,0.000101804544,0.00033162566,0.000033243,0.00006940674,0.000107367894,0.00032671753],"category_scores_gemma":[0.0000796043,0.00020254211,0.00007299864,0.000178795,0.0003894366,0.00007668245,0.000013333267,0.00015303014,0.000015693218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066368404,0.0013357841,0.9829439,0.00009947711,0.00030412243,0.000015766924,0.00020662033,0.00018377234,0.000057368736,0.00021418973,0.0012255469,0.012749754],"study_design_scores_gemma":[0.04406343,0.05896291,0.31142065,0.00050038035,0.0041085375,0.00011152472,0.00017304702,0.012818942,0.0008133644,0.0046370565,0.56138986,0.0010002948],"about_ca_topic_score_codex":0.0004147902,"about_ca_topic_score_gemma":0.00008968313,"teacher_disagreement_score":0.6715233,"about_ca_system_score_codex":0.00017055812,"about_ca_system_score_gemma":0.00041098776,"threshold_uncertainty_score":0.82594275},"labels":[],"label_agreement":null},{"id":"W2056856149","doi":"10.1016/j.jvir.2009.04.048","title":"Embolotherapy for Lower Urinary Tract Hemorrhage","year":2009,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Medicine; Internal iliac artery; Surgery; Urinary system; Embolization; Asymptomatic; Occlusion; Radiology; Catheter; Upper urinary tract; Urinary bladder; Internal medicine","score_opus":0.01860468465884873,"score_gpt":0.3156874994821497,"score_spread":0.29708281482330096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056856149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713845,0.015325385,0.009396661,0.0026162188,0.0004182653,0.0002235722,0.0000109177,0.0000075533044,0.0006168744],"genre_scores_gemma":[0.99565583,0.00039524655,0.0021025103,0.0010632813,0.00044897717,0.000003341039,0.000006750672,0.000007755463,0.0003163257],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99935955,0.000034392786,0.00029923194,0.00009400873,0.00010046778,0.000112322065],"domain_scores_gemma":[0.9996067,0.000031336265,0.00011603047,0.00006742086,0.00009382504,0.00008466858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022308745,0.00008769602,0.00031150624,0.00008988579,0.000032526423,0.000006565754,0.00004411702,0.000065978864,0.00023979785],"category_scores_gemma":[0.000029473964,0.00006265553,0.00059429515,0.000029006653,0.00003471285,0.00006962063,0.00000334905,0.00010973375,0.0000016907954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048593264,0.061193295,0.06865212,0.0013722411,0.016629169,0.0102190375,0.0016878628,0.0001226,0.051108114,0.017367713,0.06679197,0.65626264],"study_design_scores_gemma":[0.030099336,0.10796265,0.6878029,0.00040741503,0.0012930565,0.07956548,0.00009194959,0.00022786672,0.0012423241,0.016047778,0.07491885,0.00034040987],"about_ca_topic_score_codex":0.0000010768653,"about_ca_topic_score_gemma":1.1880414e-7,"teacher_disagreement_score":0.65592223,"about_ca_system_score_codex":0.000033925415,"about_ca_system_score_gemma":0.000045340446,"threshold_uncertainty_score":0.26256183},"labels":[],"label_agreement":null},{"id":"W2056948196","doi":"10.1097/coc.0b013e31818b9486","title":"Bladder Conservation Treatment in the Elderly Population","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Univariate analysis; Bladder cancer; Radiation therapy; Surgery; Chemotherapy; Carcinoma; Medical record; Cancer; Multivariate analysis; Internal medicine","score_opus":0.08724261910795172,"score_gpt":0.4652728854638044,"score_spread":0.3780302663558527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056948196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95550036,0.00011067265,0.00006157615,0.040904004,0.00020529781,0.00019482731,9.894353e-7,0.0000046770597,0.0030176102],"genre_scores_gemma":[0.9865631,0.00030526277,0.0013327978,0.011202322,0.0005131718,0.0000034732318,0.0000041295802,0.000004958799,0.00007081968],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981494,0.0004342333,0.0009788354,0.000106783635,0.00019467965,0.00013605523],"domain_scores_gemma":[0.99832565,0.0006721461,0.00066615525,0.0001358692,0.000100748344,0.000099411445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007697785,0.000092264214,0.0006904529,0.00007655357,0.000023934334,0.0000060785815,0.000078746656,0.000069226284,0.000041386007],"category_scores_gemma":[0.00025823922,0.00005005647,0.00021768692,0.00019654499,0.000120077464,0.000058800124,0.0000026427972,0.00025937005,0.0000071686827],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014403755,0.0012255993,0.19353426,6.5402503e-7,0.00008985324,0.00018499944,0.00025185608,0.00000413794,0.000013515634,0.000080691425,0.00055336126,0.8026207],"study_design_scores_gemma":[0.0046885232,0.07238084,0.89771855,0.000017192046,0.0002238867,0.00032134564,0.00039287403,0.00001648354,0.000008081016,0.00064597797,0.02354278,0.000043465003],"about_ca_topic_score_codex":0.00040822075,"about_ca_topic_score_gemma":0.00012105795,"teacher_disagreement_score":0.80257726,"about_ca_system_score_codex":0.00015108193,"about_ca_system_score_gemma":0.00046859644,"threshold_uncertainty_score":0.20412436},"labels":[],"label_agreement":null},{"id":"W2057642187","doi":"10.5489/cuaj.1578","title":"Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Ottawa; McGill University; University of British Columbia; McMaster University","funders":"","keywords":"Medicine; Urothelial carcinoma; Guideline; Urinary system; Protocol (science); Scope (computer science); Stage (stratigraphy); Upper urinary tract; Disease; Urology; Oncology; General surgery; Surgery; Internal medicine; Cancer; Pathology; Bladder cancer; Alternative medicine","score_opus":0.030316554698684495,"score_gpt":0.2841116156911278,"score_spread":0.2537950609924433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057642187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88828796,0.000496597,0.00003502938,0.10630292,0.00043377487,0.0007980889,0.00047212534,0.000012933918,0.0031605824],"genre_scores_gemma":[0.98564106,0.00004032525,0.00059751223,0.011374695,0.0005685857,0.000050593146,0.0000446743,0.000019354658,0.0016631976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845153,0.000098175995,0.0004503048,0.0001936157,0.000241834,0.00056455773],"domain_scores_gemma":[0.99687237,0.00011282003,0.0001866977,0.00011240686,0.0016132763,0.0011024217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003630421,0.00016853472,0.00036562714,0.00021227694,0.000241888,0.000051937353,0.00011699773,0.0002345227,0.0017310702],"category_scores_gemma":[0.0009280218,0.00012934425,0.00020274277,0.00013471193,0.000028711307,0.000114700524,0.000005490868,0.00027295094,0.00005634434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053412045,0.00006354877,0.9617072,0.0000049575424,0.00010107411,0.000036701458,0.00011086549,0.0000093056005,0.00017484593,0.000057978632,0.03572461,0.00195553],"study_design_scores_gemma":[0.0016039556,0.0011910831,0.94358206,0.000009796079,0.000049286922,0.00033107842,0.00008768691,0.00012876412,0.00007561083,0.0003963865,0.052411802,0.00013247922],"about_ca_topic_score_codex":0.27735287,"about_ca_topic_score_gemma":0.040939398,"teacher_disagreement_score":0.23641348,"about_ca_system_score_codex":0.0015488219,"about_ca_system_score_gemma":0.0027095762,"threshold_uncertainty_score":0.9991815},"labels":[],"label_agreement":null},{"id":"W2057691584","doi":"10.1016/j.eururo.2007.12.026","title":"Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"World Health Organization","keywords":"Medicine; Grading (engineering); Prospective cohort study; Oncology; Internal medicine; Bladder cancer; Immunohistochemistry; Pathology; Gastroenterology; Cancer","score_opus":0.016608149045817963,"score_gpt":0.2775340917394621,"score_spread":0.2609259426936441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057691584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379086,0.0035466019,0.0000804614,0.000095708536,0.00006656716,0.000976471,0.0001571758,0.000024370473,0.001261782],"genre_scores_gemma":[0.9986459,0.00086050294,0.00005502044,0.00009429545,0.00005314656,0.00004057596,0.00003423183,0.000030260973,0.00018605172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892634,0.00015542483,0.0002588763,0.00031971364,0.00016161143,0.00017806159],"domain_scores_gemma":[0.9994665,0.00004181095,0.00016946794,0.0001223286,0.000107575084,0.00009234018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103213555,0.00014395482,0.00029009042,0.00007729487,0.0000748875,0.0000033751212,0.00003062978,0.000040609575,0.000025394953],"category_scores_gemma":[0.000042704793,0.00011854976,0.00002343092,0.000112657515,0.00021461872,0.00007289884,0.000034410874,0.00011615825,0.0000011955026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000825959,0.0008223348,0.9426626,0.000086817265,0.00037938182,0.00010204028,0.013061048,0.000004771584,0.028067047,0.0000026012922,0.0039494415,0.010035956],"study_design_scores_gemma":[0.006460605,0.008469303,0.9776369,0.00006104379,0.00034386857,0.00007062976,0.000577952,0.00005875814,0.0057629133,0.000012237845,0.00045450858,0.00009130041],"about_ca_topic_score_codex":0.00021991383,"about_ca_topic_score_gemma":0.000017960696,"teacher_disagreement_score":0.03497428,"about_ca_system_score_codex":0.000034854795,"about_ca_system_score_gemma":0.00006693544,"threshold_uncertainty_score":0.4834319},"labels":[],"label_agreement":null},{"id":"W2057853521","doi":"10.1016/j.urology.2008.09.036","title":"Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Regimen; Radiation therapy; Urology; Cisplatin; Surgery; Chemoradiotherapy; Chemotherapy; Toxicity; Cancer; Internal medicine","score_opus":0.018806261950725402,"score_gpt":0.28348371080853996,"score_spread":0.2646774488578146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057853521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363846,0.0026981544,0.00045406356,0.00095425785,0.000079164136,0.001960284,0.00011635696,0.000054676697,0.000044601733],"genre_scores_gemma":[0.9964627,0.0015217437,0.00018169291,0.0011928827,0.000092966184,0.00020820182,0.00008051591,0.00007833314,0.00018095392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775517,0.00024116292,0.00048659992,0.00065891375,0.0004124441,0.0004457215],"domain_scores_gemma":[0.9985298,0.0005421506,0.00023757256,0.00026358746,0.000212122,0.00021477875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001575379,0.00040197346,0.00093428383,0.00017005266,0.00021977203,0.000009748279,0.00007514706,0.00022328467,0.00021538649],"category_scores_gemma":[0.000073316434,0.00028718924,0.00008503995,0.00031798397,0.00039708326,0.0002024732,0.00001948625,0.00026445003,5.07036e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029441323,0.006634258,0.92869806,0.00011571701,0.0034658972,0.0001285511,0.015920157,0.000010099561,0.0035455467,0.000003241406,0.005341503,0.0066956608],"study_design_scores_gemma":[0.19448711,0.07495777,0.7190136,0.000122031095,0.0019335225,0.0001658309,0.00070081645,0.00034259865,0.0034105028,0.000045070417,0.0039275335,0.0008936605],"about_ca_topic_score_codex":0.0004910089,"about_ca_topic_score_gemma":0.0007030004,"teacher_disagreement_score":0.20968449,"about_ca_system_score_codex":0.00008552838,"about_ca_system_score_gemma":0.0005079132,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W2058331779","doi":"10.1016/j.juro.2016.10.101","title":"Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1537,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bacillus (shape); Bladder tumor; Urinary bladder; Urology; Surgery; Pathology; Internal medicine; Bladder cancer; Cancer","score_opus":0.021065903305368474,"score_gpt":0.2788720960361228,"score_spread":0.25780619273075434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058331779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234206,0.0017936097,0.000069571615,0.014921759,0.00018886323,0.00019843168,0.000011167012,0.0000027574915,0.00047178514],"genre_scores_gemma":[0.99740154,0.0011512976,0.000037884893,0.0009061574,0.00039208127,0.000004457547,5.907358e-7,0.000010683151,0.00009531162],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99885637,0.00026872993,0.0004002075,0.000072726245,0.00020491351,0.0001970678],"domain_scores_gemma":[0.99917746,0.00034664365,0.0001469378,0.00021557699,0.000063737774,0.000049651753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003685287,0.000120196055,0.0003541209,0.00010017216,0.000029507388,0.0000017385498,0.00016415678,0.00006166575,0.00023321167],"category_scores_gemma":[0.000040426898,0.000042319625,0.00012085249,0.00010673309,0.00018517392,0.000038873684,0.000010071224,0.00012848385,0.000012636272],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035882767,0.009084568,0.18289404,0.00005594295,0.003182417,0.004094992,0.034072813,0.00012492819,0.11315071,0.0008513988,0.0062953597,0.6103101],"study_design_scores_gemma":[0.037019957,0.07440056,0.76854897,0.00013406522,0.0031897456,0.014021078,0.0024014006,0.000027039412,0.027206665,0.0038777424,0.06879625,0.00037654204],"about_ca_topic_score_codex":0.00015087245,"about_ca_topic_score_gemma":0.000079853664,"teacher_disagreement_score":0.60993356,"about_ca_system_score_codex":0.00007523381,"about_ca_system_score_gemma":0.00013646047,"threshold_uncertainty_score":0.25535044},"labels":[],"label_agreement":null},{"id":"W2058841252","doi":"10.1309/ajcpprzlg9kt9axl","title":"Accuracy of Urine Cytology and the Significance of an Atypical Category","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Cytology; Biopsy; Medicine; Pathology; Clinical significance","score_opus":0.03758564563616307,"score_gpt":0.40129619243090353,"score_spread":0.36371054679474046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058841252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934891,0.00059578224,0.00041357102,0.0047679637,0.00014369414,0.0001602933,0.0000047431986,0.0000038469893,0.0004210417],"genre_scores_gemma":[0.99493843,0.0008627759,0.0018944783,0.0020320858,0.00024470597,0.0000016734913,0.0000010608761,0.000007572685,0.000017215796],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99756163,0.00066301005,0.0012901447,0.0001599425,0.00016725564,0.00015801485],"domain_scores_gemma":[0.99663216,0.0013485104,0.001351343,0.0002709952,0.00022595968,0.00017102041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011002145,0.00011143011,0.0013421411,0.000065504966,0.000019881685,0.0000017823309,0.00016268394,0.00008076808,0.000035024274],"category_scores_gemma":[0.001218794,0.00006280484,0.00023180984,0.0001276901,0.0024007985,0.000048224152,0.000020946409,0.00041595197,0.0000011788883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05404151,0.002006763,0.110770606,0.000030931365,0.0003658521,0.00079123315,0.0006925818,0.000011904683,0.0034054914,0.0018056841,0.0001883033,0.8258891],"study_design_scores_gemma":[0.01113646,0.03274075,0.94699466,0.000039005015,0.0005037816,0.002594453,0.00036470345,0.000029219278,0.0010647423,0.0038877637,0.0005589081,0.00008552233],"about_ca_topic_score_codex":0.000031979755,"about_ca_topic_score_gemma":0.0000036592678,"teacher_disagreement_score":0.8362241,"about_ca_system_score_codex":0.000008159721,"about_ca_system_score_gemma":0.00025559176,"threshold_uncertainty_score":0.8845842},"labels":[],"label_agreement":null},{"id":"W2059042560","doi":"10.1016/j.urology.2008.08.164","title":"POD-7.11: The Effect of the Patient 's Age on Bladder Cancer Immunotherapy Response and Adverse Events: MCC Experience","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Adverse effect; Immunotherapy; Adjuvant; Urothelial cancer; Population; Internal medicine; Cancer; Oncology; Immunology; Surgery","score_opus":0.011040874835607587,"score_gpt":0.2787543345097663,"score_spread":0.2677134596741587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059042560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959305,0.000926836,0.000004215991,0.0019361404,0.00028935424,0.0005733292,0.000011326319,0.0000190765,0.00030923483],"genre_scores_gemma":[0.9957102,0.0002318577,0.00000459263,0.0034495192,0.000040899995,0.00015848651,9.22608e-7,0.00002040643,0.00038314448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989719,0.00034198648,0.00014723635,0.00019022773,0.00016984079,0.00017883441],"domain_scores_gemma":[0.9992488,0.00023663745,0.000071307724,0.00038288775,0.000021279186,0.00003911161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097381664,0.00013622103,0.00021201135,0.000032468237,0.000109823064,8.5644996e-7,0.00010065543,0.0000677496,0.00013627038],"category_scores_gemma":[0.000057345682,0.000064013955,0.00008220664,0.00009333776,0.0003145951,0.000019152998,0.000035017856,0.00012588885,0.000004717967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08406598,0.0006879221,0.79133457,0.00004692503,0.0009699317,0.00045434042,0.042516287,0.00019072038,0.049217723,0.00009141634,0.0036231114,0.02680108],"study_design_scores_gemma":[0.0062440373,0.007844484,0.9145606,0.000029786577,0.00013366512,0.0002089539,0.0001441412,0.000018264387,0.026979249,0.000023450317,0.04369326,0.000120102646],"about_ca_topic_score_codex":0.00029439994,"about_ca_topic_score_gemma":0.00003098089,"teacher_disagreement_score":0.12322604,"about_ca_system_score_codex":0.000037902842,"about_ca_system_score_gemma":0.00006086587,"threshold_uncertainty_score":0.26104134},"labels":[],"label_agreement":null},{"id":"W2060168804","doi":"10.1038/modpathol.2008.193","title":"Diagnosis of urothelial carcinoma from urine","year":2009,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Urothelial carcinoma; Pathology; Medicine; Urine; Carcinoma; Urology; Internal medicine; Cancer; Bladder cancer","score_opus":0.05398519789950733,"score_gpt":0.3349439624701023,"score_spread":0.28095876457059493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060168804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011776622,0.9947147,0.00008746162,0.00006375941,0.00028212043,0.0009451565,0.0008652662,0.00005138979,0.0018125016],"genre_scores_gemma":[0.0027642313,0.9946137,0.0004326126,0.00022395488,0.00054458034,0.00029721553,0.0004679052,0.00008579992,0.0005699822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980143,0.00016060314,0.0006539681,0.00063040183,0.00021311067,0.00032765733],"domain_scores_gemma":[0.99863374,0.000109859466,0.00028662372,0.000773857,0.000058808466,0.00013713754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007134535,0.00047664842,0.0028048933,0.00019463501,0.00002944731,0.0000051237316,0.00019826632,0.0005388512,0.00041869187],"category_scores_gemma":[0.000037765854,0.00036408365,0.0006754666,0.00012593152,0.00010198453,0.000022541231,0.000068095986,0.00035365802,0.00012214578],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057359084,0.00034876846,0.00087599456,0.0021202848,0.00021655326,0.0009686468,0.00011448507,1.1975513e-7,0.000004638118,0.000011822657,0.0003432376,0.9949381],"study_design_scores_gemma":[0.002466258,0.0011320091,0.0021280092,0.0047085565,0.0065721595,0.0006096637,0.0000032562848,0.000005111504,0.000101750775,0.0010249228,0.9808082,0.0004401161],"about_ca_topic_score_codex":0.00019720416,"about_ca_topic_score_gemma":0.000014908752,"teacher_disagreement_score":0.99449795,"about_ca_system_score_codex":0.000114796,"about_ca_system_score_gemma":0.00038823302,"threshold_uncertainty_score":0.9998811},"labels":[],"label_agreement":null},{"id":"W2060982248","doi":"10.1054/modi.2001.26588","title":"Allelic deletion fingerprinting of urine cell sediments in bladder cancer","year":2001,"lang":"en","type":"article","venue":"Molecular Diagnosis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bladder cancer; Urine cytology; Biology; Urine; Allele; Cancer; Microsatellite; Genotype; Pathology; Cytology; Medicine; Genetics; Gene; Endocrinology","score_opus":0.014142908494452369,"score_gpt":0.2840923585427628,"score_spread":0.26994945004831045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060982248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930289,0.0022216837,0.00026790614,0.0010024583,0.00007523975,0.00035434403,0.000007788654,0.000022150478,0.0030195746],"genre_scores_gemma":[0.9966617,0.001301283,0.000366069,0.0011510823,0.000046142308,0.0002698862,0.000011492241,0.000027937007,0.00016441228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902356,0.000031787342,0.00024057773,0.00024039236,0.00023287763,0.00023082565],"domain_scores_gemma":[0.99957395,0.000024511546,0.00006879807,0.00020313088,0.00005464394,0.000074993004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006941865,0.00013749082,0.00023917187,0.00012835705,0.000019839577,0.0000055810274,0.00006134685,0.0000684295,0.00057794404],"category_scores_gemma":[0.000020968726,0.00013254011,0.00009416724,0.00025948934,0.000022701986,0.00003595261,0.000028016073,0.00009785665,0.000019595822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112000154,0.00089725276,0.95435375,0.00008115859,0.00015307151,0.0002738932,0.000223323,0.00026775146,0.030161187,0.000008680605,0.00056318205,0.012904722],"study_design_scores_gemma":[0.006207596,0.0003727463,0.5616323,0.0003250557,0.00035295493,0.000014729118,0.000045415727,0.00017296398,0.42353207,0.000055341243,0.007036849,0.00025203844],"about_ca_topic_score_codex":0.0014609126,"about_ca_topic_score_gemma":0.000083040366,"teacher_disagreement_score":0.39337087,"about_ca_system_score_codex":0.00009970129,"about_ca_system_score_gemma":0.000057843008,"threshold_uncertainty_score":0.6328082},"labels":[],"label_agreement":null},{"id":"W2061351979","doi":"10.1016/j.jvs.2007.01.054","title":"Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin","year":2007,"lang":"en","type":"review","venue":"Journal of Vascular Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Mycobacterium bovis; BCG vaccine; Pneumonitis; Tuberculosis; Surgery; Mycobacterium tuberculosis; Lung; Pathology; Internal medicine","score_opus":0.033509569385816444,"score_gpt":0.3084259167738757,"score_spread":0.27491634738805926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061351979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0079647275,0.98918146,0.00025008927,0.000121979545,0.0011304619,0.0011278088,0.0000796337,0.000026450689,0.000117414864],"genre_scores_gemma":[0.0021376181,0.99390835,0.00077026605,0.0005096216,0.001849763,0.00009375834,0.00006076037,0.00019916057,0.00047069258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995357,0.00030481373,0.0018599543,0.0005809763,0.0011053019,0.00079195923],"domain_scores_gemma":[0.9966487,0.00042362526,0.00079637766,0.00074215996,0.0003078241,0.0010812993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075152854,0.0010062719,0.0049335747,0.0010874498,0.00006600776,0.00008028616,0.00018086308,0.0004497354,0.0005991375],"category_scores_gemma":[0.00008466347,0.0005473009,0.0031072702,0.00061637204,0.000098861616,0.00015005025,0.000047149224,0.0009338519,0.000117564545],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014807407,0.0007434589,0.00045468772,0.006866929,0.0049298783,0.024254376,0.0001275946,5.381166e-7,0.0000060835164,2.1076565e-7,0.0009485168,0.96018696],"study_design_scores_gemma":[0.0021701,0.0028193933,0.003253525,0.015685217,0.013720319,0.018858902,0.000019937353,5.4036485e-7,0.000032523796,0.0000018146753,0.942813,0.0006247373],"about_ca_topic_score_codex":0.00004631974,"about_ca_topic_score_gemma":0.000012654932,"teacher_disagreement_score":0.95956224,"about_ca_system_score_codex":0.0012375899,"about_ca_system_score_gemma":0.0027661189,"threshold_uncertainty_score":0.99969786},"labels":[],"label_agreement":null},{"id":"W2061476777","doi":"10.3747/co.v16i3.396","title":"High-Grade Hyperinvasive Sarcomatoid Urothelial Bladder Carcinoma Demonstrating Complete Response to Bladder-Preserving Chemoradiation","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Regimen; Sarcomatoid carcinoma; Urothelial carcinoma; Radiation therapy; Urology; Bladder cancer; Carcinoma; Oncology; Urinary bladder; Biopsy; Internal medicine; Cancer","score_opus":0.08954828616958972,"score_gpt":0.3684757911729477,"score_spread":0.278927505003358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061476777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449236,0.0010741272,0.00047511465,0.010147089,0.0010379973,0.0012243906,0.000082873165,0.00016949105,0.0012965674],"genre_scores_gemma":[0.99419934,0.000052807,0.0028477593,0.0016264141,0.0009111619,0.000112206704,0.0000820476,0.00004222512,0.00012604223],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975393,0.00029918514,0.0005358684,0.0006073576,0.00038017108,0.0006381261],"domain_scores_gemma":[0.99843913,0.00026128825,0.00016735242,0.00050316646,0.0001780896,0.0004509604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002987507,0.00035386515,0.0006576863,0.00025851323,0.0002180267,0.00003800788,0.00023960274,0.00018460721,0.00026567516],"category_scores_gemma":[0.00032762633,0.00034603255,0.00016820173,0.00034238587,0.00008897242,0.00012272052,0.00008431054,0.00040078367,0.0001932344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014369487,0.004454957,0.07063291,0.00021022056,0.000649671,0.00095099676,0.007066452,0.00017098573,0.49413568,0.00096232095,0.019808136,0.3865882],"study_design_scores_gemma":[0.019857991,0.0100470735,0.8386535,0.00024374187,0.0007675862,0.0007676306,0.0007368769,0.0010355713,0.038244866,0.0010620778,0.08759947,0.0009835927],"about_ca_topic_score_codex":0.00009415565,"about_ca_topic_score_gemma":0.00004156104,"teacher_disagreement_score":0.76802063,"about_ca_system_score_codex":0.0005681611,"about_ca_system_score_gemma":0.0006659743,"threshold_uncertainty_score":0.99989915},"labels":[],"label_agreement":null},{"id":"W2062038545","doi":"10.1159/000353091","title":"Radical Cystectomy in the Elderly: National Trends and Disparities in Perioperative Outcomes and Quality of Care","year":2013,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Propensity score matching; Perioperative; Adverse effect; Bladder cancer; Emergency medicine; Surgery; Internal medicine; Urology; Cancer","score_opus":0.03131895262858616,"score_gpt":0.3378492547582788,"score_spread":0.3065303021296927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062038545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874833,0.00050309574,0.0000052390374,0.0067419875,0.00002801724,0.00017159861,0.00005096958,0.0000051460524,0.005010603],"genre_scores_gemma":[0.99868876,0.000027979851,0.00008750454,0.00082762446,0.00001903236,0.00010407458,0.00003626267,0.0000034254497,0.00020535536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927634,0.000083411185,0.0001983339,0.00012880046,0.0002389775,0.00007413399],"domain_scores_gemma":[0.99960995,0.00018779981,0.00003677495,0.00005530089,0.00008953582,0.000020636042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013133907,0.00007667902,0.0001787002,0.000121522506,0.000017900591,0.000018042854,0.000054208533,0.00004668744,0.00015162677],"category_scores_gemma":[0.00011333848,0.000046644134,0.000027061451,0.00007256491,0.00014134112,0.00007813916,0.00002254138,0.000103195736,0.0000011188582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007274262,0.000068994625,0.9884313,0.000022092448,0.000035514324,0.0000031285206,0.0020523055,0.0000015082377,0.000051644118,0.0063551664,0.00006234674,0.0028433092],"study_design_scores_gemma":[0.0020050833,0.0002629158,0.9963864,0.000014154185,0.0000082943825,0.000009535018,0.00053714565,0.00005130502,0.00004986421,0.000406758,0.00022700001,0.000041513595],"about_ca_topic_score_codex":0.003917654,"about_ca_topic_score_gemma":0.0010419715,"teacher_disagreement_score":0.011205398,"about_ca_system_score_codex":0.000043574535,"about_ca_system_score_gemma":0.00003222862,"threshold_uncertainty_score":0.5922347},"labels":[],"label_agreement":null},{"id":"W2062038960","doi":"10.1158/1538-7445.am10-lb-65","title":"Abstract LB-65: A gene expression predictor of pathological node stage of urothelial bladder cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Oncology; Lymph node; Stage (stratigraphy); Internal medicine; Pathology; Cancer; Biology","score_opus":0.08556634410160663,"score_gpt":0.4168279943365776,"score_spread":0.33126165023497095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062038960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315655,0.0012386097,0.00002616196,0.00039110973,0.00039088906,0.0008577233,0.0011167291,0.00003390453,0.0027883146],"genre_scores_gemma":[0.99424326,0.00089936785,0.0005734136,0.000086904925,0.000635764,0.00046787315,0.000018893048,0.000048347654,0.003026153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973509,0.000086726104,0.0004263939,0.00046460365,0.0011254352,0.00054596557],"domain_scores_gemma":[0.99825376,0.0001256003,0.00012832202,0.0006054963,0.00059240183,0.00029438885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052391586,0.00020024502,0.00047842343,0.00019922071,0.0000907237,0.000012743213,0.0002790073,0.00025436308,0.010516865],"category_scores_gemma":[0.00016306815,0.00014337337,0.00014873262,0.00031245314,0.00054709817,0.0000810876,0.00013247265,0.00087176077,0.000019416748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014943661,0.00044767704,0.044334594,0.00030791707,0.00010056228,0.000060501017,0.00040427575,0.000011417771,0.9472692,0.00003138678,0.0017115537,0.003826526],"study_design_scores_gemma":[0.0029874034,0.00045501144,0.114170775,0.00023207681,0.000048492206,0.0000064409537,0.000089669185,0.000012978257,0.8772732,0.00007579088,0.0045272955,0.00012083802],"about_ca_topic_score_codex":0.0024413744,"about_ca_topic_score_gemma":0.00022083762,"teacher_disagreement_score":0.06999599,"about_ca_system_score_codex":0.00011634493,"about_ca_system_score_gemma":0.0010680163,"threshold_uncertainty_score":0.9903877},"labels":[],"label_agreement":null},{"id":"W2062146824","doi":"10.1016/j.eururo.2008.05.001","title":"Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Urology; Urothelial carcinoma; Urine; Urinary system; Multicenter study; Prospective cohort study; Carcinoma; Bladder cancer; Internal medicine; Oncology; Cancer; Randomized controlled trial","score_opus":0.08350172055388473,"score_gpt":0.3657386511952072,"score_spread":0.2822369306413225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062146824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920518,0.00062074384,0.000094038915,0.000017901675,0.00024232597,0.0059499475,0.0009478045,0.0000100369125,0.000065416134],"genre_scores_gemma":[0.9993363,0.00023780137,0.00009630802,0.000025026597,0.00007988593,0.00012808619,0.00004241055,0.00003816845,0.000016031216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955137,0.0017877815,0.0013724135,0.00078258,0.00023539444,0.0003081551],"domain_scores_gemma":[0.9966555,0.0015553862,0.0006138596,0.00060595846,0.00046311095,0.00010614166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016616383,0.00029909686,0.001910993,0.0003016625,0.000037978563,0.000001892807,0.00017324147,0.00010712933,0.000029127077],"category_scores_gemma":[0.0006326477,0.00025469312,0.0005163135,0.00050827826,0.0007491319,0.000046955374,0.00013454854,0.0002166864,4.027224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12922925,0.0066563487,0.85524344,0.00040200414,0.0021729986,0.000051251012,0.0018529656,0.000021211898,0.0039915037,0.00000136215,0.0000030295973,0.00037465096],"study_design_scores_gemma":[0.0965779,0.009514365,0.8866361,0.000040479386,0.0015219917,0.0000040550003,0.00013274726,0.000087351924,0.005338486,0.000009245987,0.0000071123995,0.00013016471],"about_ca_topic_score_codex":0.0019758265,"about_ca_topic_score_gemma":0.0016383217,"teacher_disagreement_score":0.032651342,"about_ca_system_score_codex":0.00007259899,"about_ca_system_score_gemma":0.00027741707,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2062220412","doi":"10.1155/2012/486245","title":"Metastatic Transitional Cell Carcinoma of the Bladder to the Testis: A Case Report","year":2012,"lang":"en","type":"article","venue":"Case Reports in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lymphovascular invasion; Gross hematuria; Urothelium; Transitional cell carcinoma; Presentation (obstetrics); Rete testis; Urothelial carcinoma; Pathology; Urology; Urinary bladder; Epididymis; Metastasis; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.025963847173221748,"score_gpt":0.2900820450549731,"score_spread":0.26411819788175134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062220412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922473,0.0011515095,0.00012478848,0.0019311919,0.00054425676,0.0007378352,0.000022696815,0.0000095596615,0.0032308584],"genre_scores_gemma":[0.99758446,0.00000176686,0.00025274415,0.0014528229,0.0001511909,0.00012792561,0.0000071072113,0.000019381429,0.00040257457],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986273,0.000118431024,0.0005283863,0.00023943937,0.00018780645,0.00029861546],"domain_scores_gemma":[0.9988281,0.00011892537,0.00017935953,0.00065620884,0.000080316415,0.00013704746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049273163,0.00014185469,0.00027647262,0.000072147646,0.0000751553,0.0000030557615,0.00003296063,0.00006360852,0.00024812104],"category_scores_gemma":[0.00016735986,0.000079698555,0.00011574694,0.00023325953,0.00012273251,0.00003642827,0.000036265657,0.00019314776,0.0000070214846],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000729547,0.00035019472,0.0774574,0.0000312059,0.000063532745,0.9188723,0.0014945702,0.000051297386,0.00019469997,0.00002546431,0.0009840761,0.0004022963],"study_design_scores_gemma":[0.00052835216,0.0001858346,0.035067998,0.0000056335043,0.00047397052,0.9588577,0.00023443761,0.000014552709,0.0012641456,0.0000759938,0.0032226206,0.00006877088],"about_ca_topic_score_codex":0.0007437393,"about_ca_topic_score_gemma":0.0002586882,"teacher_disagreement_score":0.0423894,"about_ca_system_score_codex":0.00005112248,"about_ca_system_score_gemma":0.00024978118,"threshold_uncertainty_score":0.3250013},"labels":[],"label_agreement":null},{"id":"W2062583323","doi":"10.1016/j.juro.2008.11.111","title":"Associations Between Comorbidity, and Overall Survival and Bladder Cancer Specific Survival After Radical Cystectomy: Results From the Alberta Urology Institute Radical Cystectomy Database","year":2009,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Solar Energy Technologies Office","keywords":"Cystectomy; Medicine; Bladder cancer; Comorbidity; Urology; Urinary diversion; Database; Oncology; Internal medicine; Cancer","score_opus":0.03742191039404347,"score_gpt":0.3008359249399178,"score_spread":0.2634140145458743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062583323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9284067,0.005928436,0.00021238286,0.06298158,0.0008109791,0.00033302975,0.00071040646,0.0000132983605,0.0006031748],"genre_scores_gemma":[0.9919083,0.0027862748,0.00007102353,0.0030218319,0.0020081566,0.0000041686644,0.00008008874,0.000020930749,0.000099208424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974026,0.00080216525,0.0006907311,0.00028781933,0.00042361734,0.00039306746],"domain_scores_gemma":[0.99703735,0.0018081858,0.0003783422,0.00040247221,0.0001128154,0.0002608132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010393613,0.00026485068,0.0007590135,0.000084650186,0.00021013837,0.0000319984,0.00027214029,0.0002295181,0.00013567855],"category_scores_gemma":[0.0003008484,0.00014968887,0.000109516324,0.00013016819,0.0006502076,0.0001534943,0.000112967224,0.00095801125,0.000008323545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07197903,0.0020234226,0.82342,0.000042336527,0.010722103,0.0029460576,0.011309657,0.00013837796,0.0049894084,0.0027184684,0.04334924,0.026361894],"study_design_scores_gemma":[0.013437862,0.001429287,0.9196455,0.000025516638,0.0017084029,0.00055326364,0.000035654924,0.000030496616,0.000046043406,0.0009655616,0.061948966,0.00017345209],"about_ca_topic_score_codex":0.0029157803,"about_ca_topic_score_gemma":0.0023045563,"teacher_disagreement_score":0.09622549,"about_ca_system_score_codex":0.00008356867,"about_ca_system_score_gemma":0.00025830884,"threshold_uncertainty_score":0.6104135},"labels":[],"label_agreement":null},{"id":"W2063170049","doi":"10.1158/1535-7163.mct-06-0043","title":"Effect of an epidermal growth factor receptor tyrosine kinase inhibitor on actin remodeling in an<i>in vitro</i>bladder cancer carcinogenesis model","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Erlotinib; Epidermal growth factor receptor; Cancer research; Tyrosine-kinase inhibitor; Epidermal growth factor; MAPK/ERK pathway; Tyrosine kinase; Biology; Chemistry; Kinase; Cell biology; Molecular biology; Signal transduction; Receptor; Cancer; Biochemistry","score_opus":0.024786608915299935,"score_gpt":0.31071206138325674,"score_spread":0.2859254524679568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063170049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940492,0.0035428994,0.00033678644,0.000507407,0.0002063187,0.0009309664,0.0002664129,0.000050266357,0.0001097631],"genre_scores_gemma":[0.9967137,0.0003333079,0.0006314811,0.0015261999,0.00023178845,0.00027978115,0.00009297709,0.00013819778,0.000052571475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974445,0.0002829196,0.0005452631,0.00065104186,0.00051326334,0.0005629897],"domain_scores_gemma":[0.99899185,0.000049572533,0.00015085003,0.0005061072,0.00014523012,0.00015641899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019425702,0.000475893,0.0007367837,0.00029093816,0.000050650506,0.00002155765,0.00016743549,0.00024306861,0.000055083834],"category_scores_gemma":[0.000009004732,0.00041428243,0.00017738577,0.00041591006,0.0000713344,0.00015592595,0.00002776625,0.0003301417,0.0000024466556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053031817,0.0006365445,0.013084754,0.00016061123,0.00010272799,0.00006036001,0.00029057125,0.018151212,0.9349087,0.000011614311,0.000009401761,0.027280359],"study_design_scores_gemma":[0.0061210543,0.0011365155,0.0036849938,0.00021878065,0.0002775681,0.0000033360313,0.00001889001,0.026713038,0.9613395,0.000066391556,0.000064631284,0.00035529767],"about_ca_topic_score_codex":0.005883958,"about_ca_topic_score_gemma":0.00069115404,"teacher_disagreement_score":0.02692506,"about_ca_system_score_codex":0.00061590516,"about_ca_system_score_gemma":0.00033432632,"threshold_uncertainty_score":0.9998309},"labels":[],"label_agreement":null},{"id":"W2063204018","doi":"10.1016/j.juro.2010.02.163","title":"113 IMPACT OF HOSPITAL AND SURGEONS VOLUME ON COMPLICATION RATES AFTER RADICAL CYSTECTOMY: POPULATION BASED STUDY","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Medicine; Cystectomy; Power (physics); Art history; History","score_opus":0.010180444124398794,"score_gpt":0.3018407366795673,"score_spread":0.2916602925551685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063204018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974916,0.000074569,0.00004780728,0.0019629514,0.00014147704,0.00024162995,0.000006346231,0.0000036435856,0.00002998222],"genre_scores_gemma":[0.9996982,0.000005405751,0.000027332055,0.00015650809,0.00008682093,0.0000034593775,0.0000025754173,0.000008137235,0.000011552587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993777,0.000121078316,0.00022671964,0.000059900573,0.00012624115,0.00008832273],"domain_scores_gemma":[0.9994055,0.00011505287,0.00018096987,0.00014232536,0.00009095707,0.00006518355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028779407,0.000076038545,0.00023180839,0.00008076355,0.00002905307,0.000003552517,0.00004929977,0.000049988677,0.00013249496],"category_scores_gemma":[0.00005707291,0.000041340267,0.00006968416,0.00005504485,0.000056898887,0.000030487497,0.000008264124,0.00023355905,0.0000027931544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002499612,0.00056002586,0.9941446,0.000003873289,0.00013074005,0.000013036042,0.00023629282,0.000018156961,0.0017356344,0.0000035089581,0.00007693761,0.0005775774],"study_design_scores_gemma":[0.0024032237,0.009191309,0.98760074,0.0000060077496,0.00027164968,0.000099752244,0.00001615197,0.00015476048,0.0001145387,0.00006795738,0.00004279152,0.00003109503],"about_ca_topic_score_codex":0.00022983614,"about_ca_topic_score_gemma":0.000041873067,"teacher_disagreement_score":0.0086312825,"about_ca_system_score_codex":0.000022839466,"about_ca_system_score_gemma":0.00006792371,"threshold_uncertainty_score":0.16858073},"labels":[],"label_agreement":null},{"id":"W2063349142","doi":"10.1111/j.1464-410x.2008.08003.x","title":"Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Architecture; Medicine; Internal medicine; Computer science; Geography","score_opus":0.011901203492232611,"score_gpt":0.26815787263152246,"score_spread":0.25625666913928985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063349142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972909,0.0009394888,0.000731415,0.00035435968,0.00014232309,0.00015878738,0.00030581982,0.0000058099254,0.00007107591],"genre_scores_gemma":[0.9971809,0.00008445327,0.0010493404,0.0015338588,0.00008461547,0.0000028693448,0.000027594002,0.000009242028,0.000027130605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984369,0.00009555214,0.0006618473,0.0001733783,0.00044093176,0.00019135716],"domain_scores_gemma":[0.9988615,0.000029268458,0.00041369017,0.00013893675,0.0003849948,0.00017163201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013409098,0.0001480904,0.00081284484,0.00041268772,0.000028266322,0.000008185498,0.000133563,0.00013149309,0.00035665496],"category_scores_gemma":[0.000077104094,0.00012436551,0.00044248835,0.00024379822,0.000110596244,0.00009665822,0.000018613882,0.00028448712,8.4532195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019850507,0.0018052078,0.9708198,0.000020777916,0.0026134166,0.0005725037,0.00054515863,0.0001810736,0.00046906644,0.0000044755066,0.0001053394,0.020878177],"study_design_scores_gemma":[0.0058355913,0.002554401,0.98761487,0.000049871473,0.0025911345,0.00070069137,0.000013957777,0.000066271314,0.000226322,0.00009880849,0.00017016254,0.00007789731],"about_ca_topic_score_codex":0.00013645027,"about_ca_topic_score_gemma":0.00013958411,"teacher_disagreement_score":0.02080028,"about_ca_system_score_codex":0.000048250266,"about_ca_system_score_gemma":0.00018819986,"threshold_uncertainty_score":0.50714785},"labels":[],"label_agreement":null},{"id":"W2063695170","doi":"10.1007/s00345-012-0832-2","title":"Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; Western University; McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphovascular invasion; Urology; Internal medicine; Stage (stratigraphy); Nephrology; Chemotherapy; Pathological; Carcinoma; Hydronephrosis; Cancer; Oncology; Gastroenterology; Metastasis; Urinary system","score_opus":0.034763360491921164,"score_gpt":0.3749431397911097,"score_spread":0.3401797792991885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063695170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967878,0.0044693537,0.00065743906,0.01913123,0.005559307,0.001623057,0.0001060701,0.000038190155,0.00053736405],"genre_scores_gemma":[0.98178667,0.0014701445,0.0013905951,0.010747523,0.0036163656,0.00010008489,0.000008683728,0.00005966527,0.0008202579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996806,0.00031817454,0.0014515155,0.00033762574,0.00038904743,0.00069759344],"domain_scores_gemma":[0.99413115,0.0030843797,0.0008372405,0.0003800251,0.00033072647,0.0012364615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011650457,0.00032839391,0.001284246,0.00026415192,0.000115974275,0.000016249161,0.00026605246,0.00020568022,0.0005421797],"category_scores_gemma":[0.0020109494,0.00020092742,0.0010761605,0.00018088397,0.00036713376,0.00018189583,0.00007521105,0.0007368159,0.00003714857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006445643,0.0013963119,0.9659846,0.00010444624,0.0016099697,0.00030143044,0.0001952694,0.0000052573214,0.00018230085,0.000054599375,0.007856438,0.015863732],"study_design_scores_gemma":[0.016475262,0.0032406766,0.92608905,0.000116944386,0.0029437223,0.00013172092,0.0000401202,0.000008067717,0.00011903892,0.000299459,0.050298378,0.0002375464],"about_ca_topic_score_codex":0.000025106923,"about_ca_topic_score_gemma":0.0001865361,"teacher_disagreement_score":0.042441938,"about_ca_system_score_codex":0.00012889446,"about_ca_system_score_gemma":0.001384898,"threshold_uncertainty_score":0.8193582},"labels":[],"label_agreement":null},{"id":"W2063805596","doi":"10.1038/labinvest.2008.27","title":"Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy","year":2008,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Biology; Bladder cancer; Urothelium; Cancer; Genetics; Genome; Cancer research; Gene; Computational biology; Anatomy","score_opus":0.16899049853216272,"score_gpt":0.3120489775664694,"score_spread":0.14305847903430666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063805596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977571,0.00048405176,0.00085917313,0.00020614074,0.00006983814,0.00029941704,0.000035196175,0.000032803353,0.0002563146],"genre_scores_gemma":[0.998648,0.000013792738,0.0006295081,0.00041591784,0.000087977576,0.000023639739,0.00004446262,0.000025489313,0.00011122034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990723,0.00004869579,0.00030515133,0.00017965413,0.00022847466,0.00016572818],"domain_scores_gemma":[0.9994817,0.000012809867,0.00015312264,0.00015819911,0.00010237958,0.000091807175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115115385,0.00013610357,0.0001754715,0.00006464871,0.00037975883,0.000012244986,0.00006128918,0.00006679396,0.00006455483],"category_scores_gemma":[0.000007747445,0.000106670974,0.000025238609,0.00032588412,0.00019786308,0.000104074476,0.000015613434,0.000113479015,0.000004844097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011962269,0.00003216266,0.06100276,0.000051399333,0.00016006645,0.0000035490186,0.008322021,0.00006221455,0.9293485,0.000099767996,0.00080271985,0.00010283447],"study_design_scores_gemma":[0.004482329,0.0002708359,0.18536496,0.0005906032,0.00040780523,0.0000260811,0.009548045,0.00062688615,0.7944847,0.001117811,0.0024512184,0.0006287725],"about_ca_topic_score_codex":0.00009806157,"about_ca_topic_score_gemma":0.00006247649,"teacher_disagreement_score":0.13486388,"about_ca_system_score_codex":0.00051572686,"about_ca_system_score_gemma":0.0010763324,"threshold_uncertainty_score":0.4349916},"labels":[],"label_agreement":null},{"id":"W2063844943","doi":"10.1159/000369357","title":"Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus","year":2014,"lang":"en","type":"review","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Urine cytology; Disease; Cancer; Gold standard (test); Molecular diagnostics; Intensive care medicine; Urinary system; Internal medicine; Bioinformatics","score_opus":0.043931641973994046,"score_gpt":0.3601680913910242,"score_spread":0.3162364494170301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063844943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043953306,0.9922782,0.00028555986,0.0022726315,0.00045461796,0.0021288586,0.0010690033,0.000051884104,0.0010196642],"genre_scores_gemma":[0.0013345518,0.9916132,0.00019203828,0.0020004718,0.0004982577,0.0027733333,0.00031581664,0.00008436854,0.0011879606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816537,0.00018073384,0.00046285274,0.0005452244,0.00034305404,0.00030275798],"domain_scores_gemma":[0.9980841,0.0008804951,0.00032718034,0.00036279703,0.00023270263,0.00011267618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033641554,0.00042919547,0.0010932094,0.00012187231,0.00009700365,0.00006739222,0.00025612692,0.0002889399,0.00025243778],"category_scores_gemma":[0.00031284758,0.00026481404,0.00045824616,0.00011383157,0.00021413252,0.00002062767,0.0000868167,0.00031236417,0.000011851923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029597283,0.000095593285,0.016620662,0.0030481457,0.005929509,0.00006261016,0.00006222826,0.000005970151,4.1990776e-7,0.0011450639,0.060756605,0.91197723],"study_design_scores_gemma":[0.001075069,0.00033411157,0.0027074032,0.0013116586,0.0013225317,0.00007224401,0.0000035594776,0.00004327277,0.000002925277,0.00008295572,0.9927951,0.0002491768],"about_ca_topic_score_codex":0.00064232555,"about_ca_topic_score_gemma":0.00007617244,"teacher_disagreement_score":0.9320385,"about_ca_system_score_codex":0.00009483973,"about_ca_system_score_gemma":0.00018929962,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W2064595093","doi":"10.5489/cuaj.10118","title":"Micropapillary carcinoma of the bladder presented with spontaneous intraperitoneal bladder rupture","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Etiology; Perforation; Presentation (obstetrics); Bladder rupture; Urinary bladder; Carcinoma; Surgery; Pathology","score_opus":0.008235630341893297,"score_gpt":0.21157088053455056,"score_spread":0.20333525019265727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064595093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983037,0.0010295066,0.0000056551644,0.012268536,0.00038071003,0.00027330674,0.000052834584,0.000011278356,0.0029411654],"genre_scores_gemma":[0.9941852,0.000031747524,0.000094609364,0.0040520723,0.00074003096,0.000006509176,0.000009909399,0.000017781298,0.0008621477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984534,0.00015836053,0.0002555671,0.00012748664,0.00044995476,0.0005552747],"domain_scores_gemma":[0.99867475,0.000060170376,0.0002085541,0.00015815112,0.00025856183,0.00063979905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022730189,0.00016002923,0.00026439785,0.00007613837,0.00021498323,0.000026356434,0.00013058796,0.00024745526,0.000736031],"category_scores_gemma":[0.00012632695,0.000088847126,0.00014218758,0.0002113023,0.00007330326,0.000077485696,0.000016080903,0.00061885343,0.000015168455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017931679,0.00011076854,0.9895973,0.0000045420834,0.00036188742,0.00024548898,0.00035001207,0.0000054427683,0.0005579379,0.000033206667,0.008058157,0.0004959239],"study_design_scores_gemma":[0.0012309314,0.0003855698,0.9540845,0.000011686148,0.0002910779,0.005763632,0.00012822979,0.000007644824,0.00041367704,0.000029584991,0.037548356,0.00010508627],"about_ca_topic_score_codex":0.0015869664,"about_ca_topic_score_gemma":0.0008693554,"teacher_disagreement_score":0.03551279,"about_ca_system_score_codex":0.00060239696,"about_ca_system_score_gemma":0.000680181,"threshold_uncertainty_score":0.8059023},"labels":[],"label_agreement":null},{"id":"W2064988955","doi":"10.1016/j.eururo.2012.10.008","title":"A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Center for Advancing Translational Sciences; National Institutes of Health","keywords":"Medicine; Cystectomy; Bladder cancer; Surgical pathology; Dissection (medical); General surgery; Lymph node; Anatomical pathology; Cancer; Pathology; Surgery; Immunohistochemistry; Internal medicine","score_opus":0.08446840903479175,"score_gpt":0.37118038104542417,"score_spread":0.2867119720106324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064988955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012129728,0.98144335,0.00012430413,0.0006267353,0.0010245828,0.0020182866,0.0014033664,0.00009854222,0.013139537],"genre_scores_gemma":[0.0046420726,0.9905416,0.00008016776,0.0013025652,0.001995531,0.00025892677,0.00039003335,0.000215318,0.0005738084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684894,0.0010291896,0.0006000956,0.00074046984,0.00024383003,0.00053749396],"domain_scores_gemma":[0.9987796,0.00018985664,0.00023717819,0.00041889635,0.00009052623,0.00028395408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077512517,0.00054636126,0.0017832128,0.00024115285,0.000116105555,0.000015381464,0.00012987135,0.0003619074,0.000322182],"category_scores_gemma":[0.000052361404,0.0004076537,0.00038413514,0.000121304845,0.00030228533,0.00004145079,0.000047006848,0.0007086273,0.00007183275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003314936,0.0002811315,0.00006291045,0.00540792,0.0015341707,0.000999353,0.00022879578,2.3120586e-7,0.000006191834,0.00016560328,0.020374889,0.9676239],"study_design_scores_gemma":[0.004456548,0.003382451,0.0001437699,0.00067828153,0.002818093,0.0008348874,0.0000049568152,9.355379e-7,0.0000032916441,0.000013735672,0.9873741,0.00028892932],"about_ca_topic_score_codex":0.000016019285,"about_ca_topic_score_gemma":0.000012475396,"teacher_disagreement_score":0.9673349,"about_ca_system_score_codex":0.000171625,"about_ca_system_score_gemma":0.00056962133,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W2065064543","doi":"10.5489/cuaj.212","title":"The incidence of prostate cancer and urothelial cancer in the prostate in cystoprostatectomy specimens in a tertiary care Canadian centre","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cystoprostatectomy; Medicine; Prostate cancer; Urology; Bladder cancer; Prostate; Cystectomy; Prostatectomy; Cancer; Perineural invasion; Oncology; Gynecology; Internal medicine","score_opus":0.005970019552997066,"score_gpt":0.23448352298797567,"score_spread":0.22851350343497862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065064543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9310045,0.0026985426,6.171528e-8,0.06439796,0.00013496025,0.0011434443,0.00017601559,0.000003359297,0.00044114175],"genre_scores_gemma":[0.9940851,0.0013639063,0.000008256324,0.003996672,0.00010261511,0.00018627649,0.0000065714626,0.000012447406,0.00023815721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981085,0.00023216075,0.0004370533,0.00021033837,0.00029941357,0.0007125258],"domain_scores_gemma":[0.9989921,0.00012318381,0.00017185701,0.000112957394,0.000199335,0.00040058687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048257833,0.00016422091,0.0002508252,0.00024594725,0.00017823323,0.00009237976,0.00015581647,0.00014037472,0.00022820309],"category_scores_gemma":[0.00016600972,0.000096593365,0.000047921334,0.00036419177,0.000077459124,0.00012652781,0.000013197617,0.0006708222,0.00000581299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055846063,0.000018153945,0.98391056,0.000010459056,0.000023528812,0.00016505548,0.0062196115,0.00004987448,0.000043848595,0.000014698189,0.0006779046,0.008810463],"study_design_scores_gemma":[0.0018585469,0.00009513714,0.98920214,0.00009109552,0.000022134234,0.000035387173,0.0018752195,0.000057376757,0.000025995483,0.00034220025,0.006293999,0.00010074497],"about_ca_topic_score_codex":0.76466197,"about_ca_topic_score_gemma":0.9640873,"teacher_disagreement_score":0.19942531,"about_ca_system_score_codex":0.0026815215,"about_ca_system_score_gemma":0.0022098105,"threshold_uncertainty_score":0.7012086},"labels":[],"label_agreement":null},{"id":"W2065153594","doi":"10.1016/j.eururo.2006.06.010","title":"Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Cystectomy; Stage (stratigraphy); Lymphadenectomy; Bladder cancer; Multivariate analysis; Multivariate statistics; Urology; T-stage; Logistic regression; Lymph node; Oncology; Surgery; Cancer; Internal medicine; Statistics; Mathematics","score_opus":0.01630425556545365,"score_gpt":0.27568795261437345,"score_spread":0.2593836970489198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065153594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8776273,0.0026190716,0.004209361,0.000936825,0.0009901596,0.002062286,0.00104864,0.00026896782,0.1102374],"genre_scores_gemma":[0.99175435,0.000041756037,0.00058891537,0.00036508733,0.00043468858,0.00009130294,0.00011448204,0.000048774727,0.0065606222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991089,0.00006857188,0.0002558384,0.0002519812,0.00009435988,0.00022033072],"domain_scores_gemma":[0.999498,0.000037804693,0.00010251751,0.00021564026,0.00009529107,0.000050728217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009692398,0.00012681494,0.00022670852,0.000069784684,0.000037661266,0.000003406616,0.00006169947,0.000043688906,0.00021850946],"category_scores_gemma":[0.000019846348,0.000108773434,0.0000924291,0.00008639941,0.00007080637,0.00003635169,0.000020011032,0.00007945772,0.000017327015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016396932,0.004178258,0.44915405,0.0013290878,0.0024593852,0.0003468518,0.0015464288,0.004840436,0.23973134,0.0038183841,0.055147056,0.2210518],"study_design_scores_gemma":[0.012992617,0.00390921,0.5049829,0.000025874546,0.0005259524,0.000036971367,0.00003340002,0.0002481729,0.010371378,0.00014011901,0.46656314,0.00017029696],"about_ca_topic_score_codex":0.00009242263,"about_ca_topic_score_gemma":0.00003458275,"teacher_disagreement_score":0.41141605,"about_ca_system_score_codex":0.000029942417,"about_ca_system_score_gemma":0.000052320513,"threshold_uncertainty_score":0.4435652},"labels":[],"label_agreement":null},{"id":"W2065184640","doi":"10.1097/mou.0b013e32832c9178","title":"Management of pediatric neurogenic bladder","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bladder augmentation; Intensive care medicine; Neurogenic bladder dysfunction; Population; Urinary system; Anticholinergic; Urinary bladder; Surgery; Internal medicine","score_opus":0.10586938832368652,"score_gpt":0.41298882163675593,"score_spread":0.3071194333130694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065184640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007789167,0.99368626,0.000013993004,0.000044119923,0.004012922,0.0012132445,0.000032869175,0.000029000297,0.0009597782],"genre_scores_gemma":[0.00003433939,0.998614,0.000036312627,0.000023803588,0.0008023348,0.00016039754,0.00022369267,0.000039646122,0.00006548956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980238,0.00013927465,0.0007793915,0.00050780823,0.00021296808,0.00033676726],"domain_scores_gemma":[0.9990705,0.000047628553,0.00029346187,0.00045796295,0.00003229573,0.000098151526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010065841,0.00037335884,0.0014370836,0.00048584267,0.000015841693,0.0000035914625,0.00019250954,0.0002470652,0.00015258144],"category_scores_gemma":[0.000007712541,0.00030693243,0.0004340183,0.00052226894,0.000043314623,0.000020672927,0.00008035481,0.0004532138,0.000108506756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003499774,0.00050171145,0.00016404875,0.01733797,0.0002898182,0.000022751992,0.000011929552,4.4086136e-7,5.2106994e-9,0.00026257164,0.0020978148,0.97927594],"study_design_scores_gemma":[0.0011819936,0.0004747975,0.00070978736,0.0014017599,0.0024894061,0.00007195187,0.0000014219245,0.0000012759269,4.8095792e-8,0.0000789634,0.9934175,0.00017110184],"about_ca_topic_score_codex":0.0000022045137,"about_ca_topic_score_gemma":1.4739804e-7,"teacher_disagreement_score":0.99131966,"about_ca_system_score_codex":0.00007574406,"about_ca_system_score_gemma":0.00021101067,"threshold_uncertainty_score":0.99993825},"labels":[],"label_agreement":null},{"id":"W2065521889","doi":"10.1016/j.ejca.2011.11.024","title":"Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Cystectomy; Medicine; Survivorship curve; Urology; Urinary diversion; Bladder cancer; Proportional hazards model; Overall survival; Oncology; Internal medicine; Survival rate; Cancer","score_opus":0.019820169217201592,"score_gpt":0.23461291856718805,"score_spread":0.21479274934998646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065521889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902698,0.0003201707,0.0000606259,0.00008470391,0.00013272798,0.00024019243,0.00012198718,0.0000047598814,0.00876507],"genre_scores_gemma":[0.99916357,0.000016638434,0.00019152752,0.00009266428,0.00018397854,0.0000026425832,0.0000048767497,0.00004066469,0.0003034163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848336,0.0002068062,0.00041196225,0.00012144574,0.00062593067,0.0001505197],"domain_scores_gemma":[0.9986549,0.000021131524,0.00049622415,0.00019746466,0.0005048353,0.00012543195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001462043,0.00016174268,0.0003673943,0.000077801764,0.000038675007,0.0000032801934,0.00016576218,0.000021251293,0.000710453],"category_scores_gemma":[0.000012141943,0.00007974394,0.00013008219,0.00016056457,0.0003216877,0.000072656745,0.000024054136,0.00019524904,0.000002423488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087986635,0.00073749415,0.98720545,0.000046277688,0.00077915774,0.00023647607,0.0005774558,0.000007812931,0.00032415122,0.000026063219,0.0002996506,0.0009613788],"study_design_scores_gemma":[0.012034853,0.0049370686,0.9741662,0.00025869388,0.00058255275,0.00012017711,0.000055280172,0.0000010348122,0.006714415,0.0000060380708,0.001037336,0.00008636458],"about_ca_topic_score_codex":0.00006143616,"about_ca_topic_score_gemma":0.0000068119407,"teacher_disagreement_score":0.013039232,"about_ca_system_score_codex":0.00005387504,"about_ca_system_score_gemma":0.00036345178,"threshold_uncertainty_score":0.7778962},"labels":[],"label_agreement":null},{"id":"W2066075018","doi":"10.5489/cuaj.09101","title":"Renal and functional outcomes following cystectomy and neobladder reconstruction","year":2010,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cystectomy; Medicine; Hydronephrosis; Urology; Creatinine; Renal function; Urinary diversion; Urinary system; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.01125325225581882,"score_gpt":0.22995850090115483,"score_spread":0.218705248645336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066075018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853332,0.00011854296,0.000033351716,0.011514331,0.0007708928,0.000108922024,0.000010658427,0.000017845521,0.002092238],"genre_scores_gemma":[0.9963885,0.000017026621,0.00042667962,0.0022339078,0.00033478226,0.0000057666084,0.0000056526987,0.0000075563876,0.0005801113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991878,0.000042426193,0.00018227533,0.00015116468,0.00019165555,0.00024467343],"domain_scores_gemma":[0.99914914,0.000077181554,0.000092517694,0.00005062205,0.00008411971,0.00054642797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027854883,0.00010417892,0.00019346036,0.00011745756,0.00029519308,0.00008006693,0.000021054295,0.00019609327,0.0005425945],"category_scores_gemma":[0.00029706483,0.00007813741,0.00008191789,0.000069497735,0.000032836033,0.00011573464,0.0000072535704,0.00054682925,0.000010726218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020463598,0.000009531343,0.98766345,0.0000013147185,0.00015322823,0.000038177295,0.000034814617,3.967342e-7,0.00047828263,0.000081060214,0.000715061,0.010804216],"study_design_scores_gemma":[0.0017079497,0.00011265492,0.985889,0.0000058120227,0.00012214847,0.0011748298,0.000033131055,0.000022652173,0.0000179606,0.001012812,0.009821819,0.00007921456],"about_ca_topic_score_codex":0.00052117207,"about_ca_topic_score_gemma":0.0011157993,"teacher_disagreement_score":0.011055299,"about_ca_system_score_codex":0.00017786345,"about_ca_system_score_gemma":0.0002471129,"threshold_uncertainty_score":0.594103},"labels":[],"label_agreement":null},{"id":"W2067530428","doi":"10.1007/s00345-010-0594-7","title":"Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma","year":2010,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Lymphovascular invasion; Interquartile range; Proportional hazards model; Internal medicine; Oncology; Urology; Stage (stratigraphy); Cancer; Cohort; Cystectomy; Nephrology; Lymph node; Bladder cancer; Metastasis","score_opus":0.02902874535196696,"score_gpt":0.2937832027499204,"score_spread":0.26475445739795345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067530428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180716,0.0006988814,0.00019883859,0.004053031,0.0014280871,0.0002726354,0.000009485337,0.000007402747,0.001524502],"genre_scores_gemma":[0.99511516,0.000039404178,0.0013415336,0.0017099353,0.0014653471,0.000013959232,0.0000023639723,0.000020779771,0.00029152996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989033,0.000060097,0.00041455228,0.00015374244,0.00017505365,0.00029326195],"domain_scores_gemma":[0.99928075,0.00018588775,0.00015225598,0.00013022915,0.000080008314,0.00017086204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022981326,0.00014642534,0.0004661741,0.0003518866,0.0000350818,0.0000105683475,0.00013001193,0.000119782744,0.0006253343],"category_scores_gemma":[0.00007782552,0.0001033239,0.00021020274,0.000116035866,0.00012244248,0.000062833096,0.000012560612,0.00064034475,0.000005665554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030330475,0.0005209014,0.9735535,0.000023557079,0.0001312562,0.00033989287,0.00040525696,6.790002e-7,0.008765026,0.000491494,0.0017884345,0.010946977],"study_design_scores_gemma":[0.008728724,0.0016493659,0.9066539,0.000010163067,0.00023034916,0.0018124514,0.000022018387,0.00003985882,0.0006014869,0.0012122992,0.07892914,0.00011027594],"about_ca_topic_score_codex":0.000026003283,"about_ca_topic_score_gemma":0.00013018228,"teacher_disagreement_score":0.077140704,"about_ca_system_score_codex":0.000030932668,"about_ca_system_score_gemma":0.00028363627,"threshold_uncertainty_score":0.6846972},"labels":[],"label_agreement":null},{"id":"W2067710309","doi":"10.5489/cuaj.1690","title":"A rare case of testicular metastasis of bladder transitional cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Transitional cell carcinoma; Metastasis; Prostate; Urinary bladder; Pathology; Differential diagnosis; Urology; Bladder cancer; Cancer; Internal medicine","score_opus":0.012798863855996614,"score_gpt":0.22710164711324993,"score_spread":0.21430278325725333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067710309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915047,0.0002850421,0.0002615432,0.0030781964,0.000094984716,0.00013362466,0.00021508278,0.000005906244,0.00442089],"genre_scores_gemma":[0.9980539,0.0000073903034,0.0005710679,0.0010450897,0.00015301423,0.0000038297867,0.00001853084,0.000008536218,0.00013861335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998929,0.00014542746,0.00032373524,0.00011582738,0.00024808242,0.00023792197],"domain_scores_gemma":[0.9987699,0.00012624286,0.0002168203,0.0000849042,0.0003582275,0.0004439452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032917873,0.00010180076,0.00030726302,0.00013520547,0.000089339854,0.0000094579445,0.0000497701,0.0001339684,0.0016850993],"category_scores_gemma":[0.00024398658,0.00008011536,0.00018509687,0.00014695537,0.000036365454,0.00004000131,0.0000038142055,0.00022252343,0.00001217878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021220939,0.0004133761,0.9803223,0.000064513275,0.0005059116,0.002268488,0.0004925095,0.000109146706,0.0020272185,0.00040651573,0.008445216,0.0047325743],"study_design_scores_gemma":[0.008125287,0.0026839639,0.958193,0.00003148149,0.0018400763,0.008840098,0.00022292377,0.00052344904,0.005125067,0.0014663074,0.0126449065,0.00030341384],"about_ca_topic_score_codex":0.0017903602,"about_ca_topic_score_gemma":0.0003216689,"teacher_disagreement_score":0.022129294,"about_ca_system_score_codex":0.00025059123,"about_ca_system_score_gemma":0.00045137154,"threshold_uncertainty_score":0.9992275},"labels":[],"label_agreement":null},{"id":"W2068523052","doi":"10.1038/nature12965","title":"Comprehensive molecular characterization of urothelial bladder carcinoma","year":2014,"lang":"en","type":"article","venue":"Nature","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3055,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Center for Advancing Translational Sciences; National Cancer Institute; National Human Genome Research Institute; Massachusetts Institute of Technology; Dan L. Duncan Cancer Center, Baylor College of Medicine; School of Medicine, Indiana University; University of California, San Diego; National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Brigham and Women's Hospital; University of North Carolina at Chapel Hill; Broad Institute; National Institute of Dental and Craniofacial Research; Research Institute, Nationwide Children's Hospital; Memorial Sloan-Kettering Cancer Center; University of Texas Southwestern Medical Center; Cleveland Clinic Foundation; Cleveland Clinic; University of Chicago; Harvard University; University of Pittsburgh; Nationwide Children's Hospital; SRA International; University of Miami","keywords":"Cancer research; Biology; microRNA; Chromatin; Gene; Targeted therapy; PI3K/AKT/mTOR pathway; Cancer; Genetics; Signal transduction","score_opus":0.00806371073911861,"score_gpt":0.25925010457823433,"score_spread":0.25118639383911573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068523052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942717,0.0002574367,0.0003285589,0.00068646105,0.0002342743,0.00027543586,0.000037420326,0.000029553545,0.0038791597],"genre_scores_gemma":[0.9966241,0.000011981687,0.00020356782,0.002454719,0.00019843774,0.000008778554,0.000105151885,0.0000208559,0.0003723841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993647,0.00002888466,0.00012084042,0.00016079795,0.00020863728,0.00011616315],"domain_scores_gemma":[0.9995022,0.000011946142,0.00005393268,0.00021233835,0.00015797479,0.0000616538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023129856,0.00010847868,0.00020110905,0.000054705397,0.000020906595,0.000004573175,0.000051048122,0.00042699615,0.00012706198],"category_scores_gemma":[0.000017661021,0.000088003384,0.000076115844,0.000100981495,0.000033005424,0.000031154847,0.000015022333,0.00044167956,0.00001876417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002567699,0.00011740215,0.013743186,0.000098711236,0.00010859333,0.000018488523,0.00017313102,8.8931364e-7,0.97936493,0.00081906177,0.0002448562,0.0050539714],"study_design_scores_gemma":[0.0030292706,0.00048810284,0.48024127,0.000049621012,0.00019240855,0.00003474018,0.000012884069,0.00011115564,0.48275092,0.00015382539,0.03280366,0.00013214105],"about_ca_topic_score_codex":0.000012285244,"about_ca_topic_score_gemma":4.4534357e-7,"teacher_disagreement_score":0.496614,"about_ca_system_score_codex":0.000019314572,"about_ca_system_score_gemma":0.00004662741,"threshold_uncertainty_score":0.35886738},"labels":[],"label_agreement":null},{"id":"W2068816549","doi":"10.1038/sc.2013.33","title":"Bladder cancer in individuals with spinal cord injuries","year":2013,"lang":"en","type":"review","venue":"Spinal Cord","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St Joseph's Health Care; Lawson Health Research Institute; St. Joseph's Hospital","funders":"","keywords":"Medicine; Bladder cancer; Spinal cord injury; Epidemiology; Cancer; CINAHL; Population; Intensive care medicine; Internal medicine; Psychological intervention; Spinal cord; Psychiatry","score_opus":0.08919826337614266,"score_gpt":0.41409274034730714,"score_spread":0.32489447697116447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068816549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068669353,0.9927311,0.0000067314472,0.0002072017,0.00038535005,0.0025165025,0.00020256752,0.00007305194,0.003190832],"genre_scores_gemma":[0.0008592785,0.99202406,0.00043461495,0.0003366693,0.00066921324,0.0016208433,0.00010419575,0.00014399744,0.0038071135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713665,0.000099660196,0.00072882854,0.00077106414,0.0006032984,0.00066047534],"domain_scores_gemma":[0.99860096,0.00002246571,0.00038105904,0.0005837369,0.00013363168,0.00027813765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012881919,0.00081973884,0.0024716516,0.00042173124,0.000080087404,0.000071061295,0.00028694776,0.00037455957,0.0015790696],"category_scores_gemma":[0.00002075065,0.0005376054,0.0003331165,0.00066580577,0.00020522423,0.00013750877,0.00010286429,0.0008511891,0.0004164932],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015117541,0.00015240995,0.0016335349,0.007426797,0.0007144767,0.00011838638,0.00001424179,3.121371e-8,2.966277e-7,0.00005210514,0.0019166968,0.98645926],"study_design_scores_gemma":[0.0014030435,0.015532268,0.0044962955,0.03260002,0.0027919086,0.00018272326,0.00003557199,1.2693353e-7,0.0000044557733,0.000051113733,0.94231486,0.00058760506],"about_ca_topic_score_codex":0.001318138,"about_ca_topic_score_gemma":0.00025114563,"teacher_disagreement_score":0.9858717,"about_ca_system_score_codex":0.0004300319,"about_ca_system_score_gemma":0.0016117938,"threshold_uncertainty_score":0.9997075},"labels":[],"label_agreement":null},{"id":"W2069085243","doi":"10.5489/cuaj.11094","title":"Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Transitional cell carcinoma; Transitional Cell; Urothelium; Metaplasia; Urothelial Cell; Pathology; Carcinoma; Medicine; Cancer; Bladder cancer; Urinary bladder; Urology; Internal medicine","score_opus":0.013814693265240707,"score_gpt":0.23892769122522742,"score_spread":0.2251129979599867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069085243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8952927,0.065661125,0.000018827777,0.035534497,0.00082777656,0.0005748578,0.00023285429,0.000009378198,0.001848007],"genre_scores_gemma":[0.9942992,0.0012081332,0.00007722145,0.003800206,0.00034111895,0.000009159975,0.000028000497,0.000007117418,0.00022987816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879575,0.00021116277,0.00033574904,0.000114457784,0.0002563932,0.00028648542],"domain_scores_gemma":[0.9987958,0.00005466183,0.0002566129,0.00010969297,0.0002364717,0.00054677046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005480348,0.000112926384,0.00024624847,0.000052823365,0.00017240632,0.000020550127,0.000044203218,0.00014408889,0.0002329059],"category_scores_gemma":[0.0002239099,0.00006853544,0.0001440982,0.00020119007,0.00002638456,0.00007317553,0.000007461102,0.00041196018,0.0000024482076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012111434,0.00041182264,0.90077734,0.00035040863,0.00031082876,0.048927076,0.0012551768,0.0000010995058,0.00009842195,0.00020539522,0.04313049,0.004410846],"study_design_scores_gemma":[0.0011522179,0.00021147114,0.69924366,0.00025677154,0.0005495077,0.28121167,0.00004439733,0.000007318598,0.000040622715,0.00008689988,0.017091349,0.000104094885],"about_ca_topic_score_codex":0.00027857308,"about_ca_topic_score_gemma":0.00018988426,"teacher_disagreement_score":0.23228459,"about_ca_system_score_codex":0.00030575038,"about_ca_system_score_gemma":0.00042039136,"threshold_uncertainty_score":0.2794794},"labels":[],"label_agreement":null},{"id":"W2070044025","doi":"10.1111/j.1464-410x.2008.07524.x","title":"Adjuvant chemotherapy for bladder cancer does not alter cancer‐specific survival after cystectomy in a matched case‐control study","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Gemcitabine; Internal medicine; Oncology; Vinblastine; Lymphovascular invasion; Cancer; Proportional hazards model; Chemotherapy; Urology; Survival analysis; Metastasis","score_opus":0.020545649039006627,"score_gpt":0.29558543136568804,"score_spread":0.2750397823266814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070044025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144233,0.013633064,0.0002162832,0.0022505936,0.00096445554,0.0011479497,0.0002929515,0.000014442132,0.00003790122],"genre_scores_gemma":[0.99166024,0.0038411254,0.00012359071,0.0024977792,0.0011393457,0.00039123397,0.0000014518374,0.00006035106,0.00028486643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802935,0.00016957667,0.0007219425,0.00032700115,0.00029073088,0.00046141207],"domain_scores_gemma":[0.9989719,0.00012247358,0.0002592697,0.00016966295,0.00029897428,0.00017776944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032688136,0.00023495837,0.00097392494,0.00017479391,0.00008301329,0.000020763975,0.00012063107,0.0001409701,0.0009993388],"category_scores_gemma":[0.000023491519,0.00019406012,0.0002343427,0.00012997625,0.00011203134,0.00011059414,0.000015232058,0.00038966737,0.0000029249015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030243414,0.0035265884,0.6739051,0.00010530919,0.0033084468,0.16722932,0.004288534,0.00011577011,0.0028697904,0.0000023640775,0.0021936065,0.11221177],"study_design_scores_gemma":[0.06464149,0.0036733118,0.86189973,0.0001263571,0.0006781916,0.06385042,0.00046876806,0.000041458927,0.00060386234,0.00005202729,0.0036403278,0.00032407328],"about_ca_topic_score_codex":0.0020537823,"about_ca_topic_score_gemma":0.006503514,"teacher_disagreement_score":0.18799464,"about_ca_system_score_codex":0.00017171883,"about_ca_system_score_gemma":0.00032018157,"threshold_uncertainty_score":0.9999139},"labels":[],"label_agreement":null},{"id":"W2070107163","doi":"10.1097/01.coc.0000200044.81711.57","title":"A Phase I Dose Finding Study of Cisplatin, Gemcitabine, and Weekly Docetaxel for Patients With Advanced Transitional Cell Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Cisplatin; Oncology; Internal medicine; Chemotherapy","score_opus":0.03829447789951697,"score_gpt":0.4331444057135976,"score_spread":0.3948499278140806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070107163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977782,0.00015208885,0.00031990488,0.0006286403,0.0001662045,0.00059539103,0.00006431852,0.0000039781753,0.00029130498],"genre_scores_gemma":[0.99348503,0.00007806471,0.0056943307,0.00034877597,0.00028366654,0.000029458448,0.000008269379,0.000018787461,0.000053620683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981143,0.000116502066,0.0011279756,0.00019139479,0.0002686784,0.00018113833],"domain_scores_gemma":[0.9973596,0.00072563346,0.001210619,0.00009268569,0.00044107216,0.00017040159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030383162,0.00014076964,0.0011190587,0.00009087029,0.000041577307,0.0000035512248,0.000062637686,0.000053552154,0.000037181435],"category_scores_gemma":[0.000073527146,0.0000950382,0.00015020164,0.00014589881,0.00027334524,0.0000777215,0.000008857629,0.00023460017,3.027607e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04229304,0.029719153,0.5828975,0.000043547283,0.000554943,0.00007413624,0.00039678815,0.000072569266,0.00021058519,0.000008651259,0.00036539647,0.34336373],"study_design_scores_gemma":[0.12300718,0.20148447,0.67157805,0.00008407008,0.0011884207,0.000029580748,0.0006778756,0.000030592266,0.00006228999,0.00005256484,0.0016828455,0.00012205163],"about_ca_topic_score_codex":0.00011654474,"about_ca_topic_score_gemma":0.00006929369,"teacher_disagreement_score":0.3432417,"about_ca_system_score_codex":0.000059883365,"about_ca_system_score_gemma":0.00051914796,"threshold_uncertainty_score":0.38755456},"labels":[],"label_agreement":null},{"id":"W2070363335","doi":"10.5489/cuaj.10002","title":"Virtual cystoscopy: the evaluation of bladder lesions with computed tomographic virtual cystoscopy","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Radiology; Urinary bladder; Biopsy; Urinary system; Urology; Internal medicine","score_opus":0.04016224703061211,"score_gpt":0.2695581035983762,"score_spread":0.22939585656776407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070363335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886293,0.00024845486,0.0005173858,0.0040633003,0.00045601756,0.0005623663,0.000058608737,0.000028086544,0.0052028717],"genre_scores_gemma":[0.99730104,0.000030708165,0.0002374177,0.0019443632,0.0002587642,0.000024690957,0.00002189518,0.0000173244,0.00016379208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976626,0.00043374245,0.00037569963,0.00020554425,0.00091543,0.00040695688],"domain_scores_gemma":[0.9979979,0.00011978508,0.00034298192,0.00018766375,0.0008397236,0.00051194325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011619693,0.00017973174,0.00030909796,0.00021899803,0.00035505046,0.000032499313,0.00016831863,0.00021143416,0.001743957],"category_scores_gemma":[0.00024926435,0.00010605551,0.00014338644,0.0004342312,0.00011702825,0.00009946997,0.0000130747285,0.0005208784,0.000033780943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011904666,0.0006665594,0.9531125,0.0000063446573,0.002366183,0.00013428966,0.0031691305,0.00038479286,0.0004987187,0.0018296822,0.013868647,0.022772688],"study_design_scores_gemma":[0.0037568924,0.0034451715,0.98670125,0.00003758219,0.0011073174,0.0002120684,0.00053330883,0.00058998546,0.00021925599,0.00068425236,0.002547052,0.00016583774],"about_ca_topic_score_codex":0.0018924447,"about_ca_topic_score_gemma":0.0017941708,"teacher_disagreement_score":0.03358878,"about_ca_system_score_codex":0.0005923228,"about_ca_system_score_gemma":0.0015187976,"threshold_uncertainty_score":0.9991686},"labels":[],"label_agreement":null},{"id":"W2070572016","doi":"10.1016/j.juro.2013.02.2870","title":"1780 FEMALE GENDER IS ASSOCIATED WITH HIGHER RISK OF DISEASE RECURRENCE IN PATIENTS WITH PRIMARY T1 HIGH GRADE UROTHELIAL CARCINOMA OF THE BLADDER","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Classics; Gerontology; History","score_opus":0.013065929516133954,"score_gpt":0.2231866993700518,"score_spread":0.21012076985391787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070572016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765015,0.00042133933,0.000010731802,0.0010263768,0.0001481953,0.00048247547,0.000065254186,0.0000028898082,0.00019256175],"genre_scores_gemma":[0.9988868,0.00005908244,0.000037687976,0.0008047061,0.00005896036,0.0000072903813,0.0000035378669,0.00002175284,0.000120147575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984306,0.00035827197,0.00040939834,0.00011879693,0.0004611539,0.0002217892],"domain_scores_gemma":[0.9984039,0.0001367223,0.0007155793,0.00031852443,0.00032299018,0.00010228065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021697613,0.00016297222,0.00043402368,0.00008235175,0.000042832413,0.000003268568,0.00022895726,0.00007037704,0.00026522958],"category_scores_gemma":[0.00004828298,0.000070809874,0.00008878553,0.00021147024,0.0002882484,0.00007755876,0.000041645733,0.00037234905,0.00000275898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004100916,0.00073586084,0.993019,0.000021148186,0.00049284083,0.000009612609,0.0007298434,0.000042600637,0.000090944275,0.000008670067,0.00043603146,0.00031253576],"study_design_scores_gemma":[0.007358852,0.0025943392,0.9882153,0.000053464053,0.0010247573,0.000011519683,0.000028793853,0.000005994907,0.00028790513,0.00031420926,0.000035502664,0.000069354785],"about_ca_topic_score_codex":0.00032675185,"about_ca_topic_score_gemma":0.00001636791,"teacher_disagreement_score":0.0048036883,"about_ca_system_score_codex":0.000065885266,"about_ca_system_score_gemma":0.00029429336,"threshold_uncertainty_score":0.29040778},"labels":[],"label_agreement":null},{"id":"W2071087305","doi":"10.1016/s0167-8140(12)72485-4","title":"98 DOES CURATIVE TREATMENT OF PROSTATE CANCER AFFECT CAUSE-SPECIFIC SURVIVAL? UPDATE FROM THE SASKATCHEWAN PROSTATE CANCER DATABASE","year":2009,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Medicine; Affect (linguistics); Oncology; Prostate; Cancer; Internal medicine; Database; Overall survival; Computer science; Psychology","score_opus":0.028970752049131084,"score_gpt":0.34345881846777465,"score_spread":0.3144880664186436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071087305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92573863,0.05164121,0.000040308987,0.01807268,0.00068409985,0.0019878559,0.001607075,0.00005132634,0.00017681655],"genre_scores_gemma":[0.8260991,0.16816576,0.0004172482,0.0025902183,0.0006862177,0.0004078887,0.00016655498,0.000042289765,0.0014247228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998443,0.00025378374,0.0003091294,0.00046688362,0.0001794369,0.00034778652],"domain_scores_gemma":[0.9989781,0.00023747617,0.0001824072,0.0003848792,0.00007406358,0.0001430806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013120817,0.00032446053,0.00075053104,0.000048204198,0.0001395219,0.00001910099,0.00008901083,0.00011261499,0.00062146795],"category_scores_gemma":[0.0000043871005,0.0001632261,0.00010460732,0.00015684142,0.00023739779,0.000099696976,0.000009980248,0.00013423894,0.0000029433331],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012415239,0.0018071566,0.2118257,0.000048307327,0.0026477564,0.00026882117,0.051462393,0.000021455437,0.043551777,0.00011533348,0.0062071527,0.6696289],"study_design_scores_gemma":[0.031097885,0.012580009,0.26534653,0.00031848767,0.0011314626,0.00004377307,0.0043317387,0.00009501196,0.05056214,0.0005169918,0.633317,0.0006589978],"about_ca_topic_score_codex":0.005432106,"about_ca_topic_score_gemma":0.01159454,"teacher_disagreement_score":0.6689699,"about_ca_system_score_codex":0.000707385,"about_ca_system_score_gemma":0.0005656885,"threshold_uncertainty_score":0.8211756},"labels":[],"label_agreement":null},{"id":"W2071306239","doi":"10.1038/nrurol.2013.301","title":"Conditional survival after radical cystectomy","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Survivorship curve; Retrospective cohort study; Proportional hazards model; Survival analysis; Oncology; Urology; Internal medicine; Surgery; Cancer","score_opus":0.04068136917902416,"score_gpt":0.37739515756993336,"score_spread":0.3367137883909092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071306239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.066995e-7,0.98936397,0.000023594384,0.00037050166,0.0012166573,0.0036496096,0.00017936327,0.00006399184,0.005131697],"genre_scores_gemma":[0.000013204655,0.9897273,0.00027800968,0.0027968215,0.0018564555,0.0024127557,0.0010862824,0.000100346006,0.0017288158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966636,0.0007006256,0.0009788371,0.0007892318,0.00035827042,0.0005094748],"domain_scores_gemma":[0.9982907,0.00021747475,0.00037323104,0.0007114578,0.000094296345,0.00031280261],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00031729005,0.00075678644,0.0046124365,0.00023021601,0.000049283,0.000017404851,0.00024808708,0.0023521641,0.0063629],"category_scores_gemma":[0.00018525166,0.0004633304,0.0014335829,0.00031396205,0.00020529861,0.00004943621,0.00008231144,0.0030932168,0.0045328545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049362658,0.00013922887,0.00002735544,0.016590739,0.0005983818,0.00031343143,0.000004784114,3.505404e-9,1.0827468e-7,0.0003410638,0.019917263,0.96201825],"study_design_scores_gemma":[0.0008194206,0.000282493,0.00004071306,0.003114747,0.0047320738,0.0019604822,2.5637553e-7,1.4124883e-7,1.0361104e-7,0.00009953256,0.9886341,0.00031589784],"about_ca_topic_score_codex":0.0000061917594,"about_ca_topic_score_gemma":0.0000037547609,"teacher_disagreement_score":0.96871686,"about_ca_system_score_codex":0.00017429546,"about_ca_system_score_gemma":0.0006106793,"threshold_uncertainty_score":0.99978185},"labels":[],"label_agreement":null},{"id":"W2071971787","doi":"10.1111/j.1464-410x.2006.06036.x","title":"Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder","year":2006,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytology; Medicine; Cystoscopy; Transitional cell carcinoma; Logistic regression; Urine cytology; Urology; Urinary system; Cohort; Receiver operating characteristic; Urinary bladder; Bladder cancer; Cancer; Internal medicine; Pathology","score_opus":0.015410161576177948,"score_gpt":0.2605177635618352,"score_spread":0.24510760198565726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071971787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954468,0.0013182831,0.000971126,0.0008718223,0.00018714614,0.00030076876,0.00016202744,0.000001045068,0.0007409871],"genre_scores_gemma":[0.9992437,0.000045091325,0.00040183755,0.00014414891,0.00013782327,0.0000091100555,0.000008673487,0.000004425081,0.0000051962807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986614,0.00026105766,0.000639656,0.00010085931,0.00020801662,0.0001289929],"domain_scores_gemma":[0.9985776,0.0005971927,0.00041431055,0.00010780946,0.00028229153,0.000020791163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006895435,0.00006962573,0.00031634182,0.000056835423,0.000043394306,0.0000017948622,0.00017070273,0.00008927008,0.000043801996],"category_scores_gemma":[0.00025499557,0.000051295243,0.0001736923,0.000120020624,0.00035970027,0.000055604854,0.000015947842,0.00023968222,7.355093e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029574253,0.0048558805,0.9721867,0.00046874123,0.00017533699,0.0003176189,0.0008710364,0.0010860208,0.0058698775,0.0018910298,0.00094219757,0.008378125],"study_design_scores_gemma":[0.0037487287,0.0012881171,0.98206246,0.00007382561,0.00019873312,0.0067792106,0.000056506648,0.00010085515,0.001947757,0.0034967682,0.00021028043,0.000036766694],"about_ca_topic_score_codex":0.00025539452,"about_ca_topic_score_gemma":0.000045371416,"teacher_disagreement_score":0.00987574,"about_ca_system_score_codex":0.000025576284,"about_ca_system_score_gemma":0.0004989215,"threshold_uncertainty_score":0.20917593},"labels":[],"label_agreement":null},{"id":"W2072143254","doi":"10.3389/fonc.2014.00206","title":"Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer","year":2014,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Concomitant; Radiation therapy; Disease; Population; Urology; Cancer; Surgery; Oncology; Internal medicine","score_opus":0.06757795798527279,"score_gpt":0.40004406259334263,"score_spread":0.33246610460806986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072143254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048394655,0.98798394,0.0010438887,0.0009716602,0.0008842281,0.007453889,0.000076835226,0.00002365118,0.0010779416],"genre_scores_gemma":[0.001067,0.9888432,0.0013538427,0.0010300871,0.0005607142,0.0059727756,0.0006481628,0.00007160866,0.00045262947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975777,0.0005868248,0.00065823854,0.00054201385,0.00024924477,0.0003859567],"domain_scores_gemma":[0.99859065,0.00039133194,0.00041982994,0.00044660532,0.000094923504,0.000056687582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057196856,0.0004025039,0.001916343,0.00029600857,0.00006167592,0.00001882567,0.00025659747,0.00059734634,0.00004549506],"category_scores_gemma":[0.00009941721,0.00023283935,0.00023915319,0.00044017844,0.000088472065,0.000107538326,0.000015757307,0.00048042845,0.0000022603313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007998614,0.00036382102,0.00827806,0.0017955028,0.00048359792,0.000016999798,0.00054649817,0.000007461056,1.12049946e-7,0.00006933979,0.016319253,0.9713195],"study_design_scores_gemma":[0.006103673,0.0032747318,0.004487214,0.0015502849,0.0010060022,0.000020453575,0.00012586608,0.000021941038,0.0000010099787,0.0007823819,0.98236424,0.0002622223],"about_ca_topic_score_codex":0.0015156716,"about_ca_topic_score_gemma":0.002708077,"teacher_disagreement_score":0.9710573,"about_ca_system_score_codex":0.00099351,"about_ca_system_score_gemma":0.0015804569,"threshold_uncertainty_score":0.94949126},"labels":[],"label_agreement":null},{"id":"W2073172970","doi":"10.1007/s00345-012-0915-0","title":"The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma","year":2012,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Cuff; Upper urinary tract; Urology; Stage (stratigraphy); Surgery; Nephrology; Laparoscopy; Retrospective cohort study; Urinary system; Internal medicine","score_opus":0.02167971303739337,"score_gpt":0.33293739889549057,"score_spread":0.3112576858580972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073172970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219936,0.0020792105,0.000081207574,0.0036704496,0.0010808647,0.0003212761,0.0000060760094,0.000008995387,0.0005525494],"genre_scores_gemma":[0.9965757,0.0002495371,0.0011285414,0.00085529545,0.00059232354,0.0000127494295,7.832618e-7,0.000025653544,0.0005594081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976512,0.0005996711,0.00073562644,0.00016446927,0.0003543057,0.00049473427],"domain_scores_gemma":[0.9980739,0.0010218326,0.00039864224,0.00024203329,0.00007128485,0.00019231852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009859869,0.000224174,0.0008428076,0.00034136424,0.000086431246,0.0000106559155,0.00020683209,0.0001427464,0.0003295734],"category_scores_gemma":[0.00022146372,0.000110812754,0.00030789428,0.00019129225,0.00017693573,0.00012782401,0.00005200959,0.00065386924,0.000008672089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039887656,0.00068911066,0.9747964,0.000037492326,0.00023467926,0.00019198879,0.0005425287,0.000008358775,0.013086208,0.00009557249,0.00015595782,0.0061729215],"study_design_scores_gemma":[0.009468868,0.0014567188,0.9660686,0.000032173255,0.00036356694,0.0008781121,0.000066184264,0.000008145038,0.015991447,0.00022171624,0.005337689,0.00010677796],"about_ca_topic_score_codex":0.00004990013,"about_ca_topic_score_gemma":0.000067340006,"teacher_disagreement_score":0.008727816,"about_ca_system_score_codex":0.00013443035,"about_ca_system_score_gemma":0.00016686713,"threshold_uncertainty_score":0.4518813},"labels":[],"label_agreement":null},{"id":"W2073304550","doi":"10.1159/000325400","title":"Immunostaining as a Diagnostic Aid in Cytopathologic Study of Upper Urinary Tract Urothelial Carcinoma","year":2009,"lang":"en","type":"article","venue":"Acta Cytologica","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Urothelial carcinoma; Immunostaining; Urinary system; Carcinoma; Pathology; Cytopathology; Upper urinary tract; Urology; Internal medicine; Immunohistochemistry; Cytology; Cancer; Bladder cancer","score_opus":0.023390032758534574,"score_gpt":0.30134611350873053,"score_spread":0.27795608075019596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073304550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903156,0.0006872451,0.0000015626549,0.0007212462,0.000081621285,0.0011840897,0.00000986405,0.000067733265,0.006931],"genre_scores_gemma":[0.99878013,0.00011118815,0.00011381879,0.00068013725,0.00006944203,0.000083774125,0.000011444071,0.000017231334,0.00013283921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826294,0.00016174636,0.0004654836,0.0004364058,0.00026825976,0.00040516234],"domain_scores_gemma":[0.9989809,0.00029140254,0.0001314084,0.0004454499,0.000053628486,0.00009724103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018496363,0.00026997572,0.0006584535,0.00018955382,0.00007236916,0.00001107545,0.00019057086,0.00014907304,0.00029631864],"category_scores_gemma":[0.00048503725,0.00019918119,0.00011874731,0.0002830115,0.000065479166,0.00009187055,0.000052088388,0.00031607618,0.000031896867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014723035,0.009978997,0.96876943,0.000019224724,0.00003650191,0.0052913353,0.002731727,0.000003129501,0.0074484865,0.000039976436,0.00003369836,0.0041752006],"study_design_scores_gemma":[0.0061405445,0.026669277,0.9619923,0.000059771013,0.00013863007,0.00090564357,0.0017373164,0.000004044231,0.0016089595,0.00042734478,0.00013956365,0.00017656041],"about_ca_topic_score_codex":0.0002520316,"about_ca_topic_score_gemma":0.000003746349,"teacher_disagreement_score":0.01669028,"about_ca_system_score_codex":0.00009889854,"about_ca_system_score_gemma":0.00013113322,"threshold_uncertainty_score":0.81223726},"labels":[],"label_agreement":null},{"id":"W2073502643","doi":"10.1016/j.celrep.2014.04.038","title":"Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"Cell Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"APOBEC; Biology; Gene; Context (archaeology); Transcriptome; Genetics; Mutation; Exome sequencing; Cancer; Exome; Cancer research; Genome; Gene expression","score_opus":0.014936207324706494,"score_gpt":0.25787365156288206,"score_spread":0.24293744423817556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073502643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472356,0.0006432931,0.00001654975,0.00011689581,0.00010778129,0.00017289742,0.0000018484133,0.000010769626,0.004206414],"genre_scores_gemma":[0.99653924,0.000050348786,0.00023781553,0.000368727,0.00004639156,0.000029724319,0.000010442235,0.000009130544,0.0027082092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993521,0.000010529902,0.00017397989,0.00020766823,0.0001386303,0.00011710225],"domain_scores_gemma":[0.9997209,0.000018256997,0.00005615342,0.00006980446,0.000036331596,0.00009856808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008585589,0.00008702531,0.00013893841,0.000041948348,0.00003940546,0.000011009743,0.000009073586,0.00003972556,0.00013337586],"category_scores_gemma":[0.000011402883,0.00007302495,0.0000133319,0.00003500668,0.00004296424,0.000040161678,0.000020745501,0.00006005068,0.00000466941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007923933,0.0000792878,0.9597402,0.000045673867,0.000051862087,0.00069572823,0.0018721585,0.0000032791284,0.000816697,0.00001908803,0.00021553208,0.036381263],"study_design_scores_gemma":[0.0013882917,0.00006732156,0.97879714,0.000046054567,0.00004230746,0.0001357359,0.00004502913,0.000021796974,0.0035054258,0.00014394076,0.015716571,0.00009037847],"about_ca_topic_score_codex":0.00045190103,"about_ca_topic_score_gemma":0.00018404935,"teacher_disagreement_score":0.036290884,"about_ca_system_score_codex":0.000040627445,"about_ca_system_score_gemma":0.00012806065,"threshold_uncertainty_score":0.2977871},"labels":[],"label_agreement":null},{"id":"W2074650678","doi":"10.1016/j.urolonc.2013.06.009","title":"Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder","year":2013,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Biomarker; Bladder cancer; Oncology; Malignancy; Internal medicine; Stage (stratigraphy); Cancer; Intensive care medicine","score_opus":0.06003637401086036,"score_gpt":0.3502248774312612,"score_spread":0.2901885034204008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074650678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066058986,0.92722124,0.000014770005,0.0010942913,0.0002983187,0.0038919586,0.0010124168,0.000017645083,0.0003903452],"genre_scores_gemma":[0.004986936,0.977899,0.014293716,0.00052897044,0.0001359844,0.0010747841,0.000236983,0.000055409462,0.00078821846],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986061,0.00015715948,0.00059509854,0.00032577856,0.000120380704,0.00019548397],"domain_scores_gemma":[0.9987194,0.000466776,0.00040313977,0.00023954672,0.0000651974,0.000105932435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020053133,0.00027655048,0.0012340576,0.0002114908,0.00007404553,0.0000056167423,0.00010283047,0.00042766175,0.000032899134],"category_scores_gemma":[0.00014865975,0.00016526038,0.00017200048,0.00022654122,0.0008324032,0.000034934677,0.000037242233,0.00022053214,8.143564e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017211368,0.0010302162,0.8057314,0.010285449,0.0013224232,0.00002599269,0.00030788526,0.0000038802355,0.00013860434,0.00111526,0.0018675016,0.17799924],"study_design_scores_gemma":[0.0025303063,0.0033147987,0.0061009354,0.0012840081,0.0052426057,0.00011541912,0.000032072727,0.000039435938,0.00016236497,0.00062261114,0.980411,0.00014442421],"about_ca_topic_score_codex":0.00018701551,"about_ca_topic_score_gemma":0.000025066469,"teacher_disagreement_score":0.9785435,"about_ca_system_score_codex":0.00006266135,"about_ca_system_score_gemma":0.000900242,"threshold_uncertainty_score":0.6739123},"labels":[],"label_agreement":null},{"id":"W2074660011","doi":"10.5489/cuaj.677","title":"Rôle de la cystoscopie de fluorescence en lumière bleue induite par Hexvix dans la prise en charge des tumeurs urothéliales vésicales","year":2014,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.008313886486700419,"score_gpt":0.24488529499176606,"score_spread":0.23657140850506564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074660011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603158,0.002828048,0.000985982,0.022437615,0.0010669571,0.0004304918,0.00025084487,0.000071271956,0.011612937],"genre_scores_gemma":[0.9885574,0.001217401,0.0010922143,0.002096905,0.0032005624,0.000038555383,0.00002471126,0.00005600399,0.0037162348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99374366,0.0033072284,0.00053961365,0.00040077683,0.0004896949,0.0015190004],"domain_scores_gemma":[0.9955782,0.001508663,0.0003331205,0.00020794313,0.00019038783,0.0021816574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003034263,0.00039347378,0.00056815246,0.00018739897,0.0006264698,0.0002934938,0.000388271,0.001080725,0.00078477984],"category_scores_gemma":[0.004077722,0.0003577975,0.0002616584,0.0002739751,0.000443063,0.00021092451,0.000039964318,0.0017128091,0.00018115726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007580119,0.00026319528,0.9663932,0.00005282193,0.00033323298,0.0007128982,0.0031411338,0.00007294122,0.002478065,0.0033900144,0.007358097,0.01572861],"study_design_scores_gemma":[0.002057916,0.000646401,0.8182436,0.00025262914,0.00046463287,0.0009665221,0.00026537877,0.0005535079,0.000527776,0.0037111908,0.17198238,0.00032802759],"about_ca_topic_score_codex":0.0058405264,"about_ca_topic_score_gemma":0.0025010272,"teacher_disagreement_score":0.16462429,"about_ca_system_score_codex":0.0050877887,"about_ca_system_score_gemma":0.0027483967,"threshold_uncertainty_score":0.9998874},"labels":[],"label_agreement":null},{"id":"W2075361673","doi":"10.1016/j.eururo.2012.07.026","title":"Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Cystectomy; Bladder cancer; Lymphovascular invasion; Lymphadenectomy; Proportional hazards model; Lymph node; Urology; Stage (stratigraphy); Metastasis; Cancer; Retrospective cohort study; Confidence interval; Internal medicine; Oncology; Surgery","score_opus":0.01974532135692254,"score_gpt":0.2669175957561475,"score_spread":0.24717227439922496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075361673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091357,0.0013770998,0.00007810961,0.0006238947,0.00030113154,0.0004991362,0.000087498454,0.00005713852,0.006062442],"genre_scores_gemma":[0.9945863,0.000047506473,0.000209919,0.0044629257,0.00018288521,0.000020905067,0.000035661124,0.00008198902,0.00037189035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836725,0.00020834735,0.00024993616,0.00037342325,0.00023871746,0.0005623422],"domain_scores_gemma":[0.9992646,0.000046107933,0.00007910563,0.0002947456,0.00009163702,0.00022381944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010375606,0.0002574064,0.00033319264,0.00013743056,0.00004080661,0.000008859461,0.000087496286,0.000056996018,0.00152403],"category_scores_gemma":[0.000043466,0.00018202279,0.00006467109,0.0001809926,0.00008154634,0.00011245577,0.000048818598,0.00017335873,0.00040832936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000764843,0.0008360927,0.99064046,0.000020095404,0.00018599506,0.000096693686,0.001034796,0.0000031920852,0.00024587428,0.0000043833065,0.00061890663,0.0055486374],"study_design_scores_gemma":[0.004982115,0.00061752636,0.9841906,0.000028319673,0.00031365524,0.000034016073,0.000018648887,0.000007737511,0.00022031678,0.0000024137487,0.009407791,0.00017689198],"about_ca_topic_score_codex":0.00010201823,"about_ca_topic_score_gemma":0.000012920462,"teacher_disagreement_score":0.008788885,"about_ca_system_score_codex":0.00007365911,"about_ca_system_score_gemma":0.0000725026,"threshold_uncertainty_score":0.9993887},"labels":[],"label_agreement":null},{"id":"W2075720094","doi":"10.1002/cncr.24634","title":"Cost‐effectiveness analysis of immediate radical cystectomy versus intravesical <i>Bacillus</i> Calmette‐Guerin therapy for high‐risk, high‐grade (T1G3) bladder cancer","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Comorbidity; Malignancy; Cancer; Internal medicine","score_opus":0.03597328546733888,"score_gpt":0.34446856690303196,"score_spread":0.3084952814356931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075720094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98546636,0.005713822,0.0020963312,0.0016709361,0.0011795319,0.0021650842,0.0014969503,0.00009260581,0.000118386415],"genre_scores_gemma":[0.99194974,0.0042369915,0.00033889138,0.0010298929,0.0008453421,0.0012233277,0.00019378572,0.00005872116,0.00012332514],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974736,0.00016709747,0.0005020593,0.00070233754,0.0005284099,0.00062652526],"domain_scores_gemma":[0.99825805,0.0003864999,0.00024728442,0.0005173666,0.00024215387,0.00034865996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025262116,0.0004485395,0.0013077757,0.00031016167,0.00012323925,0.000020892183,0.0001986683,0.00026597694,0.0006878968],"category_scores_gemma":[0.000063246705,0.0003502692,0.000524161,0.0011018884,0.0002341011,0.00009975918,0.000021561662,0.00034339604,0.000005935531],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06407031,0.0034230833,0.05541284,0.0004828717,0.043025438,0.00015019125,0.0020008632,0.0032812352,0.05189117,0.0011924017,0.00699902,0.7680706],"study_design_scores_gemma":[0.0676442,0.004940904,0.70562226,0.00023818438,0.017229015,0.000006094683,0.000097119955,0.00082788884,0.18542552,0.0003667934,0.016669273,0.00093273603],"about_ca_topic_score_codex":0.0046203053,"about_ca_topic_score_gemma":0.00033544225,"teacher_disagreement_score":0.7671378,"about_ca_system_score_codex":0.00061461964,"about_ca_system_score_gemma":0.0004593775,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W2075807787","doi":"10.1016/j.urolonc.2006.09.015","title":"Long-term outcome of radiation-based conservation therapy for invasive bladder cancer","year":2007,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Cystectomy; Bladder cancer; Chemotherapy; Oncology; Cisplatin; Cystoscopy; Urology; Surgery; Lymph node; Carcinoma; Internal medicine; Cancer; Urinary system","score_opus":0.058491059918654484,"score_gpt":0.37542339868715424,"score_spread":0.31693233876849974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075807787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986783,0.0020818568,0.0013761502,0.008064665,0.0002090931,0.000935665,0.000068259935,0.00003423072,0.00044702966],"genre_scores_gemma":[0.9682039,0.000895105,0.01653724,0.013186186,0.00020255694,0.00029806566,0.00019742441,0.000019655821,0.00045985638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990266,0.00003660002,0.00036263748,0.00024110859,0.00011314017,0.00021992004],"domain_scores_gemma":[0.9987562,0.0005989197,0.00021466771,0.00013419961,0.00014312072,0.00015292632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028306514,0.0001521369,0.00032371812,0.00013708217,0.0001333082,0.000006881379,0.000054414195,0.00019159776,0.00012448577],"category_scores_gemma":[0.00014067217,0.00012239674,0.000074865166,0.00017923777,0.0004029303,0.000060564613,0.0000075781504,0.000120780925,0.000002307035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005074482,0.00022243934,0.98364913,0.00004951772,0.00012147825,0.000015745345,0.0001970962,0.000019463043,0.001315065,0.00088447094,0.0011299527,0.011888189],"study_design_scores_gemma":[0.007348785,0.0053206864,0.8356569,0.00006432075,0.0005691781,0.000043927514,0.00009119812,0.00020239208,0.031477947,0.0018446301,0.117152706,0.00022737471],"about_ca_topic_score_codex":0.00018363056,"about_ca_topic_score_gemma":0.00027750767,"teacher_disagreement_score":0.14799228,"about_ca_system_score_codex":0.00011639074,"about_ca_system_score_gemma":0.00063469337,"threshold_uncertainty_score":0.49911943},"labels":[],"label_agreement":null},{"id":"W2075960506","doi":"10.1002/ijc.24503","title":"High frequency of MAGE‐A4 and MAGE‐A9 expression in high‐risk bladder cancer","year":2009,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Bladder cancer; Immunotherapy; Immunohistochemistry; Medicine; Cancer; Lymph node; Pathology; Oncology; Cancer research; Internal medicine","score_opus":0.010847716336948974,"score_gpt":0.3210534347159663,"score_spread":0.31020571837901734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075960506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818258,0.012563113,0.00012190565,0.0036924332,0.0010046735,0.0001354498,0.00014295298,0.000006269455,0.00050739554],"genre_scores_gemma":[0.98849016,0.008642255,0.0011236893,0.00072358985,0.0007607782,0.000009059948,0.000004577745,0.000013796636,0.00023209282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985865,0.000038828548,0.0005020966,0.00014963352,0.0005791691,0.00014380593],"domain_scores_gemma":[0.99891126,0.000035243986,0.00042019243,0.00009932578,0.00042857317,0.00010542956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012561232,0.00014209251,0.00035511382,0.00023883786,0.00001864118,0.000017369808,0.00015466979,0.00007410453,0.0010459535],"category_scores_gemma":[0.000035409077,0.00010697318,0.000094622475,0.00009561052,0.000051558156,0.00021742698,0.000020636535,0.00025780103,0.0000018490223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023980937,0.00062666985,0.65366495,0.00004103155,0.0010106505,0.00047692866,0.00092220755,0.00040266014,0.053529516,0.00036652558,0.0034515373,0.28310925],"study_design_scores_gemma":[0.006046079,0.0004163574,0.93655,0.0009268444,0.0002464391,0.000082798106,0.000057554887,0.0000140244665,0.05207598,0.0027088863,0.00074851187,0.0001264995],"about_ca_topic_score_codex":0.0025288665,"about_ca_topic_score_gemma":0.00028161966,"teacher_disagreement_score":0.28298277,"about_ca_system_score_codex":0.00024186725,"about_ca_system_score_gemma":0.00026125385,"threshold_uncertainty_score":0.9998672},"labels":[],"label_agreement":null},{"id":"W2076160687","doi":"10.1038/nature14075","title":"Resistance through repopulation","year":2014,"lang":"en","type":"letter","venue":"Nature","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Repopulation; Cancer research; Cancer stem cell; Chemotherapy; Stem cell; Bladder cancer; Cancer; Cancer cell; Medicine; Prostaglandin E2; Biology; Immunology; Internal medicine; Cell biology","score_opus":0.020252101519050804,"score_gpt":0.3107022688433295,"score_spread":0.2904501673242787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076160687","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060076818,0.004857439,0.000038864422,0.88907754,0.00093100395,0.00036971428,0.000035665693,0.00010823201,0.10452146],"genre_scores_gemma":[0.0059167836,0.000065819455,0.0010101807,0.90410626,0.0088980645,0.000024984358,0.0010987454,0.000059061764,0.07882012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987817,0.00003284622,0.00017350679,0.00037589463,0.00043393773,0.00020211416],"domain_scores_gemma":[0.99919504,0.000028356937,0.000117130585,0.0005357538,0.00009748569,0.000026209385],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00003810379,0.00022009881,0.00035149397,0.000041236835,0.000049513026,0.000015906817,0.00008074455,0.0052153864,0.00019016078],"category_scores_gemma":[0.000051071613,0.0001705448,0.00014276298,0.00010120333,0.00002448821,0.000039994084,0.000011377704,0.006644485,0.00009170631],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058456975,0.000009608422,0.0003003341,0.0002368328,0.000079881705,0.00039480862,0.00003123748,5.3186696e-8,0.000008605966,0.000060494964,0.99863243,0.00018723309],"study_design_scores_gemma":[0.00063307217,0.000050898372,0.0010698343,0.00028629857,0.00023500284,0.000060131115,0.0000011869971,4.8339854e-7,0.000136386,0.0014988795,0.99588287,0.00014498524],"about_ca_topic_score_codex":0.000022550625,"about_ca_topic_score_gemma":0.000010305599,"teacher_disagreement_score":0.025701342,"about_ca_system_score_codex":0.0001308649,"about_ca_system_score_gemma":0.00007821425,"threshold_uncertainty_score":0.99607605},"labels":[],"label_agreement":null},{"id":"W2076237002","doi":"10.1016/j.urology.2009.09.048","title":"Gender-related Differences in Patients With Stage I to III Upper Tract Urothelial Carcinoma: Results From the Surveillance, Epidemiology, and End Results Database","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Epidemiology; Stage (stratigraphy); Logistic regression; Hazard ratio; Incidence (geometry); Urothelial carcinoma; Demography; Proportional hazards model; T-stage; Surveillance, Epidemiology, and End Results; Urology; Gynecology; Internal medicine; Oncology; Cancer; Bladder cancer; Confidence interval; Cancer registry","score_opus":0.03216890861555528,"score_gpt":0.2763291513292014,"score_spread":0.24416024271364611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076237002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871987,0.00033600413,0.000027633549,0.0068886615,0.00015398618,0.00081158755,0.00250291,0.000034843768,0.0020456917],"genre_scores_gemma":[0.9942093,0.00006214892,0.0001248102,0.0043367064,0.00010245734,0.000018369341,0.0009205004,0.000016186224,0.00020953872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977033,0.00040739906,0.0005636899,0.00068810285,0.00016592472,0.00047158226],"domain_scores_gemma":[0.9981516,0.0009190635,0.00014588029,0.00054401055,0.000052139418,0.00018731158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005040552,0.0002617008,0.0005858375,0.00009981316,0.000086638844,0.000008002948,0.00014518436,0.00017239242,0.000047847483],"category_scores_gemma":[0.0005430426,0.00015119051,0.000040993295,0.00017602021,0.00017240594,0.000056047164,0.00004555848,0.0003536404,0.00001723386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01730817,0.00038162473,0.97703135,0.0000028605918,0.000071309594,0.00007076383,0.0013426417,0.0000112847365,0.0000342032,0.000058820373,0.00088534947,0.0028016274],"study_design_scores_gemma":[0.019948518,0.0027377394,0.97477025,0.000011492963,0.00006445378,0.0000092381015,0.00005488546,0.000056625624,0.000016177724,0.00014289583,0.0020404467,0.00014729387],"about_ca_topic_score_codex":0.0024041962,"about_ca_topic_score_gemma":0.0005717067,"teacher_disagreement_score":0.007010601,"about_ca_system_score_codex":0.000040388197,"about_ca_system_score_gemma":0.0001004245,"threshold_uncertainty_score":0.61653703},"labels":[],"label_agreement":null},{"id":"W2076384592","doi":"10.1038/labinvest.3700483","title":"Inhibition of EGFR signaling abrogates smooth muscle proliferation resulting from sustained distension of the urinary bladder","year":2006,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Societies for Pediatric Urology; New York Academy of Medicine","keywords":"Hyperplasia; Epidermal growth factor receptor; Apoptosis; In vivo; Muscle hypertrophy; Gefitinib; Ex vivo; Urinary bladder; Epidermal growth factor; Endocrinology; DNA synthesis; Biology; Organ culture; Cancer research; Internal medicine; Medicine; Receptor; In vitro; Biochemistry","score_opus":0.012232099274147873,"score_gpt":0.23487161440348003,"score_spread":0.22263951512933217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076384592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818295,0.00024377894,0.000072579765,0.0005108752,0.00009182141,0.00048663205,0.00010617945,0.00004368095,0.00026149914],"genre_scores_gemma":[0.9983273,0.000003931808,0.00086616597,0.0002717177,0.0001940181,0.000022044973,0.0002530704,0.000019026018,0.00004273756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988713,0.0001111276,0.000411427,0.00019144411,0.00030154127,0.00011316143],"domain_scores_gemma":[0.9989275,0.000060300594,0.00030970067,0.00022801464,0.00043179115,0.000042708925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001455082,0.000121525176,0.00018926947,0.000058534988,0.00009743392,0.000010699182,0.00003663468,0.00009251947,0.000024661136],"category_scores_gemma":[0.0001418025,0.00009135973,0.000053619082,0.0003758145,0.00013902843,0.00016942524,0.000020053392,0.0000964947,0.0000019873123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011437777,0.00013112518,0.093901336,0.00009946086,0.000025063679,0.0000036682297,0.0007456995,0.0002553043,0.9040027,0.00027820753,0.00028641103,0.0001566331],"study_design_scores_gemma":[0.0011435926,0.00015933787,0.28984457,0.00037106406,0.00013388236,6.199113e-7,0.0004293408,0.00045837,0.70552975,0.0017720717,0.000082574836,0.00007484493],"about_ca_topic_score_codex":0.00043330475,"about_ca_topic_score_gemma":0.000035254816,"teacher_disagreement_score":0.19847298,"about_ca_system_score_codex":0.000090055146,"about_ca_system_score_gemma":0.00023682503,"threshold_uncertainty_score":0.37255418},"labels":[],"label_agreement":null},{"id":"W2076548828","doi":"10.1016/j.urology.2011.07.672","title":"UP-01.120 Chronological Age Is not an Independent Predictor of Clinical Outcomes after Radical Nephroureterectomy","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Cohort; Urology; Oncology; Internal medicine; Cancer","score_opus":0.08708899985418186,"score_gpt":0.35530268221362005,"score_spread":0.2682136823594382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076548828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505615,0.00012993262,0.0001618139,0.00074713,0.0007742943,0.00038858113,0.00005146467,0.00007657806,0.0026140804],"genre_scores_gemma":[0.9895835,0.000046377343,0.00057362625,0.00890376,0.00032008102,0.000062701154,0.000018080696,0.000026719717,0.00046518992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979996,0.00020434735,0.00065860094,0.0005026074,0.00026102003,0.0003738039],"domain_scores_gemma":[0.9988909,0.00010072174,0.00013068835,0.00051502313,0.00004584255,0.00031685297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021985757,0.0002268243,0.00080844737,0.00008419933,0.000025367208,0.000004086598,0.0001891914,0.00053585327,0.00724059],"category_scores_gemma":[0.00010210366,0.00015689673,0.00029109573,0.000060848073,0.0004923907,0.000059996,0.000097757365,0.00045360232,0.00013153054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006334627,0.0010072977,0.98487866,0.000018321109,0.0004364888,0.00058201846,0.0009131797,6.326255e-8,0.000078781,0.00010126055,0.0007306046,0.0049186954],"study_design_scores_gemma":[0.0062292987,0.0053778263,0.9782056,0.0000055230344,0.00036821043,0.00009610428,0.00001923653,0.000020718548,0.00047837457,0.00032295627,0.008748314,0.00012779006],"about_ca_topic_score_codex":0.0001611162,"about_ca_topic_score_gemma":0.000055114473,"teacher_disagreement_score":0.008156631,"about_ca_system_score_codex":0.000026865553,"about_ca_system_score_gemma":0.00014314256,"threshold_uncertainty_score":0.99366695},"labels":[],"label_agreement":null},{"id":"W2077177633","doi":"10.1007/s00240-002-0248-3","title":"The role of antisense oligonucleotides in the treatment of bladder cancer","year":2002,"lang":"en","type":"review","venue":"Urological Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oligonucleotide; RNA; Bladder cancer; Antisense therapy; Apoptosis; Cancer research; Chemotherapy; Antisense RNA; Biology; Messenger RNA; Sense (electronics); Cancer; DNA; Molecular biology; Chemistry; Gene; Biochemistry; Genetics; Locked nucleic acid","score_opus":0.22722957431736582,"score_gpt":0.47630820753419967,"score_spread":0.24907863321683385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077177633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013416967,0.98473907,7.7562895e-8,0.0003356153,0.000037078873,0.0018391843,0.00006611914,0.000007182644,0.011633971],"genre_scores_gemma":[0.011840693,0.98654133,0.00000827986,0.000026691812,0.00015046037,0.0005726021,0.0000093424105,0.000024215633,0.00082640065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677026,0.0009519833,0.0005575906,0.00035072948,0.00083301973,0.00053640787],"domain_scores_gemma":[0.9968904,0.002079874,0.00012924365,0.0006580643,0.000153935,0.00008845899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007337092,0.00026238846,0.0012293297,0.00016904387,0.00011254435,0.000017687567,0.0003860492,0.00026156098,0.0006366815],"category_scores_gemma":[0.00020679654,0.00009662047,0.00045667164,0.00067294925,0.0006459726,0.0000131249635,0.000055783144,0.00052968285,0.00005782559],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015015836,0.0010720659,0.0004993477,0.0005530108,0.00032467878,0.00009065003,0.00021583344,2.8082619e-7,0.0000039201636,0.0002301482,0.00037061307,0.9964893],"study_design_scores_gemma":[0.00057228893,0.002968408,0.00076056534,0.0006971197,0.00037212836,0.000027191847,0.00009354129,0.00000657759,0.00003453078,0.00028415318,0.9941114,0.00007207958],"about_ca_topic_score_codex":0.0005819849,"about_ca_topic_score_gemma":0.000053670734,"teacher_disagreement_score":0.9964172,"about_ca_system_score_codex":0.00015443435,"about_ca_system_score_gemma":0.00029511497,"threshold_uncertainty_score":0.69712156},"labels":[],"label_agreement":null},{"id":"W2077515641","doi":"10.1007/s00345-011-0705-0","title":"No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study","year":2011,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Interquartile range; Hazard ratio; Proportional hazards model; Urology; Internal medicine; Nephrology; Retrospective cohort study; Cancer; Lymph node; Oncology; Confidence interval","score_opus":0.033544645277983336,"score_gpt":0.30023948752832874,"score_spread":0.2666948422503454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077515641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943438,0.00069868803,0.00008953831,0.00035052595,0.001719121,0.00046752766,0.000023041333,0.000014511387,0.002293231],"genre_scores_gemma":[0.9982231,0.00035022487,0.00056618603,0.00030109307,0.0003770926,0.000022434295,0.000003109109,0.00003184512,0.0001249087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978164,0.00018802773,0.00077155634,0.00035802016,0.00054661726,0.0003193738],"domain_scores_gemma":[0.9985483,0.00022292366,0.0004215942,0.00022322447,0.00041986242,0.00016404867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026294423,0.0002930142,0.00073889643,0.0005934051,0.000060335984,0.000008878137,0.00029276524,0.00010696257,0.0006842216],"category_scores_gemma":[0.00020309603,0.00023862942,0.00018688223,0.0003374577,0.00024156684,0.00020025838,0.000051829757,0.0005268288,0.000014156011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055081077,0.005375277,0.9301597,0.000019178731,0.00063514913,0.0023032252,0.0011244578,0.0003819961,0.0030849145,0.00033802303,0.000035909623,0.0014610987],"study_design_scores_gemma":[0.038890015,0.010743729,0.94741863,0.0001242223,0.00016038494,0.00037633744,0.00011649781,0.00004726786,0.00054515485,0.000046672496,0.0013611933,0.00016987254],"about_ca_topic_score_codex":0.00032497913,"about_ca_topic_score_gemma":0.00041725245,"teacher_disagreement_score":0.017258959,"about_ca_system_score_codex":0.0007585098,"about_ca_system_score_gemma":0.0010754527,"threshold_uncertainty_score":0.9731025},"labels":[],"label_agreement":null},{"id":"W2077803775","doi":"10.1016/j.urology.2008.03.005","title":"Effect of Healthcare Provider Characteristics on Nodal Yield at Radical Cystectomy","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cystectomy; Yield (engineering); Urology; Health care; Internal medicine; Bladder cancer; Cancer","score_opus":0.01865716201674905,"score_gpt":0.2890345417421632,"score_spread":0.27037737972541415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077803775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386936,0.00025520351,0.000015905192,0.0033849222,0.00027600516,0.00045413736,0.00002783939,0.000038763446,0.0016778836],"genre_scores_gemma":[0.99666786,0.0000404828,0.0000135329165,0.0023743992,0.0002206022,0.00003736571,0.000025949243,0.000018724228,0.000601079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991388,0.00009433383,0.00018860378,0.00020717956,0.0001518376,0.00021924841],"domain_scores_gemma":[0.9993623,0.00020417849,0.000060930008,0.00022428694,0.000030174198,0.000118136726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006685803,0.00012856702,0.00039584926,0.00005638843,0.000055531462,7.704738e-7,0.000046923815,0.00015332851,0.00025839184],"category_scores_gemma":[0.000111638066,0.00009296429,0.000080084355,0.000054644977,0.00013949684,0.000010376488,0.000024601926,0.00017865603,0.00011044113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03654183,0.0008892816,0.90784705,0.0012350704,0.0004997331,0.0029865096,0.0011495753,0.0000031699224,0.011468392,0.00028022032,0.007978762,0.029120412],"study_design_scores_gemma":[0.031071495,0.14440222,0.58518696,0.00022688457,0.0009854581,0.007732558,0.000011789457,0.00020998679,0.118818134,0.000052355983,0.11065266,0.00064951135],"about_ca_topic_score_codex":0.0001184335,"about_ca_topic_score_gemma":0.000011135503,"teacher_disagreement_score":0.32266012,"about_ca_system_score_codex":0.000061615276,"about_ca_system_score_gemma":0.0000870657,"threshold_uncertainty_score":0.37909737},"labels":[],"label_agreement":null},{"id":"W2077936479","doi":"10.1016/j.eururo.2013.03.059","title":"Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":450,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Carcinoma in situ; Confidence interval; Odds ratio; Urology; Relative risk; Meta-analysis; Carcinoma; Prospective cohort study; Cancer; Internal medicine; Surgery; Urinary system","score_opus":0.11765074424705113,"score_gpt":0.3583073433956708,"score_spread":0.24065659914861964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077936479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013574001,0.9938762,0.00026622982,0.00007147532,0.00011599352,0.0017201202,0.001498072,0.000026058045,0.001068418],"genre_scores_gemma":[0.07401942,0.92433006,0.00016544183,0.000315423,0.00005434153,0.0003839929,0.0005217536,0.00010651421,0.00010305022],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968039,0.000840688,0.00075215346,0.0010225895,0.00029652563,0.00028414713],"domain_scores_gemma":[0.99661314,0.0005687601,0.0009425955,0.0015664592,0.00017461836,0.00013443541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034432262,0.0005641264,0.0038611894,0.00071724283,0.000043757853,0.000010560069,0.00039424654,0.00015724059,0.0006008014],"category_scores_gemma":[0.000106678875,0.0003607323,0.00063458324,0.0008154623,0.000269416,0.000058000966,0.00015514162,0.0003913505,0.000021734468],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039877545,0.00064118486,0.00033500197,0.008077653,0.22223106,0.00022556238,0.00013477099,0.00015393937,0.000050945822,0.0000018302477,0.00019160735,0.7675577],"study_design_scores_gemma":[0.001477236,0.003765653,0.0028392978,0.00097032945,0.91975814,0.000028209564,0.000008099067,0.00093503017,0.00010716685,8.8040986e-7,0.06968186,0.00042811886],"about_ca_topic_score_codex":0.00058396946,"about_ca_topic_score_gemma":0.00042823932,"teacher_disagreement_score":0.76712954,"about_ca_system_score_codex":0.000053935604,"about_ca_system_score_gemma":0.00030601877,"threshold_uncertainty_score":0.9998845},"labels":[],"label_agreement":null},{"id":"W2078098503","doi":"10.5489/cuaj.1768","title":"Confirming the volume-outcome relationship in bladder cancer: Now what?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Outcome (game theory); Volume (thermodynamics); Cancer; Medicine; Oncology; Internal medicine; Economics; Physics; Mathematical economics","score_opus":0.028845177351525853,"score_gpt":0.2767262306468292,"score_spread":0.24788105329530336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078098503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76876444,0.0013826898,0.000018037514,0.22514208,0.00070015504,0.0004966639,0.000012918974,0.000020838566,0.0034621654],"genre_scores_gemma":[0.98144686,0.0002231674,0.000040779738,0.013792701,0.0004286412,0.00006913114,0.0000070136384,0.000011938195,0.0039797793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985587,0.00016146392,0.0003736361,0.00015323354,0.00028695984,0.00046603076],"domain_scores_gemma":[0.9988711,0.00018987712,0.0001726715,0.00011179255,0.00020166844,0.00045287286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044897335,0.00012504989,0.00022274387,0.00013301177,0.0002970559,0.00023858012,0.00011537355,0.00020433673,0.004240759],"category_scores_gemma":[0.00042661067,0.000081286715,0.00010514764,0.00025122956,0.00003551855,0.0003113814,0.000009305274,0.00077265344,0.00038660658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009091671,0.00001896731,0.98276734,0.0000014650702,0.000056413784,0.000025193593,0.00016634408,0.000028348453,0.000006621349,0.000070717266,0.0123457825,0.004503704],"study_design_scores_gemma":[0.0008959337,0.000081367056,0.95439994,0.000016391152,0.000061808074,0.0000683053,0.00025196868,0.00017857493,0.0000026085045,0.00092843577,0.04302979,0.00008490063],"about_ca_topic_score_codex":0.011914613,"about_ca_topic_score_gemma":0.011034523,"teacher_disagreement_score":0.2126824,"about_ca_system_score_codex":0.0014404386,"about_ca_system_score_gemma":0.0005659165,"threshold_uncertainty_score":0.9966695},"labels":[],"label_agreement":null},{"id":"W2078439563","doi":"10.1016/j.juro.2010.02.1769","title":"1831 THE PROGNOSTIC ABILITY OF VARIOUS NODAL CODING SCHEMES IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: RESULTS FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS DATABASE","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Epidemiology; Bladder cancer; Surveillance, Epidemiology, and End Results; Lymph node; Cancer; Library science; Pathology; Internal medicine; Cancer registry","score_opus":0.021826970749279997,"score_gpt":0.29189917162301604,"score_spread":0.27007220087373607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078439563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879953,0.00090927305,0.000020217316,0.0097528035,0.00018080385,0.00050046796,0.00051093235,0.000006362402,0.00012383814],"genre_scores_gemma":[0.9983986,0.0004952632,0.00012468523,0.000713506,0.00019942228,0.000010006424,0.00003538754,0.000014005335,0.000009132304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974455,0.0010147427,0.00081322354,0.00021944295,0.00021739746,0.00028964656],"domain_scores_gemma":[0.99273276,0.0058613094,0.00064324593,0.00045490635,0.00020962537,0.000098152006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002712453,0.00018142893,0.00057507504,0.00005387268,0.00010602561,0.0000052891432,0.00025711814,0.00012739272,0.000028573502],"category_scores_gemma":[0.0032788995,0.00007018182,0.000056662113,0.00017576719,0.001035945,0.000051774856,0.000069920054,0.00092622754,8.7408756e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023688845,0.00031413542,0.9702258,0.000011029736,0.00041883564,0.00003548029,0.0011259466,0.000024708968,0.0016371276,0.00001945552,0.0005001724,0.0019984578],"study_design_scores_gemma":[0.012316161,0.0015656304,0.9836489,0.000051381005,0.00040257623,0.00019392709,0.000059804584,0.0001580552,0.0002627215,0.000121059406,0.0011497949,0.00006999661],"about_ca_topic_score_codex":0.0042505604,"about_ca_topic_score_gemma":0.0033955819,"teacher_disagreement_score":0.013423087,"about_ca_system_score_codex":0.00003641435,"about_ca_system_score_gemma":0.00027094863,"threshold_uncertainty_score":0.6425604},"labels":[],"label_agreement":null},{"id":"W2078598893","doi":"10.1016/j.juro.2015.02.229","title":"MP5-02 PARTIAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER: PRACTICE PATTERNS AND OUTCOMES IN THE GENERAL POPULATION","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Proportional hazards model; Epidemiology; Urinary diversion; Population; Urothelial carcinoma; Logistic regression; Urology; Cancer; Surgery; Internal medicine; Environmental health","score_opus":0.032524528183175985,"score_gpt":0.32573028070546417,"score_spread":0.2932057525222882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078598893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801918,0.00041803927,0.00017875868,0.018272195,0.0003492981,0.00044776438,0.000014150758,0.0000019336483,0.00012605003],"genre_scores_gemma":[0.9970128,0.000034159642,0.00007770631,0.002429303,0.00037832026,0.000009215065,0.0000012016778,0.000010279293,0.000047017526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876267,0.00044426142,0.00034343015,0.000066961125,0.000239106,0.00014356282],"domain_scores_gemma":[0.9989493,0.00035775432,0.00032927134,0.00019144775,0.00012844687,0.000043815166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091084733,0.000094394294,0.00026209155,0.000046326782,0.00004786006,0.000006672075,0.00016042052,0.00005903072,0.0000075607263],"category_scores_gemma":[0.00030080468,0.000038815924,0.00008483546,0.000059558995,0.000068593545,0.000070116526,0.000028330476,0.0002073965,5.6714396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049353205,0.0002832547,0.9859699,0.000020728243,0.00026483045,0.000028234103,0.005075134,0.00012875676,0.0004675894,0.00025787158,0.0005826844,0.001985696],"study_design_scores_gemma":[0.008420408,0.0029144136,0.9803484,0.000010854215,0.0010200419,0.0017439261,0.00083145464,0.0002283939,0.00052143645,0.00075638527,0.0031432186,0.00006106875],"about_ca_topic_score_codex":0.000720858,"about_ca_topic_score_gemma":0.000142563,"teacher_disagreement_score":0.016820988,"about_ca_system_score_codex":0.00002890027,"about_ca_system_score_gemma":0.0001134634,"threshold_uncertainty_score":0.15828674},"labels":[],"label_agreement":null},{"id":"W2078616394","doi":"","title":"Have Progression-Free Survival and Cancer-Specific Survival in Bladder Tumors Changed in Recent Decades?","year":2013,"lang":"en","type":"article","venue":"World Journal of Nephrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Lymph node; Multivariate analysis; Progression-free survival; Oncology; Perioperative; Univariate analysis; Cancer; Stage (stratigraphy); Proportional hazards model; Internal medicine; Urology; Surgery; Overall survival","score_opus":0.02798662193530427,"score_gpt":0.30331293876400417,"score_spread":0.2753263168286999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078616394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94185704,0.02058444,0.000007247824,0.035861045,0.0004475999,0.00040903193,0.0000047078393,0.000007830507,0.00082107395],"genre_scores_gemma":[0.98665714,0.009986712,0.00015703624,0.0026156763,0.00036010658,0.0000494361,0.0000026006376,0.000021203166,0.0001501031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982709,0.00029436804,0.00054404105,0.00027370494,0.00018205158,0.00043489118],"domain_scores_gemma":[0.9990841,0.00020555407,0.00022386663,0.00017059424,0.00011293721,0.00020293318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046016427,0.00020987412,0.0007003085,0.0005521561,0.00005073926,0.000012536007,0.00012260393,0.00018434766,0.0006687728],"category_scores_gemma":[0.000048849448,0.00016024045,0.00004681908,0.00024208653,0.00030250865,0.000112602276,0.000082189756,0.0006880726,0.0000039191123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004498099,0.0004820472,0.90828884,0.000031703898,0.00023269492,0.0010231357,0.0008780573,0.000007685239,0.0018313535,0.00037134808,0.00372554,0.078629486],"study_design_scores_gemma":[0.008948045,0.0013612427,0.9503543,0.00005441557,0.00007924131,0.00064619276,0.00017622231,0.000029153405,0.00009525112,0.002012002,0.03610965,0.00013429835],"about_ca_topic_score_codex":0.00022459889,"about_ca_topic_score_gemma":0.0041170525,"teacher_disagreement_score":0.07849518,"about_ca_system_score_codex":0.00006337626,"about_ca_system_score_gemma":0.00012874688,"threshold_uncertainty_score":0.73225933},"labels":[],"label_agreement":null},{"id":"W2078903648","doi":"10.1007/s00345-013-1207-z","title":"Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer","year":2013,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; Western University; McGill University","funders":"","keywords":"Cystectomy; Concomitant; Medicine; Bladder cancer; Urology; Carcinoma in situ; Stage (stratigraphy); Nephrology; Univariate analysis; Lymph node; Carcinoma; Internal medicine; Multivariate analysis; Oncology; Cancer","score_opus":0.024945178551731704,"score_gpt":0.3390984343768661,"score_spread":0.31415325582513437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078903648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386877,0.002525409,0.000041838477,0.0022267015,0.0002736846,0.0003315893,0.000005428687,0.0000033349902,0.0007232335],"genre_scores_gemma":[0.99879396,0.000042255993,0.00016250355,0.00064379675,0.00014089532,0.000017243976,6.8143225e-7,0.000017639595,0.00018104991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998984,0.0000520718,0.0004753946,0.0001191857,0.00013180418,0.0002375386],"domain_scores_gemma":[0.99928665,0.00020848279,0.00020162022,0.00009653218,0.000071583876,0.00013513658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018081961,0.0001301179,0.00058606284,0.00031559862,0.000018861367,0.000006199195,0.00006075805,0.00005558267,0.00011369357],"category_scores_gemma":[0.0000533817,0.000087181856,0.00024164734,0.000107756605,0.000063197884,0.00006331403,0.000013840479,0.00023790335,0.0000013340341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001231105,0.00013489148,0.9846743,0.000025862744,0.00042943336,0.00013695317,0.00035957017,0.000038157534,0.0064696823,0.000030437544,0.0005455409,0.00592412],"study_design_scores_gemma":[0.013650663,0.0030615372,0.98101085,0.00007418318,0.0003454313,0.00021264427,0.000046858404,0.00013644643,0.00035918047,0.00030169962,0.00070667616,0.00009382124],"about_ca_topic_score_codex":0.00037466723,"about_ca_topic_score_gemma":0.00012953111,"teacher_disagreement_score":0.012419559,"about_ca_system_score_codex":0.00017289176,"about_ca_system_score_gemma":0.00021572167,"threshold_uncertainty_score":0.3555173},"labels":[],"label_agreement":null},{"id":"W2079516587","doi":"10.1016/j.urology.2009.12.070","title":"Contemporary Cost Analysis of Single Instillation of Mitomycin After Transurethral Resection of Bladder Tumor in a Universal Health Care System","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Mitomycin C; Cystoscopy; Bladder cancer; Cost–benefit analysis; Productivity; Health care; Surgery; Urinary system; Emergency medicine; Intensive care medicine; Cancer; Internal medicine","score_opus":0.016006104438756764,"score_gpt":0.2791217359843773,"score_spread":0.2631156315456205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079516587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970168,0.0005596247,0.00012395524,0.0001632498,0.00013421204,0.00035765194,0.00010458907,0.000008971149,0.0015309579],"genre_scores_gemma":[0.99978155,0.0000032076898,0.00005395105,0.00006007978,0.000023770965,0.0000095308815,0.00005056883,0.000007886412,0.000009480337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992002,0.00009469296,0.00034372907,0.00014536017,0.00011488908,0.000101086625],"domain_scores_gemma":[0.99946517,0.000035883306,0.00017179438,0.00016311913,0.00012118841,0.000042842832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009621075,0.000074979565,0.0004770101,0.00043860005,0.000008747987,6.425081e-7,0.00003080741,0.0000917379,0.000051510688],"category_scores_gemma":[0.000012339485,0.00006767625,0.00009721622,0.0004165442,0.00008927418,0.000031408665,0.000006187488,0.00011242413,4.464453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009140526,0.0004094711,0.9477209,0.00063873065,0.0011527902,0.00004813789,0.007627877,0.0002751249,0.031869482,0.00007751861,0.0000639814,0.0009754953],"study_design_scores_gemma":[0.008859619,0.0058117015,0.9630461,0.00009343474,0.0014228041,0.000027429316,0.0027643587,0.0011999952,0.016075818,0.0000051594316,0.00057267805,0.00012092991],"about_ca_topic_score_codex":0.002748506,"about_ca_topic_score_gemma":0.005476851,"teacher_disagreement_score":0.015793666,"about_ca_system_score_codex":0.00006339691,"about_ca_system_score_gemma":0.00022837956,"threshold_uncertainty_score":0.4154937},"labels":[],"label_agreement":null},{"id":"W2080015838","doi":"10.1016/j.urolonc.2010.02.011","title":"Statistical consideration for clinical biomarker research in bladder cancer","year":2010,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Overfitting; Biomarker; Biomarker discovery; Computer science; Bladder cancer; Medicine; Cancer; Bioinformatics; Machine learning; Internal medicine; Biology; Proteomics","score_opus":0.40200322786244064,"score_gpt":0.5735555181218225,"score_spread":0.17155229025938185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080015838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006210997,0.99049735,0.00006941117,0.003292364,0.000675355,0.0026775105,0.00042351257,0.000034602963,0.0017087825],"genre_scores_gemma":[0.000021441829,0.96685475,0.028325954,0.0008858155,0.0004936072,0.0020913281,0.0004795984,0.000039268154,0.00080821506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691975,0.00068442745,0.0009148152,0.0007626084,0.00021348048,0.00050492014],"domain_scores_gemma":[0.9954594,0.0034930587,0.00021522367,0.00028295282,0.00017470405,0.00037465754],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016558458,0.00033859396,0.0015770086,0.0003959457,0.00025141888,0.0000374718,0.00010713951,0.0013038557,0.00029628124],"category_scores_gemma":[0.00074677804,0.00025104987,0.00017821534,0.00036895223,0.0016389424,0.00005712425,0.000057779664,0.0016666752,0.00003226926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014675665,0.00047217045,0.016697573,0.001547673,0.00025852185,0.00021134593,0.000060242826,1.7186626e-7,0.0000010887617,0.005880398,0.035715383,0.93900865],"study_design_scores_gemma":[0.0012335008,0.0017176619,0.0003249885,0.0011272385,0.0014168902,0.00028202374,0.000021712021,0.00005535769,6.2900875e-7,0.0046891677,0.9889279,0.00020292065],"about_ca_topic_score_codex":0.00014120244,"about_ca_topic_score_gemma":0.0003325261,"teacher_disagreement_score":0.9532125,"about_ca_system_score_codex":0.0002503334,"about_ca_system_score_gemma":0.003865401,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W2080056464","doi":"10.1016/j.juro.2012.02.1861","title":"1410 RADICAL CYSTECTOMY FOR CLINICALLY MUSCLE INVASIVE BLADDER CANCER: DOES PRIOR NON-INVASIVE DISEASE AFFECT CLINICAL OUTCOMES?","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; General surgery; Library science; Internal medicine","score_opus":0.03803098026330721,"score_gpt":0.37817149463881616,"score_spread":0.34014051437550896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080056464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97819257,0.0021177612,0.0005942672,0.015093677,0.0026058832,0.0011603251,0.00006152624,0.000019902005,0.00015408148],"genre_scores_gemma":[0.9841734,0.0020072446,0.00044467242,0.010095572,0.0029162546,0.00006030913,0.0000046657624,0.000048525748,0.000249342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711543,0.00053542346,0.0011714635,0.00021577335,0.0003663956,0.0005955394],"domain_scores_gemma":[0.9930571,0.004653694,0.00076799985,0.00043362766,0.0002911901,0.0007964278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019485282,0.0002796593,0.0010072946,0.00010164816,0.00014417476,0.000010995161,0.0003454594,0.0002337522,0.00028845406],"category_scores_gemma":[0.0024452813,0.00013507417,0.00078308326,0.0001020949,0.00045860859,0.000140025,0.000085242595,0.00071092614,0.000035498026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013322889,0.001450912,0.9651928,0.00010735028,0.0023180514,0.00014665836,0.0007410849,0.000011557901,0.00056091655,0.000033724184,0.0068439436,0.009270121],"study_design_scores_gemma":[0.014807712,0.0052634566,0.963095,0.00007878833,0.004880092,0.00025118145,0.00012585401,0.000015196166,0.00028573992,0.00041634144,0.010579765,0.00020084709],"about_ca_topic_score_codex":0.000038911738,"about_ca_topic_score_gemma":0.000057844092,"teacher_disagreement_score":0.009069274,"about_ca_system_score_codex":0.0000896873,"about_ca_system_score_gemma":0.0011879449,"threshold_uncertainty_score":0.5508165},"labels":[],"label_agreement":null},{"id":"W2080100450","doi":"10.1016/j.urology.2006.08.435","title":"MP-13.09","year":2006,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; General surgery; Surgery; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.010875519457740011,"score_gpt":0.26186466916825907,"score_spread":0.25098914971051905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080100450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6279949,0.0014269045,0.0005075521,0.006759061,0.00045988386,0.00025753377,0.000010215161,0.00014321381,0.36244076],"genre_scores_gemma":[0.99097925,0.000009701681,0.00007981032,0.0022856146,0.0003546984,0.000012717538,0.000017527416,0.000010442809,0.0062502474],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995734,0.000012163396,0.00007888247,0.00012605237,0.000056640725,0.00015285435],"domain_scores_gemma":[0.9997856,0.00001378576,0.000014658356,0.00013264098,0.00001696038,0.000036358753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002036794,0.000061574865,0.000116977266,0.000034074175,0.000022514003,0.0000022149475,0.000027142785,0.00006227993,0.00070098304],"category_scores_gemma":[0.0000056667836,0.000049431706,0.000037517486,0.00004569508,0.00003763394,0.0000120653685,0.000009746961,0.00006285797,0.0004677972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002108824,0.0017131896,0.68752676,0.00007101529,0.00039485976,0.0015296009,0.00038590038,0.00012099564,0.015533118,0.01323159,0.22302832,0.0543558],"study_design_scores_gemma":[0.0057454137,0.001770447,0.3168632,0.0000041444387,0.0002910376,0.00048036006,0.000014182227,0.00011770161,0.0035861826,0.0069356626,0.66402465,0.00016697594],"about_ca_topic_score_codex":0.0002996945,"about_ca_topic_score_gemma":0.000066715016,"teacher_disagreement_score":0.44099635,"about_ca_system_score_codex":0.000015439913,"about_ca_system_score_gemma":0.000033441185,"threshold_uncertainty_score":0.7675273},"labels":[],"label_agreement":null},{"id":"W2080221673","doi":"10.1002/cncr.25122","title":"Highly predictive survival nomogram after upper urinary tract urothelial carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Urology; Proportional hazards model; Cohort; Upper urinary tract; Bladder cancer; Surveillance, Epidemiology, and End Results; Renal pelvis; Cancer; Nephrectomy; Oncology; Internal medicine; Ureter; Surgery; Urinary system; Cancer registry; Kidney","score_opus":0.013431573785530436,"score_gpt":0.2819348742464822,"score_spread":0.2685033004609518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080221673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796153,0.000987587,0.000033887136,0.00094041263,0.00268459,0.00061562675,0.00032335447,0.00011650133,0.014682753],"genre_scores_gemma":[0.99151355,0.00007913041,0.00014450385,0.0008064437,0.0023108541,0.0005757391,0.000024059595,0.00006508171,0.0044806562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986406,0.000026752736,0.00020177799,0.00042234466,0.00031121465,0.00039732715],"domain_scores_gemma":[0.9991169,0.000028856193,0.000048670674,0.00040858626,0.00011469832,0.00028227924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006693382,0.00025972872,0.00032873044,0.000080101236,0.00007251525,0.00002299549,0.00010594276,0.00017475674,0.0031083133],"category_scores_gemma":[0.00001501369,0.00020659731,0.00018669502,0.00013281773,0.0001401699,0.000120509845,0.00003595649,0.00044545816,0.00014227226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035272709,0.0010753945,0.973703,0.00007325755,0.00021630425,0.0004604748,0.00069754064,0.0000018584152,0.0058337445,0.000049816532,0.0015432076,0.012818087],"study_design_scores_gemma":[0.0033173412,0.0010113581,0.9390587,0.00004363849,0.00031494783,0.00013190549,0.0000448041,0.000050950217,0.004184564,0.00006059488,0.051550373,0.00023077895],"about_ca_topic_score_codex":0.00050932873,"about_ca_topic_score_gemma":0.00006313224,"teacher_disagreement_score":0.05000717,"about_ca_system_score_codex":0.00012265256,"about_ca_system_score_gemma":0.00040041105,"threshold_uncertainty_score":0.997803},"labels":[],"label_agreement":null},{"id":"W2080467376","doi":"10.1002/cncr.23162","title":"Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Nomogram; Biomarker; Concordance; Oncology; Internal medicine; Lymphadenectomy; Cancer; Urology","score_opus":0.021918415365416208,"score_gpt":0.3023876017629164,"score_spread":0.2804691863975002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080467376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957322,0.0019435065,0.00009525867,0.000037853835,0.0005498941,0.0005833868,0.00021362149,0.000021033966,0.00082326285],"genre_scores_gemma":[0.9989886,0.0005640682,0.00006911315,0.00009674097,0.000094693816,0.0000761318,0.000017909522,0.000016036536,0.000076659206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989821,0.000016576818,0.00028672072,0.0002769848,0.00020698008,0.00023067143],"domain_scores_gemma":[0.9994825,0.000048142603,0.000104207174,0.00016025496,0.00010314711,0.000101734484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013408129,0.00013263187,0.00022863016,0.00009744225,0.000029846946,0.0000047499384,0.000036478436,0.00008321658,0.00009579984],"category_scores_gemma":[0.000042349533,0.00011555328,0.00003991693,0.00021238596,0.00008251895,0.00009457009,0.00002256076,0.00010056792,0.0000010696165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044142036,0.00012251765,0.9729749,0.00016872889,0.00017925528,0.00000330839,0.000250196,0.0000050110402,0.0016712853,0.000002192374,0.0001229659,0.02405821],"study_design_scores_gemma":[0.005889062,0.00025371724,0.9832176,0.00032263945,0.00012634705,8.3392484e-7,0.00008081674,0.00010899198,0.00969932,0.00001983142,0.00019512347,0.000085742744],"about_ca_topic_score_codex":0.0035031512,"about_ca_topic_score_gemma":0.00333734,"teacher_disagreement_score":0.023972467,"about_ca_system_score_codex":0.0002860574,"about_ca_system_score_gemma":0.0001887622,"threshold_uncertainty_score":0.529574},"labels":[],"label_agreement":null},{"id":"W2080902602","doi":"10.5489/cuaj.10040","title":"Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University; Western University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Stage (stratigraphy); Proportional hazards model; Disease; Urology; Multivariate analysis; Cancer; Internal medicine; Oncology; Surgery","score_opus":0.043579963801658295,"score_gpt":0.28558306501775843,"score_spread":0.24200310121610014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080902602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7587099,0.03857952,0.0003160866,0.17499332,0.006826573,0.006149334,0.0013384154,0.000091354435,0.012995474],"genre_scores_gemma":[0.98762,0.0018734995,0.00011328549,0.0069783116,0.0016905977,0.0005479338,0.000009080324,0.00002505222,0.0011422385],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795216,0.00013574235,0.00040972934,0.00024755698,0.00036909545,0.0008857338],"domain_scores_gemma":[0.997935,0.00025354428,0.0002799455,0.00023035494,0.00034538322,0.00095576403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034630665,0.00023458702,0.00038141524,0.000086766646,0.0010556831,0.000059317717,0.00026402736,0.00026793583,0.0030244146],"category_scores_gemma":[0.00012081895,0.00012086311,0.00029152702,0.00027987364,0.00018703163,0.000061995226,0.0000070514684,0.0003290814,0.00001048995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040950062,0.00018722791,0.91508055,0.0000061943024,0.0023911842,0.000084754676,0.006755602,0.0002169411,0.000017286091,0.0005000374,0.044329353,0.030021368],"study_design_scores_gemma":[0.0024294134,0.0010172218,0.4931897,0.000018766952,0.00076359004,0.0000798571,0.00032771088,0.00022110155,0.00010331503,0.0004267351,0.5012466,0.00017601854],"about_ca_topic_score_codex":0.5679512,"about_ca_topic_score_gemma":0.7499022,"teacher_disagreement_score":0.45691723,"about_ca_system_score_codex":0.0030144593,"about_ca_system_score_gemma":0.0033341232,"threshold_uncertainty_score":0.99788696},"labels":[],"label_agreement":null},{"id":"W2081334372","doi":"10.5489/cuaj.1002","title":"Blood transfusion and hemostatic agents used during radical cystectomy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystectomy; Medicine; Blood loss; Blood transfusion; Hemostatic Agent; Bladder cancer; Surgery; Hemostasis; Internal medicine; Cancer","score_opus":0.011615650737926817,"score_gpt":0.2262282457200032,"score_spread":0.21461259498207638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081334372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804601,0.00018525514,0.000012602123,0.018005813,0.000110254725,0.00031162857,0.000011646396,0.00002231011,0.0008803599],"genre_scores_gemma":[0.99598,0.00013217445,0.00013327453,0.0029548004,0.00018309317,0.000016892707,0.000007251058,0.000012341637,0.0005801595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880856,0.0000954886,0.00024011543,0.00016612145,0.00028985506,0.00039984976],"domain_scores_gemma":[0.9987513,0.000053144988,0.000085424785,0.000065076725,0.00009494887,0.0009501384],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015322903,0.00012373821,0.00022945394,0.00011354274,0.00027193478,0.000084089246,0.000050708775,0.00017350682,0.0020879917],"category_scores_gemma":[0.00014459003,0.000094717274,0.00007977159,0.0001141182,0.000029251265,0.000105297,0.0000064239407,0.0003830584,0.00006910829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039142556,0.00008392729,0.99303895,0.000012137153,0.0002151481,0.0002572399,0.00031593587,0.0000018399561,0.001888064,0.00001231456,0.002021192,0.0021140988],"study_design_scores_gemma":[0.004671832,0.00035017324,0.98923796,0.000020401969,0.00017563693,0.00083253783,0.00005532286,0.0000530578,0.000257223,0.00030971982,0.003928364,0.000107758635],"about_ca_topic_score_codex":0.0023445631,"about_ca_topic_score_gemma":0.0003459885,"teacher_disagreement_score":0.015519882,"about_ca_system_score_codex":0.0004153435,"about_ca_system_score_gemma":0.00021899151,"threshold_uncertainty_score":0.99882424},"labels":[],"label_agreement":null},{"id":"W2081362989","doi":"10.1016/j.prp.2013.07.007","title":"Primary carcinoma of renal calyx","year":2013,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Renal pelvis; Medicine; Nephrectomy; Pathology; Urothelium; Kidney; Urology; Urinary bladder; Internal medicine","score_opus":0.09802831580003572,"score_gpt":0.41286525702220395,"score_spread":0.3148369412221682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081362989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8637388,0.0021631184,0.000089934096,0.010336981,0.00006260962,0.00061378436,0.000019085275,0.000014695536,0.12296103],"genre_scores_gemma":[0.9950178,0.00046395097,0.001344912,0.0007133931,0.0000994555,0.00006963844,0.000010170788,0.000010571165,0.0022700748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986499,0.00043008276,0.00014038886,0.00021143361,0.0002853061,0.0002828735],"domain_scores_gemma":[0.9981305,0.0010177436,0.000041751104,0.00023402926,0.0004097894,0.00016620208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000887545,0.000071302595,0.00018708517,0.000111469075,0.00008056152,0.000011881265,0.000054253498,0.0000865657,0.00042696728],"category_scores_gemma":[0.0009490571,0.0000479558,0.000024129044,0.00014750831,0.00032035113,0.00017759636,0.000057438057,0.00035145695,0.000113848895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010758149,0.0033739447,0.4698976,0.0008917872,0.00064917584,0.0050164177,0.0035597426,4.3016277e-7,0.3278665,0.0017240124,0.039223425,0.13703883],"study_design_scores_gemma":[0.005210151,0.0062747,0.9375067,0.000057533933,0.00019295397,0.0042236806,0.0008922131,0.000018421835,0.0109999785,0.0028107802,0.03165589,0.00015704452],"about_ca_topic_score_codex":0.0006885636,"about_ca_topic_score_gemma":0.0000058460646,"teacher_disagreement_score":0.46760905,"about_ca_system_score_codex":0.00003199034,"about_ca_system_score_gemma":0.00019399186,"threshold_uncertainty_score":0.46749926},"labels":[],"label_agreement":null},{"id":"W2081547800","doi":"10.1038/modpathol.3800757","title":"Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness","year":2007,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Cystectomy; Lymphovascular invasion; Bladder cancer; Medicine; Urothelium; Lymph node; Biomarker; Tissue microarray; Immunohistochemistry; Carcinoma; Pathology; Concordance; Cancer; Urinary bladder; Oncology; Urology; Internal medicine; Metastasis; Biology","score_opus":0.013622318979627216,"score_gpt":0.2954040238621424,"score_spread":0.28178170488251514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081547800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620545,0.0015777213,0.0008018612,0.000040370753,0.00013680295,0.0003951737,0.000011058094,0.000026055068,0.00080553174],"genre_scores_gemma":[0.9989348,0.00007565106,0.0003908487,0.00019316807,0.00003381969,0.00006322698,0.000013737982,0.000018563778,0.00027615027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990268,0.00008809227,0.00020316883,0.0003279551,0.00011931266,0.0002346675],"domain_scores_gemma":[0.99950284,0.00009243798,0.00009490385,0.00017327073,0.0000485539,0.000088023226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019834,0.00018246911,0.00037498563,0.000086942535,0.00007248229,0.0000026995572,0.000044101493,0.00015446897,0.00005158322],"category_scores_gemma":[0.000018464822,0.00011758609,0.00003610718,0.000065988446,0.00011955892,0.000021721096,0.000040830313,0.000108313674,0.000005630522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042471495,0.00046425415,0.13263558,0.00022830306,0.00015831612,0.0011334559,0.003760317,0.00013988672,0.74497527,0.000025814137,0.00008194944,0.11214973],"study_design_scores_gemma":[0.0026543958,0.0014142053,0.10226758,0.0001488535,0.00005995517,0.00006682468,0.000032589494,0.0000314506,0.8930767,0.00004352238,0.000094866555,0.00010903117],"about_ca_topic_score_codex":0.000013625182,"about_ca_topic_score_gemma":0.000011035565,"teacher_disagreement_score":0.14810148,"about_ca_system_score_codex":0.00006161859,"about_ca_system_score_gemma":0.00006698883,"threshold_uncertainty_score":0.47950217},"labels":[],"label_agreement":null},{"id":"W2081556908","doi":"10.1016/j.juro.2008.03.093","title":"Complications of the Catheterizable Channel Following Continent Urinary Diversion: Their Nature and Timing","year":2008,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urinary diversion; Surgery; Urinary system; Anatomy; Internal medicine; Cystectomy","score_opus":0.027172531319971906,"score_gpt":0.2672235418708668,"score_spread":0.24005101055089487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081556908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98477733,0.0037092534,0.00006589862,0.010383114,0.0002368827,0.00011257208,0.000004385128,0.0000028769514,0.0007076769],"genre_scores_gemma":[0.99820316,0.0004649142,0.00003597558,0.0011026608,0.000071802264,9.545557e-7,5.174992e-7,0.0000055953146,0.00011441587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955785,0.00006539598,0.00014910959,0.000045448025,0.000095822616,0.00008639159],"domain_scores_gemma":[0.9995351,0.0000815658,0.00014739428,0.00014519106,0.000056044657,0.000034719833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012315804,0.00006156768,0.00017534451,0.000030773153,0.00015657661,0.0000011531282,0.00011707156,0.000052166528,0.000009114787],"category_scores_gemma":[0.00001735365,0.000028126931,0.00009937857,0.0000565553,0.0001123451,0.000027218006,0.000057714195,0.00023769103,7.276678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016464073,0.0065429723,0.52370995,0.0003912805,0.01039318,0.0014653037,0.103950754,0.0011690011,0.29509452,0.0008872554,0.028079687,0.011852032],"study_design_scores_gemma":[0.007872856,0.004827517,0.9314519,0.00017720344,0.00173685,0.02440899,0.001217643,0.00035640263,0.0089894105,0.0011049222,0.01767778,0.00017853064],"about_ca_topic_score_codex":0.000011360582,"about_ca_topic_score_gemma":6.209746e-7,"teacher_disagreement_score":0.40774196,"about_ca_system_score_codex":0.000012186646,"about_ca_system_score_gemma":0.000046233676,"threshold_uncertainty_score":0.12042766},"labels":[],"label_agreement":null},{"id":"W2081916428","doi":"10.1016/j.juro.2008.03.057","title":"Associations Among Age, Comorbidity and Clinical Outcomes After Radical Cystectomy: Results From the Alberta Urology Institute Radical Cystectomy Database","year":2008,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cystectomy; Medicine; Comorbidity; Urology; Database; General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.04814016418042442,"score_gpt":0.3294605259183979,"score_spread":0.2813203617379735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081916428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714881,0.0009913846,0.00018668405,0.02544795,0.000892128,0.00032246468,0.00020601228,0.000014777621,0.00045045785],"genre_scores_gemma":[0.99047345,0.0010855094,0.00016159237,0.007113702,0.0008706117,0.0000062981767,0.00005187161,0.0000208317,0.00021611745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685764,0.0011442563,0.001042716,0.00024678072,0.00037222105,0.0003363707],"domain_scores_gemma":[0.99476826,0.0037899488,0.00052577065,0.0005372799,0.00010528737,0.00027347848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013036069,0.00022543938,0.0008390123,0.00007236116,0.00026300107,0.000011536242,0.00033822484,0.00028439658,0.00009534971],"category_scores_gemma":[0.0020883079,0.000114053706,0.00025673414,0.00012762817,0.0018046907,0.00013678994,0.00014936224,0.0013027729,0.000025363892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007223112,0.000500317,0.97837746,0.0000033083186,0.0014588442,0.002158347,0.00115051,0.000008204148,0.000029373949,0.000043103937,0.008553209,0.0004941966],"study_design_scores_gemma":[0.011501879,0.000995426,0.95741534,0.000011857751,0.0014802675,0.0021483768,0.000020182428,0.000050093477,0.0000072033827,0.00016808431,0.026103025,0.00009824342],"about_ca_topic_score_codex":0.0032896262,"about_ca_topic_score_gemma":0.0036529312,"teacher_disagreement_score":0.020962114,"about_ca_system_score_codex":0.00005994559,"about_ca_system_score_gemma":0.0003293267,"threshold_uncertainty_score":0.66494584},"labels":[],"label_agreement":null},{"id":"W2082130387","doi":"10.5539/cco.v3n2p36","title":"Immunotherapy for Bladder Cancer: Changing the Landscape","year":2014,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Bladder cancer; Chemotherapy; Clinical trial; Cancer; Oncology; Targeted therapy; Drug development; Drug; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.05938712996161956,"score_gpt":0.4342094471672967,"score_spread":0.37482231720567716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082130387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83854717,0.030394765,0.0024561344,0.0922278,0.0058405977,0.0028032253,0.00012888992,0.00016706617,0.027434334],"genre_scores_gemma":[0.9526777,0.013362061,0.00022249793,0.02598328,0.0031708595,0.0007510127,0.0000109059565,0.000035378012,0.003786283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989835,0.00006730778,0.00030822706,0.00027097983,0.00008139177,0.0002885763],"domain_scores_gemma":[0.9989221,0.0005925663,0.00009672684,0.00019472654,0.00007491171,0.00011895283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004710182,0.00012640806,0.00045764836,0.000030395558,0.00014869403,0.000010844705,0.00008098644,0.00016459341,0.0003591026],"category_scores_gemma":[0.000062264306,0.00007336145,0.00016375052,0.000084783795,0.00016718534,0.000023941144,0.00002531283,0.00018880807,0.000006435695],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011332909,0.0001616338,0.055803023,0.00002645082,0.00051627075,0.0000019891631,0.0003115507,0.0000017709875,0.00006392758,0.0005135746,0.0070274435,0.93443906],"study_design_scores_gemma":[0.012888738,0.0040184767,0.06662319,0.00005339955,0.0006243156,0.00001523118,0.00025413095,0.00069396466,0.00014343401,0.00068849034,0.91383415,0.0001624533],"about_ca_topic_score_codex":0.000116566036,"about_ca_topic_score_gemma":0.00019099422,"teacher_disagreement_score":0.93427664,"about_ca_system_score_codex":0.00005709994,"about_ca_system_score_gemma":0.00029467593,"threshold_uncertainty_score":0.39319214},"labels":[],"label_agreement":null},{"id":"W2082922220","doi":"10.1016/j.eururo.2012.01.006","title":"Reply to Maximilian Burger, Wolfgang Otto, and Arndt Hartmann's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hyperfractionation; Hazard ratio; Cumulative incidence; Confidence interval; Nuclear medicine; Urology; Surgery; Radiation therapy; Internal medicine; Dose fractionation; Transplantation","score_opus":0.014764921136303752,"score_gpt":0.2612066068535865,"score_spread":0.24644168571728273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082922220","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3926452,0.010348163,0.0017395113,0.564549,0.009521995,0.006859913,0.00037838897,0.0006670397,0.013290757],"genre_scores_gemma":[0.769118,0.00012734965,0.0003109051,0.21174543,0.008617728,0.00019901199,0.00003536499,0.0002508295,0.009595351],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959581,0.0007598877,0.00057631737,0.0010756865,0.00044673996,0.0011832805],"domain_scores_gemma":[0.99711096,0.0002425191,0.00015597047,0.0009976588,0.00014044261,0.0013524588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008850951,0.00063169864,0.0006594469,0.00023401435,0.00028777364,0.0001465081,0.0003385591,0.00010764977,0.00043588996],"category_scores_gemma":[0.00024997775,0.00044011482,0.00010831205,0.00036811086,0.00013973845,0.00024038041,0.00035987148,0.0004990009,0.00089839275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010563248,0.00015374989,0.022654295,0.000059857735,0.0003776569,0.00028369576,0.0055455137,0.000030977848,0.0011682482,0.00008580934,0.96054995,0.008033918],"study_design_scores_gemma":[0.0017783082,0.0009972722,0.10181353,0.000103046186,0.0004990978,0.00015023988,0.0001841999,0.000013004297,0.00022496714,0.000005313575,0.8938075,0.00042356344],"about_ca_topic_score_codex":0.00068531575,"about_ca_topic_score_gemma":0.00039016487,"teacher_disagreement_score":0.37647283,"about_ca_system_score_codex":0.000101835525,"about_ca_system_score_gemma":0.00012862064,"threshold_uncertainty_score":0.99987954},"labels":[],"label_agreement":null},{"id":"W2083032684","doi":"10.1016/j.juro.2011.02.1877","title":"1844 ACCURACY OF THE CHARLSON COMORBIDITY INDEX (CCI) IN PREDICTING IN-HOSPITAL MORTALITY (IHM) IN PATIENTS TREATED WITH RADICAL CYSTECTOMY (RC)","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Charlson comorbidity index; Cystectomy; Comorbidity; Bladder cancer; Cancer; Internal medicine","score_opus":0.023985699126095324,"score_gpt":0.2651903995775498,"score_spread":0.24120470045145448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083032684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843365,0.000122058234,0.0000052884698,0.00036097784,0.00013476255,0.0004473367,0.000005152826,0.000004026863,0.0004867585],"genre_scores_gemma":[0.9997029,0.000056110428,0.000009102103,0.00015795015,0.000048355247,0.0000055895757,0.0000012422142,0.000012959681,0.0000058381465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984417,0.00035604398,0.0005728794,0.00011050685,0.0002866001,0.0002322555],"domain_scores_gemma":[0.9990349,0.00012270412,0.00045170565,0.00024158173,0.00008766236,0.000061483224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005324675,0.00013668662,0.00043825363,0.00013762806,0.000027716944,0.0000020295788,0.00023091877,0.00010624704,0.00006335906],"category_scores_gemma":[0.00015951983,0.000068065434,0.00006535797,0.00028372498,0.0001967414,0.00008798307,0.000050371782,0.0006323047,0.0000012385372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035437795,0.0010796401,0.992083,0.000015388261,0.00009661785,0.00007313394,0.0024707024,0.000015193594,0.000049923558,0.000003920334,0.000015382178,0.0005533094],"study_design_scores_gemma":[0.009466193,0.003284449,0.9860847,0.000094193514,0.00014459805,0.000082322586,0.0001168105,0.00006463637,0.0005128939,0.00007582325,0.000020141873,0.00005325422],"about_ca_topic_score_codex":0.002331586,"about_ca_topic_score_gemma":0.00081843894,"teacher_disagreement_score":0.0059983246,"about_ca_system_score_codex":0.00010585077,"about_ca_system_score_gemma":0.0001602322,"threshold_uncertainty_score":0.35246763},"labels":[],"label_agreement":null},{"id":"W2084748232","doi":"10.1016/j.urolonc.2012.09.012","title":"Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Cystectomy; Perioperative; Volume (thermodynamics); Medicine; Urology; Internal medicine; Surgery; Bladder cancer; Physics; Thermodynamics","score_opus":0.041638716118398436,"score_gpt":0.3262084826597272,"score_spread":0.28456976654132876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084748232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629029,0.002298981,0.000037190424,0.030656416,0.00006262357,0.0006366533,0.00004400325,0.000059196525,0.0033020086],"genre_scores_gemma":[0.97929066,0.0001211674,0.010234128,0.004691993,0.000118232616,0.00036671944,0.000032863984,0.000017023689,0.0051272353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881893,0.00011201508,0.00026903354,0.000383408,0.00014062309,0.00027595865],"domain_scores_gemma":[0.9990593,0.00028191425,0.00007267507,0.00018478383,0.00006311482,0.00033818174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001250558,0.00023020426,0.00042921235,0.00009935458,0.00027729754,0.00004568252,0.00005865724,0.00030689815,0.0007700053],"category_scores_gemma":[0.0001164237,0.00016312588,0.0000623755,0.00014856011,0.0009694122,0.00018241738,0.00004742088,0.000390444,0.00013006324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041096842,0.00006605513,0.9940721,0.000019608402,0.00009236383,0.000045168174,0.0011873775,3.9742233e-7,0.000018137132,0.0008112775,0.0028267046,0.0008197246],"study_design_scores_gemma":[0.0012650413,0.0011430102,0.81804657,0.000029022953,0.00031221073,0.00016546804,0.00023026331,0.000064075444,0.000026468046,0.004411658,0.17416526,0.0001409691],"about_ca_topic_score_codex":0.00020272363,"about_ca_topic_score_gemma":0.000025544192,"teacher_disagreement_score":0.17602554,"about_ca_system_score_codex":0.00008379152,"about_ca_system_score_gemma":0.00021681603,"threshold_uncertainty_score":0.8431018},"labels":[],"label_agreement":null},{"id":"W2084771027","doi":"10.1007/s10517-010-0917-0","title":"Cellular Expression of INK4a Gene in Cells of Bladder Cancer Associated with Human Papilloma Virus-16","year":2010,"lang":"en","type":"article","venue":"Bulletin of Experimental Biology and Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Human papilloma virus; Gene; Cancer; Papilloma; Cancer research; Biology; Virus; Virology; Cervical cancer; Medicine; Pathology; Genetics","score_opus":0.013906638342222182,"score_gpt":0.3028659205513768,"score_spread":0.2889592822091546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084771027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925454,0.0044797366,0.000002120079,0.00022160563,0.000118903255,0.00030533972,0.00003443824,0.000007419265,0.002285013],"genre_scores_gemma":[0.99906015,0.00019496745,0.00012689142,0.00019081873,0.00007019041,0.00003348216,0.000059117436,0.000014036853,0.00025031198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990805,0.000048996935,0.0003663915,0.00021975522,0.00012270003,0.00016168739],"domain_scores_gemma":[0.9994261,0.00005226564,0.00021255753,0.00016539797,0.000061113664,0.00008256649],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013907402,0.00015717314,0.00055567553,0.00009409875,0.000027454706,4.3089779e-7,0.00006104377,0.00017195106,0.0029234695],"category_scores_gemma":[0.000022587514,0.00010104952,0.00003546665,0.00007259012,0.00068551005,0.0000075650614,0.00003556965,0.0001520799,9.960843e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000647643,0.00055122084,0.027777078,0.00003229894,0.00009376194,0.0000095465775,0.00066154986,9.605295e-8,0.96940905,0.000050811614,0.00060565537,0.00016128106],"study_design_scores_gemma":[0.006508407,0.002792205,0.011245655,0.00036572618,0.0000836,0.0000047738718,0.00042705485,3.6543221e-7,0.9771183,0.00001837968,0.0013540135,0.00008152635],"about_ca_topic_score_codex":0.0021385145,"about_ca_topic_score_gemma":0.000074327014,"teacher_disagreement_score":0.016531425,"about_ca_system_score_codex":0.000022548822,"about_ca_system_score_gemma":0.000037799808,"threshold_uncertainty_score":0.997988},"labels":[],"label_agreement":null},{"id":"W2084954166","doi":"10.1016/j.juro.2013.02.2288","title":"1869 UTILIZATION AND IMPACT OF PERI-OPERATIVE CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A POPULATION-BASED OUTCOMES STUDY","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Population; Cancer; Perioperative; Cancer registry; Gerontology; General surgery; Surgery; Internal medicine; Environmental health","score_opus":0.03570734756474586,"score_gpt":0.3700214405659419,"score_spread":0.334314093001196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084954166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954459,0.00066978304,0.000305032,0.002571607,0.00007172928,0.0008991685,0.00001359542,0.0000037258455,0.000019477182],"genre_scores_gemma":[0.9987322,0.00019436447,0.00009770853,0.00081278646,0.000075464835,0.000028551261,0.0000029031646,0.000015105727,0.00004088377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930096,0.00010384201,0.00028754887,0.00007322861,0.00012028818,0.000114155744],"domain_scores_gemma":[0.9990157,0.00024367,0.00025913812,0.00010920004,0.00031641917,0.000055866272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015695607,0.00011209368,0.0003624748,0.00008130097,0.000055173117,0.0000063316197,0.000058192854,0.000044180426,0.00029875396],"category_scores_gemma":[0.000068844,0.00005737222,0.000106074076,0.000065525135,0.00005143044,0.0000652272,0.000006280389,0.00008434303,6.379441e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014127649,0.0004949632,0.9813073,0.000016542263,0.0011365442,0.000002164441,0.0036855065,0.00041796413,0.002752218,0.0000057908105,0.00027604355,0.008492191],"study_design_scores_gemma":[0.006281333,0.006486383,0.98517245,0.000009900527,0.0004943106,0.000020582955,0.00049778586,0.00037666727,0.00044191885,0.00014922374,0.000023133049,0.000046315217],"about_ca_topic_score_codex":0.0012770704,"about_ca_topic_score_gemma":0.0001366351,"teacher_disagreement_score":0.008445876,"about_ca_system_score_codex":0.00005719607,"about_ca_system_score_gemma":0.00022240654,"threshold_uncertainty_score":0.32711464},"labels":[],"label_agreement":null},{"id":"W2085420626","doi":"10.1016/j.eururo.2008.01.004","title":"Nomograms for Bladder Cancer","year":2008,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Generalizability theory; Bladder cancer; Clinical trial; Predictive modelling; MEDLINE; Clinical study design; Medical physics; Intensive care medicine; Cancer; Oncology; Machine learning; Internal medicine; Statistics; Computer science","score_opus":0.08507779769368708,"score_gpt":0.3759497747433012,"score_spread":0.29087197704961415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085420626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013686783,0.96519744,0.00007809267,0.00016554617,0.0007987312,0.0015216318,0.00019046136,0.00011717263,0.031929567],"genre_scores_gemma":[0.000009669412,0.9879075,0.00018030862,0.0016007703,0.0018695602,0.0003549173,0.00033875485,0.00024107737,0.0074974247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814314,0.00022074052,0.00046299794,0.00059888995,0.00011832831,0.00045591898],"domain_scores_gemma":[0.9989459,0.00011508573,0.00019886633,0.0004913417,0.000068479494,0.00018031285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008140876,0.00046666965,0.0015468935,0.00014319835,0.000089041314,0.00000934027,0.00019925891,0.0001956903,0.00044090292],"category_scores_gemma":[0.000041592553,0.00034363102,0.000752595,0.00014727635,0.0001265204,0.00001829113,0.00006541614,0.00035289486,0.00073205156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054529068,0.00010636346,0.000012472323,0.0017085935,0.0008523959,0.00031647307,0.000039462248,1.5293442e-7,1.3255125e-7,0.000022142085,0.03452644,0.96236086],"study_design_scores_gemma":[0.001171785,0.00073386345,0.000034757817,0.000523525,0.0027420355,0.00089079275,0.0000010395669,8.366384e-7,2.4774835e-7,0.000005362079,0.99364513,0.00025061917],"about_ca_topic_score_codex":0.000021322896,"about_ca_topic_score_gemma":0.000005663835,"teacher_disagreement_score":0.9621102,"about_ca_system_score_codex":0.000081940525,"about_ca_system_score_gemma":0.00038036847,"threshold_uncertainty_score":0.9999016},"labels":[],"label_agreement":null},{"id":"W2085689874","doi":"10.1016/j.urology.2009.07.1296","title":"A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Lymph node; Proportional hazards model; Dissection (medical); Stage (stratigraphy); Epidemiology; Pathological; T-stage; Population; Carcinoma; Lymphadenectomy; Internal medicine; Oncology; Surgery; Overall survival","score_opus":0.014744760803445308,"score_gpt":0.31270630544236144,"score_spread":0.2979615446389161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085689874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285495,0.00018847751,0.00068166223,0.00346625,0.00071064493,0.0003616549,0.00006689871,0.00001626874,0.0016531867],"genre_scores_gemma":[0.9982956,0.0000036606273,0.00020689724,0.001016354,0.00032083926,0.000027536606,0.000009792628,0.000014688811,0.00010460215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991826,0.00006265444,0.00022701953,0.00018904838,0.000129249,0.00020942345],"domain_scores_gemma":[0.99929,0.00028395283,0.00005910814,0.00023622546,0.000075529715,0.00005519786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065652916,0.00011612549,0.0002858745,0.00004702939,0.0000492789,0.000002022528,0.00007882088,0.00013095688,0.00009530063],"category_scores_gemma":[0.0002446504,0.000077639066,0.000208763,0.00007036101,0.00014285145,0.000027324288,0.000016712742,0.000075785094,0.0000028165769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017545305,0.0029063819,0.693092,0.0003604805,0.0003529893,0.00004126355,0.0024746975,0.00009081592,0.25840214,0.012779578,0.002371296,0.009583053],"study_design_scores_gemma":[0.005561412,0.0028983601,0.943181,0.000017771466,0.0005645599,0.00044076296,0.000029989651,0.00060765294,0.041673597,0.0008136585,0.004105008,0.00010627311],"about_ca_topic_score_codex":0.000058397087,"about_ca_topic_score_gemma":0.0000037862167,"teacher_disagreement_score":0.25008896,"about_ca_system_score_codex":0.000039927905,"about_ca_system_score_gemma":0.00009908395,"threshold_uncertainty_score":0.31660295},"labels":[],"label_agreement":null},{"id":"W2085707564","doi":"10.1111/j.1464-410x.2008.07938.x","title":"OUTCOMES FOR PATIENTS WITH pT0 DISEASE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER‐TRACT UROTHELIAL CARCINOMA","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Center (category theory); University hospital; Medicine; Gerontology; Library science; History; Family medicine","score_opus":0.011992728463207614,"score_gpt":0.25159359174832413,"score_spread":0.2396008632851165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085707564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948755,0.001103925,0.0010398455,0.0012221498,0.00045567882,0.0009005985,0.0003506296,0.000012139974,0.000039523005],"genre_scores_gemma":[0.99413276,0.00009004411,0.0019676033,0.0027273935,0.0007040024,0.00011441177,0.000035588368,0.00004858845,0.00017962471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987458,0.000046204972,0.00039254004,0.00020752543,0.0002586263,0.00034932143],"domain_scores_gemma":[0.9988806,0.00014563814,0.00017522732,0.000121141675,0.00031562077,0.00036173445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008369709,0.00017372098,0.0005188478,0.00009618512,0.000107645246,0.000014982986,0.00009965933,0.000098238204,0.00011485964],"category_scores_gemma":[0.00016183517,0.00014231418,0.00034984472,0.000045764762,0.00016272029,0.00011549569,0.000012571829,0.00019472606,0.0000024098267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015249704,0.00085786055,0.9730309,0.00004482741,0.0002509312,0.002029194,0.00005989245,0.0000013910399,0.00000533949,0.000003864247,0.0031289686,0.005337078],"study_design_scores_gemma":[0.021784147,0.005297453,0.9450109,0.000041001433,0.00058383617,0.004681826,0.0000035356807,0.000008586823,0.000011635145,0.00008940602,0.022355227,0.00013244373],"about_ca_topic_score_codex":0.000023597942,"about_ca_topic_score_gemma":0.0000073826386,"teacher_disagreement_score":0.028020047,"about_ca_system_score_codex":0.000054349188,"about_ca_system_score_gemma":0.00035663095,"threshold_uncertainty_score":0.5803404},"labels":[],"label_agreement":null},{"id":"W2086274716","doi":"10.1371/journal.pone.0059536","title":"Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Cancer Society Research Institute; Vancouver Coastal Health Research Institute; Deutsche Forschungsgemeinschaft","keywords":"Bladder cancer; Ultrasound; Medicine; Pathology; Cancer; Cancer research; Urology; Radiology; Internal medicine","score_opus":0.060840167251806396,"score_gpt":0.2757808360255571,"score_spread":0.21494066877375068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086274716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486375,0.00031890543,0.0005675716,0.0003786236,0.00007967432,0.0012638787,0.00003352487,0.00006393875,0.0024301074],"genre_scores_gemma":[0.9839659,0.00014486547,0.013875798,0.00029036822,0.0002934907,0.00035028954,0.00010431024,0.0000323262,0.00094265834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99861014,0.000024230756,0.0003561198,0.00028261633,0.0004893768,0.00023749706],"domain_scores_gemma":[0.9990936,0.000049435952,0.00011745163,0.0003365554,0.0002793555,0.00012359513],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060720056,0.00017916097,0.0004108289,0.00010437569,0.00004678942,0.000019834197,0.00008541104,0.00011907302,0.0012083361],"category_scores_gemma":[0.00006252527,0.00014153046,0.00007779033,0.00024397501,0.00006403977,0.00016041184,0.000025768095,0.00014367209,0.000044255194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002814559,0.009488382,0.23152134,0.0006382383,0.0026779862,0.000004016032,0.0014242171,0.000053867465,0.74534845,0.00033945893,0.0020788745,0.0061437096],"study_design_scores_gemma":[0.008286379,0.00072152686,0.7601657,0.00066321075,0.001658984,0.00004457521,0.00018573322,0.001345108,0.22596778,0.00043969793,0.00010621912,0.00041510977],"about_ca_topic_score_codex":0.0035072677,"about_ca_topic_score_gemma":0.000028972616,"teacher_disagreement_score":0.5286443,"about_ca_system_score_codex":0.00010145124,"about_ca_system_score_gemma":0.000091629416,"threshold_uncertainty_score":0.9997047},"labels":[],"label_agreement":null},{"id":"W2086515666","doi":"10.1016/j.urology.2006.05.060","title":"Radiotherapy for Bladder Cancer","year":2007,"lang":"en","type":"review","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Cancer; Urology; Radiology; Internal medicine","score_opus":0.10187568979299463,"score_gpt":0.4438720873681748,"score_spread":0.3419963975751802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086515666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.4420106e-7,0.99352205,0.001091668,0.00039016738,0.0008389488,0.0018380873,0.00013627995,0.00005798494,0.0021244828],"genre_scores_gemma":[9.725445e-7,0.9888968,0.00035319035,0.002766023,0.0016509263,0.0008762582,0.00013959473,0.00011148931,0.005204739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869776,0.00003696844,0.0003439311,0.00041347355,0.00010096976,0.00040687475],"domain_scores_gemma":[0.99920756,0.00016162528,0.00013064679,0.00032564884,0.000052184096,0.0001223172],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000096649215,0.0003409138,0.0015792114,0.00017989754,0.00004100192,0.0000054645143,0.00010689633,0.00054323656,0.0011542751],"category_scores_gemma":[0.0000147236715,0.00024275847,0.000540328,0.00012903221,0.00007139562,0.000012586018,0.000012474705,0.00025195075,0.00005507332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013070455,0.00007268166,0.000007243793,0.0027487131,0.0013369715,0.000031891384,0.000021483553,1.8485986e-7,2.9661177e-7,0.00010339129,0.008807182,0.9867393],"study_design_scores_gemma":[0.0014205727,0.00077411777,0.0000030794843,0.0003600472,0.0033507745,0.00018731614,8.067064e-7,0.0000029411333,9.880667e-7,0.000048482736,0.99367607,0.00017478979],"about_ca_topic_score_codex":0.0000418988,"about_ca_topic_score_gemma":0.000020111062,"teacher_disagreement_score":0.98656446,"about_ca_system_score_codex":0.00016942651,"about_ca_system_score_gemma":0.00054949493,"threshold_uncertainty_score":0.9997588},"labels":[],"label_agreement":null},{"id":"W2087264624","doi":"10.1016/j.juro.2011.02.580","title":"485 MULTI-INSTITUTIONAL QUALITY OF CARE INITIATIVE FOR NON-METASTATIC MUSCLE-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER: PHASE 1","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transitional cell carcinoma; Urology; Quality (philosophy); Transitional Cell; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.08664399505231046,"score_gpt":0.3393103350942101,"score_spread":0.25266634004189964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087264624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919118,0.0008276142,0.0048675477,0.00050210935,0.0002353318,0.00049674977,0.00048279855,0.0000018575005,0.0006741721],"genre_scores_gemma":[0.9982151,0.000043374257,0.0010729464,0.0005423243,0.00008495983,0.000009254263,0.000009802024,0.000009846868,0.000012438894],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9987616,0.00024038981,0.0005412097,0.00008204833,0.0002349399,0.000139822],"domain_scores_gemma":[0.9982525,0.00037841118,0.00054876634,0.00016530561,0.00059466367,0.000060336108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033715885,0.00012419387,0.00042066158,0.000070027614,0.00008182068,9.4172225e-7,0.00016884752,0.000053031417,0.00012927149],"category_scores_gemma":[0.00009827945,0.00006409965,0.0003001361,0.000082496,0.00039863389,0.000052237207,0.000016908001,0.00018894584,0.0000011240154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11521283,0.025032192,0.08133851,0.0042285323,0.008415315,0.00038933137,0.37385517,0.00080433366,0.37330192,0.0038948825,0.0019803555,0.011546618],"study_design_scores_gemma":[0.06084776,0.01797738,0.66647893,0.00013287735,0.0050107744,0.00068972266,0.009511662,0.00014393665,0.2364864,0.002239638,0.00023499853,0.0002458822],"about_ca_topic_score_codex":0.00008268611,"about_ca_topic_score_gemma":0.00006249246,"teacher_disagreement_score":0.58514047,"about_ca_system_score_codex":0.000040563144,"about_ca_system_score_gemma":0.0007679188,"threshold_uncertainty_score":0.26139078},"labels":[],"label_agreement":null},{"id":"W2087735475","doi":"10.1016/j.juro.2010.02.2067","title":"1032 VALIDATION OF RESIDUAL PATHOLOGIC STAGE AT RADICAL CYSTECTOMY AS A PROGNOSTIC FACTOR IN PATIENTS WITH CT2N0 BLADDER CANCER","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Stage (stratigraphy); Bladder cancer; Art history; Classics; Cancer; History; Internal medicine","score_opus":0.013077904945683365,"score_gpt":0.27689967810370275,"score_spread":0.2638217731580194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087735475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980962,0.00019319667,0.0000132213445,0.0009395822,0.00018778576,0.00037733963,0.000024749952,0.0000053584595,0.00016251029],"genre_scores_gemma":[0.9992961,0.00003732326,0.000082892344,0.00031265465,0.000109509456,0.00000797453,0.0000045938186,0.000015188623,0.00013376305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988466,0.00018021672,0.00035712915,0.00010181249,0.0003216931,0.00019256493],"domain_scores_gemma":[0.9990622,0.0001595991,0.00034958284,0.00016824374,0.00017956836,0.00008084772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025563966,0.000121801066,0.00033027504,0.00011818631,0.00003433773,0.000003140406,0.00011984492,0.000115800096,0.00069091923],"category_scores_gemma":[0.00015303302,0.000062615196,0.00004517622,0.00011345011,0.00018580326,0.000054052834,0.00003131133,0.00045076924,0.0000069935186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006035973,0.00040181505,0.98547065,0.000019999274,0.0001603852,0.00011533806,0.0008310975,0.000033828874,0.0061020693,0.000009713918,0.000102279024,0.0007168512],"study_design_scores_gemma":[0.007910529,0.0058005927,0.9792391,0.00002627298,0.0003546446,0.00028987008,0.000034193345,0.000003981955,0.005704298,0.0000706823,0.00049805513,0.000067796886],"about_ca_topic_score_codex":0.00009018464,"about_ca_topic_score_gemma":0.00012547566,"teacher_disagreement_score":0.006231567,"about_ca_system_score_codex":0.00005064039,"about_ca_system_score_gemma":0.00023395513,"threshold_uncertainty_score":0.75650805},"labels":[],"label_agreement":null},{"id":"W2087890372","doi":"10.1016/j.juro.2012.09.036","title":"Prediction of True Nodal Status in Patients with Pathological Lymph Node Negative Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Pathological; Lymph node; Urology; Carcinoma; Lymph; Oncology; Internal medicine; Pathology; Cancer; Bladder cancer","score_opus":0.016837019545662534,"score_gpt":0.24397802354914194,"score_spread":0.22714100400347942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087890372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981876,0.0003509868,0.000076558674,0.00045101807,0.00025348528,0.00027521793,0.000057116325,0.0000058989685,0.00034213578],"genre_scores_gemma":[0.9988189,0.00005248889,0.00022958974,0.0005555372,0.00029048751,0.0000047617727,0.000008474357,0.000019176521,0.000020629717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833274,0.00038430517,0.00045286308,0.00010216539,0.00034599105,0.00038193414],"domain_scores_gemma":[0.9990383,0.0001943766,0.000310307,0.00016165957,0.00011541868,0.00017994865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003485754,0.00016414993,0.00045091714,0.00012465214,0.000045291774,0.0000023973544,0.00009946456,0.0001442259,0.00021920908],"category_scores_gemma":[0.0000874277,0.00008501632,0.00009928831,0.0001150579,0.00027164075,0.000117036834,0.000031965927,0.00035052683,0.0000053201666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01655677,0.00090395584,0.97895986,0.00000953111,0.000106630156,0.000036487934,0.0016880883,0.000015895414,0.00076325267,0.000007215475,0.00007151247,0.0008808261],"study_design_scores_gemma":[0.013559065,0.0047244723,0.9793721,0.000017109993,0.00038358587,0.00073105836,0.000070689006,0.000016722182,0.00067835423,0.0000370911,0.00034927198,0.000060513765],"about_ca_topic_score_codex":0.00006205859,"about_ca_topic_score_gemma":0.0000033670633,"teacher_disagreement_score":0.0038205166,"about_ca_system_score_codex":0.00019168887,"about_ca_system_score_gemma":0.00014944526,"threshold_uncertainty_score":0.34668648},"labels":[],"label_agreement":null},{"id":"W2088299344","doi":"10.5489/cuaj.10161","title":"Carcinosarcoma of the bladder: case report and review of the literature","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoprostatectomy; Cystectomy; Carcinosarcoma; Cystoscopy; Osteosarcoma; Surgery; Chemotherapy; Bladder Neoplasm; Urology; Radiology; Carcinoma; Bladder cancer; Pathology; Urinary system; Internal medicine; Cancer","score_opus":0.018713078640406212,"score_gpt":0.2398549271087975,"score_spread":0.22114184846839127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088299344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94307595,0.02554279,0.0000014808122,0.022598274,0.00041935258,0.0004676022,0.00010068607,0.000004911934,0.007788964],"genre_scores_gemma":[0.99382514,0.0011210085,0.00003292784,0.004533723,0.00008164278,0.000002799797,0.0000014638051,0.000004267397,0.00039704167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912494,0.00014571504,0.00029445076,0.000084141495,0.00020569997,0.0001450638],"domain_scores_gemma":[0.998992,0.00003748769,0.00035444027,0.000164905,0.00026661935,0.00018454423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037574675,0.00007194122,0.00020267449,0.000028978591,0.000118204225,0.0000067801516,0.0000797483,0.00010065162,0.00024334808],"category_scores_gemma":[0.00071662065,0.0000336574,0.0001450602,0.00018703713,0.00005146412,0.000028085251,0.000017042721,0.00031656658,5.7066313e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001677538,0.000035501558,0.9863454,0.00011622507,0.00014684025,0.0043324796,0.00050947175,4.9496638e-8,0.000021040913,0.00009124153,0.007343796,0.0010411583],"study_design_scores_gemma":[0.0003827208,0.00014237876,0.92457974,0.0006482968,0.0003025043,0.06725572,0.000039576847,8.9112996e-7,0.00015679521,0.00039744412,0.0060491785,0.00004476334],"about_ca_topic_score_codex":0.0015996484,"about_ca_topic_score_gemma":0.0006040646,"teacher_disagreement_score":0.06292324,"about_ca_system_score_codex":0.00015332764,"about_ca_system_score_gemma":0.00043331675,"threshold_uncertainty_score":0.2664491},"labels":[],"label_agreement":null},{"id":"W2088529382","doi":"10.1016/j.juro.2013.02.1988","title":"592 ULTRASOUND-GUIDED INTRAMURAL INOCULATION OF ORTHOTOPIC BLADDER CANCER XENOGRAFTS","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine","score_opus":0.021821321663306536,"score_gpt":0.29936447608190814,"score_spread":0.2775431544186016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088529382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257517,0.0014812557,0.00015497774,0.004179303,0.00039734432,0.000241008,0.000002392853,0.000006061017,0.0009624994],"genre_scores_gemma":[0.99746376,0.0005165215,0.0001455649,0.0012164155,0.00039868054,0.0000066457346,0.0000015792994,0.000011524265,0.00023932518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990756,0.00011056248,0.00040173548,0.00006050199,0.0001888938,0.00016274198],"domain_scores_gemma":[0.9990742,0.00011839966,0.00030175576,0.00015564248,0.00027702612,0.00007293891],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018320976,0.00009746977,0.00028485834,0.000082767954,0.000035594785,0.0000048017628,0.00010671468,0.000075882665,0.0013312763],"category_scores_gemma":[0.000051927673,0.000054623746,0.00009496885,0.00010897892,0.00011881783,0.00008441189,0.000013458898,0.00021317991,0.000015527254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023490165,0.0007926739,0.6994461,0.00011882119,0.0032773332,0.00006849277,0.006281033,0.0009502163,0.21962862,0.0004247709,0.031762917,0.034900043],"study_design_scores_gemma":[0.0044698454,0.0022396476,0.9719712,0.000037647627,0.0012555742,0.0028627382,0.0001928192,0.00009858455,0.010986146,0.0017513785,0.004016017,0.00011840676],"about_ca_topic_score_codex":0.00067249173,"about_ca_topic_score_gemma":0.00004256223,"teacher_disagreement_score":0.27252513,"about_ca_system_score_codex":0.00003556034,"about_ca_system_score_gemma":0.00013111839,"threshold_uncertainty_score":0.99958163},"labels":[],"label_agreement":null},{"id":"W2088616529","doi":"10.1097/spc.0b013e3282f125ec","title":"Predicting outcomes in patients with urologic cancers","year":2007,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nomogram; Prostate cancer; Kidney cancer; Stage (stratigraphy); Bladder cancer; Disease; Prostatectomy; Cancer; Oncology; Internal medicine; Prostate; Nephrology; Natural history","score_opus":0.12675941175748692,"score_gpt":0.42975420520058394,"score_spread":0.302994793443097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088616529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033903476,0.9924082,0.000006221234,0.0000071773443,0.0010840782,0.0022563238,0.0005751002,0.000020983702,0.00025157],"genre_scores_gemma":[0.0036817614,0.99407655,0.000023163062,0.000029005241,0.00013653189,0.000302082,0.001689339,0.00004194601,0.00001963741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997906,0.00009862444,0.00064410525,0.00061799475,0.000327897,0.00040532745],"domain_scores_gemma":[0.99900955,0.0001284296,0.00034895222,0.00018913629,0.00017616352,0.00014777159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009030031,0.00051322544,0.0016059194,0.0003662847,0.00004158914,0.000013063834,0.00008032243,0.00021789131,0.000051152085],"category_scores_gemma":[0.000052663414,0.00033534752,0.00016972791,0.00038655545,0.00009991849,0.00006642083,0.00005202516,0.00063146855,0.00000608494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009605538,0.00010571818,0.71835446,0.008490627,0.00010092884,0.000006125881,0.0006766954,2.1101916e-7,3.7170442e-10,0.0000059246718,0.000029602139,0.27213365],"study_design_scores_gemma":[0.0035936513,0.0009870883,0.60457563,0.025484718,0.0003066683,7.921556e-7,0.00035810066,5.664889e-7,9.159194e-8,0.000004184361,0.3643497,0.0003387754],"about_ca_topic_score_codex":0.00006736574,"about_ca_topic_score_gemma":0.000049914135,"teacher_disagreement_score":0.3643201,"about_ca_system_score_codex":0.00078003044,"about_ca_system_score_gemma":0.00057229004,"threshold_uncertainty_score":0.9999099},"labels":[],"label_agreement":null},{"id":"W2088751098","doi":"10.4081/nr.2012.e15","title":"An Ileal Neobladder Urinary Leak Mimicking Rapidly Progressive Glomerulonephritis","year":2012,"lang":"en","type":"article","venue":"Nephrology Research & Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Dysuria; Urinary system; Cystectomy; Urinary diversion; Urology; Proteinuria; Urinalysis; Complication; Surgery; Internal medicine; Kidney; Bladder cancer; Cancer","score_opus":0.11364936557272219,"score_gpt":0.44334271111170676,"score_spread":0.32969334553898455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088751098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5111857,0.46293727,0.00007115629,0.004371014,0.00050206133,0.0059530223,0.000033027634,0.00021020524,0.0147365155],"genre_scores_gemma":[0.9524685,0.03308985,0.0022700042,0.006021611,0.0031760533,0.0016484966,0.0001306845,0.00011159051,0.0010831855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948966,0.0015724944,0.00057938823,0.00061574875,0.00067635044,0.0016594112],"domain_scores_gemma":[0.9975945,0.00015185539,0.00013227033,0.0009999321,0.00028113468,0.00084030954],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023920669,0.00035012283,0.0009161194,0.0003222511,0.00038439626,0.00003901485,0.00032298252,0.00031680023,0.003634282],"category_scores_gemma":[0.00020772967,0.0002689081,0.00024649772,0.0005945147,0.00060786423,0.00045939317,0.00015909258,0.0011026524,0.0016606676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019940299,0.004052436,0.08629316,0.0009654192,0.00055713166,0.0011415657,0.0029014486,3.6834984e-7,0.018176695,0.00042334537,0.09052385,0.79297054],"study_design_scores_gemma":[0.002611029,0.0043860753,0.053680994,0.00033287943,0.00019991864,0.0023942331,0.00014220434,0.000013804381,0.0005788619,0.00016980746,0.93519604,0.00029416115],"about_ca_topic_score_codex":0.00010421248,"about_ca_topic_score_gemma":0.000022762806,"teacher_disagreement_score":0.8446722,"about_ca_system_score_codex":0.00018548952,"about_ca_system_score_gemma":0.00028299523,"threshold_uncertainty_score":0.99997634},"labels":[],"label_agreement":null},{"id":"W2088906049","doi":"10.1364/boe.2.002961","title":"Double-clad fiber with a tapered end for confocal endomicroscopy","year":2011,"lang":"en","type":"article","venue":"Biomedical Optics Express","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Endomicroscopy; Optics; Materials science; Achromatic lens; Optical sectioning; Confocal; Cladding (metalworking); Speckle pattern; Optical fiber; Optical coherence tomography; Confocal microscopy; Optoelectronics; Physics","score_opus":0.04510085473750319,"score_gpt":0.29532520072347984,"score_spread":0.25022434598597665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088906049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66042435,0.002295927,0.06401323,0.0036375201,0.0033653106,0.013400827,0.0017532133,0.0010537797,0.25005582],"genre_scores_gemma":[0.8837424,0.000063792366,0.10467976,0.0010697824,0.0007801206,0.00070520054,0.0002469625,0.00011125269,0.008600716],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859893,0.000013218025,0.00027016606,0.0003537936,0.00034604166,0.00041785717],"domain_scores_gemma":[0.99898016,0.000072041614,0.00006494754,0.00033032364,0.00010983574,0.00044268754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008666618,0.00022772643,0.000394946,0.000071828865,0.00007038226,0.00001905587,0.00013778743,0.00018207631,0.0015068853],"category_scores_gemma":[0.000021280975,0.00015373829,0.00010921342,0.000102164755,0.0004000339,0.00005534641,0.000041041232,0.00013887907,0.00007987004],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24014966,0.02165714,0.0070935553,0.0034076176,0.00906867,0.0028454666,0.01997801,0.0000021735152,0.48053217,0.018979235,0.10005799,0.096228294],"study_design_scores_gemma":[0.114857264,0.010696497,0.0016857021,0.0006232879,0.0016214073,0.00045710042,0.00040852508,0.00023974586,0.3770747,0.00045054595,0.4908991,0.0009861301],"about_ca_topic_score_codex":0.000100072146,"about_ca_topic_score_gemma":0.0000031497727,"teacher_disagreement_score":0.39084113,"about_ca_system_score_codex":0.000052769617,"about_ca_system_score_gemma":0.00024084287,"threshold_uncertainty_score":0.99940586},"labels":[],"label_agreement":null},{"id":"W2089075052","doi":"10.1002/cncr.25345","title":"A population‐based competing‐risks analysis of the survival of patients treated with radical cystectomy for bladder cancer","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; Population; Mortality rate; Comorbidity; Epidemiology; Surgery; Internal medicine","score_opus":0.028435693610610376,"score_gpt":0.32567941274568946,"score_spread":0.2972437191350791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089075052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977623,0.00009936926,0.000068214445,0.00020458942,0.00019775282,0.0007138739,0.00072263734,0.000015238212,0.0002160318],"genre_scores_gemma":[0.9990699,0.0000068397903,0.0001754616,0.00015122906,0.000079531324,0.00022930543,0.000120181256,0.000023621169,0.00014390555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900615,0.00003311789,0.00026533936,0.0002113546,0.00031706668,0.00016698241],"domain_scores_gemma":[0.9989846,0.00007438667,0.00022097028,0.0003172573,0.00032783847,0.00007497486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066037595,0.00014343539,0.0004998201,0.00011875464,0.000056003337,0.00000407751,0.00009632204,0.00008013988,0.00059213553],"category_scores_gemma":[0.000032747026,0.000082532395,0.00022132199,0.00066714233,0.000116773466,0.000023714407,0.00001188815,0.00011450746,2.6044773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086150167,0.00020077059,0.99441093,0.00006865074,0.00164748,3.1909985e-7,0.00009208287,0.00027310816,0.00096788845,0.000017304867,0.000063992076,0.0013959452],"study_design_scores_gemma":[0.0052966294,0.00018584468,0.98118925,0.00007531453,0.004517032,1.4560658e-7,0.000014896434,0.00096639915,0.007103615,0.0000032455227,0.0005580519,0.000089601526],"about_ca_topic_score_codex":0.006351646,"about_ca_topic_score_gemma":0.004859,"teacher_disagreement_score":0.013221731,"about_ca_system_score_codex":0.00008030109,"about_ca_system_score_gemma":0.0002536451,"threshold_uncertainty_score":0.96018314},"labels":[],"label_agreement":null},{"id":"W2089217611","doi":"10.1016/j.urology.2008.08.419","title":"UP.91: Total Pelvic Exenteration for Colorectal Cancer: A Review of General and Genitourinary Outcomes","year":2008,"lang":"en","type":"review","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pelvic exenteration; Genitourinary system; Cystectomy; Colorectal cancer; Demographics; Urinary diversion; Population; Radiation therapy; Oncology; Surgery; Bladder cancer; General surgery; Urology; Cancer; Internal medicine","score_opus":0.039145056871798006,"score_gpt":0.36955956308601867,"score_spread":0.33041450621422064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089217611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030681028,0.9959967,0.0000139193735,0.00026344013,0.000627239,0.0022355919,0.0002898038,0.000019551715,0.00024692103],"genre_scores_gemma":[0.000049113813,0.9962592,0.00011921038,0.0006190245,0.00040462843,0.0009760942,0.000355097,0.00004433782,0.0011732922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869615,0.00008979702,0.0005239814,0.00035027435,0.00011701556,0.00022277355],"domain_scores_gemma":[0.9992933,0.000097524484,0.0002597416,0.00018116864,0.00008328965,0.00008494888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050171813,0.0003169159,0.0020490843,0.000108156186,0.000046000037,0.0000028230622,0.000061845894,0.00022690203,0.00013101607],"category_scores_gemma":[0.0000415457,0.00022928849,0.00045990804,0.00008145253,0.00008352473,0.000025577827,0.00004080932,0.0001593288,0.000006085022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001972241,0.00013504688,0.00038386032,0.07906284,0.0009081811,0.000057822675,0.000053520907,1.4415913e-7,0.000002955104,0.000022980337,0.007521781,0.91165364],"study_design_scores_gemma":[0.0016455379,0.0018055124,0.00027340563,0.0068925335,0.0036014535,0.002114492,0.0000010520915,0.000007794067,0.0000042277734,0.000008246867,0.9834575,0.00018825023],"about_ca_topic_score_codex":0.000061531595,"about_ca_topic_score_gemma":0.000008303433,"teacher_disagreement_score":0.9759357,"about_ca_system_score_codex":0.00007688034,"about_ca_system_score_gemma":0.00042273352,"threshold_uncertainty_score":0.9350113},"labels":[],"label_agreement":null},{"id":"W2091172403","doi":"10.1016/j.eururo.2009.06.004","title":"The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphadenectomy; Urology; Hazard ratio; Proportional hazards model; Lymphovascular invasion; Lymph; Stage (stratigraphy); Lymph node; Population; Carcinoma; Cancer; Oncology; Internal medicine; Surgery; Metastasis; Pathology; Confidence interval","score_opus":0.01975750519065544,"score_gpt":0.24438450789171723,"score_spread":0.22462700270106178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091172403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850398,0.00010375356,0.00007925954,0.010256009,0.00012996506,0.00073035393,0.000076368764,0.00004247204,0.0035420433],"genre_scores_gemma":[0.9908415,0.000009539646,0.00018829308,0.008212207,0.00009030443,0.000015055738,0.000071795315,0.000079756646,0.0004915401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997498,0.00053103897,0.00035616657,0.000496191,0.0005339163,0.00058469805],"domain_scores_gemma":[0.99879444,0.00018000795,0.00018537593,0.0005101389,0.0001512412,0.00017878471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037699283,0.00035477956,0.0005523874,0.00015256679,0.000103645565,0.00003090635,0.00024605248,0.00006753272,0.000033155364],"category_scores_gemma":[0.00012068647,0.00021296051,0.00008823417,0.00030205716,0.00015605743,0.000073501345,0.00005033223,0.00020377494,0.00001229914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033667043,0.001045464,0.9898933,0.000011348268,0.0002291213,0.0004143086,0.00067326747,0.000036669142,0.0003992659,0.00003498235,0.00018038218,0.0037151626],"study_design_scores_gemma":[0.010765905,0.0036613985,0.9834112,0.000034141154,0.00027248065,0.000028114795,0.00006893463,0.000025777148,0.00017921458,0.000009435243,0.0013296164,0.00021376183],"about_ca_topic_score_codex":0.0000898184,"about_ca_topic_score_gemma":0.000055149514,"teacher_disagreement_score":0.0073992005,"about_ca_system_score_codex":0.00014532595,"about_ca_system_score_gemma":0.000119504315,"threshold_uncertainty_score":0.86842775},"labels":[],"label_agreement":null},{"id":"W2091661100","doi":"10.1097/mou.0b013e32830b86d1","title":"The detection of genetic markers of bladder cancer in urine and serum","year":2008,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Loss of heterozygosity; Oncology; Cancer; Cancer research; Bioinformatics; Internal medicine; Gene; Allele; Genetics; Biology","score_opus":0.0553746453855662,"score_gpt":0.37719946015897393,"score_spread":0.32182481477340774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091661100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037133353,0.9967342,0.000007247683,0.00005135937,0.0019934608,0.00073780137,0.000045728488,0.000004304221,0.000054560645],"genre_scores_gemma":[0.003940401,0.995658,0.0000041317203,0.0000051934376,0.00014998451,0.0001945002,0.000011860565,0.000019983752,0.000015964188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986864,0.0001620212,0.0006005926,0.00024946523,0.00011277646,0.00018878948],"domain_scores_gemma":[0.99933535,0.00012430814,0.0002564332,0.0002093609,0.000034730452,0.00003984568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007927686,0.00019691032,0.000866251,0.00022670344,0.000019244744,0.000001379075,0.00007716936,0.00017453877,0.00004099401],"category_scores_gemma":[0.000027925993,0.00013232949,0.0001163944,0.00024699094,0.00017821857,0.000011839466,0.000045655986,0.00030227916,0.0000017358542],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012790682,0.000086692635,0.0061251386,0.0050134845,0.00008054074,0.0000014634807,0.000037464473,0.000001873178,5.4228764e-7,0.0000039655365,0.00007651484,0.9884444],"study_design_scores_gemma":[0.001434023,0.0005577852,0.050380044,0.0029903073,0.00021935704,0.00010535908,0.000006707762,0.000022693204,0.0000024963153,0.000026619879,0.94414353,0.00011108392],"about_ca_topic_score_codex":0.00011733742,"about_ca_topic_score_gemma":0.00007788136,"teacher_disagreement_score":0.98833334,"about_ca_system_score_codex":0.00007191262,"about_ca_system_score_gemma":0.00026098636,"threshold_uncertainty_score":0.539624},"labels":[],"label_agreement":null},{"id":"W2091837648","doi":"10.1016/j.ijrobp.2014.05.1451","title":"The Outcomes of Radiation Therapy and Surgery for Bladder Cancer: A Population-Based Study","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Cancer; Surgery; General surgery; Internal medicine","score_opus":0.033316152866863596,"score_gpt":0.3602958018697545,"score_spread":0.3269796490028909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091837648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871631,0.0009831322,0.003564086,0.006077436,0.0015440458,0.0005670644,0.000048820886,0.00001469511,0.000037581278],"genre_scores_gemma":[0.99672705,0.0007398517,0.0002953681,0.0010556374,0.0010266482,0.000059659702,0.00004957807,0.000020095007,0.00002613281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986602,0.00019619995,0.0006278129,0.00014795788,0.00023093035,0.00013686703],"domain_scores_gemma":[0.99665695,0.0016949744,0.0009201382,0.000119888115,0.00054220785,0.00006582254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006626245,0.00014383673,0.00046199362,0.00011281666,0.00010157296,0.000019354531,0.00013796378,0.000099203666,0.000016156479],"category_scores_gemma":[0.0003412884,0.00009494347,0.00020449334,0.0000846447,0.00006943605,0.00010792805,0.000010842313,0.0001333023,8.6009675e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005436408,0.0003190751,0.6946585,0.000002978,0.000809315,6.685548e-7,0.00014978935,0.000109052155,0.00009000077,0.00066132215,0.00024034163,0.30241534],"study_design_scores_gemma":[0.008561141,0.0015920077,0.97376466,0.00001715667,0.0002226459,0.0000069269413,0.00006105399,0.0014667321,0.0007375877,0.002989128,0.010485321,0.00009566311],"about_ca_topic_score_codex":0.00013500774,"about_ca_topic_score_gemma":0.000029010462,"teacher_disagreement_score":0.30231968,"about_ca_system_score_codex":0.0002527648,"about_ca_system_score_gemma":0.00042741298,"threshold_uncertainty_score":0.38716823},"labels":[],"label_agreement":null},{"id":"W2092082274","doi":"10.1007/s00345-014-1457-4","title":"High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec","year":2014,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bladder cancer; Cystectomy; Nephrology; Cohort; Proportional hazards model; Retrospective cohort study; Quartile; Cancer; Surgery; Internal medicine; Confidence interval","score_opus":0.0036065005594111996,"score_gpt":0.23274225756807096,"score_spread":0.22913575700865976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092082274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996993,0.000950591,0.0000058825262,0.0014437672,0.00028418383,0.00019348614,0.000014666076,0.000005019993,0.00010939812],"genre_scores_gemma":[0.99878263,0.00010883359,0.000014877022,0.00044122935,0.00021034537,0.000008690912,0.0000025493823,0.000022687134,0.00040815727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891096,0.00011932146,0.0002793551,0.0001867137,0.00023661161,0.0002670141],"domain_scores_gemma":[0.9993525,0.00008198235,0.00016115262,0.00009004161,0.00009235224,0.00022194233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014873294,0.0001878804,0.00050053484,0.00024056401,0.000023634646,0.000015420712,0.000042518237,0.00007768355,0.00031236556],"category_scores_gemma":[0.000025879826,0.00011776286,0.00005695026,0.000094251984,0.00011248098,0.00012054398,0.000019815934,0.00033752032,0.0000021462631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046868944,0.00023653981,0.9900284,0.00001320183,0.00022340285,0.00015382413,0.0001567502,0.0000311386,0.00000829159,0.00001739275,0.00019911352,0.0042450535],"study_design_scores_gemma":[0.009536511,0.0037175815,0.98512113,0.00007387182,0.0001682106,0.00002838631,0.0000036560978,0.000041399377,0.00001018937,0.000030501378,0.0011575564,0.00011098337],"about_ca_topic_score_codex":0.0036777921,"about_ca_topic_score_gemma":0.008695781,"teacher_disagreement_score":0.005017989,"about_ca_system_score_codex":0.00010101077,"about_ca_system_score_gemma":0.000097357086,"threshold_uncertainty_score":0.5559746},"labels":[],"label_agreement":null},{"id":"W2092124378","doi":"10.1016/j.urology.2011.04.070","title":"Diminished Efficacy of Bacille Calmette-Guérin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Proportional hazards model; Internal medicine; Cancer; Cohort; Stage (stratigraphy); Prospective cohort study; Log-rank test; Urology; Oncology; Confidence interval","score_opus":0.01931887798177135,"score_gpt":0.24222204444240283,"score_spread":0.2229031664606315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092124378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906267,0.00012782727,0.00004673086,0.00013211291,0.00019605595,0.0005785653,0.000040539187,0.000034138764,0.009781387],"genre_scores_gemma":[0.998541,0.000024578316,0.00016987545,0.0006821743,0.00006375077,0.00008624774,0.000029151452,0.000035857935,0.0003673602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988692,0.000046252728,0.0002439309,0.00033091934,0.0001922598,0.000317439],"domain_scores_gemma":[0.9991623,0.000069004906,0.0001264455,0.00034102227,0.00015571006,0.00014547742],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000037577454,0.00019309297,0.00039305768,0.000095148316,0.000041517404,0.0000026851458,0.000105363506,0.00013414797,0.0019703025],"category_scores_gemma":[0.000041787167,0.00014067098,0.00007552194,0.000145111,0.00023544121,0.00006194505,0.000039402887,0.00015432789,0.000036598256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022188122,0.001025851,0.9864092,0.00003471454,0.00056034845,0.00005304276,0.0018239162,0.000007811545,0.00019413873,0.000027125627,0.00089906005,0.0067459736],"study_design_scores_gemma":[0.009425368,0.005443461,0.9796814,0.0000219347,0.00046867717,0.000005177474,0.00004982599,0.0000054180628,0.0040358217,0.000028011524,0.00069112406,0.00014378897],"about_ca_topic_score_codex":0.0014700029,"about_ca_topic_score_gemma":0.0006556903,"teacher_disagreement_score":0.00947836,"about_ca_system_score_codex":0.000033626195,"about_ca_system_score_gemma":0.00016329625,"threshold_uncertainty_score":0.998942},"labels":[],"label_agreement":null},{"id":"W2092388888","doi":"10.1097/00042307-200009000-00013","title":"Can biological markers predict recurrence and progression of superficial bladder cancer?","year":2000,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"PTEN; Medicine; Urothelium; Tumor progression; Cancer research; Pathology; Vascular endothelial growth factor; Cancer; Clinical significance; Oncology; Urinary bladder; Internal medicine; VEGF receptors; Biology; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.11127015672054591,"score_gpt":0.4241037801748647,"score_spread":0.3128336234543188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092388888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003268611,0.99429643,0.0000015526548,0.00014123508,0.0031185101,0.0014914474,0.00040906967,0.00002847299,0.00018643714],"genre_scores_gemma":[0.0008591326,0.9974587,0.000018762757,0.000017935588,0.00061918603,0.0005069406,0.00047932696,0.000029999808,0.000009991833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976973,0.00031396814,0.00074159383,0.00066007394,0.00019728177,0.00038977803],"domain_scores_gemma":[0.99916655,0.00012504618,0.00023841554,0.00026978686,0.000043080538,0.00015709939],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015727428,0.00042343125,0.001652751,0.00029217527,0.000036351426,0.0000059079525,0.00015367469,0.00050784036,0.0003767495],"category_scores_gemma":[0.000050707775,0.00029417893,0.00020378639,0.00030930043,0.0003454438,0.000024149065,0.00008338542,0.00064638845,0.0000057592456],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000299277,0.00026978707,0.005596144,0.006561516,0.00010376766,0.000004351967,0.000057283512,1.8076567e-7,1.1118289e-7,0.000025958447,0.00091957377,0.98616207],"study_design_scores_gemma":[0.0012228278,0.0014998078,0.0018184358,0.011542798,0.00040839135,0.00008949151,0.000005654515,0.000007855835,4.3849403e-7,0.000050652983,0.9831208,0.00023283856],"about_ca_topic_score_codex":0.000050976854,"about_ca_topic_score_gemma":0.000006492467,"teacher_disagreement_score":0.9859292,"about_ca_system_score_codex":0.00010461502,"about_ca_system_score_gemma":0.0007176838,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W2092934604","doi":"10.1038/modpathol.2014.158","title":"Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer","year":2014,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Grading (engineering); Terminology; Disease; Urine cytology; Gynecology; Pathology; Family medicine; Cancer; Internal medicine","score_opus":0.05791752029981536,"score_gpt":0.36970232288296667,"score_spread":0.31178480258315133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092934604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010254779,0.9591133,0.007776596,0.018011477,0.0030130425,0.006298194,0.0017557393,0.00013553804,0.002870637],"genre_scores_gemma":[0.045408845,0.9439804,0.00007551774,0.0066404087,0.0006617728,0.0013669346,0.00087274273,0.000095601914,0.0008977869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698454,0.0010411981,0.0006922323,0.00060847896,0.00035265682,0.00032088795],"domain_scores_gemma":[0.99391603,0.0037907164,0.0013622973,0.0005141619,0.00035386087,0.00006290257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011712599,0.00039068668,0.00094906124,0.00014596048,0.00019305063,0.00002718199,0.00031916282,0.00029653337,0.00007137663],"category_scores_gemma":[0.0029447672,0.00021011956,0.00035993138,0.00011617402,0.0001916826,0.000037036836,0.000058219328,0.0005479585,0.00008876262],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015824963,0.00046381538,0.00033421986,0.0010353812,0.001383057,0.00011160372,0.0008054843,0.0006519351,0.000020230545,0.0015485422,0.00318384,0.9888794],"study_design_scores_gemma":[0.00349025,0.0013269953,0.0020747208,0.00061464123,0.007240629,0.00010054572,0.000031982287,0.0013289112,0.000007337161,0.0010412997,0.98244286,0.00029983133],"about_ca_topic_score_codex":0.000016313978,"about_ca_topic_score_gemma":0.000021590953,"teacher_disagreement_score":0.9885796,"about_ca_system_score_codex":0.00028921964,"about_ca_system_score_gemma":0.000297249,"threshold_uncertainty_score":0.8568427},"labels":[],"label_agreement":null},{"id":"W2093470910","doi":"10.1016/j.purol.2010.02.008","title":"Nécrose vésicale dans les suites d’une instillation postopératoire précoce (Ipop) de mitomycine C","year":2010,"lang":"fr","type":"article","venue":"Progrès en Urologie","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Mitomycin C; Cystectomy; Necrosis; Urology; Urinary bladder; Gynecology; Bladder cancer; Surgery; Cancer; Internal medicine","score_opus":0.018808352456671732,"score_gpt":0.30191287758216406,"score_spread":0.28310452512549233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093470910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432037,0.017578926,0.0002940677,0.02090069,0.0030768772,0.0013358376,0.00012116174,0.00037932745,0.013109452],"genre_scores_gemma":[0.9828348,0.0008766389,0.003784028,0.0008370395,0.0027166929,0.0001862425,0.00010626013,0.000088445515,0.008569864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972736,0.00017435291,0.0004733674,0.00066508754,0.00035974523,0.0010538285],"domain_scores_gemma":[0.9981599,0.00043922657,0.00016106911,0.0006246241,0.00019870287,0.00041652154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040888975,0.00048281348,0.0005264139,0.0001133278,0.0002966895,0.00008956686,0.00031400457,0.000707167,0.00056940696],"category_scores_gemma":[0.0009611753,0.00042399406,0.00020134394,0.00042753862,0.000659349,0.00023904846,0.00014162794,0.0010423345,0.00031006872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039247255,0.0009209351,0.56253755,0.00020338918,0.00020923669,0.00034174358,0.002962671,0.000019043353,0.041340474,0.0006798435,0.001042066,0.3893506],"study_design_scores_gemma":[0.0057550464,0.003176992,0.5396054,0.00022204376,0.0013324243,0.00073460524,0.00063119945,0.0011890981,0.052059636,0.0014011327,0.39310947,0.00078296097],"about_ca_topic_score_codex":0.0014223598,"about_ca_topic_score_gemma":0.0011440384,"teacher_disagreement_score":0.3920674,"about_ca_system_score_codex":0.00023740908,"about_ca_system_score_gemma":0.000662829,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W2093842066","doi":"10.1159/000325463","title":"Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery","year":2011,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; Université Laval; Université de Montréal","funders":"","keywords":"Concomitant; Medicine; Cystectomy; Bladder cancer; Lymphovascular invasion; Carcinoma in situ; Urology; Carcinoma; Lymphadenectomy; Proportional hazards model; Stage (stratigraphy); Cancer; Surgery; Internal medicine; Oncology; Metastasis","score_opus":0.07541865413050217,"score_gpt":0.31618322939264615,"score_spread":0.24076457526214398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093842066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909268,0.00005304364,0.0000058141495,0.0010644399,0.0002445776,0.00028287372,0.0000669514,0.000031211363,0.0073242653],"genre_scores_gemma":[0.99404556,0.000011536253,0.000075850185,0.0051788334,0.000054070642,0.00008744198,0.000036601145,0.000020000214,0.000490081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985242,0.00010460762,0.00052415143,0.00032798498,0.00028158366,0.00023745566],"domain_scores_gemma":[0.9990818,0.00042104282,0.00012352609,0.00019823477,0.000099768265,0.00007565188],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034988884,0.00017379339,0.00048250426,0.0002209844,0.000010342464,0.000008422927,0.00009576071,0.0001435814,0.0009867109],"category_scores_gemma":[0.0002675659,0.00012525116,0.00014661992,0.0001496343,0.000091111746,0.000074214884,0.000038153717,0.00025570483,0.000055162633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015503584,0.00050446426,0.99557245,0.000004306797,0.00020900178,0.0011169902,0.0004489877,2.54101e-7,0.00001309183,0.00004851554,0.0003913701,0.00014019472],"study_design_scores_gemma":[0.0038674243,0.00028739305,0.994758,0.000053943597,0.000058787522,0.000019279414,0.000027102047,0.000016890514,0.00047063333,0.00008648299,0.00023023148,0.00012379329],"about_ca_topic_score_codex":0.0011982771,"about_ca_topic_score_gemma":0.0023946685,"teacher_disagreement_score":0.0068341843,"about_ca_system_score_codex":0.00019764375,"about_ca_system_score_gemma":0.00012545657,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W2094784241","doi":"10.1097/01.coc.0000054890.69365.3e","title":"Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Cystectomy; Radiation therapy; Bladder cancer; Chemotherapy; Surgery; Neutropenia; Toxicity; Urinary bladder; Urology; Retrospective cohort study; Urinary system; Cancer; Internal medicine","score_opus":0.025108387793313806,"score_gpt":0.397683006252059,"score_spread":0.3725746184587452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094784241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376076,0.0006945027,0.00015798725,0.004768081,0.00015623744,0.00018368887,0.000003869063,0.0000030271813,0.00027184145],"genre_scores_gemma":[0.98661536,0.0030792025,0.0062357574,0.0038143243,0.00021153608,0.000004931367,5.2481323e-7,0.00001823074,0.000020114507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847996,0.00009733483,0.00089141284,0.0001523803,0.00021409804,0.00016482148],"domain_scores_gemma":[0.99846226,0.00020731318,0.0008382366,0.00011319241,0.00020444475,0.00017455676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028702794,0.00012050249,0.0011599973,0.00008794118,0.000011434411,0.000002470359,0.000074844844,0.00007464154,0.000067144356],"category_scores_gemma":[0.00004978346,0.00007791479,0.00011255436,0.00019495339,0.000556791,0.000060542756,0.000005742215,0.00032116275,4.2318783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064073834,0.0010820553,0.5817926,0.000006264218,0.00027240152,0.00003719606,0.00029981066,0.00003234578,0.000026729822,0.0000073640995,0.00003589121,0.40999997],"study_design_scores_gemma":[0.031591043,0.040936254,0.9220066,0.00014899214,0.00010747674,0.000046260717,0.00009843031,0.0000026859911,0.0000914908,0.000074602554,0.0048181373,0.00007803959],"about_ca_topic_score_codex":0.00033508765,"about_ca_topic_score_gemma":0.000112053036,"teacher_disagreement_score":0.4099219,"about_ca_system_score_codex":0.00013032212,"about_ca_system_score_gemma":0.0009323894,"threshold_uncertainty_score":0.31772727},"labels":[],"label_agreement":null},{"id":"W2094863360","doi":"10.1007/s11255-012-0319-5","title":"Does using comprehensive preoperative bowel preparation offer any advantage for urinary diversion using ileum? A meta-analysis","year":2012,"lang":"en","type":"review","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Relative risk; Internal medicine; Randomized controlled trial; Confidence interval; Ileus; Perioperative; Urinary system; Urinary diversion; Gastroenterology; Cohort study; Meta-analysis; Bowel obstruction; Surgery; Cystectomy; Bladder cancer","score_opus":0.15937790572514424,"score_gpt":0.4225479043027502,"score_spread":0.2631699985776059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094863360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004502412,0.9900269,0.0020506277,0.0002454235,0.0006828078,0.0016405275,0.000705707,0.000028583923,0.000117022275],"genre_scores_gemma":[0.04064623,0.9504049,0.002592702,0.0027195225,0.0008952129,0.00045205984,0.0014243242,0.00007264729,0.0007924414],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99813664,0.000245407,0.0005148832,0.00062865333,0.00016244908,0.00031198043],"domain_scores_gemma":[0.9986805,0.00034768035,0.00038718345,0.00024086658,0.00023526223,0.00010852584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013370709,0.00044178983,0.002280869,0.00048578883,0.00016915558,0.000015044978,0.00013357794,0.00052254,0.00067614747],"category_scores_gemma":[0.000017535625,0.0002619851,0.0011817622,0.00013490045,0.00020425716,0.00016713832,0.00015079007,0.00027182815,0.000009566929],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006724266,0.0014870606,0.0032007894,0.0034420008,0.96562135,0.00030623408,0.0011501551,0.00023292273,0.00017472618,0.0013603229,0.00028142004,0.016018758],"study_design_scores_gemma":[0.0010899137,0.00088262855,0.0002801977,0.00003746272,0.5540462,0.00066186796,0.000021212347,0.0013989359,0.0000072315843,0.00018944815,0.4411068,0.00027807167],"about_ca_topic_score_codex":0.00005833319,"about_ca_topic_score_gemma":0.000018092282,"teacher_disagreement_score":0.44082537,"about_ca_system_score_codex":0.00012986248,"about_ca_system_score_gemma":0.00015335421,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2094959719","doi":"10.1007/s003450050006","title":"Urothelium-lined enteric segments","year":2000,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Urothelium; Medicine; Nephrology; Internal medicine; Pathology; Urinary bladder","score_opus":0.039754373333598214,"score_gpt":0.34558032129269617,"score_spread":0.30582594795909795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094959719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000047301064,0.98937625,0.00002246668,0.0003218984,0.0009909442,0.00044955857,0.000026581305,0.000016294312,0.008791251],"genre_scores_gemma":[0.00006262022,0.9874032,0.00023018259,0.0011963701,0.0012909555,0.000017116838,0.000022497079,0.00008217594,0.009694848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976157,0.00023439637,0.0011991572,0.00025903113,0.00032168243,0.0003700416],"domain_scores_gemma":[0.998384,0.00010229891,0.0008174109,0.00033533352,0.00009351339,0.0002674447],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020326792,0.00043574037,0.002611779,0.00081350945,0.00004204006,0.000014527315,0.00027586165,0.00022279573,0.0038005102],"category_scores_gemma":[0.000023641109,0.00029539174,0.0009831242,0.00038754262,0.000080677026,0.000050032708,0.00003645571,0.0008500455,0.0003169588],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037641948,0.00028566262,0.000044100212,0.0013559299,0.0012270731,0.0010759467,0.000022688691,4.931573e-7,7.619025e-7,0.000008154434,0.0059995935,0.98960316],"study_design_scores_gemma":[0.0019271037,0.0013216239,0.000023802111,0.0022842262,0.005176197,0.005937035,0.0000012636816,3.7677475e-7,6.0997996e-7,0.000042882188,0.9831241,0.00016079827],"about_ca_topic_score_codex":0.0000050870535,"about_ca_topic_score_gemma":0.0000046474415,"teacher_disagreement_score":0.98944235,"about_ca_system_score_codex":0.00017685432,"about_ca_system_score_gemma":0.00070677244,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2095486825","doi":"10.1016/j.juro.2011.02.1760","title":"1650 PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL-DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Refractory (planetary science); Cancer; Oncology; Urothelial carcinoma; Carcinoma in situ; Internal medicine; Urology","score_opus":0.02938658360869692,"score_gpt":0.31096491657407216,"score_spread":0.28157833296537527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095486825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975333,0.00033671892,0.0000018370787,0.0003402543,0.000066352375,0.0016138061,0.00007223443,0.0000010833089,0.000034377936],"genre_scores_gemma":[0.9990213,0.0006817179,0.000032918568,0.00017003047,0.000052253436,0.000019480956,0.000002212626,0.000012494993,0.0000076031492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985506,0.00047527524,0.0004235106,0.000123163,0.0002834108,0.0001440172],"domain_scores_gemma":[0.99866277,0.00026951137,0.00051854685,0.00025473826,0.00021817429,0.00007625451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039073225,0.00015352236,0.00050962524,0.000074629046,0.00006381498,0.0000022708766,0.00013177427,0.000036206828,0.00007112389],"category_scores_gemma":[0.000030839932,0.000059149304,0.00003756037,0.00010205758,0.0001482573,0.000030038203,0.000045497887,0.000105350264,4.6537326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13882731,0.01359775,0.6946827,0.000053183703,0.0012743695,0.000032298278,0.12211277,0.000048476388,0.01053205,7.9914474e-7,0.00018628067,0.018652003],"study_design_scores_gemma":[0.024339912,0.05195949,0.9176102,0.00006774102,0.0013687783,0.000008075927,0.0009851414,0.0000024245207,0.0034677573,0.000007218637,0.00013430249,0.000048926275],"about_ca_topic_score_codex":0.0006570837,"about_ca_topic_score_gemma":0.00058062875,"teacher_disagreement_score":0.22292753,"about_ca_system_score_codex":0.00006095078,"about_ca_system_score_gemma":0.000085323954,"threshold_uncertainty_score":0.24120386},"labels":[],"label_agreement":null},{"id":"W2095617542","doi":"10.1016/j.urolonc.2010.01.001","title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Concomitant; Medicine; Lymphovascular invasion; Bladder cancer; Cancer; Carcinoma in situ; Urology; Carcinoma; Internal medicine; Cohort; Stage (stratigraphy); Oncology; Metastasis; Biology","score_opus":0.010567045500921166,"score_gpt":0.26545005740970884,"score_spread":0.25488301190878765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095617542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941345,0.0003524421,0.0000023940877,0.003918236,0.00016729815,0.00078837783,0.000072535804,0.000018208038,0.0005460246],"genre_scores_gemma":[0.99410814,0.000017577886,0.0038754505,0.0016704989,0.00006763655,0.000081717284,0.000075373086,0.000019206233,0.0000843993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865085,0.000101682286,0.0003070404,0.00040997323,0.00020565603,0.00032480396],"domain_scores_gemma":[0.9989641,0.00014925755,0.00024033603,0.00022852897,0.00006632456,0.00035150617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001212606,0.00024883501,0.00054595567,0.00021320561,0.000080746126,0.0000108522945,0.00010026447,0.00026839715,0.00007779523],"category_scores_gemma":[0.0001907982,0.0001852453,0.00007087885,0.00031461497,0.0006342474,0.00008300136,0.000035919307,0.00061188743,0.0000026897715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016088255,0.00042845125,0.99389035,0.000028005445,0.000048777332,0.0008017532,0.00095618557,0.0000016156447,0.0012369343,0.00026344263,0.00032767237,0.00040801463],"study_design_scores_gemma":[0.011748901,0.0031099387,0.9686537,0.00010825363,0.00032772787,0.000050944655,0.000091176786,0.00008460983,0.0011647061,0.00054373953,0.013919109,0.00019723615],"about_ca_topic_score_codex":0.00029331242,"about_ca_topic_score_gemma":0.00040460995,"teacher_disagreement_score":0.025236664,"about_ca_system_score_codex":0.00010202475,"about_ca_system_score_gemma":0.0008924333,"threshold_uncertainty_score":0.7554084},"labels":[],"label_agreement":null},{"id":"W2096184386","doi":"10.1586/era.09.148","title":"Management of patients with advanced bladder cancer following major response to systemic chemotherapy","year":2009,"lang":"en","type":"article","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Chemotherapy; Cystectomy; Metastasectomy; Bladder cancer; Oncology; Lymphadenectomy; Metastasis; Radiation therapy; Internal medicine; Surgery; Cancer","score_opus":0.010274311507300767,"score_gpt":0.3310750683976366,"score_spread":0.3208007568903358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096184386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7180208,0.27310577,0.00023596028,0.004128901,0.00021828913,0.003589317,0.00002637356,0.00004572681,0.0006288494],"genre_scores_gemma":[0.75731266,0.22982238,0.0029690063,0.009303016,0.0000568982,0.00023881072,0.000009407945,0.000043935623,0.00024389931],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812144,0.0000704413,0.0005249897,0.00037742025,0.00061642315,0.00028926934],"domain_scores_gemma":[0.9988539,0.00002626889,0.00020533579,0.00058257516,0.00019832526,0.00013356959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019854636,0.0002964729,0.0009183459,0.00008836827,0.000037344947,0.0000050391677,0.0001735119,0.000043323078,0.00033871154],"category_scores_gemma":[0.00000678832,0.00019613131,0.00024316175,0.00044745495,0.00003913985,0.00007944846,0.000011686998,0.00006749285,0.0000049189903],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03033773,0.0017065691,0.013746953,0.003212068,0.0028276956,0.000043448857,0.0015238746,0.000004002367,0.024315123,0.000058273283,0.0020397967,0.9201845],"study_design_scores_gemma":[0.053565435,0.016126007,0.58500665,0.12417714,0.0010971429,0.000012962666,0.00042245534,0.0000038816993,0.1012621,0.000046422767,0.11687007,0.0014097267],"about_ca_topic_score_codex":0.000032331795,"about_ca_topic_score_gemma":7.563144e-7,"teacher_disagreement_score":0.9187747,"about_ca_system_score_codex":0.00014232514,"about_ca_system_score_gemma":0.00012340289,"threshold_uncertainty_score":0.7998002},"labels":[],"label_agreement":null},{"id":"W2096396115","doi":"10.6000/1929-2279.2013.02.03.7","title":"Case Report: Primary Squamous Cell Carcinoma of Kidney-An Unusual Malignancy","year":2013,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Presentation (obstetrics); Renal cell carcinoma; Kidney; Biopsy; Basal cell; Stage (stratigraphy); Kidney disease; Pathology; Radiology; Internal medicine","score_opus":0.050983794252150036,"score_gpt":0.378551230889368,"score_spread":0.32756743663721793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096396115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869821,0.004942484,0.000010702703,0.00213331,0.00024756356,0.0005255736,0.000052395302,0.00000901507,0.005096865],"genre_scores_gemma":[0.9959924,0.00028170808,0.00048353238,0.0004064157,0.0006567997,0.00004653218,0.000016176633,0.0000439314,0.0020725],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970228,0.00019763257,0.0008187166,0.00024705683,0.0012169089,0.00049686106],"domain_scores_gemma":[0.9961974,0.000109978166,0.0004213644,0.0004485962,0.001834842,0.0009878168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084070495,0.00018242531,0.00055581634,0.00041490336,0.00010721438,0.000048105972,0.00022397512,0.00010506022,0.0015969761],"category_scores_gemma":[0.00026089858,0.00013071304,0.00018815904,0.00037635575,0.00020790698,0.000432343,0.000075843775,0.00059313426,0.000023407356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030974778,0.0036121358,0.32487896,0.0020170962,0.00057241885,0.27902716,0.0023844314,0.000018172308,0.15914959,0.00007321419,0.19402026,0.03114907],"study_design_scores_gemma":[0.015737709,0.012540587,0.09082204,0.00069214706,0.0007394071,0.13828534,0.0019976562,0.00006175119,0.71951497,0.0012942749,0.017767344,0.0005467975],"about_ca_topic_score_codex":0.004583852,"about_ca_topic_score_gemma":0.00004789199,"teacher_disagreement_score":0.5603654,"about_ca_system_score_codex":0.00035167922,"about_ca_system_score_gemma":0.0029778078,"threshold_uncertainty_score":0.9993157},"labels":[],"label_agreement":null},{"id":"W2096543518","doi":"10.1016/j.urolonc.2014.06.013","title":"Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Bladder Cancer Advocacy Network","keywords":"Bladder cancer; Medicine; Multidisciplinary approach; Disease; Theme (computing); Cancer; Health care; Clinical trial; Quality of life (healthcare); Family medicine; Nursing; Political science; Internal medicine; Computer science","score_opus":0.0821095605138395,"score_gpt":0.4331758683550666,"score_spread":0.3510663078412271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096543518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017719459,0.9833166,0.000008517548,0.00522748,0.000536365,0.002470913,0.0007162531,0.000040127292,0.005911799],"genre_scores_gemma":[0.00007130927,0.9836858,0.0064070346,0.002505003,0.00057255226,0.000783153,0.00008467571,0.000052553525,0.005837925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690497,0.0007655881,0.0006998374,0.00063236384,0.0004626441,0.00053461676],"domain_scores_gemma":[0.99739933,0.0008551845,0.00038681275,0.000545959,0.0004298109,0.00038289683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009875426,0.00041137132,0.0016556059,0.00029753445,0.00045371449,0.000024788631,0.0003489851,0.00066677126,0.00011408753],"category_scores_gemma":[0.00059483986,0.0002487441,0.00023528349,0.0012723989,0.0010841393,0.0000629339,0.0002497868,0.0011119064,0.00002575449],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000196353,0.00051566056,0.013280289,0.006563104,0.0015023118,0.00012502969,0.0030775627,0.000028461393,0.000013152203,0.006969851,0.25526676,0.7124615],"study_design_scores_gemma":[0.00042830806,0.0016117736,0.000088066176,0.0030822246,0.0017762452,0.00011313592,0.00026344243,0.000010631595,0.000012535206,0.0010990844,0.99131376,0.00020079924],"about_ca_topic_score_codex":0.00034667892,"about_ca_topic_score_gemma":0.00017098463,"teacher_disagreement_score":0.73604697,"about_ca_system_score_codex":0.0004224997,"about_ca_system_score_gemma":0.003975819,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W2097150676","doi":"10.1158/1078-0432.ccr-09-3013","title":"<i>Fibroblast Growth Factor Receptor 3</i> Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"KWF Kankerbestrijding","keywords":"Concomitant; Urine; Bladder cancer; Medicine; Cystoscopy; Fibroblast growth factor receptor 3; Urology; Internal medicine; Gastroenterology; Proportional hazards model; Prospective cohort study; Cancer; Urinary system; Pathology; Fibroblast growth factor; Receptor","score_opus":0.059444911751871866,"score_gpt":0.426285465540906,"score_spread":0.36684055378903413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097150676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938721,0.00006864421,0.0000866531,0.0014613573,0.00033207887,0.0020827248,0.0018370752,0.000032729757,0.0002266252],"genre_scores_gemma":[0.99652046,0.0002984673,0.00036271915,0.00032894095,0.00069391093,0.00085288327,0.00031610916,0.00007449727,0.0005520048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629235,0.00020383621,0.00077354687,0.00086595514,0.0012058776,0.00065841596],"domain_scores_gemma":[0.99491686,0.00143599,0.00028621207,0.0006347043,0.0022817191,0.00044450688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068025995,0.00030121795,0.00091849215,0.0003637432,0.00016211328,0.000032388718,0.00027029414,0.00025300324,0.0011051462],"category_scores_gemma":[0.0009464728,0.0002152321,0.00039632004,0.0013175049,0.00051685167,0.00010839989,0.00006396212,0.000898409,0.000024137496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007899396,0.002188832,0.96679896,0.00048772254,0.0028008472,0.000008190775,0.00026912577,0.000046513323,0.0054064835,0.000027530705,0.0042835907,0.009782829],"study_design_scores_gemma":[0.009336935,0.003789706,0.9655832,0.00025095974,0.00033490692,2.2816657e-7,0.00003999037,0.0000707308,0.019521048,0.000052761774,0.00077245425,0.00024704594],"about_ca_topic_score_codex":0.0019446046,"about_ca_topic_score_gemma":0.0059959237,"teacher_disagreement_score":0.014114565,"about_ca_system_score_codex":0.00019920606,"about_ca_system_score_gemma":0.001053655,"threshold_uncertainty_score":0.99980795},"labels":[],"label_agreement":null},{"id":"W2097705796","doi":"10.1016/j.urolonc.2011.02.011","title":"Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder","year":2011,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymph node; Urology; Lymph; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Prognostic variable; Cancer; Pathology","score_opus":0.03265623160195851,"score_gpt":0.30829055490778384,"score_spread":0.2756343233058253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097705796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994794,0.00030746352,0.00030193088,0.00042187443,0.000046745445,0.00023904708,0.000028638546,0.000011436237,0.003848863],"genre_scores_gemma":[0.9649959,0.00007808161,0.03442545,0.0003468314,0.000022376957,0.0000346274,0.000022756405,0.0000064506244,0.00006751826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901295,0.00011318825,0.00032494368,0.00026214606,0.00011260223,0.00017414874],"domain_scores_gemma":[0.9992436,0.0002481097,0.000104787454,0.00014325148,0.00011857478,0.00014165479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000219628,0.00012666524,0.00044036066,0.0002604253,0.00005641959,0.000004195291,0.0000450973,0.00017417353,0.00021280015],"category_scores_gemma":[0.00037048414,0.00010759716,0.000047367674,0.00045289297,0.00070797285,0.0000754735,0.000032241063,0.00011889933,0.0000027265257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022436342,0.00038506306,0.990463,0.000052813815,0.00017927657,0.000050205068,0.0006934903,0.0000070440706,0.0012647365,0.0064496826,0.000020960746,0.00020936431],"study_design_scores_gemma":[0.0018323468,0.0024843577,0.95353997,0.000049690978,0.0037874037,0.00020836639,0.0002503205,0.00053900067,0.016487516,0.01982117,0.0008525974,0.00014726474],"about_ca_topic_score_codex":0.0014870664,"about_ca_topic_score_gemma":0.000037256534,"teacher_disagreement_score":0.036923036,"about_ca_system_score_codex":0.000041014686,"about_ca_system_score_gemma":0.00035339402,"threshold_uncertainty_score":0.43876848},"labels":[],"label_agreement":null},{"id":"W2098190677","doi":"10.1016/j.eursup.2008.08.002","title":"Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer","year":2008,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"Astellas Pharma; National Comprehensive Cancer Network; Amgen","keywords":"Medicine; Grading (engineering); Risk stratification; Epidemiology; Bladder cancer; Stratification (seeds); Oncology; Internal medicine; Cancer","score_opus":0.05318098561243778,"score_gpt":0.3284035645049127,"score_spread":0.2752225788924749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098190677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947006,0.0022225212,0.0003205156,0.00082759757,0.00017161471,0.00039896579,0.00023588321,0.000044856075,0.0063079763],"genre_scores_gemma":[0.99412113,0.0031799038,0.0007897589,0.00081718556,0.00011565713,0.000020341118,0.00011524701,0.000031354954,0.0008093907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984358,0.00041869038,0.00041130866,0.00035159942,0.000103191705,0.00027939046],"domain_scores_gemma":[0.99922174,0.00008423081,0.00022841434,0.0002811054,0.000059251608,0.00012528294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037800285,0.00016240212,0.00032518266,0.00009267248,0.0001221021,0.0000013320986,0.000081083745,0.000044750795,0.001031288],"category_scores_gemma":[0.000091150025,0.00013823865,0.000056309156,0.000078974874,0.00029610159,0.000048481812,0.000048207166,0.0001746446,0.0000424984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012826643,0.00011611796,0.9867697,0.000014595717,0.00035316925,0.000035700254,0.00044561198,0.000004607363,0.0003890403,0.00009931411,0.0092913555,0.0023525537],"study_design_scores_gemma":[0.0024204054,0.0006429327,0.97570753,0.000007779791,0.00033781107,0.000065109,0.000037999504,0.00004915765,0.0006932092,0.00014562927,0.019791294,0.0001011656],"about_ca_topic_score_codex":0.0005023309,"about_ca_topic_score_gemma":0.00003674802,"teacher_disagreement_score":0.011062161,"about_ca_system_score_codex":0.000023514724,"about_ca_system_score_gemma":0.00005721496,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W2098702198","doi":"10.3945/jn.113.174920","title":"Fruit and Vegetable Intakes Are Associated with Lower Risk of Bladder Cancer among Women in the Multiethnic Cohort Study1,2","year":2013,"lang":"en","type":"article","venue":"Journal of Nutrition","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Quartile; Cohort; Prospective cohort study; Proportional hazards model; Lower risk; Nutrient; Cohort study; Carotenoid; Cancer; Food science; Internal medicine; Confidence interval; Biology","score_opus":0.013547924487529738,"score_gpt":0.2596246243771557,"score_spread":0.246076699889626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098702198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711907,0.001696948,0.0000040350665,0.00039070667,0.00005976765,0.0005440654,0.000010905463,0.0000032527882,0.0001712453],"genre_scores_gemma":[0.9980497,0.0014950522,0.000035940684,0.00010767397,0.00009541884,0.000101118174,0.0000019046545,0.000010362177,0.00010287519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991216,0.00009774649,0.00024754045,0.00008083911,0.000296787,0.00015548],"domain_scores_gemma":[0.99914575,0.00007301116,0.00037238534,0.0000829207,0.00025906513,0.00006686033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035019428,0.00009204773,0.00032168833,0.0000911775,0.000032591437,0.000015585145,0.000048841302,0.00005752702,0.00013582072],"category_scores_gemma":[0.00006463285,0.000051478215,0.00004537594,0.0001601991,0.00006174052,0.00018203484,0.0000061112996,0.00023882183,9.995324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002671722,0.0011219437,0.9950005,0.000040690742,0.000493579,0.000025733669,0.0015797217,0.000008227684,0.00024097071,2.2563488e-7,0.000868807,0.00035244875],"study_design_scores_gemma":[0.005937148,0.0011629891,0.9890851,0.0007238831,0.0003264712,0.000021057705,0.0022212747,0.000029784243,0.00024572134,0.00011474906,0.0000788422,0.000053015232],"about_ca_topic_score_codex":0.0005353204,"about_ca_topic_score_gemma":0.0003650149,"teacher_disagreement_score":0.005915415,"about_ca_system_score_codex":0.0001760058,"about_ca_system_score_gemma":0.00005042457,"threshold_uncertainty_score":0.20992206},"labels":[],"label_agreement":null},{"id":"W2099243020","doi":"10.1158/1078-0432.ccr-10-2981","title":"<i>In vivo</i> Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Drug Research and Development","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Chemistry; Bladder cancer; Docetaxel; In vitro; Pharmacology; Cancer research; Cancer; Medicine; Biochemistry; Internal medicine; Biology","score_opus":0.4088717360453616,"score_gpt":0.5471438405819348,"score_spread":0.13827210453657318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099243020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913787,0.0021058053,0.000014701099,0.00074747397,0.000359539,0.0032771584,0.00020788121,0.000008892521,0.0018998317],"genre_scores_gemma":[0.9924017,0.003612228,0.00030862444,0.0001490524,0.00041054824,0.0024822548,0.000008080549,0.000039484832,0.00058802223],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964189,0.00039922347,0.000994889,0.0005775629,0.001048416,0.00056100806],"domain_scores_gemma":[0.9965321,0.00075405394,0.00021114138,0.000489268,0.0017387001,0.00027478076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018872013,0.00021402708,0.0008522454,0.00020093806,0.000055130666,0.0000059670087,0.0001587879,0.0002158283,0.0020220147],"category_scores_gemma":[0.00052612636,0.00016021982,0.00033737253,0.00043854475,0.0005403457,0.0000934645,0.000044954486,0.00022460739,0.000011471922],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03536116,0.025501795,0.34637752,0.0018426877,0.0051254393,0.00017525068,0.01562754,0.00014484327,0.20871778,0.00063622906,0.011783452,0.34870633],"study_design_scores_gemma":[0.02549501,0.010933265,0.21862623,0.0005571044,0.001388268,0.000003486824,0.00046522447,0.000846448,0.7379889,0.0017156737,0.0017257739,0.00025462828],"about_ca_topic_score_codex":0.005062894,"about_ca_topic_score_gemma":0.0016707688,"teacher_disagreement_score":0.5292711,"about_ca_system_score_codex":0.00053552975,"about_ca_system_score_gemma":0.002667912,"threshold_uncertainty_score":0.9988903},"labels":[],"label_agreement":null},{"id":"W2099543594","doi":"10.1016/j.jmir.2012.03.022","title":"Patient-Specific PTV Margins and Their Implementation in Radiation Therapy for Bladder Cancer","year":2012,"lang":"en","type":"article","venue":"Journal of medical imaging and radiation sciences","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Michener Institute; University of Toronto","funders":"","keywords":"Margin (machine learning); Bladder cancer; Radiation therapy; Medicine; Patient data; Position (finance); Cancer; Volume (thermodynamics); Medical physics; Radiology; Nuclear medicine; Urology; Computer science; Machine learning; Internal medicine","score_opus":0.02948730945330687,"score_gpt":0.3732444651365633,"score_spread":0.34375715568325643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099543594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92167914,0.061585344,0.0007365209,0.015133193,0.000592305,0.00021595576,0.0000075963203,0.000003941879,0.00004601574],"genre_scores_gemma":[0.97187597,0.026347008,0.00018653783,0.0010337958,0.00053362024,0.000011760756,0.0000027070298,0.000004398438,0.000004210106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999057,0.000041249896,0.00026908418,0.00009129651,0.00037982877,0.00016156296],"domain_scores_gemma":[0.99944544,0.00014295129,0.00016062145,0.000028879564,0.000052404008,0.00016967842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008156508,0.00007082484,0.00014855675,0.00016920883,0.000093127506,0.00003741739,0.00003752342,0.000029597095,0.000099413606],"category_scores_gemma":[0.000059356273,0.00004260519,0.000031645373,0.00014249462,0.000109817585,0.00036340873,0.0000065630898,0.000082944935,1.9206529e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045583703,0.000057195713,0.23934592,0.000005294304,0.000018638451,8.8547404e-7,0.0029445218,0.0000012215938,0.0002804705,0.00004483402,0.0017921639,0.75546324],"study_design_scores_gemma":[0.0071157855,0.00047726082,0.9273366,0.00011820674,0.000034494315,0.0001436885,0.009581289,0.0017645253,0.002023455,0.0002946779,0.05099216,0.0001178935],"about_ca_topic_score_codex":0.00006372987,"about_ca_topic_score_gemma":0.0000063479233,"teacher_disagreement_score":0.75534534,"about_ca_system_score_codex":0.000049490107,"about_ca_system_score_gemma":0.00016591784,"threshold_uncertainty_score":0.17373891},"labels":[],"label_agreement":null},{"id":"W2099815527","doi":"10.1016/j.eururo.2009.08.024","title":"An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McGill University Health Centre; Montreal General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Disease; Cancer; Urology; Intensive care medicine; Internal medicine","score_opus":0.059345227700210224,"score_gpt":0.3838745589587246,"score_spread":0.32452933125851435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099815527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067397964,0.9933697,0.000093073875,0.00048230807,0.000429033,0.0024597463,0.0011267709,0.00008959359,0.0012757786],"genre_scores_gemma":[0.013027201,0.9823023,0.0001249722,0.0012524129,0.00064730836,0.0002617494,0.0015221753,0.00015948158,0.00070236326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996061,0.0011588488,0.00094545004,0.00090260466,0.00024204486,0.0006900282],"domain_scores_gemma":[0.9976375,0.00031048874,0.00037496668,0.001234633,0.0001548073,0.00028758394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022934905,0.0007103647,0.0029958144,0.0003583982,0.00012968286,0.000027888987,0.0004582899,0.0002780347,0.0007868653],"category_scores_gemma":[0.00005744228,0.00041832085,0.0014953441,0.0008144891,0.0002458316,0.00004287072,0.000039062717,0.00032504436,0.00003135465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023373765,0.0021372684,0.00020999632,0.00072727725,0.013398917,0.00029229128,0.00020753274,0.00011316161,0.0000056199437,0.00035624593,0.0033454017,0.97897255],"study_design_scores_gemma":[0.0027355622,0.0053095724,0.004064652,0.0002938083,0.100030296,0.00003545194,0.000010605117,0.000043921507,0.0000065155937,0.000031289437,0.88708717,0.0003511834],"about_ca_topic_score_codex":0.00044586242,"about_ca_topic_score_gemma":0.00032502128,"teacher_disagreement_score":0.97862136,"about_ca_system_score_codex":0.00022713104,"about_ca_system_score_gemma":0.0005717045,"threshold_uncertainty_score":0.99982685},"labels":[],"label_agreement":null},{"id":"W2100426374","doi":"10.5489/cuaj.236","title":"Bladder cancer: Validating what we've got","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Art; Internal medicine","score_opus":0.019789825384512214,"score_gpt":0.2602707501575212,"score_spread":0.240480924773009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100426374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76921624,0.0048553036,0.000048315313,0.21284853,0.0017717954,0.0006794264,0.000045375036,0.00007764937,0.010457374],"genre_scores_gemma":[0.9776473,0.0016399899,0.00019592754,0.016109642,0.0011468071,0.00005523226,0.0000146111715,0.000020341146,0.003170158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843353,0.000109104934,0.0003073751,0.0001984029,0.0003600597,0.0005915059],"domain_scores_gemma":[0.99830365,0.00008648453,0.00019816836,0.000104380546,0.0003301269,0.0009771935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023991794,0.00015978755,0.00027307722,0.000119790384,0.00029934445,0.00035131944,0.00010383876,0.00022812627,0.010455643],"category_scores_gemma":[0.00021421937,0.00012175968,0.00014267246,0.00017815377,0.000023812916,0.00041791226,0.000012015867,0.0005396822,0.00048225667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003343705,0.00009394827,0.74903965,0.000009281222,0.0006654556,0.00012589413,0.0006798102,0.000036292036,0.00042164524,0.0000939812,0.12846884,0.12033175],"study_design_scores_gemma":[0.0035191076,0.00073160155,0.7730844,0.00012179274,0.0004291396,0.00041517345,0.0012039441,0.00028287256,0.00033294334,0.0035784736,0.21586336,0.0004371841],"about_ca_topic_score_codex":0.0064317333,"about_ca_topic_score_gemma":0.0009954298,"teacher_disagreement_score":0.20843105,"about_ca_system_score_codex":0.0015083691,"about_ca_system_score_gemma":0.0007124844,"threshold_uncertainty_score":0.99044895},"labels":[],"label_agreement":null},{"id":"W2101441170","doi":"10.1016/j.juro.2010.04.007","title":"pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Lymph node; Carcinoma; Oncology; Bladder cancer; Internal medicine; Cancer","score_opus":0.01526152518056124,"score_gpt":0.2735448771343341,"score_spread":0.2582833519537729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101441170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887724,0.00033601568,0.00018090062,0.0090193115,0.00060243165,0.00050881633,0.000034876688,0.0000047535896,0.0004356595],"genre_scores_gemma":[0.99628925,0.000024528856,0.00024233163,0.002821432,0.000463006,0.000012720706,5.471041e-7,0.000024198835,0.00012198684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989493,0.00010857332,0.00037396542,0.0000986234,0.00023667145,0.00023284786],"domain_scores_gemma":[0.9985556,0.00042273934,0.00045051432,0.0002805129,0.00020508436,0.00008557243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039077844,0.00013460277,0.00032804997,0.000084588915,0.00010331952,0.000005171841,0.0002953316,0.00010001829,0.00017655439],"category_scores_gemma":[0.00025817627,0.000065508386,0.00019843568,0.00011249337,0.000312769,0.0000405229,0.00004150011,0.00038426724,0.0000054415696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00786845,0.00074590783,0.86392194,0.000108146116,0.0015941972,0.00004460566,0.014401541,0.0000168373,0.10319738,0.0004504424,0.0030716376,0.004578919],"study_design_scores_gemma":[0.011768767,0.002241634,0.8992807,0.00004263477,0.0028733222,0.0019921837,0.00047718274,0.00016917234,0.07433733,0.003047475,0.0036088785,0.00016068998],"about_ca_topic_score_codex":0.000057235633,"about_ca_topic_score_gemma":0.000013882595,"teacher_disagreement_score":0.035358794,"about_ca_system_score_codex":0.000024908573,"about_ca_system_score_gemma":0.00047301443,"threshold_uncertainty_score":0.26713544},"labels":[],"label_agreement":null},{"id":"W2101525607","doi":"10.1586/14737140.2014.953938","title":"Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives","year":2014,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Cystectomy; Radiation therapy; Bladder cancer; Transitional cell carcinoma; Surgery; Intensive care medicine; Cancer; Internal medicine","score_opus":0.042291909942723624,"score_gpt":0.37384449329490244,"score_spread":0.3315525833521788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101525607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040257924,0.9904886,0.000041574705,0.0012717122,0.00019302014,0.007510264,0.00035725808,0.0000045428087,0.00009277489],"genre_scores_gemma":[0.0003541506,0.997545,0.00012210872,0.0003421935,0.0005456018,0.00095107633,0.00006751085,0.00004832781,0.000023999239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976437,0.0003109598,0.0010317898,0.00039375064,0.00044660142,0.00017316613],"domain_scores_gemma":[0.99695265,0.0004296621,0.0011659128,0.00067585154,0.00072376424,0.000052158673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025132962,0.000455708,0.0029750422,0.000058370388,0.00006072066,0.00000267322,0.00023417461,0.00010228929,0.00014890583],"category_scores_gemma":[0.000041164145,0.000207274,0.0013655347,0.00039269374,0.00028868607,0.0000433302,0.000014240887,0.00012579052,2.527612e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009535153,0.00072162325,0.000022077762,0.30088922,0.0008707758,1.727765e-7,0.0018849509,1.2482434e-8,0.00003874896,0.000109624256,0.00094626547,0.6944212],"study_design_scores_gemma":[0.0015425108,0.0016462874,0.0002928665,0.20149888,0.0029366082,0.0000065683034,0.00013293006,5.3899186e-7,0.0011949338,0.000015669792,0.7905795,0.00015270332],"about_ca_topic_score_codex":0.00006392856,"about_ca_topic_score_gemma":0.00000537769,"teacher_disagreement_score":0.7896332,"about_ca_system_score_codex":0.00014189175,"about_ca_system_score_gemma":0.0009986834,"threshold_uncertainty_score":0.84523886},"labels":[],"label_agreement":null},{"id":"W2101691094","doi":"10.1016/j.urolonc.2014.04.006","title":"Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: Results from the Canadian Upper Tract Collaboration","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Western University; Université de Montréal; Université Laval; University of Alberta; McGill University; Dalhousie University","funders":"McGill University Health Centre","keywords":"Medicine; Renal pelvis; Bladder cancer; Urology; Ureter; Hazard ratio; Retrospective cohort study; Cuff; Proportional hazards model; Urothelium; Cancer; Internal medicine; Surgery; Urinary bladder; Confidence interval","score_opus":0.02870974550337815,"score_gpt":0.3176958690155359,"score_spread":0.2889861235121578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101691094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96624553,0.00079434237,0.00027619724,0.023008043,0.00077063387,0.0020684176,0.0062069944,0.000047087146,0.00058273383],"genre_scores_gemma":[0.9691544,0.000347986,0.017960262,0.0076567885,0.0013632369,0.0017432774,0.0011706378,0.000040174193,0.0005632455],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982224,0.00019059818,0.0004037016,0.00056166993,0.00015530865,0.00046631688],"domain_scores_gemma":[0.9973688,0.0015146796,0.00023481414,0.00027866656,0.00020660693,0.0003964494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004070066,0.000306265,0.00040972265,0.00010538683,0.00070511847,0.000081746184,0.00013289553,0.00034331367,0.00011482773],"category_scores_gemma":[0.0009263311,0.00020251908,0.00013122639,0.00019714292,0.0004422123,0.00016072464,0.000013046494,0.00034700634,0.0000063227467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019622066,0.0002894671,0.94458294,0.000023619163,0.0002789307,0.000014158214,0.005438547,0.000095084535,0.00013426632,0.00084801955,0.0400122,0.006320533],"study_design_scores_gemma":[0.0031445734,0.0025497337,0.10263902,0.000060341023,0.000863929,0.000025740048,0.00034819826,0.00095135154,0.0003908503,0.0037224665,0.8850592,0.00024461822],"about_ca_topic_score_codex":0.04232259,"about_ca_topic_score_gemma":0.06799077,"teacher_disagreement_score":0.845047,"about_ca_system_score_codex":0.00031298812,"about_ca_system_score_gemma":0.0015878056,"threshold_uncertainty_score":0.96405464},"labels":[],"label_agreement":null},{"id":"W2101793731","doi":"10.1016/j.urology.2014.06.070","title":"Processes of Care and the Impact of Surgical Volumes on Cancer-specific Survival: A Population-based Study in Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Cancer registry; Population; Multivariate analysis; Cohort; Cancer; Internal medicine; Oncology; Dissection (medical); Surgery; Urology","score_opus":0.019043249654280166,"score_gpt":0.3327506071645946,"score_spread":0.3137073575103144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101793731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952089,0.0032878865,0.0000036239417,0.00043119446,0.00006931389,0.0005472672,0.000034137698,0.000008147356,0.00040950353],"genre_scores_gemma":[0.9994951,0.00022688524,0.0000029481644,0.000054848028,0.00007126685,0.00010703342,0.000009242275,0.000012892964,0.000019777806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991864,0.00015225721,0.00020807971,0.00018371675,0.00013642368,0.00013312232],"domain_scores_gemma":[0.9993011,0.00029025544,0.00008847468,0.00017162558,0.00011310844,0.000035478486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106668376,0.00011216334,0.00043173798,0.00007984329,0.000022341375,0.0000025595564,0.000052096348,0.000056499426,0.0001477552],"category_scores_gemma":[0.00003726373,0.00006349377,0.00005436046,0.0001647908,0.00009654466,0.0000128959055,0.000011017175,0.00009027845,5.0930896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003992918,0.00028325207,0.9892334,0.00007225822,0.000114133305,0.000004406593,0.0012697063,0.0013336788,0.000009470307,0.000035474706,0.000035091012,0.0036162306],"study_design_scores_gemma":[0.0119029265,0.0033796353,0.9835941,0.000030659103,0.00012629355,0.0000016650278,0.0002142286,0.00031889888,0.00008594354,0.00005035486,0.00023413287,0.000061169805],"about_ca_topic_score_codex":0.016176742,"about_ca_topic_score_gemma":0.0060753897,"teacher_disagreement_score":0.010101353,"about_ca_system_score_codex":0.00005120442,"about_ca_system_score_gemma":0.00019136458,"threshold_uncertainty_score":0.9903746},"labels":[],"label_agreement":null},{"id":"W2101982119","doi":"10.1016/j.juro.2012.02.2563","title":"Cost-Effectiveness of Fluorescent Cystoscopy for Noninvasive Papillary Tumors","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Cystoscopy; Bladder cancer; Medicine; Cystectomy; Urology; Cancer; Transitional cell carcinoma; Pathology; Urinary system; Internal medicine","score_opus":0.04363327963814939,"score_gpt":0.3362318391665184,"score_spread":0.292598559528369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101982119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127215,0.004866657,0.0015687301,0.00059740845,0.00055925135,0.0007442023,0.000014047516,0.00000408797,0.00037343538],"genre_scores_gemma":[0.99887,0.00020948944,0.00022794912,0.0003128688,0.00032864738,0.000013273632,0.0000020786765,0.000015026504,0.000020670997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991181,0.00022875966,0.00025809434,0.000046141988,0.00013611726,0.00021278686],"domain_scores_gemma":[0.99882257,0.0005141134,0.00024329683,0.00013367567,0.00018506078,0.00010128379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081440917,0.00009246394,0.0003614653,0.00006323836,0.000036732185,0.0000011762289,0.00009572447,0.000055254033,0.000042502386],"category_scores_gemma":[0.00009997129,0.000051834926,0.00012735352,0.000058644822,0.0000986969,0.0000470802,0.000018166727,0.00014474094,0.000004345468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11377387,0.0043188254,0.41015327,0.0015700547,0.005107241,0.00034648937,0.008749253,0.00039041106,0.43050185,0.0016630042,0.0058761067,0.017549656],"study_design_scores_gemma":[0.018246232,0.018838765,0.43189633,0.00032801152,0.0033936931,0.011604611,0.0005442559,0.000030838837,0.5056519,0.001300888,0.007943172,0.00022132903],"about_ca_topic_score_codex":0.00001241876,"about_ca_topic_score_gemma":6.9146114e-7,"teacher_disagreement_score":0.095527634,"about_ca_system_score_codex":0.000052877585,"about_ca_system_score_gemma":0.00014266513,"threshold_uncertainty_score":0.2113767},"labels":[],"label_agreement":null},{"id":"W2102058177","doi":"10.1111/j.1464-410x.2012.11370.x","title":"Accurate preoperative prediction of non‐organ‐confined bladder urothelial carcinoma at cystectomy","year":2012,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphovascular invasion; Nomogram; Stage (stratigraphy); Dissection (medical); Urology; Perioperative; Lymph node; Surgery; Oncology; Internal medicine; Cancer; Metastasis","score_opus":0.01700942095194604,"score_gpt":0.2621278996696554,"score_spread":0.24511847871770934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102058177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065334,0.0039648726,0.00039702872,0.00036164347,0.00072345755,0.00035239197,0.00012197044,0.000012695105,0.0034125815],"genre_scores_gemma":[0.997485,0.00028395932,0.00020000772,0.0004257782,0.0008758138,0.000010945539,0.000013328561,0.00003106194,0.00067412306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985003,0.00013518563,0.0006073122,0.00014615913,0.0002721743,0.0003389021],"domain_scores_gemma":[0.99883956,0.000057915193,0.0003650314,0.0001388969,0.00036036276,0.00023825037],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026044337,0.00015756144,0.0005301636,0.00012362543,0.000076800236,0.0000104151795,0.000102535916,0.00016566506,0.0010276862],"category_scores_gemma":[0.00010136946,0.00014924745,0.0001747494,0.00012219558,0.00013823669,0.00020768782,0.000042602154,0.00030590096,0.000023905957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009893757,0.0026155047,0.82313603,0.00024104734,0.0029449828,0.002327741,0.004344099,0.00007431528,0.1182678,0.000065556356,0.017725427,0.018363737],"study_design_scores_gemma":[0.011969719,0.0039728237,0.92362887,0.000081697224,0.0008979374,0.031714283,0.00011328025,0.000059092796,0.02139606,0.000022630093,0.0060097086,0.00013388747],"about_ca_topic_score_codex":0.00013883659,"about_ca_topic_score_gemma":0.000027852142,"teacher_disagreement_score":0.10049284,"about_ca_system_score_codex":0.00009478626,"about_ca_system_score_gemma":0.00023581609,"threshold_uncertainty_score":0.9998855},"labels":[],"label_agreement":null},{"id":"W2102672521","doi":"10.1158/1535-7163.mct-12-0753","title":"New Directions for Biologic Targets in Urothelial Carcinoma – Response","year":2012,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Cancer; Angiogenesis; Oncology; Kidney cancer; Bladder cancer; Renal cell carcinoma; Internal medicine; Cabozantinib; Disease; Urothelial cancer; Clinical trial; Metastatic Urothelial Carcinoma; Cancer research; Urothelial carcinoma","score_opus":0.042735871982933736,"score_gpt":0.33199900550733463,"score_spread":0.2892631335244009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102672521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9011327,0.064485535,0.019660173,0.008260029,0.0018315543,0.0026096036,0.00018426072,0.00017112432,0.0016650152],"genre_scores_gemma":[0.991244,0.0003525381,0.0023393866,0.0039988244,0.00035025578,0.0003174986,0.000015508884,0.0000523891,0.0013295749],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989076,0.000085784515,0.0001897574,0.0002229585,0.00013792062,0.00045592725],"domain_scores_gemma":[0.9994284,0.00005246939,0.00004482602,0.0002535289,0.000049728875,0.000171043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016374045,0.0001933798,0.00025483003,0.00011818055,0.000059272876,0.000010480847,0.00007568777,0.00012354268,0.00013995163],"category_scores_gemma":[0.000018084802,0.00016328802,0.00014430171,0.00021930496,0.000034170433,0.000048279817,0.000017187587,0.00012412302,0.0000142175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014289079,0.0008948355,0.254121,0.000089069916,0.00076967553,0.000058125097,0.0026161135,0.000030747386,0.5810325,0.0006360911,0.0013759943,0.14408675],"study_design_scores_gemma":[0.008374556,0.0010808398,0.1888983,0.000056855446,0.0005565834,0.00004101232,0.000101193946,0.000074337084,0.30885255,0.0005695674,0.49097046,0.00042375043],"about_ca_topic_score_codex":0.000391425,"about_ca_topic_score_gemma":0.00004314218,"teacher_disagreement_score":0.48959446,"about_ca_system_score_codex":0.00027111458,"about_ca_system_score_gemma":0.00036037405,"threshold_uncertainty_score":0.66586924},"labels":[],"label_agreement":null},{"id":"W2102799191","doi":"10.4103/0974-7796.84954","title":"Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin","year":2011,"lang":"en","type":"article","venue":"Urology Annals","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Univariate analysis; Internal medicine; Oncology; Tumor progression; Cancer; Urology; Multivariate analysis","score_opus":0.012602870324286766,"score_gpt":0.25261649227929267,"score_spread":0.24001362195500592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102799191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825794,0.00023569749,0.000038733866,0.0001652942,0.000044005574,0.0009604445,0.00005528075,0.0000074997747,0.0002351182],"genre_scores_gemma":[0.9992863,0.0000936961,0.00003355043,0.00043751832,0.000008544267,0.00008626675,0.000019665076,0.000019829364,0.000014612696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988531,0.00017988277,0.00029093912,0.0002646824,0.00018832975,0.00022310617],"domain_scores_gemma":[0.99927956,0.00007744305,0.00019851062,0.00021051336,0.00015179018,0.00008219526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011866328,0.00017257188,0.00035808043,0.0001047037,0.000032487795,0.0000019693944,0.000077816665,0.00014432475,0.000076472],"category_scores_gemma":[0.00008698618,0.00011142678,0.00006439667,0.00020669487,0.0003091443,0.0000426856,0.000036907033,0.0001735596,0.0000010798865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011525038,0.00085989025,0.9943922,0.00006976374,0.00040266945,0.000043072363,0.00055773696,0.000005965403,0.00072980684,0.00005833874,0.000023072711,0.0017049419],"study_design_scores_gemma":[0.0043859077,0.0027579817,0.97990125,0.00009196043,0.00048744396,0.0000074539853,0.00001702824,0.00006446165,0.012109693,0.00008138726,0.0000023493644,0.00009309769],"about_ca_topic_score_codex":0.0010118444,"about_ca_topic_score_gemma":0.00025281264,"teacher_disagreement_score":0.014491003,"about_ca_system_score_codex":0.000024475954,"about_ca_system_score_gemma":0.00008155172,"threshold_uncertainty_score":0.45438522},"labels":[],"label_agreement":null},{"id":"W2103257412","doi":"10.1200/jco.2005.07.757","title":"Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1854,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vinblastine; Gemcitabine; Internal medicine; Transitional cell carcinoma; Hazard ratio; Cisplatin; Bladder cancer; Urology; Oncology; Methotrexate; Chemotherapy; Doxorubicin; Antimetabolite; Progression-free survival; Gastroenterology; Cancer; Confidence interval","score_opus":0.08192046514609955,"score_gpt":0.42374901589519676,"score_spread":0.34182855074909724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103257412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221325,0.0002857507,0.00033865494,0.001348793,0.000882586,0.0017065809,0.00002692611,0.000013231966,0.0031842005],"genre_scores_gemma":[0.99256927,0.0002221709,0.004952338,0.00037490204,0.0013121039,0.000041748248,0.000021109407,0.000048792113,0.00045759632],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99209386,0.0011275965,0.0048945877,0.00042066586,0.0010066273,0.00045666486],"domain_scores_gemma":[0.9899384,0.004171566,0.00410124,0.00032191607,0.001041457,0.00042545848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043168864,0.00038907927,0.00563351,0.00032069779,0.000042502183,0.000013570358,0.00023136627,0.00037564125,0.00021057784],"category_scores_gemma":[0.0024303054,0.00022224546,0.00053737714,0.00038568536,0.0004534547,0.00020926578,0.00006353101,0.0011885146,0.0000045269003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79479307,0.0023568282,0.18737827,0.0000416278,0.0017540449,0.0001856618,0.00023032358,0.0012621686,0.0000116546835,0.000006929673,0.00020104193,0.011778356],"study_design_scores_gemma":[0.6875517,0.017183756,0.29235923,0.00049349555,0.0016220221,0.000030624295,0.000023445253,0.0003322453,0.000066282366,0.000006639565,0.0001698765,0.00016071105],"about_ca_topic_score_codex":0.0003635754,"about_ca_topic_score_gemma":0.0025375083,"teacher_disagreement_score":0.10724141,"about_ca_system_score_codex":0.00050338346,"about_ca_system_score_gemma":0.0029567776,"threshold_uncertainty_score":0.9062907},"labels":[],"label_agreement":null},{"id":"W2103324021","doi":"10.5489/cuaj.12220","title":"Achieving the achievable in muscle-invasive bladder cancer","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Urology; Computer science; Cancer research; Internal medicine","score_opus":0.021109691053670616,"score_gpt":0.26713125210366984,"score_spread":0.24602156104999923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103324021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93846613,0.0023324026,0.00000835575,0.05086805,0.0006350216,0.00025231432,0.000025432131,0.000015143478,0.007397147],"genre_scores_gemma":[0.9852859,0.0003525221,0.000039173676,0.012275751,0.0011383628,0.000029625833,0.000005153259,0.000012879136,0.00086064276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985006,0.00017006646,0.00023809006,0.00011795822,0.00028042743,0.0006928958],"domain_scores_gemma":[0.99890214,0.00016656156,0.00013467776,0.00009843575,0.00009901607,0.0005991711],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006350357,0.00012503928,0.00020377125,0.00011252014,0.00027636148,0.000051834053,0.00010484076,0.00017096441,0.0015551448],"category_scores_gemma":[0.00044136372,0.000077649835,0.00010646864,0.00023303922,0.000025798368,0.00015121371,0.000012758716,0.0006647568,0.000075638425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021689999,0.000054005966,0.9900182,0.0000021078167,0.000102871694,0.000024642179,0.0004389149,0.000020351028,0.0001063425,0.00006835271,0.0054914984,0.0036510245],"study_design_scores_gemma":[0.0007919897,0.00008817575,0.9308659,0.000015053517,0.000092454145,0.000069778915,0.00015438299,0.0000070712517,0.000019172892,0.00009448173,0.06772098,0.000080589845],"about_ca_topic_score_codex":0.0057941377,"about_ca_topic_score_gemma":0.007069516,"teacher_disagreement_score":0.062229484,"about_ca_system_score_codex":0.001637536,"about_ca_system_score_gemma":0.0006941275,"threshold_uncertainty_score":0.9993576},"labels":[],"label_agreement":null},{"id":"W2103484997","doi":"10.1007/s00345-009-0478-x","title":"Practice patterns and recurrence after partial cystectomy for bladder cancer","year":2009,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphadenectomy; Nephrology; Concomitant; Surgery; Urology; Cancer; Internal medicine","score_opus":0.01736403005702328,"score_gpt":0.328662632324629,"score_spread":0.3112986022676057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103484997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7121563,0.06946331,0.007322131,0.19871396,0.004459576,0.0017485943,0.0001229109,0.000049910603,0.0059632882],"genre_scores_gemma":[0.9880348,0.0009995498,0.00065509474,0.008939742,0.00074413244,0.000021353775,9.974979e-7,0.0000094356,0.000594898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992211,0.000050896317,0.0002730136,0.00012989393,0.00012591915,0.00019917435],"domain_scores_gemma":[0.99927634,0.0001197799,0.00019629132,0.00009217813,0.00018625737,0.0001291405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016117877,0.00010652219,0.00027232914,0.00011362745,0.000025954638,0.000011103767,0.000046421592,0.000047389298,0.00016748087],"category_scores_gemma":[0.00007737146,0.00007941705,0.00007678093,0.000073282725,0.000037995087,0.00011870267,0.000008465424,0.00020656522,0.0000022598651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044266794,0.0014489689,0.21517801,0.00013967221,0.0016525699,0.001955965,0.0024555828,0.000025143927,0.0016074645,0.00038553015,0.023063153,0.70782113],"study_design_scores_gemma":[0.011229431,0.0072424877,0.2194863,0.00013352717,0.0019719885,0.0030431184,0.000061997045,0.000051864317,0.0005522801,0.0007319451,0.75527775,0.00021728777],"about_ca_topic_score_codex":0.00002396501,"about_ca_topic_score_gemma":0.00006767928,"teacher_disagreement_score":0.7322146,"about_ca_system_score_codex":0.000042388656,"about_ca_system_score_gemma":0.00013852594,"threshold_uncertainty_score":0.3238533},"labels":[],"label_agreement":null},{"id":"W2103701043","doi":"10.1016/j.urolonc.2009.04.017","title":"Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer","year":2009,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Concomitant; Surgery; Lymph node; Proportional hazards model; Dissection (medical); Chemotherapy; Urology; Cancer; Internal medicine","score_opus":0.044051661040566036,"score_gpt":0.3529124054344132,"score_spread":0.3088607443938472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103701043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865847,0.0012194637,0.0000378778,0.004574962,0.00010141014,0.00084557204,0.00007673552,0.000040468934,0.006518803],"genre_scores_gemma":[0.98217255,0.00042843094,0.010114203,0.006011921,0.000052913514,0.00012840169,0.00006667775,0.000012468323,0.0010124586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884325,0.00006633328,0.00033382385,0.00036304127,0.0001538524,0.00023972243],"domain_scores_gemma":[0.99921334,0.00003963101,0.0001146876,0.00019575791,0.00009459479,0.0003419836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012918035,0.00019155357,0.00045434237,0.00013749267,0.0001311985,0.000012858636,0.00007304755,0.00013965415,0.00006729203],"category_scores_gemma":[0.000017858712,0.0001536573,0.00003321927,0.00025109295,0.00022536927,0.00012111421,0.000033997603,0.00014798909,0.0000035316618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039414747,0.0004883829,0.9860767,0.00006666253,0.00016515264,0.00014758455,0.00039894716,0.000012544778,0.0001080286,0.0013523707,0.0043509733,0.006438518],"study_design_scores_gemma":[0.003934704,0.008391492,0.7370652,0.00012106398,0.00046939662,0.000049667105,0.00020981775,0.00009460108,0.000374325,0.0012278123,0.24784075,0.00022118929],"about_ca_topic_score_codex":0.00023420277,"about_ca_topic_score_gemma":0.00004256631,"teacher_disagreement_score":0.2490115,"about_ca_system_score_codex":0.00007510275,"about_ca_system_score_gemma":0.0001499868,"threshold_uncertainty_score":0.6265963},"labels":[],"label_agreement":null},{"id":"W2103725052","doi":"10.1016/j.eururo.2014.09.007","title":"Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia Hospital; Alberta Cancer Foundation; McGill University Health Centre; University of Alberta; McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Cystectomy; Tolerability; Regimen; Neoadjuvant therapy; Internal medicine; Urology; Vinblastine; Gemcitabine; Oncology; Chemotherapy; Odds ratio; Surgery; Cancer; Adverse effect; Breast cancer","score_opus":0.018837636679873423,"score_gpt":0.3187905982001069,"score_spread":0.2999529615202335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103725052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87624764,0.00081055897,0.016411293,0.010882348,0.0014759526,0.0023024492,0.00014200073,0.00016718035,0.09156059],"genre_scores_gemma":[0.988596,0.00015187036,0.001985189,0.007866424,0.00044946605,0.00005195293,0.000024782472,0.00006442976,0.0008098931],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989232,0.00013950736,0.0002589301,0.00029979242,0.00011605505,0.00026252543],"domain_scores_gemma":[0.99923515,0.00012816812,0.00012112414,0.0002998128,0.000118231386,0.000097520904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018789209,0.00016269673,0.0003263835,0.00006134728,0.0000392449,0.000004857849,0.00010167769,0.00004487598,0.00044469733],"category_scores_gemma":[0.000049484788,0.00012916834,0.00013113009,0.000050050072,0.00008712525,0.000024871288,0.000029234721,0.000102673104,0.000025343783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042080637,0.0035875647,0.25120133,0.0007594566,0.0035668109,0.00015232564,0.004074922,0.00034619603,0.20057069,0.0024463919,0.03585874,0.4932275],"study_design_scores_gemma":[0.018036166,0.0041072974,0.73441637,0.000051707684,0.0005355315,0.000017594146,0.000046972,0.0012938963,0.006929862,0.00009351726,0.23421988,0.0002512002],"about_ca_topic_score_codex":0.00003984337,"about_ca_topic_score_gemma":0.00002043035,"teacher_disagreement_score":0.4929763,"about_ca_system_score_codex":0.000034575343,"about_ca_system_score_gemma":0.00008319724,"threshold_uncertainty_score":0.5267332},"labels":[],"label_agreement":null},{"id":"W2104939756","doi":"10.1111/bju.12922","title":"Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma","year":2014,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nomogram; Library science; Medicine; Cancer; Gerontology; History; Oncology; Internal medicine; Computer science","score_opus":0.011183344973637304,"score_gpt":0.25580529429506926,"score_spread":0.24462194932143197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104939756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98344785,0.00769965,0.0042038453,0.002336871,0.0009288615,0.0008845435,0.00015150744,0.000020830274,0.0003260658],"genre_scores_gemma":[0.99250996,0.00049675914,0.00072479236,0.0043988624,0.0016051318,0.00006850734,0.0000114940685,0.000040317635,0.00014419672],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987469,0.00009206956,0.00044384113,0.00020549445,0.00021817692,0.00029352255],"domain_scores_gemma":[0.9989285,0.00022769334,0.00020478551,0.00021330231,0.00023704748,0.0001886757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029589082,0.0001464368,0.00047238442,0.00006604135,0.00010697911,0.000032347176,0.00023477065,0.00010764961,0.000078608835],"category_scores_gemma":[0.00013586204,0.00011266914,0.00023052526,0.00007798797,0.00005902217,0.00005566955,0.000021479871,0.00023672135,0.000009802303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00977576,0.00047594763,0.04293815,0.00004236512,0.00073080993,0.0004100788,0.0006277277,0.00022650199,0.012202616,0.000112279835,0.006564554,0.9258932],"study_design_scores_gemma":[0.053668104,0.030819336,0.666302,0.0004964475,0.0011765677,0.02521247,0.000247758,0.0003644209,0.003696364,0.0035454554,0.21393026,0.00054077624],"about_ca_topic_score_codex":0.00024690013,"about_ca_topic_score_gemma":0.00007402113,"teacher_disagreement_score":0.92535245,"about_ca_system_score_codex":0.00004764173,"about_ca_system_score_gemma":0.00011122679,"threshold_uncertainty_score":0.4594514},"labels":[],"label_agreement":null},{"id":"W2105398102","doi":"10.1016/j.eururo.2009.12.029","title":"Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Lymphovascular invasion; Medicine; Hazard ratio; Urothelial carcinoma; Proportional hazards model; Urology; Upper urinary tract; Internal medicine; Cohort; Urinary system; Stage (stratigraphy); Oncology; Cancer; Metastasis; Bladder cancer; Confidence interval","score_opus":0.008469725238063056,"score_gpt":0.22965426993734156,"score_spread":0.2211845446992785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105398102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968935,0.000011154821,0.0000020648188,0.000051926338,0.00019092848,0.00072916475,0.000012202473,0.000008729113,0.0021003173],"genre_scores_gemma":[0.9997302,0.0000010148269,0.00004387661,0.000074927724,0.00006720679,0.000010241521,0.0000267617,0.000024899875,0.000020868398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989883,0.00022410719,0.00023094003,0.00020870155,0.0002416536,0.000106320374],"domain_scores_gemma":[0.9993775,0.000022893648,0.0001094375,0.0003485412,0.00010326357,0.000038395996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018009228,0.00010188433,0.00016324458,0.00009427035,0.000022087856,0.00000340757,0.00017467533,0.000032038948,0.00008475404],"category_scores_gemma":[0.00006353368,0.00006497964,0.000044695797,0.000094902665,0.00007490419,0.00007332627,0.00005881367,0.0001435598,0.0000067048163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007778095,0.004315638,0.9900719,0.000006339814,0.000047561225,0.00002006393,0.0008770211,0.000010143654,0.0022010568,0.000015973319,0.0000012652026,0.0016552209],"study_design_scores_gemma":[0.005587764,0.0044678994,0.9881927,0.000008605075,0.000116933195,0.000026774665,0.000062217,0.000018826515,0.0013443548,0.00001125116,0.000111137146,0.000051557134],"about_ca_topic_score_codex":0.000091160124,"about_ca_topic_score_gemma":0.000013045655,"teacher_disagreement_score":0.0048099547,"about_ca_system_score_codex":0.000015014081,"about_ca_system_score_gemma":0.0000661908,"threshold_uncertainty_score":0.26497927},"labels":[],"label_agreement":null},{"id":"W2105534980","doi":"10.1136/jech.2008.082438","title":"Marital status and survival following bladder cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Epidemiology & Community Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Marital status; Socioeconomic status; Bladder cancer; Hazard ratio; Proportional hazards model; Demography; Confidence interval; Cancer; Mediation; Gerontology; Disease; Gynecology; Oncology; Internal medicine; Population; Environmental health","score_opus":0.10024123524176135,"score_gpt":0.43666654197733623,"score_spread":0.3364253067355749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105534980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9480591,0.01964273,0.0001915676,0.029487131,0.00069039117,0.00018143542,0.0000135005785,0.000016895852,0.001717238],"genre_scores_gemma":[0.97292686,0.008027688,0.0025054738,0.016161684,0.00027839883,0.0000017189985,0.000008501908,0.000012175613,0.00007750368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671793,0.0017024382,0.0008184159,0.00011756451,0.00014158047,0.0005020891],"domain_scores_gemma":[0.9972956,0.0012353414,0.00047977307,0.00032768157,0.00010852235,0.00055306667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036632135,0.00016284968,0.0010650529,0.00012214207,0.00029581625,0.0000052801706,0.000113687274,0.000117079355,0.00005486715],"category_scores_gemma":[0.0010947661,0.00012223065,0.00020280406,0.000106834166,0.000091018126,0.00010629832,0.000036196987,0.0012925683,0.0000016259239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048786323,0.00040631957,0.92816687,0.00005685844,0.00044240308,0.00002830226,0.0008411021,0.000007659741,0.000056843364,0.0003330118,0.0037704406,0.06540234],"study_design_scores_gemma":[0.0027916464,0.0035211341,0.981795,0.00019850642,0.00016930157,0.00012699686,0.0005003621,0.000011846996,0.0000068564605,0.0033697272,0.007423808,0.00008482484],"about_ca_topic_score_codex":0.0067963116,"about_ca_topic_score_gemma":0.0012580109,"teacher_disagreement_score":0.06531751,"about_ca_system_score_codex":0.00035344486,"about_ca_system_score_gemma":0.00085570145,"threshold_uncertainty_score":0.9998175},"labels":[],"label_agreement":null},{"id":"W2105737543","doi":"10.1016/j.eururo.2012.11.042","title":"Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; McMaster University; Ontario Clinical Oncology Group","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Proportional hazards model; Retrospective cohort study; Context (archaeology); Carboplatin; Metastatic Urothelial Carcinoma; Oncology; Performance status; Prospective cohort study; Chemotherapy; Cancer; Cisplatin; Urothelial carcinoma; Bladder cancer","score_opus":0.01676099696267899,"score_gpt":0.3059331095521803,"score_spread":0.2891721125895013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105737543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401903,0.0013254449,0.00020539954,0.00017941056,0.000112975584,0.0014111259,0.00043941473,0.000027653348,0.0022795203],"genre_scores_gemma":[0.998562,0.000046664874,0.0003906751,0.00036093075,0.00040173202,0.000050257102,0.00006740751,0.000042834417,0.0000774903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659073,0.0015361634,0.0008528547,0.0004032693,0.0002527284,0.0003642706],"domain_scores_gemma":[0.99781066,0.00080784,0.00078314374,0.00040501787,0.00011925517,0.00007405998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019512499,0.00025595824,0.001270551,0.0002906596,0.000058563684,0.0000066471166,0.00018846287,0.00006727656,0.00061642536],"category_scores_gemma":[0.0008862851,0.00017470725,0.00032435267,0.00075416715,0.00017048272,0.000098613586,0.000039464052,0.0003002366,0.000018717146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005807206,0.0019301302,0.8814492,0.0000368333,0.0037521422,0.00003730762,0.02027042,0.000026119089,0.078246236,0.000029257362,0.000030294214,0.008384811],"study_design_scores_gemma":[0.011973701,0.0024040516,0.96152437,0.00002343396,0.0041093486,0.000008377588,0.0003694735,0.00022919282,0.01902885,0.0000733674,0.000113128524,0.00014272724],"about_ca_topic_score_codex":0.00011673182,"about_ca_topic_score_gemma":0.0000625175,"teacher_disagreement_score":0.08007511,"about_ca_system_score_codex":0.000068506706,"about_ca_system_score_gemma":0.00006426004,"threshold_uncertainty_score":0.7124355},"labels":[],"label_agreement":null},{"id":"W2105869562","doi":"10.1016/j.urology.2014.08.013","title":"A New Way of Thinking About Bladder Cancer","year":2014,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Disease; DNA microarray; Cancer; Bioinformatics; Computational biology; Gene expression; Gene; Pathology; Internal medicine; Genetics","score_opus":0.02093681042781591,"score_gpt":0.2893796550908034,"score_spread":0.26844284466298746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105869562","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003770051,0.0065119765,0.0009456146,0.9550498,0.0016408146,0.000558559,0.0000566813,0.00009658905,0.034762926],"genre_scores_gemma":[0.007040618,0.00030620437,0.0003201414,0.9643818,0.008646766,0.000054951182,0.00014796513,0.00009655048,0.019004997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984615,0.0000692486,0.00032274539,0.0004229121,0.0003057243,0.00041789174],"domain_scores_gemma":[0.999041,0.0000885805,0.0002051026,0.0004976625,0.00008227906,0.00008537026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000063138556,0.00030664567,0.00080000446,0.00015661928,0.00003402601,0.0000066672515,0.00019487362,0.0009800299,0.0040361336],"category_scores_gemma":[0.00002056337,0.00024363399,0.0002088784,0.00008564024,0.000100871766,0.000018465353,0.000048601873,0.0010703255,0.00013133453],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012791809,0.000020156365,0.00096075126,0.000147012,0.000665424,0.00024299782,0.00025220183,0.0000037182883,0.000067415844,0.000048464895,0.990744,0.006719926],"study_design_scores_gemma":[0.0017682321,0.00065672636,0.0007935659,0.00006995917,0.0011085902,0.000119846394,0.000001686877,0.000010005644,0.0002248193,0.0009942657,0.99408025,0.0001720293],"about_ca_topic_score_codex":0.0016776148,"about_ca_topic_score_gemma":0.00006710317,"teacher_disagreement_score":0.015757928,"about_ca_system_score_codex":0.00006023581,"about_ca_system_score_gemma":0.00042474832,"threshold_uncertainty_score":0.99687433},"labels":[],"label_agreement":null},{"id":"W2105984075","doi":"10.1054/mehy.2001.1469","title":"Spontaneous regression: a hidden treasure buried in time","year":2002,"lang":"en","type":"article","venue":"Medical Hypotheses","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Treasure; Regression; Regression analysis; Computer science; Geography; Statistics; Archaeology; Mathematics; Machine learning","score_opus":0.03450707833800574,"score_gpt":0.2749119862178613,"score_spread":0.24040490787985555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105984075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89680797,0.0038297407,0.000004808371,0.011343538,0.00017922139,0.0005231598,0.000014982288,0.00019761822,0.08709896],"genre_scores_gemma":[0.9732762,0.00026478735,0.00014956268,0.0018469804,0.0004779735,0.000041784857,0.0000066660828,0.000033622586,0.023902427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814236,0.00007428994,0.0002518263,0.00028621746,0.00092593813,0.00031936803],"domain_scores_gemma":[0.99907637,0.00018472035,0.00003404542,0.0002882922,0.000025486728,0.0003910691],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015881954,0.00018473208,0.0003990229,0.00009961288,0.000041254087,0.000013129243,0.00015707286,0.00019597511,0.027700258],"category_scores_gemma":[0.00058538537,0.000120967146,0.00009438399,0.00020302858,0.00011606376,0.000037564663,0.000034477875,0.00026321047,0.0012060256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019128838,0.004580437,0.050469864,0.00019024272,0.00032358002,0.11885987,0.002282125,3.0443078e-7,0.0010517328,0.00007506571,0.08869148,0.73156244],"study_design_scores_gemma":[0.054772068,0.006941858,0.20421559,0.009256974,0.0010581443,0.07161342,0.0005691481,0.0028172808,0.007377524,0.0032773595,0.6356705,0.00243017],"about_ca_topic_score_codex":0.00010063808,"about_ca_topic_score_gemma":0.000029327397,"teacher_disagreement_score":0.72913224,"about_ca_system_score_codex":0.00009231898,"about_ca_system_score_gemma":0.00007979995,"threshold_uncertainty_score":0.9995716},"labels":[],"label_agreement":null},{"id":"W2107854852","doi":"10.1245/s10434-011-1618-2","title":"Surgical Caseload is an Important Determinant of Continent Urinary Diversion Rate at Radical Cystectomy: A Population-Based Study","year":2011,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Cystectomy; Urinary diversion; Surgical oncology; Bladder cancer; Surgery; Population; Urology; Internal medicine; Cancer","score_opus":0.10031027640977562,"score_gpt":0.37388305551616685,"score_spread":0.2735727791063912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107854852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965772,0.00031510368,0.0000012586945,0.0008995429,0.00012490331,0.00068664417,0.0000759046,0.000027139664,0.0012922887],"genre_scores_gemma":[0.99902385,0.0003033277,0.00007601954,0.00025243434,0.00006661679,0.000031376214,0.000048649632,0.000018953195,0.0001787633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772453,0.00035566196,0.0008314297,0.00041296723,0.00033996472,0.0003354212],"domain_scores_gemma":[0.9984971,0.00021513503,0.00036163986,0.00035627425,0.00021699657,0.00035283552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005463835,0.00022518639,0.0009959462,0.00013948338,0.000073007024,0.000002133984,0.00012221496,0.00021213981,0.0015783634],"category_scores_gemma":[0.000016682407,0.00016393255,0.00025485113,0.00018118732,0.00016479689,0.00006153599,0.00008908676,0.00015113094,0.00001138694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020144574,0.012113389,0.9415372,0.00008559919,0.0002891841,0.019303408,0.00083883,9.018265e-7,0.00024396284,0.00003276779,0.00039087716,0.005019293],"study_design_scores_gemma":[0.025532523,0.049181946,0.8665981,0.00014500089,0.00064481836,0.0011373335,0.00034838694,0.00017979153,0.01691582,0.00006911688,0.03887918,0.00036794596],"about_ca_topic_score_codex":0.0015776687,"about_ca_topic_score_gemma":0.000069422334,"teacher_disagreement_score":0.07493907,"about_ca_system_score_codex":0.00008313374,"about_ca_system_score_gemma":0.00025208658,"threshold_uncertainty_score":0.99933434},"labels":[],"label_agreement":null},{"id":"W2108384264","doi":"10.1016/j.urolonc.2015.06.007","title":"Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelium; Bladder cancer; Immunohistochemistry; Pathology; Cancer; Biology; Cancer research; Medicine; Internal medicine; Urinary bladder","score_opus":0.0459573828688726,"score_gpt":0.3343158383290297,"score_spread":0.28835845546015715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108384264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98450875,0.0041322955,0.000025920903,0.007527505,0.00016859038,0.0005149176,0.00026905345,0.000044520337,0.0028084302],"genre_scores_gemma":[0.95119643,0.006034454,0.016930614,0.01817323,0.00056150975,0.00070933724,0.00038888067,0.00005586065,0.005949658],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885654,0.00008175572,0.00028965803,0.00033352282,0.00019304933,0.00024545417],"domain_scores_gemma":[0.99896234,0.00010853471,0.00019468018,0.00019499316,0.000139019,0.00040045232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013584009,0.00020265269,0.0004321649,0.00008557449,0.000094553834,0.0000089917985,0.00007652905,0.00022701242,0.00040178362],"category_scores_gemma":[0.00008617592,0.0001539221,0.000062116575,0.00017777245,0.00046169528,0.00010915914,0.000047872938,0.00020645426,0.00001450804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001517419,0.001578543,0.49981952,0.00021886881,0.000544076,0.00017309294,0.0038048958,0.000009217026,0.26259974,0.0009362938,0.21307914,0.015719207],"study_design_scores_gemma":[0.003677519,0.0033241524,0.0032741614,0.00014943066,0.00047075268,0.00008261004,0.00029477358,0.000055452292,0.04207587,0.0020559698,0.9443478,0.00019149425],"about_ca_topic_score_codex":0.00026969402,"about_ca_topic_score_gemma":0.000011806735,"teacher_disagreement_score":0.7312687,"about_ca_system_score_codex":0.00011683942,"about_ca_system_score_gemma":0.000695983,"threshold_uncertainty_score":0.62767607},"labels":[],"label_agreement":null},{"id":"W2108821921","doi":"10.1093/jnci/dju290","title":"Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nomogram; Bladder cancer; Receiver operating characteristic; Cystectomy; Medicine; Area under the curve; Oncology; Internal medicine; Cancer","score_opus":0.03383158570562197,"score_gpt":0.33234291040397324,"score_spread":0.2985113246983513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108821921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219155,0.0014823957,0.002119571,0.0016561889,0.0016062871,0.00040178862,0.00041189737,0.0000030150043,0.00012727403],"genre_scores_gemma":[0.99732506,0.00042674554,0.00097016443,0.00033635026,0.0007146583,0.00004042352,0.000008415621,0.000010306524,0.00016788705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988294,0.000036504967,0.00036884515,0.0001337498,0.0005260062,0.00010543997],"domain_scores_gemma":[0.9987179,0.00009957994,0.00051043095,0.00007756669,0.0005490208,0.000045508426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032604107,0.000113662696,0.0002597798,0.00012466044,0.000065987486,0.000015837764,0.000111519876,0.000080177306,0.000014836725],"category_scores_gemma":[0.00031407693,0.00006979401,0.00009926779,0.00017775079,0.000079403115,0.00039957016,0.000027801136,0.00023098715,1.16847765e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012179952,0.0019677593,0.39904574,0.001299787,0.0015806021,0.000006726231,0.0022571073,0.059817474,0.4446804,0.0036997148,0.017112648,0.05635208],"study_design_scores_gemma":[0.031162126,0.0010138322,0.41697386,0.0045786644,0.00091855385,0.00010874242,0.00006793925,0.0010859492,0.52364486,0.0043603657,0.01567311,0.0004120232],"about_ca_topic_score_codex":0.00037961386,"about_ca_topic_score_gemma":0.00020258533,"teacher_disagreement_score":0.078964435,"about_ca_system_score_codex":0.00024805008,"about_ca_system_score_gemma":0.0005814439,"threshold_uncertainty_score":0.28461173},"labels":[],"label_agreement":null},{"id":"W2108999080","doi":"10.1016/j.urology.2007.10.041","title":"Outcomes of Patients with Clinical T1 Grade 3 Urothelial Cell Bladder Carcinoma Treated with Radical Cystectomy","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Stage (stratigraphy); Hazard ratio; Lymphadenectomy; Urology; Carcinoma; Carcinoma in situ; Transitional cell carcinoma; Surgery; Confidence interval; Lymph node; Cancer; Internal medicine","score_opus":0.020971243730190985,"score_gpt":0.27006949917302997,"score_spread":0.24909825544283898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108999080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964795,0.0000849273,0.00008559196,0.0002619314,0.00012077143,0.00067517447,0.00005532224,0.00005867372,0.0021781055],"genre_scores_gemma":[0.9977589,0.000014663881,0.00030844103,0.000869866,0.000102759,0.00003823613,0.000052812124,0.0000504662,0.00080382905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982992,0.00013087262,0.00043545943,0.0004269245,0.000338635,0.00036895482],"domain_scores_gemma":[0.9989542,0.00012713303,0.00015537161,0.00040874816,0.0001266875,0.00022788001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005760498,0.00027335828,0.00075865653,0.00011187853,0.00006527112,0.000002136736,0.0001111146,0.00021117704,0.0002604141],"category_scores_gemma":[0.000023076602,0.00016234956,0.0001343194,0.0001566783,0.00061437226,0.00003854256,0.000026862146,0.0002802963,0.00003361037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050226673,0.0016180356,0.9916347,0.00001779508,0.00037116293,0.0003324812,0.0001344413,0.000003487913,0.000025924985,0.000007904368,0.0006556089,0.00017575975],"study_design_scores_gemma":[0.026483748,0.009895597,0.95972204,0.000004628996,0.0005768757,0.00008902223,0.000010933055,0.000014404654,0.0008004553,0.0000057444367,0.0022400494,0.00015648412],"about_ca_topic_score_codex":0.00022372758,"about_ca_topic_score_gemma":0.000047832164,"teacher_disagreement_score":0.031912673,"about_ca_system_score_codex":0.000029996607,"about_ca_system_score_gemma":0.00024117556,"threshold_uncertainty_score":0.6620423},"labels":[],"label_agreement":null},{"id":"W2109080929","doi":"10.1111/j.1464-410x.2008.07988.x","title":"Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph‐node density","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphadenectomy; Hazard ratio; Urology; Lymph node; Stage (stratigraphy); Ureteral neoplasm; Genitourinary system; Carcinoma; Internal medicine; Cancer; Oncology; Bladder cancer; Transitional cell carcinoma; Confidence interval","score_opus":0.008803384225663955,"score_gpt":0.23533968043507988,"score_spread":0.22653629620941593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109080929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837214,0.00070282945,0.00018661296,0.00017157868,0.0000860195,0.00022860896,0.00006136143,0.000002802086,0.00018803346],"genre_scores_gemma":[0.9988903,0.00018506477,0.00058205327,0.00023557278,0.00007095941,0.0000016777672,0.000016149897,0.000010178673,0.000008084628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986719,0.00012249616,0.0005937328,0.00013796668,0.00030973923,0.00016419786],"domain_scores_gemma":[0.9989443,0.000031875607,0.00050577585,0.00012224799,0.00031400815,0.00008181672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021836934,0.00010525913,0.00043678324,0.00013215918,0.000024420866,0.000005064789,0.000083804545,0.000091234084,0.00003895721],"category_scores_gemma":[0.000054314638,0.00009699296,0.000096058524,0.000107132684,0.000080887396,0.00008582649,0.00000710981,0.00020397075,6.4436284e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002048847,0.001915394,0.97774273,0.000022313692,0.0000787439,0.00017486342,0.00021900662,0.00008968626,0.00064204005,0.00003230672,0.00003036306,0.01700373],"study_design_scores_gemma":[0.008897375,0.0032103558,0.985186,0.00006637265,0.00025589333,0.00041433843,0.000037899787,0.000028143975,0.0015284824,0.00028437216,0.000026557705,0.00006422365],"about_ca_topic_score_codex":0.0007478211,"about_ca_topic_score_gemma":0.000082751976,"teacher_disagreement_score":0.016939506,"about_ca_system_score_codex":0.00007258585,"about_ca_system_score_gemma":0.0002524693,"threshold_uncertainty_score":0.3955258},"labels":[],"label_agreement":null},{"id":"W2109166448","doi":"10.1016/j.urolonc.2014.07.017","title":"World Urologic Oncology Federation Bladder Cancer Prevention Program: A global initiative","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Bladder cancer; Family medicine; Smoking cessation; Global health; Public health; Incidence (geometry); Population; Oncology; Cancer; Internal medicine; Environmental health; Nursing; Pathology","score_opus":0.09745354459747134,"score_gpt":0.43686144975296753,"score_spread":0.3394079051554962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109166448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052970025,0.9685513,0.0000987362,0.0038383964,0.0008212334,0.0039779297,0.00019443799,0.00029384546,0.021694463],"genre_scores_gemma":[0.00008802355,0.9637591,0.02335131,0.00397733,0.0009028127,0.0044987733,0.0009762287,0.000054223998,0.0023921737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959862,0.0009399144,0.0010244988,0.0010824404,0.0002862196,0.00068068475],"domain_scores_gemma":[0.9976238,0.000416442,0.0009071128,0.00037343387,0.00017742101,0.0005017798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047715678,0.0007949821,0.0025764627,0.00031898427,0.00050007435,0.00007756314,0.00020271294,0.0012385981,0.0004719146],"category_scores_gemma":[0.00018377863,0.0006028148,0.0004375314,0.0008304956,0.0009871932,0.0001516573,0.00011736375,0.0010514568,0.00011334991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015871233,0.001034556,0.004973861,0.0016160791,0.0010429261,0.00018717154,0.00015795915,0.0000054253874,3.8412284e-7,0.0032732286,0.012679064,0.9748706],"study_design_scores_gemma":[0.0014260829,0.008448641,0.00008333372,0.0014218285,0.006946411,0.0008183921,0.000043356897,0.000055333774,0.0000012155527,0.004803083,0.9755029,0.00044943587],"about_ca_topic_score_codex":0.000118304975,"about_ca_topic_score_gemma":0.00092285033,"teacher_disagreement_score":0.9744212,"about_ca_system_score_codex":0.001334216,"about_ca_system_score_gemma":0.003968033,"threshold_uncertainty_score":0.9996423},"labels":[],"label_agreement":null},{"id":"W2110508454","doi":"10.1016/j.eururo.2010.05.023","title":"A Critical Analysis of Orthotopic Bladder Substitutes in Adult Patients with Bladder Cancer: Is There a Perfect Solution?","year":2010,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urinary diversion; Surgery; Quality of life (healthcare); Cancer; Urology; General surgery; Internal medicine","score_opus":0.02114202816562201,"score_gpt":0.32098729133185927,"score_spread":0.2998452631662373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110508454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010941385,0.9790252,0.000025705353,0.00022537472,0.0002856055,0.0011305927,0.0004700813,0.00004815365,0.007847917],"genre_scores_gemma":[0.0465027,0.9512876,0.00011710774,0.00085086015,0.00021972111,0.00014287006,0.00035171956,0.00013582963,0.0003915727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724513,0.00050633634,0.0007211508,0.0007453364,0.00030650446,0.00047553485],"domain_scores_gemma":[0.99835503,0.00019880723,0.00026490702,0.0006918439,0.00032233458,0.00016709203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015616283,0.0005228682,0.002239899,0.0006562206,0.0000562607,0.00001390354,0.00023819246,0.00028894184,0.0017044925],"category_scores_gemma":[0.00014719361,0.00035256756,0.00056663656,0.00095120084,0.00035437665,0.00005282559,0.00007913028,0.0008131246,0.00007996139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060417916,0.0022610563,0.23912735,0.005149317,0.017496914,0.0008039478,0.0008931463,0.00000457808,0.0000018607666,0.00026010576,0.0008191508,0.7325784],"study_design_scores_gemma":[0.0037050575,0.0017244502,0.1541741,0.0016997167,0.056157626,0.000043626034,0.00001041144,0.000028621023,0.0000019695624,0.0000062277227,0.7818069,0.0006412826],"about_ca_topic_score_codex":0.00033811587,"about_ca_topic_score_gemma":0.0008036087,"teacher_disagreement_score":0.78098774,"about_ca_system_score_codex":0.00007479586,"about_ca_system_score_gemma":0.00040489444,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W2110568962","doi":"10.1016/j.eururo.2013.09.003","title":"Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Proportional hazards model; Concordance; Urology; Surgery; Cohort; Retrospective cohort study; Prospective cohort study; Bladder cancer; Internal medicine; Cancer","score_opus":0.03562128064193753,"score_gpt":0.31931701469133467,"score_spread":0.28369573404939713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110568962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903008,0.00016377884,0.0051089968,0.00013786931,0.00037226794,0.00033529542,0.000009448893,0.000028739127,0.0035428551],"genre_scores_gemma":[0.9826256,0.000023641993,0.01644947,0.00058936665,0.00023493219,0.000017920012,0.000006645522,0.000021372072,0.000031066593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981185,0.00026945557,0.00091618014,0.0002879604,0.0002101507,0.00019772889],"domain_scores_gemma":[0.99907976,0.0002744002,0.00016973782,0.00026513144,0.00010794502,0.000103023456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044880348,0.00012995831,0.00041215142,0.0000800058,0.000022986855,0.000004474426,0.00010933977,0.000088347486,0.00089852],"category_scores_gemma":[0.00044719674,0.00009983073,0.00010902716,0.00009816335,0.00021468704,0.000050434715,0.000087641674,0.00024445922,0.00017578334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023977528,0.0005557488,0.19437674,0.00005048313,0.0002131201,0.000095699346,0.0008527545,0.0000010710667,0.00066608115,0.000036517475,0.0016321457,0.79912186],"study_design_scores_gemma":[0.0017935395,0.0012440266,0.9850276,0.000112387075,0.000091442,0.00006702239,0.000010473529,0.00011842583,0.00025226083,0.00013120232,0.011080345,0.00007124265],"about_ca_topic_score_codex":0.0000030830186,"about_ca_topic_score_gemma":0.0000011589987,"teacher_disagreement_score":0.7990506,"about_ca_system_score_codex":0.000019626536,"about_ca_system_score_gemma":0.00017897469,"threshold_uncertainty_score":0.9838164},"labels":[],"label_agreement":null},{"id":"W2111065321","doi":"10.1093/carcin/bgs025","title":"Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies","year":2012,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Dental and Craniofacial Research; School of Medicine, New York University; York University","keywords":"Cancer research; PI3K/AKT/mTOR pathway; Protein kinase B; MAPK/ERK pathway; Carcinogenesis; Urothelium; Biology; Signal transduction; Cancer; Cell biology; Endocrinology; Genetics; Urinary system","score_opus":0.05821207765051322,"score_gpt":0.2857597837805758,"score_spread":0.2275477061300626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111065321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570143,0.001464298,0.0015793818,0.00023015158,0.00008332139,0.00048156793,0.00006937284,0.00003841003,0.00035205492],"genre_scores_gemma":[0.9969223,0.000011268608,0.0023097,0.00030550524,0.00017704179,0.00015098175,0.00008283717,0.000027990347,0.000012364323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991104,0.00006301925,0.00029553732,0.00015464074,0.00015692163,0.00021950353],"domain_scores_gemma":[0.99937755,0.00009921302,0.000108769884,0.00022396601,0.00010879988,0.00008168354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014093998,0.00012744157,0.00022448272,0.00016705609,0.000053802254,0.000005583756,0.00004942628,0.000056392655,0.00011457164],"category_scores_gemma":[0.00006697164,0.00011416355,0.00009120634,0.0002289813,0.000042510528,0.00012194493,0.000009387124,0.00004294608,0.000007331457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013312609,0.00018806398,0.685109,0.000051003215,0.000024631214,9.2527847e-7,0.0006470767,0.00008209714,0.31195667,0.000117636955,0.000012180439,0.001677576],"study_design_scores_gemma":[0.0012235121,0.000068565685,0.59123516,0.000039375533,0.00005665909,0.0000020397783,0.00010910303,0.00016016584,0.40682516,0.00015043053,0.000059027152,0.000070795584],"about_ca_topic_score_codex":0.00016658577,"about_ca_topic_score_gemma":0.000013749064,"teacher_disagreement_score":0.09486848,"about_ca_system_score_codex":0.00010460266,"about_ca_system_score_gemma":0.00015145478,"threshold_uncertainty_score":0.46554545},"labels":[],"label_agreement":null},{"id":"W2111159270","doi":"10.5489/cuaj.2051","title":"Robot-assisted versus laparoscopic nephroureterectomy for uppertract urothelial cancer: A population-based assessment of costs and perioperative outcomes","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Perioperative; Propensity score matching; Urothelial carcinoma; Retrospective cohort study; Nephrectomy; Population; Logistic regression; Blood transfusion; Stage (stratigraphy); Odds ratio; Cohort; Surgery; Urology; Cancer; Bladder cancer; Internal medicine; Kidney","score_opus":0.021824514259838283,"score_gpt":0.31889239620946935,"score_spread":0.2970678819496311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111159270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98300827,0.00009341857,0.00043277568,0.014396877,0.00070658175,0.00057370873,0.00020146785,0.000017329832,0.00056958717],"genre_scores_gemma":[0.9956156,0.000019413374,0.001284589,0.0025333685,0.0002912819,0.00006683345,0.000046572735,0.00001448243,0.00012782933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878937,0.00014968248,0.00031436642,0.00018455622,0.00025543652,0.00030659535],"domain_scores_gemma":[0.998641,0.00036756886,0.0002480281,0.00008055067,0.0002616464,0.0004012138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028710967,0.00015632324,0.00043818617,0.00011600121,0.000234812,0.000059400838,0.00005790792,0.00017216794,0.00021871405],"category_scores_gemma":[0.0004501041,0.00011738938,0.00013570025,0.00008940191,0.000025539111,0.00006431297,0.0000048710203,0.0002343697,0.0000010269817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025713496,0.00005260712,0.99331075,0.000010459552,0.00022217576,0.00000273283,0.000037131198,0.00007168197,0.000212413,0.00013681116,0.00021254859,0.005473552],"study_design_scores_gemma":[0.00851189,0.0011906105,0.9843756,0.000024695444,0.00022923115,0.0000068985746,0.000019719928,0.0011316763,0.000057891593,0.000028644701,0.004315799,0.00010732401],"about_ca_topic_score_codex":0.005975042,"about_ca_topic_score_gemma":0.005306579,"teacher_disagreement_score":0.012607376,"about_ca_system_score_codex":0.0014684023,"about_ca_system_score_gemma":0.00085041625,"threshold_uncertainty_score":0.9032516},"labels":[],"label_agreement":null},{"id":"W2111328277","doi":"10.1002/ijc.23240","title":"Tissue factor expression correlates with disease‐specific survival in patients with node‐negative muscle‐invasive bladder cancer","year":2007,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Bladder cancer; Medicine; Tissue microarray; Cystectomy; Immunohistochemistry; Cancer; Proportional hazards model; Pathology; Oncology; Metastasis; Transitional cell carcinoma; Internal medicine; Carcinoma; Angiogenesis","score_opus":0.015520707159831178,"score_gpt":0.3016635794400026,"score_spread":0.28614287228017143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111328277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946888,0.0020632385,0.00047163764,0.00070001563,0.0011587243,0.00031161122,0.00019103575,0.000010020703,0.00040491376],"genre_scores_gemma":[0.9978792,0.000685599,0.00023719038,0.0003147577,0.0006107611,0.000018960569,0.000015253231,0.000036295987,0.00020196219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803954,0.000026717593,0.0003866131,0.00021210947,0.0011060229,0.00022898162],"domain_scores_gemma":[0.99807906,0.000113194656,0.00036532537,0.0001105553,0.0010988867,0.00023299917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000075640346,0.00020932776,0.00030337868,0.00023736511,0.00003263515,0.000029019842,0.00016858449,0.000055768833,0.00100276],"category_scores_gemma":[0.000028397642,0.00013111455,0.00006589495,0.00014873371,0.00008557529,0.0002768374,0.000024073104,0.00027525067,0.0000052379214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011208645,0.00045011446,0.96367705,0.000013933868,0.0006219521,0.0003209371,0.0007379952,0.0004052145,0.00054951035,0.000013797632,0.00033567403,0.021665186],"study_design_scores_gemma":[0.010026065,0.0005196856,0.97778195,0.0013250742,0.00012541386,0.000006862982,0.00015103714,0.0000025065497,0.008041222,0.000030246176,0.0018300293,0.00015989985],"about_ca_topic_score_codex":0.00021342775,"about_ca_topic_score_gemma":0.0006020627,"teacher_disagreement_score":0.021505287,"about_ca_system_score_codex":0.000614005,"about_ca_system_score_gemma":0.00048581717,"threshold_uncertainty_score":0.9999105},"labels":[],"label_agreement":null},{"id":"W2111591069","doi":"10.1016/j.eursup.2010.01.005","title":"Staging and Staging Errors in Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Bladder cancer; Urology; General surgery; Cancer; Radiology; Internal medicine","score_opus":0.01494470848205617,"score_gpt":0.2997258816259799,"score_spread":0.28478117314392376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111591069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839987,0.00020307934,0.000024951752,0.002657043,0.00044863566,0.00034317988,0.000060645285,0.000052581396,0.012211152],"genre_scores_gemma":[0.9952722,0.00009968886,0.000423122,0.00307239,0.0001765438,0.000023829787,0.0000455545,0.000053168995,0.00083350297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986655,0.00010550896,0.0002566665,0.00039719502,0.00014940133,0.00042572225],"domain_scores_gemma":[0.9994826,0.000024562274,0.000056069628,0.00025574063,0.000028719167,0.00015233888],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002605018,0.00018921719,0.00022247252,0.00016718509,0.000074811345,0.000016541038,0.00009470356,0.000042338783,0.0020878138],"category_scores_gemma":[0.000024289035,0.00017083468,0.00003336674,0.000113437534,0.00010798647,0.00008086731,0.0001115165,0.00041581492,0.000062329615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013158888,0.00011209505,0.97950304,0.00001655446,0.000110209614,0.00032443655,0.00089214,0.000002611271,0.0062122154,0.000056726996,0.0018030293,0.010835353],"study_design_scores_gemma":[0.0059622186,0.0002848514,0.8965222,0.000016356014,0.00014420426,0.000044355023,0.00017139092,0.00008020797,0.0009472835,0.00006535,0.095552236,0.00020930804],"about_ca_topic_score_codex":0.00034465437,"about_ca_topic_score_gemma":0.0004248555,"teacher_disagreement_score":0.0937492,"about_ca_system_score_codex":0.000027846801,"about_ca_system_score_gemma":0.000060185124,"threshold_uncertainty_score":0.9988244},"labels":[],"label_agreement":null},{"id":"W2112366277","doi":"10.1016/j.urolonc.2013.12.005","title":"Bladder cancer: A portal into men׳s health","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine","score_opus":0.05600527733549215,"score_gpt":0.409072407161369,"score_spread":0.35306712982587685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112366277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006930422,0.9845193,0.000022372906,0.005821438,0.00039069832,0.0012708935,0.00010076158,0.000111327034,0.007693882],"genre_scores_gemma":[0.000011206636,0.9804722,0.01031727,0.00477907,0.00061457785,0.0008031253,0.00042968473,0.00005580982,0.0025170753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974003,0.00031081305,0.00078528584,0.00076335325,0.00021863078,0.0005216141],"domain_scores_gemma":[0.9980813,0.00021857023,0.0005754831,0.0003842741,0.00006197097,0.00067836215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037781175,0.0005757481,0.0024990877,0.0002651319,0.00036350676,0.000027007285,0.00016055406,0.0006597434,0.00040732353],"category_scores_gemma":[0.00007374925,0.00041927947,0.00030223213,0.00035757606,0.00069672463,0.000060424947,0.00007874011,0.00079577055,0.0000889096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027937967,0.00023775622,0.0023244931,0.004585345,0.00073162105,0.00019148276,0.0003333312,8.5037135e-7,2.6015667e-7,0.0027437254,0.07048185,0.91834134],"study_design_scores_gemma":[0.0006535942,0.002592049,0.000014470845,0.0022370527,0.0027741594,0.00104328,0.000043422413,0.000012779916,5.2828136e-7,0.001208079,0.98911655,0.00030402959],"about_ca_topic_score_codex":0.0006776153,"about_ca_topic_score_gemma":0.00016450348,"teacher_disagreement_score":0.9186347,"about_ca_system_score_codex":0.00046160092,"about_ca_system_score_gemma":0.004176176,"threshold_uncertainty_score":0.9998259},"labels":[],"label_agreement":null},{"id":"W2112640474","doi":"10.1016/j.eururo.2012.12.061","title":"Radical Locoregional Therapy for Bladder Cancer: Underutilized, or Unsuitable in Many?","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; General surgery; Urology; Surgery; Internal medicine","score_opus":0.056047969735519114,"score_gpt":0.3122638391787825,"score_spread":0.25621586944326336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112640474","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028280907,0.0082707945,0.00045598103,0.95845103,0.0015781983,0.0039060079,0.00025739043,0.00018863601,0.024063839],"genre_scores_gemma":[0.005055738,0.002603904,0.00030347172,0.92957413,0.0069216467,0.00067354814,0.000676676,0.0003228845,0.053868007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970933,0.00036887455,0.0005027965,0.0008645196,0.0002915686,0.0008789106],"domain_scores_gemma":[0.99882025,0.0002938612,0.00016190071,0.0004908866,0.00009429,0.00013881653],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019401938,0.0005306347,0.00085967034,0.0002646584,0.000074778916,0.000027134787,0.00031120284,0.00055613625,0.007720182],"category_scores_gemma":[0.000036440648,0.00038068093,0.0002481017,0.000120834906,0.0002925015,0.000049033595,0.00007046896,0.0013431361,0.0007478359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020423755,0.00017947948,0.001025681,0.000093715396,0.00048541118,0.0019899087,0.00007161961,0.000002353477,0.000027577576,0.000034313205,0.9821769,0.01187064],"study_design_scores_gemma":[0.010663626,0.001704134,0.004297786,0.000041425043,0.00021640975,0.0002827387,0.000006494888,0.000054420216,0.00001881131,0.00021611704,0.9821628,0.00033527313],"about_ca_topic_score_codex":0.0003078289,"about_ca_topic_score_gemma":0.000041655327,"teacher_disagreement_score":0.029804168,"about_ca_system_score_codex":0.00016785976,"about_ca_system_score_gemma":0.00052669464,"threshold_uncertainty_score":0.9998645},"labels":[],"label_agreement":null},{"id":"W2113746837","doi":"10.1016/j.urolonc.2011.12.004","title":"Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; McMaster University; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University; Western University","funders":"","keywords":"Renal pelvis; Medicine; Ureter; Urothelial carcinoma; Urology; Cohort; Retrospective cohort study; Ureteral neoplasm; Upper urinary tract; Carcinoma; Internal medicine; Oncology; Cancer; Urinary system; Transitional cell carcinoma; Bladder cancer","score_opus":0.031695058724388755,"score_gpt":0.3077854945877818,"score_spread":0.27609043586339305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113746837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934823,0.00055103813,0.000034552842,0.0066186567,0.00012812186,0.0012035407,0.000048548794,0.00005290892,0.0020144216],"genre_scores_gemma":[0.9882689,0.000047535224,0.0058643,0.004385919,0.00012780428,0.00046974467,0.0000438688,0.000018995268,0.00077294075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863255,0.00012852973,0.0003266433,0.00042569006,0.00014716956,0.0003394298],"domain_scores_gemma":[0.9991612,0.00016798187,0.00010517669,0.00020642663,0.000096848446,0.00026239664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012390254,0.00022972855,0.00036791532,0.00013849576,0.00012570122,0.000028037284,0.00007750005,0.00019813095,0.0005664278],"category_scores_gemma":[0.00015598285,0.00017665607,0.000059423124,0.00025819856,0.00037922722,0.000162167,0.000025223097,0.00031014677,0.00012773287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065360124,0.0005058861,0.99464345,0.000032430322,0.000026382464,0.00006669915,0.0011182766,0.0000040291347,0.0005747177,0.0002005864,0.0011277223,0.0016344507],"study_design_scores_gemma":[0.0022829152,0.0023331943,0.88603926,0.00005688903,0.00017344451,0.00025317635,0.0003007174,0.0011603879,0.0009929189,0.0023187548,0.103863545,0.00022477834],"about_ca_topic_score_codex":0.0011329803,"about_ca_topic_score_gemma":0.00007698776,"teacher_disagreement_score":0.10860418,"about_ca_system_score_codex":0.00016860005,"about_ca_system_score_gemma":0.00049812393,"threshold_uncertainty_score":0.7203826},"labels":[],"label_agreement":null},{"id":"W2113993502","doi":"10.1016/j.juro.2010.02.021","title":"Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Gerontology; Cancer; Bladder cancer","score_opus":0.008274450731051708,"score_gpt":0.2874536520746579,"score_spread":0.2791792013436062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113993502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973389,0.00027975452,0.00001131297,0.0011872612,0.00048594622,0.0005464476,0.000060728074,0.0000055631,0.00008407227],"genre_scores_gemma":[0.99927324,0.00003160705,0.000059754944,0.0003594056,0.00012391082,0.0000055177675,0.0000018734546,0.00002239604,0.000122301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998219,0.0002065253,0.00067404547,0.00012579812,0.0004976704,0.00027694632],"domain_scores_gemma":[0.9985974,0.00022149077,0.0004169989,0.00032115914,0.00025857956,0.00018439395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029474968,0.00017792404,0.0006911765,0.00013815955,0.000022182481,0.0000031062534,0.00019222619,0.0001305991,0.0007039342],"category_scores_gemma":[0.00009769076,0.00009512085,0.00014817811,0.00008959306,0.00024785957,0.000050944953,0.00007052331,0.00051949074,0.0000071186655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011893369,0.0029450434,0.976523,0.000030003714,0.00064694276,0.00016832289,0.006402825,0.0000012346259,0.0004141117,0.0000010289831,0.00025775455,0.00071636843],"study_design_scores_gemma":[0.02063266,0.00839298,0.965752,0.00002273867,0.0009426847,0.00017746811,0.0003337737,0.000018774144,0.000519181,0.000017324443,0.0031193714,0.00007102914],"about_ca_topic_score_codex":0.00015005181,"about_ca_topic_score_gemma":0.000055648994,"teacher_disagreement_score":0.010770979,"about_ca_system_score_codex":0.000024323614,"about_ca_system_score_gemma":0.000120960794,"threshold_uncertainty_score":0.77075857},"labels":[],"label_agreement":null},{"id":"W2114303749","doi":"10.1111/j.1464-410x.2003.04516.x","title":"Endourological management of upper tract transitional cell carcinoma","year":2003,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Genitourinary system; Prostatectomy; Prostate cancer; Transitional cell carcinoma; Upper urinary tract; Urology; General surgery; Gynecology; Urinary incontinence; Cancer; Urinary system; Internal medicine; Bladder cancer","score_opus":0.03618122557715897,"score_gpt":0.30237577706454166,"score_spread":0.2661945514873827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114303749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046115223,0.99097896,0.00008964456,0.000069662565,0.0003695321,0.00041007655,0.000116177755,0.0000051278043,0.0074996445],"genre_scores_gemma":[0.010462014,0.9878535,0.00064850395,0.0002985002,0.00023952167,0.000015869997,0.000047771493,0.000041030024,0.0003932813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977623,0.00027857034,0.0010616069,0.0002480662,0.00035280836,0.00029661914],"domain_scores_gemma":[0.9988518,0.00007873436,0.00060362834,0.00014755051,0.00013727536,0.00018105346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026939326,0.00027561956,0.0019807906,0.00018682516,0.00003589192,0.000009850051,0.00017778095,0.00037455195,0.0010539436],"category_scores_gemma":[0.000007746488,0.00024362096,0.0011060056,0.00013292537,0.000118208896,0.000038687365,0.000017400675,0.00074818084,0.000013986597],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023203607,0.0015177741,0.00017525093,0.0070704035,0.0008834927,0.023363257,0.000017224662,0.0000014540018,8.558524e-7,0.0000681975,0.0018213533,0.9648487],"study_design_scores_gemma":[0.0031402854,0.0019254608,0.0019604107,0.0016088474,0.0062397807,0.111175865,0.000008919505,1.9535962e-7,0.000001941413,0.00008265234,0.8737003,0.00015531338],"about_ca_topic_score_codex":0.0000076253896,"about_ca_topic_score_gemma":4.284405e-7,"teacher_disagreement_score":0.96469337,"about_ca_system_score_codex":0.000070259484,"about_ca_system_score_gemma":0.00032775966,"threshold_uncertainty_score":0.9998592},"labels":[],"label_agreement":null},{"id":"W2115135540","doi":"10.1111/bju.12012","title":"Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer ( <scp>NMIBC</scp> ) with emphasis on the use of bacillus <scp>C</scp> almette‐ <scp>G</scp> uérin ( <scp>BCG</scp> ): results of an international individual patient data survey ( <scp>IPDS</scp> )","year":2013,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Medicine; Guideline; Bladder cancer; Carcinoma in situ; Internal medicine; Maintenance therapy; Oncology; Urology; Cancer; Chemotherapy; Pathology","score_opus":0.06990992516850342,"score_gpt":0.3331235692294382,"score_spread":0.2632136440609348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115135540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98062396,0.0073072356,0.000064401764,0.00044292051,0.001504792,0.0021378617,0.0074574593,0.000026259131,0.00043508652],"genre_scores_gemma":[0.9464838,0.048869453,0.00080566626,0.0014837956,0.0009040456,0.00020211673,0.00091646664,0.00014629182,0.00018836182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98802024,0.0036216807,0.0035440323,0.001404524,0.0022155016,0.0011940286],"domain_scores_gemma":[0.9622623,0.028843332,0.004623724,0.0016082088,0.0019730488,0.00068938866],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003629409,0.00096033484,0.0022056994,0.0007143962,0.00022530876,0.00023443112,0.0017175474,0.000607983,0.000029343599],"category_scores_gemma":[0.02514373,0.0006808457,0.00046328106,0.00078587426,0.0013508613,0.0013101078,0.0004516381,0.0018609085,0.000017103392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009931958,0.02601776,0.5206352,0.00028228518,0.013000118,0.0029814846,0.030710608,0.0008969031,0.00037506013,0.00004836453,0.16636477,0.23769428],"study_design_scores_gemma":[0.018008102,0.019289834,0.87373537,0.00066233653,0.002458022,0.001910815,0.006129384,0.00021611794,0.0012046149,0.00009804128,0.076209456,0.000077882454],"about_ca_topic_score_codex":0.008294241,"about_ca_topic_score_gemma":0.005032215,"teacher_disagreement_score":0.3531002,"about_ca_system_score_codex":0.00027211232,"about_ca_system_score_gemma":0.0012048286,"threshold_uncertainty_score":0.9995643},"labels":[],"label_agreement":null},{"id":"W2115253184","doi":"10.1016/j.urology.2011.07.435","title":"POD-05.04 Stage pT0 After Radical Cystectomy: Are All Patients Equal?","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Stage (stratigraphy); Point of delivery; Resection; Urology; Chemotherapy; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.032254172316523645,"score_gpt":0.2689862436076014,"score_spread":0.2367320712910778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115253184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97480136,0.0004991525,0.00023596868,0.00074346934,0.000729957,0.0005819616,0.00010662686,0.00012429876,0.02217719],"genre_scores_gemma":[0.9894044,0.00001952245,0.00014117859,0.008569094,0.00015281411,0.0000816936,0.000039374798,0.000035549143,0.0015564066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879605,0.00007851682,0.00021919556,0.00033366878,0.00017686421,0.0003957163],"domain_scores_gemma":[0.9992947,0.000027226431,0.000070567214,0.00033983093,0.000056602683,0.00021105324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005620971,0.00018450788,0.00032663468,0.00008614949,0.000029791005,0.0000042541697,0.00009508014,0.00019492976,0.003536944],"category_scores_gemma":[0.000036315123,0.00014454985,0.000095062045,0.00006721978,0.00011757682,0.00004453576,0.000057570312,0.00020656794,0.00053603464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00515604,0.0017148724,0.9766769,0.0000917464,0.0005215009,0.001281005,0.0024440626,4.9308426e-7,0.00014816427,0.0003328172,0.005779756,0.005852674],"study_design_scores_gemma":[0.010646061,0.0047141626,0.7827255,0.000020095713,0.00042212714,0.00007402776,0.000047332564,0.000014715984,0.00080462376,0.00038175276,0.19987242,0.0002771468],"about_ca_topic_score_codex":0.00020679171,"about_ca_topic_score_gemma":0.00006643329,"teacher_disagreement_score":0.19409266,"about_ca_system_score_codex":0.00005475523,"about_ca_system_score_gemma":0.000060998766,"threshold_uncertainty_score":0.99737394},"labels":[],"label_agreement":null},{"id":"W2115444715","doi":"10.5489/cuaj.1156","title":"Radical cystectomy is the treatment of choice for invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Bladder cancer; Urology; Medicine; Cancer; Internal medicine","score_opus":0.02269299057969629,"score_gpt":0.27332890271017607,"score_spread":0.25063591213047975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115444715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88616174,0.00214535,0.00003306749,0.10826766,0.00041805126,0.0013688595,0.00019453888,0.000014312236,0.0013964396],"genre_scores_gemma":[0.98583156,0.0007025468,0.00010938154,0.010202948,0.0008545578,0.00027867462,0.000011075314,0.000013820171,0.001995432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988974,0.00007012875,0.00027355267,0.00014653902,0.00023591165,0.0003764695],"domain_scores_gemma":[0.99851334,0.00036574664,0.00020040158,0.00010736606,0.00035035354,0.00046277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113719056,0.00013247023,0.00028401296,0.00007044692,0.00021666066,0.000041152693,0.00008969281,0.00016837697,0.002834112],"category_scores_gemma":[0.00023762563,0.00007318178,0.00023137615,0.000119835786,0.000050902,0.000057537793,0.0000033564324,0.00015410005,0.000037047328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000896645,0.00024515213,0.88322765,0.000010131811,0.0012833461,0.000012826203,0.0008788322,0.000009630871,0.00028725408,0.000060784037,0.092435084,0.021459663],"study_design_scores_gemma":[0.0042154025,0.0018587515,0.6294605,0.000014786828,0.00043196898,0.000050794275,0.00009999365,0.000058968893,0.00070054265,0.0007282749,0.362272,0.00010801857],"about_ca_topic_score_codex":0.014354825,"about_ca_topic_score_gemma":0.0029672722,"teacher_disagreement_score":0.2698369,"about_ca_system_score_codex":0.0012571474,"about_ca_system_score_gemma":0.00089000334,"threshold_uncertainty_score":0.99807745},"labels":[],"label_agreement":null},{"id":"W2115495562","doi":"10.5489/cuaj.1991","title":"Distal ureteral stricture: A unexpected complication of further adjuvant intravesical mitomycin C thermotherapy","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mitomycin C; Medicine; Complication; Adjuvant; Urology; Bladder cancer; Surgery; Ureter; Urethral stricture; Cancer; Internal medicine; Urethra","score_opus":0.009292378307997704,"score_gpt":0.2340153170568095,"score_spread":0.2247229387488118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115495562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742577,0.00020101352,0.0012121546,0.021231072,0.00021290024,0.00027131633,0.00005883405,0.00002915456,0.0025258267],"genre_scores_gemma":[0.99626905,0.000021825846,0.00019308893,0.0027766917,0.00050818454,0.0000078019,0.000033966193,0.000014958228,0.00017443078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986764,0.00018506113,0.00033153495,0.00016656957,0.00031489102,0.00032551875],"domain_scores_gemma":[0.9988561,0.00009030293,0.00024263418,0.00012561237,0.00021245044,0.00047287723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022972755,0.00013995955,0.000320618,0.0001149006,0.00010259694,0.00003234556,0.00009949047,0.00020263118,0.0006855001],"category_scores_gemma":[0.0001792748,0.00010012842,0.00014747398,0.0001786159,0.00003960653,0.000046903024,0.0000053855356,0.0003605638,0.000018671006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047527117,0.00027927101,0.9528379,0.000010204379,0.00049752695,0.00002904823,0.00087259704,0.0000261171,0.006822095,0.0011182531,0.006642927,0.030388828],"study_design_scores_gemma":[0.0022278256,0.0007977674,0.9745643,0.000011979973,0.00009544193,0.00010003825,0.00003176634,0.00035520378,0.00028142528,0.0013113928,0.02011094,0.00011192344],"about_ca_topic_score_codex":0.000820639,"about_ca_topic_score_gemma":0.00031392026,"teacher_disagreement_score":0.030276904,"about_ca_system_score_codex":0.000539651,"about_ca_system_score_gemma":0.00025467528,"threshold_uncertainty_score":0.7505745},"labels":[],"label_agreement":null},{"id":"W2115616445","doi":"10.1016/j.hoc.2014.10.013","title":"Diagnosis and Staging of Bladder Cancer","year":2014,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Overdiagnosis; Medicine; Natural history; Bladder cancer; Disease; Cancer; Incidence (geometry); Carcinoma in situ; Internal medicine; Oncology; Urology","score_opus":0.06517071868304054,"score_gpt":0.4275711364986,"score_spread":0.3624004178155595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115616445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012750421,0.995804,0.000032255506,0.0002129262,0.00042794534,0.0011247658,0.0002686295,0.00003485393,0.00081959943],"genre_scores_gemma":[0.000799848,0.9964726,0.0011013626,0.0005776112,0.00013224914,0.0006009262,0.00012294941,0.00007919276,0.000113263115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663603,0.0003050836,0.001763267,0.00065847643,0.00021182682,0.00042531278],"domain_scores_gemma":[0.99513876,0.0017823295,0.0019979107,0.00062690215,0.00022188424,0.00023221319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020290207,0.00052509335,0.0065133236,0.00030255347,0.000049667316,0.0000026305684,0.00022934585,0.0006039184,0.00032342115],"category_scores_gemma":[0.0002938933,0.00041281854,0.0006472422,0.00037121947,0.0010265631,0.000031099386,0.00016948034,0.00061196793,0.00003243786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007538603,0.000430911,0.08066735,0.015913205,0.0017067896,0.000060320406,0.00007062621,3.381489e-7,2.1000181e-8,0.00001898385,0.0018790432,0.899177],"study_design_scores_gemma":[0.001272519,0.0014563956,0.0014918721,0.0046531674,0.006997553,0.00016542299,0.000025056699,0.0000040395103,0.0000021093058,0.000023201694,0.9836332,0.00027543903],"about_ca_topic_score_codex":0.00017255897,"about_ca_topic_score_gemma":0.0000978682,"teacher_disagreement_score":0.9817542,"about_ca_system_score_codex":0.00009516255,"about_ca_system_score_gemma":0.0014826178,"threshold_uncertainty_score":0.9998324},"labels":[],"label_agreement":null},{"id":"W2116380170","doi":"10.1016/j.urolonc.2009.10.011","title":"BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer","year":2010,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bladder cancer; Grading (engineering); Epidemiology; Medicine; Causation; Cancer; Pathology; Internal medicine; Political science; Biology","score_opus":0.10086557556012189,"score_gpt":0.4145295704181021,"score_spread":0.31366399485798024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116380170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898374,0.0047572595,0.000030127116,0.0037642578,0.00021154986,0.00047338675,0.00013524023,0.000017485925,0.0007733092],"genre_scores_gemma":[0.9514972,0.005769293,0.03957051,0.00218584,0.00017167405,0.00017296577,0.00004042524,0.000018342846,0.0005737588],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992549,0.000035280398,0.00024891135,0.0002190366,0.00008817401,0.00015369574],"domain_scores_gemma":[0.999218,0.00021220164,0.00017722989,0.00014111561,0.000105767656,0.00014570897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015957252,0.00013104081,0.00037791193,0.00007591226,0.00010152442,0.000004145779,0.000047526628,0.00020276218,0.00017338473],"category_scores_gemma":[0.00010755972,0.000095404546,0.00004748811,0.00010977071,0.00066661974,0.0000670068,0.000027561466,0.0001934595,7.021745e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036022183,0.00038631578,0.93137866,0.00036547912,0.00028101093,0.000015009645,0.0010111125,0.0000063853245,0.03134731,0.01599156,0.004860863,0.013996054],"study_design_scores_gemma":[0.004640901,0.006691405,0.1275153,0.00027233476,0.0021900043,0.00025002603,0.00037203802,0.00035057485,0.029086823,0.029826894,0.79850787,0.00029583165],"about_ca_topic_score_codex":0.00051107927,"about_ca_topic_score_gemma":0.00024267238,"teacher_disagreement_score":0.8038634,"about_ca_system_score_codex":0.000020465908,"about_ca_system_score_gemma":0.0003790376,"threshold_uncertainty_score":0.38904846},"labels":[],"label_agreement":null},{"id":"W2116496261","doi":"10.1097/01.ju.0000083887.58315.7e","title":"Long-Term Evaluation of Metabolic Profile and Bone Mineral Density After Ileocystoplasty in Children","year":2003,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bone mineral; Term (time); Internal medicine; Osteoporosis","score_opus":0.01463673416063162,"score_gpt":0.2815937912386872,"score_spread":0.2669570570780556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116496261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920223,0.0072737643,0.000017892087,0.00020571255,0.00007312121,0.00022907654,0.0000026416149,0.0000010860734,0.00017442746],"genre_scores_gemma":[0.9994126,0.00022671146,0.00006433599,0.0001853298,0.00006286516,0.0000039815695,0.000001025133,0.000005358992,0.000037792946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990928,0.00031179955,0.0002368502,0.000056953006,0.0001999847,0.00010158954],"domain_scores_gemma":[0.9995493,0.00003088646,0.0001479851,0.00009714992,0.00013431361,0.00004033419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008465932,0.000068906804,0.00026007037,0.000088416644,0.00001308067,0.0000015877802,0.000028964876,0.0000471805,0.00016548793],"category_scores_gemma":[0.00007346578,0.000040907704,0.000039032468,0.00006503506,0.00006824021,0.000038165992,0.000009779132,0.00014150672,0.0000020327138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001108178,0.00013405147,0.9939466,0.0000056079602,0.0001296807,0.000017652746,0.00029923554,0.000009357309,0.001774695,0.000016185842,0.000024338855,0.0025343893],"study_design_scores_gemma":[0.00393079,0.0004950657,0.9896357,0.000008667001,0.00084293814,0.0031477893,0.0000074010572,0.000014465077,0.0017345735,0.00013695861,0.000016703923,0.000028948029],"about_ca_topic_score_codex":0.000016445285,"about_ca_topic_score_gemma":0.000033958553,"teacher_disagreement_score":0.0073903208,"about_ca_system_score_codex":0.0000149433135,"about_ca_system_score_gemma":0.000113495065,"threshold_uncertainty_score":0.18119767},"labels":[],"label_agreement":null},{"id":"W2116860528","doi":"10.1177/1066896914567329","title":"Novel Technique of Sampling the Urinary Bladder for Urothelial Carcinoma Specimens","year":2015,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cystectomy; Urinary bladder; Sampling (signal processing); Anatomy; Pathology; Medicine; Bladder cancer; Urology; Cancer; Physics; Optics","score_opus":0.08055521571306162,"score_gpt":0.35901508762103973,"score_spread":0.2784598719079781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116860528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92690027,0.0010604587,0.049052563,0.012504438,0.002530059,0.00081146194,0.00019745376,0.000017591105,0.006925705],"genre_scores_gemma":[0.9911047,0.000047258738,0.007125878,0.00027724283,0.001176964,0.000018836334,0.0000069795697,0.000015174506,0.00022693869],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989054,0.00003822824,0.00045507733,0.00010835624,0.00036312055,0.00012979034],"domain_scores_gemma":[0.9985636,0.00019134219,0.0002619172,0.00010957964,0.00077128125,0.00010231647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045417133,0.000101051206,0.00028748458,0.00012226036,0.000019528936,0.0000070703704,0.00021865727,0.00008479443,0.00007745076],"category_scores_gemma":[0.00010727612,0.00006169019,0.0002193099,0.000051566312,0.00013613993,0.0000515334,0.0000483886,0.0001894015,0.0000039606357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0849998,0.014953423,0.17153633,0.00020220182,0.0063888,0.025426088,0.0065093823,0.000664265,0.5973873,0.036291026,0.017379178,0.038262196],"study_design_scores_gemma":[0.07152032,0.019776048,0.1338464,0.0004907089,0.0012728135,0.24655958,0.0010976086,0.000205102,0.11223022,0.019942606,0.39237526,0.000683344],"about_ca_topic_score_codex":0.000010207232,"about_ca_topic_score_gemma":8.200586e-7,"teacher_disagreement_score":0.4851571,"about_ca_system_score_codex":0.00009214055,"about_ca_system_score_gemma":0.00025840127,"threshold_uncertainty_score":0.2515653},"labels":[],"label_agreement":null},{"id":"W2117532460","doi":"10.5489/cuaj.988","title":"Isolated cervical lymph node metastasis of renal pelvic squamous cell carcinoma: A case report","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymph node; Metastasis; Renal pelvis; Cervical lymph nodes; Pathological; Lymph; Radiology; Renal cell carcinoma; Kidney; Pathology; Internal medicine; Cancer","score_opus":0.014014587292033401,"score_gpt":0.2333658320940794,"score_spread":0.219351244802046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117532460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552513,0.00038388747,0.00012585263,0.007787421,0.00021727625,0.0002876287,0.00007237932,0.000022259632,0.0055781896],"genre_scores_gemma":[0.9963695,0.000008096656,0.00022770422,0.0021260993,0.00027217786,0.000018008363,0.00003096178,0.000019613793,0.000927866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980009,0.00017826191,0.00062227977,0.00025058215,0.00040070098,0.00054724095],"domain_scores_gemma":[0.99762034,0.000111987996,0.00042662545,0.00019235142,0.00056489784,0.0010838126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003763494,0.0001907206,0.0004433274,0.00019990522,0.00020434486,0.000054284945,0.00009504058,0.00028990474,0.003645032],"category_scores_gemma":[0.00035778582,0.00014736882,0.00025118788,0.00026938823,0.000037547605,0.000107314816,0.000013337277,0.000447181,0.0001064656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001234779,0.0002826136,0.9335196,0.000024500756,0.00022140708,0.05320169,0.0002276302,0.000034037563,0.00049333245,0.0000120814775,0.010270741,0.0015889015],"study_design_scores_gemma":[0.0051637264,0.0009038011,0.87533164,0.000010878988,0.0008215862,0.1120003,0.00020117399,0.0006724937,0.0004183167,0.0003564703,0.0038351188,0.00028449725],"about_ca_topic_score_codex":0.024050755,"about_ca_topic_score_gemma":0.0007232676,"teacher_disagreement_score":0.05879861,"about_ca_system_score_codex":0.0011335077,"about_ca_system_score_gemma":0.00097644347,"threshold_uncertainty_score":0.99726576},"labels":[],"label_agreement":null},{"id":"W2117756899","doi":"10.1016/j.juro.2009.04.017","title":"Residual Pathological Stage at Radical Cystectomy Significantly Impacts Outcomes for Initial T2N0 Bladder Cancer","year":2009,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphovascular invasion; Urology; Perioperative; Stage (stratigraphy); Proportional hazards model; Surgery; Cancer; Internal medicine; Metastasis","score_opus":0.04187396737318639,"score_gpt":0.360966781860993,"score_spread":0.31909281448780663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117756899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722639,0.0016761827,0.00032045986,0.024192473,0.00037922178,0.00046351927,0.00007020328,0.000020563662,0.0006134994],"genre_scores_gemma":[0.9890771,0.0003107901,0.00020967254,0.009016967,0.0007762938,0.00000908789,0.0000042531806,0.000018392298,0.0005774513],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983821,0.00023263544,0.00050702033,0.00014642076,0.00031804884,0.00041379547],"domain_scores_gemma":[0.9987112,0.0004047237,0.0003045498,0.00020778638,0.00015001267,0.0002216968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005790318,0.00020115016,0.0005985649,0.00009855934,0.00012613482,0.000009217854,0.00019584308,0.00018099337,0.0005188056],"category_scores_gemma":[0.00022144744,0.000102669524,0.00021776727,0.00006714545,0.00021815616,0.000058023852,0.000029273617,0.0004057169,0.000010696155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24233796,0.0067736213,0.24480124,0.00026883488,0.008558144,0.012275081,0.014720658,0.0008286713,0.2568505,0.0016627386,0.14131466,0.0696079],"study_design_scores_gemma":[0.037074164,0.03868509,0.85988903,0.000057044203,0.0038787615,0.007665053,0.00034783524,0.000057111618,0.013517036,0.0027908576,0.035544507,0.0004935197],"about_ca_topic_score_codex":0.000024382784,"about_ca_topic_score_gemma":0.000030310817,"teacher_disagreement_score":0.6150878,"about_ca_system_score_codex":0.000118596625,"about_ca_system_score_gemma":0.00028373027,"threshold_uncertainty_score":0.56805575},"labels":[],"label_agreement":null},{"id":"W2118258628","doi":"10.1016/j.urology.2004.04.076","title":"Urinary conduit formation using retubularized bowel from continent urinary diversion or intestinal augmentations: I. A multi-institutional experience","year":2004,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Urinary diversion; Cystectomy; Urinary system; Hydronephrosis; Surgery; Laparotomy; Electrical conduit; Bladder augmentation; Urinary bladder; Urology; Internal medicine; Bladder cancer","score_opus":0.06701813040138334,"score_gpt":0.3321197062551312,"score_spread":0.2651015758537479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118258628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95540386,0.00031693303,0.04240462,0.00081739976,0.0003009737,0.00046839862,0.00003556473,0.00007116395,0.00018107475],"genre_scores_gemma":[0.9867609,0.00003267121,0.01142948,0.0013053996,0.00009876716,0.000056473607,0.00020215484,0.000010756013,0.00010340118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990655,0.000039279643,0.0002520863,0.00026852958,0.00017623571,0.00019835723],"domain_scores_gemma":[0.99952376,0.00003937258,0.000091311194,0.00016419166,0.00007853019,0.00010286333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036453333,0.00015831999,0.00020971638,0.000093144205,0.00021437266,0.000011211249,0.00007389655,0.00009466023,0.000448721],"category_scores_gemma":[0.000057909594,0.00012311981,0.000063069776,0.00009720609,0.00016930439,0.00024790244,0.00007048467,0.00013621562,0.000059695416],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07064424,0.020054465,0.14469104,0.00045834057,0.0016082327,0.03042837,0.053769503,0.0070326827,0.65990967,0.0040768175,0.00073427835,0.006592379],"study_design_scores_gemma":[0.2611789,0.037595183,0.4245628,0.0015179273,0.004183696,0.049282197,0.009509814,0.082699224,0.10382178,0.0054288995,0.017422952,0.0027966006],"about_ca_topic_score_codex":0.0008549065,"about_ca_topic_score_gemma":0.000016517835,"teacher_disagreement_score":0.5560879,"about_ca_system_score_codex":0.00026233454,"about_ca_system_score_gemma":0.00023473092,"threshold_uncertainty_score":0.502068},"labels":[],"label_agreement":null},{"id":"W2118979446","doi":"10.1093/jnci/93.8.571-b","title":"MEMORANDUM FOR: Science Writers and Editors on the Journal Press List: Improved Treatment Developed for Superficial Bladder Cancer","year":2001,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memorandum; Medicine; Library science; History; Computer science; Archaeology","score_opus":0.10774209035827607,"score_gpt":0.37975652988678305,"score_spread":0.27201443952850696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118979446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085186,0.0032760564,0.0007709298,0.052136816,0.030215709,0.00294609,0.0006332953,0.000017348055,0.001485156],"genre_scores_gemma":[0.96773154,0.0027487027,0.0006678484,0.0036387448,0.022953838,0.0002379752,0.000003740127,0.000034280645,0.0019833131],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982754,0.0000307276,0.0004099631,0.0001652139,0.0008387511,0.0002799593],"domain_scores_gemma":[0.9977376,0.00015808335,0.00033547528,0.00010130947,0.001504314,0.00016322697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006751714,0.00019582047,0.00027564567,0.00013137829,0.0007843693,0.00009784922,0.00029068897,0.00006257586,0.00003918993],"category_scores_gemma":[0.00031149987,0.00009502883,0.00019010204,0.00022888283,0.00032056574,0.00035760386,0.000027027532,0.00021611039,2.7381637e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06775618,0.0032944875,0.03150777,0.00040723174,0.010103062,0.000075595904,0.012859693,0.008890613,0.10345528,0.004165132,0.5494342,0.20805077],"study_design_scores_gemma":[0.018846273,0.002458423,0.013789793,0.0005388571,0.0015262951,0.0008425994,0.00024459604,0.0012466816,0.04146386,0.0010557697,0.91761434,0.0003725359],"about_ca_topic_score_codex":0.00024380264,"about_ca_topic_score_gemma":0.0003457776,"teacher_disagreement_score":0.36818013,"about_ca_system_score_codex":0.0013366073,"about_ca_system_score_gemma":0.0034225865,"threshold_uncertainty_score":0.60715216},"labels":[],"label_agreement":null},{"id":"W2119101863","doi":"10.1158/0008-5472.can-12-1170","title":"Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Cancer research; Radioresistance; Cancer; Imatinib; Bladder cancer; Lapatinib; Medicine; Olaparib; Cancer cell; Homologous recombination; Tyrosine-kinase inhibitor; Radiation therapy; Biology; Internal medicine; Breast cancer; Poly ADP ribose polymerase; DNA","score_opus":0.0504590839508199,"score_gpt":0.3939906157245511,"score_spread":0.3435315317737312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119101863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628352,0.012355431,0.000025682826,0.0117322,0.0004917687,0.0018449908,0.00006920686,0.00012018773,0.010525366],"genre_scores_gemma":[0.9755506,0.0033503869,0.00022691177,0.0006936152,0.00049503363,0.002150812,0.000067931986,0.000063985324,0.017400755],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976266,0.00019866333,0.0002965576,0.0004508385,0.00071785355,0.00070947164],"domain_scores_gemma":[0.99848074,0.0001495536,0.00006344821,0.00029205135,0.00074419804,0.00027002572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004700024,0.00019099293,0.00038924575,0.00018108734,0.00026757928,0.000083473125,0.00014031457,0.00013235156,0.007909789],"category_scores_gemma":[0.00014462271,0.00015203166,0.00009665817,0.00043532476,0.00020039637,0.00018325546,0.000064129,0.0005106069,0.0003997989],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026926716,0.0002523463,0.0070161913,0.00015720235,0.00039718547,0.000038665807,0.00083910197,0.0000060190723,0.20378512,0.000062944615,0.7031535,0.08402247],"study_design_scores_gemma":[0.024058236,0.0021625054,0.041107547,0.001138282,0.00047298818,0.00012980457,0.0027301267,0.00104218,0.80729115,0.0045218626,0.11390542,0.0014398675],"about_ca_topic_score_codex":0.009361634,"about_ca_topic_score_gemma":0.000054648408,"teacher_disagreement_score":0.603506,"about_ca_system_score_codex":0.0006074994,"about_ca_system_score_gemma":0.0004687626,"threshold_uncertainty_score":0.9972351},"labels":[],"label_agreement":null},{"id":"W2119594135","doi":"10.1093/hmg/ddu264","title":"Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer","year":2014,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Cancer Research UK","keywords":"Genome-wide association study; Biology; Genetics; Genetic association; Bladder cancer; Genome; Imputation (statistics); Single-nucleotide polymorphism; Gene; Cancer; Computational biology; Genotype; Missing data","score_opus":0.020404428908186733,"score_gpt":0.2790173463045092,"score_spread":0.2586129173963225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119594135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061817,0.0008161268,0.00033580555,0.0003625711,0.0001293019,0.0008878557,0.000019804915,0.000070763715,0.006759574],"genre_scores_gemma":[0.991738,0.00009430775,0.0001932187,0.0016088992,0.00018688956,0.00012708426,0.00005203096,0.00008951208,0.0059100287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979504,0.000161091,0.00024133595,0.00047294624,0.0007190164,0.00045523298],"domain_scores_gemma":[0.99889827,0.00004880621,0.000202383,0.0005109234,0.00015224036,0.0001873805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021752619,0.000298377,0.00040047956,0.00008100561,0.00023115521,0.00004445327,0.00013668474,0.00016568978,0.00044234644],"category_scores_gemma":[0.000035220834,0.00025948093,0.0001033171,0.00013630751,0.000031786112,0.000032082262,0.000097716984,0.00020943559,0.000068092755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111774694,0.0007619169,0.990799,0.000022253967,0.0012278557,0.00017304224,0.00079996156,0.00008778617,0.0051318537,0.000006191204,0.0005990097,0.00027937317],"study_design_scores_gemma":[0.004180258,0.0022179908,0.9865842,0.000033888875,0.001129016,0.000008376797,0.00009571213,0.000019558283,0.0028695944,0.000096872755,0.0024766566,0.0002878595],"about_ca_topic_score_codex":0.0001545301,"about_ca_topic_score_gemma":0.00030384163,"teacher_disagreement_score":0.004214765,"about_ca_system_score_codex":0.00062689587,"about_ca_system_score_gemma":0.000100959674,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W2120154443","doi":"10.5489/cuaj.2339","title":"Delivering high-quality care to patients with muscle-invasive bladder cancer: Insights from routine practice in Ontario","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Quality (philosophy); Cancer; Intensive care medicine; Internal medicine","score_opus":0.010475061540980343,"score_gpt":0.24009631269801926,"score_spread":0.2296212511570389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120154443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242324,0.00012376058,0.000037768987,0.0049324157,0.00026841834,0.00032299478,0.00006952462,0.0000150774185,0.0018067801],"genre_scores_gemma":[0.9886546,0.000023920873,0.0005104939,0.010332648,0.00029031682,0.000024862811,0.00008029531,0.000016156753,0.000066679946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982373,0.000244607,0.00033952334,0.0002949588,0.00047130452,0.00041226755],"domain_scores_gemma":[0.9979417,0.00027370435,0.0002491928,0.000132269,0.0006264747,0.0007766842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015945113,0.00018229223,0.00034985234,0.00013952356,0.00017856488,0.00006448406,0.00009915257,0.00018445995,0.0004753644],"category_scores_gemma":[0.0008398754,0.00013819756,0.000059085392,0.00017943465,0.000014144325,0.00017152129,0.000016975902,0.0006138815,0.00003206968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000250398,0.0000782389,0.99291754,0.0000021155681,0.00015912674,0.000049189806,0.0025877738,0.00018171592,0.000014855681,0.00002429905,0.00016447551,0.0035702712],"study_design_scores_gemma":[0.0037243324,0.0006436694,0.97868866,0.000040107087,0.00017136814,0.0000031074048,0.00018871474,0.0000023183152,0.000023561215,0.00010297862,0.016247217,0.00016397511],"about_ca_topic_score_codex":0.8103725,"about_ca_topic_score_gemma":0.94041526,"teacher_disagreement_score":0.13004276,"about_ca_system_score_codex":0.005340751,"about_ca_system_score_gemma":0.0013232237,"threshold_uncertainty_score":0.9984776},"labels":[],"label_agreement":null},{"id":"W2120680169","doi":"10.1158/1078-0432.ccr-05-2081","title":"Novel Blood Biomarkers of Human Urinary Bladder Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Biology; Cancer research; Pathology; Oncology; Internal medicine","score_opus":0.22950828589444366,"score_gpt":0.5299358628931056,"score_spread":0.3004275769986619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120680169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701949,0.006115309,0.000011169028,0.0023199434,0.0003369173,0.0008159531,0.00017348673,0.000052174248,0.01998017],"genre_scores_gemma":[0.98939425,0.0011369038,0.00020681946,0.00025780016,0.0014232732,0.0003225198,0.00003013397,0.000058487294,0.007169824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675316,0.0001758655,0.00081304065,0.00061583583,0.0009921606,0.00064993836],"domain_scores_gemma":[0.99809635,0.00033387786,0.00012458324,0.0005967426,0.00055469514,0.00029377642],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011456361,0.00020169558,0.0005914463,0.00021886158,0.00017314286,0.000019083864,0.0002657418,0.00023891528,0.002542577],"category_scores_gemma":[0.00011168392,0.00016360034,0.00029900734,0.00063591194,0.00088831567,0.000066570836,0.00015465618,0.0006881626,0.000035478402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024630954,0.00806866,0.84813505,0.00042265296,0.0018892393,0.00020497947,0.00008920438,0.0000058192563,0.07963607,0.0005750954,0.044168077,0.014342042],"study_design_scores_gemma":[0.013876911,0.0039711026,0.9333556,0.00050038367,0.00063615973,0.000033065902,0.000091174006,0.000022443633,0.03104918,0.0007299538,0.0154239535,0.00031007006],"about_ca_topic_score_codex":0.018856285,"about_ca_topic_score_gemma":0.00079667143,"teacher_disagreement_score":0.08522053,"about_ca_system_score_codex":0.00016163306,"about_ca_system_score_gemma":0.0009842538,"threshold_uncertainty_score":0.9983692},"labels":[],"label_agreement":null},{"id":"W2120908115","doi":"10.1016/j.eursup.2009.06.008","title":"Cytology and Urinary Markers for the Diagnosis of Bladder Cancer","year":2009,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cytology; Urine cytology; Cystoscopy; Urine; Bladder cancer; Urinary system; Urology; Gold standard (test); Internal medicine; Cancer; Pathology","score_opus":0.025750281414939666,"score_gpt":0.3125650597725544,"score_spread":0.2868147783576147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120908115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91520673,0.0123096015,0.0006104245,0.05004563,0.00081395236,0.003313103,0.00075241417,0.00009033655,0.016857814],"genre_scores_gemma":[0.9917583,0.0012471112,0.00023159703,0.005971178,0.00014055021,0.00009696494,0.000039121,0.00002235024,0.00049283233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907386,0.00010386847,0.00022448906,0.0002465611,0.000089433335,0.0002617693],"domain_scores_gemma":[0.9994351,0.00014027068,0.00007739968,0.00023200829,0.000045371657,0.0000698442],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017120912,0.00013942512,0.00022221681,0.000054048745,0.000089967805,0.000004263908,0.00010578754,0.000035340163,0.0009538615],"category_scores_gemma":[0.000030629006,0.00009484833,0.00006925119,0.000059111873,0.00013664884,0.000027094025,0.00004442565,0.00008904424,0.000011237164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045229536,0.000831201,0.77886796,0.000060169506,0.0015245314,0.00016692432,0.00059478515,0.000010666493,0.00065201294,0.00024278907,0.13363612,0.07888989],"study_design_scores_gemma":[0.0050132484,0.004987644,0.7891006,0.000010823505,0.0007714652,0.00007984664,0.00006261474,0.000039822746,0.00059596304,0.00014262377,0.19909209,0.000103283666],"about_ca_topic_score_codex":0.000037087895,"about_ca_topic_score_gemma":0.000009513118,"teacher_disagreement_score":0.078786604,"about_ca_system_score_codex":0.000015468711,"about_ca_system_score_gemma":0.00003343342,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2121290839","doi":"10.5489/cuaj.2255","title":"Total ureterectomy and ileal ureteric replacement for TCC ureter in a solitary kidney","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Transitional cell carcinoma; Ureter; Medicine; Urology; Cuff; Ureteral neoplasm; Nephrectomy; Kidney; Kidney disease; Urothelial carcinoma; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.010315727967931567,"score_gpt":0.2404140734618323,"score_spread":0.23009834549390074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121290839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682818,0.00019773724,0.00020403787,0.027474584,0.00045546205,0.0005316871,0.00008325462,0.000020334835,0.0027511085],"genre_scores_gemma":[0.9870322,0.000021720503,0.00046700455,0.0114000365,0.0005223031,0.000040152412,0.000029972254,0.000013044648,0.0004736202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876,0.000110898785,0.00027705668,0.00021300162,0.0001848118,0.00045423774],"domain_scores_gemma":[0.9987829,0.00009891233,0.000107415144,0.00008033784,0.00008946956,0.0008410007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004976776,0.00013451035,0.00027354917,0.0001467587,0.00012746987,0.000049482493,0.00004686658,0.00018909662,0.00023386258],"category_scores_gemma":[0.0005809756,0.00010741758,0.000093861534,0.000086367305,0.00002117411,0.000054567732,0.000009649653,0.00030723787,0.000007742626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043464688,0.000045214816,0.9805181,0.000015671774,0.00012405273,0.00002919729,0.00023880212,0.0000035648402,0.000103415594,0.000101006124,0.012850912,0.0055354033],"study_design_scores_gemma":[0.0057767457,0.002066765,0.9053356,0.000031380256,0.0001129076,0.00036038778,0.000036374873,0.00058879034,0.000022499844,0.0013837987,0.08411132,0.00017340429],"about_ca_topic_score_codex":0.0007488764,"about_ca_topic_score_gemma":0.00035472857,"teacher_disagreement_score":0.07518248,"about_ca_system_score_codex":0.00079622306,"about_ca_system_score_gemma":0.0003337304,"threshold_uncertainty_score":0.43803617},"labels":[],"label_agreement":null},{"id":"W2121489059","doi":"10.1016/j.urolonc.2015.06.016","title":"Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: A multi-institutional study","year":2015,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Survivin; Medicine; Lymphovascular invasion; Proportional hazards model; Pathological; Immunohistochemistry; Oncology; Internal medicine; Cohort; Lymph node; Cancer; Urology; Cancer research; Metastasis","score_opus":0.07031325358400829,"score_gpt":0.3367219696790415,"score_spread":0.2664087160950332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121489059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528277,0.00010222859,0.00020878925,0.0010117101,0.00023853988,0.00252466,0.00042394278,0.0000580362,0.00014931845],"genre_scores_gemma":[0.9799206,0.0000061845767,0.017445229,0.0014411113,0.00014964545,0.0005322183,0.0001864123,0.00002286723,0.00029569972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984146,0.000120254605,0.000283904,0.00052916293,0.00032198435,0.00033013267],"domain_scores_gemma":[0.9987377,0.00013958855,0.00011854926,0.0002087391,0.00027132404,0.0005241011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020132257,0.00028800775,0.00041464044,0.00012845927,0.00027635024,0.000031620148,0.000099092824,0.00018682375,0.00005596334],"category_scores_gemma":[0.00017332722,0.00019297392,0.00005504086,0.00013942654,0.00037490056,0.00019612287,0.000029803017,0.00024343077,0.000011217226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093380595,0.004570879,0.9904995,0.000015475089,0.00010781551,0.000052882373,0.0023761224,0.000010787764,0.00001729312,0.00016679551,0.00020260527,0.0010460287],"study_design_scores_gemma":[0.015451656,0.032598585,0.89243484,0.000019965784,0.00071427337,0.000121947174,0.0006121395,0.0003636283,0.000103058024,0.00024647304,0.057057545,0.0002759222],"about_ca_topic_score_codex":0.00022469788,"about_ca_topic_score_gemma":0.0001653594,"teacher_disagreement_score":0.0980647,"about_ca_system_score_codex":0.00021698151,"about_ca_system_score_gemma":0.0012580911,"threshold_uncertainty_score":0.78692484},"labels":[],"label_agreement":null},{"id":"W2121607722","doi":"10.1093/annonc/mdj965","title":"Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Vinblastine; Gemcitabine; Internal medicine; Oncology; Hazard ratio; Bladder cancer; Cisplatin; Transitional cell carcinoma; Progression-free survival; Chemotherapy; Urology; Confidence interval; Cancer","score_opus":0.04530653708582257,"score_gpt":0.36108207929186137,"score_spread":0.3157755422060388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121607722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460244,0.0008388073,0.00012310538,0.00038970474,0.00011426713,0.0020239635,0.000076866614,0.000013074233,0.0018177715],"genre_scores_gemma":[0.9975007,0.0002549193,0.0017213009,0.00009730319,0.00005084461,0.00011980034,0.000068227004,0.000028151308,0.00015873868],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974416,0.00038735985,0.0011089985,0.0004006366,0.0003271201,0.0003343074],"domain_scores_gemma":[0.99778074,0.0009387487,0.00063681364,0.00019969103,0.0003350928,0.00010889984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844592,0.00028201684,0.0020733688,0.0002363533,0.000032019307,0.0000072430475,0.00006627789,0.00010313062,0.00003282128],"category_scores_gemma":[0.00028430205,0.00020229413,0.000099093835,0.00023950373,0.00037653584,0.00010165468,0.000051978033,0.00017380211,5.2667724e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8292875,0.0011304476,0.15127999,0.00017037852,0.0006025949,0.00003639455,0.00027833978,0.00014315899,0.00038839778,0.000049089136,0.000051211555,0.016582498],"study_design_scores_gemma":[0.68589574,0.005236481,0.30606246,0.00028412906,0.0005379933,0.0000050728654,0.000028681461,0.0001426236,0.0015580871,0.00007932754,0.00002470906,0.00014472511],"about_ca_topic_score_codex":0.001673668,"about_ca_topic_score_gemma":0.002134534,"teacher_disagreement_score":0.15478246,"about_ca_system_score_codex":0.00003673025,"about_ca_system_score_gemma":0.00023710572,"threshold_uncertainty_score":0.82493156},"labels":[],"label_agreement":null},{"id":"W2121664617","doi":"10.1200/jco.2009.27.15_suppl.e16058","title":"A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Tolerability; Internal medicine; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Progressive disease; Nausea; Adverse effect; Phases of clinical research; Oncology; Cancer; Paclitaxel; Urology; Gastroenterology; Surgery; Bladder cancer; Urothelial carcinoma","score_opus":0.08418983834576428,"score_gpt":0.4412281365829351,"score_spread":0.3570382982371708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121664617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966698,0.00021123906,0.000006124332,0.00080810353,0.00040318706,0.0007836445,0.000007413274,0.000005428957,0.0011050266],"genre_scores_gemma":[0.99708146,0.00007039201,0.00038440496,0.0019407173,0.0003489328,0.000004945793,0.0000030534463,0.000016456255,0.00014961536],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99696094,0.0002589427,0.0019082087,0.00021129008,0.00044524428,0.00021536698],"domain_scores_gemma":[0.9976435,0.0002491621,0.0012383217,0.00021766136,0.00039202438,0.00025936402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006437561,0.00017689851,0.0014885595,0.00015662197,0.000029785278,0.00000326787,0.0001338391,0.00016465997,0.00029317563],"category_scores_gemma":[0.00029067774,0.00011052054,0.00021135581,0.00017446055,0.000076784745,0.00010085743,0.000018510094,0.00051261345,0.0000029507446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1120475,0.16119191,0.22468469,0.000008712746,0.00038847205,0.00070937094,0.0010547331,0.000013266882,0.00084445946,0.0000035654145,0.00014418355,0.49890915],"study_design_scores_gemma":[0.12722214,0.4634945,0.40653142,0.000039347728,0.00013127316,0.000024837389,0.00012909342,0.0000019089123,0.00046621857,0.000046461082,0.0018522075,0.000060568756],"about_ca_topic_score_codex":0.00002529331,"about_ca_topic_score_gemma":0.000060532762,"teacher_disagreement_score":0.49884856,"about_ca_system_score_codex":0.0001430488,"about_ca_system_score_gemma":0.0008871959,"threshold_uncertainty_score":0.45068967},"labels":[],"label_agreement":null},{"id":"W2124017956","doi":"10.1016/j.eururo.2010.02.024","title":"Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer","year":2010,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Quality of life (healthcare); MEDLINE; Sexual function; Intensive care medicine; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.05861563086777336,"score_gpt":0.3833460492484744,"score_spread":0.324730418380701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124017956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047346985,0.9860961,0.0006478359,0.0001658411,0.0003038429,0.0020463178,0.00006516169,0.00003367873,0.0105938725],"genre_scores_gemma":[0.00028264354,0.9960852,0.0013779133,0.0001456524,0.00017766414,0.00039286725,0.00015797216,0.00007540358,0.001304649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988426,0.00013905119,0.00039180237,0.0003587635,0.000087972265,0.00017982788],"domain_scores_gemma":[0.99931914,0.00006439218,0.00018900073,0.000316492,0.000028259581,0.00008271397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016661927,0.00021466339,0.00081077294,0.000098921795,0.000054140277,0.000005730379,0.000108196116,0.00011400007,0.000048690148],"category_scores_gemma":[0.000009962302,0.00017064887,0.00035006204,0.000084696716,0.00008553049,0.000015478272,0.000067389716,0.00020732527,0.00001980739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029211664,0.00011146376,0.00002735349,0.0061112996,0.0012383288,0.000032643533,0.000022058297,6.707748e-8,0.0000032379023,0.00039705716,0.00054257247,0.9914847],"study_design_scores_gemma":[0.0015061819,0.00032113653,0.00049005944,0.0015315681,0.0061403653,0.00007272609,0.0000022781257,0.0000017197088,7.945061e-7,0.00003405781,0.9897885,0.00011065239],"about_ca_topic_score_codex":0.000005474005,"about_ca_topic_score_gemma":0.0000039048705,"teacher_disagreement_score":0.9913741,"about_ca_system_score_codex":0.000024813655,"about_ca_system_score_gemma":0.000076510914,"threshold_uncertainty_score":0.6958859},"labels":[],"label_agreement":null},{"id":"W2124163052","doi":"10.1016/j.eururo.2012.04.052","title":"Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Cuff; Urology; Ureter; Concomitant; Bladder cancer; Stage (stratigraphy); Retrospective cohort study; Upper urinary tract; Surgery; Carcinoma; Urinary system; Cancer; Internal medicine","score_opus":0.02826661581038656,"score_gpt":0.32752612508702833,"score_spread":0.2992595092766418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124163052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698067,0.00016833625,0.0002515597,0.00035959325,0.00074545183,0.00084692176,0.000060881324,0.00005441082,0.027706191],"genre_scores_gemma":[0.99658173,0.0000050253393,0.000572536,0.0015270018,0.00050127757,0.000039825434,0.000052542404,0.00006991009,0.00065017195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841654,0.00022052044,0.0003246997,0.0002979814,0.0001877969,0.0005524806],"domain_scores_gemma":[0.9991815,0.00015742773,0.00009657694,0.00032970187,0.00002017226,0.00021463147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027820445,0.00027509846,0.00049585785,0.00013215646,0.000062295665,0.000008016792,0.00013521925,0.00007917406,0.00025951926],"category_scores_gemma":[0.000051956755,0.00018460238,0.00071982923,0.0000676397,0.000086135304,0.00006213874,0.000052902495,0.00017757635,0.00008896252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001782741,0.0010475313,0.9871894,0.000034749744,0.0008200936,0.0002217257,0.00038713336,0.000003073128,0.00083843066,0.00020576971,0.0017696931,0.005699651],"study_design_scores_gemma":[0.0070121065,0.005546499,0.97016346,0.000009623789,0.0006087033,0.00006024961,0.000016664935,0.000006641253,0.00016648289,0.000019696769,0.016233603,0.00015629237],"about_ca_topic_score_codex":0.00001608955,"about_ca_topic_score_gemma":4.0537373e-7,"teacher_disagreement_score":0.02705602,"about_ca_system_score_codex":0.000118828684,"about_ca_system_score_gemma":0.000038273305,"threshold_uncertainty_score":0.75278664},"labels":[],"label_agreement":null},{"id":"W2124300655","doi":"10.1016/j.ijrobp.2007.07.1418","title":"Hypofractionated Chemoradiotherapy for Muscle Invasive Bladder Cancer in Elderly Patients","year":2007,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Bladder cancer; Carboplatin; Regimen; Radiation therapy; Population; Chemoradiotherapy; Gemcitabine; Chemotherapy; Cancer; Progressive disease; Performance status; Surgery; Internal medicine; Oncology; Cisplatin","score_opus":0.022073075912395816,"score_gpt":0.35481215237533703,"score_spread":0.3327390764629412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124300655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98461455,0.00065216917,0.0070856097,0.0029883366,0.0032659308,0.00058899284,0.000144438,0.00002510654,0.0006348617],"genre_scores_gemma":[0.9923772,0.00087806134,0.0018469491,0.0024482878,0.0021808974,0.00003432113,0.000111559464,0.000034327488,0.00008836793],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859214,0.000054707216,0.00065831066,0.00020533087,0.00024378803,0.00024569873],"domain_scores_gemma":[0.9976659,0.0003963263,0.00068429933,0.00009311417,0.0010443344,0.000116042735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035033355,0.00017466799,0.0004194507,0.00022286765,0.00004568818,0.000013485002,0.00018487337,0.00021998414,0.00014766479],"category_scores_gemma":[0.00020436606,0.00015439953,0.00019255767,0.0001753659,0.00008172728,0.00029510437,0.000014265247,0.0002972535,0.000007827041],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016915433,0.0012125623,0.45440406,0.000009132114,0.0007782436,0.00003062225,0.0004646025,0.00015832862,0.005427643,0.0006024571,0.0012238233,0.533997],"study_design_scores_gemma":[0.04794348,0.0056813597,0.8190448,0.00013909274,0.00029259987,0.00008955674,0.00018935827,0.0004185031,0.023662534,0.00837098,0.0937779,0.00038983056],"about_ca_topic_score_codex":0.000090340254,"about_ca_topic_score_gemma":0.0000650351,"teacher_disagreement_score":0.5336071,"about_ca_system_score_codex":0.0013498655,"about_ca_system_score_gemma":0.000741866,"threshold_uncertainty_score":0.629623},"labels":[],"label_agreement":null},{"id":"W2125198595","doi":"10.1016/j.ejso.2014.03.018","title":"Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","year":2014,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Perioperative; Proportional hazards model; Blood transfusion; Cancer; Retrospective cohort study; Internal medicine; Surgery; Confounding; Urology","score_opus":0.014342211144864206,"score_gpt":0.2781291470610408,"score_spread":0.2637869359161766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125198595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807615,0.00014895228,0.0005627105,0.004957812,0.00033888564,0.00045020436,0.000022023854,0.000011697035,0.012746165],"genre_scores_gemma":[0.9948342,0.00016268007,0.0027200824,0.0006325315,0.00081642927,0.000012521676,0.000005464309,0.000036941085,0.0007791861],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761254,0.00088135566,0.0006849982,0.00019637994,0.00035793573,0.00026677805],"domain_scores_gemma":[0.99830407,0.00058306585,0.00044845403,0.00011388396,0.00033434696,0.00021616693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114745,0.00020688651,0.00090742286,0.000116864765,0.000056570694,0.000011557469,0.000109558874,0.00011373384,0.00038235632],"category_scores_gemma":[0.00009821322,0.00012049758,0.00040263459,0.00009018019,0.0001267506,0.00008525293,0.000014258864,0.00037602443,0.0000067991855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03769781,0.004751499,0.8895596,0.00012487188,0.0017043327,0.004697085,0.0030540288,0.000016885417,0.0044430676,0.00014018735,0.0007064685,0.053104166],"study_design_scores_gemma":[0.052284937,0.042963736,0.43869385,0.00011959621,0.001791528,0.002268672,0.00012170183,0.000016304552,0.0018572714,0.000011020983,0.45966458,0.00020681477],"about_ca_topic_score_codex":0.0000065613694,"about_ca_topic_score_gemma":0.000006208379,"teacher_disagreement_score":0.4589581,"about_ca_system_score_codex":0.00020277413,"about_ca_system_score_gemma":0.00030347783,"threshold_uncertainty_score":0.49137485},"labels":[],"label_agreement":null},{"id":"W2125483126","doi":"10.5489/cuaj.1698","title":"Optimizing care and outcomes of patients with muscle-invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Intensive care medicine; Internal medicine","score_opus":0.009103777474197614,"score_gpt":0.22809549946256918,"score_spread":0.21899172198837158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125483126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944849,0.00046266933,0.0000059262024,0.0035483395,0.000094203584,0.00027001684,0.00006802485,0.000007559594,0.0010583312],"genre_scores_gemma":[0.99698955,0.00010121261,0.00038106192,0.0022857147,0.000072433606,0.000020338273,0.000013634589,0.000010361112,0.00012568926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915475,0.000038349823,0.00017937123,0.00012292036,0.00024018296,0.00026445888],"domain_scores_gemma":[0.9987569,0.000061795756,0.00016531184,0.00005937976,0.00051704113,0.00043960876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004615339,0.0001101717,0.00024753893,0.00008586867,0.000117641204,0.0000336011,0.00004233387,0.0001103429,0.000856879],"category_scores_gemma":[0.00011315185,0.000070325834,0.000055716544,0.000078847035,0.000030334037,0.00009757112,0.0000075785097,0.00020162454,0.0000070155793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016522037,0.00002438439,0.99311614,0.0000061058595,0.00022226103,0.0000062442055,0.0004952898,0.000010956873,0.000008263256,0.0000049829064,0.0006920809,0.005396755],"study_design_scores_gemma":[0.0018469715,0.00046705385,0.9958246,0.000014449228,0.00016858224,0.0000035104667,0.0002744128,0.0000035534636,0.000018511586,0.000041207673,0.0012614825,0.00007567365],"about_ca_topic_score_codex":0.0048879744,"about_ca_topic_score_gemma":0.0020645238,"teacher_disagreement_score":0.0053210813,"about_ca_system_score_codex":0.00049258536,"about_ca_system_score_gemma":0.00040004868,"threshold_uncertainty_score":0.93822235},"labels":[],"label_agreement":null},{"id":"W2126284441","doi":"10.1016/j.juro.2013.03.087","title":"Re: Regional Differences in Practice Patterns and Associated Outcomes for Upper Tract Urothelial Carcinoma in Canada","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.027283446819005398,"score_gpt":0.2788843622754317,"score_spread":0.25160091545642627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126284441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96172655,0.00036347637,0.0000079393185,0.03739232,0.00013629158,0.00026689286,0.000010701581,0.0000012232912,0.00009462999],"genre_scores_gemma":[0.9947096,0.00018049858,0.000024865005,0.0049464996,0.00006467495,0.000011537887,0.0000015720841,0.000008482945,0.000052243257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909735,0.00018130254,0.00030545867,0.000071314484,0.00015985782,0.0001847107],"domain_scores_gemma":[0.9986506,0.0009224224,0.00020400221,0.00007244898,0.00008989769,0.000060591734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002825947,0.000091832,0.00031715402,0.000072177994,0.000024276833,0.000005511151,0.00007972214,0.00005258853,0.00006049505],"category_scores_gemma":[0.00026980002,0.000051796098,0.00003751547,0.000046459387,0.000030695734,0.00008397286,0.000010857807,0.0002524093,5.879083e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005647258,0.00012184561,0.99729323,0.000005418645,0.00008331735,0.000055217937,0.0005292393,0.0000025741779,0.000036132984,0.0000066072243,0.00055210845,0.0007495722],"study_design_scores_gemma":[0.0035681643,0.0007467806,0.99377334,0.000013761413,0.00014945623,0.00024309002,0.00085525675,0.000067044275,0.000013824885,0.00017898064,0.0003458416,0.00004445231],"about_ca_topic_score_codex":0.5016755,"about_ca_topic_score_gemma":0.46867543,"teacher_disagreement_score":0.03300008,"about_ca_system_score_codex":0.00017098739,"about_ca_system_score_gemma":0.00058404164,"threshold_uncertainty_score":0.54101986},"labels":[],"label_agreement":null},{"id":"W2126548486","doi":"10.5489/cuaj.1203","title":"Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelial cancer; Medicine; Cystectomy; Chemotherapy; Cisplatin; Metastatic Urothelial Carcinoma; Metastasectomy; Disease; Oncology; Cancer; Internal medicine; Bladder cancer; Metastasis; Urothelial carcinoma","score_opus":0.01761708799208685,"score_gpt":0.2644936326446354,"score_spread":0.24687654465254852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126548486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97909343,0.0004557816,0.000020674514,0.017135005,0.00017938395,0.0005286693,0.000047157486,0.000007378709,0.0025325394],"genre_scores_gemma":[0.99429303,0.0002677319,0.00018640753,0.0045928685,0.00015707413,0.000055611054,0.0000052215423,0.000012797994,0.00042927216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872285,0.00012438098,0.000349505,0.00012841354,0.00036864658,0.00030617975],"domain_scores_gemma":[0.99881077,0.000089235626,0.00023400357,0.00013619599,0.00025580544,0.00047401804],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040044732,0.00011336691,0.00031903284,0.00011971489,0.000091754475,0.000025083446,0.00012578318,0.00006406338,0.002881753],"category_scores_gemma":[0.00006785618,0.000070722,0.00014784031,0.00021949066,0.000028046636,0.000070251306,0.000008179804,0.0001664249,0.000043021904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029167713,0.0002806032,0.81140137,0.000024277295,0.001442964,0.00004527704,0.0007111865,0.00005916892,0.0011955396,0.00059523946,0.007020696,0.17693202],"study_design_scores_gemma":[0.0011887414,0.0006065077,0.96356475,0.000041857318,0.0002841911,0.000045409153,0.0005359656,0.00005081132,0.0015334786,0.003892589,0.028137011,0.000118705284],"about_ca_topic_score_codex":0.014792461,"about_ca_topic_score_gemma":0.00049721193,"teacher_disagreement_score":0.1768133,"about_ca_system_score_codex":0.0003699563,"about_ca_system_score_gemma":0.0004497287,"threshold_uncertainty_score":0.99802977},"labels":[],"label_agreement":null},{"id":"W2126705382","doi":"10.1016/j.urolonc.2013.10.015","title":"Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Survivin; Oncology; Lymphadenectomy; Hazard ratio; Internal medicine; Biomarker; Urology; Carcinoma; Tissue microarray; Disease; Cancer; Pathology; Confidence interval","score_opus":0.007235451908877756,"score_gpt":0.2360748174698737,"score_spread":0.22883936556099593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126705382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964814,0.00007426475,0.00007610829,0.0014844311,0.000050924846,0.0005358418,0.0000073275933,0.000010553104,0.0012791305],"genre_scores_gemma":[0.9945469,0.000013151155,0.004137147,0.001196486,0.000011975371,0.000052255913,0.00002449149,0.000005712792,0.000011867877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993237,0.00007798861,0.00020886288,0.00013562076,0.00012165134,0.0001321445],"domain_scores_gemma":[0.9995213,0.00008742915,0.00014015763,0.00011855698,0.00006408423,0.00006846638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015172441,0.000105720115,0.00017560073,0.000082943276,0.000086713575,0.0000107803,0.000044958753,0.00009482218,0.0000049122013],"category_scores_gemma":[0.00013474481,0.00006824705,0.000017436145,0.00015225969,0.00038459152,0.0001220044,0.000029591038,0.00014811516,5.060356e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017490286,0.00007699725,0.9915779,0.000026195934,0.000026878704,0.000001010665,0.0003810891,0.000008684461,0.00013193715,0.0018886051,0.000033071025,0.0056726956],"study_design_scores_gemma":[0.00313824,0.0027769418,0.97986203,0.00006166977,0.00021768214,0.000016752829,0.00011466185,0.0005426257,0.00065138197,0.0012819164,0.01124927,0.000086797314],"about_ca_topic_score_codex":0.00008940758,"about_ca_topic_score_gemma":0.00001213909,"teacher_disagreement_score":0.011715872,"about_ca_system_score_codex":0.00004101493,"about_ca_system_score_gemma":0.00014963721,"threshold_uncertainty_score":0.27830338},"labels":[],"label_agreement":null},{"id":"W2127186482","doi":"10.1016/j.juro.2014.03.083","title":"Bladder Tumor Resection: Doing it Right","year":2014,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Randomized controlled trial; Urology; Resection; Surgery; Cancer; Urinary system; Internal medicine","score_opus":0.020604302606708574,"score_gpt":0.28422872896215357,"score_spread":0.263624426355445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127186482","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010469995,0.0019104894,0.0003235915,0.97344315,0.0017801957,0.0002000364,0.000004775516,0.000013539275,0.021277199],"genre_scores_gemma":[0.030646462,0.0003020982,0.000110682304,0.9438104,0.019549534,0.0000041781645,0.00000793526,0.0000587283,0.0055099945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981629,0.00040675327,0.00052657956,0.00014387794,0.00042401385,0.00033583547],"domain_scores_gemma":[0.9983825,0.0003361319,0.00058142206,0.00039145656,0.0002317557,0.000076720404],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005601491,0.0002434846,0.0006554212,0.00020353751,0.000108749,0.000012607497,0.00028847993,0.00037929087,0.0017189382],"category_scores_gemma":[0.000051281284,0.00013042334,0.00025902814,0.000096638796,0.00016425844,0.000040505693,0.00003664132,0.0027284399,0.00014981719],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008798326,0.000030168643,0.00007058005,0.000042006723,0.0007073297,0.0021044316,0.00012766277,0.0000065636473,0.000079464975,0.000004088591,0.9956579,0.0002899205],"study_design_scores_gemma":[0.0017044594,0.0026160888,0.00016998262,0.000057877984,0.0017261744,0.027430685,0.000011047605,0.0000054964,0.00014686186,0.000339545,0.9656914,0.000100382684],"about_ca_topic_score_codex":0.000030134743,"about_ca_topic_score_gemma":0.000009608527,"teacher_disagreement_score":0.029966554,"about_ca_system_score_codex":0.00008446067,"about_ca_system_score_gemma":0.00025833666,"threshold_uncertainty_score":0.9995723},"labels":[],"label_agreement":null},{"id":"W2127379225","doi":"10.1586/era.10.183","title":"Optimal timing of radical cystectomy in T1 high-grade bladder cancer","year":2010,"lang":"en","type":"article","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Oncology; Internal medicine; Cancer","score_opus":0.028507667430453364,"score_gpt":0.3710593233446714,"score_spread":0.34255165591421805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127379225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6155336,0.37550828,0.00007117324,0.0056810006,0.0006974998,0.0013465399,0.000030049074,0.00003477051,0.0010970581],"genre_scores_gemma":[0.6361142,0.35655528,0.0038497094,0.002819611,0.00035480302,0.00017375205,0.000008718346,0.000038249083,0.00008569258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983169,0.000057574103,0.00060012215,0.00031414253,0.0004242011,0.00028705847],"domain_scores_gemma":[0.9990732,0.00005874766,0.0001840255,0.00045510486,0.000111364105,0.000117544565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002191498,0.00023775797,0.0009597714,0.00009897145,0.000024151977,0.0000041545863,0.00017747261,0.00010521492,0.0034498423],"category_scores_gemma":[0.000032422995,0.00016892282,0.00021826854,0.00032573802,0.00024546884,0.000071144685,0.000022119377,0.0002846966,0.0000057817347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018813496,0.003049891,0.03064019,0.006092971,0.0014373384,0.0001120759,0.0027589283,0.0000057922666,0.53692347,0.0006450125,0.011966621,0.40448636],"study_design_scores_gemma":[0.021125516,0.0019067125,0.056086395,0.02424437,0.0003585826,0.000110893234,0.00014233628,0.00013805897,0.61349165,0.00008490235,0.28142852,0.0008820567],"about_ca_topic_score_codex":0.0015097595,"about_ca_topic_score_gemma":0.000049516904,"teacher_disagreement_score":0.4036043,"about_ca_system_score_codex":0.000053171116,"about_ca_system_score_gemma":0.0003270935,"threshold_uncertainty_score":0.99746114},"labels":[],"label_agreement":null},{"id":"W2127663325","doi":"10.5489/cuaj.1162","title":"Intermittent self-catheterization and the risk of squamous cell cancer of the bladder: An emerging clinical entity?","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoscopy; Squamous metaplasia; Cancer; Squamous cell cancer; Urinary system; Basal cell; Cohort; Bladder cancer; Internal medicine; Oncology; Urology; Pathology","score_opus":0.013508709501776486,"score_gpt":0.2661083619546399,"score_spread":0.2525996524528634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127663325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991108,0.00029672057,0.000027488766,0.007425816,0.00031431435,0.00032575213,0.000029686824,0.0000060682337,0.0004661238],"genre_scores_gemma":[0.99761313,0.00053355086,0.000049809983,0.0014300658,0.00020817415,0.000013787047,0.0000022879215,0.0000073572273,0.00014181633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985508,0.00048615175,0.00043206665,0.00011614945,0.00022800644,0.000186852],"domain_scores_gemma":[0.9986856,0.0001536395,0.0005449792,0.00012737754,0.0002524216,0.00023600228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006243158,0.0000877028,0.00024950175,0.000045773188,0.00017080926,0.00002991634,0.0001203997,0.00012220322,0.00036437597],"category_scores_gemma":[0.00032159436,0.00004401904,0.00017162901,0.00010471525,0.000095629264,0.000079608864,0.000020326426,0.00036119137,0.0000031606487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042503703,0.00009103399,0.9927488,0.0000052764367,0.00014695355,0.0000010183297,0.0004910326,0.000013380617,0.00005885358,0.000032946606,0.00061892055,0.00574927],"study_design_scores_gemma":[0.0022750574,0.00028801247,0.99456364,0.000008040115,0.00041465653,0.000009710191,0.0001289483,0.0005663847,0.000074973956,0.00052873755,0.0010949213,0.00004693373],"about_ca_topic_score_codex":0.0069791283,"about_ca_topic_score_gemma":0.00095112115,"teacher_disagreement_score":0.0065051215,"about_ca_system_score_codex":0.00017630955,"about_ca_system_score_gemma":0.0002799202,"threshold_uncertainty_score":0.9996335},"labels":[],"label_agreement":null},{"id":"W2128076126","doi":"10.1136/jcp.2005.035196","title":"Adenocarcinoma arising in a gastrocystoplasty: Figure 1","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bladder augmentation; Medicine; Surgery; Adenocarcinoma; Cystectomy; Urology; Bladder cancer; Urinary bladder; Internal medicine; Cancer","score_opus":0.06672772910236968,"score_gpt":0.42230826394891996,"score_spread":0.3555805348465503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128076126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928454,0.00084556907,0.0013014735,0.0011037537,0.0007828295,0.000088105604,0.0000013400294,0.0000057681896,0.0030257367],"genre_scores_gemma":[0.99372554,0.000077829034,0.0035710437,0.0014529909,0.00097175385,5.2215813e-7,8.6496806e-7,0.000012167266,0.00018726569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979677,0.00011452698,0.0013224657,0.00014180157,0.00019970688,0.00025377964],"domain_scores_gemma":[0.9987211,0.00039513034,0.00041019442,0.00013653988,0.00011993425,0.00021707795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001966632,0.000099450306,0.00067597267,0.00017989911,0.000016658027,0.0000041641056,0.00007633072,0.00021010626,0.00010961299],"category_scores_gemma":[0.0007313102,0.00007309749,0.00025707213,0.000121529,0.00008820522,0.00005322029,0.000019253377,0.0007648259,0.00002367015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025397218,0.0004271497,0.95798045,0.000012434298,0.000045183617,0.011115265,0.00011513143,0.0000016339156,0.0004892624,0.000023430439,0.00047938712,0.026770927],"study_design_scores_gemma":[0.0062463772,0.0029112103,0.98240894,0.000104876235,0.000102723905,0.004917541,0.000113889866,0.0000031136549,0.0002452012,0.00030495977,0.0025875762,0.000053585904],"about_ca_topic_score_codex":0.0000047515,"about_ca_topic_score_gemma":0.000021745243,"teacher_disagreement_score":0.02671734,"about_ca_system_score_codex":0.000054217147,"about_ca_system_score_gemma":0.00022369596,"threshold_uncertainty_score":0.33228305},"labels":[],"label_agreement":null},{"id":"W2128089432","doi":"10.1016/s0360-3016(01)01591-7","title":"Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bladder cancer; Proportional hazards model; Univariate analysis; Population; Multivariate analysis; Lymphovascular invasion; Cystectomy; Hazard ratio; Radiation therapy; Oncology; Internal medicine; Lymph node; Cancer registry; Transitional cell carcinoma; Cancer; Surgery; Metastasis","score_opus":0.018785865459395465,"score_gpt":0.29970891999169685,"score_spread":0.2809230545323014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128089432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979991,0.00031119818,0.00030727233,0.00024514514,0.0003813567,0.00042842748,0.00022699442,0.0000046420055,0.00009590546],"genre_scores_gemma":[0.9993702,0.0000630512,0.00013679214,0.00009100093,0.00022293202,0.00000836221,0.0000875496,0.000014805243,0.0000053152216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986227,0.00017184018,0.0006376969,0.00014449729,0.00031937347,0.00010385357],"domain_scores_gemma":[0.9978066,0.00036460807,0.0009386497,0.00012072564,0.000709846,0.000059534515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009578893,0.00014556949,0.0004216072,0.00013172624,0.00003992462,0.0000034856487,0.00017255869,0.000106438194,0.00004068863],"category_scores_gemma":[0.000073325544,0.00010578392,0.00019663484,0.000113099595,0.00007911609,0.0000824218,0.000023814095,0.00018123651,2.7080696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004619868,0.0017499478,0.9889509,0.00005235243,0.0003184078,0.000018130018,0.0024077778,0.0005076748,0.001414039,0.00008848777,0.0000063256884,0.004023974],"study_design_scores_gemma":[0.006921789,0.005236143,0.9811845,0.00008669221,0.00038950873,0.00003639934,0.0014301154,0.0000809091,0.0042783176,0.00024426437,0.000040301118,0.0000710498],"about_ca_topic_score_codex":0.00021587519,"about_ca_topic_score_gemma":0.00004172539,"teacher_disagreement_score":0.007766386,"about_ca_system_score_codex":0.00020470745,"about_ca_system_score_gemma":0.0005053359,"threshold_uncertainty_score":0.43137428},"labels":[],"label_agreement":null},{"id":"W2128422065","doi":"10.1634/theoncologist.2012-0461","title":"Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival","year":2013,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Ohio State University; Pennsylvania Department of Health","keywords":"Medicine; Bladder cancer; Vascular endothelial growth factor; Cystectomy; Radiation therapy; Urology; Metastasis; Internal medicine; Oncology; Pathology; Cancer; VEGF receptors","score_opus":0.08997251775910423,"score_gpt":0.3525537434276973,"score_spread":0.2625812256685931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128422065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789637,0.0021657306,0.002739083,0.0025113728,0.0006274126,0.011424839,0.0009041157,0.00011561936,0.0005481654],"genre_scores_gemma":[0.98748446,0.0052637993,0.0007015055,0.0017422154,0.00089018577,0.0034649926,0.00027386213,0.0000767887,0.00010220018],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997257,0.0006408715,0.0006229106,0.0006219479,0.0003866004,0.00047067332],"domain_scores_gemma":[0.9960073,0.0028023433,0.00039467268,0.00038208428,0.00020215184,0.00021140734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013410959,0.0004217061,0.0009594434,0.00011386327,0.0003855153,0.000108146865,0.00016242823,0.00027391885,0.00021442844],"category_scores_gemma":[0.0006988544,0.00024396485,0.0002661357,0.000118587246,0.0002484076,0.00030354233,0.00003928648,0.00019008211,0.000002099406],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041839853,0.0027277882,0.026036417,0.0003803379,0.007854313,0.000011885099,0.0056844684,0.00002798052,0.24742822,0.0024970374,0.018481137,0.6470306],"study_design_scores_gemma":[0.16252539,0.04487615,0.50872076,0.00044300192,0.0032225535,0.000027180002,0.0016971097,0.0049827336,0.09108465,0.011990088,0.1685497,0.0018806739],"about_ca_topic_score_codex":0.0025411162,"about_ca_topic_score_gemma":0.00015792881,"teacher_disagreement_score":0.6451499,"about_ca_system_score_codex":0.00040253391,"about_ca_system_score_gemma":0.00029070053,"threshold_uncertainty_score":0.9948598},"labels":[],"label_agreement":null},{"id":"W2128580887","doi":"10.1016/j.urology.2005.08.064","title":"Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers","year":2005,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":431,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Tumor marker; Cytology; Urine cytology; Oncology; Prostate cancer; Bladder tumor; Urology; Cancer; Prospective cohort study; Internal medicine; Pathology","score_opus":0.01920896340608052,"score_gpt":0.2761713243428109,"score_spread":0.25696236093673036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128580887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7120119,0.00054115074,0.000067182045,0.07059346,0.0023475701,0.0010040832,0.00019663738,0.00026884623,0.21296918],"genre_scores_gemma":[0.95691574,0.00003064227,0.00069402717,0.036560558,0.0007918849,0.00008560072,0.00008504717,0.00006238833,0.004774132],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979004,0.00012902985,0.000414876,0.0006338451,0.0003212579,0.0006005481],"domain_scores_gemma":[0.9988195,0.00023865099,0.00014040511,0.00043465552,0.00011483366,0.00025196397],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017375223,0.0003494517,0.00047153363,0.00025540494,0.00009655677,0.00001625991,0.00020868747,0.00017378728,0.0063974545],"category_scores_gemma":[0.00015126039,0.0003059195,0.0001748136,0.00012466135,0.00036610145,0.000044215543,0.00007176895,0.000430429,0.0011457996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04197156,0.003467322,0.078207366,0.000080595906,0.007520266,0.007716643,0.0010468093,0.0004600695,0.005655611,0.0038192985,0.79933494,0.05071953],"study_design_scores_gemma":[0.02096474,0.0052372455,0.112111695,0.000031539632,0.0011951197,0.0059750923,0.00039322014,0.0023047295,0.002354516,0.0011470634,0.84742653,0.0008585174],"about_ca_topic_score_codex":0.00007612689,"about_ca_topic_score_gemma":0.00007570208,"teacher_disagreement_score":0.24490383,"about_ca_system_score_codex":0.00018417346,"about_ca_system_score_gemma":0.0002520153,"threshold_uncertainty_score":0.99993926},"labels":[],"label_agreement":null},{"id":"W2128766159","doi":"10.1158/1078-0432.ccr-08-2554","title":"Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Survivin; Medicine; Bladder cancer; Cystectomy; Oncology; Hazard ratio; Internal medicine; Concordance; Cancer; Proportional hazards model; Lymphadenectomy; Urology; Confidence interval","score_opus":0.18005516118753936,"score_gpt":0.513638916897088,"score_spread":0.33358375570954857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128766159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075747,0.00034222778,0.000046572615,0.0023251255,0.00040247286,0.0051400717,0.00005707932,0.000017624174,0.00091134704],"genre_scores_gemma":[0.9959066,0.00006669335,0.00010382254,0.0004436019,0.00068680133,0.0005762853,0.00000479486,0.00002864286,0.0021827572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671876,0.0006943836,0.0006511511,0.000487584,0.0009911219,0.00045699353],"domain_scores_gemma":[0.99753714,0.0008876203,0.00011831044,0.0005797234,0.00067542103,0.00020176919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021690861,0.00016135965,0.00041578306,0.00008990197,0.00015734255,0.000033858098,0.00030961886,0.00011402986,0.00045852063],"category_scores_gemma":[0.0015367045,0.0001017952,0.0002936133,0.00031832512,0.00023511873,0.000058827853,0.00009173998,0.00050296297,0.000029671359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00596363,0.0030115866,0.9638739,0.000056955505,0.00016837334,0.000013034263,0.00037568324,0.0000015049027,0.00088771153,0.000028229622,0.0009956135,0.024623781],"study_design_scores_gemma":[0.00962807,0.006030399,0.9783204,0.00017235006,0.00024377616,0.000004664076,0.00019531853,0.00012120398,0.0038475655,0.00040568685,0.00093358645,0.00009697358],"about_ca_topic_score_codex":0.0008969876,"about_ca_topic_score_gemma":0.00015730623,"teacher_disagreement_score":0.024526808,"about_ca_system_score_codex":0.00013038074,"about_ca_system_score_gemma":0.00087869336,"threshold_uncertainty_score":0.50204796},"labels":[],"label_agreement":null},{"id":"W212939345","doi":"10.1016/s1695-3290(08)35032-0","title":"10.1016/s1695-3290(08)35032-0","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Art","score_opus":0.012316268707430458,"score_gpt":0.20825846027122044,"score_spread":0.19594219156378997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W212939345","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.803971e-7,0.0010053219,3.0297107e-7,0.00035858585,0.000007268426,0.00082139677,0.00022528683,0.00019791034,0.9973831],"genre_scores_gemma":[0.0000030915942,0.000008927843,0.00006238308,0.00028934304,0.000933429,0.000044707183,0.00027373055,0.0001886385,0.99819577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828315,0.000010733625,0.00034251253,0.00055155443,0.00044400396,0.00036805996],"domain_scores_gemma":[0.9987131,0.000031378204,0.000081962135,0.00068939425,0.00008658159,0.0003975804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000056000747,0.00052235724,0.00073063106,0.00021518141,0.00006818863,0.000026383406,0.00017395394,0.00038861373,0.9989493],"category_scores_gemma":[0.0000098544,0.00046891332,0.0002889439,0.000044791446,0.00006333422,0.000040044742,0.00005643977,0.00039093883,0.9972549],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005845788,0.00006517263,3.960294e-8,0.000043509153,0.00035206863,0.00016804099,0.000015473628,7.1454946e-7,0.0000049198875,0.000022754455,0.47677907,0.52196366],"study_design_scores_gemma":[0.0012753443,0.00088492926,0.000005398243,0.00036218704,0.00065628916,0.00011415124,2.4140485e-7,0.0000016520846,0.000036028927,0.00021538045,0.9960401,0.00040831623],"about_ca_topic_score_codex":0.000040588144,"about_ca_topic_score_gemma":4.5635647e-7,"teacher_disagreement_score":0.5215553,"about_ca_system_score_codex":0.00019842731,"about_ca_system_score_gemma":0.0002304494,"threshold_uncertainty_score":0.99977624},"labels":[],"label_agreement":null},{"id":"W2129695172","doi":"10.1016/j.urology.2011.04.073","title":"Oncological and Functional Outcomes After Robot-assisted Radical Cystectomy: Critical Review of Current Status","year":2011,"lang":"en","type":"review","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Current (fluid); General surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.13300183822031733,"score_gpt":0.40522606854880067,"score_spread":0.2722242303284833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129695172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044569483,0.99663764,0.000107212305,0.0003254263,0.00079185504,0.0009318195,0.0001278336,0.000035701196,0.0010380455],"genre_scores_gemma":[0.00020103407,0.99734426,0.00014622818,0.0013644805,0.00021414828,0.00044612627,0.00014437232,0.00003607442,0.00010326797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976331,0.0003756531,0.0008099365,0.00054096145,0.00022599235,0.00041436596],"domain_scores_gemma":[0.9985717,0.00046723973,0.00017915561,0.00035127866,0.00010905698,0.00032159145],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017745522,0.00042515495,0.0030188907,0.00013774724,0.000029539435,0.000003827406,0.00007545026,0.0004609288,0.003383461],"category_scores_gemma":[0.0004471621,0.0002611504,0.0005676162,0.00013251998,0.00049761165,0.000023658213,0.00011076196,0.0006430569,0.00008878392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026429203,0.00059612753,0.0010720855,0.08495693,0.00044251408,0.00016328793,0.00000859886,2.5113123e-9,5.5517923e-8,0.00045869808,0.0017842471,0.91025317],"study_design_scores_gemma":[0.0010505194,0.0009069617,0.0079820305,0.012817931,0.0059353425,0.00075579877,5.2323384e-7,1.9262363e-7,4.722169e-8,0.00006318619,0.9703079,0.0001795664],"about_ca_topic_score_codex":0.000009257014,"about_ca_topic_score_gemma":0.0000027860926,"teacher_disagreement_score":0.9685237,"about_ca_system_score_codex":0.00011412238,"about_ca_system_score_gemma":0.0006938612,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2130456918","doi":"10.1016/j.eururo.2014.04.008","title":"All Bacillus Calmette-Guérin (BCG) Strains Are Equal, but Some BCG Strains Are More Equal Than Others","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bacillus (shape); BCG vaccine; Microbiology; Virology; Vaccination","score_opus":0.055396853291983475,"score_gpt":0.29031367116690987,"score_spread":0.2349168178749264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130456918","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044272657,0.0024424852,0.0011202635,0.86840874,0.0038636005,0.0027433645,0.0047010104,0.0011891728,0.07125869],"genre_scores_gemma":[0.27222174,0.0001111338,0.0000824888,0.70245165,0.012570302,0.000050219936,0.0016216886,0.00061979296,0.010271016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931632,0.0014091484,0.0009802113,0.0018052056,0.00085780304,0.0017843837],"domain_scores_gemma":[0.99657655,0.0001922323,0.0007893016,0.0017746086,0.00015917409,0.00050810754],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0004938838,0.0013622844,0.001805417,0.00046966915,0.00019077152,0.00008202139,0.0009185276,0.0011001652,0.0014416055],"category_scores_gemma":[0.00017413218,0.0011942633,0.00066455035,0.0001821164,0.00066353724,0.00011096819,0.00027794173,0.0035677443,0.0024378311],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034243992,0.00034047713,0.002260411,0.0005046133,0.00212536,0.024228875,0.0010666996,0.0000414384,0.0005162926,0.00012475549,0.9657771,0.0026715102],"study_design_scores_gemma":[0.0062094736,0.002697655,0.021350073,0.00017098086,0.0013906949,0.0008620479,0.00023009675,0.000034478788,0.000050896746,0.00015130483,0.96564585,0.0012064334],"about_ca_topic_score_codex":0.00029250543,"about_ca_topic_score_gemma":0.00007173231,"teacher_disagreement_score":0.22794908,"about_ca_system_score_codex":0.00026105667,"about_ca_system_score_gemma":0.0002603811,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W2130894756","doi":"10.5489/cuaj.1205","title":"Surveillance strategies after definitive therapy of invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bladder cancer; Medicine; Urinary system; Urothelial cancer; Cancer; Cancer therapy; Urology; Oncology; Internal medicine","score_opus":0.01795947694762832,"score_gpt":0.2517126560958781,"score_spread":0.2337531791482498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130894756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807926,0.0018545315,0.000010380754,0.010505609,0.00023201959,0.00028274918,0.000089868794,0.0000117181025,0.0062205624],"genre_scores_gemma":[0.9926875,0.001450436,0.00005679753,0.005134647,0.00027919552,0.00007222861,0.000008209384,0.000011161213,0.0002997851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988984,0.000112742106,0.00025242692,0.00013652488,0.00025345045,0.00034646387],"domain_scores_gemma":[0.9986714,0.00012361706,0.0001921354,0.0000750921,0.00054816453,0.00038955986],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014828639,0.00012700695,0.00026896142,0.00009504899,0.00008324641,0.00006187479,0.00006627013,0.00017922303,0.0062076175],"category_scores_gemma":[0.00014392752,0.000090621084,0.00011709794,0.00013812257,0.000046442332,0.00014492519,0.000005639698,0.00030489892,0.000068761256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000868952,0.000046410467,0.9898996,0.000002984855,0.00033491565,0.00003479996,0.00027390817,0.000007903958,0.00020539171,0.0000605174,0.0053928373,0.0036538807],"study_design_scores_gemma":[0.0011971279,0.0003854194,0.99146265,0.000012615721,0.000024186678,0.000031111693,0.00021736066,0.0000038077912,0.00015898903,0.0015817003,0.00483337,0.00009168837],"about_ca_topic_score_codex":0.011327997,"about_ca_topic_score_gemma":0.005230508,"teacher_disagreement_score":0.0118949795,"about_ca_system_score_codex":0.00048422656,"about_ca_system_score_gemma":0.0013511482,"threshold_uncertainty_score":0.99525565},"labels":[],"label_agreement":null},{"id":"W2131023570","doi":"10.1016/j.ijrobp.2016.09.001","title":"In Reply to Leung","year":2016,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Contouring; Adjuvant radiotherapy; Pubic symphysis; Symphysis; Radiation therapy; Cancer; Medical physics; Surgery; Internal medicine","score_opus":0.025370503404668638,"score_gpt":0.34919327789943216,"score_spread":0.32382277449476354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131023570","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057502957,0.0005130531,0.0023449971,0.9789349,0.008228826,0.0004651122,0.00022306562,0.000031937787,0.0035078335],"genre_scores_gemma":[0.026457686,0.0007430643,0.0015323051,0.92216927,0.046647135,0.00004152027,0.00019006549,0.000089387664,0.00212959],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762064,0.0002143852,0.0009951052,0.00036662078,0.0004428149,0.0003604423],"domain_scores_gemma":[0.99750924,0.0003642853,0.0010014671,0.0002536048,0.0007349218,0.0001364541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038374457,0.0003245638,0.00084430235,0.00045865154,0.000031572687,0.000023152868,0.00048828754,0.00067947566,0.0003022363],"category_scores_gemma":[0.00026309583,0.00024927317,0.00034709758,0.00016525603,0.00010250832,0.00022103936,0.00007246284,0.0013673409,0.00022695321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000600289,0.00018437057,0.035524607,0.000016937314,0.00095010654,0.0013163745,0.00026291303,0.000014649672,0.00068718917,0.00037792482,0.86257535,0.0974893],"study_design_scores_gemma":[0.005611159,0.0013854383,0.002474304,0.00023986296,0.00016276036,0.00048594113,0.000008533381,0.000011009276,0.00076996366,0.005650392,0.9829875,0.00021311665],"about_ca_topic_score_codex":0.00006516756,"about_ca_topic_score_gemma":0.0000042775905,"teacher_disagreement_score":0.12041218,"about_ca_system_score_codex":0.002204476,"about_ca_system_score_gemma":0.0012359243,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2131278581","doi":"10.1089/end.2006.0374","title":"Transitional-Cell Carcinoma Recurrence Rate after Nephroureterectomy in Patients Who Undergo Open Excision of Bladder Cuff <i>v</i> Transurethral Incision of the Ureteral Orifice","year":2007,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Transitional cell carcinoma; Ureter; Surgery; Cuff; Urology; Ureteroscopy; Upper urinary tract; Stage (stratigraphy); Bladder cancer; Urinary system; Internal medicine; Cancer","score_opus":0.01506033476504827,"score_gpt":0.27739135650552904,"score_spread":0.2623310217404808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131278581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969675,0.00045268761,0.00035024836,0.00044036962,0.0004574805,0.00044957467,0.000034789984,0.0000017169116,0.0008456655],"genre_scores_gemma":[0.99865794,0.000058176214,0.00035460666,0.0007541281,0.00009948859,0.0000040368586,0.000004597993,0.000018644976,0.0000483799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978817,0.00029857052,0.00093906303,0.00019139829,0.0004208126,0.0002684306],"domain_scores_gemma":[0.9985554,0.00022290055,0.00051567244,0.00023653488,0.0003621132,0.000107346124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008083877,0.00018347726,0.0006035039,0.00021277802,0.000030398905,0.000007675996,0.0003150836,0.0001522564,0.0001690427],"category_scores_gemma":[0.000048623693,0.00011962049,0.00023916284,0.00028249907,0.00012661965,0.00018704447,0.000048517424,0.00047245156,0.0000014966508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0513648,0.0018331234,0.92527485,0.00015236092,0.00018329614,0.00025205695,0.0029037192,0.00006140506,0.011118783,0.000035473822,0.0008840169,0.005936108],"study_design_scores_gemma":[0.014576971,0.0033091547,0.9579517,0.00018101932,0.00019614592,0.00011406507,0.000051752013,0.000011309188,0.022445075,0.00046298644,0.0005988023,0.00010101933],"about_ca_topic_score_codex":0.00008431734,"about_ca_topic_score_gemma":0.000090116795,"teacher_disagreement_score":0.03678783,"about_ca_system_score_codex":0.00007425135,"about_ca_system_score_gemma":0.0002658827,"threshold_uncertainty_score":0.4877982},"labels":[],"label_agreement":null},{"id":"W2131455154","doi":"10.5489/cuaj.604","title":"Perioperative chemotherapy: the case for adjuvant chemotherapy for muscle-invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Perioperative; Multimodal therapy; Disease; Cancer; Adjuvant chemotherapy; Oncology; Internal medicine; Surgery; Urology","score_opus":0.01905220130143358,"score_gpt":0.27578959666365666,"score_spread":0.25673739536222306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131455154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6870361,0.0012506396,0.00066954084,0.30487463,0.00070869207,0.0039206375,0.0004526645,0.000039115726,0.0010480137],"genre_scores_gemma":[0.9451177,0.00031731487,0.0004885459,0.049243476,0.0014234708,0.0010019927,0.000022018065,0.00003767837,0.0023478146],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986579,0.0000735161,0.00029054336,0.00023798001,0.00016844059,0.0005716382],"domain_scores_gemma":[0.9981396,0.00031952717,0.00019932292,0.00012401973,0.0007031257,0.0005144023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030067677,0.00020372416,0.00032606648,0.00006768258,0.00066907646,0.0001516811,0.00011178956,0.00021460505,0.0027380334],"category_scores_gemma":[0.00030227823,0.000121531804,0.0002668266,0.00011264807,0.00005106619,0.00011331086,0.000004922216,0.0002970216,0.000021037757],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092781644,0.00048690083,0.14140342,0.00006392195,0.0046021645,0.00045333797,0.008645522,0.000107090134,0.0027498987,0.0007512046,0.5561955,0.28361323],"study_design_scores_gemma":[0.021921806,0.0032588898,0.3829044,0.000051056384,0.00079667993,0.0018883677,0.003124426,0.0013870746,0.0011222417,0.0036477204,0.5792014,0.00069592905],"about_ca_topic_score_codex":0.0053112474,"about_ca_topic_score_gemma":0.004936602,"teacher_disagreement_score":0.28291732,"about_ca_system_score_codex":0.0011312581,"about_ca_system_score_gemma":0.0010492558,"threshold_uncertainty_score":0.9981736},"labels":[],"label_agreement":null},{"id":"W2131524311","doi":"10.1111/j.1442-2042.2011.02809.x","title":"Immunohistochemical biomarkers for bladder cancer prognosis","year":2011,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Immunohistochemistry; Cancer; Pathology; Oncology; Internal medicine","score_opus":0.0404566118174245,"score_gpt":0.3376844453692724,"score_spread":0.2972278335518479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131524311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532717,0.0064471383,0.004665619,0.016786171,0.006681649,0.00071393955,0.00010112036,0.000035536123,0.011297111],"genre_scores_gemma":[0.9951415,0.00018158283,0.002555732,0.0014165301,0.0004930403,0.000035989717,0.0000051335705,0.000013699667,0.00015681247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932057,0.000012911606,0.00028069323,0.00009116703,0.00017748348,0.00011715997],"domain_scores_gemma":[0.99914855,0.000036953767,0.00017596575,0.00005538888,0.00051217125,0.00007097327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008493325,0.00007843339,0.00017169968,0.0001269624,0.000014619887,0.0000044051994,0.00015702315,0.00006910099,0.0007296049],"category_scores_gemma":[0.000055902325,0.00006053699,0.00016818104,0.000032446143,0.00007038683,0.00005519049,0.000017492897,0.00009846568,0.0000057907514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06497623,0.0046558836,0.4030059,0.00007469688,0.032895215,0.0013405957,0.004072482,0.000007596121,0.17107452,0.0023772826,0.079922915,0.23559669],"study_design_scores_gemma":[0.049146056,0.014923868,0.35682628,0.00025998225,0.0048980764,0.010381767,0.0003484464,0.00029619806,0.22211434,0.011715553,0.32827032,0.0008191206],"about_ca_topic_score_codex":0.000054145716,"about_ca_topic_score_gemma":0.0000034575894,"teacher_disagreement_score":0.24834742,"about_ca_system_score_codex":0.00009285428,"about_ca_system_score_gemma":0.00017584432,"threshold_uncertainty_score":0.7988662},"labels":[],"label_agreement":null},{"id":"W2132893951","doi":"10.3747/co.22.2052","title":"Urologist Referral Delay and Its Impact on Survival after Radical Cystectomy for Bladder Cancer","year":2015,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Referral; Confidence interval; Proportional hazards model; Urology; Population; Cohort; Cancer; Surgery; Gynecology; Internal medicine; Family medicine","score_opus":0.19480428282810125,"score_gpt":0.47663743761054156,"score_spread":0.2818331547824403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132893951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823776,0.010224101,0.00007520174,0.0021042968,0.0022039243,0.0009275257,0.0001921195,0.000054174194,0.001841076],"genre_scores_gemma":[0.9973208,0.0002680618,0.00005216992,0.00053066347,0.0009046847,0.0005608086,0.000044518776,0.000027884998,0.00029043033],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877256,0.00009296113,0.00020740258,0.00035659925,0.00018465376,0.00038581993],"domain_scores_gemma":[0.9991262,0.000103921746,0.00006114211,0.0001582323,0.00014096446,0.00040952023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018361314,0.00022137833,0.00046020202,0.00007687592,0.000040701885,0.000009875102,0.00006288391,0.00017871967,0.00021876744],"category_scores_gemma":[0.00008771397,0.00014775073,0.00011212564,0.00007427891,0.00011580262,0.000043868265,0.000037028934,0.00024563834,0.00003541054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067229435,0.0052328547,0.6083242,0.00045937244,0.0020446968,0.0005563055,0.0024953252,0.00004665449,0.0003670036,0.0007477398,0.09439174,0.21810465],"study_design_scores_gemma":[0.037111577,0.020349264,0.20660603,0.00013036536,0.0011601674,0.00030162482,0.0001099832,0.00074336457,0.00040271573,0.00039658524,0.7321602,0.0005281177],"about_ca_topic_score_codex":0.00008100492,"about_ca_topic_score_gemma":0.00010055073,"teacher_disagreement_score":0.63776845,"about_ca_system_score_codex":0.0004471266,"about_ca_system_score_gemma":0.00059109705,"threshold_uncertainty_score":0.60251004},"labels":[],"label_agreement":null},{"id":"W2132908363","doi":"10.1111/j.1464-410x.2008.07571.x","title":"Paclitaxel and cisplatin as intravesical agents against non‐muscle‐invasive bladder cancer","year":2008,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Paclitaxel; Cisplatin; In vivo; Pharmacokinetics; Bladder cancer; Pharmacology; Medicine; Chemotherapy; Urinary bladder; Urology; Chemistry; Cancer; Internal medicine; Biology","score_opus":0.020525982511264643,"score_gpt":0.2812727205554579,"score_spread":0.26074673804419324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132908363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889773,0.006015623,0.000052885534,0.001603356,0.00033881897,0.00017298451,0.00002829174,0.000009231855,0.0028014956],"genre_scores_gemma":[0.97595286,0.017478667,0.00024283369,0.005243838,0.0005903376,0.000008251079,0.000005289361,0.000026899374,0.0004510124],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987514,0.00006836001,0.0004162424,0.00019994081,0.00026499535,0.0002990792],"domain_scores_gemma":[0.9991104,0.0000803473,0.00019676345,0.00009827559,0.00019806217,0.00031612976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011323708,0.00014872529,0.0004622833,0.00009593844,0.000117199255,0.000015490294,0.00008413737,0.00015227526,0.00045409217],"category_scores_gemma":[0.00015680198,0.00014692578,0.00012354317,0.00008969063,0.00023983153,0.00010308102,0.00003398328,0.0004213029,0.000018697112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029883597,0.0019914657,0.18104874,0.00016759953,0.0031281454,0.10990198,0.0036012544,0.0000737887,0.011358297,0.00006261977,0.09406158,0.59161615],"study_design_scores_gemma":[0.0083579775,0.0027811094,0.91453743,0.00017058435,0.000430477,0.062186245,0.00010603173,0.000032960426,0.00063349074,0.0002925148,0.010271512,0.00019967966],"about_ca_topic_score_codex":0.00026592877,"about_ca_topic_score_gemma":0.00008294654,"teacher_disagreement_score":0.7334887,"about_ca_system_score_codex":0.000056335324,"about_ca_system_score_gemma":0.00042590022,"threshold_uncertainty_score":0.59914595},"labels":[],"label_agreement":null},{"id":"W2133323182","doi":"10.5430/jst.v3n3p1","title":"A feasibility study of transurethral resection followed by radiotherapy combined with concurrent twice-weekly gemcitabine in the treatment of invasive bladder carcinoma","year":2013,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Medicine; Cystectomy; Urology; Bladder cancer; Cystoscopy; Radiation therapy; Surgery; Chemotherapy; Cancer; Urinary system; Internal medicine","score_opus":0.028680504681638453,"score_gpt":0.3064855954454366,"score_spread":0.2778050907637981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133323182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959296,0.0010994426,0.000018311654,0.00061999477,0.00011449548,0.0021264707,0.000022590511,0.0000039161764,0.000065189226],"genre_scores_gemma":[0.99953455,0.0001707723,0.00003813852,0.00004904552,0.00007520592,0.0000615491,0.0000045286065,0.000020107615,0.00004611021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980222,0.00024150657,0.00078549003,0.0001747642,0.00057244796,0.00020358556],"domain_scores_gemma":[0.99866295,0.0001250841,0.0005108424,0.00026139492,0.00033125325,0.00010847356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025752225,0.00022156836,0.00083289575,0.00016218207,0.000035851222,0.0000095591995,0.0001281093,0.00004958559,0.000090619986],"category_scores_gemma":[0.000018666533,0.00011659293,0.00019160492,0.0002885288,0.00011341602,0.00012223955,0.0000036293507,0.0001858395,5.025211e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010782634,0.018576868,0.9312658,0.000091754104,0.0010647882,0.00015610959,0.02499717,0.000030970477,0.011430955,0.0000028558923,0.0007753462,0.00082478655],"study_design_scores_gemma":[0.04496917,0.11352632,0.8180248,0.00015074735,0.0005190434,0.00016348815,0.009054806,0.000025600686,0.01341209,0.000023951849,0.000021190373,0.00010877707],"about_ca_topic_score_codex":0.0012940483,"about_ca_topic_score_gemma":0.0004276389,"teacher_disagreement_score":0.11324095,"about_ca_system_score_codex":0.00027282862,"about_ca_system_score_gemma":0.00032312245,"threshold_uncertainty_score":0.47545218},"labels":[],"label_agreement":null},{"id":"W2133483236","doi":"10.1136/jclinpath-2013-201586","title":"Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Health Research Board; University Health Network","keywords":"Prostate; Immunohistochemistry; Pathology; Androgen receptor; Carcinoma; Medicine; Anatomical pathology; PCA3; Prostate cancer; Internal medicine; Cancer","score_opus":0.04828318174030625,"score_gpt":0.3587168332709217,"score_spread":0.3104336515306154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133483236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800414,0.0005342369,0.000051771298,0.00054667564,0.00031618343,0.00036114303,0.000014906732,0.0000041183184,0.00016680158],"genre_scores_gemma":[0.99855894,0.0002725366,0.00081567734,0.00012737021,0.0001530587,0.000009851354,0.0000037276402,0.000012513856,0.00004629904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786144,0.00035573,0.0012625254,0.00017594818,0.00016949212,0.00017485312],"domain_scores_gemma":[0.998194,0.000765824,0.0005426818,0.00013636399,0.00018842207,0.00017272972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057862204,0.000119233955,0.0007483278,0.00009254271,0.000020058356,0.0000065183217,0.00006850871,0.00014785503,0.00020306952],"category_scores_gemma":[0.0021002134,0.00007784129,0.00012262785,0.00006667,0.00018261063,0.00009669942,0.00004897414,0.00037604923,0.000004470554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000801646,0.0006129365,0.9542786,0.00007251014,0.00002735117,0.00016663363,0.00037079502,1.5812486e-7,0.009904045,0.0000019764889,0.0002104229,0.033552956],"study_design_scores_gemma":[0.006084754,0.002411218,0.98534536,0.00023529597,0.000107368556,0.00015678836,0.00011034989,0.0000369366,0.004933995,0.00048016116,0.000037992908,0.000059778653],"about_ca_topic_score_codex":0.00004449166,"about_ca_topic_score_gemma":0.000005429453,"teacher_disagreement_score":0.033493176,"about_ca_system_score_codex":0.000012875488,"about_ca_system_score_gemma":0.00012598818,"threshold_uncertainty_score":0.31742755},"labels":[],"label_agreement":null},{"id":"W2133646931","doi":"10.1016/j.eururo.2012.09.057","title":"ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Urine cytology; MEDLINE; Cancer; Gold standard (test); Urinary system; Oncology; Internal medicine; Urology","score_opus":0.05054170174184221,"score_gpt":0.3471694749275516,"score_spread":0.29662777318570943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133646931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003915518,0.9602073,0.0000723605,0.000655247,0.00082978373,0.0007622252,0.0001585709,0.00005831218,0.037217088],"genre_scores_gemma":[0.00064982177,0.99327666,0.00012838034,0.0027608944,0.0007327651,0.00019758151,0.00039384872,0.00013262453,0.0017274484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980769,0.00046462717,0.00039152298,0.0005123401,0.00022014447,0.00033444058],"domain_scores_gemma":[0.99899936,0.00018210705,0.0002468018,0.00028944385,0.00007250325,0.00020976638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021181689,0.00041696662,0.0007866465,0.000217928,0.00005405679,0.000022499287,0.0001541877,0.0001686344,0.0014275257],"category_scores_gemma":[0.00006841095,0.0003327841,0.00019976428,0.000102445214,0.00013501414,0.000058961337,0.000096105236,0.000428203,0.0004053151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013652793,0.00012530938,0.0004693055,0.0005480767,0.0013116504,0.00026301248,0.00006469769,7.6308226e-7,8.4881043e-7,0.00011629823,0.008589018,0.9883745],"study_design_scores_gemma":[0.0012765534,0.00035668802,0.0015496674,0.00083216926,0.0029760718,0.00017492668,0.0000044670105,0.0000017749214,0.000002072869,0.000003016872,0.99258274,0.00023983583],"about_ca_topic_score_codex":0.000044372053,"about_ca_topic_score_gemma":0.000006967998,"teacher_disagreement_score":0.9881347,"about_ca_system_score_codex":0.0000741055,"about_ca_system_score_gemma":0.00009739156,"threshold_uncertainty_score":0.99991244},"labels":[],"label_agreement":null},{"id":"W2134868034","doi":"10.1016/j.eururo.2015.09.051","title":"The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gemcitabine; Taxane; Docetaxel; Oncology; Internal medicine; Paclitaxel; Chemotherapy; Regimen; Cancer; Urology; Breast cancer","score_opus":0.12192699752079104,"score_gpt":0.4142933770080399,"score_spread":0.29236637948724886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134868034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020288837,0.9892367,0.00009385053,0.0010153324,0.00003654409,0.008695421,0.00083000545,0.000014244194,0.000057613666],"genre_scores_gemma":[0.000347334,0.99644506,0.00017665968,0.0009343887,0.00006343669,0.0013120705,0.000029166216,0.00010334769,0.00058852276],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99703985,0.0007168789,0.0012705484,0.0004498321,0.00022626194,0.00029665275],"domain_scores_gemma":[0.9959728,0.0016292919,0.0012073915,0.0007974419,0.0002618361,0.00013123255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014944297,0.0005664659,0.0069602737,0.00016684101,0.000108921085,0.000017598575,0.00032334586,0.00005544634,0.0001335888],"category_scores_gemma":[0.0004276112,0.00020470598,0.0015493341,0.00057245267,0.00017458982,0.000028340386,0.00006984646,0.00017075497,0.00000247033],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001815957,0.00018603234,0.000008874474,0.31881517,0.5112947,0.000020114445,0.000639682,0.000050006096,0.0000034596276,0.000020255742,0.0010211854,0.16612455],"study_design_scores_gemma":[0.0022194337,0.003534458,0.000024867768,0.0041306815,0.77607024,0.00012028157,0.000019876647,0.000020848189,0.0000016804657,0.000010053801,0.21360074,0.0002468476],"about_ca_topic_score_codex":0.00008263333,"about_ca_topic_score_gemma":0.000047130674,"teacher_disagreement_score":0.3146845,"about_ca_system_score_codex":0.000047006142,"about_ca_system_score_gemma":0.00023905886,"threshold_uncertainty_score":0.8347668},"labels":[],"label_agreement":null},{"id":"W2135108459","doi":"10.1634/theoncologist.5-6-471","title":"The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response","year":2000,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Alberta","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Bladder cancer; Urology; Cystoscopy; Radiation therapy; Concomitant; Cisplatin; Cystectomy; Surgery; Urinary bladder; Chemotherapy; Urinary system; Cancer; Internal medicine","score_opus":0.09270750294284641,"score_gpt":0.3860997258673921,"score_spread":0.2933922229245457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135108459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227095,0.00075396465,0.000018725392,0.0030153594,0.00018567753,0.0026095272,0.00026747902,0.000025121672,0.00085318775],"genre_scores_gemma":[0.9974539,0.0013011022,0.00000848375,0.00023307443,0.0002162435,0.00047671393,0.000050909366,0.000029467721,0.00023008024],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99692774,0.0012000685,0.0007053377,0.00032374702,0.00051601627,0.00032709763],"domain_scores_gemma":[0.9945543,0.0045477855,0.0004089757,0.00029946555,0.00012600825,0.0000634727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020909673,0.0002707472,0.00054966885,0.000078806625,0.00037048923,0.000030448855,0.00015993702,0.00015071606,0.0001254395],"category_scores_gemma":[0.0005385877,0.00012432563,0.00010929971,0.0004529897,0.00042679804,0.00014942801,0.000016851525,0.00038500456,8.3768265e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8586194,0.0011875469,0.00037173822,0.000022768807,0.0005669504,0.000033254397,0.00832435,0.00013497069,0.0036796334,0.000027232281,0.0034596839,0.123572506],"study_design_scores_gemma":[0.76312935,0.07062022,0.03623755,0.0011688374,0.0014258449,0.00007934706,0.0032800885,0.0027394455,0.10368836,0.00017367894,0.01644246,0.001014841],"about_ca_topic_score_codex":0.0013085299,"about_ca_topic_score_gemma":0.0010869146,"teacher_disagreement_score":0.12255766,"about_ca_system_score_codex":0.00030407854,"about_ca_system_score_gemma":0.00095838215,"threshold_uncertainty_score":0.5069852},"labels":[],"label_agreement":null},{"id":"W2135508352","doi":"10.1002/dc.23069","title":"Three‐dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low‐grade urothelial neoplasia","year":2013,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Urine; Urine cytology; Pathology; Sensitivity (control systems); Urology; Internal medicine; Cystoscopy","score_opus":0.010305391653472842,"score_gpt":0.21422611115710508,"score_spread":0.20392071950363222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135508352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943708,0.00056893355,0.001393156,0.0009018625,0.00011825863,0.0021547102,0.0004012758,0.00006430856,0.000026654747],"genre_scores_gemma":[0.9973007,0.00016742565,0.0014755738,0.00025852348,0.000113010865,0.00041919874,0.00017731701,0.00006288614,0.000025378104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791145,0.00016465515,0.0003782615,0.00075871433,0.00029402217,0.0004928661],"domain_scores_gemma":[0.9970194,0.0019487106,0.0002758718,0.00032975015,0.00018431556,0.00024192217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019196016,0.00044070132,0.0009830717,0.00011349945,0.00016074833,0.000026329046,0.00006477334,0.00025133102,0.00008160062],"category_scores_gemma":[0.00046794882,0.00030108128,0.00007751392,0.00015966593,0.00060424366,0.00010407806,0.00009717158,0.00025633955,0.000007145762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008902367,0.0016882936,0.9812291,0.00024333915,0.00007360071,0.001178378,0.00018870842,0.00001609387,0.013710057,0.00011734419,0.000109573506,0.0005552767],"study_design_scores_gemma":[0.008383384,0.0049831243,0.96202415,0.00046025336,0.0004948597,0.000364574,0.00010471371,0.000121950005,0.022206694,0.0005093191,0.000014867056,0.00033210966],"about_ca_topic_score_codex":0.00027946374,"about_ca_topic_score_gemma":0.0006457429,"teacher_disagreement_score":0.019204946,"about_ca_system_score_codex":0.000060216567,"about_ca_system_score_gemma":0.00007371059,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W2135532181","doi":"10.1016/j.urolonc.2014.06.008","title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Dipstick; Urinary system; Cytology; Urology; Prospective cohort study; Bladder cancer; Urine; Gastroenterology; Internal medicine; Urine cytology; Urinalysis; Cancer; Urinary bladder; Pathology","score_opus":0.031121225003031473,"score_gpt":0.3306907502232353,"score_spread":0.2995695252202038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135532181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477005,0.0015576956,0.00035415922,0.0015781347,0.00005347595,0.0004777544,0.0001668002,0.000015822206,0.0010260928],"genre_scores_gemma":[0.98609775,0.00047000212,0.012515254,0.00064725516,0.000051758616,0.0000842085,0.000018798803,0.000010054551,0.00010491396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989951,0.00013501673,0.00025703348,0.00035712656,0.000075985125,0.00017969415],"domain_scores_gemma":[0.9989769,0.00046368135,0.00018734467,0.00014092217,0.000094195486,0.00013695618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003050493,0.00016081621,0.000632156,0.00023480796,0.00010557546,0.0000038625726,0.000027632206,0.00018136213,0.000038203234],"category_scores_gemma":[0.000091489586,0.00013002088,0.000072307754,0.00028371142,0.001280976,0.00004221474,0.00003793429,0.000107202526,2.3140208e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006545445,0.00035852523,0.9895463,0.000069780304,0.0015178539,0.000016666676,0.00045089715,0.000022556695,0.0023142425,0.0031782885,0.00018247687,0.0016878889],"study_design_scores_gemma":[0.0030615963,0.012229677,0.9011788,0.00005413315,0.008007461,0.00039567344,0.0003799763,0.0059425933,0.0032427097,0.0049644406,0.060294844,0.00024810582],"about_ca_topic_score_codex":0.000318246,"about_ca_topic_score_gemma":0.00013875178,"teacher_disagreement_score":0.088367485,"about_ca_system_score_codex":0.000043135937,"about_ca_system_score_gemma":0.00012418407,"threshold_uncertainty_score":0.5302098},"labels":[],"label_agreement":null},{"id":"W2136098219","doi":"10.1016/j.eururo.2012.01.019","title":"Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Urology","score_opus":0.04862427174382285,"score_gpt":0.28588005207882544,"score_spread":0.2372557803350026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136098219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919046,0.003560718,0.00040905742,0.0020828885,0.00083486,0.0018911902,0.00041417644,0.000022540416,0.0015941123],"genre_scores_gemma":[0.9994322,0.00014555787,0.000072231094,0.000029277775,0.00019038738,0.000023209737,0.000017845523,0.00003054679,0.000058750007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981899,0.00057306536,0.00047004607,0.0002476073,0.00030793188,0.00021143342],"domain_scores_gemma":[0.99829876,0.0001157922,0.0006325241,0.0005844852,0.00030390502,0.00006453157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055592356,0.00015510916,0.00035846254,0.000050017963,0.00007990921,0.0000040870755,0.00024636072,0.000055494,0.000011412927],"category_scores_gemma":[0.00013626531,0.00008316878,0.00010948383,0.00023264042,0.00033384,0.000040853894,0.00007782279,0.00017747318,0.0000010814917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00403213,0.0010209123,0.8881443,0.0009860813,0.00035145748,0.0000013226291,0.003948307,0.0000038835806,0.02132302,0.008121006,0.0032261782,0.06884141],"study_design_scores_gemma":[0.0032197176,0.0008295065,0.9817961,0.0003220588,0.00047184824,0.000012433826,0.000089133806,0.00016326582,0.0055935397,0.000029107892,0.007379642,0.00009363826],"about_ca_topic_score_codex":0.000029373372,"about_ca_topic_score_gemma":0.000012719788,"teacher_disagreement_score":0.093651816,"about_ca_system_score_codex":0.00008053311,"about_ca_system_score_gemma":0.00022666,"threshold_uncertainty_score":0.33915246},"labels":[],"label_agreement":null},{"id":"W2136401477","doi":"10.1007/s10147-008-0788-9","title":"Contemporary management of muscle-invasive bladder cancer","year":2008,"lang":"en","type":"review","venue":"International Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Surgical oncology; Lymphadenectomy; Disease; Stage (stratigraphy); Urology; Cancer; Oncology; General surgery; Internal medicine","score_opus":0.2925499349865334,"score_gpt":0.5509766176595975,"score_spread":0.25842668267306407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136401477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105961655,0.9705714,0.000026163121,0.000868251,0.0055031613,0.00044996644,0.00009614764,0.0000068155355,0.022372158],"genre_scores_gemma":[0.0009177152,0.99370646,0.0008319326,0.00072491675,0.002563137,0.000029671119,0.000031917793,0.00003971757,0.0011545466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948874,0.0003049852,0.003611961,0.00026403213,0.00077353255,0.00015806049],"domain_scores_gemma":[0.99367005,0.0011152218,0.003777157,0.00020932665,0.0009869819,0.0002412471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004879859,0.00028903753,0.003517033,0.00028257718,0.000015893716,0.0000057152497,0.00052830525,0.00049797806,0.00052228465],"category_scores_gemma":[0.00024029751,0.0001963054,0.0020443937,0.000114372175,0.00024876505,0.00007535979,0.00012422161,0.00084283086,0.00003485304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057448295,0.0012466243,0.0003582506,0.0011254577,0.013738168,0.0058287377,0.000028995968,5.6905265e-7,1.3833991e-7,0.0000456791,0.022858223,0.95419466],"study_design_scores_gemma":[0.0048080347,0.0020053159,0.0010479102,0.012576085,0.0025389255,0.001279358,0.00002713173,3.2162518e-7,0.0000018654385,0.00005081105,0.9755391,0.00012517112],"about_ca_topic_score_codex":0.000042302356,"about_ca_topic_score_gemma":0.0000053105505,"teacher_disagreement_score":0.9540695,"about_ca_system_score_codex":0.00038992547,"about_ca_system_score_gemma":0.005793605,"threshold_uncertainty_score":0.99984264},"labels":[],"label_agreement":null},{"id":"W2136434401","doi":"10.1016/j.juro.2014.09.109","title":"Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin","year":2014,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Campbell Scientific (Canada); Queen's University","funders":"","keywords":"Medicine; Cystoscopy; Discontinuation; Surgery; Carcinoma in situ; Bladder cancer; Adverse effect; Internal medicine; Clinical endpoint; Refractory (planetary science); Urology; Cancer; Urinary system; Randomized controlled trial","score_opus":0.008007698988835047,"score_gpt":0.25152736900094974,"score_spread":0.2435196700121147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136434401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976658,0.000899745,0.00008107556,0.00054735015,0.000042369833,0.0007109896,0.00003627426,0.000002023372,0.000014334343],"genre_scores_gemma":[0.99867994,0.0007602037,0.0003072676,0.00013431872,0.000046625442,0.000036190933,0.0000031988461,0.000013599769,0.000018657793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919045,0.00012879599,0.00024384998,0.0001309475,0.00014409715,0.0001618348],"domain_scores_gemma":[0.9991092,0.0002565531,0.0003010191,0.00012705858,0.00012520784,0.0000809525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017211276,0.00014093111,0.00037732912,0.000066073124,0.000047574675,0.0000028377099,0.00004237429,0.000053705913,0.000027786406],"category_scores_gemma":[0.000030427529,0.00006330168,0.000023148987,0.00006297152,0.00017344714,0.000042771942,0.000023268838,0.000112502436,3.1758842e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051976237,0.0003116764,0.885549,0.000029325365,0.00030348674,0.000007889958,0.0009876244,0.000034899764,0.000056990986,0.0000015100331,0.000016380134,0.060724966],"study_design_scores_gemma":[0.028626533,0.025005074,0.9444747,0.00013519454,0.00073814846,0.00003340681,0.000025752202,0.000019377532,0.0005339636,0.000024071935,0.00031630194,0.0000674572],"about_ca_topic_score_codex":0.00017553044,"about_ca_topic_score_gemma":0.00068070774,"teacher_disagreement_score":0.06065751,"about_ca_system_score_codex":0.00007523569,"about_ca_system_score_gemma":0.00008227991,"threshold_uncertainty_score":0.25813675},"labels":[],"label_agreement":null},{"id":"W2136671570","doi":"10.1158/1535-7163.mct-11-0756","title":"New Directions for Biologic Targets in Urothelial Carcinoma","year":2012,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Context (archaeology); Metastatic Urothelial Carcinoma; Clinical trial; Urothelial carcinoma; Disease; Oncology; Cancer; Stage (stratigraphy); Urothelial cancer; Internal medicine; Bladder cancer; Intensive care medicine; Biology","score_opus":0.09693421337094198,"score_gpt":0.37602540015036656,"score_spread":0.27909118677942457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136671570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000767585,0.99310845,0.0017686351,0.0002164158,0.0010120504,0.0028174345,0.00028800542,0.000066400644,0.0007149589],"genre_scores_gemma":[0.00025415883,0.9934798,0.0011302397,0.0009680381,0.0008365679,0.0014473571,0.00018666223,0.0001712956,0.0015258912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980975,0.000102546095,0.0004946183,0.0005071619,0.00019429471,0.00060388335],"domain_scores_gemma":[0.9990199,0.00005455195,0.00017948715,0.0004758614,0.00006195154,0.0002082233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000100888064,0.00057298865,0.0015152956,0.00024425724,0.00006351875,0.000020512993,0.00018546132,0.0004770741,0.00020583994],"category_scores_gemma":[0.0000064547366,0.000439953,0.0007469528,0.00038170046,0.00004463888,0.000032403314,0.000037070076,0.00037063757,0.0000332114],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000779318,0.00014028403,0.00017346824,0.0025061995,0.0007354917,0.000024515351,0.00007686341,4.238298e-7,0.000048512025,0.00007646788,0.00013917532,0.99600065],"study_design_scores_gemma":[0.0015872983,0.00026709435,0.000061569335,0.0014174039,0.0051516527,0.000040423016,0.000004909605,0.0000025310171,0.00024408531,0.000117621115,0.99071074,0.0003946616],"about_ca_topic_score_codex":0.00045577335,"about_ca_topic_score_gemma":0.00008111739,"teacher_disagreement_score":0.995606,"about_ca_system_score_codex":0.00060108537,"about_ca_system_score_gemma":0.0013550763,"threshold_uncertainty_score":0.9998052},"labels":[],"label_agreement":null},{"id":"W2137543730","doi":"10.6000/1927-7229.2013.02.04.1","title":"Pathological Complete Response Induced by the Combination Therapy of Gemcitabine and 24-h Infusion of Cisplatin in Two Cases Initially Diagnosed as Node-Positive Advanced Urothelial Carcinomas","year":2013,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Medicine; Cisplatin; Regimen; Neutropenia; Chemotherapy; Oncology; Internal medicine; Urology; Urothelial cancer; Cancer; Bladder cancer","score_opus":0.04350587817899046,"score_gpt":0.3579462865502121,"score_spread":0.31444040837122167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137543730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946628,0.00026359814,0.000029823956,0.0038775848,0.00007024248,0.00049652375,0.000022478394,0.000002869506,0.0005740654],"genre_scores_gemma":[0.9985092,0.0002616181,0.00025284573,0.0008767532,0.00004561564,0.000011768074,0.000004798057,0.000010616117,0.000026737756],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980182,0.00059522956,0.0007678243,0.00014209193,0.00030229532,0.00017434625],"domain_scores_gemma":[0.99684477,0.0020391946,0.00045664664,0.00010887558,0.0004288472,0.00012165191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005903927,0.0001467563,0.00072816346,0.00018213272,0.00003553325,0.0000069395114,0.00009772391,0.00011946505,0.00016430793],"category_scores_gemma":[0.00089574314,0.00008714578,0.000115176445,0.00020501568,0.00028716406,0.00009831774,0.000039279563,0.00035602148,0.0000022971972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05855061,0.0044628102,0.07834377,0.000035428824,0.0003945177,0.0028031238,0.002510367,0.00002465457,0.80303276,0.0007122982,0.0003275077,0.048802145],"study_design_scores_gemma":[0.024704566,0.029525835,0.93247515,0.00012576755,0.00016456144,0.0010009626,0.0004701702,0.00032920262,0.010211746,0.0007079427,0.00017520049,0.0001088983],"about_ca_topic_score_codex":0.00040629588,"about_ca_topic_score_gemma":0.000027774095,"teacher_disagreement_score":0.8541314,"about_ca_system_score_codex":0.00013569313,"about_ca_system_score_gemma":0.00030470273,"threshold_uncertainty_score":0.3553702},"labels":[],"label_agreement":null},{"id":"W2137616140","doi":"10.1016/s1470-2045(14)71160-x","title":"Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Eli Lilly and Company","keywords":"Cystectomy; Urothelial carcinoma; Medicine; Urology; Open label; Chemotherapy; Carcinoma; Oncology; Urothelial cancer; Bladder cancer; Randomized controlled trial; Internal medicine; Cancer","score_opus":0.051772857023881236,"score_gpt":0.35889775882615577,"score_spread":0.30712490180227453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137616140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912723,0.00005377618,0.00003066866,0.0016308285,0.000939205,0.0042451443,0.000071737195,0.000026066116,0.0017303219],"genre_scores_gemma":[0.99543864,0.000021982902,0.0001806169,0.0024796114,0.00094051904,0.000688847,0.000034008903,0.00005636874,0.0001594257],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997358,0.0008421267,0.00053703797,0.00041487563,0.00035445727,0.00049346866],"domain_scores_gemma":[0.9982937,0.00037104837,0.00026621207,0.0008302934,0.000088590954,0.00015016945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007043824,0.0003116741,0.001167613,0.00007442013,0.00007714509,0.000025126297,0.0006603099,0.00019829343,0.00042206384],"category_scores_gemma":[0.00014952634,0.00014523156,0.000093874114,0.00025098154,0.00042921837,0.00010358285,0.00012645379,0.0003925225,0.000012157809],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97077745,0.0034976073,0.012139959,0.000026740743,0.00033290486,0.000026197855,0.001241759,8.938037e-7,0.00023947361,0.000028249666,0.00047420844,0.011214531],"study_design_scores_gemma":[0.922922,0.02568744,0.04271385,0.000060102317,0.00035610265,0.000012083608,0.000060292503,0.00007084658,0.000671204,0.000051464034,0.007209624,0.0001849856],"about_ca_topic_score_codex":0.00028380463,"about_ca_topic_score_gemma":0.0006410227,"teacher_disagreement_score":0.04785547,"about_ca_system_score_codex":0.00020673861,"about_ca_system_score_gemma":0.00051329524,"threshold_uncertainty_score":0.5922371},"labels":[],"label_agreement":null},{"id":"W2137937825","doi":"10.1158/1078-0432.ccr-10-0457","title":"The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Cystectomy; Hazard ratio; Chemotherapy; Proportional hazards model; Bladder cancer; Internal medicine; Oncology; Adjuvant; Confidence interval; Urology; Cancer; Surgery","score_opus":0.06501876921638866,"score_gpt":0.4640252263772062,"score_spread":0.39900645716081756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137937825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416716,0.00007463057,0.0000055212313,0.0005546388,0.00031002585,0.056464627,0.00010627452,0.000008327876,0.0008043367],"genre_scores_gemma":[0.95561326,0.00003247631,0.000052958978,0.00008681261,0.00032112258,0.04349578,0.0000037070208,0.000045729514,0.00034814034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732274,0.00056392624,0.0005033504,0.00036320067,0.0008453712,0.00040143172],"domain_scores_gemma":[0.9951694,0.0026088369,0.00016225131,0.000836119,0.0010818727,0.00014153171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025697341,0.00016069517,0.00046010347,0.000045280398,0.00022113296,0.000012338259,0.0004317284,0.00015324197,0.00012271533],"category_scores_gemma":[0.00061450276,0.00007229608,0.00026198165,0.0002901543,0.001315374,0.000036761183,0.00011067469,0.0007181204,0.000002605249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04440045,0.0017575115,0.90552366,0.00041325646,0.00027962026,0.0000016970826,0.00006467995,5.3028896e-7,0.001211323,0.00016730094,0.0006673369,0.04551266],"study_design_scores_gemma":[0.017714342,0.006220755,0.94592613,0.00020206433,0.0000669343,0.0000014869053,0.00002041427,0.000014666203,0.01574833,0.00034867556,0.013654689,0.000081528044],"about_ca_topic_score_codex":0.0002849236,"about_ca_topic_score_gemma":0.00009466965,"teacher_disagreement_score":0.045431133,"about_ca_system_score_codex":0.00006282786,"about_ca_system_score_gemma":0.0012143012,"threshold_uncertainty_score":0.48465505},"labels":[],"label_agreement":null},{"id":"W2138662111","doi":"10.1016/j.canep.2013.02.002","title":"Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis","year":2013,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé","keywords":"Medicine; Incidence (geometry); Demography; Stage (stratigraphy); Epidemiology; Mortality rate; Cancer; Bladder cancer; Proportional hazards model; Internal medicine","score_opus":0.1053071801249395,"score_gpt":0.4100337642303641,"score_spread":0.3047265841054246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138662111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099196,0.015665641,0.00014401283,0.0017541704,0.00022307283,0.00046060016,0.0003880389,0.000024433632,0.00034809625],"genre_scores_gemma":[0.9810617,0.016288908,0.00014960267,0.0010202157,0.00011241349,0.00040913426,0.00019851758,0.000022125601,0.0007373966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769306,0.00042573028,0.0007630976,0.0005252417,0.00013330756,0.00045953787],"domain_scores_gemma":[0.9983632,0.00062610937,0.0002722771,0.00037803402,0.00015316585,0.00020719256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005636023,0.0002539344,0.0013053025,0.0005028387,0.00003628834,0.0000056065137,0.00010039207,0.00016661941,0.0034575004],"category_scores_gemma":[0.00011582486,0.00019652571,0.00014374878,0.0011423664,0.00037325424,0.000097130986,0.000048340367,0.00022558581,0.000006966686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014403448,0.00008211581,0.991896,0.000094154915,0.0014978653,0.000009904366,0.0004113977,0.0015710656,0.00015568927,0.00021601382,0.0011004779,0.0028212834],"study_design_scores_gemma":[0.0015616602,0.0001464684,0.9910052,0.0000767976,0.0006584432,0.0000011444401,0.0004357753,0.002820608,0.0001976042,0.00083391205,0.0020966653,0.00016572047],"about_ca_topic_score_codex":0.074853405,"about_ca_topic_score_gemma":0.019015731,"teacher_disagreement_score":0.05583767,"about_ca_system_score_codex":0.00018721855,"about_ca_system_score_gemma":0.00015028,"threshold_uncertainty_score":0.9988847},"labels":[],"label_agreement":null},{"id":"W2139218362","doi":"10.5489/cuaj.1411","title":"Complications of Intravesical Bacillus Calmette-Guérin","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Sepsis; Urinary system; Urology; Surgery; Internal medicine; Cancer","score_opus":0.01715815868745009,"score_gpt":0.2500517414619498,"score_spread":0.23289358277449973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139218362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80538714,0.00022770601,0.0028965888,0.09993842,0.0006461073,0.00045402363,0.00013606853,0.00005546101,0.09025851],"genre_scores_gemma":[0.99383074,0.000017640168,0.00045953275,0.0050042565,0.00030803445,0.0000057363864,0.000015923011,0.0000076288948,0.0003505109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894834,0.000109542554,0.00028489262,0.0001210521,0.00024934785,0.00028680314],"domain_scores_gemma":[0.9987842,0.00011665108,0.00015573883,0.000110797315,0.00022753233,0.0006051175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032484907,0.000089630885,0.00024153302,0.00011076918,0.00013454919,0.000020475942,0.000086020525,0.00014899462,0.00045115783],"category_scores_gemma":[0.00050135015,0.00007028493,0.00011399207,0.00014481405,0.000039444436,0.000036186215,0.000007244109,0.0003281466,0.00007586318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078291756,0.00020772425,0.92748964,0.000010654669,0.00029571255,0.000027177677,0.00015997197,0.000032434185,0.0007077575,0.0053784,0.020094832,0.045517422],"study_design_scores_gemma":[0.0011850771,0.00047353483,0.88724524,0.000008002547,0.000086479806,0.00013995556,0.000014609345,0.00016805464,0.00009270808,0.00167501,0.10883833,0.00007300524],"about_ca_topic_score_codex":0.0008766112,"about_ca_topic_score_gemma":0.00031958506,"teacher_disagreement_score":0.18844362,"about_ca_system_score_codex":0.0005240638,"about_ca_system_score_gemma":0.00033129257,"threshold_uncertainty_score":0.4939862},"labels":[],"label_agreement":null},{"id":"W2139650877","doi":"10.1016/j.juro.2012.03.007","title":"Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Medicine; Cystoscopy; Bladder cancer; Urology; Term (time); Radiology; Cancer; Internal medicine; Urinary system","score_opus":0.023460940004464446,"score_gpt":0.3030388670640131,"score_spread":0.27957792705954865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139650877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878958,0.009099756,0.00016498315,0.0020030832,0.00031471037,0.00021409486,0.0000032500755,0.0000065889926,0.0002977732],"genre_scores_gemma":[0.9965152,0.0017444311,0.00017199924,0.0010713659,0.0003330922,0.00000999808,0.0000010585474,0.000017493134,0.00013536049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879676,0.0001846846,0.00030327978,0.000094576986,0.00022459913,0.0003961141],"domain_scores_gemma":[0.99906385,0.00011638224,0.0002305946,0.00021079188,0.0001249739,0.00025338185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004373165,0.00015250397,0.0003341126,0.00011927039,0.000045084562,0.000005166879,0.00017429091,0.000071822564,0.00037135565],"category_scores_gemma":[0.00006123691,0.000081311024,0.000046444457,0.00018115525,0.00015388968,0.00014205146,0.000027055808,0.00042276058,0.0000148694435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007255453,0.00055864087,0.9740772,0.00003415899,0.0002797576,0.00036296374,0.0015294848,0.00003616998,0.0046964544,0.000023284752,0.00035058067,0.010795828],"study_design_scores_gemma":[0.004708207,0.0020696898,0.983042,0.00015124508,0.00066710263,0.0037287588,0.000049584673,0.000018653467,0.005088031,0.00004691046,0.0003128044,0.00011703588],"about_ca_topic_score_codex":0.00014634286,"about_ca_topic_score_gemma":0.00009727403,"teacher_disagreement_score":0.010678792,"about_ca_system_score_codex":0.0000884455,"about_ca_system_score_gemma":0.00032526962,"threshold_uncertainty_score":0.4066084},"labels":[],"label_agreement":null},{"id":"W2140531006","doi":"10.1007/s00345-015-1566-8","title":"TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma","year":2015,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Stage (stratigraphy); Cohort; Internal medicine; Nephrology; Ureteral neoplasm; Oncology; T-stage; Urology; Overall survival; Cancer; Bladder cancer; Transitional cell carcinoma","score_opus":0.047621891702495,"score_gpt":0.30856649068658926,"score_spread":0.2609445989840943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140531006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849214,0.0010906546,0.0023973214,0.008465014,0.0017169152,0.0009716773,0.00023190038,0.000016341832,0.00018878734],"genre_scores_gemma":[0.99183905,0.000022043136,0.004361485,0.0018148419,0.0014407662,0.00009137019,0.00002128145,0.000029724797,0.00037945027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850327,0.00008868821,0.00064770406,0.0001875699,0.00027087363,0.00030192445],"domain_scores_gemma":[0.9987163,0.00027356076,0.00031856817,0.00014625794,0.0002734555,0.000271847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036088037,0.00018946851,0.0007485474,0.00024914002,0.000030814594,0.000007068163,0.00011971311,0.00017334794,0.00011876813],"category_scores_gemma":[0.00018654364,0.00012667822,0.0003902767,0.00009198999,0.0001622755,0.00008415274,0.00001895888,0.0002665881,0.0000019803747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029172622,0.0015972131,0.94752693,0.00009186504,0.0006314815,0.00022244685,0.0004052631,0.000020895068,0.0013139091,0.0004930124,0.014112533,0.004411811],"study_design_scores_gemma":[0.031482786,0.01790117,0.83791125,0.000037447546,0.001403269,0.0010203595,0.000036043195,0.000051435738,0.00088610785,0.002876944,0.106252745,0.00014042373],"about_ca_topic_score_codex":0.000016639879,"about_ca_topic_score_gemma":0.000018985467,"teacher_disagreement_score":0.10961568,"about_ca_system_score_codex":0.00013301449,"about_ca_system_score_gemma":0.00038243676,"threshold_uncertainty_score":0.5165788},"labels":[],"label_agreement":null},{"id":"W2142088661","doi":"10.1158/1078-0432.ccr-06-0372","title":"Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Cystectomy; Bladder cancer; Lymphovascular invasion; Urology; Lymphadenectomy; Proportional hazards model; Radiation therapy; Stage (stratigraphy); AJCC staging system; Carcinoma in situ; Lymph node; Surgery; Cancer; Oncology; Internal medicine; Metastasis","score_opus":0.14711538628860785,"score_gpt":0.4994884676199847,"score_spread":0.3523730813313769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142088661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800597,0.0028659876,0.0005419917,0.005735564,0.0011860443,0.0049823206,0.00022983713,0.00019795568,0.004200639],"genre_scores_gemma":[0.9854672,0.00018445397,0.0008583398,0.00039703128,0.0049690856,0.0033535145,0.00005741484,0.00008278719,0.00463015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961862,0.0003085264,0.00086142647,0.0008144061,0.0008310835,0.0009983542],"domain_scores_gemma":[0.9962496,0.0020529223,0.00010159543,0.000560235,0.0005947311,0.00044088348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023537162,0.00023401045,0.0006139862,0.00012415135,0.00021915948,0.000086370055,0.00024942105,0.00029874154,0.00047730096],"category_scores_gemma":[0.001553623,0.00018022068,0.00040207655,0.00040025476,0.00055258116,0.00012234466,0.00014235172,0.0009962565,0.000046227957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019622007,0.0020565805,0.80945265,0.0007808434,0.0004818263,0.00017111261,0.00013428465,0.0000027386363,0.0017887558,0.000111970534,0.014002017,0.1513952],"study_design_scores_gemma":[0.03569177,0.0066332715,0.49300328,0.0007271988,0.00051367737,0.0000335671,0.00016906607,0.0015410477,0.004072478,0.0017028193,0.45525387,0.00065797236],"about_ca_topic_score_codex":0.0039245025,"about_ca_topic_score_gemma":0.001068752,"teacher_disagreement_score":0.44125184,"about_ca_system_score_codex":0.00031143357,"about_ca_system_score_gemma":0.0012260663,"threshold_uncertainty_score":0.7349186},"labels":[],"label_agreement":null},{"id":"W2142799714","doi":"10.1016/j.urology.2009.07.1149","title":"POD-07.10: Outcome Analysis of Bladder Cancer Patients Treated with Radical Cystectomy in a Universal Health Care System: A Multicenter Canadian Series of 2,287 Patients","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; Western University; McGill University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Transitional cell carcinoma; Series (stratigraphy); General surgery; Surgery; Cancer; Internal medicine","score_opus":0.008315130316119003,"score_gpt":0.2604847092319774,"score_spread":0.2521695789158584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142799714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968709,0.000254259,0.0000030167796,0.00043814987,0.00005102631,0.00067668484,0.0005246492,0.0000181192,0.0011631954],"genre_scores_gemma":[0.99889827,0.0000105554345,0.000030238074,0.0006020265,0.000012564705,0.00001916657,0.0003151288,0.000015904197,0.000096131735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849755,0.000117114425,0.00047134,0.00030182875,0.00022402352,0.00038817464],"domain_scores_gemma":[0.99902505,0.000017988688,0.00020588325,0.00024025947,0.00025340513,0.00025739011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039030077,0.00019899388,0.000860736,0.0007040999,0.00003637032,0.0000025989,0.00008593433,0.0001300716,0.00025215335],"category_scores_gemma":[0.000013956977,0.00015394119,0.00010956524,0.0006387548,0.00010320048,0.000051853778,0.00001089468,0.00011869156,0.0000043795376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022178497,0.00036783703,0.99369496,0.00010044668,0.0009575093,0.00004317223,0.0017873457,0.0000765156,0.0000046264904,0.000013574147,0.000073975905,0.0006621677],"study_design_scores_gemma":[0.009901671,0.004436935,0.983013,0.00005231935,0.0014765111,0.0000023031682,0.0003776432,0.00011171958,0.00003482954,2.3036993e-7,0.0004850469,0.0001078175],"about_ca_topic_score_codex":0.17940104,"about_ca_topic_score_gemma":0.21395332,"teacher_disagreement_score":0.034552265,"about_ca_system_score_codex":0.00068473036,"about_ca_system_score_gemma":0.0004939856,"threshold_uncertainty_score":0.8260634},"labels":[],"label_agreement":null},{"id":"W2142850606","doi":"10.1016/s0022-5347(06)00317-x","title":"Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder","year":2006,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Transitional cell carcinoma; Urology; Carcinoma; Oncology; Bladder cancer; Internal medicine; Cancer","score_opus":0.01749416454586604,"score_gpt":0.2791744992545826,"score_spread":0.26168033470871654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142850606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860444,0.000758117,0.0013501735,0.009159727,0.0007111226,0.0007686789,0.00012936757,0.000004234883,0.0010741955],"genre_scores_gemma":[0.9955154,0.0000046743544,0.0005234451,0.0033123945,0.0004012705,0.000011058177,0.000008481819,0.000027757855,0.00019548272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997375,0.00044669947,0.001097884,0.00017075149,0.00060348376,0.00030617134],"domain_scores_gemma":[0.997993,0.00082783157,0.000457374,0.00036131864,0.00024848402,0.00011200217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074736314,0.00021763625,0.0007938771,0.00008379297,0.00014382292,0.000004591158,0.00042921962,0.00016022351,0.000093064315],"category_scores_gemma":[0.0000335738,0.00010600042,0.0011172837,0.00016239366,0.00036401636,0.000043715445,0.000044760487,0.0004541907,0.000002126974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009289016,0.0029927362,0.9416148,0.00019196601,0.0011586332,0.00007245192,0.0015605427,0.0013973567,0.032047797,0.00018573231,0.009164895,0.00032406274],"study_design_scores_gemma":[0.011726552,0.0012613047,0.97732717,0.000021972322,0.0019772495,0.00024870803,0.000095106516,0.000053506683,0.005869061,0.00041903704,0.00089797296,0.00010235686],"about_ca_topic_score_codex":0.00010669783,"about_ca_topic_score_gemma":0.00003792104,"teacher_disagreement_score":0.03571236,"about_ca_system_score_codex":0.000062128056,"about_ca_system_score_gemma":0.00060908415,"threshold_uncertainty_score":0.43225715},"labels":[],"label_agreement":null},{"id":"W2143211426","doi":"10.1016/j.juro.2015.02.1659","title":"PD25-10 RESIDENT INVOLVEMENT IN ENDOSCOPIC BLADDER CANCER SURGERY IS ASSOCIATED WITH INADEQUATE PATHOLOGY SPECIMENS AND PROLONGED TIME TO CYSTECTOMY","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Logistic regression; Surgical pathology; Cancer; General surgery; Urology; Surgery; Pathology; Internal medicine","score_opus":0.03511128025116646,"score_gpt":0.28003379654104704,"score_spread":0.2449225162898806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143211426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784585,0.0021120422,0.000008671027,0.018625114,0.00011406804,0.00038290775,0.000008229801,0.000007923155,0.00028251926],"genre_scores_gemma":[0.9933092,0.00020015602,0.000028897895,0.0048591727,0.0001399631,0.000023178209,0.0000022203456,0.000021534912,0.0014156678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848914,0.00037109954,0.00040600565,0.0001472876,0.00027434024,0.00031215113],"domain_scores_gemma":[0.9989388,0.00021716833,0.00026738277,0.0001690053,0.00021212145,0.00019553668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00098191,0.000158059,0.00055364805,0.00022826105,0.000032837004,0.0000071838886,0.000091824586,0.000094945724,0.00047886846],"category_scores_gemma":[0.00013810817,0.00009235026,0.00003959872,0.00020417289,0.00010323885,0.000050110273,0.000047468202,0.00028829055,0.000037500184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045558512,0.0017722315,0.7142129,0.000093037524,0.00539986,0.008532164,0.041796118,0.00044951148,0.014891592,0.000018997163,0.15950756,0.0077675],"study_design_scores_gemma":[0.028046845,0.018256549,0.9260004,0.0004250585,0.0026925008,0.002555643,0.0008452481,0.00008995219,0.005347036,0.0007199909,0.014557787,0.0004629455],"about_ca_topic_score_codex":0.00021399475,"about_ca_topic_score_gemma":0.0005186959,"teacher_disagreement_score":0.21178754,"about_ca_system_score_codex":0.00020979333,"about_ca_system_score_gemma":0.00048498152,"threshold_uncertainty_score":0.5243274},"labels":[],"label_agreement":null},{"id":"W2144151932","doi":"10.1186/s12885-015-1089-0","title":"Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer","year":2015,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Cytology; Urine cytology; Urine; Internal medicine; Surgical oncology; Urology; Urinary system; Tumor marker; Clinical significance; Gastroenterology; Cancer; Pathology","score_opus":0.0140165026924686,"score_gpt":0.27360953983140474,"score_spread":0.2595930371389361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144151932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958083,0.0012135485,0.000020976104,0.00006329393,0.00014620398,0.0010739887,0.0002938517,0.000015553278,0.0013642872],"genre_scores_gemma":[0.9982511,0.00013871277,0.00065478013,0.00004889811,0.000065102264,0.0002327387,0.000017068538,0.000036574977,0.00055505027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985476,0.00005983021,0.00033973416,0.00032440125,0.00044813525,0.00028027894],"domain_scores_gemma":[0.99880046,0.00008842954,0.0002411796,0.00023689815,0.0004992987,0.0001337601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080866484,0.00021345218,0.00051112793,0.00011122195,0.00001873147,0.0000035470673,0.00007846867,0.000060346065,0.00015420697],"category_scores_gemma":[0.00011345108,0.00016621176,0.0000528895,0.0004084634,0.00015023474,0.000100051984,0.000031933152,0.00012337239,0.0000031591485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009119491,0.0003299708,0.9880303,0.0002619104,0.00022301618,0.0000075922003,0.0006583775,0.00034613244,0.00021860818,0.0000035035532,0.00014329162,0.0006577681],"study_design_scores_gemma":[0.011602019,0.0009189873,0.9761778,0.0009809048,0.00011007529,0.0000016313714,0.00011858615,0.000030417204,0.009854473,0.000014206086,0.000030368681,0.00016053572],"about_ca_topic_score_codex":0.004700281,"about_ca_topic_score_gemma":0.0032374915,"teacher_disagreement_score":0.011852544,"about_ca_system_score_codex":0.0003961191,"about_ca_system_score_gemma":0.0006095212,"threshold_uncertainty_score":0.710545},"labels":[],"label_agreement":null},{"id":"W2144234476","doi":"10.1177/1756287209103923","title":"Review: Use of nomograms for predictions of outcome in patients with advanced bladder cancer","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nomogram; Medicine; Bladder cancer; Generalizability theory; Cystectomy; Clinical trial; Oncology; Cancer; Internal medicine; Statistics","score_opus":0.029200712434061183,"score_gpt":0.34598659169124524,"score_spread":0.31678587925718404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144234476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7281906,0.25285095,0.0068155774,0.0029634584,0.0005517846,0.0075976145,0.0002988466,0.000072575116,0.00065858115],"genre_scores_gemma":[0.9814334,0.014270859,0.0010350003,0.0029839918,0.000016386683,0.00018719133,0.000024272784,0.000016092315,0.00003278652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893326,0.0000372817,0.00046204677,0.00022010806,0.000118528485,0.00022879665],"domain_scores_gemma":[0.9993315,0.00009157461,0.0001818031,0.00024205787,0.000117149204,0.000035946843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006521592,0.0001471127,0.00056001585,0.00011550827,0.000012265658,8.3757527e-7,0.0000698617,0.0000628532,0.000036914178],"category_scores_gemma":[0.000025996038,0.00010821981,0.00006022327,0.00026310413,0.000112564776,0.00014293731,0.0000069367807,0.00011047112,3.5385813e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038271386,0.0009973272,0.78974444,0.00029864378,0.000092252434,0.0000014234316,0.00012304127,0.00095543155,0.0000485399,0.00014576627,0.000015324458,0.20375067],"study_design_scores_gemma":[0.014059988,0.0088108685,0.9459499,0.000576783,0.0004822057,0.0000032186936,0.000018070412,0.00012574925,0.00020248003,0.0010966479,0.028479006,0.00019507567],"about_ca_topic_score_codex":0.000030656218,"about_ca_topic_score_gemma":0.00011456551,"teacher_disagreement_score":0.25324282,"about_ca_system_score_codex":0.00005026939,"about_ca_system_score_gemma":0.00004939567,"threshold_uncertainty_score":0.44130754},"labels":[],"label_agreement":null},{"id":"W2145118120","doi":"10.1016/s1470-2045(13)70162-1","title":"Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Medicine; Tolerability; Response Evaluation Criteria in Solid Tumors; Internal medicine; Regimen; Metastatic Urothelial Carcinoma; Paclitaxel; Clinical endpoint; Adverse effect; Gastroenterology; Progressive disease; Refractory (planetary science); Phases of clinical research; Oncology; Progression-free survival; Chemotherapy; Bladder cancer; Cancer; Clinical trial; Urothelial carcinoma","score_opus":0.10664524640324281,"score_gpt":0.38548825514371515,"score_spread":0.27884300874047235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145118120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914436,0.0006044806,0.00005987929,0.0018742656,0.00027357275,0.004740172,0.00017314992,0.000040159033,0.0007907704],"genre_scores_gemma":[0.99563843,0.000018919232,0.00091541535,0.0005820418,0.00047735142,0.0013223877,0.000033362216,0.000035265093,0.0009768297],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984183,0.00021638592,0.00043299282,0.00030519284,0.00015803467,0.00046909708],"domain_scores_gemma":[0.9986592,0.00040812377,0.00017657343,0.0004960735,0.00012586724,0.00013415788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002184668,0.00023430849,0.0008984948,0.000051741903,0.00010412158,0.00001634778,0.00013006965,0.000052492764,0.00054445775],"category_scores_gemma":[0.000056228404,0.00013951701,0.000151402,0.00011878544,0.00015459322,0.00006676752,0.000027765474,0.00007076407,0.00006044465],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029481277,0.12845775,0.0636709,0.000580598,0.0048696534,0.00032256305,0.033371918,0.000015535812,0.60379046,0.0005576562,0.006032946,0.12884873],"study_design_scores_gemma":[0.40183094,0.26833233,0.055149633,0.000062324536,0.0070903436,0.00022789298,0.012394323,0.0015804443,0.19259728,0.0023700972,0.057619922,0.0007444522],"about_ca_topic_score_codex":0.0009591978,"about_ca_topic_score_gemma":0.0007145761,"teacher_disagreement_score":0.41119316,"about_ca_system_score_codex":0.00029316582,"about_ca_system_score_gemma":0.00016911092,"threshold_uncertainty_score":0.59614307},"labels":[],"label_agreement":null},{"id":"W2145623483","doi":"10.1158/0008-5472.can-10-1202","title":"MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Cystectomy; Medicine; Radiation therapy; Bladder cancer; Cohort; Oncology; Immunohistochemistry; Cancer; Internal medicine; Predictive marker; Survival analysis; Urology; Pathology","score_opus":0.10061902072895273,"score_gpt":0.42862922649996565,"score_spread":0.3280102057710129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145623483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827162,0.00788942,0.00055515283,0.0022639807,0.002282553,0.0026410674,0.00072735304,0.00006639466,0.00085785676],"genre_scores_gemma":[0.9876093,0.004926185,0.0007240985,0.00027763945,0.0022200088,0.0021349322,0.000038977694,0.00013001461,0.001938824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996861,0.0001268433,0.00036745958,0.0006884931,0.0011905326,0.0007656741],"domain_scores_gemma":[0.99782526,0.00048528795,0.00008853915,0.00062060734,0.00058778253,0.00039253407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000596221,0.00026518825,0.00059310114,0.00025153396,0.00026110077,0.000032932123,0.00029382945,0.00027447788,0.0028624577],"category_scores_gemma":[0.00012410711,0.00021235638,0.0003193169,0.0004493528,0.00042252927,0.00013939537,0.00006854367,0.0007920867,0.000008127211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024982868,0.00034327875,0.016398512,0.00019871918,0.0008648174,0.000041451465,0.002952927,0.0000058209584,0.92677885,0.000084437204,0.037390653,0.012442246],"study_design_scores_gemma":[0.014112531,0.00170748,0.019892868,0.0008304663,0.0002653295,0.000006758438,0.0008489347,0.00008712556,0.8027147,0.00036268623,0.15875162,0.0004195208],"about_ca_topic_score_codex":0.00074178743,"about_ca_topic_score_gemma":0.00038403794,"teacher_disagreement_score":0.12406418,"about_ca_system_score_codex":0.00040369158,"about_ca_system_score_gemma":0.0014552759,"threshold_uncertainty_score":0.9980491},"labels":[],"label_agreement":null},{"id":"W2146102224","doi":"10.1016/s1470-2045(02)00930-0","title":"The role of systemic chemotherapy in the management of muscle-invasive bladder cancer","year":2002,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Bladder cancer; Gemcitabine; Cystectomy; Oncology; Context (archaeology); Transitional cell carcinoma; Vinblastine; Internal medicine; Cisplatin; Clinical trial; Cancer; Surgery","score_opus":0.06863531054331733,"score_gpt":0.3817276324511727,"score_spread":0.31309232190785535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146102224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002087076,0.97606564,9.09669e-7,0.0012403687,0.00022916571,0.002338861,0.000058442474,0.000011286818,0.019846646],"genre_scores_gemma":[0.0034366217,0.9938548,0.000025954401,0.00048713834,0.0004772105,0.0010115877,0.000010073312,0.000038052123,0.00065852335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979664,0.00052551634,0.00063078786,0.00024528877,0.0002829853,0.00034904145],"domain_scores_gemma":[0.9978918,0.00056059676,0.0005579427,0.0009072325,0.00005522372,0.000027234459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006623445,0.00028798607,0.0018743234,0.000057128367,0.00006393915,0.000006358688,0.0007164707,0.00020609035,0.00013544872],"category_scores_gemma":[0.0000094845855,0.0001141985,0.00031861852,0.0003225478,0.0002324994,0.0000123358495,0.000063957166,0.0004042567,0.000019505409],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010843008,0.00017819798,0.00005188995,0.0066777356,0.001601411,0.000031658423,0.0013167945,9.21427e-7,0.0000033561153,0.0007445686,0.0015809786,0.98770404],"study_design_scores_gemma":[0.001883007,0.00034006915,0.00024561805,0.007985418,0.0021671893,0.000101683574,0.0010746054,0.0000016152597,0.00000953629,0.00019284805,0.9858975,0.00010092025],"about_ca_topic_score_codex":0.00026300809,"about_ca_topic_score_gemma":0.0001596522,"teacher_disagreement_score":0.9876031,"about_ca_system_score_codex":0.00029077113,"about_ca_system_score_gemma":0.00032634256,"threshold_uncertainty_score":0.46568796},"labels":[],"label_agreement":null},{"id":"W2146222484","doi":"10.1186/s13000-015-0234-z","title":"Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth","year":2015,"lang":"en","type":"article","venue":"Diagnostic Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; University of Calgary","funders":"","keywords":"Medicine; Ureter; Ureteral neoplasm; Biopsy; Urology; Carcinoma; Pathology; Cancer; Transitional cell carcinoma; Internal medicine; Bladder cancer","score_opus":0.03553490414338145,"score_gpt":0.28055262246592383,"score_spread":0.24501771832254238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146222484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480516,0.00076903484,0.001293932,0.00031543942,0.0004983402,0.0007579418,0.00013042708,0.000056142195,0.0013735585],"genre_scores_gemma":[0.99782896,0.00021734386,0.0006919973,0.00073297013,0.00016919676,0.00006746643,0.00013226479,0.000056357454,0.000103415565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789923,0.00014811817,0.0006438515,0.0004262433,0.00046160913,0.00042091595],"domain_scores_gemma":[0.99834543,0.00031556873,0.00030292483,0.00043872776,0.00032718387,0.0002701309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024907154,0.00031810076,0.00097174937,0.00021993413,0.000042856882,0.000006076067,0.0001812208,0.00021537274,0.00005500904],"category_scores_gemma":[0.00067991985,0.00023806903,0.0001390829,0.00024541395,0.00036307203,0.000089570545,0.00014576907,0.00020794911,0.000029084686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001068017,0.00076241983,0.9799656,0.0005218664,0.00022391276,0.0046315333,0.00061005424,0.000012158705,0.010044977,0.00009686648,0.0001613431,0.0019012517],"study_design_scores_gemma":[0.010749733,0.002924529,0.9584312,0.00049035606,0.00075301493,0.0017066754,0.000078241035,0.000021856127,0.024277791,0.0002607842,0.000015668698,0.0002901381],"about_ca_topic_score_codex":0.00017307783,"about_ca_topic_score_gemma":0.00003025104,"teacher_disagreement_score":0.021534387,"about_ca_system_score_codex":0.00012437055,"about_ca_system_score_gemma":0.00043904225,"threshold_uncertainty_score":0.9708173},"labels":[],"label_agreement":null},{"id":"W2146646572","doi":"10.1016/j.eururo.2009.09.024","title":"Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urothelial carcinoma; Urology; Cohort; Stage (stratigraphy); Chemotherapy; Lymph node; Oncology; Internal medicine; Surgery; Cancer","score_opus":0.017163952590407035,"score_gpt":0.2848521973894684,"score_spread":0.26768824479906134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146646572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957946,0.000011388737,0.000030032503,0.00055148,0.00014461379,0.00036161765,0.00051358703,0.000047754937,0.00254494],"genre_scores_gemma":[0.99718326,0.000018284805,0.00033426067,0.001450735,0.00022763034,0.0000025658417,0.00063346926,0.00003288604,0.00011692179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983948,0.00026329173,0.00047500926,0.0004469998,0.00023478703,0.00018512677],"domain_scores_gemma":[0.9990735,0.00009421773,0.00019574755,0.00033809306,0.000106062434,0.00019238281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015100853,0.00020286412,0.00049347256,0.00007201461,0.000033714055,0.0000104307155,0.00012364957,0.00006857412,0.00003781751],"category_scores_gemma":[0.00009074209,0.00013029986,0.000045442375,0.000056235644,0.00023998664,0.00006128071,0.000025467927,0.00020574822,0.000009008326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010796547,0.00077604305,0.98404753,0.0000020912744,0.00028586076,0.00029136767,0.00012529505,3.0827354e-7,0.00002388598,0.000012129182,0.000067831774,0.0035711005],"study_design_scores_gemma":[0.017162554,0.007518518,0.9729897,0.000010277359,0.00038602843,0.000019110366,0.0000043863624,0.000025680552,0.000037529207,0.00000520757,0.0017223028,0.00011871206],"about_ca_topic_score_codex":0.00009806899,"about_ca_topic_score_gemma":0.000015361342,"teacher_disagreement_score":0.011057846,"about_ca_system_score_codex":0.000020127236,"about_ca_system_score_gemma":0.000053938842,"threshold_uncertainty_score":0.5313474},"labels":[],"label_agreement":null},{"id":"W2147075353","doi":"10.1016/j.urology.2004.11.028","title":"Differences between urologists in United States and Canada in approach to bladder cancer","year":2005,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Cystoscopy; Bladder cancer; Demographics; Disease; Urology; General surgery; Gynecology; Cancer; Surgery; Internal medicine; Urinary system; Demography","score_opus":0.02394683873625351,"score_gpt":0.27770547092878556,"score_spread":0.25375863219253203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147075353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907315,0.0005607378,0.000026664347,0.007135669,0.00003754449,0.0002622873,0.000038409067,0.000012056421,0.0011951831],"genre_scores_gemma":[0.9929777,0.00019189304,0.00008478692,0.0063395435,0.000087067485,0.00007727809,0.000044582717,0.000009802133,0.00018735988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914527,0.000052225943,0.00016542712,0.00025227878,0.0000951736,0.00028964347],"domain_scores_gemma":[0.99967813,0.00006306573,0.00002164371,0.00010392696,0.000018292136,0.0001149194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053652566,0.000118603944,0.00026986163,0.00017769895,0.000016579057,0.000004073809,0.000057380264,0.000080728816,0.000049291684],"category_scores_gemma":[0.000018446586,0.00009499522,0.000009374727,0.00019004467,0.000052187886,0.000019342004,0.000029203244,0.00015974039,0.0000022863583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014699376,0.00007438091,0.9938614,0.000009604342,0.00003932065,0.000022327577,0.0005137479,0.00040747187,0.000010243736,0.000019398998,0.0006582825,0.004236875],"study_design_scores_gemma":[0.0016694313,0.00029183607,0.9837714,0.000005507609,0.00003971955,0.0000085887295,0.000075248056,0.00068097794,0.00005615556,0.0000437233,0.013260936,0.00009646909],"about_ca_topic_score_codex":0.7294959,"about_ca_topic_score_gemma":0.8797946,"teacher_disagreement_score":0.1502987,"about_ca_system_score_codex":0.000113839735,"about_ca_system_score_gemma":0.00020117538,"threshold_uncertainty_score":0.3873793},"labels":[],"label_agreement":null},{"id":"W2148011531","doi":"10.1093/carcin/21.4.783","title":"Calcium phosphate-containing precipitate and the carcinogenicity of sodium salts in rats","year":2000,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"National Cancer Institute","keywords":"Chemistry; Calcium; Sodium; Magnesium; Phosphate; Nuclear chemistry; Biochemistry; Inorganic chemistry; Organic chemistry","score_opus":0.023197387909402033,"score_gpt":0.2688184317975368,"score_spread":0.24562104388813474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148011531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862489,0.008604692,0.0000052234022,0.0005000949,0.00008139739,0.0006511348,0.000021968128,0.000021987953,0.0038646085],"genre_scores_gemma":[0.9978912,0.0006373454,0.00006592421,0.00045345695,0.00007746406,0.000078498044,0.000008069221,0.000026697115,0.0007613524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873006,0.00010828907,0.00034598168,0.00029986116,0.00021464493,0.0003011302],"domain_scores_gemma":[0.9993163,0.00011089622,0.000060753937,0.000330221,0.00006439185,0.000117481526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026860717,0.00019042219,0.0005057177,0.00007216515,0.00006928299,0.000010295752,0.000095481184,0.00007909971,0.00026305547],"category_scores_gemma":[0.000028557144,0.00012786807,0.00012671336,0.00022530452,0.00022465063,0.000053970547,0.00003116665,0.00010888408,0.000012845419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008657508,0.00017891175,0.9300913,0.00016167437,0.00023287076,0.000092252194,0.00547007,0.00002170282,0.007456807,0.00013697843,0.00013975847,0.04736015],"study_design_scores_gemma":[0.010809465,0.0003236753,0.8392842,0.00009446585,0.00036581518,0.000050414325,0.0003064202,0.00018215748,0.14786799,0.00016036452,0.00038760056,0.00016742009],"about_ca_topic_score_codex":0.0028220227,"about_ca_topic_score_gemma":0.00015515635,"teacher_disagreement_score":0.14041118,"about_ca_system_score_codex":0.00006748161,"about_ca_system_score_gemma":0.00013543798,"threshold_uncertainty_score":0.52143085},"labels":[],"label_agreement":null},{"id":"W2148228688","doi":"10.1007/s00345-007-0225-0","title":"Bladder cancer markers in patient management: the current perspective","year":2007,"lang":"en","type":"editorial","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Nephrology; Bladder cancer; Internal medicine; Perspective (graphical); Oncology; Cancer; Urology; Intensive care medicine","score_opus":0.010508281803608925,"score_gpt":0.31734358328687345,"score_spread":0.30683530148326454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148228688","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040640568,0.06889509,0.000023890098,0.003931547,0.9013229,0.00071255106,0.000055065768,0.000010317683,0.024642225],"genre_scores_gemma":[0.04288779,0.03830237,0.000111911446,0.0017721982,0.9134471,0.00008606209,0.000025825033,0.00012707528,0.0032397052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751586,0.00016018024,0.00070455944,0.00028829538,0.000903541,0.00042756638],"domain_scores_gemma":[0.9981272,0.00034396962,0.0006054484,0.00026677205,0.0005204345,0.0001361628],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000500454,0.0003147173,0.00067890383,0.00080110936,0.000053814278,0.000015050234,0.00025618105,0.00019887739,0.00043418258],"category_scores_gemma":[0.00010252414,0.00019939365,0.0002897118,0.0004045444,0.00015632717,0.0000437994,0.000074783115,0.0025433432,0.000013977584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032192194,0.00029869113,0.0003025161,0.00005068107,0.0011170629,0.001157868,0.00061186263,0.000018329216,5.1078575e-7,0.000055417047,0.8756715,0.11749635],"study_design_scores_gemma":[0.0033548472,0.00090837444,0.0032043825,0.00022590783,0.0012416769,0.000055650857,0.0002690945,0.0000020213013,0.0000020531256,0.00036033854,0.9902307,0.00014495986],"about_ca_topic_score_codex":0.0002138334,"about_ca_topic_score_gemma":0.0008622575,"teacher_disagreement_score":0.11735139,"about_ca_system_score_codex":0.0008982295,"about_ca_system_score_gemma":0.0006296465,"threshold_uncertainty_score":0.9997578},"labels":[],"label_agreement":null},{"id":"W2150267964","doi":"10.1016/j.eururo.2014.10.040","title":"Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Carcinoma in situ; Urology; Urinary system; Carcinoma; General surgery; Gynecology; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.03233820772248965,"score_gpt":0.3026795715473506,"score_spread":0.27034136382486096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150267964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021575863,0.98521686,9.879327e-7,0.000116699506,0.00016442011,0.0037521254,0.000024408831,0.000008697432,0.010500039],"genre_scores_gemma":[0.015338519,0.98351663,0.000012378979,0.00047222135,0.000053162556,0.00023489291,0.000008693638,0.00006355541,0.00029991977],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99702567,0.0011956572,0.0010525929,0.00034796025,0.0001848276,0.00019330892],"domain_scores_gemma":[0.9983862,0.00016099283,0.00059088547,0.0007733704,0.00003005425,0.000058464273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005597716,0.00032304603,0.0027085277,0.00011593553,0.000017091812,0.0000025253996,0.00026826398,0.00008213024,0.000044607044],"category_scores_gemma":[0.000067830806,0.0001864111,0.00042699324,0.00020098683,0.00012527964,0.000013052658,0.00018959325,0.00024272494,0.000035440273],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022491147,0.00054252933,0.0001932603,0.9738638,0.0003062896,0.0005467816,0.000038165326,3.5770203e-8,1.2843495e-7,0.00004868078,0.00015428117,0.024283558],"study_design_scores_gemma":[0.0012975666,0.001717612,0.0039223963,0.6739287,0.017708408,0.0011807962,0.0000047222916,2.7962346e-7,9.507179e-7,0.00000596528,0.30001187,0.00022077805],"about_ca_topic_score_codex":0.0000100357265,"about_ca_topic_score_gemma":0.0000014457247,"teacher_disagreement_score":0.29993513,"about_ca_system_score_codex":0.000035509827,"about_ca_system_score_gemma":0.00005517138,"threshold_uncertainty_score":0.7601624},"labels":[],"label_agreement":null},{"id":"W2150552573","doi":"10.5489/cuaj.1514","title":"Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma; Sanofi; Amgen","keywords":"Medicine; Cystectomy; Bladder cancer; Stage (stratigraphy); Urology; Hazard ratio; Internal medicine; Regimen; Multivariate analysis; Pathological; Oncology; Cancer; Confidence interval","score_opus":0.01209594211532362,"score_gpt":0.24400771165874088,"score_spread":0.23191176954341727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150552573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952364,0.00007023736,0.000068467496,0.0029703602,0.0003379297,0.00038184325,0.00038353621,0.000014042147,0.0005371969],"genre_scores_gemma":[0.9987739,0.00015105844,0.0001232257,0.00052292296,0.00027998016,0.00002302392,0.000031302217,0.000017535549,0.000077050354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981392,0.00026015445,0.00029534294,0.00026432922,0.0006542348,0.00038671374],"domain_scores_gemma":[0.99832964,0.00021170684,0.00039508933,0.00013837306,0.0003890961,0.00053611706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055903924,0.00017416637,0.0003243177,0.0001472299,0.00026458458,0.000040073908,0.00010193829,0.00017429779,0.00019664472],"category_scores_gemma":[0.00074269343,0.00012095822,0.000057735888,0.00017304005,0.00006177901,0.0001163644,0.000012067329,0.00059442234,0.000001874791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005957705,0.00009873186,0.9914001,0.000018480396,0.00014909529,0.000010930943,0.00028933832,0.000074671916,0.000033602395,0.000019554169,0.0007786018,0.0065311063],"study_design_scores_gemma":[0.004942393,0.0031483434,0.9902148,0.0001375706,0.0001636839,0.0000017984935,0.00006150303,0.0000636956,0.00020651399,0.00023210906,0.0007057907,0.00012176923],"about_ca_topic_score_codex":0.0033529403,"about_ca_topic_score_gemma":0.008090419,"teacher_disagreement_score":0.0064093373,"about_ca_system_score_codex":0.0005015365,"about_ca_system_score_gemma":0.0004973616,"threshold_uncertainty_score":0.5068665},"labels":[],"label_agreement":null},{"id":"W2150945950","doi":"10.1016/j.eursup.2008.08.001","title":"Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events","year":2008,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"Astellas Pharma; Amgen","keywords":"Medicine; Adverse effect; Bladder cancer; Intensive care medicine; Urology; Internal medicine; Cancer","score_opus":0.07457187294538084,"score_gpt":0.3895499089156888,"score_spread":0.31497803597030793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150945950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91664684,0.0018357461,0.008549633,0.043070085,0.0018920761,0.009056988,0.00048706104,0.000151262,0.018310336],"genre_scores_gemma":[0.9838613,0.0067488668,0.005271804,0.002334899,0.00010870399,0.00007352323,0.00024873586,0.00003078415,0.0013213363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857014,0.00040081152,0.00045088903,0.00024240337,0.00014905493,0.00018669556],"domain_scores_gemma":[0.9991542,0.00026414165,0.000200526,0.00022637336,0.00008856474,0.00006619725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007317675,0.00011725699,0.00019365943,0.000036002697,0.00016648263,0.0000015954455,0.00009482313,0.000037563368,0.0001773807],"category_scores_gemma":[0.00009300593,0.00008397304,0.00010474828,0.00007638005,0.00011056834,0.000065675515,0.00006829733,0.00012242304,0.00001718065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011665185,0.01181761,0.5187205,0.00015297056,0.01616544,0.00039466307,0.002897004,0.000008193882,0.00016261135,0.0015763238,0.1348269,0.3016126],"study_design_scores_gemma":[0.013053165,0.0029529866,0.61388934,0.000027752567,0.0008788911,0.000069075526,0.00022794852,0.000042705822,0.000045341265,0.00010795658,0.36860707,0.00009777783],"about_ca_topic_score_codex":0.000009133538,"about_ca_topic_score_gemma":0.0000027179171,"teacher_disagreement_score":0.3015148,"about_ca_system_score_codex":0.000020615265,"about_ca_system_score_gemma":0.000032892407,"threshold_uncertainty_score":0.34243214},"labels":[],"label_agreement":null},{"id":"W2151152705","doi":"10.5489/cuaj.10094","title":"Surgical management of bladder transitional cell carcinoma in a vesicular diverticulum: case report","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoscopy; Diverticulum (mollusc); Transitional cell carcinoma; Cystectomy; Gross hematuria; Urology; Surgery; Carcinoma; Urinary bladder; Bladder cancer; Internal medicine; Urinary system; Cancer","score_opus":0.01926629250053182,"score_gpt":0.2262980510552722,"score_spread":0.20703175855474037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151152705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746119,0.00021482776,0.000019363504,0.0011201397,0.000119385695,0.00019604516,0.000026913705,0.0000068967706,0.023684561],"genre_scores_gemma":[0.9988679,0.000025166371,0.00025368718,0.00038880424,0.00008865836,0.000011173938,0.000015556516,0.0000083548275,0.0003406794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986875,0.00009416118,0.00040678887,0.00017628886,0.00030117802,0.00033407155],"domain_scores_gemma":[0.99913657,0.000022462982,0.0001479073,0.00009659729,0.0001377883,0.00045867809],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003454003,0.000114589915,0.00024721384,0.00014350015,0.000083773004,0.0000099407935,0.000053845903,0.00015307353,0.0018972139],"category_scores_gemma":[0.00001644248,0.000093841154,0.00015144212,0.00017538763,0.000029542873,0.00005569402,0.000006747568,0.00028226268,0.00001883291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012410576,0.0002540409,0.63222516,0.000012615207,0.00013980661,0.3659321,0.00029380014,0.000006569412,0.000007816217,0.00010526846,0.0005910544,0.0003076547],"study_design_scores_gemma":[0.0032325648,0.0003259781,0.94382805,0.000014288551,0.00026008172,0.049928524,0.00023088598,0.000026161066,0.00016372719,0.00035503163,0.0015225942,0.00011211743],"about_ca_topic_score_codex":0.0037753223,"about_ca_topic_score_gemma":0.00045558022,"teacher_disagreement_score":0.3160036,"about_ca_system_score_codex":0.000574378,"about_ca_system_score_gemma":0.00026122958,"threshold_uncertainty_score":0.9990152},"labels":[],"label_agreement":null},{"id":"W2152331744","doi":"10.1155/2014/973406","title":"Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"Disease Markers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cytology; Cystoscopy; Bladder cancer; Urine cytology; Urine; Urology; Urinary system; Prospective cohort study; Urinalysis; Cancer; Pathology; Internal medicine","score_opus":0.008082869383222125,"score_gpt":0.26452622854527136,"score_spread":0.25644335916204924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152331744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933333,0.00015839326,0.0022183594,0.0003596701,0.00020872915,0.0027522792,0.00034550918,0.000031358915,0.0005924112],"genre_scores_gemma":[0.99764854,0.000053920892,0.0005056294,0.00054075377,0.000071148614,0.0009752726,0.000101768885,0.00003985225,0.000063109146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985419,0.000062021616,0.0003289369,0.00046142,0.0002795567,0.00032619515],"domain_scores_gemma":[0.99869645,0.00024958962,0.00014101097,0.00038496323,0.00018538737,0.00034260057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019171361,0.00021506166,0.00033509274,0.00014590028,0.000045215624,0.00000962365,0.00011899482,0.000036941015,0.000042547126],"category_scores_gemma":[0.0004302729,0.00020407436,0.000120504046,0.00029949806,0.000045832294,0.00006279888,0.000038247937,0.00006735856,0.000007979948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066557657,0.0002545859,0.91984934,0.00070361415,0.00012054814,0.0000029944968,0.000086910164,0.00010791536,0.00018499505,0.000006215989,0.0011674666,0.07085967],"study_design_scores_gemma":[0.0055147237,0.0005957188,0.9911878,0.00038061413,0.00011516418,1.6402288e-7,0.00004590761,0.0008276715,0.00029910533,0.00008322117,0.0007426197,0.00020726085],"about_ca_topic_score_codex":0.00031520415,"about_ca_topic_score_gemma":0.0006167271,"teacher_disagreement_score":0.07133851,"about_ca_system_score_codex":0.00023202722,"about_ca_system_score_gemma":0.00031053,"threshold_uncertainty_score":0.83219105},"labels":[],"label_agreement":null},{"id":"W2152455106","doi":"10.1016/j.eururo.2009.06.028","title":"Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":760,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Carcinoma in situ; Cystoscopy; Epidemiology; Disease; Stage (stratigraphy); Oncology; Internal medicine; Urology; Cancer; Urinary system","score_opus":0.08428718980636966,"score_gpt":0.40038776636539947,"score_spread":0.3161005765590298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152455106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026146928,0.9931884,0.000009341431,0.00041415816,0.00018735614,0.0018080797,0.0004013676,0.000024464154,0.0013521342],"genre_scores_gemma":[0.008456618,0.9897869,0.0001646376,0.0005795264,0.00032560152,0.00018563739,0.00028943058,0.00006570969,0.0001459385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650747,0.0011605329,0.00083909807,0.0009065885,0.0001015262,0.00048478256],"domain_scores_gemma":[0.99815255,0.00046731872,0.00037430628,0.0005254538,0.00004614955,0.00043419143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024316917,0.00053168926,0.0023044206,0.00024857593,0.000033699816,0.0000046464575,0.00016599482,0.00017370547,0.00011866576],"category_scores_gemma":[0.0002030786,0.00036962703,0.00023477932,0.00020915183,0.00013999436,0.000025910389,0.0000945165,0.00029489433,0.00006610254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002936481,0.00031036913,0.0026187703,0.00081162044,0.00021960515,0.00051809003,0.00012949234,0.0000056239337,0.0000016199024,0.000010926835,0.00022186355,0.9948584],"study_design_scores_gemma":[0.0028398614,0.009380648,0.10657619,0.009484064,0.0038739878,0.00003328402,0.000010943295,0.000006779561,0.0000031639836,0.0001388128,0.86712396,0.0005282907],"about_ca_topic_score_codex":0.00042650182,"about_ca_topic_score_gemma":0.00013274167,"teacher_disagreement_score":0.9943301,"about_ca_system_score_codex":0.00015770101,"about_ca_system_score_gemma":0.00056408596,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2152675128","doi":"10.1111/iju.12943","title":"Augmentation cystoplasty: Urodynamic and metabolic outcomes at 10‐year follow‐up","year":2015,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hand and Upper Limb Clinic","funders":"","keywords":"Medicine; Renal function; Urology; Urinary system; Complication; Bladder augmentation; Neurogenic bladder dysfunction; Nephrology; Surgery; Urinary bladder; Internal medicine","score_opus":0.024150820584502183,"score_gpt":0.3205973912507014,"score_spread":0.2964465706661992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152675128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879153,0.00086709444,0.00022529326,0.0069924123,0.0020319726,0.0000744815,0.000016485283,0.000008729338,0.0018682377],"genre_scores_gemma":[0.99468994,0.00011593971,0.0003157943,0.0016459823,0.00025618324,0.0000026575397,0.000014719858,0.000010982636,0.0029478087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991593,0.00003947995,0.00026329487,0.00009712137,0.00034400306,0.00009679564],"domain_scores_gemma":[0.9991566,0.000045788,0.00017474456,0.00006212465,0.0004276704,0.0001330873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013787784,0.00008896536,0.00023204504,0.0001712453,0.0000167239,0.000011871845,0.00008701062,0.000051566538,0.00027075372],"category_scores_gemma":[0.00014598067,0.00006716777,0.00008303586,0.00003279809,0.000044269153,0.00010174048,0.000042575903,0.00009641886,0.00005299134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011040721,0.00037813908,0.9445734,0.000009010118,0.0032045855,0.00088903063,0.0015918231,0.000081117345,0.0035607906,0.0016527368,0.013813923,0.019204736],"study_design_scores_gemma":[0.04605783,0.0035323761,0.8038912,0.000025168023,0.0011493987,0.0084931785,0.00037016097,0.00023844176,0.001560225,0.0029716264,0.13146439,0.0002460092],"about_ca_topic_score_codex":0.000025604859,"about_ca_topic_score_gemma":0.000028176091,"teacher_disagreement_score":0.1406822,"about_ca_system_score_codex":0.00010695786,"about_ca_system_score_gemma":0.000120206765,"threshold_uncertainty_score":0.29645634},"labels":[],"label_agreement":null},{"id":"W2153259455","doi":"10.1586/era.12.140","title":"Cause–effect? Understanding the risk factors associated with bladder cancer","year":2012,"lang":"en","type":"editorial","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Internal medicine; Cancer; Risk factor","score_opus":0.053259192481108296,"score_gpt":0.3702735817520474,"score_spread":0.3170143892709391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153259455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094448053,0.74236006,0.00008017893,0.00070786965,0.2517215,0.0027225974,0.00056317117,0.00008750443,0.0008126612],"genre_scores_gemma":[0.009772108,0.78758085,0.000011058804,0.00088316726,0.20051043,0.00040968886,0.0002803252,0.00017447009,0.0003779104],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612105,0.0004447225,0.0006281485,0.000558274,0.0016140059,0.0006337718],"domain_scores_gemma":[0.99649286,0.0012407888,0.0008629907,0.0008691765,0.00033278202,0.00020140076],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066201005,0.0008077347,0.002002935,0.00008344929,0.00022212227,0.000029940253,0.00034232513,0.00047657755,0.0015994426],"category_scores_gemma":[0.00031438287,0.0003773598,0.0005514821,0.00044284484,0.00036099541,0.00010894268,0.000036715202,0.0009745919,0.0000071943937],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056756794,0.00029634676,0.0075897467,0.0015421319,0.008279884,0.000008319617,0.0010690071,3.4076254e-7,0.000046249694,0.000008700953,0.9754196,0.005172107],"study_design_scores_gemma":[0.004741809,0.0017606649,0.0017059349,0.03080883,0.0038257083,0.0000021707974,0.00013282604,0.0000015696426,0.0010146273,0.0000168775,0.955313,0.0006759568],"about_ca_topic_score_codex":0.0013734612,"about_ca_topic_score_gemma":0.00011397511,"teacher_disagreement_score":0.051211055,"about_ca_system_score_codex":0.00097143435,"about_ca_system_score_gemma":0.00097400544,"threshold_uncertainty_score":0.99986786},"labels":[],"label_agreement":null},{"id":"W2153481935","doi":"10.1016/j.eururo.2015.07.034","title":"Fine-tuning Risk Stratification for Non–Muscle-invasive Bladder Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Trapping; Positron; Doping; Positron annihilation; Spectroscopy; Chalcogenide; Chalcogen; Medicine; Atomic physics; Molecular physics; Condensed matter physics; Crystallography; Materials science; Physics; Optoelectronics; Nuclear physics; Chemistry; Electron","score_opus":0.041971260394933596,"score_gpt":0.2991049233562622,"score_spread":0.2571336629613286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153481935","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077658994,0.0041668075,0.0029406345,0.8502679,0.0049484917,0.0050315703,0.0027835586,0.0004904932,0.12160463],"genre_scores_gemma":[0.07546584,0.000631397,0.0010857955,0.8541718,0.02914241,0.0006416549,0.0050137495,0.00066740403,0.03317995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976002,0.00035663668,0.0004366202,0.00078735204,0.00027096362,0.00054823153],"domain_scores_gemma":[0.9981833,0.00022840734,0.00039021042,0.00069422903,0.00035957695,0.00014426638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002987247,0.00045410733,0.00059770443,0.00017327265,0.00012589461,0.000030783856,0.00024563173,0.0004226095,0.00041168506],"category_scores_gemma":[0.00022708983,0.0003959642,0.0002171186,0.00011079806,0.0001290458,0.000049882074,0.000057244746,0.0012666121,0.00042189012],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017480188,0.00004895168,0.00060663314,0.000116906405,0.0005411017,0.00045592303,0.0003612237,0.0000144661635,0.0002846931,0.000004433002,0.986746,0.0106448345],"study_design_scores_gemma":[0.0028709979,0.0013640587,0.0049544456,0.000052497002,0.0017080584,0.000052754815,0.000016765085,0.000061290026,0.000105822975,0.00014726509,0.9883211,0.00034491424],"about_ca_topic_score_codex":0.00015210471,"about_ca_topic_score_gemma":0.00010848862,"teacher_disagreement_score":0.088424675,"about_ca_system_score_codex":0.00013829317,"about_ca_system_score_gemma":0.0005836464,"threshold_uncertainty_score":0.9998492},"labels":[],"label_agreement":null},{"id":"W2153987453","doi":"10.1016/j.urology.2014.03.034","title":"Re: Jarow JP et al.: Clinical Trial Design For the Development of New Therapies for Non–muscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop (Urology 2014;83:262-265)","year":2014,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Campbell Scientific (Canada)","funders":"","keywords":"Medicine; Food and drug administration; Clinical trial; Bladder cancer; Drug development; Family medicine; Drug; Cancer; Internal medicine; Pharmacology","score_opus":0.10401615486439661,"score_gpt":0.3740220195713119,"score_spread":0.27000586470691534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153987453","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034914397,0.0014011755,0.022530396,0.935714,0.00084026606,0.004436004,0.00008880253,0.000032476546,0.00004248954],"genre_scores_gemma":[0.4865126,0.001909427,0.00635062,0.4991247,0.0026179778,0.0022513028,0.0005400212,0.00010620423,0.0005871339],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655676,0.00057331304,0.001285733,0.0007907213,0.00031203718,0.00048143254],"domain_scores_gemma":[0.99033904,0.006951026,0.0018329871,0.00041520942,0.00034552522,0.0001162269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020345163,0.0003891193,0.0013668536,0.00013452624,0.00011749587,0.000024158422,0.00018120593,0.00083640567,0.000039190385],"category_scores_gemma":[0.001746975,0.00027227137,0.00024755337,0.00010077131,0.00042982548,0.0000472784,0.000059632297,0.0007335001,6.651136e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026392339,0.0002611423,0.004670924,0.00009408184,0.003267716,0.000020656795,0.0010404853,0.0000037481614,0.000033396598,0.000026012533,0.9388839,0.025305584],"study_design_scores_gemma":[0.032438014,0.02413961,0.0060169953,0.00002205967,0.0024014935,0.000074468364,0.00012785061,0.000090811656,0.00015103213,0.00090639223,0.9332732,0.00035806355],"about_ca_topic_score_codex":0.00005490432,"about_ca_topic_score_gemma":0.00060078,"teacher_disagreement_score":0.45159823,"about_ca_system_score_codex":0.00007294389,"about_ca_system_score_gemma":0.0021402724,"threshold_uncertainty_score":0.99997294},"labels":[],"label_agreement":null},{"id":"W2154723247","doi":"10.1097/spc.0b013e328309c72c","title":"Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond","year":2008,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Oncology; Transitional cell carcinoma; Cisplatin; Internal medicine; Urothelium; Carcinoma; Chemotherapy; Cancer research; Cancer; Bladder cancer; Urinary bladder","score_opus":0.1300291474484849,"score_gpt":0.39560367400416035,"score_spread":0.2655745265556755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154723247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018301303,0.9910823,0.00006834754,0.000039341507,0.00045483172,0.0033791887,0.0030820328,0.0000041956646,0.000059601352],"genre_scores_gemma":[0.024916418,0.9736366,0.00003109208,0.000020823429,0.00012490783,0.00059545616,0.0006026131,0.00003353589,0.000038551658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851763,0.00012674613,0.00052482623,0.00042849177,0.00019872194,0.00020360954],"domain_scores_gemma":[0.99897647,0.00025791288,0.0002984189,0.00016031352,0.00021069747,0.000096201395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066654895,0.00037489212,0.0011971086,0.00012313727,0.000104889084,0.00001012999,0.00006393454,0.00010561531,0.000023176492],"category_scores_gemma":[0.000018464356,0.00023077532,0.00023966942,0.00016750957,0.00018572838,0.000043162694,0.000030475181,0.00022381668,5.2732395e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007878268,0.00067966885,0.06253324,0.28602076,0.00076816516,0.000011280461,0.017558794,0.0000014183893,0.0000040195364,0.0002814896,0.0012281166,0.6301252],"study_design_scores_gemma":[0.018143049,0.0031767245,0.019837206,0.05314924,0.0018612316,0.00018432293,0.0025406498,0.000021841272,0.00012785467,0.00026811435,0.89971983,0.0009699385],"about_ca_topic_score_codex":0.000016007374,"about_ca_topic_score_gemma":0.000004972774,"teacher_disagreement_score":0.89849174,"about_ca_system_score_codex":0.00008324427,"about_ca_system_score_gemma":0.00042521785,"threshold_uncertainty_score":0.94107443},"labels":[],"label_agreement":null},{"id":"W2154997696","doi":"10.1016/j.eururo.2010.01.015","title":"Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cancer; Lymph node; Lymph; Internal medicine; Carcinoma; Cohort; Urology; Oncology; Surgery; Pathology","score_opus":0.02384119592272884,"score_gpt":0.26682718451557796,"score_spread":0.24298598859284912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154997696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926295,0.00007323238,0.00004599787,0.000969175,0.00029766336,0.00030879205,0.00002993811,0.000031274012,0.005614391],"genre_scores_gemma":[0.9982507,0.000017513803,0.00006000787,0.0011143453,0.00006635083,0.000006835299,0.000015860693,0.000042878837,0.000425496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998763,0.00022130359,0.00033492723,0.00024363058,0.00022726199,0.00020982794],"domain_scores_gemma":[0.9989919,0.00008529985,0.0002948108,0.0004063134,0.00015516995,0.00006650552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028916728,0.0001480745,0.00029800643,0.000071852875,0.00006160981,0.0000049152027,0.00016386701,0.00006239203,0.00048356314],"category_scores_gemma":[0.00012864708,0.00009410192,0.000085588166,0.00023691666,0.0001848389,0.000042385116,0.000053371252,0.00028879326,0.000016389993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036305943,0.0003441255,0.857183,0.000034407596,0.00034985342,0.000044583394,0.0024453658,0.000050639177,0.13409194,0.000052751893,0.0003810563,0.0046592243],"study_design_scores_gemma":[0.002664013,0.00048686308,0.9558396,0.00003094989,0.00048408753,0.000013544192,0.00008203098,0.00005815849,0.039116625,0.000029033046,0.001080872,0.00011424408],"about_ca_topic_score_codex":0.00018842898,"about_ca_topic_score_gemma":0.00020383364,"teacher_disagreement_score":0.09865659,"about_ca_system_score_codex":0.000023531322,"about_ca_system_score_gemma":0.00008693819,"threshold_uncertainty_score":0.52946776},"labels":[],"label_agreement":null},{"id":"W2155002005","doi":"10.14440/bladder.2015.55","title":"Peri-operative mortality and long-term survival after partial versus radical cystectomy for muscle invasive bladder cancer","year":2015,"lang":"en","type":"article","venue":"Bladder","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Propensity score matching; Bladder cancer; Urology; Proportional hazards model; Surgery; Survival rate; Internal medicine; Cancer","score_opus":0.09584578970275748,"score_gpt":0.3747818753265794,"score_spread":0.27893608562382194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155002005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992766,0.0020527765,0.00021339285,0.000777841,0.0011436988,0.0013541693,0.00023031475,0.00007107818,0.0013907225],"genre_scores_gemma":[0.9958604,0.00012637873,0.000188282,0.0006313912,0.001197364,0.0010340725,0.00006887525,0.000058862475,0.00083434925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817127,0.00008397473,0.00029028382,0.00056993496,0.00041605314,0.00046846538],"domain_scores_gemma":[0.9987159,0.0001167008,0.00006564907,0.00033695422,0.00024313606,0.00052168296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015717553,0.00032931982,0.00048979477,0.000056600944,0.00010085647,0.000057511654,0.00008268307,0.00017514174,0.0008128988],"category_scores_gemma":[0.00012592398,0.00026194067,0.00014290365,0.00011229298,0.0002799915,0.00017814395,0.00007134277,0.0001775299,0.000036547593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019165903,0.0015185539,0.94038874,0.00040706343,0.006118929,0.0007958247,0.009579315,0.000013444856,0.002174407,0.00024860832,0.0074808355,0.012108365],"study_design_scores_gemma":[0.04268067,0.0025660316,0.9330536,0.00014737181,0.0024124295,0.00004598046,0.00089774386,0.000069573514,0.0079297675,0.00007866097,0.0093484,0.00076975784],"about_ca_topic_score_codex":0.0005684986,"about_ca_topic_score_gemma":0.0019172076,"teacher_disagreement_score":0.023514766,"about_ca_system_score_codex":0.00018292127,"about_ca_system_score_gemma":0.0006201035,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2158384054","doi":"10.1007/s00345-012-0947-5","title":"Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma","year":2012,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphadenectomy; Urothelial carcinoma; Nephrology; MEDLINE; Predictive modelling; Oncology; Internal medicine; Intensive care medicine; Machine learning; Cancer; Computer science; Bladder cancer","score_opus":0.05760905496858305,"score_gpt":0.3808703364940711,"score_spread":0.32326128152548805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158384054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003712316,0.9930861,0.0008871411,0.0000326176,0.0008033537,0.0011279114,0.00020353381,0.000004943122,0.00014206617],"genre_scores_gemma":[0.095038265,0.9014921,0.0019874324,0.00019784382,0.0011372459,0.000024880243,0.000022524056,0.00007082891,0.000028851773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974405,0.0001838952,0.0014770891,0.0002565357,0.000338786,0.00030317894],"domain_scores_gemma":[0.99509794,0.002551645,0.0014898959,0.00021241663,0.00045003812,0.00019806708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067966303,0.00033062152,0.0024794613,0.0003748601,0.00004897815,0.000013663921,0.00014438828,0.00026465498,0.00007320475],"category_scores_gemma":[0.00031633896,0.00020079261,0.00058844354,0.00014022375,0.00016529759,0.00014128488,0.000028771223,0.0006460586,0.0000015797026],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043995134,0.0005217643,0.04067317,0.0011611031,0.0009009747,0.00003482085,0.000089518435,5.71296e-7,3.5006025e-8,0.000010686248,0.00017143863,0.9520364],"study_design_scores_gemma":[0.0060938094,0.006912328,0.030290337,0.0043651224,0.012205356,0.00053442444,0.000011586785,0.0000027529418,1.3241565e-7,0.000076126984,0.9393209,0.00018712807],"about_ca_topic_score_codex":0.0000012815005,"about_ca_topic_score_gemma":0.0000032302228,"teacher_disagreement_score":0.9518493,"about_ca_system_score_codex":0.00007406547,"about_ca_system_score_gemma":0.00063423056,"threshold_uncertainty_score":0.8188085},"labels":[],"label_agreement":null},{"id":"W2158982666","doi":"10.1245/s10434-012-2499-8","title":"Risk of Cancer-specific Mortality following Recurrence After Radical Nephroureterectomy","year":2012,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Hazard ratio; Proportional hazards model; Cancer; Surgery; Stage (stratigraphy); Adjuvant therapy; Internal medicine; Surgical oncology; Lymph node; Urology; Confidence interval","score_opus":0.08993867097557312,"score_gpt":0.4129012502940499,"score_spread":0.3229625793184768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158982666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97488767,0.0151033,0.000014453831,0.0014252097,0.00054187694,0.00024965286,0.00007582567,0.000016702728,0.007685304],"genre_scores_gemma":[0.9842236,0.014715596,0.00023416846,0.00029027963,0.0003791674,0.000063483756,0.000008970816,0.000013535764,0.00007118391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842125,0.00020270559,0.0004699683,0.0002089935,0.00029781295,0.00039924314],"domain_scores_gemma":[0.9989291,0.00023296372,0.00020140765,0.00024947562,0.000102974576,0.00028406546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047877594,0.0001556118,0.0007259749,0.000064052794,0.000026735686,0.000002114033,0.00008539786,0.00019651088,0.0010455975],"category_scores_gemma":[0.000022263775,0.000117741474,0.0003869248,0.00018733171,0.00023613828,0.000092933704,0.00004328282,0.0002381608,0.000016470814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019109845,0.0010797146,0.90626824,0.000059426773,0.00068858924,0.00016867655,0.00035808227,6.216316e-7,0.00021643483,0.00012919483,0.0025357995,0.08658423],"study_design_scores_gemma":[0.0024374085,0.0009453782,0.4961551,0.000103469174,0.00033394495,0.0000294431,0.000027933687,0.000002493544,0.0065981,0.00013790811,0.49310973,0.000119089345],"about_ca_topic_score_codex":0.00049808604,"about_ca_topic_score_gemma":0.000025106627,"teacher_disagreement_score":0.4905739,"about_ca_system_score_codex":0.00004811743,"about_ca_system_score_gemma":0.00016657318,"threshold_uncertainty_score":0.99986756},"labels":[],"label_agreement":null},{"id":"W2159399461","doi":"10.1111/codi.13039","title":"Near‐infrared fluorescence laparoscopy‐ technical description of PINPOINT<sup>®</sup> a novel and commercially available system","year":2015,"lang":"en","type":"article","venue":"Colorectal Disease","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rick Hansen Foundation","funders":"","keywords":"Indocyanine green; Medicine; Laparoscopy; Fluorescence; Laparoscopes; Fluorescence-lifetime imaging microscopy; Endoscopy; Infrared; Medical physics; Nuclear medicine; Biomedical engineering; Radiology; Surgery; Optics; Physics","score_opus":0.035917633380949,"score_gpt":0.26694085647950355,"score_spread":0.23102322309855455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159399461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886776,0.0009747331,0.00015347023,0.00017534838,0.00013122705,0.0009963647,0.00020991937,0.00016617887,0.00832497],"genre_scores_gemma":[0.99716693,0.000021658303,0.0017535082,0.00015093492,0.00008126661,0.000106823754,0.00006095323,0.000028340424,0.00062958646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987559,0.000044426586,0.0002848479,0.00032324024,0.00034046857,0.00025112453],"domain_scores_gemma":[0.9987148,0.000028619092,0.000075860655,0.00028541885,0.00019423329,0.00070104457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001390091,0.00019131921,0.00037868007,0.00006170583,0.00008063472,0.000039683546,0.000096590185,0.0000937922,0.00005668772],"category_scores_gemma":[0.00019157816,0.00016655875,0.000085419575,0.00019978828,0.00025234418,0.00014171368,0.00008030615,0.000121420315,0.000070639486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058496762,0.0071502696,0.7031905,0.004590905,0.00067859277,0.0007784267,0.0037604163,0.00018043177,0.11349151,0.0020982842,0.100515425,0.005068439],"study_design_scores_gemma":[0.039513927,0.01002836,0.8427652,0.0044682506,0.0040624975,0.00053273747,0.0022879776,0.06678248,0.017927472,0.00057540246,0.009309836,0.0017458407],"about_ca_topic_score_codex":0.00017640743,"about_ca_topic_score_gemma":0.0000071083346,"teacher_disagreement_score":0.13957469,"about_ca_system_score_codex":0.00021968495,"about_ca_system_score_gemma":0.00070680154,"threshold_uncertainty_score":0.67920685},"labels":[],"label_agreement":null},{"id":"W2159433570","doi":"10.1093/annonc/mdu204","title":"Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Bladder cancer; Carboplatin; Gemcitabine; Hazard ratio; Cystectomy; Internal medicine; Oncology; Cancer registry; Regimen; Population; Vinblastine; Cancer; Chemotherapy; Confidence interval; Surgery; Cisplatin","score_opus":0.11257244180116344,"score_gpt":0.4948351416433074,"score_spread":0.38226269984214395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159433570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330953,0.001507621,0.00026999952,0.032068897,0.0003284115,0.00092170003,0.000056358764,0.000011721853,0.031739995],"genre_scores_gemma":[0.98443204,0.0022399565,0.002463776,0.010098055,0.00025428977,0.00007654352,0.000006544601,0.000015381975,0.0004134019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894416,0.00014000596,0.00046892161,0.00018304153,0.00009918811,0.00016467106],"domain_scores_gemma":[0.99853545,0.00057315285,0.00021336332,0.00014793698,0.00047001324,0.0000601049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006186955,0.000093942625,0.00056299235,0.00005474836,0.0000138940095,0.0000013672634,0.000057548415,0.0001425001,0.00022130222],"category_scores_gemma":[0.0003985303,0.000074911804,0.00012158949,0.00008432274,0.00012836106,0.000058215206,0.000013637022,0.00010851238,0.000002713992],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018386535,0.005417894,0.09672143,0.00017610002,0.0014416531,0.000018589299,0.0035814582,0.000036530007,0.004317144,0.0018715926,0.010404397,0.8576267],"study_design_scores_gemma":[0.031897217,0.034738474,0.20643929,0.00018288336,0.00042044974,0.000028627888,0.001029106,0.00058135675,0.037878565,0.00028836948,0.6862724,0.0002432969],"about_ca_topic_score_codex":0.000508945,"about_ca_topic_score_gemma":0.00016593716,"teacher_disagreement_score":0.8573834,"about_ca_system_score_codex":0.000028480561,"about_ca_system_score_gemma":0.0004346412,"threshold_uncertainty_score":0.30548146},"labels":[],"label_agreement":null},{"id":"W2159476925","doi":"10.1186/s12913-015-0972-3","title":"Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada","year":2015,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Bladder Cancer Canada; McGill University","keywords":"Medicine; Cystectomy; Total cost; Bladder cancer; Health economics; Indirect costs; Health care; Health administration; Retrospective cohort study; Public health; Population; General surgery; Emergency medicine; Surgery; Cancer; Nursing; Environmental health; Internal medicine","score_opus":0.07420605983892498,"score_gpt":0.4107307691471518,"score_spread":0.3365247093082268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159476925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847009,0.005532406,0.00002017098,0.0022913443,0.000040525116,0.007173564,0.00019099249,0.000017073116,0.000033030978],"genre_scores_gemma":[0.9971402,0.00003391952,0.00008929833,0.0015922729,0.00004594006,0.0007219333,0.00031514082,0.000024950015,0.000036295765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664694,0.0009189997,0.00040832657,0.0003568398,0.0011607836,0.0005080816],"domain_scores_gemma":[0.9980981,0.00034657956,0.00019092963,0.00025990725,0.0007929581,0.00031152708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011936851,0.00015566632,0.00043765272,0.00015788713,0.00023318472,0.000033355143,0.00016939131,0.0000612475,0.000004348153],"category_scores_gemma":[0.000032415217,0.00010284877,0.000016563063,0.00071257923,0.000040909395,0.000088441484,0.000027822047,0.00021669663,1.8659787e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018988701,0.0004420624,0.97583807,0.0030368473,0.000059882812,0.0000083609675,0.014642146,0.00005243492,4.8049924e-7,0.000008429776,0.0001104662,0.0039019485],"study_design_scores_gemma":[0.008493222,0.0024469823,0.9311057,0.0012019441,0.000028161747,0.0000011770348,0.054255076,0.001971858,0.000011563851,0.000004161274,0.0003945739,0.00008560842],"about_ca_topic_score_codex":0.9757786,"about_ca_topic_score_gemma":0.999309,"teacher_disagreement_score":0.0447324,"about_ca_system_score_codex":0.002808865,"about_ca_system_score_gemma":0.018997343,"threshold_uncertainty_score":0.98656404},"labels":[],"label_agreement":null},{"id":"W2159738538","doi":"10.1016/j.clgc.2014.08.010","title":"Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy","year":2014,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cisplatin; Hazard ratio; Perioperative; Internal medicine; Proportional hazards model; Gemcitabine; Chemotherapy; Oncology; Confidence interval; Anemia; Urology; Gastroenterology; Surgery","score_opus":0.05456261629408484,"score_gpt":0.37659038282777574,"score_spread":0.3220277665336909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159738538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809811,0.005472964,0.002893723,0.003441279,0.0014468189,0.004264902,0.00034537722,0.00017526391,0.000978534],"genre_scores_gemma":[0.97338647,0.0012417373,0.00380969,0.012302659,0.0033689798,0.004022796,0.000117278316,0.0001822959,0.0015680977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99636894,0.0002675605,0.0010716469,0.0011065626,0.00046967238,0.0007156336],"domain_scores_gemma":[0.9969178,0.00096281973,0.0002955507,0.0009083911,0.00044049308,0.00047496037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004419055,0.0006724637,0.0011507544,0.00011678153,0.0002939215,0.000048844304,0.00027238936,0.00036511585,0.0013163328],"category_scores_gemma":[0.00018302164,0.00051002647,0.00083613524,0.00023317226,0.0003080262,0.000100702426,0.000033089895,0.00048587416,0.000050555114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09658166,0.004137147,0.33704746,0.00034760294,0.00070922764,0.00016219067,0.00042719068,0.0014702594,0.0019209677,0.000017526338,0.001996417,0.55518234],"study_design_scores_gemma":[0.15243211,0.05113437,0.419318,0.0007831271,0.00081748376,0.000024068371,0.000054048276,0.017825767,0.028731994,0.00022516008,0.32658845,0.0020654253],"about_ca_topic_score_codex":0.00007211825,"about_ca_topic_score_gemma":0.00005391915,"teacher_disagreement_score":0.5531169,"about_ca_system_score_codex":0.0002085764,"about_ca_system_score_gemma":0.0010581277,"threshold_uncertainty_score":0.9997351},"labels":[],"label_agreement":null},{"id":"W2160092994","doi":"10.1158/0008-5472.can-14-1531","title":"The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; National Institute on Aging; Instituto de Salud Carlos III; Stavros Niarchos Foundation; World Cancer Research Fund; Medical Research Council; U.S. Public Health Service; National Institutes of Health; Deutsche Krebshilfe; Hellenic Health Foundation; Institut National de la Santé et de la Recherche Médicale; Fondation de France; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; Bundesministerium für Bildung und Forschung; Purdue University; World Health Organization; Wellcome Trust; Cancer Research UK; British Heart Foundation; European Commission; Association pour la Recherche sur le Cancer; Cancerfonden","keywords":"Genome-wide association study; Bladder cancer; Cyclin E; Single-nucleotide polymorphism; Biology; Allele; Cancer research; Cancer; Cyclin D1; Oncology; Genetic association; Cell cycle; Genetics; Medicine; Gene; Genotype","score_opus":0.037376963235006215,"score_gpt":0.3738532822423926,"score_spread":0.3364763190073864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160092994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96475816,0.016775312,0.00011557435,0.014651335,0.0002958258,0.0011358985,0.00007626111,0.00006256128,0.0021290751],"genre_scores_gemma":[0.98744583,0.0039374316,0.000008990509,0.00052250864,0.00079879415,0.0008799404,0.000012472545,0.000036007063,0.0063580424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798787,0.00020915401,0.00013471376,0.00033392836,0.0008683323,0.00046601257],"domain_scores_gemma":[0.9985449,0.00033334567,0.00010171769,0.00025548914,0.00045987323,0.00030468107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055384554,0.0001359902,0.00017327265,0.000073753705,0.00048555332,0.00008695696,0.00008153313,0.00007030556,0.0002931897],"category_scores_gemma":[0.00017649797,0.00007904585,0.000040571816,0.00027816094,0.00017682026,0.00008634519,0.0000419507,0.000382815,0.000025194884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008114355,0.00023528888,0.7329662,0.00019324823,0.0014465745,0.000037163612,0.0005656711,0.00006974642,0.0026931386,0.0007316728,0.03943162,0.21351533],"study_design_scores_gemma":[0.008938376,0.0025960018,0.8041847,0.0007951089,0.0007923958,0.000008478842,0.0003503927,0.00045290717,0.0043728435,0.0030379947,0.17408149,0.00038936024],"about_ca_topic_score_codex":0.00087774574,"about_ca_topic_score_gemma":0.0008569622,"teacher_disagreement_score":0.21312596,"about_ca_system_score_codex":0.0005287329,"about_ca_system_score_gemma":0.00052316365,"threshold_uncertainty_score":0.37345326},"labels":[],"label_agreement":null},{"id":"W2160129064","doi":"10.1016/j.juro.2011.09.008","title":"The <i>FGFR3</i> Mutation is Related to Favorable pT1 Bladder Cancer","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Stage (stratigraphy); Internal medicine; Cancer; Univariate analysis; Urinary bladder; Bladder Neoplasm; Multivariate analysis; Carcinoma; Pathology; Urology; Gastroenterology; Biology","score_opus":0.02637007847949815,"score_gpt":0.29592698832360553,"score_spread":0.2695569098441074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160129064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92896324,0.007985465,0.00025900037,0.044160854,0.0012573753,0.00043756,0.00000816901,0.000019787623,0.01690856],"genre_scores_gemma":[0.9880386,0.0010737895,0.00007511697,0.008189779,0.00013381681,0.000006675208,3.711311e-7,0.000016526443,0.0024653408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991347,0.000118152086,0.00029795594,0.00007065597,0.0001753701,0.0002031613],"domain_scores_gemma":[0.9992446,0.00009658297,0.00018552448,0.00019248441,0.0001840406,0.00009681604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040071615,0.00009281202,0.00018279557,0.00004971096,0.0001363909,0.0000058364235,0.00016292512,0.000063400745,0.00068473746],"category_scores_gemma":[0.000040456605,0.00004344616,0.000073699746,0.0001427498,0.000084876025,0.000048321665,0.00002203823,0.0002645567,0.00008489855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043320987,0.0017952641,0.07282624,0.00007190614,0.011167523,0.0013925695,0.1400711,0.00068191113,0.029322226,0.00282781,0.474324,0.22219849],"study_design_scores_gemma":[0.021823758,0.026673982,0.3362279,0.00016124178,0.009171909,0.014211134,0.0042153914,0.00034212336,0.057769965,0.041638795,0.48701087,0.00075291947],"about_ca_topic_score_codex":0.0002504289,"about_ca_topic_score_gemma":0.000054979522,"teacher_disagreement_score":0.26340166,"about_ca_system_score_codex":0.0000425403,"about_ca_system_score_gemma":0.0001648637,"threshold_uncertainty_score":0.7497395},"labels":[],"label_agreement":null},{"id":"W2160379180","doi":"10.1016/j.urolonc.2013.12.012","title":"Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States","year":2014,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Bladder Cancer Advocacy Network","keywords":"Medicine; Gemcitabine; Bladder cancer; Carboplatin; Oncology; Internal medicine; Cisplatin; Chemotherapy; Cystectomy; Vinblastine; Lymphovascular invasion; Cancer","score_opus":0.04109061550821144,"score_gpt":0.33443319142500966,"score_spread":0.29334257591679824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160379180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646574,0.0011719897,0.00007248245,0.029345967,0.00011318041,0.00047396263,0.000022096765,0.000021280024,0.0041216146],"genre_scores_gemma":[0.9676072,0.006677038,0.0029772648,0.021644969,0.000108890876,0.0004319314,0.00013262742,0.000013774722,0.00040632286],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998582,0.0003248196,0.00030042697,0.00025900154,0.0002791172,0.00025460363],"domain_scores_gemma":[0.9986099,0.00086923933,0.00013394782,0.00021807053,0.00004640642,0.00012241541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074343145,0.00015819474,0.00027750948,0.000084742795,0.00016103775,0.000010822901,0.00020323777,0.00017020782,0.00015390427],"category_scores_gemma":[0.00011442619,0.00008391422,0.000033353575,0.0003880298,0.0010021025,0.00003376163,0.000055349756,0.00034253325,0.000004213044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003099606,0.0013168834,0.86514413,0.0002494322,0.0007851295,0.0004711498,0.008519703,0.00040371256,0.000244656,0.01742228,0.057224054,0.04790893],"study_design_scores_gemma":[0.0023809506,0.003059453,0.054248773,0.00018509004,0.0006359196,0.00012171822,0.004026906,0.0010142027,0.00017898552,0.0043603643,0.9296363,0.00015133599],"about_ca_topic_score_codex":0.0008360727,"about_ca_topic_score_gemma":0.0003074325,"teacher_disagreement_score":0.87241226,"about_ca_system_score_codex":0.000081372906,"about_ca_system_score_gemma":0.00022004473,"threshold_uncertainty_score":0.36922887},"labels":[],"label_agreement":null},{"id":"W2160754769","doi":"10.1016/j.juro.2014.02.2422","title":"PD35-09 TALL SCORE FOR PREDICTION OF ONCOLOGICAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR HIGH GRADE UPPER TRACT UROTHELIAL CARCINOMA","year":2014,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Urothelial carcinoma; Medicine; Cancer; Bladder cancer; Internal medicine","score_opus":0.029108295955528947,"score_gpt":0.28905781498474636,"score_spread":0.2599495190292174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160754769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98396754,0.0002965896,0.0059418776,0.007933145,0.000849307,0.0007987061,0.0001237054,0.000011222747,0.00007787676],"genre_scores_gemma":[0.99516743,0.00003602692,0.0011666742,0.0020813572,0.0013466901,0.000056968514,0.000011068435,0.000026367527,0.00010740668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862844,0.00018796699,0.0005493735,0.00013432762,0.00022324914,0.00027663825],"domain_scores_gemma":[0.9985356,0.00068159885,0.00031696828,0.00018502524,0.00015745912,0.00012339313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005982789,0.00017408087,0.0006293706,0.000099667974,0.000058386155,0.000005075872,0.0001643902,0.00020269936,0.00010742182],"category_scores_gemma":[0.00021162358,0.00009277306,0.00034473647,0.000047909627,0.00020870703,0.000056987552,0.000020086174,0.00027115564,0.0000019553179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06590956,0.0025235175,0.8919703,0.00025065162,0.0014577892,0.00007104429,0.001385584,0.00006324236,0.015134121,0.0009867799,0.007747201,0.012500217],"study_design_scores_gemma":[0.01696587,0.020439137,0.93428636,0.000024972214,0.0018574263,0.0010793091,0.000028855347,0.00017162622,0.0021254409,0.0030071666,0.019913059,0.000100788406],"about_ca_topic_score_codex":0.000020031623,"about_ca_topic_score_gemma":0.0000052711302,"teacher_disagreement_score":0.048943687,"about_ca_system_score_codex":0.000059555165,"about_ca_system_score_gemma":0.00014109383,"threshold_uncertainty_score":0.37831756},"labels":[],"label_agreement":null},{"id":"W2160781078","doi":"10.5489/cuaj.201","title":"Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal health care system","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Western University; Dalhousie University; McGill University","funders":"","keywords":"Cystectomy; Medicine; Lymphadenectomy; Bladder cancer; Lymphovascular invasion; Stage (stratigraphy); Concomitant; Chemotherapy; Urology; Surgery; General surgery; Cancer; Internal medicine; Metastasis","score_opus":0.010507212350541318,"score_gpt":0.23213574018165634,"score_spread":0.22162852783111503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160781078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868155,0.00011397938,0.0000017281852,0.012320051,0.000032730757,0.00042827456,0.000022365193,0.000007967847,0.00025736535],"genre_scores_gemma":[0.9978216,0.000031997835,0.000040798084,0.002004006,0.000028773173,0.000019699582,0.000018554527,0.0000067871206,0.000027763048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986064,0.0003054035,0.00028336624,0.00017490349,0.00027252114,0.00035744687],"domain_scores_gemma":[0.9991297,0.00012126028,0.00016801842,0.000048909857,0.00011589867,0.00041619365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001614941,0.00012208437,0.00035503382,0.00027474793,0.000062710074,0.000039432947,0.000048126167,0.0001340357,0.000037167978],"category_scores_gemma":[0.00010954274,0.00008292685,0.000026637796,0.0001806499,0.000021234431,0.00014533877,0.000006054186,0.00042143153,0.0000038824783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013645757,0.00009146604,0.9979871,0.0000106884345,0.000042773936,0.00014975293,0.00068015576,0.0000013090523,1.0288411e-7,0.000017845638,0.00007575951,0.0008066198],"study_design_scores_gemma":[0.006196102,0.0008855778,0.99059594,0.00009152622,0.00002080093,0.000053539985,0.0018405331,0.000023739032,1.2499673e-7,0.0000040167943,0.00021298105,0.000075100696],"about_ca_topic_score_codex":0.07522011,"about_ca_topic_score_gemma":0.0334369,"teacher_disagreement_score":0.041783214,"about_ca_system_score_codex":0.003381917,"about_ca_system_score_gemma":0.0005310252,"threshold_uncertainty_score":0.98420036},"labels":[],"label_agreement":null},{"id":"W2162130153","doi":"10.1016/j.eururo.2012.07.033","title":"Epidemiology and Risk Factors of Urothelial Bladder Cancer","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Epidemiology; Incidence (geometry); Risk factor; Disease; Bladder cancer; Cancer; Genetic predisposition; Malignancy; Environmental health; Internal medicine; Gynecology","score_opus":0.11074265965547934,"score_gpt":0.37335568263733554,"score_spread":0.2626130229818562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162130153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005014281,0.9902901,0.000023207383,0.00004738738,0.0006893605,0.0006836279,0.0004182755,0.000049024202,0.007297582],"genre_scores_gemma":[0.0013545459,0.99620414,0.00008217635,0.00026893735,0.00090782,0.00003470973,0.00009381623,0.00015115544,0.0009026935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960065,0.0019563176,0.00084342103,0.0005487619,0.000098836965,0.0005461659],"domain_scores_gemma":[0.9978179,0.0006545225,0.0006901147,0.0005040463,0.00004716702,0.0002862677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006228058,0.00052819424,0.002701691,0.00020171407,0.00005831893,0.0000018836909,0.00016755646,0.00031006188,0.0007997957],"category_scores_gemma":[0.00027054566,0.0003533897,0.00044399756,0.00012286838,0.00037153144,0.000028502905,0.00014613052,0.00065288186,0.00017254951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086141335,0.00015142631,0.034772325,0.0029020957,0.0022615714,0.00004308092,0.00019452878,3.7953384e-7,6.5743814e-7,0.00010172383,0.00066875474,0.9588173],"study_design_scores_gemma":[0.0006658593,0.0005873602,0.010723487,0.00033698976,0.010188911,0.00015608348,0.0000041180933,5.191037e-7,9.707328e-7,0.000017288832,0.9770913,0.00022709637],"about_ca_topic_score_codex":0.00035117418,"about_ca_topic_score_gemma":0.000013568782,"teacher_disagreement_score":0.97642255,"about_ca_system_score_codex":0.00004660506,"about_ca_system_score_gemma":0.00018443119,"threshold_uncertainty_score":0.9998918},"labels":[],"label_agreement":null},{"id":"W2162717580","doi":"10.1016/s0022-5347(05)65642-x","title":"MYCOBACTERIAL CELL WALL EXTRACT FOR TREATMENT OF CARCINOMA IN SITU OF THE BLADDER","year":2001,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Manitoba; Western University","funders":"","keywords":"Medicine; Carcinoma in situ; In situ; Carcinoma; Pathology; Cancer research; Oncology; Urology","score_opus":0.024299313628278387,"score_gpt":0.2788062156766604,"score_spread":0.25450690204838206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162717580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527895,0.0011924086,0.000017700853,0.0019325333,0.00029668186,0.00031790347,0.0000067765086,0.0000012024092,0.0009558092],"genre_scores_gemma":[0.99884456,0.0004386318,0.000038401064,0.00020865687,0.00023137948,0.0000040451296,8.8758344e-7,0.000010817276,0.00022260447],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99916816,0.00011024715,0.00039141637,0.00005853494,0.0001213269,0.00015029324],"domain_scores_gemma":[0.9991824,0.00016526449,0.0003264079,0.00019818128,0.00008981476,0.0000379487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018638607,0.00009706049,0.00036979586,0.000062553096,0.000020292147,0.000001241896,0.0001224428,0.00006690576,0.00008750689],"category_scores_gemma":[0.000018625004,0.00004511314,0.00017497447,0.000072485964,0.00008326743,0.000024049012,0.000011457801,0.00006876075,0.0000010468182],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043046698,0.0045463024,0.28134325,0.00008894369,0.0009214898,0.00015831445,0.008075862,0.00021228989,0.64796084,0.00006899777,0.0009553563,0.012621667],"study_design_scores_gemma":[0.026343253,0.02072351,0.7434641,0.000030638126,0.0021263647,0.0014638404,0.0002774277,0.00004517211,0.19165152,0.00082097406,0.012942602,0.00011057873],"about_ca_topic_score_codex":0.00012503534,"about_ca_topic_score_gemma":0.00009672367,"teacher_disagreement_score":0.46212086,"about_ca_system_score_codex":0.000057487592,"about_ca_system_score_gemma":0.0001690052,"threshold_uncertainty_score":0.18396604},"labels":[],"label_agreement":null},{"id":"W2162889193","doi":"10.1016/j.urology.2011.07.436","title":"POD-05.05 Risk Stratification of Patients Who Are pT0N0 after Radical Cystectomy","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Risk stratification; Pathological; Point of delivery; Disease; Internal medicine; Oncology; Urology; Bladder cancer; Cancer","score_opus":0.016486340459307445,"score_gpt":0.24621456144812873,"score_spread":0.22972822098882129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162889193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925714,0.00027472575,0.00023991583,0.00019078123,0.00023535862,0.00037858225,0.00009165764,0.000028869441,0.005988713],"genre_scores_gemma":[0.9988726,0.00003457728,0.00016201608,0.00054560695,0.000073961906,0.000054848588,0.000032823034,0.000016057063,0.00020752466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991683,0.00007541527,0.00022874202,0.00022071194,0.00013236792,0.0001745093],"domain_scores_gemma":[0.999392,0.000021493966,0.00013225761,0.00028045458,0.00008396905,0.0000898574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050819217,0.000112198344,0.00026174117,0.00006944624,0.000024328388,0.0000018723536,0.00006273194,0.00013944681,0.00084027264],"category_scores_gemma":[0.00003923809,0.000089489746,0.00006600006,0.000072279196,0.000117932184,0.000035516918,0.000017708528,0.00013510743,0.000068834015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00242753,0.0007805069,0.984351,0.00004696531,0.00017343633,0.000048695227,0.0010818709,4.4441222e-7,0.000097921686,0.00014649934,0.0014149472,0.009430219],"study_design_scores_gemma":[0.0030192668,0.0017259148,0.9892802,0.00001243712,0.0002488085,0.0000121206285,0.000025109335,0.00001868937,0.0013881128,0.00039877964,0.0037972876,0.00007323441],"about_ca_topic_score_codex":0.00016063731,"about_ca_topic_score_gemma":0.00004586604,"teacher_disagreement_score":0.009356985,"about_ca_system_score_codex":0.000022799994,"about_ca_system_score_gemma":0.00004510475,"threshold_uncertainty_score":0.9200396},"labels":[],"label_agreement":null},{"id":"W2163539852","doi":"10.1016/j.urolonc.2013.10.010","title":"Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer","year":2014,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Urine; Medicine; Cancer; Oncology; Urology; Internal medicine","score_opus":0.04851700687135616,"score_gpt":0.32036497459203694,"score_spread":0.27184796772068076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163539852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4344525,0.5435208,0.000028311795,0.0044146786,0.000566891,0.01193055,0.001684774,0.000041924686,0.0033595518],"genre_scores_gemma":[0.009156857,0.9853396,0.0022644822,0.001810936,0.000057281446,0.0010086228,0.0001786357,0.00002746134,0.000156168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982417,0.0004045763,0.000559222,0.0003430972,0.00023303549,0.000218327],"domain_scores_gemma":[0.9972947,0.0015226593,0.00059895986,0.0004033244,0.00009813947,0.000082195715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027834577,0.0003162767,0.0009592707,0.0001628411,0.00013585125,0.000014391979,0.00013982308,0.00020246288,0.00013700924],"category_scores_gemma":[0.0001113648,0.0001507836,0.00012876882,0.0002969864,0.00089013716,0.000046848076,0.00004873908,0.00046852522,0.0000048549127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013528574,0.006332677,0.3899827,0.02162855,0.010013579,0.0006190348,0.0043392135,0.00050455314,0.0000014054174,0.014276471,0.054481696,0.49646726],"study_design_scores_gemma":[0.001516958,0.0035724782,0.01895928,0.004898324,0.0049586254,0.000018226645,0.0001401416,0.00001725822,0.0000028420266,0.0004363305,0.9652925,0.00018703705],"about_ca_topic_score_codex":0.00020185272,"about_ca_topic_score_gemma":0.00024736795,"teacher_disagreement_score":0.9108108,"about_ca_system_score_codex":0.00010384823,"about_ca_system_score_gemma":0.0005327591,"threshold_uncertainty_score":0.61487764},"labels":[],"label_agreement":null},{"id":"W2163823502","doi":"10.1016/j.ejca.2013.02.001","title":"Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy","year":2013,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Cystectomy; Urothelial carcinoma; Medicine; Urology; Carcinoma; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.016020914517722105,"score_gpt":0.2691430066409575,"score_spread":0.25312209212323544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163823502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577105,0.00018212218,0.00001828353,0.00026524148,0.00008491987,0.00047519637,0.00005757479,0.0000050689378,0.0031405701],"genre_scores_gemma":[0.9993507,0.000015855649,0.00016035441,0.00013987957,0.00008005147,0.0000049157898,0.0000015552189,0.00003113127,0.00021554863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802697,0.0003177677,0.0006219728,0.00015813501,0.0006702948,0.00020486453],"domain_scores_gemma":[0.99806446,0.00007815359,0.0008096622,0.00026472667,0.00061535364,0.00016762778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001508139,0.00022779389,0.000771327,0.00009458439,0.00003287176,0.000005283026,0.00022789642,0.000046649322,0.00091134565],"category_scores_gemma":[0.00007444896,0.0000876643,0.0002921205,0.00018860355,0.00038058884,0.00006404329,0.000030218824,0.00027830774,0.0000036550382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057523004,0.0011459183,0.98676026,0.000022352793,0.0010180331,0.00008524552,0.00018117105,0.000048736823,0.00077901175,0.0000072662756,0.00052487355,0.0036748473],"study_design_scores_gemma":[0.01244735,0.015907144,0.96943057,0.00021124174,0.0005187236,0.00004343171,0.00001937744,0.0000036874671,0.0011812838,0.000003495504,0.0001450385,0.000088651206],"about_ca_topic_score_codex":0.00025137851,"about_ca_topic_score_gemma":0.0000059956174,"teacher_disagreement_score":0.017329667,"about_ca_system_score_codex":0.00016779754,"about_ca_system_score_gemma":0.00044911465,"threshold_uncertainty_score":0.9978596},"labels":[],"label_agreement":null},{"id":"W2164589152","doi":"10.1200/jco.2005.05.516","title":"Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Lymphovascular invasion; Medicine; Cystectomy; Proportional hazards model; Lymph node; Urology; Internal medicine; Stage (stratigraphy); Bladder cancer; Oncology; Retrospective cohort study; Cancer; Metastasis","score_opus":0.061425761275025755,"score_gpt":0.351058263771608,"score_spread":0.28963250249658223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164589152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968572,0.00089456764,0.00013894419,0.001245398,0.00024423192,0.0003254649,0.000017966382,0.000008103356,0.0002680821],"genre_scores_gemma":[0.99697345,0.0018003387,0.00038330385,0.0005861601,0.00015496068,0.0000051019033,0.00000888409,0.000026995087,0.000060791124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660456,0.00059834024,0.0012798143,0.00039429683,0.00080968934,0.00031331723],"domain_scores_gemma":[0.99683774,0.0012802591,0.0008712096,0.00018376664,0.0003664796,0.00046057964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014089266,0.0002570901,0.0015170038,0.00012161475,0.00007299905,0.000019525889,0.00010420723,0.00036754418,0.00007633091],"category_scores_gemma":[0.00051523466,0.00015676249,0.00012891155,0.00018157018,0.00060094165,0.00020399818,0.00007902227,0.0005842151,0.0000034698828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015465373,0.0020213218,0.9553369,0.000019262377,0.00068407867,0.00043358412,0.0002500916,0.000008179367,0.0000043260266,0.000018462242,0.0001593098,0.02559906],"study_design_scores_gemma":[0.057652876,0.0079541635,0.93095094,0.00042655825,0.00035624884,0.000115141025,0.00011151498,0.00005076744,0.000031297248,0.00005683084,0.002123057,0.00017061182],"about_ca_topic_score_codex":0.00009292458,"about_ca_topic_score_gemma":0.0006014804,"teacher_disagreement_score":0.042187504,"about_ca_system_score_codex":0.00084505684,"about_ca_system_score_gemma":0.0008824727,"threshold_uncertainty_score":0.6392589},"labels":[],"label_agreement":null},{"id":"W2165795293","doi":"10.5489/cuaj.2111","title":"Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Genitourinary system; Referral; Internal medicine; Disease; Renal function; Family medicine; Gynecology; Cancer; Oncology","score_opus":0.022916432363881738,"score_gpt":0.27165409133022,"score_spread":0.24873765896633826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165795293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912623,0.001016164,0.0000051511,0.006647227,0.00020623575,0.00019035931,0.0001715718,0.0000036907495,0.00049727986],"genre_scores_gemma":[0.9972954,0.0014469691,0.00002953328,0.0010023755,0.00013467064,0.000015739919,0.000014596968,0.000008965425,0.000051763203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980562,0.00041482996,0.00048535573,0.00019428204,0.00046489955,0.00038447586],"domain_scores_gemma":[0.9980274,0.0005999808,0.00031760774,0.0000985979,0.0002834666,0.0006729499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005019362,0.00015242827,0.0005640587,0.00013713921,0.000055844954,0.00000656888,0.00008776918,0.00023873283,0.000462399],"category_scores_gemma":[0.0013901626,0.000112527116,0.0000656112,0.00018726315,0.00007697117,0.00002976971,0.000012620564,0.0002423293,0.0000010423935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014042453,0.00012155806,0.9804277,0.000007372382,0.0001640399,0.00021103804,0.00008400028,0.000028010696,0.000025096973,0.000009227782,0.00044171183,0.018339822],"study_design_scores_gemma":[0.0026798847,0.0016096153,0.9934929,0.000017320699,0.00008463741,0.00011100069,0.000031867086,0.00015044172,0.0000597064,0.000050638788,0.001627437,0.000084519634],"about_ca_topic_score_codex":0.968729,"about_ca_topic_score_gemma":0.99223095,"teacher_disagreement_score":0.023501897,"about_ca_system_score_codex":0.0030922033,"about_ca_system_score_gemma":0.009534769,"threshold_uncertainty_score":0.9960803},"labels":[],"label_agreement":null},{"id":"W2166477602","doi":"10.1016/j.eursup.2008.07.005","title":"Diagnosis of Non-Muscle Invasive Bladder Cancer","year":2008,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"Astellas Pharma; Amgen","keywords":"Medicine; Cystoscopy; Bladder cancer; Resection; Urothelial cancer; Cancer; Urology; Radiology; General surgery; Surgery; Urinary system; Internal medicine","score_opus":0.028566860789549082,"score_gpt":0.2897131863336148,"score_spread":0.26114632554406575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166477602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784005,0.000625929,0.00002695697,0.0011161043,0.00030761608,0.00049455167,0.00023204509,0.00004021347,0.018756036],"genre_scores_gemma":[0.9936303,0.0016146047,0.0002641928,0.0029258397,0.000218295,0.0000902349,0.00010288341,0.000056055134,0.0010976029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986121,0.00012190545,0.00034533686,0.0003434331,0.00022918865,0.00034805015],"domain_scores_gemma":[0.99921453,0.00005879031,0.00012093714,0.0003573378,0.00009816789,0.00015025467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009679203,0.00019881551,0.00033093907,0.00011226724,0.000097470154,0.0000027504686,0.00015096314,0.000045599652,0.005071324],"category_scores_gemma":[0.00004023246,0.00017385172,0.00011746542,0.00014964673,0.00018195534,0.00005801751,0.00010481366,0.00014358008,0.00029416409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019817124,0.00052438834,0.9190401,0.00003547485,0.0005466782,0.00063106953,0.0011020731,0.000007592444,0.0025675013,0.000005871543,0.07051269,0.004828374],"study_design_scores_gemma":[0.00488941,0.001105285,0.9063585,0.00002461967,0.0003310301,0.000067025365,0.00004959134,0.0000046203727,0.012742192,0.000012082282,0.07425711,0.00015852829],"about_ca_topic_score_codex":0.00029486162,"about_ca_topic_score_gemma":0.00006209207,"teacher_disagreement_score":0.017658433,"about_ca_system_score_codex":0.00004035024,"about_ca_system_score_gemma":0.00014820205,"threshold_uncertainty_score":0.99583817},"labels":[],"label_agreement":null},{"id":"W2166635410","doi":"10.1016/j.eursup.2008.07.007","title":"Current Approaches to the Management of Non-Muscle Invasive Bladder Cancer: Comparison of Current Guidelines and Recommendations","year":2008,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"Astellas Pharma; Eli Lilly and Company; Amgen","keywords":"Medicine; Guideline; Bladder cancer; Cancer; Cystectomy; Intensive care medicine; Gynecology; Oncology; Urology; Internal medicine; Pathology","score_opus":0.23504654221840432,"score_gpt":0.38710080572449374,"score_spread":0.15205426350608942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166635410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95497525,0.014848793,0.002226476,0.018079367,0.001425404,0.0031237653,0.0007909299,0.000045888395,0.0044841287],"genre_scores_gemma":[0.99344987,0.004256731,0.0014154195,0.00037941098,0.00013022813,0.000089886234,0.00015775126,0.000027347929,0.00009334423],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985087,0.00013420066,0.00059145014,0.00031352756,0.00021986065,0.00023226853],"domain_scores_gemma":[0.9992069,0.000035041623,0.00019576032,0.00034922903,0.00010761494,0.00010547034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020705491,0.00018124543,0.00032779766,0.00010148101,0.00012184892,0.0000037493826,0.00018157049,0.000017606215,0.0002342886],"category_scores_gemma":[0.000014019064,0.00013078038,0.00006739736,0.00017176934,0.00012577637,0.000034421675,0.00023823135,0.00013369069,0.000024442967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034498022,0.0016206432,0.40517077,0.00038939217,0.0013601657,0.00002096271,0.0063574365,0.00016148327,0.00024593493,0.00021236617,0.19108477,0.3930311],"study_design_scores_gemma":[0.0045266096,0.0011783504,0.47968918,0.00022615913,0.0009462084,0.000016031267,0.0008419047,0.00017614731,0.0017619504,0.000029206623,0.5103808,0.00022745952],"about_ca_topic_score_codex":0.000051401035,"about_ca_topic_score_gemma":0.00005046103,"teacher_disagreement_score":0.39280364,"about_ca_system_score_codex":0.00002647004,"about_ca_system_score_gemma":0.000057311667,"threshold_uncertainty_score":0.5333069},"labels":[],"label_agreement":null},{"id":"W2166912658","doi":"10.5489/cuaj.1643","title":"Improving the outcome of patients with muscle invasive urothelial carcinoma of the bladder with neoadjuvant gemcitabine/cisplatin chemotherapy: A single institution experience","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Alberta; University of Calgary","funders":"","keywords":"Gemcitabine; Cisplatin; Urothelial carcinoma; Medicine; Chemotherapy; Oncology; Bladder cancer; Neoadjuvant therapy; Urology; Internal medicine; Carcinoma; Cancer","score_opus":0.010478896481005919,"score_gpt":0.20465455655043455,"score_spread":0.19417566006942863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166912658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643034,0.0000257124,0.00022814893,0.00227895,0.00012407855,0.00040628327,0.00003380685,0.0000057274747,0.00046693935],"genre_scores_gemma":[0.9976714,0.0000019027177,0.00013870509,0.001976282,0.000119247845,0.000013214779,0.000004039725,0.000012519063,0.00006266021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864215,0.00012403411,0.00033042757,0.00015897267,0.00046730036,0.00027713538],"domain_scores_gemma":[0.99863845,0.000100863916,0.00051220733,0.00018956717,0.00037543775,0.00018345752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023698188,0.00014174874,0.00026322354,0.000058881476,0.00023046431,0.000025376188,0.00016186804,0.00010005741,0.00009925477],"category_scores_gemma":[0.00041157287,0.00006452084,0.00008838361,0.0002109811,0.00015006904,0.00008858943,0.000014498718,0.00028059876,0.0000014363558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019137334,0.00008956474,0.9953183,0.000006386741,0.00006482851,0.0000026387024,0.00072818366,0.00004126284,0.00045287877,0.00004318718,0.00004412302,0.0030172865],"study_design_scores_gemma":[0.0031605344,0.0012198878,0.99348414,0.000022198761,0.00011872761,0.000015558635,0.00014257229,0.000058251262,0.0009287753,0.00003360378,0.00073505804,0.000080692],"about_ca_topic_score_codex":0.0024886478,"about_ca_topic_score_gemma":0.0019138525,"teacher_disagreement_score":0.0029691611,"about_ca_system_score_codex":0.00041732308,"about_ca_system_score_gemma":0.00048859225,"threshold_uncertainty_score":0.37621075},"labels":[],"label_agreement":null},{"id":"W2167312747","doi":"10.1016/j.urology.2006.05.059","title":"Urothelial Carcinoma of the Prostate","year":2007,"lang":"en","type":"review","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate; Urothelial carcinoma; Radiation therapy; Carcinoma in situ; Carcinoma; Oncology; Prostate cancer; Incidence (geometry); Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.05588527138054028,"score_gpt":0.35519646913795816,"score_spread":0.2993111977574179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167312747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004669973,0.9883389,0.000006937025,0.000103378756,0.0005878096,0.001269011,0.00008857571,0.000016725937,0.009541955],"genre_scores_gemma":[0.0008405053,0.99532735,0.000017394084,0.00048479164,0.00032789746,0.0000662961,0.000025968975,0.000052655938,0.0028571454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877965,0.000101761085,0.00041623175,0.00026723067,0.00016626042,0.00026886383],"domain_scores_gemma":[0.9990661,0.00007366219,0.00021834148,0.0005284376,0.00004762164,0.00006583085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010637371,0.0002541003,0.0011782798,0.000106413776,0.000032412205,0.0000021898504,0.0001797774,0.00031624755,0.0001924501],"category_scores_gemma":[0.000032630614,0.00013561833,0.000496062,0.00020007374,0.00017493269,0.000008326802,0.00007312334,0.00035899092,0.000080046586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011421794,0.000110080335,0.00046324654,0.004729428,0.0002750352,0.000072174786,0.000071132235,8.580582e-8,0.0000010461849,0.00014351915,0.00079971,0.9932203],"study_design_scores_gemma":[0.0006991393,0.00048798326,0.00020019921,0.00046177403,0.0019432895,0.00039253666,0.0000015820976,3.419148e-7,0.0000118108555,0.000037024423,0.9956763,0.00008803031],"about_ca_topic_score_codex":0.00005588895,"about_ca_topic_score_gemma":0.000009105961,"teacher_disagreement_score":0.99487656,"about_ca_system_score_codex":0.000055697874,"about_ca_system_score_gemma":0.0006386303,"threshold_uncertainty_score":0.5530355},"labels":[],"label_agreement":null},{"id":"W2167513403","doi":"10.5539/cco.v4n1p14","title":"Adjuvant Chemotherapy for Bladder Cancer: One Step Forward, two Steps Back","year":2014,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adjuvant; Medicine; Cystectomy; Bladder cancer; Adjuvant chemotherapy; Chemotherapy; Oncology; Randomized controlled trial; Internal medicine; Cancer; Breast cancer","score_opus":0.07390663808480974,"score_gpt":0.4413320114800083,"score_spread":0.36742537339519854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167513403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7332095,0.032065444,0.014191374,0.12344944,0.009930619,0.008747659,0.0008189607,0.00038261196,0.07720439],"genre_scores_gemma":[0.8730134,0.030721545,0.006873972,0.06172352,0.00780669,0.0014652549,0.00007744972,0.00016511847,0.018153055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980668,0.00009370308,0.0006456665,0.00058689504,0.00016145741,0.00044547694],"domain_scores_gemma":[0.9983582,0.0005513194,0.00019184382,0.00030807962,0.0001739712,0.00041658114],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043203472,0.00024558647,0.0011110235,0.00004027484,0.000090586116,0.000013264546,0.00011061315,0.00030175754,0.0013220104],"category_scores_gemma":[0.00008218758,0.00019310376,0.0002756066,0.000089582005,0.00027691887,0.00005125306,0.000037901595,0.00028760734,0.000039952465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030091663,0.00069776847,0.051550638,0.0001021221,0.0009282166,0.00000370801,0.00009127828,0.0000020458185,0.00011180125,0.00028324986,0.02416351,0.9190565],"study_design_scores_gemma":[0.042757418,0.007720735,0.062427014,0.0001297971,0.0012586712,0.000011938046,0.00006242465,0.0006559163,0.00041760076,0.00075194857,0.8834966,0.00030992803],"about_ca_topic_score_codex":0.00054963474,"about_ca_topic_score_gemma":0.0012250772,"teacher_disagreement_score":0.9187466,"about_ca_system_score_codex":0.00021093646,"about_ca_system_score_gemma":0.0006559114,"threshold_uncertainty_score":0.99959093},"labels":[],"label_agreement":null},{"id":"W2167964554","doi":"10.7314/apjcp.2013.14.2.645","title":"Prognostic Value of Tissue Vascular Endothelial Growth Factor Expression in Bladder Cancer: a Meta-analysis","year":2013,"lang":"en","type":"review","venue":"Asian Pacific Journal of Cancer Prevention","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Vascular endothelial growth factor; Meta-analysis; Oncology; Medicine; Vascular endothelial growth factor C; VEGF receptors; Value (mathematics); Internal medicine; Cancer; Cancer research; Vascular endothelial growth factor A; Computer science","score_opus":0.06102219436350665,"score_gpt":0.3755569203541815,"score_spread":0.31453472599067483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167964554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118888456,0.995601,0.0006647889,0.0001038687,0.00041505686,0.0022737628,0.00033968088,0.000011769527,0.0004711735],"genre_scores_gemma":[0.009715416,0.9872204,0.0006725521,0.000011169511,0.00043468786,0.00067098445,0.00005470409,0.00009289314,0.0011271574],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99510884,0.00070565793,0.0021882858,0.0005089231,0.0010808505,0.0004074488],"domain_scores_gemma":[0.9959783,0.00011829035,0.0026571704,0.0004908306,0.0004935059,0.0002619248],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046385004,0.00066439813,0.0058440263,0.0012523481,0.0000443415,0.000039722006,0.00031455912,0.0004105808,0.003402386],"category_scores_gemma":[0.00008589467,0.00043492333,0.005016096,0.0011434605,0.00007768995,0.0002866261,0.000044773522,0.0006913616,0.000011758206],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014781517,0.0011643636,0.0012651619,0.012222522,0.28577194,0.0001083537,0.0006753564,0.00001953984,0.00015236133,0.00001964585,0.00042852873,0.6980244],"study_design_scores_gemma":[0.0025784802,0.0011261539,0.0009967968,0.010206287,0.8086713,0.00009491087,0.00015080778,0.0000048906904,0.0009454988,0.0002481964,0.17440987,0.00056679343],"about_ca_topic_score_codex":0.0004596812,"about_ca_topic_score_gemma":0.00008625994,"teacher_disagreement_score":0.6974576,"about_ca_system_score_codex":0.0005066071,"about_ca_system_score_gemma":0.0015014035,"threshold_uncertainty_score":0.9998103},"labels":[],"label_agreement":null},{"id":"W2168020987","doi":"10.1016/j.eururo.2012.08.055","title":"Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Gemcitabine; Salvage therapy; Taxane; Prostatectomy; Intensive care medicine; Regimen; Chemotherapy; Oncology; Internal medicine; Surgery; Cancer; Prostate cancer","score_opus":0.07887159433563308,"score_gpt":0.33870304126964607,"score_spread":0.259831446934013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168020987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040336286,0.9784505,0.000035901296,0.00052632845,0.0007239699,0.0033900915,0.0007258985,0.000079779624,0.016027218],"genre_scores_gemma":[0.0003423403,0.97860634,0.00038323578,0.0006045438,0.0015361976,0.0016650687,0.0006739842,0.00027542893,0.015912855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681115,0.00046821593,0.0007494562,0.0008963589,0.00016083171,0.0009140108],"domain_scores_gemma":[0.99825895,0.00027696035,0.00028762597,0.0007656467,0.00008849556,0.00032232748],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021489146,0.00079743407,0.0020990693,0.00037998616,0.00011056654,0.000021164302,0.00023977523,0.00033863165,0.0021708414],"category_scores_gemma":[0.000050814295,0.0005939423,0.00069977995,0.0003052941,0.000120963465,0.00006796429,0.00009635442,0.0004457881,0.002688709],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011572959,0.0007577788,0.00018393858,0.0033632035,0.001624988,0.0005460187,0.00029517387,0.0000052105274,0.000008170209,0.00004639551,0.013686117,0.97936726],"study_design_scores_gemma":[0.0034922413,0.0015471742,0.00022790508,0.0006752229,0.0057078553,0.00022278316,0.000012782531,0.000002783968,0.0000027456908,0.0000036741096,0.9876869,0.00041798133],"about_ca_topic_score_codex":0.00028816442,"about_ca_topic_score_gemma":0.00068883953,"teacher_disagreement_score":0.9789493,"about_ca_system_score_codex":0.0006493343,"about_ca_system_score_gemma":0.0007343296,"threshold_uncertainty_score":0.9996512},"labels":[],"label_agreement":null},{"id":"W2168241437","doi":"10.1016/j.eururo.2010.01.043","title":"Should Urologists Always Perform a Bladder Cuff Resection During Nephroureterectomy, and Which Method Should They Use?","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cuff; Urology; Resection; Surgery","score_opus":0.06077078477150742,"score_gpt":0.31643928395628323,"score_spread":0.2556684991847758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168241437","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39215448,0.0011042529,0.00040932582,0.54139,0.0035481246,0.0024618045,0.00023104016,0.0009528781,0.057748083],"genre_scores_gemma":[0.38433903,0.000696827,0.0018979638,0.5935515,0.011568244,0.00009292887,0.0004891734,0.0005872613,0.0067770896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995134,0.0012240161,0.000620402,0.0014597474,0.000524625,0.001037234],"domain_scores_gemma":[0.99764013,0.00039816857,0.00030102578,0.0011723317,0.00024558636,0.0002427435],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00071854074,0.000869873,0.0010258695,0.00046437065,0.00030787216,0.00012951132,0.0003485749,0.0021299266,0.00069679733],"category_scores_gemma":[0.00036672252,0.0007072834,0.0002488522,0.00020193623,0.00023648668,0.00017371382,0.0003632964,0.009003166,0.00023603912],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006620102,0.0003854761,0.033645663,0.00080353813,0.003707429,0.014609418,0.0025903666,0.00001892478,0.01118429,0.0000531497,0.9142949,0.012086749],"study_design_scores_gemma":[0.003926907,0.0026097326,0.07227245,0.000042657866,0.0015115151,0.0049727852,0.000012173935,0.000102076854,0.00075649563,0.00012025704,0.9129563,0.0007166766],"about_ca_topic_score_codex":0.00039673116,"about_ca_topic_score_gemma":0.00036259711,"teacher_disagreement_score":0.05216149,"about_ca_system_score_codex":0.000097927084,"about_ca_system_score_gemma":0.00014901359,"threshold_uncertainty_score":0.9995378},"labels":[],"label_agreement":null},{"id":"W2168289480","doi":"10.1016/j.juro.2012.10.057","title":"Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nomogram; Urothelial carcinoma; Urology; General surgery; Cancer; Oncology; Internal medicine; Bladder cancer","score_opus":0.047576224140934424,"score_gpt":0.32849913488728144,"score_spread":0.280922910746347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168289480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97210103,0.0023954122,0.0243334,0.0001367824,0.0005600346,0.00037497107,0.00007986018,0.0000033838708,0.000015121492],"genre_scores_gemma":[0.98206013,0.000101311714,0.017194197,0.00008974083,0.00050381717,0.000012356058,0.000010895066,0.000019861214,0.0000076748465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831593,0.00027472674,0.0007263613,0.00011442568,0.0003188308,0.00024972463],"domain_scores_gemma":[0.9986977,0.00022809295,0.00042241102,0.00017721421,0.00032986808,0.00014469655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087960344,0.0001621562,0.00068602065,0.0002782806,0.00006453068,0.000004651011,0.00011739204,0.00011917359,0.00025839827],"category_scores_gemma":[0.000034762405,0.00009715992,0.00029087224,0.00022635955,0.00013782183,0.0001438244,0.000020978045,0.00019894498,4.1235324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099869885,0.003091562,0.79790425,0.000059590395,0.007292087,0.000042368236,0.016398275,0.0028672856,0.0409625,0.000012458527,0.00008592055,0.03141383],"study_design_scores_gemma":[0.0124770915,0.0034201625,0.95649624,0.00004179407,0.007100299,0.00042784784,0.00035021524,0.001608816,0.016008865,0.000022512782,0.0019030409,0.00014313603],"about_ca_topic_score_codex":0.00007715393,"about_ca_topic_score_gemma":0.000027272135,"teacher_disagreement_score":0.15859199,"about_ca_system_score_codex":0.000119702585,"about_ca_system_score_gemma":0.0003087441,"threshold_uncertainty_score":0.39620668},"labels":[],"label_agreement":null},{"id":"W2169227073","doi":"10.1086/314063","title":"Immunology of Bacille Calmette-Guérin and Related Topics","year":2000,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunology; Virology","score_opus":0.021326961488560576,"score_gpt":0.34011797928890214,"score_spread":0.3187910178003416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169227073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785189,0.0024552038,0.0000024714313,0.00040718872,0.00020167041,0.00019242201,0.000026990674,0.00007011595,0.01812504],"genre_scores_gemma":[0.99461514,0.0020398533,0.000009048333,0.00048589968,0.000119301665,0.000012267246,0.000016095935,0.000011420621,0.0026909914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991648,0.000070659225,0.00036537444,0.0001995726,0.00007145449,0.00012813363],"domain_scores_gemma":[0.9994226,0.00013088343,0.000050153893,0.00021121225,0.000041663916,0.00014345605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053958494,0.00009590776,0.00035138137,0.000031668485,0.00003915456,0.000004408834,0.000030942596,0.000117588184,0.0023376006],"category_scores_gemma":[0.00014920888,0.00007722173,0.00014456832,0.000092160204,0.00024875565,0.000030233297,0.00001904554,0.00013267482,0.00006859943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019780178,0.0009392075,0.82215667,0.00003734774,0.0003759816,0.000043266937,0.000030816824,0.0000017182696,0.00002402219,0.00015198212,0.0009648788,0.17507629],"study_design_scores_gemma":[0.004286122,0.0015877112,0.98051554,0.000040750234,0.00040812363,0.000035189252,0.0000110668025,0.00001573393,0.00007257219,0.00135441,0.011584804,0.000087962624],"about_ca_topic_score_codex":0.00006871798,"about_ca_topic_score_gemma":0.0000063005914,"teacher_disagreement_score":0.17498833,"about_ca_system_score_codex":0.000018034572,"about_ca_system_score_gemma":0.000072872215,"threshold_uncertainty_score":0.9985744},"labels":[],"label_agreement":null},{"id":"W2170235048","doi":"10.1016/j.eururo.2009.11.035","title":"Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Necrosis; Stage (stratigraphy); Urology; Pathology; Cancer; Carcinoma; Metastasis; T-stage; Ureteral neoplasm; Lymph node; Oncology; Transitional cell carcinoma; Internal medicine; Bladder cancer; Biology","score_opus":0.010936577657274984,"score_gpt":0.24459689892668932,"score_spread":0.23366032126941433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170235048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957799,0.00016319232,0.0000024898645,0.0005343171,0.00007550895,0.00037217847,0.000078466015,0.000010497598,0.0029834574],"genre_scores_gemma":[0.99793524,0.00000922119,0.000053111762,0.0018566959,0.00005753727,0.0000033723431,0.000017556195,0.000025362837,0.00004192431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987546,0.00031654027,0.00029389298,0.00028383176,0.00012313502,0.00022796303],"domain_scores_gemma":[0.99911696,0.000024117964,0.00035749015,0.00037156238,0.000055178392,0.00007471189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093708324,0.00015932489,0.00033334477,0.0001263066,0.000029476698,0.0000018781443,0.0002013328,0.000062892264,0.00012775532],"category_scores_gemma":[0.000036322494,0.00009692469,0.000074801435,0.00014601699,0.00020433504,0.00003694792,0.00003913698,0.00018776009,0.000012808393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015816621,0.0016639632,0.9915064,0.000010256802,0.000034032633,0.000055161217,0.0009750871,0.0000013102008,0.0018604177,0.000027998154,0.000053231954,0.0022305055],"study_design_scores_gemma":[0.0047264155,0.011756677,0.979921,0.000025089825,0.0000932736,0.000040880084,0.000016895276,0.0000023219657,0.0030864412,0.000046113357,0.00020636233,0.000078526384],"about_ca_topic_score_codex":0.000054249573,"about_ca_topic_score_gemma":0.0000016850539,"teacher_disagreement_score":0.01158537,"about_ca_system_score_codex":0.000020708632,"about_ca_system_score_gemma":0.00009039233,"threshold_uncertainty_score":0.3952474},"labels":[],"label_agreement":null},{"id":"W2170777530","doi":"10.1016/s1010-7940(02)00469-4","title":"Reply to Velissaris et al.","year":2002,"lang":"en","type":"article","venue":"European Journal of Cardio-Thoracic Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Philosophy","score_opus":0.0542567905444021,"score_gpt":0.31049269346255076,"score_spread":0.2562359029181487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170777530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5693723,0.01791629,0.0031165103,0.09284772,0.004903721,0.0005838817,0.000045991237,0.00019402396,0.31101954],"genre_scores_gemma":[0.95186526,0.0012422936,0.0011469673,0.042708516,0.0007929105,0.0000018849419,0.0000031791267,0.00009304472,0.0021459288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971372,0.00096297794,0.00070457783,0.00022814065,0.00064029684,0.00032679818],"domain_scores_gemma":[0.9982795,0.00019008426,0.00026299426,0.00041965686,0.0003211895,0.0005265693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034865008,0.00021142855,0.00067503814,0.00034214678,0.000063614716,0.00004753162,0.00012267714,0.000019239447,0.00045146802],"category_scores_gemma":[0.0005074847,0.0001692453,0.000634782,0.00034400265,0.00003559381,0.00015838056,0.00004062324,0.00034743318,0.0005054823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004716932,0.00012987055,0.011443955,0.000021449276,0.00045130125,0.0067950333,0.00048429973,0.000025138448,0.00043408043,0.0000015621434,0.74470156,0.23504007],"study_design_scores_gemma":[0.00045231447,0.0004093262,0.030301478,0.00032247548,0.00024750404,0.0033145507,0.00008000505,0.0000032737948,0.0014387805,0.0000037473915,0.9632495,0.00017705845],"about_ca_topic_score_codex":0.000007116896,"about_ca_topic_score_gemma":1.6089605e-7,"teacher_disagreement_score":0.38249296,"about_ca_system_score_codex":0.00010091131,"about_ca_system_score_gemma":0.00009214147,"threshold_uncertainty_score":0.69016224},"labels":[],"label_agreement":null},{"id":"W2171550288","doi":"10.5489/cuaj.508","title":"V-Loc urethro-intestinal anastomosis during robotic cystectomy with orthotopic urinary diversion","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urinary diversion; Cystectomy; Anastomosis; Medicine; Surgery; Fibrous joint; Urinary system; Leak; Barbed suture; Bladder cancer; Urology; Internal medicine; Cancer","score_opus":0.009588706556920385,"score_gpt":0.20985309432419527,"score_spread":0.2002643877672749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171550288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98589164,0.00015026524,0.000064602835,0.010583293,0.00015923363,0.0003484232,0.00000548429,0.000041887375,0.0027551425],"genre_scores_gemma":[0.9960067,0.000028250875,0.0004349649,0.0016665801,0.00032705208,0.000022466886,0.000009291125,0.000015184163,0.0014894962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985802,0.00009409628,0.00022466164,0.00021524147,0.00036809972,0.0005176657],"domain_scores_gemma":[0.9985406,0.00005033572,0.00016135152,0.00011066398,0.00029049028,0.0008465736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012585337,0.00017003293,0.0002707026,0.00016289757,0.00039819628,0.0000821815,0.000095277675,0.00016214364,0.0024207644],"category_scores_gemma":[0.00012207698,0.00011996478,0.00010316445,0.00022100861,0.00003567545,0.00016548621,0.000016758297,0.00052848377,0.00019649928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008263279,0.00006917639,0.996603,0.000009639198,0.00014244179,0.0005519749,0.00007487609,0.00004568132,0.0001413165,0.000008839733,0.0014413105,0.00082912744],"study_design_scores_gemma":[0.0020926371,0.0012349059,0.99231464,0.000047529244,0.00015699746,0.002042907,0.00007872561,0.000072031806,0.000062547515,0.00009752344,0.00166011,0.00013944184],"about_ca_topic_score_codex":0.0032964265,"about_ca_topic_score_gemma":0.0003682699,"teacher_disagreement_score":0.010115046,"about_ca_system_score_codex":0.0013017944,"about_ca_system_score_gemma":0.00040632335,"threshold_uncertainty_score":0.99849117},"labels":[],"label_agreement":null},{"id":"W2171610349","doi":"10.5489/cuaj.840","title":"Determining when to recommend continent urinary diversion","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Urinary diversion; Medicine; Bladder cancer; Quality of life (healthcare); Urinary system; Comorbidity; Perioperative; Surgery; Disease; Intensive care medicine; Cancer; Internal medicine","score_opus":0.018540931380553276,"score_gpt":0.24114882569428742,"score_spread":0.22260789431373415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171610349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87237686,0.00007141615,0.00005476017,0.11886034,0.000437519,0.00032569896,0.000016010043,0.00002514504,0.007832223],"genre_scores_gemma":[0.9755026,0.000021985012,0.0006518405,0.021151822,0.00038231493,0.000016661766,0.000009085736,0.000008958153,0.002254708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989849,0.00007052342,0.00020106431,0.00014220248,0.00021490907,0.00038642835],"domain_scores_gemma":[0.99856555,0.000054394106,0.000095246825,0.00007351269,0.00017811138,0.0010331691],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018591392,0.00010252858,0.00018562324,0.00012791342,0.0002241127,0.00007634707,0.000078296354,0.0001236325,0.0045961235],"category_scores_gemma":[0.00021485257,0.000080126425,0.00008643794,0.000077876546,0.000008049663,0.00010064935,0.000019928868,0.00027933193,0.00057901506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029817062,0.00004971968,0.84672314,0.0000016437667,0.00007699444,0.00011537439,0.00023770792,0.000002049008,0.0001097991,0.000007286377,0.13345072,0.019195762],"study_design_scores_gemma":[0.0010293282,0.00089771114,0.8190485,0.000015787215,0.000055378656,0.00021302857,0.000083580104,0.000030565352,0.000028644337,0.0004009448,0.17809968,0.00009680524],"about_ca_topic_score_codex":0.0019032845,"about_ca_topic_score_gemma":0.00014559845,"teacher_disagreement_score":0.103125736,"about_ca_system_score_codex":0.0010211016,"about_ca_system_score_gemma":0.00019221476,"threshold_uncertainty_score":0.9963138},"labels":[],"label_agreement":null},{"id":"W2172142251","doi":"10.4103/2152-7806.89879","title":"Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy","year":2011,"lang":"en","type":"article","venue":"Surgical Neurology International","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Spondylodiscitis; Mycobacterium bovis; Ethambutol; Surgery; Back pain; Debridement (dental); Tuberculosis; Mycobacterium tuberculosis; Pathology","score_opus":0.025639360333231113,"score_gpt":0.2688660539143156,"score_spread":0.2432266935810845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172142251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96050066,0.00011430344,0.000037046968,0.00411599,0.0014586066,0.00022191436,0.000094623974,0.000082618964,0.03337424],"genre_scores_gemma":[0.9920661,0.00023235222,0.00014040203,0.0051685455,0.0006947677,0.00008593483,0.00006300632,0.000029093553,0.0015197834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855614,0.000087145156,0.0002879958,0.00042690264,0.00031848066,0.0003233211],"domain_scores_gemma":[0.99935776,0.00006286705,0.0000494115,0.0002286629,0.00009275935,0.00020855795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008289407,0.00021532716,0.0002860717,0.00012481525,0.000036990677,0.000014938253,0.00016804105,0.00018073704,0.015475363],"category_scores_gemma":[0.000022330132,0.00014808799,0.00018909814,0.00008983018,0.00020623239,0.00009106893,0.00007242676,0.00035925006,0.00040639032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059296947,0.0036198061,0.79661024,0.000028974433,0.0015102584,0.03568338,0.0015580747,9.863801e-7,0.001780761,0.0037942766,0.004778761,0.09133755],"study_design_scores_gemma":[0.006300827,0.0019530202,0.751556,0.000009563277,0.00004860753,0.0026659,0.0000063304324,0.000038520633,0.0016259396,0.0006538599,0.234928,0.00021347837],"about_ca_topic_score_codex":0.000072315066,"about_ca_topic_score_gemma":0.00001070246,"teacher_disagreement_score":0.23014924,"about_ca_system_score_codex":0.000032154127,"about_ca_system_score_gemma":0.000059262853,"threshold_uncertainty_score":0.98542464},"labels":[],"label_agreement":null},{"id":"W2172237991","doi":"10.1016/j.urology.2011.11.058","title":"The Contemporary Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; University of British Columbia; Western University; Université de Montréal; Université Laval; University of Alberta; McMaster University; McGill University; Dalhousie University","funders":"","keywords":"Medicine; Hazard ratio; Urology; Interquartile range; Proportional hazards model; Lymph node; Upper urinary tract; Dissection (medical); Ureteral neoplasm; Cohort; Confidence interval; Carcinoma; Urinary system; Internal medicine; Survival analysis; Oncology; Surgery; Transitional cell carcinoma; Cancer; Bladder cancer","score_opus":0.017581046260457336,"score_gpt":0.2665763918310316,"score_spread":0.24899534557057426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172237991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438966,0.002516716,0.000002451543,0.0013616362,0.00018367318,0.00047362887,0.000009525317,0.0000059285626,0.011056767],"genre_scores_gemma":[0.9991864,0.000044972552,0.0000075954795,0.00040269166,0.00011343597,0.00013380006,0.0000034998673,0.000012031851,0.0000955484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907744,0.00013672697,0.00021443052,0.00012355481,0.00015322698,0.0002946141],"domain_scores_gemma":[0.9994427,0.00006726954,0.00007194282,0.00033597593,0.00002074543,0.00006139113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020597043,0.000109269335,0.00015404777,0.00005811466,0.00016452758,0.000005992085,0.00018552334,0.00006321219,0.000038666476],"category_scores_gemma":[0.0000068561017,0.000054749693,0.000067299894,0.00012061137,0.00017870715,0.00005798827,0.000028142696,0.00012683189,0.000004270413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000690248,0.00027905832,0.98705655,0.000033778313,0.000089792986,0.000053416214,0.009588368,0.000004871945,0.0009212292,0.00048972917,0.000027815584,0.0007651164],"study_design_scores_gemma":[0.001207166,0.00020851419,0.9901057,0.000010031716,0.00006542932,0.00027739696,0.0030995389,0.000020477253,0.0013550653,0.00005905041,0.0035424973,0.000049165003],"about_ca_topic_score_codex":0.027790328,"about_ca_topic_score_gemma":0.0016186249,"teacher_disagreement_score":0.026171703,"about_ca_system_score_codex":0.000075334305,"about_ca_system_score_gemma":0.00010895638,"threshold_uncertainty_score":0.9786837},"labels":[],"label_agreement":null},{"id":"W2173098200","doi":"10.1016/j.urpr.2015.03.004","title":"A Review of Neoadjuvant and Adjuvant Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer","year":2015,"lang":"en","type":"review","venue":"Urology Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Chemotherapy; Oncology; Neoadjuvant therapy; Perioperative; Internal medicine; Cancer; Randomized controlled trial; Surgery; Breast cancer","score_opus":0.07825543001150696,"score_gpt":0.4234136745409185,"score_spread":0.3451582445294115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173098200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001486662,0.9912021,0.000052273128,0.0032631806,0.00024998482,0.0038643926,0.0002598816,0.000021783888,0.0010848748],"genre_scores_gemma":[0.0000016005653,0.9815658,0.0016869066,0.014822702,0.00020592855,0.0011144556,0.00015121086,0.0000940787,0.00035734166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978402,0.00032919334,0.00073000503,0.0005532539,0.00022446958,0.00032283223],"domain_scores_gemma":[0.9965778,0.0012834639,0.0009833489,0.0004969696,0.00046110013,0.0001973269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007014659,0.0004527411,0.0028702153,0.00012355276,0.00004030716,0.0000072761327,0.00013352105,0.00028268513,0.00025307506],"category_scores_gemma":[0.0013182957,0.0003254652,0.000338665,0.00020458862,0.00015386245,0.0001260004,0.000055002078,0.00037889963,0.000025540116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002156877,0.00023585137,0.0000023458185,0.09292076,0.0018207203,0.000042864776,0.00011959075,4.8157293e-8,9.475105e-7,0.000019024397,0.020281678,0.88434047],"study_design_scores_gemma":[0.0022729738,0.0013649224,0.0000044956914,0.023438705,0.02246801,0.0005898646,0.000025098367,0.0000014801086,0.0000016389355,0.000039065908,0.9495744,0.00021930749],"about_ca_topic_score_codex":0.0001239505,"about_ca_topic_score_gemma":0.000016444845,"teacher_disagreement_score":0.92929274,"about_ca_system_score_codex":0.00010903799,"about_ca_system_score_gemma":0.0019099048,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W2174702408","doi":"10.5489/cuaj.3320","title":"CUA guidelines on the management of non-muscle invasive bladder cancer","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; Queen's University; Université Laval; University of Alberta; University of Ottawa; Dalhousie University; University of Toronto; University of British Columbia; McGill University","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Urology; General surgery; Internal medicine","score_opus":0.06015377788192377,"score_gpt":0.30815247590389305,"score_spread":0.24799869802196928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174702408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7925862,0.0007543053,0.000037958962,0.16879639,0.0008247223,0.0005353941,0.000081646314,0.00001734199,0.03636605],"genre_scores_gemma":[0.9798509,0.00035522788,0.00021315648,0.017078556,0.00047372992,0.000028035298,0.000005442997,0.000010739494,0.0019842335],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998821,0.00006210756,0.00028546934,0.00012476003,0.00042413684,0.00028251112],"domain_scores_gemma":[0.9986165,0.000058184243,0.00019374528,0.000118407785,0.00053433125,0.00047882515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046522677,0.00010939817,0.00019161518,0.0000720997,0.000114978255,0.00002602845,0.00011803442,0.00010364278,0.0007081046],"category_scores_gemma":[0.00022351935,0.00006396055,0.00010027567,0.00016443277,0.00002554208,0.000037458318,0.000013350276,0.0002506389,0.000058989102],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023743804,0.0002030881,0.36400765,0.000019807812,0.0020287193,0.00033333525,0.0006819942,0.00043953818,0.00012033151,0.0009777003,0.60228026,0.028670168],"study_design_scores_gemma":[0.0032687597,0.0010139756,0.80500686,0.00012636905,0.0005064671,0.000046384223,0.00083567214,0.00010673953,0.00028482004,0.0022736352,0.18634573,0.00018457386],"about_ca_topic_score_codex":0.0022643665,"about_ca_topic_score_gemma":0.0008529516,"teacher_disagreement_score":0.44099924,"about_ca_system_score_codex":0.00085526553,"about_ca_system_score_gemma":0.0007028873,"threshold_uncertainty_score":0.7753249},"labels":[],"label_agreement":null},{"id":"W2176022013","doi":"10.14740/wjon942w","title":"Utility of SOX2 and Livin Co-Expression in the Prognosis of Bladder Cancer With Bilharzial and Non-Bilharzial Bladder Status","year":2015,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine; Oncology","score_opus":0.04209147856827919,"score_gpt":0.3566548756597204,"score_spread":0.3145633970914412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176022013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924542,0.0022491582,0.000019095189,0.0013486135,0.00013996697,0.0004185439,0.000027408218,0.000002467835,0.0033405907],"genre_scores_gemma":[0.99822617,0.0005482672,0.0006572502,0.00025137383,0.0001933402,0.000015964268,0.0000015955501,0.000012747317,0.00009328104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985837,0.00018380808,0.0005033767,0.00015351665,0.00035289113,0.00022273973],"domain_scores_gemma":[0.9987988,0.00018689112,0.00043641136,0.00013114173,0.00026352998,0.00018325311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005388409,0.00014595792,0.00061072817,0.00020405401,0.0000275262,0.000007119367,0.000085950196,0.000083366256,0.00018465983],"category_scores_gemma":[0.00005772233,0.00007921018,0.000052639924,0.00021204112,0.00035651823,0.00009482259,0.000032840933,0.00031165546,4.1057123e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070998454,0.0012120958,0.9496668,0.0000957046,0.0003151509,0.00012240502,0.0056594014,0.000004160658,0.003429167,0.0000067785977,0.0063783685,0.026010126],"study_design_scores_gemma":[0.015792929,0.007477049,0.94977194,0.0003965805,0.0005904382,0.00028552674,0.0018453506,0.000038026683,0.009519256,0.000108831315,0.014050405,0.000123682],"about_ca_topic_score_codex":0.0004439496,"about_ca_topic_score_gemma":0.0013605687,"teacher_disagreement_score":0.025886444,"about_ca_system_score_codex":0.000067807094,"about_ca_system_score_gemma":0.0010616159,"threshold_uncertainty_score":0.32300973},"labels":[],"label_agreement":null},{"id":"W2177799537","doi":"10.14740/jmc.v6i12.2359","title":"External Iliac Vein Injury During the Bipolar Transurethral Resection of Bladder Tumor: A Case Report","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Obturator nerve; Resection; Bladder tumor; Perforation; Surgery; Urology; Urinary bladder; Bladder cancer; Cancer; Internal medicine","score_opus":0.03940027546239157,"score_gpt":0.3433646993548935,"score_spread":0.30396442389250194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2177799537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158067,0.0052511753,0.00012020078,0.0020187397,0.00067384006,0.00014088256,0.00001329919,0.000009815988,0.0001913884],"genre_scores_gemma":[0.9978982,0.0002058061,0.00012479867,0.00020583859,0.0013010886,0.0000039724114,9.585682e-7,0.000017927076,0.00024138452],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99701065,0.00014749501,0.0007641626,0.00012546277,0.0017579644,0.00019429288],"domain_scores_gemma":[0.9984009,0.00012267595,0.00037545493,0.00022028938,0.000353697,0.0005269858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014591257,0.00013421141,0.00039905315,0.00012874369,0.00006659292,0.00001323614,0.0001244673,0.00010762884,0.000495113],"category_scores_gemma":[0.0013789965,0.00007571889,0.00022809871,0.00017170468,0.00018511005,0.00011713989,0.000026556558,0.0005915348,0.000003567917],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076376107,0.0008583091,0.029575432,0.00020351271,0.00060997164,0.9350733,0.0014478884,0.0000059422073,0.0027055724,0.000012865717,0.0068362225,0.015033332],"study_design_scores_gemma":[0.0049364464,0.003580066,0.006170759,0.0004762708,0.0004784413,0.962871,0.0010534695,0.00003795756,0.0137325935,0.000069957896,0.0065015736,0.00009145038],"about_ca_topic_score_codex":0.0006054137,"about_ca_topic_score_gemma":0.00009611266,"teacher_disagreement_score":0.027797673,"about_ca_system_score_codex":0.00011929134,"about_ca_system_score_gemma":0.00088023854,"threshold_uncertainty_score":0.5421141},"labels":[],"label_agreement":null},{"id":"W2178144908","doi":"10.5114/wo.2015.54391","title":"Photodynamic diagnosis – current tool in diagnosis of carcinoma in situ of the urinary bladder","year":2015,"lang":"pl","type":"article","venue":"Współczesna Onkologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinoma in situ; Urology; Current (fluid); Medicine; Urinary system; Urinary bladder; In situ; Carcinoma; Photodynamic therapy; Pathology; Internal medicine; Chemistry; Engineering","score_opus":0.03915795076671584,"score_gpt":0.30025938570521576,"score_spread":0.2611014349384999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178144908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705733,0.023301728,0.0000013822973,0.00071801466,0.0016254558,0.0018080713,0.0002024611,0.000020038759,0.0017495231],"genre_scores_gemma":[0.9961092,0.002614471,0.000036045476,0.00018553894,0.00014578809,0.00067722664,0.000030924533,0.00005413153,0.00014666947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996075,0.00047972784,0.0012672711,0.00069098733,0.00074865494,0.00073837535],"domain_scores_gemma":[0.99764925,0.0004095672,0.00048308767,0.0011016555,0.00019232932,0.0001641266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060944655,0.00054033904,0.001228042,0.00041691645,0.000039843406,0.00001184706,0.0006136874,0.00037210615,0.0003330881],"category_scores_gemma":[0.0005552553,0.0004000083,0.00033982188,0.0011521969,0.00047897873,0.00013912092,0.00039550214,0.000708429,0.000047891288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064079155,0.004788147,0.981269,0.0004637225,0.00015535788,0.00016882751,0.0028448484,0.000081793434,0.00032243982,0.00014043722,0.001739899,0.0073847156],"study_design_scores_gemma":[0.007520492,0.0019583704,0.9708535,0.0012718625,0.0004385953,0.000020208658,0.0008224838,0.00011338126,0.015515105,0.0005121545,0.0006108896,0.0003629216],"about_ca_topic_score_codex":0.0041414564,"about_ca_topic_score_gemma":0.0016203739,"teacher_disagreement_score":0.02553588,"about_ca_system_score_codex":0.0007013437,"about_ca_system_score_gemma":0.0009849372,"threshold_uncertainty_score":0.9998452},"labels":[],"label_agreement":null},{"id":"W2184608137","doi":"10.1007/s00345-015-1706-1","title":"Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy","year":2015,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Bladder cancer; Nephrology; Renal function; Surgery; Urinary system; Stoma (medicine); Quality of life (healthcare); Urology; Cancer; Internal medicine","score_opus":0.04909439820065409,"score_gpt":0.3494778549334929,"score_spread":0.30038345673283884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184608137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009112716,0.9957355,0.00015068467,0.00026467824,0.0014390466,0.0009820695,0.00011879863,0.000015142979,0.0012029283],"genre_scores_gemma":[0.0016787641,0.9955298,0.00051804,0.00031140837,0.0009557155,0.000023082215,0.00008440992,0.000074754775,0.0008240539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977024,0.00022718143,0.0009246122,0.0002787367,0.0004880201,0.00037903807],"domain_scores_gemma":[0.997696,0.0003649621,0.0009035759,0.00022114156,0.00043546272,0.00037886607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004141756,0.000373245,0.0023557881,0.00056317885,0.00008957658,0.000014753603,0.00022532573,0.00029955985,0.00018197356],"category_scores_gemma":[0.0001041462,0.00026304816,0.0007697165,0.0002053722,0.00012185337,0.000080657876,0.000074640615,0.00073022133,0.000022210175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025942822,0.00038065136,0.0003916131,0.0038559998,0.0011523481,0.0005722857,0.00006572011,4.9843504e-7,1.1649116e-7,0.000048007336,0.02237735,0.9685611],"study_design_scores_gemma":[0.0101607395,0.016350353,0.000022962264,0.0023160956,0.00463226,0.0013404948,0.000008707361,6.7114826e-7,2.6774177e-7,0.00016381379,0.96482927,0.00017439635],"about_ca_topic_score_codex":0.0000047565486,"about_ca_topic_score_gemma":0.000008521576,"teacher_disagreement_score":0.9683867,"about_ca_system_score_codex":0.00052198046,"about_ca_system_score_gemma":0.0016080261,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W2184741314","doi":"","title":"Neoadjuvant gemcitabine/cisplatin chemotherapy for muscle invasive urothelial carcinoma of the bladder: a single institution experience","year":2012,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Cisplatin; Cystectomy; Medicine; Urothelial carcinoma; Chemotherapy; Oncology; Bladder cancer; Neoadjuvant therapy; Urology; Internal medicine; Retrospective cohort study; Carcinoma; Cancer","score_opus":0.032969002235277794,"score_gpt":0.2823083449720139,"score_spread":0.2493393427367361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184741314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989247,0.00029354298,0.0012866718,0.000627277,0.0004530009,0.0013101798,0.000034119228,0.000033519456,0.0067146723],"genre_scores_gemma":[0.99603087,0.000017060172,0.0013617254,0.0011464015,0.00033378298,0.00017127488,0.000007220813,0.000024659845,0.0009069949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899215,0.00002180316,0.00025487397,0.00018876819,0.00023176023,0.0003106449],"domain_scores_gemma":[0.9992845,0.000056009885,0.00009947742,0.00034297514,0.000103702965,0.000113343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007865771,0.00016715446,0.00024737124,0.000042344007,0.000107019536,0.000008601508,0.000113199436,0.00007739792,0.00027504074],"category_scores_gemma":[0.000081320824,0.000103025915,0.00016609393,0.0001544542,0.00015125431,0.00015727297,0.000031810046,0.00006715927,0.000009482044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001498074,0.002538112,0.2770689,0.000237755,0.0002609927,0.000003974278,0.02069365,0.000008451659,0.6424482,0.0034644206,0.0024937114,0.04928373],"study_design_scores_gemma":[0.006613136,0.0008092302,0.25550404,0.00008079776,0.0001442939,0.00003421248,0.0009760202,0.000059092745,0.72663534,0.00010788056,0.008850341,0.0001856532],"about_ca_topic_score_codex":0.0002842146,"about_ca_topic_score_gemma":0.000042719414,"teacher_disagreement_score":0.084187105,"about_ca_system_score_codex":0.00009993665,"about_ca_system_score_gemma":0.00018729905,"threshold_uncertainty_score":0.42012748},"labels":[],"label_agreement":null},{"id":"W2186328349","doi":"10.1016/s1701-2163(16)32998-x","title":"Suprapubic or Urethral Catheter: What Is the Optimal Method of Bladder Drainage After Radical Hysterectomy?","year":2008,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radical Hysterectomy; Surgery; Urinary catheterization; Confounding; Cervical cancer; Hysterectomy; Incidence (geometry); Urinary system; Retrospective cohort study; Urology; Catheter; Cancer; Internal medicine","score_opus":0.018230094033386716,"score_gpt":0.2709120946537956,"score_spread":0.2526820006204089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186328349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666824,0.023533395,0.00024041103,0.0034859043,0.0050538373,0.0003270015,0.00003717899,0.000004021768,0.0006358661],"genre_scores_gemma":[0.9933737,0.0010313529,0.0020965284,0.002698884,0.000064089465,0.0000070228743,0.0000013576794,0.000018220697,0.0007088453],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99852115,0.00012293272,0.00049886305,0.0001566504,0.00042511022,0.00027527637],"domain_scores_gemma":[0.99763435,0.0014189816,0.00028493686,0.00019133714,0.00024151058,0.00022890008],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022905399,0.00017176961,0.0005529861,0.00015466494,0.000100176614,0.000018071112,0.00014065066,0.00013412803,0.0011729283],"category_scores_gemma":[0.0004334979,0.00009488415,0.00014948113,0.00028444806,0.00019671158,0.00014106129,0.00004062877,0.00037970862,7.224863e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022273548,0.0023392707,0.3530947,0.0005687108,0.0082068425,0.07249221,0.015403851,0.00007151758,0.00026381647,0.00014406694,0.043548197,0.5016395],"study_design_scores_gemma":[0.020160101,0.008850404,0.8370354,0.00008788819,0.0020998488,0.010955891,0.0030426213,0.00021683739,0.0029591182,0.0002073543,0.1138369,0.00054763636],"about_ca_topic_score_codex":0.00478266,"about_ca_topic_score_gemma":0.0026835662,"teacher_disagreement_score":0.50109184,"about_ca_system_score_codex":0.00036187103,"about_ca_system_score_gemma":0.0021959993,"threshold_uncertainty_score":0.9997401},"labels":[],"label_agreement":null},{"id":"W2191471066","doi":"10.3233/blc-150021","title":"Bladder Cancer Patient Advocacy: A Global Perspective","year":2015,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Globe; Patient advocacy; Medicine; Public relations; Political science; Non profit; Perspective (graphical); Cancer; Nursing; Family medicine; MEDLINE; Public administration; Internal medicine","score_opus":0.07879779033624489,"score_gpt":0.4203128336327744,"score_spread":0.3415150432965295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191471066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015849555,0.9538047,0.000009675022,0.00059159216,0.0022153982,0.0034219455,0.0023519609,0.0002471209,0.03734179],"genre_scores_gemma":[0.00006729824,0.9865329,0.00013241787,0.0014714265,0.0024936567,0.004153236,0.00020122329,0.0002674257,0.004680398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948395,0.00019890166,0.0009870119,0.0016095295,0.0012466913,0.0011183582],"domain_scores_gemma":[0.9964377,0.000046252153,0.000587891,0.0011220148,0.00091235153,0.0008937555],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00013201236,0.0014296451,0.0035876518,0.0002204702,0.00015801344,0.00008521334,0.0003906222,0.000777344,0.0044362186],"category_scores_gemma":[0.000053827483,0.0010696335,0.0012935189,0.0010317271,0.00024291418,0.00015325351,0.00023172647,0.0008246483,0.0005930749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001752837,0.00042676582,0.00011076532,0.0030639973,0.0051894262,0.00022443378,0.00080632855,0.0000024045703,1.5156957e-7,0.00012893352,0.10608076,0.88379073],"study_design_scores_gemma":[0.0022630747,0.0005362299,0.000058069083,0.010007362,0.011296312,0.00021597515,0.0005196459,0.0000029049672,0.0000028442785,0.00020339494,0.97389805,0.0009961157],"about_ca_topic_score_codex":0.009634802,"about_ca_topic_score_gemma":0.0009096638,"teacher_disagreement_score":0.8827946,"about_ca_system_score_codex":0.0081783645,"about_ca_system_score_gemma":0.013347744,"threshold_uncertainty_score":0.9998453},"labels":[],"label_agreement":null},{"id":"W2196142402","doi":"10.1016/j.clgc.2015.10.005","title":"Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin","year":2015,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McMaster University; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Cisplatin; Chemotherapy; Oncology; Internal medicine; Regimen; Proportional hazards model; Chemotherapy regimen; Perioperative; Confidence interval; Retrospective cohort study; Surgery","score_opus":0.09136507234050824,"score_gpt":0.3933785982598038,"score_spread":0.3020135259192956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196142402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714334,0.0010285603,0.0009831135,0.0019443973,0.0010134458,0.0041716634,0.0003015159,0.00016832026,0.003245644],"genre_scores_gemma":[0.982722,0.00025981772,0.0065448633,0.0017858675,0.0023090665,0.0017686625,0.0002240863,0.00020128003,0.0041843583],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99646014,0.0001174984,0.0009940286,0.0010885892,0.0005591967,0.00078053505],"domain_scores_gemma":[0.9967642,0.00057327206,0.0003527766,0.00076964346,0.0007046457,0.000835493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003458149,0.0006962333,0.0012430425,0.000114402355,0.00024871668,0.00004674284,0.00025260285,0.00034769689,0.00040078745],"category_scores_gemma":[0.00021702732,0.0005209302,0.00044234126,0.00037175874,0.00031867906,0.00016104389,0.00004541176,0.00048207736,0.000051282015],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3947639,0.004647872,0.41763473,0.00063266675,0.0023159457,0.0008754712,0.0018566471,0.0049043223,0.0013112744,0.000019156074,0.009416546,0.16162148],"study_design_scores_gemma":[0.5362134,0.1455278,0.15191555,0.0016602491,0.0046703927,0.00013607541,0.0007757619,0.024614494,0.031212268,0.00006772013,0.099824175,0.0033820958],"about_ca_topic_score_codex":0.0002541286,"about_ca_topic_score_gemma":0.00025304372,"teacher_disagreement_score":0.26571918,"about_ca_system_score_codex":0.000524632,"about_ca_system_score_gemma":0.0020308092,"threshold_uncertainty_score":0.9997242},"labels":[],"label_agreement":null},{"id":"W2198737519","doi":"10.5489/cuaj.3023","title":"La codification de la surveillance active","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Computer science; Political science","score_opus":0.02221727465208249,"score_gpt":0.279721916477843,"score_spread":0.2575046418257605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198737519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8915124,0.00028535957,0.00023652324,0.02187028,0.0002632915,0.000176923,0.00006118198,0.0000438664,0.0855502],"genre_scores_gemma":[0.9967952,0.000053030188,0.00013785163,0.0021281678,0.00030253534,0.0000071019,0.000014231493,0.000007649861,0.0005542569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988866,0.00043026754,0.00012861486,0.00009782068,0.00020826046,0.00024844863],"domain_scores_gemma":[0.9987042,0.00017727925,0.0001058755,0.000058813777,0.00020418395,0.0007496438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092099694,0.00007325431,0.00013722964,0.0000672588,0.0000913944,0.00005438469,0.000054731325,0.00021686638,0.00015032038],"category_scores_gemma":[0.0009881466,0.000059326998,0.000055662633,0.00010926401,0.00003192195,0.000052650783,0.0000039523597,0.00039565034,0.000054253123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011047518,0.000052792835,0.9708149,0.0000012373935,0.000091633425,0.000119509845,0.00037725453,0.000015761576,0.000052622985,0.00025505232,0.019240538,0.008868233],"study_design_scores_gemma":[0.0012256657,0.0001549307,0.8382784,0.0000033061856,0.000029079743,0.0003753563,0.000107355205,0.000036032056,0.00003125929,0.0013185265,0.15838316,0.000056932426],"about_ca_topic_score_codex":0.0012693781,"about_ca_topic_score_gemma":0.00036594263,"teacher_disagreement_score":0.13914262,"about_ca_system_score_codex":0.0020518212,"about_ca_system_score_gemma":0.0013027785,"threshold_uncertainty_score":0.5365441},"labels":[],"label_agreement":null},{"id":"W2201237979","doi":"10.1016/j.eururo.2006.03.034","title":"Plasmacytoid Urothelial Carcinoma of the Urinary Bladder","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Curriculum; Medicine; Obstetrics and gynaecology; Specialty; Competence (human resources); Gynecology; Medical education; Sociology; Management; Pedagogy; Family medicine; Pregnancy","score_opus":0.010933734831924918,"score_gpt":0.22706489558853937,"score_spread":0.21613116075661445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201237979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7881257,0.0003557951,0.000021771004,0.0011595947,0.00031660014,0.00023131093,0.00002110668,0.000036190733,0.20973194],"genre_scores_gemma":[0.9926661,0.000006738394,0.00006552921,0.0014105837,0.00050329714,0.000005015253,0.00000871939,0.000043260632,0.005290707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998938,0.00020626998,0.00024216707,0.00022865554,0.00015244324,0.00023244038],"domain_scores_gemma":[0.99937105,0.000036013706,0.00008285835,0.00041999953,0.00004067488,0.00004938226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094991614,0.00014353984,0.00020423606,0.000050709255,0.00006586807,0.000003912141,0.0001670403,0.000041564475,0.00033325367],"category_scores_gemma":[0.000021073763,0.00009430368,0.00013551756,0.00011177237,0.0001974134,0.000020277783,0.00009767888,0.0001647199,0.00019733736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022743254,0.0018094,0.90992594,0.00008013489,0.0003202557,0.0013970111,0.00055052777,0.00007864492,0.038115844,0.0027795432,0.038475648,0.0041927295],"study_design_scores_gemma":[0.0027835574,0.0010131495,0.92199403,0.000005849789,0.00017279063,0.0005548448,0.0000102830545,0.00001742613,0.007078368,0.00015489076,0.066121615,0.00009320397],"about_ca_topic_score_codex":0.0001101657,"about_ca_topic_score_gemma":0.0000075111584,"teacher_disagreement_score":0.20454046,"about_ca_system_score_codex":0.00002010706,"about_ca_system_score_gemma":0.000079565434,"threshold_uncertainty_score":0.38455924},"labels":[],"label_agreement":null},{"id":"W2202588822","doi":"10.1159/000381589","title":"A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium","year":2015,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Steinbach Bible College","funders":"AstraZeneca","keywords":"Medicine; Gefitinib; Gemcitabine; Chemotherapy; Internal medicine; Oncology; Concomitant; Tolerability; Phases of clinical research; Nausea; Epidermal growth factor receptor; Clinical endpoint; Adverse effect; Cancer; Randomized controlled trial","score_opus":0.11651800563922421,"score_gpt":0.3822319459424833,"score_spread":0.26571394030325907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202588822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939152,0.00001854805,0.000019764077,0.00013916133,0.00007050234,0.0041131866,0.001497121,0.000005083453,0.0002214387],"genre_scores_gemma":[0.99881715,0.0000025302775,0.0007264575,0.000060592913,0.000021847105,0.000081859995,0.0000600413,0.000035111105,0.00019440737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960707,0.0008145793,0.0009472943,0.00039786796,0.0015214075,0.00024818227],"domain_scores_gemma":[0.9973228,0.00021014914,0.00071961246,0.0005270045,0.0011342799,0.000086183936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095402024,0.00022561853,0.0006785477,0.00010753543,0.00006504955,0.000008804478,0.00068099244,0.000031663785,0.0000570069],"category_scores_gemma":[0.00014195421,0.00010192204,0.000052812964,0.00057214487,0.00044074588,0.00016230541,0.00023888361,0.0002545263,1.5347715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35723576,0.10311295,0.47704393,0.00032940102,0.0015596611,0.00005339824,0.055137962,0.0010359571,0.003599285,0.000039614904,0.00015459137,0.0006975033],"study_design_scores_gemma":[0.35520014,0.1568727,0.463066,0.0003407546,0.0008519631,0.000013607521,0.014126586,0.0016717413,0.007618083,0.000015530091,0.000022825978,0.00020003489],"about_ca_topic_score_codex":0.004069056,"about_ca_topic_score_gemma":0.0035147748,"teacher_disagreement_score":0.053759754,"about_ca_system_score_codex":0.00012078184,"about_ca_system_score_gemma":0.0007424735,"threshold_uncertainty_score":0.61512226},"labels":[],"label_agreement":null},{"id":"W2210425373","doi":"10.5489/cuaj.2796","title":"A standardized protocol for identifying and counting lymph nodes harvested by pelvic lymph node dissection at the time of radical cystectomy","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bladder Cancer Canada; Canadian Urological Oncology Group","keywords":"Cystectomy; Lymph node; Lymph; Medicine; Dissection (medical); Urology; Radiology; Bladder cancer; Pathology; Internal medicine; Cancer","score_opus":0.02727875520416456,"score_gpt":0.29935673471876034,"score_spread":0.2720779795145958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210425373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96055007,0.00025904962,0.0009477375,0.011416676,0.00021953801,0.025012575,0.00034495915,0.000046784153,0.0012026265],"genre_scores_gemma":[0.98665303,0.0000063477787,0.000312324,0.0018416452,0.00041837417,0.008690816,0.00005208231,0.00003227058,0.0019930843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985654,0.00016989448,0.0003497639,0.00016947152,0.00041654843,0.00032895702],"domain_scores_gemma":[0.9986004,0.00016747513,0.0003193036,0.00007908119,0.00035614145,0.00047758542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009863894,0.00013049897,0.00030019315,0.000073392715,0.00034075623,0.0001009314,0.000069557216,0.00016708556,0.0001714174],"category_scores_gemma":[0.00076186826,0.000084656844,0.000104202976,0.00013029319,0.00006637232,0.00010825768,0.000015537855,0.00015610077,0.0000075767193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016770208,0.00009334042,0.97309417,0.00006118337,0.00037124747,0.000025892363,0.00046555945,0.000012405107,0.0026699787,0.000023661974,0.019596718,0.0019088284],"study_design_scores_gemma":[0.04695378,0.0008908105,0.8404028,0.00021821384,0.00066691136,0.0012464811,0.00044675518,0.0014621267,0.0016278739,0.0012060372,0.104453705,0.0004245115],"about_ca_topic_score_codex":0.00086859136,"about_ca_topic_score_gemma":0.00019189781,"teacher_disagreement_score":0.13269137,"about_ca_system_score_codex":0.0018272474,"about_ca_system_score_gemma":0.0007147007,"threshold_uncertainty_score":0.47781885},"labels":[],"label_agreement":null},{"id":"W2215619052","doi":"10.1002/cncy.21668","title":"The atypical urothelial cell category in the Paris System: Strengthening the Achilles' heel","year":2015,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Heel; Urothelial cancer; Dermatology; Cancer; Internal medicine; Anatomy; Bladder cancer","score_opus":0.03198369788495293,"score_gpt":0.2981440843057405,"score_spread":0.2661603864207876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215619052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8961154,0.024810279,0.00030960515,0.02060331,0.002915056,0.0022529452,0.00007755164,0.00014945476,0.05276638],"genre_scores_gemma":[0.99472606,0.00037713867,0.00002900599,0.0026479163,0.0008808477,0.00053858844,0.000007859533,0.000031959495,0.00076064904],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980233,0.00051529997,0.000347397,0.0003255544,0.00031703836,0.00047142786],"domain_scores_gemma":[0.9987929,0.00025381686,0.00010840853,0.000651117,0.000081678416,0.00011208207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081735244,0.00022241993,0.00032118597,0.000040852938,0.00029089145,0.000041176703,0.0004107944,0.00014137191,0.00002028005],"category_scores_gemma":[0.00005818371,0.000096019445,0.000108539694,0.00020261832,0.00032310546,0.000037576323,0.00007732235,0.0005458454,0.00007469454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017166553,0.0019775531,0.59353435,0.00064495497,0.00062391075,0.005244727,0.09314452,0.0010857062,0.0042723785,0.026198965,0.15164302,0.104463354],"study_design_scores_gemma":[0.02688949,0.003616663,0.26597542,0.00037797232,0.0017297734,0.0036579354,0.067706645,0.0013000712,0.004570781,0.0020920157,0.6208778,0.0012054367],"about_ca_topic_score_codex":0.0005503075,"about_ca_topic_score_gemma":0.0002993164,"teacher_disagreement_score":0.4692348,"about_ca_system_score_codex":0.00026490056,"about_ca_system_score_gemma":0.0004883965,"threshold_uncertainty_score":0.39155594},"labels":[],"label_agreement":null},{"id":"W2221909862","doi":"10.1016/j.urolonc.2015.05.010","title":"Re: Herr et al.: BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4)","year":2015,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Campbell Scientific (Canada); Queen's University","funders":"","keywords":"Medicine; Prospective cohort study; Bladder cancer; Cohort; Refractory (planetary science); Oncology; Internal medicine; Cancer","score_opus":0.03602959298876951,"score_gpt":0.36498020033081774,"score_spread":0.32895060734204823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221909862","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19693182,0.004762354,0.000030046938,0.7665254,0.0031588203,0.009501153,0.0010231703,0.000431985,0.017635234],"genre_scores_gemma":[0.04519523,0.0031503995,0.004584324,0.9230785,0.0025727975,0.0055418485,0.0011967293,0.00030977908,0.014370407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99351263,0.00084465044,0.0011869674,0.002084046,0.0011443263,0.0012273984],"domain_scores_gemma":[0.9954463,0.0010244669,0.0009996435,0.001088172,0.00064966636,0.0007916991],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.000998022,0.0013943339,0.0025585855,0.0005765328,0.0006491094,0.00012440073,0.0004805694,0.0017974081,0.00061855593],"category_scores_gemma":[0.0004917174,0.0011318619,0.0003670978,0.0006001112,0.0014714526,0.00036892455,0.00026689764,0.0046080337,0.00016420372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023805442,0.00087156624,0.41334787,0.00006225667,0.0015436895,0.0019215574,0.0018093422,0.000014778816,0.000024382072,0.000017639,0.5797525,0.00039635223],"study_design_scores_gemma":[0.006130864,0.012308568,0.04910938,0.00030826803,0.0048973253,0.00028420953,0.0011501543,0.000027365399,0.000026670255,0.0011588491,0.9236404,0.0009579815],"about_ca_topic_score_codex":0.0025059173,"about_ca_topic_score_gemma":0.0016382429,"teacher_disagreement_score":0.36423847,"about_ca_system_score_codex":0.002064211,"about_ca_system_score_gemma":0.005948503,"threshold_uncertainty_score":0.99988073},"labels":[],"label_agreement":null},{"id":"W2222013202","doi":"10.1007/s00345-015-1755-5","title":"Evolving concepts in muscle-invasive bladder cancer","year":2016,"lang":"en","type":"editorial","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Prehabilitation; Urinary diversion; Bladder cancer; Nephrology; Psychological intervention; Quality of life (healthcare); Intensive care medicine; Internal medicine; General surgery; Cancer; Physical therapy; Nursing","score_opus":0.012942550612094974,"score_gpt":0.32949300029854356,"score_spread":0.3165504496864486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2222013202","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054412184,0.035707813,0.00001888408,0.0037832668,0.9523972,0.00030711482,0.00014426875,0.000015466736,0.007081829],"genre_scores_gemma":[0.046813328,0.01091403,0.000087219116,0.0010603158,0.92460513,0.000031982167,0.000019437373,0.00010037165,0.016368156],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748397,0.00017609555,0.0008586231,0.00033219432,0.0006551032,0.0004940272],"domain_scores_gemma":[0.9969714,0.0010582338,0.0008007647,0.00026961247,0.0006682099,0.00023173873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032303008,0.00036478307,0.0012039109,0.00072784704,0.000031664928,0.00001531753,0.00026283413,0.00056553434,0.0021890616],"category_scores_gemma":[0.0006928977,0.00025430004,0.00031413528,0.00022941812,0.00018314869,0.00011460304,0.00005819997,0.0015006112,0.000040774252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009011729,0.0001325391,0.0022642582,0.00006384921,0.0006039701,0.0014805518,0.000270784,0.0000036905114,0.00025027632,0.000005885922,0.98199934,0.012023679],"study_design_scores_gemma":[0.007303045,0.0010685038,0.0026324322,0.0006993015,0.0007463048,0.000088555375,0.000018009347,9.759104e-7,0.00003503361,0.0002452106,0.9869556,0.00020702109],"about_ca_topic_score_codex":0.00016868052,"about_ca_topic_score_gemma":0.0017799829,"teacher_disagreement_score":0.04626921,"about_ca_system_score_codex":0.0007371001,"about_ca_system_score_gemma":0.003784149,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W2227453873","doi":"10.1007/s00432-015-2107-y","title":"Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma","year":2016,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Deutsche Gesellschaft für Urologie","keywords":"Hematology; Prostate carcinoma; Cancer research; Urothelial carcinoma; Internal medicine; Oncology; Prostate; Medicine; Prostate cancer; Carcinoma; Biology; Cancer; Bladder cancer","score_opus":0.13272732300682794,"score_gpt":0.4977827771389683,"score_spread":0.36505545413214036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227453873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872165,0.0018423062,0.0000073108636,0.008964969,0.0002996934,0.00040934957,0.000020725729,0.000003886833,0.001235308],"genre_scores_gemma":[0.98894227,0.008634325,0.00018950345,0.00047990607,0.0008609335,0.000039813014,4.2652675e-7,0.000017357914,0.00083547854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748504,0.00046844958,0.0008570402,0.0002453787,0.0005357831,0.0004082933],"domain_scores_gemma":[0.9969574,0.0016030167,0.0002794734,0.00015872717,0.00052477117,0.00047658957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001595574,0.00011542126,0.00065221114,0.00021957677,0.00004983477,0.000012627796,0.00013777602,0.00015054228,0.0003752014],"category_scores_gemma":[0.0010969295,0.00006078711,0.00012913632,0.00015685198,0.00043903835,0.00014383307,0.00009065273,0.00069672824,0.000011003042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025364017,0.0013260484,0.79336226,0.000069751324,0.00013428318,0.0019417829,0.00024093581,2.0923032e-7,0.09142069,0.00003040368,0.006155082,0.07995454],"study_design_scores_gemma":[0.04449819,0.034695305,0.8003303,0.0016701614,0.00009735993,0.00030696677,0.00036638882,0.0000021546946,0.06715658,0.0031636471,0.04754368,0.00016928118],"about_ca_topic_score_codex":0.00020641982,"about_ca_topic_score_gemma":0.00030836332,"teacher_disagreement_score":0.07978526,"about_ca_system_score_codex":0.0003888363,"about_ca_system_score_gemma":0.0032483824,"threshold_uncertainty_score":0.57624906},"labels":[],"label_agreement":null},{"id":"W2238983210","doi":"10.1200/jco.2014.32.4_suppl.298","title":"Multi-institutional quality care initiative (QCI) to improve the care of patients with invasive bladder cancer (BlCa).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Mount Sinai Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cisplatin; Regimen; Chemotherapy; Cystectomy; Multimodal therapy; Internal medicine; Chemotherapy regimen; Oncology; Cancer; Bladder cancer","score_opus":0.11481107534141441,"score_gpt":0.46490110204930074,"score_spread":0.35009002670788636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238983210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205047,0.00048048134,0.00040454246,0.0026295832,0.0012249494,0.0006312647,0.00017570429,0.0000046343785,0.0023983542],"genre_scores_gemma":[0.99190784,0.00008524605,0.001902311,0.0052366764,0.0007761944,0.000024889327,0.0000126289815,0.000013943137,0.000040295625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973165,0.0004485471,0.0013487018,0.00020389898,0.0004908726,0.0001914763],"domain_scores_gemma":[0.9945447,0.0012990485,0.001220601,0.0002150072,0.002416874,0.00030377062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006143708,0.00016706235,0.0011045686,0.00006366795,0.0000772554,0.000005095397,0.00017536797,0.00020930162,0.000104434446],"category_scores_gemma":[0.0023551255,0.00008141626,0.00031097286,0.000117924814,0.00033822632,0.000085126965,0.000054457978,0.00057057326,0.00000789285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008905141,0.0015130725,0.88211006,0.00011458697,0.0013176422,0.00003616923,0.005273629,0.00008522119,0.00009492281,0.00009385973,0.00071870664,0.09973702],"study_design_scores_gemma":[0.016166953,0.015606948,0.95302474,0.00014596715,0.0006416827,0.0000058050828,0.0017248297,0.0000029862235,0.0005947184,0.000026835582,0.011959291,0.000099261546],"about_ca_topic_score_codex":0.0002636067,"about_ca_topic_score_gemma":0.0014390635,"teacher_disagreement_score":0.099637754,"about_ca_system_score_codex":0.00032313628,"about_ca_system_score_gemma":0.0038356679,"threshold_uncertainty_score":0.680431},"labels":[],"label_agreement":null},{"id":"W2239178350","doi":"10.1007/s00262-015-1789-y","title":"Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Bladder cancer; Immunotherapy; Cancer research; Immunogenicity; TLR2; TLR3; Cytotoxic T cell; Cancer; Adjuvant; Immune system; Medicine; Immunology; Toll-like receptor; In vitro; Chemistry; Innate immune system; Internal medicine","score_opus":0.02437876967905506,"score_gpt":0.31402596941648786,"score_spread":0.2896471997374328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239178350","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37313533,0.5742315,0.00944677,0.030867528,0.0055028554,0.0037998296,0.0012339272,0.00070307316,0.0010791671],"genre_scores_gemma":[0.7910373,0.14573455,0.0019785895,0.015404064,0.0014702874,0.007895888,0.00010728228,0.0006410108,0.03573101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966086,0.00011526619,0.00076901674,0.0009442943,0.00033173198,0.0012310923],"domain_scores_gemma":[0.9977895,0.00020118507,0.00032085486,0.0011252274,0.00040979785,0.00015345933],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021282565,0.000742228,0.0010791644,0.0003112749,0.00036885336,0.00004762968,0.0004934762,0.00048492564,0.00677829],"category_scores_gemma":[0.000029768478,0.00050262036,0.000616539,0.0003655583,0.0005919792,0.00027146778,0.000055837943,0.0003033033,0.00013709435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005396856,0.00030772883,0.010415704,0.00003122714,0.0046579754,0.000014913044,0.00033380982,7.892266e-7,0.42337766,0.00021343683,0.003081437,0.5521684],"study_design_scores_gemma":[0.05068064,0.0029566616,0.09469345,0.00057612656,0.0005545985,0.0001669751,0.00015794944,0.000012752501,0.30662543,0.0011540235,0.54106176,0.0013596173],"about_ca_topic_score_codex":0.002016937,"about_ca_topic_score_gemma":0.00013764594,"teacher_disagreement_score":0.55080885,"about_ca_system_score_codex":0.0008183914,"about_ca_system_score_gemma":0.00079319126,"threshold_uncertainty_score":0.99974257},"labels":[],"label_agreement":null},{"id":"W2248318148","doi":"","title":"Response of bladder cancer cells and xenografts to treatment with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and gemcitabine","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Apoptosis; Necrosis; Chemistry; Cell culture; Molecular biology; Cytotoxicity; Bladder cancer; Flow cytometry; Medicine; Cancer cell; Cancer; Pharmacology; Cancer research; Pathology; In vitro; Biology; Internal medicine; Biochemistry","score_opus":0.02166410143764098,"score_gpt":0.2942671363975314,"score_spread":0.2726030349598904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248318148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156976,0.005491788,0.0003199515,0.0012950771,0.00013312795,0.00091671455,0.00012257864,0.00004197713,0.000109042034],"genre_scores_gemma":[0.995288,0.0012157578,0.0006703992,0.0022339888,0.00004199157,0.00009627863,0.0000047445933,0.00008281918,0.00036603448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838084,0.000052602398,0.00033392198,0.00047494314,0.00031491087,0.00044278262],"domain_scores_gemma":[0.99904984,0.00006376633,0.00011920426,0.0003245729,0.00013908745,0.00030350412],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013982736,0.0003760432,0.0005159562,0.00018368369,0.00009011516,0.000028885042,0.00006176382,0.0001130465,0.00006456355],"category_scores_gemma":[0.0000034639706,0.00028001203,0.000077924444,0.00036188975,0.0001454967,0.000049632512,0.000029661574,0.00012814818,0.0000018896995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004924731,0.00023084384,0.015447613,0.000059626793,0.0015130033,0.00006733339,0.003617956,0.000023603845,0.9419995,0.0000057634916,0.000013753309,0.032096274],"study_design_scores_gemma":[0.0053276806,0.0028147432,0.041216604,0.00024469,0.0010170809,0.000027577014,0.0002187816,0.000019659736,0.9452956,0.000010754141,0.0035096416,0.00029721786],"about_ca_topic_score_codex":0.001181058,"about_ca_topic_score_gemma":0.00023205095,"teacher_disagreement_score":0.031799056,"about_ca_system_score_codex":0.0002618974,"about_ca_system_score_gemma":0.0002448494,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W2258126254","doi":"10.3233/blc-150034","title":"Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)","year":2016,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Guideline; Nice; Medicine; Presentation (obstetrics); Bladder cancer; Family medicine; Cancer; Intensive care medicine; Pathology; Internal medicine; Computer science; Surgery","score_opus":0.16288173485036742,"score_gpt":0.47426121375546115,"score_spread":0.31137947890509377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258126254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014274582,0.98281413,0.00003245703,0.00094916846,0.0023490088,0.0029819002,0.0019197487,0.00012154476,0.008689292],"genre_scores_gemma":[0.00046424472,0.97849476,0.00020987971,0.0016514681,0.0034219828,0.002239332,0.00020008946,0.00036929452,0.012948965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374276,0.00014758942,0.002296357,0.0015263389,0.0012355138,0.0010514439],"domain_scores_gemma":[0.9951325,0.00033616935,0.0014764019,0.0016028271,0.0009318288,0.00052028353],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00021653897,0.0015008581,0.005170206,0.00050691963,0.00017079967,0.000044795765,0.0006584622,0.0009127081,0.007869844],"category_scores_gemma":[0.00016279591,0.0009968597,0.0014855184,0.00067622436,0.00030519243,0.00015878292,0.00020577485,0.00080833514,0.0006684167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018555016,0.0005018235,0.00036770754,0.008778568,0.0035813178,0.00004047617,0.00028323027,0.0000066983534,0.000048781854,0.000022449536,0.18502708,0.80115634],"study_design_scores_gemma":[0.0031059517,0.00064108666,0.00024745398,0.057910543,0.005995269,0.000017381024,0.00007370354,0.000006487829,0.0007161859,0.00002845194,0.9303028,0.00095469045],"about_ca_topic_score_codex":0.002780407,"about_ca_topic_score_gemma":0.0012369467,"teacher_disagreement_score":0.80020165,"about_ca_system_score_codex":0.0010484777,"about_ca_system_score_gemma":0.0050107418,"threshold_uncertainty_score":0.99977404},"labels":[],"label_agreement":null},{"id":"W2261580129","doi":"10.1200/jco.2015.33.7_suppl.295","title":"Interim results of a randomized phase 2 study of docetaxel with ramucirumab versus docetaxel in second-line advanced or metastatic urothelial carcinoma.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Docetaxel; Medicine; Ramucirumab; Taxane; Metastatic Urothelial Carcinoma; Internal medicine; Clinical endpoint; Paclitaxel; Oncology; Regimen; Interim analysis; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Chemotherapy regimen; Concomitant; Progression-free survival; Chemotherapy; Urology; Clinical trial; Cancer; Breast cancer; Bladder cancer; Urothelial carcinoma","score_opus":0.24961236287668484,"score_gpt":0.5155956843028914,"score_spread":0.2659833214262065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261580129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437296,0.0004862,0.000108466345,0.00072615966,0.0010138828,0.0014970643,0.00004026285,0.000005967006,0.0017490581],"genre_scores_gemma":[0.9958761,0.00011534175,0.0031551996,0.00020932862,0.00028792737,0.000030481797,0.0000048611673,0.000026922875,0.00029388146],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99235964,0.0014182514,0.005016838,0.0002894944,0.0006532272,0.00026252546],"domain_scores_gemma":[0.9909129,0.003636373,0.003715377,0.0003474102,0.00096239283,0.00042551596],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005486579,0.0002571316,0.0050273906,0.0003117282,0.000013455439,0.0000049146934,0.00023260836,0.00016084389,0.0001366528],"category_scores_gemma":[0.00853889,0.00014184523,0.0004922696,0.0003163441,0.00037686963,0.00015128167,0.000055246852,0.00072859577,0.0000030387914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95314795,0.020574864,0.0015486282,0.00006717337,0.0021033532,0.0015806613,0.0016979221,0.000080550206,0.00012815683,0.0000068423196,0.0002298617,0.018834056],"study_design_scores_gemma":[0.7998972,0.19166091,0.0017444206,0.00016418888,0.0022814095,0.00020309142,0.0022652752,0.00011473943,0.00055822346,0.000068975176,0.0009382393,0.000103331346],"about_ca_topic_score_codex":0.0002225474,"about_ca_topic_score_gemma":0.0008819293,"teacher_disagreement_score":0.17108604,"about_ca_system_score_codex":0.00017824941,"about_ca_system_score_gemma":0.0039949496,"threshold_uncertainty_score":0.9998126},"labels":[],"label_agreement":null},{"id":"W2263980547","doi":"10.3233/blc-150026","title":"Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer","year":2016,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Blockade; Immune checkpoint; Immune system; Medicine; Cancer; Immunotherapy; Oncology; Cancer research; Immunology; Internal medicine; Receptor","score_opus":0.08522930557432609,"score_gpt":0.39982140468445465,"score_spread":0.31459209911012853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263980547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020820202,0.98869795,0.00007164846,0.00069338153,0.0013292644,0.0054374654,0.0021300495,0.000072143645,0.0015472777],"genre_scores_gemma":[0.00008872667,0.97105587,0.00009659895,0.0001879607,0.0027215346,0.010700444,0.00010531284,0.00026394584,0.014779606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659705,0.000079966405,0.0012212826,0.00084738893,0.0004749946,0.00077929924],"domain_scores_gemma":[0.99721545,0.00048237128,0.0008507984,0.00095865555,0.0002915275,0.00020117762],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015918046,0.0009785456,0.0029940417,0.00018927656,0.00021284341,0.000031972708,0.00030096716,0.00043954817,0.003650176],"category_scores_gemma":[0.000035379904,0.00048164447,0.001934197,0.00034842594,0.00025229395,0.00007826151,0.000056478686,0.00021506826,0.00008984155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001740292,0.00037160362,0.00003455483,0.005371262,0.0067451396,0.000010442547,0.00026537295,5.7097594e-7,0.00002521217,0.000025713038,0.00389073,0.9830854],"study_design_scores_gemma":[0.00411763,0.0006750645,0.00006022017,0.018935813,0.01123041,0.000030235085,0.000046061108,0.000003560869,0.000802615,0.000026648167,0.9635926,0.00047915746],"about_ca_topic_score_codex":0.0013881862,"about_ca_topic_score_gemma":0.00020729528,"teacher_disagreement_score":0.98260623,"about_ca_system_score_codex":0.0011268355,"about_ca_system_score_gemma":0.0021942973,"threshold_uncertainty_score":0.99976355},"labels":[],"label_agreement":null},{"id":"W2266807489","doi":"10.1007/978-3-319-22864-8_9","title":"Ancillary Studies in Urinary Cytology","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Cytology; Medicine; Urine cytology; Urinary system; Urology; Transitional cell carcinoma; Food and drug administration; Urothelial Cell; Urine; Bladder cancer; Gynecology; Pathology; Internal medicine; Cancer; Cystoscopy; Urothelium","score_opus":0.179293757489891,"score_gpt":0.38267198599386215,"score_spread":0.20337822850397116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266807489","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019524634,0.051990442,0.0000013568748,0.00048906635,0.00035552285,0.0003643292,0.0000131401475,0.000054734723,0.9465362],"genre_scores_gemma":[0.0130979605,0.0042892145,0.00014771699,0.0009415788,0.00034956489,0.000022725353,0.000042111973,0.000050229024,0.9810589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990879,0.000007906036,0.0002328731,0.00029466985,0.00019891326,0.00017770116],"domain_scores_gemma":[0.9994318,0.000026460344,0.00004852608,0.0002741532,0.00012127006,0.00009779006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007237395,0.00025654418,0.00068635424,0.00015218469,0.000014221842,0.0000016719911,0.000048682665,0.00026691667,0.0009048974],"category_scores_gemma":[0.000016236936,0.00019055173,0.00008633071,0.000016744381,0.00012732286,0.000020587824,0.000071186645,0.00024036445,0.0003884454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021780708,0.00086740736,0.014815546,0.0014377933,0.0055221603,0.037270695,0.0021340365,0.0000023470543,0.000027770066,0.09372705,0.8101654,0.03185173],"study_design_scores_gemma":[0.0038897481,0.0022875287,0.0011438086,0.00061809394,0.00046848578,0.0013456285,0.00013757072,0.000001406746,0.000019400642,0.030296506,0.9594168,0.00037504119],"about_ca_topic_score_codex":0.000032593598,"about_ca_topic_score_gemma":0.00006756928,"teacher_disagreement_score":0.14925139,"about_ca_system_score_codex":0.00031839093,"about_ca_system_score_gemma":0.00027332036,"threshold_uncertainty_score":0.9907992},"labels":[],"label_agreement":null},{"id":"W2267222845","doi":"10.1038/nrurol.2015.265","title":"A step closer to individualized treatment for bladder cancer","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Oncology; Disease; Internal medicine; Cancer","score_opus":0.12379781233226712,"score_gpt":0.47026255926576926,"score_spread":0.34646474693350215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267222845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.928237e-7,0.97934383,0.000040042352,0.0009355858,0.0013647516,0.014903355,0.0010281357,0.00007506897,0.0023087566],"genre_scores_gemma":[4.2269738e-7,0.9701853,0.0022913744,0.005387338,0.0018078276,0.014169409,0.00087861,0.00018633956,0.005093413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962778,0.00043776524,0.001101302,0.0011306003,0.0003171003,0.0007354384],"domain_scores_gemma":[0.997503,0.00018276628,0.0005073328,0.0009987651,0.00024116065,0.00056696474],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00049836526,0.0010819004,0.0065254713,0.0003633397,0.0000717184,0.000021628795,0.00031515953,0.001954201,0.00051813177],"category_scores_gemma":[0.00020999098,0.00063972175,0.0016240667,0.00053293706,0.00005179042,0.000034771554,0.00008134392,0.0008738004,0.00049267546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019192169,0.0002210905,0.0000076141982,0.006569793,0.001570352,0.000029965548,0.00006281995,4.4238206e-8,1.1053046e-7,0.000064248896,0.08990366,0.9013784],"study_design_scores_gemma":[0.003052551,0.00228227,0.0000024929345,0.0031484752,0.018178472,0.00021223076,0.0000017426013,3.5575283e-7,5.7481606e-7,0.000032934844,0.9726353,0.0004525883],"about_ca_topic_score_codex":0.000051317766,"about_ca_topic_score_gemma":0.00010315901,"teacher_disagreement_score":0.9009258,"about_ca_system_score_codex":0.00085166254,"about_ca_system_score_gemma":0.0017155486,"threshold_uncertainty_score":0.9996054},"labels":[],"label_agreement":null},{"id":"W2274364094","doi":"10.1007/s00345-015-1734-x","title":"Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy","year":2015,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Dissection (medical); Nephrology; Lymph node; Urology; General surgery; Surgery; Internal medicine; Oncology; Bladder cancer; Cancer","score_opus":0.010361321916316694,"score_gpt":0.2557221911492835,"score_spread":0.24536086923296682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274364094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675304,0.0016463837,0.00014928912,0.00031245215,0.0002935963,0.000088668705,0.0000025861038,0.0000045912916,0.00074936927],"genre_scores_gemma":[0.9991861,0.00016784783,0.00030396218,0.0001536396,0.00010869784,0.0000013088558,0.0000016531217,0.000011666771,0.00006512493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990787,0.00006380664,0.00039443682,0.00010844092,0.00019893081,0.00015571056],"domain_scores_gemma":[0.99929047,0.0000901833,0.00027295272,0.000084980675,0.000113047645,0.00014836526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024028902,0.00009442678,0.00035328892,0.00031320713,0.000021119806,0.000003916826,0.00004310858,0.00005569927,0.000022811573],"category_scores_gemma":[0.00011795377,0.000074761694,0.000054702745,0.00016762834,0.00005478499,0.00006725718,0.000019780062,0.00020153147,0.000001446784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019919572,0.00023777851,0.98762465,0.000024660969,0.00008471111,0.000061505365,0.00028516343,0.00008270452,0.00009956457,0.00004224736,0.000039201048,0.009425831],"study_design_scores_gemma":[0.014559912,0.0014392601,0.9816397,0.00008322893,0.00019500333,0.00030754367,0.00006408676,0.000101029895,0.00009624783,0.001194644,0.00026332817,0.000056018074],"about_ca_topic_score_codex":0.000078880184,"about_ca_topic_score_gemma":0.00017825408,"teacher_disagreement_score":0.012567954,"about_ca_system_score_codex":0.0001269538,"about_ca_system_score_gemma":0.00012135929,"threshold_uncertainty_score":0.30486932},"labels":[],"label_agreement":null},{"id":"W2276372248","doi":"10.1159/000444093","title":"Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec","year":2016,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Urology; Internal medicine; Proportional hazards model; Retrospective cohort study; Cancer; Gastroenterology; Surgery; Confidence interval","score_opus":0.015750591516895715,"score_gpt":0.29638197900170876,"score_spread":0.28063138748481303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276372248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836393,0.00012374707,0.001095674,0.013111589,0.0003527466,0.0010534115,0.0002740584,0.000023383873,0.00032607783],"genre_scores_gemma":[0.9942979,0.000026407793,0.00018865764,0.0016058979,0.00021900622,0.0014274038,0.000031440035,0.000021735326,0.0021815063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888843,0.000039001257,0.0002686891,0.00034092335,0.00024272692,0.00022021029],"domain_scores_gemma":[0.99933237,0.00022017956,0.000048355574,0.00015519166,0.00010263055,0.00014129086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121105506,0.00013851996,0.0001958728,0.00021915308,0.000015767213,0.000012728094,0.000096122094,0.00008434485,0.00076045666],"category_scores_gemma":[0.0003643006,0.00009681169,0.000076828816,0.00013303618,0.00004447913,0.00013445187,0.00003843529,0.00007949785,0.00004680636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036376505,0.00026333146,0.98245746,0.000030813095,0.00009022342,0.00011518363,0.00047830507,0.000066071734,0.00160094,0.00026789863,0.00061189063,0.010380225],"study_design_scores_gemma":[0.0049419613,0.00017678419,0.9893478,0.00018994609,0.00004208728,0.000001065686,0.000011254098,0.00008422075,0.00045042095,0.00034335043,0.0042917538,0.00011931527],"about_ca_topic_score_codex":0.008536725,"about_ca_topic_score_gemma":0.03528335,"teacher_disagreement_score":0.026746623,"about_ca_system_score_codex":0.00049781037,"about_ca_system_score_gemma":0.00029883886,"threshold_uncertainty_score":0.99806553},"labels":[],"label_agreement":null},{"id":"W2276942708","doi":"10.1016/j.juro.2015.10.175","title":"Root Causes and Modifiability of 30-Day Hospital Readmissions after Radical Cystectomy for Bladder Cancer","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Multivariate analysis; Hospital readmission; Emergency medicine; Surgery; Intensive care medicine; Cancer; Internal medicine; General surgery","score_opus":0.027173359026978858,"score_gpt":0.31547203382187244,"score_spread":0.2882986747948936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276942708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858812,0.005070159,0.0003870238,0.007887604,0.0002931577,0.0003038745,0.000030587842,0.0000046669393,0.00014171851],"genre_scores_gemma":[0.99896324,0.00014650346,0.00010300861,0.00037258284,0.00027961013,0.000017996223,6.4287946e-7,0.000012470889,0.000103927574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991504,0.00013346488,0.00030280647,0.00008706926,0.00016750468,0.00015877465],"domain_scores_gemma":[0.99900365,0.0002097401,0.00016776845,0.00015844879,0.0002443033,0.00021607944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005067278,0.00009980144,0.0003442204,0.000048036713,0.000028873386,0.0000028187424,0.00007823354,0.0000849258,0.00014029042],"category_scores_gemma":[0.0002548634,0.000053187225,0.00008040494,0.00004668755,0.00024200573,0.000042147014,0.000028019818,0.00017415115,0.0000012239203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047637522,0.004230429,0.8284019,0.00047960615,0.005897463,0.00043211607,0.026627354,0.00040202303,0.011637507,0.00032144322,0.04917846,0.024754142],"study_design_scores_gemma":[0.037137024,0.032847736,0.82991654,0.00020880126,0.0075400244,0.0019031864,0.0010500668,0.00045958185,0.010175872,0.0099974675,0.06828101,0.00048271983],"about_ca_topic_score_codex":0.000086062406,"about_ca_topic_score_gemma":0.000024216077,"teacher_disagreement_score":0.028617308,"about_ca_system_score_codex":0.000043245156,"about_ca_system_score_gemma":0.00035545308,"threshold_uncertainty_score":0.2168912},"labels":[],"label_agreement":null},{"id":"W2277020184","doi":"10.5489/cuaj.3143","title":"Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Health; University of Calgary","funders":"Alberta Health Services","keywords":"Medicine; Bladder cancer; Cancer; Retrospective cohort study; Medical record; Cancer registry; Internal medicine; Urology","score_opus":0.027525155809582095,"score_gpt":0.30152775828685613,"score_spread":0.27400260247727404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277020184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8320885,0.00013440692,0.000047909056,0.16694,0.00007514824,0.00055707304,0.000085299456,0.0000020295745,0.00006965227],"genre_scores_gemma":[0.9916328,0.00008074457,0.00006142218,0.007911159,0.000090408255,0.000052367977,0.0000028549557,0.000007609111,0.00016058683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998898,0.00012329557,0.00030837615,0.00013534511,0.0002463323,0.00028865048],"domain_scores_gemma":[0.9989757,0.00042719368,0.00022253659,0.000090975635,0.0001626182,0.00012095767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040203333,0.000120114746,0.00028378476,0.000074304386,0.000089711735,0.000024627661,0.000090986745,0.000068674315,0.00004787156],"category_scores_gemma":[0.00042904392,0.000042067128,0.000072988165,0.000085667714,0.000062990315,0.000050005998,0.0000057763577,0.00017836978,7.185487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010018143,0.000091942595,0.98737836,0.000005578259,0.00015949034,0.000034368575,0.00032195295,0.00031805006,0.000022740687,0.0001243762,0.002991385,0.0075499224],"study_design_scores_gemma":[0.008024373,0.00075178925,0.98909986,0.00011192225,0.000070463335,0.000018967523,0.00012325663,0.00017343122,0.00003519666,0.0006568776,0.00085524214,0.00007859409],"about_ca_topic_score_codex":0.019380957,"about_ca_topic_score_gemma":0.03762037,"teacher_disagreement_score":0.15954438,"about_ca_system_score_codex":0.0005252319,"about_ca_system_score_gemma":0.00041170424,"threshold_uncertainty_score":0.98714906},"labels":[],"label_agreement":null},{"id":"W2277180156","doi":"10.1007/s00345-016-1795-5","title":"Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study","year":2016,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Internal medicine; Bladder cancer; Prospective cohort study; Proportional hazards model; Urology; Univariate analysis; Cytology; Cystoscopy; Urinary system; Nephrology; Multivariate analysis; Gastroenterology; Cancer; Oncology; Pathology","score_opus":0.019534510624666882,"score_gpt":0.3372956907641188,"score_spread":0.3177611801394519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277180156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845506,0.007919616,0.00007570033,0.0022183165,0.00014040997,0.001062446,0.000009882792,0.0000036269917,0.00011493925],"genre_scores_gemma":[0.9989851,0.00033213876,0.0003593975,0.00012186642,0.00006420165,0.00008085324,1.2371606e-7,0.000011728848,0.000044568802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916136,0.00009865469,0.00031452457,0.0001692166,0.00009290197,0.00016332579],"domain_scores_gemma":[0.9993122,0.00021055149,0.00023357756,0.00007257595,0.00010037356,0.00007069952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002422149,0.00010453995,0.00037277688,0.00025110616,0.000021492706,0.000002200138,0.000044274053,0.000045627105,0.000023709874],"category_scores_gemma":[0.00009629402,0.00006013756,0.000033525725,0.00012019618,0.00019264773,0.000043999644,0.000025903437,0.00009341802,1.8706481e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004204625,0.0007212704,0.95408964,0.00003440871,0.000311147,0.000084873,0.00050721935,4.0417044e-7,0.00069452805,0.000064092266,0.00005646858,0.03923132],"study_design_scores_gemma":[0.011321969,0.016811222,0.96803427,0.00027532093,0.00041159967,0.0006247582,0.00013576105,0.000016255826,0.00025724896,0.00091958244,0.0011163068,0.00007568762],"about_ca_topic_score_codex":0.000028729184,"about_ca_topic_score_gemma":0.00011318601,"teacher_disagreement_score":0.039155632,"about_ca_system_score_codex":0.000038131944,"about_ca_system_score_gemma":0.00013081964,"threshold_uncertainty_score":0.24523385},"labels":[],"label_agreement":null},{"id":"W2281119841","doi":"","title":"Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Perioperative; Chemotherapy; Stage (stratigraphy); Lymph node; Transitional cell carcinoma; Neoadjuvant therapy; Oncology; Urology; Internal medicine; Surgery; Cancer; Breast cancer","score_opus":0.02897668630336633,"score_gpt":0.2695732654067318,"score_spread":0.2405965791033655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281119841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98787534,0.0028944016,0.0000023613181,0.001429142,0.000037297617,0.0014212223,0.00001583632,0.00001045788,0.006313948],"genre_scores_gemma":[0.9954775,0.000944203,0.000038709866,0.0003554036,0.00012674653,0.002387864,0.0000062721383,0.0000124611115,0.00065084145],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993627,0.00003195062,0.00014072303,0.00016191012,0.00011797462,0.00018474253],"domain_scores_gemma":[0.99971855,0.000049444123,0.00003931726,0.00013037286,0.000028367715,0.000033924087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051425897,0.00011680601,0.00021497504,0.00004776624,0.000036601818,0.000011651495,0.000034276563,0.0000356335,0.000042638243],"category_scores_gemma":[0.0000051794914,0.000068370624,0.00004399161,0.00012421819,0.00006743741,0.000037323298,0.0000038056085,0.00003630841,7.6573e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078865286,0.0025041085,0.34388456,0.000116529474,0.0005068498,0.00012660158,0.022555329,0.000027012691,0.0025832162,0.00018241456,0.0005469102,0.6261778],"study_design_scores_gemma":[0.0054946635,0.00027703238,0.9759047,0.000017229326,0.00008932294,0.000011816264,0.0006746561,0.000007588141,0.013051002,0.0000317669,0.0043700333,0.00007020297],"about_ca_topic_score_codex":0.0031037333,"about_ca_topic_score_gemma":0.0010066023,"teacher_disagreement_score":0.6320201,"about_ca_system_score_codex":0.0001213571,"about_ca_system_score_gemma":0.000052815674,"threshold_uncertainty_score":0.4691937},"labels":[],"label_agreement":null},{"id":"W2281945010","doi":"10.5489/cuaj.3600","title":"Perioperative chemotherapy for muscle-invasive bladder cancer: Closing the gap between evidence and practice","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Closing (real estate); Bladder cancer; Perioperative; Medicine; Cancer; Chemotherapy; Intensive care medicine; General surgery; Oncology; Internal medicine; Surgery; Business","score_opus":0.05653701808853977,"score_gpt":0.3316641889660266,"score_spread":0.27512717087748684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281945010","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33596534,0.0029754885,0.0005369835,0.65816116,0.0002896528,0.0008637648,0.00017885398,0.000021375083,0.0010074142],"genre_scores_gemma":[0.9770498,0.0024884897,0.0003049206,0.01825028,0.0011984612,0.00005873574,0.0000022459653,0.000015026139,0.0006320269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878216,0.00021539719,0.00021129937,0.00019610127,0.00023126234,0.00036375652],"domain_scores_gemma":[0.99664223,0.0022190155,0.0002087932,0.000084228726,0.0004453782,0.00040037974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070391066,0.00013060801,0.00021844966,0.00004883908,0.00047705957,0.000098228214,0.000081650775,0.00014296071,0.00032147428],"category_scores_gemma":[0.0033113754,0.00006550137,0.00008746636,0.00009025981,0.000069662354,0.00023716563,0.000008014187,0.00022404971,0.000007837505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005874505,0.00006638852,0.82394403,0.000014336682,0.001396723,0.000051566527,0.0028157798,0.0000028518682,0.0033867832,0.00036405626,0.021563578,0.14580646],"study_design_scores_gemma":[0.0035783106,0.0010654512,0.8169743,0.00014266979,0.0005768186,0.00016777116,0.0005133854,0.000007302613,0.00042897314,0.0008056344,0.17554726,0.0001921206],"about_ca_topic_score_codex":0.0011451349,"about_ca_topic_score_gemma":0.0008032502,"teacher_disagreement_score":0.6410845,"about_ca_system_score_codex":0.0010355178,"about_ca_system_score_gemma":0.0009805223,"threshold_uncertainty_score":0.3964265},"labels":[],"label_agreement":null},{"id":"W2282908553","doi":"10.1186/s40064-016-1757-9","title":"Risk factors of postoperative complications after radical cystectomy with continent or conduit urinary diversion in Armenia","year":2016,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Logistic regression; Urinary diversion; Incidence (geometry); Complication; Mortality rate; Retrospective cohort study; Emergency medicine; Surgery; Bladder cancer; General surgery; Internal medicine; Cancer","score_opus":0.01641975672533654,"score_gpt":0.2676066202430713,"score_spread":0.2511868635177348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282908553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726456,0.000116656054,0.0001854727,0.00089464674,0.000042192052,0.0005176232,0.000078531084,0.000024786656,0.0008755473],"genre_scores_gemma":[0.998796,0.000057815916,0.0003182142,0.00010892151,0.000014005445,0.000057403773,0.0000051772927,0.000014353104,0.000628126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992236,0.000037268856,0.00017742655,0.0002258254,0.0001715957,0.00016428807],"domain_scores_gemma":[0.999476,0.00006708309,0.00006868892,0.00022374134,0.000062941064,0.000101530175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004288205,0.00013323833,0.00025897878,0.00008968484,0.00003636621,0.0000037448356,0.00005784992,0.00004936283,0.00038004722],"category_scores_gemma":[0.000019089168,0.00006576873,0.000046759436,0.00011213792,0.00013033765,0.000059669233,0.00004302415,0.00008819678,0.000026710191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003863176,0.00050188083,0.9867964,0.000027344524,0.0001424977,0.0001439499,0.0012186919,0.0000010280869,0.005437979,0.000044859044,0.00008505771,0.0017371468],"study_design_scores_gemma":[0.0067924834,0.0016106303,0.97590023,0.00037059814,0.00009999162,0.000033603,0.0001767486,0.000005254963,0.011819973,0.000011520686,0.0030653737,0.00011359348],"about_ca_topic_score_codex":0.0005904933,"about_ca_topic_score_gemma":0.0000936616,"teacher_disagreement_score":0.010896159,"about_ca_system_score_codex":0.00013824248,"about_ca_system_score_gemma":0.00010931858,"threshold_uncertainty_score":0.41612506},"labels":[],"label_agreement":null},{"id":"W2283097513","doi":"10.1016/j.eururo.2014.07.025","title":"RETRACTED: Narrowing the Cystoscopy Gap","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; General surgery; MEDLINE; Pathology; Alternative medicine; Law","score_opus":0.03444900414761905,"score_gpt":0.27487068114346896,"score_spread":0.24042167699584993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283097513","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006843654,0.0007520874,0.00006427202,0.70137125,0.001331232,0.00037239355,0.00001579626,0.0001601542,0.29524848],"genre_scores_gemma":[0.05014233,0.000052697702,0.00006392415,0.9200354,0.014822768,0.00001526436,0.0002588977,0.00019919446,0.014409515],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973293,0.00091201003,0.00034153895,0.00055918295,0.00032191945,0.0005360557],"domain_scores_gemma":[0.9985162,0.00019921825,0.00016938632,0.0009699975,0.00006528667,0.00007992431],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039733565,0.0003876051,0.00051300036,0.000111047964,0.00014918284,0.000029292065,0.00037319597,0.0004869069,0.0007661725],"category_scores_gemma":[0.00010747194,0.0002477641,0.00023022637,0.00010578981,0.00020493931,0.00002437266,0.00008637062,0.0032634824,0.0029414622],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009223712,0.00002095141,0.00029389496,0.000049748734,0.00022353492,0.0037769822,0.00014815935,5.4169226e-7,0.00011570141,0.000011567171,0.9941817,0.0010849638],"study_design_scores_gemma":[0.00094262214,0.000777455,0.0020464885,0.000034261415,0.0005331545,0.001188068,0.000004422673,0.0000049464365,0.000027008877,0.00004277975,0.9942031,0.00019567377],"about_ca_topic_score_codex":0.000026900741,"about_ca_topic_score_gemma":0.0000014616594,"teacher_disagreement_score":0.28083897,"about_ca_system_score_codex":0.000051271312,"about_ca_system_score_gemma":0.00008802147,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W2283199873","doi":"10.5489/cuaj.3185","title":"Muscle invasive bladder cancer culminating with leptomeningeal carcinomatosis","year":2015,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Meningeal carcinomatosis; Cancer; Transitional cell carcinoma; Pathology; Internal medicine","score_opus":0.027125643578574606,"score_gpt":0.25865229513825594,"score_spread":0.23152665155968133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283199873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97168756,0.00047858557,0.000021248698,0.016595414,0.0002526432,0.00021078144,0.000037591464,0.00003256421,0.010683629],"genre_scores_gemma":[0.99356824,0.000043407912,0.0002680412,0.0046323435,0.00058672443,0.000031998075,0.000012407761,0.000019452482,0.0008373958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852335,0.00009457761,0.0002203886,0.00019377371,0.00046463887,0.0005032406],"domain_scores_gemma":[0.99790525,0.00006592563,0.0001898142,0.00008588568,0.00049544766,0.0012576624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029839846,0.0001542904,0.00026568654,0.00014076392,0.00021501981,0.000078168094,0.000083268416,0.00016124322,0.00058122695],"category_scores_gemma":[0.00031431424,0.000110111425,0.00007738528,0.00023586708,0.00003295316,0.00012358643,0.000011081775,0.00042369045,0.00004451919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060644128,0.00003763665,0.9840713,0.0000034079628,0.00023381719,0.00022513892,0.00078761514,0.000044634304,0.000057312347,0.00001980719,0.011711826,0.0027468519],"study_design_scores_gemma":[0.0036947553,0.0010907343,0.9641047,0.0000386668,0.00032462936,0.0003936498,0.00080197275,0.000058080914,0.00018372906,0.00017999511,0.028908975,0.00022009737],"about_ca_topic_score_codex":0.007504053,"about_ca_topic_score_gemma":0.005647059,"teacher_disagreement_score":0.021880686,"about_ca_system_score_codex":0.002313567,"about_ca_system_score_gemma":0.0023366972,"threshold_uncertainty_score":0.99910504},"labels":[],"label_agreement":null},{"id":"W2284278449","doi":"10.5489/cuaj.3315","title":"The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; St. Michael's Hospital; University of Saskatchewan; Royal University Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Chemotherapy; Cohort; Cancer; Attendance; Adjuvant; Oncology; Urology","score_opus":0.01301827542099462,"score_gpt":0.27012535508122026,"score_spread":0.25710707966022567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284278449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043826,0.0019416034,0.00006410156,0.091957,0.00013161126,0.00032329,0.00012257298,0.0000077460645,0.0010694764],"genre_scores_gemma":[0.99555004,0.0021659974,0.000056457025,0.00072313775,0.00013169897,0.000016151238,0.0000035463554,0.0000065306726,0.0013464399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989107,0.00013269039,0.000418101,0.00010491324,0.00023338886,0.00020020902],"domain_scores_gemma":[0.9987091,0.00033681013,0.00042866965,0.000108311426,0.00025760834,0.00015951354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080158986,0.00008911174,0.0003238942,0.00008508893,0.00021212352,0.000017847455,0.00007968223,0.00010417223,0.00068389357],"category_scores_gemma":[0.00032567087,0.000035951558,0.0001938395,0.00023821805,0.00017785492,0.00005934057,0.000011196494,0.00013748177,0.0000044132626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014697181,0.000058002483,0.9577351,0.0000042363026,0.003387877,0.000007642871,0.00084670074,0.0000070632746,0.0003717316,0.00016497844,0.001878941,0.03406801],"study_design_scores_gemma":[0.0037536803,0.000302332,0.9886303,0.00001663766,0.0009339038,0.000014954804,0.000109822344,0.00007481157,0.00010818635,0.0011655202,0.0048383106,0.00005153842],"about_ca_topic_score_codex":0.00067129213,"about_ca_topic_score_gemma":0.0014167913,"teacher_disagreement_score":0.091233864,"about_ca_system_score_codex":0.0002117105,"about_ca_system_score_gemma":0.0004161817,"threshold_uncertainty_score":0.74881554},"labels":[],"label_agreement":null},{"id":"W2285399374","doi":"10.5489/cuaj.3583","title":"Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Université Laval; University of Manitoba; Queen's University; Université de Montréal; University of Alberta; McGill University Health Centre; University of Ottawa; University of Toronto; Western University; Dawson College; University of Calgary; Princess Margaret Cancer Centre; Dalhousie University; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Family medicine; Genitourinary system; Multidisciplinary approach; Cancer; MEDLINE; Gynecology; Internal medicine","score_opus":0.023231711670848604,"score_gpt":0.30106136717253495,"score_spread":0.27782965550168637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285399374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53010756,0.015599443,0.000011181103,0.44138473,0.0010956952,0.0025801188,0.008605063,0.000009171983,0.0006070145],"genre_scores_gemma":[0.9803751,0.0043169847,0.00006316249,0.01434629,0.0001462347,0.0003414933,0.00008002081,0.00002218415,0.00030849405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634314,0.00049474125,0.0010970449,0.00044844003,0.00051770214,0.0010989292],"domain_scores_gemma":[0.9952615,0.001293493,0.00090761896,0.00019530172,0.00079042517,0.0015516916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012476542,0.00033021832,0.0008840852,0.00020375464,0.00037829307,0.000031071533,0.00018779458,0.0004077336,0.0011411482],"category_scores_gemma":[0.0012571918,0.00021605479,0.000115854804,0.0002777389,0.00009852872,0.000076149336,0.000025564857,0.0005076472,7.202627e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021588983,0.000033140805,0.84028435,0.000033740373,0.00075529615,0.000023471073,0.00019919823,0.000018662258,0.00014129918,0.00007148639,0.13362798,0.024595516],"study_design_scores_gemma":[0.0045355144,0.0007829011,0.5744511,0.00005760107,0.00047092515,0.000018166387,0.0005794037,0.000028459363,0.000051635147,0.00019383039,0.41853967,0.0002907885],"about_ca_topic_score_codex":0.9999019,"about_ca_topic_score_gemma":0.9999972,"teacher_disagreement_score":0.45026755,"about_ca_system_score_codex":0.028131334,"about_ca_system_score_gemma":0.033169996,"threshold_uncertainty_score":0.99977195},"labels":[],"label_agreement":null},{"id":"W2285819080","doi":"10.1002/jso.24132","title":"Predictors of costs associated with radical cystectomy for bladder cancer: A population‐based retrospective cohort study in the province of Quebec, Canada","year":2015,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cystectomy; Bladder cancer; Retrospective cohort study; Cohort; Multivariate analysis; Surgery; Cancer; Internal medicine","score_opus":0.018829373350414683,"score_gpt":0.3092749448891801,"score_spread":0.29044557153876543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285819080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604523,0.00017495753,0.000013148054,0.0017015794,0.00018633039,0.0013436925,0.00004816781,0.0000029737046,0.00048388992],"genre_scores_gemma":[0.9995552,0.000012911031,0.000040814957,0.00011209954,0.00012229061,0.000053944277,0.000009512673,0.000011065973,0.000082205945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980246,0.00030021454,0.0006341569,0.00012607255,0.0007444901,0.00017051223],"domain_scores_gemma":[0.9979909,0.00046604304,0.00066793885,0.000111794,0.0006263525,0.00013694969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008613122,0.00011773832,0.00085551187,0.00009437313,0.000020988342,0.0000029617331,0.00011528548,0.00009719093,0.000025802787],"category_scores_gemma":[0.0002049714,0.000064663596,0.00008418237,0.0002631313,0.00009363217,0.000044173263,0.00000922746,0.0002601213,3.842334e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047726845,0.0015618621,0.9897248,0.000014052962,0.00065254007,0.0005999847,0.00021832947,0.00011064848,0.000004864627,0.000010333546,0.0019994923,0.0003303667],"study_design_scores_gemma":[0.01927625,0.007981385,0.9692553,0.00011552962,0.00060947944,0.00007043613,0.00042156977,0.000045902074,0.000049934104,0.000009961046,0.0021051655,0.000059034894],"about_ca_topic_score_codex":0.32351613,"about_ca_topic_score_gemma":0.83183235,"teacher_disagreement_score":0.5083162,"about_ca_system_score_codex":0.002933971,"about_ca_system_score_gemma":0.0071967137,"threshold_uncertainty_score":0.99843156},"labels":[],"label_agreement":null},{"id":"W2289712604","doi":"10.1016/s0140-6736(16)00561-4","title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3714,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; Genentech","keywords":"Atezolizumab; Metastatic Urothelial Carcinoma; Medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Population; Chemotherapy; Cancer; Progressive disease; Cohort; Urology; Immunotherapy; Bladder cancer; Pembrolizumab; Urothelial carcinoma","score_opus":0.02430309705466145,"score_gpt":0.2865667378326373,"score_spread":0.26226364077797587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289712604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994328,0.00020382469,0.0001694736,0.0010704512,0.00004856945,0.0037157051,0.00012229632,0.00005391741,0.0002877459],"genre_scores_gemma":[0.997496,0.000014383798,0.0012502118,0.0004586745,0.00014973702,0.00036550278,0.000029797362,0.00006330943,0.00017238772],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99839026,0.000099021396,0.0002680722,0.00040790238,0.00036592892,0.00046881524],"domain_scores_gemma":[0.9990952,0.00012889823,0.0001382217,0.0004525174,0.000055676668,0.00012945918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008889219,0.00035287158,0.0007800146,0.00007022296,0.00007928454,0.000033827808,0.000100335325,0.00004286881,0.00003629658],"category_scores_gemma":[0.000020899939,0.00015102536,0.00007364742,0.00013054025,0.00012498496,0.00010391244,0.000011831932,0.00008448296,0.0000032116843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60988545,0.006217946,0.21469338,0.00007305997,0.00069648965,0.00026717375,0.001313439,0.000009771544,0.0005700608,0.0000063388025,0.000044175955,0.1662227],"study_design_scores_gemma":[0.9232555,0.036978256,0.03127707,0.00069853646,0.0005759877,0.000008223214,0.00009140423,0.00020126473,0.0058944784,0.000024023926,0.0006903118,0.00030492397],"about_ca_topic_score_codex":0.00010566253,"about_ca_topic_score_gemma":0.00018728268,"teacher_disagreement_score":0.31337005,"about_ca_system_score_codex":0.0002633846,"about_ca_system_score_gemma":0.0002213459,"threshold_uncertainty_score":0.61586356},"labels":[],"label_agreement":null},{"id":"W2292562657","doi":"10.1200/jco.2015.65.0218","title":"Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ramucirumab; Metastatic Urothelial Carcinoma; Docetaxel; Urothelial carcinoma; Randomized controlled trial; Urology; Oncology; Internal medicine; Phases of clinical research; Chemotherapy; Cancer; Bladder cancer","score_opus":0.1909879434777271,"score_gpt":0.502909767407231,"score_spread":0.31192182392950396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292562657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96915275,0.0004296104,0.0028889624,0.0077981693,0.0013590385,0.017871793,0.00011181216,0.000026143898,0.00036170267],"genre_scores_gemma":[0.9674345,0.0011474103,0.015525383,0.003798947,0.0012841366,0.0017208527,0.000015056104,0.00012020329,0.0089535015],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99144715,0.001623023,0.005191938,0.0006204561,0.0005145374,0.00060291804],"domain_scores_gemma":[0.98392475,0.010956918,0.0031997394,0.0004942524,0.0006811413,0.0007432109],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048207254,0.0006053159,0.009857548,0.00027149206,0.00013237598,0.000043558102,0.00047769715,0.0003640465,0.0026073891],"category_scores_gemma":[0.0047520553,0.00021979633,0.0007583892,0.00022325607,0.000425762,0.0004278666,0.000053910615,0.00044068936,0.000009179697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75091434,0.04641236,0.000037422353,0.000019739895,0.0037679235,0.0016617815,0.0001390746,0.0000039201213,0.00035472843,0.00007488226,0.00012725688,0.19648656],"study_design_scores_gemma":[0.5620873,0.4300595,0.000020441823,0.00015319561,0.002195502,0.00028441648,0.00004944261,0.00019781747,0.0002974137,0.0005349582,0.0039417134,0.0001783049],"about_ca_topic_score_codex":0.000117078984,"about_ca_topic_score_gemma":0.003352679,"teacher_disagreement_score":0.38364714,"about_ca_system_score_codex":0.00060770084,"about_ca_system_score_gemma":0.013506635,"threshold_uncertainty_score":0.99830437},"labels":[],"label_agreement":null},{"id":"W2293043909","doi":"10.6004/jnccn.2016.0034","title":"Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Referral; Cancer; Medical record; Cancer registry; Population; Chemotherapy; Internal medicine; Poisson regression; Palliative care; Intensive care medicine; Oncology; Family medicine; Nursing","score_opus":0.0860858806100914,"score_gpt":0.42137763597446964,"score_spread":0.3352917553643783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293043909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95058,0.021983888,0.0011934914,0.020938989,0.0026642305,0.0017433213,0.00073510373,0.0000081980825,0.00015278123],"genre_scores_gemma":[0.984247,0.008207947,0.0024604397,0.0035951673,0.0012744353,0.00003970643,0.0000029862397,0.000026086911,0.00014621626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803954,0.00014419504,0.0008866789,0.00015975238,0.0005918345,0.00017802056],"domain_scores_gemma":[0.9926294,0.0015707355,0.0013485642,0.00012642212,0.0042557796,0.00006908866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018360824,0.00015263441,0.000602528,0.000066125496,0.000034872988,0.000004530258,0.00015472791,0.00008665187,0.00006734211],"category_scores_gemma":[0.00042973328,0.00008522935,0.00034672164,0.00020508037,0.000086568696,0.00017013002,0.000031419066,0.00019769563,2.2029263e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032357205,0.00068465044,0.8674458,0.0003061629,0.003288948,0.000008387468,0.0012311408,0.014610441,0.002943081,0.00041633417,0.012716431,0.06399137],"study_design_scores_gemma":[0.020921988,0.001970223,0.89262015,0.0034372916,0.0006105841,0.000015946986,0.00035951746,0.00009111322,0.006000853,0.0006508484,0.073127866,0.00019359104],"about_ca_topic_score_codex":0.000072992225,"about_ca_topic_score_gemma":0.000090676665,"teacher_disagreement_score":0.06379778,"about_ca_system_score_codex":0.00042159477,"about_ca_system_score_gemma":0.0007756501,"threshold_uncertainty_score":0.34755522},"labels":[],"label_agreement":null},{"id":"W2293384795","doi":"10.1016/j.humpath.2016.02.011","title":"Neoadjuvant chemotherapy–related histologic changes in radical cystectomy: assessment accuracy and prediction of response","year":2016,"lang":"en","type":"article","venue":"Human Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Hyaline; Medicine; Stage (stratigraphy); Hydronephrosis; Fibrosis; Chemotherapy; Calcification; Urology; Pathology; Radiology; Surgery; Internal medicine; Bladder cancer; Urinary system; Cancer","score_opus":0.0266264516785639,"score_gpt":0.31932889913006,"score_spread":0.2927024474514961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293384795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525553,0.0005413991,0.000047567977,0.0030688152,0.00009204012,0.0003622267,0.000023243929,0.00004237305,0.0005667904],"genre_scores_gemma":[0.9986959,0.0002522335,0.00015874284,0.00024388517,0.00003067627,0.00005418929,0.000009359359,0.000014217017,0.0005407928],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990283,0.00020963831,0.00023855142,0.0002524635,0.000097173746,0.00017384709],"domain_scores_gemma":[0.9994967,0.00012427696,0.00009550518,0.00019897016,0.000027361677,0.000057192745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303697,0.00011511967,0.00033023418,0.0001680081,0.000031783366,0.000001816306,0.00004300547,0.00015515696,0.00030866478],"category_scores_gemma":[0.0000682306,0.00007376778,0.000032306452,0.00007205046,0.0002302029,0.000030045787,0.000023189137,0.000104559396,0.000004283644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024717983,0.00043853512,0.25249514,0.0000531414,0.00006619401,0.0006795601,0.0011994587,1.060046e-7,0.70791966,0.00041647343,0.00022372167,0.034036234],"study_design_scores_gemma":[0.009963749,0.0026292703,0.97851604,0.00012606624,0.00005012337,0.00047042995,0.000043673506,0.0000056968347,0.0058525368,0.00065598835,0.0016173976,0.00006903612],"about_ca_topic_score_codex":0.000023387736,"about_ca_topic_score_gemma":0.000027980283,"teacher_disagreement_score":0.7260209,"about_ca_system_score_codex":0.00014434502,"about_ca_system_score_gemma":0.000063112944,"threshold_uncertainty_score":0.33796626},"labels":[],"label_agreement":null},{"id":"W2293619070","doi":"10.1016/j.eururo.2015.09.015","title":"Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer — At What Cost? Eur Urol 2016;69:642–44","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Urology; Salvage therapy; Bladder cancer; Surgery; General surgery; Cancer; Internal medicine; Chemotherapy","score_opus":0.08441656718375008,"score_gpt":0.31338070184851446,"score_spread":0.2289641346647644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293619070","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0131254075,0.08931156,0.0016856871,0.82584935,0.02626319,0.01953876,0.010783232,0.0013851105,0.012057707],"genre_scores_gemma":[0.0032054116,0.004044941,0.0026734006,0.8750121,0.020590654,0.0020764265,0.0064655556,0.0014478731,0.08448363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925605,0.0013535278,0.0013409393,0.0023865374,0.0006997566,0.0016587529],"domain_scores_gemma":[0.99559957,0.00060959964,0.00089409715,0.0019034512,0.00036780056,0.0006254907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00068161666,0.0015763643,0.002228216,0.00037324827,0.00024341645,0.00021738463,0.0006638833,0.00064569485,0.0014895541],"category_scores_gemma":[0.00020862454,0.0012618231,0.0008430843,0.0002109253,0.00028319043,0.0002537307,0.00029500568,0.0015741062,0.0011061698],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026062857,0.00033973184,0.00013308553,0.00026141232,0.0031770454,0.00430966,0.0021297554,0.000013024018,0.0003040989,0.0000011125742,0.9321318,0.054592974],"study_design_scores_gemma":[0.012574931,0.004369186,0.00042126788,0.00019235275,0.007500354,0.00019513932,0.00012595452,0.000118042524,0.00020407727,0.000070591996,0.97326946,0.00095861935],"about_ca_topic_score_codex":0.0025358049,"about_ca_topic_score_gemma":0.0003339375,"teacher_disagreement_score":0.08526662,"about_ca_system_score_codex":0.001215205,"about_ca_system_score_gemma":0.0009818122,"threshold_uncertainty_score":0.99969846},"labels":[],"label_agreement":null},{"id":"W2294343390","doi":"10.1093/annonc/mdu337.58","title":"The Significance of Complete Response (Cr) in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma (Uc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Salvage therapy; Oncology; Carcinoma; Internal medicine; Urology; Chemotherapy; Cancer; Bladder cancer","score_opus":0.06490892029599489,"score_gpt":0.363615231792738,"score_spread":0.29870631149674315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294343390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368286,0.00030624834,0.00008098306,0.002850838,0.00020266426,0.0012151583,0.000059016398,0.000009337251,0.0015928647],"genre_scores_gemma":[0.9978783,0.0001935348,0.00036571082,0.0011537235,0.00006597656,0.00015442428,0.00000985374,0.00002200258,0.00015648076],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859035,0.00031562572,0.00042391705,0.00020754202,0.00015867478,0.00030389996],"domain_scores_gemma":[0.99794215,0.0011893967,0.00024441638,0.00030115657,0.00026435827,0.000058529615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000793054,0.00012759551,0.00046564025,0.00007845286,0.00006233398,0.000002793279,0.00014596469,0.000087471606,0.000014475737],"category_scores_gemma":[0.00045975886,0.00008993876,0.00011715205,0.00012110138,0.00016727023,0.00003635681,0.000022667558,0.00009455072,0.0000024110493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11109116,0.0015824107,0.20845959,0.00010915746,0.00018481525,0.0000052142345,0.0015871319,0.00002297286,0.061129607,0.00040868815,0.002130936,0.61328834],"study_design_scores_gemma":[0.014617665,0.021101117,0.84772813,0.0000564214,0.000022654947,0.0000013341922,0.00008506479,0.0000443643,0.031852134,0.00062230334,0.08376393,0.00010488986],"about_ca_topic_score_codex":0.00010469471,"about_ca_topic_score_gemma":0.00007293145,"teacher_disagreement_score":0.6392685,"about_ca_system_score_codex":0.000045298068,"about_ca_system_score_gemma":0.0002317647,"threshold_uncertainty_score":0.3667596},"labels":[],"label_agreement":null},{"id":"W2295555919","doi":"10.1007/s00345-015-1737-7","title":"Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent","year":2015,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; ERCC1; Nephrology; Internal medicine; Urology; Protein expression; Carcinoma; Oncology; Urothelial cancer; Cancer research; Cancer; DNA repair; Gene; Nucleotide excision repair; Bladder cancer","score_opus":0.0190769132803938,"score_gpt":0.2744774213171682,"score_spread":0.2554005080367744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295555919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946866,0.001965542,0.00019211524,0.0014733714,0.0001488444,0.0005726576,0.0000029181094,0.0000070940305,0.000950864],"genre_scores_gemma":[0.9978753,0.000007348994,0.00154266,0.00024520847,0.00017499199,0.000027106298,0.0000022916925,0.000024554238,0.000100545854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984862,0.00020480804,0.00050965935,0.00016635482,0.00037381361,0.0002591315],"domain_scores_gemma":[0.9991181,0.00007522611,0.00028915904,0.00013260946,0.00015959922,0.00022532139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028094326,0.00017581599,0.0005729799,0.0003485591,0.00002008591,0.0000068007907,0.00011360362,0.00008055938,0.000058710786],"category_scores_gemma":[0.00013602138,0.00011235435,0.00014945082,0.00022047742,0.000107467844,0.00013226575,0.000025304471,0.00048604727,0.0000028976435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012952981,0.0011032105,0.9269392,0.00002918467,0.00022465829,0.001699268,0.003336935,0.000026313604,0.04761301,0.000045575507,0.00021233303,0.0058173332],"study_design_scores_gemma":[0.066656634,0.0413924,0.757663,0.0019297544,0.0015024424,0.0057061873,0.00263121,0.0002454443,0.08709568,0.0022054992,0.032294266,0.0006774912],"about_ca_topic_score_codex":0.000051502273,"about_ca_topic_score_gemma":0.00004225411,"teacher_disagreement_score":0.16927621,"about_ca_system_score_codex":0.00011225715,"about_ca_system_score_gemma":0.00052063155,"threshold_uncertainty_score":0.45816773},"labels":[],"label_agreement":null},{"id":"W2296581273","doi":"10.21037/tau.2016.02.01","title":"Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing","year":2016,"lang":"en","type":"article","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cisplatin; Chemotherapy; Medicine; Complete response; Oncology; Pathological; DNA sequencing; Biomarker; Neoadjuvant therapy; Internal medicine; Cancer; Bioinformatics; DNA; Biology; Genetics","score_opus":0.01197156036507098,"score_gpt":0.25604210799205057,"score_spread":0.2440705476269796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296581273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93767697,0.0006913698,0.00056023314,0.060351558,0.000048845817,0.00032154855,0.00003962458,0.000025704063,0.00028412923],"genre_scores_gemma":[0.9928324,0.00014287565,0.000225999,0.0063867774,0.00008485976,0.00005403122,0.0000044181893,0.000014846804,0.00025376005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907124,0.00009823692,0.0001786461,0.0003000454,0.00008223278,0.00026961532],"domain_scores_gemma":[0.9993811,0.0003662343,0.00003519075,0.00008953128,0.000032998316,0.00009494587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001921646,0.00013733045,0.00028803278,0.00012879953,0.00006230945,0.0000028716224,0.00003640731,0.00012588728,0.00023511394],"category_scores_gemma":[0.000021854936,0.00008748109,0.000027716631,0.000077590346,0.00015352076,0.000051243765,0.0000064767587,0.00009890367,0.0000062317645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061626207,0.00006764048,0.83791536,0.000012648647,0.00029871624,0.0001475161,0.0018190502,0.00015245534,0.08760021,0.0003872919,0.00006459481,0.009908297],"study_design_scores_gemma":[0.016660152,0.0027292941,0.97297883,0.00003727277,0.00012576903,0.00043096356,0.00004252189,0.00016964259,0.0011113295,0.0010058309,0.0045512086,0.00015715639],"about_ca_topic_score_codex":0.00012617219,"about_ca_topic_score_gemma":0.00062756933,"teacher_disagreement_score":0.13506348,"about_ca_system_score_codex":0.000051846764,"about_ca_system_score_gemma":0.00022791036,"threshold_uncertainty_score":0.35673752},"labels":[],"label_agreement":null},{"id":"W2297542691","doi":"10.1155/2011/273241","title":"Urothelial Bladder Cancer with Cavitary Lung Metastases","year":2011,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; St. Michael's Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Urothelial cancer; Bladder cancer; Lung; Lung cancer; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.042870548118431544,"score_gpt":0.28207046117147233,"score_spread":0.23919991305304078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297542691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9410475,0.011952511,0.00014290061,0.0009091095,0.0010437007,0.0008379007,0.00045675566,0.0000715261,0.043538123],"genre_scores_gemma":[0.98522836,0.00010940613,0.00054983114,0.011770358,0.0010182835,0.0000572872,0.000005782887,0.000085385145,0.0011753204],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855417,0.00006973284,0.0002576846,0.00024497567,0.0003025713,0.00057084137],"domain_scores_gemma":[0.9978803,0.000010300078,0.00009029177,0.0002654223,0.00020409738,0.001549582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000156314,0.0002420455,0.00030088448,0.00033600416,0.00029179946,0.00003895557,0.00013906753,0.00008968605,0.0068939617],"category_scores_gemma":[0.00001669881,0.00017597184,0.00011663433,0.00020101015,0.000120952056,0.00017787171,0.000009066521,0.0004207671,0.00005633717],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023273635,0.00036417946,0.8132739,0.00011578116,0.0041919556,0.018010788,0.0030930587,0.000017779546,0.0017776629,0.0005026646,0.110938445,0.045386408],"study_design_scores_gemma":[0.013541608,0.0035630583,0.4016658,0.0005945764,0.0031179155,0.0046173083,0.0010000766,0.0000133053445,0.014625022,0.0002608899,0.55577177,0.0012286955],"about_ca_topic_score_codex":0.046739556,"about_ca_topic_score_gemma":0.10640423,"teacher_disagreement_score":0.44483328,"about_ca_system_score_codex":0.00055975124,"about_ca_system_score_gemma":0.004767881,"threshold_uncertainty_score":0.99401385},"labels":[],"label_agreement":null},{"id":"W2299120060","doi":"10.5489/cuaj.3298","title":"Profil évolutif et pronostic des tumeurs urothéliales de la vessie chez le sujet jeune","year":2016,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine","score_opus":0.018391309182749387,"score_gpt":0.2688737443612749,"score_spread":0.25048243517852553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299120060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6382496,0.02212565,0.0017966268,0.30364904,0.003509518,0.0010016832,0.0007524468,0.00011076934,0.028804723],"genre_scores_gemma":[0.9694354,0.0017403535,0.00034285194,0.0029842919,0.0019272427,0.00003901751,0.000013339405,0.0000468049,0.02347073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957735,0.0016492637,0.0004748751,0.00033211088,0.00040276255,0.0013674748],"domain_scores_gemma":[0.996673,0.00081743393,0.0003318247,0.00015404215,0.0002859484,0.0017377649],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021528227,0.0003109555,0.00044105048,0.00017302323,0.0004940958,0.00017240267,0.00021837512,0.0006254298,0.0026421852],"category_scores_gemma":[0.0036192127,0.00022392052,0.00022028972,0.00023422918,0.00043257396,0.0002810989,0.000025415116,0.00080842234,0.00033664276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00013129976,0.00028000853,0.93403375,0.00003342681,0.0004314652,0.00046551434,0.00068234437,0.00001909793,0.0010290636,0.0031183665,0.03595528,0.023820354],"study_design_scores_gemma":[0.0034512854,0.00070851983,0.82570857,0.00028174283,0.00033494172,0.0007145788,0.00013600606,0.00003357507,0.0003401444,0.010445344,0.15756999,0.0002752899],"about_ca_topic_score_codex":0.007018626,"about_ca_topic_score_gemma":0.002844334,"teacher_disagreement_score":0.33118582,"about_ca_system_score_codex":0.0053316127,"about_ca_system_score_gemma":0.0065518813,"threshold_uncertainty_score":0.99959373},"labels":[],"label_agreement":null},{"id":"W2299129160","doi":"10.1096/fasebj.27.1_supplement.372.1","title":"Fruit and vegetable intake and bladder cancer risk: the Multiethnic Cohort Study","year":2013,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bladder cancer; Cohort; Quartile; Cruciferous vegetables; Nutrient; Cohort study; Lower risk; Cancer; Environmental health; Biology; Internal medicine; Confidence interval","score_opus":0.019604372185682624,"score_gpt":0.2834264906997145,"score_spread":0.26382211851403187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299129160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903871,0.0058393446,0.000014197317,0.0016794563,0.00021237935,0.0010276351,0.0000069528774,0.000013052772,0.00081991276],"genre_scores_gemma":[0.9942873,0.0026234624,0.000033203884,0.0006325944,0.00035913926,0.000100686586,6.202353e-7,0.000018936425,0.001944043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903905,0.00014112229,0.00018461008,0.00015066226,0.00025644642,0.00022811833],"domain_scores_gemma":[0.99935037,0.00008678737,0.00010119937,0.00022932535,0.000081996164,0.00015030477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044167408,0.00014425446,0.00021183863,0.000030392845,0.00045980618,0.00010046275,0.00009761285,0.00003596327,0.0007163656],"category_scores_gemma":[0.000030079385,0.00006307284,0.000044058605,0.00007609559,0.00013712377,0.000103927356,0.000053715838,0.00048022036,0.000029787207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006660573,0.000112390866,0.982419,0.0000049638547,0.00067092193,0.000013213887,0.0028236832,0.0000046082237,0.0010392349,0.0000019444049,0.0016837858,0.011159613],"study_design_scores_gemma":[0.00248307,0.0003590641,0.9922649,0.000029930936,0.0008430855,0.00031722698,0.0018919504,0.00011405949,0.0008663083,0.00020241534,0.00054723636,0.00008074222],"about_ca_topic_score_codex":0.0028546257,"about_ca_topic_score_gemma":0.0003369853,"teacher_disagreement_score":0.011078871,"about_ca_system_score_codex":0.000046324723,"about_ca_system_score_gemma":0.00007939425,"threshold_uncertainty_score":0.78437006},"labels":[],"label_agreement":null},{"id":"W2300094344","doi":"10.5489/cuaj.3037","title":"A minimally invasive approach to transperitoneal perforation of the bladder during bladder tumour resection","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Resection; Perforation; Medicine; Urology; Bladder cancer; Invasive surgery; Surgery; Internal medicine; Materials science; Cancer","score_opus":0.014736821248944076,"score_gpt":0.22543290133750885,"score_spread":0.21069608008856477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300094344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97531706,0.000044023327,0.00008004382,0.0201959,0.00022505264,0.00035547276,0.000044882705,0.000011663906,0.0037259264],"genre_scores_gemma":[0.99704224,0.00002561775,0.0001788434,0.0012686364,0.00047798245,0.00002318179,0.0000033367003,0.000013551719,0.00096660113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985838,0.00015168595,0.00031476174,0.00019203767,0.00040775974,0.00034997895],"domain_scores_gemma":[0.99890673,0.00006022953,0.0001736601,0.00011351818,0.00030793084,0.0004379422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028170136,0.00012651745,0.0002121023,0.0001344228,0.0002671323,0.000030501486,0.000117628086,0.00017644398,0.00028711828],"category_scores_gemma":[0.0004440958,0.000068823654,0.00016002633,0.00024455352,0.000036208512,0.0001075268,0.000010618713,0.00025823925,0.000021074833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010805224,0.00029275194,0.82292056,0.000028358987,0.0007000882,0.000036237005,0.001837242,0.0000892116,0.16430725,0.00016764455,0.006590497,0.0019496273],"study_design_scores_gemma":[0.002094763,0.0005579087,0.98179144,0.000037874717,0.00014502133,0.00017708928,0.00014404215,0.000010631458,0.013352402,0.00015702972,0.001422621,0.00010916698],"about_ca_topic_score_codex":0.0004323072,"about_ca_topic_score_gemma":0.0015064636,"teacher_disagreement_score":0.15887088,"about_ca_system_score_codex":0.001037868,"about_ca_system_score_gemma":0.00075689494,"threshold_uncertainty_score":0.3143744},"labels":[],"label_agreement":null},{"id":"W2300740433","doi":"10.1200/jco.2009.27.15_suppl.5017","title":"Randomized trial of p53 targeted adjuvant therapy for patients (pts) with organ- confined node-negative urothelial bladder cancer (UBC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lymphovascular invasion; Cystectomy; Internal medicine; Bladder cancer; Randomization; Randomized controlled trial; Lymph node; Oncology; Clinical endpoint; Population; Urology; Stage (stratigraphy); Adjuvant therapy; Cancer; Gastroenterology","score_opus":0.06812904040344381,"score_gpt":0.43027706456962816,"score_spread":0.36214802416618436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300740433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833662,0.00053178257,0.0005305507,0.0076559754,0.0020764868,0.0039083026,0.00008105955,0.000015174119,0.0018344866],"genre_scores_gemma":[0.9879717,0.001656091,0.003257528,0.004747111,0.0018867443,0.00007561643,0.0000110474875,0.000034128985,0.00036001118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99549454,0.00062373513,0.0027684001,0.00026485592,0.0005476018,0.00030084737],"domain_scores_gemma":[0.99207044,0.0030223262,0.0027832508,0.00020245621,0.0015990766,0.00032243138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018611164,0.0002709773,0.0036576162,0.00012977941,0.000048077745,0.000007488263,0.00017329169,0.00037523668,0.0005118977],"category_scores_gemma":[0.003149208,0.0001487033,0.0009393451,0.0001566266,0.00036075126,0.00009395697,0.00001091546,0.0005284267,0.0000031525458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.901242,0.006205119,0.0018771703,0.000011164755,0.0021285396,0.000032106473,0.00026803656,0.000006912468,0.00016403769,0.000031530137,0.0018242341,0.08620912],"study_design_scores_gemma":[0.88576245,0.09343455,0.01081673,0.00010060443,0.001387105,0.0000126929635,0.000039107876,0.000032583393,0.0014137453,0.0006243761,0.0062396335,0.00013641987],"about_ca_topic_score_codex":0.00008564909,"about_ca_topic_score_gemma":0.000025087475,"teacher_disagreement_score":0.08722943,"about_ca_system_score_codex":0.00013336955,"about_ca_system_score_gemma":0.003161144,"threshold_uncertainty_score":0.60639447},"labels":[],"label_agreement":null},{"id":"W2300746496","doi":"10.5489/cuaj.3292","title":"Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Stage (stratigraphy); Logistic regression; Epidemiology; Bladder cancer; Marital status; Odds ratio; Internal medicine; Comorbidity; Odds; Radiation therapy; Chemotherapy; Population; Urology; Oncology; Cancer","score_opus":0.015518318005554947,"score_gpt":0.24618354896047095,"score_spread":0.230665230954916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300746496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255043,0.000020766403,0.000043818738,0.0067361975,0.00011651643,0.00041376197,0.000046890178,0.0000109873135,0.00006064793],"genre_scores_gemma":[0.9978157,0.00000641581,0.0001640899,0.0017834718,0.00010038012,0.0000130620665,0.000011594194,0.00001246852,0.000092802606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849665,0.00018517759,0.000431115,0.00016953614,0.0003874173,0.0003301101],"domain_scores_gemma":[0.9988939,0.00018116206,0.0002218541,0.00010290595,0.0002038534,0.00039630337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028664764,0.00012398961,0.0003239561,0.00023694977,0.0000652197,0.000022730219,0.00006733674,0.0001516334,0.00059303676],"category_scores_gemma":[0.0005702677,0.00007707102,0.00010580545,0.00019869933,0.000017270666,0.0001052195,0.000004425392,0.0002069084,0.000009702461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032228805,0.00046381087,0.9939863,0.0000016022694,0.000067244764,0.000042018102,0.000057310663,0.000015508058,0.000024776073,0.000006651524,0.00035795692,0.004654499],"study_design_scores_gemma":[0.0100872535,0.0013246539,0.9862573,0.000027063841,0.000043575204,0.000006206626,0.000012311249,0.000033172488,0.000016615113,0.000049924412,0.002059559,0.00008237886],"about_ca_topic_score_codex":0.005256851,"about_ca_topic_score_gemma":0.0024247356,"teacher_disagreement_score":0.009764966,"about_ca_system_score_codex":0.0015316589,"about_ca_system_score_gemma":0.00044567822,"threshold_uncertainty_score":0.79468215},"labels":[],"label_agreement":null},{"id":"W2302397867","doi":"10.1517/14712598.2016.1134483","title":"<i>Mycobacterium phlei</i>cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Regimen; Clinical trial; BCG vaccine; Refractory (planetary science); Oncology; Internal medicine; Intensive care medicine; Surgery; Cancer; Immunology; Vaccination; Biology","score_opus":0.26248453615048944,"score_gpt":0.4282477445639823,"score_spread":0.16576320841349285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302397867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033726122,0.98932797,0.0000023768805,0.0010903535,0.00064918306,0.0042721475,0.0004515358,0.000048347487,0.0007854565],"genre_scores_gemma":[0.0013945715,0.98962086,0.00011680844,0.0052663865,0.00070807076,0.002208129,0.000524036,0.00007166261,0.00008948211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641514,0.00087759626,0.00081477314,0.00088323967,0.00045463987,0.0005545998],"domain_scores_gemma":[0.9979919,0.00044347916,0.00030114816,0.00083008583,0.00014492503,0.00028843744],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024136817,0.000888903,0.002559759,0.00023455235,0.00007613383,0.000025819527,0.00044786226,0.0005294793,0.0009149758],"category_scores_gemma":[0.000037100403,0.00042241334,0.00072909886,0.00055134017,0.000165616,0.000031866268,0.000048390506,0.00029542085,0.00015454655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021595813,0.0028169444,0.000057703044,0.00013256197,0.00051483716,0.00006372769,0.0025938926,0.0000010362471,0.0009885905,0.0000141195,0.005445884,0.98521113],"study_design_scores_gemma":[0.0037589772,0.013854519,0.00040889508,0.0011896185,0.000020494448,0.000024624786,0.00020836259,4.9948903e-7,0.00051245943,0.000011024535,0.9795835,0.00042700852],"about_ca_topic_score_codex":0.00039001243,"about_ca_topic_score_gemma":0.000023044246,"teacher_disagreement_score":0.9847841,"about_ca_system_score_codex":0.00074222666,"about_ca_system_score_gemma":0.0005110255,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W2307238247","doi":"10.1093/annonc/mdu337.60","title":"Outcomes with Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma (Uc) Following Previous Perioperative Cisplatin-Based Therapy","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; BC Cancer Agency","funders":"","keywords":"Medicine; Cisplatin; Oncology; Perioperative; Urothelial carcinoma; Internal medicine; Carcinoma; Urology; Chemotherapy; Surgery; Bladder cancer; Cancer","score_opus":0.06617528993288303,"score_gpt":0.3766195366427865,"score_spread":0.3104442467099035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307238247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811096,0.0008424211,0.0040062023,0.008413674,0.00026861226,0.002841611,0.000083445826,0.00007408333,0.0023603027],"genre_scores_gemma":[0.98379874,0.00011508224,0.004585217,0.010098229,0.000186624,0.0007026703,0.00008072369,0.00008574969,0.000346951],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792796,0.00015227114,0.0005307574,0.0005166905,0.000327797,0.00054454565],"domain_scores_gemma":[0.99784225,0.00080570165,0.0002965672,0.0004839043,0.0003931167,0.00017844755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037072052,0.00042985118,0.0011885938,0.00015131576,0.0002052902,0.000014371415,0.00017456339,0.00020365503,0.00014278642],"category_scores_gemma":[0.00014056305,0.00028878057,0.00043933486,0.00017890919,0.00015904101,0.00007570777,0.000012555743,0.0001732849,0.0000063914326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053299326,0.004499959,0.42035165,0.0002865699,0.0019068464,0.0001133395,0.0024108354,0.0022418338,0.011576283,0.0002987076,0.000663696,0.502351],"study_design_scores_gemma":[0.20022245,0.19502787,0.21664833,0.0004905751,0.0006631924,0.000029853765,0.00025429248,0.006262207,0.24916644,0.00032573115,0.12956639,0.0013426848],"about_ca_topic_score_codex":0.00012418139,"about_ca_topic_score_gemma":0.00013105782,"teacher_disagreement_score":0.5010083,"about_ca_system_score_codex":0.00007042714,"about_ca_system_score_gemma":0.0007943735,"threshold_uncertainty_score":0.9999564},"labels":[],"label_agreement":null},{"id":"W2308167615","doi":"10.1200/jco.2015.65.9797","title":"Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Cystectomy; Guideline; Bladder cancer; Oncology; Internal medicine; Carboplatin; Clinical trial; Chemotherapy; Chemoradiotherapy; Cancer; Cisplatin; Pathology","score_opus":0.15246535138942274,"score_gpt":0.5239426716527221,"score_spread":0.3714773202632994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308167615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5090241,0.0027806908,0.0083978325,0.45586777,0.008840749,0.0018483916,0.00033213166,0.000059457387,0.01284891],"genre_scores_gemma":[0.6784429,0.0499169,0.14909346,0.11318199,0.008321438,0.000023396078,0.000029131153,0.00012595842,0.0008648259],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97339565,0.0063163275,0.0178476,0.0007277559,0.0011462925,0.00056636625],"domain_scores_gemma":[0.94879323,0.025823977,0.019175192,0.00056180015,0.004802379,0.0008433901],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.035168413,0.00042562067,0.005147182,0.00018097849,0.00005978379,0.000006747173,0.00038316025,0.0006785695,0.00051469373],"category_scores_gemma":[0.056278158,0.00026236882,0.0018929266,0.00027643476,0.0011894079,0.00020066558,0.00022338991,0.00162044,0.000024656956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009647143,0.006627515,0.05505438,0.000031417716,0.0057666022,0.00032541918,0.00011494509,0.000024021016,0.00046783866,0.000061559236,0.24430943,0.67756975],"study_design_scores_gemma":[0.032123044,0.065229006,0.0646405,0.00014599606,0.00561288,0.00016677416,0.0004997896,0.00011731788,0.00012469251,0.00023367305,0.8308757,0.00023066215],"about_ca_topic_score_codex":0.0003306194,"about_ca_topic_score_gemma":0.00023015968,"teacher_disagreement_score":0.6773391,"about_ca_system_score_codex":0.0005158007,"about_ca_system_score_gemma":0.0065532373,"threshold_uncertainty_score":0.99998283},"labels":[],"label_agreement":null},{"id":"W231161082","doi":"10.1007/978-1-4939-1501-9_3","title":"Upper Urinary Tract Urothelial Carcinoma Pathology","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Rockyview General Hospital; University of Calgary","funders":"","keywords":"Urothelial carcinoma; Upper urinary tract; Urinary system; Medicine; Pathology; Urology; Internal medicine; Cancer; Bladder cancer","score_opus":0.02287422051122306,"score_gpt":0.26378150288862906,"score_spread":0.240907282377406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W231161082","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017889662,0.0010809429,0.00011426837,0.000709852,0.0005856535,0.000673039,0.00009373096,0.0001458402,0.9948077],"genre_scores_gemma":[0.16615309,0.0001868453,0.00025689212,0.002554389,0.0013486528,0.000030019673,0.0001252356,0.00014535245,0.8291995],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983913,0.000018827104,0.000353231,0.0005954384,0.00030480942,0.0003364417],"domain_scores_gemma":[0.9988771,0.000040921193,0.00010702862,0.0006582491,0.00008049962,0.00023617798],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000073560346,0.0005072245,0.000803347,0.00017415815,0.00006064181,0.000011702192,0.00012138062,0.00061238505,0.013294795],"category_scores_gemma":[0.000008467004,0.00039061188,0.00041459035,0.000013423729,0.0001280998,0.00002367189,0.000055652898,0.00047468534,0.0023711063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007882578,0.004130304,0.057233997,0.002271147,0.0036046668,0.04790299,0.00137072,0.0000012916771,0.0019189869,0.44149515,0.18591207,0.24627608],"study_design_scores_gemma":[0.0043046027,0.0045112455,0.014017301,0.0001669022,0.0010538077,0.005965794,0.0000072398225,0.000004515071,0.0002869539,0.003829671,0.9652466,0.00060535653],"about_ca_topic_score_codex":0.000045514713,"about_ca_topic_score_gemma":0.0000027527926,"teacher_disagreement_score":0.77933455,"about_ca_system_score_codex":0.00012346738,"about_ca_system_score_gemma":0.00025794952,"threshold_uncertainty_score":0.99985456},"labels":[],"label_agreement":null},{"id":"W2312329262","doi":"10.1016/j.juro.2016.02.1270","title":"MP31-17 VALIDATING THE BLADDER UTILITY SYMPTOM SCALE (BUSS): A NOVEL PATIENT REPORTED OUTCOME QUALITY OF LIFE MEASURE FOR ALL PATIENTS WITH BLADDER CANCER","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Quality of life (healthcare); Scale (ratio); Bladder cancer; Modalities; Cancer; Nursing; Internal medicine; Social science","score_opus":0.07560326090449374,"score_gpt":0.33413240932174604,"score_spread":0.2585291484172523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312329262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674107,0.00042974297,0.0023454085,0.009010819,0.0003043177,0.0008231544,0.0001340271,0.000011522128,0.00019991584],"genre_scores_gemma":[0.9966943,0.000041303367,0.0001924737,0.0027427843,0.00017535087,0.000029112447,0.0000031825045,0.000030609703,0.00009087019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973002,0.00029535402,0.0012185997,0.00020231979,0.00063904753,0.0003445008],"domain_scores_gemma":[0.9960137,0.0006305003,0.0015857574,0.00053342833,0.0010751829,0.00016140536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013751545,0.0002283631,0.00068258494,0.00006138784,0.00011313575,0.000006812681,0.00024147565,0.00011807565,0.00020462938],"category_scores_gemma":[0.00056250545,0.0000863086,0.00022377135,0.00011797502,0.00029121464,0.000092813614,0.00005580255,0.00025974217,0.0000012262375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013194963,0.0009539307,0.96957725,0.000044969373,0.0028054207,0.000003299331,0.0014697153,0.000027846852,0.0029641006,0.000014762414,0.0017757849,0.0071679293],"study_design_scores_gemma":[0.012564909,0.0027170903,0.979103,0.00006992444,0.0020017761,0.00007254945,0.00017881837,0.000017664423,0.001052714,0.00014489517,0.0019281764,0.00014843336],"about_ca_topic_score_codex":0.00025818733,"about_ca_topic_score_gemma":0.00014588605,"teacher_disagreement_score":0.00995322,"about_ca_system_score_codex":0.00008187337,"about_ca_system_score_gemma":0.0003940806,"threshold_uncertainty_score":0.35195628},"labels":[],"label_agreement":null},{"id":"W2313001289","doi":"10.1111/iju.12131","title":"<scp>IJU</scp> this issue","year":2013,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Nephrectomy; Dissection (medical); Bladder cancer; Prostate cancer; Cancer; Renal cell carcinoma; Lymph node; Metastasis; Kidney cancer; Urology; General surgery; Surgery; Oncology; Kidney; Internal medicine","score_opus":0.012817707247573758,"score_gpt":0.29472764913356836,"score_spread":0.2819099418859946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313001289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83902365,0.0025762082,0.0007369017,0.036244728,0.0052809548,0.00026030603,0.000013537081,0.000030710755,0.115833],"genre_scores_gemma":[0.9833366,0.00023685789,0.0006017038,0.0068833125,0.0015808956,0.000005593303,0.0000041344674,0.000013646044,0.0073372396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991218,0.00003064303,0.00029828103,0.00008856374,0.00032474665,0.00013599009],"domain_scores_gemma":[0.99892396,0.00011103268,0.00018199183,0.00008326317,0.00058236,0.000117371084],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008634139,0.00008732932,0.00019602776,0.00017085212,0.000015983507,0.00001896939,0.0001949438,0.00007715419,0.0030073235],"category_scores_gemma":[0.00017348788,0.000065099564,0.00011909126,0.000041134146,0.00005095102,0.00013059925,0.00003017902,0.00021307135,0.00083681097],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043282483,0.0011527686,0.12832245,0.000018764238,0.0034137433,0.0019028417,0.0016704592,0.000040921164,0.016744787,0.0013193829,0.768942,0.07603907],"study_design_scores_gemma":[0.0042766775,0.0017770805,0.09430914,0.000025934098,0.00019018126,0.0052237804,0.00010279248,0.000082819024,0.003614165,0.003236215,0.88711697,0.00004426876],"about_ca_topic_score_codex":0.00007808443,"about_ca_topic_score_gemma":0.0000022588017,"teacher_disagreement_score":0.14431296,"about_ca_system_score_codex":0.000061220075,"about_ca_system_score_gemma":0.000110595036,"threshold_uncertainty_score":0.9999412},"labels":[],"label_agreement":null},{"id":"W2313750719","doi":"10.1016/j.juro.2015.02.2466","title":"MP68-04 A FIVE—GENE DNA—METHYLATION BIOMARKER PANEL SENSITIVELY DETECTS BLADDER CANCER AND DISCRIMINATES BETWEEN HIGH—GRADE AND LOW—GRADE DISEASE IN VOIDED URINE","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Biomarker; Urine; Cancer; Gynecology; Internal medicine; Genetics; Biology","score_opus":0.04921502225663464,"score_gpt":0.3034498939386509,"score_spread":0.25423487168201625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313750719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98282945,0.005565243,0.00006758484,0.0111160455,0.00012112824,0.0002423757,0.000035578236,0.000007867427,0.000014755388],"genre_scores_gemma":[0.99804556,0.0009620761,0.0000798404,0.00054690463,0.00025135613,0.0000057143498,0.0000067928017,0.000021574313,0.00008019197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988048,0.0002658843,0.00032611354,0.0001559653,0.00020829395,0.00023890637],"domain_scores_gemma":[0.9990151,0.00022925017,0.0002030559,0.00012671182,0.000112877744,0.00031302244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041030144,0.00017748053,0.00040225507,0.00017454702,0.000050118273,0.0000106136495,0.00006287358,0.00008342675,0.000011210183],"category_scores_gemma":[0.00012457687,0.00011005071,0.00004423974,0.00012941711,0.00020204966,0.000099608806,0.000051976298,0.00023890739,0.0000015316054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023381693,0.0010903913,0.7662688,0.00026779048,0.0028610479,0.0029164914,0.013433729,0.00035894784,0.12617892,0.000051649273,0.0010562557,0.062134285],"study_design_scores_gemma":[0.0064422665,0.0009266005,0.98109573,0.00004780315,0.0011703317,0.00035514,0.00018297625,0.00023908305,0.0074821734,0.0018287773,0.00011186699,0.00011724733],"about_ca_topic_score_codex":0.00063602696,"about_ca_topic_score_gemma":0.000112330155,"teacher_disagreement_score":0.21482694,"about_ca_system_score_codex":0.00006600007,"about_ca_system_score_gemma":0.00016413233,"threshold_uncertainty_score":0.44877377},"labels":[],"label_agreement":null},{"id":"W2315140281","doi":"10.1586/era.11.193","title":"Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma","year":2011,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Urology; Bladder cancer; Cuff; Immunotherapy; Urothelium; Upper urinary tract; Chemotherapy; Transitional cell carcinoma; Surgery; Cancer; Urinary bladder; Internal medicine; Urinary system","score_opus":0.07196198303568058,"score_gpt":0.4023826596960664,"score_spread":0.3304206766603858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315140281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002699256,0.9902862,0.00023370094,0.00012258238,0.0004504923,0.00794187,0.000100592624,0.00004462455,0.00055003696],"genre_scores_gemma":[0.0004187952,0.9934755,0.0027968637,0.0007489338,0.0005457939,0.0013171228,0.00013534212,0.00023654092,0.00032510416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969286,0.00016527956,0.0013791883,0.0006529989,0.00046033808,0.0004136514],"domain_scores_gemma":[0.9974256,0.00030455884,0.00090292137,0.001002849,0.00024270074,0.0001213424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029697994,0.00077232724,0.0041137165,0.00026838877,0.00009865654,0.000011931875,0.0003192484,0.00026878747,0.00081134576],"category_scores_gemma":[0.00004911413,0.00044137944,0.0018804682,0.0006036417,0.00016811171,0.00011328951,0.000013230172,0.00025839012,0.0000041999815],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034170696,0.00082995166,0.0001525169,0.033107627,0.0022158527,0.0000068232066,0.00048324757,2.3096671e-8,0.00006799222,0.000035189685,0.00031507795,0.95936865],"study_design_scores_gemma":[0.0084644295,0.0049584256,0.00024019783,0.1114133,0.0010515538,0.000050623858,0.000013187353,4.0193916e-7,0.0008226995,0.0000056342146,0.87262446,0.0003551176],"about_ca_topic_score_codex":0.00018167803,"about_ca_topic_score_gemma":0.000006235214,"teacher_disagreement_score":0.9590135,"about_ca_system_score_codex":0.00018876194,"about_ca_system_score_gemma":0.0016240729,"threshold_uncertainty_score":0.9998038},"labels":[],"label_agreement":null},{"id":"W2315977973","doi":"10.1097/pai.0000000000000334","title":"Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma","year":2016,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Urothelium; Cytokeratin; Pathology; CD44; Immunostaining; Carcinoma in situ; Medicine; Dysplasia; Immunohistochemistry; Carcinoma; Biology; Internal medicine; Cell; Urinary bladder","score_opus":0.00662435511451183,"score_gpt":0.21352142132242877,"score_spread":0.20689706620791692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315977973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881619,0.00038131644,0.0033985453,0.00025399533,0.0002382466,0.0030257253,0.0014639348,0.00014420423,0.0029321013],"genre_scores_gemma":[0.9958173,0.00006429058,0.0014695474,0.00048778486,0.0002359985,0.0009129742,0.00029640962,0.00029503045,0.00042065963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953514,0.00021576486,0.0011569848,0.0014421372,0.00061759853,0.0012161477],"domain_scores_gemma":[0.9965312,0.0007064728,0.000884522,0.0011868634,0.0002993416,0.00039161614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041442018,0.0011068027,0.0015956796,0.00019253553,0.0003420685,0.000058427813,0.00046167965,0.000724997,0.00015548615],"category_scores_gemma":[0.00010376531,0.00090601295,0.00035533076,0.00026766057,0.0009705627,0.00012611307,0.0002267215,0.0006590692,0.000016099466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010157096,0.0009956205,0.00084120675,0.0003577526,0.00053705164,0.00063455966,0.00051233644,0.000002666148,0.9825197,0.00010364636,0.00020465585,0.0031337033],"study_design_scores_gemma":[0.03194656,0.0023727685,0.0028213337,0.00024843632,0.0010658095,0.0005562382,0.00030263743,0.000015967677,0.9595501,0.00012610301,0.000103571634,0.0008904772],"about_ca_topic_score_codex":0.00032826286,"about_ca_topic_score_gemma":0.000006831969,"teacher_disagreement_score":0.022969607,"about_ca_system_score_codex":0.0005938428,"about_ca_system_score_gemma":0.001161559,"threshold_uncertainty_score":0.99933904},"labels":[],"label_agreement":null},{"id":"W2316080442","doi":"10.1097/pai.0000000000000224","title":"Noninvasive Papillary Basal-like Urothelial Carcinoma: A Subgroup of Urothelial Carcinomas With Immunohistochemical Features of Basal Urothelial Cells Associated With a High Rate of Recurrence and Progression","year":2015,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Urothelium; Basal (medicine); Cytokeratin; Immunohistochemistry; Pathology; Medicine; Keratin 5; Metastasis; Urothelial Cell; Keratin 7; Urology; Internal medicine; Cancer; Urinary bladder","score_opus":0.0084236257125084,"score_gpt":0.23910208006161604,"score_spread":0.23067845434910764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316080442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936025,0.0026932075,0.00022162341,0.000091970585,0.0001496901,0.001574606,0.00030881644,0.000043801585,0.0013137592],"genre_scores_gemma":[0.9966142,0.000046215748,0.0022224912,0.00019519981,0.000059509395,0.00028676627,0.00029207233,0.0001311673,0.00015238683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967387,0.0001561528,0.0008745804,0.0009183689,0.0006906866,0.00062156445],"domain_scores_gemma":[0.9969863,0.00013240443,0.0009280622,0.0009835317,0.00066495244,0.00030469135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003198282,0.00071586255,0.0015224402,0.00016410746,0.000078502446,0.0000112344815,0.0003806833,0.0005030288,0.000046285484],"category_scores_gemma":[0.00009984287,0.00058631634,0.00019456999,0.00043199715,0.0017216397,0.000056440178,0.00018900313,0.0006010334,0.0000022573047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01392217,0.00080699247,0.0023768386,0.00037172122,0.00060502416,0.0005418685,0.0007245255,0.000009451506,0.98009336,0.00008046666,0.00026021802,0.0002073778],"study_design_scores_gemma":[0.014302611,0.003573357,0.0063502514,0.00042418292,0.0009044609,0.000428838,0.0002187988,0.000004693273,0.97316146,0.00012460076,0.000016561393,0.00049017434],"about_ca_topic_score_codex":0.00079008006,"about_ca_topic_score_gemma":0.0000017459053,"teacher_disagreement_score":0.006931876,"about_ca_system_score_codex":0.000297106,"about_ca_system_score_gemma":0.0013835962,"threshold_uncertainty_score":0.9996588},"labels":[],"label_agreement":null},{"id":"W2318535516","doi":"10.1016/j.juro.2016.02.2483","title":"MP13-02 IS RE-RESECTION NECESSARY? RE-RESECTION OF NON-MUSCLE INVASIVE BLADDER CANCER AT A TERTIARY CARE CENTER","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Resection; Tertiary care; Bladder tumor; General surgery; Cancer; Surgery; Internal medicine","score_opus":0.016005081777415456,"score_gpt":0.29085285421587603,"score_spread":0.2748477724384606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318535516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836,0.0028775353,0.00009715497,0.0108619025,0.00082791166,0.0002720159,0.000043593394,0.000008333532,0.0014115424],"genre_scores_gemma":[0.99363375,0.0027161464,0.000017780803,0.0022221184,0.0006491664,0.000011237622,0.0000023333068,0.000027408661,0.00072008854],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986779,0.00017352069,0.00043581837,0.00015369902,0.0003046679,0.0002543667],"domain_scores_gemma":[0.99864775,0.00015851599,0.00042649978,0.00028604062,0.00037241913,0.00010875368],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020515574,0.00016189068,0.00034709982,0.00015644311,0.00009679433,0.0000040147665,0.00015802578,0.00014559564,0.0014339328],"category_scores_gemma":[0.000055337965,0.00008302191,0.00017380626,0.0001182732,0.00014912733,0.00013661447,0.000067251734,0.00023876087,0.000023097737],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022080889,0.0006250171,0.34023777,0.00027514112,0.002591854,0.00019554436,0.01707203,0.00006801295,0.49680552,0.0000048020543,0.08267976,0.03736365],"study_design_scores_gemma":[0.021154847,0.014795734,0.54053354,0.00068582885,0.0025511924,0.0015081813,0.0022744318,0.000029008737,0.39602324,0.0004059153,0.019685952,0.000352132],"about_ca_topic_score_codex":0.00049720134,"about_ca_topic_score_gemma":0.0013189756,"teacher_disagreement_score":0.20029578,"about_ca_system_score_codex":0.0002529958,"about_ca_system_score_gemma":0.00020807692,"threshold_uncertainty_score":0.9994789},"labels":[],"label_agreement":null},{"id":"W2320307911","doi":"10.1097/01.mib.0000456962.52100.b5","title":"P-202 Role of NOD1 and NOD2 in Colitis-Associated Cancer (CAC)","year":2014,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"NOD1; NOD2; Intestinal epithelium; Colitis; Inflammation; Cancer research; Carcinogenesis; Nod; Biology; Immunology; Colorectal cancer; Genetically modified mouse; Inflammatory bowel disease; Cancer; Innate immune system; Epithelium; Immune system; Medicine; Transgene; Pathology; Gene; Genetics; Disease","score_opus":0.007333025952869942,"score_gpt":0.24986077584101826,"score_spread":0.24252774988814832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320307911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947477,0.0025460266,7.2942413e-7,0.00011495794,0.000075798765,0.0002946504,0.00015375587,0.000044947104,0.0020214387],"genre_scores_gemma":[0.9990682,0.00021799839,0.0000073518736,0.000263799,0.00008995015,0.000095341326,0.000019909223,0.00002305576,0.00021437072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990963,0.00005615607,0.00024330032,0.00019882858,0.00019265791,0.00021278177],"domain_scores_gemma":[0.9994432,0.000043696735,0.00008460639,0.00018180175,0.00006560737,0.00018110653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005852795,0.00014140381,0.00028292238,0.00008488842,0.000033952252,0.000009348165,0.000052837237,0.00006841207,0.00016743978],"category_scores_gemma":[0.000084424486,0.00012895251,0.000064527645,0.00008474801,0.00009543793,0.00007372314,0.000030900588,0.0000722302,0.000009755425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039009412,0.00022635267,0.99295205,0.00016726532,0.00009414616,0.00003088227,0.00025860092,0.000005346909,0.0011308154,0.00018841779,0.00023767147,0.0043183514],"study_design_scores_gemma":[0.0029086135,0.00009059356,0.99299765,0.00033755574,0.00016017421,0.0000020572675,0.000095031355,0.00013708608,0.0011724507,0.00045662918,0.0015257846,0.000116352894],"about_ca_topic_score_codex":0.00067299546,"about_ca_topic_score_gemma":0.0006252966,"teacher_disagreement_score":0.0043205284,"about_ca_system_score_codex":0.000092735485,"about_ca_system_score_gemma":0.00017430817,"threshold_uncertainty_score":0.52585304},"labels":[],"label_agreement":null},{"id":"W2322194776","doi":"10.1016/j.juro.2016.02.2196","title":"MP83-14 GENOMIC EXPRESSION EVIDENCE FOR ANDROGEN RECEPTOR AXIS ACTIVATION IN UROTHELIAL CARCINOMA: DATA FROM THE CANCER GENOME ATLAS","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"","keywords":"Androgen receptor; Carcinogenesis; Bladder cancer; Androgen; Medicine; Dihydrotestosterone; Cancer research; Cancer; Oncology; Internal medicine; Prostate cancer; Hormone","score_opus":0.095718593037591,"score_gpt":0.3429941896670903,"score_spread":0.24727559662949927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322194776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706206,0.0057326225,0.0014858397,0.02103333,0.00039648177,0.0005207953,0.00018441396,0.0000051626635,0.000020755844],"genre_scores_gemma":[0.9951042,0.0020697769,0.00017149666,0.0011292294,0.001342023,0.000023725781,0.000010849867,0.000022884105,0.00012581714],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99877113,0.00024510946,0.00037635726,0.00019861496,0.00018854179,0.0002202557],"domain_scores_gemma":[0.9979153,0.0010402248,0.00030907354,0.00056066364,0.000108190754,0.00006651326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068140676,0.0001321454,0.00028546623,0.000052825424,0.00008471825,0.00000798843,0.0005998472,0.00009057539,0.000403887],"category_scores_gemma":[0.00030547476,0.000055379303,0.000066254244,0.00006922121,0.00010039209,0.00019522055,0.00012577283,0.00019241817,0.000017457009],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011990648,0.00008807729,0.04620856,0.000010377303,0.0001659879,0.000006362803,0.0009883705,0.000015845633,0.92770976,0.000003939623,0.0059395535,0.006872509],"study_design_scores_gemma":[0.026059896,0.0047478266,0.70724225,0.00069599587,0.0017148884,0.00026850845,0.00033831387,0.0001341318,0.15083425,0.0018757667,0.105665214,0.00042295296],"about_ca_topic_score_codex":0.0005278467,"about_ca_topic_score_gemma":0.00014614974,"teacher_disagreement_score":0.7768755,"about_ca_system_score_codex":0.00016365912,"about_ca_system_score_gemma":0.00035296218,"threshold_uncertainty_score":0.44222796},"labels":[],"label_agreement":null},{"id":"W2324711160","doi":"10.1016/j.juro.2015.02.2092","title":"PD31-07 DIFFERENCES IN LYMPH NODE COUNT AT RADICAL CYSTECTOMY WITH A STANDARDIZED SURGICAL TEMPLATE DO NOT INFLUENCE LONG-TERM SURVIVAL FOR BLADDER CANCER","year":2015,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymph node; Cystectomy; Medicine; Bladder cancer; Lymph; Dissection (medical); Cancer; General surgery; Gynecology; Surgery; Internal medicine; Pathology","score_opus":0.03676259690554353,"score_gpt":0.3180211362401244,"score_spread":0.2812585393345809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324711160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347204,0.0021716019,0.000290224,0.0031801849,0.00026884765,0.0003778294,0.000045194258,0.000010043673,0.00018402055],"genre_scores_gemma":[0.9983597,0.00049583445,0.00006558463,0.0006033826,0.00028694497,0.000029724553,0.0000023111156,0.000024271341,0.00013227017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981324,0.00026040827,0.0004843429,0.00017569834,0.00056574726,0.00038137587],"domain_scores_gemma":[0.99852616,0.00040851117,0.00029035768,0.00020145011,0.00032335162,0.00025018188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087571895,0.00021286405,0.00074783503,0.00010526555,0.000070265116,0.000015749296,0.00021655753,0.00013332794,0.0001563814],"category_scores_gemma":[0.000071650764,0.00010797296,0.000099680336,0.000121651356,0.00034587513,0.00007969832,0.000048769285,0.00029286544,0.000006983394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07569742,0.00028550826,0.919393,0.000046042274,0.00075168285,0.0010104397,0.0010598681,0.00028843083,0.00045970577,0.000022692462,0.00021369601,0.00077149476],"study_design_scores_gemma":[0.06572034,0.0052123936,0.9147582,0.00020792175,0.001377125,0.0075206356,0.00012392116,0.00008702089,0.00074317254,0.0001665415,0.003791698,0.00029103874],"about_ca_topic_score_codex":0.00022618844,"about_ca_topic_score_gemma":0.0002676253,"teacher_disagreement_score":0.009977081,"about_ca_system_score_codex":0.00031834893,"about_ca_system_score_gemma":0.0007728184,"threshold_uncertainty_score":0.44030097},"labels":[],"label_agreement":null},{"id":"W2324911549","doi":"10.1016/j.ijrobp.2014.05.1444","title":"Patterns of Referral to Radiation Oncology Among Patients Who Undergo Cystectomy for Invasive Bladder Cancer in Ontario: A Population-Based Study","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Radiation oncology; Referral; Oncology; Internal medicine; Urothelial cancer; Population; Radiation therapy; Cancer; Family medicine; Environmental health","score_opus":0.02656375639727129,"score_gpt":0.3460749384331017,"score_spread":0.31951118203583045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324911549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911635,0.00003099021,0.004535135,0.001033615,0.0017099037,0.0012224644,0.00013697319,0.000013377323,0.00015405328],"genre_scores_gemma":[0.99706334,0.000021944006,0.00057743245,0.0011267288,0.0007190741,0.00015906339,0.0002368254,0.000033859083,0.0000617468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774903,0.00031066022,0.0010410898,0.0003045485,0.00034587245,0.0002487993],"domain_scores_gemma":[0.9969006,0.0005796274,0.001210634,0.0001637733,0.0009948368,0.00015050503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043907043,0.00023481563,0.000747439,0.00038240445,0.000051003848,0.000014523219,0.00025610882,0.00024132755,0.000106435065],"category_scores_gemma":[0.0003728974,0.00021182666,0.00020602896,0.00016314245,0.00003493974,0.00021056809,0.00003558182,0.00034152484,0.000003528064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015029022,0.0015344076,0.95360583,0.000014324234,0.00060445035,0.0000057985358,0.0014289573,0.0033274796,0.00013085164,0.00024113244,0.00014637176,0.037457503],"study_design_scores_gemma":[0.020420173,0.0067793396,0.96838456,0.00011814916,0.00024749618,0.0000037634406,0.0001313266,0.00063828187,0.00053280784,0.000798088,0.0017844384,0.0001615849],"about_ca_topic_score_codex":0.013274321,"about_ca_topic_score_gemma":0.050583474,"teacher_disagreement_score":0.037309155,"about_ca_system_score_codex":0.003386056,"about_ca_system_score_gemma":0.0014706999,"threshold_uncertainty_score":0.9932964},"labels":[],"label_agreement":null},{"id":"W2325068191","doi":"10.1097/spc.0b013e3283627903","title":"Urinary diversions","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Randomized controlled trial; Intensive care medicine; Surgery; Bladder cancer; Internal medicine","score_opus":0.21258264798273763,"score_gpt":0.45641393866936636,"score_spread":0.24383129068662873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325068191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025480525,0.9947449,0.000007541534,0.00002110593,0.0018050502,0.0018513323,0.0006361662,0.00002458466,0.00088386226],"genre_scores_gemma":[0.00008584767,0.99649304,0.000030501456,0.000015904698,0.00037996678,0.0004920134,0.0022489536,0.00003597034,0.000217771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983967,0.00010637208,0.00045260086,0.00054211507,0.00021122601,0.0002909638],"domain_scores_gemma":[0.99907655,0.00008696311,0.00021977448,0.0002273778,0.00017094807,0.00021836345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000035769106,0.0004488946,0.0012910262,0.00023569146,0.000075555945,0.000019086829,0.00008788998,0.00020659874,0.000550957],"category_scores_gemma":[0.000029265751,0.00032768078,0.0003343899,0.00024421135,0.00010231782,0.00007549717,0.00013023162,0.00049507973,0.0001766698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002058045,0.00020259804,0.013280012,0.039441064,0.00017781081,0.000016890946,0.0012680888,1.05630855e-8,1.7087032e-8,0.000087579116,0.0047779894,0.94072735],"study_design_scores_gemma":[0.00085794844,0.00040846612,0.0038997063,0.032732837,0.00045553572,0.000009976726,0.0005769752,3.1814903e-7,2.781399e-7,0.000023449003,0.9607493,0.00028516407],"about_ca_topic_score_codex":0.000014937232,"about_ca_topic_score_gemma":5.470704e-7,"teacher_disagreement_score":0.95597136,"about_ca_system_score_codex":0.00027464406,"about_ca_system_score_gemma":0.00042313844,"threshold_uncertainty_score":0.9999175},"labels":[],"label_agreement":null},{"id":"W2327426140","doi":"10.1097/spc.0b013e3283490441","title":"Are we undertreating invasive bladder cancer? Optimizing outcomes in a high-risk disease","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Disease; Lymph node; Multidisciplinary approach; Oncology; Quality of life (healthcare); Cancer; Internal medicine","score_opus":0.21652510762466373,"score_gpt":0.4389901274046585,"score_spread":0.22246501977999475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327426140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062720594,0.9928852,0.000019243505,0.0000668418,0.001459436,0.0023177422,0.0025035278,0.000032993466,0.00008782043],"genre_scores_gemma":[0.0023643703,0.99461204,0.000060595677,0.00003690611,0.00028066814,0.0014766316,0.0010251807,0.000085501146,0.00005812563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969928,0.0003046176,0.00092830614,0.000978853,0.0002748081,0.00052060996],"domain_scores_gemma":[0.9977047,0.00029948924,0.001078157,0.0003406325,0.00021240722,0.0003646329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008576817,0.0008263362,0.0024220338,0.000477537,0.00009713503,0.00003243861,0.00014082178,0.000249014,0.00023950239],"category_scores_gemma":[0.00019746322,0.00062400074,0.00044065516,0.00042941442,0.00013177992,0.0001258462,0.00013881449,0.00084644236,0.000014471173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097054755,0.00024554518,0.67899996,0.029507255,0.0004606716,0.00007207463,0.00373801,0.0000018245908,7.1043207e-9,0.000057920774,0.00021706219,0.2866026],"study_design_scores_gemma":[0.008005433,0.0005791682,0.39111927,0.30023542,0.0041640745,0.00000580412,0.009115722,0.0000069836415,0.0000021647313,0.0003897958,0.284479,0.0018971486],"about_ca_topic_score_codex":0.00042724508,"about_ca_topic_score_gemma":0.00029199568,"teacher_disagreement_score":0.2878807,"about_ca_system_score_codex":0.0007437725,"about_ca_system_score_gemma":0.0010657557,"threshold_uncertainty_score":0.99962115},"labels":[],"label_agreement":null},{"id":"W2328566020","doi":"10.1158/1538-7445.am2015-3316","title":"Abstract 3316: The role of high mobility group box 1 in the combination therapy of gemcitabine and radiation in muscle invasive bladder cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Gemcitabine; Bladder cancer; Medicine; Cancer research; Clonogenic assay; Cancer; Radiation therapy; HMGB1; Urology; Viability assay; Oncology; Internal medicine; Pathology; In vivo; Inflammation; Cell; Biology","score_opus":0.07257318120202744,"score_gpt":0.3844806850768114,"score_spread":0.31190750387478394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328566020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420745,0.011903051,7.4253063e-7,0.002031409,0.00005127285,0.0011631575,0.000035474655,0.00000367047,0.0006037773],"genre_scores_gemma":[0.9940406,0.005185644,0.0000052163487,0.0001075668,0.00006933657,0.00053982716,0.000012917103,0.000011449839,0.000027421771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853766,0.00023786534,0.00024320142,0.00019543523,0.0005741171,0.00021174319],"domain_scores_gemma":[0.9990531,0.0002799295,0.00007042058,0.0002764422,0.00026679656,0.000053310716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013277965,0.00008882063,0.00020721085,0.00013800479,0.00003793195,0.000011526933,0.00014507835,0.0000631707,0.000120913064],"category_scores_gemma":[0.00011476158,0.00005150915,0.00002810398,0.00049893244,0.00025007396,0.00010089911,0.00003041311,0.0002863944,0.0000010883035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028018188,0.00215346,0.6399572,0.0002473317,0.00019115738,0.00001292448,0.027552476,0.00015471279,0.057943363,0.0014767443,0.0012056465,0.26630315],"study_design_scores_gemma":[0.004365127,0.0004482392,0.96406454,0.00009325818,0.000010128823,8.192092e-7,0.0027096902,0.000031922875,0.023963373,0.003595266,0.0006690136,0.000048615802],"about_ca_topic_score_codex":0.048995297,"about_ca_topic_score_gemma":0.007493262,"teacher_disagreement_score":0.32410735,"about_ca_system_score_codex":0.00026864457,"about_ca_system_score_gemma":0.00047231372,"threshold_uncertainty_score":0.9573375},"labels":[],"label_agreement":null},{"id":"W2328814368","doi":"10.1016/j.juro.2012.02.720","title":"641 MANAGEMENT OF THE INTRAVESICAL URETER AND BLADDER CUFF DURING RADICAL NEPHROURETERECTOMY: OUTCOMES FROM THE CANADIAN UPPER TRACT COLLABORATION","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Art history; History","score_opus":0.014180765093206102,"score_gpt":0.265538954880424,"score_spread":0.2513581897872179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328814368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688175,0.0013169671,0.000012918763,0.028828165,0.00035355918,0.00021865482,0.000011708118,0.0000023141279,0.0004382427],"genre_scores_gemma":[0.9962735,0.00017639495,0.000080759084,0.0030508146,0.00032740785,0.0000024052272,0.0000011472832,0.000011073981,0.0000764767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990174,0.00023118779,0.00026230185,0.000058885693,0.0002134371,0.00021678992],"domain_scores_gemma":[0.9993159,0.00014666935,0.00015203448,0.00019858523,0.000051408962,0.00013541107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034442556,0.000104784296,0.00022801963,0.00003778203,0.00013854691,0.000011361442,0.00015230128,0.00008105601,0.00018264295],"category_scores_gemma":[0.000028971612,0.000042352935,0.00007644195,0.000082814666,0.00019819042,0.00006984857,0.00003186601,0.00031607735,0.000003049061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014391695,0.00019830748,0.9818739,0.000019651534,0.0019473111,0.000050200728,0.0075546955,0.000009137674,0.0011909923,0.00051198585,0.0022460069,0.0029586302],"study_design_scores_gemma":[0.0016964722,0.0001965794,0.99119014,0.000015164946,0.0009322335,0.00033942622,0.00031718652,0.000007223482,0.00057795824,0.00024713812,0.004439081,0.000041396877],"about_ca_topic_score_codex":0.0018440919,"about_ca_topic_score_gemma":0.0017731315,"teacher_disagreement_score":0.02745605,"about_ca_system_score_codex":0.00007462234,"about_ca_system_score_gemma":0.00013248366,"threshold_uncertainty_score":0.27877277},"labels":[],"label_agreement":null},{"id":"W2329034162","doi":"10.1136/jech.2011.142976b.76","title":"O6-2.6 Bladder cancer survival disparities in the United States: results from SEER-Medicare","year":2011,"lang":"en","type":"article","venue":"Journal of Epidemiology & Community Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Comorbidity; Marital status; Receipt; Relative survival; Cancer registry; Population; Cancer; Demography; Internal medicine; Gerontology; Gynecology; Environmental health","score_opus":0.26981626765282357,"score_gpt":0.4322090147412763,"score_spread":0.16239274708845275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329034162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93532413,0.004879835,0.00023299945,0.056750134,0.00064009987,0.00031809992,0.0003379919,0.00001824433,0.0014984552],"genre_scores_gemma":[0.9466082,0.011222664,0.0009314278,0.04064491,0.00030671697,0.000012434699,0.00021901345,0.000019754272,0.000034897177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9899335,0.0076076174,0.0015188919,0.00016130532,0.000260669,0.0005180324],"domain_scores_gemma":[0.9913401,0.006366076,0.0009126183,0.00079120946,0.00025493625,0.0003350543],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009425373,0.00021694704,0.0011150232,0.00023273751,0.0002796181,0.0000050874164,0.0005063639,0.00017972701,0.00013263726],"category_scores_gemma":[0.0030337926,0.00013036444,0.00016860435,0.0003126091,0.000285991,0.00008682067,0.00007705194,0.0025548858,0.0000048466145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031090046,0.001138219,0.92984927,0.000098272525,0.0005873854,0.00007201611,0.031618465,0.000051218307,0.00000253921,0.0003706769,0.029897206,0.0032057138],"study_design_scores_gemma":[0.0045511737,0.0017927327,0.96514463,0.0005420573,0.00014717941,0.000066262866,0.010725003,0.00006526733,0.0000062289014,0.0060178745,0.010836402,0.000105174884],"about_ca_topic_score_codex":0.4395961,"about_ca_topic_score_gemma":0.054464236,"teacher_disagreement_score":0.38513184,"about_ca_system_score_codex":0.00037952224,"about_ca_system_score_gemma":0.0009109309,"threshold_uncertainty_score":0.99974626},"labels":[],"label_agreement":null},{"id":"W2330616178","doi":"10.1016/j.urology.2016.03.033","title":"Building the Case for Adjuvant Chemotherapy After Radical Cystectomy","year":2016,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymph node; Chemotherapy; Adjuvant chemotherapy; Urology; Retrospective cohort study; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.014892773848691625,"score_gpt":0.29022039553659323,"score_spread":0.2753276216879016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330616178","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002478683,0.0023186165,0.0032197386,0.9886815,0.00091023464,0.0014484101,0.00020725073,0.0000707243,0.0006648331],"genre_scores_gemma":[0.038064066,0.00006249293,0.00036925604,0.94465125,0.01234207,0.0009813798,0.000038036545,0.00011505018,0.0033763885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852645,0.00008401142,0.00024327726,0.00046652497,0.00013440632,0.00054533494],"domain_scores_gemma":[0.998924,0.00032914075,0.000088850335,0.00053614954,0.0000536145,0.00006824432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011325651,0.00031523092,0.00053881994,0.000087911714,0.0000810524,0.000011742536,0.00014373589,0.0007824764,0.0008444865],"category_scores_gemma":[0.000028474436,0.0001606303,0.00027815448,0.000045203808,0.00022843701,0.000018163259,0.00003167345,0.0007125955,0.000070541595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012121528,0.000027181351,0.000084604595,0.00011441539,0.0005021925,0.018476019,0.000081220474,6.996172e-8,0.00008018834,0.000028066248,0.95362085,0.025773035],"study_design_scores_gemma":[0.004719025,0.00083285,0.00004016875,0.00003089846,0.00053407473,0.012785656,0.0000018548614,0.000011430747,0.00013247166,0.00066558266,0.9800832,0.00016276598],"about_ca_topic_score_codex":0.000043839547,"about_ca_topic_score_gemma":0.000008585432,"teacher_disagreement_score":0.04403025,"about_ca_system_score_codex":0.00008450605,"about_ca_system_score_gemma":0.00013900614,"threshold_uncertainty_score":0.92465353},"labels":[],"label_agreement":null},{"id":"W2331298537","doi":"10.1016/j.juro.2012.02.1364","title":"1591 AGE, COMORBIDITIES, AND RACE ARE PREDICTORS TO UNDERGO RADICAL CYSTECTOMY AT LOW VOLUME INSTITUTIONS","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Charlson comorbidity index; Demography; Comorbidity; Bladder cancer; Cancer; Psychiatry; Internal medicine; Sociology","score_opus":0.029914703085535482,"score_gpt":0.2902855404859919,"score_spread":0.2603708374004564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331298537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98446006,0.0035607764,0.00044812125,0.009805984,0.0006204123,0.0001875004,0.000014432517,0.000012808917,0.0008898795],"genre_scores_gemma":[0.9958174,0.00024129085,0.00008752138,0.002428388,0.00060242746,0.0000035824132,0.0000018917744,0.000012216134,0.0008052851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991304,0.00013786867,0.00023465624,0.00006493239,0.00018489646,0.00024719577],"domain_scores_gemma":[0.9992476,0.000106079606,0.0001343647,0.00015299603,0.00005381285,0.0003051137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002815227,0.00010810097,0.00028971408,0.00008662909,0.000116156065,0.000006223159,0.00009657727,0.00008236462,0.0002010951],"category_scores_gemma":[0.00008991328,0.00006581289,0.000057081666,0.00008812782,0.00025115476,0.00007664646,0.000061763305,0.00026823633,0.00004018496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007224315,0.0011483567,0.8041669,0.00012379586,0.0015975492,0.0008035575,0.008652443,0.00021090721,0.005325279,0.0011381435,0.16833155,0.0012772132],"study_design_scores_gemma":[0.005690465,0.0028037454,0.61504,0.00007716771,0.0012389018,0.01265259,0.00035413034,0.000019448715,0.0004986275,0.00015840742,0.36130968,0.00015683811],"about_ca_topic_score_codex":0.000041309213,"about_ca_topic_score_gemma":0.00003262657,"teacher_disagreement_score":0.19297814,"about_ca_system_score_codex":0.0001202116,"about_ca_system_score_gemma":0.0001295699,"threshold_uncertainty_score":0.26837718},"labels":[],"label_agreement":null},{"id":"W2332469386","doi":"10.1016/j.juro.2013.02.2794","title":"1440 EMERGENCE OF VARIANT HISTOLOGY DURING NEO-ADJUVANT CHEMO-THERAPY FOR MUSCLE INVASIVE URETHELIAL BLADDER CANCER IS COMMON AND ASSOCIATED WITH POOR PROGNOSIS","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cancer; Internal medicine; Oncology","score_opus":0.01955615491102508,"score_gpt":0.2702295456303856,"score_spread":0.2506733907193605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332469386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458815,0.0036356582,0.000049694718,0.010799831,0.00017538795,0.00065471756,0.000027780148,0.000006646963,0.00006215477],"genre_scores_gemma":[0.9955117,0.0021981432,0.00011893835,0.0018415347,0.00014027361,0.0000564839,0.0000019638014,0.000025434305,0.00010548991],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989252,0.000120424294,0.0003978982,0.0001299987,0.00016774706,0.00025874094],"domain_scores_gemma":[0.9986611,0.0002065258,0.000520624,0.00012639615,0.0003894059,0.00009592757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021943523,0.00015973486,0.0005450529,0.00007844795,0.00008727968,0.0000042293573,0.00013299112,0.000119520184,0.00045662618],"category_scores_gemma":[0.000064980355,0.00009031365,0.00008483818,0.000098124816,0.00022486394,0.000068011796,0.000024326282,0.00022194636,0.0000013461366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029459553,0.0028168096,0.2790845,0.000322059,0.01106614,0.00026269667,0.022475561,0.00013710056,0.59814817,0.00007614069,0.019917848,0.03623341],"study_design_scores_gemma":[0.027353352,0.019133054,0.82409173,0.00020436298,0.0031679894,0.0017612164,0.00080420607,0.00025578515,0.12005124,0.0014139598,0.0013850686,0.0003780079],"about_ca_topic_score_codex":0.00059339724,"about_ca_topic_score_gemma":0.00023853008,"teacher_disagreement_score":0.5450072,"about_ca_system_score_codex":0.000044576,"about_ca_system_score_gemma":0.0002158164,"threshold_uncertainty_score":0.49997365},"labels":[],"label_agreement":null},{"id":"W2333456198","doi":"10.1097/00000421-200210000-00019","title":"Carboplatin and Vinblastine for the Treatment of Metastatic Transitional Cell Carcinoma of the Urothelial Tract","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vinblastine; Carboplatin; Transitional cell carcinoma; Urothelial carcinoma; Transitional Cell; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Urology; Carcinoma; Internal medicine; Cisplatin; Bladder cancer; Cancer","score_opus":0.09289857469421467,"score_gpt":0.3973515386408462,"score_spread":0.30445296394663157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333456198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991802,0.0012318162,0.00027578816,0.005360642,0.00028299075,0.00040833137,0.000069354595,0.000001265599,0.0005678418],"genre_scores_gemma":[0.9964595,0.0007061666,0.0018973519,0.00045368375,0.00031892266,0.000011442504,6.3283915e-7,0.000011970127,0.00014037425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982883,0.00022793954,0.0010397825,0.00010951274,0.00020595267,0.00012853206],"domain_scores_gemma":[0.9956767,0.0028874387,0.0010091832,0.00014406307,0.0001693715,0.000113236514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034540592,0.00011592413,0.0009616803,0.000039293613,0.000038318103,0.0000018051918,0.00009212077,0.000041221676,0.0001424175],"category_scores_gemma":[0.00014201397,0.000053509757,0.0005074444,0.00010518122,0.00073486986,0.000020601261,0.0000057281313,0.00015194659,6.7172124e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008752132,0.010721561,0.12770446,0.000074140255,0.0014303111,0.000083292725,0.0026411184,0.00007673497,0.0018561097,0.00006224043,0.0005455968,0.8460523],"study_design_scores_gemma":[0.037791073,0.16115049,0.76154935,0.00007695837,0.0060847653,0.0008620293,0.0011954567,0.0010224998,0.0053495173,0.0001939169,0.024564454,0.00015948461],"about_ca_topic_score_codex":0.000082178354,"about_ca_topic_score_gemma":0.000014899726,"teacher_disagreement_score":0.84589285,"about_ca_system_score_codex":0.000045587985,"about_ca_system_score_gemma":0.000333046,"threshold_uncertainty_score":0.27076587},"labels":[],"label_agreement":null},{"id":"W2334419423","doi":"10.1016/j.juro.2013.02.1732","title":"346 DO ASIAN AND CAUCASIAN MEN DEVELOP HIGH GRADE (GLEASON &amp;[GE]7) PROSTATE CANCER AT THE SAME AGE? AN AUTOPSY STUDY","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Epidemiology; Demography; Gynecology; Gerontology; Cancer; Pathology; Internal medicine","score_opus":0.023330104999351974,"score_gpt":0.3049014264846304,"score_spread":0.28157132148527847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334419423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96266913,0.0022561082,0.000007156593,0.03332312,0.00026134448,0.0008194222,0.000008477468,0.0000138005735,0.00064142415],"genre_scores_gemma":[0.99481785,0.0006106267,0.00009527127,0.001899141,0.00033588737,0.000039325743,0.0000028778525,0.000031152416,0.0021678638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998422,0.00042434756,0.00036473916,0.00016586216,0.0002931527,0.0003298867],"domain_scores_gemma":[0.99895644,0.00008908634,0.0002658582,0.0003321876,0.00015955899,0.00019683855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049878727,0.00020134146,0.00039662595,0.00007244522,0.0002261264,0.00003357136,0.00021437563,0.00007794246,0.0005866035],"category_scores_gemma":[0.0000386278,0.00009469838,0.000046484187,0.00014613793,0.00020671512,0.000115721974,0.000078746976,0.0004167913,0.00003263816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006777225,0.002219874,0.6762893,0.00006838392,0.0038076602,0.000908389,0.13056868,0.000085077685,0.008596715,0.00013121901,0.038484227,0.13206325],"study_design_scores_gemma":[0.0042383657,0.0032073946,0.97056115,0.00001839139,0.0008894895,0.0020367894,0.0024974938,0.0000073850315,0.00012011429,0.001092646,0.015203323,0.00012748079],"about_ca_topic_score_codex":0.0028375855,"about_ca_topic_score_gemma":0.002260905,"teacher_disagreement_score":0.29427183,"about_ca_system_score_codex":0.000122026475,"about_ca_system_score_gemma":0.00019770209,"threshold_uncertainty_score":0.6422897},"labels":[],"label_agreement":null},{"id":"W2334824567","doi":"10.1097/01.pat.0000454566.75199.43","title":"Mapping of urothelial carcinoma in radical cystectomy specimens","year":2014,"lang":"en","type":"article","venue":"Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cystectomy; Ureter; Medicine; Lesion; Prostatic urethra; Pathology; Prostate; Urology; Urinary bladder; Carcinoma; Carcinoma in situ; Urethra; Cancer; Bladder cancer; Internal medicine","score_opus":0.018270848007669017,"score_gpt":0.26583755567386125,"score_spread":0.24756670766619224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334824567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789447,0.00016136887,0.00041474355,0.0004093611,0.00016942975,0.00021388473,0.000007173062,0.000019050338,0.019660296],"genre_scores_gemma":[0.99846154,0.000009030114,0.00075229304,0.0003591355,0.00019201518,0.000019814843,0.0000057537172,0.000013814172,0.00018659268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919575,0.0000887644,0.00022110326,0.0001936035,0.000099676836,0.00020110152],"domain_scores_gemma":[0.9996225,0.000044657685,0.00004353085,0.00020548383,0.000021802472,0.00006198349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014960491,0.00009350907,0.00032804685,0.00014036914,0.000013564705,0.0000013855498,0.00005381479,0.000090034926,0.00020100403],"category_scores_gemma":[0.000056431487,0.00007926405,0.000058540052,0.000116791416,0.00010507488,0.000013733284,0.000024472378,0.00012017326,0.000051268857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044089556,0.00038107697,0.8914933,0.0001327548,0.000036758363,0.00072231755,0.0018656311,0.0000033771244,0.09225489,0.0012345972,0.00021483417,0.011219533],"study_design_scores_gemma":[0.0071741496,0.0008146408,0.9680062,0.000054589298,0.000036256242,0.0005219126,0.000089051005,0.00011521791,0.015150935,0.0005633362,0.00736432,0.00010936801],"about_ca_topic_score_codex":0.00009425737,"about_ca_topic_score_gemma":0.000019592944,"teacher_disagreement_score":0.07710396,"about_ca_system_score_codex":0.00004066189,"about_ca_system_score_gemma":0.000055437282,"threshold_uncertainty_score":0.3232294},"labels":[],"label_agreement":null},{"id":"W2336513311","doi":"10.1097/spc.0000000000000151","title":"A review of the 2014 English Language publications pertinent to the treatment of invasive bladder cancer by radiotherapy","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Bladder cancer; English language; Radiation therapy; Urothelial cancer; Cancer; Intensive care medicine; Radiology; Internal medicine; Psychology","score_opus":0.12104059685373543,"score_gpt":0.4519335338639503,"score_spread":0.3308929370102149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336513311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051114464,0.9905105,0.0000045633346,0.00052867556,0.0009504922,0.004239993,0.0036076414,0.0000075155335,0.00009949866],"genre_scores_gemma":[0.00003542172,0.9962107,0.000008552267,0.00015935316,0.00033155797,0.0020162459,0.0010623324,0.000030036086,0.00014582384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817735,0.00025776838,0.00068528915,0.00038338898,0.0003002564,0.00019594654],"domain_scores_gemma":[0.9979762,0.00012717828,0.0005728799,0.00048409088,0.0007072205,0.00013243133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011574425,0.00037064424,0.0013744981,0.00009556911,0.0000409236,0.000008461202,0.00018766787,0.00009443903,0.0002175191],"category_scores_gemma":[0.00012294961,0.00017763604,0.00040696497,0.00045968866,0.000116303585,0.000031714917,0.00004136354,0.00017431374,0.0000029047553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038976337,0.00051590847,0.0057866927,0.0751363,0.0007650851,4.335612e-7,0.03453899,1.7768318e-7,6.055421e-7,0.000022912987,0.13799556,0.74519837],"study_design_scores_gemma":[0.00076503144,0.00046690268,0.0004563184,0.07270569,0.00071594416,9.5020044e-7,0.001225308,1.482608e-7,0.00001515369,0.0000010536814,0.9235061,0.00014141896],"about_ca_topic_score_codex":0.00012782113,"about_ca_topic_score_gemma":0.000040533836,"teacher_disagreement_score":0.78551054,"about_ca_system_score_codex":0.00049184053,"about_ca_system_score_gemma":0.0011662146,"threshold_uncertainty_score":0.72437876},"labels":[],"label_agreement":null},{"id":"W2337651696","doi":"10.5489/cuaj.3456","title":"Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Sudbury; Université de Montréal; Ottawa Hospital; Health Sciences Centre; Queen's University; Northeast Cancer Centre; BC Cancer Agency; Hôpital Notre-Dame; Kingston Health Sciences Centre; University of Ottawa; McGill University Health Centre; McGill University; Sunnybrook Health Science Centre; Montreal General Hospital","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Urothelial carcinoma; Stage (stratigraphy); Urothelial cancer; Incidence (geometry); Carcinoma; Gynecology; Internal medicine; Cancer","score_opus":0.028481201061414104,"score_gpt":0.2952351714287058,"score_spread":0.2667539703672917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337651696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94099605,0.0013475732,0.0015910664,0.049822643,0.0025252185,0.002023621,0.00059115834,0.000065950786,0.001036716],"genre_scores_gemma":[0.99467856,0.000041809344,0.0005631553,0.0029658983,0.00086025824,0.00017725735,0.000015563986,0.000020053541,0.00067746715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997794,0.00015829457,0.00042352578,0.00034888723,0.0004258418,0.00084947876],"domain_scores_gemma":[0.9975578,0.00020137559,0.00017330525,0.00011860116,0.0003002132,0.0016486879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006836668,0.00023040103,0.00039000623,0.00025956315,0.00089623866,0.00009509663,0.00015199743,0.0002344456,0.0006887577],"category_scores_gemma":[0.001243278,0.00014722071,0.00026740538,0.00021434091,0.000041580715,0.00016300738,0.000009772191,0.0003844938,0.000044316002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007508523,0.0001353139,0.9708508,0.000004150721,0.0006229975,0.00030727082,0.0002887965,0.000010167971,0.00011638009,0.000061435865,0.0044478914,0.023079673],"study_design_scores_gemma":[0.015437551,0.0013276445,0.85212964,0.0001330645,0.0006208364,0.00029355346,0.00022799232,0.00024997917,0.000044776243,0.00022875312,0.12885843,0.00044776493],"about_ca_topic_score_codex":0.08735026,"about_ca_topic_score_gemma":0.31243637,"teacher_disagreement_score":0.22508611,"about_ca_system_score_codex":0.0046910895,"about_ca_system_score_gemma":0.005226281,"threshold_uncertainty_score":0.9991297},"labels":[],"label_agreement":null},{"id":"W2338547913","doi":"10.5489/cuaj.3362","title":"Laparoscopic Nephroureterectomy is Associated with Higher Risk of Adverse Events compared to Laparoscopic Radical Nephrectomy","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adverse effect; Complication; Nephrectomy; Urinary system; Surgery; Internal medicine; Kidney","score_opus":0.014572251460238871,"score_gpt":0.24627789466565275,"score_spread":0.23170564320541387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338547913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858929,0.00006321316,0.000053703418,0.011894455,0.000345711,0.00040246485,0.00029226826,0.000036197147,0.0010190908],"genre_scores_gemma":[0.99157816,0.000038349797,0.00030763628,0.005663645,0.00026146977,0.000022995315,0.000014500128,0.000025826605,0.002087413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997624,0.00031453138,0.0004642949,0.00030417074,0.00062596257,0.0006670892],"domain_scores_gemma":[0.99758637,0.00023332321,0.00043966377,0.00018866608,0.0003359555,0.0012160139],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003864458,0.00024791854,0.0006555963,0.00021676703,0.0001974806,0.000012135952,0.00017008094,0.00029149363,0.0025704622],"category_scores_gemma":[0.00050981564,0.00014880595,0.00017873905,0.00037917658,0.00006178305,0.000109501714,0.000018136352,0.00040498612,0.00011257937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003868482,0.00011469985,0.98857445,0.0000032678377,0.0007069937,0.000057863246,0.000115335475,0.0000043511795,0.00021964472,0.00001251173,0.009334618,0.00046941268],"study_design_scores_gemma":[0.009568345,0.001095355,0.94994813,0.00014322963,0.00040886286,0.000035233636,0.000014337064,0.0000049301484,0.00041219033,0.00024656125,0.037941027,0.00018180064],"about_ca_topic_score_codex":0.0013646212,"about_ca_topic_score_gemma":0.0012064567,"teacher_disagreement_score":0.038626324,"about_ca_system_score_codex":0.0017422378,"about_ca_system_score_gemma":0.00077520474,"threshold_uncertainty_score":0.9983413},"labels":[],"label_agreement":null},{"id":"W2339035757","doi":"10.5489/cuaj.3772","title":"Mitigating pelvic recurrence and improving overall survival","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.015390929238078707,"score_gpt":0.24149038216300267,"score_spread":0.22609945292492395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339035757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96705484,0.00035853666,0.00012072306,0.028226282,0.0004206618,0.00012472327,0.000036667272,0.000021604315,0.0036359474],"genre_scores_gemma":[0.9965009,0.00010099448,0.00018417499,0.002016139,0.00043722123,0.0000035718556,0.000002156061,0.000007691318,0.0007471543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990099,0.000083761144,0.0001851907,0.0001544693,0.00021194629,0.00035470977],"domain_scores_gemma":[0.9989324,0.00013862131,0.0001285909,0.00005654647,0.00012985813,0.0006139554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003502444,0.00009499416,0.00016847828,0.000065336266,0.00019070049,0.00005194933,0.000046028337,0.00012026082,0.00039956399],"category_scores_gemma":[0.0007495737,0.000058878835,0.000056933844,0.0000582636,0.000026422138,0.000101356396,0.000010092337,0.00022676952,0.000027085563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026924967,0.00001200157,0.94672894,0.0000032788234,0.000049209237,0.000055226854,0.00005761162,1.545292e-7,0.0007073993,0.0001615186,0.0010341173,0.05116363],"study_design_scores_gemma":[0.0018926264,0.00032138865,0.9847621,0.00003783775,0.00005910463,0.00019920382,0.000025860614,0.000018423192,0.00006650788,0.0014944039,0.011015148,0.00010742364],"about_ca_topic_score_codex":0.0009453461,"about_ca_topic_score_gemma":0.0004742609,"teacher_disagreement_score":0.051056206,"about_ca_system_score_codex":0.0007060085,"about_ca_system_score_gemma":0.00038573277,"threshold_uncertainty_score":0.43749455},"labels":[],"label_agreement":null},{"id":"W2339536820","doi":"","title":"Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Transitional cell carcinoma; Cytology; Medicine; Urine; Urology; Papanicolaou stain; Urine cytology; Urinary bladder; Urinary system; Carcinoma; Pathology; Carcinoembryonic antigen; Bladder Neoplasm; Bladder cancer; Internal medicine; Cancer","score_opus":0.027125496646675528,"score_gpt":0.2443536143798594,"score_spread":0.21722811773318387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339536820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807382,0.0020057834,0.0000022707861,0.0015868322,0.00013413918,0.0012033189,0.00006723985,0.000002637636,0.014259582],"genre_scores_gemma":[0.998658,0.000091878,0.000011749587,0.00032408864,0.000024551087,0.000695476,0.000002724218,0.000009890147,0.00018162651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883425,0.00025992337,0.00027816728,0.0001129869,0.0003407441,0.00017392922],"domain_scores_gemma":[0.99905086,0.00029416048,0.00014177598,0.00043563748,0.000052667765,0.000024876477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003610506,0.00010021395,0.0002058725,0.00003360102,0.000038923892,0.000002636874,0.00022710397,0.00004927317,0.00008011696],"category_scores_gemma":[0.00011825952,0.000046838246,0.00019452238,0.00028511006,0.00015058303,0.00003560882,0.000021079126,0.00013814084,6.021984e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000291541,0.002234166,0.9821642,0.00021326805,0.00015120412,0.000009472594,0.0029342382,0.00001361943,0.00069684524,0.0004783558,0.0012088822,0.0096042175],"study_design_scores_gemma":[0.0017006205,0.000063978005,0.91505545,0.000024685472,0.00015572966,0.000017427807,0.00029123973,0.0000011411961,0.0816642,0.0001941855,0.0007926132,0.000038746468],"about_ca_topic_score_codex":0.00023915574,"about_ca_topic_score_gemma":0.000018139855,"teacher_disagreement_score":0.08096735,"about_ca_system_score_codex":0.00003881671,"about_ca_system_score_gemma":0.00013407617,"threshold_uncertainty_score":0.19100083},"labels":[],"label_agreement":null},{"id":"W2340210533","doi":"10.1016/j.eururo.2016.03.053","title":"The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging–Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging–Assisted TURBT in Primary Non–Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Narrow-band imaging; Urology; Prospective cohort study; Surgery; Endoscopy; Internal medicine; Cancer","score_opus":0.04879894981340178,"score_gpt":0.35394337775457774,"score_spread":0.30514442794117597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340210533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9469961,0.0001693776,0.000007068993,0.0060092406,0.0012439045,0.04069893,0.00022028394,0.000027637812,0.004627464],"genre_scores_gemma":[0.9963106,0.000089770976,0.000045609395,0.00018069106,0.0004940659,0.0025307268,0.000024614335,0.00004961742,0.00027429924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924762,0.0037436872,0.0017010415,0.0007194483,0.00082000816,0.000539591],"domain_scores_gemma":[0.9951169,0.0025621874,0.0008062356,0.0005304846,0.00083537115,0.0001488114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033907066,0.0003097969,0.0007946247,0.00011936984,0.0001912672,0.000018446532,0.00036251414,0.0001749716,0.0001116727],"category_scores_gemma":[0.0021231202,0.00016187855,0.0005428434,0.0003500598,0.0015622289,0.00009652663,0.00014667657,0.00073451,0.0000043774726],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9571465,0.0020201425,0.024472533,0.00008714432,0.00047047288,0.000024058012,0.0005770685,0.0000022817019,0.008343466,0.0000052296077,0.004212175,0.0026388771],"study_design_scores_gemma":[0.62151575,0.0047849454,0.36979574,0.000098112374,0.00027325365,0.0000055801015,0.00008171016,0.000015335241,0.0013375101,0.000008873009,0.001972151,0.000111032874],"about_ca_topic_score_codex":0.00006447976,"about_ca_topic_score_gemma":0.000113064474,"teacher_disagreement_score":0.3453232,"about_ca_system_score_codex":0.000119033524,"about_ca_system_score_gemma":0.00065249973,"threshold_uncertainty_score":0.66012156},"labels":[],"label_agreement":null},{"id":"W2340984423","doi":"10.1111/iju.13098","title":"Editorial Comment to Robotic transmural ablation of bladder tumors using high‐intensity focused ultrasound: Experimental study","year":2016,"lang":"en","type":"editorial","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Library science; Columbia university; Media studies; Sociology","score_opus":0.017364138348028774,"score_gpt":0.32886560509391605,"score_spread":0.3115014667458873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340984423","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08097416,0.0001130028,0.00094813784,0.0012047843,0.91609204,0.0004858583,0.000129066,0.000010702738,0.000042258125],"genre_scores_gemma":[0.45609885,0.000013400199,0.00018726006,0.00018226524,0.5434104,0.0000057903053,0.000032168533,0.000031602132,0.000038213013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962309,0.00015967204,0.0011167027,0.00030991877,0.0019216737,0.00026110592],"domain_scores_gemma":[0.9960955,0.00046743886,0.0008649861,0.00021081044,0.0021629946,0.00019826395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036967295,0.00034276533,0.0010407321,0.0005257896,0.0000434692,0.000027379247,0.00042384633,0.00039057364,0.0003334232],"category_scores_gemma":[0.00035933984,0.0002599436,0.0003244639,0.00008306917,0.000098478835,0.00014191342,0.0000676746,0.00060915324,0.000012392978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0145445345,0.0027177343,0.0014069211,0.000013108959,0.0035476896,0.00026494684,0.0010049226,0.0002695261,0.01184001,0.000007732383,0.96409,0.00029290962],"study_design_scores_gemma":[0.09389179,0.089910485,0.010157671,0.0012988875,0.007432704,0.0018062515,0.0011944803,0.00007232315,0.020272711,0.00067662715,0.77160877,0.0016773222],"about_ca_topic_score_codex":0.0004510888,"about_ca_topic_score_gemma":0.000018132447,"teacher_disagreement_score":0.3751247,"about_ca_system_score_codex":0.00079275493,"about_ca_system_score_gemma":0.0006799494,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W2341235120","doi":"10.1093/annonc/mdw170","title":"Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; Cancer Research UK","keywords":"Medicine; Fibroblast growth factor receptor 3; Fibroblast growth factor receptor; Cancer research; Fibroblast growth factor; Fibroblast growth factor receptor 2; Bladder cancer; Oncology; Cancer; Perioperative; Internal medicine; Receptor; Surgery","score_opus":0.10870815571985691,"score_gpt":0.41077029809141236,"score_spread":0.30206214237155543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341235120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821504,0.00035790697,0.00009831283,0.012746483,0.00008184346,0.0013006148,0.0027300683,0.000014975124,0.00051940203],"genre_scores_gemma":[0.99652374,0.0010175882,0.0006252868,0.0005404391,0.000080416765,0.00088174583,0.00005908491,0.000022976374,0.00024871685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881774,0.000078611934,0.00044512574,0.00030622908,0.00008219015,0.0002701094],"domain_scores_gemma":[0.99859893,0.00031100147,0.0002300788,0.000218676,0.00052458845,0.0001167113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056465764,0.000186224,0.0006147164,0.0001489062,0.000053866785,0.0000029921255,0.00008536797,0.00010704134,0.00027707536],"category_scores_gemma":[0.00014578943,0.00012364089,0.00018026413,0.00016299418,0.00020534915,0.000093796836,0.000021557824,0.000044000324,0.00000894888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014314912,0.0037508998,0.2801382,0.00021582833,0.0015407092,0.000010340351,0.0039692665,0.000013396239,0.6371583,0.0008491548,0.0031028038,0.067819655],"study_design_scores_gemma":[0.006049827,0.009076948,0.36322075,0.00016488467,0.0001247244,0.000011870482,0.00022071865,0.0000019273082,0.61702085,0.00020283619,0.0037647625,0.00013990319],"about_ca_topic_score_codex":0.00073667755,"about_ca_topic_score_gemma":0.0014685015,"teacher_disagreement_score":0.08308254,"about_ca_system_score_codex":0.00023600008,"about_ca_system_score_gemma":0.0010923925,"threshold_uncertainty_score":0.5041929},"labels":[],"label_agreement":null},{"id":"W2341904544","doi":"10.1007/s00345-016-1826-2","title":"Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review","year":2016,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Nephrology; Internal medicine; Oncology; Carcinoma; Urology; Bladder cancer; Cancer","score_opus":0.04590604158865451,"score_gpt":0.3353109377067109,"score_spread":0.28940489611805637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341904544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011836364,0.9928867,0.000121509416,0.00038291034,0.0004974227,0.005589121,0.00030385735,0.0000108596305,0.00019578182],"genre_scores_gemma":[0.0015607568,0.9963777,0.000059016827,0.00044118369,0.0005883826,0.0003615248,0.000032471013,0.00007926169,0.00049970474],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714565,0.00036685754,0.001541346,0.00031030478,0.00027839135,0.00035743893],"domain_scores_gemma":[0.99581474,0.0018950073,0.0014774143,0.00029149506,0.00025884184,0.00026250345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050680747,0.0005207323,0.0049897097,0.00042836915,0.00005567615,0.000024051824,0.00019485717,0.00021279849,0.00010078123],"category_scores_gemma":[0.0012801654,0.0002560741,0.0011447932,0.00016284357,0.000105517516,0.00012649332,0.000031175347,0.00047186424,0.000010818914],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022496408,0.00021584581,0.00055981096,0.92900896,0.0017732363,0.00022404577,0.00006197252,1.1988184e-8,3.385499e-7,0.00003905442,0.0010866732,0.066805065],"study_design_scores_gemma":[0.0018188767,0.0030663887,0.00022725557,0.40200773,0.042300858,0.0047495947,0.0000065419435,2.97387e-7,3.2909787e-7,0.000051275434,0.5455464,0.00022445296],"about_ca_topic_score_codex":0.0000013375998,"about_ca_topic_score_gemma":0.0000013335256,"teacher_disagreement_score":0.5444597,"about_ca_system_score_codex":0.00016836327,"about_ca_system_score_gemma":0.0007592078,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W2342281855","doi":"10.1097/spc.0000000000000148","title":"Perioperative chemotherapy for muscle invasive bladder cancer","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Chemotherapy; Oncology; Vinblastine; Cisplatin; Perioperative; Internal medicine; Doxorubicin; Intensive care medicine; Cancer; Surgery","score_opus":0.2204041578663954,"score_gpt":0.4807055930645399,"score_spread":0.2603014351981445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342281855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048926526,0.9903,0.000034097542,0.00007671579,0.0019253602,0.0045331796,0.002750028,0.000024375273,0.00030731395],"genre_scores_gemma":[0.00007505011,0.992094,0.0000672097,0.00008855018,0.0009347201,0.0036413402,0.0028057613,0.0000871169,0.0002062636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978137,0.00011727151,0.00060734164,0.0007949206,0.00026866273,0.00039809977],"domain_scores_gemma":[0.9982973,0.0001298488,0.00033868005,0.00023642008,0.0007382198,0.0002595837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009894818,0.00065110234,0.0019281163,0.0002042199,0.000084754196,0.00003508176,0.00010701891,0.00027954835,0.00027886956],"category_scores_gemma":[0.000071754344,0.00048363826,0.0004069586,0.00027794985,0.00014760072,0.00009267706,0.000052739273,0.00041485857,0.000014298426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012073284,0.00015869016,0.0027714933,0.030450098,0.00048039225,0.0000029567327,0.00941883,1.6177664e-7,2.5317044e-7,0.000080563936,0.0049505015,0.9515653],"study_design_scores_gemma":[0.0035224438,0.000646487,0.0011041338,0.022974962,0.00060708734,0.0000022974,0.0020507795,0.0000012343156,0.0000057852653,0.00003088863,0.9685901,0.0004638323],"about_ca_topic_score_codex":0.000031463354,"about_ca_topic_score_gemma":0.000023958068,"teacher_disagreement_score":0.96363956,"about_ca_system_score_codex":0.00066696113,"about_ca_system_score_gemma":0.0023190577,"threshold_uncertainty_score":0.9997615},"labels":[],"label_agreement":null},{"id":"W2342783650","doi":"10.3233/blc-169007","title":"Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bladder cancer; Multidisciplinary approach; Variety (cybernetics); Multidisciplinary team; Medicine; Medical education; Public relations; Cancer; Psychology; Engineering ethics; Political science; Engineering; Computer science; Nursing; Artificial intelligence; Internal medicine","score_opus":0.0353898670531876,"score_gpt":0.3639863883548209,"score_spread":0.3285965213016333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342783650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92814934,0.0032797463,0.000030068335,0.035208073,0.0010891353,0.0035607433,0.0016789922,0.00013627007,0.026867608],"genre_scores_gemma":[0.96140105,0.00056556053,0.00036902164,0.002815935,0.0012393685,0.0010390095,0.000002420093,0.00011155053,0.03245612],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966492,0.000049965012,0.0004743617,0.000675259,0.0013144008,0.00083678495],"domain_scores_gemma":[0.99697316,0.00011657787,0.0001741003,0.00045264675,0.0019442802,0.00033923856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000454968,0.0003342701,0.0005118619,0.00019889092,0.00027857182,0.000043696833,0.00040672475,0.00018940757,0.0015681293],"category_scores_gemma":[0.00025896172,0.0001801202,0.00016947578,0.0014087607,0.00029932574,0.00025835296,0.00024538106,0.00032955233,0.00006084829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022444904,0.0006164701,0.16464171,0.00043324506,0.0021538588,0.000020924093,0.017797621,0.000019355326,0.15370223,0.0018769822,0.5545889,0.10190422],"study_design_scores_gemma":[0.01147828,0.001590783,0.27279475,0.0033539184,0.00093720027,0.000036286612,0.008384221,0.000033437434,0.44976613,0.0014658214,0.24909613,0.001063049],"about_ca_topic_score_codex":0.0018619534,"about_ca_topic_score_gemma":0.0005423595,"teacher_disagreement_score":0.3054928,"about_ca_system_score_codex":0.0006683344,"about_ca_system_score_gemma":0.001490184,"threshold_uncertainty_score":0.9993446},"labels":[],"label_agreement":null},{"id":"W2343178457","doi":"10.3233/blc-150032","title":"Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Toronto","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Dissection (medical); Urology; Chemotherapy; Randomized controlled trial; Internal medicine; Surgery; Gynecology; Cancer","score_opus":0.0074304128108973674,"score_gpt":0.2530944535279718,"score_spread":0.2456640407170744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343178457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939799,0.0031306583,0.000033828706,0.0011179696,0.0000823995,0.00074191927,0.00028736348,0.000037344158,0.0005886258],"genre_scores_gemma":[0.99561113,0.0026148865,0.000077023484,0.0005943116,0.000117837495,0.00027262667,0.000021180545,0.00006727059,0.00062371977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837404,0.00003577083,0.00032298765,0.0005547633,0.00033484393,0.00037758343],"domain_scores_gemma":[0.99922866,0.000052546013,0.00013828279,0.00021677623,0.00016171123,0.00020204851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048664853,0.00034181128,0.0005644117,0.00016387932,0.00006086457,0.0000142919025,0.000056092435,0.00015045526,0.00041850342],"category_scores_gemma":[0.00000892462,0.00020849146,0.000056733097,0.00025562482,0.0002473889,0.00015520297,0.000026748228,0.00010322862,0.0000024983551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00272703,0.00039465382,0.9464371,0.00009163094,0.0005516671,0.000021877659,0.0007774221,0.0000031574348,0.0054964717,0.000010151977,0.00011882411,0.043369994],"study_design_scores_gemma":[0.021823466,0.00056911237,0.957515,0.0010632485,0.0003366712,0.000029502418,0.000071834686,0.00004033469,0.018027667,0.000024119285,0.00021997455,0.00027905958],"about_ca_topic_score_codex":0.00510401,"about_ca_topic_score_gemma":0.0011250793,"teacher_disagreement_score":0.043090936,"about_ca_system_score_codex":0.00033767152,"about_ca_system_score_gemma":0.00019092103,"threshold_uncertainty_score":0.8502035},"labels":[],"label_agreement":null},{"id":"W2344339416","doi":"10.3109/21681805.2016.1163616","title":"Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes","year":2016,"lang":"en","type":"article","venue":"Scandinavian Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Perioperative; Logistic regression; Odds ratio; Pathological; Stage (stratigraphy); Urology; Surgery; Cancer; Internal medicine","score_opus":0.042266059567445426,"score_gpt":0.3481742688102184,"score_spread":0.30590820924277295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344339416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481195,0.0009736607,0.000022451437,0.0034952925,0.00036988533,0.00014958676,0.000022192819,0.000004372601,0.00015062439],"genre_scores_gemma":[0.99828297,0.00084214687,0.000024709974,0.000547053,0.000121355086,0.000010521418,9.0618795e-7,0.000013416235,0.0001569108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854267,0.00014583285,0.00060039863,0.00015852899,0.00025766765,0.000294923],"domain_scores_gemma":[0.99896353,0.00026266716,0.00033639913,0.00017416288,0.00010305646,0.0001601527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030064717,0.00016234459,0.0007179418,0.00036962453,0.000016432146,0.000003109661,0.000089610236,0.00010413488,0.0010334717],"category_scores_gemma":[0.0001303391,0.00007934309,0.0003283648,0.00012156482,0.00011895859,0.000054355063,0.000019896846,0.00017805705,0.0000076088236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016127019,0.0003182984,0.98742485,0.000010887311,0.00028099312,0.0006505022,0.00015018588,0.0000064589676,0.0016918562,0.000017898283,0.0009857665,0.0068496144],"study_design_scores_gemma":[0.0039412184,0.003967553,0.9902075,0.00020701934,0.000117653406,0.00012416736,0.00002129405,3.0094586e-7,0.0008549005,0.00041375196,0.00008239015,0.00006228119],"about_ca_topic_score_codex":0.00020716783,"about_ca_topic_score_gemma":0.000054553057,"teacher_disagreement_score":0.006787333,"about_ca_system_score_codex":0.000298735,"about_ca_system_score_gemma":0.00033759917,"threshold_uncertainty_score":0.9998797},"labels":[],"label_agreement":null},{"id":"W2344440359","doi":"10.1186/s12957-016-0890-9","title":"p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis","year":2016,"lang":"en","type":"review","venue":"World Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Subgroup analysis; Bladder cancer; Internal medicine; Surgical oncology; Oncology; Stage (stratigraphy); Relative risk; Publication bias; Study heterogeneity; Confidence interval; Cancer","score_opus":0.0720659486995275,"score_gpt":0.4152371510236489,"score_spread":0.3431712023241214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344440359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007161149,0.99447376,0.000012333304,0.001353696,0.00014948506,0.00074461574,0.00020047548,0.00000564876,0.0029883704],"genre_scores_gemma":[0.0011499791,0.9942362,0.00015727339,0.000060387873,0.00020887976,0.000113038266,0.00001007135,0.0000413916,0.004022821],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99582565,0.001182607,0.0015772852,0.000318168,0.000656046,0.00044022076],"domain_scores_gemma":[0.99424887,0.0016516043,0.0031504608,0.00036450746,0.00031046188,0.00027410453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011334345,0.00045934078,0.007203361,0.000885331,0.00005155766,0.000011012333,0.00025880054,0.00027338194,0.0038545819],"category_scores_gemma":[0.000030356488,0.00015902899,0.003113875,0.0014728601,0.0003329919,0.000062898594,0.00006199822,0.0012553117,0.000008881144],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014737764,0.0006488834,0.0026244994,0.0007414358,0.22897634,0.0021334148,0.00011721111,0.000023361348,1.3632675e-7,0.00003981986,0.0007210479,0.76250005],"study_design_scores_gemma":[0.0020348653,0.0011175375,0.00009586763,0.001194295,0.3116924,0.00020678938,0.000019908535,8.827737e-7,9.258971e-7,0.0000085080255,0.6835179,0.00011016501],"about_ca_topic_score_codex":0.00018875423,"about_ca_topic_score_gemma":0.0010739489,"teacher_disagreement_score":0.7623899,"about_ca_system_score_codex":0.0005532838,"about_ca_system_score_gemma":0.0021396165,"threshold_uncertainty_score":0.997056},"labels":[],"label_agreement":null},{"id":"W2345387467","doi":"","title":"Urothelial cancer of the upper urinary tract: emerging biomarkers and integrative models for risk stratification.","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Disease; Risk stratification; Urothelial carcinoma; MEDLINE; Intensive care medicine; Grading (engineering); Risk assessment; Perioperative; Oncology; Cancer; Internal medicine; Bioinformatics; Bladder cancer; Surgery","score_opus":0.029136003201509088,"score_gpt":0.2763675292240595,"score_spread":0.2472315260225504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345387467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744619,0.0023423804,0.0037637502,0.0086316075,0.00046869586,0.0045462744,0.0009798182,0.000041518844,0.0047640363],"genre_scores_gemma":[0.9950828,0.000455035,0.00016242114,0.00008785656,0.000088796834,0.00257135,0.0000019663057,0.000015710857,0.0015340544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993344,0.000029694858,0.00016276832,0.00018584872,0.00011813112,0.00016914705],"domain_scores_gemma":[0.9994972,0.00007851596,0.00009951629,0.0001790688,0.00007717151,0.00006858038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117536285,0.00010436652,0.00015258072,0.000038229377,0.00006763007,0.000005899821,0.000061227605,0.00004221244,0.000026371456],"category_scores_gemma":[0.00005796069,0.00004799973,0.00008480754,0.00007214278,0.000107521475,0.00009865337,0.000014167758,0.00004396007,3.8549072e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012669199,0.00045380986,0.1417966,0.00008486279,0.0006317195,0.0000012418272,0.0012852331,0.0000055533214,0.0024871174,0.0010083662,0.0010430508,0.84993553],"study_design_scores_gemma":[0.0043274476,0.0001741545,0.95849776,0.00010823022,0.0004921949,0.000013612431,0.00029302246,0.00020446787,0.029102422,0.005076337,0.0015709528,0.00013938021],"about_ca_topic_score_codex":0.00018757489,"about_ca_topic_score_gemma":0.000016407532,"teacher_disagreement_score":0.8497961,"about_ca_system_score_codex":0.00006215689,"about_ca_system_score_gemma":0.00007693034,"threshold_uncertainty_score":0.19573721},"labels":[],"label_agreement":null},{"id":"W2345595560","doi":"10.3109/02656736.2016.1157903","title":"A systematic review of regional hyperthermia therapy in bladder cancer","year":2016,"lang":"en","type":"review","venue":"International Journal of Hyperthermia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Hyperthermia; Bladder cancer; Medicine; Cancer therapy; Cancer; Intensive care medicine; Internal medicine","score_opus":0.05470552951039543,"score_gpt":0.3923107188635952,"score_spread":0.3376051893531998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345595560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006353874,0.9965401,0.000003213511,0.0008913456,0.0006970968,0.0011307079,0.00008172586,0.0000073576225,0.0005848888],"genre_scores_gemma":[0.000098481374,0.9968044,0.00004352588,0.0014284981,0.00068886596,0.00012915158,0.000014020164,0.00007951178,0.0007135407],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959493,0.00022552644,0.0022339816,0.00024648482,0.0011334716,0.00021120267],"domain_scores_gemma":[0.99624026,0.0002671391,0.0020886108,0.00034108502,0.00093639287,0.00012648862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004932818,0.00043736855,0.0035251898,0.00053241133,0.000013292518,0.0000140685115,0.00066121056,0.00021022862,0.0010616805],"category_scores_gemma":[0.00019186748,0.00023072991,0.0013733224,0.0002153522,0.00008078626,0.0001253794,0.0000390258,0.00039020838,0.000038061564],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023911569,0.00041013685,0.000065864166,0.3940473,0.0065351874,0.0005952725,0.00007739594,1.2055621e-7,0.000017918259,0.000018534332,0.0013112439,0.59668195],"study_design_scores_gemma":[0.0016497736,0.00022905978,0.000023794759,0.78882647,0.0015520088,0.0023428835,0.000007479345,2.3818122e-7,0.00000923677,0.000026433749,0.20516078,0.0001718465],"about_ca_topic_score_codex":0.00005548163,"about_ca_topic_score_gemma":0.0000080431555,"teacher_disagreement_score":0.5965101,"about_ca_system_score_codex":0.0005263632,"about_ca_system_score_gemma":0.0016348305,"threshold_uncertainty_score":0.99985147},"labels":[],"label_agreement":null},{"id":"W2345977364","doi":"10.1038/srep25596","title":"FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma","year":2016,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; School of Medicine, New York University; York University; Office of Research and Development; U.S. Department of Veterans Affairs","keywords":"Carcinogenesis; Cancer research; Urothelium; Urothelial Cell; Biology; Missense mutation; Mutation; Genetically modified mouse; Cell growth; Protein kinase B; Transgene; Cancer; Phosphorylation; Gene; Cell biology; Endocrinology; Genetics","score_opus":0.015060637338312378,"score_gpt":0.25195150891220763,"score_spread":0.23689087157389527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345977364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941136,0.00048366524,0.00021761312,0.00074393454,0.0022863701,0.0013782396,0.000043741275,0.0000760832,0.0006567409],"genre_scores_gemma":[0.98865336,0.000008166868,0.0005275793,0.00009832235,0.00014922947,0.00012472036,0.000023128216,0.00004518272,0.010370337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99656165,0.000078888035,0.00064842263,0.0011795647,0.0009322958,0.00059917953],"domain_scores_gemma":[0.99803627,0.000044810837,0.00025401986,0.0009181465,0.00039237374,0.00035439405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071910815,0.00031239053,0.0004202824,0.00036828362,0.0002358252,0.00012532079,0.00013092217,0.000116947915,0.0003658784],"category_scores_gemma":[0.00015493846,0.00019986939,0.00007258706,0.0013658475,0.00025549083,0.00019142339,0.000051716153,0.00013054164,0.000073020085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029074174,0.0005734629,0.2601665,0.00006600222,0.000033514756,0.008201373,0.0008566772,0.000034822868,0.72554934,0.00006668953,0.0020321398,0.0021287706],"study_design_scores_gemma":[0.00276734,0.00092451693,0.08648051,0.0002997157,0.00014592428,0.001335097,0.00043157028,0.000014287492,0.90089715,0.00079303875,0.005420278,0.00049057655],"about_ca_topic_score_codex":0.0010866357,"about_ca_topic_score_gemma":0.00050388597,"teacher_disagreement_score":0.17534782,"about_ca_system_score_codex":0.00036622374,"about_ca_system_score_gemma":0.001204078,"threshold_uncertainty_score":0.8150437},"labels":[],"label_agreement":null},{"id":"W2346782574","doi":"10.1016/j.ijrobp.2016.04.032","title":"Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Contouring; Radiation therapy; Bladder cancer; Adjuvant radiotherapy; Radiation oncologist; Surgery; Radiology; Nuclear medicine; Cancer; Internal medicine","score_opus":0.056024719725781345,"score_gpt":0.38742757315557813,"score_spread":0.3314028534297968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346782574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95057434,0.002965515,0.03578226,0.008158185,0.0014322383,0.00081025466,0.00022599628,0.000017328797,0.00003388751],"genre_scores_gemma":[0.9780187,0.001504755,0.017152945,0.0009220661,0.0020799756,0.00018449342,0.00004606717,0.000027005055,0.00006399443],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859625,0.00006153713,0.00080253236,0.00018830349,0.0001911171,0.0001602345],"domain_scores_gemma":[0.9970334,0.00043663423,0.00080046407,0.00007560677,0.0015642861,0.00008957848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041370664,0.00016004429,0.00042784418,0.0001199386,0.00004479212,0.000009918589,0.000099988385,0.00015483733,0.000036795456],"category_scores_gemma":[0.00032719702,0.00010763784,0.0001530973,0.00004698741,0.00011790337,0.000112182344,0.0000150750975,0.000075292424,0.0000011657513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044187144,0.00026195127,0.10650893,0.000025772672,0.0014903616,0.000005284082,0.0005457628,0.000033899767,0.025520653,0.000765495,0.001328955,0.8590942],"study_design_scores_gemma":[0.08662864,0.004324129,0.08545805,0.00057759206,0.0007142183,0.0002085436,0.0001476858,0.0009454843,0.4522041,0.007361446,0.36090672,0.00052338117],"about_ca_topic_score_codex":0.000012564395,"about_ca_topic_score_gemma":0.000004376718,"teacher_disagreement_score":0.8585708,"about_ca_system_score_codex":0.00042596474,"about_ca_system_score_gemma":0.0007684495,"threshold_uncertainty_score":0.4389344},"labels":[],"label_agreement":null},{"id":"W2374969104","doi":"10.1093/carcin/21.1.101","title":"P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers","year":2000,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Point mutation; Carcinogenesis; Missense mutation; Exon; Silent mutation; Medicine; Cancer research; Cancer; Bladder cancer; Single-strand conformation polymorphism; Immunostaining; Carcinogen; Pathology; Tumor suppressor gene; Nonsense mutation; Immunohistochemistry; Mutation; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.048005454439689316,"score_gpt":0.3362446108379489,"score_spread":0.2882391563982596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2374969104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920369,0.0035206275,0.000004131798,0.0012539711,0.0004648721,0.00070930715,0.00054121285,0.00004802519,0.001420998],"genre_scores_gemma":[0.9957406,0.0017997555,0.000044567852,0.0011276215,0.0005252175,0.0002615742,0.00024736839,0.000051970943,0.00020130485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800175,0.000101021236,0.00051397644,0.000538943,0.00036759835,0.0004766974],"domain_scores_gemma":[0.9992777,0.000066239096,0.000049355167,0.0003119983,0.00008402132,0.0002106778],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008729856,0.0003006269,0.0004915152,0.0002499578,0.00006662956,0.000021003778,0.00012019468,0.000119978584,0.011380453],"category_scores_gemma":[0.000042225936,0.00025785522,0.00011794265,0.0006205514,0.00008397532,0.0001063797,0.00002432855,0.0002595752,0.00006271117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023201643,0.00075575896,0.62221044,0.000044297736,0.0001719367,0.0006697622,0.003765169,0.0001531586,0.00043570818,0.000008587896,0.0013923201,0.36807266],"study_design_scores_gemma":[0.0067152553,0.00026183177,0.9771564,0.00034233366,0.00036146853,0.00002597055,0.0006894211,0.00010650053,0.008032733,0.00009113652,0.005818019,0.0003989078],"about_ca_topic_score_codex":0.01045546,"about_ca_topic_score_gemma":0.009491643,"teacher_disagreement_score":0.36767375,"about_ca_system_score_codex":0.0006189115,"about_ca_system_score_gemma":0.001288573,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W2396123380","doi":"10.1007/978-1-60327-969-7_79","title":"Urinary Bladder Carcinoma Surveillance Counterpoint: Canada","year":2012,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Ninth; Medicine; Cancer; Counterpoint; Carcinoma; Demography; Internal medicine; Psychology","score_opus":0.044979145956040974,"score_gpt":0.2547934328677487,"score_spread":0.20981428691170773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396123380","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036516943,0.037230052,0.0000027919825,0.000043556345,0.00073527393,0.0008424996,0.00041621877,0.00009311376,0.9602713],"genre_scores_gemma":[0.23802836,0.0004688738,0.000016151267,0.00069291145,0.0011979622,0.00006251333,0.00016923208,0.00017574769,0.75918823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779457,0.000022406413,0.00042710948,0.0005627997,0.0006501648,0.00054295384],"domain_scores_gemma":[0.9983145,0.000041308613,0.0002130663,0.00092730497,0.00014458236,0.00035923722],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000746428,0.0006325189,0.00078608294,0.00008017656,0.00013316669,0.000027161408,0.00021804815,0.0003098985,0.0013092615],"category_scores_gemma":[0.0000039654246,0.0005787783,0.00021057842,0.0000038725225,0.00014130816,0.000033518965,0.00013161889,0.0005155073,0.000049734343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035342528,0.0006295085,0.004032059,0.004668825,0.010945471,0.012652757,0.0027292005,0.0000028987133,0.000068377965,0.15231065,0.6430029,0.16542305],"study_design_scores_gemma":[0.0014931713,0.000261714,0.0043555666,0.00022458317,0.00055013807,0.00025885057,0.0000057327816,0.0000034402717,0.00011164554,0.00025484606,0.9919214,0.0005589058],"about_ca_topic_score_codex":0.23417446,"about_ca_topic_score_gemma":0.14522983,"teacher_disagreement_score":0.34891847,"about_ca_system_score_codex":0.00050918595,"about_ca_system_score_gemma":0.0008600321,"threshold_uncertainty_score":0.9996664},"labels":[],"label_agreement":null},{"id":"W2397377428","doi":"10.1016/j.clgc.2016.05.003","title":"Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; Internal medicine; Docetaxel; Oncology; Taxane; Meta-analysis; Paclitaxel; Chemotherapy; Cisplatin; Cancer; Urology; Breast cancer","score_opus":0.17177038917727194,"score_gpt":0.4438781869271826,"score_spread":0.2721077977499107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397377428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002518247,0.99102557,0.000016938335,0.0007451625,0.00006203452,0.0069045573,0.0008984261,0.000010500689,0.00008499875],"genre_scores_gemma":[0.0045507653,0.9925375,0.00015629262,0.0005535299,0.00016230857,0.0012763212,0.000034633773,0.000069129484,0.00065951014],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99348354,0.001321019,0.0036423367,0.00073703896,0.00048705764,0.00032899712],"domain_scores_gemma":[0.9935032,0.0032272974,0.0019194856,0.0010302515,0.00015842219,0.00016133887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021278744,0.0006777315,0.012997672,0.0002548932,0.000054512788,0.000010506513,0.0003134234,0.00022469419,0.0004722992],"category_scores_gemma":[0.000725271,0.00028910625,0.0021190392,0.00092030474,0.00027167614,0.00004632898,0.0001545301,0.00048289206,0.0000040563705],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006513204,0.00041505782,0.00018731847,0.8797908,0.10153593,0.00017922126,0.00016222506,0.000002130741,1.2282973e-7,0.0000035334829,0.000093343006,0.016979024],"study_design_scores_gemma":[0.0038694867,0.00094474043,0.00040467622,0.052723214,0.9342286,0.00014532435,0.000025901618,0.0000073102833,5.238576e-7,0.0000049764863,0.007330911,0.00031433286],"about_ca_topic_score_codex":0.00025020342,"about_ca_topic_score_gemma":0.0001844651,"teacher_disagreement_score":0.8326927,"about_ca_system_score_codex":0.000108671185,"about_ca_system_score_gemma":0.00066766574,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W2398059503","doi":"10.1007/s00345-016-1859-6","title":"Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma","year":2016,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Urothelial carcinoma; Nephrology; Internal medicine; Bladder cancer; Urology; Biopsy; Oncology; Cancer","score_opus":0.024124567922998223,"score_gpt":0.3071437194807492,"score_spread":0.283019151557751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398059503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020411575,0.9704367,0.000021187849,0.0011246757,0.002319385,0.002280884,0.0013805752,0.000016304512,0.0020087117],"genre_scores_gemma":[0.2072927,0.78873026,0.00006423762,0.0002669361,0.0013719642,0.000058814767,0.000039291062,0.00013647243,0.0020393173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946673,0.0010120067,0.0023971058,0.00055878167,0.0007504985,0.00061431085],"domain_scores_gemma":[0.9939936,0.0008742982,0.003495038,0.0008833793,0.00045162512,0.00030208132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046060217,0.0009092543,0.0037371148,0.00091285806,0.00012143343,0.000015274314,0.00051388436,0.00049477397,0.0009003594],"category_scores_gemma":[0.0001872794,0.00046439894,0.0023722434,0.00041745673,0.00045985804,0.00011012253,0.000045684013,0.00083633896,0.00008581473],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057759266,0.0038362995,0.014298404,0.002082017,0.0026650093,0.000498969,0.00067832693,0.0000073720653,0.0001671013,0.00019601887,0.0017578946,0.96803665],"study_design_scores_gemma":[0.014433267,0.008217741,0.014005216,0.0036699304,0.009542995,0.002054886,0.000023585844,0.0000024556302,0.0005701258,0.000118690754,0.9469291,0.0004320142],"about_ca_topic_score_codex":0.00013313824,"about_ca_topic_score_gemma":0.000024310773,"teacher_disagreement_score":0.96760464,"about_ca_system_score_codex":0.000504017,"about_ca_system_score_gemma":0.0023687435,"threshold_uncertainty_score":0.9997808},"labels":[],"label_agreement":null},{"id":"W2400766581","doi":"","title":"Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Chemotherapy; Chemoradiotherapy; Progressive disease; Radiation therapy; Nausea; Oncology; Internal medicine; Bladder cancer; Disease; Surgery; Cancer","score_opus":0.0205452016771306,"score_gpt":0.27679007768639985,"score_spread":0.25624487600926926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400766581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911197,0.021133013,0.0021100147,0.020858321,0.0013393017,0.01413342,0.00044271813,0.0005121119,0.028274117],"genre_scores_gemma":[0.9494929,0.000269632,0.001718494,0.0051464755,0.00094586756,0.022109957,0.000039217066,0.00009358281,0.020183926],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987802,0.000013080214,0.00021684391,0.0003137553,0.00020137623,0.00047477765],"domain_scores_gemma":[0.9994625,0.000031285916,0.000059245707,0.00024805783,0.00007105201,0.00012787468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009263679,0.00021305987,0.0003780201,0.000072274815,0.000046381752,0.000027970713,0.00006540846,0.000052927167,0.0005752538],"category_scores_gemma":[0.0000067648875,0.00016923164,0.00018342996,0.00015103946,0.000052721534,0.000068320005,0.000005198112,0.00006674296,0.000009654643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072708554,0.0020552443,0.06470693,0.00054148515,0.0024665864,0.00009526565,0.00045815777,0.00001394196,0.0014635691,0.00033967462,0.07050307,0.8500852],"study_design_scores_gemma":[0.017156085,0.00018460961,0.7887108,0.000022607284,0.00060411735,0.000038568618,0.0000210781,0.00005182011,0.020516858,0.0011366587,0.17117658,0.0003802278],"about_ca_topic_score_codex":0.0003589745,"about_ca_topic_score_gemma":0.00008987389,"teacher_disagreement_score":0.849705,"about_ca_system_score_codex":0.00016947862,"about_ca_system_score_gemma":0.00007702529,"threshold_uncertainty_score":0.6901066},"labels":[],"label_agreement":null},{"id":"W2400825377","doi":"","title":"Prostate sparing radical cystectomy--not for all, but an option for some.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cystectomy; Urology; Prostate cancer; Bladder cancer; Prostate; Stage (stratigraphy); Cumulative incidence; Overall survival; Transitional cell carcinoma; Incidence (geometry); Oncology; Internal medicine; Cancer","score_opus":0.03877596666750006,"score_gpt":0.28007894704025027,"score_spread":0.24130298037275022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400825377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849529,0.0003517191,0.003041805,0.0022301904,0.00044523427,0.007769798,0.00017545841,0.0001975341,0.0008353559],"genre_scores_gemma":[0.9832201,0.000013222711,0.0014756352,0.00061123207,0.0009854771,0.010515598,0.00021015994,0.00003928559,0.0029292994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989607,0.000011577787,0.00018895527,0.00026906122,0.00014568368,0.00042407805],"domain_scores_gemma":[0.99955654,0.00003401711,0.00004889837,0.00016569017,0.000044694745,0.00015017712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016429859,0.00012694235,0.00021096424,0.00005730442,0.00006965298,0.000029638602,0.000052029776,0.000061119965,0.000004339805],"category_scores_gemma":[0.000032950145,0.00010613451,0.000096122654,0.000042762487,0.00003182645,0.0001527466,0.000010352645,0.00005472381,0.000003326107],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013429628,0.0018323588,0.02323671,0.0011564675,0.0007085379,0.000062227016,0.00030737458,0.00008350229,0.009296846,0.008147559,0.009838225,0.93190056],"study_design_scores_gemma":[0.0383176,0.0014641095,0.6783755,0.00006021925,0.0010274618,0.00010370502,0.000067632005,0.0014477394,0.136952,0.007994185,0.13357855,0.00061129883],"about_ca_topic_score_codex":0.00014884492,"about_ca_topic_score_gemma":0.000024340803,"teacher_disagreement_score":0.93128926,"about_ca_system_score_codex":0.00012462027,"about_ca_system_score_gemma":0.00004090789,"threshold_uncertainty_score":0.43280396},"labels":[],"label_agreement":null},{"id":"W2405439315","doi":"","title":"A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Gemcitabine; Tolerability; Regimen; Internal medicine; Performance status; Cisplatin; Progressive disease; Toxicity; Chemotherapy; Oncology; Adverse effect","score_opus":0.050492420474837346,"score_gpt":0.29669033636730935,"score_spread":0.246197915892472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405439315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9012894,0.0054521556,0.008053075,0.028778361,0.0024892725,0.023401354,0.0010897504,0.0006789225,0.028767735],"genre_scores_gemma":[0.97366077,0.00008327388,0.0026891162,0.0015904771,0.00048081565,0.015669208,0.00003596302,0.00006157438,0.0057288054],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986851,0.000014885607,0.00023713191,0.00031951675,0.00023916399,0.0005042013],"domain_scores_gemma":[0.99931085,0.000043344593,0.00007341539,0.0002472428,0.00007983403,0.0002453296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014112452,0.0001925202,0.00033851247,0.00008129045,0.00008046644,0.000022744964,0.00008470228,0.000047794412,0.00006645122],"category_scores_gemma":[0.00008254628,0.00015597406,0.00014895354,0.00015998716,0.000049006343,0.00008750348,0.000018006069,0.00008928026,0.000023574605],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010983215,0.004452226,0.015418264,0.0014301414,0.0041811666,0.0003857113,0.0028899168,0.00045263738,0.0020198142,0.006534796,0.018964566,0.9322875],"study_design_scores_gemma":[0.15168452,0.0036220117,0.549782,0.00043871856,0.0065234317,0.00043737688,0.00044532426,0.00019613898,0.075178824,0.031091653,0.17859304,0.002007005],"about_ca_topic_score_codex":0.00047489154,"about_ca_topic_score_gemma":0.000089652545,"teacher_disagreement_score":0.93028057,"about_ca_system_score_codex":0.00027179482,"about_ca_system_score_gemma":0.00022920215,"threshold_uncertainty_score":0.6360438},"labels":[],"label_agreement":null},{"id":"W2406724659","doi":"10.1590/s1677-5538.ibju.2014.0596","title":"Chromophobe renal cell carcinoma mimicking cortical invasion by synchronous invasive urothelial carcinoma of the intra-renal collecting system on CT urography","year":2016,"lang":"en","type":"article","venue":"International braz j urol","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Urine cytology; Kidney; Carcinoma; Radiology; Nodule (geology); Renal hilum; Nephrectomy; Upper urinary tract; Clear cell carcinoma; Pathology; Urology; Urinary system; Anatomy; Cystoscopy; Internal medicine","score_opus":0.012080440957776746,"score_gpt":0.23826610055444836,"score_spread":0.2261856595966716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406724659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891573,0.00019671343,0.00019558174,0.00091595954,0.00094288593,0.0007147395,0.00028992948,0.00005079041,0.0075360998],"genre_scores_gemma":[0.99829423,0.000019029716,0.00007056395,0.0005373405,0.00048197366,0.000073834315,0.000021617676,0.000051834064,0.00044956754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976345,0.00014255116,0.0005451973,0.00049730414,0.000832747,0.000347721],"domain_scores_gemma":[0.99854743,0.00040119592,0.00028249045,0.00037764138,0.00022335225,0.00016790767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015260561,0.00030357813,0.00036798225,0.00019707852,0.00017856425,0.000032137043,0.0003797429,0.000091087386,0.00024210934],"category_scores_gemma":[0.00016564156,0.00018429445,0.00031618794,0.00024716317,0.00018916503,0.000108604385,0.0001109793,0.00027575056,0.000047491852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015130402,0.0007789709,0.20894828,0.00013512082,0.0003707479,0.00029138647,0.0003583532,0.000009356823,0.77902824,0.0002696479,0.004131418,0.004165456],"study_design_scores_gemma":[0.0071229693,0.0014192963,0.072311096,0.0008335825,0.0002450018,0.00045014214,0.00011219894,0.00012917344,0.9159021,0.000030102536,0.0011903237,0.00025402315],"about_ca_topic_score_codex":0.00041163334,"about_ca_topic_score_gemma":0.000031802294,"teacher_disagreement_score":0.13687387,"about_ca_system_score_codex":0.0005305378,"about_ca_system_score_gemma":0.00044279319,"threshold_uncertainty_score":0.75153095},"labels":[],"label_agreement":null},{"id":"W2408992011","doi":"","title":"Treatment of BCG failures with intravesical BCG/Interferon: the University of Montreal experience.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Interferon; Internal medicine; Urology; Bladder cancer; Transitional cell carcinoma; BCG vaccine; Stage (stratigraphy); Gastroenterology; Surgery; Cancer; Immunology; Vaccination","score_opus":0.013325418066140082,"score_gpt":0.2077547813742292,"score_spread":0.19442936330808913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408992011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98330444,0.00029953514,0.000084429754,0.00087993,0.000033494423,0.00068641314,0.000018472881,0.000017796816,0.014675486],"genre_scores_gemma":[0.99779546,0.00004222065,0.000073261865,0.000014360623,0.00006444809,0.000050103274,0.0000064971077,0.000006926237,0.001946739],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994322,0.000019608473,0.000101584315,0.00013281792,0.00014955399,0.00016420578],"domain_scores_gemma":[0.9996298,0.000023323777,0.000053481854,0.00019838521,0.000037395108,0.000057639525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018503202,0.00009693914,0.00021238335,0.000026805421,0.00003608057,0.0000031051911,0.00006302808,0.000031662345,0.000060778748],"category_scores_gemma":[0.000002148816,0.000053360167,0.00006562026,0.00008113124,0.00020748762,0.00003189354,0.000010450119,0.000028591048,0.0000017487733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014060521,0.004958072,0.38702375,0.00011794894,0.0013542908,0.0004244893,0.0149937915,0.000044548095,0.0008554578,0.0013262252,0.00295992,0.571881],"study_design_scores_gemma":[0.003747333,0.0010547807,0.97602576,0.000011206088,0.00024630642,0.000032044147,0.0011711788,0.000010140499,0.012705824,0.00004394427,0.0048882114,0.000063293046],"about_ca_topic_score_codex":0.0070262724,"about_ca_topic_score_gemma":0.00085660885,"teacher_disagreement_score":0.589002,"about_ca_system_score_codex":0.00008668846,"about_ca_system_score_gemma":0.00003977451,"threshold_uncertainty_score":0.99958605},"labels":[],"label_agreement":null},{"id":"W2409177147","doi":"10.1001/jamaoncol.2016.0149","title":"Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.019787550496334384,"score_gpt":0.3232224669575325,"score_spread":0.3034349164611981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409177147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92035294,0.002742863,0.00015113721,0.04985446,0.00036937091,0.0011681988,0.000041164643,0.000035747264,0.025284138],"genre_scores_gemma":[0.9933621,0.0027743082,0.00052676356,0.000806572,0.00019192071,0.00025811372,0.0000018796259,0.000015119071,0.0020631682],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991326,0.000099224606,0.0002091622,0.00021977497,0.00014892904,0.00019035439],"domain_scores_gemma":[0.9992385,0.00031417498,0.000085862375,0.00022177442,0.000052492054,0.00008720273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016456927,0.000114720206,0.00033479102,0.000041168892,0.00005356077,0.0000032886956,0.0000783939,0.00011039569,0.00037189364],"category_scores_gemma":[0.000024585614,0.00005172252,0.00007863291,0.00007457325,0.0005547454,0.00003854718,0.00011505584,0.000087902714,0.000017807042],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073457547,0.00076529244,0.02856492,0.00041548695,0.0023370336,0.0008034024,0.002585624,0.0000011445551,0.0069349664,0.005669785,0.0076624183,0.93691415],"study_design_scores_gemma":[0.12140664,0.0029448243,0.75305164,0.0010000269,0.0021440834,0.0003347614,0.001757665,0.000036513375,0.007917595,0.0027447357,0.10634501,0.0003165287],"about_ca_topic_score_codex":0.0001727622,"about_ca_topic_score_gemma":0.000077510726,"teacher_disagreement_score":0.93659765,"about_ca_system_score_codex":0.00013630332,"about_ca_system_score_gemma":0.000155069,"threshold_uncertainty_score":0.40719745},"labels":[],"label_agreement":null},{"id":"W2410250363","doi":"","title":"Ruptured Aortic Aneurysm Secondary to Psoas abscess after Intravesical Bacilli Calmette-Guérin.","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Psoas Muscles; Aneurysm; Abdomen; Surgery; Aortic aneurysm; Urinary bladder; Abscess; Abdominal aortic aneurysm; Abdominal aorta; Pelvis; Transitional cell carcinoma; Aorta; Radiology; Bladder cancer; Cancer; Internal medicine","score_opus":0.019645743935319482,"score_gpt":0.2563046380164058,"score_spread":0.2366588940810863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410250363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790644,0.001322938,0.00007329486,0.0026687924,0.0010058505,0.0015972044,0.00006137314,0.0001206043,0.014085545],"genre_scores_gemma":[0.98718184,0.000016047292,0.00018749948,0.005590862,0.0009372606,0.0024961678,0.000019490062,0.00004651029,0.0035242971],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982272,0.00003875351,0.00025794547,0.00030735208,0.00032907404,0.0008396831],"domain_scores_gemma":[0.99858856,0.000031983363,0.00003578634,0.000384932,0.000042281237,0.00091646926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015188775,0.0002359643,0.0003379999,0.000108967615,0.000046629622,0.000028316243,0.00010127512,0.000120042365,0.0007330164],"category_scores_gemma":[0.000057228313,0.00018592055,0.0001143271,0.0002084009,0.000054181066,0.00013771346,0.0000602691,0.00025517747,0.0003423479],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025883086,0.0015631092,0.3299265,0.00041436995,0.00061115634,0.0005660705,0.0024257733,0.0000010907067,0.00078167504,0.00010358039,0.022293668,0.6387247],"study_design_scores_gemma":[0.0016221071,0.00007104961,0.9629322,0.000014213937,0.00020079294,0.00014064336,0.000029650995,0.0000016963919,0.0034661982,0.000032317163,0.031284593,0.00020452582],"about_ca_topic_score_codex":0.000065833054,"about_ca_topic_score_gemma":0.000011183509,"teacher_disagreement_score":0.6385202,"about_ca_system_score_codex":0.00014242431,"about_ca_system_score_gemma":0.00005549941,"threshold_uncertainty_score":0.8026015},"labels":[],"label_agreement":null},{"id":"W2410255810","doi":"","title":"Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Urinary diversion; Medicine; Electrical conduit; Bladder cancer; Urology; Quality of life (healthcare); Urinary system; Urinary bladder; Internal medicine; Surgery; Cancer","score_opus":0.1199818165197781,"score_gpt":0.30418030136441565,"score_spread":0.18419848484463755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410255810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954298,0.00048161513,0.000028549211,0.0019222044,0.00008313098,0.0009123937,0.000098923294,0.00002202963,0.0010213314],"genre_scores_gemma":[0.99923414,0.000062278006,0.000032886426,0.00013942552,0.000055505043,0.00007823088,0.0001744959,0.000009288062,0.00021377481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882096,0.00009350887,0.00048184086,0.0001646292,0.00026785585,0.00017118709],"domain_scores_gemma":[0.9991637,0.000061262996,0.00037002625,0.00013103998,0.000111905785,0.0001620579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033665568,0.00009622099,0.00042814587,0.0000493247,0.00004097051,0.0000041434487,0.000034510696,0.000054949225,0.000023529969],"category_scores_gemma":[0.00015974237,0.000080415964,0.000051609895,0.00007314105,0.0000686084,0.00011386975,0.00003181265,0.000061935854,0.0000014476013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020712869,0.00018280605,0.89224267,0.000111032554,0.00008817746,2.0182995e-7,0.0006874013,4.9399557e-7,0.000003108946,0.00003291322,0.00037748457,0.106066585],"study_design_scores_gemma":[0.0042293114,0.00013544077,0.9936171,0.00003661295,0.00007419614,1.7638638e-7,0.00014227345,0.0000015874108,0.00073568185,0.000040246894,0.0009280919,0.000059250637],"about_ca_topic_score_codex":0.0015878697,"about_ca_topic_score_gemma":0.000034179495,"teacher_disagreement_score":0.10600733,"about_ca_system_score_codex":0.00007123051,"about_ca_system_score_gemma":0.000040507213,"threshold_uncertainty_score":0.32792678},"labels":[],"label_agreement":null},{"id":"W2410416992","doi":"10.5489/cuaj.2015","title":"Canadian content at GU-ASCO 2014: Highlights of research involving Canadian researchers","year":2014,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Listing (finance); Library science; Medicine; Computer science","score_opus":0.1887229182932837,"score_gpt":0.387154992978524,"score_spread":0.19843207468524032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410416992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033682658,0.9662226,5.2156594e-7,0.0155562805,0.0008257669,0.0013901715,0.0007506938,0.00001875845,0.014898422],"genre_scores_gemma":[0.0069022398,0.97751,0.000041117746,0.0017708829,0.0013017531,0.00008200904,0.00035165157,0.000094657335,0.011945695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99231315,0.0018214826,0.0012066303,0.00063332944,0.0014682205,0.0025571615],"domain_scores_gemma":[0.9875894,0.0007214128,0.0005966465,0.000505095,0.0017054724,0.008881934],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0046789823,0.00051547703,0.0021276309,0.002916224,0.0011660946,0.00017904438,0.0006612556,0.0015883308,0.003846539],"category_scores_gemma":[0.0025567475,0.0003964732,0.0007660411,0.0008629962,0.00018733769,0.000097823846,0.000055818917,0.0030063807,0.00097539613],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010214252,0.00011840133,0.066917144,0.002842466,0.0035607994,0.003051758,0.00047635427,0.0000027174717,0.0000033222354,0.0015773997,0.75625175,0.16509573],"study_design_scores_gemma":[0.0007161794,0.0004975868,0.00663777,0.0017052428,0.0005153678,0.00033988777,0.0000452715,0.000003055544,9.718597e-7,0.00014458827,0.9890831,0.0003109946],"about_ca_topic_score_codex":0.9727704,"about_ca_topic_score_gemma":0.99283445,"teacher_disagreement_score":0.23283131,"about_ca_system_score_codex":0.049926307,"about_ca_system_score_gemma":0.03913425,"threshold_uncertainty_score":0.9998487},"labels":[],"label_agreement":null},{"id":"W2411764169","doi":"","title":"Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Bladder cancer; Incidence (geometry); Nova scotia; Cancer; Cancer registry; Demography; Urinary bladder; Cohort; Gynecology; Risk factor; Internal medicine","score_opus":0.031164692776016887,"score_gpt":0.30231577306016005,"score_spread":0.27115108028414314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411764169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9035807,0.002288605,0.0000041667777,0.0023632466,0.0002192096,0.000820344,0.000018685723,0.000012908865,0.090692125],"genre_scores_gemma":[0.9982171,0.000068944915,0.000026240088,0.00040777095,0.000049664784,0.00037533982,0.0000013683187,0.000012151134,0.00084142736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989949,0.00007699134,0.00018685464,0.00020821996,0.0002463212,0.00028672192],"domain_scores_gemma":[0.9995966,0.000035036977,0.000046903064,0.0002198611,0.00004973692,0.000051876057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027227236,0.000108601176,0.00021888438,0.00021607956,0.000011518981,0.000006905203,0.00009165201,0.000051327883,0.0005820627],"category_scores_gemma":[0.000085566906,0.000073592375,0.000059543563,0.0007426851,0.00006663816,0.00006106222,0.000011151482,0.00016651436,0.000008277157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023523664,0.00059267675,0.96617514,0.00002413177,0.00010437754,0.00007209499,0.00356612,0.000014609256,0.000060241517,0.0013946306,0.001156331,0.0266044],"study_design_scores_gemma":[0.0024143793,0.000048228416,0.99450403,0.000026709968,0.00005524949,0.000013540886,0.0012325001,0.0000020550729,0.0008847504,0.00023217895,0.00051767036,0.000068726586],"about_ca_topic_score_codex":0.0067521534,"about_ca_topic_score_gemma":0.00841462,"teacher_disagreement_score":0.09463638,"about_ca_system_score_codex":0.00023966175,"about_ca_system_score_gemma":0.00008982867,"threshold_uncertainty_score":0.99986196},"labels":[],"label_agreement":null},{"id":"W2412787761","doi":"","title":"Update on clinical and radiological staging and surveillance of bladder cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Stage (stratigraphy); Radiology; Radiological weapon; Magnetic resonance imaging; Positron emission tomography; Cancer staging; Bladder Neoplasm; Cancer; Urinary system; Internal medicine","score_opus":0.04001210282237612,"score_gpt":0.3096889649310708,"score_spread":0.2696768621086947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412787761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280286,0.002151453,0.000010233506,0.0012394513,0.000111955145,0.0003836025,0.0000333128,0.00002362056,0.0032435197],"genre_scores_gemma":[0.9975621,0.0011111745,0.000060138907,0.000514424,0.00021371247,0.00014642342,0.000006877869,0.000008832574,0.00037632644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992352,0.000045752502,0.00021119257,0.00022043656,0.00010011606,0.00018726075],"domain_scores_gemma":[0.99964285,0.00007519902,0.000051175404,0.000110017434,0.000024394407,0.00009636835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021233768,0.0000906511,0.0002838159,0.0000275404,0.000024632298,0.00000678911,0.000024453533,0.00005824485,0.000028554869],"category_scores_gemma":[0.000034302007,0.000063958614,0.000033885557,0.000051019626,0.00014367363,0.000020493255,0.00001910345,0.00009166863,0.0000011939476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028709948,0.00008325589,0.9125135,0.000017415054,0.000065259046,0.0000123590335,0.0000071250874,0.0000010782431,0.000012843401,0.00013270785,0.0012859676,0.08558142],"study_design_scores_gemma":[0.0021281396,0.00012063483,0.99384177,0.000007639752,0.000035905763,0.000009253084,0.0000059097706,0.000009964216,0.00016726153,0.00019726038,0.0034156197,0.00006061481],"about_ca_topic_score_codex":0.00016495697,"about_ca_topic_score_gemma":0.00002658263,"teacher_disagreement_score":0.085520804,"about_ca_system_score_codex":0.000015073373,"about_ca_system_score_gemma":0.000019240075,"threshold_uncertainty_score":0.26081565},"labels":[],"label_agreement":null},{"id":"W2415260229","doi":"","title":"A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cytology; Urine cytology; Urinary system; Upper urinary tract; Malignancy; Urine; Urinalysis; Urology; Internal medicine; Pathology; Cystoscopy","score_opus":0.06434196675484682,"score_gpt":0.3163981897635716,"score_spread":0.25205622300872477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415260229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117703,0.007422732,0.00009481763,0.0005767816,0.00010575858,0.0026112506,0.00022070162,0.00001666269,0.0077742813],"genre_scores_gemma":[0.99506366,0.0002965686,0.00016340209,0.00012161874,0.00002709198,0.0038354637,0.000016476979,0.000008804988,0.0004669385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917364,0.000041492003,0.0002586647,0.00016116384,0.00016520068,0.00019983396],"domain_scores_gemma":[0.9990474,0.00037942466,0.00012340069,0.00027245548,0.00010641155,0.0000708871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017862239,0.00011391784,0.00051236287,0.00014134613,0.000033737404,0.0000032715316,0.000067109424,0.000036181165,0.00018198922],"category_scores_gemma":[0.00008890677,0.00007000016,0.00030537433,0.00050993456,0.00007334868,0.000033883905,0.0000085321135,0.00004586299,9.35111e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005223709,0.0029434166,0.9683222,0.000105760046,0.0062792297,0.0000083591785,0.0007822062,0.000040348554,0.000058330083,0.00025719768,0.0010254817,0.01965508],"study_design_scores_gemma":[0.0017325424,0.0003779524,0.97329813,0.0000136575745,0.004644514,0.000008132376,0.00011600445,0.000025035639,0.015435028,0.00004350257,0.004243496,0.0000619853],"about_ca_topic_score_codex":0.000061810926,"about_ca_topic_score_gemma":0.0000083133045,"teacher_disagreement_score":0.019593095,"about_ca_system_score_codex":0.000032468404,"about_ca_system_score_gemma":0.00004070567,"threshold_uncertainty_score":0.28545237},"labels":[],"label_agreement":null},{"id":"W2415416460","doi":"10.1097/mou.0000000000000202","title":"Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"Universität Basel","keywords":"Medicine; Urothelial carcinoma; Clinical significance; Oncology; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.1469901133234905,"score_gpt":0.39058390330647735,"score_spread":0.24359378998298686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415416460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011653381,0.99252725,0.000010728946,0.00005919897,0.0029187594,0.0030062345,0.00015663772,0.000006859161,0.00014902462],"genre_scores_gemma":[0.049080364,0.9499738,0.0000039656265,0.000005129225,0.00023633734,0.00054473535,0.00008799668,0.000034135926,0.00003354312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772215,0.0004846415,0.00091070065,0.0004074917,0.0002471413,0.00022788277],"domain_scores_gemma":[0.99868524,0.00015702612,0.00054690934,0.0004326971,0.000109579254,0.00006854256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003253198,0.00028085275,0.0014609193,0.00027155955,0.000013691319,0.0000047223925,0.0001881607,0.00028264505,0.000009044438],"category_scores_gemma":[0.00011384938,0.00018829203,0.00013492724,0.00040294073,0.00024541578,0.000028197277,0.00006149545,0.0004085961,0.0000031869524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004761893,0.0015936813,0.23935804,0.12501657,0.00030056716,0.000008132417,0.0014082564,0.000010321894,0.000014849466,0.0028312423,0.0018191105,0.62716305],"study_design_scores_gemma":[0.002830158,0.00069886114,0.05476606,0.011901245,0.00065390306,0.000065194385,0.00006670409,0.00013278042,0.0000025608863,0.00006330742,0.9285574,0.0002618189],"about_ca_topic_score_codex":0.00012347178,"about_ca_topic_score_gemma":0.000009635309,"teacher_disagreement_score":0.9267383,"about_ca_system_score_codex":0.00012789182,"about_ca_system_score_gemma":0.0008337287,"threshold_uncertainty_score":0.76783264},"labels":[],"label_agreement":null},{"id":"W2415809973","doi":"10.1186/s13690-016-0140-1","title":"International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics","year":2016,"lang":"en","type":"article","venue":"Archives of Public Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; Health Canada; University of Ottawa","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; World Cancer Research Fund; Norges Forskningsråd; Institut Gustave-Roussy; Deutsche Krebshilfe; Mutuelle Générale de l'Education Nationale; Associazione Italiana per la Ricerca sul Cancro; U.S. Department of Energy; Vetenskapsrådet; Smoking Research Foundation; Ministry of Health, Labour and Welfare; Cancerfonden; Institut National de la Santé et de la Recherche Médicale; Medical Research Council; Bundesministerium für Bildung und Forschung; Swedish Cancer Foundation; National Science Council; Cancer Research UK; Wellcome Trust; KWF Kankerbestrijding; British Heart Foundation; Ligue Contre le Cancer; Centre International de Recherche sur le Cancer; Jonsson Comprehensive Cancer Center; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Bladder cancer; Medicine; Epidemiology; Cancer; Cohort study; Observational study; Environmental health; Internal medicine; Oncology","score_opus":0.10692631390643484,"score_gpt":0.3915889503236673,"score_spread":0.28466263641723244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415809973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93053293,0.002005021,0.0015533419,0.06301887,0.00027266328,0.00196452,0.0005582142,0.000023382989,0.00007106062],"genre_scores_gemma":[0.9888368,0.0079140635,0.0004404493,0.0020316408,0.0002783732,0.0002849054,0.000013881825,0.000020390169,0.00017946439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977172,0.0008153076,0.0004859654,0.00042076828,0.00020304613,0.00035768785],"domain_scores_gemma":[0.99750596,0.0016763374,0.00022646462,0.00021531327,0.00007077178,0.0003051441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011273717,0.00019676659,0.0005191545,0.00013955409,0.0001615927,0.000014954865,0.00010699228,0.000034112512,0.00008016649],"category_scores_gemma":[0.0003647907,0.00010970296,0.00003143054,0.000055423057,0.00030552212,0.000082217135,0.000096278265,0.00013533684,9.072619e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009019215,0.0012644713,0.66802704,0.000060590603,0.0005645797,0.000009836796,0.0022120248,1.9045991e-7,0.00007334367,0.000088074,0.00047416613,0.32632375],"study_design_scores_gemma":[0.0060441317,0.004679187,0.98485374,0.00019290006,0.0001162033,0.00001909131,0.0007259919,0.00024152764,0.000016743865,0.00037107265,0.0026300433,0.00010935555],"about_ca_topic_score_codex":0.0008595607,"about_ca_topic_score_gemma":0.000227545,"teacher_disagreement_score":0.3262144,"about_ca_system_score_codex":0.000049603223,"about_ca_system_score_gemma":0.00043017388,"threshold_uncertainty_score":0.4473557},"labels":[],"label_agreement":null},{"id":"W2415926757","doi":"","title":"Perioperative chemotherapy for localized bladder cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Bladder cancer; Perioperative; Chemotherapy; Randomized controlled trial; Oncology; Cancer; Internal medicine; Clinical trial; Surgery; Intensive care medicine","score_opus":0.022030650027437124,"score_gpt":0.2803836477794251,"score_spread":0.25835299775198795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415926757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7335731,0.012640554,0.006795851,0.038704246,0.001956951,0.023324236,0.00055083714,0.0007565555,0.18169771],"genre_scores_gemma":[0.9584641,0.00011408972,0.00055369193,0.0028451344,0.0008040759,0.013047594,0.000042150357,0.000044478074,0.02408467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999165,0.0000105630215,0.00014536773,0.00022688584,0.0001298885,0.00032228843],"domain_scores_gemma":[0.9996307,0.000019248939,0.00003303445,0.00014306784,0.00008240072,0.000091530645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057514066,0.00013757471,0.00023653863,0.000035552184,0.00006850391,0.000020498872,0.00004308427,0.000058993395,0.00027561875],"category_scores_gemma":[0.000009880931,0.000104982275,0.0001055082,0.00009461394,0.00005119868,0.00004514075,0.000005848993,0.000050591785,0.0000069712837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048241853,0.0012693474,0.056602392,0.00017889783,0.0012777157,0.000031180505,0.0006689977,0.000040203533,0.0015484934,0.0018692213,0.09070796,0.8409814],"study_design_scores_gemma":[0.022365378,0.00021979799,0.46670613,0.000019008037,0.00033376695,0.00001712918,0.00008656681,0.00012337157,0.04049959,0.0004892422,0.46882495,0.00031506832],"about_ca_topic_score_codex":0.0005708681,"about_ca_topic_score_gemma":0.000086270506,"teacher_disagreement_score":0.84066635,"about_ca_system_score_codex":0.00013423793,"about_ca_system_score_gemma":0.00007835029,"threshold_uncertainty_score":0.42810526},"labels":[],"label_agreement":null},{"id":"W2415970979","doi":"","title":"Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Medicine; Carcinoma in situ; Transitional cell carcinoma; Urology; Carcinoma; Lamina propria; Tumor progression; Surgery; Lesion; Urinary bladder; Bladder cancer; Internal medicine; Cancer; Pathology","score_opus":0.027330759840822314,"score_gpt":0.24640781032946774,"score_spread":0.21907705048864543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415970979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922717,0.0012023147,0.00018186147,0.00066081784,0.00015138397,0.0021001352,0.0002859386,0.000013996907,0.0031318597],"genre_scores_gemma":[0.9933871,0.0001729872,0.00008790275,0.00012128177,0.00020789691,0.0015768213,0.000058326583,0.000021675041,0.00436601],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990008,0.000021149,0.00027329414,0.00020037858,0.00022084934,0.00028353388],"domain_scores_gemma":[0.99942786,0.00010618861,0.00004748336,0.0002445052,0.000054376593,0.000119567136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062749765,0.00016027472,0.00033531702,0.000042187774,0.000045542605,0.000004786055,0.000068684334,0.00006647959,0.00062036386],"category_scores_gemma":[0.0000045339966,0.00009904937,0.00027374263,0.0000914387,0.00011436048,0.000030105954,0.0000031405716,0.000043650136,0.000005299543],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042328876,0.0022110823,0.026945027,0.00018362077,0.000765452,0.00003050018,0.0014449866,0.000013079577,0.0006960366,0.000036525234,0.0006301873,0.96281064],"study_design_scores_gemma":[0.012642672,0.0009076676,0.92959,0.000007893763,0.0009408719,0.000020034164,0.000040511077,0.000029415767,0.05219475,0.000031043302,0.0034887404,0.00010641508],"about_ca_topic_score_codex":0.00013214449,"about_ca_topic_score_gemma":0.000028661687,"teacher_disagreement_score":0.9627042,"about_ca_system_score_codex":0.000092826886,"about_ca_system_score_gemma":0.00007290331,"threshold_uncertainty_score":0.6792549},"labels":[],"label_agreement":null},{"id":"W2416383586","doi":"10.1007/s00345-016-1871-x","title":"HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)","year":2016,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Internal medicine; Immunohistochemistry; Stage (stratigraphy); Nephrology; Urothelial carcinoma; Oncology; Cancer; Gastroenterology; Metastasis; Urology; Pathology; Bladder cancer","score_opus":0.009415213581114544,"score_gpt":0.2452456976319483,"score_spread":0.23583048405083376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416383586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530226,0.00011296325,0.000019199386,0.0033060396,0.0001397627,0.00024401445,0.000026350437,0.000009690994,0.0008397348],"genre_scores_gemma":[0.99628645,0.000014830296,0.00009218792,0.0017272166,0.00009387794,0.0000057278153,0.0000030458139,0.000034688113,0.0017419856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985874,0.000106660125,0.00039323705,0.0001910931,0.00039806525,0.00032349408],"domain_scores_gemma":[0.9989973,0.00013472803,0.00034453438,0.00018259643,0.0001795363,0.00016134573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013028819,0.0002091536,0.00057589385,0.00032354586,0.000035768633,0.0000072124144,0.00010381569,0.000088909735,0.0006230104],"category_scores_gemma":[0.00005602151,0.000096790085,0.00010181425,0.00018694217,0.000087246925,0.00014797495,0.000017343125,0.00027937267,0.000011210632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006036308,0.0010062625,0.9882709,0.000004170338,0.0002249855,0.00024921834,0.00020006114,0.0000015574266,0.00018122063,0.00000688902,0.00059083145,0.003227589],"study_design_scores_gemma":[0.022887519,0.0043544886,0.96953195,0.00021741363,0.00019596063,0.000070674425,0.00001027321,8.3603237e-7,0.00024545522,0.000053440912,0.0023138921,0.00011807185],"about_ca_topic_score_codex":0.000034970526,"about_ca_topic_score_gemma":0.00009202622,"teacher_disagreement_score":0.018738931,"about_ca_system_score_codex":0.00016471675,"about_ca_system_score_gemma":0.00019503332,"threshold_uncertainty_score":0.6821527},"labels":[],"label_agreement":null},{"id":"W2422527033","doi":"","title":"Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Magnetic resonance imaging; Pathology; Bladder tumor; Transitional cell carcinoma; Bone marrow; Implant; Bladder cancer; Cancer; Urology; Cancer research; Internal medicine; Surgery; Radiology","score_opus":0.022128951551156132,"score_gpt":0.24871243762158474,"score_spread":0.2265834860704286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422527033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878914,0.00041352736,0.00011403957,0.00032806507,0.00004822744,0.0013215273,0.000057683013,0.00003478506,0.00979076],"genre_scores_gemma":[0.9940479,0.00006569175,0.0002205173,0.00021408696,0.000035827034,0.00068427634,0.00007269118,0.000016611188,0.0046423934],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990527,0.000023372542,0.0003195618,0.00017038171,0.00019610884,0.00023786239],"domain_scores_gemma":[0.9996375,0.000013665106,0.0000889632,0.00013975844,0.000033413817,0.00008674026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086475164,0.000113494076,0.0002330939,0.00007897373,0.0000175797,0.000007034996,0.000042654898,0.000053112984,0.00066886254],"category_scores_gemma":[0.000023511513,0.00010105705,0.000070943934,0.0001589347,0.00002652536,0.00017825495,0.000008215457,0.00007983874,0.000022057682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031321612,0.0034685938,0.009368677,0.00041495933,0.00035877692,0.00004611449,0.0018951457,0.000012442281,0.21110022,0.000015490645,0.009653492,0.7605339],"study_design_scores_gemma":[0.012200289,0.00028126614,0.7608431,0.00011174084,0.0001939232,0.00010911555,0.000120770965,0.00013168294,0.22044533,0.00013501468,0.005169674,0.00025805825],"about_ca_topic_score_codex":0.0001645215,"about_ca_topic_score_gemma":0.000034707547,"teacher_disagreement_score":0.7602759,"about_ca_system_score_codex":0.0001093093,"about_ca_system_score_gemma":0.000026112935,"threshold_uncertainty_score":0.73235756},"labels":[],"label_agreement":null},{"id":"W2423517989","doi":"10.1016/j.urolonc.2016.05.012","title":"Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Chemotherapy; Medicine; Cancer; Oncology; Neoadjuvant therapy; Internal medicine; Urology; Breast cancer","score_opus":0.1261711172978729,"score_gpt":0.42594511324257484,"score_spread":0.29977399594470194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423517989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008210322,0.98325163,0.000799956,0.0095437,0.00043492304,0.004481005,0.0002917628,0.00005696239,0.00031901326],"genre_scores_gemma":[0.000008568754,0.9648157,0.025389368,0.0056868484,0.0007246967,0.0022201575,0.00007602233,0.00007288086,0.0010057595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977495,0.00021146177,0.0006032642,0.000731732,0.00019675086,0.0005072754],"domain_scores_gemma":[0.9976179,0.0010779882,0.00037317586,0.00041349267,0.00017815513,0.00033926158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036314872,0.00056768203,0.0014325734,0.00019423732,0.00046065878,0.000038612376,0.0002476978,0.00056958356,0.00025962992],"category_scores_gemma":[0.00019654869,0.00028867257,0.00024892282,0.0005146467,0.00046293274,0.00006752638,0.000057532026,0.00036012966,0.000033249835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001478176,0.0001281273,0.00020345453,0.0003635948,0.00055904174,0.00002418703,0.00040331186,0.0000028761158,0.000020996786,0.0006323271,0.008275265,0.989239],"study_design_scores_gemma":[0.001137026,0.0019533334,0.000028243876,0.0027349873,0.0012700169,0.00023886397,0.000033943677,0.000009507191,0.00004022489,0.0028703907,0.98935735,0.000326113],"about_ca_topic_score_codex":0.00006838961,"about_ca_topic_score_gemma":0.000038711863,"teacher_disagreement_score":0.9889129,"about_ca_system_score_codex":0.0004507501,"about_ca_system_score_gemma":0.0036886446,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W2427081384","doi":"10.5489/cuaj.3917","title":"What’s new bladder cancer research?","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Oncology; Urology; Internal medicine","score_opus":0.11289001937263138,"score_gpt":0.4006371329426934,"score_spread":0.287747113570062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427081384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000050717817,0.97091025,0.000002644372,0.022783358,0.0023429762,0.00060502696,0.00012532747,0.00002610174,0.0031992206],"genre_scores_gemma":[0.000019311276,0.9393193,0.000019055178,0.0024373862,0.0056618163,0.00006732334,0.0000335221,0.000057457677,0.05238482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962265,0.0006181429,0.0006502446,0.00043346945,0.0009107474,0.001160927],"domain_scores_gemma":[0.99597913,0.0003923449,0.00042932475,0.00025078058,0.00053090864,0.0024174815],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010916201,0.00037312726,0.0013525793,0.00059523626,0.0003952105,0.0003655169,0.00029727933,0.0010260191,0.012950829],"category_scores_gemma":[0.00072344614,0.00022314038,0.00066311366,0.00047966893,0.000059612008,0.0002284573,0.00003328868,0.0020309307,0.0014356689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000011120934,0.000019531497,0.00039159943,0.000103505845,0.00068969204,0.00017734936,0.000023797229,4.0563013e-8,8.748016e-8,0.000040521652,0.26137522,0.73716754],"study_design_scores_gemma":[0.00070993823,0.00024301416,0.00045704696,0.0038706993,0.0007822966,0.00034877402,0.000012022685,1.0220262e-7,1.7891459e-7,0.0006952153,0.99266136,0.00021934885],"about_ca_topic_score_codex":0.0033407062,"about_ca_topic_score_gemma":0.0017316516,"teacher_disagreement_score":0.7369482,"about_ca_system_score_codex":0.007253799,"about_ca_system_score_gemma":0.013776461,"threshold_uncertainty_score":0.99934185},"labels":[],"label_agreement":null},{"id":"W2431600878","doi":"","title":"Open cystolithotomy for very large calculi in a Studer ileal neobladder.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Urinary system; Complication; Urology; Surgery; Anatomy; Internal medicine; Bladder cancer; Cancer","score_opus":0.0941599497186529,"score_gpt":0.34379159259538594,"score_spread":0.24963164287673306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431600878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7827975,0.001966145,0.0006274851,0.006933453,0.0015409829,0.025399089,0.00033877557,0.0002066909,0.18018985],"genre_scores_gemma":[0.97963786,0.000008963231,0.00038893835,0.001845801,0.00024990932,0.0110733425,0.000044340544,0.000032773023,0.0067180553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987244,0.000036480025,0.00021438251,0.00029309583,0.00021292303,0.0005187078],"domain_scores_gemma":[0.999249,0.0000334193,0.00004128129,0.0002612747,0.000081357,0.00033368412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004417699,0.00014403535,0.00034200717,0.00007806956,0.000035933135,0.000046269834,0.00019778807,0.00007719294,0.000036438567],"category_scores_gemma":[0.00011622077,0.00011714142,0.000068181034,0.00016127324,0.000023104796,0.00015230112,0.0001286444,0.00009934091,0.000025940237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011794271,0.0063002263,0.495598,0.00044122708,0.0013094957,0.001174141,0.0067199217,0.00001103804,0.000027168533,0.0022718525,0.24835587,0.22599682],"study_design_scores_gemma":[0.035453256,0.00036048808,0.5948764,0.000037827187,0.00019797124,0.000078039724,0.0007172174,0.00005874343,0.00022096155,0.00073697086,0.3669881,0.00027401382],"about_ca_topic_score_codex":0.0005560811,"about_ca_topic_score_gemma":0.0003478877,"teacher_disagreement_score":0.2257228,"about_ca_system_score_codex":0.00023610285,"about_ca_system_score_gemma":0.00021916718,"threshold_uncertainty_score":0.47768885},"labels":[],"label_agreement":null},{"id":"W2439346366","doi":"10.1016/j.urology.2014.06.074","title":"Reply","year":2014,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Quartile; Scopus; Population; Multidisciplinary approach; Cystectomy; Family medicine; MEDLINE; Cancer; Internal medicine","score_opus":0.021949831317717904,"score_gpt":0.277280754099809,"score_spread":0.25533092278209113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2439346366","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004163196,0.000388128,0.00009659297,0.9269742,0.00061294774,0.00020275268,0.000010663839,0.00008302285,0.071590066],"genre_scores_gemma":[0.0022315315,0.000026271618,0.00004907789,0.96635324,0.0074053155,0.00003908016,0.0002692833,0.000051574363,0.023574634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990374,0.000052952393,0.00015122186,0.00034113188,0.00013279368,0.00028449993],"domain_scores_gemma":[0.99931014,0.000054017728,0.00006045072,0.0004950334,0.00003586962,0.00004449479],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00003848848,0.00018270845,0.00040898268,0.00008532364,0.000023263101,0.00000442216,0.00008122475,0.0006132197,0.0012637377],"category_scores_gemma":[0.000026304228,0.00014611588,0.00012069902,0.000036980644,0.00006783429,0.00000722804,0.00002124154,0.0009332308,0.0012497073],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006009094,0.00001343816,0.00028204755,0.000046017136,0.00013194914,0.0011789578,0.00001422585,1.3167688e-7,0.00000600909,0.000009290275,0.99731034,0.00094747916],"study_design_scores_gemma":[0.0008636395,0.00084224995,0.00015997957,0.0000070070146,0.00036677247,0.000730323,2.9794487e-7,0.0000046302293,0.000021468646,0.00030295248,0.9965996,0.00010105752],"about_ca_topic_score_codex":0.000070925365,"about_ca_topic_score_gemma":0.0000012651664,"teacher_disagreement_score":0.04801543,"about_ca_system_score_codex":0.000032919015,"about_ca_system_score_gemma":0.00009274157,"threshold_uncertainty_score":0.9996492},"labels":[],"label_agreement":null},{"id":"W2442181867","doi":"10.1093/neuonc/now073.67","title":"HG-71ULTRA-SENSITIVE DETECTION OF HOTSPOT MUTATIONS IN PEDIATRIC THALAMIC TUMOURS TO REVEAL NEGATIVE PROGNOSTIC MARKERS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Hotspot (geology); Biology; Medicine; Computational biology; Genetics; Geology","score_opus":0.015588353714222262,"score_gpt":0.2911796878861485,"score_spread":0.27559133417192627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442181867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924259,0.000025157287,0.00019581587,0.0028770647,0.00037370564,0.0011314134,0.000040889587,0.00005037582,0.002879665],"genre_scores_gemma":[0.9986579,0.00006307371,0.00025647483,0.0006080657,0.00017360995,0.00012575045,0.000004200252,0.000026727837,0.0000842412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986544,0.00023658041,0.0003151564,0.0003410114,0.00016796155,0.00028488014],"domain_scores_gemma":[0.99850446,0.00092671154,0.00013214863,0.00015320517,0.00014639333,0.0001371061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012767068,0.00015869655,0.00036285273,0.00032955434,0.000036252524,0.0000027875437,0.000055448698,0.00011482601,0.000022832219],"category_scores_gemma":[0.0008140448,0.00011916268,0.000072342,0.0004723269,0.00010703664,0.00006178417,0.000022670607,0.00016448583,0.00006085226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028760387,0.0005612643,0.23589286,0.000057186426,0.00006238002,0.00053082855,0.0017915952,0.000014020434,0.7107427,0.000020888847,0.0004828065,0.046967413],"study_design_scores_gemma":[0.0051406254,0.005179659,0.8726908,0.000053972133,0.00028877685,0.00020919208,0.00033523736,0.000011720616,0.11562691,0.00015377937,0.0001821536,0.00012716185],"about_ca_topic_score_codex":0.00014283665,"about_ca_topic_score_gemma":0.00026635625,"teacher_disagreement_score":0.63679796,"about_ca_system_score_codex":0.00036369744,"about_ca_system_score_gemma":0.00039115394,"threshold_uncertainty_score":0.4859313},"labels":[],"label_agreement":null},{"id":"W2442538157","doi":"10.1358/dot.2015.51.5.2336329","title":"A report from the American Association of Urology Annual Meeting2015 (May 15-19 - New Orleans, Louisiana, USA)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Convention; Quarter (Canadian coin); Gerontology; Family medicine; Library science; Archaeology","score_opus":0.019357152547271227,"score_gpt":0.3010949530022958,"score_spread":0.28173780045502456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442538157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95780003,0.0010662079,0.00008357524,0.024622105,0.0004360884,0.0003804789,0.00024211343,0.000036654215,0.015332756],"genre_scores_gemma":[0.99261284,0.00003821085,0.0006032295,0.0015182683,0.00038438506,0.000006598541,0.00006790201,0.000018804025,0.004749777],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986186,0.00010320057,0.00038042216,0.0002188908,0.00048314384,0.00019573959],"domain_scores_gemma":[0.99839497,0.00019949877,0.0006237803,0.00039203954,0.00020508029,0.00018463243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050602393,0.0001256291,0.00045177812,0.0000437452,0.000023586492,0.0000045569955,0.00013341015,0.000068166024,0.00011141867],"category_scores_gemma":[0.00074333395,0.000087524,0.000107818116,0.00018655903,0.00009437869,0.000048016995,0.00004239479,0.00012353853,0.000029290324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061926275,0.00017691149,0.584323,0.000008956731,0.00045439208,0.00005156992,0.0056342473,0.000012941702,0.00034652662,0.000037519232,0.3994229,0.008911781],"study_design_scores_gemma":[0.006187893,0.0015827451,0.4793979,0.00006192367,0.0011266809,0.00005276706,0.0037029365,0.000025227007,0.004760047,0.0010690743,0.5017753,0.00025747283],"about_ca_topic_score_codex":0.026707338,"about_ca_topic_score_gemma":0.0004989119,"teacher_disagreement_score":0.104925066,"about_ca_system_score_codex":0.00014057521,"about_ca_system_score_gemma":0.0005429363,"threshold_uncertainty_score":0.9797739},"labels":[],"label_agreement":null},{"id":"W2444208589","doi":"10.1016/j.anndiagpath.2016.06.002","title":"Comparative study of TERT gene mutation analysis on voided liquid-based urine cytology and paraffin-embedded tumorous tissue","year":2016,"lang":"en","type":"article","venue":"Annals of Diagnostic Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Sanger sequencing; Mutation; Molecular biology; Gene mutation; Mutation testing; Telomerase reverse transcriptase; Biology; Urine; Pathology; DNA sequencing; Gene; Cancer research; Medicine; Telomerase; Genetics","score_opus":0.05391761432009931,"score_gpt":0.3751239389804917,"score_spread":0.32120632466039234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2444208589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706,0.00038783165,0.00062203396,0.0009877748,0.00005418276,0.0006539522,0.00009225405,0.000021230522,0.00012071802],"genre_scores_gemma":[0.9989946,0.00012468579,0.0001962285,0.0004660257,0.00003204396,0.00010562262,0.000036916124,0.000012465961,0.00003143909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985285,0.00024881185,0.0004582535,0.00036788723,0.00017419111,0.00022237755],"domain_scores_gemma":[0.9975462,0.0015314914,0.0002572702,0.00033751858,0.00022806345,0.00009948986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016202424,0.00019256669,0.0009608363,0.00034799761,0.000030514053,0.0000019549873,0.00007119483,0.00008683887,0.00009414855],"category_scores_gemma":[0.00052686705,0.00013149834,0.00008173402,0.0002782538,0.00019898097,0.000030696134,0.00002628774,0.00006123337,0.000012056717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024800645,0.029244952,0.6308559,0.0003774513,0.011876442,0.009910302,0.016468324,0.0019292203,0.2439348,0.00023968215,0.00078532513,0.029576955],"study_design_scores_gemma":[0.005774408,0.027123991,0.5279062,0.0000732053,0.0016705145,0.00007014784,0.0002522693,0.00003707258,0.43685126,0.00009262511,0.000014980596,0.00013335014],"about_ca_topic_score_codex":0.00011376377,"about_ca_topic_score_gemma":0.00012187613,"teacher_disagreement_score":0.19291647,"about_ca_system_score_codex":0.000013671709,"about_ca_system_score_gemma":0.0000661973,"threshold_uncertainty_score":0.5362346},"labels":[],"label_agreement":null},{"id":"W2461367843","doi":"10.5489/cuaj.3412","title":"Urothelial carcinoma of the bladder in a pediatric patient","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Urothelial carcinoma; Medicine; Gross hematuria; Carcinoma; Urology; Bladder cancer; Internal medicine; Cancer; Surgery","score_opus":0.0100362066538449,"score_gpt":0.21321476567053488,"score_spread":0.20317855901668996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461367843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781878,0.00016143826,0.000005756537,0.018631138,0.00031523628,0.00018710292,0.000032153865,0.000004190974,0.0024752105],"genre_scores_gemma":[0.9971656,0.000056042754,0.000018128945,0.0020205711,0.00029448973,0.000007521702,5.634121e-7,0.0000073696588,0.000429668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988792,0.00012558191,0.00028643364,0.00011236121,0.00029257132,0.00030386887],"domain_scores_gemma":[0.99924207,0.00007796079,0.00018026424,0.00009870018,0.00012888189,0.00027210888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019319777,0.00008637653,0.0001725546,0.00011970418,0.00007120528,0.00000954069,0.00009061812,0.00013046575,0.00045696844],"category_scores_gemma":[0.0003933443,0.00004169002,0.00012562067,0.00020710059,0.000023698694,0.000040137245,0.000012316396,0.00021274957,0.000019159106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042302174,0.000044817232,0.99409634,0.0000015394287,0.000022732977,0.000028713648,0.0000984036,0.0000012867562,0.00009844485,0.000048495247,0.0019049511,0.003612003],"study_design_scores_gemma":[0.0016494931,0.00028992328,0.99028045,0.000008516103,0.000056817666,0.00006173198,0.000014763472,0.0000021722192,0.00015569781,0.0004317801,0.006996918,0.000051751587],"about_ca_topic_score_codex":0.0008958142,"about_ca_topic_score_gemma":0.001086578,"teacher_disagreement_score":0.018977873,"about_ca_system_score_codex":0.00083811674,"about_ca_system_score_gemma":0.00083369174,"threshold_uncertainty_score":0.5003484},"labels":[],"label_agreement":null},{"id":"W2463941227","doi":"10.5430/jst.v6n2p56","title":"Impact of a teaching program on outcome quality of white light transurethral resection for bladder tumor: A cohort study","year":2016,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi di Perugia","keywords":"Medicine; Cystoscopy; Bladder cancer; Pathological; Logistic regression; Complication; Cohort; Retrospective cohort study; Urology; Observational study; Bladder tumor; Resection; Stage (stratigraphy); Surgery; Internal medicine; Cancer; Urinary system","score_opus":0.05040774485753225,"score_gpt":0.43001504452797584,"score_spread":0.3796072996704436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463941227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973349,0.00004352275,0.0001710548,0.00035564214,0.00017105934,0.001441272,0.00006376128,0.00001453648,0.00040428035],"genre_scores_gemma":[0.9991654,0.000005683154,0.0003151024,0.000025416071,0.0002399023,0.000039258473,0.00000107858,0.000029873043,0.00017829007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975687,0.00017565659,0.0012154437,0.00017233146,0.000625949,0.00024191155],"domain_scores_gemma":[0.99820507,0.00011914238,0.00089254737,0.00023821293,0.00038013406,0.00016492214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014706122,0.00019475195,0.00097396073,0.00023941882,0.00006913047,0.000005870348,0.00010833504,0.000050564668,0.000051529212],"category_scores_gemma":[0.000282204,0.000102626625,0.00065309054,0.000115397284,0.000051766405,0.00013323498,0.000012195687,0.0002534214,8.2847026e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009645159,0.0043763043,0.97157586,0.00011358981,0.0013175522,0.000035053235,0.0015964465,0.000009221689,0.008222007,0.000008847135,0.00019864998,0.0029013415],"study_design_scores_gemma":[0.009673106,0.034582492,0.94904435,0.00039938165,0.0004968586,0.000116855554,0.00033951123,0.000004837862,0.0051326174,0.00007507313,0.00003250198,0.00010240612],"about_ca_topic_score_codex":0.00010087162,"about_ca_topic_score_gemma":0.000031425592,"teacher_disagreement_score":0.030206187,"about_ca_system_score_codex":0.00022654166,"about_ca_system_score_gemma":0.00023945972,"threshold_uncertainty_score":0.41849923},"labels":[],"label_agreement":null},{"id":"W2466170860","doi":"10.1177/1066896916660195","title":"Clear Cell Urothelial Carcinoma","year":2016,"lang":"en","type":"review","venue":"International Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pathology; Immunohistochemistry; PAX8; Clear cell; GATA3; Carcinoma; Metastasis; CD44; Medicine; Urothelial Cell; Cell; Biology; Cancer; Urothelium; Internal medicine; Urinary bladder","score_opus":0.039499382373751356,"score_gpt":0.35908930881777823,"score_spread":0.3195899264440269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466170860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026571788,0.9857596,0.000030754665,0.0005402623,0.0027988243,0.00021131002,0.00013602547,0.0000117772925,0.010245722],"genre_scores_gemma":[0.0013952232,0.992617,0.00014333472,0.00014427009,0.003557817,0.0000089517935,0.00001997957,0.000053118354,0.0020602923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774647,0.00018913664,0.0010076761,0.00024793507,0.0005760097,0.00023279371],"domain_scores_gemma":[0.9982048,0.00022342657,0.00074035797,0.00018490088,0.00042986235,0.00021664523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002521514,0.00030631365,0.0015624823,0.00038746902,0.000021280168,0.00001879229,0.00041813002,0.0003598693,0.001410164],"category_scores_gemma":[0.000041921827,0.00017633886,0.0011607526,0.00007176371,0.00012519308,0.000066471854,0.00008711627,0.0005515314,0.00043530457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007713177,0.00035651217,0.00013275609,0.0005969634,0.00054657535,0.04404244,0.000028978413,5.431303e-8,0.000007319289,0.00015937333,0.0018544737,0.9515032],"study_design_scores_gemma":[0.00314594,0.00077684456,0.000031977914,0.0029870453,0.00061488675,0.038646806,0.0000033024437,9.7108284e-8,0.000015833855,0.00010091572,0.95353717,0.0001391979],"about_ca_topic_score_codex":0.0000031880265,"about_ca_topic_score_gemma":1.9727092e-7,"teacher_disagreement_score":0.9516827,"about_ca_system_score_codex":0.00028902595,"about_ca_system_score_gemma":0.0007162502,"threshold_uncertainty_score":0.99950266},"labels":[],"label_agreement":null},{"id":"W2469074081","doi":"10.1016/j.ccell.2016.06.012","title":"Molecular Subtypes of Non-muscle Invasive Bladder Cancer","year":2016,"lang":"en","type":"letter","venue":"Cancer Cell","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Bladder cancer; Cancer; Cancer research; Biology; Cancer cell; Pathology; Oncology; Medicine; Genetics","score_opus":0.014867872864098356,"score_gpt":0.27424966031195636,"score_spread":0.259381787447858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469074081","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05419907,0.106790125,0.00018457908,0.65492696,0.006164118,0.004374898,0.0045791576,0.00022562746,0.16855544],"genre_scores_gemma":[0.09687021,0.021167582,0.00015272133,0.81842464,0.011618946,0.001285259,0.00031950703,0.00045083574,0.04971032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977879,0.00004099898,0.00039650968,0.0006685214,0.0005258095,0.0005802458],"domain_scores_gemma":[0.998443,0.00006797157,0.00030656205,0.00073716725,0.00030365365,0.00014164127],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000042359643,0.00051061955,0.0008745938,0.00010566032,0.00004052728,0.000012463395,0.00025684678,0.0006841761,0.0060227206],"category_scores_gemma":[0.0000089282785,0.00037752214,0.00036303836,0.00014213556,0.00016428338,0.0000711058,0.00006961131,0.0005993988,0.000111404755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010154032,0.00006116642,0.0012184754,0.0012804518,0.00074831786,0.00054013357,0.00021184709,0.0000029728874,0.035961702,0.000001229305,0.9521698,0.007702373],"study_design_scores_gemma":[0.002530643,0.0002959379,0.00081653986,0.0011382399,0.0012924896,0.000005870733,0.000020537122,0.0000015118821,0.24316761,0.000047328915,0.75025,0.00043331482],"about_ca_topic_score_codex":0.0033457791,"about_ca_topic_score_gemma":0.00021221867,"teacher_disagreement_score":0.20720589,"about_ca_system_score_codex":0.00054461276,"about_ca_system_score_gemma":0.0016170455,"threshold_uncertainty_score":0.9998677},"labels":[],"label_agreement":null},{"id":"W2469882367","doi":"10.1016/j.clgc.2016.05.001","title":"Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Taxane; Carboplatin; Salvage therapy; Hazard ratio; Internal medicine; Oncology; Cisplatin; Chemotherapy; Confidence interval; Gemcitabine; Surgery; Urology; Cancer; Breast cancer","score_opus":0.07187810949543827,"score_gpt":0.4065238027753753,"score_spread":0.33464569327993704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469882367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458987,0.0007206689,0.00007340581,0.0002074061,0.00078183564,0.0025636714,0.0007151786,0.00005933748,0.00028863712],"genre_scores_gemma":[0.9960834,0.00082652614,0.00030855316,0.0002470091,0.0008993703,0.00072386937,0.00003225266,0.00008600512,0.0007930402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997768,0.00012522242,0.0008076892,0.00058967766,0.00028739526,0.00042205222],"domain_scores_gemma":[0.9978212,0.0007416833,0.00035286794,0.0005682555,0.00024381968,0.0002721523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014357868,0.0003793332,0.000836659,0.00009688538,0.000081961596,0.0000069917496,0.00013346909,0.00018691833,0.00021665815],"category_scores_gemma":[0.00013351828,0.0002075723,0.0008523785,0.00011003832,0.00010998957,0.000064563,0.000017485072,0.00010381099,0.000020023443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019401124,0.001881745,0.6077642,0.00005662228,0.0003919299,0.000014918697,0.000066454195,0.000024072431,0.005383405,9.054181e-7,0.00036606786,0.36464855],"study_design_scores_gemma":[0.05938547,0.040656075,0.8852199,0.0007632095,0.00023584494,0.0000041453927,0.000008152303,0.000030010004,0.012373757,0.000017002229,0.001018666,0.00028777064],"about_ca_topic_score_codex":0.00011573788,"about_ca_topic_score_gemma":0.000008852787,"teacher_disagreement_score":0.36436078,"about_ca_system_score_codex":0.0008068689,"about_ca_system_score_gemma":0.00094200735,"threshold_uncertainty_score":0.8464553},"labels":[],"label_agreement":null},{"id":"W2470592255","doi":"","title":"[Pathologic anatomy of infiltrating epithelial tumors of the bladder].","year":2002,"lang":"fr","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Pathology; Anatomy; Urinary bladder; Urology","score_opus":0.031814459182079306,"score_gpt":0.254792954627451,"score_spread":0.22297849544537168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470592255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86354715,0.034900285,0.000022457147,0.0044710822,0.0033694676,0.002514811,0.00038240466,0.000042705025,0.09074966],"genre_scores_gemma":[0.9903516,0.0004907786,0.00010618721,0.00034889043,0.0005542738,0.00032107707,0.0000024059514,0.000028358938,0.007796406],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979632,0.00018404849,0.0005919605,0.00026479634,0.00040735517,0.0005886709],"domain_scores_gemma":[0.9987608,0.00012428706,0.0003526721,0.0004956749,0.00010852273,0.0001580443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033080502,0.0002312817,0.0005039878,0.00007761486,0.00007153719,0.000008708141,0.0002535369,0.00015533865,0.00081665063],"category_scores_gemma":[0.00034661213,0.00016005964,0.00027013055,0.0004566624,0.00051462423,0.00008629684,0.00008004344,0.00026423924,0.000027807531],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014742675,0.0015424123,0.18169801,0.000769298,0.00068512216,0.00016800329,0.003788175,0.000041914485,0.0015535917,0.0015815244,0.0034918215,0.8045327],"study_design_scores_gemma":[0.0045846635,0.00038215585,0.9102766,0.00042398676,0.0010009328,0.00023263448,0.0007930268,0.00019800826,0.074393496,0.000702822,0.006715339,0.00029634897],"about_ca_topic_score_codex":0.00031564108,"about_ca_topic_score_gemma":0.00001771324,"teacher_disagreement_score":0.80423635,"about_ca_system_score_codex":0.00009910634,"about_ca_system_score_gemma":0.000066755434,"threshold_uncertainty_score":0.89417523},"labels":[],"label_agreement":null},{"id":"W2471359461","doi":"10.1016/j.urolonc.2016.05.028","title":"Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendations","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urine cytology; Cytology; Cancer; Urinary system; Urology; Oncology; Radiology; Internal medicine; Pathology","score_opus":0.061535952180295284,"score_gpt":0.3924444408448101,"score_spread":0.33090848866451483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471359461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005289683,0.9722552,0.000031387117,0.014590861,0.0035439935,0.0017404408,0.0008225166,0.00008595952,0.0064007174],"genre_scores_gemma":[0.00004578451,0.97963244,0.0037404194,0.0032464312,0.0017150246,0.0027804591,0.0005900508,0.00007673083,0.008172681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967606,0.00027365345,0.00096019614,0.0009929594,0.00027837674,0.0007341934],"domain_scores_gemma":[0.9977042,0.0006934477,0.00059665134,0.00040212602,0.00016779648,0.0004357526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032394845,0.00070224196,0.0018096371,0.00042062683,0.00030817091,0.000046133035,0.00032156473,0.0008838236,0.0025982677],"category_scores_gemma":[0.000158064,0.00051270175,0.00036181408,0.0006023463,0.0005820348,0.00018211441,0.00014586658,0.00088869204,0.000110917426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089499146,0.00031323035,0.0154801,0.00074767036,0.0017576249,0.00026936887,0.0003407269,0.000017760216,0.0000032910814,0.0009877002,0.11879322,0.8611998],"study_design_scores_gemma":[0.0019295675,0.0006208917,0.00027649838,0.006417157,0.002565476,0.00018328265,0.00005036664,0.000018497396,0.0000020674722,0.0013513566,0.9861221,0.0004627942],"about_ca_topic_score_codex":0.0006058857,"about_ca_topic_score_gemma":0.0018039846,"teacher_disagreement_score":0.8673288,"about_ca_system_score_codex":0.0010590146,"about_ca_system_score_gemma":0.0032946449,"threshold_uncertainty_score":0.99973243},"labels":[],"label_agreement":null},{"id":"W2473053524","doi":"10.1200/jco.2011.29.7_suppl.240","title":"Multi-institutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: Phase I.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Bladder cancer; Chemotherapy; Neoadjuvant therapy; Lymphadenectomy; Cisplatin; Oncology; Retrospective cohort study; Internal medicine; Cancer; Urology; Surgery","score_opus":0.3090803812751522,"score_gpt":0.4821556244112892,"score_spread":0.17307524313613698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473053524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885263,0.00057737075,0.0045796772,0.00083274185,0.0010105729,0.0006010305,0.0004938185,0.0000030011702,0.0033755212],"genre_scores_gemma":[0.9739633,0.000085752145,0.024513554,0.0010515623,0.00031464966,0.000012341104,0.000013401269,0.000011499003,0.00003390482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684626,0.0004023884,0.002094478,0.00014784503,0.0003579118,0.00015112718],"domain_scores_gemma":[0.995066,0.0018263588,0.0017167532,0.00015699968,0.0010539654,0.000179907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096833764,0.00013945156,0.0011918758,0.000077432946,0.00005796331,0.0000013742405,0.00016596387,0.00019530475,0.00025043494],"category_scores_gemma":[0.0011675685,0.00008164969,0.001018413,0.000091760805,0.00051998446,0.00008655825,0.000021801507,0.00038208463,0.0000023344214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14234741,0.12266187,0.4333309,0.0040021227,0.009470699,0.0010402123,0.04344977,0.00009251142,0.030870648,0.0056517357,0.0046494994,0.20243263],"study_design_scores_gemma":[0.076325625,0.029829312,0.8626289,0.00018169456,0.0020799818,0.00009384286,0.0022100278,0.000036655558,0.022959815,0.00076138554,0.002740451,0.00015231592],"about_ca_topic_score_codex":0.000033376436,"about_ca_topic_score_gemma":0.00006112004,"teacher_disagreement_score":0.429298,"about_ca_system_score_codex":0.00008413236,"about_ca_system_score_gemma":0.0038842896,"threshold_uncertainty_score":0.68905634},"labels":[],"label_agreement":null},{"id":"W2474315449","doi":"10.5489/cuaj.3557","title":"Can lymphovascular invasion replace the prognostic value of lymph node involvement in patients with upper tract urothelial carcinoma after radical nephroureterectomy?","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; Ministry of Science, ICT and Future Planning; National Research Foundation","keywords":"Lymphovascular invasion; Urothelial carcinoma; Medicine; Oncology; Lymph node; Urology; Lymph node metastasis; Internal medicine; Metastasis; Cancer","score_opus":0.007511063490761808,"score_gpt":0.19796219004570806,"score_spread":0.19045112655494625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474315449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851568,0.00014055753,0.000024423047,0.013771233,0.00013809717,0.00056195486,0.00008386607,0.000009086849,0.000113987626],"genre_scores_gemma":[0.9955259,0.000027488273,0.00010288992,0.003993065,0.00018275774,0.000050831775,0.000014481485,0.000021742917,0.00008082304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977813,0.00033699267,0.00042830696,0.00026597994,0.000672822,0.00051460275],"domain_scores_gemma":[0.9986923,0.00017437553,0.00023371917,0.00020920375,0.00021705429,0.0004733716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053469173,0.00020152208,0.00034570595,0.0001635871,0.00011817763,0.000031537424,0.00014233113,0.00020398051,0.00034053836],"category_scores_gemma":[0.0004160385,0.00009715223,0.00015929536,0.0002058721,0.000087092274,0.000086808526,0.000017321352,0.00025486844,0.000009567906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070639706,0.00020212255,0.99674284,0.0000069413636,0.00013455105,0.000090385714,0.0002076973,0.0000043176365,0.000029232267,0.000020273568,0.00020974518,0.0016454771],"study_design_scores_gemma":[0.008471053,0.0007582386,0.98847663,0.000098784585,0.00018260918,0.000056789464,0.00002607528,0.000009633712,0.00006814393,0.00015706585,0.0015664848,0.00012847455],"about_ca_topic_score_codex":0.003509937,"about_ca_topic_score_gemma":0.0009111789,"teacher_disagreement_score":0.010369126,"about_ca_system_score_codex":0.0022285883,"about_ca_system_score_gemma":0.0012642889,"threshold_uncertainty_score":0.58276814},"labels":[],"label_agreement":null},{"id":"W2478136527","doi":"10.1016/j.eururo.2016.07.014","title":"Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Systematic review; Urology; Urothelial carcinoma; Cochrane Library; Nephrectomy; Kidney cancer; MEDLINE; Bladder cancer; Meta-analysis; Surgery; Cancer; Kidney; Internal medicine","score_opus":0.13376593551474786,"score_gpt":0.3754905467695089,"score_spread":0.24172461125476102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478136527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056792167,0.98548895,0.000053379572,0.0038794084,0.0019405059,0.0065970877,0.0008226487,0.00006368429,0.0010975357],"genre_scores_gemma":[0.00048650647,0.9850427,0.0000650998,0.010079563,0.0011769544,0.0016526371,0.00023052197,0.0002423256,0.001023711],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939718,0.0016565467,0.0023575027,0.00086987205,0.0004098335,0.000734408],"domain_scores_gemma":[0.9923939,0.0043185344,0.0014826738,0.0011073678,0.0003083351,0.00038920308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014536837,0.00092756306,0.0058737807,0.00019259883,0.00013606375,0.000021102172,0.00065316487,0.00032138693,0.0003465321],"category_scores_gemma":[0.0059004687,0.00045561523,0.002021388,0.00023335438,0.0003264897,0.00006054288,0.00017526472,0.0004999134,0.00014535456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044293917,0.00038452665,0.00041847155,0.6307964,0.0045274957,0.00029625185,0.00011987676,1.4681873e-7,0.000012813775,0.000011139661,0.27843437,0.08455559],"study_design_scores_gemma":[0.0031768973,0.0008117575,0.00015837714,0.09784629,0.02017152,0.0002584273,0.00000951528,0.0000012182269,0.0000038520975,0.0000027425594,0.8770903,0.0004691217],"about_ca_topic_score_codex":0.000113299306,"about_ca_topic_score_gemma":0.0000085341435,"teacher_disagreement_score":0.5986559,"about_ca_system_score_codex":0.00024866618,"about_ca_system_score_gemma":0.0021446864,"threshold_uncertainty_score":0.99978954},"labels":[],"label_agreement":null},{"id":"W2478515289","doi":"10.1200/jco.2016.34.18_suppl.lba4500","title":"Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Atezolizumab; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Cohort; Cisplatin; Urology; Clinical endpoint; Radiation therapy; Cancer; Chemotherapy; Nivolumab; Clinical trial; Bladder cancer; Immunotherapy; Urothelial carcinoma","score_opus":0.0732569150031822,"score_gpt":0.43176995279368185,"score_spread":0.35851303779049964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478515289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886862,0.0010790329,0.000828346,0.004069373,0.0006627139,0.00054346153,0.000045711688,0.000012300787,0.0040728836],"genre_scores_gemma":[0.9884313,0.006762967,0.002003993,0.0017249,0.00043170343,0.000028186365,0.000008394385,0.000038901228,0.00056967675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426,0.0004385049,0.0037689975,0.00039435056,0.00072300254,0.0004151029],"domain_scores_gemma":[0.993637,0.0027758519,0.002064533,0.00042722342,0.0006653651,0.0004300221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179047,0.00030488012,0.003434036,0.00064847706,0.000036305017,0.000006556434,0.000294331,0.0003317714,0.00083770073],"category_scores_gemma":[0.0016594689,0.0001765429,0.0010912542,0.0007731916,0.00032280677,0.00018044654,0.00005968664,0.0005914538,0.000032770084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02495585,0.0031616848,0.6990369,0.000045737903,0.004218373,0.0012005515,0.00009314463,0.00017335136,0.0013408085,0.00003796743,0.00040054446,0.26533508],"study_design_scores_gemma":[0.040697675,0.025331365,0.9198405,0.0002706157,0.0037208956,0.00024490204,0.00003204127,0.00012718923,0.0016229716,0.00078456127,0.0071088937,0.00021834759],"about_ca_topic_score_codex":0.0002788009,"about_ca_topic_score_gemma":0.00024942763,"teacher_disagreement_score":0.26511672,"about_ca_system_score_codex":0.00041247156,"about_ca_system_score_gemma":0.0034743438,"threshold_uncertainty_score":0.9172236},"labels":[],"label_agreement":null},{"id":"W2479289770","doi":"10.1038/nrurol.2016.139","title":"Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; General surgery; Cancer; Internal medicine","score_opus":0.18072608766521844,"score_gpt":0.4701809526388338,"score_spread":0.2894548649736154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479289770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.1367008e-7,0.98006207,0.0010751882,0.0016387802,0.0012793796,0.014546955,0.00054244295,0.00009925175,0.0007557386],"genre_scores_gemma":[0.000022307515,0.9746402,0.0018868399,0.0024301654,0.002724179,0.015390215,0.0003487589,0.00020093261,0.0023563895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99554217,0.00053604,0.0015997235,0.0013185213,0.00026338326,0.00074014347],"domain_scores_gemma":[0.99507004,0.0023361144,0.0011313899,0.0008881553,0.00026216256,0.00031215703],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00083140907,0.0010050577,0.0059840376,0.0002628444,0.00015604185,0.000022985803,0.00040868865,0.0023318157,0.00026861898],"category_scores_gemma":[0.0017425932,0.00056516466,0.0024409841,0.000338008,0.00017431981,0.00010311438,0.00006679011,0.0011265954,0.000067307476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004132992,0.00008931372,0.000016113192,0.036884014,0.0010870812,0.000025727948,0.000010380287,1.25842385e-8,0.000005143448,0.000046984063,0.046640925,0.91478103],"study_design_scores_gemma":[0.0031179227,0.0010005393,0.000010358434,0.04387607,0.0074503636,0.0003877353,7.492475e-7,0.0000018577127,0.0000033210197,0.000029097075,0.943667,0.00045496618],"about_ca_topic_score_codex":0.000019660893,"about_ca_topic_score_gemma":0.000012558463,"teacher_disagreement_score":0.914326,"about_ca_system_score_codex":0.00043710487,"about_ca_system_score_gemma":0.0020056062,"threshold_uncertainty_score":0.99968},"labels":[],"label_agreement":null},{"id":"W2480427128","doi":"10.1158/1538-7445.am2016-128","title":"Abstract 128: Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; HRAS; Cancer research; PTEN; Bladder cancer; ARID1A; Cancer; KRAS; APOBEC; CDKN2A; Gene; Colorectal cancer; Mutation; Genetics; PI3K/AKT/mTOR pathway; Genome","score_opus":0.10124883430881362,"score_gpt":0.38550400945704344,"score_spread":0.28425517514822984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480427128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944382,0.000884844,0.000046790246,0.0012166115,0.00014102286,0.001411146,0.0013584533,0.000015732601,0.00048722167],"genre_scores_gemma":[0.99667037,0.0015380834,0.000017740007,0.00014379021,0.00020913899,0.00045104793,0.000048194124,0.00004613118,0.0008755174],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99715984,0.00020391306,0.00046769547,0.00053543394,0.0011189744,0.00051415653],"domain_scores_gemma":[0.99747723,0.0001616788,0.00024185184,0.0007508225,0.0012374375,0.00013099368],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023468732,0.00023404848,0.00062569376,0.00053985574,0.000114884526,0.000015609154,0.0003722788,0.0001318881,0.0012352554],"category_scores_gemma":[0.00008400504,0.00013691634,0.00037151,0.0016411702,0.00049203786,0.0001000453,0.0001461824,0.00026448138,0.000010168766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006404041,0.0001640246,0.03405564,0.00022692664,0.0021195586,0.000023282591,0.0007780459,0.000025171872,0.95793617,0.000029567513,0.00007884776,0.003922385],"study_design_scores_gemma":[0.0017216802,0.00020983217,0.6267866,0.0002734191,0.0008354654,0.000001404967,0.000087135566,0.000009642707,0.36875865,0.000014727725,0.001185971,0.000115484814],"about_ca_topic_score_codex":0.0045325775,"about_ca_topic_score_gemma":0.00037483577,"teacher_disagreement_score":0.59273094,"about_ca_system_score_codex":0.00045508228,"about_ca_system_score_gemma":0.0019311967,"threshold_uncertainty_score":0.9996778},"labels":[],"label_agreement":null},{"id":"W2483975375","doi":"10.1158/1538-7445.am2016-3798","title":"Abstract 3798: A glycan-binding malaria protein provides therapeutic access to cisplatin-resistant bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Cisplatin; Bladder cancer; Gemcitabine; Chemotherapy; Medicine; Cancer research; Cancer; Cystectomy; Oncology; Internal medicine; Immunology","score_opus":0.1485938238233176,"score_gpt":0.4497339109973408,"score_spread":0.3011400871740232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483975375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96714175,0.002169934,0.00006257983,0.02048082,0.00026785643,0.0042283465,0.000265523,0.00011719724,0.0052660047],"genre_scores_gemma":[0.9789569,0.00031665424,0.000078997036,0.0006277281,0.0005865867,0.004926816,0.0000055529886,0.00010908793,0.014391694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99620646,0.00012337045,0.00038604529,0.00081726315,0.0012927355,0.0011741412],"domain_scores_gemma":[0.9979812,0.00017130359,0.00008347801,0.0006614663,0.00053783634,0.00056469836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062249025,0.0003245239,0.00043862918,0.0004033632,0.00031783216,0.00020216484,0.00050596736,0.00015949647,0.007319044],"category_scores_gemma":[0.00014101021,0.00020148547,0.00012534246,0.0007955522,0.00021467492,0.00033849364,0.00020465213,0.0004530802,0.0003181458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041741384,0.00018033879,0.01619753,0.0003424717,0.0005389165,0.00014539874,0.00042272813,0.0000032355672,0.87686193,0.00032139706,0.0078115235,0.09300041],"study_design_scores_gemma":[0.008730034,0.0015847952,0.29401043,0.004914112,0.00024156165,0.000015781701,0.00028125173,0.000010275171,0.6077006,0.0010594823,0.08058454,0.0008671344],"about_ca_topic_score_codex":0.0058565917,"about_ca_topic_score_gemma":0.0018621456,"teacher_disagreement_score":0.2778129,"about_ca_system_score_codex":0.0017844673,"about_ca_system_score_gemma":0.0024064197,"threshold_uncertainty_score":0.9935884},"labels":[],"label_agreement":null},{"id":"W2484375749","doi":"10.1200/jco.2016.34.2_suppl.405","title":"Comprehensive characterization of 412 muscle invasive urothelial carcinomas: Final analysis of The Cancer Genome Atlas (TCGA) project.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Biology; KRAS; Gene; DNA methylation; APOBEC; CDKN2A; Germline mutation; Mutation; Genetics; Gene expression; Genome","score_opus":0.16875312405602524,"score_gpt":0.4365463415071847,"score_spread":0.26779321745115947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484375749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950359,0.00017991733,0.00011646346,0.0031557002,0.0006807621,0.00034564929,0.00015287618,0.0000030408044,0.00032970528],"genre_scores_gemma":[0.99672717,0.0012795839,0.00016660163,0.00083490106,0.0006603425,0.000009698893,0.000004910076,0.000013572365,0.00030322222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969947,0.00040534345,0.0018420701,0.00018795178,0.00039944606,0.00017050818],"domain_scores_gemma":[0.9952484,0.00089642406,0.002490046,0.00027118443,0.00096836535,0.00012563063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005161989,0.00013597091,0.0015774567,0.00021975876,0.000030265406,0.0000026066284,0.0002305019,0.00022183584,0.00030576665],"category_scores_gemma":[0.0006351097,0.00006616346,0.0008753254,0.00045496807,0.00033179266,0.00008409746,0.000066154294,0.00027298322,0.0000026686182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052685,0.0014871213,0.6113658,0.000087745524,0.005700221,0.000070040405,0.0005784301,0.000015344327,0.3311027,0.00003293068,0.00018014856,0.04411103],"study_design_scores_gemma":[0.0063439067,0.0042267633,0.96960735,0.0001303674,0.0042263838,0.000018657869,0.00006113292,0.000010349425,0.005713662,0.00002869475,0.009568164,0.000064566666],"about_ca_topic_score_codex":0.00019953054,"about_ca_topic_score_gemma":0.0001331144,"teacher_disagreement_score":0.35824156,"about_ca_system_score_codex":0.00016922795,"about_ca_system_score_gemma":0.0030084662,"threshold_uncertainty_score":0.53368896},"labels":[],"label_agreement":null},{"id":"W2488239967","doi":"10.1158/1538-7445.am2016-4243","title":"Abstract 4243: ChAcNLS-A14-B105, a novel fluorescence imaging agent for enhanced detection of muscle invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"BODIPY; Bladder cancer; Fluorescence; Chemistry; Intracellular; Biophysics; Cancer; Cancer research; Medicine; Molecular biology; Biochemistry; Biology; Internal medicine","score_opus":0.09028813708704128,"score_gpt":0.4038143285245093,"score_spread":0.31352619143746807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488239967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532224,0.0034753638,0.0033640238,0.002865003,0.00066752173,0.0026240214,0.00048892037,0.00007163053,0.0011213042],"genre_scores_gemma":[0.9931238,0.0023554955,0.00018254307,0.00017971371,0.00057499873,0.0021268055,0.0000067805026,0.000066327746,0.0013834768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749047,0.000040093968,0.0003606838,0.00060394837,0.00075304066,0.0007517774],"domain_scores_gemma":[0.99792856,0.00030728395,0.00012432344,0.00045795183,0.00095422764,0.00022766886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004206992,0.00022435914,0.00037144776,0.00026352372,0.00018309375,0.000023524932,0.00021490426,0.00009954826,0.0009532338],"category_scores_gemma":[0.0002736171,0.00015747784,0.00016575404,0.00039624763,0.0003073722,0.00018994628,0.00007971337,0.0002434863,0.000032691085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076703675,0.00016530238,0.00088374823,0.00027649518,0.00014762965,0.0000062436347,0.000394565,0.000002479986,0.8138668,0.000013749834,0.00089273206,0.18258324],"study_design_scores_gemma":[0.0046021966,0.00032007764,0.03430772,0.0010668184,0.00007696444,0.0000036953154,0.00020781215,0.000016919088,0.9551401,0.000105553605,0.0039750845,0.00017707326],"about_ca_topic_score_codex":0.0032371373,"about_ca_topic_score_gemma":0.0012899891,"teacher_disagreement_score":0.18240617,"about_ca_system_score_codex":0.0008512616,"about_ca_system_score_gemma":0.0011504053,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W2489345005","doi":"10.1200/jco.2014.32.15_suppl.4509","title":"Comprehensive molecular profiling of urothelial bladder cancer at the DNA, RNA, and protein levels: A TCGA project.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; ARID1A; Epigenetics; Chromatin remodeling; DNA methylation; Exome sequencing; Gene; Genetics; Gene expression; Mutation","score_opus":0.13915660953287382,"score_gpt":0.4589655985544102,"score_spread":0.3198089890215364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489345005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891022,0.0014205287,0.00022745316,0.0051544704,0.0004765613,0.00085843616,0.000017155342,0.000006524964,0.002736671],"genre_scores_gemma":[0.9924519,0.00024557114,0.002660725,0.0029549384,0.0009392001,0.00003974558,0.0000010787122,0.00002729523,0.00067951274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997144,0.0005546956,0.0014586234,0.00021255977,0.00040393934,0.00022617074],"domain_scores_gemma":[0.9970001,0.00076373725,0.0012338901,0.00021751599,0.00059858104,0.00018619598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011726359,0.00017098727,0.0012025841,0.000072910094,0.000058938065,0.000007510663,0.00014257268,0.00026005812,0.00012794163],"category_scores_gemma":[0.001003616,0.00009476451,0.0003387023,0.00010706337,0.00044064422,0.00005697631,0.00008890593,0.0006149347,0.000004923889],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028224776,0.0040487493,0.07622116,0.0007389807,0.006207985,0.0008401502,0.0017107716,0.00008454954,0.32973197,0.0011858458,0.005797248,0.5452078],"study_design_scores_gemma":[0.065517545,0.062519796,0.1888701,0.0012194176,0.0045338487,0.0012769947,0.00073249283,0.0005810325,0.24087925,0.002776193,0.43041268,0.00068064575],"about_ca_topic_score_codex":0.00012324087,"about_ca_topic_score_gemma":0.000038617938,"teacher_disagreement_score":0.5445272,"about_ca_system_score_codex":0.000103690814,"about_ca_system_score_gemma":0.0015737966,"threshold_uncertainty_score":0.38643846},"labels":[],"label_agreement":null},{"id":"W2489494679","doi":"10.1200/jco.2016.34.2_suppl.468","title":"Baseline neutrophil to lymphocyte ratio as a prognostic marker for patients with muscle-invasive bladder cancer being treated with neoadjuvant chemotherapy.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Bladder cancer; Neutrophil to lymphocyte ratio; Hazard ratio; Chemotherapy; Proportional hazards model; Oncology; Cystectomy; Stage (stratigraphy); Gastroenterology; Cancer; Lymphocyte; Confidence interval","score_opus":0.035582961019515746,"score_gpt":0.3781707328350752,"score_spread":0.34258777181555944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489494679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98270893,0.00014353801,0.0012375474,0.013623017,0.0003480919,0.0014317612,0.000038082384,0.000018188104,0.00045084802],"genre_scores_gemma":[0.98418057,0.0005837621,0.00394441,0.008949107,0.0011823549,0.00013799244,0.000007047969,0.0000690017,0.00094572984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973832,0.0001919321,0.001273263,0.00036075435,0.00041914798,0.00037174477],"domain_scores_gemma":[0.994977,0.001953994,0.0009368696,0.00022547042,0.001322796,0.0005838869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006370163,0.0002709433,0.0012913436,0.00012340487,0.000060734405,0.000011836782,0.0001263674,0.00021872156,0.00032866411],"category_scores_gemma":[0.0013376294,0.00012460705,0.0002665217,0.00017194533,0.0001402489,0.00013462466,0.000019315607,0.00021357574,0.000014560794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06601326,0.0026044294,0.5187912,0.000034158882,0.0018172932,0.00035795424,0.00012927562,0.000013297308,0.00035745354,0.000010380989,0.0016122988,0.40825897],"study_design_scores_gemma":[0.0835317,0.08644614,0.7903112,0.0009307427,0.001968456,0.00011768287,0.00003659624,0.00002052328,0.00082602125,0.00007128148,0.035480753,0.00025890474],"about_ca_topic_score_codex":0.00007313485,"about_ca_topic_score_gemma":0.00014959575,"teacher_disagreement_score":0.40800008,"about_ca_system_score_codex":0.0004050182,"about_ca_system_score_gemma":0.0035253214,"threshold_uncertainty_score":0.6253769},"labels":[],"label_agreement":null},{"id":"W2490020479","doi":"10.1016/j.jpurol.2016.05.046","title":"Outcomes of seromuscular bladder augmentation versus standard ileocystoplasty: A single institution experience over 14 years","year":2016,"lang":"en","type":"article","venue":"Journal of Pediatric Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Surgery; Bladder augmentation; Cystectomy; Urinary bladder; Urinary system; Perforation; Bladder cancer; Internal medicine; Cancer","score_opus":0.024056923523065973,"score_gpt":0.3037664005288566,"score_spread":0.27970947700579063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490020479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608886,0.0005028031,0.0015285048,0.00035908606,0.0012030218,0.00010979447,0.000014683264,0.000008009756,0.00018525565],"genre_scores_gemma":[0.9986736,0.000313245,0.00037021714,0.00012609444,0.0004394651,0.0000036386748,0.0000010433971,0.0000102368895,0.00006243915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989121,0.00004579951,0.00040344932,0.00011608611,0.00036824387,0.00015432718],"domain_scores_gemma":[0.99916863,0.00009570629,0.0003524006,0.00012099144,0.00016791411,0.00009437426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012667602,0.00010250423,0.00031392562,0.00020314552,0.00002199836,0.000004111588,0.000066405075,0.00009230967,0.00024018771],"category_scores_gemma":[0.00015587594,0.000066291665,0.00013956797,0.00013489355,0.000076074415,0.00016911693,0.000018687935,0.00008927989,0.000008554761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021983586,0.0011395719,0.9342613,0.0000386409,0.0017037052,0.0005436301,0.0023237187,0.000027502057,0.015203282,0.00017074714,0.002701213,0.019903075],"study_design_scores_gemma":[0.049693465,0.014723677,0.91921204,0.000013837962,0.0026904598,0.00025345857,0.00021207286,0.0000038762455,0.0046527293,0.00018856936,0.008133727,0.00022209364],"about_ca_topic_score_codex":0.000011140431,"about_ca_topic_score_gemma":0.0000070054025,"teacher_disagreement_score":0.027709879,"about_ca_system_score_codex":0.00014325145,"about_ca_system_score_gemma":0.00023000491,"threshold_uncertainty_score":0.27032956},"labels":[],"label_agreement":null},{"id":"W2494558159","doi":"10.1200/jco.2016.34.15_suppl.e16024","title":"Platinum retreatment in second line chemotherapy for metastatic urothelial carcinoma (UC): Assessing the concept of platinum sensitivity and predictors of survival.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Oxaliplatin; Internal medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Cisplatin; Nedaplatin; Oncology; Progression-free survival; Multivariate analysis; Confidence interval; Proportional hazards model; Gastroenterology; Surgery; Cancer; Urothelial carcinoma; Bladder cancer; Colorectal cancer","score_opus":0.09961161169306863,"score_gpt":0.4375837362689387,"score_spread":0.33797212457587006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494558159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422973,0.00032191098,0.00079521484,0.0030633335,0.000618709,0.00052039913,0.00009699445,0.0000029284877,0.00035075416],"genre_scores_gemma":[0.9968539,0.00013418947,0.0019918452,0.00032429112,0.0005051121,0.000006267084,0.0000018908684,0.000018660612,0.00016386856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969879,0.0005524429,0.0018189667,0.00017307406,0.00026888656,0.00019876736],"domain_scores_gemma":[0.9910911,0.0067023225,0.0015983788,0.00016683206,0.0003044743,0.00013693258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028746475,0.00015447305,0.0015991708,0.00008050219,0.00002649025,0.000003965859,0.00006779045,0.00017152919,0.0000870132],"category_scores_gemma":[0.0014229459,0.000074888354,0.00031040216,0.00008392759,0.00040290313,0.000092405855,0.000025448677,0.0002588324,2.8402354e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008946179,0.0022221634,0.8268534,0.0001152817,0.0014590312,0.00018272243,0.0010162875,0.000007093492,0.010772362,0.00009911312,0.00041551335,0.14791088],"study_design_scores_gemma":[0.045246944,0.019537436,0.9106112,0.00030577998,0.0007733037,0.0001696148,0.00039444782,0.00010128832,0.020167302,0.00047508985,0.0021128089,0.000104763676],"about_ca_topic_score_codex":0.000047942947,"about_ca_topic_score_gemma":0.00014420491,"teacher_disagreement_score":0.14780611,"about_ca_system_score_codex":0.00010860999,"about_ca_system_score_gemma":0.0011332469,"threshold_uncertainty_score":0.30538586},"labels":[],"label_agreement":null},{"id":"W2497409075","doi":"10.1200/jco.2015.33.15_suppl.tps4573","title":"A multicenter randomized phase II trial comparing nab-paclitaxel to paclitaxel in patients with advanced urothelial cancer progressing on or after a platinum containing regimen: NCIC Clinical Trials Group BL 12 (NCT02033993).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; Queen's University; Hôpital Notre-Dame; Baker Hughes (Canada); University Health Network","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Oncology; Hazard ratio; Clinical trial; Regimen; Randomized controlled trial; Prostate cancer; Paclitaxel; Cancer; Adverse effect; Confidence interval","score_opus":0.26525811093850715,"score_gpt":0.5433718220890612,"score_spread":0.27811371115055405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497409075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98590624,0.0003760734,0.00021378927,0.0031421357,0.0040179584,0.005681782,0.00003165655,0.000027534099,0.0006028348],"genre_scores_gemma":[0.9843017,0.00009712529,0.006616731,0.0048652613,0.0033575054,0.00049106026,0.0000104973,0.00007566301,0.00018447205],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98389393,0.0054834974,0.008125543,0.00068038574,0.0011203912,0.00069627276],"domain_scores_gemma":[0.98416764,0.008592826,0.004626297,0.0004101907,0.00077950675,0.0014235676],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021803891,0.0005236417,0.007778159,0.000348968,0.0000864429,0.000045587843,0.0002624602,0.0005845185,0.00016334839],"category_scores_gemma":[0.030342171,0.00029240773,0.0011722129,0.00026171523,0.00040548414,0.0003088464,0.00012336807,0.0017730095,0.000014049731],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79553187,0.015784055,0.07991455,0.000025434969,0.0012028175,0.00053563766,0.00084032293,0.000023718829,0.000004649277,0.0000040696227,0.00062641356,0.10550648],"study_design_scores_gemma":[0.7929991,0.18216608,0.014056664,0.0013550232,0.0014018815,0.000017480903,0.00024007322,0.00015670298,0.000009364867,0.000033993314,0.007300473,0.000263145],"about_ca_topic_score_codex":0.00007903972,"about_ca_topic_score_gemma":0.000339334,"teacher_disagreement_score":0.16638203,"about_ca_system_score_codex":0.00067107886,"about_ca_system_score_gemma":0.0033212462,"threshold_uncertainty_score":0.9999528},"labels":[],"label_agreement":null},{"id":"W2499103454","doi":"10.1016/j.clon.2016.07.007","title":"Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Internal medicine; Univariate analysis; Retrospective cohort study; Oncology; Lymphocyte; Chemotherapy; Urology; Gastroenterology; Cancer; Surgery; Multivariate analysis","score_opus":0.05593029139930578,"score_gpt":0.40222581408149705,"score_spread":0.34629552268219127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499103454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8872166,0.00027036123,0.0001465073,0.110955946,0.00034711097,0.00070470176,0.00010053789,0.000030442818,0.00022778935],"genre_scores_gemma":[0.9706336,0.0010056875,0.0003316223,0.025391428,0.0008668416,0.00017567672,0.000008417452,0.000032545733,0.0015541674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976539,0.00065104547,0.0006914795,0.00041603338,0.00023873981,0.0003487753],"domain_scores_gemma":[0.9908359,0.008259367,0.0002388253,0.00028566003,0.00014664196,0.00023361386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002436756,0.0001769517,0.0006445736,0.00007306654,0.00005813163,0.0000084288,0.00010348674,0.00034042582,0.00034889317],"category_scores_gemma":[0.0022754697,0.00009724957,0.000113377115,0.00016243196,0.00013053762,0.000036942543,0.000037421465,0.00020858177,0.000071692484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010460233,0.0004031605,0.53461236,0.000011194143,0.00041031043,0.00007565239,0.00034061878,0.0000054645466,0.0017448404,0.0000035582104,0.008753462,0.44317913],"study_design_scores_gemma":[0.019166624,0.0024294844,0.8682922,0.00012679516,0.00021680037,0.0000023558869,0.000030316627,0.0000381879,0.0005678157,0.00005726404,0.108950354,0.00012177078],"about_ca_topic_score_codex":0.0003685924,"about_ca_topic_score_gemma":0.0011093955,"teacher_disagreement_score":0.44305736,"about_ca_system_score_codex":0.001483784,"about_ca_system_score_gemma":0.0018276746,"threshold_uncertainty_score":0.39657223},"labels":[],"label_agreement":null},{"id":"W2499544841","doi":"10.1200/jco.2014.32.15_suppl.e15507","title":"Patterns of referral for peri-operative chemotherapy among patients with muscle-invasive bladder cancer (MIBC): A population-based study.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cystectomy; Referral; Bladder cancer; Chemotherapy; Population; Internal medicine; Cancer registry; Multivariate analysis; Cancer; Logistic regression; Oncology; Family medicine","score_opus":0.0716785728482256,"score_gpt":0.4398960107893673,"score_spread":0.3682174379411417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499544841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670184,0.000026150408,0.0005122942,0.0011666114,0.0004861524,0.00093368685,0.000034489618,0.0000059673657,0.00013279694],"genre_scores_gemma":[0.99589556,0.00002449105,0.0010490314,0.00215754,0.0006667855,0.000052463107,0.000014438694,0.0000318346,0.000107827655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751824,0.00029153982,0.0013987278,0.00021999217,0.00038080735,0.00019067457],"domain_scores_gemma":[0.996173,0.0010492486,0.0014049261,0.00018435808,0.0009676998,0.00022072667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068473344,0.00017705967,0.0013274677,0.00009031709,0.00004725234,0.000006549615,0.00011060524,0.00019394417,0.0002468127],"category_scores_gemma":[0.00061668723,0.00010729404,0.0003205813,0.00007592843,0.00006489655,0.00009353716,0.000011047981,0.00033536612,8.268327e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067145196,0.0039833314,0.95602626,0.000032874414,0.0008664453,0.000009835189,0.00040130442,0.00006490655,0.000010198544,0.0000046999776,0.00017018226,0.03171546],"study_design_scores_gemma":[0.03533534,0.04475346,0.9177055,0.00013679468,0.00073279487,0.0000013964562,0.00019963735,0.0000589794,0.00008246723,0.000023261064,0.0008728973,0.0000975151],"about_ca_topic_score_codex":0.00041691825,"about_ca_topic_score_gemma":0.0014031186,"teacher_disagreement_score":0.04077013,"about_ca_system_score_codex":0.00016645117,"about_ca_system_score_gemma":0.0010528964,"threshold_uncertainty_score":0.43753242},"labels":[],"label_agreement":null},{"id":"W2500755305","doi":"10.1200/jco.2016.67.9423","title":"Management Considerations After Cystectomy for Bladder Cancer","year":2016,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Radiation therapy; Randomized controlled trial; Stage (stratigraphy); Chemotherapy; Clinical trial; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.13253901663200732,"score_gpt":0.4801574624115642,"score_spread":0.3476184457795569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500755305","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005467845,0.0018455951,0.0004621476,0.97955775,0.0057613794,0.0010260702,0.00017167671,0.00001410957,0.010614475],"genre_scores_gemma":[0.0075003034,0.0021301748,0.005099719,0.92514,0.0395591,0.00034911663,0.000013837363,0.000076132594,0.020131618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625146,0.00024448257,0.0023742479,0.00031994455,0.00043192442,0.00037793376],"domain_scores_gemma":[0.9949866,0.0021461195,0.0016401521,0.0003001083,0.00070072425,0.00022632035],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008806467,0.00028073788,0.0020694076,0.00019232737,0.000046063207,0.000015663678,0.0001263958,0.0013100096,0.0024878564],"category_scores_gemma":[0.00041795356,0.00016591238,0.0011852646,0.000048022335,0.00019527618,0.00007164779,0.00004285527,0.0016221062,0.00005543523],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023306645,0.00024668782,0.00090679416,0.00016926738,0.0039407443,0.006636954,0.000019265479,2.5387249e-7,0.0000017751862,0.000023814644,0.92902213,0.05670167],"study_design_scores_gemma":[0.013453055,0.0054308563,0.0037290072,0.00048278703,0.0040747593,0.0004562861,0.0000072695443,9.4323804e-7,0.000011506689,0.0018333131,0.97035754,0.00016269475],"about_ca_topic_score_codex":0.000010798996,"about_ca_topic_score_gemma":0.000020723759,"teacher_disagreement_score":0.056538977,"about_ca_system_score_codex":0.00034462946,"about_ca_system_score_gemma":0.0024430633,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W2502507727","doi":"10.1200/jco.2015.33.15_suppl.4503","title":"First-line randomized phase II study of gemcitabine/cisplatin plus apatorsen or placebo in patients with advanced bladder cancer: The International Borealis-1 trial.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hôpital Notre-Dame; BC Cancer Agency","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Bladder cancer; Chemotherapy; Placebo; Clinical endpoint; Gastroenterology; Cancer; Oncology; Cisplatin; Surgery; Randomized controlled trial; Pathology","score_opus":0.12148471512901843,"score_gpt":0.47163188908456355,"score_spread":0.3501471739555451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502507727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909607,0.000147858,0.000044421602,0.0037685097,0.0017299743,0.0025662438,0.000037340447,0.0000060590796,0.00073889445],"genre_scores_gemma":[0.9974427,0.00029241084,0.00036118354,0.00063174346,0.0008317451,0.00011510851,0.000014007932,0.000022224118,0.00028883424],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952523,0.00063826144,0.0028566683,0.00021159528,0.0008462605,0.00019491864],"domain_scores_gemma":[0.99383837,0.0023859052,0.002309714,0.00023611549,0.00094848,0.00028139877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035820277,0.00019672235,0.002323483,0.00014980501,0.000039732404,0.000006161726,0.00027814758,0.00017315798,0.00017246786],"category_scores_gemma":[0.004956995,0.00008978754,0.0002585748,0.00020653773,0.00020955999,0.00013338272,0.00007702808,0.00067304954,0.0000014774616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9301344,0.014602253,0.022864254,0.0000073156375,0.0014285281,0.00012891747,0.0010954817,0.00042871758,6.086592e-7,0.0000069321354,0.0019666147,0.027335979],"study_design_scores_gemma":[0.87672293,0.10895766,0.0074138483,0.00009486702,0.0010151492,0.000012293973,0.0005400408,0.0002737119,0.0000063877324,0.000053224805,0.004826904,0.00008296041],"about_ca_topic_score_codex":0.00048419653,"about_ca_topic_score_gemma":0.0020273156,"teacher_disagreement_score":0.09435541,"about_ca_system_score_codex":0.0003296271,"about_ca_system_score_gemma":0.0028134654,"threshold_uncertainty_score":0.5934344},"labels":[],"label_agreement":null},{"id":"W2508667271","doi":"10.1016/j.eururo.2016.08.029","title":"Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Stage (stratigraphy); Urothelial carcinoma; Urothelial cancer; Carcinoma; Oncology; Internal medicine; Cancer research; Bladder cancer; Cancer","score_opus":0.03834620235858986,"score_gpt":0.27602998643502996,"score_spread":0.23768378407644009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508667271","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13645893,0.002334697,0.0006968388,0.69614935,0.0021825673,0.001580584,0.0068408404,0.00026629725,0.15348992],"genre_scores_gemma":[0.43760467,0.00010028891,0.000079554404,0.537707,0.0044945595,0.00001844161,0.0010452124,0.00017348281,0.018776817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971538,0.0006216365,0.000585653,0.000708113,0.00043369993,0.00049705093],"domain_scores_gemma":[0.9984551,0.00016958956,0.00027874397,0.0007719153,0.00021267161,0.00011199405],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113699905,0.00044214807,0.0011699096,0.0006947686,0.00005359115,0.000009614331,0.00028254476,0.0003731776,0.0035193297],"category_scores_gemma":[0.000018339942,0.0003392839,0.0007794163,0.00033711933,0.00033894982,0.00003389482,0.0000588564,0.00087424665,0.00039954967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029561599,0.00022865893,0.047029797,0.00036590025,0.018663673,0.012154278,0.0011070571,0.000016751284,0.0044447496,0.0001381344,0.9101708,0.0027240491],"study_design_scores_gemma":[0.0023045624,0.0011670317,0.15820323,0.00001744566,0.0064687207,0.000027917984,0.000006699972,0.0000069521075,0.000060856848,0.0000098300125,0.8314961,0.00023062516],"about_ca_topic_score_codex":0.00014473687,"about_ca_topic_score_gemma":0.00001269451,"teacher_disagreement_score":0.30114576,"about_ca_system_score_codex":0.0000646909,"about_ca_system_score_gemma":0.00015475255,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2511558499","doi":"10.1186/s12885-016-2748-5","title":"Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"Assistance publique-Hôpitaux de Paris; Bpifrance","keywords":"Bladder cancer; Medicine; DNA methylation; Oncology; Internal medicine; Methylation; Logistic regression; Area under the curve; Epigenetics; Multiplex; Cancer; Bioinformatics; Biology; Gene; Gene expression; Genetics","score_opus":0.012743157419488449,"score_gpt":0.26121023648892594,"score_spread":0.2484670790694375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511558499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956985,0.0003129891,0.00037257065,0.0003030104,0.00007199328,0.0022504167,0.00092540315,0.000019717503,0.000045397952],"genre_scores_gemma":[0.99609774,0.0007969384,0.0011153134,0.00008043523,0.00007903622,0.0013841095,0.000050787534,0.000052648753,0.00034296268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868256,0.00008812037,0.00025325958,0.0004687235,0.0002482589,0.00025909196],"domain_scores_gemma":[0.9986327,0.00049723487,0.00020288306,0.0002016248,0.0003498336,0.0001157223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117833995,0.00025062409,0.00044737483,0.000116626805,0.00007580738,0.000012521557,0.00003229385,0.000084972264,0.00012748358],"category_scores_gemma":[0.000068689435,0.00014212154,0.00003582872,0.00021142945,0.00017580939,0.00014970814,0.000021853979,0.00007668032,0.0000014528702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069321613,0.00042547355,0.97163916,0.00022363596,0.00023524968,0.000012854726,0.0008083235,0.000013606392,0.00027420733,0.000005738304,0.00011773913,0.019311829],"study_design_scores_gemma":[0.01870894,0.0040539717,0.97226655,0.0008595541,0.00018361851,0.000005172193,0.00012294088,0.000024232306,0.0034066937,0.00003299411,0.00010812126,0.00022718094],"about_ca_topic_score_codex":0.0011577817,"about_ca_topic_score_gemma":0.0048421263,"teacher_disagreement_score":0.019084647,"about_ca_system_score_codex":0.00017228951,"about_ca_system_score_gemma":0.00036749535,"threshold_uncertainty_score":0.5795548},"labels":[],"label_agreement":null},{"id":"W2512146270","doi":"10.1093/ajcp/aqw127","title":"Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cargill (Canada); McGill University; McGill University Health Centre","funders":"","keywords":"Urine cytology; Medicine; Cytology; Urothelial carcinoma; Urine; Medical diagnosis; Urinary system; Internal medicine; Pathology; Cancer; Bladder cancer; Cystoscopy","score_opus":0.06473458649125699,"score_gpt":0.4444638744136608,"score_spread":0.3797292879224038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512146270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651676,0.00017537961,0.0004409714,0.0021162494,0.00019831456,0.00030177197,0.000016585844,0.000004181448,0.0002297593],"genre_scores_gemma":[0.9984074,0.00026069413,0.00076301506,0.00020454312,0.0003156205,0.00001588597,0.0000014010609,0.0000149673615,0.000016440621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949157,0.00061875564,0.0037216858,0.00018804504,0.00018951316,0.00036627534],"domain_scores_gemma":[0.99042785,0.0023440055,0.00645222,0.00037621887,0.0003252191,0.00007446457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00520708,0.00014625434,0.0015160767,0.000113777336,0.000043462613,0.0000019170516,0.00025787216,0.00008013486,0.000026665592],"category_scores_gemma":[0.0020456177,0.000058819263,0.0005730765,0.00019352447,0.000766484,0.000042677366,0.00005516502,0.00030885614,0.0000010536417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002307022,0.00025540066,0.9336991,0.00005111831,0.0002825487,0.0001949191,0.00024530443,0.000004365008,0.0018867408,0.000049205613,0.000096221505,0.0609281],"study_design_scores_gemma":[0.0048535513,0.019719452,0.9673871,0.00018164207,0.00034674854,0.00542588,0.0007170297,0.00002481422,0.0009092208,0.00005153745,0.0003162217,0.00006681656],"about_ca_topic_score_codex":0.00010977723,"about_ca_topic_score_gemma":0.000016787095,"teacher_disagreement_score":0.060861282,"about_ca_system_score_codex":0.00005161895,"about_ca_system_score_gemma":0.00036089867,"threshold_uncertainty_score":0.28241423},"labels":[],"label_agreement":null},{"id":"W2512650232","doi":"10.1111/iju.13193","title":"Recent progress with next‐generation biomarkers in muscle‐invasive bladder cancer","year":2016,"lang":"en","type":"review","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Liquid biopsy; Pathological; Biopsy; Disease; Cancer; Muscle biopsy; Oncology; Bioinformatics; Pathology; Internal medicine","score_opus":0.07474037459572484,"score_gpt":0.38041294568479483,"score_spread":0.30567257108907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512650232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003201383,0.99369264,0.000027879498,0.0034381247,0.0017303856,0.0004087134,0.000050236256,0.0000064218034,0.00032546418],"genre_scores_gemma":[0.0010713194,0.9963817,0.00014414654,0.00047696225,0.0016498799,0.00008245392,0.000042254695,0.000042721458,0.0001085566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981986,0.00014436933,0.0007333206,0.00024887064,0.00046938244,0.00020545498],"domain_scores_gemma":[0.9981923,0.00010271604,0.0008060665,0.00013379619,0.0006529222,0.00011218787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017003433,0.0002730727,0.0009171605,0.00057262176,0.000015624479,0.000025766527,0.00025718322,0.00022448256,0.0006527062],"category_scores_gemma":[0.00006371771,0.00015484849,0.00023520917,0.00014404573,0.00011589446,0.00013244807,0.00003408437,0.0003214786,0.000021834981],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041686997,0.00018585025,0.0004980488,0.00017394341,0.0035407718,0.0011400189,0.000043281507,0.0000012766853,0.00001154384,0.000019168252,0.0011304382,0.9928388],"study_design_scores_gemma":[0.0025793365,0.0008672483,0.0003116175,0.004546996,0.0010371689,0.0020592522,0.000006016143,0.0000023916396,0.000010499313,0.000023145938,0.98840976,0.00014656474],"about_ca_topic_score_codex":0.000018367573,"about_ca_topic_score_gemma":0.00012262914,"teacher_disagreement_score":0.99269223,"about_ca_system_score_codex":0.00055521925,"about_ca_system_score_gemma":0.001775472,"threshold_uncertainty_score":0.71466756},"labels":[],"label_agreement":null},{"id":"W2513147643","doi":"10.1007/s11626-016-0085-2","title":"Hypoxia-increased expression of genes involved in inflammation, dedifferentiation, pro-fibrosis, and extracellular matrix remodeling of human bladder smooth muscle cells","year":2016,"lang":"en","type":"article","venue":"In Vitro Cellular & Developmental Biology - Animal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Urology Foundation","keywords":"Fibronectin; Extracellular matrix; CTGF; Inflammation; Fibrosis; SMAD; Desmin; Hypoxia (environmental); Molecular biology; Downregulation and upregulation; Biology; Cytokine; Transforming growth factor; Cell biology; Endocrinology; Chemistry; Internal medicine; Vimentin; Medicine; Immunology; Growth factor; Gene; Immunohistochemistry; Biochemistry","score_opus":0.018875754338752264,"score_gpt":0.26120261628455216,"score_spread":0.2423268619457999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513147643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965702,0.0023379447,0.00029376146,0.000053311756,0.000050544622,0.00059317466,0.000036415197,0.000021382395,0.00004324106],"genre_scores_gemma":[0.99346817,0.00017157696,0.0060394835,0.000010237688,0.00004689688,0.000047920537,0.00014222883,0.000027574446,0.000045930097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998143,0.00013120845,0.00081961026,0.00042222944,0.00017840299,0.0003055513],"domain_scores_gemma":[0.99934,0.00006369906,0.00024779743,0.0001678281,0.00009029738,0.00009036402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026470263,0.00025146402,0.00050890434,0.00030928466,0.000052396666,0.0000058188357,0.00010665384,0.0002341999,0.00009215828],"category_scores_gemma":[0.000027615717,0.00018914035,0.00006637624,0.00017465334,0.00017573561,0.00011830282,0.00009187803,0.00010410587,0.000003991359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006411996,0.0001875781,0.15847859,0.00009722105,0.000029965979,0.000009299513,0.00036930272,4.319551e-7,0.83808446,0.000027419443,0.0000051121688,0.0020694342],"study_design_scores_gemma":[0.0036696352,0.0002440624,0.13034774,0.0002421571,0.00004044097,0.0000024342205,0.00017309486,0.000042668107,0.8648203,0.0001764659,0.00007106014,0.00016994927],"about_ca_topic_score_codex":0.00027824056,"about_ca_topic_score_gemma":0.00005481982,"teacher_disagreement_score":0.028130835,"about_ca_system_score_codex":0.00013354603,"about_ca_system_score_gemma":0.00016143305,"threshold_uncertainty_score":0.771292},"labels":[],"label_agreement":null},{"id":"W2515715601","doi":"10.3390/biom6030037","title":"An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer","year":2016,"lang":"en","type":"article","venue":"Biomolecules","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"Association Française d'Urologie; Oesterreichische Nationalbank","keywords":"Bladder cancer; Cisplatin; Decitabine; Medicine; Chemotherapy; Oncology; DNA methylation; Cancer research; Cancer; Epigenetics; Internal medicine; Cystectomy; Biomarker; Biology; Gene; Gene expression","score_opus":0.01716130599233783,"score_gpt":0.31012636423725254,"score_spread":0.2929650582449147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515715601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871234,0.00030321116,0.0058705476,0.0048889653,0.00009677041,0.00089644117,0.000062853396,0.00006340035,0.00069437124],"genre_scores_gemma":[0.9906889,0.00003106367,0.005050878,0.002840342,0.00014596879,0.00024132966,0.0000048145193,0.000056778885,0.000939925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986395,0.0000742042,0.00022760006,0.00048886676,0.00018634276,0.00038348738],"domain_scores_gemma":[0.9991548,0.000029601228,0.00003597568,0.00041417126,0.000044657034,0.00032079677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019717538,0.00020734117,0.00026696263,0.00023440298,0.000039059254,0.00002093639,0.0001382886,0.000080885206,0.0001060622],"category_scores_gemma":[0.000037778096,0.00013811736,0.000056796518,0.00026553584,0.000040755516,0.000047391753,0.000030026873,0.000049977676,0.0000820796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003790753,0.00024596867,0.003624449,0.000010472895,0.00003794338,0.000024768162,0.00089485495,0.000004150083,0.8138487,0.000023288456,0.000214966,0.17727971],"study_design_scores_gemma":[0.01061552,0.002507813,0.35197383,0.00028303295,0.000079072764,0.000036274792,0.00038055677,0.00010508454,0.62168515,0.000060809783,0.011609824,0.0006630412],"about_ca_topic_score_codex":0.0012360163,"about_ca_topic_score_gemma":0.00020279564,"teacher_disagreement_score":0.3483494,"about_ca_system_score_codex":0.0003064991,"about_ca_system_score_gemma":0.00022791928,"threshold_uncertainty_score":0.5632263},"labels":[],"label_agreement":null},{"id":"W2518030659","doi":"10.1111/his.13063","title":"Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of <i><scp>CDKN</scp>2A</i> deletions in the <i><scp>FGFR</scp>3</i> pathway","year":2016,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"CDKN2A; Biology; Cancer research; Immunohistochemistry; Fluorescence in situ hybridization; Pathology; Carcinoma; Carcinogenesis; In situ hybridization; Mutation; Cancer; Medicine; Gene; Gene expression; Genetics","score_opus":0.03746038239340448,"score_gpt":0.2866700539032492,"score_spread":0.2492096715098447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518030659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994969,0.0021333194,0.00043024946,0.00019426187,0.00009503356,0.0010674399,0.0005389053,0.000016957056,0.00055482215],"genre_scores_gemma":[0.99856186,0.00013195616,0.0002094566,0.00045510568,0.000064747044,0.00025053506,0.000028111755,0.000037788315,0.00026042215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975429,0.0004470449,0.0006606669,0.00049978273,0.00043032225,0.0004192507],"domain_scores_gemma":[0.99731374,0.0007661782,0.00052457355,0.0009909978,0.00030450334,0.00010001619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050782424,0.00028085406,0.0008561825,0.00031218547,0.000091753194,0.000004948884,0.00041115726,0.00017439816,0.00000931104],"category_scores_gemma":[0.00032390913,0.00014576042,0.00042208814,0.0007892528,0.00069327356,0.00012181551,0.00006255345,0.00015458636,0.0000018661358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001488782,0.00061195693,0.72255236,0.00006719759,0.0002856931,0.00003243767,0.005550639,0.000017759516,0.26972458,0.00024592044,0.00018951343,0.00057304476],"study_design_scores_gemma":[0.0024997585,0.003385196,0.851534,0.00018426894,0.0030732797,0.00009058779,0.0009840077,0.000020677551,0.13626042,0.00025794303,0.0016486289,0.00006123055],"about_ca_topic_score_codex":0.00058603677,"about_ca_topic_score_gemma":0.0010413078,"teacher_disagreement_score":0.13346416,"about_ca_system_score_codex":0.00009209434,"about_ca_system_score_gemma":0.0003739855,"threshold_uncertainty_score":0.59439373},"labels":[],"label_agreement":null},{"id":"W2518047113","doi":"10.5489/cuaj.3874","title":"Effect of contrast media on urinary cytopathology specimens","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urine cytology; Cytology; Urine; Urinary system; Medicine; Urothelial carcinoma; Bladder cancer; Cytopathology; Urinary bladder; Pathology; Urology; Saline; Cancer; Internal medicine","score_opus":0.00964977200799651,"score_gpt":0.2450301616237697,"score_spread":0.23538038961577318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518047113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759925,0.00012673326,0.000017773511,0.014822186,0.00044312564,0.00016912355,0.00008842811,0.000014118705,0.008325987],"genre_scores_gemma":[0.99729764,0.000063953565,0.00001740219,0.0016620817,0.0005149861,0.0000058941328,0.000004364545,0.0000091421325,0.00042453123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879,0.00026039,0.00023218099,0.00013705362,0.00024062938,0.0003396957],"domain_scores_gemma":[0.99858207,0.00056345866,0.00015964582,0.00008950932,0.000105604675,0.00049972767],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051750627,0.00011533135,0.00032496586,0.00013001925,0.000075244614,0.000007615611,0.000066112494,0.00018525955,0.001332458],"category_scores_gemma":[0.00089497614,0.00006207601,0.000128336,0.000075111704,0.000044997294,0.000032876116,0.000005816247,0.00022367307,0.00012684298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008932774,0.00010534696,0.97022474,0.000004954344,0.00015357594,0.0007345236,0.00006364334,5.030205e-7,0.0026213385,0.0003246679,0.0054366775,0.019436754],"study_design_scores_gemma":[0.0045649083,0.007244678,0.97129333,0.000034367404,0.0001383401,0.00058727514,0.0000056907706,9.2509924e-7,0.0017946665,0.00039870283,0.01385336,0.000083731145],"about_ca_topic_score_codex":0.00009669709,"about_ca_topic_score_gemma":0.00007545787,"teacher_disagreement_score":0.02130512,"about_ca_system_score_codex":0.00077542546,"about_ca_system_score_gemma":0.00024004537,"threshold_uncertainty_score":0.99958044},"labels":[],"label_agreement":null},{"id":"W2519041701","doi":"10.1016/j.urolonc.2016.05.030","title":"Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urodynamic testing; Cystoscopy; Context (archaeology); Microhematuria; Urine cytology; Bladder cancer; Medical physics; Intensive care medicine; Gynecology; Cancer; Pathology; Internal medicine; Alternative medicine","score_opus":0.1876702843046566,"score_gpt":0.5009867709406035,"score_spread":0.3133164866359469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519041701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004362235,0.98916435,0.00007776662,0.0076035345,0.000496245,0.001380671,0.00046409183,0.000056442575,0.0007132789],"genre_scores_gemma":[0.0000031167115,0.95101523,0.045206,0.0024688302,0.0003273793,0.00038142558,0.00043158105,0.00003730918,0.00012909691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681026,0.0005558136,0.0013033086,0.0006764057,0.00027447898,0.00037975295],"domain_scores_gemma":[0.997264,0.00076150673,0.00057615957,0.0005186177,0.00041047507,0.00046921807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006840214,0.0005362878,0.002506353,0.00021834325,0.00013735691,0.000012232937,0.00017568318,0.00048494778,0.00033164443],"category_scores_gemma":[0.0008167753,0.0003342205,0.00037857276,0.00026067233,0.000942683,0.000046705016,0.00005907131,0.00056363264,0.00003214027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006833926,0.001138339,0.0009788838,0.124262765,0.0003821337,0.0002663453,0.000023547283,1.5264926e-7,0.000015633306,0.006928544,0.05539944,0.81053585],"study_design_scores_gemma":[0.00059071387,0.0020109569,0.0000051929906,0.09667398,0.004350796,0.0006012275,0.0000046437776,0.000013417113,0.000004238331,0.0009657667,0.89452344,0.00025564164],"about_ca_topic_score_codex":0.000010843755,"about_ca_topic_score_gemma":0.0000040829214,"teacher_disagreement_score":0.83912396,"about_ca_system_score_codex":0.00025463867,"about_ca_system_score_gemma":0.004194325,"threshold_uncertainty_score":0.999911},"labels":[],"label_agreement":null},{"id":"W2521286539","doi":"10.1016/j.juro.2016.09.078","title":"Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nomogram; Urothelial carcinoma; General surgery; Cancer; Bladder cancer; Internal medicine","score_opus":0.01336184664722176,"score_gpt":0.2510892320767383,"score_spread":0.23772738542951652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521286539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588306,0.0001513368,0.0002588276,0.012607342,0.0003787325,0.0005104608,0.00006007361,0.0000057594243,0.00014443962],"genre_scores_gemma":[0.9983917,0.000033798922,0.00022974488,0.0008673901,0.000231408,0.000010580114,0.000003319243,0.000028086426,0.00020400369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988785,0.00017274966,0.00032639276,0.00011735562,0.00023831398,0.00026671548],"domain_scores_gemma":[0.99897164,0.00029840553,0.00018560587,0.00024709944,0.00020388667,0.00009336984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031629668,0.00015345323,0.00037987417,0.000113907445,0.000050998355,0.0000045962256,0.00019772272,0.00008518077,0.000073350755],"category_scores_gemma":[0.00011110878,0.00006437365,0.000090845264,0.00007928762,0.00013201377,0.00009196468,0.000022662989,0.00020817705,0.00000471379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027943749,0.0011783894,0.96203864,0.000009737098,0.00029196483,0.00007169766,0.0009303592,0.000008662746,0.001219638,0.000294391,0.00087671157,0.0051360554],"study_design_scores_gemma":[0.030043248,0.016229862,0.94952816,0.000027267915,0.00034467128,0.00019535274,0.000046505138,0.0000017297383,0.0007616726,0.0007517715,0.001974356,0.00009539128],"about_ca_topic_score_codex":0.000077273166,"about_ca_topic_score_gemma":0.00005222893,"teacher_disagreement_score":0.015051474,"about_ca_system_score_codex":0.000083759805,"about_ca_system_score_gemma":0.00017493623,"threshold_uncertainty_score":0.2625081},"labels":[],"label_agreement":null},{"id":"W2521353679","doi":"10.1101/075705","title":"Assessing Prediction Performance of Neoadjuvant Chemotherapy Response in Bladder Cancer","year":2016,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bladder cancer; Chemotherapy; Medicine; Complete response; Oncology; Neoadjuvant therapy; Internal medicine; Cancer; Breast cancer","score_opus":0.020229579468968036,"score_gpt":0.2777180495227317,"score_spread":0.2574884700537637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521353679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951384,0.0017631596,0.000152921,0.00065868313,0.0008983831,0.0009356417,0.0002662442,0.0001562115,0.000030347594],"genre_scores_gemma":[0.9966283,0.0014223241,0.0007324058,0.00025837627,0.0004674561,0.00033401191,3.192305e-7,0.00013459694,0.000022243166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974666,0.00014644569,0.000666393,0.0007699336,0.00047666027,0.0004739343],"domain_scores_gemma":[0.99801016,0.000064022905,0.0004071533,0.00094465597,0.0003808022,0.00019321985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060601387,0.0004833186,0.0007908172,0.00040474883,0.000062897845,0.000054486103,0.00021266907,0.0004984716,0.00016386928],"category_scores_gemma":[0.00007573666,0.00040798646,0.00015570274,0.00037214544,0.00013560403,0.00024712787,0.000119768796,0.00054508616,0.000013504267],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030957954,0.00035540995,0.26690707,0.0006162955,0.0003651721,0.00004882367,0.000038055507,0.000051505438,0.7283037,0.000007807144,0.00013620668,0.000074205134],"study_design_scores_gemma":[0.0027278531,0.00026356446,0.68733805,0.0026098632,0.00015360133,3.9280852e-8,0.000002638251,0.00030294296,0.30571118,6.179231e-7,0.000615102,0.00027453352],"about_ca_topic_score_codex":0.000107242464,"about_ca_topic_score_gemma":0.0000017952335,"teacher_disagreement_score":0.42259246,"about_ca_system_score_codex":0.0007692711,"about_ca_system_score_gemma":0.0018673048,"threshold_uncertainty_score":0.9998372},"labels":[],"label_agreement":null},{"id":"W2521599253","doi":"10.1016/j.urolonc.2016.07.006","title":"The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Interquartile range; Oncology; Bladder cancer; Internal medicine; Lymph node; Retrospective cohort study; Immunohistochemistry; Cancer","score_opus":0.015134288671178974,"score_gpt":0.306970386741322,"score_spread":0.291836098070143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521599253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932255,0.00035204276,0.0000055443143,0.0041518714,0.000115907504,0.00061597105,0.00010195467,0.000016683045,0.001414502],"genre_scores_gemma":[0.9968197,0.0007395281,0.0009443382,0.00076652993,0.000032911877,0.00018792796,0.000011943941,0.000011029716,0.00048608743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988806,0.00016196133,0.00026079026,0.00023655128,0.00020204186,0.00025803613],"domain_scores_gemma":[0.9975809,0.0017459993,0.00021941704,0.00018935975,0.00010291525,0.00016143736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015384374,0.00018133015,0.0004620827,0.00005792216,0.00013357954,0.000003833744,0.00007627675,0.00014316602,0.00009923186],"category_scores_gemma":[0.0003127,0.00006907225,0.000060672555,0.00012775407,0.0011969538,0.000042128646,0.000029267925,0.00013563847,0.0000046824225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014182671,0.00020281559,0.9862239,0.000018355711,0.00026811447,0.00001153152,0.000094925614,0.000004154746,0.00014185646,0.0007303796,0.0008631083,0.010022606],"study_design_scores_gemma":[0.006017852,0.03892154,0.84206516,0.00010606856,0.00064610667,0.000007891221,0.000046083922,0.0000021217159,0.005163135,0.0007754288,0.10612892,0.00011969859],"about_ca_topic_score_codex":0.00009913211,"about_ca_topic_score_gemma":0.000113890135,"teacher_disagreement_score":0.14415874,"about_ca_system_score_codex":0.00012088246,"about_ca_system_score_gemma":0.00035201327,"threshold_uncertainty_score":0.44102263},"labels":[],"label_agreement":null},{"id":"W2523653648","doi":"10.1016/j.urolonc.2016.03.004","title":"Taking the next step—Advancing bladder cancer management","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.04637663941155458,"score_gpt":0.3391658116760182,"score_spread":0.29278917226446366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523653648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8263593,0.0060936217,0.001322217,0.11889823,0.00076294935,0.0011846465,0.000037370075,0.00017013216,0.045171596],"genre_scores_gemma":[0.89109737,0.010049274,0.055357445,0.030150397,0.0007081032,0.00086107774,0.000014854264,0.000047147092,0.01171436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998918,0.00007261833,0.00020690887,0.00031939603,0.00014339807,0.00033967497],"domain_scores_gemma":[0.9992368,0.00019175265,0.00012844411,0.00022273984,0.000042310432,0.00017790448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019196085,0.00017230124,0.00022776135,0.00007296499,0.00032063742,0.00001994506,0.00009748816,0.00010961343,0.0007576059],"category_scores_gemma":[0.000048808306,0.0000864731,0.00005251892,0.00017049369,0.00051313476,0.00011548043,0.000060807157,0.0001576294,0.000039164457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027435186,0.0002711466,0.5399074,0.00006160228,0.0006658958,0.00038684523,0.00070427294,0.000021456772,0.0027593446,0.022454266,0.03662281,0.3958706],"study_design_scores_gemma":[0.0014188326,0.00076485635,0.01696425,0.000109851135,0.0005638867,0.00020008687,0.00031620407,0.00007238404,0.00039454116,0.0033493703,0.9757113,0.00013445459],"about_ca_topic_score_codex":0.00011705679,"about_ca_topic_score_gemma":0.00009766463,"teacher_disagreement_score":0.93908846,"about_ca_system_score_codex":0.00018046885,"about_ca_system_score_gemma":0.00018050132,"threshold_uncertainty_score":0.82952535},"labels":[],"label_agreement":null},{"id":"W2524386165","doi":"10.1186/s13104-016-2256-3","title":"Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts","year":2016,"lang":"en","type":"article","venue":"BMC Research Notes","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Hilfe für krebskranke Kinder Frankfurt; Frankfurter Stiftung für krebskranke Kinder","keywords":"Dasatinib; Gemcitabine; Medicine; Bladder cancer; Oncology; Cancer research; Internal medicine; Cabozantinib; Cancer; Tyrosine kinase; Receptor","score_opus":0.13085914758602704,"score_gpt":0.4209566270351765,"score_spread":0.29009747944914943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524386165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879746,0.0018353019,0.00008531217,0.0040484653,0.00020251998,0.0010510732,0.00006640675,0.000066105786,0.0046702353],"genre_scores_gemma":[0.99445474,0.00067577726,0.0005564377,0.00020331655,0.00055273017,0.00065468857,0.000006097935,0.00004176276,0.0028544352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971475,0.00024005478,0.0003464415,0.00053725345,0.0009099611,0.0008187761],"domain_scores_gemma":[0.9981243,0.0008252201,0.000051010644,0.00039596963,0.00034303748,0.00026047137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000657476,0.0002124141,0.00036702066,0.00036403845,0.00012364835,0.000039321676,0.00021007532,0.000080496815,0.0014610733],"category_scores_gemma":[0.0010732608,0.00012602855,0.00010198844,0.00062296307,0.00029179995,0.00016457816,0.000097895,0.0002631454,0.00018564878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016980832,0.00048782746,0.8599271,0.00032350444,0.00013655373,0.00024053047,0.00040302586,4.4997677e-7,0.12194721,0.00067768164,0.0019983957,0.012159617],"study_design_scores_gemma":[0.00606566,0.00092109595,0.7646465,0.00092905096,0.00004424216,0.000012112716,0.00015298693,0.000010418626,0.21808697,0.0014223688,0.007418331,0.0002903051],"about_ca_topic_score_codex":0.004177829,"about_ca_topic_score_gemma":0.0050440244,"teacher_disagreement_score":0.096139774,"about_ca_system_score_codex":0.00026343047,"about_ca_system_score_gemma":0.0007789559,"threshold_uncertainty_score":0.9994517},"labels":[],"label_agreement":null},{"id":"W2525374711","doi":"10.21037/tau.2016.08.18","title":"Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?","year":2016,"lang":"en","type":"review","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Cystectomy; Radiation therapy; Lymphadenectomy; Bladder cancer; Oncology; Adjuvant; Lymph node; Internal medicine; Dissection (medical); Nomogram; Cancer; Surgery","score_opus":0.035508189597900815,"score_gpt":0.3266622605219112,"score_spread":0.2911540709240104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525374711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005460906,0.9884633,0.00067147275,0.0059807654,0.0002500619,0.0019389569,0.0018861997,0.000054011514,0.00020913049],"genre_scores_gemma":[0.00032746696,0.9927785,0.000824797,0.003109571,0.0006197582,0.0010141265,0.0002991081,0.0000563889,0.0009702759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794436,0.00025904694,0.00050603977,0.0007570597,0.000101981874,0.00043148987],"domain_scores_gemma":[0.99826604,0.0010530234,0.00017464694,0.00021091843,0.00008010881,0.000215269],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019307982,0.00044277238,0.0018283365,0.00019265487,0.00015110707,0.0000066236694,0.000097751414,0.00081173243,0.0033897047],"category_scores_gemma":[0.00004702662,0.0002831566,0.0003459155,0.00009157245,0.00024782488,0.00003602893,0.000016380425,0.00030669343,0.00016092992],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008388729,0.000101136946,0.00022897586,0.0005106123,0.0010836094,0.000055354813,0.00007479462,0.0000024124076,0.000010347809,0.00023077193,0.0016496861,0.99521345],"study_design_scores_gemma":[0.0036369755,0.0027903006,0.001876993,0.00031109093,0.0023976522,0.0005470683,6.8264245e-7,0.000006968214,0.0000015991624,0.002767256,0.98535603,0.00030740572],"about_ca_topic_score_codex":0.000025549783,"about_ca_topic_score_gemma":0.00004027241,"teacher_disagreement_score":0.994906,"about_ca_system_score_codex":0.000035660716,"about_ca_system_score_gemma":0.00048813637,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W2529206793","doi":"10.1016/j.eururo.2016.09.042","title":"Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; St. Thomas Hospital","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Urothelium; Metastatic Urothelial Carcinoma; Oncology; Chemotherapy; Urothelial carcinoma; Urothelial cancer; Vinblastine; Retrospective cohort study; Internal medicine; Bladder cancer; Urology; Cancer; Urinary bladder","score_opus":0.014713076496097545,"score_gpt":0.24209026157429,"score_spread":0.22737718507819246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529206793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966165,0.000022467771,0.00027469214,0.00047216238,0.00032321006,0.001263775,0.0003975787,0.000017342798,0.0006122624],"genre_scores_gemma":[0.99943864,0.000009445084,0.00011856125,0.00019155329,0.00006073276,0.000041997693,0.00001575301,0.000056603858,0.000066704146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805075,0.00036641755,0.00056329765,0.00036413028,0.00045279955,0.00020259226],"domain_scores_gemma":[0.9985218,0.00019405098,0.0005036687,0.00040591558,0.00032656398,0.000048010283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023604151,0.00022038732,0.0004954314,0.000177502,0.000031593376,0.0000027186745,0.00022097708,0.000035761546,0.00020068952],"category_scores_gemma":[0.00017453318,0.0001289444,0.000094122435,0.00022139934,0.00018568595,0.000058488833,0.000044291395,0.00014056513,0.0000014839835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007074245,0.0019273607,0.9847488,0.00004029764,0.00026666926,0.000008194672,0.000592023,0.00085481536,0.003047177,0.000005383874,0.000011720743,0.0014233607],"study_design_scores_gemma":[0.036278885,0.006659235,0.951113,0.00015164785,0.00016791334,7.7335056e-7,0.000034704593,0.00010167638,0.005341792,0.000011580884,0.000048302016,0.00009051653],"about_ca_topic_score_codex":0.00038204968,"about_ca_topic_score_gemma":0.00065494655,"teacher_disagreement_score":0.033635776,"about_ca_system_score_codex":0.00015288324,"about_ca_system_score_gemma":0.00021252711,"threshold_uncertainty_score":0.52582},"labels":[],"label_agreement":null},{"id":"W2529608586","doi":"10.1016/j.eururo.2016.09.035","title":"Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Urothelium; Cystectomy; Urology; Bladder cancer; Prostatic urethra; Carcinoma in situ; Metastasis; Urethra; Upper urinary tract; Radiation therapy; Chemotherapy; Ureter; Carcinoma; Urinary bladder; Urinary system; Oncology; Internal medicine; Prostate; Cancer","score_opus":0.026846812147496613,"score_gpt":0.2948770115014079,"score_spread":0.26803019935391126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529608586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022330887,0.9754303,0.000006340515,0.0019566722,0.00043116728,0.0047047106,0.00007753824,0.000035379788,0.017355626],"genre_scores_gemma":[0.0002313762,0.98821396,0.0000033738168,0.0073481416,0.00029731347,0.00037700133,0.0000059840595,0.0001343552,0.0033885061],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99365175,0.004014448,0.001150905,0.00046481565,0.00037216736,0.00034591428],"domain_scores_gemma":[0.9967036,0.0005730948,0.0007106627,0.0018506383,0.00006186636,0.0001001266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00103587,0.00050878245,0.0027053242,0.00007726932,0.00006361739,0.000007695799,0.00066924695,0.00012864781,0.00052253413],"category_scores_gemma":[0.00062278437,0.00016493889,0.0010871271,0.00021384237,0.00031153773,0.000012049879,0.00019012144,0.00054891343,0.0020533993],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093727474,0.00012663801,0.000003958359,0.9618714,0.0013305583,0.00038905637,0.000047599362,8.132614e-9,0.0000012274143,0.00031915566,0.004698546,0.031118168],"study_design_scores_gemma":[0.00030523146,0.00025074353,0.000014441885,0.3836419,0.0048542954,0.0004964181,6.0332763e-7,4.8042043e-8,9.531472e-7,0.0000062338454,0.6103213,0.00010785076],"about_ca_topic_score_codex":0.0000022055178,"about_ca_topic_score_gemma":5.279975e-7,"teacher_disagreement_score":0.6056227,"about_ca_system_score_codex":0.00007431509,"about_ca_system_score_gemma":0.00020935108,"threshold_uncertainty_score":0.9987236},"labels":[],"label_agreement":null},{"id":"W2530356958","doi":"10.5489/cuaj.3568","title":"Administration of Mycobacterium phlei cell wall-nucleic acid complex in the immediate postoperative period for the treatment of nonmuscle- invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Surgery; Adverse effect; Biopsy; Urinary system; Cancer; Internal medicine","score_opus":0.02878783423870328,"score_gpt":0.27280418944269524,"score_spread":0.24401635520399195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530356958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93081665,0.00048253624,0.000022228545,0.0670461,0.0001740743,0.0007592626,0.00043423628,0.0000032519197,0.00026166497],"genre_scores_gemma":[0.9963826,0.00088855793,0.000038779275,0.0021360347,0.00022461564,0.00010977563,0.000020692314,0.000009568741,0.00018937983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988231,0.00015106812,0.000364385,0.00013922827,0.00023344131,0.00028874137],"domain_scores_gemma":[0.9987603,0.0003651225,0.00031572385,0.000115998635,0.0002861259,0.00015675426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024794662,0.00013841347,0.0002873787,0.00007118801,0.00014780636,0.00002380778,0.00011815632,0.000119953795,0.00053370465],"category_scores_gemma":[0.00013068225,0.000060362014,0.00016373546,0.00011640919,0.00006940413,0.00006412695,0.0000036669069,0.000105761625,0.000004392638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029298582,0.0015266637,0.86089915,0.000038354472,0.0013649837,0.000120615165,0.016118526,0.000026683214,0.07985204,0.00019037002,0.0069019822,0.030030755],"study_design_scores_gemma":[0.0052371253,0.0042866347,0.9685345,0.000024256811,0.00030695912,0.00004060384,0.0007282397,0.000024839914,0.005953192,0.000118855816,0.014643136,0.000101651865],"about_ca_topic_score_codex":0.0014784158,"about_ca_topic_score_gemma":0.00817311,"teacher_disagreement_score":0.107635334,"about_ca_system_score_codex":0.00086853735,"about_ca_system_score_gemma":0.0010091482,"threshold_uncertainty_score":0.5843691},"labels":[],"label_agreement":null},{"id":"W2530993582","doi":"10.21037/tau.2016.09.07","title":"Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature","year":2016,"lang":"en","type":"review","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urothelial carcinoma; Medicine; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.043681894038206576,"score_gpt":0.31924968779602725,"score_spread":0.2755677937578207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530993582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047395437,0.993168,0.00016622723,0.0012610912,0.00014729546,0.0026633528,0.001983809,0.000011017869,0.00012525944],"genre_scores_gemma":[0.010410362,0.98798007,0.00004164811,0.00072138326,0.00013289494,0.00027127206,0.00033791823,0.00002734214,0.000077107696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986417,0.0001972192,0.00043082715,0.00040484636,0.00011169421,0.00021366354],"domain_scores_gemma":[0.9986349,0.0007929439,0.0001902763,0.00016153968,0.00014272264,0.00007764173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007667101,0.00034110653,0.0013946239,0.000089986126,0.000091508984,0.000003310834,0.00007775266,0.00047512457,0.000039621547],"category_scores_gemma":[0.00003424548,0.00016879496,0.0003876375,0.00008954887,0.00037239026,0.000050185743,0.000018904588,0.00029105283,6.118491e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034053358,0.00086678186,0.018459737,0.37286928,0.0045280685,0.000061091596,0.0022124567,0.0000029099147,0.000007418403,0.00621712,0.00075528736,0.5906145],"study_design_scores_gemma":[0.0058767013,0.0034619751,0.018195083,0.037326302,0.012951005,0.0024617803,0.00000649446,0.00006173224,0.000002073496,0.008319775,0.9108665,0.00047059968],"about_ca_topic_score_codex":0.0000027505284,"about_ca_topic_score_gemma":8.3138474e-7,"teacher_disagreement_score":0.9101112,"about_ca_system_score_codex":0.000009194983,"about_ca_system_score_gemma":0.00029960266,"threshold_uncertainty_score":0.6883258},"labels":[],"label_agreement":null},{"id":"W2532785857","doi":"10.3233/blc-160071","title":"Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Renal function; Stage (stratigraphy); Chemotherapy; Cohort; Logistic regression; Urothelial carcinoma; Internal medicine; Surgery; Oncology; Cancer","score_opus":0.011106744369064803,"score_gpt":0.30958864481717724,"score_spread":0.29848190044811246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532785857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134004,0.0024048307,0.00030703263,0.0015482458,0.0004354248,0.00068997784,0.000056846446,0.00008956334,0.0031280327],"genre_scores_gemma":[0.9967315,0.00024075975,0.000022444912,0.0010141514,0.00047325544,0.00013498947,0.0000046092982,0.00006725612,0.001310998],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984306,0.00008660167,0.00026103313,0.00039079066,0.00047608875,0.0003548521],"domain_scores_gemma":[0.9991553,0.00012288295,0.00011326542,0.00038081285,0.000049127644,0.00017864416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001819785,0.00030773782,0.0005531617,0.00010108175,0.00005861258,0.000010618334,0.00008642668,0.00014655363,0.0024914683],"category_scores_gemma":[0.000027958697,0.00015810119,0.00047045152,0.00018059462,0.00006892874,0.00008375007,0.000015685475,0.00013484093,0.000060050304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022598723,0.00043409428,0.13342498,0.00021758256,0.005265604,0.00012122116,0.0010292983,0.00000608664,0.17830086,0.00003454662,0.017894346,0.6406727],"study_design_scores_gemma":[0.058218867,0.023168063,0.13883412,0.003679796,0.002094877,0.000058755144,0.000041429696,0.00005245951,0.7442337,0.00015868718,0.028775865,0.00068333244],"about_ca_topic_score_codex":0.00035036766,"about_ca_topic_score_gemma":0.000014593093,"teacher_disagreement_score":0.6399893,"about_ca_system_score_codex":0.00032378096,"about_ca_system_score_gemma":0.0002414107,"threshold_uncertainty_score":0.9984204},"labels":[],"label_agreement":null},{"id":"W2538113786","doi":"10.1016/j.urolonc.2016.09.004","title":"Emerging role of checkpoint inhibition in localized bladder cancer","year":2016,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"G2-M DNA damage checkpoint; Cancer research; Bladder cancer; Cancer; Cell cycle checkpoint; Medicine; Internal medicine; Cell cycle","score_opus":0.04110599783235761,"score_gpt":0.3729253368420641,"score_spread":0.33181933900970645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538113786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025470797,0.99242765,0.0000127526455,0.0009997669,0.00015566143,0.00085868564,0.00012121999,0.000033462136,0.002843697],"genre_scores_gemma":[0.00013494317,0.99558634,0.002566766,0.00035761404,0.00017596163,0.0005428542,0.00009974963,0.00003192057,0.00050385273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981308,0.0001854596,0.00073876145,0.00046885296,0.0001536628,0.0003224689],"domain_scores_gemma":[0.9989248,0.00018197851,0.0004186546,0.00022005585,0.000060721668,0.00019378682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024155916,0.00036057143,0.0015641176,0.00036042137,0.00007216047,0.000006791989,0.00006197268,0.00055406033,0.00042238238],"category_scores_gemma":[0.000077281285,0.00024268281,0.00020854326,0.0003710657,0.0005408649,0.000068402835,0.00005551185,0.00041851195,0.000023346522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098810626,0.00035345778,0.006336253,0.0025258488,0.00039941235,0.00019477014,0.00034978922,0.0000023606276,0.00006208582,0.0018982765,0.00095534173,0.9868236],"study_design_scores_gemma":[0.0011071907,0.0007535384,0.000029432342,0.006296941,0.001339787,0.00025292757,0.00005362152,0.000012320554,0.00007723954,0.0028851302,0.9869884,0.00020343829],"about_ca_topic_score_codex":0.00023852335,"about_ca_topic_score_gemma":0.00007700094,"teacher_disagreement_score":0.9866201,"about_ca_system_score_codex":0.00034299126,"about_ca_system_score_gemma":0.0012682456,"threshold_uncertainty_score":0.98963183},"labels":[],"label_agreement":null},{"id":"W2538875560","doi":"10.7326/l16-0328","title":"Hematuria as a Marker of Occult Urinary Tract Cancer","year":2016,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Context (archaeology); Occult; Family medicine; General surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.05518500840019302,"score_gpt":0.37930338265960756,"score_spread":0.32411837425941453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538875560","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014729898,0.0155727435,0.00001379356,0.9158491,0.0014841947,0.0006430168,0.0005026729,0.000036100235,0.051168486],"genre_scores_gemma":[0.10450108,0.006290191,0.00004508828,0.8265801,0.012653893,0.00009341382,0.00011776076,0.00013028707,0.049588185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711704,0.00007557022,0.0009417134,0.00045116633,0.00096597424,0.00044850507],"domain_scores_gemma":[0.99767816,0.00022334035,0.0007193468,0.0005948274,0.00060965953,0.00017463612],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023485883,0.00048700778,0.0015502936,0.00034179984,0.000018112334,0.0000030551316,0.0003218196,0.00052985054,0.008387825],"category_scores_gemma":[0.0001959919,0.00027975743,0.00043137668,0.00013053641,0.00038727213,0.00006812051,0.00006394539,0.000895183,0.000060499693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019439968,0.00025177418,0.0031011016,0.001408029,0.0015382537,0.0023834887,0.00023784349,1.6631445e-8,0.0012072561,0.000008789613,0.980777,0.007142449],"study_design_scores_gemma":[0.0037265434,0.006088173,0.0053513614,0.0205645,0.0008165633,0.0011410277,0.000034058237,7.186398e-7,0.012641217,0.0004508911,0.94891596,0.00026899946],"about_ca_topic_score_codex":0.0022047493,"about_ca_topic_score_gemma":0.0000036629706,"teacher_disagreement_score":0.08977119,"about_ca_system_score_codex":0.000056502056,"about_ca_system_score_gemma":0.00028841555,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W2539843209","doi":"10.1111/bju.13674","title":"Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death ( <scp>PD</scp> )‐1 or <scp>PD</scp> ligand 1 inhibitor therapy","year":2016,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Salvage therapy; Combination therapy; Immunotherapy; Proportional hazards model; Oncology; Chemotherapy; Surgery; Cancer","score_opus":0.010365881572433917,"score_gpt":0.2448260783827616,"score_spread":0.23446019681032768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539843209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964993,0.0015493396,0.00015026263,0.0002556005,0.00035934706,0.000953759,0.000089879024,0.000017399936,0.00012511878],"genre_scores_gemma":[0.99771315,0.00044561262,0.0005015193,0.00041411025,0.00025226752,0.00008238612,0.000009815371,0.000061181774,0.000519948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766487,0.00015446662,0.0008307875,0.00032336143,0.0005137412,0.0005128036],"domain_scores_gemma":[0.9982567,0.00030317385,0.00057854486,0.0002016543,0.00043578973,0.00022414775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023726534,0.00028811904,0.000874798,0.0002429027,0.000044663557,0.000027740429,0.0001626331,0.0001902502,0.00002950644],"category_scores_gemma":[0.00046849015,0.00018136927,0.00018370758,0.00018393538,0.0001741818,0.00030916694,0.00003343592,0.0002805989,0.00000498801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002358496,0.0014051269,0.91089845,0.000022195534,0.00025417813,0.0006214458,0.00045382642,0.000001071595,0.0006645443,0.000004079886,0.00019929043,0.08311729],"study_design_scores_gemma":[0.032562483,0.010855316,0.9502219,0.00028012577,0.00016336412,0.00047849742,0.00007100065,8.8350083e-7,0.0032515991,0.00008555836,0.0019726008,0.000056682944],"about_ca_topic_score_codex":0.000099415854,"about_ca_topic_score_gemma":0.00023483328,"teacher_disagreement_score":0.083060615,"about_ca_system_score_codex":0.000106306965,"about_ca_system_score_gemma":0.00034276492,"threshold_uncertainty_score":0.7396024},"labels":[],"label_agreement":null},{"id":"W2543554890","doi":"10.1200/jco.2009.27.15_suppl.5075","title":"Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Oncology; Internal medicine; Chemotherapy; Hazard ratio; Cancer; Proportional hazards model; Cohort; Stage (stratigraphy); Urology; Confidence interval","score_opus":0.05733589957730952,"score_gpt":0.39925409083762553,"score_spread":0.34191819126031603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543554890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9390331,0.0010009803,0.00030616162,0.053531516,0.002931938,0.0012926415,0.00078232714,0.000025628513,0.001095704],"genre_scores_gemma":[0.973047,0.00093597383,0.0032186492,0.011765408,0.010275071,0.000022689856,0.000084464955,0.000056842604,0.0005939006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944166,0.0007201509,0.003178518,0.00051928393,0.0006724376,0.0004930125],"domain_scores_gemma":[0.99209094,0.0037670687,0.0023308457,0.00053756725,0.0008050818,0.00046852214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027026741,0.00039790763,0.001979454,0.000114280105,0.00020491515,0.000049776227,0.0003874233,0.00073086406,0.00019588055],"category_scores_gemma":[0.002945547,0.00023617894,0.0010163974,0.00021896148,0.00021277182,0.00024330102,0.000018463912,0.001301196,0.000025196092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13115701,0.011347911,0.2962507,0.000020985139,0.0011775629,0.00074393034,0.00361706,0.000040263378,0.0022583958,0.00026663914,0.05792882,0.4951907],"study_design_scores_gemma":[0.057708837,0.030048812,0.78854585,0.000054963508,0.001327406,0.000173829,0.00034058472,0.000083049265,0.0014717401,0.0015659396,0.11845726,0.00022174527],"about_ca_topic_score_codex":0.0005142217,"about_ca_topic_score_gemma":0.00008823976,"teacher_disagreement_score":0.49496898,"about_ca_system_score_codex":0.0003516591,"about_ca_system_score_gemma":0.0036101849,"threshold_uncertainty_score":0.9631098},"labels":[],"label_agreement":null},{"id":"W2547861511","doi":"10.1016/j.clon.2016.09.018","title":"Patterns of Referral to Radiation Oncology among Patients with Bladder Cancer: a Population-based Study","year":2016,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Research Chairs; Ontario Ministry of Health and Long-Term Care; Radiation Oncology Institute; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Radiation oncology; Referral; Bladder cancer; Oncology; Internal medicine; Population; Cancer; Radiation therapy; Family medicine; Medical physics; Environmental health","score_opus":0.06372712338474336,"score_gpt":0.4297391816556997,"score_spread":0.36601205827095634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547861511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951332,0.000013269248,0.00014900432,0.0022310826,0.0005584295,0.0014157991,0.00006873738,0.000031956708,0.0003984823],"genre_scores_gemma":[0.9971819,0.000012386082,0.00021101876,0.0017151582,0.0002848938,0.00023109306,0.000039148017,0.000026010901,0.00029838298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804235,0.000302955,0.0007567522,0.0004107059,0.00024550827,0.00024174487],"domain_scores_gemma":[0.9982517,0.0005905136,0.00032935964,0.00032248674,0.00023439698,0.0002715541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029197187,0.00015630301,0.0007546127,0.00010164462,0.000035425164,0.00000239096,0.00009368451,0.0002278128,0.0005406679],"category_scores_gemma":[0.000262645,0.000090254005,0.000102179176,0.00012883931,0.000054204043,0.00005085203,0.0000309781,0.00014722516,0.0000257744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027450982,0.0035659624,0.8411053,0.00000820559,0.00024111588,0.000015919746,0.00010108416,0.000006219352,0.000005638122,0.0000042716356,0.0002933787,0.1519078],"study_design_scores_gemma":[0.019764896,0.02809082,0.9486204,0.000062695515,0.00039546716,4.4589714e-7,0.00004634549,0.000004757473,0.00003072024,0.00000931897,0.0028693562,0.00010477251],"about_ca_topic_score_codex":0.0019249722,"about_ca_topic_score_gemma":0.004600296,"teacher_disagreement_score":0.15180303,"about_ca_system_score_codex":0.0005263384,"about_ca_system_score_gemma":0.0006757337,"threshold_uncertainty_score":0.59199345},"labels":[],"label_agreement":null},{"id":"W2548002414","doi":"10.1016/j.urolonc.2016.07.022","title":"External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Lymph node; Cohort; Lymphadenectomy; Pathological; Stage (stratigraphy); Dissection (medical); Pathological staging; T-stage; Urology; Radiology; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.03588254356410598,"score_gpt":0.3159358956159071,"score_spread":0.28005335205180115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548002414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949506,0.00010618579,0.00008888168,0.0037360443,0.00014620836,0.00073032116,0.000029392768,0.000022072256,0.00019027165],"genre_scores_gemma":[0.9965981,0.000009913377,0.0024273624,0.0006335119,0.00007799401,0.00010181997,0.000010137756,0.00001013168,0.00013103084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986629,0.00025634613,0.00035571103,0.00031263687,0.0002001992,0.00021224443],"domain_scores_gemma":[0.99925065,0.00023314863,0.00015685042,0.00020905137,0.000049698414,0.00010057729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029715386,0.00016073833,0.00030849694,0.00012531785,0.00012674107,0.00000866585,0.00009808023,0.00013761461,0.000106459185],"category_scores_gemma":[0.00017151904,0.00008532885,0.000070536786,0.00020579656,0.0002574968,0.00007942641,0.000032948705,0.00019362298,0.0000035776432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022149515,0.0007029919,0.9952629,0.000010016495,0.000011281097,0.00007064785,0.00030025357,0.000024746696,0.0014882832,0.00039398155,0.000016930077,0.0014964704],"study_design_scores_gemma":[0.0032182042,0.0026712543,0.9884925,0.00007746682,0.00016496936,0.00006914381,0.00012276681,0.000056702596,0.0014842725,0.0020940807,0.0014519824,0.000096643635],"about_ca_topic_score_codex":0.00022707366,"about_ca_topic_score_gemma":0.000045469857,"teacher_disagreement_score":0.006770389,"about_ca_system_score_codex":0.0001622014,"about_ca_system_score_gemma":0.00034476194,"threshold_uncertainty_score":0.34796095},"labels":[],"label_agreement":null},{"id":"W2548970834","doi":"10.1158/2326-6066.imm2016-b103","title":"Abstract B103: Intralesional administration of CTLA-4 blocking monoclonal antibodies as a means to optimize bladder cancer therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Cancer; Cytokine release syndrome; Immunology; Oncology; Internal medicine; Chimeric antigen receptor","score_opus":0.11231420276211847,"score_gpt":0.4422574268791818,"score_spread":0.32994322411706334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548970834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97219354,0.00967675,0.000040415453,0.013858249,0.00029399933,0.00082223216,0.0001473208,0.000038534952,0.00292897],"genre_scores_gemma":[0.9787581,0.015612496,0.00029046615,0.00034546107,0.00033106876,0.0005690037,0.00001081831,0.000042048567,0.0040405183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997725,0.00011999442,0.00038650198,0.00049416133,0.0006152844,0.0006590464],"domain_scores_gemma":[0.9983419,0.0002642149,0.00008851299,0.0004102129,0.000719965,0.00017517895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038013692,0.00022683638,0.00045962125,0.00031411325,0.00017235639,0.000018733688,0.00025643787,0.00020357934,0.004556945],"category_scores_gemma":[0.0001230768,0.00015057962,0.000121845216,0.0002937024,0.0005571901,0.00011965818,0.00008815509,0.000353633,0.00008441776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013910326,0.00052987295,0.041451123,0.00007072477,0.0017981401,0.00011152331,0.0012609628,0.000019691535,0.7561789,0.00030206435,0.005631897,0.17873475],"study_design_scores_gemma":[0.0060834703,0.0024972772,0.32228425,0.00091325317,0.000069449045,0.00006990293,0.00024331476,0.000009664566,0.65348005,0.0004488954,0.013612597,0.00028786453],"about_ca_topic_score_codex":0.0015143765,"about_ca_topic_score_gemma":0.00020101218,"teacher_disagreement_score":0.28083313,"about_ca_system_score_codex":0.00036612002,"about_ca_system_score_gemma":0.001969294,"threshold_uncertainty_score":0.99635303},"labels":[],"label_agreement":null},{"id":"W2549228809","doi":"10.1016/j.ijrobp.2021.07.302","title":"NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Radiation therapy; Clinical endpoint; Stage (stratigraphy); Oncology; Cancer; Chemotherapy; Internal medicine; Surgery; Clinical trial","score_opus":0.03944898843216105,"score_gpt":0.4163941023554752,"score_spread":0.37694511392331415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549228809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94692934,0.0005765542,0.010920265,0.0069551463,0.0011318761,0.032380946,0.00055896863,0.00007886397,0.0004680246],"genre_scores_gemma":[0.97392714,0.00041834422,0.0036798962,0.00198471,0.0019588587,0.017158838,0.00050105224,0.00013114083,0.00023999746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708843,0.00042174652,0.0008181644,0.00058124267,0.00060760323,0.00048281482],"domain_scores_gemma":[0.99666446,0.00040946243,0.00090150896,0.0001984631,0.0015569042,0.0002692032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043783267,0.00047573107,0.0009475272,0.0001498584,0.00025021026,0.000055690794,0.00020761247,0.00025013,0.00013359035],"category_scores_gemma":[0.000064592234,0.00034348524,0.0003579521,0.00028921437,0.000103154256,0.00038772615,0.000026269023,0.00039481203,0.0000018919121],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037541598,0.010771798,0.15716337,0.00003865923,0.013372864,0.00028571585,0.008903656,0.0014521861,0.008003819,0.00015998092,0.0027512147,0.75955516],"study_design_scores_gemma":[0.40056214,0.08118853,0.010801627,0.000559219,0.0017136607,0.00017787851,0.0007663259,0.003773838,0.079677716,0.0003744079,0.41923517,0.0011695029],"about_ca_topic_score_codex":0.00007993989,"about_ca_topic_score_gemma":0.000037613943,"teacher_disagreement_score":0.75838566,"about_ca_system_score_codex":0.0034009835,"about_ca_system_score_gemma":0.0024620837,"threshold_uncertainty_score":0.9999017},"labels":[],"label_agreement":null},{"id":"W2549654250","doi":"10.1097/icb.0000000000000493","title":"ENDOPHTHALMITIS IN A PATIENT TREATED WITH BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY","year":2016,"lang":"en","type":"article","venue":"Retinal Cases & Brief Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Endophthalmitis; Mycobacterium bovis; Surgery; Immunotherapy; Bladder cancer; BCG vaccine; Dermatology; Tuberculosis; Internal medicine; Cancer; Mycobacterium tuberculosis; Pathology","score_opus":0.014148108136358686,"score_gpt":0.25987850167805293,"score_spread":0.24573039354169424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549654250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98739904,0.0009834489,0.000024361365,0.00034230272,0.00006800374,0.0006869096,0.00003245797,0.00008101029,0.010382451],"genre_scores_gemma":[0.997317,0.0001501688,0.00018178114,0.00028878666,0.00007922663,0.00014784378,0.000022672231,0.000054636992,0.0017578496],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9980512,0.00006366503,0.0004975297,0.00053044874,0.00043964674,0.00041745766],"domain_scores_gemma":[0.9988806,0.00008341582,0.00020421554,0.00053220586,0.00011556813,0.00018397445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010569976,0.00028687934,0.00045890882,0.0001270425,0.000053464057,0.000016764288,0.000037323232,0.00008571387,0.0007598497],"category_scores_gemma":[0.00007335933,0.0001685458,0.00012358934,0.00025287768,0.000110157154,0.00009027037,0.000020800519,0.000115495655,0.000017345745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028516361,0.00046325612,0.5597414,0.0000349037,0.00015206331,0.33798024,0.00013510522,6.30609e-7,0.009411835,0.0000117358295,0.00033954805,0.08887768],"study_design_scores_gemma":[0.00946552,0.011022871,0.39028528,0.0014626181,0.00023550991,0.49482766,0.00009010251,0.0000017411011,0.06270972,0.00008502703,0.02917109,0.0006428549],"about_ca_topic_score_codex":0.0035373855,"about_ca_topic_score_gemma":0.000090697395,"teacher_disagreement_score":0.16945608,"about_ca_system_score_codex":0.0003183753,"about_ca_system_score_gemma":0.00022883111,"threshold_uncertainty_score":0.8319821},"labels":[],"label_agreement":null},{"id":"W2555968680","doi":"10.23736/s0393-2249.16.02713-2","title":"Use of adjuvant chemotherapy in radical cystectomy patients aged &gt;65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database","year":2017,"lang":"en","type":"article","venue":"Minerva Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Surveillance, Epidemiology, and End Results; Epidemiology; Internal medicine; Stage (stratigraphy); Bladder cancer; Logistic regression; Lymph node; Marital status; Odds ratio; Chemotherapy; Urology; Oncology; Population; Cancer; Cancer registry","score_opus":0.03969391810440449,"score_gpt":0.3079397051772022,"score_spread":0.2682457870727977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555968680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917057,0.00092915527,0.000012316891,0.006070915,0.00013599051,0.0007121882,0.00040671998,0.00001397948,0.000013047633],"genre_scores_gemma":[0.99341387,0.00014976684,0.0001791014,0.0056759827,0.00010632957,0.000048358364,0.00039313815,0.000016707612,0.000016757716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775356,0.00077966595,0.00051390444,0.00052398274,0.00011644276,0.00031245154],"domain_scores_gemma":[0.99700063,0.0018305645,0.0002968218,0.00071621226,0.00004398283,0.00011177126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066413026,0.00020166906,0.0007536236,0.00007906416,0.00012763619,0.0000069915404,0.00016301306,0.00025531714,0.00004921097],"category_scores_gemma":[0.0013944134,0.00014014416,0.0000465218,0.000053457614,0.0005652216,0.00006581261,0.000092686525,0.00030012292,0.0000016102913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005586413,0.00042563965,0.98643583,0.000009928216,0.00015633903,0.000091134374,0.000437819,0.0000030782412,0.00018120033,0.000006113122,0.00048361006,0.0061829193],"study_design_scores_gemma":[0.016877161,0.0017107147,0.97901756,0.000017372482,0.00010759745,0.000013136016,0.000020094563,0.00028330894,0.0000088622555,0.00006094256,0.0017864312,0.00009685163],"about_ca_topic_score_codex":0.008622022,"about_ca_topic_score_gemma":0.009958568,"teacher_disagreement_score":0.011290749,"about_ca_system_score_codex":0.000018471434,"about_ca_system_score_gemma":0.000061729676,"threshold_uncertainty_score":0.99797964},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2556883211","doi":"10.1016/s1569-9056(16)30309-8","title":"Impact of the level of urothelial carcinoma involvement of the prostate on survival after radical cystectomy","year":2016,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Urology; Prostate; Prostate carcinoma; Oncology; Carcinoma; Internal medicine; General surgery; Cancer; Bladder cancer","score_opus":0.04180608449532552,"score_gpt":0.293056825524647,"score_spread":0.2512507410293215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556883211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944129,0.000049542978,0.00002011887,0.00092983997,0.00034204347,0.0009216047,0.00154526,0.0000073390192,0.0017713769],"genre_scores_gemma":[0.998705,0.00001049333,0.000023932605,0.0003273071,0.000086894994,0.000021976422,0.000008999022,0.000040084436,0.0007752606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978751,0.0005751175,0.0005208499,0.0002701286,0.00045262257,0.00030615937],"domain_scores_gemma":[0.9987556,0.00006975066,0.000274911,0.0007233172,0.00009780365,0.000078654644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032025113,0.0002138723,0.00036152112,0.00006720296,0.00004132793,0.0000020608802,0.00033112758,0.000042493863,0.0007640193],"category_scores_gemma":[0.00006135795,0.00008918303,0.00033097607,0.00013370281,0.0004377082,0.000026733724,0.00022984749,0.00012958566,0.00002011382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002719593,0.00048575134,0.9714904,0.00003986513,0.0004107703,0.000017794573,0.00045981075,0.0000016129534,0.022226112,0.000040087925,0.0009999712,0.0011082366],"study_design_scores_gemma":[0.008622179,0.0026032887,0.9568977,0.0000709198,0.00020562798,0.000010114157,0.00001477871,9.986879e-7,0.029161233,0.0000307699,0.002306141,0.000076281285],"about_ca_topic_score_codex":0.00023359655,"about_ca_topic_score_gemma":0.000038650436,"teacher_disagreement_score":0.014592726,"about_ca_system_score_codex":0.000076055745,"about_ca_system_score_gemma":0.00020405136,"threshold_uncertainty_score":0.83654755},"labels":[],"label_agreement":null},{"id":"W2557161290","doi":"10.1111/iju.13261","title":"Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA","year":2016,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Fondation du CHUM","keywords":"Medicine; Adenocarcinoma; Bladder cancer; Hazard ratio; Cancer; Internal medicine; Proportional hazards model; Oncology; Urinary bladder; Population; Confidence interval; Urology","score_opus":0.05874112930083461,"score_gpt":0.35683087208540537,"score_spread":0.2980897427845708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557161290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882928,0.001513349,0.00006010077,0.009404531,0.00021964681,0.00013723204,0.0000344067,6.147445e-7,0.0003372857],"genre_scores_gemma":[0.99881816,0.0000919272,0.000050686198,0.000856578,0.00012502285,0.0000048683937,7.739913e-7,0.0000030735118,0.00004891562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932337,0.00009524939,0.00027870745,0.00006456178,0.00018030308,0.00005781776],"domain_scores_gemma":[0.99922657,0.0002792429,0.00022582033,0.0000785788,0.00017164431,0.000018156838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002584541,0.00005516092,0.00017638359,0.000052856296,0.000009482173,0.0000021977728,0.00017860394,0.00005151511,0.00003112029],"category_scores_gemma":[0.00014357772,0.000021381928,0.00009346793,0.000025684545,0.00019287455,0.00003882074,0.00003104532,0.00008733781,1.8963469e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013984368,0.0002166525,0.99237925,0.000006341069,0.0002008948,0.000099896984,0.00020557312,6.25238e-7,0.0034954497,0.000491524,0.00074004574,0.0007653333],"study_design_scores_gemma":[0.0024343934,0.0012288805,0.99044335,0.000025620424,0.000056755067,0.0013059984,0.000048284808,0.0000015530569,0.0020322707,0.0020769527,0.00032658258,0.000019361016],"about_ca_topic_score_codex":0.000027363383,"about_ca_topic_score_gemma":0.000011635285,"teacher_disagreement_score":0.010525321,"about_ca_system_score_codex":0.000012016976,"about_ca_system_score_gemma":0.000087809334,"threshold_uncertainty_score":0.08719297},"labels":[],"label_agreement":null},{"id":"W2557753766","doi":"10.1016/j.ijrobp.2016.08.029","title":"In Regard to Zietman et al","year":2016,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.025665114426563655,"score_gpt":0.36002804529131743,"score_spread":0.33436293086475377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557753766","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056609586,0.00029937347,0.0019992618,0.98163724,0.006329971,0.00039179725,0.00024237647,0.000027525535,0.0034115033],"genre_scores_gemma":[0.019558623,0.00087143265,0.0013870468,0.9592144,0.017214477,0.000035857385,0.00023323437,0.00007826042,0.0014066513],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758285,0.0002902097,0.0009120013,0.0003713023,0.00048632658,0.0003573283],"domain_scores_gemma":[0.9976588,0.0003628643,0.00092370587,0.00023641741,0.00067656353,0.0001416385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047055856,0.00034073216,0.0008344954,0.00043904915,0.000028553357,0.000026407039,0.00048769702,0.0006502148,0.0002785979],"category_scores_gemma":[0.00021297528,0.00026151346,0.0003576207,0.0001461599,0.000106377476,0.00023675385,0.00007949131,0.001580458,0.00022003656],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005488081,0.00017766781,0.02185293,0.000008908686,0.0007799513,0.00089313794,0.00022128632,0.000012735843,0.00054219,0.0005578063,0.92869747,0.045707125],"study_design_scores_gemma":[0.0062056417,0.0015365535,0.0023275868,0.00022920228,0.00012810566,0.00043580114,0.000007689022,0.000010403855,0.00047319222,0.005487396,0.9829394,0.00021903354],"about_ca_topic_score_codex":0.00004466433,"about_ca_topic_score_gemma":0.000009673057,"teacher_disagreement_score":0.05424194,"about_ca_system_score_codex":0.0017955671,"about_ca_system_score_gemma":0.0012384346,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W2558970092","doi":"10.1016/j.urolonc.2016.10.021","title":"Preoperative anemia is associated with disease recurrence and progression in patients with non–muscle-invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Bladder cancer; Anemia; Proportional hazards model; Internal medicine; Cancer; Cohort; Retrospective cohort study; Disease; Urology; Oncology; Surgery","score_opus":0.016629097210813865,"score_gpt":0.3002979414051745,"score_spread":0.28366884419436067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558970092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928456,0.0005606285,0.000010385896,0.005299748,0.0000384294,0.0008109033,0.00012728332,0.000024199036,0.0002828413],"genre_scores_gemma":[0.99499714,0.00052787986,0.0019458286,0.0016963595,0.000031580163,0.00035396733,0.000044711556,0.000014385504,0.000388165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988988,0.00007856721,0.00016416078,0.00042884596,0.00016799447,0.000261655],"domain_scores_gemma":[0.99915737,0.00015635163,0.00012010593,0.00012608977,0.00013308204,0.0003069738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007537785,0.00020697259,0.0002873998,0.00008390409,0.0001447033,0.000013195163,0.000043927714,0.00012509915,0.00008510314],"category_scores_gemma":[0.00010475044,0.00010685559,0.000015077434,0.00020655502,0.0007081177,0.00015678497,0.000027315806,0.00016706933,0.0000026532864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006961528,0.00033486594,0.9921899,0.000019262123,0.000068958056,0.0000889521,0.0006173835,0.0000017685454,0.00003795856,0.0000587025,0.00057498686,0.005311138],"study_design_scores_gemma":[0.005673829,0.0061972463,0.98032236,0.0008664351,0.00039027966,0.000010247427,0.000056047887,0.000021138543,0.00020729832,0.0003873726,0.005675972,0.00019177845],"about_ca_topic_score_codex":0.000045021105,"about_ca_topic_score_gemma":0.0001822025,"teacher_disagreement_score":0.011867517,"about_ca_system_score_codex":0.00017058903,"about_ca_system_score_gemma":0.0006969745,"threshold_uncertainty_score":0.43574443},"labels":[],"label_agreement":null},{"id":"W2559115131","doi":"10.25011/cim.v39i6.27514","title":"Protective Effect of Intravesical Platelet-Rich Plasma on Cyclophosphamide-Induced Hemorrhagic Cystitis","year":2016,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hemorrhagic cystitis; Cyclophosphamide; Interstitial cystitis; Platelet-rich plasma; Inflammation; Saline; Medicine; Edema; Pharmacology; Platelet; Intraperitoneal injection; Internal medicine; Urology; Chemotherapy; Urinary system","score_opus":0.07241088718495012,"score_gpt":0.3374477780622101,"score_spread":0.26503689087726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559115131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836806,0.00015763904,0.000047085152,0.0122430455,0.00055975444,0.0010725672,0.00001812929,0.000048965296,0.0021721818],"genre_scores_gemma":[0.997374,0.00012399974,0.00009366313,0.0011261856,0.00062892894,0.00008705758,0.0000073791584,0.000027460941,0.000531303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99781024,0.0002701291,0.0007205005,0.00054797396,0.00037209006,0.00027904272],"domain_scores_gemma":[0.99775666,0.001081729,0.0002049159,0.00028426203,0.00013473112,0.0005377024],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0005627974,0.00032244987,0.0011209733,0.00009090025,0.00006323992,0.0000030380143,0.000087276174,0.00020806356,0.00019247673],"category_scores_gemma":[0.003592169,0.0001495139,0.00010726738,0.00022053238,0.0048876097,0.0000725067,0.000045049805,0.0003849146,0.00005273453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009144912,0.0008728439,0.3872832,0.00075724965,0.0013065167,0.00056544755,0.0010310235,3.1272722e-7,0.10383942,0.0053196987,0.004142938,0.48573643],"study_design_scores_gemma":[0.023803787,0.051539805,0.51349473,0.0026960254,0.00040805797,0.0001095673,0.000045580036,0.000013507074,0.3958607,0.0111400895,0.00061601336,0.00027216919],"about_ca_topic_score_codex":0.00007970136,"about_ca_topic_score_gemma":0.000005261266,"teacher_disagreement_score":0.48546425,"about_ca_system_score_codex":0.000050501665,"about_ca_system_score_gemma":0.000120686535,"threshold_uncertainty_score":0.9978205},"labels":[],"label_agreement":null},{"id":"W2559804019","doi":"10.1016/s0140-6736(16)32455-2","title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Cancer Institute; EMD Serono; Ipsen; Astellas Pharma; F. Hoffmann-La Roche; Eisai; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Atezolizumab; Medicine; Metastatic Urothelial Carcinoma; Clinical endpoint; Oncology; Internal medicine; Cisplatin; Chemotherapy; Progression-free survival; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Cancer; Bladder cancer; Urology; Clinical trial; Urothelial carcinoma; Immunotherapy; Pembrolizumab","score_opus":0.03479870827848872,"score_gpt":0.3052424545209158,"score_spread":0.27044374624242706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559804019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353236,0.0003385424,0.000082679915,0.0020078905,0.00012631787,0.0026117973,0.00019054394,0.00004913047,0.0010607386],"genre_scores_gemma":[0.997759,0.000207158,0.00043375645,0.00038120517,0.00031037588,0.00025861475,0.00003479283,0.000042088086,0.0005730279],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984878,0.000076283824,0.00032151048,0.00037745674,0.00029074572,0.00044622255],"domain_scores_gemma":[0.9990206,0.00018240606,0.000117714975,0.00046174272,0.00006960025,0.00014794171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008508254,0.00030724477,0.00069057907,0.00007532709,0.00008374831,0.000023451163,0.00010520997,0.00004303681,0.000117865595],"category_scores_gemma":[0.000076852964,0.00013788692,0.00006208517,0.00015656007,0.000109925706,0.00010376173,0.000030921135,0.0000834988,0.00004108617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7106431,0.013677773,0.076283954,0.00015242578,0.0006392344,0.0004899074,0.00215727,0.000033218224,0.0009845643,0.00011887281,0.00031166992,0.19450799],"study_design_scores_gemma":[0.9469596,0.028062725,0.014538078,0.00036923555,0.0006390527,0.0000425603,0.000067566696,0.00008823645,0.0037720017,0.00034634297,0.0047950908,0.0003194848],"about_ca_topic_score_codex":0.00044168447,"about_ca_topic_score_gemma":0.00049011793,"teacher_disagreement_score":0.2363165,"about_ca_system_score_codex":0.00025051404,"about_ca_system_score_gemma":0.00015535884,"threshold_uncertainty_score":0.56228656},"labels":[],"label_agreement":null},{"id":"W2559857122","doi":"10.1200/jco.2012.30.5_suppl.316","title":"Urothelial cancer: Impact of gender on stage at diagnosis and survival.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Stage (stratigraphy); Carboplatin; Internal medicine; Chemotherapy; Cancer; Radiation therapy; Disease; Oncology; Cisplatin","score_opus":0.24006407378325242,"score_gpt":0.5268482598088098,"score_spread":0.28678418602555733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559857122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997295,0.0023116255,0.0000074756995,0.0009932523,0.0014166206,0.00016463523,0.00004887914,0.0000039186243,0.005080673],"genre_scores_gemma":[0.990422,0.006235437,0.00018219386,0.0008385357,0.0018246574,0.000007369419,0.0000010055563,0.000017896935,0.00047089692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979306,0.00027190777,0.0011346762,0.00011286788,0.00030731887,0.00024263558],"domain_scores_gemma":[0.99691105,0.0013383431,0.0009152691,0.00013809899,0.00017382899,0.00052340154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001331647,0.00013270727,0.001200471,0.000077705066,0.000027130345,0.0000024693552,0.00006933692,0.00023780456,0.0012669365],"category_scores_gemma":[0.0007272353,0.000079871184,0.00050236715,0.00006387471,0.00015055457,0.00007875926,0.00003839855,0.000412858,0.00001165325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005680894,0.0018223491,0.9397447,0.00002724946,0.00088815106,0.00005530285,0.00015544769,0.000006488936,0.00015510108,0.00003786607,0.0035745895,0.047851823],"study_design_scores_gemma":[0.008329206,0.014531551,0.9450607,0.00005032817,0.0005285491,0.00006595758,0.000032551827,0.0000029768041,0.00050562184,0.000036274832,0.030788895,0.000067442175],"about_ca_topic_score_codex":0.0002139279,"about_ca_topic_score_gemma":0.000035868088,"teacher_disagreement_score":0.04778438,"about_ca_system_score_codex":0.00030125948,"about_ca_system_score_gemma":0.00089641486,"threshold_uncertainty_score":0.99964607},"labels":[],"label_agreement":null},{"id":"W2560249597","doi":"10.1200/jco.2012.30.5_suppl.303","title":"The neoadjuvant management of muscle-invasive bladder cancer (MIBC) in Canada: A national survey of urologists.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Referral; Internal medicine; Cancer; Cystoscopy; General surgery; Oncology; Family medicine; Urinary system","score_opus":0.19055156153014477,"score_gpt":0.4646989688525063,"score_spread":0.27414740732236154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560249597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581594,0.0038384134,0.000012942667,0.0045719915,0.0016706003,0.0002430807,0.000043865588,0.0000012920168,0.0038018976],"genre_scores_gemma":[0.99351513,0.0045288512,0.00024204535,0.0013181781,0.00027105975,0.000008518198,0.0000022788315,0.000008434664,0.00010548698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996808,0.00044753277,0.0018283441,0.00009658227,0.000581523,0.00023800206],"domain_scores_gemma":[0.9950336,0.0025920707,0.0013918972,0.0001265332,0.0006718076,0.00018404408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035500627,0.00009856875,0.0008835205,0.0000569332,0.000020858313,0.000001370413,0.00016559116,0.00012234796,0.00009987287],"category_scores_gemma":[0.0012443444,0.000057417572,0.00017032122,0.00015865109,0.00017630821,0.00005017375,0.00004697257,0.0004041497,0.0000012858021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025707132,0.0010823056,0.89238244,0.00003645704,0.0011005087,0.00011649037,0.00007577531,0.00005815457,0.000017779468,0.00014916646,0.006430638,0.09597956],"study_design_scores_gemma":[0.0046869065,0.0015709897,0.98231626,0.00007172884,0.00022893972,0.000025830868,0.00015378873,0.000011516409,0.0000830607,0.00008208688,0.01072449,0.000044407276],"about_ca_topic_score_codex":0.2985072,"about_ca_topic_score_gemma":0.6804605,"teacher_disagreement_score":0.38195327,"about_ca_system_score_codex":0.00056802615,"about_ca_system_score_gemma":0.009078779,"threshold_uncertainty_score":0.9965388},"labels":[],"label_agreement":null},{"id":"W2560259678","doi":"10.1200/jco.2011.29.7_suppl.285","title":"The neoadjuvant management of bladder cancer in Canada: A survey of genitourinary medical oncologists.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Bladder cancer; Stage (stratigraphy); Genitourinary system; Cystoscopy; Gemcitabine; Cystectomy; Cancer; Gynecology; General surgery; Oncology; Internal medicine; Urinary system","score_opus":0.22134077731878132,"score_gpt":0.4657628962123015,"score_spread":0.24442211889352017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560259678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798612,0.0035335566,0.000018857734,0.003520964,0.0020583554,0.00029474462,0.000023071712,0.0000020860357,0.010687157],"genre_scores_gemma":[0.98970526,0.008750049,0.00040911735,0.0007516542,0.00018278143,0.000008568376,8.552644e-7,0.000010882428,0.00018084171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956704,0.00062732067,0.0026335863,0.00013822493,0.000688481,0.00024202077],"domain_scores_gemma":[0.99596727,0.0015881744,0.0014966369,0.00021526926,0.00043302606,0.00029964297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003949174,0.000119182805,0.001312455,0.00005970104,0.000020844891,9.460567e-7,0.00032462654,0.00021636355,0.0007518002],"category_scores_gemma":[0.00088679226,0.00006642949,0.0002151534,0.00017951889,0.00032822095,0.000030000818,0.00009114013,0.00066190574,0.0000016519758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008286208,0.0018271167,0.6902764,0.000052676492,0.0013604226,0.0030209227,0.0000877271,0.0000047669964,0.000003866604,0.000046498204,0.0059722955,0.2890611],"study_design_scores_gemma":[0.006640484,0.0055161137,0.98117614,0.00017983976,0.00032313305,0.00011514722,0.00024041889,0.00002330933,0.0000700958,0.00009939374,0.0055621318,0.00005379046],"about_ca_topic_score_codex":0.6153971,"about_ca_topic_score_gemma":0.84114414,"teacher_disagreement_score":0.29089972,"about_ca_system_score_codex":0.0004895844,"about_ca_system_score_gemma":0.015537263,"threshold_uncertainty_score":0.9900437},"labels":[],"label_agreement":null},{"id":"W2560419359","doi":"10.1200/jco.2012.30.5_suppl.304","title":"Neoadjuvant cisplatin/gemcitabine (CG) chemotherapy for muscle-invasive transitional cell carcinoma of the bladder (TCCB): A single-institution experience.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Gemcitabine; Neoadjuvant therapy; Retrospective cohort study; Cystectomy; Contraindication; Medical record; Cisplatin; Bladder cancer; Surgery; Internal medicine; Oncology; Cancer; Pathology; Breast cancer","score_opus":0.1114895497710876,"score_gpt":0.4129933114946542,"score_spread":0.3015037617235666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560419359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885371,0.0006685209,0.0013789955,0.0043724193,0.0020357342,0.0005058343,0.000026735746,0.000005167454,0.002469518],"genre_scores_gemma":[0.992003,0.000110947476,0.0029345253,0.002762199,0.0019983407,0.000018460996,0.000003982775,0.00001863888,0.00014991044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750537,0.00016225863,0.0015270371,0.00014876031,0.00037603267,0.0002805299],"domain_scores_gemma":[0.997057,0.00090713194,0.0011178072,0.00019047868,0.0004498147,0.0002777495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082581304,0.00015985765,0.00093197846,0.000064652595,0.00007174601,0.000004159938,0.00015102916,0.0002857943,0.00024534846],"category_scores_gemma":[0.00055117183,0.00009496156,0.0007577653,0.00012261748,0.0003314711,0.00016398677,0.000017383923,0.00037810748,0.000003486679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029531797,0.03126779,0.5218855,0.0004378206,0.0016498849,0.00017454528,0.01299321,0.0000854579,0.08564085,0.0009322756,0.009434965,0.30596587],"study_design_scores_gemma":[0.034786895,0.016727388,0.8703233,0.00017928338,0.0010714782,0.0004440882,0.0009316125,0.00005260709,0.038504023,0.00045371745,0.036324687,0.00020091432],"about_ca_topic_score_codex":0.000018870936,"about_ca_topic_score_gemma":0.000015391257,"teacher_disagreement_score":0.3484378,"about_ca_system_score_codex":0.00015733794,"about_ca_system_score_gemma":0.0013792436,"threshold_uncertainty_score":0.387242},"labels":[],"label_agreement":null},{"id":"W2560743903","doi":"10.1200/jco.2011.29.7_suppl.249","title":"Prognostic factors of cancer recurrence and progression in non-muscle-invasive urothelial carcinoma: A multicenter study of over 4,300 patients.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Proportional hazards model; Oncology; Cancer; Disease; Tumor progression; Stage (stratigraphy); Population; Carcinoma in situ; Chemotherapy; Urology","score_opus":0.11276722229075488,"score_gpt":0.4469037268728961,"score_spread":0.3341365045821412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560743903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979039,0.00026859314,0.0000019706686,0.00004411434,0.00065944245,0.0009044615,0.00001417928,0.0000017864119,0.00020155132],"genre_scores_gemma":[0.99929065,0.00023128708,0.0002451977,0.000071884344,0.00012178205,0.000017360242,9.1701145e-7,0.000012631457,0.000008278507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973237,0.0002556254,0.0017346969,0.00019005704,0.0003280449,0.00016789071],"domain_scores_gemma":[0.99707186,0.000659166,0.0015208791,0.00012816908,0.00042801673,0.00019188388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049697387,0.00014223105,0.0011537522,0.00013956454,0.000014240887,0.0000016610367,0.00010522064,0.00018154172,0.00008502028],"category_scores_gemma":[0.0011778494,0.00008887107,0.00016018796,0.00011416646,0.00017352687,0.00008824552,0.0000572333,0.00043204715,4.92363e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050844857,0.012835709,0.9429332,0.000086525295,0.0001875805,0.000097202326,0.003925813,3.3564035e-7,0.00006885844,6.484417e-7,0.00003475154,0.034744885],"study_design_scores_gemma":[0.020649815,0.038743924,0.9385285,0.00043936042,0.00048418477,0.0000030695726,0.00059535215,0.0000080244035,0.00043397487,0.000014672879,0.000036460347,0.000062697756],"about_ca_topic_score_codex":0.00089232053,"about_ca_topic_score_gemma":0.00065979536,"teacher_disagreement_score":0.03468219,"about_ca_system_score_codex":0.000078586665,"about_ca_system_score_gemma":0.0007745256,"threshold_uncertainty_score":0.36240572},"labels":[],"label_agreement":null},{"id":"W2560750372","doi":"10.1200/jco.2011.29.7_suppl.241","title":"Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC).","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Nausea; Tolerability; Docetaxel; Response Evaluation Criteria in Solid Tumors; Paclitaxel; Progressive disease; Refractory (planetary science); Gastroenterology; Adverse effect; Phases of clinical research; Chemotherapy; Metastatic Urothelial Carcinoma; Oncology; Performance status; Surgery; Cancer; Bladder cancer; Urothelial carcinoma","score_opus":0.27510356231521305,"score_gpt":0.4665840911058216,"score_spread":0.19148052879060856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560750372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994092,0.0003681518,0.000024310759,0.0002423036,0.000844409,0.0006248015,0.00007782428,0.0000048866323,0.0037213515],"genre_scores_gemma":[0.9972669,0.00005395112,0.0016413329,0.0003090039,0.0003734811,0.0000080078,0.000003561827,0.00002510523,0.00031865257],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99340147,0.0007438494,0.0048002214,0.00026613133,0.00050344534,0.0002848798],"domain_scores_gemma":[0.99445474,0.0012281904,0.0031756419,0.00032468155,0.00049057737,0.00032616706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030183797,0.00021698658,0.0023935954,0.0003136463,0.0000278014,0.0000019371485,0.00021434849,0.00022103198,0.0004919288],"category_scores_gemma":[0.0023278063,0.00015405127,0.0004573071,0.0002132293,0.00021752031,0.00011443778,0.00008314065,0.0007669805,0.0000045947827],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25537497,0.36020243,0.11905445,0.00033948198,0.004322809,0.0066426313,0.02658981,0.000016265485,0.017972494,0.000038215243,0.002014769,0.20743167],"study_design_scores_gemma":[0.20965257,0.571211,0.20276456,0.0002393841,0.0020534978,0.00026912495,0.0033772842,0.00003788878,0.0056689605,0.0003251517,0.0041946988,0.00020588377],"about_ca_topic_score_codex":0.00041298967,"about_ca_topic_score_gemma":0.0006171095,"teacher_disagreement_score":0.21100856,"about_ca_system_score_codex":0.00016421612,"about_ca_system_score_gemma":0.001639482,"threshold_uncertainty_score":0.62820286},"labels":[],"label_agreement":null},{"id":"W2562774782","doi":"10.1016/j.clgc.2016.12.014","title":"Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies","year":2016,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Univariate analysis; Performance status; Multivariate analysis; Oncology; Proportional hazards model; Gastroenterology; Toxicity; Adverse effect; Cancer; Urothelial carcinoma; Bladder cancer","score_opus":0.054823167612941544,"score_gpt":0.3807051565461041,"score_spread":0.32588198893316256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562774782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434,0.0025572113,0.000032632382,0.0008747044,0.0003183611,0.000905668,0.00057473924,0.00003275013,0.00036396057],"genre_scores_gemma":[0.9896762,0.0007719822,0.00031080897,0.0012713661,0.0003996857,0.00018752391,0.0000502646,0.00006385789,0.007268325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997011,0.00018309205,0.0012175741,0.0007106165,0.00043768177,0.00044002253],"domain_scores_gemma":[0.99785197,0.00044079483,0.00038977183,0.00061118376,0.0004661232,0.00024015909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003260626,0.00040068722,0.0016914849,0.00037274265,0.00004474126,0.0000066749376,0.00017656389,0.00013243864,0.008430994],"category_scores_gemma":[0.00010187106,0.00023174516,0.0004753022,0.0008204513,0.0003328353,0.00012206059,0.00006755413,0.00022931841,0.000025288959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009786718,0.00320181,0.94552094,0.00021946266,0.012289775,0.0001356247,0.00034707677,0.000021093736,0.0005326566,0.000002763303,0.0014603836,0.026481675],"study_design_scores_gemma":[0.031984627,0.0041821077,0.9524791,0.00023803143,0.005621738,0.000002870591,0.000087603534,0.000036783567,0.0030430749,0.000040809628,0.0019493271,0.0003339001],"about_ca_topic_score_codex":0.00006422687,"about_ca_topic_score_gemma":0.0005912899,"teacher_disagreement_score":0.026147775,"about_ca_system_score_codex":0.0002222136,"about_ca_system_score_gemma":0.00041677183,"threshold_uncertainty_score":0.99247545},"labels":[],"label_agreement":null},{"id":"W2563935720","doi":"10.1158/1538-7445.am2015-2969","title":"Abstract 2969: Progress in The Cancer Genome Atlas bladder cancer project","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; microRNA; PTEN; Bladder cancer; DNA methylation; HRAS; Cancer research; Genetics; Gene; Cancer; Bioinformatics; Mutation; Gene expression; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.21697498463621262,"score_gpt":0.48829513254434087,"score_spread":0.27132014790812825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563935720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91410553,0.056421366,0.000001205235,0.013745883,0.000433968,0.0031765471,0.00019757562,0.00006506617,0.011852829],"genre_scores_gemma":[0.98305583,0.0042366693,0.00003472082,0.000793173,0.0014970376,0.007368991,0.000028402234,0.00007579367,0.0029093635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960257,0.0002265128,0.00034613494,0.0006769073,0.0016438495,0.0010808923],"domain_scores_gemma":[0.99822515,0.00009476651,0.00006863499,0.00068572146,0.0006209883,0.00030471315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001333826,0.0002820585,0.00040408943,0.00033076323,0.00017125515,0.00011906283,0.0005634912,0.00016214835,0.0011278932],"category_scores_gemma":[0.000059864997,0.00017717258,0.00010376014,0.0012863773,0.0004216294,0.00016956824,0.00012351044,0.0010162804,0.00011133258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056094676,0.002177001,0.6303802,0.001069711,0.0013475057,0.0016545476,0.031624015,0.0001392551,0.00615503,0.00023420287,0.19173464,0.12787439],"study_design_scores_gemma":[0.010625049,0.0010877317,0.620833,0.000860526,0.00023024753,0.00006151108,0.0046207667,0.00005116063,0.0055159424,0.00033525412,0.3551153,0.00066352525],"about_ca_topic_score_codex":0.026930874,"about_ca_topic_score_gemma":0.005711552,"teacher_disagreement_score":0.16338065,"about_ca_system_score_codex":0.0014136548,"about_ca_system_score_gemma":0.0045497986,"threshold_uncertainty_score":0.9997852},"labels":[],"label_agreement":null},{"id":"W2565001787","doi":"10.1016/j.ijrobp.2016.12.018","title":"A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Paclitaxel; Trastuzumab; Radiation therapy; Toxicity; Cystectomy; Clinical endpoint; Internal medicine; Urology; Bladder cancer; Gastroenterology; Oncology; Survival rate; Chemotherapy; Surgery; Cancer; Randomized controlled trial; Breast cancer","score_opus":0.026547066012807333,"score_gpt":0.3417204703878922,"score_spread":0.3151734043750849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565001787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829651,0.0004942002,0.009756873,0.002943927,0.00093227474,0.0019842472,0.0008438286,0.000022886645,0.000056634784],"genre_scores_gemma":[0.9951519,0.0010184958,0.0016111579,0.00026068577,0.0012632484,0.00042567943,0.00016600429,0.000058826354,0.000044054374],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99713385,0.00034293512,0.0012224903,0.0004185438,0.0005496213,0.00033256022],"domain_scores_gemma":[0.9939229,0.001766559,0.0022732064,0.00019402959,0.0016529249,0.00019040814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006615734,0.00038003325,0.0012394086,0.0003839091,0.00007294166,0.00001984669,0.00017038763,0.0003336823,0.0000659672],"category_scores_gemma":[0.0002877627,0.00022472505,0.00022665499,0.00028159554,0.00047705838,0.00054575165,0.000015172678,0.00025284788,0.0000010288259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76470673,0.00450805,0.07059377,0.00010946671,0.0036921424,0.00006839462,0.0022373258,0.000038543425,0.004780141,0.00026873482,0.00025937942,0.14873731],"study_design_scores_gemma":[0.8387358,0.10196242,0.04609968,0.0007385727,0.0023468067,0.00026913988,0.00038361654,0.00027167582,0.0059169736,0.0009688534,0.0018372809,0.00046913297],"about_ca_topic_score_codex":0.00019610663,"about_ca_topic_score_gemma":0.0004445385,"teacher_disagreement_score":0.14826818,"about_ca_system_score_codex":0.000979243,"about_ca_system_score_gemma":0.0036342985,"threshold_uncertainty_score":0.91640216},"labels":[],"label_agreement":null},{"id":"W2565317983","doi":"10.3747/co.23.3304","title":"The Risk of Colorectal Cancer Is Not Increased after a Diagnosis of Urothelial Cancer: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Manitoba Health; CancerCare Manitoba; University of Manitoba","funders":"University of Chinese Academy of Sciences; Manitoba Medical Service Foundation","keywords":"Medicine; Colorectal cancer; Hazard ratio; Cancer; Cancer registry; Internal medicine; Incidence (geometry); Confidence interval; Record linkage; Cohort; Confounding; Population; Oncology; Proportional hazards model; Cohort study; Environmental health","score_opus":0.04484413834296121,"score_gpt":0.3838750586379898,"score_spread":0.3390309202950286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565317983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929761,0.0025563955,0.000011458694,0.0012101377,0.0008215525,0.0012550597,0.0011090345,0.000017338052,0.000042876018],"genre_scores_gemma":[0.9956238,0.0013730265,0.000018725968,0.0001306176,0.00019999756,0.0025918712,0.00000523874,0.000021350097,0.000035352674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985296,0.00023264014,0.00043353596,0.0002714382,0.00029659556,0.00023615068],"domain_scores_gemma":[0.99850744,0.00058831484,0.00032010485,0.00025870718,0.00022238892,0.00010301682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018932497,0.00017536107,0.000495087,0.000080003716,0.00007153977,0.0000033813556,0.00011737487,0.00008092212,0.0007937901],"category_scores_gemma":[0.00014831085,0.000091516,0.00016895836,0.00015663911,0.00013493813,0.00002857775,0.00003527055,0.0001143478,0.000006637065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043713604,0.0015493524,0.89145744,0.000041998428,0.00032064767,0.000004030897,0.0005449274,0.0000013486566,0.00030285024,0.000003490135,0.00041254523,0.10098999],"study_design_scores_gemma":[0.009068389,0.002291802,0.9707657,0.00018838432,0.0009698419,7.150584e-7,0.000058395617,0.000028418914,0.009403801,0.00002743394,0.0070963274,0.00010076424],"about_ca_topic_score_codex":0.008577136,"about_ca_topic_score_gemma":0.0049705436,"teacher_disagreement_score":0.10088923,"about_ca_system_score_codex":0.00042598502,"about_ca_system_score_gemma":0.0008170631,"threshold_uncertainty_score":0.9980248},"labels":[],"label_agreement":null},{"id":"W2565985412","doi":"10.1016/j.clgc.2016.12.025","title":"Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population","year":2016,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Institute for Clinical Evaluative Sciences","keywords":"Medicine; Gemcitabine; Bladder cancer; Carboplatin; Regimen; Internal medicine; Oncology; Vinblastine; Population; Chemotherapy; Cancer registry; Cancer; Cisplatin","score_opus":0.08039182811776317,"score_gpt":0.4279513018811414,"score_spread":0.3475594737633782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565985412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98195,0.0028230473,0.000030447107,0.013285697,0.00039688495,0.0012087001,0.00015855841,0.000023764767,0.00012292276],"genre_scores_gemma":[0.9689504,0.02098934,0.0003828093,0.0041440357,0.0012617721,0.0012344815,0.000016713919,0.00003334478,0.002987117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868345,0.00008856455,0.00041705728,0.00038946318,0.00015457216,0.00026686979],"domain_scores_gemma":[0.9990758,0.00041664444,0.00010430451,0.00024123277,0.000058879603,0.00010317874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015013733,0.00021615179,0.00044821153,0.00004363912,0.00007629507,0.000012211261,0.000076857184,0.0001202622,0.00014455638],"category_scores_gemma":[0.000029214048,0.00010170741,0.0002110772,0.000074465715,0.00009063217,0.000068916896,0.000015740008,0.000079007645,0.000004198035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010845722,0.0004081967,0.7630975,0.000013169032,0.00035789577,0.000013844676,0.00018412757,0.0000020303148,0.00011707784,0.000014709972,0.0008903217,0.23381655],"study_design_scores_gemma":[0.010766165,0.0015620592,0.97588116,0.00007732974,0.0002376395,0.0000032465966,0.00004481542,0.000038007634,0.00023512055,0.00030251988,0.0107040405,0.00014790618],"about_ca_topic_score_codex":0.0011208488,"about_ca_topic_score_gemma":0.0004920364,"teacher_disagreement_score":0.23366866,"about_ca_system_score_codex":0.0002643499,"about_ca_system_score_gemma":0.00016007612,"threshold_uncertainty_score":0.41475078},"labels":[],"label_agreement":null},{"id":"W2566240993","doi":"10.1007/s00345-016-1992-2","title":"Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications","year":2016,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Quality of life (healthcare); Prospective cohort study; Urinary diversion; Subgroup analysis; Urinary system; Nephrology; Internal medicine; Surgery; Urology; Bladder cancer; Confidence interval; Cancer","score_opus":0.04846475699541016,"score_gpt":0.3558637870082769,"score_spread":0.3073990300128668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566240993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545784,0.0049472093,0.00016651685,0.03858427,0.0000854162,0.00046052167,0.00002424102,0.0000038679364,0.0011495426],"genre_scores_gemma":[0.9990552,0.00007567969,0.00011784995,0.00064492977,0.000027814296,0.000016518361,8.490468e-7,0.0000074143745,0.00005373732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998275,0.0005269295,0.0006898507,0.00011701564,0.00029017948,0.00010102826],"domain_scores_gemma":[0.99854857,0.00018635577,0.00053068274,0.0001244404,0.0005086404,0.00010131629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090071454,0.00008235282,0.0004913977,0.00016857528,0.000029312134,0.0000014433643,0.000038194758,0.00004541717,0.0002205816],"category_scores_gemma":[0.00025357158,0.000049145703,0.000072108465,0.00011555251,0.00021630616,0.000039580314,0.000011132941,0.00013199153,0.0000026184173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023242285,0.002230194,0.8096611,0.00009604711,0.0019817522,0.000018723946,0.0056405,0.000022691585,0.01703676,0.008890202,0.0007236637,0.13045609],"study_design_scores_gemma":[0.008943505,0.0033777133,0.98367965,0.0000913538,0.0001756461,0.00008277561,0.000040474777,0.000011256788,0.00056324987,0.0027533683,0.00023782295,0.000043209733],"about_ca_topic_score_codex":0.00006312868,"about_ca_topic_score_gemma":0.00007297007,"teacher_disagreement_score":0.17401853,"about_ca_system_score_codex":0.00012385515,"about_ca_system_score_gemma":0.00046005973,"threshold_uncertainty_score":0.24152137},"labels":[],"label_agreement":null},{"id":"W2566519625","doi":"10.1093/annonc/mdv341.09","title":"Gemcitabine and Platinum (GC) chemotherapy alone or with a Taxane (GC-T) as first-line therapy for urothelial cancer (UC): a meta-analysis","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Taxane; Docetaxel; Gemcitabine; Oncology; Meta-analysis; Paclitaxel; Confidence interval; Carboplatin; Adverse effect; Chemotherapy; Clinical trial; Cancer; Breast cancer; Cisplatin","score_opus":0.23291121346663723,"score_gpt":0.43319080693029927,"score_spread":0.20027959346366203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566519625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86861384,0.016979609,0.0012267355,0.105804816,0.00017547325,0.0040751398,0.000639373,0.00014019641,0.002344812],"genre_scores_gemma":[0.9667445,0.004869288,0.0041668895,0.017241985,0.00036882327,0.0012074177,0.000068925525,0.000106624335,0.0052255434],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982852,0.000072190174,0.00047263422,0.00045941237,0.0003291961,0.0003814131],"domain_scores_gemma":[0.9982337,0.00022276561,0.00033695166,0.00036228128,0.0005577058,0.00028662232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040488996,0.00032544715,0.0019165884,0.00020951671,0.000053529646,0.000011726377,0.00011317214,0.00018218352,0.0008781452],"category_scores_gemma":[0.00008418449,0.00018891277,0.00045213616,0.00045651014,0.00019418997,0.000080339385,0.000022085422,0.000118250944,0.0000042495667],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19206773,0.0070433794,0.019645594,0.00033514982,0.56536174,0.00038754725,0.008015165,0.00037649335,0.0023370327,0.00025743194,0.030862099,0.17331064],"study_design_scores_gemma":[0.08751184,0.11533819,0.008047633,0.00004458726,0.1369585,0.0003067203,0.0005732667,0.0004357017,0.03724929,0.0014222646,0.611137,0.00097503024],"about_ca_topic_score_codex":0.0021471719,"about_ca_topic_score_gemma":0.0024343324,"teacher_disagreement_score":0.5802749,"about_ca_system_score_codex":0.000056115317,"about_ca_system_score_gemma":0.0007773278,"threshold_uncertainty_score":0.96150744},"labels":[],"label_agreement":null},{"id":"W2568625379","doi":"10.5489/cuaj.4280","title":"Update on Bladder, Kidney, and Prostate Cancer from the European Society for Medical Oncology (ESMO) Annual Meeting 2016","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Urological Association; McMaster University","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Bladder cancer; Kidney cancer; Internal medicine; Urology; Cancer","score_opus":0.0116805453982041,"score_gpt":0.26390855898801924,"score_spread":0.2522280135898151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568625379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18867058,0.0012781833,0.000111314745,0.8011356,0.0009606191,0.00063104765,0.002220155,0.00004592957,0.004946602],"genre_scores_gemma":[0.8818299,0.0032681988,0.00022652114,0.109639555,0.0032195689,0.000053084957,0.000046157835,0.000037775408,0.0016791999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998231,0.00032428282,0.00031206646,0.00026077955,0.00036678588,0.00050507946],"domain_scores_gemma":[0.9977707,0.0006000029,0.00022405064,0.000096216914,0.00021897207,0.0010900332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013496157,0.00015887365,0.0002580702,0.000031458047,0.00042767846,0.000045057903,0.00013807043,0.00022695564,0.0007989508],"category_scores_gemma":[0.001346183,0.00007747123,0.00017796854,0.00006571156,0.00009908388,0.00007018965,0.00002538021,0.00040658985,0.000040744748],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002726711,0.00006765883,0.21209773,0.000002951518,0.0007514093,0.000084620035,0.00068852876,8.262542e-7,0.00008820311,0.00007353107,0.6129872,0.17288466],"study_design_scores_gemma":[0.00496534,0.0006272865,0.21425496,0.000094452334,0.00023448744,0.000054172026,0.00012848413,0.00001816838,0.000025846215,0.0008701442,0.77859616,0.00013049852],"about_ca_topic_score_codex":0.0022819487,"about_ca_topic_score_gemma":0.0015859164,"teacher_disagreement_score":0.69315934,"about_ca_system_score_codex":0.00093587325,"about_ca_system_score_gemma":0.0017373137,"threshold_uncertainty_score":0.8747951},"labels":[],"label_agreement":null},{"id":"W2569595297","doi":"10.5489/cuaj.4281","title":"Bladder cancer, ESMO 2016","year":2016,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Urology; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.03530861096018505,"score_gpt":0.3189381003531492,"score_spread":0.2836294893929641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569595297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004381859,0.9832596,0.000008086806,0.006392399,0.0013045225,0.00047230892,0.00046984007,0.00003510796,0.008053709],"genre_scores_gemma":[0.000040313043,0.9782287,0.000027124417,0.0028654416,0.0030305276,0.00008894842,0.000049410064,0.00005552305,0.01561402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738836,0.00026953462,0.00066976005,0.00036990692,0.00046059865,0.0008418276],"domain_scores_gemma":[0.99723434,0.00019144565,0.000650538,0.00020655764,0.00027526036,0.001441862],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004038774,0.00042601177,0.0015057022,0.00033530727,0.0002751364,0.00009266696,0.00022431515,0.00096019974,0.008037231],"category_scores_gemma":[0.0003312455,0.00024542958,0.0008093905,0.00024067727,0.000040507915,0.000080316764,0.00001989193,0.0010689084,0.0011550954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000009999233,0.000029292189,0.0015586651,0.0001603715,0.0011340164,0.000198708,0.000009415656,5.3320736e-8,4.8614822e-8,0.000027580858,0.12222736,0.87464446],"study_design_scores_gemma":[0.00077475974,0.0001842472,0.00094425137,0.0022268295,0.0016346416,0.00049005204,0.0000021206642,2.4285544e-7,1.0747843e-7,0.00017852394,0.9933026,0.00026164882],"about_ca_topic_score_codex":0.001810793,"about_ca_topic_score_gemma":0.0005578228,"teacher_disagreement_score":0.87438285,"about_ca_system_score_codex":0.005160717,"about_ca_system_score_gemma":0.00685196,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2570031758","doi":"10.1016/b978-0-12-804003-4.00010-4","title":"Metastatic Bladder Cancer","year":2017,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Occult; Bladder cancer; Disease; Magnetic resonance imaging; Cancer; Oncology; Genitourinary system; Chemotherapy; Metastasis; Positron emission tomography; Internal medicine; Radiology; Pathology","score_opus":0.03993279583197653,"score_gpt":0.317718000442274,"score_spread":0.2777852046102975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570031758","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018813636,0.008359447,0.0000012408913,0.00033401608,0.0006942798,0.0010414581,0.00021339554,0.000082323,0.989255],"genre_scores_gemma":[0.0009802233,0.0010110467,0.00021294167,0.0013558123,0.0008906436,0.00018036106,0.000055264594,0.00019018233,0.9951235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822736,0.000012240337,0.00036731389,0.00056162267,0.00047413982,0.0003573101],"domain_scores_gemma":[0.99815553,0.000024297879,0.00030065313,0.0010968931,0.00014586758,0.00027673162],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008700758,0.00056609506,0.0009715777,0.00012835844,0.0001804435,0.000052881373,0.00022100638,0.00024399074,0.004036953],"category_scores_gemma":[0.000012745113,0.0004509535,0.00043432697,0.000003590172,0.00021003145,0.000037744816,0.00008361892,0.0004968855,0.0007414688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008971007,0.000020462943,0.000029396873,0.0001919063,0.001722214,0.00036265675,0.0001339441,6.367186e-8,0.000019812689,0.0006824498,0.0018377102,0.99490964],"study_design_scores_gemma":[0.0015670522,0.0001985862,0.00011546518,0.0009842777,0.003000682,0.00008781319,0.000003054619,0.0000010744382,0.00013239255,0.0049254363,0.9885857,0.00039846273],"about_ca_topic_score_codex":0.0000122457795,"about_ca_topic_score_gemma":0.00011043986,"teacher_disagreement_score":0.9945112,"about_ca_system_score_codex":0.0001942255,"about_ca_system_score_gemma":0.0006565724,"threshold_uncertainty_score":0.99979424},"labels":[],"label_agreement":null},{"id":"W2570494786","doi":"10.1016/j.urolonc.2016.12.003","title":"Quality indicators in the management of bladder cancer: A modified Delphi study","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Dalhousie University; Université Laval; University of Alberta; McGill University; McGill University Health Centre; University of Ottawa; University of Manitoba; University of Calgary; Princess Margaret Cancer Centre; Western University; University of Toronto; University Health Network; Université de Montréal; Queen's University; University of British Columbia","funders":"Bladder Cancer Canada","keywords":"Benchmarking; Medicine; Delphi method; Bladder cancer; Delphi; Quality management; Best practice; Quality (philosophy); Medical physics; Operations management; Cancer; Management system; Computer science; Artificial intelligence; Management","score_opus":0.08052186606323836,"score_gpt":0.40997048396774216,"score_spread":0.3294486179045038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570494786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98106956,0.000531422,0.000007552221,0.0061620763,0.000093441464,0.000850548,0.000015987014,0.000012659281,0.011256765],"genre_scores_gemma":[0.9959,0.0005721399,0.0018630484,0.00096087356,0.000042411768,0.00034141063,0.000006647203,0.0000060962143,0.00030737766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891955,0.00014777642,0.00030009623,0.00026235072,0.00018431924,0.0001859197],"domain_scores_gemma":[0.99913985,0.00008566826,0.0002346638,0.0004265331,0.000025849822,0.000087436965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005486026,0.0001323687,0.00031356348,0.00013169371,0.00030726683,0.000019160148,0.00022677082,0.00009884116,0.000049116024],"category_scores_gemma":[0.000031487954,0.00008552764,0.000041156763,0.00017235627,0.00058941304,0.00006383735,0.00006707892,0.00021308016,0.0000031254742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016545077,0.00088902574,0.9809072,0.000038017366,0.00024639236,0.00016020254,0.002458829,0.000012381421,0.000015491993,0.007881311,0.00035221752,0.006873474],"study_design_scores_gemma":[0.0033497915,0.0021541093,0.9365504,0.00004687762,0.00063390716,0.000034224322,0.0036649907,0.000044863857,0.000044055865,0.005381907,0.047976952,0.000117919226],"about_ca_topic_score_codex":0.0009140007,"about_ca_topic_score_gemma":0.0003074033,"teacher_disagreement_score":0.047624733,"about_ca_system_score_codex":0.00006355669,"about_ca_system_score_gemma":0.00015925903,"threshold_uncertainty_score":0.3487716},"labels":[],"label_agreement":null},{"id":"W2570552273","doi":"10.1007/s00345-016-1995-z","title":"Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review","year":2017,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Cisplatin; Urology; Urothelium; Chemotherapy; Randomized controlled trial; Internal medicine; Perioperative; Oncology; Nephrology; Upper urinary tract; Urothelial carcinoma; Prospective cohort study; Cancer; Bladder cancer; Surgery; Urinary system","score_opus":0.08767314273322378,"score_gpt":0.40105130032072434,"score_spread":0.31337815758750054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570552273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020252823,0.9923923,0.000002189243,0.0022348564,0.0006227393,0.0012913413,0.000029421533,0.000006643105,0.0034002273],"genre_scores_gemma":[0.00030981266,0.9933145,0.00010966657,0.0037408206,0.0009109307,0.000053263473,0.000019045914,0.00008381754,0.0014581257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714667,0.0004333169,0.0013711113,0.00035380878,0.0003039876,0.00039111386],"domain_scores_gemma":[0.9974876,0.00016623626,0.0013427553,0.0005292848,0.00026653305,0.00020761472],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032391833,0.0005619563,0.0048290286,0.00062536896,0.00007550383,0.000023011075,0.00039608026,0.00025454708,0.00094331906],"category_scores_gemma":[0.00008436929,0.0003738854,0.001206405,0.00022369335,0.00019143875,0.00009558275,0.000040309358,0.0014471977,0.000055429464],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037582518,0.00042804336,0.00041221644,0.013111664,0.0006553741,0.0025030633,0.0001490121,1.3699383e-7,0.0000013649087,0.000023505867,0.0028905568,0.9794492],"study_design_scores_gemma":[0.0036882085,0.0011708937,0.00095690263,0.020109024,0.002629317,0.006599766,0.0000059829767,3.03877e-7,5.1081537e-7,0.000011308397,0.9645989,0.00022891116],"about_ca_topic_score_codex":0.00002924437,"about_ca_topic_score_gemma":0.000018538114,"teacher_disagreement_score":0.97922033,"about_ca_system_score_codex":0.0002694902,"about_ca_system_score_gemma":0.0016119363,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null},{"id":"W2573900640","doi":"10.5489/cuaj.3789","title":"Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Urothelial carcinoma; Radiology; Carcinoma; Pathology; Internal medicine; Cancer; Bladder cancer","score_opus":0.01084299845315784,"score_gpt":0.23610699809706692,"score_spread":0.22526399964390909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573900640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9287784,0.0003548709,0.00023694534,0.03881637,0.0008878661,0.00038817019,0.00006979341,0.00005773605,0.030409807],"genre_scores_gemma":[0.9928997,0.000024338286,0.00031789535,0.0034941144,0.0008145221,0.00001284091,0.000019600984,0.000019362398,0.002397625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845135,0.000100099845,0.00024048303,0.00027235935,0.00041287768,0.0005228013],"domain_scores_gemma":[0.9983639,0.000057030713,0.0003730252,0.00024228632,0.0002476886,0.0007160774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033809818,0.00019666697,0.0003056111,0.0001243871,0.0012423396,0.0002748427,0.00019890253,0.00020603351,0.00049672317],"category_scores_gemma":[0.0005497898,0.00013547989,0.00013107288,0.00005372807,0.00010135819,0.0002029981,0.000019968591,0.0007373865,0.000071851886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002855939,0.000040627277,0.9879323,0.0000021270287,0.000045592176,0.0009629039,0.00008580747,0.000012225177,0.00007378295,0.00013349408,0.006213169,0.0042123534],"study_design_scores_gemma":[0.0027285826,0.0004706647,0.9703114,0.000014770827,0.00014719879,0.0021208287,0.000032098913,0.00009281634,0.0000430107,0.000367176,0.023516571,0.00015486847],"about_ca_topic_score_codex":0.0021042186,"about_ca_topic_score_gemma":0.0010303046,"teacher_disagreement_score":0.06412126,"about_ca_system_score_codex":0.0014153055,"about_ca_system_score_gemma":0.0007432111,"threshold_uncertainty_score":0.95551974},"labels":[],"label_agreement":null},{"id":"W2576982875","doi":"","title":"ChAcNLS-A14, a novel antibody-conjugate PET tracer for targeting human IL-5Rα-positive muscle invasive bladder cancer","year":2016,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Biodistribution; Monoclonal antibody; Cancer research; Positron emission tomography; Chemistry; In vivo; Intracellular; Antibody; Endosome; Imaging agent; Medicine; In vitro; Nuclear medicine; Biology; Immunology; Biochemistry","score_opus":0.0285778879119965,"score_gpt":0.33152819185849686,"score_spread":0.30295030394650035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576982875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557309,0.0005648339,0.006324825,0.008268172,0.00065165776,0.0032587524,0.0017016415,0.0002915429,0.023207642],"genre_scores_gemma":[0.9808777,0.00020364516,0.001648792,0.002352842,0.0007879436,0.00044874335,0.0001139804,0.000094889634,0.013471462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810934,0.000024144802,0.0004020234,0.0006103808,0.00024525617,0.00060884893],"domain_scores_gemma":[0.99884903,0.00015954567,0.00014401745,0.00028970372,0.00030869502,0.00024900972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001527075,0.00035085352,0.00047935537,0.000102836944,0.0002414761,0.00003051115,0.0001172356,0.00010078698,0.0021387641],"category_scores_gemma":[0.000075386044,0.0002190676,0.00023771233,0.000126552,0.00012567326,0.00021982864,0.000049070277,0.00011485583,0.0000802276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048055153,0.0005028825,0.0063827075,0.000102807746,0.0007645293,0.00004383152,0.0011658082,0.0000010420933,0.9763834,0.0006647354,0.006827516,0.0066802083],"study_design_scores_gemma":[0.044368338,0.0041534975,0.10464901,0.0015997548,0.0019324019,0.0001292509,0.0017349203,0.00008507317,0.8024784,0.0010132502,0.036182135,0.0016740077],"about_ca_topic_score_codex":0.0010121743,"about_ca_topic_score_gemma":0.00031459177,"teacher_disagreement_score":0.17390501,"about_ca_system_score_codex":0.00020780705,"about_ca_system_score_gemma":0.00027598577,"threshold_uncertainty_score":0.9987734},"labels":[],"label_agreement":null},{"id":"W2580323927","doi":"10.1200/jco.2012.30.5_suppl.287","title":"Extended lymphadenectomy and adjuvant chemotherapy in muscle-invasive bladder cancer treated by radical cystectomy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphadenectomy; Lymph node; Urology; Dissection (medical); Proportional hazards model; Adjuvant; Cisplatin; Cohort; Chemotherapy; Oncology; Stage (stratigraphy); Internal medicine; Cancer; Surgery","score_opus":0.06565529934703658,"score_gpt":0.43626167899297397,"score_spread":0.3706063796459374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580323927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97880596,0.012498623,0.000015848638,0.0062483745,0.0007156089,0.00029749083,0.000009398866,0.000012238021,0.0013964674],"genre_scores_gemma":[0.9838487,0.009126281,0.00042272196,0.0049105324,0.0013119418,0.0000189742,0.0000031692648,0.00003087113,0.00032680164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971419,0.0003662128,0.001540123,0.00021605987,0.00032258232,0.00041309703],"domain_scores_gemma":[0.99730396,0.0009735203,0.00072955695,0.00014907481,0.00015303606,0.0006908248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001147598,0.00021054054,0.0015913129,0.0001327163,0.000029650291,0.000006998672,0.00010308123,0.0004684725,0.0005296158],"category_scores_gemma":[0.0005823057,0.00014129994,0.00028813837,0.00016797628,0.000257333,0.00016223364,0.000025579984,0.00059504376,0.000009110874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051022638,0.003937185,0.6727909,0.000029913195,0.0008693995,0.00046790953,0.00039483377,4.4021843e-7,0.002092197,0.000012570328,0.008905368,0.30539703],"study_design_scores_gemma":[0.036960877,0.005740888,0.88686275,0.00014834413,0.00050848856,0.00056211423,0.000108834916,0.000010965004,0.0016148386,0.00006300148,0.067270465,0.00014844033],"about_ca_topic_score_codex":0.00024583805,"about_ca_topic_score_gemma":0.000090691334,"teacher_disagreement_score":0.3052486,"about_ca_system_score_codex":0.00031863016,"about_ca_system_score_gemma":0.0012353517,"threshold_uncertainty_score":0.57989216},"labels":[],"label_agreement":null},{"id":"W2580444273","doi":"10.3233/blc-160081","title":"The Rationale for Post-Operative Radiation in Localized Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Radiation therapy; Medical physics; General surgery; Radiology; Internal medicine","score_opus":0.1166406513632305,"score_gpt":0.45455093499995636,"score_spread":0.33791028363672587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580444273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009577249,0.9869263,0.000051302184,0.0021080482,0.0013930756,0.0065445853,0.0012971116,0.00004234813,0.0016276449],"genre_scores_gemma":[0.000029709301,0.9630736,0.000075749034,0.0009353749,0.0017783232,0.015958115,0.00056206726,0.00014697885,0.017440088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721223,0.000155912,0.00081407354,0.00076482305,0.00044741321,0.00060553727],"domain_scores_gemma":[0.9977516,0.0003526913,0.00055549556,0.00078386307,0.000382305,0.0001740569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029018935,0.00066397275,0.0017601644,0.00017788704,0.00055172166,0.00017318153,0.0003660488,0.00042801673,0.00085115194],"category_scores_gemma":[0.00018130626,0.00041206984,0.0006751051,0.00020978427,0.00021231023,0.0001829692,0.000059054455,0.0004581265,0.000063067426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026423144,0.000102555045,0.00004889826,0.0019786635,0.0015999736,0.000011530755,0.00040050532,0.0000065492522,0.0000012963595,0.00014593215,0.018174913,0.97726494],"study_design_scores_gemma":[0.0036123157,0.00017764588,0.00013923491,0.004832345,0.002331548,0.000013748126,0.000074805204,0.00004644111,0.000015782036,0.0000685211,0.98825586,0.00043174956],"about_ca_topic_score_codex":0.0016603147,"about_ca_topic_score_gemma":0.004107318,"teacher_disagreement_score":0.9768332,"about_ca_system_score_codex":0.0010460645,"about_ca_system_score_gemma":0.0048632706,"threshold_uncertainty_score":0.9998331},"labels":[],"label_agreement":null},{"id":"W2581289368","doi":"10.3233/blc-160084","title":"Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Campbell Scientific (Canada)","funders":"","keywords":"Medicine; Cystoscopy; Biopsy; Cytology; Internal medicine; BCG vaccine; Urology; Surgery; Urinary system; Vaccination; Pathology","score_opus":0.023480088925008715,"score_gpt":0.2858945950353526,"score_spread":0.2624145061103439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581289368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268574,0.0005883939,0.00001650925,0.001108532,0.00035234122,0.0008187362,0.00023155892,0.00004763578,0.004150567],"genre_scores_gemma":[0.9962644,0.0002902748,0.00013639765,0.0010464046,0.00016836575,0.00011766977,0.0000334464,0.000061730265,0.0018813366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981657,0.000076498596,0.0004390639,0.00045233621,0.00040412383,0.0004622743],"domain_scores_gemma":[0.99887514,0.0000968405,0.0001731448,0.000456577,0.00020811026,0.0001901582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007368882,0.00029294964,0.000529915,0.00018623353,0.00003916958,0.00000952733,0.0001574231,0.00012860668,0.0029341555],"category_scores_gemma":[0.00005051966,0.00020090517,0.000157943,0.0002719039,0.00013349413,0.000120722405,0.00006862702,0.00012202899,0.00015006124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073823687,0.0024861142,0.59628165,0.00025845866,0.0004577415,0.00006565225,0.0016834859,0.0000032522414,0.32103223,0.00003574565,0.014040001,0.056273304],"study_design_scores_gemma":[0.01807342,0.0006709878,0.89397794,0.0003564031,0.00017715846,0.0000038119226,0.000043170967,0.0000049589435,0.074570544,0.000032300166,0.011832221,0.0002570682],"about_ca_topic_score_codex":0.00045464616,"about_ca_topic_score_gemma":0.00011708232,"teacher_disagreement_score":0.2976963,"about_ca_system_score_codex":0.00032653467,"about_ca_system_score_gemma":0.00032088393,"threshold_uncertainty_score":0.9979773},"labels":[],"label_agreement":null},{"id":"W2582477473","doi":"10.20381/ruor-18370","title":"Recreational physical activity, relative body weight and risk of bladder cancer: A case-control study","year":2004,"lang":"en","type":"article","venue":"uO Research (University of Ottawa)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weight control; Recreation; Physical activity; Bladder cancer; Medicine; Body weight; Relative risk; Environmental health; Cancer; Physical therapy; Obesity; Internal medicine; Biology; Confidence interval","score_opus":0.03743884280951079,"score_gpt":0.34242368892330177,"score_spread":0.30498484611379095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582477473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917903,0.00007902033,0.00019364021,0.0007508925,0.000015871066,0.0008410809,0.0002818309,0.000012959562,0.006034412],"genre_scores_gemma":[0.99812675,0.0002526193,0.00022658776,0.0000037476896,0.000054040087,0.000003349617,0.0000028248382,0.000010053655,0.0013200351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986147,0.0002343259,0.00007011556,0.0002766701,0.000588884,0.00021525082],"domain_scores_gemma":[0.9989628,0.00024371236,0.00008111388,0.00020769346,0.00034252708,0.0001621063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031833368,0.00010347581,0.00032542317,0.00022635104,0.00024334661,0.0000049789687,0.000087518165,0.00006001464,0.0002582111],"category_scores_gemma":[0.0000645258,0.000099359066,0.000086781176,0.0003261232,0.0003886685,0.00019458718,0.00007534581,0.00034576084,0.000008932888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008091373,0.0044423407,0.9636313,0.000090141395,0.0034088949,0.0017778518,0.006458475,0.000024656754,0.0019814586,0.0026032887,0.00031813412,0.014454334],"study_design_scores_gemma":[0.012095464,0.0027602657,0.9796612,0.000075988435,0.00076013384,0.000060935516,0.00248097,0.00027119328,0.0007705575,0.0007224084,0.00024694687,0.00009393327],"about_ca_topic_score_codex":0.0061359,"about_ca_topic_score_gemma":0.0017095448,"teacher_disagreement_score":0.016029915,"about_ca_system_score_codex":0.0001973082,"about_ca_system_score_gemma":0.0003615713,"threshold_uncertainty_score":0.9275687},"labels":[],"label_agreement":null},{"id":"W2583154960","doi":"10.1200/jco.2012.30.5_suppl.281","title":"Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Lymph node; Urology; Cancer; Retrospective cohort study; Oncology; Cohort; Lymphovascular invasion; Cutoff; Metastasis","score_opus":0.06613269030895551,"score_gpt":0.3862691484980403,"score_spread":0.32013645818908476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583154960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788105,0.00039687142,0.00003970745,0.0003907804,0.00045714993,0.00029792127,0.000007742642,0.0000030134688,0.00052574265],"genre_scores_gemma":[0.99514693,0.000040900293,0.0032734852,0.0012067348,0.0002834259,0.0000035943197,0.00000123924,0.000022031487,0.000021663749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978345,0.0002675479,0.0011912357,0.00014273691,0.00031894405,0.0002450274],"domain_scores_gemma":[0.9980013,0.0007279978,0.00067656237,0.00012964997,0.0001609417,0.00030355377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009724938,0.00013767053,0.0009987084,0.00011209479,0.000015036712,0.0000029313521,0.000060833405,0.00022322545,0.0000411428],"category_scores_gemma":[0.00061750674,0.00008261678,0.00017214868,0.0000789452,0.00018934566,0.00011541791,0.000015698086,0.0003514508,0.0000028853256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010001667,0.004168546,0.9686434,0.000028694516,0.00013359492,0.000054069245,0.00019877478,0.0000067108817,0.00003844885,0.000015434833,0.00003085595,0.016679764],"study_design_scores_gemma":[0.019940218,0.009063793,0.9692246,0.00014799325,0.00047747206,0.0001311151,0.000042797597,0.000016995973,0.00009562755,0.000034199442,0.000749195,0.00007600765],"about_ca_topic_score_codex":0.00007119933,"about_ca_topic_score_gemma":0.0000033434596,"teacher_disagreement_score":0.016603755,"about_ca_system_score_codex":0.00008051986,"about_ca_system_score_gemma":0.00054623664,"threshold_uncertainty_score":0.33690146},"labels":[],"label_agreement":null},{"id":"W2583780966","doi":"10.1016/b0-32-301206-x/50046-9","title":"Urinary Tract","year":2006,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Urinary system; Medicine; Internal medicine","score_opus":0.019923646150527108,"score_gpt":0.26634791402480135,"score_spread":0.24642426787427424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583780966","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007018849,0.003952139,9.1122325e-7,0.00011593475,0.00030570087,0.000735417,0.00008008252,0.00011961257,0.99462],"genre_scores_gemma":[0.004510251,0.00012085092,0.00013199277,0.0007582553,0.0010722339,0.000042615484,0.00012640867,0.00015254751,0.99308485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858546,0.000008441096,0.00034129928,0.00043547348,0.00035745182,0.0002718905],"domain_scores_gemma":[0.99907917,0.000019839123,0.00012599838,0.000545524,0.00006274805,0.00016669508],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000052776704,0.00044918075,0.00064571516,0.00012755275,0.00006481889,0.000016250757,0.00009882279,0.0003651303,0.0011464081],"category_scores_gemma":[0.0000025289587,0.0003786092,0.00039341475,0.000006846819,0.000093943796,0.00001960554,0.00003938601,0.00045505902,0.0007212389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101271784,0.00013067457,0.00008657997,0.00015880866,0.0002462074,0.0014250476,0.000040783027,7.168909e-8,0.000012822128,0.00046950334,0.0036839333,0.9936443],"study_design_scores_gemma":[0.001185298,0.0006979322,0.0006006295,0.0005150852,0.000743922,0.00066456676,0.0000012026909,4.180395e-7,0.000051362764,0.0027541802,0.99246985,0.00031552618],"about_ca_topic_score_codex":0.0000022674017,"about_ca_topic_score_gemma":0.0000023659704,"teacher_disagreement_score":0.99332875,"about_ca_system_score_codex":0.00016484199,"about_ca_system_score_gemma":0.0002389826,"threshold_uncertainty_score":0.9998666},"labels":[],"label_agreement":null},{"id":"W2584427226","doi":"10.1016/j.tranon.2017.01.001","title":"Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Translational Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Canada Research Chairs; Sinai Health System","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"DNA methylation; CpG site; Methylation; Epigenetics; Biology; Bladder cancer; Epigenomics; Differentially methylated regions; Gene; Cancer research; Molecular biology; Cancer; Genetics; Gene expression","score_opus":0.04840957955166663,"score_gpt":0.36209339141559627,"score_spread":0.31368381186392963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584427226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816042,0.00082366134,0.0026914338,0.009632825,0.00092434726,0.00092254684,0.000077039316,0.000049325914,0.0032746152],"genre_scores_gemma":[0.99704576,0.00014927171,0.0014762928,0.00017045253,0.00034518013,0.00018328692,0.00026628387,0.000030231698,0.00033324945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840003,0.00012338278,0.00045910344,0.00039018947,0.00033359003,0.00029368585],"domain_scores_gemma":[0.9990924,0.00019818221,0.00022878054,0.0002737547,0.00010565218,0.00010125816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002424619,0.00020904478,0.00043323968,0.00023907285,0.00026777232,0.000042338615,0.00013165867,0.00023040937,0.0007363069],"category_scores_gemma":[0.000060329887,0.00019131509,0.00012702153,0.000107086074,0.00015924346,0.0002974783,0.000018385103,0.00020279177,0.000026514279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00247336,0.0008959453,0.76346433,0.00014974178,0.0018051635,0.00008916814,0.0017921723,0.00036899286,0.1631571,0.0029204504,0.00015401542,0.06272957],"study_design_scores_gemma":[0.006014158,0.00019889502,0.96223307,0.000043779783,0.00036882306,0.0000023848454,0.0000449945,0.00042116773,0.0247915,0.004603759,0.0010890798,0.00018839244],"about_ca_topic_score_codex":0.0010780204,"about_ca_topic_score_gemma":0.0019426483,"teacher_disagreement_score":0.19876875,"about_ca_system_score_codex":0.00026944745,"about_ca_system_score_gemma":0.0004487936,"threshold_uncertainty_score":0.8062044},"labels":[],"label_agreement":null},{"id":"W2586170806","doi":"10.1093/annonc/mdw373.08","title":"Interim analysis of a phase I dose escalation trial of the antibody drug conjugate (ADC) AGS15E (ASG-15ME) in patients (Pts) with metastatic urothelial cancer (mUC)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"Amgen","keywords":"Medicine; Internal medicine; Adverse effect; Interim analysis; Response Evaluation Criteria in Solid Tumors; Cancer; Gastroenterology; Phases of clinical research; Chemotherapy; Surgery; Urology; Clinical trial","score_opus":0.06243164239010057,"score_gpt":0.4239651933169824,"score_spread":0.36153355092688183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586170806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963785,0.000071067494,0.00005681508,0.001465156,0.00017697387,0.00089889,0.0003026375,0.0000055410237,0.00064444874],"genre_scores_gemma":[0.99918604,0.00018231107,0.000053921223,0.00029149716,0.000037654157,0.00007494665,0.000022876893,0.000015153836,0.00013562733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983058,0.0002641416,0.00068339915,0.00023208576,0.00031010163,0.00020449061],"domain_scores_gemma":[0.9984632,0.00019525192,0.00061693153,0.00031650026,0.00034151258,0.00006656667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030844854,0.00015917719,0.0009566963,0.0003069473,0.000018176583,0.000002014285,0.00013060548,0.000065475215,0.0003195567],"category_scores_gemma":[0.00013719224,0.000081998754,0.00023736795,0.0005848234,0.0002677109,0.00008039609,0.000038823076,0.00007958768,0.0000017679429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32397142,0.018695543,0.3688247,0.00024382274,0.010634283,0.000028711296,0.0038212999,0.000087774,0.041445352,0.00015024356,0.00067992206,0.23141693],"study_design_scores_gemma":[0.40108037,0.03486912,0.43769848,0.0008055104,0.008407213,0.0000031551594,0.00021339188,0.00023021699,0.11410589,0.00019604027,0.0020748717,0.0003157376],"about_ca_topic_score_codex":0.0015978732,"about_ca_topic_score_gemma":0.0008562185,"teacher_disagreement_score":0.23110119,"about_ca_system_score_codex":0.00007187618,"about_ca_system_score_gemma":0.00044089978,"threshold_uncertainty_score":0.34989217},"labels":[],"label_agreement":null},{"id":"W2587352635","doi":"10.1016/j.ijrobp.2017.01.239","title":"Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Radiation therapy; Bladder cancer; Cystoscopy; Cumulative incidence; Genitourinary system; Toxicity; Adverse effect; Internal medicine; Population; Surgery; Incidence (geometry); Cancer; Urology; Urinary system; Cohort","score_opus":0.06330127146312493,"score_gpt":0.4300675497050437,"score_spread":0.36676627824191876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587352635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97681844,0.0005409308,0.00810323,0.0066572917,0.004602164,0.0019526185,0.0009882618,0.00002029238,0.00031679272],"genre_scores_gemma":[0.9911836,0.0019998362,0.004083383,0.0006767472,0.0014942605,0.00016759626,0.0001964497,0.00003560344,0.00016256954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805856,0.00012893217,0.0010816209,0.00026476217,0.00024011817,0.00022602883],"domain_scores_gemma":[0.995888,0.00067303766,0.0018524895,0.00018408081,0.0012907863,0.00011162799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046742792,0.00021892047,0.00078963855,0.00015110018,0.00011346795,0.000023342978,0.00027019682,0.0002631144,0.000059647627],"category_scores_gemma":[0.0005851921,0.00016934409,0.00047513848,0.000051974046,0.00021140676,0.00042926628,0.00002209475,0.00018968123,0.000003057404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00358349,0.0017926762,0.6872748,0.0000038858807,0.0018395081,0.0000027170295,0.00010242812,0.00005588349,0.00025627858,0.00055081735,0.0011455602,0.30339193],"study_design_scores_gemma":[0.053086244,0.006853586,0.9137403,0.000036961857,0.00031436383,0.0000058290802,0.00002744575,0.0012377278,0.0022625404,0.0035963962,0.01868696,0.00015165708],"about_ca_topic_score_codex":0.0002033272,"about_ca_topic_score_gemma":0.000019543826,"teacher_disagreement_score":0.30324027,"about_ca_system_score_codex":0.0010980266,"about_ca_system_score_gemma":0.0009907318,"threshold_uncertainty_score":0.69056517},"labels":[],"label_agreement":null},{"id":"W2587762331","doi":"10.1136/esmoopen-2016-000123","title":"Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?","year":2017,"lang":"en","type":"article","venue":"ESMO Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Canadian Urological Oncology Group","keywords":"Cystectomy; Medicine; Radiation therapy; Bladder cancer; Adjuvant; Oncology; Occult; Internal medicine; Cancer; Pathology","score_opus":0.04459885941320157,"score_gpt":0.33904296998624284,"score_spread":0.29444411057304126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587762331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94427234,0.008358369,0.0024605398,0.0150923375,0.001211699,0.017856067,0.0009818025,0.00012759534,0.00963927],"genre_scores_gemma":[0.9857351,0.000249894,0.0063879048,0.00083145563,0.00037549072,0.0021472224,0.00003785584,0.00007624973,0.0041587935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859935,0.000034051463,0.00024876682,0.0005776606,0.00014360034,0.00039654612],"domain_scores_gemma":[0.9987016,0.00017244508,0.00015058751,0.00073460024,0.00004911329,0.00019166844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001617624,0.00030895055,0.00072141294,0.000047041554,0.00064757373,0.000196104,0.00039129824,0.00014708216,0.0001259281],"category_scores_gemma":[0.00010508463,0.00022098297,0.00030703546,0.000022921944,0.00011503461,0.0001874133,0.000097748336,0.00006821596,0.0000054440957],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027239073,0.0036221342,0.205843,0.001017743,0.010754397,0.0020594175,0.028831927,0.000003522953,0.012458749,0.0028178208,0.021508174,0.68384403],"study_design_scores_gemma":[0.11789747,0.015190723,0.2077231,0.00055711734,0.0026674843,0.0002826474,0.0012608547,0.0006915928,0.019858684,0.0028587813,0.6299852,0.0010263317],"about_ca_topic_score_codex":0.004366981,"about_ca_topic_score_gemma":0.00044789372,"teacher_disagreement_score":0.6828177,"about_ca_system_score_codex":0.00032214628,"about_ca_system_score_gemma":0.00046965198,"threshold_uncertainty_score":0.9011424},"labels":[],"label_agreement":null},{"id":"W2587799561","doi":"10.1093/annonc/mdw373.10","title":"IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Atezolizumab; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Clinical endpoint; Urology; Oncology; Gastroenterology; Clinical trial; Cancer; Urothelial carcinoma; Nivolumab; Bladder cancer; Immunotherapy","score_opus":0.11868851925964756,"score_gpt":0.4243890684159451,"score_spread":0.3057005491562975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587799561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98564804,0.0011158303,0.000715963,0.004374688,0.00018515726,0.000689272,0.00025240748,0.00003664186,0.006981983],"genre_scores_gemma":[0.99646974,0.0011360972,0.00098963,0.0005298946,0.00008119716,0.000083625004,0.00003978206,0.000042599037,0.0006274574],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754083,0.00014509214,0.0010355462,0.00043606773,0.0003281409,0.0005143027],"domain_scores_gemma":[0.9981377,0.00032655173,0.00042691722,0.00047098458,0.00045264725,0.00018516339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028244217,0.00030820226,0.001233938,0.00043462645,0.000034606448,0.0000035223943,0.00020734427,0.00017053074,0.0008051405],"category_scores_gemma":[0.00025236874,0.00020908169,0.000227752,0.0005358974,0.00026938348,0.00013723767,0.000077041346,0.00014570706,0.000051259496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040697638,0.0078036427,0.19734189,0.0010027117,0.0022419535,0.0018599338,0.0011722198,0.000660747,0.26124895,0.0005473792,0.01158143,0.47384152],"study_design_scores_gemma":[0.04347269,0.026983485,0.08873529,0.0010160017,0.0008618623,0.00023996051,0.00022297648,0.00042834037,0.81732,0.0034339384,0.01660725,0.0006782279],"about_ca_topic_score_codex":0.0012818403,"about_ca_topic_score_gemma":0.00057154405,"teacher_disagreement_score":0.55607104,"about_ca_system_score_codex":0.000111665155,"about_ca_system_score_gemma":0.00066584663,"threshold_uncertainty_score":0.88157237},"labels":[],"label_agreement":null},{"id":"W2588087814","doi":"10.1016/j.urolonc.2017.01.012","title":"Prognostic role of N-cadherin expression in patients with non–muscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Bladder cancer; Proportional hazards model; Immunohistochemistry; Oncology; Pathological; Adjuvant therapy; Biomarker; Cadherin; Stage (stratigraphy); Cancer; Urology; Adjuvant; Gastroenterology; Biology","score_opus":0.01764593332350883,"score_gpt":0.2994738744372035,"score_spread":0.2818279411136947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588087814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525833,0.00042835355,0.000005371716,0.0010342897,0.00007651704,0.00059694354,0.000033770164,0.0000140580605,0.002552371],"genre_scores_gemma":[0.99212414,0.00023541851,0.0067764297,0.00036790204,0.000053539374,0.00020255284,0.000025589012,0.00001361662,0.00020082298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990905,0.000037969352,0.00021136492,0.0002929946,0.00014203251,0.00022513422],"domain_scores_gemma":[0.99917334,0.000083790816,0.0002279053,0.00026834375,0.00009105846,0.0001555879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007534958,0.00016361666,0.00033619461,0.00008665604,0.00020160913,0.000014273589,0.000107662,0.000159044,0.00009052872],"category_scores_gemma":[0.00011351153,0.00011558877,0.000030000885,0.00007529795,0.000579885,0.00013139825,0.00005250388,0.00020026942,0.00000448407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002625119,0.0003832224,0.9938901,0.000029938936,0.000047883084,0.000029891626,0.00044413807,0.000014442118,0.0012065372,0.00008345874,0.0002127271,0.0033951448],"study_design_scores_gemma":[0.003145045,0.0033395372,0.9707537,0.00024027727,0.00023353522,0.000008372216,0.00013197305,0.00003972498,0.0024964898,0.000829877,0.01865953,0.00012192391],"about_ca_topic_score_codex":0.00035252472,"about_ca_topic_score_gemma":0.00028420053,"teacher_disagreement_score":0.02313639,"about_ca_system_score_codex":0.00007402485,"about_ca_system_score_gemma":0.00041521003,"threshold_uncertainty_score":0.47135735},"labels":[],"label_agreement":null},{"id":"W2588442711","doi":"10.1038/srep42713","title":"Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Bladder cancer; Targeted therapy; Context (archaeology); Breast cancer; Cancer; Medicine; Bioinformatics; Oncology; Cancer research; Internal medicine; Biology","score_opus":0.024446522330282737,"score_gpt":0.30847480051559195,"score_spread":0.28402827818530924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588442711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919987,0.00039463615,0.000105028405,0.00063106423,0.002846003,0.0029143684,0.000019401232,0.000045241944,0.0010455741],"genre_scores_gemma":[0.99365646,0.000023090795,0.00084357726,0.000091142094,0.00016458516,0.0015629606,0.000094672556,0.000024957262,0.0035385548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998297,0.000028275264,0.00037856892,0.00065359095,0.0003532378,0.0002893519],"domain_scores_gemma":[0.99854964,0.000013200169,0.00034712683,0.0006921596,0.00028122033,0.00011666047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026583503,0.00015938393,0.00021723937,0.000138163,0.0008340226,0.00023448514,0.00007188975,0.000080398284,0.00022482022],"category_scores_gemma":[0.0001377592,0.0001252633,0.00010098845,0.00013366378,0.00011024416,0.0002703481,0.000026845637,0.00009656505,0.000004022944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002850273,0.000625584,0.027335674,0.000057734243,0.000075334654,0.00015499286,0.0020895633,0.000056848705,0.92124903,0.000013476421,0.012773155,0.0352836],"study_design_scores_gemma":[0.0016186321,0.00039592021,0.027166849,0.00025807382,0.000033332435,0.000035602676,0.000113242786,0.00009199723,0.9486274,0.0023072867,0.019167446,0.00018419043],"about_ca_topic_score_codex":0.00065463636,"about_ca_topic_score_gemma":0.00085474155,"teacher_disagreement_score":0.03509941,"about_ca_system_score_codex":0.0001569338,"about_ca_system_score_gemma":0.00056433916,"threshold_uncertainty_score":0.6414712},"labels":[],"label_agreement":null},{"id":"W2588699504","doi":"10.1007/s00345-017-2009-5","title":"Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study","year":2017,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Cystectomy; Poisson regression; Bladder cancer; Proportional hazards model; Nephrology; Internal medicine; Blood transfusion; Perioperative; Population; Stage (stratigraphy); Surgery; Cancer","score_opus":0.014441034299228675,"score_gpt":0.31121060729255656,"score_spread":0.2967695729933279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588699504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929929,0.00096974254,0.00003748882,0.0052677444,0.00021786896,0.00031331775,0.000004435937,0.00000619899,0.00019032745],"genre_scores_gemma":[0.9982314,0.00004048087,0.00021371568,0.0010670291,0.00014785545,0.000013856184,0.0000011160752,0.000014586905,0.0002699568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909365,0.000110983536,0.00030750662,0.0001520943,0.00018804941,0.00014769145],"domain_scores_gemma":[0.999354,0.000058272024,0.00016473887,0.00021113963,0.00007365577,0.00013821345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017262368,0.00013668682,0.0004557742,0.00016755804,0.00016650674,0.00002662593,0.000088840454,0.000052398565,0.0002743727],"category_scores_gemma":[0.00005313473,0.000090203255,0.00010954894,0.00003402383,0.00007650678,0.00007040646,0.000016903417,0.00022744664,0.0000023126152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001747437,0.0006274595,0.99271727,0.00000816853,0.00036910878,0.0007673856,0.0004204968,0.0000042212705,0.00029705797,0.000007854622,0.000010925306,0.003022628],"study_design_scores_gemma":[0.011422984,0.0025768722,0.9839897,0.000018469553,0.0008839943,0.00023318616,0.00003295379,0.000011242048,0.00007113912,0.00003697604,0.0006517911,0.00007067644],"about_ca_topic_score_codex":0.00011805383,"about_ca_topic_score_gemma":0.00083585625,"teacher_disagreement_score":0.009675547,"about_ca_system_score_codex":0.000026913252,"about_ca_system_score_gemma":0.00010316751,"threshold_uncertainty_score":0.3678382},"labels":[],"label_agreement":null},{"id":"W2588777013","doi":"10.1093/annonc/mdw373.16","title":"Interim analysis of a phase I dose escalation trial of ASG-22CE (ASG-22ME; enfortumab vedotin), an antibody drug conjugate (ADC), in patients (Pts) with metastatic urothelial cancer (mUC)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Oncology; Interim analysis; Gastroenterology; Phases of clinical research; Chemotherapy; Clinical trial","score_opus":0.0723208167170428,"score_gpt":0.4419982571152622,"score_spread":0.36967744039821937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588777013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702984,0.00007126934,0.00013576292,0.0004740725,0.00016857807,0.0009668383,0.00046335623,0.000012065182,0.0006782324],"genre_scores_gemma":[0.9989845,0.00022443483,0.0001696125,0.0002102412,0.00005904701,0.00010012222,0.00012430317,0.000025730267,0.00010201046],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99767965,0.00028517566,0.0009849189,0.00035942387,0.00038667777,0.00030413645],"domain_scores_gemma":[0.99798346,0.00020261976,0.0007974329,0.00037992647,0.0004907468,0.00014581603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043672958,0.00023557869,0.0013905801,0.00058805244,0.000021188058,0.0000036758352,0.00014496259,0.00009911532,0.00048985274],"category_scores_gemma":[0.00013971906,0.00015308509,0.00023098062,0.0005926102,0.00027029717,0.00020264248,0.000033957036,0.000102237485,0.0000029764185],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40828392,0.02605293,0.2099537,0.0003067363,0.009058163,0.00007321939,0.004343441,0.000114590366,0.031096052,0.00016000376,0.00030420962,0.31025305],"study_design_scores_gemma":[0.50818014,0.100060396,0.27925304,0.0008316793,0.009595508,0.000006714007,0.0004075196,0.00072472426,0.09842229,0.00020070883,0.00174671,0.00057057437],"about_ca_topic_score_codex":0.002491146,"about_ca_topic_score_gemma":0.0011951727,"teacher_disagreement_score":0.30968246,"about_ca_system_score_codex":0.0001007634,"about_ca_system_score_gemma":0.00068778027,"threshold_uncertainty_score":0.62426287},"labels":[],"label_agreement":null},{"id":"W2588916311","doi":"10.1056/nejmoa1613683","title":"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3390,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Janssen Pharmaceuticals; National Cancer Institute; Genentech; Cilag; Astellas Pharma; Sanofi; Exelixis; Eisai; BioClinica; Takeda Oncology; Amgen; Pfizer; Les Laboratories Pierre Fabre; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Hazard ratio; Internal medicine; Docetaxel; Chemotherapy; Oncology; Population; Gastroenterology; Urology; Cancer; Confidence interval; Surgery; Immunotherapy","score_opus":0.03598082071968254,"score_gpt":0.340225763948257,"score_spread":0.3042449432285744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588916311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96554077,0.0045108898,0.00047618232,0.018102452,0.0018289677,0.00062607974,0.000018247827,0.000015716078,0.008880679],"genre_scores_gemma":[0.9799058,0.0008723125,0.0005526911,0.0017517623,0.01077238,0.000008777483,0.000007904268,0.000040583982,0.0060878024],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998579,0.000031726602,0.0005041458,0.00018420976,0.0004302015,0.0002707145],"domain_scores_gemma":[0.9981565,0.00012024472,0.0005262593,0.00042926066,0.00033295018,0.0004348175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039931954,0.0002266536,0.00070972793,0.00013052895,0.00019863535,0.000022819644,0.00025945995,0.00008281365,0.001033872],"category_scores_gemma":[0.0004218985,0.00013717682,0.00018380192,0.000037439866,0.00013518283,0.00015995307,0.00001700674,0.0002696252,0.00000814261],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055180006,0.00031338524,0.017831067,0.00011246258,0.0006309718,0.00069337443,0.0016869812,0.0000043069263,0.033607837,0.0002865399,0.015523477,0.8741296],"study_design_scores_gemma":[0.52076006,0.029145079,0.050266888,0.0005136797,0.0005374528,0.0037785424,0.00013930463,0.00002277712,0.02689056,0.0036914963,0.36401746,0.00023672087],"about_ca_topic_score_codex":0.0001300462,"about_ca_topic_score_gemma":0.00003265554,"teacher_disagreement_score":0.87389284,"about_ca_system_score_codex":0.000066687055,"about_ca_system_score_gemma":0.00058552925,"threshold_uncertainty_score":0.9998793},"labels":[],"label_agreement":null},{"id":"W2589090321","doi":"10.1213/ane.0000000000001781","title":"Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based Study","year":2017,"lang":"en","type":"article","venue":"Anesthesia & Analgesia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Cystectomy; Medicine; Quartile; Bladder cancer; Proportional hazards model; Anesthesiology; Population; Perioperative; Logistic regression; Surgery; Urology; Cancer; Internal medicine; Anesthesia; Confidence interval","score_opus":0.01788857977441424,"score_gpt":0.3026689831160946,"score_spread":0.28478040334168037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589090321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940326,0.0004453213,0.000006914037,0.0042044013,0.000024630424,0.0012053911,0.000011841769,0.00004870416,0.000020157124],"genre_scores_gemma":[0.99778634,0.000025168694,0.00014609561,0.0005602474,0.00013400616,0.00041255372,0.000016217227,0.00003952626,0.0008798365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987308,0.0000717255,0.00027232716,0.00041189435,0.00021161018,0.00030163868],"domain_scores_gemma":[0.9989681,0.00015374651,0.00025808605,0.0003736407,0.00010592799,0.00014049704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022314307,0.00025000176,0.0006215728,0.00010348005,0.0003535389,0.00011220305,0.00009157561,0.00016066986,0.000026107866],"category_scores_gemma":[0.000055061228,0.00020099244,0.00009862317,0.00004355674,0.00004456581,0.00014327846,0.00001587173,0.000098972145,0.0000038049095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002728325,0.000092132796,0.99534106,0.000044667206,0.0004988967,0.000074814605,0.00023170433,5.2864766e-7,0.0000072823627,0.000005490699,0.000030862597,0.0033997102],"study_design_scores_gemma":[0.004027822,0.0007904392,0.99283725,0.000043000317,0.0013460503,0.000008745893,0.000030400908,0.000035667847,0.000023418233,0.0001139315,0.0005465732,0.00019669787],"about_ca_topic_score_codex":0.0046355557,"about_ca_topic_score_gemma":0.00054989796,"teacher_disagreement_score":0.0040856577,"about_ca_system_score_codex":0.00009328743,"about_ca_system_score_gemma":0.00007133076,"threshold_uncertainty_score":0.8196234},"labels":[],"label_agreement":null},{"id":"W2589193077","doi":"10.1200/jco.2016.34.2_suppl.368","title":"Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the U.S. and Canada in 2015.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Multidisciplinary approach; Modalities; Family medicine; Community practice; Pharmacy; Cancer; Internal medicine","score_opus":0.20252220958062464,"score_gpt":0.4767857431331576,"score_spread":0.27426353355253297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589193077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482978,0.0005795993,0.0000072681637,0.049666293,0.00056396116,0.0002592058,0.0000125725255,9.0582574e-7,0.00061241124],"genre_scores_gemma":[0.98461676,0.012984455,0.00014098182,0.0018771009,0.0002677318,0.000035847715,2.4032116e-7,0.000008044368,0.00006886658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792147,0.0003832298,0.0010520048,0.0001326868,0.0003133647,0.0001972424],"domain_scores_gemma":[0.9958964,0.003051504,0.0006649344,0.00016934164,0.00012812117,0.00008967721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002105985,0.00009349687,0.00051743485,0.000031356645,0.00003208659,0.0000041772264,0.00016641017,0.00007073142,0.00003566945],"category_scores_gemma":[0.00043557913,0.000038855884,0.00008368818,0.000082981926,0.00012239949,0.00017489899,0.00009081262,0.0004011382,9.28568e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029628277,0.0013143787,0.6717804,0.0000882385,0.0007194359,0.003111889,0.0035306925,0.000016249916,0.000055686116,0.00003837021,0.0014719826,0.31490985],"study_design_scores_gemma":[0.0069362037,0.0012938133,0.9701152,0.00039106008,0.00021127403,0.00009007403,0.008043024,0.0000015481564,0.000049234397,0.000045535588,0.012776019,0.000047055848],"about_ca_topic_score_codex":0.09218956,"about_ca_topic_score_gemma":0.5071469,"teacher_disagreement_score":0.41495737,"about_ca_system_score_codex":0.00022342359,"about_ca_system_score_gemma":0.0011410686,"threshold_uncertainty_score":0.9138556},"labels":[],"label_agreement":null},{"id":"W2589215978","doi":"10.1200/jco.2013.31.6_suppl.301","title":"Impact of baseline prognostic factors on progression-free survival at 6 months (PFS6) and response in patients receiving second-line therapy for advanced urothelial carcinoma (UC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Progression-free survival; Anemia; Overall survival; Oncology; Chemotherapy; Confidence interval","score_opus":0.07199907428177772,"score_gpt":0.43668257297948737,"score_spread":0.36468349869770966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589215978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962769,0.000347101,0.00001317102,0.0009568275,0.00062399916,0.0016010893,0.0000734876,0.0000066545635,0.00010075551],"genre_scores_gemma":[0.9980673,0.00020247317,0.00095537957,0.00026539966,0.00031389034,0.000041038304,0.000010731147,0.00003474747,0.00010903784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996403,0.0007382674,0.0018803491,0.00026466828,0.0003852705,0.0003284451],"domain_scores_gemma":[0.99089986,0.006599182,0.0012792571,0.00026149035,0.0005869534,0.00037323037],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002317565,0.00023631782,0.0014794006,0.00019169356,0.00004338876,0.0000068832883,0.00015548276,0.0003004705,0.00026312852],"category_scores_gemma":[0.0095124515,0.00013953769,0.0004490465,0.00011351998,0.00014373918,0.00013132316,0.00005828455,0.00046980404,0.000002258641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11633465,0.0029409132,0.771365,0.00002356331,0.0002025349,0.000024596251,0.00016407145,0.000007766909,0.00060297706,7.0171427e-7,0.00034047585,0.107992776],"study_design_scores_gemma":[0.040044066,0.111495264,0.8471437,0.00016550308,0.00008543801,0.000009262514,0.000037379676,0.0000600156,0.00044590197,0.000086077685,0.0003303356,0.00009707135],"about_ca_topic_score_codex":0.00005042976,"about_ca_topic_score_gemma":0.00005834268,"teacher_disagreement_score":0.108554356,"about_ca_system_score_codex":0.0003144296,"about_ca_system_score_gemma":0.0011501511,"threshold_uncertainty_score":0.99883085},"labels":[],"label_agreement":null},{"id":"W2589250691","doi":"10.1200/jco.2016.34.2_suppl.409","title":"Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Cystectomy; Contouring; Bladder cancer; Adjuvant radiotherapy; Radiation therapy; Clinical trial; Cancer; Surgery; Nuclear medicine; Urology; Radiology; Internal medicine","score_opus":0.21738115833288513,"score_gpt":0.505035433597135,"score_spread":0.28765427526424986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589250691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894512,0.001363329,0.001277287,0.006882412,0.00056607125,0.00026336257,0.000015096712,0.000002747433,0.00017848301],"genre_scores_gemma":[0.98405385,0.0010841156,0.013549533,0.00050414907,0.0006334943,0.000010144702,0.0000016975853,0.0000092469845,0.00015375645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997678,0.00006853878,0.001883457,0.00009421908,0.00018263108,0.00009319365],"domain_scores_gemma":[0.99607754,0.0007630608,0.0015450424,0.000066968496,0.001434492,0.0001129236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012040348,0.000074670534,0.0008255666,0.00007495231,0.000015041045,0.0000013253346,0.000046626585,0.00013619025,0.000059108395],"category_scores_gemma":[0.0021704715,0.00004143846,0.00015279693,0.00003520715,0.000067870526,0.000071440634,0.000013744957,0.000073928066,6.113136e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004383256,0.0003723182,0.05365318,0.00009303919,0.0007027157,0.000009192082,0.0001879844,0.0000041799117,0.012586457,0.000031142947,0.0012409635,0.9267356],"study_design_scores_gemma":[0.05724612,0.019105313,0.5566285,0.0012090906,0.001563513,0.0001247402,0.0002956897,0.000040328054,0.22716483,0.00033732472,0.136101,0.00018349684],"about_ca_topic_score_codex":0.00003079579,"about_ca_topic_score_gemma":0.00002669174,"teacher_disagreement_score":0.92655206,"about_ca_system_score_codex":0.00008742318,"about_ca_system_score_gemma":0.0014940499,"threshold_uncertainty_score":0.26503804},"labels":[],"label_agreement":null},{"id":"W2589348657","doi":"10.1111/bju.13819","title":"Systematic review of the oncological and functional outcomes of pelvic organ‐preserving radical cystectomy ( <scp>RC</scp> ) compared with standard <scp>RC</scp> in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer","year":2017,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Cystectomy; Medicine; Urology; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.05265729409262196,"score_gpt":0.33168846540834673,"score_spread":0.27903117131572475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589348657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023171103,0.97303766,0.0001223315,0.00023286074,0.00030226412,0.0027818233,0.00023100927,0.000007339442,0.00011359319],"genre_scores_gemma":[0.014357094,0.98437935,0.000065389824,0.00043514202,0.00013835558,0.00034594323,0.000021241172,0.000043689924,0.00021379768],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99570143,0.0008769233,0.0019748537,0.00039424165,0.0006177598,0.00043476518],"domain_scores_gemma":[0.99282,0.0031652397,0.0028383005,0.00033202022,0.00062730996,0.00021711957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013801676,0.0004434178,0.005812959,0.0002448349,0.00016826208,0.000043615728,0.0002652722,0.0003815829,0.000045555476],"category_scores_gemma":[0.003468108,0.00027797173,0.0005042044,0.0002454788,0.00063449267,0.00016984121,0.00011174568,0.0007415882,3.5320946e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004089274,0.0006315485,0.023014415,0.9341981,0.009665161,0.0010584142,0.0008215042,0.000009563508,0.0000028655854,0.00010830188,0.005445985,0.024635212],"study_design_scores_gemma":[0.011034419,0.002274815,0.054210685,0.75951785,0.014664072,0.02126583,0.00047691652,0.000012704771,0.0000050384233,0.00025372085,0.13604066,0.00024330943],"about_ca_topic_score_codex":0.000099093675,"about_ca_topic_score_gemma":0.0002597917,"teacher_disagreement_score":0.17468026,"about_ca_system_score_codex":0.00037521348,"about_ca_system_score_gemma":0.0021271897,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W2589378283","doi":"10.5489/cuaj.4008","title":"Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Bladder cancer; Medicine; Chemoradiotherapy; Primary treatment; Oncology; Internal medicine; Urology; Cancer","score_opus":0.030886361005747275,"score_gpt":0.3061141040775852,"score_spread":0.27522774307183795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589378283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89842397,0.0011316348,0.000026464939,0.08928365,0.0007520934,0.0010145495,0.00023276614,0.00002280974,0.009112038],"genre_scores_gemma":[0.98222023,0.0013331124,0.00020623433,0.011502357,0.0011203978,0.0001676928,0.00002827586,0.000026567413,0.0033951055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870145,0.000049715425,0.00026040748,0.00024311573,0.00021614437,0.00052913744],"domain_scores_gemma":[0.9986885,0.000098368,0.00027420852,0.00019908493,0.00016476768,0.00057504943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022451636,0.00018238548,0.00040835526,0.00012266205,0.0005134854,0.00014006431,0.00014704512,0.0002452883,0.00082573603],"category_scores_gemma":[0.00031342055,0.00013921033,0.0002039429,0.000051996412,0.000037573027,0.000116903255,0.0000063778416,0.00022270078,0.000022071039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033985515,0.00021657227,0.95030767,0.000008634646,0.0005687703,0.0003016053,0.00049318216,0.000018745815,0.00060966006,0.00007637606,0.0061512897,0.04090762],"study_design_scores_gemma":[0.0073219086,0.0010845915,0.889328,0.000024456695,0.00016238958,0.00008178805,0.000044270055,0.000018991943,0.00024397882,0.0008265639,0.100704186,0.00015886541],"about_ca_topic_score_codex":0.014323673,"about_ca_topic_score_gemma":0.018585619,"teacher_disagreement_score":0.09455289,"about_ca_system_score_codex":0.004666677,"about_ca_system_score_gemma":0.0022713968,"threshold_uncertainty_score":0.99932265},"labels":[],"label_agreement":null},{"id":"W2589385382","doi":"10.1200/jco.2016.34.2_suppl.456","title":"Predictive models for improved prognostication and selection of neoadjuvant and adjuvant systemic chemotherapy in upper tract urothelial cell carcinoma.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nomogram; Lymphadenectomy; Oncology; Internal medicine; Chemotherapy; Cancer","score_opus":0.05183069055577775,"score_gpt":0.3833531651343911,"score_spread":0.33152247457861334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589385382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98978555,0.00084382057,0.006006969,0.0020939475,0.00020668902,0.00087265094,0.00002028076,0.000004281893,0.00016582856],"genre_scores_gemma":[0.99617887,0.001389656,0.00173725,0.00022122978,0.00035915055,0.000025300626,9.360252e-7,0.000015432737,0.00007217503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828154,0.00012717277,0.001168309,0.00017484624,0.00010866418,0.00013949262],"domain_scores_gemma":[0.99779946,0.000910343,0.0007838229,0.000059823917,0.00030067202,0.00014590507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008965118,0.00010625919,0.00086680404,0.00009756275,0.000015589181,0.0000028392976,0.00004062237,0.00023592204,0.000008045701],"category_scores_gemma":[0.00036608856,0.00006116754,0.00012995019,0.00004792608,0.00010758323,0.00012189777,0.000009027315,0.00018695746,2.0803881e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031702213,0.002878782,0.45375827,0.00022108227,0.00024365401,0.000020247608,0.0006261646,0.000009616107,0.06426862,0.000060421477,0.00015658535,0.44605434],"study_design_scores_gemma":[0.06380611,0.057003446,0.858021,0.0004897125,0.0007484884,0.00061900564,0.00017355263,0.006509321,0.009904017,0.0018099673,0.00076731056,0.00014803302],"about_ca_topic_score_codex":0.000023217623,"about_ca_topic_score_gemma":0.000008326502,"teacher_disagreement_score":0.4459063,"about_ca_system_score_codex":0.0001131926,"about_ca_system_score_gemma":0.000759741,"threshold_uncertainty_score":0.24943401},"labels":[],"label_agreement":null},{"id":"W2589481545","doi":"10.1200/jco.2015.33.7_suppl.336","title":"Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gemcitabine; Bladder cancer; Cystectomy; Dosing; Cisplatin; Urology; Internal medicine; Chemotherapy; Cohort; Cancer; Neoadjuvant therapy; Oncology; Gastroenterology; Surgery","score_opus":0.16153477344881828,"score_gpt":0.4737695148506772,"score_spread":0.3122347414018589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589481545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345804,0.0007429602,0.00044144454,0.013667472,0.00087932084,0.00040682455,0.000011858479,0.000011093208,0.00038101355],"genre_scores_gemma":[0.9855294,0.00017881561,0.009742432,0.0031848885,0.0011080537,0.000008830715,0.0000014510782,0.000029554323,0.00021656681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975413,0.00033683563,0.0013893277,0.00022722388,0.00027219317,0.00023313843],"domain_scores_gemma":[0.99391514,0.004016421,0.00093127426,0.00013395895,0.000434354,0.0005688712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037278517,0.00017205764,0.0013160327,0.000105603016,0.00006153104,0.000024329258,0.00007063531,0.00028633064,0.000013530999],"category_scores_gemma":[0.0073933126,0.00011625475,0.00023002517,0.00006078031,0.00019090548,0.00016364641,0.000038532733,0.0004601013,0.0000010324162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024222128,0.0006859669,0.7988028,0.000047945436,0.00038636653,0.0004093853,0.0007849428,0.000002150314,0.001019452,0.000015282141,0.0011761131,0.17244747],"study_design_scores_gemma":[0.04580562,0.01810375,0.92324233,0.00009866862,0.0005179833,0.00059013494,0.0005285947,0.00016476527,0.00019046527,0.00040699737,0.010241271,0.00010944876],"about_ca_topic_score_codex":0.000029502826,"about_ca_topic_score_gemma":0.000016002912,"teacher_disagreement_score":0.17233802,"about_ca_system_score_codex":0.00013619714,"about_ca_system_score_gemma":0.0023283141,"threshold_uncertainty_score":0.885102},"labels":[],"label_agreement":null},{"id":"W2589557101","doi":"10.1200/jco.2016.34.2_suppl.385","title":"Outcomes of advanced urothelial carcinoma following discontinuation of programmed death (PD)-1 or PD-ligand (L)-1 inhibitors.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Salvage therapy; Oncology; Proportional hazards model; Immunotherapy; Chemotherapy; Cancer","score_opus":0.10481926618742168,"score_gpt":0.45382248907565464,"score_spread":0.34900322288823293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589557101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934629,0.00024823652,0.0002395497,0.003348442,0.0015833286,0.000444821,0.000012337405,0.0000078443845,0.00065251626],"genre_scores_gemma":[0.9951806,0.00015467973,0.0030661118,0.0002649109,0.00064086687,0.000010448662,0.0000013143224,0.000022465862,0.0006586111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962378,0.00022438171,0.0026415368,0.0001871726,0.00047540246,0.00023369532],"domain_scores_gemma":[0.9955696,0.0015407179,0.0020372395,0.0002082786,0.00038806756,0.00025611842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013510624,0.00017026326,0.0019291771,0.00012426655,0.000023263809,0.0000033933272,0.00014062549,0.00026859788,0.00006217527],"category_scores_gemma":[0.0033712396,0.00008129944,0.0008495982,0.00011495895,0.00016691431,0.00016594,0.000038794264,0.0002615974,0.000003847505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008866345,0.001675527,0.72638786,0.000027070455,0.00051837333,0.00016898391,0.0001227593,4.4621572e-7,0.004903071,0.000031656098,0.00015172017,0.2571462],"study_design_scores_gemma":[0.038305294,0.029189643,0.9029183,0.00040376908,0.0011499552,0.000056847817,0.00016746197,0.0000021752749,0.020989314,0.0002919778,0.006403412,0.000121872086],"about_ca_topic_score_codex":0.00004058519,"about_ca_topic_score_gemma":0.00006352703,"teacher_disagreement_score":0.25702435,"about_ca_system_score_codex":0.00011714112,"about_ca_system_score_gemma":0.0016508009,"threshold_uncertainty_score":0.4035932},"labels":[],"label_agreement":null},{"id":"W2589609144","doi":"10.1200/jco.2016.34.2_suppl.417","title":"Are we systemically under treating cisplatin-eligible patients with muscle invasive bladder cancer (MIBC) who are undergoing bladder preservation by chemoradiotherapy?","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; University Health Network; Lakeridge Health; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Cisplatin; Chemoradiotherapy; Neutropenia; Urology; Radiation therapy; Febrile neutropenia; Chemotherapy; Oncology; Cystoscopy; Internal medicine; Cancer; Surgery; Urinary system","score_opus":0.08324105154999831,"score_gpt":0.39913078654151457,"score_spread":0.3158897349915163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589609144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755751,0.0017454068,0.0010296445,0.01924117,0.00061962527,0.0006027643,0.00004577424,0.000029808696,0.0011107442],"genre_scores_gemma":[0.9879088,0.003427457,0.0008654982,0.00460485,0.0011598693,0.00003582103,0.000005370674,0.000076032935,0.0019163263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961945,0.00034660043,0.0019219874,0.0004104421,0.0007131729,0.0004133051],"domain_scores_gemma":[0.99201035,0.0023900769,0.0038105377,0.00030364294,0.0010313115,0.00045405925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006277121,0.00032085966,0.0018499123,0.00012114375,0.00009971617,0.000026768314,0.00020819622,0.0004655543,0.00039178648],"category_scores_gemma":[0.0011334788,0.00017498326,0.00033604307,0.00020909203,0.00019163509,0.00043990018,0.000042820953,0.00052157027,0.000011083994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049418625,0.0020426165,0.9214209,0.0002141981,0.002532886,0.0001391565,0.00022705589,0.000057263962,0.0012299294,0.000017741213,0.026630174,0.040546227],"study_design_scores_gemma":[0.059895415,0.013301209,0.8993297,0.006797894,0.0018375596,0.00008084394,0.00072231033,0.00003926431,0.0014073668,0.00043385432,0.015645579,0.00050895754],"about_ca_topic_score_codex":0.00007294564,"about_ca_topic_score_gemma":0.00046012565,"teacher_disagreement_score":0.05495355,"about_ca_system_score_codex":0.0006501872,"about_ca_system_score_gemma":0.0017885405,"threshold_uncertainty_score":0.71356106},"labels":[],"label_agreement":null},{"id":"W2589629201","doi":"10.1200/jco.2014.32.4_suppl.334","title":"Comparative effectiveness of radical cystectomy versus bladder-sparing treatment for muscle-invasive urothelial carcinoma: A population-based report.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Confidence interval; Proportional hazards model; Radiation therapy; Chemotherapy; Retrospective cohort study; Stage (stratigraphy); Population; Oncology; Cohort; Confounding; Internal medicine; Urology; Surgery; Cancer","score_opus":0.1539236396010719,"score_gpt":0.46470202795964544,"score_spread":0.3107783883585735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589629201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209857,0.00015158144,0.0029468308,0.00053112954,0.001764424,0.00094373006,0.000016607033,0.000012011591,0.001535095],"genre_scores_gemma":[0.9950129,0.000017298606,0.003471606,0.00013631997,0.001221482,0.000054226268,0.000024381052,0.000023270763,0.00003852258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623466,0.0008570856,0.0020217185,0.00029306833,0.00035006853,0.0002434042],"domain_scores_gemma":[0.9847054,0.012298607,0.0018311028,0.0002613387,0.0005642401,0.00033930433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020449169,0.00022323462,0.0024346355,0.00012160726,0.00009546139,0.000010221858,0.000111177,0.0003201348,0.000028885166],"category_scores_gemma":[0.0033678438,0.00015469042,0.00091802725,0.000110246576,0.00018405124,0.00006065051,0.000016795624,0.0003140746,0.0000031085565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22088984,0.012832014,0.68965495,0.0008007401,0.0059703537,0.0017219316,0.00042245392,0.0011205759,0.003507694,0.0004704679,0.0004398428,0.06216915],"study_design_scores_gemma":[0.10896903,0.08599394,0.78534704,0.00031450455,0.0031367796,0.00027195626,0.000073446776,0.0006211412,0.008062873,0.0003260452,0.006692658,0.00019060657],"about_ca_topic_score_codex":0.00037020328,"about_ca_topic_score_gemma":0.00016946747,"teacher_disagreement_score":0.111920804,"about_ca_system_score_codex":0.000484612,"about_ca_system_score_gemma":0.0027276187,"threshold_uncertainty_score":0.63080925},"labels":[],"label_agreement":null},{"id":"W2589671106","doi":"10.1200/jco.2014.32.4_suppl.320","title":"Concurrent cisplatin and radiotherapy: Decision making, tolerability, and outcomes for patients treated in a multidisciplinary bladder clinic.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Tolerability; Bladder cancer; Cystoscopy; External beam radiotherapy; Cisplatin; Urology; Radiation therapy; Surgery; Urinary system; Chemotherapy; Internal medicine; Cancer; Adverse effect; Brachytherapy","score_opus":0.0813056010773686,"score_gpt":0.4859404120487397,"score_spread":0.4046348109713711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589671106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961766,0.0005115274,0.00044975852,0.0013656258,0.0006975185,0.00054729957,0.000008909133,0.0000054092447,0.00023732222],"genre_scores_gemma":[0.9924295,0.00051720825,0.005778654,0.0009309643,0.00025116233,0.000011724901,0.0000025199433,0.000017112507,0.0000611671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709547,0.00028697262,0.001980385,0.00025411896,0.00019761283,0.00018543102],"domain_scores_gemma":[0.99314183,0.0054641324,0.00082558964,0.00012939675,0.00020763176,0.00023140234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019529968,0.00015980995,0.0015600577,0.000113293514,0.00003383545,0.000009313029,0.00006676185,0.00029806318,0.00006271111],"category_scores_gemma":[0.0027975417,0.000101846344,0.00024659256,0.000058267535,0.00017452918,0.000074791154,0.000046628265,0.00038241685,0.0000013800199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027229192,0.0013892663,0.6086205,0.000017367838,0.00011939678,0.000009427469,0.0000922313,7.006188e-7,0.0000023035536,0.0000064988953,0.0002932747,0.38672608],"study_design_scores_gemma":[0.03375968,0.022622036,0.93794626,0.00015341211,0.00023321305,0.000029442572,0.000024607709,0.00062938064,0.0000023667722,0.0006457218,0.0038681687,0.00008570774],"about_ca_topic_score_codex":0.00001156054,"about_ca_topic_score_gemma":0.000056576235,"teacher_disagreement_score":0.38664037,"about_ca_system_score_codex":0.000093826144,"about_ca_system_score_gemma":0.00020624085,"threshold_uncertainty_score":0.41531733},"labels":[],"label_agreement":null},{"id":"W2589756810","doi":"10.1200/jco.2016.34.2_suppl.386","title":"Impact of prior platinum on patients receiving salvage systemic therapy for advanced urothelial carcinoma (UC).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Taxane; Medicine; Carboplatin; Salvage therapy; Chemotherapy; Oncology; Cisplatin; Internal medicine; Gemcitabine; Surgery; Urology; Cancer; Breast cancer","score_opus":0.08306237165049717,"score_gpt":0.45369411177645275,"score_spread":0.37063174012595557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589756810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959846,0.00022062137,0.00019930757,0.0006397634,0.0013058872,0.0007578671,0.000053285847,0.000007929937,0.00083069765],"genre_scores_gemma":[0.9970551,0.0004267198,0.0008271508,0.00041644764,0.001004222,0.000015303985,0.0000018736265,0.000033369473,0.00021981096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699366,0.0002484477,0.0019435463,0.0002034075,0.00032899354,0.00028194283],"domain_scores_gemma":[0.9943642,0.002624203,0.0019063007,0.00022378472,0.0006086173,0.00027290886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010966457,0.00018123465,0.0014816952,0.000115528084,0.000035543144,0.0000032873063,0.00015028178,0.0002829285,0.00010371353],"category_scores_gemma":[0.0023473208,0.00008937599,0.00092581403,0.000068854344,0.00009925956,0.000095724805,0.000018428907,0.0002823184,0.000008902152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033075985,0.001714268,0.49817932,0.000026637403,0.0004627948,0.000027280841,0.00008676458,0.000002661588,0.0041119754,0.000008645843,0.0007615845,0.4615421],"study_design_scores_gemma":[0.055640787,0.09442615,0.84621066,0.00045718809,0.00018255989,0.000056823188,0.000017105336,0.000003520111,0.0011895362,0.00011239534,0.0016114922,0.00009180912],"about_ca_topic_score_codex":0.000013523143,"about_ca_topic_score_gemma":0.0000039647657,"teacher_disagreement_score":0.46145028,"about_ca_system_score_codex":0.0003716479,"about_ca_system_score_gemma":0.0016576461,"threshold_uncertainty_score":0.36446473},"labels":[],"label_agreement":null},{"id":"W2589858858","doi":"10.1200/jco.2014.32.4_suppl.336","title":"Impact of prior platinum agent and site of primary in patients with advanced urothelial carcinoma (UC) receiving salvage therapy.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Oncology; Pazopanib; Docetaxel; Regimen; Gemcitabine; Chemotherapy regimen; Chemotherapy; Urology; Cisplatin; Sunitinib; Cancer","score_opus":0.04430694764260752,"score_gpt":0.3876285428344488,"score_spread":0.3433215951918413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589858858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998245,0.0002602368,0.000033342774,0.00014533546,0.00017228822,0.0003095348,0.000013565424,0.0000024398903,0.0008182785],"genre_scores_gemma":[0.99784714,0.00023967955,0.0014485444,0.00024327796,0.00017378389,0.0000018551207,0.000003143069,0.000017682425,0.000024870531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977226,0.00022538203,0.0014325547,0.00014787314,0.0002952693,0.00017627049],"domain_scores_gemma":[0.9972026,0.0008004264,0.0013973741,0.00015551153,0.00026216637,0.00018193258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089587265,0.00013568036,0.0013870565,0.00011802369,0.000014394741,0.0000028968261,0.00007054978,0.00016466655,0.00004735988],"category_scores_gemma":[0.00057422236,0.00008010227,0.00023935328,0.000097510274,0.00012708087,0.000102300524,0.000029373772,0.00038621674,8.176836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016607193,0.0013894134,0.75170827,0.0000278822,0.0001664161,0.00001884626,0.00021332974,0.000009900165,0.000458572,0.0000010842333,0.000029591205,0.22936949],"study_design_scores_gemma":[0.03209247,0.050642088,0.9164201,0.00015781244,0.00011152773,0.000016607099,0.000012110237,0.000010253613,0.000101923135,0.000028803164,0.0003455894,0.00006072459],"about_ca_topic_score_codex":0.00004855526,"about_ca_topic_score_gemma":0.00001632656,"teacher_disagreement_score":0.22930877,"about_ca_system_score_codex":0.00013503584,"about_ca_system_score_gemma":0.0008404184,"threshold_uncertainty_score":0.32664758},"labels":[],"label_agreement":null},{"id":"W2589883191","doi":"10.5489/cuaj.4476","title":"Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Bladder cancer; Chemoradiotherapy; Medicine; Primary treatment; Oncology; Cancer; Internal medicine","score_opus":0.05068410446922847,"score_gpt":0.330676103364396,"score_spread":0.27999199889516757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589883191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8182682,0.0012221346,0.00003579887,0.16764353,0.0011838123,0.0017503977,0.0066616577,0.000021680518,0.0032128107],"genre_scores_gemma":[0.97503024,0.0023931277,0.00054031983,0.017024392,0.0019116135,0.0001795828,0.0009594012,0.000038829072,0.0019225025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843556,0.00005982816,0.00031519085,0.00035131426,0.0002585422,0.0005795926],"domain_scores_gemma":[0.9984766,0.00011092977,0.0002931412,0.0004268603,0.00012788645,0.0005645808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003245028,0.00020202367,0.00042827934,0.000121240126,0.00054858124,0.00015773393,0.0003228951,0.00019845966,0.002344058],"category_scores_gemma":[0.00024391423,0.00015752537,0.00013617796,0.000052047202,0.000040656116,0.00018690768,0.000023101653,0.00023426574,0.000011103661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000354348,0.00030002763,0.9387999,0.000010299809,0.00081450643,0.00034039625,0.00034653425,0.000010109484,0.0003371804,0.0000331066,0.030717837,0.027935743],"study_design_scores_gemma":[0.009365548,0.0012399425,0.66936177,0.000024490673,0.000296677,0.000088302324,0.00008216342,0.000038110786,0.00015570293,0.00046782652,0.31868783,0.00019162141],"about_ca_topic_score_codex":0.040522117,"about_ca_topic_score_gemma":0.069816865,"teacher_disagreement_score":0.28796998,"about_ca_system_score_codex":0.0041706963,"about_ca_system_score_gemma":0.0024972872,"threshold_uncertainty_score":0.9996521},"labels":[],"label_agreement":null},{"id":"W2589975200","doi":"10.1200/jco.2015.33.7_suppl.314","title":"Correlation of the clinical frailty scale with long-term survival after radical cystectomy.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Frailty Index; Cohort; Interquartile range; Comorbidity; Internal medicine; Bladder cancer; Surgery; Cancer","score_opus":0.15390579951562225,"score_gpt":0.46710887733237144,"score_spread":0.31320307781674916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589975200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881017,0.00040365322,0.00075278996,0.0036770578,0.0032764405,0.00027982504,0.0000053722238,0.0000070887577,0.0034960664],"genre_scores_gemma":[0.995311,0.00010682769,0.0010897678,0.0011859008,0.001773267,0.0000041132707,0.0000014734183,0.000018441564,0.0005091887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568015,0.0009053457,0.0023420437,0.00018770632,0.0006945211,0.00019021229],"domain_scores_gemma":[0.9957896,0.0012232643,0.0015234337,0.00030982037,0.0006107678,0.0005431209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032615243,0.00014251714,0.0014461306,0.00005072863,0.000024136905,0.000005462607,0.00019861272,0.00047636358,0.00014697199],"category_scores_gemma":[0.0016927823,0.00007023952,0.00060500123,0.00015138827,0.00069228036,0.00009145613,0.000062238054,0.0011725967,0.000020188689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01619299,0.0017767302,0.94878584,0.000016288544,0.00042705785,0.0002923805,0.00008088876,0.0000075373455,0.0000041286876,0.000007627043,0.00083624385,0.03157226],"study_design_scores_gemma":[0.019425338,0.015942601,0.9554678,0.00017735867,0.0009433141,0.0005190366,0.000039158178,0.0000191615,0.00003459117,0.00009960343,0.007261955,0.00007007564],"about_ca_topic_score_codex":0.000022164197,"about_ca_topic_score_gemma":0.00015355712,"teacher_disagreement_score":0.031502184,"about_ca_system_score_codex":0.00012147388,"about_ca_system_score_gemma":0.0032915645,"threshold_uncertainty_score":0.5839094},"labels":[],"label_agreement":null},{"id":"W2590024561","doi":"10.1200/jco.2014.32.4_suppl.351","title":"Evaluation of the neutrophil-lymphocyte ratio (NLR) during neoadjuvant chemotherapy (NC) for muscle-invasive bladder cancer (MIBC) and correlation with pathologic response to treatment.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Neutrophil to lymphocyte ratio; Internal medicine; Gastroenterology; Univariate analysis; Receiver operating characteristic; Cystectomy; Pathological; Logistic regression; Urology; Stage (stratigraphy); Oncology; Cancer; Multivariate analysis; Lymphocyte","score_opus":0.09948004143879045,"score_gpt":0.43744735700544785,"score_spread":0.3379673155666574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590024561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898989,0.00042651815,0.00049823767,0.00753278,0.000493642,0.0009780674,0.000009626293,0.000004945102,0.00015728358],"genre_scores_gemma":[0.99634165,0.0005234609,0.0009008736,0.0014005621,0.00056829484,0.00006629284,0.0000011729645,0.000019119081,0.00017855594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974332,0.00087830715,0.000923688,0.00019855113,0.0004136241,0.00015264208],"domain_scores_gemma":[0.99642086,0.001346938,0.0010319903,0.00017586668,0.000863763,0.00016060648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028195942,0.00014553174,0.0007847522,0.00007625321,0.00007398756,0.000006399331,0.00006910979,0.00018253163,0.000043634245],"category_scores_gemma":[0.0017434219,0.00007527725,0.00021756651,0.0001041036,0.00012624438,0.00006708485,0.000014728212,0.0001607201,0.0000011088495],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09744069,0.0017472265,0.079253435,0.000046946887,0.0012606913,0.00005232113,0.0017681327,0.0029938996,0.023833146,0.000023653913,0.00021742503,0.7913624],"study_design_scores_gemma":[0.045029655,0.032677058,0.9109427,0.00014254985,0.0021469023,0.00017395793,0.00011145362,0.0010294854,0.004302562,0.00019988076,0.0031514482,0.00009239985],"about_ca_topic_score_codex":0.00003658801,"about_ca_topic_score_gemma":0.00013749658,"teacher_disagreement_score":0.83168924,"about_ca_system_score_codex":0.00049441244,"about_ca_system_score_gemma":0.002477861,"threshold_uncertainty_score":0.43956193},"labels":[],"label_agreement":null},{"id":"W2590282482","doi":"10.1200/jco.2014.32.4_suppl.230","title":"Transurethral (TURP) biopsy of suspected anterior prostate cancers identified by MRI: Pilot study of a novel technique.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Biopsy; Prostate; Prostate cancer; Radiology; Prostate biopsy; Magnetic resonance imaging; Cancer; Internal medicine","score_opus":0.09917786022845647,"score_gpt":0.4479231714725311,"score_spread":0.3487453112440746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590282482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492043,0.00022609864,0.0013408517,0.0009858293,0.0007785136,0.0008874939,0.000035362194,0.00001191171,0.0008134904],"genre_scores_gemma":[0.9970054,0.00020863439,0.0020460254,0.00023516812,0.00026878965,0.000019537809,0.0000022075549,0.000024137651,0.00019010364],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959606,0.0003616024,0.0027866107,0.00021976222,0.00045545312,0.00021596653],"domain_scores_gemma":[0.99634546,0.00052507326,0.002054778,0.00024026577,0.0005929142,0.00024151476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002064377,0.00017362341,0.0019907071,0.00014883808,0.000024447643,0.0000042285633,0.00019839522,0.00018196915,0.00009228826],"category_scores_gemma":[0.000603955,0.000121011006,0.000311147,0.00021656048,0.00027457403,0.00007304268,0.000025463693,0.0006099873,0.0000010211803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099509805,0.06626838,0.30485776,0.00043698706,0.004646826,0.000401732,0.002198775,0.00002149677,0.47185427,0.000038012513,0.0058281305,0.043937843],"study_design_scores_gemma":[0.09612323,0.40149325,0.47364652,0.0006928744,0.0025718575,0.00055955566,0.0008546226,0.000067978945,0.019718613,0.00017227598,0.0038097724,0.00028945375],"about_ca_topic_score_codex":0.0005977701,"about_ca_topic_score_gemma":0.00024212072,"teacher_disagreement_score":0.45213565,"about_ca_system_score_codex":0.0001432433,"about_ca_system_score_gemma":0.0010900605,"threshold_uncertainty_score":0.49346855},"labels":[],"label_agreement":null},{"id":"W2590307037","doi":"10.1200/jco.2015.33.7_suppl.335","title":"Impact of first-line cisplatin versus non-cisplatin based chemotherapy on progression-free survival in patients with advanced urothelial carcinoma previously treated with perioperative cisplatin based chemotherapy.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Cisplatin; Regimen; Oncology; Proportional hazards model; Chemotherapy regimen; Progression-free survival; Perioperative; Neutropenia; Surgery","score_opus":0.06260395794880635,"score_gpt":0.417628241629942,"score_spread":0.35502428368113564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590307037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523306,0.000060145536,0.00019738472,0.001156815,0.00030824184,0.0017002065,0.000062880354,0.000016818107,0.0012644316],"genre_scores_gemma":[0.99232566,0.000028782064,0.0065631606,0.00051035604,0.00033669546,0.000044413722,0.00003978542,0.00009345393,0.000057684887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952373,0.0004921928,0.0021228325,0.00049036107,0.0011569656,0.00050033064],"domain_scores_gemma":[0.9939529,0.0015154375,0.0020558184,0.00057645136,0.0012263753,0.000673063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013634086,0.00054399465,0.002577297,0.00028866663,0.000057046655,0.000015922038,0.00031676036,0.00044072734,0.00025012143],"category_scores_gemma":[0.0011297084,0.0003065504,0.00047288294,0.00047736955,0.00032905806,0.00017040891,0.000025244262,0.0009406366,0.0000041892895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30076608,0.0062219338,0.6573836,0.000033473225,0.0004776544,0.00019147019,0.0002692456,0.0011793042,0.000033650842,0.000001032463,0.00012417116,0.033318404],"study_design_scores_gemma":[0.20692395,0.18720579,0.60287046,0.0005152608,0.00027152363,0.000008714669,0.00004229517,0.0012777623,0.00048940757,0.0000040321797,0.00018023918,0.00021056109],"about_ca_topic_score_codex":0.00018167148,"about_ca_topic_score_gemma":0.00029064683,"teacher_disagreement_score":0.18098386,"about_ca_system_score_codex":0.00074626924,"about_ca_system_score_gemma":0.0047110813,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W2590440658","doi":"10.1200/jco.2014.32.4_suppl.lba287","title":"The initial report of RTOG 0524: Phase I/II trial of a combination of paclitaxel and trastuzumab with daily irradiation or paclitaxel alone with daily irradiation following transurethral surgery for noncystectomy candidates with muscle-invasive bladder cancer.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Trastuzumab; Internal medicine; Paclitaxel; Clinical endpoint; Oncology; Radiation therapy; Population; Gastroenterology; Urology; Chemotherapy; Surgery; Bladder cancer; Cancer; Randomized controlled trial; Breast cancer","score_opus":0.07959428162180378,"score_gpt":0.4301499064487896,"score_spread":0.3505556248269858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590440658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940354,0.00037598595,0.0013732677,0.002194559,0.00054396945,0.0012648493,0.00006453422,0.000006888732,0.00014050154],"genre_scores_gemma":[0.9975601,0.00041140366,0.0012183359,0.0001277751,0.0004951473,0.000080745915,0.000030283063,0.00003436655,0.00004188188],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957214,0.00047846447,0.002596587,0.00027584817,0.0006702718,0.00025745525],"domain_scores_gemma":[0.98888975,0.005668267,0.004034005,0.0002359087,0.0009596495,0.00021239335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003340851,0.00024043536,0.002052961,0.00017067566,0.000121893245,0.000010298742,0.00009936896,0.0002636721,0.000011225549],"category_scores_gemma":[0.0020535048,0.0001254968,0.00036736194,0.00024821656,0.0004281009,0.00024348816,0.000010080122,0.00034995071,6.262239e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7468896,0.0077844886,0.0807,0.0004977563,0.0056861215,0.00037825573,0.0026468753,0.00004810391,0.0009475611,0.00006310423,0.00045886307,0.15389927],"study_design_scores_gemma":[0.48052943,0.31613576,0.1895236,0.00123366,0.0067336326,0.000622382,0.0011938815,0.00033342367,0.0018790743,0.0002619043,0.0012376338,0.00031561722],"about_ca_topic_score_codex":0.00042550263,"about_ca_topic_score_gemma":0.001849819,"teacher_disagreement_score":0.30835128,"about_ca_system_score_codex":0.00013606368,"about_ca_system_score_gemma":0.00450588,"threshold_uncertainty_score":0.7993238},"labels":[],"label_agreement":null},{"id":"W2590571433","doi":"10.5489/cuaj.4136","title":"Inverted urothelial papilloma: A review of diagnostic pitfalls and clinical management","year":2017,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Inverted papilloma; Medicine; Papilloma; Pathology","score_opus":0.07404904996607484,"score_gpt":0.3738091053905787,"score_spread":0.2997600554245039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590571433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000087388935,0.9914978,0.0000036450617,0.0021045303,0.0004895187,0.001214745,0.0001779095,0.000012322941,0.004490748],"genre_scores_gemma":[0.00005809526,0.9943789,0.00009521498,0.003668531,0.00064281124,0.000048101432,0.00006974279,0.000032377684,0.0010062178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968379,0.0005532657,0.0013296625,0.00036613498,0.00045593982,0.00045707973],"domain_scores_gemma":[0.9962106,0.0007099583,0.001496393,0.0003381495,0.000235557,0.0010093567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014493496,0.0003554679,0.0024422014,0.00020901761,0.00021495327,0.00006152015,0.00026960458,0.00059022574,0.00051678607],"category_scores_gemma":[0.0042155194,0.00024699126,0.0008460606,0.00013150666,0.00009937346,0.000056612455,0.000053107746,0.0009894327,0.00007872252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000126321775,0.00009948994,0.009636451,0.012664364,0.0017514194,0.00053958985,0.0000051188217,5.954316e-9,5.109193e-9,0.000053618787,0.020471426,0.95476586],"study_design_scores_gemma":[0.0010605187,0.00043701983,0.01175709,0.031950075,0.0060493816,0.0003956628,0.0000016927103,3.394233e-7,1.31807365e-8,0.00010102912,0.9480545,0.00019266465],"about_ca_topic_score_codex":0.00037337528,"about_ca_topic_score_gemma":0.0001411762,"teacher_disagreement_score":0.9545732,"about_ca_system_score_codex":0.0008177171,"about_ca_system_score_gemma":0.0014463289,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W2590632696","doi":"10.1200/jco.2013.31.6_suppl.299","title":"Using micro-RNA expression to predict response to neoadjuvant chemotherapy in urothelial carcinoma of the bladder.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"microRNA; Medicine; Chemotherapy; Bladder cancer; Oncology; Pathological; Gene expression; Cancer research; Carcinoma; Internal medicine; Gene; Cancer; Biology; Genetics","score_opus":0.10354131106993009,"score_gpt":0.442964800491746,"score_spread":0.33942348942181594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590632696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98162055,0.00013228197,0.00012997052,0.015846241,0.0009836251,0.00077613106,0.000007018661,0.0000038779895,0.00050027866],"genre_scores_gemma":[0.9857085,0.000039330745,0.0059521776,0.007218281,0.00074028684,0.000010337934,1.8362145e-7,0.000024795367,0.00030614308],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99664885,0.0006747123,0.0018276647,0.00019949807,0.00038808715,0.0002612076],"domain_scores_gemma":[0.99740237,0.00080481067,0.00073510065,0.00031815513,0.00032399318,0.0004155765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017336115,0.00015478733,0.001104257,0.0001714521,0.000032210544,0.000007271975,0.00027619366,0.00026961885,0.00030281738],"category_scores_gemma":[0.001677532,0.00008852896,0.00038241723,0.00024065381,0.00010761897,0.00007553087,0.00008747467,0.00055850577,0.000016677073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049711447,0.0022980687,0.26178545,0.00002336006,0.00020401152,0.00019466171,0.0013017426,0.00010939749,0.6030101,0.0000025556203,0.009153016,0.072206184],"study_design_scores_gemma":[0.014226691,0.012722364,0.8979188,0.00035680956,0.00012397599,0.00016792153,0.0001785885,0.000048039186,0.06198522,0.00008867602,0.012084072,0.00009880188],"about_ca_topic_score_codex":0.00022577423,"about_ca_topic_score_gemma":0.000021303555,"teacher_disagreement_score":0.6361334,"about_ca_system_score_codex":0.0002310319,"about_ca_system_score_gemma":0.0018526558,"threshold_uncertainty_score":0.36101064},"labels":[],"label_agreement":null},{"id":"W2590714628","doi":"10.1200/jco.2014.32.4_suppl.284","title":"Long-term outcomes among patients who achieve complete or near-complete responses after the induction phase of bladder-preserving combined modality therapy for muscle-invasive bladder cancer: A pooled analysis of RTOG 9906 and 0233.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Cumulative incidence; Surgery; Internal medicine; Oncology; Cohort; Cancer","score_opus":0.15992891190645198,"score_gpt":0.46372382415040536,"score_spread":0.3037949122439534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590714628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393016,0.00021637749,0.000357759,0.0039235894,0.00043506332,0.0008606281,0.00022948344,0.0000065183067,0.00004042465],"genre_scores_gemma":[0.9969516,0.0006419663,0.00036085834,0.0016085249,0.00024305959,0.000057271518,0.000019542596,0.000026466967,0.0000907515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99544364,0.0011198126,0.0023817362,0.00031331048,0.00046437423,0.00027712164],"domain_scores_gemma":[0.9903405,0.0053833243,0.0025659301,0.00042748067,0.0010310563,0.00025175393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001986102,0.00025969712,0.0025568816,0.00022758212,0.00010765236,0.000019065219,0.00025990696,0.00028809492,0.00025222692],"category_scores_gemma":[0.0024050558,0.00014312449,0.0009052412,0.0003383158,0.00065582374,0.00016238332,0.00008598096,0.00047151142,4.6766928e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06922473,0.0025044451,0.8754225,0.00006937297,0.010699738,0.000015999847,0.00061177363,0.000033288477,0.00024333512,0.000006412717,0.00014683495,0.041021597],"study_design_scores_gemma":[0.030926608,0.021091465,0.93953973,0.000119227756,0.0067634746,0.0000052600903,0.00008196499,0.00075530424,0.00012246438,0.00022126322,0.00025229176,0.00012096887],"about_ca_topic_score_codex":0.00047067736,"about_ca_topic_score_gemma":0.0012868448,"teacher_disagreement_score":0.06411724,"about_ca_system_score_codex":0.000089430825,"about_ca_system_score_gemma":0.00072545744,"threshold_uncertainty_score":0.58364475},"labels":[],"label_agreement":null},{"id":"W2590749769","doi":"10.1200/jco.2013.31.15_suppl.4542","title":"Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Receiver operating characteristic; Logistic regression; Classifier (UML); Oncology; Internal medicine; Cancer; Artificial intelligence","score_opus":0.0819361119725455,"score_gpt":0.4297834293374855,"score_spread":0.34784731736494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590749769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964605,0.00022362599,0.00010518117,0.0009964742,0.0006439936,0.0012588181,0.000007659022,0.0000057862494,0.00029796292],"genre_scores_gemma":[0.9683707,0.00007963035,0.029810727,0.0008363778,0.0006244751,0.00018552502,0.0000044204617,0.000027469941,0.0000607004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562335,0.00024338094,0.003151546,0.00026825533,0.00041384497,0.00029961768],"domain_scores_gemma":[0.99585426,0.0012078926,0.0017017965,0.00015461836,0.0006870221,0.00039442402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014431403,0.00017588622,0.0014703381,0.00011878379,0.00003251499,0.0000069475027,0.00013610185,0.00041959164,0.00028857612],"category_scores_gemma":[0.0010165406,0.00010548174,0.00030783337,0.00009862899,0.00025121032,0.0001310383,0.000058034384,0.0006938715,0.000007820858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009101822,0.0028113255,0.7726489,0.00006513485,0.0005028609,0.000036254027,0.0002772627,0.0000014468654,0.000052181204,0.0000010771623,0.0004489994,0.2140528],"study_design_scores_gemma":[0.03037609,0.013334852,0.9464272,0.00050115585,0.0003399723,0.000009752762,0.00010484194,0.000025872789,0.00009322722,0.000027101554,0.008659671,0.000100210025],"about_ca_topic_score_codex":0.000023080249,"about_ca_topic_score_gemma":0.00014918036,"teacher_disagreement_score":0.21395259,"about_ca_system_score_codex":0.00025297859,"about_ca_system_score_gemma":0.00424967,"threshold_uncertainty_score":0.75387317},"labels":[],"label_agreement":null},{"id":"W2590790023","doi":"10.1200/jco.2016.34.2_suppl.458","title":"The impact of histological variants on bladder cancer survival: A population-based analysis.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Oncology; Proportional hazards model; Surveillance, Epidemiology, and End Results; Population; Cohort; Adenocarcinoma; Cancer; Pathology; Cancer registry","score_opus":0.1849036059960199,"score_gpt":0.5213591067956634,"score_spread":0.33645550079964354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590790023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373103,0.0004425059,0.00034333696,0.012521369,0.0009108908,0.00015060687,0.000024042367,0.0000066067255,0.0018696233],"genre_scores_gemma":[0.99785495,0.00042369455,0.00015185836,0.00068070914,0.0005338159,0.000004454548,0.0000014209749,0.000009755296,0.00033933195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971289,0.00052773784,0.001618507,0.00015289464,0.00037636925,0.00019556917],"domain_scores_gemma":[0.9929908,0.004552078,0.0015144685,0.00024036325,0.0004465233,0.00025578114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017040323,0.00012599786,0.0014226348,0.00012467407,0.0000494256,0.000003937737,0.00015402868,0.00024980292,0.00076204847],"category_scores_gemma":[0.0028031168,0.0000460252,0.0012963502,0.00024009628,0.00017817164,0.000036751415,0.000013878584,0.00031940787,0.00000743357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008331024,0.0013562039,0.898404,0.0000026230184,0.0049119517,0.000086547174,0.000009843738,0.0001540369,0.000077134944,0.00011366602,0.0020482014,0.08450476],"study_design_scores_gemma":[0.0067014527,0.010852597,0.9775335,0.000038909133,0.0019945109,0.00001087178,0.0000053295958,0.00008185648,0.000019981862,0.0003828877,0.002326359,0.000051706036],"about_ca_topic_score_codex":0.0006675872,"about_ca_topic_score_gemma":0.00027829545,"teacher_disagreement_score":0.08445306,"about_ca_system_score_codex":0.00035574762,"about_ca_system_score_gemma":0.0023765366,"threshold_uncertainty_score":0.8343896},"labels":[],"label_agreement":null},{"id":"W2590808165","doi":"10.1200/jco.2013.31.6_suppl.256","title":"Post-treatment prognostic model for patients (pts) with metastatic urothelial cancer (UC) treated with first-line chemotherapy.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nomogram; Proportional hazards model; Docetaxel; Internal medicine; Oncology; Discontinuation; Chemotherapy; Hazard ratio; Concordance; Prognostic variable; Survival analysis; Cancer; Confidence interval","score_opus":0.08535991598127514,"score_gpt":0.4134286707482571,"score_spread":0.328068754766982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590808165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605293,0.00022814353,0.001913699,0.0084319785,0.00024937038,0.0026456413,0.000092770875,0.00002128475,0.00036418624],"genre_scores_gemma":[0.97963405,0.00087883783,0.013975114,0.0028183667,0.0005692561,0.000449984,0.000023254202,0.00007301733,0.0015781194],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9975006,0.00010118168,0.0013404777,0.000299646,0.0003906641,0.00036742183],"domain_scores_gemma":[0.99573904,0.0010116529,0.0011176108,0.00021056585,0.001446883,0.0004742357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002711405,0.00031862862,0.001641813,0.000102333455,0.00007131196,0.000017379625,0.000119862234,0.00017704349,0.00028145337],"category_scores_gemma":[0.00035055637,0.00015821247,0.0003606832,0.000117396296,0.00017195466,0.00015828235,0.000011189154,0.00028065423,0.00001526503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062363233,0.022795368,0.58616304,0.0001707232,0.007031852,0.0002181495,0.00056735484,0.0011429095,0.00006746243,0.000017863573,0.001236779,0.31822523],"study_design_scores_gemma":[0.21403064,0.44549963,0.300962,0.00067050505,0.009348067,0.0002508631,0.00013864625,0.0107275285,0.0003994807,0.00037006068,0.017010752,0.0005918028],"about_ca_topic_score_codex":0.00037673116,"about_ca_topic_score_gemma":0.00075968646,"teacher_disagreement_score":0.42270428,"about_ca_system_score_codex":0.0003899257,"about_ca_system_score_gemma":0.002711979,"threshold_uncertainty_score":0.64517176},"labels":[],"label_agreement":null},{"id":"W2591161534","doi":"10.1200/jco.2016.34.2_suppl.467","title":"Molecular tumor grading of non muscle invasive bladder cancer based on whole transcriptome analysis.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Grading (engineering); Bladder cancer; Transcriptome; Medicine; Pathological; Correlation; Pathology; Oncology; Computational biology; Internal medicine; Bioinformatics; Cancer; Gene; Gene expression; Biology; Genetics","score_opus":0.07414910570578977,"score_gpt":0.4336104160529946,"score_spread":0.35946131034720485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591161534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98484963,0.00023732161,0.0018034859,0.010057549,0.00062034605,0.00018500733,0.000029273175,0.000005958644,0.0022114043],"genre_scores_gemma":[0.9933681,0.00018345336,0.0006811483,0.005169539,0.00043016745,0.000008382892,0.0000014019353,0.000019282628,0.00013854369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972899,0.00026089264,0.0015744483,0.00021389418,0.00044042978,0.0002204675],"domain_scores_gemma":[0.99686533,0.0011015575,0.0011196764,0.00023045493,0.00034714577,0.00033585934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009735883,0.00015395069,0.0016541578,0.0003085309,0.000021700353,0.0000033682943,0.00014836952,0.00019001347,0.0004890837],"category_scores_gemma":[0.00066905224,0.0000865483,0.0010954739,0.000284042,0.00017543534,0.00007053014,0.000010981433,0.00035744547,0.000010778485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016048413,0.009092245,0.32973993,0.00015609848,0.015294817,0.004085135,0.00034329703,0.0009811395,0.31554815,0.00006693984,0.0058289156,0.3028149],"study_design_scores_gemma":[0.033923507,0.031646494,0.8493319,0.00065304537,0.011466352,0.00004113059,0.00008888821,0.00037446475,0.05448801,0.00026850856,0.0174659,0.0002517617],"about_ca_topic_score_codex":0.00006905636,"about_ca_topic_score_gemma":0.000070624454,"teacher_disagreement_score":0.519592,"about_ca_system_score_codex":0.00018934085,"about_ca_system_score_gemma":0.0018021599,"threshold_uncertainty_score":0.5355124},"labels":[],"label_agreement":null},{"id":"W2591193595","doi":"10.1200/jco.2016.34.2_suppl.393","title":"Incidence, characteristics, and implications of thrombo-embolic events in patients with urothelial carcinoma of the bladder undergoing neoadjuvant chemotherapy.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network; University of British Columbia; McMaster University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cumulative incidence; Chemotherapy; Pulmonary embolism; Incidence (geometry); Urology; Thrombosis; Surgery; Internal medicine; Cancer; Cohort","score_opus":0.038275387806383177,"score_gpt":0.3691996249696561,"score_spread":0.3309242371632729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591193595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539787,0.00006726208,0.00005241493,0.0036527084,0.00023624244,0.00028928075,0.00001921761,0.0000015530826,0.00028344506],"genre_scores_gemma":[0.9985567,0.00030990472,0.00026769796,0.00063835894,0.00016086859,0.000003144918,6.107036e-7,0.000013583866,0.00004913312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979808,0.00016749484,0.0013333354,0.00013082077,0.0002488016,0.00013875635],"domain_scores_gemma":[0.9972474,0.00069338665,0.0013927633,0.00021038101,0.00033974956,0.000116298674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005064258,0.00010645099,0.0009110391,0.00007653911,0.00002058189,0.00000117429,0.00013765835,0.00014400715,0.000049126545],"category_scores_gemma":[0.0005886975,0.000048661892,0.00015063045,0.000109251196,0.00026844503,0.000072948926,0.00004071688,0.00022219351,9.632897e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019691507,0.0010524495,0.95158273,0.000017925657,0.00018726128,0.0000032688802,0.00010505437,1.5868099e-7,0.00032311777,0.0000470727,0.000051392948,0.044660434],"study_design_scores_gemma":[0.015145208,0.0056633973,0.9776096,0.00028852667,0.00019247041,0.000023102362,0.000019609275,8.227693e-7,0.000299459,0.00045339463,0.0002556103,0.000048815225],"about_ca_topic_score_codex":0.000037833328,"about_ca_topic_score_gemma":0.00006528522,"teacher_disagreement_score":0.044611618,"about_ca_system_score_codex":0.00008381728,"about_ca_system_score_gemma":0.0012747729,"threshold_uncertainty_score":0.22613923},"labels":[],"label_agreement":null},{"id":"W2591246871","doi":"10.1200/jco.2016.34.2_suppl.455","title":"Impact of multidisciplinary bladder cancer care for muscle invasive bladder cancer: A propensity score matched analysis of survival outcomes.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Propensity score matching; Radiation therapy; Comorbidity; Proportional hazards model; Cancer; Cohort; Internal medicine; Urology; Surgery; Oncology","score_opus":0.20110187636747193,"score_gpt":0.5000804061531497,"score_spread":0.29897852978567785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591246871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942206,0.0009481569,0.00013908504,0.0023891993,0.00085606874,0.00069212605,0.00051606627,0.0000070489536,0.00023161771],"genre_scores_gemma":[0.9967102,0.0016721213,0.0005951865,0.00020523157,0.00046757894,0.000040208924,0.0000091110205,0.00003217173,0.00026819986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996063,0.00028856855,0.0024908348,0.00032696902,0.00048970344,0.00034095556],"domain_scores_gemma":[0.99209684,0.0022150627,0.0027636716,0.00036709197,0.0021528364,0.00040450224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010134599,0.0002667207,0.0040686387,0.0003084696,0.00004662811,0.0000037662764,0.00024161531,0.00040002604,0.0006869198],"category_scores_gemma":[0.0014083022,0.00013542594,0.002541443,0.000400314,0.00036758438,0.00013064123,0.00009767464,0.000340489,0.0000018140892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070118182,0.0015592565,0.9184066,0.000102076076,0.018769618,0.000068329864,0.0007604436,0.00009355892,0.0023468465,0.00000411028,0.00047269717,0.05040465],"study_design_scores_gemma":[0.015585892,0.010271705,0.96036595,0.00022946732,0.012062199,0.000007903197,0.00030192165,0.000020848014,0.00072926236,0.000051354524,0.00023409876,0.0001394066],"about_ca_topic_score_codex":0.0020503404,"about_ca_topic_score_gemma":0.005452364,"teacher_disagreement_score":0.050265245,"about_ca_system_score_codex":0.00056084775,"about_ca_system_score_gemma":0.006149406,"threshold_uncertainty_score":0.9994848},"labels":[],"label_agreement":null},{"id":"W2591364804","doi":"10.1200/jco.2014.32.4_suppl.353","title":"Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Docetaxel; Chemotherapy; Pazopanib; Sunitinib; Paclitaxel; Urology; Cancer","score_opus":0.04561009356560923,"score_gpt":0.43272369703405417,"score_spread":0.3871136034684449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591364804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978473,0.00013374965,0.000047259942,0.0002737839,0.00025876367,0.0003237509,0.000009486429,0.0000029575097,0.0011029398],"genre_scores_gemma":[0.99616224,0.0004899105,0.0027038069,0.00025804204,0.00031036942,0.0000028578406,0.0000015980172,0.000028749933,0.000042425254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968067,0.0003137826,0.002127554,0.00016255,0.00037979882,0.00020960656],"domain_scores_gemma":[0.99573916,0.0008741978,0.002346078,0.00023462548,0.00064456486,0.00016139814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011492156,0.00017370978,0.001916712,0.00012103172,0.000011407168,0.0000015875501,0.00015594819,0.00023992985,0.00019149687],"category_scores_gemma":[0.00076929235,0.00010267404,0.00049773685,0.00018110652,0.00018357173,0.00008909123,0.00001876129,0.00040570335,0.0000013489413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025451815,0.0034233169,0.7703598,0.000036946483,0.00034776566,0.000009681293,0.00023863974,0.000014837072,0.0009709158,0.0000038612657,0.00005163812,0.19909073],"study_design_scores_gemma":[0.042444255,0.046266362,0.9083352,0.00023547698,0.00011779252,0.00002160691,0.000023569522,0.00001485879,0.001938606,0.000068486166,0.0004600623,0.00007372419],"about_ca_topic_score_codex":0.0001579245,"about_ca_topic_score_gemma":0.00002933021,"teacher_disagreement_score":0.19901702,"about_ca_system_score_codex":0.000110790774,"about_ca_system_score_gemma":0.0011274464,"threshold_uncertainty_score":0.4186926},"labels":[],"label_agreement":null},{"id":"W2591424448","doi":"10.5489/cuaj.4409","title":"Finding treatment success in patients unfit for radical cystectomy","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Cystectomy; Medicine; General surgery; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.025837944000318518,"score_gpt":0.28856231392221693,"score_spread":0.2627243699218984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591424448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855138,0.000060152037,0.000023410501,0.01128048,0.00043350304,0.0004993825,0.00008407225,0.0000101677715,0.002095055],"genre_scores_gemma":[0.997785,0.000023847886,0.00011268547,0.0009932602,0.00039165939,0.000040651383,0.00002885904,0.000011789303,0.0006122832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988269,0.000052332598,0.000256397,0.0001804645,0.00021685827,0.00046704523],"domain_scores_gemma":[0.99885434,0.00007562341,0.00023596402,0.00014085713,0.00014282487,0.00055038626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002535319,0.00013091121,0.00029287094,0.00013682366,0.0005597109,0.00015480346,0.00013326263,0.00020234221,0.00022010453],"category_scores_gemma":[0.0006430952,0.00009816979,0.00014221708,0.000045632318,0.000028735485,0.00012238824,0.000008447832,0.00021429964,0.000019808815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001650338,0.00011505518,0.99093574,0.0000026888022,0.00009051404,0.00004698692,0.00006939213,0.000002876706,0.0000032488779,0.000047156936,0.0008286549,0.0076926714],"study_design_scores_gemma":[0.008504904,0.0010453619,0.95499635,0.000016512886,0.00007784824,0.00001623984,0.000008159668,0.00003520461,0.000016646829,0.00041674782,0.034776468,0.00008953639],"about_ca_topic_score_codex":0.0028900837,"about_ca_topic_score_gemma":0.002810246,"teacher_disagreement_score":0.03593935,"about_ca_system_score_codex":0.002957847,"about_ca_system_score_gemma":0.00049389247,"threshold_uncertainty_score":0.7734667},"labels":[],"label_agreement":null},{"id":"W2591484293","doi":"10.1200/jco.2014.32.4_suppl.306","title":"Neoadjuvant gemcitabine-cisplatin (GC) for muscle-invasive bladder cancer (MIBC): Does midway CT staging predict for pathologic complete response (pCR)?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Radiological weapon; Gemcitabine; Cisplatin; Neoadjuvant therapy; Internal medicine; Radiation therapy; Chemotherapy; Progressive disease; Cancer; Urology; Oncology; Surgery","score_opus":0.1305535509564767,"score_gpt":0.4537866521078087,"score_spread":0.323233101151332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591484293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960967,0.0006434495,0.010407347,0.021233104,0.0042408383,0.0016246282,0.00036727314,0.000040120478,0.0004762289],"genre_scores_gemma":[0.96753484,0.00058285915,0.018480958,0.008183316,0.003949999,0.00019482739,0.000019845314,0.000066861474,0.0009864853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952169,0.00082768145,0.0025341564,0.00045081542,0.00040556843,0.00056489545],"domain_scores_gemma":[0.9839028,0.012506503,0.0018833852,0.0003343485,0.00085464056,0.0005183356],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0055910414,0.00031939265,0.0021298456,0.00017260047,0.00015406424,0.000021256405,0.00027382144,0.00032174902,0.00020457117],"category_scores_gemma":[0.010209229,0.00019135904,0.0010115686,0.00011246267,0.00029138697,0.00014216985,0.00006149753,0.00071152195,0.000008361696],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14307742,0.004303437,0.09517687,0.000587113,0.0034018226,0.0016194457,0.0009923478,0.00030789047,0.011621388,0.00032551415,0.03572208,0.7028647],"study_design_scores_gemma":[0.068309285,0.069125265,0.32004756,0.0006662314,0.0033098396,0.0005063752,0.00046957083,0.0015162693,0.0012409998,0.005260632,0.52903944,0.0005085067],"about_ca_topic_score_codex":0.000039564376,"about_ca_topic_score_gemma":0.0001221686,"teacher_disagreement_score":0.70235616,"about_ca_system_score_codex":0.00028392675,"about_ca_system_score_gemma":0.002177589,"threshold_uncertainty_score":0.9981282},"labels":[],"label_agreement":null},{"id":"W2591863070","doi":"10.1016/j.urolonc.2017.01.024","title":"Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Cohort; Medicine; Oncology; Concordance; Internal medicine; Cancer; Lymph node; Nomogram; Disease; Stage (stratigraphy); Biology","score_opus":0.057552263672976625,"score_gpt":0.38292398158697494,"score_spread":0.3253717179139983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591863070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92323744,0.007268651,0.000010021133,0.06120408,0.00047981157,0.0010967719,0.0004574788,0.00003375597,0.0062119956],"genre_scores_gemma":[0.9377713,0.034975212,0.0028170361,0.012958248,0.0008096985,0.0021016542,0.00005976882,0.000051918567,0.008455117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810475,0.00012611416,0.00041084707,0.00064564135,0.00029052456,0.0004221174],"domain_scores_gemma":[0.99794173,0.00024934852,0.0005534806,0.00071090297,0.0002661223,0.0002784212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024570848,0.0003156879,0.0006241319,0.00009102522,0.00087447837,0.000047520603,0.0003696607,0.0002665101,0.001261737],"category_scores_gemma":[0.00018603788,0.00021055577,0.00013311212,0.00016605637,0.0021312744,0.00017867742,0.00016612551,0.00044073802,0.000015956555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021935234,0.00015780526,0.96459615,0.000044228145,0.0013027235,0.00007808667,0.0030178651,0.000062681764,0.00246604,0.00054771337,0.026050972,0.0014563602],"study_design_scores_gemma":[0.0028633112,0.0017108731,0.5756414,0.00017712849,0.0033568947,0.000109202716,0.001178014,0.00016076787,0.012397551,0.0039304146,0.39807084,0.00040359556],"about_ca_topic_score_codex":0.011171483,"about_ca_topic_score_gemma":0.002051391,"teacher_disagreement_score":0.38895476,"about_ca_system_score_codex":0.0002445345,"about_ca_system_score_gemma":0.0015411865,"threshold_uncertainty_score":0.99965125},"labels":[],"label_agreement":null},{"id":"W2593384642","doi":"10.1038/nrurol.2017.16","title":"BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Medicine; Bladder cancer; Immunotherapy; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.10054941897050151,"score_gpt":0.44096908622188385,"score_spread":0.34041966725138234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593384642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.771986e-7,0.97745115,0.000011729222,0.009840733,0.0029885496,0.0050550727,0.001401752,0.000052107243,0.00319791],"genre_scores_gemma":[0.000009479866,0.9814893,0.00021104545,0.008604535,0.003082971,0.0023037815,0.0014707558,0.0001442065,0.002683944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995544,0.0011614353,0.0011780256,0.0011636873,0.0003133626,0.000639492],"domain_scores_gemma":[0.9938341,0.0016885767,0.0014896537,0.0024798752,0.00024668907,0.0002611509],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00058514875,0.0010169796,0.0046709045,0.00017867456,0.0004903834,0.00006604566,0.0010400224,0.002045302,0.0021515246],"category_scores_gemma":[0.0015016879,0.0005596007,0.0016873769,0.00031663402,0.00026298023,0.0000920984,0.00024705238,0.0036811004,0.001083469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040314593,0.000074349606,0.000020125,0.0017245705,0.0012432956,0.00008293214,0.00009900985,2.1637716e-8,4.6295744e-7,0.000034506214,0.13124107,0.86543936],"study_design_scores_gemma":[0.00075619767,0.00025675498,0.00013470091,0.009995634,0.012520356,0.00017227572,0.000008561344,3.1382527e-7,6.9702224e-7,0.00008972164,0.9756533,0.00041151812],"about_ca_topic_score_codex":0.00034770457,"about_ca_topic_score_gemma":0.0006442703,"teacher_disagreement_score":0.86502784,"about_ca_system_score_codex":0.00031493793,"about_ca_system_score_gemma":0.0021529011,"threshold_uncertainty_score":0.9996943},"labels":[],"label_agreement":null},{"id":"W2594288328","doi":"10.1007/s00345-017-2026-4","title":"Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy","year":2017,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Concomitant; Medicine; Perioperative; Lymphadenectomy; Urology; Nephrology; Urothelial carcinoma; Laparoscopy; Renal pelvis; Surgery; Ureteroscopy; Statistical significance; Ureter; Internal medicine; Cancer; Bladder cancer","score_opus":0.014599715552695052,"score_gpt":0.2739821387044004,"score_spread":0.25938242315170534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594288328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165314,0.00038901975,0.000007517325,0.001719434,0.00019002579,0.00014503271,0.000014542931,0.000006216361,0.0058750696],"genre_scores_gemma":[0.9984673,0.000049698476,0.00020769588,0.00033818657,0.0002543106,0.000005860068,0.000006711686,0.000031681397,0.00063852506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998481,0.00011221091,0.00055952114,0.00019749315,0.0003321706,0.0003176177],"domain_scores_gemma":[0.9986304,0.000056580546,0.0006039564,0.00034267304,0.00017324583,0.0001931265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015142794,0.0002174466,0.0007505532,0.000691033,0.00007106869,0.000017105942,0.00024756847,0.000112257905,0.0004585123],"category_scores_gemma":[0.000046952555,0.00014761966,0.00019945492,0.00018045979,0.00026202883,0.00016056812,0.000027820764,0.00031280064,0.0000037770417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066777747,0.00085150613,0.967482,0.000014566002,0.00020281618,0.0007206614,0.00020438468,0.000002844147,0.00040976045,0.000018873954,0.00032794266,0.023086928],"study_design_scores_gemma":[0.022660058,0.004416188,0.96322834,0.000062260755,0.00038450854,0.0006597802,0.00000858964,0.000014341259,0.0008992772,0.000029000299,0.007524721,0.00011294846],"about_ca_topic_score_codex":0.00023260168,"about_ca_topic_score_gemma":0.0001768378,"teacher_disagreement_score":0.022973979,"about_ca_system_score_codex":0.00011171485,"about_ca_system_score_gemma":0.00023536042,"threshold_uncertainty_score":0.60197556},"labels":[],"label_agreement":null},{"id":"W2594798307","doi":"10.1200/jco.2012.30.15_suppl.e15020","title":"Urothelial cancer: Gender discrepancies and impact on overall survival.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Stage (stratigraphy); Cancer; Oncology; Chemotherapy; Urothelial carcinoma; Bladder cancer","score_opus":0.19096560195336396,"score_gpt":0.5116201035681026,"score_spread":0.32065450161473863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594798307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815055,0.0024999985,0.000027024942,0.0038118472,0.002524456,0.00014735364,0.00001793692,0.000008340021,0.009457506],"genre_scores_gemma":[0.9893727,0.0026519704,0.00035000313,0.002760433,0.004425739,0.0000038633266,9.877507e-7,0.000018877578,0.00041546387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980461,0.00024556875,0.0009705259,0.00012183128,0.0003208075,0.00029518377],"domain_scores_gemma":[0.9976845,0.0008261524,0.00060006743,0.00013265498,0.00014505353,0.0006116199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013971749,0.00015233965,0.0011089093,0.00006719395,0.000036063626,0.0000075088124,0.00006829832,0.00022592592,0.00045595827],"category_scores_gemma":[0.00059114577,0.00008461853,0.00042894948,0.000048611866,0.00013492913,0.00013549125,0.0000281363,0.0005704345,0.00001745815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009447636,0.0019892089,0.8980833,0.000023343535,0.0010897259,0.000112732116,0.00025242296,0.000005734523,0.00016524456,0.0004961593,0.006082714,0.082251735],"study_design_scores_gemma":[0.007858203,0.009120749,0.90798086,0.000040975865,0.00050853024,0.0002226966,0.000049996484,0.000005883399,0.00008004775,0.0002664398,0.073781446,0.00008419008],"about_ca_topic_score_codex":0.00015360992,"about_ca_topic_score_gemma":0.000016662982,"teacher_disagreement_score":0.08216754,"about_ca_system_score_codex":0.00018149383,"about_ca_system_score_gemma":0.0010231033,"threshold_uncertainty_score":0.49924234},"labels":[],"label_agreement":null},{"id":"W2595050339","doi":"10.5489/cuaj.4047","title":"Intravesical formalin for hemorrhagic cystitis: A contemporary cohort","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hemorrhagic cystitis; Cystography; Cystectomy; Surgery; Vesicoureteral reflux; Cystoscopy; Cohort; Refractory (planetary science); Retrospective cohort study; Urology; Bladder cancer; Urinary system; Reflux; Internal medicine; Chemotherapy; Cyclophosphamide; Cancer","score_opus":0.025359765710595117,"score_gpt":0.27506282653496084,"score_spread":0.24970306082436572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595050339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.743908,0.0009677518,0.0014089602,0.1892553,0.00238634,0.0020979727,0.0005568192,0.00008972258,0.059329174],"genre_scores_gemma":[0.9902512,0.000027824584,0.0003902804,0.006674344,0.0010334941,0.000042599895,0.000037081005,0.000013771263,0.001529443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988276,0.000042582247,0.00028273166,0.00017200684,0.00024353432,0.00043158958],"domain_scores_gemma":[0.99840033,0.000068365385,0.00028763793,0.00017459579,0.00024870934,0.00082034414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049476547,0.00012987245,0.00031241047,0.00007454099,0.0007927652,0.00020290758,0.00016315992,0.00023023137,0.00026804823],"category_scores_gemma":[0.0008845524,0.00010184475,0.00018195505,0.000028848392,0.000047501326,0.00016978382,0.000012390994,0.00035216886,0.00004853639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018858537,0.000050463666,0.96276003,0.000007119974,0.00023120665,0.0002187607,0.00003984098,6.7302784e-7,0.000031877502,0.000513277,0.032826852,0.0031313298],"study_design_scores_gemma":[0.003344939,0.00070153916,0.88909024,0.000016893508,0.00014790348,0.0004114535,0.000019677756,0.00011307857,0.00006715326,0.0024476843,0.103506446,0.00013300618],"about_ca_topic_score_codex":0.0017597834,"about_ca_topic_score_gemma":0.0005377696,"teacher_disagreement_score":0.2463432,"about_ca_system_score_codex":0.00077583606,"about_ca_system_score_gemma":0.0010274798,"threshold_uncertainty_score":0.6097389},"labels":[],"label_agreement":null},{"id":"W2595999070","doi":"10.5489/cuaj.3848","title":"Diabetes and elevated urea level predict for uretero-ileal stricture after radical cystectomy and ileal conduit formation","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Anastomosis; Urinary diversion; Urology; Surgery; Diabetes mellitus; Complication; Ileum; Bladder cancer; Retrospective cohort study; Urethral stricture; Odds ratio; Internal medicine; Gastroenterology; Cancer; Endocrinology; Urethra","score_opus":0.021108554363452017,"score_gpt":0.24821640553819838,"score_spread":0.22710785117474636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595999070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585695,0.00040996328,0.00015304572,0.012222716,0.00020297458,0.00050305674,0.00041948582,0.000019206114,0.00021257851],"genre_scores_gemma":[0.9958316,0.00006937086,0.00017143972,0.0030858752,0.00050630834,0.000049487066,0.00005249322,0.0000132037085,0.00022022676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998811,0.000062564555,0.0002628556,0.00019121457,0.00023353234,0.000438813],"domain_scores_gemma":[0.99863565,0.00009736872,0.0002552662,0.00011284953,0.00017942516,0.0007194472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032400596,0.00016196608,0.0002961425,0.00010182178,0.0005868259,0.00024669938,0.00008287984,0.00033932383,0.00012276655],"category_scores_gemma":[0.00049195584,0.000121154226,0.00007914759,0.000034471304,0.000079043195,0.00025308685,0.000017327382,0.00038333944,0.0000033359645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028593,0.000028356588,0.98630184,0.00003135616,0.00024051004,0.00004773065,0.0002236293,9.670503e-7,0.0002225429,0.000039625404,0.007081018,0.005496483],"study_design_scores_gemma":[0.004571462,0.0007684227,0.9714893,0.000029651968,0.00023164626,0.00014503914,0.000022532018,0.0004357403,0.000101120284,0.00054307736,0.02153307,0.00012894366],"about_ca_topic_score_codex":0.00041584266,"about_ca_topic_score_gemma":0.00054408883,"teacher_disagreement_score":0.014812558,"about_ca_system_score_codex":0.00039977516,"about_ca_system_score_gemma":0.00022932106,"threshold_uncertainty_score":0.4940526},"labels":[],"label_agreement":null},{"id":"W2596227191","doi":"10.1200/jco.2012.30.15_suppl.tps4675","title":"Randomized phase II study of docetaxel with or without ramucirumab (IMC-1121B) or icrucumab (IMC-18F1) in patients with urothelial transitional cell carcinoma (TCC) following progression on first-line platinum-based therapy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ramucirumab; Docetaxel; Medicine; Paclitaxel; Oncology; Vascular endothelial growth factor; Internal medicine; Cancer research; Cancer; VEGF receptors","score_opus":0.09876581949273502,"score_gpt":0.439622911102911,"score_spread":0.34085709161017597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596227191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486697,0.00019725825,0.00017382429,0.00058791996,0.0005244516,0.0032596667,0.000024412739,0.000014094182,0.00035141],"genre_scores_gemma":[0.9962373,0.000031462478,0.0021877557,0.0006566295,0.00058609,0.00010177439,0.000017679362,0.000063792526,0.00011756324],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99420476,0.0010246544,0.0027467278,0.00035681078,0.0012014358,0.0004656147],"domain_scores_gemma":[0.9948584,0.0019473053,0.0020174326,0.000300545,0.00041539175,0.00046091704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025308614,0.0004236266,0.003423948,0.00029512797,0.00013744923,0.000010164968,0.00018991544,0.00032220344,0.0003068617],"category_scores_gemma":[0.0004485014,0.00019641893,0.00052949897,0.0003057714,0.00020962082,0.00024735602,0.000022354287,0.00091987284,0.0000027867538],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6620442,0.06718982,0.25073528,0.00003647223,0.0006346803,0.00032019755,0.0010797671,0.000059372203,0.000014468125,0.0000010864865,0.000033680422,0.017850945],"study_design_scores_gemma":[0.70910007,0.23352487,0.05461687,0.00041505994,0.0011367155,0.000034841138,0.0001883261,0.00010375444,0.0002928337,0.0000050763665,0.00039638253,0.00018518347],"about_ca_topic_score_codex":0.000056468885,"about_ca_topic_score_gemma":0.00017335951,"teacher_disagreement_score":0.19611841,"about_ca_system_score_codex":0.00020806382,"about_ca_system_score_gemma":0.0019952913,"threshold_uncertainty_score":0.8009732},"labels":[],"label_agreement":null},{"id":"W2597802438","doi":"10.1200/jco.2013.31.15_suppl.4539","title":"Impact of response to prior chemotherapy (RTPC) on outcomes in second-line therapy for advanced urothelial carcinoma (UC): Implications for trial design.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Oncology; Pazopanib; Internal medicine; Docetaxel; Metastatic Urothelial Carcinoma; Chemotherapy; Progression-free survival; Gemcitabine; Response Evaluation Criteria in Solid Tumors; Progressive disease; Cancer; Sunitinib; Urothelial carcinoma; Bladder cancer","score_opus":0.18920341546983926,"score_gpt":0.5262245445798065,"score_spread":0.33702112910996723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597802438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742412,0.00008209695,0.0021740333,0.0176268,0.00054862484,0.0051919324,0.00007860541,0.0000066592934,0.000050077037],"genre_scores_gemma":[0.9798574,0.00011570052,0.014643496,0.0037207983,0.00071990566,0.00048045348,0.0000030037854,0.000040455187,0.00041882956],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996834,0.00035210987,0.0020941037,0.00023920176,0.00016362203,0.0003169807],"domain_scores_gemma":[0.9907893,0.006974223,0.0010445758,0.00028706054,0.0005783131,0.00032650586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002377471,0.00020269869,0.0017614063,0.00023650365,0.00003663479,0.000007304967,0.00019552343,0.00028829038,0.00020911256],"category_scores_gemma":[0.0026828365,0.0001264109,0.0010283659,0.00013137488,0.000070532624,0.00008492206,0.0000093897825,0.000295379,0.0000052343344],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7750943,0.004528097,0.036071245,0.000010479726,0.00048176493,0.0000041923995,0.00017100153,0.000034676923,0.011190303,0.000012790496,0.0019201395,0.17048101],"study_design_scores_gemma":[0.20689626,0.18168288,0.6056714,0.000024344836,0.00007284658,0.000011490935,0.000015956926,0.00001534923,0.0014941851,0.0006677911,0.0033658363,0.00008162609],"about_ca_topic_score_codex":0.000026555506,"about_ca_topic_score_gemma":0.0000145492895,"teacher_disagreement_score":0.56960016,"about_ca_system_score_codex":0.00030778954,"about_ca_system_score_gemma":0.002596735,"threshold_uncertainty_score":0.51548874},"labels":[],"label_agreement":null},{"id":"W2598548323","doi":"10.1200/jco.2017.35.6_suppl.287","title":"Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Medicine; Transcriptome; Oncology; Basal (medicine); Microarray; Subtyping; Gene expression profiling; Chemotherapy; Internal medicine; Tissue microarray; Cancer; Pathology; Gene; Gene expression; Biology","score_opus":0.4174777389471016,"score_gpt":0.5841523085155853,"score_spread":0.1666745695684837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598548323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272188,0.00034337142,0.00029693707,0.06484215,0.004654382,0.00059068075,0.000015302205,0.000014735511,0.0020236184],"genre_scores_gemma":[0.9662866,0.0013914371,0.0021852783,0.024674682,0.0045090523,0.000026842856,6.2261836e-7,0.000036573852,0.0008889256],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941545,0.0015033458,0.0029390124,0.0004396051,0.00054389547,0.00041961428],"domain_scores_gemma":[0.9894587,0.0050303843,0.0020565267,0.0008152741,0.0012174385,0.0014216944],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009915794,0.0002408906,0.0022142646,0.00013840938,0.00020861554,0.000053567786,0.00058708235,0.00056356686,0.00039441965],"category_scores_gemma":[0.02694218,0.0001666321,0.0008597652,0.00012710874,0.00022116138,0.00018295326,0.00016116851,0.0012057592,0.000095523166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09752521,0.003271585,0.43074962,0.00001773127,0.0016225046,0.0014125587,0.00031684578,0.000013878992,0.0012671163,0.00003164595,0.01946685,0.44430444],"study_design_scores_gemma":[0.012656105,0.019121977,0.8127582,0.00018904345,0.0003386749,0.000062933876,0.00007091963,0.0000029753712,0.00033792792,0.00012676654,0.15419202,0.00014242795],"about_ca_topic_score_codex":0.00022898329,"about_ca_topic_score_gemma":0.00031446145,"teacher_disagreement_score":0.444162,"about_ca_system_score_codex":0.00029963936,"about_ca_system_score_gemma":0.008318711,"threshold_uncertainty_score":0.9973032},"labels":[],"label_agreement":null},{"id":"W2598715439","doi":"10.1200/jco.2017.35.6_suppl.346","title":"Nomogram to assess benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials: Effect of atezolizumab on 12-month survival.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Oncology; Nomogram; Internal medicine; Docetaxel; Pazopanib; Sunitinib; Salvage therapy; Atezolizumab; Carboplatin; Progression-free survival; Urology; Cancer; Chemotherapy; Overall survival; Pembrolizumab; Cisplatin; Immunotherapy","score_opus":0.3327630428131123,"score_gpt":0.5385285176088863,"score_spread":0.205765474795774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598715439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894238,0.0002860673,0.00030397082,0.0023219578,0.0032337264,0.0026514179,0.000031347376,0.0000042247016,0.0017434832],"genre_scores_gemma":[0.9956704,0.0004516186,0.0014317223,0.0005141547,0.0011774639,0.00008807785,0.0000029162682,0.000041567073,0.00062209065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99289834,0.001742818,0.004089863,0.0003088056,0.0006435449,0.00031663856],"domain_scores_gemma":[0.9769607,0.017538493,0.004205092,0.0004971364,0.00030075677,0.0004978281],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012780848,0.000302068,0.007559682,0.00026601148,0.000050021372,0.000014002532,0.00041847565,0.00033502013,0.00017528198],"category_scores_gemma":[0.02771371,0.00018281356,0.0021511829,0.00008061801,0.00017320336,0.00009483999,0.00004914666,0.00053011783,0.000004712481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7383772,0.0032153127,0.05393684,0.00009969517,0.0018968955,0.00025733883,0.00020831467,0.000020610636,0.00032449802,0.000041405507,0.0031051238,0.19851676],"study_design_scores_gemma":[0.5912831,0.09094603,0.30299345,0.00030769792,0.0023051216,0.000026618905,0.000016929102,0.000067412715,0.0024767998,0.0005976454,0.008810033,0.00016915839],"about_ca_topic_score_codex":0.002413671,"about_ca_topic_score_gemma":0.00024936587,"teacher_disagreement_score":0.24905662,"about_ca_system_score_codex":0.00047929265,"about_ca_system_score_gemma":0.0017012515,"threshold_uncertainty_score":0.98047626},"labels":[],"label_agreement":null},{"id":"W2598741724","doi":"10.1200/jco.2017.35.6_suppl.388","title":"The impact of peri-operative chemotherapy for patients with lymph node-positive urothelial cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Medicine; Chemotherapy; Cystectomy; Stage (stratigraphy); Bladder cancer; Urothelial cancer; Internal medicine; Lymph node; Proportional hazards model; Cancer; Oncology; Surgery; Urology","score_opus":0.06450535148327566,"score_gpt":0.4889928042519054,"score_spread":0.42448745276862976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598741724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914194,0.00021078778,0.00011706848,0.004819686,0.0006710549,0.0005848364,0.00009536223,0.0000026250243,0.0020792028],"genre_scores_gemma":[0.9964743,0.00076802797,0.00077134586,0.0006287882,0.0010108107,0.000021506346,0.000002176508,0.000022788994,0.0003002236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827754,0.00012846636,0.0009828758,0.00014243911,0.00026112158,0.00020757449],"domain_scores_gemma":[0.99545485,0.00096319953,0.0019663095,0.00026826857,0.0011427498,0.00020464053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007122959,0.00015186777,0.001078181,0.000028431657,0.00023806072,0.000022586915,0.00024657528,0.00017255844,0.00007393469],"category_scores_gemma":[0.00092690537,0.0000670996,0.0005865727,0.000027056338,0.0004942918,0.00011820211,0.000022239019,0.000276599,0.0000015352874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05104856,0.0020946465,0.758834,0.000010293715,0.002474126,0.000020792058,0.00029717627,0.0000117268755,0.00007839768,0.000029143257,0.0011467582,0.18395436],"study_design_scores_gemma":[0.032618586,0.033147898,0.93076205,0.00011243423,0.00038760196,0.00001716751,0.00004436753,0.00003473566,0.00032226226,0.00011118411,0.0023705608,0.00007113149],"about_ca_topic_score_codex":0.00027867607,"about_ca_topic_score_gemma":0.000037128862,"teacher_disagreement_score":0.18388322,"about_ca_system_score_codex":0.00026123127,"about_ca_system_score_gemma":0.0031513257,"threshold_uncertainty_score":0.55903167},"labels":[],"label_agreement":null},{"id":"W2599150633","doi":"10.1200/jco.2017.35.6_suppl.286","title":"Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Durvalumab; Metastatic Urothelial Carcinoma; Internal medicine; Clinical endpoint; Tolerability; Oncology; Population; Urology; Gastroenterology; Surgery; Immunotherapy; Clinical trial; Adverse effect; Bladder cancer; Urothelial carcinoma; Cancer; Nivolumab","score_opus":0.15712397564556346,"score_gpt":0.4943208089412711,"score_spread":0.33719683329570765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599150633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427104,0.00026219775,0.000044414355,0.0028127872,0.0005608919,0.00037140603,0.000009280376,0.0000033598378,0.001664596],"genre_scores_gemma":[0.99568194,0.00028332046,0.0030948326,0.00049768196,0.00021701267,0.0000035279293,0.0000011256908,0.00001259562,0.00020795404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691993,0.00034402622,0.0020951193,0.00019671381,0.00025996566,0.0001842656],"domain_scores_gemma":[0.99644667,0.0009700146,0.0016544946,0.0003511837,0.00030671537,0.00027093422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019572966,0.0001324405,0.0018045414,0.00007978383,0.000046267443,0.000008937936,0.00019434578,0.00016937207,0.00018439553],"category_scores_gemma":[0.005074588,0.000082523846,0.00020960822,0.0000531916,0.00043799725,0.00013501078,0.000063107946,0.00054877356,0.0000035651688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06687346,0.004732342,0.46657553,0.00010635307,0.0004860562,0.0015707671,0.00021517904,0.000018467372,0.0005310729,0.00004329753,0.00025688866,0.45859057],"study_design_scores_gemma":[0.047341004,0.020465825,0.9266308,0.00012410819,0.0004480448,0.0002486932,0.00006011814,0.00006354874,0.0003114266,0.00028302995,0.003948985,0.00007439605],"about_ca_topic_score_codex":0.0001631884,"about_ca_topic_score_gemma":0.0002526568,"teacher_disagreement_score":0.46005526,"about_ca_system_score_codex":0.00009342009,"about_ca_system_score_gemma":0.0023009654,"threshold_uncertainty_score":0.60751224},"labels":[],"label_agreement":null},{"id":"W2599180674","doi":"10.1186/s13063-017-1843-5","title":"Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C","year":2017,"lang":"en","type":"letter","venue":"Trials","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Radboud Universiteit","keywords":"Medicine; Mitomycin C; Urology; Resection; Bladder cancer; Bladder tumor; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.12976739605793422,"score_gpt":0.4458081558888992,"score_spread":0.316040759830965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599180674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832967,0.0010679079,0.000009450561,0.0077679176,0.00057497236,0.00641124,0.00025621342,0.000018045552,0.0005975578],"genre_scores_gemma":[0.9955524,0.000042508495,0.000018517498,0.0015622086,0.0022383868,0.00025028412,0.00007147684,0.000035906247,0.00022829919],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955641,0.001490038,0.0016881085,0.00036815388,0.00066080515,0.00022876155],"domain_scores_gemma":[0.99542665,0.0016194847,0.002054521,0.00068237504,0.00016491047,0.000052037514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003927693,0.00034947615,0.003360866,0.00014241823,0.000080711216,0.000016154796,0.00021090842,0.0004176711,0.00007722416],"category_scores_gemma":[0.0019312998,0.00019924027,0.00055922614,0.000098637924,0.00036937985,0.0000617729,0.000026912237,0.0006700312,8.376292e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84831953,0.00047075274,0.0049260124,0.00934394,0.004699974,0.000045243072,0.0016166037,0.000002905435,0.050856613,0.0000050381905,0.0775145,0.0021989206],"study_design_scores_gemma":[0.706072,0.018791866,0.0055525294,0.0021338586,0.0063444832,0.000042136024,0.000048294518,0.0000078850535,0.2569485,0.00011806233,0.0035734228,0.0003669937],"about_ca_topic_score_codex":0.0015037198,"about_ca_topic_score_gemma":0.00004961905,"teacher_disagreement_score":0.20609188,"about_ca_system_score_codex":0.00003594952,"about_ca_system_score_gemma":0.00029739036,"threshold_uncertainty_score":0.8124782},"labels":[],"label_agreement":null},{"id":"W2599564927","doi":"10.1200/jco.2015.33.15_suppl.6525","title":"Utilization of palliative chemotherapy for advanced bladder cancer: Patterns of care in routine clinical practice.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Bladder cancer; Cancer registry; Comorbidity; Cancer; Internal medicine; Poisson regression; Referral; Population; Chemotherapy; Lung cancer; Medical record; Cohort; Palliative care; Family medicine","score_opus":0.22860531872505893,"score_gpt":0.5640090565918715,"score_spread":0.33540373786681255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599564927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98227257,0.0038626557,0.0018925803,0.007945439,0.0017467499,0.0008146424,0.000054027132,0.0000052714477,0.0014060409],"genre_scores_gemma":[0.9831443,0.0064934664,0.0075957915,0.0018855266,0.00076692493,0.000014804336,0.000008613417,0.000020341142,0.00007025185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959334,0.00038338348,0.0030057996,0.00017674679,0.00034086208,0.00015981194],"domain_scores_gemma":[0.9923711,0.0021889354,0.003022871,0.00015746347,0.0020234184,0.00023622118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022487382,0.000124817,0.0016986184,0.00008854735,0.000008727606,0.0000017253147,0.00011553643,0.00033642427,0.00005453623],"category_scores_gemma":[0.0057638674,0.00008986375,0.00042167408,0.00012564172,0.00011245647,0.000118008014,0.000019854344,0.0004345346,7.0617466e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036392063,0.002692748,0.62241584,0.00009749924,0.00061775267,0.000036147063,0.0011291379,0.000053573505,0.000023289329,0.000057331963,0.0005988729,0.33588573],"study_design_scores_gemma":[0.09684492,0.07722076,0.7399705,0.00054315606,0.0012133463,0.000023345074,0.004551156,0.00013559232,0.0017886539,0.00043353334,0.077121004,0.00015405177],"about_ca_topic_score_codex":0.00010438644,"about_ca_topic_score_gemma":0.00025490994,"teacher_disagreement_score":0.3357317,"about_ca_system_score_codex":0.00020810752,"about_ca_system_score_gemma":0.0031676993,"threshold_uncertainty_score":0.6900304},"labels":[],"label_agreement":null},{"id":"W2600669512","doi":"10.1200/jco.2017.35.6_suppl.281","title":"Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of Alberta; University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Medicine; Cystectomy; Concordance; Cisplatin; Oncology; Transcriptome; Internal medicine; Chemotherapy; Basal (medicine); Neoadjuvant therapy; Regimen; Pathology; Cancer; Gene expression; Gene; Biology","score_opus":0.08460426618305014,"score_gpt":0.47344365460566734,"score_spread":0.3888393884226172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600669512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.934529,0.0011572366,0.00005030769,0.061397117,0.0008881959,0.0002176041,0.0000065224167,0.0000061332053,0.0017478956],"genre_scores_gemma":[0.9824493,0.0025191505,0.001818967,0.011679697,0.0008750691,0.0000072552066,2.953828e-7,0.00002286786,0.0006274272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981589,0.00023354054,0.0009274037,0.00021059657,0.00025956903,0.0002100432],"domain_scores_gemma":[0.99710655,0.00075829244,0.0009047145,0.0003476675,0.00033388543,0.00054891116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015180205,0.00014031376,0.001050092,0.000079648766,0.00009851107,0.000025519372,0.00019789701,0.00024726326,0.00018820529],"category_scores_gemma":[0.0034009244,0.00009720238,0.00027469586,0.00003558487,0.00021395237,0.00008920164,0.000063229534,0.00044181675,0.000015819416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043932166,0.0011362716,0.10054035,0.000027366363,0.001367192,0.003662082,0.0005892419,0.000005970695,0.01634297,0.000037543177,0.007045042,0.8253138],"study_design_scores_gemma":[0.013303481,0.015207563,0.8488354,0.00015014259,0.00046685737,0.00024703343,0.00008209966,0.000004631778,0.0029136506,0.00029407445,0.11838075,0.00011429447],"about_ca_topic_score_codex":0.00011753872,"about_ca_topic_score_gemma":0.000101736725,"teacher_disagreement_score":0.8251995,"about_ca_system_score_codex":0.00011514413,"about_ca_system_score_gemma":0.002132404,"threshold_uncertainty_score":0.407147},"labels":[],"label_agreement":null},{"id":"W2601254283","doi":"10.1200/jco.2017.35.6_suppl.372","title":"Prognostic classification of muscle-invasive bladder cancer (MIBC) following radical cystectomy (RC) alone or with perioperative chemotherapy: Analysis of the U.S. National Cancer Database (NCDB).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Stage (stratigraphy); Chemotherapy; Perioperative; Internal medicine; Cancer; Urology; Population; Oncology; Multivariate analysis; Performance status; Nomogram; Surgery","score_opus":0.16018380278427885,"score_gpt":0.4829737571777138,"score_spread":0.32278995439343494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601254283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857793,0.0004894402,0.00012679817,0.011515188,0.0005654058,0.00049041276,0.00011383954,0.0000042650395,0.00091535714],"genre_scores_gemma":[0.9957342,0.0008336137,0.00107414,0.0013705704,0.00060299045,0.000046799774,0.000007427872,0.000020005791,0.0003102484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968224,0.0003206088,0.0015660471,0.00025921265,0.0008496584,0.00018203232],"domain_scores_gemma":[0.99407166,0.0012924337,0.002989746,0.00035269675,0.0011032626,0.0001901995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012334245,0.0001771467,0.0016398317,0.00015369375,0.00014833626,0.000014764533,0.00035070785,0.00021904807,0.0005904595],"category_scores_gemma":[0.0032010162,0.0000883885,0.0006822352,0.000317474,0.0006468703,0.00018658908,0.0000500739,0.0005247885,8.5769136e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008983522,0.0024100665,0.93357235,0.0000876181,0.020282336,0.00012960738,0.0008056989,0.00013496626,0.0056553697,0.00004997084,0.0009571627,0.02693133],"study_design_scores_gemma":[0.012396212,0.0030732716,0.9706005,0.00044595794,0.008490562,0.000028366154,0.00020978379,0.0003399604,0.0014035637,0.000011838428,0.002900048,0.00009994684],"about_ca_topic_score_codex":0.00050904026,"about_ca_topic_score_gemma":0.0025611073,"teacher_disagreement_score":0.037028138,"about_ca_system_score_codex":0.00027433006,"about_ca_system_score_gemma":0.0069602323,"threshold_uncertainty_score":0.9986694},"labels":[],"label_agreement":null},{"id":"W2601689261","doi":"10.1200/jco.2017.35.6_suppl.282","title":"Health-related quality of life (HRQoL) in the KEYNOTE-045 study of pembrolizumab versus investigator-choice chemotherapy for previously treated advanced urothelial cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Discontinuation; Docetaxel; Quality of life (healthcare); Internal medicine; Urothelial cancer; Cancer; Proportional hazards model; Oncology; Bladder cancer","score_opus":0.28357311814599295,"score_gpt":0.5467906929124001,"score_spread":0.26321757476640717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601689261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807789,0.0011379969,0.000006959859,0.014863991,0.001018379,0.0017522731,0.000027220152,0.000006411745,0.00040791513],"genre_scores_gemma":[0.9960091,0.001082962,0.0002740695,0.001979507,0.000500033,0.000056851615,0.0000023175733,0.00002707247,0.000068068985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99369574,0.0011644599,0.004065979,0.000266414,0.0005010239,0.00030641523],"domain_scores_gemma":[0.98869616,0.00351776,0.00624811,0.00060224603,0.00052449084,0.00041121722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004210567,0.00021560607,0.00286433,0.000098963734,0.00011213825,0.0000092638875,0.0005288762,0.0003098649,0.000042392458],"category_scores_gemma":[0.011591578,0.0001346069,0.0005168578,0.00012790484,0.00038566889,0.00012386795,0.00003510378,0.0007070071,8.338801e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19274676,0.01268055,0.6426723,0.00030090794,0.002275569,0.000045258173,0.0033156625,0.00006315752,0.00030876248,0.00006891714,0.001658196,0.14386395],"study_design_scores_gemma":[0.1477187,0.057657436,0.790385,0.00019450237,0.00042471781,0.000009353283,0.0005357812,0.000023453616,0.00011930358,0.00017084813,0.0026590703,0.00010183694],"about_ca_topic_score_codex":0.0047383774,"about_ca_topic_score_gemma":0.0033990273,"teacher_disagreement_score":0.1477127,"about_ca_system_score_codex":0.00024345201,"about_ca_system_score_gemma":0.004962404,"threshold_uncertainty_score":0.9967342},"labels":[],"label_agreement":null},{"id":"W2601890455","doi":"10.1016/j.euf.2017.03.011","title":"Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study","year":2017,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Interquartile range; Bladder cancer; Perioperative; Urology; Chemotherapy; Stage (stratigraphy); Proportional hazards model; Surgery; Internal medicine; Oncology; Cancer","score_opus":0.0514235564784612,"score_gpt":0.35859841318508523,"score_spread":0.30717485670662403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601890455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646818,0.0004858288,0.000029083683,0.009426573,0.00090229616,0.006105453,0.00012233286,0.000055063378,0.018191546],"genre_scores_gemma":[0.9973041,0.00007951123,0.0002567977,0.0010285833,0.00038202578,0.0004542026,0.00002182757,0.0000852181,0.00038774888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973474,0.0007342035,0.00037123318,0.0008533933,0.00022183808,0.00047194125],"domain_scores_gemma":[0.9979408,0.00045127198,0.00030851905,0.0008937318,0.0002604363,0.00014528939],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003549168,0.0003601022,0.00061809976,0.00006584533,0.00070753484,0.00016935154,0.00087876304,0.00010541371,0.00026918866],"category_scores_gemma":[0.0007914624,0.00024746847,0.00014020507,0.000085344545,0.00038414547,0.0001700587,0.00035633743,0.00043376235,0.00003722663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056408368,0.00871941,0.69797385,0.000019696328,0.0049635745,0.0009635016,0.07298754,0.00005178008,0.0006853135,0.00008382678,0.0024694093,0.15467376],"study_design_scores_gemma":[0.06827063,0.005306958,0.9183639,0.00003604709,0.0004792064,0.0000025681811,0.004790019,0.00003739194,0.00011796841,0.000017686249,0.002349151,0.00022842738],"about_ca_topic_score_codex":0.007054413,"about_ca_topic_score_gemma":0.011849693,"teacher_disagreement_score":0.22039013,"about_ca_system_score_codex":0.0005534606,"about_ca_system_score_gemma":0.00033125762,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W2602255124","doi":"10.1016/j.urology.2017.03.034","title":"European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non–muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors","year":2017,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Urology; Gynecology; Internal medicine; Oncology; Cancer","score_opus":0.039002811453147726,"score_gpt":0.35040053909230184,"score_spread":0.31139772763915413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602255124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94085324,0.0003424346,0.0011473557,0.052589852,0.0005712984,0.002402716,0.0010695568,0.00005568926,0.0009678745],"genre_scores_gemma":[0.98539656,0.0009793597,0.0020288136,0.009492028,0.0005023167,0.00057364197,0.00008085104,0.000059593196,0.00088680466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972562,0.00028465057,0.00076337997,0.0007392325,0.00027926892,0.00067723397],"domain_scores_gemma":[0.9954237,0.001401003,0.0017427064,0.0005219862,0.0007324138,0.00017821044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008076381,0.0003888359,0.0012110999,0.00011697879,0.00031562435,0.000017877888,0.00025757862,0.00038264162,0.000047743655],"category_scores_gemma":[0.0025790248,0.00031198814,0.00037025064,0.00010223523,0.00036092804,0.000059175807,0.0001292453,0.0002688744,0.000008569009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061040316,0.0017439921,0.90277475,0.0001528464,0.0047777663,0.000026848007,0.0021205386,0.0008631907,0.006341434,0.0004279388,0.044585407,0.030081255],"study_design_scores_gemma":[0.016259091,0.044582695,0.8434873,0.00002533662,0.004039338,0.000020728867,0.00034274088,0.0010420817,0.005050188,0.001536551,0.08304357,0.0005703532],"about_ca_topic_score_codex":0.00092619745,"about_ca_topic_score_gemma":0.00051596516,"teacher_disagreement_score":0.05928743,"about_ca_system_score_codex":0.000410134,"about_ca_system_score_gemma":0.00032741678,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W2602730024","doi":"10.1200/jco.2017.35.6_suppl.288","title":"Long-term incidence of venous thromboembolic events following cystectomy: A population-based analysis.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cystectomy; Pulmonary embolism; Cumulative incidence; Interquartile range; Bladder cancer; Deep vein; Incidence (geometry); Population; Surgery; Thrombosis; Internal medicine; Cohort; Cancer","score_opus":0.10413616232066382,"score_gpt":0.490483556115177,"score_spread":0.3863473937945132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602730024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658585,0.00031306408,0.00033553547,0.0008996844,0.0010086205,0.00016964806,0.000004100026,0.00000565045,0.0006778778],"genre_scores_gemma":[0.99787974,0.000067207286,0.00095826684,0.0005255714,0.00048951927,0.0000027459696,0.0000047581575,0.000012838373,0.00005934763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971156,0.00023080115,0.0018342546,0.00017340592,0.00046200212,0.00018391824],"domain_scores_gemma":[0.9954863,0.00053777144,0.0029658508,0.00046754067,0.00028223277,0.0002602833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015843713,0.00012835125,0.0022154609,0.00019506144,0.00010589654,0.000010188834,0.00030457453,0.00025973527,0.00009805068],"category_scores_gemma":[0.002342747,0.00009284223,0.0013467763,0.00013426552,0.00008850978,0.00014023065,0.0000430532,0.00042175542,0.0000070283763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009458642,0.0015554446,0.9740561,0.00002956151,0.0023798223,0.000545287,0.000038877428,0.00004099398,0.00006232621,0.0000058822843,0.000019568195,0.020320266],"study_design_scores_gemma":[0.00745832,0.0057541938,0.98070294,0.000186023,0.005414752,0.000041581017,0.000006289339,0.00006765761,0.00007194398,0.00015208035,0.00007635275,0.00006789178],"about_ca_topic_score_codex":0.0003742767,"about_ca_topic_score_gemma":0.00032828038,"teacher_disagreement_score":0.020252375,"about_ca_system_score_codex":0.00016382831,"about_ca_system_score_gemma":0.0015313092,"threshold_uncertainty_score":0.3785996},"labels":[],"label_agreement":null},{"id":"W2602742435","doi":"10.1200/jco.2015.33.15_suppl.e15541","title":"Is there a gender effect in bladder cancer?: A population-based study of practice and outcomes.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cancer registry; Population; Cancer; Cohort; Proportional hazards model; Internal medicine; Gynecology; Surgery; Oncology; Environmental health","score_opus":0.18315755291984348,"score_gpt":0.5335265469531486,"score_spread":0.3503689940333051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602742435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921624,0.00089460384,0.000009073896,0.0050538955,0.00044198486,0.00039600872,0.0000027142553,0.0000029679811,0.0010363203],"genre_scores_gemma":[0.9956317,0.00007293248,0.00043294532,0.0035921661,0.00019698343,0.000009981324,4.6757378e-7,0.000011566008,0.00005123443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974116,0.00067531446,0.001290423,0.00013718761,0.0003683573,0.0001170803],"domain_scores_gemma":[0.99606615,0.002245814,0.0009924244,0.00013278113,0.00032513397,0.00023768227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023305914,0.00010811469,0.0012154757,0.00010197627,0.0000111629015,0.0000037306406,0.000062172716,0.00017747072,0.00007081619],"category_scores_gemma":[0.002951113,0.0000658725,0.0001484905,0.00011274695,0.000036260622,0.00008556319,0.000018857325,0.0004564883,0.0000018796999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053927647,0.0035686449,0.9702358,0.000019833791,0.00065515103,0.00028400696,0.000726158,0.000030732368,0.0000021694648,0.0000022972051,0.00048954645,0.01859287],"study_design_scores_gemma":[0.031199858,0.022950029,0.942743,0.000040201307,0.0009322146,0.000028967002,0.000586956,0.000042969576,0.000007887791,0.00008186021,0.0013364776,0.000049583385],"about_ca_topic_score_codex":0.0013920078,"about_ca_topic_score_gemma":0.00043155247,"teacher_disagreement_score":0.02749283,"about_ca_system_score_codex":0.00015544117,"about_ca_system_score_gemma":0.0013435468,"threshold_uncertainty_score":0.3532971},"labels":[],"label_agreement":null},{"id":"W2603621145","doi":"10.1111/his.13225","title":"p53 immunohistochemistry in high‐grade urothelial carcinoma of the bladder is prognostically significant","year":2017,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"International Business Machines Corporation","keywords":"Tissue microarray; Univariate analysis; Immunohistochemistry; Cystectomy; Multivariate analysis; Medicine; Pathology; Oncology; Univariate; Internal medicine; Bladder cancer; Survival analysis; Immunostaining; Phenotype; Urothelial carcinoma; Carcinoma; Biology; Cancer; Multivariate statistics","score_opus":0.019354790166461043,"score_gpt":0.28534521341752705,"score_spread":0.26599042325106603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603621145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845311,0.0004193963,0.00001657739,0.0028126766,0.0004928258,0.00050382403,0.00005640644,0.000016142143,0.011151045],"genre_scores_gemma":[0.9959993,0.000019976273,0.00025699442,0.0005275026,0.00011761179,0.00007668649,0.000005723496,0.000025997657,0.0029702496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879926,0.00005118932,0.00032661244,0.00033762382,0.00020263699,0.00028267535],"domain_scores_gemma":[0.9985386,0.00003108473,0.00020014137,0.0010854652,0.00007293803,0.000071778384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011479886,0.00017786487,0.00039662785,0.000048398466,0.00015921841,0.000008868305,0.0003663552,0.0001668888,0.00020572335],"category_scores_gemma":[0.00018662242,0.00012780365,0.00013811796,0.000051117237,0.0006751265,0.000032360535,0.000111863774,0.00026439613,0.000022714947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041315792,0.000557308,0.545017,0.000096315474,0.000018000923,0.0004523231,0.00085663045,3.497247e-7,0.44947633,0.00048815948,0.0014674797,0.0011569229],"study_design_scores_gemma":[0.002753788,0.00028161937,0.946308,0.000055418026,0.00013809261,0.00016122068,0.00002863077,0.0000048838724,0.04852895,0.0004821106,0.001137304,0.00011998235],"about_ca_topic_score_codex":0.0006822665,"about_ca_topic_score_gemma":0.000013915977,"teacher_disagreement_score":0.40129095,"about_ca_system_score_codex":0.00015271213,"about_ca_system_score_gemma":0.00033863692,"threshold_uncertainty_score":0.5211681},"labels":[],"label_agreement":null},{"id":"W2604225431","doi":"10.1016/j.juro.2017.02.1799","title":"MP58-04 DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3-4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE","year":2017,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lambton College","funders":"Sidney Kimmel Center for Prostate and Urologic Cancers; Memorial Sloan-Kettering Cancer Center","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Urothelial cancer; Cancer; Internal medicine","score_opus":0.02224180805854004,"score_gpt":0.30589339073467225,"score_spread":0.2836515826761322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604225431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612355,0.00029247033,0.000008377116,0.0016833245,0.0002196957,0.0003195351,0.000006908185,0.00001031842,0.0013358208],"genre_scores_gemma":[0.9988248,0.00019602154,0.000065764216,0.00039991728,0.0001957895,0.000019284469,0.0000017111364,0.000029026576,0.00026768376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986376,0.00014213166,0.00031855254,0.00017606911,0.00037236942,0.0003532344],"domain_scores_gemma":[0.9986519,0.0001043322,0.00042378006,0.0004646464,0.00017467009,0.00018067715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017472052,0.00021111708,0.0004810552,0.00015023164,0.00016875411,0.000020888972,0.0003050075,0.0000818522,0.00017819363],"category_scores_gemma":[0.00004573962,0.00010540833,0.000055594526,0.0001381434,0.0004689761,0.00012198401,0.000043059154,0.00043569994,0.000006156021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10525512,0.0004987593,0.8862614,0.000009656242,0.000642524,0.0007084005,0.0021330835,0.00004689807,0.00012157558,0.000012094098,0.00022942878,0.004081055],"study_design_scores_gemma":[0.03726544,0.007789932,0.95235056,0.000086147316,0.0007251598,0.00018829128,0.00012154988,0.000019607385,0.00032251395,0.0000136704375,0.0009827403,0.0001344034],"about_ca_topic_score_codex":0.001718453,"about_ca_topic_score_gemma":0.003084282,"teacher_disagreement_score":0.067989685,"about_ca_system_score_codex":0.00017124883,"about_ca_system_score_gemma":0.00032602614,"threshold_uncertainty_score":0.4298427},"labels":[],"label_agreement":null},{"id":"W2604376168","doi":"10.1038/srep45983","title":"Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; National Cancer Institute; School of Medicine, New York University; Cancer Research UK; National Taiwan University; York University; Office of Research and Development; U.S. Department of Veterans Affairs","keywords":"Cisplatin; PKM2; Pyruvate kinase; Cancer research; Apoptosis; Kinase; Cell growth; Pharmacology; Chemistry; Metastasis; Warburg effect; Downregulation and upregulation; Cancer cell; Medicine; Cancer; Glycolysis; Chemotherapy; Internal medicine; Biochemistry; Enzyme","score_opus":0.01952090601170939,"score_gpt":0.31415701561363923,"score_spread":0.2946361096019298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604376168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98645025,0.0004643888,0.000016651418,0.0004911932,0.002262198,0.0005657106,0.000029235696,0.000019734394,0.009700619],"genre_scores_gemma":[0.9898382,0.00002929179,0.0008888496,0.00004166457,0.000071821436,0.00006591441,0.000023773704,0.000018663462,0.009021813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981057,0.000013655258,0.0005383953,0.0005595113,0.00055098947,0.00023177308],"domain_scores_gemma":[0.9975747,0.000011418872,0.0006932143,0.0011668946,0.0003989208,0.00015486749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004334409,0.0001481888,0.00036445065,0.00012566685,0.00022681271,0.000052414736,0.000099073324,0.000053955217,0.0003403274],"category_scores_gemma":[0.00023051974,0.00012514036,0.00011046956,0.00019596939,0.0003396564,0.00018059419,0.000066100714,0.00006500254,0.000005536371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003865604,0.0001847482,0.014273981,0.00019910517,0.000071914255,0.00024549858,0.00050332095,0.000020239631,0.9580412,0.000014300816,0.007863355,0.01819579],"study_design_scores_gemma":[0.00068471924,0.00010258732,0.06001037,0.00047994673,0.000099867066,0.000016077243,0.000079613616,0.00000552593,0.93375933,0.00075687334,0.0038908783,0.00011423381],"about_ca_topic_score_codex":0.0002506839,"about_ca_topic_score_gemma":0.000113858936,"teacher_disagreement_score":0.045736387,"about_ca_system_score_codex":0.00007446432,"about_ca_system_score_gemma":0.0003330989,"threshold_uncertainty_score":0.5103076},"labels":[],"label_agreement":null},{"id":"W2604535399","doi":"10.1016/j.eururo.2017.03.030","title":"Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":792,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Genome British Columbia; University of British Columbia","funders":"National Cancer Institute","keywords":"Subtyping; Medicine; Bladder cancer; Concordance; Oncology; Proportional hazards model; Internal medicine; Hazard ratio; Surgical oncology; Context (archaeology); Cancer; Confidence interval; Biology","score_opus":0.016112525959410505,"score_gpt":0.31020482395376325,"score_spread":0.29409229799435277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604535399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372655,0.0007050905,0.000008553063,0.0010051578,0.00012674216,0.00023662864,0.000027594773,0.000017430984,0.004146243],"genre_scores_gemma":[0.998743,0.0002524493,0.000020785927,0.0006887685,0.000106424326,0.000012402211,0.000002656019,0.000048387894,0.00012510108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988329,0.00030368636,0.00019353983,0.00030711913,0.000116976065,0.00024580606],"domain_scores_gemma":[0.9991834,0.00010320167,0.00012388844,0.00044857257,0.00004572299,0.00009519245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002834296,0.00017276892,0.0003046775,0.000100001795,0.000050120398,0.000013611242,0.00010676163,0.000054953307,0.00018037471],"category_scores_gemma":[0.00020809568,0.00013406108,0.000085130065,0.00003579228,0.0001648934,0.000041695068,0.000055557546,0.00016930651,0.000012700231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016840471,0.00021295833,0.9342785,0.00001981527,0.00030847767,0.0013705561,0.0013805991,0.000038811268,0.029712358,0.000006099725,0.000038939008,0.015792426],"study_design_scores_gemma":[0.00423003,0.0024154545,0.9911926,0.000045634493,0.00006984334,0.000021144371,0.000015274098,0.000019134766,0.001679801,0.00001927857,0.00019713701,0.000094712035],"about_ca_topic_score_codex":0.00039891363,"about_ca_topic_score_gemma":0.00011891011,"teacher_disagreement_score":0.05691407,"about_ca_system_score_codex":0.00004545351,"about_ca_system_score_gemma":0.00010524421,"threshold_uncertainty_score":0.54668516},"labels":[],"label_agreement":null},{"id":"W2604565681","doi":"10.1200/jco.2004.22.90140.4716","title":"Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concomitant; Cystoscopy; Urology; Surgery; Bladder cancer; Urinary system; Cancer; Internal medicine; Gastroenterology","score_opus":0.13201078615437872,"score_gpt":0.4775697687222078,"score_spread":0.3455589825678291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604565681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957279,0.0004161314,0.000048820046,0.0022257415,0.00058423646,0.00067279505,0.0000872503,0.0000012561782,0.00023584306],"genre_scores_gemma":[0.99820536,0.000753279,0.00061414856,0.000054216576,0.00033473503,0.000010527068,0.000006553425,0.000007849297,0.000013341725],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9947046,0.0006255214,0.0039237947,0.00018294298,0.00042511884,0.00013800163],"domain_scores_gemma":[0.99538505,0.0010765156,0.0027933232,0.0002030925,0.0004377212,0.00010428198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025414014,0.00014075106,0.0015827076,0.00013711936,0.000014558041,0.0000014471791,0.00016439697,0.00030251875,0.000030511754],"category_scores_gemma":[0.0022751652,0.000092429735,0.00033119402,0.0001955338,0.0005570353,0.00009071559,0.000040798448,0.0004980253,9.329728e-8],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8040256,0.020027138,0.000488128,0.0002064806,0.0004918522,0.000082376464,0.0025947539,0.000023529139,0.03058319,0.00009395276,0.00016260282,0.1412204],"study_design_scores_gemma":[0.2923984,0.59282136,0.030508976,0.0014720884,0.0014267772,0.00013533374,0.00086878834,0.00004999512,0.07925222,0.00074197777,0.00020595256,0.00011817253],"about_ca_topic_score_codex":0.00023583855,"about_ca_topic_score_gemma":0.00025359762,"teacher_disagreement_score":0.5727942,"about_ca_system_score_codex":0.00008990432,"about_ca_system_score_gemma":0.002688712,"threshold_uncertainty_score":0.47696593},"labels":[],"label_agreement":null},{"id":"W2604918430","doi":"10.1158/1557-3125.dnarepair16-pr18","title":"Abstract PR18: Somatic ERCC2 mutations, nucleotide excision repair (NER) function, and cisplatin response in muscle-invasive bladder cancer (MIBC)","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ERCC2; Biology; DNA repair; Nucleotide excision repair; Cisplatin; Cancer research; Genetics; Gene; Chemotherapy","score_opus":0.060188045855928025,"score_gpt":0.4041259248883789,"score_spread":0.3439378790324509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604918430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846346,0.0039341482,0.00004206018,0.004459853,0.0001869256,0.001361448,0.00005470971,0.00007091224,0.0014264988],"genre_scores_gemma":[0.9960685,0.0011252098,0.00024017433,0.00036922997,0.00015028611,0.0008616107,0.000017560673,0.00008177041,0.0010857001],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967793,0.0003300698,0.00043343095,0.0007459325,0.0010456996,0.0006655505],"domain_scores_gemma":[0.99779314,0.00029340072,0.0001431937,0.0010382589,0.00041685154,0.00031514035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001242194,0.00027496042,0.00040566956,0.00044931535,0.0006255992,0.00017651086,0.00023742078,0.0001767843,0.0008039123],"category_scores_gemma":[0.0010152442,0.00024679062,0.00013391647,0.0003088586,0.00036670966,0.0002758968,0.00017678793,0.0006303056,0.00006316297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019161578,0.0011361323,0.25258377,0.0013230302,0.0012305044,0.00430487,0.0037830283,0.0003224824,0.6300102,0.00023715601,0.007465699,0.07844157],"study_design_scores_gemma":[0.004693245,0.0006063442,0.9749997,0.0010223124,0.00013342476,0.000015267253,0.00042001935,0.0001825775,0.0147933,0.0011098861,0.0017649446,0.00025893713],"about_ca_topic_score_codex":0.008122095,"about_ca_topic_score_gemma":0.0022750227,"teacher_disagreement_score":0.722416,"about_ca_system_score_codex":0.00058330485,"about_ca_system_score_gemma":0.0012953784,"threshold_uncertainty_score":0.99999845},"labels":[],"label_agreement":null},{"id":"W2604969928","doi":"10.1016/j.juro.2017.02.884","title":"PD19-11 WHAT FALSE-NEGATIVE RATES ARE BLADDER CANCER PATIENTS AND URO-ONCOLOGISTS WILLING TO ACCEPT IN ORDER TO AVOID SURVEILLANCE CYSTOSCOPY?","year":2017,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Cancer; Test (biology); General surgery; Population; Gynecology; Surgery; Urinary system; Internal medicine","score_opus":0.024069131075977843,"score_gpt":0.3386619393240969,"score_spread":0.314592808248119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604969928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97802985,0.0016035129,0.000078161494,0.018940255,0.00073599204,0.0004726644,0.000016203172,0.000005743608,0.00011763576],"genre_scores_gemma":[0.99213856,0.0015813966,0.00017339841,0.0057095815,0.00024817465,0.000019249133,9.441436e-7,0.000023165949,0.00010554788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864584,0.00022543927,0.00038240364,0.00019479339,0.00022230884,0.00032920676],"domain_scores_gemma":[0.99824524,0.00026185258,0.00044958704,0.00027832598,0.0005629006,0.00020210867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047931282,0.00019443668,0.0005412641,0.0001358309,0.00019993556,0.00006338522,0.00029582405,0.00010307586,0.00009808792],"category_scores_gemma":[0.0009301067,0.00012090633,0.000038889688,0.00016171289,0.00015609359,0.00025496734,0.00012650242,0.00031718236,0.00001266031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003600903,0.00022988996,0.97913843,0.000022458249,0.00022963205,0.0000911628,0.004055981,0.00039441956,0.0014488916,0.000003510295,0.0019305451,0.0088541545],"study_design_scores_gemma":[0.004218871,0.002325474,0.9884767,0.00013607302,0.00012820451,0.000075034215,0.0005816445,0.000022775846,0.0015549648,0.00014416379,0.0021933678,0.0001427407],"about_ca_topic_score_codex":0.00060093077,"about_ca_topic_score_gemma":0.003812337,"teacher_disagreement_score":0.01410871,"about_ca_system_score_codex":0.000119478646,"about_ca_system_score_gemma":0.00018870967,"threshold_uncertainty_score":0.4930417},"labels":[],"label_agreement":null},{"id":"W2605018682","doi":"10.1016/j.juro.2017.02.2610","title":"PD57-08 CENTRALIZATION OF RADICAL CYSTECTOMY FOR BLADDER CANCER IN A UNIVERSAL HEALTHCARE SYSTEM: EARLY RESULTS FROM A CANADIAN ACADEMIC CENTER","year":2017,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Health care; Clinical epidemiology; General surgery; Cancer; Epidemiology; Internal medicine","score_opus":0.027783136067853036,"score_gpt":0.31561638960049093,"score_spread":0.2878332535326379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605018682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97147405,0.0018018312,0.00011471159,0.024749031,0.0005929985,0.0004719975,0.0005750946,0.0000041898556,0.00021611119],"genre_scores_gemma":[0.9987128,0.0004427831,0.000030748273,0.00039737797,0.00032933254,0.000003754824,0.000009500798,0.0000136504,0.000060044586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890256,0.00014853578,0.00043428838,0.00010099137,0.00015074661,0.0002628535],"domain_scores_gemma":[0.99885094,0.000090791604,0.00048466984,0.00022210223,0.00015633488,0.00019515742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003087785,0.00009551097,0.0003428149,0.00013407995,0.000097738455,0.00000546355,0.00023752339,0.00016988012,0.00002449632],"category_scores_gemma":[0.00009174064,0.00006397133,0.00007253488,0.000044921868,0.00011437635,0.0000748535,0.000016246508,0.00032819458,0.0000016070998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06418451,0.0003171962,0.8852246,0.00040941464,0.0022336754,0.0007703062,0.023171293,0.00040874662,0.0037885583,0.0012422071,0.0072451383,0.011004393],"study_design_scores_gemma":[0.04455201,0.0030292734,0.9327549,0.0008502248,0.001230248,0.0005712343,0.0009180945,0.00076314015,0.0007612294,0.0003249897,0.014046941,0.00019773011],"about_ca_topic_score_codex":0.18760006,"about_ca_topic_score_gemma":0.08307364,"teacher_disagreement_score":0.10452642,"about_ca_system_score_codex":0.0003081528,"about_ca_system_score_gemma":0.0008069834,"threshold_uncertainty_score":0.9336579},"labels":[],"label_agreement":null},{"id":"W2605748880","doi":"10.1590/s1677-5538.ibju.2017.02.03","title":"Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes","year":2017,"lang":"en","type":"article","venue":"International braz j urol","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; General surgery; Cancer; Urology; Surgery; Internal medicine","score_opus":0.024986516741147862,"score_gpt":0.3288055419710904,"score_spread":0.30381902522994253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605748880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8983443,0.0009897861,0.0006157373,0.06673747,0.0049183685,0.0038270194,0.0024532685,0.00010531604,0.022008779],"genre_scores_gemma":[0.9912252,0.00009953262,0.00016774387,0.0043560397,0.0013874039,0.00043826073,0.00011071023,0.00003617907,0.0021789304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988174,0.000012213134,0.00017583088,0.0003119762,0.0004820301,0.00020057632],"domain_scores_gemma":[0.9987933,0.00015798802,0.0001632224,0.00041198233,0.0003689829,0.00010453691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043317505,0.00017595103,0.00017822906,0.000044006847,0.0003349592,0.0001092384,0.00040147634,0.000065480206,0.0004427343],"category_scores_gemma":[0.00018003435,0.00010806168,0.000095672716,0.000035236622,0.00017245683,0.00017792694,0.00006445507,0.00013194267,0.000048270103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015563791,0.0011235523,0.89417976,0.000089456684,0.0024922972,0.000024176701,0.00071595586,0.000012534127,0.00022027061,0.00042166276,0.040518984,0.058644995],"study_design_scores_gemma":[0.012212421,0.00080873526,0.60185593,0.0002473397,0.0002864587,0.000013706479,0.00005575569,0.00014015178,0.0016072434,0.00014196291,0.3824103,0.00022000176],"about_ca_topic_score_codex":0.0008274229,"about_ca_topic_score_gemma":0.00018779714,"teacher_disagreement_score":0.3418913,"about_ca_system_score_codex":0.00010861129,"about_ca_system_score_gemma":0.00021984593,"threshold_uncertainty_score":0.48476303},"labels":[],"label_agreement":null},{"id":"W2606278562","doi":"10.3233/blc-160090","title":"Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Everolimus; Medicine; Clinical endpoint; Bladder cancer; Toxicity; Radiation therapy; Gemcitabine; Internal medicine; Urology; Oncology; Cohort; Clinical trial; Biopsy; Surgery; Cancer","score_opus":0.06506383417355531,"score_gpt":0.391303302315246,"score_spread":0.3262394681416907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606278562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305046,0.00039830783,0.000014402396,0.0009383552,0.0006515984,0.0032338237,0.0002974472,0.000040701616,0.0013749128],"genre_scores_gemma":[0.9960256,0.0011754557,0.00008390972,0.000893424,0.000519828,0.00075251184,0.00004482196,0.00008560592,0.00041883482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708885,0.00014484672,0.00070538936,0.0007537601,0.00077151303,0.0005356432],"domain_scores_gemma":[0.9971989,0.00011522436,0.0007133266,0.0012287376,0.00045281244,0.00029099622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027462927,0.0004600414,0.0011623506,0.00011532199,0.00018082828,0.000046649362,0.00033429428,0.00022706266,0.00073623535],"category_scores_gemma":[0.000084953506,0.0002999659,0.00021716075,0.00018163171,0.00050962815,0.00027042162,0.000056969602,0.00038671793,0.0000065645927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32460138,0.008768354,0.6133035,0.000056027948,0.0016442311,0.00004277114,0.00041403025,0.000006946651,0.000050408868,0.00001589496,0.0009624293,0.050134048],"study_design_scores_gemma":[0.40840244,0.018709268,0.5700576,0.00027464525,0.00044006336,7.191703e-7,0.00003969917,0.000007764731,0.0010442755,0.000026104857,0.00072197855,0.00027549476],"about_ca_topic_score_codex":0.0038804302,"about_ca_topic_score_gemma":0.0032797484,"teacher_disagreement_score":0.083801046,"about_ca_system_score_codex":0.00021266847,"about_ca_system_score_gemma":0.0018533163,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W2606921055","doi":"10.3233/blc-160086","title":"Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology","keywords":"Medicine; Urology; Cystectomy; Stromal cell; Prostate; Lamina propria; Lymphovascular invasion; Carcinoma in situ; Carcinoma; Prostatic urethra; Internal medicine; Oncology; Cancer; Bladder cancer; Pathology; Metastasis; Epithelium","score_opus":0.0703343992348148,"score_gpt":0.3408266273139776,"score_spread":0.27049222807916284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606921055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943745,0.00038190692,0.0000042735464,0.000748353,0.0005661772,0.001048823,0.0008968019,0.0000054377642,0.001973694],"genre_scores_gemma":[0.9981208,0.00004436457,0.00001682074,0.00016106004,0.00019291413,0.00012913956,0.0000018774699,0.00003112868,0.0013019019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998461,0.0000771758,0.0003600516,0.00023696535,0.000616306,0.00024847273],"domain_scores_gemma":[0.9981999,0.000029245908,0.00038717882,0.0011443102,0.00015890447,0.000080486774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012918303,0.0002120149,0.0004388744,0.000038954597,0.00010725341,0.0000100952675,0.00037926482,0.00008111273,0.00040121085],"category_scores_gemma":[0.000049778133,0.00010125233,0.00045244815,0.00008928346,0.000512641,0.0000479899,0.0001465552,0.00017411595,0.0000025581185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022025343,0.00039967406,0.98251384,0.00017575265,0.0006425876,0.0000050788835,0.0010350891,0.000013585138,0.009918981,0.000042286654,0.00072485284,0.0023257567],"study_design_scores_gemma":[0.004649842,0.0005615363,0.917801,0.0003583507,0.0002783899,0.0000030939889,0.000036765112,0.000009234641,0.075773254,0.00004968405,0.00039053636,0.000088320165],"about_ca_topic_score_codex":0.008307625,"about_ca_topic_score_gemma":0.0007145537,"teacher_disagreement_score":0.065854274,"about_ca_system_score_codex":0.00016505564,"about_ca_system_score_gemma":0.0008987382,"threshold_uncertainty_score":0.99829614},"labels":[],"label_agreement":null},{"id":"W2607199659","doi":"10.1016/j.eururo.2017.04.006","title":"Seeking the Molecular Truth in Bladder Cancer: Biology = Genome × (Transcriptome) 2","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Transcriptome; Genome; Bladder cancer; Computational biology; Cancer; Genetics; Gene; Internal medicine; Gene expression; Biology","score_opus":0.024545535611393256,"score_gpt":0.289450091162787,"score_spread":0.26490455555139375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607199659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010539301,0.017030368,0.00018222403,0.8380989,0.0029466497,0.0012151536,0.0002612865,0.00015319123,0.12957293],"genre_scores_gemma":[0.33860925,0.00073695765,0.000027965487,0.6520848,0.0047628386,0.00008580432,0.0003593988,0.00022543788,0.0031074914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967931,0.0008629076,0.0004484122,0.00086175045,0.00019762135,0.0008362378],"domain_scores_gemma":[0.9982095,0.00011380581,0.00025329247,0.0012771675,0.00006228985,0.0000839857],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032873335,0.0005279078,0.0007910334,0.00025350027,0.00016196031,0.000040862324,0.000763538,0.0005093162,0.00065389846],"category_scores_gemma":[0.00007009866,0.00036918258,0.00026718315,0.000103756,0.00044894253,0.000033830947,0.00014360563,0.0024611582,0.00037163432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013162993,0.00044840912,0.015310103,0.0006253218,0.005948874,0.10148396,0.0036015161,0.000058577712,0.023733128,0.00057425135,0.82076246,0.026137117],"study_design_scores_gemma":[0.002108089,0.00048335423,0.011544766,0.000035205143,0.00057158055,0.00034306443,0.000006347299,0.000008013401,0.000030832154,0.00016779265,0.98438716,0.0003138115],"about_ca_topic_score_codex":0.00035872243,"about_ca_topic_score_gemma":0.000026546038,"teacher_disagreement_score":0.32806996,"about_ca_system_score_codex":0.0001174873,"about_ca_system_score_gemma":0.00022132833,"threshold_uncertainty_score":0.999876},"labels":[],"label_agreement":null},{"id":"W2607756307","doi":"10.1111/bju.13900","title":"Clinical and patient‐reported outcomes of <scp>SPARE</scp> – a randomised feasibility study of selective bladder preservation versus radical cystectomy","year":2017,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK; Royal Marsden NHS Foundation Trust","keywords":"Cystectomy; Medicine; Spare part; Surgery; Urology; Bladder cancer; Internal medicine; Operations management; Cancer","score_opus":0.05714206731459165,"score_gpt":0.3600090428132853,"score_spread":0.3028669754986936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607756307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971991,0.0008229794,0.00003337394,0.00014492063,0.0003989731,0.0009082874,0.000013130039,0.000005871546,0.0004733448],"genre_scores_gemma":[0.9994967,0.00017758807,0.0001284769,0.00006784523,0.000076597345,0.0000111211275,0.0000018521816,0.000013418739,0.0000264239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976232,0.00039511741,0.0012059124,0.00023107,0.0003716758,0.00017301158],"domain_scores_gemma":[0.996833,0.00067257736,0.0014358882,0.00029661835,0.0006003873,0.00016149666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006878944,0.00012676076,0.0010585648,0.00007710021,0.00009530148,0.000016877168,0.00014341116,0.0001560686,0.000019095034],"category_scores_gemma":[0.005572127,0.000113295355,0.00020688676,0.000054425538,0.0004048316,0.00016005141,0.00006580195,0.00035643158,2.6943724e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013872641,0.003053581,0.97098166,0.000023473422,0.0021594677,0.00059824117,0.0005338603,0.0000031665884,0.00007102169,0.0000014734629,0.00040663918,0.008294757],"study_design_scores_gemma":[0.1228665,0.010209794,0.8642619,0.000030877036,0.0010371706,0.0009730669,0.00027501478,0.00001483248,0.000112884976,0.00009875169,0.000088016655,0.000031152034],"about_ca_topic_score_codex":0.00039428496,"about_ca_topic_score_gemma":0.00016838625,"teacher_disagreement_score":0.10899386,"about_ca_system_score_codex":0.000025430054,"about_ca_system_score_gemma":0.00023097414,"threshold_uncertainty_score":0.66707593},"labels":[],"label_agreement":null},{"id":"W2607764237","doi":"10.1016/j.urology.2017.04.001","title":"Expanding Immunotherapy Options for Bladder Cancer","year":2017,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Cancer immunotherapy; Urothelial cancer; Cancer; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04338472005693136,"score_gpt":0.35717197683565366,"score_spread":0.3137872567787223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607764237","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003875554,0.009343281,0.0010052831,0.97705895,0.0028946798,0.001450203,0.00053003174,0.0001072199,0.007222823],"genre_scores_gemma":[0.0033751118,0.0017556486,0.00032044563,0.9250617,0.013325615,0.0019191571,0.00070234714,0.00016881086,0.05337115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987233,0.00003163057,0.00020515143,0.00043872072,0.00013295209,0.00046821893],"domain_scores_gemma":[0.9989573,0.000088521025,0.00016567112,0.00064913125,0.00009053346,0.00004889124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005464582,0.0002919621,0.00056286313,0.00013564904,0.0002295072,0.000028058115,0.0001956356,0.00083952805,0.0014681014],"category_scores_gemma":[0.000022023625,0.0002445006,0.0002708909,0.000025223782,0.00013446786,0.000037821766,0.000024823707,0.0007096889,0.00006947779],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026961873,0.000036933918,0.00024543356,0.00006559037,0.0009817879,0.00017333921,0.00009312383,0.0000017920884,0.00026955552,0.000017887649,0.9927134,0.005131535],"study_design_scores_gemma":[0.0029766422,0.00065065984,0.0002909558,0.000028327888,0.0006549265,0.000114481074,0.0000028907796,0.000011793833,0.00014384494,0.00049719017,0.9944293,0.00019902042],"about_ca_topic_score_codex":0.00021721298,"about_ca_topic_score_gemma":0.000022473912,"teacher_disagreement_score":0.05199721,"about_ca_system_score_codex":0.000107209904,"about_ca_system_score_gemma":0.00028913247,"threshold_uncertainty_score":0.99944466},"labels":[],"label_agreement":null},{"id":"W2609244474","doi":"10.3233/blc-170105","title":"CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Disease; Internal medicine; Targeted therapy; Chemotherapy; Cisplatin; Blockade","score_opus":0.31958293087640177,"score_gpt":0.48469369882958757,"score_spread":0.1651107679531858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609244474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007522836,0.9814702,0.000019154668,0.0006882133,0.0022985407,0.0085683875,0.0037210353,0.0001235213,0.0030357086],"genre_scores_gemma":[0.00027432613,0.9451845,0.000081868144,0.0007348441,0.0037340405,0.032406855,0.00033160968,0.00046562098,0.016786305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942186,0.00009924945,0.0015619162,0.0018517982,0.00079157803,0.0014768838],"domain_scores_gemma":[0.99654394,0.00012270163,0.0010871935,0.0014279257,0.00032984323,0.0004884101],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002923324,0.0017055598,0.0042849993,0.0005765781,0.00032397176,0.00019406946,0.0006473523,0.0009766499,0.002928508],"category_scores_gemma":[0.000030747782,0.001269827,0.001481368,0.00047489966,0.00024379775,0.00027118454,0.00012425092,0.0008547062,0.000045518937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003689923,0.000815859,0.0004885419,0.0071344823,0.0043630777,0.00004834301,0.00027863332,0.000020236312,0.000013802883,0.00002434426,0.019058835,0.9673849],"study_design_scores_gemma":[0.008878308,0.000542984,0.00038275486,0.022041008,0.0042316047,0.000022680979,0.000054472053,0.000016916925,0.00008893179,0.0000277488,0.96250355,0.0012090278],"about_ca_topic_score_codex":0.019714618,"about_ca_topic_score_gemma":0.009835042,"teacher_disagreement_score":0.96617585,"about_ca_system_score_codex":0.0024429192,"about_ca_system_score_gemma":0.0070936144,"threshold_uncertainty_score":0.99956906},"labels":[],"label_agreement":null},{"id":"W2609464379","doi":"10.1016/j.eururo.2017.04.015","title":"Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Reproducibility; Disease; Repeatability; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.10392295709868216,"score_gpt":0.35299454891618864,"score_spread":0.2490715918175065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609464379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002993034,0.98654157,0.00001055379,0.0018034705,0.00072602974,0.0072647114,0.0001528869,0.000032497646,0.00047526392],"genre_scores_gemma":[0.09967034,0.89810616,0.000013815809,0.0007531421,0.00030745947,0.00026903895,0.00009762163,0.00013341327,0.00064899545],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917424,0.003399722,0.0026002848,0.0014221148,0.00037100847,0.00046448718],"domain_scores_gemma":[0.99150735,0.00058036664,0.0049331877,0.0019531128,0.0008826048,0.00014339789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047558085,0.00058101554,0.0032222068,0.00030488727,0.00020723295,0.00003157157,0.00044730754,0.00017194057,0.00001854879],"category_scores_gemma":[0.0067149,0.00039835667,0.00018641975,0.00064717466,0.00024443856,0.00012509558,0.0002491734,0.00053912256,0.0000139394715],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042150114,0.00026300873,0.047687788,0.85917354,0.001384418,0.00003108751,0.0011254254,0.000023053553,0.000056178465,0.000013658678,0.004355131,0.08584456],"study_design_scores_gemma":[0.0031747988,0.0013670839,0.3854506,0.5405928,0.017550632,0.00026232545,0.000113120965,0.00015592876,0.000009184219,0.000007890683,0.050313476,0.0010021994],"about_ca_topic_score_codex":0.000667624,"about_ca_topic_score_gemma":0.0005759871,"teacher_disagreement_score":0.3377628,"about_ca_system_score_codex":0.00045372924,"about_ca_system_score_gemma":0.0013256724,"threshold_uncertainty_score":0.9998468},"labels":[],"label_agreement":null},{"id":"W2610066140","doi":"10.6004/jnccn.2017.0032","title":"Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Comorbidity; Cohort; Akaike information criterion; Internal medicine; Logistic regression; Retrospective cohort study; Hazard ratio; Population; Charlson comorbidity index; Perioperative; Proportional hazards model; Bladder cancer; Database; Surgery; Cancer; Confidence interval; Statistics","score_opus":0.11222096430922492,"score_gpt":0.42711369084857614,"score_spread":0.31489272653935124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610066140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889952,0.0019918696,0.00076980627,0.0033426501,0.002145848,0.0010262248,0.0002307378,0.000005953539,0.0014917119],"genre_scores_gemma":[0.9958743,0.00019196665,0.000549709,0.0009942285,0.0021318172,0.0000741727,0.000004170569,0.000016244638,0.00016342428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982834,0.000065308435,0.0004771752,0.00014656414,0.000841924,0.00018566636],"domain_scores_gemma":[0.9969332,0.00011252631,0.00059580954,0.00022671824,0.0020227514,0.00010899321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023192726,0.00016430758,0.0005114374,0.000041100597,0.0003065047,0.000037311645,0.0002856348,0.000084117026,0.00010156337],"category_scores_gemma":[0.000073438096,0.000103088474,0.00037869904,0.00006669774,0.0002338147,0.00015710882,0.00008197233,0.00032742956,3.1881225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025421523,0.000316896,0.97983855,0.00018563613,0.0021955296,0.000018945168,0.00026440428,0.0029622717,0.0008057912,0.0005544519,0.0077586183,0.0025567822],"study_design_scores_gemma":[0.0031308553,0.0002973011,0.9815066,0.00038865593,0.00032856993,0.000048313505,0.000026240272,0.0011994423,0.0004588439,0.00049180235,0.012028094,0.00009526752],"about_ca_topic_score_codex":0.00004273741,"about_ca_topic_score_gemma":0.00004324471,"teacher_disagreement_score":0.0068790684,"about_ca_system_score_codex":0.00045648502,"about_ca_system_score_gemma":0.00074493256,"threshold_uncertainty_score":0.4203826},"labels":[],"label_agreement":null},{"id":"W2610237020","doi":"10.1016/j.urolonc.2017.04.005","title":"Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cystectomy; Bladder cancer; Cohort; Retrospective cohort study; Health care; Radiation therapy; Urinary system; Cancer; Emergency medicine; Surgery; Internal medicine","score_opus":0.015227017950246755,"score_gpt":0.2880855705536628,"score_spread":0.272858552603416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610237020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898156,0.001856694,0.0000032054381,0.0071250987,0.000100452045,0.0006042356,0.00005666321,0.000011133335,0.00042690596],"genre_scores_gemma":[0.99747884,0.0003301511,0.00022235686,0.0015556881,0.000053284642,0.00010499064,0.00004916416,0.000011241003,0.00019426794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896324,0.00008496902,0.000259405,0.0002508914,0.00020409147,0.00023739194],"domain_scores_gemma":[0.9991017,0.000051125993,0.0002980668,0.00024839747,0.0000936141,0.00020711159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000637714,0.00015482097,0.00035512587,0.000055781537,0.0004691101,0.000022402095,0.0001265066,0.00009955351,0.000029078717],"category_scores_gemma":[0.000031796706,0.00009823484,0.000019994877,0.000104310915,0.00056982547,0.00011226608,0.000043464774,0.00019952454,2.9910322e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016053546,0.0000812305,0.99667704,0.00013490794,0.00007275992,0.000015673104,0.0012804036,0.00012225572,0.0000022911825,0.00007213177,0.0004222578,0.00095848955],"study_design_scores_gemma":[0.002597907,0.00051064,0.9631663,0.00017807768,0.000101497564,0.000003964776,0.000841374,0.00009215567,0.000047857033,0.000022788554,0.03235001,0.000087417844],"about_ca_topic_score_codex":0.73295933,"about_ca_topic_score_gemma":0.977047,"teacher_disagreement_score":0.24408767,"about_ca_system_score_codex":0.00044335125,"about_ca_system_score_gemma":0.002396359,"threshold_uncertainty_score":0.4251038},"labels":[],"label_agreement":null},{"id":"W2610791421","doi":"10.1016/j.eururo.2017.03.019","title":"Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Life expectancy; Radiation therapy; Incidence (geometry); Quality of life (healthcare); MEDLINE; Geriatric oncology; Cancer; Internal medicine; Intensive care medicine; Population","score_opus":0.1060390419798309,"score_gpt":0.3951790412339981,"score_spread":0.2891399992541672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610791421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031340821,0.97974753,0.0000050386975,0.00024256937,0.00039451572,0.012739849,0.0005165268,0.000039262548,0.006311548],"genre_scores_gemma":[0.000046954035,0.9912623,0.00002160213,0.0014548047,0.00022979826,0.004232797,0.00040695598,0.00016871197,0.0021760298],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964487,0.0009900853,0.0011419257,0.00077516027,0.00016947153,0.00047464506],"domain_scores_gemma":[0.9972899,0.00035919898,0.0010007446,0.0010144416,0.00017477784,0.0001609588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027794827,0.0007120241,0.0043898723,0.00019876618,0.000107192325,0.000025308449,0.00032938473,0.00016764163,0.00017358371],"category_scores_gemma":[0.00060855655,0.00045820232,0.00079283497,0.000120333745,0.00009537648,0.00006669581,0.00007046074,0.00026538954,0.0003263091],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044971257,0.00043175532,0.000017875578,0.5960979,0.0016050523,0.00023851276,0.00022493598,8.351602e-8,4.3896474e-8,0.000012140299,0.0017037189,0.399623],"study_design_scores_gemma":[0.0024047538,0.0028167202,0.000055260134,0.27301937,0.0125869615,0.0000352591,0.0000055919068,3.0929385e-7,1.2573405e-7,0.000005329331,0.70877916,0.00029117716],"about_ca_topic_score_codex":0.00007261735,"about_ca_topic_score_gemma":0.0001763494,"teacher_disagreement_score":0.7070754,"about_ca_system_score_codex":0.00048609174,"about_ca_system_score_gemma":0.0006840566,"threshold_uncertainty_score":0.999787},"labels":[],"label_agreement":null},{"id":"W2610958056","doi":"10.25011/cim.v40i2.28199","title":"Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"Clinical and investigative medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cisplatin; Hazard ratio; Chemotherapy; Oncology; Radiation therapy; Internal medicine; Neoadjuvant therapy; Urology; Randomized controlled trial; Confidence interval; Surgery; Cancer; Breast cancer","score_opus":0.33376574802693787,"score_gpt":0.4651702039374242,"score_spread":0.13140445591048633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610958056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043208073,0.9903444,0.0000054851566,0.0015687995,0.00021828109,0.0027074222,0.0002310213,0.000019182326,0.00058457477],"genre_scores_gemma":[0.013961679,0.98286796,0.00007738364,0.0012009102,0.00034524445,0.00044113968,0.00046017117,0.000092534196,0.00055296917],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958184,0.0008839236,0.0014769731,0.00087278435,0.00065863924,0.00028931658],"domain_scores_gemma":[0.9961246,0.0012588814,0.001206274,0.00081167783,0.00017930074,0.00041923957],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0012797419,0.00077114423,0.011016512,0.0003904175,0.00006307466,0.0000084354715,0.00020499919,0.00034641929,0.0004120094],"category_scores_gemma":[0.0007759549,0.0003424073,0.0014288896,0.0005429689,0.0046969294,0.000041736115,0.00003120664,0.0007497319,0.0000044593635],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016074999,0.00064594275,0.1658629,0.0070679765,0.16676812,0.000041614978,0.00008021716,0.000002026126,8.062715e-8,0.000029672616,0.0002576813,0.6576363],"study_design_scores_gemma":[0.023728434,0.029008055,0.06539212,0.011888476,0.7816935,9.910775e-7,0.0000043200257,0.00001782256,0.00001287952,0.00006749833,0.087626144,0.0005597159],"about_ca_topic_score_codex":0.00044756505,"about_ca_topic_score_gemma":0.000090336085,"teacher_disagreement_score":0.65707654,"about_ca_system_score_codex":0.000059083228,"about_ca_system_score_gemma":0.00045184206,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W2611553464","doi":"10.1016/j.eururo.2017.04.028","title":"Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Population; Surgery; Cancer; Internal medicine; Environmental health","score_opus":0.3241282466932805,"score_gpt":0.41843067829454245,"score_spread":0.09430243160126195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611553464","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29238817,0.0135881305,0.00056413043,0.6810338,0.0014746537,0.006197762,0.0029790283,0.00006310276,0.0017112376],"genre_scores_gemma":[0.36651346,0.0009673864,0.0005312199,0.6256458,0.0047047627,0.00014323591,0.00033687163,0.00019575455,0.0009614949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967641,0.0006609983,0.00062871556,0.0009701787,0.00042810207,0.00054789364],"domain_scores_gemma":[0.9966248,0.00062334136,0.00045257615,0.002053556,0.00016545353,0.000080262434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059450144,0.00047964556,0.0008804422,0.00020934473,0.00016419918,0.00006141789,0.0012798198,0.00037528825,0.00049402134],"category_scores_gemma":[0.0003941714,0.000326643,0.00021462856,0.00014510484,0.00021558607,0.00017232478,0.00021627716,0.0009274888,0.00006821499],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018325242,0.00020085108,0.03715026,0.00046701846,0.0011749575,0.0014497357,0.0037782267,0.000010154306,0.0007544064,0.0000045929887,0.93367606,0.01950121],"study_design_scores_gemma":[0.0056838416,0.0014840532,0.18966998,0.00057115435,0.0009291568,0.00015146863,0.000035157143,0.00009089573,0.00017420216,0.000050679115,0.8006604,0.00049903215],"about_ca_topic_score_codex":0.0021501987,"about_ca_topic_score_gemma":0.00021010154,"teacher_disagreement_score":0.15251972,"about_ca_system_score_codex":0.000102720995,"about_ca_system_score_gemma":0.00058185105,"threshold_uncertainty_score":0.9999186},"labels":[],"label_agreement":null},{"id":"W2611625034","doi":"10.1016/j.urolonc.2013.03.011","title":"Commentary on “Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.” Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada","year":2013,"lang":"en","type":"letter","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Dissection (medical); Lymph node; Cancer; Urinary diversion; Disease; Cohort; Regimen; Urology; Surgery; General surgery; Oncology; Internal medicine","score_opus":0.036880496608188804,"score_gpt":0.2948694637530366,"score_spread":0.25798896714484776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611625034","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1452657,0.0027099831,0.000020692501,0.8366301,0.0018719212,0.002668927,0.01059143,0.000057775167,0.00018347612],"genre_scores_gemma":[0.12702762,0.0019826714,0.0010828575,0.8605734,0.0023937414,0.0018416025,0.0031986516,0.00011161456,0.0017878532],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533683,0.00071659166,0.0009134351,0.0012001841,0.0006055579,0.0012274093],"domain_scores_gemma":[0.99619967,0.0013600509,0.0007061698,0.00075974007,0.00033065543,0.00064369256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003860891,0.0008914041,0.0013865666,0.00031335372,0.0008917283,0.00003420571,0.00048851484,0.0011618028,0.00047034188],"category_scores_gemma":[0.00013729901,0.0006911824,0.0002797024,0.00040951453,0.0009765625,0.000101680416,0.000097211094,0.0017699385,0.0000048949796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032856103,0.000106378546,0.22742236,0.00009220088,0.00044202647,0.00060457987,0.00014097137,0.00071248115,0.0000015981685,0.000012026185,0.76911217,0.0010246442],"study_design_scores_gemma":[0.0015801167,0.0010279939,0.016419776,0.00035993237,0.00077989546,0.00004437835,0.00007186542,0.00057427183,0.00002971298,0.000073023744,0.9784365,0.0006024772],"about_ca_topic_score_codex":0.9243641,"about_ca_topic_score_gemma":0.9867055,"teacher_disagreement_score":0.21100259,"about_ca_system_score_codex":0.0025323592,"about_ca_system_score_gemma":0.0053526675,"threshold_uncertainty_score":0.9995539},"labels":[],"label_agreement":null},{"id":"W2612201852","doi":"10.1200/jop.2017.022137","title":"Evolving Treatment of Advanced Urothelial Cancer","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Tolerability; Cisplatin; Oncology; Cystectomy; Internal medicine; Cancer; Disease; Clinical trial; Urothelial cancer; Chemotherapy; Intensive care medicine; Adverse effect","score_opus":0.17454575956809598,"score_gpt":0.5213854210169301,"score_spread":0.3468396614488341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612201852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014076391,0.9794576,0.000007964967,0.00082214974,0.0018853737,0.0007818265,0.000051980805,0.00000660518,0.016972382],"genre_scores_gemma":[0.00004094812,0.9930006,0.0028618695,0.000121521756,0.001646715,0.000061451734,0.000005264824,0.00005919087,0.0022023823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975112,0.00036127603,0.0012439254,0.00023576795,0.00038828683,0.00025951417],"domain_scores_gemma":[0.991875,0.0009811977,0.0057097063,0.0004732411,0.00074814126,0.00021273002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004554583,0.00039107742,0.0036808033,0.00026960557,0.00009761927,0.00001904771,0.0002502038,0.0004346513,0.00030942523],"category_scores_gemma":[0.0011098218,0.0002498531,0.0010147225,0.00009862612,0.00012404368,0.00039274152,0.000032880867,0.000542456,0.000023983663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011095994,0.0014688693,0.000030684383,0.0019941805,0.003544409,0.0012859729,0.00019491887,7.8586396e-7,0.000006187403,0.0000060361995,0.0008664282,0.98949194],"study_design_scores_gemma":[0.004845127,0.010126982,0.000033997476,0.0067980536,0.020684015,0.0058239372,0.00007181281,3.083483e-7,0.000013037204,0.0000066469825,0.95145,0.00014607215],"about_ca_topic_score_codex":0.00012736999,"about_ca_topic_score_gemma":0.000015816822,"teacher_disagreement_score":0.98934585,"about_ca_system_score_codex":0.0018859096,"about_ca_system_score_gemma":0.0076823514,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2612425293","doi":"10.1016/j.urolonc.2017.04.013","title":"Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Cystectomy; Medicine; Sexual function; Bladder cancer; Urology; Urinary diversion; Confounding; Surgery; Internal medicine; Cancer","score_opus":0.0956517045637671,"score_gpt":0.3825237011726574,"score_spread":0.2868719966088903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612425293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015832481,0.9914592,0.000037027046,0.0009461029,0.00011798297,0.0038893404,0.000121867255,0.000052533716,0.0017926866],"genre_scores_gemma":[0.00038758403,0.9929877,0.0033294077,0.0007299643,0.00008717792,0.0014649222,0.00019985349,0.000037376572,0.0007760465],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965861,0.00063462806,0.00123749,0.0007390081,0.00042225432,0.00038056046],"domain_scores_gemma":[0.99702597,0.00092420867,0.0010126808,0.0005603135,0.00013280229,0.00034403373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008861741,0.0006022485,0.0052168006,0.00031358667,0.0002670752,0.000033496515,0.00019556085,0.00057876855,0.00011794211],"category_scores_gemma":[0.00055150053,0.0003586278,0.00017216428,0.00030108402,0.0011970651,0.00012067368,0.00013594869,0.00081764674,0.0000075305225],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009165914,0.0007916131,0.05042035,0.92243457,0.002934156,0.0010877489,0.00024675907,0.000003490867,0.0000013914334,0.0012145467,0.0039505777,0.015998196],"study_design_scores_gemma":[0.0034368418,0.006031282,0.0008897858,0.13907327,0.01581787,0.00267641,0.00012228463,0.000018988398,2.4389718e-7,0.00024617594,0.83128834,0.00039850204],"about_ca_topic_score_codex":0.00008721624,"about_ca_topic_score_gemma":0.000082716455,"teacher_disagreement_score":0.8273378,"about_ca_system_score_codex":0.0004367856,"about_ca_system_score_gemma":0.0015637163,"threshold_uncertainty_score":0.9998866},"labels":[],"label_agreement":null},{"id":"W2613354668","doi":"10.1016/j.clgc.2017.05.007","title":"Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi-institutional Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Cystectomy; Cystoprostatectomy; Radiation therapy; Surgery; Genitourinary system; Urology; Urinary diversion; Internal medicine; Bladder cancer; Cancer","score_opus":0.09100725329578864,"score_gpt":0.43840633249904226,"score_spread":0.34739907920325364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613354668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931526,0.0007635227,0.00023458661,0.0010632093,0.0015015845,0.0015341288,0.00007762458,0.000041301533,0.0016314494],"genre_scores_gemma":[0.9926571,0.00040742164,0.0018213722,0.00095313846,0.0015259514,0.00024311291,0.0000029477421,0.000030492578,0.0023584187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981233,0.00007643093,0.0005874494,0.00056228833,0.00036467134,0.00028589647],"domain_scores_gemma":[0.99830186,0.000040380488,0.00024497253,0.00089166325,0.00021326779,0.00030784906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023850585,0.00024270528,0.00074421475,0.000064176544,0.0003115442,0.000025885678,0.00030445933,0.00012073786,0.00043781844],"category_scores_gemma":[0.00016815668,0.00019031146,0.0002958613,0.000093160765,0.00031311504,0.00011259229,0.00010019192,0.00030818026,0.000026496591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018018276,0.0023228577,0.96785825,0.00003510986,0.0005735568,0.0002561949,0.00045301716,0.000046562473,0.00033036043,0.0000108490185,0.0010621598,0.02524924],"study_design_scores_gemma":[0.008895718,0.0033433968,0.9822665,0.00012378064,0.00019624476,0.000014316674,0.00010944787,0.00009461262,0.0002484443,0.000015442554,0.0045098416,0.00018226034],"about_ca_topic_score_codex":0.0006591408,"about_ca_topic_score_gemma":0.000253725,"teacher_disagreement_score":0.025066981,"about_ca_system_score_codex":0.00020385813,"about_ca_system_score_gemma":0.0005224203,"threshold_uncertainty_score":0.7760676},"labels":[],"label_agreement":null},{"id":"W2613441869","doi":"10.1016/j.urology.2017.04.049","title":"Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients","year":2017,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Interquartile range; Bladder cancer; Urothelium; Proportional hazards model; Logistic regression; Internal medicine; Urology; Cohort; Urothelial cancer; Biochemical recurrence; Gastroenterology; Cancer; Oncology; Urinary bladder; Prostate cancer; Prostatectomy","score_opus":0.009751056908929927,"score_gpt":0.28339528428715294,"score_spread":0.273644227378223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613441869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843085,0.00007637178,0.00003271178,0.00024154804,0.00024971177,0.0004299818,0.00013293349,0.000005054366,0.00040083186],"genre_scores_gemma":[0.9993091,0.00009331623,0.000014462506,0.00030610527,0.00003781953,0.00009212193,0.00004120112,0.000010481311,0.0000953803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992519,0.00003747963,0.00024387043,0.00017723403,0.00011797666,0.00017155615],"domain_scores_gemma":[0.9994296,0.00001138262,0.00017570543,0.0002536497,0.00008460338,0.000045064964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006282658,0.00008864109,0.00028381456,0.00006770245,0.000020903813,0.000002742444,0.00007962069,0.000096960066,0.00050007086],"category_scores_gemma":[0.000046364952,0.00007344454,0.0000423857,0.00003369518,0.00011013218,0.000062217754,0.000043824748,0.00009538645,0.000009743485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001166162,0.00045664917,0.99285394,0.000047167323,0.000076426375,0.000013073747,0.00027433888,3.151888e-7,0.004076514,0.0000040056852,0.000008581428,0.0010228375],"study_design_scores_gemma":[0.0050413124,0.0003369725,0.98983246,0.000051922885,0.000101170495,0.0000010926299,0.0000012906589,0.00014107999,0.003528007,0.000007868011,0.0009070146,0.000049793583],"about_ca_topic_score_codex":0.00019393876,"about_ca_topic_score_gemma":0.0001294542,"teacher_disagreement_score":0.0038751503,"about_ca_system_score_codex":0.000024196568,"about_ca_system_score_gemma":0.00005141115,"threshold_uncertainty_score":0.5475425},"labels":[],"label_agreement":null},{"id":"W2613761563","doi":"10.1016/j.clgc.2017.05.006","title":"Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional Study","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Interquartile range; Medicine; Cystectomy; Quartile; Odds ratio; Confidence interval; Bladder cancer; Internal medicine; Surgery; Cancer","score_opus":0.11917036530780481,"score_gpt":0.4432306947105458,"score_spread":0.324060329402741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613761563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957494,0.00026541113,0.00018611184,0.0014601575,0.00041045013,0.0011544257,0.0005229877,0.000024778135,0.00022624864],"genre_scores_gemma":[0.9961558,0.00011121585,0.0004434213,0.0001355228,0.0002093286,0.0003593032,0.000008852224,0.000010719332,0.0025658635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981306,0.00018473262,0.0005478115,0.00049236143,0.00041957488,0.00022488787],"domain_scores_gemma":[0.99853,0.00019664304,0.00025563687,0.00058097596,0.00015165289,0.00028514324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045584622,0.00023028982,0.0008150451,0.00002827321,0.00019780766,0.000026056014,0.00010327411,0.00010709901,0.000080994214],"category_scores_gemma":[0.0002924329,0.00014286145,0.00016776688,0.000043882308,0.0002348602,0.000087659115,0.00007575516,0.00015333814,0.000010058709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050487006,0.0029199957,0.97882396,0.00004537497,0.00086040585,0.000095841395,0.00024115642,0.0000022696831,0.000012715197,0.000002935821,0.000026192085,0.011920436],"study_design_scores_gemma":[0.013281378,0.0024525279,0.9801716,0.000051056442,0.0004228868,0.0000020859304,0.00010360979,0.000005205921,0.000047076726,0.0000035001551,0.0033125551,0.00014650862],"about_ca_topic_score_codex":0.0014637684,"about_ca_topic_score_gemma":0.0033662922,"teacher_disagreement_score":0.011773927,"about_ca_system_score_codex":0.00043264267,"about_ca_system_score_gemma":0.0003542747,"threshold_uncertainty_score":0.5825721},"labels":[],"label_agreement":null},{"id":"W2613853566","doi":"10.5489/cuaj.4172","title":"Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Pathological; Resection; Artifact (error); Bladder cancer; Radiology; Surgery; Cancer; Pathology; Internal medicine","score_opus":0.03679154766449051,"score_gpt":0.3206328331356611,"score_spread":0.2838412854711706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613853566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97027314,0.00028173896,0.00007572857,0.022700949,0.0010810207,0.0002613377,0.0004101968,0.00002012035,0.004895782],"genre_scores_gemma":[0.99535847,0.00018511257,0.00002616413,0.0017920607,0.00096690137,0.000013389339,0.000018174314,0.000019911698,0.0016198322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829006,0.00013477824,0.00034983634,0.00021357859,0.00045303247,0.00055870024],"domain_scores_gemma":[0.99848264,0.000058548165,0.00042708023,0.00019477516,0.0002451754,0.0005917829],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004637261,0.0001698315,0.0003538842,0.00014142622,0.000873604,0.00009412952,0.00015732218,0.00029687208,0.0025728748],"category_scores_gemma":[0.00032021955,0.0001385315,0.00022827274,0.00006151345,0.00008646294,0.00017822057,0.00001818071,0.0005118244,0.000028563803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006704762,0.00009999653,0.9877171,0.000011231188,0.00042092576,0.00017390343,0.00037131686,0.0000137713905,0.00073539827,0.000084848056,0.007724276,0.0019767755],"study_design_scores_gemma":[0.004091055,0.0007827147,0.97268987,0.000032745826,0.00030075992,0.00013599153,0.000084321255,0.000039486065,0.0017683991,0.0005429431,0.019367902,0.00016379396],"about_ca_topic_score_codex":0.006486351,"about_ca_topic_score_gemma":0.025035713,"teacher_disagreement_score":0.025085328,"about_ca_system_score_codex":0.0015802706,"about_ca_system_score_gemma":0.0008894647,"threshold_uncertainty_score":0.99833894},"labels":[],"label_agreement":null},{"id":"W2614729080","doi":"10.1080/2162402x.2017.1331195","title":"Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Sherbrooke; Fédération des Maisons D'Hébergement pour Femmes; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Cancer Research Society","keywords":"Immunoconjugate; Medicine; Bladder cancer; Vinblastine; Internalization; Cancer research; In vivo; Cancer; Antibody; Monoclonal antibody; Internal medicine; Immunology; Chemotherapy; Biology; Receptor","score_opus":0.0328047252033114,"score_gpt":0.3537519918207152,"score_spread":0.3209472666174038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614729080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638627,0.026349597,0.00052845065,0.004742292,0.00030461993,0.0024904623,0.00022566569,0.00006306567,0.0014331245],"genre_scores_gemma":[0.99114484,0.0047552045,0.0013747776,0.00076875807,0.0002570706,0.00067256106,0.000068204565,0.00005238388,0.0009061948],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999,0.000019897881,0.00018618345,0.00036117778,0.000056996258,0.0003757204],"domain_scores_gemma":[0.9990865,0.00014040875,0.00020050978,0.0003244317,0.0001932422,0.00005493751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011308031,0.00020891074,0.00042592158,0.000048953945,0.00044301647,0.000065453874,0.00012287522,0.00008657531,0.000056519053],"category_scores_gemma":[0.000083017956,0.00014988829,0.00007628423,0.000022658533,0.0002636702,0.0001523471,0.000031380558,0.00010256495,0.0000022796935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009208732,0.00040293185,0.35443953,0.00038483654,0.0034154113,0.00008276086,0.0018305714,0.0000084275625,0.4458227,0.00084143516,0.004062695,0.17949998],"study_design_scores_gemma":[0.0978969,0.01752468,0.7061604,0.0015316873,0.0021089115,0.0007966196,0.0043101734,0.0004112134,0.091891676,0.009995747,0.06552258,0.0018493714],"about_ca_topic_score_codex":0.00073617726,"about_ca_topic_score_gemma":0.00009215355,"teacher_disagreement_score":0.353931,"about_ca_system_score_codex":0.000048779104,"about_ca_system_score_gemma":0.00032570626,"threshold_uncertainty_score":0.6112267},"labels":[],"label_agreement":null},{"id":"W2620698050","doi":"10.1007/s13566-017-0318-3","title":"Hemostatic radiotherapy in advanced bladder cancer: a single-institution experience","year":2017,"lang":"en","type":"article","venue":"Journal of Radiation Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Hemostasis; Surgical oncology; Radiation therapy; Stage (stratigraphy); Bladder cancer; Retrospective cohort study; Cancer; Internal medicine; External beam radiotherapy; Carcinoma; Multivariate analysis; Surgery; Oncology; Brachytherapy","score_opus":0.03569064578333483,"score_gpt":0.39902763171933947,"score_spread":0.36333698593600466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620698050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851957,0.00279089,0.0009083399,0.007581271,0.0011833565,0.00024848327,0.0000028849693,0.000007089366,0.0020819698],"genre_scores_gemma":[0.9942759,0.0025801018,0.0015911058,0.001036633,0.00032146153,0.000019981004,0.0000011089293,0.00000974358,0.00016392903],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991596,0.00004457392,0.00036610404,0.00010670869,0.00017447036,0.00014859797],"domain_scores_gemma":[0.9990058,0.000040578194,0.0005850124,0.00016505325,0.00010367103,0.00009990644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013957772,0.000090656475,0.0003372199,0.00014000526,0.00009942454,0.00002116613,0.000108008055,0.000081476166,0.00015775619],"category_scores_gemma":[0.00014756275,0.00007434742,0.000069376605,0.00006186648,0.00009318107,0.0003377848,0.00000715032,0.0001561899,0.000002844095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017555226,0.00064025196,0.15562865,0.000019574889,0.00014301247,0.00037842075,0.0044146325,0.00038300964,0.018618982,0.00009313554,0.0007387288,0.81718606],"study_design_scores_gemma":[0.03545297,0.0071372828,0.7175469,0.00028830825,0.00019655495,0.0012450266,0.0008401205,0.0008247958,0.023306753,0.00031740835,0.21257341,0.000270484],"about_ca_topic_score_codex":0.00011328809,"about_ca_topic_score_gemma":0.00010871493,"teacher_disagreement_score":0.8169156,"about_ca_system_score_codex":0.0010245596,"about_ca_system_score_gemma":0.0006511766,"threshold_uncertainty_score":0.30318},"labels":[],"label_agreement":null},{"id":"W2620846984","doi":"10.1016/j.eururo.2017.05.049","title":"Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Chemotherapy; Carcinoma; Oncology; Urothelial cancer; Internal medicine; Cancer research; Cancer; Bladder cancer","score_opus":0.020412164458466706,"score_gpt":0.2620784331030494,"score_spread":0.24166626864458268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620846984","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027614893,0.0035244448,0.00015333603,0.680781,0.0024459728,0.0013544726,0.0006586281,0.00018905854,0.28327817],"genre_scores_gemma":[0.6768454,0.000060459453,0.00014052069,0.30092174,0.009363784,0.000017117192,0.00028411386,0.00023525096,0.012131619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976611,0.00037567364,0.00047639123,0.0006319747,0.00037615682,0.00047867268],"domain_scores_gemma":[0.99806696,0.00006377687,0.00045752112,0.0011829329,0.00013764751,0.000091145645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022645434,0.0004223614,0.0007669155,0.0001964101,0.00011585536,0.000016544867,0.00042301326,0.0004440417,0.00073726964],"category_scores_gemma":[0.00007571666,0.00036557118,0.00033395662,0.000055862332,0.00037652545,0.000035173598,0.000093380215,0.0011395122,0.00033484717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017148799,0.00012176554,0.005459665,0.00021557494,0.00041891463,0.004481247,0.00017075145,3.8725508e-7,0.0016132551,0.000027344347,0.98420835,0.0015678626],"study_design_scores_gemma":[0.0037935874,0.0019836666,0.060925484,0.0000511236,0.0005421884,0.00019980442,0.000007812624,0.0000041633666,0.00033635416,0.000098685196,0.9317919,0.00026522463],"about_ca_topic_score_codex":0.00023743931,"about_ca_topic_score_gemma":0.000012579467,"teacher_disagreement_score":0.6492305,"about_ca_system_score_codex":0.00017075874,"about_ca_system_score_gemma":0.00040858824,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W2621004257","doi":"10.1016/j.euf.2017.05.006","title":"Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis","year":2017,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Propensity score matching; Lymphadenectomy; Hazard ratio; Urology; Bladder cancer; Confidence interval; Subgroup analysis; Lymph node; Oncology; Chemotherapy; Internal medicine; Cystectomy; Surgery; Radiology; Cancer","score_opus":0.10077752202057463,"score_gpt":0.37968875593957724,"score_spread":0.27891123391900263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621004257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794024,0.0006065938,0.0001055924,0.00012398341,0.000067536916,0.00073861156,0.00005516505,0.000012387069,0.00034986468],"genre_scores_gemma":[0.99931806,0.00011961456,0.00028730978,0.00014255481,0.000027268854,0.00001575228,0.000011211268,0.000045627192,0.000032585194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694234,0.0012459195,0.00070588605,0.00050338404,0.0003435493,0.0002589235],"domain_scores_gemma":[0.9974705,0.00039537397,0.00075383205,0.00085017236,0.0004267571,0.000103353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009398585,0.00025523457,0.0013581112,0.0002351796,0.00005423151,0.000009005143,0.00033036034,0.000066586435,0.000098192635],"category_scores_gemma":[0.00032868105,0.00016320642,0.00023389788,0.00036718205,0.00074610463,0.000105707084,0.000077562385,0.00013440647,0.0000039844695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029774021,0.0013693352,0.96119577,0.00036100426,0.00212704,0.00012527483,0.000108375105,0.00006841055,0.0009407112,0.0000034549962,0.0000021387038,0.003924477],"study_design_scores_gemma":[0.014137143,0.0037729826,0.9722899,0.00054043625,0.0025000493,0.000005384854,0.0000057141838,0.00006503225,0.0065363967,0.000004501424,0.0000045929437,0.00013784746],"about_ca_topic_score_codex":0.0019230694,"about_ca_topic_score_gemma":0.00051361014,"teacher_disagreement_score":0.015636878,"about_ca_system_score_codex":0.00007136127,"about_ca_system_score_gemma":0.0006388608,"threshold_uncertainty_score":0.66553646},"labels":[],"label_agreement":null},{"id":"W2622306623","doi":"10.1136/bmjopen-2017-016054","title":"Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol","year":2017,"lang":"en","type":"review","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Kom op tegen Kanker","keywords":"Medicine; Bladder cancer; Rehabilitation; Protocol (science); Physical therapy; Psychological intervention; Physical fitness; Physical medicine and rehabilitation; Systematic review; MEDLINE; Cancer; Intensive care medicine; Alternative medicine; Pathology; Internal medicine; Nursing","score_opus":0.14272987953525962,"score_gpt":0.5079832863393374,"score_spread":0.3652534068040778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622306623","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063389365,0.31866276,0.0000011592784,0.00021727965,0.00009301062,0.68047774,0.00016387907,0.000010287845,0.00031050676],"genre_scores_gemma":[0.000043654603,0.18460506,0.000089733556,0.00008709878,0.000025108218,0.8145787,0.000046124613,0.000045125496,0.00047938983],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967832,0.00043350525,0.0017365363,0.0005185822,0.00033671304,0.00019145609],"domain_scores_gemma":[0.9964454,0.0003376248,0.0017169549,0.0011377031,0.00023057678,0.00013170374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007267204,0.0003788869,0.0045858435,0.00016310431,0.00004998879,0.000051347477,0.0003423699,0.000108923225,0.000049562103],"category_scores_gemma":[0.0024048532,0.00024696364,0.0006068606,0.00022488029,0.000062059335,0.00015752236,0.00037958298,0.00015023534,0.000009761966],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004000711,0.00038667326,0.00043552168,0.9064132,0.00048546735,0.000018049244,0.00039363667,4.172764e-8,2.7338788e-7,0.00000532279,0.00016812078,0.09165366],"study_design_scores_gemma":[0.0016038646,0.0010162614,0.0010161144,0.9837421,0.0046635927,0.0000139956155,0.00008861833,4.949175e-7,0.0000016803427,0.000026260397,0.0075651617,0.0002618275],"about_ca_topic_score_codex":0.0026617798,"about_ca_topic_score_gemma":0.0020757585,"teacher_disagreement_score":0.13410097,"about_ca_system_score_codex":0.00020948837,"about_ca_system_score_gemma":0.00092437817,"threshold_uncertainty_score":0.9999983},"labels":[],"label_agreement":null},{"id":"W2625220193","doi":"10.5489/cuaj.4606","title":"New research in bladder cancer, ASCO-GU 2017","year":2017,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Oncology; Internal medicine; Urology; Gynecology; Cancer","score_opus":0.26500906028864474,"score_gpt":0.46436874921828003,"score_spread":0.1993596889296353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625220193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011693421,0.97114575,0.0000016898155,0.008544639,0.0009595572,0.0007291085,0.00015579209,0.00001403421,0.01843775],"genre_scores_gemma":[0.00014032476,0.9813587,0.00005078839,0.00059178896,0.0031932564,0.00007764056,0.00005405134,0.00004579478,0.01448765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961861,0.0006043332,0.00071458257,0.0004663887,0.00085330947,0.0011753167],"domain_scores_gemma":[0.996607,0.0002656606,0.00062584766,0.00040093448,0.00033476323,0.0017657975],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017609736,0.0003688422,0.0016447827,0.00086905016,0.000647894,0.00029404325,0.00052422227,0.0011439776,0.0017938165],"category_scores_gemma":[0.0008203613,0.00027349245,0.000529658,0.00035132546,0.00006275181,0.0001182007,0.00004454897,0.0033603427,0.00042820262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000018019877,0.000036424484,0.0075920625,0.00020835952,0.0004472339,0.0008176479,0.000029565736,3.6779102e-7,2.574221e-8,0.000032647957,0.13882151,0.8519961],"study_design_scores_gemma":[0.0009845757,0.0002219446,0.009175814,0.0020670802,0.0005325288,0.0003765443,0.000006723853,8.25141e-7,4.8692993e-8,0.00039442393,0.9860194,0.00022011547],"about_ca_topic_score_codex":0.041972883,"about_ca_topic_score_gemma":0.017202271,"teacher_disagreement_score":0.851776,"about_ca_system_score_codex":0.0073022926,"about_ca_system_score_gemma":0.015611511,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W2626071259","doi":"10.1007/s00345-017-2065-x","title":"Dose dense MVAC prior to radical cystectomy: a real-world experience","year":2017,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Western University; University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Proportional hazards model; Bladder cancer; Cohort; Urology; Hazard ratio; Internal medicine; Nephrology; Retrospective cohort study; Oncology; Surgery; Cancer; Metastasis; Confidence interval","score_opus":0.029474975782781073,"score_gpt":0.3470680155973147,"score_spread":0.31759303981453363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626071259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570237,0.000943635,0.00013372958,0.02286921,0.0013110775,0.00036428543,0.000004775389,0.000025182035,0.01732444],"genre_scores_gemma":[0.98909897,0.00016411763,0.00118613,0.003303721,0.0008172194,0.00001352741,4.859301e-7,0.000024249728,0.0053915987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985953,0.000074498916,0.00045936636,0.00021622937,0.00030132642,0.00035327688],"domain_scores_gemma":[0.99840754,0.00007962106,0.0003594371,0.0005379411,0.00014358523,0.00047186014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024774502,0.00017112828,0.00054356904,0.00036365178,0.00021685469,0.000039326133,0.0003555014,0.000062141145,0.0005457888],"category_scores_gemma":[0.00021328828,0.00012853554,0.00016911139,0.00013874973,0.00020864284,0.00011712884,0.00008924097,0.00037551482,0.00007487388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034495268,0.0018564195,0.6512326,0.000109835026,0.0013565768,0.021582017,0.008464133,0.000028269775,0.023285871,0.002080847,0.04341635,0.21209179],"study_design_scores_gemma":[0.009174889,0.0027835115,0.6045642,0.00011196847,0.00038172794,0.0023877085,0.000055994897,0.000013313915,0.0015759883,0.00035144348,0.37839255,0.00020674271],"about_ca_topic_score_codex":0.0001788059,"about_ca_topic_score_gemma":0.0007371585,"teacher_disagreement_score":0.3349762,"about_ca_system_score_codex":0.000120695266,"about_ca_system_score_gemma":0.00028690035,"threshold_uncertainty_score":0.59760046},"labels":[],"label_agreement":null},{"id":"W2626351964","doi":"10.5489/cuaj.4126","title":"Pathology review impacts clinical management of patients with T1‒T2 bladder cancer","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Lymphovascular invasion; Bladder cancer; Pathological; Genitourinary system; Surgical pathology; Conservative management; Stage (stratigraphy); Bladder Neoplasm; Cancer; General surgery; Pathology; Surgery; Internal medicine; Metastasis","score_opus":0.029462883034220524,"score_gpt":0.32963062192876436,"score_spread":0.30016773889454385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626351964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429912,0.0061276234,0.000019286837,0.03808443,0.00085589726,0.0009219352,0.00021960141,0.000017507811,0.010762525],"genre_scores_gemma":[0.9783546,0.011988808,0.0001880259,0.008599513,0.00024942058,0.000018995179,0.000020972831,0.000014234192,0.00056548126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984501,0.00012791874,0.00046069952,0.00020211835,0.0003643895,0.0003947987],"domain_scores_gemma":[0.99791914,0.000037725968,0.00072078995,0.00027015607,0.00040226572,0.00064994127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005708828,0.00014197668,0.00047636515,0.000055179175,0.00028088593,0.000036892827,0.00018323855,0.00017072297,0.0011980665],"category_scores_gemma":[0.0002582492,0.000092624985,0.00015735396,0.00006002918,0.000079832964,0.00009361146,0.000024065657,0.0003931102,0.000026240088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011339093,0.000121266065,0.9709051,0.000054306216,0.0005390415,0.00017977442,0.000011954064,5.229154e-7,3.9498858e-7,0.00002730982,0.011247892,0.016799008],"study_design_scores_gemma":[0.0029281524,0.00066989893,0.96693456,0.00030917578,0.0006264306,0.000022993923,0.0000056477984,0.0000011056342,0.0000018433545,0.00008120802,0.028328318,0.000090668786],"about_ca_topic_score_codex":0.0006452254,"about_ca_topic_score_gemma":0.0006889224,"teacher_disagreement_score":0.035363354,"about_ca_system_score_codex":0.00047970176,"about_ca_system_score_gemma":0.00045531138,"threshold_uncertainty_score":0.999715},"labels":[],"label_agreement":null},{"id":"W2626675704","doi":"10.5489/cuaj.4568","title":"Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute for Work & Health; University of British Columbia; McGill University Health Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Generalizability theory; Bladder cancer; Cystoscopy; Medicine; Time horizon; Robustness (evolution); Surgery; Urology; Cancer; Internal medicine; Psychology; Urinary system","score_opus":0.02600777064881577,"score_gpt":0.28475041750018143,"score_spread":0.25874264685136567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626675704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97973514,0.00038315653,0.000029383278,0.015215978,0.0001548527,0.00036017108,0.00016838936,0.000007723013,0.0039451835],"genre_scores_gemma":[0.99695617,0.00018050976,0.00005612515,0.0021780592,0.0001252489,0.000040731247,0.000018242117,0.000013013779,0.00043192753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984614,0.0001036433,0.00040166642,0.0002601885,0.00035245976,0.000420624],"domain_scores_gemma":[0.99801314,0.000104097875,0.00067150174,0.00026523074,0.0003918996,0.0005541094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036484824,0.0001803986,0.00061511126,0.00043155282,0.00027292548,0.00008122718,0.0002170357,0.00022130895,0.00038141088],"category_scores_gemma":[0.0003465351,0.00013300039,0.00016431884,0.0003253824,0.00009431787,0.0001714859,0.000015181416,0.0004612085,0.0000079251595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017795086,0.000069184614,0.9939943,0.000006692412,0.0016406672,0.0010178695,0.0003396847,0.0001463277,0.0005342828,0.000007809063,0.0009935433,0.0010717124],"study_design_scores_gemma":[0.002372595,0.00045031746,0.9936528,0.00007266349,0.0008764025,0.000044097465,0.00010979509,0.000112893285,0.0006378459,0.00004150905,0.001489368,0.00013966976],"about_ca_topic_score_codex":0.026745379,"about_ca_topic_score_gemma":0.039596017,"teacher_disagreement_score":0.01722098,"about_ca_system_score_codex":0.0011418199,"about_ca_system_score_gemma":0.0020972479,"threshold_uncertainty_score":0.9797356},"labels":[],"label_agreement":null},{"id":"W2731312174","doi":"10.1200/jco.2017.35.15_suppl.106","title":"A phase I study of enfortumab vedotin (ASG-22CE; ASG-22ME): Updated analysis of patients with metastatic urothelial cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Clinical endpoint; Adverse effect; Oncology; Nausea; Cancer; Gastroenterology; Clinical trial","score_opus":0.12336007878596328,"score_gpt":0.5077908715803896,"score_spread":0.3844307927944263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731312174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973703,0.000095647454,0.00007043638,0.00039758036,0.00054684957,0.00060547347,0.0001413373,0.000004788931,0.0007675646],"genre_scores_gemma":[0.9986103,0.00010464477,0.000620153,0.00025413267,0.0002189918,0.000012485865,0.000016335971,0.000022793181,0.0001401637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954354,0.00038476137,0.0029031206,0.00025903218,0.0007761819,0.00024148043],"domain_scores_gemma":[0.9917222,0.0005015449,0.005682399,0.0005886201,0.0011603255,0.0003448891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013547532,0.00021993817,0.0032361771,0.00034013906,0.00008576811,0.000011784154,0.00037696995,0.00015389457,0.0006025491],"category_scores_gemma":[0.0010884611,0.00013643599,0.00064661005,0.0002908696,0.00033484813,0.000167369,0.00006546847,0.0005254618,0.0000024695184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035552632,0.039295033,0.8316533,0.000038175753,0.022161948,0.00030725624,0.00057860935,0.00006756819,0.000046593,0.000008499205,0.00032634573,0.06996407],"study_design_scores_gemma":[0.09006781,0.08913716,0.79178673,0.000076577104,0.02680816,0.000008344239,0.0003190761,0.0001259525,0.00015256208,0.000021774335,0.0013839637,0.00011190318],"about_ca_topic_score_codex":0.00090738264,"about_ca_topic_score_gemma":0.00085419335,"teacher_disagreement_score":0.069852166,"about_ca_system_score_codex":0.00012774074,"about_ca_system_score_gemma":0.0021516713,"threshold_uncertainty_score":0.65974903},"labels":[],"label_agreement":null},{"id":"W2732881054","doi":"10.3233/blc-170118","title":"Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Oncology; Internal medicine; Cancer","score_opus":0.32443124169326165,"score_gpt":0.5705046334976933,"score_spread":0.24607339180443166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732881054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7018692,0.004630018,0.00064484077,0.25761458,0.006962745,0.020845056,0.00070029875,0.00017024466,0.0065630083],"genre_scores_gemma":[0.80277103,0.0027026357,0.002611833,0.14620131,0.0067061456,0.015829535,0.000044077948,0.00027963758,0.022853814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917926,0.0023145818,0.0018907384,0.0018676615,0.0009626288,0.001171785],"domain_scores_gemma":[0.9934148,0.0011987495,0.00072881894,0.0031431147,0.0004849558,0.0010295322],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060446025,0.0007830036,0.0020764123,0.00028415126,0.0007993753,0.0006033572,0.002179143,0.0003991333,0.0030764716],"category_scores_gemma":[0.0035314371,0.00054568955,0.00038893375,0.00048433398,0.00030729565,0.0006481978,0.0010678914,0.0008865307,0.0005210477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025167996,0.0013441403,0.03298597,0.0000817237,0.001916336,0.0004406664,0.008758545,0.00029344615,0.010831231,0.00012450453,0.48624995,0.4318055],"study_design_scores_gemma":[0.0071232403,0.0021623315,0.19885181,0.001012763,0.00071077346,0.0000136151475,0.0005329625,0.000050283303,0.018905621,0.0002324468,0.76947534,0.00092883175],"about_ca_topic_score_codex":0.021318864,"about_ca_topic_score_gemma":0.04141029,"teacher_disagreement_score":0.43087664,"about_ca_system_score_codex":0.0009888118,"about_ca_system_score_gemma":0.002322188,"threshold_uncertainty_score":0.9996995},"labels":[],"label_agreement":null},{"id":"W2733733621","doi":"","title":"Photodiagnostic et PDT en urologie","year":2007,"lang":"fr","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Physics; Prostate disease; Humanities; Molecular biology; Art; Medicine; Cancer; Biology","score_opus":0.02160447928069827,"score_gpt":0.2834011973271178,"score_spread":0.2617967180464196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733733621","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1370615,0.03103077,0.10445682,0.07514702,0.0034692676,0.0031356353,0.00057981425,0.00074611796,0.64437306],"genre_scores_gemma":[0.88869447,0.014821994,0.026507018,0.0021459989,0.00026453412,0.00025701485,0.0012989107,0.0001631469,0.065846905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98820454,0.007857389,0.0008962868,0.0013013205,0.00077039696,0.0009700913],"domain_scores_gemma":[0.9874835,0.00664232,0.0005143091,0.0028715383,0.0018872845,0.00060102],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008898962,0.0007266348,0.00084799563,0.00029151488,0.0003431337,0.00024530292,0.0011765098,0.00082062563,0.00218183],"category_scores_gemma":[0.0049496274,0.00075011706,0.0004640198,0.00050504354,0.00052438135,0.0001476577,0.0012226914,0.0015952899,0.001065061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061014545,0.011270258,0.09565254,0.0018937456,0.002469456,0.00083735836,0.051528227,0.00039243684,0.0077433796,0.326009,0.01862974,0.48296368],"study_design_scores_gemma":[0.00892214,0.000015000505,0.22151549,0.015542113,0.0020887023,0.0003029985,0.0006537532,0.005353967,0.1560618,0.011938408,0.5752769,0.0023286883],"about_ca_topic_score_codex":0.00582561,"about_ca_topic_score_gemma":0.0024985021,"teacher_disagreement_score":0.751633,"about_ca_system_score_codex":0.00063011225,"about_ca_system_score_gemma":0.0012503117,"threshold_uncertainty_score":0.9997127},"labels":[],"label_agreement":null},{"id":"W2734411129","doi":"10.5489/cuaj.4150","title":"The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cytology; Cystectomy; Malignancy; Biopsy; Urinary system; Urine cytology; Urology; Upper urinary tract; Bladder cancer; Cancer; Radiology; Pathology; Internal medicine","score_opus":0.01450537457297826,"score_gpt":0.255664501342313,"score_spread":0.24115912676933474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734411129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491079,0.0017918738,0.000019719375,0.044472504,0.0006620063,0.00056660164,0.00035430212,0.000013478702,0.0030116315],"genre_scores_gemma":[0.993874,0.00014426609,0.00008736496,0.0037586559,0.0008585453,0.000049607675,0.000009147373,0.000022937676,0.0011954868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831456,0.00011026747,0.00042932702,0.00022918222,0.00029602138,0.0006206406],"domain_scores_gemma":[0.9976705,0.00058940786,0.00055837433,0.00029012424,0.00033151606,0.0005601234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043732827,0.00019559904,0.00040506313,0.00009788028,0.0011350437,0.00012175212,0.00034868263,0.00031425178,0.00054771424],"category_scores_gemma":[0.0012847555,0.00013500702,0.00031237947,0.000035476118,0.00013623055,0.00009599466,0.000024662777,0.00045306986,0.000032634456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001844905,0.00010548373,0.9858418,0.000005386437,0.0001909032,0.00013440895,0.00037038318,4.728777e-7,0.00018718581,0.000117665695,0.008743154,0.0041186702],"study_design_scores_gemma":[0.0022268968,0.0009567993,0.90299344,0.000017598008,0.00024760255,0.000626134,0.00017569079,0.000046847876,0.00056244957,0.0032856578,0.08872567,0.00013518774],"about_ca_topic_score_codex":0.0030518463,"about_ca_topic_score_gemma":0.00032692114,"teacher_disagreement_score":0.08284833,"about_ca_system_score_codex":0.0005770382,"about_ca_system_score_gemma":0.0010086115,"threshold_uncertainty_score":0.8729953},"labels":[],"label_agreement":null},{"id":"W2734642530","doi":"","title":"PDT following fluorescence guided transurethral resection as a possible tool for reducing non-muscle invasive bladder cancer recurrence; a preclinical study","year":2009,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Bladder cancer; Clonogenic assay; Photodynamic therapy; Medicine; Urology; Cancer; Cell; Lumen (anatomy); Cancer cell; Pathological; Pathology; Cancer research; Internal medicine; Chemistry","score_opus":0.04411373721240713,"score_gpt":0.3444850119338211,"score_spread":0.30037127472141395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734642530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96773255,0.0018701226,0.008395837,0.0071176016,0.0009761957,0.005833621,0.00014068642,0.00024794924,0.0076854452],"genre_scores_gemma":[0.9726899,0.0009702163,0.019662034,0.00020558637,0.00017300836,0.0013502678,0.0003605762,0.00008713828,0.00450127],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9938656,0.0022861324,0.001020485,0.0014759675,0.00075953134,0.00059225643],"domain_scores_gemma":[0.9940321,0.0011556211,0.00050765293,0.0019507649,0.002059374,0.00029448204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044488427,0.00054486044,0.0008840788,0.00024518376,0.0005062696,0.00029488964,0.00071856624,0.0004609548,0.00011995271],"category_scores_gemma":[0.0027400453,0.00053786405,0.0006575209,0.00048546793,0.00013874403,0.00019496781,0.00033693027,0.0009834914,0.000015530013],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040346384,0.02454926,0.12086904,0.0033288533,0.0063487254,0.00025178544,0.17024545,0.00075709936,0.034711927,0.001366046,0.018837387,0.6146998],"study_design_scores_gemma":[0.045734372,0.00037264588,0.3597274,0.06349312,0.008172499,0.00015476633,0.0036318416,0.01688401,0.47960943,0.013656113,0.003548278,0.005015514],"about_ca_topic_score_codex":0.0067814924,"about_ca_topic_score_gemma":0.0033517338,"teacher_disagreement_score":0.6096843,"about_ca_system_score_codex":0.00043352362,"about_ca_system_score_gemma":0.0021410594,"threshold_uncertainty_score":0.99983245},"labels":[],"label_agreement":null},{"id":"W2735471586","doi":"10.5489/cuaj.4173","title":"Conservative treatment of upper urinary tract carcinoma: Long-term results","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Term (time); Urinary system; Upper urinary tract; Medicine; Carcinoma; Conservative treatment; Urology; Surgery; Internal medicine; Physics; Astronomy","score_opus":0.039611577793475676,"score_gpt":0.2952032511134542,"score_spread":0.2555916733199785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735471586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724142,0.00036956026,0.0000029776222,0.017753916,0.00027329932,0.0002309052,0.0002121813,0.000008637669,0.0087343175],"genre_scores_gemma":[0.9962313,0.00015916275,0.000053765154,0.0006819375,0.0003952868,0.0000090045905,0.000030833,0.000010220274,0.0024284911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988053,0.000087803324,0.0003343572,0.00018186792,0.00023944414,0.00035121446],"domain_scores_gemma":[0.9983677,0.00009085753,0.00048561473,0.00023643073,0.0002458779,0.00057347206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019351835,0.00014926096,0.00035755915,0.0000942898,0.00045504796,0.0000637979,0.000120350174,0.00018881029,0.0003177975],"category_scores_gemma":[0.00035989497,0.00010724306,0.00019930379,0.000039771938,0.000070563015,0.00011086641,0.000008355179,0.00019605293,0.000028972881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003631484,0.00040989023,0.99411505,0.0000032301575,0.00019483689,0.0007165289,0.00023476049,6.2170136e-7,0.000028594191,0.00001633322,0.0009079509,0.0030090378],"study_design_scores_gemma":[0.004936203,0.003183926,0.98602575,0.000015229256,0.00019393166,0.00051036075,0.000023611561,0.0000057831926,0.00015374995,0.00009625882,0.0047673276,0.00008789635],"about_ca_topic_score_codex":0.0041208672,"about_ca_topic_score_gemma":0.00048216322,"teacher_disagreement_score":0.023817092,"about_ca_system_score_codex":0.0013807206,"about_ca_system_score_gemma":0.00081917044,"threshold_uncertainty_score":0.62295455},"labels":[],"label_agreement":null},{"id":"W2736033387","doi":"10.1016/j.eururo.2005.12.047","title":"Plasmacytoid Urothelial Carcinoma of the Urinary Bladder","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Urothelial carcinoma; Pathology; Pathological; Urinary bladder; Cystoscopy; Carcinoma; Transitional cell carcinoma; Urinary system; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.010933734831924918,"score_gpt":0.22706489558853937,"score_spread":0.21613116075661445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736033387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7881257,0.0003557951,0.000021771004,0.0011595947,0.00031660014,0.00023131093,0.00002110668,0.000036190733,0.20973194],"genre_scores_gemma":[0.9926661,0.000006738394,0.00006552921,0.0014105837,0.00050329714,0.000005015253,0.00000871939,0.000043260632,0.005290707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998938,0.00020626998,0.00024216707,0.00022865554,0.00015244324,0.00023244038],"domain_scores_gemma":[0.99937105,0.000036013706,0.00008285835,0.00041999953,0.00004067488,0.00004938226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094991614,0.00014353984,0.00020423606,0.000050709255,0.00006586807,0.000003912141,0.0001670403,0.000041564475,0.00033325367],"category_scores_gemma":[0.000021073763,0.00009430368,0.00013551756,0.00011177237,0.0001974134,0.000020277783,0.00009767888,0.0001647199,0.00019733736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022743254,0.0018094,0.90992594,0.00008013489,0.0003202557,0.0013970111,0.00055052777,0.00007864492,0.038115844,0.0027795432,0.038475648,0.0041927295],"study_design_scores_gemma":[0.0027835574,0.0010131495,0.92199403,0.000005849789,0.00017279063,0.0005548448,0.0000102830545,0.00001742613,0.007078368,0.00015489076,0.066121615,0.00009320397],"about_ca_topic_score_codex":0.0001101657,"about_ca_topic_score_gemma":0.0000075111584,"teacher_disagreement_score":0.20454046,"about_ca_system_score_codex":0.00002010706,"about_ca_system_score_gemma":0.000079565434,"threshold_uncertainty_score":0.38455924},"labels":[],"label_agreement":null},{"id":"W2737219695","doi":"10.1200/jco.2018.36.6_suppl.tps527","title":"S1605: Phase II trial of atezolizumab in BCG-unresponsive nonmuscle invasive bladder cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Atezolizumab; Cystectomy; Bladder cancer; Clinical endpoint; Oncology; Internal medicine; Population; Immunotherapy; Cancer; Urology; Pembrolizumab; Randomized controlled trial","score_opus":0.16962735630686301,"score_gpt":0.5273361999820035,"score_spread":0.35770884367514055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737219695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851631,0.00044180936,0.000020036357,0.005283109,0.0028371355,0.0005062326,0.000021966844,0.0000055793316,0.0057210526],"genre_scores_gemma":[0.99142575,0.0013112781,0.00061611395,0.0022813075,0.0037312906,0.000015281372,0.000001966407,0.000021461816,0.00059552403],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958972,0.00051711407,0.0026466774,0.00023017345,0.00041613344,0.00029272097],"domain_scores_gemma":[0.9951009,0.0016715734,0.0017916342,0.00023878152,0.00084251777,0.0003545759],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017504309,0.00017414139,0.0018633406,0.0002244057,0.000048369257,0.000003825311,0.00019365668,0.00041651307,0.0011155374],"category_scores_gemma":[0.0041513927,0.00012454332,0.00051680254,0.0002561559,0.0005010116,0.00011770437,0.00007583227,0.00071939256,0.000023160057],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6690548,0.01669833,0.0072346064,0.000034496672,0.0012739754,0.0012693808,0.0012357523,0.000003975959,0.0019474939,0.00005791261,0.011163196,0.29002607],"study_design_scores_gemma":[0.5624724,0.3354745,0.039028622,0.00034481625,0.0010563812,0.00023225129,0.00035813998,0.000023641673,0.005209382,0.0006715587,0.05494496,0.0001833612],"about_ca_topic_score_codex":0.0002525229,"about_ca_topic_score_gemma":0.0006804272,"teacher_disagreement_score":0.31877616,"about_ca_system_score_codex":0.00026311912,"about_ca_system_score_gemma":0.0063260337,"threshold_uncertainty_score":0.9997976},"labels":[],"label_agreement":null},{"id":"W2737755444","doi":"10.1016/j.clgc.2017.07.018","title":"Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Positron emission tomography; Confidence interval; Odds ratio; Bladder cancer; Magnetic resonance imaging; Stage (stratigraphy); Logistic regression; Radiology; Nuclear medicine; Cancer; Computed tomography; Internal medicine","score_opus":0.03682113614610499,"score_gpt":0.3799245230723125,"score_spread":0.3431033869262075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737755444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935812,0.0035914592,0.000021511285,0.00021185332,0.00050526985,0.0013526188,0.00051140203,0.000042309755,0.00018242003],"genre_scores_gemma":[0.9965666,0.0019519916,0.0002328109,0.00021583564,0.00052912626,0.00026404054,0.00011062484,0.000059594175,0.00006940912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824375,0.000065111104,0.00056137564,0.00058293727,0.00019377966,0.000353049],"domain_scores_gemma":[0.9981862,0.00017865389,0.00051297026,0.00047991314,0.0002700048,0.00037227632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015397914,0.00032268124,0.0006440522,0.00015179791,0.00027840032,0.000052141408,0.00019153194,0.000043903594,0.00012755941],"category_scores_gemma":[0.00006084014,0.00024156416,0.00033634185,0.00008914762,0.0001984286,0.00027133027,0.000087204135,0.00016781826,0.0000012022768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034975652,0.00055449246,0.9685047,0.00014536409,0.0006638706,0.000060253264,0.000032218748,0.000019603227,0.00023838789,0.0000017141525,0.0015411127,0.024740681],"study_design_scores_gemma":[0.01209804,0.002021805,0.9795496,0.00047258422,0.000786322,0.000018831568,0.000018008679,0.0017233654,0.002403449,0.00003103062,0.00060035556,0.00027659253],"about_ca_topic_score_codex":0.0014882559,"about_ca_topic_score_gemma":0.00009287165,"teacher_disagreement_score":0.02446409,"about_ca_system_score_codex":0.00015383337,"about_ca_system_score_gemma":0.00048415601,"threshold_uncertainty_score":0.98507005},"labels":[],"label_agreement":null},{"id":"W2738087673","doi":"10.1111/iju.13389","title":"Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non‐muscle‐invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Kidney disease; Bladder cancer; Urology; Hazard ratio; Cancer; Internal medicine; Kidney; Risk factor; Urothelium; Disease; Renal function; Stage (stratigraphy); Gastroenterology; Oncology; Urinary bladder; Confidence interval; Biology","score_opus":0.01199668376138572,"score_gpt":0.3191158071344894,"score_spread":0.30711912337310365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738087673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936442,0.0007847503,0.000085009226,0.004063587,0.00061464764,0.00039142874,0.00031677235,0.0000027007213,0.00009692355],"genre_scores_gemma":[0.99794364,0.0006930695,0.00018045075,0.0006694463,0.00041312553,0.000032851887,0.00001421755,0.0000122732445,0.000040945484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992118,0.000022199029,0.00020705223,0.00015307714,0.000272932,0.00013292381],"domain_scores_gemma":[0.9987968,0.000050079623,0.00043975154,0.00011527693,0.00040039624,0.00019767096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060119546,0.000105587824,0.00019592077,0.00010680079,0.000059599282,0.000026804091,0.00016860939,0.000047003155,0.000095683325],"category_scores_gemma":[0.0002900358,0.000071221235,0.000052092364,0.000014448247,0.00010468456,0.00017698464,0.000043471406,0.0001665798,0.000001495532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004347672,0.0002160414,0.88170207,0.000026004758,0.00029040594,0.0000920324,0.00014470059,0.000004746758,0.000069849026,0.0000058823907,0.00015545702,0.11294517],"study_design_scores_gemma":[0.010413998,0.0023184414,0.9842904,0.00027704032,0.00015573211,0.000018607681,0.0000037910577,0.000022567707,0.00008654918,0.00018743057,0.0021595515,0.000065857894],"about_ca_topic_score_codex":0.000058390717,"about_ca_topic_score_gemma":0.000054180877,"teacher_disagreement_score":0.112879306,"about_ca_system_score_codex":0.00017224645,"about_ca_system_score_gemma":0.00092300563,"threshold_uncertainty_score":0.29043177},"labels":[],"label_agreement":null},{"id":"W2738752481","doi":"10.1016/j.urolonc.2017.07.004","title":"Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; General surgery; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.02013023970879372,"score_gpt":0.31173808250322815,"score_spread":0.2916078427944344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738752481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953831,0.00042833597,0.0007320645,0.002551683,0.000053791617,0.0003649372,0.00012349777,0.00002804287,0.00033456608],"genre_scores_gemma":[0.992345,0.00016121127,0.0066223987,0.0004234168,0.000038425664,0.00015921246,0.00020752406,0.000008536881,0.000034271332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990393,0.00010997557,0.00028752367,0.0002944256,0.00011747823,0.00015128676],"domain_scores_gemma":[0.99881154,0.00023308875,0.00035307463,0.00031919393,0.000103839244,0.0001792644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021450334,0.00014514144,0.00044567237,0.0002442123,0.0004060885,0.000026017873,0.00005223241,0.00016551069,0.00004334845],"category_scores_gemma":[0.00032349784,0.00011807466,0.00011184642,0.00021058587,0.0007328554,0.000100304,0.000027124684,0.00014121644,0.0000016975679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082037324,0.00015233638,0.99681944,0.000029308325,0.00037736766,0.000015522199,0.0001768166,0.000053009604,0.00001190863,0.0010512825,0.000048686652,0.0011822609],"study_design_scores_gemma":[0.0006673265,0.00064719893,0.98598474,0.000037576294,0.0024830746,0.000023685376,0.000021246311,0.0017974571,0.000054189273,0.003422376,0.0047696503,0.000091497444],"about_ca_topic_score_codex":0.0012638465,"about_ca_topic_score_gemma":0.00056838326,"teacher_disagreement_score":0.010834741,"about_ca_system_score_codex":0.00009709735,"about_ca_system_score_gemma":0.00024605455,"threshold_uncertainty_score":0.4814945},"labels":[],"label_agreement":null},{"id":"W2739036608","doi":"10.1093/annonc/mdx400","title":"Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Notre-Dame; BC Cancer Agency","funders":"","keywords":"Medicine; Placebo; Gemcitabine; Hazard ratio; Internal medicine; Chemotherapy; Adverse effect; Clinical endpoint; Gastroenterology; Surgery; Randomized controlled trial; Urology; Confidence interval; Pathology","score_opus":0.06507839117461117,"score_gpt":0.4452299838262008,"score_spread":0.38015159265158965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739036608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852158,0.00035096123,0.000070514245,0.00344005,0.00017286776,0.009218097,0.00024192804,0.000020464704,0.0012693463],"genre_scores_gemma":[0.9946157,0.00054541975,0.0005958205,0.0009780644,0.00022889902,0.0027288443,0.00002953858,0.000042651747,0.00023510215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99844575,0.000118119715,0.00048349917,0.00037176115,0.00027139345,0.0003094865],"domain_scores_gemma":[0.9978846,0.00038501463,0.0006430907,0.00040677976,0.000541051,0.00013950828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070683664,0.0002575811,0.0015438035,0.0000789977,0.00039638003,0.000017433424,0.00013209792,0.00010321919,0.000059133894],"category_scores_gemma":[0.0005618849,0.00016864519,0.00017398078,0.00003556978,0.00024465125,0.00011627865,0.000042743235,0.00009725997,4.854101e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7335304,0.004413721,0.011753493,0.000053430915,0.0013464441,0.0000063182365,0.0014115034,0.0000085950505,0.000044990185,0.000015368209,0.00041000024,0.24700575],"study_design_scores_gemma":[0.92001927,0.070502885,0.0044499715,0.00009817691,0.0009031206,0.0000024701658,0.00010800928,0.00040061274,0.00033055255,0.00015962466,0.0028628912,0.00016240227],"about_ca_topic_score_codex":0.0009276164,"about_ca_topic_score_gemma":0.0005181811,"teacher_disagreement_score":0.24684335,"about_ca_system_score_codex":0.000042709493,"about_ca_system_score_gemma":0.00034842035,"threshold_uncertainty_score":0.6877151},"labels":[],"label_agreement":null},{"id":"W2740756466","doi":"10.1136/jclinpath-2017-204562","title":"Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lymphovascular invasion; Necrosis; Inflammation; Pathology; Carcinoma in situ; Oncology; Cystectomy; Internal medicine; Pathological; Carcinoma; Bladder cancer; Cancer; Metastasis","score_opus":0.043247635903182334,"score_gpt":0.3441685921642653,"score_spread":0.300920956261083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740756466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945597,0.00019944929,0.000017411185,0.0037924629,0.0009454038,0.00033036867,0.00001555454,0.0000029177738,0.00013670792],"genre_scores_gemma":[0.9988208,0.00013493093,0.0001803597,0.00016059354,0.0006007294,0.000006482794,7.5866205e-7,0.0000131207125,0.000082249164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799556,0.00025345033,0.0011265685,0.00016323572,0.00030164793,0.00015952122],"domain_scores_gemma":[0.99773985,0.00021756545,0.0014483248,0.00030872243,0.00015956874,0.00012597382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008405043,0.00012328377,0.00068727974,0.00007839255,0.00007153766,0.000016548105,0.00021172177,0.00021088975,0.000029420224],"category_scores_gemma":[0.0020242196,0.00007326077,0.00019924786,0.000028345466,0.00032049895,0.000102182436,0.000094515744,0.00054105953,0.0000022795678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062182156,0.0002772597,0.9940942,0.000030738847,0.00007716695,0.00030769597,0.00029167056,0.0000036556416,0.0015161198,0.0000152082375,0.00009429556,0.0026701677],"study_design_scores_gemma":[0.0070089595,0.00122395,0.98821354,0.00018510265,0.0002965588,0.00028062696,0.00007538776,0.000016001457,0.0018655267,0.0007188839,0.0000601441,0.0000553404],"about_ca_topic_score_codex":0.00010422594,"about_ca_topic_score_gemma":0.00019459001,"teacher_disagreement_score":0.006387138,"about_ca_system_score_codex":0.00003769611,"about_ca_system_score_gemma":0.00027865867,"threshold_uncertainty_score":0.29874876},"labels":[],"label_agreement":null},{"id":"W2741360647","doi":"10.1158/1538-7445.am2017-1643","title":"Abstract 1643: Cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; CD8; Hazard ratio; Proportional hazards model; Oncology; Internal medicine; Immune system; Multivariate analysis; Lymphocyte; Cytotoxic T cell; CD3; Cancer; Urology; Immunology; Confidence interval; Biology","score_opus":0.04157411918238067,"score_gpt":0.3824690089953049,"score_spread":0.3408948898129242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741360647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893651,0.0029798797,3.0638026e-7,0.0005661731,0.00018082505,0.0013915836,0.00004359722,0.000022220514,0.005450327],"genre_scores_gemma":[0.9961488,0.0009287707,0.000022518732,0.00014785884,0.00019236183,0.00094963424,0.000014156562,0.00005003125,0.0015458602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763286,0.00008477886,0.0002639586,0.0005207414,0.0008076924,0.0006899488],"domain_scores_gemma":[0.99862427,0.00009248642,0.00006296427,0.0007049203,0.00019542618,0.0003199508],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041633696,0.00021214937,0.0003464891,0.0002146295,0.00028972412,0.00015261983,0.00025626656,0.00015990391,0.0010550618],"category_scores_gemma":[0.00032329955,0.00017087064,0.00006624073,0.00013698768,0.0005165048,0.00020294837,0.00021416975,0.00051990274,0.00016255207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004784353,0.00032216698,0.9659638,0.00026651102,0.00010422179,0.00046220556,0.0002770598,1.5916656e-7,0.0016239926,0.0000071575037,0.00038753377,0.025800852],"study_design_scores_gemma":[0.009128906,0.0005468897,0.98353064,0.0008189849,0.000033119264,0.000011906161,0.0000312282,0.000005365921,0.0026897371,0.000094013005,0.0029534807,0.00015573192],"about_ca_topic_score_codex":0.0031020243,"about_ca_topic_score_gemma":0.00023854479,"teacher_disagreement_score":0.02564512,"about_ca_system_score_codex":0.00066433527,"about_ca_system_score_gemma":0.0007812341,"threshold_uncertainty_score":0.9998581},"labels":[],"label_agreement":null},{"id":"W2743268041","doi":"10.1136/bmjopen-2017-016538","title":"Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada","year":2017,"lang":"en","type":"article","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; University of New Brunswick; University of Toronto; Toronto Metropolitan University; Public Health Ontario; Simon Fraser University; Occupational Cancer Research Centre","funders":"Canadian Cancer Society Research Institute; Health Canada; Workplace Safety and Insurance Board; Nordic Cancer Union","keywords":"Medicine; Incidence (geometry); Bladder cancer; Epidemiology; Demography; Cancer incidence; Variation (astronomy); Population; Environmental health; Cancer; Pathology; Internal medicine","score_opus":0.07089574576196259,"score_gpt":0.44622765481403204,"score_spread":0.3753319090520695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743268041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964256,0.00010114377,0.000019282445,0.0004995997,0.00008944802,0.0017593087,0.00031248023,0.0000014911027,0.0007916015],"genre_scores_gemma":[0.9992341,0.000015047061,0.000274304,0.0000947377,0.00003266889,0.00018045977,0.00007605907,0.000004919433,0.0000877021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991921,0.000033011693,0.00028201294,0.00014743775,0.00027899892,0.00006640102],"domain_scores_gemma":[0.9991708,0.00008560731,0.0003510646,0.00024147873,0.0001147547,0.000036298214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010913166,0.00006740402,0.00033010877,0.000026794578,0.00006678482,0.000022463326,0.00011522477,0.000029435498,0.00024081624],"category_scores_gemma":[0.00011312969,0.000060141392,0.000011647981,0.000028626853,0.000052293446,0.00018168624,0.0000928218,0.000039424594,4.6402178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006675373,0.000042166223,0.99675137,0.000030121195,0.00009596369,0.000004694534,0.00092224806,0.00003692244,0.00009540422,0.00006436016,0.0009386915,0.00035052467],"study_design_scores_gemma":[0.0017182989,0.000052783053,0.996324,0.00021690049,0.00007380106,8.92528e-7,0.0001463242,0.00037376932,0.0007947462,0.00018291725,0.000061359286,0.000054198095],"about_ca_topic_score_codex":0.98998773,"about_ca_topic_score_gemma":0.9483519,"teacher_disagreement_score":0.04163581,"about_ca_system_score_codex":0.00010539244,"about_ca_system_score_gemma":0.0009531557,"threshold_uncertainty_score":0.2636769},"labels":[],"label_agreement":null},{"id":"W2743914984","doi":"10.5489/cuaj.4841","title":"New research in bladder cancer, ASCO 2017","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Oncology; Medicine; Internal medicine; Urology; Cancer","score_opus":0.09457065522490647,"score_gpt":0.3842271562613953,"score_spread":0.2896565010364888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743914984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5478374,0.002771635,0.000022995253,0.3278167,0.00175686,0.0006180215,0.000077545796,0.000028288303,0.11907057],"genre_scores_gemma":[0.9875127,0.0007093652,0.0001132247,0.001905242,0.0014704638,0.000013775402,0.000004046457,0.00001209006,0.008259056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982652,0.0001331407,0.00022552766,0.00020358573,0.0005004916,0.0006720269],"domain_scores_gemma":[0.99823403,0.00007316549,0.00016542146,0.00023778873,0.00024646966,0.0010431168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009374049,0.00010649908,0.00023572493,0.00024246685,0.0008614732,0.00024083669,0.00026249202,0.000250348,0.0014754013],"category_scores_gemma":[0.0006382571,0.000085747975,0.00008720251,0.00010669949,0.000049808168,0.0001504548,0.00002498984,0.0009946241,0.00014817662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006336553,0.000029224699,0.8848883,0.0000017834279,0.00008395176,0.00034001164,0.00007561127,0.0000038634785,0.000026407006,0.00011482647,0.09695589,0.017416753],"study_design_scores_gemma":[0.0017261154,0.00018888271,0.855997,0.00002561963,0.000028992223,0.00007164322,0.00002427615,0.000013234419,0.000020265508,0.0020506594,0.13977925,0.00007405683],"about_ca_topic_score_codex":0.08618999,"about_ca_topic_score_gemma":0.036293622,"teacher_disagreement_score":0.43967533,"about_ca_system_score_codex":0.0021291545,"about_ca_system_score_gemma":0.002602649,"threshold_uncertainty_score":0.9994374},"labels":[],"label_agreement":null},{"id":"W2744262013","doi":"10.5489/cuaj.4800","title":"Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urothelial cancer; Urology; Oncology; Cancer; Internal medicine","score_opus":0.036521393807544766,"score_gpt":0.29817358423110185,"score_spread":0.2616521904235571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744262013","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44754803,0.0005318487,0.0058914307,0.54025835,0.0013226523,0.0021296057,0.00043888684,0.000042720698,0.001836491],"genre_scores_gemma":[0.98228055,0.000055908735,0.00050185056,0.014892028,0.0008952125,0.0001639224,0.000012546615,0.000020473706,0.0011775021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984866,0.000075608994,0.00024696375,0.00025787717,0.00035354515,0.0005794531],"domain_scores_gemma":[0.99809545,0.00011746867,0.0003462255,0.00025603487,0.00034802133,0.0008367865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034137483,0.00020392287,0.00042553167,0.00007627193,0.001228142,0.00020271787,0.0002014481,0.00011615707,0.0005931681],"category_scores_gemma":[0.0003381001,0.000107091546,0.00016032306,0.00006954445,0.000085297994,0.0000814727,0.000014994156,0.0002951983,0.000033891283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038058672,0.00050200854,0.69903874,0.00002473632,0.0065720053,0.0012942172,0.0017810586,0.0007547261,0.00009441625,0.00043946056,0.112698205,0.17299454],"study_design_scores_gemma":[0.0077942163,0.0038777594,0.6063458,0.00005468243,0.0014519581,0.00056526775,0.0002057459,0.0003828332,0.00015153085,0.00031469707,0.3785887,0.00026682977],"about_ca_topic_score_codex":0.02099331,"about_ca_topic_score_gemma":0.03670612,"teacher_disagreement_score":0.5347325,"about_ca_system_score_codex":0.002478935,"about_ca_system_score_gemma":0.0010286156,"threshold_uncertainty_score":0.98552597},"labels":[],"label_agreement":null},{"id":"W2744361458","doi":"10.5489/cuaj.4208","title":"Radical cystectomy in patients with disseminated disease: An assessment of perioperative outcomes using the National Surgical Quality Improvement Program database","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cystectomy; Perioperative; Medicine; Database; Quality (philosophy); Intensive care medicine; General surgery; Surgery; Internal medicine; Bladder cancer; Computer science; Cancer","score_opus":0.03153644113037155,"score_gpt":0.3851359157735604,"score_spread":0.3535994746431888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744361458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945019,0.00001723324,0.000013940835,0.004060331,0.000075913114,0.00067581516,0.0002797914,0.00000774873,0.00036736214],"genre_scores_gemma":[0.99890006,0.0000044946396,0.0003693098,0.0004253771,0.00008950051,0.000038104783,0.00010528288,0.0000088615625,0.000058983886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980267,0.00024965603,0.00037898915,0.00020806826,0.00082258205,0.00031395952],"domain_scores_gemma":[0.9983136,0.0000811593,0.00040084927,0.0001797027,0.00046872106,0.0005559889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007830892,0.00014553311,0.0003148635,0.000078517514,0.0004991037,0.00013050777,0.0001790507,0.000087490225,0.00016330743],"category_scores_gemma":[0.0004502756,0.000079843645,0.00008300635,0.0000801245,0.00012426084,0.00021544601,0.000024622412,0.0004055998,5.6575084e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002397318,0.0005848237,0.99712837,0.0000052190107,0.00013433126,0.000045223762,0.00006061388,0.000020049107,0.000013040322,0.00015064536,0.00001958082,0.0015983528],"study_design_scores_gemma":[0.0050554588,0.00075739366,0.9927083,0.00002604907,0.000081794584,0.0000063378134,0.000042961787,0.00043279768,0.000005347552,0.000024530513,0.0007636666,0.00009532825],"about_ca_topic_score_codex":0.001981933,"about_ca_topic_score_gemma":0.0011217477,"teacher_disagreement_score":0.004815727,"about_ca_system_score_codex":0.0014146473,"about_ca_system_score_gemma":0.0012553816,"threshold_uncertainty_score":0.38387525},"labels":[],"label_agreement":null},{"id":"W2744757402","doi":"10.1016/j.ijrobp.2017.05.036","title":"The “Dirty Harry” Approach","year":2017,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Prostate cancer; Radiation oncology; General surgery; Cancer; Urology; Surgery; Internal medicine","score_opus":0.034322614704619364,"score_gpt":0.34656565161997716,"score_spread":0.3122430369153578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744757402","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025140103,0.004937209,0.005600065,0.9344095,0.020787386,0.0009861992,0.0004835286,0.00008996609,0.030192155],"genre_scores_gemma":[0.1341093,0.0105344765,0.005602783,0.6400418,0.19314818,0.00018585114,0.0025478387,0.00036566542,0.013464095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754673,0.00028107167,0.00086193066,0.00034289344,0.00059346785,0.0003739007],"domain_scores_gemma":[0.9955201,0.00047120717,0.0023019523,0.0004941165,0.0010952686,0.0001173377],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000562066,0.00038136216,0.0008121691,0.00013619657,0.00030302556,0.00012425582,0.0011483395,0.00094554294,0.000067281675],"category_scores_gemma":[0.00035543562,0.000247992,0.00060863065,0.00006320473,0.00045018032,0.00021097624,0.00010280527,0.002419511,0.0000810886],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004301625,0.0002672053,0.015191658,0.000022046457,0.0030349286,0.00041961408,0.00017925476,0.00001535128,0.00007494125,0.00085512624,0.8367582,0.1427515],"study_design_scores_gemma":[0.0044168727,0.0008221204,0.002409715,0.00007429023,0.0005060668,0.0008859273,0.000017854592,0.00014365508,0.00015649144,0.0058662742,0.9844938,0.00020695223],"about_ca_topic_score_codex":0.000037519534,"about_ca_topic_score_gemma":0.0000018470978,"teacher_disagreement_score":0.29436767,"about_ca_system_score_codex":0.0011091596,"about_ca_system_score_gemma":0.0015986817,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W2747805206","doi":"10.1111/his.13280","title":"Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases","year":2017,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cytokeratin; Medicine; Immunophenotyping; Immunohistochemistry; Urothelial carcinoma; Pathology; Staining; Internal medicine; Gastroenterology; Cancer; Bladder cancer; Antigen","score_opus":0.06528634043461674,"score_gpt":0.35358770291146996,"score_spread":0.28830136247685323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747805206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498206,0.00031530156,0.000053208936,0.00011249025,0.0005245383,0.0006500639,0.00008888938,0.000026099406,0.003247347],"genre_scores_gemma":[0.998896,0.000017240176,0.0001842922,0.00011663224,0.00013508931,0.000050427774,0.000007930666,0.00002138392,0.0005709961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984991,0.00017278764,0.0005103395,0.0003692074,0.00019100668,0.0002575595],"domain_scores_gemma":[0.9982937,0.00007351693,0.00040424915,0.0009911181,0.0001441235,0.0000933163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031788705,0.00017649819,0.0007811442,0.000100542115,0.00016247183,0.0000046978366,0.0002233537,0.00015306327,0.00018354054],"category_scores_gemma":[0.00041914394,0.00013829638,0.00013750361,0.000048915434,0.00029338058,0.000041917643,0.00013240811,0.00016749668,0.000016931881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023910308,0.0056467596,0.9679698,0.00008292385,0.000017348624,0.012151939,0.0029023746,3.2674723e-7,0.007664159,0.00032326087,0.0001586087,0.0006914684],"study_design_scores_gemma":[0.008368166,0.008221182,0.97932136,0.000024200554,0.0003942087,0.0018230277,0.0004778999,0.0000062457716,0.0006088079,0.00006958149,0.0005825292,0.00010281935],"about_ca_topic_score_codex":0.0004839981,"about_ca_topic_score_gemma":0.00015324572,"teacher_disagreement_score":0.011351531,"about_ca_system_score_codex":0.000043747696,"about_ca_system_score_gemma":0.00016717962,"threshold_uncertainty_score":0.56395626},"labels":[],"label_agreement":null},{"id":"W2748271565","doi":"10.1016/j.clgc.2017.07.001","title":"Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Bladder cancer; Internal medicine; Proportional hazards model; Lymph node; Oncology; Tissue microarray; Cystectomy; Stage (stratigraphy); Cancer; Confidence interval; Cadherin; Biomarker; Survival analysis; Cell","score_opus":0.037392255950071576,"score_gpt":0.36233653435889096,"score_spread":0.3249442784088194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748271565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949428,0.001360225,0.0000015675511,0.00027546711,0.00039126616,0.0009240136,0.00007674423,0.000019920639,0.0020080372],"genre_scores_gemma":[0.9970656,0.0009792452,0.00025593114,0.00023582984,0.00047332648,0.00033005176,0.000014839459,0.000044129676,0.0006010228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829525,0.00006260214,0.0005265404,0.00046004582,0.00033981088,0.0003157551],"domain_scores_gemma":[0.9984176,0.00010927237,0.00037094846,0.0006771954,0.00021141759,0.0002135299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104763414,0.00022898792,0.0005708994,0.00006060528,0.000110021,0.000017609154,0.00024181863,0.00016836249,0.000503162],"category_scores_gemma":[0.0001624805,0.00016311741,0.00013075482,0.00007532642,0.00026807628,0.000163149,0.00013869694,0.000319437,0.000015544407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028339634,0.001210196,0.97089463,0.00008128222,0.00017746603,0.000050426348,0.00011685628,0.0000118468815,0.0004722942,0.0000010088569,0.00045893804,0.023691095],"study_design_scores_gemma":[0.008106521,0.001793857,0.9838522,0.0008419682,0.00020872275,0.0000011878702,0.00004816033,0.000007654277,0.0038636788,0.000045340963,0.0010487447,0.00018194209],"about_ca_topic_score_codex":0.00060804165,"about_ca_topic_score_gemma":0.000333376,"teacher_disagreement_score":0.023509152,"about_ca_system_score_codex":0.00010084936,"about_ca_system_score_gemma":0.0005694832,"threshold_uncertainty_score":0.6651735},"labels":[],"label_agreement":null},{"id":"W2749858941","doi":"10.1002/1878-0261.12132","title":"Rho<scp>GDI</scp>β promotes Sp1/<scp>MMP</scp>‐2 expression and bladder cancer invasion through perturbing miR‐200c‐targeted <scp>JNK</scp>2 protein translation","year":2017,"lang":"en","type":"article","venue":"Molecular Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; School of Medicine, New York University; National Institutes of Health; National Natural Science Foundation of China; York University; University of Alabama; University of Alabama at Birmingham","keywords":"Protein expression; Translation (biology); Matrix metalloproteinase; microRNA; Cell biology; Biology; Cancer research; Chemistry; Messenger RNA; Biochemistry; Gene","score_opus":0.03839770651844352,"score_gpt":0.3233139216660085,"score_spread":0.28491621514756493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749858941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673195,0.011365382,0.0015263637,0.0014528151,0.0005979549,0.0032870169,0.00006550109,0.0002063213,0.01417915],"genre_scores_gemma":[0.9865449,0.00078158046,0.006369345,0.0014590704,0.0005300967,0.00090587477,0.0001693234,0.00018502577,0.0030547767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960472,0.0003637451,0.0006639362,0.001219364,0.0006708514,0.0010349031],"domain_scores_gemma":[0.99728453,0.00036189068,0.0006487729,0.0010213429,0.00026090164,0.00042258415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035706066,0.00071589695,0.0010341451,0.00019586626,0.0007689986,0.00015377211,0.00039919658,0.0008713448,0.00006421418],"category_scores_gemma":[0.0011295795,0.0006132219,0.00027256474,0.00019734999,0.0003993918,0.00047734444,0.00020802203,0.00073443464,0.000057499536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008116728,0.00072971196,0.0068341168,0.00034402552,0.0004848752,0.0007575568,0.006449315,0.000014944761,0.96350455,0.00007948278,0.0051518506,0.015568422],"study_design_scores_gemma":[0.009834999,0.0024931417,0.014416011,0.00080188573,0.0007766185,0.00020143333,0.0010653447,0.00038648193,0.8761922,0.0014241853,0.09224928,0.00015841247],"about_ca_topic_score_codex":0.0009850771,"about_ca_topic_score_gemma":0.0002960795,"teacher_disagreement_score":0.08731233,"about_ca_system_score_codex":0.00043524196,"about_ca_system_score_gemma":0.0006944673,"threshold_uncertainty_score":0.99963194},"labels":[],"label_agreement":null},{"id":"W2752419800","doi":"10.1016/j.ejso.2017.08.013","title":"Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study","year":2017,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Prostate cancer; Retrospective cohort study; Medicine; Oncology; Urology; Bladder cancer; Cancer; Internal medicine","score_opus":0.03059918511564887,"score_gpt":0.34536279644787565,"score_spread":0.3147636113322268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752419800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875995,0.00030868116,0.000003048395,0.0013310738,0.000580388,0.00040348127,0.0001666631,0.000008369602,0.009598788],"genre_scores_gemma":[0.99811137,0.0006005411,0.00031510228,0.000053258605,0.0006883523,0.000005370471,0.000009887207,0.000022561073,0.00019353826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800307,0.00044782777,0.00070682296,0.00028308335,0.00039626658,0.00016290933],"domain_scores_gemma":[0.998146,0.00011639292,0.0009304247,0.0002526596,0.00029056869,0.0002639604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074148754,0.0001490405,0.0005517227,0.00007491186,0.00012646282,0.000029014402,0.00027600408,0.000042106396,0.00017141958],"category_scores_gemma":[0.00023689868,0.00010738188,0.00008761537,0.0000377106,0.00038169252,0.00021453424,0.00013078247,0.00033495433,0.000006551458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008935722,0.001325351,0.95401454,0.000007453272,0.00050380256,0.014045891,0.0023006853,0.0000024297929,0.0022829215,0.000011199176,0.00010901658,0.016460974],"study_design_scores_gemma":[0.020337876,0.008372855,0.9645184,0.00013380173,0.00025175163,0.0005571383,0.00021289432,0.000007670902,0.000401893,0.0000443875,0.005067772,0.0000935277],"about_ca_topic_score_codex":0.0003754059,"about_ca_topic_score_gemma":0.00012037853,"teacher_disagreement_score":0.016367445,"about_ca_system_score_codex":0.00038709884,"about_ca_system_score_gemma":0.00025513177,"threshold_uncertainty_score":0.4378906},"labels":[],"label_agreement":null},{"id":"W2754917529","doi":"10.1007/s00125-017-4430-0","title":"Bladder cancer in the EMPA-REG OUTCOME trial","year":2017,"lang":"en","type":"letter","venue":"Diabetologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"Novo Nordisk; Intarcia Therapeutics; Sanofi; AstraZeneca; Eli Lilly and Company","keywords":"EMPA; Empagliflozin; Human physiology; Medicine; Cancer; Diabetes mellitus; Internal medicine; Bladder cancer; Oncology; Type 2 diabetes; Endocrinology; Chemistry","score_opus":0.07815138698429328,"score_gpt":0.3762121577773796,"score_spread":0.29806077079308635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754917529","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060471635,0.0022348491,0.0000013800062,0.9090305,0.003411355,0.0028964002,0.0003631822,0.00009373344,0.02149699],"genre_scores_gemma":[0.13783365,0.00021147096,0.000022377726,0.8304983,0.010659812,0.0014188911,0.00036776147,0.00009994462,0.018887796],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976652,0.00017311264,0.0004506808,0.0005570863,0.0005117229,0.00064219325],"domain_scores_gemma":[0.9981892,0.00017923638,0.00026566203,0.0012557046,0.00005774358,0.000052430954],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026310718,0.00045862485,0.0010524725,0.00014766594,0.00013407711,0.00007574751,0.0006430537,0.0010125665,0.0009768186],"category_scores_gemma":[0.00015701132,0.00026134227,0.0003349462,0.00010113192,0.00020253452,0.00005888141,0.00006388155,0.0021187551,0.00020815927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011660489,0.000114254304,0.049187846,0.000101902,0.00033528756,0.0019234605,0.00019081237,2.0240347e-7,0.0000027994759,0.00000434562,0.9438675,0.003105537],"study_design_scores_gemma":[0.035459798,0.00060257927,0.05400746,0.00016745256,0.0009040922,0.000035429548,0.000029131312,0.0000018891672,0.00004128112,0.00017367974,0.9081655,0.0004116666],"about_ca_topic_score_codex":0.0008792759,"about_ca_topic_score_gemma":0.00014250138,"teacher_disagreement_score":0.07853218,"about_ca_system_score_codex":0.00018632098,"about_ca_system_score_gemma":0.00033058083,"threshold_uncertainty_score":0.9999839},"labels":[],"label_agreement":null},{"id":"W2754941761","doi":"10.1200/jco.2012.30.15_suppl.4522","title":"Time from prior chemotherapy (TFPC) as a prognostic factor in advanced urothelial carcinoma (UC) receiving second-line systemic therapy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Sunnybrook Health Science Centre; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Chemotherapy; Gemcitabine; Oncology; Proportional hazards model; Paclitaxel; Carboplatin; Performance status; Gastroenterology; Urology; Cisplatin","score_opus":0.08035251361175413,"score_gpt":0.4181253611300205,"score_spread":0.3377728475182664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754941761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047714,0.0043238453,0.00002593494,0.0014111309,0.0015986549,0.00079082325,0.000024835968,0.000021397022,0.0013262449],"genre_scores_gemma":[0.9906937,0.0009490065,0.0012831211,0.0029763784,0.0031667699,0.000022660257,0.0000056473546,0.000056249828,0.0008464927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960009,0.00053715735,0.0022665607,0.00027333846,0.0004023779,0.00051965826],"domain_scores_gemma":[0.99557185,0.0020392598,0.001330154,0.00027062415,0.00024264996,0.0005454768],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00146143,0.00027680115,0.0019196266,0.00015519514,0.00004020105,0.000010907721,0.00021253404,0.00049241376,0.0025351306],"category_scores_gemma":[0.001452922,0.00019230467,0.0004845722,0.00016129049,0.00010306961,0.00024120833,0.00003350273,0.0010151697,0.00016940503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012523146,0.0031333768,0.71840745,0.000040930765,0.0005357266,0.00031953544,0.0012187427,0.0000024610733,0.009038298,0.0000032664645,0.00026065807,0.2545164],"study_design_scores_gemma":[0.033837173,0.014970764,0.93077666,0.00045248918,0.00021033477,0.00063079136,0.00016134977,0.00003203141,0.0018706532,0.00010320764,0.016737457,0.00021709087],"about_ca_topic_score_codex":0.000071116905,"about_ca_topic_score_gemma":0.0000274857,"teacher_disagreement_score":0.25429928,"about_ca_system_score_codex":0.0003597464,"about_ca_system_score_gemma":0.0018216254,"threshold_uncertainty_score":0.99837667},"labels":[],"label_agreement":null},{"id":"W2755235721","doi":"10.1111/bju.14016","title":"Guideline of guidelines: asymptomatic microscopic haematuria","year":2017,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urine cytology; Guideline; Cystoscopy; Asymptomatic; Gynecology; Urinary system; General surgery; Surgery; Internal medicine; Pathology","score_opus":0.10089386358125596,"score_gpt":0.42360083952337774,"score_spread":0.3227069759421218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755235721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038361894,0.9969905,0.00011837143,0.0002791283,0.0011902099,0.00048738724,0.000110533954,0.000010409615,0.00077511463],"genre_scores_gemma":[0.000045949313,0.9938429,0.003690653,0.00043931286,0.0011744485,0.000010519256,0.00005026681,0.000073362135,0.0006726141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958045,0.00018703028,0.0030932792,0.0002537604,0.0003546596,0.00030680362],"domain_scores_gemma":[0.99493235,0.00010440037,0.0032639117,0.0005028689,0.0009975497,0.00019888888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069900963,0.0003536551,0.004238326,0.0002881446,0.00007150565,0.000036448084,0.00051585125,0.000506999,0.0003548804],"category_scores_gemma":[0.0009918889,0.00030412822,0.0011208402,0.000092980656,0.00019040011,0.00007714819,0.00008310489,0.00066919567,0.000029711911],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049445975,0.00016042164,0.000017761788,0.0064219343,0.0011555925,0.0026462532,0.000009836749,3.3604837e-7,0.0000025072072,0.000003059099,0.039946675,0.94958615],"study_design_scores_gemma":[0.0018944158,0.00090953923,0.000045891076,0.022479454,0.0053126393,0.08174387,0.0000031325112,0.00000115188,0.0000029415519,0.000091058224,0.88736564,0.0001502918],"about_ca_topic_score_codex":0.000096742566,"about_ca_topic_score_gemma":0.000018266493,"teacher_disagreement_score":0.9494359,"about_ca_system_score_codex":0.00008422213,"about_ca_system_score_gemma":0.0015904171,"threshold_uncertainty_score":0.9999411},"labels":[],"label_agreement":null},{"id":"W2755504204","doi":"10.1002/uog.17995","title":"OP31.07: Papillary bladder carcinoma of low‐malignant potential during pregnancy: 2D and 3D ultrasonography","year":2017,"lang":"en","type":"article","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Pregnancy; Dysuria; Radiology; Urinary system; Urology; Surgery; Internal medicine","score_opus":0.011359134099469289,"score_gpt":0.2467997177970511,"score_spread":0.2354405836975818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755504204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98307323,0.013949481,0.0000091683105,0.000112786176,0.00067508663,0.00046840915,0.00005371788,0.000015224548,0.0016429168],"genre_scores_gemma":[0.9849666,0.014370876,0.00025192133,0.00006240546,0.00005524306,0.000029744238,0.000016885799,0.000027148859,0.00021917261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985287,0.000046550176,0.0003795598,0.0004513164,0.00017861814,0.00041521294],"domain_scores_gemma":[0.99729854,0.0017483837,0.00021000099,0.00048517672,0.00008565778,0.00017222823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008411901,0.00023649397,0.0005221415,0.00027796603,0.0002633552,0.00005208188,0.00013799459,0.00024029054,0.00011140351],"category_scores_gemma":[0.0026875418,0.00021146362,0.000089271234,0.00013709323,0.00038394798,0.00013793627,0.00008158528,0.00020691926,0.000003512257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009308719,0.0003433847,0.9760699,0.0003561182,0.00018591477,0.00046671898,0.0006050339,0.0000028956106,0.007110216,0.00011283211,0.000029013101,0.014624885],"study_design_scores_gemma":[0.0051568844,0.00064984005,0.9889929,0.00017216042,0.00017613303,0.0002748809,0.0002132836,0.00002242277,0.0033488665,0.00024237786,0.00053318165,0.00021705097],"about_ca_topic_score_codex":0.00021434324,"about_ca_topic_score_gemma":0.000047096306,"teacher_disagreement_score":0.014407834,"about_ca_system_score_codex":0.00005224905,"about_ca_system_score_gemma":0.000089557776,"threshold_uncertainty_score":0.86232364},"labels":[],"label_agreement":null},{"id":"W2755607580","doi":"10.1016/s0140-6736(17)32365-6","title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Eli Lilly and Company","keywords":"Docetaxel; Ramucirumab; Medicine; Internal medicine; Placebo; Metastatic Urothelial Carcinoma; Hazard ratio; Clinical endpoint; Oncology; Population; Tolerability; Discontinuation; Chemotherapy; Surgery; Clinical trial; Adverse effect; Cancer; Confidence interval; Bladder cancer; Urothelial carcinoma; Pathology","score_opus":0.07605140914426525,"score_gpt":0.35002075506826796,"score_spread":0.2739693459240027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755607580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984304,0.00044105825,0.00022047597,0.0012048514,0.00073209585,0.011032146,0.00031031086,0.00008778066,0.0016672743],"genre_scores_gemma":[0.994113,0.00006248167,0.00065280916,0.00094726786,0.0008963336,0.0025789246,0.00009797296,0.00010767736,0.0005435035],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968193,0.00021310718,0.00062230026,0.00066935096,0.0008465716,0.0008293715],"domain_scores_gemma":[0.9970486,0.00030988207,0.00045410308,0.0017821066,0.00016706329,0.00023820763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005073559,0.00061879324,0.0016224892,0.00014594913,0.00034118802,0.00019075621,0.00066575635,0.0001299056,0.00048463402],"category_scores_gemma":[0.00014687053,0.00033651147,0.0002447048,0.00018843045,0.00032431877,0.00027961255,0.00006646494,0.000497334,0.00005790659],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98546576,0.0011204521,0.0040981346,0.00008549346,0.0005400388,0.00025594645,0.000692087,0.00012999565,0.000017016773,0.000010159098,0.00022290827,0.0073619857],"study_design_scores_gemma":[0.9801276,0.008470404,0.008130017,0.00021762135,0.00058562506,0.000007724169,0.00006315089,0.00040080157,0.00043514694,0.000023073373,0.0011117501,0.00042710133],"about_ca_topic_score_codex":0.00043524054,"about_ca_topic_score_gemma":0.00060641894,"teacher_disagreement_score":0.009809023,"about_ca_system_score_codex":0.00036489387,"about_ca_system_score_gemma":0.0011861892,"threshold_uncertainty_score":0.9999087},"labels":[],"label_agreement":null},{"id":"W2757114898","doi":"10.1016/j.radonc.2017.08.036","title":"Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Referral; Bladder cancer; Context (archaeology); Cystectomy; Radiation therapy; Logistic regression; Internal medicine; Oncology; Urology; Cancer; Family medicine; Gynecology","score_opus":0.048792064855450165,"score_gpt":0.35288533273049333,"score_spread":0.30409326787504315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757114898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828027,0.008332604,0.0013708575,0.0043763937,0.00042535778,0.0021601846,0.00016032242,0.00003442503,0.00033714485],"genre_scores_gemma":[0.97661674,0.012479158,0.0058640046,0.0035867332,0.00033204217,0.00043040936,0.000012342094,0.000078610174,0.00059996947],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985432,0.00009005054,0.00031763007,0.0005009435,0.00013081274,0.00041737294],"domain_scores_gemma":[0.9984699,0.0003310112,0.0002314763,0.00042596023,0.00013672293,0.00040491903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035452697,0.0002751318,0.0008138973,0.0001327473,0.00034110274,0.000049169936,0.00015731543,0.00020711575,0.00013078647],"category_scores_gemma":[0.00021407843,0.00023468041,0.00008821894,0.0000691972,0.00036625273,0.00013402147,0.000028685883,0.000117926334,3.072648e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008743045,0.0002836319,0.26796257,0.00043661654,0.0030707153,0.00006850442,0.008810517,0.00005833781,0.067762114,0.00007031626,0.004181846,0.6385518],"study_design_scores_gemma":[0.043264642,0.017571552,0.7891305,0.00036046136,0.00077785604,0.00019565718,0.0007367667,0.0015269014,0.02277819,0.000142998,0.12253396,0.0009804765],"about_ca_topic_score_codex":0.0054792264,"about_ca_topic_score_gemma":0.006827809,"teacher_disagreement_score":0.63757133,"about_ca_system_score_codex":0.00032588915,"about_ca_system_score_gemma":0.00072204345,"threshold_uncertainty_score":0.95699894},"labels":[],"label_agreement":null},{"id":"W2757224339","doi":"10.1016/j.clon.2017.09.001","title":"Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers","year":2017,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Radiation therapy; Bladder cancer; Context (archaeology); Cystectomy; Referral; Radiation oncologist; Family medicine; Cancer; Internal medicine","score_opus":0.17391850847057883,"score_gpt":0.5528849097814145,"score_spread":0.37896640131083564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757224339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98430866,0.00060224015,0.00028549857,0.0088703055,0.0014553228,0.0029296705,0.000060312945,0.000048243084,0.0014397583],"genre_scores_gemma":[0.98938984,0.0008218348,0.001505671,0.0051412866,0.0010029247,0.00079388655,0.0000058820083,0.000053422387,0.0012852267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975053,0.00035111947,0.0007085907,0.0007688952,0.00020024122,0.00046583256],"domain_scores_gemma":[0.9964684,0.0015871441,0.00034881002,0.00063997664,0.00021315989,0.00074246153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013192765,0.00026352526,0.001093123,0.00008558625,0.00048640097,0.00006717889,0.00026470766,0.00022881573,0.00024657595],"category_scores_gemma":[0.002378245,0.00021941058,0.00022349494,0.00006220029,0.00044407623,0.00012626417,0.0001269465,0.00031117038,0.000016300584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0133102015,0.005424294,0.37696084,0.00023450982,0.012344899,0.00059005636,0.18501496,0.000015967256,0.0022669227,0.00029145018,0.03741667,0.36612922],"study_design_scores_gemma":[0.050855663,0.040739536,0.73910743,0.0001932176,0.0024908094,0.000023881978,0.08913694,0.00006707284,0.00048200935,0.000987803,0.07517005,0.00074559276],"about_ca_topic_score_codex":0.0011898433,"about_ca_topic_score_gemma":0.0021899429,"teacher_disagreement_score":0.36538363,"about_ca_system_score_codex":0.00028263178,"about_ca_system_score_gemma":0.0010424489,"threshold_uncertainty_score":0.8947304},"labels":[],"label_agreement":null},{"id":"W2758014718","doi":"10.1016/j.ijrobp.2017.06.277","title":"The Impact of MRE11 in Nuclear to Cytoplasmic Ratio on Outcomes in Muscle Invasive Bladder Cancer: an Analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Urology; Cancer; Internal medicine","score_opus":0.027479943088731456,"score_gpt":0.3862829928936971,"score_spread":0.35880304980496563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758014718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965233,0.0001279259,0.000056949662,0.0022525492,0.00038734116,0.00024790858,0.00014583612,0.0000045032243,0.00025364972],"genre_scores_gemma":[0.99827415,0.00093150174,0.00013868611,0.00035963368,0.00022615374,0.000011729906,0.000020110334,0.00001701525,0.000020998008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852175,0.0001656147,0.0007065097,0.00020281547,0.0002228111,0.0001804784],"domain_scores_gemma":[0.9977161,0.0004124028,0.0010749877,0.00026534477,0.0004186009,0.00011254044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004097601,0.00017465571,0.00071625435,0.00040636616,0.000080302605,0.000028776798,0.00038232104,0.0001411674,0.000052615986],"category_scores_gemma":[0.0004108302,0.000120239085,0.00025610547,0.00018762132,0.0001987615,0.00023569165,0.000057762813,0.0002760646,0.0000028233771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009962136,0.00053727307,0.95405495,0.0000036687115,0.0021590455,0.000019290694,0.0012785158,0.0035448829,0.0036246134,0.0010809804,0.00008067012,0.032619905],"study_design_scores_gemma":[0.005095658,0.0020927605,0.9875273,0.0000557116,0.00033865604,0.000009033373,0.00020757747,0.0020721827,0.0013083377,0.0010455059,0.00015141028,0.00009586986],"about_ca_topic_score_codex":0.0018786459,"about_ca_topic_score_gemma":0.0017514589,"teacher_disagreement_score":0.033472355,"about_ca_system_score_codex":0.0007083561,"about_ca_system_score_gemma":0.0005832379,"threshold_uncertainty_score":0.49032077},"labels":[],"label_agreement":null},{"id":"W2758067311","doi":"10.1016/j.ijrobp.2017.06.278","title":"Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Subtyping; Bladder cancer; Oncology; Cancer; Internal medicine","score_opus":0.11825263737359128,"score_gpt":0.4668102988902705,"score_spread":0.3485576615166792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758067311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96090937,0.00026892018,0.005738682,0.026804473,0.005144289,0.00048728552,0.00010158668,0.000027348213,0.00051802094],"genre_scores_gemma":[0.9840302,0.0009027229,0.0015978591,0.008355299,0.00487459,0.000041254083,0.00001401896,0.000033478802,0.0001505964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977342,0.00046916073,0.0008465154,0.00033664546,0.00034488365,0.0002685836],"domain_scores_gemma":[0.9959755,0.0007832058,0.001049346,0.00037837087,0.0014526282,0.00036095147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013823061,0.00022052489,0.0006349566,0.00014943519,0.00018774849,0.000073238625,0.0006339381,0.00025178868,0.00013519445],"category_scores_gemma":[0.0020915521,0.00018202652,0.000311646,0.000105263236,0.00015401928,0.00027008608,0.000102067635,0.00045548365,0.00006218775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010971296,0.00081455894,0.6508079,0.000004391519,0.0015854533,0.00010819503,0.00071045413,0.00016124615,0.0117209,0.00074522826,0.0033040582,0.3190663],"study_design_scores_gemma":[0.0109362295,0.0033269313,0.9104558,0.000120265446,0.00015668602,0.000056491266,0.00006533343,0.000058308964,0.005884191,0.0016613108,0.0670677,0.00021075315],"about_ca_topic_score_codex":0.0001391782,"about_ca_topic_score_gemma":0.000036869576,"teacher_disagreement_score":0.31885552,"about_ca_system_score_codex":0.00085699797,"about_ca_system_score_gemma":0.0023284545,"threshold_uncertainty_score":0.7422826},"labels":[],"label_agreement":null},{"id":"W2759289569","doi":"10.1097/rct.0000000000000664","title":"Diagnostic Accuracy of Qualitative and Quantitative Computed Tomography Analysis for Diagnosis of Pathological Grade and Stage in Upper Tract Urothelial Cell Carcinoma","year":2017,"lang":"en","type":"article","venue":"Journal of Computer Assisted Tomography","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Receiver operating characteristic; Radiology; Confidence interval; Hydronephrosis; Stage (stratigraphy); Carcinoma; Nuclear medicine; Institutional review board; Pathology; Surgery; Internal medicine; Urinary system","score_opus":0.06916519494009685,"score_gpt":0.36896192612428563,"score_spread":0.2997967311841888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759289569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884719,0.0024170075,0.007747131,0.00030760802,0.00012893642,0.0005859282,0.00030296884,0.000006095149,0.000032379834],"genre_scores_gemma":[0.976249,0.0003048412,0.02325235,0.000066454486,0.00006609915,0.00002707491,0.0000141335895,0.000017384555,0.0000026956313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782,0.00031491122,0.000968673,0.00030033314,0.00035841632,0.00023763839],"domain_scores_gemma":[0.99472356,0.0028865607,0.0014623443,0.0002964688,0.00043862802,0.00019241507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060201687,0.000272727,0.0013014565,0.0013125674,0.00010548924,0.00005338202,0.00020772754,0.00013066687,0.000009060355],"category_scores_gemma":[0.00026353868,0.00020588748,0.0007676035,0.00055580266,0.00044504664,0.00024057784,0.00006377474,0.00024813408,5.907429e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009035297,0.0015997526,0.9865373,0.00032778797,0.0012500233,0.00013604622,0.0055467165,0.000025170375,0.00033113873,0.000083006125,0.000041424988,0.003218133],"study_design_scores_gemma":[0.0070876074,0.00461298,0.9822475,0.00028108945,0.0018190617,0.0000394271,0.0007055664,0.00039548406,0.0023307162,0.0002654255,0.000042685788,0.00017249344],"about_ca_topic_score_codex":0.00013772288,"about_ca_topic_score_gemma":0.00002306933,"teacher_disagreement_score":0.015505218,"about_ca_system_score_codex":0.000019613906,"about_ca_system_score_gemma":0.0000766136,"threshold_uncertainty_score":0.83958477},"labels":[],"label_agreement":null},{"id":"W2760139092","doi":"10.1016/j.urolonc.2017.08.027","title":"Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Bladder cancer; Proportional hazards model; Internal medicine; Risk stratification; Disease; Cystectomy; Adjuvant; Lower risk; Oncology; Cancer; Urology; Confidence interval","score_opus":0.03197959785697537,"score_gpt":0.34013693470499823,"score_spread":0.3081573368480229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760139092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931034,0.0008702481,0.000067301145,0.004244347,0.00010075484,0.0009210247,0.00020459724,0.0000052289543,0.00048313785],"genre_scores_gemma":[0.9960651,0.00042335366,0.002887756,0.00019708028,0.000039139893,0.00020635649,0.000028187877,0.0000066345306,0.00014644017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931514,0.00006685498,0.00022309579,0.00017176676,0.000107525615,0.00011559953],"domain_scores_gemma":[0.99865544,0.00030796696,0.000541517,0.00027023815,0.00017161372,0.000053198615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015109823,0.000111504356,0.00032040034,0.000023860628,0.0005664759,0.000015791105,0.00010816022,0.000088949164,0.000014298975],"category_scores_gemma":[0.00021528389,0.000053717573,0.000037080074,0.00004983931,0.0023359628,0.00006965967,0.000031213316,0.00012297113,1.568463e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005154253,0.00014079183,0.98995876,0.000042024316,0.00015508136,2.5326614e-7,0.0012623791,0.000027920398,0.000072680064,0.0056302967,0.00044912143,0.0017452568],"study_design_scores_gemma":[0.0058228844,0.0024034947,0.95045334,0.00007460174,0.0018419826,0.000004668883,0.00083777204,0.00033683793,0.0040806197,0.011142944,0.022892544,0.00010831857],"about_ca_topic_score_codex":0.0009318807,"about_ca_topic_score_gemma":0.0012191128,"teacher_disagreement_score":0.03950544,"about_ca_system_score_codex":0.000024406305,"about_ca_system_score_gemma":0.00032943487,"threshold_uncertainty_score":0.86069524},"labels":[],"label_agreement":null},{"id":"W2760735711","doi":"10.1200/jco.2017.35.15_suppl.4501","title":"Planned survival analysis from KEYNOTE-045: Phase 3, open-label study of pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Pembrolizumab; Internal medicine; Clinical endpoint; Hazard ratio; Oncology; Phases of clinical research; Cancer; Chemotherapy; Clinical trial; Confidence interval","score_opus":0.34443439443311963,"score_gpt":0.5819199167132969,"score_spread":0.23748552228017727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760735711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900367,0.0006884651,0.000034732675,0.0020936318,0.003833294,0.0009914548,0.0002893133,0.000009736587,0.002022634],"genre_scores_gemma":[0.9951516,0.0017318112,0.0010921404,0.00035872284,0.0011551557,0.000046898018,0.000019676861,0.000039721723,0.0004042761],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993623,0.0009178586,0.003668051,0.0005738486,0.0007636878,0.00045352633],"domain_scores_gemma":[0.99108875,0.002301209,0.004446156,0.0009561379,0.0006396196,0.0005681464],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002185091,0.0003788852,0.004318529,0.0003714057,0.00015637602,0.00005651677,0.0011182277,0.0004216602,0.00093431515],"category_scores_gemma":[0.004596986,0.0002611266,0.00049629336,0.0003959486,0.00029465696,0.0004571893,0.00032071862,0.0011978539,0.000009798926],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6177699,0.047947653,0.15654655,0.000032225133,0.009929856,0.0018632612,0.00057771866,0.000059151458,0.00025551554,0.00001059269,0.00070989836,0.16429766],"study_design_scores_gemma":[0.52299225,0.14040512,0.31785125,0.0002506245,0.009088262,0.000017425547,0.0011084987,0.00025592576,0.00014046786,0.00008814413,0.007485949,0.00031608262],"about_ca_topic_score_codex":0.004901,"about_ca_topic_score_gemma":0.021465605,"teacher_disagreement_score":0.16398157,"about_ca_system_score_codex":0.0003732676,"about_ca_system_score_gemma":0.002896602,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2761102138","doi":"10.1093/annonc/mdx361.056","title":"Integrated molecular signatures of TERT promoter deregulation predict disease outcomes in non-muscle invasive bladder cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Telomerase; DNA methylation; Medicine; Epigenetics; Promoter; Sanger sequencing; Cancer research; Cancer; Methylation; Bisulfite sequencing; Oncology; Internal medicine; Gene expression; Gene; Biology; Genetics; Mutation","score_opus":0.047165155117322596,"score_gpt":0.3831475053201856,"score_spread":0.335982350202863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761102138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911815,0.0004120098,0.000023451305,0.0057716314,0.00012820569,0.00060521974,0.000102476864,0.000008375579,0.0017671322],"genre_scores_gemma":[0.99848086,0.00013970751,0.00014326238,0.00083762646,0.00003580097,0.00008861971,0.000030033347,0.000016508691,0.00022760536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908966,0.000048446014,0.00029764092,0.00020889887,0.0001680956,0.00018723738],"domain_scores_gemma":[0.998984,0.000043964345,0.00025352123,0.00037376984,0.0002366461,0.000108113134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009550421,0.00014000513,0.0004667051,0.000116943556,0.000033807184,0.000005969429,0.0001399396,0.00013713092,0.00014430947],"category_scores_gemma":[0.00017312753,0.000104700695,0.00011527688,0.000054056665,0.00016802475,0.00009741616,0.00004802778,0.00011824797,0.0000021492808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017491693,0.001998403,0.8584025,0.00030588327,0.0009941919,0.0004073471,0.0010112552,0.000088281464,0.052306857,0.00006226602,0.0018236744,0.08085021],"study_design_scores_gemma":[0.0026031726,0.0011910293,0.9490027,0.00022097719,0.00016287684,0.0000014510247,0.00003773832,0.00008863932,0.04568709,0.00050621614,0.00041604345,0.00008209155],"about_ca_topic_score_codex":0.0013837924,"about_ca_topic_score_gemma":0.00056895346,"teacher_disagreement_score":0.09060021,"about_ca_system_score_codex":0.000043637123,"about_ca_system_score_gemma":0.0005545303,"threshold_uncertainty_score":0.42695707},"labels":[],"label_agreement":null},{"id":"W2761469494","doi":"10.1017/s0007114517002574","title":"Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case–control study","year":2017,"lang":"en","type":"article","venue":"British Journal Of Nutrition","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Institute of Nutrition, Metabolism and Diabetes; Alpro Foundation; Fondazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Canola Council of Canada; Danish Cancer Society Research Center; Canadian Nutrition Society; Saskatchewan Pulse Growers; Loblaw Companies Limited; Kræftens Bekæmpelse; Agriculture and Agri-Food Canada; Almond Board of California; Danone; Arizona State University; California Strawberry Commission; Peanut Institute; PepsiCo; Coca-Cola Foundation; Kellogg's; Abbott Laboratories; U.S. Department of Agriculture","keywords":"Medicine; Bladder cancer; Confounding; Logistic regression; Case-control study; Internal medicine; Cancer; Odds ratio; Gastroenterology","score_opus":0.01762929651913141,"score_gpt":0.28792334090820226,"score_spread":0.27029404438907084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761469494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867827,0.011310253,0.000028335278,0.00018286337,0.00009719704,0.00057009625,0.0009323565,0.0000054360203,0.000090743255],"genre_scores_gemma":[0.9949782,0.004570358,0.00013353185,0.000030310197,0.00022222177,0.000021101201,0.0000046642467,0.000018386349,0.000021228923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987148,0.00009173861,0.0004953499,0.00014272671,0.00040813212,0.00014725402],"domain_scores_gemma":[0.99786997,0.00006346046,0.0010848584,0.00017837984,0.00069009134,0.00011322778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026573264,0.00012350074,0.00058370834,0.000094287105,0.00019495738,0.000039480692,0.00008573182,0.00007883868,0.0000340677],"category_scores_gemma":[0.00012588932,0.00011733134,0.00011036642,0.000074339885,0.0001227319,0.00023953078,0.000016099148,0.00027109287,2.2404399e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020730502,0.003459248,0.9540936,0.00016604821,0.0029269056,0.004750134,0.00050308317,0.000023238807,0.0018033851,7.0312205e-7,0.0006300574,0.029570581],"study_design_scores_gemma":[0.02403132,0.00315896,0.95883197,0.0012368317,0.0027432893,0.008832887,0.00045150417,0.000059126854,0.0004230772,0.000103728635,0.000021368473,0.00010595182],"about_ca_topic_score_codex":0.014915077,"about_ca_topic_score_gemma":0.0040810993,"teacher_disagreement_score":0.029464629,"about_ca_system_score_codex":0.00015298516,"about_ca_system_score_gemma":0.00026341807,"threshold_uncertainty_score":0.9916447},"labels":[],"label_agreement":null},{"id":"W2762432377","doi":"10.1097/spv.0000000000000468","title":"A Novel Presentation of Bladder Mass: Self-palpation by a Patient With Cystocele","year":2017,"lang":"en","type":"article","venue":"Female Pelvic Medicine & Reconstructive Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute of Steel Construction","keywords":"Medicine; Palpation; Transitional cell carcinoma; Urinary retention; Presentation (obstetrics); Surgery; Urinary bladder; Case presentation; Urology; Bladder cancer; Cancer; Internal medicine","score_opus":0.026596125190704818,"score_gpt":0.2804461801287412,"score_spread":0.25385005493803636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762432377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783985,0.0005410558,0.0013220292,0.0006356107,0.000593249,0.0010198753,0.000102878745,0.000064691594,0.017322136],"genre_scores_gemma":[0.99687904,0.0000875725,0.0019965593,0.00013336456,0.00024911002,0.0001072895,0.00012500184,0.000041092902,0.0003809576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998073,0.000051127758,0.00054716005,0.00044728836,0.000578891,0.00030253278],"domain_scores_gemma":[0.99771607,0.00025583673,0.00077401486,0.00062701106,0.00042176264,0.0002052824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019954999,0.0002829931,0.0007423515,0.0002083657,0.0002056665,0.000017361577,0.000099142584,0.00010644592,0.00069035694],"category_scores_gemma":[0.00024446705,0.0002047427,0.00012502576,0.00014246946,0.00045628924,0.00026370154,0.000033783348,0.00016756727,0.0000150419255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017668245,0.0006302519,0.88643795,0.00034385468,0.0014261612,0.000096088275,0.0028935797,0.0000020930959,0.013090572,0.00004018259,0.00557535,0.08769712],"study_design_scores_gemma":[0.016783765,0.004282685,0.91225415,0.002942154,0.0025274067,0.0015264113,0.0065801935,0.00037104805,0.048793208,0.0002822097,0.0027586685,0.0008981103],"about_ca_topic_score_codex":0.000779422,"about_ca_topic_score_gemma":0.000044843695,"teacher_disagreement_score":0.086799,"about_ca_system_score_codex":0.00013638118,"about_ca_system_score_gemma":0.00035737132,"threshold_uncertainty_score":0.83491653},"labels":[],"label_agreement":null},{"id":"W2762476265","doi":"10.1093/annonc/mdx440.031","title":"Pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine for recurrent, advanced urothelial cancer (UC): Mature results from the phase 3 KEYNOTE-045 trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Urothelial cancer; Internal medicine; Pembrolizumab; Oncology; Phases of clinical research; Chemotherapy; Cancer","score_opus":0.21489378205266058,"score_gpt":0.49785635348724117,"score_spread":0.2829625714345806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762476265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88737214,0.004792958,0.00006783793,0.062852174,0.009241913,0.006173925,0.014367548,0.000113810165,0.015017682],"genre_scores_gemma":[0.9817182,0.004567153,0.0011388988,0.0029554714,0.0046662274,0.0009460703,0.00047004392,0.0000915625,0.0034464062],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751014,0.00015188947,0.00076454855,0.0006294859,0.00035375782,0.0005901599],"domain_scores_gemma":[0.9960148,0.0010969095,0.00090679486,0.0012770483,0.000470917,0.00023356419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041978154,0.00038207145,0.0010246368,0.000068113935,0.0004390136,0.000045945195,0.0005885609,0.00037123795,0.00044429058],"category_scores_gemma":[0.0022402443,0.00023733337,0.00038603376,0.00009517004,0.0003788805,0.00020287979,0.00011967036,0.0003837402,0.000020819733],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74650687,0.0011344462,0.000033286342,0.00003981355,0.0006774269,0.00004510228,0.0004810332,0.0000027510468,0.0010399064,0.00008697842,0.040029123,0.20992324],"study_design_scores_gemma":[0.4589138,0.039962042,0.0010666698,0.00018524409,0.0006456926,0.000008931523,0.000115643736,0.00003505867,0.005681448,0.00036998047,0.49278194,0.00023354506],"about_ca_topic_score_codex":0.0013102309,"about_ca_topic_score_gemma":0.0015120435,"teacher_disagreement_score":0.45275283,"about_ca_system_score_codex":0.00012379045,"about_ca_system_score_gemma":0.0012676133,"threshold_uncertainty_score":0.96781737},"labels":[],"label_agreement":null},{"id":"W2762830460","doi":"10.1093/annonc/mdx371.006","title":"Subgroup analyses from KEYNOTE-045: Pembrolizumab (pembro) versus individual investigator’s choice of chemotherapy (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (uc)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Internal medicine; Oncology; Pembrolizumab; Chemotherapy; Cancer","score_opus":0.30800080682063685,"score_gpt":0.5058922580437564,"score_spread":0.19789145122311952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762830460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850211,0.0036028342,0.000008524114,0.004944418,0.0008176439,0.000705336,0.000711382,0.00003307178,0.004155683],"genre_scores_gemma":[0.9905234,0.0052130185,0.0010832425,0.0020955415,0.00048294166,0.00013869876,0.00008241732,0.000060042647,0.00032070457],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973144,0.00018552972,0.0008668068,0.0005958263,0.00048272105,0.0005547025],"domain_scores_gemma":[0.9969284,0.00046130642,0.000979184,0.00094535586,0.0003309313,0.0003548412],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002675768,0.0004099388,0.0014317094,0.00029229405,0.00012148886,0.000023750845,0.0006057801,0.00036080924,0.00086621894],"category_scores_gemma":[0.001164397,0.00033555686,0.00026448595,0.0002568236,0.00062634016,0.00031233203,0.00013793635,0.00038089007,0.000011509806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15423723,0.005679232,0.2872222,0.0007352742,0.0058155567,0.00032662824,0.0051696775,0.00007525261,0.07901859,0.0002358432,0.014278184,0.44720632],"study_design_scores_gemma":[0.087836385,0.018074635,0.678865,0.00093650434,0.0010341397,0.000010506808,0.00042695226,0.00005339025,0.14555867,0.0005853489,0.06592539,0.00069305766],"about_ca_topic_score_codex":0.016378924,"about_ca_topic_score_gemma":0.0071393303,"teacher_disagreement_score":0.44651327,"about_ca_system_score_codex":0.00015728537,"about_ca_system_score_gemma":0.0016566165,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W2763670669","doi":"10.1016/j.cell.2017.09.007","title":"Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Cell","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2495,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Cancer Institute; Universidade Estadual de Campinas; Pró-Reitoria de Pesquisa, Universidade Federal do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Baylor College of Medicine; Leukemia and Lymphoma Society; U.S. Department of Defense; National Center for Advancing Translational Sciences; National Human Genome Research Institute; Michael and Susan Dell Foundation; AstraZeneca; Fundo de Apoio ao Ensino, à Pesquisa e Extensão, Universidade Estadual de Campinas; Mary K. Chapman Foundation; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Biology; Bladder cancer; Cancer; Computational biology; Cancer research; Genetics","score_opus":0.025392575698639737,"score_gpt":0.2933327346288253,"score_spread":0.2679401589301856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763670669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903495,0.00027576732,0.00007927593,0.00036912144,0.00022244254,0.000279787,0.00005192422,0.000014373592,0.009672344],"genre_scores_gemma":[0.9974199,0.0003545213,0.00007265241,0.00046682387,0.000097667325,0.000025289788,0.00004012142,0.000018715804,0.0015043267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994829,0.000010589534,0.00011289711,0.0001527526,0.00012490833,0.000115902425],"domain_scores_gemma":[0.9992646,0.000008058806,0.00013589872,0.00038402187,0.00014170026,0.000065745764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000011605764,0.00009580702,0.00018900353,0.000027935946,0.00007207357,0.000012784308,0.0000824713,0.00005079001,0.0003146472],"category_scores_gemma":[0.0000084218345,0.000082933926,0.00006654947,0.000023065311,0.000068581074,0.00005759663,0.00003122342,0.00005312413,0.000030790194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048074995,0.00009720843,0.0053833937,0.00012500145,0.00007417178,0.000037296595,0.00024256582,0.0000010764242,0.99095446,0.000010003041,0.00008993779,0.0029368121],"study_design_scores_gemma":[0.00136883,0.0001123471,0.25421605,0.00006779114,0.00013978386,0.0000019773208,0.000021217375,0.000010406091,0.7400888,0.000021685297,0.0038843344,0.000066746456],"about_ca_topic_score_codex":0.00019395657,"about_ca_topic_score_gemma":0.0000057969964,"teacher_disagreement_score":0.25086564,"about_ca_system_score_codex":0.000026554462,"about_ca_system_score_gemma":0.000107848304,"threshold_uncertainty_score":0.3445166},"labels":[],"label_agreement":null},{"id":"W2764336049","doi":"10.1093/annonc/mdx371.073","title":"Pembrolizumab ± chemotherapy versus chemotherapy in advanced urothelial cancer: Phase 3 KEYNOTE-361 trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Medicine; Urothelial cancer; Pembrolizumab; Chemotherapy; Oncology; Internal medicine; Cancer; Bladder cancer; Immunotherapy","score_opus":0.1276922113237782,"score_gpt":0.48509128756598274,"score_spread":0.35739907624220457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764336049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96289945,0.00074256764,0.000011128948,0.015059781,0.001398111,0.0012702998,0.000067758294,0.000035353572,0.018515553],"genre_scores_gemma":[0.9900708,0.005254593,0.00018588614,0.0025472965,0.00083226245,0.00022378021,0.000013783694,0.000052204603,0.00081936095],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982842,0.00006746983,0.0004882931,0.0004191282,0.00026424276,0.00047665252],"domain_scores_gemma":[0.9984403,0.00009638669,0.0004158519,0.00071805133,0.00016010703,0.00016929845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000227657,0.00027071388,0.0009171599,0.00014066219,0.0001232906,0.000017606319,0.00032391315,0.00026411706,0.00080097007],"category_scores_gemma":[0.00012949639,0.00024069357,0.00023969129,0.00008978736,0.00026606742,0.00015249505,0.00003641984,0.00024328702,0.00002070614],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4855563,0.0020438405,0.0010864905,0.000031474105,0.00028817277,0.00007752377,0.00055833993,0.0000032980481,0.004165958,0.00007104731,0.001519485,0.5045981],"study_design_scores_gemma":[0.74465567,0.033649452,0.008754181,0.00010011738,0.000096612275,0.00001303653,0.00007607758,0.000038327016,0.05032915,0.00033327896,0.16168158,0.00027252725],"about_ca_topic_score_codex":0.0010594015,"about_ca_topic_score_gemma":0.00034917932,"teacher_disagreement_score":0.50432557,"about_ca_system_score_codex":0.00015679783,"about_ca_system_score_gemma":0.0009047786,"threshold_uncertainty_score":0.9815199},"labels":[],"label_agreement":null},{"id":"W2765116280","doi":"10.7150/jca.21130","title":"Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Proportional hazards model; Hazard ratio; Urology; Urinary diversion; Multivariate analysis; Internal medicine; Urinary system; Retrospective cohort study; Survival analysis; Overall survival; Urinary bladder; Oncology; Cancer; Surgery; Gastroenterology; Confidence interval","score_opus":0.04025208936441399,"score_gpt":0.3603451311186854,"score_spread":0.3200930417542714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765116280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874795,0.0036965285,0.000013876915,0.0022805503,0.001610089,0.0002555692,0.000015666285,0.000010117496,0.004638092],"genre_scores_gemma":[0.99680334,0.0010920876,0.00010165023,0.0006070707,0.00043554563,0.000017989481,0.0000013031818,0.000034110784,0.00090688874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982423,0.000037790593,0.00069211295,0.0001770953,0.00054405566,0.00030661104],"domain_scores_gemma":[0.9985971,0.00003866039,0.00065099465,0.0002694107,0.00022081651,0.00022302919],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000178615,0.00018757899,0.0005416957,0.00017066789,0.00013271344,0.00004928293,0.00021727092,0.00013538808,0.00092275924],"category_scores_gemma":[0.00012841662,0.0001374439,0.0002060517,0.000084347295,0.00009571961,0.00026979542,0.00004275473,0.000456796,0.000011873204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044798196,0.00024619716,0.98731166,0.00006670807,0.00048553746,0.00017543302,0.00031295425,0.00003907477,0.00015190318,0.000018590474,0.0011207953,0.0096231885],"study_design_scores_gemma":[0.015839241,0.0003649938,0.9769563,0.00047764217,0.00038794632,0.000043056603,0.0000402553,0.00003039448,0.00060366065,0.00018961375,0.0049158214,0.00015105441],"about_ca_topic_score_codex":0.0005296813,"about_ca_topic_score_gemma":0.000538117,"teacher_disagreement_score":0.015391259,"about_ca_system_score_codex":0.0006200104,"about_ca_system_score_gemma":0.000768722,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2765165203","doi":"10.5041/rmmj.10318","title":"Update on Screening for Urological Malignancies","year":2017,"lang":"en","type":"review","venue":"Rambam Maimonides Medical Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer screening; Prostate cancer; Intensive care medicine; Cancer screening; Cancer; Bioinformatics; Prostate-specific antigen; Internal medicine; Biology","score_opus":0.1769335618295667,"score_gpt":0.4338515096995366,"score_spread":0.2569179478699699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765165203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000074204577,0.9916,0.0019272725,0.0016263004,0.001215459,0.0011607644,0.00009054884,0.000072476556,0.002299794],"genre_scores_gemma":[0.00007625201,0.99022084,0.0019002164,0.0019579781,0.0040321457,0.00018129023,0.000108636996,0.00011900812,0.0014036092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958391,0.00019894911,0.0011077072,0.00058503967,0.0014168326,0.00085235713],"domain_scores_gemma":[0.99670625,0.00044519678,0.0007870397,0.0006286404,0.00015715098,0.0012757296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012607492,0.0007002761,0.0029922356,0.00026225488,0.00062421156,0.00022587193,0.00073280936,0.000987988,0.0013816005],"category_scores_gemma":[0.0017392004,0.00041534044,0.0017638057,0.00009173756,0.00031706574,0.00009232737,0.00012638906,0.0020164168,0.00019692442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002672407,0.00019813288,0.00003749959,0.0023811415,0.00083610136,0.0017128122,0.000007883129,1.3092256e-7,8.595873e-8,0.00018864691,0.015629308,0.978741],"study_design_scores_gemma":[0.0016774631,0.0013627243,0.00012929198,0.02717185,0.002724041,0.006522914,0.0000072710413,0.000010023173,0.0000012095694,0.0003233982,0.95972496,0.00034484043],"about_ca_topic_score_codex":0.000004633733,"about_ca_topic_score_gemma":0.0000019496974,"teacher_disagreement_score":0.9783962,"about_ca_system_score_codex":0.00021220186,"about_ca_system_score_gemma":0.0016786848,"threshold_uncertainty_score":0.9998298},"labels":[],"label_agreement":null},{"id":"W2765268081","doi":"10.1016/j.euf.2017.09.002","title":"Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non–muscle-invasive Bladder Cancer: Results of a European Survey","year":2017,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Ipsen Biopharmaceuticals","keywords":"Medicine; Bladder cancer; Urology; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.04660626549336423,"score_gpt":0.34059892065256947,"score_spread":0.29399265515920525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765268081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74648213,0.0019432511,0.000084912775,0.009517028,0.00024089128,0.0008578302,0.0005056973,0.000025096873,0.24034314],"genre_scores_gemma":[0.9961115,0.0022754471,0.00034657272,0.00048805788,0.00022438697,0.000006053013,0.000051286417,0.000059276812,0.00043741113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468255,0.0031231856,0.0010533916,0.00048203094,0.00033744227,0.00032138932],"domain_scores_gemma":[0.99621856,0.00069482636,0.0015931845,0.0009962104,0.00042307208,0.00007414941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005095032,0.00024731384,0.00056949904,0.00012806046,0.00011554997,0.000017829434,0.00053740945,0.00005897287,0.00001132434],"category_scores_gemma":[0.0018655213,0.00018453253,0.00010026922,0.00014197022,0.00028341694,0.00012464321,0.00033834256,0.00028010402,0.00001809702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003958839,0.00091381295,0.8320929,0.0002894408,0.0032601221,0.0014841842,0.006858266,0.000035795096,0.0012468358,0.00021281507,0.005040385,0.14460659],"study_design_scores_gemma":[0.005894436,0.0012911927,0.9840159,0.00008402501,0.0010449644,0.000016389207,0.00018922375,0.0000041211565,0.00016394936,0.00003867665,0.0071311113,0.00012604073],"about_ca_topic_score_codex":0.0016683528,"about_ca_topic_score_gemma":0.0005207893,"teacher_disagreement_score":0.24962935,"about_ca_system_score_codex":0.00003027824,"about_ca_system_score_gemma":0.00006211949,"threshold_uncertainty_score":0.75250185},"labels":[],"label_agreement":null},{"id":"W2765862113","doi":"10.5489/cuaj.4471","title":"Preoperative nutritional factors and outcomes after radical cystectomy: A narrative review","year":2017,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research; Sanofi; AstraZeneca; Pfizer","keywords":"Cystectomy; Medicine; Context (archaeology); Intensive care medicine; Narrative review; Prospective cohort study; Adverse effect; Intervention (counseling); Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.049386793163222205,"score_gpt":0.34489763182231675,"score_spread":0.29551083865909455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765862113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000220754,0.9906236,0.0000013130102,0.0063021197,0.0002938403,0.0011707993,0.00053714623,0.00001622662,0.0008341815],"genre_scores_gemma":[0.0014242099,0.99302524,0.000045972916,0.0033864595,0.00046095552,0.00019088357,0.00016687065,0.000029300054,0.0012701275],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974831,0.00048391908,0.0006742416,0.00038904962,0.00047157743,0.0004981513],"domain_scores_gemma":[0.99745697,0.0002683763,0.0006665901,0.00019573227,0.0002652459,0.0011470662],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004488963,0.0004908836,0.0024103362,0.00020406031,0.00051905186,0.00016265298,0.00016710273,0.000637165,0.0013874348],"category_scores_gemma":[0.001275352,0.00028858098,0.00074221427,0.000105668674,0.0001089442,0.00013282594,0.000027697697,0.0013277059,0.00005067744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012661034,0.00039235948,0.6010923,0.013840111,0.008282083,0.0024733054,0.0009699969,3.6985476e-8,3.6694527e-8,0.00011450752,0.06590395,0.30680472],"study_design_scores_gemma":[0.00082163734,0.00024472811,0.05564607,0.008754949,0.0021187656,0.00064858247,0.000014914965,1.3467685e-7,2.009928e-8,0.000068009926,0.9314304,0.00025176315],"about_ca_topic_score_codex":0.00030546312,"about_ca_topic_score_gemma":0.0003677455,"teacher_disagreement_score":0.8655265,"about_ca_system_score_codex":0.0019621393,"about_ca_system_score_gemma":0.0025830867,"threshold_uncertainty_score":0.9999566},"labels":[],"label_agreement":null},{"id":"W2766065714","doi":"10.5489/cuaj.4403","title":"Partial cystectomy for urothelial carcinoma of the bladder: Practice patterns and outcomes in the general population","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Cancer Care Ontario","keywords":"Cystectomy; Medicine; Hazard ratio; Bladder cancer; Urology; Proportional hazards model; Confidence interval; Odds ratio; Dissection (medical); Internal medicine; Urothelial carcinoma; Cancer registry; Logistic regression; Lymph node; Oncology; Population; Cancer; Surgery","score_opus":0.021442687268444966,"score_gpt":0.2953038301635043,"score_spread":0.27386114289505936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766065714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472583,0.000040876006,0.000020434098,0.051503852,0.00027765086,0.00043360694,0.00008489256,0.000002273941,0.0003781014],"genre_scores_gemma":[0.99567735,0.0000138958685,0.0000590121,0.0037067267,0.0003819954,0.000024388999,0.000005209044,0.000006330553,0.00012511827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999006,0.00018052328,0.00023466689,0.00010898023,0.000242097,0.00022778226],"domain_scores_gemma":[0.9990631,0.0001781834,0.0003592521,0.0001664627,0.00011219611,0.00012080393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057383045,0.000086955464,0.00018942845,0.00004132197,0.00044734398,0.00009423423,0.00015648924,0.00011190607,0.000029452774],"category_scores_gemma":[0.0013548989,0.000045651923,0.00010468412,0.000030015397,0.000029224931,0.000110170804,0.000013389514,0.00024346072,7.8817544e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075282675,0.000034039753,0.9979165,0.0000030824312,0.00005839635,0.000011491641,0.0002053786,0.000003491809,0.000012303065,0.00017441095,0.0002495635,0.0012560168],"study_design_scores_gemma":[0.002118278,0.00021766439,0.99233246,0.0000060737952,0.00014083015,0.00008806271,0.00007675073,0.000078962265,0.000021275147,0.000344475,0.004528201,0.000046952344],"about_ca_topic_score_codex":0.014956407,"about_ca_topic_score_gemma":0.0060646916,"teacher_disagreement_score":0.04841901,"about_ca_system_score_codex":0.00023379829,"about_ca_system_score_gemma":0.00020166316,"threshold_uncertainty_score":0.9916031},"labels":[],"label_agreement":null},{"id":"W2766194852","doi":"10.1016/j.eururo.2017.10.003","title":"Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunotherapy; Urology; Internal medicine; Immunology; Immune system","score_opus":0.04937522301427826,"score_gpt":0.33522190961141674,"score_spread":0.28584668659713847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766194852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002654431,0.98839545,0.000044795717,0.0017585449,0.0005521345,0.005311879,0.0001247118,0.00020524542,0.0035807197],"genre_scores_gemma":[0.000060838032,0.9880681,0.00009271385,0.0067836684,0.0007047448,0.0003612576,0.000048147136,0.00032490326,0.003555641],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908825,0.0055374173,0.0015623479,0.0009657725,0.00039299997,0.00065895944],"domain_scores_gemma":[0.99641365,0.00069036626,0.0007447395,0.0016426423,0.00013808631,0.0003705084],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002074852,0.00085227535,0.004536403,0.00028326872,0.00012238506,0.000034721674,0.00061651063,0.0002622748,0.0005085128],"category_scores_gemma":[0.00130593,0.00056830625,0.0008056947,0.00048234142,0.00014691138,0.000033924203,0.00022821367,0.0008005882,0.004395811],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089421833,0.0002132552,0.000014824934,0.8923045,0.0021672486,0.002532539,0.00031282858,7.0829046e-8,0.000003265876,0.000008756403,0.012088509,0.089460015],"study_design_scores_gemma":[0.0006442742,0.0016671359,0.000033692886,0.3160846,0.004572955,0.0013761212,0.000009547931,6.1669596e-7,2.9836158e-7,0.000001952034,0.675308,0.0003008399],"about_ca_topic_score_codex":0.000009287724,"about_ca_topic_score_gemma":0.0000045299894,"teacher_disagreement_score":0.66321945,"about_ca_system_score_codex":0.0002524391,"about_ca_system_score_gemma":0.00035225274,"threshold_uncertainty_score":0.9996768},"labels":[],"label_agreement":null},{"id":"W2766319621","doi":"10.1016/j.jval.2017.08.137","title":"Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Carboplatin; Gemcitabine; Medicine; Regimen; Cisplatin; Internal medicine; Oncology; Chemotherapy; Cancer","score_opus":0.05453436083096245,"score_gpt":0.337921771874297,"score_spread":0.28338741104333454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766319621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920717,0.0012909875,0.00001923562,0.0044225506,0.00032022982,0.0012832468,0.00018244366,0.00001914896,0.0003904693],"genre_scores_gemma":[0.99611396,0.0019169038,0.00017511066,0.0012096424,0.000095288575,0.00011188722,0.000034821052,0.00003976043,0.00030265586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985123,0.00009758817,0.00032840142,0.00031123593,0.00035429854,0.0003961727],"domain_scores_gemma":[0.9991469,0.000045343804,0.00017606134,0.00043132974,0.000043118464,0.00015728694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024895385,0.00019052002,0.00045792255,0.00008112361,0.00013387312,0.000025621095,0.00013211677,0.000041435505,0.00012644922],"category_scores_gemma":[0.000031830124,0.00013695327,0.000038227387,0.000072701674,0.00005490208,0.00010728251,0.000019217985,0.00019256819,0.000008971164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020003961,0.0008857212,0.9857097,0.00012589138,0.00006225817,0.0000148447425,0.00046816727,0.00021048213,0.0000047445874,0.00003690603,0.00035033186,0.01013051],"study_design_scores_gemma":[0.025475947,0.0020401862,0.96690345,0.00043335493,0.000016445034,9.861233e-7,0.000011641216,0.00023832075,0.00007603441,0.0001713119,0.0044743284,0.00015797689],"about_ca_topic_score_codex":0.07608103,"about_ca_topic_score_gemma":0.0023250678,"teacher_disagreement_score":0.07375596,"about_ca_system_score_codex":0.00036036177,"about_ca_system_score_gemma":0.00048535797,"threshold_uncertainty_score":0.9300714},"labels":[],"label_agreement":null},{"id":"W2766530906","doi":"10.1016/j.urolonc.2017.06.034","title":"Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Cisplatin; Bladder cancer; Chemotherapy; Medicine; Oncology; Neoadjuvant therapy; Urology; Internal medicine; Cancer","score_opus":0.02364812231578766,"score_gpt":0.32528145425208527,"score_spread":0.3016333319362976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766530906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832873,0.0005327539,0.000026627202,0.014473124,0.00013236188,0.0004252184,0.000057423178,0.000027379303,0.0010378483],"genre_scores_gemma":[0.9852674,0.000564841,0.00740216,0.0059157168,0.00014980759,0.000279029,0.000015007942,0.000017465793,0.00038857508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989286,0.00004347964,0.0002215405,0.00039642822,0.00011408143,0.00029586742],"domain_scores_gemma":[0.9992102,0.00014154686,0.00014551799,0.00021663053,0.00004808969,0.00023803514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009414132,0.00021760669,0.00037679612,0.000103468104,0.00030732833,0.000037875485,0.00008389211,0.0002327171,0.00021354387],"category_scores_gemma":[0.00012989569,0.00017037704,0.00004212522,0.00006559342,0.00090953504,0.000106030944,0.000038043243,0.00028511506,0.000005911834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031590322,0.00016286314,0.9846978,0.00003523744,0.000056362504,0.00027618188,0.00056410214,0.000017086792,0.00034473973,0.00022443909,0.00033496736,0.012970325],"study_design_scores_gemma":[0.004514853,0.0023315079,0.91386193,0.00016743368,0.0002931495,0.00008221328,0.000089959656,0.0008581672,0.0007673235,0.0030558724,0.07377451,0.00020309923],"about_ca_topic_score_codex":0.0005723592,"about_ca_topic_score_gemma":0.002987183,"teacher_disagreement_score":0.073439546,"about_ca_system_score_codex":0.00011045999,"about_ca_system_score_gemma":0.00049439137,"threshold_uncertainty_score":0.69477737},"labels":[],"label_agreement":null},{"id":"W2767163758","doi":"10.1002/9780471420194.tnmc43.pub2","title":"Renal Pelvis and Ureter","year":2010,"lang":"en","type":"other","venue":"TNM Online","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Grading (engineering); Pathological; Lymph node metastasis; Distant metastasis; Renal pelvis; Medicine; Stage (stratigraphy); Ureter; Metastasis; Lymph node; Pathology; Cancer; Internal medicine; Biology; Surgery; Paleontology","score_opus":0.015653944782059385,"score_gpt":0.2983328130106838,"score_spread":0.2826788682286244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767163758","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095515774,0.0028710393,0.000015100429,0.0011085519,0.000442356,0.0005193012,0.00418978,0.00023846494,0.98966026],"genre_scores_gemma":[0.00037729158,0.00039285497,0.0030885045,0.00094274775,0.0020303589,0.0000128969095,0.0012526232,0.00030702038,0.9915957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937236,0.0000071705317,0.00010891853,0.00023312304,0.00013519445,0.00014321883],"domain_scores_gemma":[0.99953276,0.000008916018,0.000056531026,0.00026419095,0.000015333824,0.0001222517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000017734012,0.00019082363,0.00030492444,0.00009484394,0.000013535803,0.0000071091085,0.000040481158,0.00028192592,0.033276495],"category_scores_gemma":[0.00001368784,0.00013969639,0.000055146236,0.000038499034,0.000060692113,0.000007609626,0.00002504163,0.00029449994,0.0001398119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006732281,0.00015053572,0.00069191534,0.00008950603,0.0001884116,0.000084630316,0.00003552686,1.7264343e-9,0.00029890495,0.000009488181,0.9708944,0.02748935],"study_design_scores_gemma":[0.0014086007,0.00018950371,0.0021103239,0.00023064173,0.00024079056,0.00007387008,0.000003312693,0.0000024079197,0.000059291175,0.00002193624,0.9955328,0.00012651084],"about_ca_topic_score_codex":0.00019815267,"about_ca_topic_score_gemma":0.0003481269,"teacher_disagreement_score":0.03313668,"about_ca_system_score_codex":0.000012443441,"about_ca_system_score_gemma":0.00007105472,"threshold_uncertainty_score":0.9676072},"labels":[],"label_agreement":null},{"id":"W2767182382","doi":"10.1016/j.clgc.2017.10.012","title":"Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Internal medicine; Oncology; Bone metastasis; Retrospective cohort study; Proportional hazards model; Metastasis; Cancer; Urothelial carcinoma; Bladder cancer","score_opus":0.038967938103646564,"score_gpt":0.3499311026994399,"score_spread":0.3109631645957933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767182382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249035,0.00027097476,0.000001526965,0.001662378,0.0009321292,0.0014349753,0.00024463868,0.000022144417,0.0029408634],"genre_scores_gemma":[0.99586827,0.00008154255,0.000120615645,0.001206301,0.0019677458,0.0001586068,0.00006284245,0.00004996333,0.0004841306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761903,0.00020801228,0.000658372,0.00054443895,0.00059368345,0.00037644902],"domain_scores_gemma":[0.9982304,0.00016623717,0.00038956062,0.0008832326,0.000118877535,0.00021167581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021765496,0.00031063388,0.00061425386,0.00008582011,0.0003323985,0.000063552936,0.00017608973,0.000084545034,0.00039583212],"category_scores_gemma":[0.00020333086,0.00018384334,0.00023120188,0.00009928185,0.00020468472,0.00015131172,0.0000991603,0.00042198444,0.00010727961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009731598,0.0017342619,0.90414286,0.00002188298,0.00022508916,0.00038224328,0.00016836113,0.000018415403,0.0000028619959,0.00003247766,0.0010391001,0.08250084],"study_design_scores_gemma":[0.01094155,0.0060082413,0.9786664,0.00013748588,0.00048746876,0.00001327509,0.000031501913,0.000010065938,0.000073730895,0.00021841923,0.0031976146,0.00021422164],"about_ca_topic_score_codex":0.002626493,"about_ca_topic_score_gemma":0.0009973086,"teacher_disagreement_score":0.08228662,"about_ca_system_score_codex":0.00020440189,"about_ca_system_score_gemma":0.00036580666,"threshold_uncertainty_score":0.74969137},"labels":[],"label_agreement":null},{"id":"W2767198233","doi":"10.3233/blc-170120","title":"Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer","year":2017,"lang":"en","type":"erratum","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Germinal center; Bladder cancer; Pathology; Follicular dendritic cells; CD20; Immune system; Lymphatic system; Cystectomy; H&E stain; CD8; CD3; Cancer; Medicine; Immunohistochemistry; B cell; T cell; Antibody; Immunology; Internal medicine; Antigen-presenting cell","score_opus":0.021314949336668693,"score_gpt":0.3151798573109079,"score_spread":0.29386490797423925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767198233","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10071856,0.23017538,0.00008369793,0.021017764,0.12905996,0.018904993,0.03216504,0.001762653,0.46611196],"genre_scores_gemma":[0.08268669,0.018285176,0.00017727305,0.007033215,0.014863213,0.003126482,0.0010967089,0.00094685855,0.8717844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940887,0.0001524099,0.00086099625,0.0017592121,0.0015501207,0.0015885497],"domain_scores_gemma":[0.9966095,0.000050797753,0.0009303512,0.0015182704,0.00035819315,0.0005328492],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00020308878,0.0015218947,0.0020827372,0.0004952488,0.00038191827,0.00025735862,0.00078304455,0.0012987686,0.0069081616],"category_scores_gemma":[0.00006456855,0.0011680033,0.0004686647,0.0003026602,0.0003993191,0.00032719807,0.00021039421,0.0020382209,0.00008133996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017912284,0.00043111577,0.07843599,0.0008757117,0.004322048,0.0015688809,0.0010204894,0.000052890093,0.00040293767,0.000021867398,0.8986809,0.012395947],"study_design_scores_gemma":[0.015831837,0.0006193524,0.24199498,0.0037311523,0.0029360494,0.0001295451,0.00018544869,0.00006491246,0.0022932196,0.00018595379,0.7298714,0.0021561666],"about_ca_topic_score_codex":0.032959737,"about_ca_topic_score_gemma":0.030586502,"teacher_disagreement_score":0.40567243,"about_ca_system_score_codex":0.0021451665,"about_ca_system_score_gemma":0.0077351485,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W2767459057","doi":"10.1016/j.eururo.2017.09.030","title":"The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Metastasectomy; Lymphadenectomy; Bladder cancer; Metastasis; Lymph node; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.11183418547563065,"score_gpt":0.38515343788039763,"score_spread":0.27331925240476695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767459057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.006367e-7,0.9876082,5.421008e-7,0.00017183952,0.0002497459,0.0024455378,0.000045786168,0.000018397888,0.009459261],"genre_scores_gemma":[0.000063705265,0.997877,0.0000047986905,0.00042257333,0.00010456082,0.00041921833,0.000034162003,0.00009585897,0.0009781435],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557394,0.0020982476,0.0014021237,0.00036383444,0.00021431333,0.0003475674],"domain_scores_gemma":[0.9964618,0.0009048336,0.0012281465,0.0012471883,0.00006981718,0.00008822076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015584152,0.0003897043,0.0046114004,0.0001547984,0.00007866482,0.000014835859,0.00042860257,0.00006528918,0.00008642824],"category_scores_gemma":[0.0008894429,0.00020873909,0.00073747244,0.00016015724,0.00016358118,0.000024710587,0.00010261948,0.00038286287,0.0002289894],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014745465,0.000059145157,0.000027074926,0.6655391,0.0011363369,0.0002739384,0.00002417615,2.7538468e-8,4.6337384e-8,0.000028281165,0.00079466,0.33210248],"study_design_scores_gemma":[0.0001630161,0.00006804954,0.000021494787,0.26789254,0.010277055,0.00024551054,0.0000037156278,4.5490606e-7,1.03179616e-7,0.000012297107,0.7211997,0.00011606185],"about_ca_topic_score_codex":0.00007753432,"about_ca_topic_score_gemma":0.00003317216,"teacher_disagreement_score":0.72040504,"about_ca_system_score_codex":0.00006812026,"about_ca_system_score_gemma":0.00060209056,"threshold_uncertainty_score":0.8512133},"labels":[],"label_agreement":null},{"id":"W2767594459","doi":"10.1007/s00345-017-2116-3","title":"Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder","year":2017,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Cystectomy; Concordance; Lymph node; Stage (stratigraphy); Proportional hazards model; Bladder cancer; Internal medicine; Urology; Oncology; Metastasis; Cancer; Biology","score_opus":0.021250513705469178,"score_gpt":0.28783011935955244,"score_spread":0.2665796056540833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767594459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847326,0.011666243,0.00014329325,0.0023424397,0.0002870263,0.00017923175,0.000003807664,0.000002508652,0.00064279744],"genre_scores_gemma":[0.99731565,0.0020128323,0.00032728433,0.00012411174,0.000089197034,0.0000020531331,0.0000010349601,0.000010605405,0.0001172318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990834,0.00011239087,0.00038743016,0.00013041412,0.00015379922,0.00013259305],"domain_scores_gemma":[0.99887794,0.00015865499,0.0005215296,0.00020941778,0.00014095656,0.00009149406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003277146,0.000100270416,0.00047780623,0.00018773801,0.00009023885,0.000004383776,0.000079700745,0.00009041741,0.00008266903],"category_scores_gemma":[0.00026131893,0.00007565416,0.00009177606,0.00004146312,0.0003376836,0.00008212204,0.0000397839,0.00014849678,5.722994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01835734,0.0008712153,0.8056078,0.00058076036,0.0026887413,0.0013017472,0.0020430193,0.00003493906,0.102615185,0.0014959576,0.00090989895,0.06349342],"study_design_scores_gemma":[0.012689919,0.005970917,0.957224,0.00013769671,0.001865023,0.007928149,0.000026512414,0.00008764491,0.007390748,0.0016867091,0.004885653,0.00010699676],"about_ca_topic_score_codex":0.00012837882,"about_ca_topic_score_gemma":0.00016975483,"teacher_disagreement_score":0.15161626,"about_ca_system_score_codex":0.000035325324,"about_ca_system_score_gemma":0.00012358496,"threshold_uncertainty_score":0.30850872},"labels":[],"label_agreement":null},{"id":"W2767628662","doi":"10.2196/resprot.8761","title":"Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol","year":2017,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Council NSW; Australian and New Zealand Urogenital and Prostate Cancer Trials Group; University of Sydney; Cancer Australia","keywords":"Medicine; Context (archaeology); Bladder cancer; Clinical trial; External validity; Cancer; Internal medicine; Psychology","score_opus":0.4430780050955342,"score_gpt":0.5981087379218627,"score_spread":0.1550307328263285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767628662","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022155752,0.000004089555,0.000030134386,0.0003908501,0.000016158196,0.9686657,0.000025603296,0.000035536163,0.008676179],"genre_scores_gemma":[0.17207749,3.502226e-7,0.0002954723,0.000056188495,0.00018704543,0.82701874,0.0000053637355,0.000037833368,0.0003215098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962318,0.00017700663,0.0005586327,0.0005290084,0.001934787,0.0005687555],"domain_scores_gemma":[0.99418896,0.0003892945,0.0005280449,0.0011358091,0.003538109,0.00021977014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001687619,0.00020450538,0.00039065105,0.00046249013,0.000505506,0.00012658878,0.000351811,0.00017907708,0.00043107237],"category_scores_gemma":[0.0049439487,0.00016406029,0.0001278123,0.00059531356,0.00016327333,0.00024820986,0.0001511273,0.00036814585,0.00000935531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041527553,0.0018289338,0.55020267,0.0018517583,0.0003138356,0.000007916225,0.00040677848,0.000008629188,0.007366212,0.000015431297,0.008195412,0.4256497],"study_design_scores_gemma":[0.062246263,0.02396146,0.69849944,0.0118285855,0.00016819577,0.000028158689,0.0002369584,0.0015478743,0.1489411,0.0023189608,0.049628854,0.0005941384],"about_ca_topic_score_codex":0.00091751706,"about_ca_topic_score_gemma":0.00012280245,"teacher_disagreement_score":0.42505556,"about_ca_system_score_codex":0.00029334787,"about_ca_system_score_gemma":0.002282222,"threshold_uncertainty_score":0.66901845},"labels":[],"label_agreement":null},{"id":"W2767847180","doi":"10.1016/j.urolonc.2017.10.014","title":"Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"Cancer Research UK","keywords":"Medicine; Cystectomy; Bladder cancer; Regimen; Oncology; Immunotherapy; Radiation therapy; Internal medicine; Clinical trial; Cisplatin; Biomarker; Chemotherapy; Cancer","score_opus":0.09999600311254865,"score_gpt":0.40669450208148555,"score_spread":0.3066984989689369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767847180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017696223,0.9207619,0.0000052054615,0.072510146,0.0006210156,0.004469693,0.00032388492,0.000028463232,0.0011027752],"genre_scores_gemma":[0.000025079531,0.98408496,0.00056309026,0.0021858255,0.003359344,0.0056375144,0.000121997335,0.000037327907,0.0039848583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980179,0.00040516857,0.00043740374,0.0005664452,0.00016048251,0.0004126214],"domain_scores_gemma":[0.99655145,0.0018816573,0.0005565574,0.0007310756,0.00008514312,0.0001941323],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00041222872,0.0005432741,0.0014264081,0.00006221597,0.0016869353,0.000102756596,0.00034960048,0.00043845078,0.00004047464],"category_scores_gemma":[0.000087043976,0.00019348736,0.00040208318,0.000115137605,0.0026824758,0.0000553853,0.000106610925,0.0005314613,0.0000069491402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014557473,0.000112608366,0.0006521263,0.00059352303,0.0013152615,0.00004601161,0.00080369017,0.0000014390062,1.2938206e-7,0.003056129,0.03069272,0.9625808],"study_design_scores_gemma":[0.002400465,0.0015759742,0.00008674271,0.0005889262,0.010531984,0.0005025968,0.00025263673,0.000020509688,6.3247353e-7,0.0022691954,0.9815862,0.00018412422],"about_ca_topic_score_codex":0.0003431304,"about_ca_topic_score_gemma":0.00034985307,"teacher_disagreement_score":0.9623967,"about_ca_system_score_codex":0.00020164993,"about_ca_system_score_gemma":0.0015080465,"threshold_uncertainty_score":0.99961275},"labels":[],"label_agreement":null},{"id":"W2767891373","doi":"10.1016/j.prp.2017.11.003","title":"An update on the molecular pathology of urinary bladder tumors","year":2017,"lang":"en","type":"review","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Bladder cancer; Malignancy; Urinary bladder; Carcinoma; Medicine; Pathology; Cancer research; Urothelial carcinoma; Targeted therapy; Cancer; Oncology; Internal medicine","score_opus":0.2879797877352342,"score_gpt":0.5336723310171254,"score_spread":0.24569254328189122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767891373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005713163,0.97474194,0.000007925159,0.0029803128,0.00012972768,0.0014472778,0.0001301087,0.000018609448,0.019972773],"genre_scores_gemma":[0.0019631702,0.9959004,0.0002397372,0.0005654868,0.00019222178,0.0003197549,0.00010154003,0.00006436439,0.000653347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99350226,0.0042698053,0.00042748274,0.0007138955,0.0005059173,0.00058063533],"domain_scores_gemma":[0.9947429,0.002569248,0.0004032519,0.0016957531,0.00034142938,0.00024747412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00399639,0.0003498716,0.0013146083,0.00030256138,0.0003708699,0.000050035113,0.00048160373,0.00044345076,0.00022581317],"category_scores_gemma":[0.0034648932,0.00018612368,0.00018395964,0.00017438659,0.0011598814,0.00014889971,0.00023221523,0.0017911379,0.00017278473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017378385,0.0020759741,0.00003946695,0.004396603,0.000897482,0.040857654,0.00032697286,4.9510195e-8,0.00008919845,0.005524755,0.0013523354,0.9427017],"study_design_scores_gemma":[0.00060321525,0.00589173,0.000114178256,0.0014948959,0.0010054257,0.013301448,0.00014540233,6.107174e-7,0.000036071193,0.0007560485,0.97647583,0.00017512104],"about_ca_topic_score_codex":0.000044712484,"about_ca_topic_score_gemma":0.0000025822542,"teacher_disagreement_score":0.9751235,"about_ca_system_score_codex":0.000051295483,"about_ca_system_score_gemma":0.0007619845,"threshold_uncertainty_score":0.7781702},"labels":[],"label_agreement":null},{"id":"W2768672079","doi":"10.5489/cuaj.4759","title":"Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cohort; BCG vaccine; Immunology; Disease; Bacillus (shape); Vaccination; Pediatrics; Internal medicine; Microbiology; Biology","score_opus":0.036380617668161905,"score_gpt":0.27035428821348917,"score_spread":0.23397367054532725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768672079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820771,0.00004871085,0.000011283618,0.0141217,0.0005437607,0.00027832828,0.00005786975,0.000034974637,0.0028262276],"genre_scores_gemma":[0.9933823,0.000016558744,0.00015173218,0.002464257,0.00065646734,0.000019078114,0.00003487059,0.000029377636,0.0032453607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980625,0.00017375677,0.00033078244,0.00037817576,0.00044964402,0.0006051237],"domain_scores_gemma":[0.9975764,0.000036468155,0.00043394728,0.00044351426,0.00027214107,0.0012375235],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004855322,0.00023672284,0.0003920554,0.0001574985,0.0014841266,0.00023644521,0.00016571119,0.00037871636,0.0010987237],"category_scores_gemma":[0.0002979189,0.00017265056,0.0001198975,0.000093988594,0.000057461173,0.00036747067,0.00002757312,0.0007050576,0.00010348588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058061717,0.00013432604,0.9283636,0.000011041151,0.0005698098,0.054501887,0.0003073561,0.000011162888,0.0005635543,0.000027944901,0.0042486168,0.010680089],"study_design_scores_gemma":[0.0031518214,0.003452256,0.8677486,0.0000293238,0.00029278945,0.10926744,0.000074070595,0.000033938362,0.00015085349,0.00010047469,0.015410578,0.00028785662],"about_ca_topic_score_codex":0.007495793,"about_ca_topic_score_gemma":0.011927657,"teacher_disagreement_score":0.060615,"about_ca_system_score_codex":0.0025595215,"about_ca_system_score_gemma":0.00047355372,"threshold_uncertainty_score":0.9998158},"labels":[],"label_agreement":null},{"id":"W2769510106","doi":"10.1016/j.euf.2017.10.003","title":"Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Perioperative; Context (archaeology); Cochrane Library; Randomized controlled trial; Meta-analysis; Laparoscopy; Cuff; Laparoscopic surgery; Retrospective cohort study; Surgery; General surgery; Urology; Internal medicine","score_opus":0.17375326044058031,"score_gpt":0.4355560427640092,"score_spread":0.2618027823234289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769510106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026317075,0.9763107,0.000038706097,0.0009430567,0.0015521813,0.0099844765,0.00057888863,0.00009113816,0.0102377115],"genre_scores_gemma":[0.004357455,0.98915976,0.00084028783,0.0017413781,0.0011963344,0.00055643683,0.0005732149,0.00036162877,0.001213497],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98782706,0.006281509,0.0034088136,0.0011801725,0.00052580296,0.00077666],"domain_scores_gemma":[0.9913912,0.0014972973,0.0042609456,0.0019510655,0.00055743754,0.00034207868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040385514,0.0010637828,0.009021235,0.0002972043,0.00019527861,0.00006321214,0.0020558857,0.00058980804,0.00020020746],"category_scores_gemma":[0.005008595,0.00073235715,0.0017968211,0.00017843202,0.0003438662,0.00017954675,0.00052075955,0.00083875004,0.000115264535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00410937,0.0032036665,0.0040068324,0.7326299,0.012509886,0.0013977182,0.00033068334,7.20145e-7,0.000014770051,0.00034214486,0.018296024,0.22315829],"study_design_scores_gemma":[0.014124561,0.011035446,0.0020180375,0.034903076,0.041382022,0.00041675425,0.000007815444,0.0000029229884,0.000003827827,0.000023850796,0.8953335,0.0007481745],"about_ca_topic_score_codex":0.00006852037,"about_ca_topic_score_gemma":0.000018988332,"teacher_disagreement_score":0.87703747,"about_ca_system_score_codex":0.0002950903,"about_ca_system_score_gemma":0.0007893388,"threshold_uncertainty_score":0.99951273},"labels":[],"label_agreement":null},{"id":"W2769557137","doi":"10.1016/j.euf.2017.09.015","title":"Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lymphadenectomy; Urology; Dissection (medical); Renal pelvis; Bladder cancer; Lymph node; Stage (stratigraphy); Oncology; Cancer; Ureter; Surgery; Internal medicine","score_opus":0.0525707998709094,"score_gpt":0.3343407134926781,"score_spread":0.2817699136217687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769557137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012212072,0.98829544,0.00007216177,0.0012028198,0.0010398029,0.005085154,0.00107594,0.000053172505,0.0019542926],"genre_scores_gemma":[0.046801485,0.9481979,0.000026300691,0.00082630647,0.001788986,0.0005029451,0.00027737487,0.000306276,0.001272416],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99349564,0.0022579131,0.0022377423,0.0008798408,0.00051451,0.00061434216],"domain_scores_gemma":[0.99430984,0.00055934844,0.0032547757,0.0012327499,0.00048034388,0.00016294277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017360952,0.0008268545,0.0037316456,0.00022332983,0.00027728284,0.000028163713,0.0007374234,0.00035395147,0.00007417342],"category_scores_gemma":[0.0013336564,0.0005314036,0.0015780252,0.00015279527,0.00021647655,0.00006799811,0.00014110572,0.00059984555,0.000053225787],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012661763,0.0013485919,0.0008192296,0.8024435,0.008869182,0.00068513805,0.0004679846,0.000020514866,0.00042561814,0.000027357231,0.010667384,0.17295934],"study_design_scores_gemma":[0.025695853,0.006743951,0.021174548,0.29989368,0.1879544,0.0041362955,0.000055578726,0.000042988944,0.00022777198,0.000047626276,0.45108604,0.002941275],"about_ca_topic_score_codex":0.00013634023,"about_ca_topic_score_gemma":0.00001322236,"teacher_disagreement_score":0.5025498,"about_ca_system_score_codex":0.00029366103,"about_ca_system_score_gemma":0.0003819208,"threshold_uncertainty_score":0.9997138},"labels":[],"label_agreement":null},{"id":"W2771131151","doi":"10.1016/j.urolonc.2017.11.010","title":"Impact of age on outcomes of patients with non–muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Mitomycin C; Proportional hazards model; Bladder cancer; Cohort; Surgery; Pathological; Disease; Urology; Cancer; Internal medicine","score_opus":0.02377074411454563,"score_gpt":0.3297511915495603,"score_spread":0.3059804474350147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771131151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708796,0.00007043678,0.000004596291,0.00056495407,0.00003788339,0.0006083644,0.00025665032,0.00000820845,0.0013609234],"genre_scores_gemma":[0.99742335,0.00012468951,0.001995465,0.0001650135,0.000018785515,0.000053742664,0.000079210724,0.000013159479,0.0001265988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909854,0.00004672473,0.00027286203,0.00024044902,0.00017752514,0.00016388469],"domain_scores_gemma":[0.9986634,0.00013728948,0.00052845554,0.000272358,0.0002719668,0.00012652043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005684451,0.00020686301,0.0005926914,0.00012831249,0.00013409734,0.0000063332272,0.00008007274,0.00013235665,0.000048449732],"category_scores_gemma":[0.00008837835,0.00011661437,0.00006552215,0.00010643024,0.000944931,0.00010764878,0.000020367843,0.00013446576,8.299922e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011574362,0.0004893019,0.9947827,0.00002689299,0.0005946575,0.000028462955,0.0007666058,0.00013393362,0.0007714836,0.00007550743,0.000097209486,0.0010758205],"study_design_scores_gemma":[0.0047007604,0.017352602,0.9733261,0.00013408749,0.0006762199,0.0000048037614,0.00006730683,0.000023578983,0.0031952464,0.000072398376,0.00034358076,0.00010333051],"about_ca_topic_score_codex":0.001638036,"about_ca_topic_score_gemma":0.00039399692,"teacher_disagreement_score":0.021456603,"about_ca_system_score_codex":0.00009618295,"about_ca_system_score_gemma":0.00057249016,"threshold_uncertainty_score":0.4755396},"labels":[],"label_agreement":null},{"id":"W2773177438","doi":"10.1016/j.urolonc.2017.11.015","title":"Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?","year":2017,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Cancer Research Institute","keywords":"Medicine; Bladder cancer; Cystectomy; Referral; Perioperative; Population; Chemotherapy; Internal medicine; Cancer; Oncology; General surgery; Surgery; Family medicine","score_opus":0.044216247731591454,"score_gpt":0.38817271314940316,"score_spread":0.3439564654178117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773177438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8923715,0.0008165445,0.00010722478,0.1036637,0.00020973267,0.0008917698,0.00008466816,0.0000185559,0.0018363383],"genre_scores_gemma":[0.94639224,0.0013651534,0.016602397,0.031549476,0.00077546254,0.0011558909,0.000072330164,0.000022103033,0.0020649761],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990717,0.00008710874,0.00018025648,0.00028707704,0.00011463132,0.00025923812],"domain_scores_gemma":[0.9992097,0.00016083189,0.00020871693,0.0002551157,0.00008451351,0.000081142745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029353792,0.00016124481,0.00026228724,0.0000718085,0.0007019149,0.000071222334,0.00013585085,0.00014367195,0.000113605725],"category_scores_gemma":[0.00015510585,0.00010711302,0.00005098964,0.00007205001,0.00024355696,0.00018478355,0.000023480832,0.00021259619,0.0000027490823],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032598662,0.00023816424,0.9838628,0.000024682275,0.00011376873,0.0000947374,0.0033547923,0.00003593044,0.000059868227,0.004189346,0.0018122074,0.0058877263],"study_design_scores_gemma":[0.003464827,0.001919831,0.41787535,0.000075405296,0.00039793106,0.00027478332,0.0021511673,0.0008830482,0.000108343476,0.0013402904,0.57131296,0.00019603809],"about_ca_topic_score_codex":0.00060294085,"about_ca_topic_score_gemma":0.00048463055,"teacher_disagreement_score":0.56950074,"about_ca_system_score_codex":0.000102473954,"about_ca_system_score_gemma":0.00019447417,"threshold_uncertainty_score":0.5398633},"labels":[],"label_agreement":null},{"id":"W2773290139","doi":"10.1177/0269215517746472","title":"A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy","year":2017,"lang":"en","type":"review","venue":"Clinical Rehabilitation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Kom op tegen Kanker","keywords":"Psychosocial; Cystectomy; Medicine; Randomized controlled trial; Physical therapy; Psychological intervention; Bladder cancer; Quality of life (healthcare); Rehabilitation; MEDLINE; Meta-analysis; Anxiety; Physical fitness; Cancer; Surgery; Internal medicine; Psychiatry; Nursing","score_opus":0.054553442597800886,"score_gpt":0.4629185928128428,"score_spread":0.40836515021504194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773290139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013765098,0.97921586,0.00001561121,0.001758551,0.00041964444,0.017017493,0.00013727149,0.00003049973,0.000028545026],"genre_scores_gemma":[0.000765958,0.9943297,0.0013847091,0.00014924738,0.00003346084,0.0029849529,0.00012773504,0.000070257534,0.00015398396],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99312955,0.0010281149,0.0042708735,0.00077542453,0.000515739,0.00028031727],"domain_scores_gemma":[0.99254256,0.0037677898,0.0021812867,0.0008347542,0.00037793207,0.00029567507],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022591965,0.00043516682,0.005629415,0.00031577432,0.00008535208,0.000022109862,0.00017136276,0.00035063823,0.000034103723],"category_scores_gemma":[0.012912622,0.00029453004,0.0011334483,0.00035017912,0.00029963267,0.00013445278,0.00005908117,0.00047774002,0.00001347899],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001539256,0.0009265167,0.008810046,0.8397872,0.00044836354,8.437451e-7,0.0002751807,5.3816574e-8,3.3488199e-9,0.000016344055,0.00014149027,0.14944007],"study_design_scores_gemma":[0.004085353,0.005465403,0.03268799,0.9523407,0.004218886,0.0000010071652,0.00005218481,5.641384e-7,5.075222e-9,0.00009754365,0.0008220863,0.00022824295],"about_ca_topic_score_codex":0.00017274043,"about_ca_topic_score_gemma":0.00013110299,"teacher_disagreement_score":0.14921182,"about_ca_system_score_codex":0.00061042386,"about_ca_system_score_gemma":0.0010563779,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W2773593291","doi":"10.1016/j.clgc.2017.11.004","title":"Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Cancer Research UK","keywords":"Multidisciplinary approach; Medicine; Bladder cancer; Family medicine; Nursing; Cancer; Internal medicine","score_opus":0.05583987742814905,"score_gpt":0.38280239173580316,"score_spread":0.3269625143076541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773593291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174815,0.002688664,0.0000024082024,0.0005389279,0.00081411604,0.0011350546,0.00057252304,0.00002834281,0.002471787],"genre_scores_gemma":[0.9968022,0.0011126995,0.00010922983,0.0003062009,0.00063747907,0.00028108826,0.00007677017,0.00006661791,0.0006076739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977738,0.0000883702,0.0007294199,0.0006357738,0.0004076833,0.00036495063],"domain_scores_gemma":[0.9977549,0.000114605486,0.00049600116,0.0009857826,0.00037360075,0.00027514013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010782285,0.00032681145,0.0008127743,0.000092952934,0.00017231093,0.000019943345,0.00031980147,0.00021701759,0.00030690865],"category_scores_gemma":[0.00006762976,0.00024490338,0.00024140727,0.00007286314,0.00029373914,0.00021397087,0.00022239161,0.0004158979,0.000010276083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035995955,0.0011987457,0.9704541,0.00027836394,0.00034472308,0.000238257,0.000494351,0.00001220204,0.000023142362,5.712318e-7,0.0005630368,0.02279292],"study_design_scores_gemma":[0.01645248,0.002791184,0.97779506,0.0009621286,0.000246002,0.0000011761786,0.00036706193,0.000004719783,0.00040951403,0.000007262595,0.0006925005,0.0002709083],"about_ca_topic_score_codex":0.002175798,"about_ca_topic_score_gemma":0.0010635222,"teacher_disagreement_score":0.022522012,"about_ca_system_score_codex":0.00018843479,"about_ca_system_score_gemma":0.0011088494,"threshold_uncertainty_score":0.99868697},"labels":[],"label_agreement":null},{"id":"W2774178388","doi":"10.5489/cuaj.4791","title":"Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour","year":2017,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Perioperative; Chemotherapy; Bladder cancer; Cancer; Qualitative research; Cancer chemotherapy; Oncology; Intensive care medicine; General surgery; Internal medicine; Anesthesia; Sociology","score_opus":0.03464590475316081,"score_gpt":0.37553173444948096,"score_spread":0.34088582969632014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774178388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912723,0.00045413282,0.000011915594,0.006218703,0.00016088458,0.00064499344,0.00012100833,0.0000062457216,0.0011098507],"genre_scores_gemma":[0.9976552,0.0001028416,0.00007807873,0.000960172,0.00031791028,0.00007890955,0.000004979947,0.000013324947,0.0007885523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990554,0.0001145769,0.00022680442,0.00018315161,0.0001625341,0.0002575697],"domain_scores_gemma":[0.99872416,0.000075667966,0.00031730937,0.00011998713,0.00044243276,0.00032043445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034002366,0.00013176081,0.00035910797,0.000066852306,0.00062073587,0.00008971422,0.00010102648,0.00010817052,0.00012102545],"category_scores_gemma":[0.00016225192,0.0001009362,0.000084191015,0.000039814262,0.00006192968,0.00010078431,0.000010853963,0.00021547636,0.0000019009167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025550788,0.0007224355,0.95103735,0.00001121672,0.00091473886,0.0000127970625,0.035808362,0.0000014465357,0.00011366513,0.00009710081,0.0021822015,0.008843201],"study_design_scores_gemma":[0.0063180863,0.0022538577,0.98095024,0.000021488702,0.00024898138,0.000008195111,0.00726146,0.000017576991,0.00006540781,0.0001422668,0.002598561,0.000113883965],"about_ca_topic_score_codex":0.0054547857,"about_ca_topic_score_gemma":0.010377329,"teacher_disagreement_score":0.029912906,"about_ca_system_score_codex":0.00048135538,"about_ca_system_score_gemma":0.00051976426,"threshold_uncertainty_score":0.8246041},"labels":[],"label_agreement":null},{"id":"W2775642364","doi":"10.5489/cuaj.5102","title":"Supplementary data: Preoperative nutritional factors and outcomes after radical cystectomy: A narrative review","year":2017,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Cystectomy; Narrative; Medicine; Narrative review; General surgery; Intensive care medicine; Internal medicine; Bladder cancer; Art; Cancer; Literature","score_opus":0.0752733623307631,"score_gpt":0.36783349914213,"score_spread":0.2925601368113669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775642364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012612883,0.9763055,0.0000013762037,0.011012871,0.00033013447,0.0013839317,0.010611794,0.000010406003,0.000217872],"genre_scores_gemma":[0.0005330789,0.98991996,0.000106922496,0.0041684,0.0006010452,0.00014613871,0.0039575053,0.000030308034,0.00053664256],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970849,0.00053191214,0.0007772347,0.0005396218,0.0005349752,0.00053132564],"domain_scores_gemma":[0.997355,0.00028738874,0.00068061927,0.00041061352,0.00019783703,0.0010685669],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064874376,0.0005084175,0.002311465,0.00019075931,0.00054239325,0.00017749392,0.00035901373,0.00048384976,0.003854118],"category_scores_gemma":[0.0009387766,0.00030767376,0.00045656128,0.000099760975,0.00010997592,0.00020634144,0.00009271158,0.0012785541,0.000023638064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009751553,0.0003256175,0.62133783,0.008959814,0.007574595,0.001842818,0.0004581483,1.7893887e-8,1.8538627e-8,0.000045694815,0.21053654,0.14882138],"study_design_scores_gemma":[0.0010046392,0.00022776559,0.030100953,0.0062125837,0.0030275793,0.00056275586,0.000024906147,2.8815253e-7,1.5663193e-8,0.000047856443,0.9585287,0.000261944],"about_ca_topic_score_codex":0.0011391497,"about_ca_topic_score_gemma":0.0022898957,"teacher_disagreement_score":0.74799216,"about_ca_system_score_codex":0.0017675173,"about_ca_system_score_gemma":0.002962522,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W2777881468","doi":"10.1002/cncy.21958","title":"Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its prediction of subsequent high‐grade urothelial carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Urinary system; Cytology; Biopsy; Internal medicine; Predictive value; Gastroenterology; Cancer; Bladder cancer; Pathology","score_opus":0.056023478685852376,"score_gpt":0.340588266840599,"score_spread":0.2845647881547466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777881468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534637,0.0007278366,0.000009908212,0.0017674639,0.00021898803,0.0015644036,0.00021367085,0.000007633686,0.00014372589],"genre_scores_gemma":[0.9988635,0.00008817199,0.000029512523,0.00017879534,0.00014567278,0.00064269983,0.000020598263,0.00001680456,0.000014212935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974779,0.0005930953,0.0010845803,0.00037065035,0.000109488436,0.00036427446],"domain_scores_gemma":[0.9978547,0.00018855536,0.0011114171,0.0007030953,0.0000839932,0.00005822943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023889588,0.00016136904,0.00049884204,0.00010131057,0.00018237138,0.000011013004,0.00026082926,0.00012468566,0.0000035659584],"category_scores_gemma":[0.00086754834,0.000090704736,0.000069873626,0.00011575207,0.00026226748,0.000075783624,0.0001211112,0.00024500652,1.1552423e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026905886,0.00020420246,0.9823724,0.00021450265,0.000019001362,0.00035306107,0.0025719146,0.000013779213,0.010214584,0.00054086413,0.000016965565,0.0007881246],"study_design_scores_gemma":[0.006168906,0.0005541139,0.9824933,0.0001887531,0.00013140313,0.00040265036,0.0010749128,0.000267881,0.008342825,0.00025000153,0.00006011342,0.00006515148],"about_ca_topic_score_codex":0.013242892,"about_ca_topic_score_gemma":0.005207906,"teacher_disagreement_score":0.008034986,"about_ca_system_score_codex":0.00016716837,"about_ca_system_score_gemma":0.00041299564,"threshold_uncertainty_score":0.99332803},"labels":[],"label_agreement":null},{"id":"W2779497146","doi":"10.1097/jom.0000000000001242","title":"The Economic Burden of Bladder Cancer Due to Occupational Exposure","year":2017,"lang":"en","type":"article","venue":"Journal of Occupational and Environmental Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Indirect costs; Environmental health; Total cost; Economic cost; Occupational cancer; Quality of life (healthcare); Cancer; Quality-adjusted life year; Occupational exposure; Demography; Cost effectiveness; Internal medicine; Risk analysis (engineering); Business; Economics","score_opus":0.02915701543280276,"score_gpt":0.32314163617077035,"score_spread":0.2939846207379676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779497146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081564,0.0017610738,0.000057970537,0.006039493,0.00046612785,0.00016084105,0.00008414941,0.000001532822,0.00061318564],"genre_scores_gemma":[0.99688596,0.0008829306,0.0001531463,0.00031037105,0.0011813329,0.00000852684,0.00001083503,0.0000088884535,0.0005580156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990364,0.000014907669,0.00038571452,0.000102333506,0.00035533294,0.00010534719],"domain_scores_gemma":[0.99918514,0.00007342225,0.00037836423,0.00017138265,0.000028813705,0.00016288043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018021012,0.00010883182,0.00027073832,0.00005440619,0.00022831862,0.0000117510635,0.00012382836,0.0000375102,0.00069208536],"category_scores_gemma":[0.000047827998,0.00006184201,0.00006280038,0.0000125267625,0.00027792004,0.00010634992,0.00004148064,0.00009732379,0.000008256273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007558077,0.00017411525,0.8858481,0.000047861133,0.0008938246,0.00008710263,0.0012264162,0.00037620877,0.012306586,0.00026441505,0.014594409,0.07662287],"study_design_scores_gemma":[0.0026089072,0.0010039293,0.98653775,0.00012546795,0.00017782953,0.00022561474,0.000244321,0.000057070298,0.0007319036,0.00014954523,0.008078205,0.000059464302],"about_ca_topic_score_codex":0.00023421815,"about_ca_topic_score_gemma":0.000021896867,"teacher_disagreement_score":0.100689635,"about_ca_system_score_codex":0.00014157398,"about_ca_system_score_gemma":0.00013915461,"threshold_uncertainty_score":0.7577849},"labels":[],"label_agreement":null},{"id":"W2781421846","doi":"10.1111/cyt.12514","title":"Improving the cytological diagnosis of high‐grade serous carcinoma in ascites with a panel of complementary biomarkers in cell blocks","year":2017,"lang":"en","type":"article","venue":"Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"National Natural Science Foundation of China","keywords":"Calretinin; Medicine; Ascites; Mesothelial Cell; Serous fluid; Serous carcinoma; Pathology; Differential diagnosis; Immunohistochemistry; Internal medicine; Cancer; Ovarian cancer","score_opus":0.03902533163872969,"score_gpt":0.2804143765504593,"score_spread":0.24138904491172963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781421846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773246,0.0005090986,0.000011074456,0.00084140146,0.00006092642,0.00046601827,0.00004681805,0.0000068190047,0.00032537224],"genre_scores_gemma":[0.9992342,0.00004319579,0.00041553658,0.00015494165,0.00002029881,0.00009648178,0.000012076884,0.000011524708,0.000011752983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899507,0.00009465983,0.00029501045,0.00025499566,0.00011677119,0.0002434731],"domain_scores_gemma":[0.99912614,0.00012612528,0.00020619745,0.0004752628,0.000031976782,0.000034295117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018575757,0.0001387539,0.00046067944,0.000106633,0.00005766523,0.0000050886156,0.00021919218,0.000082783,0.000050029652],"category_scores_gemma":[0.00004532666,0.00008438373,0.000050536008,0.00008423542,0.00041905543,0.000034807785,0.00010542671,0.00014763996,9.518802e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000497439,0.0004038679,0.98606807,0.000071338305,0.0000266303,0.00065133796,0.00054525066,0.0000030536926,0.0087335305,0.00002020244,0.000018676346,0.002960617],"study_design_scores_gemma":[0.004708102,0.0011928454,0.9495217,0.00005759688,0.000098230805,0.00012939259,0.00042889302,0.00002858509,0.043651327,0.00009198848,0.000017620414,0.00007369741],"about_ca_topic_score_codex":0.00874698,"about_ca_topic_score_gemma":0.0015336302,"teacher_disagreement_score":0.036546335,"about_ca_system_score_codex":0.000050478135,"about_ca_system_score_gemma":0.0000746635,"threshold_uncertainty_score":0.9978539},"labels":[],"label_agreement":null},{"id":"W2781506439","doi":"10.1016/j.radonc.2017.12.009","title":"Concurrent chemoradiotherapy for bladder cancer: Practice patterns and outcomes in the general population","year":2018,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"H2020 European Research Council; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Carboplatin; Bladder cancer; Internal medicine; Cancer registry; Propensity score matching; Proportional hazards model; Hazard ratio; Cancer; Population; Chemoradiotherapy; Oncology; Poisson regression; Cisplatin; Surgery; Urology; Chemotherapy; Confidence interval","score_opus":0.03093533833034816,"score_gpt":0.3993243956520284,"score_spread":0.3683890573216802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781506439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97205883,0.0052903425,0.0008922,0.01994745,0.0004172047,0.0010852879,0.000033341094,0.000018639737,0.00025670038],"genre_scores_gemma":[0.97154987,0.0070741903,0.001479886,0.018376367,0.0009742801,0.00027006722,0.000017286184,0.000023024035,0.00023505409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992302,0.00009237646,0.00017283652,0.0002254267,0.0000893353,0.00018981168],"domain_scores_gemma":[0.9995043,0.00021019731,0.00007331147,0.00011694265,0.000042950047,0.00005226699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020624918,0.000133831,0.00034102384,0.00005004236,0.000090141744,0.000018773668,0.000044425306,0.0001009665,0.00008140584],"category_scores_gemma":[0.000018438817,0.00008411891,0.000039228813,0.00005678805,0.00009823987,0.00007429919,0.000004628287,0.000090977155,3.7755274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084476726,0.0004013548,0.54815376,0.000040081315,0.00033729267,0.00001325241,0.004939364,7.843367e-7,0.000626113,0.0006629918,0.0009750012,0.44300523],"study_design_scores_gemma":[0.013479919,0.004380572,0.74385566,0.000025270092,0.00018713578,0.00022538943,0.0003434906,0.0006281614,0.00025570646,0.0001361114,0.23630787,0.00017469967],"about_ca_topic_score_codex":0.0012619011,"about_ca_topic_score_gemma":0.0009281759,"teacher_disagreement_score":0.44283053,"about_ca_system_score_codex":0.00020386704,"about_ca_system_score_gemma":0.000073516974,"threshold_uncertainty_score":0.34302697},"labels":[],"label_agreement":null},{"id":"W2781546173","doi":"10.1016/j.clgc.2017.12.016","title":"Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level Analysis","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Epidemiology; Population; Hazard ratio; Odds ratio; Logistic regression; Internal medicine; Cancer; Confidence interval; Environmental health","score_opus":0.07452605924954833,"score_gpt":0.39969779965112495,"score_spread":0.3251717404015766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781546173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969669,0.00023708286,0.00016528735,0.00038675696,0.00049886573,0.0005441176,0.00037705767,0.000044472596,0.00077944744],"genre_scores_gemma":[0.9924995,0.00007122522,0.0011303341,0.00082634075,0.0019037819,0.00036488628,0.00023916454,0.000052822597,0.0029119926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801517,0.000050849998,0.00053534715,0.00058321346,0.0003109614,0.0005044539],"domain_scores_gemma":[0.9989254,0.00008294361,0.00015725898,0.00035741634,0.00025365228,0.00022333277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018108207,0.00025176234,0.0006582995,0.00046691703,0.00012227223,0.000017780823,0.000112636124,0.00015967456,0.0008941916],"category_scores_gemma":[0.00003233303,0.0001949492,0.00029479768,0.0010948409,0.000092228045,0.00009543336,0.000045785484,0.00018689186,0.000011668514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037568458,0.00055272947,0.96474695,0.000021319553,0.0013749198,0.000010066325,0.00012265715,0.00004148652,0.0000014324701,0.000005250589,0.0005791873,0.028787151],"study_design_scores_gemma":[0.008297633,0.001898197,0.98598903,0.00006319581,0.0018923017,6.175486e-7,0.000032416487,0.00028036765,0.00004015644,0.00002011598,0.0012505666,0.0002353798],"about_ca_topic_score_codex":0.0011912179,"about_ca_topic_score_gemma":0.0018403252,"teacher_disagreement_score":0.028551772,"about_ca_system_score_codex":0.0002485525,"about_ca_system_score_gemma":0.00020229677,"threshold_uncertainty_score":0.9790771},"labels":[],"label_agreement":null},{"id":"W2782762180","doi":"10.1016/j.juro.2017.12.062","title":"Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Gemcitabine; Cystectomy; Urology; Bladder cancer; Cisplatin; Urothelial cancer; Oncology; Chemotherapy; Cancer; Internal medicine","score_opus":0.011439152139079945,"score_gpt":0.2628293941476983,"score_spread":0.25139024200861837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782762180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682665,0.0007875064,0.000026133266,0.0016037243,0.0001258825,0.00029689018,0.000007746047,0.000008144832,0.00031734025],"genre_scores_gemma":[0.9988436,0.00012440572,0.00012799338,0.00056563667,0.0002227675,0.0000061300916,0.00000235841,0.000025772975,0.00008132687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888843,0.00013657966,0.00028984787,0.0001407328,0.00026870024,0.00027572943],"domain_scores_gemma":[0.99913436,0.00012206098,0.00020526804,0.00017761142,0.00021441653,0.0001463094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017941622,0.00018090726,0.00040855035,0.00013363716,0.00006371064,0.000006979161,0.00009152182,0.00008619382,0.00021023641],"category_scores_gemma":[0.000029351067,0.00008627448,0.000029337987,0.00019133007,0.0003886425,0.000069109155,0.000024061437,0.00031780978,0.000005735823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17601357,0.0006021966,0.8080444,0.000018977726,0.0012194567,0.00045677958,0.0015195288,0.000035453082,0.00044095912,0.000012097672,0.0006889518,0.010947653],"study_design_scores_gemma":[0.058950856,0.027169473,0.9100998,0.00007827263,0.0012127965,0.00065008726,0.00007550568,0.000063814274,0.0003469312,0.000020757096,0.0011966077,0.00013511354],"about_ca_topic_score_codex":0.00026270436,"about_ca_topic_score_gemma":0.0004560999,"teacher_disagreement_score":0.117062725,"about_ca_system_score_codex":0.000077951816,"about_ca_system_score_gemma":0.00017714163,"threshold_uncertainty_score":0.35181713},"labels":[],"label_agreement":null},{"id":"W2783614467","doi":"10.1200/jco.2017.35.15_suppl.4500","title":"Comprehensive molecular characterization and analysis of muscle-invasive urothelial carcinomas.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Biology; DNA methylation; APOBEC; Germline mutation; microRNA; Somatic cell; Gene; Mutation; CpG site; Medicine; Gene expression; Genetics","score_opus":0.10829738884019939,"score_gpt":0.4407294001944145,"score_spread":0.3324320113542151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783614467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958252,0.00020500539,0.0004464738,0.0020719145,0.00045369542,0.00013732805,0.000028144053,0.000002504178,0.0008297609],"genre_scores_gemma":[0.99705523,0.00083185657,0.0006627505,0.0010287347,0.0003210147,0.0000015643469,0.000009513732,0.000009514744,0.0000797904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818194,0.00016843784,0.0011651923,0.00014479388,0.0002280333,0.000111622954],"domain_scores_gemma":[0.99649453,0.0004176708,0.0020449422,0.00026937702,0.0005578447,0.00021565337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004255887,0.00010124473,0.0014633157,0.0001691497,0.00005561773,0.000011114006,0.00012626807,0.00020030396,0.00006878307],"category_scores_gemma":[0.0010286473,0.00007394173,0.0004940056,0.00007752717,0.00027679317,0.00009543396,0.000049764334,0.0002715565,0.0000017820572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030327644,0.0010003971,0.76073194,0.00006478695,0.006605381,0.0009633587,0.00027686547,0.0000064600003,0.05527423,0.00010474391,0.00004900262,0.17189008],"study_design_scores_gemma":[0.0053039417,0.004659183,0.97790724,0.000041542397,0.005197305,0.000048007256,0.000031261607,0.000069509464,0.0018026942,0.000051528197,0.004833442,0.000054366017],"about_ca_topic_score_codex":0.000052586114,"about_ca_topic_score_gemma":0.000015869527,"teacher_disagreement_score":0.21717529,"about_ca_system_score_codex":0.000038919425,"about_ca_system_score_gemma":0.0006914564,"threshold_uncertainty_score":0.30152562},"labels":[],"label_agreement":null},{"id":"W2784743320","doi":"10.1016/j.euf.2018.01.003","title":"Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”","year":2018,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Allergan; Kyowa Hakko Kirin; GlaxoSmithKline foundation; Olympus; Astellas Pharma Canada; Alere; Bayer HealthCare; Meso Scale Diagnostics; Sanofi; Novartis; General Electric; Eli Lilly and Company; International Parkinson and Movement Disorder Society; Bayer; Takeda Oncology; British Microcirculation Society; Amgen","keywords":"Medicine; Grading (engineering); Pathological; Context (archaeology); Oncology; Internal medicine; Pathology","score_opus":0.03414681607016186,"score_gpt":0.2848166716286423,"score_spread":0.2506698555584805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784743320","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067157075,0.9851089,0.000047839145,0.00069107837,0.0002818413,0.0015458171,0.00010095188,0.000017634597,0.005490236],"genre_scores_gemma":[0.6747292,0.32383233,0.00004638385,0.00005373084,0.00031927606,0.000008869656,0.000017191323,0.00007465858,0.00091834477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976058,0.0010309519,0.000718395,0.0003055595,0.00016808382,0.00017123857],"domain_scores_gemma":[0.9982996,0.000152595,0.0009251811,0.00047843775,0.00005868812,0.0000855179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005407782,0.0002447717,0.0010772911,0.00013739425,0.000090275214,0.0000053164945,0.0001934534,0.000074625335,0.00003003965],"category_scores_gemma":[0.000041092444,0.0001353683,0.00017032637,0.00017965556,0.00059113395,0.000024600136,0.00011605665,0.00021988974,0.000009173724],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004048754,0.0010466329,0.049675766,0.07682848,0.0032796592,0.00017714768,0.01481276,4.9891156e-7,0.0004488331,0.015107239,0.016111514,0.8184627],"study_design_scores_gemma":[0.03097408,0.013964576,0.30272305,0.019518852,0.028385986,0.014395363,0.0014058216,0.00005301616,0.00079405296,0.00038163204,0.5859638,0.0014397706],"about_ca_topic_score_codex":0.00018068899,"about_ca_topic_score_gemma":0.00001699901,"teacher_disagreement_score":0.817023,"about_ca_system_score_codex":0.00006429305,"about_ca_system_score_gemma":0.0005483837,"threshold_uncertainty_score":0.5520159},"labels":[],"label_agreement":null},{"id":"W2784972860","doi":"10.3233/blc-170148","title":"Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Referral; Bladder cancer; Chemotherapy; Specialty; Family medicine; Logistic regression; Oncology; Internal medicine; Cancer","score_opus":0.039327710959015244,"score_gpt":0.3484307314601679,"score_spread":0.3091030205011527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784972860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850369,0.003225809,0.0006470136,0.0045562163,0.0006203207,0.003561535,0.0010973697,0.00007316635,0.0011816592],"genre_scores_gemma":[0.98617685,0.00074892555,0.0012976256,0.0066712354,0.00051518297,0.0013884839,0.000026581254,0.00010115474,0.0030739512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982307,0.000053673913,0.0003478751,0.0005987817,0.00027554654,0.0004934056],"domain_scores_gemma":[0.9984433,0.000076539276,0.00011376758,0.00033724596,0.00059671816,0.00043241403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019279424,0.00034007963,0.0006023684,0.00013013526,0.000157409,0.000033893917,0.00011941047,0.00012549464,0.0017256084],"category_scores_gemma":[0.00011610539,0.00027723887,0.000099876954,0.00032992935,0.00032913132,0.0001328597,0.000036965248,0.00009802535,0.000006030715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022879006,0.0006846734,0.38308793,0.0010564869,0.00822826,0.000026452088,0.046141405,0.00009911563,0.08129149,0.00007529614,0.16322914,0.29320073],"study_design_scores_gemma":[0.036626033,0.011026931,0.40442452,0.0010511297,0.0017361385,0.00004152663,0.0031008672,0.0015983888,0.3934706,0.00011868417,0.14485547,0.0019496992],"about_ca_topic_score_codex":0.011904083,"about_ca_topic_score_gemma":0.00861639,"teacher_disagreement_score":0.31217912,"about_ca_system_score_codex":0.0002050261,"about_ca_system_score_gemma":0.0011003084,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W2785240241","doi":"10.3233/blc-170140","title":"Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Liquid biopsy; Bladder cancer; Circulating tumor DNA; DNA; Biopsy; Medicine; Pathology; Cancer research; Oncology; Cancer; Internal medicine; Chemistry; Biochemistry","score_opus":0.07686118986522397,"score_gpt":0.3952291138831574,"score_spread":0.31836792401793346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785240241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021371467,0.9902552,0.000015662148,0.000116981,0.00081675773,0.0017984003,0.0011860911,0.00008583061,0.0035879267],"genre_scores_gemma":[0.002503964,0.9917201,0.00013679544,0.00045756123,0.0012717517,0.0017330284,0.0003141268,0.00025338627,0.001609314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946788,0.0002140101,0.0018348375,0.0014236982,0.00090384344,0.00094482023],"domain_scores_gemma":[0.9967512,0.00015042593,0.0011372226,0.0012611077,0.00035756396,0.0003425111],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033480418,0.0010968762,0.005444027,0.0016351816,0.00009428322,0.000037365113,0.00044497824,0.0005659405,0.0070223035],"category_scores_gemma":[0.000076357595,0.0008759755,0.0021136815,0.003912797,0.00029327086,0.00012744372,0.00016285224,0.0006471092,0.00007949987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095543696,0.0018878945,0.0085026985,0.046358947,0.13391478,0.0009877668,0.002336117,0.000093399474,0.00018685448,0.000097101554,0.010681456,0.7939975],"study_design_scores_gemma":[0.0026804379,0.0005028803,0.0023586182,0.027410135,0.10946555,0.000082813815,0.00011211249,0.000109718334,0.00014805303,0.000014975355,0.85559803,0.0015166879],"about_ca_topic_score_codex":0.0058492,"about_ca_topic_score_gemma":0.0023507504,"teacher_disagreement_score":0.8449166,"about_ca_system_score_codex":0.0011538352,"about_ca_system_score_gemma":0.003023851,"threshold_uncertainty_score":0.9993691},"labels":[],"label_agreement":null},{"id":"W2785248624","doi":"10.3233/blc-170147","title":"Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Overweight; Observational study; Internal medicine; Body mass index; Meta-analysis; Randomized controlled trial; Obesity; Cancer; Oncology; Confidence interval","score_opus":0.08219347439400798,"score_gpt":0.37341704542907805,"score_spread":0.2912235710350701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785248624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000073766128,0.9880707,0.000009054968,0.0004811247,0.00019730876,0.009330792,0.0013890213,0.00014317429,0.000371396],"genre_scores_gemma":[0.00028873104,0.9799297,0.00004073628,0.0011999996,0.00019065234,0.011965896,0.00025643283,0.00023613925,0.005891716],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99402153,0.0005240441,0.002046337,0.0017413818,0.00085363095,0.0008130628],"domain_scores_gemma":[0.9962567,0.00019011315,0.0013499459,0.001230085,0.00036799334,0.0006051418],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00045437226,0.0017229419,0.014846495,0.00056777336,0.00021349074,0.0001442338,0.00032437342,0.00074997975,0.004915229],"category_scores_gemma":[0.000091609814,0.0009915408,0.0032674454,0.0016512163,0.00031986207,0.00018737146,0.0001664701,0.0007173211,0.00004526722],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016457028,0.00009411241,0.00044312066,0.5217303,0.4741145,0.000026290214,0.00010191258,7.9131475e-8,9.4551346e-8,0.0000052208165,0.0026614654,0.0008064385],"study_design_scores_gemma":[0.0005749388,0.00022039429,0.00011695989,0.06185635,0.85870624,0.00003856482,0.000026094067,0.0000045879565,0.0000013856562,0.0000119288825,0.077636495,0.000806046],"about_ca_topic_score_codex":0.0013583661,"about_ca_topic_score_gemma":0.00041233684,"teacher_disagreement_score":0.45987394,"about_ca_system_score_codex":0.00039986137,"about_ca_system_score_gemma":0.000902435,"threshold_uncertainty_score":0.99977916},"labels":[],"label_agreement":null},{"id":"W2785777839","doi":"10.1038/nrurol.2018.2","title":"A practical guide to bladder cancer pathology","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Grading (engineering); Bladder cancer; Medicine; Pathological; Urothelial cancer; Pathology; Lymphadenectomy; Cancer; Oncology; Internal medicine","score_opus":0.07418863563316157,"score_gpt":0.4803964588290602,"score_spread":0.4062078231958986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785777839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.0630128e-7,0.98167324,0.000110840025,0.0036580844,0.0020245612,0.0043275678,0.000112031325,0.0000817816,0.00801171],"genre_scores_gemma":[3.2712174e-7,0.965767,0.003936105,0.020334449,0.003287431,0.0021038894,0.00014917157,0.0001490324,0.004272563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995428,0.00085247145,0.0012991771,0.0013247019,0.0002981738,0.0007974483],"domain_scores_gemma":[0.9972215,0.00025255638,0.00054085057,0.0012681409,0.00023259888,0.000484321],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0006783084,0.000901377,0.005157824,0.00034804767,0.00007890163,0.000016524915,0.00032631497,0.0028170357,0.002332099],"category_scores_gemma":[0.0011978939,0.00057263544,0.0011404839,0.0006628325,0.00016686691,0.00004408532,0.00020081214,0.0025812618,0.0040494786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049191633,0.00010652549,0.000005546729,0.0046935203,0.0004267979,0.0004531275,0.000014963727,4.0723402e-9,2.955658e-7,0.000101861435,0.37595212,0.618196],"study_design_scores_gemma":[0.00049237715,0.00095907133,0.0000064521587,0.00380276,0.008719587,0.0047605974,7.846493e-7,1.7174375e-7,6.4879157e-7,0.000018720495,0.9808408,0.00039804218],"about_ca_topic_score_codex":0.00001956933,"about_ca_topic_score_gemma":0.00005494934,"teacher_disagreement_score":0.617798,"about_ca_system_score_codex":0.0003160073,"about_ca_system_score_gemma":0.0015139343,"threshold_uncertainty_score":0.9997198},"labels":[],"label_agreement":null},{"id":"W2785897485","doi":"10.1016/j.eururo.2018.01.034","title":"Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Propensity score matching; Multidisciplinary approach; Urology; Urothelial cancer; Cancer; Surgery; Internal medicine","score_opus":0.08947373137303824,"score_gpt":0.3400682012875923,"score_spread":0.25059446991455403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785897485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90456533,0.0018417147,0.00001901959,0.08085795,0.0007348442,0.0015501751,0.00014439427,0.00005197514,0.010234615],"genre_scores_gemma":[0.9386252,0.00044241548,0.000076121905,0.057736903,0.0023103382,0.000061524006,0.00029176948,0.00012462083,0.0003311151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533594,0.0015891752,0.0010746171,0.0008583482,0.0005618005,0.0005800943],"domain_scores_gemma":[0.9972848,0.0006068982,0.0007429742,0.0011053496,0.00018941736,0.00007054781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011518579,0.0004943257,0.0016304888,0.00063158787,0.000093805655,0.000012729575,0.0006082518,0.0004592023,0.0007265161],"category_scores_gemma":[0.00014208972,0.00032858385,0.0006077155,0.0010416406,0.00062719063,0.000043760494,0.0002274309,0.001770646,0.00003339361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027758505,0.0016920095,0.61831164,0.0007145357,0.034155034,0.0059035593,0.014424714,0.0001385985,0.00071046443,0.0000035971577,0.28553724,0.010650118],"study_design_scores_gemma":[0.022630703,0.0079356115,0.9017762,0.00022972516,0.015357056,0.000063545565,0.00020447245,0.0003621711,0.0002891332,0.000012705051,0.05046567,0.00067298464],"about_ca_topic_score_codex":0.0006617057,"about_ca_topic_score_gemma":0.00046924592,"teacher_disagreement_score":0.2834646,"about_ca_system_score_codex":0.00008482396,"about_ca_system_score_gemma":0.0003380075,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W2787018430","doi":"10.1186/s12957-018-1317-6","title":"Does previous abdominal surgery adversely affect perioperative and oncologic outcomes of laparoscopic radical cystectomy?","year":2018,"lang":"en","type":"article","venue":"World Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Natural Science Foundation of China","keywords":"Medicine; Cystectomy; Perioperative; Urinary diversion; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.02441129703306544,"score_gpt":0.3387841784279244,"score_spread":0.31437288139485897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787018430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855029,0.0014329687,0.000012900478,0.004404731,0.0010138284,0.0003271373,0.000008551352,0.000013468228,0.0072835432],"genre_scores_gemma":[0.99555004,0.0011734056,0.0007813665,0.00045354202,0.0006257922,0.000009712399,0.0000013739302,0.000015431673,0.0013893641],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799925,0.00037145903,0.0007950181,0.00021376705,0.0003251957,0.00029533444],"domain_scores_gemma":[0.9975307,0.001290561,0.0004704865,0.00013650674,0.00026756895,0.0003041725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068830216,0.00021779684,0.0016534771,0.0002861114,0.000080350794,0.000009741876,0.000095724004,0.0001527945,0.0009157163],"category_scores_gemma":[0.00013206982,0.00010728105,0.00032294134,0.00023590188,0.0008799764,0.00009560711,0.00004920291,0.0003754968,0.000010817219],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014651202,0.0022958545,0.86614466,0.0002238371,0.0016915853,0.007131709,0.00109945,0.0000013700261,0.0017899967,0.00030818945,0.0032310751,0.101431064],"study_design_scores_gemma":[0.028273156,0.02069623,0.37857717,0.00065742794,0.0015845684,0.0064148703,0.00039202295,0.000014808896,0.006653318,0.00017157526,0.55618834,0.0003765229],"about_ca_topic_score_codex":0.000032788244,"about_ca_topic_score_gemma":0.00011632356,"teacher_disagreement_score":0.55295724,"about_ca_system_score_codex":0.00023697657,"about_ca_system_score_gemma":0.0006891374,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W2787509831","doi":"10.2196/resprot.8862","title":"Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies","year":2018,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Mauna Kea Technologies","keywords":"Urothelial carcinoma; Medicine; Urinary system; Urology; Upper urinary tract; Endomicroscopy; Confocal; Pathology; Radiology; Bladder cancer; Internal medicine; Cancer; Physics","score_opus":0.26501803771978144,"score_gpt":0.5550446163159137,"score_spread":0.2900265785961323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787509831","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02071443,0.000092764145,0.00004914852,0.00534553,0.000013755977,0.9730808,0.0001656608,0.000015632728,0.0005222583],"genre_scores_gemma":[0.25505763,0.00000730316,0.00012743303,0.0002652848,0.0004647394,0.74372447,0.000002827148,0.000034526292,0.00031578643],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714416,0.0006598723,0.0004589581,0.00048080832,0.00064205023,0.0006141485],"domain_scores_gemma":[0.99392545,0.004245968,0.00013755936,0.0006094117,0.0010060446,0.00007555681],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0027894692,0.00027458274,0.0005714885,0.00011461828,0.0006118872,0.000097538716,0.00042018734,0.00008734767,0.000048734808],"category_scores_gemma":[0.00079478085,0.00011502775,0.0001889662,0.00033357932,0.0027411233,0.00016342114,0.0001562963,0.00045811976,0.0000068524273],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37784016,0.01757698,0.30648974,0.0050644097,0.0026890107,0.00009435477,0.19516596,0.000003348282,0.004436214,0.018329747,0.053336862,0.01897322],"study_design_scores_gemma":[0.23957954,0.07568719,0.09057991,0.0045012576,0.00027510227,0.00013238446,0.037237402,0.00029537702,0.34810492,0.02063338,0.18229252,0.00068102835],"about_ca_topic_score_codex":0.00008885365,"about_ca_topic_score_gemma":0.000052299936,"teacher_disagreement_score":0.3436687,"about_ca_system_score_codex":0.00012833138,"about_ca_system_score_gemma":0.00046078052,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W2789636480","doi":"10.1200/jco.2018.36.6_suppl.448","title":"Nomogram-based risk prediction of local and distant relapse after radical cystectomy, and role of perioperative chemotherapy, in patients with muscle-invasive bladder cancer (MIBC): A multicenter study.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Nomogram; Urology; Internal medicine; Perioperative; Proportional hazards model; Chemotherapy; Odds ratio; Oncology; Cumulative incidence; Surgery; Cancer; Cohort","score_opus":0.018127789149063416,"score_gpt":0.34901620782591125,"score_spread":0.3308884186768478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789636480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983023,0.00037962693,0.00013696826,0.0002648034,0.0001675762,0.00063556497,0.000052063693,0.000002746891,0.00005839461],"genre_scores_gemma":[0.9987148,0.00022810177,0.00056714594,0.00028147188,0.00016095549,0.000021885578,0.0000015925127,0.000016585262,0.0000074660293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977356,0.00034738594,0.0012376034,0.00022124563,0.0003095709,0.000148593],"domain_scores_gemma":[0.9979503,0.0004009454,0.0008336852,0.0001266285,0.00048674305,0.0002016992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005892751,0.0001503923,0.0010174233,0.00010551806,0.00002433724,0.000004222386,0.000049982293,0.00018924853,0.000100736484],"category_scores_gemma":[0.0002264078,0.00009100681,0.00010734894,0.00010390795,0.00086434174,0.00007999851,0.000024218822,0.0004286509,3.0720807e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041107193,0.005145135,0.9151924,0.000031248466,0.00058629416,0.00004838594,0.0020191441,0.0000036512547,0.00005070912,7.111014e-7,0.000012159087,0.035802927],"study_design_scores_gemma":[0.052966233,0.054597747,0.8895352,0.00024715907,0.0006477541,0.0000056506965,0.0010797774,0.00019000686,0.0002511776,0.0000062739778,0.0004119548,0.000061075414],"about_ca_topic_score_codex":0.00031801494,"about_ca_topic_score_gemma":0.0009933704,"teacher_disagreement_score":0.049452614,"about_ca_system_score_codex":0.000110515895,"about_ca_system_score_gemma":0.0006766624,"threshold_uncertainty_score":0.371115},"labels":[],"label_agreement":null},{"id":"W2789745920","doi":"10.1200/jco.2018.36.6_suppl.483","title":"Transcriptome-wide analysis of alternative splicing events in bladder cancer: Novel biomarkers discovery for early diagnosis.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Alternative splicing; RNA splicing; Computational biology; Gene; Spliceosome; Biology; Bladder cancer; Transcriptome; Intron; Gene expression; Bioinformatics; Medicine; Messenger RNA; Cancer research; Cancer; Genetics; RNA","score_opus":0.12227715883377618,"score_gpt":0.4749567653030908,"score_spread":0.3526796064693146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789745920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991717,0.00037674053,0.0028457588,0.002996352,0.0012478294,0.00036414337,0.00007678608,0.0000030809654,0.0003723396],"genre_scores_gemma":[0.9951533,0.0009330681,0.0013682591,0.0015997645,0.00076487154,0.000036605397,0.0000038552926,0.000018206669,0.00012205402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969222,0.00015081481,0.0021090028,0.00023572368,0.00032838856,0.00025387167],"domain_scores_gemma":[0.995742,0.0020635796,0.001362493,0.00015918456,0.00046521233,0.00020751728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014742746,0.00015366825,0.0018720604,0.00049330544,0.000025682593,0.000004325294,0.0001728855,0.00022352827,0.00010355174],"category_scores_gemma":[0.0010878684,0.000110120665,0.000995764,0.00055165123,0.00022646626,0.0001963856,0.000020437099,0.000313875,0.0000012141345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008245189,0.0022828258,0.95749915,0.000021860918,0.011687471,0.000031123254,0.0004893038,0.00003362201,0.00065379555,0.000026824364,0.00041190637,0.018616939],"study_design_scores_gemma":[0.014746434,0.011045968,0.96261245,0.0001952635,0.0063900733,0.000006482063,0.00011508977,0.00017231666,0.0016170351,0.00017878233,0.0028239517,0.000096128184],"about_ca_topic_score_codex":0.0013504279,"about_ca_topic_score_gemma":0.0016737503,"teacher_disagreement_score":0.018520812,"about_ca_system_score_codex":0.00024920347,"about_ca_system_score_gemma":0.0009448321,"threshold_uncertainty_score":0.44905904},"labels":[],"label_agreement":null},{"id":"W2789800123","doi":"10.1200/jco.2018.36.6_suppl.412","title":"RNA-sequencing to identify three different molecular grades and immune checkpoint cascades with distinct clinical behaviour in NMIBC.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Grading (engineering); Immune checkpoint; Bladder cancer; Oncology; Neuroblastoma RAS viral oncogene homolog; Cancer research; Internal medicine; Cancer; Biology; KRAS; Immunotherapy","score_opus":0.13006698591338242,"score_gpt":0.48517773374710854,"score_spread":0.3551107478337261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789800123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247265,0.0005625807,0.0006655636,0.004426712,0.00078245107,0.0003409076,0.0000034908444,0.000009930114,0.0007357436],"genre_scores_gemma":[0.99502856,0.00016301595,0.0026836582,0.0009861053,0.0010291914,0.00000919395,0.0000013058952,0.000028451544,0.00007049558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958285,0.0003626261,0.0027504775,0.0003349553,0.00040046126,0.00032298322],"domain_scores_gemma":[0.9971624,0.00071148574,0.00094354333,0.0002591466,0.00031630023,0.00060709484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023787154,0.00022307278,0.0017753969,0.00015335844,0.00004816841,0.000021115704,0.00017558825,0.0003470383,0.00007897054],"category_scores_gemma":[0.0015820477,0.00013572504,0.0003761535,0.00015110159,0.00048765473,0.000087752356,0.00010403297,0.0010649994,0.000012015657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00561671,0.0014288581,0.92900723,0.000024585881,0.00041538727,0.002700991,0.00019007425,8.8159175e-7,0.0022164814,0.000042446813,0.000113853144,0.05824247],"study_design_scores_gemma":[0.009731996,0.028809616,0.95638055,0.00034573136,0.00061553676,0.00074019027,0.00013496354,0.00001526481,0.0020449609,0.0006480486,0.000397506,0.00013563836],"about_ca_topic_score_codex":0.0002675358,"about_ca_topic_score_gemma":0.0011910876,"teacher_disagreement_score":0.058106832,"about_ca_system_score_codex":0.00023700597,"about_ca_system_score_gemma":0.0008771743,"threshold_uncertainty_score":0.5534706},"labels":[],"label_agreement":null},{"id":"W2789984763","doi":"10.1200/jco.2018.36.6_suppl.426","title":"Impact of number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Metastatic Urothelial Carcinoma; Cisplatin; Retrospective cohort study; Urothelial carcinoma; Oncology; Proportional hazards model; Chemotherapy; Nomogram; Internal medicine; Urology; Cancer; Bladder cancer","score_opus":0.09649097531424405,"score_gpt":0.5002311399256388,"score_spread":0.4037401646113948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789984763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598944,0.00012034203,0.0009145401,0.00090091635,0.0004747704,0.00037467896,0.0000797306,0.00000367732,0.001141897],"genre_scores_gemma":[0.9879254,0.00011904713,0.0104549555,0.00035283595,0.0010421169,0.00000482649,0.0000034496293,0.000025800646,0.00007155235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970158,0.0001034627,0.0022694226,0.00014448086,0.00027873288,0.00018810979],"domain_scores_gemma":[0.994578,0.0015412276,0.0024340127,0.00022365534,0.0010338579,0.00018924811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008702595,0.00015302325,0.0018227319,0.00008633759,0.000019425644,0.0000011444268,0.00014818733,0.0002773563,0.000528369],"category_scores_gemma":[0.0011196701,0.000100257435,0.001048187,0.00011422615,0.0004259207,0.000051851046,0.000013769865,0.0002331266,0.0000024551807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073477976,0.0048448467,0.81274825,0.00018005229,0.0012169926,0.00002190522,0.0002273481,0.00006399084,0.0071402094,0.000030817147,0.0011680797,0.09887954],"study_design_scores_gemma":[0.071825854,0.098915905,0.78479606,0.00028984214,0.0007718494,0.000076782846,0.00003844778,0.0002643317,0.038527876,0.0008252596,0.003538808,0.00012898524],"about_ca_topic_score_codex":0.00009595731,"about_ca_topic_score_gemma":0.00003493536,"teacher_disagreement_score":0.098750554,"about_ca_system_score_codex":0.00009830136,"about_ca_system_score_gemma":0.0021384356,"threshold_uncertainty_score":0.578527},"labels":[],"label_agreement":null},{"id":"W2790010232","doi":"10.1080/14737140.2018.1439744","title":"Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy","year":2018,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cancer; Urology; Internal medicine","score_opus":0.04318979486945958,"score_gpt":0.39493306722686167,"score_spread":0.3517432723574021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790010232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000320962,0.9903603,0.00023125348,0.0010144896,0.0005894491,0.0067318315,0.00022852622,0.00007065679,0.00074136886],"genre_scores_gemma":[0.00027383983,0.9864104,0.0005943999,0.0060591414,0.0015442774,0.004166715,0.00010922706,0.00026143793,0.00058056106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99602133,0.00018603109,0.0014462486,0.0010890722,0.0005675219,0.0006897788],"domain_scores_gemma":[0.99742275,0.0001921025,0.0006468336,0.0010371223,0.00041011657,0.00029108342],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003624809,0.001166695,0.0050163404,0.00019628192,0.000111158224,0.00006373734,0.0003773072,0.00046839062,0.0041665607],"category_scores_gemma":[0.00003062196,0.0007402434,0.001132135,0.0004933967,0.0006509906,0.00013138287,0.000052111394,0.00036424876,0.000028982724],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000654755,0.00029500178,0.000020539974,0.089551546,0.003668666,0.000022155606,0.00042960668,3.5982068e-9,0.00011160986,0.000058805992,0.005982693,0.8992046],"study_design_scores_gemma":[0.003485543,0.0011120217,0.000040462317,0.102002375,0.0024222964,0.0000743161,0.0000381512,0.0000012938978,0.00028036968,0.00004476607,0.88985664,0.0006417755],"about_ca_topic_score_codex":0.00021492656,"about_ca_topic_score_gemma":0.00002189007,"teacher_disagreement_score":0.89856285,"about_ca_system_score_codex":0.0001808878,"about_ca_system_score_gemma":0.0025059397,"threshold_uncertainty_score":0.99950486},"labels":[],"label_agreement":null},{"id":"W2790098578","doi":"10.1200/jco.2018.36.6_suppl.438","title":"Correlation of MTOR protein expression in the tumor and its microenvironment with more aggressive pathology at cystectomy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PI3K/AKT/mTOR pathway; Cystectomy; Immunohistochemistry; Medicine; Stroma; Protein kinase B; Pathology; Cancer research; Tumor microenvironment; Apoptosis; Bladder cancer; Internal medicine; Biology; Cancer; Tumor cells","score_opus":0.04633276023454817,"score_gpt":0.39099780697556885,"score_spread":0.34466504674102066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790098578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959374,0.0008566616,0.000043873268,0.0022744462,0.00014323913,0.00042292633,0.0000033285485,0.0000014864632,0.00031663527],"genre_scores_gemma":[0.997723,0.00014965032,0.0008233576,0.00083530217,0.00033221874,0.000012286604,9.943135e-7,0.000007883858,0.00011531872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832445,0.0003680048,0.0008515888,0.00012787005,0.00021307741,0.000115019124],"domain_scores_gemma":[0.99789095,0.00036097836,0.0014364982,0.000112543334,0.00011047354,0.0000885764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081601157,0.00008834933,0.0006149716,0.000054174703,0.000029815017,0.0000016062868,0.00007386739,0.00014136243,0.00006987551],"category_scores_gemma":[0.00045609986,0.00004284096,0.00007700197,0.00005332249,0.00029457,0.00004397984,0.000036085647,0.00034171465,0.000005154909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06483017,0.0053815623,0.784714,0.00018120748,0.00040936805,0.0087932255,0.0055066366,0.000022263464,0.08252637,0.00003963243,0.0017108362,0.045884743],"study_design_scores_gemma":[0.017383171,0.041531052,0.91760445,0.0006603253,0.00027342065,0.0034253,0.00039836686,0.00006566341,0.01379961,0.00007641124,0.0047063758,0.00007588234],"about_ca_topic_score_codex":0.0000048155703,"about_ca_topic_score_gemma":0.000023561219,"teacher_disagreement_score":0.13289043,"about_ca_system_score_codex":0.00008262145,"about_ca_system_score_gemma":0.00024709388,"threshold_uncertainty_score":0.17470035},"labels":[],"label_agreement":null},{"id":"W2790210454","doi":"10.1200/jco.2018.36.6_suppl.512","title":"Between-surgeon variation in 90-day mortality after radical cystectomy for bladder cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Bladder cancer; Mortality rate; Surgery; Retrospective cohort study; General surgery; Urology; Cancer; Internal medicine","score_opus":0.14497182955351218,"score_gpt":0.500408627386627,"score_spread":0.35543679783311477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790210454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879781,0.00043914295,0.0016654765,0.0058428715,0.0023032234,0.00044860534,0.000026282201,0.000009120607,0.0012871571],"genre_scores_gemma":[0.9895636,0.00018173573,0.0012108911,0.0022888244,0.006523832,0.000043577427,0.0000030873744,0.000018627206,0.00016581726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968112,0.0003866814,0.0019850507,0.00022385648,0.00031970607,0.00027349536],"domain_scores_gemma":[0.9968041,0.0014204214,0.00085522706,0.00016911488,0.00042564,0.0003254553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033783712,0.00013856341,0.0013070229,0.000114136754,0.000030752282,0.000007113569,0.000104536244,0.0004647029,0.00053151086],"category_scores_gemma":[0.0015846995,0.000098133285,0.0004185318,0.00014722288,0.00023237566,0.000104744766,0.000023759101,0.00055768376,0.000014755266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048258305,0.0010422404,0.8904455,0.000033811095,0.0008285505,0.00018327763,0.00021056588,0.0000012444107,0.000063626176,0.000024666306,0.0024330902,0.0999076],"study_design_scores_gemma":[0.012283168,0.008701368,0.9159914,0.000098884244,0.00076823315,0.000025087033,0.00001215604,0.000056727564,0.00010064491,0.000600241,0.061278284,0.00008377018],"about_ca_topic_score_codex":0.0001913587,"about_ca_topic_score_gemma":0.0004342223,"teacher_disagreement_score":0.09982383,"about_ca_system_score_codex":0.0002762242,"about_ca_system_score_gemma":0.0019353189,"threshold_uncertainty_score":0.5819671},"labels":[],"label_agreement":null},{"id":"W2790214444","doi":"10.1200/jco.2018.36.6_suppl.413","title":"New 6-factor prognostic model for patients (pts) with advanced urothelial carcinoma (UC) receiving post-platinum atezolizumab.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Atezolizumab; Oncology; Gastroenterology; Proportional hazards model; Neutrophil to lymphocyte ratio; Performance status; Anemia; Chemotherapy; Cancer; Overall survival; Immunotherapy; Pembrolizumab","score_opus":0.07924778264830289,"score_gpt":0.41244393023660864,"score_spread":0.33319614758830574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790214444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872462,0.00008702568,0.006356952,0.0019179684,0.0016951057,0.00095897546,0.000048221937,0.000020051037,0.0016694777],"genre_scores_gemma":[0.9609449,0.00004487943,0.033820815,0.0015611356,0.0025822893,0.000016067352,0.0000086054015,0.000051513016,0.0009697805],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971369,0.00011750425,0.0015881137,0.00030066067,0.0004309443,0.0004258985],"domain_scores_gemma":[0.9953836,0.0010140417,0.0012536899,0.0002215937,0.0015153665,0.0006116791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004601847,0.00023665269,0.0013016149,0.000102618,0.00009153298,0.000013171155,0.00018019865,0.00031555668,0.00016985275],"category_scores_gemma":[0.0026729768,0.0001519407,0.00037663916,0.00010713487,0.00016012555,0.00018694071,0.000039448645,0.00050158694,0.000022441229],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051096827,0.0024329454,0.43133825,0.000060556675,0.0006068209,0.00010248577,0.0006988715,0.000029491117,0.00022541004,0.00003960554,0.0028569682,0.51051176],"study_design_scores_gemma":[0.07298587,0.19995648,0.7073646,0.00033983449,0.001323401,0.00017419455,0.00008916807,0.0021669648,0.00029739205,0.0005638255,0.014406852,0.00033139132],"about_ca_topic_score_codex":0.000031073363,"about_ca_topic_score_gemma":0.00010182897,"teacher_disagreement_score":0.51018035,"about_ca_system_score_codex":0.00023501823,"about_ca_system_score_gemma":0.00422616,"threshold_uncertainty_score":0.74970263},"labels":[],"label_agreement":null},{"id":"W2790686747","doi":"10.1016/j.urolonc.2017.11.006","title":"Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series","year":2018,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Series (stratigraphy); Medicine; Internal medicine; Biology","score_opus":0.014709881811839704,"score_gpt":0.3270386121538218,"score_spread":0.3123287303419821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790686747","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015405782,0.012209665,0.000054175118,0.011789479,0.96348083,0.0011022163,0.0007683618,0.00029291742,0.008761792],"genre_scores_gemma":[0.00006148685,0.046759233,0.012597162,0.0025481791,0.91892,0.0012627146,0.0011901626,0.00013467987,0.016526407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99529815,0.00021082452,0.0009057743,0.0014506631,0.0010860679,0.0010485249],"domain_scores_gemma":[0.996554,0.00062414585,0.0007311062,0.00057969725,0.0008775428,0.0006334699],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005544591,0.0009575606,0.0013594814,0.00027885445,0.00070065935,0.00013540695,0.00052217394,0.002172396,0.0009794016],"category_scores_gemma":[0.00047749208,0.0008444605,0.00024344248,0.00048403276,0.001770071,0.0003995979,0.00029488414,0.0019799448,0.000065345375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012780422,0.00019181945,0.0071188114,0.00011077772,0.0014113045,0.00017569256,0.0004258051,0.00026467134,0.000039817773,0.00029605674,0.98382187,0.004865362],"study_design_scores_gemma":[0.0026422937,0.0030081277,0.00006852072,0.0006935612,0.0021406857,0.00008307744,0.00017493218,0.00012352236,0.000055880548,0.0045709265,0.98572403,0.00071445276],"about_ca_topic_score_codex":0.00085295434,"about_ca_topic_score_gemma":0.0010266379,"teacher_disagreement_score":0.044560842,"about_ca_system_score_codex":0.0010122426,"about_ca_system_score_gemma":0.004042734,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W2790746043","doi":"10.1200/jco.2018.36.6_suppl.433","title":"Apparent plasticity in the biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Cisplatin; Medicine; Pathology; Neoadjuvant therapy; Immunohistochemistry; Chemotherapy; Cancer research; GATA3; Cancer; Oncology; Internal medicine; Biology; Breast cancer; Gene","score_opus":0.17333692287129587,"score_gpt":0.4930251903307318,"score_spread":0.3196882674594359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790746043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96162003,0.00016929265,0.00006137356,0.036145635,0.0007602081,0.00038236778,0.000006189979,0.0000046698856,0.0008502482],"genre_scores_gemma":[0.97593254,0.0007032807,0.0005722121,0.021115752,0.0015861086,0.000023752142,4.839644e-7,0.000010275664,0.00005556974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672014,0.0009267646,0.0015237753,0.00022813372,0.00030049923,0.00030070168],"domain_scores_gemma":[0.9951447,0.0037345178,0.0004824304,0.00015897492,0.0002263545,0.00025298106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027951633,0.00014937624,0.0010505075,0.00015235925,0.000030643445,0.000007291298,0.0002506115,0.00030497392,0.00040194017],"category_scores_gemma":[0.003994379,0.000077675606,0.00023601415,0.0002899632,0.00027066696,0.000040632378,0.000037362228,0.0007766547,0.000027342405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15522134,0.008331681,0.47033846,0.000015343565,0.00045736704,0.003097422,0.004915869,0.000042971158,0.0053924033,0.000044346703,0.015415471,0.33672732],"study_design_scores_gemma":[0.011747773,0.030194849,0.90717673,0.00012955042,0.00006495956,0.000117500895,0.00043857985,0.000011368421,0.0003894679,0.0002014634,0.049446296,0.00008143117],"about_ca_topic_score_codex":0.00016613452,"about_ca_topic_score_gemma":0.001184588,"teacher_disagreement_score":0.4368383,"about_ca_system_score_codex":0.00028563393,"about_ca_system_score_gemma":0.0018887423,"threshold_uncertainty_score":0.47819334},"labels":[],"label_agreement":null},{"id":"W2790847752","doi":"10.1200/jco.2018.36.6_suppl.516","title":"Centralization of radical cystectomy for bladder cancer in a universal healthcare system: Early results from a Canadian academic center.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Retrospective cohort study; Urology; Cancer; Surgery; General surgery; Internal medicine","score_opus":0.10613560939035803,"score_gpt":0.4604713902634751,"score_spread":0.35433578087311707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790847752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805887,0.00059981743,0.00014458124,0.014531134,0.0021360514,0.00058418117,0.0005817868,0.0000072865882,0.0008264938],"genre_scores_gemma":[0.9959357,0.0004284854,0.0005446722,0.0010852845,0.0019010047,0.0000055336764,0.00001691448,0.000016022756,0.0000664082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699014,0.00031433985,0.0019557155,0.00019790776,0.00024089024,0.00030098952],"domain_scores_gemma":[0.9970994,0.00057385536,0.0010625597,0.00012828113,0.0005268915,0.00060901884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094784476,0.00011223215,0.0010282141,0.00019122327,0.000032283373,0.0000029955359,0.00014033467,0.0005394901,0.00005329113],"category_scores_gemma":[0.0007587363,0.000086942084,0.00022661727,0.00016828396,0.00018893719,0.0000788621,0.000013468181,0.0005786897,0.0000034991158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055168487,0.0009889642,0.86153144,0.00022041526,0.0013273999,0.0006801993,0.0030396937,0.000014787464,0.00020653877,0.00047391112,0.0103485305,0.06599964],"study_design_scores_gemma":[0.076290205,0.020456504,0.8117445,0.0019289828,0.0007897993,0.00013622023,0.000770997,0.0004884291,0.00028224746,0.00017452476,0.08675787,0.00017971273],"about_ca_topic_score_codex":0.10660983,"about_ca_topic_score_gemma":0.1278266,"teacher_disagreement_score":0.07640934,"about_ca_system_score_codex":0.00095599337,"about_ca_system_score_gemma":0.006196793,"threshold_uncertainty_score":0.99943715},"labels":[],"label_agreement":null},{"id":"W2790862281","doi":"10.1200/jco.2018.36.6_suppl.431","title":"Enfortumab vedotin (EV) in patients (Pts) with metastatic urothelial carcinoma (mUC) with prior checkpoint inhibitor (CPI) failure: A prospective cohort of an ongoing phase 1 study.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Clinical endpoint; Oncology; Nausea; Population; Rash; Metastatic Urothelial Carcinoma; Cancer; Adverse effect; Gastroenterology; Clinical trial; Bladder cancer","score_opus":0.04831238446769352,"score_gpt":0.4116602642828975,"score_spread":0.36334787981520394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790862281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967609,0.0000213995,0.000056032564,0.00026329476,0.0003121303,0.0019208564,0.00001724527,0.000009920919,0.00063821796],"genre_scores_gemma":[0.994338,0.0000058651076,0.004523163,0.00024289363,0.000742363,0.000057740785,0.000003929825,0.000043758715,0.000042337633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956289,0.00048346998,0.002363336,0.00038971595,0.00079403137,0.00034052966],"domain_scores_gemma":[0.99583846,0.0004192984,0.0019178338,0.00031315518,0.0010862047,0.0004250235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019112242,0.00028263367,0.002073126,0.00023781098,0.00005577042,0.000012556433,0.00017967005,0.00015810275,0.00013445977],"category_scores_gemma":[0.00094265875,0.00016870131,0.0002067582,0.0003150668,0.00046231295,0.0002517119,0.000037077934,0.0007960524,0.0000066077578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05798905,0.023532148,0.89514524,0.00003743657,0.001021497,0.0007657498,0.0014432536,0.0000024098083,0.00008010674,0.000005854038,0.000049603677,0.019927666],"study_design_scores_gemma":[0.083268106,0.2269739,0.6855792,0.00018298923,0.0011951555,0.00015414882,0.00067428657,0.000023079721,0.0015987264,0.000022403268,0.00020043818,0.00012758437],"about_ca_topic_score_codex":0.00029308244,"about_ca_topic_score_gemma":0.0013927078,"teacher_disagreement_score":0.20956604,"about_ca_system_score_codex":0.0003979911,"about_ca_system_score_gemma":0.0041935714,"threshold_uncertainty_score":0.7439216},"labels":[],"label_agreement":null},{"id":"W2791194794","doi":"10.1016/j.urolonc.2018.01.018","title":"Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology; World Health Organization","keywords":"Nomogram; Medicine; Bladder cancer; Lymphovascular invasion; Internal medicine; Retrospective cohort study; Oncology; Proportional hazards model; Cystectomy; Urology; Disease; Cohort; Cancer; Metastasis","score_opus":0.030298481486270658,"score_gpt":0.3754081287208728,"score_spread":0.34510964723460213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791194794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967256,0.0002028513,0.00019180085,0.0013217113,0.00024384946,0.00094107975,0.000113662085,0.000031523254,0.0002278878],"genre_scores_gemma":[0.9718866,0.00016492346,0.02580486,0.0016818895,0.00018534226,0.0001975693,0.000034551384,0.000013726176,0.000030573996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985811,0.00010042577,0.0004457146,0.00041702995,0.00021592314,0.00023979213],"domain_scores_gemma":[0.9988164,0.00029994146,0.00018379914,0.00020580954,0.00021241646,0.00028164237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021249853,0.00016914186,0.00035275414,0.00016016058,0.00012759306,0.000010066161,0.00007373876,0.00015289367,0.00009825691],"category_scores_gemma":[0.00045383882,0.000117657524,0.000043005304,0.00035258624,0.00057319546,0.000114330796,0.000052810563,0.00019795662,0.000008123035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002201145,0.000577993,0.9640754,0.000020174513,0.00005685844,0.000037218237,0.0003194194,0.00003888101,0.000016521013,0.000084601175,0.001008938,0.031562857],"study_design_scores_gemma":[0.002832403,0.009887913,0.957903,0.0006110924,0.0003266123,0.000005400749,0.000047290338,0.00026492888,0.000042743734,0.0010310693,0.02693458,0.00011295199],"about_ca_topic_score_codex":0.000039213577,"about_ca_topic_score_gemma":0.00012309165,"teacher_disagreement_score":0.031449907,"about_ca_system_score_codex":0.00011676925,"about_ca_system_score_gemma":0.0007540034,"threshold_uncertainty_score":0.47979346},"labels":[],"label_agreement":null},{"id":"W2791514940","doi":"10.5489/cuaj.4877","title":"Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Urinary continence; Urology; Surgery; Urinary incontinence; Urinary system; Confidence interval; Bladder cancer; Internal medicine; Cancer","score_opus":0.012160545146064634,"score_gpt":0.23649461974801778,"score_spread":0.22433407460195315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791514940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848483,0.00046177662,0.00012499858,0.006353671,0.0011511912,0.0002113176,0.0000074276522,0.000042190528,0.0067990795],"genre_scores_gemma":[0.9942193,0.000052080057,0.0003018959,0.0030940522,0.0015020269,0.000010135344,0.000008565012,0.000012970983,0.0007989779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987223,0.0001313502,0.0002699357,0.00022648659,0.00025777143,0.00039214283],"domain_scores_gemma":[0.99893147,0.00005005931,0.00012965674,0.000089824876,0.00013225652,0.00066672836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003289449,0.00014148194,0.00023946751,0.00017287373,0.00047088196,0.000065715,0.000046616813,0.00026915548,0.0010717381],"category_scores_gemma":[0.00017530195,0.00011625745,0.00013208156,0.00016788642,0.00006808883,0.00016049205,0.000012452673,0.00044234982,0.00006731801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023294555,0.00007380114,0.9706625,0.000005974355,0.0003207523,0.00050340896,0.000104775376,3.418908e-7,0.0001320475,0.000058607828,0.0027689522,0.025135903],"study_design_scores_gemma":[0.0026364925,0.0028357352,0.92592055,0.00003212566,0.00028047207,0.0074886954,0.00007879327,0.000060994207,0.000020589936,0.00133473,0.059161488,0.00014932398],"about_ca_topic_score_codex":0.00038257882,"about_ca_topic_score_gemma":0.0001273719,"teacher_disagreement_score":0.056392536,"about_ca_system_score_codex":0.0006810193,"about_ca_system_score_gemma":0.00039297037,"threshold_uncertainty_score":0.9998414},"labels":[],"label_agreement":null},{"id":"W2791728754","doi":"10.1016/j.clgc.2018.02.005","title":"Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; AJCC staging system; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Renal pelvis; Oncology; Confidence interval; Cancer staging; Cancer; Surveillance, Epidemiology, and End Results; Cancer registry; Survival analysis; Internal medicine; Urinary system; Staging system","score_opus":0.08032134750045948,"score_gpt":0.3931273802920347,"score_spread":0.3128060327915752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791728754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904408,0.0036980282,0.000007297833,0.0015424142,0.0007705072,0.0008188272,0.00009831437,0.000021916065,0.0026019006],"genre_scores_gemma":[0.994766,0.0004500458,0.000121888836,0.00068718893,0.0026830954,0.00006497762,0.0000038500984,0.000035214707,0.0011877278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978191,0.00029528377,0.0008271793,0.00037230938,0.00038054684,0.00030555323],"domain_scores_gemma":[0.9979787,0.00039130074,0.0003889272,0.0008456014,0.00026297584,0.000132501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004874067,0.00021350636,0.00053500145,0.000031829233,0.00015657232,0.000006995403,0.00033385726,0.0001355974,0.00040374845],"category_scores_gemma":[0.00024272788,0.000113737144,0.00051282684,0.0002435101,0.0007702496,0.00005399,0.00019406286,0.0003742377,0.000015249839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065303507,0.0006033378,0.9855209,0.00019751459,0.00022877291,0.000036094043,0.00015563345,0.0000030433657,0.0008516975,0.00000966075,0.00033385574,0.011406471],"study_design_scores_gemma":[0.0015158542,0.0018152925,0.98305535,0.000326324,0.00047503837,0.00006293013,0.00009264629,0.00004663434,0.006464445,0.000027348271,0.0060044415,0.00011370784],"about_ca_topic_score_codex":0.00015975421,"about_ca_topic_score_gemma":0.000007001342,"teacher_disagreement_score":0.011292763,"about_ca_system_score_codex":0.00006227242,"about_ca_system_score_gemma":0.00044609953,"threshold_uncertainty_score":0.46380663},"labels":[],"label_agreement":null},{"id":"W2791757400","doi":"10.1200/jco.2018.36.6_suppl.434","title":"Docetaxel with or without ramucirumab after immune checkpoint inhibition in platinum-refractory metastatic urothelial carcinoma (mUC): Prespecified subgroup analysis from the phase 3 RANGE trial.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Clinical endpoint; Metastatic Urothelial Carcinoma; Atezolizumab; Oncology; Progression-free survival; Neutropenia; Ramucirumab; Progressive disease; Population; Tolerability; Discontinuation; Febrile neutropenia; Gastroenterology; Pembrolizumab; Chemotherapy; Cancer; Randomized controlled trial; Adverse effect; Bladder cancer; Immunotherapy","score_opus":0.12710766081345845,"score_gpt":0.444385500738038,"score_spread":0.3172778399245796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791757400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414366,0.0005953118,0.0005621053,0.0022864789,0.0006980324,0.0009802799,0.0000635626,0.000011247201,0.000659324],"genre_scores_gemma":[0.9936281,0.00015456899,0.0016334424,0.0013932916,0.0028038686,0.000088158355,0.00001393261,0.000035049252,0.00024963263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945102,0.0011596469,0.0030015735,0.00036665102,0.00062967365,0.0003322895],"domain_scores_gemma":[0.99449855,0.0024035398,0.0019260426,0.0004560202,0.0004198053,0.0002960593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002870178,0.00028825368,0.0025313213,0.00025982573,0.000065182976,0.000029512443,0.0001685154,0.00027048486,0.0022035],"category_scores_gemma":[0.0015100425,0.00014059652,0.0007822894,0.0005423647,0.0004978395,0.0002034484,0.000047420068,0.0010384372,0.000032082007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8803297,0.007231791,0.08271546,0.000016902983,0.0043672733,0.0023408558,0.0012810869,0.0000031113075,0.00044801136,0.000003853303,0.00035445328,0.020907495],"study_design_scores_gemma":[0.47121146,0.07235244,0.4334328,0.00021166053,0.012021972,0.0002431099,0.00048281325,0.00021433507,0.0012662108,0.0001735229,0.008122817,0.0002668802],"about_ca_topic_score_codex":0.0006867513,"about_ca_topic_score_gemma":0.0025004284,"teacher_disagreement_score":0.40911824,"about_ca_system_score_codex":0.00026403274,"about_ca_system_score_gemma":0.002025007,"threshold_uncertainty_score":0.9987086},"labels":[],"label_agreement":null},{"id":"W2791763446","doi":"10.1200/jco.2018.36.6_suppl.513","title":"Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Cystectomy; Transcriptome; Oncology; Gene expression profiling; Internal medicine; Radiation therapy; Microarray; Survival analysis; Biomarker; Cancer; Gene expression; Gene; Biology; Genetics","score_opus":0.15586708864566995,"score_gpt":0.4707449192174971,"score_spread":0.31487783057182717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791763446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812675,0.00040062328,0.0003287515,0.007356382,0.001495511,0.0007406751,0.000024880545,0.000013336062,0.0015130755],"genre_scores_gemma":[0.9856396,0.00045840538,0.0038692707,0.006964668,0.0027252818,0.000027528917,8.97819e-7,0.000033488483,0.0002808952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99604315,0.0006621792,0.0021845812,0.00032307298,0.0004373196,0.00034972653],"domain_scores_gemma":[0.995225,0.0016879675,0.0010610188,0.00034844136,0.0009646639,0.00071290205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036631464,0.00019869638,0.0015033424,0.00021125027,0.00006087288,0.000008882092,0.00027068748,0.0003132482,0.0004358109],"category_scores_gemma":[0.0038304483,0.00014281254,0.00043279448,0.00027558667,0.00018945278,0.00008443784,0.00010342656,0.00055216975,0.00003508387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17114227,0.003964766,0.36142868,0.000055870572,0.0033524646,0.00037315354,0.0030141305,0.000103636645,0.1854987,0.000036485068,0.009220348,0.2618095],"study_design_scores_gemma":[0.012688781,0.047544174,0.86489695,0.00020589835,0.00048255557,0.00006820047,0.00025936455,0.000016585953,0.04214697,0.000154052,0.031371787,0.00016467746],"about_ca_topic_score_codex":0.00020527098,"about_ca_topic_score_gemma":0.00018392222,"teacher_disagreement_score":0.5034683,"about_ca_system_score_codex":0.00032400896,"about_ca_system_score_gemma":0.0055013555,"threshold_uncertainty_score":0.9759168},"labels":[],"label_agreement":null},{"id":"W2791964283","doi":"10.1016/s0022-5347(18)34449-5","title":"184: Effect of Preoperative Delay on Survival of Bladder Cancer Patients in Quebec: Population-Based Study","year":2005,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Population; Cancer; Urology; General surgery; Gynecology; Internal medicine","score_opus":0.011854385242129117,"score_gpt":0.3055995285980643,"score_spread":0.29374514335593516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791964283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985715,0.00020215494,0.000014084907,0.0004379481,0.00016082468,0.00044481474,0.00000932856,0.000001804756,0.00015749568],"genre_scores_gemma":[0.9996096,0.000015755246,0.000013263599,0.00018834062,0.00009011621,0.000006774965,0.0000021806743,0.000010773284,0.00006321008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858564,0.0005302721,0.00043408578,0.00007063601,0.00026589588,0.000113466835],"domain_scores_gemma":[0.9990402,0.0003383052,0.0003051615,0.00012467493,0.00015410794,0.0000375644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040230868,0.00010855583,0.00044050426,0.00013040876,0.000019209683,0.0000014022141,0.0000895994,0.000048951984,0.00021384974],"category_scores_gemma":[0.00006340389,0.000058804493,0.00006960427,0.00010843855,0.00003210978,0.000040293384,0.000009988503,0.00019077795,0.0000028421991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007222034,0.0009850321,0.9827528,0.0000124842845,0.00027606066,0.0000063991656,0.0011037379,0.0046567423,0.00015468388,0.0000031444467,0.000068953785,0.0027579418],"study_design_scores_gemma":[0.008806873,0.010880616,0.97749513,0.000030007897,0.00044808644,0.0000030441793,0.000052109724,0.000085634914,0.0021308106,0.0000051085276,0.00002287841,0.000039709998],"about_ca_topic_score_codex":0.0066966205,"about_ca_topic_score_gemma":0.011545233,"teacher_disagreement_score":0.009895584,"about_ca_system_score_codex":0.000097883574,"about_ca_system_score_gemma":0.0001317304,"threshold_uncertainty_score":0.99991786},"labels":[],"label_agreement":null},{"id":"W2792689212","doi":"10.5489/cuaj.4922","title":"Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients’ and urologic oncologists’ perspectives","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urinary system; Biomarker; Urologic disease; Urology; Cancer; Internal medicine","score_opus":0.0066696767876722384,"score_gpt":0.23169882265938507,"score_spread":0.22502914587171283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792689212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958679,0.00026678754,0.000010507194,0.0019953467,0.00012166111,0.00047577303,0.00009182049,0.000012708336,0.0011574867],"genre_scores_gemma":[0.9984547,0.00013818457,0.000260361,0.000917057,0.00012609709,0.000025904174,0.00001994576,0.00001824432,0.00003952024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982575,0.0001685011,0.00033217948,0.00036570607,0.0003836672,0.0004924384],"domain_scores_gemma":[0.9982015,0.00016368616,0.00041704773,0.00011684718,0.0006912607,0.0004096954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030976607,0.00021842723,0.0004437804,0.00023857698,0.00019897272,0.000029454284,0.000091735455,0.00020277455,0.00017271494],"category_scores_gemma":[0.0003469597,0.00014616885,0.000058488404,0.000359855,0.0002208437,0.00012097809,0.00001797717,0.00034129675,0.000002693876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013952543,0.00029828574,0.9959795,0.000009623229,0.00038750732,0.00006943327,0.00075693504,0.0000055129626,0.000016732596,0.000003559634,0.00044065923,0.0006370206],"study_design_scores_gemma":[0.006050253,0.009651539,0.9831499,0.00004861811,0.00010190737,0.000019311401,0.00035228903,0.000011192415,0.000024234052,0.0000347719,0.00039301795,0.00016295987],"about_ca_topic_score_codex":0.0030948683,"about_ca_topic_score_gemma":0.008679973,"teacher_disagreement_score":0.01282957,"about_ca_system_score_codex":0.0013485365,"about_ca_system_score_gemma":0.000886675,"threshold_uncertainty_score":0.59605926},"labels":[],"label_agreement":null},{"id":"W2792717752","doi":"10.1016/j.eururo.2018.03.006","title":"Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Willingness to pay; Bladder cancer; Cost effectiveness; Cancer; Internal medicine; Oncology; Immunotherapy","score_opus":0.041437149618426775,"score_gpt":0.3442876869679283,"score_spread":0.3028505373495015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792717752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93180853,0.0008212118,0.0001607993,0.00023339465,0.00041811683,0.0006439944,0.000033030326,0.000042089876,0.06583885],"genre_scores_gemma":[0.9975405,0.00006919399,0.00007042497,0.0011806906,0.00025605585,0.000046770532,0.00001635225,0.00004716494,0.0007728716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986616,0.00038157214,0.0002524494,0.00032148417,0.00010024508,0.0002826704],"domain_scores_gemma":[0.9993435,0.00008886067,0.00007665,0.00029102236,0.00011599396,0.00008393359],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024776874,0.00015830762,0.00036016817,0.00012464299,0.00002620719,0.0000025771376,0.0001019211,0.000051478823,0.0016018278],"category_scores_gemma":[0.000052382147,0.00013596923,0.0000606348,0.00018506621,0.00020842731,0.000043541324,0.000054288328,0.00016254814,0.00015748345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068220526,0.0037125724,0.33678064,0.0011209621,0.0018670389,0.002277828,0.0045978315,0.00046894836,0.2963464,0.0017340856,0.004182488,0.27869067],"study_design_scores_gemma":[0.017252332,0.004555269,0.891931,0.00007830231,0.00016233446,0.00010861194,0.00003068532,0.000076573575,0.03506841,0.0001540627,0.0503679,0.00021454145],"about_ca_topic_score_codex":0.00005666424,"about_ca_topic_score_gemma":0.00015311607,"teacher_disagreement_score":0.55515033,"about_ca_system_score_codex":0.000062006824,"about_ca_system_score_gemma":0.00010469217,"threshold_uncertainty_score":0.99931085},"labels":[],"label_agreement":null},{"id":"W2792782785","doi":"10.1016/j.eururo.2018.02.014","title":"Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Bladder cancer; Resection; Detrusor muscle; Cancer; Urology; Surgery; Internal medicine; Urinary bladder","score_opus":0.04492470978304158,"score_gpt":0.34777947095349376,"score_spread":0.3028547611704522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792782785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007690418,0.98049366,0.000009362908,0.00028527266,0.00070246484,0.0051608994,0.000065072534,0.0000864484,0.013189148],"genre_scores_gemma":[0.000104883096,0.99389905,0.000020778409,0.0021683048,0.00081490306,0.00073371246,0.0001444723,0.00021380131,0.0019000896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944118,0.0022605993,0.0014958311,0.0009664828,0.00030660446,0.00055866194],"domain_scores_gemma":[0.997815,0.00021870446,0.0005700687,0.0010675953,0.00013549323,0.00019312804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009972526,0.0006885412,0.00421777,0.00034927676,0.00006821739,0.000016321192,0.00033771733,0.00028778627,0.0004391895],"category_scores_gemma":[0.0003698531,0.0004957563,0.00077985105,0.00056674797,0.00014828006,0.000052589712,0.00007198392,0.00081256597,0.0010478129],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000625479,0.00012123017,0.000008774674,0.9580708,0.00088242115,0.0011491402,0.00019747634,1.057068e-7,6.6397007e-7,0.000003565503,0.0052945064,0.034208782],"study_design_scores_gemma":[0.0011555966,0.0013486702,0.00005993427,0.5694992,0.014052591,0.0008651285,0.0000068895324,7.6584195e-7,6.630504e-7,0.0000046084187,0.41261694,0.0003889826],"about_ca_topic_score_codex":0.00009852867,"about_ca_topic_score_gemma":0.00022096792,"teacher_disagreement_score":0.40732244,"about_ca_system_score_codex":0.0003028531,"about_ca_system_score_gemma":0.00049647846,"threshold_uncertainty_score":0.9997494},"labels":[],"label_agreement":null},{"id":"W2792882062","doi":"10.1067/j.cpradiol.2018.02.001","title":"Comprehensive Imaging and Surgical Review of Urinary Diversions: What the Radiologist Needs to Know","year":2018,"lang":"en","type":"review","venue":"Current Problems in Diagnostic Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Urinary diversion; Cystectomy; Urinary system; Urethra; Stoma (medicine); Surgery; Modalities; General surgery; Radiology; Bladder cancer; Anatomy; Cancer; Internal medicine","score_opus":0.06366078551329737,"score_gpt":0.37559727960336825,"score_spread":0.31193649409007085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792882062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000062290936,0.9931818,0.000010099898,0.00083097053,0.0014962838,0.0042112023,0.00006726849,0.000023799106,0.000116289295],"genre_scores_gemma":[0.000060562288,0.99802697,0.00003837479,0.000378657,0.00040521403,0.0008001786,0.00022313395,0.000037670266,0.000029244351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969088,0.00071685907,0.0011099849,0.0006142269,0.00018518696,0.0004649379],"domain_scores_gemma":[0.994096,0.0045143478,0.00039222644,0.0006514898,0.00014720087,0.0001987289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048594724,0.0005327411,0.0028174599,0.00033783333,0.00009848601,0.00002422054,0.00037794004,0.00019367502,0.00010399433],"category_scores_gemma":[0.0011669885,0.00031340084,0.00036754506,0.000592048,0.0009686125,0.00008578539,0.00037991535,0.00060675316,0.00005293711],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002261736,0.00026558977,0.0017615296,0.11007079,0.00019824038,0.00016877892,0.0001932227,7.084496e-7,4.9581487e-8,0.00006315028,0.022797156,0.86445814],"study_design_scores_gemma":[0.0006350491,0.00047950025,0.00016513132,0.25783727,0.0010657947,0.0022393346,0.00003951346,0.0000010607819,8.852072e-8,0.00004099691,0.7373022,0.00019405926],"about_ca_topic_score_codex":0.00002148825,"about_ca_topic_score_gemma":9.761472e-7,"teacher_disagreement_score":0.86426413,"about_ca_system_score_codex":0.00018950184,"about_ca_system_score_gemma":0.0003629292,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W2793043667","doi":"10.22374/cjgim.v13i1.214","title":"Late Presentation of Disseminated Bacillus Calmette-Guerin Infection in an Immunocompetent Male","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Adjuvant; Gynecology; BCG vaccine; Gastroenterology; Surgery; Internal medicine; Immunology; Vaccination","score_opus":0.02392662565009099,"score_gpt":0.3163420233905752,"score_spread":0.2924153977404842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793043667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942422,0.00052158296,0.0001964764,0.0009544376,0.00095507666,0.0001510887,0.000009668438,0.000003192044,0.0029662591],"genre_scores_gemma":[0.99633026,0.00008032914,0.00025505104,0.00026187504,0.0011940624,0.0000028691456,0.000013125775,0.00001619253,0.0018462377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988114,0.000068261594,0.0005657032,0.00011670374,0.0002155213,0.00022238225],"domain_scores_gemma":[0.9987254,0.000015736263,0.00023207942,0.0001412037,0.00041358796,0.00047200389],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024010615,0.00012928325,0.00038976964,0.0005216338,0.00003180109,0.000008349012,0.00010531957,0.00006225737,0.00096352294],"category_scores_gemma":[0.000084579944,0.00009693105,0.00006808716,0.00022805146,0.00020940331,0.000116289986,0.000007244921,0.00021975399,0.00000494992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010983663,0.000118628304,0.8403334,0.000068346926,0.000259699,0.0008663913,0.0026444984,0.000049897473,0.12151307,0.000046135934,0.0026106779,0.030390903],"study_design_scores_gemma":[0.00516369,0.0074499934,0.9515507,0.001158569,0.00018196293,0.0014096117,0.00015805825,0.00042153895,0.028847013,0.00010436598,0.0034336746,0.000120782934],"about_ca_topic_score_codex":0.09237595,"about_ca_topic_score_gemma":0.06625557,"teacher_disagreement_score":0.11121735,"about_ca_system_score_codex":0.00028716263,"about_ca_system_score_gemma":0.00035877095,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W2793199699","doi":"10.1200/jco.2018.36.6_suppl.436","title":"C-reactive protein as a prognostic factor in advanced urothelial carcinoma receiving chemotherapy or immunotherapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Performance status; Proportional hazards model; Oncology; Gastroenterology; Discontinuation; C-reactive protein; Lactate dehydrogenase; Inflammation","score_opus":0.08753861650590891,"score_gpt":0.4555690492437165,"score_spread":0.36803043273780756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793199699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057597,0.00026109733,0.00007731811,0.00341145,0.00089334813,0.0010214952,0.0000049880673,0.000015686895,0.0037386452],"genre_scores_gemma":[0.9902614,0.00012893346,0.00364434,0.002848677,0.0019005038,0.000037422942,8.1300516e-7,0.000045850225,0.0011320724],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967947,0.0003808604,0.0018152691,0.00028597278,0.0003727573,0.0003504676],"domain_scores_gemma":[0.99689806,0.0009446221,0.0011664036,0.00023452888,0.00047149428,0.00028491102],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010226952,0.0002261965,0.0014539674,0.00017272998,0.000045708992,0.000011865668,0.00019499067,0.0003787507,0.0011104479],"category_scores_gemma":[0.002756811,0.00014311525,0.00036460557,0.00023754688,0.0002589956,0.00017274423,0.000024612105,0.0008915891,0.000058675116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07769247,0.0037145528,0.4080956,0.000031976222,0.0005588429,0.0011720735,0.0013550556,4.015284e-7,0.01573016,0.000018804758,0.0002058429,0.49142423],"study_design_scores_gemma":[0.037523463,0.07502161,0.8384439,0.00039378883,0.00011822103,0.0005965355,0.00022622976,0.0000139450985,0.008295712,0.00048690598,0.03868392,0.0001957652],"about_ca_topic_score_codex":0.000107958214,"about_ca_topic_score_gemma":0.00013688282,"teacher_disagreement_score":0.49122846,"about_ca_system_score_codex":0.00035217765,"about_ca_system_score_gemma":0.0038699603,"threshold_uncertainty_score":0.99980265},"labels":[],"label_agreement":null},{"id":"W2793296002","doi":"10.5489/cuaj.5246","title":"Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association- Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; Dalhousie University; University of British Columbia; Western University; University of Manitoba; University of Calgary; Princess Margaret Cancer Centre; McGill University Health Centre; University of Ottawa; Université Laval; University of Alberta; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Family medicine; Quality (philosophy); Patient care; Oncology; Internal medicine; Urology; Gynecology; Nursing","score_opus":0.02596985434525657,"score_gpt":0.2879783364823105,"score_spread":0.26200848213705397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793296002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9469789,0.008660574,0.0000024309718,0.030457739,0.001366035,0.0008238053,0.0068888725,0.00001989,0.0048017204],"genre_scores_gemma":[0.97718483,0.00033840092,0.00012333316,0.02087846,0.001038814,0.000063803076,0.00014948282,0.000039045342,0.00018382007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99340916,0.0017372188,0.0016028653,0.0006798722,0.0010186175,0.0015522696],"domain_scores_gemma":[0.9915234,0.0015471879,0.0019191394,0.00036033732,0.0022112557,0.002438674],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016722784,0.0004954593,0.0012933335,0.00027064848,0.0011116274,0.0000970663,0.000387832,0.0010436233,0.0027877532],"category_scores_gemma":[0.0028698838,0.00037814677,0.00030485884,0.00045936243,0.0002952167,0.00010125383,0.0000615887,0.001476257,0.000004878333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033509242,0.000044561413,0.97382754,0.000036312133,0.0010691128,0.00006654315,0.0024949315,0.000026191112,0.00027505987,0.00006565322,0.015448756,0.0063102324],"study_design_scores_gemma":[0.0025529484,0.0012118856,0.8900629,0.00004998344,0.00051814603,0.000022522181,0.0034535239,0.000039081937,0.00015394103,0.00012974857,0.10139054,0.00041476483],"about_ca_topic_score_codex":0.99818903,"about_ca_topic_score_gemma":0.99986315,"teacher_disagreement_score":0.085941784,"about_ca_system_score_codex":0.0151148625,"about_ca_system_score_gemma":0.021941045,"threshold_uncertainty_score":0.999867},"labels":[],"label_agreement":null},{"id":"W2793367136","doi":"10.1016/j.juro.2018.03.006","title":"The Bladder Utility Symptom Scale: A Novel Patient Reported Outcome Instrument for Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Scale (ratio); Outcome (game theory); Patient-reported outcome; Cancer; Urology; Internal medicine; Quality of life (healthcare); Nursing","score_opus":0.05384717053762204,"score_gpt":0.33425136084898743,"score_spread":0.2804041903113654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793367136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711817,0.0016347615,0.0015733342,0.021712597,0.0018587288,0.00077994063,0.000028651697,0.000016021326,0.0012142531],"genre_scores_gemma":[0.9947697,0.0002582631,0.00022643415,0.0035973438,0.00070666726,0.000033084245,0.0000013393462,0.000023170043,0.000384007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982992,0.00009810354,0.00077253196,0.0001491493,0.00032534762,0.0003556624],"domain_scores_gemma":[0.9980641,0.00025122357,0.00058659015,0.00041776127,0.0005477401,0.0001326016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074093277,0.00017319419,0.00036820557,0.000052078925,0.00028671048,0.000013714565,0.00020675441,0.00009953064,0.00022156553],"category_scores_gemma":[0.00015832823,0.000079815705,0.00018808701,0.00011332828,0.0004167651,0.000048971935,0.000056691286,0.00028737434,0.000006694414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062253166,0.0040482352,0.43128765,0.000119827724,0.01717042,0.00014020115,0.011928888,0.000063314095,0.021149162,0.0006460918,0.07917663,0.3720164],"study_design_scores_gemma":[0.019198759,0.017964274,0.50703096,0.00006591003,0.006541281,0.0047700475,0.0011208821,0.0008781413,0.008792085,0.0021326554,0.43109155,0.0004134623],"about_ca_topic_score_codex":0.00012662818,"about_ca_topic_score_gemma":0.0001556698,"teacher_disagreement_score":0.37160295,"about_ca_system_score_codex":0.000094906245,"about_ca_system_score_gemma":0.000328055,"threshold_uncertainty_score":0.325479},"labels":[],"label_agreement":null},{"id":"W2793782219","doi":"10.1200/jco.2018.36.6_suppl.472","title":"Cost-effectiveness of pembrolizumab in second-line advanced bladder cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Bladder cancer; Willingness to pay; Cost effectiveness; Oncology; Internal medicine; Quality-adjusted life year; Cancer; Immunotherapy","score_opus":0.18572527601231326,"score_gpt":0.5304688733149896,"score_spread":0.34474359730267634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793782219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830795,0.00096879323,0.00014190796,0.0010793407,0.0018251584,0.00044662645,0.000012868035,0.00000547237,0.0072118887],"genre_scores_gemma":[0.9960485,0.0006650512,0.0007078281,0.0011122224,0.0011533757,0.00001894116,0.0000016360649,0.000018199127,0.0002742607],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970677,0.0004978413,0.0017661481,0.00018420772,0.00025805904,0.00022604264],"domain_scores_gemma":[0.9963968,0.0014418049,0.0010656014,0.00017723776,0.0006760302,0.00024255001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019401979,0.00013632796,0.0016379652,0.00013959802,0.000018302235,0.0000022493423,0.00013527565,0.00029461682,0.0010259806],"category_scores_gemma":[0.0010728542,0.00009651277,0.0003317358,0.00019868725,0.00032388937,0.0001020637,0.000034083205,0.0006112742,0.000012752104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09850152,0.005965476,0.2528757,0.000275525,0.0014898027,0.000786864,0.00030656788,0.00006669504,0.0054839305,0.00016323572,0.001768485,0.63231623],"study_design_scores_gemma":[0.051700424,0.04301187,0.8466723,0.00046302093,0.0004605471,0.00025580425,0.00008868961,0.000053317548,0.010390508,0.00081141066,0.04596298,0.0001291221],"about_ca_topic_score_codex":0.00006211102,"about_ca_topic_score_gemma":0.00038709032,"teacher_disagreement_score":0.63218707,"about_ca_system_score_codex":0.0002617179,"about_ca_system_score_gemma":0.0024699233,"threshold_uncertainty_score":0.9998872},"labels":[],"label_agreement":null},{"id":"W2794154391","doi":"10.1200/jco.2018.36.6_suppl.408","title":"Selective bladder preservation with twice-daily radiation plus 5-flourouracil/cisplatin (FCT) or daily radiation plus gemcitabine (GD) for patients with muscle invasive bladder cancer: Primary results of NRG/RTOG 0712—A randomized phase 2 multicenter trial.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Gemcitabine; Bladder cancer; Regimen; Urology; Cystectomy; Clinical endpoint; Internal medicine; Toxicity; Cisplatin; Gastroenterology; Surgery; Oncology; Nuclear medicine; Chemotherapy; Cancer; Randomized controlled trial","score_opus":0.06305900183668589,"score_gpt":0.4121444219876597,"score_spread":0.3490854201509738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794154391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840669,0.00026940994,0.0032042204,0.0031318972,0.0013549372,0.006811636,0.0002406153,0.000026327032,0.0008940594],"genre_scores_gemma":[0.98723745,0.0006459196,0.0058440217,0.002203076,0.0028143048,0.00033028924,0.00025265562,0.000076239216,0.00059602165],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933863,0.001076791,0.0036218944,0.00053521595,0.00093880936,0.00044094244],"domain_scores_gemma":[0.9838147,0.0061815716,0.005711266,0.0003485928,0.0035501432,0.00039371528],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029681108,0.0004067018,0.0029342428,0.0002884892,0.00013750869,0.000027667294,0.00021882531,0.00047954867,0.00014823201],"category_scores_gemma":[0.008683118,0.00024127304,0.0004732575,0.0004190318,0.00046082027,0.0007302821,0.000040947198,0.00064595597,0.00000509841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93162096,0.004304991,0.0031695627,0.00010221494,0.0032133937,0.000030691655,0.0018338109,0.00018239948,0.00011834212,0.0000042461224,0.0060043405,0.049415063],"study_design_scores_gemma":[0.85542053,0.08871138,0.0440753,0.00026954195,0.00393939,0.000012086732,0.00013843755,0.0015944052,0.00060512463,0.000039205148,0.004952363,0.00024221942],"about_ca_topic_score_codex":0.00034135106,"about_ca_topic_score_gemma":0.0004937561,"teacher_disagreement_score":0.08440639,"about_ca_system_score_codex":0.0009583834,"about_ca_system_score_gemma":0.0067459126,"threshold_uncertainty_score":0.99966717},"labels":[],"label_agreement":null},{"id":"W2794297331","doi":"10.1200/jco.2018.36.6_suppl.410","title":"Two-year follow-up from the phase 3 KEYNOTE-045 trial of pembrolizumab (pembro) vs investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Docetaxel; Medicine; Pembrolizumab; Internal medicine; Paclitaxel; Regimen; Clinical endpoint; Oncology; Chemotherapy; Cancer; Clinical trial; Immunotherapy","score_opus":0.15059133438656336,"score_gpt":0.49691032084698405,"score_spread":0.3463189864604207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794297331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779296,0.0010367981,0.0000330084,0.009011968,0.008032629,0.0010910447,0.00016505859,0.000018311966,0.0026815603],"genre_scores_gemma":[0.97705585,0.0019813182,0.0022249517,0.006964795,0.011036153,0.000058940805,0.00001095112,0.000062936306,0.0006041133],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99341947,0.0011354693,0.0036957788,0.00046451244,0.00077820395,0.00050657726],"domain_scores_gemma":[0.99115413,0.004048733,0.0026838002,0.0005831528,0.0007836892,0.0007465042],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002242972,0.00037472954,0.0025841931,0.00017542942,0.000089345835,0.000018875959,0.000567531,0.00048759897,0.0013998516],"category_scores_gemma":[0.013180541,0.00021837662,0.0007546617,0.00044995704,0.00088615075,0.00025719462,0.00011444998,0.0014912705,0.000036806792],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8393025,0.0049327477,0.028697884,0.000042203883,0.0011070173,0.00022749383,0.00060294435,0.0000052098194,0.0012203942,0.00009888555,0.014749666,0.109013066],"study_design_scores_gemma":[0.6799118,0.08436862,0.027897514,0.0006582725,0.00147345,0.0000518094,0.00023380657,0.00005452876,0.0010434554,0.00073489256,0.20329393,0.0002779437],"about_ca_topic_score_codex":0.001419178,"about_ca_topic_score_gemma":0.003270295,"teacher_disagreement_score":0.18854427,"about_ca_system_score_codex":0.0003724094,"about_ca_system_score_gemma":0.0074865683,"threshold_uncertainty_score":0.99951303},"labels":[],"label_agreement":null},{"id":"W2794426755","doi":"10.1200/jco.2018.36.6_suppl.451","title":"Nivolumab demonstrates benefit over nomogram-predicted 12-month survival as salvage therapy for metastatic urothelial carcinoma.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nomogram; Nivolumab; Internal medicine; Oncology; Metastatic Urothelial Carcinoma; Clinical endpoint; Confidence interval; Urology; Statistical significance; Clinical trial; Cancer; Bladder cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.12614052563275158,"score_gpt":0.45635219054460147,"score_spread":0.3302116649118499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794426755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853575,0.0007426182,0.0005783468,0.002612687,0.0033543669,0.0008279239,0.00008938064,0.000027973261,0.0064092046],"genre_scores_gemma":[0.98607385,0.00049291947,0.0045200386,0.0031411075,0.0048232274,0.000024955621,0.00001447601,0.00005405765,0.0008553666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631757,0.000297479,0.0021154464,0.0003262944,0.0004988969,0.000444321],"domain_scores_gemma":[0.9953358,0.0018315163,0.0012065273,0.00029565164,0.0007645378,0.00056592503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017820396,0.0002763741,0.0018306555,0.00014404465,0.000110273126,0.000023885292,0.00025442618,0.00035778308,0.0007743082],"category_scores_gemma":[0.0012590836,0.00018906045,0.00090530387,0.00014517234,0.00048334087,0.00014291416,0.0000342566,0.0006116063,0.000029581648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08374781,0.008211624,0.46084207,0.00006824743,0.004873917,0.001008734,0.00047550825,0.000003752197,0.0014234744,0.0006256791,0.012964709,0.4257545],"study_design_scores_gemma":[0.07502171,0.14448845,0.6484239,0.000102243874,0.0019878757,0.00055582623,0.00021026291,0.00025662678,0.0013641968,0.0039529544,0.12332576,0.0003102096],"about_ca_topic_score_codex":0.0002495126,"about_ca_topic_score_gemma":0.0003307573,"teacher_disagreement_score":0.42544428,"about_ca_system_score_codex":0.00015520348,"about_ca_system_score_gemma":0.0026647523,"threshold_uncertainty_score":0.84781325},"labels":[],"label_agreement":null},{"id":"W2795000153","doi":"10.1111/bju.14220","title":"Modelling cost‐effectiveness of a biomarker‐based approach to neoadjuvant chemotherapy for muscle‐invasive bladder cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bladder cancer; Biomarker; Oncology; Medicine; Cystectomy; Cost effectiveness; ERCC2; Internal medicine; Chemotherapy; Cancer; DNA repair; Gene; Biology; Nucleotide excision repair","score_opus":0.04571252368406054,"score_gpt":0.31804074047739456,"score_spread":0.272328216793334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795000153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63570064,0.004389345,0.35567442,0.0006921228,0.0005877591,0.00172578,0.00015436218,0.00001698066,0.0010586012],"genre_scores_gemma":[0.9910714,0.0004014601,0.00648755,0.0014508917,0.00040461888,0.00010257398,0.000008584116,0.000043161257,0.00002974855],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874234,0.00011951082,0.00040888577,0.00023293839,0.00020272355,0.00029362662],"domain_scores_gemma":[0.99848044,0.00019813562,0.00024215062,0.00013362919,0.00076332357,0.00018233739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043925026,0.00014903751,0.0005908826,0.00015902238,0.0000621466,0.000012061464,0.00012985569,0.00012939205,0.000063353466],"category_scores_gemma":[0.00007599703,0.00014558416,0.0002206414,0.00017202744,0.00014804024,0.000055100605,0.000013234617,0.00013778254,0.0000014865643],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07127429,0.0073243757,0.009284967,0.0018629874,0.006682525,0.00076678896,0.0019949619,0.055170637,0.122255474,0.00015639397,0.011330506,0.71189606],"study_design_scores_gemma":[0.22343639,0.06987545,0.21854655,0.0073083886,0.0072556925,0.017316934,0.0006617717,0.13683413,0.24366263,0.004573138,0.06797795,0.0025509857],"about_ca_topic_score_codex":0.00043095977,"about_ca_topic_score_gemma":0.00003451386,"teacher_disagreement_score":0.7093451,"about_ca_system_score_codex":0.00008840085,"about_ca_system_score_gemma":0.0004710976,"threshold_uncertainty_score":0.5936749},"labels":[],"label_agreement":null},{"id":"W2795278882","doi":"10.5489/cuaj.5039","title":"Recurrence and upstaging rates of T1 high-grade urothelial carcinoma of the bladder on repeat resection in a Canadian, resource-limited, healthcare system","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bladder cancer; Malignancy; Resection; Carcinoma; Pathological; Urology; Surgery; Cancer; Internal medicine","score_opus":0.02212604886917119,"score_gpt":0.26473077033044673,"score_spread":0.24260472146127554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795278882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802222,0.00028484027,0.0000017395527,0.017635781,0.0003326499,0.0003373304,0.00011894381,0.0000056249337,0.0010608416],"genre_scores_gemma":[0.9980668,0.000029721949,0.000019565323,0.0014107954,0.0003313779,0.000008344726,0.0000057674724,0.000011613726,0.00011600961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823064,0.00038311246,0.0004092615,0.00020709481,0.00032136953,0.00044853878],"domain_scores_gemma":[0.9986112,0.0001105162,0.00029184317,0.00016389696,0.00028299214,0.0005395288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006721394,0.00012964701,0.00029759813,0.000322238,0.000247309,0.000022693706,0.000109923014,0.00020573597,0.00004975108],"category_scores_gemma":[0.00047648558,0.00009037778,0.000073905314,0.0003844832,0.00009222503,0.000042075535,0.000011660669,0.0004695489,0.0000028350328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020564209,0.000022926717,0.9966462,0.00002620462,0.00005092898,0.000035236455,0.0005611074,0.000009435307,0.00006769763,0.00038592485,0.0010665687,0.000922084],"study_design_scores_gemma":[0.0014116152,0.0010501907,0.99211025,0.00020028082,0.00005397896,0.0001529631,0.0003981773,0.00012580867,0.000675168,0.00016605604,0.0035719173,0.000083576146],"about_ca_topic_score_codex":0.41935056,"about_ca_topic_score_gemma":0.4451525,"teacher_disagreement_score":0.02580194,"about_ca_system_score_codex":0.0019887257,"about_ca_system_score_gemma":0.0013579549,"threshold_uncertainty_score":0.58451605},"labels":[],"label_agreement":null},{"id":"W2795998039","doi":"10.1016/j.juro.2018.02.198","title":"MP06-06 DOES URINARY CYTOLOGY HAVE A ROLE IN HEMATURIA INVESTIGATIONS? RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY (DETECT I)","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytology; Observational study; Urology; Urinary system; Gynecology; Internal medicine; Pathology","score_opus":0.04754623683991114,"score_gpt":0.327796542362027,"score_spread":0.28025030552211583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795998039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462694,0.00036111294,0.000019057034,0.00368652,0.00013690912,0.00048080328,0.000010517437,0.0000054928555,0.0006726364],"genre_scores_gemma":[0.99871224,0.000022941618,0.00033385342,0.0004745636,0.00029462745,0.000011814565,0.0000022146555,0.000010286555,0.00013743943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986243,0.00031945572,0.00057358964,0.000118214826,0.00020627798,0.00015816286],"domain_scores_gemma":[0.99873453,0.000268479,0.0004031125,0.00020722457,0.000329532,0.00005712886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068019476,0.000110219895,0.0003870255,0.00017309182,0.00005264065,0.0000027057476,0.00014474052,0.000078479825,0.000041160965],"category_scores_gemma":[0.00036154702,0.000059612703,0.00005895042,0.0001735518,0.00031929623,0.000065032036,0.000044465312,0.00030007132,0.00000641139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017423786,0.0019217534,0.9510538,0.000017724562,0.00065970677,0.00019321628,0.016439706,0.000035204528,0.011060408,0.00016583187,0.00074000255,0.00028888887],"study_design_scores_gemma":[0.008228347,0.014771895,0.95613116,0.00002679787,0.00030740976,0.0010720136,0.0011284588,0.00005101457,0.004724259,0.013197159,0.0003038851,0.00005758511],"about_ca_topic_score_codex":0.00013915524,"about_ca_topic_score_gemma":0.00029168808,"teacher_disagreement_score":0.015311248,"about_ca_system_score_codex":0.00006145727,"about_ca_system_score_gemma":0.00027488204,"threshold_uncertainty_score":0.24309355},"labels":[],"label_agreement":null},{"id":"W2796150689","doi":"10.1002/cncr.31372","title":"Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis","year":2018,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Lymphovascular invasion; Medicine; Hazard ratio; Renal pelvis; Oncology; Internal medicine; Cancer; Carcinoma; Urology; Confidence interval; Metastasis; Urinary system","score_opus":0.021995314904648757,"score_gpt":0.2793213167184626,"score_spread":0.2573260018138139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796150689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578154,0.0016179589,0.000008970051,0.00022899343,0.00021090465,0.0004802394,0.000027283826,0.0000062145577,0.0016378943],"genre_scores_gemma":[0.9990589,0.00007612487,0.000056507863,0.00026643556,0.00021522948,0.000056854584,0.00000210272,0.000015859488,0.00025198673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991562,0.00002894839,0.00024458015,0.0001779019,0.00024185663,0.00015055592],"domain_scores_gemma":[0.99937534,0.000017179143,0.00010465615,0.0003380977,0.00012204234,0.000042681866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008278149,0.00009893067,0.00024052768,0.00004647229,0.000023100863,0.0000018014122,0.000102739396,0.00005381062,0.00033217506],"category_scores_gemma":[0.0000561755,0.000062891006,0.000106506486,0.00026213037,0.0001910436,0.00002971238,0.00003511781,0.00006130004,0.0000041630633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023539638,0.000092673625,0.9798968,0.0000900016,0.000048809125,0.000007163749,0.00044353222,0.0000020608045,0.016022762,0.000032676115,0.00030762528,0.0028205304],"study_design_scores_gemma":[0.002395944,0.0002627384,0.8588275,0.00032908336,0.00011912223,0.000009585654,0.000030262532,0.000031377345,0.13709226,0.00008736428,0.0007576358,0.000057154855],"about_ca_topic_score_codex":0.0010468714,"about_ca_topic_score_gemma":0.00055784814,"teacher_disagreement_score":0.1210695,"about_ca_system_score_codex":0.000119053955,"about_ca_system_score_gemma":0.0004970741,"threshold_uncertainty_score":0.36370838},"labels":[],"label_agreement":null},{"id":"W2796329816","doi":"10.1016/j.clgc.2018.03.016","title":"Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Oncology; Docetaxel; Internal medicine; Pazopanib; Sunitinib; Confidence interval; Carboplatin; Renal cell carcinoma; Urology; Chemotherapy; Cisplatin","score_opus":0.18361739499181,"score_gpt":0.45337110015947707,"score_spread":0.26975370516766706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796329816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917793,0.001159922,0.00027108865,0.0029600316,0.0010774075,0.001965871,0.00018123382,0.000011186816,0.00059394154],"genre_scores_gemma":[0.9931731,0.00037944913,0.0010321435,0.0027438877,0.0016270853,0.00026926716,0.0000108163695,0.000042472468,0.00072175806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979397,0.00018816767,0.00083582196,0.0003342336,0.00037899413,0.0003230715],"domain_scores_gemma":[0.9981312,0.0006603353,0.0002176931,0.000661102,0.00020201707,0.00012762393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078919734,0.00021510333,0.000638574,0.000054713597,0.00007328524,0.000012466537,0.0004430365,0.00008437277,0.000287398],"category_scores_gemma":[0.00011522605,0.00012195033,0.0003802188,0.00033558064,0.00024119327,0.000043177657,0.0000583848,0.0002707306,0.000009530578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018533496,0.0036140864,0.5824702,0.0002869378,0.0016093864,0.00007073682,0.005738864,0.000067656176,0.0035295652,0.00020785262,0.016080465,0.36779076],"study_design_scores_gemma":[0.010607479,0.0077782795,0.9427561,0.00020735421,0.00049914746,0.00001221335,0.0005041412,0.000079586345,0.0049538333,0.00060553005,0.031778593,0.00021771234],"about_ca_topic_score_codex":0.0015448643,"about_ca_topic_score_gemma":0.0004152816,"teacher_disagreement_score":0.36757305,"about_ca_system_score_codex":0.000055656343,"about_ca_system_score_gemma":0.0005428051,"threshold_uncertainty_score":0.49729902},"labels":[],"label_agreement":null},{"id":"W2796765559","doi":"10.1111/bju.14238","title":"The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer","year":2018,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Bladder cancer; Proportional hazards model; Hazard ratio; Concomitant; Oncology; Cancer; Confidence interval","score_opus":0.028383580562622572,"score_gpt":0.31465105700726514,"score_spread":0.28626747644464257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796765559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94971484,0.009176279,0.0016464384,0.034671728,0.0019135706,0.0024038136,0.0001750043,0.000046117817,0.00025221403],"genre_scores_gemma":[0.99488443,0.0015556664,0.00030768104,0.0021348053,0.00092170207,0.000051428888,0.000018342427,0.00003384327,0.00009210708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998586,0.00010045536,0.0006453917,0.00019559359,0.00018354358,0.0002890181],"domain_scores_gemma":[0.99849993,0.000112453556,0.0005135446,0.00014198263,0.0005644014,0.00016767393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041076986,0.00010630875,0.0003114783,0.00011483999,0.00020094056,0.000038856375,0.00012584186,0.00007650242,0.000049901824],"category_scores_gemma":[0.0001675247,0.00008829135,0.00005595906,0.00030237113,0.00014669255,0.00009688294,0.000011449035,0.00018417796,0.0000033057377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028841968,0.002541243,0.6326885,0.00069996767,0.0015136334,0.0007379618,0.0054944977,0.000011564432,0.0087819705,0.0023954094,0.08316909,0.25908196],"study_design_scores_gemma":[0.006741023,0.0048387204,0.9626665,0.00049074745,0.00040564864,0.0036405488,0.000996817,0.00033330932,0.0028912444,0.00028051937,0.016518675,0.00019621424],"about_ca_topic_score_codex":0.000331116,"about_ca_topic_score_gemma":0.004306438,"teacher_disagreement_score":0.32997802,"about_ca_system_score_codex":0.0002335031,"about_ca_system_score_gemma":0.00094001566,"threshold_uncertainty_score":0.36004168},"labels":[],"label_agreement":null},{"id":"W2796945520","doi":"10.1016/j.urolonc.2018.03.015","title":"Monopolar vs. bipolar transurethral resection for non–muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Perforation; Randomized controlled trial; Perioperative; Surgery; Incidence (geometry); Urology; Cancer; Urinary system; Internal medicine","score_opus":0.022346264565417197,"score_gpt":0.30980139577893673,"score_spread":0.2874551312135195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796945520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839015,0.0024536774,0.000865748,0.005879602,0.00055177364,0.0054730657,0.00022105813,0.00006713691,0.00058643095],"genre_scores_gemma":[0.9721221,0.0005559496,0.019794015,0.002912921,0.0010763186,0.0024392966,0.00040937518,0.000029527002,0.00066053367],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758464,0.00047497847,0.0006871006,0.00062822725,0.00021905774,0.00040599724],"domain_scores_gemma":[0.9970433,0.0016262018,0.00031245642,0.00029290482,0.00039110897,0.00033404247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008245256,0.00033887615,0.0019814903,0.00042274414,0.0004765059,0.000042822838,0.000110798195,0.00044805295,0.00030470555],"category_scores_gemma":[0.0007928975,0.00024482314,0.00067359983,0.0005062691,0.0012242352,0.00013909566,0.000023504144,0.00030024862,0.000014650597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97769976,0.00044657072,0.012739941,0.000016011903,0.0039092805,0.00003635198,0.0019287985,0.000005657289,0.0011941718,0.00038506318,0.0010530982,0.0005852795],"study_design_scores_gemma":[0.8930694,0.031027816,0.0018126519,0.000020950602,0.020080313,0.000025849959,0.00027994046,0.0023334033,0.00089743664,0.0042616185,0.04592337,0.0002672891],"about_ca_topic_score_codex":0.0011339854,"about_ca_topic_score_gemma":0.0012712306,"teacher_disagreement_score":0.084630415,"about_ca_system_score_codex":0.00014493553,"about_ca_system_score_gemma":0.0008412869,"threshold_uncertainty_score":0.99835974},"labels":[],"label_agreement":null},{"id":"W2799698221","doi":"10.1007/s00345-018-2306-7","title":"Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Lymph node; Dissection (medical); Bladder cancer; Logistic regression; Univariate analysis; Urology; Population; Surgery; Internal medicine; Multivariate analysis; Cancer","score_opus":0.07810269801065191,"score_gpt":0.4023485188918468,"score_spread":0.3242458208811949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799698221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136066,0.00030919525,0.0015557179,0.0052766073,0.0007776199,0.0004441428,0.000009643841,0.0000059681965,0.00026041322],"genre_scores_gemma":[0.996752,0.0000027244826,0.0013164069,0.0012363305,0.00051104446,0.000021105683,0.0000068982426,0.000010825876,0.00014265219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988907,0.00006704453,0.0006372005,0.00012287285,0.00017932052,0.000102888305],"domain_scores_gemma":[0.9988602,0.00012141198,0.00025144208,0.00009094084,0.0006027705,0.00007327574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031337875,0.00008989503,0.00032979815,0.0004309705,0.000022350108,0.000004992775,0.00009620615,0.000035726334,0.00011538044],"category_scores_gemma":[0.00034593375,0.00006954229,0.000079067075,0.00020023208,0.0000324917,0.000049619037,0.000011905374,0.00007767608,0.0000025248623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061333594,0.0005301448,0.98828685,0.000013990028,0.00012410298,0.000035245495,0.0001915641,0.00010912779,0.000855714,0.000013757727,0.001116284,0.0025898507],"study_design_scores_gemma":[0.012499392,0.006013186,0.9769752,0.000114766015,0.00010431273,0.0000754579,0.00013431834,0.00090627617,0.0005439915,0.00015271097,0.0024034516,0.000076912],"about_ca_topic_score_codex":0.0003133384,"about_ca_topic_score_gemma":0.0005073032,"teacher_disagreement_score":0.011311634,"about_ca_system_score_codex":0.0000836414,"about_ca_system_score_gemma":0.00025044548,"threshold_uncertainty_score":0.28358525},"labels":[],"label_agreement":null},{"id":"W2800216148","doi":"10.5206/uwomj.v86is1.2111","title":"Two cases of plasmacytoid variant of bladder cancer","year":2018,"lang":"en","type":"article","venue":"University of Western Ontario Medical Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoprostatectomy; Cystoscopy; Bladder cancer; Urinary diversion; Maspin; Surgery; Ileostomy; Urology; Cystectomy; Urinary system; Cancer; Internal medicine; Metastasis","score_opus":0.023697669478482526,"score_gpt":0.2815975525909473,"score_spread":0.2578998831124648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800216148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944024,0.00013233034,0.00050969596,0.00054014655,0.0002552972,0.000087187094,0.000025639025,0.0000056113304,0.0040416615],"genre_scores_gemma":[0.9968875,0.00018128364,0.0006303427,0.00015453115,0.00020695536,6.135167e-8,0.0000026734922,0.000007421498,0.0019292098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876297,0.000037981663,0.00026309182,0.00012051514,0.00064955064,0.00016589997],"domain_scores_gemma":[0.9989387,0.000052721756,0.00024731786,0.00014145006,0.00030237914,0.0003174351],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015562233,0.00010295252,0.00040369562,0.00010992302,0.00006265584,0.00000255347,0.00018098965,0.00008677218,0.010285401],"category_scores_gemma":[0.000034489138,0.00008760145,0.00013943248,0.000079683035,0.0004495897,0.00007569637,0.00006170442,0.0002637685,0.000008250601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037109596,0.0009843595,0.96395534,0.00010555671,0.0015936694,0.00327389,0.008629686,0.0000033510526,0.0014575284,0.000051711828,0.0023905933,0.013843378],"study_design_scores_gemma":[0.035873033,0.0082372585,0.8716025,0.0031322117,0.0030108928,0.009899061,0.003282517,0.00006457374,0.019895768,0.0001660986,0.04440727,0.00042881284],"about_ca_topic_score_codex":0.104849346,"about_ca_topic_score_gemma":0.17871577,"teacher_disagreement_score":0.092352815,"about_ca_system_score_codex":0.00018726819,"about_ca_system_score_gemma":0.0019210248,"threshold_uncertainty_score":0.99061936},"labels":[],"label_agreement":null},{"id":"W2800694556","doi":"10.5114/jcb.2018.75604","title":"Don’t forget the bladder!","year":2018,"lang":"en","type":"article","venue":"Journal of Contemporary Brachytherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brachytherapy; Medicine; Surgery; Radiation therapy","score_opus":0.03295499212706933,"score_gpt":0.3112015547251296,"score_spread":0.2782465625980603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800694556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852515,0.01740092,0.0014338886,0.032721825,0.0019409828,0.00074213586,0.000013828411,0.000047260597,0.06044761],"genre_scores_gemma":[0.9874613,0.0003055461,0.00035264084,0.006999652,0.002746822,0.0000043778946,0.000001836783,0.000028987304,0.002098781],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879396,0.00007762151,0.000469485,0.00011149879,0.00037455515,0.00017290274],"domain_scores_gemma":[0.99882,0.00007136779,0.00034881395,0.0002811717,0.0003387421,0.00013988181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000385023,0.00015271538,0.00035287754,0.000089248555,0.00011725512,0.000030106936,0.00016955916,0.000066014785,0.00029578822],"category_scores_gemma":[0.000026308251,0.000080927,0.00024906633,0.00015860848,0.00017655773,0.00024283827,0.000012400278,0.0002503084,0.00002425018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019783126,0.0018173037,0.22288674,0.0000715545,0.0054125567,0.0014511126,0.007844293,0.0000017548308,0.019384306,0.001174705,0.5449263,0.17524625],"study_design_scores_gemma":[0.010290854,0.008140655,0.057307683,0.00015517294,0.00016946555,0.0022590493,0.0005423419,0.000023761504,0.013373968,0.0023186859,0.9052227,0.00019563096],"about_ca_topic_score_codex":0.000026414007,"about_ca_topic_score_gemma":0.0000080184545,"teacher_disagreement_score":0.36029643,"about_ca_system_score_codex":0.000040249837,"about_ca_system_score_gemma":0.0004664106,"threshold_uncertainty_score":0.33001074},"labels":[],"label_agreement":null},{"id":"W2801341857","doi":"10.5489/cuaj.5427","title":"Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Call to action; Urology; Substitution (logic); Cancer; Internal medicine; Computer science; Business","score_opus":0.024611782134218253,"score_gpt":0.28975132587835617,"score_spread":0.2651395437441379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801341857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97957,0.00009883047,0.0013706747,0.015106046,0.0015392959,0.00090878655,0.00010667086,0.00004849835,0.0012512179],"genre_scores_gemma":[0.98642117,0.00004113651,0.00037489523,0.009838283,0.002017842,0.0000981336,0.000039245042,0.000021294923,0.0011479844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829406,0.000088230714,0.0003387191,0.00029135955,0.00037533193,0.00061231776],"domain_scores_gemma":[0.9980278,0.00009827765,0.00017401982,0.00010225489,0.00064069376,0.00095692836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002691076,0.00017963271,0.00027843946,0.00020546073,0.0005004667,0.00008046486,0.00008997939,0.00029602263,0.0008397688],"category_scores_gemma":[0.0006639927,0.00014707884,0.00015364957,0.00024985147,0.000046331676,0.00012402417,0.0000108418335,0.0003198327,0.00009105519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005166175,0.00018232892,0.9497557,0.000015070689,0.0005783777,0.000023885996,0.00030200303,0.000022595941,0.00028727142,0.00017758622,0.037594773,0.010543763],"study_design_scores_gemma":[0.0049858,0.0021522236,0.76191014,0.000038748567,0.00033401686,0.000046952093,0.000028771907,0.00011594403,0.0003019009,0.00034523208,0.22951053,0.00022973136],"about_ca_topic_score_codex":0.0015641697,"about_ca_topic_score_gemma":0.011770696,"teacher_disagreement_score":0.19191577,"about_ca_system_score_codex":0.0027809562,"about_ca_system_score_gemma":0.0013350623,"threshold_uncertainty_score":0.91948795},"labels":[],"label_agreement":null},{"id":"W2801389053","doi":"10.1111/bju.14366","title":"Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta‐analysis","year":2018,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University; University of Ottawa","funders":"","keywords":"Medicine; Magnetic resonance imaging; Meta-analysis; Confidence interval; Stage (stratigraphy); Diagnostic accuracy; Bladder cancer; Gold standard (test); Radiology; Nuclear medicine; Internal medicine; Cancer","score_opus":0.038947764978397956,"score_gpt":0.35051801965966956,"score_spread":0.3115702546812716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801389053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000641825,0.996803,0.00012047448,0.0002209175,0.000095674244,0.0021701904,0.00054964324,0.0000047304825,0.000028990247],"genre_scores_gemma":[0.000408525,0.99826616,0.00032713384,0.00043494726,0.00012307541,0.00026598742,0.000015274381,0.000052849133,0.000106074476],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99635,0.00043967925,0.0022855317,0.00032280321,0.00030577928,0.00029622208],"domain_scores_gemma":[0.99412835,0.0017408254,0.002914074,0.00029954134,0.000772666,0.00014452083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009069565,0.00035078285,0.009462938,0.0003723454,0.000044060922,0.000016980697,0.0002691079,0.00012204467,0.0003365109],"category_scores_gemma":[0.0018413402,0.00028143296,0.00207965,0.00045325953,0.00020517863,0.000083924846,0.00005649966,0.00031075228,0.0000011623431],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033621112,0.00012694536,0.000066634784,0.8761356,0.0647549,0.00034990997,0.000027789585,4.707523e-7,3.3283354e-7,0.000004126745,0.0011412185,0.05735843],"study_design_scores_gemma":[0.0007525146,0.0005455525,0.00009872684,0.110902876,0.86253506,0.004994802,0.0000070536644,0.0000034018958,0.0000010865492,0.000028708657,0.019969484,0.00016073651],"about_ca_topic_score_codex":0.00018158389,"about_ca_topic_score_gemma":0.000037588932,"teacher_disagreement_score":0.79778016,"about_ca_system_score_codex":0.000053888954,"about_ca_system_score_gemma":0.0005263694,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W2801392223","doi":"10.1007/s10067-018-4136-9","title":"The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis","year":2018,"lang":"en","type":"review","venue":"Clinical Rheumatology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Ethambutol; Vasculitis; Pathology; Meningitis; Pyrazinamide; Necrotizing Vasculitis; Rifampicin; Tuberculosis; Surgery","score_opus":0.10822017484653203,"score_gpt":0.3945412404350069,"score_spread":0.28632106558847487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801392223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023573148,0.98940605,0.000034584842,0.0002698995,0.0044816216,0.0019217083,0.00015024222,0.000119390024,0.0012592059],"genre_scores_gemma":[0.0059261387,0.9927468,0.00010721154,0.00010082135,0.0004162362,0.00024357565,0.000068561196,0.00011785659,0.00027282845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99391204,0.0007779824,0.0031830855,0.00095952465,0.00025249063,0.00091487],"domain_scores_gemma":[0.9932609,0.0031637475,0.0011615152,0.0016230758,0.0002574828,0.00053326174],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00090640585,0.00069947384,0.0052901534,0.00010756331,0.00030666977,0.00002688401,0.0005369128,0.0013184041,0.00008266156],"category_scores_gemma":[0.0011045753,0.00041378013,0.0020872871,0.00030950966,0.00077617244,0.000024995266,0.00023831932,0.0009873131,0.0003641772],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016826803,0.0003344252,0.0007232378,0.02783711,0.0030915649,0.0043518287,0.0000676201,3.1043424e-8,1.1591728e-8,0.00083007023,0.0049919537,0.9576039],"study_design_scores_gemma":[0.002729768,0.0011947632,0.00016515404,0.013764292,0.0040888977,0.04143149,0.0000896868,0.000009999249,8.340109e-7,0.000015878813,0.9361512,0.0003580351],"about_ca_topic_score_codex":0.0011867632,"about_ca_topic_score_gemma":0.00062599254,"teacher_disagreement_score":0.9572458,"about_ca_system_score_codex":0.00028013982,"about_ca_system_score_gemma":0.0014168322,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2802165589","doi":"10.3233/blc-189032","title":"New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21–23, 2017","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.07536507639488435,"score_gpt":0.38340234043299337,"score_spread":0.30803726403810905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802165589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87483966,0.02066544,0.000035985406,0.029414702,0.009362138,0.0038095769,0.00042267755,0.000080721635,0.061369084],"genre_scores_gemma":[0.96459764,0.0034317472,0.00026665165,0.0017707365,0.0042619244,0.000618485,0.00002026988,0.00013320595,0.024899356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99452394,0.00027667327,0.0013371601,0.0009300519,0.0018593706,0.0010727822],"domain_scores_gemma":[0.9964792,0.00017786425,0.0007357845,0.0014013407,0.00095807057,0.00024770593],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011669579,0.00048648042,0.00082986424,0.00030309876,0.00023184807,0.000045147448,0.0010015783,0.00032736323,0.0037536398],"category_scores_gemma":[0.00032342813,0.00031829224,0.00035263805,0.0017828186,0.0007717609,0.00023317228,0.00055921584,0.0009891302,0.00001556241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007438699,0.00037129148,0.6249367,0.00008886356,0.0010826143,0.00009675179,0.0028206515,0.00056017545,0.0039718277,0.00018357477,0.35910326,0.006040446],"study_design_scores_gemma":[0.0070913676,0.000347116,0.7901183,0.004108805,0.00064609206,0.00011068474,0.0008900935,0.0002655278,0.026718965,0.0010248735,0.167986,0.00069218065],"about_ca_topic_score_codex":0.07824801,"about_ca_topic_score_gemma":0.11209564,"teacher_disagreement_score":0.19111726,"about_ca_system_score_codex":0.0008947124,"about_ca_system_score_gemma":0.0048710047,"threshold_uncertainty_score":0.9999269},"labels":[],"label_agreement":null},{"id":"W2804118663","doi":"10.23736/s0022-4707.17.06830-x","title":"Physical activity in the prevention and management of bladder cancer","year":2017,"lang":"en","type":"review","venue":"The Journal of Sports Medicine and Physical Fitness","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cohort; Physical therapy; Cancer prevention; Physical fitness; Cancer; Disease; Cohort study; Physical activity; Gerontology; Internal medicine","score_opus":0.09638753266271208,"score_gpt":0.4263286385315226,"score_spread":0.32994110586881054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804118663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07184437,0.9257031,0.0000058197147,0.00081041065,0.00014343135,0.00073375227,0.000007569345,0.0000019813417,0.00074957014],"genre_scores_gemma":[0.12953542,0.869353,0.0000026543141,0.000030892643,0.00081723597,0.000015368943,0.000002533039,0.000014638936,0.00022825702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987694,0.00011074811,0.0003343522,0.00013558367,0.0005121891,0.00013769556],"domain_scores_gemma":[0.9986778,0.00014528629,0.0007404276,0.00030562867,0.000059427628,0.00007142487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000511253,0.00024533004,0.0015509843,0.000073822055,0.00006580007,0.0000067089445,0.00018196099,0.000057885296,0.000016964685],"category_scores_gemma":[0.000008782425,0.0000962493,0.0002042065,0.00012182003,0.00032938836,0.000062870895,0.000047157882,0.00044817888,2.991007e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016181495,0.000358615,0.00006109108,0.006355061,0.00049999333,0.00009305765,0.0010326216,2.3579209e-7,0.0000024707317,0.00007487128,0.00026142297,0.99109876],"study_design_scores_gemma":[0.011904236,0.0044674925,0.082880184,0.32282165,0.078233175,0.001838056,0.0020054423,0.000040639075,0.000058626385,0.006725227,0.48819482,0.0008304559],"about_ca_topic_score_codex":0.00006978839,"about_ca_topic_score_gemma":0.0000027083236,"teacher_disagreement_score":0.9902683,"about_ca_system_score_codex":0.000027389613,"about_ca_system_score_gemma":0.00010988901,"threshold_uncertainty_score":0.39249325},"labels":[],"label_agreement":null},{"id":"W2804142894","doi":"10.1002/mp.13240","title":"Multiregion segmentation of bladder cancer structures in MRI with progressive dilated convolutional networks","year":2018,"lang":"en","type":"article","venue":"Medical Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure","funders":"","keywords":"Segmentation; Bladder cancer; Image segmentation; Magnetic resonance imaging; Convolutional neural network; Pattern recognition (psychology); Medical imaging","score_opus":0.015319131131591635,"score_gpt":0.312627944330444,"score_spread":0.2973088131988524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804142894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979556,0.0010381989,0.016387137,0.0009290014,0.00033538853,0.00089871197,0.000025243866,0.000049325514,0.0007809611],"genre_scores_gemma":[0.9984179,0.000049293423,0.00026412762,0.00044450763,0.0006388023,0.00005352657,0.0000663548,0.000014560741,0.000050936396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900776,0.000023006643,0.00016521788,0.00017357545,0.00046435712,0.0001660931],"domain_scores_gemma":[0.9995466,0.000024545248,0.00008214035,0.00010111241,0.00013852895,0.000107100845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038808837,0.00011071321,0.0002038167,0.000024267367,0.000033524895,0.0000032024652,0.000046336983,0.000086433305,0.00055071997],"category_scores_gemma":[0.000011479889,0.00007420473,0.000029680614,0.00020077104,0.0003947749,0.00004823825,0.000015131578,0.00014603129,0.000003451013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048517324,0.0018835895,0.77940434,0.00026172082,0.0013148752,0.00021113113,0.0032678274,0.00069812837,0.0011893603,0.0006985801,0.006483314,0.19973537],"study_design_scores_gemma":[0.028927043,0.003684463,0.8605098,0.0018736782,0.0007175677,0.00006868213,0.00032949552,0.029505685,0.07069976,0.0025321823,0.0005683896,0.0005832245],"about_ca_topic_score_codex":0.00024757825,"about_ca_topic_score_gemma":0.00008437265,"teacher_disagreement_score":0.19915216,"about_ca_system_score_codex":0.000074104304,"about_ca_system_score_gemma":0.0002593971,"threshold_uncertainty_score":0.60299975},"labels":[],"label_agreement":null},{"id":"W2804521665","doi":"10.5489/cuaj.5244","title":"Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystectomy; Medicine; Radiation therapy; Bladder cancer; Jadad scale; Randomized controlled trial; Meta-analysis; Odds ratio; Oncology; Surgery; Internal medicine; Urology; Cancer; Cochrane Library","score_opus":0.05633889923363689,"score_gpt":0.3387128882906641,"score_spread":0.2823739890570272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804521665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.202663e-7,0.98664266,0.00014258348,0.008563181,0.000059375732,0.0038585388,0.0006261526,0.000020847263,0.00008616197],"genre_scores_gemma":[0.0000120200675,0.9867244,0.00037615953,0.009151428,0.0003707591,0.0014449432,0.000103018516,0.00005282968,0.0017644445],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968028,0.00060167,0.001033565,0.00049318187,0.00047750882,0.0005912456],"domain_scores_gemma":[0.99663603,0.0003762763,0.0012209648,0.00029046557,0.0004416159,0.0010346387],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011308199,0.0005400042,0.008189169,0.00042098915,0.00027371358,0.00012554043,0.00019624482,0.0005272677,0.0015420811],"category_scores_gemma":[0.0003380455,0.0002775117,0.0026370736,0.00071765005,0.00007522386,0.00005788798,0.000008608074,0.0006107815,0.000009758796],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029997756,0.000053629905,0.00014722052,0.21294473,0.7729066,0.00008962484,0.00003273571,3.645718e-7,7.650648e-9,0.000022120646,0.011914796,0.0018581741],"study_design_scores_gemma":[0.0004605187,0.0003628261,0.00001097195,0.0036561799,0.60603315,0.00044605893,0.0000017270625,0.0000021093406,1.0403623e-8,0.0000114512795,0.38883355,0.00018143574],"about_ca_topic_score_codex":0.0005117501,"about_ca_topic_score_gemma":0.00088427076,"teacher_disagreement_score":0.37691876,"about_ca_system_score_codex":0.0018270577,"about_ca_system_score_gemma":0.0019225723,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W2804629518","doi":"10.1016/j.critrevonc.2018.05.005","title":"Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Urothelial carcinoma; Meta-analysis; Medicine; Perioperative; Urology; Chemotherapy; Upper urinary tract; Urinary system; Carcinoma; Oncology; Internal medicine; Surgery; Cancer; Bladder cancer","score_opus":0.13255033513568734,"score_gpt":0.4548627842880608,"score_spread":0.32231244915237345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804629518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017359306,0.9801705,0.000056071767,0.0028822292,0.0001320032,0.015835127,0.00021643192,0.000012246458,0.0006936889],"genre_scores_gemma":[0.00008113855,0.9831731,0.00090607046,0.0045588124,0.00007248476,0.010521314,0.00003159367,0.00007266487,0.0005828281],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99291486,0.0022699044,0.0030902321,0.0009549642,0.00023274157,0.0005372889],"domain_scores_gemma":[0.995088,0.002303098,0.00083649234,0.0012769182,0.00029960935,0.00019589782],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0017101284,0.00084644416,0.024305178,0.0002844116,0.00010373803,0.000012169448,0.0004739768,0.00075503736,0.0008548073],"category_scores_gemma":[0.0034715317,0.0004148626,0.005598095,0.0008103395,0.00096199487,0.000050625764,0.00012966809,0.0006011652,0.000037100504],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033787433,0.0009548075,0.000029298102,0.9667274,0.026305275,0.00005311073,0.00013843791,1.6367224e-9,9.59051e-8,0.0028280385,0.00057688775,0.0023529092],"study_design_scores_gemma":[0.0006452497,0.0010706236,0.000005816017,0.06185005,0.67844963,0.0021890097,0.000018327039,0.0000012194058,0.00000231033,0.0000894084,0.25541162,0.00026670005],"about_ca_topic_score_codex":0.000009854543,"about_ca_topic_score_gemma":0.00000853765,"teacher_disagreement_score":0.9048773,"about_ca_system_score_codex":0.00026976992,"about_ca_system_score_gemma":0.0008370009,"threshold_uncertainty_score":0.9998303},"labels":[],"label_agreement":null},{"id":"W2804768258","doi":"10.5489/cuaj.5086","title":"Gynecological organ involvement at robot-assisted radical cystectomy in females: Is anterior exenteration necessary?","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cystectomy; Pelvic exenteration; Lymphovascular invasion; Bladder cancer; Perioperative; Urology; Odds ratio; Surgery; Cancer; Internal medicine; Metastasis","score_opus":0.0246812767024421,"score_gpt":0.2686357582511421,"score_spread":0.2439544815487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804768258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664305,0.00020043315,0.00005829315,0.030449612,0.00050203904,0.00038440007,0.000031156207,0.00003386055,0.0019097056],"genre_scores_gemma":[0.9825562,0.00008034464,0.00028600238,0.015333947,0.0007295457,0.0000265614,0.00003677198,0.00001698705,0.00093359424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771005,0.00024718148,0.00057908986,0.00035057534,0.0004603756,0.0006527001],"domain_scores_gemma":[0.9984585,0.00008626258,0.00024659536,0.000143244,0.00024662542,0.00081874966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005232991,0.00021798768,0.00043614313,0.00025508174,0.00038288094,0.00010306373,0.00014203688,0.00038813712,0.005945483],"category_scores_gemma":[0.0003684818,0.00016828247,0.00015537647,0.00034152615,0.000095214215,0.00012473819,0.000035047186,0.0004959169,0.00025430124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024253763,0.00018536474,0.98683715,0.000006534506,0.000114975315,0.00032979745,0.0003748255,0.0000011857015,0.0010105596,0.000013492356,0.0074731135,0.0034104525],"study_design_scores_gemma":[0.0038239092,0.00141857,0.96886927,0.00004517752,0.00007587177,0.00033999988,0.000088772525,0.00011202301,0.0004223754,0.00011428325,0.024525063,0.00016471281],"about_ca_topic_score_codex":0.0009782102,"about_ca_topic_score_gemma":0.00862343,"teacher_disagreement_score":0.017967919,"about_ca_system_score_codex":0.0044117705,"about_ca_system_score_gemma":0.00057024264,"threshold_uncertainty_score":0.9994101},"labels":[],"label_agreement":null},{"id":"W2804894884","doi":"10.1111/his.13654","title":"Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy","year":2018,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary; McGill University Health Centre","funders":"","keywords":"Cystectomy; Lymphovascular invasion; Medicine; Stage (stratigraphy); Stromal cell; Bladder cancer; Internal medicine; Oncology; Carcinoma; Chemotherapy; Pathological; Cancer; Pathology; Urology; Gastroenterology; Metastasis; Biology","score_opus":0.01665120670946636,"score_gpt":0.2782622738550952,"score_spread":0.2616110671456289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804894884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399287,0.0006277992,0.00016787116,0.000658207,0.00039870568,0.00046140165,0.000009398108,0.00009243517,0.0035913195],"genre_scores_gemma":[0.99657565,0.000030469053,0.00070942106,0.0016006939,0.0002746822,0.00012493956,0.000014025989,0.000028753318,0.0006413497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986737,0.00009666856,0.00026487702,0.00042516744,0.00015028256,0.00038932892],"domain_scores_gemma":[0.99945104,0.0000387158,0.000044320084,0.00028464428,0.000045106284,0.00013617809],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011466881,0.0002051779,0.00042335788,0.00014354613,0.00004315497,0.0000052815144,0.0000819895,0.00022206358,0.001116873],"category_scores_gemma":[0.00007751726,0.00014943957,0.00009303072,0.0001635606,0.0004872574,0.000032526677,0.000029833906,0.00023131698,0.0002046802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087655947,0.0004316997,0.9859865,0.000021484158,0.000004767108,0.0027711566,0.0013214569,4.2668248e-8,0.005498172,0.000048212936,0.00031205313,0.0027279358],"study_design_scores_gemma":[0.003113308,0.0018032104,0.97729975,0.000042284326,0.000043359272,0.0007316594,0.00004008867,0.0000069789453,0.0009741112,0.00017948715,0.015621317,0.00014443524],"about_ca_topic_score_codex":0.000037291873,"about_ca_topic_score_gemma":0.00004481502,"teacher_disagreement_score":0.015309264,"about_ca_system_score_codex":0.00017453273,"about_ca_system_score_gemma":0.0000947434,"threshold_uncertainty_score":0.9997962},"labels":[],"label_agreement":null},{"id":"W2805117322","doi":"10.5489/cuaj.5058","title":"Case – Causation vs. correlation: Naturopathic medicine vs. natural history of a disease","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Naturopathy; Natural history; Disease; Medicine; Causation; Natural (archaeology); Traditional medicine; Internal medicine; Alternative medicine; History; Philosophy; Epistemology; Pathology; Archaeology","score_opus":0.016817589733106767,"score_gpt":0.24498145072872854,"score_spread":0.22816386099562178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805117322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.925293,0.00521347,0.00023370615,0.049415912,0.0075690206,0.00064309913,0.00008545646,0.00007484207,0.011471479],"genre_scores_gemma":[0.9878302,0.000049661525,0.000060529368,0.0072773225,0.0015335139,0.000005373959,0.000034307992,0.00001272373,0.0031963252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985264,0.00017403532,0.00038756945,0.00018427125,0.00042222653,0.00030548047],"domain_scores_gemma":[0.9979346,0.000100735444,0.00034195065,0.00012792434,0.0006800477,0.00081473234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047258672,0.00014198366,0.0002938979,0.00022260316,0.00017102477,0.00001052005,0.00006699997,0.0001790309,0.0018366334],"category_scores_gemma":[0.0011717957,0.000108091626,0.00010687943,0.00017551232,0.0001522873,0.00010564453,0.0000082338975,0.0005208755,0.000043600263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015995447,0.00012676221,0.8724331,0.000028702185,0.00030939304,0.004491585,0.0016419346,0.0000104426745,0.0001225619,0.00060050876,0.1133868,0.005248652],"study_design_scores_gemma":[0.003378815,0.00197009,0.8580051,0.00006562708,0.00053265167,0.003570607,0.000059208935,0.0009592083,0.00000998978,0.0006705686,0.13059153,0.00018662003],"about_ca_topic_score_codex":0.0016886049,"about_ca_topic_score_gemma":0.00087917736,"teacher_disagreement_score":0.06253723,"about_ca_system_score_codex":0.0035889032,"about_ca_system_score_gemma":0.001588467,"threshold_uncertainty_score":0.99907583},"labels":[],"label_agreement":null},{"id":"W2805215598","doi":"10.1016/j.euo.2018.02.001","title":"Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cancer; Oncology; Bladder Neoplasm; General surgery; Urology; Internal medicine","score_opus":0.020059077603888316,"score_gpt":0.34007945176971327,"score_spread":0.32002037416582496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805215598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993146,0.0008981342,0.00010747654,0.000664172,0.0003737563,0.00042621052,0.00001027633,0.00001607145,0.007572468],"genre_scores_gemma":[0.99831545,0.000055842625,0.00028636446,0.0009471397,0.00017182798,0.000055307573,0.0000052908285,0.000028080149,0.00013466805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983327,0.00045150568,0.00051027746,0.0003072727,0.00013944479,0.0002587993],"domain_scores_gemma":[0.9991212,0.00007419704,0.00020660486,0.00029866488,0.00020859353,0.00009072348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031731295,0.00015205074,0.0005302335,0.00014254842,0.000017468095,0.0000013057064,0.00010926652,0.00008217603,0.0005971482],"category_scores_gemma":[0.00012150713,0.00012442969,0.00006985762,0.00023935312,0.0008290412,0.000036550453,0.00006317882,0.00016786592,0.000091774724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00869349,0.0062699174,0.91609395,0.0006105866,0.0018052126,0.0045503653,0.009261549,0.000015922698,0.009827656,0.00029576797,0.0010299389,0.041545633],"study_design_scores_gemma":[0.005971016,0.013069537,0.9703417,0.000061683655,0.00067889184,0.00019699991,0.000074354735,0.00006107653,0.003524567,0.00010619163,0.0057847,0.00012931119],"about_ca_topic_score_codex":0.00046357556,"about_ca_topic_score_gemma":0.00039712293,"teacher_disagreement_score":0.05424771,"about_ca_system_score_codex":0.00008353215,"about_ca_system_score_gemma":0.00044451136,"threshold_uncertainty_score":0.6538354},"labels":[],"label_agreement":null},{"id":"W2805258017","doi":"10.1016/j.euo.2018.03.005","title":"Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Institute of Clinical and Translational Sciences; University of Texas Medical Branch","keywords":"Comorbidity; Medicine; Cystectomy; Bladder cancer; MEDLINE; Perioperative; Intensive care medicine; Risk assessment; Systematic review; Internal medicine; Cancer; Surgery","score_opus":0.05377424198456397,"score_gpt":0.39814201089946516,"score_spread":0.3443677689149012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805258017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81358135,0.05257361,0.000906285,0.004951381,0.0029981367,0.01163485,0.00045013812,0.00020389032,0.11270039],"genre_scores_gemma":[0.9817957,0.0046200817,0.0006048562,0.012133464,0.0002770311,0.0001586639,0.00006138456,0.00004872358,0.00030008444],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9981481,0.00060738623,0.0005548346,0.00031196003,0.00012484827,0.00025288004],"domain_scores_gemma":[0.99865115,0.00022707735,0.0003716055,0.0002672693,0.00037213217,0.00011075422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060090417,0.0001745585,0.00087030645,0.000060825114,0.000080154154,0.0000031738973,0.00011473137,0.00007512106,0.00021458545],"category_scores_gemma":[0.00029087465,0.00013537084,0.000087858665,0.00007863641,0.00033402737,0.000027566883,0.00008503654,0.00012772522,0.00004100013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040253666,0.006462735,0.28643468,0.6213328,0.006987583,0.00021600511,0.0024449772,8.54803e-7,0.0013236902,0.0006867851,0.053723156,0.016361356],"study_design_scores_gemma":[0.05172889,0.09579627,0.6476327,0.07885215,0.025004499,0.00054375886,0.0002592884,0.00031629694,0.0011357112,0.00026450233,0.09708174,0.0013842009],"about_ca_topic_score_codex":0.000036143818,"about_ca_topic_score_gemma":0.000019463394,"teacher_disagreement_score":0.5424807,"about_ca_system_score_codex":0.00006960158,"about_ca_system_score_gemma":0.00013403478,"threshold_uncertainty_score":0.5520263},"labels":[],"label_agreement":null},{"id":"W2805446030","doi":"10.1111/tid.12931","title":"Disseminated<i>Mycobacterium bovis</i>infection post‐kidney transplant following remote intravesical<scp>BCG</scp>therapy for bladder cancer","year":2018,"lang":"en","type":"article","venue":"Transplant Infectious Disease","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health; University of Manitoba","funders":"Institute of Nutrition, Metabolism and Diabetes","keywords":"Medicine; Immunosuppression; Bladder cancer; Sepsis; Urology; Cancer; Surgery; Internal medicine","score_opus":0.011731407469893283,"score_gpt":0.28208617846483314,"score_spread":0.2703547709949399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805446030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984524,0.00077864184,0.00483088,0.00070759,0.0020259393,0.0023920112,0.0027222799,0.0006206589,0.0013980154],"genre_scores_gemma":[0.9891772,0.0035650542,0.00008504924,0.0033429093,0.0013516016,0.0003483673,0.0011208375,0.00015845065,0.0008505163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972464,0.00008426445,0.0005181169,0.0008293531,0.00043180355,0.0008900838],"domain_scores_gemma":[0.99775356,0.00016030452,0.00012315712,0.00047489133,0.00024587184,0.0012421915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016922878,0.0006380875,0.0006457254,0.00023467072,0.00045327801,0.00008424821,0.00012995805,0.00024330012,0.00023018068],"category_scores_gemma":[0.00006667852,0.0004962325,0.00071084284,0.00035045613,0.00015275789,0.00025607643,0.000008730973,0.00029560327,0.00007712078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019125337,0.006851103,0.652524,0.0035978127,0.009560005,0.0017778062,0.011477525,0.000028547578,0.20678164,0.00027008262,0.016825408,0.07118076],"study_design_scores_gemma":[0.05209513,0.012997054,0.6187756,0.0046978584,0.015675575,0.000842108,0.00011416093,0.0015470963,0.16274309,0.0017074706,0.1267779,0.0020269207],"about_ca_topic_score_codex":0.0012643541,"about_ca_topic_score_gemma":0.00022863373,"teacher_disagreement_score":0.1099525,"about_ca_system_score_codex":0.00022082472,"about_ca_system_score_gemma":0.00058656506,"threshold_uncertainty_score":0.99974895},"labels":[],"label_agreement":null},{"id":"W2805702731","doi":"10.5489/cuaj.5207","title":"Comparison of three different antibiotic protocols in transurethral resection of bladder tumour and the possible infectious risk factors: A non-randomized, prospective study","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoscopy; Mitomycin C; Urinary system; Odds ratio; Prospective cohort study; Randomized controlled trial; Catheter; Surgery; Antibiotics; Urology; Resection; Internal medicine","score_opus":0.022446880506701714,"score_gpt":0.310551917313007,"score_spread":0.2881050368063053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805702731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898339,0.00006142817,0.00008130327,0.0004768534,0.00009562235,0.00890757,0.000020212512,0.0000061766395,0.0005169293],"genre_scores_gemma":[0.9995215,0.000012588268,0.000010324126,0.000040956675,0.00014477647,0.00024078054,0.0000015775737,0.0000087585395,0.000018726652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980879,0.00058879727,0.00056627893,0.00016890203,0.00033599412,0.0002521422],"domain_scores_gemma":[0.99857235,0.0003259441,0.0005274193,0.00009166035,0.000308381,0.00017421677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011279517,0.00014843362,0.0008321292,0.0001844708,0.00018017222,0.00003124761,0.00006957219,0.00014258717,0.00008388151],"category_scores_gemma":[0.0007349391,0.00007994251,0.00014649634,0.00023326014,0.00026683338,0.000057160352,0.000009426954,0.000531188,0.0000011691907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011999235,0.0004821505,0.98288286,0.00000953347,0.00045508854,0.0000035485548,0.003856164,0.000009110672,0.000066710105,0.000021673924,0.00003640222,0.00017752279],"study_design_scores_gemma":[0.08122291,0.004287313,0.9115249,0.000040458315,0.00032476452,0.000011262593,0.0005583396,0.00029393425,0.00045622932,0.0012124418,0.000003705374,0.000063755324],"about_ca_topic_score_codex":0.012729851,"about_ca_topic_score_gemma":0.034696557,"teacher_disagreement_score":0.07135797,"about_ca_system_score_codex":0.00039706804,"about_ca_system_score_gemma":0.00023814943,"threshold_uncertainty_score":0.99384445},"labels":[],"label_agreement":null},{"id":"W2805956893","doi":"10.1007/s00345-018-2361-0","title":"Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Concomitant; Nephrology; Chemotherapy; Proportional hazards model; Internal medicine; Oncology; Neoadjuvant therapy; Carcinoma in situ; Stage (stratigraphy); Carcinoma; Cancer","score_opus":0.015008910443347541,"score_gpt":0.30252933352545597,"score_spread":0.2875204230821084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805956893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381393,0.0000629112,0.000015665266,0.0049590287,0.0003279193,0.00039500717,0.000019341182,0.000017110451,0.0003890648],"genre_scores_gemma":[0.9954729,0.000044782155,0.00011881105,0.0033835499,0.0002454225,0.000009267129,0.000008082391,0.000026437316,0.00069075596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983957,0.00016306812,0.00053332676,0.00023760794,0.00033900444,0.00033130735],"domain_scores_gemma":[0.9990012,0.00013847635,0.00032858018,0.00016997222,0.00015141751,0.00021037609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019582044,0.00025367347,0.0008430811,0.00032418294,0.000049919818,0.000011493155,0.00011126164,0.00015587335,0.00060330884],"category_scores_gemma":[0.00007379844,0.00010932194,0.00015582514,0.00027145923,0.00022659964,0.000073107796,0.000011315814,0.00045987463,0.000013387984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08379428,0.0020300304,0.8934999,0.0000049845726,0.0006150438,0.00045921473,0.0002138023,0.0000017304391,0.0018557385,0.0000046162836,0.003952321,0.013568318],"study_design_scores_gemma":[0.044809982,0.067499466,0.87306803,0.000060826544,0.00025205727,0.00030493864,0.000022879054,0.0000089189825,0.0030993954,0.000024815361,0.010671495,0.0001772173],"about_ca_topic_score_codex":0.0000681251,"about_ca_topic_score_gemma":0.00015826897,"teacher_disagreement_score":0.06546943,"about_ca_system_score_codex":0.00036467172,"about_ca_system_score_gemma":0.00018497783,"threshold_uncertainty_score":0.6605809},"labels":[],"label_agreement":null},{"id":"W2806059653","doi":"10.21037/tau.2018.06.04","title":"The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada—space for improvement with regular and organized multidisciplinary team meetings","year":2018,"lang":"en","type":"letter","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Bladder cancer; Perioperative; Multidisciplinary approach; Cancer; Retrospective cohort study; Multidisciplinary team; Population; Oncology; General surgery; Internal medicine; Surgery; Nursing; Environmental health","score_opus":0.008924189604945081,"score_gpt":0.2587195904616044,"score_spread":0.24979540085665933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806059653","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32582867,0.0037027472,0.00027198266,0.667174,0.00018140987,0.0025023601,0.00020979045,0.0000066066946,0.000122437],"genre_scores_gemma":[0.92405635,0.00078194536,0.0007807847,0.070363246,0.00060514285,0.0011911686,0.00024538304,0.000080654,0.0018953093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988261,0.000037269903,0.0002784681,0.00042856095,0.00011487769,0.0003147664],"domain_scores_gemma":[0.9993207,0.00025825034,0.00012202461,0.00010910318,0.000155326,0.000034638764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013362616,0.00022677405,0.0004811452,0.0000741195,0.00010897433,0.0000028544157,0.000061796985,0.00033542237,0.00009770749],"category_scores_gemma":[0.000008535265,0.00015195964,0.00003953972,0.000055654804,0.0003381989,0.000022618247,0.000010377917,0.00036767512,4.406036e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081612684,0.0006189501,0.76881975,0.0009015105,0.004614349,0.00024930848,0.02071254,0.00018472678,0.0020476524,0.0009286983,0.112226985,0.007082847],"study_design_scores_gemma":[0.05473847,0.013331151,0.80604,0.00018604375,0.0014855316,0.0002692029,0.0006979315,0.0013630915,0.0011355246,0.0116205355,0.10824705,0.00088547956],"about_ca_topic_score_codex":0.3647778,"about_ca_topic_score_gemma":0.958976,"teacher_disagreement_score":0.5982277,"about_ca_system_score_codex":0.000083465035,"about_ca_system_score_gemma":0.0011138755,"threshold_uncertainty_score":0.63945216},"labels":[],"label_agreement":null},{"id":"W2806535129","doi":"10.1016/j.euo.2018.04.010","title":"Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review","year":2018,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Urinary system; Bladder cancer; Randomized controlled trial; Clinical trial; Urology; Cancer; Internal medicine; Oncology","score_opus":0.12933062305410345,"score_gpt":0.42197412263934186,"score_spread":0.2926434995852384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806535129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001302315,0.97394526,0.00014575591,0.0006896804,0.0015381306,0.014686628,0.00015509526,0.00007814816,0.008748274],"genre_scores_gemma":[0.000006742017,0.98719627,0.0024113723,0.0031162673,0.001726823,0.0040468713,0.00017522491,0.00022287757,0.0010975584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99154097,0.0048553534,0.0014241787,0.001196642,0.0001886537,0.0007942272],"domain_scores_gemma":[0.99704045,0.0010829062,0.0007981336,0.0006078787,0.00024348339,0.0002271263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022259282,0.0007878155,0.004275967,0.00037746804,0.00013061489,0.0000119552815,0.00041915243,0.0004921941,0.00053051446],"category_scores_gemma":[0.00040911592,0.0006274496,0.0005897548,0.00062150724,0.00039231885,0.000051230883,0.00019540348,0.0008023274,0.00026479384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052756976,0.0017744089,0.000007973572,0.015743097,0.0030570158,0.0027347119,0.00027356792,0.0000034893035,2.0284288e-7,0.000010094935,0.113905944,0.8097325],"study_design_scores_gemma":[0.036743212,0.034095585,0.000012291206,0.0070327595,0.007552373,0.0004902188,0.000021235719,0.0000038271382,1.1921342e-7,0.000004031029,0.9136523,0.00039207403],"about_ca_topic_score_codex":0.000012284446,"about_ca_topic_score_gemma":0.000012771835,"teacher_disagreement_score":0.8093405,"about_ca_system_score_codex":0.0007489044,"about_ca_system_score_gemma":0.0038805387,"threshold_uncertainty_score":0.9996177},"labels":[],"label_agreement":null},{"id":"W2807062801","doi":"10.1089/end.2018.0313","title":"Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis","year":2018,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Population; Surgery; General surgery; Urology; Internal medicine; Bladder cancer; Environmental health","score_opus":0.05685269200507037,"score_gpt":0.4154808911415682,"score_spread":0.35862819913649785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807062801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954529,0.00019364363,0.0017855586,0.0017747391,0.000084262814,0.0001779009,0.000009041931,0.0000034268614,0.00051854254],"genre_scores_gemma":[0.9971928,0.0000028928382,0.0022331707,0.000349117,0.00014499066,0.0000021556123,0.000007887831,0.000007983172,0.000059004095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998955,0.00013002439,0.00050709676,0.000114025366,0.00017136226,0.00012247072],"domain_scores_gemma":[0.9990348,0.00018131046,0.00034956558,0.00012261553,0.00018954174,0.00012214422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019830343,0.00010184179,0.0010469741,0.00027179078,0.000052267704,0.000013482788,0.00011358119,0.00007481384,0.0002572046],"category_scores_gemma":[0.00011369779,0.0000683172,0.00014862575,0.00021448429,0.00013048093,0.000059510898,0.000032166852,0.0001557445,0.000001505746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005551412,0.00013889489,0.99636906,0.000009177596,0.0016623371,0.000017925664,0.00031755026,0.000095394105,0.00015855973,0.000050034585,0.000033421533,0.0005925151],"study_design_scores_gemma":[0.004886994,0.0034436095,0.98701847,0.00001586981,0.0029384801,0.000036025882,0.000060982133,0.00051564997,0.00079714064,0.000040669594,0.00019507477,0.00005101914],"about_ca_topic_score_codex":0.00032290182,"about_ca_topic_score_gemma":0.00014849375,"teacher_disagreement_score":0.009350564,"about_ca_system_score_codex":0.00004019672,"about_ca_system_score_gemma":0.00014936604,"threshold_uncertainty_score":0.281621},"labels":[],"label_agreement":null},{"id":"W2807307046","doi":"10.1016/j.urolonc.2018.05.007","title":"Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Erasmus+; University Health Network","keywords":"Interquartile range; Perineural invasion; Medicine; Carcinoma in situ; Bladder cancer; Hazard ratio; Cancer; Internal medicine; Oncology; Retrospective cohort study; Adjuvant therapy; Urology","score_opus":0.03432888449356644,"score_gpt":0.33620665978230285,"score_spread":0.3018777752887364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807307046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893987,0.0022083344,0.000041145042,0.006230706,0.00022955335,0.0009721226,0.000022442318,0.000041855397,0.0008551532],"genre_scores_gemma":[0.9597373,0.0013333389,0.032107443,0.0055723717,0.00028860368,0.0002802246,0.000019509152,0.000023335286,0.00063789537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986705,0.0000733467,0.0002777594,0.0004881158,0.00012620712,0.00036406782],"domain_scores_gemma":[0.9990912,0.00019623993,0.000099287216,0.00016112275,0.00015871631,0.00029343896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021140777,0.00022198769,0.0003872991,0.00033863535,0.00020346313,0.000028673565,0.00007063292,0.00021642474,0.000041092557],"category_scores_gemma":[0.00038261662,0.00017487757,0.000028777504,0.0006182241,0.00058929325,0.000106244566,0.00008579669,0.00025582837,0.000015111902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031470056,0.00022527085,0.95423615,0.000052007974,0.00008516621,0.00018825805,0.001662633,0.000002461268,0.021260297,0.00065130106,0.0015752411,0.019746508],"study_design_scores_gemma":[0.0061840806,0.01871965,0.46402344,0.00045287932,0.0013515924,0.00078425615,0.0032002195,0.00049461477,0.036894668,0.005793821,0.46124458,0.00085618265],"about_ca_topic_score_codex":0.00037900126,"about_ca_topic_score_gemma":0.00035896045,"teacher_disagreement_score":0.4902127,"about_ca_system_score_codex":0.00016190762,"about_ca_system_score_gemma":0.00041237177,"threshold_uncertainty_score":0.71313006},"labels":[],"label_agreement":null},{"id":"W2807338383","doi":"10.5489/cuaj.5122","title":"Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence","year":2018,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Saline; Bladder cancer; Resection; Lymph node metastasis; Cystoscopy; Surgery; Stage (stratigraphy); Metastasis; Urology; Cancer; Anesthesia; Urinary system; Internal medicine","score_opus":0.02000338322578814,"score_gpt":0.28022330563857434,"score_spread":0.2602199224127862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807338383","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4807003,0.0010042457,0.00026194906,0.510426,0.0023635824,0.0023353097,0.0022624678,0.000023357421,0.00062280113],"genre_scores_gemma":[0.8385023,0.0004246195,0.00021185173,0.14863168,0.007788742,0.0004191361,0.00046560503,0.000069726,0.0034863644],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.997283,0.00024470472,0.0007723762,0.00043621202,0.0006250857,0.0006386573],"domain_scores_gemma":[0.9976105,0.00018052534,0.00077387475,0.00016225378,0.0010038739,0.00026896322],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005591552,0.00031713225,0.0006950355,0.00039184195,0.00012247155,0.00006065833,0.00013595745,0.00138515,0.001268236],"category_scores_gemma":[0.00033104466,0.00027637216,0.00039510932,0.00027710982,0.00006527851,0.00015983116,0.000007584336,0.0014846523,0.000014336436],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020245006,0.00016053999,0.28350356,0.0002332932,0.00097039907,0.00024587222,0.001521452,0.000003847125,0.00015770097,0.000002818165,0.7037914,0.0073846476],"study_design_scores_gemma":[0.006172099,0.005920805,0.7771443,0.00088845374,0.0009882855,0.000057414134,0.000040006074,0.000041019,0.0004954481,0.002482855,0.20526531,0.00050397526],"about_ca_topic_score_codex":0.0046693254,"about_ca_topic_score_gemma":0.014683939,"teacher_disagreement_score":0.49852604,"about_ca_system_score_codex":0.00216585,"about_ca_system_score_gemma":0.0018925932,"threshold_uncertainty_score":0.9999688},"labels":[],"label_agreement":null},{"id":"W2808040186","doi":"10.1200/jco.2017.35.15_suppl.tps4590","title":"Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Gemcitabine; Medicine; Chemotherapy; Carboplatin; Urothelial cancer; Cisplatin; Pembrolizumab; Oncology; Docetaxel; Bladder cancer; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.1709571782320348,"score_gpt":0.5346557741687141,"score_spread":0.3636985959366793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808040186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800108,0.00044563372,0.000102188395,0.011546703,0.0030645013,0.0012501829,0.000015143461,0.000023143306,0.0035416675],"genre_scores_gemma":[0.98398876,0.004939705,0.0028051913,0.0032724603,0.003367542,0.00006722693,0.0000024256617,0.00008701121,0.0014696865],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960212,0.00027074752,0.0021618411,0.00043993385,0.0006114553,0.0004948194],"domain_scores_gemma":[0.99482685,0.00076871325,0.002793419,0.0006850687,0.00038818573,0.0005377816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014104861,0.00037448647,0.0029323408,0.00015593466,0.0001453319,0.000042987886,0.0005011708,0.0004979859,0.00071271864],"category_scores_gemma":[0.0011641086,0.00022641063,0.0004986871,0.00012689624,0.00048141487,0.00031375216,0.0000363575,0.0011632014,0.000013515232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.682035,0.0047792555,0.010764035,0.000021187221,0.00071412424,0.0006688997,0.00019099207,0.000005068084,0.00025779122,0.000005629352,0.00048175544,0.30007628],"study_design_scores_gemma":[0.7904508,0.1268554,0.019977266,0.00027259093,0.00048228318,0.00019521911,0.00008500017,0.00006460792,0.0010387538,0.000060937127,0.060272407,0.00024474662],"about_ca_topic_score_codex":0.0003476134,"about_ca_topic_score_gemma":0.0010374725,"teacher_disagreement_score":0.2998315,"about_ca_system_score_codex":0.00045282388,"about_ca_system_score_gemma":0.005292134,"threshold_uncertainty_score":0.9388019},"labels":[],"label_agreement":null},{"id":"W2810225072","doi":"10.5489/cuaj.5377","title":"Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; University of Alberta; Université Laval; Université de Montréal; McMaster University; Western University; Dalhousie University; McGill University; University of British Columbia","funders":"","keywords":"Lymphovascular invasion; Medicine; Urothelial carcinoma; Urothelium; Retrospective cohort study; Cohort; Pathological; Internal medicine; Disease; Adverse effect; Proportional hazards model; Oncology; Urology; Cancer; Urinary system; Bladder cancer; Metastasis","score_opus":0.038698291646659846,"score_gpt":0.3018419647990666,"score_spread":0.2631436731524068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810225072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.893318,0.00019387943,0.002527755,0.09442326,0.0024697059,0.0009811035,0.0012006274,0.00006398442,0.004821702],"genre_scores_gemma":[0.9772857,0.000018120676,0.00045459848,0.01902651,0.0026551317,0.000028410645,0.000053093958,0.000018636605,0.00045981366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845314,0.00010769699,0.0003484082,0.00025147852,0.00033344,0.0005058311],"domain_scores_gemma":[0.9981308,0.00018564555,0.00018470477,0.00013914761,0.0007739009,0.0005858311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000573217,0.00016876814,0.00026962298,0.00014310631,0.00029888368,0.00006369168,0.00011842691,0.00019929613,0.00088831683],"category_scores_gemma":[0.0012757415,0.00012758022,0.00019507097,0.00011841358,0.000031366355,0.000049376362,0.000004268091,0.0002861376,0.00005677094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023910089,0.00006617709,0.9704953,0.000004253034,0.000033338176,0.000026814121,0.00003194855,0.000008408789,0.00002267254,0.000024305313,0.022303285,0.006744407],"study_design_scores_gemma":[0.0023453583,0.0020091466,0.8630429,0.000024123343,0.00004566948,0.00005735139,0.000011937718,0.001106565,0.00009322996,0.00017906133,0.13094392,0.00014072546],"about_ca_topic_score_codex":0.0009469738,"about_ca_topic_score_gemma":0.0009207612,"teacher_disagreement_score":0.10864063,"about_ca_system_score_codex":0.0008058183,"about_ca_system_score_gemma":0.00092325243,"threshold_uncertainty_score":0.9726446},"labels":[],"label_agreement":null},{"id":"W2810444162","doi":"10.1111/his.13696","title":"Basal‐subtype bladder tumours show a ‘hot’ immunophenotype","year":2018,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cytokeratin; GATA3; Tissue microarray; Immunophenotyping; Pathology; Immunohistochemistry; FOXP3; CD20; Basal (medicine); CD8; Immune system; Medicine; Biology; Internal medicine; Immunology; Antigen","score_opus":0.01953077386099581,"score_gpt":0.27879103002500216,"score_spread":0.25926025616400633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810444162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8457478,0.002859619,0.00053348177,0.0022680087,0.0027811162,0.0005308911,0.000025582996,0.00027824167,0.14497524],"genre_scores_gemma":[0.98087883,0.000042728116,0.0012780444,0.0039047971,0.00077310135,0.000038192815,0.00002424818,0.0000490982,0.01301093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988054,0.000060992017,0.0002124537,0.000382824,0.00016029226,0.00037800724],"domain_scores_gemma":[0.9991248,0.000021103891,0.00006742794,0.000498957,0.00015235606,0.00013534864],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011719861,0.00019771674,0.00034268075,0.00011820858,0.00013478828,0.000007849226,0.000115850045,0.00014642887,0.0026609881],"category_scores_gemma":[0.000057560654,0.0001713606,0.00009814924,0.00016894705,0.00037418766,0.00004718989,0.000046965168,0.00018415645,0.0018892797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011232906,0.0028579216,0.27336055,0.00022052097,0.00027255144,0.0058194892,0.011227163,0.0000013964168,0.41065612,0.00692535,0.2361483,0.041277725],"study_design_scores_gemma":[0.004030132,0.0038134577,0.8031413,0.00004459987,0.00045591348,0.0011846675,0.000120208104,0.000022212753,0.008467917,0.0014093199,0.17690712,0.0004031407],"about_ca_topic_score_codex":0.00010731027,"about_ca_topic_score_gemma":0.000047767837,"teacher_disagreement_score":0.52978075,"about_ca_system_score_codex":0.0001541525,"about_ca_system_score_gemma":0.00021419901,"threshold_uncertainty_score":0.99888784},"labels":[],"label_agreement":null},{"id":"W2810579527","doi":"10.1016/j.euo.2018.08.009","title":"Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Cystectomy; Medicine; Bladder cancer; Perioperative; Oncology; Nomogram; Neoadjuvant therapy; Internal medicine; Stage (stratigraphy); Chemotherapy; Proportional hazards model; Confidence interval; Urology; Clinical trial; Surgery; Cancer; Breast cancer","score_opus":0.04498250182132508,"score_gpt":0.35564242784721484,"score_spread":0.31065992602588977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810579527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003196,0.00022454876,0.0016285061,0.0018598953,0.00095824525,0.0020607403,0.00013198936,0.00007331007,0.0030307833],"genre_scores_gemma":[0.99172527,0.00005358522,0.0024026684,0.003538346,0.0018139266,0.000107631124,0.000054447373,0.00013657726,0.00016752949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951516,0.001822358,0.001186954,0.00091809,0.00025139746,0.000669637],"domain_scores_gemma":[0.998062,0.00054607005,0.0002332257,0.0006175689,0.00020384986,0.00033727693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002534837,0.00040596962,0.0014259793,0.00021251496,0.000101869155,0.000015952171,0.00023613434,0.00033788904,0.0003139312],"category_scores_gemma":[0.0007650936,0.0003024189,0.00019979288,0.0001286081,0.0007751371,0.00007798022,0.00013147286,0.0005297128,0.000069321344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32572073,0.008101516,0.5991666,0.000078346784,0.0014954003,0.0013051376,0.0021842003,0.000011037154,0.0002598106,0.00015871509,0.0029021814,0.05861635],"study_design_scores_gemma":[0.43502602,0.0849108,0.4373075,0.0000576663,0.0013904179,0.00018948746,0.000101224476,0.0014689787,0.000120351986,0.00034084683,0.038343858,0.00074283005],"about_ca_topic_score_codex":0.000036343117,"about_ca_topic_score_gemma":0.00009003912,"teacher_disagreement_score":0.16185907,"about_ca_system_score_codex":0.000108333974,"about_ca_system_score_gemma":0.000348865,"threshold_uncertainty_score":0.9999428},"labels":[],"label_agreement":null},{"id":"W2810837006","doi":"10.1016/j.jval.2018.04.234","title":"Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Cisplatin; Internal medicine; Chemotherapy; Oncology; Cancer; Performance status; Urothelial cancer; Bladder cancer; Urology","score_opus":0.07991176340706468,"score_gpt":0.35837939078157655,"score_spread":0.27846762737451186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810837006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390346,0.00091746077,0.00006619112,0.0018880161,0.0004143972,0.0014936511,0.0011785172,0.000007691666,0.00013060184],"genre_scores_gemma":[0.99709165,0.00033143428,0.00046931504,0.0010745422,0.00019967294,0.00041864446,0.000023926166,0.00002648417,0.0003643151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986446,0.0000775128,0.0004960808,0.00024320197,0.000171946,0.00036664677],"domain_scores_gemma":[0.99935853,0.00012016743,0.00012345343,0.00020117109,0.000053356558,0.00014331122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016412506,0.00015301238,0.0005127706,0.00011157231,0.000027608368,0.000002388942,0.000053472017,0.000025378042,0.0004549028],"category_scores_gemma":[0.000025358184,0.00012185141,0.00005046442,0.0001420144,0.000018561694,0.000024534822,0.0000083393625,0.0000634242,0.0000020093573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025675492,0.0013420667,0.9093274,0.0025714075,0.00038348546,0.000088670946,0.004189172,0.00081813405,0.00036471777,0.0002589973,0.0010882142,0.0770002],"study_design_scores_gemma":[0.07078996,0.022631831,0.77571064,0.004439661,0.00050015777,0.00007995837,0.0022010654,0.012017317,0.055896852,0.001091764,0.053632133,0.0010086452],"about_ca_topic_score_codex":0.9896213,"about_ca_topic_score_gemma":0.9857408,"teacher_disagreement_score":0.13361673,"about_ca_system_score_codex":0.002231346,"about_ca_system_score_gemma":0.006802445,"threshold_uncertainty_score":0.99882805},"labels":[],"label_agreement":null},{"id":"W2811132458","doi":"10.1016/j.urology.2018.05.042","title":"Ureteroscopic Management of Large ≥2 cm Upper Tract Urothelial Carcinoma: A Comprehensive 23-Year Experience","year":2018,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ureteroscopy; Urothelial carcinoma; Urology; Urothelial cancer; Biopsy; Cystoscopy; Surgery; Lesion; Cancer; Ureter; Radiology; Urinary system; Internal medicine; Bladder cancer","score_opus":0.02183131922645991,"score_gpt":0.31057036424615114,"score_spread":0.2887390450196912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811132458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890708,0.00036368574,0.000288876,0.0003385525,0.00046844996,0.0004513123,0.000036868114,0.00003634054,0.008945117],"genre_scores_gemma":[0.99685574,0.000035318004,0.00042726606,0.0016100206,0.00021955348,0.000053750937,0.000017251834,0.000022488082,0.0007586325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989226,0.000042678723,0.00021592916,0.00031275404,0.00016883839,0.0003371987],"domain_scores_gemma":[0.99936926,0.000019127207,0.000062079765,0.00036879122,0.00008729716,0.00009341915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003236755,0.00015641961,0.00031174108,0.00007408082,0.000057876237,0.0000040807813,0.00011589905,0.000098407545,0.0009336285],"category_scores_gemma":[0.0000051271163,0.00013126904,0.00008417359,0.00010194689,0.00022577908,0.000036586578,0.000066485685,0.00010116368,0.00019355929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066624032,0.0033518549,0.91436315,0.00064821733,0.0012115005,0.0011796429,0.017106596,0.0000031651377,0.03785625,0.0072142896,0.0059432257,0.004459696],"study_design_scores_gemma":[0.015617751,0.008482178,0.8617655,0.000056740533,0.00058109255,0.00023724571,0.0011491164,0.00010823961,0.022822643,0.00028993594,0.08856245,0.00032711588],"about_ca_topic_score_codex":0.00004043447,"about_ca_topic_score_gemma":0.0000043704663,"teacher_disagreement_score":0.08261923,"about_ca_system_score_codex":0.000029566962,"about_ca_system_score_gemma":0.0000406881,"threshold_uncertainty_score":0.9999797},"labels":[],"label_agreement":null},{"id":"W287806724","doi":"","title":"Dr. So's rebuttal.","year":2008,"lang":"fr","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rebuttal; Cystectomy; Bladder cancer; Multidisciplinary approach; Chemotherapy; Medicine; General surgery; Oncology; Cancer; Internal medicine; History; Sociology; Archaeology; Social science","score_opus":0.04289802365341764,"score_gpt":0.26023441273292414,"score_spread":0.2173363890795065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W287806724","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1406611,0.27244523,0.00015318264,0.04829414,0.02096809,0.0044388403,0.0002485084,0.0003696523,0.51242125],"genre_scores_gemma":[0.65591556,0.0045635384,0.000066382185,0.0018777074,0.0029697875,0.0011104518,0.000018592416,0.000046169815,0.3334318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980758,0.000059452414,0.00026204606,0.00035148402,0.00033083674,0.00092037115],"domain_scores_gemma":[0.9989185,0.000047503472,0.000058975133,0.0003877298,0.00006276384,0.00052455027],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015148662,0.00023543277,0.00034120725,0.00007174673,0.00019899503,0.000020809623,0.000112375186,0.00017516977,0.0010480587],"category_scores_gemma":[0.00008764198,0.00022072489,0.00016656367,0.00023226642,0.00035645528,0.00013086546,0.000042881184,0.00023470487,0.0011280853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021837391,0.0007021633,0.053213324,0.0001448249,0.0004764764,0.001383156,0.00075433054,0.000001943504,0.000013470362,0.0005829776,0.21234542,0.7301635],"study_design_scores_gemma":[0.0021294302,0.00008178066,0.44470093,0.00003654188,0.00022824283,0.00040708858,0.000032878004,0.000005220887,0.0010097362,0.00013631463,0.5510827,0.00014915099],"about_ca_topic_score_codex":0.0006333205,"about_ca_topic_score_gemma":0.00002422308,"teacher_disagreement_score":0.7300144,"about_ca_system_score_codex":0.00032053544,"about_ca_system_score_gemma":0.00024305652,"threshold_uncertainty_score":0.9998651},"labels":[],"label_agreement":null},{"id":"W2883205706","doi":"10.1016/j.aca.2018.07.044","title":"Microchips for detection of exfoliated tumor cells in urine for identification of bladder cancer","year":2018,"lang":"en","type":"article","venue":"Analytica Chimica Acta","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Key Research and Development Program of China; National Science and Technology Major Project","keywords":"Urine; Urine cytology; Bladder cancer; Filtration (mathematics); Chemistry; Urology; Cytology; Cancer; Malignancy; Urinary system; Internal medicine; Chromatography; Pathology; Medicine","score_opus":0.021075891149032418,"score_gpt":0.30722613302139656,"score_spread":0.28615024187236415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883205706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765515,0.000024027035,0.00027461973,0.00037278354,0.0001510607,0.0010400903,0.00027298165,0.000014346456,0.00019494699],"genre_scores_gemma":[0.9987167,0.000042038562,0.00032247818,0.00010454363,0.0001561365,0.00012861437,0.000036695426,0.000023752036,0.00046900834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990248,0.000012621226,0.0004445305,0.00023198768,0.00010813138,0.00017792439],"domain_scores_gemma":[0.9991652,0.000058993453,0.00021241693,0.00023154254,0.00028132965,0.000050516348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001182848,0.00011488126,0.00032012362,0.00017260556,0.000030222973,0.0000046932823,0.000075127595,0.000056586352,0.0000795954],"category_scores_gemma":[0.000059520175,0.00010107173,0.00012687841,0.00023989125,0.00008456209,0.00004782624,0.000011972097,0.000046520316,0.0000032021587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010347734,0.0002837817,0.000982082,0.00018636523,0.00020917521,2.058192e-7,0.00019817289,4.937569e-7,0.9960546,0.000012613881,0.0005054923,0.0005322311],"study_design_scores_gemma":[0.0026824279,0.00059163355,0.017311104,0.00007791857,0.00050618564,0.0000016331551,0.000050131224,0.0020988102,0.9753855,0.0001882442,0.0010231411,0.00008326467],"about_ca_topic_score_codex":0.00013937226,"about_ca_topic_score_gemma":0.0002702477,"teacher_disagreement_score":0.020669106,"about_ca_system_score_codex":0.00006987288,"about_ca_system_score_gemma":0.00010935627,"threshold_uncertainty_score":0.41215858},"labels":[],"label_agreement":null},{"id":"W2883475115","doi":"10.1016/j.ctrv.2018.07.011","title":"Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Dissection (medical); Radiation therapy; Systematic review; Oncology; Perioperative; Pathological; Cancer; Internal medicine; MEDLINE; Surgery","score_opus":0.07949940888877625,"score_gpt":0.4023044407904984,"score_spread":0.3228050319017221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883475115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001304567,0.948265,0.0008738855,0.00015003596,0.000490484,0.04454029,0.005614276,0.000042110194,0.0000108460035],"genre_scores_gemma":[0.0000035295272,0.8992466,0.0034455128,0.00051453966,0.0007463769,0.095189326,0.00037762919,0.00018827041,0.00028824445],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946704,0.00048694623,0.0023709822,0.0014005837,0.0003769348,0.00069416576],"domain_scores_gemma":[0.9941735,0.0013279574,0.0024668686,0.0012526801,0.00031715268,0.00046183384],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004353145,0.0015814713,0.011643741,0.00020176043,0.00015441666,0.000034764376,0.0003228933,0.0005632871,0.00047180572],"category_scores_gemma":[0.0003702574,0.00088430784,0.0030159107,0.00041574228,0.0003483443,0.00009043456,0.00003617466,0.00029263375,0.000011617458],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011206572,0.00025523713,0.00008911512,0.67679816,0.004652804,0.000004113327,0.00022419676,2.7631641e-8,1.4800281e-7,0.000012643445,0.0022538442,0.31559765],"study_design_scores_gemma":[0.0015285678,0.0012144273,0.000009799497,0.42198175,0.052568994,0.000020819558,0.000007693232,9.295117e-7,0.0000038876096,0.000022433967,0.5222317,0.00040901947],"about_ca_topic_score_codex":0.00028659627,"about_ca_topic_score_gemma":0.0000963365,"teacher_disagreement_score":0.51997787,"about_ca_system_score_codex":0.001465789,"about_ca_system_score_gemma":0.0016858525,"threshold_uncertainty_score":0.99969333},"labels":[],"label_agreement":null},{"id":"W2883565725","doi":"10.1016/j.juro.2018.07.035","title":"Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma","year":2018,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Urothelial carcinoma; Classics; Cancer; Library science; Internal medicine; History; Bladder cancer","score_opus":0.017920399907410647,"score_gpt":0.32789824108356413,"score_spread":0.3099778411761535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883565725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966425,0.00020735076,0.00063976744,0.0016284137,0.0001793576,0.0003157184,0.000060802424,0.0000022033284,0.00032390706],"genre_scores_gemma":[0.99882704,0.000050624603,0.00042219987,0.00032261582,0.00030478538,0.0000025786674,8.83198e-7,0.000020258338,0.00004900616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990542,0.00007687578,0.00047320555,0.00006532435,0.00017825182,0.0001521589],"domain_scores_gemma":[0.99837935,0.00027336608,0.00066841673,0.00027268915,0.00036232753,0.000043856795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709796,0.0001174523,0.00045601837,0.00004825977,0.000040007293,9.0937215e-7,0.00020592412,0.00007293888,0.00028844128],"category_scores_gemma":[0.0000943305,0.000055460634,0.00032204212,0.000103289334,0.00033335752,0.000026410105,0.000016344367,0.000121139026,9.684321e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06789695,0.0013493111,0.69214064,0.00018972183,0.0015142051,0.0000053352624,0.0029237668,0.0006419788,0.22165187,0.0000672173,0.0012333979,0.010385634],"study_design_scores_gemma":[0.02376905,0.016204696,0.7166583,0.00010401089,0.0009096897,0.00032620085,0.000064246466,0.00047258032,0.2394504,0.0012074895,0.0007307296,0.000102594306],"about_ca_topic_score_codex":0.000100952,"about_ca_topic_score_gemma":0.000022746975,"teacher_disagreement_score":0.044127896,"about_ca_system_score_codex":0.000030844756,"about_ca_system_score_gemma":0.00028989353,"threshold_uncertainty_score":0.315823},"labels":[],"label_agreement":null},{"id":"W2884031435","doi":"10.3233/blc-180175","title":"Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Agence Nationale de la Recherche; Bladder Cancer Canada","keywords":"Bladder cancer; Immunotherapy; Context (archaeology); Medicine; Cancer; Disease; Perspective (graphical); Clinical trial; Cancer immunotherapy; Tumor microenvironment; Immune system; Oncology; Immunology; Internal medicine; Biology; Computer science","score_opus":0.03307595279235583,"score_gpt":0.3637603148918905,"score_spread":0.33068436209953467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884031435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8652617,0.085777484,0.0009896315,0.029082954,0.0031406386,0.0037321728,0.00014287575,0.00023375513,0.011638814],"genre_scores_gemma":[0.9839919,0.0036231978,0.00095726416,0.0055194316,0.0013820523,0.001110242,0.000005370698,0.00007807946,0.0033324615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980161,0.000039765713,0.00036695576,0.0006385365,0.00032440462,0.0006142215],"domain_scores_gemma":[0.99879366,0.000094971685,0.0001295333,0.000517948,0.00033373001,0.00013017531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041924958,0.00029826042,0.0003804674,0.00011914781,0.000805919,0.00007485904,0.00028252456,0.00012703685,0.0021915385],"category_scores_gemma":[0.00004192683,0.00019595437,0.00013998999,0.0004547587,0.0018982742,0.000198771,0.00005853538,0.00023328308,0.0000440351],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028508047,0.00032621255,0.029675268,0.00015781882,0.0026574554,0.0000070652145,0.03163993,0.0000040205828,0.11689277,0.0003893633,0.012244043,0.80315524],"study_design_scores_gemma":[0.035485096,0.0060838535,0.25174487,0.0011579125,0.0028403983,0.00014093041,0.0059088184,0.001671026,0.13222086,0.004860411,0.555803,0.0020828121],"about_ca_topic_score_codex":0.002011012,"about_ca_topic_score_gemma":0.0009841638,"teacher_disagreement_score":0.8010724,"about_ca_system_score_codex":0.0001942933,"about_ca_system_score_gemma":0.0011031608,"threshold_uncertainty_score":0.9987206},"labels":[],"label_agreement":null},{"id":"W2884217060","doi":"10.1016/j.urolonc.2018.05.023","title":"Female radical cystectomy patients have a higher risk of surgical site infections","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystectomy; Surgical site infection; Medicine; General surgery; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.02060501496152117,"score_gpt":0.31017183520950414,"score_spread":0.28956682024798297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884217060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858303,0.00031482993,0.000033560504,0.0012223537,0.00022988318,0.0003567729,0.00008451994,0.000052850235,0.0118749365],"genre_scores_gemma":[0.9881834,0.00034663494,0.008950691,0.00069996354,0.00034672176,0.00007307128,0.000069345144,0.000014557433,0.0013156155],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988182,0.00015282423,0.00030486792,0.00031532027,0.0001592827,0.0002494824],"domain_scores_gemma":[0.9990229,0.00020553943,0.00016317934,0.00018791233,0.00014472051,0.00027573688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016272222,0.00017096868,0.00037508018,0.00013148617,0.00025319486,0.000008410794,0.000053680164,0.00024963618,0.0004929806],"category_scores_gemma":[0.0000702972,0.00013064507,0.00008626413,0.00022646713,0.0014594581,0.000067128385,0.000043649972,0.00028281592,0.000055857035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021196532,0.0006279306,0.9942323,0.000016070167,0.00011807309,0.000046567846,0.00040459604,0.0000015175042,0.00006852731,0.00084539235,0.0021949667,0.0012320856],"study_design_scores_gemma":[0.0036603094,0.008483425,0.10653316,0.000035354497,0.00059834885,0.00017472554,0.000042510143,0.00006561246,0.0005563131,0.0012499718,0.8784736,0.00012668381],"about_ca_topic_score_codex":0.00025658077,"about_ca_topic_score_gemma":0.00006681874,"teacher_disagreement_score":0.8876991,"about_ca_system_score_codex":0.00008577791,"about_ca_system_score_gemma":0.00022474468,"threshold_uncertainty_score":0.5397792},"labels":[],"label_agreement":null},{"id":"W2884458916","doi":"10.1016/j.eururo.2018.06.024","title":"Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Disease; Clinical trial; Oncology; Surgery; Internal medicine; Cancer","score_opus":0.0744495674123909,"score_gpt":0.33871565536885617,"score_spread":0.2642660879564653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884458916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021674114,0.9868748,0.00018960517,0.0010259864,0.0009960114,0.0035448004,0.00058636954,0.00017346155,0.006392191],"genre_scores_gemma":[0.0014753895,0.9819373,0.00066121796,0.00078094186,0.0029133218,0.00024607655,0.0032727444,0.00029371463,0.0084192995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967697,0.00061608077,0.00079116906,0.0010616197,0.00013424162,0.0006271513],"domain_scores_gemma":[0.9981106,0.00028233824,0.00034506855,0.00070876686,0.00008995907,0.00046327952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010935277,0.0008344147,0.0018333928,0.00030705184,0.0002259564,0.000056780384,0.0002177397,0.0003123764,0.0004929935],"category_scores_gemma":[0.000050019105,0.000604991,0.00043053756,0.0002363072,0.0001855514,0.00006752047,0.00009720142,0.0002994871,0.00043876134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003140289,0.0006127152,0.000025745603,0.00071858574,0.0019315504,0.0005556346,0.00035271543,4.7375778e-7,0.0000030808137,0.0004799389,0.067497835,0.9275077],"study_design_scores_gemma":[0.008330926,0.00596365,0.00021791764,0.00020894712,0.005796412,0.0003511724,0.000012521964,0.0000045400993,0.0000050299263,0.000112188536,0.97857666,0.00042001304],"about_ca_topic_score_codex":0.00032581945,"about_ca_topic_score_gemma":0.00010722617,"teacher_disagreement_score":0.92708766,"about_ca_system_score_codex":0.00018982739,"about_ca_system_score_gemma":0.0008536767,"threshold_uncertainty_score":0.99964017},"labels":[],"label_agreement":null},{"id":"W2885788645","doi":"10.1158/1538-7445.am2018-ct031","title":"Abstract CT031: Updated efficacy and safety profile of durvalumab monotherapy in urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Metastatic Urothelial Carcinoma; Gastroenterology; Chemotherapy; Oncology; Carcinoma; Urology; Urothelial carcinoma; Surgery; Immunotherapy; Cancer; Bladder cancer; Pembrolizumab","score_opus":0.06887245459075661,"score_gpt":0.408279224729423,"score_spread":0.3394067701386664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885788645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890237,0.0011644756,0.000003390822,0.0007117243,0.00009341747,0.001137176,0.00009106243,0.000020292166,0.0077547682],"genre_scores_gemma":[0.99775237,0.00054347387,0.000079307625,0.00009437444,0.00034061313,0.0001272747,0.000017134113,0.000037364753,0.0010080705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983495,0.00009272337,0.00028591562,0.00036440196,0.00047679836,0.00043066347],"domain_scores_gemma":[0.99909854,0.00007118336,0.000043234653,0.00033476873,0.00029706216,0.00015519142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004645832,0.00013814516,0.00031636262,0.00024634175,0.000090534035,0.0000148534455,0.00012201123,0.00010263054,0.0023514768],"category_scores_gemma":[0.000044452467,0.000113057096,0.00003910565,0.00045945673,0.00044907985,0.00006520046,0.00004872316,0.0003166895,0.00004913607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040892158,0.001464213,0.3104986,0.00056634657,0.0003930018,0.00017780255,0.0055409656,0.0000033359208,0.46104434,0.00030378616,0.008253334,0.17086214],"study_design_scores_gemma":[0.013389766,0.0013389935,0.8214221,0.00021979993,0.000020887508,0.0000090643525,0.0001296696,0.00003376658,0.15630199,0.0000908533,0.0069128247,0.00013029021],"about_ca_topic_score_codex":0.0041821664,"about_ca_topic_score_gemma":0.00032574552,"teacher_disagreement_score":0.5109235,"about_ca_system_score_codex":0.00024395026,"about_ca_system_score_gemma":0.00067747955,"threshold_uncertainty_score":0.9985605},"labels":[],"label_agreement":null},{"id":"W2886065680","doi":"10.1016/j.euo.2018.07.003","title":"Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Carboplatin; Medicine; Gemcitabine; Oncology; Internal medicine; Cisplatin; Hazard ratio; Chemotherapy; Metastatic Urothelial Carcinoma; Cancer; Bladder cancer; Urothelial carcinoma; Nivolumab; Confidence interval; Immunotherapy","score_opus":0.07254437410222264,"score_gpt":0.41245632057114395,"score_spread":0.3399119464689213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886065680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303967,0.00010554986,0.0003965315,0.0003669195,0.00039368117,0.004084267,0.00014518696,0.000019008956,0.0014492108],"genre_scores_gemma":[0.9987604,0.0000077635,0.00013017908,0.000470445,0.00015911552,0.00024827028,0.00017931307,0.00003144928,0.000013086535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960538,0.0025466576,0.00053410296,0.00039480897,0.00014847361,0.00032214847],"domain_scores_gemma":[0.99809647,0.0010804421,0.00026613558,0.00029669105,0.00018876605,0.000071526214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010439355,0.0002509042,0.0007958271,0.00014179431,0.0001557017,0.0000068602117,0.00016545322,0.00005166388,0.000033740365],"category_scores_gemma":[0.00007755818,0.0001732993,0.00009501706,0.00020790844,0.0003145232,0.00004410874,0.000024765543,0.00018258831,0.000019858486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33390763,0.049928933,0.50615346,0.00037678736,0.0023706062,0.00053488126,0.08035934,0.00004196787,0.0017862514,0.00008260102,0.0005194623,0.023938108],"study_design_scores_gemma":[0.08384993,0.23210354,0.6809677,0.000015895075,0.00044210136,0.000022055316,0.00059706747,0.0001658497,0.0005583275,0.000013362232,0.0011496968,0.00011447938],"about_ca_topic_score_codex":0.00029373766,"about_ca_topic_score_gemma":0.0013866712,"teacher_disagreement_score":0.2500577,"about_ca_system_score_codex":0.00012886368,"about_ca_system_score_gemma":0.0002626784,"threshold_uncertainty_score":0.706694},"labels":[],"label_agreement":null},{"id":"W2886529900","doi":"10.1016/j.euo.2018.07.006","title":"Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of British Columbia","funders":"National Center for Advancing Translational Sciences; DOD Peer Reviewed Cancer Research Program; National Cancer Institute; National Institutes of Health; Institute of Clinical and Translational Sciences; University of Texas Medical Branch; U.S. Department of Defense","keywords":"Medicine; Psychological intervention; Comorbidity; Cystectomy; Socioeconomic status; Corpectomy; Marital status; Receipt; Bladder cancer; MEDLINE; Systematic review; Cancer; Family medicine; Emergency medicine; Gerontology; Environmental health; Internal medicine; Surgery; Psychiatry; Population","score_opus":0.1034561736754374,"score_gpt":0.39005715634427907,"score_spread":0.28660098266884165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886529900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023540491,0.9913198,0.00010641936,0.000236451,0.00024544186,0.005313857,0.00021870217,0.000030882045,0.0025049248],"genre_scores_gemma":[0.00026750405,0.99729675,0.000019464367,0.0009539037,0.00015691158,0.00043268336,0.00031635255,0.00010748648,0.00044891922],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553734,0.0023527914,0.001202068,0.00039508208,0.00022098556,0.00029173392],"domain_scores_gemma":[0.9958999,0.0011705399,0.0019126574,0.0005390334,0.00039639533,0.00008146962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010670203,0.00040474767,0.0040619737,0.0001295296,0.000059255533,0.0000023071684,0.00032538042,0.0002904698,0.00018396588],"category_scores_gemma":[0.00089083903,0.00019664488,0.0005399335,0.00033428345,0.00061366626,0.00001664443,0.000059078004,0.00029800876,0.000012317181],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012847874,0.00035094595,0.000028846349,0.9764944,0.0066281315,0.000028415006,0.00019431737,1.1476248e-7,6.7780377e-7,0.000042874603,0.0069220853,0.009180756],"study_design_scores_gemma":[0.0020235705,0.004672288,0.00006347159,0.31079376,0.044563092,0.00009849975,0.00001686586,0.0000017990184,0.0000030033184,0.000002317644,0.63757116,0.00019015853],"about_ca_topic_score_codex":0.000008969854,"about_ca_topic_score_gemma":0.000021202386,"teacher_disagreement_score":0.6657006,"about_ca_system_score_codex":0.00018733382,"about_ca_system_score_gemma":0.0009790538,"threshold_uncertainty_score":0.80189455},"labels":[],"label_agreement":null},{"id":"W2887103583","doi":"10.1007/s00345-018-2438-9","title":"ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer","year":2018,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cystoscopy; Urine cytology; Malignancy; Grading (engineering); Nephrology; Carcinoma in situ; Internal medicine; Oncology; Urology; Cancer; Urinary system","score_opus":0.050873834344542,"score_gpt":0.3845335463060826,"score_spread":0.3336597119615406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887103583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008467488,0.97454435,0.000049809343,0.0012651301,0.004302082,0.00082332065,0.000183806,0.000009524417,0.018737279],"genre_scores_gemma":[0.0011873624,0.98567796,0.00028380478,0.0011065424,0.0015801397,0.00012879637,0.00004575966,0.00006535227,0.009924289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739754,0.00013505292,0.0011989358,0.00037808032,0.00056476734,0.00032560466],"domain_scores_gemma":[0.9968868,0.00022346509,0.0017306394,0.00031284406,0.0006703487,0.00017590776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025229604,0.00043802639,0.0016557587,0.00076638703,0.000045745466,0.00001536738,0.00037007345,0.00022640389,0.0024139727],"category_scores_gemma":[0.000041957388,0.00032077794,0.0005600187,0.00035658255,0.00022111337,0.00008660265,0.00008092761,0.00060057396,0.000081313745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081776176,0.0005365038,0.00014947094,0.003078603,0.0118604535,0.000584044,0.00032328267,0.000027170056,0.000010361632,0.00013004562,0.08128298,0.90119934],"study_design_scores_gemma":[0.0032924507,0.0009327746,0.00084099,0.0071355193,0.0068937284,0.00020342342,0.000033595694,0.000004166357,0.000012848638,0.00007131329,0.9803571,0.0002220563],"about_ca_topic_score_codex":0.00010341396,"about_ca_topic_score_gemma":0.000249077,"teacher_disagreement_score":0.90097725,"about_ca_system_score_codex":0.000502941,"about_ca_system_score_gemma":0.0012341428,"threshold_uncertainty_score":0.9999244},"labels":[],"label_agreement":null},{"id":"W2887233605","doi":"10.1158/1538-7445.am2018-3689","title":"Abstract 3689: Identification of candidate therapeutic targets in BCG unresponsive bladder cancer- inflammatory subtypes of BCG unresponsive bladder cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Immunotherapy; Transcriptome; Cystectomy; Cancer; Immune system; Medicine; Cancer research; Immunology; Oncology; Internal medicine; Biology; Gene; Gene expression","score_opus":0.058954576434500194,"score_gpt":0.4182035846874836,"score_spread":0.3592490082529834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887233605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763682,0.01831116,0.000015476688,0.001464635,0.00057241955,0.0016889304,0.0005643965,0.00003591343,0.0009788908],"genre_scores_gemma":[0.98959947,0.0058849053,0.000019005789,0.0002512612,0.00052492076,0.0009790096,0.00003643814,0.000093419294,0.002611601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956033,0.00042819418,0.00096125965,0.0007683166,0.0013235987,0.0009153247],"domain_scores_gemma":[0.9957325,0.00041732914,0.0003995418,0.00083928386,0.0023283823,0.00028297983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011254833,0.00037248453,0.00075113494,0.0009126442,0.00017995844,0.000034156412,0.00043079068,0.0002768873,0.0043253787],"category_scores_gemma":[0.00026788164,0.0003248402,0.00016358576,0.0012872374,0.0011615719,0.00024619044,0.00012559061,0.00067167555,0.00006969277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013528833,0.00056033477,0.10321501,0.0007957731,0.0016453444,0.00011071346,0.008699682,0.00012983281,0.8410468,0.00020188437,0.0061367634,0.023928998],"study_design_scores_gemma":[0.0030275853,0.0005122981,0.44564432,0.00060916774,0.0001805171,0.0000048473116,0.00094931416,0.000052567877,0.54417723,0.00034937958,0.0042255786,0.00026716688],"about_ca_topic_score_codex":0.018810812,"about_ca_topic_score_gemma":0.013446898,"teacher_disagreement_score":0.3424293,"about_ca_system_score_codex":0.0010265923,"about_ca_system_score_gemma":0.004467555,"threshold_uncertainty_score":0.99992037},"labels":[],"label_agreement":null},{"id":"W2887698070","doi":"10.1158/1538-7445.am2018-ct112","title":"Abstract CT112: Durvalumab + tremelimumab in patients with metastatic urothelial cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Tremelimumab; Discontinuation; Internal medicine; Refractory (planetary science); Blockade; Cancer; Gastroenterology; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Cohort; Oncology; Phases of clinical research; Immunotherapy; Pembrolizumab","score_opus":0.07978595004423476,"score_gpt":0.41202032060803323,"score_spread":0.33223437056379845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887698070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067223,0.00076017994,0.0000049549885,0.0007578978,0.00023427585,0.0014212361,0.00015637556,0.00004165447,0.005951221],"genre_scores_gemma":[0.9963337,0.00021619104,0.00009672134,0.00031897385,0.0005320778,0.00071443315,0.0000227084,0.000076926204,0.0016882733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968994,0.000110025925,0.00030329925,0.0005687821,0.0012758101,0.0008426778],"domain_scores_gemma":[0.9983822,0.000071768474,0.00005738055,0.0004743056,0.00073401444,0.000280325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040236302,0.00024058543,0.00040893973,0.0003680389,0.00017491651,0.000045946268,0.00020570985,0.00007545722,0.005487926],"category_scores_gemma":[0.00006136808,0.00017347919,0.00006410289,0.0008160633,0.0004287361,0.00015708883,0.000058737816,0.00051366724,0.00024370398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018384013,0.002211463,0.8610356,0.00045343957,0.0007464794,0.0001857036,0.0020888008,0.000017175575,0.003911827,0.00008004936,0.009518149,0.10136733],"study_design_scores_gemma":[0.018992396,0.002292772,0.95883095,0.00063018606,0.00010621693,0.0000028706968,0.00013571316,0.000014440397,0.009557004,0.00011896747,0.009044577,0.00027390572],"about_ca_topic_score_codex":0.008196265,"about_ca_topic_score_gemma":0.0048164893,"teacher_disagreement_score":0.10109343,"about_ca_system_score_codex":0.0009337496,"about_ca_system_score_gemma":0.0014514636,"threshold_uncertainty_score":0.99840826},"labels":[],"label_agreement":null},{"id":"W2887967651","doi":"10.5489/cuaj.5405","title":"Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Cystectomy; Medicine; Bladder cancer; Receipt; Chemotherapy; Logistic regression; Cancer; Internal medicine; Oncology; Urology","score_opus":0.035905046328977244,"score_gpt":0.2644372861824678,"score_spread":0.22853223985349058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887967651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645562,0.00015058437,0.00003661482,0.03440253,0.00014421296,0.00022259359,0.00012668231,0.000004445671,0.00035609494],"genre_scores_gemma":[0.99051344,0.0000787243,0.00019351426,0.0084303245,0.00047604312,0.000016799057,0.000008898354,0.000008229226,0.00027404117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914336,0.00008631245,0.00021491929,0.00011504921,0.00016638724,0.00027399577],"domain_scores_gemma":[0.99922556,0.0002443116,0.00012137589,0.000074287615,0.00015437281,0.00018008679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025903023,0.00009359062,0.00020666973,0.00014447152,0.0001344758,0.00004727366,0.00006448141,0.0001183032,0.00012771891],"category_scores_gemma":[0.00030595734,0.000059071168,0.000085159314,0.0001321032,0.000076189695,0.00006796899,0.0000040535724,0.00016912918,0.0000012805784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002330613,0.000057979556,0.96892715,0.0000058478017,0.00006530641,0.00002208362,0.0008530716,0.0000012376038,0.00012385895,0.00020261732,0.007944346,0.021563439],"study_design_scores_gemma":[0.002381394,0.0010954979,0.96031034,0.000010618403,0.0000571963,0.000058707585,0.00006578162,0.00005119819,0.00007690631,0.00048011617,0.03535385,0.00005839985],"about_ca_topic_score_codex":0.0040379358,"about_ca_topic_score_gemma":0.005706114,"teacher_disagreement_score":0.027409503,"about_ca_system_score_codex":0.00023669451,"about_ca_system_score_gemma":0.0002821382,"threshold_uncertainty_score":0.6104178},"labels":[],"label_agreement":null},{"id":"W2889184937","doi":"10.1097/mou.0000000000000548","title":"A risk-stratified approach to the management of high-grade T1 bladder cancer","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Amgen","keywords":"Cystectomy; Medicine; Bladder cancer; Lamina propria; Lymphovascular invasion; Urology; Carcinoma in situ; Stage (stratigraphy); Urinary diversion; Cancer; Oncology; Surgery; Internal medicine; Pathology; Metastasis","score_opus":0.12176720965643882,"score_gpt":0.4097530954887585,"score_spread":0.28798588583231965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889184937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017827779,0.9891323,0.00021061576,0.00021305364,0.0059886207,0.0029996652,0.00027652222,0.000025139265,0.0011362894],"genre_scores_gemma":[0.0002208154,0.99592596,0.00022994139,0.00006006929,0.00092151755,0.0021511759,0.00029464375,0.000050990755,0.0001448867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975899,0.00028744436,0.0007522231,0.00068109116,0.00028813683,0.0004011907],"domain_scores_gemma":[0.99863106,0.000062579675,0.0003815222,0.0007477302,0.000057561083,0.00011952525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025704905,0.00043378148,0.0013901737,0.00025236348,0.00005353592,0.000009496093,0.000374512,0.00025682987,0.0001329638],"category_scores_gemma":[0.000011337368,0.0002656935,0.0003050193,0.00051873876,0.00014251839,0.000019234458,0.00015451015,0.00055023265,0.000091893875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012153407,0.0009064739,0.00015319757,0.022479447,0.0014835072,0.0000022179624,0.00026022916,0.000011382235,2.0774527e-8,0.0014657255,0.023429906,0.94968635],"study_design_scores_gemma":[0.0011469914,0.00034793888,0.0007586151,0.0035992328,0.0018468362,0.000018812661,0.00001772614,0.0000094592915,3.533734e-7,0.00012323826,0.9919318,0.00019898785],"about_ca_topic_score_codex":0.00017887569,"about_ca_topic_score_gemma":0.000012484773,"teacher_disagreement_score":0.9685019,"about_ca_system_score_codex":0.0001373828,"about_ca_system_score_gemma":0.00025397184,"threshold_uncertainty_score":0.99997956},"labels":[],"label_agreement":null},{"id":"W2889545789","doi":"10.5489/cuaj.5341","title":"Images – Isolated forearm soft tissue metastasis from bladder cancer","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Soft tissue; Forearm; Metastasis; Bladder cancer; Medicine; Cancer metastasis; Cancer; Pathology; Internal medicine","score_opus":0.016975863042791993,"score_gpt":0.27814904620667735,"score_spread":0.2611731831638854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889545789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8361827,0.0055862027,0.0019615304,0.12403537,0.0032009673,0.00095506746,0.0021706081,0.00021132728,0.025696224],"genre_scores_gemma":[0.9849582,0.00014191115,0.00037894215,0.010026056,0.0019799485,0.000016199358,0.00004778382,0.000022669608,0.0024283119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998502,0.00010338547,0.0002836997,0.00024071027,0.0003296942,0.0005405152],"domain_scores_gemma":[0.9983508,0.00007455799,0.00018160054,0.00012311083,0.00043726168,0.00083266303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021405224,0.00017431787,0.0003173093,0.00012684205,0.00033199135,0.00009844593,0.00011280415,0.00024068958,0.013191627],"category_scores_gemma":[0.00023712247,0.00013295664,0.000120891345,0.00021157778,0.00006093025,0.00011515575,0.000013201027,0.0004097161,0.00033747678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024868033,0.00011545166,0.71583915,0.0000029740852,0.0017512873,0.0002791329,0.00038562305,0.0000051386637,0.0014720386,0.000026610534,0.21579352,0.064080365],"study_design_scores_gemma":[0.002260018,0.0010302316,0.6103436,0.000018484623,0.000728639,0.00011816936,0.00006440629,0.00008188634,0.0016171323,0.0014596548,0.38203984,0.00023794948],"about_ca_topic_score_codex":0.020550348,"about_ca_topic_score_gemma":0.0059894584,"teacher_disagreement_score":0.16624632,"about_ca_system_score_codex":0.0010181488,"about_ca_system_score_gemma":0.0007049099,"threshold_uncertainty_score":0.9877105},"labels":[],"label_agreement":null},{"id":"W2889641238","doi":"10.1007/s00345-018-2466-5","title":"SIU–ICUD on bladder cancer: pathology","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Pathology; Consensus conference; Cancer; Internal medicine","score_opus":0.020340858674792423,"score_gpt":0.31410230854606114,"score_spread":0.29376144987126873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889641238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8287201,0.009005862,0.00028800382,0.059196234,0.0062677264,0.00040942183,0.000024255525,0.0000560978,0.09603228],"genre_scores_gemma":[0.98021156,0.0004998474,0.00023210883,0.013524273,0.0023003106,0.0000052022615,0.0000010798572,0.000022199478,0.0032034346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989614,0.00008250521,0.0003379016,0.0001570836,0.00018334434,0.00027779565],"domain_scores_gemma":[0.9991458,0.00006809403,0.00021481588,0.00018702967,0.00022376502,0.00016047925],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016324832,0.00013781282,0.00039500138,0.00029703224,0.00005797301,0.000005200045,0.00010978843,0.00008312492,0.0023134754],"category_scores_gemma":[0.000041973715,0.00009870646,0.00012899806,0.00018526787,0.00021416921,0.000037490645,0.000020667621,0.0003409433,0.00014617716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02544848,0.0028216846,0.19304612,0.000065323,0.00335379,0.01016047,0.0025457945,0.00006655059,0.02553721,0.005222379,0.29964238,0.43208984],"study_design_scores_gemma":[0.008626482,0.0158252,0.119931504,0.0000602131,0.0008769056,0.004458428,0.000038877533,0.000019426923,0.00427343,0.0019412127,0.8437366,0.00021175278],"about_ca_topic_score_codex":0.000021044376,"about_ca_topic_score_gemma":0.00014390644,"teacher_disagreement_score":0.5440942,"about_ca_system_score_codex":0.000069505535,"about_ca_system_score_gemma":0.00020519775,"threshold_uncertainty_score":0.9985985},"labels":[],"label_agreement":null},{"id":"W2889696398","doi":"10.1038/s41416-018-0261-0","title":"Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Everolimus; Medicine; Oncology; Internal medicine; Clinical endpoint; PI3K/AKT/mTOR pathway; Progression-free survival; Targeted therapy; Cancer; Sunitinib; Chemotherapy; Clinical trial; Biology","score_opus":0.008266148816195511,"score_gpt":0.2463326452171442,"score_spread":0.2380664964009487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889696398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508065,0.0038535378,0.00005491044,0.00014492817,0.00018396937,0.00027219142,0.00009654513,0.0000102945905,0.00030299477],"genre_scores_gemma":[0.9970365,0.00046669535,0.0010754932,0.0005826083,0.00056771835,0.000010049571,0.0000052552277,0.000038607002,0.00021704903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988476,0.00002785664,0.00032785698,0.00017358475,0.0003758441,0.00024727263],"domain_scores_gemma":[0.9985149,0.000019793733,0.00020102585,0.00008856229,0.00093216373,0.00024356521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007435134,0.00014571013,0.00038380036,0.00007127085,0.00009123714,0.000050220915,0.00007492152,0.00004005779,0.00042007692],"category_scores_gemma":[0.000030025825,0.0001232578,0.000058373138,0.00015822265,0.00012739764,0.00013240796,0.000017336217,0.0001789618,0.0000045447614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004765192,0.00043378343,0.7998309,0.0000738975,0.0009535596,0.00052539574,0.0003243329,0.0000028122206,0.0010122291,0.000007815333,0.001110418,0.19095965],"study_design_scores_gemma":[0.011224834,0.0026426995,0.9791263,0.00030951097,0.0006767787,0.0014404685,0.000015584752,0.000007786942,0.0012755424,0.000054190885,0.0030876563,0.00013865512],"about_ca_topic_score_codex":0.000736877,"about_ca_topic_score_gemma":0.0007960821,"teacher_disagreement_score":0.19082099,"about_ca_system_score_codex":0.00013365322,"about_ca_system_score_gemma":0.0004075771,"threshold_uncertainty_score":0.5026307},"labels":[],"label_agreement":null},{"id":"W2889894882","doi":"10.1200/jco.2018.36.15_suppl.e16515","title":"Clinical validation of an ultra-deep next generation DNA sequencing approach for the detection of bladder cancer in the urine.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Urine; Cancer; Internal medicine; Incidence (geometry); Cohort; Urinary system; Urology; False positive paradox; Oncology","score_opus":0.2867035589713152,"score_gpt":0.4901314975346996,"score_spread":0.20342793856338437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889894882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829351,0.0003653613,0.012952517,0.0012661844,0.0012135432,0.0005715172,0.000004905004,0.0000029797825,0.00068789895],"genre_scores_gemma":[0.99171835,0.0005407159,0.0024714135,0.00090386835,0.0043070656,0.000024053372,0.000003701318,0.000010975297,0.000019847781],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99671155,0.00068979233,0.002038472,0.00015150766,0.00028085793,0.00012779099],"domain_scores_gemma":[0.99610096,0.0015777507,0.0014473172,0.000209388,0.00058841193,0.000076169315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005256688,0.000092120594,0.00071912934,0.000064985834,0.00005111244,0.000008071557,0.00016431033,0.00026187464,0.000054655764],"category_scores_gemma":[0.0013964616,0.00004669535,0.0003257393,0.00014489904,0.00028283306,0.00016803145,0.000007341391,0.000427788,7.319852e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008182826,0.0032627208,0.033263694,0.00007225112,0.0010003354,0.000012318938,0.0016240393,0.0006120712,0.052843004,0.000056636378,0.00031346484,0.8987566],"study_design_scores_gemma":[0.04498417,0.12324562,0.5448748,0.0002189461,0.0061033405,0.00055325753,0.005518175,0.056596268,0.20626593,0.0013789188,0.009869989,0.00039062242],"about_ca_topic_score_codex":0.00013462984,"about_ca_topic_score_gemma":0.00029989134,"teacher_disagreement_score":0.89836603,"about_ca_system_score_codex":0.000101248326,"about_ca_system_score_gemma":0.0008935283,"threshold_uncertainty_score":0.2019817},"labels":[],"label_agreement":null},{"id":"W2890138337","doi":"10.1200/jco.2021.39.15_suppl.4532","title":"Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Docetaxel; Medicine; Regimen; Internal medicine; Randomization; Clinical trial; Phases of clinical research; Oncology; Cancer","score_opus":0.2242483104486075,"score_gpt":0.5124252516500166,"score_spread":0.28817694120140913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890138337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97330964,0.0045022573,0.000020733392,0.01078599,0.009000014,0.0007086236,0.0001990715,0.000013787809,0.0014599083],"genre_scores_gemma":[0.9781342,0.0080290865,0.0022742597,0.004795421,0.0055480595,0.00007129512,0.000031166866,0.000070625276,0.0010458772],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99384785,0.0012055959,0.0033573364,0.00044403365,0.0007163106,0.00042890207],"domain_scores_gemma":[0.98932546,0.0064833057,0.0021908437,0.0005552137,0.0007640063,0.0006811523],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015359671,0.00032861947,0.002498768,0.00011818596,0.00006436687,0.000017521948,0.00039338844,0.00049531966,0.0016308259],"category_scores_gemma":[0.021525325,0.00020062306,0.00081630907,0.00050677947,0.00039752637,0.00020716221,0.000110834204,0.0015428049,0.00001656384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82027304,0.005746971,0.014960707,0.00006127787,0.0017021389,0.00092841266,0.00041755004,0.000015961512,0.001633557,0.00007156248,0.01010519,0.1440836],"study_design_scores_gemma":[0.73402345,0.04239864,0.022386448,0.0006242697,0.0018419331,0.000044296958,0.00036075767,0.000029767454,0.0017106985,0.00036173293,0.19597192,0.00024605633],"about_ca_topic_score_codex":0.0006532999,"about_ca_topic_score_gemma":0.002683597,"teacher_disagreement_score":0.18586673,"about_ca_system_score_codex":0.00040331006,"about_ca_system_score_gemma":0.01104702,"threshold_uncertainty_score":0.9992818},"labels":[],"label_agreement":null},{"id":"W2890455003","doi":"10.1200/jco.2017.35.15_suppl.e16011","title":"Standard of care for MIBC is becoming more standard.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Regimen; Guideline; Chemotherapy; Cisplatin; Chemotherapy regimen; Stage (stratigraphy); Cancer; Internal medicine; Oncology; Surgery; Pathology","score_opus":0.15935648269332112,"score_gpt":0.5357403778493247,"score_spread":0.37638389515600357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890455003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954247,0.0022617525,0.0008307589,0.029879091,0.003007327,0.000599979,0.00032464796,0.000007369288,0.00884206],"genre_scores_gemma":[0.98618615,0.0005571904,0.010011059,0.0015809794,0.0012987508,0.0000041176454,0.0000020783746,0.000018455046,0.00034120574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787205,0.000059399685,0.0014291018,0.00013527182,0.00033300137,0.0001711624],"domain_scores_gemma":[0.9958567,0.0006119422,0.0019411925,0.0003172656,0.0010259536,0.00024695956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010904426,0.000107557884,0.001687511,0.00005334135,0.00011341271,0.000011207263,0.00020985022,0.0002627171,0.00015555177],"category_scores_gemma":[0.002318219,0.000073407144,0.00068694935,0.00001860706,0.00024628913,0.00009004889,0.000043152704,0.00036753717,0.0000017394028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06320378,0.0007191773,0.24825801,0.00035861955,0.0015276414,0.0003607274,0.0017457692,0.0000022037968,0.00013164553,0.00014922295,0.026793972,0.65674925],"study_design_scores_gemma":[0.04821472,0.08417174,0.16715056,0.0005163427,0.0019111864,0.00014233719,0.0014983953,0.000011050846,0.0044600125,0.0013135553,0.69046134,0.00014878699],"about_ca_topic_score_codex":0.000024607714,"about_ca_topic_score_gemma":0.00006140255,"teacher_disagreement_score":0.6636673,"about_ca_system_score_codex":0.00017196163,"about_ca_system_score_gemma":0.0022571916,"threshold_uncertainty_score":0.4004161},"labels":[],"label_agreement":null},{"id":"W2890545119","doi":"10.1158/1078-0432.ccr-18-1106","title":"Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Bladder cancer; Chemotherapy; Cancer; Medicine; Neoadjuvant therapy; Oncology; Pathology; Cancer research; Internal medicine; Breast cancer","score_opus":0.30430948962792254,"score_gpt":0.5521982739499504,"score_spread":0.24788878432202782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890545119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96840334,0.0014436721,0.000012963501,0.026499497,0.00074918446,0.0014729003,0.00008202499,0.000055362758,0.0012810768],"genre_scores_gemma":[0.9803913,0.0057469043,0.00018708035,0.0075994018,0.002095491,0.0008594096,0.0000065704526,0.00005241686,0.003061385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554485,0.00089161587,0.00070106477,0.0009971414,0.00085459487,0.0010107113],"domain_scores_gemma":[0.9967116,0.0010989642,0.00006221744,0.0006623028,0.0006871628,0.00077774836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002904909,0.00025722955,0.00065243384,0.00030632765,0.00017884579,0.000033581906,0.00037039316,0.00031693844,0.00668538],"category_scores_gemma":[0.0015345801,0.00018603055,0.00021249111,0.0010456366,0.0008056359,0.000057369874,0.0002656454,0.0008812585,0.00069323333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0660243,0.0027217548,0.5934778,0.00005869542,0.00046201068,0.0004797654,0.0021634004,0.000005186928,0.021542156,0.000045942936,0.06577838,0.24724059],"study_design_scores_gemma":[0.008393999,0.006010667,0.8514041,0.00032474866,0.00002884523,0.0000042032716,0.00022367801,0.000016170745,0.007100114,0.00020659265,0.12604104,0.0002458565],"about_ca_topic_score_codex":0.0033027444,"about_ca_topic_score_gemma":0.0023194123,"teacher_disagreement_score":0.2579263,"about_ca_system_score_codex":0.000700324,"about_ca_system_score_gemma":0.0017401626,"threshold_uncertainty_score":0.99422264},"labels":[],"label_agreement":null},{"id":"W2890551042","doi":"10.1002/jmri.26294","title":"Update on multiparametric MRI of urinary bladder cancer","year":2018,"lang":"en","type":"review","venue":"Journal of Magnetic Resonance Imaging","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiology; Diffusion MRI; Magnetic resonance imaging; Artifact (error); Bladder cancer; Dynamic imaging; Effective diffusion coefficient; Nuclear medicine; Cancer; Computer science; Image processing; Artificial intelligence; Digital image processing","score_opus":0.037520208754470215,"score_gpt":0.360210188542242,"score_spread":0.3226899797877718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890551042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013935645,0.9965659,0.00001769064,0.00025739428,0.0008847734,0.000618158,0.00006890396,0.0000113040405,0.0014365423],"genre_scores_gemma":[0.00016731293,0.99534094,0.0017058548,0.0002880553,0.00118649,0.00003239124,0.0000055632026,0.00009766,0.0011757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677515,0.00014841666,0.0014715828,0.00038311174,0.0008093242,0.00041243152],"domain_scores_gemma":[0.997143,0.00019865943,0.001455954,0.0005338206,0.00044308952,0.00022552353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039556317,0.00051490514,0.0024050202,0.00084443827,0.00005147546,0.000028279424,0.00037423716,0.00015343715,0.0007813446],"category_scores_gemma":[0.00015174728,0.00035338718,0.00090565765,0.0007297386,0.00021249382,0.00011044537,0.00007130017,0.0007289403,0.00006169991],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023544033,0.0003730875,0.00053532096,0.0033005383,0.0001863634,0.000535702,0.00004412695,8.735833e-7,0.000001179555,0.0000034975833,0.011971002,0.9828129],"study_design_scores_gemma":[0.0019442188,0.0015997632,0.0014321386,0.032324865,0.00275708,0.0016012251,0.000012304911,0.000022960225,0.000018033974,0.000019522357,0.95801204,0.0002558203],"about_ca_topic_score_codex":0.000040332852,"about_ca_topic_score_gemma":9.3153943e-7,"teacher_disagreement_score":0.98255706,"about_ca_system_score_codex":0.00031712317,"about_ca_system_score_gemma":0.0010311838,"threshold_uncertainty_score":0.9998918},"labels":[],"label_agreement":null},{"id":"W2890593119","doi":"10.1200/jco.2017.35.15_suppl.e16012","title":"Nomogram to assess survival benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Nomogram; Oncology; Internal medicine; Docetaxel; Pazopanib; Salvage therapy; Sunitinib; Progression-free survival; Urology; Surgery; Chemotherapy; Cancer; Overall survival","score_opus":0.42450118140751847,"score_gpt":0.5525516053763351,"score_spread":0.1280504239688166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890593119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98130035,0.00044850135,0.0012739279,0.008042143,0.005016443,0.002054984,0.000026586249,0.0000051434417,0.0018319337],"genre_scores_gemma":[0.98722833,0.00057640753,0.006602434,0.0015376705,0.002305139,0.00007068865,0.0000027302428,0.00004015048,0.0016364355],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99378514,0.0009359599,0.0041038305,0.00029011435,0.0005595272,0.00032543502],"domain_scores_gemma":[0.9863101,0.008614369,0.0035673263,0.00043574776,0.0004126511,0.00065979356],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011477977,0.0002498582,0.006128734,0.00022120004,0.00006271568,0.000023330958,0.00042208828,0.0003236584,0.00033140474],"category_scores_gemma":[0.02471503,0.00016205551,0.0019269972,0.000084008745,0.00016490565,0.00012839749,0.00005750156,0.00055631524,0.000007649318],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63434416,0.0050211963,0.08846743,0.000058830945,0.0023946462,0.00055448234,0.00043668138,0.000013022963,0.00037428408,0.00014593436,0.012215196,0.25597414],"study_design_scores_gemma":[0.55299354,0.021417463,0.3725397,0.00013612206,0.0018642282,0.000052455962,0.000042826236,0.00006602002,0.00042887742,0.0021348973,0.04813703,0.00018680932],"about_ca_topic_score_codex":0.002025157,"about_ca_topic_score_gemma":0.00028451538,"teacher_disagreement_score":0.28407228,"about_ca_system_score_codex":0.00044140566,"about_ca_system_score_gemma":0.0029030857,"threshold_uncertainty_score":0.9835002},"labels":[],"label_agreement":null},{"id":"W2891071077","doi":"10.1016/j.euf.2018.08.019","title":"Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non–muscle-invasive Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Maintenance therapy; Bladder cancer; Regimen; Context (archaeology); Epirubicin; Chemotherapy; Randomized controlled trial; Oncology; Internal medicine; Chemotherapy regimen; Surgery; Intensive care medicine; Cancer; Cyclophosphamide","score_opus":0.04852767501623593,"score_gpt":0.33744414669501205,"score_spread":0.2889164716787761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891071077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019340927,0.9797221,0.0000375421,0.0009722657,0.0001233921,0.0049392576,0.000032438653,0.000010615362,0.0141430935],"genre_scores_gemma":[0.0015444346,0.9948415,0.000017996024,0.0027242976,0.000119396056,0.00036690966,0.000016603954,0.00006946867,0.00029936837],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967407,0.0012540296,0.0010486041,0.00038660437,0.00031482693,0.00025522805],"domain_scores_gemma":[0.9978009,0.00029502073,0.00077746,0.0009932126,0.0000965204,0.00003692858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010826642,0.000380516,0.0018407132,0.000097638665,0.00003505539,0.000005292436,0.00054349186,0.00009312739,0.00015717103],"category_scores_gemma":[0.00008230279,0.00016890475,0.00039512312,0.00041812166,0.00025012612,0.00001468564,0.00005891305,0.00032385875,0.0000909822],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008820856,0.00039751324,0.000004023976,0.8333978,0.0025059492,0.00020993112,0.00050188764,2.4066148e-7,6.2173837e-7,0.0009226341,0.0047472655,0.15722391],"study_design_scores_gemma":[0.0014871813,0.0015577325,0.0005640094,0.8135033,0.013490476,0.00011665171,0.0000854749,0.0000028949264,0.000011616137,0.00005990934,0.16882789,0.0002928444],"about_ca_topic_score_codex":0.000013081713,"about_ca_topic_score_gemma":0.0000067798806,"teacher_disagreement_score":0.16408062,"about_ca_system_score_codex":0.00006902245,"about_ca_system_score_gemma":0.00011678439,"threshold_uncertainty_score":0.68877363},"labels":[],"label_agreement":null},{"id":"W2891104247","doi":"10.1016/j.clgc.2018.09.008","title":"Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Nomogram; Bladder cancer; Proportional hazards model; Retrospective cohort study; Concordance; Perioperative; Lymph node; Cumulative incidence; Stage (stratigraphy); Confidence interval; Cancer; Hazard ratio; Urology; Internal medicine; Oncology; Cohort; Surgery","score_opus":0.03668717770792943,"score_gpt":0.3472813592159894,"score_spread":0.31059418150805995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891104247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958397,0.00048405532,0.00028302832,0.00022354983,0.0007774071,0.0019147582,0.00032266474,0.000026992666,0.00012784246],"genre_scores_gemma":[0.99037325,0.0001842683,0.0049699517,0.0006559306,0.0013393358,0.002169318,0.000074329786,0.000043663294,0.00018993451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766856,0.00006257711,0.000845524,0.000609242,0.00042854954,0.0003855374],"domain_scores_gemma":[0.99867564,0.00016484255,0.00023788422,0.000287272,0.00043664043,0.00019770219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016080386,0.00027078242,0.00054146996,0.000112011694,0.00008124171,0.000007165317,0.0001235238,0.00020115037,0.00042147143],"category_scores_gemma":[0.00007214728,0.00020511923,0.00015204695,0.0002500386,0.00042852154,0.00010985485,0.00007299419,0.00024742566,0.000008869964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015537905,0.0015283644,0.9104586,0.00021833369,0.00055324467,0.000027859767,0.0007463251,0.000004176527,0.00006725926,0.0000023750656,0.0013821607,0.06947337],"study_design_scores_gemma":[0.013404365,0.0032114224,0.9708613,0.00088545075,0.0002781378,0.0000030401786,0.000048003112,0.00003062382,0.00086204347,0.000024586749,0.010153415,0.00023758433],"about_ca_topic_score_codex":0.000027789572,"about_ca_topic_score_gemma":0.00014689102,"teacher_disagreement_score":0.06923579,"about_ca_system_score_codex":0.00026120726,"about_ca_system_score_gemma":0.0016005641,"threshold_uncertainty_score":0.83645195},"labels":[],"label_agreement":null},{"id":"W2891124641","doi":"10.1200/jco.2017.35.15_suppl.e16025","title":"Concurrent chemoradiotherapy (CRT) for bladder cancer: Practice patterns and outcomes in the general population.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Carboplatin; Cancer registry; Cystectomy; Internal medicine; Proportional hazards model; Cancer; Population; Hazard ratio; Cisplatin; Oncology; Chemoradiotherapy; Surgery; Urology; Chemotherapy; Confidence interval","score_opus":0.16789627523740164,"score_gpt":0.5547314183440867,"score_spread":0.38683514310668504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891124641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92074937,0.00093692093,0.00013379588,0.0757366,0.00155389,0.0004032556,0.000016190847,0.0000023389882,0.0004676533],"genre_scores_gemma":[0.9840322,0.0029913224,0.0010550463,0.010075196,0.001631235,0.000023276312,0.0000018643093,0.000010519859,0.00017932056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847955,0.00017555791,0.00089560286,0.00012115694,0.00019159762,0.00013652338],"domain_scores_gemma":[0.9969649,0.0013491163,0.0012181129,0.00018586463,0.00017152724,0.00011049092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014603463,0.00009517524,0.000854022,0.00003292234,0.00008603782,0.000028778702,0.00015554136,0.00014378603,0.000042064905],"category_scores_gemma":[0.0017876802,0.000050818264,0.00020955912,0.000014900469,0.00008953009,0.00015362051,0.000015975287,0.00036990788,6.047191e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077028753,0.0006693162,0.77062494,0.000011919927,0.00031886602,0.00006881219,0.00015165226,0.0000015663067,0.000004763652,0.0000877923,0.0012309899,0.22605911],"study_design_scores_gemma":[0.012702123,0.0035243253,0.92537093,0.00003099307,0.0003751996,0.0001389401,0.00008303365,0.000053685653,0.000008320353,0.0001567642,0.05750576,0.000049951126],"about_ca_topic_score_codex":0.0006379053,"about_ca_topic_score_gemma":0.0003910863,"teacher_disagreement_score":0.22600915,"about_ca_system_score_codex":0.000085974214,"about_ca_system_score_gemma":0.00042607888,"threshold_uncertainty_score":0.21401493},"labels":[],"label_agreement":null},{"id":"W2891338044","doi":"10.1200/jco.2018.36.15_suppl.4535","title":"Relapse-free survival (RFS) of clinical T2-4N0 urothelial bladder carcinoma (UBC) after radical cystectomy (RC), with or without perioperative chemotherapy (POC): Endpoints for clinical trial design.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Nomogram; Oncology; Cystectomy; Internal medicine; Bladder cancer; Urology; Adjuvant; Cisplatin; Proportional hazards model; Overall survival; Chemotherapy; Cancer","score_opus":0.2348426878479415,"score_gpt":0.5021674275938941,"score_spread":0.2673247397459526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891338044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97353107,0.00037313637,0.0072158366,0.0052926918,0.008046409,0.0036590584,0.00008516968,0.000039753075,0.0017568641],"genre_scores_gemma":[0.92713416,0.00077551097,0.04501018,0.0044769836,0.020810446,0.00014150754,0.000006578771,0.0001581183,0.0014865163],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9846443,0.003540184,0.008764525,0.0009840267,0.0012771466,0.00078981277],"domain_scores_gemma":[0.9817347,0.0097694695,0.0040309927,0.0010531361,0.0020414665,0.001370267],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01401109,0.00065823173,0.0063729137,0.00021851067,0.00013980569,0.000034481858,0.00077449117,0.0017123417,0.0015825045],"category_scores_gemma":[0.0123350965,0.0003827496,0.002253521,0.00029325302,0.003103721,0.00025488806,0.00014437566,0.0023153296,0.000041107476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8252801,0.007585133,0.12886547,0.0000649842,0.003163498,0.0006870899,0.00046418144,6.442227e-7,0.000045101944,0.000033584252,0.0075805984,0.026229639],"study_design_scores_gemma":[0.48182318,0.3382842,0.12047278,0.00029272845,0.0028561796,0.00069169246,0.00034394328,0.00016723719,0.0005120535,0.00017709979,0.053910762,0.0004681679],"about_ca_topic_score_codex":0.00005671741,"about_ca_topic_score_gemma":0.00018504701,"teacher_disagreement_score":0.34345692,"about_ca_system_score_codex":0.00019939504,"about_ca_system_score_gemma":0.010911084,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W2891707856","doi":"10.23889/ijpds.v3i4.738","title":"Utilization of Radiotherapy for Bladder Cancer: Evolving referral and practice patterns in the general population","year":2018,"lang":"en","type":"article","venue":"International Journal for Population Data Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Referral; Logistic regression; Population; Cancer registry; Radiation therapy; Cohort; Cancer; General surgery; Internal medicine; Emergency medicine; Family medicine; Environmental health","score_opus":0.15467151309004548,"score_gpt":0.4848082886634835,"score_spread":0.330136775573438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891707856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948803,0.00047641306,0.039588347,0.0074596745,0.0020254962,0.0009908555,0.00052703015,0.000011075743,0.00011808325],"genre_scores_gemma":[0.9870305,0.0002809935,0.010727236,0.0007120038,0.00086749723,0.000020778882,0.0003143964,0.000008391126,0.00003820992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987847,0.0000379676,0.00030907453,0.00021840991,0.0005216359,0.00012821693],"domain_scores_gemma":[0.99874234,0.00012278267,0.0002470311,0.0001899409,0.0006566654,0.000041254003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010610173,0.00007339192,0.00010420979,0.00019196412,0.00017714758,0.00011359151,0.0003642247,0.000028707795,0.000030715826],"category_scores_gemma":[0.0006689474,0.000052009837,0.000026110753,0.00016854865,0.000078566416,0.001438073,0.00003688598,0.000059278027,1.4638337e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020615237,0.0002879609,0.8175677,0.000038049504,0.00019669926,0.0000038804897,0.0020231516,0.00019506023,0.00442997,0.0048249774,0.0018916803,0.16647935],"study_design_scores_gemma":[0.002195856,0.00033673082,0.9337633,0.00010190496,0.00007535546,0.00019733884,0.00021870107,0.05702089,0.00026546285,0.00066451414,0.0050787823,0.00008111948],"about_ca_topic_score_codex":0.001467474,"about_ca_topic_score_gemma":0.0003756245,"teacher_disagreement_score":0.16639823,"about_ca_system_score_codex":0.00015754307,"about_ca_system_score_gemma":0.00011907378,"threshold_uncertainty_score":0.22183914},"labels":[],"label_agreement":null},{"id":"W2892019215","doi":"10.1136/bmjopen-2017-020500","title":"Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study","year":2018,"lang":"en","type":"article","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Urology Foundation; Intuitive Surgical","keywords":"Medicine; Cystectomy; Urinary diversion; Randomized controlled trial; Bladder cancer; Extracorporeal; Quality of life (healthcare); Surgery; Prospective cohort study; Physical therapy; Cancer; Internal medicine; Nursing","score_opus":0.13036484066751738,"score_gpt":0.4480890299500846,"score_spread":0.3177241892825672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892019215","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17468974,0.0000018877979,0.0006702258,0.00036372858,0.00023893494,0.81464016,0.000031374097,0.000077494726,0.009286443],"genre_scores_gemma":[0.47584444,9.340886e-8,0.0021547328,0.00011546176,0.00052642485,0.5205985,0.000028870596,0.000050483402,0.00068101106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957824,0.0006939949,0.00092412956,0.0011000172,0.0009308632,0.00056864216],"domain_scores_gemma":[0.9971157,0.0004377305,0.00056615134,0.0009830928,0.00036601935,0.0005313609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018039696,0.0005553334,0.0019714308,0.00012300556,0.00042713666,0.00034418688,0.0011123721,0.00018164184,0.0007079396],"category_scores_gemma":[0.00026735337,0.00031865525,0.00025392638,0.00032178868,0.0004635975,0.00042180944,0.0007429044,0.0003407398,0.000024677765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97621644,0.009351691,0.0074530244,0.0001395683,0.00199914,0.0006225657,0.00039182723,7.9386894e-7,0.00008885524,0.000007725226,0.0015407316,0.002187619],"study_design_scores_gemma":[0.8625627,0.12136236,0.011560022,0.0005768589,0.0012270621,0.00036380996,0.00032979823,0.0001247092,0.00022972834,0.00001562136,0.0012580708,0.0003892183],"about_ca_topic_score_codex":0.0010511543,"about_ca_topic_score_gemma":0.00044126535,"teacher_disagreement_score":0.3011547,"about_ca_system_score_codex":0.0004779333,"about_ca_system_score_gemma":0.0017520478,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W2892218953","doi":"10.1200/jco.2017.35.15_suppl.4530","title":"Health-related quality of life (HRQoL) of pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated advanced urothelial cancer (UC) in KEYNOTE-045.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Discontinuation; Docetaxel; Quality of life (healthcare); Internal medicine; Urothelial cancer; Cancer; Proportional hazards model; Oncology; Bladder cancer","score_opus":0.17778016552948103,"score_gpt":0.5218018808113934,"score_spread":0.3440217152819124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892218953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793824,0.0022796735,0.000068721965,0.014974576,0.0009433851,0.001177851,0.000069994974,0.000010531232,0.0010928875],"genre_scores_gemma":[0.9904043,0.004501655,0.0019725957,0.0020768852,0.00050655374,0.00003826685,0.0000057101374,0.00004572519,0.00044827492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99299675,0.00053608423,0.0052780034,0.00033092586,0.00043730103,0.00042091432],"domain_scores_gemma":[0.98927253,0.0013453589,0.007614124,0.0005568972,0.0007347364,0.0004763258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033712003,0.00026754313,0.004253644,0.00015726654,0.00007917211,0.0000074766263,0.0004056685,0.00055631355,0.00017530182],"category_scores_gemma":[0.004554659,0.00019980008,0.0009299546,0.00011570993,0.00042528647,0.0001569592,0.000043426742,0.00070906215,0.0000021589376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22070973,0.005979842,0.43041602,0.0007568105,0.0017332006,0.00004915184,0.0006830012,0.0000449429,0.0022267606,0.0001129358,0.001607803,0.3356798],"study_design_scores_gemma":[0.116712876,0.023068687,0.85042095,0.0006576385,0.00033944234,0.000037263086,0.00005949893,0.00006790743,0.0022718469,0.000605283,0.0055745053,0.00018411262],"about_ca_topic_score_codex":0.0025733258,"about_ca_topic_score_gemma":0.0010256548,"teacher_disagreement_score":0.4200049,"about_ca_system_score_codex":0.00039568226,"about_ca_system_score_gemma":0.0054556676,"threshold_uncertainty_score":0.96781206},"labels":[],"label_agreement":null},{"id":"W2892289693","doi":"10.1200/jco.2017.35.15_suppl.4534","title":"Circulating tumor (ct)-DNA alterations in urothelial/bladder cancer (UC/BC): Updates on a dynamic genomic landscape.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"KRAS; ARID1A; Medicine; CDKN2A; Bladder cancer; Cancer research; Oncology; Copy-number variation; Cancer; Gene; Internal medicine; Bioinformatics; Biology; Mutation; Colorectal cancer; Genetics; Genome","score_opus":0.09577273611006674,"score_gpt":0.4675657469478829,"score_spread":0.37179301083781613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892289693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776984,0.00036211143,0.000025646697,0.0110748345,0.001661552,0.00030064996,0.000021107036,0.000009631296,0.008846058],"genre_scores_gemma":[0.9934818,0.0005025318,0.0006718353,0.003378466,0.0014077344,0.000020217916,0.0000041211356,0.000031018848,0.0005022628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973271,0.00020998922,0.0016435653,0.00025760685,0.00027011905,0.0002916491],"domain_scores_gemma":[0.9970521,0.0005749395,0.0015436226,0.00037642234,0.00017315669,0.00027978868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010902978,0.00018323255,0.0011881797,0.00015390862,0.00015982345,0.00004379261,0.00026275552,0.00013848285,0.0005897693],"category_scores_gemma":[0.0012285755,0.00013283895,0.00037388722,0.00005410934,0.00015959222,0.00015782111,0.00005336836,0.00085008965,0.00005690172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063020126,0.0036720554,0.82382447,0.000061674844,0.0013522321,0.007198475,0.00041949324,0.00038192145,0.0027404819,0.00025079257,0.0030483496,0.15074806],"study_design_scores_gemma":[0.016396027,0.0052088886,0.96183354,0.00032596482,0.00048395962,0.00069782254,0.00010258618,0.001247311,0.00015070173,0.0008128643,0.012554071,0.00018624784],"about_ca_topic_score_codex":0.00033950078,"about_ca_topic_score_gemma":0.001122223,"teacher_disagreement_score":0.15056182,"about_ca_system_score_codex":0.00029023757,"about_ca_system_score_gemma":0.0018675498,"threshold_uncertainty_score":0.64575595},"labels":[],"label_agreement":null},{"id":"W2892569486","doi":"10.1016/j.eururo.2018.09.001","title":"Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":840,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Health and Care Research; World Health Organization","keywords":"Medicine; Epidemiology; Bladder cancer; Population; Environmental health; Risk factor; MEDLINE; Systematic review; Incidence (geometry); Disease; Cancer; Demography; Gerontology; Pathology; Internal medicine","score_opus":0.08891836199494443,"score_gpt":0.3647492421572954,"score_spread":0.2758308801623509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892569486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008083455,0.9952965,0.000004376513,0.000063859465,0.0001859246,0.0022342317,0.00042060253,0.000017516435,0.001696171],"genre_scores_gemma":[0.0015777677,0.99725527,0.000030315066,0.00066924747,0.000083167935,0.000069297814,0.000109396424,0.00008144873,0.00012407509],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929042,0.0040921317,0.0020991485,0.0005271871,0.000093933,0.0002833979],"domain_scores_gemma":[0.99632335,0.00085635093,0.0019233772,0.0006929389,0.00008232366,0.00012167847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014547876,0.00045771073,0.007033738,0.00025745624,0.000018276069,6.907414e-7,0.00022694288,0.00019877583,0.00018540885],"category_scores_gemma":[0.0011283858,0.00029326862,0.00039622842,0.00022859877,0.00040776684,0.000025393689,0.00013015069,0.00038980506,0.00007064636],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048114725,0.00011843042,0.0075674253,0.9839785,0.0018190193,0.00006434486,0.00011448031,6.994573e-8,5.6789087e-8,0.000025565765,0.0033811498,0.0028828513],"study_design_scores_gemma":[0.0023550363,0.0023317214,0.0050587426,0.5622261,0.046000786,0.0002777197,0.00002156457,0.0000019560362,0.0000011059467,0.000058297,0.3810152,0.00065172295],"about_ca_topic_score_codex":0.0003321059,"about_ca_topic_score_gemma":0.000021449328,"teacher_disagreement_score":0.42175236,"about_ca_system_score_codex":0.000044709628,"about_ca_system_score_gemma":0.00027457552,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W2892603354","doi":"10.1016/j.euf.2018.09.007","title":"Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis","year":2018,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Renal pelvis; Hazard ratio; Bladder cancer; Urology; Confidence interval; Cuff; Guideline; Incidence (geometry); Cumulative incidence; Urothelial carcinoma; Internal medicine; Surgery; Cancer; Ureter; Pathology; Cohort","score_opus":0.022670576726443473,"score_gpt":0.2772288582695373,"score_spread":0.25455828154309385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892603354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96343094,0.00025505788,0.004954847,0.0014216492,0.00042801045,0.0016557202,0.00006276583,0.00008581977,0.027705211],"genre_scores_gemma":[0.9934045,0.000006998882,0.0012138551,0.0016203811,0.00084024726,0.000031859952,0.0000060798484,0.00009295455,0.0027830892],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983712,0.00028639613,0.0003174624,0.0004196018,0.00024122673,0.00036410356],"domain_scores_gemma":[0.9988005,0.00008938611,0.00016840332,0.0006141617,0.00020749499,0.00012002947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022586234,0.0002583267,0.00041922758,0.00007571587,0.00015291707,0.000011558172,0.00024504872,0.00007811502,0.0004306734],"category_scores_gemma":[0.00007828115,0.00013078257,0.00015466525,0.00018611434,0.0005839982,0.000042218093,0.00009105145,0.00018002067,0.000073164025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28265247,0.0024737848,0.44617337,0.000336692,0.0041382974,0.0010614473,0.011065033,0.000017140708,0.045136448,0.0010817822,0.06376116,0.14210238],"study_design_scores_gemma":[0.076565504,0.058475964,0.28221482,0.00023735323,0.0037269234,0.0022743056,0.00020638217,0.0006627231,0.10286829,0.0007022568,0.471073,0.0009924631],"about_ca_topic_score_codex":0.00007809628,"about_ca_topic_score_gemma":0.00009016534,"teacher_disagreement_score":0.40731186,"about_ca_system_score_codex":0.000029464205,"about_ca_system_score_gemma":0.00022077569,"threshold_uncertainty_score":0.5333159},"labels":[],"label_agreement":null},{"id":"W2894059501","doi":"10.5489/cuaj.5447","title":"Use of radiotherapy for bladder cancer: A population-based study of evolving referral and practice patterns","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Cystectomy; Bladder cancer; Referral; Radiation therapy; Cancer registry; Population; Comorbidity; Cancer; Logistic regression; General surgery; Internal medicine; Family medicine","score_opus":0.05429403334037518,"score_gpt":0.33279224077804787,"score_spread":0.2784982074376727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894059501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939589,0.00018408748,0.00021479791,0.0048884614,0.00015217875,0.00044959542,0.000099504745,0.0000057030743,0.000046794456],"genre_scores_gemma":[0.99656767,0.000035461875,0.000852533,0.0021466343,0.00029927125,0.000018002973,0.000008614052,0.000010667029,0.00006112662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990231,0.00014778317,0.00029295264,0.00012522421,0.00021798462,0.00019296317],"domain_scores_gemma":[0.9983514,0.00039061697,0.00035863943,0.00007521035,0.0006022501,0.0002218623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003260809,0.00008601501,0.00025002353,0.00011728068,0.00012253913,0.000027190512,0.000038058693,0.00009932307,0.00029522457],"category_scores_gemma":[0.0009311408,0.0000681351,0.000055663168,0.000096272524,0.000015848327,0.00012049411,0.000003099551,0.00012422739,2.286618e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004162663,0.00016807037,0.99530226,0.000006497062,0.0003482248,0.0000042537617,0.00043388005,0.000019491607,0.00009641678,0.0000060592165,0.00091870205,0.0022798856],"study_design_scores_gemma":[0.002754833,0.0027974958,0.9907597,0.00001875885,0.00028355664,0.000015202987,0.0001841178,0.0005560866,0.000027696551,0.000027508702,0.002513732,0.00006131403],"about_ca_topic_score_codex":0.02364944,"about_ca_topic_score_gemma":0.00926471,"teacher_disagreement_score":0.014384729,"about_ca_system_score_codex":0.00051379635,"about_ca_system_score_gemma":0.0003601875,"threshold_uncertainty_score":0.98285216},"labels":[],"label_agreement":null},{"id":"W2894069389","doi":"10.1002/jmri.26327","title":"Quantitative Identification of Nonmuscle‐Invasive and Muscle‐Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis","year":2018,"lang":"en","type":"article","venue":"Journal of Magnetic Resonance Imaging","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure","funders":"National Cancer Institute; National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Bladder cancer; Radiomics; Receiver operating characteristic; Discriminative model; Medicine; Diffusion MRI; Support vector machine; Effective diffusion coefficient; Mann–Whitney U test; Artificial intelligence; Radiology; Computer science; Magnetic resonance imaging; Cancer; Internal medicine","score_opus":0.01800361044754601,"score_gpt":0.2911347290153263,"score_spread":0.2731311185677803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894069389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96063197,0.035225794,0.0026623746,0.00057882845,0.00020716207,0.00033429379,0.000034064476,0.0000087982835,0.0003166958],"genre_scores_gemma":[0.9869577,0.0029861454,0.009498755,0.00017340918,0.00019424105,0.0000071541685,0.0000037333934,0.0000252418,0.00015357172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788666,0.000104398125,0.0009330741,0.00030752004,0.0005059177,0.0002624276],"domain_scores_gemma":[0.9971677,0.00039867175,0.0008447734,0.0003191697,0.0010982176,0.00017148351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004767072,0.00021270268,0.0006848326,0.0009969826,0.00008661556,0.000044976798,0.00015358784,0.00005604134,0.0000850391],"category_scores_gemma":[0.00073038094,0.00017924405,0.00028052888,0.0013546044,0.0004226638,0.00025514,0.000039880706,0.0001972428,0.0000058745436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016498901,0.0006323831,0.7083541,0.0002480242,0.0013788856,0.0003734908,0.008620255,0.000058658385,0.105590776,0.000099469136,0.0010804938,0.17191358],"study_design_scores_gemma":[0.00354596,0.0015528076,0.9675455,0.00023073058,0.0030491569,0.00022566554,0.0017114733,0.004112998,0.017210647,0.00017288566,0.0004598567,0.00018229133],"about_ca_topic_score_codex":0.00015507326,"about_ca_topic_score_gemma":0.000048378344,"teacher_disagreement_score":0.25919142,"about_ca_system_score_codex":0.000119166936,"about_ca_system_score_gemma":0.000315461,"threshold_uncertainty_score":0.730936},"labels":[],"label_agreement":null},{"id":"W2894186044","doi":"10.1016/j.euf.2018.09.004","title":"Critical Questions To Optimize Intravesical Therapy for Non–muscle-invasive Bladder Cancer","year":2018,"lang":"en","type":"editorial","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Prostate cancer; Kidney cancer; Cancer; Oncology; Urothelial cancer; Blockade; Internal medicine; Urology","score_opus":0.018110613947012015,"score_gpt":0.3323928793887905,"score_spread":0.31428226544177845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894186044","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008184428,0.0029784949,0.004770923,0.013937492,0.94594157,0.0035526354,0.0025834998,0.00036754672,0.025049409],"genre_scores_gemma":[0.011386503,0.001381647,0.0030277998,0.0045475727,0.974065,0.0007947998,0.0003612437,0.00042848312,0.004006958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966066,0.00032573505,0.00055143924,0.0011823223,0.00047022995,0.00086371094],"domain_scores_gemma":[0.99620634,0.001378669,0.00012104769,0.0007859581,0.00091162126,0.00059638557],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036072198,0.00065751706,0.0009418982,0.00022277304,0.00023753288,0.000062336556,0.00040729213,0.0006965135,0.00090573926],"category_scores_gemma":[0.0021808492,0.00055050384,0.0003660157,0.00016529615,0.0004676432,0.00006137392,0.00013566256,0.00094907725,0.0007891128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022749826,0.00037701198,0.000017381912,0.000050545474,0.00063821307,0.00026737482,0.00035025392,0.0000035006192,0.00022040118,0.000054487802,0.9852479,0.010497928],"study_design_scores_gemma":[0.0051486795,0.00812411,0.0009546071,0.00012610623,0.001044356,0.000022920445,0.0000121440835,0.000008905044,0.00030776547,0.00020852282,0.9835444,0.00049744843],"about_ca_topic_score_codex":0.00013557458,"about_ca_topic_score_gemma":0.000081328435,"teacher_disagreement_score":0.028123436,"about_ca_system_score_codex":0.00018318972,"about_ca_system_score_gemma":0.0011462023,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W2894543473","doi":"10.1016/j.clgc.2018.09.017","title":"Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Urology; Cohort; Internal medicine; Oncology; Chemotherapy; Population; Cancer","score_opus":0.05022373847367602,"score_gpt":0.4042056028138359,"score_spread":0.3539818643401599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894543473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134064,0.0015265311,0.000011550292,0.0005961241,0.0013461107,0.00091167405,0.000059535072,0.000040850682,0.004166983],"genre_scores_gemma":[0.9949753,0.00064263004,0.00025546466,0.00065245014,0.0020852468,0.0001364592,0.000011562524,0.00006906413,0.0011718109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974152,0.0003802916,0.00085243635,0.000548636,0.00036823298,0.00043520643],"domain_scores_gemma":[0.9985129,0.00043283435,0.00017706961,0.0005167362,0.000114397546,0.00024601753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064377405,0.00033022795,0.0010535063,0.00014263602,0.000050290953,0.000007820177,0.00018743589,0.00016604483,0.0014737796],"category_scores_gemma":[0.0001015157,0.0002500701,0.00044197906,0.00030935963,0.0004108527,0.00008543627,0.00005534928,0.00038700202,0.00008460207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010174835,0.0022715754,0.9533392,0.00019194212,0.00026473796,0.00042904157,0.00016951494,0.0000014254582,0.0011448134,0.000004127881,0.0006438654,0.03136493],"study_design_scores_gemma":[0.01617157,0.019715004,0.94634706,0.00017146613,0.00037088039,0.000105488354,0.000033144235,0.00006863474,0.011575352,0.000054306936,0.0051308987,0.0002562103],"about_ca_topic_score_codex":0.00034219256,"about_ca_topic_score_gemma":0.000014708328,"teacher_disagreement_score":0.031108718,"about_ca_system_score_codex":0.00012565272,"about_ca_system_score_gemma":0.00043454397,"threshold_uncertainty_score":0.9999952},"labels":[],"label_agreement":null},{"id":"W2894680519","doi":"10.1186/s12957-018-1497-0","title":"Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies","year":2018,"lang":"en","type":"review","venue":"World Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Guangdong Medical Research Foundation","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Meta-analysis; Cochrane Library; Subgroup analysis; Oncology; Surgical oncology; Urology; Odds ratio; Internal medicine; Cancer; Surgery; Confidence interval","score_opus":0.2311160411313873,"score_gpt":0.45098991286264667,"score_spread":0.21987387173125936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894680519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008731882,0.99351954,0.00011813001,0.0011125146,0.0010143869,0.0022911443,0.00030186717,0.000015077211,0.0015399879],"genre_scores_gemma":[0.0005521757,0.9922503,0.002787198,0.00011943333,0.0016639129,0.0008781399,0.00017091297,0.00008298752,0.0014948887],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.994291,0.00067923544,0.0028235978,0.00068561244,0.00096766354,0.0005528681],"domain_scores_gemma":[0.9907603,0.003741638,0.0031717299,0.00053410465,0.0014039975,0.00038820546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001456433,0.0007494652,0.013007691,0.0014871529,0.000111083114,0.000017857401,0.0004518505,0.0005817221,0.00081583584],"category_scores_gemma":[0.00022258793,0.00045057657,0.0066725556,0.0019481924,0.00062299735,0.00014114828,0.00012289177,0.00084658834,0.0000051713632],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022298186,0.0013428372,0.000035150253,0.00443705,0.9280005,0.00037569128,0.00017897612,0.000037096106,8.5311626e-7,0.00012588776,0.01227694,0.050959192],"study_design_scores_gemma":[0.004459952,0.0018633722,0.000023906672,0.0003893475,0.47505644,0.00009896267,0.00003478467,0.000007122552,0.0000043652244,0.000021950333,0.51785445,0.00018531602],"about_ca_topic_score_codex":0.00012314944,"about_ca_topic_score_gemma":0.000254584,"teacher_disagreement_score":0.50557756,"about_ca_system_score_codex":0.0010596702,"about_ca_system_score_gemma":0.0025317038,"threshold_uncertainty_score":0.9997946},"labels":[],"label_agreement":null},{"id":"W2894787506","doi":"","title":"Urethral cancer: Epidemiology and risk factors","year":2012,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epidemiology; Medicine; Cancer; Risk factor; Internal medicine","score_opus":0.06025417236874156,"score_gpt":0.36084557815688745,"score_spread":0.3005914057881459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894787506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839417,0.007944006,0.00012425802,0.00090693723,0.0003582672,0.00014736115,0.000022229317,0.000044234603,0.006511026],"genre_scores_gemma":[0.9946523,0.0016481528,0.00044281612,0.00066434126,0.0002871707,0.000014546207,0.000006603373,0.0000091091215,0.0022750176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994602,0.000044673252,0.00010076718,0.00010362158,0.00004081413,0.0002498946],"domain_scores_gemma":[0.99955356,0.00009968115,0.000029680317,0.00009528219,0.000011522883,0.00021029986],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000121340985,0.00008428105,0.00021216439,0.000021272672,0.000041446518,0.0000012214407,0.000015274118,0.000060448077,0.0009586584],"category_scores_gemma":[0.000057029676,0.0000514966,0.000037143494,0.00002671897,0.00004903406,0.00004726153,0.000013392789,0.00009099945,0.00002883023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031011667,0.000035489964,0.9914906,0.0000087714225,0.00010076888,4.1635653e-7,0.00023022981,3.0863168e-7,0.000016204753,0.0002814344,0.0030277476,0.0047770175],"study_design_scores_gemma":[0.0007560828,0.00013188783,0.97444767,0.000007683075,0.00021565837,0.000008216263,0.000086106185,0.000016121834,0.00071490975,0.00019206022,0.023359774,0.00006381833],"about_ca_topic_score_codex":0.0044194423,"about_ca_topic_score_gemma":0.000060916846,"teacher_disagreement_score":0.020332027,"about_ca_system_score_codex":0.000032110012,"about_ca_system_score_gemma":0.000022219276,"threshold_uncertainty_score":0.9999546},"labels":[],"label_agreement":null},{"id":"W2894787580","doi":"10.1007/s00345-018-2504-3","title":"The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Internal medicine; Cumulative incidence; Incidence (geometry); Oncology; Bladder cancer; Gynecology; Proportional hazards model; Nephrology; Urology; Cancer; Cohort","score_opus":0.013375634055429608,"score_gpt":0.29794213005281295,"score_spread":0.2845664959973833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894787580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948966,0.0028996328,0.000003353558,0.00069649017,0.00030771646,0.00090346957,0.00012802631,0.000002533689,0.00016218094],"genre_scores_gemma":[0.99436474,0.004579914,0.000018221745,0.00008977498,0.00013653042,0.0003875776,0.000006486016,0.000017841685,0.0003988962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886495,0.0001576476,0.00047956698,0.00013264242,0.00016255726,0.00020263511],"domain_scores_gemma":[0.9986398,0.0003456155,0.00055793946,0.00014474252,0.0002515242,0.00006037064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021089235,0.00014780118,0.00044894862,0.00019114415,0.0000454876,0.0000031642571,0.00006934848,0.000050330862,0.000114169656],"category_scores_gemma":[0.00006916865,0.00008009472,0.00014812897,0.00019398352,0.00012774779,0.000032224034,0.000009055554,0.0000912223,0.000001243654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010670465,0.00032897454,0.9040111,0.000020901274,0.0006955143,0.0000067046867,0.00028374503,0.000060198723,0.00021184076,0.000003086017,0.00075488875,0.08295258],"study_design_scores_gemma":[0.022731408,0.036848407,0.8357629,0.00015179273,0.0016401898,0.000011437987,0.000010410148,0.000067657704,0.08813077,0.00007763637,0.014467497,0.00009986203],"about_ca_topic_score_codex":0.0010638034,"about_ca_topic_score_gemma":0.002818155,"teacher_disagreement_score":0.08791893,"about_ca_system_score_codex":0.00029598895,"about_ca_system_score_gemma":0.00016285172,"threshold_uncertainty_score":0.3266168},"labels":[],"label_agreement":null},{"id":"W2894922686","doi":"10.1016/j.clgc.2018.09.021","title":"Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Cisplatin; Chemoradiotherapy; Radiation therapy; Chemotherapy; Confidence interval; Oncology; Stage (stratigraphy); Internal medicine; Urology; External beam radiotherapy; Cancer; Surgery; Brachytherapy","score_opus":0.028054779955515932,"score_gpt":0.3492026512342951,"score_spread":0.3211478712787792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894922686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311244,0.0013206667,0.000045433135,0.0016761052,0.0009860656,0.0015275521,0.00009842964,0.00010085696,0.0011324597],"genre_scores_gemma":[0.98466736,0.0020863113,0.0014292105,0.006811699,0.0028817672,0.00045881694,0.00004851468,0.00018403358,0.0014322953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965005,0.00011309304,0.0009168274,0.0010296995,0.0006075245,0.00083235995],"domain_scores_gemma":[0.99799824,0.00012661645,0.00030835957,0.00074741663,0.00035854787,0.00046079454],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022550265,0.0005737341,0.0011395392,0.00017686347,0.00015151691,0.000037386875,0.00027665732,0.00026514,0.0025020542],"category_scores_gemma":[0.000044488857,0.00043083527,0.00027329702,0.0005412389,0.000543398,0.00020654195,0.00006908279,0.0005822254,0.000077505116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037084718,0.0017514831,0.827162,0.00008421729,0.0009971574,0.00012272722,0.0008203254,0.000018736215,0.00012340529,0.0000020699179,0.0022834186,0.16292596],"study_design_scores_gemma":[0.022880148,0.005968084,0.96126294,0.00048179107,0.00037500454,0.000007983104,0.000092854476,0.00009120435,0.0011986464,0.000058413247,0.007078167,0.0005047768],"about_ca_topic_score_codex":0.0006516395,"about_ca_topic_score_gemma":0.0011075985,"teacher_disagreement_score":0.16242118,"about_ca_system_score_codex":0.0004544057,"about_ca_system_score_gemma":0.0008907141,"threshold_uncertainty_score":0.99981433},"labels":[],"label_agreement":null},{"id":"W2895533545","doi":"10.1016/s1569-9056(18)33147-6","title":"Comparison of perioperative outcomes between open and robotic radical cystectomy: A population based analysis","year":2018,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Perioperative; General surgery; Urology; Surgery; Internal medicine; Bladder cancer","score_opus":0.052320252785460375,"score_gpt":0.39164639004635676,"score_spread":0.3393261372608964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895533545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911585,0.000050833398,0.0018309891,0.0010621833,0.00007203954,0.0007030323,0.00012811767,0.000026611966,0.0049676867],"genre_scores_gemma":[0.99664336,0.000001314111,0.0017645364,0.00067620137,0.00007336269,0.000009934177,0.00055922446,0.00002347232,0.00024856784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984566,0.00038804737,0.0004246621,0.00034245095,0.00017825178,0.00020996598],"domain_scores_gemma":[0.99932075,0.000061388906,0.00013830051,0.00028603626,0.0000699429,0.0001235739],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002520879,0.00016735864,0.0007006653,0.00020163528,0.0001167949,0.000022501034,0.0001612554,0.000041568186,0.0010194783],"category_scores_gemma":[0.00004521349,0.00013233311,0.000086008484,0.00026074183,0.00015757342,0.00006432736,0.0001485279,0.00010243855,0.000027325928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002179444,0.00015721661,0.9968435,0.000010416096,0.0012528987,0.000010527064,0.00046846384,0.000013093171,0.00007610236,0.000033823504,0.00013488866,0.00078109314],"study_design_scores_gemma":[0.0047550146,0.0017484193,0.98812914,0.000007046939,0.0023458698,0.0000020439359,0.00005294239,0.0005954767,0.00034028836,0.000006567059,0.001919427,0.00009778184],"about_ca_topic_score_codex":0.0004889175,"about_ca_topic_score_gemma":0.00017811188,"teacher_disagreement_score":0.00871441,"about_ca_system_score_codex":0.00003541258,"about_ca_system_score_gemma":0.00004124917,"threshold_uncertainty_score":0.9998937},"labels":[],"label_agreement":null},{"id":"W2896515906","doi":"10.1093/annonc/mdy283.073","title":"Pembrolizumab for high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG): Phase II KEYNOTE-057 trial","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Bladder cancer; Cystectomy; Internal medicine; Population; Urology; Carcinoma in situ; Oncology; Clinical endpoint; Cancer; Surgery; Clinical trial; Immunotherapy","score_opus":0.08749010236186354,"score_gpt":0.4272855037666303,"score_spread":0.3397954014047668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896515906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97845733,0.00035297056,0.0004905753,0.01123631,0.0016612335,0.0033493128,0.0011510047,0.000051402683,0.0032498592],"genre_scores_gemma":[0.9829476,0.00046264852,0.0009764859,0.009698306,0.0025438073,0.0009966645,0.00007357881,0.00007451245,0.0022264202],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9972311,0.00020593368,0.000720816,0.0007018384,0.0003612232,0.0007790802],"domain_scores_gemma":[0.9967601,0.0006100464,0.00039860338,0.00059067894,0.0011706206,0.0004699796],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042853242,0.00039782198,0.0011700289,0.00032361867,0.00027686474,0.00001227163,0.00026151966,0.00037778734,0.0012430743],"category_scores_gemma":[0.000954486,0.0003410834,0.00033078392,0.00038523547,0.00034587106,0.00011140432,0.00015407302,0.00025337783,0.00011692777],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30508944,0.0041975225,0.00022306849,0.00009468186,0.0017958479,0.0001455388,0.0037975141,0.000016867692,0.013185293,0.00020190475,0.14250216,0.5287502],"study_design_scores_gemma":[0.2507233,0.3397396,0.004255801,0.00014500815,0.0012702874,0.00003528695,0.00038920552,0.000031433763,0.13266794,0.0010730927,0.26910695,0.00056209817],"about_ca_topic_score_codex":0.0036665108,"about_ca_topic_score_gemma":0.0021754978,"teacher_disagreement_score":0.52818805,"about_ca_system_score_codex":0.00023361138,"about_ca_system_score_gemma":0.002129263,"threshold_uncertainty_score":0.9999041},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2896633866","doi":"10.1016/j.urolonc.2018.09.001","title":"Post-translational modifications in bladder cancer: Expanding the tumor target repertoire","year":2018,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"SUMO protein; Proteome; Epitope; Antigen; Computational biology; Glycosylation; Biology; Bladder cancer; Tumor antigen; Cancer; Cancer research; Bioinformatics; Immunotherapy; Ubiquitin; Immunology; Gene; Genetics","score_opus":0.06425938409968128,"score_gpt":0.3812216493640114,"score_spread":0.3169622652643301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896633866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001266626,0.98644733,0.000019900455,0.0073213275,0.00034584312,0.0014212211,0.00036564417,0.00005878013,0.0027533222],"genre_scores_gemma":[0.00015510933,0.9860917,0.007577609,0.0022530914,0.0005417478,0.0014502138,0.0004285815,0.000042490894,0.0014594679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978237,0.00026862902,0.0006679474,0.00063757,0.00020563524,0.00039647333],"domain_scores_gemma":[0.9985235,0.00045189157,0.00031883025,0.00037700715,0.00011197698,0.00021682931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033719698,0.00042457532,0.0010873132,0.000280048,0.00046568474,0.00003400485,0.0002074915,0.00041408135,0.00036675722],"category_scores_gemma":[0.00013864825,0.00026680066,0.0002220234,0.00051301636,0.0010234823,0.00009581382,0.000047561356,0.0007272844,0.000045982084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052183215,0.0026584754,0.08189533,0.008096511,0.0036343632,0.0013148923,0.0071652886,0.00009030648,0.000039299943,0.021392453,0.06230043,0.8108908],"study_design_scores_gemma":[0.0004970456,0.00060210377,0.0001695485,0.0013028341,0.0015500407,0.00063115597,0.00009984641,0.00006450536,0.0000034213174,0.0016703383,0.9931716,0.00023758243],"about_ca_topic_score_codex":0.00027068504,"about_ca_topic_score_gemma":0.00019348213,"teacher_disagreement_score":0.9308711,"about_ca_system_score_codex":0.00028969155,"about_ca_system_score_gemma":0.0023709638,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W2896681462","doi":"10.5489/cuaj.5548","title":"Opportunities for augmentation cystoplasty revision without additional bowel harvest: “Hourglass” deformity or non-detubularized augment","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Augment; Hourglass; Deformity; Medicine; Surgery; Anatomy","score_opus":0.0431686967307164,"score_gpt":0.2855056123642284,"score_spread":0.242336915633512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896681462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8501181,0.00017846469,0.011672788,0.10598519,0.0040238574,0.0043410687,0.010111897,0.00022028685,0.013348338],"genre_scores_gemma":[0.9664358,0.000079134355,0.0033554318,0.015386071,0.002480395,0.00013046735,0.0013005888,0.00003569808,0.010796449],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816793,0.000108761466,0.0004583532,0.000255269,0.00048922846,0.0005204682],"domain_scores_gemma":[0.99769247,0.00016824633,0.0003540746,0.00011716667,0.0008184498,0.0008496206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006095932,0.00020753825,0.0003432323,0.00018383906,0.0006700125,0.00012548665,0.00009720326,0.00025512805,0.007493598],"category_scores_gemma":[0.00075881166,0.00014894403,0.00018991392,0.00012055264,0.000071900235,0.00024416606,0.000013420565,0.00030051905,0.000073715775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043081557,0.00037873123,0.18836333,0.00005310531,0.0009065586,0.00025565588,0.00043364055,0.00000773261,0.0002006297,0.0002959656,0.76433253,0.040463973],"study_design_scores_gemma":[0.009592279,0.0041906987,0.38382336,0.00013120317,0.000468516,0.0008162251,0.0003804321,0.0005543456,0.00021535842,0.0010112049,0.5984518,0.00036455854],"about_ca_topic_score_codex":0.00034596122,"about_ca_topic_score_gemma":0.0013443705,"teacher_disagreement_score":0.19546004,"about_ca_system_score_codex":0.0020195998,"about_ca_system_score_gemma":0.0016895466,"threshold_uncertainty_score":0.9934137},"labels":[],"label_agreement":null},{"id":"W2896689522","doi":"10.1002/ijc.31935","title":"Combined genetic and epigenetic alterations of the <i>TERT</i> promoter affect clinical and biological behavior of bladder cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; University of Toronto; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Epigenetics; Bladder cancer; Affect (linguistics); Biology; Cancer; Genetics; Cancer research; Gene; Psychology","score_opus":0.045394021729491744,"score_gpt":0.39986232409755545,"score_spread":0.3544683023680637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896689522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942162,0.003064739,0.000071337534,0.0014238874,0.0008632551,0.00022291281,0.000054822263,0.0000018855072,0.0000809335],"genre_scores_gemma":[0.9966695,0.0019499606,0.00031659575,0.00041407967,0.00055067206,0.000018349621,7.875386e-7,0.000008098407,0.00007200792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990152,0.000060431783,0.00046747772,0.000109232824,0.000269348,0.00007831125],"domain_scores_gemma":[0.9989671,0.00005365489,0.00029728914,0.00008934964,0.0005234321,0.00006918352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011268365,0.00008804668,0.0002535551,0.00005252746,0.000024602534,0.000009784062,0.00011769116,0.00005772584,0.00031249956],"category_scores_gemma":[0.00003687567,0.000050166745,0.00010654217,0.00004847502,0.0004249585,0.000038099122,0.000047923193,0.00011186337,5.0463456e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053375226,0.00023277322,0.9664837,0.000011209218,0.00051558873,0.00000942954,0.00017170465,0.0000026021319,0.007884709,0.000026571763,0.00026562583,0.023862328],"study_design_scores_gemma":[0.0027606855,0.0011498355,0.97542363,0.0002191795,0.00037668255,0.00009236385,0.00001021222,0.000027845126,0.019324657,0.00011267938,0.00045553042,0.000046721954],"about_ca_topic_score_codex":0.00010461995,"about_ca_topic_score_gemma":0.000067224915,"teacher_disagreement_score":0.023815608,"about_ca_system_score_codex":0.000027637818,"about_ca_system_score_gemma":0.00019257056,"threshold_uncertainty_score":0.3421651},"labels":[],"label_agreement":null},{"id":"W2897267859","doi":"10.1007/s00345-018-2516-z","title":"Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract","year":2018,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Nephrology; Chemotherapy; Internal medicine; Lymph node; Oncology; Perioperative; Urinary system; Urology; Carcinoma; Metastatic Urothelial Carcinoma; Surgery; Cancer; Bladder cancer","score_opus":0.014093680667027623,"score_gpt":0.29824603850908377,"score_spread":0.28415235784205617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897267859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971581,0.00055846036,0.000041615425,0.00082327035,0.00026237074,0.00048175023,0.000025649455,0.0000022004106,0.0006465646],"genre_scores_gemma":[0.9985678,0.00012336866,0.000082208346,0.0008726369,0.00016317178,0.000008945588,0.0000013879281,0.000021340245,0.0001591323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833554,0.00042451898,0.00055203977,0.00018641526,0.0003039962,0.00019749287],"domain_scores_gemma":[0.9988327,0.00030749378,0.00040011658,0.00019810158,0.00018401658,0.00007757438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003862283,0.00020479965,0.0007872193,0.00018109445,0.00003999212,0.0000035825178,0.00012826207,0.00005793973,0.00007703679],"category_scores_gemma":[0.00005191811,0.00011405867,0.0001782664,0.00016490142,0.00035615446,0.00006278022,0.000022181055,0.00024564678,0.0000012336741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050593127,0.0011288192,0.91927534,0.00019086146,0.00057654316,0.00035752982,0.0020409697,0.0000959046,0.022970583,0.000110793764,0.000019313868,0.0026401859],"study_design_scores_gemma":[0.01571387,0.0140143335,0.9608814,0.00039621355,0.00025589106,0.0016547479,0.0000707563,0.00010381465,0.006741746,0.000027922408,0.000050067207,0.00008925416],"about_ca_topic_score_codex":0.000117774885,"about_ca_topic_score_gemma":0.000035626243,"teacher_disagreement_score":0.041606016,"about_ca_system_score_codex":0.000110369525,"about_ca_system_score_gemma":0.00036211268,"threshold_uncertainty_score":0.46511775},"labels":[],"label_agreement":null},{"id":"W2897382994","doi":"10.21037/tau.2018.10.01","title":"Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer","year":2018,"lang":"en","type":"editorial","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Medicine; Eleventh; Cancer; Urology; Urothelial cancer; Internal medicine","score_opus":0.020083665595506024,"score_gpt":0.3144736815625604,"score_spread":0.2943900159670544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897382994","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017084343,0.0048900237,0.000027112279,0.01158603,0.9598022,0.0015209084,0.0011113646,0.00007764276,0.003900339],"genre_scores_gemma":[0.037884943,0.004177164,0.000025274903,0.0012156847,0.95193857,0.00058735884,0.0026865657,0.00006655289,0.0014178586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730027,0.00022092972,0.00055571145,0.0008636856,0.00046449827,0.0005948836],"domain_scores_gemma":[0.99832547,0.0007554912,0.00017807868,0.00026149806,0.0002988452,0.00018061072],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019160511,0.00054550084,0.00088433316,0.00026702537,0.00016698184,0.000020847092,0.000118791,0.0020723604,0.0015167134],"category_scores_gemma":[0.000074405645,0.00046204115,0.00015328579,0.00014938287,0.00040955536,0.00014703521,0.000028636332,0.000723401,0.00005068283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006120704,0.0006751543,0.002949264,0.00008247638,0.0012807113,0.00008823266,0.00066081947,0.00007106168,0.000058036578,0.00023838383,0.98494613,0.00282903],"study_design_scores_gemma":[0.012880192,0.007535137,0.0051792054,0.00003509015,0.001104817,0.000026199981,0.00001547765,0.00007918123,0.00002525287,0.0041683055,0.96861476,0.00033638996],"about_ca_topic_score_codex":0.0024974348,"about_ca_topic_score_gemma":0.0045258477,"teacher_disagreement_score":0.0208006,"about_ca_system_score_codex":0.00011820347,"about_ca_system_score_gemma":0.0016639953,"threshold_uncertainty_score":0.99978316},"labels":[],"label_agreement":null},{"id":"W2897536537","doi":"10.1371/journal.pone.0205746","title":"Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy","year":2018,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University","funders":"Canadian Urological Association; Pfizer","keywords":"Cystectomy; Bladder cancer; Cytotoxic T cell; CD8; Tumor-infiltrating lymphocytes; Medicine; Immune system; Oncology; Cancer research; CD3; Cancer; Internal medicine; Immunology; Biology","score_opus":0.016966217868782014,"score_gpt":0.2389645160310492,"score_spread":0.22199829816226718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897536537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962993,0.0007978818,0.0000019105566,0.00004455926,0.000051535462,0.001163407,0.000027666887,0.000032891436,0.0015808177],"genre_scores_gemma":[0.9984916,0.00016027798,0.0003818247,0.0002271305,0.00008527284,0.00020522809,0.000015567499,0.000035679815,0.00039745885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983841,0.0000701376,0.0003715395,0.00035172293,0.00048608042,0.00033642896],"domain_scores_gemma":[0.99915636,0.00008125815,0.000091307615,0.0003500906,0.00015654456,0.00016444788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095168914,0.00021659203,0.00046511122,0.0001449461,0.000035786983,0.000015858488,0.000095520954,0.00011647083,0.00031950747],"category_scores_gemma":[0.00021693528,0.00018216044,0.000047301244,0.00025698388,0.0003388068,0.00012040374,0.000077978024,0.00010543634,0.00008802927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005168605,0.0021229335,0.9813311,0.0005143674,0.0003714252,0.00007347517,0.0006277395,1.09603995e-7,0.008629257,0.0000062303525,0.000018027076,0.0011367104],"study_design_scores_gemma":[0.013455353,0.0030164982,0.9227075,0.0021087208,0.00041883477,0.000017628037,0.000025341351,0.0001827979,0.057733547,0.00009256234,0.000036331032,0.00020487672],"about_ca_topic_score_codex":0.00026832084,"about_ca_topic_score_gemma":0.000021389893,"teacher_disagreement_score":0.058623612,"about_ca_system_score_codex":0.00030032633,"about_ca_system_score_gemma":0.00040514898,"threshold_uncertainty_score":0.7428287},"labels":[],"label_agreement":null},{"id":"W2897581755","doi":"10.1093/annonc/mdy283.110","title":"Impact of prognostic factors and risk groups on overall survival (OS) in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer (UC): Post hoc analysis of KEYNOTE-045","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Urothelial cancer; Chemotherapy; Oncology; Internal medicine; Randomization; Pembrolizumab; Gemcitabine; Post-hoc analysis; Overall survival; Clinical trial; Cancer; Bladder cancer; Immunotherapy","score_opus":0.034400133800335804,"score_gpt":0.3667194996359786,"score_spread":0.3323193658356428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897581755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997396,0.000108708686,0.0000050905683,0.00017338405,0.000051352727,0.0010589974,0.0010523885,0.000011162899,0.0001429117],"genre_scores_gemma":[0.99898255,0.0004018207,0.00008398007,0.00024735817,0.00005243052,0.000060907772,0.000115531715,0.0000346697,0.000020725785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850154,0.000116936986,0.00046740434,0.00035426335,0.00024197847,0.00031787175],"domain_scores_gemma":[0.99806154,0.00035394536,0.0005244934,0.00025172168,0.0006220564,0.00018623348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001229779,0.00027676602,0.0011935078,0.00041302486,0.00003276783,0.0000032163803,0.00009198989,0.0001620646,0.00008595007],"category_scores_gemma":[0.0002791385,0.00018727002,0.00022914601,0.00048549174,0.0003261728,0.00007800287,0.000015968348,0.00010908269,3.5070371e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04260031,0.0013983208,0.9441203,0.00006538549,0.003181459,0.0000015138963,0.0007830323,0.00004422079,0.0011033951,0.000007648654,0.000056018136,0.006638387],"study_design_scores_gemma":[0.019669022,0.06992586,0.90214574,0.00009944312,0.0011676935,3.544666e-7,0.000023762961,0.0000647747,0.0066721397,0.00002036816,0.00007741019,0.00013342808],"about_ca_topic_score_codex":0.008671404,"about_ca_topic_score_gemma":0.0029333564,"teacher_disagreement_score":0.06852754,"about_ca_system_score_codex":0.00013042912,"about_ca_system_score_gemma":0.00050943316,"threshold_uncertainty_score":0.99792993},"labels":[],"label_agreement":null},{"id":"W2898021123","doi":"10.3233/blc-189037","title":"A Festschrift in Honor of Edward M. Messing, MD, FACS","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Honor; Medicine; Gerontology; Computer science","score_opus":0.024279809841021176,"score_gpt":0.33363532590499817,"score_spread":0.309355516063977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898021123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89748836,0.007907114,0.00016006586,0.0014100487,0.00093919394,0.00082292676,0.0000831183,0.00009206285,0.09109712],"genre_scores_gemma":[0.9949338,0.00057384575,0.0005070743,0.0010605634,0.00054728554,0.000102588085,0.000006973516,0.0000363835,0.0022315255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988558,0.000026164631,0.00027619748,0.00028937016,0.0002518906,0.00030057383],"domain_scores_gemma":[0.999353,0.000017486536,0.00008533285,0.00030480686,0.00012614448,0.00011323495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007366356,0.00017289568,0.00035984913,0.0001276135,0.000037215337,0.000009651557,0.00009004377,0.00010150161,0.0019141124],"category_scores_gemma":[0.000021833957,0.000142219,0.00008939426,0.00028809236,0.00017278765,0.00007882019,0.000033657063,0.00012569939,0.00007628611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020782512,0.0012375788,0.74721855,0.00041699348,0.00090207567,0.0001336197,0.0056630806,0.000008553855,0.026630942,0.00065315905,0.08234506,0.13271217],"study_design_scores_gemma":[0.014614355,0.0018277052,0.5337151,0.0013162221,0.0005726116,0.000058496546,0.0004480357,0.00010873229,0.17178062,0.00048385904,0.27442247,0.000651766],"about_ca_topic_score_codex":0.0019342733,"about_ca_topic_score_gemma":0.0012879717,"teacher_disagreement_score":0.21350339,"about_ca_system_score_codex":0.000090231966,"about_ca_system_score_gemma":0.00046130407,"threshold_uncertainty_score":0.9989983},"labels":[],"label_agreement":null},{"id":"W2898545403","doi":"10.1007/s11934-018-0852-6","title":"Current Clinical Trials in Non-muscle Invasive Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Disease; Oncology; Intensive care medicine; Clinical study design; Biomarker; Internal medicine; Cancer","score_opus":0.28456074708010054,"score_gpt":0.5323148599467623,"score_spread":0.24775411286666177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898545403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030117808,0.9756957,0.000015134407,0.000106072934,0.019072685,0.004072533,0.00010326346,0.000068340916,0.0005650633],"genre_scores_gemma":[0.00032476964,0.99193114,0.000014659021,0.00017706047,0.0049872976,0.0017655113,0.0004926509,0.00012328335,0.00018362001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897343,0.0018672259,0.005396432,0.0017550745,0.00044855077,0.0007984134],"domain_scores_gemma":[0.99382335,0.0011076325,0.0030337595,0.0013040929,0.00024239544,0.0004887468],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004925317,0.00091726286,0.0076234154,0.00050981314,0.000072207826,0.000025299481,0.00022985096,0.00095465296,0.0009973608],"category_scores_gemma":[0.0033541087,0.0006560785,0.0022163633,0.00048123547,0.00038856437,0.00007107942,0.00021558703,0.0018651718,0.00026151421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069771624,0.00097530964,0.008523883,0.0057368777,0.0007877829,0.0011050957,0.00005336269,1.04048596e-7,9.484723e-8,0.000002169616,0.0274115,0.95533407],"study_design_scores_gemma":[0.0014342223,0.00053717755,0.0023798698,0.009837481,0.0077892714,0.00068684993,0.0000025882894,0.0000012111205,6.418621e-7,0.0000965582,0.9767697,0.0004644132],"about_ca_topic_score_codex":0.0000496063,"about_ca_topic_score_gemma":0.00010533687,"teacher_disagreement_score":0.9548696,"about_ca_system_score_codex":0.00032354845,"about_ca_system_score_gemma":0.0043667457,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W2898667390","doi":"10.1007/s11934-018-0859-z","title":"Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy","year":2018,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Nephrology; Randomized controlled trial; Urinary diversion; Urology; Quality of life (healthcare); Surgery; Internal medicine; Cancer","score_opus":0.05785599175513771,"score_gpt":0.3797442313852314,"score_spread":0.32188823963009366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898667390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007509632,0.9954356,0.0000022207512,0.00021796956,0.0015847784,0.0020540282,0.000070911694,0.000028908114,0.000530511],"genre_scores_gemma":[0.000017027593,0.9976411,0.00002572594,0.00015464229,0.0011448757,0.00024016219,0.0005873706,0.00004373892,0.00014535939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977619,0.000217161,0.0010712593,0.0005249389,0.00024065695,0.00018409485],"domain_scores_gemma":[0.9975516,0.000057654746,0.0011932644,0.00071270793,0.00039524207,0.00008953168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003143604,0.00039640543,0.0020448188,0.00019167767,0.000041904197,0.000005918539,0.00007625288,0.00040102252,0.00020954398],"category_scores_gemma":[0.00006276456,0.00025249517,0.00052065443,0.00044126355,0.0001685766,0.000072041934,0.000033882763,0.0004007845,0.000001354295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065966444,0.00032306364,0.00025910628,0.039688006,0.0007412083,0.000031866723,0.00012915205,1.5353786e-9,7.7599833e-7,0.000009993682,0.00485408,0.95389676],"study_design_scores_gemma":[0.00048472293,0.0006657111,0.00028975765,0.028670961,0.0015348756,0.0010370337,8.047809e-7,9.755517e-8,0.000004973961,0.00008448307,0.96708745,0.00013914373],"about_ca_topic_score_codex":0.000005651174,"about_ca_topic_score_gemma":5.9546403e-7,"teacher_disagreement_score":0.96223336,"about_ca_system_score_codex":0.000024535704,"about_ca_system_score_gemma":0.0004902882,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W2898890568","doi":"10.1002/dc.24095","title":"Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology","year":2018,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; Dalhousie University; Saint John Regional Hospital","funders":"","keywords":"Medicine; Urine cytology; Cytology; Atypia; Urothelial carcinoma; Malignancy; Urinary system; Urine; Clinical significance; Gynecology; Urology; Internal medicine; Pathology; Cancer; Bladder cancer; Cystoscopy","score_opus":0.015406351254701595,"score_gpt":0.34258928536675426,"score_spread":0.3271829341120527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898890568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972423,0.0001464825,0.00008199004,0.0005567489,0.00024533694,0.0009823375,0.000040787494,0.000006138648,0.0006978966],"genre_scores_gemma":[0.9994152,0.00006303821,0.00007477457,0.00023915814,0.00009639194,0.0000805377,0.0000087757835,0.000010474468,0.000011655666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827164,0.0006767996,0.0004508626,0.00021411812,0.00018886881,0.00019772412],"domain_scores_gemma":[0.99689454,0.0022426103,0.00020485817,0.0004900053,0.00012659615,0.00004141143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006223156,0.00013843106,0.0005821995,0.000036456247,0.000054895074,0.0000036637973,0.00017212165,0.00010742685,0.000029472412],"category_scores_gemma":[0.00065724127,0.00004968358,0.00014096448,0.0001561677,0.001218484,0.000015363494,0.00008379526,0.00022728796,0.000002172523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015505615,0.00042125856,0.9954116,0.000030497959,0.00009254479,0.000030443298,0.00048653252,0.0000010955232,0.000004008523,0.0008991539,0.00018146497,0.0008908803],"study_design_scores_gemma":[0.010926657,0.003222532,0.98493475,0.000101188394,0.0003046758,0.0001159776,0.00014773487,0.00004498957,0.000021665037,0.00008973836,0.000044532273,0.000045590794],"about_ca_topic_score_codex":0.00024237443,"about_ca_topic_score_gemma":0.00011380892,"teacher_disagreement_score":0.010476841,"about_ca_system_score_codex":0.000045229306,"about_ca_system_score_gemma":0.00017115954,"threshold_uncertainty_score":0.4489555},"labels":[],"label_agreement":null},{"id":"W2899096912","doi":"10.1016/j.jpurol.2018.10.021","title":"Return to emergency department after pediatric urology procedures","year":2018,"lang":"en","type":"article","venue":"Journal of Pediatric Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Emergency department; Pediatric urology; Urology; General surgery; Emergency medicine; Nursing","score_opus":0.013103142841053432,"score_gpt":0.29090418443312593,"score_spread":0.27780104159207253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899096912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837455,0.0071564,0.00031650712,0.0046590087,0.0026008922,0.0003732592,0.000014483098,0.000025924035,0.001107993],"genre_scores_gemma":[0.9772462,0.0026206349,0.0005792087,0.0029777105,0.016193971,0.000033664182,0.0000025037307,0.000038372364,0.00030771014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979153,0.00009729133,0.0007844927,0.00030279774,0.00038003968,0.0005200635],"domain_scores_gemma":[0.99834365,0.00005181364,0.0003818475,0.00025679098,0.00050686445,0.00045905917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002741205,0.00024971666,0.0004908589,0.00058784074,0.00006967224,0.0000076244773,0.00019397192,0.00022105774,0.0016529855],"category_scores_gemma":[0.00027858207,0.0001892485,0.0002203747,0.00052471267,0.0000473963,0.00008629646,0.00007042035,0.00033597226,0.0002856886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006686302,0.0010957143,0.8589236,0.00006292808,0.0005841903,0.0010281273,0.0008076101,0.0000030984013,0.00019964264,0.000023645836,0.12938473,0.0012003947],"study_design_scores_gemma":[0.0066588325,0.03052993,0.8864636,0.0000019978445,0.0074009136,0.0030095787,0.000034859237,0.000009818889,0.00023961606,0.000882375,0.06433383,0.0004346481],"about_ca_topic_score_codex":0.000007887575,"about_ca_topic_score_gemma":0.000035466834,"teacher_disagreement_score":0.06505091,"about_ca_system_score_codex":0.00008061034,"about_ca_system_score_gemma":0.0004886873,"threshold_uncertainty_score":0.99925965},"labels":[],"label_agreement":null},{"id":"W2899154682","doi":"10.1007/s11934-018-0853-5","title":"Molecular Characterization of Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrology; Bladder cancer; Internal medicine; Urology; Oncology; Cancer","score_opus":0.052995553154335164,"score_gpt":0.38318186475026145,"score_spread":0.33018631159592626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899154682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006948122,0.99475443,0.00005646153,0.000030868992,0.0026695828,0.0010752367,0.00007245515,0.000042760417,0.0006033661],"genre_scores_gemma":[0.0004445522,0.9974038,0.0000071561917,0.00007144934,0.0005427803,0.00032766748,0.00091392687,0.000068189765,0.00022046661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796903,0.000083819876,0.00088962936,0.0005698479,0.00022509306,0.00026259816],"domain_scores_gemma":[0.9980746,0.000014195349,0.0009773378,0.00062814663,0.00018523565,0.000120472934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010745323,0.00037464275,0.0016541417,0.00018994088,0.000027462393,0.000004842044,0.000073357325,0.00034591838,0.0006547707],"category_scores_gemma":[0.000035581124,0.00028685035,0.00047391985,0.00021724892,0.00015095323,0.000030446281,0.00005746193,0.00027880791,0.000040081482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002716078,0.00031436974,0.00074301806,0.010300233,0.0011158229,0.00059344934,0.000033515073,4.1829246e-8,0.000059903865,0.000009665127,0.0008849688,0.98591787],"study_design_scores_gemma":[0.00019823105,0.00021100361,0.00021925503,0.0025961364,0.005652893,0.0010746846,2.4671633e-7,6.4535266e-7,0.00007509715,0.00001814046,0.9897739,0.0001797136],"about_ca_topic_score_codex":0.000008320604,"about_ca_topic_score_gemma":8.0767836e-7,"teacher_disagreement_score":0.988889,"about_ca_system_score_codex":0.00007218256,"about_ca_system_score_gemma":0.0008463241,"threshold_uncertainty_score":0.99995834},"labels":[],"label_agreement":null},{"id":"W2899226971","doi":"10.14740/wjnu361w","title":"A Second-Look at the Repeat Resections of Bladder Tumors","year":2018,"lang":"en","type":"article","venue":"World Journal of Nephrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Stage (stratigraphy); Proportional hazards model; Urology; Poisson regression; Cancer; Surgery; Internal medicine; Population","score_opus":0.015491494228874345,"score_gpt":0.28130735654784345,"score_spread":0.2658158623189691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899226971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700612,0.00284382,0.000028206887,0.011702515,0.0003345231,0.00012990955,0.000006222464,0.000006507669,0.014887114],"genre_scores_gemma":[0.98282236,0.0001456514,0.00007387043,0.00924727,0.0005996047,0.0000040577984,0.0000011546771,0.000011148654,0.007094907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901503,0.00014954951,0.00038476873,0.00013898997,0.00010257188,0.00020907055],"domain_scores_gemma":[0.99907315,0.00017740634,0.00026117987,0.00020728422,0.000185474,0.00009553198],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002831944,0.00011041886,0.0003624993,0.00020832702,0.0001578817,0.0000029179346,0.00008724326,0.000094273346,0.0039983187],"category_scores_gemma":[0.000040713338,0.000066873305,0.00010804008,0.0001611384,0.0009457109,0.000041039006,0.000057235713,0.00032285962,0.000022465803],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041351505,0.0012212837,0.35433424,0.00010404988,0.006221853,0.00197636,0.0045356536,0.0000147830615,0.07896805,0.004313799,0.49678645,0.010171991],"study_design_scores_gemma":[0.0050138826,0.009038366,0.4035794,0.000016473208,0.000885882,0.019370772,0.00008986654,0.000014289941,0.004303101,0.002934762,0.55464506,0.00010814548],"about_ca_topic_score_codex":0.000018571387,"about_ca_topic_score_gemma":0.0009804816,"teacher_disagreement_score":0.07466494,"about_ca_system_score_codex":0.000024185632,"about_ca_system_score_gemma":0.00012244127,"threshold_uncertainty_score":0.9969122},"labels":[],"label_agreement":null},{"id":"W2899640389","doi":"10.1186/s42155-018-0036-y","title":"Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma","year":2018,"lang":"en","type":"article","venue":"CVIR Endovascular","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Surgery; Stent; Stage (stratigraphy); Radiology; Disease; Aortic aneurysm; Aneurysm; Internal medicine","score_opus":0.026305204742237916,"score_gpt":0.2904675474176791,"score_spread":0.2641623426754412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899640389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935862,0.0007085737,0.0010678336,0.0003698855,0.00042104346,0.0018053724,0.00009529844,0.00013532239,0.0018104594],"genre_scores_gemma":[0.991566,0.00005326725,0.0012438617,0.00062271254,0.0010196663,0.0003030622,0.000101700985,0.00008810519,0.005001642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806225,0.000049540697,0.0003184206,0.000607986,0.00033086233,0.00063096284],"domain_scores_gemma":[0.9985613,0.00006111461,0.000059985512,0.00076873804,0.0002030033,0.00034586355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009814978,0.0003741956,0.00052471773,0.000111039066,0.00017571199,0.000040090938,0.00012375873,0.00013991122,0.0006656888],"category_scores_gemma":[0.00005724116,0.0002821397,0.0005478341,0.00014933036,0.00018997217,0.000089467365,0.000031195512,0.0001060965,0.00040492963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014952306,0.013341183,0.4057305,0.0016532063,0.021602765,0.005383772,0.01750041,0.000023188923,0.17078426,0.0032340009,0.004548867,0.34124556],"study_design_scores_gemma":[0.035913248,0.026418429,0.5860869,0.00011268172,0.0052064834,0.0006761595,0.00040051914,0.00092778966,0.2862161,0.00044647363,0.056439772,0.0011553928],"about_ca_topic_score_codex":0.00056207157,"about_ca_topic_score_gemma":0.000043978784,"teacher_disagreement_score":0.34009016,"about_ca_system_score_codex":0.00025655658,"about_ca_system_score_gemma":0.00021551292,"threshold_uncertainty_score":0.9999631},"labels":[],"label_agreement":null},{"id":"W2900683197","doi":"10.1200/jco.18.00537","title":"Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Gemcitabine; Bladder cancer; Regimen; Urology; Cystectomy; Clinical endpoint; Fluorouracil; Surgery; Chemoradiotherapy; Internal medicine; Radiation therapy; Cancer; Gastroenterology; Randomized controlled trial","score_opus":0.12176141321705831,"score_gpt":0.4691346344075544,"score_spread":0.3473732211904961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900683197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466875,0.0014694455,0.020296907,0.017005589,0.005950832,0.006916674,0.00011891947,0.00006452214,0.0014895671],"genre_scores_gemma":[0.9666922,0.002286491,0.006867297,0.0044425693,0.016425524,0.00053977274,0.00011987617,0.0000946828,0.002531582],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934279,0.0011183908,0.0035695774,0.0005293724,0.0008402838,0.0005144909],"domain_scores_gemma":[0.9860754,0.0071320278,0.004088898,0.00037247952,0.001789618,0.0005415862],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005148747,0.00041570776,0.0031287014,0.00025975122,0.00028742387,0.00004256606,0.0002626979,0.0006491131,0.00088034477],"category_scores_gemma":[0.011400023,0.00026030254,0.0007652757,0.00036790955,0.00045166304,0.00074999646,0.000052413023,0.0007666476,0.000014847609],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7742079,0.0019221833,0.00014267427,0.0000450274,0.0021517305,0.0000817198,0.0012747966,0.0001672581,0.00024162431,0.000041211017,0.010307946,0.20941594],"study_design_scores_gemma":[0.8508933,0.09134068,0.0015524451,0.00018837987,0.004191597,0.00006995471,0.0001703531,0.005283093,0.0007387885,0.00023225289,0.045064062,0.00027508708],"about_ca_topic_score_codex":0.00024891185,"about_ca_topic_score_gemma":0.00057399814,"teacher_disagreement_score":0.20914085,"about_ca_system_score_codex":0.0009405654,"about_ca_system_score_gemma":0.009307646,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W2900705575","doi":"10.5489/cuaj.5455","title":"30-day readmission after radical cystectomy: Identifying targets for improvement using the phases of surgical care","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Odds ratio; COPD; Complication; Confidence interval; Body mass index; Overweight; Surgery; Bladder cancer; Logistic regression; Internal medicine; Cancer","score_opus":0.023091368053239185,"score_gpt":0.301008174510491,"score_spread":0.2779168064572518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900705575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417103,0.002327557,0.0010374043,0.009153514,0.0010301829,0.0009350943,0.00020068805,0.000023659846,0.0011208797],"genre_scores_gemma":[0.99691606,0.000042434855,0.00026341766,0.0012766024,0.0012858474,0.000023164568,0.000014177127,0.00001365747,0.00016462471],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985722,0.000117320735,0.00036102004,0.00017959865,0.0003538923,0.00041601073],"domain_scores_gemma":[0.99857396,0.00013294915,0.00022600788,0.00011007458,0.00046161303,0.0004953859],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005027371,0.00013268832,0.00027035055,0.000092551454,0.00036100202,0.00004809645,0.000097577264,0.00018434101,0.0011529326],"category_scores_gemma":[0.00028270905,0.00008052251,0.00020163514,0.000117192765,0.000079639576,0.00005974854,0.000015437256,0.00025328746,0.0000056614963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003658968,0.00065531716,0.86285603,0.00018581965,0.002462075,0.0010645265,0.007195316,0.000024119972,0.013279177,0.00036699703,0.02715801,0.081093654],"study_design_scores_gemma":[0.020673523,0.008405469,0.1969832,0.0003417376,0.0019980858,0.0007071637,0.0021085155,0.0008396716,0.016346399,0.0016565591,0.7492232,0.000716481],"about_ca_topic_score_codex":0.0005447039,"about_ca_topic_score_gemma":0.00025694788,"teacher_disagreement_score":0.7220652,"about_ca_system_score_codex":0.0010557736,"about_ca_system_score_gemma":0.00071725127,"threshold_uncertainty_score":0.99976015},"labels":[],"label_agreement":null},{"id":"W2900982922","doi":"10.1016/j.urolonc.2018.10.013","title":"Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cystectomy; Lymphovascular invasion; Medicine; Stage (stratigraphy); Histology; Bladder cancer; Urothelial carcinoma; Internal medicine; Oncology; Urology; Proportional hazards model; Carcinoma; Cancer; Gastroenterology; Metastasis; Biology","score_opus":0.040835047969700326,"score_gpt":0.3191051004624758,"score_spread":0.2782700524927755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900982922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689455,0.00044394736,0.00059376046,0.008140961,0.0002862846,0.00079376437,0.00008253765,0.000075459655,0.0026887301],"genre_scores_gemma":[0.9255986,0.00006471429,0.07040884,0.003143117,0.00028862534,0.00021393358,0.0000938867,0.000017904118,0.000170346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985075,0.00013165482,0.00041899207,0.00046061398,0.00018880688,0.00029241404],"domain_scores_gemma":[0.99897933,0.00016376136,0.00017030553,0.0002429533,0.0001275393,0.0003161265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024506214,0.00024520783,0.0004227263,0.00021371873,0.00043850765,0.000014971457,0.00010949613,0.00026239475,0.000084601095],"category_scores_gemma":[0.00019503586,0.00019105212,0.00012817809,0.0003670609,0.0016151716,0.00009085033,0.000043269683,0.00025969927,0.000031736272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035520998,0.0007601855,0.95449024,0.000054393608,0.00025579132,0.00016741402,0.0009775813,0.000008457218,0.022913212,0.015561102,0.0016006097,0.0028557987],"study_design_scores_gemma":[0.014079443,0.022348573,0.48483065,0.00046769556,0.00250247,0.0030676515,0.0003078418,0.0016845422,0.051744975,0.015786828,0.40233397,0.0008453585],"about_ca_topic_score_codex":0.0001431948,"about_ca_topic_score_gemma":0.00003609696,"teacher_disagreement_score":0.4696596,"about_ca_system_score_codex":0.00019527596,"about_ca_system_score_gemma":0.0011209109,"threshold_uncertainty_score":0.77908796},"labels":[],"label_agreement":null},{"id":"W2901062149","doi":"10.1016/j.urolonc.2018.10.012","title":"Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy","year":2018,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Propensity score matching; Medicine; Bladder cancer; Cohort; Logistic regression; Urology; Surgery; Internal medicine; Cancer","score_opus":0.09781590432359291,"score_gpt":0.3827681028913831,"score_spread":0.2849521985677902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901062149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986685,0.0008528956,0.00017243043,0.0036371814,0.000113706854,0.0009112503,0.00003985412,0.000042690972,0.004363121],"genre_scores_gemma":[0.97240263,0.00010435189,0.026115878,0.00047104535,0.00020289178,0.000056280307,0.00009504453,0.00001682834,0.00053504674],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983703,0.00019730728,0.00044803417,0.00044024352,0.00017904176,0.00036509757],"domain_scores_gemma":[0.9987015,0.00028110892,0.00020035534,0.00022738632,0.00011738795,0.00047225706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002740937,0.00022350607,0.0009211588,0.00010644856,0.00026662642,0.000035927253,0.00014180683,0.00028665393,0.00015953383],"category_scores_gemma":[0.00010572039,0.00017066054,0.000037556678,0.00025338383,0.0019831937,0.00011045106,0.00018011912,0.00031388493,0.000015584024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043814076,0.00036114184,0.9873417,0.00005202114,0.00015598461,0.000118736214,0.00071772316,0.0000025835634,0.00061621564,0.0010576241,0.0015977809,0.0075403266],"study_design_scores_gemma":[0.0054501607,0.011889737,0.34419593,0.00012271982,0.0010021982,0.00065413426,0.00023952647,0.00022150992,0.0032969464,0.0016846738,0.6309775,0.00026494634],"about_ca_topic_score_codex":0.0004731813,"about_ca_topic_score_gemma":0.00012499599,"teacher_disagreement_score":0.6431458,"about_ca_system_score_codex":0.000093627394,"about_ca_system_score_gemma":0.00049552263,"threshold_uncertainty_score":0.730716},"labels":[],"label_agreement":null},{"id":"W2901127133","doi":"10.1016/j.euo.2018.10.008","title":"Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes","year":2018,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Perioperative; Randomized controlled trial; Hazard ratio; Surgery; Confidence interval; Cancer; Internal medicine","score_opus":0.22061064428387933,"score_gpt":0.44183294748994956,"score_spread":0.22122230320607023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901127133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022124572,0.94380665,0.00007343406,0.0017272814,0.0005327613,0.003644355,0.00030328575,0.00013888518,0.049552128],"genre_scores_gemma":[0.009258462,0.9765118,0.0037930682,0.002662296,0.0002888916,0.0010334069,0.0017297084,0.00031959426,0.0044027995],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.98879343,0.0062900833,0.0022254568,0.0016847948,0.0003515183,0.00065468514],"domain_scores_gemma":[0.9945175,0.0019268547,0.0014385127,0.0013553703,0.00028521082,0.000476544],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015944886,0.0010336775,0.012123352,0.0009268098,0.0002606234,0.000048936163,0.0011105927,0.0010052259,0.0031480398],"category_scores_gemma":[0.00049798534,0.0006805319,0.002695261,0.0013405195,0.0022284572,0.00008176538,0.0009365669,0.0011495767,0.00033703508],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026113817,0.0026351959,0.0003589298,0.0016888034,0.77854556,0.001980361,0.0005668877,0.0000050553494,0.000011725353,0.0008617144,0.0024578776,0.2082765],"study_design_scores_gemma":[0.0063240947,0.0046145995,0.0036057308,0.00004564588,0.40053442,0.00053025945,0.000013617478,0.000011863565,3.973274e-7,0.000003825337,0.5840085,0.00030705656],"about_ca_topic_score_codex":0.00012938955,"about_ca_topic_score_gemma":0.00013688332,"teacher_disagreement_score":0.5815506,"about_ca_system_score_codex":0.00047435416,"about_ca_system_score_gemma":0.0013397264,"threshold_uncertainty_score":0.9995646},"labels":[],"label_agreement":null},{"id":"W2901236948","doi":"10.5489/cuaj.5555","title":"Segmental ureterectomy can be performed safely in patients with urothelial carcinoma of distal ureter","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Urology; Ureter; Proportional hazards model; Urothelial carcinoma; T-stage; Retrospective cohort study; Stage (stratigraphy); Ureteral neoplasm; Confidence interval; Carcinoma; Cohort; Surgery; Overall survival; Internal medicine; Cancer; Transitional cell carcinoma; Bladder cancer","score_opus":0.008961071240866236,"score_gpt":0.214442963513652,"score_spread":0.20548189227278577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901236948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946028,0.000015939508,0.000004378675,0.0025295175,0.00019592025,0.0002995023,0.00022526312,0.0000071910263,0.002119486],"genre_scores_gemma":[0.9970611,0.0000023867267,0.00009541902,0.0022337984,0.00033019698,0.000008121468,0.000053921198,0.000016261663,0.00019883954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985153,0.00008787381,0.00031873633,0.00018644129,0.00043055406,0.000461111],"domain_scores_gemma":[0.9989162,0.00003207214,0.00018996726,0.000096605254,0.00026632528,0.0004988233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001763732,0.00016005579,0.00030224933,0.00018067975,0.00013060743,0.000027402508,0.000089308014,0.00016391688,0.00092511345],"category_scores_gemma":[0.00009349658,0.00011342335,0.000087600434,0.00018115796,0.0000863717,0.0000779522,0.000010726172,0.00034839934,0.000008952004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006785734,0.00010188598,0.9972673,0.0000037419684,0.00008922266,0.000025255991,0.00036631044,5.403789e-7,0.000061535015,0.000007943864,0.00055923127,0.00083847216],"study_design_scores_gemma":[0.0060811834,0.0029884442,0.98829156,0.000018214416,0.00007773882,0.000033779743,0.000050283506,0.000011525599,0.00035323214,0.000028413577,0.0019471822,0.00011841805],"about_ca_topic_score_codex":0.003225688,"about_ca_topic_score_gemma":0.0058658263,"teacher_disagreement_score":0.008975702,"about_ca_system_score_codex":0.0014213847,"about_ca_system_score_gemma":0.00073834334,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W2901439945","doi":"10.1016/j.euf.2018.11.005","title":"Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel","year":2018,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Bladder cancer; Risk stratification; Oncology; Internal medicine; Urology; Cancer","score_opus":0.08506840032471714,"score_gpt":0.36538737183616693,"score_spread":0.2803189715114498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901439945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054067113,0.9712695,0.0008238559,0.0039471295,0.0011841906,0.004412583,0.0037850805,0.00010968303,0.009061253],"genre_scores_gemma":[0.13000032,0.86510307,0.00036139446,0.0010813242,0.00200647,0.0005494746,0.00047526427,0.0002575746,0.00016514181],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9908096,0.00417051,0.0020260164,0.0015544231,0.0005859455,0.00085346715],"domain_scores_gemma":[0.9928658,0.0033378343,0.0015450689,0.0010636355,0.00092193054,0.0002657557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018626552,0.00096927537,0.002192045,0.0002657331,0.00023851509,0.000093758266,0.0006101646,0.0005083265,0.00021202704],"category_scores_gemma":[0.002200535,0.00070397893,0.0004550701,0.0004279148,0.0005354263,0.00021166823,0.0003171978,0.0013623476,0.00009729759],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000187754,0.00076243,0.008863506,0.001696158,0.004037652,0.00054089713,0.0019665444,0.00012440041,0.000086677,0.00011503558,0.008824152,0.9727948],"study_design_scores_gemma":[0.014822771,0.0077091157,0.58470184,0.013031281,0.0647663,0.00023064853,0.0006761871,0.0012709437,0.00004688003,0.003023536,0.3059618,0.003758693],"about_ca_topic_score_codex":0.0017451537,"about_ca_topic_score_gemma":0.0023103368,"teacher_disagreement_score":0.9690361,"about_ca_system_score_codex":0.00042123682,"about_ca_system_score_gemma":0.0015338666,"threshold_uncertainty_score":0.99954116},"labels":[],"label_agreement":null},{"id":"W2901812877","doi":"10.1016/j.clgc.2018.11.003","title":"More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder","year":2018,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Hazard ratio; Propensity score matching; Proportional hazards model; Urology; Bladder cancer; Lymph node; Dissection (medical); Internal medicine; Overall survival; Surgery; Oncology; Cancer; Confidence interval","score_opus":0.04512874150609205,"score_gpt":0.36884425104176705,"score_spread":0.323715509535675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901812877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513847,0.00096131186,0.00001750957,0.0007373196,0.0015943777,0.0006841688,0.00007979798,0.000026246107,0.00076077867],"genre_scores_gemma":[0.9971785,0.00015469718,0.0002193148,0.00048445354,0.0011606943,0.00008501091,0.0000051296906,0.00007159208,0.00064060895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977142,0.00017120627,0.00093583466,0.00044537496,0.00041702844,0.00031632648],"domain_scores_gemma":[0.99842066,0.00023013495,0.00030120878,0.0005756134,0.00031607307,0.00015628607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026388848,0.00024336085,0.0007674764,0.00008907092,0.000053002565,0.000005026295,0.00021187463,0.00015466605,0.0003239568],"category_scores_gemma":[0.00017820833,0.00016160695,0.00039843694,0.00036011304,0.00086665136,0.00006184453,0.000110095694,0.0002781084,0.000013288863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005862917,0.0016065908,0.96205246,0.00029172364,0.0006893185,0.00010302561,0.0006904161,0.000021045424,0.014880055,0.000033094286,0.0007287978,0.0130405715],"study_design_scores_gemma":[0.007122708,0.0012494439,0.9727146,0.00021843419,0.00051415333,0.000044633383,0.00029646605,0.00020314379,0.016886562,0.00012656896,0.00045929733,0.00016398933],"about_ca_topic_score_codex":0.0011855505,"about_ca_topic_score_gemma":0.00013122853,"teacher_disagreement_score":0.012876582,"about_ca_system_score_codex":0.00012447819,"about_ca_system_score_gemma":0.0005242255,"threshold_uncertainty_score":0.65901405},"labels":[],"label_agreement":null},{"id":"W2902348306","doi":"10.1111/ajco.13059","title":"Prime time for immunotherapy in advanced urothelial cancer","year":2018,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Oncology; Internal medicine; Clinical trial; Chemotherapy; Disease; Cisplatin; Immunotherapy; Cancer; Intensive care medicine","score_opus":0.13085102567069737,"score_gpt":0.5175727264392097,"score_spread":0.3867217007685123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902348306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009621189,0.9864908,0.00006801769,0.0009403688,0.0038256936,0.0021875696,0.00012153964,0.000017460547,0.006252372],"genre_scores_gemma":[0.00005693485,0.9869514,0.0029733672,0.0003394667,0.00484385,0.0002024003,0.000027952969,0.00013625425,0.0044683754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931754,0.0007079555,0.004618569,0.0005435021,0.0003887359,0.000565866],"domain_scores_gemma":[0.9931852,0.002072549,0.003363538,0.0004925726,0.0005147053,0.0003713978],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026258978,0.0005600483,0.007224597,0.00039229525,0.00005066441,0.000015802489,0.0004556625,0.0013037401,0.0007217655],"category_scores_gemma":[0.0008252143,0.0003780744,0.0025231186,0.0003123584,0.00033802987,0.000107901455,0.000042591535,0.001492163,0.00016063362],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042284103,0.0011925258,0.00015701127,0.00091738126,0.0015638411,0.00018960238,0.00005534006,1.4921294e-7,0.000005102993,0.00000960669,0.005860115,0.9858209],"study_design_scores_gemma":[0.012518082,0.013010712,0.00014904648,0.007116407,0.002078021,0.00054209767,0.000025986632,0.0000017987838,0.000007810004,0.00015253754,0.9641153,0.00028215986],"about_ca_topic_score_codex":0.000016430167,"about_ca_topic_score_gemma":0.00001737858,"teacher_disagreement_score":0.9855388,"about_ca_system_score_codex":0.000755434,"about_ca_system_score_gemma":0.009737429,"threshold_uncertainty_score":0.9999928},"labels":[],"label_agreement":null},{"id":"W2904495714","doi":"10.1016/j.urolonc.2018.11.015","title":"Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy","year":2018,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Biomarker; Immunotherapy; Medicine; Targeted therapy; Tumor heterogeneity; Biomarker discovery; Precision medicine; Circulating tumor cell; Oncology; Genetic heterogeneity; Computational biology; Bioinformatics; Cancer; Internal medicine; Phenotype; Biology; Pathology; Proteomics; Gene; Genetics; Metastasis","score_opus":0.07521439352814811,"score_gpt":0.3891175472210551,"score_spread":0.313903153692907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904495714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034887865,0.9598931,0.000015123493,0.0020171467,0.00013954255,0.0023302843,0.00043496964,0.000038258248,0.0002437095],"genre_scores_gemma":[0.0002776822,0.9884876,0.006364954,0.0018846602,0.00015808298,0.0024167025,0.00030697457,0.000042803887,0.00006055346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982044,0.00016609063,0.0004687804,0.000717638,0.00007609,0.0003670163],"domain_scores_gemma":[0.99867773,0.00037388134,0.00027772997,0.00031067894,0.00008964323,0.0002703339],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000227282,0.0004101824,0.0011382813,0.00024602763,0.00020056675,0.000025011748,0.00012476915,0.00042180743,0.000030197472],"category_scores_gemma":[0.00010741928,0.00031763437,0.00017336791,0.00033209272,0.0007490282,0.00005785168,0.000053666085,0.00027398192,0.0000048696425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026669097,0.00086939835,0.10090932,0.004156016,0.002190076,0.00019397552,0.00036005114,0.0000015536248,0.00014519939,0.0027342092,0.010005482,0.87816805],"study_design_scores_gemma":[0.0011481747,0.0017387376,0.0013820444,0.00081314374,0.0013413662,0.00029526596,0.00001639045,0.0000056597155,0.00003957386,0.0019431051,0.99101394,0.0002625829],"about_ca_topic_score_codex":0.00019929008,"about_ca_topic_score_gemma":0.00032176226,"teacher_disagreement_score":0.98100847,"about_ca_system_score_codex":0.00023048704,"about_ca_system_score_gemma":0.0015456821,"threshold_uncertainty_score":0.9999276},"labels":[],"label_agreement":null},{"id":"W2904555583","doi":"10.1016/j.eururo.2018.11.052","title":"Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Internal medicine; Meta-analysis; Systematic review; Confidence interval; Cochrane Library; Oncology; Lymph node; Urology; Gynecology; Surgery; Cancer; MEDLINE","score_opus":0.06669638066961328,"score_gpt":0.32100160023820185,"score_spread":0.25430521956858854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904555583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021484825,0.9950957,0.0000012586971,0.00024152298,0.00005323162,0.002788418,0.0013508132,0.000010289903,0.00024395074],"genre_scores_gemma":[0.0027547504,0.99502593,0.000014430581,0.0009741402,0.00003938007,0.00010288215,0.000084915795,0.00006682308,0.0009367237],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964468,0.0014770142,0.0012205873,0.0004837721,0.00017762765,0.00019418982],"domain_scores_gemma":[0.9973721,0.00022576803,0.0010405774,0.0011024401,0.00009832062,0.00016082622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031752515,0.0005335374,0.008269059,0.00020453657,0.000047957223,0.0000076071965,0.00019674201,0.0000749699,0.0001347607],"category_scores_gemma":[0.00017794459,0.00024568415,0.002194504,0.00028534426,0.0003437115,0.000013451167,0.00015936609,0.000118904594,0.0000129204345],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005643645,0.00028304014,0.0013068317,0.62378603,0.37223455,0.0001198303,0.00013281275,1.2055981e-8,5.807669e-7,0.000021710179,0.00011276688,0.001945416],"study_design_scores_gemma":[0.00033606743,0.0005124317,0.003705645,0.0030609316,0.9656212,0.00006678821,0.0000017497624,4.637898e-7,3.462337e-7,9.900749e-7,0.026547274,0.00014611788],"about_ca_topic_score_codex":0.000021153939,"about_ca_topic_score_gemma":0.0000040883633,"teacher_disagreement_score":0.6207251,"about_ca_system_score_codex":0.00003344488,"about_ca_system_score_gemma":0.0001672965,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W2904848139","doi":"10.1016/j.ejso.2018.12.004","title":"Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Renal pelvis; Urology; Interquartile range; Lymph node; Ureter; Lymph; Stage (stratigraphy); Upper urinary tract; Dissection (medical); Urinary system; Ureteral neoplasm; Proportional hazards model; Percentile; Carcinoma; Oncology; Internal medicine; Cancer; Transitional cell carcinoma; Radiology; Bladder cancer; Pathology; Biology","score_opus":0.05932136572863022,"score_gpt":0.3523586696889989,"score_spread":0.2930373039603687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904848139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801839,0.0014031294,0.000004477736,0.0007180965,0.00029325052,0.00013138868,0.000028477481,0.00000459429,0.017232694],"genre_scores_gemma":[0.9965072,0.0022464392,0.00005118196,0.00020497334,0.0008982659,0.0000011935006,0.000002001205,0.000027235743,0.00006145816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982613,0.0005505847,0.0005924067,0.00018943865,0.00018059486,0.00022568998],"domain_scores_gemma":[0.99902594,0.00017570889,0.00028981752,0.00015571824,0.00013576694,0.0002170376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006982351,0.00019693795,0.0006615211,0.00017122673,0.000034133493,0.0000073239576,0.00010607093,0.00005965629,0.00064113137],"category_scores_gemma":[0.00001664895,0.000110155874,0.0001956087,0.00013044021,0.00026673125,0.00007099088,0.0000379335,0.00027940737,0.000015726118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010080674,0.002215376,0.94132626,0.00003163029,0.00017969757,0.006354576,0.0009992459,0.000010214643,0.006074631,0.000018246312,0.00033814073,0.032371312],"study_design_scores_gemma":[0.008303539,0.009840622,0.96076053,0.00018776051,0.000059136622,0.002463511,0.00009417259,0.000010895866,0.0037806842,0.00002669542,0.014379748,0.000092700604],"about_ca_topic_score_codex":0.00008429835,"about_ca_topic_score_gemma":0.000002645064,"teacher_disagreement_score":0.032278612,"about_ca_system_score_codex":0.00022772711,"about_ca_system_score_gemma":0.00031702282,"threshold_uncertainty_score":0.7019939},"labels":[],"label_agreement":null},{"id":"W2904995363","doi":"10.5489/cuaj.5827","title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49th parallel","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Chemotherapy; Medicine; Neoadjuvant therapy; Cancer; Oncology; Urology; Internal medicine; Breast cancer","score_opus":0.025017049843860772,"score_gpt":0.30098735163336704,"score_spread":0.27597030178950627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904995363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7066252,0.0011811809,0.0011002542,0.2843894,0.0017186892,0.001521976,0.0004464816,0.00007538394,0.0029413928],"genre_scores_gemma":[0.9530233,0.0003961497,0.0002507175,0.04192978,0.0025597026,0.000087036984,0.000016528715,0.000027189282,0.0017095938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983558,0.00008773541,0.0002885903,0.00023422246,0.0003033426,0.00073027954],"domain_scores_gemma":[0.998369,0.00020852598,0.00023224525,0.000155062,0.0004723788,0.0005628281],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044922574,0.00018209004,0.0002860311,0.00004838268,0.0008321917,0.000115409835,0.00017652546,0.00023559669,0.0011287918],"category_scores_gemma":[0.00030287806,0.00011222463,0.00021539807,0.00016422222,0.00010804398,0.00007121647,0.000010099773,0.00036333193,0.000052562827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012470605,0.00030835732,0.5920997,0.000019931465,0.0026991214,0.00010772117,0.0056808325,0.00006942273,0.00074362283,0.00060579774,0.2941317,0.10228671],"study_design_scores_gemma":[0.006029306,0.001263765,0.6208982,0.000020493191,0.0002005099,0.000082791346,0.00039145147,0.00012449332,0.00018811268,0.0024054302,0.36819035,0.00020508579],"about_ca_topic_score_codex":0.0029486574,"about_ca_topic_score_gemma":0.012951335,"teacher_disagreement_score":0.24639808,"about_ca_system_score_codex":0.0012348094,"about_ca_system_score_gemma":0.0012095714,"threshold_uncertainty_score":0.9997843},"labels":[],"label_agreement":null},{"id":"W2905102064","doi":"10.1101/488460","title":"The consensus molecular classification of muscle-invasive bladder cancer","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; Canada's Michael Smith Genome Sciences Centre; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Human Genome Research Institute; Cancerfonden","keywords":"Bladder cancer; Stromal cell; Disease; Transcriptome; Biology; Computational biology; Bioinformatics; Clinical trial; Medicine; Cancer; Pathology; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.024479079133087594,"score_gpt":0.2716072786808798,"score_spread":0.24712819954779222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905102064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891399,0.0055633215,0.00016448111,0.001612556,0.0013774083,0.0014498277,0.00040433402,0.00016271547,0.00012545317],"genre_scores_gemma":[0.9963748,0.0013405326,0.0008134648,0.00033011998,0.00053491665,0.00046004454,5.828517e-7,0.00012385278,0.000021698082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975949,0.00012845197,0.0005696271,0.0007495604,0.0005176286,0.0004398429],"domain_scores_gemma":[0.9963339,0.0001214342,0.00054782565,0.0015465866,0.0012168812,0.0002333912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030008654,0.00045913845,0.00057876564,0.00012988853,0.0001715202,0.00006260337,0.0003301255,0.0004381404,0.00008958034],"category_scores_gemma":[0.00025788604,0.00035918714,0.00023829959,0.000310771,0.00046903163,0.000027171835,0.0001938204,0.00048186374,0.000045099983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020053034,0.00022784813,0.010476875,0.00048561065,0.0013121654,0.00007184256,0.000024456876,0.000007913375,0.9844149,0.00049090036,0.0022650727,0.00002190957],"study_design_scores_gemma":[0.0013582632,0.00019322119,0.32549682,0.0007765178,0.0010602234,4.060717e-8,0.000011103702,0.000089965666,0.6642762,0.000009141996,0.0062957015,0.0004328194],"about_ca_topic_score_codex":0.00024265274,"about_ca_topic_score_gemma":0.000016845108,"teacher_disagreement_score":0.3201387,"about_ca_system_score_codex":0.00034089418,"about_ca_system_score_gemma":0.002190736,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W2905539785","doi":"10.1016/j.canep.2018.11.007","title":"Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?","year":2018,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Chemotherapy; Neoadjuvant therapy; Internal medicine; Population; Cancer; Breast cancer; Environmental health","score_opus":0.07228863351713502,"score_gpt":0.39775551096741635,"score_spread":0.32546687745028136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905539785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697965,0.0028006886,0.0021221074,0.022405034,0.0005419319,0.0013664016,0.0005674004,0.0000916148,0.0003083445],"genre_scores_gemma":[0.97832465,0.00016431748,0.0006673038,0.018066585,0.00054271024,0.000969765,0.0002916829,0.000053440028,0.00091951806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793863,0.0001287164,0.00053353765,0.00064157863,0.00014283982,0.0006147095],"domain_scores_gemma":[0.9983147,0.00060132844,0.00028447673,0.00035732109,0.00027925926,0.0001629189],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005013469,0.00029278974,0.0012489841,0.0002553947,0.000089096575,0.0000052699943,0.00010609287,0.0002459004,0.0014755507],"category_scores_gemma":[0.00019906391,0.00021909089,0.00025437915,0.0007228015,0.000141465,0.000044140685,0.000009936097,0.000156982,0.000006251038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015423842,0.00013999341,0.9895406,0.000024170587,0.0023217825,0.0000031551829,0.00020801634,0.0005506467,0.00003464889,0.00009167099,0.0015173022,0.0040256255],"study_design_scores_gemma":[0.0075520035,0.0007397801,0.9787983,0.0001406565,0.0013735624,6.8835953e-7,0.000018299024,0.00795629,0.00030116702,0.00081323937,0.0020618762,0.00024417488],"about_ca_topic_score_codex":0.015570739,"about_ca_topic_score_gemma":0.03692159,"teacher_disagreement_score":0.02135085,"about_ca_system_score_codex":0.00062972977,"about_ca_system_score_gemma":0.00038459353,"threshold_uncertainty_score":0.9994372},"labels":[],"label_agreement":null},{"id":"W2908423177","doi":"10.1097/ede.0000000000000964","title":"Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"Epidemiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; World Cancer Research Fund","keywords":"Bladder cancer; Medicine; Odds ratio; Smoking history; Intensity (physics); Epidemiology; Cancer; Case-control study; Internal medicine; Demography","score_opus":0.11406380567233007,"score_gpt":0.3489312049743713,"score_spread":0.23486739930204123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908423177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742484,0.011373219,0.00034363638,0.0028925163,0.00078609545,0.0004365608,0.000008116109,0.000028710125,0.009882734],"genre_scores_gemma":[0.9948285,0.0002057821,0.000220555,0.0036004463,0.00017755854,0.000044240638,0.000008763438,0.000016618362,0.0008975208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987603,0.00021851965,0.00044425952,0.00023030037,0.00008191308,0.0002646971],"domain_scores_gemma":[0.9991105,0.00041705446,0.000111203306,0.00027626054,0.00004298894,0.000041956515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068419735,0.00011220392,0.00050255464,0.00006117333,0.000016696069,4.807538e-7,0.00008999687,0.00010764208,0.00071973086],"category_scores_gemma":[0.0002374798,0.000073665964,0.00008628669,0.00006320017,0.00006851037,0.000029274628,0.00003488926,0.00024989375,0.000008592231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117736025,0.000038607417,0.9858759,0.000049955244,0.00011473627,0.0000030369333,0.0010348212,0.0082189515,0.00061997573,0.00045719306,0.0017228264,0.0017462756],"study_design_scores_gemma":[0.0049394676,0.0006156277,0.7542981,0.00038804856,0.00025892162,0.000043024287,0.0006700201,0.2245714,0.000081252605,0.00234612,0.011545724,0.00024231519],"about_ca_topic_score_codex":0.0037600666,"about_ca_topic_score_gemma":0.00022150733,"teacher_disagreement_score":0.23157781,"about_ca_system_score_codex":0.00035790695,"about_ca_system_score_gemma":0.0002020635,"threshold_uncertainty_score":0.7880548},"labels":[],"label_agreement":null},{"id":"W2908453839","doi":"10.1002/path.5230","title":"Molecular profiling in muscle‐invasive bladder cancer: more than the sum of its parts","year":2019,"lang":"en","type":"review","venue":"The Journal of Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University","funders":"Geochemical Society; Cancer Research Society","keywords":"Subtyping; Bladder cancer; Profiling (computer programming); Transcriptome; Gene expression profiling; Bioinformatics; Biology; Medicine; Oncology; Internal medicine; Cancer; Gene expression; Computer science; Gene","score_opus":0.06350403810990926,"score_gpt":0.3676798625173298,"score_spread":0.3041758244074205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908453839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011991063,0.98536485,0.00000867286,0.0006082236,0.000541572,0.0011254839,0.00005431786,0.0000037386512,0.000302047],"genre_scores_gemma":[0.012596418,0.98656046,0.00002854385,0.00028195055,0.00028997968,0.00003789033,0.0000075408534,0.000051883573,0.00014533487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976394,0.00065148034,0.0008983163,0.00017361307,0.00033501093,0.00030214572],"domain_scores_gemma":[0.9977753,0.00032265767,0.0011526847,0.0004636812,0.00021767737,0.00006799862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078422786,0.000319046,0.0018423528,0.00019102704,0.000034321412,0.0000049255364,0.0004157732,0.0002522354,0.00005838491],"category_scores_gemma":[0.00013359248,0.00014353207,0.000526737,0.00024921208,0.00016123297,0.000036038153,0.00008043824,0.0008796131,0.00001190851],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009462337,0.0009780563,0.0020851004,0.03628451,0.005610126,0.009965755,0.007898286,0.0002826854,0.0025161456,0.00029972778,0.0011289493,0.93200445],"study_design_scores_gemma":[0.017179973,0.0091659,0.0066330447,0.13538292,0.07652938,0.045049038,0.003993936,0.00002921872,0.009559976,0.00067243696,0.6937981,0.0020060434],"about_ca_topic_score_codex":0.000034271874,"about_ca_topic_score_gemma":0.000029892612,"teacher_disagreement_score":0.9299984,"about_ca_system_score_codex":0.0001303632,"about_ca_system_score_gemma":0.0012835334,"threshold_uncertainty_score":0.5853068},"labels":[],"label_agreement":null},{"id":"W2908997167","doi":"10.2217/cer-2018-0113","title":"Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Metastasis; Cancer; Bone metastasis; Asymptomatic; Lung cancer; Radiology; Population; Lung; Oncology; Internal medicine","score_opus":0.1506586076286012,"score_gpt":0.4861626378263604,"score_spread":0.3355040301977592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908997167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89286083,0.0021526194,0.08313068,0.008474715,0.0010985885,0.010038691,0.002180628,0.000012606009,0.000050623872],"genre_scores_gemma":[0.9939484,0.00003073757,0.003305923,0.00021768412,0.0008873714,0.0012854612,0.00018475889,0.000033754914,0.00010592871],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99714065,0.00089869706,0.0006730352,0.0002677569,0.0006764093,0.0003434489],"domain_scores_gemma":[0.9840612,0.0072118305,0.0005535037,0.0001605671,0.007904654,0.00010825317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003300793,0.00019690301,0.00073603506,0.0002826662,0.00036332375,0.00003151197,0.00013093559,0.000059945134,0.00011892621],"category_scores_gemma":[0.0004603586,0.00013900496,0.0003681253,0.00054168154,0.000084886444,0.00017132069,0.000028384475,0.00027435424,7.1104176e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05581086,0.0027441166,0.45313758,0.003985216,0.0040052976,0.000018740186,0.0011288121,0.3828529,0.02852122,0.0013395735,0.049406514,0.017049173],"study_design_scores_gemma":[0.074652985,0.0058725453,0.24819118,0.006548349,0.0018965992,0.00035739713,0.0011192563,0.46808234,0.16245417,0.0049361074,0.025093455,0.00079560705],"about_ca_topic_score_codex":0.00047431217,"about_ca_topic_score_gemma":0.00013722354,"teacher_disagreement_score":0.20494638,"about_ca_system_score_codex":0.0007832757,"about_ca_system_score_gemma":0.0014116176,"threshold_uncertainty_score":0.5668458},"labels":[],"label_agreement":null},{"id":"W2909533581","doi":"10.1016/j.eururo.2019.01.009","title":"Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Concomitant; Pembrolizumab; Radiation therapy; Adverse effect; Oncology; Common Terminology Criteria for Adverse Events; Internal medicine; Tolerability; Cancer; Immunotherapy","score_opus":0.039707263629051734,"score_gpt":0.31667370917701404,"score_spread":0.2769664455479623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909533581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77709955,0.0037401682,0.0004711619,0.14048669,0.009362997,0.020695865,0.00081256055,0.00022191797,0.047109075],"genre_scores_gemma":[0.8529542,0.00023106816,0.00018792735,0.13813484,0.0047901017,0.00019356958,0.00061230507,0.00044088045,0.0024550846],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934053,0.0034326045,0.0011218246,0.000834945,0.00054417556,0.0006611903],"domain_scores_gemma":[0.99711204,0.0010629843,0.0007068337,0.0009107045,0.00010989997,0.00009754858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006950473,0.0007098994,0.0029650456,0.00050344714,0.000033578515,0.000024613222,0.0003235195,0.00028033744,0.00072187855],"category_scores_gemma":[0.00015917818,0.00051699043,0.0005355025,0.00018417058,0.00049346243,0.00006566199,0.000052001837,0.0015234948,0.00010235087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9642394,0.00058797095,0.00005866185,0.00020834112,0.002629426,0.0094280215,0.00032854162,0.000003629252,0.00022484334,0.000012671521,0.02202243,0.00025606985],"study_design_scores_gemma":[0.87684536,0.019921945,0.00005051715,0.00005289863,0.0031514254,0.0004155323,0.0000074079935,0.00007666104,0.0000750019,0.0000062410327,0.09904454,0.00035248615],"about_ca_topic_score_codex":0.00020628859,"about_ca_topic_score_gemma":0.00000948486,"teacher_disagreement_score":0.08739405,"about_ca_system_score_codex":0.00021022839,"about_ca_system_score_gemma":0.00082135457,"threshold_uncertainty_score":0.99972814},"labels":[],"label_agreement":null},{"id":"W2911573386","doi":"10.5489/cuaj.5902","title":"Canadian Urological Association guideline: Muscle-invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université Laval; University of Calgary; Princess Margaret Cancer Centre; McMaster University; Dalhousie University; University Health Network; University of Toronto; University of British Columbia","funders":"","keywords":"Bladder cancer; Guideline; Medicine; Disease; Cancer; Internal medicine; Presentation (obstetrics); Cystectomy; Oncology; Pathology; Surgery","score_opus":0.01327034549096992,"score_gpt":0.2583752170884485,"score_spread":0.2451048715974786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911573386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78556645,0.0008973943,0.000015785126,0.18407708,0.002410273,0.0008854909,0.0004385376,0.00008764949,0.025621336],"genre_scores_gemma":[0.9430822,0.00034780768,0.00014507957,0.046384014,0.0014747126,0.00003894282,0.00011010299,0.000037839625,0.008379261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638313,0.00027052552,0.0006961133,0.00047175813,0.0008149863,0.0013634625],"domain_scores_gemma":[0.99582016,0.00024435486,0.0004886051,0.00022437352,0.00092838274,0.0022941264],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00096780574,0.00033232433,0.0005823378,0.00037560627,0.00041532866,0.00016860472,0.00023695848,0.000864958,0.015497787],"category_scores_gemma":[0.0013156788,0.00027338404,0.00033140788,0.0004112351,0.000022592827,0.00018847293,0.000021096794,0.0011772015,0.0011130731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000043019078,0.000045116863,0.880797,0.00000392947,0.0004230505,0.00013362928,0.00009985247,0.000088836496,0.00012322387,0.00006946739,0.115896635,0.0022762078],"study_design_scores_gemma":[0.0018307416,0.00042273707,0.6423204,0.0000152514085,0.00025304395,0.00008351242,0.00007157451,0.000089691486,0.000026314101,0.00043965573,0.35419622,0.00025083852],"about_ca_topic_score_codex":0.21521382,"about_ca_topic_score_gemma":0.22606377,"teacher_disagreement_score":0.23847662,"about_ca_system_score_codex":0.013177204,"about_ca_system_score_gemma":0.0058821384,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W2912011158","doi":"10.1158/2326-6074.cricimteatiaacr18-a008","title":"Abstract A008: Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Cystectomy; Medicine; Gemcitabine; Bladder cancer; Nivolumab; Oncology; Internal medicine; Cisplatin; Neoadjuvant therapy; Chemotherapy; Urology; Lymph node; Cancer; Immunotherapy; Breast cancer","score_opus":0.05267920487446963,"score_gpt":0.3912411751698508,"score_spread":0.33856197029538115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912011158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712194,0.021163303,6.072431e-7,0.0023641994,0.0004606029,0.0023598406,0.00006303941,0.00004575133,0.0023232645],"genre_scores_gemma":[0.986802,0.00899084,0.00002088408,0.00023982767,0.00016667291,0.0008737616,0.000021703263,0.00006363138,0.0028207118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969321,0.0002706633,0.00044491317,0.00083758566,0.0005406364,0.00097410363],"domain_scores_gemma":[0.9984736,0.000240097,0.00008479176,0.0006917288,0.00034229583,0.00016752262],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007309229,0.00030318942,0.0006892552,0.0005098828,0.00015755133,0.000041391246,0.00026920062,0.00023022552,0.003760544],"category_scores_gemma":[0.00008304006,0.00026164838,0.000069875045,0.00063813623,0.00037013795,0.00017349454,0.00025940978,0.001188143,0.00032233863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019728767,0.0010632885,0.84165436,0.00018726832,0.0010215557,0.00049482397,0.003066648,0.000018086466,0.037876785,0.00004383184,0.0015013354,0.11109914],"study_design_scores_gemma":[0.012011391,0.0015872604,0.9775331,0.0002882577,0.00007930395,0.000025371623,0.0026927658,0.000025882773,0.0024984966,0.000110548615,0.0028982675,0.00024933237],"about_ca_topic_score_codex":0.0128794685,"about_ca_topic_score_gemma":0.0052584982,"teacher_disagreement_score":0.13587876,"about_ca_system_score_codex":0.00059626746,"about_ca_system_score_gemma":0.0010512838,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W2912079315","doi":"10.1016/j.urolonc.2019.01.003","title":"Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1","year":2019,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Translational research; Bladder cancer; Cancer; Cancer research; Basic research; Urothelial cancer; Organoid; Ex vivo; Medicine; Computational biology; Oncology; Bioinformatics; Biology; Neuroscience; In vivo; Computer science; Pathology; Internal medicine; Library science; Biotechnology","score_opus":0.07443235410740094,"score_gpt":0.39945151020432523,"score_spread":0.3250191560969243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912079315","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01355281,0.009559922,0.0000014504251,0.014950469,0.9495687,0.0012668472,0.0005828447,0.00010144149,0.0104155475],"genre_scores_gemma":[0.0004256316,0.0140696755,0.001631531,0.0013958131,0.96593255,0.0013880773,0.0008374513,0.000113242946,0.014206034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949977,0.000752004,0.00074587634,0.0011831973,0.0012691548,0.0010520975],"domain_scores_gemma":[0.993603,0.0043648174,0.00033952744,0.0007829216,0.0005390005,0.00037076746],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022270258,0.000619099,0.0011606453,0.0004727071,0.000602248,0.00014370431,0.00048589858,0.0023775229,0.00027273817],"category_scores_gemma":[0.0015688518,0.0004391814,0.00015636146,0.00095742464,0.0017586198,0.00023900307,0.00027538385,0.0046068933,0.000120267614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005534725,0.00019348788,0.014816171,0.00013933053,0.0002184383,0.00016404258,0.0008101217,0.00002523183,0.00004422811,0.00030692498,0.9789012,0.003827351],"study_design_scores_gemma":[0.0021019261,0.0031608008,0.00019923194,0.00058863417,0.00057758414,0.000053130683,0.00047522277,0.00002914218,0.00003430948,0.0015251596,0.9908749,0.0003799893],"about_ca_topic_score_codex":0.0020480542,"about_ca_topic_score_gemma":0.00095597276,"teacher_disagreement_score":0.016363876,"about_ca_system_score_codex":0.0011491375,"about_ca_system_score_gemma":0.0063559003,"threshold_uncertainty_score":0.999806},"labels":[],"label_agreement":null},{"id":"W2912754254","doi":"10.1016/j.clgc.2019.01.009","title":"Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Brigham Research Institute","keywords":"Medicine; Bladder cancer; Cancer therapy; Cancer; Oncology; Internal medicine","score_opus":0.1357726139639858,"score_gpt":0.4188765261547862,"score_spread":0.28310391219080044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912754254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732086,0.0040729265,0.000033256005,0.0012614714,0.0012288007,0.0041180123,0.0011504932,0.00013045243,0.014795969],"genre_scores_gemma":[0.9720963,0.008911753,0.00033426992,0.0047075227,0.0017592584,0.002417207,0.00022259407,0.00018542522,0.00936565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680626,0.00019212403,0.0008122213,0.0011007481,0.00041457693,0.0006740634],"domain_scores_gemma":[0.9962947,0.0016472262,0.00035781815,0.00055938377,0.0007085657,0.000432346],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026345713,0.00062909554,0.0013447496,0.00011554646,0.00016288152,0.000039258757,0.00020869548,0.00035046853,0.0018975531],"category_scores_gemma":[0.00009792023,0.00040209194,0.00048572032,0.0003634316,0.00034546855,0.00020289776,0.00006019126,0.00048458134,0.00013638427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067413665,0.002466597,0.87384325,0.00028545954,0.0055397777,0.00071921985,0.00063617574,0.000018223187,0.0013170001,0.00001872451,0.018110175,0.029631717],"study_design_scores_gemma":[0.08058147,0.035913285,0.8180184,0.0016051573,0.0014463501,0.000054344953,0.002319913,0.00008095038,0.015683385,0.00013266059,0.042499892,0.0016642273],"about_ca_topic_score_codex":0.0009683593,"about_ca_topic_score_gemma":0.00022901534,"teacher_disagreement_score":0.055824902,"about_ca_system_score_codex":0.00021625725,"about_ca_system_score_gemma":0.0031160712,"threshold_uncertainty_score":0.9998431},"labels":[],"label_agreement":null},{"id":"W2913091944","doi":"10.1016/j.ejso.2019.01.218","title":"Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy","year":2019,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Urothelial carcinoma; Urology; Perioperative; Oncology; Internal medicine; Overall survival; Bladder cancer; Surgery; Cancer","score_opus":0.010558569084001553,"score_gpt":0.23631617370537694,"score_spread":0.2257576046213754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913091944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622905,0.0002392604,0.000023003395,0.00023598611,0.000093860464,0.00090150867,0.000017196644,0.0000044708713,0.002255645],"genre_scores_gemma":[0.99923235,0.000047629095,0.00021071233,0.00020436235,0.000050050927,0.0000061191545,0.0000027581607,0.000045935896,0.00020006421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978186,0.00078092463,0.00060388504,0.00022339652,0.00036820988,0.000204988],"domain_scores_gemma":[0.99882793,0.00015947223,0.00036906084,0.0001928321,0.0002877471,0.00016292877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003267105,0.00023358283,0.0008566513,0.00010485778,0.000024283985,0.000014070081,0.0001122043,0.000043005144,0.0000881653],"category_scores_gemma":[0.000012660598,0.0001123008,0.000096913216,0.00019148662,0.0002992706,0.00015102664,0.000029972669,0.0003632328,0.00000469243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044603854,0.0006683798,0.9487606,0.00006004425,0.00035813724,0.0025394864,0.0008038046,0.000024390865,0.00032616657,0.0000026966898,0.0000124191765,0.0018400203],"study_design_scores_gemma":[0.0720128,0.016612053,0.9067909,0.0006460181,0.00014191322,0.0009437398,0.00024801903,0.000012160222,0.00024718393,2.7895737e-7,0.0022074126,0.00013753583],"about_ca_topic_score_codex":0.00002370118,"about_ca_topic_score_gemma":0.000005349488,"teacher_disagreement_score":0.041969713,"about_ca_system_score_codex":0.0001245937,"about_ca_system_score_gemma":0.00050659286,"threshold_uncertainty_score":0.45794934},"labels":[],"label_agreement":null},{"id":"W2913753481","doi":"10.1097/md.0000000000014573","title":"Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization","year":2019,"lang":"en","type":"article","venue":"Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; Sichuan University; China Postdoctoral Science Foundation","keywords":"Medicine; Bladder cancer; Fluorescence in situ hybridization; In situ; In situ hybridization; Carcinoma in situ; Cancer; Cancer detection; Pathology; Internal medicine","score_opus":0.021328347323838214,"score_gpt":0.30437262980088714,"score_spread":0.28304428247704894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913753481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421686,0.0008985457,0.00011194048,0.00083700713,0.0003490592,0.00054481585,0.00000893165,0.000014716431,0.0030181196],"genre_scores_gemma":[0.9984163,0.00042500076,0.00020851441,0.00040812357,0.00019445393,0.000013735836,0.000022602986,0.000021363228,0.0002899166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989138,0.000029281753,0.00029854788,0.00025192788,0.00030408552,0.00020235716],"domain_scores_gemma":[0.99935526,0.0000608779,0.000110137444,0.00026118176,0.00013581818,0.000076719676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014778758,0.00013807607,0.00043224206,0.00014503498,0.000015787566,0.0000019371864,0.00006831785,0.000053352844,0.00060451374],"category_scores_gemma":[0.00008263142,0.00010600359,0.00003405274,0.00040420165,0.0000850727,0.00006394538,0.00002235073,0.00010636795,0.000017345536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000128044,0.00008262746,0.5512104,0.00018767653,0.000044493983,0.00002518676,0.00070271816,0.000081475744,0.44349584,0.000006158544,0.0003658476,0.0036695378],"study_design_scores_gemma":[0.0057494272,0.0005306577,0.9275755,0.0012364866,0.00007876639,0.000014409192,0.000273144,0.0008434975,0.06320762,0.000024406545,0.0003283893,0.00013764852],"about_ca_topic_score_codex":0.002565044,"about_ca_topic_score_gemma":0.00047287086,"teacher_disagreement_score":0.3802882,"about_ca_system_score_codex":0.00013260003,"about_ca_system_score_gemma":0.00024430192,"threshold_uncertainty_score":0.66190016},"labels":[],"label_agreement":null},{"id":"W2913857335","doi":"10.1016/j.eururo.2019.01.011","title":"Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"National Cancer Institute; Bladder Cancer Advocacy Network; Burroughs Wellcome Fund","keywords":"Medicine; Bladder cancer; Cystectomy; Stromal cell; Interquartile range; Oncology; Hazard ratio; Cohort; Internal medicine; Urology; Cancer; Confidence interval","score_opus":0.027204802501490773,"score_gpt":0.32716684181275496,"score_spread":0.2999620393112642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913857335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389696,0.00050990126,0.000068940106,0.0002996091,0.0002779349,0.0008809165,0.00004713225,0.000037057933,0.0039815474],"genre_scores_gemma":[0.9988251,0.0001058248,0.0000607073,0.00056069583,0.00009977938,0.000026901942,0.000031486084,0.00004939243,0.00024014844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881554,0.0001407147,0.0003162979,0.00033179938,0.00012774643,0.00026790737],"domain_scores_gemma":[0.999215,0.00020222804,0.0001492357,0.0002986549,0.000056805748,0.00007808667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020941184,0.0002130616,0.00045907625,0.00008739938,0.0000525332,0.000011336802,0.00007652786,0.00006130428,0.00014978102],"category_scores_gemma":[0.00006810307,0.00015683085,0.00029772992,0.0000661546,0.0000467835,0.00007105835,0.000027416065,0.00013294838,0.000014788763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015960478,0.0002940748,0.93193465,0.00003131396,0.0016309432,0.0000182419,0.0007431349,0.00009974658,0.052668676,0.00011663324,0.000081597675,0.010784917],"study_design_scores_gemma":[0.007833792,0.004997985,0.9842735,0.000017116827,0.00019421714,0.000003945908,0.000032896536,0.000034306307,0.0022840279,0.000038903174,0.00016662008,0.00012269845],"about_ca_topic_score_codex":0.00025659965,"about_ca_topic_score_gemma":0.000016328824,"teacher_disagreement_score":0.052338816,"about_ca_system_score_codex":0.000048328224,"about_ca_system_score_gemma":0.00013731077,"threshold_uncertainty_score":0.63953763},"labels":[],"label_agreement":null},{"id":"W2913908440","doi":"10.1016/b978-0-12-809939-1.00032-1","title":"Microbiome","year":2017,"lang":"en","type":"book-chapter","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computer science","score_opus":0.038567343996304626,"score_gpt":0.31177386915045674,"score_spread":0.2732065251541521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913908440","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043579486,0.01614544,0.0000062043728,0.0013554636,0.0011685822,0.0006872474,0.00056542555,0.00011213813,0.9799159],"genre_scores_gemma":[0.0021772936,0.00424137,0.00010674171,0.0017504802,0.0019218142,0.00009062007,0.00014687348,0.00019065748,0.98937416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846244,0.000004359519,0.0002742604,0.0005938676,0.0003186223,0.0003464317],"domain_scores_gemma":[0.99835956,0.0000112610205,0.00024035454,0.0010216074,0.00013874841,0.0002284773],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000039585506,0.00050638575,0.00071970414,0.00013896763,0.00016010557,0.00005220998,0.00021431582,0.00047268986,0.015169506],"category_scores_gemma":[0.000005989434,0.00043189494,0.000375995,0.000009256581,0.00019673322,0.000060822884,0.00008170088,0.00040307117,0.0013658901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084102736,0.00020352514,0.00085200055,0.00082714466,0.007088632,0.0012793879,0.00037434278,6.7118486e-7,0.0021083564,0.007846304,0.7870744,0.19150423],"study_design_scores_gemma":[0.001860144,0.00016635972,0.0006780207,0.00090668385,0.001191626,0.00009344774,0.0000021833637,6.1202155e-7,0.00066749897,0.0015677707,0.99243873,0.00042689324],"about_ca_topic_score_codex":0.00026023723,"about_ca_topic_score_gemma":0.00014688831,"teacher_disagreement_score":0.20536438,"about_ca_system_score_codex":0.000305096,"about_ca_system_score_gemma":0.0007469478,"threshold_uncertainty_score":0.99981326},"labels":[],"label_agreement":null},{"id":"W2913964724","doi":"10.1111/iju.13916","title":"Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population‐based analysis","year":2019,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Odds ratio; Perioperative; Logistic regression; Nephrectomy; Surgery; Poisson regression; Urology; Internal medicine; Population; Kidney","score_opus":0.03998112852778259,"score_gpt":0.3959715748502185,"score_spread":0.3559904463224359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913964724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953164,0.00016925341,0.00016469863,0.0034093077,0.00015814861,0.00016983897,0.000033271615,0.00000226298,0.00057685626],"genre_scores_gemma":[0.9977213,0.000012403425,0.0013608336,0.000683514,0.00006933799,0.0000022868671,0.00002871464,0.0000070410106,0.00011457902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990014,0.00007278603,0.00046662037,0.00011601445,0.0002663942,0.00007678531],"domain_scores_gemma":[0.99877185,0.00022821916,0.0004236004,0.00008788175,0.0004245208,0.00006395794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012507712,0.00009426185,0.00066123623,0.0003555902,0.000014636816,0.000024021147,0.00022103114,0.000058986545,0.0003910667],"category_scores_gemma":[0.00007855083,0.00006992681,0.00015480357,0.00011104926,0.00003646343,0.00012080633,0.000063237414,0.00012477885,0.000003979578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008820885,0.000116866926,0.99299353,0.000006633012,0.003721754,0.00001847876,0.0004370841,0.00012958611,0.0007264318,0.00006370451,0.000023247718,0.00088056916],"study_design_scores_gemma":[0.003899041,0.0013684289,0.99209243,0.000019398356,0.0010730106,0.00002469431,0.00009587574,0.00017503001,0.000765834,0.000055901997,0.0003785836,0.000051782466],"about_ca_topic_score_codex":0.00025424536,"about_ca_topic_score_gemma":0.00013439108,"teacher_disagreement_score":0.0030169527,"about_ca_system_score_codex":0.000060473216,"about_ca_system_score_gemma":0.00018698399,"threshold_uncertainty_score":0.4281906},"labels":[],"label_agreement":null},{"id":"W2914015594","doi":"10.1007/s00520-019-4649-z","title":"Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory","year":2019,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ottawa Hospital; University Health Network; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Quality of life (healthcare); Disease; Cancer; Physical therapy; Internal medicine; Nursing","score_opus":0.011432800241447428,"score_gpt":0.317575722428463,"score_spread":0.30614292218701555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914015594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471587,0.0011852825,0.000003686935,0.00011386602,0.00016785495,0.001647724,0.0013949,0.0000065998343,0.00076418923],"genre_scores_gemma":[0.9986322,0.00040368552,0.000020205202,0.00042750643,0.00002394215,0.0003251569,0.00012581496,0.000020873826,0.000020627143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982877,0.00007665881,0.0006377508,0.00026055906,0.00043612407,0.00030122956],"domain_scores_gemma":[0.9982152,0.00010454425,0.00042298806,0.0002704439,0.0008800299,0.0001067922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001615104,0.0002358695,0.00060544355,0.0001411112,0.000044988974,0.000012937722,0.00008655267,0.00010770014,0.00020257803],"category_scores_gemma":[0.00004274443,0.0001614017,0.000056455272,0.00038652556,0.0002604284,0.00037826571,0.00007126582,0.00021801236,5.934429e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048465017,0.00009248155,0.9224841,0.0009568186,0.00013365645,0.0000014711683,0.066136725,0.000054198925,0.00009314614,0.000007315707,0.00003074135,0.009524679],"study_design_scores_gemma":[0.0066308514,0.0007109258,0.89331585,0.00035467665,0.000077332974,2.1168326e-7,0.09752798,0.0000033109618,0.0010653285,0.000003762996,0.0001360876,0.00017369766],"about_ca_topic_score_codex":0.010163763,"about_ca_topic_score_gemma":0.012956013,"teacher_disagreement_score":0.031391256,"about_ca_system_score_codex":0.00042102055,"about_ca_system_score_gemma":0.001531849,"threshold_uncertainty_score":0.99642766},"labels":[],"label_agreement":null},{"id":"W2914138346","doi":"10.1097/ju.0000000000000136","title":"Predictive Biomarkers for Checkpoint Blockade in Urothelial Cancer: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Urothelial cancer; Blockade; Oncology; Cancer; Bladder cancer; Internal medicine","score_opus":0.05212596417660361,"score_gpt":0.3722109062352066,"score_spread":0.320084942058603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914138346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035296753,0.99086,0.00006023464,0.0012607833,0.0006576137,0.0068838336,0.00011618949,0.000006893898,0.00015095137],"genre_scores_gemma":[0.000035461064,0.9979045,0.000028164346,0.0008430786,0.00042594387,0.00043807903,0.000008217958,0.00006409981,0.00025244898],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99671566,0.00073121063,0.001738706,0.00019566358,0.00029061717,0.00032814327],"domain_scores_gemma":[0.9967248,0.00071902986,0.0018228261,0.00043806082,0.0001896256,0.00010567401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001638941,0.00039285916,0.0048328335,0.0002726895,0.000031360414,0.000005527706,0.00040495733,0.00026614426,0.00007343391],"category_scores_gemma":[0.00039489171,0.00019270291,0.0010192366,0.00025910654,0.00008883242,0.00003496118,0.000042914224,0.00063458417,0.00002234754],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008376305,0.00013102347,0.0000055507867,0.9715613,0.0038757198,0.00005393446,0.000116155745,0.0000016958834,0.0000020680973,0.000004111042,0.0009685374,0.022442272],"study_design_scores_gemma":[0.002931683,0.0030917933,0.000005353055,0.6407048,0.076018855,0.004240756,0.000022257638,0.00001245254,0.000002581684,0.000051154584,0.27271476,0.00020352573],"about_ca_topic_score_codex":0.000037079957,"about_ca_topic_score_gemma":0.000010806939,"teacher_disagreement_score":0.33085647,"about_ca_system_score_codex":0.00036717433,"about_ca_system_score_gemma":0.0014780882,"threshold_uncertainty_score":0.78581965},"labels":[],"label_agreement":null},{"id":"W2914171857","doi":"10.1016/j.critrevonc.2019.01.008","title":"Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Oncology; Urinary bladder; Schistosomiasis; Carcinoma; Schistosoma; Urinary system; Internal medicine; Basal cell; Cancer research; Urology; Immunology; Cancer; Schistosoma mansoni","score_opus":0.057432181218545375,"score_gpt":0.395503240123607,"score_spread":0.3380710589050616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914171857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004344019,0.96854836,0.0000020986247,0.0013241953,0.0011198681,0.008233274,0.000043496155,0.000019025907,0.020666227],"genre_scores_gemma":[0.0019396708,0.9941477,0.00022492395,0.0016227581,0.00005493427,0.001488752,0.0000625079,0.000112237045,0.00034650203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910744,0.0024662677,0.004010443,0.0011825508,0.00032592955,0.00094044383],"domain_scores_gemma":[0.9946907,0.0022517166,0.00091585447,0.0017653727,0.00011752079,0.0002588397],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014462668,0.0009778172,0.010874972,0.0004868163,0.000053428455,0.000004876435,0.0008434633,0.001584812,0.0006465743],"category_scores_gemma":[0.0026625048,0.00062226696,0.0019182957,0.0014219052,0.00086135784,0.000056713186,0.0003823338,0.001976248,0.0005722651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010688717,0.002958044,0.0012255986,0.44937295,0.00020609988,0.0016483966,0.00010370031,2.1308217e-8,0.000001398987,0.0011110592,0.012276469,0.53098935],"study_design_scores_gemma":[0.0023750914,0.0011153691,0.00016814304,0.1532355,0.0049410397,0.0038076628,0.000016821232,0.0000021617852,0.0000052057794,0.00011520595,0.8337615,0.00045627108],"about_ca_topic_score_codex":0.000058422207,"about_ca_topic_score_gemma":0.000029999432,"teacher_disagreement_score":0.82148504,"about_ca_system_score_codex":0.00107649,"about_ca_system_score_gemma":0.0023515986,"threshold_uncertainty_score":0.99971133},"labels":[],"label_agreement":null},{"id":"W2914367957","doi":"10.1016/j.canep.2019.02.002","title":"Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients","year":2019,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urology; Lymph node; Dissection (medical); Hazard ratio; Bladder cancer; Internal medicine; Surgery; Cancer; Confidence interval","score_opus":0.15064155826127404,"score_gpt":0.3959532753521904,"score_spread":0.24531171709091634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914367957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870227,0.008748827,0.000046035235,0.00070632435,0.0005748425,0.0008657584,0.0015251535,0.000021773292,0.0004886158],"genre_scores_gemma":[0.9982561,0.0002789281,0.000083101535,0.00017071271,0.00018503379,0.00025294023,0.00057568774,0.00003230358,0.00016522294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980006,0.00024569075,0.00078970427,0.0005239008,0.00014108351,0.00029902084],"domain_scores_gemma":[0.9980985,0.0007221664,0.00053017534,0.0003112419,0.00016901454,0.00016893285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002950588,0.0002465693,0.0012043504,0.0001265934,0.00007802995,0.0000024703727,0.00008025905,0.00024585318,0.0001452364],"category_scores_gemma":[0.000098679244,0.0002137323,0.00014153059,0.00014179428,0.0003483457,0.000070850176,0.000058752867,0.00012581202,0.0000018002482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026355316,0.00025155483,0.99202067,0.00022635762,0.0007648242,8.1538036e-7,0.00019874661,0.000007817818,0.0005344992,0.000052193773,0.0016167156,0.0016902784],"study_design_scores_gemma":[0.013583239,0.0010513477,0.9821105,0.000113518705,0.0004548003,0.0000028040413,0.00004278729,0.00022595687,0.0004721303,0.000046424433,0.0017331776,0.00016333013],"about_ca_topic_score_codex":0.0027466242,"about_ca_topic_score_gemma":0.00008367403,"teacher_disagreement_score":0.011233399,"about_ca_system_score_codex":0.0003804611,"about_ca_system_score_gemma":0.00016928428,"threshold_uncertainty_score":0.871575},"labels":[],"label_agreement":null},{"id":"W2914624304","doi":"10.5489/cuaj.5809","title":"Quality and cost assessment of Canadian Urological Association microscopic hematuria guidelines in clinical practice: Turning urine into gold","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Gold standard (test); Microscopic hematuria; Urine; Medicine; Quality (philosophy); Clinical Practice; Gross hematuria; Urology; Family medicine; Surgery; Internal medicine","score_opus":0.04994360422539265,"score_gpt":0.40299081536286324,"score_spread":0.3530472111374706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914624304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9142555,0.00052653986,0.00001258857,0.07727675,0.00067568436,0.0005980701,0.0000619054,0.000014695949,0.006578237],"genre_scores_gemma":[0.98227334,0.0004888544,0.0026475014,0.013328558,0.00041836963,0.00001444845,0.000041644165,0.000015937916,0.0007713432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626833,0.00075976975,0.0013801295,0.00036874204,0.000582923,0.0006400797],"domain_scores_gemma":[0.9960988,0.00086435134,0.00095987413,0.00016725749,0.000845287,0.001064435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004765093,0.00021503771,0.0007555913,0.00048205146,0.00012581747,0.000087926586,0.00013321024,0.00066189846,0.00045584372],"category_scores_gemma":[0.0077421963,0.00017755924,0.00016624964,0.0004467559,0.000037180842,0.00018931058,0.000028195598,0.0012666037,0.000026369671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000883164,0.000095380085,0.9913088,0.000014082281,0.00018071396,0.00005926458,0.00007583824,0.000020848467,0.00015912796,0.0002011001,0.005225637,0.0025708585],"study_design_scores_gemma":[0.0028769842,0.00055063306,0.9058235,0.000034556786,0.00010596522,0.00007109149,0.000091230504,0.000114843,0.000009141717,0.00032469208,0.08985318,0.00014414439],"about_ca_topic_score_codex":0.1416744,"about_ca_topic_score_gemma":0.090712376,"teacher_disagreement_score":0.085485294,"about_ca_system_score_codex":0.0034899588,"about_ca_system_score_gemma":0.0023328094,"threshold_uncertainty_score":0.92686915},"labels":[],"label_agreement":null},{"id":"W2914903365","doi":"10.5489/cuaj.5595","title":"Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Urothelial carcinoma; Medicine; Carcinoma; Oncology; Pathology; Internal medicine; Cancer; Bladder cancer","score_opus":0.022270751140996376,"score_gpt":0.25191041707461564,"score_spread":0.22963966593361926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914903365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821785,0.0003555221,0.000016064607,0.013141875,0.00018317821,0.00013444107,0.00014529678,0.000018493949,0.003826605],"genre_scores_gemma":[0.9923875,0.00003198819,0.0000739465,0.0048436658,0.0020461774,0.000005503442,0.000008107533,0.000014418332,0.0005887115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873453,0.00013614011,0.00021753786,0.00019190882,0.0002303517,0.0004895365],"domain_scores_gemma":[0.99862295,0.000094175,0.00020749487,0.000077908255,0.00015884457,0.00083863514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000283922,0.00015350743,0.0003004924,0.00010821079,0.00034639932,0.00009530597,0.00009025828,0.00023916327,0.0015438972],"category_scores_gemma":[0.00022641913,0.00011241859,0.000093655624,0.000090846326,0.00008165478,0.00008201017,0.000010475076,0.00053365884,0.000041724736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039941904,0.000026263315,0.9946875,0.0000031405839,0.00007470325,0.00018147746,0.00017047598,3.9388155e-8,0.000028795437,0.00001633422,0.0015580244,0.0032133004],"study_design_scores_gemma":[0.0013757162,0.0006232972,0.9865836,0.000014573801,0.00014379383,0.00043735967,0.00013554403,0.0000056296312,0.00005801018,0.00079225056,0.009715758,0.000114469876],"about_ca_topic_score_codex":0.0012021502,"about_ca_topic_score_gemma":0.0010365266,"teacher_disagreement_score":0.010208958,"about_ca_system_score_codex":0.0006187246,"about_ca_system_score_gemma":0.00068823335,"threshold_uncertainty_score":0.99936885},"labels":[],"label_agreement":null},{"id":"W2914922236","doi":"10.1016/j.urology.2009.11.037","title":"Reply","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cytology; Population; Feeling; Gynecology; Pathology","score_opus":0.012044468788864369,"score_gpt":0.28125054245806275,"score_spread":0.26920607366919835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914922236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8229429,0.00011235735,0.000100273945,0.014537234,0.0009592533,0.00016149408,0.000003456061,0.00009808091,0.16108492],"genre_scores_gemma":[0.983873,0.0000043545824,0.00020466984,0.013244443,0.00024162066,0.00000930122,0.000004135287,0.0000072502407,0.002411229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997019,0.000005377705,0.00005127048,0.00010252744,0.000037857404,0.00010106093],"domain_scores_gemma":[0.9997311,0.0000121948715,0.000010223021,0.00017667495,0.000016491276,0.0000532635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025696032,0.00004009151,0.00007780599,0.000022950171,0.000017117234,0.0000015667326,0.000024908522,0.000047894657,0.0013193269],"category_scores_gemma":[0.000026640935,0.00003100248,0.000025712741,0.00002849706,0.000038400784,0.000009600376,0.000008817398,0.00013253657,0.00034047395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002341289,0.0010954227,0.48227835,0.000046303332,0.00047014546,0.00112319,0.0009049308,0.0000024820245,0.22197227,0.01866208,0.1325588,0.13854477],"study_design_scores_gemma":[0.0015374846,0.00068940636,0.064558536,5.9829597e-7,0.00007614755,0.00045913883,0.0000038598314,0.000023859488,0.0038800118,0.0011616579,0.92755944,0.00004989155],"about_ca_topic_score_codex":0.00004182816,"about_ca_topic_score_gemma":0.00001823761,"teacher_disagreement_score":0.7950006,"about_ca_system_score_codex":0.0000031780976,"about_ca_system_score_gemma":0.00003549333,"threshold_uncertainty_score":0.9995936},"labels":[],"label_agreement":null},{"id":"W2914983882","doi":"10.1097/ju.0000000000000025","title":"Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Life expectancy; Years of potential life lost; Cancer; Incidence (geometry); Disease burden; Mortality rate; Burden of disease; Demography; Standardized mortality ratio; Disease; Gerontology; Internal medicine; Population; Environmental health","score_opus":0.026585596710686946,"score_gpt":0.31668483814873555,"score_spread":0.2900992414380486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914983882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589321,0.0045978557,0.000013210012,0.034134183,0.00036122047,0.00038375313,0.00014840442,0.0000032603655,0.0014260325],"genre_scores_gemma":[0.99509925,0.000778842,0.00003803824,0.002788097,0.00065894256,0.000003187809,0.000002788978,0.0000076205047,0.00062326196],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988291,0.00016802136,0.00035944625,0.00011383462,0.00039758786,0.00013197702],"domain_scores_gemma":[0.99881446,0.00038066265,0.00026548168,0.00019412472,0.00026913921,0.00007609998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005210111,0.00010140309,0.00027505783,0.000038211623,0.00004584606,0.0000050478397,0.00019806037,0.000050322873,0.00022981537],"category_scores_gemma":[0.00008501448,0.00004805855,0.00005488849,0.00009939697,0.00009044707,0.000039536983,0.000056090616,0.00015364258,0.000028371593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056817714,0.0013957799,0.16419844,0.000018518826,0.006246886,0.0000815184,0.015981825,0.002238823,0.0048376154,0.00026073566,0.7336454,0.014276742],"study_design_scores_gemma":[0.020491984,0.008660364,0.8533908,0.00011175566,0.00147187,0.00058324594,0.0019929274,0.00007730756,0.00011139216,0.002832511,0.11010991,0.0001659359],"about_ca_topic_score_codex":0.0030598629,"about_ca_topic_score_gemma":0.00016293988,"teacher_disagreement_score":0.68919235,"about_ca_system_score_codex":0.000055560187,"about_ca_system_score_gemma":0.00040238415,"threshold_uncertainty_score":0.4625618},"labels":[],"label_agreement":null},{"id":"W2917562662","doi":"10.3332/ecancer.2019.905","title":"The use of intravesical BCG in urothelial carcinoma of the bladder","year":2019,"lang":"en","type":"review","venue":"ecancermedicalscience","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Carcinoma in situ; Disease; Immunotherapy; Malignancy; Urothelial carcinoma; Urology; Oncology; Internal medicine; Cancer","score_opus":0.12671542184209353,"score_gpt":0.3628818868881165,"score_spread":0.23616646504602298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917562662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006848328,0.9947979,0.000015681595,0.00038931417,0.0012290458,0.0019043171,0.000109096465,0.000008744104,0.00086108263],"genre_scores_gemma":[0.004584494,0.99340665,0.000056682587,0.00021152399,0.00023033179,0.00011019539,0.0000041030016,0.000032246327,0.0013637834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967923,0.00022308042,0.00097533345,0.00047424954,0.0010805933,0.00045444275],"domain_scores_gemma":[0.99749,0.0007122939,0.0005039676,0.0010514639,0.00009499279,0.00014727129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004664365,0.00032225993,0.0014873823,0.000110611974,0.00008584176,0.00001883772,0.00085562124,0.00024874762,0.00014507075],"category_scores_gemma":[0.00063424255,0.00014272371,0.0005008832,0.0009782608,0.0018611155,0.00007007709,0.00022362133,0.00061734015,0.000019606076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051948486,0.00016228565,0.0010809271,0.0034493385,0.000092139555,0.000012276924,0.0001760524,0.0000014282522,0.0000072504236,0.00028263693,0.0016582168,0.9930255],"study_design_scores_gemma":[0.0007566852,0.00024817823,0.0046579936,0.008235028,0.00057655777,0.000056972916,0.000016034237,0.000048969276,0.0000529357,0.00004000486,0.9851523,0.00015831107],"about_ca_topic_score_codex":0.00038454283,"about_ca_topic_score_gemma":0.00007671247,"teacher_disagreement_score":0.9928672,"about_ca_system_score_codex":0.00024334386,"about_ca_system_score_gemma":0.0044011166,"threshold_uncertainty_score":0.78073925},"labels":[],"label_agreement":null},{"id":"W2920739957","doi":"10.1016/j.urolonc.2019.02.004","title":"Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Meta-analysis; Oncology; Carcinoma; Internal medicine; Cancer; Bladder cancer","score_opus":0.16526443577367167,"score_gpt":0.41447866170771147,"score_spread":0.2492142259340398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920739957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043522395,0.99156946,0.000008774303,0.0009993692,0.00039986134,0.0031356541,0.0030342126,0.000019868383,0.00039759735],"genre_scores_gemma":[0.00017685215,0.99157494,0.0027686579,0.000470961,0.00020887313,0.0016596321,0.0012475455,0.000037608548,0.0018549047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977423,0.00032437057,0.0007226498,0.00067539944,0.00019871713,0.00033655085],"domain_scores_gemma":[0.9978339,0.0006916169,0.0005572023,0.00061786047,0.00010935398,0.00019004228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019948705,0.0005992676,0.0041601732,0.00042866214,0.00017517626,0.000021362335,0.00019870109,0.00044243754,0.000101929196],"category_scores_gemma":[0.00007046724,0.00029438958,0.0038119203,0.0008355658,0.00039687206,0.000052917756,0.000048492624,0.0004909516,0.0000060961193],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029670878,0.003229317,0.014108566,0.0105801,0.2778172,0.00012754483,0.0014816079,0.000025938489,0.0000031773923,0.003989093,0.004768208,0.68357253],"study_design_scores_gemma":[0.00046880083,0.0014412262,0.000049868406,0.00017021886,0.4133176,0.00010679554,0.0000059098015,0.000013751591,0.000002323009,0.00018851504,0.58411086,0.0001241045],"about_ca_topic_score_codex":0.000046383222,"about_ca_topic_score_gemma":0.000018255803,"teacher_disagreement_score":0.68344843,"about_ca_system_score_codex":0.00029008856,"about_ca_system_score_gemma":0.0016869425,"threshold_uncertainty_score":0.9999508},"labels":[],"label_agreement":null},{"id":"W2921034390","doi":"10.1016/j.urolonc.2019.01.017","title":"Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Cystectomy; Urinary system; Antibiotics; Odds ratio; Antibiotic prophylaxis; Internal medicine; Logistic regression; Perioperative; Bladder cancer; Confidence interval; Urinary diversion; Cohort; Surgery; Urology; Cancer","score_opus":0.022046408063709607,"score_gpt":0.2953727078975592,"score_spread":0.2733262998338496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921034390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953598,0.0016185449,0.000018308623,0.0016782659,0.00007675847,0.0011014033,0.000092341674,0.0000075094977,0.000047115438],"genre_scores_gemma":[0.99465144,0.0019628739,0.0029816704,0.0001461475,0.00002831689,0.00006532353,0.000015791007,0.0000063010116,0.00014215005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991733,0.00012980291,0.00033287186,0.0001922916,0.00006450754,0.00010722976],"domain_scores_gemma":[0.9990293,0.00044374474,0.00025258385,0.00010775206,0.00010677131,0.00005989316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002694136,0.000109138484,0.0003579085,0.00009106434,0.00005512886,0.000006352256,0.000021338346,0.00013279007,0.0000088177285],"category_scores_gemma":[0.00022642812,0.00006852631,0.000040072347,0.00014092054,0.00097463926,0.0001305968,0.000018508097,0.00010683473,2.1853087e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00925787,0.00043605999,0.98124313,0.00049405405,0.00018519569,0.0000117835525,0.0013243745,0.000025803349,0.004382052,0.000999968,0.00006466093,0.0015750324],"study_design_scores_gemma":[0.025479442,0.03196576,0.88929325,0.0003970579,0.0020706372,0.0006988103,0.00033655265,0.002365257,0.019188859,0.0021780229,0.025779832,0.00024649844],"about_ca_topic_score_codex":0.0004508938,"about_ca_topic_score_gemma":0.00003413185,"teacher_disagreement_score":0.09194987,"about_ca_system_score_codex":0.000023603518,"about_ca_system_score_gemma":0.000164066,"threshold_uncertainty_score":0.3591099},"labels":[],"label_agreement":null},{"id":"W2921052390","doi":"10.1016/j.euo.2019.02.004","title":"Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"EMD Serono; MedImmune; Exelixis; Novartis; Merck; Bayer; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Taxane; Liquid biopsy; Carcinoma; Cancer; Confidence interval; Breast cancer","score_opus":0.03538344053251901,"score_gpt":0.33735410156659135,"score_spread":0.30197066103407233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921052390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794558,0.000036991438,0.00001679384,0.0010187739,0.00036211387,0.0012905088,0.000006623146,0.00005079648,0.017761568],"genre_scores_gemma":[0.9954616,0.0000044717194,0.00024412392,0.003400418,0.00014709898,0.000042673106,0.0000105586005,0.000041876596,0.00064720545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975104,0.001035906,0.0005038008,0.00049242895,0.00014660339,0.00031087114],"domain_scores_gemma":[0.9989181,0.0004348722,0.00021171366,0.00026098196,0.000067385554,0.00010693369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080268004,0.00018421818,0.0005894983,0.00011940172,0.000061501756,0.000010282961,0.0000735668,0.00005238581,0.00008877344],"category_scores_gemma":[0.00022702993,0.00014566515,0.00004138911,0.00011928058,0.00006309424,0.000064272484,0.00006028019,0.0004216773,0.00015428718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017228688,0.0015779971,0.9928747,0.000007108312,0.0001526937,0.00095294876,0.0007378396,0.00001753101,0.00047413463,0.000024203042,0.000027260525,0.0014307034],"study_design_scores_gemma":[0.018388238,0.032377474,0.94749117,0.0000065531594,0.00018220009,0.00018409072,0.00025388788,0.000056740977,0.0000055563128,0.000011582092,0.0009263127,0.000116221956],"about_ca_topic_score_codex":0.00009325089,"about_ca_topic_score_gemma":0.00033746293,"teacher_disagreement_score":0.04538357,"about_ca_system_score_codex":0.00019224902,"about_ca_system_score_gemma":0.00022485486,"threshold_uncertainty_score":0.5940052},"labels":[],"label_agreement":null},{"id":"W2921136669","doi":"10.1097/01.ju.0000556958.45525.c0","title":"PD52-02 FGFR3 MUTATIONS AND THEIR RELATION TO FGFR3 EXPRESSION AND CLINICAL OUTCOME IN A LARGE RADICAL CYSTECTOMY COHORT: IMPLICATIONS FOR ANTI-FGFR3 BLADDER CANCER TREATMENT?","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Oncology; Cohort; Outcome (game theory); Urology; Internal medicine; Cancer","score_opus":0.03661886766548811,"score_gpt":0.3792802512268069,"score_spread":0.3426613835613188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921136669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852075,0.0014721389,0.0011698545,0.010654435,0.00019573893,0.0011128518,0.000064353706,0.000009279015,0.00011384856],"genre_scores_gemma":[0.99729,0.00088620797,0.00028784876,0.0010857295,0.00017717999,0.000057624817,0.000010173316,0.00002031221,0.00018490187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987115,0.00019464364,0.00059236155,0.0001894691,0.00008588771,0.00022612569],"domain_scores_gemma":[0.9985813,0.0007117126,0.00024018523,0.00020720117,0.00010040948,0.00015921841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005463472,0.00015172409,0.0004953201,0.00014557112,0.00009925689,0.000009665003,0.0000763246,0.00014487599,0.000076840915],"category_scores_gemma":[0.00012487562,0.00008491416,0.000101769285,0.00011154697,0.000087519475,0.00008280947,0.000031060546,0.00023211072,0.0000058118453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010511695,0.00028872487,0.9901604,0.000012144288,0.0002518563,0.0000039260226,0.00094571424,0.00003666566,0.0034538747,0.00006980603,0.0001940302,0.003531692],"study_design_scores_gemma":[0.008496415,0.0024829048,0.9832909,0.00002930861,0.0005162827,0.00027258604,0.00014247275,0.00020826988,0.00014334332,0.00042028798,0.00391834,0.00007888203],"about_ca_topic_score_codex":0.0000571072,"about_ca_topic_score_gemma":0.00008055598,"teacher_disagreement_score":0.012082522,"about_ca_system_score_codex":0.00007899625,"about_ca_system_score_gemma":0.00014076427,"threshold_uncertainty_score":0.34626988},"labels":[],"label_agreement":null},{"id":"W2921168318","doi":"10.1200/jco.2019.37.7_suppl.411","title":"FGFR3 mutation as a prognostic indicator in patients with urothelial carcinoma: A systematic review and meta-analysis.","year":2019,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Hazard ratio; Fibroblast growth factor receptor 3; Meta-analysis; Oncology; Internal medicine; Urothelial carcinoma; Carcinoma; Mutation; Carcinogenesis; Proportional hazards model; Gastroenterology; Cancer; Confidence interval; Bladder cancer; Fibroblast growth factor; Receptor; Biology; Genetics; Gene","score_opus":0.18605412222159087,"score_gpt":0.4832615048870897,"score_spread":0.29720738266549884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921168318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003173638,0.99372464,0.000005409942,0.00033453997,0.00013033046,0.005260866,0.000038019487,0.000004386966,0.00018444093],"genre_scores_gemma":[0.0042031826,0.9931119,0.00023852877,0.0017988576,0.00012034369,0.00021833132,0.000037436188,0.000045660327,0.00022572237],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9915658,0.0019147209,0.0052334447,0.00040393387,0.00064977235,0.00023228985],"domain_scores_gemma":[0.9901846,0.0020440933,0.006653037,0.000385187,0.00038314392,0.00034993066],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0028748375,0.00043196688,0.023163065,0.00054358714,0.000019073384,0.000013665134,0.00020180029,0.00056896213,0.0002116875],"category_scores_gemma":[0.0028533703,0.0002072878,0.0032083173,0.00056416047,0.000109320885,0.00008569053,0.000042715084,0.0012153292,0.000059930575],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056476105,0.002287506,0.010183745,0.7339948,0.23871525,0.00079468277,0.00004215647,2.2178692e-7,7.3453843e-10,0.000008391356,0.00011527917,0.01329322],"study_design_scores_gemma":[0.004324476,0.011393675,0.005940735,0.021014603,0.9457982,0.0003165637,0.0000044076455,3.3063563e-7,5.5729767e-9,0.0000073840606,0.011036575,0.0001630511],"about_ca_topic_score_codex":0.000021946635,"about_ca_topic_score_gemma":0.000013167397,"teacher_disagreement_score":0.71298015,"about_ca_system_score_codex":0.0002478788,"about_ca_system_score_gemma":0.004087967,"threshold_uncertainty_score":0.9913391},"labels":[],"label_agreement":null},{"id":"W2921333418","doi":"10.1016/j.euf.2019.02.022","title":"Mental Illness and Bladder Cancer Patients: The Time for Assertive Intervention Is Now","year":2019,"lang":"en","type":"letter","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Disease; Internal medicine; Cancer; Mental illness; Mental health; Oncology; Psychiatry","score_opus":0.010488184065284204,"score_gpt":0.2632921058706105,"score_spread":0.25280392180532635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921333418","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027094642,0.0041168155,0.00007608757,0.93461996,0.003099281,0.0047426545,0.0020409618,0.00012623181,0.024083367],"genre_scores_gemma":[0.05971817,0.00024157301,0.000020050033,0.8934695,0.003018211,0.00024843455,0.0009882889,0.00024082063,0.042054947],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982647,0.00028395903,0.00030069955,0.0005765913,0.0001989413,0.00037514302],"domain_scores_gemma":[0.9991308,0.000114450304,0.00021108791,0.0003643895,0.00013443585,0.000044870016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015060678,0.00036602622,0.00043434315,0.000084672894,0.00014537027,0.00003058248,0.00018509706,0.00024899628,0.0009108294],"category_scores_gemma":[0.000024316025,0.0002409182,0.00024226542,0.000056490357,0.0001641313,0.00005623205,0.00012264872,0.0006801666,0.000587983],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043098602,0.00011974427,0.0025234562,0.00007165533,0.00092017767,0.000046481164,0.0005891482,8.828557e-8,0.000017137963,0.0000015289618,0.9842187,0.011060868],"study_design_scores_gemma":[0.004692827,0.0019772898,0.012004894,0.000067669345,0.0011533147,0.000027497623,0.000016001286,0.000017643537,0.0001188902,0.000040941377,0.97962236,0.00026064218],"about_ca_topic_score_codex":0.000057262452,"about_ca_topic_score_gemma":0.000012299492,"teacher_disagreement_score":0.041150454,"about_ca_system_score_codex":0.000087630324,"about_ca_system_score_gemma":0.000047278158,"threshold_uncertainty_score":0.99729437},"labels":[],"label_agreement":null},{"id":"W2921357372","doi":"10.1200/jco.2019.37.15_suppl.tps4590","title":"A phase III, randomized, open label, multicenter, global study of first-line (1L) durvalumab in combination with standard of care (SOC) chemotherapy and durvalumab in combination with tremelimumab and SOC chemotherapy versus SOC chemotherapy alone in patients with unresectable locally advanced or metastatic urothelial cancer (UC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Tremelimumab; Medicine; Oncology; Internal medicine; Carboplatin; Gemcitabine; Cetuximab; Chemotherapy; Cancer; Cisplatin; Ipilimumab; Immunotherapy; Nivolumab","score_opus":0.04679858788516644,"score_gpt":0.42469434791247646,"score_spread":0.37789576002731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921357372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917246,0.00052925915,0.00011422112,0.0010734258,0.0001703575,0.0062474045,0.00005143446,0.0000060771595,0.00008319668],"genre_scores_gemma":[0.99544793,0.0019973519,0.0019591162,0.00033757385,0.0000302563,0.00011843885,0.00001591891,0.000050414455,0.000042967247],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99553007,0.000658948,0.0021645403,0.0004684512,0.0008438616,0.00033411995],"domain_scores_gemma":[0.9957557,0.0009280853,0.0019756565,0.00025602707,0.00090955145,0.00017502699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017524466,0.0003806213,0.003683119,0.0002369084,0.000038984588,0.000023945538,0.00023441516,0.00019522436,0.00009669387],"category_scores_gemma":[0.00023137941,0.00023679712,0.00008807481,0.0005012287,0.00033350443,0.00036409154,0.00004587303,0.00049376965,2.033424e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6865274,0.022351798,0.21363865,0.00015788239,0.0010366231,0.00005607142,0.0026019944,0.00010391032,0.000018583962,0.0000046588502,0.000005691455,0.07349677],"study_design_scores_gemma":[0.75638396,0.1691383,0.07065171,0.0008198601,0.0004329397,0.000009030927,0.0017115499,0.00040619052,0.00015990237,0.00003323924,0.00006608666,0.00018724514],"about_ca_topic_score_codex":0.0019844417,"about_ca_topic_score_gemma":0.022777973,"teacher_disagreement_score":0.1467865,"about_ca_system_score_codex":0.0008370661,"about_ca_system_score_gemma":0.0016546717,"threshold_uncertainty_score":0.99505377},"labels":[],"label_agreement":null},{"id":"W2921510652","doi":"10.1200/jco.2019.37.7_suppl.476","title":"Validated five-factor prognostic model for survival of patients (pts) with metastatic urothelial carcinoma (mUC) receiving different post-platinum PD-L1 inhibitors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Atezolizumab; Medicine; Internal medicine; Proportional hazards model; Oncology; Avelumab; Hazard ratio; Metastatic Urothelial Carcinoma; Cancer; Confidence interval; Immunotherapy; Urothelial carcinoma; Bladder cancer; Nivolumab","score_opus":0.08776305482482193,"score_gpt":0.3905054433023566,"score_spread":0.30274238847753465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921510652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518144,0.000051413863,0.00065811694,0.0006326229,0.0016156276,0.0013007584,0.00024152863,0.000011081255,0.00030740217],"genre_scores_gemma":[0.996084,0.000027854705,0.0025960023,0.0003116203,0.00045370075,0.000027954207,0.000032651424,0.000052498894,0.0004137416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603105,0.00037659364,0.0022697668,0.00030876216,0.00065976253,0.00035405045],"domain_scores_gemma":[0.9932871,0.0027736716,0.0019746528,0.00024660045,0.0013441631,0.0003738268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079759874,0.00028612715,0.0022370266,0.00014560173,0.00003880512,0.000011121168,0.00018189273,0.0002466591,0.00017321663],"category_scores_gemma":[0.0024516063,0.00017377388,0.00056401396,0.00010959414,0.00012859875,0.00013503348,0.00005148184,0.000589549,0.000009297102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028276702,0.0047408002,0.95001507,0.00027220257,0.0013171873,0.000057986013,0.00049591606,0.00015080486,0.0007113018,0.000021121557,0.0003226334,0.013618275],"study_design_scores_gemma":[0.044106223,0.055564158,0.89242613,0.00037350133,0.0022608638,0.00003714561,0.00017213801,0.0031606532,0.0010321027,0.00013767579,0.00047746373,0.00025192925],"about_ca_topic_score_codex":0.00003461966,"about_ca_topic_score_gemma":0.00004772485,"teacher_disagreement_score":0.057588924,"about_ca_system_score_codex":0.00019324539,"about_ca_system_score_gemma":0.0019530933,"threshold_uncertainty_score":0.7086293},"labels":[],"label_agreement":null},{"id":"W2921560039","doi":"10.1200/jco.2019.37.7_suppl.350","title":"Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Cohort; Pembrolizumab; Cystectomy; Internal medicine; Clinical endpoint; Urology; Cancer; Carcinoma in situ; Discontinuation; Surgery; Oncology; Clinical trial; Immunotherapy","score_opus":0.062360026302152996,"score_gpt":0.43040390942938983,"score_spread":0.36804388312723685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921560039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895701,0.00014043956,0.00024068722,0.0030058874,0.003158997,0.0027241223,0.00032946488,0.0000116581,0.0008186488],"genre_scores_gemma":[0.9903524,0.00045411327,0.0028819956,0.0032576504,0.0017268655,0.00010470829,0.000018443649,0.00006514227,0.0011386701],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99493366,0.000564933,0.002711474,0.0004928549,0.0007848264,0.0005122632],"domain_scores_gemma":[0.99080676,0.0034925833,0.0027379205,0.00045385645,0.0017721516,0.0007367225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014236342,0.0003647257,0.0027460842,0.0002839592,0.00009568948,0.000010477342,0.00030575535,0.0005050846,0.0006428751],"category_scores_gemma":[0.0039064893,0.00024379592,0.00076417666,0.00028991533,0.00020609098,0.00017219683,0.00011079801,0.0008565728,0.000038009446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75362325,0.013118501,0.017988894,0.00008671405,0.0026422332,0.00015139759,0.00050031586,0.00013464759,0.00035575664,0.00003229703,0.007799536,0.20356648],"study_design_scores_gemma":[0.506713,0.41101906,0.03451626,0.0002494832,0.002183591,0.00003710814,0.00013033205,0.000018305087,0.0010736247,0.00013848254,0.043663684,0.00025710423],"about_ca_topic_score_codex":0.00046593693,"about_ca_topic_score_gemma":0.0003901718,"teacher_disagreement_score":0.39790055,"about_ca_system_score_codex":0.0004654258,"about_ca_system_score_gemma":0.0051557655,"threshold_uncertainty_score":0.9941709},"labels":[],"label_agreement":null},{"id":"W2921604675","doi":"10.1200/jco.2019.37.7_suppl.422","title":"Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pembrolizumab; Adverse effect; Concomitant; Common Terminology Criteria for Adverse Events; Internal medicine; Randomized controlled trial; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical trial; Surgery; Phases of clinical research; Cancer; Immunotherapy","score_opus":0.12270569597161524,"score_gpt":0.4737296795899862,"score_spread":0.35102398361837095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921604675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990898,0.00093858683,0.00013717978,0.0029800013,0.0019325276,0.0016984259,0.000036256566,0.0000050837257,0.001373925],"genre_scores_gemma":[0.99533266,0.0011096884,0.002122207,0.0004695387,0.0008197997,0.000013275198,0.000006570188,0.000026908436,0.000099332676],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920888,0.0020013952,0.0047863163,0.0003234107,0.00055419223,0.00024589375],"domain_scores_gemma":[0.986608,0.010231771,0.002274106,0.00024792596,0.0002953506,0.00034281518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006419094,0.00023597559,0.004380251,0.00019233799,0.000019214816,0.000009182362,0.00013003567,0.00027246692,0.00014357328],"category_scores_gemma":[0.0020711352,0.00014251788,0.00075738045,0.00013643166,0.0006222965,0.00013799946,0.000013569963,0.00094148156,0.0000034101608],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.956468,0.00482138,0.020757329,0.000038154634,0.0018477441,0.00055112917,0.00021847388,0.000007212293,0.000039225615,0.00010218964,0.00006966361,0.015079529],"study_design_scores_gemma":[0.8799072,0.089394055,0.025889384,0.00009491017,0.0017469547,0.00027641596,0.00006420865,0.00050898234,0.000021992804,0.00012682694,0.0018546113,0.00011447701],"about_ca_topic_score_codex":0.000064564745,"about_ca_topic_score_gemma":0.000036148595,"teacher_disagreement_score":0.08457267,"about_ca_system_score_codex":0.00007329284,"about_ca_system_score_gemma":0.0036296498,"threshold_uncertainty_score":0.6438843},"labels":[],"label_agreement":null},{"id":"W2921696120","doi":"10.1200/jco.2019.37.7_suppl.479","title":"Impact of pure versus mixed metastatic urothelial carcinoma (mUC) histology on response with immune checkpoint inhibitors (ICIs).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Metastatic Urothelial Carcinoma; Medicine; Durvalumab; Histology; Nivolumab; Atezolizumab; Internal medicine; Oncology; Urothelial carcinoma; Urology; Bladder cancer; Cancer; Immunotherapy","score_opus":0.09284589838312211,"score_gpt":0.43653079119132965,"score_spread":0.3436848928082075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921696120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929154,0.0003745029,0.000012471311,0.0020849372,0.0023539774,0.00048144886,0.000019675013,0.0000083272,0.0017492564],"genre_scores_gemma":[0.9981375,0.00006608164,0.00068700715,0.0002432022,0.00045877046,0.000011279491,0.000002903217,0.000037325855,0.00035594485],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99526143,0.0010275713,0.0026335127,0.00026340567,0.0004921412,0.00032191165],"domain_scores_gemma":[0.9929159,0.0034980124,0.0023597085,0.0003865414,0.00046675146,0.0003730854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002690626,0.00025998204,0.0024100025,0.0002663141,0.000026587562,0.0000043409773,0.00019137512,0.00032000782,0.0005935062],"category_scores_gemma":[0.0026534228,0.00015257139,0.0012257458,0.00018783276,0.00029205545,0.00007971084,0.000038474165,0.001010037,0.00005706601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8231644,0.00451406,0.13568015,0.00006333085,0.0032594923,0.0019074923,0.00028160578,0.00008201652,0.0046693604,0.000039129154,0.0015087521,0.024830196],"study_design_scores_gemma":[0.051590376,0.1968664,0.7432182,0.00012785077,0.0013518397,0.0007766428,0.00015518055,0.000014267327,0.0025505137,0.000048099857,0.0031554217,0.00014520698],"about_ca_topic_score_codex":0.000112499736,"about_ca_topic_score_gemma":0.000029378265,"teacher_disagreement_score":0.771574,"about_ca_system_score_codex":0.00056682737,"about_ca_system_score_gemma":0.0046003843,"threshold_uncertainty_score":0.81608844},"labels":[],"label_agreement":null},{"id":"W2921705093","doi":"10.1016/j.urolonc.2018.12.014","title":"New horizons in bladder cancer research","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Identification (biology); Subtyping; Translational research; Medicine; Cancer; Library science; Oncology; Internal medicine; Pathology; Biology; Computer science","score_opus":0.18594623414356412,"score_gpt":0.47233861367372104,"score_spread":0.28639237953015695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921705093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003682292,0.985644,0.0000052078003,0.0026595995,0.00046885162,0.0016639141,0.00007709315,0.000045275257,0.0090678735],"genre_scores_gemma":[0.0000074933832,0.97824866,0.0066679716,0.0005877516,0.00052880443,0.0005830059,0.00013574048,0.000049639293,0.013190951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727124,0.00042179742,0.0005702644,0.0007850595,0.00030499374,0.0006466493],"domain_scores_gemma":[0.99823606,0.00061145064,0.00018085235,0.00041630433,0.00008314248,0.0004722016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005261382,0.00043228586,0.0017730083,0.00067047647,0.00016746137,0.00003179867,0.00020530491,0.0009273948,0.0006795427],"category_scores_gemma":[0.00014106472,0.00032278534,0.00019787904,0.0009616018,0.0005293879,0.00007797553,0.000117580435,0.0016754946,0.00026628948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006392908,0.0002457147,0.008339829,0.0025139232,0.00039731045,0.0004079168,0.0002785672,0.0000018978083,0.0000017915318,0.0031500938,0.059753172,0.9248459],"study_design_scores_gemma":[0.00084718736,0.0018716264,0.000060667207,0.0029251669,0.0016548424,0.0003507438,0.00004697087,0.000004274771,0.0000014867005,0.0016458068,0.99034184,0.00024937093],"about_ca_topic_score_codex":0.0010937875,"about_ca_topic_score_gemma":0.00031820318,"teacher_disagreement_score":0.93058866,"about_ca_system_score_codex":0.00067988946,"about_ca_system_score_gemma":0.006756323,"threshold_uncertainty_score":0.9999224},"labels":[],"label_agreement":null},{"id":"W2921811836","doi":"10.1097/01.ju.0000555883.61031.df","title":"MP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Multicenter study; Urology; General surgery; Surgery; Cancer; Internal medicine; Randomized controlled trial","score_opus":0.03472799315836589,"score_gpt":0.35631859215564726,"score_spread":0.3215905989972814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921811836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974908,0.00046086864,0.000030176901,0.00025937668,0.00027737085,0.0007405929,0.000018411041,0.0000012984464,0.00072106894],"genre_scores_gemma":[0.999704,0.000049251154,0.000044363245,0.000119864206,0.000026716772,0.000008051282,0.000012142684,0.0000070923825,0.000028514629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868387,0.0005611064,0.000405556,0.000091610505,0.00018250791,0.00007533307],"domain_scores_gemma":[0.99877626,0.00024984338,0.0004125824,0.00010249053,0.0004114965,0.000047343867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046285003,0.000087320135,0.0005282099,0.00010732562,0.000012427927,0.000006069787,0.00015105659,0.00005935616,0.00017222403],"category_scores_gemma":[0.00003856731,0.000055005075,0.000029640827,0.000103952734,0.00012618492,0.00021266025,0.0000463501,0.00013880528,0.0000012507861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022469921,0.0011102036,0.96425307,0.00006590818,0.0007082724,0.000012146506,0.0014808758,0.00044195124,0.009082834,0.000025861285,0.00010167281,0.00024729676],"study_design_scores_gemma":[0.014835286,0.0034958937,0.9778431,0.00014930389,0.0001907796,0.000035297013,0.00020549541,0.00043691587,0.0026004917,0.000029616725,0.00013172424,0.00004611202],"about_ca_topic_score_codex":0.00023090608,"about_ca_topic_score_gemma":0.000069201546,"teacher_disagreement_score":0.013590028,"about_ca_system_score_codex":0.000064938264,"about_ca_system_score_gemma":0.00022560732,"threshold_uncertainty_score":0.2243042},"labels":[],"label_agreement":null},{"id":"W2921911282","doi":"10.1200/jco.2019.37.7_suppl.429","title":"Avelumab treatment in metastatic urothelial carcinoma: Association between early response and durable outcomes in the phase Ib JAVELIN Solid Tumor Study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Javelin; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Chemotherapy; Urothelial carcinoma; Phases of clinical research; Immunotherapy; Cancer; Pembrolizumab; Bladder cancer","score_opus":0.11009727768758071,"score_gpt":0.4788035239572756,"score_spread":0.3687062462696949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921911282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179155,0.000100391146,0.0000030059743,0.006375285,0.0003591698,0.0011251097,0.000019731346,0.0000034881496,0.00022228327],"genre_scores_gemma":[0.9979532,0.000053612916,0.00016274166,0.0008080797,0.00024521345,0.000026316899,0.0000015143559,0.0000150178475,0.0007343266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99500346,0.0021721155,0.0019112508,0.00021290421,0.00043302172,0.00026726056],"domain_scores_gemma":[0.99294007,0.0056105247,0.0009854044,0.00019040477,0.00012218137,0.0001514207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006058601,0.00017486833,0.0017719278,0.0001998263,0.000029797122,0.000017949567,0.00012290194,0.00013351285,0.00006325798],"category_scores_gemma":[0.002094108,0.00008929131,0.00025431125,0.00015338486,0.00004348437,0.00010965146,0.000022664917,0.000618292,0.00002725265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013600406,0.0065979725,0.96717584,0.000007586067,0.0005312067,0.0011389303,0.002105919,0.0000022420231,0.000049984104,0.0000016877184,0.000048378974,0.008739831],"study_design_scores_gemma":[0.0660398,0.051444218,0.879313,0.00002517436,0.000731091,0.00006124762,0.001206619,0.000015207956,0.000034452554,0.00007829474,0.0009805049,0.000070366994],"about_ca_topic_score_codex":0.00053212536,"about_ca_topic_score_gemma":0.00035642556,"teacher_disagreement_score":0.087862834,"about_ca_system_score_codex":0.0006857318,"about_ca_system_score_gemma":0.0015260263,"threshold_uncertainty_score":0.36411938},"labels":[],"label_agreement":null},{"id":"W2921946378","doi":"10.1200/jco.2019.37.7_suppl.425","title":"Avelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Javelin; Chemotherapy; Urology; Gastroenterology; Phases of clinical research; Oncology; Surgery; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy; Nivolumab","score_opus":0.0944301480800086,"score_gpt":0.4722891942763653,"score_spread":0.3778590461963567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921946378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970119,0.00014889754,0.00013929329,0.0007495466,0.00022451613,0.0014947619,0.000050464507,0.000003020741,0.00017761403],"genre_scores_gemma":[0.9982098,0.00007206976,0.000885732,0.00048083338,0.00017407215,0.000018585386,0.000012200046,0.000017739203,0.00012901689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686265,0.0005620822,0.0017802521,0.00024397865,0.0003365256,0.0002144956],"domain_scores_gemma":[0.99642444,0.0018589769,0.0010561367,0.00027186004,0.00022334613,0.00016526102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019588189,0.0001749433,0.0021692065,0.00022710276,0.000026500691,0.000008454984,0.00013979427,0.00006834118,0.00010227242],"category_scores_gemma":[0.00034408388,0.000093995324,0.00051393645,0.0003402226,0.00011420607,0.00005395198,0.000018388802,0.0002887722,0.0000036357078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1921399,0.03294018,0.5834766,0.000042420143,0.01748002,0.001883067,0.004720997,0.00031108258,0.00019496809,0.00003884174,0.00014842418,0.16662352],"study_design_scores_gemma":[0.26396737,0.13430484,0.58061486,0.00004109252,0.015041744,0.00019469405,0.0018509714,0.00062171643,0.00010919617,0.000037544298,0.003088162,0.00012779263],"about_ca_topic_score_codex":0.0002347541,"about_ca_topic_score_gemma":0.0005152006,"teacher_disagreement_score":0.16649573,"about_ca_system_score_codex":0.00013869519,"about_ca_system_score_gemma":0.0012473833,"threshold_uncertainty_score":0.38330182},"labels":[],"label_agreement":null},{"id":"W2922015761","doi":"10.1200/jco.2019.37.7_suppl.377","title":"Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Gastroenterology; Cancer; Anemia; Chemotherapy; Bladder cancer; Oncology; Adverse effect","score_opus":0.07501301366022906,"score_gpt":0.45484002772730087,"score_spread":0.3798270140670718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922015761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963653,0.00012949033,0.000004368239,0.0006076521,0.00094716327,0.00089736114,0.00016862006,0.0000045608076,0.0008754561],"genre_scores_gemma":[0.9981794,0.000062294945,0.00064583163,0.0005654871,0.0003476361,0.0000143670195,0.000011896364,0.000023815765,0.0001493179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602,0.00040394446,0.0024894422,0.00026387433,0.0006057211,0.00021699474],"domain_scores_gemma":[0.9959288,0.0011705221,0.0019778819,0.0002830641,0.00040521764,0.0002344945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010333625,0.00018522861,0.0019133689,0.00014914018,0.000014035315,0.00000519404,0.00016582348,0.0001824719,0.00045934232],"category_scores_gemma":[0.00085980166,0.00011185618,0.00021264829,0.00018233102,0.000074816955,0.000109403685,0.000027012602,0.00084695994,0.000013588602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1411001,0.025897624,0.7864201,0.000029657527,0.0015086017,0.00040714815,0.0011891372,0.000059652317,0.000039630824,0.0000027812166,0.0007428658,0.042602707],"study_design_scores_gemma":[0.18577258,0.07268797,0.7374518,0.00026002937,0.0010938226,0.0000095731375,0.0005282773,0.000021886422,0.00007797275,0.00003721455,0.0019598182,0.00009905587],"about_ca_topic_score_codex":0.0009344109,"about_ca_topic_score_gemma":0.0004750524,"teacher_disagreement_score":0.048968296,"about_ca_system_score_codex":0.00017262688,"about_ca_system_score_gemma":0.0021027878,"threshold_uncertainty_score":0.5029476},"labels":[],"label_agreement":null},{"id":"W2922191218","doi":"10.1200/jco.2019.37.7_suppl.428","title":"Avelumab treatment in metastatic urothelial carcinoma: Post-hoc analysis of high-risk populations in the phase Ib JAVELIN Solid Tumor Study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Javelin; Response Evaluation Criteria in Solid Tumors; Oncology; Adverse effect; Urology; Neutropenia; Gastroenterology; Chemotherapy; Phases of clinical research; Cancer; Urothelial carcinoma; Immunotherapy; Bladder cancer; Nivolumab","score_opus":0.145055644120517,"score_gpt":0.4980796812358861,"score_spread":0.3530240371153691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922191218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643046,0.0002491422,0.000024609337,0.001444998,0.0004926406,0.0010312813,0.00008513545,0.0000029326402,0.00023882506],"genre_scores_gemma":[0.99817044,0.000115642295,0.0007428002,0.0006142474,0.0002151266,0.000025493428,0.000015488034,0.00001534662,0.00008544598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946695,0.001434395,0.0029459228,0.0002496378,0.00045906115,0.0002414753],"domain_scores_gemma":[0.9960023,0.0016169745,0.0015932157,0.00036802902,0.00026551573,0.00015393493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002582866,0.00019609714,0.0025069828,0.0006378236,0.000028361592,0.000007543584,0.00019903368,0.0001111318,0.0003320485],"category_scores_gemma":[0.0007716523,0.00011038901,0.0007584574,0.0007242314,0.00008445903,0.00008040583,0.000025179059,0.0005777847,0.000016795575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0150421485,0.02745379,0.91647416,0.000012646055,0.0031837416,0.0013648589,0.002677213,0.0005615294,0.000047772362,0.000042646276,0.00003982384,0.03309968],"study_design_scores_gemma":[0.052656937,0.07344501,0.8618752,0.000022495225,0.008445978,0.00006452053,0.0024388349,0.00055462134,0.000020870068,0.00014718372,0.00024728128,0.000081102495],"about_ca_topic_score_codex":0.0037168893,"about_ca_topic_score_gemma":0.0067330766,"teacher_disagreement_score":0.054598983,"about_ca_system_score_codex":0.00033944356,"about_ca_system_score_gemma":0.0016566388,"threshold_uncertainty_score":0.56188494},"labels":[],"label_agreement":null},{"id":"W2922253981","doi":"10.1200/jco.2019.37.7_suppl.431","title":"Impact of bone metastasis on clinical outcomes in metastatic urothelial bladder cancer (mUC) for patients treated with first-line platinum-based chemotherapy.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Baker Hughes (Canada); University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Proportional hazards model; Oncology; Bone metastasis; Metastasis; Cancer; Progressive disease; Bladder cancer; Progression-free survival; Surgery; Urology","score_opus":0.1107324041417388,"score_gpt":0.4820809997094317,"score_spread":0.3713485955676929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922253981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579257,0.0000827339,0.00007963136,0.0017802661,0.0004843544,0.0013073396,0.00021768805,0.000008479389,0.0002469185],"genre_scores_gemma":[0.99460185,0.00029575988,0.0028425336,0.0016562794,0.0002776368,0.000056654884,0.000015600946,0.0000572015,0.00019647511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490863,0.00039593232,0.003469913,0.00034543336,0.0005232482,0.00035682923],"domain_scores_gemma":[0.9900064,0.0061500366,0.002539572,0.00030991598,0.00064659986,0.0003474737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017483798,0.00033109135,0.0036569275,0.00027331884,0.000023026843,0.000006523938,0.00014912318,0.00030086807,0.000753595],"category_scores_gemma":[0.0020879246,0.00018190275,0.0014983371,0.00022904342,0.00018025302,0.00008934331,0.000014961068,0.00065733603,0.000010240709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05945334,0.012023509,0.88130075,0.00005886872,0.0037491997,0.000065416556,0.000038468646,0.00038318144,0.0000114990235,0.000003089788,0.00057228946,0.042340398],"study_design_scores_gemma":[0.08432153,0.114395596,0.7978384,0.0002271509,0.0014652408,0.000010498761,0.000011533526,0.00016454044,0.00011913039,0.000032185704,0.0012678392,0.00014639462],"about_ca_topic_score_codex":0.00030974075,"about_ca_topic_score_gemma":0.00033126253,"teacher_disagreement_score":0.10237209,"about_ca_system_score_codex":0.00029518508,"about_ca_system_score_gemma":0.0030083056,"threshold_uncertainty_score":0.82513374},"labels":[],"label_agreement":null},{"id":"W2922256160","doi":"10.1200/jco.2019.37.15_suppl.e16024","title":"First-line PD(L)1 inhibitors for platinum-ineligible advanced urothelial carcinoma (aUC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Internal medicine; Nivolumab; Durvalumab; Gastroenterology; Oncology; Urology; Cancer; Immunotherapy","score_opus":0.08396877193433286,"score_gpt":0.43964204991986605,"score_spread":0.35567327798553316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922256160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799708,0.0006000319,0.00039349106,0.0075471103,0.0049292217,0.0009188189,0.00002624648,0.000019195248,0.0055950494],"genre_scores_gemma":[0.98458797,0.00031898837,0.0059235953,0.002748465,0.0039280527,0.000019409255,0.0000065101517,0.00004236804,0.0024246436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670005,0.00010638533,0.002208926,0.00027714664,0.00036629502,0.00034117544],"domain_scores_gemma":[0.99597484,0.0016302438,0.0012564579,0.0002549353,0.00046468832,0.00041884067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012125344,0.00021122934,0.001689026,0.00013153971,0.000050105566,0.000008948252,0.00017014485,0.0004147748,0.00038622637],"category_scores_gemma":[0.0013860724,0.00014738375,0.0008236426,0.00012776215,0.00009587108,0.00013956384,0.00004208524,0.00065017707,0.00010278054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06293315,0.0049525467,0.64208233,0.00036948553,0.0012729026,0.0005913702,0.0003504505,0.0004361098,0.0027094912,0.000327245,0.028194334,0.25578058],"study_design_scores_gemma":[0.088337846,0.07517004,0.1564587,0.0003181324,0.001029076,0.00054295425,0.00015340529,0.00042442183,0.0032305273,0.0018269928,0.67216974,0.00033813794],"about_ca_topic_score_codex":0.000025572741,"about_ca_topic_score_gemma":0.000029783094,"teacher_disagreement_score":0.64397544,"about_ca_system_score_codex":0.00018998356,"about_ca_system_score_gemma":0.0015994773,"threshold_uncertainty_score":0.6010135},"labels":[],"label_agreement":null},{"id":"W2922362450","doi":"10.1200/jco.2019.37.7_suppl.454","title":"Circulating cell-free methylated DNA (cfmeDNA) to predict postoperative recurrence in patients with muscle-invasive bladder cancer (MIBC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Methylation; CpG site; DNA methylation; Medicine; Cystectomy; Bladder cancer; Biomarker; Bisulfite sequencing; Methylated DNA immunoprecipitation; Internal medicine; Cancer; Oncology; Liquid biopsy; Differentially methylated regions; Cell-free fetal DNA; Cancer research; Molecular biology; DNA; Gene; Biology; Gene expression; Genetics","score_opus":0.05001349509028416,"score_gpt":0.39549508723748905,"score_spread":0.34548159214720486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922362450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905872,0.0002193404,0.000024287547,0.0033011546,0.0012278805,0.00087411737,0.000029097328,0.0000094875695,0.0037274433],"genre_scores_gemma":[0.99405676,0.00013562515,0.0015707419,0.0036131009,0.00034412442,0.000017849115,0.0000062984464,0.000030141693,0.00022533974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967097,0.0004029674,0.0016022138,0.00035620513,0.00058085663,0.00034804156],"domain_scores_gemma":[0.99628365,0.0010897452,0.0010003689,0.00032228467,0.00083800167,0.0004659466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009629433,0.00022558543,0.0014186894,0.00018958807,0.000033281358,0.000010748115,0.00024839392,0.0003118006,0.0004435254],"category_scores_gemma":[0.0015575171,0.00014823039,0.0002216758,0.00034372526,0.00009060342,0.0001798168,0.000080890364,0.0009827806,0.000034707547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059253424,0.0020023347,0.9440555,0.000037171165,0.00048137803,0.00034323937,0.0008377286,0.00021388983,0.00036493802,0.0000050055028,0.0015163437,0.04421713],"study_design_scores_gemma":[0.026205795,0.02760887,0.9419733,0.00044770347,0.0003774918,0.000021973778,0.00021270728,0.000024141591,0.00041279147,0.00004904058,0.002497713,0.00016846553],"about_ca_topic_score_codex":0.00014648709,"about_ca_topic_score_gemma":0.00027262024,"teacher_disagreement_score":0.044048663,"about_ca_system_score_codex":0.00041123093,"about_ca_system_score_gemma":0.0028622278,"threshold_uncertainty_score":0.60446596},"labels":[],"label_agreement":null},{"id":"W2922525744","doi":"10.1200/jco.2019.37.7_suppl.434","title":"The cost of obesity in radical cystectomy.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cystectomy; Overweight; Body mass index; Obesity; Population; Internal medicine; Bladder cancer; Cancer; Environmental health","score_opus":0.08849562201145696,"score_gpt":0.4670757647496304,"score_spread":0.3785801427381735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922525744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829992,0.0006410484,0.000019668538,0.004776336,0.0012244988,0.00026279376,0.0000014711486,0.0000021398128,0.010072832],"genre_scores_gemma":[0.9973573,0.00063416077,0.00027627233,0.0008666981,0.00038564028,0.0000017022737,3.0027184e-7,0.000006206759,0.00047170598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976965,0.0003128388,0.0014936641,0.00008651449,0.0002666422,0.00014384113],"domain_scores_gemma":[0.9966668,0.002093608,0.0007576583,0.00015940837,0.00016239796,0.00016011314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024288888,0.00006606081,0.0009554087,0.00004820588,0.000014728979,0.000002397362,0.00013797318,0.00021277477,0.00015993536],"category_scores_gemma":[0.0012600207,0.000034457928,0.0003070228,0.00009647455,0.00018369925,0.000036234385,0.000027669625,0.00068668823,0.000034210232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005266482,0.0014290876,0.8956607,0.000019978956,0.00019753705,0.00023036814,0.000050399754,0.000004228422,0.000100285935,0.00018790478,0.0015424745,0.09531054],"study_design_scores_gemma":[0.01332234,0.008985155,0.8574573,0.00008387009,0.000119361386,0.00020832579,0.00006663108,0.000025567982,0.00015368043,0.00033493605,0.119209275,0.000033554363],"about_ca_topic_score_codex":0.0000488766,"about_ca_topic_score_gemma":0.00008209099,"teacher_disagreement_score":0.1176668,"about_ca_system_score_codex":0.00010800429,"about_ca_system_score_gemma":0.0013757932,"threshold_uncertainty_score":0.29833567},"labels":[],"label_agreement":null},{"id":"W2923432595","doi":"10.1245/s10434-019-07313-y","title":"Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy","year":2019,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Medicine; Comorbidity; Cystectomy; Perioperative; Cohort; Context (archaeology); Bladder cancer; Heart failure; Anemia; Internal medicine; Diabetes mellitus; Intensive care medicine; Cancer; Surgery; Oncology","score_opus":0.1335987341662599,"score_gpt":0.3910230572781697,"score_spread":0.2574243231119098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923432595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925053,0.000094464915,0.000053152376,0.00023466612,0.00005491035,0.0014455577,0.00011739046,0.0000076005904,0.005486944],"genre_scores_gemma":[0.9981066,0.00011818728,0.0013422827,0.000041597432,0.00002429065,0.00006208066,0.00016606183,0.000009781607,0.00012914799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985983,0.00009002552,0.00066505146,0.00022390635,0.00027054688,0.00015219783],"domain_scores_gemma":[0.9991421,0.00011094134,0.00024177598,0.00014757393,0.0002680869,0.000089532434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026559853,0.00013229622,0.0008031396,0.00008215356,0.000014026908,0.0000014942756,0.000051831532,0.00012591953,0.00015354437],"category_scores_gemma":[0.000006195411,0.00009294221,0.00009172336,0.00014200914,0.00011751032,0.000058978592,0.000020247391,0.00010060933,0.0000012287152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068127424,0.002819235,0.9796847,0.00017141736,0.00037531115,0.00002645247,0.0006926231,0.00000438685,0.0011401748,0.00014818575,0.0003746199,0.0077501554],"study_design_scores_gemma":[0.020434007,0.007633113,0.8887423,0.00018631271,0.00004299828,0.0000058457804,0.000118155585,0.00002643236,0.015538479,0.00000878333,0.067183234,0.00008032576],"about_ca_topic_score_codex":0.00019039183,"about_ca_topic_score_gemma":0.000024696032,"teacher_disagreement_score":0.090942375,"about_ca_system_score_codex":0.000101648715,"about_ca_system_score_gemma":0.001107895,"threshold_uncertainty_score":0.37900734},"labels":[],"label_agreement":null},{"id":"W2925231435","doi":"10.1039/c8pp00576a","title":"Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report","year":2019,"lang":"en","type":"article","venue":"Photochemical & Photobiological Sciences","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Cervical cancer; Cervix; Laparotomy; Chemotherapy; Carcinoma; Cancer; Hysterectomy; Surgery; Radiology; Oncology; Internal medicine","score_opus":0.026920824517670156,"score_gpt":0.30095109026935507,"score_spread":0.27403026575168493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925231435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797333,0.00029024325,0.0000017877219,0.0002601308,0.00007937591,0.001963877,0.000047329035,0.00007568783,0.017548298],"genre_scores_gemma":[0.997748,0.000034411092,0.00067101594,0.00031785728,0.000073348085,0.00024115747,0.000040979605,0.000014029598,0.0008591946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763757,0.00005076958,0.0004563465,0.00089632365,0.0004193146,0.0005396822],"domain_scores_gemma":[0.998716,0.00018812035,0.0001874217,0.0004670716,0.00010941377,0.00033196172],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015283978,0.00035995405,0.0007946127,0.00007441213,0.00017511596,0.000018850078,0.00016561754,0.00017423823,0.0017733607],"category_scores_gemma":[0.00008552406,0.00019158024,0.00025045534,0.00047804957,0.00073594996,0.00006533547,0.000080809674,0.00013074315,0.000047599755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029603976,0.0023341181,0.14579919,0.00006138971,0.00024201222,0.039926898,0.0007018336,0.0000033689257,0.8067287,0.00009018134,0.00015636739,0.0009955243],"study_design_scores_gemma":[0.0048228716,0.01900155,0.003946592,0.00009161139,0.0002011004,0.104690425,0.0004046444,0.0001100646,0.86437255,0.00018417268,0.0018217586,0.00035265565],"about_ca_topic_score_codex":0.0025218867,"about_ca_topic_score_gemma":0.000021617267,"teacher_disagreement_score":0.1418526,"about_ca_system_score_codex":0.00018035606,"about_ca_system_score_gemma":0.0003147364,"threshold_uncertainty_score":0.99913913},"labels":[],"label_agreement":null},{"id":"W2925278720","doi":"10.18332/tpc/105594","title":"The role of urologists in smoking cessation: what they can do for urological cancer patients","year":2019,"lang":"en","type":"article","venue":"Tobacco Prevention & Cessation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Third Health Programme; University of Waterloo; Canadian Institutes of Health Research; European Commission","keywords":"Medicine; Smoking cessation; Cancer; Family medicine; Oncology; Internal medicine; Pathology","score_opus":0.018113463597095574,"score_gpt":0.29756496913968256,"score_spread":0.27945150554258696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925278720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995931,0.0010111198,0.00004681648,0.00053567457,0.000371938,0.0013243973,0.00002045538,0.000021324098,0.0007372322],"genre_scores_gemma":[0.9985442,0.00055394496,0.00005458405,0.00012736446,0.00006504679,0.00031306257,0.00012682751,0.000013440223,0.00020149355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988602,0.000087015826,0.00034179413,0.0002442554,0.0002808447,0.00018589101],"domain_scores_gemma":[0.9992551,0.000089592446,0.00023869006,0.0002026864,0.00017889733,0.000035038887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031094518,0.00011810853,0.00019516432,0.000065875334,0.000073510855,0.000047401383,0.00009646715,0.00010947632,0.00012734624],"category_scores_gemma":[0.000044028857,0.00008222365,0.00009351237,0.000119823664,0.000029817375,0.00026190066,0.00002490076,0.000095297095,0.000003568393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004060256,0.0001995644,0.85579485,0.00002260949,0.000050168,1.4293028e-7,0.0004411997,0.00013096689,0.00014961649,0.00049612834,0.00001810392,0.1422906],"study_design_scores_gemma":[0.0040089777,0.0006723055,0.98404104,0.0001392089,0.00010889417,6.9218447e-7,0.00053282955,0.00023242582,0.0015017685,0.006744604,0.001912866,0.00010438205],"about_ca_topic_score_codex":0.00027645726,"about_ca_topic_score_gemma":0.00041388854,"teacher_disagreement_score":0.14218622,"about_ca_system_score_codex":0.0001415795,"about_ca_system_score_gemma":0.00009645975,"threshold_uncertainty_score":0.33529833},"labels":[],"label_agreement":null},{"id":"W2929795591","doi":"10.1002/jso.25456","title":"Short‐ and long‐term survival has improved after radical cystectomy for bladder cancer in Québec during the years 2000‐2015","year":2019,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"International Development Research Centre; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University Health Centre; McGill University","keywords":"Medicine; Cystectomy; Hazard ratio; Bladder cancer; Confidence interval; Proportional hazards model; Urology; Internal medicine; Survival analysis; Surgery; Cancer","score_opus":0.0194607036690509,"score_gpt":0.321412217376833,"score_spread":0.3019515137077821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929795591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721695,0.004921907,0.000007105564,0.006606937,0.0005168402,0.00048080133,0.000012837772,0.0000051058432,0.00023152909],"genre_scores_gemma":[0.99748766,0.0007010525,0.000040089457,0.00027040468,0.0005747315,0.000044682693,8.126462e-7,0.000020804526,0.00085976784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882704,0.00008697696,0.00043933204,0.00016734455,0.00019836836,0.00028091486],"domain_scores_gemma":[0.99924165,0.0002493857,0.00011973583,0.000118858385,0.00008888477,0.00018150877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003423748,0.00013578213,0.0005840255,0.00009163574,0.000030650946,0.000017271634,0.000087839886,0.00016521696,0.0007768696],"category_scores_gemma":[0.000015037851,0.00008091152,0.0001648947,0.00008333901,0.00016417899,0.000073205665,0.00003697359,0.00038707274,0.00000538421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019420898,0.0006310024,0.91940695,0.0001429751,0.00071105483,0.002953815,0.00096427096,0.00000984538,0.0021733171,0.0000069809334,0.0003066249,0.05327224],"study_design_scores_gemma":[0.014165923,0.0016046833,0.8909256,0.000098277545,0.00022014674,0.0013990196,0.0000564371,0.000020778682,0.00014061475,0.000010269885,0.091248505,0.00010977321],"about_ca_topic_score_codex":0.0004360461,"about_ca_topic_score_gemma":0.0023571823,"teacher_disagreement_score":0.09094188,"about_ca_system_score_codex":0.000500948,"about_ca_system_score_gemma":0.0009809003,"threshold_uncertainty_score":0.8506177},"labels":[],"label_agreement":null},{"id":"W2930221971","doi":"10.1634/theoncologist.2019-0039","title":"Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice","year":2019,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Guideline; Systemic therapy; Oncology; Internal medicine; Chemotherapy; Targeted therapy; Cancer; Pathology","score_opus":0.02766453742285076,"score_gpt":0.3211048916340345,"score_spread":0.29344035421118375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930221971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92664653,0.0017661335,0.00000393327,0.0049159545,0.00047486267,0.0014587151,0.00010620083,0.000024619529,0.06460306],"genre_scores_gemma":[0.9870902,0.00033070214,0.0002461037,0.0016097436,0.0003951189,0.00023337339,0.000059198162,0.000035455618,0.010000131],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986009,0.00017247607,0.00039484806,0.00032393893,0.0002608781,0.0002469581],"domain_scores_gemma":[0.9980647,0.0008714297,0.00028972162,0.0006171744,0.00008437761,0.000072577044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024448524,0.0002129263,0.00045048204,0.00008672865,0.00009015839,0.00001156707,0.00021368658,0.0000942505,0.00047999577],"category_scores_gemma":[0.0000774806,0.00010674074,0.00016799009,0.0002788418,0.00022980208,0.0000806465,0.00006853379,0.00021567864,0.000047155198],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14049354,0.007752056,0.15753926,0.00026763827,0.0009893037,0.00012264609,0.019541882,0.0002658709,0.5131162,0.0015395673,0.020752756,0.1376193],"study_design_scores_gemma":[0.04168803,0.007161643,0.40453067,0.00008735505,0.00040868795,0.00000896543,0.0016937249,0.000091872935,0.3009468,0.000617358,0.2423619,0.00040299245],"about_ca_topic_score_codex":0.004884917,"about_ca_topic_score_gemma":0.003719772,"teacher_disagreement_score":0.24699141,"about_ca_system_score_codex":0.0003604333,"about_ca_system_score_gemma":0.0002987803,"threshold_uncertainty_score":0.7384566},"labels":[],"label_agreement":null},{"id":"W2930807162","doi":"10.1038/modpathol.2018.10","title":"USCAP 2018 Abstracts: Genitourinary Pathology (894–1126)","year":2018,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Houston Methodist Research Institute; University of Texas MD Anderson Cancer Center; School of Medicine, Stanford University; Universidade de São Paulo; Houston Methodist Hospital; McMaster University; Foundation Medicine; McGill University; University of Pennsylvania; Emory University; Cleveland Clinic; Henry Ford Health System","keywords":"Genitourinary system; Pathology; Medicine; Anatomical pathology; Anatomy; Immunohistochemistry","score_opus":0.02833171415971428,"score_gpt":0.2988372768095595,"score_spread":0.2705055626498452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930807162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9476693,0.0010456566,0.0020810657,0.0013254513,0.0011481855,0.00041922793,0.000055293316,0.00019978086,0.04605602],"genre_scores_gemma":[0.9880229,0.00010369727,0.0023765978,0.003046479,0.0013652456,0.00007070438,0.000049442235,0.000064383465,0.00490055],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99809253,0.00010113694,0.00038138937,0.0006339345,0.00019076574,0.0006002569],"domain_scores_gemma":[0.9988023,0.000036997306,0.000109334724,0.0007062027,0.00013551822,0.00020963103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001815257,0.00028626632,0.0004760315,0.00015048042,0.00014990517,0.000011682183,0.0001576271,0.00034320488,0.00079916394],"category_scores_gemma":[0.000048160935,0.00024710418,0.00013646107,0.000108512395,0.00044775737,0.00007987679,0.00010246454,0.00027990664,0.0016441981],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006555081,0.0057076514,0.16936126,0.00040714358,0.0010423688,0.05994427,0.012192404,0.000029452638,0.4694329,0.00091815525,0.06724452,0.2071648],"study_design_scores_gemma":[0.01432309,0.013911371,0.7905874,0.00013486043,0.0009996654,0.03245956,0.00028034847,0.00060154445,0.049992725,0.020278791,0.075133815,0.0012967758],"about_ca_topic_score_codex":0.00004481807,"about_ca_topic_score_gemma":0.000052052495,"teacher_disagreement_score":0.6212262,"about_ca_system_score_codex":0.00009410155,"about_ca_system_score_gemma":0.0001437338,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2933596744","doi":"10.1016/j.clgc.2019.03.003","title":"Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Urology; Proportional hazards model; Cohort; Upper urinary tract; Internal medicine; Population; Oncology; Epidemiology; Chemotherapy; Urinary system","score_opus":0.04144192562534474,"score_gpt":0.38248303098953385,"score_spread":0.3410411053641891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933596744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993486,0.0020473474,0.0000032111227,0.00029377316,0.001646495,0.0014016592,0.0000747555,0.000038792114,0.0045591136],"genre_scores_gemma":[0.99638444,0.00040225362,0.00015921053,0.00035723325,0.00070427055,0.00015025641,0.000020334037,0.00006728601,0.0017546932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712354,0.0005032628,0.0009083288,0.00059613417,0.0004122587,0.0004565054],"domain_scores_gemma":[0.9982202,0.0006940646,0.00019538826,0.0005730696,0.00007305025,0.00024420972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061773264,0.00035471108,0.001268678,0.00016126747,0.000027218648,0.000009020496,0.0001932974,0.00018002412,0.001704134],"category_scores_gemma":[0.00008451596,0.0002702492,0.00055982935,0.00028693103,0.00014036252,0.0001143854,0.00008436447,0.00055505574,0.00017478724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066841305,0.001438165,0.97893065,0.00040354047,0.0002466389,0.00058745965,0.00008614067,0.0000132318255,0.0010949033,0.0000036596307,0.00023620953,0.010275295],"study_design_scores_gemma":[0.015677119,0.012486782,0.96436864,0.00023328244,0.00046175442,0.0001296813,0.000039835002,0.000091412956,0.0029359253,0.000029796254,0.0032722154,0.00027356076],"about_ca_topic_score_codex":0.00038548996,"about_ca_topic_score_gemma":0.000008306857,"teacher_disagreement_score":0.014561992,"about_ca_system_score_codex":0.00014454298,"about_ca_system_score_gemma":0.00047095932,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W2933974970","doi":"10.1158/1078-0432.ccr-18-3558","title":"Molecular Characterization of Neuroendocrine-like Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada); University of British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Medicine; Cohort; Oncology; Internal medicine; Subtyping; Cancer; Neuroendocrine tumors; Pathology; Prospective cohort study","score_opus":0.13018276175129784,"score_gpt":0.49513753211973555,"score_spread":0.3649547703684377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933974970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909763,0.00079101045,0.000012307255,0.003140613,0.00080861663,0.00102033,0.00007896391,0.00003233415,0.003139554],"genre_scores_gemma":[0.9891341,0.0031313268,0.000020399719,0.0013483503,0.00037522457,0.0002196237,0.000035866215,0.00005103354,0.005684105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737465,0.00025167892,0.0005465936,0.0005155108,0.0008395749,0.00047196282],"domain_scores_gemma":[0.99836403,0.0001612006,0.00010222965,0.00056999613,0.0005439694,0.0002585521],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004367883,0.00015084863,0.00049483596,0.00014562091,0.000043642853,0.000016490892,0.00019598716,0.00008404851,0.003593887],"category_scores_gemma":[0.00010603667,0.00012345408,0.0001987448,0.0004993185,0.00022200635,0.000081750164,0.00012141327,0.0006111681,0.00019244997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027794011,0.00091714057,0.6598097,0.0004542861,0.00058484025,0.00017222647,0.0001026212,0.000011420145,0.28049037,0.00023971147,0.0027260263,0.05171226],"study_design_scores_gemma":[0.009016347,0.0028000963,0.7541106,0.00049037323,0.00026036202,0.000019797499,0.000053775362,0.00028988783,0.12898067,0.00013219705,0.103524774,0.00032112657],"about_ca_topic_score_codex":0.0006768441,"about_ca_topic_score_gemma":0.000027174263,"teacher_disagreement_score":0.15150972,"about_ca_system_score_codex":0.00011184917,"about_ca_system_score_gemma":0.00078668015,"threshold_uncertainty_score":0.99731696},"labels":[],"label_agreement":null},{"id":"W2936186613","doi":"10.1111/bju.14751","title":"Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy","year":2019,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Histology; Incidence (geometry); Lymph node; Urology; Confidence interval; Urothelial carcinoma; Internal medicine; Pathological; Proportional hazards model; Gastroenterology; Cancer; Bladder cancer","score_opus":0.006188041730772461,"score_gpt":0.21944567419160876,"score_spread":0.21325763246083632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936186613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981629,0.0008224939,0.000016774475,0.00029011784,0.00006974663,0.00043152767,0.00001886992,0.000007965491,0.00017960698],"genre_scores_gemma":[0.9990249,0.00011643416,0.0002813546,0.00042866415,0.000036701407,0.000009110751,0.000005717181,0.000031351694,0.00006574547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878305,0.00014138703,0.00029615185,0.00027054342,0.0002288907,0.0002799749],"domain_scores_gemma":[0.9992503,0.00013197967,0.00020225458,0.0001187513,0.00014130164,0.00015543852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001155736,0.00019964988,0.0007288839,0.00015610506,0.00003850967,0.000019467558,0.0000675981,0.000110519635,0.0000731515],"category_scores_gemma":[0.000023731769,0.00013906983,0.00003220574,0.000095942545,0.00019011175,0.00016479625,0.00002121309,0.00034883988,0.0000013919545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009002485,0.0007495229,0.9755977,0.000025328445,0.00018791282,0.012029364,0.0001827315,0.0000029483194,0.000016437754,0.000003975975,0.000010213481,0.0021914032],"study_design_scores_gemma":[0.026401248,0.022043718,0.91886336,0.00010199375,0.0002648727,0.032015543,0.00004186591,0.0000056178505,0.000005947793,0.000008742492,0.000106626445,0.00014048074],"about_ca_topic_score_codex":0.00094318535,"about_ca_topic_score_gemma":0.00029242935,"teacher_disagreement_score":0.05673433,"about_ca_system_score_codex":0.000058899477,"about_ca_system_score_gemma":0.00018321823,"threshold_uncertainty_score":0.5671103},"labels":[],"label_agreement":null},{"id":"W2936754020","doi":"10.1007/s00345-019-02769-9","title":"Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization","year":2019,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Cystectomy; Perioperative; Lymph node; Lymphadenectomy; Surgery; Bladder cancer; Lymph; Cancer; Internal medicine","score_opus":0.007224737892361532,"score_gpt":0.2542330256868834,"score_spread":0.24700828779452186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936754020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98485047,0.0012162658,0.00019614128,0.0074980683,0.000111186775,0.00030062214,0.0000075002417,0.000007773625,0.0058119544],"genre_scores_gemma":[0.9973429,0.00013847492,0.00038882034,0.0005983256,0.000053274503,0.0000051011693,0.000007977255,0.000011887496,0.0014532423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991994,0.00008006891,0.00028274843,0.000114223556,0.00020798577,0.00011559394],"domain_scores_gemma":[0.99918693,0.00008691916,0.0002794748,0.0001040041,0.00026535205,0.00007729095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012895867,0.00008897065,0.00032664408,0.0001489281,0.00004201506,0.000005772087,0.00004443834,0.000056202345,0.00023685647],"category_scores_gemma":[0.000031604817,0.00006351379,0.000050942806,0.00015381341,0.00006838415,0.00007417438,0.000015619718,0.0001020044,0.0000072803177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012961278,0.00023566566,0.98804736,0.000031881962,0.0005559445,0.00002284923,0.0008256476,0.000039167568,0.0066134064,0.00065277895,0.0006058347,0.0010733292],"study_design_scores_gemma":[0.010363846,0.0032372456,0.9596011,0.00005811722,0.00048890477,0.0005378255,0.000107056985,0.000117575415,0.0013498472,0.0000812273,0.023963131,0.00009413293],"about_ca_topic_score_codex":0.000013757156,"about_ca_topic_score_gemma":0.000077536766,"teacher_disagreement_score":0.028446278,"about_ca_system_score_codex":0.0001819365,"about_ca_system_score_gemma":0.00012246765,"threshold_uncertainty_score":0.25934124},"labels":[],"label_agreement":null},{"id":"W2938622136","doi":"10.1016/j.jgo.2019.04.011","title":"The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis","year":2019,"lang":"en","type":"article","venue":"Journal of Geriatric Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Interquartile range; Confidence interval; Comorbidity; Odds ratio; Perioperative; Poisson regression; Population; Logistic regression; Internal medicine; Bladder cancer; Surgery; Cancer","score_opus":0.012048563505455046,"score_gpt":0.3054557235505597,"score_spread":0.2934071600451047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938622136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995323,0.0009406175,0.000038688624,0.0020864313,0.00014596755,0.0003743915,0.000017582055,0.000003889411,0.0010694517],"genre_scores_gemma":[0.99934936,0.000027202139,0.00010974961,0.00029971392,0.000066091896,0.000015238448,0.000008004509,0.000007222798,0.00011744796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898094,0.00028226868,0.00037824933,0.00009239907,0.00017816608,0.00008796692],"domain_scores_gemma":[0.99850905,0.0008620055,0.0003099654,0.00014212029,0.00010151,0.00007535351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000282057,0.0000953313,0.0005672019,0.00022825788,0.00005332606,0.0000114336635,0.000057478195,0.00007263669,0.00005384128],"category_scores_gemma":[0.000051574058,0.00005235136,0.00018749098,0.00024633727,0.000079215984,0.00003693738,0.00000977206,0.00016719416,0.0000045254496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063426555,0.00015673775,0.98913586,0.00003631435,0.0012784735,0.00013770121,0.00028276365,0.000036293084,0.00033968547,0.00004575907,0.00036257727,0.0018451901],"study_design_scores_gemma":[0.005120136,0.011520361,0.9800859,0.00003150894,0.00093379646,0.000049215905,0.00003995331,0.000055532342,0.00019755954,0.000021779946,0.0018980387,0.00004622298],"about_ca_topic_score_codex":0.00018203916,"about_ca_topic_score_gemma":0.000022118644,"teacher_disagreement_score":0.011363623,"about_ca_system_score_codex":0.00012744947,"about_ca_system_score_gemma":0.00022885056,"threshold_uncertainty_score":0.21348265},"labels":[],"label_agreement":null},{"id":"W2940440831","doi":"10.1007/s00345-019-02708-8","title":"Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Research Council of Thailand","keywords":"Medicine; Cystectomy; Meta-analysis; Randomized controlled trial; Lymph node; Systematic review; Bladder cancer; Urology; Surgery; Internal medicine; MEDLINE; Cancer","score_opus":0.17243210489848457,"score_gpt":0.42835697177535487,"score_spread":0.2559248668768703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940440831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.0764923e-7,0.9927999,0.000015235539,0.0026604906,0.00028210762,0.0033615856,0.00004263328,0.00000930021,0.0008284838],"genre_scores_gemma":[0.00020823983,0.9904715,0.00036131308,0.003944,0.00006350019,0.0003825637,0.000016797687,0.00004899983,0.004503129],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99498594,0.001494626,0.0023115377,0.0004537022,0.000413442,0.00034072646],"domain_scores_gemma":[0.99543345,0.0009917906,0.0023349659,0.00075205317,0.00019083754,0.00029690514],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012457792,0.000638217,0.02203492,0.0008862813,0.00004198658,0.00005284622,0.00059432467,0.0002927177,0.002192164],"category_scores_gemma":[0.00029971896,0.00031834346,0.0050240075,0.00093218544,0.000114170114,0.00008941859,0.00023136789,0.0008677797,0.0000783346],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040055203,0.00022005345,0.00003536291,0.43057644,0.5606953,0.0011510436,0.000011472218,3.0669278e-7,1.0479051e-8,0.00001575202,0.0006499291,0.0062437523],"study_design_scores_gemma":[0.0018461864,0.00082218857,0.000073092306,0.0077039828,0.76423407,0.0014474182,0.00000158614,1.812186e-7,4.673552e-9,0.0000047619224,0.22369397,0.00017254484],"about_ca_topic_score_codex":0.00001643111,"about_ca_topic_score_gemma":0.00007726472,"teacher_disagreement_score":0.42287245,"about_ca_system_score_codex":0.00026234894,"about_ca_system_score_gemma":0.00066085486,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2940601802","doi":"10.1097/01.ju.0000555708.92392.e3","title":"MP28-03 DO ELDERLY MEN (&gt;75) HARBOR MORE AGGRESSIVE PROSTATE CANCER? COMPARISON OF DECIPHER AND PAM50 TESTS AMONG DIFFERENT AGE GROUPS","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; DECIPHER; Prostate cancer; Cancer; Gynecology; Population; Gerontology; Internal medicine; Bioinformatics","score_opus":0.01337347275848616,"score_gpt":0.2998278141215237,"score_spread":0.28645434136303755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940601802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98787534,0.009621645,0.0000111187765,0.0013603705,0.00024003725,0.00043124455,0.0000149864245,0.0000067273386,0.00043852793],"genre_scores_gemma":[0.9981178,0.001172872,0.000029688346,0.00025250012,0.00014645724,0.000009035778,0.0000017178935,0.000025119563,0.0002448093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987201,0.00014487951,0.0004609026,0.00013669896,0.00028362754,0.00025379672],"domain_scores_gemma":[0.99854374,0.00017492559,0.00077063387,0.00022897561,0.0001445217,0.00013720406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018241476,0.0001880371,0.000679311,0.0000847354,0.00004558724,0.000010082229,0.0001547788,0.000097443495,0.00018534613],"category_scores_gemma":[0.000034825185,0.000102116566,0.00008846563,0.00007550907,0.00022249752,0.000064596585,0.00005246314,0.00036148517,0.000005154229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003793078,0.00033563358,0.9685496,0.00007611987,0.0006959184,0.00014931904,0.0050421576,0.00006328529,0.011061784,0.000026057198,0.0011459853,0.00906106],"study_design_scores_gemma":[0.0056673987,0.0060158614,0.9832469,0.00018653674,0.0008785022,0.0002456926,0.00048494388,0.000119136304,0.0023558848,0.00031921253,0.00037153385,0.00010836351],"about_ca_topic_score_codex":0.000120515855,"about_ca_topic_score_gemma":0.000061000446,"teacher_disagreement_score":0.014697332,"about_ca_system_score_codex":0.000052604086,"about_ca_system_score_gemma":0.000075988064,"threshold_uncertainty_score":0.41641927},"labels":[],"label_agreement":null},{"id":"W2940618041","doi":"10.5489/cuaj.6015","title":"Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; University of Ottawa; McGill University Health Centre; Spinal Cord Injury BC; Queen's University; University of British Columbia; Princess Margaret Cancer Centre; University Health Network; CancerCare Manitoba; Ottawa Hospital; Juravinski Cancer Centre; University of Manitoba; Western University; University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Genitourinary system; Oncology; Bladder cancer; Disease; Internal medicine; Cancer; Stage (stratigraphy); Renal pelvis; Ureter; Urology","score_opus":0.010088257578885252,"score_gpt":0.24394493548064825,"score_spread":0.23385667790176298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940618041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685598,0.00062533567,0.000009474138,0.021212272,0.00051961734,0.00073571346,0.00040126502,0.000011207743,0.007925309],"genre_scores_gemma":[0.9945564,0.00017427263,0.00036541699,0.0026927083,0.00009452674,0.00001952916,0.00003280759,0.000019477275,0.0020448228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627143,0.00035418157,0.0008746112,0.00033755825,0.0012306162,0.00093159574],"domain_scores_gemma":[0.9965425,0.00039191535,0.00063236133,0.00017832298,0.00053624343,0.0017186408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012723434,0.00025591403,0.00073083903,0.00023339747,0.00019202763,0.000026992571,0.00021099992,0.00030675452,0.0022622696],"category_scores_gemma":[0.0006622429,0.00021342355,0.00012858112,0.00030416582,0.00006476323,0.00005773739,0.000041374864,0.00062107545,0.000011612972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00044096456,0.00012538554,0.9871248,0.000081410435,0.0009056283,0.0012225616,0.0000744714,0.00013412641,0.000053727184,0.00027875966,0.0076751537,0.001883002],"study_design_scores_gemma":[0.007553362,0.002086097,0.9590653,0.0000784702,0.00043154234,0.00034466936,0.0004053172,0.00026628858,0.00010510592,0.0005083674,0.028870579,0.00028488654],"about_ca_topic_score_codex":0.7298027,"about_ca_topic_score_gemma":0.7730028,"teacher_disagreement_score":0.043200064,"about_ca_system_score_codex":0.0059860754,"about_ca_system_score_gemma":0.011030836,"threshold_uncertainty_score":0.9986498},"labels":[],"label_agreement":null},{"id":"W2940813293","doi":"10.1097/01.ju.0000555300.24108.86","title":"MP14-04 RENAL BIOPSY - WHEN WILL IT CHANGE MANAGEMENT?","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Medicine; Biopsy; Nephrectomy; Renal biopsy; General surgery; Radiology; Kidney; Internal medicine","score_opus":0.0276839703194406,"score_gpt":0.2818448827630535,"score_spread":0.2541609124436129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940813293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8755235,0.004595228,0.0003197262,0.070734695,0.0016887973,0.0008220927,0.000010619997,0.000025835108,0.046279475],"genre_scores_gemma":[0.9860382,0.0006989706,0.00022821965,0.008207323,0.00059951004,0.0000036611978,0.0000017068884,0.000017590917,0.004204821],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991985,0.00008379595,0.00023455321,0.00008056709,0.0002016903,0.00020088571],"domain_scores_gemma":[0.9994174,0.000043190175,0.0001717013,0.00022933632,0.000061192346,0.000077150355],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003053206,0.00010287671,0.0002534402,0.00010468283,0.000032439886,0.0000049095866,0.00017296159,0.000059758913,0.0014662133],"category_scores_gemma":[0.000006869118,0.000057824655,0.00009211893,0.00007020414,0.000054312368,0.00009085371,0.000045125405,0.00022366933,0.00021521587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062262658,0.0039964295,0.26067936,0.0008612001,0.018017592,0.008372574,0.033394154,0.0001208686,0.046321526,0.0075832447,0.3068175,0.2515729],"study_design_scores_gemma":[0.019319408,0.011581544,0.19134317,0.00018595385,0.0038143382,0.014404513,0.0007051252,0.00007316443,0.0009062608,0.0076794596,0.7496443,0.00034279557],"about_ca_topic_score_codex":0.0000257541,"about_ca_topic_score_gemma":0.0000036328581,"teacher_disagreement_score":0.44282678,"about_ca_system_score_codex":0.000033921704,"about_ca_system_score_gemma":0.00003002228,"threshold_uncertainty_score":0.9994466},"labels":[],"label_agreement":null},{"id":"W2940893743","doi":"10.1097/01.ju.0000556624.17353.4f","title":"MP57-11 PD-1/PD-L1 IMMUNE-CHECKPOINT INHIBITION WITH RADIATION IN BLADDER CANCER: IN SITU AND ABSCOPAL EFFECTS","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immune system; Bladder cancer; Radiation therapy; Cancer; Immune checkpoint; Cancer research; Tumor microenvironment; Flow cytometry; Immunotherapy; Oncology; Internal medicine; Immunology","score_opus":0.005657511822532342,"score_gpt":0.2500148249179691,"score_spread":0.24435731309543676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940893743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912281,0.004446421,0.000024027744,0.0033703512,0.00016832308,0.00034997376,0.0000015029585,0.000003969223,0.00040730002],"genre_scores_gemma":[0.9978806,0.0011904873,0.000024310131,0.0007129755,0.00011657254,0.0000071991376,0.0000016199456,0.000013640432,0.00005259099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913204,0.00015445804,0.00029993337,0.000094020375,0.00014379768,0.0001757656],"domain_scores_gemma":[0.9994799,0.00012067567,0.00019557474,0.00011092677,0.000043047366,0.000049882867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003803815,0.00011090453,0.000324543,0.00016912306,0.000018680521,0.0000051375355,0.00004391073,0.000079309146,0.000069022855],"category_scores_gemma":[0.000021158272,0.00006620722,0.00003428641,0.00013098659,0.00006132543,0.00008919794,0.00001610062,0.00030461285,0.0000075357834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019675812,0.00060406316,0.6996723,0.00022818462,0.00044858715,0.000599451,0.0070742755,0.0013673392,0.24671593,0.00009621753,0.00020889325,0.023308966],"study_design_scores_gemma":[0.012914503,0.0034657088,0.9633362,0.00016381122,0.00024072564,0.0008345088,0.00012355714,0.00009352441,0.01816249,0.00033657273,0.0002406738,0.00008769062],"about_ca_topic_score_codex":0.00042607787,"about_ca_topic_score_gemma":0.00070874055,"teacher_disagreement_score":0.26366395,"about_ca_system_score_codex":0.000104943414,"about_ca_system_score_gemma":0.00013952314,"threshold_uncertainty_score":0.2699852},"labels":[],"label_agreement":null},{"id":"W2941005461","doi":"10.1097/01.ju.0000555680.51731.d0","title":"MP26-15 MOLECULAR SUBTYPING REVEALS LUMINAL BLADDER TUMORS HAVE LOWER RATES OF PATHOLOGICAL UPSTAGING AT RADICAL CYSTECTOMY","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Subtyping; Medicine; Pathological; Urology; Bladder cancer; Pathology; Internal medicine; Cancer","score_opus":0.015268578782416728,"score_gpt":0.2845394560033557,"score_spread":0.26927087722093895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941005461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926928,0.0027060653,0.00023037301,0.0023853187,0.00029909224,0.00026162935,0.000004036081,0.0000086034615,0.0014120608],"genre_scores_gemma":[0.9974504,0.00010341557,0.00017967238,0.0016231487,0.00019812722,0.0000022514362,0.000001651342,0.000024097628,0.00041722122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99822265,0.0003729312,0.00058301474,0.00015594039,0.00033849795,0.00032694158],"domain_scores_gemma":[0.99874556,0.00024067402,0.00043175166,0.00028751398,0.00016124739,0.00013324548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081421743,0.00018315761,0.0006488888,0.000121635305,0.000051297462,0.00000502596,0.00021797574,0.00013273892,0.0007468457],"category_scores_gemma":[0.000118853946,0.000105141226,0.00022424318,0.00010032597,0.00027907456,0.00004772129,0.000085991014,0.00047007788,0.0000444302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018040096,0.0008313108,0.34385484,0.00017078221,0.0014224995,0.004956019,0.0026600768,0.00036799448,0.62368923,0.0002672964,0.0021741753,0.001565693],"study_design_scores_gemma":[0.044367097,0.041107174,0.5905752,0.0009456945,0.0065146037,0.09032907,0.0024494142,0.00072112813,0.20261171,0.006212886,0.012915124,0.0012508605],"about_ca_topic_score_codex":0.000012130522,"about_ca_topic_score_gemma":0.0000014421772,"teacher_disagreement_score":0.42107752,"about_ca_system_score_codex":0.00007624559,"about_ca_system_score_gemma":0.00012502432,"threshold_uncertainty_score":0.81774366},"labels":[],"label_agreement":null},{"id":"W2941023559","doi":"10.1097/01.ju.0000556224.50163.ad","title":"MP43-01 PHASE 2 KEYNOTE-057 STUDY: PEMBROLIZUMAB FOR PATIENTS WITH HIGH-RISK NON–MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Cancer; Psychoanalysis; Internal medicine; Psychology; Immunotherapy","score_opus":0.011985517215725234,"score_gpt":0.2898276754528961,"score_spread":0.2778421582371709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941023559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383676,0.00024158199,0.00039882405,0.0022243836,0.0006463555,0.0023671829,0.00017361768,0.000010955385,0.00010032062],"genre_scores_gemma":[0.9961561,0.000110037225,0.00019674376,0.0026828512,0.00034392657,0.00007087889,0.0000076064953,0.000056899906,0.00037496226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981029,0.00027612384,0.00047688457,0.00025906615,0.00043651919,0.00044850318],"domain_scores_gemma":[0.9976916,0.00053709943,0.00046419926,0.00042344013,0.0006235964,0.00026007145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038394344,0.00028605145,0.00070463674,0.0002120859,0.00012268216,0.000012669991,0.00026987158,0.00010054426,0.00045345398],"category_scores_gemma":[0.00019184683,0.00016240196,0.0001316758,0.0002272583,0.00008473893,0.00009923581,0.00006769392,0.0004057884,0.000054741853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42126963,0.011895492,0.42768714,0.00015418258,0.0106052,0.00055070285,0.021529563,0.004205925,0.0079610385,0.000029702944,0.014931855,0.07917956],"study_design_scores_gemma":[0.12303926,0.17149277,0.68511385,0.00008629438,0.005257388,0.00019907753,0.001283391,0.000043940538,0.0018919117,0.00016564761,0.010969383,0.0004570594],"about_ca_topic_score_codex":0.00061389105,"about_ca_topic_score_gemma":0.00037176366,"teacher_disagreement_score":0.29823038,"about_ca_system_score_codex":0.00017784603,"about_ca_system_score_gemma":0.00053908856,"threshold_uncertainty_score":0.662256},"labels":[],"label_agreement":null},{"id":"W2941080801","doi":"10.1097/01.ju.0000556803.20663.98","title":"MP61-01 LONG TERM FUNCTIONAL OUTCOMES AND COMPLICATIONS OF STUDER ORTHOTOPIC NEOBLADDER","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Surgery; Bladder cancer; Fistula; Anastomosis; General surgery; Cancer; Internal medicine","score_opus":0.026210255694713656,"score_gpt":0.3024062360091399,"score_spread":0.27619598031442627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941080801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193674,0.0008206197,0.0002794912,0.0049504717,0.00017933098,0.00016759621,0.0000026916493,0.0000032117673,0.0016598537],"genre_scores_gemma":[0.9977106,0.00011658296,0.000057332563,0.0013940772,0.000063971056,0.0000016227814,0.0000014129186,0.0000065534086,0.0006478441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994329,0.000053433167,0.00023821586,0.000054329477,0.000134776,0.00008633912],"domain_scores_gemma":[0.9994071,0.00013698848,0.00016603529,0.00014983272,0.000095361145,0.0000446418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014328245,0.00006689408,0.00023965382,0.000058517388,0.000029793235,0.0000023661562,0.00006464372,0.000037871094,0.0004413289],"category_scores_gemma":[0.000013938952,0.000036530575,0.00005987844,0.00004169991,0.00008072254,0.000033599455,0.00002352783,0.0001451546,0.000013742412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033101297,0.00013205572,0.9955922,0.000015132607,0.00038032845,0.0000054999705,0.00022420456,0.000014353721,0.0013158058,0.00015467986,0.0002983697,0.0015363556],"study_design_scores_gemma":[0.0021348246,0.00064404384,0.9952465,0.000007943887,0.00032604975,0.000617218,0.0000430385,0.000005640927,0.000070368566,0.00023765775,0.0006395738,0.00002713252],"about_ca_topic_score_codex":0.000011489101,"about_ca_topic_score_gemma":0.000009312928,"teacher_disagreement_score":0.00577387,"about_ca_system_score_codex":0.000011365252,"about_ca_system_score_gemma":0.00006337829,"threshold_uncertainty_score":0.4832242},"labels":[],"label_agreement":null},{"id":"W2941090869","doi":"10.1371/journal.pone.0216255","title":"Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?","year":2019,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Uniscientia Foundation; Swiss Cancer Research Foundation; Kurt und Senta Herrmann Stiftung","keywords":"Cystectomy; Bladder cancer; Medicine; Hazard ratio; Meta-analysis; Confidence interval; Observational study; Systematic review; MEDLINE; Surgery; Cancer; Internal medicine","score_opus":0.5914096303677484,"score_gpt":0.48212237716877987,"score_spread":0.10928725319896854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941090869","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024465699,0.9798887,0.000009263606,0.0012314195,0.000098840566,0.016774824,0.0018994724,0.00002173845,0.000051292267],"genre_scores_gemma":[0.0004336466,0.9909973,0.0000692459,0.0005154015,0.00010381771,0.0074955127,0.000115594376,0.0000550777,0.00021436055],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948341,0.0014257132,0.0016493095,0.0007757877,0.0010058429,0.00030921263],"domain_scores_gemma":[0.9879977,0.008644234,0.0015428375,0.0011522083,0.0005003493,0.00016268542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011944248,0.00068391673,0.012490688,0.00019344363,0.00013343175,0.000023993309,0.00033290166,0.00019220225,0.000305543],"category_scores_gemma":[0.0019562575,0.00026659673,0.0034149364,0.0005914589,0.00020970571,0.00005635811,0.000088209345,0.00049509224,0.000017331267],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023025348,0.0006015529,0.0000014567863,0.67964625,0.31036925,0.0000015623107,0.00008866611,5.6446684e-8,6.934308e-7,0.000052058676,0.000038692546,0.008969517],"study_design_scores_gemma":[0.0015582585,0.0006796669,0.000005067385,0.18241951,0.8128273,0.000001146884,0.000023612061,9.930457e-7,0.00001698318,0.000008957142,0.002211273,0.00024724955],"about_ca_topic_score_codex":0.0001661958,"about_ca_topic_score_gemma":0.00004962086,"teacher_disagreement_score":0.50245804,"about_ca_system_score_codex":0.00026049727,"about_ca_system_score_gemma":0.001024267,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W2941189819","doi":"10.1097/01.ju.0000555579.23708.62","title":"PD18-07 A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Noon; Bladder cancer; Cancer; Internal medicine","score_opus":0.03450888036527358,"score_gpt":0.30647804660005284,"score_spread":0.2719691662347793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941189819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98365545,0.0010011437,0.008960742,0.004613766,0.00076378306,0.0006438322,0.000011068929,0.000009566974,0.0003406433],"genre_scores_gemma":[0.9972423,0.00013959984,0.00017529419,0.0017545477,0.00032058707,0.000021638856,0.0000025824152,0.000021009386,0.00032247382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920934,0.00008977221,0.00027061676,0.00009569374,0.00015616824,0.00017837896],"domain_scores_gemma":[0.9989503,0.000303596,0.0002770291,0.00015689542,0.00024783157,0.00006433055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035609887,0.00011418829,0.00027052363,0.00012122653,0.000050622668,0.0000048537504,0.00008154474,0.0000961134,0.0004064093],"category_scores_gemma":[0.000057524958,0.00006781339,0.0001468632,0.000096901495,0.000045055815,0.000054571516,0.000009585851,0.00016196907,0.000041171264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029340256,0.00047089346,0.023350237,0.00018247374,0.0025100429,0.00003978755,0.0009088931,0.001935238,0.880962,0.000017016362,0.0024811968,0.057801973],"study_design_scores_gemma":[0.0452402,0.020762358,0.40554503,0.00015565442,0.007263372,0.0013672463,0.00035095064,0.008629712,0.47986582,0.0018897553,0.028424414,0.0005055016],"about_ca_topic_score_codex":0.00008873431,"about_ca_topic_score_gemma":0.000054621327,"teacher_disagreement_score":0.40109617,"about_ca_system_score_codex":0.00007817301,"about_ca_system_score_gemma":0.00026807238,"threshold_uncertainty_score":0.44498965},"labels":[],"label_agreement":null},{"id":"W2941356607","doi":"10.1097/01.ju.0000556757.85628.f0","title":"PD47-01 BMS-986205, AN INDOLEAMINE 2,3-DIOXYGENASE 1 INHIBITOR, PLUS NIVOLUMAB: UPDATED SAFETY ACROSS ALL TUMOR COHORTS AND EFFICACY IN ADVANCED BLADDER CANCER","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Indoleamine 2,3-dioxygenase; Bladder cancer; Oncology; Internal medicine; Cancer; Immunotherapy; Tryptophan","score_opus":0.013235650381449767,"score_gpt":0.30693786803396134,"score_spread":0.2937022176525116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941356607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343103,0.003453038,0.000016103379,0.0017778806,0.0004830846,0.0006057677,0.000032739455,0.000017792589,0.00018256136],"genre_scores_gemma":[0.995392,0.0009370081,0.0000522462,0.0028970388,0.00031989563,0.000007451364,0.000015661359,0.000044390054,0.000334291],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806273,0.00025295408,0.00064459274,0.0002547171,0.0002915549,0.0004934325],"domain_scores_gemma":[0.9987347,0.00014505624,0.00036270352,0.00036302727,0.00015179263,0.00024270144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060556014,0.00026276425,0.00075367006,0.00012526503,0.00006986503,0.000013686429,0.0001979044,0.00013630484,0.00043984735],"category_scores_gemma":[0.000053229487,0.00017235326,0.00008379746,0.00019799879,0.00016816198,0.00019428472,0.000081378996,0.0006457239,0.000021126822],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23996456,0.006796482,0.28772706,0.0003614236,0.0053849467,0.0052817785,0.028738456,0.014615539,0.31731054,0.00010939721,0.008006004,0.08570379],"study_design_scores_gemma":[0.07231261,0.011338802,0.86801773,0.0001742929,0.0007354758,0.0051372354,0.0009790866,0.00065698585,0.014682814,0.00018792675,0.025193874,0.0005831504],"about_ca_topic_score_codex":0.00036434754,"about_ca_topic_score_gemma":0.00063424034,"teacher_disagreement_score":0.5802907,"about_ca_system_score_codex":0.000185278,"about_ca_system_score_gemma":0.0002995142,"threshold_uncertainty_score":0.7028362},"labels":[],"label_agreement":null},{"id":"W2941476437","doi":"10.1097/ju.0000000000000282","title":"Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Intensive care medicine; Internal medicine; Bladder cancer; Cancer","score_opus":0.036511843761909996,"score_gpt":0.33695068634261366,"score_spread":0.30043884258070364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941476437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881435,0.0015591889,0.0008754422,0.0080818795,0.00066101464,0.00053825806,0.000025562465,0.000007670158,0.00010746486],"genre_scores_gemma":[0.9979164,0.00012681847,0.0001314565,0.0014955743,0.00012468481,0.0000034356096,0.0000021806125,0.0000118108,0.00018762956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990575,0.00012178003,0.0003418724,0.000104528146,0.0002075428,0.000166807],"domain_scores_gemma":[0.99887824,0.00038475232,0.00016552147,0.00021011497,0.00011674167,0.00024462183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200776,0.00010382681,0.00040657385,0.00009129538,0.000037223268,0.000006571644,0.000101103404,0.000058827878,0.00007845147],"category_scores_gemma":[0.00024905548,0.000057504167,0.0001218707,0.00011904046,0.00007287365,0.000036257257,0.00002950135,0.0001900039,0.00001591465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005090005,0.00031866788,0.98974675,0.000038031478,0.0005244242,0.000048748654,0.00041942322,0.000017650264,0.0002845309,0.0003080237,0.0014504946,0.0017532242],"study_design_scores_gemma":[0.0048069935,0.002618094,0.9846136,0.000007660451,0.00056266855,0.00007986935,0.000058178008,0.00003102121,0.00004310142,0.00060428854,0.006506486,0.000068029854],"about_ca_topic_score_codex":0.000021193257,"about_ca_topic_score_gemma":0.000002065909,"teacher_disagreement_score":0.00977289,"about_ca_system_score_codex":0.000044346285,"about_ca_system_score_gemma":0.00009617411,"threshold_uncertainty_score":0.23449518},"labels":[],"label_agreement":null},{"id":"W2941696086","doi":"10.1097/01.ju.0000557168.51553.0b","title":"PD57-12 ROLE OF ROUTINE BIOPSY AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Biopsy; Cystectomy; Radiation therapy; Cancer; Cystoscopy; General surgery; Surgery; Radiology; Internal medicine; Urinary system","score_opus":0.011673928877796756,"score_gpt":0.2765171006291802,"score_spread":0.26484317175138344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941696086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98618615,0.007777231,0.00017231276,0.004725537,0.00034717013,0.00048268147,0.000037718117,0.000005013533,0.0002661877],"genre_scores_gemma":[0.99566025,0.00070731645,0.00011600004,0.0029282446,0.00036559734,0.000023337861,0.0000032823334,0.00002213491,0.00017383887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916506,0.000083235056,0.00032077273,0.00008706225,0.00016389911,0.0001799816],"domain_scores_gemma":[0.9989171,0.0002860391,0.00032702685,0.00019489712,0.00021257905,0.000062363826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024704222,0.000117760326,0.0003419023,0.000093776915,0.000024363628,0.0000029138807,0.00011502754,0.0000816298,0.00087011],"category_scores_gemma":[0.000031302017,0.000067237415,0.00016719161,0.00007062092,0.000065698194,0.000039264807,0.000007992425,0.00013998942,0.000008857896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065293476,0.0016418227,0.5990223,0.00016442941,0.004095556,0.000049179656,0.006027331,0.0020536913,0.23554228,0.00013003303,0.002697741,0.08328216],"study_design_scores_gemma":[0.03547798,0.013926993,0.8461901,0.000097824886,0.0018790913,0.00027885314,0.00041588812,0.000643191,0.07144041,0.0012583208,0.028112268,0.00027910597],"about_ca_topic_score_codex":0.00009660389,"about_ca_topic_score_gemma":0.000023091714,"teacher_disagreement_score":0.24716777,"about_ca_system_score_codex":0.000040573923,"about_ca_system_score_gemma":0.00036889178,"threshold_uncertainty_score":0.95270944},"labels":[],"label_agreement":null},{"id":"W2941775196","doi":"","title":"Mucin gene expression in human urothelium","year":2001,"lang":"en","type":"article","venue":"The Journal of Otolaryngology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelium; Medicine; Mucin; Gene expression; Gene; Pathology; Genetics; Urinary bladder; Internal medicine; Biology","score_opus":0.022716823851230628,"score_gpt":0.3009443486720337,"score_spread":0.27822752482080304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941775196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939209,0.0010126779,0.00030507834,0.0015116911,0.00015643882,0.0001765211,7.653765e-7,0.000006832909,0.0029090436],"genre_scores_gemma":[0.9975447,0.00041838054,0.00030968047,0.0008794434,0.0002972973,0.0000032939247,0.0000011522903,0.0000153772,0.0005306743],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990706,0.00016003558,0.0003446645,0.00007414685,0.00016229965,0.00018826743],"domain_scores_gemma":[0.99944335,0.00005215752,0.0001601899,0.00020163537,0.000064020525,0.00007863818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037484182,0.0000991904,0.0002988187,0.00014398247,0.000053629443,0.0000037049185,0.00014908526,0.00007413777,0.00041751025],"category_scores_gemma":[0.000029589402,0.000056122266,0.00007823375,0.00012430936,0.00006303394,0.00006185998,0.000028867209,0.00031098476,0.000021884267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002304787,0.00054163067,0.28775832,0.000019404568,0.00011284315,0.0015560981,0.0012275736,0.000032368258,0.70350647,0.000054447693,0.0013759692,0.001510069],"study_design_scores_gemma":[0.009403725,0.0027292036,0.782588,0.00019866416,0.00024844462,0.0171432,0.00018399376,0.00001588821,0.17792042,0.0016207243,0.0078035393,0.00014419532],"about_ca_topic_score_codex":0.00007922747,"about_ca_topic_score_gemma":0.000027014694,"teacher_disagreement_score":0.52558607,"about_ca_system_score_codex":0.00006035321,"about_ca_system_score_gemma":0.00007418028,"threshold_uncertainty_score":0.45714444},"labels":[],"label_agreement":null},{"id":"W2941819948","doi":"10.1097/01.ju.0000556457.60096.07","title":"MP51-15 PREDICTIVE VALUE AND POTENTIALS FOR CO-TARGETED THERAPY OF STAT1 SIGNALING IN GEMCITABINE/CISPLATIN RESISTANT BLADDER CANCER","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Medicine; Cisplatin; Bladder cancer; Value (mathematics); Cancer; Oncology; Psychoanalysis; Chemotherapy; Internal medicine; Psychology; Computer science","score_opus":0.018286289432731286,"score_gpt":0.3076831095402712,"score_spread":0.2893968201075399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941819948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884044,0.009018863,0.0003479305,0.001135743,0.00018660502,0.00069722463,0.00006723772,0.0000035795363,0.00013844697],"genre_scores_gemma":[0.9974523,0.0015042995,0.00018343836,0.00059541035,0.00013533258,0.000014629016,0.000002865625,0.000019966694,0.00009171879],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884075,0.00018092876,0.00046275248,0.000107769774,0.00019445599,0.00021336172],"domain_scores_gemma":[0.9989215,0.00034019945,0.00036751525,0.00012551979,0.00018332826,0.00006191416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007146226,0.0001219025,0.000468465,0.00012959211,0.00003042068,0.0000038239455,0.00009031817,0.000082662096,0.00017347798],"category_scores_gemma":[0.00004791119,0.00007243385,0.00007932124,0.000087746004,0.00009334549,0.00005520684,0.000012656181,0.0001962984,8.213288e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09247333,0.0006141438,0.15029258,0.00015209395,0.0030092138,0.000057525893,0.008787494,0.0041199015,0.7319443,0.00018846434,0.0010064798,0.0073544667],"study_design_scores_gemma":[0.052278087,0.027943557,0.7800886,0.00028262637,0.0017804422,0.00041067874,0.001656216,0.0014780551,0.124475725,0.0057048285,0.0035296448,0.0003715206],"about_ca_topic_score_codex":0.00016137777,"about_ca_topic_score_gemma":0.0000219887,"teacher_disagreement_score":0.629796,"about_ca_system_score_codex":0.000053677773,"about_ca_system_score_gemma":0.00027203085,"threshold_uncertainty_score":0.2953767},"labels":[],"label_agreement":null},{"id":"W2941837699","doi":"10.1097/01.ju.0000556426.17926.c6","title":"MP50-11 PARALLELS BETWEEN IMMUNOHISTOCHEMICAL CLASSIFICATION OF UPPER AND LOWER TRACT UROTHELIAL CARCINOMA USING MARKERS OF UROTHELIAL DIFFERENTIATION","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Medicine; Immunohistochemistry; Bladder cancer; Transitional cell carcinoma; Pathology; Cancer; Internal medicine","score_opus":0.02333256348079815,"score_gpt":0.28274498673923704,"score_spread":0.2594124232584389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941837699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977378,0.00053799833,0.00042412884,0.00059597584,0.0002104438,0.00029111645,0.000015017235,0.0000030031586,0.00018448663],"genre_scores_gemma":[0.99943155,0.00007981298,0.00014247223,0.00008431094,0.00019021107,0.0000011471541,0.000004003915,0.000018610805,0.000047898622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987659,0.00016891719,0.0005647441,0.00010430417,0.00024434156,0.00015180427],"domain_scores_gemma":[0.9988324,0.00017476385,0.0005704805,0.00020939672,0.00015177853,0.00006116188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033130773,0.00012972965,0.00047640776,0.00011727671,0.000028061864,0.0000031386573,0.00012309378,0.00013160845,0.00015563745],"category_scores_gemma":[0.000036479792,0.00008483861,0.00014016285,0.00006960063,0.0001674383,0.000067992594,0.00002882759,0.000178976,0.000002240008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048941816,0.00019504971,0.4661335,0.000050326384,0.00023367607,0.0000031409475,0.00040410768,0.000013433706,0.5269099,0.000037030935,0.000039704537,0.0010859775],"study_design_scores_gemma":[0.004477785,0.0025148783,0.974854,0.00004084749,0.0011033602,0.00027002802,0.00008763743,0.00027078725,0.015892493,0.0002312445,0.0001752327,0.000081692786],"about_ca_topic_score_codex":0.000078010315,"about_ca_topic_score_gemma":0.0000010045205,"teacher_disagreement_score":0.5110174,"about_ca_system_score_codex":0.00005439767,"about_ca_system_score_gemma":0.00014582371,"threshold_uncertainty_score":0.34596184},"labels":[],"label_agreement":null},{"id":"W2942397799","doi":"10.1097/01.ju.0000555927.90500.b0","title":"MP34-20 METASTASIS-FREE SURVIVAL (MFS) IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS (PTS) WITH PROSTATE-SPECIFIC ANTIGEN (PSA) DECLINE TO &lt; 0.2 NG/ML FOLLOWING APALUTAMIDE (APA) TREATMENT: POST HOC RESULTS FROM THE PHASE 3 SPARTAN STUDY","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Urology; Prostate-specific antigen; Oncology; Internal medicine; Metastasis; Prostate; Antigen; Cancer; Immunology","score_opus":0.02707255799377112,"score_gpt":0.30370752492515884,"score_spread":0.2766349669313877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942397799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872722,0.0014714996,0.000014797267,0.0057944483,0.0005851674,0.0033003776,0.0014430262,0.000016084266,0.00010236987],"genre_scores_gemma":[0.99796116,0.00043408226,0.00025395822,0.00072137517,0.00020280374,0.00006644845,0.00011635861,0.000071706505,0.00017212918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594617,0.0008052618,0.0012186773,0.00047544998,0.00093642046,0.0006180464],"domain_scores_gemma":[0.9970936,0.00068625284,0.0007187704,0.00089834357,0.0003492935,0.00025372865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012101094,0.00048422636,0.0010624997,0.00022136084,0.00019517449,0.000062530264,0.00048636796,0.00007151124,0.0000922081],"category_scores_gemma":[0.00014148586,0.00024490283,0.00019364935,0.0005003537,0.00010629062,0.00021297153,0.00009753499,0.000408804,0.000031014784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39335674,0.011620064,0.4860922,0.00003743186,0.007400178,0.0021620374,0.049610842,0.0038380583,0.021773102,0.0000137860925,0.0008374961,0.023258053],"study_design_scores_gemma":[0.16672555,0.095487475,0.7139789,0.00026557225,0.004370141,0.00011490749,0.0075320285,0.00010178818,0.001550399,0.00015239137,0.0090967985,0.00062409946],"about_ca_topic_score_codex":0.0022885883,"about_ca_topic_score_gemma":0.01708918,"teacher_disagreement_score":0.22788663,"about_ca_system_score_codex":0.00031538596,"about_ca_system_score_gemma":0.0005279781,"threshold_uncertainty_score":0.9986847},"labels":[],"label_agreement":null},{"id":"W2942569296","doi":"10.14740/jmc.v10i4.3277","title":"Systemic Tumor Seeding Secondary to Peritonitis due to the Immediate Postoperative Intravesical Instillation of Pirarubicin After Intravesical Explosion Induced Bladder Perforation During Bipolar Transurethral Resection of Bladder Tumors","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pirarubicin; Surgery; Perforation; Bladder cancer; Urology; Chemotherapy; Cancer; Internal medicine","score_opus":0.017199171381885467,"score_gpt":0.2783738547777805,"score_spread":0.261174683395895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942569296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413806,0.0006248492,0.00021039697,0.0035186678,0.00061773177,0.000797185,0.000038157683,0.0000100594025,0.000044891178],"genre_scores_gemma":[0.9983392,0.00006787016,0.000120450066,0.0005019282,0.00088809704,0.000023542565,0.0000072790685,0.000033377542,0.000018290677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965176,0.0002385684,0.0011170144,0.00024869494,0.0016004429,0.00027770596],"domain_scores_gemma":[0.99830294,0.00021146722,0.00033210946,0.00019679447,0.00050718494,0.00044953547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008023441,0.00024134759,0.0007590329,0.0003854813,0.00008061163,0.00002487016,0.00016335423,0.00018791958,0.00069537933],"category_scores_gemma":[0.0006173393,0.00015390369,0.00019822255,0.00039695858,0.00008666658,0.00029146738,0.000049779952,0.00075519,0.000014975081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02225078,0.00088122213,0.03130839,0.0012724499,0.00083582994,0.0028723988,0.030400682,0.0002375068,0.8874249,0.00005123687,0.00037107317,0.02209352],"study_design_scores_gemma":[0.00843216,0.017761216,0.3984968,0.005476326,0.0005981445,0.01741359,0.009679079,0.0005151442,0.5410326,0.000018018805,0.00018155342,0.0003953798],"about_ca_topic_score_codex":0.00012486905,"about_ca_topic_score_gemma":0.00005675962,"teacher_disagreement_score":0.3671884,"about_ca_system_score_codex":0.00020166983,"about_ca_system_score_gemma":0.0006794288,"threshold_uncertainty_score":0.76139164},"labels":[],"label_agreement":null},{"id":"W2943108118","doi":"10.1093/annonc/mdz127","title":"Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of &gt;2 years of follow-up","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":488,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cilag; National Center for Advancing Translational Sciences; National Cancer Institute; Foundation Medicine; Ipsen; EMD Serono; Sanofi; Fidia Farmaceutici; Eisai; Astellas Pharma; Merck Sharp and Dohme; Genentech; GlaxoSmithKline; UroGen Pharma; Pfizer; Incyte; Exelixis; Kidney Cancer Association; Merck; Bristol-Myers Squibb; Eli Lilly and Company; American Society of Clinical Oncology; AstraZeneca; Amgen","keywords":"Medicine; Docetaxel; Urothelial cancer; Paclitaxel; Pembrolizumab; Oncology; Internal medicine; Cancer; Chemotherapy; Randomized controlled trial; Bladder cancer; Immunotherapy","score_opus":0.08149898714952458,"score_gpt":0.4267595225361745,"score_spread":0.3452605353866499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943108118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877571,0.0015402256,0.0000055794007,0.0007250923,0.0016277232,0.0028434985,0.0005644446,0.000012467916,0.004923911],"genre_scores_gemma":[0.9942096,0.0044133444,0.00017905023,0.00010135299,0.00013916497,0.00015167781,0.00005211673,0.000029492137,0.00072421884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99668056,0.00037321544,0.0017492129,0.00037768623,0.00045870076,0.0003606536],"domain_scores_gemma":[0.99661946,0.0010494968,0.0012420902,0.00051616784,0.0004492701,0.00012350132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091265154,0.00025338796,0.0027105373,0.00033294962,0.000011750669,0.000001638136,0.00020989745,0.0002445354,0.00039242842],"category_scores_gemma":[0.0011178483,0.00020355963,0.00047938552,0.00038664584,0.0003313766,0.00008801796,0.000063248684,0.00020405352,0.000004959696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91033447,0.0025984836,0.000044409822,0.00021846368,0.0007177831,0.000024063791,0.00096632534,0.00002785824,0.008117405,0.00011073136,0.0006399567,0.07620005],"study_design_scores_gemma":[0.9180848,0.04180964,0.00018688907,0.0003874239,0.00043629875,0.0000034823345,0.00012780521,0.000034501132,0.030614903,0.000094497846,0.008080275,0.00013948734],"about_ca_topic_score_codex":0.0013094884,"about_ca_topic_score_gemma":0.00035915567,"teacher_disagreement_score":0.07606056,"about_ca_system_score_codex":0.00009749288,"about_ca_system_score_gemma":0.0013270789,"threshold_uncertainty_score":0.8300921},"labels":[],"label_agreement":null},{"id":"W2943235486","doi":"10.1097/ju.0000000000000297","title":"Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer","year":2019,"lang":"en","type":"review","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Immunotherapy; Bacillus (shape); Cancer immunotherapy; Cancer research; Urology; Cancer; Internal medicine; Microbiology","score_opus":0.0730889221987946,"score_gpt":0.3880559693428924,"score_spread":0.3149670471440978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943235486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000175734,0.994073,0.00035591435,0.0021361005,0.0013474239,0.0015176758,0.00016368684,0.000009731042,0.00022078463],"genre_scores_gemma":[0.00015472485,0.99513775,0.0001600376,0.0016634122,0.0009906819,0.00011484568,0.000018425586,0.00009807798,0.0016620266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977657,0.00048279468,0.0008773726,0.00021356787,0.00025701636,0.0004035557],"domain_scores_gemma":[0.9966852,0.0013071118,0.0010482236,0.00045772473,0.000386035,0.000115724346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063024083,0.0004078247,0.002018199,0.00033118736,0.0001310564,0.000012356311,0.00038848742,0.00031734104,0.0006279423],"category_scores_gemma":[0.00014645832,0.00022982206,0.00094365625,0.00022939628,0.0001370561,0.00006272426,0.000051789706,0.00078031135,0.000056564597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021515258,0.0001847268,0.000014167754,0.002089242,0.0069036414,0.00008346875,0.00070287404,0.00007145543,0.00009727437,0.00005990268,0.0072698323,0.9803719],"study_design_scores_gemma":[0.0029814097,0.0023470689,0.00004553331,0.001248453,0.008877642,0.0016196371,0.00007226907,0.0000038829044,0.000012904089,0.00009169521,0.9825065,0.00019300843],"about_ca_topic_score_codex":0.000070168,"about_ca_topic_score_gemma":0.000035747107,"teacher_disagreement_score":0.9801789,"about_ca_system_score_codex":0.00026271152,"about_ca_system_score_gemma":0.0020368018,"threshold_uncertainty_score":0.9371872},"labels":[],"label_agreement":null},{"id":"W2943659946","doi":"10.3747/co.26.4070","title":"Second-Line Systemic Therapies for Metastatic Urothelial Carcinoma: A Population-Based Cohort Analysis","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Island Health; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Docetaxel; Gemcitabine; Internal medicine; Oncology; Chemotherapy; Population; Cohort; Cancer; Urothelial carcinoma; Bladder cancer","score_opus":0.06597393562623936,"score_gpt":0.38487635807461723,"score_spread":0.31890242244837785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943659946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990777,0.0026211469,0.0021516993,0.0002619102,0.0010919493,0.002345811,0.00027515265,0.000057351655,0.0004179341],"genre_scores_gemma":[0.997324,0.000027064942,0.0004199485,0.00024449933,0.00022015611,0.0005110505,0.00069935754,0.000027796972,0.000526114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986864,0.000101186284,0.00038183434,0.00037597172,0.00018298485,0.0002716709],"domain_scores_gemma":[0.99903834,0.00021058857,0.000160739,0.00032601866,0.00015607396,0.00010822595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020483322,0.00020066927,0.0008082551,0.00027114668,0.00005429762,0.000010659447,0.00008277933,0.00007600559,0.0012047208],"category_scores_gemma":[0.000028956416,0.00015683779,0.0003563618,0.00030272995,0.000028644885,0.00004470224,0.000011717562,0.0001186208,0.000066169574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006115609,0.0004754107,0.9917324,0.00046137275,0.0015966276,0.0000056060853,0.00020396305,0.0000926414,0.00036071485,0.00012695591,0.00017342526,0.0041592848],"study_design_scores_gemma":[0.019678317,0.0036256725,0.92848456,0.00012583249,0.012994501,0.00004655653,0.00025074373,0.00954167,0.00052337896,0.00020129193,0.024107095,0.0004204016],"about_ca_topic_score_codex":0.00011556458,"about_ca_topic_score_gemma":0.00012951132,"teacher_disagreement_score":0.0632479,"about_ca_system_score_codex":0.0003771592,"about_ca_system_score_gemma":0.000418689,"threshold_uncertainty_score":0.9997083},"labels":[],"label_agreement":null},{"id":"W2943898827","doi":"10.1111/bju.14791","title":"Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration","year":2019,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Surgery; General surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.022109955241785207,"score_gpt":0.2925986096922693,"score_spread":0.2704886544504841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943898827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981976,0.0004686486,6.4760025e-7,0.0009984362,0.00002960195,0.0002518127,0.000026169022,0.0000012402885,0.000025807665],"genre_scores_gemma":[0.99873877,0.0008384682,0.00008916239,0.00025041075,0.0000134922475,0.0000054420198,0.000018967354,0.0000057942398,0.000039504022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989996,0.0003526517,0.00027477407,0.00014361697,0.00011902664,0.000110348585],"domain_scores_gemma":[0.99959433,0.000111776055,0.00012913147,0.00004363343,0.000078612204,0.000042532418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090858346,0.00008308507,0.00037679228,0.00023792898,0.00001256426,0.00006279246,0.00008340325,0.000048419886,0.00006447767],"category_scores_gemma":[0.00010521407,0.00006373566,0.000008847098,0.00034183316,0.0001064265,0.00028519225,0.000037459296,0.00018662769,1.415221e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069289363,0.0002779977,0.9812904,0.0000059136573,0.000039492512,0.00033530415,0.0024057243,0.000016597905,0.0002001968,0.0000011149789,0.000014058325,0.014720279],"study_design_scores_gemma":[0.0073989327,0.00074696477,0.9897656,0.0000701486,0.000024057947,0.0002924848,0.00030769373,0.0012103362,0.000005175003,8.7987354e-7,0.00012541053,0.00005235633],"about_ca_topic_score_codex":0.0023290794,"about_ca_topic_score_gemma":0.051626656,"teacher_disagreement_score":0.049297575,"about_ca_system_score_codex":0.00003498687,"about_ca_system_score_gemma":0.000049083585,"threshold_uncertainty_score":0.9656787},"labels":[],"label_agreement":null},{"id":"W2944471807","doi":"10.1016/j.eururo.2019.05.001","title":"Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Risk stratification; Medical physics; Cancer; Internal medicine","score_opus":0.029982643837709613,"score_gpt":0.3119230620012545,"score_spread":0.2819404181635449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944471807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68503743,0.0071158996,0.0008501654,0.1838959,0.004646252,0.0040117414,0.00014130477,0.00061937695,0.113681905],"genre_scores_gemma":[0.9620766,0.00030953172,0.00010419513,0.02139556,0.0005151403,0.000018087809,0.00006111086,0.00006687406,0.015452873],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984234,0.0004533813,0.00025501547,0.00034499486,0.0001738365,0.00034937606],"domain_scores_gemma":[0.99922997,0.00010528718,0.00014732414,0.00034778292,0.00005095415,0.00011869704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035479607,0.00018013704,0.00025698,0.00009725317,0.00014707343,0.000019615803,0.00012338335,0.00003508132,0.0021039664],"category_scores_gemma":[0.000038526483,0.00011467715,0.00005634188,0.0002071782,0.0000774521,0.00006207613,0.00004581458,0.00026697098,0.0007557963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005530894,0.0010648597,0.5330494,0.00046517837,0.0022143594,0.0012343491,0.020573309,0.0008952581,0.006815476,0.008449237,0.3117933,0.10791439],"study_design_scores_gemma":[0.0076215276,0.0044214544,0.27130383,0.00014404357,0.00053588365,0.0006198158,0.0005773803,0.00018407585,0.0019882359,0.00017334898,0.7119402,0.0004901693],"about_ca_topic_score_codex":0.0004563658,"about_ca_topic_score_gemma":0.0006129198,"teacher_disagreement_score":0.40014693,"about_ca_system_score_codex":0.00019263834,"about_ca_system_score_gemma":0.00033385254,"threshold_uncertainty_score":0.99880826},"labels":[],"label_agreement":null},{"id":"W2944489822","doi":"10.1016/j.eururo.2019.04.036","title":"Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Pathological; Urology; Logistic regression; Subtyping; Bladder cancer; Stage (stratigraphy); Oncology; Internal medicine; Retrospective cohort study; Cancer","score_opus":0.01567969441747168,"score_gpt":0.2775872557985292,"score_spread":0.26190756138105753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944489822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826011,0.00036842606,0.00024024483,0.00020400647,0.0002623181,0.00060536904,0.000023901279,0.00004834279,0.015646305],"genre_scores_gemma":[0.99771076,0.00001477712,0.00036453176,0.0011430677,0.00014673603,0.000007832128,0.000023583127,0.0000676568,0.00052102236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968454,0.00083407486,0.0010315102,0.00055673317,0.00029880196,0.00043346075],"domain_scores_gemma":[0.9985033,0.0002205915,0.00040099933,0.0005611797,0.000119669225,0.00019421498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008114111,0.00027708174,0.00091078074,0.00012910826,0.000038231432,0.000005147285,0.00024509963,0.00013550335,0.0007006714],"category_scores_gemma":[0.0002725909,0.00022186195,0.00031523238,0.00016213363,0.0006162407,0.000034958415,0.00021037017,0.00034115746,0.00013058913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049178605,0.0003393695,0.9070775,0.0001295096,0.00014098658,0.0023230584,0.00026364662,0.00004102337,0.08409132,0.00009498717,0.00018996595,0.00039076383],"study_design_scores_gemma":[0.014481267,0.008760265,0.9533703,0.00019693945,0.0005009258,0.00083186285,0.00006774825,0.00024656922,0.018508183,0.00009514635,0.0025281443,0.0004126915],"about_ca_topic_score_codex":0.000032408792,"about_ca_topic_score_gemma":0.0000012920381,"teacher_disagreement_score":0.06558313,"about_ca_system_score_codex":0.00004481773,"about_ca_system_score_gemma":0.00009411661,"threshold_uncertainty_score":0.90472674},"labels":[],"label_agreement":null},{"id":"W2944914845","doi":"10.1016/j.ctrv.2019.05.002","title":"PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Bladder cancer; Context (archaeology); Immunotherapy; Meta-analysis; Odds ratio; PD-L1; Pembrolizumab; Carcinoma; Urothelial carcinoma; Cancer","score_opus":0.1338417283217021,"score_gpt":0.406187911463415,"score_spread":0.2723461831417129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944914845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048502414,0.9821775,0.0000033600645,0.000039562474,0.00009784819,0.011933333,0.0005592425,0.000048119775,0.00029077585],"genre_scores_gemma":[0.0010672144,0.98963434,0.00048538164,0.00012590781,0.0001185424,0.005945722,0.00075669726,0.00017004869,0.001696165],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941661,0.000629295,0.0022194553,0.0018280734,0.0005476725,0.0006094424],"domain_scores_gemma":[0.99635845,0.00018297366,0.0013870177,0.001516657,0.00013201302,0.00042288064],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00026526977,0.0017276078,0.015206681,0.0005298823,0.00007625675,0.00005050945,0.00018333572,0.00041103843,0.0005102094],"category_scores_gemma":[0.000024464178,0.0007464765,0.004338097,0.0010425028,0.00014672476,0.00016581995,0.00006623604,0.00043150893,0.000059183792],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088516,0.0016908878,0.36374,0.004719659,0.10057938,0.00006503405,0.000058271507,9.2861694e-7,1.04131075e-7,3.797327e-7,0.000046502475,0.5282137],"study_design_scores_gemma":[0.010184955,0.0040468755,0.020305205,0.0044986526,0.55645674,0.0000062341746,0.0000053869517,4.59246e-7,0.000004338221,3.0099665e-7,0.4038466,0.0006442501],"about_ca_topic_score_codex":0.0007455763,"about_ca_topic_score_gemma":0.00038293548,"teacher_disagreement_score":0.5275695,"about_ca_system_score_codex":0.0011465251,"about_ca_system_score_gemma":0.00071571546,"threshold_uncertainty_score":0.999547},"labels":[],"label_agreement":null},{"id":"W2945646193","doi":"10.1016/j.clgc.2019.05.019","title":"Genomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant Histology","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cyclophosphamide; Chemotherapy; Sarcomatoid carcinoma; Urothelial carcinoma; Radiation therapy; Oncology; Disease; Histology; Internal medicine; Cancer; Carcinoma","score_opus":0.030470337433298546,"score_gpt":0.33155655983775306,"score_spread":0.30108622240445454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945646193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951252,0.0023064355,0.00003536687,0.0006125834,0.00023690466,0.00074320514,0.000108105654,0.000029267232,0.000802935],"genre_scores_gemma":[0.99403864,0.0008179516,0.0006909525,0.00043417735,0.00024704382,0.00009785127,0.000015530679,0.00003958787,0.0036182571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806595,0.00025765816,0.000581649,0.00059718295,0.00019320173,0.00030434775],"domain_scores_gemma":[0.998531,0.0003086907,0.00020420368,0.0006014485,0.00009772171,0.0002569439],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022277128,0.00027410558,0.0010496072,0.00021628772,0.00004677543,0.000007138555,0.000093366034,0.00016639431,0.0010934917],"category_scores_gemma":[0.000020039051,0.00018988141,0.00033263655,0.0003108841,0.00025517464,0.00003847667,0.000053940323,0.00015936774,0.000045229735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028885324,0.00077725225,0.95602185,0.000035378125,0.0037897974,0.0005471373,0.00021843643,0.000020510399,0.003758278,0.0000064841665,0.00012182022,0.0058177616],"study_design_scores_gemma":[0.009657444,0.008936444,0.9709898,0.000027419783,0.0038174898,0.00018261932,0.00006338828,0.00013113272,0.0011569897,0.000010938231,0.004824194,0.0002020908],"about_ca_topic_score_codex":0.0007602145,"about_ca_topic_score_gemma":0.000107554704,"teacher_disagreement_score":0.01922788,"about_ca_system_score_codex":0.00023158421,"about_ca_system_score_gemma":0.0007786941,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W2946197179","doi":"10.1016/s0167-8140(19)30869-2","title":"SP-0449 Stepwise Development of Personalized Radiation Therapy for Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bladder cancer; Radiation therapy; Medicine; Medical physics; Oncology; Cancer; Internal medicine","score_opus":0.026886947875104424,"score_gpt":0.34397549790154736,"score_spread":0.31708855002644293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946197179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735979,0.022031186,0.0007431711,0.0010786573,0.00032382677,0.0013830692,0.000019855848,0.00002148593,0.0008008416],"genre_scores_gemma":[0.9534422,0.021102557,0.014049787,0.0046670446,0.0005062822,0.0005752768,0.000052695832,0.00006925627,0.005534863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926436,0.00003290545,0.00021348319,0.00021337724,0.000102037244,0.0001738662],"domain_scores_gemma":[0.99958795,0.00007768307,0.00009631558,0.00010904072,0.00005835053,0.000070665905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012117762,0.000129149,0.00040566767,0.000066773224,0.000046313187,0.0000042714214,0.000038623664,0.0001224007,0.0009649228],"category_scores_gemma":[0.0000033909735,0.00009911832,0.000073241856,0.00006322015,0.0000580082,0.000037791924,0.000003917364,0.000055591918,0.000003128031],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005947082,0.0004465885,0.057060014,0.00011486332,0.0010396331,0.0000024616932,0.007538427,0.0000034853958,0.040001243,0.00029181456,0.0010089594,0.8865454],"study_design_scores_gemma":[0.030544404,0.003440303,0.07893133,0.00004361312,0.00009545196,0.000021031708,0.00021842915,0.00019270956,0.017539646,0.00006916881,0.8687139,0.00019002813],"about_ca_topic_score_codex":0.00004088916,"about_ca_topic_score_gemma":0.000025736204,"teacher_disagreement_score":0.8863554,"about_ca_system_score_codex":0.00029313235,"about_ca_system_score_gemma":0.0005544112,"threshold_uncertainty_score":0.9999483},"labels":[],"label_agreement":null},{"id":"W2946503736","doi":"10.22374/cjgim.v14i2.283","title":"Disseminated Mycobacterium Sepsis with Bone Marrow, Liver, and Lung Involvement Following Intravesical Bacillus Calmette-Guerin (BCG) Therapy","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Ethambutol; Pancytopenia; Bone marrow; Bone marrow suppression; Pathology; Isoniazid; Internal medicine; Gastroenterology; Chemotherapy; Tuberculosis","score_opus":0.013324149775767768,"score_gpt":0.25579844004339647,"score_spread":0.2424742902676287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946503736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847591,0.008984561,0.00012793423,0.003277849,0.0011286205,0.0003430753,0.000014760526,0.000008181071,0.0013559446],"genre_scores_gemma":[0.9926326,0.0008105424,0.00041114472,0.0023240852,0.00083027297,0.000005694452,0.000016492122,0.000043580174,0.0029255627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831975,0.000056814373,0.0005236284,0.00025316773,0.0004163237,0.00043031506],"domain_scores_gemma":[0.9981085,0.000041837942,0.0002060425,0.00020407222,0.00020016919,0.0012393575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025504525,0.00030024283,0.0007155137,0.00036315696,0.00006520277,0.000033903994,0.00014178979,0.00009535035,0.0009989698],"category_scores_gemma":[0.000033496744,0.00019056862,0.00013222989,0.00018597988,0.00015414128,0.00014493968,0.00001576393,0.00041301796,0.0000071537966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047734645,0.00022866402,0.6838162,0.00039073566,0.0048146565,0.023578105,0.006193568,0.000012737256,0.17440934,0.00014912429,0.030191105,0.07144229],"study_design_scores_gemma":[0.070817895,0.049526654,0.6971189,0.014183262,0.0036721805,0.022030776,0.003273749,0.0018149184,0.057760213,0.00021181248,0.077595055,0.0019946017],"about_ca_topic_score_codex":0.014018477,"about_ca_topic_score_gemma":0.0034072713,"teacher_disagreement_score":0.11664913,"about_ca_system_score_codex":0.0003987671,"about_ca_system_score_gemma":0.00052720937,"threshold_uncertainty_score":0.9999142},"labels":[],"label_agreement":null},{"id":"W2946582426","doi":"10.1111/tri.13464","title":"Significance of atypical urinary cytology in the evaluation of patients with end‐stage renal disease for kidney transplantation – a retrospective study","year":2019,"lang":"en","type":"article","venue":"Transplant International","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cystoscopy; Urine cytology; Cytology; Bladder cancer; Urology; Urinary system; Transplantation; End stage renal disease; Cancer; Internal medicine; Hemodialysis; Pathology","score_opus":0.024553660137693153,"score_gpt":0.31401159829240655,"score_spread":0.2894579381547134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946582426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949632,0.000011997982,0.00043346925,0.00018628714,0.0000928558,0.0023619768,0.0015353407,0.000004743177,0.00041009995],"genre_scores_gemma":[0.9987236,0.000008081064,0.00007406707,0.000066207445,0.000024345953,0.00022837179,0.0008314631,0.000007950664,0.000035858793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987495,0.000088399465,0.00023452831,0.00018825235,0.00065282267,0.000086514614],"domain_scores_gemma":[0.99944365,0.00006511202,0.00009102285,0.00011766612,0.0002447145,0.000037825124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025176804,0.00009091244,0.00017694326,0.00008549877,0.000012915976,0.0000025890004,0.00009588026,0.000027158412,0.00025599916],"category_scores_gemma":[0.000016155953,0.00005969544,0.000052485422,0.00007384433,0.00003849337,0.000059398724,0.0000019270292,0.00007012745,0.0000013658273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018229133,0.0022196164,0.9760573,0.00009826555,0.00018267815,0.000012413108,0.002235601,0.00009182322,0.00030894257,0.000392338,0.000007658328,0.00016426438],"study_design_scores_gemma":[0.012892221,0.0021659262,0.98323715,0.00012512159,0.00044205526,0.0000042013926,0.00011051639,0.0004500065,0.00038262972,0.00011660688,0.000018669307,0.00005492083],"about_ca_topic_score_codex":0.000056364494,"about_ca_topic_score_gemma":0.000044899323,"teacher_disagreement_score":0.0071798586,"about_ca_system_score_codex":0.00007350395,"about_ca_system_score_gemma":0.00019777403,"threshold_uncertainty_score":0.28030112},"labels":[],"label_agreement":null},{"id":"W2946988085","doi":"10.2147/cmar.s199432","title":"&lt;p&gt;Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion&lt;/p&gt;","year":2019,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Korea Health Industry Development Institute; National Research Foundation; Société Internationale D'Urologie","keywords":"Medicine; Cystectomy; Urinary diversion; Perioperative; Extracorporeal; Urinary system; Surgery; Odds ratio; Logistic regression; Anastomosis; Ileus; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.03365447327549187,"score_gpt":0.32413062899865863,"score_spread":0.29047615572316676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946988085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94331837,0.0030962136,0.000063774045,0.0029209978,0.00012610912,0.001961915,0.000076976765,0.000040856554,0.04839481],"genre_scores_gemma":[0.98258346,0.0010589256,0.00034638017,0.00017277319,0.00006081609,0.00037603485,0.000052554737,0.000025196938,0.0153238475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981488,0.00009147487,0.00020558207,0.0004506569,0.0007440439,0.0003594389],"domain_scores_gemma":[0.99905735,0.00005329941,0.00004941628,0.00038742524,0.00024052325,0.00021195592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019890784,0.00017343344,0.00029886424,0.00028874923,0.00015932902,0.000027648948,0.0001452148,0.00007362871,0.00072652573],"category_scores_gemma":[0.0000036060565,0.000119750526,0.00006112486,0.00045033553,0.0004143712,0.000102247475,0.00020116236,0.00021872962,0.000039845945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0127866585,0.002616982,0.8808727,0.0021733136,0.0035088037,0.0010552246,0.002418805,0.00004781444,0.01608867,0.0042707818,0.03303196,0.04112828],"study_design_scores_gemma":[0.005159685,0.0016344971,0.9414383,0.0005117407,0.0002031726,0.000030339903,0.00023722513,0.00008287263,0.0004244272,0.000038289792,0.050085645,0.0001537863],"about_ca_topic_score_codex":0.00008177836,"about_ca_topic_score_gemma":0.00002971165,"teacher_disagreement_score":0.060565617,"about_ca_system_score_codex":0.00018119876,"about_ca_system_score_gemma":0.00012731836,"threshold_uncertainty_score":0.7954947},"labels":[],"label_agreement":null},{"id":"W2947165750","doi":"10.1200/jco.2019.37.15_suppl.4552","title":"5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Atezolizumab; Durvalumab; Medicine; Avelumab; Metastatic Urothelial Carcinoma; Oncology; Internal medicine; Proportional hazards model; Hazard ratio; Urothelial carcinoma; Cancer; Nivolumab; Immunotherapy; Bladder cancer; Confidence interval","score_opus":0.08777987752887684,"score_gpt":0.3847421826644194,"score_spread":0.29696230513554256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947165750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945312,0.00007672463,0.0013686706,0.0006308973,0.0016653731,0.0013127528,0.00014540013,0.000008026772,0.0002609463],"genre_scores_gemma":[0.9957733,0.0000161548,0.0031417676,0.0002986144,0.0005153613,0.000017501072,0.000017182118,0.00004519084,0.00017491782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658436,0.00019446318,0.0020288955,0.00026119393,0.00061945117,0.0003116471],"domain_scores_gemma":[0.99443513,0.0021993597,0.0017359672,0.00023270163,0.0010748006,0.00032201433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067650137,0.0002466837,0.0019969423,0.00011815256,0.000032639186,0.000008233184,0.0001601872,0.00021015698,0.00013194421],"category_scores_gemma":[0.00150405,0.00014501125,0.0005322501,0.00008084979,0.000120697674,0.000120599856,0.000044002758,0.0005330097,0.000006572059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019691152,0.002938317,0.9611967,0.0001713467,0.0007632341,0.000024400726,0.0001925036,0.000056091187,0.00022410975,0.000027013884,0.00009059714,0.014624526],"study_design_scores_gemma":[0.029429907,0.040113147,0.92667973,0.00019875017,0.0012052377,0.000014186257,0.000054770637,0.0015474444,0.00016360592,0.00025782693,0.00019124556,0.00014414467],"about_ca_topic_score_codex":0.000019048974,"about_ca_topic_score_gemma":0.000107289765,"teacher_disagreement_score":0.037174832,"about_ca_system_score_codex":0.00015102996,"about_ca_system_score_gemma":0.0017034728,"threshold_uncertainty_score":0.5913387},"labels":[],"label_agreement":null},{"id":"W2947269397","doi":"10.1200/jco.2019.37.15_suppl.6639","title":"A cost-utility analysis of atezolizumab in the second-line treatment of metastatic urothelial carcinoma.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Atezolizumab; Medicine; Docetaxel; Metastatic Urothelial Carcinoma; Cost effectiveness; Taxane; Oncology; Chemotherapy; Cost-effectiveness analysis; Quality-adjusted life year; Internal medicine; Cancer; Bladder cancer; Immunotherapy; Breast cancer; Urothelial carcinoma; Pembrolizumab","score_opus":0.2139740202085181,"score_gpt":0.4899264956342296,"score_spread":0.27595247542571144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947269397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468476,0.0006079545,0.000037589143,0.0011477809,0.0003287051,0.0005591703,0.00007173921,0.0000016353667,0.0025606842],"genre_scores_gemma":[0.99832207,0.00024659908,0.00042876415,0.0005251983,0.00014622445,0.000008312137,0.000006791503,0.000008336093,0.000307682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960595,0.0007277756,0.002494564,0.00016961436,0.00037212673,0.0001764205],"domain_scores_gemma":[0.9956852,0.0020253502,0.0015225089,0.00034997615,0.0002850613,0.00013189552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018434931,0.0001431051,0.0025790446,0.0002804008,0.000010500233,0.0000024278174,0.00016598085,0.00014627402,0.001263818],"category_scores_gemma":[0.00037493007,0.000075108874,0.0011155909,0.0004710821,0.00016367805,0.00004773956,0.000016034013,0.000296826,0.0000074258323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013884254,0.009354726,0.90131956,0.00007837688,0.006326764,0.00034600552,0.0012520571,0.00006727403,0.00023563113,0.000051303712,0.0001290078,0.066955045],"study_design_scores_gemma":[0.021604633,0.03477526,0.92531186,0.000027188344,0.0073987474,0.000084457286,0.00045420404,0.00047256213,0.00064476964,0.00014996903,0.009015465,0.00006090878],"about_ca_topic_score_codex":0.00029654696,"about_ca_topic_score_gemma":0.0006405025,"teacher_disagreement_score":0.06689414,"about_ca_system_score_codex":0.00015904485,"about_ca_system_score_gemma":0.0015137647,"threshold_uncertainty_score":0.99964917},"labels":[],"label_agreement":null},{"id":"W2947386937","doi":"10.22374/jeleu.v2i2.40","title":"Comparison of Efficacy and Safety Between Postoperative Intravesical Instillation of Mitomycin-C and Continuous Saline Bladder Irrigation after TURBT in Non-muscle Invasive Bladder Cancers","year":2019,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Saline; Mitomycin C; Urology; Bladder cancer; Medicine; Surgery; Internal medicine; Cancer","score_opus":0.013185025009185855,"score_gpt":0.30224574187684805,"score_spread":0.2890607168676622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947386937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975491,0.00092288596,0.00006860684,0.00052192225,0.00014008848,0.0004629701,0.000025799694,0.0000025631512,0.00030605815],"genre_scores_gemma":[0.99901533,0.00012388839,0.000509001,0.00014382988,0.00015579033,0.0000038316566,0.000010663715,0.000015333462,0.000022349204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984223,0.00012443821,0.0008348705,0.00019124428,0.0002368252,0.00019027214],"domain_scores_gemma":[0.99856746,0.00039234935,0.0005407461,0.00011148243,0.00026635427,0.00012157832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022237675,0.00017208882,0.0009443428,0.00024700363,0.000018769451,0.000005990494,0.000054606633,0.00014777112,0.0000797756],"category_scores_gemma":[0.00013301418,0.00013945854,0.000071907176,0.00013153542,0.000219071,0.00012997481,0.000033299693,0.00035520346,0.0000013021195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007611189,0.00026055798,0.9345584,0.00011459246,0.00045330296,0.00007299881,0.0046518105,0.00013828214,0.04248659,0.000031443687,0.00004240512,0.009578423],"study_design_scores_gemma":[0.010982547,0.0057850904,0.9661417,0.00018192065,0.00038154703,0.00018410082,0.00057211175,0.00012945347,0.015366971,0.00004741254,0.0001276025,0.000099562174],"about_ca_topic_score_codex":0.00025409358,"about_ca_topic_score_gemma":0.00013005611,"teacher_disagreement_score":0.031583276,"about_ca_system_score_codex":0.00008462021,"about_ca_system_score_gemma":0.0002442461,"threshold_uncertainty_score":0.5686954},"labels":[],"label_agreement":null},{"id":"W2947399181","doi":"10.1200/jco.2019.37.15_suppl.4530","title":"Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin (BCG): Updated follow-up from KEYNOTE-057.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Bladder cancer; Cystectomy; Pembrolizumab; Internal medicine; Urology; Carcinoma in situ; Cancer; Surgery; Oncology; Immunotherapy","score_opus":0.04361577754928139,"score_gpt":0.3796368207711966,"score_spread":0.33602104322191517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947399181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748577,0.00017745642,0.0004344547,0.0042443373,0.0043140454,0.001953935,0.00059243134,0.000024266403,0.0007732968],"genre_scores_gemma":[0.98263,0.00041162485,0.004140409,0.009249687,0.0015911852,0.00010021481,0.00009346358,0.000101652564,0.0016817286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99484134,0.0005671677,0.002385577,0.0007137463,0.00081774074,0.00067443226],"domain_scores_gemma":[0.9908495,0.003580774,0.0020857642,0.0005686152,0.0019002989,0.0010150794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095182157,0.00048384382,0.002727784,0.00027138588,0.00011142633,0.000028884142,0.000405972,0.00068560353,0.0013978952],"category_scores_gemma":[0.0025441807,0.0003288483,0.0007488979,0.00035215847,0.00017068346,0.00023651429,0.00012613308,0.0011772788,0.00023408525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22083983,0.005440312,0.4351757,0.00008614065,0.007695883,0.0006549837,0.0012380817,0.00034610712,0.000948886,0.000028796574,0.061787125,0.26575816],"study_design_scores_gemma":[0.12802765,0.10790681,0.68227386,0.0003635202,0.0034309335,0.00003900165,0.00040206808,0.00005046499,0.001164513,0.00031214915,0.07551645,0.00051260577],"about_ca_topic_score_codex":0.0031347913,"about_ca_topic_score_gemma":0.0021684896,"teacher_disagreement_score":0.26524556,"about_ca_system_score_codex":0.00074079126,"about_ca_system_score_gemma":0.004622179,"threshold_uncertainty_score":0.9999164},"labels":[],"label_agreement":null},{"id":"W2947781721","doi":"10.1016/j.urolonc.2019.01.013","title":"Prognostic performance of the 1973 and 2004 WHO grading classification in upper tract urothelial carcinoma","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Beijing Municipality; Capital Health","keywords":"Medicine; Grading (engineering); Univariate analysis; Urothelial carcinoma; Internal medicine; Multivariate analysis; Ureteral neoplasm; Gastroenterology; Oncology; Cancer; Bladder cancer; Transitional cell carcinoma","score_opus":0.02583108560197167,"score_gpt":0.2865401860522031,"score_spread":0.26070910045023143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947781721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189115,0.0007595378,0.0000014826433,0.002749266,0.00012132322,0.00062417827,0.000011578518,0.000011544269,0.003829927],"genre_scores_gemma":[0.9973947,0.0002381796,0.0010264945,0.0006155682,0.000042628395,0.00005717594,0.000009470988,0.000008148326,0.0006076395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920297,0.00006973302,0.00021912731,0.00023405267,0.00010227612,0.00017185583],"domain_scores_gemma":[0.99950826,0.00012137476,0.00010426321,0.00015465739,0.0000313439,0.00008008671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015814278,0.00011986707,0.00025272675,0.0000893077,0.00008824704,0.0000073906776,0.00006106559,0.00013171828,0.000032857657],"category_scores_gemma":[0.000057696034,0.000080383084,0.000032184766,0.00019335166,0.00037112506,0.00008250683,0.00002311412,0.00021953198,0.0000050827566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082668295,0.00011402032,0.99570984,0.000053469623,0.000012457897,0.000005325438,0.00043397682,0.000013390068,0.0012784448,0.0011097254,0.000114323695,0.0010723708],"study_design_scores_gemma":[0.0012612432,0.0018153497,0.9626946,0.0001026458,0.00014158073,0.00016381829,0.00014441561,0.0018828969,0.00068800425,0.0005101023,0.030511066,0.000084296335],"about_ca_topic_score_codex":0.00007303897,"about_ca_topic_score_gemma":0.000014037157,"teacher_disagreement_score":0.033015247,"about_ca_system_score_codex":0.00007320603,"about_ca_system_score_gemma":0.0002753794,"threshold_uncertainty_score":0.3277927},"labels":[],"label_agreement":null},{"id":"W2947988059","doi":"10.1200/jco.2019.37.15_suppl.4535","title":"Squamous-cell carcinoma variant histology (SCC-VH) in muscle-invasive bladder cancer (MIBC): A comprehensive clinical, genomic, and therapeutic assessment from multiple datasets.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Oncology; Proportional hazards model; Cohort; Logistic regression; Cancer; Gastroenterology","score_opus":0.11342934441014209,"score_gpt":0.4429583004609353,"score_spread":0.32952895605079324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947988059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985692,0.005983262,0.000044009517,0.003635313,0.0028422603,0.000740217,0.00024953764,0.000009398945,0.0008039746],"genre_scores_gemma":[0.98375803,0.0028750063,0.0022102115,0.009970838,0.00095649913,0.000019906262,0.000056595516,0.0000432895,0.000109643646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99431294,0.0011748082,0.0031335077,0.0006119493,0.00033794477,0.00042886502],"domain_scores_gemma":[0.98961973,0.0072229616,0.001848337,0.0004906191,0.00029961238,0.0005187521],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012708063,0.00032348945,0.0026959574,0.00016543745,0.000047617512,0.000014862344,0.00028159592,0.000681719,0.00094382046],"category_scores_gemma":[0.00043865654,0.00024023445,0.00047313378,0.00011044581,0.00037495402,0.00010105903,0.00016119379,0.0016828505,0.000050546674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004815526,0.0042046453,0.9356066,0.000060965853,0.00070877513,0.0021724387,0.00026449907,0.000027904725,0.0020865723,0.000018849147,0.002875101,0.047158152],"study_design_scores_gemma":[0.037482027,0.011823721,0.8896753,0.000056325196,0.0010227815,0.0001442744,0.0003314816,0.00033202494,0.000044166827,0.00019276865,0.058691237,0.00020386792],"about_ca_topic_score_codex":0.0020457893,"about_ca_topic_score_gemma":0.0014285026,"teacher_disagreement_score":0.055816136,"about_ca_system_score_codex":0.0004614528,"about_ca_system_score_gemma":0.00411667,"threshold_uncertainty_score":0.9999694},"labels":[],"label_agreement":null},{"id":"W2948168772","doi":"10.1089/end.2019.0226","title":"Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts","year":2019,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Odds ratio; Cochrane Library; Observational study; Meta-analysis; Bladder cancer; Randomized controlled trial; Confidence interval; MEDLINE; Grading (engineering); Surgery; Internal medicine; Cancer","score_opus":0.37753634295417055,"score_gpt":0.4447177294067118,"score_spread":0.06718138645254124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948168772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004358431,0.9933016,0.00019024256,0.0016147363,0.000048843154,0.004766143,0.000023438764,0.0000020293073,0.000009424371],"genre_scores_gemma":[0.0059990254,0.99192363,0.00021884977,0.0013856051,0.000022649783,0.00032204538,0.000006517397,0.000023911269,0.00009774795],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960629,0.0014814115,0.0017464842,0.00023110709,0.00032040608,0.00015769649],"domain_scores_gemma":[0.99407077,0.0016646065,0.002946814,0.00070084684,0.0004907826,0.00012616754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012911607,0.0003302094,0.010966009,0.00023378602,0.00004792783,0.000029533108,0.0004596515,0.000064616506,0.000045790483],"category_scores_gemma":[0.00047065364,0.00009491706,0.0011311033,0.0004565544,0.00017620875,0.000064150794,0.00016474962,0.00030581185,0.00000192571],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004026288,0.00022845948,0.000085034015,0.4486814,0.54928267,0.000042832744,0.00022888197,0.00031692514,9.641215e-7,0.000053277585,0.0003108826,0.00036603864],"study_design_scores_gemma":[0.0006918045,0.00091074815,0.000051974537,0.037391197,0.95387083,0.0007572708,0.000034190256,0.00002127739,7.676132e-7,0.000003717999,0.0061785458,0.00008766745],"about_ca_topic_score_codex":0.00008071068,"about_ca_topic_score_gemma":0.00012442505,"teacher_disagreement_score":0.41129023,"about_ca_system_score_codex":0.0000689139,"about_ca_system_score_gemma":0.0003316699,"threshold_uncertainty_score":0.7496145},"labels":[],"label_agreement":null},{"id":"W2948800262","doi":"10.11575/prism/36163","title":"Understanding Patient Experience With Bladder Cancer In Alberta","year":2018,"lang":"en","type":"article","venue":"Open MIND","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Internal medicine","score_opus":0.11497110451644281,"score_gpt":0.3591614216942343,"score_spread":0.2441903171777915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948800262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8745982,0.000043773056,0.000063109255,0.0006092914,0.00009466194,0.00052308117,0.0000071069708,8.96425e-7,0.124059856],"genre_scores_gemma":[0.99609166,0.000010065874,0.00054623187,0.0002523237,0.00005563938,0.00006677478,0.00000276722,0.000012470166,0.0029620389],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993226,0.000011122691,0.00010964886,0.00024150558,0.000133498,0.00018160425],"domain_scores_gemma":[0.999673,0.000014370254,0.000031432563,0.00017549456,0.0000263889,0.00007931121],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00002623419,0.00009501015,0.00014324764,0.000036824025,0.00005283687,0.000035757523,0.00008405977,0.000031108833,0.0076881913],"category_scores_gemma":[0.0000062299805,0.00006602557,0.000013076949,0.00015395311,0.000093402734,0.00011848172,0.000046945606,0.00005316898,0.00010899513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004826414,0.0010494934,0.67250216,0.00002304703,0.00045309882,0.00036250398,0.121980764,0.000018995164,0.0029595625,0.00016601573,0.0022428555,0.19341509],"study_design_scores_gemma":[0.04790348,0.018127901,0.2056232,0.003992728,0.0008913259,0.0004190402,0.057344254,0.0009564217,0.34406313,0.0006011374,0.31754628,0.0025311222],"about_ca_topic_score_codex":0.0043848483,"about_ca_topic_score_gemma":0.01608742,"teacher_disagreement_score":0.46687898,"about_ca_system_score_codex":0.00020950122,"about_ca_system_score_gemma":0.00016946637,"threshold_uncertainty_score":0.9932189},"labels":[],"label_agreement":null},{"id":"W2948878352","doi":"10.1186/s40425-019-0619-8","title":"DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Queen's University","keywords":"Immunoediting; Bladder cancer; Immune checkpoint; DNA repair; Immune system; Gene; Cancer; Cancer research; DNA mismatch repair; Immunotherapy; Tumor microenvironment; Medicine; Bioinformatics; Biology; Immunology; Genetics; Internal medicine","score_opus":0.010395492579599383,"score_gpt":0.275885229973412,"score_spread":0.26548973739381265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948878352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798083,0.018319596,0.00004231024,0.00047791566,0.0003565945,0.00079952,0.00009287269,0.000020102427,0.000082834755],"genre_scores_gemma":[0.9915912,0.0049490742,0.0010119185,0.0004162235,0.00020037698,0.00018710211,0.000015700247,0.00006128922,0.0015670988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987871,0.000053260053,0.00041485668,0.00022073287,0.00027205312,0.0002519858],"domain_scores_gemma":[0.99883807,0.00010333988,0.0004731418,0.0002214993,0.0002972671,0.00006668422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027415677,0.00019958206,0.00045852814,0.00015494839,0.00011016185,0.000022249773,0.00007581437,0.000090037625,0.00035968274],"category_scores_gemma":[0.000018568164,0.00013747421,0.00015940148,0.00015470792,0.000047981106,0.00021797244,0.000012011342,0.00020343081,0.0000010786005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018988356,0.00014409439,0.15472098,0.000075468655,0.00070738536,0.0000057999,0.00201382,0.0001518263,0.8363015,0.000003218892,0.0002527384,0.003724312],"study_design_scores_gemma":[0.007835858,0.00064210064,0.45520154,0.00048620143,0.000106183375,0.000021783288,0.00041734145,0.000040961706,0.5331228,0.00010079274,0.001876361,0.00014811497],"about_ca_topic_score_codex":0.0004082809,"about_ca_topic_score_gemma":0.00027061615,"teacher_disagreement_score":0.30317876,"about_ca_system_score_codex":0.0005049428,"about_ca_system_score_gemma":0.000576036,"threshold_uncertainty_score":0.56060356},"labels":[],"label_agreement":null},{"id":"W2949028331","doi":"10.22374/jeleu.v2i2.41","title":"A Retrospective Audit of the TURBT Quality in Two Major Cancer Centres in Lancashire","year":2019,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Audit; Bladder cancer; Medicine; Retrospective cohort study; Work (physics); Resection; Cancer; General surgery; Quality (philosophy); Surgery; Internal medicine; Engineering; Business; Accounting","score_opus":0.016391637254241555,"score_gpt":0.33836669210309755,"score_spread":0.321975054848856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949028331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356025,0.0010641816,0.0000018472075,0.0023635018,0.00061239244,0.00026958267,0.000021286047,0.0000027794404,0.002104158],"genre_scores_gemma":[0.9987475,0.00012693353,0.00006263478,0.00046016148,0.00022938037,0.0000071339396,6.8254553e-7,0.000012599623,0.00035292594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843997,0.00022728805,0.0005987521,0.0001583947,0.000308371,0.0002672225],"domain_scores_gemma":[0.9990043,0.00010519856,0.00048671666,0.00020421302,0.00013439261,0.00006515806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003814433,0.00012990464,0.0006537478,0.00017120207,0.000014010246,0.0000036918764,0.00016501073,0.00006824545,0.00043556807],"category_scores_gemma":[0.00013292611,0.000084534564,0.00018553792,0.00024628482,0.00009341586,0.00006850834,0.000042517775,0.0005534208,0.0000060077377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002414063,0.0002732739,0.9896071,0.000048566384,0.000105711166,0.00017256915,0.00046696895,0.00003868938,0.0058129937,0.00034839936,0.00013754146,0.0005741527],"study_design_scores_gemma":[0.01001028,0.00070501264,0.9843427,0.00015985043,0.00008991755,0.00036938596,0.00023212809,0.000012226098,0.0027870326,0.00039357477,0.0008336406,0.00006428575],"about_ca_topic_score_codex":0.0032791807,"about_ca_topic_score_gemma":0.0044074794,"teacher_disagreement_score":0.0075962166,"about_ca_system_score_codex":0.00036916937,"about_ca_system_score_gemma":0.00036222566,"threshold_uncertainty_score":0.4957162},"labels":[],"label_agreement":null},{"id":"W2949728994","doi":"10.1016/j.euo.2019.06.003","title":"Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Mitomycin C; Disease; Cancer; Urology; Carcinoma in situ; Surgery; Internal medicine; Oncology","score_opus":0.023462383481248718,"score_gpt":0.3043653441791391,"score_spread":0.28090296069789034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949728994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90212256,0.009900988,0.000031501095,0.043655105,0.0052777776,0.0016310826,0.000043547552,0.00014526867,0.0371922],"genre_scores_gemma":[0.9687141,0.007077515,0.00007501899,0.02042878,0.0010110462,0.00011662089,0.00004908367,0.00008388013,0.0024439183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975209,0.0006973546,0.00038129388,0.00063254114,0.00019707167,0.00057080603],"domain_scores_gemma":[0.99840677,0.00029186194,0.0002486054,0.0007225771,0.00013397018,0.00019621963],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003427207,0.00031556917,0.0005459686,0.00011608675,0.00017067211,0.00003419394,0.00033906504,0.00016897562,0.001466128],"category_scores_gemma":[0.00006297506,0.0002173959,0.00019140846,0.00020625914,0.0003248875,0.0001377234,0.00018039336,0.00065245776,0.0030692879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006252379,0.0077645774,0.23577523,0.0005266197,0.0056816135,0.0067222766,0.0125007685,0.00089949777,0.024039438,0.0012801664,0.21241914,0.48613828],"study_design_scores_gemma":[0.00930404,0.006675069,0.44041586,0.00017078362,0.0009250076,0.0005793774,0.001720995,0.00009442201,0.00047847527,0.00013267889,0.53905725,0.0004460493],"about_ca_topic_score_codex":0.000051070707,"about_ca_topic_score_gemma":0.00016694928,"teacher_disagreement_score":0.48569223,"about_ca_system_score_codex":0.00022967834,"about_ca_system_score_gemma":0.00041491058,"threshold_uncertainty_score":0.9994467},"labels":[],"label_agreement":null},{"id":"W2950270989","doi":"10.3233/blc-190218","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2019,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Bladder cancer; PD-L1; Meta-analysis; Immunotherapy; Blockade; Clinical trial; Disease; Cancer","score_opus":0.03949301475115467,"score_gpt":0.3752436445870284,"score_spread":0.3357506298358737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950270989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005365829,0.98425615,0.00002081212,0.0008751948,0.0012721793,0.005618832,0.00084412505,0.00009214389,0.001654764],"genre_scores_gemma":[0.0025592817,0.9875316,0.00034369057,0.00063065055,0.00030552802,0.0036460776,0.00012860162,0.00041503666,0.004439519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99368757,0.00043589465,0.0020438076,0.0016228934,0.0010037774,0.0012060743],"domain_scores_gemma":[0.9963136,0.00022208584,0.0008290123,0.0018208775,0.00030387347,0.0005105694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005597577,0.0013851908,0.004583901,0.0011084182,0.000063285945,0.00003424447,0.0006316558,0.00079494866,0.002305022],"category_scores_gemma":[0.00017408277,0.0011653852,0.0014664725,0.0018467988,0.00018581167,0.00012853832,0.0002841243,0.00085243915,0.00022412666],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009157984,0.00085373264,0.00033953149,0.02173097,0.0085933,0.00049799506,0.0008490017,0.00016108954,0.008346513,0.000011564823,0.0019459861,0.9475123],"study_design_scores_gemma":[0.006531715,0.00080774794,0.0016800849,0.03237378,0.0056220456,0.00006427098,0.00012636223,0.00000911114,0.0060505625,0.000014112746,0.9453644,0.0013557975],"about_ca_topic_score_codex":0.0029371525,"about_ca_topic_score_gemma":0.00033386823,"teacher_disagreement_score":0.94615656,"about_ca_system_score_codex":0.001804625,"about_ca_system_score_gemma":0.0046397415,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W2951183264","doi":"10.1097/pas.0000000000001305","title":"Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter—Nephroureterectomy and Ureterectomy Specimens","year":2019,"lang":"en","type":"review","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; McGill University Health Centre; University of Toronto","funders":"","keywords":"Medicine; Renal pelvis; Ureter; Cancer; Ureteral neoplasm; General surgery; Urology; Internal medicine; Bladder cancer; Transitional cell carcinoma","score_opus":0.15711247268117368,"score_gpt":0.40083582318248384,"score_spread":0.24372335050131017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951183264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085918404,0.9113476,0.000026991,0.00085191557,0.00026168308,0.0010102687,0.000447613,0.000003224708,0.00013229075],"genre_scores_gemma":[0.101020806,0.8978674,0.00031115336,0.00013855708,0.00048308232,0.00001277725,0.000020191907,0.000047491456,0.00009853846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965043,0.0005695345,0.0020498754,0.0003093235,0.00031126192,0.0002556719],"domain_scores_gemma":[0.989843,0.0017294403,0.007137243,0.0010298825,0.00017123406,0.00008917989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020050185,0.00031005737,0.002921277,0.00009070083,0.00007760243,0.000011896893,0.0005849821,0.00010181739,0.000026405663],"category_scores_gemma":[0.00036525825,0.00011831954,0.00055802957,0.00022275887,0.0012581195,0.00004025902,0.0003530964,0.0006243872,5.1312696e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001980682,0.00011885532,0.009360223,0.0043572304,0.0027019156,0.00073839707,0.00081793126,6.555497e-7,0.000081251696,0.000048845424,0.0012340164,0.97856],"study_design_scores_gemma":[0.0035024656,0.0045326045,0.015211912,0.005261561,0.013364229,0.06627716,0.00038408852,0.00001520431,0.000038560716,0.00011536665,0.8909924,0.00030443154],"about_ca_topic_score_codex":0.000033962988,"about_ca_topic_score_gemma":0.0000022527117,"teacher_disagreement_score":0.97825557,"about_ca_system_score_codex":0.000034019737,"about_ca_system_score_gemma":0.0003763233,"threshold_uncertainty_score":0.4824931},"labels":[],"label_agreement":null},{"id":"W2951849211","doi":"10.17269/s41997-019-00227-y","title":"Trends in socio-economic inequalities in bladder cancer incidence in Canada: 1992–2010","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Public Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"Australian Research Data Commons; Dalhousie University; Dalhousie Medical Research Foundation","keywords":"Bladder cancer; Incidence (geometry); Population; Demography; Inequality; Medicine; Cancer registry; Disadvantaged; Cancer; Environmental health; Economic growth; Economics; Sociology; Internal medicine","score_opus":0.06349843144776386,"score_gpt":0.31941632885699994,"score_spread":0.2559178974092361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951849211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95412433,0.0027940841,0.0000012625867,0.041071784,0.00068458036,0.0001686635,0.000084517094,0.0000017970233,0.00106896],"genre_scores_gemma":[0.99431616,0.0002721236,0.000025014577,0.0046265633,0.00014959706,0.000010611371,0.0000102257745,0.00002016878,0.0005695374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978565,0.00015832437,0.00080068497,0.00018067518,0.00020132879,0.0008025071],"domain_scores_gemma":[0.9982724,0.000056252575,0.00023828974,0.00016858567,0.000052385865,0.0012120598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009937617,0.00015215289,0.00059684087,0.0012809676,0.000028554565,0.000024408215,0.00016481164,0.00007792429,0.0018276811],"category_scores_gemma":[0.00005782096,0.00014380399,0.000054699696,0.00042107928,0.000039951145,0.0002527535,0.000008205056,0.00052818394,0.000007848847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000016428288,0.000017168748,0.96818155,0.000036903097,0.000025568259,0.00020146079,0.0025395034,0.0000689999,0.000001541612,0.00011996281,0.0047278795,0.024063028],"study_design_scores_gemma":[0.0025724983,0.00018116903,0.98094493,0.00022816956,0.000004696527,0.00007062616,0.0035411427,0.000061894105,0.0000030448844,0.00005896134,0.01221137,0.00012151004],"about_ca_topic_score_codex":0.9991931,"about_ca_topic_score_gemma":0.9999471,"teacher_disagreement_score":0.091579325,"about_ca_system_score_codex":0.017849177,"about_ca_system_score_gemma":0.1094285,"threshold_uncertainty_score":0.9990848},"labels":[],"label_agreement":null},{"id":"W2951863725","doi":"10.21037/tau.2019.05.12","title":"Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers","year":2019,"lang":"en","type":"letter","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Cystectomy; Subtyping; Infiltration (HVAC); Medicine; Cancer therapy; Perioperative; Chemotherapy; Oncology; Internal medicine; Cancer; Surgery; Computer science","score_opus":0.017079568178324008,"score_gpt":0.2853360889777596,"score_spread":0.26825652079943557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951863725","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2222349,0.015309838,0.0008952611,0.75780976,0.00046011334,0.0019704106,0.00090179354,0.00006557045,0.00035235225],"genre_scores_gemma":[0.43800968,0.002347554,0.00023017041,0.5552715,0.0012556098,0.000563009,0.0018217127,0.000073426265,0.00042735337],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983807,0.00011047484,0.00031831342,0.00064414076,0.00015310293,0.00039323446],"domain_scores_gemma":[0.9990911,0.00036022742,0.00012820431,0.00018883079,0.0001539226,0.00007770492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008796592,0.00038489953,0.0006276878,0.00019607083,0.000163424,0.00001433232,0.000073571784,0.0008413663,0.00016582626],"category_scores_gemma":[0.000018772253,0.0003341448,0.0001539059,0.00007578899,0.0004171247,0.00007001478,0.000008905069,0.0006787066,0.0000038792955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02675656,0.0013512216,0.4229542,0.0029093993,0.01702357,0.0021921904,0.007185492,0.0011054322,0.009255538,0.00798375,0.46672338,0.034559265],"study_design_scores_gemma":[0.02014404,0.005488072,0.2064411,0.00007375536,0.0024212126,0.0012057972,0.000027391476,0.0006370439,0.00035675341,0.009110525,0.75315523,0.0009390427],"about_ca_topic_score_codex":0.00017749134,"about_ca_topic_score_gemma":0.0000914217,"teacher_disagreement_score":0.28643188,"about_ca_system_score_codex":0.000016509117,"about_ca_system_score_gemma":0.0005483918,"threshold_uncertainty_score":0.99991107},"labels":[],"label_agreement":null},{"id":"W2953226449","doi":"10.1016/j.celrep.2019.04.048","title":"Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"Cell Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Alzheimer Society of B.C.; Center for Outcomes Research and Evaluation, Yale School of Medicine","keywords":"Bladder cancer; Cancer; Cancer research; Medicine; Urothelial cancer; Sarcomatoid carcinoma; Biology; Internal medicine; Immunohistochemistry","score_opus":0.013504439872804632,"score_gpt":0.3270446529681723,"score_spread":0.31354021309536767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953226449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807572,0.0011683719,0.00003313925,0.00070848776,0.0005591913,0.001235433,0.00000394304,0.000032439115,0.015501817],"genre_scores_gemma":[0.9945768,0.00010113086,0.00042112052,0.00041588466,0.00013763212,0.00008137781,0.00001373539,0.000024310768,0.004227994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862784,0.0000337771,0.0004892253,0.00030368118,0.00036880674,0.00017664883],"domain_scores_gemma":[0.99859333,0.000050757295,0.000532938,0.0005460605,0.00016417398,0.00011276919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016457122,0.00013295608,0.00028244572,0.000044298387,0.00004445058,0.000010023483,0.000059849193,0.00007995254,0.000532066],"category_scores_gemma":[0.000054783115,0.00007742721,0.00011255272,0.00013858834,0.000054885582,0.000043818793,0.000051196388,0.000100424004,0.000036775014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004935386,0.00046155177,0.89376897,0.00016655771,0.00017850184,0.00036445368,0.0017796849,0.0000808084,0.051878795,0.000016799326,0.004826848,0.04598348],"study_design_scores_gemma":[0.0022059404,0.0015269634,0.70380795,0.001141557,0.00041149207,0.00030490043,0.00035691203,0.00008490721,0.26439095,0.00030048323,0.025158077,0.00030987855],"about_ca_topic_score_codex":0.000058655205,"about_ca_topic_score_gemma":0.0000066766215,"teacher_disagreement_score":0.21251217,"about_ca_system_score_codex":0.000032496726,"about_ca_system_score_gemma":0.00022932861,"threshold_uncertainty_score":0.58257496},"labels":[],"label_agreement":null},{"id":"W2954147811","doi":"10.1016/j.euo.2019.06.002","title":"Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Roche; Merck","keywords":"Cystectomy; Medicine; Bladder cancer; Chemotherapy; Cisplatin; Oncology; Guideline; Cancer; Neoadjuvant therapy; Internal medicine; Clinical trial; DNA Damage Repair; DNA repair; Pathology; Gene; Breast cancer","score_opus":0.03674697873142426,"score_gpt":0.3119977905155355,"score_spread":0.27525081178411126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954147811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.927575,0.00089971453,0.0000148391855,0.028389875,0.00072557887,0.000892789,0.00003073696,0.000044928856,0.041426573],"genre_scores_gemma":[0.9751638,0.0006134705,0.00026338725,0.019892393,0.00015321885,0.000026766886,0.000015371297,0.00006010829,0.0038114502],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981675,0.0005406461,0.00042836263,0.00036321033,0.00012398112,0.00037630732],"domain_scores_gemma":[0.9989666,0.00021839108,0.00016870529,0.0004933711,0.000067668494,0.00008527491],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032693596,0.00019612252,0.00048002924,0.00013708559,0.000032119784,0.000004871967,0.0001996012,0.000114762384,0.0009980258],"category_scores_gemma":[0.00004959465,0.00013252132,0.00010313808,0.00021072345,0.00029485335,0.000035044235,0.00006957757,0.0002783031,0.00013115729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005964007,0.0012626535,0.68439573,0.000059758702,0.0018295682,0.0011273114,0.004155837,0.00038223056,0.025019497,0.00032695103,0.062201925,0.21327455],"study_design_scores_gemma":[0.007471111,0.0024108232,0.39962295,0.00001732191,0.00014896152,0.00015403995,0.0000898091,0.0001291404,0.00057522807,0.000026961274,0.589224,0.00012965717],"about_ca_topic_score_codex":0.0014783336,"about_ca_topic_score_gemma":0.00076097884,"teacher_disagreement_score":0.52702206,"about_ca_system_score_codex":0.00016291159,"about_ca_system_score_gemma":0.00037683974,"threshold_uncertainty_score":0.9999152},"labels":[],"label_agreement":null},{"id":"W2954218874","doi":"10.1016/j.jval.2019.04.429","title":"PCN311 CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA AFTER PROGRESSION ON PLATINUM-BASED THERAPY: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; Medical record; Internal medicine; Retrospective cohort study; Disease; Regimen; Cisplatin; Cancer; Oncology; Chemotherapy","score_opus":0.048399791486402555,"score_gpt":0.3538531635827382,"score_spread":0.30545337209633566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954218874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882328,0.0016711412,6.31608e-7,0.0047923187,0.00006369246,0.0051516327,0.00007739995,0.000007705633,0.0000027012782],"genre_scores_gemma":[0.9845394,0.0064561027,0.000021447064,0.008414497,0.000027442375,0.00025792565,0.00025673394,0.00002302001,0.0000034573204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714154,0.00104822,0.0006485624,0.00039990453,0.00049417693,0.0002676072],"domain_scores_gemma":[0.99909824,0.00025592654,0.00016847321,0.00026744444,0.00004025992,0.00016967843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064082426,0.00020395457,0.0005367695,0.00011264865,0.000034543802,0.000008221303,0.000053090294,0.00006118039,0.000017326836],"category_scores_gemma":[0.000055861692,0.00011565386,0.000016039607,0.00020380635,0.000028285385,0.000023516048,0.000011809793,0.00026395742,3.880285e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003980947,0.0011108271,0.90208036,0.0006009675,0.000009170322,0.000058791637,0.0007947519,0.0000029494201,1.0690111e-8,6.178729e-7,0.000010345042,0.09135026],"study_design_scores_gemma":[0.014118994,0.013739852,0.9651547,0.0053864107,0.000011414953,0.0000016476221,0.00027942617,0.00033976114,5.1651847e-7,0.000001328949,0.0008739772,0.0000919743],"about_ca_topic_score_codex":0.49085826,"about_ca_topic_score_gemma":0.2792838,"teacher_disagreement_score":0.21157448,"about_ca_system_score_codex":0.00039709164,"about_ca_system_score_gemma":0.0010048605,"threshold_uncertainty_score":0.7338674},"labels":[],"label_agreement":null},{"id":"W2954311990","doi":"10.14740/wjon1210","title":"Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa","year":2019,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cancer; Oncology; Incidence (geometry); Urology; Internal medicine","score_opus":0.09381156799087913,"score_gpt":0.4113660629541875,"score_spread":0.31755449496330834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954311990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044747544,0.98762006,4.8657125e-7,0.0011310567,0.0016544082,0.0011461778,0.00004868337,0.0000019560246,0.008392678],"genre_scores_gemma":[0.00004972251,0.99788785,0.000047956877,0.0004226074,0.00048576173,0.00007220534,0.000005768213,0.000036180205,0.0009919585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729764,0.00030738203,0.001517021,0.00021321348,0.00037462637,0.0002901218],"domain_scores_gemma":[0.99691886,0.00029654414,0.0021030365,0.00038309934,0.0001749242,0.00012353688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004669516,0.0003264321,0.0036335776,0.00043467942,0.00002087206,0.0000036751953,0.0003864664,0.00013190613,0.00058068597],"category_scores_gemma":[0.00010018414,0.00017493447,0.0011125454,0.0008696681,0.00009724392,0.000040253824,0.00009319525,0.0011952257,0.000017886081],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032998098,0.00034551305,0.000081372214,0.052312177,0.00045563863,0.00007194225,0.00010468948,2.2482364e-7,5.9240847e-7,0.000004811441,0.032933567,0.9136565],"study_design_scores_gemma":[0.0012170079,0.0005407906,0.00014773203,0.22389661,0.004215605,0.00019467065,0.0000058512046,5.4103822e-8,0.0000011449198,0.0000115662,0.7696727,0.000096298376],"about_ca_topic_score_codex":0.000025880447,"about_ca_topic_score_gemma":0.0006058272,"teacher_disagreement_score":0.91356015,"about_ca_system_score_codex":0.00097527326,"about_ca_system_score_gemma":0.006465992,"threshold_uncertainty_score":0.9991664},"labels":[],"label_agreement":null},{"id":"W2954374086","doi":"10.1097/won.0b013e31827759ea","title":"Orthotopic Bladder Substitution (Neobladder)","year":2012,"lang":"en","type":"article","venue":"Journal of Wound Ostomy and Continence Nursing","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Continental (Canada)","funders":"University of Toronto","keywords":"Cystectomy; Urinary diversion; Medicine; Bladder cancer; Transitional cell carcinoma; Urology; Quality of life (healthcare); Urinary bladder; General surgery; Surgery; Cancer; Nursing; Internal medicine","score_opus":0.01887246616531541,"score_gpt":0.29876301901911734,"score_spread":0.27989055285380193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954374086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842394,0.00725237,0.0011519808,0.0012373157,0.0007254461,0.00013705283,0.0000010736123,0.000009034954,0.0052463524],"genre_scores_gemma":[0.9969174,0.00026103685,0.0012058493,0.00034924172,0.000805232,0.0000017019474,0.0000011605847,0.000008643758,0.0004496864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915445,0.000026806581,0.00028468305,0.0000805141,0.00021658563,0.00023694997],"domain_scores_gemma":[0.99936396,0.000027602302,0.00017369472,0.00008703709,0.00013099884,0.00021668251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894032,0.000114241884,0.0002513461,0.00009565451,0.00009826674,0.000026768816,0.000039150094,0.00006618185,0.00012164176],"category_scores_gemma":[0.00003137882,0.00008528525,0.00008528007,0.000103041384,0.000113793045,0.00038827205,0.000005121098,0.00019556737,0.000007597885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018142594,0.0015115727,0.66282994,0.00013359029,0.00057557307,0.00016052477,0.0066666,0.000002944815,0.018979141,0.0035410766,0.0028905813,0.30089423],"study_design_scores_gemma":[0.008372723,0.001557776,0.88330615,0.0019143968,0.0016313823,0.008657925,0.0019290185,0.000038097976,0.013269669,0.0007465887,0.078161255,0.00041499356],"about_ca_topic_score_codex":0.00000789339,"about_ca_topic_score_gemma":7.64567e-7,"teacher_disagreement_score":0.30047923,"about_ca_system_score_codex":0.00007027411,"about_ca_system_score_gemma":0.0000990142,"threshold_uncertainty_score":0.34778315},"labels":[],"label_agreement":null},{"id":"W2955007835","doi":"10.1016/j.urolonc.2019.05.019","title":"Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urokinase receptor; Interquartile range; Medicine; Bladder cancer; Hazard ratio; Plasminogen activator; Proportional hazards model; SuPAR; Internal medicine; Plasminogen activator inhibitor-1; Biomarker; Urokinase; Adjuvant; Cancer; Oncology; Adjuvant therapy; Urology; Biology","score_opus":0.010315779000670813,"score_gpt":0.24918202695293418,"score_spread":0.23886624795226336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955007835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957228,0.00033632875,7.4398156e-7,0.0006060036,0.00012805735,0.0011944463,0.000062087325,0.00002020591,0.0019293829],"genre_scores_gemma":[0.99808353,0.000031535546,0.000866947,0.0005491397,0.00003364722,0.00019256173,0.00001880153,0.00001480255,0.00020902533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989883,0.00008097632,0.000222123,0.00029170504,0.00018624894,0.00023066622],"domain_scores_gemma":[0.9992474,0.00015447654,0.0001726979,0.00021878284,0.00008490926,0.0001217897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007555409,0.00016928685,0.0003343141,0.00008507725,0.00008368816,0.0000067346314,0.00009677532,0.00014609771,0.000074351796],"category_scores_gemma":[0.00005065677,0.000102640886,0.000040354178,0.0002774421,0.00030918382,0.0000802839,0.00004610152,0.00022351349,0.000010083955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003982052,0.00028769483,0.9970306,0.00007074703,0.000097732016,0.000011022558,0.00044526515,0.000052442505,0.0005572341,0.00044096427,0.00012466399,0.00048341867],"study_design_scores_gemma":[0.0034611234,0.0030164144,0.96965396,0.00028873567,0.0003934612,0.000029522716,0.00056899275,0.00009412416,0.0028090954,0.0001784609,0.019366663,0.0001394712],"about_ca_topic_score_codex":0.0002748765,"about_ca_topic_score_gemma":0.0001505719,"teacher_disagreement_score":0.027376674,"about_ca_system_score_codex":0.00019134412,"about_ca_system_score_gemma":0.0006791019,"threshold_uncertainty_score":0.41855738},"labels":[],"label_agreement":null},{"id":"W2955125638","doi":"10.1016/j.euf.2019.05.016","title":"Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Prehabilitation; Medicine; Cystectomy; Perioperative; Randomized controlled trial; Multimodal therapy; Bladder cancer; Adverse effect; Sham surgery; Surgery; Physical therapy; Cancer; Internal medicine","score_opus":0.010391447237629827,"score_gpt":0.2669082183574125,"score_spread":0.2565167711197827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955125638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95905185,0.00024187616,0.0025873268,0.0018893727,0.0019246602,0.007590004,0.0000060150405,0.00013996608,0.026568929],"genre_scores_gemma":[0.9949293,0.0000024725005,0.00077441626,0.0011861898,0.0005675347,0.00043092945,0.000012368658,0.00004640739,0.0020503704],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996764,0.0014435039,0.0005925574,0.0005345278,0.00033101876,0.00033438305],"domain_scores_gemma":[0.9983518,0.00088814384,0.00012874957,0.00034693634,0.00007846409,0.00020587488],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014185458,0.00025149502,0.0013218723,0.00014466648,0.00007764623,0.00001627971,0.00009542633,0.00009299485,0.0005765572],"category_scores_gemma":[0.0011751241,0.00018402717,0.0007138281,0.00012875115,0.00011344217,0.00006667239,0.00004141438,0.00027621828,0.0014025932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9927073,0.00032318232,0.00068522803,0.0000112325415,0.0006868991,0.0000503911,0.0004838416,0.000038797494,0.0032280365,0.000119131655,0.000246941,0.0014190172],"study_design_scores_gemma":[0.9903927,0.0029107097,0.0034593835,0.000019064419,0.0006182773,0.000025681766,0.000013410553,0.00019631138,0.000334736,0.00012476646,0.0017414372,0.00016353784],"about_ca_topic_score_codex":0.00004238929,"about_ca_topic_score_gemma":0.0000051603183,"teacher_disagreement_score":0.03587746,"about_ca_system_score_codex":0.00008679177,"about_ca_system_score_gemma":0.000117932796,"threshold_uncertainty_score":0.9993749},"labels":[],"label_agreement":null},{"id":"W2955650241","doi":"10.1200/jco.18.02257","title":"Immunotherapy for Urothelial Cancer: Where Are the Randomized Trials?","year":2019,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Urothelial cancer; Medicine; Cancer; Randomized controlled trial; Immunotherapy; Bladder cancer; Oncology; Internal medicine","score_opus":0.20257949305617207,"score_gpt":0.5056114660832302,"score_spread":0.3030319730270581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955650241","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006051501,0.019062119,0.00035687446,0.9585539,0.01581747,0.003880856,0.00020031935,0.000013591692,0.0015096832],"genre_scores_gemma":[0.00070365716,0.048489578,0.00081138645,0.86238086,0.07507186,0.00030986566,0.000021621363,0.00012867758,0.012082521],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9879388,0.004486607,0.006065665,0.00035818527,0.0007172438,0.00043345266],"domain_scores_gemma":[0.9485856,0.039420262,0.010324098,0.00052795483,0.001002836,0.00013923884],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.016563706,0.00045272376,0.0116462195,0.0001412162,0.000081412676,0.000034853892,0.0005365352,0.0024320506,0.00090994925],"category_scores_gemma":[0.008174968,0.00020762409,0.006759447,0.0000874162,0.0004539545,0.000066261455,0.000034374487,0.0047533265,0.00003919349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2484742,0.0002819108,0.00046665894,0.0001286491,0.0063431966,0.00025357874,0.000044078733,0.0000017265371,0.0000066020216,0.000004544571,0.6990204,0.044974465],"study_design_scores_gemma":[0.30434242,0.0047268267,0.00020129132,0.00038833314,0.0048332717,0.00014787585,0.000024591714,0.000007906855,0.000009109276,0.00037789595,0.6848063,0.00013422171],"about_ca_topic_score_codex":0.00009800489,"about_ca_topic_score_gemma":0.000023297802,"teacher_disagreement_score":0.0961731,"about_ca_system_score_codex":0.00032484176,"about_ca_system_score_gemma":0.0064105084,"threshold_uncertainty_score":0.9992222},"labels":[],"label_agreement":null},{"id":"W2955659266","doi":"10.1016/j.urolonc.2019.05.021","title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review","year":2019,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urothelial carcinoma; Medicine; Upper urinary tract; Adjuvant radiotherapy; Adjuvant; Urology; Radiation therapy; Urinary system; Carcinoma; Oncology; General surgery; Internal medicine; Cancer; Bladder cancer","score_opus":0.03762698539632905,"score_gpt":0.33983755501991086,"score_spread":0.30221056962358184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955659266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054407393,0.992761,0.0000050811063,0.0007645697,0.00027851484,0.005199522,0.00021407739,0.000020630978,0.00021248503],"genre_scores_gemma":[0.00021299548,0.9937733,0.0011889769,0.0011046383,0.00016796475,0.002668403,0.00007569306,0.000049337523,0.00075868977],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765086,0.0003749551,0.00096324756,0.0004911656,0.00017161122,0.00034818205],"domain_scores_gemma":[0.99657845,0.0020572175,0.0006183278,0.00046188262,0.00008753738,0.00019657139],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069440214,0.0004676485,0.0032435553,0.000145073,0.00017133416,0.00002008238,0.00012810185,0.00040746588,0.0000380982],"category_scores_gemma":[0.0002391004,0.00025869807,0.00057428336,0.00017409987,0.0005756481,0.000057841105,0.00004765439,0.0003488703,0.0000075993935],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042758207,0.0008275763,0.0075925016,0.8729649,0.0011334821,0.0002507991,0.00020675261,9.106958e-8,0.0000015356661,0.000754492,0.0024651613,0.113375105],"study_design_scores_gemma":[0.00043873096,0.0025180175,0.000038940892,0.065454364,0.0101821115,0.002471439,0.000023501876,0.00001030655,6.649637e-7,0.00036200348,0.91828763,0.00021229679],"about_ca_topic_score_codex":0.000018271901,"about_ca_topic_score_gemma":0.0000017580917,"teacher_disagreement_score":0.91582245,"about_ca_system_score_codex":0.00013870961,"about_ca_system_score_gemma":0.001203006,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2955796504","doi":"10.1016/j.jval.2019.04.196","title":"PCN72 COST OF MANAGING METASTATIC BLADDER CANCER WITH THE INTRODUCTION OF IMMUNOTHERAPIES FROM A CANADIAN HEALTHCARE PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Docetaxel; Pembrolizumab; Gemcitabine; Medicine; Atezolizumab; Oncology; Adverse effect; Internal medicine; Paclitaxel; Carboplatin; Prostate cancer; Metastatic Urothelial Carcinoma; Cisplatin; Bladder cancer; Cancer; Immunotherapy; Chemotherapy; Urothelial carcinoma","score_opus":0.02545748039092295,"score_gpt":0.30961575421447696,"score_spread":0.284158273823554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955796504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84197,0.023309762,0.000043406908,0.13124686,0.0002980506,0.002394878,0.00025045723,0.0000142319395,0.00047230293],"genre_scores_gemma":[0.99725235,0.0009707151,0.00028235558,0.0011600839,0.00010218558,0.00005793366,0.000015922005,0.000022165414,0.00013631838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989392,0.0001441169,0.0002506281,0.00021609134,0.00020662672,0.00024334494],"domain_scores_gemma":[0.9992635,0.00005580218,0.00015897884,0.0002935467,0.00013478233,0.000093357216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021001122,0.00011222177,0.0003666739,0.00015440288,0.000044120483,0.000004061592,0.00006523937,0.00002453162,0.00022713022],"category_scores_gemma":[0.000008823835,0.00007268017,0.00003769044,0.0002953554,0.00006858574,0.00004359676,0.0000066176663,0.00016316408,0.0000038153366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069365883,0.0010180061,0.62594503,0.004231996,0.0050866315,0.00004976926,0.24685621,0.01809334,0.0018627464,0.02209729,0.0037946056,0.06402779],"study_design_scores_gemma":[0.021118155,0.0075726113,0.7711962,0.0040506534,0.00068023783,0.00007067391,0.16478963,0.0034828007,0.0045170877,0.005115386,0.016640823,0.00076576736],"about_ca_topic_score_codex":0.960374,"about_ca_topic_score_gemma":0.30893108,"teacher_disagreement_score":0.65144295,"about_ca_system_score_codex":0.00083121925,"about_ca_system_score_gemma":0.0017562192,"threshold_uncertainty_score":0.70367914},"labels":[],"label_agreement":null},{"id":"W2957715479","doi":"10.1016/j.euo.2019.06.014","title":"Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Interquartile range; Cystectomy; Proportional hazards model; Chemotherapy; Primary tumor; Internal medicine; Confidence interval; Metastasis; Carboplatin; Oncology; Clinical endpoint; Cancer; Bladder cancer; Surgery; Cisplatin; Clinical trial","score_opus":0.04766636536898497,"score_gpt":0.36295574273882414,"score_spread":0.3152893773698392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957715479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525696,0.00025748648,0.000083470666,0.00069748826,0.00043744678,0.0009599722,0.0006107193,0.000013733705,0.0016827236],"genre_scores_gemma":[0.9963645,0.00012496309,0.0009381571,0.0015644794,0.00010239667,0.00005969499,0.0007386952,0.000029750534,0.000077398756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783134,0.00076730613,0.00061560335,0.0003777535,0.0001723742,0.00023562083],"domain_scores_gemma":[0.99770427,0.001278796,0.0003503643,0.00050141965,0.00010624269,0.00005888148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009870796,0.00016194544,0.00079467305,0.00049936114,0.000025320356,0.0000032503688,0.00027828015,0.00003598931,0.00022244606],"category_scores_gemma":[0.00016150852,0.00011697153,0.00026290823,0.00035287993,0.00016714395,0.000085853164,0.00009290214,0.00016295,0.000017167951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020026026,0.006918218,0.926009,0.0002440281,0.004113293,0.0006112876,0.0037079717,0.0011652169,0.024553545,0.000065527376,0.00032189963,0.0122639695],"study_design_scores_gemma":[0.010232113,0.0018091311,0.97681785,0.00002474274,0.0030817084,0.000037900736,0.0001571315,0.0028716095,0.00035010907,0.0000044974377,0.0045030867,0.00011011209],"about_ca_topic_score_codex":0.00024455742,"about_ca_topic_score_gemma":0.00019545705,"teacher_disagreement_score":0.05080884,"about_ca_system_score_codex":0.00007652834,"about_ca_system_score_gemma":0.00024406456,"threshold_uncertainty_score":0.47699606},"labels":[],"label_agreement":null},{"id":"W2957815062","doi":"10.1007/s00345-019-02875-8","title":"Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Meta-analysis; Radiology; Cochrane Library; Systematic review; Diagnostic accuracy; Urothelial carcinoma; Diagnostic odds ratio; Gold standard (test); False positive paradox; MEDLINE; Internal medicine; Cancer; Bladder cancer","score_opus":0.05272961438826038,"score_gpt":0.3262777169803858,"score_spread":0.2735481025921254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957815062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004961708,0.996434,0.000009376433,0.00020119778,0.00013092863,0.0026138893,0.00007604344,0.000005922544,0.000032481537],"genre_scores_gemma":[0.05557086,0.9434855,0.00011243829,0.00043435598,0.00006538717,0.000110039415,0.000016416358,0.000048535454,0.00015648815],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953908,0.00086446555,0.0026465468,0.00037090806,0.00039914149,0.0003281527],"domain_scores_gemma":[0.99534804,0.0013871894,0.0023010427,0.000557211,0.00022903277,0.0001774582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091570464,0.0005713824,0.014020259,0.0022740008,0.000024992183,0.0000102007225,0.00029906965,0.00020839427,0.00030451917],"category_scores_gemma":[0.00027556776,0.00034116098,0.0035145935,0.0015744684,0.00011247961,0.00007491465,0.0000508174,0.0008276174,0.000010222404],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010803111,0.00037090745,0.0028582928,0.86773413,0.12433474,0.00035217075,0.00006626249,0.000009694097,3.6272615e-7,0.0000052951195,0.000045664416,0.0041144504],"study_design_scores_gemma":[0.0012511921,0.0012532072,0.0013468638,0.025928551,0.9605483,0.0017158827,0.0000022194822,0.000025196854,4.607135e-7,0.0000021914466,0.0076930765,0.00023285227],"about_ca_topic_score_codex":0.000044852648,"about_ca_topic_score_gemma":0.000037763428,"teacher_disagreement_score":0.8418056,"about_ca_system_score_codex":0.00008696103,"about_ca_system_score_gemma":0.00036363647,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W2959343983","doi":"10.1016/j.urolonc.2019.05.020","title":"How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Cystectomy; Medicine; Proportional hazards model; Hazard ratio; Bladder cancer; Urology; Internal medicine; Cohort; Oncology; Cancer; Confidence interval","score_opus":0.01861578946876259,"score_gpt":0.2690129087415232,"score_spread":0.25039711927276065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959343983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950962,0.0005842782,0.000010158669,0.0022339772,0.00018685075,0.0008060636,0.00072355935,0.00001180956,0.00034710928],"genre_scores_gemma":[0.99728924,0.00006014699,0.0010359124,0.00058849296,0.00008578603,0.00013321888,0.00009783142,0.000016019603,0.000693375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876165,0.0001471062,0.00022254988,0.00030934298,0.0003403654,0.00021900811],"domain_scores_gemma":[0.9991399,0.0001375222,0.0002222225,0.00026134422,0.000108665074,0.00013035907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011358974,0.00020098072,0.00047583206,0.00007724285,0.0000732589,0.000008171278,0.000099006196,0.00013844931,0.0006954819],"category_scores_gemma":[0.00001910206,0.00012310385,0.000074929565,0.00019523443,0.0011068358,0.00007379581,0.000049453072,0.000209979,0.0000055049536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006940417,0.0004538746,0.9968487,0.00007435356,0.00022235043,0.000022666789,0.00020311457,0.000007460442,0.00049808295,0.000445242,0.00038489245,0.00014522593],"study_design_scores_gemma":[0.0034944266,0.0037270472,0.946718,0.000057896872,0.00051783724,0.00003233816,0.000045088196,0.000048909154,0.0007242279,0.00048795014,0.04401651,0.00012981812],"about_ca_topic_score_codex":0.00007290586,"about_ca_topic_score_gemma":0.00003489348,"teacher_disagreement_score":0.050130744,"about_ca_system_score_codex":0.00008684043,"about_ca_system_score_gemma":0.00041517618,"threshold_uncertainty_score":0.7615039},"labels":[],"label_agreement":null},{"id":"W2959688418","doi":"10.1016/j.eururo.2019.06.032","title":"Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Bladder cancer; Cystectomy; Chemotherapy; Internal medicine; Oncology; Adjuvant; Proportional hazards model; Urology; Stage (stratigraphy); Cancer","score_opus":0.02131265361603766,"score_gpt":0.27833898707411386,"score_spread":0.2570263334580762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959688418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906822,0.0015096356,0.000010339225,0.00050647603,0.000163977,0.0009453232,0.000032659835,0.00004083916,0.006108586],"genre_scores_gemma":[0.9978241,0.000402214,0.000008652876,0.0015020509,0.000049091825,0.000021748785,0.000016034599,0.000057622605,0.000118486154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771935,0.0010909993,0.00029382878,0.0003652215,0.00021392058,0.00031670855],"domain_scores_gemma":[0.99883455,0.00040980862,0.0002259589,0.0004227479,0.000053201085,0.00005375148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007369909,0.00022439488,0.00045989075,0.000072788374,0.00005516898,0.0000064042947,0.00015818278,0.00006432931,0.0005287322],"category_scores_gemma":[0.00007741354,0.000131346,0.00009849661,0.000224219,0.00016900367,0.000038885693,0.000042390224,0.00039057768,0.000054468743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019484687,0.00026068193,0.9737897,0.000031214164,0.000637534,0.00006173179,0.0012667985,0.000020448115,0.0052368217,0.00000810264,0.00009635109,0.016642166],"study_design_scores_gemma":[0.00845728,0.002783711,0.98479766,0.000070904855,0.00032559564,0.000013435334,0.000104691,0.00015910402,0.0025651017,0.000012499915,0.000591497,0.000118535994],"about_ca_topic_score_codex":0.0006195787,"about_ca_topic_score_gemma":0.0005271562,"teacher_disagreement_score":0.01652363,"about_ca_system_score_codex":0.000065652974,"about_ca_system_score_gemma":0.00010811612,"threshold_uncertainty_score":0.57892466},"labels":[],"label_agreement":null},{"id":"W2961834569","doi":"10.22374/jeleu.v2i3.45","title":"Delays to Diagnosis and Management of Upper Tract Urothelial Carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial carcinoma; Urothelial cancer; Urology; Pathological; Referral; Biopsy; Renal cell carcinoma; Urothelial Cell; Bladder cancer; Ureter; Ureteroscopy; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.01732084833859366,"score_gpt":0.28304415760759866,"score_spread":0.265723309269005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961834569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932349,0.0010437041,0.000068155845,0.001355567,0.0003842465,0.00039702098,0.00001303868,0.0000046683626,0.0034986993],"genre_scores_gemma":[0.99646103,0.00058186287,0.0016215921,0.0007139121,0.00019747057,0.000015558677,0.0000012969497,0.000020678339,0.0003866227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988348,0.000050982333,0.00044105735,0.0001689398,0.00026388493,0.0002403294],"domain_scores_gemma":[0.99920565,0.000088507644,0.00021210416,0.00017041639,0.00011703017,0.00020632175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018703539,0.00014672025,0.0005159796,0.00022008782,0.000020666941,0.000006257328,0.00010478132,0.000070572656,0.00037986433],"category_scores_gemma":[0.000020449164,0.000116166804,0.00016485085,0.00010242471,0.000051107807,0.00006663846,0.000046521498,0.00019111438,0.000021573676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039087078,0.00068055396,0.9701267,0.00027604436,0.000546049,0.0012810044,0.00043846178,0.00001925058,0.004377163,0.00041495703,0.0008617234,0.017069368],"study_design_scores_gemma":[0.009477427,0.011964016,0.9391144,0.00016813686,0.0009281742,0.004902513,0.00027159063,0.000013180237,0.009368103,0.00011046643,0.023531193,0.00015079982],"about_ca_topic_score_codex":0.000047344874,"about_ca_topic_score_gemma":0.0000022845495,"teacher_disagreement_score":0.031012319,"about_ca_system_score_codex":0.00004400126,"about_ca_system_score_gemma":0.00007075112,"threshold_uncertainty_score":0.47371447},"labels":[],"label_agreement":null},{"id":"W2962324291","doi":"10.1016/j.urology.2019.05.046","title":"Upper Tract Urothelial Carcinoma Grade Prediction Based on the Ureteroscopic Appearance: Caution Should be Taken","year":2019,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMS Ingénierie; Boston Scientific Corporation","keywords":"Medicine; Concordance; Ureteroscopy; Urothelial carcinoma; Kappa; Cohen's kappa; Biopsy; Histopathology; Ureter; Radiology; Urology; Nuclear medicine; Cancer; Internal medicine; Pathology; Bladder cancer","score_opus":0.03322248266189934,"score_gpt":0.27763120826381277,"score_spread":0.24440872560191343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962324291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759727,0.00020973466,0.00023450343,0.016342917,0.000997523,0.0010898197,0.000073126816,0.00009333161,0.0049863057],"genre_scores_gemma":[0.98511547,0.000009948803,0.000013644138,0.0136172045,0.0003330885,0.00010021682,0.000060214046,0.000031544925,0.0007186953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987805,0.000118108896,0.00018369088,0.00034680826,0.00026793784,0.0003029622],"domain_scores_gemma":[0.99933743,0.000062287225,0.00005550699,0.00043546731,0.000031110212,0.00007816723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012352238,0.00018605696,0.00023913075,0.00008239122,0.00008583454,0.000011574363,0.0000962526,0.00020262721,0.0007751453],"category_scores_gemma":[0.000025485493,0.000121501886,0.000115071714,0.00010165744,0.00008065284,0.0000426791,0.000011604717,0.0003416062,0.0001979705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034454174,0.0010527881,0.9612808,0.000119048855,0.00018427905,0.000076982986,0.00092589826,0.00079854135,0.023228161,0.0010925471,0.0058114184,0.0019841038],"study_design_scores_gemma":[0.010328651,0.008138161,0.89724064,0.000052577405,0.00042076144,0.000118345495,0.000060275914,0.015428125,0.008416471,0.00023643822,0.059299856,0.0002597087],"about_ca_topic_score_codex":0.000089100715,"about_ca_topic_score_gemma":0.000005934646,"teacher_disagreement_score":0.064040184,"about_ca_system_score_codex":0.00008079396,"about_ca_system_score_gemma":0.00012111593,"threshold_uncertainty_score":0.8487297},"labels":[],"label_agreement":null},{"id":"W2962707973","doi":"10.5489/cuaj.5923","title":"Are there differences among Bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscle invasive bladder cancer? The jury is still out but the answer is likely no","year":2019,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network","funders":"","keywords":"Bladder cancer; Jury; Bacillus (shape); Medicine; Internal medicine; Microbiology; Urology; Cancer; Biology; Political science; Law","score_opus":0.05731545266440377,"score_gpt":0.2970568455668543,"score_spread":0.23974139290245053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962707973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56030583,0.0010372223,0.0000024744672,0.43345234,0.0011647802,0.0012839198,0.00132514,0.00001078568,0.0014175209],"genre_scores_gemma":[0.6649577,0.0021417018,0.0000038970593,0.32646322,0.004098924,0.000065103806,0.00004170858,0.00004134853,0.0021863717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951512,0.0012543645,0.0010560803,0.00061266345,0.00095539354,0.00097027014],"domain_scores_gemma":[0.9946923,0.0023720197,0.0015270361,0.00066023984,0.00046414224,0.00028423205],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009633333,0.000631944,0.0012780067,0.00016799897,0.00042174757,0.00020503152,0.00081738277,0.0012704778,0.0011818239],"category_scores_gemma":[0.00056910055,0.00026352418,0.0009525082,0.0002355918,0.00032230752,0.00008635319,0.000033974855,0.0033039488,0.00007215154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000714638,0.00021891843,0.5663591,0.000018105591,0.0015972418,0.00038001116,0.004291001,0.000007531243,0.000003116688,7.3877493e-7,0.42098886,0.0060638967],"study_design_scores_gemma":[0.0021197968,0.0011287612,0.7504775,0.00012900894,0.0006419676,0.00003171043,0.0008561106,0.000033038075,0.0000064485303,0.000049860388,0.24429144,0.00023435435],"about_ca_topic_score_codex":0.0085593425,"about_ca_topic_score_gemma":0.017443357,"teacher_disagreement_score":0.18411839,"about_ca_system_score_codex":0.0016348305,"about_ca_system_score_gemma":0.0016520207,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W2964363953","doi":"10.1016/j.urolonc.2019.06.025","title":"Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series","year":2019,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Series (stratigraphy); Focus (optics); Medicine; Geology; Physics","score_opus":0.052414555709831,"score_gpt":0.4061191334540965,"score_spread":0.3537045777442655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964363953","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038669992,0.0125876255,0.0000024873184,0.010501599,0.9333896,0.0016305676,0.00064893055,0.000067458124,0.0025017557],"genre_scores_gemma":[0.0014017833,0.02591741,0.0027883276,0.00053754624,0.96095896,0.00039748978,0.00023704705,0.00008667035,0.007674745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576277,0.0008405503,0.0009282759,0.000931736,0.0009772563,0.00055941084],"domain_scores_gemma":[0.9933543,0.004313362,0.0005791642,0.00063250813,0.0007144943,0.00040615269],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002538098,0.0004902007,0.0012716635,0.00022876622,0.00045102366,0.00005656376,0.0003193034,0.0020562657,0.000101111866],"category_scores_gemma":[0.0024406805,0.00032038064,0.00017124649,0.000408056,0.004389323,0.00014693543,0.00025090054,0.0030379372,0.000019864565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085840124,0.00023352109,0.03180583,0.00014515153,0.00055974425,0.00004569244,0.00060579367,0.0000035543521,0.000031333406,0.00070946716,0.96366715,0.0013343443],"study_design_scores_gemma":[0.0019588973,0.007955041,0.00033353476,0.00035209744,0.0015925507,0.000060262417,0.00044855656,0.000019210278,0.00008734349,0.005160031,0.98176795,0.0002645339],"about_ca_topic_score_codex":0.0013207968,"about_ca_topic_score_gemma":0.00063530257,"teacher_disagreement_score":0.03726821,"about_ca_system_score_codex":0.00025994377,"about_ca_system_score_gemma":0.004963852,"threshold_uncertainty_score":0.99992484},"labels":[],"label_agreement":null},{"id":"W2964559192","doi":"10.1016/j.urolonc.2019.06.021","title":"Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Urothelial cancer; Bladder cancer; Cancer; Biology; Pathology; Cancer research; Medicine; Genetics","score_opus":0.018139160072410038,"score_gpt":0.29046182176507557,"score_spread":0.2723226616926655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964559192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277,0.0003569889,0.000038673064,0.0052800197,0.00012451637,0.00080390275,0.00008827407,0.000021933136,0.00051565253],"genre_scores_gemma":[0.9901912,0.0011208045,0.003894401,0.004231637,0.000066384186,0.00014543896,0.00007050592,0.000014127078,0.00026547827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990517,0.00007416783,0.0002657194,0.000321898,0.00008801339,0.00019848303],"domain_scores_gemma":[0.99952173,0.00007403117,0.000094312956,0.00012065819,0.000043445958,0.00014581345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012034068,0.0001527971,0.0003570376,0.00018729384,0.000051164046,0.0000073872156,0.000045578123,0.00016921885,0.00020083401],"category_scores_gemma":[0.000024760408,0.00013084048,0.000031786734,0.00020245838,0.0002039116,0.000080272126,0.00002379546,0.00015211155,0.000015835572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003352543,0.0002293043,0.57981676,0.00008270964,0.00005895306,0.00005728206,0.002207516,0.00006499071,0.41130552,0.0007393347,0.000078702185,0.005023696],"study_design_scores_gemma":[0.0055912016,0.007218507,0.89571303,0.00025991307,0.00042994003,0.0003640261,0.00047419322,0.00069443334,0.015405162,0.003024418,0.07040932,0.00041588355],"about_ca_topic_score_codex":0.00018706553,"about_ca_topic_score_gemma":0.00007303187,"teacher_disagreement_score":0.39590034,"about_ca_system_score_codex":0.000095264964,"about_ca_system_score_gemma":0.0002691946,"threshold_uncertainty_score":0.53355193},"labels":[],"label_agreement":null},{"id":"W2964930251","doi":"10.1001/jamainternmed.2019.2280","title":"Comparison of the Harms, Advantages, and Costs Associated With Alternative Guidelines for the Evaluation of Hematuria","year":2019,"lang":"en","type":"article","venue":"JAMA Internal Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoscopy; Cohort; Urinary system; Pyelogram; Cohort study; Radiology; Surgery; Internal medicine","score_opus":0.11758654301400893,"score_gpt":0.4473203975854881,"score_spread":0.32973385457147913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964930251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288023,0.0037296633,0.00025795845,0.009043581,0.0005311806,0.0016951213,0.00004599129,0.000007077125,0.0018092218],"genre_scores_gemma":[0.9983658,0.000068157016,0.000086576154,0.0006821162,0.00019353777,0.00003925613,0.000014421955,0.000012814293,0.00053728564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986758,0.000063958374,0.0003626077,0.00013502319,0.0006690676,0.00009351964],"domain_scores_gemma":[0.99769104,0.00045291046,0.00037489453,0.00020691656,0.0012392123,0.00003505899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006965002,0.00011218983,0.00037854465,0.00003636735,0.000025453155,0.00000366877,0.00011918289,0.000040559684,0.00011553139],"category_scores_gemma":[0.00134,0.000044779077,0.000047400947,0.000086028114,0.00014295816,0.000040477535,0.000029427378,0.00012030518,7.165148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004602363,0.00038761605,0.8753321,0.00025154074,0.002336947,0.0000020854068,0.003815329,0.00011467909,0.0129822325,0.0003215943,0.018818295,0.0810352],"study_design_scores_gemma":[0.037658423,0.005726157,0.8392514,0.00939956,0.003565796,0.000047727077,0.003723328,0.026869815,0.07071208,0.00039491858,0.0024919636,0.00015886188],"about_ca_topic_score_codex":0.00059347815,"about_ca_topic_score_gemma":0.0001014295,"teacher_disagreement_score":0.080876336,"about_ca_system_score_codex":0.000089680536,"about_ca_system_score_gemma":0.00007390085,"threshold_uncertainty_score":0.18260378},"labels":[],"label_agreement":null},{"id":"W2965046842","doi":"10.1200/jco.2013.31.15_suppl.4524","title":"Nomogram to estimate the activity of second-line therapy for advanced urothelial carcinoma (UC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Nomogram; Medicine; Internal medicine; Oncology; Hazard ratio; Anemia; Overall survival; Progression-free survival; Confidence interval","score_opus":0.1046274200903648,"score_gpt":0.49395154282305276,"score_spread":0.38932412273268796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965046842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815417,0.00025528378,0.0008131681,0.013997127,0.0010856899,0.0011765852,0.000018268976,0.0000070633096,0.0011051485],"genre_scores_gemma":[0.9881691,0.00010753346,0.0064918576,0.0035108086,0.0010745365,0.00006533079,0.0000010973663,0.000022517605,0.0005572197],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979014,0.00018356334,0.0012582327,0.00016601053,0.00023117417,0.0002596553],"domain_scores_gemma":[0.99629414,0.0015993157,0.0009563333,0.00024760238,0.000597644,0.00030495776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001216276,0.00014709664,0.0011980023,0.00006466119,0.000048701357,0.000007553118,0.00020104197,0.00019874194,0.0004266901],"category_scores_gemma":[0.000925593,0.00007845636,0.0005670233,0.00010041719,0.00014675554,0.000100005556,0.000033419376,0.0004348892,0.000016470818],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018702187,0.0025411833,0.026840646,0.000037545593,0.00054152106,0.000031174044,0.00018234708,0.000027762308,0.012813323,0.000045788944,0.004107073,0.9341295],"study_design_scores_gemma":[0.030784959,0.07957045,0.77125454,0.000064658394,0.0003779736,0.0001596321,0.0000725427,0.00017856201,0.015823139,0.0011600133,0.1004021,0.00015140734],"about_ca_topic_score_codex":0.000050746687,"about_ca_topic_score_gemma":0.00005156886,"teacher_disagreement_score":0.933978,"about_ca_system_score_codex":0.00006996874,"about_ca_system_score_gemma":0.0010880161,"threshold_uncertainty_score":0.46719572},"labels":[],"label_agreement":null},{"id":"W2965370576","doi":"10.1007/s00345-019-02885-6","title":"Hope, hype and biology: the current biomarker landscape in bladder cancer","year":2019,"lang":"en","type":"editorial","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Bladder cancer; Biomarker; Nephrology; Internal medicine; Cancer; Oncology; Biology; Genetics","score_opus":0.02408399559267875,"score_gpt":0.3383375282071183,"score_spread":0.31425353261443956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965370576","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020377634,0.18691576,0.0000057343605,0.0058177426,0.8021773,0.00038077385,0.00011033367,0.000007449303,0.0025471265],"genre_scores_gemma":[0.08320288,0.080605656,0.00003490358,0.0014587414,0.82793075,0.00004790626,0.00008524077,0.000108740816,0.006525166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984088,0.00019266848,0.0005544489,0.0002681604,0.0002445343,0.00033137816],"domain_scores_gemma":[0.9983479,0.0005977312,0.00046536428,0.00024416734,0.00023427581,0.00011058369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043011145,0.00028330137,0.0008448524,0.000488446,0.00003105801,0.000016489264,0.00020822893,0.0003198897,0.0002953766],"category_scores_gemma":[0.00016952121,0.00016066885,0.00015207884,0.00024671562,0.00017362233,0.000041383508,0.000076667915,0.0016913671,0.000016153794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013857981,0.000110351684,0.02230594,0.00005095261,0.0005102843,0.000060332568,0.00009321474,0.0000018946957,0.000025223222,0.000007390096,0.9042514,0.071197204],"study_design_scores_gemma":[0.0042898194,0.000639458,0.012217633,0.00012844287,0.0007050418,0.00007088051,0.0000064762053,0.000009352718,0.0000012560554,0.00016603773,0.9816369,0.00012872404],"about_ca_topic_score_codex":0.00010045842,"about_ca_topic_score_gemma":0.0005332837,"teacher_disagreement_score":0.1063101,"about_ca_system_score_codex":0.00011441858,"about_ca_system_score_gemma":0.0013235245,"threshold_uncertainty_score":0.7348243},"labels":[],"label_agreement":null},{"id":"W2965386530","doi":"10.1016/j.clgc.2019.07.016","title":"Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Janssen Pharmaceuticals; Janssen Biotech; Fonds de Recherche du Québec - Santé; Amgen; AbbVie Canada; AstraZeneca; Innocrin Pharmaceuticals; Ferring Pharmaceuticals; Astellas Pharma Canada; Bayer; Merck; MedImmune; Roche; Sanofi","keywords":"Medicine; Cystectomy; 5 Alpha-Reductase Inhibitor; Bladder cancer; Receipt; Alpha (finance); Oncology; Internal medicine; Urology; Cancer; Finasteride; Surgery; World Wide Web","score_opus":0.035415946778967325,"score_gpt":0.3493478301064011,"score_spread":0.31393188332743377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965386530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860853,0.004728127,0.0000025272489,0.0022374664,0.0030647086,0.0012145694,0.00021676092,0.00011298735,0.002337578],"genre_scores_gemma":[0.99059075,0.001300348,0.00040576214,0.00079081015,0.0030591015,0.0001535444,0.00007940017,0.00012161427,0.0034986422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587125,0.00030756075,0.0013905187,0.000997258,0.0007666634,0.0006667809],"domain_scores_gemma":[0.99709815,0.00023453793,0.00071788375,0.0011024742,0.00024005097,0.00060688064],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004281865,0.00051031436,0.0013577986,0.00017651891,0.00010097035,0.000022417264,0.00035988155,0.000477772,0.0013956615],"category_scores_gemma":[0.00017609505,0.00038972255,0.0006396696,0.0003535232,0.0005021221,0.00015098148,0.00019144439,0.0009374112,0.00015535354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010838377,0.0062895217,0.73889846,0.0011672422,0.0038158186,0.0028942819,0.0016913294,0.00009337288,0.007715293,0.0002675867,0.059858337,0.16647038],"study_design_scores_gemma":[0.06854444,0.022087969,0.7695288,0.0073196916,0.004204011,0.0012212535,0.0024339969,0.00009905227,0.054366868,0.0045688865,0.06274582,0.0028792336],"about_ca_topic_score_codex":0.00052632944,"about_ca_topic_score_gemma":0.000042555814,"teacher_disagreement_score":0.16359115,"about_ca_system_score_codex":0.00025053445,"about_ca_system_score_gemma":0.0010055556,"threshold_uncertainty_score":0.99985546},"labels":[],"label_agreement":null},{"id":"W2966773770","doi":"10.1002/cncy.22167","title":"Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Biomarker; Immunocytochemistry; Cytology; Urine cytology; Bladder cancer; Urine; Cancer; Pathology; ARID1A; Oncology; Urology; Internal medicine","score_opus":0.01788707367242749,"score_gpt":0.33384930866202434,"score_spread":0.31596223498959686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966773770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876977,0.005992125,0.00010471709,0.0010893169,0.0008573683,0.0010573968,0.00018173558,0.00003171826,0.0029879042],"genre_scores_gemma":[0.99402523,0.000649915,0.00023227211,0.00083610043,0.00015939676,0.000823073,0.00005508996,0.000046829406,0.003172075],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984191,0.000039575123,0.0004289462,0.0005107999,0.00013870721,0.00046285737],"domain_scores_gemma":[0.9991286,0.00004293635,0.00016178245,0.00041834032,0.00015802043,0.00009032007],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011364157,0.00024594026,0.0007282673,0.00015483038,0.000025793004,0.000004314456,0.00014681104,0.00027652152,0.0026461945],"category_scores_gemma":[0.0000305142,0.00022298716,0.00018046303,0.00019607625,0.0001703469,0.000047856447,0.000064760905,0.0001885108,0.000042786593],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054900036,0.00040611732,0.21775009,0.00049636874,0.00035025846,0.00025980518,0.0002969448,0.000051517774,0.7628973,0.0001347052,0.00083474355,0.011032146],"study_design_scores_gemma":[0.03127125,0.0022357546,0.61188436,0.00042919174,0.0008801095,0.00124409,0.00034251218,0.0003007634,0.33625045,0.0011629761,0.013281929,0.0007166195],"about_ca_topic_score_codex":0.0009204645,"about_ca_topic_score_gemma":0.00010121865,"teacher_disagreement_score":0.42664686,"about_ca_system_score_codex":0.0002296421,"about_ca_system_score_gemma":0.0006299689,"threshold_uncertainty_score":0.9982655},"labels":[],"label_agreement":null},{"id":"W2968700707","doi":"10.3390/jcm8081192","title":"Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Propensity score matching; Cystectomy; Survival analysis; Internal medicine; Oncology; Bladder cancer; Cancer","score_opus":0.30397605842379194,"score_gpt":0.46946041750687173,"score_spread":0.1654843590830798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968700707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763009,0.00026052495,0.00024851345,0.007046099,0.0032288833,0.0006478123,0.0000014891414,0.000016231374,0.012249556],"genre_scores_gemma":[0.9964198,0.000088156215,0.00049570267,0.0008454498,0.0007729141,0.0000026829039,0.000007588729,0.000022868402,0.0013448687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964136,0.00024599896,0.0019133141,0.00030343386,0.0008573404,0.000266353],"domain_scores_gemma":[0.99649614,0.0009972057,0.0010211513,0.00052009424,0.00046914356,0.00049624976],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025128725,0.00023240347,0.0037017665,0.00024783268,0.0000428491,0.000029088895,0.0004744056,0.00013464665,0.000975244],"category_scores_gemma":[0.0018493923,0.00013085036,0.0006360398,0.0005905643,0.00014281385,0.00017753404,0.00018494952,0.00068936945,0.000071725015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072807726,0.0004387055,0.9838429,0.00006040366,0.005513971,0.00022351251,0.00011271964,0.00006880405,0.00003883111,0.000030750423,0.00038974616,0.0019988515],"study_design_scores_gemma":[0.036055606,0.004849237,0.9500869,0.0005690988,0.0073079783,0.0000482193,0.00019627504,0.00022926422,0.000017697483,0.000053052536,0.00046520203,0.00012145865],"about_ca_topic_score_codex":0.00027671628,"about_ca_topic_score_gemma":0.00012956132,"teacher_disagreement_score":0.03375602,"about_ca_system_score_codex":0.000099412435,"about_ca_system_score_gemma":0.000396392,"threshold_uncertainty_score":0.999938},"labels":[],"label_agreement":null},{"id":"W2970060324","doi":"10.1002/cam4.2449","title":"Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University of Calgary","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Canada Foundation for Innovation; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Perioperative; Bladder cancer; Benchmarking; Population; Case mix index; Multivariate analysis; Cancer registry; Emergency medicine; Cancer; Surgery; Internal medicine; Environmental health","score_opus":0.04891107964704261,"score_gpt":0.36066356067103367,"score_spread":0.31175248102399106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970060324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9224754,0.0123024015,0.0067120674,0.043616284,0.003567317,0.006292083,0.00014936074,0.0001627259,0.004722387],"genre_scores_gemma":[0.9690585,0.0013489046,0.0011021303,0.015497413,0.002978374,0.0018528326,0.0000947136,0.00010246396,0.007964683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856424,0.000044991353,0.00030832435,0.0004457695,0.00027669102,0.0003599779],"domain_scores_gemma":[0.9988454,0.00017115251,0.0001457431,0.0003529114,0.0003511046,0.00013370009],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021501507,0.0002883387,0.00048456574,0.000060908395,0.00018334229,0.000018348781,0.00013129723,0.00008984721,0.004472853],"category_scores_gemma":[0.000099707475,0.000165814,0.00009935382,0.00025267643,0.00019475553,0.0001066368,0.0000190111,0.00017569729,0.000021507894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071168235,0.00070981175,0.07936227,0.002633623,0.005654949,0.00005493233,0.07177603,0.017760431,0.22709614,0.0012798808,0.093641415,0.4929137],"study_design_scores_gemma":[0.10354857,0.010662137,0.2691534,0.0077767763,0.0052781473,0.00010085218,0.013670437,0.12841979,0.11888355,0.00045719766,0.33973217,0.0023169862],"about_ca_topic_score_codex":0.000579977,"about_ca_topic_score_gemma":0.000101242644,"teacher_disagreement_score":0.4905967,"about_ca_system_score_codex":0.0002590613,"about_ca_system_score_gemma":0.0005609691,"threshold_uncertainty_score":0.9964372},"labels":[],"label_agreement":null},{"id":"W2970389063","doi":"10.1007/s00345-019-02915-3","title":"Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator","year":2019,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Brier score; Cystectomy; Surgery; Receiver operating characteristic; Retrospective cohort study; Bladder cancer; Cohort; Complication; General surgery; Internal medicine; Cancer","score_opus":0.009131684974319284,"score_gpt":0.2573587236402079,"score_spread":0.2482270386658886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970389063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838499,0.000991535,0.00021924645,0.008082538,0.00025334803,0.0002512134,0.000005311367,0.000018155417,0.0063287597],"genre_scores_gemma":[0.9984137,0.000035145844,0.00020094297,0.0005254485,0.000269871,0.0000027767396,0.0000020413302,0.000017057457,0.00053303497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989866,0.0001442405,0.0002515088,0.00013502856,0.00026914725,0.0002134979],"domain_scores_gemma":[0.99905777,0.00028313155,0.00022920135,0.00020392763,0.000082519924,0.00014344284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026153176,0.00011467791,0.0003285976,0.00012416653,0.00011544211,0.000010305436,0.00013995387,0.000054967295,0.00012768843],"category_scores_gemma":[0.000021461496,0.00006356459,0.00016713716,0.00022862265,0.0001093824,0.00006051193,0.000026105548,0.0005548568,0.000024612424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018180083,0.00017727619,0.9921473,0.000010201386,0.0010190109,0.00076070597,0.00034513048,0.00031218628,0.0002748676,0.0005586389,0.0008124584,0.0017642175],"study_design_scores_gemma":[0.027437676,0.004351519,0.58239615,0.0001301552,0.0028456056,0.009170161,0.00042019525,0.00079074164,0.00012454779,0.00013489778,0.37194687,0.00025148992],"about_ca_topic_score_codex":0.000042299744,"about_ca_topic_score_gemma":0.000044929548,"teacher_disagreement_score":0.40975115,"about_ca_system_score_codex":0.00007237181,"about_ca_system_score_gemma":0.00019926134,"threshold_uncertainty_score":0.2592089},"labels":[],"label_agreement":null},{"id":"W2971534475","doi":"10.1007/s00428-019-02661-2","title":"Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder","year":2019,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Canada Research Chairs; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; International Business Machines Corporation","keywords":"Medicine; Immunotherapy; Immune system; Tissue microarray; Bladder cancer; Major histocompatibility complex; Antigen; Cancer; Cancer research; Oncology; Immune checkpoint; Immunology; Internal medicine","score_opus":0.04085845701525223,"score_gpt":0.3723619870491594,"score_spread":0.3315035300339072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971534475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728555,0.007517147,0.00003474301,0.00079958764,0.00045480274,0.001959339,0.00012903068,0.00003418818,0.0017856156],"genre_scores_gemma":[0.996645,0.0014241667,0.0010155771,0.00043240556,0.00017502964,0.00012300622,0.000044652093,0.000044414846,0.00009576298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961136,0.0008438257,0.00079711847,0.000738766,0.0010064367,0.000500229],"domain_scores_gemma":[0.9976056,0.0005802273,0.00049895694,0.00090970413,0.00026036106,0.0001451051],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013444539,0.0004184377,0.000985278,0.00022855926,0.000085364794,0.000008730314,0.00038884327,0.00027983973,0.00017421797],"category_scores_gemma":[0.00078231015,0.0002527892,0.00019238323,0.00044932342,0.00083681656,0.00010797278,0.00029091147,0.0006214523,0.000009210785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059622625,0.0005824739,0.5941357,0.00019498986,0.00031296618,0.000018979043,0.001414004,0.0003050741,0.3861612,0.0002571543,0.00018909272,0.015832134],"study_design_scores_gemma":[0.0075711654,0.0010632634,0.82254547,0.00056823244,0.00087984605,0.0000084392095,0.00047767424,0.0011890014,0.16218048,0.0030895197,0.00018747301,0.00023945495],"about_ca_topic_score_codex":0.0021224974,"about_ca_topic_score_gemma":0.00015789177,"teacher_disagreement_score":0.22840974,"about_ca_system_score_codex":0.00008853038,"about_ca_system_score_gemma":0.0009226674,"threshold_uncertainty_score":0.99999243},"labels":[],"label_agreement":null},{"id":"W2971789413","doi":"10.1016/j.urology.2019.08.032","title":"Age Differences in Patient-reported Psychological and Physical Distress Symptoms in Bladder Cancer Patients – A Cross Sectional Study","year":2019,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Comorbidity; Cross-sectional study; Internal medicine; Distress; Cancer; Disease; Psychological distress; Physical therapy; Psychiatry; Pathology; Clinical psychology; Mental health","score_opus":0.0210906436330249,"score_gpt":0.32872487152364016,"score_spread":0.3076342278906153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971789413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829096,0.000057941106,6.1794094e-7,0.000055091,0.00030154872,0.00075770344,0.000024299528,0.000017652073,0.0004941635],"genre_scores_gemma":[0.99936366,0.00000714947,0.0000015178025,0.00026993646,0.00005069515,0.00016747751,0.00002496865,0.00001039808,0.00010417139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877805,0.00008028366,0.00025746852,0.00045211823,0.0001856849,0.00024638188],"domain_scores_gemma":[0.999641,0.000051536506,0.00006142998,0.00014797779,0.000031098945,0.00006694411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036381083,0.000148671,0.00034062174,0.000085757914,0.00002116251,0.000011923099,0.000049538703,0.000103374856,0.0001875563],"category_scores_gemma":[0.000018702429,0.00010817199,0.000034161087,0.00012624945,0.00010008786,0.000040231083,0.000045728564,0.00021991691,0.000011927576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008741858,0.0036202637,0.9924456,0.000006848094,0.00008159047,0.00017565089,0.0011084265,0.0000069039606,0.000053440894,0.0000062742492,0.000008521207,0.0016122839],"study_design_scores_gemma":[0.0074160746,0.003769607,0.98840785,0.0000062478866,0.00003359005,0.000013935045,0.000051244526,0.00007699818,0.0000076471615,0.00010160681,0.000021376343,0.000093845985],"about_ca_topic_score_codex":0.0005255887,"about_ca_topic_score_gemma":0.00038471026,"teacher_disagreement_score":0.0065418887,"about_ca_system_score_codex":0.000049205813,"about_ca_system_score_gemma":0.000019268298,"threshold_uncertainty_score":0.44111255},"labels":[],"label_agreement":null},{"id":"W2972160710","doi":"10.1016/j.eururo.2019.08.021","title":"Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Disease; Bladder cancer; Cancer; Pathology; Internal medicine","score_opus":0.03733691755352884,"score_gpt":0.3213158959399568,"score_spread":0.28397897838642794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972160710","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3053805,0.018550279,0.009906806,0.08802186,0.002396486,0.014471482,0.00021553566,0.0026907844,0.5583663],"genre_scores_gemma":[0.98570025,0.0003631718,0.00026530167,0.008731695,0.0002659167,0.00016090293,0.000039644317,0.00008535308,0.0043877824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717015,0.0012170662,0.00033940256,0.00061114953,0.00012007255,0.0005421743],"domain_scores_gemma":[0.99824363,0.00031547484,0.00014880116,0.0010823697,0.000081690654,0.00012805744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007892446,0.00030389428,0.0003768999,0.0001159616,0.00021707088,0.000028176184,0.00052185624,0.00013560322,0.00076895347],"category_scores_gemma":[0.00016285735,0.00016024499,0.00018364406,0.0002123465,0.00052259595,0.00004508739,0.0002735062,0.0006631303,0.0009217437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061727325,0.0010935845,0.33163226,0.0003028916,0.0018338766,0.0005672071,0.0019381086,0.000022318354,0.22489646,0.05221688,0.025562463,0.35376123],"study_design_scores_gemma":[0.0015027398,0.0031143248,0.099525794,0.00004300539,0.0004033865,0.00028258676,0.00008664161,0.000033240463,0.0013949919,0.0030228992,0.8902498,0.00034062026],"about_ca_topic_score_codex":0.000050011007,"about_ca_topic_score_gemma":0.0000043771734,"teacher_disagreement_score":0.8646873,"about_ca_system_score_codex":0.00005008549,"about_ca_system_score_gemma":0.00012687652,"threshold_uncertainty_score":0.9998562},"labels":[],"label_agreement":null},{"id":"W2972475028","doi":"10.1016/j.euf.2019.09.003","title":"What Is the Significance of Variant Histology in Urothelial Carcinoma?","year":2019,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Lymph node; Carcinoma; Chemotherapy; Radiation therapy; Oncology; Adenocarcinoma; Stage (stratigraphy); Internal medicine; Pathology; Bladder cancer; Cancer","score_opus":0.048429111898732266,"score_gpt":0.3105415743893578,"score_spread":0.26211246249062553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972475028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004779581,0.9764432,0.000013828336,0.0009134204,0.0015072956,0.0019394027,0.00007281263,0.000026562104,0.019035686],"genre_scores_gemma":[0.0052756523,0.98996186,0.000021684256,0.001156335,0.0003673194,0.000084628206,0.000030634805,0.00014187505,0.002960029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964081,0.001305192,0.00088296406,0.000733046,0.00020430984,0.0004663806],"domain_scores_gemma":[0.9979041,0.00032163085,0.00047466115,0.0011525155,0.0000565358,0.00009054637],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048603877,0.0005047555,0.0021332125,0.00024901176,0.000041301133,0.000014842268,0.0005319736,0.00027592073,0.0003868446],"category_scores_gemma":[0.000048573256,0.00031642104,0.0005455731,0.00028783633,0.00034436953,0.000057140714,0.00015513657,0.00080834155,0.0009077863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003009355,0.0002795684,0.00021403053,0.003972002,0.0005385633,0.0020236366,0.0007965449,6.398021e-7,0.000005282195,0.00038252474,0.0026403603,0.9888459],"study_design_scores_gemma":[0.0014407956,0.0008976734,0.0004053756,0.00090451754,0.002091706,0.000770216,0.000020000358,0.0000014713609,0.0000055955884,0.000047010795,0.99318975,0.00022588178],"about_ca_topic_score_codex":0.00015354276,"about_ca_topic_score_gemma":0.000019367408,"teacher_disagreement_score":0.9905494,"about_ca_system_score_codex":0.00013538654,"about_ca_system_score_gemma":0.0006391035,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W2972535768","doi":"10.1097/pas.0000000000001371","title":"Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma","year":2019,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Multicenter study; Neoadjuvant therapy; Carcinoma; Oncology; Urology; Pathology; Internal medicine; Cancer; Randomized controlled trial","score_opus":0.013348038020396864,"score_gpt":0.2786497727380485,"score_spread":0.2653017347176516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972535768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660414,0.00067272777,0.000013911699,0.0020130584,0.00020830487,0.00028117193,0.0000062604395,0.0000060054913,0.00019441562],"genre_scores_gemma":[0.9983412,0.00033983254,0.00032846114,0.00076195574,0.0001155592,0.000009316338,0.000002529722,0.000021212505,0.00007990782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833584,0.000378592,0.00057238986,0.00019685969,0.0002700694,0.00024628002],"domain_scores_gemma":[0.99860656,0.00020359636,0.0006823516,0.0002837735,0.00013165353,0.000092070804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039920164,0.00017813401,0.000755966,0.00017483498,0.000018172961,0.0000040015075,0.00015021011,0.000047893045,0.00026722954],"category_scores_gemma":[0.000033276392,0.00009608544,0.00022915848,0.00020950534,0.00037542288,0.0000617236,0.000034458782,0.00034149305,0.000017182285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010820493,0.0009830325,0.90486735,0.00004920497,0.00008182215,0.008728237,0.0029248537,0.00003251478,0.056930855,0.000012706077,0.000080793805,0.014488156],"study_design_scores_gemma":[0.0075766984,0.004121608,0.9696052,0.00019465869,0.00012416614,0.0036783854,0.00074410543,0.000014656016,0.013262119,0.0001237154,0.0004289842,0.00012571896],"about_ca_topic_score_codex":0.000037548776,"about_ca_topic_score_gemma":0.0000017796823,"teacher_disagreement_score":0.06473785,"about_ca_system_score_codex":0.00010276702,"about_ca_system_score_gemma":0.00010319667,"threshold_uncertainty_score":0.39182502},"labels":[],"label_agreement":null},{"id":"W2973105086","doi":"10.1016/j.ijrobp.2019.06.1950","title":"Selective Use of Radiation-Based Management in Localized Muscle-Invasive Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Radiation therapy; Urology; Cohort; Chemotherapy; Stage (stratigraphy); Metastasis; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.023976660283857327,"score_gpt":0.3368626591017415,"score_spread":0.3128859988178842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973105086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988215,0.0007497582,0.0042269966,0.0022348224,0.0023189532,0.00085254334,0.00013671315,0.000024034467,0.0012411452],"genre_scores_gemma":[0.9944693,0.0012893312,0.0016665756,0.0017355619,0.00056509976,0.000037402962,0.000079814505,0.000028205552,0.00012873375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983114,0.00018042025,0.0007274468,0.0002405396,0.00033241746,0.00020775346],"domain_scores_gemma":[0.997772,0.00043052592,0.00089307444,0.00015221474,0.0006602843,0.00009194542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000228139,0.00019446257,0.00054173346,0.000317297,0.000023268287,0.000013802447,0.00020387273,0.00018172173,0.00025356203],"category_scores_gemma":[0.00011524852,0.00017184019,0.00022207128,0.0002756303,0.00009659693,0.00024559195,0.00002929752,0.000305869,0.0000242095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015882434,0.00094486703,0.7881481,0.00003488657,0.0019525209,0.000051622686,0.00050208415,0.008454411,0.0030892496,0.0017915437,0.00096850767,0.19247396],"study_design_scores_gemma":[0.05815599,0.004341067,0.8379571,0.0006313002,0.00096867775,0.00005528142,0.000307363,0.009066921,0.040822085,0.0055587464,0.041562065,0.00057344005],"about_ca_topic_score_codex":0.0002043154,"about_ca_topic_score_gemma":0.00003577993,"teacher_disagreement_score":0.19190052,"about_ca_system_score_codex":0.0012599112,"about_ca_system_score_gemma":0.001005629,"threshold_uncertainty_score":0.700744},"labels":[],"label_agreement":null},{"id":"W2974766534","doi":"10.1158/1535-7163.mct-18-0986","title":"PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: <i>In Situ</i> and Abscopal Effects","year":2019,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Cancer Research Society","keywords":"Abscopal effect; Bladder cancer; Immune system; Cancer research; In situ; Medicine; Cancer; Immune checkpoint; Immunology; Chemistry; Internal medicine; Immunotherapy","score_opus":0.0077958635843792725,"score_gpt":0.2630815545146738,"score_spread":0.2552856909302945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974766534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97795695,0.017940212,0.00013991511,0.0014242749,0.00018133078,0.0012384508,0.000014972951,0.000032590946,0.0010713039],"genre_scores_gemma":[0.9934142,0.0032494888,0.000100850455,0.0026730793,0.0000637587,0.00026201285,0.000024302524,0.000059888374,0.00015240075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986495,0.00006556276,0.00027008133,0.00038975896,0.00028417262,0.00034095225],"domain_scores_gemma":[0.999493,0.00002295635,0.00009214065,0.0002657771,0.000047772897,0.000078357996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001024195,0.0002625405,0.0003988622,0.00015047415,0.000027759634,0.000024581575,0.000047588797,0.00012972634,0.00007097515],"category_scores_gemma":[0.0000023044151,0.00022273298,0.000060500282,0.00032806135,0.000058558067,0.000092774004,0.000021826825,0.00025967407,0.000010776044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019188441,0.00033200157,0.11847648,0.0004030141,0.00044502428,0.00023849412,0.0016219612,0.0004997492,0.81629187,0.000074652125,0.000010159606,0.059687734],"study_design_scores_gemma":[0.016097123,0.0009750933,0.29003158,0.00090538006,0.00036581917,0.000029784933,0.000100933226,0.00041980445,0.68906707,0.00017900078,0.0014229964,0.00040538886],"about_ca_topic_score_codex":0.0013530308,"about_ca_topic_score_gemma":0.00075059047,"teacher_disagreement_score":0.17155512,"about_ca_system_score_codex":0.00040106368,"about_ca_system_score_gemma":0.00024406325,"threshold_uncertainty_score":0.90827876},"labels":[],"label_agreement":null},{"id":"W2975084321","doi":"10.1136/bmjopen-2019-029468","title":"Graham Roberts Study protocol: first ‘trials within cohort study’ for bladder cancer","year":2019,"lang":"en","type":"article","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Bladder cancer; Informed consent; Cohort; Clinical trial; Family medicine; Protocol (science); Cohort study; Prospective cohort study; Research ethics; Quality of life (healthcare); Cancer; Alternative medicine; Gerontology; Nursing; Pathology; Psychiatry; Internal medicine","score_opus":0.15545213441661598,"score_gpt":0.5006435764995482,"score_spread":0.3451914420829322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975084321","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13824712,0.000010847833,0.000008527351,0.0005240283,0.0004806971,0.85296416,0.00004958412,0.000051439816,0.007663613],"genre_scores_gemma":[0.24797224,7.443092e-7,0.00019815037,0.00047230846,0.0003275845,0.7336045,0.000013444314,0.00006168224,0.017349338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974303,0.00021156407,0.00079493754,0.0006791689,0.0005513795,0.00033259732],"domain_scores_gemma":[0.99825114,0.0001431171,0.0003326806,0.0009093912,0.0001998904,0.00016378294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002602474,0.0003084837,0.001230197,0.000070477116,0.00015046171,0.00014486669,0.0003765906,0.00007958251,0.002389677],"category_scores_gemma":[0.00019179848,0.00020933649,0.0001502416,0.00018433329,0.000021482996,0.00019296644,0.00026085888,0.000121647245,0.0001567961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059142616,0.0032583317,0.9679811,0.00016669155,0.0017474316,0.00003188329,0.0020678304,0.000025118272,0.000027090982,0.00001102455,0.01776587,0.0010033849],"study_design_scores_gemma":[0.06533397,0.012588101,0.8761159,0.00046684462,0.0018745193,0.00001801286,0.0028008153,0.00007114306,0.00069130055,0.00012311852,0.039310515,0.00060577283],"about_ca_topic_score_codex":0.0059977197,"about_ca_topic_score_gemma":0.005245099,"teacher_disagreement_score":0.11935964,"about_ca_system_score_codex":0.00016055732,"about_ca_system_score_gemma":0.0006124249,"threshold_uncertainty_score":0.9985223},"labels":[],"label_agreement":null},{"id":"W2975148585","doi":"10.1002/jso.25717","title":"The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder","year":2019,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Chemotherapy; Proportional hazards model; Urology; Metastatic Urothelial Carcinoma; Hazard ratio; Bladder cancer; Internal medicine; Propensity score matching; Oncology; Cohort; Urinary bladder; Surgery; Cancer; Urothelial carcinoma; Confidence interval","score_opus":0.009185000265786879,"score_gpt":0.2749807647180561,"score_spread":0.2657957644522692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975148585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944312,0.00018648144,0.000001068021,0.00080877554,0.00047388554,0.0006078403,0.000008459859,0.0000016825907,0.0034806156],"genre_scores_gemma":[0.99965566,0.00003521704,0.000022856811,0.000051008883,0.00008543713,0.0000058965206,8.3816013e-7,0.000014917127,0.00012817228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977872,0.0006696275,0.00060015306,0.00011862691,0.0006170531,0.00020734579],"domain_scores_gemma":[0.99780697,0.0012878479,0.0004642355,0.00022257755,0.00012424182,0.00009412847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006831327,0.00014993131,0.000833089,0.00009023037,0.00002953815,0.0000030263109,0.00018686592,0.00008508474,0.00011703728],"category_scores_gemma":[0.00005624673,0.000058369267,0.0002467554,0.00019647431,0.00024986718,0.000034993325,0.000038630955,0.00044153022,0.000005266013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038109813,0.0012245382,0.9537818,0.00007742964,0.0004416554,0.000360655,0.000111883055,0.00003276432,0.00009993942,0.00007428575,0.000085400054,0.005599835],"study_design_scores_gemma":[0.04463035,0.061257903,0.8810471,0.0001994332,0.00041004719,0.0003860573,0.000046401496,0.000010292471,0.0018251309,0.000025932328,0.010084534,0.00007680147],"about_ca_topic_score_codex":0.00003030832,"about_ca_topic_score_gemma":0.0000059858808,"teacher_disagreement_score":0.072734684,"about_ca_system_score_codex":0.00015562093,"about_ca_system_score_gemma":0.00036806983,"threshold_uncertainty_score":0.23802297},"labels":[],"label_agreement":null},{"id":"W2975300000","doi":"10.1016/j.clgc.2019.09.008","title":"Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urology; Hazard ratio; Stage (stratigraphy); Proportional hazards model; Dissection (medical); Lymph node; Bladder cancer; Logistic regression; Cohort; Internal medicine; Surgery; Confidence interval; Cancer","score_opus":0.02686335273150627,"score_gpt":0.33224553994996825,"score_spread":0.305382187218462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975300000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629396,0.0002664615,0.0000892426,0.00025662297,0.00070575526,0.001274967,0.0005818009,0.000046767538,0.0004844077],"genre_scores_gemma":[0.9949475,0.000053384225,0.0007471072,0.00016578023,0.000443004,0.0002758391,0.00014361125,0.00009185234,0.0031319277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754053,0.0001237033,0.00070707314,0.000707101,0.00048110326,0.000440511],"domain_scores_gemma":[0.99841887,0.0002603151,0.00033943274,0.00048610408,0.00020115709,0.00029414266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018730963,0.0004165951,0.0010498416,0.00014348656,0.000094406074,0.000019179646,0.00011856734,0.00014706393,0.00030308808],"category_scores_gemma":[0.000025243837,0.0002754623,0.0002442125,0.00022570125,0.00023831053,0.00015854773,0.00006262617,0.00021423212,0.00000809909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01606726,0.0017659903,0.9745518,0.000370603,0.00073986663,0.000062260435,0.00010818697,0.000026185537,0.000033714965,0.0000056152453,0.00006244937,0.006206096],"study_design_scores_gemma":[0.029096719,0.011952739,0.95617086,0.00013006142,0.0008120621,0.00001847015,0.00012228586,0.00015195625,0.00014230321,0.0000048452853,0.0010659547,0.00033172173],"about_ca_topic_score_codex":0.00032373538,"about_ca_topic_score_gemma":0.00005601965,"teacher_disagreement_score":0.01838089,"about_ca_system_score_codex":0.00010668852,"about_ca_system_score_gemma":0.00039864928,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2975497362","doi":"10.1016/j.eururo.2019.09.006","title":"A Consensus Molecular Classification of Muscle-invasive Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University Health Network; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; Novo Nordisk Fonden; Cancerfonden","keywords":"Medicine; Bladder cancer; Clinical trial; Disease; Bioinformatics; Computational biology; Oncology; Internal medicine; Cancer; Biology","score_opus":0.022014076230808866,"score_gpt":0.280815197036909,"score_spread":0.2588011208061001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975497362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022064,0.0006806442,0.0000396698,0.0016964416,0.00023777803,0.0003376396,0.000020431322,0.00003880691,0.09474218],"genre_scores_gemma":[0.99644965,0.00006580104,0.000111224006,0.0020860755,0.0000782611,0.000009726361,0.00001684604,0.000038685917,0.0011437592],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990623,0.00016348893,0.00020921932,0.00026642237,0.000119595265,0.00017897731],"domain_scores_gemma":[0.9993189,0.000057420646,0.000105491796,0.00034083994,0.00010397584,0.00007334693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087894885,0.00011783193,0.00022655289,0.00007085686,0.000015503874,0.0000027905166,0.000074386466,0.0000463076,0.00080870034],"category_scores_gemma":[0.000045886576,0.000101983605,0.00007819097,0.00009683522,0.00009269811,0.000011695435,0.000030354038,0.00011410576,0.0005130194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075248274,0.00036860284,0.09786865,0.00012867477,0.00065630017,0.0004553102,0.00078614673,0.00006997757,0.8785426,0.0016643186,0.0036145893,0.0150923515],"study_design_scores_gemma":[0.004995829,0.0016891382,0.9413806,0.00003937604,0.00047783705,0.00010399923,0.00011845236,0.00009971888,0.019218504,0.00010609704,0.0315642,0.00020620285],"about_ca_topic_score_codex":0.00004946866,"about_ca_topic_score_gemma":0.000008447407,"teacher_disagreement_score":0.8593241,"about_ca_system_score_codex":0.000026031967,"about_ca_system_score_gemma":0.00012525746,"threshold_uncertainty_score":0.8854702},"labels":[],"label_agreement":null},{"id":"W2977386089","doi":"10.1093/annonc/mdz249.028","title":"Biomarker analyses of ramucirumab in patients with platinum refractory urothelial cancer from RANGE, a global, randomized, double-blind, phase III study","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Oncology; Tissue microarray; Biomarker; Confidence interval; PD-L1; Ramucirumab; Gastroenterology; Immunohistochemistry; Cancer; Immunotherapy; Biology","score_opus":0.11531999902706094,"score_gpt":0.4482914297616633,"score_spread":0.33297143073460234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977386089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090904,0.00090230827,0.000009316809,0.00021710695,0.00025039888,0.003423445,0.0003008555,0.000014204783,0.0039733336],"genre_scores_gemma":[0.9989914,0.000120206874,0.00006039246,0.00035797543,0.000055223492,0.00019711042,0.00007661371,0.000022619271,0.00011850369],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784064,0.00026671053,0.0007827518,0.00039748938,0.00042608613,0.00028632506],"domain_scores_gemma":[0.9983842,0.00021233427,0.0005263664,0.00040147663,0.00036567918,0.000109984954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003347431,0.00025434987,0.0017704336,0.00019999332,0.000022142496,0.0000046969208,0.00013782129,0.00016473648,0.0009861424],"category_scores_gemma":[0.000039609135,0.0001741647,0.00019605356,0.00037371388,0.00019313517,0.000101922626,0.000045664525,0.00014019458,0.000012150275],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6526555,0.007984822,0.32455215,0.000027645614,0.0018932635,0.00002311675,0.00051255507,0.0000090502035,0.0002569864,0.0000036042338,0.00026364977,0.011817706],"study_design_scores_gemma":[0.85117793,0.009834469,0.1361257,0.00012198794,0.00084039505,9.673322e-7,0.00025417755,0.000015391504,0.0011219284,0.000034450444,0.00032844988,0.00014417926],"about_ca_topic_score_codex":0.015513066,"about_ca_topic_score_gemma":0.0014525261,"teacher_disagreement_score":0.19852245,"about_ca_system_score_codex":0.000113948845,"about_ca_system_score_gemma":0.0005364619,"threshold_uncertainty_score":0.9999271},"labels":[],"label_agreement":null},{"id":"W2977457247","doi":"10.1093/annonc/mdz249.018","title":"Three-year follow-up from the phase III KEYNOTE-045 trial: Pembrolizumab (Pembro) versus investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Docetaxel; Pembrolizumab; Urothelial cancer; Oncology; Paclitaxel; Internal medicine; Chemotherapy; Cancer; Bladder cancer; Immunotherapy","score_opus":0.13291646505372293,"score_gpt":0.4271093793534019,"score_spread":0.294192914299679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977457247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97644657,0.0029178495,0.000011602605,0.007928011,0.0039337254,0.0028680274,0.00046034405,0.00006901899,0.005364873],"genre_scores_gemma":[0.9891101,0.0022466893,0.00032476409,0.0050235903,0.0012479037,0.0005480549,0.0001231145,0.000097962504,0.0012777828],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968643,0.00026761356,0.0009237704,0.0007257484,0.0005078159,0.0007107466],"domain_scores_gemma":[0.99681884,0.0011270384,0.0005064317,0.00088268815,0.00028574266,0.00037928094],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000411566,0.00046299133,0.0013458058,0.00017356934,0.000088804125,0.00002055205,0.00046880305,0.00036324328,0.0021604362],"category_scores_gemma":[0.0010149807,0.00031680835,0.00032336608,0.00052335585,0.00029215895,0.00023340088,0.00013182551,0.0005866334,0.00013192867],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8451033,0.0024577095,0.010339106,0.00011582789,0.001209925,0.00009271864,0.0015525789,0.00002094164,0.0046540946,0.00034385524,0.028492786,0.10561712],"study_design_scores_gemma":[0.67006177,0.03132587,0.007885432,0.0004217448,0.0005708885,0.0000072051957,0.00033620308,0.00008733231,0.0042513534,0.0005942557,0.28398222,0.00047573654],"about_ca_topic_score_codex":0.009331503,"about_ca_topic_score_gemma":0.011364071,"teacher_disagreement_score":0.25548944,"about_ca_system_score_codex":0.0002652573,"about_ca_system_score_gemma":0.0024436158,"threshold_uncertainty_score":0.9999284},"labels":[],"label_agreement":null},{"id":"W2978011912","doi":"10.1002/cncr.32532","title":"Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108","year":2019,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Durvalumab; Quality of life (healthcare); Internal medicine; Bladder cancer; Cancer; Metastatic Urothelial Carcinoma; Oncology; Performance status; Urothelial carcinoma; Immunotherapy","score_opus":0.01074326363061002,"score_gpt":0.27488264309529487,"score_spread":0.26413937946468485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978011912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537015,0.00016460854,0.000004204789,0.00003772325,0.000079068115,0.004014403,0.000038165384,0.000034350363,0.00025733156],"genre_scores_gemma":[0.9991564,0.000009855749,0.00006753956,0.000140615,0.000009991902,0.0003896323,0.000048282556,0.00005178037,0.00012587631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982476,0.00007473875,0.0004523928,0.0005006783,0.00041608117,0.00030849176],"domain_scores_gemma":[0.99919003,0.00003232101,0.00018099001,0.0003158381,0.00015069661,0.00013013004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007526883,0.00030901824,0.00054290314,0.00025463555,0.000027951393,0.000016513828,0.00004344385,0.00005030329,0.00010137073],"category_scores_gemma":[0.000017423705,0.00020997232,0.000028395161,0.00046114915,0.000069374975,0.00021269414,0.000019754347,0.00014215878,0.000005262137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011213314,0.0016293161,0.9653296,0.00007372584,0.00037568787,0.00018213443,0.0010986689,0.00008126201,0.000082701736,7.101249e-7,0.000004747468,0.019928116],"study_design_scores_gemma":[0.08003314,0.005195251,0.913338,0.00024033971,0.0002207934,0.000004454549,0.0004577686,0.000098034114,0.00015703705,0.0000025401453,0.00002684131,0.00022577116],"about_ca_topic_score_codex":0.0010869749,"about_ca_topic_score_gemma":0.00092479767,"teacher_disagreement_score":0.06881983,"about_ca_system_score_codex":0.00036072562,"about_ca_system_score_gemma":0.00035532922,"threshold_uncertainty_score":0.85624224},"labels":[],"label_agreement":null},{"id":"W2978318234","doi":"10.1093/annonc/mdz249.001","title":"An adaptive, biomarker directed platform study in metastatic urothelial cancer (BISCAY) with durvalumab in combination with targeted therapies","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Urothelial cancer; Biomarker; Bladder cancer; Oncology; Targeted therapy; Cancer; Cancer research; Internal medicine; Immunotherapy; Nivolumab; Genetics","score_opus":0.07869265397895547,"score_gpt":0.38046623947386193,"score_spread":0.30177358549490646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978318234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951955,0.0002904431,0.000009297851,0.00054906984,0.000061343475,0.0018078533,0.000026890808,0.000029008834,0.0020305803],"genre_scores_gemma":[0.99883634,0.00007662025,0.0003242323,0.00029648095,0.000011581025,0.00024018178,0.000024225954,0.00002923944,0.00016107447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987177,0.00017191096,0.0003001075,0.00029590892,0.0002551919,0.00025914484],"domain_scores_gemma":[0.999297,0.00007715144,0.00015208095,0.0002173389,0.00019244273,0.00006393576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002583089,0.0001853766,0.0006070516,0.00030909106,0.000019016501,0.0000054785464,0.00008250407,0.00006550231,0.00024023544],"category_scores_gemma":[0.000009398827,0.00012267222,0.000029731125,0.00046100662,0.000084209576,0.00017456933,0.000011580547,0.00013894818,0.0000052597047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03766817,0.009040883,0.90965986,0.00005449917,0.0009696529,0.00022552708,0.0063377907,0.0000873524,0.0022861382,0.000077785335,0.000059626087,0.03353273],"study_design_scores_gemma":[0.024714446,0.042452894,0.92756593,0.0001123426,0.00011424561,0.00001474705,0.0023535874,0.0004082804,0.001698582,0.00011239731,0.00029704152,0.00015552132],"about_ca_topic_score_codex":0.005073542,"about_ca_topic_score_gemma":0.0139412,"teacher_disagreement_score":0.03341201,"about_ca_system_score_codex":0.00010903962,"about_ca_system_score_gemma":0.0005193981,"threshold_uncertainty_score":0.7779517},"labels":[],"label_agreement":null},{"id":"W2979377184","doi":"10.1016/j.euo.2019.09.003","title":"What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Oncology; Internal medicine; Cancer; Clinical trial; Meta-analysis","score_opus":0.09390410564921418,"score_gpt":0.384706383792036,"score_spread":0.2908022781428218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979377184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16444032,0.8247159,0.0000050655103,0.0016825866,0.0004923925,0.00787864,0.00064099964,0.000021499638,0.00012256691],"genre_scores_gemma":[0.071886815,0.9236106,0.00016807848,0.0033924507,0.00010509786,0.00057289907,0.00004446579,0.00012858643,0.00009098767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98592144,0.007424819,0.004025495,0.0013990562,0.00052343484,0.00070577994],"domain_scores_gemma":[0.98820996,0.0059686317,0.004373016,0.00061097305,0.0006114146,0.00022602157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003476776,0.00093947415,0.007067197,0.00036346543,0.00008226772,0.000022794382,0.00038729745,0.00042378344,0.00014253057],"category_scores_gemma":[0.0043620495,0.00056241016,0.00031888078,0.00043024812,0.0012380235,0.00017958054,0.00043799356,0.0011178488,0.0000042515862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010483941,0.0019182276,0.7675415,0.14175639,0.008476404,0.0006414178,0.002005343,0.000010058811,0.00000914841,0.00002331855,0.00023825112,0.076331526],"study_design_scores_gemma":[0.018738765,0.013354351,0.84225273,0.060427494,0.05928976,0.00030101722,0.00046235567,0.00007695681,9.000249e-7,0.00004982669,0.0040486515,0.0009972069],"about_ca_topic_score_codex":0.00034878546,"about_ca_topic_score_gemma":0.0019619123,"teacher_disagreement_score":0.09889469,"about_ca_system_score_codex":0.00029883388,"about_ca_system_score_gemma":0.0013978982,"threshold_uncertainty_score":0.9996827},"labels":[],"label_agreement":null},{"id":"W2979453720","doi":"10.1002/jcp.29279","title":"Multi‐omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Cellular Physiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Urothelial carcinoma; Immune system; Omics; Mutation; Carcinoma; Medicine; Cancer research; Biology; Bladder cancer; Oncology; Bioinformatics; Internal medicine; Cancer; Immunology; Genetics; Gene","score_opus":0.009590005710090565,"score_gpt":0.24544930698329873,"score_spread":0.23585930127320817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979453720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998928,0.0003548143,0.00012227299,0.000092716844,0.00011635858,0.00027262286,0.000011668603,0.000003840328,0.00009768935],"genre_scores_gemma":[0.9990187,0.000024402656,0.00062408834,0.000072126524,0.00008632898,0.0000036783351,0.000037786933,0.00001897508,0.00011387248],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881274,0.00009339545,0.00057678786,0.00014835842,0.00019405776,0.00017464969],"domain_scores_gemma":[0.9989143,0.00006388711,0.0005090748,0.00020860757,0.00024009489,0.00006403996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001411133,0.00015235915,0.0008918188,0.000463158,0.000013815687,0.0000047241992,0.000103874394,0.0000705324,0.00020625592],"category_scores_gemma":[0.000018437297,0.000106665786,0.00023735366,0.00045183432,0.00007193181,0.00007817291,0.00001580379,0.00020991731,0.0000074288337],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039282227,0.00035366142,0.07615958,0.00005352599,0.0017846724,0.00012758306,0.0006921272,0.0025904549,0.9141754,0.000014312048,0.0000043004156,0.000116170435],"study_design_scores_gemma":[0.013388236,0.0051912814,0.7401221,0.00007022457,0.0023303318,0.00010186743,0.0005837435,0.005586659,0.23236912,0.00007060955,0.000034322926,0.00015154766],"about_ca_topic_score_codex":0.0003038591,"about_ca_topic_score_gemma":0.000018806919,"teacher_disagreement_score":0.68180627,"about_ca_system_score_codex":0.00006919555,"about_ca_system_score_gemma":0.00023795215,"threshold_uncertainty_score":0.43497044},"labels":[],"label_agreement":null},{"id":"W2980147869","doi":"10.1200/jco.2012.30.15_suppl.4525","title":"Correlation of progression-free survival at 6 months (PFS6) with overall survival at 12 months (OS12) in an analysis of 10 trials of second-line therapy for advanced urothelial carcinoma (UC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Confidence interval; Progression-free survival; Internal medicine; Pearson product-moment correlation coefficient; Clinical endpoint; Chemotherapy; Oncology; Clinical trial; Statistics","score_opus":0.14119004843249544,"score_gpt":0.4662632227507314,"score_spread":0.32507317431823596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980147869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949134,0.0015928452,0.00022999418,0.0004237306,0.0009370126,0.0010924143,0.00023964317,0.000005043163,0.00056589104],"genre_scores_gemma":[0.99594396,0.00044505773,0.0023186202,0.00011411921,0.0006835408,0.000028656112,0.000055474196,0.00003384894,0.00037669358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930791,0.0012523821,0.004331141,0.00026251457,0.00071925105,0.00035560815],"domain_scores_gemma":[0.98854226,0.004675985,0.0051928465,0.00044980363,0.000788848,0.00035028704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072220694,0.00025555654,0.0043656183,0.00037406912,0.00003576911,0.0000026785626,0.0002387525,0.00044079934,0.00085030304],"category_scores_gemma":[0.0025390408,0.00016050384,0.0010875989,0.00028255652,0.00024301762,0.00023294661,0.0000645304,0.00034046764,7.9878464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16056646,0.0044860863,0.79574364,0.000061813684,0.0023476046,0.000019163796,0.0004268705,0.00045155262,0.0030212807,0.000034106644,0.00011289203,0.03272853],"study_design_scores_gemma":[0.058907837,0.03967518,0.8918838,0.000112642425,0.003094421,0.00001257881,0.00013723926,0.0006014197,0.0036171554,0.00008376111,0.0017313069,0.00014266209],"about_ca_topic_score_codex":0.00011540588,"about_ca_topic_score_gemma":0.002314514,"teacher_disagreement_score":0.101658635,"about_ca_system_score_codex":0.00027108614,"about_ca_system_score_gemma":0.00094883284,"threshold_uncertainty_score":0.9310222},"labels":[],"label_agreement":null},{"id":"W2980545575","doi":"10.2196/15363","title":"Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society","year":2019,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Observational study; Medicine; Protocol (science); Cohort; Randomized controlled trial; Clinical trial; Cohort study; Family medicine; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.547238077897048,"score_gpt":0.6684617208639847,"score_spread":0.12122364296693666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980545575","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3325868,0.0000029878256,0.000005553009,0.0010320378,0.000014998559,0.66595644,0.00018843547,0.0000033181748,0.00020944247],"genre_scores_gemma":[0.33766213,0.0000027432736,0.00008036606,0.000042468146,0.000047138445,0.66194504,0.00001451313,0.00001665371,0.00018897624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918691,0.0030708408,0.00096649124,0.00039928666,0.0034304492,0.00026381284],"domain_scores_gemma":[0.98961395,0.002476475,0.00058345625,0.00067768473,0.0065815286,0.00006690731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014256757,0.00013218762,0.0004442969,0.00009457435,0.00010218632,0.00001988119,0.0004886279,0.00011542706,0.00019653508],"category_scores_gemma":[0.002098869,0.000075783115,0.00017298794,0.00026097024,0.00042551814,0.00024302269,0.0001860514,0.0004674119,8.5922363e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052399253,0.0084780995,0.97692937,0.0005378667,0.000618505,1.2169679e-7,0.0010616794,0.000011034492,0.002943511,0.00005109726,0.0017775645,0.0023511993],"study_design_scores_gemma":[0.018709084,0.0056934915,0.95767236,0.0003460032,0.00009476558,0.0000012763261,0.0013884075,0.00057606405,0.0048437137,0.00007641913,0.010544134,0.000054274253],"about_ca_topic_score_codex":0.0011258818,"about_ca_topic_score_gemma":0.000073407304,"teacher_disagreement_score":0.01925703,"about_ca_system_score_codex":0.00011417155,"about_ca_system_score_gemma":0.0013123705,"threshold_uncertainty_score":0.49411356},"labels":[],"label_agreement":null},{"id":"W2980687929","doi":"10.2174/1874467212666191016124935","title":"Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis","year":2019,"lang":"en","type":"article","venue":"Current Molecular Pharmacology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; UniProt; Human Protein Atlas; Cancer research; Cancer; Epidermal growth factor receptor; Cancer cell; Proteomics; Heat shock protein; Biology; Medicine; Gene; Internal medicine","score_opus":0.07088692130702971,"score_gpt":0.4167950677847303,"score_spread":0.3459081464777006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980687929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95376766,0.008914896,0.030944467,0.00040754737,0.0009841045,0.004580826,0.00028442868,0.000048501886,0.0000675844],"genre_scores_gemma":[0.99691385,0.00010828808,0.0010827612,0.00045637746,0.00025416032,0.0006652721,0.00032356658,0.000051116913,0.00014459537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841803,0.00007131309,0.00024994672,0.0006513734,0.00018919854,0.00042013978],"domain_scores_gemma":[0.9991505,0.0000143839625,0.00011673883,0.00051777053,0.00007911427,0.00012145202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011885468,0.00024049114,0.00046619965,0.00017855362,0.00006208049,0.000018800249,0.0002556912,0.000070070724,0.00084279804],"category_scores_gemma":[0.000006538793,0.00020692938,0.00020000942,0.0003368511,0.00004650138,0.00011343723,0.00014402189,0.0001845008,0.00002159104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053867546,0.00037651559,0.010305062,0.00029883758,0.0054024905,0.000016380787,0.00008565939,0.00092507683,0.97443974,0.000038406095,0.0002261494,0.0073470245],"study_design_scores_gemma":[0.015360046,0.0006597642,0.004628876,0.00017116552,0.025140405,0.00002074688,0.000037384787,0.12530687,0.79743767,0.00021011304,0.030176941,0.0008500138],"about_ca_topic_score_codex":0.000078269826,"about_ca_topic_score_gemma":0.0000052524206,"teacher_disagreement_score":0.17700206,"about_ca_system_score_codex":0.00016379883,"about_ca_system_score_gemma":0.00033312594,"threshold_uncertainty_score":0.9228047},"labels":[],"label_agreement":null},{"id":"W2981079561","doi":"10.1016/j.clgc.2019.10.012","title":"Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urology; Hazard ratio; Bladder cancer; Proportional hazards model; Perioperative; Confidence interval; Population; Internal medicine; Oncology; Cancer; Surgery","score_opus":0.036086200905455966,"score_gpt":0.34745412947923465,"score_spread":0.3113679285737787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981079561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493635,0.0004419575,0.000008385032,0.00060857314,0.00012501347,0.002197627,0.00013447057,0.000040556446,0.0015070509],"genre_scores_gemma":[0.99619603,0.00041339197,0.00044129396,0.0004730051,0.0002727917,0.00036363536,0.000035465073,0.000107586224,0.0016968237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745935,0.0002941088,0.00061352196,0.00068631675,0.00047883496,0.00046785036],"domain_scores_gemma":[0.99831814,0.000285805,0.00043695557,0.000369242,0.000381086,0.0002087802],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034747954,0.00042359918,0.0011081379,0.000095791445,0.000066506705,0.000025970588,0.00013599875,0.00018428886,0.0005409333],"category_scores_gemma":[0.000055511395,0.0002572493,0.000101201425,0.00041236507,0.00030813634,0.00017843685,0.0000391859,0.00050638086,0.000004679487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03193379,0.0010951471,0.95785105,0.00012140556,0.0011107621,0.00012622116,0.00080359983,0.00012848312,0.0052584964,0.0000017870962,0.000034386747,0.0015348973],"study_design_scores_gemma":[0.032187164,0.010646892,0.94611037,0.0018129456,0.00040483024,0.00002530838,0.0015128714,0.0005213349,0.006254515,0.0000037879913,0.00009288776,0.0004270726],"about_ca_topic_score_codex":0.0020949934,"about_ca_topic_score_gemma":0.0016738707,"teacher_disagreement_score":0.011740633,"about_ca_system_score_codex":0.00031111957,"about_ca_system_score_gemma":0.0015384256,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W2981238229","doi":"10.1016/j.clgc.2019.10.016","title":"Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urothelial carcinoma; Urothelial cancer; Histology; Oncology; Urology; Population; Internal medicine; Cancer","score_opus":0.04974038611521558,"score_gpt":0.3695354914271372,"score_spread":0.3197951053119216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981238229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899243,0.0008297634,0.0001792215,0.0008924474,0.0029067611,0.0045269886,0.0003411472,0.00009860987,0.000300751],"genre_scores_gemma":[0.99053985,0.000016923494,0.00036340632,0.0012928111,0.0022938638,0.0035411406,0.00007523958,0.000107876964,0.0017688726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968925,0.00025430997,0.00083507993,0.0009762304,0.00044384846,0.0005980095],"domain_scores_gemma":[0.9981026,0.00033807484,0.0002444535,0.00068969623,0.00028347582,0.00034167475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027009443,0.00043605067,0.0011393294,0.00010436261,0.00011756928,0.000024092664,0.00018113563,0.00022335876,0.0019220589],"category_scores_gemma":[0.000033100976,0.00032907212,0.0003467673,0.00020080211,0.00010225662,0.00007875968,0.000052005773,0.00036825327,0.00005603717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025886152,0.002110175,0.968606,0.00012792689,0.0007894353,0.00035771434,0.00014394686,0.00024548956,0.000042822492,0.0000039581996,0.00042646166,0.0012599019],"study_design_scores_gemma":[0.032385692,0.006414116,0.95110726,0.000094097326,0.0015027283,0.000019464795,0.000113657254,0.0006823179,0.00007516956,0.000012138882,0.0071385475,0.00045481877],"about_ca_topic_score_codex":0.0030909234,"about_ca_topic_score_gemma":0.0015142102,"teacher_disagreement_score":0.017498765,"about_ca_system_score_codex":0.0003594293,"about_ca_system_score_gemma":0.0011307355,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W2981737993","doi":"10.21037/tau.2019.10.09","title":"Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer—an evaluation of radical cystectomy versus trimodal therapy costs","year":2019,"lang":"en","type":"editorial","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Context (archaeology); Health care; Cancer; Intensive care medicine; Urology; Internal medicine","score_opus":0.07390898131037872,"score_gpt":0.3516711140190776,"score_spread":0.2777621327086989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981737993","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0874485,0.0055442536,0.00029375672,0.005632896,0.8950892,0.003937749,0.00092534814,0.00002309527,0.0011051904],"genre_scores_gemma":[0.73676205,0.0012019074,0.000009783742,0.00021493527,0.2603609,0.00022787473,0.0011794129,0.000029540935,0.000013636618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712515,0.00068592816,0.00056597445,0.00043482773,0.0009202403,0.00026786316],"domain_scores_gemma":[0.996757,0.0021854697,0.000316405,0.00024210768,0.00043083675,0.00006821118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009705885,0.0002781229,0.0006900726,0.00020575579,0.000085936226,0.000006912399,0.00015507943,0.0011340781,0.0003575554],"category_scores_gemma":[0.00017546679,0.00021075513,0.00010837633,0.0001702338,0.00048582218,0.00013775307,0.000019517662,0.00069658295,0.0000015274685],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16923548,0.003131105,0.022917505,0.0006500096,0.0071999994,0.000017898317,0.008094357,0.0057561635,0.001718813,0.0038684532,0.7605305,0.016879726],"study_design_scores_gemma":[0.28834975,0.022983575,0.060647745,0.00030668813,0.008895552,0.000024401877,0.00061707984,0.009727264,0.0004359116,0.014630956,0.5921684,0.0012126644],"about_ca_topic_score_codex":0.0008515199,"about_ca_topic_score_gemma":0.0014711362,"teacher_disagreement_score":0.6493135,"about_ca_system_score_codex":0.00017583116,"about_ca_system_score_gemma":0.0017615923,"threshold_uncertainty_score":0.8747049},"labels":[],"label_agreement":null},{"id":"W2981744421","doi":"10.1016/j.suronc.2019.10.014","title":"Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy","year":2019,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Perioperative; Medicine; General surgery; Intensive care medicine; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.018028696602427625,"score_gpt":0.3131355664041396,"score_spread":0.29510686980171197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981744421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85893774,0.0006266824,0.0000023084206,0.0023750158,0.00059812755,0.0009940253,0.000033558772,0.000050456536,0.1363821],"genre_scores_gemma":[0.9897275,0.00007642924,0.0001383826,0.0024855463,0.00013623356,0.00022031751,0.000018048984,0.00001994563,0.0071775983],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987551,0.00012059358,0.00024779234,0.0003544727,0.0002200361,0.00030198495],"domain_scores_gemma":[0.999261,0.00015654566,0.00004294537,0.00019471436,0.00005226297,0.00029252685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000681263,0.00019254115,0.0005856947,0.00004849869,0.000038281552,0.000011341278,0.000037473194,0.000227656,0.0047211433],"category_scores_gemma":[0.00001273637,0.00012323423,0.0001010168,0.00007972136,0.00018635143,0.00005311601,0.00006864888,0.00026329595,0.0003290767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008646292,0.0017265419,0.667697,0.000098486154,0.0006713792,0.0047670202,0.0019361665,0.0000018304258,0.00017957021,0.0007792747,0.0010847972,0.31241164],"study_design_scores_gemma":[0.0074848076,0.002317567,0.24216878,0.000029848201,0.000085050175,0.00016511773,0.000048742415,0.0000074553063,0.00006995728,0.00001680102,0.74749416,0.00011171574],"about_ca_topic_score_codex":0.000047628175,"about_ca_topic_score_gemma":0.000014752697,"teacher_disagreement_score":0.74640936,"about_ca_system_score_codex":0.00018208202,"about_ca_system_score_gemma":0.00017705973,"threshold_uncertainty_score":0.9961887},"labels":[],"label_agreement":null},{"id":"W2982865643","doi":"10.1016/s1470-2045(19)30668-0","title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Roche; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Docetaxel; Medicine; Ramucirumab; Clinical endpoint; Internal medicine; Metastatic Urothelial Carcinoma; Population; Oncology; Placebo; Progression-free survival; Surgery; Clinical trial; Chemotherapy; Cancer; Urothelial carcinoma; Bladder cancer; Pathology","score_opus":0.0584573287324271,"score_gpt":0.3466840245943807,"score_spread":0.2882266958619536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982865643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630637,0.00028254002,0.00005202714,0.0007148662,0.00063970365,0.009751482,0.00038968038,0.000045307184,0.0018179974],"genre_scores_gemma":[0.99715924,0.00007692796,0.0005325208,0.00056730176,0.0002401511,0.0007589902,0.00023290113,0.00006400637,0.00036795685],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968677,0.00053846545,0.0008101468,0.00061082613,0.00055045594,0.00062239886],"domain_scores_gemma":[0.99769646,0.0007928398,0.000457112,0.0007014297,0.00019174292,0.00016039381],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077859976,0.00046652928,0.001868829,0.00017734556,0.00005760202,0.000023646831,0.00025082743,0.00018240522,0.0003018766],"category_scores_gemma":[0.00008394589,0.00026406508,0.00013909487,0.0003203748,0.0002552227,0.00012781448,0.000052460226,0.00042857532,0.000017929575],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9900825,0.0014618792,0.0029490944,0.00009338162,0.0005890677,0.00012732222,0.000865245,0.00026957935,0.00008768275,0.000021271273,0.00010543767,0.0033475528],"study_design_scores_gemma":[0.9626059,0.028306741,0.005913953,0.000095132964,0.00045054374,0.00000953751,0.00011653964,0.0004552579,0.00035223924,0.000015712361,0.0013899958,0.00028843287],"about_ca_topic_score_codex":0.00047000468,"about_ca_topic_score_gemma":0.00069984153,"teacher_disagreement_score":0.027476572,"about_ca_system_score_codex":0.00040006,"about_ca_system_score_gemma":0.001532333,"threshold_uncertainty_score":0.99998116},"labels":[],"label_agreement":null},{"id":"W2982946475","doi":"10.1007/s00345-019-02982-6","title":"Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases","year":2019,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Nephrology; Radiation therapy; Complication; Retrospective cohort study; Multicenter study; General surgery; Internal medicine; Urology; Surgery; Bladder cancer; Cancer; Randomized controlled trial","score_opus":0.013660041535717728,"score_gpt":0.2977719861722185,"score_spread":0.2841119446365008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982946475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947422,0.0017533203,0.00011027332,0.001421316,0.0008511491,0.00021769806,0.000009975725,0.000008831025,0.000885232],"genre_scores_gemma":[0.9975678,0.00025131198,0.00064659334,0.0006794723,0.00021248305,0.000006050362,0.0000049000528,0.000017743883,0.00061364874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915177,0.0000879637,0.00034472457,0.00013382031,0.00016162933,0.000120125114],"domain_scores_gemma":[0.9992179,0.00005259023,0.00029027287,0.0001759297,0.00019655176,0.000066744185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015912975,0.00010589808,0.00036424046,0.00023354583,0.000018036391,0.000009125379,0.00010258974,0.000037629663,0.0003931431],"category_scores_gemma":[0.000026957741,0.000084491614,0.00014932956,0.000109527115,0.00004468735,0.000239241,0.000013540947,0.0001558103,0.000008206127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074126846,0.0003830159,0.9638628,0.000028126111,0.0008611629,0.00032678866,0.00071819365,0.000027370355,0.024372151,0.00011242085,0.00009880449,0.0017964921],"study_design_scores_gemma":[0.008396289,0.003540045,0.96815777,0.00008882487,0.00030099478,0.0010056611,0.00009782148,0.00010274694,0.0018535049,0.00012793958,0.016224997,0.00010339378],"about_ca_topic_score_codex":0.000032194454,"about_ca_topic_score_gemma":0.000054142827,"teacher_disagreement_score":0.022518646,"about_ca_system_score_codex":0.00011341143,"about_ca_system_score_gemma":0.000059041588,"threshold_uncertainty_score":0.43046412},"labels":[],"label_agreement":null},{"id":"W2984768217","doi":"10.1016/j.urolonc.2019.10.002","title":"Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pathological; Concordance; Proportional hazards model; Pathology; Internal medicine","score_opus":0.01707292954371076,"score_gpt":0.2806001909357846,"score_spread":0.26352726139207383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984768217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922993,0.0013516364,0.00015101241,0.0027602036,0.00043563428,0.0015524859,0.00018458873,0.00005077996,0.0012143465],"genre_scores_gemma":[0.9794219,0.00048809667,0.015406502,0.0023777073,0.00018911158,0.00028497248,0.0001904712,0.0000377863,0.0016034575],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978631,0.00016448292,0.00058796396,0.0006377311,0.00022771598,0.0005190218],"domain_scores_gemma":[0.998758,0.0002952307,0.00027764085,0.00028077507,0.000119990706,0.0002683284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033645277,0.00034222074,0.00080524315,0.0002521134,0.00011066359,0.0000124449,0.00015391334,0.00042685226,0.00018987915],"category_scores_gemma":[0.00014442216,0.00027110582,0.0001644425,0.00023615446,0.0007398348,0.000108437795,0.00006856895,0.00040329865,0.000036122517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004332835,0.0038811094,0.86465925,0.00079183566,0.0006789442,0.0041193375,0.0065046456,0.0013993647,0.076587796,0.018201431,0.014127631,0.004715831],"study_design_scores_gemma":[0.047797117,0.06843236,0.1427133,0.001250102,0.0038616774,0.011417853,0.004120314,0.006412603,0.033257205,0.06542776,0.6123414,0.002968319],"about_ca_topic_score_codex":0.00022357715,"about_ca_topic_score_gemma":0.00006076631,"teacher_disagreement_score":0.72194594,"about_ca_system_score_codex":0.00019230378,"about_ca_system_score_gemma":0.00084081816,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2985196057","doi":"10.5489/cuaj.5998","title":"Effect of centralization on complex surgical care: A population-based case study of radical cystectomy","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cystectomy; Hazard ratio; Cancer registry; Confidence interval; Retrospective cohort study; Population; Cohort; Bladder cancer; Emergency medicine; Cancer; Surgery; Internal medicine; Environmental health","score_opus":0.011652994945383513,"score_gpt":0.2743928794531474,"score_spread":0.26273988450776387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985196057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796456,0.000044409513,0.0000037383568,0.0004381207,0.0001653064,0.0007225978,0.000039395993,0.000010802171,0.0006110972],"genre_scores_gemma":[0.99955255,0.0000019903175,0.000014128377,0.00022731602,0.00010457798,0.0000074612567,0.00005473807,0.000010836751,0.000026400145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820477,0.00051499595,0.00040394234,0.00016188379,0.00046401884,0.0002504077],"domain_scores_gemma":[0.99871,0.0003243272,0.00028824154,0.000119037686,0.00019552922,0.00036288015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037440305,0.0001316324,0.00045123458,0.00018296728,0.00008908436,0.000013822636,0.00005723274,0.00016330855,0.0006206832],"category_scores_gemma":[0.00018034603,0.00009576163,0.0001442296,0.00021817221,0.000014702769,0.00002983674,0.000004426694,0.0002584846,0.000009473118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054110715,0.00021939546,0.9962777,0.00003150133,0.0001183847,0.00087267405,0.00019940204,0.00044549123,0.000020482104,0.000026929025,0.00010891315,0.0011380529],"study_design_scores_gemma":[0.018987073,0.016592313,0.95994663,0.00004646855,0.00038892092,0.0011148165,0.00038641764,0.00051866256,0.00014665103,0.000009301208,0.0017182403,0.00014450855],"about_ca_topic_score_codex":0.0083919205,"about_ca_topic_score_gemma":0.0009927084,"teacher_disagreement_score":0.03633104,"about_ca_system_score_codex":0.0008784152,"about_ca_system_score_gemma":0.0002800097,"threshold_uncertainty_score":0.99821126},"labels":[],"label_agreement":null},{"id":"W2985585348","doi":"10.5489/cuaj.5945","title":"Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Radiation therapy; Hazard ratio; Retrospective cohort study; Chemotherapy; Urology; Surgery; Cohort; Proportional hazards model; Cancer; Oncology; Internal medicine; Confidence interval","score_opus":0.027268465446329614,"score_gpt":0.28908745168502925,"score_spread":0.26181898623869965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985585348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821555,0.0004697802,0.000047325182,0.0139161665,0.000582153,0.0007374669,0.00017171867,0.000017633827,0.0019022342],"genre_scores_gemma":[0.99220955,0.0003438374,0.0001248952,0.0057340157,0.00030746718,0.00004759089,0.000016389662,0.000018999095,0.0011972451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985327,0.00008179702,0.00038427964,0.00021829076,0.0003224405,0.00046045368],"domain_scores_gemma":[0.99841744,0.00027261177,0.00033117304,0.00013922145,0.00039816982,0.00044139053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038961833,0.00016758218,0.00049104926,0.00012272551,0.00013103086,0.000032347198,0.00011479973,0.00023373679,0.0015541473],"category_scores_gemma":[0.00032264498,0.00012227942,0.00030121658,0.00013283931,0.000024395382,0.00008659982,0.000008338343,0.00029710514,0.000021062766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014355694,0.00008437085,0.99016076,0.00000745801,0.00075147854,0.0000061944415,0.00015970804,0.000027284144,0.00046720382,0.00010677357,0.0023588513,0.0057263616],"study_design_scores_gemma":[0.0044869757,0.00063570694,0.9789444,0.000013137283,0.00015052914,0.000009819283,0.000076862954,0.000032183863,0.00050566235,0.0007312927,0.014288509,0.00012489613],"about_ca_topic_score_codex":0.0040324647,"about_ca_topic_score_gemma":0.0016428418,"teacher_disagreement_score":0.011929658,"about_ca_system_score_codex":0.0008148429,"about_ca_system_score_gemma":0.0012570518,"threshold_uncertainty_score":0.9993586},"labels":[],"label_agreement":null},{"id":"W2986820418","doi":"10.6004/jnccn.2019.7319","title":"Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Logistic regression; Odds ratio; Internal medicine; Palliative care; Genitourinary system; Cancer; Guideline; Bladder cancer; Oncology; Emergency medicine; Nursing","score_opus":0.03137088782638336,"score_gpt":0.3416066677829699,"score_spread":0.3102357799565865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986820418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821806,0.012711903,0.000015582365,0.0031130044,0.0008958186,0.00065995444,0.00025780697,0.0000050901945,0.00016025602],"genre_scores_gemma":[0.99690884,0.0001080362,0.00036089963,0.0020045722,0.00046663726,0.000065320695,0.000013068035,0.000025337844,0.000047294645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859834,0.000089695044,0.0003022403,0.0001748051,0.0006135929,0.00022131308],"domain_scores_gemma":[0.9971666,0.0002317844,0.00024915507,0.00005742877,0.0022178327,0.00007720837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047772577,0.00017818899,0.0003993183,0.00010776194,0.00015925468,0.00002241189,0.00009018294,0.000050302056,0.00011873125],"category_scores_gemma":[0.000033894637,0.0001097445,0.00013490704,0.00024686143,0.00009799786,0.00010605513,0.000028508804,0.00024414802,2.5866078e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044216863,0.00007025283,0.9653999,0.00028333222,0.0010231436,0.0000018702295,0.013522789,0.0049590254,0.00001747576,0.00013692497,0.0017228355,0.008440718],"study_design_scores_gemma":[0.008370851,0.0010397151,0.9813801,0.00056605256,0.00042316428,0.0000018591784,0.0032797928,0.00006746726,0.000036639918,0.00022725013,0.0044515743,0.0001555524],"about_ca_topic_score_codex":0.000026634303,"about_ca_topic_score_gemma":0.000095188174,"teacher_disagreement_score":0.015980136,"about_ca_system_score_codex":0.0006698078,"about_ca_system_score_gemma":0.00049523107,"threshold_uncertainty_score":0.44752508},"labels":[],"label_agreement":null},{"id":"W2986993017","doi":"10.22374/jeleu.v2i4.57","title":"Comparative Outcomes of Bladder Cancer in Patients Under 40 Years of Age","year":2019,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cancer; Disease; Epidemiology; Urothelial carcinoma; Internal medicine; Surgery","score_opus":0.025778275077425982,"score_gpt":0.32477979949949815,"score_spread":0.2990015244220722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986993017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972127,0.00037492783,0.00001033184,0.00017744905,0.00041194502,0.00022170163,0.000023824328,0.0000021016551,0.0015649841],"genre_scores_gemma":[0.9991069,0.00006797185,0.00019322352,0.00025162203,0.000051337975,0.0000031695565,0.0000025355284,0.0000125410525,0.0003107116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866885,0.00008398975,0.00061952055,0.00011824384,0.0003135656,0.00019583828],"domain_scores_gemma":[0.9989006,0.00014396444,0.00053155964,0.0001424766,0.00020487055,0.000076552904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013056966,0.00012385797,0.00093400606,0.00025915814,0.000006403166,0.0000019375384,0.0001113825,0.00008349928,0.00064553635],"category_scores_gemma":[0.000031728985,0.00009986807,0.00018393756,0.00013252509,0.00011390783,0.00006930439,0.000027905255,0.00026233128,0.000010113837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003199766,0.0008094246,0.9898906,0.000041874777,0.0006697051,0.000091889095,0.0007601027,0.00024574398,0.0030091822,0.00005967307,0.00020940097,0.0010126818],"study_design_scores_gemma":[0.009820427,0.0031699692,0.9836539,0.00005836187,0.00022536618,0.000039629238,0.00019297557,0.000008835987,0.0023167133,0.00010337678,0.00034603756,0.00006438994],"about_ca_topic_score_codex":0.00021702387,"about_ca_topic_score_gemma":0.000071816066,"teacher_disagreement_score":0.0066206614,"about_ca_system_score_codex":0.00007051403,"about_ca_system_score_gemma":0.00019176745,"threshold_uncertainty_score":0.70681703},"labels":[],"label_agreement":null},{"id":"W2987235359","doi":"10.1016/s0167-8140(19)33149-4","title":"10 The Impact of Dose to Bladder Neck on Urinary Toxicity in Patients Treated with HDR Brachytherapy Boost for Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Queen's University; University of British Columbia","funders":"","keywords":"Brachytherapy; Medicine; Prostate cancer; Urology; Neck of urinary bladder; Prostate; Toxicity; Urinary system; Urinary bladder; Cancer; Oncology; Radiation therapy; Radiology; Internal medicine","score_opus":0.013363392290911368,"score_gpt":0.32333321679296484,"score_spread":0.30996982450205346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987235359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950527,0.00058855215,0.000002939123,0.0008030957,0.000041811043,0.0026310717,0.00008552751,0.000012421915,0.00078189385],"genre_scores_gemma":[0.99559945,0.00040525917,0.000098126045,0.0014753763,0.00007070959,0.00025270542,0.000017371554,0.00003319,0.0020478382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991347,0.00005797914,0.00018609643,0.00026481156,0.0001017638,0.00025460677],"domain_scores_gemma":[0.9994572,0.0000916646,0.00008361955,0.00021059443,0.000066492794,0.000090457375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007959037,0.00018771629,0.00045207562,0.00008965214,0.000038875205,0.000006155511,0.00005734717,0.00009712815,0.0006774338],"category_scores_gemma":[0.0000043962064,0.0000987493,0.00007581892,0.00015954894,0.000060114122,0.00004097591,0.0000061065343,0.000098200195,0.00000506049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08640521,0.0021820108,0.82486814,0.000043579297,0.0006759437,0.00001143545,0.0022987118,0.00017670475,0.0019944385,0.000011836616,0.0014557989,0.079876184],"study_design_scores_gemma":[0.024575373,0.08546581,0.8793431,0.00008234924,0.000047846443,0.000012432277,0.000031812975,0.000101790356,0.0010884267,0.000013058956,0.009103993,0.0001340136],"about_ca_topic_score_codex":0.0006224026,"about_ca_topic_score_gemma":0.0001350436,"teacher_disagreement_score":0.0832838,"about_ca_system_score_codex":0.00047302662,"about_ca_system_score_gemma":0.00023359565,"threshold_uncertainty_score":0.74174255},"labels":[],"label_agreement":null},{"id":"W2987800544","doi":"10.1038/s41379-019-0403-9","title":"Dataset for the reporting of urinary tract carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)","year":2019,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre; University of Toronto","funders":"","keywords":"Medicine; Cancer; Surgical pathology; Lymphovascular invasion; Biopsy; Pathology; General surgery; Internal medicine; Metastasis","score_opus":0.07907730078428353,"score_gpt":0.3735865966636038,"score_spread":0.29450929587932023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987800544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98033696,0.00048235775,0.0007970105,0.013918123,0.0007112305,0.0007526122,0.0027366579,0.000009636364,0.00025542104],"genre_scores_gemma":[0.9965022,0.000084884974,0.00042143828,0.0005211855,0.0002679202,0.00012868989,0.0018722502,0.000014428829,0.00018699456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985873,0.000051566087,0.00082247483,0.00028391345,0.00014178034,0.00011295236],"domain_scores_gemma":[0.99812657,0.0002483516,0.001179408,0.00031187185,0.00011106076,0.000022759046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000643114,0.00009636818,0.00021880418,0.000032534776,0.00011749386,0.000015047482,0.00006991564,0.000068509304,0.00011390814],"category_scores_gemma":[0.00030987826,0.00005936444,0.0000519783,0.000060961513,0.00004585548,0.000069533984,0.000020334997,0.00014138472,0.0000013142425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036010914,0.0006521937,0.8676283,0.00007916342,0.0004527062,0.00017829161,0.0075838664,0.0004312468,0.07883844,0.00012460974,0.008036582,0.032393537],"study_design_scores_gemma":[0.004069228,0.0014785554,0.9621066,0.00013876722,0.00045073687,0.0008510463,0.0015321388,0.00826302,0.011484264,0.0009853197,0.008467847,0.00017249715],"about_ca_topic_score_codex":0.00045414185,"about_ca_topic_score_gemma":0.00016237536,"teacher_disagreement_score":0.09447831,"about_ca_system_score_codex":0.00006850882,"about_ca_system_score_gemma":0.0001109736,"threshold_uncertainty_score":0.24208117},"labels":[],"label_agreement":null},{"id":"W2990279784","doi":"10.5489/cuaj.6094","title":"The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University Health Centre; McGill University","keywords":"Cystectomy; Perioperative; Bladder cancer; Medicine; Chemotherapy; General surgery; Urology; Cancer; Surgery; Internal medicine","score_opus":0.012055326746003327,"score_gpt":0.23457357559552924,"score_spread":0.22251824884952592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990279784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834104,0.000258129,0.0000068763234,0.014961164,0.00029796726,0.0007043767,0.000075178854,0.0000031280804,0.0002827418],"genre_scores_gemma":[0.99375945,0.0001350825,0.00003902817,0.0030554782,0.000099358636,0.000034158227,0.00000861988,0.000013244191,0.0028555896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865,0.00012334163,0.0003650252,0.00015470876,0.00029762473,0.00040925998],"domain_scores_gemma":[0.9989511,0.0003651683,0.00017815187,0.000078134246,0.00020001599,0.00022745518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021865989,0.000120912046,0.0002862728,0.000092967275,0.000103814586,0.00004696084,0.00008337643,0.00014479882,0.0003978159],"category_scores_gemma":[0.00032641998,0.00007877324,0.00007470608,0.00016388633,0.000028899787,0.000100524936,0.0000055325236,0.00030920285,0.0000023716552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00038623228,0.00005152763,0.99202913,0.000004858031,0.00011206463,0.0000071536933,0.00023923503,0.0001574747,0.000015608543,0.000038313807,0.002957631,0.004000755],"study_design_scores_gemma":[0.006937811,0.00032487357,0.93207985,0.000045159944,0.000021350692,0.0000024720503,0.00009150449,0.00018132578,0.000026236194,0.000025027093,0.060177393,0.00008697106],"about_ca_topic_score_codex":0.6006097,"about_ca_topic_score_gemma":0.9704367,"teacher_disagreement_score":0.369827,"about_ca_system_score_codex":0.004539331,"about_ca_system_score_gemma":0.005914906,"threshold_uncertainty_score":0.99972063},"labels":[],"label_agreement":null},{"id":"W2991380951","doi":"10.1016/j.urolonc.2019.10.018","title":"Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Marital status; Logistic regression; Urothelial cancer; Epidemiology; Incidence (geometry); Proportional hazards model; Internal medicine; Urology; Oncology; Demography; Gynecology; Cancer; Population","score_opus":0.02520090591740231,"score_gpt":0.3361745134918298,"score_spread":0.3109736075744275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991380951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97495073,0.0013053069,0.00016310648,0.0140603,0.0005190598,0.0025797628,0.00024190203,0.00010597824,0.006073826],"genre_scores_gemma":[0.8988476,0.00056826696,0.05800715,0.01955018,0.00047161453,0.0039135697,0.00014949874,0.00007917414,0.018412951],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979996,0.0001414501,0.00044766787,0.0006292824,0.00023208676,0.000549895],"domain_scores_gemma":[0.9985176,0.00050348276,0.00017696791,0.0003007396,0.00009259948,0.00040866173],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029398542,0.0003731159,0.0008056388,0.00017000591,0.0001924778,0.000029062483,0.00012821973,0.00035865014,0.0014537034],"category_scores_gemma":[0.00013529246,0.0002687526,0.00018175314,0.0001733227,0.00066933886,0.000119926844,0.000058085396,0.00037152827,0.00009734822],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015661134,0.00048714885,0.9845235,0.00011042557,0.0005733939,0.00016629708,0.00074254867,0.00004129137,0.0005383021,0.0013181185,0.0066743703,0.0032585075],"study_design_scores_gemma":[0.010349006,0.005812629,0.039478615,0.00008117155,0.0017257967,0.00025026285,0.00043559028,0.00094174437,0.00045170484,0.0054583307,0.9345623,0.0004528133],"about_ca_topic_score_codex":0.00016684791,"about_ca_topic_score_gemma":0.00010347035,"teacher_disagreement_score":0.9450449,"about_ca_system_score_codex":0.00028062143,"about_ca_system_score_gemma":0.0007930309,"threshold_uncertainty_score":0.99997646},"labels":[],"label_agreement":null},{"id":"W2991613194","doi":"10.1289/isee.2013.p-1-10-24","title":"Spatial-temporal analysis of bladder cancer risk in the New England Bladder Cancer Study","year":2013,"lang":"en","type":"article","venue":"ISEE Conference Abstracts","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Internal medicine","score_opus":0.03369287086947101,"score_gpt":0.3193175476366782,"score_spread":0.28562467676720715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991613194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932215,0.00064115133,0.000043429125,0.001146224,0.00016712844,0.0014516686,0.00010024416,0.000025097215,0.0032035229],"genre_scores_gemma":[0.9973496,0.0004693996,0.000030127914,0.00040191086,0.00023935713,0.00033755857,0.00003506271,0.000022309618,0.0011146594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787927,0.00012940307,0.00059671956,0.00044246056,0.0005640065,0.0003881641],"domain_scores_gemma":[0.9984877,0.00014524363,0.00031612182,0.0005841591,0.00027092342,0.00019581467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026115874,0.00029984902,0.00069391774,0.0002857357,0.000063808635,0.000067113244,0.00026426866,0.000118398035,0.008998145],"category_scores_gemma":[0.000064509004,0.0001935985,0.00017154597,0.0007025238,0.00008692581,0.00017062001,0.00003508077,0.00035204217,0.000058403824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022275768,0.0011281038,0.9330162,0.000020713002,0.0038305863,0.00005270209,0.010550705,0.0023094611,0.0004280612,0.0000042216943,0.0024067573,0.046029735],"study_design_scores_gemma":[0.0042785765,0.00035955623,0.98815954,0.000052558677,0.0036376296,0.0000018278917,0.0015978812,0.00018469116,0.00048211956,0.000099208635,0.00095487834,0.00019154702],"about_ca_topic_score_codex":0.3725196,"about_ca_topic_score_gemma":0.1640119,"teacher_disagreement_score":0.20850772,"about_ca_system_score_codex":0.00007851803,"about_ca_system_score_gemma":0.00074182526,"threshold_uncertainty_score":0.9919078},"labels":[],"label_agreement":null},{"id":"W2991616458","doi":"10.1093/annonc/mdz296","title":"EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; Pharmacyclics; Chugai Pharmaceutical; MSD Australia; EMD Serono; Genentech; Active Biotech; Medac; Ipsen; Bavarian Nordic; Shionogi; Astellas Pharma; Eisai; European Society for Medical Oncology; European Association of Urology; Sirtex Medical; Cancer Research UK; GlaxoSmithKline; UroGen Pharma; Pfizer; Incyte; Manchester Biomedical Research Centre; Accuray; National Institute for Health and Care Research; Clovis Oncology; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Celldex Therapeutics; Siemens Healthineers; Amgen; Elekta; Sanofi Pasteur; Royal Marsden NHS Foundation Trust; Alere; Bayer HealthCare; Exelixis; Sanofi; Endocyte; Novartis; Bayer; Allergan; AstraZeneca; Associazione Italiana per la Ricerca sul Cancro; Eli Lilly and Company","keywords":"Medicine; Delphi method; Stakeholder; Delphi; Bladder cancer; Voting; Consensus conference; Family medicine; Cancer; Public relations; Internal medicine; Political science","score_opus":0.16532931734192985,"score_gpt":0.4504202926011262,"score_spread":0.28509097525919636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991616458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699375,0.00067634345,0.000009222681,0.025112005,0.00031899917,0.001041957,0.00017349154,0.000004864809,0.002725589],"genre_scores_gemma":[0.9933047,0.0019907635,0.00044654947,0.0033560942,0.000028342254,0.00006210677,0.00000759479,0.000012186625,0.00079164904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998857,0.00011942614,0.0004125267,0.00020629093,0.00025751095,0.00014725303],"domain_scores_gemma":[0.9986037,0.00018790278,0.00037616503,0.00031727893,0.00047632316,0.000038619677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003199475,0.00014702062,0.00033043657,0.000041402815,0.00006622423,0.0000067783835,0.00018115906,0.000059399757,0.000112606125],"category_scores_gemma":[0.00001971105,0.000070662434,0.000043875385,0.00011431167,0.00037258083,0.000053821528,0.00010316261,0.000096824515,0.0000010065804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018359007,0.008941478,0.5704621,0.0016802486,0.038624518,0.00012565029,0.029292675,0.0075397,0.013797655,0.08296071,0.030709706,0.19750652],"study_design_scores_gemma":[0.011229119,0.004352849,0.91464186,0.0006011018,0.0006565717,0.000014237025,0.016840216,0.0006033287,0.013998384,0.0011707515,0.03568428,0.0002073104],"about_ca_topic_score_codex":0.00077914796,"about_ca_topic_score_gemma":0.0006531183,"teacher_disagreement_score":0.34417972,"about_ca_system_score_codex":0.000028005712,"about_ca_system_score_gemma":0.0001442311,"threshold_uncertainty_score":0.28815302},"labels":[],"label_agreement":null},{"id":"W2992532234","doi":"10.1016/j.euf.2019.11.015","title":"From Famine to Feast: Treating Urinary Malignancies in the Immunotherapy Era","year":2019,"lang":"en","type":"letter","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Genitourinary system; Prostate cancer; Bench to bedside; Immunotherapy; Cancer; Kidney cancer; Intensive care medicine; Internal medicine","score_opus":0.018698569652480446,"score_gpt":0.25941473197174486,"score_spread":0.2407161623192644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992532234","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08959056,0.0061129504,0.00004801487,0.7999294,0.00097620464,0.0016915672,0.00027484464,0.00013167465,0.10124483],"genre_scores_gemma":[0.16939351,0.00011430743,0.00019303442,0.81398255,0.006043511,0.000075083706,0.00037623564,0.00020891927,0.009612874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971313,0.0008257894,0.0004327282,0.00071257405,0.00031804515,0.00057954545],"domain_scores_gemma":[0.99840325,0.00031262307,0.00014487756,0.0010530837,0.000041079817,0.00004508749],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026728824,0.0005049378,0.0006882296,0.00022615885,0.000078519566,0.000039208608,0.00051740103,0.00029346504,0.00041540348],"category_scores_gemma":[0.000040353352,0.00033974936,0.00021072148,0.00020159558,0.00009254134,0.0000381994,0.000105498904,0.0016276601,0.0018643695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009275807,0.0002589074,0.00591357,0.000043012435,0.00045638834,0.017775657,0.004472538,0.000004085762,0.00089190295,0.0000054010143,0.9541906,0.01506033],"study_design_scores_gemma":[0.0031250522,0.0026619842,0.07889485,0.00010455445,0.00022134458,0.0004425684,0.00007939097,0.0000019210834,0.000049553862,0.00006631037,0.9140295,0.00032301265],"about_ca_topic_score_codex":0.00058176677,"about_ca_topic_score_gemma":0.000013316608,"teacher_disagreement_score":0.09163196,"about_ca_system_score_codex":0.00008690393,"about_ca_system_score_gemma":0.000098895514,"threshold_uncertainty_score":0.99990547},"labels":[],"label_agreement":null},{"id":"W2992712678","doi":"10.1016/j.urolonc.2019.11.004","title":"Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada); University of Calgary","funders":"National Cancer Institute","keywords":"Cystectomy; Bladder cancer; Medicine; Cisplatin; Chemotherapy; Oncology; Neuroendocrine tumors; Carcinoma; Internal medicine; Cohort; Pathology; Cancer","score_opus":0.015945987217303743,"score_gpt":0.2848942911665937,"score_spread":0.26894830394929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992712678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945826,0.000069136724,0.000013043896,0.0034672169,0.00006583553,0.0009936152,0.000051161413,0.00003131508,0.0007260628],"genre_scores_gemma":[0.9924423,0.000037401333,0.0032040116,0.0032674146,0.000015376852,0.00013864123,0.00011421843,0.000024009636,0.0007565895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988269,0.000068273315,0.0002830343,0.00036053202,0.00020565857,0.00025557392],"domain_scores_gemma":[0.9992432,0.00012005871,0.00019838652,0.00019338688,0.0001118937,0.00013307047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054492924,0.00023847067,0.0005232389,0.0001677198,0.000051995958,0.000009241262,0.00005878718,0.000091767506,0.00026101642],"category_scores_gemma":[0.000013406238,0.00014849879,0.00003813393,0.00027853998,0.0003165412,0.00008049048,0.000009493008,0.00020457187,0.0000054394013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016038943,0.00057109573,0.9958431,0.00002912457,0.00014347392,0.000037545113,0.00010709951,0.00024098004,0.0002812986,0.00007923885,0.00017378568,0.00088937115],"study_design_scores_gemma":[0.019587295,0.01314653,0.93459785,0.00013098559,0.00049902924,0.000031067306,0.000080266414,0.00055120455,0.0042896303,0.000081508515,0.026748238,0.0002564192],"about_ca_topic_score_codex":0.00037018466,"about_ca_topic_score_gemma":0.00008281681,"teacher_disagreement_score":0.061245266,"about_ca_system_score_codex":0.00009957111,"about_ca_system_score_gemma":0.00040375415,"threshold_uncertainty_score":0.6055605},"labels":[],"label_agreement":null},{"id":"W2995340453","doi":"10.1016/j.euo.2019.11.005","title":"The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphadenectomy; MEDLINE; Meta-analysis; Cochrane Library; Systematic review; Cancer; Surgery; Urology; Internal medicine","score_opus":0.04368535579554485,"score_gpt":0.3663460669193838,"score_spread":0.322660711123839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995340453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01682308,0.9739299,0.000012303867,0.0026116043,0.00029518147,0.0048158877,0.0013510254,0.000011692759,0.00014934877],"genre_scores_gemma":[0.022322513,0.9752252,0.00005144758,0.001225039,0.00008490836,0.00059458293,0.00009980226,0.00008101876,0.00031549545],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929905,0.0037756627,0.0020139783,0.0006434628,0.000193792,0.0003825914],"domain_scores_gemma":[0.9941818,0.002047781,0.0027562894,0.00053706934,0.00034526337,0.00013179544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032400687,0.00047171055,0.0034291719,0.00008784517,0.00011893269,0.000011001249,0.00021265606,0.00019630643,0.000057022036],"category_scores_gemma":[0.0012443963,0.00028247313,0.00023692207,0.00014374765,0.00077029405,0.000053882348,0.00022548453,0.0003888257,0.000002385525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058264256,0.0009756031,0.08212426,0.62584096,0.01808178,0.00026725707,0.0015477494,4.6952226e-7,0.000021222417,0.00005212037,0.02323277,0.24727316],"study_design_scores_gemma":[0.012398765,0.0118328,0.05917075,0.03460593,0.20262839,0.0014825121,0.00030451812,0.00007635125,0.0000075141775,0.00014983233,0.67598933,0.0013533151],"about_ca_topic_score_codex":0.00030136527,"about_ca_topic_score_gemma":0.00071533566,"teacher_disagreement_score":0.6527566,"about_ca_system_score_codex":0.00010362176,"about_ca_system_score_gemma":0.000465561,"threshold_uncertainty_score":0.99996275},"labels":[],"label_agreement":null},{"id":"W2995993425","doi":"10.1016/j.eururo.2019.08.026","title":"Reply to Eva Compérat, Mahul Amin, Victor Reuter’s Editorial Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol 2019;76:413–5","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Grading (engineering)","score_opus":0.028121047620976378,"score_gpt":0.3045412718670938,"score_spread":0.2764202242461174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995993425","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006457441,0.002646456,0.0004033702,0.9297228,0.054530703,0.0044058273,0.0011890199,0.0005029479,0.0059531704],"genre_scores_gemma":[0.003800529,0.0005428343,0.0004608783,0.8180294,0.13004664,0.00018499263,0.0016950466,0.0006564109,0.044583272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895069,0.0035344807,0.0016654417,0.0022588277,0.0012869356,0.0017474404],"domain_scores_gemma":[0.994079,0.000982121,0.0013041879,0.0025575454,0.00059944077,0.00047772028],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0015418374,0.0013778731,0.0016926627,0.0006052758,0.000636551,0.00020283295,0.0011300162,0.0005387645,0.0027593586],"category_scores_gemma":[0.0004429347,0.0010073133,0.00039785943,0.0007415486,0.0003351272,0.00023430292,0.00043773177,0.0037133612,0.0019463828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001872641,0.000121631034,0.00089066866,0.00016416582,0.0011116633,0.0014248774,0.0019554659,0.000062827676,0.000113042144,0.000023653514,0.99125975,0.0009996054],"study_design_scores_gemma":[0.0041656336,0.002834838,0.0016259571,0.00027676404,0.0013031665,0.0006641897,0.000073472824,0.00001567763,0.00011293221,0.00004354504,0.9879939,0.00088994665],"about_ca_topic_score_codex":0.0026114997,"about_ca_topic_score_gemma":0.00078893115,"teacher_disagreement_score":0.11169337,"about_ca_system_score_codex":0.0011539813,"about_ca_system_score_gemma":0.0018228786,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W2996143663","doi":"10.5737/23688076294226231","title":"Quality of life in men after total cystoprostatectomy: Perceptions of Tunisian patients","year":2019,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université Laval","funders":"","keywords":"Quality of life (healthcare); Medicine; Cystoprostatectomy; Sexual function; Arabic; Stoma (medicine); Psychology; Gerontology; Physical therapy; General surgery; Bladder cancer; Cystectomy; Cancer; Nursing; Internal medicine","score_opus":0.015214344016465814,"score_gpt":0.3196684727192203,"score_spread":0.30445412870275446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996143663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98333895,0.00022317625,0.000007120935,0.0011598676,0.00045571115,0.0002681413,0.00006392561,0.0000028771567,0.014480226],"genre_scores_gemma":[0.9991105,0.000020586609,0.00018046767,0.000283503,0.00007939426,0.000005037418,0.000011160661,0.000013139415,0.00029618386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890333,0.000115175346,0.00043734323,0.00011955853,0.00015163602,0.00027296055],"domain_scores_gemma":[0.99905753,0.000026007916,0.00015340614,0.00013896391,0.00015363097,0.00047046915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019556668,0.00009408304,0.00042270904,0.00033001596,0.000035775716,0.0000046155264,0.00005576248,0.00012735538,0.000836602],"category_scores_gemma":[0.00004417676,0.00008630185,0.0000904779,0.00013919306,0.00012169062,0.000063852254,0.0000044239937,0.00026940447,0.000015530724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007006644,0.0003203395,0.9811843,0.000029354022,0.000057597,0.00003423192,0.0030538193,0.0000046520854,0.00047087835,0.000015179451,0.0009599927,0.013168963],"study_design_scores_gemma":[0.004940079,0.0010754778,0.9917535,0.00034295532,0.000041840096,0.000068447844,0.0012245224,0.000010271747,0.000032297175,0.00009895133,0.00034171165,0.000069903894],"about_ca_topic_score_codex":0.010077187,"about_ca_topic_score_gemma":0.010670442,"teacher_disagreement_score":0.015771573,"about_ca_system_score_codex":0.0021116096,"about_ca_system_score_gemma":0.003488825,"threshold_uncertainty_score":0.9965148},"labels":[],"label_agreement":null},{"id":"W2996535743","doi":"10.3233/blc-190252","title":"Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial","year":2019,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Ipsen; Incyte; Astellas Pharma; Clovis Oncology; Exelixis; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Docetaxel; Ramucirumab; Medicine; Internal medicine; Placebo; Hazard ratio; Subgroup analysis; Oncology; Chemotherapy; Adverse effect; Progression-free survival; Urology; Confidence interval; Pathology","score_opus":0.016504199327409465,"score_gpt":0.29406316570677776,"score_spread":0.2775589663793683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996535743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919558,0.0020561405,0.00014523402,0.0010764755,0.0002565809,0.0038522054,0.0002929389,0.00006019253,0.00030443838],"genre_scores_gemma":[0.9946009,0.0001377019,0.00039075443,0.001808558,0.0006429517,0.0013896872,0.000060077586,0.0000909532,0.00087845296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974665,0.00010535161,0.0005354163,0.00084546924,0.0005605919,0.0004866406],"domain_scores_gemma":[0.9986643,0.00013761291,0.00021131786,0.00071211735,0.000087080334,0.0001875607],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017114832,0.0004919035,0.0010084707,0.00019740852,0.00007054563,0.00006819987,0.0001490806,0.00016625776,0.0028776547],"category_scores_gemma":[0.000016958082,0.00027943458,0.0002500255,0.0007704877,0.00015322705,0.0001547736,0.000030326326,0.00033898582,0.000013889782],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5149277,0.0008582533,0.46904188,0.00005526405,0.0014901531,0.0000720063,0.0031705683,0.000058778503,0.0011713883,0.0000016170791,0.00014335969,0.00900907],"study_design_scores_gemma":[0.5322753,0.0037479748,0.4471123,0.0003215265,0.002536817,0.000008034291,0.0005104314,0.0015678804,0.007724505,0.000018022507,0.0035109827,0.0006662333],"about_ca_topic_score_codex":0.0042067715,"about_ca_topic_score_gemma":0.0066563743,"teacher_disagreement_score":0.02192958,"about_ca_system_score_codex":0.00025815342,"about_ca_system_score_gemma":0.00057573174,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W2996730987","doi":"10.1016/j.clgc.2019.12.001","title":"Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities","year":2019,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Université de Montréal","funders":"","keywords":"Medicine; Chemotherapy; Cystectomy; Bladder cancer; Internal medicine; Oncology; Hazard ratio; Transitional cell carcinoma; Cancer; Urology; Surgery; Confidence interval","score_opus":0.07390756539667452,"score_gpt":0.3492164704109788,"score_spread":0.2753089050143043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996730987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907235,0.0007495506,0.000032080156,0.00011184285,0.0007378357,0.0018877115,0.0003604241,0.000018430814,0.005378628],"genre_scores_gemma":[0.9963262,0.00013626063,0.000628723,0.0002011405,0.0002674731,0.00015950747,0.00005609752,0.00006388013,0.002160691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976815,0.00014088287,0.0008817611,0.00055406505,0.00041223937,0.00032956983],"domain_scores_gemma":[0.99808294,0.00031680605,0.00039324284,0.0005693599,0.00033737524,0.00030025348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001504291,0.00036284782,0.0011770083,0.00014318048,0.000036356367,0.0000069673447,0.00018382554,0.00008715974,0.00019046493],"category_scores_gemma":[0.000019887375,0.00026245276,0.00030989092,0.00021596334,0.0001422889,0.00009665435,0.00011284019,0.0001714523,0.000027999662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072954716,0.0039118715,0.9832443,0.00033725667,0.00082821766,0.000107861575,0.00059427804,0.00010306058,0.00023894568,0.0000037440236,0.00012773086,0.0032072717],"study_design_scores_gemma":[0.024489742,0.037534274,0.9251204,0.00040760572,0.0006818725,0.000006185074,0.0016095453,0.00008340605,0.009229474,0.000026469612,0.00042414828,0.0003868418],"about_ca_topic_score_codex":0.0012695116,"about_ca_topic_score_gemma":0.000014724102,"teacher_disagreement_score":0.058123853,"about_ca_system_score_codex":0.00017708766,"about_ca_system_score_gemma":0.00079814636,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2996739473","doi":"10.14740/wjon1234","title":"Prognostic Role of Epithelial-Mesenchymal Transition Markers “E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63” in Bladder Carcinoma","year":2019,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Epithelial–mesenchymal transition; Immunohistochemistry; Catenin; Cadherin; Zinc finger; Vimentin; Internal medicine; Transitional cell carcinoma; Pathology; Oncology; Cancer research; Cell; Bladder cancer; Biology; Cancer; Metastasis; Wnt signaling pathway; Signal transduction; Transcription factor; Gene","score_opus":0.010235080358619645,"score_gpt":0.2659390296213978,"score_spread":0.2557039492627782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996739473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887764,0.0019038467,0.000011730558,0.0017151515,0.00028892184,0.00042011158,0.000009315657,0.0000052326104,0.0068693026],"genre_scores_gemma":[0.9982572,0.0001823252,0.0005072758,0.00029007308,0.00016909387,0.0000073392416,0.0000031285706,0.000020424406,0.00056313165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869883,0.000116335985,0.000565777,0.00016187041,0.00021589558,0.00024131259],"domain_scores_gemma":[0.9991676,0.00014089464,0.0002819862,0.0001101357,0.00015337588,0.00014599616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003070199,0.00015112384,0.0006155991,0.00038033526,0.000017954735,0.000005344351,0.000074535186,0.00010571226,0.0004711586],"category_scores_gemma":[0.000033324937,0.000121042656,0.00012180357,0.00022726558,0.00010657201,0.000102349746,0.000016976233,0.00032073073,0.000013738954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007021908,0.0010021161,0.8606378,0.00017645412,0.00043630978,0.0006074337,0.002508399,0.00003963113,0.06941302,0.000115052964,0.00056852907,0.05747335],"study_design_scores_gemma":[0.012677099,0.0068575814,0.96445507,0.00025604258,0.0004482764,0.0012694071,0.0009778714,0.0001131017,0.0050878846,0.0004268145,0.007279183,0.00015165606],"about_ca_topic_score_codex":0.00013106849,"about_ca_topic_score_gemma":0.00015240657,"teacher_disagreement_score":0.10381729,"about_ca_system_score_codex":0.00016682457,"about_ca_system_score_gemma":0.00041226475,"threshold_uncertainty_score":0.51588565},"labels":[],"label_agreement":null},{"id":"W2997128272","doi":"10.1016/j.bcp.2019.113778","title":"Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways","year":2019,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Université du Québec à Trois-Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Consejo Nacional de Investigaciones Científicas y Técnicas; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Bladder cancer; In vivo; Metastasis; Apoptosis; Inflammation; Tumor necrosis factor alpha; Cancer; Cell growth; Pharmacology; Medicine; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.022102771847304806,"score_gpt":0.2856950284683135,"score_spread":0.2635922566210087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997128272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896004,0.009165775,0.000032557833,0.00014497242,0.000031589825,0.0006399812,0.00009464999,0.000008152095,0.000281878],"genre_scores_gemma":[0.99698955,0.0019117162,0.00054580433,0.00042027736,0.00002346446,0.00006498473,0.000019094676,0.00002075751,0.0000043393816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899924,0.00005339705,0.00031808837,0.00029392113,0.00015782622,0.00017754681],"domain_scores_gemma":[0.999494,0.000041501204,0.00016578815,0.00009812898,0.00013671746,0.000063818996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004873827,0.0001860945,0.0005425751,0.00009120875,0.000008672556,0.000001462808,0.000040316478,0.000080673664,0.00012185529],"category_scores_gemma":[0.000008233352,0.00014086772,0.000043316417,0.00018767161,0.0002912968,0.00008980038,0.000050463284,0.0001171978,5.200181e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019532202,0.0004889536,0.0059811897,0.0004104274,0.00035724923,0.00001257749,0.0005221169,0.0000061932014,0.989876,0.00009601634,0.000101644204,0.00019443882],"study_design_scores_gemma":[0.008349894,0.0012562984,0.0038859744,0.00014357794,0.00018333345,0.000013232789,0.00006887448,0.000054047272,0.985573,0.00034888435,0.000009952226,0.0001129619],"about_ca_topic_score_codex":0.00017009104,"about_ca_topic_score_gemma":0.000001297849,"teacher_disagreement_score":0.007389118,"about_ca_system_score_codex":0.000025112893,"about_ca_system_score_gemma":0.00009544479,"threshold_uncertainty_score":0.5744419},"labels":[],"label_agreement":null},{"id":"W2997330577","doi":"10.21037/tau.2019.12.06","title":"Capturing recurrence in urothelial carcinoma: “more than meets the eye”","year":2019,"lang":"en","type":"letter","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Malignancy; Oncology; Chemotherapy; Lamina propria; Cisplatin; Bladder cancer; Carcinoma; Urothelial carcinoma; Immune checkpoint; Internal medicine; Targeted therapy; Carcinoma in situ; Disease; Cancer; Immunotherapy; Pathology; Epithelium","score_opus":0.020011531983810716,"score_gpt":0.2695763667430607,"score_spread":0.24956483475924995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997330577","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09673122,0.005346327,0.00002339354,0.8937834,0.00060004415,0.00074060605,0.00015388885,0.000025053725,0.0025960645],"genre_scores_gemma":[0.69462585,0.00014651942,0.000024794183,0.30259028,0.0011392994,0.00007006449,0.0003032436,0.000027991038,0.001071981],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998315,0.0001890788,0.00031494617,0.0005490953,0.00019659127,0.0004352906],"domain_scores_gemma":[0.999295,0.00028831186,0.00008241053,0.0002548996,0.000039579307,0.000039798757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014678402,0.00032332801,0.00055754266,0.00016606507,0.00009579643,0.0000081045255,0.0001434878,0.0009581309,0.00022965069],"category_scores_gemma":[0.00001223764,0.00022182328,0.00012189708,0.0000917049,0.00039099224,0.000041620016,0.000024187035,0.0016152428,0.000041125193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004084851,0.00022353762,0.9065005,0.00049644074,0.0006855129,0.0024939026,0.0025241433,0.00007079282,0.000084452295,0.00084839755,0.07859404,0.0033933911],"study_design_scores_gemma":[0.0044590523,0.00069025834,0.46003276,0.000028000119,0.00042525103,0.00078546954,0.000008003836,0.00018782326,0.0000137058205,0.0018355135,0.5312577,0.00027645202],"about_ca_topic_score_codex":0.00022836667,"about_ca_topic_score_gemma":0.000119058044,"teacher_disagreement_score":0.5978946,"about_ca_system_score_codex":0.000018314302,"about_ca_system_score_gemma":0.00023757528,"threshold_uncertainty_score":0.90456915},"labels":[],"label_agreement":null},{"id":"W2998188806","doi":"10.1016/j.urology.2019.12.013","title":"Robot-assisted Laparoscopic Radical Cystectomy and Sigmoid Orthotopic Neobladder Reconstruction for a Bladder Rhabdomyosarcoma Child: Case Report and Literature Review","year":2019,"lang":"en","type":"review","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Capital Health","keywords":"Medicine; Cystectomy; Rhabdomyosarcoma; Cystoscopy; Surgery; Urinary diversion; Hydronephrosis; Urology; Ureter; Bladder cancer; Urinary system; Internal medicine","score_opus":0.030463214743752225,"score_gpt":0.3369292098106039,"score_spread":0.3064659950668517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998188806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011172626,0.99237734,0.00006837323,0.000765289,0.00066299684,0.0052266293,0.0001289272,0.00007190625,0.00058682647],"genre_scores_gemma":[0.000090395326,0.9947714,0.0006996009,0.0013505409,0.0004923212,0.00081417017,0.00054864475,0.000093717535,0.0011391597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970578,0.0002684835,0.0009770313,0.0010885587,0.0001576584,0.0004504685],"domain_scores_gemma":[0.99815875,0.00023049618,0.00050365645,0.0007195043,0.00012014929,0.0002674464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025948405,0.00066293176,0.0031160056,0.00025706497,0.00015005232,0.000042928856,0.000084655774,0.0008861707,0.00013496059],"category_scores_gemma":[0.00018679445,0.0004860281,0.00043449312,0.00028586757,0.00022934002,0.000082270235,0.000077702025,0.0007659871,0.000011606798],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010024191,0.000087138775,0.000055843626,0.08247532,0.0011076451,0.031062027,0.000042879325,2.4387433e-8,8.825318e-7,0.000039617895,0.0011316424,0.8838967],"study_design_scores_gemma":[0.001737071,0.0005285791,0.00002120747,0.013785585,0.004982179,0.47609305,0.000002378335,0.0000026456987,4.1891036e-7,0.000014093757,0.50262487,0.00020790129],"about_ca_topic_score_codex":0.000016861093,"about_ca_topic_score_gemma":0.000018537225,"teacher_disagreement_score":0.8836888,"about_ca_system_score_codex":0.00006917508,"about_ca_system_score_gemma":0.00036088424,"threshold_uncertainty_score":0.99975914},"labels":[],"label_agreement":null},{"id":"W2998563491","doi":"10.1002/9780471420194.tnmc44.pub2","title":"Urinary Bladder","year":2010,"lang":"en","type":"other","venue":"TNM Online","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Grading (engineering); Pathological; Distant metastasis; Lymph node metastasis; Medicine; Stage (stratigraphy); Metastasis; Lymph node; Pathology; Urinary bladder; Cancer; Oncology; Internal medicine; Biology","score_opus":0.01971809350870704,"score_gpt":0.3124528546438969,"score_spread":0.2927347611351898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998563491","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018238137,0.0018432544,0.0000075028597,0.0006987525,0.00065649993,0.00046466687,0.003446228,0.00038742882,0.99231327],"genre_scores_gemma":[0.00024501455,0.00037477753,0.0028209167,0.001226608,0.0032384365,0.000028822766,0.002878002,0.0006115525,0.9885759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910456,0.000009999756,0.00014149724,0.00030794076,0.0002119142,0.00022406683],"domain_scores_gemma":[0.9992064,0.000010652825,0.000076651406,0.0005244268,0.000022653894,0.00015916573],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000017938833,0.00027681098,0.00041077595,0.00015180928,0.00001853388,0.0000059784174,0.00009380202,0.00042801042,0.13311589],"category_scores_gemma":[0.000014572571,0.00021568124,0.00012550235,0.000081726204,0.0000648388,0.000009936024,0.000038985156,0.00045684935,0.0012174605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057710262,0.000759699,0.00022719378,0.00008160726,0.0002917543,0.0002574775,0.00001670631,5.285613e-9,0.00008268617,0.000012539078,0.9857517,0.012460915],"study_design_scores_gemma":[0.0014148145,0.00033769172,0.0015859294,0.00021425626,0.0003233283,0.00015288555,0.000006764832,0.0000019497677,0.00004323462,0.00002683316,0.9957051,0.00018721244],"about_ca_topic_score_codex":0.00020175248,"about_ca_topic_score_gemma":0.00020552597,"teacher_disagreement_score":0.13189843,"about_ca_system_score_codex":0.000026831833,"about_ca_system_score_gemma":0.00018153363,"threshold_uncertainty_score":0.9995602},"labels":[],"label_agreement":null},{"id":"W2998819711","doi":"10.1016/j.prp.2020.152822","title":"Clinical and pathological characteristics of bladder cancer in post brachytherapy patients","year":2020,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Brachytherapy; Bladder cancer; Histopathology; Pathology; Malignancy; Cancer; Carcinoma; Immunophenotyping; Adenocarcinoma; Histology; Radiation therapy; Urology; Oncology; Internal medicine","score_opus":0.1532615522220107,"score_gpt":0.4788224834733055,"score_spread":0.3255609312512948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998819711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829965,0.0012579404,0.00000982161,0.013720365,0.00007328812,0.00042707106,0.00011922293,0.000010131439,0.0013856151],"genre_scores_gemma":[0.98552334,0.0103555,0.00044147432,0.0034071542,0.0001457746,0.000036514513,0.000019303787,0.000013380484,0.000057532015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978945,0.0008420805,0.00034827628,0.0003798765,0.00025105523,0.0002841766],"domain_scores_gemma":[0.9979037,0.001227595,0.00008941289,0.00013810823,0.00038912144,0.00025206257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011168293,0.00010858568,0.00037938482,0.00007069511,0.000056466357,0.000013206399,0.000056818826,0.0001743739,0.00022797687],"category_scores_gemma":[0.0036973685,0.00007519689,0.00002897616,0.00017431063,0.0005741187,0.0001234284,0.000097702476,0.00066951534,0.000012101017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061917137,0.000783839,0.90217674,0.0000613595,0.0000659522,0.0006877911,0.00092616223,1.6208944e-8,0.0013657778,0.00005895584,0.00014161994,0.087540075],"study_design_scores_gemma":[0.0034271518,0.0049636485,0.9872884,0.000024878884,0.000049627346,0.00009904544,0.0002796084,0.000011117436,0.000089147405,0.00011754331,0.0035784035,0.00007141404],"about_ca_topic_score_codex":0.00008280977,"about_ca_topic_score_gemma":0.0000152036755,"teacher_disagreement_score":0.08746866,"about_ca_system_score_codex":0.000013125834,"about_ca_system_score_gemma":0.0001446457,"threshold_uncertainty_score":0.44263625},"labels":[],"label_agreement":null},{"id":"W2998822731","doi":"10.1136/jclinpath-2019-206256","title":"Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"MSH2; PMS2; MSH6; Tissue microarray; DNA mismatch repair; PD-L1; Urothelial carcinoma; CD8; Cytotoxic T cell; Medicine; Bladder cancer; MLH1; Carcinoma; Immune system; Immune checkpoint; Cancer research; Immunohistochemistry; Pathology; Internal medicine; Biology; Immunology; Immunotherapy; Cancer","score_opus":0.04886020052927932,"score_gpt":0.34045794431905413,"score_spread":0.2915977437897748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998822731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955445,0.00052834675,0.00022143517,0.0028797202,0.00027915675,0.00034642732,0.0000090889525,0.0000046807554,0.00018667984],"genre_scores_gemma":[0.9977701,0.00006538772,0.0014313875,0.00046455316,0.00021164316,0.0000033101153,7.24649e-7,0.0000110559895,0.000041881838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977388,0.00037995516,0.001319451,0.00016737677,0.00027297754,0.00012144005],"domain_scores_gemma":[0.9985687,0.0002182124,0.00080145564,0.00016980646,0.00013034267,0.00011148148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064712303,0.00010281548,0.0006654004,0.000055089473,0.00002011543,0.0000018119524,0.00010614419,0.0001952304,0.00003798236],"category_scores_gemma":[0.00097511464,0.000060933253,0.00024658267,0.00013881813,0.00022874467,0.00004833281,0.00005508141,0.00046702698,0.0000012437308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003336089,0.00078744144,0.9338631,0.00014264278,0.000043439337,0.00023397799,0.0010621346,0.000039291524,0.057863064,0.00007791235,0.0003987669,0.0021521414],"study_design_scores_gemma":[0.006998197,0.003544412,0.9737222,0.00022438633,0.00016507303,0.00018401939,0.00014903556,0.00016267516,0.014070148,0.00056484767,0.00015495601,0.000060054197],"about_ca_topic_score_codex":0.000021915972,"about_ca_topic_score_gemma":0.0000047159674,"teacher_disagreement_score":0.043792915,"about_ca_system_score_codex":0.000014513584,"about_ca_system_score_gemma":0.00024617306,"threshold_uncertainty_score":0.2484786},"labels":[],"label_agreement":null},{"id":"W2999089735","doi":"10.1111/bju.14995","title":"Risk‐adapted management of low‐grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)","year":2020,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Fulguration; Cancer; Disease; Urinary system; Surgery; Internal medicine","score_opus":0.037146876114958316,"score_gpt":0.329145170053092,"score_spread":0.2919982939381337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999089735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066742636,0.9900432,0.00020654273,0.005071629,0.0017711548,0.000625585,0.001486604,0.00001543377,0.00071308855],"genre_scores_gemma":[0.00085708144,0.9951569,0.00075104745,0.0011492803,0.0014647065,0.000068725174,0.00029386955,0.00007086679,0.00018753877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722576,0.0003497591,0.0012893081,0.00035719838,0.00050605205,0.0002719254],"domain_scores_gemma":[0.9974893,0.00029093723,0.001553449,0.00025595384,0.00023027998,0.00018010916],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002894058,0.00033952307,0.0015887418,0.0001359443,0.000093594455,0.0000466991,0.0006433005,0.00023868318,0.0024870778],"category_scores_gemma":[0.000075194264,0.00026965135,0.00078910094,0.00025315137,0.00014036732,0.00009027377,0.00015374385,0.0011614158,0.000025521604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013196885,0.0003636434,0.00016471634,0.0003970871,0.009382414,0.0014607046,0.00007780042,0.000002896087,6.5097015e-7,0.000036184272,0.043893375,0.9440886],"study_design_scores_gemma":[0.002417877,0.00038075037,0.0017964867,0.005929709,0.010405626,0.0028330374,0.00009064793,0.000008376651,0.0000011967195,0.0001680067,0.97578293,0.00018535086],"about_ca_topic_score_codex":0.00070744706,"about_ca_topic_score_gemma":0.00019970104,"teacher_disagreement_score":0.9439032,"about_ca_system_score_codex":0.00018360508,"about_ca_system_score_gemma":0.00037436254,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W2999163403","doi":"10.5737/23688076294219225","title":"La qualité de vie à la suite à d’une cystoprostatectomie totale chez les hommes : perception des patients tunisiens","year":2019,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Art; Humanities","score_opus":0.01807419363706192,"score_gpt":0.31137246866720747,"score_spread":0.29329827503014555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999163403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93688625,0.010910262,0.000080783684,0.0058092144,0.0033851047,0.00044855813,0.00016549186,0.000024480658,0.04228984],"genre_scores_gemma":[0.9873531,0.0016188229,0.0005578388,0.0009995977,0.000967407,0.000011007265,0.00005167848,0.00008095247,0.008359606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966122,0.0010168526,0.0004739765,0.0003410635,0.00025192852,0.0013039702],"domain_scores_gemma":[0.99747366,0.00025622727,0.00021489024,0.00023318478,0.00023426228,0.0015877541],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082245487,0.00035006364,0.00057295174,0.00039026278,0.0005828862,0.00012307195,0.00018797965,0.0007066093,0.0022405048],"category_scores_gemma":[0.00012698282,0.0003550286,0.00021118973,0.00027167497,0.000973866,0.00023863987,0.000013553493,0.0011835083,0.00028358193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00030036882,0.00053800846,0.23724751,0.00010097375,0.00021736971,0.001036364,0.031134067,0.000018278686,0.0006302735,0.000108823966,0.009276784,0.71939117],"study_design_scores_gemma":[0.008119259,0.003015036,0.7311038,0.0038474272,0.00068994804,0.0068791513,0.01589232,0.00011882221,0.00008588395,0.0009531091,0.22885934,0.00043589468],"about_ca_topic_score_codex":0.03473984,"about_ca_topic_score_gemma":0.02914794,"teacher_disagreement_score":0.7189553,"about_ca_system_score_codex":0.016574549,"about_ca_system_score_gemma":0.008137447,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2999522288","doi":"10.5489/cuaj.6378","title":"Continuing towards optimization of bladder cancer care in Canada: Summary of the 3rd BCC-CUA-CUOG bladder cancer quality of care consensus meeting","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; Dalhousie University; Université Laval; Queen's University; Université de Sherbrooke; Western University; University of Toronto; McMaster University Medical Centre; University Health Network; McGill University Health Centre; University of Ottawa; BC Cancer Agency; Princess Margaret Cancer Centre; University of Calgary; University of Alberta; Université de Montréal","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Quality (philosophy); Medical physics; Gynecology; Internal medicine","score_opus":0.02144124050387425,"score_gpt":0.26953880534361013,"score_spread":0.24809756483973588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999522288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97708315,0.006543009,0.000009315981,0.012949843,0.00037030232,0.0004284648,0.00082026125,0.000006439807,0.0017892038],"genre_scores_gemma":[0.99730694,0.0003309927,0.00011126867,0.0019852587,0.00017812803,0.000013775267,0.000017283006,0.000016169064,0.000040161172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976741,0.0003311877,0.0008223411,0.00020778249,0.0005998503,0.00036475202],"domain_scores_gemma":[0.9974935,0.0001335129,0.0008604802,0.000118594,0.0010440733,0.00034982874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025217226,0.00017215882,0.00063150463,0.000075983844,0.00008365489,0.00001008881,0.00016194333,0.00018285595,0.0004331525],"category_scores_gemma":[0.00074125297,0.0001292565,0.00017169597,0.00038284683,0.000064512235,0.000037764476,0.000027573318,0.00044022003,2.0060982e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022354469,0.000017274373,0.9738336,0.00009828982,0.0002767763,0.000015390138,0.0030179846,0.01791262,0.0002898106,0.0000075868065,0.0013582037,0.0029489107],"study_design_scores_gemma":[0.0031149397,0.0002342807,0.98602974,0.00025577552,0.0003499091,0.0000054968064,0.0056986683,0.00051519606,0.0020345415,0.000009659419,0.0015679672,0.00018383183],"about_ca_topic_score_codex":0.8846833,"about_ca_topic_score_gemma":0.9157162,"teacher_disagreement_score":0.03103282,"about_ca_system_score_codex":0.0028398645,"about_ca_system_score_gemma":0.0077867107,"threshold_uncertainty_score":0.9978382},"labels":[],"label_agreement":null},{"id":"W2999800225","doi":"10.1007/s00428-019-02727-1","title":"Dataset for the reporting of carcinoma of the bladder—cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)","year":2020,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre; University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Multidisciplinary approach; Medical physics; Cancer; Family medicine; Internal medicine","score_opus":0.09525429311595623,"score_gpt":0.4011576262584999,"score_spread":0.30590333314254364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999800225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9421215,0.0025564884,0.00043053253,0.047670316,0.00063449977,0.0021080873,0.0040556346,0.00003775663,0.00038515305],"genre_scores_gemma":[0.9922679,0.0006372295,0.00095925975,0.004424761,0.0004572695,0.00020184247,0.0009929804,0.000028671602,0.000030090052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964171,0.00024292943,0.001979871,0.0006030505,0.00045127005,0.0003057533],"domain_scores_gemma":[0.99362636,0.0018485613,0.0033976866,0.00076682214,0.00025835028,0.00010220227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010980754,0.00030489103,0.00069489935,0.000049855065,0.0003652355,0.00002934658,0.00049692695,0.00010883122,0.000055319488],"category_scores_gemma":[0.007024585,0.00014506411,0.00020632806,0.0003699784,0.0006570055,0.00008678452,0.00034920807,0.00050227274,0.000001773534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071054795,0.001044642,0.45247182,0.0005421908,0.006584918,0.00020296371,0.023613496,0.0007635288,0.38603863,0.002165139,0.07602937,0.043437805],"study_design_scores_gemma":[0.011586769,0.002948682,0.6770412,0.0009843726,0.0041290396,0.000046820714,0.012917986,0.006976229,0.24008135,0.003060422,0.039563626,0.0006635317],"about_ca_topic_score_codex":0.0012162385,"about_ca_topic_score_gemma":0.00018651977,"teacher_disagreement_score":0.22456934,"about_ca_system_score_codex":0.000053598484,"about_ca_system_score_gemma":0.00045479552,"threshold_uncertainty_score":0.84095913},"labels":[],"label_agreement":null},{"id":"W2999970393","doi":"10.1016/s0923-7534(20)33403-7","title":"Neoadjuvant (NACT) and Adjuvant Chemotherapy (ACT) for Muscle-Invasive Bladder Cancer: A Population-Based Outcomes Study","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Chemotherapy; Internal medicine; Adjuvant chemotherapy; Adjuvant; Neoadjuvant therapy; Cancer; Breast cancer","score_opus":0.08392121770293089,"score_gpt":0.42220445834939085,"score_spread":0.33828324064646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999970393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887099,0.0016451894,0.0000344149,0.007145532,0.00029827733,0.001624726,0.00006784315,0.000031116022,0.0004429774],"genre_scores_gemma":[0.99224144,0.00030793794,0.00041969906,0.0062100156,0.00021851645,0.00033255064,0.00003391833,0.00003503648,0.0002009053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987898,0.00006257431,0.00035329018,0.00024240828,0.00017269666,0.0003792447],"domain_scores_gemma":[0.9988364,0.0003487171,0.00019903392,0.00023312659,0.00018528318,0.00019741888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023068264,0.00020694172,0.00072569255,0.000112106456,0.000067293266,0.0000050295575,0.00006359499,0.000122031845,0.00018820491],"category_scores_gemma":[0.00008753805,0.00015684008,0.0001459806,0.00008648563,0.000055721575,0.0000857887,0.000017143842,0.00008870129,0.0000034010145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006518362,0.0022646834,0.8829882,0.0000567537,0.0005724652,0.0000061380947,0.0014157798,0.0000042984443,0.00032924447,0.000027921275,0.001438292,0.110244386],"study_design_scores_gemma":[0.009434794,0.006115066,0.97096586,0.000038939008,0.00034408047,0.000005087469,0.00051483704,0.000020055673,0.0026278512,0.00008157426,0.009702394,0.00014948357],"about_ca_topic_score_codex":0.0016850786,"about_ca_topic_score_gemma":0.0006552552,"teacher_disagreement_score":0.1100949,"about_ca_system_score_codex":0.00008001527,"about_ca_system_score_gemma":0.00036245334,"threshold_uncertainty_score":0.63957524},"labels":[],"label_agreement":null},{"id":"W3000281526","doi":"10.1200/jco.19.01731","title":"Framing Pragmatic Strategies to Reduce Mortality From Bladder Cancer: An Endorsement From the Society of Urologic Oncology","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Framing (construction); Urothelial cancer; Clinical Oncology; Oncology; Internal medicine; Cancer","score_opus":0.20458011642438761,"score_gpt":0.4975481715894315,"score_spread":0.2929680551650439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000281526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346598,0.0014473493,0.0006918889,0.060779586,0.00097486953,0.0004204812,0.00009782886,0.000013905373,0.0009143105],"genre_scores_gemma":[0.9559699,0.0012797344,0.009531369,0.030167023,0.0029893047,0.000018873228,0.000012662026,0.000017755849,0.0000133209405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959631,0.000821927,0.0021892237,0.00031263178,0.00046186527,0.00025125736],"domain_scores_gemma":[0.9948953,0.0023706788,0.001608612,0.00029008626,0.00031329188,0.0005220609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013656488,0.00019312296,0.0016836332,0.000018734732,0.000057756457,0.000014211071,0.00036208399,0.00039780885,0.00085129077],"category_scores_gemma":[0.0009028452,0.00011320248,0.00067087123,0.00014183475,0.00026684438,0.00013424108,0.00009751347,0.0010200959,0.00001116246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016898869,0.0090274615,0.44521412,0.00012856082,0.018153517,0.00084872526,0.023740228,0.0010824607,0.01802613,0.00023860476,0.06020733,0.406434],"study_design_scores_gemma":[0.015705142,0.048909985,0.7364766,0.0001525585,0.0053127524,0.00003319962,0.01093006,0.0006295197,0.0015157947,0.003457519,0.17661297,0.00026391225],"about_ca_topic_score_codex":0.0021653841,"about_ca_topic_score_gemma":0.0005983964,"teacher_disagreement_score":0.40617007,"about_ca_system_score_codex":0.0001816846,"about_ca_system_score_gemma":0.0040143467,"threshold_uncertainty_score":0.9321037},"labels":[],"label_agreement":null},{"id":"W3000596532","doi":"10.1016/s0923-7534(20)33372-x","title":"Prognostic Stratification of Advanced Urothelial Carcinoma (UC) Receiving Second-Line Systemic Therapy Including Time from Prior Chemotherapy (TFPC) as a Prognostic Factor","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Urothelial carcinoma; Chemotherapy; Oncology; Internal medicine; Systemic therapy; Risk stratification; Stratification (seeds); Carcinoma; Cancer; Bladder cancer","score_opus":0.0880873230321215,"score_gpt":0.37543947145164697,"score_spread":0.2873521484195255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000596532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917074,0.0035006881,0.000053496304,0.00068510603,0.00024103685,0.0018860635,0.00014076945,0.00005257732,0.0017328608],"genre_scores_gemma":[0.9972942,0.00045477823,0.00071459555,0.0005230974,0.00038958614,0.00016560032,0.00008275227,0.000054420492,0.00032100856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980611,0.00017488401,0.0006944156,0.00032861164,0.00028319084,0.0004577517],"domain_scores_gemma":[0.99809194,0.00046581303,0.0005557532,0.00036207476,0.00034126404,0.00018317986],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029056435,0.00027148137,0.0008164931,0.00014039024,0.00006539486,0.000007174512,0.000155638,0.00023244943,0.0010471481],"category_scores_gemma":[0.00024828655,0.00022671078,0.00015822597,0.00019575171,0.00011024974,0.00018270836,0.00003055404,0.00017952806,0.00005290699],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002664476,0.0017452405,0.22730774,0.00026952723,0.0005362248,0.000010823821,0.0049758595,0.000002836545,0.59024173,0.00004115851,0.00013840574,0.17206597],"study_design_scores_gemma":[0.007996601,0.00963691,0.5678538,0.00059408444,0.00019832871,0.00008713518,0.00038722943,0.000057318375,0.4105167,0.00024681905,0.0021171567,0.00030792394],"about_ca_topic_score_codex":0.00016786702,"about_ca_topic_score_gemma":0.000013430851,"teacher_disagreement_score":0.34054604,"about_ca_system_score_codex":0.00009848196,"about_ca_system_score_gemma":0.0005681646,"threshold_uncertainty_score":0.999866},"labels":[],"label_agreement":null},{"id":"W3002208273","doi":"10.5489/cuaj.6101","title":"Emerging intravesical therapies for the management of bacillus Calmette–Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward","year":2020,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Context (archaeology); Salvage therapy; Clinical trial; Disease; Oncology; Intensive care medicine; Urology; Internal medicine; Surgery; Cancer; Chemotherapy","score_opus":0.030196979810983186,"score_gpt":0.30679897342119766,"score_spread":0.2766019936102145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002208273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002568199,0.9783526,0.00041499498,0.016633306,0.0006950574,0.0024848552,0.0007412684,0.000023814178,0.0003972863],"genre_scores_gemma":[0.004654387,0.9902077,0.0002935532,0.002562034,0.0013617778,0.00049915933,0.00005542116,0.00006537394,0.0003006393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970099,0.00026544862,0.00096350047,0.00042746624,0.00056602136,0.0007676924],"domain_scores_gemma":[0.99682957,0.0008356104,0.0010777907,0.00021304161,0.00037062643,0.00067337323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070924795,0.00047396717,0.0016231069,0.0002027243,0.00044611175,0.000084654246,0.00033891367,0.0004217911,0.00041665832],"category_scores_gemma":[0.0003952307,0.00029067745,0.0010207834,0.00040912718,0.0000673013,0.00006002029,0.000049267368,0.0009876854,0.000018976802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008963871,0.00004161656,0.0003506038,0.0011428184,0.0058674966,0.0002468142,0.0006308884,0.000005541135,0.0000014192885,0.00010902237,0.0037631793,0.98775095],"study_design_scores_gemma":[0.0013561163,0.0006668335,0.0025587855,0.001794126,0.005416825,0.0000883801,0.00045780413,0.000045299377,0.0000021930282,0.00016413225,0.9871648,0.00028470406],"about_ca_topic_score_codex":0.0006539856,"about_ca_topic_score_gemma":0.0003594008,"teacher_disagreement_score":0.9874663,"about_ca_system_score_codex":0.0019068313,"about_ca_system_score_gemma":0.002102849,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W3003052912","doi":"10.1111/bju.15007","title":"Modifiable lifestyle behaviours impact the health‐related quality of life of bladder cancer survivors","year":2020,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research; University Health Network; University of Toronto; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Bladder cancer; Quality of life (healthcare); Gerontology; Medicine; Cancer; Psychology; Internal medicine; Nursing","score_opus":0.04431360848915898,"score_gpt":0.3389086302881094,"score_spread":0.2945950217989504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003052912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96439725,0.023973929,0.000052809646,0.010672213,0.00023380031,0.00022419183,0.00019772316,0.000008085543,0.00023998672],"genre_scores_gemma":[0.99564123,0.001964973,0.000044373028,0.0021040118,0.0001639047,0.0000036438266,0.0000071929935,0.000022602135,0.00004808526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977885,0.00037686303,0.0010902204,0.00014028359,0.0003400145,0.00026411115],"domain_scores_gemma":[0.99808615,0.00013004417,0.00097175303,0.00013838377,0.0003298689,0.00034379069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000603051,0.00012585295,0.00087246305,0.000053620206,0.0000532649,0.000007165835,0.00017338539,0.000116500305,0.0008464503],"category_scores_gemma":[0.00027918635,0.00009815363,0.0003081266,0.00022344795,0.00019618856,0.00006739007,0.000030510948,0.0004392366,0.0000023610962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007318964,0.0017444737,0.9222133,0.00032800026,0.0040102787,0.00050321437,0.0034317698,0.0033336594,0.002082792,0.000080062106,0.028022083,0.026931373],"study_design_scores_gemma":[0.0072934395,0.00595809,0.9826033,0.000121698155,0.00056724605,0.001628061,0.0002964929,0.00014389966,0.00035346716,0.00015853415,0.0007324564,0.00014329201],"about_ca_topic_score_codex":0.044904057,"about_ca_topic_score_gemma":0.0008032227,"teacher_disagreement_score":0.06038999,"about_ca_system_score_codex":0.00004974506,"about_ca_system_score_gemma":0.0010547783,"threshold_uncertainty_score":0.961456},"labels":[],"label_agreement":null},{"id":"W3003349858","doi":"10.1016/j.eururo.2020.01.019","title":"Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Atezolizumab; Oncology; Urothelial carcinoma; Biomarker; Bladder cancer; Internal medicine; Clinical trial; Cancer; Immunotherapy","score_opus":0.07430930771093772,"score_gpt":0.34230889060095676,"score_spread":0.267999582890019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003349858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57148904,0.0017796877,0.000007756038,0.4062392,0.00079506653,0.0022170062,0.00018562053,0.000038841987,0.017247759],"genre_scores_gemma":[0.7018285,0.0002649983,0.000023622772,0.2959174,0.0014572116,0.00001952812,0.00024889436,0.00006817851,0.00017168217],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99434865,0.0028667627,0.0011976918,0.0008306634,0.00031299592,0.00044321833],"domain_scores_gemma":[0.9981814,0.0007230452,0.00026345134,0.00070479943,0.00004020047,0.00008711906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085717026,0.00038890756,0.0015751048,0.0005582336,0.000036378762,0.000020325382,0.00038657835,0.0003622953,0.00021167481],"category_scores_gemma":[0.0003368096,0.00026287363,0.00037979684,0.0008202978,0.0003463928,0.000026285545,0.00014439685,0.0017687922,0.00005348359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15663706,0.0020267386,0.13604346,0.00027796294,0.0068940576,0.06918358,0.0047407458,0.00003256252,0.00009153325,0.000017098495,0.5949587,0.029096462],"study_design_scores_gemma":[0.10793027,0.006520469,0.45949173,0.000039882812,0.005760133,0.000080443366,0.000051357303,0.00033038342,0.000003856607,0.000011823483,0.41941583,0.00036379535],"about_ca_topic_score_codex":0.00046290108,"about_ca_topic_score_gemma":0.00011759078,"teacher_disagreement_score":0.32344827,"about_ca_system_score_codex":0.00004175431,"about_ca_system_score_gemma":0.0001956518,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W3003732818","doi":"10.1016/j.ejca.2019.12.019","title":"Is it time to redefine cisplatin ineligibility in metastatic urothelial cancer?","year":2020,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Carboplatin; Oxaliplatin; Cisplatin; Medicine; Oncology; Internal medicine; Chemotherapy; Urology; Cancer; Colorectal cancer","score_opus":0.05733706939636016,"score_gpt":0.34325992382897896,"score_spread":0.2859228544326188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003732818","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003532185,0.004242716,0.000044233846,0.9764146,0.0008119542,0.0007346648,0.00068049424,0.000023687291,0.0135154165],"genre_scores_gemma":[0.00811605,0.001034984,0.0007466493,0.96082234,0.00926335,0.000030669005,0.00003132682,0.00023375078,0.01972089],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610615,0.0004842645,0.0013627488,0.0005391044,0.0010193258,0.0004884174],"domain_scores_gemma":[0.99804455,0.00008257234,0.00070577266,0.00042807576,0.00038024012,0.0003587959],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00050051406,0.0005382537,0.0013798261,0.0003689143,0.000044305434,0.000052822837,0.00041574132,0.00009334793,0.010193258],"category_scores_gemma":[0.00017254581,0.0004270034,0.0004364266,0.000490851,0.00007088969,0.00009241892,0.00009427627,0.0020790522,0.00090533623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011228621,0.00006717285,0.00078173756,0.00026290177,0.00063298526,0.008311397,0.00090640335,0.000033838605,0.0006735288,1.4074871e-7,0.97144085,0.015766207],"study_design_scores_gemma":[0.0044313357,0.0012285667,0.0024282674,0.0017741187,0.0009790829,0.00015859406,0.000017297029,0.000016259379,0.00070461334,0.000019700941,0.98787796,0.00036418508],"about_ca_topic_score_codex":0.0002846257,"about_ca_topic_score_gemma":0.000032442804,"teacher_disagreement_score":0.016437154,"about_ca_system_score_codex":0.00063909724,"about_ca_system_score_gemma":0.0012152259,"threshold_uncertainty_score":0.99987257},"labels":[],"label_agreement":null},{"id":"W3003749847","doi":"10.1007/s11912-020-0880-5","title":"Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions","year":2020,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Clinical trial; Quality of life (healthcare); Oncology; Cancer; Internal medicine","score_opus":0.14453638867600485,"score_gpt":0.4703635494230795,"score_spread":0.32582716074707463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003749847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000143631905,0.9888855,0.000068215406,0.00093226443,0.0036919017,0.005360774,0.00035193568,0.000111903566,0.00058313226],"genre_scores_gemma":[0.00002946308,0.9934553,0.00014440794,0.00020834633,0.0010980532,0.0042419676,0.0005986886,0.00008099413,0.0001428171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970103,0.00019456366,0.0010869682,0.0010679149,0.00023161974,0.00040866435],"domain_scores_gemma":[0.9975688,0.00030085968,0.0009925807,0.00047265925,0.0002857732,0.00037933118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002347503,0.00060502166,0.002781438,0.000117568285,0.0001539388,0.000019938594,0.000089254325,0.0004230367,0.00014961595],"category_scores_gemma":[0.00027958985,0.0004439566,0.00054249325,0.00026629996,0.00019502582,0.00007617888,0.000055128072,0.00050571933,0.00000501666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081248596,0.0005233554,0.00017041591,0.0067478823,0.0007120779,0.00029973077,0.00011891232,8.15298e-8,6.874057e-7,0.000022859,0.00344019,0.98788255],"study_design_scores_gemma":[0.0015604981,0.0011637241,0.00011931638,0.0046589766,0.0036839892,0.0006984612,0.00001778651,4.3982337e-7,0.0000052980317,0.00035161874,0.98743826,0.0003016454],"about_ca_topic_score_codex":0.00002715186,"about_ca_topic_score_gemma":0.00005286744,"teacher_disagreement_score":0.9875809,"about_ca_system_score_codex":0.00071003137,"about_ca_system_score_gemma":0.006342853,"threshold_uncertainty_score":0.9998012},"labels":[],"label_agreement":null},{"id":"W3004941033","doi":"10.1016/j.eururo.2019.12.014","title":"Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia; University of Toronto; University Health Network; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Novo Nordisk Fonden","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Internal medicine","score_opus":0.015225321649509477,"score_gpt":0.25063531271796263,"score_spread":0.23540999106845314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004941033","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13428795,0.008033522,0.00012996176,0.82254964,0.0024081476,0.004989732,0.0011140013,0.00026729304,0.026219761],"genre_scores_gemma":[0.19021031,0.0007901728,0.00025169918,0.7972032,0.004605273,0.0002250257,0.000278799,0.0003309223,0.0061046174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942772,0.0017720651,0.0010256871,0.0014860075,0.00052300585,0.0009160296],"domain_scores_gemma":[0.9972287,0.0006457712,0.0004893259,0.0011166504,0.00023054505,0.00028903017],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005003453,0.00078808627,0.0012945448,0.0004249543,0.000119639015,0.000043872406,0.0006876661,0.00031466523,0.00072123605],"category_scores_gemma":[0.00047513703,0.00060993124,0.00036968666,0.0005977445,0.00023692336,0.000033036988,0.00029089427,0.0017992109,0.00096720416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014587715,0.00011869054,0.0037032363,0.00033059818,0.0007234824,0.017825983,0.0025559196,0.000051050116,0.0011081279,0.0000024828132,0.9680652,0.0040564598],"study_design_scores_gemma":[0.002364651,0.0025915343,0.1032115,0.00020491095,0.0011829747,0.00046693813,0.000064908665,0.000012502111,0.00022348533,0.0000085670645,0.8891629,0.0005051292],"about_ca_topic_score_codex":0.002138361,"about_ca_topic_score_gemma":0.0009690179,"teacher_disagreement_score":0.09950826,"about_ca_system_score_codex":0.00025561202,"about_ca_system_score_gemma":0.00036972685,"threshold_uncertainty_score":0.99981064},"labels":[],"label_agreement":null},{"id":"W3004971171","doi":"10.1016/j.clgc.2020.01.007","title":"Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Oncology; Internal medicine; Odds ratio; Proportional hazards model; Chemotherapy; Cancer; Adenocarcinoma; Neoadjuvant therapy; Urology; Population; Gastroenterology; Confidence interval","score_opus":0.038623644687281564,"score_gpt":0.32093572236471685,"score_spread":0.28231207767743527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004971171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453027,0.010730872,0.00004443587,0.0018921322,0.0005007806,0.0018806728,0.00023731754,0.000055109653,0.00012839679],"genre_scores_gemma":[0.9923326,0.0031820037,0.00033826602,0.0022242356,0.0009356408,0.0006631669,0.000017034337,0.000072389674,0.0002346981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971512,0.0001564357,0.0006725659,0.0010350815,0.00049460196,0.0004901471],"domain_scores_gemma":[0.99870384,0.000119488504,0.00014166207,0.0002830805,0.00013754863,0.00061437476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017481546,0.00046292273,0.00091361447,0.000077388766,0.0001328521,0.000041640673,0.00012482876,0.00019918136,0.00060263945],"category_scores_gemma":[0.00002034525,0.00033440633,0.000103855884,0.00032242085,0.00038120753,0.0001473378,0.00010544211,0.00061830535,0.000008624474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012273432,0.0033201217,0.9662266,0.00012631314,0.00029252385,0.00072040677,0.0009080798,0.000058155707,0.00002764491,0.0000011406124,0.00036175505,0.015683841],"study_design_scores_gemma":[0.0510969,0.0035620704,0.93706495,0.00013182669,0.000311814,0.00000838526,0.00016558084,0.00021266997,0.000041719464,0.0000029835867,0.0069962675,0.0004048233],"about_ca_topic_score_codex":0.0011031087,"about_ca_topic_score_gemma":0.0005328843,"teacher_disagreement_score":0.03882347,"about_ca_system_score_codex":0.00021368326,"about_ca_system_score_gemma":0.00064318546,"threshold_uncertainty_score":0.9999108},"labels":[],"label_agreement":null},{"id":"W3005116118","doi":"10.1200/jco.2020.38.15_suppl.e16656","title":"Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.","year":2020,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Western University; Ontario Clinical Oncology Group; McMaster University","funders":"","keywords":"Medicine; Neoadjuvant therapy; Meta-analysis; Immunotherapy; Internal medicine; Oncology; Renal cell carcinoma; Randomized controlled trial; Adverse effect; Hepatocellular carcinoma; Cancer; Surgery; Breast cancer","score_opus":0.10044782707395385,"score_gpt":0.47906806090004056,"score_spread":0.3786202338260867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005116118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009948163,0.99611527,0.0000015543403,0.0004196575,0.00005925852,0.0023405645,0.000019582594,0.0000034063644,0.000045889916],"genre_scores_gemma":[0.003581677,0.99572015,0.000055744058,0.00042637953,0.000076878285,0.00007088341,0.000010235963,0.000028778928,0.000029303132],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99087596,0.0040838844,0.004140191,0.00029997574,0.0004478405,0.00015214935],"domain_scores_gemma":[0.9913758,0.003653196,0.004306027,0.00025015874,0.0002144758,0.00020033619],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004032175,0.00038463253,0.024680763,0.00030257626,0.000018215476,0.000007839937,0.00011409245,0.0003489911,0.00007135587],"category_scores_gemma":[0.0009565577,0.00016268334,0.0024012055,0.0004489401,0.00014053294,0.000047037032,0.000024309036,0.0010079244,0.0000015548649],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010403256,0.001464195,0.0017184025,0.48696852,0.3866016,0.0007310411,0.00006793729,3.346674e-7,3.66383e-8,0.00000491287,0.000058156907,0.1119816],"study_design_scores_gemma":[0.008906308,0.08372608,0.0010507016,0.049797826,0.8407962,0.00021943408,0.000004149288,9.680547e-7,4.1072306e-7,0.000005222398,0.01533983,0.00015290867],"about_ca_topic_score_codex":0.0000120606655,"about_ca_topic_score_gemma":0.0000058028995,"teacher_disagreement_score":0.45419458,"about_ca_system_score_codex":0.00010557343,"about_ca_system_score_gemma":0.00052121683,"threshold_uncertainty_score":0.98979884},"labels":[],"label_agreement":null},{"id":"W3005196664","doi":"10.1055/s-0039-3402486","title":"Transitional Cell Carcinoma of the Bladder in Pediatric Patients: Where Do We Stand?","year":2020,"lang":"en","type":"article","venue":"Revista Urología Colombiana / Colombian Urology Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Transitional cell carcinoma; Etiology; Natural history; Presentation (obstetrics); Population; Ultrasonography; Urinary bladder; Carcinoma; Macroscopic hematuria; Surgery; Pathology; Internal medicine; Bladder cancer; Cancer","score_opus":0.011247728300530576,"score_gpt":0.22662036345148914,"score_spread":0.21537263515095856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005196664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482611,0.024976103,0.000045716533,0.02366682,0.0003320481,0.0010589793,0.00013419837,0.000026302378,0.0014987722],"genre_scores_gemma":[0.9939688,0.0023389705,0.00008499819,0.003040464,0.0003450617,0.000029190356,0.000008179092,0.000056235513,0.0001280904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965193,0.00058941595,0.001055802,0.0005513253,0.0006090082,0.0006751349],"domain_scores_gemma":[0.99811316,0.00015921563,0.0005388401,0.00037959273,0.00033470665,0.00047450373],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035223612,0.0003952373,0.0008760433,0.0002171599,0.00021056608,0.00004859598,0.00047334676,0.00038884796,0.0009910176],"category_scores_gemma":[0.00014246594,0.0003102691,0.00043897942,0.0008319557,0.0002926251,0.0001336599,0.000099049554,0.0013378296,0.000035407513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025918023,0.0010863664,0.97634864,0.00036423493,0.00014144763,0.00032154558,0.0008868077,0.00005202449,0.00019342905,0.00014184197,0.01624949,0.0016224007],"study_design_scores_gemma":[0.014953281,0.006384254,0.93032426,0.000048060076,0.0011420728,0.00027353148,0.00013155711,0.00009151569,0.00011702807,0.00024527073,0.045938887,0.00035025677],"about_ca_topic_score_codex":0.000010541405,"about_ca_topic_score_gemma":0.000023162002,"teacher_disagreement_score":0.046024323,"about_ca_system_score_codex":0.00018921604,"about_ca_system_score_gemma":0.0011468619,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W3005373687","doi":"10.1002/tbio.201900032","title":"Evaluation of a Ruthenium coordination complex as photosensitizer for PDT of bladder cancer: Cellular response, tissue selectivity and in vivo response","year":2020,"lang":"en","type":"article","venue":"Translational Biophotonics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Urothelium; In vivo; Photosensitizer; In vitro; Bladder cancer; Photodynamic therapy; Chemistry; Necrosis; Urinary bladder; Cancer research; Pathology; Urology; Cancer; Medicine; Internal medicine; Biology; Biochemistry","score_opus":0.06053916295309479,"score_gpt":0.3469826011168596,"score_spread":0.2864434381637648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005373687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289453,0.0006961943,0.00033871687,0.003767254,0.000032310858,0.001578972,0.0005208587,0.000013236191,0.00015794869],"genre_scores_gemma":[0.99843913,0.000026922426,0.0010731872,0.0002160316,0.000022919397,0.000102729355,0.000047197773,0.0000195422,0.000052324263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984429,0.00028158328,0.00032868353,0.0002547033,0.00056399876,0.00012816516],"domain_scores_gemma":[0.99883306,0.00032422916,0.000113983944,0.00010276844,0.00055213954,0.00007381568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010829293,0.00013365192,0.00032315886,0.00012174096,0.000034745994,0.000004471518,0.000036188532,0.00009976327,0.00036255416],"category_scores_gemma":[0.00018909825,0.00013348591,0.000064492895,0.00031469425,0.00008040115,0.000055575627,0.0000059067324,0.00007462198,0.0000013627538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034721877,0.00014880823,0.0011933243,0.000101389705,0.00012282922,0.0000020913624,0.0015027501,0.00028844835,0.96076465,0.000027685164,0.00007168286,0.0010544412],"study_design_scores_gemma":[0.0085652135,0.001002327,0.049234577,0.000057885532,0.0004993266,0.0000063712732,0.00007750305,0.030526506,0.9079449,0.00039398024,0.0015683499,0.00012304127],"about_ca_topic_score_codex":0.0001808366,"about_ca_topic_score_gemma":0.00006580908,"teacher_disagreement_score":0.05281975,"about_ca_system_score_codex":0.00008885688,"about_ca_system_score_gemma":0.0008986208,"threshold_uncertainty_score":0.5443398},"labels":[],"label_agreement":null},{"id":"W3006222801","doi":"10.1016/j.urolonc.2020.01.010","title":"Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Hazard ratio; Medicine; Confidence interval; Bladder cancer; Proportional hazards model; Internal medicine; Logistic regression; Cystectomy; Oncology; Menopause; Stage (stratigraphy); Odds ratio; Cancer; Chemotherapy; Gynecology; Biology","score_opus":0.023471895500540445,"score_gpt":0.3305486323638788,"score_spread":0.30707673686333836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006222801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422414,0.000104903535,0.000008215902,0.014559819,0.000025683034,0.0005404581,0.000059792226,0.000019996412,0.00045700706],"genre_scores_gemma":[0.9869166,0.000062855666,0.0033862563,0.00935662,0.000045776815,0.00007407054,0.000016592598,0.000015138027,0.000126106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910456,0.00008222812,0.00019245897,0.00028315565,0.00013536993,0.00020221554],"domain_scores_gemma":[0.99935156,0.00010365323,0.00007399713,0.00012165351,0.000053643937,0.00029551133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088621426,0.00016348329,0.00035336055,0.000107723994,0.000043657423,0.0000047945614,0.0000544961,0.00010585305,0.00017430636],"category_scores_gemma":[0.0000638708,0.000108508946,0.000041603584,0.00031250785,0.00018404474,0.000037209018,0.000014752528,0.00018023058,0.000007889184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01068225,0.0004118802,0.9806654,0.000008135918,0.00011163992,0.00003179995,0.0016452158,0.00027887692,0.00048130075,0.000030994077,0.0015905034,0.004062023],"study_design_scores_gemma":[0.0063644205,0.037077665,0.90386546,0.000057755664,0.00010800198,0.000007596859,0.000077456694,0.00008767061,0.0005541767,0.00009639305,0.051564675,0.000138742],"about_ca_topic_score_codex":0.00017741723,"about_ca_topic_score_gemma":0.000019133278,"teacher_disagreement_score":0.07679994,"about_ca_system_score_codex":0.00015951187,"about_ca_system_score_gemma":0.0004783036,"threshold_uncertainty_score":0.44248664},"labels":[],"label_agreement":null},{"id":"W3006345461","doi":"10.1111/vsu.13395","title":"Partial cystectomy with a bipolar sealing device in seven dogs with naturally occurring bladder tumors","year":2020,"lang":"en","type":"article","venue":"Veterinary Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Cystectomy; Medicine; Surgery; Absorbable suture; Urinary system; Urinary bladder; Clinical significance; Fibrous joint; Urine; Urology; Bladder cancer; Anatomy; Pathology; Internal medicine; Cancer","score_opus":0.045318544880979444,"score_gpt":0.27601583345596975,"score_spread":0.2306972885749903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006345461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724156,0.000987126,0.000047690817,0.000776904,0.000082777544,0.00041094553,0.000018270488,0.00014165988,0.0002930549],"genre_scores_gemma":[0.9969723,0.000018384491,0.00047450286,0.0021216462,0.0002290791,0.00006836894,0.000027877548,0.0000599993,0.00002780762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983819,0.00008078503,0.00030099077,0.0004560811,0.00033469015,0.00044556495],"domain_scores_gemma":[0.99924845,0.00011443655,0.00009033808,0.00022482531,0.000053989184,0.00026793766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013066482,0.00028974933,0.00053556205,0.00013975697,0.00006637825,0.000030134202,0.00007877576,0.000071277136,0.000086823675],"category_scores_gemma":[0.000027524527,0.00020929893,0.000089021145,0.0005425749,0.000055587894,0.00020820809,0.000048589452,0.00030425563,0.000027841626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012107214,0.00028516434,0.94827753,0.00081179413,0.0005606879,0.021105578,0.0030460781,0.00014850691,0.0066237664,0.000004295379,0.00032859086,0.0067007765],"study_design_scores_gemma":[0.023351632,0.01843514,0.7745954,0.007845906,0.001168918,0.013850471,0.0027710642,0.0026152728,0.014344501,0.0000115081875,0.1375164,0.0034938336],"about_ca_topic_score_codex":0.0003925499,"about_ca_topic_score_gemma":0.00003429879,"teacher_disagreement_score":0.1736822,"about_ca_system_score_codex":0.00007889702,"about_ca_system_score_gemma":0.00033969607,"threshold_uncertainty_score":0.85349625},"labels":[],"label_agreement":null},{"id":"W3006614516","doi":"10.1158/1078-0432.ccr-19-2230","title":"<i>Kdm6a</i> Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with <i>p53</i> Dysfunction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Macrophage; Inflammation; Macrophage polarization; Cancer; Cancer research; Bladder cancer; Medicine; Immunology; Biology; Internal medicine; In vitro; Genetics","score_opus":0.1170406606635378,"score_gpt":0.41247045517879666,"score_spread":0.29542979451525886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006614516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876932,0.003942709,0.000067228706,0.006265459,0.00013076574,0.0013080265,0.000086332,0.000060053848,0.00044623716],"genre_scores_gemma":[0.99438936,0.002740934,0.00006663723,0.001540396,0.0005143067,0.00039600974,0.00002515687,0.000052973774,0.00027421015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734056,0.00031886683,0.0005224121,0.0007046766,0.000632225,0.0004812663],"domain_scores_gemma":[0.998499,0.00025246307,0.0000871921,0.0002392982,0.000530819,0.00039127088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006222457,0.00021913236,0.000414595,0.00011921504,0.0002075975,0.000080087026,0.00011335042,0.00019806308,0.00039510295],"category_scores_gemma":[0.00042133956,0.00016244529,0.00004805306,0.000830104,0.00040632553,0.00021370733,0.00008814878,0.000858083,0.000022640123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033059546,0.0004470405,0.929139,0.0003669612,0.00013650686,0.00011870646,0.0010790424,0.00005781772,0.040491823,0.00012407283,0.0011613402,0.023571696],"study_design_scores_gemma":[0.01767585,0.0070774257,0.89126676,0.00094118295,0.0002996093,0.000030171095,0.0010878413,0.0011363607,0.07015791,0.00018189687,0.009386208,0.000758751],"about_ca_topic_score_codex":0.0012287514,"about_ca_topic_score_gemma":0.0012055468,"teacher_disagreement_score":0.037872247,"about_ca_system_score_codex":0.00019379522,"about_ca_system_score_gemma":0.0014094297,"threshold_uncertainty_score":0.6624327},"labels":[],"label_agreement":null},{"id":"W3006786257","doi":"10.1200/jco.2020.38.6_suppl.540","title":"Impact of histology and toxicities on outcomes of patients with muscle invasive bladder cancer receiving neoadjuvant chemotherapy.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Internal medicine; Oncology; Chemotherapy; Histology; Proportional hazards model; Stage (stratigraphy); Demographics; Cisplatin; Neoadjuvant therapy; Carcinoma; Urology; Cancer; Gastroenterology","score_opus":0.0835691232584176,"score_gpt":0.42929613441903136,"score_spread":0.3457270111606138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006786257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939038,0.00035939162,0.000013395449,0.004751657,0.00021420025,0.00018310867,0.000025854428,0.0000033114236,0.00054528104],"genre_scores_gemma":[0.9952593,0.00082419656,0.00044671146,0.003232327,0.00017947555,0.000002355848,0.0000013675335,0.000016543718,0.000037720463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816513,0.0001386333,0.0011643138,0.0001442787,0.00024564416,0.00014200476],"domain_scores_gemma":[0.99687827,0.0010066293,0.0014004754,0.00010139197,0.00037329254,0.00023996009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024257341,0.00013969507,0.0016155015,0.000068000496,0.000015224154,0.0000016978992,0.00008046626,0.00017541612,0.00029079427],"category_scores_gemma":[0.00087314454,0.00007828023,0.00030183184,0.00007608337,0.00026570886,0.000056849727,0.00002097335,0.00035633723,8.043031e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008509881,0.0011328176,0.9268531,0.000037150363,0.0014442151,0.000040348277,0.00075715897,0.0000149135885,0.0001435677,0.00000632486,0.00081397645,0.060246512],"study_design_scores_gemma":[0.013498597,0.046524346,0.9384671,0.00008810609,0.0004146114,0.000008161448,0.00009444801,0.000003933216,0.0002257778,0.000041106003,0.000572866,0.00006096898],"about_ca_topic_score_codex":0.00013084277,"about_ca_topic_score_gemma":0.000055446602,"teacher_disagreement_score":0.06018554,"about_ca_system_score_codex":0.00011064246,"about_ca_system_score_gemma":0.0012562457,"threshold_uncertainty_score":0.31921753},"labels":[],"label_agreement":null},{"id":"W3006974698","doi":"10.21037/tau.2020.02.10","title":"Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer","year":2020,"lang":"en","type":"review","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Cystectomy; Urology; Multimodal therapy; Radiation therapy; Regimen; Chemotherapy; Detrusor muscle; Urinary bladder; Surgery; Cancer; Radiology; Urinary system; Internal medicine","score_opus":0.08524418447247487,"score_gpt":0.38012866800571116,"score_spread":0.29488448353323626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006974698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031428863,0.98706955,0.000014849158,0.002503908,0.000062423074,0.009048568,0.00015962882,0.000014825903,0.00081199035],"genre_scores_gemma":[0.0032195412,0.9857589,0.000039871076,0.00062214554,0.00024645525,0.009893711,0.00014143928,0.000027156084,0.000050793096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834853,0.00025802414,0.0005331527,0.00045138123,0.00014018125,0.00026875336],"domain_scores_gemma":[0.9991044,0.00043456428,0.0001680363,0.00018622873,0.000033630957,0.00007314043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083849896,0.0003653545,0.0015288114,0.0001418872,0.00006179356,0.0000049733285,0.00010831955,0.00043322917,0.00027220225],"category_scores_gemma":[0.000008759042,0.00021764086,0.00028621775,0.00019501349,0.00025068058,0.000027910868,0.000008576013,0.00028609665,0.000009478445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006175795,0.0007645026,0.0028315678,0.002522556,0.001505074,0.0002635827,0.0018882607,0.0000085904485,0.0000029646856,0.00068816077,0.00006668453,0.98884046],"study_design_scores_gemma":[0.0031189348,0.0031084756,0.0044417926,0.0003403274,0.002585958,0.0003253716,0.00001182486,0.0000134624925,0.000002829279,0.0004869647,0.98539746,0.00016660625],"about_ca_topic_score_codex":0.00010004717,"about_ca_topic_score_gemma":0.0003023614,"teacher_disagreement_score":0.98867387,"about_ca_system_score_codex":0.000027211112,"about_ca_system_score_gemma":0.00055913324,"threshold_uncertainty_score":0.8875137},"labels":[],"label_agreement":null},{"id":"W3007024026","doi":"10.1200/jco.2020.38.15_suppl.e19390","title":"Resource utilization and cost efficacy analysis of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (DD-MVAC) versus gemcitabine-cisplatin (GC) as neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Bladder cancer; Chemotherapy; Cisplatin; Gemcitabine; Vinblastine; Urology; Oncology; Cancer","score_opus":0.20807854021477282,"score_gpt":0.48082730939563917,"score_spread":0.2727487691808663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007024026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855896,0.0016227978,0.0006833867,0.010074067,0.00033169522,0.00082219037,0.0000733214,0.000015893977,0.00078701193],"genre_scores_gemma":[0.9867214,0.0041151787,0.003781746,0.0043912837,0.0007205304,0.000021550577,0.0000274646,0.00004863826,0.00017221131],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965183,0.00034809325,0.0020193432,0.00043236834,0.00039629324,0.0002856106],"domain_scores_gemma":[0.99131733,0.005518064,0.0017829573,0.00019765299,0.0005986378,0.00058537547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011116443,0.00027959218,0.0022332103,0.00024584564,0.00007272135,0.000017231088,0.00013237091,0.00038233053,0.00036905057],"category_scores_gemma":[0.0045142393,0.0002088014,0.00050762296,0.0005858903,0.000271485,0.00011235039,0.000058378646,0.0005071433,0.0000020605955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120724715,0.0024666965,0.048509493,0.00027362467,0.016865758,0.00032537535,0.0032744317,0.00082019303,0.01163416,0.000112002745,0.009281975,0.7857116],"study_design_scores_gemma":[0.13602595,0.051127493,0.6799734,0.0003705666,0.02469022,0.00009113477,0.0012391951,0.00838068,0.005768701,0.00012938945,0.09164063,0.00056261284],"about_ca_topic_score_codex":0.0001282503,"about_ca_topic_score_gemma":0.00022155534,"teacher_disagreement_score":0.785149,"about_ca_system_score_codex":0.000104116516,"about_ca_system_score_gemma":0.0009992394,"threshold_uncertainty_score":0.85146743},"labels":[],"label_agreement":null},{"id":"W3007228526","doi":"10.1097/pas.0000000000001453","title":"Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Molecular pathology; Bladder cancer; Medicine; Immunohistochemistry; Genitourinary system; Pathology; Anatomical pathology; Surgical pathology; Cancer; Microsatellite instability; Carcinoma; Oncology; Cancer research; Internal medicine; Biology; Gene","score_opus":0.02833092077266008,"score_gpt":0.3051950642326525,"score_spread":0.27686414345999244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007228526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729109,0.0014233248,0.0011059606,0.023211475,0.0002851695,0.00030027906,0.00026880568,0.000011731005,0.0004823772],"genre_scores_gemma":[0.99224585,0.0014784684,0.0009557241,0.0050209155,0.0001960274,0.000023887094,0.000036434933,0.000027850032,0.000014862167],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99668336,0.0006925834,0.0012884658,0.0004340729,0.0005639705,0.0003375441],"domain_scores_gemma":[0.9959838,0.0005962085,0.0020361145,0.00041633012,0.0008022299,0.00016531773],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00061107735,0.00030322623,0.0013758255,0.000072747105,0.00006178074,0.0000048276306,0.00054505165,0.00019456104,0.00034189093],"category_scores_gemma":[0.00034448755,0.00018066028,0.00058043754,0.00033255838,0.0027609868,0.00004221292,0.00019360526,0.0007316252,0.000003484648],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0135319065,0.0010618682,0.0379502,0.000039167193,0.0024305345,0.038166415,0.0072923815,0.0009728651,0.8821616,0.0015628095,0.0014814805,0.013348753],"study_design_scores_gemma":[0.045593284,0.069340855,0.4036664,0.0005291597,0.007809903,0.09739769,0.013735392,0.0016215463,0.3389516,0.010326003,0.009226765,0.001801399],"about_ca_topic_score_codex":0.00013990552,"about_ca_topic_score_gemma":0.0000047672247,"teacher_disagreement_score":0.54321,"about_ca_system_score_codex":0.00008178831,"about_ca_system_score_gemma":0.00062527845,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W3007231702","doi":"10.1200/jco.2020.38.6_suppl.539","title":"Development of a composite biomarker-based calculator to predict the probability of pathologic complete response (pT0) after neoadjuvant pembrolizumab (pembro) in muscle invasive bladder cancer (MIBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Decipher Biosciences (Canada)","funders":"","keywords":"Medicine; Bladder cancer; Logistic regression; Oncology; Internal medicine; Cystectomy; Biomarker; Pembrolizumab; Stage (stratigraphy); Calculator; Cancer; Immunotherapy","score_opus":0.18666821107000617,"score_gpt":0.4288550273042523,"score_spread":0.24218681623424612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007231702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840162,0.0004103651,0.00021567255,0.014013603,0.0002759199,0.0009000577,0.00007365492,0.0000073812903,0.00008714112],"genre_scores_gemma":[0.98515123,0.000043376305,0.008798635,0.005771613,0.00014134996,0.000064278494,0.0000028448135,0.00001843094,0.000008229159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946062,0.0012610395,0.0030159694,0.00031354546,0.0005201964,0.00028304922],"domain_scores_gemma":[0.99537295,0.002089189,0.0013171205,0.00027884508,0.00050665106,0.00043524837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002690892,0.00021751125,0.0017255188,0.00012605944,0.000033738077,0.000004584924,0.00027582742,0.00026193392,0.00019083047],"category_scores_gemma":[0.0023887837,0.00012878371,0.0004414943,0.0003238925,0.00035817386,0.000049212453,0.00011891866,0.0005806772,0.0000058288633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33906293,0.006345473,0.49530917,0.00047341545,0.001339438,0.0019370398,0.0056558372,0.0005113572,0.07034704,0.000007258336,0.00105061,0.07796044],"study_design_scores_gemma":[0.015594091,0.010072596,0.96426934,0.00032506013,0.00034087952,0.000043063654,0.00014244809,0.00017215231,0.002109198,0.000035361947,0.006781601,0.000114197144],"about_ca_topic_score_codex":0.000072145485,"about_ca_topic_score_gemma":0.000296502,"teacher_disagreement_score":0.46896017,"about_ca_system_score_codex":0.000308795,"about_ca_system_score_gemma":0.0055606845,"threshold_uncertainty_score":0.98644155},"labels":[],"label_agreement":null},{"id":"W3007232749","doi":"10.1200/jco.2020.38.6_suppl.450","title":"Survival outcomes associated with different palliative systemic therapies (PSTs) in patients with metastatic bladder cancer (mBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of the Fraser Valley; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Regimen; Bladder cancer; Chemotherapy; Carboplatin; Cancer; Gastroenterology; Log-rank test; Surgery; Cisplatin; Survival analysis","score_opus":0.13027051627619174,"score_gpt":0.4303632811520404,"score_spread":0.3000927648758487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007232749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919122,0.0003549281,0.00007502558,0.0065549486,0.00038463093,0.000455643,0.000027984408,0.000011107766,0.00022352305],"genre_scores_gemma":[0.99619937,0.00028489716,0.00017263133,0.00303392,0.00018198288,0.00001851006,0.000006732984,0.00003000678,0.00007197588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968456,0.0006016333,0.0014532816,0.00022448016,0.000619275,0.00025573265],"domain_scores_gemma":[0.9962789,0.0013757182,0.0014224723,0.000109314205,0.00047267668,0.00034095487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051544845,0.00023708669,0.0022800833,0.00007052248,0.000026596457,0.000009356021,0.00012627247,0.00014906061,0.0001791141],"category_scores_gemma":[0.00078473636,0.000114193776,0.00023506666,0.00018401323,0.0001365938,0.00010354615,0.00002261287,0.00074104645,0.0000041190697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008813323,0.0023460882,0.9788666,0.000031822736,0.0043758294,0.00023999797,0.0008758308,0.00002791566,0.0000036213937,0.000010536464,0.00013030304,0.0042781387],"study_design_scores_gemma":[0.03420829,0.021225465,0.9422681,0.0002990372,0.0012043875,0.000004184514,0.00042249702,0.000016020811,0.0000073870438,0.000021016975,0.00020462353,0.000118990705],"about_ca_topic_score_codex":0.00006508891,"about_ca_topic_score_gemma":0.00048738084,"teacher_disagreement_score":0.036598492,"about_ca_system_score_codex":0.00033660216,"about_ca_system_score_gemma":0.0010813919,"threshold_uncertainty_score":0.4656687},"labels":[],"label_agreement":null},{"id":"W3007386821","doi":"10.21037/tau.2020.01.16","title":"Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy","year":2020,"lang":"en","type":"article","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pennsylvania State University; University of Pennsylvania","keywords":"Medicine; Perioperative; Complication; Quartile; Convalescence; Surgery; Logistic regression; Charlson comorbidity index; Retrospective cohort study; Internal medicine; Confidence interval","score_opus":0.043094132661543064,"score_gpt":0.33078106050628153,"score_spread":0.2876869278447385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007386821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849367,0.0023765848,0.0003550616,0.011595748,0.000070781934,0.00042343128,0.000014265545,0.000011369186,0.00021601726],"genre_scores_gemma":[0.9982929,0.0000139692265,0.000053185107,0.0015615894,0.000028512295,0.000022839726,0.000015459582,0.000005944047,0.00000555822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917555,0.00013690945,0.00026976792,0.00020414584,0.00009491764,0.0001186864],"domain_scores_gemma":[0.9996149,0.00017999522,0.000062224775,0.00005706841,0.000027949645,0.000057839337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047222158,0.00010661832,0.00041236126,0.000036352536,0.00008456351,0.0000041427097,0.00003942702,0.00013197427,0.000012139781],"category_scores_gemma":[0.0000142856425,0.00007322468,0.000049135306,0.000083178325,0.00023042274,0.00003774908,0.00001628904,0.00022404276,5.505361e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050352566,0.000050890703,0.9946178,0.00003428819,0.000124196,0.0000040573964,0.0024076412,0.00022109755,0.0008696568,0.00073036,0.0000052918217,0.00043120125],"study_design_scores_gemma":[0.0039916965,0.00044149475,0.9814967,0.0000107207625,0.00011430666,0.00004553563,0.00013508658,0.012987102,0.00003863697,0.00010635908,0.00058021396,0.000052137402],"about_ca_topic_score_codex":0.00006473575,"about_ca_topic_score_gemma":0.00002827505,"teacher_disagreement_score":0.013356202,"about_ca_system_score_codex":0.000005513727,"about_ca_system_score_gemma":0.000043395623,"threshold_uncertainty_score":0.29860157},"labels":[],"label_agreement":null},{"id":"W3007407981","doi":"10.5489/cuaj.6505","title":"Improving outcomes of radical cystectomy: A call for passive over active regionalization","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Internal medicine; Bladder cancer","score_opus":0.018471410423362693,"score_gpt":0.25790976733803905,"score_spread":0.23943835691467635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007407981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7825177,0.00030598312,0.009526976,0.20312631,0.0006153813,0.0016601128,0.0006483901,0.000070232774,0.0015289519],"genre_scores_gemma":[0.98722935,0.000012037913,0.0003569468,0.011801705,0.00037416836,0.000019039737,0.000033310553,0.000012230319,0.00016123259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897194,0.000064684624,0.00027927646,0.00015352851,0.00026813353,0.00026245476],"domain_scores_gemma":[0.9986331,0.00014898258,0.0002996361,0.000048317674,0.00027808314,0.0005918909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011430271,0.000106872205,0.00031756976,0.00006956263,0.00011370628,0.000019501518,0.00006426771,0.00018308732,0.00020599211],"category_scores_gemma":[0.0013266659,0.00008115269,0.00018785756,0.00012727827,0.000026098201,0.00007027466,0.000007266408,0.00023611171,0.0000045897696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070055836,0.00009035291,0.96969837,0.000031095136,0.00071534404,0.00006593308,0.000634946,0.000027012415,0.0006685812,0.0005547267,0.017546535,0.009266567],"study_design_scores_gemma":[0.0059806122,0.0012885389,0.9528325,0.000015104535,0.00035884333,0.000046391404,0.000081416794,0.00091066625,0.00032394988,0.00057216344,0.03743898,0.0001507858],"about_ca_topic_score_codex":0.0007642827,"about_ca_topic_score_gemma":0.00019855308,"teacher_disagreement_score":0.20471166,"about_ca_system_score_codex":0.00076171925,"about_ca_system_score_gemma":0.00076774356,"threshold_uncertainty_score":0.33093107},"labels":[],"label_agreement":null},{"id":"W3007515340","doi":"10.1177/0846537120902134","title":"Prevalence of Urologic Disease Among Patients Investigated for Hematuria With CT Urography","year":2020,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Malignancy; Microscopic hematuria; Pyelogram; Radiology; Urinary system; Gross hematuria; Odds ratio; Intravenous urography; Urology; Pathology; Internal medicine; Kidney","score_opus":0.014956599669554819,"score_gpt":0.23230224930022153,"score_spread":0.21734564963066672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007515340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995784,0.00034755058,0.000096014686,0.0024003787,0.00009892748,0.0005624875,0.0004633729,0.000013307787,0.00023398387],"genre_scores_gemma":[0.9981,0.00008044222,0.0005824595,0.0010008593,0.00009533886,0.000014493786,0.000045606423,0.000012457286,0.00006837938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990235,0.000074645315,0.00029664164,0.00014847801,0.00021765391,0.00023907995],"domain_scores_gemma":[0.9981371,0.00006431729,0.00051899697,0.00008647155,0.00037250516,0.0008205809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001655996,0.00011519913,0.00029103027,0.000113145914,0.00006719001,0.000009775555,0.00009863716,0.000056010973,0.000047278634],"category_scores_gemma":[0.00086337625,0.00008745545,0.00013252659,0.00019351889,0.00011265591,0.00007123885,0.000004331007,0.00015351406,8.22732e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002921018,0.00004093169,0.9932282,0.00014158216,0.00024217696,0.000023725315,0.0000960332,0.000026944363,0.000019304007,0.000031182662,0.005614683,0.00024314653],"study_design_scores_gemma":[0.002915191,0.0012880979,0.99409944,0.000073370684,0.00036225552,0.000008359083,0.000015207375,0.00005862033,0.00013215277,0.00017334573,0.0007934345,0.000080542304],"about_ca_topic_score_codex":0.00045331812,"about_ca_topic_score_gemma":0.000384565,"teacher_disagreement_score":0.0048212484,"about_ca_system_score_codex":0.00027322306,"about_ca_system_score_gemma":0.00075964583,"threshold_uncertainty_score":0.356633},"labels":[],"label_agreement":null},{"id":"W3007531526","doi":"10.1200/jco.2020.38.6_suppl.473","title":"Any regression of tumor (ART) within 12 weeks versus RECIST 1.1 response category as an intermediate endpoint to assess the activity of immune checkpoint inhibitors (ICIs) for metastatic urothelial carcinoma (mUC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Proportional hazards model; Internal medicine; Oncology; Population; Demographics; Progressive disease; Disease; Demography","score_opus":0.2078916644777719,"score_gpt":0.4648295088600726,"score_spread":0.2569378443823007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007531526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858753,0.00011289992,0.00028166958,0.010321622,0.0020862245,0.0009000611,0.000062516425,0.000009146307,0.00035054976],"genre_scores_gemma":[0.99602544,0.000041782936,0.0017580864,0.0010816213,0.0008966607,0.000049103168,0.0000038088772,0.00003935628,0.0001041208],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939322,0.001708856,0.0032092961,0.00031389738,0.0005607187,0.0002750186],"domain_scores_gemma":[0.9900885,0.0051092645,0.0032694498,0.0003709906,0.00055615476,0.0006056414],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006390733,0.00025878666,0.0020912585,0.00013851133,0.000057603484,0.000009883406,0.00035149485,0.00019311014,0.00010798648],"category_scores_gemma":[0.0152311595,0.00014764638,0.00089599885,0.00018245875,0.00037239274,0.00015575606,0.000121816,0.0009014981,0.000008162379],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85575235,0.0037574242,0.0043767933,0.00026420673,0.0012833707,0.00079799164,0.0030141675,0.000038986607,0.08334533,0.000057570465,0.0022525073,0.045059305],"study_design_scores_gemma":[0.059524383,0.2332974,0.27961552,0.00056547637,0.0035317985,0.00036723763,0.0029790981,0.00040805712,0.40508392,0.00047837198,0.013739456,0.00040931464],"about_ca_topic_score_codex":0.00012739499,"about_ca_topic_score_gemma":0.00007633059,"teacher_disagreement_score":0.796228,"about_ca_system_score_codex":0.0002086364,"about_ca_system_score_gemma":0.003354307,"threshold_uncertainty_score":0.993064},"labels":[],"label_agreement":null},{"id":"W3007533337","doi":"10.1200/jco.2020.38.6_suppl.533","title":"Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia; Decipher Biosciences (Canada)","funders":"","keywords":"Medicine; Oncology; Internal medicine; Bladder cancer; Cohort; Gene signature; Pembrolizumab; Immune system; Chemotherapy; Cancer; Immunology; Immunotherapy; Gene; Biology; Gene expression","score_opus":0.06356085146431742,"score_gpt":0.4128073460469631,"score_spread":0.3492464945826457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007533337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670132,0.0013109449,0.00004273956,0.030697808,0.00030351352,0.0005117115,0.00004396116,0.000011399656,0.00006471186],"genre_scores_gemma":[0.98211634,0.0006706146,0.0029274474,0.013619534,0.0004920116,0.000025195455,0.000004421511,0.000033726512,0.00011073573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597925,0.0008362058,0.0020438118,0.00035024685,0.00047490562,0.0003155858],"domain_scores_gemma":[0.9962129,0.0010796319,0.001500164,0.00020482516,0.00047819363,0.0005242715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016898885,0.0002538715,0.0021095204,0.00014833825,0.00002675325,0.00001103614,0.000163415,0.00048440957,0.00018700861],"category_scores_gemma":[0.0014095794,0.00016814261,0.0002608463,0.00025595853,0.000109553905,0.00013085776,0.000047855825,0.0009788293,0.000003840471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26408008,0.0026139733,0.6519737,0.00008919971,0.0010241248,0.0046881265,0.0037489664,0.0002785661,0.027018635,0.0000019000054,0.0005985089,0.04388422],"study_design_scores_gemma":[0.033072464,0.026401745,0.93539566,0.00013428596,0.00049008086,0.00014622192,0.0002932182,0.00006365036,0.0016139501,0.000028091832,0.0021928025,0.00016780365],"about_ca_topic_score_codex":0.00008998662,"about_ca_topic_score_gemma":0.00036049084,"teacher_disagreement_score":0.28342196,"about_ca_system_score_codex":0.00037982894,"about_ca_system_score_gemma":0.0014608215,"threshold_uncertainty_score":0.68566567},"labels":[],"label_agreement":null},{"id":"W3007839305","doi":"10.1200/jco.2020.38.6_suppl.439","title":"Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Nivolumab; Bladder cancer; Gemcitabine; Oncology; Internal medicine; Cisplatin; Population; Clinical endpoint; Urology; Chemotherapy; Cancer; Immunotherapy; Clinical trial","score_opus":0.1345553341513558,"score_gpt":0.4258172032994331,"score_spread":0.29126186914807733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007839305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097944,0.0022256991,0.00009624365,0.013247928,0.0010236787,0.00059194636,0.000117915006,0.000012771318,0.00170438],"genre_scores_gemma":[0.98820996,0.0043109055,0.0011087433,0.0037515846,0.0024220883,0.00002143213,0.000007028176,0.000039686023,0.00012854136],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948035,0.0005286764,0.0033125954,0.00046000083,0.00054683187,0.00034838973],"domain_scores_gemma":[0.99180573,0.0047534076,0.0023289751,0.00019578921,0.00040231625,0.0005137974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011953325,0.000272641,0.002179295,0.0001567116,0.00004582456,0.000015537356,0.0001902789,0.0004882414,0.00046431765],"category_scores_gemma":[0.0035212857,0.00021278678,0.0004003951,0.00031954932,0.00023620979,0.00019536314,0.00010235271,0.0011467232,0.000005146878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45334092,0.0044600107,0.18708995,0.00037612693,0.0063689207,0.0030640722,0.0068876487,0.0009832203,0.012744903,0.00003692832,0.011764814,0.3128825],"study_design_scores_gemma":[0.5792053,0.039410494,0.3563605,0.0018320879,0.003014193,0.000073159295,0.0017203215,0.0015261521,0.0019276545,0.0005731174,0.013783561,0.00057349005],"about_ca_topic_score_codex":0.002915338,"about_ca_topic_score_gemma":0.0071768356,"teacher_disagreement_score":0.312309,"about_ca_system_score_codex":0.00025711497,"about_ca_system_score_gemma":0.0045663374,"threshold_uncertainty_score":0.8677193},"labels":[],"label_agreement":null},{"id":"W3007860954","doi":"10.1200/jco.2020.38.6_suppl.484","title":"An open-label, multicenter, phase IIIb study of patients with urinary tract carcinoma (UTC) (STRONG): Interim safety results for fixed-dose durvalumab (D) monotherapy (module A).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Urology; Discontinuation; Chemotherapy; Internal medicine; Interim analysis; Clinical endpoint; Adverse effect; Oncology; Gastroenterology; Surgery; Cancer; Clinical trial; Immunotherapy; Pembrolizumab","score_opus":0.20180322045614688,"score_gpt":0.4996626713896408,"score_spread":0.297859450933494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007860954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944587,0.00009855132,0.00029936706,0.0019107376,0.0005424013,0.0022226563,0.00021209956,0.000010559441,0.00024497785],"genre_scores_gemma":[0.99464846,0.000065169676,0.0029678014,0.0015301746,0.0006358521,0.000026887794,0.000040641087,0.000044894354,0.000040129235],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9955455,0.00054226123,0.0028097678,0.00041725294,0.0004107829,0.0002744278],"domain_scores_gemma":[0.99553156,0.0007325672,0.0021002041,0.00035668627,0.0006605446,0.0006184381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011105133,0.00025470916,0.0019313489,0.00007749413,0.00006883527,0.000016541719,0.00046887068,0.0002045036,0.00006399906],"category_scores_gemma":[0.00066493265,0.00017040232,0.00019380002,0.00012354244,0.00012695634,0.0003165935,0.000076518685,0.00059403677,0.0000025717545],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56569445,0.169123,0.16018686,0.000044189477,0.0010138329,0.00042708006,0.0014083715,0.000012251602,0.00011922296,0.000001801632,0.0008558523,0.101113126],"study_design_scores_gemma":[0.25493985,0.4128189,0.32734615,0.000048291764,0.00055166736,0.000020660435,0.00040329524,0.00022524588,0.000059046903,0.000004420348,0.0034891025,0.00009336078],"about_ca_topic_score_codex":0.000070675014,"about_ca_topic_score_gemma":0.000030126945,"teacher_disagreement_score":0.31075457,"about_ca_system_score_codex":0.0001540012,"about_ca_system_score_gemma":0.0009854804,"threshold_uncertainty_score":0.6948805},"labels":[],"label_agreement":null},{"id":"W3008151045","doi":"10.1200/jco.2020.38.6_suppl.568","title":"Comprehensive targeted gene profiling to determine the genomic signature likely to drive progression of high-grade nonmuscle invasive bladder cancer to muscle invasive bladder cancer.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Regional Hospital; University of Windsor","funders":"Windsor Cancer Centre Foundation","keywords":"HRAS; Bladder cancer; Medicine; CDKN2A; Cancer research; PDGFRA; Cancer; Oncology; Neuroblastoma RAS viral oncogene homolog; Cystectomy; KRAS; Internal medicine; Colorectal cancer","score_opus":0.116224501610971,"score_gpt":0.4256094270890541,"score_spread":0.30938492547808305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008151045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9303068,0.0019299043,0.00016866504,0.06369559,0.0014293484,0.0022266016,0.00014741815,0.000020401929,0.0000752716],"genre_scores_gemma":[0.9347865,0.0010200217,0.011388853,0.049444597,0.0030359735,0.00017200311,0.000010530024,0.00007034757,0.00007120511],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99545115,0.00046470185,0.0022262265,0.0006017778,0.00070933206,0.0005468282],"domain_scores_gemma":[0.99375415,0.0016021312,0.0014502666,0.0003614773,0.0014488015,0.0013831592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004930488,0.00040421454,0.0021259428,0.00017615387,0.00011784648,0.000019508336,0.00054450496,0.0004657772,0.00035933268],"category_scores_gemma":[0.0018489069,0.00025584866,0.00052719994,0.00061368314,0.00018909019,0.00011196136,0.00031845146,0.0012221244,0.00004039723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017646858,0.002118641,0.026760327,0.0002591541,0.0038949524,0.0014587124,0.008152946,0.0052208635,0.72382075,0.000014443331,0.032788035,0.17786431],"study_design_scores_gemma":[0.019952368,0.062774114,0.5585254,0.0011186652,0.0029057253,0.00013619958,0.0018516255,0.00012935018,0.306021,0.0001275354,0.04569031,0.0007677457],"about_ca_topic_score_codex":0.00039724,"about_ca_topic_score_gemma":0.00065723475,"teacher_disagreement_score":0.53176504,"about_ca_system_score_codex":0.00039977476,"about_ca_system_score_gemma":0.0043283636,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W3008187114","doi":"10.1200/jco.2020.38.6_suppl.tps586","title":"INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer—SWOG/NRG1806.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Atezolizumab; Gemcitabine; Clinical endpoint; Urology; Oncology; Radiation therapy; Chemoradiotherapy; Internal medicine; Surgery; Cancer; Randomized controlled trial; Immunotherapy; Pembrolizumab","score_opus":0.1448530786885959,"score_gpt":0.4884129881730352,"score_spread":0.34355990948443926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008187114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844101,0.0013304525,0.0006275542,0.009420285,0.001156857,0.0021966374,0.00001909332,0.000013204805,0.0008257903],"genre_scores_gemma":[0.9851748,0.007149054,0.00091928383,0.004861124,0.0016912039,0.00007287092,0.0000048932393,0.00003769667,0.00008909143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99453354,0.00080872525,0.0035203344,0.00030890846,0.0005387335,0.000289745],"domain_scores_gemma":[0.9938902,0.0021926155,0.0027090958,0.00018182836,0.00044739596,0.0005788103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016703134,0.0002801911,0.005781233,0.00012481287,0.000023184708,0.000008453324,0.00020653955,0.00033918556,0.001144224],"category_scores_gemma":[0.002200655,0.00015489798,0.0006798873,0.0003021377,0.0005378962,0.00011294335,0.00003034441,0.0009172978,0.0000041596345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91000307,0.004194538,0.0014322298,0.000060891467,0.0016948265,0.0006529944,0.0014584005,0.000014124408,0.00019079496,0.000013654351,0.0010686568,0.07921584],"study_design_scores_gemma":[0.9284101,0.057919323,0.00028428953,0.00028877702,0.0011761758,0.00008818666,0.00037487084,0.00031212933,0.0009265507,0.000033855522,0.010035852,0.00014988336],"about_ca_topic_score_codex":0.00028170628,"about_ca_topic_score_gemma":0.0003138692,"teacher_disagreement_score":0.079065956,"about_ca_system_score_codex":0.00023983885,"about_ca_system_score_gemma":0.006780996,"threshold_uncertainty_score":0.99976885},"labels":[],"label_agreement":null},{"id":"W3008352064","doi":"10.1200/jco.2020.38.6_suppl.508","title":"Perioperative chemotherapy for upper tract urothelial carcinoma: A microsimulation Markov model.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Perioperative; Chemotherapy; Bladder cancer; Adverse effect; Gemcitabine; Surgery; Oncology; Internal medicine; Cancer; Urology","score_opus":0.12890917517578315,"score_gpt":0.45625398058955896,"score_spread":0.3273448054137758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008352064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391284,0.00039289054,0.0099007,0.04652328,0.00062674657,0.0008058721,0.00003689475,0.000013929892,0.0025712573],"genre_scores_gemma":[0.96043175,0.00016311923,0.016929109,0.019751098,0.0023547371,0.000011280843,0.0000057038233,0.000029086961,0.0003241134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798524,0.00012307739,0.0013098106,0.00019741821,0.00020391957,0.00018050443],"domain_scores_gemma":[0.9980063,0.0005254107,0.0006037575,0.000092822054,0.00040530215,0.0003664112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060160854,0.00014621892,0.0011114891,0.00004217805,0.000047000758,0.000010751672,0.00009712764,0.0002814491,0.0002074854],"category_scores_gemma":[0.0007443451,0.000101086385,0.0006776687,0.0000649116,0.00009107398,0.00010673893,0.000011929561,0.00046369046,0.000006191904],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15534279,0.009341117,0.2334025,0.00023662516,0.0021053848,0.0005567523,0.0073760278,0.0012932773,0.02812759,0.00026930115,0.02850378,0.5334448],"study_design_scores_gemma":[0.19107729,0.1272055,0.2751569,0.00014550511,0.0026476078,0.0006055811,0.0006900015,0.10162656,0.008465851,0.0006820364,0.2910518,0.00064537703],"about_ca_topic_score_codex":0.0000054278275,"about_ca_topic_score_gemma":0.0000015168754,"teacher_disagreement_score":0.5327995,"about_ca_system_score_codex":0.00011573619,"about_ca_system_score_gemma":0.0019229909,"threshold_uncertainty_score":0.41221833},"labels":[],"label_agreement":null},{"id":"W3008517425","doi":"10.1016/j.urolonc.2020.02.008","title":"Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Proportional hazards model; Urology; Odds ratio; Metastatic Urothelial Carcinoma; Internal medicine; Bladder cancer; Urothelial carcinoma; Oncology; Gastroenterology; Cancer","score_opus":0.02105563623263535,"score_gpt":0.2806656774549817,"score_spread":0.2596100412223464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008517425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991946,0.00068566133,0.000041813466,0.0043615154,0.000013215074,0.0007231747,0.00004661359,0.000033775723,0.0021482455],"genre_scores_gemma":[0.98631257,0.00008662297,0.011161495,0.0020392854,0.00007839996,0.00017549888,0.000049438,0.000014833197,0.00008188418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989905,0.00013381813,0.00024125073,0.0002954389,0.00010273416,0.00023627175],"domain_scores_gemma":[0.9994025,0.00012963053,0.00008558015,0.000090809124,0.000057689067,0.00023374097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007540964,0.00017816969,0.0003842592,0.00008022863,0.00007272371,0.000011029153,0.00005600916,0.00015192205,0.000098960845],"category_scores_gemma":[0.000092920665,0.00013337229,0.000038489914,0.000264544,0.00038999773,0.00008979342,0.000015299496,0.0002582848,0.0000042747565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005826462,0.0002671766,0.9914481,0.000028726487,0.000053453474,0.00023520744,0.0027553309,0.000033352713,0.0032527887,0.0004935008,0.00013168229,0.00071801717],"study_design_scores_gemma":[0.007275635,0.024176825,0.8952673,0.00013745787,0.000840666,0.0010087268,0.0012727949,0.0030384623,0.0149228,0.0010561427,0.050677314,0.00032587556],"about_ca_topic_score_codex":0.00034520432,"about_ca_topic_score_gemma":0.000064833686,"teacher_disagreement_score":0.09618082,"about_ca_system_score_codex":0.00008716649,"about_ca_system_score_gemma":0.0006469531,"threshold_uncertainty_score":0.5438764},"labels":[],"label_agreement":null},{"id":"W3008645455","doi":"10.1016/j.urolonc.2020.01.007","title":"A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; University Health Network; University of Toronto; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Urological Association","keywords":"Medicine; Bladder cancer; Urine; Receiver operating characteristic; Biomarker; Cancer; Urinary system; Methylation; Logistic regression; Internal medicine; Oncology; Urology; Area under the curve; DNA methylation; Gene; Biology; Gene expression; Genetics","score_opus":0.09088514481609229,"score_gpt":0.35365624715395694,"score_spread":0.26277110233786466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008645455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8981904,0.0036050826,0.00045718506,0.09612739,0.00013924566,0.0007702467,0.00012900068,0.00008463119,0.0004968288],"genre_scores_gemma":[0.93537027,0.0014885177,0.02790302,0.033693716,0.00026610505,0.0007973774,0.000060141912,0.000037140355,0.00038369233],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986723,0.00008960863,0.00024966203,0.0005202269,0.00015354971,0.00031462568],"domain_scores_gemma":[0.99893993,0.00015782756,0.00010415455,0.00012974202,0.000077006116,0.0005913629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102029495,0.00025759634,0.00039789523,0.000119302495,0.00021463433,0.000025232439,0.00006733514,0.0001828784,0.00018007385],"category_scores_gemma":[0.000113251655,0.00020369368,0.00005627266,0.00034670712,0.00037665066,0.00008387623,0.000048161655,0.0002363281,0.000011599395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023095186,0.00047630322,0.7882869,0.00045007459,0.0011965676,0.0010429694,0.0074787308,0.00084232586,0.0634845,0.0013600278,0.021403136,0.11166891],"study_design_scores_gemma":[0.007015081,0.008035766,0.08145344,0.00022340208,0.0032484566,0.00027636735,0.0005607286,0.0056669656,0.03645312,0.0034340716,0.85280097,0.0008316337],"about_ca_topic_score_codex":0.00068136415,"about_ca_topic_score_gemma":0.00025791276,"teacher_disagreement_score":0.83139783,"about_ca_system_score_codex":0.00012781938,"about_ca_system_score_gemma":0.0005178424,"threshold_uncertainty_score":0.8306387},"labels":[],"label_agreement":null},{"id":"W3008651000","doi":"10.1200/jco.2020.38.6_suppl.532","title":"Comprehensive immune profiling of patients (pts) with metastatic urothelial cancer (mUC) or renal cell cancer (mRCC) receiving immune checkpoint inhibitors (CPIs).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Medicine; Immune system; Immune checkpoint; Granzyme B; CD8; Flow cytometry; Mass cytometry; Peripheral blood mononuclear cell; Immunology; T cell; Cancer; Cancer research; Chemokine; Oncology; Internal medicine; Immunotherapy; Biology; In vitro","score_opus":0.11514704566042708,"score_gpt":0.41860541265549617,"score_spread":0.3034583669950691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008651000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897622,0.0024512557,0.00013714888,0.00465758,0.0014199417,0.00078455656,0.00008612434,0.00001526741,0.00068593124],"genre_scores_gemma":[0.98843694,0.0022353067,0.005837224,0.0017336657,0.001433125,0.0000526345,0.000008114426,0.000062207124,0.00020081383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943586,0.0004735707,0.0036900495,0.00035794437,0.00072931795,0.00039049788],"domain_scores_gemma":[0.99344546,0.0010201402,0.0035699874,0.00021665277,0.0012193901,0.0005284018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076293544,0.00033447176,0.0026974403,0.000117085685,0.00006760364,0.000011031613,0.00024304829,0.0002503372,0.0009115686],"category_scores_gemma":[0.0010499371,0.00020209064,0.0006554061,0.00034610654,0.00031741842,0.000167898,0.00009569081,0.0012527166,0.000011203771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21225272,0.0128109865,0.4266485,0.002454424,0.009996143,0.0022080215,0.004157906,0.0014888543,0.08431797,0.000013643072,0.0031257079,0.24052511],"study_design_scores_gemma":[0.1168734,0.111263245,0.43974075,0.003200808,0.00874626,0.0001967734,0.0017222881,0.00045612338,0.27396703,0.000059541642,0.04281025,0.000963517],"about_ca_topic_score_codex":0.00048795683,"about_ca_topic_score_gemma":0.00007409496,"teacher_disagreement_score":0.23956159,"about_ca_system_score_codex":0.00031381784,"about_ca_system_score_gemma":0.0047672885,"threshold_uncertainty_score":0.9981037},"labels":[],"label_agreement":null},{"id":"W3008892941","doi":"10.1002/jso.25877","title":"Contemporary conditional cancer‐specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract","year":2020,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Urology; Cancer; Cohort; Upper urinary tract; Internal medicine; Urothelial carcinoma; Oncology; Gastroenterology; Urinary system; Confidence interval; Bladder cancer","score_opus":0.03200636631122202,"score_gpt":0.29400504752706397,"score_spread":0.26199868121584197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008892941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927926,0.0010999899,0.000032716347,0.0040143877,0.00022748261,0.0003555951,0.00014246367,0.0000049908103,0.0013297527],"genre_scores_gemma":[0.9982373,0.00016204955,0.00034047535,0.0007059937,0.00046622998,0.000018303255,0.000023354965,0.000025432593,0.000020864314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794227,0.00024421976,0.0008058186,0.00020601036,0.00056690926,0.00023474598],"domain_scores_gemma":[0.99872917,0.00024172109,0.0003822985,0.000089059795,0.00020120457,0.00035652108],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017749432,0.00020149676,0.0010132522,0.00014385326,0.000019392905,0.000005920618,0.00010363525,0.00013739872,0.0015181206],"category_scores_gemma":[0.000014124538,0.00013576404,0.00022414238,0.00019663642,0.00025044734,0.00014258134,0.00002487594,0.0005189948,0.0000075936364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043023963,0.0032388084,0.9433936,0.00006818277,0.00026897373,0.0070634857,0.0003595269,0.000010203844,0.00006727139,0.000015943646,0.0007492767,0.001740801],"study_design_scores_gemma":[0.031413455,0.016136194,0.8949344,0.00010918148,0.00015201836,0.00058638817,0.00007164011,0.00000802404,0.00010441119,0.00002311101,0.056332447,0.00012872205],"about_ca_topic_score_codex":0.000027854625,"about_ca_topic_score_gemma":0.000001221372,"teacher_disagreement_score":0.05558317,"about_ca_system_score_codex":0.00023209679,"about_ca_system_score_gemma":0.0010642812,"threshold_uncertainty_score":0.99939466},"labels":[],"label_agreement":null},{"id":"W3008910065","doi":"10.1200/jco.2020.38.15_suppl.tps5095","title":"PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible <i>FGFR3</i> alterations.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Clinical endpoint; Cisplatin; Placebo; Internal medicine; Oncology; Adjuvant therapy; Chemotherapy; Urology; Gastroenterology; Clinical trial; Adverse effect; Pathology","score_opus":0.0946758322408685,"score_gpt":0.4131305022468749,"score_spread":0.3184546700060064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008910065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869666,0.00033965628,0.00010684229,0.0034604971,0.00072285614,0.006678033,0.000015481819,0.000009146796,0.0017008563],"genre_scores_gemma":[0.99466467,0.00036142315,0.0005326117,0.002566164,0.0015261432,0.00023492666,0.000013489993,0.00003531886,0.00006528284],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99371123,0.0009143549,0.004030144,0.00032850594,0.00071180187,0.00030394635],"domain_scores_gemma":[0.9934306,0.002249958,0.0028269258,0.00021894685,0.0007914299,0.0004821165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021974037,0.00030954403,0.004449777,0.0002111215,0.00004818242,0.000020166914,0.00020712482,0.0003092438,0.00024219087],"category_scores_gemma":[0.0022287157,0.00018497702,0.0008392592,0.00027895486,0.00026913916,0.00022714336,0.000034323453,0.00093360373,0.0000070603587],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96345246,0.0075234375,0.014934134,0.000031642805,0.0012329362,0.00021845977,0.000899459,0.000042342428,0.00015988133,0.000038379,0.00023375361,0.0112331305],"study_design_scores_gemma":[0.8744915,0.12133954,0.0006259851,0.0001263217,0.0008436148,0.000017166345,0.000089184665,0.00005550363,0.0014992275,0.000045283865,0.0007286485,0.00013800744],"about_ca_topic_score_codex":0.00013027985,"about_ca_topic_score_gemma":0.00010052054,"teacher_disagreement_score":0.113816105,"about_ca_system_score_codex":0.00011695125,"about_ca_system_score_gemma":0.0049506314,"threshold_uncertainty_score":0.87822074},"labels":[],"label_agreement":null},{"id":"W3008920943","doi":"10.3233/blc-190262","title":"Does 5-alpha Reductase Inhibitor Use Improve The Efficacy of Intravesical Bacille Calmette-Guérin (BCG) for Non-muscle Invasive Bladder Cancer?","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Bladder cancer; Medicine; Concomitant; Proportional hazards model; Internal medicine; Urology; Cancer; Univariate analysis; Multivariate analysis; Oncology","score_opus":0.03247378600753348,"score_gpt":0.3002018281045135,"score_spread":0.26772804209698003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008920943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578053,0.001722711,0.00026089785,0.0299135,0.0019775736,0.0047970572,0.0028476417,0.00013051328,0.0005448055],"genre_scores_gemma":[0.9851823,0.0008475084,0.00049747655,0.0073056766,0.003556866,0.0014251454,0.00008192177,0.00013509455,0.00096803455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713284,0.00007278625,0.0006808269,0.0008557479,0.00056198554,0.0006958004],"domain_scores_gemma":[0.9977023,0.00047025498,0.00028315381,0.0006645627,0.000380866,0.0004988446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012549946,0.0005199928,0.000824839,0.00007918192,0.00020369171,0.00006424363,0.0003258394,0.00022239004,0.0010209221],"category_scores_gemma":[0.0003890155,0.00029013513,0.00042853816,0.00043296372,0.00036816133,0.00023599193,0.00014125112,0.00042478714,0.000025995645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011602038,0.0025055546,0.0155270435,0.0020265095,0.007198342,0.00018451626,0.019384554,0.00020292679,0.55988,0.00039217353,0.23665182,0.14444453],"study_design_scores_gemma":[0.027419027,0.0035965405,0.050821353,0.00069995207,0.0035004783,0.000012845992,0.0022056294,0.0007078798,0.8235049,0.00018851279,0.086094804,0.0012480243],"about_ca_topic_score_codex":0.002557335,"about_ca_topic_score_gemma":0.00056611665,"teacher_disagreement_score":0.26362497,"about_ca_system_score_codex":0.00024914963,"about_ca_system_score_gemma":0.0013328706,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W3009271488","doi":"10.1016/j.eururo.2020.02.028","title":"Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Pathological; Neoadjuvant therapy; Oncology; Complete response; Infiltration (HVAC); Subtyping; Immune system; Pathology; Internal medicine; Immunotherapy; Urology; Cancer; Chemotherapy; Immunology","score_opus":0.03256325318126531,"score_gpt":0.32039077979070874,"score_spread":0.28782752660944344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009271488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957488,0.0013027361,0.000031494714,0.0016560337,0.00004646742,0.00027032325,0.0000130203325,0.000025416575,0.00090570434],"genre_scores_gemma":[0.997897,0.00010781741,0.000048001613,0.0018557253,0.00003880657,0.0000073327724,0.0000072226962,0.00002807045,0.000010007671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986206,0.000461684,0.00030356174,0.0003144484,0.000097281896,0.00020237287],"domain_scores_gemma":[0.9995063,0.00013245438,0.00008138096,0.00014040372,0.000023085231,0.000116397714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021447575,0.00016609504,0.00036930738,0.00009003198,0.000028869319,0.000007752485,0.000047890644,0.000059844897,0.000047291836],"category_scores_gemma":[0.0003733322,0.00012916578,0.00009761216,0.000110809124,0.000075244505,0.000039144677,0.000055526358,0.00021035434,0.0000063729335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011594017,0.00016138016,0.52534825,0.000043897864,0.00023994602,0.0039558164,0.003024062,0.00021129145,0.44800174,0.00005329501,0.00002041067,0.007345894],"study_design_scores_gemma":[0.0044543887,0.0040735356,0.9898869,0.000026757441,0.00010665053,0.000057764613,0.000042800464,0.00006887431,0.0011262217,0.000018162877,0.0000372723,0.000100671954],"about_ca_topic_score_codex":0.000073886215,"about_ca_topic_score_gemma":0.000005786684,"teacher_disagreement_score":0.46453863,"about_ca_system_score_codex":0.000036758418,"about_ca_system_score_gemma":0.00007068415,"threshold_uncertainty_score":0.5267228},"labels":[],"label_agreement":null},{"id":"W3009410127","doi":"10.1016/j.eururo.2020.02.012","title":"Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non–muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Urology; Urinary bladder; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.045430518186591745,"score_gpt":0.34184871876276784,"score_spread":0.29641820057617607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009410127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047605998,0.98759264,0.00005900502,0.000549473,0.000500899,0.008634137,0.00025301616,0.0000386787,0.002324535],"genre_scores_gemma":[0.0012698031,0.9946877,0.00006262469,0.0021518266,0.00033384832,0.0006209341,0.00008950113,0.00023545288,0.0005483082],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994763,0.0015450512,0.0019161886,0.00078593334,0.00046852487,0.00052129553],"domain_scores_gemma":[0.9957772,0.0012378492,0.0013181012,0.0013077422,0.00016093283,0.00019815986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004983199,0.0007968829,0.0051489486,0.0001347815,0.00009717348,0.00001132602,0.0008503332,0.00021540925,0.00019738737],"category_scores_gemma":[0.00096914615,0.0004626907,0.0025047234,0.00049485045,0.00017162417,0.000039418017,0.0003040883,0.0004995363,0.00006578494],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085106934,0.00035034659,0.000015089887,0.87766653,0.01567316,0.00017525282,0.00031602898,8.1974844e-7,0.000033071447,0.00002044618,0.00091771694,0.1047464],"study_design_scores_gemma":[0.0055770003,0.002562177,0.000348414,0.6713171,0.14404091,0.00018646909,0.000033694785,0.000016574508,0.000058747297,0.00001588363,0.17514212,0.0007009256],"about_ca_topic_score_codex":0.000035033754,"about_ca_topic_score_gemma":0.0000066934763,"teacher_disagreement_score":0.20634949,"about_ca_system_score_codex":0.00018405364,"about_ca_system_score_gemma":0.0008089602,"threshold_uncertainty_score":0.9997825},"labels":[],"label_agreement":null},{"id":"W3009981521","doi":"10.3747/co.27.5713","title":"Complex Surgery and Perioperative Systemic Therapy for Genitourinary Cancer of the Retroperitoneum","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; St. Joseph’s Healthcare Hamilton; University of Ottawa; University Health Network; Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Cancer Care Ontario; McMaster University; Kingston General Hospital; Princess Margaret Cancer Centre; Western University; University of Toronto","funders":"","keywords":"Medicine; Systemic therapy; Guideline; Perioperative; Renal cell carcinoma; Lymph node; Nephrectomy; Cancer; Cystectomy; Dissection (medical); Adjuvant therapy; Surgery; General surgery; Bladder cancer; Oncology; Internal medicine; Breast cancer; Kidney; Pathology","score_opus":0.24496100058072753,"score_gpt":0.4219092636049703,"score_spread":0.17694826302424274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009981521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97456443,0.017205678,0.00002811575,0.006099241,0.0007891231,0.00097436126,0.000105607665,0.000015576557,0.00021785077],"genre_scores_gemma":[0.9956338,0.0029024608,0.00003584503,0.0006816375,0.0004580668,0.00021674976,0.000011205509,0.000013669053,0.000046556495],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935526,0.00007646015,0.0001864895,0.00017539944,0.00008044169,0.00012595418],"domain_scores_gemma":[0.9995601,0.000084200066,0.00007813276,0.00010049218,0.00010272045,0.000074351505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048434977,0.00010159703,0.00038369192,0.000017592596,0.000064241794,0.0000035026533,0.000052245963,0.000047239235,0.00007995379],"category_scores_gemma":[0.000029491404,0.000060128907,0.00009934821,0.00007556316,0.00012326347,0.000019075573,0.00003089684,0.000094979594,0.0000011733111],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044931504,0.0007734276,0.67315775,0.0013338097,0.00053211924,0.000016143451,0.007551364,0.000004441004,0.078430936,0.00012594473,0.026088847,0.20749208],"study_design_scores_gemma":[0.0111591015,0.005375938,0.35620016,0.00054029556,0.00048481172,0.00022630478,0.0015972309,0.0007297134,0.017026696,0.000026870275,0.6062838,0.00034908688],"about_ca_topic_score_codex":0.000027089756,"about_ca_topic_score_gemma":0.0000050604476,"teacher_disagreement_score":0.58019495,"about_ca_system_score_codex":0.00007981591,"about_ca_system_score_gemma":0.00034694409,"threshold_uncertainty_score":0.24519856},"labels":[],"label_agreement":null},{"id":"W3010820367","doi":"10.1016/j.eururo.2020.02.031","title":"Converging Roads to Early Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"Novo Nordisk Fonden","keywords":"Medicine; Bladder cancer; Urothelial cancer; Urology; General surgery; Cancer; Internal medicine","score_opus":0.030506977357041894,"score_gpt":0.28321182134739903,"score_spread":0.25270484399035714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010820367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8172153,0.00074554933,0.00064334663,0.048704594,0.00051418203,0.0004435408,0.000022994936,0.00025354038,0.13145696],"genre_scores_gemma":[0.9322641,0.000028165767,0.00013222062,0.06530185,0.0007496615,0.000011485314,0.000005256655,0.000051116833,0.0014561316],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904335,0.00009818643,0.00015336473,0.00032392537,0.000111808564,0.00026936847],"domain_scores_gemma":[0.9994022,0.000016732773,0.00002919072,0.00017414376,0.000040546638,0.00033718933],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054658496,0.00013613624,0.00020850608,0.00004072583,0.000042600757,0.0000106832695,0.000101868514,0.000029237035,0.0015023843],"category_scores_gemma":[0.000040484458,0.00011869509,0.00005935971,0.00014393867,0.000037683174,0.000028563762,0.0000736828,0.00015678961,0.0026649446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059634973,0.00047986026,0.50622284,0.0001359173,0.0020336316,0.006174069,0.026721418,0.00038982308,0.056576002,0.00088900124,0.25583798,0.13857596],"study_design_scores_gemma":[0.0033138117,0.0025547135,0.37290168,0.000011251216,0.00027737577,0.000051813888,0.000049681712,0.000090446556,0.001667137,0.0000126189625,0.6188296,0.00023985791],"about_ca_topic_score_codex":0.000077703095,"about_ca_topic_score_gemma":0.0000049810105,"teacher_disagreement_score":0.3629916,"about_ca_system_score_codex":0.00002135235,"about_ca_system_score_gemma":0.000052399082,"threshold_uncertainty_score":0.9994104},"labels":[],"label_agreement":null},{"id":"W3011222032","doi":"10.1016/j.eururo.2020.03.005","title":"Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Resection; Bladder cancer; Urology; Diligence; Cystoscopy; Cancer; Surgery; Urinary system; Internal medicine","score_opus":0.022359662781911573,"score_gpt":0.2784904849868241,"score_spread":0.2561308222049125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011222032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8810346,0.0026809145,0.000047236652,0.10586715,0.00011411717,0.0008458427,0.000011067061,0.00006162645,0.009337444],"genre_scores_gemma":[0.9925682,0.00020822928,0.000018039298,0.00682562,0.00018768212,0.00005702241,0.000006152638,0.00003420354,0.000094857576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984295,0.00049748085,0.00031233334,0.00031079075,0.00016106103,0.00028883826],"domain_scores_gemma":[0.99951255,0.0000749602,0.00007861167,0.00023903127,0.000054880657,0.000039979383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019123404,0.00015841727,0.00027435762,0.00013388135,0.00004410141,0.000005571669,0.00026019372,0.00009749003,0.00021913798],"category_scores_gemma":[0.00015393848,0.000092375376,0.000057559148,0.00093638845,0.00021440275,0.000031731746,0.00003407111,0.0006685448,0.000032413678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021414323,0.0026136772,0.5257542,0.0005609175,0.0015364664,0.0032741583,0.102991685,0.0017942279,0.2543805,0.0016950647,0.044474613,0.03951014],"study_design_scores_gemma":[0.010803087,0.005261738,0.94301337,0.00006584578,0.00041774163,0.0003620855,0.0019371622,0.00067045056,0.0059776357,0.00032154296,0.030871436,0.00029788903],"about_ca_topic_score_codex":0.00012165838,"about_ca_topic_score_gemma":0.00059639965,"teacher_disagreement_score":0.41725916,"about_ca_system_score_codex":0.000026363328,"about_ca_system_score_gemma":0.00012521031,"threshold_uncertainty_score":0.37669587},"labels":[],"label_agreement":null},{"id":"W3011470625","doi":"10.1016/j.eururo.2019.09.035","title":"EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; Sanofi Pasteur; Pharmacyclics; Chugai Pharmaceutical; Genentech; European Association of Urology; European Society for Medical Oncology; Astellas Pharma; Eisai; Bayer; Universitat Autònoma de Barcelona; Cancer Research UK; GlaxoSmithKline; UroGen Pharma; MSD Australia; EMD Serono; Radboud Universitair Medisch Centrum; Pfizer; Incyte; Medac; Ipsen; Clovis Oncology; Alere; Bayer HealthCare; Sanofi; Amgen; Radboud Universiteit; Novartis; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Consensus conference; Bladder cancer; MEDLINE; Family medicine; Urology; General surgery; Oncology; Cancer; Internal medicine","score_opus":0.02578443331298604,"score_gpt":0.3183087991993905,"score_spread":0.29252436588640446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011470625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9338018,0.00015066729,0.000020598278,0.0018026716,0.00051020493,0.00082538987,0.000120482284,0.000022811399,0.062745415],"genre_scores_gemma":[0.9949311,0.00026251876,0.00035483434,0.0020815267,0.000048571314,0.00002751169,0.000030060224,0.000029713687,0.0022341548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898064,0.00013814797,0.00022270616,0.00030876687,0.00017796237,0.00017175305],"domain_scores_gemma":[0.9993789,0.000047457143,0.00011903973,0.00029195668,0.00009638399,0.000066219334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015844846,0.00014641657,0.0001881691,0.00005014357,0.000042321015,0.000009601731,0.000112855094,0.00002358587,0.00059402356],"category_scores_gemma":[0.0000070176816,0.00009897742,0.000026446864,0.00007764274,0.00010686178,0.000039782746,0.00006243196,0.0001068777,0.00006944224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049232185,0.007932373,0.41520512,0.0009871966,0.03466279,0.008618267,0.024854276,0.0058864276,0.025492225,0.121882915,0.016716687,0.28852955],"study_design_scores_gemma":[0.014844882,0.0038447601,0.8768343,0.0001154082,0.0004855803,0.000059398983,0.0013548016,0.00044601425,0.0010754657,0.00013931254,0.10052146,0.0002786672],"about_ca_topic_score_codex":0.000042188447,"about_ca_topic_score_gemma":0.000013526025,"teacher_disagreement_score":0.46162912,"about_ca_system_score_codex":0.00003412668,"about_ca_system_score_gemma":0.000034053523,"threshold_uncertainty_score":0.6504141},"labels":[],"label_agreement":null},{"id":"W3011534960","doi":"10.1016/j.eururo.2019.11.011","title":"Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420–33","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden","keywords":"Medicine; Gynecology; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.027457939979029553,"score_gpt":0.29489693889459145,"score_spread":0.2674389989155619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011534960","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023994211,0.0047324146,0.00019083482,0.89316285,0.0016608714,0.0022376105,0.00116851,0.0002814798,0.07257123],"genre_scores_gemma":[0.17332602,0.0016594359,0.00026762998,0.8152398,0.0013125595,0.000107241365,0.0011819045,0.00044778184,0.0064576734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937885,0.0020055487,0.0010190757,0.001498468,0.00067979965,0.0010086128],"domain_scores_gemma":[0.9962294,0.00057772716,0.0008982782,0.0016699948,0.00041231824,0.00021224697],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00063316704,0.00086699333,0.0013059974,0.00032487782,0.000090518384,0.000036797435,0.00061050017,0.0006942954,0.0008647692],"category_scores_gemma":[0.00047992697,0.000826334,0.00047204646,0.0002898283,0.0005203525,0.000053109037,0.00020832251,0.002308845,0.0006707225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005099281,0.0001878399,0.0012982981,0.0002640508,0.0012814327,0.0053638835,0.00055788015,0.00005247477,0.015195355,0.000037961647,0.9739237,0.0013271879],"study_design_scores_gemma":[0.003908346,0.0017021102,0.018961258,0.00017191062,0.0016793654,0.0003166188,0.000055996305,0.000055901965,0.0007617789,0.00006367864,0.9716897,0.00063332176],"about_ca_topic_score_codex":0.00046537485,"about_ca_topic_score_gemma":0.00011932472,"teacher_disagreement_score":0.14933181,"about_ca_system_score_codex":0.0002609681,"about_ca_system_score_gemma":0.0013144475,"threshold_uncertainty_score":0.99999285},"labels":[],"label_agreement":null},{"id":"W3011774818","doi":"10.1111/iju.14206","title":"Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non‐urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes","year":2020,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Stage (stratigraphy); Hazard ratio; Adenocarcinoma; Urology; Proportional hazards model; Oncology; Bladder cancer; Carcinoma; Internal medicine; Cancer; Confidence interval","score_opus":0.04448982427613298,"score_gpt":0.3450199936936983,"score_spread":0.30053016941756533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011774818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96228164,0.000050540875,0.000879008,0.035354152,0.00047748577,0.0003085281,0.0005374677,0.0000029724038,0.00010819855],"genre_scores_gemma":[0.9960789,0.000014792564,0.002600168,0.0009830182,0.00018901561,0.00001271314,0.000036449608,0.000011563059,0.00007338419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988676,0.00004948139,0.0005687065,0.0001355856,0.0002797863,0.00009884296],"domain_scores_gemma":[0.99867177,0.00009736587,0.00039964233,0.000104513485,0.0006192557,0.000107434884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007907712,0.00012507691,0.00039025396,0.00010213105,0.000024157556,0.00000423987,0.00015852539,0.000042697426,0.000102165446],"category_scores_gemma":[0.00007443977,0.00007246429,0.00014870803,0.00007817843,0.00007350223,0.000050556402,0.000038941613,0.00006390218,4.6026204e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055169403,0.0008907666,0.9719059,0.0000087028675,0.00068895106,0.0000094618135,0.0006916205,0.00002763565,0.00019725003,0.000025325482,0.0005860246,0.019451417],"study_design_scores_gemma":[0.012197631,0.016019285,0.9645629,0.000015590405,0.00029699298,0.000027444417,0.00006792147,0.00012829981,0.00094967306,0.000050445356,0.0056168027,0.00006703102],"about_ca_topic_score_codex":0.00018581582,"about_ca_topic_score_gemma":0.000041887677,"teacher_disagreement_score":0.034371134,"about_ca_system_score_codex":0.000053422442,"about_ca_system_score_gemma":0.00016999235,"threshold_uncertainty_score":0.2955008},"labels":[],"label_agreement":null},{"id":"W3011976965","doi":"10.21037/tau.2020.01.22","title":"Incidence and preoperative predictors for major complications following radical nephroureterectomy","year":2020,"lang":"en","type":"article","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Pennsylvania State University; University of Pennsylvania","keywords":"Medicine; Comorbidity; Cohort; Incidence (geometry); Charlson comorbidity index; Logistic regression; Diabetes mellitus; Kidney disease; Internal medicine; Univariate analysis; Surgery; Multivariate analysis","score_opus":0.024426168460889595,"score_gpt":0.28947408909739797,"score_spread":0.2650479206365084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011976965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92445624,0.0016925018,0.012967675,0.059597984,0.000052211064,0.00063225505,0.00007384502,0.000041354546,0.00048591816],"genre_scores_gemma":[0.9895997,0.00003441681,0.0016611611,0.008400998,0.00009747824,0.00009683486,0.00007822473,0.000008273361,0.000022920236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993627,0.000039929113,0.00014266104,0.00026045172,0.0000554465,0.00013878409],"domain_scores_gemma":[0.9995922,0.0001800109,0.000021839835,0.000045209053,0.00002634208,0.00013440331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004735337,0.000101523314,0.00021411563,0.000028020733,0.00013790576,0.0000049958853,0.000028998664,0.00011859746,0.00005533487],"category_scores_gemma":[0.000023400067,0.00008521666,0.000049199392,0.000046302957,0.00019538986,0.000054122924,0.000009060045,0.000113002476,0.0000026381056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003670746,0.00011533229,0.97681254,0.00007661297,0.0006719208,0.000028276798,0.0028356838,0.000020596366,0.0023251984,0.01002863,0.00045942242,0.002955056],"study_design_scores_gemma":[0.007915286,0.0025277736,0.9694782,0.0000063759608,0.0005924189,0.00027527334,0.000019161891,0.0032439083,0.00013300123,0.0048874957,0.0107841715,0.0001369139],"about_ca_topic_score_codex":0.000007510925,"about_ca_topic_score_gemma":0.000011283807,"teacher_disagreement_score":0.065143436,"about_ca_system_score_codex":0.0000031981515,"about_ca_system_score_gemma":0.00006136137,"threshold_uncertainty_score":0.34750348},"labels":[],"label_agreement":null},{"id":"W3011994487","doi":"10.1002/cam4.2980","title":"Required efficacy for novel therapies in BCG‐unresponsive non‐muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?","year":2020,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Clinical trial; Randomized controlled trial; Placebo; Oncology; Cancer; Intensive care medicine; Internal medicine; Alternative medicine; Pathology","score_opus":0.14007939740678196,"score_gpt":0.43979719473914286,"score_spread":0.2997177973323609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011994487","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3735882,0.029107068,0.005075197,0.56842536,0.0065551507,0.010811651,0.0015153288,0.00049114734,0.0044308933],"genre_scores_gemma":[0.94870716,0.015138981,0.0016889967,0.028590078,0.0026782688,0.0021828758,0.00029014456,0.00016430393,0.00055920664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966868,0.0001040034,0.0011583269,0.00091742387,0.0005100453,0.00062336505],"domain_scores_gemma":[0.99696624,0.0010588467,0.0004196006,0.0005158398,0.0005095126,0.0005299345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045381457,0.00050200074,0.0012713262,0.00022084413,0.00015168198,0.00002226674,0.00030471635,0.00017385559,0.0010121241],"category_scores_gemma":[0.0017420063,0.00037787427,0.00025189063,0.00070555415,0.00024655802,0.00015004115,0.00007752982,0.0005351392,0.000019167219],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017541943,0.0027270077,0.115244955,0.0012489192,0.0037321064,0.00012740896,0.07546915,0.00015317868,0.049770836,0.0004638957,0.14902037,0.58450025],"study_design_scores_gemma":[0.12030879,0.013304558,0.42891866,0.008310963,0.003576627,0.000021902018,0.006636176,0.0004908928,0.0032315927,0.00070179213,0.41267717,0.0018208855],"about_ca_topic_score_codex":0.0006703053,"about_ca_topic_score_gemma":0.0006326437,"teacher_disagreement_score":0.58267933,"about_ca_system_score_codex":0.000535407,"about_ca_system_score_gemma":0.0015205072,"threshold_uncertainty_score":0.99990106},"labels":[],"label_agreement":null},{"id":"W3012125381","doi":"10.1016/j.euo.2020.02.006","title":"Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"Ferring Pharmaceuticals","keywords":"Medicine; Bladder cancer; Meta-analysis; Cystectomy; Randomized controlled trial; Subgroup analysis; Cochrane Library; Internal medicine; Systematic review; Population; Oncology; MEDLINE; Clinical trial; Confidence interval; Carcinoma in situ; Cancer","score_opus":0.18456111749564127,"score_gpt":0.42578762561179667,"score_spread":0.2412265081161554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012125381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028254715,0.989483,0.00064369675,0.0023767927,0.00015224509,0.006849411,0.00028595026,0.000041612326,0.00013904955],"genre_scores_gemma":[0.002484578,0.98742247,0.00046247864,0.0047833878,0.00014737462,0.0044144806,0.00006588517,0.00014116715,0.000078180965],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993543,0.0027077992,0.0017288232,0.0012167866,0.00029881232,0.000504751],"domain_scores_gemma":[0.99575263,0.0015571103,0.0014156688,0.00074399356,0.00026371513,0.00026687307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012654145,0.0009406302,0.01090293,0.00044768405,0.00010465191,0.000025248939,0.00029414348,0.00023359303,0.000497808],"category_scores_gemma":[0.0002453757,0.00060646725,0.0021306076,0.000561973,0.00033209333,0.00007397224,0.00019023898,0.00061714783,0.000008016145],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014347023,0.0002871074,0.00009291586,0.5668133,0.28585622,0.00026217973,0.00047592976,0.0000036267204,0.000004702031,0.000011065674,0.00023233856,0.14581712],"study_design_scores_gemma":[0.0013140998,0.0021371755,0.0002165356,0.013896058,0.81214976,0.0000618821,0.000021478712,0.000029799774,0.0000010334978,0.000003150863,0.16974196,0.00042708367],"about_ca_topic_score_codex":0.000031599822,"about_ca_topic_score_gemma":0.000058828176,"teacher_disagreement_score":0.55291724,"about_ca_system_score_codex":0.00019619706,"about_ca_system_score_gemma":0.001043522,"threshold_uncertainty_score":0.9996387},"labels":[],"label_agreement":null},{"id":"W3012312365","doi":"10.1016/j.ejso.2020.03.204","title":"Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients","year":2020,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cystectomy; Odds ratio; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.12388897035192623,"score_gpt":0.3584908127082619,"score_spread":0.23460184235633566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012312365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755554,0.00012757491,0.0000138788155,0.0064932974,0.0003284989,0.0003489804,0.000009659756,0.000011053209,0.017111665],"genre_scores_gemma":[0.99867064,0.00012542268,0.0003736347,0.00040608045,0.00033327742,0.000003393081,0.0000118202615,0.000029492441,0.00004625646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695027,0.0010090405,0.0010672017,0.0002756921,0.00037280587,0.00032501738],"domain_scores_gemma":[0.99872136,0.00039182208,0.00019746466,0.00012657621,0.000082612736,0.00048016297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055484567,0.00022046141,0.0012430856,0.00016465913,0.00003170481,0.000032901906,0.00045641296,0.000092869246,0.00036722928],"category_scores_gemma":[0.00012870411,0.00015260067,0.00018860628,0.00028781456,0.00011757012,0.00013992784,0.0002087992,0.000732236,0.000038365888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005438599,0.0007825646,0.9377369,0.00001730853,0.00018922056,0.011528755,0.00039373952,0.0000013044441,0.000018033823,0.0000034337766,0.00026177103,0.043628354],"study_design_scores_gemma":[0.038113542,0.007034076,0.9362519,0.000116879644,0.00012039965,0.000072541625,0.00005561543,0.0000029828207,0.000019875055,0.0000025490879,0.018080227,0.00012941059],"about_ca_topic_score_codex":0.000022030355,"about_ca_topic_score_gemma":0.000016073582,"teacher_disagreement_score":0.04349894,"about_ca_system_score_codex":0.0002605998,"about_ca_system_score_gemma":0.0002493532,"threshold_uncertainty_score":0.62228745},"labels":[],"label_agreement":null},{"id":"W3012356371","doi":"10.1007/s11934-020-0960-y","title":"Genomic Subtyping in Bladder Cancer","year":2020,"lang":"en","type":"review","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Decipher Biosciences (Canada); University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Carcinogenesis; Genomics; Epigenetics; Medicine; Cancer; Surgical oncology; Bioinformatics; Oncology; Internal medicine; Computational biology; Biology; Genome; Gene; Genetics","score_opus":0.07917903122634054,"score_gpt":0.3933020541295697,"score_spread":0.31412302290322913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012356371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008581257,0.9944899,0.0000057540387,0.00019764385,0.0027658811,0.0013963449,0.000026531678,0.00007536158,0.00095678633],"genre_scores_gemma":[0.00034570834,0.997475,0.000011073981,0.00022718094,0.00087096833,0.0005971502,0.00021245006,0.00009538891,0.00016507445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729735,0.00010999723,0.0010320138,0.0009190834,0.00017903543,0.00046249875],"domain_scores_gemma":[0.99864584,0.000043595737,0.0005302579,0.0005159729,0.00004027658,0.00022403379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013125753,0.00051925273,0.002371455,0.0002525656,0.000037081714,0.000010877862,0.00010238131,0.00037934812,0.00051802996],"category_scores_gemma":[0.00005813132,0.00042055626,0.0004913302,0.00032071333,0.000081004415,0.00003081491,0.00010615323,0.000946998,0.00011719757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025691517,0.00012979246,0.0059646782,0.0046858746,0.00041278522,0.0043810015,0.00006294031,4.8469457e-7,4.427058e-7,0.000005091256,0.0016734276,0.9826578],"study_design_scores_gemma":[0.0003828962,0.000104161074,0.0007338052,0.002353949,0.0028617086,0.002695645,0.0000015273882,0.0000021302874,3.9020424e-7,0.000035226145,0.9905526,0.000275933],"about_ca_topic_score_codex":0.000055403245,"about_ca_topic_score_gemma":0.00002713004,"teacher_disagreement_score":0.9888792,"about_ca_system_score_codex":0.0003540653,"about_ca_system_score_gemma":0.0017988279,"threshold_uncertainty_score":0.99982464},"labels":[],"label_agreement":null},{"id":"W3012478583","doi":"10.1016/j.euo.2020.02.010","title":"Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada); University of British Columbia","funders":"BC Cancer Agency; Decipher Biosciences","keywords":"Bladder cancer; Basal (medicine); Medicine; Cancer; Transcriptome; Subtyping; Internal medicine; Hormone; Androgen; Oncology; Physiology; Biology; Gene; Gene expression","score_opus":0.024928849280036216,"score_gpt":0.2774925359515167,"score_spread":0.2525636866714805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012478583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793713,0.002737539,0.00022468831,0.010646821,0.00016009912,0.0003340172,0.00022110832,0.00004216529,0.006262259],"genre_scores_gemma":[0.9921063,0.0010494444,0.00004234651,0.006367239,0.00013470065,0.000023165183,0.00012563434,0.00003163352,0.00011953845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983593,0.00040318412,0.00035178615,0.00045319326,0.00013163745,0.00030085136],"domain_scores_gemma":[0.99936736,0.000092260976,0.00013495948,0.00018880084,0.00006705622,0.00014959369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008701873,0.00019481388,0.0005066833,0.000048576625,0.00003167249,0.0000039035767,0.00015778164,0.00012837353,0.00060952205],"category_scores_gemma":[0.000046835557,0.00017178907,0.00008818599,0.00019137244,0.0002637308,0.00003026248,0.000075930904,0.0002821617,0.00009084202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020427334,0.001518356,0.7065058,0.00012628858,0.0008414913,0.002929078,0.007988781,0.000057752157,0.16023679,0.00029011158,0.052553933,0.06490892],"study_design_scores_gemma":[0.007971469,0.0071056387,0.81794995,0.000027542606,0.0003466593,0.00004777831,0.00024646442,0.00007998455,0.02138368,0.00010747318,0.1444137,0.00031967644],"about_ca_topic_score_codex":0.000056887875,"about_ca_topic_score_gemma":0.000029323664,"teacher_disagreement_score":0.13885312,"about_ca_system_score_codex":0.000089520836,"about_ca_system_score_gemma":0.0001718397,"threshold_uncertainty_score":0.7005355},"labels":[],"label_agreement":null},{"id":"W3012590719","doi":"10.1016/j.urolonc.2020.02.002","title":"The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lymphovascular invasion; Medicine; Urokinase receptor; Cystectomy; Bladder cancer; Plasminogen activator; Proportional hazards model; Hazard ratio; Metastasis; Internal medicine; Lymph node; Cancer; Urokinase; Oncology; SuPAR; Pathology; Confidence interval","score_opus":0.018933880395659696,"score_gpt":0.2715359821409866,"score_spread":0.25260210174532693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012590719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888627,0.00061213557,0.000004496359,0.008474316,0.00008823022,0.0010504145,0.00005223628,0.000037306894,0.0008181698],"genre_scores_gemma":[0.9974906,0.000085432206,0.0005830064,0.001335903,0.00007287408,0.00030227302,0.000014763335,0.000016534666,0.00009863124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986932,0.00021248467,0.00029505862,0.0003070371,0.00022548815,0.00026669673],"domain_scores_gemma":[0.9990705,0.00029449744,0.000181279,0.00017252094,0.00007641509,0.00020475236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001062771,0.0001946663,0.00034854785,0.0000421141,0.00024297167,0.000012418954,0.00014203279,0.00015411778,0.00001609708],"category_scores_gemma":[0.00014562179,0.0000965805,0.00005229914,0.0004276157,0.0008136804,0.000048104626,0.000043716595,0.0003165775,0.0000034483521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006383724,0.0001898113,0.9959643,0.000062209954,0.0001561108,0.000047192567,0.00045616293,0.000040671905,0.00026985293,0.0008847432,0.0007586097,0.0005319864],"study_design_scores_gemma":[0.009039463,0.010038068,0.768558,0.00047089343,0.0017505572,0.0002158296,0.00075210066,0.0018232865,0.0058502997,0.00018525998,0.20097081,0.0003454165],"about_ca_topic_score_codex":0.0002691922,"about_ca_topic_score_gemma":0.00007277375,"teacher_disagreement_score":0.22740626,"about_ca_system_score_codex":0.00017676526,"about_ca_system_score_gemma":0.0005944898,"threshold_uncertainty_score":0.39384386},"labels":[],"label_agreement":null},{"id":"W3012844237","doi":"10.5489/cuaj.6458","title":"Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection","year":2020,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; Jewish General Hospital; University of Toronto; University Health Network; McGill University; University of Ottawa; Kingston Health Sciences Centre; McGill University Health Centre; Université de Montréal; Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency; University of British Columbia; Princess Margaret Cancer Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"Janssen Canada","keywords":"Urothelial carcinoma; Biomarker; Selection (genetic algorithm); Medicine; Oncology; Internal medicine; Cancer; Bladder cancer; Computer science; Biology","score_opus":0.02617189444472702,"score_gpt":0.28954107392339107,"score_spread":0.26336917947866406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012844237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021754776,0.9966574,0.000018299328,0.0014846311,0.00015288014,0.00087956764,0.00009702203,0.000009784798,0.00048291142],"genre_scores_gemma":[0.002947359,0.99529433,0.0010197232,0.0005133563,0.00009361008,0.000042127747,0.000031442414,0.000025233394,0.000032840144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806845,0.0002475189,0.00080783287,0.00024581217,0.0003497996,0.0002805879],"domain_scores_gemma":[0.99827284,0.000060542076,0.0010104704,0.00009003858,0.00021030512,0.00035582605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023877675,0.00026099032,0.0013904517,0.00019286791,0.00009806178,0.000014367492,0.00009098238,0.00019940532,0.0001810252],"category_scores_gemma":[0.00008974234,0.00019442018,0.0004014891,0.000361864,0.000028891884,0.000046119883,0.000025239327,0.00039516797,0.000002806174],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003457771,0.00003666069,0.0011372878,0.014214618,0.0010818192,0.000073490446,0.0001231057,0.0000011052806,0.0000018606898,0.000016474516,0.0005160784,0.98276293],"study_design_scores_gemma":[0.00087443675,0.00069538376,0.0016262067,0.021289043,0.002744694,0.00018379517,0.00007613297,0.00000925412,0.0000017616475,0.00001856945,0.97230065,0.00018009967],"about_ca_topic_score_codex":0.0001994661,"about_ca_topic_score_gemma":0.000026927559,"teacher_disagreement_score":0.9825828,"about_ca_system_score_codex":0.00081199344,"about_ca_system_score_gemma":0.00062183663,"threshold_uncertainty_score":0.7928225},"labels":[],"label_agreement":null},{"id":"W3014058489","doi":"10.5489/cuaj.6243","title":"The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Body mass index; Bladder cancer; Odds ratio; Confidence interval; Complication; Surgery; Database; Cancer; Internal medicine","score_opus":0.01905247795595586,"score_gpt":0.3178707527644433,"score_spread":0.29881827480848744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014058489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932363,0.000052224786,0.00003525569,0.0051806495,0.00013185125,0.00066093187,0.0005640788,0.000013476651,0.0001252133],"genre_scores_gemma":[0.998985,0.000016943957,0.00012811106,0.0005658787,0.000094151284,0.000027265283,0.00007127822,0.000010204268,0.0001011823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677783,0.0007756613,0.0006210039,0.00025899717,0.0011135157,0.0004529778],"domain_scores_gemma":[0.9973041,0.0008987263,0.0007461127,0.00015582501,0.00044362023,0.00045162794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021318384,0.00017803817,0.0006237612,0.00016007278,0.0006049371,0.00010558175,0.0001254637,0.00012898953,0.000046411824],"category_scores_gemma":[0.0006555728,0.00010078772,0.0003282884,0.00056677056,0.00008333778,0.00013325928,0.000026661615,0.00049012667,0.0000016048602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080848775,0.000079389945,0.99581957,0.000002077041,0.0023626927,0.000017596725,0.000114453076,0.00004149202,0.00006204381,0.000105580926,0.000029136187,0.0012851165],"study_design_scores_gemma":[0.0016481337,0.0006957791,0.99190754,0.0000052714167,0.0008040385,0.0000074838076,0.00069434656,0.000979481,0.000016750617,0.000061634906,0.0030635505,0.00011599866],"about_ca_topic_score_codex":0.0049508964,"about_ca_topic_score_gemma":0.0022314577,"teacher_disagreement_score":0.005748667,"about_ca_system_score_codex":0.002399679,"about_ca_system_score_gemma":0.000905969,"threshold_uncertainty_score":0.7484308},"labels":[],"label_agreement":null},{"id":"W3014059972","doi":"10.21037/tau.2020.03.23","title":"Radical cystectomy: a review of techniques, developments and controversies","year":2020,"lang":"en","type":"review","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Urinary diversion; Medicine; Standard of care; General surgery; Intensive care medicine; Surgery; Cancer; Internal medicine","score_opus":0.026863542822627387,"score_gpt":0.3228811738048634,"score_spread":0.29601763098223605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014059972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044056565,0.9946137,0.00006194017,0.003204268,0.000039937873,0.0008092392,0.00010258159,0.000025718753,0.0011382289],"genre_scores_gemma":[0.00013946388,0.9956538,0.00045163452,0.0033558211,0.000063284126,0.00008122397,0.00019246008,0.000016874461,0.000045401754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998817,0.00013493712,0.00046169656,0.00032800154,0.000103092345,0.00015524043],"domain_scores_gemma":[0.9993598,0.00026812244,0.00014179778,0.000083716746,0.000037640635,0.00010893266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118195574,0.00025023677,0.0017971596,0.00009549833,0.00004084961,0.0000016255892,0.000049728587,0.0003767836,0.00014012643],"category_scores_gemma":[0.000040260114,0.00018612696,0.00014666672,0.00009792448,0.0003403119,0.000022076383,0.000021954464,0.00029094142,0.000004813986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031168072,0.000056452787,0.00028395525,0.053149674,0.0008460683,0.00009935526,0.00003841509,2.9170748e-9,8.587383e-7,0.001135392,0.0004468031,0.94363135],"study_design_scores_gemma":[0.0011151052,0.0006161254,0.00019595379,0.004850792,0.0025530418,0.0017009157,4.1927595e-7,7.949213e-7,9.68157e-7,0.00024029662,0.98860866,0.00011694946],"about_ca_topic_score_codex":0.0000050960357,"about_ca_topic_score_gemma":0.0000016620556,"teacher_disagreement_score":0.98816186,"about_ca_system_score_codex":0.000009644751,"about_ca_system_score_gemma":0.00039342063,"threshold_uncertainty_score":0.7590037},"labels":[],"label_agreement":null},{"id":"W3014110767","doi":"10.1159/000506717","title":"Can a Simple Geriatric Assessment Predict the Outcome of TURP?","year":2020,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prospective cohort study; Urinary retention; Perioperative; Geriatrics; American society of anesthesiologists; Urinary system; Surgery; Internal medicine","score_opus":0.03897115239479109,"score_gpt":0.32946166468122207,"score_spread":0.29049051228643097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014110767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.904486,0.00022263044,0.0010858667,0.07422139,0.00035173268,0.00076513615,0.00047726042,0.000102294085,0.018287688],"genre_scores_gemma":[0.9922125,0.00001411235,0.00023242159,0.0068981755,0.00023601162,0.00004207624,0.00007730218,0.000010590438,0.00027684637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991439,0.000032917356,0.0002477487,0.00015948899,0.00030974322,0.00010620567],"domain_scores_gemma":[0.9995166,0.000073233896,0.00009848974,0.00014660478,0.00009674534,0.00006829816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080433994,0.000093922295,0.00017491677,0.00003484728,0.000027879061,0.000009515481,0.00015928966,0.000040236937,0.00079732813],"category_scores_gemma":[0.0001173252,0.000056865676,0.00010644277,0.00012327005,0.000047437865,0.000024849962,0.00005641588,0.00012804143,0.000012638642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017795745,0.000118028605,0.9870824,0.000029856987,0.00033690274,0.000024837229,0.00034533872,0.00005834102,0.0004856696,0.0019770386,0.008256204,0.0011073856],"study_design_scores_gemma":[0.0024307566,0.0011596848,0.9655775,0.0000069174107,0.00029282915,0.000026589081,0.000079792284,0.0016661001,0.0011990494,0.0008939562,0.026562596,0.00010423289],"about_ca_topic_score_codex":0.00042369805,"about_ca_topic_score_gemma":0.000020773392,"teacher_disagreement_score":0.08772646,"about_ca_system_score_codex":0.000054059794,"about_ca_system_score_gemma":0.000084187515,"threshold_uncertainty_score":0.8730184},"labels":[],"label_agreement":null},{"id":"W3014928912","doi":"10.1002/jso.25919","title":"Rates of other‐cause mortality after radical cystectomy are decreasing over time—A population‐based analysis over two decades","year":2020,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Epidemiology; Proportional hazards model; Demography; Socioeconomic status; Marital status; Internal medicine; Population; Surgery; Cancer","score_opus":0.04604443480365827,"score_gpt":0.39227015297249146,"score_spread":0.3462257181688332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014928912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964883,0.00052571506,0.00018350712,0.0021231074,0.00006909389,0.0001438374,0.00003223595,0.00001200964,0.00042219827],"genre_scores_gemma":[0.99710464,0.000044471293,0.00092487043,0.0014257757,0.000438261,0.000004093317,0.000009423379,0.000018663264,0.00002978444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980213,0.00028018907,0.0008189894,0.0001957284,0.00047757238,0.0002061866],"domain_scores_gemma":[0.99831957,0.00033744687,0.0006114658,0.0001448504,0.00017202066,0.00041463232],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003055742,0.00017553348,0.0011558399,0.00021856387,0.000030004318,0.000011672361,0.000093315924,0.00016993113,0.0035833563],"category_scores_gemma":[0.000090147696,0.00012278518,0.0006124532,0.00057008286,0.00010845143,0.000099390214,0.000024241921,0.000304257,0.000008980083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004367263,0.0005349714,0.9890866,0.00004292598,0.002897138,0.0014440326,0.00008087031,0.00016903754,0.000532456,0.000012660875,0.00018544786,0.0006465493],"study_design_scores_gemma":[0.010608636,0.0011902482,0.9721649,0.00010290672,0.005287233,0.00017630936,0.000016412507,0.0010306215,0.0010927087,0.000053625023,0.008145331,0.00013103927],"about_ca_topic_score_codex":0.00018600978,"about_ca_topic_score_gemma":0.000031848627,"teacher_disagreement_score":0.016921718,"about_ca_system_score_codex":0.00021445121,"about_ca_system_score_gemma":0.00028928238,"threshold_uncertainty_score":0.9973275},"labels":[],"label_agreement":null},{"id":"W3016352045","doi":"10.3747/co.27.5121","title":"Immune Checkpoint Inhibitors in Genitourinary Malignancies","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Oncology; Renal cell carcinoma; Prostate cancer; Kidney cancer; Genitourinary system; Durvalumab; Clinical trial; Disease; Immunotherapy; Metastatic Urothelial Carcinoma; Immune checkpoint; Cancer; Internal medicine; Nivolumab; Bladder cancer; Urothelial carcinoma","score_opus":0.15202257782270387,"score_gpt":0.43363611085503256,"score_spread":0.2816135330323287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016352045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041247433,0.9920066,0.0000025915328,0.00028725504,0.002715301,0.001548618,0.000051534476,0.00006777693,0.0032790825],"genre_scores_gemma":[0.00006036163,0.9973436,0.00006882869,0.000042089574,0.0013988868,0.0005448317,0.00023649912,0.00007176923,0.00023316196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759537,0.00020218758,0.0010205318,0.0005592806,0.00020151093,0.00042114302],"domain_scores_gemma":[0.9989964,0.00008292669,0.0003238972,0.00033811925,0.000049319257,0.00020937898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014587503,0.0005057576,0.0028921599,0.00027867468,0.000035331595,0.000009113929,0.00018338501,0.00041767542,0.000236026],"category_scores_gemma":[0.00007662244,0.00039203375,0.0007417291,0.00042818356,0.000104572915,0.00003529811,0.0001852028,0.0009552216,0.00047731822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054960496,0.0006316834,0.00013012401,0.012241773,0.00015352514,0.0009060307,0.0001585237,1.8209313e-8,0.0000022551815,0.000012610664,0.0015673046,0.9841412],"study_design_scores_gemma":[0.001455912,0.0010030575,0.000110313216,0.011735704,0.0012020164,0.00047738705,0.000033447817,7.022935e-7,0.000010171753,0.0000244218,0.98367435,0.00027251308],"about_ca_topic_score_codex":0.000030174733,"about_ca_topic_score_gemma":0.0000091637285,"teacher_disagreement_score":0.98386866,"about_ca_system_score_codex":0.0011785341,"about_ca_system_score_gemma":0.0019170855,"threshold_uncertainty_score":0.99985313},"labels":[],"label_agreement":null},{"id":"W3017846458","doi":"10.1186/s13643-020-01353-2","title":"Antibiotic prophylaxis in transurethral resection of bladder tumours: study protocol for a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Systematic Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bacteriuria; Antibiotic prophylaxis; Meta-analysis; MEDLINE; Urinary system; Systematic review; Randomized controlled trial; Regimen; Placebo; Intensive care medicine; Antibiotic resistance; Asymptomatic; Publication bias; Antibiotics; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.20095885989766538,"score_gpt":0.4590644415941864,"score_spread":0.25810558169652104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017846458","genre_codex":"review","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.9958936e-8,0.5174982,0.000035210425,0.000021025688,0.000010188002,0.4823439,0.000039623992,0.000013091148,0.000038754595],"genre_scores_gemma":[0.000007808727,0.47924504,0.000103438804,0.000036890397,0.000018657498,0.5203418,0.0000151360155,0.000055522363,0.00017570241],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847606,0.005745655,0.007423761,0.0010106468,0.000724658,0.00033470834],"domain_scores_gemma":[0.9935402,0.0005424062,0.004013886,0.0014905581,0.00022270386,0.00019019019],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0058616376,0.001127918,0.046387143,0.00060477795,0.000048804424,0.000043135708,0.00032138388,0.000251191,0.00013339447],"category_scores_gemma":[0.0014941898,0.00053112174,0.0065757986,0.0023747121,0.000049857157,0.000084319894,0.000041749725,0.00038104976,0.000036825393],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021040178,0.00040393596,0.0000037276266,0.88456994,0.11443224,0.000017532679,0.00022244989,2.6017744e-8,4.2612985e-8,0.0000026617247,0.00005163622,0.00027475227],"study_design_scores_gemma":[0.0006530078,0.0013777969,4.913037e-7,0.4494838,0.5458513,0.000055682474,0.000042888743,0.0000013282381,1.4129495e-7,0.0000015433245,0.0023274512,0.00020453769],"about_ca_topic_score_codex":0.00003841323,"about_ca_topic_score_gemma":0.00005224336,"teacher_disagreement_score":0.43508613,"about_ca_system_score_codex":0.00019229262,"about_ca_system_score_gemma":0.00027088515,"threshold_uncertainty_score":0.999714},"labels":[],"label_agreement":null},{"id":"W3020833564","doi":"10.1097/ju.0000000000000836.04","title":"PD09-04 TECHNOLOGY APPLICATIONS TO IMPROVE COMPLIANCE WITH HEMATURIA GUIDELINE RECOMMENDATIONS: ADDRESSING BARRIERS IN A LARGE ACADEMIC CENTER","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; American Society of Hematology","keywords":"Medicine; Guideline; Bladder cancer; Cystoscopy; Family medicine; Cancer; Alternative medicine; Pathology; Internal medicine","score_opus":0.04814527188550939,"score_gpt":0.361744980673374,"score_spread":0.31359970878786464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020833564","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0924042,0.0057680663,0.061721515,0.8372052,0.00025261947,0.0016892727,0.00010536855,0.00006237168,0.0007913816],"genre_scores_gemma":[0.9710519,0.00031755998,0.0030430357,0.025247274,0.00024736754,0.000037270434,0.000006276908,0.000019267316,0.000030050618],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989992,0.00006783742,0.00046520372,0.00012903634,0.000112598995,0.00022615577],"domain_scores_gemma":[0.9992307,0.000052133328,0.00023469237,0.00016993009,0.00014623831,0.00016634795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028008482,0.00010958201,0.0002988723,0.00014039906,0.00006764936,0.0000040325267,0.00021682194,0.000103413964,0.00012432419],"category_scores_gemma":[0.000109331406,0.00006763403,0.000034790017,0.0003814695,0.0000674358,0.00005307505,0.000053572963,0.0006685524,0.000020528627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054988123,0.0023415403,0.29395851,0.00060428574,0.0033647553,0.0006698219,0.02408606,0.0011506373,0.18478018,0.0041864705,0.23196344,0.19790615],"study_design_scores_gemma":[0.027675824,0.009683034,0.0075833476,0.00053896557,0.0010825536,0.0043505603,0.004078652,0.0010886175,0.0072108177,0.0035404232,0.9326582,0.0005090227],"about_ca_topic_score_codex":0.000004374346,"about_ca_topic_score_gemma":0.000011237684,"teacher_disagreement_score":0.8786477,"about_ca_system_score_codex":0.00005740672,"about_ca_system_score_gemma":0.00016269632,"threshold_uncertainty_score":0.29045647},"labels":[],"label_agreement":null},{"id":"W3020905255","doi":"10.1097/md.0000000000020184","title":"Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma","year":2020,"lang":"en","type":"article","venue":"Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Urology; Neoadjuvant therapy; Cochrane Library; Carcinoma; Confidence interval; Cancer","score_opus":0.020253671884600158,"score_gpt":0.27788729132990175,"score_spread":0.2576336194453016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020905255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962962,0.000118526485,0.000017013515,0.002102812,0.000052439776,0.00080952304,0.000040238687,0.000031172123,0.0005320385],"genre_scores_gemma":[0.99902165,0.00008095561,0.00012940614,0.00042873345,0.00023172246,0.000023937984,0.000035352714,0.000032973916,0.000015286536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849075,0.00008270443,0.00032698698,0.00038686048,0.00042760238,0.0002851229],"domain_scores_gemma":[0.99934417,0.000075489246,0.00013696033,0.00016183825,0.000069277165,0.00021228385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014075568,0.0002497325,0.00063622795,0.000103137645,0.00003680118,0.000005616881,0.00006463579,0.000071815,0.00015429988],"category_scores_gemma":[0.00010917066,0.00013741152,0.000067038214,0.00023770299,0.0001484664,0.000049545168,0.000020670688,0.0002687149,0.0000019438774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027238503,0.0005590714,0.98357195,0.00005616323,0.00009848212,0.000089240755,0.0020936988,0.0000063071802,0.0006135492,0.000004148438,0.000061988474,0.0101215355],"study_design_scores_gemma":[0.018091327,0.012530894,0.9678054,0.00014450251,0.0001612357,0.000007728958,0.00013439557,0.00008688168,0.00088112627,0.00000917749,0.000029449633,0.00011792217],"about_ca_topic_score_codex":0.00093632255,"about_ca_topic_score_gemma":0.0000050971307,"teacher_disagreement_score":0.015766606,"about_ca_system_score_codex":0.000060466966,"about_ca_system_score_gemma":0.0000644242,"threshold_uncertainty_score":0.5603479},"labels":[],"label_agreement":null},{"id":"W3021314346","doi":"10.1007/s00345-020-03205-z","title":"The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrology; Multicenter study; Bladder cancer; Oncology; Internal medicine; Cancer; Overall survival; Randomized controlled trial","score_opus":0.029168767586622523,"score_gpt":0.34855562645676563,"score_spread":0.3193868588701431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021314346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061954,0.0002161564,0.000011945857,0.007936382,0.00020446841,0.0003517042,0.0003598433,0.0000030654066,0.0002968711],"genre_scores_gemma":[0.99881804,0.00024626104,0.000049745733,0.0005913461,0.0002315902,0.000004929272,0.000024054265,0.000011978699,0.00002206809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998481,0.00031409037,0.00066780945,0.00017347271,0.00020583473,0.0001578324],"domain_scores_gemma":[0.99854803,0.0004252283,0.0004902775,0.00014253808,0.00025151574,0.00014239346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017390234,0.00014203646,0.00049250235,0.000060790175,0.000032855707,0.0000074161167,0.00007237652,0.000054657266,0.000033711476],"category_scores_gemma":[0.000102300386,0.00007120241,0.00014319243,0.00020071524,0.00009621877,0.000048415222,0.000011606471,0.00023371575,0.0000020151313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10435053,0.0010602843,0.8853096,0.0000015397314,0.0011394175,0.000039365106,0.000938472,0.0008562237,0.00003276774,0.00000597658,0.00024348804,0.006022352],"study_design_scores_gemma":[0.028202463,0.015269768,0.9554609,0.000031351505,0.00029362508,8.818511e-7,0.000050495437,0.00024332044,0.000089996494,0.000022423606,0.00028201006,0.000052753512],"about_ca_topic_score_codex":0.0013269049,"about_ca_topic_score_gemma":0.0014250621,"teacher_disagreement_score":0.07614806,"about_ca_system_score_codex":0.00027843218,"about_ca_system_score_gemma":0.00046572287,"threshold_uncertainty_score":0.29035503},"labels":[],"label_agreement":null},{"id":"W3021403359","doi":"10.1016/j.eururo.2020.04.059","title":"An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Research Grants Council, University Grants Committee","keywords":"Medicine; Delphi method; Delphi; Confidence interval; Systematic review; Randomized controlled trial; Statement (logic); MEDLINE; Perforation; Evidence-based medicine; Medical physics; Surgery; Internal medicine; Alternative medicine; Statistics; Pathology","score_opus":0.08279533778653005,"score_gpt":0.3928676001667775,"score_spread":0.3100722623802475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021403359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022419577,0.984251,0.0000280923,0.0002742549,0.00059977197,0.0053794114,0.00055891834,0.00007327076,0.0065932795],"genre_scores_gemma":[0.058576163,0.9382993,0.0008830325,0.00048740982,0.0006428819,0.00019984468,0.0005842138,0.00019101563,0.00013612256],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858958,0.010749389,0.0019416355,0.000782027,0.00035669567,0.00027445328],"domain_scores_gemma":[0.99542993,0.0015868426,0.0019219011,0.00043838617,0.00040961808,0.00021331382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033475473,0.0005799518,0.0027721608,0.00028077507,0.00009855084,0.000046043035,0.00021758069,0.00010275589,0.00003812648],"category_scores_gemma":[0.0022330778,0.00044157606,0.00018251823,0.0003915717,0.00019864259,0.000030234218,0.0001313106,0.00053700927,0.000086799875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011283974,0.0036560828,0.0040170783,0.55466497,0.029358279,0.015802337,0.010638363,0.00023958497,0.00075322785,0.0015144831,0.010338666,0.35773295],"study_design_scores_gemma":[0.022437863,0.030131495,0.0010263979,0.14580002,0.019456925,0.006086879,0.0014697294,0.0011912462,0.00004521994,0.00011002822,0.76953965,0.002704561],"about_ca_topic_score_codex":0.00015986509,"about_ca_topic_score_gemma":0.00019105442,"teacher_disagreement_score":0.759201,"about_ca_system_score_codex":0.00022373175,"about_ca_system_score_gemma":0.0005027363,"threshold_uncertainty_score":0.9998036},"labels":[],"label_agreement":null},{"id":"W3021606747","doi":"10.14740/jocmr4162","title":"Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Hazard ratio; Internal medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Confidence interval; Oncology; Gastroenterology; Urothelial carcinoma; Cancer; Bladder cancer; Immunotherapy","score_opus":0.21127678510942663,"score_gpt":0.5336645998358557,"score_spread":0.3223878147264291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021606747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96875376,0.00042467986,0.000037689548,0.017583152,0.00051221566,0.0016724573,0.000018285156,0.000018575294,0.010979166],"genre_scores_gemma":[0.988878,0.0006462474,0.0027824873,0.0019488181,0.005263588,0.0000380371,0.000015813986,0.00007461311,0.00035237664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99194074,0.001221344,0.003406849,0.0005581414,0.002223235,0.0006496875],"domain_scores_gemma":[0.98127806,0.013480588,0.001172282,0.0003881014,0.0024476505,0.0012333366],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006739345,0.0002905719,0.0018809455,0.00039558765,0.000107551125,0.000018978326,0.00033378857,0.00023294514,0.00017248635],"category_scores_gemma":[0.036633328,0.00017726138,0.0003521827,0.0008413811,0.0005448863,0.00034174803,0.00007536064,0.002683376,0.000014498439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09746312,0.0023461322,0.8042907,0.00023266904,0.0003492005,0.00063654437,0.0012794285,0.000008417377,0.000038912745,0.000024824947,0.0038832917,0.08944672],"study_design_scores_gemma":[0.1026686,0.070863985,0.794343,0.001256935,0.0005111548,0.00005681959,0.0018887842,0.00024725715,0.000044404536,0.00006610686,0.027839031,0.00021392206],"about_ca_topic_score_codex":0.00028951562,"about_ca_topic_score_gemma":0.000079917154,"teacher_disagreement_score":0.0892328,"about_ca_system_score_codex":0.00021860545,"about_ca_system_score_gemma":0.0015844353,"threshold_uncertainty_score":0.99961746},"labels":[],"label_agreement":null},{"id":"W3021629923","doi":"10.1016/j.urolonc.2020.03.030","title":"The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Urokinase receptor; Lymphovascular invasion; Medicine; Hazard ratio; Lymph node; Immunohistochemistry; Plasminogen activator; Cancer; Oncology; Stage (stratigraphy); Internal medicine; Plasminogen activator inhibitor-1; Urology; Pathology; Confidence interval; Metastasis; Biology","score_opus":0.026213661176739535,"score_gpt":0.28464493734980706,"score_spread":0.25843127617306755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021629923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915373,0.0030546042,0.0000061978576,0.0041479985,0.00011380827,0.000729041,0.000030829477,0.00003081458,0.000349413],"genre_scores_gemma":[0.9965112,0.00021088903,0.0017997142,0.0011197856,0.0001445275,0.00014159888,0.000012439428,0.000015769936,0.000044027176],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987467,0.00019672493,0.00031116745,0.00033327896,0.00015796775,0.0002541445],"domain_scores_gemma":[0.9990587,0.00038018645,0.000112210444,0.00011651372,0.00004391654,0.0002884631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015111896,0.00019198189,0.00036556707,0.00006175091,0.00014459935,0.000015196033,0.00008010889,0.00021057263,0.000025072695],"category_scores_gemma":[0.0002214807,0.00012424574,0.000046123892,0.00019197018,0.00040260234,0.000079559584,0.000049314545,0.00032078163,0.000005067962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019808656,0.00017964744,0.9812628,0.00016876256,0.00004599046,0.00038156903,0.001399182,0.000006694821,0.012370301,0.001057986,0.0004095831,0.00073661946],"study_design_scores_gemma":[0.010729271,0.01957974,0.41460285,0.00067619025,0.0013733504,0.0020172556,0.0016243954,0.004155617,0.060359742,0.0008086245,0.48340273,0.0006702278],"about_ca_topic_score_codex":0.000029801353,"about_ca_topic_score_gemma":0.0000035713736,"teacher_disagreement_score":0.5666599,"about_ca_system_score_codex":0.000076334865,"about_ca_system_score_gemma":0.00037879986,"threshold_uncertainty_score":0.50665945},"labels":[],"label_agreement":null},{"id":"W3022147006","doi":"10.1097/ju.0000000000000857.010","title":"MP24-10 NO SURVIVAL DIFFERENCE BETWEEN PATIENTS WITH DE NOVO MUSCLE-INVASIVE BLADDER CANCER COMPARED TO THOSE THAT PROGRESS IN ROUTINE CLINICAL PRACTICE","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Confounding; Proportional hazards model; Disease; Cancer; Internal medicine; Population; Cancer registry; Oncology; Stage (stratigraphy); Retrospective cohort study; Statistical significance","score_opus":0.07477917535361724,"score_gpt":0.37569527304738076,"score_spread":0.30091609769376354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022147006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765985,0.00050662766,0.00019122765,0.021677017,0.00021817295,0.000484198,0.000028064029,0.000010554403,0.0002856352],"genre_scores_gemma":[0.9915942,0.00018377195,0.00055578817,0.006881915,0.00069279067,0.000011722698,0.000005095399,0.00002606937,0.000048654732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979174,0.0006093982,0.0005332033,0.00018930981,0.00041235465,0.00033833706],"domain_scores_gemma":[0.99766225,0.0009116841,0.00043939464,0.00019126898,0.00045150673,0.0003438884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005836876,0.00018833141,0.00064330443,0.000057218516,0.00004583783,0.00001171173,0.00026902248,0.00010201677,0.00014320757],"category_scores_gemma":[0.0005426572,0.00010606266,0.00007749479,0.00019056488,0.00015216181,0.00008396252,0.000079873746,0.0006297339,0.000023461118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012725437,0.0004931282,0.9788035,0.000016761278,0.00047263002,0.0001380853,0.001768762,0.000025748895,0.000019876548,0.0000027634198,0.0005378975,0.0049954103],"study_design_scores_gemma":[0.008417116,0.006305469,0.980472,0.00006683056,0.0008969067,0.0000402167,0.00020784509,0.000013999124,0.000055741835,0.000009231592,0.0034099396,0.00010468461],"about_ca_topic_score_codex":0.00009207161,"about_ca_topic_score_gemma":0.00010891077,"teacher_disagreement_score":0.014995689,"about_ca_system_score_codex":0.00008050563,"about_ca_system_score_gemma":0.00047823664,"threshold_uncertainty_score":0.43251097},"labels":[],"label_agreement":null},{"id":"W3022262803","doi":"10.1016/j.juro.2012.02.1868","title":"1417 HYPOXIA IS INDEPENDENTLY ASSOCIATED WITH POOR OUTCOME IN UROTHELIAL BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Library science; Cancer; Internal medicine","score_opus":0.01926919844000826,"score_gpt":0.27909391907830317,"score_spread":0.2598247206382949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022262803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554235,0.0006377632,0.000017842525,0.0026488786,0.00017789484,0.00040444208,0.000030313893,0.000013558972,0.00052695535],"genre_scores_gemma":[0.9959946,0.00006355523,0.0000235968,0.0031653838,0.00023947122,0.000014519534,0.0000048754387,0.000044025663,0.00044993818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804264,0.00028118776,0.0004995898,0.00013130701,0.0005370554,0.0005082182],"domain_scores_gemma":[0.9988191,0.00014101922,0.0004260344,0.00017656323,0.00020968886,0.00022759018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042185475,0.00024509773,0.0005971827,0.00018817508,0.00006409138,0.000008127504,0.00017647207,0.00017059273,0.00044989545],"category_scores_gemma":[0.000064958665,0.00011971795,0.00008405434,0.00027211776,0.00018382019,0.00014104175,0.00002586207,0.00062667695,0.000015754855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073015327,0.0009427165,0.988491,0.0000069944226,0.0009128267,0.00009555299,0.0008779919,0.000012096796,0.00024237085,0.0000033278914,0.00054880965,0.0005647577],"study_design_scores_gemma":[0.02056073,0.0050758948,0.970118,0.000055520264,0.0014308647,0.00055276614,0.00006352754,0.000012067706,0.000671251,0.000012823268,0.001294041,0.00015249978],"about_ca_topic_score_codex":0.00039393545,"about_ca_topic_score_gemma":0.0002012046,"teacher_disagreement_score":0.018373009,"about_ca_system_score_codex":0.00022724415,"about_ca_system_score_gemma":0.00022868093,"threshold_uncertainty_score":0.49260396},"labels":[],"label_agreement":null},{"id":"W3023667587","doi":"10.1097/ju.0000000000000857.016","title":"MP24-16 PREVALENCE, PREDICTORS OF EXPOSURE AND ATHEROEMBOLIC COMPLICATIONS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN BLADDER CARCINOMA","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Chemotherapy; Cohort; Internal medicine; Multivariate analysis; Population; Retrospective cohort study; Cancer; Surgery; Oncology","score_opus":0.017177729783983693,"score_gpt":0.2488080705552956,"score_spread":0.23163034077131192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023667587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98939955,0.002378022,0.000065186214,0.0075190524,0.000026251824,0.00022034215,0.000009892211,0.0000055050004,0.00037619553],"genre_scores_gemma":[0.9977226,0.00052765943,0.00002792717,0.0015935922,0.000072175375,0.0000030582032,0.0000014819352,0.000013609019,0.000037876158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923784,0.0001210192,0.00028685096,0.000083230276,0.00014760139,0.00012347779],"domain_scores_gemma":[0.9993378,0.000105492705,0.00025046006,0.00011630252,0.0001045627,0.00008539507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016905264,0.000094522984,0.00031228157,0.000053305783,0.000024251003,0.0000021798182,0.0001021101,0.0000581826,0.000048533],"category_scores_gemma":[0.000041726464,0.000053219457,0.000038790156,0.00014210536,0.00014942038,0.000032158216,0.000013569544,0.00021193798,6.6513e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018564813,0.0002515134,0.98851615,0.000033432487,0.0004065074,0.000019089757,0.0048065176,0.000047664085,0.0028635806,0.000027889177,0.00032985312,0.00084132847],"study_design_scores_gemma":[0.0049305144,0.0043307706,0.98903245,0.000035590016,0.0003420156,0.00021637672,0.00016323474,0.00005203139,0.0005310504,0.00007796728,0.0002459187,0.00004205712],"about_ca_topic_score_codex":0.00002120257,"about_ca_topic_score_gemma":0.000019027442,"teacher_disagreement_score":0.008323068,"about_ca_system_score_codex":0.000026554811,"about_ca_system_score_gemma":0.00011251826,"threshold_uncertainty_score":0.21702266},"labels":[],"label_agreement":null},{"id":"W3024338611","doi":"10.5489/cuaj.6293","title":"Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: A long-term, single-center study","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Perioperative; Single Center; Medicine; Center (category theory); Term (time); Surgery; General surgery; Bladder cancer; Cancer; Internal medicine; Chemistry","score_opus":0.02044952008979186,"score_gpt":0.27726709956327444,"score_spread":0.2568175794734826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024338611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079037,0.00008389998,0.000035195473,0.0058144554,0.0004107609,0.0011790376,0.000027157485,0.000034954886,0.001624156],"genre_scores_gemma":[0.99640775,0.0000062154418,0.000036155503,0.0029067162,0.0001674423,0.00006451625,0.00002711757,0.000016664366,0.0003674229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796283,0.0003186512,0.00042090798,0.00035258094,0.00044602776,0.00049900636],"domain_scores_gemma":[0.99854493,0.00018725386,0.00017874592,0.00013690155,0.00012416646,0.0008280266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027692618,0.00024554442,0.00057802134,0.0001462474,0.0003969214,0.00018061357,0.00011993845,0.0002405337,0.00049496774],"category_scores_gemma":[0.0002307774,0.00016527499,0.00023578628,0.000120793185,0.0000604672,0.00013534215,0.00003681831,0.0006451889,0.000049533057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059630293,0.00074855116,0.99681914,0.0000030737115,0.0004361571,0.00019743534,0.00068526436,0.0000010049445,0.000064449116,0.000025348878,0.00008212144,0.0008778015],"study_design_scores_gemma":[0.0068845265,0.0019655956,0.98964024,0.000021817954,0.00021440086,0.000114743976,0.00025249773,0.000018236213,0.0000025258423,0.000028784205,0.0006926424,0.00016400914],"about_ca_topic_score_codex":0.0002574052,"about_ca_topic_score_gemma":0.0020530438,"teacher_disagreement_score":0.0071789427,"about_ca_system_score_codex":0.0015755249,"about_ca_system_score_gemma":0.00020979723,"threshold_uncertainty_score":0.67397183},"labels":[],"label_agreement":null},{"id":"W3024396987","doi":"10.1016/j.ejso.2020.05.006","title":"Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder","year":2020,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Adenocarcinoma; Stage (stratigraphy); Internal medicine; Urology; Bladder cancer; Oncology; Proportional hazards model; Carcinoma; Urinary bladder; Surveillance, Epidemiology, and End Results; Cancer; Gastroenterology; Cancer registry; Biology","score_opus":0.015487196530970039,"score_gpt":0.23986710202560224,"score_spread":0.22437990549463221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024396987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894921,0.00043698988,0.000003671714,0.0023405135,0.0001759444,0.00029212976,0.00001487725,0.0000058187297,0.0072379597],"genre_scores_gemma":[0.9991051,0.000038243477,0.00007723952,0.0004119071,0.00020847295,0.0000010287473,0.000002123699,0.000036327816,0.00011958049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977992,0.00074249436,0.0006128754,0.00022117366,0.00036492103,0.00025931062],"domain_scores_gemma":[0.99889314,0.00015691922,0.00034997432,0.00015934082,0.00011460571,0.00032599096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020360497,0.00019485908,0.0006250379,0.00007598601,0.000037145255,0.0000071708378,0.00018347512,0.00002762651,0.00008068252],"category_scores_gemma":[0.000036579906,0.000110470915,0.00013059011,0.0001970477,0.000260292,0.00006272953,0.00013463253,0.0005587098,0.0000038197372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010977111,0.0014617041,0.9619744,0.00012784627,0.000060998173,0.020486709,0.0005159493,0.000008987081,0.0005077913,0.000009954074,0.00023439262,0.0036342042],"study_design_scores_gemma":[0.029284757,0.02134154,0.92321813,0.00002287171,0.00015492161,0.00083983695,0.00011529153,0.000012583111,0.0005571053,0.0000010676514,0.024352161,0.000099739824],"about_ca_topic_score_codex":0.00001699898,"about_ca_topic_score_gemma":0.0000014919062,"teacher_disagreement_score":0.03875623,"about_ca_system_score_codex":0.00006540855,"about_ca_system_score_gemma":0.00024033399,"threshold_uncertainty_score":0.45048732},"labels":[],"label_agreement":null},{"id":"W3024509073","doi":"10.1007/s11934-020-00977-0","title":"Correction to: Genomic Subtyping in Bladder Cancer","year":2020,"lang":"en","type":"erratum","venue":"Current Urology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Decipher Biosciences (Canada); University of British Columbia","funders":"","keywords":"Mistake; Subtyping; Statement (logic); Nephrology; Medicine; Internal medicine; Bladder cancer; Cancer; Computational biology; Bioinformatics; General surgery; Computer science; Programming language; Biology; Linguistics; Philosophy; Law; Political science","score_opus":0.029736414690408643,"score_gpt":0.326427351445973,"score_spread":0.29669093675556435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024509073","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01604574,0.09419409,0.00013993957,0.0071801348,0.82165897,0.0035858667,0.00006434615,0.00039297977,0.05673796],"genre_scores_gemma":[0.53290683,0.023040717,0.000092604954,0.016118133,0.041235983,0.003311777,0.00480371,0.00081615953,0.3776741],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974193,0.00006502244,0.00071031984,0.0010308205,0.00026809954,0.0005064132],"domain_scores_gemma":[0.9987303,0.000027586375,0.0003480145,0.00048708016,0.00010125586,0.00030574764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011876763,0.000442458,0.0009025426,0.00032276544,0.000056506302,0.000015838023,0.0000897754,0.00045482095,0.00065782364],"category_scores_gemma":[0.00017571224,0.00042719877,0.0002009678,0.00033387484,0.000056349774,0.000036970523,0.00010644413,0.0017673813,0.00011854174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021813178,0.00014664841,0.05138976,0.00013412866,0.00019377364,0.0017357265,0.00028991958,0.000021972897,0.000057634843,8.696386e-7,0.9274501,0.018361297],"study_design_scores_gemma":[0.00056204025,0.0003532624,0.07809988,0.00031296318,0.000578913,0.00086569256,0.000009712181,0.00009455118,0.000024977298,0.000037850154,0.91874754,0.00031261385],"about_ca_topic_score_codex":0.0004648288,"about_ca_topic_score_gemma":0.00057910284,"teacher_disagreement_score":0.780423,"about_ca_system_score_codex":0.00047789558,"about_ca_system_score_gemma":0.0015535606,"threshold_uncertainty_score":0.99981797},"labels":[],"label_agreement":null},{"id":"W3024665518","doi":"10.1016/j.clgc.2020.05.004","title":"Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada; Eisai; Astellas Pharma; British Microcirculation Society; Merck Sharp and Dohme; Janssen Biotech; Meso Scale Diagnostics; Les Laboratories Pierre Fabre; Ipsen; Pharmacyclics; Astellas Pharma Canada; Sanofi España; Sanofi; GlaxoSmithKline Japan; Boehringer Ingelheim; Roche; Novartis; Bayer; University of Bristol; Merck; Novartis Farmacéutica; Ipsen Biopharmaceuticals; Bristol-Myers Squibb; AstraZeneca; Pfizer; Takeda Pharmaceutical Company","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Internal medicine; Urothelial cancer; Overall survival; Cancer; Bladder cancer","score_opus":0.08429556182043416,"score_gpt":0.40567108539705654,"score_spread":0.32137552357662236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024665518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928056,0.0011295516,0.000017446739,0.0026781287,0.0007996688,0.0014775533,0.00062210136,0.000028557155,0.0004413682],"genre_scores_gemma":[0.99603635,0.0005699479,0.0000681427,0.0016045626,0.0008536961,0.0002929521,0.000044529337,0.00005755897,0.00047228465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969485,0.00019995146,0.0010727098,0.00079530216,0.0005229993,0.00046058305],"domain_scores_gemma":[0.99824166,0.00020012638,0.00031611163,0.00066106045,0.00027330688,0.0003077342],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016727974,0.00039907556,0.0012417543,0.00011612563,0.000073442156,0.000011822424,0.00032726588,0.00015927496,0.0010444502],"category_scores_gemma":[0.00014572077,0.00028958818,0.00076140754,0.0009445415,0.00023500617,0.00009044628,0.00015932298,0.0005434301,0.000012268661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066160455,0.0031097447,0.9146055,0.00010924406,0.0016752294,0.00052352337,0.0021423446,0.00053410913,0.00017224663,0.0000013869898,0.00016437947,0.010801856],"study_design_scores_gemma":[0.059427254,0.011071705,0.9205159,0.00010301974,0.0031060805,0.0000018846556,0.0011620496,0.00041564938,0.00052728585,0.0000041017865,0.003344179,0.00032088507],"about_ca_topic_score_codex":0.0005113893,"about_ca_topic_score_gemma":0.0016484067,"teacher_disagreement_score":0.010480971,"about_ca_system_score_codex":0.00027044557,"about_ca_system_score_gemma":0.0005673624,"threshold_uncertainty_score":0.99995565},"labels":[],"label_agreement":null},{"id":"W3025062498","doi":"10.1016/j.euo.2020.04.005","title":"Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro; Merck","keywords":"Fibroblast growth factor receptor 3; Bladder cancer; Medicine; Fibroblast growth factor receptor 4; Cancer research; Oncology; Pathological; Fibroblast growth factor receptor 2; Fibroblast growth factor receptor; Cancer; Internal medicine; Biology; Receptor; Fibroblast growth factor","score_opus":0.03695168064423887,"score_gpt":0.29507588222711273,"score_spread":0.25812420158287386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025062498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533364,0.00010501488,0.000028336137,0.038211897,0.00019554705,0.0031743958,0.004372414,0.000039482373,0.0005364989],"genre_scores_gemma":[0.98515195,0.00003090885,0.00021488685,0.013817621,0.00017730624,0.00012363443,0.00037998913,0.00005547243,0.000048259455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752414,0.00087145745,0.00049019186,0.0005968894,0.00020394246,0.00031338795],"domain_scores_gemma":[0.9979825,0.0006172824,0.00038026104,0.0003789835,0.00046798875,0.00017299246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000741803,0.0003052803,0.00060239225,0.000036064506,0.0002189547,0.000017158147,0.00021687245,0.00008527469,0.00014608206],"category_scores_gemma":[0.00018297024,0.00017072086,0.00007949324,0.00015420122,0.00044815388,0.00004292472,0.00018006613,0.00035489892,0.0000035396404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034184013,0.0064868922,0.71942264,0.00015831825,0.012538741,0.00029802864,0.08951134,0.00040128746,0.017636152,0.00025416695,0.11366856,0.0054398435],"study_design_scores_gemma":[0.030293806,0.012968501,0.94285923,0.000018800194,0.0013690669,0.00000793562,0.0012594102,0.000039697577,0.00024403658,0.000021599368,0.010736593,0.00018130637],"about_ca_topic_score_codex":0.00061865797,"about_ca_topic_score_gemma":0.0018855832,"teacher_disagreement_score":0.2234366,"about_ca_system_score_codex":0.000100095174,"about_ca_system_score_gemma":0.0006110321,"threshold_uncertainty_score":0.69617945},"labels":[],"label_agreement":null},{"id":"W3025146952","doi":"10.1016/j.urolonc.2020.04.016","title":"A novel prevention bundle to reduce incisional infections after radical cystectomy","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cystectomy; Surgery; Surgical site infection; Cohort; Bladder cancer; Internal medicine; Cancer","score_opus":0.043439840515320696,"score_gpt":0.33974015162747684,"score_spread":0.29630031111215616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025146952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94960237,0.00041827108,0.002844021,0.04346495,0.00017460874,0.00067917403,0.000047764956,0.00010424954,0.0026645828],"genre_scores_gemma":[0.88132924,0.00008027311,0.09586931,0.020719443,0.0004997619,0.00049719843,0.000062315485,0.000021393837,0.00092108466],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888796,0.000061169936,0.00025648763,0.0003951057,0.00016457192,0.00023468926],"domain_scores_gemma":[0.9990524,0.000101177466,0.000060681,0.00012719275,0.000060777325,0.00059774355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011635269,0.00016994699,0.00028985259,0.0001029883,0.00018030922,0.000018665272,0.00006091849,0.00018746601,0.0003594927],"category_scores_gemma":[0.00021856463,0.00014253601,0.000074626034,0.000372122,0.00028867097,0.00008920892,0.00006249261,0.00029666116,0.000107073414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050244485,0.008661177,0.85539436,0.00023566518,0.00080036774,0.0006525943,0.0059526693,0.00033669276,0.031202702,0.013021632,0.058105107,0.020612592],"study_design_scores_gemma":[0.0022930629,0.011755694,0.011735309,0.00005781088,0.00035333887,0.000765847,0.000086636595,0.0002961933,0.00067463884,0.0017148012,0.9700878,0.00017881632],"about_ca_topic_score_codex":0.00004827024,"about_ca_topic_score_gemma":0.000025427002,"teacher_disagreement_score":0.9119827,"about_ca_system_score_codex":0.000116391406,"about_ca_system_score_gemma":0.0005009511,"threshold_uncertainty_score":0.581245},"labels":[],"label_agreement":null},{"id":"W3026191433","doi":"10.1101/2020.05.22.101428","title":"Personalized <i>in-silico</i> drug response prediction based on the genetic landscape of muscle-invasive bladder cancer","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"In silico; Drug response; Drug; Bladder cancer; Computational biology; Bioinformatics; Workflow; Clinical trial; Personalized medicine; Medicine; Oncology; Gene; Biology; Cancer; Computer science; Internal medicine; Pharmacology; Database; Genetics","score_opus":0.018638003174723427,"score_gpt":0.24162862356545095,"score_spread":0.22299062039072753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026191433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897207,0.0020815833,0.00006977374,0.0050785905,0.00061909,0.0018659862,0.0011084056,0.00016311395,0.000041380066],"genre_scores_gemma":[0.99537593,0.0005863072,0.00037879832,0.002266003,0.0004284832,0.0008118991,0.0000011561822,0.00013450262,0.000016915552],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970031,0.00041692294,0.0005649363,0.0009258602,0.0006766745,0.00041249784],"domain_scores_gemma":[0.99761844,0.00034257278,0.0003449546,0.0010923791,0.00034729624,0.00025437944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045103615,0.0005446008,0.00075747987,0.0002627902,0.00008839096,0.00004370354,0.0003136875,0.0003243701,0.0003482614],"category_scores_gemma":[0.00034887844,0.00042893272,0.00028456928,0.0005639915,0.00016453743,0.000038647027,0.00012439695,0.00077146513,0.000025080799],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009330809,0.0011057486,0.15738067,0.0016392912,0.0010949529,0.00043136664,0.00036347742,0.0009860843,0.8219234,0.000070419104,0.005661892,0.0000119244105],"study_design_scores_gemma":[0.0048644664,0.00042740442,0.8087169,0.0019253284,0.0007616711,3.159659e-8,0.00002839678,0.0019778917,0.17851943,0.0000018463376,0.0023076318,0.00046902598],"about_ca_topic_score_codex":0.00022689765,"about_ca_topic_score_gemma":0.000015864165,"teacher_disagreement_score":0.6513362,"about_ca_system_score_codex":0.00036366066,"about_ca_system_score_gemma":0.002454901,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W3027333880","doi":"10.1007/s00345-020-03247-3","title":"Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Bladder cancer; Urology; Oncology; Internal medicine; Chemotherapy; Lymph node; Proportional hazards model; Population; Cancer; Surgery","score_opus":0.010037830364062313,"score_gpt":0.24134017188527468,"score_spread":0.23130234152121237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027333880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943347,0.00036875086,0.00006237733,0.0043268157,0.00009535174,0.0005872749,0.000003867772,0.000011556441,0.00020929292],"genre_scores_gemma":[0.99565494,0.000001337262,0.0001579688,0.0039013922,0.00019621593,0.000008029934,0.0000073692513,0.00003137996,0.000041354226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986836,0.00011927715,0.00042558735,0.00019630406,0.00035181505,0.00022345572],"domain_scores_gemma":[0.9992648,0.00006097453,0.00022195841,0.00013424823,0.0001061945,0.00021182717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088776294,0.00017426844,0.0005055633,0.00023266926,0.00003160957,0.000007955969,0.00010595427,0.000060371378,0.000285963],"category_scores_gemma":[0.000021888898,0.00012280482,0.00008459092,0.00033293903,0.000031732583,0.000045927038,0.00001063344,0.00041270975,0.0000057063226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009741239,0.0013686069,0.986612,0.000019533436,0.000079686724,0.00044097577,0.0006339945,0.00030665335,0.000015523878,0.0000016625585,0.00027168184,0.000508404],"study_design_scores_gemma":[0.05208245,0.009386284,0.9372543,0.000007458342,0.0002392382,0.000018321281,0.0000521752,0.0001158826,0.000026680225,0.000007373777,0.00071241433,0.00009739805],"about_ca_topic_score_codex":0.00006517468,"about_ca_topic_score_gemma":0.000115979376,"teacher_disagreement_score":0.049357716,"about_ca_system_score_codex":0.0001291984,"about_ca_system_score_gemma":0.00026926785,"threshold_uncertainty_score":0.5007835},"labels":[],"label_agreement":null},{"id":"W3027479246","doi":"10.1186/s12881-020-01050-w","title":"A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)","year":2020,"lang":"en","type":"article","venue":"BMC Medical Genetics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"Région Normandie","keywords":"Biology; Multiplex polymerase chain reaction; Multiplex; Molecular biology; Polymerase chain reaction; Bladder cancer; DNA; Genetics; Gene; Cancer","score_opus":0.03477461244651903,"score_gpt":0.30047778337297637,"score_spread":0.26570317092645734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027479246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6001759,0.00044561506,0.39293748,0.00037216884,0.00023848818,0.00415287,0.0016519992,0.0000066892235,0.000018756522],"genre_scores_gemma":[0.9897879,0.00025026148,0.008981954,0.00032753742,0.00009288795,0.00047241527,0.00003293399,0.00003883272,0.000015274842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801546,0.00012285769,0.00063682295,0.00029525883,0.0006989288,0.00023064818],"domain_scores_gemma":[0.9964575,0.0016722997,0.00049765233,0.00025003531,0.0009940752,0.0001284268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023718672,0.00020342837,0.00054913067,0.0000560435,0.00004475017,0.0000022408824,0.00017288332,0.00012695066,0.00005001404],"category_scores_gemma":[0.0010708167,0.00012036909,0.00015413278,0.00037782677,0.00026899838,0.000021192798,0.000032812324,0.00012780892,1.7701312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011390372,0.0042142416,0.7922345,0.003677815,0.0029469896,0.0000013474878,0.010919993,0.025367858,0.08621205,0.000015486366,0.00041342268,0.062605955],"study_design_scores_gemma":[0.012461455,0.0024444,0.75159895,0.000320351,0.0007557203,5.691622e-7,0.0003174543,0.00832006,0.22356506,0.00001734313,0.000052310632,0.00014629567],"about_ca_topic_score_codex":0.0006434514,"about_ca_topic_score_gemma":0.0018066759,"teacher_disagreement_score":0.389612,"about_ca_system_score_codex":0.000058963422,"about_ca_system_score_gemma":0.0011043255,"threshold_uncertainty_score":0.49085093},"labels":[],"label_agreement":null},{"id":"W3028210810","doi":"10.1016/j.eururo.2020.03.017","title":"Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]","year":2020,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Regret; Urology; Bladder cancer; Consensus conference; General surgery; Gynecology; Cancer; Internal medicine","score_opus":0.05825446353727916,"score_gpt":0.3427683230842654,"score_spread":0.28451385954698627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028210810","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14076048,0.008346729,0.0006514023,0.2825548,0.103528954,0.015535124,0.0066114487,0.00036358344,0.44164747],"genre_scores_gemma":[0.83074886,0.004703751,0.00080045935,0.068137765,0.0026120166,0.00026414904,0.0007450253,0.0004985818,0.09148939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500734,0.0015685449,0.0011980211,0.0010023513,0.0006970246,0.0005267366],"domain_scores_gemma":[0.9966943,0.00017101357,0.0009874387,0.0012808705,0.0006545884,0.00021173574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007486125,0.00070225156,0.0008587224,0.00013292584,0.00029469182,0.000041427204,0.0012273286,0.00016249054,0.00040851292],"category_scores_gemma":[0.00011846064,0.00039466625,0.00017842358,0.00040861586,0.0007897294,0.000054687825,0.0007780017,0.000991171,0.000049689483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038843963,0.0007541705,0.0019619125,0.00024833818,0.008234844,0.0011727869,0.0037600321,0.0014737496,0.00022087226,0.0039209817,0.967849,0.0065189213],"study_design_scores_gemma":[0.0044064033,0.0024063203,0.106040694,0.00020650485,0.0016682904,0.00007577665,0.0017143487,0.0002804135,0.000056421697,0.00009065412,0.8826649,0.00038925256],"about_ca_topic_score_codex":0.00036907964,"about_ca_topic_score_gemma":0.00052222435,"teacher_disagreement_score":0.6899884,"about_ca_system_score_codex":0.00010856203,"about_ca_system_score_gemma":0.00029706015,"threshold_uncertainty_score":0.9998505},"labels":[],"label_agreement":null},{"id":"W3029005700","doi":"10.1200/jco.2020.38.15_suppl.5035","title":"Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Atezolizumab; Clinical endpoint; Adverse effect; Internal medicine; Performance status; Post-hoc analysis; Population; Clinical trial; Oncology; Cancer; Surgery; Immunotherapy","score_opus":0.06485087495779752,"score_gpt":0.41273114503154756,"score_spread":0.34788027007375005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029005700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963373,0.0003136368,0.00006489588,0.0011287743,0.00021111089,0.0015983949,0.00006044016,0.0000049510195,0.00028051037],"genre_scores_gemma":[0.9975778,0.00019689856,0.00079506973,0.0012410803,0.00011526579,0.00003376932,0.000004636381,0.000017476756,0.000018040075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967868,0.0003255434,0.0017648154,0.00029009883,0.000532996,0.00029975947],"domain_scores_gemma":[0.9970321,0.00044446407,0.0014422853,0.00020024025,0.00060733483,0.00027359044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060131826,0.00021045073,0.0018538237,0.00009804429,0.000044665663,0.0000058298715,0.00021526837,0.000109426954,0.00003775089],"category_scores_gemma":[0.00043683816,0.000112211106,0.0005437336,0.00080345897,0.0001642018,0.00013886034,0.00003704358,0.0004938259,0.0000012197339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059981655,0.011542939,0.8607129,0.000033879776,0.0025402561,0.00013279487,0.00062653836,0.00038719943,0.0000024120038,0.0000024562992,0.000040566294,0.06399641],"study_design_scores_gemma":[0.0436091,0.14973806,0.80318105,0.000044776807,0.002211782,0.000020636713,0.00045979256,0.0003392282,0.000025322854,0.000024145853,0.00026316018,0.00008291792],"about_ca_topic_score_codex":0.000055920893,"about_ca_topic_score_gemma":0.00007407103,"teacher_disagreement_score":0.13819513,"about_ca_system_score_codex":0.0004051842,"about_ca_system_score_gemma":0.0019872237,"threshold_uncertainty_score":0.4575836},"labels":[],"label_agreement":null},{"id":"W3029044426","doi":"10.1200/jco.2020.38.15_suppl.5041","title":"Pembrolizumab (pembro) for the treatment of patients with Bacillus Calmette-Guérin (BCG) unresponsive, high-risk (HR) non–muscle-invasive bladder cancer (NMIBC): Over two years follow-up of KEYNOTE-057.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Discontinuation; Bladder cancer; Cystectomy; Pembrolizumab; Cohort; Internal medicine; Clinical endpoint; Surgery; Cancer; Urology; Clinical trial; Immunotherapy","score_opus":0.06598830685295298,"score_gpt":0.40478647719333694,"score_spread":0.33879817034038395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029044426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924733,0.00083004707,0.00038132988,0.0032044915,0.0012736573,0.0012390782,0.0004369067,0.000008156455,0.0001530078],"genre_scores_gemma":[0.9927674,0.0026091717,0.0012953404,0.0018864154,0.0010791224,0.00005869902,0.000014093209,0.00005628378,0.00023348106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961078,0.00038766876,0.002096874,0.00036795274,0.00066933536,0.0003703734],"domain_scores_gemma":[0.99140066,0.004237062,0.0025258153,0.0003614814,0.0010137644,0.00046119973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050514605,0.00032951904,0.00224762,0.000113443915,0.000065384425,0.000007527448,0.00026531937,0.00030087357,0.00035418733],"category_scores_gemma":[0.0012987823,0.00018382576,0.0009788495,0.00026007355,0.00038155925,0.00009718894,0.000045721077,0.0004870183,0.0000063411567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17200439,0.0063016573,0.3879206,0.00012361853,0.009972875,0.00031071884,0.0021809,0.0005448474,0.00028092595,0.0000380809,0.00659043,0.41373098],"study_design_scores_gemma":[0.11089004,0.105120115,0.74909174,0.00012277455,0.005074513,0.0000109116045,0.00018166886,0.00007675049,0.00084096123,0.00007033427,0.028340137,0.00018004503],"about_ca_topic_score_codex":0.0009224051,"about_ca_topic_score_gemma":0.00057870185,"teacher_disagreement_score":0.41355094,"about_ca_system_score_codex":0.00032982332,"about_ca_system_score_gemma":0.0030279972,"threshold_uncertainty_score":0.74961966},"labels":[],"label_agreement":null},{"id":"W3029622210","doi":"10.1200/jco.2020.38.15_suppl.tps5091","title":"A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± linrodostat mesylate, followed by adjuvant postsurgical NIVO ± linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Bladder cancer; Cystectomy; Cisplatin; Internal medicine; Oncology; Chemotherapy; Nivolumab; Carboplatin; Cancer; Urology; Immunotherapy","score_opus":0.07030212255951653,"score_gpt":0.43265832980849134,"score_spread":0.3623562072489748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029622210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337823,0.0013233757,0.00017184035,0.011570011,0.0004081347,0.0027897416,0.00003219734,0.000017969705,0.0003085086],"genre_scores_gemma":[0.99065423,0.0040548397,0.0006027138,0.0040155975,0.00028833628,0.00008703845,0.000020117248,0.00006533189,0.00021181339],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9919638,0.0013775832,0.0047335215,0.0005693144,0.00087919575,0.00047658902],"domain_scores_gemma":[0.99227536,0.0034864678,0.0027381275,0.0002740998,0.00065004005,0.0005759058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027517783,0.00043305996,0.0055222223,0.0003115549,0.000045162487,0.000016601061,0.00027538257,0.00044921337,0.0005068543],"category_scores_gemma":[0.001994747,0.00027406667,0.0005165144,0.0007498815,0.00036405431,0.00023655788,0.00006555013,0.0013678381,0.0000049335767],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86951077,0.03736599,0.026356027,0.00008227545,0.0020254003,0.0037061283,0.006686719,0.00011849961,0.0015902541,0.000008693716,0.0036731923,0.048876043],"study_design_scores_gemma":[0.88662386,0.093807265,0.011835161,0.0004312839,0.0010983099,0.00009771906,0.0019971274,0.0008913865,0.0010016358,0.00005063942,0.0018783245,0.00028728205],"about_ca_topic_score_codex":0.0016001727,"about_ca_topic_score_gemma":0.002259963,"teacher_disagreement_score":0.05644127,"about_ca_system_score_codex":0.00035943347,"about_ca_system_score_gemma":0.0034757736,"threshold_uncertainty_score":0.99997115},"labels":[],"label_agreement":null},{"id":"W3029752697","doi":"10.1007/s10147-020-01690-1","title":"Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"International Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Hazard ratio; Meta-analysis; Internal medicine; Oncology; Confidence interval; Surgical oncology; Urology; Neutrophil to lymphocyte ratio; Carcinoma; Cancer; Lymphocyte","score_opus":0.13748467742122927,"score_gpt":0.4598249686503109,"score_spread":0.32234029122908164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029752697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006966762,0.9940982,0.000026853446,0.0020320944,0.00011339057,0.0027397992,0.0001239522,0.0000033261783,0.00016574323],"genre_scores_gemma":[0.053503387,0.9450459,0.00039175584,0.0007253668,0.00008740929,0.00015399595,0.000010903106,0.000028397002,0.000052919277],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99170566,0.0024730377,0.0046257223,0.00032991476,0.0007240282,0.00014161335],"domain_scores_gemma":[0.9913925,0.0026812076,0.0047572893,0.00027461944,0.0007253747,0.00016900463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014769456,0.00036657252,0.013154538,0.00033682364,0.000013031391,0.000007878572,0.00052372937,0.00033974132,0.00013902332],"category_scores_gemma":[0.0029381248,0.0001552077,0.0034227846,0.000655365,0.0004639779,0.00004698312,0.00010148846,0.0007219974,0.0000018525169],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011976042,0.0015466436,0.009661635,0.17497426,0.80748314,0.0016078481,0.00011335852,0.0000024061983,3.4678516e-7,0.000118591,0.000074617514,0.0032195572],"study_design_scores_gemma":[0.0031269584,0.0035030814,0.0011192324,0.032734346,0.9542526,0.0023289,0.000022824923,0.000013856908,0.0000037561615,0.0000179203,0.0027390264,0.00013749681],"about_ca_topic_score_codex":0.000055352757,"about_ca_topic_score_gemma":0.000026528998,"teacher_disagreement_score":0.14676946,"about_ca_system_score_codex":0.0001843537,"about_ca_system_score_gemma":0.002521837,"threshold_uncertainty_score":0.8992179},"labels":[],"label_agreement":null},{"id":"W3031108451","doi":"10.1200/jco.2020.38.15_suppl.tps5090","title":"A phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): CheckMate 9UT.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Bladder cancer; Internal medicine; Oncology; Tolerability; Mesylate; Immunotherapy; Cancer; Urology; Adverse effect","score_opus":0.11478549514335204,"score_gpt":0.44579637863702554,"score_spread":0.33101088349367347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031108451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847512,0.00102839,0.00018459867,0.008802994,0.0017719031,0.0028483574,0.00014056863,0.000037483056,0.00043447834],"genre_scores_gemma":[0.9877292,0.004076266,0.0012833673,0.0041727154,0.0017430548,0.00012768377,0.000012441524,0.00010088276,0.0007543751],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98771805,0.0032892372,0.006162874,0.00086080114,0.0011539058,0.00081513275],"domain_scores_gemma":[0.9864319,0.0068711494,0.003867692,0.00053729356,0.0010073629,0.0012846113],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040496644,0.00069070485,0.007583558,0.00043724527,0.00014802898,0.000026538944,0.0005849179,0.00082824496,0.0015452793],"category_scores_gemma":[0.013198031,0.00046910273,0.0011659958,0.0008369961,0.00075840746,0.00029872553,0.00034071328,0.0028690319,0.000032541087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88663524,0.01949721,0.0034744926,0.00016181706,0.0053590667,0.008377428,0.008211304,0.00053991674,0.0008811262,0.000015444033,0.0050845025,0.06176247],"study_design_scores_gemma":[0.8501204,0.12345165,0.011264106,0.00035049964,0.0042806542,0.00027389597,0.0025681064,0.0012194517,0.0011739589,0.000114790586,0.004674838,0.0005076291],"about_ca_topic_score_codex":0.0037047758,"about_ca_topic_score_gemma":0.0043481337,"teacher_disagreement_score":0.10395444,"about_ca_system_score_codex":0.00092239166,"about_ca_system_score_gemma":0.009400509,"threshold_uncertainty_score":0.99977607},"labels":[],"label_agreement":null},{"id":"W3031320380","doi":"10.1097/coc.0000000000000704","title":"The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Chemotherapy; Hazard ratio; Internal medicine; Propensity score matching; Oncology; Urology; Surgery; Confidence interval","score_opus":0.05299939664535952,"score_gpt":0.38595632455785617,"score_spread":0.33295692791249665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031320380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927536,0.00030969415,0.00002339811,0.006084423,0.00019540168,0.00048219052,0.000005153616,0.000002483676,0.00014363075],"genre_scores_gemma":[0.9973158,0.00027616922,0.00016537867,0.0020574208,0.0001345913,0.0000067790365,6.8432337e-7,0.000020048068,0.000023121294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657124,0.0013334431,0.0012808566,0.00015688268,0.0004901445,0.00016740999],"domain_scores_gemma":[0.99436915,0.0034300296,0.0016392757,0.00023463767,0.00016810036,0.00015881442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009000359,0.00015318008,0.0014977315,0.000041005856,0.00002667512,0.0000022505917,0.00025991566,0.000052534164,0.000029447894],"category_scores_gemma":[0.00060569716,0.000058611728,0.00031241597,0.000331446,0.0008481936,0.000024706891,0.000027135446,0.00047090868,0.0000018973935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093570456,0.00080207316,0.8588848,0.00005099951,0.000954755,0.00008355571,0.00024890585,0.00002374192,0.000008443778,0.000008407408,0.00033328534,0.04503056],"study_design_scores_gemma":[0.025704654,0.19334501,0.77786195,0.00033266243,0.00059006206,0.00011776572,0.00045005546,0.000016303919,0.00011303164,0.000009398677,0.0013905925,0.00006847941],"about_ca_topic_score_codex":0.00004296405,"about_ca_topic_score_gemma":0.00000783382,"teacher_disagreement_score":0.19254294,"about_ca_system_score_codex":0.00007096548,"about_ca_system_score_gemma":0.0007659458,"threshold_uncertainty_score":0.31252044},"labels":[],"label_agreement":null},{"id":"W3031541689","doi":"10.1200/jco.19.02959","title":"Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Western University","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Cancer; Oncology; Urothelial cancer; Internal medicine","score_opus":0.26619828502869874,"score_gpt":0.5065429100194535,"score_spread":0.24034462499075476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031541689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66998047,0.003816652,0.001245294,0.31869835,0.0032205652,0.0014337058,0.00015478334,0.000031588013,0.0014185825],"genre_scores_gemma":[0.8661502,0.01289263,0.0008752901,0.11512892,0.004727836,0.000033523243,0.0000039134584,0.00003293383,0.00015474929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970024,0.00020851815,0.0018363326,0.0003038964,0.00036695861,0.0002818748],"domain_scores_gemma":[0.99580455,0.0014724373,0.0013353821,0.00016196037,0.0006223209,0.00060334406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087110855,0.00021210594,0.0017625426,0.00003778141,0.000050888866,0.000010435028,0.00019706583,0.00035682064,0.00092543394],"category_scores_gemma":[0.00092748075,0.00014307759,0.0010194822,0.00011506144,0.00017081588,0.00008481054,0.000019761785,0.00064942724,0.000013658479],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020026065,0.0025935397,0.012650284,0.000062087325,0.002441684,0.0001141739,0.0014382233,0.0000029236526,0.0015074197,0.00011265806,0.060464025,0.8985869],"study_design_scores_gemma":[0.057646316,0.040078904,0.07478327,0.00007284223,0.00067277707,0.00003809993,0.00015865269,0.000059805785,0.009876113,0.00028457804,0.8161367,0.00019192723],"about_ca_topic_score_codex":0.000043404103,"about_ca_topic_score_gemma":0.000011129287,"teacher_disagreement_score":0.898395,"about_ca_system_score_codex":0.00015768058,"about_ca_system_score_gemma":0.0042621233,"threshold_uncertainty_score":0.99998784},"labels":[],"label_agreement":null},{"id":"W3031636641","doi":"10.1136/jclinpath-2020-206631","title":"Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Immune system; Transcriptome; Chemokine; Cancer research; Immunotherapy; PD-L1; Immune checkpoint; Atezolizumab; Biology; Gene expression; Immunology; Medicine; Gene; Nivolumab; Genetics","score_opus":0.0696583508737638,"score_gpt":0.36540148456563865,"score_spread":0.2957431336918748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031636641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500275,0.00054692506,0.000034076485,0.0031382462,0.0006727097,0.00051195396,0.000010868764,0.000005257116,0.00007720202],"genre_scores_gemma":[0.99792594,0.000086548345,0.0006361565,0.0005965993,0.0006998239,0.000006884019,7.894583e-7,0.000018439163,0.000028828179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970356,0.0005859528,0.0016583008,0.00020419878,0.00033716077,0.00017874411],"domain_scores_gemma":[0.9984734,0.00023992184,0.00077084126,0.00025113786,0.00012072514,0.00014397231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007201647,0.00013948561,0.0009565945,0.000066651926,0.00003110413,0.0000041284843,0.00024209723,0.00015371703,0.00005350778],"category_scores_gemma":[0.00090855616,0.00007961648,0.00034491913,0.00017814078,0.00013281815,0.00004802963,0.00011632107,0.0006880971,0.000003808218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024010262,0.0016888939,0.90730256,0.000027246837,0.000097137054,0.0010681823,0.0009504621,0.000013067017,0.0843642,0.0000049300947,0.00012192266,0.0019603444],"study_design_scores_gemma":[0.012292142,0.0058819125,0.90411896,0.00009533223,0.000216305,0.00021155468,0.0003682122,0.000009091463,0.07656796,0.0000800759,0.00009378695,0.000064652086],"about_ca_topic_score_codex":0.000024914449,"about_ca_topic_score_gemma":0.00000474041,"teacher_disagreement_score":0.009891116,"about_ca_system_score_codex":0.000023357416,"about_ca_system_score_gemma":0.00033230367,"threshold_uncertainty_score":0.3246666},"labels":[],"label_agreement":null},{"id":"W3031660308","doi":"10.1200/jco.2020.38.15_suppl.5043","title":"Dissecting outcomes of patients (pts) with &lt;ypT2N0 disease after neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC): Results from a large, international, multicenter collaboration.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Internal medicine; Regimen; Cisplatin; Gemcitabine; Oncology; Urology; Chemotherapy; Gastroenterology; Cancer","score_opus":0.06037504938319243,"score_gpt":0.4225081107538845,"score_spread":0.36213306137069207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031660308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692886,0.00023773083,0.00023768295,0.026932959,0.0012494723,0.0006703205,0.0012043886,0.0000070247534,0.00017184782],"genre_scores_gemma":[0.9872712,0.00038599412,0.002374436,0.008488001,0.0011927997,0.000043135125,0.00007156747,0.000031048017,0.00014184506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727666,0.000101369165,0.0017141957,0.00028598146,0.00043016564,0.0001915997],"domain_scores_gemma":[0.9948949,0.0012707746,0.0016110727,0.00015346645,0.0016254558,0.00044429093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032672696,0.00018205422,0.0010447676,0.000057419744,0.000034156565,0.000014329172,0.00015064266,0.00014795952,0.0003731256],"category_scores_gemma":[0.0037000217,0.00011631897,0.00034651623,0.0001122194,0.00008529131,0.00018076046,0.000036822476,0.00028861978,0.0000041850953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0892683,0.0036966433,0.88543826,0.000034493238,0.002272475,0.00012828481,0.001888853,0.00003771738,0.00006818192,0.0000036795798,0.003780744,0.013382372],"study_design_scores_gemma":[0.05811441,0.006199383,0.89798653,0.00017367076,0.0008131196,6.5583197e-7,0.00046408141,0.00019683322,0.00018638714,0.000043057316,0.035703164,0.00011872006],"about_ca_topic_score_codex":0.00004257237,"about_ca_topic_score_gemma":0.00033168428,"teacher_disagreement_score":0.03192242,"about_ca_system_score_codex":0.0001584253,"about_ca_system_score_gemma":0.0012653535,"threshold_uncertainty_score":0.474335},"labels":[],"label_agreement":null},{"id":"W3032077319","doi":"10.1200/jco.2020.38.15_suppl.5046","title":"Detection of urothelial carcinoma using plasma cell-free methylated DNA.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia","funders":"Dana-Farber Cancer Institute","keywords":"Differentially methylated regions; Bladder cancer; DNA methylation; Cell-free fetal DNA; Bisulfite sequencing; Medicine; Methylated DNA immunoprecipitation; Epigenetics; Molecular biology; Cancer research; Oncology; Cancer; Internal medicine; Biology; Gene; Gene expression; Genetics; Fetus; Prenatal diagnosis","score_opus":0.16159154446492577,"score_gpt":0.4295596021902208,"score_spread":0.2679680577252951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032077319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992697,0.0002770463,0.0007496589,0.0026970645,0.001067297,0.0001786416,0.00000916167,0.000009179863,0.0023149643],"genre_scores_gemma":[0.9938966,0.000095843,0.00304847,0.0013216985,0.0015689649,9.242066e-7,6.270182e-7,0.000020779014,0.000046113226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972432,0.00031219207,0.0017955209,0.00015800325,0.0003265618,0.0001644841],"domain_scores_gemma":[0.9971766,0.00056729064,0.001345323,0.00016165683,0.0003500325,0.000399108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007547103,0.00012627884,0.0012507738,0.00008084967,0.000027743044,0.000003504918,0.0001617493,0.00033771235,0.00013818548],"category_scores_gemma":[0.0016086746,0.00009281448,0.0005100816,0.00017592974,0.00012047427,0.00007207324,0.000051095143,0.00065964175,0.000009723179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053642165,0.0040937546,0.08559131,0.00030375575,0.0018265673,0.0021916127,0.0011271276,0.00018409171,0.6486019,0.000025196132,0.0020451434,0.2003674],"study_design_scores_gemma":[0.08918588,0.107096165,0.123719804,0.00015369967,0.0049022133,0.001123289,0.00052702776,0.0039572846,0.621581,0.00053739926,0.046846572,0.00036964976],"about_ca_topic_score_codex":0.00006467076,"about_ca_topic_score_gemma":0.000011072562,"teacher_disagreement_score":0.19999775,"about_ca_system_score_codex":0.00012284,"about_ca_system_score_gemma":0.0016634098,"threshold_uncertainty_score":0.37848648},"labels":[],"label_agreement":null},{"id":"W3032169917","doi":"10.1200/jco.2020.38.15_suppl.5022","title":"Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"National Institutes of Health","keywords":"Medicine; Atezolizumab; Concomitant; Bladder cancer; Clinical endpoint; Cystectomy; Urology; Cystoscopy; Internal medicine; Oncology; Surgery; Cancer; Clinical trial; Immunotherapy; Urinary system; Pembrolizumab","score_opus":0.16231594956720488,"score_gpt":0.4948129775006119,"score_spread":0.33249702793340696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032169917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729054,0.0007184803,0.000037214748,0.020988429,0.0016943046,0.00072502694,0.000039362618,0.000008549565,0.0028832334],"genre_scores_gemma":[0.9872896,0.0023410337,0.0005080433,0.0067126406,0.0028985906,0.000022336173,0.0000043701475,0.000031270567,0.00019213452],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995125,0.00055314484,0.00315034,0.00031792987,0.00051433913,0.00033923893],"domain_scores_gemma":[0.9945497,0.0020104835,0.002004298,0.00022199939,0.00055652903,0.000657016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012725497,0.0002394413,0.0025347376,0.00017639658,0.000044503104,0.0000057646334,0.00025915142,0.00047172586,0.0007857903],"category_scores_gemma":[0.0050447625,0.00017697817,0.00076332106,0.00034515737,0.0002621424,0.00014302359,0.000106343294,0.0011678732,0.000024010398],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6423087,0.019553192,0.0059659216,0.00010357869,0.0017808732,0.00361929,0.0027608515,0.00004745954,0.003838389,0.000027351382,0.018554915,0.30143946],"study_design_scores_gemma":[0.6204429,0.2937184,0.02451529,0.00032215603,0.001431242,0.000121052406,0.00062756287,0.00009288843,0.00308752,0.00026435696,0.055133056,0.00024353349],"about_ca_topic_score_codex":0.00020415844,"about_ca_topic_score_gemma":0.00019152483,"teacher_disagreement_score":0.30119592,"about_ca_system_score_codex":0.00025529103,"about_ca_system_score_gemma":0.0073071374,"threshold_uncertainty_score":0.9983205},"labels":[],"label_agreement":null},{"id":"W3032218776","doi":"10.1200/jco.2020.38.15_suppl.5048","title":"Outcomes of patients (pts) with metastatic urothelial carcinoma (mUC) following discontinuation of enfortumab-vedotin (EV): Emergence of a new unmet need.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Discontinuation; Taxane; Carboplatin; Oncology; Bladder cancer; Cancer; Chemotherapy; Breast cancer; Cisplatin","score_opus":0.12284921663075102,"score_gpt":0.4289152680741216,"score_spread":0.3060660514433706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032218776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952939,0.00015183674,0.00078997464,0.002368316,0.0005061907,0.0003511774,0.000030733205,0.0000036613812,0.0005042004],"genre_scores_gemma":[0.99365884,0.000057448746,0.005444081,0.00052321766,0.0001949318,0.0000033097074,0.000005039457,0.000019428602,0.00009372542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959707,0.00023387762,0.0028235198,0.00016689337,0.0006330748,0.00017190659],"domain_scores_gemma":[0.99546224,0.0007783342,0.0028556022,0.000160889,0.00040436062,0.00033859911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074044114,0.00016867583,0.0021696428,0.00010352896,0.000015079343,0.0000021260962,0.00017632864,0.00011616347,0.00022065766],"category_scores_gemma":[0.0026234922,0.0001064849,0.0006895367,0.00022774328,0.0001304322,0.0001339949,0.00003308782,0.0003297747,0.000002096351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006808784,0.0016916135,0.95940727,0.000082382074,0.0014025888,0.00006764907,0.00093857246,0.000026842676,0.00032709315,0.000037261718,0.000819485,0.028390434],"study_design_scores_gemma":[0.025656058,0.032195117,0.93414795,0.00016246397,0.002924628,0.0000106662455,0.00062515005,0.00006407208,0.003099667,0.00010299572,0.0008979324,0.00011328144],"about_ca_topic_score_codex":0.00024260682,"about_ca_topic_score_gemma":0.000056883222,"teacher_disagreement_score":0.030503506,"about_ca_system_score_codex":0.00003700858,"about_ca_system_score_gemma":0.0022379635,"threshold_uncertainty_score":0.4342328},"labels":[],"label_agreement":null},{"id":"W3033247025","doi":"10.5489/cuaj.6263","title":"Case – Highly aggressive urothelial carcinoma of the bladder presenting with solitary metastasis to the phalanx","year":2019,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Phalanx; Urothelial carcinoma; Metastasis; Medicine; Proximal phalanx; Urology; Anatomy; Internal medicine; Bladder cancer; Cancer","score_opus":0.01302586225954761,"score_gpt":0.23159954412626932,"score_spread":0.21857368186672171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033247025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697085,0.00020140086,0.000009141313,0.026513355,0.00034334528,0.0005804317,0.00013078703,0.00000721191,0.002505796],"genre_scores_gemma":[0.9933176,0.00000768816,0.00007092322,0.0049902177,0.00040292824,0.000015692009,0.0000037239993,0.000015256664,0.0011759455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846333,0.00023083639,0.00026175397,0.00018033835,0.00044427108,0.0004194953],"domain_scores_gemma":[0.99862283,0.00013065284,0.00033954973,0.00022553296,0.00028268067,0.0003987295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003559986,0.00014482433,0.0002632358,0.00008220859,0.00029404732,0.000042477284,0.00018009736,0.00010179785,0.00058500085],"category_scores_gemma":[0.0002726274,0.00006724816,0.00016193459,0.0002585221,0.0000377201,0.000059286267,0.000030008223,0.00043263947,0.000044203378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014807611,0.000048407586,0.98930633,0.0000062480904,0.00051180465,0.0011561591,0.00074570003,0.00013330912,0.00007102784,0.000053424617,0.006768521,0.0010509738],"study_design_scores_gemma":[0.0029945963,0.0009854138,0.9529235,0.000032902502,0.00074591185,0.010242115,0.00055015745,0.00009939484,0.0006128759,0.0001591592,0.030460319,0.00019369452],"about_ca_topic_score_codex":0.0048662922,"about_ca_topic_score_gemma":0.0026047209,"teacher_disagreement_score":0.036382888,"about_ca_system_score_codex":0.00041730428,"about_ca_system_score_gemma":0.00070504396,"threshold_uncertainty_score":0.73564106},"labels":[],"label_agreement":null},{"id":"W3033340144","doi":"10.1200/jco.2020.38.18_suppl.lba1","title":"Maintenance avelumab + best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) chemotherapy in advanced urothelial carcinoma (UC): JAVELIN Bladder 100 phase III interim analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Interim analysis; Clinical endpoint; Chemotherapy; Hazard ratio; Carboplatin; Regimen; Progression-free survival; Randomization; Chemotherapy regimen; Oncology; Progressive disease; Gastroenterology; Bladder cancer; Randomized controlled trial; Cisplatin; Cancer; Urothelial carcinoma; Nivolumab; Immunotherapy; Confidence interval","score_opus":0.09353558699766583,"score_gpt":0.4407492632393891,"score_spread":0.3472136762417233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033340144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98079187,0.0008403589,0.0017901073,0.013511398,0.001132982,0.0007451163,0.0001389045,0.000022826072,0.0010264687],"genre_scores_gemma":[0.9861536,0.00039408277,0.0026712746,0.0089359395,0.0015212772,0.00004636304,0.000052195846,0.00006286223,0.00016238658],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99449074,0.00033169717,0.0033466157,0.0006288351,0.0005884625,0.0006136325],"domain_scores_gemma":[0.99545693,0.0009537965,0.0016882843,0.0003744615,0.00071969535,0.00080680626],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007592545,0.00045204212,0.0031990416,0.0003190667,0.000057257075,0.000016727969,0.00031316586,0.00052278914,0.0017535194],"category_scores_gemma":[0.0012023558,0.00035058678,0.0012806006,0.00068434194,0.00031053158,0.0001658576,0.00007011043,0.0014044606,0.00005100394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6387374,0.011706474,0.1155323,0.00019343353,0.006751261,0.011932488,0.0054318714,0.0009454704,0.00072229054,0.000008080095,0.0018058207,0.2062331],"study_design_scores_gemma":[0.6076801,0.17062984,0.14730307,0.0004956505,0.008798133,0.00014198301,0.0031252226,0.0042615277,0.0041158856,0.000054017157,0.052384384,0.0010101789],"about_ca_topic_score_codex":0.00017564709,"about_ca_topic_score_gemma":0.0010350306,"teacher_disagreement_score":0.20522292,"about_ca_system_score_codex":0.00059359294,"about_ca_system_score_gemma":0.0025226218,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W3033593544","doi":"10.21091/mppa.2013.3033","title":"Notes from the Third Annual Toronto Regional Meeting of PAMA, February 16–17, 2013","year":2013,"lang":"en","type":"article","venue":"Medical Problems of Performing Artists","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"History; Geography; Regional science","score_opus":0.01722749248183603,"score_gpt":0.26510089871438164,"score_spread":0.2478734062325456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033593544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756027,0.0064295004,0.0001329058,0.011886292,0.00020775112,0.00069741777,0.000042530308,0.00005052139,0.0049503795],"genre_scores_gemma":[0.99690205,0.00040302376,0.0008032639,0.0009937027,0.0004237926,0.000072959825,0.00004367264,0.000023626366,0.00033393694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773693,0.000058265472,0.000609774,0.0002757958,0.0009913057,0.00032792642],"domain_scores_gemma":[0.9985639,0.00040490364,0.00020674925,0.0003580119,0.00020317853,0.00026327523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043871862,0.0001874752,0.00043132657,0.000023203016,0.00010633798,0.0000095758705,0.00023799171,0.00016575359,0.0028613468],"category_scores_gemma":[0.00034492594,0.000118209384,0.00014266967,0.000075799326,0.00031975075,0.00021328604,0.00010000088,0.00025466725,0.000049236653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044725527,0.0014441094,0.48773882,0.00079348154,0.0009283121,0.00003463693,0.012825273,0.00002245636,0.009874395,0.00019370549,0.20129506,0.2844025],"study_design_scores_gemma":[0.010066999,0.0029542556,0.9313283,0.0073568523,0.0006889427,0.00018838212,0.003820814,0.003664656,0.016243953,0.0046154205,0.01826426,0.0008071626],"about_ca_topic_score_codex":0.111329,"about_ca_topic_score_gemma":0.0056056227,"teacher_disagreement_score":0.44358948,"about_ca_system_score_codex":0.00009545184,"about_ca_system_score_gemma":0.00023171223,"threshold_uncertainty_score":0.99805015},"labels":[],"label_agreement":null},{"id":"W3034189560","doi":"10.1016/j.euf.2020.05.004","title":"Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies","year":2020,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Bladder cancer; Interquartile range; Proportional hazards model; Retrospective cohort study; Oncology; Internal medicine; Disease; Adjuvant therapy; Cystectomy; Adjuvant; Risk stratification; Surgery; Cancer","score_opus":0.023432352363660727,"score_gpt":0.27780960362972595,"score_spread":0.25437725126606525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034189560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788027,0.0015927731,0.002858593,0.009526538,0.00027409315,0.0016489382,0.0010340984,0.00009896487,0.0041633267],"genre_scores_gemma":[0.9971007,0.00042785695,0.00020870146,0.001632375,0.00026865263,0.00013548389,0.00012687746,0.000049161998,0.00005018953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989539,0.000103508704,0.00033330254,0.00033510887,0.000080205464,0.00019398972],"domain_scores_gemma":[0.9990667,0.000098002594,0.00022953906,0.00025252544,0.0002300521,0.00012318505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000714529,0.00016077826,0.00026768981,0.00004834189,0.00007131671,0.0000070981764,0.00013773827,0.00004860573,0.00009334525],"category_scores_gemma":[0.00012705309,0.0001312589,0.000116174335,0.000111317684,0.00012536687,0.00005247612,0.000032734115,0.00012683132,0.000036511705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020316488,0.0012802223,0.63690007,0.00019299328,0.0017394393,0.0000110896535,0.011939753,0.000043852528,0.045506913,0.00065086706,0.0149699375,0.28473324],"study_design_scores_gemma":[0.0032670316,0.0027195106,0.986068,0.000012739613,0.00048169337,0.0000010852351,0.0001042626,0.000025421872,0.0029180895,0.0002535245,0.0040300237,0.0001185986],"about_ca_topic_score_codex":0.00003721686,"about_ca_topic_score_gemma":0.000033569053,"teacher_disagreement_score":0.34916797,"about_ca_system_score_codex":0.000023751249,"about_ca_system_score_gemma":0.000110471534,"threshold_uncertainty_score":0.53525823},"labels":[],"label_agreement":null},{"id":"W3034622263","doi":"10.1016/j.euros.2020.04.001","title":"Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Urothelial cancer; Oncology; Chemotherapy; Medicine; Internal medicine; Cancer; Urology; Bladder cancer","score_opus":0.02164251367902985,"score_gpt":0.3324060360342699,"score_spread":0.31076352235524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034622263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877134,0.000014338571,0.000011057941,0.0046310946,0.000055450946,0.0010115502,0.000048038022,0.000017224213,0.0064978525],"genre_scores_gemma":[0.99041665,0.000005862604,0.00019800395,0.009131446,0.00004583133,0.000013811268,0.0000028407737,0.00003398107,0.00015158317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982043,0.00021437983,0.00023750223,0.00059512764,0.00038115086,0.00036757137],"domain_scores_gemma":[0.9990465,0.00004718572,0.00008650534,0.00038462962,0.0001026751,0.00033249223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005803545,0.0001879612,0.0003420496,0.00015893551,0.00006882224,0.000033549753,0.00076033175,0.000024401841,0.00029370328],"category_scores_gemma":[0.0001543448,0.00012466047,0.00004799466,0.00072843675,0.0002819775,0.00014861552,0.0001829341,0.00017678447,0.00009457573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04148106,0.00065698475,0.92837495,0.000004009289,0.000036688114,0.00009044629,0.0028393464,0.00032348157,0.010991755,0.000004880561,0.0002851235,0.014911258],"study_design_scores_gemma":[0.0073572737,0.015632737,0.97348464,0.000028498605,0.000015783682,0.000004434072,0.000019393246,0.000027975211,0.0015723015,0.0000012500636,0.00173296,0.00012273178],"about_ca_topic_score_codex":0.00023068396,"about_ca_topic_score_gemma":0.00000545519,"teacher_disagreement_score":0.045109693,"about_ca_system_score_codex":0.00012720746,"about_ca_system_score_gemma":0.0006477524,"threshold_uncertainty_score":0.5083506},"labels":[],"label_agreement":null},{"id":"W3035043238","doi":"10.1007/s00345-020-03295-9","title":"Complications in adulthood for patients with paediatric genitourinary reconstruction","year":2020,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Genitourinary system; Urinary diversion; Spina bifida; Urinary system; Intensive care medicine; Population; Urinary incontinence; Nephrology; Surgery; Pediatrics; Cystectomy; Internal medicine; Bladder cancer","score_opus":0.02518538834504517,"score_gpt":0.30508275496315646,"score_spread":0.27989736661811127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035043238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039537834,0.99741215,0.00009581828,0.00060282525,0.0004103356,0.0009924603,0.000058912592,0.0000069464604,0.0003810261],"genre_scores_gemma":[0.00077985943,0.9961813,0.0020107895,0.00020302327,0.0006193267,0.00007578134,0.0000549702,0.000038549155,0.000036375674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874353,0.000096164025,0.0006832961,0.0001839058,0.00012403716,0.00016905746],"domain_scores_gemma":[0.9986978,0.00015550523,0.000697815,0.00013181311,0.00018906678,0.00012796286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000740245,0.00020409802,0.001232785,0.0005859512,0.000031842184,0.0000050165418,0.00010480852,0.0001099652,0.000027799446],"category_scores_gemma":[0.000042975094,0.00013999084,0.00028927217,0.00043213586,0.000038711034,0.000042768155,0.00001551705,0.00046598635,0.000008504481],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047871523,0.00028189676,0.0045326576,0.0013155638,0.00030481856,0.00005208322,0.0000213153,5.385128e-7,2.2292218e-8,0.000013885653,0.0005048435,0.9924937],"study_design_scores_gemma":[0.003643261,0.0029237275,0.0041345307,0.0011031599,0.0025524248,0.001170789,0.0000041893777,0.0000012018626,2.8750057e-8,0.00007931523,0.9842788,0.00010859178],"about_ca_topic_score_codex":0.0000017328382,"about_ca_topic_score_gemma":0.000010487141,"teacher_disagreement_score":0.9923851,"about_ca_system_score_codex":0.00014801553,"about_ca_system_score_gemma":0.0005253147,"threshold_uncertainty_score":0.5708661},"labels":[],"label_agreement":null},{"id":"W3036001456","doi":"10.1097/ju.0000000000001199","title":"Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Durvalumab; Atezolizumab; Oncology; Metastatic Urothelial Carcinoma; Proportional hazards model; Internal medicine; Avelumab; Cancer; Bladder cancer; Immunotherapy; Urothelial carcinoma; Nivolumab","score_opus":0.027378181990171693,"score_gpt":0.26232163731812835,"score_spread":0.23494345532795666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036001456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318445,0.00016893538,0.0026943,0.002800726,0.00022709863,0.0007004602,0.00014999036,0.000008024733,0.00006599635],"genre_scores_gemma":[0.9981273,0.000012684993,0.0007710685,0.0007676539,0.0002273567,0.000007495109,0.000008539084,0.000036068763,0.000041840467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986643,0.00014477187,0.0004889089,0.0001256628,0.00034101974,0.00023530325],"domain_scores_gemma":[0.99835217,0.00038723854,0.0004601265,0.00013338373,0.0005145349,0.00015255513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019896936,0.00017529768,0.0005493342,0.00007085517,0.000055353055,0.0000051481516,0.0001502567,0.000052446627,0.000044107095],"category_scores_gemma":[0.00038230253,0.00009807881,0.00013639056,0.00010527239,0.000101540296,0.00007579893,0.00002976717,0.00024493627,0.0000024853985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.094738066,0.0016453661,0.84752417,0.00066957786,0.0031886932,0.00008958092,0.024369378,0.005935711,0.014298825,0.00008407582,0.0011632901,0.006293262],"study_design_scores_gemma":[0.056992516,0.07609679,0.8270268,0.00021929393,0.009012075,0.00027024338,0.0012377367,0.021626424,0.0057629263,0.0006581148,0.00047965266,0.00061744364],"about_ca_topic_score_codex":0.000020541618,"about_ca_topic_score_gemma":0.000012695715,"teacher_disagreement_score":0.074451424,"about_ca_system_score_codex":0.00003257716,"about_ca_system_score_gemma":0.00035220443,"threshold_uncertainty_score":0.39995378},"labels":[],"label_agreement":null},{"id":"W3036074908","doi":"10.1016/j.clgc.2020.06.005","title":"Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Interquartile range; Hazard ratio; Bladder cancer; Internal medicine; Chemoradiotherapy; Cancer; Urology; Surgery; Confidence interval","score_opus":0.09806510995669171,"score_gpt":0.4090351033570236,"score_spread":0.3109699934003319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036074908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501604,0.00068235624,0.000015736305,0.00020710852,0.00022315005,0.0021479535,0.0013430523,0.000044461813,0.0003201361],"genre_scores_gemma":[0.9915096,0.0066983146,0.00015821005,0.00023242527,0.000291729,0.0007532123,0.00007750481,0.00007710096,0.00020187674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978175,0.00008144425,0.0007787595,0.0006180094,0.0003208462,0.000383452],"domain_scores_gemma":[0.9983215,0.00030499112,0.0004274707,0.000300355,0.00030365144,0.00034205825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000059181057,0.0004567449,0.0013387982,0.00006366004,0.0000579661,0.000006058673,0.00012348166,0.00013235911,0.00023157703],"category_scores_gemma":[0.000024339428,0.00028894714,0.0007231917,0.00020906125,0.00017257666,0.00005085766,0.00003279869,0.00014978067,0.0000031532484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011616948,0.0024773495,0.93713146,0.00034097987,0.0071934094,0.00007398448,0.00036075985,0.00015424308,0.0001747537,0.0000034915263,0.00011129235,0.04036131],"study_design_scores_gemma":[0.033928975,0.026853599,0.9340738,0.0004529972,0.0016683133,0.0000018459363,0.0001161152,0.000031794156,0.0023793466,0.0000035005191,0.00019719619,0.00029251294],"about_ca_topic_score_codex":0.000433272,"about_ca_topic_score_gemma":0.000035165587,"teacher_disagreement_score":0.040068798,"about_ca_system_score_codex":0.0006557428,"about_ca_system_score_gemma":0.0004939271,"threshold_uncertainty_score":0.99995625},"labels":[],"label_agreement":null},{"id":"W3036222856","doi":"10.5489/cuaj.6459","title":"Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Bladder cancer; Medicine; Neoadjuvant therapy; Chemotherapy; Oncology; Urology; Cancer; Internal medicine; Breast cancer","score_opus":0.02042081531044556,"score_gpt":0.25882894929039996,"score_spread":0.2384081339799544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036222856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96353835,0.00022598758,0.000011658766,0.034348503,0.00017477962,0.0008347584,0.00020812779,0.000010046636,0.0006478119],"genre_scores_gemma":[0.97959864,0.00033925203,0.000094961426,0.019521326,0.00023527809,0.00008787487,0.000027324675,0.000020903935,0.00007443503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983504,0.00008783411,0.000344183,0.00029888022,0.00036921675,0.00054950215],"domain_scores_gemma":[0.9983087,0.00010097044,0.00024817968,0.000092224465,0.0003084797,0.0009414104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015150149,0.00020531952,0.00039555228,0.00019847373,0.00015267824,0.000036144782,0.0001507938,0.00018319597,0.0006266439],"category_scores_gemma":[0.00020862487,0.00014735342,0.00011273832,0.0003229639,0.00004251884,0.00008874972,0.0000035509715,0.0003888663,0.0000046639443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012225613,0.00013961764,0.96590304,0.0000070066003,0.00027058323,0.00003755384,0.0026507697,0.000076022436,0.00003445355,0.000021616419,0.0036839964,0.02595276],"study_design_scores_gemma":[0.00918279,0.003929972,0.97227323,0.000044743403,0.000050385854,0.0000029819798,0.00036946495,0.00005587421,0.00024910364,0.00009300182,0.013550705,0.00019777367],"about_ca_topic_score_codex":0.07755788,"about_ca_topic_score_gemma":0.13899334,"teacher_disagreement_score":0.06143546,"about_ca_system_score_codex":0.0012422836,"about_ca_system_score_gemma":0.0022119367,"threshold_uncertainty_score":0.92858475},"labels":[],"label_agreement":null},{"id":"W3036494572","doi":"10.1111/bju.15146","title":"The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Retrospective cohort study; Randomized controlled trial; Meta-analysis; Relative risk; Urology; Confidence interval; Bladder cancer; Hyperplasia; Surgery; Internal medicine; Cancer","score_opus":0.023205920317900426,"score_gpt":0.3124088974166063,"score_spread":0.2892029770987059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036494572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011028661,0.9971244,0.000013005095,0.0002906119,0.000059828904,0.0021424307,0.000245658,0.0000057015686,0.00000808263],"genre_scores_gemma":[0.006865875,0.9924653,0.00013325752,0.0002001865,0.000058070214,0.00020793157,0.000007465251,0.000035587418,0.000026316973],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962236,0.0012473206,0.0015919474,0.0003562831,0.00033129135,0.0002495343],"domain_scores_gemma":[0.995301,0.0021914344,0.0018598484,0.00019477344,0.00022214677,0.00023080526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008919999,0.000371573,0.006756892,0.00017444738,0.000101995254,0.000057396534,0.00011601411,0.00017150563,0.00003190592],"category_scores_gemma":[0.001634665,0.00022256485,0.000863769,0.00032178438,0.00028228498,0.000057474434,0.000071028495,0.0006333738,0.0000010815365],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001983716,0.00013525867,0.00016496403,0.67586154,0.11590442,0.005071645,0.000102564634,1.5662125e-7,2.0248437e-7,0.000003274306,0.00010823731,0.20244935],"study_design_scores_gemma":[0.00050779217,0.00087151374,0.000058202633,0.053940292,0.902846,0.031254776,0.000012826883,0.0000062174486,3.168597e-7,0.000030706175,0.010307471,0.00016390301],"about_ca_topic_score_codex":0.000025111089,"about_ca_topic_score_gemma":0.000028830229,"teacher_disagreement_score":0.7869415,"about_ca_system_score_codex":0.000021613005,"about_ca_system_score_gemma":0.00035948638,"threshold_uncertainty_score":0.90759313},"labels":[],"label_agreement":null},{"id":"W3036693116","doi":"10.5489/cuaj.6400","title":"Factors predicting early mortality after radical cystectomy for urothelial carcinoma in a contemporary cohort of patients","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Cystectomy; Comorbidity; Logistic regression; Cohort; Bladder cancer; Mortality rate; Proportional hazards model; Internal medicine; Cancer; Stage (stratigraphy)","score_opus":0.039442124646358094,"score_gpt":0.2584432467565081,"score_spread":0.21900112211015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036693116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600875,0.00008854324,0.000029465598,0.0020705084,0.00016197558,0.0007449303,0.0004869751,0.00001267298,0.00039619856],"genre_scores_gemma":[0.9976368,0.0000025230497,0.000027148662,0.0019251327,0.00028833072,0.000041521067,0.000047332356,0.00001497414,0.000016224169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984527,0.0001252637,0.0005042406,0.00020985305,0.00036488057,0.000343011],"domain_scores_gemma":[0.9986616,0.00010565913,0.00024143502,0.0000665031,0.00020170216,0.0007231398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027498291,0.00014734463,0.00042748672,0.00009753423,0.0000686902,0.000022948872,0.00008249589,0.00021735745,0.00016170162],"category_scores_gemma":[0.000742409,0.00011455354,0.00018996726,0.00015356032,0.000035449546,0.00008875972,0.000010472143,0.0003748365,0.0000025119818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044177336,0.00007031673,0.9983215,0.000015483263,0.00014329843,0.000039004844,0.0004445476,0.000002309605,0.0000110840665,0.0000041744893,0.0004145866,0.00009194459],"study_design_scores_gemma":[0.0041437754,0.0010534263,0.9929818,0.000013250743,0.00010096504,0.00000215819,0.000038568585,0.00008185519,0.000046136778,0.000048102043,0.0014005232,0.00008943757],"about_ca_topic_score_codex":0.0030129512,"about_ca_topic_score_gemma":0.00037208677,"teacher_disagreement_score":0.0053396756,"about_ca_system_score_codex":0.00059716095,"about_ca_system_score_gemma":0.00077111984,"threshold_uncertainty_score":0.4671358},"labels":[],"label_agreement":null},{"id":"W3036728523","doi":"10.3233/blc-200291","title":"Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; University of Manitoba; Juravinski Cancer Centre; London Health Sciences Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Saint John Regional Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; McGill University Health Centre; University of Ottawa; CancerCare Manitoba; University Health Network; Ottawa Hospital; University of Calgary; Princess Margaret Cancer Centre; Dalhousie University; Western University; University of Toronto","funders":"","keywords":"Guideline; Medicine; Bladder cancer; MEDLINE; Standardization; Intensive care medicine; Genitourinary system; Multidisciplinary approach; Evidence-based medicine; Clinical trial; Medical physics; Cancer; Alternative medicine; Pathology; Internal medicine","score_opus":0.03972413607044959,"score_gpt":0.32816742248379516,"score_spread":0.28844328641334555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036728523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6710926,0.16102234,0.00054016366,0.14901313,0.0036330812,0.0042925267,0.004898161,0.00016172242,0.0053462274],"genre_scores_gemma":[0.97361463,0.0131989475,0.0006986667,0.01037357,0.0013085542,0.0003927238,0.000106398096,0.000070824964,0.00023570718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966413,0.00012439485,0.0009373375,0.0005451833,0.0012989849,0.00045280918],"domain_scores_gemma":[0.99807835,0.00023245324,0.0003721538,0.00049216836,0.00035262422,0.0004722662],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014730432,0.0003588371,0.00079091,0.000032255983,0.00008422023,0.0000068593504,0.00038049542,0.0001297643,0.005041604],"category_scores_gemma":[0.00010853145,0.00024593613,0.00020993981,0.00035042636,0.00032708718,0.00002395362,0.00020621675,0.00033388066,0.0000052342493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026901218,0.00073501427,0.025941812,0.0009256635,0.0061656046,0.0011968011,0.0015169625,0.00036105243,0.00089777017,0.0001016158,0.835596,0.123871565],"study_design_scores_gemma":[0.033476815,0.0016772194,0.13094817,0.003857073,0.006841047,0.000049078826,0.0049728896,0.002101526,0.01774136,0.00028781017,0.79678875,0.0012582428],"about_ca_topic_score_codex":0.40691555,"about_ca_topic_score_gemma":0.23020358,"teacher_disagreement_score":0.30252197,"about_ca_system_score_codex":0.00039645788,"about_ca_system_score_gemma":0.0064609908,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W3038414938","doi":"10.1177/0846537120933952","title":"The Diagnostic Yield of CT Urography in the Workup of Hematuria With Negative Cystoscopy","year":2020,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Hamilton Health Sciences; Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Cystoscopy; Pyelogram; Radiology; Gross hematuria; Urology; Urinary system; Internal medicine","score_opus":0.016983309596429155,"score_gpt":0.24924901476597186,"score_spread":0.2322657051695427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038414938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697516,0.002232255,0.0000719858,0.02272075,0.00019742273,0.00065920904,0.00010142788,0.0000057390416,0.0042596417],"genre_scores_gemma":[0.99857855,0.00040647635,0.00014259442,0.0007354331,0.00009470269,0.000007625152,0.0000031940622,0.000006501233,0.000024932415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990003,0.00016343399,0.00031668914,0.00007844553,0.00025040717,0.0001906978],"domain_scores_gemma":[0.9978426,0.0012603343,0.0004899196,0.00010177427,0.00015865169,0.00014672859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045404662,0.00008555703,0.000284037,0.000081995844,0.00007353299,0.00001100522,0.0001540197,0.00004739936,0.00002437093],"category_scores_gemma":[0.0021733353,0.000045106994,0.00009836077,0.00037860303,0.00012446317,0.000034158344,0.0000037399413,0.00028658603,6.7438964e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026254327,0.000044325738,0.9855051,0.000028021032,0.0004356236,0.00009988984,0.0021630514,0.000049065216,0.00008339247,0.0004014188,0.009711758,0.0012157871],"study_design_scores_gemma":[0.0024177814,0.0015247146,0.99016166,0.00025706907,0.0002309192,0.00012263241,0.0018030506,0.0000126096975,0.0008769973,0.00051666255,0.001991318,0.00008457694],"about_ca_topic_score_codex":0.004450484,"about_ca_topic_score_gemma":0.017640164,"teacher_disagreement_score":0.028826972,"about_ca_system_score_codex":0.00021007675,"about_ca_system_score_gemma":0.0006153377,"threshold_uncertainty_score":0.98436254},"labels":[],"label_agreement":null},{"id":"W3041324089","doi":"10.1016/j.urolonc.2020.06.009","title":"Bladder cancer incidence rates and trends in young adults aged 20-39 years","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Incidence (geometry); Medicine; Stage (stratigraphy); Epidemiology; Cohort; Demography; Cancer; Internal medicine; Biology","score_opus":0.03202457868522956,"score_gpt":0.33099694156752374,"score_spread":0.2989723628822942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041324089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778959,0.0030383628,0.000005834952,0.01699333,0.00009550317,0.0002119458,0.00003676166,0.00004304666,0.0016792971],"genre_scores_gemma":[0.9866394,0.0015785416,0.004528158,0.0062996917,0.00015642162,0.00011703724,0.000046281213,0.000013801301,0.00062070636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989621,0.00007658828,0.00022272671,0.00038578833,0.00010747639,0.00024532617],"domain_scores_gemma":[0.99942154,0.000083423896,0.000075166965,0.00009431573,0.000028033699,0.000297541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100795434,0.00016692046,0.0003239576,0.0001257421,0.000093890405,0.000016860718,0.00005931292,0.00016971922,0.00026224315],"category_scores_gemma":[0.0000696583,0.00014339213,0.0000314069,0.00037509314,0.00042379828,0.0001048387,0.0000433367,0.00031171684,0.000009076898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030440668,0.00008120157,0.9804718,0.000022167918,0.000053733962,0.00027284253,0.003070104,0.000016664382,0.0006339199,0.00020873315,0.0039567393,0.010907685],"study_design_scores_gemma":[0.005165561,0.0040287036,0.83186775,0.0001335069,0.00044217726,0.00033941003,0.0008024758,0.0015314304,0.00045838073,0.0013501252,0.15353335,0.00034711856],"about_ca_topic_score_codex":0.00073337165,"about_ca_topic_score_gemma":0.0011198795,"teacher_disagreement_score":0.14957662,"about_ca_system_score_codex":0.00007230387,"about_ca_system_score_gemma":0.00017416273,"threshold_uncertainty_score":0.58473617},"labels":[],"label_agreement":null},{"id":"W3041480747","doi":"10.21037/tau-20-880","title":"Radical cystectomy—what is the optimal surgical approach?","year":2020,"lang":"en","type":"letter","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cystectomy; Computer science; General surgery; Medicine; Bladder cancer; Internal medicine; Cancer","score_opus":0.02246433062810667,"score_gpt":0.26079607485279543,"score_spread":0.23833174422468878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041480747","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017489701,0.011992408,0.00030227064,0.98251253,0.00026197967,0.00051023596,0.00009889579,0.00005451224,0.0025182161],"genre_scores_gemma":[0.053257387,0.0012218773,0.00024855338,0.9400721,0.0033677006,0.00009860627,0.000894386,0.00004218632,0.0007971828],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816626,0.00023389838,0.00031285034,0.0006250932,0.00026475443,0.0003971143],"domain_scores_gemma":[0.9992368,0.00033677218,0.000068789486,0.00020477918,0.000037550075,0.00011525888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089989255,0.0003453504,0.0006586784,0.00007531787,0.00018916794,0.000023870001,0.00013914151,0.0011410171,0.0009017739],"category_scores_gemma":[0.0000048445195,0.00021981596,0.00022907661,0.00009489961,0.0009041619,0.0000653132,0.00002740166,0.0019801036,0.000060872266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007855047,0.00031975968,0.0044317394,0.00043152412,0.0032372018,0.00903578,0.001959683,0.000035424742,0.000013857093,0.0015900044,0.9601462,0.010943804],"study_design_scores_gemma":[0.003889803,0.00093594077,0.001055969,0.000007854226,0.00084256375,0.0069454317,0.000008188923,0.0006595306,0.000004707769,0.0012842318,0.98417544,0.00019033423],"about_ca_topic_score_codex":0.000011768265,"about_ca_topic_score_gemma":8.6088494e-7,"teacher_disagreement_score":0.05150842,"about_ca_system_score_codex":0.000008795488,"about_ca_system_score_gemma":0.00017081265,"threshold_uncertainty_score":0.9873792},"labels":[],"label_agreement":null},{"id":"W3041863946","doi":"10.1016/j.urolonc.2020.06.013","title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Compliance (psychology); Systematic review; Medicine; Oncology; Urology; MEDLINE; Psychology; Biology","score_opus":0.11931002928046197,"score_gpt":0.4102799463984164,"score_spread":0.29096991711795445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041863946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004236993,0.9845478,0.000016582055,0.008590893,0.00019644965,0.00551184,0.00012599601,0.00006412915,0.0009039301],"genre_scores_gemma":[0.000011289797,0.9695406,0.010697047,0.016395558,0.00021815766,0.002203664,0.00015542151,0.00005055853,0.0007277255],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965542,0.00040156615,0.001471691,0.0008687883,0.00025105497,0.00045267693],"domain_scores_gemma":[0.9977168,0.0005001289,0.00051529397,0.00049690175,0.00017464158,0.0005962643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003862906,0.00065660634,0.0042664716,0.00027024793,0.00012339742,0.000023395456,0.0002731421,0.00045314454,0.00008656125],"category_scores_gemma":[0.0013655925,0.000472829,0.00033226222,0.0008752159,0.0002749104,0.00006223881,0.00012473957,0.00067684206,0.0002822991],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028872151,0.00023536428,0.0007411327,0.9393874,0.00038936903,0.0019433788,0.000217334,0.0000014109005,0.0000010120613,0.0003052239,0.020503053,0.036246467],"study_design_scores_gemma":[0.00038762204,0.0011405867,0.000008194837,0.26316437,0.005402306,0.0010139208,0.000025728847,0.000009361741,9.322098e-7,0.00009827529,0.7284657,0.00028303207],"about_ca_topic_score_codex":0.000079244724,"about_ca_topic_score_gemma":0.00007753103,"teacher_disagreement_score":0.70796263,"about_ca_system_score_codex":0.0004458721,"about_ca_system_score_gemma":0.0020825146,"threshold_uncertainty_score":0.99977237},"labels":[],"label_agreement":null},{"id":"W3042013110","doi":"10.21037/tcr-20-2169","title":"Variant histology in bladder cancer: diagnostic and clinical implications","year":2020,"lang":"en","type":"review","venue":"Translational Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Chemotherapy; Radiation therapy; Pathological; Oncology; Cancer; Disease; Carcinoma; Internal medicine; Histology; Pathology","score_opus":0.3301668385051649,"score_gpt":0.5642736598506961,"score_spread":0.23410682134553124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042013110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001913014,0.9819936,0.000027477607,0.0136045115,0.00017563504,0.0022068387,0.000761161,0.000028248773,0.0011833891],"genre_scores_gemma":[0.000762798,0.99502695,0.00011651821,0.00021124513,0.000737206,0.002522965,0.0002337766,0.00007188379,0.00031666915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677473,0.00050884864,0.0008518202,0.0008325037,0.00054452283,0.00048758872],"domain_scores_gemma":[0.99678767,0.0022408946,0.00009991193,0.0003087932,0.00020122345,0.0003615143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005440189,0.00031392474,0.0015220525,0.00036397262,0.00012405355,0.000024159268,0.00020001759,0.00040171767,0.0009657608],"category_scores_gemma":[0.00021327601,0.00026046616,0.00028340268,0.0008182968,0.00036956402,0.000054809025,0.000049586924,0.0014834376,0.000066478715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011487087,0.00020076169,0.004858043,0.0030577611,0.0005619107,0.0001530582,0.000096352436,9.1754185e-7,2.707403e-7,0.0011938117,0.0017318727,0.9880304],"study_design_scores_gemma":[0.0015241274,0.00021990022,0.014143357,0.0031317004,0.0010376589,0.000098577555,0.0000040286527,0.000012505587,1.612102e-7,0.00071241806,0.9789068,0.00020873522],"about_ca_topic_score_codex":0.002094688,"about_ca_topic_score_gemma":0.0018718223,"teacher_disagreement_score":0.98782164,"about_ca_system_score_codex":0.00048331212,"about_ca_system_score_gemma":0.0052662827,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W3042127423","doi":"10.1016/j.urolonc.2020.04.028","title":"Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Queen's University; Montreal General Hospital; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Androgen deprivation therapy; Prostate cancer; Observational study; Medicine; Bladder cancer; Oncology; Internal medicine; Systematic review; Cancer therapy; Cancer; MEDLINE; Biology","score_opus":0.12348586428019602,"score_gpt":0.4168290380878311,"score_spread":0.2933431738076351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042127423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048794094,0.9877046,0.000007006425,0.0047179074,0.000089217945,0.0063058143,0.00064676936,0.000013065209,0.000027682656],"genre_scores_gemma":[0.000014124207,0.98978615,0.002167167,0.0018181434,0.000086635264,0.005873056,0.0001155987,0.000020288808,0.000118848635],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980696,0.00035843387,0.00092516805,0.000329898,0.00016898107,0.00014792205],"domain_scores_gemma":[0.99673927,0.0013626815,0.0013258648,0.00019438389,0.00029190356,0.000085870684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006244396,0.00030320804,0.0029423626,0.00007070277,0.00014185798,0.000005894485,0.000101162404,0.00017531136,0.000016571976],"category_scores_gemma":[0.0007498713,0.0001563319,0.00025682303,0.00029595988,0.00090066326,0.000043095755,0.00003999347,0.00022368762,5.2933035e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029262545,0.0001150312,0.008557041,0.89661366,0.0063001425,0.00000608385,0.0009312962,0.0000018364605,7.8945726e-7,0.0023114707,0.002469582,0.08240047],"study_design_scores_gemma":[0.001919263,0.0011224042,0.00003594291,0.15612388,0.02275769,0.000062135674,0.00007700832,0.00003415146,0.0000056926046,0.001848941,0.8158679,0.00014496119],"about_ca_topic_score_codex":0.0000783675,"about_ca_topic_score_gemma":0.000019650193,"teacher_disagreement_score":0.81339836,"about_ca_system_score_codex":0.00010196435,"about_ca_system_score_gemma":0.0011966262,"threshold_uncertainty_score":0.63750297},"labels":[],"label_agreement":null},{"id":"W3042323140","doi":"10.1016/j.eururo.2020.07.002","title":"FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"KWF Kankerbestrijding; University of Toronto","keywords":"Fibroblast growth factor receptor 3; Cystectomy; Medicine; Bladder cancer; Cancer research; Fibroblast growth factor receptor 4; Cancer; Fibroblast growth factor receptor; Oncology; Mutant; Mutation; Internal medicine; Pathology; Fibroblast growth factor; Receptor; Biology; Gene; Genetics","score_opus":0.02178128534591488,"score_gpt":0.3026336147215789,"score_spread":0.280852329375664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042323140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98353744,0.0031729592,0.0009758404,0.0071927854,0.00008315352,0.0018290383,0.00079350115,0.00015816478,0.0022570956],"genre_scores_gemma":[0.99472594,0.000764784,0.0001697627,0.0027907256,0.00017885088,0.00030903454,0.0006625911,0.0000766977,0.00032161758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982522,0.00023328503,0.000337563,0.0006110987,0.00009217334,0.00047364054],"domain_scores_gemma":[0.99921507,0.00009527672,0.00010004497,0.00022091446,0.00005501498,0.00031368723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009295762,0.00026265238,0.00044095996,0.00009250274,0.0001149037,0.000018213772,0.00006900975,0.00009742899,0.00018909917],"category_scores_gemma":[0.000068814006,0.00021493914,0.00007598259,0.0002016276,0.00009185165,0.00007021192,0.00003790343,0.0001389174,0.000029904575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017859713,0.000798677,0.9248952,0.00006246425,0.0004160091,0.0001622013,0.0020712768,0.000013116979,0.046696097,0.000059787704,0.008392559,0.014646634],"study_design_scores_gemma":[0.019015182,0.00323502,0.8473148,0.000022098762,0.00059027976,0.000054895223,0.000063442974,0.00035687638,0.0035049708,0.000028398934,0.12554087,0.00027318788],"about_ca_topic_score_codex":0.0001706561,"about_ca_topic_score_gemma":0.000051629944,"teacher_disagreement_score":0.11714831,"about_ca_system_score_codex":0.000115119394,"about_ca_system_score_gemma":0.00010936165,"threshold_uncertainty_score":0.8764963},"labels":[],"label_agreement":null},{"id":"W3042545110","doi":"10.1007/s00345-020-03358-x","title":"Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"Fonds de Recherche du Québec - Santé; Astellas Pharma Canada","keywords":"Medicine; Androgen receptor; Bladder cancer; Hazard ratio; Cystectomy; Internal medicine; Nephrology; Immunohistochemistry; Oncology; Immunotherapy; Proportional hazards model; Cancer; Immune checkpoint; Prostate cancer; Confidence interval","score_opus":0.01603825498692679,"score_gpt":0.2558078047186149,"score_spread":0.23976954973168813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042545110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625418,0.027436825,0.00004260452,0.008588561,0.00028197138,0.00022611495,0.000019724344,0.000010116728,0.0008522559],"genre_scores_gemma":[0.9968516,0.0017429636,0.00021205675,0.0008390559,0.0002204515,0.0000035321857,0.0000039617253,0.000013976443,0.000112381626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990171,0.00011406574,0.00034485196,0.00018156024,0.00016177555,0.00018062748],"domain_scores_gemma":[0.9992363,0.000069846006,0.00015941182,0.00008612764,0.00004907286,0.0003992664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001457883,0.00012852576,0.00036349444,0.00012267595,0.00003192358,0.000009070676,0.00006456942,0.000040927316,0.00017566684],"category_scores_gemma":[0.00007957195,0.000099115576,0.00004723157,0.00014260015,0.00009507891,0.00008440943,0.000052848158,0.0003033437,0.0000037740353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019984955,0.0006929427,0.9159682,0.00029352456,0.00018917382,0.0020024513,0.0027344646,0.000029524279,0.033851344,0.000045721008,0.0049565616,0.01925118],"study_design_scores_gemma":[0.020193854,0.0047282637,0.92880046,0.0003962018,0.00056602963,0.00037676332,0.0002717264,0.00021539953,0.0076368554,0.00052867475,0.035927173,0.00035861525],"about_ca_topic_score_codex":0.000006470417,"about_ca_topic_score_gemma":0.000006271538,"teacher_disagreement_score":0.034309793,"about_ca_system_score_codex":0.000017333567,"about_ca_system_score_gemma":0.00012121596,"threshold_uncertainty_score":0.4041816},"labels":[],"label_agreement":null},{"id":"W3043081582","doi":"10.1016/j.urolonc.2020.06.020","title":"Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Odds ratio; Bladder cancer; Confidence interval; Body mass index; Obesity; Logistic regression; Adverse effect; Internal medicine; Surgery; Urology; Cancer","score_opus":0.04354730382898404,"score_gpt":0.32737037243718786,"score_spread":0.28382306860820383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043081582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900305,0.00013224197,0.000020363183,0.00739527,0.000020518237,0.0017559726,0.0001833374,0.000035063287,0.00042671536],"genre_scores_gemma":[0.98733395,0.000066792076,0.0050291605,0.0064117624,0.000024810304,0.00056827173,0.00017838016,0.000021153744,0.00036571853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878633,0.000094846415,0.0002342169,0.00048442403,0.00013240297,0.0002677849],"domain_scores_gemma":[0.9992259,0.00012610729,0.00009537307,0.000102025835,0.00013406953,0.00031649665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008000434,0.00025415406,0.0006267882,0.00006194358,0.00021333361,0.000028604625,0.00008690654,0.00018794402,0.000072029536],"category_scores_gemma":[0.00008302756,0.00016287512,0.000029223092,0.0002802372,0.00052908796,0.00014919211,0.000050125003,0.0002286176,0.0000010849933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013643195,0.0004999526,0.99531716,0.000019084835,0.0003936993,0.00009273895,0.0011652233,0.000009248518,0.00005309375,0.00005599182,0.00037399578,0.0006554916],"study_design_scores_gemma":[0.012252525,0.0110596465,0.96543497,0.000096468284,0.000831681,0.000028883876,0.00022285353,0.0002884019,0.000170511,0.000023991672,0.009363925,0.00022615363],"about_ca_topic_score_codex":0.00023553886,"about_ca_topic_score_gemma":0.0005260681,"teacher_disagreement_score":0.029882202,"about_ca_system_score_codex":0.00018159823,"about_ca_system_score_gemma":0.00046552424,"threshold_uncertainty_score":0.66418546},"labels":[],"label_agreement":null},{"id":"W3043096196","doi":"10.1016/j.clgc.2020.07.011","title":"Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Cystectomy; Bladder cancer; Oncology; Internal medicine; Cancer; Hazard ratio; Urinary bladder; Carcinoma; Adenocarcinoma; Urology; Confidence interval","score_opus":0.14080938582434996,"score_gpt":0.42606383480198334,"score_spread":0.2852544489776334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043096196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97520685,0.008687601,0.00006043669,0.012467214,0.0006384255,0.0011369764,0.0012869494,0.00009874403,0.0004167898],"genre_scores_gemma":[0.9824757,0.0068249134,0.00032782226,0.004336492,0.00424111,0.000391014,0.0000484027,0.00008720045,0.001267322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969052,0.00018935656,0.0009045646,0.0010224164,0.0002917445,0.00068671594],"domain_scores_gemma":[0.99816257,0.00028193244,0.0002268663,0.0003589667,0.00010002304,0.000869647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001570064,0.0005337975,0.0014352966,0.00004763291,0.00021395853,0.00005187528,0.00015289079,0.00034192018,0.00030287218],"category_scores_gemma":[0.000045605175,0.00043186237,0.0002470004,0.00011605599,0.0006046391,0.000105876745,0.00019219037,0.00044985057,0.00002070463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035070449,0.00047348687,0.90662074,0.00017363025,0.0014142463,0.00056030374,0.0042791916,0.000012345387,0.00039933313,0.000010484967,0.00338165,0.07916754],"study_design_scores_gemma":[0.02344909,0.012033063,0.82379436,0.000118649994,0.002456267,0.000102408194,0.00086351327,0.00069388474,0.00164206,0.00008111221,0.1338968,0.0008688089],"about_ca_topic_score_codex":0.0036573883,"about_ca_topic_score_gemma":0.00026558904,"teacher_disagreement_score":0.13051514,"about_ca_system_score_codex":0.00025368083,"about_ca_system_score_gemma":0.0006163669,"threshold_uncertainty_score":0.9998133},"labels":[],"label_agreement":null},{"id":"W3043133344","doi":"10.1016/s2666-1683(20)33379-6","title":"First quarter report from the eBLOC (en-bloc vs conventional resection of primary bladder tumor) trial","year":2020,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Resection; Medicine; Bladder tumor; Surgery; History; Internal medicine; Bladder cancer; Archaeology; Cancer","score_opus":0.03775992177060921,"score_gpt":0.2977663297865403,"score_spread":0.26000640801593106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043133344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83064973,0.00021917331,0.00044453004,0.046643466,0.0013165405,0.0018928711,0.000045780012,0.000058937425,0.11872899],"genre_scores_gemma":[0.9903709,0.000009498846,0.00037163906,0.00806179,0.0006114723,0.000018382843,0.000028649383,0.000017452761,0.00051018666],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979612,0.00029734327,0.00042577047,0.0005987794,0.00048515273,0.0002317241],"domain_scores_gemma":[0.99884105,0.00016114548,0.00021128076,0.000494444,0.00013625373,0.00015582431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00132177,0.00013257827,0.0002858939,0.000039005135,0.00025650582,0.000060191356,0.00089401664,0.00002769596,0.00062584353],"category_scores_gemma":[0.00048492893,0.000089388064,0.00008338648,0.0003669076,0.0007789903,0.00019892819,0.00046248443,0.00023320277,0.00017482086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35150576,0.0035560534,0.21806695,0.00014042156,0.0015592539,0.011770005,0.015790107,0.00019254789,0.050521813,0.0019080364,0.33822536,0.006763693],"study_design_scores_gemma":[0.053951982,0.009073527,0.7700445,0.000046496916,0.000395448,0.0008264379,0.00023425074,0.00033657992,0.0019380916,0.0001990858,0.16266191,0.00029171354],"about_ca_topic_score_codex":0.00016521905,"about_ca_topic_score_gemma":0.000019668165,"teacher_disagreement_score":0.5519775,"about_ca_system_score_codex":0.000043103813,"about_ca_system_score_gemma":0.0004931227,"threshold_uncertainty_score":0.6852548},"labels":[],"label_agreement":null},{"id":"W3043336560","doi":"10.5489/cuaj.6490","title":"Re-operation within 30 days of radical cystectomy: Identifying high-risk patients and complications using ACS-NSQIP database","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Odds ratio; Confidence interval; Bladder cancer; Body mass index; Database; Logistic regression; Surgery; COPD; Complication; Urinary diversion; Cancer; Internal medicine","score_opus":0.0387263425969287,"score_gpt":0.27187230343197416,"score_spread":0.23314596083504546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043336560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99019986,0.00015667183,0.0010954366,0.007618487,0.0001470854,0.00027797977,0.0003287757,0.000017400565,0.00015832727],"genre_scores_gemma":[0.99473363,0.000056671415,0.001237038,0.0036046614,0.0002261242,0.000004779319,0.00011470449,0.000012607634,0.0000097559405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998601,0.00019191507,0.00042313983,0.00021391346,0.00033197732,0.00023804141],"domain_scores_gemma":[0.99852824,0.00007646155,0.00036754197,0.00009164396,0.00023233308,0.0007038066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002987039,0.00012214218,0.00027424595,0.00009241042,0.0003383885,0.000063270076,0.00007808156,0.0001399246,0.0002476019],"category_scores_gemma":[0.00073215645,0.00010314234,0.000056054152,0.00016834993,0.000046846046,0.0001544413,0.000021654843,0.00043114965,0.00001541155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007400639,0.00006786424,0.99583286,0.000015879717,0.0001564071,0.000019879713,0.00056711776,0.000105745865,0.00080502563,0.000109380475,0.0013461508,0.0008996728],"study_design_scores_gemma":[0.00447091,0.0006173676,0.98943025,0.00004093111,0.0004297322,0.000031757463,0.00020266318,0.0025515682,0.0003823786,0.000268524,0.0014100057,0.00016392254],"about_ca_topic_score_codex":0.002719228,"about_ca_topic_score_gemma":0.00047029977,"teacher_disagreement_score":0.0064026304,"about_ca_system_score_codex":0.0005092485,"about_ca_system_score_gemma":0.00040723596,"threshold_uncertainty_score":0.42060226},"labels":[],"label_agreement":null},{"id":"W3043745531","doi":"10.5489/cuaj.6466","title":"A systematic review and meta-analysis of the long-term outcomes of ileal conduit and orthotopic neobladder urinary diversion","year":2020,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Cochrane Library; Urology; Meta-analysis; Odds ratio; Inclusion and exclusion criteria; Urinary system; Systematic review; Bladder cancer; Surgery; MEDLINE; Internal medicine; Cancer; Pathology","score_opus":0.07084231352706685,"score_gpt":0.3222385794259447,"score_spread":0.25139626589887787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043745531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017181846,0.9954948,9.931781e-7,0.0027245397,0.00003728212,0.0012031837,0.00028116838,0.0000034062887,0.00008284728],"genre_scores_gemma":[0.0035484738,0.9935776,0.000008236942,0.0023507238,0.000023522955,0.000033253396,0.000023605515,0.000010606686,0.00042398277],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977322,0.00059127243,0.0009183196,0.00021158533,0.00035990565,0.0001866988],"domain_scores_gemma":[0.997634,0.00027404656,0.0013733044,0.0001921867,0.00016085515,0.00036561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044381758,0.0002546833,0.0053783236,0.00019153308,0.00010058392,0.000020009154,0.00014825803,0.00024394212,0.00058765773],"category_scores_gemma":[0.00041755097,0.000121715966,0.0017967435,0.0004376664,0.000053110332,0.00003498947,0.00005049739,0.00043274107,0.0000022014538],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009499322,0.00010212464,0.11616462,0.31231827,0.5665684,0.00022108231,0.00015901081,1.9588596e-7,6.294507e-8,0.000041550727,0.00053036347,0.0038848293],"study_design_scores_gemma":[0.0002341508,0.00018009661,0.039947324,0.003624663,0.9495294,0.00019669652,0.000006237791,5.9774146e-7,3.45271e-8,0.000007561959,0.0061700526,0.000103180915],"about_ca_topic_score_codex":0.0003181242,"about_ca_topic_score_gemma":0.00016020634,"teacher_disagreement_score":0.382961,"about_ca_system_score_codex":0.00026804878,"about_ca_system_score_gemma":0.00043280167,"threshold_uncertainty_score":0.643444},"labels":[],"label_agreement":null},{"id":"W3044251844","doi":"10.1097/mou.0000000000000804","title":"Smoking and bladder cancer: review of the recent literature","year":2020,"lang":"en","type":"article","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Cystectomy; Smoking cessation; Bladder cancer; Psychological intervention; MEDLINE; Intensive care medicine; Oncology; Cancer; Internal medicine; Psychiatry; Pathology","score_opus":0.06422644211522516,"score_gpt":0.36592399301789136,"score_spread":0.3016975509026662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044251844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004605195,0.92871386,0.000008246163,0.06319429,0.002539555,0.0005296723,0.00003703594,0.000012436461,0.00035972014],"genre_scores_gemma":[0.1520187,0.83957875,0.000011675616,0.007849825,0.00043274974,0.00006105223,0.000027028469,0.000011360005,0.0000088621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933845,0.00006838192,0.0001974636,0.00017858497,0.00010544212,0.0001116574],"domain_scores_gemma":[0.99967647,0.00001931872,0.00006862678,0.00012597328,0.0000522659,0.000057329085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056704717,0.00008779406,0.00022763447,0.000022326602,0.000016944228,0.0000025726586,0.00006023645,0.000050301544,0.00016784629],"category_scores_gemma":[0.00006988326,0.000055670185,0.000042772786,0.00024872334,0.00005210595,0.000019630603,0.000051772913,0.00023518426,0.0000012503899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052972924,0.00033952598,0.37702927,0.026367439,0.0002314484,0.0000049443247,0.0028940898,0.000005714537,0.00018107127,0.00094185513,0.08475293,0.506722],"study_design_scores_gemma":[0.0016562593,0.00025879475,0.04832525,0.0058899755,0.000108688684,0.00002083543,0.000009049957,0.000034029406,0.00009180988,0.000093871204,0.94343495,0.000076488766],"about_ca_topic_score_codex":0.000006150609,"about_ca_topic_score_gemma":6.611195e-7,"teacher_disagreement_score":0.85868204,"about_ca_system_score_codex":0.00001983259,"about_ca_system_score_gemma":0.000083211686,"threshold_uncertainty_score":0.22701642},"labels":[],"label_agreement":null},{"id":"W3044322824","doi":"10.1016/j.urolonc.2020.06.031","title":"Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Mitomycin C; Bladder cancer; Urology; Internal medicine; Carcinoma in situ; Surgery; Confidence interval; Cancer; Gastroenterology","score_opus":0.03296514392094393,"score_gpt":0.3126456104444776,"score_spread":0.2796804665235337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044322824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778028,0.0019610785,0.0001780148,0.01840172,0.000085278516,0.0010753225,0.00043184744,0.00001228706,0.0000516519],"genre_scores_gemma":[0.9901811,0.0012991963,0.0071852845,0.0005520649,0.00015160801,0.00041840188,0.000098706565,0.000012773887,0.000100897],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988733,0.00008801941,0.00039262674,0.00031814727,0.00014421466,0.00018368379],"domain_scores_gemma":[0.99894285,0.0003468627,0.000289757,0.00013757631,0.00012965481,0.00015330562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082311046,0.00020368882,0.00047381126,0.000058492253,0.00009481557,0.000007630918,0.000056891586,0.00015667241,0.00007720723],"category_scores_gemma":[0.00006507648,0.00014256827,0.00009219817,0.0001734808,0.0006513265,0.0000727951,0.000014465943,0.00010995971,5.1957505e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02487613,0.0075826226,0.6252465,0.0020196228,0.0071991314,0.00048694335,0.03914866,0.00038782554,0.23145548,0.0117725935,0.009234886,0.040589597],"study_design_scores_gemma":[0.011295999,0.078436784,0.04870338,0.0001598189,0.005846324,0.00022762589,0.0021374351,0.0008017083,0.74054754,0.0030178046,0.108356856,0.0004687376],"about_ca_topic_score_codex":0.0003888801,"about_ca_topic_score_gemma":0.0011764339,"teacher_disagreement_score":0.57654315,"about_ca_system_score_codex":0.000082808634,"about_ca_system_score_gemma":0.00080625707,"threshold_uncertainty_score":0.58137655},"labels":[],"label_agreement":null},{"id":"W3045778979","doi":"10.5489/cuaj.6405","title":"Clinical characteristics and outcomes for young patients with advanced urothelial carcinoma","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Carcinoma; Medicine; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.019296804075217992,"score_gpt":0.2678332335969479,"score_spread":0.24853642952172988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045778979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98157966,0.000035708705,0.0001265242,0.017050127,0.0002575923,0.00044053636,0.00025329538,0.000015898433,0.00024066388],"genre_scores_gemma":[0.98594993,0.00002294377,0.00056581886,0.012823112,0.0004650504,0.0000145266795,0.000043373195,0.00001590864,0.00009931788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891156,0.000057596975,0.00031786694,0.00019604586,0.00020883676,0.0003081208],"domain_scores_gemma":[0.9984506,0.00011279513,0.00019476542,0.000053932166,0.00026298102,0.00092497165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001604179,0.00013033961,0.00036037804,0.000036446723,0.00016693007,0.000046644607,0.00005358199,0.00014392452,0.000086712156],"category_scores_gemma":[0.0007310762,0.00008885487,0.00010039451,0.00006051265,0.000029601773,0.000065267195,0.000007750879,0.00030288514,0.000008132764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003750001,0.00004341307,0.9904556,0.000004986654,0.000112652364,0.000019397163,0.000070928676,2.843553e-7,0.0000022587087,0.00001804377,0.0009265574,0.007970835],"study_design_scores_gemma":[0.0057809954,0.0019792635,0.97478884,0.000004780713,0.00016202469,0.000011824597,0.000016305483,0.000033676482,0.0000014748855,0.0000390334,0.017091563,0.00009018683],"about_ca_topic_score_codex":0.00008407014,"about_ca_topic_score_gemma":0.00008823367,"teacher_disagreement_score":0.016165005,"about_ca_system_score_codex":0.0002334076,"about_ca_system_score_gemma":0.0003608533,"threshold_uncertainty_score":0.36233962},"labels":[],"label_agreement":null},{"id":"W3045834187","doi":"10.5489/cuaj.6522","title":"Diagnostic utility of axial imaging in the evaluation of hematuria: A systematic review and critical appraisal of the literature","year":2020,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Microscopic hematuria; Meta-analysis; Systematic review; Urinary system; Bladder cancer; MEDLINE; Cochrane Library; Radiology; Cancer; Pathology; Internal medicine","score_opus":0.03793545209718039,"score_gpt":0.3562275045724275,"score_spread":0.3182920524752471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045834187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095522075,0.992534,0.0000014919265,0.005206594,0.00017210712,0.0016530785,0.00019975174,0.000001631787,0.00013584163],"genre_scores_gemma":[0.14616889,0.8529532,0.000009211522,0.0006424366,0.0001239084,0.000075092954,0.000016277789,0.000008978641,0.0000020367147],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99553853,0.002330808,0.0010513299,0.00015936008,0.0007345214,0.0001854679],"domain_scores_gemma":[0.99497986,0.003244237,0.00089830486,0.00019185476,0.00053052,0.00015521195],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030409526,0.0001839644,0.0017503016,0.00009042935,0.00005362618,0.000022230537,0.000200059,0.00021301571,0.00007485802],"category_scores_gemma":[0.043872323,0.00008699417,0.0004036555,0.00044934734,0.00007897189,0.00004027162,0.000020108719,0.00075710576,7.4944626e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028146438,0.00027619657,0.01983088,0.9277726,0.00089951005,0.00010391319,0.0014185461,3.0388063e-7,3.7111883e-7,0.0003494713,0.0029922912,0.046327814],"study_design_scores_gemma":[0.0020216955,0.00050617376,0.0727032,0.8282522,0.06943805,0.0025006796,0.00024098801,0.000070779846,7.8350297e-7,0.0012292492,0.022655478,0.0003807415],"about_ca_topic_score_codex":0.00011071241,"about_ca_topic_score_gemma":0.00006911751,"teacher_disagreement_score":0.14607336,"about_ca_system_score_codex":0.00028250908,"about_ca_system_score_gemma":0.0013879852,"threshold_uncertainty_score":0.96418154},"labels":[],"label_agreement":null},{"id":"W3045923454","doi":"10.1080/2090598x.2020.1791563","title":"Lymph node dissection for upper tract urothelial carcinoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Arab Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Urothelial carcinoma; Dissection (medical); Lymph node; Carcinoma; General surgery; Surgery; Pathology; Cancer; Bladder cancer; Internal medicine","score_opus":0.03783857602974258,"score_gpt":0.34001933827071046,"score_spread":0.3021807622409679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045923454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000049950872,0.9947332,0.00030805377,0.0010708235,0.00079504313,0.0028030474,0.00006518905,0.000014935668,0.00020470371],"genre_scores_gemma":[0.0004868221,0.9958403,0.00013545669,0.0019449171,0.0010613863,0.0002549183,0.00003842971,0.000089427376,0.00014830417],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702466,0.00037744528,0.0017138,0.00029770753,0.00028613413,0.00030023936],"domain_scores_gemma":[0.99736506,0.00035336448,0.0014952122,0.0003147459,0.0002260637,0.00024554282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046041093,0.00045101668,0.0051490385,0.00021802339,0.000057524896,0.000013533759,0.00023707032,0.00029977935,0.00008427299],"category_scores_gemma":[0.0005460318,0.0002816697,0.0019507944,0.00019453888,0.000043692224,0.00006517396,0.000020976526,0.00050892547,0.000053131076],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023234624,0.00022507164,0.00003399586,0.95456445,0.0012524883,0.0006275334,0.00004548211,1.11076176e-7,0.0000010637739,0.000025086696,0.0009505861,0.042041756],"study_design_scores_gemma":[0.002517461,0.0022811675,0.00002544972,0.24573524,0.058159143,0.03647006,0.000007928253,0.0000038139058,0.0000010330849,0.000045221936,0.6544904,0.0002630829],"about_ca_topic_score_codex":0.00000444435,"about_ca_topic_score_gemma":3.4463136e-7,"teacher_disagreement_score":0.7088292,"about_ca_system_score_codex":0.00024019984,"about_ca_system_score_gemma":0.0010584381,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W3045937352","doi":"10.1016/j.urolonc.2020.06.034","title":"Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer – examining the utility of classifying Ta bladder cancer based on size","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Bladder tumor; Oncology; Outcome (game theory); Internal medicine; Urology; Mathematics","score_opus":0.11145792447127204,"score_gpt":0.36938070171749277,"score_spread":0.2579227772462207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045937352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704248,0.00035153318,0.000011847552,0.02652127,0.00013242832,0.0008172256,0.00029617775,0.000025559113,0.0014191937],"genre_scores_gemma":[0.98628545,0.00018948351,0.0015823613,0.011489699,0.00013777832,0.00022484649,0.000009364564,0.000019095123,0.00006191168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978579,0.0003834535,0.0006288743,0.0004502379,0.00034558377,0.00033391913],"domain_scores_gemma":[0.99407107,0.0046257153,0.000564991,0.0003542031,0.0001513129,0.00023271701],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038590652,0.00031476788,0.00082315074,0.000054300508,0.00021406217,0.000008684193,0.00024290565,0.00022073208,0.0015935415],"category_scores_gemma":[0.0016061856,0.00016218532,0.00019903999,0.00043432866,0.0015633639,0.000048600446,0.00006859334,0.00058682216,0.0000028119189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012415755,0.00074347813,0.9848366,0.00008730653,0.00049518776,0.00004916768,0.0010305655,0.00087593874,0.0049220086,0.00056920695,0.0040932954,0.0010556931],"study_design_scores_gemma":[0.003712508,0.016583756,0.9603905,0.0001959698,0.0013066063,0.000020650068,0.0007557235,0.002587866,0.0073222485,0.0011118187,0.0057591507,0.00025318284],"about_ca_topic_score_codex":0.0012266622,"about_ca_topic_score_gemma":0.00016978935,"teacher_disagreement_score":0.024446055,"about_ca_system_score_codex":0.00016643929,"about_ca_system_score_gemma":0.001261022,"threshold_uncertainty_score":0.99931914},"labels":[],"label_agreement":null},{"id":"W3045981731","doi":"10.1097/mou.0000000000000805","title":"Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy","year":2020,"lang":"en","type":"article","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphadenectomy; General surgery; Urinary diversion; Multidisciplinary approach; Surgery; Lymph node; Cancer; Internal medicine","score_opus":0.049788423627424847,"score_gpt":0.36504174009555246,"score_spread":0.3152533164681276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045981731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950278,0.0032721795,0.000017349708,0.0006474344,0.0006444134,0.00031227994,0.0000418044,0.000011228628,0.000025530086],"genre_scores_gemma":[0.9990935,0.0007215899,0.0000054397033,0.000028775996,0.00009272449,0.000011915625,0.000033772852,0.00001055759,0.0000017481558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917626,0.000046042842,0.00027086723,0.00023456535,0.00011688495,0.00015537578],"domain_scores_gemma":[0.9995928,0.00007347324,0.000063981905,0.00011276058,0.000025730731,0.00013128835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045851473,0.00013940554,0.00047217144,0.00009071258,0.000010985676,0.0000028189163,0.000043108048,0.00008036911,0.000048615373],"category_scores_gemma":[0.0000505896,0.00010453069,0.00008364138,0.00007662611,0.00017393181,0.000029166933,0.000042589636,0.00014718094,0.0000012770724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005001326,0.0003440278,0.9871588,0.000245071,0.00010100425,0.000005798756,0.00034622292,7.363855e-7,0.00008236365,0.000024722121,0.00013053635,0.01106058],"study_design_scores_gemma":[0.002793705,0.0045919954,0.9922273,0.00006866784,0.000046931422,0.000012253306,0.0000057170464,0.00004076217,0.000060184622,0.000010504302,0.000070515416,0.00007145739],"about_ca_topic_score_codex":0.000020160947,"about_ca_topic_score_gemma":0.000001348269,"teacher_disagreement_score":0.010989123,"about_ca_system_score_codex":0.000019382474,"about_ca_system_score_gemma":0.000055218155,"threshold_uncertainty_score":0.42626378},"labels":[],"label_agreement":null},{"id":"W3046935779","doi":"","title":"Improving cystectomy outcomes ANZUP co-operative multi-centre cystectomy audit - an update","year":2019,"lang":"en","type":"article","venue":"UWA Profiles and Research Repository (UWA)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Medicine; Cystectomy; Audit; General surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.033410784603787526,"score_gpt":0.3677308440062776,"score_spread":0.33432005940249004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046935779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892022,0.0013239046,0.000028134958,0.0007204883,0.00040256337,0.0025817421,0.00007644546,0.0001407417,0.005523767],"genre_scores_gemma":[0.96883947,0.00011210995,0.0008036801,0.00016100323,0.00036805472,0.00016637554,0.00007902864,0.00007201559,0.02939829],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965362,0.00044138302,0.0004075368,0.0008810799,0.00091885607,0.0008149652],"domain_scores_gemma":[0.998059,0.00012525951,0.00011255233,0.00073382165,0.0004288259,0.0005405578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000554825,0.00035985024,0.0006175843,0.00026093822,0.00059250917,0.00022730605,0.0002256827,0.00022598689,0.00025897115],"category_scores_gemma":[0.000067311004,0.0002488351,0.00014164454,0.00022729892,0.0002684169,0.00037445535,0.00016919836,0.00069730595,0.00022422727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014011806,0.0014585814,0.5775806,0.0015913689,0.0009132815,0.0011611442,0.00343832,0.0000041773555,0.39826456,0.00029010262,0.0026982902,0.011198416],"study_design_scores_gemma":[0.015199218,0.0026009534,0.13664114,0.00057631725,0.0001846822,0.00036355102,0.0052180258,0.0019730835,0.82292247,0.000025844809,0.013612958,0.00068172964],"about_ca_topic_score_codex":0.0010700407,"about_ca_topic_score_gemma":0.000004594676,"teacher_disagreement_score":0.44093943,"about_ca_system_score_codex":0.00023218626,"about_ca_system_score_gemma":0.00047730852,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W3047489111","doi":"10.1016/j.clon.2020.07.001","title":"Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy","year":2020,"lang":"en","type":"editorial","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Roche Products; Bristol-Myers Squibb Canada; National Institute for Health and Care Research; Merck Sharp and Dohme; Elekta; Varian Medical Systems; Cancer Research UK; Accuray; Roche","keywords":"Bladder cancer; Medicine; Cystectomy; Cancer; Incidence (geometry); Radiation therapy; Internal medicine; Family medicine; Oncology","score_opus":0.1555962783841463,"score_gpt":0.5417146664782309,"score_spread":0.38611838809408455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047489111","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011328743,0.030296678,0.00012451434,0.17676884,0.77584624,0.0038290382,0.00023362754,0.00012889988,0.0014434261],"genre_scores_gemma":[0.0028261382,0.063377835,0.0038052858,0.023054348,0.9058288,0.00027256654,0.00006325908,0.00012814485,0.0006436625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99181116,0.0023946492,0.0026711368,0.0015737014,0.00090862386,0.000640731],"domain_scores_gemma":[0.93399566,0.063110985,0.0007238821,0.00077602995,0.00035117086,0.0010422464],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0049177916,0.00053597114,0.0028764876,0.00010238276,0.00010744358,0.000051061812,0.0005516012,0.002955925,0.0002313697],"category_scores_gemma":[0.051666148,0.0003632809,0.00051396264,0.00038347652,0.00088252366,0.00013747695,0.00030049268,0.005635462,0.00008937737],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004377749,0.00066008174,0.029470582,0.000063432664,0.0011864933,0.0005464615,0.00036342768,6.4644024e-7,0.000002049851,0.000006619426,0.777577,0.18574548],"study_design_scores_gemma":[0.0072329943,0.009507885,0.02123457,0.0005431947,0.0021851899,0.000015821648,0.00009609655,0.00001819686,0.0000016492271,0.000059170256,0.9587799,0.0003253449],"about_ca_topic_score_codex":0.00081136625,"about_ca_topic_score_gemma":0.00052349555,"teacher_disagreement_score":0.18542013,"about_ca_system_score_codex":0.00060609577,"about_ca_system_score_gemma":0.0061689876,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W3048040415","doi":"10.1002/cncr.33071","title":"A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; NIH Clinical Center; Bladder Cancer Advocacy Network","keywords":"Medicine; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Oncology; Carcinoma; Internal medicine; Cancer; Bladder cancer","score_opus":0.03335126072263959,"score_gpt":0.3069385911879105,"score_spread":0.2735873304652709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048040415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969141,0.00026063278,0.00002589664,0.0003595676,0.000106677166,0.0012361567,0.00030358837,0.000016193271,0.00077720627],"genre_scores_gemma":[0.9988559,0.00001082179,0.00017031767,0.0005351491,0.00015619592,0.00014455448,0.00002963733,0.000027923912,0.000069515714],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989352,0.000030998643,0.00028952028,0.00024241403,0.00031377422,0.00018808908],"domain_scores_gemma":[0.99949116,0.000021622554,0.00010165695,0.00015740887,0.00007812094,0.00015004563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034805038,0.00015321809,0.00042732133,0.00005276186,0.000017198365,0.0000058085184,0.000061401886,0.000030659798,0.00042155167],"category_scores_gemma":[0.000031003834,0.0001096111,0.00005452755,0.00023526764,0.00005249294,0.00005466939,0.000014178182,0.00010338061,0.0000062803847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7942166,0.0041689584,0.17790033,0.00045101842,0.00050682575,0.00014731335,0.003141257,0.00002721006,0.0024602844,0.00005437284,0.0010710349,0.015854845],"study_design_scores_gemma":[0.8782101,0.026526466,0.08247239,0.00021642915,0.00070373766,0.0000010593963,0.00013614452,0.00011014955,0.008930358,0.000024139497,0.0023913695,0.00027760406],"about_ca_topic_score_codex":0.00036261693,"about_ca_topic_score_gemma":0.00005472577,"teacher_disagreement_score":0.09542793,"about_ca_system_score_codex":0.00009677576,"about_ca_system_score_gemma":0.00039478176,"threshold_uncertainty_score":0.46156952},"labels":[],"label_agreement":null},{"id":"W3048109011","doi":"10.1016/j.urolonc.2020.07.017","title":"Primary Ta high grade bladder tumors: Determination of the risk of progression","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Concomitant; Internal medicine; Tumor progression; Proportional hazards model; Carcinoma in situ; Stage (stratigraphy); Disease; Lower risk; Cancer; Oncology; Gastroenterology; Urology; Confidence interval","score_opus":0.026999872523391658,"score_gpt":0.30548152352513847,"score_spread":0.2784816510017468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048109011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98732275,0.00068547955,0.00011561235,0.010096794,0.00008514954,0.00049391924,0.000052892075,0.000024562445,0.0011228701],"genre_scores_gemma":[0.9640321,0.00029591663,0.03334327,0.0020492598,0.00009562517,0.000048102404,0.000029225026,0.000010285039,0.00009619141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905944,0.0001406587,0.00028918733,0.00021036343,0.00016976893,0.00013058422],"domain_scores_gemma":[0.99921775,0.00012763673,0.0003076203,0.00015222101,0.00006684645,0.00012794987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012527245,0.00012287714,0.000312026,0.000043274067,0.00010807367,0.0000035832818,0.00009201864,0.00013061844,0.000044870812],"category_scores_gemma":[0.00017503326,0.00007560613,0.00006950947,0.00023716521,0.00065618573,0.000055072003,0.000055634187,0.00022036389,0.0000021871663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002639415,0.00042023035,0.9717453,0.00014976306,0.000106331565,0.000028525035,0.0012674056,0.000015995374,0.008680658,0.0017643535,0.0016542115,0.013903253],"study_design_scores_gemma":[0.008087006,0.020303423,0.6171927,0.0005295105,0.0039775455,0.00043272882,0.00064591726,0.0022355819,0.084939115,0.025722465,0.23543356,0.0005004607],"about_ca_topic_score_codex":0.00005284361,"about_ca_topic_score_gemma":0.0000056145086,"teacher_disagreement_score":0.35455266,"about_ca_system_score_codex":0.000039812556,"about_ca_system_score_gemma":0.00031080155,"threshold_uncertainty_score":0.30831283},"labels":[],"label_agreement":null},{"id":"W3048849471","doi":"10.1111/iju.14336","title":"Ureteral location is associated with survival outcomes in upper tract urothelial carcinoma: A population‐based analysis","year":2020,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Renal pelvis; Urology; Interquartile range; Ureter; Hazard ratio; Upper urinary tract; Odds ratio; Population; Urothelial carcinoma; Carcinoma; Internal medicine; Cancer; Gynecology; Bladder cancer; Urinary system; Confidence interval","score_opus":0.023508213152349203,"score_gpt":0.30294175388188516,"score_spread":0.27943354072953597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048849471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97927827,0.000058611102,0.001342041,0.018780217,0.00023636104,0.00010085861,0.000048389767,0.000009013882,0.00014625718],"genre_scores_gemma":[0.994063,0.0000034164173,0.00017417359,0.005426305,0.00019668475,0.0000036055483,0.00008305799,0.000013465386,0.000036274832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986725,0.00011222258,0.0004346046,0.00015139846,0.00049947004,0.00012983101],"domain_scores_gemma":[0.9989924,0.000113223345,0.0002927868,0.00007070955,0.00042785174,0.00010301568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014337852,0.00012485553,0.0004536216,0.00039468042,0.0000178116,0.000016518676,0.00014141745,0.00008176122,0.0002995343],"category_scores_gemma":[0.00020305319,0.0000926849,0.00019958598,0.00034358827,0.000026628806,0.000104802886,0.000010684501,0.0002566106,0.0000044416647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001699544,0.00031259158,0.99416536,0.0000025859893,0.0015092787,0.00031599568,0.0003622062,0.0012387477,0.00006941253,0.00002252434,0.000037627262,0.0002641066],"study_design_scores_gemma":[0.0059432136,0.00095941895,0.989138,0.000009761298,0.0008002057,0.00005324461,0.00002383949,0.0027568482,0.00008178098,0.000049050355,0.00011149481,0.00007315183],"about_ca_topic_score_codex":0.00023261353,"about_ca_topic_score_gemma":0.000108422275,"teacher_disagreement_score":0.014784766,"about_ca_system_score_codex":0.0001655386,"about_ca_system_score_gemma":0.00021240207,"threshold_uncertainty_score":0.37795806},"labels":[],"label_agreement":null},{"id":"W3048908406","doi":"10.1158/1557-3265.bladder19-pr08","title":"Abstract PR08: The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PTEN; ARID1A; Somatic cell; Cancer research; Bladder cancer; Cancer; Medicine; DNA sequencing; Circulating tumor cell; Oncology; Germline mutation; Gene; Mutation; Biology; Internal medicine; Metastasis; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.288795444234291,"score_gpt":0.4772809954703104,"score_spread":0.1884855512360194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048908406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867163,0.0024407434,0.000011644762,0.006312259,0.00018706566,0.0009130395,0.00024996878,0.000027977867,0.0031410446],"genre_scores_gemma":[0.99649835,0.00017159496,0.00012511972,0.0014945276,0.0014409847,0.000116144576,0.000021717839,0.000046642595,0.000084927306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997129,0.00032738736,0.00075116917,0.0005106328,0.00084223587,0.00043956027],"domain_scores_gemma":[0.9974715,0.0012685756,0.00014845363,0.00048335653,0.00025391186,0.00037419522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010860732,0.00016719972,0.0005964505,0.00005089396,0.00013321909,0.00003237367,0.00034764886,0.000068590314,0.0021452454],"category_scores_gemma":[0.0008233407,0.00010708946,0.00027195376,0.0003433794,0.0003718415,0.000048865022,0.00015122074,0.0008930357,0.00015855813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063115275,0.00076097046,0.8925493,0.0005845366,0.0012754651,0.00059809664,0.0026994331,0.00004588028,0.036747072,0.0001003334,0.009924065,0.048403367],"study_design_scores_gemma":[0.0060942546,0.0011400318,0.97990984,0.00014781675,0.0003048665,0.000007789841,0.0006663923,0.0006852319,0.0060272506,0.00037829706,0.004468395,0.00016984437],"about_ca_topic_score_codex":0.0025718394,"about_ca_topic_score_gemma":0.00008966671,"teacher_disagreement_score":0.087360576,"about_ca_system_score_codex":0.00008129502,"about_ca_system_score_gemma":0.0012908332,"threshold_uncertainty_score":0.9987669},"labels":[],"label_agreement":null},{"id":"W3049165631","doi":"10.1158/1557-3265.bladder19-b23","title":"Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Fibroblast growth factor receptor 3; Cystectomy; Immunohistochemistry; Bladder cancer; Medicine; Cancer research; Internal medicine; Oncology; Pathology; Cancer; Gastroenterology; Fibroblast growth factor; Receptor","score_opus":0.26661711812524264,"score_gpt":0.5438236918028955,"score_spread":0.27720657367765283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049165631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95916706,0.0022988894,0.00031454442,0.032836586,0.000186322,0.0039474946,0.00086770643,0.00006882739,0.00031254673],"genre_scores_gemma":[0.9897894,0.004104413,0.00045163598,0.002184303,0.0008342547,0.0022146206,0.00011711018,0.000066344386,0.00023791307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961768,0.0003436658,0.0012887111,0.001135676,0.0003608493,0.00069432385],"domain_scores_gemma":[0.99588263,0.0021660822,0.00014902094,0.00044584525,0.0003149535,0.001041451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014721953,0.00030675254,0.00092051027,0.00017493838,0.00032601395,0.00007064746,0.00017167094,0.0003798132,0.0002519938],"category_scores_gemma":[0.0012318569,0.00022520797,0.00024550108,0.0005471504,0.00039931966,0.0001625286,0.00015247447,0.0008397371,0.000024332832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014271004,0.00074218266,0.9631812,0.000106496576,0.00024367751,0.00001273044,0.0005473879,0.0000071500153,0.0013788604,0.000050607014,0.0023631684,0.029939435],"study_design_scores_gemma":[0.010966717,0.0015849071,0.9660955,0.00017923137,0.00017429002,0.000004955638,0.00018687278,0.0002775745,0.00028083837,0.00019226257,0.019845348,0.0002114828],"about_ca_topic_score_codex":0.0007544842,"about_ca_topic_score_gemma":0.00074579834,"teacher_disagreement_score":0.030652285,"about_ca_system_score_codex":0.0002805471,"about_ca_system_score_gemma":0.00076711,"threshold_uncertainty_score":0.91837144},"labels":[],"label_agreement":null},{"id":"W3049299021","doi":"10.1158/1557-3265.bladder19-b10","title":"Abstract B10: A simple immunohistochemical algorithm to evaluate molecular subtypes and clinical associations in non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Immunohistochemistry; Subtyping; Tissue microarray; Antibody; Algorithm; Stage (stratigraphy); Transcriptome; Cancer; Oncology; Pathology; Medicine; Internal medicine; Biology; Immunology; Gene expression; Gene; Computer science","score_opus":0.17980585000074653,"score_gpt":0.5288131608495097,"score_spread":0.34900731084876313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049299021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97777516,0.0023904517,0.000048072747,0.016442934,0.00022544811,0.0016232649,0.0002470121,0.000042941752,0.0012047035],"genre_scores_gemma":[0.9887866,0.0030596275,0.00058618793,0.0058227386,0.0009057824,0.0005572322,0.000049131544,0.00006536654,0.00016738128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573475,0.00039586428,0.0011189617,0.0010029098,0.0009986399,0.0007488776],"domain_scores_gemma":[0.9964487,0.0013792736,0.00012003577,0.0004200297,0.0006142642,0.0010176932],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021567214,0.00024939564,0.00084883923,0.00013178361,0.00013090984,0.000056076202,0.00028001168,0.00035938993,0.00097381603],"category_scores_gemma":[0.0032358,0.00022364795,0.00026782838,0.00077857514,0.00037843693,0.00009107055,0.00030244933,0.0016737666,0.0001662153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002975848,0.001994,0.5519196,0.00022313968,0.0014097576,0.0006488674,0.0014977263,0.00003964081,0.016859576,0.000025120395,0.038555086,0.38385168],"study_design_scores_gemma":[0.007174951,0.0016916101,0.9819791,0.00021411454,0.00021714918,0.000001880901,0.00018613164,0.00055637764,0.0021992817,0.00030065427,0.005165982,0.00031277153],"about_ca_topic_score_codex":0.0041855774,"about_ca_topic_score_gemma":0.0007341798,"teacher_disagreement_score":0.43005952,"about_ca_system_score_codex":0.0004974025,"about_ca_system_score_gemma":0.0018973794,"threshold_uncertainty_score":0.99993944},"labels":[],"label_agreement":null},{"id":"W3049491040","doi":"10.1158/1557-3265.bladder19-ia22","title":"Abstract IA22: Realizing the potential of targeted therapy in non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Targeted therapy; Disease; Cancer; Immune checkpoint; Clinical trial; Immunotherapy; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.23171613068035943,"score_gpt":0.4963890871256152,"score_spread":0.2646729564452558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049491040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96713,0.00565746,0.0000070533674,0.02319962,0.00024878583,0.0013193712,0.000095143325,0.000024128694,0.0023184184],"genre_scores_gemma":[0.9778442,0.017665947,0.000032230073,0.0028031345,0.0011267025,0.0003211226,0.000013274076,0.000045988363,0.00014740096],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969219,0.00029985784,0.00075287465,0.00054999656,0.00090978143,0.00056559895],"domain_scores_gemma":[0.9980217,0.0006372609,0.00013293998,0.00042673104,0.0004478831,0.0003334647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012053512,0.00018542378,0.00055878435,0.0000950139,0.00011599023,0.000026703992,0.0003752103,0.00019550386,0.0023131093],"category_scores_gemma":[0.0005178829,0.000119930235,0.00024503423,0.00076627394,0.000510771,0.00008422305,0.00013170933,0.0012485288,0.000042631513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014322367,0.0020993946,0.38360712,0.0006271747,0.0016442055,0.0005980543,0.0048067304,0.0003520197,0.10233685,0.000067574394,0.055759992,0.43377852],"study_design_scores_gemma":[0.0067830333,0.0014579522,0.97438705,0.00028980974,0.000058562546,0.0000014744263,0.0009315152,0.00016174739,0.010676916,0.00016719225,0.0049216743,0.00016308062],"about_ca_topic_score_codex":0.010509162,"about_ca_topic_score_gemma":0.0012047807,"teacher_disagreement_score":0.59077996,"about_ca_system_score_codex":0.00014877402,"about_ca_system_score_gemma":0.0015848217,"threshold_uncertainty_score":0.99859893},"labels":[],"label_agreement":null},{"id":"W3049491391","doi":"10.1158/1557-3265.bladder19-ia21","title":"Abstract IA21: Intravesical gene therapy for NMIBC","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"College of Physicians and Surgeons of Ontario","funders":"","keywords":"Medicine; Oncolytic virus; Genetic enhancement; Oncology; Clinical trial; Bladder cancer; Refractory (planetary science); Internal medicine; Urothelium; Cystectomy; Gene; Cancer; Urinary system","score_opus":0.4833733599109263,"score_gpt":0.5783440767573926,"score_spread":0.09497071684646635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049491391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9149598,0.0050611864,0.0002484294,0.07064849,0.00051187706,0.0029475118,0.00019112266,0.00012708898,0.005304489],"genre_scores_gemma":[0.982612,0.004531991,0.00057327095,0.00692516,0.0041872603,0.00050564547,0.000031644347,0.000057033023,0.00057600375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975761,0.000110926194,0.0005046003,0.0005949861,0.0006418576,0.00057148834],"domain_scores_gemma":[0.9977714,0.00073943834,0.000047395417,0.00032392875,0.00037784854,0.0007400068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009505533,0.00015652158,0.0004739358,0.0000492144,0.00013345736,0.00003838518,0.00023050654,0.00019773598,0.0016893006],"category_scores_gemma":[0.00064709253,0.00011578818,0.000290353,0.00028765804,0.00031828327,0.000052758973,0.00006206598,0.0008203944,0.00021637541],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025133185,0.0017242229,0.05397095,0.00032750933,0.00082996127,0.00017355985,0.00054880464,0.0000037630623,0.0145251,0.0003581636,0.14957324,0.7528315],"study_design_scores_gemma":[0.024818424,0.011658243,0.397635,0.00014510329,0.00011592376,0.000009031064,0.00014834781,0.00027375808,0.039471183,0.0015161247,0.5237833,0.00042552472],"about_ca_topic_score_codex":0.00015373454,"about_ca_topic_score_gemma":0.000012263073,"teacher_disagreement_score":0.752406,"about_ca_system_score_codex":0.00010215337,"about_ca_system_score_gemma":0.0009400956,"threshold_uncertainty_score":0.9992233},"labels":[],"label_agreement":null},{"id":"W3049551640","doi":"10.1158/1557-3265.bladder19-a04","title":"Abstract A04: DNA damage repair gene mutations and associated tumor immune landscape as biomarkers of response to immunotherapy in muscle-invasive urothelial cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"TIGIT; Immune system; Immunotherapy; Biology; Immune checkpoint; Cancer research; Bladder cancer; Cancer; Transcriptome; Cancer immunotherapy; Tumor microenvironment; Biomarker; DNA repair; Immunology; Gene; Gene expression; Genetics","score_opus":0.11395063758917365,"score_gpt":0.4625871172768211,"score_spread":0.34863647968764744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049551640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827548,0.0025980293,0.0000013948778,0.012040931,0.00015344522,0.001428674,0.0004271798,0.000060324764,0.0005351885],"genre_scores_gemma":[0.99500203,0.0021049369,0.00011562354,0.0017760142,0.00023598014,0.00041901896,0.000027724733,0.00006424698,0.00025440022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963598,0.0007091123,0.0009547003,0.0006745394,0.000751061,0.0005507485],"domain_scores_gemma":[0.99669063,0.0017663072,0.00016138822,0.00041062012,0.00046398322,0.0005070666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024030444,0.0002248852,0.00072801544,0.00027449618,0.00011843279,0.00002877874,0.00022679083,0.00018036044,0.0012888566],"category_scores_gemma":[0.0031178247,0.00019772562,0.00024151607,0.0010868262,0.00037380695,0.000085975866,0.00012573651,0.00070732593,0.000044579447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07307072,0.0014482237,0.37145716,0.00031088118,0.0015725918,0.0007598743,0.0040837717,0.000042793934,0.5291729,0.000010331196,0.004084782,0.013986],"study_design_scores_gemma":[0.0095934095,0.002580937,0.9640806,0.00041402443,0.00007109963,0.0000024389615,0.0005846035,0.00006097349,0.020647995,0.00004711399,0.0017236012,0.00019323033],"about_ca_topic_score_codex":0.005922681,"about_ca_topic_score_gemma":0.0009801268,"teacher_disagreement_score":0.5926234,"about_ca_system_score_codex":0.0002862416,"about_ca_system_score_gemma":0.0023245623,"threshold_uncertainty_score":0.9996241},"labels":[],"label_agreement":null},{"id":"W3051680285","doi":"10.1007/s00345-020-03384-9","title":"Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)","year":2020,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Bladder cancer; Proportional hazards model; Internal medicine; Nephrology; Concordance; Youden's J statistic; Hazard ratio; Oncology; Cancer; Urology; Gastroenterology; Confidence interval; Receiver operating characteristic","score_opus":0.01146075349231861,"score_gpt":0.26026669287993187,"score_spread":0.24880593938761325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3051680285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98528206,0.00014827967,0.00008921272,0.013568087,0.00007060074,0.00023076944,0.000013008308,0.000004182912,0.00059381983],"genre_scores_gemma":[0.99483263,0.000083891355,0.00041935433,0.0043871915,0.00010167336,0.000010195959,0.0000028364648,0.000012168625,0.00015003057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990306,0.000080531325,0.00032585106,0.00011159104,0.0002660735,0.0001853666],"domain_scores_gemma":[0.9990452,0.00013851275,0.000397802,0.000057978217,0.00024086061,0.00011964441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010341234,0.0001071397,0.00049036805,0.00010680335,0.000018584129,0.000004430313,0.000065259796,0.000067309185,0.0002639093],"category_scores_gemma":[0.000105152365,0.00006766354,0.000056492776,0.0002105664,0.000045136367,0.00007084887,0.000013343087,0.00028485648,0.0000020475939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022240328,0.00039239437,0.99323577,0.0000146032635,0.00043790307,0.00012087179,0.00055090856,0.0001669857,0.00014776606,0.000005976801,0.0009947349,0.0017080456],"study_design_scores_gemma":[0.010550196,0.006614284,0.98126364,0.00003797006,0.00035204605,0.000009621441,0.000039849994,0.000010179811,0.0001977755,0.000023753428,0.0008394803,0.00006122832],"about_ca_topic_score_codex":0.00009206774,"about_ca_topic_score_gemma":0.0014041305,"teacher_disagreement_score":0.011972163,"about_ca_system_score_codex":0.00022517626,"about_ca_system_score_gemma":0.00043547867,"threshold_uncertainty_score":0.2889622},"labels":[],"label_agreement":null},{"id":"W3066367048","doi":"10.1111/bju.15209","title":"Recurrence‐ and progression‐free survival in intermediate‐risk non‐muscle‐invasive bladder cancer: the impact of conditional evaluation and subclassification","year":2020,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Internal medicine; Oncology; Cohort; Retrospective cohort study; Cancer; Urology","score_opus":0.034060803286269016,"score_gpt":0.3421957696840942,"score_spread":0.30813496639782517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3066367048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898724,0.0070452867,0.000058361617,0.0023706031,0.0001079822,0.00033230646,0.00013596551,0.0000021587816,0.00007491201],"genre_scores_gemma":[0.9928878,0.0066869445,0.000038549868,0.00014704774,0.00019054687,0.000020141983,0.000019515857,0.000007744893,0.0000017061278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989464,0.00020400494,0.00034149757,0.0001310973,0.0002618836,0.000115090916],"domain_scores_gemma":[0.99901944,0.00015699517,0.00035605958,0.000063443185,0.00029842768,0.00010565458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004458816,0.00008230007,0.0002676854,0.00005903482,0.00004121322,0.000013702212,0.000074916396,0.00006894707,0.00011990487],"category_scores_gemma":[0.00057634007,0.00006109756,0.00006197786,0.00010457343,0.00020682764,0.00009536303,0.000028301229,0.00027686404,3.9060922e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013127533,0.0002201214,0.6803831,0.000048372247,0.00037994992,0.00013158182,0.0013872341,0.00009367974,0.0012521336,0.000014417173,0.0021434517,0.3126332],"study_design_scores_gemma":[0.004550963,0.0018892434,0.9905268,0.000103088765,0.00024146218,0.00057902664,0.00014842002,0.0008618065,0.00010093794,0.00091292866,0.000038140075,0.000047203408],"about_ca_topic_score_codex":0.00028584455,"about_ca_topic_score_gemma":0.0002261393,"teacher_disagreement_score":0.312586,"about_ca_system_score_codex":0.000050060327,"about_ca_system_score_gemma":0.00049533107,"threshold_uncertainty_score":0.24914862},"labels":[],"label_agreement":null},{"id":"W3080241619","doi":"10.1158/1535-7163.mct-19-1031","title":"Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Terry Fox Research Institute","keywords":"Bladder cancer; Gene silencing; Biology; Cancer research; Slug; Metastasis; Cancer; Gene; Genetics","score_opus":0.044195244923870614,"score_gpt":0.2920252293583531,"score_spread":0.2478299844344825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080241619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97133434,0.014306166,0.0012857079,0.011008515,0.00020565522,0.00075808086,0.00020045912,0.00007838143,0.0008226683],"genre_scores_gemma":[0.988479,0.0038116483,0.00045289,0.0066159163,0.00018608269,0.00010822618,0.000018503008,0.000074995114,0.0002527021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985693,0.00006154404,0.00029638343,0.00039693425,0.00040313083,0.00027270414],"domain_scores_gemma":[0.99915844,0.000018934163,0.000120219745,0.00024149282,0.0002528616,0.00020803876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005419698,0.00026623174,0.0004396365,0.000043736767,0.000045713543,0.000020653995,0.00013169862,0.000113730945,0.0006076764],"category_scores_gemma":[0.000011395661,0.00022022586,0.00011037793,0.0001965078,0.00011161998,0.000051661907,0.00006397612,0.00015050588,0.0000070263773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084629987,0.00016389611,0.031575296,0.0002899709,0.001385442,0.00009388185,0.0014002018,0.000014535055,0.9535502,0.000048595964,0.0001998536,0.010431799],"study_design_scores_gemma":[0.0038518677,0.000647052,0.009654497,0.00013175744,0.00087594,0.000008115366,0.00006216034,0.00019168612,0.97826153,0.00026157076,0.0057735145,0.0002803311],"about_ca_topic_score_codex":0.00046066323,"about_ca_topic_score_gemma":0.000028844788,"teacher_disagreement_score":0.02471128,"about_ca_system_score_codex":0.000051953102,"about_ca_system_score_gemma":0.0002796672,"threshold_uncertainty_score":0.898055},"labels":[],"label_agreement":null},{"id":"W3080821783","doi":"10.1016/j.prp.2020.153186","title":"Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations","year":2020,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Immunohistochemistry; Cohort; Medicine; Cystectomy; Retrospective cohort study; Tissue microarray; Oncology; Internal medicine; Bladder cancer; Pathology; P53 expression; Cancer; Gastroenterology","score_opus":0.08177981890476275,"score_gpt":0.4140044506842575,"score_spread":0.33222463177949474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080821783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712332,0.0021805705,0.00009494079,0.022866732,0.00002532706,0.0005392105,0.000052028605,0.000010262677,0.0029977171],"genre_scores_gemma":[0.9962466,0.0012196086,0.0012328314,0.00083000143,0.000056707784,0.00018573177,0.000045497392,0.000014138523,0.00016889529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878806,0.0002341515,0.000175168,0.00030490928,0.00027940664,0.00021831946],"domain_scores_gemma":[0.9986341,0.00077933975,0.00008093949,0.00014251829,0.00022678918,0.00013629028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003632729,0.00010548216,0.0002153544,0.00007808774,0.00008566532,0.000015668364,0.000043854565,0.000099833596,0.000118738324],"category_scores_gemma":[0.00054667296,0.00007756199,0.000013546064,0.00022375741,0.00034064858,0.000184094,0.000052391762,0.000486663,0.0000025012039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012971721,0.0014222615,0.7205468,0.0008041156,0.00076470093,0.0031274268,0.015761998,0.000015525817,0.22349364,0.0006046058,0.0016984396,0.01878877],"study_design_scores_gemma":[0.014908971,0.007390174,0.93199074,0.00040880064,0.0007923771,0.0019404863,0.00944964,0.00010584211,0.028780082,0.002337903,0.0014737077,0.00042130245],"about_ca_topic_score_codex":0.0008163592,"about_ca_topic_score_gemma":0.0001310232,"teacher_disagreement_score":0.21144392,"about_ca_system_score_codex":0.00006188035,"about_ca_system_score_gemma":0.00034961413,"threshold_uncertainty_score":0.31628862},"labels":[],"label_agreement":null},{"id":"W3082338190","doi":"10.5489/cuaj.6812","title":"Association between surgical case volume and survival in T1 bladder cancer: A plea for regionalization of care?","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Swiss Cancer Research Foundation; Uniscientia Foundation; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Percentile; Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Confounding; Bladder cancer; Surgery; Internal medicine; Cancer; Statistics","score_opus":0.02574309659538177,"score_gpt":0.274604904491588,"score_spread":0.2488618078962062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082338190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93938506,0.0010087716,0.0001272024,0.057850275,0.00017654007,0.00049350504,0.00048249756,0.000016149532,0.0004599758],"genre_scores_gemma":[0.9974757,0.00021044584,0.000090102054,0.0011757576,0.00072975777,0.000022624761,0.00007231078,0.000013578802,0.00020976212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863654,0.00015248943,0.0003879623,0.00019647728,0.0002999532,0.00032659317],"domain_scores_gemma":[0.9985047,0.00022831945,0.00030562707,0.000043231645,0.0003876774,0.00053042395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036307808,0.00012082047,0.00040334454,0.00010406446,0.000121469864,0.000031193395,0.000045729696,0.00027808262,0.0001916494],"category_scores_gemma":[0.0006175332,0.00010900849,0.0001097157,0.00022469429,0.00001841267,0.000077768855,0.000008922435,0.00028884684,0.0000024674152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013956519,0.000017555423,0.9939,0.00002267928,0.00022932525,0.0002160806,0.00061344507,0.000030967673,0.000006046391,0.000051462914,0.0028767027,0.0018961797],"study_design_scores_gemma":[0.006257007,0.00094802346,0.9202652,0.000028078177,0.0005312265,0.00021059468,0.0004179146,0.00044669685,0.000025710122,0.00024573112,0.07043973,0.00018410258],"about_ca_topic_score_codex":0.004017606,"about_ca_topic_score_gemma":0.004729828,"teacher_disagreement_score":0.07363481,"about_ca_system_score_codex":0.0014163087,"about_ca_system_score_gemma":0.00059688906,"threshold_uncertainty_score":0.60734457},"labels":[],"label_agreement":null},{"id":"W3082808626","doi":"10.1111/andr.12898","title":"Effect of neurovascular bundle sparing radical cystectomy on post‐operative continence and sexual function: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"Andrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Neurovascular bundle; Medicine; Urinary continence; Sexual function; Meta-analysis; Cystectomy; Potency; Prospective cohort study; Urology; Surgery; Internal medicine; Prostatectomy; Bladder cancer; Prostate; Cancer","score_opus":0.02929450578411012,"score_gpt":0.3350261291563799,"score_spread":0.3057316233722698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082808626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008282424,0.9965828,0.000027830445,0.00027456813,0.000032627333,0.0028749614,0.000034845256,0.000019536592,0.0000700238],"genre_scores_gemma":[0.0014191248,0.99665594,0.000009128236,0.001228752,0.0000382101,0.00047147792,0.000051941977,0.000025604586,0.00009980579],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975778,0.0009607412,0.0005801349,0.00054562616,0.00017156426,0.00016412757],"domain_scores_gemma":[0.99871063,0.0004890681,0.00026611268,0.00034470632,0.000053369607,0.00013612323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036705675,0.00041284185,0.008626654,0.00015164023,0.00004438131,0.000010226819,0.00006835219,0.00018049445,0.000083519495],"category_scores_gemma":[0.00016858375,0.00023314125,0.00078332995,0.0003609915,0.000119081415,0.000025999778,0.00005529474,0.00029703503,0.000011653036],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010490019,0.000045140278,0.000016211672,0.8349512,0.16118936,0.00011937766,0.000034185086,1.0931076e-7,4.4369165e-7,0.000013257797,0.000014842566,0.0035109303],"study_design_scores_gemma":[0.0008263869,0.00761075,0.0000060204698,0.011836467,0.9652508,0.000699113,0.0000021855005,0.000004907586,0.0000017768364,5.1358654e-7,0.013620405,0.00014069931],"about_ca_topic_score_codex":0.000050357976,"about_ca_topic_score_gemma":0.0000054758334,"teacher_disagreement_score":0.82311475,"about_ca_system_score_codex":0.000017005203,"about_ca_system_score_gemma":0.00006978184,"threshold_uncertainty_score":0.9507224},"labels":[],"label_agreement":null},{"id":"W3083259192","doi":"10.3747/co.27.5459","title":"A Cost–Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Atezolizumab; Medicine; Population; Oncology; Cost-effectiveness analysis; Quality-adjusted life year; Cost–benefit analysis; Quality of life (healthcare); Internal medicine; Chemotherapy; Bladder cancer; Intensive care medicine; Cost effectiveness; Cancer; Immunotherapy; Environmental health; Pembrolizumab; Risk analysis (engineering)","score_opus":0.18988163007619538,"score_gpt":0.4304605137584689,"score_spread":0.2405788836822735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083259192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995439,0.0016829384,0.0000743756,0.0007199311,0.00008076874,0.001020822,0.00062643836,0.0000068641457,0.0003488411],"genre_scores_gemma":[0.99906737,0.00021146127,0.000059377388,0.0002174942,0.000029771063,0.0001987842,0.00018918485,0.0000084490575,0.000018116976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988518,0.00014184763,0.0003766435,0.00024043907,0.00021555074,0.00017375723],"domain_scores_gemma":[0.9992678,0.00010217065,0.0001900961,0.00021979812,0.00013748225,0.00008261939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000059783735,0.00015520888,0.0007933875,0.00012182466,0.000016021042,0.0000019017235,0.00008051218,0.000035825557,0.0011298467],"category_scores_gemma":[0.000017535811,0.00008429352,0.00015436776,0.0007498478,0.000115961586,0.000025759009,0.0000137544,0.0000840976,0.0000022591817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027999473,0.0055819713,0.89226145,0.00015138705,0.0033941972,0.000014998953,0.006488492,0.000050335406,0.000017333448,0.000012097019,0.00019936841,0.08902845],"study_design_scores_gemma":[0.013896945,0.00729655,0.9467712,0.000026232276,0.007922671,0.0000010101239,0.0004524046,0.0008708073,0.00055690325,0.000012683177,0.022095287,0.0000973207],"about_ca_topic_score_codex":0.00021817964,"about_ca_topic_score_gemma":0.0014618865,"teacher_disagreement_score":0.08893113,"about_ca_system_score_codex":0.00018955707,"about_ca_system_score_gemma":0.0003129503,"threshold_uncertainty_score":0.9997833},"labels":[],"label_agreement":null},{"id":"W3083419704","doi":"10.1016/j.prp.2020.153200","title":"Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?","year":2020,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bladder cancer; CD20; Immune system; FOXP3; Oncology; Internal medicine; CD8; Medicine; Cystectomy; Cancer; Immunohistochemistry; Immunology","score_opus":0.05775215473120778,"score_gpt":0.37335847732547234,"score_spread":0.3156063225942646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083419704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95836574,0.0011812503,0.0000067037113,0.034581445,0.00008580769,0.0009397525,0.00008375883,0.000024493109,0.004731026],"genre_scores_gemma":[0.9955407,0.0015772625,0.00029323032,0.0018328414,0.0000950088,0.00015065655,0.000051278166,0.00003178954,0.0004272433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763834,0.0006402322,0.00021885418,0.0004980769,0.000492801,0.0005116891],"domain_scores_gemma":[0.9982391,0.0007425903,0.000081704406,0.00025080433,0.0003524887,0.00033330015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068266375,0.00016169754,0.0002943634,0.0001425783,0.00015483417,0.000039671424,0.00010661344,0.00011964354,0.00028032286],"category_scores_gemma":[0.0018810258,0.0001166613,0.000026845679,0.00046294898,0.00030654174,0.0002708823,0.000127121,0.000801824,0.000041550433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028944224,0.0014608364,0.9160931,0.0003225532,0.0005518778,0.0047735064,0.009299378,0.000003723839,0.0047214897,0.000055420303,0.0031974632,0.030576408],"study_design_scores_gemma":[0.008707416,0.004853379,0.97755384,0.00010983035,0.00015244888,0.000084190244,0.0039660544,0.000007146794,0.0007147633,0.00010522698,0.003565453,0.00018022813],"about_ca_topic_score_codex":0.002089523,"about_ca_topic_score_gemma":0.0007333939,"teacher_disagreement_score":0.06146074,"about_ca_system_score_codex":0.00011535778,"about_ca_system_score_gemma":0.0003998248,"threshold_uncertainty_score":0.47573096},"labels":[],"label_agreement":null},{"id":"W3083711940","doi":"10.1016/j.jgo.2020.08.005","title":"Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012","year":2020,"lang":"en","type":"article","venue":"Journal of Geriatric Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Canada","keywords":"Medicine; Gemcitabine; Systemic therapy; Regimen; Metastatic Urothelial Carcinoma; Context (archaeology); Internal medicine; Oncology; Chemotherapy; Chemotherapy regimen; Cancer; Population; Bladder cancer; Urothelial carcinoma; Breast cancer","score_opus":0.03739635964027008,"score_gpt":0.3222990066432356,"score_spread":0.2849026470029655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083711940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994898,0.0021219864,0.00027575032,0.001337889,0.00019693152,0.000913443,0.00003024682,0.00001177603,0.00021396505],"genre_scores_gemma":[0.9954194,0.0025570106,0.0009592225,0.0005134488,0.000427286,0.00002067236,0.000016651877,0.00003032569,0.000056027347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834037,0.00021254875,0.00067113136,0.00019629327,0.00035573728,0.00022393849],"domain_scores_gemma":[0.99860847,0.00025349692,0.0004926292,0.00009782687,0.00024973982,0.0002978428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018922256,0.0001853531,0.00082803064,0.00025421492,0.000034997927,0.000008489041,0.00009205901,0.00008240805,0.0001517019],"category_scores_gemma":[0.00010966109,0.00011338699,0.00005925691,0.0005099529,0.000057582274,0.00015962558,0.000018510953,0.00025089353,0.0000034287739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011559155,0.0003970323,0.8969042,0.00015181629,0.00027203807,0.00082983443,0.0012695054,0.0000138724745,0.00012538984,0.0000029999737,0.0008075417,0.087666646],"study_design_scores_gemma":[0.042617507,0.01727599,0.9345791,0.00016512668,0.00053975487,0.0001388428,0.00034356947,0.000023851138,0.000105304505,0.000013059198,0.0040468676,0.00015103542],"about_ca_topic_score_codex":0.00009049424,"about_ca_topic_score_gemma":0.00012448271,"teacher_disagreement_score":0.087515615,"about_ca_system_score_codex":0.00026879832,"about_ca_system_score_gemma":0.0011429694,"threshold_uncertainty_score":0.4623787},"labels":[],"label_agreement":null},{"id":"W3085062263","doi":"10.1007/s00345-020-03440-4","title":"Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response","year":2020,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Clinical trial; Bladder cancer; Oncology; Radiation therapy; Adjuvant; Internal medicine; Atezolizumab; Cancer; Pembrolizumab","score_opus":0.018473524664173208,"score_gpt":0.31081829778377235,"score_spread":0.29234477311959917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085062263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036077413,0.98625475,0.00003243626,0.007993661,0.001119918,0.0009136039,0.000034792614,0.0000070318893,0.000036087542],"genre_scores_gemma":[0.020442197,0.9774577,0.00006348737,0.0011774682,0.0005407588,0.000029500712,0.0000017509661,0.000086852655,0.00020028888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962915,0.0013598254,0.0013860778,0.00027192198,0.0003603146,0.0003303685],"domain_scores_gemma":[0.9974748,0.00037611922,0.0015103009,0.00042984134,0.000114543094,0.00009441902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081876526,0.0004386004,0.0025676338,0.00038827473,0.00011323855,0.000028038652,0.0005076373,0.00016774883,0.00024031848],"category_scores_gemma":[0.00007052246,0.00022348033,0.0007760194,0.0006247851,0.00045195635,0.0000563421,0.000073744864,0.0012513435,0.0000015489143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022528041,0.00041744256,0.00051340216,0.0011787277,0.0034495457,0.00079153065,0.0007238255,0.000020136813,0.004530854,0.00004368802,0.00051046745,0.96529233],"study_design_scores_gemma":[0.008240885,0.0017937735,0.0054782648,0.0026039844,0.002149273,0.0027065775,0.000028603152,0.000018637409,0.000042185566,0.000052677144,0.97666335,0.00022180792],"about_ca_topic_score_codex":0.00008180597,"about_ca_topic_score_gemma":0.000024475927,"teacher_disagreement_score":0.97615284,"about_ca_system_score_codex":0.00018203087,"about_ca_system_score_gemma":0.0015732148,"threshold_uncertainty_score":0.9113263},"labels":[],"label_agreement":null},{"id":"W3087398983","doi":"10.1016/j.euf.2020.08.010","title":"Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages—A SEER-based Study","year":2020,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Stage (stratigraphy); Chemotherapy; Hazard ratio; Bladder cancer; Urology; Internal medicine; Urinary bladder; Oncology; Proportional hazards model; Urinary system; Transitional cell carcinoma; Cancer; Confidence interval","score_opus":0.03305617362202479,"score_gpt":0.3013311736708177,"score_spread":0.2682750000487929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087398983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945037,0.0007840774,0.000013739997,0.001956229,0.00015025874,0.0011000227,0.0001334086,0.000035856654,0.0013227193],"genre_scores_gemma":[0.99845564,0.00002847281,0.000040813895,0.0010056781,0.00012999233,0.000007465693,0.000013640962,0.000062322324,0.00025597468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982993,0.00045058804,0.00035398288,0.00039820798,0.00024436042,0.00025356186],"domain_scores_gemma":[0.9990557,0.0001289567,0.00020278397,0.0004274584,0.00005970708,0.00012541412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016285719,0.00022230746,0.0003617969,0.000033116572,0.000085055864,0.00000675657,0.00019673261,0.000052487085,0.00012668989],"category_scores_gemma":[0.00005622566,0.0001646029,0.00012354036,0.00013571633,0.00024640837,0.000029944607,0.00018239216,0.00018209785,0.000015086516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034700565,0.0022690382,0.8702062,0.00015172294,0.0010440899,0.0005500698,0.013803839,0.00007411408,0.07245608,0.000007893317,0.00069297233,0.004043466],"study_design_scores_gemma":[0.031481285,0.011353151,0.9179808,0.000007239772,0.0003769295,0.000017219121,0.0003338841,0.000036292415,0.03493237,0.0000011985663,0.0033401896,0.0001394177],"about_ca_topic_score_codex":0.00007478372,"about_ca_topic_score_gemma":0.000012373945,"teacher_disagreement_score":0.04777467,"about_ca_system_score_codex":0.000030546238,"about_ca_system_score_gemma":0.0000758443,"threshold_uncertainty_score":0.67123115},"labels":[],"label_agreement":null},{"id":"W3087464965","doi":"10.1056/nejmoa2002788","title":"Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1479,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Foundation Medicine; Pharmacyclics; Novartis Pharma; EMD Serono; Genentech; LEO Pharma; Bavarian Nordic; Ipsen; Janssen Pharmaceuticals; AstraZeneca Australia; Astellas Pharma; Eisai; Bayer HealthCare; GlaxoSmithKline; UroGen Pharma; Takeda Oncology; Mirati Therapeutics; University of Patras; Clovis Oncology; F. Hoffmann-La Roche; Ipsen Biopharmaceuticals; Janssen Biotech; Les Laboratories Pierre Fabre; Massachusetts Medical Society; Advanced Accelerator Applications; Merck KGaA; Endocyte; Pfizer; Incyte; Progenics Pharmaceuticals; Genesis Pharma; Yale University; Exelixis; Sanofi; Amgen; Heron Therapeutics; EUSA Pharma; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Avelumab; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Medicine; Internal medicine; Carcinoma; Standard of care; Immunotherapy; Cancer; Bladder cancer; Pembrolizumab","score_opus":0.05678166625801688,"score_gpt":0.32316093991210293,"score_spread":0.26637927365408604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087464965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75266767,0.013653103,0.035398263,0.18998216,0.0024142324,0.00291692,0.000076377706,0.000075844764,0.0028154468],"genre_scores_gemma":[0.9786221,0.0008715109,0.0044793687,0.00917345,0.005607944,0.000011540158,0.000007252479,0.000041995467,0.0011848555],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99855286,0.000048487822,0.0005510308,0.0001779046,0.00041697323,0.00025275646],"domain_scores_gemma":[0.9985788,0.00020568605,0.00028301138,0.00013504218,0.0002667824,0.0005306793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027935594,0.00020817437,0.0007463633,0.00008229515,0.000045757653,0.0000069146795,0.00013278783,0.000036289177,0.0005525155],"category_scores_gemma":[0.00054278655,0.00010825271,0.00014750574,0.00016966563,0.00007315342,0.0000846793,0.000008816451,0.00022857492,0.0000052003184],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11040101,0.00029831467,0.0045327423,0.00026650802,0.00093517493,0.0015102564,0.0061787027,0.000029658886,0.023864605,0.00018108755,0.050893307,0.8009086],"study_design_scores_gemma":[0.54505634,0.046784524,0.0041872743,0.00059973414,0.00093446666,0.0028247903,0.00075095013,0.00017126113,0.009973944,0.0009425294,0.38751706,0.00025714064],"about_ca_topic_score_codex":0.00003666545,"about_ca_topic_score_gemma":0.000007789528,"teacher_disagreement_score":0.8006515,"about_ca_system_score_codex":0.000055106295,"about_ca_system_score_gemma":0.0006208302,"threshold_uncertainty_score":0.60496575},"labels":[],"label_agreement":null},{"id":"W3087466624","doi":"10.1016/s1470-2045(20)30541-6","title":"Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":498,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McMaster University; Université Laval; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"Foundation Medicine; EMD Serono; Pharmacyclics; Genentech; AstraZeneca; EUSA Pharma; Astellas Pharma; Eisai; INOVIO Pharmaceuticals; AstraZeneca España; Pfizer; Incyte; Ipsen; Clovis Oncology; Les Laboratories Pierre Fabre; Endocyte; Sanofi; Exelixis; GlaxoSmithKline; Celldex Therapeutics; Amgen; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Tremelimumab; Chemotherapy; Metastatic Urothelial Carcinoma; Oncology; Open label; Internal medicine; Urology; Carcinoma; Randomized controlled trial; Urothelial carcinoma; Cancer; Immunotherapy; Bladder cancer","score_opus":0.09417910979039026,"score_gpt":0.3763797989152469,"score_spread":0.28220068912485663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087466624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98035765,0.0007159325,0.00006101171,0.0043714265,0.00027914086,0.0124509325,0.00014536212,0.00008938685,0.0015291334],"genre_scores_gemma":[0.992108,0.000628259,0.0014923994,0.0038360872,0.00039518625,0.001029817,0.00013793394,0.000103739854,0.00026860763],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963966,0.0007890033,0.0007138422,0.00078119163,0.00048272873,0.0008366596],"domain_scores_gemma":[0.99790186,0.00068725017,0.00032407604,0.0005491864,0.00017636282,0.00036124396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005186896,0.00052522635,0.002032255,0.00009416519,0.00016539716,0.000072191244,0.000503529,0.00014491667,0.00032377156],"category_scores_gemma":[0.000424835,0.00030797702,0.00007014356,0.00055918,0.00027379298,0.00020393867,0.00015630436,0.00045655307,0.000025828853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9603977,0.0032002477,0.0011559821,0.0001357913,0.00074692105,0.00041999758,0.002624563,0.000033119126,0.00020877592,0.000012723371,0.0004553691,0.030608775],"study_design_scores_gemma":[0.94193184,0.04964035,0.0017553357,0.00011340886,0.0009722415,0.000033586737,0.00029659717,0.0012897833,0.00032192434,0.00001701613,0.003293934,0.00033396235],"about_ca_topic_score_codex":0.0007294038,"about_ca_topic_score_gemma":0.0014673951,"teacher_disagreement_score":0.046440106,"about_ca_system_score_codex":0.00058172195,"about_ca_system_score_gemma":0.001532187,"threshold_uncertainty_score":0.99993724},"labels":[],"label_agreement":null},{"id":"W3087569099","doi":"10.1007/s00109-020-01973-0","title":"Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model","year":2020,"lang":"en","type":"article","venue":"Journal of Molecular Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Institute of Cancer Research; Fondo para la Investigación Científica y Tecnológica; Consejo Nacional de Investigaciones Científicas y Técnicas; Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Homeobox protein NANOG; SOX2; Angiogenesis; Cancer research; Cancer; Cancer stem cell; Nitric oxide synthase; Tumor progression; Biology; Pathology; Medicine; Nitric oxide; Internal medicine; Induced pluripotent stem cell; Transcription factor; Embryonic stem cell; Biochemistry; Endocrinology","score_opus":0.019306649988116806,"score_gpt":0.2858816660402312,"score_spread":0.26657501605211437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087569099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97296995,0.019965934,0.0009937835,0.005510881,0.000094721334,0.00029505385,0.000016355774,0.0000028965999,0.00015044866],"genre_scores_gemma":[0.9921836,0.0053020148,0.00071063003,0.0016592863,0.00008843822,0.000011568106,4.135484e-7,0.000022203938,0.00002179093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983409,0.000052952688,0.0007773356,0.00017950882,0.00046992773,0.00017939633],"domain_scores_gemma":[0.9989705,0.00004098077,0.00049410324,0.00011488479,0.00020076228,0.00017878134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016822504,0.00016007257,0.0007796857,0.00017702483,0.000007006568,0.0000013465194,0.00010331535,0.00005812489,0.00003512429],"category_scores_gemma":[0.000090498994,0.00010970024,0.00006825125,0.00030780595,0.00014162002,0.00006953941,0.000031120977,0.0003061261,1.3138484e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015507556,0.00013472282,0.020324744,0.0005687097,0.000086591026,0.00050667365,0.002091352,0.001094887,0.97123295,0.000017226685,0.0003691543,0.00202225],"study_design_scores_gemma":[0.014236458,0.001488649,0.012693537,0.007009427,0.00027753742,0.000050355196,0.00061162084,0.0027600687,0.9604534,0.00018510869,0.00009698982,0.0001368792],"about_ca_topic_score_codex":0.00034350363,"about_ca_topic_score_gemma":0.000036619644,"teacher_disagreement_score":0.019213729,"about_ca_system_score_codex":0.00007609158,"about_ca_system_score_gemma":0.00030744186,"threshold_uncertainty_score":0.44734457},"labels":[],"label_agreement":null},{"id":"W3087807683","doi":"10.1016/j.annonc.2020.08.816","title":"744P Association between gene expression signatures (sigs) and pembrolizumab (pembro) efficacy in patients (pts) with advanced urothelial cancer (UC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Foundation Medicine; Genentech; EUSA Pharma; EMD Serono; Bavarian Nordic; Merck Sharp and Dohme; Eisai; Incyte; Ipsen; Clovis Oncology; Mirati Therapeutics; Exelixis; Sanofi; Merck; GlaxoSmithKline; Heron Therapeutics; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Celldex Therapeutics; Pfizer","keywords":"Medicine; Oncology; Internal medicine; Stromal cell; Hazard ratio; Progression-free survival; Proportional hazards model; Overall survival; Confidence interval","score_opus":0.04089900162685077,"score_gpt":0.34601037550287433,"score_spread":0.30511137387602355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087807683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378395,0.00071719865,0.0000129112395,0.003648431,0.00006882513,0.0006417643,0.00010739854,0.00002535519,0.0009941569],"genre_scores_gemma":[0.9966494,0.0005135313,0.00035796544,0.0020653864,0.00020980673,0.000052565403,0.0000571102,0.000026640393,0.00006761799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986899,0.00010792216,0.00030531987,0.00032673156,0.00029018405,0.0002799569],"domain_scores_gemma":[0.99913055,0.00014940694,0.00024527774,0.00011764134,0.0001873168,0.00016978491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089764355,0.00017839883,0.0005712951,0.000078893456,0.000038115122,0.000005434195,0.000074709584,0.0002134991,0.000076808035],"category_scores_gemma":[0.00013805268,0.00013843513,0.00005468131,0.00017007123,0.000046115798,0.00009337937,0.000042277436,0.00022935885,0.000004362982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010195283,0.0010059157,0.8472405,0.00012566663,0.0003569994,0.000029871871,0.0017412667,0.000098605946,0.015885742,0.000007657142,0.0018480007,0.12146446],"study_design_scores_gemma":[0.025418628,0.010146234,0.89089423,0.00015622901,0.00017680744,9.295453e-7,0.000039029354,0.0000112866655,0.066160105,0.000025620422,0.0067939404,0.00017696292],"about_ca_topic_score_codex":0.0001395102,"about_ca_topic_score_gemma":0.000040424657,"teacher_disagreement_score":0.1212875,"about_ca_system_score_codex":0.00012838763,"about_ca_system_score_gemma":0.00024772773,"threshold_uncertainty_score":0.5645221},"labels":[],"label_agreement":null},{"id":"W3087874197","doi":"10.1016/j.annonc.2020.08.776","title":"704MO Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Pfizer","keywords":"Medicine; Internal medicine; Avelumab; Randomization; Hazard ratio; Gastroenterology; Metastatic Urothelial Carcinoma; Clinical endpoint; Carboplatin; Urology; Bladder cancer; Chemotherapy; Randomized controlled trial; Oncology; Urothelial carcinoma; Cisplatin; Cancer; Nivolumab; Immunotherapy; Confidence interval","score_opus":0.10648387693519867,"score_gpt":0.39048951855980796,"score_spread":0.2840056416246093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087874197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947446,0.0035228254,0.0048337975,0.034757834,0.0003357119,0.0030569714,0.0029816416,0.000120168545,0.0029450604],"genre_scores_gemma":[0.9797559,0.0011286744,0.0053653945,0.01136461,0.0007930568,0.00031093214,0.00064604566,0.000122021775,0.0005133959],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709475,0.000073380754,0.000762382,0.0008913345,0.00039352424,0.00078464765],"domain_scores_gemma":[0.9974133,0.00026646926,0.0004787487,0.00050225307,0.0009213526,0.0004178936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011352303,0.0005334639,0.0015665333,0.00012869823,0.00013968683,0.000014748303,0.00028395883,0.00030878957,0.0007309597],"category_scores_gemma":[0.00014582984,0.00042168723,0.0003839881,0.00034916485,0.00032444857,0.00014351198,0.00006416415,0.00029506176,0.00004826577],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29191464,0.010523718,0.086965784,0.0022344242,0.014416044,0.0029266553,0.049708914,0.000775455,0.09908421,0.00027881176,0.06925187,0.37191948],"study_design_scores_gemma":[0.10825133,0.13701895,0.049138907,0.0006781237,0.0034081643,0.00014478998,0.008498989,0.0007566187,0.46253535,0.00072440435,0.2269829,0.0018614717],"about_ca_topic_score_codex":0.0017203237,"about_ca_topic_score_gemma":0.0013454948,"teacher_disagreement_score":0.370058,"about_ca_system_score_codex":0.00015726706,"about_ca_system_score_gemma":0.00087756343,"threshold_uncertainty_score":0.9998235},"labels":[],"label_agreement":null},{"id":"W3087883993","doi":"10.1016/j.annonc.2020.08.2252","title":"LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; Internal medicine; Randomization; Cisplatin; Pembrolizumab; Population; Interim analysis; Oncology; Clinical endpoint; Urology; Metastatic Urothelial Carcinoma; Chemotherapy; Gastroenterology; Randomized controlled trial; Urothelial carcinoma; Cancer; Immunotherapy","score_opus":0.06526797045284466,"score_gpt":0.3556039308716964,"score_spread":0.29033596041885174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087883993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90136284,0.0010617931,0.0004695773,0.090224944,0.00018649151,0.0025361173,0.00013300992,0.00010677427,0.0039184494],"genre_scores_gemma":[0.9656119,0.001665094,0.0010994447,0.030149454,0.00046369425,0.00030824268,0.00008517692,0.000096997705,0.0005200293],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809355,0.000057908437,0.00046966196,0.0005290382,0.0002974849,0.0005523359],"domain_scores_gemma":[0.99846035,0.00018428758,0.00025969266,0.00037029767,0.00039929856,0.00032608846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012511878,0.00036816386,0.0011069004,0.00008829407,0.000110263725,0.000009253895,0.00020557758,0.00022679588,0.00040851018],"category_scores_gemma":[0.000072460294,0.00028113014,0.00025518355,0.00024488752,0.00019688388,0.00008883028,0.000030163994,0.00020086035,0.00003386439],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.670207,0.0057604546,0.01769126,0.00059705274,0.0024425099,0.00040958633,0.0049928087,0.000119869015,0.023794891,0.0007317108,0.017562188,0.25569066],"study_design_scores_gemma":[0.15520898,0.28960297,0.015409674,0.000118219294,0.0002983683,0.0001776516,0.00018716317,0.00028665288,0.20334403,0.0010877019,0.33365178,0.0006267926],"about_ca_topic_score_codex":0.00021111015,"about_ca_topic_score_gemma":0.000072430965,"teacher_disagreement_score":0.514998,"about_ca_system_score_codex":0.000062110776,"about_ca_system_score_gemma":0.0006962919,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W3087985540","doi":"10.1016/j.annonc.2020.08.819","title":"747P Association of TMB with efficacy of pembrolizumab (pembro) in patients (pts) with advanced urothelial cancer (UC): Results from KEYNOTE-045 and KEYNOTE-052","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Merck Sharp and Dohme","keywords":"Medicine; Docetaxel; Internal medicine; Oncology; Pembrolizumab; Clinical trial; Cancer; Immunotherapy","score_opus":0.03333975512778601,"score_gpt":0.3257186515375333,"score_spread":0.2923788964097473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087985540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921217,0.00029176412,0.00001448622,0.0042809686,0.00006300885,0.0007020131,0.0006310733,0.000014563697,0.0018804318],"genre_scores_gemma":[0.99759007,0.00045393858,0.000541356,0.001123198,0.000083826795,0.000026889527,0.000084763065,0.00002936698,0.00006660331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821544,0.00011988043,0.0006098679,0.00038417752,0.0004017081,0.00026892],"domain_scores_gemma":[0.9982138,0.0003060662,0.00070170464,0.00021169914,0.00042645258,0.00014026422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001316532,0.00020912978,0.0009040382,0.00010008478,0.000021641034,0.0000027569379,0.00009839412,0.0001849309,0.00004993058],"category_scores_gemma":[0.00028816404,0.0001595783,0.0000661527,0.00028040493,0.00013200159,0.00009291829,0.000038818398,0.00019168979,0.0000020051575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24277686,0.003408185,0.63013846,0.00031827315,0.0013287321,0.000049321814,0.007889643,0.00044706374,0.006302424,0.00003175031,0.0015975448,0.10571177],"study_design_scores_gemma":[0.091257945,0.027120702,0.84407705,0.00042439275,0.00036020784,0.000001592759,0.00020041708,0.00005398373,0.033077348,0.000038381975,0.003178598,0.00020936041],"about_ca_topic_score_codex":0.00258462,"about_ca_topic_score_gemma":0.0006660546,"teacher_disagreement_score":0.21393864,"about_ca_system_score_codex":0.00011842524,"about_ca_system_score_gemma":0.00050997804,"threshold_uncertainty_score":0.6507414},"labels":[],"label_agreement":null},{"id":"W3088150228","doi":"10.1016/j.annonc.2020.08.828","title":"756P Molecular subtyping and immune-gene signatures identify a subset of clinical T1 high-grade (cT1 HG) and cT2 bladder urothelial carcinoma (UC) as candidates for single-agent immune checkpoint inhibition (ICI)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cohort; Urology; Internal medicine; Oncology; Pembrolizumab; Carcinoma; Gastroenterology; Cancer; Immunotherapy","score_opus":0.10513952919844959,"score_gpt":0.39421539383965803,"score_spread":0.28907586464120844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088150228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98152226,0.008802951,0.00011628999,0.007898487,0.00020307045,0.0009681167,0.00020634843,0.000023987352,0.00025848334],"genre_scores_gemma":[0.9957499,0.0009257897,0.00058248214,0.0022463026,0.00022454943,0.000050281364,0.00014994593,0.00004299192,0.000027766602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976974,0.00017816028,0.0010601525,0.00047577886,0.00022483796,0.00036363452],"domain_scores_gemma":[0.99857897,0.0002204362,0.00047423327,0.00023148251,0.0002565675,0.00023831795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004778637,0.00026436368,0.001090936,0.00011294827,0.000070635666,0.000014115929,0.00009002611,0.00032910614,0.000065016415],"category_scores_gemma":[0.0003199052,0.00023634778,0.00028062382,0.00012850536,0.00034064168,0.00007897408,0.00011930931,0.0002497205,0.0000036733409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005011317,0.0008184028,0.008277394,0.00039936232,0.0008220534,0.00020664984,0.0009192582,0.0000060434945,0.97756577,0.00023992104,0.00040284643,0.0053310026],"study_design_scores_gemma":[0.008983887,0.011384973,0.072427474,0.0001081858,0.0005662504,0.000084649975,0.00021641982,0.00007106071,0.9039347,0.00094433763,0.0010723306,0.00020569704],"about_ca_topic_score_codex":0.0006637478,"about_ca_topic_score_gemma":0.000036405887,"teacher_disagreement_score":0.07363102,"about_ca_system_score_codex":0.00002893544,"about_ca_system_score_gemma":0.0003076058,"threshold_uncertainty_score":0.9637983},"labels":[],"label_agreement":null},{"id":"W3088168604","doi":"10.1016/j.annonc.2020.09.011","title":"Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro; Merck","keywords":"Pembrolizumab; Medicine; Cystectomy; Interquartile range; Internal medicine; Oncology; Confidence interval; Neoadjuvant therapy; Proportional hazards model; Population; Bladder cancer; Immunotherapy; Cancer","score_opus":0.08086946597310188,"score_gpt":0.3867370266547948,"score_spread":0.30586756068169296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088168604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7924572,0.00010331918,0.0000129992795,0.20383002,0.00013524157,0.0012783785,0.00011337116,0.000016242506,0.0020531907],"genre_scores_gemma":[0.99405867,0.000030494894,0.00003371867,0.005263357,0.00015965753,0.00006370878,0.000024640605,0.000013896337,0.00035184305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986851,0.00026040306,0.00037965568,0.00024395426,0.00025834137,0.00017251977],"domain_scores_gemma":[0.99855477,0.00049881,0.00016262179,0.0003080016,0.00037260965,0.00010316411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020533134,0.00015696882,0.0005525355,0.000023992336,0.00010197479,0.000008832745,0.00020613635,0.00008429878,0.00021645112],"category_scores_gemma":[0.00057135226,0.00006301493,0.00011324274,0.00016004672,0.00009379516,0.000046402514,0.00007817879,0.00014647107,0.000008431731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068146504,0.006171567,0.7398605,0.00030253694,0.004421723,0.00030457147,0.123609595,0.000045924036,0.01128398,0.00057679444,0.021925442,0.023350857],"study_design_scores_gemma":[0.007199793,0.0322713,0.8967107,0.000042306972,0.0006484768,0.0000064036185,0.028842976,0.000015920225,0.021689411,0.00010623523,0.012313443,0.0001530127],"about_ca_topic_score_codex":0.0008568444,"about_ca_topic_score_gemma":0.0017773405,"teacher_disagreement_score":0.20160145,"about_ca_system_score_codex":0.000032362317,"about_ca_system_score_gemma":0.00045347426,"threshold_uncertainty_score":0.25696743},"labels":[],"label_agreement":null},{"id":"W3088359032","doi":"10.1016/j.eururo.2020.09.006","title":"Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Gross domestic product; Per capita; Incidence (geometry); Demography; Mortality rate; Cancer; Environmental health; Population; Surgery; Internal medicine","score_opus":0.04096937007477142,"score_gpt":0.30562649293941185,"score_spread":0.26465712286464044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088359032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928119,0.0024421148,0.000020617375,0.003089173,0.000038088234,0.00014547013,0.00018098706,0.000026030166,0.0012455881],"genre_scores_gemma":[0.9976347,0.0003005045,0.000059833783,0.0017569633,0.00012393737,0.0000056119025,0.000012481086,0.00001775384,0.00008818561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915403,0.00011613492,0.00014581194,0.00032577087,0.000087913075,0.00017033554],"domain_scores_gemma":[0.99953175,0.00005156787,0.00007377381,0.00013915468,0.00006556121,0.00013817466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008564318,0.00014153088,0.00026268876,0.000026751186,0.00005502623,0.00001994102,0.000041306113,0.000025843454,0.000063737425],"category_scores_gemma":[0.00007570139,0.00009810641,0.000017812099,0.00010087295,0.00023170718,0.00008682484,0.00008860195,0.0000847348,0.0000031517563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015518608,0.000042750726,0.9940126,0.000019622736,0.00025857406,0.00006288038,0.0014177687,0.000005255554,0.0002996362,0.00007146509,0.0003626392,0.0032915997],"study_design_scores_gemma":[0.0013408569,0.00075628737,0.9966049,0.0000070599144,0.00030550876,0.00011759356,0.00005156685,0.00002192065,0.000027368309,0.00002366954,0.0006574695,0.000085791246],"about_ca_topic_score_codex":0.00050208153,"about_ca_topic_score_gemma":0.0004352118,"teacher_disagreement_score":0.004822797,"about_ca_system_score_codex":0.000019602927,"about_ca_system_score_gemma":0.000058053574,"threshold_uncertainty_score":0.40006632},"labels":[],"label_agreement":null},{"id":"W3088612416","doi":"10.1111/bju.15253","title":"Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Odds ratio; Confidence interval; Proportional hazards model; Urology; Internal medicine; Stage (stratigraphy); Logistic regression; Upper urinary tract; Pathological; Urothelial carcinoma; Bladder cancer; T-stage; Oncology; Gastroenterology; Urinary system; Cancer; Biology","score_opus":0.020590011304255335,"score_gpt":0.283873662301345,"score_spread":0.2632836509970896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088612416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905262,0.0075422246,0.000085421125,0.0009920094,0.000086629625,0.00026618296,0.000019015602,0.0000044354333,0.00047786927],"genre_scores_gemma":[0.99818075,0.0006072825,0.0001382003,0.00088487973,0.00015793722,0.0000043698733,0.000002200964,0.000016128513,0.000008246213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989522,0.00021860856,0.0003624817,0.00015873578,0.00014457044,0.00016338931],"domain_scores_gemma":[0.99941754,0.00012717278,0.00015551869,0.00005561066,0.00010259956,0.0001415405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001890771,0.000118170254,0.0007053401,0.00007838263,0.000019919651,0.0000071465515,0.00006839771,0.000089960995,0.000116407056],"category_scores_gemma":[0.00003545476,0.00011531271,0.00010469277,0.0001021289,0.00013451203,0.000076501994,0.000017007693,0.00031375262,0.00000188939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029066019,0.0037096327,0.8762331,0.0004122182,0.0008714446,0.013584126,0.004333895,0.00008012982,0.038163394,0.00004921337,0.0005018014,0.032994997],"study_design_scores_gemma":[0.0127523905,0.0080314595,0.9586998,0.00010713825,0.00012743738,0.015398334,0.00010401619,0.000060381975,0.003970712,0.000114280454,0.00054869324,0.000085320615],"about_ca_topic_score_codex":0.00010708351,"about_ca_topic_score_gemma":0.0000037372993,"teacher_disagreement_score":0.08246671,"about_ca_system_score_codex":0.000026033393,"about_ca_system_score_gemma":0.00015680745,"threshold_uncertainty_score":0.47023156},"labels":[],"label_agreement":null},{"id":"W3088645697","doi":"10.1016/j.eururo.2020.09.019","title":"Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer?","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Neoadjuvant therapy; Cancer; Urology; Oncology; Radiology; Surgery; Internal medicine; Breast cancer","score_opus":0.04181905133073745,"score_gpt":0.30261550186579694,"score_spread":0.2607964505350595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088645697","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040957117,0.0023497154,0.0005143557,0.98582304,0.0013847222,0.002066125,0.000636984,0.00026099608,0.0028683278],"genre_scores_gemma":[0.023398029,0.0008240022,0.00047346085,0.95692796,0.012312994,0.00047982438,0.0002012009,0.0005236609,0.004858873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655795,0.00031575857,0.00055299676,0.0013073494,0.0003146335,0.00095130247],"domain_scores_gemma":[0.9981524,0.00022472825,0.00039872475,0.0007430261,0.00018673265,0.0002944357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000116250565,0.0007499343,0.0010240893,0.00023711151,0.0001255733,0.000059970585,0.00038312477,0.00033052772,0.0007181647],"category_scores_gemma":[0.00013670932,0.0006617771,0.00037791813,0.00020584089,0.00010226008,0.00006346718,0.00017684266,0.0013707939,0.00042337776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001255983,0.00004537472,0.00074946566,0.000380523,0.00071112544,0.009716913,0.0012610934,0.000015546988,0.00041361235,0.0000011210799,0.9754999,0.00994934],"study_design_scores_gemma":[0.0032293138,0.00096551393,0.0077968314,0.0002901404,0.00068735564,0.00006386704,0.00004983259,0.000018702993,0.000217639,0.00004922743,0.98606247,0.0005691079],"about_ca_topic_score_codex":0.00004804871,"about_ca_topic_score_gemma":0.00004578064,"teacher_disagreement_score":0.028895108,"about_ca_system_score_codex":0.00017486059,"about_ca_system_score_gemma":0.00025570567,"threshold_uncertainty_score":0.99958336},"labels":[],"label_agreement":null},{"id":"W3088737306","doi":"10.1016/j.euo.2020.08.013","title":"Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment","year":2020,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"Ontario Ministry of Research, Innovation and Science; Queen's University","keywords":"Medicine; Bladder cancer; Immunotherapy; Context (archaeology); Immune system; Oncology; Cancer; Incidence (geometry); Clinical trial; Internal medicine; Bioinformatics; Immunology; Biology","score_opus":0.07633012349854808,"score_gpt":0.4030424398314802,"score_spread":0.32671231633293213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088737306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032923377,0.9818243,0.000018140658,0.0090742335,0.00012926708,0.0049772025,0.00059706223,0.00005104414,0.0032958197],"genre_scores_gemma":[0.00014218829,0.99008846,0.00024047698,0.004606605,0.00015335408,0.0037102292,0.0003171725,0.00009695914,0.00064452586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968187,0.0010754552,0.00073395844,0.0008905302,0.000051079835,0.0004302783],"domain_scores_gemma":[0.9982252,0.0006690486,0.00044041104,0.00039151718,0.000100286175,0.00017355016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018251248,0.0006400063,0.0042902795,0.00016150749,0.00008669738,0.000007861738,0.00018006843,0.00026720934,0.00008853738],"category_scores_gemma":[0.00007881868,0.00037697356,0.0002291192,0.0003319835,0.00035560914,0.000023561339,0.0000772582,0.00028268687,0.000036576694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023920069,0.00040527363,0.0042380993,0.0038323025,0.0029450431,0.00021592167,0.00033721773,4.194803e-8,7.719175e-7,0.00009065733,0.0011119371,0.98658353],"study_design_scores_gemma":[0.0035655636,0.008782671,0.004539275,0.0015837181,0.0077869734,0.0004424021,0.000022925007,3.1093012e-7,1.1733861e-7,0.000013692556,0.97298443,0.00027794196],"about_ca_topic_score_codex":0.000048273876,"about_ca_topic_score_gemma":0.00023026057,"teacher_disagreement_score":0.9863056,"about_ca_system_score_codex":0.00041185442,"about_ca_system_score_gemma":0.0017000792,"threshold_uncertainty_score":0.9998682},"labels":[],"label_agreement":null},{"id":"W3088838079","doi":"10.3233/blc-200315","title":"Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Radiation therapy; Adjuvant; Immune system; Oncology; Combination therapy; Cancer; Immune checkpoint; Adjuvant therapy; Neoadjuvant therapy; Urology; Internal medicine; Cancer research; Immunology; Breast cancer","score_opus":0.041541753087410156,"score_gpt":0.31149986409305747,"score_spread":0.2699581110056473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088838079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393926,0.0503922,0.000051830255,0.0074246796,0.00034418047,0.0010076122,0.00011296247,0.000069520655,0.0012043847],"genre_scores_gemma":[0.97736424,0.019094845,0.0003505953,0.0022752376,0.0004272519,0.00026302395,0.000018971288,0.000055213994,0.00015060986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830353,0.000050394992,0.00052353315,0.00046492982,0.0003209026,0.00033673606],"domain_scores_gemma":[0.9992612,0.000034335302,0.00018897034,0.00021927063,0.00010048437,0.00019573791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103699305,0.0002792723,0.00051821966,0.00011132128,0.000051290594,0.000020471436,0.00009337203,0.00013516807,0.00078727084],"category_scores_gemma":[0.000029676048,0.00024084034,0.00012373479,0.00040911723,0.00012742326,0.00018629342,0.00004398282,0.0002496911,0.000006408368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036450871,0.0005304948,0.25000477,0.0006029389,0.0016435937,0.000118979886,0.029998157,0.0012440262,0.4234552,0.00008085128,0.003037331,0.28563857],"study_design_scores_gemma":[0.026694963,0.0022145894,0.32392302,0.0012843404,0.0006187002,0.000033426117,0.002074468,0.0032651145,0.6161041,0.00018515314,0.02235081,0.0012513141],"about_ca_topic_score_codex":0.0044520977,"about_ca_topic_score_gemma":0.00019379437,"teacher_disagreement_score":0.28438726,"about_ca_system_score_codex":0.000203015,"about_ca_system_score_gemma":0.0004670227,"threshold_uncertainty_score":0.9821184},"labels":[],"label_agreement":null},{"id":"W3088957028","doi":"10.1016/j.annonc.2020.08.771","title":"699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer UK; Merck KGaA; Pfizer","keywords":"Medicine; Avelumab; Oncology; Internal medicine; Hazard ratio; Bladder cancer; Immunotherapy; Immunology; Cancer; Nivolumab","score_opus":0.1225271632506196,"score_gpt":0.4084373490325594,"score_spread":0.28591018578193983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088957028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598705,0.0008805653,0.00029874043,0.034905184,0.00042629385,0.0015565412,0.0011657268,0.00005088905,0.00084552134],"genre_scores_gemma":[0.99191135,0.0007829171,0.00085869996,0.005329866,0.00048872747,0.00015707816,0.00020107947,0.000044900324,0.00022539105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780303,0.0001353269,0.00081717555,0.00051488477,0.0002495999,0.00047997522],"domain_scores_gemma":[0.9975839,0.00073500257,0.000525915,0.00021236954,0.000606565,0.0003362189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003826092,0.00026530432,0.0012411027,0.00007409937,0.000099375284,0.000007539421,0.00011995138,0.00033553902,0.000046371275],"category_scores_gemma":[0.0010440145,0.00023137908,0.00031127458,0.00013851501,0.00016921197,0.000120893834,0.00007786804,0.00021744375,0.000019529012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049923747,0.0003799386,0.92408514,0.00026603273,0.0012185236,0.00006195763,0.0020451497,0.0000014816047,0.0001377864,0.000017871642,0.0078074927,0.058986276],"study_design_scores_gemma":[0.03537076,0.038603548,0.830154,0.00014706813,0.0014441481,0.000008948137,0.002598452,0.00003341166,0.0060382173,0.00025863506,0.08486552,0.0004773165],"about_ca_topic_score_codex":0.00012648004,"about_ca_topic_score_gemma":0.00017314621,"teacher_disagreement_score":0.09393114,"about_ca_system_score_codex":0.0001739755,"about_ca_system_score_gemma":0.00053976837,"threshold_uncertainty_score":0.9435365},"labels":[],"label_agreement":null},{"id":"W3089012621","doi":"10.1016/j.annonc.2020.08.851","title":"779P Validation of prognostic scores in patients with metastatic bladder carcinoma (mBC) enrolled in early phase clinical trials","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ipsen; Daiichi Sankyo Europe; Sanofi; Exelixis; Astellas Pharma; Cleveland Clinic; Amgen; Pfizer; Celgene; Eli Lilly and Company; AstraZeneca; Oncolytics Biotech","keywords":"Medicine; Internal medicine; Hazard ratio; Progression-free survival; Oncology; Performance status; Proportional hazards model; Clinical trial; Overall survival; Confidence interval","score_opus":0.2700922670394051,"score_gpt":0.4825466236951804,"score_spread":0.21245435665577533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089012621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635214,0.0001579796,0.000024951012,0.0015364179,0.000061718136,0.0015122328,0.00004789345,0.0000072926937,0.0002993493],"genre_scores_gemma":[0.99873,0.000038093734,0.0003489825,0.0006882864,0.000051447343,0.00006520565,0.000053047606,0.000015629652,0.000009296647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972566,0.0008102414,0.0012414525,0.00025613178,0.00023828018,0.00019732522],"domain_scores_gemma":[0.998211,0.00080709584,0.00048503018,0.0001445202,0.00022236198,0.00012998565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010636802,0.00013842403,0.0012776908,0.00016320527,0.000008446358,0.0000028868342,0.00007482713,0.000097164804,0.00010255419],"category_scores_gemma":[0.0018730937,0.000099710385,0.00012880244,0.00030401032,0.00011398909,0.00007236266,0.00002250161,0.00016147598,0.0000062070008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016521504,0.004295587,0.95864856,0.00009314281,0.00030850948,0.00006761145,0.0010370053,0.000009520027,0.00011234029,0.0000124822145,0.00022435345,0.018669406],"study_design_scores_gemma":[0.052516565,0.03956741,0.9022852,0.000088497116,0.00034117853,0.0000011947956,0.000077786906,0.00003591869,0.0048340047,0.00008101026,0.00008844028,0.000082786384],"about_ca_topic_score_codex":0.00021145411,"about_ca_topic_score_gemma":0.00003895184,"teacher_disagreement_score":0.05636333,"about_ca_system_score_codex":0.000022308031,"about_ca_system_score_gemma":0.00047085635,"threshold_uncertainty_score":0.40660715},"labels":[],"label_agreement":null},{"id":"W3089155296","doi":"10.1016/j.annonc.2020.08.834","title":"762P Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer (MIBC) reveals unique features that may inspire new sequential therapies in pathologically-nonresponders","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"","keywords":"Bladder cancer; Pembrolizumab; Cystectomy; Medicine; Cancer research; Pathology; Immunotherapy; Cancer; Internal medicine","score_opus":0.10907715530434148,"score_gpt":0.38775969897862245,"score_spread":0.27868254367428097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089155296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95648634,0.00512511,0.000059719587,0.034498602,0.00011032848,0.00092259806,0.00010020271,0.00003907614,0.002657995],"genre_scores_gemma":[0.97910196,0.0020387566,0.0010399242,0.01739165,0.000123535,0.000071046656,0.000042186475,0.000037681573,0.00015327746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980112,0.00036601693,0.0004939461,0.000437046,0.00029565368,0.0003961423],"domain_scores_gemma":[0.9987396,0.00016630339,0.0003127467,0.00025901926,0.00030195538,0.00022039341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021510806,0.00027979008,0.0008862774,0.0001640132,0.000029321629,0.000006930587,0.00020608834,0.00036938232,0.0003187395],"category_scores_gemma":[0.00026544096,0.00022367344,0.000240839,0.00029789476,0.00021978162,0.00008947052,0.00008433144,0.00034175333,0.0000039682145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011394275,0.0009354944,0.037133366,0.00053319184,0.0012420513,0.0021469006,0.0105714025,0.00016912642,0.8781264,0.0011413269,0.0034642126,0.05314229],"study_design_scores_gemma":[0.010178093,0.013980829,0.1640017,0.00040904476,0.00035938495,0.000091948044,0.0023408355,0.0000065540758,0.80280894,0.0017749835,0.0036097895,0.00043786332],"about_ca_topic_score_codex":0.0011478321,"about_ca_topic_score_gemma":0.0002838099,"teacher_disagreement_score":0.12686834,"about_ca_system_score_codex":0.00007386164,"about_ca_system_score_gemma":0.0014553184,"threshold_uncertainty_score":0.91211385},"labels":[],"label_agreement":null},{"id":"W3089262302","doi":"10.1097/coc.0000000000000766","title":"Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Internal medicine; Proportional hazards model; Epidemiology; Cancer; Stage (stratigraphy); Urology; Relative risk; Gastroenterology; Confidence interval","score_opus":0.053662678147619436,"score_gpt":0.40163046573874844,"score_spread":0.347967787591129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089262302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967481,0.000089636706,0.000004823958,0.0015190571,0.0003121333,0.00038617104,0.000024959454,0.0000025330723,0.00091257214],"genre_scores_gemma":[0.9981048,0.00009326792,0.000088739405,0.001358116,0.00032016676,0.000006345315,0.0000011582621,0.000017903265,0.000009513964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971894,0.0008038372,0.0012068443,0.00019004165,0.00043892037,0.00017095987],"domain_scores_gemma":[0.9972579,0.00079539703,0.0013601555,0.00022740498,0.0001518004,0.00020733866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055652094,0.00015484705,0.0015325261,0.00005278795,0.000015039775,0.0000014952772,0.00020748592,0.00007933127,0.000084376974],"category_scores_gemma":[0.0002747011,0.00008042025,0.00034116575,0.00029884474,0.00075775135,0.000029857409,0.0000398169,0.00058465963,0.0000017221496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026057493,0.0013502282,0.897409,0.000032088512,0.0003259522,0.00016165007,0.00020957508,0.000020072137,0.000042542306,0.0000050657054,0.00016581004,0.0742205],"study_design_scores_gemma":[0.012101466,0.119530484,0.86613566,0.00010142907,0.00032174814,0.000009121878,0.000040300183,0.0000028786994,0.0006443669,0.000005004384,0.0010519507,0.000055612934],"about_ca_topic_score_codex":0.00019395186,"about_ca_topic_score_gemma":0.000017453145,"teacher_disagreement_score":0.11818025,"about_ca_system_score_codex":0.00009154662,"about_ca_system_score_gemma":0.000684803,"threshold_uncertainty_score":0.32794425},"labels":[],"label_agreement":null},{"id":"W3089563003","doi":"10.1186/s13073-020-00781-y","title":"Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer","year":2020,"lang":"en","type":"article","venue":"Genome Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Centre National de la Recherche Scientifique; China Scholarship Council; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche","keywords":"APOBEC; Biology; Genetics; Gene; Genome","score_opus":0.04640789014985915,"score_gpt":0.31978104900751136,"score_spread":0.27337315885765223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089563003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754303,0.0015798704,0.0003681879,0.021264507,0.00015177955,0.0006334184,0.000030147561,0.000033780565,0.00050798384],"genre_scores_gemma":[0.99735063,0.00022135301,0.00017901364,0.0012019449,0.00032756414,0.00005359622,0.00007008658,0.000023146165,0.0005726477],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879694,0.000028978186,0.00047049444,0.0002905033,0.0002604608,0.00015263772],"domain_scores_gemma":[0.9993058,0.00003857879,0.00014663157,0.00016608664,0.00010503336,0.00023790773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001008519,0.00014492424,0.000347112,0.00015546425,0.000041417497,0.000005411533,0.000057580695,0.00006309863,0.0005561455],"category_scores_gemma":[0.00010831484,0.00011854121,0.00003195408,0.0004815095,0.0001074786,0.000076681885,0.0000172367,0.00014521743,0.000017649008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003293463,0.00020608574,0.045215506,0.00024450902,0.0004439282,0.00007351274,0.064439625,0.00020683125,0.8762494,0.00027443617,0.0012114019,0.011105466],"study_design_scores_gemma":[0.010151936,0.00089488697,0.960442,0.00020958284,0.0008048372,0.000028105565,0.0041168053,0.00079117744,0.020198144,0.00064204365,0.0014596616,0.00026080752],"about_ca_topic_score_codex":0.0010554733,"about_ca_topic_score_gemma":0.00022370917,"teacher_disagreement_score":0.9152265,"about_ca_system_score_codex":0.000066453824,"about_ca_system_score_gemma":0.00024816682,"threshold_uncertainty_score":0.6089403},"labels":[],"label_agreement":null},{"id":"W3090112611","doi":"10.3390/ijms21197268","title":"Targeted Molecular Therapeutics for Bladder Cancer—A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?","year":2020,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bladder cancer; Chemotherapy; Oncology; Adverse effect; Immunotherapy; Cancer; Internal medicine; Monoclonal antibody; Antibody; Cancer research; Immunology","score_opus":0.05481355308453748,"score_gpt":0.3767134574986533,"score_spread":0.3218999044141158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090112611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056132814,0.9876508,0.0051618167,0.0040037623,0.0017299722,0.0006972766,0.00006724697,0.000007258673,0.00012052595],"genre_scores_gemma":[0.0064325193,0.98982936,0.0023136584,0.00058151665,0.00066921324,0.00003833181,0.000028833312,0.000039822095,0.000066719265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970544,0.000092419956,0.0011951593,0.00026143715,0.0011979474,0.0001986655],"domain_scores_gemma":[0.9974239,0.0001199135,0.0015086372,0.00016436174,0.0006561796,0.00012699998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004701688,0.00030495465,0.0009937244,0.0002627125,0.00006323106,0.00007533647,0.0008217649,0.00013531766,0.000039509916],"category_scores_gemma":[0.00013134464,0.00017810763,0.0012982633,0.000350756,0.0002328331,0.000117045834,0.00008169687,0.0002820981,0.0000018941261],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016312547,0.00014290262,0.000008307406,0.0004885538,0.00408316,0.00014107661,0.000261041,0.000057973815,0.007937476,0.0006150106,0.00026538878,0.98583597],"study_design_scores_gemma":[0.0028607983,0.0019247611,0.00002937036,0.008523617,0.0060166805,0.0007698447,0.00021628485,0.00013207406,0.06550787,0.0031241458,0.9104694,0.0004251227],"about_ca_topic_score_codex":0.000078959914,"about_ca_topic_score_gemma":0.0000047306235,"teacher_disagreement_score":0.98541087,"about_ca_system_score_codex":0.00016027884,"about_ca_system_score_gemma":0.002385104,"threshold_uncertainty_score":0.72630185},"labels":[],"label_agreement":null},{"id":"W3090235171","doi":"10.1016/j.euo.2020.09.001","title":"Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Cystoscopy; Cytology; Bladder cancer; Urology; Urine cytology; Urine; Prostate cancer; Confidence interval; Internal medicine; Cancer; Urinary system; Pathology","score_opus":0.01914884813810823,"score_gpt":0.27980414680220383,"score_spread":0.2606552986640956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090235171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487025,0.00011695121,0.00077229284,0.0024088197,0.00012959319,0.000888238,0.00006359059,0.000020462585,0.0007298062],"genre_scores_gemma":[0.99801004,0.00000787145,0.00022390456,0.0015253137,0.000113801274,0.000043118227,0.000033359014,0.000027332326,0.000015230761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991332,0.00018020989,0.00025974604,0.0002017723,0.000088665234,0.0001363536],"domain_scores_gemma":[0.9992573,0.00020392562,0.00018726982,0.00015927348,0.00013822757,0.000053983298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014752679,0.000103765415,0.00027808972,0.00005782802,0.000027853026,0.0000014254413,0.00008467736,0.00005608432,0.00009932445],"category_scores_gemma":[0.00011508158,0.00006742625,0.000038570794,0.00013945774,0.00013087246,0.000030710788,0.000016541802,0.00012188643,0.0000042638817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034134563,0.0040800674,0.82895446,0.00027107887,0.0006382941,0.00007139347,0.0020185143,0.0036806844,0.035461333,0.000021183947,0.0003180583,0.090350345],"study_design_scores_gemma":[0.0152819585,0.02394934,0.9295498,0.000011856142,0.0004530471,0.000004659336,0.000029923449,0.00092945556,0.02598764,0.000008218101,0.0037117947,0.00008231222],"about_ca_topic_score_codex":0.000048631013,"about_ca_topic_score_gemma":0.00008454056,"teacher_disagreement_score":0.10059531,"about_ca_system_score_codex":0.000037544156,"about_ca_system_score_gemma":0.00013100119,"threshold_uncertainty_score":0.2749563},"labels":[],"label_agreement":null},{"id":"W3090667976","doi":"10.5489/cuaj.6856","title":"Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University; Queen's University","funders":"","keywords":"Cystectomy; Bladder cancer; Pathological; Medicine; Concordance; Stage (stratigraphy); Bladder tumor; Urology; Biopsy; Resection; Bladder Neoplasm; Cancer; Radiology; Surgery; Pathology; Internal medicine","score_opus":0.036093259958475475,"score_gpt":0.2738112682242143,"score_spread":0.23771800826573883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090667976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95098126,0.0021377846,0.00044667162,0.04421938,0.00034412803,0.00048265964,0.001220578,0.00002391188,0.00014365319],"genre_scores_gemma":[0.991673,0.00004695488,0.00039823304,0.0067388117,0.0006171322,0.000020627942,0.00044481573,0.000016742613,0.000043718956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998583,0.00014902398,0.00038833154,0.00032570327,0.00027452374,0.0002793695],"domain_scores_gemma":[0.9985488,0.00023492309,0.00025194485,0.00013261884,0.00016593379,0.0006657713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001410237,0.00014434646,0.0004073564,0.0000918048,0.00021837841,0.000020164249,0.00012718748,0.00023324041,0.0007815438],"category_scores_gemma":[0.00046416066,0.000118242795,0.000092987546,0.00013357746,0.000051313233,0.00008581924,0.000014423632,0.00031838752,0.000003872288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001781545,0.00006786987,0.97865707,0.000029039813,0.0006483541,0.00006438429,0.00030056827,0.00007829093,0.0010617734,0.000044189408,0.015661534,0.0016053774],"study_design_scores_gemma":[0.009212333,0.0015674814,0.9179342,0.000026354142,0.00081493164,0.00005453935,0.000042498366,0.005218105,0.00030566668,0.0005811415,0.0640211,0.00022165188],"about_ca_topic_score_codex":0.009074827,"about_ca_topic_score_gemma":0.011761255,"teacher_disagreement_score":0.060722876,"about_ca_system_score_codex":0.0007805624,"about_ca_system_score_gemma":0.0006826028,"threshold_uncertainty_score":0.99752384},"labels":[],"label_agreement":null},{"id":"W3091682715","doi":"10.1016/j.urolonc.2020.09.001","title":"Setting the stage for bladder preservation","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Clinical trial; Radiation therapy; Quality of life (healthcare); Stage (stratigraphy); Cancer; Intensive care medicine; Surgery; Internal medicine","score_opus":0.09653550182880465,"score_gpt":0.3971286896372959,"score_spread":0.30059318780849126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091682715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047424455,0.98321897,0.00016642576,0.01122152,0.00022516928,0.0025882807,0.00025702853,0.00007707689,0.0021980887],"genre_scores_gemma":[0.0000031208094,0.9721133,0.018645814,0.0035865651,0.0005702597,0.001272713,0.0004829439,0.00004015063,0.003285092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984458,0.00018294838,0.00045952937,0.00048018686,0.00013636444,0.0002951732],"domain_scores_gemma":[0.9983088,0.0008204518,0.00033409634,0.0002598067,0.00006653861,0.00021030867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029690398,0.00034719775,0.0010321105,0.00008165221,0.00037469383,0.00003645524,0.00015753778,0.00042413134,0.00008300173],"category_scores_gemma":[0.0003456035,0.00020643526,0.00024248098,0.00025940943,0.000396052,0.00008201957,0.000067473644,0.00053322106,0.00002472918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008560985,0.00015282577,0.0012496376,0.0046079624,0.00091284816,0.00010400793,0.0005388682,0.0000030847211,0.0000015857632,0.008759312,0.041759547,0.94182473],"study_design_scores_gemma":[0.00051503064,0.0014560205,0.000008657487,0.00058632425,0.0035968593,0.0001993012,0.0000648128,0.00010756096,0.0000015706748,0.0014109818,0.9918829,0.00016998837],"about_ca_topic_score_codex":0.00002235534,"about_ca_topic_score_gemma":0.00001015521,"teacher_disagreement_score":0.95012337,"about_ca_system_score_codex":0.00015218454,"about_ca_system_score_gemma":0.0012783885,"threshold_uncertainty_score":0.8418186},"labels":[],"label_agreement":null},{"id":"W3091844070","doi":"10.1016/j.urolonc.2020.09.004","title":"The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Odds ratio; Logistic regression; Confidence interval; Internal medicine; Epidemiology; Cohort; Cancer; Population; Incidence (geometry); Oncology; Gynecology; Demography","score_opus":0.016878558551475357,"score_gpt":0.30555131479473396,"score_spread":0.2886727562432586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091844070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872669,0.0008307725,0.000070244656,0.011051118,0.00004069499,0.00036222735,0.0000727379,0.000027201113,0.00027810442],"genre_scores_gemma":[0.99682564,0.00005800362,0.00070412393,0.0020467928,0.00006228377,0.00009600774,0.000056639576,0.000007615495,0.00014288038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899685,0.00023815868,0.00019666205,0.0002649278,0.00015169552,0.00015170772],"domain_scores_gemma":[0.9987208,0.00068313145,0.00008109203,0.00014275759,0.000019150357,0.00035305033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018785096,0.00014433748,0.0003698096,0.000071670605,0.00016159278,0.000013136463,0.000045257053,0.00008783568,0.000054837394],"category_scores_gemma":[0.00020540229,0.00008623382,0.00008819436,0.000296307,0.0004273452,0.000024037588,0.000018442395,0.00016749268,0.00000251198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00189414,0.00004413356,0.99600995,0.000048815757,0.000255978,0.00008172209,0.000106006184,0.00014621373,0.000023690483,0.000347912,0.000068249574,0.0009731971],"study_design_scores_gemma":[0.004886265,0.01369557,0.80617106,0.000044249697,0.005586021,0.000010053161,0.000082904335,0.009515357,0.00044212863,0.00043007563,0.15890662,0.00022966394],"about_ca_topic_score_codex":0.000082957034,"about_ca_topic_score_gemma":0.00002550426,"teacher_disagreement_score":0.18983886,"about_ca_system_score_codex":0.00004019982,"about_ca_system_score_gemma":0.00014102555,"threshold_uncertainty_score":0.3516513},"labels":[],"label_agreement":null},{"id":"W3092756061","doi":"10.48083/vuvb4988","title":"Clinical Utility of Bladder Cancer Biomarkers","year":2020,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Cystoscopy; Cancer; Disease; Intensive care medicine; Oncology; Urinary system; Internal medicine","score_opus":0.13337931943829137,"score_gpt":0.4268216637221022,"score_spread":0.2934423442838108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092756061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9309642,0.0024781213,0.0011207638,0.032350034,0.0018447258,0.0003316234,0.00013478198,0.00006546168,0.030710327],"genre_scores_gemma":[0.990805,0.0012310019,0.0006534745,0.005807488,0.0010267078,0.000009679772,0.000013410809,0.000012655117,0.00044063563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984406,0.00010110702,0.0006093373,0.00022414162,0.00043702393,0.00018775358],"domain_scores_gemma":[0.99883854,0.00016318184,0.00029773725,0.00011832089,0.00033672963,0.00024551174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033112025,0.00013450714,0.00036262043,0.000049602208,0.000055672906,0.000015380654,0.0001965034,0.00012726082,0.007463028],"category_scores_gemma":[0.0004437148,0.00010436016,0.000398647,0.00010771387,0.00017804478,0.000091179696,0.000061176645,0.00046693557,0.000025295645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014711674,0.00032557076,0.8982586,0.000026402293,0.002086068,0.00007878842,0.00020055677,0.0000055604864,0.00041591126,0.000039022165,0.042577434,0.054514866],"study_design_scores_gemma":[0.0061985687,0.0011321255,0.9437047,0.000048228492,0.00044705774,0.00012698572,0.00034770984,0.0009759273,0.0013459647,0.0008980962,0.044618793,0.00015584614],"about_ca_topic_score_codex":0.000031074105,"about_ca_topic_score_gemma":0.0000039889205,"teacher_disagreement_score":0.059840783,"about_ca_system_score_codex":0.000059243506,"about_ca_system_score_gemma":0.00044595829,"threshold_uncertainty_score":0.99344426},"labels":[],"label_agreement":null},{"id":"W3092760826","doi":"10.4103/ua.ua_111_19","title":"Rare case of upper urinary tract squamous cell carcinoma presenting with significant paraneoplastic syndrome","year":2020,"lang":"en","type":"article","venue":"Urology Annals","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Urinary system; Basal cell; Disease; Pathology; Upper urinary tract; Oncology; Dermatology; Internal medicine","score_opus":0.03397956232405942,"score_gpt":0.27738649154296857,"score_spread":0.24340692921890916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092760826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447477,0.0009618454,0.000051392413,0.0020039252,0.00004497699,0.00040964846,0.00005992461,0.000040597864,0.0019529038],"genre_scores_gemma":[0.99814,0.0000075764465,0.00006928506,0.0014114411,0.0000701625,0.000027610775,0.000018346404,0.000029972005,0.00022562606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988841,0.000087210596,0.00025001168,0.00033338272,0.00013177101,0.00031354945],"domain_scores_gemma":[0.9992388,0.00015684677,0.00010442886,0.00020829398,0.00007162079,0.00021999338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058317124,0.00018578836,0.00041518957,0.00006301982,0.000060680122,0.00000450597,0.00006860883,0.00011252065,0.000501549],"category_scores_gemma":[0.000045531207,0.00014117321,0.000093561976,0.00013727749,0.00011329578,0.00004736952,0.000026750362,0.00021969414,0.000046703735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003703594,0.001636926,0.7840451,0.00063222204,0.00016292524,0.20426652,0.0022477894,0.00022780846,0.0020780629,0.000018168254,0.00084047037,0.00014039529],"study_design_scores_gemma":[0.011165157,0.040630702,0.7598811,0.000034218436,0.0018479563,0.15832318,0.000609338,0.0012374142,0.024007395,0.00007381174,0.0015984002,0.00059132173],"about_ca_topic_score_codex":0.000079692756,"about_ca_topic_score_gemma":0.000001391959,"teacher_disagreement_score":0.045943335,"about_ca_system_score_codex":0.0000068453223,"about_ca_system_score_gemma":0.000121528785,"threshold_uncertainty_score":0.57568765},"labels":[],"label_agreement":null},{"id":"W3092810626","doi":"10.14740/wjon1305","title":"Fluorescence Emitted by Papanicolaou-Stained Urothelial Cells Improves Sensitivity of Urinary Conventional Cytology for Detection of Urothelial Tumors","year":2020,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystoscopy; Papanicolaou stain; Cytology; Urology; Urine cytology; Urothelial Cell; Urinary system; Urothelial cancer; Bladder cancer; Urinary bladder; Urine; Papanicolaou Test; Urothelium; Pathology; Cancer; Internal medicine; Cervical cancer","score_opus":0.018189579809865204,"score_gpt":0.28821101866141285,"score_spread":0.27002143885154767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092810626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852312,0.000354007,0.008287501,0.0036956097,0.00079334236,0.0010632579,0.00028566184,0.000020626185,0.00026879343],"genre_scores_gemma":[0.9967533,0.000051128343,0.0019254445,0.00055596937,0.00051088573,0.000014776399,0.000008569741,0.00002727365,0.0001526732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808985,0.00026655593,0.0008983986,0.00021680223,0.00026987088,0.00025852004],"domain_scores_gemma":[0.9978444,0.00040581977,0.0009336231,0.00011768737,0.0004901244,0.00020833912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044280116,0.00019057507,0.0009222857,0.00018269391,0.000050344508,0.0000035601113,0.00010897662,0.0001330494,0.000100048914],"category_scores_gemma":[0.00020691549,0.00016604981,0.00035146263,0.00023278498,0.00022025275,0.00008019933,0.000037510785,0.00031609728,0.0000029488278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013125459,0.00087587174,0.0014791653,0.0002020352,0.0003316398,0.00015292273,0.00022060545,0.000014604365,0.9723147,0.000058796002,0.0011015234,0.010122672],"study_design_scores_gemma":[0.014220724,0.021606017,0.006782432,0.000112867834,0.000607529,0.00071459264,0.00018090829,0.0007121793,0.94370085,0.0001727194,0.011026539,0.00016262729],"about_ca_topic_score_codex":0.00004687693,"about_ca_topic_score_gemma":0.00002697169,"teacher_disagreement_score":0.028613841,"about_ca_system_score_codex":0.00016554921,"about_ca_system_score_gemma":0.0007885621,"threshold_uncertainty_score":0.6771315},"labels":[],"label_agreement":null},{"id":"W3093155264","doi":"10.1016/j.clgc.2020.10.001","title":"Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Adverse effect; Bladder cancer; Perioperative; Gemcitabine; Internal medicine; Oncology; Urology; Cancer; Surgery","score_opus":0.13380061401930163,"score_gpt":0.4132333197204557,"score_spread":0.2794327057011541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093155264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790876,0.0026887287,0.002202652,0.011325853,0.001311365,0.001936072,0.00042163412,0.00015165699,0.0008744439],"genre_scores_gemma":[0.98169136,0.00076467404,0.0028875675,0.009342242,0.0040069474,0.0002987079,0.000098203345,0.00010588202,0.00080444047],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978668,0.00004793803,0.00068054383,0.00069964485,0.00026917973,0.00043589546],"domain_scores_gemma":[0.9986539,0.00020328064,0.00015453213,0.0003308239,0.00016491523,0.00049256085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013054954,0.00033068814,0.000693593,0.000041723575,0.0001187702,0.000021093574,0.00015787125,0.00024885757,0.0002611513],"category_scores_gemma":[0.00009503076,0.00028077475,0.00063083426,0.00013330892,0.00013373556,0.0001061138,0.00004076433,0.00033663659,0.00004376449],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19975083,0.006615119,0.23873729,0.00096609397,0.0021086195,0.00044428487,0.004095761,0.007971691,0.03504854,0.000082969826,0.08535096,0.41882783],"study_design_scores_gemma":[0.21564585,0.028023275,0.17705487,0.00032453585,0.0034889737,0.00005397887,0.00041294083,0.33065864,0.021840652,0.00048200638,0.21975511,0.0022591746],"about_ca_topic_score_codex":0.000036703732,"about_ca_topic_score_gemma":0.000003271837,"teacher_disagreement_score":0.41656867,"about_ca_system_score_codex":0.00015057968,"about_ca_system_score_gemma":0.0006780453,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W3093229010","doi":"10.48083/yvnw6070","title":"Personalized Medicine in Urologic Oncology","year":2020,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Work (physics); Internal medicine; Oncology; Family medicine; Engineering","score_opus":0.09660334841828305,"score_gpt":0.3896309787333357,"score_spread":0.29302763031505263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093229010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54799694,0.0038194621,0.0009843647,0.3225739,0.0013734002,0.00052142824,0.000020211553,0.00013118402,0.12257912],"genre_scores_gemma":[0.9593247,0.0009371346,0.00071135286,0.036411148,0.0014695084,0.000023130247,0.000027063705,0.000016003343,0.001079936],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983837,0.0001435499,0.00046988772,0.00027015375,0.0004391785,0.00029350305],"domain_scores_gemma":[0.9990712,0.00021549288,0.00019902071,0.00009164525,0.00016540675,0.00025727326],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003380682,0.00018050791,0.00047118615,0.00014094332,0.00006983914,0.0000147543515,0.0002240359,0.00016548255,0.0053444025],"category_scores_gemma":[0.0007249104,0.00013220738,0.00017321591,0.00017821896,0.00020472883,0.00009922505,0.000056005832,0.0007909661,0.00006655138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009913155,0.0013149807,0.8036085,0.00008092604,0.0014396699,0.0068418346,0.00901828,0.00017186411,0.0063562193,0.0038189972,0.08123852,0.07619704],"study_design_scores_gemma":[0.041083712,0.012137578,0.21359906,0.00011323386,0.00042975368,0.0039056118,0.0034413922,0.0014160997,0.00041010295,0.010839613,0.71216404,0.00045978357],"about_ca_topic_score_codex":0.00002717796,"about_ca_topic_score_gemma":0.000007073112,"teacher_disagreement_score":0.63092554,"about_ca_system_score_codex":0.00035850966,"about_ca_system_score_gemma":0.00035378395,"threshold_uncertainty_score":0.9955648},"labels":[],"label_agreement":null},{"id":"W3093315431","doi":"10.5152/tud.2020.20392","title":"Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma","year":2020,"lang":"en","type":"review","venue":"Urology Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Intensive care medicine; Disease; MEDLINE; Perioperative; Modalities; Internal medicine; Surgery","score_opus":0.20978833202091757,"score_gpt":0.4591552483159493,"score_spread":0.24936691629503172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093315431","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019980963,0.97144437,6.155676e-7,0.005712447,0.000037313184,0.0020595877,0.000034847937,0.000007955379,0.020503046],"genre_scores_gemma":[0.009661902,0.98933035,0.00008092739,0.00009613943,0.00015017003,0.0005326455,0.000027737757,0.000027049018,0.00009306247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970201,0.0014414759,0.00032196083,0.00048778913,0.00035146452,0.00037718166],"domain_scores_gemma":[0.9924976,0.006847536,0.000113194765,0.0003448564,0.00006681363,0.00012995947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096326804,0.0002843352,0.0009481108,0.00019519348,0.00008037698,0.00003712113,0.00014860356,0.00020470686,0.00002457988],"category_scores_gemma":[0.0003431975,0.00016415154,0.000088579436,0.0001979608,0.0003251227,0.00011275159,0.00009649218,0.0006600632,0.000017402013],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068029686,0.0007011601,0.00009087243,0.006600972,0.0007111657,0.0032599964,0.0015273439,2.5151738e-8,1.8132394e-7,0.0029138606,0.000035917074,0.9834782],"study_design_scores_gemma":[0.0013464092,0.0066154837,0.0020447688,0.0007097769,0.0018802625,0.0017247135,0.0027882888,5.781243e-7,3.2111694e-7,0.00032342016,0.9824628,0.00010317117],"about_ca_topic_score_codex":0.0002072611,"about_ca_topic_score_gemma":0.00002661347,"teacher_disagreement_score":0.983375,"about_ca_system_score_codex":0.00006106101,"about_ca_system_score_gemma":0.0004252082,"threshold_uncertainty_score":0.66939056},"labels":[],"label_agreement":null},{"id":"W3093361160","doi":"10.48083/kqgp2151","title":"Urinary-Based Markers for Bladder Cancer Detection","year":2020,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Bladder cancer; Urinary system; Clinical trial; Urine cytology; Urine; Cancer; Prospective cohort study; Tumor marker; Oncology; Internal medicine; Intensive care medicine","score_opus":0.06658699404074768,"score_gpt":0.35489030577544733,"score_spread":0.28830331173469964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093361160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7611035,0.0028007154,0.080732845,0.13565192,0.004567137,0.0020183676,0.0003559619,0.00035217206,0.012417349],"genre_scores_gemma":[0.9837126,0.00017079245,0.0011978179,0.012272564,0.0016069021,0.0001315868,0.000027592776,0.000024665791,0.0008554483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989275,0.00003686519,0.000265222,0.00022016352,0.00031950854,0.00023078853],"domain_scores_gemma":[0.9991607,0.00011821986,0.00015971948,0.0000785048,0.00028799823,0.00019485517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012990406,0.00015280259,0.00021069514,0.000072312294,0.00014703666,0.000040489813,0.0001310353,0.000100399324,0.0015484694],"category_scores_gemma":[0.0002050745,0.00012767075,0.0002912515,0.00008681771,0.00004970276,0.00010295451,0.000020830827,0.00031833205,0.00001540005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047097906,0.0025586742,0.28537634,0.0005051855,0.009313682,0.00084165385,0.001771192,0.0035421008,0.036559038,0.00033414768,0.14307801,0.46902207],"study_design_scores_gemma":[0.057878774,0.019305876,0.2725159,0.00024245158,0.002479562,0.001225589,0.0014188018,0.041910134,0.050378677,0.0045170914,0.54684436,0.0012827751],"about_ca_topic_score_codex":0.000014752623,"about_ca_topic_score_gemma":0.0000050982517,"teacher_disagreement_score":0.46773928,"about_ca_system_score_codex":0.0002532444,"about_ca_system_score_gemma":0.0003389389,"threshold_uncertainty_score":0.99936426},"labels":[],"label_agreement":null},{"id":"W3093523278","doi":"10.1016/j.ijrobp.2020.07.577","title":"Stereotactic Ablative Radiotherapy for Treatment of Upper Urinary Tract Urothelial Carcinomas","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; SABR volatility model; Radiation therapy; Ureter; Urology; Urinary system; Transitional cell carcinoma; Ablative case; Upper urinary tract; Renal pelvis; Surgery; Cancer; Internal medicine; Bladder cancer","score_opus":0.042862424364759816,"score_gpt":0.3584302768539116,"score_spread":0.31556785248915176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093523278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96673656,0.0026321174,0.015735053,0.010623444,0.0019479875,0.0010629338,0.00043177776,0.000035900004,0.0007942608],"genre_scores_gemma":[0.99061966,0.0010533459,0.0036881897,0.0013137683,0.0031168563,0.000030929226,0.000066821354,0.00003684852,0.00007357021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864453,0.000119123295,0.0006387339,0.00021353504,0.00020552428,0.00017854308],"domain_scores_gemma":[0.998092,0.0003324208,0.00079381565,0.000106220556,0.00051504443,0.0001604888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011137204,0.00021353495,0.0006543079,0.00009939373,0.000041906558,0.000010621833,0.00017700448,0.00015438348,0.0001243572],"category_scores_gemma":[0.0000837553,0.00016789418,0.00042663337,0.00009431859,0.00011458693,0.00017666726,0.000011624416,0.00012667787,0.0000072159137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011090137,0.00495448,0.773513,0.00003523935,0.005926205,0.00013620121,0.0060578124,0.00025067417,0.021256838,0.0022305262,0.0006096641,0.17393921],"study_design_scores_gemma":[0.12204891,0.14617646,0.34324446,0.00016413549,0.002784316,0.0019384044,0.00066309195,0.007003771,0.071786314,0.006912853,0.29641333,0.0008639682],"about_ca_topic_score_codex":0.000020530724,"about_ca_topic_score_gemma":3.5668614e-7,"teacher_disagreement_score":0.43026856,"about_ca_system_score_codex":0.0007897264,"about_ca_system_score_gemma":0.0007173113,"threshold_uncertainty_score":0.68465257},"labels":[],"label_agreement":null},{"id":"W3093554611","doi":"10.1016/j.urolonc.2020.10.001","title":"Refining assessment of response to radiation-based therapy for muscle-invasive bladder cancer: Is post-treatment tumor bed biopsy always necessary?","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Urine cytology; Bladder cancer; Cystoscopy; Cystectomy; Biopsy; Lymphovascular invasion; Urology; Interquartile range; Hazard ratio; Population; Cancer; Radiology; Internal medicine; Urinary system; Confidence interval; Metastasis","score_opus":0.04787274848590643,"score_gpt":0.36433957875137035,"score_spread":0.3164668302654639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093554611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9031673,0.0009766457,0.00019257626,0.09362783,0.00012005978,0.0010507092,0.00059530284,0.000054916283,0.00021464388],"genre_scores_gemma":[0.8718258,0.0005442065,0.07549559,0.05013963,0.0002240429,0.0013530146,0.00020371315,0.000038810125,0.00017519412],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985205,0.0001462903,0.0003737184,0.0004945494,0.00016939438,0.00029553907],"domain_scores_gemma":[0.99823606,0.00072785164,0.00021933937,0.00020065103,0.00019429375,0.00042183016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019368963,0.00026613742,0.00052937574,0.00014500016,0.00021587034,0.000015803513,0.00009409927,0.00014156869,0.0001919115],"category_scores_gemma":[0.00021238218,0.00020973194,0.000121378485,0.00031905458,0.00023723108,0.00006083986,0.000019213287,0.00013011319,0.000004828393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010376471,0.0014416431,0.8327908,0.00014556467,0.0010617989,0.00022237773,0.006111178,0.00096255913,0.10680305,0.0007590312,0.008344542,0.030981004],"study_design_scores_gemma":[0.012145336,0.053542644,0.06833278,0.00011386783,0.0010538754,0.000050560764,0.00085861183,0.0025884272,0.0366367,0.00030987491,0.8239216,0.00044571495],"about_ca_topic_score_codex":0.00037861924,"about_ca_topic_score_gemma":0.00004843065,"teacher_disagreement_score":0.8155771,"about_ca_system_score_codex":0.00027765895,"about_ca_system_score_gemma":0.002444633,"threshold_uncertainty_score":0.85526204},"labels":[],"label_agreement":null},{"id":"W3093720182","doi":"10.5430/jst.v10n2p22","title":"Androgen receptor expression in the urinary bladder urothelial carcinoma and its relation to known prognostic factors","year":2020,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Androgen receptor; Medicine; Immunohistochemistry; Pathology; Urinary bladder; H&E stain; Androgen; Carcinoma; Urology; Pathological; Oncology; Internal medicine; Cancer; Prostate cancer; Hormone","score_opus":0.03219902449976028,"score_gpt":0.2851893582494223,"score_spread":0.25299033374966207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093720182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949633,0.0007699317,0.00002057711,0.0034136644,0.00011094416,0.00047840635,0.000016175036,0.0000076041647,0.00021941334],"genre_scores_gemma":[0.99857706,0.000050051167,0.00013510913,0.0007367167,0.0004276152,0.000008626876,0.000003200278,0.000018631363,0.000042977783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989285,0.00008066769,0.0003619986,0.00014081178,0.00032490416,0.00016310818],"domain_scores_gemma":[0.99940157,0.00006668443,0.0001478128,0.000077392535,0.00007530746,0.00023125186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014038855,0.0001373288,0.0002803518,0.00010052887,0.00005547993,0.000016165244,0.00009394223,0.000050824765,0.000090511116],"category_scores_gemma":[0.00018558979,0.00008079784,0.00007341548,0.00018968771,0.000018377425,0.00013719288,0.000028887625,0.00026417422,0.000014180388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033348259,0.00070728647,0.88865024,0.00018150941,0.00014193395,0.0012768627,0.03370991,0.000072377625,0.06529927,0.000022530548,0.005134302,0.001468958],"study_design_scores_gemma":[0.00354166,0.0050926018,0.9518598,0.00038874842,0.00018074537,0.0006596858,0.0018845346,0.00008873064,0.03383229,0.000042509255,0.002264537,0.00016417078],"about_ca_topic_score_codex":0.0000049226605,"about_ca_topic_score_gemma":6.302324e-7,"teacher_disagreement_score":0.06320956,"about_ca_system_score_codex":0.000047676887,"about_ca_system_score_gemma":0.00013138412,"threshold_uncertainty_score":0.32948405},"labels":[],"label_agreement":null},{"id":"W3095029713","doi":"10.5489/cuaj.6698","title":"The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Renal pelvis; Medicine; Hazard ratio; Urology; Bladder cancer; Stage (stratigraphy); Proportional hazards model; Ureter; Upper urinary tract; Urothelial carcinoma; Pelvis; Surgery; Internal medicine; Cancer; Urinary system; Confidence interval","score_opus":0.01656775469397877,"score_gpt":0.2453342810509129,"score_spread":0.22876652635693412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095029713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696089,0.00038003325,0.00007063609,0.02870337,0.00045067063,0.00045800235,0.000045239816,0.000012319235,0.00027085328],"genre_scores_gemma":[0.9954889,0.000025354324,0.000019234043,0.0036245743,0.00072332314,0.000022981834,0.000016398471,0.000017164939,0.0000621019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851406,0.00025730755,0.00032955778,0.00018672484,0.00034723623,0.0003651315],"domain_scores_gemma":[0.9976119,0.0014499376,0.00018627931,0.00007069323,0.00009998572,0.000581232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082403584,0.00015119529,0.0003884583,0.00006091061,0.0003058794,0.000058204925,0.00006905093,0.0001331669,0.00005209429],"category_scores_gemma":[0.0021704442,0.00009407293,0.00027936368,0.00010731437,0.00003888676,0.000056466237,0.0000061486594,0.00033189254,0.000005242697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011044162,0.000037083955,0.9883646,0.000019345189,0.00027708246,0.00006628203,0.00011409601,0.000015500285,0.00014536211,0.00007875774,0.0057858266,0.0039916863],"study_design_scores_gemma":[0.004692848,0.0033097218,0.96510196,0.000025368638,0.0003926254,0.00007117178,0.000035623056,0.00035654657,0.0005407401,0.00016071081,0.02515651,0.00015619886],"about_ca_topic_score_codex":0.0003204946,"about_ca_topic_score_gemma":0.00005922157,"teacher_disagreement_score":0.02587999,"about_ca_system_score_codex":0.00033761738,"about_ca_system_score_gemma":0.000506899,"threshold_uncertainty_score":0.38361827},"labels":[],"label_agreement":null},{"id":"W3095444310","doi":"10.5489/cuaj.6966","title":"Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Cohort; Cancer; Urology; Oncology; General surgery; Internal medicine","score_opus":0.025654303750066648,"score_gpt":0.29368781395903587,"score_spread":0.2680335102089692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095444310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684107,0.00015225355,0.000039278137,0.02932973,0.00011794652,0.0005560743,0.00016915084,0.000007252301,0.0012176367],"genre_scores_gemma":[0.9833257,0.00008946985,0.00013795392,0.01620453,0.00017084838,0.000015039013,0.000025782594,0.000012784482,0.00001786687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748296,0.00038101792,0.0010068838,0.0002293304,0.0006037011,0.00029608727],"domain_scores_gemma":[0.99745613,0.000946513,0.0006391282,0.00011105123,0.0003567585,0.00049041456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008600829,0.00015918871,0.0007075076,0.00007703403,0.0000746269,0.000018663308,0.00017614345,0.00024328544,0.00018903906],"category_scores_gemma":[0.0012181842,0.00009136067,0.0002326209,0.00026306257,0.00013450568,0.000070821734,0.000015466068,0.0008617544,0.0000041260164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076021877,0.00025585527,0.9956091,0.0000074663994,0.0008705345,0.000069919304,0.0003241431,0.000014915031,0.0000013708338,0.00002121889,0.0015351587,0.0005301158],"study_design_scores_gemma":[0.006437181,0.0018457158,0.9903109,0.000038824644,0.00026953508,0.000006345805,0.00010063453,0.000025376898,0.000002947445,0.00004528817,0.0008274416,0.00008978275],"about_ca_topic_score_codex":0.0019654932,"about_ca_topic_score_gemma":0.0008521131,"teacher_disagreement_score":0.014915047,"about_ca_system_score_codex":0.00029951637,"about_ca_system_score_gemma":0.002057973,"threshold_uncertainty_score":0.3743942},"labels":[],"label_agreement":null},{"id":"W3095691676","doi":"10.1111/bju.15289","title":"Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis","year":2020,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Cystectomy; Urology; Bladder cancer; Medicine; Hydronephrosis; Chemotherapy; Oncology; Internal medicine; Cancer; Urinary system","score_opus":0.03495158424064424,"score_gpt":0.3303991288615385,"score_spread":0.29544754462089423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095691676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95756847,0.019326817,0.00043908466,0.020282175,0.0011625298,0.0005566387,0.000034679673,0.000049552636,0.00058004045],"genre_scores_gemma":[0.97811544,0.0072743758,0.0007368624,0.011503276,0.0021934265,0.000027585935,0.000008274938,0.00007487069,0.00006591569],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965038,0.00038929013,0.0014224879,0.00049368653,0.0005876523,0.0006031087],"domain_scores_gemma":[0.99821883,0.00021862425,0.00043549837,0.00019998795,0.00015351111,0.00077357027],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005184083,0.00030590402,0.0015190963,0.00013965243,0.000068868445,0.0000367258,0.00030399964,0.00044969982,0.0011255862],"category_scores_gemma":[0.00031198014,0.00030146967,0.0004515286,0.00032425844,0.0005095726,0.00013698921,0.00006096657,0.0015262378,0.000036801535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1411886,0.0040528453,0.15366481,0.00033289636,0.0068030995,0.0550451,0.0021333618,0.0005699405,0.004254598,0.000032866665,0.055016402,0.5769055],"study_design_scores_gemma":[0.4136967,0.026620848,0.2973902,0.0009844963,0.0033565199,0.03952166,0.0002414451,0.0040869517,0.00134878,0.00013485014,0.21134211,0.0012754222],"about_ca_topic_score_codex":0.0005502475,"about_ca_topic_score_gemma":0.00019063083,"teacher_disagreement_score":0.57563007,"about_ca_system_score_codex":0.00023998205,"about_ca_system_score_gemma":0.000955483,"threshold_uncertainty_score":0.99994373},"labels":[],"label_agreement":null},{"id":"W3096123211","doi":"10.1016/j.euf.2020.10.002","title":"Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer","year":2020,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Bladder cancer; Oncology; Cancer; Internal medicine; Androgen deprivation therapy; Prostate cancer; Gynecology; Urology","score_opus":0.03488635073262041,"score_gpt":0.34919987840088784,"score_spread":0.3143135276682674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096123211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011231313,0.9887076,0.0000056153804,0.0004141469,0.00015273735,0.0038034534,0.000051211133,0.00004223387,0.0068117827],"genre_scores_gemma":[0.0018203519,0.99577135,0.000012968047,0.0013965977,0.0002666087,0.00049840054,0.000022168606,0.00015184478,0.000059715687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954563,0.0020805814,0.0012137606,0.00058048224,0.00028396293,0.00038495826],"domain_scores_gemma":[0.9978343,0.00028133456,0.0009620149,0.00072430714,0.00007797392,0.000120068464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000562605,0.0005653383,0.003626687,0.0001317474,0.00007053592,0.00002596994,0.00048509316,0.00013874577,0.00014299383],"category_scores_gemma":[0.00015816627,0.000312802,0.00059748226,0.00045602224,0.000095019364,0.000064711465,0.00012379339,0.0007995159,0.00006193608],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036302205,0.00008194244,0.00007757311,0.30840003,0.0024111443,0.00060016394,0.0006735807,7.8536755e-7,0.0000048975403,0.000014483564,0.0002918735,0.6874072],"study_design_scores_gemma":[0.0011363297,0.00044712142,0.000024390189,0.37215477,0.011017074,0.00044639752,0.00007703716,0.000007776788,0.000012411959,0.000028027263,0.6142867,0.0003619332],"about_ca_topic_score_codex":0.0002702975,"about_ca_topic_score_gemma":0.000023200673,"teacher_disagreement_score":0.6870453,"about_ca_system_score_codex":0.0002083613,"about_ca_system_score_gemma":0.0010442921,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W3096243273","doi":"10.1080/15384047.2020.1833811","title":"A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature","year":2020,"lang":"en","type":"article","venue":"Cancer Biology & Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Scientific Research Foundation","keywords":"Bladder cancer; Nomogram; Oncology; DNA methylation; Receiver operating characteristic; Methylation; Internal medicine; Biomarker; Proportional hazards model; Stage (stratigraphy); Differentially methylated regions; Medicine; Biology; Cancer; Gene","score_opus":0.06517980457294044,"score_gpt":0.32177032483932894,"score_spread":0.2565905202663885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096243273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96088606,0.003787828,0.006911762,0.021373946,0.0007844465,0.0045298636,0.0011001391,0.0001841178,0.00044182883],"genre_scores_gemma":[0.97224146,0.00014933335,0.0006601748,0.024778407,0.0007532889,0.0010271083,0.0002594326,0.000063961976,0.00006684665],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986383,0.00006767486,0.00023364532,0.0005812436,0.0001274709,0.00035169075],"domain_scores_gemma":[0.9990658,0.00023914945,0.00010992853,0.0002375524,0.00016268632,0.0001848964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008079308,0.00030603618,0.00040579773,0.00008553999,0.00010262016,0.000012632778,0.00012514924,0.0002770081,0.00044369293],"category_scores_gemma":[0.00009101869,0.00022683971,0.00020702556,0.00023265736,0.00011887732,0.000039447143,0.000012313508,0.00016246918,0.000012782665],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057083573,0.00041257523,0.049635667,0.00007768832,0.0005021035,0.000011039573,0.000787549,0.00003489155,0.88783187,0.00009587373,0.0023926399,0.052509774],"study_design_scores_gemma":[0.052911047,0.013430033,0.41996828,0.00020638792,0.0008331184,0.000009823277,0.00018457793,0.0034845567,0.38372195,0.00043139042,0.1237556,0.0010632342],"about_ca_topic_score_codex":0.00011997204,"about_ca_topic_score_gemma":0.000041514788,"teacher_disagreement_score":0.50410986,"about_ca_system_score_codex":0.000109466506,"about_ca_system_score_gemma":0.000565492,"threshold_uncertainty_score":0.92502546},"labels":[],"label_agreement":null},{"id":"W3096567634","doi":"10.1016/s0959-8049(20)31120-5","title":"Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"","keywords":"Pembrolizumab; Cystectomy; Bladder cancer; Urothelial cancer; Medicine; Chemotherapy; Oncology; Immunotherapy; Disease; Cancer; Internal medicine","score_opus":0.03865897088886258,"score_gpt":0.3137503165967124,"score_spread":0.27509134570784977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096567634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569457,0.024789784,0.00019811596,0.014801257,0.0003409166,0.0004844887,0.000061007708,0.000021420925,0.0023572943],"genre_scores_gemma":[0.99006724,0.0026028338,0.00064548966,0.005621669,0.00063069095,0.0000065722375,0.0000053009853,0.00009032566,0.00032986279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978533,0.00043513245,0.00059408863,0.0002642877,0.00055304845,0.0003001891],"domain_scores_gemma":[0.9985388,0.000045973942,0.00052222476,0.00019189481,0.00037732878,0.0003238054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027833832,0.00028538523,0.00059573393,0.00019338394,0.000035373534,0.000027924103,0.00025124484,0.000060398863,0.00040966494],"category_scores_gemma":[0.0001112758,0.00022093217,0.0002739226,0.0002993808,0.00009285511,0.00017934515,0.000050508355,0.0005008502,0.000004082454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012726903,0.00025668042,0.055824984,0.0005692869,0.0026905076,0.0054145884,0.019460093,0.0020245132,0.8346408,0.00011449548,0.0057362015,0.06054097],"study_design_scores_gemma":[0.02158024,0.0038288916,0.28939572,0.0030192551,0.001156558,0.00023989035,0.0027712744,0.000012970902,0.66817343,0.00009824135,0.009061838,0.0006616712],"about_ca_topic_score_codex":0.00042244064,"about_ca_topic_score_gemma":0.000119644734,"teacher_disagreement_score":0.23357075,"about_ca_system_score_codex":0.00018730486,"about_ca_system_score_gemma":0.0013942615,"threshold_uncertainty_score":0.90093523},"labels":[],"label_agreement":null},{"id":"W3096587374","doi":"10.1016/j.euros.2020.10.003","title":"Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group","year":2020,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Urology; Bladder cancer; Mitomycin C; Ureteroscopy; Chemotherapy; Internal medicine; Surgery; Cancer; Ureter","score_opus":0.05290566465270226,"score_gpt":0.3288145880227204,"score_spread":0.27590892337001816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096587374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95461375,0.0006671857,0.0002643337,0.025320614,0.00039184783,0.00125435,0.0005231314,0.000064910906,0.016899865],"genre_scores_gemma":[0.9621205,0.0002084423,0.00024819246,0.03670764,0.00047809907,0.000020338504,0.000050271232,0.000055831566,0.00011070232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957123,0.0017116584,0.0006055914,0.0010148286,0.0005034764,0.00045219416],"domain_scores_gemma":[0.9984412,0.0001989681,0.0002759462,0.0005897698,0.00019948534,0.00029459922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022923904,0.000304657,0.00043739908,0.00006038261,0.00027069298,0.000105904706,0.0016869113,0.0000766479,0.0002883343],"category_scores_gemma":[0.00080562336,0.00019928257,0.000083131265,0.000708843,0.002026404,0.00033794812,0.000710639,0.0006490228,0.00015308127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047583785,0.00037336635,0.7999092,0.000014434242,0.00057095126,0.0006970439,0.030814128,0.0001223808,0.08180486,0.00012697451,0.0105880285,0.027394867],"study_design_scores_gemma":[0.0055738394,0.0013627202,0.97500664,0.000024630175,0.0000975688,0.00003410283,0.000058862428,0.00027174666,0.0010543197,0.000010407047,0.016303327,0.00020181145],"about_ca_topic_score_codex":0.001996525,"about_ca_topic_score_gemma":0.0002865949,"teacher_disagreement_score":0.17509748,"about_ca_system_score_codex":0.00006189927,"about_ca_system_score_gemma":0.00041112106,"threshold_uncertainty_score":0.81265074},"labels":[],"label_agreement":null},{"id":"W3096828774","doi":"10.1002/14651858.cd013776.pub2","title":"Blue versus white light for transurethral resection of non-muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bladder cancer; White light; Resection; Certainty; Disease; Carcinoma; Bladder tumor","score_opus":0.08485898369367934,"score_gpt":0.373588064250897,"score_spread":0.2887290805572177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096828774","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09061399,0.86708343,0.007222365,0.0014505163,0.003179551,0.02264586,0.0038564543,0.000055390345,0.0038924427],"genre_scores_gemma":[0.62543005,0.3502977,0.008893941,0.0005081129,0.0010793243,0.008352972,0.0024328271,0.00020702135,0.0027980611],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99748886,0.00023248451,0.0013083161,0.000354207,0.00040466976,0.00021144094],"domain_scores_gemma":[0.9974609,0.00032512323,0.00057518604,0.0009308056,0.00058977137,0.00011820508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007671193,0.00024474555,0.0018429478,0.00008520952,0.00004640275,0.000008976336,0.00012615933,0.0000836068,0.0004994536],"category_scores_gemma":[0.0009623262,0.00017468091,0.00043736928,0.00033958434,0.00004748973,0.00012367126,0.000025626217,0.000097735305,0.000019098119],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008746927,0.00037642356,0.00017331072,0.8776592,0.0009075884,0.0000306712,0.0015522834,0.0000042067704,0.110740334,0.000040903942,0.006942212,0.000698179],"study_design_scores_gemma":[0.018393489,0.0020958493,0.0005938396,0.616972,0.009231559,0.00009381135,0.0017799409,0.00013691453,0.34767547,0.000013008462,0.0025067134,0.0005073879],"about_ca_topic_score_codex":0.00007981186,"about_ca_topic_score_gemma":0.0003038035,"teacher_disagreement_score":0.534816,"about_ca_system_score_codex":0.00007582032,"about_ca_system_score_gemma":0.00038153294,"threshold_uncertainty_score":0.7123281},"labels":[],"label_agreement":null},{"id":"W3097843807","doi":"10.1007/s00345-020-03505-4","title":"Role of prehabilitation following major uro-oncologic surgery: a narrative review","year":2020,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Prehabilitation; Medicine; Psychological intervention; Quality of life (healthcare); Randomized controlled trial; Psychosocial; Physical therapy; Cystectomy; General surgery; Bladder cancer; Cancer; Surgery; Internal medicine; Nursing","score_opus":0.03348299369777417,"score_gpt":0.3557006954691514,"score_spread":0.3222177017713772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097843807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019795096,0.99550647,0.000006432477,0.0019727973,0.0004825273,0.0009639596,0.000014195523,0.000010524872,0.001023329],"genre_scores_gemma":[0.00080364605,0.99731106,0.00032601578,0.0009586868,0.00036056977,0.000051609408,0.000020172763,0.00004059768,0.00012767084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967378,0.0007598874,0.0016818789,0.00025762967,0.00033207008,0.00023073846],"domain_scores_gemma":[0.9964298,0.0010673021,0.0018814319,0.00022458538,0.0002151403,0.00018173558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007243153,0.0003465325,0.004646766,0.0004362985,0.000035938683,0.000004504916,0.00017367289,0.00017449388,0.00029977047],"category_scores_gemma":[0.00081407645,0.00023484361,0.0020458356,0.0006654745,0.00008090185,0.00006764574,0.00003980785,0.00067700533,0.000019398525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023299694,0.00022156994,0.00023093952,0.020461943,0.0021265023,0.00039528566,0.0003801291,1.7577757e-7,0.000008635476,0.000025569283,0.006761197,0.9691551],"study_design_scores_gemma":[0.0006153914,0.0016816031,0.00007599545,0.021598782,0.009558266,0.00072349893,0.000040375042,2.5127412e-7,0.0000012084812,0.00016313381,0.96541244,0.00012906059],"about_ca_topic_score_codex":0.000005372519,"about_ca_topic_score_gemma":0.000008589683,"teacher_disagreement_score":0.96902597,"about_ca_system_score_codex":0.00019634841,"about_ca_system_score_gemma":0.0014991083,"threshold_uncertainty_score":0.95766443},"labels":[],"label_agreement":null},{"id":"W3105853448","doi":"10.1016/j.urolonc.2020.10.006","title":"Systemic therapy in bladder preservation","year":2020,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Chemotherapy; Context (archaeology); Oncology; Neoadjuvant therapy; Cisplatin; Pathological; Disease; Internal medicine; Urology; Cancer","score_opus":0.09249236188668081,"score_gpt":0.37967331609766786,"score_spread":0.28718095421098705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105853448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082070235,0.99281067,0.000009313989,0.0018520902,0.00019018808,0.0016614252,0.0000461424,0.00007389663,0.0025355802],"genre_scores_gemma":[0.000055121447,0.9933946,0.0032440666,0.0014468112,0.00026892536,0.00065527204,0.00024620042,0.000037436042,0.000651568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811184,0.000275357,0.00059795065,0.0005662081,0.00015549567,0.0002931476],"domain_scores_gemma":[0.998937,0.00024663698,0.00027429583,0.00024653593,0.000043564844,0.0002519656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019560725,0.00040181784,0.0015876918,0.00023870385,0.00009673254,0.000022130947,0.00013306213,0.0006304681,0.00010837766],"category_scores_gemma":[0.00010800997,0.0002925729,0.00017166793,0.0005074704,0.0002783548,0.00010167278,0.000047727823,0.0006857144,0.00006750228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009345863,0.00027634908,0.01047693,0.0026285893,0.0004208537,0.00063071214,0.00044874707,0.0000019252566,0.000002870178,0.0015551683,0.0043042162,0.9791602],"study_design_scores_gemma":[0.0009323495,0.002008753,0.000047440935,0.0019878724,0.00090252445,0.0010151559,0.00003539912,0.000027266215,0.0000011138375,0.0007502977,0.99208105,0.00021078147],"about_ca_topic_score_codex":0.000069857124,"about_ca_topic_score_gemma":0.000015722588,"teacher_disagreement_score":0.9877768,"about_ca_system_score_codex":0.00029883167,"about_ca_system_score_gemma":0.0014042242,"threshold_uncertainty_score":0.9999526},"labels":[],"label_agreement":null},{"id":"W3108115836","doi":"10.1016/j.urolonc.2020.07.028","title":"A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemcitabine; Medicine; Urology; Renal pelvis; Upper urinary tract; Pharmacokinetics; Urinary system; Bladder cancer; Urine; Cmax; Ureter; Cancer; Internal medicine","score_opus":0.04201112083085735,"score_gpt":0.3156303040649413,"score_spread":0.27361918323408396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108115836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97935957,0.0020480573,0.0013322349,0.013825974,0.00012123622,0.001104606,0.00015929539,0.000051730673,0.001997269],"genre_scores_gemma":[0.98369694,0.00018613898,0.013048518,0.002172229,0.00023880934,0.00019878751,0.00011624668,0.000017082513,0.00032522183],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990351,0.000046007506,0.00029030544,0.00030481815,0.0001005421,0.00022318149],"domain_scores_gemma":[0.9992777,0.00016040199,0.0001253241,0.00011443547,0.000051997773,0.00027014868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000501401,0.00018916592,0.00043467284,0.00006905108,0.00012261215,0.0000066657003,0.000044089556,0.000110667956,0.00006764474],"category_scores_gemma":[0.000035397486,0.00014334766,0.00012137923,0.00015079629,0.00023357678,0.00006853314,0.0000107273445,0.00007535559,0.000005872578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018849057,0.0011212014,0.94940567,0.00012193392,0.0002166833,0.000069484115,0.0038500438,0.00011876039,0.0029876146,0.004279261,0.0017146309,0.034229826],"study_design_scores_gemma":[0.00951298,0.029920155,0.02605972,0.0000319248,0.0015524358,0.00025496355,0.00072244316,0.008287514,0.015926208,0.0014993888,0.9059256,0.00030667768],"about_ca_topic_score_codex":0.00014482623,"about_ca_topic_score_gemma":0.000009013183,"teacher_disagreement_score":0.9233459,"about_ca_system_score_codex":0.00011068299,"about_ca_system_score_gemma":0.00038852438,"threshold_uncertainty_score":0.5845548},"labels":[],"label_agreement":null},{"id":"W3108115906","doi":"10.1016/j.clgc.2020.11.004","title":"Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Urology; Upper urinary tract; Adenocarcinoma; Internal medicine; Odds ratio; Oncology; Cancer; Urinary system","score_opus":0.10736175486310746,"score_gpt":0.38198908150011895,"score_spread":0.2746273266370115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108115906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96210974,0.0046388926,0.000052642208,0.015242241,0.0032315315,0.00082932296,0.00014883172,0.00022144761,0.0135253295],"genre_scores_gemma":[0.98179567,0.00067538605,0.00055333093,0.00840777,0.0068089846,0.00016273922,0.000037616475,0.000091560534,0.0014669292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713874,0.0001962199,0.00084268505,0.00089080987,0.00035273546,0.0005788097],"domain_scores_gemma":[0.9980921,0.00025555448,0.0001783094,0.0005042066,0.0001159291,0.000853915],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015270621,0.00039419264,0.00089209166,0.00006338776,0.00012964985,0.000017075912,0.0002688494,0.00030616662,0.002913031],"category_scores_gemma":[0.00019077475,0.00033997063,0.00056230585,0.00022867792,0.00027080285,0.000109363085,0.00014077878,0.00076376554,0.00054670376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0691299,0.008852509,0.750284,0.000509782,0.0015797883,0.036010087,0.0012001148,0.000034287477,0.0015210347,0.000168468,0.0677348,0.062975235],"study_design_scores_gemma":[0.03376152,0.028941296,0.6381056,0.0001355613,0.0015060751,0.0013069938,0.00020522943,0.00039826267,0.0007164795,0.000096272284,0.29389575,0.00093095435],"about_ca_topic_score_codex":0.00015434356,"about_ca_topic_score_gemma":0.0000025048464,"teacher_disagreement_score":0.22616096,"about_ca_system_score_codex":0.0002192676,"about_ca_system_score_gemma":0.0010500131,"threshold_uncertainty_score":0.9999052},"labels":[],"label_agreement":null},{"id":"W3108117757","doi":"10.5489/cuaj.6887","title":"Assembling a network to promote translational bladder cancer research in Canada","year":2020,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université Laval; University of Calgary; Prevention of Organ Failure; University of British Columbia; Queen's University","funders":"","keywords":"Translational research; Bladder cancer; Translational science; Medicine; Engineering ethics; Political science; Cancer; Engineering; Pathology; Internal medicine","score_opus":0.06790557595122083,"score_gpt":0.3239534853313055,"score_spread":0.2560479093800847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108117757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6542187,0.00047106633,0.000043887576,0.34251457,0.0002696875,0.00043330365,0.000060350514,0.000010546999,0.0019778812],"genre_scores_gemma":[0.97038907,0.000041866777,0.00023501819,0.027940957,0.0012461651,0.000030052339,0.000009318275,0.00001348492,0.00009407645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786764,0.00017826169,0.00030006128,0.0002256472,0.00069350965,0.00073489925],"domain_scores_gemma":[0.9980743,0.00010163185,0.000061666266,0.00005467607,0.00028257887,0.0014251776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057355466,0.00010973428,0.00024155955,0.000116162664,0.00021030928,0.00005193491,0.00010869738,0.00011655809,0.0010422494],"category_scores_gemma":[0.0002425762,0.00009499966,0.000055107444,0.0007728898,0.000008521286,0.000057191588,0.000009844018,0.0008752807,0.000027599308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015083366,0.000017626237,0.94712245,0.0000046522173,0.00011187066,0.00031923447,0.00030780135,0.0030470635,0.000067085384,0.000038412956,0.042147882,0.006665087],"study_design_scores_gemma":[0.0014131932,0.00028655576,0.831906,0.000038342732,0.000038391703,0.000034201807,0.000086213084,0.00079243863,0.000024296658,0.0004163869,0.1648225,0.00014144168],"about_ca_topic_score_codex":0.78104424,"about_ca_topic_score_gemma":0.9476441,"teacher_disagreement_score":0.31617036,"about_ca_system_score_codex":0.0038024595,"about_ca_system_score_gemma":0.010022006,"threshold_uncertainty_score":0.99987096},"labels":[],"label_agreement":null},{"id":"W3108500360","doi":"10.3233/blc-200306","title":"Tumor Subtyping: Making Sense of Heterogeneity with a Goal Toward Treatment","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Oncology; Medicine; Cancer; Internal medicine; Biology","score_opus":0.06357876085516496,"score_gpt":0.3230142290459608,"score_spread":0.2594354681907958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108500360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898042,0.0026800241,0.00026413926,0.002987241,0.00010761952,0.000763503,0.00012906494,0.000101004465,0.0031632227],"genre_scores_gemma":[0.9959386,0.00013392273,0.00064552284,0.0026363307,0.00032888664,0.00012277898,0.00001022576,0.000046688998,0.00013701599],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988244,0.000026939444,0.00022465143,0.00037617385,0.00026611108,0.0002817302],"domain_scores_gemma":[0.99936503,0.000015484058,0.00010640624,0.00022855424,0.000084153784,0.0002003912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023046618,0.00024709772,0.00045901455,0.00003864151,0.0000412392,0.000011399119,0.000049365764,0.00004628789,0.00044199554],"category_scores_gemma":[0.000008447859,0.00017105196,0.00013999296,0.00019192116,0.0000770745,0.00005134593,0.00002446278,0.000083808205,0.000020854382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024268936,0.0023569262,0.81232977,0.0017128955,0.00942959,0.003157754,0.018677073,0.00047597967,0.043222647,0.00023446113,0.005414397,0.07871955],"study_design_scores_gemma":[0.037893783,0.016292682,0.32341295,0.0013199105,0.004828917,0.000759767,0.0016481355,0.0011830273,0.54378206,0.000047934514,0.06736833,0.0014625079],"about_ca_topic_score_codex":0.0004296742,"about_ca_topic_score_gemma":0.00014011413,"teacher_disagreement_score":0.5005594,"about_ca_system_score_codex":0.00018181794,"about_ca_system_score_gemma":0.00041485156,"threshold_uncertainty_score":0.6975296},"labels":[],"label_agreement":null},{"id":"W3109675067","doi":"10.23736/s0393-2249.20.04018-7","title":"Trimodal therapy in muscle invasive bladder cancer management","year":2020,"lang":"en","type":"review","venue":"Minerva Urologica e Nefrologica","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Radiation therapy; Quality of life (healthcare); Genitourinary system; Systematic review; Oncology; MEDLINE; Internal medicine; Cancer; Intensive care medicine; Surgery","score_opus":0.09081465935838906,"score_gpt":0.35122281061338156,"score_spread":0.2604081512549925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109675067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045629192,0.971035,0.0000019839704,0.0015401362,0.00028330792,0.0038900382,0.00015001353,0.00022751524,0.022415698],"genre_scores_gemma":[0.0008554621,0.9873451,0.00031488703,0.0057822247,0.00053490937,0.003166406,0.00020943825,0.000109646884,0.0016819104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99564266,0.00037348637,0.0010172067,0.0016089866,0.00046160558,0.0008960608],"domain_scores_gemma":[0.998189,0.00023082527,0.00041305792,0.0007625555,0.00006492212,0.00033967313],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00019654533,0.0011169128,0.003545253,0.00035000613,0.00009560672,0.000042063275,0.0006077365,0.00092517154,0.003985774],"category_scores_gemma":[0.000070038914,0.00068826904,0.0009729235,0.0009500401,0.0001801427,0.00006487065,0.000289985,0.0010448396,0.0008942541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039422442,0.0006667704,0.00031549035,0.0017294297,0.0010830398,0.0030581262,0.000071615585,0.0000017806337,0.000006254147,0.000021782349,0.006579425,0.98607206],"study_design_scores_gemma":[0.003155351,0.002832458,0.0018981518,0.0012108132,0.0016361031,0.000100604855,0.000017082439,0.000004137138,0.0000023582581,0.000088400724,0.98847234,0.0005821744],"about_ca_topic_score_codex":0.00018856776,"about_ca_topic_score_gemma":0.000044814955,"teacher_disagreement_score":0.9854899,"about_ca_system_score_codex":0.00032494747,"about_ca_system_score_gemma":0.0004905137,"threshold_uncertainty_score":0.99988365},"labels":[],"label_agreement":null},{"id":"W3110108345","doi":"10.1007/s10552-020-01366-1","title":"Bladder cancer stage and mortality: urban vs. rural residency","year":2020,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Bladder cancer; Cystectomy; Internal medicine; Multivariate analysis; Epidemiology; Cancer; Oncology; Demography","score_opus":0.036365086233536084,"score_gpt":0.3228500604913185,"score_spread":0.2864849742577824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110108345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91688615,0.049934857,0.00018229864,0.027032318,0.0007016902,0.0016898941,0.0010315682,0.0002735481,0.002267702],"genre_scores_gemma":[0.9730101,0.00301748,0.000019717094,0.019900868,0.0014129648,0.00041999124,0.00001397666,0.0000599724,0.0021448885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840105,0.000048128244,0.00031090179,0.00045084307,0.0003532468,0.00043584572],"domain_scores_gemma":[0.9989405,0.000042315063,0.000105028594,0.0002950331,0.0001284447,0.0004886222],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005401556,0.0003098543,0.0006070141,0.000045081986,0.000105648265,0.0000502299,0.000099736026,0.00010654551,0.002047731],"category_scores_gemma":[0.00004467238,0.00025645536,0.00012378705,0.00017041495,0.00013290875,0.00020351281,0.000036055422,0.00023602207,0.000028249184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018152721,0.00008190486,0.95845777,0.0002929582,0.0019285554,0.00024243616,0.0017851485,0.000021774462,0.0076673073,0.00036789078,0.021292912,0.006046088],"study_design_scores_gemma":[0.029309921,0.0016371956,0.82790494,0.0004665434,0.004879006,0.000024333383,0.0007601941,0.00066810625,0.007839209,0.0001898546,0.12529151,0.0010292121],"about_ca_topic_score_codex":0.0033464245,"about_ca_topic_score_gemma":0.0008948041,"teacher_disagreement_score":0.13055284,"about_ca_system_score_codex":0.00016051732,"about_ca_system_score_gemma":0.000680351,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W3110361823","doi":"10.1016/s1470-2045(20)30586-6","title":"Nadofaragene firadenovec: a new gold standard for BCG-unresponsive bladder cancer?","year":2020,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Cancer; Gold standard (test); Disease; Urology; Internal medicine; Oncology; Surgery","score_opus":0.09688751176217797,"score_gpt":0.37808595999089734,"score_spread":0.28119844822871937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110361823","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015669546,0.005263647,0.00043567788,0.9818407,0.001888055,0.0025579107,0.0021235682,0.00017468934,0.005559038],"genre_scores_gemma":[0.00042775617,0.0015817651,0.0015706617,0.91699934,0.041743603,0.0008422591,0.00047731638,0.0001696973,0.036187626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971632,0.0002573508,0.00046021762,0.00073640374,0.00045226002,0.0009305646],"domain_scores_gemma":[0.9978018,0.0006640306,0.00032849656,0.0008031738,0.00019003992,0.00021246655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019422949,0.00056963525,0.0019561276,0.00009327402,0.00013823953,0.0000373579,0.000546288,0.00087020185,0.0010831766],"category_scores_gemma":[0.00018281526,0.0003812336,0.00039230485,0.00022534303,0.00021156103,0.000036928115,0.00012055994,0.0019248693,0.00014006853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062332586,0.000033419583,0.00004767245,0.0002837934,0.0015462077,0.0013066554,0.0007121314,0.0000025199693,0.00017076678,0.00005551389,0.9733069,0.016301138],"study_design_scores_gemma":[0.009384457,0.0034881113,0.00011805887,0.00013506475,0.001878069,0.0002356334,0.00004652553,0.000012118965,0.00035336576,0.0015784624,0.9824156,0.00035451015],"about_ca_topic_score_codex":0.0006200072,"about_ca_topic_score_gemma":0.00023052467,"teacher_disagreement_score":0.064841405,"about_ca_system_score_codex":0.0009440039,"about_ca_system_score_gemma":0.0040773614,"threshold_uncertainty_score":0.999864},"labels":[],"label_agreement":null},{"id":"W3110798720","doi":"10.1016/j.urolonc.2020.10.048","title":"FBXW7 loss of function contributes to worse overall survival and is associated with accumulation of MYC in muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Bladder cancer; Downregulation and upregulation; Cancer research; Ubiquitin ligase; Suppressor; Gene; Cancer; Ubiquitin; Genetics","score_opus":0.06418824028544855,"score_gpt":0.33735431776999364,"score_spread":0.2731660774845451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110798720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881063,0.00060804066,0.000076477154,0.010349379,0.000052497682,0.00042117422,0.00008040602,0.000013740198,0.00029194533],"genre_scores_gemma":[0.99480706,0.00027290816,0.0009230579,0.003798845,0.000033437722,0.000051021012,0.000040172952,0.000008053395,0.000065454406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918854,0.000073393196,0.00024706285,0.00023586412,0.00010958397,0.00014553918],"domain_scores_gemma":[0.9992876,0.00022933041,0.00014876926,0.0000697003,0.00012360535,0.00014100393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011452057,0.00012290657,0.00038820461,0.00009190863,0.000046437475,0.000004963483,0.0000320858,0.00014041764,0.00006786638],"category_scores_gemma":[0.0002111774,0.00009797624,0.000023308137,0.00032065806,0.00027568132,0.00007203176,0.000024395948,0.00013568075,9.576358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076653325,0.00015160048,0.9924252,0.000038300896,0.00018796112,0.000022598346,0.0014268322,0.00021826489,0.002548433,0.0007996079,0.0006916865,0.0007229896],"study_design_scores_gemma":[0.0062492522,0.0073965616,0.9601216,0.00023236661,0.0008442501,0.000010623426,0.0005795089,0.00060390716,0.0030349614,0.0030017497,0.017745372,0.00017988739],"about_ca_topic_score_codex":0.0004488646,"about_ca_topic_score_gemma":0.00063224527,"teacher_disagreement_score":0.03230363,"about_ca_system_score_codex":0.00007305125,"about_ca_system_score_gemma":0.00031630037,"threshold_uncertainty_score":0.3995355},"labels":[],"label_agreement":null},{"id":"W3111044160","doi":"10.1016/j.euo.2020.11.005","title":"Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Incidence (geometry); Proportional hazards model; Urology; Stage (stratigraphy); Epidemiology; Internal medicine; Cancer; Oncology; Biology","score_opus":0.032265003367357104,"score_gpt":0.2766939002745177,"score_spread":0.24442889690716058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111044160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702504,0.0004116637,0.00002798948,0.0028416682,0.00012913583,0.00047258465,0.000045394077,0.00003349135,0.025787639],"genre_scores_gemma":[0.99364877,0.000031591117,0.00016229604,0.005840631,0.00016424523,0.0000081267035,0.000046348046,0.00004210263,0.000055877073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984822,0.0004760432,0.0003049844,0.00038206877,0.00013890599,0.00021578523],"domain_scores_gemma":[0.99909884,0.00022100403,0.0001680371,0.00016628757,0.000131364,0.00021446693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013644084,0.00019575155,0.00052394555,0.000059205093,0.000046649606,0.0000042308684,0.00010911918,0.000082803344,0.0001137462],"category_scores_gemma":[0.00016209272,0.00014738434,0.00004989094,0.00010162433,0.00040640836,0.00006845949,0.00008693947,0.00024299478,0.00004482872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037908412,0.00034742674,0.9907129,0.000040892308,0.00012120898,0.0006541039,0.0014001426,0.0000011545575,0.00095527025,0.000040609295,0.0005533967,0.0013820548],"study_design_scores_gemma":[0.009585277,0.015075069,0.9667438,0.00001030851,0.0001582745,0.000074015246,0.00010680758,0.000006039655,0.00071027037,0.000010919271,0.0073962985,0.00012288992],"about_ca_topic_score_codex":0.00005048845,"about_ca_topic_score_gemma":0.000011431282,"teacher_disagreement_score":0.025731761,"about_ca_system_score_codex":0.000025975472,"about_ca_system_score_gemma":0.00041195942,"threshold_uncertainty_score":0.6010159},"labels":[],"label_agreement":null},{"id":"W3111074218","doi":"10.1016/j.urolonc.2020.10.060","title":"Investigating sexual dimorphism in the tumour immune microenvironment of non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Immune system; Bladder cancer; Immune checkpoint; Cytotoxic T cell; Biology; CD163; Tissue microarray; Tumor microenvironment; CD8; Stromal cell; Cancer research; Immunotherapy; Immunology; Cancer; Pathology; Immunohistochemistry; Phenotype; Medicine; Gene","score_opus":0.03695989515403326,"score_gpt":0.3048531442562163,"score_spread":0.26789324910218304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111074218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580399,0.0020178384,0.000018385137,0.038449794,0.000064158194,0.0005552176,0.000036657122,0.000016431917,0.00080165215],"genre_scores_gemma":[0.9761531,0.0006847374,0.0076484038,0.015022926,0.00015498923,0.00019950815,0.000036245612,0.000015635658,0.00008449402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986796,0.00013531598,0.0003958949,0.0003431739,0.00017892035,0.0002671237],"domain_scores_gemma":[0.9991981,0.00022660104,0.00018893881,0.000162811,0.000027678683,0.00019588934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020571532,0.00020092192,0.0004040893,0.000065708016,0.00013510986,0.000010636376,0.00014556588,0.00014265093,0.00011957034],"category_scores_gemma":[0.0001436502,0.00014177183,0.000050631286,0.00029245336,0.0007621757,0.000074069096,0.00006753363,0.00039849774,0.000011415475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000932716,0.00041501282,0.8178368,0.00013527552,0.00016022533,0.00019922788,0.013382029,0.00023306021,0.15914091,0.00048719847,0.0044569597,0.0034600173],"study_design_scores_gemma":[0.0076596546,0.013109407,0.70614886,0.00033812982,0.0015804422,0.00040098865,0.011192209,0.0016864089,0.031257022,0.0036031252,0.22232483,0.00069893576],"about_ca_topic_score_codex":0.0005690988,"about_ca_topic_score_gemma":0.00010906979,"teacher_disagreement_score":0.21786787,"about_ca_system_score_codex":0.0000876541,"about_ca_system_score_gemma":0.00043694317,"threshold_uncertainty_score":0.57812876},"labels":[],"label_agreement":null},{"id":"W3111291785","doi":"10.1016/j.annonc.2020.10.486","title":"1O Clinical outcomes in post-operative ctDNA-positive muscle-invasive urothelial carcinoma (MIUC) patients after atezolizumab adjuvant therapy","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Internal medicine; Oncology; Cystectomy; Adjuvant; Adjuvant therapy; Clinical endpoint; Population; Bladder cancer; Interim analysis; Urology; Cancer; Clinical trial; Immunotherapy; Pembrolizumab","score_opus":0.08812706295566823,"score_gpt":0.4045047751558558,"score_spread":0.31637771220018757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111291785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98164994,0.00044050725,0.0000033420865,0.01336007,0.0002917183,0.001201722,0.0004880586,0.000023985436,0.0025406876],"genre_scores_gemma":[0.9662564,0.00068965065,0.00009915793,0.032392517,0.0002336453,0.00012550355,0.00008485234,0.000038912116,0.000079376965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976183,0.00037951203,0.0007905968,0.00052011415,0.00027938784,0.0004120874],"domain_scores_gemma":[0.99836135,0.00036204685,0.00021360852,0.00024319834,0.0005245802,0.0002952039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015034087,0.00030653842,0.0011543729,0.00010798928,0.000037048976,0.00000746453,0.00015100306,0.00027452153,0.00038211394],"category_scores_gemma":[0.0003240972,0.00023023925,0.00035923242,0.00016592117,0.00023072255,0.0001147147,0.00008303779,0.00034648887,0.00009490301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011174804,0.0026522188,0.8942387,0.000025782916,0.0005079368,0.00055527646,0.005965955,9.217211e-7,0.00039023696,0.000020344844,0.0008870736,0.08358072],"study_design_scores_gemma":[0.014648681,0.028452756,0.9486641,0.000043090306,0.000081788814,0.000004466962,0.00032014947,0.0000053905273,0.0048215818,0.000040296032,0.0027278953,0.00018978852],"about_ca_topic_score_codex":0.0005614995,"about_ca_topic_score_gemma":0.0002517258,"teacher_disagreement_score":0.08339093,"about_ca_system_score_codex":0.00007963863,"about_ca_system_score_gemma":0.00084458437,"threshold_uncertainty_score":0.93888843},"labels":[],"label_agreement":null},{"id":"W3112141484","doi":"10.1097/ju.0000000000001513","title":"Antimicrobial Prophylaxis for Postoperative Urinary Tract Infections in Transurethral Resection of Bladder Tumors: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Basel I; Basel II; Economics; Capital requirement","score_opus":0.06916716496071215,"score_gpt":0.36483467853009593,"score_spread":0.2956675135693838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112141484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064916865,0.9948567,0.000118210875,0.0015848718,0.00003717509,0.0032203577,0.000093699724,0.0000032349772,0.000020819927],"genre_scores_gemma":[0.01021528,0.9890852,0.000046489007,0.0003992278,0.000050410163,0.00012224937,0.000010131487,0.000024991723,0.0000460013],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99677306,0.0013193451,0.0014428856,0.00016672825,0.00015469761,0.00014325888],"domain_scores_gemma":[0.9979115,0.00047351254,0.0011079552,0.00021142379,0.00022961652,0.000065949585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010299499,0.00028438485,0.006890477,0.00041517813,0.00004445127,0.0000056642702,0.00012804237,0.000166205,0.000081274746],"category_scores_gemma":[0.00022244014,0.00013728006,0.0020116458,0.0006587661,0.00009929845,0.000054139386,0.000015530697,0.0006134128,0.0000013310926],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007490193,0.0013454905,0.000009811109,0.704638,0.29075852,0.00018357715,0.0009022726,0.000010046137,0.000008170455,0.00000767237,0.0001591259,0.0012282919],"study_design_scores_gemma":[0.00071646547,0.01130676,0.0000075592875,0.0068004783,0.9696264,0.0082969805,0.0000186645,0.0000017486249,0.0000023611747,0.000010928267,0.0031141443,0.00009747895],"about_ca_topic_score_codex":0.000030217358,"about_ca_topic_score_gemma":0.000018428715,"teacher_disagreement_score":0.69783753,"about_ca_system_score_codex":0.000058988648,"about_ca_system_score_gemma":0.0004108559,"threshold_uncertainty_score":0.55981183},"labels":[],"label_agreement":null},{"id":"W3112926203","doi":"10.1016/j.urolonc.2020.10.054","title":"Predictive and Prognostic Performance of IHC3 Immunohistochemistry-based Molecular Subtyping in Muscle-Invasive Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Subtyping; Immunohistochemistry; Tissue microarray; Bladder cancer; Cystectomy; Oncology; Pathology; Internal medicine; Medicine; Cancer; Biology","score_opus":0.02257981178748856,"score_gpt":0.29852312217719856,"score_spread":0.27594331038971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112926203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026376,0.0033244796,0.00004847819,0.0050966498,0.000035606336,0.00044898878,0.000033896846,0.000025817732,0.0007223216],"genre_scores_gemma":[0.9913891,0.0006687652,0.0051661837,0.0024951112,0.000039639406,0.00017671844,0.00002924209,0.000011505352,0.000023734447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991049,0.000046346064,0.00024126653,0.00030859807,0.000104282364,0.00019461647],"domain_scores_gemma":[0.9994084,0.00013047611,0.000116119925,0.000095709416,0.00006671082,0.00018257796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007487676,0.00015908403,0.00032251037,0.00006436408,0.0000706382,0.000005405482,0.000053229513,0.0001492392,0.000046735753],"category_scores_gemma":[0.00015955504,0.00014080941,0.000032642158,0.00021882358,0.000553161,0.00005411557,0.000029065302,0.00024526904,0.0000013238272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044152729,0.00015715673,0.9550863,0.00027118495,0.00009865989,0.000121479774,0.0010807944,0.00038764594,0.04049986,0.00012917625,0.00014482664,0.0015813925],"study_design_scores_gemma":[0.021113027,0.03829309,0.62058604,0.0021791465,0.004015264,0.00042007337,0.002054421,0.046681564,0.20342311,0.001993795,0.057766054,0.0014744255],"about_ca_topic_score_codex":0.000086251144,"about_ca_topic_score_gemma":0.000008987424,"teacher_disagreement_score":0.33450028,"about_ca_system_score_codex":0.00008704103,"about_ca_system_score_gemma":0.000682732,"threshold_uncertainty_score":0.57420415},"labels":[],"label_agreement":null},{"id":"W3113031067","doi":"10.1016/j.urolonc.2020.10.050","title":"Genome-wide CRISPR screen reveals SLFN11 as a potent mediator of cisplatin sensitivity in muscle-invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cisplatin; Cystectomy; CRISPR; Cancer research; Cancer; Context (archaeology); Biology; Bioinformatics; Medicine; Oncology; Internal medicine; Chemotherapy; Gene; Genetics","score_opus":0.036363836388605394,"score_gpt":0.3192518160607323,"score_spread":0.28288797967212687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113031067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691662,0.0016921479,0.00005897089,0.02627363,0.000085451145,0.0006615194,0.00013330713,0.0000392895,0.0018894749],"genre_scores_gemma":[0.9766653,0.0015012558,0.0075905155,0.013670065,0.00019875611,0.000115577226,0.000068776986,0.00002107834,0.00016866092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983698,0.00018416149,0.00043924237,0.00046413322,0.00021112616,0.000331551],"domain_scores_gemma":[0.99864316,0.0004201574,0.0002116468,0.00017192248,0.00010917484,0.00044393537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025925486,0.000240428,0.0006275856,0.00012779325,0.00009725305,0.000008340687,0.000073563606,0.00024991942,0.00024242025],"category_scores_gemma":[0.00053229945,0.00020439783,0.00008356304,0.00036761587,0.00049729034,0.00008756199,0.00006574885,0.00036922615,0.000023971974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003355716,0.00024070457,0.98109037,0.00008771072,0.00017178201,0.0007429564,0.0021886332,0.00012039965,0.011229457,0.00040279268,0.0020772784,0.0013123374],"study_design_scores_gemma":[0.0058212643,0.007987373,0.8180301,0.00024405167,0.0013428828,0.00028126623,0.0014122295,0.000517449,0.010634134,0.0044379933,0.14872582,0.0005653894],"about_ca_topic_score_codex":0.0008552131,"about_ca_topic_score_gemma":0.00049345207,"teacher_disagreement_score":0.16306023,"about_ca_system_score_codex":0.00014550882,"about_ca_system_score_gemma":0.0008633458,"threshold_uncertainty_score":0.83351016},"labels":[],"label_agreement":null},{"id":"W3113154756","doi":"10.1080/2090598x.2020.1858012","title":"Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review","year":2020,"lang":"en","type":"review","venue":"Arab Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Positron emission tomography; Lymph node; Bladder cancer; Radiology; Prospective cohort study; Cochrane Library; Nuclear medicine; Carcinoma; PET-CT; Standardized uptake value; Cancer; Meta-analysis; Pathology; Internal medicine","score_opus":0.015179041708633337,"score_gpt":0.2870924247423539,"score_spread":0.2719133830337206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113154756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044590947,0.9922655,0.00006977218,0.0003917901,0.00024462744,0.0024517605,0.000060235852,0.000014776258,0.00004243307],"genre_scores_gemma":[0.043425743,0.9548466,0.0006055434,0.0006953735,0.00020444675,0.000099971396,0.000031465635,0.00008341084,0.0000074050295],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960991,0.0004340103,0.0021948055,0.0004453358,0.0003748155,0.00045193895],"domain_scores_gemma":[0.9970997,0.0003395324,0.0016820949,0.00034795262,0.00026144023,0.0002692936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000754941,0.0005971446,0.0047242846,0.0009076022,0.00006485174,0.000018145816,0.00029726175,0.0002255671,0.0000153664],"category_scores_gemma":[0.00013220673,0.00041730815,0.0011908078,0.00057429785,0.00011211893,0.00015311224,0.000059862094,0.0006202137,0.0000013189378],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007227436,0.00045816525,0.013489334,0.88900816,0.0012680368,0.0004443595,0.00024664114,0.0000010485445,0.00009849862,0.000005255637,0.00013287237,0.094124876],"study_design_scores_gemma":[0.014938116,0.005431921,0.007304844,0.8658077,0.05395102,0.01767135,0.00007076619,0.00068534823,0.00014940782,0.00004825683,0.032667425,0.0012738302],"about_ca_topic_score_codex":0.00001531098,"about_ca_topic_score_gemma":3.4038752e-7,"teacher_disagreement_score":0.09285104,"about_ca_system_score_codex":0.0001152276,"about_ca_system_score_gemma":0.00059362646,"threshold_uncertainty_score":0.99982786},"labels":[],"label_agreement":null},{"id":"W3115608989","doi":"10.21203/rs.3.rs-19477/v1","title":"Whether pelvic radiotherapy increased the risk of secondary bladder cancer? A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Research Square (Research Square)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Meta-analysis; Bladder cancer; Medicine; Radiation therapy; Oncology; Systematic review; Cancer; Internal medicine; Urology; MEDLINE; Biology","score_opus":0.1818171560581352,"score_gpt":0.4824359941804591,"score_spread":0.30061883812232393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115608989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000048893667,0.9701652,0.0000231116,0.0031534878,0.000029560397,0.02304538,0.0026929223,0.00007096441,0.0008145093],"genre_scores_gemma":[0.00020829312,0.9841769,0.00007911398,0.00037619917,0.00025482022,0.011886516,0.00023879658,0.00028116396,0.0024982323],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96659803,0.021591617,0.0023351375,0.0018582691,0.0058224355,0.0017945139],"domain_scores_gemma":[0.98427033,0.0076139425,0.00087674434,0.0034244442,0.0026269173,0.0011876237],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016812641,0.001232175,0.015425594,0.002216124,0.00076625065,0.00024895568,0.0015713203,0.0005998956,0.009198577],"category_scores_gemma":[0.0029822986,0.0006314131,0.006090954,0.009171531,0.0014058042,0.00017492732,0.0006001718,0.005538983,0.00017998143],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011111197,0.00027781693,0.000024029167,0.67482793,0.30365855,0.00013240044,0.00042570097,3.6710185e-7,9.182918e-7,0.000039197508,0.0050168787,0.015485081],"study_design_scores_gemma":[0.0010613876,0.0011703393,0.00003472574,0.060453165,0.6927301,0.00007176595,0.00030432467,0.000029766821,0.0000040579544,0.00006524884,0.24358523,0.0004898737],"about_ca_topic_score_codex":0.0077518695,"about_ca_topic_score_gemma":0.0005212466,"teacher_disagreement_score":0.6143748,"about_ca_system_score_codex":0.0010667642,"about_ca_system_score_gemma":0.00553826,"threshold_uncertainty_score":0.9996137},"labels":[],"label_agreement":null},{"id":"W3116484428","doi":"10.1177/1756287220980192","title":"Enfortumab Vedotin in urothelial cancer","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Oncology; Internal medicine; Clinical trial; Durvalumab; Cancer; Urothelial cancer; Rash; Population; Bladder cancer; Nivolumab; Immunotherapy","score_opus":0.050860074363769485,"score_gpt":0.4063818328462285,"score_spread":0.355521758482459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116484428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000071008335,0.9931781,0.000050680213,0.0003819059,0.0006956205,0.0015237053,0.000061394356,0.000059496157,0.004041944],"genre_scores_gemma":[0.00070115115,0.9956614,0.00007062419,0.0018267606,0.00046962878,0.0008822269,0.00004418088,0.00011207521,0.00023196336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974456,0.00023895757,0.0008051656,0.00071003515,0.00021160825,0.0005886423],"domain_scores_gemma":[0.99903804,0.00019026519,0.0002398635,0.0003871286,0.000021429923,0.00012330084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012311402,0.0005745245,0.002590435,0.00032302178,0.000025221967,0.0000071707436,0.00028339666,0.00043149374,0.00059163035],"category_scores_gemma":[0.000024945271,0.00045115675,0.00029566808,0.00055514753,0.0001690045,0.00008718099,0.000065848515,0.0009566106,0.00013239491],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035073695,0.00014038399,0.00032073513,0.002461165,0.00015120197,0.00034842727,0.00014459783,0.0000070387337,4.3115313e-7,0.0002582523,0.000009284248,0.99580777],"study_design_scores_gemma":[0.0021994188,0.00057135144,0.000055479293,0.0015143914,0.0007654374,0.00013659484,0.00001095315,0.000015161273,0.0000013804303,0.00074344955,0.993676,0.00031035749],"about_ca_topic_score_codex":0.00010799591,"about_ca_topic_score_gemma":0.0003064465,"teacher_disagreement_score":0.9954974,"about_ca_system_score_codex":0.0003989652,"about_ca_system_score_gemma":0.0010580906,"threshold_uncertainty_score":0.999794},"labels":[],"label_agreement":null},{"id":"W3117168428","doi":"10.3747/co.27.6437","title":"Expression of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Metastatic Urothelial Carcinoma; Medicine; Meta-analysis; Urothelial carcinoma; Immune checkpoint; Immune system; Oncology; Cancer research; Bioinformatics; Internal medicine; Immunotherapy; Immunology; Cancer; Bladder cancer; Biology","score_opus":0.20600945351940436,"score_gpt":0.45463853121993864,"score_spread":0.24862907770053427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117168428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045464458,0.98546565,0.0001187037,0.00043825083,0.00017763399,0.013147745,0.00056694367,0.000020805706,0.000018821],"genre_scores_gemma":[0.0009344227,0.9904196,0.0005592069,0.00010231256,0.00007301423,0.007626405,0.00013383092,0.000066081426,0.000085124346],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.994334,0.0016211359,0.002678971,0.0007236216,0.00031232036,0.00032995097],"domain_scores_gemma":[0.996681,0.001052684,0.0012736056,0.00057416037,0.00016147902,0.0002571008],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001803376,0.0005901651,0.014154825,0.00066058454,0.00004029824,0.000009454939,0.00020069536,0.00017628068,0.00007662858],"category_scores_gemma":[0.0018003195,0.0003744663,0.0028930819,0.0010274788,0.000059686892,0.000038083097,0.00016513422,0.00039094387,0.000008499936],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051761663,0.0003685748,0.000012367079,0.96398455,0.027463395,0.000040001236,0.00044436968,2.5459087e-7,0.000018876766,0.0000017060123,0.00008161988,0.0070666443],"study_design_scores_gemma":[0.0013465364,0.0013159311,0.000008215882,0.058110964,0.85693884,0.000060207833,0.000057335794,0.0000058157234,0.000034974815,0.000004222355,0.08188403,0.0002329365],"about_ca_topic_score_codex":0.000031736876,"about_ca_topic_score_gemma":0.0000111354,"teacher_disagreement_score":0.9058736,"about_ca_system_score_codex":0.00045572803,"about_ca_system_score_gemma":0.0009573574,"threshold_uncertainty_score":0.9998707},"labels":[],"label_agreement":null},{"id":"W3118434887","doi":"10.1038/s41585-020-00404-6","title":"Defining cisplatin eligibility in patients with muscle-invasive bladder cancer","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Calgary; Université de Montréal; University of Alberta; University Health Network; University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cisplatin; Bladder cancer; Chemotherapy; Oncology; Renal function; Internal medicine; Cystectomy; Clinical trial; Nephrotoxicity; Intensive care medicine; Cancer; Kidney","score_opus":0.02459593155810481,"score_gpt":0.37327333146491737,"score_spread":0.34867739990681257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118434887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079389225,0.9942018,0.0000021381693,0.00011705855,0.0004948759,0.003533218,0.00017678447,0.000033550168,0.001361196],"genre_scores_gemma":[0.00013486347,0.99519444,0.00031523025,0.0019541483,0.0002263067,0.0009845259,0.00094586407,0.000114459355,0.00013013989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958341,0.0007163595,0.0011823457,0.001270511,0.00037700913,0.00061967195],"domain_scores_gemma":[0.9975808,0.0003416882,0.00065804797,0.0009932688,0.0002264913,0.0001996564],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0003793747,0.0008654826,0.005279735,0.0002781561,0.00005585689,0.000016451278,0.00023398495,0.0016351329,0.00070889096],"category_scores_gemma":[0.0005426506,0.00054371904,0.0007123994,0.0009128333,0.00009925518,0.000059144502,0.000107615,0.002770872,0.00011260656],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006363189,0.00031082472,0.00892802,0.011544059,0.00047384785,0.00013246742,0.000037229052,2.30013e-7,2.1870616e-8,0.00005259937,0.0015884314,0.9768686],"study_design_scores_gemma":[0.0018253392,0.0004790825,0.004322235,0.015568147,0.0047156746,0.000049849637,0.0000017928803,1.3635221e-7,2.3682992e-7,0.000008991008,0.9726219,0.00040657606],"about_ca_topic_score_codex":0.00006359747,"about_ca_topic_score_gemma":0.0004014795,"teacher_disagreement_score":0.97646207,"about_ca_system_score_codex":0.00044253704,"about_ca_system_score_gemma":0.0016349923,"threshold_uncertainty_score":0.99970144},"labels":[],"label_agreement":null},{"id":"W3118713882","doi":"10.5489/cuaj.7066","title":"Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guérin","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Canadian Institutes of Health Research","keywords":"Innate immune system; Immune system; Immunology; Medicine; Tumor necrosis factor alpha; Monocyte; Bladder cancer; Lipopolysaccharide; Cancer; Internal medicine","score_opus":0.011535700028554004,"score_gpt":0.22198479002691127,"score_spread":0.21044908999835726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118713882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637843,0.0005537583,0.0000027984925,0.009951023,0.00015057549,0.0003564004,0.0006900379,0.000034517205,0.0018824454],"genre_scores_gemma":[0.9923062,0.00010692707,0.000023612256,0.005636447,0.00015267421,0.000051538005,0.0002902334,0.000041990745,0.00139042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707663,0.0004148368,0.00046499164,0.00041563725,0.0008347895,0.00079310144],"domain_scores_gemma":[0.9971896,0.00014624695,0.0003254813,0.00025332137,0.0008976083,0.0011877716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035596197,0.00032222725,0.00061758375,0.00022911197,0.00024359823,0.00009297124,0.00016116585,0.000262863,0.001921549],"category_scores_gemma":[0.00084965874,0.00023098044,0.00013567637,0.0007993666,0.000061769206,0.00014671692,0.000027320664,0.0007481597,0.000016377082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006412045,0.00038991004,0.9934169,0.0000056085814,0.0008360459,0.0018058337,0.00012482636,0.00003244396,0.000027166878,0.0000046780056,0.0019722437,0.00074310944],"study_design_scores_gemma":[0.013044689,0.0006573046,0.9836951,0.00009912444,0.0004788172,0.000035860663,0.000060081777,0.000053352196,0.00011037374,0.000057630754,0.0014263428,0.00028135985],"about_ca_topic_score_codex":0.016179096,"about_ca_topic_score_gemma":0.0345767,"teacher_disagreement_score":0.018397603,"about_ca_system_score_codex":0.0032411134,"about_ca_system_score_gemma":0.0026519068,"threshold_uncertainty_score":0.99899083},"labels":[],"label_agreement":null},{"id":"W3118778664","doi":"10.5489/cuaj.6893","title":"Longitudinal experience with Studer neobladders: Outcomes and complications","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; General surgery","score_opus":0.028448621408272704,"score_gpt":0.2861012016739383,"score_spread":0.2576525802656656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118778664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9297902,0.000549662,0.00033823372,0.061913904,0.00015154578,0.00016572443,0.000025668332,0.000024554283,0.0070404992],"genre_scores_gemma":[0.9911931,0.000058885,0.0005196776,0.0072563374,0.000118253825,0.000014275505,0.00001031584,0.0000071799986,0.0008219444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991066,0.000051973515,0.00015953797,0.0001753631,0.00023701588,0.0002694983],"domain_scores_gemma":[0.9989458,0.00006689688,0.00008071001,0.0000959866,0.00026939387,0.0005412361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008910784,0.00009998571,0.000196121,0.000053821666,0.00027787636,0.00009135204,0.00004426741,0.00008072227,0.0005349089],"category_scores_gemma":[0.00015756978,0.00006963125,0.00004891032,0.00013679748,0.000041261803,0.000078460165,0.0000100108755,0.00024732217,0.000016819122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014501452,0.000048538102,0.9965291,0.0000012414121,0.00015676348,0.00018556991,0.00023158584,0.000002323177,0.000016353682,0.0001328085,0.0015775122,0.0011037003],"study_design_scores_gemma":[0.0011152322,0.0001795684,0.9834332,0.000008565732,0.00009009489,0.00080911565,0.00033700484,0.000007743664,0.000018340754,0.00014616542,0.013777786,0.000077176905],"about_ca_topic_score_codex":0.00053759076,"about_ca_topic_score_gemma":0.0016620271,"teacher_disagreement_score":0.06140292,"about_ca_system_score_codex":0.0003501706,"about_ca_system_score_gemma":0.0005050522,"threshold_uncertainty_score":0.58568776},"labels":[],"label_agreement":null},{"id":"W3118964652","doi":"10.1016/j.ijrobp.2020.12.033","title":"Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Roche","keywords":"Atezolizumab; Medicine; Tolerability; Bladder cancer; Toxicity; Adverse effect; Gemcitabine; Oncology; Internal medicine; Radiation therapy; Urology; Cancer; Gastroenterology; Immunotherapy; Pembrolizumab","score_opus":0.02566606145131956,"score_gpt":0.352959636906911,"score_spread":0.32729357545559146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118964652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948856,0.0006093511,0.00088801025,0.0010928084,0.0015733518,0.00047632158,0.0001497813,0.00001083571,0.0003139419],"genre_scores_gemma":[0.9956932,0.0015127778,0.00060312403,0.00076730776,0.0011667348,0.00003254983,0.0001573988,0.00002777677,0.000039097402],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99821025,0.00021705219,0.00075655157,0.00022717936,0.00039247362,0.0001964715],"domain_scores_gemma":[0.99737036,0.0002179981,0.0008809927,0.00014399036,0.0012816486,0.00010503539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001744784,0.0001979182,0.0006816505,0.00015598456,0.000029015924,0.000011475988,0.00018105017,0.00018518732,0.00021825233],"category_scores_gemma":[0.00014357638,0.00015135042,0.00021245505,0.00022613737,0.00014067435,0.00017579437,0.000026183896,0.00031619467,0.000003965583],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18292825,0.011228659,0.32492572,0.000017844925,0.003445726,0.00020976462,0.0013378185,0.0006383419,0.0022495412,0.00069010665,0.0005000933,0.47182813],"study_design_scores_gemma":[0.8890539,0.022098029,0.06178369,0.00019150204,0.00038509758,0.0000474386,0.00014571121,0.00026703352,0.014992083,0.0017376001,0.009021196,0.00027675828],"about_ca_topic_score_codex":0.00009671483,"about_ca_topic_score_gemma":0.00003127219,"teacher_disagreement_score":0.7061256,"about_ca_system_score_codex":0.0009138178,"about_ca_system_score_gemma":0.002962934,"threshold_uncertainty_score":0.61718917},"labels":[],"label_agreement":null},{"id":"W3119352309","doi":"10.3233/blc-200404","title":"Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Meta-analysis; Prostate; Cochrane Library; Urology; Prostate cancer; Oncology; Systematic review; Carcinoma; Internal medicine; MEDLINE; Cancer","score_opus":0.12519937408883575,"score_gpt":0.39779407978007686,"score_spread":0.2725947056912411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119352309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011891247,0.98733455,0.0000064582055,0.00017893725,0.000040428204,0.009792839,0.0024829379,0.000006714078,0.00003820015],"genre_scores_gemma":[0.00057698356,0.9945868,0.00010345641,0.0002637358,0.000075532844,0.0034568787,0.00011678144,0.00006728752,0.00075252895],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966439,0.00047889593,0.0017006691,0.0005461309,0.00039020373,0.00024021712],"domain_scores_gemma":[0.99664235,0.00025621694,0.001551097,0.0010509923,0.0003912022,0.0001081248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031435848,0.0005563462,0.012355136,0.00016649997,0.000043520326,0.000011635717,0.00017829525,0.00015619793,0.00029493787],"category_scores_gemma":[0.000061547966,0.00026825245,0.0040713097,0.0007237741,0.00015049918,0.00003673894,0.000032546897,0.000082987666,2.481053e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050288116,0.00030828896,0.000051009334,0.68947285,0.28303793,0.0000041564335,0.00039524582,4.1668184e-7,0.0000054357133,0.00006589174,0.000024603545,0.026583843],"study_design_scores_gemma":[0.0011204904,0.0006669979,0.000038217895,0.045504518,0.94421387,0.000020985244,0.000041203068,0.000004689131,0.00015936192,0.0000038188564,0.008026221,0.000199616],"about_ca_topic_score_codex":0.00041993405,"about_ca_topic_score_gemma":0.000033332162,"teacher_disagreement_score":0.66117597,"about_ca_system_score_codex":0.00013992307,"about_ca_system_score_gemma":0.0009192044,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W3120001159","doi":"10.1016/j.euo.2020.12.002","title":"Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study","year":2021,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Internal medicine; Urology; Concomitant; Stage (stratigraphy); Oncology; Concordance; Cancer; Univariate analysis; Clinical endpoint; Multivariate analysis; Clinical trial","score_opus":0.05179884433526188,"score_gpt":0.32581378281523016,"score_spread":0.2740149384799683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120001159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782098,0.0043367757,0.00019430311,0.008465821,0.0017000027,0.004242368,0.00029747383,0.000047789108,0.0025056985],"genre_scores_gemma":[0.99125934,0.0026656066,0.00017449187,0.003573445,0.0006575031,0.00053636415,0.000089160385,0.00013214022,0.00091196457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936076,0.0028476112,0.0015029791,0.0009987258,0.00036989828,0.0006732249],"domain_scores_gemma":[0.9954612,0.0012347129,0.0012928984,0.0006687204,0.0011834098,0.00015905486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00133601,0.00047035105,0.0012081271,0.00023928814,0.00014988631,0.000018171253,0.0003584456,0.0002873543,0.00004531097],"category_scores_gemma":[0.0014135544,0.00037158592,0.00022048835,0.00040069636,0.0004099954,0.000102436556,0.00029060268,0.00051414856,0.000014248972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014824998,0.0043782922,0.893594,0.00071015384,0.0027600299,0.0005060805,0.008964149,0.0011247871,0.06545783,0.00005737571,0.007999739,0.01296501],"study_design_scores_gemma":[0.013674346,0.003312716,0.9700308,0.00020099508,0.0023580545,0.0000618876,0.0014885865,0.0006521419,0.00044375786,0.000019707011,0.0074640913,0.00029292834],"about_ca_topic_score_codex":0.0006012972,"about_ca_topic_score_gemma":0.0015958502,"teacher_disagreement_score":0.076436736,"about_ca_system_score_codex":0.0005363574,"about_ca_system_score_gemma":0.001633073,"threshold_uncertainty_score":0.99987364},"labels":[],"label_agreement":null},{"id":"W3120256215","doi":"10.1038/s41467-020-20493-6","title":"Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer","year":2021,"lang":"en","type":"article","venue":"Nature Communications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Decipher Biosciences (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"Jane ja Aatos Erkon Säätiö; Canadian Institutes of Health Research; Bladder Cancer Canada","keywords":"Concordance; Circulating tumor DNA; Medicine; Oncology; Cancer research; Liquid biopsy; Cancer; Internal medicine; Pathology","score_opus":0.06349727450530956,"score_gpt":0.40109008311210714,"score_spread":0.3375928086067976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120256215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87573993,0.090665095,0.000048332895,0.023290612,0.00031067134,0.0010198947,0.00072620355,0.00007321431,0.00812602],"genre_scores_gemma":[0.9811489,0.008291611,0.008219316,0.0010994299,0.00004248034,0.000084648935,0.00017664621,0.000021614702,0.0009153504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889284,0.0001616005,0.00041854093,0.00024442736,0.0001513901,0.00013118003],"domain_scores_gemma":[0.99784386,0.0002804884,0.00017119848,0.001264076,0.0003375241,0.00010287743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017269583,0.00013012443,0.0003399491,0.000056856938,0.00012162426,0.000020111864,0.0002120503,0.000114158254,0.00031084326],"category_scores_gemma":[0.00013730086,0.0001154391,0.0000768197,0.0002504997,0.0001939581,0.00006752115,0.0001129321,0.0004688581,0.000012554243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009470491,0.008743829,0.31203702,0.0014240873,0.009552898,0.00013318741,0.009435445,0.000017043409,0.28478622,0.037232213,0.052095618,0.28359538],"study_design_scores_gemma":[0.009522972,0.000634049,0.52871275,0.00058301946,0.004333655,0.00025320196,0.0020644343,0.00097017083,0.18736218,0.0025777433,0.262299,0.00068680575],"about_ca_topic_score_codex":0.00018497433,"about_ca_topic_score_gemma":0.0011285875,"teacher_disagreement_score":0.2829086,"about_ca_system_score_codex":0.000044059307,"about_ca_system_score_gemma":0.0004892795,"threshold_uncertainty_score":0.47074696},"labels":[],"label_agreement":null},{"id":"W3120326425","doi":"10.1016/j.clgc.2020.12.001","title":"Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Cumulative incidence; Cancer; Incidence (geometry); Adenocarcinoma; Epidemiology; Proportional hazards model; Disease; Cancer registry; Oncology; Gynecology; Cohort","score_opus":0.061875441818343604,"score_gpt":0.3911019798275126,"score_spread":0.329226538009169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120326425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834358,0.009888405,0.0000014134711,0.001690901,0.0019832547,0.0003349265,0.00013524998,0.00004406204,0.0024859486],"genre_scores_gemma":[0.9804559,0.008023994,0.00007701641,0.0010816453,0.00042337022,0.00012923758,0.00004769578,0.000034341287,0.009726839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768174,0.00027921324,0.00070790533,0.000656563,0.00028006439,0.00039454564],"domain_scores_gemma":[0.9989244,0.00022389487,0.00013613011,0.00027846155,0.00014967531,0.00028746773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001876345,0.00025918515,0.0007841017,0.00007025461,0.00008609182,0.000014926755,0.00010222085,0.00030061151,0.0011745832],"category_scores_gemma":[0.00012373723,0.00021937615,0.00014474384,0.00024191978,0.00028502595,0.000076057426,0.00017858623,0.0005873522,0.000012748347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004898013,0.0010038553,0.9710552,0.00007173714,0.000242281,0.00040238825,0.0002636323,0.000003300814,0.00006950552,0.000011830836,0.0008256047,0.02556085],"study_design_scores_gemma":[0.0072974297,0.0006836091,0.98500943,0.00014265171,0.00018770232,0.0000094817415,0.00013814769,0.000042891203,0.00020085268,0.0001438964,0.005908089,0.00023581229],"about_ca_topic_score_codex":0.00096222723,"about_ca_topic_score_gemma":0.0009584621,"teacher_disagreement_score":0.025325038,"about_ca_system_score_codex":0.00022454464,"about_ca_system_score_gemma":0.00067099946,"threshold_uncertainty_score":0.99973845},"labels":[],"label_agreement":null},{"id":"W3120445389","doi":"10.1016/j.eururo.2020.12.033","title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Grading (engineering); Proportional hazards model; Risk factor; Cystectomy; Concomitant; Internal medicine; Oncology; Carcinoma in situ; Clinical endpoint; Urology; Cancer; Randomized controlled trial","score_opus":0.06401271365823098,"score_gpt":0.3034778241472664,"score_spread":0.2394651104890354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120445389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94645256,0.0101078395,0.011761485,0.021017902,0.0018189236,0.0043379846,0.003449979,0.00014034637,0.0009130024],"genre_scores_gemma":[0.9912383,0.0017206314,0.00040586555,0.0033138336,0.001901529,0.00022824331,0.00059117994,0.00012975956,0.00047063982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960289,0.001774676,0.000826798,0.0007029789,0.00023847239,0.00042817442],"domain_scores_gemma":[0.9957908,0.0016085152,0.0010101561,0.00060651073,0.00085890765,0.00012510654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090114,0.0003353915,0.0005564073,0.000058935417,0.00036620945,0.00007058985,0.00028201437,0.00013355375,0.0000256367],"category_scores_gemma":[0.001969505,0.00021462647,0.0001486049,0.0001686227,0.00017393658,0.000120767676,0.00010646818,0.00030556644,0.000016633463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022946012,0.0010416671,0.77145404,0.00051872944,0.0052464097,0.00016396002,0.011161741,0.00095722795,0.031703804,0.001651075,0.08892422,0.08488251],"study_design_scores_gemma":[0.006265527,0.0021377087,0.9295159,0.00013327488,0.0025468862,0.000038860377,0.0009518487,0.008791386,0.00034342328,0.0005955556,0.04827842,0.0004012235],"about_ca_topic_score_codex":0.0005364874,"about_ca_topic_score_gemma":0.00063176,"teacher_disagreement_score":0.15806183,"about_ca_system_score_codex":0.00008137871,"about_ca_system_score_gemma":0.0002668107,"threshold_uncertainty_score":0.8752214},"labels":[],"label_agreement":null},{"id":"W3120472630","doi":"10.1007/s00292-020-00888-4","title":"Molekularpathologie bei urologischen Tumoren","year":2021,"lang":"de","type":"review","venue":"Der Pathologe","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Calgary Laboratory Services; University of Calgary","funders":"Rheinische Friedrich-Wilhelms-Universität Bonn","keywords":"Gynecology; Medicine","score_opus":0.07320923619342376,"score_gpt":0.3593803422975712,"score_spread":0.2861711061041474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120472630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032985225,0.98377466,0.00020050997,0.00052715786,0.0030221227,0.002230904,0.0010678584,0.00029282115,0.008554106],"genre_scores_gemma":[0.0010294731,0.98480034,0.0014325839,0.0027370173,0.0022168043,0.0008018494,0.003804724,0.00030440057,0.0028728356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99219185,0.0013285455,0.0016376466,0.0023470619,0.0008129314,0.0016819789],"domain_scores_gemma":[0.9955794,0.0003150467,0.00070932513,0.0024561866,0.0003173795,0.0006226446],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0008588695,0.0017305601,0.005259747,0.0003689232,0.00028052318,0.00012453551,0.00082944415,0.0018268279,0.0020712505],"category_scores_gemma":[0.00071176025,0.0013727022,0.001886283,0.00077345734,0.0005423282,0.000104838,0.0007219595,0.002056415,0.00801384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000964866,0.0014812476,0.005750261,0.0072585996,0.0045886193,0.080299504,0.00051364093,0.0000017298063,0.00004910049,0.0002853106,0.011530446,0.888145],"study_design_scores_gemma":[0.0022398632,0.0011500126,0.0014680162,0.0058679124,0.022199403,0.0016021974,0.000069682785,0.000003542767,0.00013814488,0.00014871391,0.963861,0.0012514964],"about_ca_topic_score_codex":0.000042781383,"about_ca_topic_score_gemma":0.00000589544,"teacher_disagreement_score":0.9523306,"about_ca_system_score_codex":0.00042539413,"about_ca_system_score_gemma":0.0017879732,"threshold_uncertainty_score":0.999544},"labels":[],"label_agreement":null},{"id":"W3120485083","doi":"10.1016/j.soncn.2020.151107","title":"The Potential of Prehabilitation in Radical Cystectomy Pathways: Where Are We Now?","year":2021,"lang":"en","type":"review","venue":"Seminars in Oncology Nursing","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novo Nordisk Fonden","keywords":"Prehabilitation; Medicine; Cystectomy; Rehabilitation; CINAHL; MEDLINE; Physical therapy; Intensive care medicine; Nursing; Bladder cancer; Cancer; Internal medicine; Psychological intervention","score_opus":0.038614018890371526,"score_gpt":0.3824625529821697,"score_spread":0.34384853409179816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120485083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037120792,0.9941572,0.000010229623,0.0017752327,0.0009552698,0.0012916365,0.000022548187,0.000015075359,0.0014015924],"genre_scores_gemma":[0.0003793082,0.9982649,0.00063706416,0.000020046355,0.00018971923,0.00020653188,0.000046245397,0.000044447595,0.0002117439],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973503,0.0007213937,0.0008718207,0.00043867616,0.00026053464,0.00035727027],"domain_scores_gemma":[0.9983233,0.0007591666,0.0003894858,0.00038207733,0.000070774986,0.000075187425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048414545,0.00030121542,0.0018864842,0.00023614112,0.00006207062,0.000009480102,0.00016591662,0.0006745414,0.000038181894],"category_scores_gemma":[0.000119281394,0.00021643811,0.00035458768,0.0005007123,0.00041115537,0.000036199435,0.000036220754,0.0007707328,0.0000054398483],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012501932,0.0006376179,0.0002386946,0.0045137736,0.00009084842,0.00046472024,0.00091863226,0.0000016868496,0.0000058653072,0.000028162929,0.0020382127,0.99093676],"study_design_scores_gemma":[0.0019100253,0.0008627632,0.0001999202,0.16736372,0.00084618974,0.0004978792,0.0023002294,0.0000123750415,0.000006781415,0.00022981252,0.8255945,0.00017584227],"about_ca_topic_score_codex":0.00002014122,"about_ca_topic_score_gemma":0.00014535945,"teacher_disagreement_score":0.9907609,"about_ca_system_score_codex":0.002275078,"about_ca_system_score_gemma":0.0017493006,"threshold_uncertainty_score":0.882609},"labels":[],"label_agreement":null},{"id":"W3123717096","doi":"10.1101/2021.01.23.427909","title":"Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Queen's University","keywords":"CD163; Immune system; FOXP3; Immune checkpoint; Cytotoxic T cell; Tumor microenvironment; Bladder cancer; Tissue microarray; Transcriptome; Biology; CD8; Cancer research; Immunotherapy; Immunohistochemistry; Cancer; Immunology; Medicine; Internal medicine; Gene expression; Macrophage; Gene; In vitro","score_opus":0.010849369432923878,"score_gpt":0.2374211786753235,"score_spread":0.2265718092423996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123717096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98469675,0.012740986,0.000017912882,0.00016852487,0.000506317,0.0011738368,0.0006263664,0.000050596518,0.000018699075],"genre_scores_gemma":[0.99519974,0.0026741512,0.001419926,0.0001238906,0.00013640911,0.0002898706,0.0000017262489,0.0001319983,0.000022274433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692005,0.000098817625,0.0010326818,0.00095958455,0.00048534968,0.00050349167],"domain_scores_gemma":[0.9973722,0.00008329347,0.000641982,0.0011674394,0.0004775322,0.00025757137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029350436,0.0006410575,0.0017006552,0.00034382913,0.000048448557,0.00004184047,0.0002807444,0.0004994269,0.00017949438],"category_scores_gemma":[0.000099772085,0.00062349637,0.00023232006,0.0004606157,0.00022926861,0.000103783714,0.0005452989,0.0006789451,0.0000052632367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013072079,0.00056630577,0.11573221,0.0012699211,0.00082048075,0.0001691188,0.0001966478,0.000021021197,0.88104635,0.0000060537377,0.000019174055,0.000022004842],"study_design_scores_gemma":[0.001726423,0.0001328045,0.4744835,0.0006656108,0.0003451573,4.034234e-8,0.00005721179,0.0000276289,0.5222372,7.130121e-7,0.000052716045,0.00027102837],"about_ca_topic_score_codex":0.0054402747,"about_ca_topic_score_gemma":0.00012760828,"teacher_disagreement_score":0.35880914,"about_ca_system_score_codex":0.00031640392,"about_ca_system_score_gemma":0.001676569,"threshold_uncertainty_score":0.9996216},"labels":[],"label_agreement":null},{"id":"W3125929990","doi":"10.48083/tlfb8641","title":"Bladder Cancer Tissue-Based Biomarkers","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Immunotherapy; Medicine; Disease; Biomarker; Oncology; Pathological; Cancer; Subtyping; Bioinformatics; Internal medicine; Biology","score_opus":0.0479493138581437,"score_gpt":0.3713096793687707,"score_spread":0.32336036551062697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125929990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8213979,0.013538459,0.0035364253,0.07641396,0.0062924093,0.00050699763,0.00020654753,0.00021542939,0.077891864],"genre_scores_gemma":[0.97605324,0.00089536316,0.0017132882,0.009437813,0.0011694299,0.000027247657,0.00008056837,0.000028821469,0.01059425],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998567,0.00007467465,0.00030854065,0.0002527126,0.0005115581,0.00028552522],"domain_scores_gemma":[0.9988587,0.00011436078,0.00014723297,0.00017316549,0.00052412925,0.00018241363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015699527,0.00017279245,0.00025122473,0.00010826185,0.0001406063,0.00006981076,0.00014247726,0.00012065138,0.011115195],"category_scores_gemma":[0.00017387286,0.0001443402,0.00023360852,0.00015284939,0.00008241053,0.00010396969,0.00004015186,0.00037408536,0.000055290766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028629277,0.0022417367,0.53169876,0.000114760434,0.009142103,0.0065394277,0.00055500615,0.0007022984,0.03968455,0.0005502417,0.19064903,0.21525916],"study_design_scores_gemma":[0.022555854,0.00166235,0.33530474,0.00031315623,0.0014451181,0.003861556,0.00090746145,0.0010957379,0.10157771,0.0047677523,0.5256711,0.0008374448],"about_ca_topic_score_codex":0.000039326085,"about_ca_topic_score_gemma":0.000021799793,"teacher_disagreement_score":0.3350221,"about_ca_system_score_codex":0.00034236995,"about_ca_system_score_gemma":0.0010911516,"threshold_uncertainty_score":0.9897888},"labels":[],"label_agreement":null},{"id":"W3126428342","doi":"10.1016/j.clgc.2021.01.007","title":"The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University Health Centre; Ministère de la Santé et des Services sociaux; McGill University","keywords":"Medicine; Bladder cancer; Cystectomy; Hazard ratio; Proportional hazards model; Propensity score matching; Internal medicine; Retrospective cohort study; Confidence interval; Surgery; Cancer; Oncology; Urology","score_opus":0.05813035974551425,"score_gpt":0.36739308850707963,"score_spread":0.3092627287615654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126428342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853886,0.0025436555,0.0000024100063,0.0070644026,0.003259254,0.0012020954,0.00050028536,0.000013488474,0.000025848884],"genre_scores_gemma":[0.98692125,0.0045548356,0.00036783467,0.002201101,0.0010094641,0.00038779282,0.00003562681,0.00006163406,0.004460453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957803,0.0003495779,0.0020382812,0.00080424343,0.000436477,0.0005911111],"domain_scores_gemma":[0.99607253,0.0024467343,0.0003672784,0.00050849526,0.0002170356,0.00038792746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048582978,0.00033817661,0.0009880877,0.000073353454,0.00011664542,0.00003617615,0.00015843262,0.00029949858,0.00009263154],"category_scores_gemma":[0.0012017043,0.00022902891,0.00030171007,0.0002584636,0.00045536456,0.00014209817,0.00016534173,0.0006772144,8.2584916e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028294886,0.0007847787,0.9442349,0.00018255805,0.0003606386,0.00030389894,0.000079443795,0.000015521018,0.00016654286,0.0000031272639,0.007277607,0.04376147],"study_design_scores_gemma":[0.030771567,0.0012430251,0.9018296,0.00071583234,0.000631642,0.000016195418,0.00053874735,0.0002823927,0.0040457207,0.00004093789,0.05926473,0.0006195829],"about_ca_topic_score_codex":0.31074193,"about_ca_topic_score_gemma":0.8746017,"teacher_disagreement_score":0.56385976,"about_ca_system_score_codex":0.0005916292,"about_ca_system_score_gemma":0.004474598,"threshold_uncertainty_score":0.9339528},"labels":[],"label_agreement":null},{"id":"W3126763304","doi":"10.1016/j.euf.2020.07.002","title":"Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium","year":2020,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Hazard ratio; Nomogram; Oncology; Internal medicine; Proportional hazards model; Stage (stratigraphy); Cancer; Urology; Confidence interval; Chemotherapy; Neoadjuvant therapy; Breast cancer","score_opus":0.028817735152587308,"score_gpt":0.29993230887443983,"score_spread":0.27111457372185255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126763304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843649,0.0026171666,0.0003245957,0.007145228,0.0004979896,0.0010222764,0.0011467774,0.000121664976,0.0027593984],"genre_scores_gemma":[0.9937205,0.001074063,0.00042596148,0.0030930534,0.0012984612,0.00014566086,0.00008037946,0.00008261781,0.000079346864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997841,0.00019345996,0.0005910754,0.00074817083,0.00025755508,0.00036872365],"domain_scores_gemma":[0.99878955,0.000116771334,0.00025257716,0.00033066445,0.0001744783,0.00033593163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023957607,0.00029631602,0.00049391476,0.00007595023,0.00007662032,0.00002305531,0.00019897278,0.00011022039,0.00029663587],"category_scores_gemma":[0.00010165189,0.0002579957,0.00014454029,0.000120156226,0.00039501445,0.000113547416,0.00007456781,0.00027229782,0.0000067045708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04550605,0.001858123,0.5197778,0.0004101287,0.0074065477,0.0020929547,0.015322581,0.00018244472,0.028672328,0.00016771484,0.0065223747,0.37208098],"study_design_scores_gemma":[0.034504697,0.0051173787,0.869468,0.000102249476,0.0009861139,0.00011434956,0.0002492961,0.00088828756,0.009592243,0.0000730109,0.07837668,0.0005277305],"about_ca_topic_score_codex":0.0003023367,"about_ca_topic_score_gemma":0.00014214062,"teacher_disagreement_score":0.37155324,"about_ca_system_score_codex":0.000053765183,"about_ca_system_score_gemma":0.0001641139,"threshold_uncertainty_score":0.99998724},"labels":[],"label_agreement":null},{"id":"W3126783535","doi":"10.6004/jnccn.2020.7637","title":"Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Lung; Metastasis; Internal medicine; Upper urinary tract; Urology; Urinary system; Lymph node; Oncology; Cancer","score_opus":0.026734438216476173,"score_gpt":0.27663128568627277,"score_spread":0.2498968474697966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126783535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434185,0.0039919848,0.0000041061785,0.0010611757,0.00017548745,0.00022264919,0.00011414015,0.0000011815805,0.00008744352],"genre_scores_gemma":[0.9991025,0.00016055928,0.00003632758,0.0004743208,0.00015752233,0.000007701091,0.000020388816,0.000006626317,0.000034050954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865925,0.0002274821,0.00034067334,0.000104686595,0.00054737565,0.000120513054],"domain_scores_gemma":[0.9989093,0.00021626,0.00024125587,0.000071220165,0.0005290462,0.000032926775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115995856,0.0001103498,0.00032097552,0.000044510558,0.000051830946,0.0000114070135,0.00009169288,0.000040036863,0.000028977527],"category_scores_gemma":[0.000041336694,0.00005634015,0.00008398367,0.0003405218,0.00009832941,0.000068249916,0.000025480265,0.00026878557,1.379926e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084983377,0.0005205002,0.99595016,0.000024970343,0.0001708058,0.000054968907,0.00036922353,0.0010519226,0.000031788204,0.00008923724,0.00046762204,0.00041898468],"study_design_scores_gemma":[0.0039814776,0.00048629154,0.99371314,0.00029451755,0.00014401713,0.00012279046,0.00014407004,0.00004408065,0.00009061554,0.0005496652,0.00037463327,0.00005471311],"about_ca_topic_score_codex":0.00003653542,"about_ca_topic_score_gemma":0.000013717727,"teacher_disagreement_score":0.0047606714,"about_ca_system_score_codex":0.00013648093,"about_ca_system_score_gemma":0.0002959864,"threshold_uncertainty_score":0.22974847},"labels":[],"label_agreement":null},{"id":"W3126958718","doi":"10.3233/blc-200391","title":"Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly –An International Multicenter Study","year":2021,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Cystectomy; Urothelial carcinoma; Adjuvant chemotherapy; Medicine; Urology; Multicenter study; Chemotherapy; Adjuvant; Oncology; Internal medicine; Bladder cancer; Cancer; Randomized controlled trial","score_opus":0.024553411180815967,"score_gpt":0.32220724958652663,"score_spread":0.2976538384057107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126958718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994384,0.0013487323,0.000022907718,0.0011269515,0.00036458945,0.0020599244,0.00036985506,0.0000060061593,0.000317033],"genre_scores_gemma":[0.9976957,0.00015796961,0.0001680942,0.00039994545,0.0002638196,0.0008488702,0.000016772266,0.000035233017,0.00041361933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983364,0.000094422714,0.0005215921,0.00034066904,0.00048535375,0.00022160921],"domain_scores_gemma":[0.99884284,0.00008066913,0.00017819615,0.00059370423,0.00025022405,0.000054368855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010536845,0.00022571444,0.0005182055,0.000073054885,0.00003034683,0.000009479063,0.00023336554,0.0000801647,0.0006434672],"category_scores_gemma":[0.000016843424,0.00012583866,0.00029844345,0.00019115269,0.0001342168,0.000065587716,0.00002792076,0.000071494615,7.5142697e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005404439,0.00950353,0.9217265,0.00012711663,0.0017262358,0.000046185643,0.019043507,0.000031139054,0.006472867,0.00005200832,0.00012943981,0.035737015],"study_design_scores_gemma":[0.026203042,0.0035362162,0.9028532,0.00014735432,0.0006536389,0.000014996788,0.0024737786,0.00012564326,0.06055485,0.000046509565,0.0032444268,0.0001463596],"about_ca_topic_score_codex":0.0013887705,"about_ca_topic_score_gemma":0.0017139215,"teacher_disagreement_score":0.054081984,"about_ca_system_score_codex":0.00013956499,"about_ca_system_score_gemma":0.00037179363,"threshold_uncertainty_score":0.70455146},"labels":[],"label_agreement":null},{"id":"W3126970712","doi":"10.1093/jjco/hyaa273","title":"Sex- and age-related differences in the distribution of bladder cancer metastases","year":2020,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Surgical Specialties (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Lung cancer; Internal medicine; Performance status; Oncology","score_opus":0.13289622787655284,"score_gpt":0.4334857337571243,"score_spread":0.30058950588057143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126970712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835988,0.00055786094,0.000012642827,0.015162326,0.00011725339,0.00013595582,0.000011406931,0.0000028744287,0.0004008219],"genre_scores_gemma":[0.9973732,0.0005941987,0.00006123718,0.0017503172,0.00018500355,0.0000047146373,0.000003379276,0.0000037678574,0.000024174657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815077,0.00043409955,0.0009989066,0.000104158644,0.00020404615,0.000108004446],"domain_scores_gemma":[0.9981963,0.0010699609,0.00042398533,0.000066535715,0.00010078785,0.00014240986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008673434,0.00008057406,0.00079366675,0.000024517967,0.00001978328,0.0000042265196,0.00009311269,0.000101296246,0.00014181036],"category_scores_gemma":[0.0008329052,0.00004037749,0.0001452671,0.00015586127,0.00024125005,0.000054191194,0.000019167055,0.00036432166,0.0000018860668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043511777,0.0016882771,0.92426133,0.00004877602,0.0009005253,0.00081413606,0.0062845564,0.000014629585,0.0009273436,0.00014145172,0.0009891329,0.05957867],"study_design_scores_gemma":[0.0071534556,0.006584677,0.9811034,0.000038915634,0.00050865224,0.0002034105,0.0018209401,0.00008380099,0.00018898855,0.00028100147,0.0019827401,0.000050023846],"about_ca_topic_score_codex":0.00009884706,"about_ca_topic_score_gemma":0.000031352643,"teacher_disagreement_score":0.05952864,"about_ca_system_score_codex":0.000023362189,"about_ca_system_score_gemma":0.00023610597,"threshold_uncertainty_score":0.16465463},"labels":[],"label_agreement":null},{"id":"W3127046624","doi":"10.1016/j.urolonc.2021.01.021","title":"Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Tissue microarray; Bladder cancer; Immunohistochemistry; Medicine; Oncology; Cancer; Internal medicine; Proportional hazards model; Pathology","score_opus":0.03897733067201524,"score_gpt":0.35611397639569925,"score_spread":0.317136645723684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127046624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585516,0.005960788,0.000008810222,0.031132665,0.0006545704,0.0012361897,0.00018911879,0.00004425791,0.0022220383],"genre_scores_gemma":[0.960812,0.0049164584,0.008956478,0.01608509,0.0009779555,0.0028675527,0.00030484592,0.000053524986,0.005026098],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982629,0.00022740132,0.00035063468,0.0005884703,0.00024144676,0.00032917238],"domain_scores_gemma":[0.99898016,0.00037924244,0.00012297131,0.00025394373,0.00012793794,0.0001357383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021783316,0.00025042135,0.00038289782,0.00009741252,0.00019806412,0.00005069888,0.00017477867,0.00017670702,0.0009995216],"category_scores_gemma":[0.00018329972,0.0001760546,0.00005347363,0.0004066203,0.00039231716,0.00009270487,0.00009584255,0.00045549427,0.000014590391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026412314,0.00078448415,0.9692331,0.0000088665465,0.00057398813,0.00057546375,0.0028904332,0.00002535272,0.0011541052,0.0000847529,0.017361404,0.007043954],"study_design_scores_gemma":[0.0039711082,0.0019349513,0.21908297,0.00012735031,0.0012107184,0.00020455713,0.004623626,0.00024628438,0.0008856601,0.0009189233,0.7665108,0.00028305626],"about_ca_topic_score_codex":0.006701376,"about_ca_topic_score_gemma":0.0089107305,"teacher_disagreement_score":0.7501501,"about_ca_system_score_codex":0.0002925613,"about_ca_system_score_gemma":0.0017865197,"threshold_uncertainty_score":0.9999137},"labels":[],"label_agreement":null},{"id":"W3127072199","doi":"10.3389/fonc.2020.629692","title":"Comparison Between Urothelial and Non-Urothelial Urethral Cancer","year":2021,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Histology; Medicine; Adenocarcinoma; Cancer; Proportional hazards model; Chemotherapy; Bladder cancer; Hazard ratio; Internal medicine; Oncology; Urology; Pathology","score_opus":0.030952302645813314,"score_gpt":0.3717717811393518,"score_spread":0.34081947849353844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127072199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95638996,0.00826189,0.0026258728,0.007112621,0.00417536,0.00087031606,0.00016193671,0.00006904045,0.020333027],"genre_scores_gemma":[0.9864004,0.00053600396,0.008300164,0.0014525148,0.00104123,0.00011478013,0.00004228842,0.00003861877,0.002073992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857384,0.00010740095,0.0003419921,0.00041603413,0.00017706866,0.00038365182],"domain_scores_gemma":[0.9994131,0.00005483983,0.00007352723,0.00020992443,0.0000652134,0.00018342392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012172575,0.0001968995,0.000805705,0.00012301319,0.00006274456,0.000013593865,0.00007843499,0.0002750268,0.00025083998],"category_scores_gemma":[0.000043721837,0.00018471858,0.00007816834,0.00020321047,0.00017377289,0.000053306478,0.000060959566,0.000373832,0.000014023668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044754532,0.00022545477,0.9034372,0.000045995483,0.00015635643,0.00024095105,0.000801927,0.000005363493,0.000757095,0.000015555275,0.022239886,0.07162669],"study_design_scores_gemma":[0.014690655,0.0015325726,0.7235253,0.000113945796,0.0005391571,0.00008286295,0.0007495354,0.00029756207,0.011274333,0.0007761089,0.2460484,0.00036958154],"about_ca_topic_score_codex":0.0003786964,"about_ca_topic_score_gemma":0.0002510557,"teacher_disagreement_score":0.22380853,"about_ca_system_score_codex":0.00041372443,"about_ca_system_score_gemma":0.00086272566,"threshold_uncertainty_score":0.7532605},"labels":[],"label_agreement":null},{"id":"W3127780003","doi":"10.26443/mjm.v1i1.755","title":"Mechanism of Genetically-Regulated Response to Bacillus- Calmette Guérin Immunotherapy for Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"McGill Journal of Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Lipopolysaccharide; Immunotherapy; Molecular biology; Nitric oxide; Bladder cancer; Immunology; Intraperitoneal injection; Macrophage; Immune system; Andrology; In vitro; Pharmacology; Cancer; Internal medicine; Biology","score_opus":0.044041354442538594,"score_gpt":0.3265774393434105,"score_spread":0.2825360849008719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127780003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6286569,0.0062647117,0.015557004,0.345239,0.0011865525,0.0020827816,0.0003109438,0.000048623522,0.0006534437],"genre_scores_gemma":[0.95726717,0.0006485503,0.0048478995,0.03572888,0.00086697,0.00002920214,0.000004460105,0.000072316434,0.00053456816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980006,0.00009672199,0.0008238144,0.00020695485,0.0006040365,0.0002678265],"domain_scores_gemma":[0.9982038,0.000159811,0.0003098204,0.00020817912,0.0006267482,0.0004916431],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055167417,0.00022126228,0.0008492589,0.00018793085,0.00005698526,0.0000027308888,0.00018100209,0.000099471,0.0009554651],"category_scores_gemma":[0.00038164563,0.00014830809,0.00019860969,0.00031928884,0.00008550742,0.000039285045,0.00002456645,0.00018966502,0.000005475106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033204805,0.00016278017,0.00012035483,0.00010279059,0.0011895238,0.00013402622,0.0008288756,0.000056786062,0.9046954,0.0001628674,0.015184765,0.044157058],"study_design_scores_gemma":[0.06631969,0.048467025,0.008713547,0.0016025169,0.0020994034,0.0005266766,0.00046455415,0.0003941405,0.47310296,0.00076467165,0.39706177,0.00048305144],"about_ca_topic_score_codex":0.00005669857,"about_ca_topic_score_gemma":0.000003974944,"teacher_disagreement_score":0.4315924,"about_ca_system_score_codex":0.00011674278,"about_ca_system_score_gemma":0.00018392743,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W3128013781","doi":"10.1001/jamaoncol.2020.8017","title":"Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer—Reply","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Otorhinolaryngology; Neurology; Family medicine; Internal medicine; Psychiatry","score_opus":0.06340154576612089,"score_gpt":0.37241622273889274,"score_spread":0.30901467697277185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128013781","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.461554,0.027725384,0.000046020756,0.48102492,0.0025052025,0.007010313,0.0028386535,0.00006299136,0.017232511],"genre_scores_gemma":[0.57237905,0.0059139687,0.0022851613,0.40825394,0.0049788146,0.0013741754,0.0018366708,0.00031835306,0.0026598605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953073,0.0013024088,0.0011715551,0.0006619499,0.0011350617,0.00042172073],"domain_scores_gemma":[0.9966679,0.001090463,0.0007891837,0.0005546933,0.0007996349,0.000098111785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015205499,0.00042180778,0.0018615262,0.00037704984,0.000034749006,0.000009452944,0.00014382292,0.0007861961,0.0011526527],"category_scores_gemma":[0.0011105612,0.00037439898,0.00021281267,0.00030132922,0.00029670596,0.00008538097,0.00008539968,0.0013071194,0.0000065565496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011116678,0.003406589,0.012354505,0.0050924416,0.006311351,0.00201491,0.007445246,0.0000952639,0.0060506007,0.000058729907,0.42690882,0.5191449],"study_design_scores_gemma":[0.06747582,0.008329066,0.09381558,0.0027044371,0.010485044,0.00026119113,0.00058831245,0.0002591765,0.001908403,0.00072306505,0.812718,0.0007319275],"about_ca_topic_score_codex":0.0028775504,"about_ca_topic_score_gemma":0.000594578,"teacher_disagreement_score":0.51841295,"about_ca_system_score_codex":0.0012131348,"about_ca_system_score_gemma":0.0045822356,"threshold_uncertainty_score":0.9998708},"labels":[],"label_agreement":null},{"id":"W3130125633","doi":"10.1136/jclinpath-2021-207400","title":"Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Grading (engineering); Urology; Proportional hazards model; Bladder cancer; Urothelial carcinoma; Urinary system; Epidemiology; Internal medicine; Oncology; Gastroenterology; Surgery; Cancer","score_opus":0.05967757572941587,"score_gpt":0.3796657818204432,"score_spread":0.3199882060910273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130125633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635863,0.0022564342,0.0000889119,0.00029977164,0.00041995337,0.00019788118,0.000027860255,0.00000329213,0.0003472541],"genre_scores_gemma":[0.99877596,0.000111251866,0.00037959975,0.00013646751,0.00046718773,0.000002056375,0.000006835845,0.000019194169,0.00010146861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741083,0.00037914867,0.0014891978,0.0002184287,0.0002961665,0.00020624425],"domain_scores_gemma":[0.99822426,0.0003824073,0.0006962757,0.00019638082,0.0003011151,0.00019954979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061431207,0.00014762949,0.0014013741,0.0001265012,0.000023894452,0.000007680718,0.00007881643,0.00019596651,0.000026174019],"category_scores_gemma":[0.0002686675,0.000101383586,0.00014214845,0.00012695523,0.0001785996,0.00007303052,0.000044117765,0.0005085417,0.0000022592387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014684622,0.00093102327,0.99248725,0.00007306101,0.00018599497,0.0009416869,0.0001460283,0.000005691799,0.000041324012,0.00001044263,0.0003302756,0.003378762],"study_design_scores_gemma":[0.012249345,0.006828636,0.9789892,0.00038227113,0.000356482,0.0003413079,0.00009878295,0.00001228678,0.00009819139,0.000039970968,0.00051764137,0.0000859037],"about_ca_topic_score_codex":0.000024851943,"about_ca_topic_score_gemma":0.000004410074,"teacher_disagreement_score":0.013498067,"about_ca_system_score_codex":0.000036276386,"about_ca_system_score_gemma":0.00037067314,"threshold_uncertainty_score":0.41343027},"labels":[],"label_agreement":null},{"id":"W3131276948","doi":"10.1016/j.urolonc.2021.01.013","title":"Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cystoscopy; Lymphovascular invasion; Urology; Carcinoma in situ; Cancer; Surgery; Internal medicine; Metastasis; Urinary system","score_opus":0.14545758760256003,"score_gpt":0.4112418099487047,"score_spread":0.2657842223461446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131276948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027358385,0.9884129,0.0000014292782,0.0057859668,0.00019461625,0.0017273164,0.00017667002,0.000030463296,0.0009348049],"genre_scores_gemma":[0.000110851135,0.99183255,0.0039376803,0.0010198947,0.00030375904,0.0022011637,0.00020390816,0.000033756285,0.00035640545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980964,0.0002747945,0.0005056398,0.000675563,0.00011033342,0.00033726293],"domain_scores_gemma":[0.9976979,0.0015603717,0.00019685824,0.00020043198,0.00009329936,0.00025113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002480062,0.0003992594,0.0016716728,0.00021526238,0.00018860855,0.000027153848,0.000054492226,0.00064536254,0.00016318914],"category_scores_gemma":[0.00018938885,0.00030235454,0.0001860979,0.00016658373,0.000547541,0.00006791619,0.000042115113,0.00047351437,0.0000028049517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065273955,0.0005661575,0.0014967608,0.0018868855,0.0006958402,0.00082519295,0.0009942298,0.0000018990868,0.0000020953128,0.0118681295,0.0027408428,0.9788567],"study_design_scores_gemma":[0.0022810574,0.0015449446,0.00013215392,0.0014624709,0.001169526,0.0009035871,0.00014829845,0.0000054539055,0.0000033089782,0.003220704,0.9888777,0.000250756],"about_ca_topic_score_codex":0.000078198376,"about_ca_topic_score_gemma":0.00039730076,"teacher_disagreement_score":0.9861369,"about_ca_system_score_codex":0.0001708472,"about_ca_system_score_gemma":0.0025230357,"threshold_uncertainty_score":0.99994284},"labels":[],"label_agreement":null},{"id":"W3132190311","doi":"10.5489/cuaj.6852","title":"Incidence and predictors of occult preoperative deep vein thrombosis at radical cystectomy for urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Deep vein; Thrombosis; Perioperative; Radical surgery; Asymptomatic; Radiology; Malignancy; Urology; Surgery; Bladder cancer; Cancer; Internal medicine","score_opus":0.014954177466631828,"score_gpt":0.2529090291813039,"score_spread":0.2379548517146721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132190311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914745,0.0006965214,0.00014655593,0.00622749,0.00024818184,0.00034267313,0.00019575629,0.00001054122,0.000657783],"genre_scores_gemma":[0.99682224,0.00008439477,0.00042180758,0.001783182,0.00037924765,0.000028140115,0.000030994597,0.000012234532,0.00043774597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864244,0.00015262862,0.0003270918,0.00022850555,0.00030384876,0.00034547504],"domain_scores_gemma":[0.99849653,0.00019801756,0.00016936433,0.00008912312,0.0004393546,0.00060761225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026658594,0.00013754512,0.00036796887,0.00007578246,0.00024904925,0.00003911179,0.00006487128,0.00022607125,0.00044620835],"category_scores_gemma":[0.00093226094,0.000109066066,0.00013852713,0.00013940595,0.00007472302,0.0000839618,0.000022348635,0.00025688333,0.0000050465433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001408115,0.000052926134,0.99545515,0.00001533029,0.00023297954,0.000064222535,0.00047137792,0.000005534081,0.001058439,0.000069513844,0.0021022996,0.00033141993],"study_design_scores_gemma":[0.0032363592,0.00090420735,0.98413885,0.000022049137,0.00028143078,0.00032703378,0.0001110355,0.00011759823,0.0020722593,0.00020988745,0.008467814,0.000111469366],"about_ca_topic_score_codex":0.00055969483,"about_ca_topic_score_gemma":0.001790269,"teacher_disagreement_score":0.011316289,"about_ca_system_score_codex":0.0010153931,"about_ca_system_score_gemma":0.0010251586,"threshold_uncertainty_score":0.48856685},"labels":[],"label_agreement":null},{"id":"W3132532539","doi":"10.14740/wjon1360","title":"Diagnostic and Therapeutic Challenges of Rare Urogenital Cancers: Urothelial Carcinoma of the Renal Pelvis, Ureters and Urethra","year":2021,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Renal pelvis; Urology; Urethra; Upper urinary tract; Guideline; Ureter; Genitourinary system; Urinary system; Urothelial cancer; Urine cytology; Ureteroscopy; Bladder cancer; Cancer; Internal medicine; Pathology","score_opus":0.05886581328438902,"score_gpt":0.34891662298187487,"score_spread":0.29005080969748587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132532539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026809727,0.994816,0.0000014620615,0.00071764685,0.0005263818,0.000516263,0.00006791595,0.0000022598858,0.00067111413],"genre_scores_gemma":[0.07725571,0.92198074,0.000076076445,0.00011559204,0.00041131818,0.000016096003,0.0000027361357,0.00003791296,0.00010379155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979175,0.00044123217,0.00088327436,0.00023202364,0.0003114732,0.00021455022],"domain_scores_gemma":[0.9973825,0.0008928471,0.0011089365,0.00025516388,0.00021010905,0.00015043034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026977187,0.0003198642,0.0024020995,0.00024470422,0.000043084146,0.000006850169,0.0001802202,0.00021767366,0.00008108681],"category_scores_gemma":[0.00014973397,0.00018991268,0.00053372333,0.00020986733,0.0003895923,0.000030461404,0.000089074194,0.00062104216,3.5000716e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020199669,0.00016651073,0.0013286403,0.004731017,0.0018498584,0.0004357132,0.0007722489,3.998501e-7,0.00002096825,0.0001483911,0.00019913944,0.9901451],"study_design_scores_gemma":[0.00515444,0.0046872413,0.004481557,0.019984419,0.013275513,0.0089620575,0.0003883,7.933584e-7,0.0001090865,0.00011325385,0.9425566,0.00028668976],"about_ca_topic_score_codex":0.000044708195,"about_ca_topic_score_gemma":0.00014607985,"teacher_disagreement_score":0.98985845,"about_ca_system_score_codex":0.0002720751,"about_ca_system_score_gemma":0.0025875985,"threshold_uncertainty_score":0.7744414},"labels":[],"label_agreement":null},{"id":"W3132678176","doi":"10.5489/cuaj.6907","title":"Radical cystectomy and perioperative chemotherapy in octogenarians with bladder cancer","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Interquartile range; Perioperative; Retrospective cohort study; Renal function; Urology; Chemotherapy; Surgery; Stage (stratigraphy); Cancer; Internal medicine","score_opus":0.010427159439208323,"score_gpt":0.24816021037634722,"score_spread":0.2377330509371389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132678176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92619294,0.0014799723,0.000030224746,0.0687043,0.00009942309,0.00017948209,0.00003017964,0.000011228451,0.0032722526],"genre_scores_gemma":[0.98511755,0.0004831142,0.00021864966,0.012832735,0.00025797143,0.000020631336,0.0000079356205,0.000012924014,0.0010485016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989607,0.000110650515,0.00017497604,0.00019797789,0.0002160148,0.0003396857],"domain_scores_gemma":[0.9991627,0.000040909774,0.00006344407,0.0000602842,0.00017247583,0.0005002199],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014860685,0.00012183818,0.0002612586,0.00008219854,0.00013828753,0.00006834783,0.00003446717,0.00016288295,0.0019789415],"category_scores_gemma":[0.00008680196,0.00008588752,0.000045565426,0.00021229341,0.00004381851,0.00006314626,0.000005077494,0.0004381485,0.0000060543216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016212159,0.00006733515,0.99325454,0.0000033213698,0.00025667157,0.0009728329,0.0006549435,0.000013654894,0.00026051814,0.00007684876,0.0010778148,0.0031993997],"study_design_scores_gemma":[0.005898521,0.0004063447,0.9379201,0.00003052625,0.0000857762,0.0010864863,0.00030151976,0.00005391207,0.0002154433,0.000081038816,0.05378337,0.00013696667],"about_ca_topic_score_codex":0.0021034817,"about_ca_topic_score_gemma":0.009677758,"teacher_disagreement_score":0.058924604,"about_ca_system_score_codex":0.0009191953,"about_ca_system_score_gemma":0.0015279276,"threshold_uncertainty_score":0.9989334},"labels":[],"label_agreement":null},{"id":"W3133229457","doi":"10.1016/j.euf.2021.01.019","title":"A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation","year":2021,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Diathermy; Cochrane Library; Electrosurgery; Outpatient clinic; Surgery; MEDLINE; Ablation; Internal medicine; Randomized controlled trial","score_opus":0.024665214241038097,"score_gpt":0.2969219153976554,"score_spread":0.27225670115661726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133229457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000066545617,0.99044394,0.000013847164,0.00012576715,0.00016333105,0.00279213,0.000049730254,0.0000127448175,0.006391845],"genre_scores_gemma":[0.0005147212,0.998684,0.000026937229,0.00026825076,0.00006373702,0.00003323903,0.000039092043,0.000057416237,0.00031262744],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99630105,0.0017493418,0.0012431775,0.00032028832,0.0002324629,0.00015365981],"domain_scores_gemma":[0.997878,0.00026155278,0.00097079715,0.000692142,0.0001331666,0.000064322725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575622,0.00030037627,0.002690082,0.00007072319,0.000036420937,0.000003300454,0.00017278233,0.00009639071,0.000081190774],"category_scores_gemma":[0.0005941737,0.00016608552,0.00049846596,0.00024333812,0.00012390564,0.000013591396,0.00015085624,0.0002920177,0.000025498368],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026404085,0.00016655671,0.0000089223795,0.9466019,0.0011820341,0.000044874992,0.000105347935,1.03931875e-7,6.5350434e-7,0.0000721784,0.00031231242,0.051478688],"study_design_scores_gemma":[0.001158552,0.0006673575,0.00023820845,0.85274744,0.024651008,0.00045457872,0.000007049128,5.026722e-7,0.000003492835,0.000003102288,0.11989613,0.00017260798],"about_ca_topic_score_codex":0.0000053140343,"about_ca_topic_score_gemma":8.103439e-7,"teacher_disagreement_score":0.119583815,"about_ca_system_score_codex":0.000038873615,"about_ca_system_score_gemma":0.00020580566,"threshold_uncertainty_score":0.6772771},"labels":[],"label_agreement":null},{"id":"W3133812191","doi":"10.1200/jco.2021.39.6_suppl.432","title":"Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Gemcitabine; Urology; Oncology; Cystectomy; Cancer; Gastroenterology","score_opus":0.1304839120686588,"score_gpt":0.47286151696030826,"score_spread":0.3423776048916495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133812191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508334,0.0007045567,0.0001065177,0.012755151,0.00065059273,0.0003865407,0.000084605934,0.00000832243,0.00022035911],"genre_scores_gemma":[0.9885314,0.0009795547,0.0038145713,0.005287908,0.001111078,0.0000120014265,0.000006429405,0.000037583042,0.00021948476],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970477,0.00051981624,0.001499894,0.00029084997,0.00034797072,0.00029376612],"domain_scores_gemma":[0.9936689,0.0031177702,0.0014184099,0.000278103,0.0011871413,0.00032965394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013543761,0.00022346697,0.0018088447,0.00012084063,0.00004158425,0.000006718998,0.0001028583,0.00034457102,0.0002698276],"category_scores_gemma":[0.0019644126,0.00012945515,0.0010401558,0.0001853762,0.00025064673,0.000054898894,0.000020821033,0.00055780064,0.000003702114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41095603,0.010799304,0.16282922,0.00008786996,0.0068008355,0.009893874,0.0010103126,0.00035124415,0.047929496,0.000028034437,0.030816695,0.3184971],"study_design_scores_gemma":[0.030022293,0.0981989,0.8518991,0.00038781215,0.0007996703,0.00078491936,0.00014420498,0.000017695489,0.0043436238,0.00015509326,0.013090921,0.00015580682],"about_ca_topic_score_codex":0.000049588867,"about_ca_topic_score_gemma":0.00007684016,"teacher_disagreement_score":0.68906987,"about_ca_system_score_codex":0.00033387137,"about_ca_system_score_gemma":0.0061756237,"threshold_uncertainty_score":0.99945843},"labels":[],"label_agreement":null},{"id":"W3133826468","doi":"10.1200/jco.2021.39.6_suppl.441","title":"Identification of characteristics associated with long-term survival in patients with metastatic urothelial carcinoma (mUC) who received durvalumab (D) with or without tremelimumab (T) in clinical studies.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Internal medicine; Univariate analysis; Logistic regression; Post-hoc analysis; Oncology; Tremelimumab; Cabozantinib; Proportional hazards model; Multivariate analysis; Cancer; Immunotherapy; Ipilimumab; Nivolumab","score_opus":0.14393099389388747,"score_gpt":0.45100364951715444,"score_spread":0.30707265562326697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133826468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997898,0.00014574568,0.00005801286,0.00053718424,0.00058037887,0.00064066023,0.000036080335,0.000007081499,0.000096890784],"genre_scores_gemma":[0.9981736,0.0004778977,0.00047226323,0.0002939748,0.00022710951,0.000021662863,0.000027937522,0.000047955094,0.00025759742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99216646,0.0017621388,0.00443001,0.0004358716,0.00086268666,0.0003428177],"domain_scores_gemma":[0.9909302,0.0025998657,0.0037546738,0.00035038288,0.002088435,0.00027644163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034858382,0.0002973469,0.0036850236,0.00020676832,0.000034320146,0.000013836577,0.00017339842,0.00027505035,0.00006413146],"category_scores_gemma":[0.006120504,0.0001703667,0.00023565194,0.00053527503,0.00047103045,0.00016502212,0.00004418789,0.0010734058,0.000002617405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059344277,0.007867813,0.9157584,0.00009369058,0.0019717054,0.0020187532,0.00035509485,0.0000060611496,0.0000117188065,0.0000021078902,0.000021547052,0.012548846],"study_design_scores_gemma":[0.06439225,0.028325403,0.9038291,0.0009676885,0.0017989199,0.00008176393,0.00030588105,0.00002978985,0.0000697268,0.000009306173,0.000022569151,0.00016762498],"about_ca_topic_score_codex":0.000032177468,"about_ca_topic_score_gemma":0.002210532,"teacher_disagreement_score":0.02045759,"about_ca_system_score_codex":0.0004561815,"about_ca_system_score_gemma":0.0051945415,"threshold_uncertainty_score":0.92148936},"labels":[],"label_agreement":null},{"id":"W3133853946","doi":"10.1200/jco.2021.39.6_suppl.438","title":"Avelumab (Ave) first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): JAVELIN Bladder 100 subgroup analysis based on duration and cycles of 1L chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Avelumab; Carboplatin; Internal medicine; Metastatic Urothelial Carcinoma; Regimen; Gemcitabine; Oncology; Chemotherapy regimen; Urothelial carcinoma; Cisplatin; Bladder cancer; Urology; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.07232360652710555,"score_gpt":0.41668956359386167,"score_spread":0.3443659570667561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133853946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98311585,0.0010409754,0.0052720434,0.007859239,0.0010657003,0.00070162985,0.00021680506,0.000011310992,0.00071645714],"genre_scores_gemma":[0.98937476,0.0010667722,0.0068131527,0.0014641299,0.00082960905,0.00002729336,0.00009000028,0.000040072544,0.00029419386],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9961329,0.00023881294,0.0023549488,0.00044815117,0.00046661546,0.00035855],"domain_scores_gemma":[0.99422365,0.0019488886,0.0017555059,0.00032845314,0.0014034292,0.00034008324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084003253,0.0002867344,0.0021784422,0.00022852037,0.00009255488,0.000012831742,0.00013067517,0.00040499406,0.00028156367],"category_scores_gemma":[0.0018481541,0.00022320036,0.000928313,0.00035145198,0.00024758014,0.00010375015,0.000031990367,0.00049728487,0.0000038104056],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40151292,0.012216263,0.18079005,0.0008957845,0.015211186,0.0030189443,0.003525415,0.0043602823,0.0041698753,0.00017353619,0.0020535882,0.37207216],"study_design_scores_gemma":[0.30018586,0.11673369,0.50347126,0.00067836355,0.018505264,0.00023560449,0.0040359586,0.010870388,0.026519129,0.00034618576,0.01754348,0.000874825],"about_ca_topic_score_codex":0.00010147027,"about_ca_topic_score_gemma":0.0010831997,"teacher_disagreement_score":0.37119734,"about_ca_system_score_codex":0.00039788565,"about_ca_system_score_gemma":0.0024137397,"threshold_uncertainty_score":0.9101846},"labels":[],"label_agreement":null},{"id":"W3133926954","doi":"10.1016/j.ajur.2021.02.003","title":"Late upper urinary tract urothelial carcinoma following radical cystectomy, presenting as page kidney","year":2021,"lang":"en","type":"article","venue":"Asian journal of urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Urology; Upper urinary tract; Urinary system; General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.013759954042337456,"score_gpt":0.27948388832421805,"score_spread":0.2657239342818806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133926954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963265,0.0023012364,0.00008762679,0.016869638,0.0014596838,0.00016219895,0.000008691843,0.000021470389,0.015824448],"genre_scores_gemma":[0.99401724,0.00006603969,0.0005396907,0.0028155188,0.0013628814,0.000004268194,0.000007839152,0.000045103952,0.0011414271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812,0.00025705664,0.00055699603,0.00025960177,0.00037154945,0.00043478317],"domain_scores_gemma":[0.9988239,0.00006695006,0.00021557245,0.00025379416,0.00011694644,0.00052285433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002562863,0.00021013602,0.0005936133,0.00016604392,0.00010126366,0.000024928295,0.00014884102,0.0001870984,0.0007311705],"category_scores_gemma":[0.00034049162,0.00017492837,0.0005358661,0.00016610321,0.000080304846,0.00014381956,0.000054724376,0.0006387412,0.000059691858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027775886,0.002509964,0.7200144,0.00014559488,0.0020889915,0.22027351,0.003144573,0.000007634584,0.034407835,0.00015736166,0.0038705515,0.010602029],"study_design_scores_gemma":[0.037568618,0.013582291,0.57623756,0.0003285214,0.0039045517,0.18431342,0.00089249026,0.00010486454,0.017543135,0.0019689845,0.16283168,0.00072387175],"about_ca_topic_score_codex":0.000013515155,"about_ca_topic_score_gemma":6.3749104e-7,"teacher_disagreement_score":0.15896113,"about_ca_system_score_codex":0.00006353134,"about_ca_system_score_gemma":0.0010003021,"threshold_uncertainty_score":0.8005805},"labels":[],"label_agreement":null},{"id":"W3133927564","doi":"10.1200/jco.2021.39.6_suppl.tps498","title":"TROPiCS-04: Study of sacituzumab govitecan in metastatic or locally advanced unresectable urothelial cancer that has progressed after platinum and checkpoint inhibitor therapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Irinotecan; Internal medicine; Chemotherapy; Docetaxel; Oncology; Paclitaxel; Phases of clinical research; Cancer; Gastroenterology; Urology; Bladder cancer; Colorectal cancer; Urothelial carcinoma","score_opus":0.16044961041482275,"score_gpt":0.4574683434969437,"score_spread":0.29701873308212096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133927564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925169,0.0034979244,0.00003859683,0.0023225767,0.0006579503,0.00078564533,0.000017261627,0.000006024464,0.0001571333],"genre_scores_gemma":[0.995218,0.0015157341,0.0016562572,0.00078650424,0.00041797306,0.000082267245,0.0000012927954,0.0000294665,0.00029254874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641097,0.0005568222,0.0019671125,0.0003032316,0.00048124624,0.00028061387],"domain_scores_gemma":[0.9973207,0.0007632762,0.0010198185,0.0002182561,0.00041276548,0.0002651702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088393665,0.0002145388,0.0018623612,0.00012542002,0.000032033302,0.000018829833,0.00010307754,0.00018144403,0.0004617773],"category_scores_gemma":[0.0007627146,0.00013351256,0.00023245893,0.00024308669,0.00018894604,0.00013820798,0.000058665504,0.00071030355,0.0000012721027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10359435,0.016596787,0.5101344,0.00019967575,0.0018775342,0.006518857,0.0024615496,0.000047479924,0.0023239597,0.0000054473967,0.00016649751,0.35607344],"study_design_scores_gemma":[0.1341421,0.09113795,0.7484147,0.0008892803,0.0010043617,0.00050276355,0.0035110563,0.00007027814,0.008402699,0.0002459823,0.011383813,0.000294996],"about_ca_topic_score_codex":0.00017828138,"about_ca_topic_score_gemma":0.003026528,"teacher_disagreement_score":0.35577846,"about_ca_system_score_codex":0.00020046873,"about_ca_system_score_gemma":0.004336102,"threshold_uncertainty_score":0.7692058},"labels":[],"label_agreement":null},{"id":"W3133939255","doi":"10.1200/jco.2021.39.6_suppl.435","title":"Post-hoc analysis of long-term outcomes in patients with CR, PR, or SD to pembrolizumab (pembro) or platinum-based chemotherapy (chemo) as 1L therapy for advanced urothelial carcinoma (UC) in KEYNOTE-361.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Population; Urothelial cancer; Randomization; Clinical trial; Internal medicine; Cancer","score_opus":0.0722298073030398,"score_gpt":0.44491928812126624,"score_spread":0.37268948081822645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133939255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945746,0.00014543858,0.00017633253,0.003320817,0.0003519171,0.001213391,0.00008174681,0.000008160828,0.00012758812],"genre_scores_gemma":[0.98641473,0.00015985483,0.0050289542,0.0075964257,0.00016907541,0.000056070538,0.000037001173,0.00005432234,0.00048358054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955831,0.0003267686,0.0025897287,0.0004536535,0.0005994633,0.00044726764],"domain_scores_gemma":[0.99481225,0.0021265133,0.0012930926,0.0004017644,0.0010122498,0.0003541519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008155161,0.00033530107,0.0032256742,0.0005725882,0.000032594013,0.000012074666,0.00024306317,0.00038917494,0.0006146926],"category_scores_gemma":[0.001494721,0.00019785475,0.0007745133,0.00087736716,0.000114929666,0.000115757946,0.00003136939,0.00053350674,0.0000029456808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26737237,0.005571278,0.64828646,0.000041622974,0.0014189287,0.0004876217,0.00024258986,0.000095215866,0.00018044851,0.0000017803297,0.000026941128,0.076274745],"study_design_scores_gemma":[0.12686938,0.06122342,0.8088445,0.00013530029,0.0007919123,0.000020163374,0.00007060543,0.000042355954,0.0015034067,0.0000116668925,0.00031287578,0.00017438336],"about_ca_topic_score_codex":0.000098562065,"about_ca_topic_score_gemma":0.0021331767,"teacher_disagreement_score":0.16055806,"about_ca_system_score_codex":0.00040614876,"about_ca_system_score_gemma":0.004863398,"threshold_uncertainty_score":0.86274594},"labels":[],"label_agreement":null},{"id":"W3134072224","doi":"10.1002/cam4.3805","title":"Population‐based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non‐metastatic muscle‐invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Medicine; Perioperative; Bladder cancer; Chemotherapy; Multivariate analysis; Internal medicine; Univariate analysis; Population; Cancer; Surgery; Oncology","score_opus":0.027675424795971983,"score_gpt":0.3236182643766976,"score_spread":0.29594283958072565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134072224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537206,0.0014678952,0.0015332837,0.00056384853,0.00013485976,0.00066429214,0.00015901796,0.000021010954,0.00008374481],"genre_scores_gemma":[0.99681014,0.0007589113,0.00030541877,0.00071681157,0.00007487987,0.0002115191,0.00061245624,0.000042903048,0.00046695452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847084,0.00006343309,0.00044033496,0.00041255442,0.00040736297,0.00020548922],"domain_scores_gemma":[0.9985775,0.00006020467,0.00027013753,0.00029143805,0.00064675946,0.00015396385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000068057336,0.00024543266,0.0007641589,0.00031037795,0.00009244815,0.000012805015,0.00005042713,0.00005262024,0.0014076035],"category_scores_gemma":[0.000078677855,0.00017980675,0.00014842104,0.0011858732,0.00014571629,0.0002060903,0.000018223614,0.00009856663,4.1445864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013682318,0.00025665347,0.9901346,0.00023775971,0.003454303,0.000007753804,0.0019487053,0.0006237181,0.00035982035,0.000011891221,0.000041931333,0.002786047],"study_design_scores_gemma":[0.007131844,0.0004989874,0.982124,0.0019061939,0.006254555,6.13285e-7,0.0004031285,0.00066947564,0.0008086057,0.000006114041,0.00003838632,0.00015813821],"about_ca_topic_score_codex":0.0034409917,"about_ca_topic_score_gemma":0.00335728,"teacher_disagreement_score":0.008010636,"about_ca_system_score_codex":0.00022693512,"about_ca_system_score_gemma":0.00024473327,"threshold_uncertainty_score":0.9995052},"labels":[],"label_agreement":null},{"id":"W3134095416","doi":"10.1200/jco.2021.39.6_suppl.tps504","title":"A phase III, randomized, open-label, multicenter, global study of first-line durvalumab plus standard of care (SoC) chemotherapy and durvalumab plus tremelimumab, and SoC chemotherapy versus SoC chemotherapy alone in unresectable locally advanced or metastatic urothelial cancer (NILE).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Tremelimumab; Medicine; Atezolizumab; Gemcitabine; Oncology; Internal medicine; Carboplatin; Chemotherapy; Hazard ratio; Population; Clinical endpoint; Pembrolizumab; Cancer; Cisplatin; Immunotherapy; Ipilimumab; Clinical trial; Confidence interval","score_opus":0.10570315610834291,"score_gpt":0.4850514354823192,"score_spread":0.3793482793739763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134095416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803552,0.010494334,0.0003655749,0.0035542846,0.0009601641,0.0038203462,0.00020620566,0.00001445424,0.00022943864],"genre_scores_gemma":[0.95566994,0.037772804,0.004365488,0.0013996048,0.0003645982,0.00013260111,0.000013107277,0.00008155477,0.00020031804],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99252814,0.0011411445,0.004092924,0.00072230195,0.000954278,0.00056119857],"domain_scores_gemma":[0.9928195,0.0022968033,0.002566502,0.00047643099,0.0013502368,0.0004905467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00256557,0.00057279196,0.007036438,0.00016349641,0.00010839332,0.000042757667,0.0004040382,0.00038105075,0.0006144522],"category_scores_gemma":[0.0013647975,0.00041466873,0.00043392525,0.0004916283,0.00066805375,0.00028322815,0.00015543604,0.0007765855,6.610764e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7978611,0.014196859,0.0025446261,0.00030090724,0.0040764306,0.00064516766,0.0034241143,0.00009676198,0.00030746445,0.0000062783197,0.00018697554,0.17635334],"study_design_scores_gemma":[0.9140008,0.072944336,0.00140911,0.0006615792,0.0018592996,0.00012089642,0.0042101336,0.000822412,0.0015296305,0.000089741785,0.0020305854,0.0003214636],"about_ca_topic_score_codex":0.0012986636,"about_ca_topic_score_gemma":0.011645791,"teacher_disagreement_score":0.17603187,"about_ca_system_score_codex":0.0010956097,"about_ca_system_score_gemma":0.0064175273,"threshold_uncertainty_score":0.99983054},"labels":[],"label_agreement":null},{"id":"W3134226198","doi":"10.1200/jco.2021.39.6_suppl.415","title":"The prognostic impact of bone metastasis in urothelial carcinoma treated with first-line platinum-based chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Baker Hughes (Canada); University Health Network","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Univariate analysis; Bone metastasis; Progression-free survival; Cancer; Progressive disease; Nomogram; Metastasis; Multivariate analysis; Bladder cancer; Urothelial carcinoma","score_opus":0.08253672856301551,"score_gpt":0.4298449654276273,"score_spread":0.34730823686461176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134226198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924371,0.0011364749,0.00007940926,0.005229052,0.00014460387,0.00031390297,0.00001969441,0.0000051465518,0.0006345624],"genre_scores_gemma":[0.9971955,0.00048516216,0.0012703498,0.0005411593,0.00033850214,0.000009622948,0.000005136081,0.00002509585,0.0001294814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970243,0.00038457644,0.0018122963,0.00017703847,0.0003521991,0.00024956453],"domain_scores_gemma":[0.99464077,0.0031830394,0.0011516426,0.00024182466,0.00055265246,0.00023005849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001210855,0.00017710325,0.0015271825,0.0000966991,0.000040903433,0.000008434721,0.000099804165,0.00019728958,0.00021239709],"category_scores_gemma":[0.0019321091,0.00008673923,0.0006350707,0.00032653715,0.00022450452,0.000045477864,0.0000152801,0.0005594575,0.000002745052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023327418,0.003308856,0.91298825,0.00003805015,0.0010774746,0.0022235895,0.00007354831,0.0001776449,0.00026810763,0.0000059049535,0.00037613916,0.056135017],"study_design_scores_gemma":[0.034765948,0.034694273,0.92432934,0.0001959587,0.00081950915,0.000556912,0.00004898177,0.00018373203,0.0020198366,0.00006587656,0.0022314042,0.00008825161],"about_ca_topic_score_codex":0.00019132973,"about_ca_topic_score_gemma":0.000654724,"teacher_disagreement_score":0.056046765,"about_ca_system_score_codex":0.00020331003,"about_ca_system_score_gemma":0.0054954537,"threshold_uncertainty_score":0.9748699},"labels":[],"label_agreement":null},{"id":"W3134307717","doi":"10.1200/jco.2021.39.6_suppl.448","title":"Analysis of PFS2 by subsequent therapy in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as 1L therapy for advanced urothelial carcinoma (UC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine","score_opus":0.11866519032482792,"score_gpt":0.4613152924776658,"score_spread":0.34265010215283787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134307717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499924,0.005127626,0.00026061875,0.005795475,0.0015783673,0.00095873745,0.000086496424,0.000018307952,0.0011751585],"genre_scores_gemma":[0.97469896,0.016123535,0.0022315646,0.004487525,0.0010363318,0.00007040868,0.000065902925,0.00008738661,0.0011983962],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940734,0.0005083116,0.0033221252,0.00064578536,0.0007920469,0.00065836194],"domain_scores_gemma":[0.9932398,0.00255645,0.0020057978,0.0006108819,0.0010810881,0.0005059472],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016889949,0.0004755581,0.0042066663,0.00040149066,0.00006954665,0.00001982522,0.00039870772,0.00074107165,0.001319655],"category_scores_gemma":[0.0013030705,0.0003408998,0.0019331453,0.0010194156,0.00029327322,0.0001655704,0.00004648972,0.00091452105,0.0000066500934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58692247,0.009689595,0.037212946,0.00009003491,0.012372936,0.0008798199,0.0009156522,0.00017000617,0.024733685,0.000038415288,0.0030014701,0.32397297],"study_design_scores_gemma":[0.5488403,0.08841889,0.1622723,0.000182692,0.004314141,0.00038459257,0.0008554014,0.00072783337,0.092676625,0.0002981456,0.10021389,0.000815175],"about_ca_topic_score_codex":0.0002533346,"about_ca_topic_score_gemma":0.00030937543,"teacher_disagreement_score":0.3231578,"about_ca_system_score_codex":0.0008090486,"about_ca_system_score_gemma":0.006747637,"threshold_uncertainty_score":0.9999043},"labels":[],"label_agreement":null},{"id":"W3134411281","doi":"10.1093/jnci/djab026","title":"Mental Health Resource Use Among Patients Undergoing Curative Intent Treatment for Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Confidence interval; Mental health; Cancer registry; Population; Distress; Radiation therapy; Cancer; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.09239851946705328,"score_gpt":0.3771015644231624,"score_spread":0.2847030449561091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134411281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9410476,0.0045144754,0.0003004962,0.042935625,0.0065662926,0.0018024897,0.0017494137,0.000021960444,0.0010616328],"genre_scores_gemma":[0.9818794,0.0020394986,0.00082868186,0.008696175,0.0014065607,0.00014705355,0.00009748404,0.000039161132,0.0048659896],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981984,0.00006697945,0.00050903956,0.0002031413,0.0007916212,0.0002308381],"domain_scores_gemma":[0.9978968,0.000083833336,0.000529889,0.00011069948,0.0012067017,0.00017207394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012619674,0.00019526323,0.0003601059,0.00008932497,0.00030842965,0.00004674277,0.000112093476,0.00005425152,0.00009098688],"category_scores_gemma":[0.0001891401,0.00012291694,0.00034038993,0.00021303107,0.00009861873,0.00038939167,0.00004012472,0.0001724932,0.0000011433306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005928674,0.00389286,0.6214,0.0002894492,0.009755729,0.00005009829,0.008464007,0.0074465843,0.0010880207,0.001285523,0.29026505,0.05013398],"study_design_scores_gemma":[0.026734214,0.0021009499,0.33351937,0.0020727732,0.00078877254,0.00015882304,0.0004922337,0.0002447378,0.012331537,0.00043718147,0.6207371,0.00038233452],"about_ca_topic_score_codex":0.00044380952,"about_ca_topic_score_gemma":0.0022695742,"teacher_disagreement_score":0.33047202,"about_ca_system_score_codex":0.0037923157,"about_ca_system_score_gemma":0.004024805,"threshold_uncertainty_score":0.9916774},"labels":[],"label_agreement":null},{"id":"W3134452282","doi":"10.1200/jco.2021.39.6_suppl.450","title":"1L pembrolizumab (pembro) versus chemotherapy (chemo) for choice-of-carboplatin patients with advanced urothelial carcinoma (UC) in KEYNOTE-361.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Carboplatin; Pembrolizumab; Gemcitabine; Cisplatin; Internal medicine; Oncology; Randomization; Urothelial carcinoma; Chemotherapy; Clinical trial; Cancer; Bladder cancer","score_opus":0.09046999123262707,"score_gpt":0.43794919409116073,"score_spread":0.3474792028585337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134452282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302834,0.00041571195,0.00011783176,0.0018671582,0.0014175579,0.00056144845,0.000028208045,0.000007376278,0.0025563892],"genre_scores_gemma":[0.99033046,0.00020353873,0.0072106556,0.0011369968,0.00083974964,0.00002006822,0.000015225462,0.000046168625,0.00019712505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967395,0.00020405481,0.0019305031,0.00031360233,0.0004475221,0.00036480592],"domain_scores_gemma":[0.9953139,0.0019669277,0.0012863565,0.0002797679,0.00086547295,0.00028756258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060134014,0.00023125591,0.0017914325,0.00012507374,0.00003299953,0.000006515881,0.00015943593,0.00036962616,0.00015475952],"category_scores_gemma":[0.0018612993,0.00016848244,0.00050025695,0.00022711494,0.00015205568,0.00011519248,0.000033146098,0.0006344239,0.0000032229016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1655303,0.005557474,0.603913,0.00012672144,0.00082004163,0.00029070987,0.00023727409,0.00003113116,0.0006820653,0.00004474483,0.0006068859,0.22215965],"study_design_scores_gemma":[0.19403511,0.031494927,0.7552489,0.00016155023,0.0004553816,0.000037772897,0.000080805665,0.00004007952,0.0031785124,0.00011256034,0.014990374,0.00016403393],"about_ca_topic_score_codex":0.000045001452,"about_ca_topic_score_gemma":0.00015992463,"teacher_disagreement_score":0.22199562,"about_ca_system_score_codex":0.00029086668,"about_ca_system_score_gemma":0.0031243688,"threshold_uncertainty_score":0.6870514},"labels":[],"label_agreement":null},{"id":"W3134598999","doi":"10.1200/jco.2021.39.6_suppl.tps506","title":"SURE: An open label, sequential-arm, phase II study of neoadjuvant sacituzumab govitecan (SG), and SG plus pembrolizumab (pembro) before radical cystectomy, for patients with muscle-invasive bladder cancer (MIBC) who cannot receive or refuse cisplatin-based chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Pembrolizumab; Cystectomy; Tolerability; Bladder cancer; Irinotecan; Oncology; Internal medicine; Cisplatin; Durvalumab; Clinical trial; Chemotherapy; Urology; Cancer; Surgery; Adverse effect; Immunotherapy; Colorectal cancer","score_opus":0.1177163740229022,"score_gpt":0.46546898106996776,"score_spread":0.34775260704706557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134598999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929872,0.0003050708,0.00009201493,0.00286409,0.00064969255,0.0026158872,0.0003428863,0.000015719374,0.00012739706],"genre_scores_gemma":[0.99281734,0.00026402913,0.0025697972,0.002949547,0.00068200566,0.00013963967,0.00006823967,0.00009639176,0.00041301674],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946329,0.0007558501,0.0025919212,0.00070885936,0.0008048633,0.0005056273],"domain_scores_gemma":[0.9932044,0.001202097,0.0023231066,0.0005389825,0.001917491,0.00081389456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011599826,0.00045545396,0.003123935,0.00016918598,0.00021212744,0.00004466401,0.00041268388,0.0004954281,0.0004470304],"category_scores_gemma":[0.001190662,0.00029409165,0.00023809806,0.00036592656,0.00040844348,0.0002889306,0.00014080564,0.00088818173,6.105932e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40534216,0.093740046,0.052371137,0.00046190896,0.00805114,0.003464847,0.0069707767,0.00010687117,0.00087165646,0.000025745838,0.003124483,0.42546922],"study_design_scores_gemma":[0.46822065,0.4469006,0.06505532,0.0006976756,0.003817284,0.00023735085,0.0009345209,0.00030570425,0.0007873494,0.000062557236,0.012567755,0.00041325376],"about_ca_topic_score_codex":0.0010371534,"about_ca_topic_score_gemma":0.009715917,"teacher_disagreement_score":0.42505598,"about_ca_system_score_codex":0.0006763938,"about_ca_system_score_gemma":0.012677714,"threshold_uncertainty_score":0.9999511},"labels":[],"label_agreement":null},{"id":"W3134629139","doi":"10.1111/bju.15383","title":"Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non‐muscle‐invasive bladder cancer: a systematic review and network meta‐analysis of randomized trials","year":2021,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Cryotherapy; Odds ratio; Urology; Meta-analysis; Surgery; Cancer; Internal medicine; Urinary system","score_opus":0.05858723486760045,"score_gpt":0.3781892086660988,"score_spread":0.3196019737984983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134629139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003434441,0.9919716,0.00045579646,0.000057820434,0.00004993074,0.0036764466,0.00031646574,0.0000044266226,0.000033078326],"genre_scores_gemma":[0.031140855,0.9677681,0.00064714113,0.000055412933,0.000093002425,0.00018004882,0.000035314526,0.00005305681,0.00002709853],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.990037,0.003880761,0.0048552686,0.0003890615,0.00053873105,0.000299135],"domain_scores_gemma":[0.9870635,0.0035015242,0.0076147676,0.00033950616,0.0013125605,0.0001680992],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0049861604,0.0005124847,0.029977957,0.00045962862,0.000023018882,0.000007531145,0.00021165962,0.00038179653,0.0005677036],"category_scores_gemma":[0.0018563016,0.00030713383,0.0045444905,0.0009837077,0.0006399138,0.00006134808,0.000028911141,0.0005049623,1.5921286e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070484534,0.001369196,0.0000114502245,0.32378447,0.5760894,0.00018479486,0.00028085,0.000037177153,0.0022667267,0.0000023285208,0.00017014351,0.025318975],"study_design_scores_gemma":[0.02412473,0.010501779,0.000043592587,0.18396252,0.775886,0.0013408514,0.00000859388,0.0000075331955,0.003866448,0.000010011065,0.000015129389,0.0002327997],"about_ca_topic_score_codex":0.00016491617,"about_ca_topic_score_gemma":0.000093196264,"teacher_disagreement_score":0.19979665,"about_ca_system_score_codex":0.000107765394,"about_ca_system_score_gemma":0.0012642976,"threshold_uncertainty_score":0.9999381},"labels":[],"label_agreement":null},{"id":"W3134647918","doi":"10.1200/jco.2021.39.6_suppl.429","title":"An open-label, multicenter, phase IIIb study of patients with urinary tract carcinoma (UTC) (STRONG): Final analysis for fixed-dose durvalumab monotherapy (module A).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Durvalumab; Clinical endpoint; Discontinuation; Internal medicine; Adverse effect; Urology; Cisplatin; Tolerability; Response Evaluation Criteria in Solid Tumors; Oncology; Chemotherapy; Phases of clinical research; Gastroenterology; Surgery; Cancer; Clinical trial; Immunotherapy; Pembrolizumab","score_opus":0.19688640836431157,"score_gpt":0.5069534400515107,"score_spread":0.31006703168719907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134647918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971448,0.00023265839,0.00054967107,0.00041047213,0.00039120734,0.001075695,0.00008884532,0.0000055003197,0.00010112305],"genre_scores_gemma":[0.9942854,0.00006954783,0.004497253,0.0005348293,0.00036434055,0.00002507192,0.00005182016,0.000032360833,0.00013938197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961322,0.00061563,0.002114077,0.00039468164,0.00047073694,0.00027270147],"domain_scores_gemma":[0.9956033,0.00070355687,0.0016818307,0.00045586043,0.0011370619,0.0004183618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010367458,0.00022609328,0.0022364578,0.00018022867,0.00007678277,0.00002102123,0.00032650647,0.0001970196,0.00024295026],"category_scores_gemma":[0.00033651723,0.00015659338,0.00035417685,0.00032551686,0.00010212515,0.00026533141,0.000053526284,0.0004664117,0.0000013308885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08615019,0.2049444,0.6540355,0.000021346032,0.004066055,0.000773592,0.00030439234,0.000035736903,0.000055365374,0.0000017395071,0.00012561328,0.049486063],"study_design_scores_gemma":[0.16340433,0.23749453,0.59334207,0.000023171557,0.0042099007,0.000035608766,0.00033350312,0.0002633326,0.0000704443,0.000009234935,0.00072317565,0.00009072513],"about_ca_topic_score_codex":0.000088954424,"about_ca_topic_score_gemma":0.00012672528,"teacher_disagreement_score":0.07725414,"about_ca_system_score_codex":0.00015481244,"about_ca_system_score_gemma":0.001588207,"threshold_uncertainty_score":0.63856924},"labels":[],"label_agreement":null},{"id":"W3134708025","doi":"10.1200/jco.2021.39.6_suppl.422","title":"Bladder cancer research funding in Canada and the United States: A comparison between stakeholder priorities and resource allocation from 2017 to 2019.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Baker Hughes (Canada); University of Calgary; University of Alberta","funders":"","keywords":"Stakeholder; Bladder cancer; Agency (philosophy); Funding Agency; Medicine; Grant funding; Business; Cancer; Public relations; Political science; Public administration; Sociology; Internal medicine","score_opus":0.3931288184999084,"score_gpt":0.5199015900021072,"score_spread":0.12677277150219884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134708025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95702916,0.0033920056,0.00001944195,0.038877536,0.00021570115,0.00019694267,0.00003125986,0.0000015885262,0.00023636216],"genre_scores_gemma":[0.99270004,0.003005333,0.00023050181,0.0031097047,0.0005907816,0.000007301235,0.000014515465,0.000009984207,0.00033186446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971738,0.0009692835,0.0010422498,0.00017246486,0.0004099093,0.00023231759],"domain_scores_gemma":[0.9937144,0.0051151896,0.00031008877,0.00013675973,0.00041223798,0.00031132824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025671776,0.00008644764,0.00086586276,0.00011118207,0.00007055761,0.00002279831,0.00008480398,0.00011784736,0.000052726635],"category_scores_gemma":[0.0013874137,0.00005495911,0.000043846787,0.00022307347,0.00020364765,0.000046038804,0.00007411474,0.00090655993,8.453507e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030523113,0.00014794039,0.91953176,0.00001897778,0.00052103197,0.00028151475,0.0021801544,0.00008347928,0.000025911553,0.000026362244,0.030411487,0.043719083],"study_design_scores_gemma":[0.009660412,0.0009893324,0.88101274,0.00019940047,0.00023231347,0.000022969352,0.0048624347,0.00009260427,0.00005295728,0.0002756401,0.10253893,0.00006026547],"about_ca_topic_score_codex":0.7465228,"about_ca_topic_score_gemma":0.80080134,"teacher_disagreement_score":0.07212744,"about_ca_system_score_codex":0.00048606133,"about_ca_system_score_gemma":0.0057985545,"threshold_uncertainty_score":0.99983764},"labels":[],"label_agreement":null},{"id":"W3134766511","doi":"10.1200/jco.2021.39.6_suppl.tps501","title":"A phase Ib single-arm study of bintrafusp alfa for the treatment of pretreated, locally advanced/unresectable or metastatic urothelial cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cisplatin; Internal medicine; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Phases of clinical research; Cancer; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Clinical trial; Bladder cancer; Urothelial carcinoma","score_opus":0.23587582299242751,"score_gpt":0.5225873593168417,"score_spread":0.28671153632441426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134766511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758155,0.0060219984,0.00064465025,0.0020050504,0.0013485786,0.0018266763,0.00013395264,0.000007418019,0.00043009702],"genre_scores_gemma":[0.9893308,0.0058093006,0.00258343,0.00038280044,0.00064548576,0.00012694714,0.0000041716094,0.00003457351,0.0010824599],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9961386,0.00041506364,0.002460228,0.00026461328,0.00043846824,0.0002830405],"domain_scores_gemma":[0.9926706,0.0039847977,0.0016862082,0.00034380812,0.0010622066,0.00025237157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079210196,0.00022569021,0.002232708,0.00008804828,0.000057114492,0.0000074482655,0.00016904829,0.00014037825,0.0004957969],"category_scores_gemma":[0.0014302308,0.00011415103,0.00066775293,0.00027879444,0.00020226528,0.00007473589,0.000023490291,0.00025958338,0.0000013675635],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09780615,0.1707683,0.005906942,0.00014243677,0.007503483,0.001182695,0.0012464132,0.00029521395,0.0027018907,0.000013682012,0.00052752125,0.71190524],"study_design_scores_gemma":[0.20221981,0.7087326,0.003335406,0.0003028123,0.010025137,0.0003400937,0.002764709,0.0002847474,0.021219783,0.0001518561,0.05045665,0.00016637518],"about_ca_topic_score_codex":0.00022139771,"about_ca_topic_score_gemma":0.0011659192,"teacher_disagreement_score":0.7117389,"about_ca_system_score_codex":0.0002803634,"about_ca_system_score_gemma":0.0043566516,"threshold_uncertainty_score":0.7728513},"labels":[],"label_agreement":null},{"id":"W3134804872","doi":"10.1200/jco.2021.39.6_suppl.444","title":"Association between prior radical surgery (RS) and outcomes with immune checkpoint inhibitor (ICI) therapy for advanced urothelial carcinoma (aUC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Bladder cancer; Cohort; Proportional hazards model; Cystectomy; Hazard ratio; Oncology; Retrospective cohort study; Gastroenterology; Progression-free survival; Urology; Logistic regression; Overall survival; Cancer; Confidence interval","score_opus":0.08179383011864462,"score_gpt":0.41513063319375476,"score_spread":0.33333680307511016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134804872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738179,0.0015623451,0.00016838536,0.022814656,0.001000511,0.00040614232,0.000022525324,0.000010737121,0.00019681011],"genre_scores_gemma":[0.98991853,0.001338692,0.0037957663,0.0019290025,0.0021482185,0.000019488021,0.000011492311,0.000033195567,0.0008056417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968106,0.00031827096,0.0019334317,0.00024239956,0.0004149064,0.00028040342],"domain_scores_gemma":[0.99272734,0.0047435137,0.0014605103,0.00015714132,0.00058485754,0.00032661523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021698726,0.00018319243,0.0020816855,0.00007828352,0.000067873625,0.000014367661,0.000065760956,0.00038939776,0.00007366997],"category_scores_gemma":[0.003182063,0.00011635162,0.0006607089,0.00010087401,0.00014806789,0.00010848446,0.000025271323,0.00059365993,0.0000027383915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007464318,0.0009060986,0.84196776,0.000032742875,0.0013997996,0.00023757634,0.00009484554,4.065951e-7,0.0008813571,0.0000067127985,0.00066313887,0.14634524],"study_design_scores_gemma":[0.02830332,0.008936236,0.915237,0.000093113864,0.0007895536,0.00013887516,0.00008490249,0.0000028570253,0.0053721247,0.00014031063,0.040780738,0.00012097357],"about_ca_topic_score_codex":0.000016326574,"about_ca_topic_score_gemma":0.000016953782,"teacher_disagreement_score":0.14622426,"about_ca_system_score_codex":0.0002686324,"about_ca_system_score_gemma":0.0030078623,"threshold_uncertainty_score":0.53358185},"labels":[],"label_agreement":null},{"id":"W3134850825","doi":"10.1200/jco.2021.39.6_suppl.451","title":"Pembrolizumab for the treatment of patients with high-risk (HR) non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin: Extended follow-up of KEYNOTE-057 cohort A.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Cohort; Bladder cancer; Pembrolizumab; Internal medicine; Carcinoma in situ; Interim analysis; Cancer; Surgery; Urology; Clinical trial; Immunotherapy","score_opus":0.05192132035304191,"score_gpt":0.3963315178186893,"score_spread":0.3444101974656474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134850825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079454,0.00095307763,0.00063274667,0.0035341966,0.0019527102,0.0015102609,0.00039995674,0.0000056765502,0.00021685634],"genre_scores_gemma":[0.9906384,0.0035623938,0.0025788043,0.0013509234,0.0007898755,0.00013591378,0.00002065216,0.000048431208,0.0008746284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591106,0.00042952632,0.0021786268,0.0004039475,0.00069305097,0.00038376646],"domain_scores_gemma":[0.98912936,0.0051145502,0.0020507718,0.00051050686,0.0027439601,0.00045087398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070028636,0.00032366926,0.002452512,0.00013517255,0.000088097695,0.000007649763,0.00021135506,0.00033121792,0.00030781707],"category_scores_gemma":[0.0021309815,0.0001767447,0.00093571923,0.00030056402,0.00027668526,0.00007230836,0.000048340567,0.0003908003,0.000005152037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1074011,0.010457589,0.46067077,0.00010399958,0.013658854,0.0005283525,0.0013115713,0.0002966151,0.00030661302,0.000031671785,0.0044039967,0.40082887],"study_design_scores_gemma":[0.055251665,0.09128252,0.8261632,0.00016688876,0.0059776288,0.00003255116,0.00030695702,0.000012132716,0.0034793336,0.00008745531,0.017080905,0.00015882452],"about_ca_topic_score_codex":0.0005956113,"about_ca_topic_score_gemma":0.0012372793,"teacher_disagreement_score":0.40067005,"about_ca_system_score_codex":0.0005054253,"about_ca_system_score_gemma":0.005428968,"threshold_uncertainty_score":0.9630756},"labels":[],"label_agreement":null},{"id":"W3134917091","doi":"10.1159/000513361","title":"Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients","year":2021,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Propensity score matching; Internal medicine; Urology; Stage (stratigraphy); Gastroenterology; Incidence (geometry); Cancer; Cumulative incidence; Cohort","score_opus":0.02733259062637272,"score_gpt":0.3123824093202038,"score_spread":0.28504981869383106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134917091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98709726,0.00046747926,0.0000047940357,0.0018009315,0.0009163594,0.00023572633,0.0002472366,0.00003703142,0.009193149],"genre_scores_gemma":[0.9931931,0.000059434748,0.000059160626,0.0029037048,0.00032126898,0.00012488912,0.00027176627,0.000022644417,0.0030440176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987523,0.000059960385,0.0002775592,0.00030127587,0.00037584655,0.00023307514],"domain_scores_gemma":[0.999399,0.000035414458,0.00006287625,0.00021579118,0.00020088108,0.00008603958],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005727391,0.00017050745,0.00023769758,0.0000882971,0.000030554864,0.000018879386,0.000105001716,0.0001072999,0.005011708],"category_scores_gemma":[0.000044788852,0.00014704379,0.00012849548,0.00013810178,0.000047800077,0.00011215431,0.000057754478,0.0001988647,0.00005959793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022754005,0.0013280284,0.9956565,0.000014646648,0.00011418452,0.00034598415,0.00010184522,0.000007204007,0.00023451325,0.0002678659,0.0007186935,0.0009830254],"study_design_scores_gemma":[0.003372614,0.00029856368,0.9892266,0.00002935758,0.00007991986,0.000037900554,0.000014842455,0.000042303844,0.0013219219,0.00025695498,0.005192259,0.00012678048],"about_ca_topic_score_codex":0.002115955,"about_ca_topic_score_gemma":0.00008155571,"teacher_disagreement_score":0.006429887,"about_ca_system_score_codex":0.00024787648,"about_ca_system_score_gemma":0.00019263916,"threshold_uncertainty_score":0.9958978},"labels":[],"label_agreement":null},{"id":"W3135052528","doi":"10.1200/jco.2021.39.6_suppl.412","title":"Trends over time in survival in patients with urothelial carcinoma in the real-world: A multicenter analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; St. Michael's Hospital; University Health Network; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Multivariate analysis; Metastatic Urothelial Carcinoma; Oncology; Cancer; Urothelial cancer; Chemotherapy; Disease; Urothelial carcinoma","score_opus":0.053593956733377475,"score_gpt":0.42198054696491355,"score_spread":0.3683865902315361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135052528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890425,0.000053284242,0.0000020064685,0.0024001384,0.00023566964,0.00013064746,0.000008732013,0.0000018305196,0.008125178],"genre_scores_gemma":[0.99722505,0.000051866427,0.00018092938,0.0016371611,0.0002868554,0.000005069173,0.000012122064,0.000011802769,0.0005891694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964907,0.0009989811,0.0016071711,0.0002157271,0.00044388845,0.00024353438],"domain_scores_gemma":[0.9979828,0.0009892165,0.00051441684,0.00022005879,0.00016315049,0.0001303525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016372055,0.00013668771,0.0014326184,0.00056924764,0.000011866534,0.000008788223,0.00013506811,0.00016288819,0.00051973003],"category_scores_gemma":[0.0003783081,0.00007693232,0.00035875023,0.001240331,0.00008035673,0.000077762794,0.000029441355,0.0008190345,0.00000738849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007612548,0.004430191,0.9731815,0.000004944866,0.00039138977,0.0018709087,0.00029503225,0.0000361678,0.0000029301216,0.000008482894,0.00019568637,0.011970259],"study_design_scores_gemma":[0.031279515,0.004049909,0.96167845,0.00004497602,0.00067169487,0.0000073946912,0.00005803611,0.00012614956,0.0000038403996,0.000016089276,0.0019961854,0.000067762754],"about_ca_topic_score_codex":0.0006921581,"about_ca_topic_score_gemma":0.016888706,"teacher_disagreement_score":0.023666967,"about_ca_system_score_codex":0.00025790898,"about_ca_system_score_gemma":0.00091903127,"threshold_uncertainty_score":0.9424294},"labels":[],"label_agreement":null},{"id":"W3135119657","doi":"10.1200/jco.2021.39.6_suppl.439","title":"Impact of subsequent therapy on survival in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as first-line therapy for advanced urothelial carcinoma (UC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine","score_opus":0.16968554216152343,"score_gpt":0.48443187904374607,"score_spread":0.31474633688222264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135119657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875925,0.0019715067,0.000110752146,0.005064272,0.0026510516,0.0012164408,0.000066176784,0.000020051122,0.0013072558],"genre_scores_gemma":[0.9801326,0.01355123,0.0012623437,0.0019250463,0.0023032746,0.00005714417,0.000029657214,0.00011221014,0.00062648585],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944456,0.00047118065,0.0029774078,0.00060628215,0.0007794028,0.00072010304],"domain_scores_gemma":[0.9925049,0.0035566492,0.0017637898,0.0006078322,0.0010210131,0.0005457929],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016420216,0.00054845156,0.0035190855,0.00024271087,0.000078205296,0.000018092836,0.0003737234,0.0007211741,0.0010992832],"category_scores_gemma":[0.001872018,0.00036188815,0.0018510215,0.00042579806,0.00026128077,0.00014990334,0.000044286844,0.0010931866,0.000012098144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7581407,0.010492652,0.027571041,0.00008152918,0.0023512212,0.001029355,0.0005482872,0.00030672047,0.0056142383,0.00003956039,0.00076922716,0.19305547],"study_design_scores_gemma":[0.4571058,0.16817303,0.32963306,0.00026034567,0.00033839437,0.00047626614,0.00016972127,0.0001979824,0.025706327,0.00036958596,0.01707872,0.0004907594],"about_ca_topic_score_codex":0.00032476478,"about_ca_topic_score_gemma":0.0003316456,"teacher_disagreement_score":0.30206203,"about_ca_system_score_codex":0.0012458744,"about_ca_system_score_gemma":0.009696111,"threshold_uncertainty_score":0.9998833},"labels":[],"label_agreement":null},{"id":"W3135248026","doi":"10.1200/jco.2021.39.6_suppl.463","title":"Heterogeneity in Nectin-4 expression across molecular subtypes of urothelial cancer mediates sensitivity to enfortumab vedotin.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Cancer research; FOXA1; Internal medicine; GATA3; Oncology; Biology; Breast cancer; Gene; Transcription factor; Genetics","score_opus":0.09092638528811434,"score_gpt":0.4885105235147176,"score_spread":0.3975841382266032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135248026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479634,0.00081290153,0.0001526321,0.002471495,0.001188857,0.00016670283,0.000027153124,0.0000051534466,0.00037877247],"genre_scores_gemma":[0.9952179,0.00049895735,0.0015063714,0.0020556292,0.0006395278,0.000006053999,0.0000022114975,0.000017322776,0.000056006433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970386,0.0005419117,0.0015506351,0.0002289024,0.00037574937,0.00026417774],"domain_scores_gemma":[0.9972939,0.0009140102,0.0007229553,0.00020028799,0.00052180944,0.00034706667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016789936,0.00014085842,0.0013852699,0.000065560525,0.000023745064,0.0000055101495,0.00008093812,0.00029082282,0.00011103931],"category_scores_gemma":[0.002676426,0.00010524207,0.00041409835,0.00018769837,0.00009880586,0.00006592038,0.0000907425,0.00056376605,0.0000057279844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01219981,0.0032848578,0.71749544,0.000092574424,0.000488399,0.006318176,0.00063241366,0.00030093052,0.15373528,0.0000138510195,0.0004843959,0.10495386],"study_design_scores_gemma":[0.009474674,0.004662179,0.5165558,0.00031435752,0.00020842766,0.0003432919,0.0001636702,0.000024438717,0.46170744,0.00008383923,0.006345155,0.00011675933],"about_ca_topic_score_codex":0.00023463772,"about_ca_topic_score_gemma":0.0011856783,"teacher_disagreement_score":0.30797216,"about_ca_system_score_codex":0.00013864461,"about_ca_system_score_gemma":0.0023651563,"threshold_uncertainty_score":0.4291647},"labels":[],"label_agreement":null},{"id":"W3135473978","doi":"10.1007/s11912-021-01035-9","title":"Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer","year":2021,"lang":"en","type":"letter","venue":"Current Oncology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Neoadjuvant therapy; Oncology; Chemotherapy; Cancer; Internal medicine; Cisplatin; Urology; Breast cancer","score_opus":0.1637344394118777,"score_gpt":0.4056075239334881,"score_spread":0.24187308452161038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135473978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95672905,0.007546438,0.000007424856,0.03211931,0.0011093825,0.002100285,0.0002897818,0.000028768676,0.00006957992],"genre_scores_gemma":[0.93865675,0.018267814,0.00011527865,0.040409766,0.0010081837,0.0004241785,0.00061753835,0.00012823568,0.00037225173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631035,0.00022108143,0.0012632848,0.0010037054,0.0007195753,0.00048197506],"domain_scores_gemma":[0.9961504,0.0003690976,0.0015071088,0.00067773095,0.0011788701,0.000116819494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026358152,0.0005612671,0.0019607837,0.00021759268,0.000037262125,0.0000104168985,0.00011793964,0.0007182179,0.0003499932],"category_scores_gemma":[0.00017093838,0.00034156544,0.00017857926,0.00042882984,0.00037400186,0.00009847029,0.00006200604,0.0010756423,5.01163e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018750798,0.0021705136,0.8721895,0.0015147228,0.001288382,0.0015624311,0.0016751551,0.0000031735187,0.0011939518,0.0000015068722,0.01709028,0.0994353],"study_design_scores_gemma":[0.011207533,0.0044302503,0.93202615,0.004313272,0.0009440751,0.00012253317,0.000053737418,0.0000029055527,0.01422176,0.000111807596,0.032006845,0.0005591265],"about_ca_topic_score_codex":0.00071993395,"about_ca_topic_score_gemma":0.00044356036,"teacher_disagreement_score":0.09887617,"about_ca_system_score_codex":0.00042523618,"about_ca_system_score_gemma":0.0029316214,"threshold_uncertainty_score":0.9999036},"labels":[],"label_agreement":null},{"id":"W3135550313","doi":"10.1038/s41598-021-85151-3","title":"A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"In silico; Workflow; Drug response; Personalized medicine; Bladder cancer; Computational biology; Bioinformatics; Drug; Molecular diagnostics; Medicine; Computer science; Gene; Biology; Cancer; Database; Internal medicine; Pharmacology; Genetics","score_opus":0.02599240450436484,"score_gpt":0.2888874331334601,"score_spread":0.26289502862909525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135550313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955137,0.0002590807,0.0000023083524,0.001150823,0.0012394558,0.0010092376,0.000029800165,0.000021826043,0.000773807],"genre_scores_gemma":[0.99589235,0.0000067593946,0.000017691164,0.00033650274,0.000051069692,0.00022764382,0.000023933731,0.000018102837,0.003425956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765307,0.0003284572,0.0003969904,0.0006511317,0.00076573587,0.0002045945],"domain_scores_gemma":[0.9984425,0.00022514237,0.00015353918,0.0008716515,0.0002142463,0.00009295324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010500384,0.0001504336,0.0002542916,0.00019367789,0.00013271873,0.00004626667,0.000056418783,0.000041167856,0.0010035891],"category_scores_gemma":[0.00048646334,0.00010026595,0.00010985867,0.0006718207,0.0001284756,0.000032511605,0.000024991312,0.00014178036,0.000007340819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049093137,0.0064182593,0.8388053,0.00009818055,0.00028265698,0.013038065,0.016249089,0.0013109752,0.094534166,0.0000049726245,0.022263631,0.0020853698],"study_design_scores_gemma":[0.0040533748,0.0008872421,0.9211874,0.0004048266,0.0002603741,0.00011438976,0.0056940783,0.0006245199,0.06451671,0.000094310526,0.002002052,0.00016074242],"about_ca_topic_score_codex":0.00017118969,"about_ca_topic_score_gemma":0.00045051822,"teacher_disagreement_score":0.08238206,"about_ca_system_score_codex":0.00012106558,"about_ca_system_score_gemma":0.0011757575,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W3135800657","doi":"10.3233/blc-201510","title":"A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral Resection","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Resection; Adjuvant; Cancer; Randomized controlled trial; Urology; Oncology; Surgery; Internal medicine","score_opus":0.22093817884737793,"score_gpt":0.4348002948606458,"score_spread":0.21386211601326788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135800657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003933898,0.9823052,0.000017560133,0.000039004753,0.00040802243,0.012690645,0.00051606266,0.000019133986,0.000070446586],"genre_scores_gemma":[0.03543169,0.94688475,0.000043469267,0.000079971476,0.00014117146,0.017186437,0.00009318397,0.0001104103,0.00002893609],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895613,0.0021698726,0.0058225924,0.0009856502,0.0010337417,0.00042681894],"domain_scores_gemma":[0.99241775,0.00046591504,0.0053906157,0.00080551056,0.00074378395,0.00017641991],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00375003,0.0008844812,0.011021166,0.0003614602,0.00004729374,0.000020640451,0.000107680564,0.00041494332,0.00024131003],"category_scores_gemma":[0.0018618272,0.0005956112,0.0017895454,0.0006547205,0.00011523443,0.000110819616,0.000042752585,0.00035203973,0.0000021264066],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033898276,0.0005822163,0.002041514,0.95176166,0.004874121,0.00013795508,0.00022752235,8.671622e-7,0.000066558576,0.0000011073574,0.000011623015,0.0399559],"study_design_scores_gemma":[0.0036574975,0.0010694598,0.004492631,0.94937265,0.038966507,0.00010678183,0.0000375224,6.9555904e-7,0.001229381,0.000007597903,0.0005702512,0.0004890509],"about_ca_topic_score_codex":0.0026420716,"about_ca_topic_score_gemma":0.0028722105,"teacher_disagreement_score":0.039466847,"about_ca_system_score_codex":0.0018781993,"about_ca_system_score_gemma":0.0024053706,"threshold_uncertainty_score":0.9996495},"labels":[],"label_agreement":null},{"id":"W3136410302","doi":"10.4081/aiua.2021.1.1","title":"Bacillus Calmette-Guerin vaccine and bladder cancer incidence: Scoping literature review and preliminary analysis","year":2021,"lang":"en","type":"article","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University; NOSM University","funders":"","keywords":"Medicine; Vaccination; Bladder cancer; Incidence (geometry); BCG vaccine; Meta-analysis; Immunotherapy; Cancer; Systematic review; Oncology; Internal medicine; Immunology; MEDLINE","score_opus":0.013464466917424617,"score_gpt":0.2956942553531067,"score_spread":0.28222978843568214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136410302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6456453,0.34544307,0.000104258754,0.006837146,0.00009958289,0.0007649847,0.00018179131,0.000092041024,0.0008317995],"genre_scores_gemma":[0.84609866,0.14096007,0.0005696559,0.010746296,0.00010071251,0.0001960104,0.00022065565,0.000030308236,0.0010776287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976768,0.0001959099,0.00044673544,0.00091110216,0.0002464813,0.00052297016],"domain_scores_gemma":[0.99872726,0.00015196599,0.0001311553,0.00054553704,0.0001499576,0.00029410032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021833922,0.00041186967,0.0010622306,0.00020454619,0.00017125554,0.00006724036,0.000118140255,0.00019817917,0.00039716627],"category_scores_gemma":[0.00018149336,0.00031624644,0.0002049237,0.0009685264,0.00016245128,0.00017595351,0.0002784342,0.0004447289,0.000009390858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007620414,0.00029650365,0.9619008,0.0034676434,0.0038757818,0.0033273138,0.000530207,0.000021414506,0.0013937573,0.00007807863,0.003242625,0.021103883],"study_design_scores_gemma":[0.0025754971,0.0018549142,0.97809553,0.0026753508,0.010658961,0.0015002851,0.00003414238,0.00020147586,0.00076301437,0.00020644811,0.00091378886,0.0005206198],"about_ca_topic_score_codex":0.00010199338,"about_ca_topic_score_gemma":0.00016026803,"teacher_disagreement_score":0.20448302,"about_ca_system_score_codex":0.000033530625,"about_ca_system_score_gemma":0.00017747219,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W3136819953","doi":"10.1016/j.euf.2021.03.003","title":"Tumor Size Predicts Muscle-invasive and Non–organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Renal pelvis; Medicine; Urology; Interquartile range; Stage (stratigraphy); Logistic regression; Oncology; Internal medicine; Ureter; Biology","score_opus":0.00963214790373909,"score_gpt":0.22905427766829486,"score_spread":0.21942212976455577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136819953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98025686,0.0018511715,0.0000098603105,0.003959445,0.0002460738,0.0005281707,0.00010056739,0.00007841,0.012969462],"genre_scores_gemma":[0.9936277,0.00009969964,0.000106001375,0.0042882953,0.00046471696,0.000028378774,0.00004739521,0.00009901111,0.0012387502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976342,0.00046687262,0.00038154647,0.00075313676,0.00023100941,0.0005332496],"domain_scores_gemma":[0.9985608,0.00026725463,0.00008125198,0.00047084954,0.00006082923,0.00055902504],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001620386,0.00034398164,0.00048979156,0.000100545345,0.0001046245,0.000023990433,0.00012380829,0.000084121464,0.0010855868],"category_scores_gemma":[0.00044981876,0.00030601476,0.0001464565,0.00017933393,0.00027190064,0.00006722522,0.00017041898,0.000387518,0.00018690637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035812946,0.00082192966,0.9143405,0.00010653424,0.00017699515,0.056110784,0.0011999542,0.0000027677697,0.01789879,0.000032195097,0.0015265082,0.0042017656],"study_design_scores_gemma":[0.0113759935,0.00086813385,0.9693253,0.000041511223,0.00035851216,0.000847099,0.000030076892,0.000028816536,0.0035273563,0.00005191195,0.0132996775,0.00024561927],"about_ca_topic_score_codex":0.00007530712,"about_ca_topic_score_gemma":0.00007151531,"teacher_disagreement_score":0.055263683,"about_ca_system_score_codex":0.000096197764,"about_ca_system_score_gemma":0.0004230132,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W3137251658","doi":"10.1016/j.ctrv.2021.102187","title":"Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer Foundation; Merck KGaA; EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Carboplatin; Chemotherapy; Oncology; Internal medicine; Maintenance therapy; Cisplatin; Clinical trial; Bladder cancer; Javelin; Cancer; Immunotherapy; Nivolumab; Urothelial carcinoma","score_opus":0.3066253015532885,"score_gpt":0.5286651053873425,"score_spread":0.22203980383405397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137251658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074984906,0.9642329,0.00021010378,0.0006641616,0.003259556,0.030297222,0.0003566024,0.00007684769,0.00082759996],"genre_scores_gemma":[0.000018461476,0.9512527,0.007831436,0.0021775996,0.0025881762,0.030973354,0.00037107163,0.00027170923,0.004515489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98657775,0.002039991,0.006696,0.0027325712,0.00073194806,0.0012217233],"domain_scores_gemma":[0.9927069,0.0023262256,0.0017045868,0.0019429168,0.000309003,0.0010103735],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0025368917,0.0018430845,0.012922156,0.00035157675,0.00017025444,0.00010535656,0.0005318198,0.00064976217,0.0010124648],"category_scores_gemma":[0.003676914,0.0011282978,0.0036975758,0.0015118766,0.00017761966,0.00023018366,0.0002133976,0.0012751108,0.0006361665],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016521545,0.003503599,0.00019178161,0.0079364795,0.0015447312,0.0022804919,0.00009831563,0.0000019787,4.1155353e-8,0.000010028955,0.0028886113,0.9650224],"study_design_scores_gemma":[0.07407501,0.008125015,0.00002592496,0.044640172,0.013089196,0.00029658817,0.000034869583,0.0000032708688,6.8111865e-7,0.000002651353,0.8588973,0.0008093021],"about_ca_topic_score_codex":0.0004992231,"about_ca_topic_score_gemma":0.00082976517,"teacher_disagreement_score":0.9642131,"about_ca_system_score_codex":0.0034174218,"about_ca_system_score_gemma":0.007226739,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W3137275704","doi":"10.1016/j.urolonc.2021.01.031","title":"Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Stage (stratigraphy); Proportional hazards model; Internal medicine; Survival analysis; Intensity (physics); T-stage; Urology; Subgroup analysis; Carcinoma; Overall survival; Oncology; Hazard ratio; Urothelial carcinoma; Gastroenterology; Cancer; Confidence interval; Bladder cancer","score_opus":0.037108879440190076,"score_gpt":0.3307959744362352,"score_spread":0.2936870949960451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137275704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931501,0.00035685624,0.000021172915,0.0019415565,0.00021282329,0.000325109,0.00019350811,0.000023577204,0.00377528],"genre_scores_gemma":[0.99554425,0.00029642275,0.0018065283,0.00077491964,0.00011139545,0.000040306786,0.00013409859,0.000015732563,0.0012763207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986378,0.00015013777,0.00031898913,0.0004213776,0.00015849585,0.0003132192],"domain_scores_gemma":[0.99911356,0.00019475407,0.00010417281,0.00025294305,0.00009229904,0.00024230058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011854945,0.00025377233,0.00068777124,0.00013338179,0.0000823211,0.00000914599,0.000050261497,0.00022736138,0.00031169257],"category_scores_gemma":[0.00006792613,0.00018595629,0.00015844978,0.0001849262,0.000420717,0.00005809922,0.000025173915,0.0002497148,0.000011625807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011597244,0.0017603918,0.9898312,0.000016744752,0.0001525055,0.0012342351,0.00040192914,0.00033052743,0.0009165669,0.002042024,0.0003267146,0.0018274336],"study_design_scores_gemma":[0.0075085834,0.02149676,0.9222555,0.000054182263,0.00038901807,0.00046900412,0.00024582355,0.00039810193,0.004590364,0.0016567211,0.040697392,0.00023853715],"about_ca_topic_score_codex":0.0028971322,"about_ca_topic_score_gemma":0.00026557743,"teacher_disagreement_score":0.067575686,"about_ca_system_score_codex":0.0005818651,"about_ca_system_score_gemma":0.001155953,"threshold_uncertainty_score":0.75830775},"labels":[],"label_agreement":null},{"id":"W3139020868","doi":"10.1016/j.euf.2021.03.017","title":"International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma","year":2021,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Grading (engineering); Medicine; Bladder cancer; Oncology; Bladder tumor; Internal medicine; Cancer","score_opus":0.07309592577001212,"score_gpt":0.35012577674342327,"score_spread":0.27702985097341115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139020868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017437107,0.97075045,0.000068262365,0.0003937985,0.001270753,0.00047154512,0.00014384468,0.000037904003,0.026689077],"genre_scores_gemma":[0.0052688243,0.99233615,0.00033856515,0.00054962805,0.0009834565,0.000029790774,0.00022741282,0.00008830431,0.00017783426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973099,0.0006928929,0.0008067003,0.0006395594,0.00025751485,0.0002934347],"domain_scores_gemma":[0.99860835,0.0002051524,0.000471064,0.00051443494,0.00009828546,0.00010269485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003045214,0.00041676912,0.0018171625,0.00015811043,0.000038012437,0.0000049981313,0.0003317157,0.00033399713,0.00030995664],"category_scores_gemma":[0.00008235707,0.00031635142,0.0011122886,0.00013139732,0.0002870807,0.000019723175,0.00020514344,0.00057303236,0.000055775523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002847012,0.0006881966,0.0002731395,0.00093654444,0.0010967777,0.0007577321,0.00030024812,6.217813e-7,0.000067857974,0.00045512556,0.0068264497,0.9883126],"study_design_scores_gemma":[0.0014542807,0.0019998485,0.00035165096,0.00070985843,0.00036239787,0.0008141588,0.000012315266,0.00000211681,0.00007226689,0.0000139641825,0.99402505,0.00018211905],"about_ca_topic_score_codex":0.000011337047,"about_ca_topic_score_gemma":1.6372007e-7,"teacher_disagreement_score":0.9881305,"about_ca_system_score_codex":0.00007676987,"about_ca_system_score_gemma":0.00024994617,"threshold_uncertainty_score":0.99992883},"labels":[],"label_agreement":null},{"id":"W3140687959","doi":"10.4021/jcgo7e","title":"A Case of Muscle Invasive Bladder Cancer Treated With Systemic Chemotherapy During Pregnancy","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Pregnancy; Chemotherapy; Cancer; Oncology; Gynecology; Urology; Obstetrics; Internal medicine","score_opus":0.0509501110248648,"score_gpt":0.3541619106463671,"score_spread":0.3032117996215023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140687959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831735,0.015633585,0.000012878065,0.00013043104,0.00052539894,0.00025420234,0.000008698491,0.0000064684364,0.00025483494],"genre_scores_gemma":[0.99040216,0.0086528035,0.00024683538,0.00018264803,0.00024001961,0.000007950986,6.379131e-7,0.000018696579,0.00024824133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984884,0.0001192209,0.0008801859,0.00012848944,0.00014977019,0.00023389336],"domain_scores_gemma":[0.99632025,0.0021891352,0.0007419842,0.00014065678,0.00032263913,0.00028535997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024014371,0.00014255644,0.0007975694,0.00014186087,0.00004943798,0.0000042059582,0.000052549218,0.00023216977,0.00012900942],"category_scores_gemma":[0.0013516849,0.000089383466,0.00015558237,0.00025168975,0.00014529585,0.0001209609,0.00001651118,0.0003492245,0.0000015472925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007818806,0.00085039483,0.9624666,0.00025738962,0.00093544717,0.0032162254,0.0005188424,0.0000031075938,0.0002457732,0.000009278446,0.00004973195,0.030665318],"study_design_scores_gemma":[0.021220947,0.004484411,0.95023257,0.0008976157,0.0016106814,0.01742182,0.0005902497,0.000006443269,0.0030295567,0.00001626374,0.00032002275,0.00016943587],"about_ca_topic_score_codex":0.000023648492,"about_ca_topic_score_gemma":0.000016810585,"teacher_disagreement_score":0.03049588,"about_ca_system_score_codex":0.000063958134,"about_ca_system_score_gemma":0.00028963288,"threshold_uncertainty_score":0.3644952},"labels":[],"label_agreement":null},{"id":"W3140838881","doi":"10.1016/j.eururo.2021.03.014","title":"Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada); University of British Columbia","funders":"","keywords":"Pembrolizumab; Medicine; Cystectomy; Bladder cancer; Oncology; Internal medicine; Cohort; Neoadjuvant therapy; Pathology; Immunotherapy; Cancer","score_opus":0.010779881652693762,"score_gpt":0.2584130071316301,"score_spread":0.24763312547893637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140838881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810293,0.0013412518,0.00018389986,0.0019707128,0.0002530439,0.00014143177,0.000061861734,0.00003687382,0.014981662],"genre_scores_gemma":[0.993864,0.00021369675,0.00006559682,0.0040432857,0.0002371509,0.000017013253,0.00010913642,0.000048833135,0.0014012746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892145,0.00020486322,0.00023557457,0.00028636502,0.00014495439,0.00020681258],"domain_scores_gemma":[0.9993896,0.000011463877,0.00007219377,0.0003046465,0.0001390637,0.00008306054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005895509,0.0001337489,0.00024725308,0.000057144316,0.000021007583,0.0000062606937,0.000055510227,0.000048728172,0.0013739517],"category_scores_gemma":[0.000027330783,0.000120918674,0.00007525972,0.0001191055,0.0000670304,0.000033955854,0.00006191277,0.00012094825,0.00009448893],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002278719,0.00042614935,0.02489083,0.00008436762,0.0005616986,0.0057763383,0.00081470463,0.00001421676,0.9494976,0.00023953633,0.0005344533,0.014881403],"study_design_scores_gemma":[0.0034145552,0.0005823086,0.8736057,0.0000317,0.000441896,0.00028216632,0.000013912631,0.000020200816,0.09275233,0.000025608508,0.028671656,0.0001579463],"about_ca_topic_score_codex":0.000015739264,"about_ca_topic_score_gemma":0.0000060310413,"teacher_disagreement_score":0.85674524,"about_ca_system_score_codex":0.00002176179,"about_ca_system_score_gemma":0.00014880419,"threshold_uncertainty_score":0.9995389},"labels":[],"label_agreement":null},{"id":"W3140977709","doi":"10.1097/ju.0000000000001715","title":"No Outcome Differences after Cystectomy between Patients with De Novo Muscle-Invasive Bladder Cancer Compared to Progressors: A Retrospective Population-Based Study","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Cystectomy; Retrospective cohort study; Medicine; Cancer; Outcome (game theory); Population; Urothelial cancer; Urology; Oncology; Surgery; Internal medicine","score_opus":0.02150390700305707,"score_gpt":0.3053176953159536,"score_spread":0.2838137883128965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140977709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974081,0.00016795906,0.00007917064,0.0013676266,0.00015901057,0.0007063162,0.000051146213,0.000010980296,0.000049673807],"genre_scores_gemma":[0.9982259,0.0000034429534,0.00017862889,0.0011636881,0.0002781913,0.000057570152,0.000006349151,0.000023044959,0.000063158346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984579,0.0002879798,0.0004003806,0.00017214772,0.00041645503,0.00026515432],"domain_scores_gemma":[0.99842703,0.00018403785,0.00027041748,0.0002261199,0.00073401356,0.00015837557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017448784,0.00018261017,0.0005692626,0.000101757054,0.0000764238,0.00001554163,0.00013267729,0.00005841647,0.0001631862],"category_scores_gemma":[0.00011593541,0.000100148776,0.00008086525,0.00021766624,0.000045305147,0.000048388094,0.00003300708,0.00028981833,0.000012936387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029375514,0.00063313823,0.9941312,0.000014214799,0.0007269977,0.00013801218,0.0011422813,0.000050212537,0.000022387507,4.225332e-7,0.00002175852,0.00018181225],"study_design_scores_gemma":[0.006780944,0.0048195557,0.9866803,0.00005693472,0.0012623358,0.000021067457,0.00017596844,0.000004028116,0.00004457294,0.00002272877,0.000033563712,0.00009797437],"about_ca_topic_score_codex":0.00036791433,"about_ca_topic_score_gemma":0.0010026385,"teacher_disagreement_score":0.0074508847,"about_ca_system_score_codex":0.00022069654,"about_ca_system_score_gemma":0.00033997183,"threshold_uncertainty_score":0.40839487},"labels":[],"label_agreement":null},{"id":"W3141438650","doi":"10.14740/jmc1865w","title":"An Asymptomatic Small-Cell Bladder Cancer Until Bilateral Ureteral Obstruction Happened","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Percutaneous nephrostomy; Gross hematuria; Asymptomatic; Hydronephrosis; Surgery; Biopsy; Microscopic hematuria; Urology; Radiology; Cancer; Kidney; Percutaneous; Urinary system; Internal medicine","score_opus":0.023273913087266698,"score_gpt":0.3107119978438762,"score_spread":0.28743808475660954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141438650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423164,0.00074369437,0.00057810574,0.0028422957,0.0010360086,0.0001287419,0.000006361933,0.000026274714,0.00040685356],"genre_scores_gemma":[0.99474347,0.00022972975,0.0007235626,0.002113018,0.0019292589,0.000006867525,0.000006585353,0.000027807091,0.00021967711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99784523,0.00012307771,0.0005555072,0.0001662576,0.0010490605,0.0002608648],"domain_scores_gemma":[0.99861234,0.00008796415,0.0002660654,0.0001948756,0.00017672416,0.0006620195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040762924,0.00018456267,0.00046166524,0.00013654,0.00006747061,0.00004056621,0.00017464737,0.00018004877,0.0023408586],"category_scores_gemma":[0.0001876879,0.00012173323,0.00018178916,0.00011614274,0.00008809588,0.0001643877,0.000019949297,0.00037237882,0.000016648128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064889984,0.00528573,0.3572378,0.0015506359,0.0026116609,0.01048592,0.0037005374,0.00024438085,0.02636182,0.00025218655,0.026730547,0.5590498],"study_design_scores_gemma":[0.09350467,0.044352144,0.56423706,0.0068124225,0.009373258,0.08049325,0.0020678896,0.019354992,0.09650873,0.0027229253,0.07809378,0.0024788855],"about_ca_topic_score_codex":0.00025898707,"about_ca_topic_score_gemma":0.00007647866,"teacher_disagreement_score":0.5565709,"about_ca_system_score_codex":0.00010543199,"about_ca_system_score_gemma":0.00041115916,"threshold_uncertainty_score":0.99857116},"labels":[],"label_agreement":null},{"id":"W3145682606","doi":"10.2196/25800","title":"Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"JMIR Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Aurora Research Institute","keywords":"Medicine; Bladder cancer; Carcinoma in situ; Multivariate analysis; Univariate analysis; Internal medicine; Retrospective cohort study; Stage (stratigraphy); Cancer; Cohort; Oncology; Urology; Creatinine","score_opus":0.04211693838526354,"score_gpt":0.38232346538827267,"score_spread":0.34020652700300913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145682606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917186,0.002393113,0.000033017357,0.000322215,0.0009361599,0.0026471452,0.0002792195,0.000043313667,0.0016272073],"genre_scores_gemma":[0.993056,0.00273477,0.00007915666,0.0005753022,0.00033807877,0.0029623345,0.00004540119,0.000038385497,0.00017059677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997368,0.00025272378,0.0006111023,0.00080680416,0.00058866094,0.00037275796],"domain_scores_gemma":[0.9986768,0.00011838579,0.00022308569,0.00042227175,0.00043378084,0.0001257107],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032163228,0.0003109285,0.0009055325,0.00013026143,0.000073243275,0.000020553329,0.00012006996,0.00018352093,0.000988646],"category_scores_gemma":[0.00016274751,0.0002660125,0.00022629721,0.00068737165,0.000094076815,0.00017683211,0.00006932059,0.00041178503,0.00000633814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070112274,0.0013681891,0.98091686,0.000039768624,0.00038060677,0.00046601528,0.003624882,0.00001327108,0.0034437596,0.0000026720436,0.0003504877,0.008692352],"study_design_scores_gemma":[0.0070029856,0.0020147471,0.9833487,0.0004142379,0.00024290865,0.000007567965,0.0010924299,0.000043479093,0.0054295985,0.00006662466,0.00010797158,0.00022870515],"about_ca_topic_score_codex":0.0012075562,"about_ca_topic_score_gemma":0.0013161775,"teacher_disagreement_score":0.008463647,"about_ca_system_score_codex":0.00079120207,"about_ca_system_score_gemma":0.0008855433,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W3146689657","doi":"10.1016/j.clgc.2021.03.010","title":"Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Lymph node; Hazard ratio; Chemotherapy; Proportional hazards model; Internal medicine; Stage (stratigraphy); Dissection (medical); Surgery; Cancer; Confidence interval","score_opus":0.0627656918527785,"score_gpt":0.4133542788830282,"score_spread":0.35058858703024975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146689657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878086,0.0042921063,0.000079172016,0.0044110892,0.0006932956,0.0008110623,0.0002550254,0.000111322646,0.00056609017],"genre_scores_gemma":[0.9898303,0.0019570815,0.0011724407,0.0025209496,0.0011332879,0.0008003813,0.00041073273,0.000058060417,0.00211676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617964,0.00044398452,0.001195237,0.0010938674,0.00049943663,0.0005878402],"domain_scores_gemma":[0.99783695,0.00038363482,0.00021134502,0.00084931887,0.0001830285,0.0005357455],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026715963,0.00044763385,0.0015756416,0.00023776515,0.00011471389,0.000036328172,0.00014673494,0.00037147265,0.0028594218],"category_scores_gemma":[0.00012371798,0.00037561462,0.0010666633,0.0013220541,0.00015556836,0.00008073664,0.00006343337,0.00044865152,0.000038857706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017244406,0.0027010269,0.96644145,0.0000761857,0.0028722475,0.0025691083,0.000117028,0.0017177043,0.000073041185,0.0000027458752,0.00036654362,0.021338446],"study_design_scores_gemma":[0.012044256,0.00067505654,0.97361094,0.00012374102,0.0037692739,0.000013900612,0.00005354394,0.0027596103,0.0005280603,0.00004448451,0.0059983633,0.00037875873],"about_ca_topic_score_codex":0.01671092,"about_ca_topic_score_gemma":0.0092213405,"teacher_disagreement_score":0.020959688,"about_ca_system_score_codex":0.0011863641,"about_ca_system_score_gemma":0.0017680426,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W3147442129","doi":"10.1016/j.euf.2021.03.018","title":"Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Interquartile range; Odds ratio; Retrospective cohort study; Urology; Confidence interval; Internal medicine; Urothelial carcinoma; Oncology; Bladder cancer; Cancer","score_opus":0.03256014461290011,"score_gpt":0.3208110212091898,"score_spread":0.2882508765962897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147442129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718443,0.000034983444,0.011454449,0.002066268,0.00083032006,0.0027175776,0.001272472,0.00007298099,0.009706606],"genre_scores_gemma":[0.99205005,0.0000059868626,0.004023452,0.0018910947,0.00072422693,0.00036003115,0.0005564777,0.00008132984,0.00030737693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814653,0.00019478911,0.00040785517,0.0007004857,0.00021586538,0.0003344896],"domain_scores_gemma":[0.9984492,0.00009754621,0.00015758877,0.00040058125,0.00063608453,0.0002590073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025358424,0.00025635934,0.00030816317,0.00013014782,0.00018735958,0.000099093435,0.0001923913,0.00007479156,0.000070798815],"category_scores_gemma":[0.00027918353,0.00023621539,0.000112377675,0.00016649034,0.00004242341,0.00022861896,0.00004686555,0.00017841463,0.0000377037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055294256,0.008038772,0.9343485,0.000046256657,0.00095018215,0.00008961278,0.00783711,0.00007897507,0.019046498,0.00083483505,0.0039926437,0.019207189],"study_design_scores_gemma":[0.014745918,0.0078062844,0.94042563,0.0000124070075,0.00049782364,0.000017428762,0.0016096528,0.00023821855,0.0026870698,0.0001414981,0.031530116,0.00028797073],"about_ca_topic_score_codex":0.00004444731,"about_ca_topic_score_gemma":0.0000618873,"teacher_disagreement_score":0.027537473,"about_ca_system_score_codex":0.00009446225,"about_ca_system_score_gemma":0.00042015515,"threshold_uncertainty_score":0.9632584},"labels":[],"label_agreement":null},{"id":"W3151853001","doi":"10.1111/bju.15418","title":"Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert <sup>®</sup> Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Innovation Initiatives Ontario North; Baylis Medical (Canada); Professional Engineers Ontario","funders":"National Cancer Institute","keywords":"Medicine; Cystoscopy; Bladder cancer; Urine cytology; Cytology; Urine; Urology; Cancer; Internal medicine; Hazard ratio; Gastroenterology; Urinary system; Pathology; Confidence interval","score_opus":0.013551484292628164,"score_gpt":0.26088048691719756,"score_spread":0.2473290026245694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151853001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958184,0.0026735824,0.000071186674,0.00046764823,0.00023779363,0.0004277848,0.00026805818,0.000006687971,0.000028874787],"genre_scores_gemma":[0.99697554,0.0015459525,0.00049939007,0.00038678336,0.00032818774,0.00007278163,0.00006538795,0.00004320393,0.000082747276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835557,0.00008001216,0.0005476687,0.00033397792,0.00033880555,0.0003439418],"domain_scores_gemma":[0.99806166,0.00016085278,0.00035318482,0.00016335385,0.0010855683,0.00017535382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018172845,0.00021201256,0.00064057054,0.00014039701,0.00007854074,0.000026168484,0.00009949214,0.00013203775,0.00017050073],"category_scores_gemma":[0.00014806734,0.00020190323,0.00009394891,0.0002227746,0.00012873423,0.00024689035,0.000023519653,0.0002554434,4.4171426e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024572532,0.00077756034,0.96861917,0.00013924029,0.0003326994,0.00023475336,0.00018113072,0.0014306646,0.00033635116,2.4957288e-7,0.00026482713,0.025226083],"study_design_scores_gemma":[0.019236611,0.004517538,0.9697172,0.0003311393,0.00031215636,0.000375079,0.000054497472,0.0006858697,0.0043963618,0.0000069898315,0.00018297142,0.00018359254],"about_ca_topic_score_codex":0.0006418619,"about_ca_topic_score_gemma":0.0011870855,"teacher_disagreement_score":0.025042491,"about_ca_system_score_codex":0.00011338592,"about_ca_system_score_gemma":0.0007091703,"threshold_uncertainty_score":0.82333744},"labels":[],"label_agreement":null},{"id":"W3152417901","doi":"","title":"Nitrate in Drinking Water and Bladder Cancer: A Meta-analysis","year":2012,"lang":"zh","type":"article","venue":"华中科技大学学报：医学英德文版","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Publication bias; Meta-analysis; Confounding; Bladder cancer; Medicine; Relative risk; Nitrate; Cancer; Study heterogeneity; Demography; Internal medicine; Confidence interval; Ecology; Biology","score_opus":0.0712374823865785,"score_gpt":0.32745086980669613,"score_spread":0.2562133874201176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152417901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.707625,0.22157633,0.00016378262,0.007035618,0.0016613955,0.002331857,0.00035524424,0.00017670968,0.059074108],"genre_scores_gemma":[0.9839129,0.0024859745,0.00016820994,0.0019460801,0.00080831023,0.00033018383,0.000091190464,0.00009455684,0.010162584],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99587834,0.00029416065,0.0008219993,0.0008105225,0.00063996465,0.0015550052],"domain_scores_gemma":[0.99827,0.00010426518,0.00016370714,0.00073782995,0.00011252018,0.0006116734],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077254244,0.00072832487,0.0022348454,0.0006425497,0.00019005092,0.000110806366,0.00019854677,0.00034031086,0.011175711],"category_scores_gemma":[0.000021719834,0.0004861855,0.0010647275,0.00088611094,0.00017818664,0.0004372376,0.00017066974,0.0005666506,0.00039712145],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049500575,0.0013484056,0.5887851,0.00028210337,0.38203344,0.00022334172,0.018172512,0.0000915505,0.0021800757,0.00061386096,0.001144144,0.004630482],"study_design_scores_gemma":[0.0066585597,0.00041395816,0.11130333,0.000089768735,0.8492433,0.000053270756,0.0010059251,0.00030244782,0.010844643,0.00080284086,0.017903734,0.0013782195],"about_ca_topic_score_codex":0.0058365464,"about_ca_topic_score_gemma":0.0026611888,"teacher_disagreement_score":0.47748175,"about_ca_system_score_codex":0.00026748693,"about_ca_system_score_gemma":0.00014384241,"threshold_uncertainty_score":0.99975896},"labels":[],"label_agreement":null},{"id":"W3152595829","doi":"10.1016/j.hoc.2021.02.002","title":"Current Perioperative Therapy for Muscle Invasive Bladder Cancer","year":2021,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Perioperative; Cystectomy; Bladder cancer; Neoadjuvant therapy; Radiation therapy; Systemic therapy; Chemotherapy; Cancer; Oncology; Disease; Internal medicine; Surgery","score_opus":0.10892986060485747,"score_gpt":0.4587548008051414,"score_spread":0.34982494020028393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152595829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038419527,0.992597,0.00008530579,0.00032570714,0.0015070371,0.0037886861,0.0009285866,0.000049872655,0.00033361133],"genre_scores_gemma":[0.000065248154,0.99162906,0.0013596257,0.0011611519,0.00042772826,0.0038330848,0.0011918079,0.00013009126,0.00020221765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591994,0.00042716652,0.0017109213,0.0010739992,0.00023959004,0.00062835997],"domain_scores_gemma":[0.9947555,0.001963505,0.0014867777,0.00076484244,0.0007523356,0.0002770112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016033548,0.0007792453,0.006753169,0.0002325792,0.00013588868,0.00000911575,0.00033471923,0.0006762765,0.00055733614],"category_scores_gemma":[0.0004384741,0.0005933104,0.0016507542,0.0005156492,0.0007401353,0.000049947088,0.00013331354,0.0008738913,0.000051559746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017918965,0.0013274709,0.0018323968,0.005522703,0.0027437971,0.00010394071,0.00031226702,7.0428115e-7,1.4017667e-7,0.00004131905,0.004485595,0.9834505],"study_design_scores_gemma":[0.0030566996,0.0028372386,0.00021680171,0.003971404,0.0037232377,0.00015753887,0.000106286694,0.0000025785662,0.0000045969036,0.000010993502,0.98548555,0.00042708282],"about_ca_topic_score_codex":0.000050926614,"about_ca_topic_score_gemma":0.00022176512,"teacher_disagreement_score":0.9830234,"about_ca_system_score_codex":0.00029057605,"about_ca_system_score_gemma":0.00959581,"threshold_uncertainty_score":0.99965185},"labels":[],"label_agreement":null},{"id":"W3152739953","doi":"10.1016/j.clgc.2021.04.008","title":"Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Pharmaceuticals; EMD Serono; Genentech; National Institutes of Health; Bavarian Nordic; Bayer Schering; Astellas Pharma; Eisai; Cancer Research UK; GlaxoSmithKline; Virginia Marine Resources Commission; Advanced Accelerator Applications; Bayer Fund; Clovis Oncology; Meso Scale Diagnostics; Les Laboratories Pierre Fabre; Jounce Therapeutics; Merck Sharp and Dohme; Genzyme; National Institute on Handicapped Research; Exelixis; Sanofi; Novartis; Merck; Heron Therapeutics; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Roche; Astellas Pharma US; Boehringer Ingelheim; Amgen; Pfizer","keywords":"Medicine; Nivolumab; Internal medicine; Pembrolizumab; Durvalumab; Oncology; Atezolizumab; Metastatic Urothelial Carcinoma; Carboplatin; Cisplatin; Response Evaluation Criteria in Solid Tumors; Retrospective cohort study; Urology; Bladder cancer; Urothelial carcinoma; Cancer; Chemotherapy; Progressive disease; Immunotherapy","score_opus":0.03517358340460927,"score_gpt":0.3511806430000108,"score_spread":0.31600705959540154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152739953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947761,0.0007846003,0.000028596955,0.0006634106,0.000739531,0.0010200832,0.00029993177,0.00009340243,0.0015943298],"genre_scores_gemma":[0.9923544,0.00097425474,0.0016873353,0.0009448576,0.0009896711,0.00016314336,0.00017311946,0.00011569385,0.0025975374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960758,0.00017903034,0.0015560457,0.0009780913,0.00067379774,0.00053721084],"domain_scores_gemma":[0.99674636,0.0006035767,0.00048919575,0.0008586812,0.00078479387,0.0005174037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019816645,0.0005199944,0.001579781,0.0000933121,0.00012198476,0.00001669787,0.00017864072,0.00031118217,0.00050464785],"category_scores_gemma":[0.00023981139,0.00034146287,0.0005079704,0.00050342386,0.00040506394,0.00014053588,0.00011683376,0.00057552505,0.000029745734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009544162,0.0033787466,0.9659949,0.00013739878,0.0009622189,0.0004737128,0.000047297977,0.00007007566,0.000027280545,0.0000020655057,0.0011294329,0.018232714],"study_design_scores_gemma":[0.03051779,0.008256713,0.95243293,0.00040192247,0.0009858726,0.000020279438,0.00004286557,0.000015972091,0.001815108,0.0000132806235,0.0050961166,0.00040114872],"about_ca_topic_score_codex":0.00021502093,"about_ca_topic_score_gemma":0.00027147765,"teacher_disagreement_score":0.020973628,"about_ca_system_score_codex":0.00013071482,"about_ca_system_score_gemma":0.0012604281,"threshold_uncertainty_score":0.99990374},"labels":[],"label_agreement":null},{"id":"W3153039798","doi":"10.1016/j.eururo.2021.03.028","title":"Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907–15","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Chemotherapy; Differential (mechanical device); Oncology; Internal medicine","score_opus":0.013593204480486192,"score_gpt":0.24739706178803206,"score_spread":0.23380385730754585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153039798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7633285,0.00027955865,0.0034332038,0.22658542,0.00043893344,0.0027390302,0.0021733353,0.00020497583,0.00081702805],"genre_scores_gemma":[0.5832321,0.000048374695,0.00094501855,0.41204423,0.00051894214,0.000056629266,0.0021249317,0.00032001553,0.00070972514],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9934931,0.002404261,0.00081772014,0.0015672295,0.00066570786,0.0010519869],"domain_scores_gemma":[0.99778044,0.0005055469,0.000508318,0.00057469035,0.00031699907,0.00031402998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035143163,0.0009787093,0.0014225469,0.00035715624,0.00013888249,0.0001292187,0.00015510438,0.00031024762,0.00066235237],"category_scores_gemma":[0.0004119708,0.0008842767,0.00017932539,0.00040419775,0.0001500368,0.00013021371,0.00011538722,0.0018631525,0.00005168697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016768029,0.0020194973,0.06276583,0.0012675697,0.0036933462,0.029084414,0.012399441,0.00054434384,0.07584407,0.0000039488627,0.7842788,0.011330719],"study_design_scores_gemma":[0.13620183,0.032267347,0.50341046,0.0040977313,0.0037146166,0.0008765276,0.000503741,0.0069896514,0.023512024,0.000034744506,0.28093478,0.007456545],"about_ca_topic_score_codex":0.0002608353,"about_ca_topic_score_gemma":0.00035978152,"teacher_disagreement_score":0.503344,"about_ca_system_score_codex":0.0002968542,"about_ca_system_score_gemma":0.0005238579,"threshold_uncertainty_score":0.9993608},"labels":[],"label_agreement":null},{"id":"W3153743354","doi":"10.1136/bmjopen-2020-043266","title":"Short-term morbidity and mortality following radical cystectomy: a systematic review","year":2021,"lang":"en","type":"review","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Rigshospitalet","keywords":"Medicine; Cystectomy; Term (time); Systematic review; Epidemiology; Intensive care medicine; MEDLINE; Bladder cancer; Internal medicine; Cancer","score_opus":0.21900180412969988,"score_gpt":0.5000814159113177,"score_spread":0.28107961178161783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153743354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009033406,0.95326644,0.0000052144105,0.000055655117,0.0002560192,0.042978805,0.000067821355,0.000036251557,0.00332473],"genre_scores_gemma":[0.000025199262,0.98724157,0.00010559579,0.00041216044,0.0001788315,0.010440192,0.0002995674,0.00007515745,0.0012217412],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964476,0.0006909026,0.001291938,0.0007206901,0.0005463852,0.00030247035],"domain_scores_gemma":[0.9978135,0.00012700306,0.00031427052,0.0013845522,0.000051772015,0.0003088638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014106263,0.0005467751,0.007614531,0.00005713423,0.0000888183,0.00014465352,0.0004181484,0.0002514497,0.00015870754],"category_scores_gemma":[0.00037594803,0.00036222287,0.0010486564,0.0002855086,0.000044147353,0.00010870018,0.0005539462,0.00036375015,0.00005895389],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045720676,0.00008045345,0.00014641827,0.9654743,0.002217343,0.001544069,0.000015013977,6.7328576e-10,3.410737e-8,0.000013334639,0.0008110916,0.029693378],"study_design_scores_gemma":[0.00055738894,0.00007004983,0.00007484619,0.9035099,0.03267764,0.001264814,0.0000062307477,3.366276e-7,2.1892986e-7,0.0000036927229,0.06150104,0.0003338079],"about_ca_topic_score_codex":0.00013193297,"about_ca_topic_score_gemma":0.000019510477,"teacher_disagreement_score":0.06196436,"about_ca_system_score_codex":0.00022746413,"about_ca_system_score_gemma":0.0011052184,"threshold_uncertainty_score":0.999883},"labels":[],"label_agreement":null},{"id":"W3155792441","doi":"10.1016/j.urolonc.2021.03.005","title":"Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Lymphocyte; Bladder cancer; Chemotherapy; Gastroenterology; CD8; Cancer; Immunology; Immune system","score_opus":0.02872018240957009,"score_gpt":0.31512440863428437,"score_spread":0.2864042262247143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155792441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005029201,0.9832242,0.000004631589,0.0006767511,0.00007405233,0.010634028,0.00023421868,0.000021835365,0.00010107617],"genre_scores_gemma":[0.0003372861,0.9907088,0.0029029436,0.001818438,0.000042619908,0.0035424896,0.00043094007,0.00006264566,0.00015380609],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974283,0.00047942981,0.00095173914,0.0005726723,0.00023708843,0.00033077336],"domain_scores_gemma":[0.9978151,0.00057367154,0.00076836784,0.0005048188,0.00018167355,0.00015642255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032205135,0.00050520035,0.0029695963,0.00018138127,0.00011347467,0.000012270813,0.00019272663,0.00037125932,0.000026232228],"category_scores_gemma":[0.0003816101,0.00027131624,0.00039222988,0.00070129364,0.00051398104,0.00003029468,0.000029022462,0.00031710634,0.0000014326057],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028022978,0.0022641125,0.20524055,0.7709957,0.0031407792,0.0001556137,0.000119511926,0.0000013251229,0.0000011577598,0.00016901288,0.0010531007,0.016578903],"study_design_scores_gemma":[0.008241056,0.0099171335,0.00083327456,0.5206601,0.051496778,0.0003917881,0.000026475353,0.000031812964,0.000022533251,0.000044711807,0.4077786,0.00055573886],"about_ca_topic_score_codex":0.00005528663,"about_ca_topic_score_gemma":0.000023594566,"teacher_disagreement_score":0.4067255,"about_ca_system_score_codex":0.00018334542,"about_ca_system_score_gemma":0.0021900698,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W3157490260","doi":"10.5489/cuaj.7367","title":"Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sinai Health System; University of British Columbia; McMaster University; Dalhousie University; Western University; Memorial University of Newfoundland; Université Laval; Université de Montréal; University of Alberta; University of Calgary; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital; Queen's University; McGill University Health Centre","funders":"European Association of Urology","keywords":"Medicine; Cystoscopy; Bladder cancer; Lymphovascular invasion; Cystectomy; Urine cytology; Carcinoma in situ; Cancer; Guideline; Urology; Urinary system; Oncology; Internal medicine; Pathology","score_opus":0.01879848306796071,"score_gpt":0.2639176369639183,"score_spread":0.24511915389595756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157490260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6073031,0.0006857847,0.000034035816,0.35500583,0.0010375472,0.00064859947,0.00039260826,0.000025835154,0.034866646],"genre_scores_gemma":[0.9574791,0.00065115566,0.00018534886,0.037425242,0.00052939996,0.00004332158,0.00006039591,0.000019461131,0.0036065385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747854,0.00024366734,0.0005596972,0.00030239954,0.00068449025,0.00073117495],"domain_scores_gemma":[0.9974276,0.00023879082,0.0003972684,0.00021302172,0.000821932,0.0009014008],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008450514,0.00021233741,0.00038251464,0.00015274252,0.00039020827,0.00007654584,0.00018437518,0.0003669751,0.0055608177],"category_scores_gemma":[0.00059267844,0.00014679068,0.00023939145,0.00042448653,0.000026382926,0.000061026763,0.0000243016,0.0007010562,0.000101673504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096946074,0.00022181387,0.7555912,0.000017153747,0.0024955384,0.0009788643,0.00027271672,0.0002963862,0.00027420872,0.0008386994,0.22970319,0.00921325],"study_design_scores_gemma":[0.0015605901,0.0003766496,0.84889805,0.000049934904,0.00050073623,0.00004766097,0.00027107418,0.00007797082,0.00026526957,0.0008531038,0.14691733,0.00018161643],"about_ca_topic_score_codex":0.05267153,"about_ca_topic_score_gemma":0.09952119,"teacher_disagreement_score":0.35017604,"about_ca_system_score_codex":0.00539432,"about_ca_system_score_gemma":0.0027429885,"threshold_uncertainty_score":0.9984238},"labels":[],"label_agreement":null},{"id":"W3157809857","doi":"10.3390/curroncol28030154","title":"Prognostic Impact of APOBEC3B Expression in Metastatic Urothelial Carcinoma and Its Association with Tumor-Infiltrating Cytotoxic T Cells","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hazard ratio; Medicine; Metastatic Urothelial Carcinoma; Cytotoxic T cell; Immunohistochemistry; Proportional hazards model; Chemotherapy; Carcinoma; Oncology; Cancer research; CD8; Confidence interval; Pathology; Internal medicine; Cancer; Bladder cancer; Biology; Immunology; Urothelial carcinoma; Antigen; In vitro","score_opus":0.056884393223976974,"score_gpt":0.37284241179358596,"score_spread":0.315958018569609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157809857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704486,0.0017160608,0.00002736181,0.00006696174,0.00016751063,0.00057114713,0.00004610089,0.000012674036,0.00034732913],"genre_scores_gemma":[0.9993574,0.000078343495,0.00031048412,0.000024945892,0.0000722469,0.00007210838,0.000027011283,0.000016128417,0.00004134782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988614,0.00017759108,0.00027933638,0.00024399841,0.00020027686,0.00023740917],"domain_scores_gemma":[0.99925035,0.0002017714,0.0001937707,0.00010406959,0.00015047957,0.00009956402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014756224,0.00014703504,0.00044119643,0.000086371154,0.000029547124,0.000007556905,0.000032042717,0.00005192734,0.00009988511],"category_scores_gemma":[0.00018466933,0.00010767178,0.000064321255,0.0001902743,0.000023685001,0.00006230794,0.000027032167,0.00019660023,0.000004640399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032929692,0.00077763933,0.8102748,0.00021350413,0.000078453384,0.00016649482,0.0006826567,0.000015418367,0.18446098,0.0000060957695,0.00007967315,0.0029150213],"study_design_scores_gemma":[0.009323957,0.0036853943,0.71545386,0.0005749649,0.00044337186,0.00017565284,0.00027230752,0.00047322948,0.26920897,0.00003720097,0.00017086159,0.0001802119],"about_ca_topic_score_codex":0.000039616818,"about_ca_topic_score_gemma":0.00005178405,"teacher_disagreement_score":0.09482089,"about_ca_system_score_codex":0.0004552487,"about_ca_system_score_gemma":0.0009292688,"threshold_uncertainty_score":0.4390728},"labels":[],"label_agreement":null},{"id":"W3158712737","doi":"10.1038/s41591-021-01317-6","title":"An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Biomarker; Medicine; PARP inhibitor; Bladder cancer; Oncology; Cancer research; Cancer; Targeted therapy; Urothelium; Internal medicine; Immunotherapy; Biology; Nivolumab; Poly ADP ribose polymerase; DNA; Urinary bladder","score_opus":0.01968541919565534,"score_gpt":0.32487179614621486,"score_spread":0.3051863769505595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158712737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124914,0.0056153387,0.000010549009,0.000793711,0.00024381162,0.0011383685,0.000020448193,0.00005692629,0.00087168324],"genre_scores_gemma":[0.99866974,0.00022552724,0.0002958477,0.00031259368,0.00007570534,0.00013550588,0.00008894403,0.0000349161,0.00016123784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830365,0.00011155797,0.0003785301,0.00040081728,0.00057170563,0.00023376243],"domain_scores_gemma":[0.99907595,0.000067673274,0.00012236554,0.00031602813,0.0003295764,0.000088416105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018961963,0.00023470967,0.0006397074,0.00033394693,0.000030418985,0.0000035173903,0.00008697461,0.00018889918,0.00025898567],"category_scores_gemma":[0.000080940656,0.00015841579,0.00002656882,0.001185596,0.00008643709,0.00013175592,0.000013321881,0.00050070067,5.462757e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032831203,0.012794992,0.7048006,0.0002526266,0.00095777615,0.0015903182,0.024208821,0.0000873935,0.116529405,0.0001996465,0.00018172327,0.10556549],"study_design_scores_gemma":[0.051409613,0.008348281,0.9191741,0.0008156044,0.00017324483,0.000027105349,0.0072701536,0.00038086614,0.011875259,0.000109338755,0.00023251468,0.00018393621],"about_ca_topic_score_codex":0.0022263427,"about_ca_topic_score_gemma":0.011979955,"teacher_disagreement_score":0.21437348,"about_ca_system_score_codex":0.0002090627,"about_ca_system_score_gemma":0.00030616857,"threshold_uncertainty_score":0.66850966},"labels":[],"label_agreement":null},{"id":"W3158857567","doi":"10.1016/j.jacr.2021.02.011","title":"ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update","year":2021,"lang":"en","type":"review","venue":"Journal of the American College of Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Grading (engineering); Guideline; Appropriate Use Criteria; Cancer; Genitourinary system; Disease; Urothelial cancer; Urodynamic testing; Intensive care medicine; Oncology; Urinary system; Internal medicine; Pathology","score_opus":0.028415887525889753,"score_gpt":0.352639576349508,"score_spread":0.32422368882361824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158857567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057990053,0.988931,0.000010404192,0.0011591206,0.0013930622,0.0006770086,0.0018988982,0.0000038088665,0.000127671],"genre_scores_gemma":[0.0029914407,0.9949376,0.0005083168,0.00018742861,0.0007184821,0.00003998551,0.000030864237,0.00006727828,0.0005186251],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996433,0.0009669041,0.0015324431,0.0003400855,0.000373053,0.00035451728],"domain_scores_gemma":[0.9940848,0.00029460303,0.0039171088,0.0007603818,0.0007807054,0.0001624297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003383441,0.0005106539,0.0062563634,0.0002546765,0.000054141252,0.000005173997,0.00052888365,0.00018301279,0.0004608225],"category_scores_gemma":[0.00013807736,0.00027994908,0.0017521936,0.00078025606,0.00062230096,0.000038630114,0.000118543445,0.0003814983,0.0000034812967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018036413,0.0013405575,0.0020331868,0.005327629,0.020648254,0.0015663526,0.00018453714,0.000016088523,0.00034608893,0.00006200058,0.012927616,0.95374405],"study_design_scores_gemma":[0.0024817206,0.0038542843,0.0009394492,0.005792135,0.0062657665,0.011611421,0.00025152467,0.0000020397754,0.0002206398,0.00001720652,0.9682379,0.00032595318],"about_ca_topic_score_codex":0.00037339615,"about_ca_topic_score_gemma":0.000060478666,"teacher_disagreement_score":0.9553102,"about_ca_system_score_codex":0.0005204033,"about_ca_system_score_gemma":0.0038327049,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W3158929216","doi":"10.1590/1516-3180.2020.0349.r1.28012021","title":"The effect of proliferative hypertrophic scars on determining treatment options for preventing recurrence of vesicourethral anastomotic stenosis after radical prostatectomy: a single-center cross-sectional study","year":2021,"lang":"en","type":"article","venue":"Sao Paulo Medical Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anastomosis; Prostatectomy; Surgery; Radical retropubic prostatectomy; Neck of urinary bladder; Stenosis; Scars; Urology; Single Center; Receiver operating characteristic; Biochemical recurrence; Prostate cancer; Cancer; Radiology; Urinary bladder; Internal medicine","score_opus":0.030796846753933578,"score_gpt":0.3432267840773903,"score_spread":0.31242993732345675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158929216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680465,0.00077229564,0.0001668739,0.00029454642,0.0004546246,0.0014082958,0.00005031949,0.000010940588,0.000037464055],"genre_scores_gemma":[0.9986879,0.00010333177,0.00029844677,0.000054388955,0.00038116705,0.00036934213,0.000010480922,0.000025383899,0.00006955952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710673,0.00049960887,0.000735894,0.0003060133,0.000992684,0.00035907672],"domain_scores_gemma":[0.99828124,0.0006502825,0.00026221297,0.00020307206,0.00030468384,0.00029850163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082932936,0.00023475834,0.00053647213,0.0000884684,0.00029618377,0.000060856735,0.000111042165,0.000109915396,0.00010310286],"category_scores_gemma":[0.00058016455,0.00013166358,0.00034732136,0.00017366743,0.00024834278,0.000072461145,0.000038425896,0.0004005856,0.0000014703002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006442977,0.0032858304,0.9237162,0.00015026891,0.0011424242,0.00048000002,0.00094624166,0.0000094905645,0.0005905574,0.000002355522,0.000018244755,0.063215435],"study_design_scores_gemma":[0.036750253,0.06621614,0.86721694,0.0022727954,0.001192224,0.0032854977,0.00044737768,0.0004134839,0.02169998,0.00010486481,0.00012954009,0.00027087115],"about_ca_topic_score_codex":0.0000039328784,"about_ca_topic_score_gemma":0.000015245805,"teacher_disagreement_score":0.06294456,"about_ca_system_score_codex":0.00027265924,"about_ca_system_score_gemma":0.0006903355,"threshold_uncertainty_score":0.53690845},"labels":[],"label_agreement":null},{"id":"W3159668484","doi":"10.1111/bju.15434","title":"Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bladder cancer; Hazard ratio; Medicine; Cystectomy; Internal medicine; Cumulative incidence; Proportional hazards model; Gemcitabine; Regimen; Oncology; Neoadjuvant therapy; Pathological; Vinblastine; Chemotherapy; Stage (stratigraphy); Confidence interval; Gastroenterology; Cancer; Urology; Cohort; Biology","score_opus":0.013879066967502374,"score_gpt":0.2926835681452751,"score_spread":0.2788045011777727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159668484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96882856,0.014708951,0.00061178626,0.012846478,0.000564389,0.00036228148,0.002008204,0.000015774618,0.000053580236],"genre_scores_gemma":[0.9820064,0.0048443023,0.0063842805,0.0057686297,0.00068645756,0.000044593766,0.00007453447,0.000023358138,0.00016744458],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983039,0.0002723069,0.00056883803,0.00032832543,0.00022972797,0.00029692752],"domain_scores_gemma":[0.99817383,0.0003181416,0.00028972345,0.00015739081,0.00086672377,0.00019420483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002517261,0.00016031084,0.0004957481,0.000036363006,0.000068593545,0.0000516353,0.00008457583,0.00022333262,0.00037878656],"category_scores_gemma":[0.00090919907,0.00015779019,0.00020347997,0.00016296109,0.00009009625,0.00009967766,0.000024574783,0.00021538211,0.0000049321475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4498391,0.004305455,0.018429892,0.00007755239,0.0031213458,0.10261935,0.004477284,0.0010508746,0.043199167,0.000016105994,0.049699306,0.32316458],"study_design_scores_gemma":[0.07529399,0.0066191945,0.8343116,0.00039338408,0.0014630168,0.013193904,0.0012558352,0.0002209091,0.0054382165,0.00045664958,0.060918428,0.00043489374],"about_ca_topic_score_codex":0.00013388124,"about_ca_topic_score_gemma":0.0005574009,"teacher_disagreement_score":0.81588167,"about_ca_system_score_codex":0.00017611377,"about_ca_system_score_gemma":0.0010454849,"threshold_uncertainty_score":0.64344966},"labels":[],"label_agreement":null},{"id":"W3160130231","doi":"10.1038/s41423-021-00692-x","title":"The CXCR3alt-CXCL11 axis in bladder cancer: potential for prediction of neoadjuvant chemotherapy response","year":2021,"lang":"en","type":"letter","venue":"Cellular and Molecular Immunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Chemotherapy; Oncology; Cancer research; Internal medicine; Complete response; Cancer","score_opus":0.010337332392444321,"score_gpt":0.24882896249935754,"score_spread":0.2384916301069132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160130231","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24145466,0.21552277,0.0035174603,0.53220093,0.002601209,0.003505764,0.00085631764,0.000062818755,0.00027806754],"genre_scores_gemma":[0.44550824,0.06436732,0.0011262137,0.45534942,0.0039441455,0.0034837571,0.005814319,0.0008173508,0.019589216],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816805,0.00026487964,0.00044424366,0.00048902427,0.00020124212,0.00043253275],"domain_scores_gemma":[0.9989738,0.000105204774,0.00016895731,0.00055209914,0.0001626057,0.00003736215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022133216,0.00031850365,0.0006415082,0.00015107484,0.000099501645,0.000019478894,0.00014286344,0.0007610606,0.00006543271],"category_scores_gemma":[0.00004999251,0.0002481098,0.0002780753,0.00013258819,0.00027450442,0.00002030309,0.000054747237,0.000693579,0.0000013715846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011476165,0.0002841922,0.0002993306,0.0004908238,0.004074778,0.0024376935,0.0006176819,0.000010876084,0.8395474,0.00004145878,0.11168582,0.02903379],"study_design_scores_gemma":[0.009389198,0.001659327,0.002211935,0.00028584438,0.00078800734,0.00022161733,0.00012598693,0.00010240558,0.19739664,0.00024828114,0.7872756,0.00029513703],"about_ca_topic_score_codex":0.00022895433,"about_ca_topic_score_gemma":0.000011381173,"teacher_disagreement_score":0.6755898,"about_ca_system_score_codex":0.0001138498,"about_ca_system_score_gemma":0.00047412835,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W3160598301","doi":"10.1097/mou.0000000000000895","title":"Quality indicators for the management of high-risk upper tract urothelial carcinoma requiring radical nephroureterectomy","year":2021,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cuff; Perioperative; Lymph node; Dissection (medical); Urology; Ureter; Urothelial carcinoma; Cystectomy; Transitional cell carcinoma; Stage (stratigraphy); Chemotherapy; Bladder cancer; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.1114036670343519,"score_gpt":0.4259381678430578,"score_spread":0.31453450080870593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160598301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037434258,0.9894273,0.0006263438,0.00018510083,0.006023852,0.0028919263,0.00036513014,0.0000241463,0.00008182113],"genre_scores_gemma":[0.0037265185,0.99322903,0.00021049188,0.00003804547,0.0009871159,0.0011509908,0.0005648133,0.000067317145,0.00002565593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967305,0.0005714345,0.0011921386,0.00070883683,0.00033605585,0.00046104964],"domain_scores_gemma":[0.997886,0.00061259774,0.0006187536,0.00071447325,0.000046413046,0.0001217738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006347051,0.00046673405,0.0020503185,0.0003294218,0.00008364493,0.000013022296,0.0003393449,0.00038681875,0.00015640882],"category_scores_gemma":[0.000064140084,0.00031174484,0.0008275756,0.0004184504,0.00022988401,0.00003278569,0.0001510725,0.00081240776,0.00000913341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018580227,0.00046139833,0.003582866,0.019828381,0.00079626846,0.000008034492,0.000095829484,0.0000010931293,3.989876e-8,0.0015927324,0.00064363785,0.9728039],"study_design_scores_gemma":[0.003388634,0.00042399025,0.007806114,0.0036545836,0.0021446836,0.000056775825,0.000023200013,0.0000049740647,9.605901e-7,0.000101804515,0.982156,0.00023828415],"about_ca_topic_score_codex":0.0000783192,"about_ca_topic_score_gemma":0.0000015745969,"teacher_disagreement_score":0.98151237,"about_ca_system_score_codex":0.00019409276,"about_ca_system_score_gemma":0.00044929548,"threshold_uncertainty_score":0.9999335},"labels":[],"label_agreement":null},{"id":"W3160730820","doi":"10.1016/j.compbiomed.2021.104472","title":"MRI and CT bladder segmentation from classical to deep learning based approaches: Current limitations and lessons","year":2021,"lang":"en","type":"review","venue":"Computers in Biology and Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; Bell (Canada)","funders":"","keywords":"Segmentation; Bladder cancer; Deep learning; Artificial intelligence; Computer science; Context (archaeology); Medicine; Machine learning; Image segmentation; Medical physics; Radiology; Cancer; Internal medicine","score_opus":0.17311175766905465,"score_gpt":0.41360779351220645,"score_spread":0.2404960358431518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160730820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023736987,0.98424363,0.012226347,0.0021312388,0.0003929029,0.0006397142,0.000015596102,0.000020650092,0.00009252013],"genre_scores_gemma":[0.001121566,0.99264157,0.0041494123,0.00047874617,0.00032472948,0.00011416825,0.0011276504,0.00001977593,0.00002241229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985707,0.00025588815,0.00034152778,0.00056761014,0.00007496194,0.0001893255],"domain_scores_gemma":[0.9988591,0.0006814423,0.00009256517,0.0001365172,0.000024150006,0.00020622341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014685126,0.00028706095,0.0011952505,0.00022088595,0.00007960404,0.000009869648,0.000044090484,0.0001466924,0.000016986787],"category_scores_gemma":[0.00009078388,0.0002037451,0.000053567444,0.00017808954,0.00024441403,0.000019600267,0.00007061623,0.0004414276,0.0000016193136],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001813831,0.0000677899,0.0010190036,0.0007741341,0.00018476722,0.000028672599,0.00047704487,0.0000015114308,0.0000012389377,0.00016531521,0.00024972478,0.9970127],"study_design_scores_gemma":[0.0044736024,0.0011100862,0.0028908458,0.016715253,0.002444902,0.00014337269,0.000502267,0.0010017777,0.000001591246,0.00019018682,0.97015053,0.00037559163],"about_ca_topic_score_codex":0.000027701715,"about_ca_topic_score_gemma":0.000033969405,"teacher_disagreement_score":0.99663705,"about_ca_system_score_codex":0.00006263623,"about_ca_system_score_gemma":0.00011088297,"threshold_uncertainty_score":0.83084846},"labels":[],"label_agreement":null},{"id":"W3160760780","doi":"10.5489/cuaj.7171","title":"Single staff cystectomy in a low-volume center: Oncological outcomes and complications","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Perioperative; Interquartile range; Dissection (medical); Surgery; Bladder cancer; Lymph node; Urology; Cancer; Internal medicine","score_opus":0.020376990317514002,"score_gpt":0.2649120349253779,"score_spread":0.2445350446078639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160760780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93850285,0.0003002012,0.000035245583,0.052697223,0.00015999725,0.00018245226,0.00007069152,0.000020772273,0.008030575],"genre_scores_gemma":[0.9929306,0.000059016613,0.00026865763,0.0057913777,0.00009764515,0.000014011689,0.000031528612,0.000007699126,0.0007994869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987941,0.00014853326,0.00028887554,0.00019887554,0.0002027647,0.00036689843],"domain_scores_gemma":[0.9989745,0.00009876912,0.00010429831,0.00008920401,0.00017941864,0.0005538368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001840971,0.00011225919,0.00029687522,0.00010753895,0.00015062978,0.0000741435,0.000053908203,0.00018194939,0.00056350755],"category_scores_gemma":[0.0004435884,0.00008962835,0.000087811764,0.0001902412,0.00003075537,0.000059939623,0.000017655673,0.0003989934,0.00003583953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019647854,0.0003200517,0.99511516,0.0000036769272,0.00006230492,0.00036380775,0.00007576692,0.0000035417602,0.00007340022,0.00007916829,0.0013966959,0.0024867742],"study_design_scores_gemma":[0.0023447694,0.00030483815,0.951314,0.000019394693,0.000035966834,0.00049414736,0.00009178549,0.000034476852,0.000012327294,0.00038330886,0.044882804,0.00008221172],"about_ca_topic_score_codex":0.0005297,"about_ca_topic_score_gemma":0.003359589,"teacher_disagreement_score":0.05442773,"about_ca_system_score_codex":0.0013828877,"about_ca_system_score_gemma":0.00052192016,"threshold_uncertainty_score":0.6170013},"labels":[],"label_agreement":null},{"id":"W3160850360","doi":"","title":"Abstracts of the Mid-Atlantic Section of the American Urological Association Annual Meeting October 4 - 7, 2018 Washington, DC.","year":2018,"lang":"en","type":"article","venue":"˜The œCanadian journal of urology/Canadian journal of urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Section (typography); Association (psychology); Family medicine; Gerontology","score_opus":0.012493257607825313,"score_gpt":0.2450391551947279,"score_spread":0.23254589758690258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160850360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964848,0.0008295788,0.000020990115,0.029249495,0.0033200094,0.00026549576,0.000064446125,0.0000033398437,0.0013986347],"genre_scores_gemma":[0.99225295,0.000040414787,0.00006747909,0.005776939,0.0016618136,0.000001624909,0.0000014675513,0.000037331032,0.00015998547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957949,0.0009777775,0.0015461992,0.00022252559,0.000583661,0.000874933],"domain_scores_gemma":[0.99270684,0.0004534556,0.0039830077,0.00044792672,0.0014731004,0.0009356733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023508912,0.00030909767,0.0009380356,0.00061900617,0.0005926606,0.000038357663,0.0009770903,0.00040988825,0.00026369863],"category_scores_gemma":[0.0012132288,0.00017595003,0.00059081183,0.0006874267,0.0018670574,0.00015862964,0.00003473093,0.0016835609,0.0000097828515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008217619,0.00009479071,0.9768026,0.00001586993,0.0011632909,0.00025720306,0.002221147,0.0004492871,0.00127075,0.000058943093,0.0152638,0.0015805769],"study_design_scores_gemma":[0.0019512884,0.004898247,0.9326832,0.00005405069,0.0012796287,0.0051766946,0.00029360264,0.000029042,0.0004179227,0.00080920913,0.052250423,0.00015664462],"about_ca_topic_score_codex":0.0977738,"about_ca_topic_score_gemma":0.6450941,"teacher_disagreement_score":0.5473203,"about_ca_system_score_codex":0.00059128576,"about_ca_system_score_gemma":0.0065925703,"threshold_uncertainty_score":0.9990391},"labels":[],"label_agreement":null},{"id":"W3160934438","doi":"10.3390/curroncol28030174","title":"DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"XRCC3; ERCC2; Single-nucleotide polymorphism; Genotype; Nucleotide excision repair; Population; Oncology; Medicine; Allele; SNP; Bladder cancer; DNA repair; Genetic predisposition; Genetics; Internal medicine; Cancer research; Bioinformatics; Gene; Biology; Cancer; Environmental health","score_opus":0.07248714933201357,"score_gpt":0.36023271394137213,"score_spread":0.2877455646093586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160934438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532515,0.0010881951,0.00004500678,0.0008735118,0.00061253546,0.00040870093,0.00003543825,0.000054026284,0.0015574205],"genre_scores_gemma":[0.99866647,0.000028044451,0.0002848931,0.00035556403,0.00036177493,0.000022991495,0.00006817363,0.000021980482,0.00019013007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867785,0.00025178317,0.00027700895,0.00043419172,0.00012271696,0.00023645136],"domain_scores_gemma":[0.9994062,0.00002514866,0.000041889736,0.00027573362,0.000060989554,0.00019003524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018913676,0.00013939098,0.00030685862,0.00008960697,0.000037613092,0.000008030627,0.00003992599,0.000056718356,0.0001293892],"category_scores_gemma":[0.00007076527,0.00012862973,0.0000733758,0.00015293494,0.00003698921,0.000030487223,0.00008629674,0.00014298875,0.000058775044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033045793,0.0004885047,0.94464624,0.000037290025,0.00001795423,0.00023770773,0.0011009042,0.0000010273226,0.00422638,0.000023806628,0.00010084931,0.04878886],"study_design_scores_gemma":[0.0031020564,0.0006561157,0.9884825,0.000046072502,0.00007262448,0.00013578778,0.00011643698,0.00005133111,0.00092562067,0.000059168324,0.006241802,0.00011051299],"about_ca_topic_score_codex":0.00022974126,"about_ca_topic_score_gemma":0.0007082271,"teacher_disagreement_score":0.048678346,"about_ca_system_score_codex":0.00018434216,"about_ca_system_score_gemma":0.00017548127,"threshold_uncertainty_score":0.52453685},"labels":[],"label_agreement":null},{"id":"W3161506397","doi":"10.1016/j.clon.2021.03.023","title":"Image-guided Adaptive Radiotherapy for Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Department of Health and Social Care; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Image-guided radiation therapy; Medicine; Radiation therapy; Bladder cancer; Magnetic resonance imaging; Medical physics; Radiology; Cone beam computed tomography; Nuclear medicine; Cancer; Computed tomography; Internal medicine","score_opus":0.17355811989307723,"score_gpt":0.5011132921455881,"score_spread":0.32755517225251085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161506397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49680924,0.041478127,0.036683563,0.22416386,0.020860476,0.008245534,0.00070300035,0.00069909357,0.17035711],"genre_scores_gemma":[0.38127562,0.02046621,0.3304073,0.16895513,0.01941612,0.0028184385,0.00028916312,0.000349443,0.076022565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848026,0.00014482401,0.0005397069,0.00043371838,0.00011123122,0.00029024293],"domain_scores_gemma":[0.9982726,0.0007409973,0.00011843313,0.00027881676,0.00035613196,0.0002330026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027113207,0.00014566674,0.0007329915,0.000025816558,0.0000553543,0.0000073361994,0.00006885525,0.000293896,0.00200724],"category_scores_gemma":[0.0003612661,0.00011696195,0.00036079506,0.00010854186,0.00020355766,0.000037122827,0.000026120308,0.00024005577,0.000049865655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006308548,0.0043113995,0.034386326,0.000083457584,0.00416319,0.00090102816,0.00036258026,0.0000040408254,0.0057801735,0.0009490338,0.41851425,0.52423596],"study_design_scores_gemma":[0.025161147,0.006997615,0.055618174,0.00004897777,0.0009279803,0.00014457232,0.00014064455,0.00046987328,0.0025778124,0.0009835412,0.906685,0.00024465346],"about_ca_topic_score_codex":0.000060033715,"about_ca_topic_score_gemma":0.00008982214,"teacher_disagreement_score":0.5239913,"about_ca_system_score_codex":0.0002507415,"about_ca_system_score_gemma":0.001973542,"threshold_uncertainty_score":0.99890506},"labels":[],"label_agreement":null},{"id":"W3161904857","doi":"10.1093/bjs/znab135.029","title":"92 Reshaping the Diagnostic Pathways for Investigation of Haematuria During and After The COVID-19 Pandemic: Diagnostic Accuracy of Strategies for Detection of Bladder Cancer from The IDENTIFY Cohort Study","year":2021,"lang":"en","type":"article","venue":"British journal of surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Triage; Bladder cancer; Cohort; Prospective cohort study; Cytology; Pandemic; Radiology; Cohort study; Cancer; Coronavirus disease 2019 (COVID-19); Emergency medicine; Surgery; Urinary system; Internal medicine; Pathology; Disease","score_opus":0.07935435111394161,"score_gpt":0.3300637395009444,"score_spread":0.2507093883870028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161904857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760654,0.021359842,0.000466567,0.00047438027,0.00031783464,0.001038303,0.00027155323,0.000004398521,0.000001716987],"genre_scores_gemma":[0.99433345,0.0047583743,0.000022376518,0.00031988282,0.0002721604,0.00026165522,0.000009102184,0.00001827336,0.000004706454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984863,0.00020423577,0.0007117865,0.00014583416,0.0003176003,0.0001342611],"domain_scores_gemma":[0.9853548,0.013247137,0.00068409747,0.00015947736,0.00048750863,0.000067014545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010054221,0.0001096185,0.00045660793,0.000045042732,0.00015600736,0.00005715887,0.0000818751,0.000054874596,0.000032043845],"category_scores_gemma":[0.0070172935,0.00006936771,0.00020079654,0.00013844811,0.00018480985,0.00018624439,0.00003190745,0.00016250221,5.4837937e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000601902,0.000110740526,0.9839325,0.00038739515,0.00086228584,0.00009303739,0.0017749335,0.00004940921,0.007858662,0.0000019518523,0.0004712564,0.0038559486],"study_design_scores_gemma":[0.0015701733,0.00010450563,0.98123264,0.0012184107,0.0011490051,0.0004849084,0.0035686612,0.000009753686,0.00947447,0.0010893134,0.0000342071,0.000063961874],"about_ca_topic_score_codex":0.0016242997,"about_ca_topic_score_gemma":0.0016550336,"teacher_disagreement_score":0.018268066,"about_ca_system_score_codex":0.000057049336,"about_ca_system_score_gemma":0.0006767968,"threshold_uncertainty_score":0.8400862},"labels":[],"label_agreement":null},{"id":"W3163082319","doi":"10.1111/bju.15483","title":"The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"Rosetrees Trust; Department of Health and Social Care; National Institute for Health and Care Research; Birmingham Biomedical Research Centre; Urology Care Foundation","keywords":"Observational study; Medicine; Urinary system; Cancer; Internal medicine; Oncology","score_opus":0.04293385287419099,"score_gpt":0.30620753919766774,"score_spread":0.26327368632347675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163082319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968494,0.0016168706,0.0000049383284,0.00086923444,0.00015105976,0.0004884939,0.0000063414295,0.000003541504,0.000010085757],"genre_scores_gemma":[0.99947816,0.00024064087,0.000014044906,0.00015332495,0.00006183942,0.000022227563,0.000003836021,0.0000081018825,0.000017799066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986576,0.00040714775,0.0003870291,0.00014022832,0.00028596824,0.00012202313],"domain_scores_gemma":[0.9990142,0.00020473011,0.00024975938,0.00008615916,0.00039433077,0.00005082099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026872446,0.000080526326,0.0002312665,0.000040645416,0.0001101268,0.000023783792,0.00006251848,0.000049560953,0.000017409318],"category_scores_gemma":[0.0002511283,0.000051267165,0.000031777156,0.00019856005,0.00009762413,0.0000824633,0.000025261199,0.00032046888,1.873769e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002150664,0.002353308,0.9851514,0.0000050052336,0.00023020073,0.0007827302,0.0007814736,0.00002279852,0.00015176153,8.889982e-7,0.00001903735,0.00835074],"study_design_scores_gemma":[0.008840361,0.006347714,0.98130184,0.00002421714,0.00030745746,0.0017553461,0.001212553,0.0000408634,0.000043933545,0.000040518316,0.000046052308,0.000039161776],"about_ca_topic_score_codex":0.00034271184,"about_ca_topic_score_gemma":0.0027929589,"teacher_disagreement_score":0.008311579,"about_ca_system_score_codex":0.000047976857,"about_ca_system_score_gemma":0.00017882827,"threshold_uncertainty_score":0.20906143},"labels":[],"label_agreement":null},{"id":"W3163163893","doi":"10.1016/j.eururo.2021.05.004","title":"Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Odds ratio; Confidence interval; Urology; Logistic regression; Biopsy; Retrospective cohort study; Stage (stratigraphy); Kidney disease; Hydronephrosis; T-stage; Internal medicine; Surgery; Cancer; Urinary system","score_opus":0.029307410559832922,"score_gpt":0.3055534652005652,"score_spread":0.27624605464073226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163163893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079907,0.00017394096,0.00017172738,0.0006088186,0.0006314072,0.001070323,0.0001864824,0.000041491694,0.00631676],"genre_scores_gemma":[0.99773735,0.0000628171,0.00040154738,0.00046558445,0.0003476356,0.00015129765,0.00040991788,0.000043528824,0.00038031366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812526,0.00061088987,0.000359832,0.0005185802,0.00015149254,0.00023394052],"domain_scores_gemma":[0.9990808,0.00016411766,0.00011692637,0.00033365178,0.00016452686,0.00014001361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031445493,0.00018151036,0.00030874915,0.00013963497,0.0000749503,0.000032782285,0.00008696155,0.000043974855,0.00017224289],"category_scores_gemma":[0.00032326422,0.00016740494,0.000074359195,0.00016670354,0.00003628845,0.000120359895,0.000028036455,0.00015375495,0.000026603322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067935605,0.0025136112,0.98858446,0.000011746742,0.00019038233,0.00050121365,0.002104396,0.000022096094,0.0009389695,0.00006535997,0.00019827495,0.004190111],"study_design_scores_gemma":[0.005595848,0.0016824187,0.98599416,0.000010416473,0.00022442592,0.00003675309,0.00054872705,0.00012595746,0.0018285473,0.00003643284,0.003803292,0.00011303597],"about_ca_topic_score_codex":0.00009649703,"about_ca_topic_score_gemma":0.00011611332,"teacher_disagreement_score":0.0069383085,"about_ca_system_score_codex":0.00012214699,"about_ca_system_score_gemma":0.00045655406,"threshold_uncertainty_score":0.68265754},"labels":[],"label_agreement":null},{"id":"W3163699696","doi":"10.1016/j.ijrobp.2021.01.009","title":"A Tailored Radiation Therapy Strategy for Older Patients With Localized Bladder Cancer Not Eligible for Curative Treatment","year":2021,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Radiation therapy; Perioperative; Population; Cancer; Incidence (geometry); Internal medicine; Clinical trial; Oncology; Urology; Surgery","score_opus":0.04258626135130758,"score_gpt":0.365861697806718,"score_spread":0.32327543645541046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163699696","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14192213,0.017689416,0.09541416,0.6893615,0.022208596,0.019186279,0.01315353,0.00024814002,0.0008162479],"genre_scores_gemma":[0.3547656,0.018429685,0.010119341,0.507753,0.055886157,0.00567689,0.042368185,0.00078056747,0.004220574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751836,0.00019588353,0.0009253516,0.00052847737,0.00041742416,0.00041451326],"domain_scores_gemma":[0.9945888,0.0005651903,0.0017838626,0.0002186304,0.0027355237,0.00010802764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015317563,0.0005546213,0.0011769984,0.000229106,0.00011578518,0.00006705466,0.00026831546,0.0007684619,0.00018281305],"category_scores_gemma":[0.0000760693,0.0003998902,0.00060712115,0.00015071039,0.00014199698,0.00025715574,0.000017203318,0.00058550964,0.000006130063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011372431,0.0026037723,0.051363215,0.00007845742,0.01959278,0.00008815336,0.0013618784,0.0008015852,0.00035716745,0.00030609383,0.29062077,0.6214537],"study_design_scores_gemma":[0.068998836,0.011357093,0.005032252,0.0001952714,0.0015269018,0.000038596376,0.00006328713,0.00040410913,0.00596917,0.0011925603,0.90471643,0.00050548284],"about_ca_topic_score_codex":0.00008881676,"about_ca_topic_score_gemma":0.000011400316,"teacher_disagreement_score":0.6209482,"about_ca_system_score_codex":0.0023285362,"about_ca_system_score_gemma":0.0029527,"threshold_uncertainty_score":0.9998453},"labels":[],"label_agreement":null},{"id":"W3164160325","doi":"","title":"Moderated Poster Session I: Oncology Thursday, September 29, 2016 10:15 am – 12:00 pm","year":2016,"lang":"en","type":"article","venue":"Europe PMC (PubMed Central)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children; Université Laval; University of Toronto; BC Cancer Agency; St. Michael's Hospital; Western University","funders":"","keywords":"Thursday; Session (web analytics); Medicine; Oncology; Internal medicine; Computer science; World Wide Web; Philosophy","score_opus":0.025758038716899665,"score_gpt":0.2709235916413555,"score_spread":0.24516555292445583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164160325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49533045,0.0017357552,0.00033713604,0.012678603,0.003270414,0.0025208865,0.0002058984,0.0005981359,0.4833227],"genre_scores_gemma":[0.8075545,0.0006758184,0.0001399266,0.0022638862,0.00089963875,0.00013505973,0.000045144723,0.00012720983,0.18815883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967727,0.00027882934,0.0004647603,0.0006981135,0.00043576877,0.0013498338],"domain_scores_gemma":[0.99813306,0.00008389951,0.0001543994,0.0006239661,0.0002103993,0.00079425215],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002198362,0.00042118915,0.0005450207,0.000110295216,0.00012018086,0.00004107653,0.00020438634,0.00021068033,0.006119488],"category_scores_gemma":[0.000113158676,0.00024651742,0.00016727405,0.00022211875,0.00013597106,0.00024936625,0.000117100964,0.00024311732,0.002760477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054365117,0.0016087467,0.07677282,0.00011581518,0.00085183815,0.0012435083,0.0023833523,0.0000044314106,0.03349456,0.000060114013,0.66261727,0.21541104],"study_design_scores_gemma":[0.009053438,0.0007149129,0.13926016,0.00028673545,0.00029565385,0.00019196422,0.000022197097,0.000009024452,0.028229428,0.000056741264,0.82147354,0.00040617672],"about_ca_topic_score_codex":0.000036539994,"about_ca_topic_score_gemma":0.000021898762,"teacher_disagreement_score":0.31222403,"about_ca_system_score_codex":0.00051067525,"about_ca_system_score_gemma":0.000539168,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W3164197656","doi":"10.1016/s1470-2045(21)00152-2","title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":648,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"Janssen Pharmaceuticals; Merck Sharp and Dohme; British Microcirculation Society; Novartis; Sanofi; Merck; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Bayer; Ipsen; Clovis Oncology; Roche; Astellas Pharma US; LEO Pharma Research Foundation; Pfizer","keywords":"Medicine; Pembrolizumab; Carboplatin; Gemcitabine; Chemotherapy; Oncology; Internal medicine; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Population; Cisplatin; Cancer; Immunotherapy; Bladder cancer","score_opus":0.10115703839334929,"score_gpt":0.4104142656501243,"score_spread":0.309257227256775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164197656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9331448,0.0011361414,0.000426427,0.04724117,0.0012210109,0.011846437,0.00017101341,0.00015799745,0.004654972],"genre_scores_gemma":[0.9462907,0.006003082,0.0046645463,0.027668208,0.003895396,0.0042092185,0.00032703337,0.0002662556,0.0066756145],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970204,0.0003269806,0.00062934257,0.0007989886,0.00038916589,0.00083508436],"domain_scores_gemma":[0.9968762,0.0011126096,0.00034874943,0.0010914948,0.00033036774,0.0002406166],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005811644,0.0005705614,0.002098113,0.00006897758,0.000369308,0.00008303918,0.00062121655,0.00027572294,0.0014383445],"category_scores_gemma":[0.00019431283,0.00032992178,0.0002059412,0.00039729185,0.00027546083,0.00013168185,0.00007543431,0.00038633778,0.000033886212],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9276526,0.0058035473,0.00003734816,0.000056854624,0.0012872462,0.00027693054,0.0008339871,0.000005647238,0.0038937987,0.00016075991,0.003990805,0.056000452],"study_design_scores_gemma":[0.75019246,0.08513039,0.00006577921,0.00004934283,0.00034663687,0.00020481658,0.000116664734,0.000095091535,0.021935206,0.0002919314,0.14125642,0.0003152646],"about_ca_topic_score_codex":0.00013728566,"about_ca_topic_score_gemma":0.0003532231,"teacher_disagreement_score":0.17746016,"about_ca_system_score_codex":0.0003806034,"about_ca_system_score_gemma":0.0024027827,"threshold_uncertainty_score":0.9999153},"labels":[],"label_agreement":null},{"id":"W3164278900","doi":"10.21203/rs.3.rs-41004/v1","title":"Prognostic Role of Preoperative C-Reactive Protein in Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy - An Updated Meta-Analysis","year":2020,"lang":"en","type":"preprint","venue":"Research Square (Research Square)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Urology; Medicine; Meta-analysis; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.13170057474937183,"score_gpt":0.4241669118382649,"score_spread":0.292466337088893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164278900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96730506,0.004163607,0.000080309095,0.0036595957,0.000050545055,0.020305283,0.0025651895,0.00013537884,0.0017349987],"genre_scores_gemma":[0.9815013,0.000063235406,0.0010272168,0.000084377,0.00051405985,0.013538303,0.0024138638,0.0002621982,0.0005954844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9746676,0.010182107,0.0016874818,0.0032481258,0.007500767,0.0027139063],"domain_scores_gemma":[0.99019873,0.0011343284,0.00029217883,0.0026030724,0.003945238,0.0018264435],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060181,0.0012312252,0.004287696,0.004561119,0.00033096882,0.00039804747,0.0014341203,0.0012473447,0.006883084],"category_scores_gemma":[0.0016611007,0.00096370105,0.002594631,0.005535689,0.0015884124,0.00051876344,0.0016757074,0.009218742,0.00017570272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052917488,0.022064865,0.6567726,0.005644695,0.18506044,0.008317667,0.03830318,0.00021659299,0.026087372,0.0006551604,0.0012613182,0.002698623],"study_design_scores_gemma":[0.01163917,0.020174932,0.8270538,0.0010356018,0.061679117,0.00006635052,0.007071321,0.0059127477,0.053744942,0.0063878116,0.0029830695,0.0022511214],"about_ca_topic_score_codex":0.015366763,"about_ca_topic_score_gemma":0.0013757843,"teacher_disagreement_score":0.17028122,"about_ca_system_score_codex":0.0016317839,"about_ca_system_score_gemma":0.0066532665,"threshold_uncertainty_score":0.99928135},"labels":[],"label_agreement":null},{"id":"W3164391832","doi":"10.1007/s00262-021-02953-0","title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Cystectomy; Biomarker; Lymph node; Bladder cancer; Oncology; Internal medicine; Lymphovascular invasion; Metastasis; Proportional hazards model; Urology; Cancer; Gastroenterology","score_opus":0.02685112807642974,"score_gpt":0.34695266755807463,"score_spread":0.3201015394816449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164391832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96741295,0.02844343,0.000099577795,0.0010843123,0.0006992995,0.0010050727,0.0011584229,0.000028831537,0.00006810627],"genre_scores_gemma":[0.99207866,0.0037207352,0.00030193446,0.00056889735,0.00007476294,0.0012435977,0.00003819852,0.000076004726,0.0018972086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982211,0.00012504715,0.0005695274,0.00049935206,0.00018320336,0.00040177233],"domain_scores_gemma":[0.9986113,0.00018434828,0.0002241287,0.00051871367,0.00034688617,0.000114637936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088415494,0.00039815903,0.0009963311,0.00015825179,0.00006290273,0.00001571765,0.00014959039,0.00019504939,0.003082732],"category_scores_gemma":[0.00005669927,0.00029625033,0.00044933823,0.00017593823,0.0004940428,0.00011206563,0.00005347928,0.0002553876,0.0000042205065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072078235,0.0019306258,0.55741453,0.0004348288,0.019202571,0.000054848082,0.0067402846,0.000034801342,0.2731434,0.00015477114,0.0011985188,0.06761257],"study_design_scores_gemma":[0.02064173,0.0029868262,0.8246857,0.00081368175,0.0004079483,0.000020281663,0.00021507985,0.000033171353,0.14748852,0.00008175368,0.0022749817,0.00035030744],"about_ca_topic_score_codex":0.0005236485,"about_ca_topic_score_gemma":0.00008332398,"teacher_disagreement_score":0.26727116,"about_ca_system_score_codex":0.0004358889,"about_ca_system_score_gemma":0.0011944157,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W3164781831","doi":"10.1016/s1470-2045(21)00147-9","title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":533,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Janssen Pharmaceuticals; Pfizer Japan; Genentech; Bavarian Nordic; Merck Sharp and Dohme; Ono Pharmaceutical; European Association of Urology; Bayer Fund; Mirati Therapeutics; Clovis Oncology; Sanofi; GlaxoSmithKline; Merck; Genzyme; Genomic Health; Chugai Pharmaceutical; Roche; Astellas Pharma US; Pfizer; Heron Therapeutics; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Pembrolizumab; Cystoscopy; Bladder cancer; Cystectomy; Cancer; Internal medicine; Clinical endpoint; Surgery; Progressive disease; Urology; Oncology; Clinical trial; Immunotherapy; Disease; Urinary system","score_opus":0.11916421107182466,"score_gpt":0.43648497625447374,"score_spread":0.31732076518264907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164781831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950643,0.0018237918,0.00034230566,0.0093739955,0.0007428222,0.006996357,0.000711795,0.000042053733,0.0004604525],"genre_scores_gemma":[0.9851564,0.0036723278,0.0016670449,0.004390954,0.0011340514,0.002714235,0.000059111437,0.00008251458,0.00112333],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99741304,0.00061233155,0.00046410057,0.0006478565,0.000265525,0.00059717556],"domain_scores_gemma":[0.9963145,0.0015252508,0.00029136008,0.0012083958,0.00045515003,0.00020529648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032110917,0.00038637352,0.0012275347,0.00006992641,0.00032368882,0.000049412247,0.0005185082,0.00013359873,0.00036798915],"category_scores_gemma":[0.00014772781,0.00021669046,0.00010968973,0.0003290406,0.00014805893,0.00008540498,0.000102850194,0.00017605012,0.00001938928],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11472233,0.09657296,0.003440816,0.00007114328,0.0077957134,0.00064004184,0.052642874,0.00046233574,0.032329947,0.00017423248,0.0054197805,0.68572783],"study_design_scores_gemma":[0.4186711,0.30977035,0.03657388,0.00015936611,0.008200466,0.000112354086,0.017124107,0.00053406076,0.07832822,0.0007109439,0.12900852,0.0008066364],"about_ca_topic_score_codex":0.0053556752,"about_ca_topic_score_gemma":0.010832789,"teacher_disagreement_score":0.6849212,"about_ca_system_score_codex":0.0007021311,"about_ca_system_score_gemma":0.0011906433,"threshold_uncertainty_score":0.8836381},"labels":[],"label_agreement":null},{"id":"W3165017804","doi":"10.1097/cej.0000000000000694","title":"Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer Prevention","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Incidence (geometry); Norwegian; Lung cancer; Cancer registry; Bladder cancer; Epidemiology; Population; Cancer","score_opus":0.014303559388867963,"score_gpt":0.3117397657770841,"score_spread":0.29743620638821616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165017804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96939987,0.02569502,0.000053376498,0.0038604848,0.0001508864,0.00010374173,0.000004202414,0.000002371998,0.0007300593],"genre_scores_gemma":[0.9947387,0.0036816811,0.000037211896,0.0009998379,0.000220296,0.0000095597015,0.0000014772553,0.000013049652,0.00029820498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987155,0.00044745248,0.0003444876,0.0001270953,0.00022798774,0.00013747602],"domain_scores_gemma":[0.999577,0.000043601623,0.00016640525,0.000112254966,0.000059631835,0.00004112347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010120035,0.00010090168,0.0001893615,0.00010004137,0.000049165174,0.0000377983,0.000069318536,0.000018047473,0.0001152501],"category_scores_gemma":[0.0000315462,0.00005802574,0.00005690737,0.00022651126,0.00007818442,0.00015870995,0.00002970107,0.0002844992,3.4842773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040573315,0.000029826222,0.8922107,0.000057114572,0.00012604982,0.0006900659,0.005701778,0.000035536512,0.000058165675,0.00001595289,0.0003830051,0.10028603],"study_design_scores_gemma":[0.0018425583,0.00017796908,0.9933912,0.00076591363,0.00020959335,0.00042060923,0.0005768082,0.00003234212,0.00004592908,0.00012144377,0.0023626264,0.00005298764],"about_ca_topic_score_codex":0.00016149874,"about_ca_topic_score_gemma":0.0038712395,"teacher_disagreement_score":0.10118047,"about_ca_system_score_codex":0.00016299717,"about_ca_system_score_gemma":0.00017035405,"threshold_uncertainty_score":0.2366221},"labels":[],"label_agreement":null},{"id":"W3165106178","doi":"10.21037/tau-20-1177","title":"Combination therapies involving checkpoint-inhibitors for treatment of urothelial carcinoma: a narrative review","year":2021,"lang":"en","type":"review","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Narrative review; Narrative; Medicine; Internal medicine; Intensive care medicine; Cancer; Bladder cancer; Philosophy","score_opus":0.05318434063691852,"score_gpt":0.3510568332698044,"score_spread":0.2978724926328859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165106178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038952671,0.9951545,0.00006604056,0.0018566567,0.00018860635,0.0019672608,0.00021128413,0.000015907137,0.00015021295],"genre_scores_gemma":[0.0025591834,0.99486756,0.00015941622,0.0003420154,0.0001876844,0.00060660375,0.0010598882,0.000030738676,0.00018689455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836946,0.00023375334,0.0006475331,0.00043139752,0.00010558297,0.00021228375],"domain_scores_gemma":[0.99901265,0.0003589199,0.0002564307,0.00015431487,0.0001480948,0.00006960853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013538224,0.00036042486,0.002193675,0.00013418483,0.00010139998,0.0000034751722,0.000044781696,0.00039466567,0.00015189046],"category_scores_gemma":[0.000018661349,0.0002614219,0.0005739216,0.0001223002,0.00021539655,0.000034993627,0.0000073183205,0.00010518594,0.000001926009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009857258,0.0015148234,0.0009414605,0.042950694,0.003889766,0.000067165885,0.0028247954,5.844978e-7,0.000017578348,0.0060949586,0.0004296574,0.94028276],"study_design_scores_gemma":[0.006252618,0.0057045543,0.00033122842,0.003346097,0.007927923,0.0006419103,0.000038088398,0.000014014918,0.000016482341,0.0010303219,0.97440517,0.00029160356],"about_ca_topic_score_codex":0.000020211468,"about_ca_topic_score_gemma":0.000018660547,"teacher_disagreement_score":0.9739755,"about_ca_system_score_codex":0.00003485979,"about_ca_system_score_gemma":0.00054561935,"threshold_uncertainty_score":0.9999838},"labels":[],"label_agreement":null},{"id":"W3165126997","doi":"10.1016/j.euf.2021.05.002","title":"Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma","year":2021,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Logistic regression; T-stage; Internal medicine; Oncology; Urology; Predictive value; Nomogram; Renal cell carcinoma; Cancer","score_opus":0.07363971253337363,"score_gpt":0.36938245299883327,"score_spread":0.2957427404654596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165126997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007410008,0.987626,0.00027175836,0.00011480943,0.0001434371,0.0015877733,0.000604678,0.000039792052,0.0022017416],"genre_scores_gemma":[0.17150715,0.8272908,0.0002655416,0.0003511817,0.00016283926,0.00005046784,0.00011364405,0.00012689055,0.00013150074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950809,0.0020361997,0.0012671426,0.0010035135,0.0002231519,0.00038909176],"domain_scores_gemma":[0.9978395,0.0007084201,0.00046886955,0.0006259477,0.00008292086,0.0002743579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085668435,0.0005498153,0.0027527711,0.00022357439,0.00004404125,0.000014496722,0.00016669171,0.00027801696,0.000095129115],"category_scores_gemma":[0.00047766135,0.0004302889,0.0004926517,0.00019602776,0.00057888293,0.000050024162,0.00016006385,0.00102002,0.0000075153885],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021238257,0.002229322,0.045814365,0.00605867,0.0008278589,0.004000212,0.00026888298,0.0000051971106,0.0000013795125,0.000050416325,0.00024181408,0.93837804],"study_design_scores_gemma":[0.039846316,0.009010376,0.08624235,0.0064916313,0.015254557,0.0014759749,0.00007613943,0.007914809,0.000018693698,0.00012386189,0.8320171,0.0015281521],"about_ca_topic_score_codex":0.00009372685,"about_ca_topic_score_gemma":0.000014284813,"teacher_disagreement_score":0.9368499,"about_ca_system_score_codex":0.00004577775,"about_ca_system_score_gemma":0.0011198225,"threshold_uncertainty_score":0.99981487},"labels":[],"label_agreement":null},{"id":"W3165681703","doi":"10.1002/onco.13827","title":"The Rapidly Evolving Landscape of First-Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; University of Alberta; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa; University of Toronto","funders":"","keywords":"Metastatic Urothelial Carcinoma; Medicine; Oncology; Gemcitabine; Internal medicine; Targeted therapy; Context (archaeology); Chemotherapy; Hazard ratio; Cancer; Clinical trial; Bladder cancer; Confidence interval; Urothelial carcinoma","score_opus":0.07377794113633378,"score_gpt":0.38916663484967917,"score_spread":0.3153886937133454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165681703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027917708,0.99010324,0.000005523287,0.00095755374,0.00033823383,0.007606294,0.00013538662,0.00003099171,0.0008199866],"genre_scores_gemma":[0.000100679135,0.99444693,0.000040831444,0.0005167625,0.00018200689,0.0036009066,0.0000773375,0.00007143605,0.00096312194],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957791,0.0013084293,0.001640635,0.00039689464,0.00047502364,0.00039994912],"domain_scores_gemma":[0.9957654,0.0017471899,0.0011019859,0.001103935,0.00020236328,0.00007913177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001773679,0.0005377961,0.005020386,0.000090939815,0.00017115122,0.000035435616,0.0005846513,0.00014937772,0.00036289913],"category_scores_gemma":[0.00093554973,0.00021990138,0.0008928623,0.000824409,0.00021437378,0.00003164415,0.000091714996,0.00054579234,0.000022915574],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008210858,0.00035527008,0.00003422568,0.8347336,0.002371037,0.0001304082,0.00015367415,0.0000015758145,3.9699356e-7,0.000033316384,0.0034082741,0.15869612],"study_design_scores_gemma":[0.0016024052,0.0006337711,0.0000122828515,0.6243042,0.00971675,0.00013711145,0.00007175756,0.000013377592,0.0000026402936,0.000020341336,0.36324108,0.00024430297],"about_ca_topic_score_codex":0.00049229804,"about_ca_topic_score_gemma":0.00072837627,"teacher_disagreement_score":0.3598328,"about_ca_system_score_codex":0.00040256514,"about_ca_system_score_gemma":0.0015956834,"threshold_uncertainty_score":0.89673185},"labels":[],"label_agreement":null},{"id":"W3165763576","doi":"10.1186/s12885-021-08371-w","title":"Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor","year":2021,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Päivikki ja Sakari Sohlbergin Säätiö; Novo Nordisk; Jane ja Aatos Erkon Säätiö; European Commission; Biomedicum Helsinki-säätiö; Helsingin ja Uudenmaan Sairaanhoitopiiri; Helsingin Yliopisto","keywords":"Snuff; Medicine; Incidence (geometry); Danish; Bladder cancer; Demography; Snus; Lung cancer; Epidemiology; Risk factor; Cancer; Environmental health; Gynecology; Smokeless tobacco; Population; Internal medicine; Pathology; Tobacco use","score_opus":0.038591690528742055,"score_gpt":0.35186313406657665,"score_spread":0.3132714435378346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165763576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449767,0.011002351,0.00002470147,0.0005994071,0.00013183078,0.00029752933,0.0004333428,0.000023942215,0.0029892556],"genre_scores_gemma":[0.9886973,0.0027753224,0.0003221777,0.00041667977,0.0002565495,0.00014324521,0.000024647386,0.00004088857,0.007323198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826944,0.00008141059,0.00030004772,0.0006365687,0.00026577557,0.0004467374],"domain_scores_gemma":[0.999109,0.00010344507,0.000104934115,0.000315607,0.00007125967,0.00029572388],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010118981,0.00029106752,0.0005281731,0.00015810905,0.00010418603,0.00007189413,0.00008023534,0.0001524097,0.0018996125],"category_scores_gemma":[0.000045835586,0.0002499692,0.00007670012,0.00044872708,0.00010232581,0.00016888602,0.00011065272,0.0002706365,0.000017709499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024748803,0.000026783155,0.92964906,0.000057861595,0.00019980564,0.00007450757,0.0005699499,0.0000062403956,0.00025123102,0.000006396206,0.001204641,0.06770603],"study_design_scores_gemma":[0.0038396746,0.00014712047,0.9903014,0.00017841462,0.0003998629,0.00006546269,0.00015484338,0.000055918998,0.0022448723,0.00007845366,0.002259652,0.0002743759],"about_ca_topic_score_codex":0.019984027,"about_ca_topic_score_gemma":0.028353417,"teacher_disagreement_score":0.06743166,"about_ca_system_score_codex":0.0004554307,"about_ca_system_score_gemma":0.0007830056,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W3165802374","doi":"10.1172/jci.insight.144920","title":"mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformation","year":2021,"lang":"en","type":"article","venue":"JCI Insight","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; Emerson Collective; National Institute of General Medical Sciences; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Fred Hutchinson Cancer Research Center; eFFECTOR Therapeutics; Burroughs Wellcome Fund; National Institute of Diabetes and Digestive and Kidney Diseases; NIH Office of the Director; U.S. Department of Defense","keywords":"EIF4E; Bladder cancer; Cancer research; Phosphorylation; Eukaryotic translation; Serine; Translation (biology); Kinase; Cancer; Biology; Cell biology; Messenger RNA; Gene; Biochemistry; Genetics","score_opus":0.052878600874785256,"score_gpt":0.3237166415879693,"score_spread":0.27083804071318407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165802374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6582896,0.018726315,0.13673161,0.069140844,0.0023389054,0.0068742214,0.00088831864,0.00059407396,0.10641609],"genre_scores_gemma":[0.9939273,0.0002237868,0.0011556188,0.0033972817,0.0002761137,0.00010160375,0.0002121265,0.000027796095,0.0006783763],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999016,0.00004444797,0.00025029856,0.00027059118,0.0002216457,0.00019700163],"domain_scores_gemma":[0.9994184,0.00005767779,0.000039561262,0.0002450996,0.00015305959,0.000086246095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009358591,0.0001527968,0.0002490116,0.000038321672,0.00013573225,0.000026871869,0.000041372838,0.00012348076,0.0012329451],"category_scores_gemma":[0.000009538626,0.00012830239,0.00020024674,0.00014435039,0.000035470912,0.00018837175,0.0000036352267,0.00011975236,0.000046718014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024910935,0.0019028656,0.0027534564,0.0007334515,0.0011426113,0.00003846942,0.04190933,0.00002119977,0.095165245,0.0007293719,0.0030841704,0.85002875],"study_design_scores_gemma":[0.020453494,0.001402837,0.02996864,0.0001508492,0.0015408915,0.000110648216,0.0008257534,0.003718556,0.47055846,0.01195269,0.4586951,0.0006220775],"about_ca_topic_score_codex":0.000041050855,"about_ca_topic_score_gemma":0.000054730514,"teacher_disagreement_score":0.84940666,"about_ca_system_score_codex":0.000056886936,"about_ca_system_score_gemma":0.00021660206,"threshold_uncertainty_score":0.99968004},"labels":[],"label_agreement":null},{"id":"W3166074522","doi":"10.1158/1078-0432.ccr-20-4175","title":"Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"National Center for Advancing Translational Sciences; Council for Science, Technology and Innovation; A.P. Giannini Foundation; Svenska Läkaresällskapet; National Cancer Institute; National Institutes of Health; Vetenskapsrådet; Giannini Foundation of Agricultural Economics","keywords":"Urothelial cancer; Cancer; Oncology; Medicine; Internal medicine; Cancer research; Bladder cancer; Biology","score_opus":0.15900562498021772,"score_gpt":0.5352728762811759,"score_spread":0.37626725130095817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166074522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325496,0.002732907,0.000037202815,0.0019832384,0.00046458025,0.0007292808,0.0002713394,0.000027447237,0.00049902877],"genre_scores_gemma":[0.9960764,0.0016012896,0.00021386525,0.0009291083,0.0004985454,0.00029428164,0.000019446083,0.00004817001,0.00031887984],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99578017,0.0008621714,0.0007450659,0.00079927174,0.0010328904,0.00078042503],"domain_scores_gemma":[0.997239,0.00078131474,0.000091553484,0.000631911,0.00077275856,0.000483452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023056094,0.00021471556,0.0007733117,0.00010825421,0.000100563,0.00002787836,0.00016132073,0.00024436633,0.0003872282],"category_scores_gemma":[0.0014009788,0.00018411844,0.0002510192,0.00081408635,0.0002987391,0.00006996703,0.00036471122,0.0008516919,0.000034148346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003913328,0.0011359247,0.6754897,0.00027590833,0.00016365144,0.00095458346,0.00057450787,0.00012509368,0.2836309,0.000015559384,0.0010308537,0.03268994],"study_design_scores_gemma":[0.00370143,0.00055252184,0.19907519,0.0005628997,0.000036894427,0.000011716415,0.00015628866,0.00003714038,0.7922989,0.00006531983,0.0033317509,0.00016994202],"about_ca_topic_score_codex":0.0050477297,"about_ca_topic_score_gemma":0.008705201,"teacher_disagreement_score":0.508668,"about_ca_system_score_codex":0.00026380838,"about_ca_system_score_gemma":0.0018458549,"threshold_uncertainty_score":0.7630691},"labels":[],"label_agreement":null},{"id":"W3166145929","doi":"10.1200/jco.2021.39.15_suppl.e16526","title":"Outcomes of patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICIs): Associations with age, race, sex and smoking history.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Logistic regression; Cohort; Oncology; Population; Proportional hazards model; Retrospective cohort study","score_opus":0.04954485064468183,"score_gpt":0.3603492603798838,"score_spread":0.31080440973520196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166145929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947458,0.0005627724,0.000032933225,0.0010168027,0.000290022,0.00034901692,0.000020992285,0.000010668777,0.0029710305],"genre_scores_gemma":[0.99577147,0.00014608155,0.0020018893,0.0004892471,0.00017944053,0.00001328732,0.000017552009,0.00003748287,0.0013435632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969895,0.00026626108,0.0017125069,0.0002614471,0.0005351452,0.00023516615],"domain_scores_gemma":[0.995918,0.0006235475,0.0020955675,0.00021638464,0.00087940576,0.0002671177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058901455,0.00023064432,0.001908219,0.000117013915,0.000052280884,0.0000068056725,0.0000780591,0.00022823528,0.00007339849],"category_scores_gemma":[0.0005423688,0.00013336407,0.00025612183,0.00017307799,0.00030251523,0.00013589243,0.00003304166,0.0006214875,7.334812e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070215636,0.0022804828,0.9640904,0.000029945832,0.0014072248,0.0010364042,0.00029956145,0.000011315767,0.0000945073,0.0000069531857,0.00014271977,0.023578925],"study_design_scores_gemma":[0.035228,0.021602433,0.9341921,0.00014002707,0.001455443,0.00015763845,0.00019778662,0.0000031041905,0.0010306385,0.0000097508955,0.0058452,0.0001378577],"about_ca_topic_score_codex":0.0001061504,"about_ca_topic_score_gemma":0.00018839994,"teacher_disagreement_score":0.029898275,"about_ca_system_score_codex":0.0005631445,"about_ca_system_score_gemma":0.0019330306,"threshold_uncertainty_score":0.5438429},"labels":[],"label_agreement":null},{"id":"W3166367379","doi":"10.1007/s10147-021-01941-9","title":"Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy","year":2021,"lang":"en","type":"article","venue":"International Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Università degli Studi di Napoli Federico II","keywords":"Medicine; Grading (engineering); Hazard ratio; Proportional hazards model; Guideline; Urology; Urothelial carcinoma; Epidemiology; Surgical oncology; Internal medicine; Oncology; Surgery; Cancer; Confidence interval; Pathology; Bladder cancer","score_opus":0.08678483267676279,"score_gpt":0.4564417319501107,"score_spread":0.3696568992733479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166367379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97803223,0.00064236927,0.0004858463,0.019424744,0.00052109244,0.00015189173,0.00001567351,0.000009645632,0.0007164849],"genre_scores_gemma":[0.99362826,0.0002651764,0.002246108,0.0021811211,0.0013776129,0.000001862979,0.000043895474,0.000022046648,0.00023394098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974394,0.0003674622,0.0013851848,0.000220628,0.00040024033,0.00018709413],"domain_scores_gemma":[0.9977136,0.00077029556,0.0006479876,0.00008631085,0.00048508027,0.00029669591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000610521,0.00014037054,0.0009823405,0.0002373988,0.000031257467,0.000024926216,0.00011740497,0.00014360009,0.00023512788],"category_scores_gemma":[0.00046906175,0.00010175949,0.00011690174,0.00024400438,0.00012894624,0.00011851547,0.000030252915,0.0006230027,0.000005228782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001350898,0.0008979623,0.94334036,0.0000084870535,0.00035282565,0.0009988139,0.00015333065,0.0000042787947,0.000056360008,0.000041289873,0.0009813347,0.051814057],"study_design_scores_gemma":[0.014046881,0.003099803,0.95667255,0.00023956876,0.00016671278,0.001194043,0.000066017565,0.000033453398,0.0004869496,0.00007944627,0.023826795,0.000087798915],"about_ca_topic_score_codex":0.0001420078,"about_ca_topic_score_gemma":0.00015224559,"teacher_disagreement_score":0.051726256,"about_ca_system_score_codex":0.00039007206,"about_ca_system_score_gemma":0.0021866644,"threshold_uncertainty_score":0.41496316},"labels":[],"label_agreement":null},{"id":"W3166486552","doi":"10.1016/j.euf.2021.05.004","title":"Genitourinary Cancer Prevention: Can We Make It a Reality?","year":2021,"lang":"en","type":"editorial","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Penile cancer; Epidemiology; Cancer; Genitourinary system; Scopus; Bladder cancer; Oncology; Gynecology; Internal medicine; MEDLINE","score_opus":0.02816685669059659,"score_gpt":0.32068018760120137,"score_spread":0.2925133309106048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166486552","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015595565,0.024154602,0.00003160333,0.026740255,0.7748791,0.0007909339,0.0010630735,0.00024181789,0.17194264],"genre_scores_gemma":[0.004115425,0.006822934,0.000074532276,0.001071839,0.88899034,0.000130695,0.0009612514,0.00027672644,0.09755626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614865,0.0008737097,0.00059970544,0.0010897277,0.0006543968,0.00063379924],"domain_scores_gemma":[0.9978949,0.00017208383,0.00028696365,0.0010087002,0.00031587709,0.00032150684],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033008395,0.00060178136,0.0009443972,0.0001639604,0.00015492714,0.00004065146,0.0003305358,0.00061754003,0.0024243286],"category_scores_gemma":[0.00018969897,0.00056161976,0.00043130975,0.0002188027,0.00017016786,0.000030255509,0.00028042807,0.0014919408,0.00035105075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006289829,0.00030586397,0.00008794233,0.00018362606,0.000985722,0.0074271676,0.00025203952,0.0000016719805,0.000028561668,0.000008086277,0.9698814,0.020208925],"study_design_scores_gemma":[0.0033846835,0.0015294453,0.0004889288,0.00026243724,0.001819963,0.00018537197,0.000030189312,8.4781175e-7,0.00004621238,0.00013871829,0.9917181,0.000395088],"about_ca_topic_score_codex":0.0005573236,"about_ca_topic_score_gemma":0.0012765224,"teacher_disagreement_score":0.11411121,"about_ca_system_score_codex":0.00026558255,"about_ca_system_score_gemma":0.001637731,"threshold_uncertainty_score":0.9996835},"labels":[],"label_agreement":null},{"id":"W3166910956","doi":"10.1200/jco.2021.39.15_suppl.4540","title":"Impact of recurrence on health-related quality of life in patients at high risk of recurrence after radical surgery for muscle-invasive urothelial carcinoma (MIUC): Results from the phase 3 CheckMate 274 trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Quality of life (healthcare); Proportional hazards model; Internal medicine; Placebo; Surgery; Post-hoc analysis; Oncology; Urology; Pathology","score_opus":0.16943839481837106,"score_gpt":0.47023146081041095,"score_spread":0.3007930659920399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166910956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912018,0.0008604969,0.00000981084,0.0023201958,0.0017906529,0.00089742686,0.0028850534,0.0000028960453,0.000031649048],"genre_scores_gemma":[0.99682504,0.0018981154,0.00025657448,0.00043863925,0.00044360143,0.000018788283,0.00008917551,0.000018314277,0.000011776605],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9885987,0.0031068295,0.006974464,0.0003699592,0.0006365064,0.0003135147],"domain_scores_gemma":[0.9683675,0.022330776,0.0074754083,0.00046951693,0.00094050216,0.000416301],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0061816755,0.00023474792,0.0033756755,0.000118411124,0.000037079102,0.000003345658,0.00020253212,0.00041583387,0.00013127927],"category_scores_gemma":[0.04661556,0.00014122238,0.0014232667,0.00028239185,0.00039045422,0.000068723115,0.00006327729,0.00086103025,0.0000022388897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4905851,0.009550087,0.4484825,0.00008359565,0.000714423,0.00005347482,0.00047317182,0.000008603827,0.000039668612,0.000003491885,0.00217047,0.047835406],"study_design_scores_gemma":[0.16716902,0.032471962,0.7985556,0.00059780886,0.00030850963,0.0000036496197,0.000034737455,0.000008872533,0.00034658134,0.00022456267,0.00019303038,0.000085634856],"about_ca_topic_score_codex":0.0029324542,"about_ca_topic_score_gemma":0.00047825882,"teacher_disagreement_score":0.3500731,"about_ca_system_score_codex":0.00037420267,"about_ca_system_score_gemma":0.0077820136,"threshold_uncertainty_score":0.99784297},"labels":[],"label_agreement":null},{"id":"W3167276022","doi":"10.1016/j.urolonc.2021.03.024","title":"Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Internal medicine; Proportional hazards model; Oncology; Bladder cancer; BCG vaccine; Logistic regression; Hazard ratio; Cancer; Confidence interval; Tuberculosis; Pathology","score_opus":0.03321787774255678,"score_gpt":0.3082676663313635,"score_spread":0.2750497885888067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167276022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574953,0.0010482067,0.000031840602,0.0018578168,0.00054096436,0.00043152136,0.000057278856,0.000016536653,0.0002663184],"genre_scores_gemma":[0.99516773,0.0002727283,0.0037830914,0.00036438808,0.00010549764,0.000092987575,0.00012431019,0.000016348868,0.00007290333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986883,0.00010198607,0.00032384618,0.00042856616,0.00017685733,0.00028046183],"domain_scores_gemma":[0.99924153,0.00013531439,0.00014080832,0.00015305943,0.00012673184,0.00020257007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010701814,0.00022676568,0.0004869026,0.000116563904,0.00009865096,0.000016134094,0.000048957216,0.00020053015,0.00006856786],"category_scores_gemma":[0.00010251045,0.00018206141,0.000052126918,0.00030408453,0.00045442302,0.00014264138,0.000063229345,0.00034342817,0.0000014486181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005779739,0.0029216767,0.9308888,0.00021318642,0.001132214,0.0005995673,0.0046646735,0.00017466476,0.01085166,0.00030611045,0.0009016692,0.041566093],"study_design_scores_gemma":[0.072300375,0.07018905,0.77982104,0.0014955018,0.005141822,0.0003478559,0.004208217,0.000955972,0.020582102,0.001315988,0.04223132,0.001410737],"about_ca_topic_score_codex":0.0002655144,"about_ca_topic_score_gemma":0.00091695314,"teacher_disagreement_score":0.15106769,"about_ca_system_score_codex":0.00034715977,"about_ca_system_score_gemma":0.0008376114,"threshold_uncertainty_score":0.7424249},"labels":[],"label_agreement":null},{"id":"W3167966244","doi":"10.1200/jco.2021.39.15_suppl.e16521","title":"Bladder cancer in young adults: Disease and treatment characteristics of patients treated at tertiary cancer center.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Cancer; Population; Internal medicine; Chemotherapy; Oncology; Urology","score_opus":0.04657035451728113,"score_gpt":0.40792344655921176,"score_spread":0.3613530920419306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167966244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439186,0.0020866934,7.977882e-7,0.001766014,0.0009611734,0.0002266355,0.00032772755,0.0000033740776,0.0002357273],"genre_scores_gemma":[0.97928166,0.018778954,0.000054123157,0.00079561106,0.00051349064,0.00002136289,0.000032223306,0.000017642038,0.0005049228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765056,0.00020265438,0.0015114257,0.00021524522,0.00022531161,0.0001947826],"domain_scores_gemma":[0.99797434,0.00023684163,0.000832788,0.00013389067,0.00041221958,0.00040993438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015853232,0.00016212926,0.001170904,0.00007169927,0.000022024831,0.000003816918,0.000049365186,0.00016762599,0.00054027117],"category_scores_gemma":[0.00023149303,0.00011021079,0.0002606982,0.00009387623,0.00011644582,0.00006413307,0.000043251548,0.00022375348,0.0000018271043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009761843,0.004233256,0.8772418,0.00004734138,0.0007163786,0.0007348253,0.00015728736,8.0565735e-7,0.000054306092,6.770289e-7,0.00032711442,0.106724344],"study_design_scores_gemma":[0.02154417,0.0034659558,0.96948665,0.00036383947,0.0010025596,0.000026766713,0.00002674426,0.00002386806,0.00025652556,0.000005402408,0.0037179568,0.000079556725],"about_ca_topic_score_codex":0.00039751307,"about_ca_topic_score_gemma":0.0014903161,"teacher_disagreement_score":0.10664479,"about_ca_system_score_codex":0.0004979112,"about_ca_system_score_gemma":0.001327626,"threshold_uncertainty_score":0.59155905},"labels":[],"label_agreement":null},{"id":"W3168444608","doi":"10.1200/jco.2021.39.15_suppl.4520","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Analysis of clinical and genomic subgroups from the JAVELIN Bladder 100 trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Carboplatin; Gemcitabine; Internal medicine; Oncology; Bladder cancer; Clinical endpoint; Cystectomy; Chemotherapy; Cisplatin; Clinical trial; Pembrolizumab; Cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.13188379846529086,"score_gpt":0.45187604112465235,"score_spread":0.3199922426593615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168444608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980093,0.0025631774,0.0017828741,0.011902245,0.0023666427,0.0007139437,0.00022887265,0.0000072344383,0.00034203377],"genre_scores_gemma":[0.9814482,0.004176446,0.006095339,0.004163484,0.0034856345,0.000024848901,0.00003496023,0.000035576224,0.0005355103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99318033,0.00074188,0.0048009125,0.00049787684,0.00041133614,0.00036766237],"domain_scores_gemma":[0.9858137,0.009709803,0.0025365597,0.0005244028,0.0009991443,0.00041641598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040042656,0.00025794795,0.0036464238,0.00012006626,0.00009743456,0.000015420066,0.00027947567,0.0005349426,0.0003998018],"category_scores_gemma":[0.00811276,0.00015917962,0.002064295,0.00035636636,0.00050741737,0.00008137615,0.00011501213,0.0009198939,0.0000057541265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32767206,0.006619,0.36629808,0.00005963295,0.020046173,0.0008020858,0.00045818268,0.00014000223,0.00043110902,0.0002117628,0.0050107418,0.27225116],"study_design_scores_gemma":[0.21207856,0.02052122,0.6911002,0.00009516007,0.015821135,0.00009091821,0.00030120552,0.00094644405,0.00020811366,0.0010429118,0.057585936,0.00020824469],"about_ca_topic_score_codex":0.00015867708,"about_ca_topic_score_gemma":0.0008998209,"teacher_disagreement_score":0.32480207,"about_ca_system_score_codex":0.00009928443,"about_ca_system_score_gemma":0.0029171158,"threshold_uncertainty_score":0.9712318},"labels":[],"label_agreement":null},{"id":"W3168935284","doi":"10.1038/s41586-021-03642-9","title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Nature","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":604,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Hazard ratio; Medicine; Atezolizumab; Internal medicine; Confidence interval; Oncology; Population; Clinical endpoint; Adjuvant; Bladder cancer; Adjuvant therapy; Biomarker; Immunotherapy; Cancer; Randomized controlled trial; Nivolumab; Biology","score_opus":0.0179659904279273,"score_gpt":0.294829534070764,"score_spread":0.2768635436428367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168935284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426072,0.027559444,0.000014432374,0.0038082844,0.00074098865,0.00030744096,0.000032340467,0.000056740537,0.024873083],"genre_scores_gemma":[0.99123764,0.00029361364,0.00045262277,0.004802508,0.0003489322,0.000018739633,0.000033923352,0.000030578118,0.0027814675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908566,0.000033939126,0.00016104648,0.00026357887,0.00022800411,0.00022775085],"domain_scores_gemma":[0.99952245,0.00002083731,0.000026109201,0.00028504187,0.00007944242,0.00006609802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006553739,0.00013906232,0.00025698263,0.00007049734,0.000037865713,0.000014878561,0.00006500214,0.000560376,0.0005851037],"category_scores_gemma":[0.000041219115,0.00011570009,0.00010106948,0.0002519818,0.000018207795,0.000045749377,0.000021562448,0.0007819328,0.000035976216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018598177,0.0010552747,0.5510423,0.00017832595,0.0003640082,0.0055606505,0.0023377563,0.0000050883964,0.3210591,0.0016231824,0.015736455,0.09917798],"study_design_scores_gemma":[0.012549664,0.00033444847,0.6325203,0.00024430515,0.00009077544,0.00044495444,0.00028733705,0.00003940212,0.20207846,0.00056874834,0.15051368,0.00032788378],"about_ca_topic_score_codex":0.00008153452,"about_ca_topic_score_gemma":0.00004775873,"teacher_disagreement_score":0.13477722,"about_ca_system_score_codex":0.000131739,"about_ca_system_score_gemma":0.00029226314,"threshold_uncertainty_score":0.6406475},"labels":[],"label_agreement":null},{"id":"W3169233953","doi":"10.48083/nztc6259","title":"Incidence and Predictors of Secondary Upper Tract Urothelial Cancer in Patients with High-Risk Non-Muscle Invasive Urinary Bladder Cancer and its Impact on Imaging Surveillance: A Retrospective Analysis with 1501 Patients","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Urology; Incidence (geometry); Urinary system; Retrospective cohort study; Urothelial cancer; Radiology; Cancer; Internal medicine","score_opus":0.006380692442441157,"score_gpt":0.27879412418989913,"score_spread":0.27241343174745797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169233953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685884,0.00084234495,0.000010406946,0.0003109828,0.00020030199,0.00037458868,0.0011983593,0.000010923871,0.00019323164],"genre_scores_gemma":[0.9974667,0.0018229408,0.000050511797,0.00027361448,0.00014664736,0.000046918023,0.000083407525,0.000027210628,0.00008205612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805886,0.00011697644,0.00038767842,0.00045058253,0.00068846834,0.000297416],"domain_scores_gemma":[0.9981426,0.00018739961,0.0004687127,0.0001487424,0.0008882421,0.0001643034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001727542,0.00029310666,0.0005916045,0.00032425034,0.000113082344,0.0000445988,0.00010331766,0.00008627492,0.0005216489],"category_scores_gemma":[0.00015044825,0.0001980294,0.00013279637,0.00039240468,0.00012792158,0.00032104246,0.00006450049,0.000611588,4.5636972e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021086133,0.00068686705,0.99059504,0.000022832268,0.0024942001,0.00011261619,0.0006436383,0.00041670713,0.00004420418,0.0000015982116,0.000054141154,0.002819556],"study_design_scores_gemma":[0.009679766,0.0022522847,0.9863109,0.0001784942,0.0006645628,0.000028699467,0.00017141439,0.00011614758,0.00035095625,0.000053472337,0.000006862414,0.00018642315],"about_ca_topic_score_codex":0.00056287245,"about_ca_topic_score_gemma":0.00042122975,"teacher_disagreement_score":0.0075711533,"about_ca_system_score_codex":0.00057518587,"about_ca_system_score_gemma":0.00078995794,"threshold_uncertainty_score":0.8075405},"labels":[],"label_agreement":null},{"id":"W3169572679","doi":"10.1016/j.ijrobp.2021.01.057","title":"In Reply to Khalifa and Sargos","year":2021,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Atezolizumab; Scopus; Bladder cancer; Medicine; Internal medicine; Oncology; Cancer; MEDLINE; Biology; Pembrolizumab; Immunotherapy","score_opus":0.026372650466185095,"score_gpt":0.3442559944037826,"score_spread":0.3178833439375975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169572679","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027889602,0.0020048588,0.0010113021,0.9606156,0.005926041,0.00047112472,0.00022071938,0.000024041266,0.0018367589],"genre_scores_gemma":[0.039653525,0.001584009,0.0025194972,0.9332075,0.021537526,0.000032379092,0.00039598005,0.000072134106,0.0009974234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979804,0.00022484279,0.0008175798,0.00036060138,0.00035384393,0.00026273323],"domain_scores_gemma":[0.9980008,0.0002949858,0.00070985104,0.00019618582,0.0006687786,0.00012941063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002958295,0.00028256592,0.00081555353,0.00032678162,0.000031215557,0.00003433688,0.00026765952,0.0005874039,0.00016984253],"category_scores_gemma":[0.00027897063,0.00025356372,0.0002273221,0.00017670056,0.00009721089,0.0001595684,0.000081262435,0.001419177,0.000036238038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005294813,0.00037351387,0.08045341,0.00004364117,0.0014582835,0.0033852132,0.0006701354,0.00003213791,0.0006919902,0.00043451326,0.843352,0.06857569],"study_design_scores_gemma":[0.0049622487,0.0011591166,0.005893581,0.00020677276,0.00021460533,0.0010770212,0.000029332065,0.000028925302,0.0006492135,0.003145092,0.9824267,0.00020738991],"about_ca_topic_score_codex":0.00009755985,"about_ca_topic_score_gemma":0.000007946923,"teacher_disagreement_score":0.13907471,"about_ca_system_score_codex":0.0010708089,"about_ca_system_score_gemma":0.0010660989,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W3169728670","doi":"10.1200/jco.2021.39.15_suppl.4518","title":"PrE0807: A phase Ib feasibility trial of neoadjuvant nivolumab (N) without or with lirilumab (L) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Cisplatin; Cystectomy; Cohort; Bladder cancer; Urology; Internal medicine; Oncology; Neoadjuvant therapy; Clinical endpoint; Nivolumab; Chemotherapy; Gastroenterology; Cancer; Randomized controlled trial; Immunotherapy","score_opus":0.13624497872604938,"score_gpt":0.48572026279155106,"score_spread":0.34947528406550166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169728670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445975,0.00038317675,0.00007520051,0.0014488751,0.0008473135,0.0012139255,0.000049892045,0.000010613991,0.0015112411],"genre_scores_gemma":[0.993947,0.0007333747,0.0028285824,0.0010049301,0.000807663,0.000046665784,0.000012670558,0.000045211378,0.0005738463],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947664,0.0006065398,0.0028598027,0.00050209067,0.00084960845,0.00041554144],"domain_scores_gemma":[0.99385685,0.0012573826,0.0022741682,0.00045388928,0.0016648774,0.0004928571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011389952,0.00032314012,0.0027515683,0.00016606355,0.000044876804,0.000013562732,0.00018586018,0.0003944,0.0005831888],"category_scores_gemma":[0.0022826432,0.00018437744,0.00040088495,0.0004757952,0.0003389778,0.00020893542,0.00006253138,0.0010177847,0.000004491301],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54055816,0.023560828,0.34982318,0.00013167794,0.0013787211,0.0020799038,0.00046043066,0.00004399797,0.00010326908,0.0000048170396,0.0008124626,0.08104257],"study_design_scores_gemma":[0.6487303,0.14754312,0.19474672,0.0009813138,0.0023246242,0.00029472433,0.00036144804,0.000044649852,0.0009085559,0.00007651544,0.0037227387,0.00026530545],"about_ca_topic_score_codex":0.00033724276,"about_ca_topic_score_gemma":0.005235875,"teacher_disagreement_score":0.15507644,"about_ca_system_score_codex":0.00045374234,"about_ca_system_score_gemma":0.013658491,"threshold_uncertainty_score":0.99193317},"labels":[],"label_agreement":null},{"id":"W3169869292","doi":"10.1016/j.jval.2021.04.210","title":"PCN118 Estimated Prevalence of Treated Locally Advanced or Metastatic Urothelial Carcinoma in Canada Using Simulation Modeling","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Incidence (geometry); Population; Disease; Metastatic Urothelial Carcinoma; Cancer; Stage (stratigraphy); Clinical trial; Internal medicine; Oncology; Demography; Urothelial carcinoma; Environmental health","score_opus":0.12021920660365858,"score_gpt":0.36470048855537374,"score_spread":0.24448128195171515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169869292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582046,0.001547716,0.0016176178,0.00011604103,0.000086737695,0.00070271164,0.0000672951,0.000012312629,0.00002908707],"genre_scores_gemma":[0.99498457,0.0001592149,0.0045537404,0.00019432438,0.00001538772,0.000015037116,0.000018778528,0.000024522831,0.00003440218],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982903,0.0001875715,0.00064177543,0.0002862745,0.00028628053,0.000307825],"domain_scores_gemma":[0.9992972,0.00012721916,0.00012066491,0.00021197282,0.00012227382,0.000120688754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016921877,0.0001466772,0.00044960415,0.00011493499,0.000030805568,0.000003706799,0.00004582697,0.000030799827,0.00006126426],"category_scores_gemma":[0.00015443185,0.00012956797,0.00003037335,0.00051798666,0.000014130584,0.00006628783,0.000015303882,0.00012563304,5.799529e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006208705,0.00009857552,0.08209878,0.0012009905,0.000016115131,0.00020777773,0.0002690375,0.91262907,0.0004992012,0.000004750921,6.0255167e-7,0.0023542296],"study_design_scores_gemma":[0.003776483,0.0002508241,0.022085572,0.0013249444,0.000046890164,0.000027956905,0.00015215999,0.97075826,0.0014514118,0.00003343942,0.000002052361,0.00009003618],"about_ca_topic_score_codex":0.9206912,"about_ca_topic_score_gemma":0.38945824,"teacher_disagreement_score":0.53123295,"about_ca_system_score_codex":0.0019557315,"about_ca_system_score_gemma":0.012616033,"threshold_uncertainty_score":0.9929815},"labels":[],"label_agreement":null},{"id":"W3170286703","doi":"10.1097/pap.0000000000000309","title":"The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers","year":2021,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal","funders":"","keywords":"Genitourinary system; Medicine; Bladder cancer; Surgical pathology; Urothelial carcinoma; Oncology; Internal medicine; Pathology; Gynecology; Cancer","score_opus":0.0533391663480829,"score_gpt":0.3527384016026018,"score_spread":0.2993992352545189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170286703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005117892,0.9925978,0.0003758126,0.00017983423,0.00018457555,0.00096842786,0.00015584323,0.000017770824,0.00040201825],"genre_scores_gemma":[0.009757544,0.9866962,0.002730178,0.00014230666,0.000034349003,0.0005132996,0.00007035597,0.0000386314,0.000017146916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799865,0.0003134504,0.0007305901,0.00057427003,0.000097423625,0.00028559324],"domain_scores_gemma":[0.99814105,0.0004595609,0.0006774611,0.0005759819,0.00009895269,0.000046997655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003045786,0.00032351224,0.0013176169,0.00013033903,0.00009976529,0.000006470023,0.00018935156,0.00027384787,0.000005493269],"category_scores_gemma":[0.00010871372,0.00024250521,0.00018238474,0.00028748516,0.0007407372,0.000049423244,0.00007910677,0.00039051546,5.8617985e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007195024,0.000086499094,0.0013676704,0.0011654476,0.00016132194,0.00019111979,0.00010957087,0.0000028135657,0.000560148,0.0023067265,0.000026800675,0.99394995],"study_design_scores_gemma":[0.0040816134,0.0012875969,0.009122771,0.0046950225,0.0014989242,0.0047272323,0.0004972439,0.000070791466,0.00029500836,0.0027768174,0.9701913,0.0007556979],"about_ca_topic_score_codex":0.00005511431,"about_ca_topic_score_gemma":0.00003419349,"teacher_disagreement_score":0.9931942,"about_ca_system_score_codex":0.00031229042,"about_ca_system_score_gemma":0.00069539703,"threshold_uncertainty_score":0.9889076},"labels":[],"label_agreement":null},{"id":"W3170421887","doi":"10.1016/j.euros.2021.05.002","title":"Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint","year":2021,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Ontario Ministry of Research and Innovation; Queen's University","keywords":"Immune system; Bladder cancer; Transcriptome; Immune checkpoint; Biology; CD163; Sexual dimorphism; Tumor microenvironment; Immunology; Cancer; Internal medicine; Oncology; Cancer research; Immunotherapy; Gene expression; Medicine; Gene; Endocrinology; Genetics; Phenotype","score_opus":0.017381077767072425,"score_gpt":0.2941137366368099,"score_spread":0.27673265886973747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170421887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856616,0.0023357857,0.0000074119143,0.0009930528,0.00018080171,0.00042223086,0.000045075565,0.00000902677,0.010344975],"genre_scores_gemma":[0.9972903,0.00037757307,0.00054576754,0.0006745168,0.000027093118,0.000014850477,0.000004788881,0.000024767774,0.0010403149],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980432,0.00016722744,0.0004953813,0.0006281385,0.00029846365,0.0003675837],"domain_scores_gemma":[0.9988251,0.000076153636,0.00020520098,0.00056167843,0.0001835319,0.00014835212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071195624,0.00019244454,0.00058095425,0.00015396226,0.000119822835,0.000023759301,0.0006191665,0.00004280491,0.00024246446],"category_scores_gemma":[0.00015014055,0.00016024854,0.00005248921,0.00056392245,0.0009463048,0.0001783197,0.0012538093,0.00019826127,0.000017992963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018213301,0.000366601,0.11888109,0.000041113846,0.000089087735,0.00045277865,0.002792582,0.000023980658,0.86998963,0.000045795055,0.000041695424,0.0070935106],"study_design_scores_gemma":[0.0024473607,0.00055046775,0.77911115,0.00003385243,0.00008808776,0.00005255336,0.0004981606,0.000041732423,0.21651037,0.00002963841,0.000519479,0.000117125426],"about_ca_topic_score_codex":0.0016773798,"about_ca_topic_score_gemma":0.00026768618,"teacher_disagreement_score":0.6602301,"about_ca_system_score_codex":0.00004730202,"about_ca_system_score_gemma":0.00072087586,"threshold_uncertainty_score":0.65347457},"labels":[],"label_agreement":null},{"id":"W3170759998","doi":"10.1016/j.urolonc.2021.05.008","title":"Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cohort; Bladder cancer; Cystectomy; Radiation therapy; Urology; Oncology; Stage (stratigraphy); Proportional hazards model; Internal medicine; Cancer","score_opus":0.021050079404503905,"score_gpt":0.3062340415336144,"score_spread":0.28518396212911046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170759998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372214,0.001442803,0.00029971116,0.0028150422,0.00006758394,0.0002350552,0.000045480607,0.000018103883,0.001354097],"genre_scores_gemma":[0.96216834,0.007085418,0.027517647,0.0012073802,0.000042652337,0.00017102776,0.00031571553,0.0000072500366,0.0014845812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992068,0.00006192261,0.00021825671,0.00028079076,0.00010357864,0.00012868286],"domain_scores_gemma":[0.99954754,0.000038614777,0.000094289644,0.00013489323,0.00006679924,0.00011788818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112569374,0.000111773144,0.00034420937,0.00010981563,0.000067689914,0.00001149508,0.00002720759,0.00010136432,0.0001828848],"category_scores_gemma":[0.000013432621,0.00009281699,0.00005024327,0.00044914542,0.00028309098,0.000057103676,0.000036011043,0.00008699496,0.0000030574593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009149292,0.00015172093,0.99174315,0.000081243605,0.0008680142,0.00018729338,0.0002939646,0.000001925644,0.0008112129,0.0011677807,0.00005975034,0.0045424695],"study_design_scores_gemma":[0.0008387317,0.0007741813,0.87930775,0.000075802986,0.0056004445,0.00014124395,0.0002636026,0.0001873094,0.0014092596,0.0011532133,0.1101207,0.0001277621],"about_ca_topic_score_codex":0.000024809025,"about_ca_topic_score_gemma":0.000026778383,"teacher_disagreement_score":0.11243538,"about_ca_system_score_codex":0.000032093445,"about_ca_system_score_gemma":0.0001033805,"threshold_uncertainty_score":0.3784967},"labels":[],"label_agreement":null},{"id":"W3171334864","doi":"10.1200/jco.2021.39.15_suppl.4527","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Avelumab; Chemotherapy; Hazard ratio; Internal medicine; Metastatic Urothelial Carcinoma; Urology; Gastroenterology; Neutropenia; Intention-to-treat analysis; Post-hoc analysis; Surgery; Urothelial carcinoma; Bladder cancer; Oncology; Randomized controlled trial; Pembrolizumab; Immunotherapy; Cancer; Confidence interval","score_opus":0.07614720092709548,"score_gpt":0.40875762380772296,"score_spread":0.3326104228806275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171334864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811572,0.00058129616,0.0044074706,0.0114022745,0.0005971978,0.0010874558,0.00054595893,0.0000036445908,0.00021749476],"genre_scores_gemma":[0.9894556,0.0012372216,0.0069599594,0.001376411,0.0005168782,0.00005389685,0.00005843242,0.000028071914,0.00031352905],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947562,0.00045195656,0.0036915937,0.0003505365,0.00043712367,0.0003125854],"domain_scores_gemma":[0.99357784,0.0024420356,0.0023089424,0.00058570155,0.00091065187,0.00017483528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017185562,0.00025261167,0.0027400914,0.00020718903,0.00002835202,0.000006262133,0.00035487316,0.00029144154,0.00030391378],"category_scores_gemma":[0.0026602475,0.00015823761,0.0012956291,0.0005240579,0.00021480217,0.000090976006,0.000044980774,0.00031980473,0.0000011533884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6483689,0.022436982,0.077821106,0.00018929076,0.013251633,0.0004353656,0.004459485,0.0003587543,0.0233388,0.00015452213,0.010554772,0.19863038],"study_design_scores_gemma":[0.5487382,0.1550815,0.18672867,0.0005322315,0.008706754,0.000090046924,0.0027634164,0.0007413079,0.061340794,0.002385351,0.032439973,0.00045180006],"about_ca_topic_score_codex":0.0008021789,"about_ca_topic_score_gemma":0.0032706966,"teacher_disagreement_score":0.19817857,"about_ca_system_score_codex":0.0003411956,"about_ca_system_score_gemma":0.0015733556,"threshold_uncertainty_score":0.6452742},"labels":[],"label_agreement":null},{"id":"W3171965251","doi":"10.1200/jco.2021.39.15_suppl.4539","title":"Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Discontinuation; Internal medicine; Docetaxel; Randomized controlled trial; Performance status; Oncology; Cancer","score_opus":0.08126607043643114,"score_gpt":0.43399669406402647,"score_spread":0.35273062362759533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171965251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968899,0.00058540725,0.0001920554,0.00022792908,0.00061885803,0.0011984067,0.00004039119,0.0000049463806,0.0002421457],"genre_scores_gemma":[0.9970517,0.00035459164,0.0019329773,0.00029698107,0.00022046927,0.000023776593,0.000021782485,0.00002246521,0.00007526986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943153,0.001282588,0.0034610794,0.0002579585,0.0004893335,0.00019373388],"domain_scores_gemma":[0.99191165,0.0041535925,0.0027517916,0.00022255187,0.0006764025,0.00028403927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001821724,0.00020863106,0.003756072,0.000108350025,0.000018910974,0.000005577897,0.00008471903,0.00019139453,0.00031540816],"category_scores_gemma":[0.0058648023,0.00012535554,0.00046760394,0.0001999239,0.00031824512,0.00009895448,0.000018835379,0.00040838655,6.731163e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84954727,0.007054771,0.06818125,0.000053797678,0.00211718,0.00009281646,0.00021077438,0.0000074812424,0.000056929282,0.000005604835,0.00001801449,0.072654106],"study_design_scores_gemma":[0.8391362,0.06892653,0.089632645,0.00017027449,0.0014357166,0.000007184319,0.00009373094,0.000031069623,0.0002737011,0.000037877435,0.00016451273,0.00009058509],"about_ca_topic_score_codex":0.0002983952,"about_ca_topic_score_gemma":0.00021186999,"teacher_disagreement_score":0.07256352,"about_ca_system_score_codex":0.00011273793,"about_ca_system_score_gemma":0.004234257,"threshold_uncertainty_score":0.75113904},"labels":[],"label_agreement":null},{"id":"W3172035145","doi":"10.1200/jco.2021.39.15_suppl.e16506","title":"Is first-line immune checkpoint inhibitors (ICI) beneficial to platinum-eligible patients (pts) with advanced urothelial carcinoma (aUC)? a meta-analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Meta-analysis; Cochrane Library; Randomized controlled trial; Subgroup analysis; Confidence interval; Oncology; Study heterogeneity; Inclusion and exclusion criteria; Pathology","score_opus":0.12480162678074795,"score_gpt":0.42039177917739434,"score_spread":0.2955901523966464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172035145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803902,0.0013299924,0.00033193582,0.014398596,0.000955141,0.0005380698,0.00008451884,0.000016322312,0.0019552237],"genre_scores_gemma":[0.98617107,0.00022105193,0.0055743787,0.00593877,0.0011984042,0.000027922188,0.000024372475,0.00004732607,0.00079668494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99407905,0.00030548224,0.0036976007,0.0005340534,0.0009359869,0.000447799],"domain_scores_gemma":[0.9946125,0.00072581694,0.0018416482,0.0005079117,0.0015853277,0.00072680315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012127053,0.0003776212,0.0046145367,0.0003116921,0.00010321891,0.000023673485,0.00021994788,0.00038639875,0.001453448],"category_scores_gemma":[0.0012822412,0.00024044156,0.0033196271,0.00088110304,0.0001118739,0.0001426073,0.00011846114,0.00089862297,0.0000538463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06169212,0.02475475,0.497088,0.00019879533,0.32193848,0.005108308,0.0023216459,0.0030772514,0.0011949893,0.000069881484,0.005463664,0.077092126],"study_design_scores_gemma":[0.05610101,0.076225996,0.44513464,0.000100936806,0.3189389,0.0003261792,0.00030702696,0.00010284178,0.018950632,0.00029886997,0.08278853,0.0007244366],"about_ca_topic_score_codex":0.00021601755,"about_ca_topic_score_gemma":0.00061688595,"teacher_disagreement_score":0.07732487,"about_ca_system_score_codex":0.0002869795,"about_ca_system_score_gemma":0.0022498711,"threshold_uncertainty_score":0.9994594},"labels":[],"label_agreement":null},{"id":"W3172790476","doi":"10.1097/pap.0000000000000308","title":"The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia","year":2021,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal","funders":"","keywords":"Cystoscopy; Medicine; Grading (engineering); Terminology; Bladder cancer; Surgical pathology; Genitourinary system; Disease; Malignancy; Pathology; Anatomical pathology; General surgery; Cancer; Internal medicine; Alternative medicine","score_opus":0.042927022023592463,"score_gpt":0.34183860021059265,"score_spread":0.2989115781870002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172790476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2893366,0.7089199,0.00039861872,0.00023320857,0.000072812465,0.0008642855,0.00006158932,0.0000115413095,0.00010147811],"genre_scores_gemma":[0.049419165,0.9456673,0.004560865,0.00006494648,0.0000436629,0.0001058943,0.00006587312,0.000038697097,0.000033581786],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998013,0.0002090149,0.000800454,0.000624293,0.00011531619,0.00023789455],"domain_scores_gemma":[0.99834543,0.00028972758,0.0008743199,0.000323202,0.000047588735,0.0001197083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031862303,0.00031663096,0.001261135,0.00014612077,0.00013080338,0.000014229758,0.00006790014,0.0001979913,0.0000011539371],"category_scores_gemma":[0.00006932629,0.00020218734,0.0000666665,0.00018927142,0.0002724497,0.00008420314,0.00009139568,0.00035021958,1.2079401e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018263464,0.00007927777,0.046827354,0.00195658,0.00019315217,0.0001874234,0.0009316982,8.9017044e-7,0.000045070843,0.00042919003,0.000027673292,0.94913906],"study_design_scores_gemma":[0.026924318,0.01689418,0.43369138,0.06894757,0.012732661,0.09265634,0.023123894,0.00020275266,0.0006902052,0.0021782576,0.31805503,0.0039033971],"about_ca_topic_score_codex":0.000033497814,"about_ca_topic_score_gemma":0.00010222127,"teacher_disagreement_score":0.94523567,"about_ca_system_score_codex":0.000046143396,"about_ca_system_score_gemma":0.0002312649,"threshold_uncertainty_score":0.82449603},"labels":[],"label_agreement":null},{"id":"W3173083508","doi":"10.1136/jclinpath-2021-207573","title":"Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Sunnybrook Research Institute","keywords":"Immunohistochemistry; GATA3; Tissue microarray; Basal (medicine); Bladder cancer; Cystectomy; Pathology; Biology; Staining; Internal medicine; Medicine; Oncology; Cancer","score_opus":0.08193218367062408,"score_gpt":0.39560925435825534,"score_spread":0.3136770706876313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173083508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986924,0.00094266364,0.0062431055,0.001461097,0.00069934875,0.0002649359,0.00001677598,0.0000048614447,0.0004979562],"genre_scores_gemma":[0.99354964,0.00025612937,0.004318638,0.00077194034,0.0008448985,0.00000561652,0.000010135607,0.000019878595,0.0002231467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986549,0.00010070376,0.00069225894,0.00021535243,0.00018197007,0.00015483415],"domain_scores_gemma":[0.99817246,0.0005991693,0.00042083795,0.00013481635,0.0004904144,0.00018228994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041203428,0.00011621456,0.00058461895,0.0000523024,0.000050070503,0.000009503916,0.000046481895,0.00020849807,0.00007769529],"category_scores_gemma":[0.0009182288,0.00007550246,0.00017786358,0.00006144417,0.00008350796,0.00007227331,0.000026907594,0.00034601556,0.0000054865836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070637525,0.0012798473,0.83410716,0.00015484905,0.0002529446,0.0042585894,0.00039618282,0.000010441656,0.1318349,0.00025176845,0.0012633791,0.019126216],"study_design_scores_gemma":[0.015544024,0.0065751947,0.96175987,0.00024655406,0.00057933055,0.002532542,0.00015049068,0.00014900485,0.008769422,0.00082267914,0.0027500512,0.00012085576],"about_ca_topic_score_codex":0.00000188125,"about_ca_topic_score_gemma":0.000021938598,"teacher_disagreement_score":0.12765272,"about_ca_system_score_codex":0.000018927314,"about_ca_system_score_gemma":0.00056136993,"threshold_uncertainty_score":0.3078901},"labels":[],"label_agreement":null},{"id":"W3173892759","doi":"10.1007/s00345-021-03776-5","title":"Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival","year":2021,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Proportional hazards model; Concomitant; Stage (stratigraphy); Nephrology; Lymph node; Internal medicine; Oncology; Cohort; Surgery; Cancer","score_opus":0.01974551794850983,"score_gpt":0.29176513475168697,"score_spread":0.27201961680317716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173892759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373853,0.0031379368,0.000033438522,0.0018711647,0.00021243445,0.00011555822,0.00007534437,0.000009114777,0.00080647884],"genre_scores_gemma":[0.99846405,0.00050392863,0.0000079326255,0.00030197526,0.00021292792,0.000002934781,0.000024570325,0.000023194361,0.00045849785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987173,0.00034184757,0.0002629316,0.00019062487,0.00023829757,0.00024900876],"domain_scores_gemma":[0.99863696,0.0004721184,0.00026731365,0.00010925313,0.00028332724,0.00023104265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018822166,0.00020701297,0.000555721,0.0001443013,0.000088136854,0.000012026036,0.000044857912,0.00009874297,0.0005541689],"category_scores_gemma":[0.00007424285,0.00011141686,0.00013489765,0.00027982623,0.00013889991,0.000047608086,0.000022225628,0.00045346885,0.0000022575357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007244757,0.00057833374,0.981843,0.0000085214,0.0037372936,0.0014348484,0.0007153068,0.0002764518,0.0004771021,0.000035083176,0.0006324978,0.003016786],"study_design_scores_gemma":[0.007924839,0.002533237,0.9844489,0.00007685931,0.0006398811,0.00082378695,0.0000739967,0.000049079437,0.0013373485,0.00004093453,0.0019328953,0.00011821335],"about_ca_topic_score_codex":0.00013132968,"about_ca_topic_score_gemma":0.0006001996,"teacher_disagreement_score":0.004725509,"about_ca_system_score_codex":0.0003305018,"about_ca_system_score_gemma":0.00036599347,"threshold_uncertainty_score":0.60677606},"labels":[],"label_agreement":null},{"id":"W3174459433","doi":"10.1016/j.eucr.2021.101762","title":"Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors","year":2021,"lang":"en","type":"article","venue":"Urology Case Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Surrey Place Centre; Surrey Memorial Hospital","funders":"Canadian Institutes of Health Research; Bladder Cancer Canada; Astellas Pharma Canada; Merck; Janssen Pharmaceuticals; AstraZeneca","keywords":"Durvalumab; Medicine; Urothelial cancer; Immune checkpoint; Bladder cancer; Tremelimumab; Metastatic Urothelial Carcinoma; Avelumab; Oncology; Immunotherapy; Disease; Missense mutation; Cancer research; Cancer; Internal medicine; Urothelial carcinoma; Mutation; Nivolumab; Ipilimumab; Gene; Biology","score_opus":0.021281137158242692,"score_gpt":0.277644438413306,"score_spread":0.2563633012550633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174459433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543977,0.00079785375,0.00010154818,0.00077607017,0.0008406578,0.00043555902,0.000016191301,0.000045471843,0.0015468806],"genre_scores_gemma":[0.99446744,0.0000015925548,0.004069892,0.00061309396,0.00010022488,0.000059417987,0.00003995663,0.000038872684,0.0006095376],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978124,0.00013001256,0.0009577867,0.0004959572,0.00026198264,0.0003418886],"domain_scores_gemma":[0.99876994,0.00007458036,0.00019900493,0.0005751834,0.000145003,0.00023627435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059494935,0.00022087283,0.0005788183,0.00016264786,0.0001254976,0.000005647744,0.000028872048,0.00013796918,0.00032679585],"category_scores_gemma":[0.00025380234,0.00021081296,0.00026390026,0.00022535092,0.000052356652,0.000037421552,0.0001257536,0.00020473501,0.00002269195],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015428404,0.00021779625,0.011395705,0.00004967492,0.00032920385,0.4971788,0.002024968,0.0000026699372,0.48344177,0.0000022944382,0.000076470424,0.0037378024],"study_design_scores_gemma":[0.003243869,0.0008676316,0.08572657,0.00006216611,0.00041187933,0.29740846,0.0004507141,0.0000042370907,0.5604908,0.00003795609,0.05098572,0.0003100147],"about_ca_topic_score_codex":0.000119213124,"about_ca_topic_score_gemma":0.000066492874,"teacher_disagreement_score":0.19977035,"about_ca_system_score_codex":0.00014448415,"about_ca_system_score_gemma":0.0018592495,"threshold_uncertainty_score":0.8596703},"labels":[],"label_agreement":null},{"id":"W3174860370","doi":"10.1016/j.eururo.2021.05.034","title":"Re: Radical Cystectomy Against Intravesical BCG for High-risk High-grade Nonmuscle Invasive Bladder Cancer: Results from the Randomized Controlled BRAVO-feasibility Study","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Randomized controlled trial; Urothelial cancer; Surgery; Cancer; Internal medicine","score_opus":0.022824573759835872,"score_gpt":0.28123271869978494,"score_spread":0.25840814493994907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174860370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97008353,0.0015442623,0.00052567583,0.01585317,0.00119486,0.007510079,0.0009970538,0.00014980612,0.0021415348],"genre_scores_gemma":[0.9884016,0.0005503576,0.0003358352,0.0074583786,0.0017557902,0.00047958156,0.00040540847,0.00010248381,0.000510576],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904886,0.0059604365,0.0012960883,0.001206204,0.00044382058,0.00060484826],"domain_scores_gemma":[0.99053085,0.007219599,0.00046868637,0.0011995955,0.00028565104,0.0002956043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022793938,0.00049132516,0.0023117678,0.00006425114,0.00032149325,0.00006080772,0.0003604224,0.00015940306,0.00032646875],"category_scores_gemma":[0.0068687843,0.00029911418,0.0005896289,0.00023091718,0.000547545,0.000055788754,0.00018886112,0.000725426,0.000084200125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94340885,0.004713633,0.011951554,0.000034219243,0.01046483,0.002421912,0.0057940483,0.000097090735,0.0022596153,0.0004040163,0.01249431,0.005955922],"study_design_scores_gemma":[0.9093533,0.0021082365,0.0787061,0.000034259923,0.004741539,0.000020580468,0.00058386906,0.00016841466,0.0010562501,0.0008664013,0.0020221148,0.0003389148],"about_ca_topic_score_codex":0.0015861845,"about_ca_topic_score_gemma":0.0014280806,"teacher_disagreement_score":0.06675455,"about_ca_system_score_codex":0.00013211396,"about_ca_system_score_gemma":0.0005578267,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W3174940758","doi":"10.5489/cuaj.7158","title":"Association between radical cystectomy prophylactic antimicrobial regimen and postoperative infection","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cystectomy; Cefazolin; Regimen; Metronidazole; Surgery; Incidence (geometry); Antibiotic prophylaxis; Internal medicine; Bladder cancer; Antibiotics; Cancer","score_opus":0.011848855402754759,"score_gpt":0.24356059777529965,"score_spread":0.23171174237254488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174940758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94600505,0.00016946024,0.00004781996,0.050933402,0.0003063363,0.00021726765,0.000043749063,0.000028399638,0.0022485463],"genre_scores_gemma":[0.9927834,0.00011433642,0.00017173322,0.004091906,0.00074309256,0.000006837574,0.000047861806,0.0000131930365,0.0020276194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984499,0.000313721,0.0002800312,0.00023137902,0.0003270093,0.00039791048],"domain_scores_gemma":[0.9985623,0.00012512332,0.00022296963,0.0000725443,0.00043995443,0.0005771536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042501127,0.00014114668,0.00031868304,0.00011634963,0.00036017603,0.00014899643,0.000033011223,0.00035134953,0.00036168128],"category_scores_gemma":[0.00095084397,0.00012065578,0.00010442621,0.00023333632,0.000023860972,0.00014608256,0.000013790167,0.0006636465,0.000043154265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043234017,0.000045522283,0.99058986,0.0000071665722,0.0003986896,0.0001657603,0.00013138258,0.0000017728933,0.0006751423,0.000022505652,0.005811498,0.0021074596],"study_design_scores_gemma":[0.0024287095,0.00042188584,0.9509966,0.000018137112,0.00040533862,0.0005455161,0.00001960594,0.000010050795,0.00080543663,0.00019339124,0.04402063,0.00013472968],"about_ca_topic_score_codex":0.0012612923,"about_ca_topic_score_gemma":0.0006552167,"teacher_disagreement_score":0.046841495,"about_ca_system_score_codex":0.0027130037,"about_ca_system_score_gemma":0.0010641397,"threshold_uncertainty_score":0.709441},"labels":[],"label_agreement":null},{"id":"W3175301954","doi":"10.1016/j.urolonc.2021.04.032","title":"An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Cisplatin; Internal medicine; Bladder cancer; Vinblastine; Chemotherapy; Regimen; Cystectomy; Oncology; Urology; Cancer; Surgery","score_opus":0.06448005431455607,"score_gpt":0.376689990809975,"score_spread":0.31220993649541895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175301954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98770475,0.00856305,0.00005436541,0.0024654274,0.00007395525,0.00068812596,0.000255624,0.00002476773,0.00016993703],"genre_scores_gemma":[0.97012174,0.0059833187,0.02137489,0.0017714248,0.00008665716,0.0001585993,0.00033634203,0.000025106903,0.00014191003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846095,0.00019575105,0.00039077582,0.0005763957,0.00009067705,0.00028548026],"domain_scores_gemma":[0.9980326,0.0009994184,0.00025461297,0.00021525886,0.00012986462,0.00036823348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021387232,0.0002514026,0.00077649934,0.00018847667,0.00029116345,0.000044870565,0.00004670171,0.00016317991,0.00005482466],"category_scores_gemma":[0.00015492787,0.00021678982,0.000059001675,0.0002288653,0.00052525505,0.00014130758,0.000048528633,0.00018776646,4.1286063e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034647654,0.00031295262,0.94510293,0.00018053083,0.0020036132,0.00010836256,0.007456842,0.0012042392,0.007660304,0.001065379,0.0014693665,0.029970719],"study_design_scores_gemma":[0.04793508,0.033720557,0.67163634,0.0004629874,0.01041733,0.00061709905,0.013788954,0.017622568,0.013070302,0.0016188787,0.18773165,0.0013782707],"about_ca_topic_score_codex":0.001714993,"about_ca_topic_score_gemma":0.0039403355,"teacher_disagreement_score":0.2734666,"about_ca_system_score_codex":0.00012875574,"about_ca_system_score_gemma":0.0006496807,"threshold_uncertainty_score":0.8840432},"labels":[],"label_agreement":null},{"id":"W3175316794","doi":"10.1093/ajcp/aqab047","title":"Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"Decipher Biosciences","keywords":"Bladder cancer; Pathology; Cohort; Histology; Biology; Immunohistochemistry; Carcinoma; Subtyping; Cancer; Oncology; Medicine; Internal medicine","score_opus":0.03807308881717943,"score_gpt":0.36868202340139,"score_spread":0.3306089345842106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175316794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993252,0.001854521,0.0014943845,0.0016799716,0.0006289083,0.00012190446,0.000029283143,0.000008099897,0.0009309701],"genre_scores_gemma":[0.96211535,0.0013157551,0.0337104,0.0022107165,0.00049534126,0.000008714112,0.000007557613,0.000028484106,0.000107654225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751747,0.00048221552,0.0012003093,0.00030410738,0.0002476889,0.0002482228],"domain_scores_gemma":[0.9969367,0.00055461767,0.0012947037,0.00030067505,0.00066734845,0.0002459746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043776256,0.00016662669,0.0013658025,0.0000914484,0.00003381705,0.0000029832795,0.000114226954,0.00012222068,0.00048895646],"category_scores_gemma":[0.00049075956,0.00011257478,0.00028765592,0.00019717855,0.0007366015,0.000055109627,0.00004757149,0.0006215962,0.000003956637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008800318,0.0026102383,0.36675686,0.00015941706,0.0019439756,0.03948134,0.0011485848,0.00005923114,0.24131282,0.000070852446,0.0010713575,0.33658502],"study_design_scores_gemma":[0.02115007,0.03162335,0.5562951,0.0008684418,0.0026822388,0.027708266,0.0024681073,0.0000100088255,0.35287362,0.00053021294,0.00327478,0.0005158158],"about_ca_topic_score_codex":0.000032222837,"about_ca_topic_score_gemma":0.000023981758,"teacher_disagreement_score":0.3360692,"about_ca_system_score_codex":0.00004602488,"about_ca_system_score_gemma":0.0024412982,"threshold_uncertainty_score":0.53537303},"labels":[],"label_agreement":null},{"id":"W3181232351","doi":"10.1097/ju.0000000000001977.11","title":"PD09-11 POTENTIAL ROLE OF MICRO-ULTRASOUND IN THE DIFFERENTIATION BETWEEN MUSCLE-INVASIVE AND NON-MUSCLE INVASIVE BLADDER CANCER: A PROSPECTIVE ANALYSIS","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Magnetic resonance imaging; Cancer; General surgery; Radiology; Internal medicine","score_opus":0.009034579042186831,"score_gpt":0.2572332541993136,"score_spread":0.24819867515712676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181232351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942688,0.0028956751,0.00015071922,0.0021811626,0.00007482857,0.00025445453,0.000044089134,0.0000023771472,0.0001279424],"genre_scores_gemma":[0.99730116,0.0019097676,0.000044812125,0.0004335242,0.00025486315,0.000009508839,0.000012184487,0.000012055932,0.00002215011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986188,0.0003381902,0.0004250202,0.00015441512,0.00026455778,0.0001990126],"domain_scores_gemma":[0.99842644,0.0005925742,0.0004009352,0.00021474563,0.0003051647,0.000060168448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031753833,0.00014577841,0.00053748424,0.00018482846,0.000076105265,0.000012997805,0.00015015862,0.00009687223,0.000119967204],"category_scores_gemma":[0.00014216836,0.00008420912,0.00018777962,0.00046233402,0.00014817822,0.0000706983,0.00004188228,0.00030987634,0.0000010446528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048701573,0.000323385,0.8545233,0.000027473929,0.0033879566,0.00009541971,0.009743422,0.00014632144,0.12919855,0.000013914874,0.00006588243,0.0019873686],"study_design_scores_gemma":[0.0023967677,0.0006730527,0.96919376,0.000024091014,0.006452552,0.00018920167,0.0024247195,0.00001540395,0.01748755,0.0010284007,0.000046676636,0.0000678339],"about_ca_topic_score_codex":0.00062397524,"about_ca_topic_score_gemma":0.0022418906,"teacher_disagreement_score":0.11467046,"about_ca_system_score_codex":0.000063892454,"about_ca_system_score_gemma":0.00032269073,"threshold_uncertainty_score":0.34339482},"labels":[],"label_agreement":null},{"id":"W3181256475","doi":"10.1136/jitc-2021-002552","title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Society for Immunotherapy of Cancer; Bladder Cancer Advocacy Network","keywords":"Medicine; Immunotherapy; Urothelial cancer; Guideline; Bladder cancer; Cancer; Atezolizumab; Intensive care medicine; Oncology; Cancer immunotherapy; Internal medicine; Pembrolizumab; Pathology","score_opus":0.06021223239992654,"score_gpt":0.45781727494001123,"score_spread":0.39760504254008466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181256475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15659817,0.748272,0.026326474,0.039360374,0.011179304,0.011597816,0.0063054166,0.00006325889,0.00029719443],"genre_scores_gemma":[0.030817676,0.9018594,0.034837116,0.013431678,0.005702238,0.0049080392,0.00008458518,0.00045957876,0.007899692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99559546,0.0001235743,0.0024270338,0.00052210706,0.0007248884,0.0006069373],"domain_scores_gemma":[0.992161,0.0018037575,0.002103298,0.00079870934,0.0030094406,0.00012379028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001096546,0.00057008374,0.0017251009,0.000105887906,0.0003727555,0.000041068703,0.00038093122,0.00031892327,0.0008814077],"category_scores_gemma":[0.000118599644,0.00036971926,0.0034785431,0.00029754944,0.00032186197,0.00017504679,0.000012661568,0.00029467465,5.524415e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074105255,0.004350498,0.002630909,0.00028657063,0.024894977,0.0000029708665,0.0028319496,0.0005466116,0.13674971,0.00018704502,0.020228023,0.73318547],"study_design_scores_gemma":[0.043150775,0.009829274,0.0020402842,0.00049774116,0.0016853181,0.000023355848,0.00059159775,0.00028728019,0.16022705,0.0003200457,0.7810333,0.00031399683],"about_ca_topic_score_codex":0.0017289203,"about_ca_topic_score_gemma":0.00023436124,"teacher_disagreement_score":0.76080525,"about_ca_system_score_codex":0.00070044096,"about_ca_system_score_gemma":0.0029822048,"threshold_uncertainty_score":0.9998755},"labels":[],"label_agreement":null},{"id":"W3184137349","doi":"10.1007/978-3-030-70646-3_9","title":"Adjuvant Intravesical Therapy: Bacillus Calmette-Guerin","year":2021,"lang":"en","type":"book-chapter","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Epirubicin; Adjuvant; Bladder cancer; Immunotherapy; Mitomycin C; Urology; Pembrolizumab; Bladder tumor; Maintenance therapy; Oncology; Internal medicine; Surgery; Cancer; Chemotherapy; Breast cancer","score_opus":0.041737710216998215,"score_gpt":0.2944025851559552,"score_spread":0.25266487493895695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184137349","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091959577,0.0917335,0.00006668049,0.0046309754,0.001980553,0.001480005,0.000788075,0.00024164986,0.89815897],"genre_scores_gemma":[0.0056859218,0.026438827,0.00019170149,0.0066270083,0.0033476832,0.00025460427,0.0003578099,0.0003293514,0.9567671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971727,0.00002528995,0.0005258185,0.0009602578,0.0007586722,0.000557228],"domain_scores_gemma":[0.99826145,0.000044095323,0.00017546663,0.0008588603,0.00024209968,0.00041800193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006997403,0.00078724715,0.001248457,0.0001512306,0.00009899212,0.0000482041,0.00018057489,0.00064684305,0.033130527],"category_scores_gemma":[0.0000124642065,0.0006450168,0.0005634767,0.00007315353,0.00020201238,0.000059414077,0.00009870131,0.0008336942,0.0004448078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016157256,0.00051375624,0.0005538809,0.0004852417,0.0084130075,0.003931984,0.0006692159,0.00000551602,0.0017064716,0.011617543,0.19684047,0.7736472],"study_design_scores_gemma":[0.0039605713,0.00053510343,0.0012550608,0.0007375415,0.00083043176,0.00017929672,0.000021350485,0.0000067919354,0.0019422827,0.000690513,0.9891267,0.0007143824],"about_ca_topic_score_codex":0.00030023375,"about_ca_topic_score_gemma":0.00015668523,"teacher_disagreement_score":0.7922862,"about_ca_system_score_codex":0.00048854115,"about_ca_system_score_gemma":0.001360583,"threshold_uncertainty_score":0.9996001},"labels":[],"label_agreement":null},{"id":"W3184711033","doi":"10.22374/jeleu.v4i2.125","title":"The Implementation of a Risk Stratification Tool for the Haematuria Clinic to Optimise the Management of Patients with High-Risk Bladder Cancer in the COVID-19 Era","year":2021,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Concordance; Risk stratification; Risk assessment; Disease; Histopathology; Audit; Internal medicine; Cancer; Pathology; Urinary system","score_opus":0.022653338324352217,"score_gpt":0.35170702580549146,"score_spread":0.3290536874811392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184711033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816202,0.0010126911,0.0016877403,0.01347162,0.00031349759,0.0016088703,0.00023762502,0.0000024635367,0.000045282326],"genre_scores_gemma":[0.9958125,0.001602503,0.0010740604,0.0011007878,0.00013693895,0.00020302291,0.000012050483,0.000013060661,0.00004512588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981426,0.00039079433,0.00070101843,0.00015222172,0.00040879738,0.00020456458],"domain_scores_gemma":[0.9969853,0.0013253249,0.0009161582,0.0003569041,0.0003621208,0.00005415801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011669528,0.0001293856,0.0002968141,0.000055347726,0.00019337022,0.0000207564,0.00026663832,0.00004142511,0.00015606215],"category_scores_gemma":[0.00016260582,0.000052899097,0.0001429649,0.00022615284,0.0001288211,0.000050653816,0.000031255724,0.00029935353,8.1070164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056446914,0.0030482714,0.6233319,0.00061106763,0.012035701,0.00027572666,0.025828233,0.008584784,0.0005422427,0.0040156418,0.01641751,0.248862],"study_design_scores_gemma":[0.012613584,0.0031107205,0.96535814,0.000042889515,0.0031172966,0.00008642934,0.008071564,0.00003561881,0.0008886622,0.0007166786,0.0058701993,0.00008822417],"about_ca_topic_score_codex":0.00051784294,"about_ca_topic_score_gemma":0.0013316725,"teacher_disagreement_score":0.3420262,"about_ca_system_score_codex":0.000075156066,"about_ca_system_score_gemma":0.00040475363,"threshold_uncertainty_score":0.21571626},"labels":[],"label_agreement":null},{"id":"W3184874576","doi":"10.1016/j.urolonc.2021.07.001","title":"The effect of race on stage at presentation and survival in upper tract urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Hazard ratio; Stage (stratigraphy); Lymph node; Cohort; Incidence (geometry); Ethnic group; Proportional hazards model; Epidemiology; Internal medicine; Oncology; Urology; Demography; Confidence interval; Biology","score_opus":0.021556916846751956,"score_gpt":0.32374356141886157,"score_spread":0.30218664457210964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184874576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885456,0.0014944103,0.0000022723596,0.0041820537,0.00014954714,0.00035745557,0.000031530853,0.0000105735135,0.005226539],"genre_scores_gemma":[0.9953446,0.0006497121,0.00051508227,0.00038851972,0.000063334526,0.00007154288,0.000037456193,0.000009331673,0.0029204246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895513,0.00029720055,0.00019995395,0.00024726824,0.00012696268,0.00017348642],"domain_scores_gemma":[0.99875724,0.00088603725,0.000078333345,0.0001441773,0.000030443998,0.0001037629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028395592,0.00012841813,0.00028863942,0.000053805405,0.00016816589,0.00001084708,0.000036498306,0.000119715245,0.000046653244],"category_scores_gemma":[0.00020332226,0.000082871025,0.00003895218,0.00013360936,0.00040319745,0.000040891904,0.00003257046,0.00018414418,0.0000034850498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006774404,0.000098183875,0.99376863,0.000034604967,0.000032120515,0.0001653646,0.00034364001,0.000021024249,0.0016742086,0.0010763643,0.00031682232,0.001791621],"study_design_scores_gemma":[0.00712338,0.012427427,0.5988513,0.000067515706,0.00040149453,0.00035455887,0.00044114148,0.00037335837,0.033786617,0.00083602447,0.34514707,0.00019008372],"about_ca_topic_score_codex":0.00010903659,"about_ca_topic_score_gemma":0.00014192362,"teacher_disagreement_score":0.39491728,"about_ca_system_score_codex":0.00008727713,"about_ca_system_score_gemma":0.00018396389,"threshold_uncertainty_score":0.33793822},"labels":[],"label_agreement":null},{"id":"W3185935705","doi":"10.1016/j.xcrm.2021.100382","title":"Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture","year":2021,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bladder cancer; Cohort; Medicine; Oncology; Internal medicine; Neoadjuvant therapy; H&E stain; Cancer; Chemotherapy; Biopsy; Pathology; Immunohistochemistry; Breast cancer","score_opus":0.021135197989249916,"score_gpt":0.2987482651092273,"score_spread":0.2776130671199774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185935705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884855,0.004075871,0.00066657213,0.004215178,0.0002599178,0.0006639753,0.000015967418,0.000024918747,0.0015920979],"genre_scores_gemma":[0.9946398,0.0007768595,0.0012098221,0.0022513368,0.00018634164,0.000026628288,0.000011893316,0.0000553514,0.00084197405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982324,0.00009623618,0.0005170958,0.0005454488,0.00032209855,0.0002867127],"domain_scores_gemma":[0.9988143,0.00010661543,0.00018391844,0.0004397569,0.00020071371,0.00025473486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025914315,0.00023087105,0.00068792934,0.00021553058,0.00003608357,0.0000035472087,0.000042722702,0.00013807707,0.0005439948],"category_scores_gemma":[0.00017502916,0.00018311593,0.000045884168,0.0003379916,0.00018579132,0.00004025124,0.000052453255,0.00021757498,8.0065337e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031035768,0.0002858798,0.0046423804,0.00018345704,0.00015510822,0.009934189,0.013369879,0.001751139,0.95579374,0.0000035827982,0.000702617,0.010074448],"study_design_scores_gemma":[0.027909331,0.008855891,0.1896352,0.005450434,0.0017392405,0.011457242,0.008572085,0.0019099877,0.7230356,0.002413337,0.017935077,0.0010866204],"about_ca_topic_score_codex":0.001058337,"about_ca_topic_score_gemma":0.0000769244,"teacher_disagreement_score":0.2327582,"about_ca_system_score_codex":0.00014567965,"about_ca_system_score_gemma":0.0005218734,"threshold_uncertainty_score":0.7467251},"labels":[],"label_agreement":null},{"id":"W3188534843","doi":"10.1002/onco.13922","title":"Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors","year":2021,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Winship Cancer Institute; National Institutes of Health; Society for Immunotherapy of Cancer; National Cancer Institute; Emory University","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Oncology; Biomarker; Body mass index; Retrospective cohort study; Odds ratio; Confidence interval","score_opus":0.012922607270704961,"score_gpt":0.2742608242748707,"score_spread":0.2613382170041657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188534843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948898,0.00025275088,0.00000834879,0.0003339265,0.00008781805,0.0012949308,0.000043476914,0.0000467773,0.0030421976],"genre_scores_gemma":[0.9991043,0.00003649278,0.000073207455,0.00016025547,0.000043517186,0.00019990889,0.00020861553,0.000025480573,0.0001481917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871856,0.00016733413,0.00027104278,0.00035463396,0.0002531694,0.00023524134],"domain_scores_gemma":[0.9993372,0.00005503752,0.00010240021,0.00025241348,0.0001450891,0.00010786501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012171333,0.00019869502,0.0003030066,0.000059890186,0.00010833292,0.000025588832,0.000060545608,0.00009376285,0.000042392938],"category_scores_gemma":[0.00004524896,0.00012249114,0.000042457155,0.00021896309,0.00020819766,0.000103126156,0.00005514302,0.00018804488,0.00000790459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071090693,0.0021506639,0.9615049,0.000036973102,0.00014112706,0.00047969454,0.00082424685,0.000007761505,0.022535581,0.000017522047,0.0000121723615,0.005180306],"study_design_scores_gemma":[0.010353204,0.005596498,0.9551203,0.00013473383,0.00022130655,0.00011953442,0.00037418088,0.00008965824,0.027761418,0.000045452907,0.000054870008,0.00012881795],"about_ca_topic_score_codex":0.00080196536,"about_ca_topic_score_gemma":0.0002274709,"teacher_disagreement_score":0.006384558,"about_ca_system_score_codex":0.00031834835,"about_ca_system_score_gemma":0.00025246252,"threshold_uncertainty_score":0.49950436},"labels":[],"label_agreement":null},{"id":"W3189278449","doi":"10.1016/j.eururo.2021.07.019","title":"Adjuvant Immune Checkpoint Inhibition in Muscle-invasive Bladder Cancer: Is It Ready for Prime Time?","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Queen's University","funders":"","keywords":"Medicine; Atezolizumab; Nivolumab; Bladder cancer; Adjuvant; Oncology; Internal medicine; Chemotherapy; Neoadjuvant therapy; Immunotherapy; Adjuvant chemotherapy; Cancer; Urology; Breast cancer","score_opus":0.02389745304614387,"score_gpt":0.3051402551644497,"score_spread":0.2812428021183058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189278449","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008121214,0.01977447,0.000102438644,0.013273495,0.8930158,0.0048984624,0.005215325,0.00030740304,0.055291403],"genre_scores_gemma":[0.01162488,0.006427152,0.00027343706,0.005460606,0.9303105,0.000593859,0.011372257,0.0006229725,0.03331432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640477,0.00041968536,0.0009145669,0.0011253234,0.0004492845,0.0006863743],"domain_scores_gemma":[0.9977482,0.00045052395,0.0004048019,0.000742953,0.00047262898,0.00018089167],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049381296,0.00060212123,0.0012307958,0.0002586132,0.00008549168,0.0000312807,0.00016780102,0.0006337646,0.001854341],"category_scores_gemma":[0.0006989262,0.00057416514,0.00035920774,0.00020288526,0.00013670653,0.00006382652,0.00018293438,0.001045817,0.00067106495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009914925,0.00036236492,0.000025826133,0.00022671059,0.0005131974,0.0014443999,0.0009497831,0.0000036308454,0.006889697,0.0000028165236,0.9848774,0.0037126562],"study_design_scores_gemma":[0.008288651,0.0019825972,0.0009281574,0.00041334814,0.0009569096,0.000038287915,0.000051902396,0.000013698975,0.004790901,0.00002891333,0.9820337,0.0004729218],"about_ca_topic_score_codex":0.00047537923,"about_ca_topic_score_gemma":0.00020399645,"teacher_disagreement_score":0.037294723,"about_ca_system_score_codex":0.0003823079,"about_ca_system_score_gemma":0.001381134,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W3190588714","doi":"10.1097/ju.0000000000002001.09","title":"MP16-09 SAFETY AND EFFICACY OF TRANSURETHRAL RESECTION OF BLADDER TUMOUR COMPARING SPINAL ANAESTHESIA TO SPINAL ANAESTHESIA WITH AN OBTURATOR NERVE BLOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2021,"lang":"en","type":"review","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Spinal anesthesia; Obturator nerve; CINAHL; Resection; MEDLINE; Anesthesia; Nerve block; Meta-analysis; Surgery; Internal medicine","score_opus":0.0737010772403195,"score_gpt":0.3580814791545402,"score_spread":0.2843804019142207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190588714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047870674,0.9928115,0.00012207622,0.00071556336,0.000018653112,0.0015063591,0.000016927974,0.000004956168,0.000016885422],"genre_scores_gemma":[0.10617506,0.89323103,0.00024017938,0.00021485079,0.000054588872,0.000020397074,0.0000069056928,0.000039595045,0.000017365659],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99502295,0.0018969311,0.0019990653,0.0003225932,0.0004972023,0.00026127766],"domain_scores_gemma":[0.9966021,0.00012747322,0.001975948,0.0005613716,0.00047519486,0.00025786713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019837455,0.00049939164,0.010185921,0.0004736379,0.00007365007,0.00001532862,0.00027211173,0.0001794216,0.00004050543],"category_scores_gemma":[0.00010091978,0.00024652513,0.0012611261,0.00090136664,0.0001941239,0.00007763298,0.000034727935,0.0005991151,5.879499e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011158676,0.0008897221,0.00024338155,0.5436561,0.43143746,0.00081461377,0.00065738277,0.00010259422,0.000017520933,0.000080857724,0.00003998666,0.010901679],"study_design_scores_gemma":[0.0012234712,0.014883907,0.00087489386,0.01953995,0.95441884,0.008039275,0.00006267125,0.000006274097,0.0000048099737,0.0000036421088,0.00074020214,0.00020205848],"about_ca_topic_score_codex":0.000090275,"about_ca_topic_score_gemma":0.000110820685,"teacher_disagreement_score":0.52411616,"about_ca_system_score_codex":0.00005672964,"about_ca_system_score_gemma":0.00038843104,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W3190836299","doi":"10.1038/s41467-021-24837-8","title":"Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy","year":2021,"lang":"en","type":"letter","venue":"Nature Communications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Subtyping; Cisplatin; Chemotherapy; Computational biology; Computer science; Biology; Genetics; Programming language","score_opus":0.044548337462257996,"score_gpt":0.3601315955516039,"score_spread":0.3155832580893459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190836299","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37549874,0.005962878,0.000028356377,0.6155367,0.0001224132,0.00093423313,0.00020458033,0.000040593728,0.0016715031],"genre_scores_gemma":[0.78225905,0.00016677353,0.0019267917,0.21485063,0.000090578375,0.00008121087,0.00040753436,0.00004431445,0.00017310464],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99843943,0.00040781943,0.00034147847,0.00029862087,0.00029595682,0.00021667751],"domain_scores_gemma":[0.99653065,0.0008856663,0.00014791677,0.0021641494,0.00020927389,0.00006233584],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00022202944,0.0002642268,0.00058580196,0.00039315652,0.000056094115,0.000017387918,0.00052494806,0.0008500361,0.00009768311],"category_scores_gemma":[0.00038849027,0.00022344483,0.00028736753,0.0005257502,0.000060062037,0.000016381882,0.00005966,0.0028404952,0.0000060600128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01930723,0.003947389,0.22671032,0.0010659118,0.0045500845,0.0014564287,0.004916553,0.00032053993,0.11209128,0.00013276658,0.5974502,0.028051296],"study_design_scores_gemma":[0.014795242,0.0050818473,0.68289125,0.012712415,0.00092638563,0.00006858823,0.00017920115,0.0007833768,0.03571984,0.00020826253,0.24471426,0.0019193543],"about_ca_topic_score_codex":0.0001630659,"about_ca_topic_score_gemma":0.000091196765,"teacher_disagreement_score":0.4561809,"about_ca_system_score_codex":0.00044204903,"about_ca_system_score_gemma":0.00090487243,"threshold_uncertainty_score":0.99946},"labels":[],"label_agreement":null},{"id":"W3191763100","doi":"10.1097/ju.0000000000002078.12","title":"PD51-12 WHOLE-PELVIS COMPARED TO BLADDER-ONLY RADIATION THERAPY PROLONGS OVERALL SURVIVAL IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS: RESULTS FROM A CANADIAN MULTI-CENTER COLLABORATIVE STUDY","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Radiation therapy; Pelvis; Cancer; Psychoanalysis; Surgery; Psychology; Internal medicine","score_opus":0.02674066084611972,"score_gpt":0.2991739279946038,"score_spread":0.2724332671484841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191763100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397094,0.0011096437,0.000009835753,0.011960424,0.0007643373,0.0012301239,0.0007428648,0.000008140573,0.0002036867],"genre_scores_gemma":[0.9932003,0.000580645,0.00006340786,0.0055080815,0.0003428267,0.000032908316,0.00009636014,0.00003526455,0.00014019219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972943,0.00083906355,0.0007270873,0.00031011,0.00040079994,0.00042861508],"domain_scores_gemma":[0.99781394,0.00031068063,0.0003779032,0.00032066932,0.0008413907,0.00033543707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038721642,0.00026661396,0.0006355508,0.00024542876,0.000107979045,0.000030227857,0.00021624753,0.00012312572,0.00017419866],"category_scores_gemma":[0.00029036342,0.00018653023,0.00009135956,0.00037621526,0.00006382897,0.00013217077,0.000038521222,0.000447919,0.000018502471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021188585,0.007318013,0.8633314,0.000007806524,0.0030738467,0.0009811451,0.08214123,0.0007128651,0.0016452781,0.0000028209322,0.008221112,0.011375954],"study_design_scores_gemma":[0.045655347,0.0034605379,0.93838495,0.000037967788,0.0003053426,0.000027007462,0.0025250253,0.00004346833,0.0002589058,0.00002141682,0.009111131,0.0001689002],"about_ca_topic_score_codex":0.05865683,"about_ca_topic_score_gemma":0.51382416,"teacher_disagreement_score":0.45516735,"about_ca_system_score_codex":0.00044684933,"about_ca_system_score_gemma":0.0022639777,"threshold_uncertainty_score":0.94761163},"labels":[],"label_agreement":null},{"id":"W3191774812","doi":"10.1097/ju.0000000000002004.03","title":"MP19-03 COMPARISON OF FACT-G SCORES WITH CANCER AND GENERAL POPULATION NORMS IN CANADIAN PATIENTS UNDERGOING RADICAL CYSTECTOMY","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Quality of life (healthcare); Bladder cancer; Population; Normative; Survivorship curve; Cancer; Family medicine; Physical therapy; Internal medicine; Nursing; Environmental health","score_opus":0.016387948319312663,"score_gpt":0.2931224633507446,"score_spread":0.2767345150314319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191774812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964597,0.0017584544,0.000013333911,0.001444652,0.00009830972,0.000084164065,0.0000060080806,0.0000011550898,0.00013417559],"genre_scores_gemma":[0.9992846,0.00017665114,0.00008225139,0.00035648735,0.00006127349,0.0000010879047,0.00000538463,0.0000074454265,0.000024816563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999328,0.00007885399,0.0002453604,0.000059678292,0.00013727187,0.00015083884],"domain_scores_gemma":[0.99953336,0.00005454104,0.00014461714,0.00006809917,0.00008864995,0.00011073742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009648106,0.00006765289,0.00027078463,0.0000984275,0.000033411165,0.0000032892276,0.000038769886,0.000049056962,0.000046301706],"category_scores_gemma":[0.000030139141,0.000038907794,0.000022198827,0.00009256147,0.000055966095,0.000037892372,0.000009400083,0.00017306076,3.8701174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062803726,0.00006686457,0.9962055,0.000018023466,0.00009278273,0.000037486952,0.00052006467,0.00038186458,0.00017533144,0.000017300035,0.00006264322,0.0017941052],"study_design_scores_gemma":[0.0037844307,0.0010756558,0.9937396,0.00005264137,0.00017138703,0.00018364388,0.000068944275,0.00015315259,0.000460509,0.000066777815,0.00020614023,0.000037085632],"about_ca_topic_score_codex":0.07398522,"about_ca_topic_score_gemma":0.37642202,"teacher_disagreement_score":0.3024368,"about_ca_system_score_codex":0.00011417487,"about_ca_system_score_gemma":0.00048001675,"threshold_uncertainty_score":0.9321812},"labels":[],"label_agreement":null},{"id":"W3191863614","doi":"10.1101/2021.08.06.455345","title":"Immunohistochemical assays for bladder cancer molecular subtyping: Optimizing parsimony and performance using Lund taxonomy","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ontario Institute for Cancer Research; Government of Ontario; Bladder Cancer Canada; Cancer Research Society","keywords":"Subtyping; Immunohistochemistry; Bladder cancer; Decision tree; Pathology; Computational biology; Biology; Computer science; Medicine; Internal medicine; Artificial intelligence; Cancer","score_opus":0.032940296524034574,"score_gpt":0.26475549264314996,"score_spread":0.23181519611911539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191863614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728365,0.016225817,0.007575995,0.00016630205,0.0007844233,0.0020563044,0.0001585106,0.00016195353,0.000034174493],"genre_scores_gemma":[0.95324343,0.0011733301,0.043161467,0.0004179014,0.0004494019,0.0013413328,0.000002361721,0.00019865266,0.000012120765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972234,0.000053096835,0.0005329698,0.0011802851,0.0003339762,0.00067629456],"domain_scores_gemma":[0.99777085,0.00004387277,0.00031988352,0.00093465584,0.00057841226,0.00035230312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002453783,0.00068015413,0.00094243465,0.00018000229,0.0002207108,0.00018900179,0.00021781572,0.0005860871,0.00006263126],"category_scores_gemma":[0.00007490364,0.0007342985,0.00026075364,0.00025236543,0.00016344957,0.00015835272,0.0003436873,0.00070195267,0.0000022987806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003539693,0.00022652511,0.014870874,0.0017127276,0.0014248024,0.00010969476,0.000025135243,0.00024947413,0.98083174,0.00003809673,0.0001323841,0.00002454691],"study_design_scores_gemma":[0.0040575443,0.00022551892,0.015383123,0.0027438207,0.002655351,5.565528e-7,0.000018188202,0.009417724,0.9589934,7.961986e-7,0.0050593177,0.0014446982],"about_ca_topic_score_codex":0.00016301584,"about_ca_topic_score_gemma":0.0000011879158,"teacher_disagreement_score":0.03558547,"about_ca_system_score_codex":0.00078462245,"about_ca_system_score_gemma":0.0016618789,"threshold_uncertainty_score":0.9995108},"labels":[],"label_agreement":null},{"id":"W3192058930","doi":"10.1007/s00345-021-03793-4","title":"Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Quartile; Bladder cancer; Internal medicine; Chemotherapy; Logistic regression; Proportional hazards model; Oncology; Cohort; Nephrology; Cancer; Confidence interval","score_opus":0.008026332282574392,"score_gpt":0.2634873052906405,"score_spread":0.25546097300806614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192058930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901615,0.00030026503,0.000027416976,0.008685326,0.000100134246,0.00022997013,0.000012626603,0.0000026835976,0.000480083],"genre_scores_gemma":[0.9931209,0.00008666277,0.00049594796,0.0029865624,0.000065805456,0.000010854125,0.0000028730306,0.00001784051,0.003212567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989615,0.00018320362,0.00027583892,0.0001314027,0.00028228117,0.00016574873],"domain_scores_gemma":[0.9988326,0.00014752705,0.0002609823,0.0001082435,0.0005645507,0.00008613266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017626409,0.000108962,0.00038951827,0.00020442886,0.000014821245,0.0000052255587,0.000046579215,0.000046968904,0.0002694773],"category_scores_gemma":[0.00009463152,0.00007331143,0.00004385483,0.00037768314,0.000030657593,0.000057474066,0.000009713192,0.00019819863,0.0000015528407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030850051,0.0006317559,0.95824677,0.000012781811,0.00080008176,0.00037138409,0.003008881,0.00020251551,0.0023339465,0.000004028341,0.0011824463,0.0023553534],"study_design_scores_gemma":[0.012128633,0.0044897124,0.9767507,0.00009852677,0.00023271744,0.000016876416,0.000079862424,8.0296644e-7,0.00221242,0.000013746042,0.0039068838,0.000069130205],"about_ca_topic_score_codex":0.000038602775,"about_ca_topic_score_gemma":0.00216391,"teacher_disagreement_score":0.018721417,"about_ca_system_score_codex":0.00030320312,"about_ca_system_score_gemma":0.00077975536,"threshold_uncertainty_score":0.29895532},"labels":[],"label_agreement":null},{"id":"W3192086138","doi":"10.1016/j.euo.2021.07.001","title":"Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Gene; Bladder cancer; Disease; Cancer; DNA; Affect (linguistics)","score_opus":0.057073407007179174,"score_gpt":0.29183743248532434,"score_spread":0.23476402547814518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192086138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98424095,0.011541745,0.000036485595,0.0013568187,0.000096869226,0.0019821653,0.00026921104,0.000042923497,0.00043283988],"genre_scores_gemma":[0.9865182,0.0003128199,0.000057008587,0.00035773712,0.000029361656,0.011341055,0.00010287655,0.000024619452,0.0012562963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825263,0.000083998544,0.00027042895,0.0004906329,0.00051005336,0.00039223867],"domain_scores_gemma":[0.9992124,0.00011689144,0.00017904433,0.00024900312,0.000096452895,0.00014621456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035425148,0.00021238519,0.00073557626,0.0002892617,0.00016839594,0.000037841255,0.00010741617,0.00004418968,0.00026563098],"category_scores_gemma":[0.00008162813,0.00015356847,0.00021901785,0.0010969889,0.00007501581,0.000102207916,0.00010864856,0.00019668108,7.740752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055450323,0.0012672128,0.8377467,0.0000979214,0.1311698,0.00023465474,0.0020773574,0.0005601409,0.0005430094,0.0000034584884,0.00021612787,0.025529135],"study_design_scores_gemma":[0.0016157759,0.000107143016,0.9452049,0.0000068919794,0.051748894,0.0000049152754,0.00024699868,0.000025111558,0.00060997554,0.000014756529,0.0002464774,0.00016812024],"about_ca_topic_score_codex":0.00059443834,"about_ca_topic_score_gemma":0.0022056354,"teacher_disagreement_score":0.10745826,"about_ca_system_score_codex":0.00025976988,"about_ca_system_score_gemma":0.00012954371,"threshold_uncertainty_score":0.62623405},"labels":[],"label_agreement":null},{"id":"W3192231024","doi":"10.1097/ju.0000000000002053.12","title":"MP38-12 PREHABILITATION BODY MASS INDEX (BMI) TARGET FOR COMPLICATION RISK REDUCTION FOLLOWING RADICAL CYSTECTOMY","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Prehabilitation; Index (typography); Body mass index; Bladder cancer; Cancer; Internal medicine; Physiology","score_opus":0.014721840968694309,"score_gpt":0.29600500887809145,"score_spread":0.2812831679093971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192231024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.929899,0.0015898333,0.057558596,0.009049963,0.0009831766,0.0005110202,0.000010613449,0.000016840833,0.00038100695],"genre_scores_gemma":[0.9960857,0.000094622475,0.002999917,0.00020003771,0.0004566084,0.000016596507,0.000012449711,0.000015341226,0.000118701886],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989002,0.00029858897,0.00035659107,0.00011007945,0.00018539175,0.00014916908],"domain_scores_gemma":[0.999013,0.00026581294,0.00027018375,0.00017988762,0.00020090862,0.00007022534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006014078,0.000089124325,0.00026225578,0.0000691582,0.00010766384,0.000006980901,0.000073973926,0.000092558446,0.00005143547],"category_scores_gemma":[0.00028223172,0.00006094016,0.0001821148,0.000097926444,0.00006235016,0.000076216274,0.000010627156,0.00025563966,0.0000041523526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02815978,0.002678523,0.31670597,0.00037975184,0.0059617413,0.00020998016,0.0047111744,0.004237475,0.57397455,0.0011256699,0.011882458,0.049972944],"study_design_scores_gemma":[0.03971527,0.017908644,0.76708496,0.00015593393,0.0071658734,0.0073845424,0.0018149051,0.0055981693,0.0293254,0.05770679,0.065676026,0.0004634687],"about_ca_topic_score_codex":0.000013919868,"about_ca_topic_score_gemma":0.0000021963754,"teacher_disagreement_score":0.5446491,"about_ca_system_score_codex":0.000095149815,"about_ca_system_score_gemma":0.00019152633,"threshold_uncertainty_score":0.24850677},"labels":[],"label_agreement":null},{"id":"W3192283218","doi":"10.1097/ju.0000000000002004.02","title":"MP19-02 IMPAIRED EMOTIONAL, PHYSICAL AND SOCIAL WELL-BEING IN RADICAL CYSTECTOMY PATIENTS","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Quality of life (healthcare); Bladder cancer; Physical therapy; Distress; Urinary diversion; Emotional distress; Survivorship curve; Cancer; Clinical psychology; Internal medicine; Psychiatry; Anxiety; Nursing","score_opus":0.010759937181638143,"score_gpt":0.26888609563234767,"score_spread":0.2581261584507095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192283218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921718,0.00025857743,0.000023622244,0.006508677,0.00013590841,0.00006760565,0.0000016224238,0.0000034611264,0.0008286971],"genre_scores_gemma":[0.9981264,0.000065334534,0.00003054806,0.001306018,0.00040822767,9.2180943e-7,0.000002667665,0.0000088275865,0.000051044768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991772,0.00020142712,0.00021508362,0.00007370614,0.0001857084,0.00014686276],"domain_scores_gemma":[0.9995937,0.00011149829,0.00009300673,0.000060647722,0.00008636907,0.000054774155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016014838,0.00007785885,0.0002708787,0.00005290863,0.000056672056,0.0000047728563,0.000050825012,0.00005767939,0.00007750467],"category_scores_gemma":[0.000041292675,0.000049691367,0.000073363015,0.00008276817,0.000106739404,0.000037762595,0.000031893287,0.00028919982,0.0000065196446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009579305,0.004875165,0.91843545,0.00015418814,0.0013333799,0.0021067776,0.021421887,0.00004616529,0.008892444,0.001370171,0.0056646895,0.026120363],"study_design_scores_gemma":[0.011575207,0.0018912124,0.9775043,0.000030714084,0.00040710403,0.0016681115,0.00017467907,0.00012075552,0.00075904466,0.0029985195,0.0027856303,0.00008469962],"about_ca_topic_score_codex":0.0000100453135,"about_ca_topic_score_gemma":0.000006540964,"teacher_disagreement_score":0.05906886,"about_ca_system_score_codex":0.000043415574,"about_ca_system_score_gemma":0.00012573841,"threshold_uncertainty_score":0.20263551},"labels":[],"label_agreement":null},{"id":"W3193688084","doi":"10.1007/s00345-021-03802-6","title":"The argument against screening for bladder cancer in neuro-urological patients","year":2021,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Nephrology; Bladder cancer; Argument (complex analysis); Urology; Internal medicine; Oncology; Cancer","score_opus":0.024377960722386953,"score_gpt":0.3021645347995292,"score_spread":0.27778657407714225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193688084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9014835,0.016981225,0.00083605,0.07403665,0.0025278402,0.00079874526,0.00003553464,0.000017276885,0.0032831833],"genre_scores_gemma":[0.988342,0.0011296654,0.0003407262,0.00927733,0.0003269714,0.000025288553,0.0000040140385,0.000015609146,0.00053838064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988905,0.000102119804,0.0004002914,0.00014427744,0.00018414958,0.00027862887],"domain_scores_gemma":[0.99907905,0.0002971198,0.00017496344,0.00012129959,0.00022999216,0.000097553304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019789311,0.00010889737,0.0002872838,0.000095668365,0.00007943165,0.00001319866,0.00009314674,0.000050496023,0.00011282745],"category_scores_gemma":[0.00017677314,0.000067176596,0.00014522963,0.00016887623,0.000061161096,0.00003478878,0.000034216297,0.00031051197,0.0000020604978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005317642,0.00087891147,0.7042457,0.000018018485,0.0006374479,0.0007455503,0.00021309445,0.0007534483,0.0008035337,0.00030460075,0.009643671,0.27643842],"study_design_scores_gemma":[0.010661026,0.0017747303,0.60048103,0.0000338949,0.00028494158,0.00012161913,0.0000420608,0.00020385017,0.00035076277,0.0005532969,0.3853819,0.00011083724],"about_ca_topic_score_codex":0.000005423243,"about_ca_topic_score_gemma":0.00017113541,"teacher_disagreement_score":0.37573823,"about_ca_system_score_codex":0.000052200572,"about_ca_system_score_gemma":0.00017012283,"threshold_uncertainty_score":0.27393818},"labels":[],"label_agreement":null},{"id":"W3193879193","doi":"10.1016/j.vaccine.2021.08.026","title":"A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment","year":2021,"lang":"en","type":"review","venue":"Vaccine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Immunotherapy; Tuberculosis; Oncology; Internal medicine; Disease; Clinical trial; Cancer; Intensive care medicine; Surgery; Immunology; Pathology","score_opus":0.052747907206690425,"score_gpt":0.3797173029256761,"score_spread":0.3269693957189857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193879193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027194838,0.99345905,0.000029076162,0.0003142128,0.00042387808,0.0019275845,0.00086938986,0.000043584427,0.0002137276],"genre_scores_gemma":[0.00020722896,0.99147,0.0005605264,0.00008414439,0.000706513,0.0010756506,0.0010656151,0.000108378015,0.0047219694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979353,0.00015440739,0.00059151347,0.0006990307,0.00031311807,0.00030665242],"domain_scores_gemma":[0.9985537,0.00007920695,0.00026188875,0.000693907,0.00015294524,0.00025836652],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000069688125,0.00057845743,0.0028460159,0.0002291771,0.00004991693,0.0000176067,0.00013914682,0.0002733237,0.0037151943],"category_scores_gemma":[0.000023228828,0.0004130954,0.0008662435,0.00048752714,0.0000064971,0.000052681382,0.0000729043,0.00019804694,0.00007327903],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012030232,0.00073346926,0.00030458605,0.0027442207,0.005121655,0.00006792769,0.00021640507,0.000004100644,0.0000088623965,0.0000030746091,0.003546161,0.9871292],"study_design_scores_gemma":[0.002524264,0.0011572362,0.00048359562,0.01672449,0.015227015,0.000023054046,0.000035728535,0.0000019307415,0.00021219006,0.0000019579527,0.96328205,0.0003265028],"about_ca_topic_score_codex":0.0021901259,"about_ca_topic_score_gemma":0.00038456387,"teacher_disagreement_score":0.98680276,"about_ca_system_score_codex":0.00076822663,"about_ca_system_score_gemma":0.001012265,"threshold_uncertainty_score":0.9998321},"labels":[],"label_agreement":null},{"id":"W3194363332","doi":"10.1016/j.euf.2021.07.016","title":"Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications","year":2021,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Prostate Cancer Foundation of Australia; Queensland Health","keywords":"Medicine; Glutamate carboxypeptidase II; Stage (stratigraphy); Prostate cancer; Oncology; Immunohistochemistry; Positron emission tomography; Pathological; Internal medicine; Cancer; Pathology; Radiology","score_opus":0.031625049061273024,"score_gpt":0.2874096472960862,"score_spread":0.2557845982348132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194363332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054026645,0.9860349,0.00003917107,0.0005705641,0.00024286876,0.0017736483,0.00019376627,0.000106368985,0.010498421],"genre_scores_gemma":[0.008414852,0.9892094,0.00014254368,0.00024678197,0.00050258543,0.00011838821,0.00031236463,0.0002047434,0.00084833376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971998,0.0005441767,0.0005807128,0.0010503876,0.00014302526,0.0004819007],"domain_scores_gemma":[0.99856764,0.00013178911,0.00022027844,0.00068221986,0.00009503539,0.00030302792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021470457,0.0005907221,0.0014374532,0.00020936802,0.00018486737,0.00007378518,0.00015508743,0.00014045922,0.00012480194],"category_scores_gemma":[0.000050017145,0.00048283394,0.00023692023,0.0002290248,0.0003516365,0.000048221085,0.00021657522,0.0005377847,0.00014357496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004391409,0.00018574165,0.0050392877,0.0022328768,0.00034137056,0.0022400308,0.00020656896,2.4696202e-8,0.00006267702,0.0002556415,0.0016528055,0.9877391],"study_design_scores_gemma":[0.0012924813,0.00034448254,0.0047568865,0.00068293884,0.0018403375,0.002957977,0.000011138727,7.612689e-7,0.00001639912,0.000020037845,0.9877169,0.00035965838],"about_ca_topic_score_codex":0.000015797721,"about_ca_topic_score_gemma":0.0000023045768,"teacher_disagreement_score":0.98737943,"about_ca_system_score_codex":0.000043546235,"about_ca_system_score_gemma":0.0002910324,"threshold_uncertainty_score":0.99976236},"labels":[],"label_agreement":null},{"id":"W3194907215","doi":"10.1177/17562872211039583","title":"Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Magnetic resonance imaging; Prospective cohort study; Retrospective cohort study; MEDLINE; Cancer; Radiology; Medical physics; Internal medicine","score_opus":0.07545497741378115,"score_gpt":0.43436978318095215,"score_spread":0.358914805767171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194907215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021123316,0.9920661,0.0006768336,0.00018529897,0.00027783224,0.0065658647,0.00014934041,0.000024630715,0.00003297879],"genre_scores_gemma":[0.00301788,0.9933548,0.0005183113,0.00074837357,0.00016173418,0.002062292,0.000055519493,0.000059210506,0.000021854063],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9951966,0.00058936013,0.002626581,0.0009604464,0.00025663822,0.00037042057],"domain_scores_gemma":[0.99550587,0.00092661777,0.0020838857,0.0011902344,0.00020833148,0.00008507358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008909866,0.00043648863,0.0037141594,0.00013242803,0.000110878646,0.00001582744,0.00045382566,0.00014371303,0.000005181336],"category_scores_gemma":[0.00033896646,0.00028525232,0.0002623249,0.0005164466,0.0005052753,0.00010599893,0.00033326406,0.0004897942,9.507509e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025279809,0.000056509387,0.0006920602,0.42577466,0.000114616065,0.000010916152,0.0000111553445,6.3998266e-7,2.304181e-7,0.00003283306,0.00000616146,0.5732749],"study_design_scores_gemma":[0.0028174645,0.00030136562,0.00097460335,0.5723542,0.021627113,0.0032358046,0.0001118732,0.0053252415,6.069184e-7,0.000039198712,0.39264542,0.0005670991],"about_ca_topic_score_codex":0.000013797575,"about_ca_topic_score_gemma":0.000003244442,"teacher_disagreement_score":0.57270783,"about_ca_system_score_codex":0.00009306458,"about_ca_system_score_gemma":0.0004382,"threshold_uncertainty_score":0.99995995},"labels":[],"label_agreement":null},{"id":"W3195235629","doi":"10.1097/ju.0000000000002190","title":"Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation; University of Alberta; McGill University Health Centre; University of British Columbia","funders":"","keywords":"Bladder cancer; Prospective cohort study; Chemotherapy; Pathological; Neoadjuvant therapy; Toxicity","score_opus":0.015652946755664053,"score_gpt":0.2931697105444563,"score_spread":0.27751676378879225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195235629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943249,0.0014501099,0.000051955834,0.0035784275,0.00014287051,0.00013826847,0.000005524972,0.0000020780035,0.00030581877],"genre_scores_gemma":[0.99702066,0.00091836596,0.00016769067,0.0016867894,0.00010605965,0.0000028817883,0.0000013102923,0.000016380036,0.00007986804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907994,0.00013969172,0.00029575845,0.00008054009,0.00024036539,0.00016370724],"domain_scores_gemma":[0.9991447,0.0001318773,0.0002570246,0.00017896063,0.00024650432,0.000040985622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001886793,0.00010040609,0.000292829,0.000038410024,0.000036859088,0.0000053134304,0.00012660114,0.000048159007,0.0005139023],"category_scores_gemma":[0.000029518682,0.000047323017,0.000069378235,0.0001484647,0.00012971614,0.000057471378,0.000028345394,0.00026097582,0.0000038425296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049921107,0.00078620453,0.9683165,0.000034932786,0.0012070473,0.00016858894,0.007135321,0.0006250073,0.003666936,0.000033530057,0.00076102134,0.012272819],"study_design_scores_gemma":[0.0067253,0.0006911705,0.985883,0.00006554681,0.000421662,0.0002360453,0.0005972987,0.000009135962,0.0047118864,0.00017910612,0.00042199617,0.000057840687],"about_ca_topic_score_codex":0.00013712703,"about_ca_topic_score_gemma":0.00014117148,"teacher_disagreement_score":0.01756653,"about_ca_system_score_codex":0.00004032424,"about_ca_system_score_gemma":0.00028688487,"threshold_uncertainty_score":0.562687},"labels":[],"label_agreement":null},{"id":"W3195299022","doi":"10.1177/17588359211039052","title":"Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Carcinoma; Cancer research; Oncology; Bladder cancer; Internal medicine; Cancer","score_opus":0.09591219510996234,"score_gpt":0.4072967351049521,"score_spread":0.3113845399949898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195299022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017156887,0.9913728,0.00035718287,0.0004953008,0.0002461095,0.0014019927,0.00001120613,0.0000067112437,0.0059370813],"genre_scores_gemma":[0.003726918,0.99378926,0.000992495,0.0007035467,0.0001674255,0.00050598616,0.00003178305,0.0000351834,0.000047402005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975502,0.0003162193,0.0007823824,0.00048190248,0.0005141363,0.00035519598],"domain_scores_gemma":[0.99864966,0.0006335935,0.00023507047,0.0003600366,0.000021575383,0.00010009138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071949395,0.00034179148,0.0019665018,0.00017571199,0.000031101317,0.00000491693,0.0003303746,0.000369084,0.0001246633],"category_scores_gemma":[0.00003412816,0.00021006801,0.00018675973,0.00047238267,0.00038373464,0.000047224454,0.00013486002,0.0007147522,0.000002933851],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004947634,0.00062510604,0.000114538256,0.008531822,0.00023704549,0.00066318753,0.00074904255,6.198646e-7,5.6328867e-7,0.0005924317,0.0000037385716,0.9884324],"study_design_scores_gemma":[0.004404988,0.00075985136,0.00073811354,0.013091683,0.0014478207,0.0004806655,0.0020242603,0.000024026911,0.0000022369986,0.00024726696,0.9765386,0.00024050384],"about_ca_topic_score_codex":0.000044088516,"about_ca_topic_score_gemma":0.00012045185,"teacher_disagreement_score":0.9881919,"about_ca_system_score_codex":0.00022341059,"about_ca_system_score_gemma":0.00091800216,"threshold_uncertainty_score":0.8566325},"labels":[],"label_agreement":null},{"id":"W3195690345","doi":"10.5489/cuaj.7487","title":"Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sinai Health System; University of British Columbia; McMaster University; Dalhousie University; Université Laval; University of Toronto; Western University; Memorial University of Newfoundland; Université de Montréal; University of Alberta; McGill University Health Centre; University of Ottawa; Queen's University; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Guideline; Bladder cancer; Medicine; Association (psychology); Urology; Cancer; General surgery; Internal medicine; Pathology; Psychology","score_opus":0.015416575540447747,"score_gpt":0.25956767086147436,"score_spread":0.2441510953210266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195690345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.714002,0.0005359982,0.000034716093,0.26213187,0.0011784178,0.00061487034,0.0004918929,0.000027269525,0.020982917],"genre_scores_gemma":[0.96748245,0.00074795005,0.0001574351,0.027766954,0.0005327213,0.000031980282,0.00010186834,0.000020540263,0.0031580743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731016,0.00027221075,0.0005591851,0.00033155616,0.00078137795,0.0007454788],"domain_scores_gemma":[0.99729043,0.0002547044,0.0004246817,0.00022204788,0.00088639266,0.00092172826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008985186,0.00022996793,0.00039889204,0.00017344677,0.00046668432,0.000073504394,0.00018906525,0.00039480464,0.0050256555],"category_scores_gemma":[0.0005863414,0.00016205334,0.00027073448,0.00042900932,0.000026779751,0.00006698255,0.000026641532,0.00072965585,0.00013362846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023414083,0.0002532215,0.6258877,0.000022293161,0.002689846,0.0012081729,0.0002575327,0.00038656633,0.00048711963,0.00044496244,0.3600718,0.008056635],"study_design_scores_gemma":[0.0020125494,0.0004318959,0.8438195,0.000064472435,0.0005796675,0.00004498543,0.00026957283,0.00010853888,0.00038029946,0.00032824776,0.15176941,0.00019083473],"about_ca_topic_score_codex":0.044952903,"about_ca_topic_score_gemma":0.05410428,"teacher_disagreement_score":0.25348043,"about_ca_system_score_codex":0.0063290237,"about_ca_system_score_gemma":0.0024810177,"threshold_uncertainty_score":0.9974855},"labels":[],"label_agreement":null},{"id":"W3196418876","doi":"10.1111/iju.14682","title":"Stage and cancer‐specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population‐based study","year":2021,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Vietnamese; Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Stage (stratigraphy); Cancer; Oncology; Epidemiology; Ethnic group; Population; Relative risk; Survival rate; Urothelial carcinoma; Demography; Bladder cancer; Confidence interval; Biology","score_opus":0.049644589208819194,"score_gpt":0.35314479775214097,"score_spread":0.30350020854332177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196418876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993706,0.0009873545,0.0006967334,0.0026699323,0.0012715581,0.00035410767,0.00024536918,0.000010455094,0.000058494315],"genre_scores_gemma":[0.99728423,0.00016318828,0.00040817246,0.0008777368,0.001014318,0.000029934996,0.00007811669,0.000030431516,0.00011385066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983282,0.00013053851,0.00057967415,0.00028950672,0.00047836165,0.000193687],"domain_scores_gemma":[0.9986502,0.00010700703,0.00040746713,0.00017526874,0.00050652825,0.00015351649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017813077,0.00018515305,0.0004634617,0.00016491833,0.000054820946,0.00003245754,0.00015183854,0.000050380342,0.00022257186],"category_scores_gemma":[0.00004840607,0.00015393994,0.0001808754,0.00013775962,0.00007655856,0.00009684558,0.00002816472,0.00029000407,0.0000016175446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016984576,0.0010311602,0.9861713,0.000009585979,0.00051189796,0.0006660809,0.0005967716,0.00008481189,0.00046439163,0.00007106864,0.00009401758,0.008600475],"study_design_scores_gemma":[0.0059939893,0.0015561876,0.9890607,0.000010005418,0.00023117634,0.00024201408,0.0003175063,0.00007052034,0.00023136934,0.00007654247,0.0020959247,0.000114058435],"about_ca_topic_score_codex":0.0002518594,"about_ca_topic_score_gemma":0.000911183,"teacher_disagreement_score":0.008486416,"about_ca_system_score_codex":0.00020485747,"about_ca_system_score_gemma":0.0002653398,"threshold_uncertainty_score":0.62774885},"labels":[],"label_agreement":null},{"id":"W3196657023","doi":"10.1016/j.clgc.2021.08.003","title":"Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cohort; Urology; Chemotherapy; Radiation therapy; Internal medicine; Confidence interval; Concomitant; Urothelial carcinoma; Oncology; Cancer","score_opus":0.027970536787984952,"score_gpt":0.35711583299522026,"score_spread":0.3291452962072353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196657023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97837704,0.015633294,0.000010132885,0.002761731,0.001385307,0.0007978133,0.000110066256,0.000047546986,0.0008770694],"genre_scores_gemma":[0.97244036,0.020089671,0.00036763842,0.0034899642,0.0016228093,0.00039906517,0.000029865745,0.00008949137,0.0014711395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996709,0.00031260456,0.0009904613,0.00093073584,0.0004326776,0.00062454847],"domain_scores_gemma":[0.9986446,0.00024190698,0.0001316396,0.00044227202,0.00014016873,0.0003994003],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002575371,0.00038832478,0.0009774147,0.0001740908,0.000066133594,0.000036376736,0.0001465282,0.00040129886,0.0015113392],"category_scores_gemma":[0.00010801517,0.0003513273,0.00024050935,0.00047811551,0.0002648333,0.00015317928,0.000084204905,0.00082396896,0.000016728789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031484633,0.0016444668,0.8049292,0.00010800067,0.00027106714,0.0011724124,0.0002540241,0.000018618104,0.00034740573,0.000004575953,0.0020645962,0.18603718],"study_design_scores_gemma":[0.029647019,0.0029634936,0.92570907,0.0005135858,0.00017641153,0.00005009728,0.00006626933,0.00011507357,0.0005779667,0.000089455345,0.039623033,0.00046852033],"about_ca_topic_score_codex":0.0009059408,"about_ca_topic_score_gemma":0.0009802171,"teacher_disagreement_score":0.18556866,"about_ca_system_score_codex":0.0003960682,"about_ca_system_score_gemma":0.0011932012,"threshold_uncertainty_score":0.99989384},"labels":[],"label_agreement":null},{"id":"W3197071230","doi":"10.1016/j.prp.2021.153607","title":"Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Canada Research Chairs","funders":"","keywords":"Multiplex; Bladder cancer; Medicine; Concordance; Digital pathology; Biomarker; Immune system; Pathology; Tissue microarray; Oncology; Immunohistochemistry; Cancer research; Cancer; Internal medicine; Bioinformatics; Immunology; Biology","score_opus":0.17129867298470394,"score_gpt":0.4700114703734423,"score_spread":0.29871279738873835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197071230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545283,0.0028999345,0.0014040155,0.0024318015,0.00014796032,0.0008863762,0.00015707215,0.000010693921,0.0066093174],"genre_scores_gemma":[0.9338559,0.0006590766,0.06471139,0.000123101,0.000047898717,0.00018056345,0.00006901531,0.000019449784,0.0003335984],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980657,0.0004734845,0.00040511918,0.0004099971,0.0002591287,0.00038653688],"domain_scores_gemma":[0.9962447,0.0024534636,0.00014086734,0.00026002695,0.00075592066,0.00014498303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015626319,0.00013872857,0.00046645929,0.0001616389,0.00013879601,0.00001835315,0.00006604511,0.00019245932,0.000055744193],"category_scores_gemma":[0.0020913358,0.000108542336,0.000049582268,0.00018518821,0.0005301643,0.00013881423,0.00019459055,0.0002514449,0.0000016798726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010260429,0.0029147281,0.09239463,0.00065548543,0.0006536671,0.0026079426,0.0042559025,1.4415413e-7,0.4666127,0.0005837046,0.0002365569,0.4188241],"study_design_scores_gemma":[0.03170689,0.012809809,0.6700875,0.000287687,0.0006155242,0.014564121,0.011057998,0.00021027189,0.08454748,0.0021980521,0.17135367,0.0005609757],"about_ca_topic_score_codex":0.000021289603,"about_ca_topic_score_gemma":0.000030510551,"teacher_disagreement_score":0.57769287,"about_ca_system_score_codex":0.000078302655,"about_ca_system_score_gemma":0.001477428,"threshold_uncertainty_score":0.4426228},"labels":[],"label_agreement":null},{"id":"W3197566640","doi":"10.1007/s42399-021-01052-6","title":"Survivin and Caspase-3 Cannot Predict Recurrence for Urinary Bladder Carcinoma","year":2021,"lang":"en","type":"article","venue":"SN Comprehensive Clinical Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; NOSM University","funders":"","keywords":"Survivin; Medicine; Cystoscopy; Bladder cancer; Immunohistochemistry; Cancer; Oncology; Urinary system; Urology; Internal medicine; Pathology","score_opus":0.11783614881618341,"score_gpt":0.40337475767029235,"score_spread":0.2855386088541089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197566640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551905,0.016574873,0.00052853365,0.018944483,0.0028857428,0.0015646176,0.0002520106,0.000114548115,0.0039446913],"genre_scores_gemma":[0.98596716,0.0018407216,0.001119343,0.0065489514,0.0021358146,0.00011816619,0.000272872,0.000052805168,0.0019441376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972613,0.00022072601,0.00084490323,0.00084210845,0.00038087126,0.00045009417],"domain_scores_gemma":[0.9957884,0.0019191555,0.00015188132,0.000608708,0.00091446145,0.000617426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030331482,0.0003368571,0.0010603614,0.00008428859,0.00014167752,0.000011270017,0.00010643192,0.00021062265,0.00041598853],"category_scores_gemma":[0.0014059035,0.00026072332,0.00019669103,0.0002606354,0.0006454898,0.000055998004,0.00012846325,0.00043947913,0.000017356799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003971992,0.0021856031,0.75742024,0.001224709,0.0016517517,0.002720169,0.00089670334,0.0000016078252,0.0017981989,0.00062368397,0.13931689,0.088188455],"study_design_scores_gemma":[0.017069463,0.008718964,0.87862206,0.00074123393,0.0012619448,0.0010540562,0.00075688894,0.00025423462,0.00060359895,0.00083268905,0.08972399,0.00036088514],"about_ca_topic_score_codex":0.00018187774,"about_ca_topic_score_gemma":0.000047395108,"teacher_disagreement_score":0.121201806,"about_ca_system_score_codex":0.000056486635,"about_ca_system_score_gemma":0.0005090161,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W3198666804","doi":"10.1016/j.euf.2021.08.006","title":"The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology; Uehara Memorial Foundation","keywords":"Medicine; Cystectomy; Urology; Internal medicine; Oncology; Proportional hazards model; Bladder cancer; Lymph node; Concordance; Logistic regression; Carcinoma; Cancer","score_opus":0.013555182804211894,"score_gpt":0.23905050799377156,"score_spread":0.22549532518955967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198666804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97052,0.00076952815,0.000018965064,0.0014400226,0.00009711588,0.00046724433,0.000043554406,0.0000149028465,0.026628634],"genre_scores_gemma":[0.9984059,0.000018752127,0.00006103631,0.00024815084,0.000081041195,0.00001602444,0.0000035204669,0.000041039868,0.0011245555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791306,0.0009175683,0.00036220168,0.00030257998,0.00023613381,0.00026844486],"domain_scores_gemma":[0.9989929,0.00018087882,0.0001241087,0.00051059196,0.00012577533,0.00006575099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021247195,0.00019097124,0.0003632654,0.000046624842,0.000089442736,0.0000070928295,0.00020281023,0.000063898086,0.000086082066],"category_scores_gemma":[0.00010666954,0.00009597352,0.00010902242,0.00030790007,0.0005586132,0.000026074324,0.00009475868,0.00030248566,0.000015272684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069615156,0.0013485905,0.9386011,0.00008611977,0.0016423885,0.0027691294,0.006333024,0.00020815794,0.029977283,0.0028802885,0.0006318009,0.008560601],"study_design_scores_gemma":[0.008994891,0.0017822649,0.88343185,0.00004981874,0.0003266137,0.00046493602,0.00016570375,0.00007619412,0.102441005,0.000042485794,0.002108822,0.000115385345],"about_ca_topic_score_codex":0.00012623637,"about_ca_topic_score_gemma":0.00013350214,"teacher_disagreement_score":0.07246373,"about_ca_system_score_codex":0.000036335896,"about_ca_system_score_gemma":0.00036814623,"threshold_uncertainty_score":0.39136866},"labels":[],"label_agreement":null},{"id":"W3199159458","doi":"10.1007/s00345-021-03831-1","title":"Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies","year":2021,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Nephrology; Urology; Bladder cancer; General surgery; Cystectomy; Internal medicine; Cancer","score_opus":0.0644293866282556,"score_gpt":0.40836697778354925,"score_spread":0.34393759115529365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199159458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019889757,0.99544084,0.00020269626,0.0017063977,0.0012078485,0.0005915111,0.00038091015,0.000019055995,0.00025183544],"genre_scores_gemma":[0.0007688599,0.9964227,0.00064716634,0.0002867826,0.0010024701,0.00008356116,0.000076901924,0.00006892646,0.00064261776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641997,0.00035183644,0.0021321932,0.0003812323,0.00031107196,0.00040367857],"domain_scores_gemma":[0.996529,0.0002948129,0.002117528,0.00023816095,0.0005963041,0.00022422963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011783072,0.0003680623,0.0032446436,0.00059181533,0.0001395252,0.000023206638,0.00010946644,0.00040134977,0.00036927554],"category_scores_gemma":[0.0005583463,0.0002664133,0.00077452045,0.0004160216,0.00029935007,0.000047843947,0.000033128646,0.0010279991,4.9521134e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089862366,0.00018057362,0.0004441354,0.0038786246,0.004217032,0.0041087624,0.00019248351,0.0000026620714,0.00001750124,0.00012312506,0.012408199,0.97352827],"study_design_scores_gemma":[0.002587093,0.0011569334,0.00008244843,0.0020314232,0.007393984,0.024724156,0.000021846981,0.0000016261347,0.000005164424,0.00006619885,0.96175617,0.00017293819],"about_ca_topic_score_codex":0.00003319977,"about_ca_topic_score_gemma":0.00023041629,"teacher_disagreement_score":0.97335535,"about_ca_system_score_codex":0.00025797458,"about_ca_system_score_gemma":0.003079794,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W3199329805","doi":"10.2139/ssrn.3924600","title":"Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"General Electric (Canada)","funders":"","keywords":"Immunotherapy; Tumor microenvironment; Cancer research; Pembrolizumab; Immune checkpoint; Immune system; Bladder cancer; Transcriptome; Oncology; Neoadjuvant therapy; Biology; Medicine; Cancer; Immunology; Internal medicine; Breast cancer; Gene expression; Gene; Genetics","score_opus":0.01239724771298981,"score_gpt":0.27653097955107503,"score_spread":0.2641337318380852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199329805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97205675,0.018315421,0.00029844927,0.008340868,0.00034531887,0.00036153058,0.000016363165,0.000041045234,0.00022426309],"genre_scores_gemma":[0.9936977,0.0030533415,0.00032302793,0.0012320442,0.00029132288,0.00009100932,0.000013632996,0.000054609467,0.0012433076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996374,0.0003303197,0.0005759328,0.00044815594,0.00042474066,0.0018468419],"domain_scores_gemma":[0.9988424,0.00016753432,0.00015838043,0.0003543502,0.00022946778,0.00024786865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011448778,0.000304298,0.0004873766,0.00027489924,0.0001475856,0.000036415735,0.0001437074,0.0001551417,0.00036950666],"category_scores_gemma":[0.0005344144,0.00023928827,0.00026253387,0.00051034125,0.000046286314,0.000086167514,0.00005909962,0.001508468,0.000050518218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008798524,0.0010840006,0.037398346,0.000047825142,0.00032973217,0.0032606858,0.0012680811,0.0005430244,0.91387403,0.00017432489,0.00034167364,0.03287974],"study_design_scores_gemma":[0.02272525,0.005435473,0.1851009,0.0020248394,0.00048908254,0.0030091037,0.0065422324,0.00004174109,0.7586125,0.010767646,0.0041848007,0.0010664297],"about_ca_topic_score_codex":0.00032587338,"about_ca_topic_score_gemma":0.0023505988,"teacher_disagreement_score":0.15526155,"about_ca_system_score_codex":0.0020534154,"about_ca_system_score_gemma":0.010893281,"threshold_uncertainty_score":0.994714},"labels":[],"label_agreement":null},{"id":"W3199365618","doi":"10.1016/j.prro.2021.07.006","title":"Stereotactic Ablative Radiation Therapy for the Treatment of Upper Urinary Tract Urothelial Carcinoma","year":2021,"lang":"en","type":"article","venue":"Practical Radiation Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Boston Scientific Corporation; Sanofi; Bayer","keywords":"Medicine; SABR volatility model; Common Terminology Criteria for Adverse Events; Renal pelvis; Urology; Ureter; Radiation therapy; Urinary system; Upper urinary tract; Surgery; Radiology; Internal medicine","score_opus":0.058036902040400615,"score_gpt":0.39827980315584344,"score_spread":0.3402429011154428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199365618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9178354,0.011534506,0.0028031184,0.054049667,0.0015370806,0.0042732027,0.0001792862,0.00006549276,0.0077222474],"genre_scores_gemma":[0.99072045,0.005477642,0.00091904524,0.0010951053,0.00053728966,0.0004210296,0.0000812175,0.000026114272,0.0007220974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987708,0.0002278788,0.00032450666,0.00027356483,0.0001866217,0.0002166287],"domain_scores_gemma":[0.99684274,0.0023988483,0.00020512124,0.00025720563,0.00019212726,0.000103983315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014609934,0.00015992994,0.0003672665,0.00005864823,0.00011488561,0.000014032024,0.000036522564,0.00014599552,0.00059607165],"category_scores_gemma":[0.00033025918,0.00010588509,0.00020467854,0.00014516595,0.00007485933,0.00014462817,0.000005861538,0.00011004476,0.000023717519],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013136251,0.022932434,0.16216986,0.000053145213,0.0022429437,0.00029992094,0.00601634,0.00002678153,0.004220207,0.0028003247,0.0012520434,0.78484976],"study_design_scores_gemma":[0.015349627,0.018998856,0.5090733,0.0000059307445,0.00080144854,0.0005581312,0.00034229216,0.0010415245,0.019133344,0.00033247896,0.4342293,0.00013372858],"about_ca_topic_score_codex":0.00006325306,"about_ca_topic_score_gemma":0.0000032660976,"teacher_disagreement_score":0.784716,"about_ca_system_score_codex":0.0005335492,"about_ca_system_score_gemma":0.0012640373,"threshold_uncertainty_score":0.6526567},"labels":[],"label_agreement":null},{"id":"W3199658963","doi":"10.1097/ju.0000000000002229","title":"Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Psychological intervention; Population; Equity (law); MEDLINE; Promotion (chess); Epidemiology","score_opus":0.06916035072624031,"score_gpt":0.333178458058441,"score_spread":0.26401810733220066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199658963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947683,0.0015017343,0.000041585354,0.0027794086,0.0005176238,0.00021320714,0.000033958342,0.0000052066434,0.00013898336],"genre_scores_gemma":[0.9982382,0.00031881992,0.000009668416,0.00094762153,0.0001509612,0.000004985123,0.00004884286,0.000020950503,0.00025991697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844307,0.000363346,0.00048674073,0.00013072349,0.0003728906,0.00020321921],"domain_scores_gemma":[0.9985056,0.00016860795,0.00046640818,0.00017734335,0.0006281803,0.00005389301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032326314,0.00014149146,0.0003293091,0.00008558,0.00015206556,0.00001323592,0.00009914512,0.00009400756,0.00019389942],"category_scores_gemma":[0.00023044029,0.000069630376,0.000084242114,0.00023060483,0.000043940116,0.00008741707,0.00004202999,0.0003712133,0.000001488436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00213377,0.00010848608,0.9851072,0.000011706018,0.00053609663,0.000045342218,0.0055815796,0.0011566613,0.00081437465,0.0000033848146,0.0015489953,0.0029524479],"study_design_scores_gemma":[0.003937318,0.00093173183,0.9890812,0.000101253914,0.0005994191,0.00004368352,0.001581261,0.000040995463,0.0031615642,0.000060890106,0.00038194878,0.00007874516],"about_ca_topic_score_codex":0.0012674329,"about_ca_topic_score_gemma":0.014236786,"teacher_disagreement_score":0.012969354,"about_ca_system_score_codex":0.00055474555,"about_ca_system_score_gemma":0.00020562178,"threshold_uncertainty_score":0.7944461},"labels":[],"label_agreement":null},{"id":"W3200382101","doi":"10.1101/2021.09.10.459788","title":"The influence of age and sex on the pre-treatment immune microenvironment of a carcinogen induced murine model of bladder cancer","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Queen's University; Bladder Cancer Canada","keywords":"Immune system; Bladder cancer; Biology; Tumor microenvironment; Immunotherapy; Myeloid; Immunology; Cancer research; Cancer; Genetics","score_opus":0.020276901296253504,"score_gpt":0.24375928651122175,"score_spread":0.22348238521496824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200382101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923707,0.005524981,0.000009455163,0.00027491277,0.000089322144,0.0013866909,0.00031779328,0.000017713844,0.000008422993],"genre_scores_gemma":[0.9937729,0.0053414498,0.00023213845,0.0000900885,0.000050874296,0.00042305788,4.539049e-7,0.000062862164,0.000026131198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980299,0.00010414564,0.00062747387,0.0005296738,0.00041891861,0.0002898835],"domain_scores_gemma":[0.99766064,0.00009417777,0.0005305628,0.0014049271,0.0001980043,0.00011171753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021608079,0.0004307236,0.00079305365,0.00007873705,0.000089837966,0.000021684447,0.00026075204,0.00021135515,0.00002385183],"category_scores_gemma":[0.0000411253,0.0002660673,0.00018883398,0.0001594066,0.00029761498,0.000031233605,0.00031357375,0.00030732792,7.0598094e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002074906,0.0004600673,0.017866965,0.000394488,0.0013224788,0.000022912152,0.00021379344,0.0012792186,0.9781759,0.000034406512,0.0000074177424,0.0000148666395],"study_design_scores_gemma":[0.0008900633,0.00027868288,0.33279893,0.0006016351,0.00052818557,2.4387727e-8,0.000016989128,0.00016503995,0.6645353,0.0000010342956,0.000041581665,0.00014257974],"about_ca_topic_score_codex":0.001463956,"about_ca_topic_score_gemma":0.0000218674,"teacher_disagreement_score":0.31493196,"about_ca_system_score_codex":0.00028612014,"about_ca_system_score_gemma":0.00076600333,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W3200464632","doi":"10.48083/dhhv3158","title":"Dissecting patterns of care in patients with variant histology of bladder cancer and lymph node invasion","year":2021,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Stage (stratigraphy); Lymph node; Oncology; Internal medicine; Adenocarcinoma; Dissection (medical); Cancer; Proportional hazards model; Cystectomy; T-stage; Chemotherapy; Radiology; Biology","score_opus":0.018584645688568012,"score_gpt":0.29802468692140377,"score_spread":0.2794400412328358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200464632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669904,0.0013453916,0.00008093449,0.00047280974,0.00033615972,0.000097745135,0.000059859154,0.000004549462,0.0009034886],"genre_scores_gemma":[0.99879265,0.00038954377,0.00026277744,0.00023852197,0.00007953691,0.000008538561,0.000037783713,0.000010329491,0.00018029555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908376,0.000040969288,0.00031167764,0.00016149733,0.00026853054,0.00013354415],"domain_scores_gemma":[0.99890167,0.0000824084,0.00023924331,0.00009097396,0.0006342804,0.000051440988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006900576,0.000102839054,0.00028961926,0.00009969444,0.000034067027,0.000006482882,0.0000644166,0.00007377132,0.00037145716],"category_scores_gemma":[0.00011766688,0.00007818422,0.00006261837,0.00006837276,0.000048111666,0.000066669876,0.000048422316,0.00018407611,2.821093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006857037,0.00023171575,0.9933296,0.00006995127,0.0002596595,0.000092550355,0.0007551964,0.000045522625,0.00024224322,0.000040973937,0.000015815727,0.0042310706],"study_design_scores_gemma":[0.0058266125,0.00041551312,0.9904439,0.00022090913,0.000116062554,0.000105940475,0.0010032693,0.00001700722,0.0015866304,0.000120690725,0.00007815695,0.000065310014],"about_ca_topic_score_codex":0.00017127648,"about_ca_topic_score_gemma":0.0001641225,"teacher_disagreement_score":0.0051409085,"about_ca_system_score_codex":0.00020644593,"about_ca_system_score_gemma":0.00028966583,"threshold_uncertainty_score":0.40671954},"labels":[],"label_agreement":null},{"id":"W3200709869","doi":"10.1136/bmjopen-2021-055782","title":"Bladder cancer and exeRcise trAining during intraVesical thErapy—the BRAVE trial: a study protocol for a prospective, single-centre, phase II randomised controlled trial","year":2021,"lang":"en","type":"article","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Alberta Cancer Foundation","keywords":"Medicine; Bladder cancer; Randomized controlled trial; Quality of life (healthcare); Physical therapy; Clinical trial; Cystoscopy; Cancer; Internal medicine; Urinary system; Nursing","score_opus":0.14377288369502914,"score_gpt":0.45412048066950395,"score_spread":0.3103475969744748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200709869","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25664195,0.00004135045,0.000010830102,0.00095626834,0.00015982866,0.74115723,0.000017776982,0.000030606538,0.0009841435],"genre_scores_gemma":[0.14532146,0.0000044365142,0.00012882959,0.00024379692,0.0007399681,0.8494674,0.0000056269023,0.00005282315,0.0040356475],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976909,0.00025763235,0.0006921114,0.00059726316,0.00037559358,0.00038648388],"domain_scores_gemma":[0.9986426,0.00026969714,0.00025343933,0.0004144299,0.00023827939,0.00018155646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081141933,0.00032414004,0.0013331944,0.000048786897,0.00042583753,0.00025625617,0.00017867492,0.00008624318,0.00047633296],"category_scores_gemma":[0.00041311726,0.00019310643,0.00025001218,0.00018264395,0.000073596464,0.00014585536,0.0001465878,0.00017038148,0.0000013525347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95997655,0.00982447,0.00008986097,0.000055884146,0.0013152355,0.000079493635,0.008940907,5.309324e-7,0.00088482106,0.000009183533,0.00029419616,0.018528875],"study_design_scores_gemma":[0.9780679,0.013594092,0.00017033187,0.00028020312,0.00075409946,0.000016490845,0.0020326846,0.000051374478,0.0036362316,0.00008530805,0.001077342,0.00023396943],"about_ca_topic_score_codex":0.00006971919,"about_ca_topic_score_gemma":0.00011702938,"teacher_disagreement_score":0.11132049,"about_ca_system_score_codex":0.000110556284,"about_ca_system_score_gemma":0.0010699874,"threshold_uncertainty_score":0.78746516},"labels":[],"label_agreement":null},{"id":"W3200978041","doi":"10.1093/jjco/hyab011","title":"Age-specific bladder cancer incidence rate in the world","year":2021,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Oncology; Bladder cancer; Internal medicine","score_opus":0.1444104254319653,"score_gpt":0.4746959095171381,"score_spread":0.3302854840851728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200978041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96093655,0.0012356279,0.000010984269,0.026249072,0.0009258007,0.00014601936,0.0000011671231,0.000005270623,0.010489535],"genre_scores_gemma":[0.9815805,0.0014724128,0.0005007205,0.013535552,0.0012670369,0.000014708014,0.0000011016522,0.00001092602,0.0016170654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701977,0.0008629653,0.0013602185,0.00019169033,0.00032712694,0.00023821619],"domain_scores_gemma":[0.9964918,0.0022892833,0.00044182027,0.0002479511,0.0003381378,0.00019099575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024857372,0.000120315264,0.00083380955,0.00009565989,0.000042597407,0.000016140331,0.00020353304,0.00012434601,0.0011183472],"category_scores_gemma":[0.0008770383,0.00006733535,0.00030829446,0.0004841109,0.00018341397,0.000106238855,0.000037063717,0.0008647035,0.000038157228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008323512,0.0062170364,0.7197909,0.00004162811,0.00086569204,0.048810713,0.0057715736,0.00013622118,0.006871679,0.0005284936,0.022474267,0.18016833],"study_design_scores_gemma":[0.0075608855,0.0016201679,0.8447099,0.00009062576,0.00017493032,0.0011090736,0.0010653888,0.000012531903,0.00044824072,0.0005909651,0.14253224,0.00008507886],"about_ca_topic_score_codex":0.00005218872,"about_ca_topic_score_gemma":0.0014044953,"teacher_disagreement_score":0.18008325,"about_ca_system_score_codex":0.00013226041,"about_ca_system_score_gemma":0.00109931,"threshold_uncertainty_score":0.9997948},"labels":[],"label_agreement":null},{"id":"W3201746679","doi":"10.1016/j.annonc.2021.08.112","title":"716TiP IMvigor011: A global, double-blind, randomised phase III study of atezolizumab (atezo; anti–PD-L1) vs placebo (pbo) as adjuvant therapy in patients (pts) with high-risk muscle-invasive bladder cancer (MIBC) who are circulating tumour (ct)DNA+ post cystectomy","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Atezolizumab; Adjuvant; Placebo; Oncology; Internal medicine; Bladder cancer; Urology; Immunotherapy; Cancer; Pathology; Pembrolizumab","score_opus":0.04872930099097921,"score_gpt":0.36501031612659074,"score_spread":0.3162810151356115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201746679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99147856,0.0013067783,0.0000037368782,0.0007331073,0.00028058505,0.004742793,0.0003799813,0.00004530968,0.0010291409],"genre_scores_gemma":[0.9967375,0.0012385997,0.000033795404,0.0009992741,0.00013867671,0.0005605093,0.00014285107,0.00007777918,0.000071011185],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956315,0.00062770315,0.0013145785,0.0009179565,0.00076058187,0.00074763893],"domain_scores_gemma":[0.9958048,0.00029257187,0.0013161376,0.0006592809,0.0016301932,0.00029702668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040059755,0.0006037061,0.0024913622,0.0002723449,0.00014691825,0.000023627706,0.00026178072,0.0002262684,0.00042337913],"category_scores_gemma":[0.00016904596,0.00047761918,0.0002865498,0.00078829686,0.00019166268,0.00019846416,0.000097954195,0.00042095105,0.000010418547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5783696,0.026017364,0.33429527,0.00031975468,0.0052312124,0.0033863683,0.0075923232,0.0004120468,0.0034855555,0.000015072911,0.00044250023,0.0404329],"study_design_scores_gemma":[0.6998795,0.03084523,0.24249516,0.0007646339,0.00081022154,0.000091048176,0.004472216,0.000018716106,0.019976227,0.00003269172,0.0001832481,0.00043110634],"about_ca_topic_score_codex":0.019348266,"about_ca_topic_score_gemma":0.00696075,"teacher_disagreement_score":0.12150989,"about_ca_system_score_codex":0.00033203547,"about_ca_system_score_gemma":0.0020132214,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W3201788153","doi":"10.5489/cuaj.7411","title":"Small cell carcinoma of the bladder: A population-based analysis of long-term outcomes after radical cystectomy and bladder conservation with chemoradiotherapy","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Chemoradiotherapy; Internal medicine; Oncology; Population; Radiation therapy; Urology; Surgery; Cancer","score_opus":0.013622669613390436,"score_gpt":0.2295041586684228,"score_spread":0.21588148905503238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201788153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911946,0.000400419,0.00010211425,0.007902183,0.00005069149,0.00017811403,0.00006915088,0.0000045635306,0.00009813267],"genre_scores_gemma":[0.9955736,0.000014094548,0.00023568654,0.003906816,0.000043370357,0.000009566332,0.00003846279,0.000010300278,0.00016813651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987793,0.00016386183,0.00034873886,0.00017123499,0.00032478417,0.00021208207],"domain_scores_gemma":[0.99879056,0.00014119288,0.00032881656,0.00015659262,0.00032906418,0.0002537443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017449602,0.00013232406,0.00048275536,0.00017576378,0.00009130482,0.000026144287,0.00006278862,0.00015711666,0.0005109271],"category_scores_gemma":[0.00010522283,0.00008204665,0.0002214975,0.000534758,0.000056349818,0.000034148645,0.000006573729,0.00021971163,4.096705e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012683884,0.00008656244,0.9982435,0.0000142065865,0.0009241136,0.0000651675,0.00009879878,0.000042907377,0.000091234295,0.000005398238,0.000040895047,0.00026036534],"study_design_scores_gemma":[0.0026485682,0.0001706446,0.9945274,0.000012925567,0.0017364848,0.00003782971,0.000020214755,0.00019955762,0.00049129524,0.000014001553,0.00006140731,0.00007969979],"about_ca_topic_score_codex":0.00232957,"about_ca_topic_score_gemma":0.008012049,"teacher_disagreement_score":0.0056824787,"about_ca_system_score_codex":0.00034583037,"about_ca_system_score_gemma":0.0008194447,"threshold_uncertainty_score":0.55942935},"labels":[],"label_agreement":null},{"id":"W3202079268","doi":"10.21203/rs.3.rs-931975/v1","title":"Prognostic Value of Hepatocyte Growth Factor for Muscle-invasive Bladder Cancer","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Hepatocyte growth factor; Bladder cancer; Value (mathematics); Cancer; Factor (programming language); Medicine; Oncology; Internal medicine; Computer science; Mathematics; Statistics","score_opus":0.09868410326525508,"score_gpt":0.4222166248312937,"score_spread":0.3235325215660386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202079268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97159994,0.011093012,0.00030964622,0.0016661676,0.000599333,0.009534186,0.003808414,0.00009124297,0.0012980752],"genre_scores_gemma":[0.9889612,0.003891331,0.0007545353,0.00009549509,0.0007004028,0.004062574,0.00049666193,0.00012413574,0.0009136264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606746,0.00027820363,0.00047283917,0.0009259491,0.0014410897,0.0008144344],"domain_scores_gemma":[0.99498755,0.00078817393,0.0001520102,0.0008094554,0.0028819186,0.00038091076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003580272,0.0003939943,0.00090062997,0.00036671173,0.00013832147,0.000073149116,0.0003046254,0.00045739667,0.0008907038],"category_scores_gemma":[0.0013698664,0.00033325303,0.0005390413,0.00039436657,0.0002152203,0.0000633206,0.0005493876,0.0010689314,0.000012840906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064532496,0.0065972866,0.72120625,0.12505446,0.0138043165,0.0015874689,0.01959595,0.00019557704,0.025273515,0.0013616399,0.012100723,0.06676953],"study_design_scores_gemma":[0.011046159,0.004747121,0.80153036,0.02130856,0.0017017971,0.000028332597,0.0025783386,0.0007256076,0.14957982,0.002503756,0.0030728977,0.0011772334],"about_ca_topic_score_codex":0.0033750543,"about_ca_topic_score_gemma":0.00040944884,"teacher_disagreement_score":0.124306306,"about_ca_system_score_codex":0.0006057162,"about_ca_system_score_gemma":0.0054324795,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W3202591591","doi":"10.3390/curroncol28050325","title":"Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of the Fraser Valley; University of British Columbia","funders":"","keywords":"Medicine; Systemic therapy; Bladder cancer; Palliative care; Cancer; Overall survival; Oncology; Internal medicine; Nursing","score_opus":0.08399246496767655,"score_gpt":0.37648315671665206,"score_spread":0.2924906917489755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202591591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373263,0.004211487,0.000021217182,0.00069771317,0.00035715074,0.00057028665,0.00015898474,0.000023967392,0.00022655226],"genre_scores_gemma":[0.9985597,0.00054065476,0.000056926725,0.00018482869,0.000031990257,0.00018445578,0.00014242786,0.000025945097,0.00027303654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880475,0.00014729552,0.0002405216,0.00032363393,0.0002200814,0.0002637179],"domain_scores_gemma":[0.99912715,0.00025073922,0.00013747414,0.00014170873,0.00024965918,0.00009327141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083953215,0.00021813327,0.000690043,0.00006860526,0.000052146523,0.000011114987,0.000039843748,0.00005880989,0.0003388999],"category_scores_gemma":[0.000058970625,0.0001353849,0.0000355944,0.000210786,0.00009748729,0.00006541002,0.000026172635,0.00019995852,0.000003329076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004876643,0.0011561449,0.9927046,0.00014458579,0.0010822754,0.00005989569,0.0018192921,0.000005685972,0.0000040407986,0.000019129202,0.00008493866,0.0024317666],"study_design_scores_gemma":[0.016936678,0.001380328,0.9786902,0.0004709653,0.0004715647,0.000005409933,0.0006607094,0.000012531084,0.00002928959,0.000017827282,0.001169027,0.00015544615],"about_ca_topic_score_codex":0.00006885832,"about_ca_topic_score_gemma":0.010161858,"teacher_disagreement_score":0.016449014,"about_ca_system_score_codex":0.0003872148,"about_ca_system_score_gemma":0.0005189246,"threshold_uncertainty_score":0.5670555},"labels":[],"label_agreement":null},{"id":"W3202814886","doi":"10.5489/cuaj.7263","title":"Assessing geographic and industry-related trends in bladder cancer in Ontario: A population-based study","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Geography; Census; Demography; Population; Bladder cancer; Cohort; Medicine; Cartography; Environmental health; Cancer; Pathology","score_opus":0.024192112621282645,"score_gpt":0.2939060857345627,"score_spread":0.2697139731132801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202814886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091136,0.00024516848,6.434908e-7,0.0078446735,0.0001544163,0.00011923906,0.000009162683,0.000008098554,0.00070721284],"genre_scores_gemma":[0.9978196,0.0000063476054,0.000023532248,0.0015725001,0.000049033453,0.000016943215,0.000026641981,0.000009313676,0.00047610878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860007,0.00021961668,0.00035520014,0.00022633972,0.00024785215,0.00035094793],"domain_scores_gemma":[0.9992793,0.00005757072,0.0001267151,0.000068931906,0.00010541311,0.0003620249],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003547646,0.00012523598,0.00028564804,0.0004981908,0.000116803494,0.000115411574,0.000035899306,0.0003560616,0.002779231],"category_scores_gemma":[0.00012593048,0.00011154943,0.00005924933,0.0006276802,0.000009634249,0.00012219288,0.0000068423974,0.0012731664,0.0000013079386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001939912,0.00017953035,0.99435014,8.5097963e-7,0.00009020348,0.0005486115,0.00022596441,0.00021511817,0.000005330806,0.0000045517154,0.000043956108,0.0043163733],"study_design_scores_gemma":[0.003545624,0.00014654566,0.9952556,0.000028266893,0.00009304223,0.000036336412,0.00022949475,0.000116397176,0.0000012399483,0.00015411324,0.00029304618,0.00010029756],"about_ca_topic_score_codex":0.4299502,"about_ca_topic_score_gemma":0.9241105,"teacher_disagreement_score":0.49416026,"about_ca_system_score_codex":0.0024526562,"about_ca_system_score_gemma":0.0014450051,"threshold_uncertainty_score":0.99813235},"labels":[],"label_agreement":null},{"id":"W3202895789","doi":"10.1016/j.annonc.2021.08.054","title":"658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Carboplatin; Cisplatin; Oncology; Urothelial cancer; Chemotherapy; Internal medicine; Cancer; Cancer research; Bladder cancer; Immunotherapy; Nivolumab","score_opus":0.04713711442678768,"score_gpt":0.3681801738621347,"score_spread":0.321043059435347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202895789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743886,0.0020192568,0.000071908056,0.006207198,0.0001255761,0.00072163425,0.000060858507,0.000038079208,0.0033166418],"genre_scores_gemma":[0.99582916,0.00070210366,0.0010125863,0.0018311874,0.000054454977,0.00012352415,0.00008144062,0.00005892323,0.00030664034],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980281,0.00019437434,0.0006119309,0.00047828615,0.00028691886,0.0004003625],"domain_scores_gemma":[0.99870896,0.0002540659,0.00028128634,0.00033529956,0.00028718653,0.00013317098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023018992,0.0003074254,0.000936768,0.00020067455,0.000052573334,0.000013417235,0.000080824524,0.00019568055,0.0005748374],"category_scores_gemma":[0.000081185164,0.00025915404,0.000113642476,0.0004898571,0.0001830304,0.00007080667,0.000026202875,0.0002731979,0.0000064671967],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06018826,0.006290028,0.090098105,0.00090498745,0.0041715875,0.0022965663,0.005396602,0.0037706003,0.10022947,0.0004818939,0.0015759952,0.7245959],"study_design_scores_gemma":[0.09024854,0.015013732,0.54874814,0.0012910254,0.0011193011,0.00038445488,0.00033403095,0.0065149674,0.32963705,0.001095851,0.0046338835,0.000979022],"about_ca_topic_score_codex":0.0012809561,"about_ca_topic_score_gemma":0.00038809495,"teacher_disagreement_score":0.7236169,"about_ca_system_score_codex":0.00015224713,"about_ca_system_score_gemma":0.0012790397,"threshold_uncertainty_score":0.99998605},"labels":[],"label_agreement":null},{"id":"W3202940729","doi":"10.1177/17588359211047352","title":"Metastatic Urothelial Cancer: a rapidly changing treatment landscape","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Urothelial cancer; Immunotherapy; Clinical trial; Oncology; Chemotherapy; Disease; Cancer; Internal medicine; Intensive care medicine; Bladder cancer; Urothelial carcinoma","score_opus":0.06794330522167166,"score_gpt":0.45002674657035063,"score_spread":0.382083441348679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202940729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005270002,0.99182296,0.00023558774,0.0007403705,0.0013539058,0.0017023672,0.00007354908,0.00007709854,0.003988894],"genre_scores_gemma":[0.00002908967,0.9933809,0.00041076957,0.001517966,0.001098849,0.002190909,0.00015351479,0.000120839715,0.0010971717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957273,0.00071913836,0.0010745103,0.00085090025,0.0007124457,0.0009157005],"domain_scores_gemma":[0.99781126,0.0008223364,0.0003574659,0.0005058432,0.00006138186,0.00044170703],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047982312,0.0007679282,0.0048359595,0.00049578457,0.00008238496,0.000013661124,0.00029714624,0.00059455034,0.004923851],"category_scores_gemma":[0.00008913102,0.000506514,0.00071573793,0.0008755055,0.00026092355,0.00007910856,0.000087838365,0.0008119365,0.00008497536],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013770936,0.00092677353,0.000033041593,0.0036519119,0.0010940074,0.0024500473,0.00030570445,0.0000011196479,1.4530039e-7,0.00017570921,0.00003415394,0.99118966],"study_design_scores_gemma":[0.005128925,0.0017863263,0.000001843911,0.011972473,0.0038745806,0.0009701292,0.00016576823,0.000028379225,0.0000022739664,0.00009589373,0.9756038,0.0003695694],"about_ca_topic_score_codex":0.00005300783,"about_ca_topic_score_gemma":0.00023727739,"teacher_disagreement_score":0.9908201,"about_ca_system_score_codex":0.0014737326,"about_ca_system_score_gemma":0.006274284,"threshold_uncertainty_score":0.99973863},"labels":[],"label_agreement":null},{"id":"W3203355818","doi":"10.1016/j.annonc.2021.08.094","title":"698P Analysis of hard-to-treat subgroups from EV-301: A phase III trial of enfortumab vedotin (EV) vs chemotherapy for previously treated advanced urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Internal medicine; Subgroup analysis; Cancer; Bladder cancer; Meta-analysis","score_opus":0.06765254941092885,"score_gpt":0.3978981944408646,"score_spread":0.33024564502993575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203355818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993193,0.00088276266,0.00029154285,0.0012336702,0.00018434576,0.0019479133,0.0012129913,0.00002519499,0.0010286035],"genre_scores_gemma":[0.9948366,0.00060982356,0.0016096124,0.0010512845,0.00022242374,0.00026286853,0.00063236954,0.000047429716,0.0007275484],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974306,0.00015485527,0.0011163033,0.00055372436,0.00032508097,0.00041939053],"domain_scores_gemma":[0.99738926,0.00036682718,0.0005968544,0.00065842335,0.00075753755,0.0002311104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002652814,0.0003186691,0.002353364,0.00038667122,0.000040646777,0.000005128359,0.00017889288,0.00025365106,0.00068145484],"category_scores_gemma":[0.00021365231,0.00028045283,0.0009212298,0.0008281994,0.00013344445,0.00006481683,0.000024663876,0.00010944176,0.0000031754944],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5658718,0.009824913,0.013475049,0.00024339334,0.009295116,0.00012722146,0.0035319305,0.000051835068,0.2405055,0.00006465111,0.0018072684,0.15520133],"study_design_scores_gemma":[0.26878446,0.034631334,0.013290973,0.000094676994,0.0061610756,0.0000072393223,0.00024869785,0.00013076703,0.6701565,0.000103499246,0.0061571333,0.0002336792],"about_ca_topic_score_codex":0.0019987302,"about_ca_topic_score_gemma":0.00045110393,"teacher_disagreement_score":0.42965096,"about_ca_system_score_codex":0.000100044985,"about_ca_system_score_gemma":0.0010235843,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W3203610883","doi":"10.1002/mc.23355","title":"Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder","year":2021,"lang":"en","type":"article","venue":"Molecular Carcinogenesis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology; Uehara Memorial Foundation","keywords":"Cystectomy; Urothelial carcinoma; Biology; Urology; Bladder cancer; Endoglin; Internal medicine; Oncology; Cancer research; Cancer; Medicine; Cell biology","score_opus":0.03831440981630657,"score_gpt":0.2896867266965179,"score_spread":0.25137231688021133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203610883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827368,0.0015043102,0.0076078726,0.0007368951,0.00020290274,0.002894113,0.0042250566,0.000013082922,0.000078940684],"genre_scores_gemma":[0.99294543,0.000008058061,0.0036671131,0.00062354805,0.00006941089,0.0016051669,0.000074572985,0.00007486739,0.00093185325],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980843,0.00013375175,0.00048951886,0.00046636068,0.00049607217,0.00032999436],"domain_scores_gemma":[0.9984078,0.0001813724,0.00013702421,0.0006352346,0.00041671356,0.00022189305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100248704,0.0003041963,0.0006776591,0.00007892101,0.00006901359,0.000010968413,0.0001591772,0.00009150769,0.00010818474],"category_scores_gemma":[0.00035525343,0.00021033012,0.00086098287,0.00019341777,0.00018213861,0.000036764744,0.0000805177,0.00007244002,0.0000020351695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009140209,0.0015613589,0.76242524,0.0022587844,0.003491579,0.0004156083,0.0017168904,0.00006432139,0.21665932,0.00051322393,0.0002946786,0.0014587697],"study_design_scores_gemma":[0.0099348845,0.0005082595,0.30248666,0.00010789051,0.0027789895,0.000032708027,0.00011692975,0.00030981214,0.68309665,0.00018195935,0.00025820814,0.00018706164],"about_ca_topic_score_codex":0.00008334612,"about_ca_topic_score_gemma":0.000026002595,"teacher_disagreement_score":0.46643734,"about_ca_system_score_codex":0.000075733886,"about_ca_system_score_gemma":0.0011490347,"threshold_uncertainty_score":0.85770136},"labels":[],"label_agreement":null},{"id":"W3204626226","doi":"10.1016/j.euf.2021.07.018","title":"Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non–muscle-invasive bladder cancer: Pro","year":2021,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Astellas Pharma; UroGen Pharma; AbbVie; Sanofi; Merck; Bayer; AstraZeneca; Pfizer","keywords":"Medicine; Gemcitabine; Docetaxel; Bladder cancer; Oncology; Urology; Second-line therapy; Standard of care; Internal medicine; Cancer; Chemotherapy","score_opus":0.03189313507915331,"score_gpt":0.3081511934025167,"score_spread":0.27625805832336336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204626226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87969935,0.015014216,0.004216505,0.0724304,0.0020558978,0.0043273233,0.0021100452,0.00024867692,0.019897584],"genre_scores_gemma":[0.9711273,0.0012652688,0.00043608982,0.018983435,0.0019351128,0.00025516693,0.000102349426,0.00015655598,0.005738768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972245,0.00047056287,0.0004864774,0.0008044995,0.00033422315,0.00067973137],"domain_scores_gemma":[0.99799186,0.00034297985,0.00017422748,0.0007173864,0.00053447223,0.00023908509],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003971618,0.00043440508,0.0006435403,0.00008903872,0.00029572137,0.000056212662,0.0002757809,0.00014151366,0.0027889342],"category_scores_gemma":[0.00019071207,0.00029683526,0.00035264474,0.00024540303,0.0003545598,0.000080120684,0.00013568353,0.00050700735,0.00013181033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079386495,0.0025106522,0.0040776148,0.00043863375,0.014975311,0.012687047,0.028715344,0.00020231518,0.15719685,0.0024639012,0.249611,0.44773483],"study_design_scores_gemma":[0.05072825,0.0134657975,0.035519723,0.000113150694,0.0021675213,0.0010367834,0.00070808636,0.00019418504,0.22736485,0.0014578954,0.6661387,0.0011050317],"about_ca_topic_score_codex":0.000044079206,"about_ca_topic_score_gemma":0.00017338316,"teacher_disagreement_score":0.4466298,"about_ca_system_score_codex":0.000154423,"about_ca_system_score_gemma":0.001309821,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W3204900667","doi":"10.5489/cuaj.7313","title":"Systematic review of robotic radical cystectomy functional and quality of life outcomes","year":2021,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cystectomy; Urinary continence; Urinary diversion; Sexual function; Medicine; Quality of life (healthcare); Urology; Urinary system; Surgery; General surgery; Internal medicine; Bladder cancer; Cancer; Prostatectomy","score_opus":0.0672081914869637,"score_gpt":0.3317892677674188,"score_spread":0.2645810762804551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204900667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020764013,0.997172,0.000021629705,0.0013421711,0.00023615843,0.00081247586,0.00013149485,0.0000062195563,0.00025711564],"genre_scores_gemma":[0.0004730384,0.9969374,0.000053923042,0.0019568542,0.00013858751,0.000038903607,0.00008922748,0.00001705935,0.00029502006],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957666,0.0011535705,0.0019215608,0.00022279004,0.0006626003,0.00027291023],"domain_scores_gemma":[0.9959709,0.00080000714,0.0018460742,0.0001935196,0.00045697443,0.00073254487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015591116,0.00027024827,0.004861282,0.00018576326,0.00007419354,0.000019189498,0.00010457343,0.0004213026,0.00066912314],"category_scores_gemma":[0.006887612,0.00017205763,0.00097003306,0.00027850698,0.000056003013,0.000034438268,0.000019677364,0.000634476,0.0000072573657],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009591871,0.00010673857,0.016382005,0.9732541,0.0039201886,0.000045680146,0.000012528581,3.5039855e-7,7.7201506e-8,0.00027739778,0.0018844972,0.004106887],"study_design_scores_gemma":[0.002569712,0.0005246639,0.030291885,0.8324374,0.022773966,0.0010673956,0.000032357075,0.0000017337221,1.4554765e-7,0.00007613854,0.10970187,0.0005227216],"about_ca_topic_score_codex":0.00042538423,"about_ca_topic_score_gemma":0.00008247695,"teacher_disagreement_score":0.14081664,"about_ca_system_score_codex":0.00083809183,"about_ca_system_score_gemma":0.0032654689,"threshold_uncertainty_score":0.82456124},"labels":[],"label_agreement":null},{"id":"W3204951365","doi":"10.1097/spc.0000000000000573","title":"The emerging treatment landscape of advanced urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Urothelial carcinoma; Disease; Chemotherapy; Targeted therapy; Urothelial cancer; MEDLINE","score_opus":0.05747086344637162,"score_gpt":0.3758799459704819,"score_spread":0.31840908252411027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204951365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86612904,0.12908608,0.00003840341,0.00047787858,0.0018031264,0.00070474116,0.00029227947,0.000015375024,0.0014530971],"genre_scores_gemma":[0.98152465,0.01781137,0.000040703482,0.000016499713,0.0001717176,0.00010313114,0.00018658592,0.000013002246,0.00013236888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990318,0.00006183183,0.00027386678,0.00026968433,0.00016387082,0.00019895067],"domain_scores_gemma":[0.9993013,0.00008483124,0.00009923227,0.00017110466,0.0002616181,0.00008189027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003597246,0.00016362143,0.00028616402,0.00004621701,0.00008653903,0.000010361612,0.00003599735,0.00003766771,0.000077854755],"category_scores_gemma":[0.000040592055,0.000107396176,0.00010201141,0.00016865732,0.00007359154,0.00003887857,0.000030362173,0.00009601745,0.0000030683138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036976385,0.000158674,0.90656346,0.00031651306,0.000080032405,0.000012042588,0.007094024,0.0000027625429,0.0001980686,0.0003469279,0.00016501023,0.08469273],"study_design_scores_gemma":[0.007071485,0.0010465645,0.869737,0.00068015995,0.00009536749,0.000005907005,0.015908496,0.000027656846,0.010464843,0.00011117429,0.094662,0.00018932455],"about_ca_topic_score_codex":0.00001396265,"about_ca_topic_score_gemma":0.000022129901,"teacher_disagreement_score":0.1153956,"about_ca_system_score_codex":0.0000952305,"about_ca_system_score_gemma":0.00030780563,"threshold_uncertainty_score":0.43794888},"labels":[],"label_agreement":null},{"id":"W3204984910","doi":"10.1097/ju.0000000000002261","title":"Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy","year":2021,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"National Institutes of Health; National Comprehensive Cancer Network; U.S. Department of Defense","keywords":"Subtyping; Bladder cancer; Chemotherapy; Neoadjuvant therapy; Overall survival","score_opus":0.00992572334972014,"score_gpt":0.2373446037062206,"score_spread":0.22741888035650046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204984910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339604,0.001074428,0.00031180648,0.004517755,0.00015293893,0.00020982197,0.000067110785,0.000009535914,0.00026056767],"genre_scores_gemma":[0.99371606,0.00020796839,0.00074494514,0.004840128,0.00029348597,0.0000075363578,0.00002858289,0.00004339577,0.00011792246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882454,0.00008263224,0.00028079402,0.0001815889,0.00035895404,0.0002715066],"domain_scores_gemma":[0.99839854,0.00021261838,0.00035078343,0.00026817014,0.00062475255,0.0001451503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007518638,0.00022257042,0.00045391815,0.00005998921,0.00008508495,0.000011600011,0.00012937335,0.00008865363,0.0011293915],"category_scores_gemma":[0.00002223105,0.000115757655,0.0000775046,0.00016418665,0.00015344078,0.00006858579,0.000016552916,0.00033189525,0.0000081223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024527904,0.0011039318,0.94253564,0.000026308635,0.0027583444,0.0012661137,0.0024522597,0.0008011063,0.0048827026,0.0000071120476,0.0005464574,0.01909212],"study_design_scores_gemma":[0.018731445,0.007229894,0.95896685,0.000120486635,0.0019774444,0.0003549722,0.00023354734,0.000055475954,0.01072187,0.000088898894,0.0013327596,0.0001863318],"about_ca_topic_score_codex":0.00038052275,"about_ca_topic_score_gemma":0.0009143487,"teacher_disagreement_score":0.018905789,"about_ca_system_score_codex":0.00008304921,"about_ca_system_score_gemma":0.0006985729,"threshold_uncertainty_score":0.9997837},"labels":[],"label_agreement":null},{"id":"W3205470832","doi":"10.3390/curroncol28050348","title":"Incidence, Etiology, Prevention and Management of Ureteroenteric Strictures after Robot-Assisted Radical Cystectomy: A Review of Published Evidence and Personal Experience","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Anastomosis; Incidence (geometry); Perioperative; Ureter; Surgery; Dissection (medical); Etiology; Bladder cancer; General surgery; Urology; Internal medicine; Cancer","score_opus":0.1470601879118394,"score_gpt":0.46974694326443706,"score_spread":0.32268675535259767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205470832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094434334,0.9965512,0.000069512615,0.00012815652,0.000426914,0.0017742398,0.000033841625,0.000011831891,0.00005992558],"genre_scores_gemma":[0.0022506996,0.99602,0.00049513596,0.00007615886,0.00007171313,0.0009132768,0.00010207005,0.00001896923,0.00005195135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729645,0.0005512244,0.0009592579,0.00065157376,0.00030598487,0.0002355301],"domain_scores_gemma":[0.9985492,0.0001565267,0.0006495261,0.00032396617,0.00016941628,0.00015137046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003268601,0.00035763183,0.002524895,0.00019016236,0.000027193799,0.000011555503,0.00014216728,0.00024934046,0.00029734],"category_scores_gemma":[0.00015799714,0.00026009965,0.00034810693,0.00037868743,0.0004153369,0.000101534984,0.00026669385,0.00033733415,9.762578e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008335053,0.00031780422,0.0011668382,0.22799125,0.00038111917,0.00008575467,0.00013002036,2.4909625e-9,9.4869245e-7,0.000010221567,0.00043073657,0.76940197],"study_design_scores_gemma":[0.001273901,0.0014249919,0.010471157,0.47998583,0.0054236734,0.00088806625,0.00005588834,0.0000014821384,0.000001377446,0.000006876482,0.50026023,0.00020651342],"about_ca_topic_score_codex":0.000008237384,"about_ca_topic_score_gemma":0.000004025775,"teacher_disagreement_score":0.76919544,"about_ca_system_score_codex":0.00022185464,"about_ca_system_score_gemma":0.0004936667,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W3206129590","doi":"10.22374/jeleu.v4i3.126","title":"Should National Institute for Clinical Excellence (NICE) Guidelines Remove Urine Cytology as a Suggested Adjunct in Suspected Bladder Cancer (haematuria) Investigations?","year":2021,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nice; Excellence; Adjunct; Medicine; Cytology; Urine cytology; Bladder cancer; Urology; Urine; General surgery; Cancer; Medical physics; Gynecology; Internal medicine; Pathology; Political science; Computer science","score_opus":0.19689452007173913,"score_gpt":0.46193841093269505,"score_spread":0.2650438908609559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206129590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9288448,0.008997938,0.00055544055,0.05633713,0.00296083,0.00064674806,0.00009812627,0.000026899996,0.0015320679],"genre_scores_gemma":[0.96069276,0.0048253015,0.016886584,0.011777785,0.0035013605,0.00010749847,0.00012591817,0.000060676106,0.0020220939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966429,0.00027722397,0.0016938427,0.00043058617,0.0005223059,0.0004331279],"domain_scores_gemma":[0.99498963,0.000707495,0.0006708159,0.00023408924,0.0030991596,0.00029882233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089780363,0.00027316745,0.0010405468,0.0003567926,0.00007656871,0.000018237331,0.00019660282,0.00033146585,0.00050717645],"category_scores_gemma":[0.006703421,0.0002373445,0.0003410689,0.0004926068,0.00033499283,0.00019833246,0.000066203436,0.00078548526,0.000012995727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035670634,0.0069356,0.6420957,0.00069798675,0.0062943064,0.026851233,0.0011895268,0.0019976024,0.046316717,0.0083908355,0.20716828,0.01639157],"study_design_scores_gemma":[0.07311251,0.011141977,0.45828414,0.0009859954,0.00294013,0.060229037,0.0005355314,0.0014632025,0.02075722,0.011932487,0.35756063,0.0010571447],"about_ca_topic_score_codex":0.0002606842,"about_ca_topic_score_gemma":0.0014399195,"teacher_disagreement_score":0.18381158,"about_ca_system_score_codex":0.00021969716,"about_ca_system_score_gemma":0.004148601,"threshold_uncertainty_score":0.9678628},"labels":[],"label_agreement":null},{"id":"W3206526175","doi":"10.5489/cuaj.7294","title":"Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bladder cancer; Medicine; Radiomics; Cystectomy; Pathological; Discriminative model; Radiology; Oncology; Neoadjuvant therapy; Internal medicine; Cancer; Artificial intelligence; Computer science","score_opus":0.016509875354708197,"score_gpt":0.2732552775378035,"score_spread":0.2567454021830953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206526175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97140634,0.00066366844,0.00012407253,0.026944784,0.00023079413,0.00037979262,0.000098149496,0.0000081984435,0.0001441853],"genre_scores_gemma":[0.98845327,0.0000721895,0.0030830053,0.007467648,0.00024197508,0.000067991336,0.000017934777,0.000017265598,0.0005787243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866486,0.00011113971,0.00038334934,0.00020559953,0.00024379721,0.0003912548],"domain_scores_gemma":[0.9987357,0.0002183367,0.0001650142,0.00007618555,0.00035214002,0.00045257487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058040966,0.00012262403,0.00031242188,0.00017734017,0.00011594001,0.000022507646,0.000064017775,0.00020607219,0.0005852417],"category_scores_gemma":[0.0009535916,0.00010515194,0.00010550047,0.00027496432,0.000010341958,0.00003851853,0.000008305002,0.00029445373,0.000003518586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051728967,0.0004320088,0.73345006,0.00005514558,0.0012860728,0.0005604448,0.011127986,0.0004450507,0.121667676,0.000019642952,0.017577326,0.10820568],"study_design_scores_gemma":[0.005440516,0.0003766241,0.9268462,0.00011233993,0.00007603032,0.000055644854,0.0004639655,0.000051007333,0.009043962,0.00009025928,0.05729273,0.00015073924],"about_ca_topic_score_codex":0.0003725178,"about_ca_topic_score_gemma":0.007767822,"teacher_disagreement_score":0.19339612,"about_ca_system_score_codex":0.0021038912,"about_ca_system_score_gemma":0.004591227,"threshold_uncertainty_score":0.814464},"labels":[],"label_agreement":null},{"id":"W3207089250","doi":"10.1111/bju.15622","title":"Oncological benefit of re‐resection for T1 bladder cancer: a comparative effectiveness study","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Swiss Cancer Research Foundation; Uniscientia Foundation; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Hazard ratio; Interquartile range; Confounding; Proportional hazards model; Bladder cancer; Confidence interval; Retrospective cohort study; Population; Cohort study; Resection; Cancer; Internal medicine; Surgery","score_opus":0.052219602740012375,"score_gpt":0.3700567228738384,"score_spread":0.31783712013382603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207089250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913696,0.0063963183,0.00037200275,0.0003218895,0.00047830804,0.0005512313,0.000044102097,0.0000059075523,0.0004606138],"genre_scores_gemma":[0.99864703,0.0004824155,0.00019793618,0.00021347603,0.00029793708,0.000060933395,0.000005230675,0.000011164768,0.00008386237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885464,0.00022480242,0.0003920511,0.00017547708,0.00018552809,0.00016748482],"domain_scores_gemma":[0.99851996,0.000296747,0.00023996328,0.00008078059,0.00077313645,0.00008940697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303883,0.0000972915,0.00069630187,0.0000621976,0.00006158382,0.000010044951,0.00006348534,0.000100389625,0.00026036846],"category_scores_gemma":[0.000119323304,0.00009280629,0.00017879497,0.00013671484,0.00007152905,0.00005322471,0.000023423687,0.00023394432,9.207852e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08297855,0.028577631,0.61433315,0.0006959866,0.0145711545,0.015136436,0.004479811,0.002106217,0.0215866,0.0002694728,0.009370672,0.20589434],"study_design_scores_gemma":[0.022881007,0.03748448,0.9154521,0.0002159969,0.0015945239,0.008761443,0.0010635725,0.00004911826,0.008397142,0.0011603415,0.0027948,0.00014547081],"about_ca_topic_score_codex":0.00019922602,"about_ca_topic_score_gemma":0.0010654563,"teacher_disagreement_score":0.30111897,"about_ca_system_score_codex":0.00009785809,"about_ca_system_score_gemma":0.00031205904,"threshold_uncertainty_score":0.37845305},"labels":[],"label_agreement":null},{"id":"W3207222598","doi":"10.3389/fonc.2021.741145","title":"The Impact of Diabetes on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; Sichuan University; Department of Science and Technology of Sichuan Province; Guangzhou Medical University","keywords":"Medicine; Diabetes mellitus; Meta-analysis; Urothelial carcinoma; Cochrane Library; Urology; Oncology; Internal medicine; Cancer; Bladder cancer; Endocrinology","score_opus":0.052477264234656894,"score_gpt":0.3684370211617429,"score_spread":0.315959756927086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207222598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016539478,0.99394685,0.000005450134,0.00057636487,0.000097525946,0.0048215603,0.00024306246,0.0000052438395,0.00013856743],"genre_scores_gemma":[0.0029921718,0.99281204,0.00019565207,0.0003907544,0.000040409413,0.0033314764,0.000035372046,0.000042100302,0.00016001204],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953324,0.0022291366,0.0013716078,0.0004269322,0.00030458273,0.00033533375],"domain_scores_gemma":[0.9969991,0.0011955817,0.0008269051,0.00077717466,0.000101182486,0.000100058845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010674372,0.0004968337,0.011283105,0.00028227255,0.000043354932,0.00001396529,0.00028050164,0.00033495118,0.00026618553],"category_scores_gemma":[0.00041011244,0.00019232229,0.0046383864,0.0007915041,0.00035947154,0.000022596565,0.00006182539,0.00049686694,0.0000016485488],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011544149,0.00083624653,0.009486936,0.49031737,0.4741462,0.00008924533,0.000281342,1.9253342e-7,1.2646325e-7,0.000017043534,0.0050312877,0.019678582],"study_design_scores_gemma":[0.00046531603,0.0012715431,0.000578869,0.01921574,0.95684844,0.000034539546,0.000038918668,0.0000041966046,0.0000014203395,0.000016259663,0.021347834,0.00017691225],"about_ca_topic_score_codex":0.00006583435,"about_ca_topic_score_gemma":0.000008605503,"teacher_disagreement_score":0.48270226,"about_ca_system_score_codex":0.00039970712,"about_ca_system_score_gemma":0.0009207147,"threshold_uncertainty_score":0.7842675},"labels":[],"label_agreement":null},{"id":"W3207290793","doi":"10.1016/j.clgc.2021.10.002","title":"Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology; Uehara Memorial Foundation","keywords":"Medicine; Urothelial carcinoma; Pathological; Grading (engineering); Urothelial cancer; Oncology; Carcinoma; Internal medicine; Bladder cancer; Cancer","score_opus":0.10614644549365204,"score_gpt":0.4237975035817943,"score_spread":0.31765105808814226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207290793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900435,0.0061496007,0.000031373173,0.002149183,0.0005796642,0.00035323369,0.00007403512,0.000039154704,0.0005802395],"genre_scores_gemma":[0.9889982,0.005996421,0.00095264293,0.0013601173,0.002045425,0.000055888064,0.000020823638,0.000038898535,0.0005316313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971411,0.00036223428,0.0009602607,0.00088684773,0.00022092003,0.0004286352],"domain_scores_gemma":[0.9984852,0.00057562726,0.00011266825,0.0003276152,0.000063407635,0.0004354678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057812646,0.00027137698,0.00090558524,0.00006179955,0.00009643831,0.000035916386,0.00008389135,0.00025985306,0.00012129849],"category_scores_gemma":[0.00026667182,0.00022230213,0.00021644749,0.00017998877,0.000423792,0.00011799715,0.00017522076,0.00084151485,0.000006822351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036730437,0.0004246062,0.9182423,0.00005914097,0.00006390867,0.0021274306,0.00010232291,4.076674e-7,0.0001125837,0.000012769094,0.00013614801,0.07835108],"study_design_scores_gemma":[0.0053936355,0.0008490208,0.98977023,0.00017269929,0.00022202427,0.00015595464,0.00015173417,0.000035575482,0.00016363744,0.00032436242,0.002522621,0.00023851202],"about_ca_topic_score_codex":0.00006693902,"about_ca_topic_score_gemma":0.000020743519,"teacher_disagreement_score":0.07811257,"about_ca_system_score_codex":0.000057787594,"about_ca_system_score_gemma":0.0003624866,"threshold_uncertainty_score":0.9065218},"labels":[],"label_agreement":null},{"id":"W3207815998","doi":"10.1093/bjs/znab259.935","title":"728 A Systematic Review of The Efficacy and Safety of Outpatient Bladder Tumour Ablation","year":2021,"lang":"en","type":"review","venue":"British journal of surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Diathermy; Electrosurgery; Cochrane Library; Surgery; Complication; Outpatient procedure; Ablation; Bladder cancer; Outpatient clinic; Randomized controlled trial; Cancer; Internal medicine","score_opus":0.04705412829017727,"score_gpt":0.31048335929756066,"score_spread":0.26342923100738336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207815998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094110655,0.99807006,0.00000672862,0.00004904075,0.0003663411,0.0012162656,0.00007947431,0.0000025222405,0.000115472954],"genre_scores_gemma":[0.00037278977,0.99919367,0.000035599744,0.00010648022,0.00012488912,0.000015853482,0.000020185133,0.000032733577,0.000097818374],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99596137,0.0005688616,0.0025612947,0.00014924565,0.0006228421,0.0001363718],"domain_scores_gemma":[0.99543387,0.0007384512,0.0029145305,0.0002495042,0.0005605223,0.00010311943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012185624,0.00021901946,0.0046104235,0.00012000701,0.000037055073,0.000014800907,0.00010547211,0.00012385681,0.000103504484],"category_scores_gemma":[0.0015520708,0.00014724855,0.0013511685,0.00033927246,0.000066757246,0.00005832704,0.00004513682,0.0003515614,0.0000010025957],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015326072,0.00018649836,0.000043695873,0.8007961,0.0010221336,0.00018836629,0.000019500338,5.8431205e-8,2.746424e-7,0.000001232759,0.0012865299,0.1964403],"study_design_scores_gemma":[0.00042109578,0.000066351306,0.00051171967,0.96647424,0.010007351,0.009094524,0.000014829839,9.8989126e-8,0.000003139826,0.0000015704343,0.013307517,0.00009757604],"about_ca_topic_score_codex":0.000025691288,"about_ca_topic_score_gemma":0.0000013335579,"teacher_disagreement_score":0.19634272,"about_ca_system_score_codex":0.00009973803,"about_ca_system_score_gemma":0.0010115087,"threshold_uncertainty_score":0.60046214},"labels":[],"label_agreement":null},{"id":"W3208308746","doi":"10.1016/j.purol.2021.08.112","title":"Qualité de vie et symptômes chez les patients atteints d’un carcinome urothélial localement avancé ou métastatique précédemment traité de l’étude Ev-301 : une étude randomisée de phase 3 comparant enfortumab vedotin à la chimiothérapie","year":2021,"lang":"fr","type":"article","venue":"Progrès en Urologie","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecology","score_opus":0.03288865332380924,"score_gpt":0.345923913186135,"score_spread":0.3130352598623258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208308746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495937,0.02473178,0.007285055,0.01123106,0.0008797981,0.0037785885,0.00084152224,0.00028447752,0.001374013],"genre_scores_gemma":[0.98043394,0.0055989833,0.0058184373,0.004583317,0.00074177195,0.0015472391,0.0005975805,0.00019674869,0.00048196837],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9906265,0.002953087,0.0015903731,0.0013371544,0.0009876727,0.0025052214],"domain_scores_gemma":[0.99619687,0.0011227737,0.00052365405,0.00082189124,0.00032231718,0.0010124951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027462991,0.0011638231,0.0017018565,0.00018869524,0.00032701288,0.00017674954,0.0005966597,0.0006565511,0.0009060346],"category_scores_gemma":[0.00073058775,0.0011084684,0.0006331714,0.0004356292,0.000546726,0.00021865657,0.00027499272,0.0012854852,0.00007736603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016365217,0.025990723,0.4081032,0.001989692,0.005008268,0.0038153545,0.02906736,0.0011455393,0.004561474,0.0014909038,0.00135239,0.5011099],"study_design_scores_gemma":[0.2222968,0.011492055,0.5925895,0.0018471195,0.006081015,0.0007725186,0.0024296097,0.0035591961,0.08478301,0.0019701472,0.069586225,0.002592832],"about_ca_topic_score_codex":0.0013812685,"about_ca_topic_score_gemma":0.00063229265,"teacher_disagreement_score":0.49851707,"about_ca_system_score_codex":0.0014643326,"about_ca_system_score_gemma":0.0033504632,"threshold_uncertainty_score":0.99913657},"labels":[],"label_agreement":null},{"id":"W3208320358","doi":"10.1089/end.2021.0688","title":"Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis, and Network Meta-Analysis with Focus on Different Energy Sources","year":2021,"lang":"en","type":"review","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Adverse effect; Randomized controlled trial; Relative risk; Perforation; Surgery; Bladder cancer; Internal medicine; Urology; Confidence interval; Cancer","score_opus":0.20431875710752892,"score_gpt":0.43556416764905015,"score_spread":0.23124541054152123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208320358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034044615,0.9941923,0.0008637055,0.0004618048,0.000053515934,0.0008725298,0.00012391708,0.000006440449,0.000021349932],"genre_scores_gemma":[0.25062174,0.7486527,0.00026959623,0.00011464088,0.00010523293,0.00010753212,0.000055214212,0.000026052543,0.00004729943],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99028426,0.0047391616,0.0033344836,0.00057572854,0.0007773365,0.00028901905],"domain_scores_gemma":[0.9924612,0.0029120708,0.0036900402,0.0003690039,0.00036140977,0.0002062527],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0025093693,0.0006454699,0.024975173,0.0008120319,0.00007640282,0.000019153103,0.00015187163,0.00045242973,0.0002663714],"category_scores_gemma":[0.00021090153,0.0003139868,0.006975377,0.00081257656,0.00031611513,0.000049614948,0.000038049147,0.00089021807,1.3277496e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006314582,0.00044587976,0.012656932,0.043589037,0.94172597,0.000120210454,0.00007198281,0.000041219202,8.6827515e-7,0.00004731752,0.000023039363,0.0006460825],"study_design_scores_gemma":[0.0014936693,0.008571651,0.0029865578,0.0025412145,0.9831045,0.0006471006,0.000032573156,0.000006659328,0.000011250361,0.00008422559,0.00032604623,0.00019452813],"about_ca_topic_score_codex":0.000043628188,"about_ca_topic_score_gemma":0.0003004608,"teacher_disagreement_score":0.24721728,"about_ca_system_score_codex":0.00005125918,"about_ca_system_score_gemma":0.00015015044,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W3208602919","doi":"","title":"Étude rétrospective de deux groupes de patients appariés comparant la cystectomie totale pour cancer de vessie par voie ouverte ou robot-assistée avec dérivation urinaire intra-corporelle","year":2021,"lang":"fr","type":"article","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.011468979618646603,"score_gpt":0.24625576711458497,"score_spread":0.23478678749593837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208602919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8768555,0.013669005,0.06927467,0.016769921,0.0008987541,0.00096690713,0.00030839437,0.00023698343,0.021019902],"genre_scores_gemma":[0.97132945,0.0030475946,0.012681851,0.0004936488,0.00017909454,0.00025350263,0.0003595418,0.000107589556,0.011547729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99262226,0.0041222987,0.00071084686,0.0009142453,0.00058136665,0.0010490001],"domain_scores_gemma":[0.9948292,0.0009974402,0.0004908476,0.0012547455,0.0018467866,0.0005810046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001967179,0.00054614496,0.00070331024,0.00014983318,0.00061467086,0.0002685841,0.00057924027,0.0003899344,0.0005655231],"category_scores_gemma":[0.0009954739,0.0005987248,0.00031836302,0.0006947241,0.00040843413,0.0002811236,0.0003159141,0.00069172983,0.00008778261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035697204,0.007260968,0.84424156,0.0007438487,0.0011365368,0.0003033111,0.03505771,0.00055144215,0.015149233,0.010625153,0.0062180045,0.07835527],"study_design_scores_gemma":[0.006201775,0.00001024726,0.8073788,0.004009973,0.00066001015,0.00013987663,0.00054029486,0.013717135,0.15843347,0.0023431228,0.005934246,0.00063100376],"about_ca_topic_score_codex":0.008727736,"about_ca_topic_score_gemma":0.011927856,"teacher_disagreement_score":0.14328425,"about_ca_system_score_codex":0.002152093,"about_ca_system_score_gemma":0.002148247,"threshold_uncertainty_score":0.9996464},"labels":[],"label_agreement":null},{"id":"W3209209610","doi":"10.1002/cjp2.245","title":"Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Queen's University; Ontario Institute for Cancer Research; Government of Ontario; Bladder Cancer Canada; Cancer Research Society","keywords":"Immunohistochemistry; Bladder cancer; Subtyping; Medicine; GATA3; Basal (medicine); Internal medicine; Oncology; Pathology; Cancer; Algorithm; Biology","score_opus":0.14793417169844697,"score_gpt":0.5002481472883815,"score_spread":0.35231397558993455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209209610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740531,0.0057250685,0.010905032,0.00825329,0.00014274867,0.0007470928,0.00006650162,0.0000032738462,0.00010392148],"genre_scores_gemma":[0.98872995,0.00750988,0.0029278363,0.00044125994,0.00025205713,0.00006436255,0.0000088517345,0.00001824717,0.000047539117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980441,0.00049628067,0.0006543107,0.00018903702,0.0003126319,0.00030369213],"domain_scores_gemma":[0.9878737,0.009730108,0.00022327065,0.00029832384,0.0016919184,0.00018273188],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0027687007,0.000096260046,0.00046041026,0.000099634264,0.0001200621,0.000010002899,0.00016981878,0.0001305759,0.000056347126],"category_scores_gemma":[0.009098611,0.00006158403,0.00016862349,0.00026978488,0.0005795316,0.000038160542,0.000119385084,0.000641337,0.0000035375951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091038307,0.0020639712,0.55962664,0.00032152102,0.00163973,0.0021486627,0.0009181081,0.000012173299,0.11946555,0.00028958838,0.0016142231,0.31098947],"study_design_scores_gemma":[0.004152782,0.0032673073,0.9753244,0.00044218302,0.0009531935,0.0010223478,0.00033268635,0.00011497329,0.007927591,0.0061885538,0.0001879584,0.0000860093],"about_ca_topic_score_codex":0.000027788174,"about_ca_topic_score_gemma":0.000061122395,"teacher_disagreement_score":0.4156978,"about_ca_system_score_codex":0.000036184945,"about_ca_system_score_gemma":0.0013802971,"threshold_uncertainty_score":0.99924815},"labels":[],"label_agreement":null},{"id":"W3209816014","doi":"10.1016/j.breast.2021.10.007","title":"Response to Soran et al.","year":2021,"lang":"en","type":"letter","venue":"The Breast","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine","score_opus":0.025517602676456187,"score_gpt":0.29945844350591333,"score_spread":0.27394084082945713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209816014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001139311,0.00037453166,0.000016723407,0.9902971,0.0003455611,0.00044112073,0.00031840388,0.000059652917,0.007007592],"genre_scores_gemma":[0.0027846075,0.0000281152,0.00006753612,0.95153385,0.0012230583,0.00007509091,0.00021938844,0.00007262269,0.043995745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857086,0.0002821733,0.00014716556,0.00032559736,0.00038737056,0.00028680422],"domain_scores_gemma":[0.9988914,0.00012604397,0.00003934513,0.0007771836,0.00007806462,0.00008792266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002534481,0.00024082075,0.00034467306,0.00006783697,0.0000624326,0.000037058053,0.00016796724,0.0001730282,0.0009763116],"category_scores_gemma":[0.000031271717,0.0001483913,0.00016224869,0.00015528296,0.000042632848,0.000017433882,0.00007379608,0.00083434675,0.00070224283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012940665,0.00003497556,0.000049673563,0.000019806976,0.00018548289,0.0011431056,0.0002492232,2.1690187e-7,0.00034807686,0.000002277457,0.99409926,0.002573834],"study_design_scores_gemma":[0.00085164665,0.00014790475,0.004134845,0.00023327225,0.00020639041,0.002102998,0.00002877199,3.6475998e-7,0.000115197385,0.000022046821,0.99201316,0.0001434258],"about_ca_topic_score_codex":0.00020361583,"about_ca_topic_score_gemma":0.00001027838,"teacher_disagreement_score":0.03876327,"about_ca_system_score_codex":0.00010101662,"about_ca_system_score_gemma":0.00037539031,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W3211940103","doi":"10.1002/dc.24906","title":"Synchronous uterine and bladder cancers detected in urine and vaginal samples by cytology","year":2021,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Urine cytology; Cytology; Genitourinary system; Uterine cancer; Pathology; Vagina; Urinary system; Bladder cancer; Gynecology; Urine; Cancer; Carcinosarcoma; Carcinoma; Internal medicine; Surgery","score_opus":0.010605198085276688,"score_gpt":0.27490562418353426,"score_spread":0.26430042609825755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211940103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986686,0.010659911,0.0002606691,0.0014923522,0.00015907412,0.00025101742,0.0001312335,0.000038434107,0.00032130326],"genre_scores_gemma":[0.99354273,0.0042391364,0.0006924375,0.0010570209,0.00008089807,0.00010186101,0.00010079819,0.000023789325,0.00016132432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878937,0.00008898306,0.00022663048,0.00046880782,0.000079173384,0.0003470197],"domain_scores_gemma":[0.9990963,0.00046097764,0.000040778847,0.00020302406,0.000054538847,0.0001443941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006307711,0.00019459675,0.0004515265,0.00009079353,0.000045713972,0.0000115520625,0.000037098445,0.00012673691,0.00030361608],"category_scores_gemma":[0.00049579574,0.00018580495,0.000022537452,0.00014756252,0.00023034068,0.00003560499,0.000083916406,0.00018085685,0.0000067252918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029864314,0.0003957438,0.9336834,0.00017606525,0.00011271347,0.011385639,0.00055796513,0.0000029526332,0.020207854,0.0001476645,0.0009848655,0.032046475],"study_design_scores_gemma":[0.005398746,0.0011594233,0.97081304,0.00008241358,0.00018124214,0.008077172,0.00014435129,0.000029315828,0.0075038797,0.00022886087,0.006161669,0.00021988773],"about_ca_topic_score_codex":0.00062330643,"about_ca_topic_score_gemma":0.0010993694,"teacher_disagreement_score":0.037129622,"about_ca_system_score_codex":0.00010126836,"about_ca_system_score_gemma":0.00021448254,"threshold_uncertainty_score":0.75769055},"labels":[],"label_agreement":null},{"id":"W3212128550","doi":"10.1093/jscr/rjab501","title":"Micropapillary bladder cancer: an added indication to prophylactic urethrectomy","year":2021,"lang":"en","type":"article","venue":"Journal of Surgical Case Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Cystectomy; Medicine; Urethra; Cystoprostatectomy; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.02371022569765508,"score_gpt":0.33452932229695675,"score_spread":0.3108190965993017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212128550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913838,0.004282222,0.000027764981,0.002308345,0.0005144785,0.00024956788,0.0000064709793,0.000017879936,0.0012095061],"genre_scores_gemma":[0.9969233,0.0004598225,0.0007933211,0.00048757248,0.0008338169,0.000014592,0.0000100376155,0.000028675357,0.0004488639],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981335,0.00009918678,0.00074105343,0.00027118035,0.0005295758,0.00022549566],"domain_scores_gemma":[0.9978598,0.00004208123,0.00046149438,0.00031302415,0.00070206355,0.0006215399],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000338448,0.00016588991,0.00047916587,0.00014243784,0.0000779086,0.000037299153,0.000028439037,0.00011238344,0.0010343593],"category_scores_gemma":[0.00009334141,0.00012299705,0.00020749732,0.0003673894,0.00003420222,0.0001682145,0.000026421041,0.0003197463,0.0000070937185],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061027374,0.00063326966,0.015542611,0.00006509933,0.00029524762,0.9537204,0.00030772373,0.0000132842215,0.0072799833,0.0000046270006,0.0010837761,0.020443706],"study_design_scores_gemma":[0.0017365301,0.0009484132,0.007967084,0.00013838134,0.00056401675,0.9130429,0.00015897406,0.0000033795143,0.03405979,0.00007992121,0.041142985,0.00015759666],"about_ca_topic_score_codex":0.000085611595,"about_ca_topic_score_gemma":0.000027073382,"teacher_disagreement_score":0.04067747,"about_ca_system_score_codex":0.00021427391,"about_ca_system_score_gemma":0.0011802235,"threshold_uncertainty_score":0.9998788},"labels":[],"label_agreement":null},{"id":"W3212389038","doi":"10.1111/vco.12788","title":"Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients","year":2021,"lang":"en","type":"article","venue":"Veterinary and Comparative Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust","keywords":"Medicine; Cytokine; CD8; Tumor necrosis factor alpha; Lymphocyte; Immunology; Immune system; Immunotherapy; Urinary system; Internal medicine","score_opus":0.09636823941715167,"score_gpt":0.3405560044146247,"score_spread":0.24418776499747302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212389038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949063,0.003023663,0.0000016904687,0.00005703265,0.00004839451,0.0010644323,0.000022212293,0.00000577993,0.000870506],"genre_scores_gemma":[0.9984908,0.0002941171,0.00075740076,0.000020456446,0.000033860844,0.0002946877,0.000042024094,0.000007661347,0.000058968923],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99870765,0.00038571586,0.00026262033,0.000315452,0.00017567852,0.00015288446],"domain_scores_gemma":[0.9995398,0.00004089468,0.00008398007,0.0000986246,0.00016385595,0.00007283556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019284683,0.00014782039,0.00041768266,0.00009715438,0.000032614502,0.0000065851596,0.000023779201,0.00008208532,0.00005448565],"category_scores_gemma":[0.00001514263,0.00012611548,0.000016761644,0.00012488394,0.000088273184,0.000060928433,0.00006539033,0.00008801877,5.676058e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043911785,0.0028986535,0.42045763,0.0001963001,0.000044713255,0.00018942804,0.003339444,0.0000029986184,0.5475707,0.000030198671,0.000015400785,0.020863362],"study_design_scores_gemma":[0.034606215,0.01351098,0.7681336,0.0002553351,0.00013391889,0.00014749327,0.00070706167,0.00016724091,0.18075745,0.00008386196,0.0013168565,0.00018000335],"about_ca_topic_score_codex":0.00016708026,"about_ca_topic_score_gemma":0.00008923702,"teacher_disagreement_score":0.36681324,"about_ca_system_score_codex":0.00012467972,"about_ca_system_score_gemma":0.00027480524,"threshold_uncertainty_score":0.514284},"labels":[],"label_agreement":null},{"id":"W3212464218","doi":"10.48083/zvxi1252","title":"Urothelial Carcinoma Seeding at Site of Nephrostomy","year":2021,"lang":"fr","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Seeding; Urothelial carcinoma; Carcinoma; Nephrostomy; Geology; Medicine; Urology; Radiology; Internal medicine; Bladder cancer; Biology; Cancer","score_opus":0.039479228760042985,"score_gpt":0.32358259670289086,"score_spread":0.28410336794284785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212464218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88501525,0.049095426,0.0003877585,0.013934658,0.013729159,0.00025379774,0.0005414994,0.00003283872,0.037009615],"genre_scores_gemma":[0.9101408,0.004457824,0.00087998295,0.0023828559,0.0058954847,0.000013208379,0.00010033763,0.000046671343,0.07608285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692565,0.00024174384,0.0008606247,0.00040906077,0.00091180205,0.00065108965],"domain_scores_gemma":[0.9974469,0.00039721286,0.0005411531,0.00028278728,0.000999948,0.00033202098],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046341895,0.0003496715,0.0006219545,0.00017307258,0.0002613754,0.000077349854,0.00026275506,0.0003265875,0.015103032],"category_scores_gemma":[0.00052871567,0.00034184832,0.00066091365,0.00023146257,0.00031008688,0.00027582163,0.00029174023,0.0008542666,0.00025009358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022805247,0.001318182,0.8431688,0.00031749893,0.0029416406,0.005019819,0.0024736149,0.00017870915,0.049222287,0.0022852046,0.042338103,0.04845562],"study_design_scores_gemma":[0.018403206,0.002725787,0.45980296,0.00093474594,0.0020431553,0.01452072,0.0021645473,0.00080919947,0.06973452,0.003845461,0.42425913,0.0007565501],"about_ca_topic_score_codex":0.00010915506,"about_ca_topic_score_gemma":0.000038642855,"teacher_disagreement_score":0.38336584,"about_ca_system_score_codex":0.0012843868,"about_ca_system_score_gemma":0.0013592624,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W3213383090","doi":"10.1016/j.clgc.2021.10.010","title":"Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder","year":2021,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Lymph node; Bladder cancer; Stage (stratigraphy); Urology; Dissection (medical); Urinary bladder; Carcinoma; Proportional hazards model; Hazard ratio; Adenocarcinoma; Internal medicine; Oncology; Cancer; Surgery; Confidence interval","score_opus":0.050856143172672355,"score_gpt":0.35134109118836987,"score_spread":0.30048494801569753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213383090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98346525,0.011684174,0.000026844498,0.002145146,0.00086173345,0.00042569448,0.00017631217,0.000015859334,0.0011989945],"genre_scores_gemma":[0.99562216,0.00053600525,0.00022747701,0.00041341575,0.00058842846,0.000089004476,0.00002488963,0.0000348644,0.0024637496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818915,0.00020763343,0.0006940268,0.00049956643,0.0001901587,0.00021945602],"domain_scores_gemma":[0.9985743,0.00046628955,0.00023854873,0.00040736824,0.0001278152,0.00018566556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017556448,0.00021117208,0.00070893246,0.00006527925,0.000112015616,0.0000045208812,0.000090366586,0.00022675861,0.00017027499],"category_scores_gemma":[0.00013661537,0.0001515048,0.000310877,0.00017242278,0.0006037501,0.000039199538,0.00017204563,0.00018394088,7.5730594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011952258,0.0021195482,0.9503702,0.0006122513,0.00087055034,0.00046609264,0.00035876688,0.0000034615164,0.006854245,0.000045464447,0.003976112,0.022371076],"study_design_scores_gemma":[0.015759068,0.0015693747,0.9702366,0.00013716098,0.0006601828,0.0009773817,0.000052861207,0.000093794464,0.003385918,0.000046333585,0.006925222,0.00015609048],"about_ca_topic_score_codex":0.00012432635,"about_ca_topic_score_gemma":0.000011627914,"teacher_disagreement_score":0.022214986,"about_ca_system_score_codex":0.0001007655,"about_ca_system_score_gemma":0.0006157275,"threshold_uncertainty_score":0.6178187},"labels":[],"label_agreement":null},{"id":"W3213418960","doi":"10.3390/curroncol28060380","title":"ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"ERCC1; Medicine; Internal medicine; Oncology; Chemotherapy; Genotyping; Pembrolizumab; Immunotherapy; Genotype; Gastroenterology; Cancer; Nucleotide excision repair; DNA repair; Biology; Genetics","score_opus":0.020138782008250075,"score_gpt":0.32822072448892103,"score_spread":0.30808194248067095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213418960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893007,0.0042493576,0.0000142123245,0.00068319123,0.00043093128,0.0049706134,0.00020385768,0.000032286192,0.00011479403],"genre_scores_gemma":[0.9955162,0.00041261973,0.00001106962,0.0002576828,0.00010835481,0.0033091828,0.00009500612,0.00006590683,0.00022400614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763966,0.0004180073,0.0003703177,0.00059590384,0.00045320007,0.0005229125],"domain_scores_gemma":[0.9987852,0.00019175754,0.0002689514,0.00054442155,0.00010198885,0.00010766116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014932391,0.00045940984,0.0009117185,0.00010653988,0.00014801095,0.000010316597,0.00016202952,0.00009559986,0.00020331523],"category_scores_gemma":[0.000011819171,0.0002139376,0.00013704319,0.0007126729,0.00019283092,0.00004595929,0.000033761535,0.0002633944,0.000001958536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061858264,0.0036797451,0.9128509,0.000058206366,0.00072285085,0.00005319273,0.001347468,0.00005933241,0.00024113579,9.350201e-7,0.000081831466,0.07471854],"study_design_scores_gemma":[0.0835956,0.018784368,0.8804289,0.0006605961,0.0020017277,0.000025755282,0.00027340915,0.00015044604,0.009185736,0.000002589842,0.0045196423,0.00037123717],"about_ca_topic_score_codex":0.0019083511,"about_ca_topic_score_gemma":0.004243059,"teacher_disagreement_score":0.077409774,"about_ca_system_score_codex":0.0012456934,"about_ca_system_score_gemma":0.00070597633,"threshold_uncertainty_score":0.8724122},"labels":[],"label_agreement":null},{"id":"W3215100814","doi":"10.1371/journal.pone.0259272","title":"Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study","year":2021,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"Genentech; Sanofi; AstraZeneca; Astellas Pharma; Bristol-Myers Squibb","keywords":"Cystectomy; Bladder cancer; Medicine; PTEN; Oncology; Internal medicine; Cancer; Pathology; Biology","score_opus":0.021963478664295717,"score_gpt":0.22156881798938105,"score_spread":0.19960533932508534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215100814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967431,0.00033231606,0.0000033965173,0.00009357307,0.00008155609,0.0009315727,0.0000666954,0.000017786504,0.0017299922],"genre_scores_gemma":[0.99871564,0.000029620152,0.000055635734,0.0000596009,0.00005864283,0.000057408146,0.000033076827,0.00003519227,0.0009551943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879634,0.00009260657,0.00034734682,0.00026598992,0.00036029876,0.00013742241],"domain_scores_gemma":[0.9989536,0.00001701014,0.00021227218,0.00051007164,0.0002495793,0.00005747821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006459237,0.00014550035,0.00045752633,0.0000614416,0.000057258512,0.0000036804593,0.000092321854,0.00006884645,0.00017482085],"category_scores_gemma":[0.000025005029,0.00011743684,0.000105705985,0.00029115108,0.000059670278,0.000052198822,0.000077534096,0.00016487249,0.000012784772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018254355,0.011714603,0.39568886,0.00012559952,0.00027229104,0.000037125952,0.004138151,2.2924655e-7,0.58780247,0.0000021847775,0.000005524406,0.00003043801],"study_design_scores_gemma":[0.0024991431,0.0012871592,0.60483027,0.000052456362,0.0007237011,0.0000042766687,0.00051013485,0.000015285998,0.39001027,0.0000071936315,0.0000013747213,0.00005871666],"about_ca_topic_score_codex":0.000034526453,"about_ca_topic_score_gemma":0.000008494221,"teacher_disagreement_score":0.20914142,"about_ca_system_score_codex":0.00015806555,"about_ca_system_score_gemma":0.00029908953,"threshold_uncertainty_score":0.47889352},"labels":[],"label_agreement":null},{"id":"W3215176122","doi":"10.1016/j.canlet.2021.11.028","title":"Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Letters","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Alberta","funders":"Allard Foundation; Alberta Cancer Foundation","keywords":"Tolerability; Bladder cancer; Cisplatin; Medicine; Gemcitabine; Cancer research; Colchicine; In vivo; Population; Cytotoxic T cell; Carcinoma; Oncology; Cancer; Internal medicine; Pharmacology; Chemotherapy; Biology; In vitro; Adverse effect","score_opus":0.028699818277232458,"score_gpt":0.28472607360918334,"score_spread":0.2560262553319509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215176122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98109585,0.00070240983,0.00050783926,0.01568383,0.00059670483,0.00049776916,0.00013294339,0.00004493549,0.0007377186],"genre_scores_gemma":[0.98818314,0.000074267744,0.00044095208,0.010381824,0.00040499476,0.00015328868,0.000019926118,0.000043979984,0.0002976374],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998479,0.000051616804,0.00024258885,0.00051385426,0.00027820954,0.00043472668],"domain_scores_gemma":[0.9993157,0.000046286932,0.000083160485,0.0003014119,0.00009221998,0.0001612145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000062891064,0.00027713476,0.000490818,0.00010337861,0.00007546009,0.000026704747,0.00008572952,0.00006548543,0.00023196045],"category_scores_gemma":[0.000031698175,0.00025124315,0.00012314937,0.00039515356,0.00013070468,0.000116951895,0.000044413315,0.0003193183,0.00001895911],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034240496,0.00030660987,0.28118086,0.00008479879,0.00013075922,0.00079655915,0.00033061128,0.000048059246,0.71348417,0.000018380239,0.0011873905,0.002089372],"study_design_scores_gemma":[0.005416285,0.000119761215,0.63218045,0.00019423504,0.00013462694,0.00012997034,0.00012049515,0.00008651997,0.36040565,0.000008189497,0.0009802378,0.00022356438],"about_ca_topic_score_codex":0.001710392,"about_ca_topic_score_gemma":0.00044908622,"teacher_disagreement_score":0.3530785,"about_ca_system_score_codex":0.00046234,"about_ca_system_score_gemma":0.0006525021,"threshold_uncertainty_score":0.999994},"labels":[],"label_agreement":null},{"id":"W3215246947","doi":"10.4081/aiua.2021.3.375","title":"Studying the electrolyte changes in ileal urine at the time of radical cystectomy and ileal conduit diversion","year":2021,"lang":"en","type":"article","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Urine; Bladder cancer; Urology; Pouch; Surgery; Ileum; Cancer; Internal medicine","score_opus":0.015773813116646652,"score_gpt":0.24827271224438047,"score_spread":0.2324988991277338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215246947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890845,0.0017960251,0.000006562867,0.0060471026,0.000074744064,0.00056815863,0.00004401961,0.000035393277,0.0023434882],"genre_scores_gemma":[0.99588865,0.0004139225,0.000028398941,0.0019799261,0.00007907359,0.000057742058,0.000050680603,0.00001831952,0.0014832658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825466,0.0002982842,0.0002629716,0.00043661558,0.0002883522,0.0004591426],"domain_scores_gemma":[0.99895096,0.00039746604,0.00010186829,0.00041429827,0.000042186974,0.00009324848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003344047,0.00023305026,0.00045363794,0.00007494073,0.000204122,0.000016962278,0.00018750632,0.00011348869,0.00031361158],"category_scores_gemma":[0.000088687964,0.00012738814,0.00010175006,0.000246371,0.00055144564,0.00004238096,0.00038587922,0.00038085514,0.00003181169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003546899,0.00064486836,0.90784305,0.0001042606,0.00057854573,0.0011624265,0.002581585,0.000018995044,0.0713259,0.00022705863,0.0024885545,0.009477849],"study_design_scores_gemma":[0.00895066,0.0050098514,0.94532394,0.00007773769,0.0006038551,0.0011333332,0.0003677945,0.00039108298,0.031417627,0.00038543512,0.0060121594,0.00032651264],"about_ca_topic_score_codex":0.00019198253,"about_ca_topic_score_gemma":0.00030460826,"teacher_disagreement_score":0.039908268,"about_ca_system_score_codex":0.00004710047,"about_ca_system_score_gemma":0.00008902519,"threshold_uncertainty_score":0.51947373},"labels":[],"label_agreement":null},{"id":"W3215250616","doi":"10.1016/j.eururo.2021.11.008","title":"Not “If”, but “When” and “How”: Testing Antibody-Drug Conjugates in Patients with Non–muscle-invasive Bladder Cancer","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Drug; Cancer; Antibody; Antibody-drug conjugate; Urology; Internal medicine; Oncology; Pathology; Pharmacology; Immunology; Monoclonal antibody","score_opus":0.018863785653275345,"score_gpt":0.244590630052256,"score_spread":0.22572684439898066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215250616","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6988666,0.0016564733,0.000013954867,0.2846671,0.00085671654,0.001452216,0.00045586337,0.00013391927,0.011897144],"genre_scores_gemma":[0.4571002,0.0002503981,0.00034278142,0.53397626,0.002423659,0.00005331799,0.0009911902,0.00030884764,0.004553304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969582,0.00044978122,0.00036353024,0.0011193505,0.00037035753,0.00073877163],"domain_scores_gemma":[0.9983608,0.00035781204,0.0002757188,0.00054833875,0.00030873396,0.00014858604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014234368,0.0006429725,0.00093828264,0.00024149704,0.00010034784,0.00006479397,0.00019374942,0.00028393147,0.00024237687],"category_scores_gemma":[0.00019216105,0.0005182117,0.00008585892,0.00020179566,0.00029287566,0.00008595896,0.0001965599,0.0016367241,0.000055258566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006361574,0.00031105516,0.65669954,0.0006665568,0.0011123309,0.018023878,0.001279648,0.0000095469495,0.0007007941,0.0000017379729,0.3148058,0.0057529663],"study_design_scores_gemma":[0.010437932,0.0019331962,0.7874196,0.0006710524,0.001101783,0.0001474809,0.000058989095,0.000014155989,0.00021192907,0.000009292512,0.19718874,0.00080583233],"about_ca_topic_score_codex":0.00042025995,"about_ca_topic_score_gemma":0.00010487529,"teacher_disagreement_score":0.24930917,"about_ca_system_score_codex":0.00009210795,"about_ca_system_score_gemma":0.00035681398,"threshold_uncertainty_score":0.99972695},"labels":[],"label_agreement":null},{"id":"W3215841463","doi":"10.1136/bmjgh-2020-004128","title":"Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019","year":2021,"lang":"en","type":"article","venue":"BMJ Global Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Shahid Beheshti University of Medical Sciences; Fundação para a Ciência e a Tecnologia; Ministério da Ciência, Tecnologia e Ensino Superior; Bill and Melinda Gates Foundation","keywords":"Life expectancy; Demography; Medicine; Years of potential life lost; Incidence (geometry); Mortality rate; Population; Bladder cancer; Disease burden; Burden of disease; Epidemiology; Cancer; Gerontology; Environmental health; Surgery; Internal medicine","score_opus":0.03328198464542703,"score_gpt":0.38021372011457943,"score_spread":0.3469317354691524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215841463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9007102,0.07222855,0.00006360549,0.0033896992,0.00016648605,0.0032214373,0.020179361,0.000012127517,0.000028494816],"genre_scores_gemma":[0.9961464,0.003138232,0.000045335957,0.00016154096,0.00013659352,0.00014108834,0.00015218295,0.0000067046453,0.00007193128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979031,0.0001639833,0.0006138438,0.00038424987,0.00065136905,0.00028344264],"domain_scores_gemma":[0.9985238,0.00021075229,0.00035157352,0.00021705148,0.00043708066,0.0002597994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004497522,0.00021695519,0.0008980377,0.000044725773,0.0001414377,0.000030568564,0.00007689265,0.00006468454,0.000016269061],"category_scores_gemma":[0.00020805254,0.00015102896,0.000090835994,0.0006587491,0.000111152425,0.000086328044,0.00007357608,0.000054643413,2.87264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007524395,0.00021356928,0.9907156,0.0031253342,0.0019676788,0.000006857649,0.00052315876,0.0003743154,2.9760233e-7,0.0006249735,0.0016146004,0.000081132224],"study_design_scores_gemma":[0.0040876246,0.00048056364,0.98666537,0.00096235034,0.0026462208,0.000018131906,0.0026489126,0.0014645739,0.0000017909204,0.00048417933,0.0004000059,0.00014025492],"about_ca_topic_score_codex":0.08221422,"about_ca_topic_score_gemma":0.0141151305,"teacher_disagreement_score":0.095436156,"about_ca_system_score_codex":0.0006994859,"about_ca_system_score_gemma":0.0020317296,"threshold_uncertainty_score":0.9238974},"labels":[],"label_agreement":null},{"id":"W3216069950","doi":"10.5489/cuaj.7453","title":"Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Astellas Pharma; Seagen; Boston Scientific Corporation; Sanofi; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Cystectomy; Bladder cancer; Medicine; Life expectancy; Microsimulation; Urology; Surgery; Cancer; Internal medicine; Population","score_opus":0.022147925785236593,"score_gpt":0.27653666695960905,"score_spread":0.25438874117437243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216069950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91887504,0.0036193659,0.002005058,0.070480235,0.0008651289,0.0011460653,0.0006298529,0.00006784794,0.0023113978],"genre_scores_gemma":[0.97876406,0.00095816154,0.0012150687,0.015788345,0.00096201734,0.00007677984,0.00010190973,0.00003143643,0.002102253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823505,0.00013559205,0.00037499782,0.00031913474,0.0003558286,0.0005793864],"domain_scores_gemma":[0.9980864,0.00021664354,0.00020716984,0.00012873765,0.00061643694,0.0007446142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031322398,0.00019942729,0.0003965878,0.0001232759,0.0003326785,0.00010217098,0.00009115128,0.00035795258,0.0012244745],"category_scores_gemma":[0.0004670615,0.00016586618,0.00031606428,0.00020628882,0.00003334642,0.000100604055,0.000009260039,0.00043263938,0.000021269045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003678154,0.0009892824,0.6995061,0.00006907763,0.003287194,0.00082321826,0.0013220279,0.004001659,0.015616078,0.00038566778,0.19126193,0.07905963],"study_design_scores_gemma":[0.04274398,0.0024089844,0.5573652,0.00012004344,0.0010975748,0.0007112036,0.0001644042,0.02284146,0.0044174204,0.004860216,0.36225876,0.0010107561],"about_ca_topic_score_codex":0.0008084312,"about_ca_topic_score_gemma":0.0013102959,"teacher_disagreement_score":0.17099683,"about_ca_system_score_codex":0.0017555519,"about_ca_system_score_gemma":0.0040309974,"threshold_uncertainty_score":0.99968857},"labels":[],"label_agreement":null},{"id":"W3216141323","doi":"10.1016/j.euros.2021.09.019","title":"The Studer Neobladder: An Established and Reproducible Technique for Intracorporeal Urinary Diversion","year":2021,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Urinary diversion; Urology; Cystectomy; Medicine; Bladder cancer; Internal medicine","score_opus":0.03400920691767064,"score_gpt":0.33185013927602197,"score_spread":0.29784093235835135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216141323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69402695,0.0017403763,0.0028171109,0.026064526,0.0010948187,0.005800521,0.00004158094,0.00017229056,0.2682418],"genre_scores_gemma":[0.9907149,0.00014257849,0.0048152944,0.0020336828,0.00012526829,0.00006204778,0.00001401511,0.000021252223,0.0020709634],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998307,0.00018974206,0.00016875574,0.0008307135,0.00019256448,0.00031124032],"domain_scores_gemma":[0.99862796,0.000081333106,0.00006549401,0.0008406862,0.00021201716,0.00017252826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021722203,0.00011566013,0.00016159029,0.000050674353,0.0008568737,0.00022008007,0.0007012471,0.00002647719,0.000038407696],"category_scores_gemma":[0.000293176,0.000077489516,0.000025521065,0.00032379673,0.00073243305,0.00040701297,0.0010264751,0.00014103737,0.00001187552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073144133,0.00403523,0.12641159,0.00012966956,0.00036752573,0.0051467107,0.005825394,0.000029158973,0.44125032,0.010087759,0.039246753,0.36015546],"study_design_scores_gemma":[0.00813183,0.012638889,0.6117117,0.000060386632,0.0004134769,0.0047261575,0.0016038297,0.000253764,0.061985474,0.0036145782,0.29421768,0.00064225745],"about_ca_topic_score_codex":0.000037942333,"about_ca_topic_score_gemma":0.000011905904,"teacher_disagreement_score":0.4853001,"about_ca_system_score_codex":0.000027740514,"about_ca_system_score_gemma":0.00035093862,"threshold_uncertainty_score":0.6590466},"labels":[],"label_agreement":null},{"id":"W3217654711","doi":"10.3390/curroncol28060418","title":"Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Urology; Clamping; Renal function; Creatinine; Acute kidney injury; Ureter; Clamp; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.04387469897003508,"score_gpt":0.3725847186601623,"score_spread":0.3287100196901272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217654711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285656,0.0006355307,0.000045761146,0.0038906203,0.0007609828,0.00028018357,0.00014403737,0.00008746554,0.0012988431],"genre_scores_gemma":[0.9948114,0.0003214495,0.00046852848,0.0004934165,0.0011370719,0.000045641358,0.0005516753,0.000030522162,0.0021402834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987609,0.00015170891,0.0002658954,0.0003209903,0.0001974176,0.0003030829],"domain_scores_gemma":[0.99929965,0.00006294263,0.000112737565,0.0001451918,0.000095343144,0.0002841446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112295944,0.00015237869,0.00046484102,0.00007131957,0.00010095615,0.000020552117,0.00004342958,0.00020717259,0.00026120656],"category_scores_gemma":[0.00013515647,0.00014278431,0.00009171439,0.00014934555,0.000042728403,0.000064387044,0.00007533327,0.00033568122,0.000054927856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047569413,0.0005083051,0.85489583,0.00023376312,0.0018696338,0.0003180547,0.0005135774,1.3350599e-7,0.0377384,0.000009788379,0.011066872,0.09236997],"study_design_scores_gemma":[0.008777762,0.0006524662,0.8850058,0.00025965573,0.001747139,0.0002571711,0.000012658932,0.000052307878,0.008466652,0.000045789155,0.094491035,0.00023160716],"about_ca_topic_score_codex":0.0000073650194,"about_ca_topic_score_gemma":0.0000019143247,"teacher_disagreement_score":0.09213837,"about_ca_system_score_codex":0.00075485755,"about_ca_system_score_gemma":0.00043418646,"threshold_uncertainty_score":0.5822575},"labels":[],"label_agreement":null},{"id":"W3217756212","doi":"10.1016/j.critrevonc.2021.103534","title":"Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Atezolizumab; Pembrolizumab; Durvalumab; Medicine; Oncology; Regimen; Internal medicine; Avelumab; Adverse effect; Immunotherapy; Cancer","score_opus":0.2226408354437612,"score_gpt":0.5032529699975057,"score_spread":0.28061213455374445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217756212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.5910222e-7,0.98426485,0.00004516255,0.003340916,0.00032074293,0.0109989345,0.00007070749,0.00003536102,0.00092308654],"genre_scores_gemma":[0.000005064974,0.9654556,0.0015038573,0.009218965,0.00008725627,0.023193158,0.00016472541,0.00011037755,0.0002609957],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98041844,0.010341347,0.0058557848,0.0017255761,0.00035355779,0.0013052975],"domain_scores_gemma":[0.98993254,0.0065352665,0.0012157424,0.0016174505,0.00027233455,0.00042669594],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0044936473,0.0014289868,0.056590572,0.0007643978,0.00009110339,0.000030931664,0.000532538,0.0011735449,0.0031812878],"category_scores_gemma":[0.004216064,0.0009082599,0.0050975243,0.0033087824,0.000627471,0.00009045597,0.00026744674,0.0017076527,0.000112757516],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026134234,0.0010108614,0.000020620695,0.77934355,0.11354358,0.0026936724,0.00008216827,2.2214739e-7,3.5782847e-8,0.0030220514,0.0023254314,0.097931705],"study_design_scores_gemma":[0.00063286436,0.00041680026,7.4610284e-7,0.12312422,0.46779338,0.0020092698,0.000019378578,0.000001789604,9.339406e-8,0.00015611012,0.4054676,0.0003777634],"about_ca_topic_score_codex":0.00011962575,"about_ca_topic_score_gemma":0.00072390825,"teacher_disagreement_score":0.6562193,"about_ca_system_score_codex":0.0011431054,"about_ca_system_score_gemma":0.0024620288,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W331187240","doi":"10.1007/978-1-4939-1501-9_4","title":"Prognostics Factors, Molecular Markers, and Predictive Tools in Upper Tract Urothelial Carcinoma","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prognostics; Urothelial carcinoma; Medicine; Oncology; Internal medicine; Reliability engineering; Cancer; Engineering; Bladder cancer","score_opus":0.021251902320122567,"score_gpt":0.25070211607664505,"score_spread":0.2294502137565225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W331187240","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0351487,0.0019654082,0.0005202215,0.00033650346,0.00032756192,0.0033446848,0.00086998794,0.00011184963,0.9573751],"genre_scores_gemma":[0.8018524,0.00029140466,0.0003255284,0.0005591321,0.00027621302,0.000055653534,0.00054620806,0.00015867609,0.19593476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982586,0.000025455978,0.00038481908,0.000599865,0.00040384682,0.00032740535],"domain_scores_gemma":[0.9990747,0.00012251653,0.00010467054,0.0003691514,0.0000838072,0.0002451713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008569699,0.0005497019,0.00076337066,0.00020723767,0.000034978435,0.00003816756,0.0000861338,0.00050851575,0.0007880131],"category_scores_gemma":[0.000060694892,0.0004294654,0.000185635,0.000025697222,0.0001290817,0.000055059867,0.00005604448,0.00048659625,0.000027886796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007746536,0.0013112081,0.81683284,0.002247848,0.003863116,0.0053256853,0.0024004262,0.000006905649,0.0011872705,0.056246758,0.0131319845,0.08969944],"study_design_scores_gemma":[0.020529268,0.010833235,0.6281301,0.002645256,0.0047438378,0.0005531314,0.00021438024,0.0002007917,0.003711937,0.006131386,0.31949013,0.0028165712],"about_ca_topic_score_codex":0.00010684886,"about_ca_topic_score_gemma":0.000014556999,"teacher_disagreement_score":0.7667037,"about_ca_system_score_codex":0.00016803475,"about_ca_system_score_gemma":0.0002460671,"threshold_uncertainty_score":0.9998157},"labels":[],"label_agreement":null},{"id":"W390058084","doi":"10.1016/j.prp.2015.05.005","title":"Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features","year":2015,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cytokeratin; Pathology; Atypia; Biology; Immunohistochemistry; Keratin 7; Medicine","score_opus":0.07023607438833136,"score_gpt":0.35434391677335675,"score_spread":0.2841078423850254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W390058084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566976,0.0027980267,0.000029077008,0.0020413627,0.00014002748,0.0010919529,0.00017724934,0.00003193431,0.036992796],"genre_scores_gemma":[0.99648505,0.00016478247,0.0012557039,0.00041467516,0.0002680952,0.00013663073,0.00007120167,0.000056142093,0.0011477035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958976,0.0014786378,0.00036104993,0.000626662,0.00089237216,0.0007437122],"domain_scores_gemma":[0.9943531,0.0029895613,0.00038042088,0.00044394413,0.001352616,0.00048034842],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021581526,0.00029295418,0.00056374323,0.0002439401,0.00021442359,0.00004701032,0.00018664253,0.00031146524,0.000080375394],"category_scores_gemma":[0.010475873,0.00020853298,0.00007479325,0.00036930543,0.0008506089,0.00025523064,0.00019605343,0.0010934985,0.00001804767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19749637,0.0073627625,0.20069171,0.0009767136,0.0017554585,0.084761,0.02740263,0.0000030719148,0.4559698,0.0006465121,0.018915478,0.0040184627],"study_design_scores_gemma":[0.098259866,0.070359536,0.27129304,0.0019105589,0.0030050785,0.035971865,0.042634882,0.00009378831,0.46751404,0.0033734858,0.0034597933,0.0021240583],"about_ca_topic_score_codex":0.0012653335,"about_ca_topic_score_gemma":0.00006529777,"teacher_disagreement_score":0.0992365,"about_ca_system_score_codex":0.0002505469,"about_ca_system_score_gemma":0.0019742378,"threshold_uncertainty_score":0.9978593},"labels":[],"label_agreement":null},{"id":"W4200020699","doi":"10.5489/cuaj.7546","title":"Associations between body mass index and bladder cancer survival: Is the obesity paradox short-lived?","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overweight; Bladder cancer; Body mass index; Hazard ratio; Cystectomy; Proportional hazards model; Confidence interval; Urology; Internal medicine; Obesity; Cancer","score_opus":0.04078167117120011,"score_gpt":0.2960458100785568,"score_spread":0.25526413890735666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200020699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8780703,0.0016508148,0.00012558447,0.11395551,0.0006019315,0.00032329047,0.0007793389,0.000035965495,0.004457247],"genre_scores_gemma":[0.9882199,0.00061804586,0.00004628153,0.008873548,0.0009267333,0.000014286425,0.000057407276,0.000016720713,0.0012270509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809444,0.00028380647,0.00034413036,0.000262052,0.00050171925,0.00051386544],"domain_scores_gemma":[0.998272,0.0002786931,0.00017221738,0.00014686641,0.0004442613,0.0006859831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052852527,0.00017437516,0.00039022588,0.0000706674,0.00062691455,0.00016056628,0.00010480691,0.00030637984,0.0015817615],"category_scores_gemma":[0.00041130063,0.00012449932,0.00016042292,0.0002763455,0.000047095666,0.00008982561,0.000021949438,0.000755472,0.000021722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009725261,0.0000312094,0.98633754,0.0000015898188,0.00063711096,0.00006540864,0.0001542211,0.0000028709067,0.00003133435,0.000044912147,0.011615461,0.0010686294],"study_design_scores_gemma":[0.0007727518,0.000076985256,0.97634107,0.000008531085,0.00043548265,0.00003324392,0.00014681969,0.00003802481,0.0000448919,0.0012912704,0.020682994,0.00012791154],"about_ca_topic_score_codex":0.004392322,"about_ca_topic_score_gemma":0.0035343424,"teacher_disagreement_score":0.110149615,"about_ca_system_score_codex":0.0012293537,"about_ca_system_score_gemma":0.0011743259,"threshold_uncertainty_score":0.99933094},"labels":[],"label_agreement":null},{"id":"W4200128746","doi":"10.1038/s41591-021-01579-0","title":"Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Pfizer","keywords":"Javelin; Avelumab; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Biomarker; Medicine; Bladder cancer; Oncology; Carcinoma; Urothelial cancer; Internal medicine; Urology; Immunotherapy; Cancer; Chemistry; Nivolumab","score_opus":0.02005866707782456,"score_gpt":0.34294504056686564,"score_spread":0.3228863734890411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200128746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777832,0.0061277286,0.000090964946,0.007499398,0.0014492995,0.0010291864,0.00012562056,0.000026055268,0.0058685136],"genre_scores_gemma":[0.99381477,0.00012828835,0.0001668461,0.0024584266,0.0004230007,0.000053339405,0.00012133771,0.000031019514,0.0028029743],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975337,0.0001541327,0.00066233054,0.00053075986,0.0007523122,0.0003667711],"domain_scores_gemma":[0.99835366,0.0001487605,0.0002035864,0.0008032921,0.00034762235,0.00014304895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003421978,0.0002884583,0.0010380865,0.00039218145,0.000055215656,0.000004918397,0.00019694983,0.00032780904,0.0013169431],"category_scores_gemma":[0.0008226013,0.00016859295,0.0003782787,0.002919184,0.00023650085,0.000048118767,0.00006243129,0.00072387,0.0000047469202],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3292425,0.0133443065,0.15057324,0.0007420399,0.018725328,0.0044062147,0.007936079,0.000100894584,0.2890551,0.0018761865,0.030465411,0.15353267],"study_design_scores_gemma":[0.5690553,0.0025996477,0.34252828,0.00076571817,0.011100237,0.00013030977,0.001050462,0.0011269375,0.04576463,0.00028180453,0.025085773,0.0005108732],"about_ca_topic_score_codex":0.00024260336,"about_ca_topic_score_gemma":0.00041374777,"teacher_disagreement_score":0.24329048,"about_ca_system_score_codex":0.00018265547,"about_ca_system_score_gemma":0.0005360441,"threshold_uncertainty_score":0.999596},"labels":[],"label_agreement":null},{"id":"W4200135951","doi":"10.1016/j.urolonc.2021.10.010","title":"Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients","year":2021,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"KWF Kankerbestrijding; University of Toronto","keywords":"Cystectomy; Medicine; Bladder cancer; Immunohistochemistry; Stage (stratigraphy); Lymph node; Internal medicine; Ki-67; Gastroenterology; Single Center; Oncology; Pathology; Cancer; Urology; Biology","score_opus":0.030364975677093516,"score_gpt":0.328080711827127,"score_spread":0.2977157361500335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200135951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438614,0.003359866,0.00004654229,0.0009966315,0.00023684803,0.0006668146,0.00015927518,0.000030622406,0.000117284835],"genre_scores_gemma":[0.97223514,0.0022475945,0.02335534,0.0010869518,0.0000473312,0.00047312843,0.00043455578,0.000020014319,0.0000999275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980003,0.00035373558,0.0004326282,0.0006069708,0.00019408177,0.00041223218],"domain_scores_gemma":[0.9987591,0.00040387528,0.00015863428,0.0001741397,0.00015189988,0.0003523355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015976063,0.00025674183,0.0005290718,0.0003876436,0.00012929464,0.000025323847,0.000056605488,0.00028041747,0.000106494124],"category_scores_gemma":[0.00057767745,0.00022911846,0.000060318584,0.0009846562,0.0004767454,0.0001511343,0.000062880485,0.0003940109,0.000003853932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066696963,0.0013830636,0.99337035,0.00005265321,0.00030076553,0.0007463005,0.0011899315,0.000084431056,0.00025523463,0.000017730134,0.00023425432,0.0016983036],"study_design_scores_gemma":[0.03616525,0.0023971298,0.93395406,0.00025036235,0.0016622287,0.000050879564,0.0014422187,0.0029150012,0.00065635605,0.00007516583,0.020061702,0.00036962493],"about_ca_topic_score_codex":0.00046345423,"about_ca_topic_score_gemma":0.0035059997,"teacher_disagreement_score":0.05941628,"about_ca_system_score_codex":0.0003712824,"about_ca_system_score_gemma":0.0010503918,"threshold_uncertainty_score":0.934318},"labels":[],"label_agreement":null},{"id":"W4200180513","doi":"10.1016/j.eururo.2021.12.005","title":"International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Bladder cancer; Clinical trial; Clinical endpoint; Internal medicine; Randomized controlled trial; Carcinoma in situ; Randomization; Clinical study design; Oncology; Gemcitabine; Cohort; Cancer; Surgery","score_opus":0.11399722070787006,"score_gpt":0.3872158354096365,"score_spread":0.27321861470176645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200180513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008819759,0.93341,0.0017089606,0.0014646662,0.018942293,0.022424592,0.009665738,0.00027045558,0.003293547],"genre_scores_gemma":[0.0020604618,0.9841151,0.0012573055,0.0026860593,0.004063136,0.001885669,0.0022045975,0.00044194845,0.0012856823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923506,0.0023501753,0.0019744849,0.0017890442,0.00069631264,0.00083938485],"domain_scores_gemma":[0.99486715,0.0018126094,0.0014059898,0.00087924296,0.00060163386,0.00043340033],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008967482,0.0010778735,0.002928786,0.0002897156,0.0001823788,0.000059186994,0.00046068282,0.00041741363,0.0014651718],"category_scores_gemma":[0.0005396734,0.00077115966,0.00088256504,0.0002478067,0.0003177626,0.00004407457,0.0001890576,0.0011191122,0.00016584866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034856062,0.0027006771,0.0005540308,0.000859187,0.013668148,0.0008537451,0.00011676861,0.000063867425,6.6306563e-7,0.00002263249,0.03794607,0.90835816],"study_design_scores_gemma":[0.086470105,0.021419264,0.0010788519,0.0014087007,0.009201718,0.00001659333,0.000011765684,0.000008418476,0.000001913528,0.0000044056796,0.87969685,0.00068139506],"about_ca_topic_score_codex":0.00023681621,"about_ca_topic_score_gemma":0.00013506212,"teacher_disagreement_score":0.90767676,"about_ca_system_score_codex":0.0005625867,"about_ca_system_score_gemma":0.0017235817,"threshold_uncertainty_score":0.9994739},"labels":[],"label_agreement":null},{"id":"W4200189697","doi":"10.5489/cuaj.7539","title":"En bloc transurethral resection of bladder tumors: A review of current techniques","year":2021,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Detrusor muscle; Obturator nerve; Surgery; Data extraction; Urinary bladder; Urology; MEDLINE","score_opus":0.04546733976974524,"score_gpt":0.3542463510501196,"score_spread":0.3087790112803743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200189697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000075508387,0.9966055,0.000020204117,0.0011712364,0.00026467984,0.00070797966,0.00023316948,0.000013600999,0.0009760765],"genre_scores_gemma":[0.000102762504,0.9983367,0.00011706952,0.0004921461,0.0005730905,0.000051548635,0.00014433473,0.000026575162,0.00015578864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968824,0.0007683667,0.0011928427,0.00025247617,0.00055790646,0.0003460154],"domain_scores_gemma":[0.99747413,0.00018092469,0.0010740102,0.00018722245,0.0006502508,0.00043347332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011213934,0.00028614193,0.0022267955,0.00029957754,0.000064375476,0.000014919324,0.00015662615,0.00049367273,0.0013776176],"category_scores_gemma":[0.00088249356,0.00020754535,0.0010559731,0.0004936741,0.00003900805,0.00004451564,0.000012744094,0.0012122729,0.00000768616],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001803293,0.00016011078,0.00081975304,0.026458398,0.0010426344,0.00009017815,0.000036886257,4.6834273e-8,0.000001411232,0.00004322232,0.019402733,0.9519266],"study_design_scores_gemma":[0.00028865132,0.00057227875,0.00024005922,0.06653358,0.0025519538,0.0004371625,0.000005191326,1.7668788e-7,0.000010398493,0.000042949472,0.9291769,0.00014069647],"about_ca_topic_score_codex":0.0002631958,"about_ca_topic_score_gemma":0.00011045807,"teacher_disagreement_score":0.9517859,"about_ca_system_score_codex":0.001373951,"about_ca_system_score_gemma":0.0038657263,"threshold_uncertainty_score":0.99953526},"labels":[],"label_agreement":null},{"id":"W4200200097","doi":"10.1016/j.urology.2021.10.004","title":"Hemi-Kock Continent Stoma With Augmentation Cystoplasty: Modifications and Outcomes","year":2021,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Medicine; Surgery; Stoma (medicine); Bladder augmentation; Urinary diversion; Ileocecal valve; Retrospective cohort study; Urinary bladder; Cystectomy; Bladder cancer; Ileum","score_opus":0.014108614685028137,"score_gpt":0.2784817185407123,"score_spread":0.26437310385568413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200200097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98019755,0.00043927506,0.0012670495,0.012649604,0.00009888593,0.0002070058,0.000021169064,0.00004535333,0.0050740964],"genre_scores_gemma":[0.9943049,0.000035599158,0.00040763442,0.0026336121,0.000030182748,0.000044827,0.000058025467,0.000009838007,0.0024753867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953276,0.000020144646,0.0000903281,0.00017544822,0.00007370581,0.00010759519],"domain_scores_gemma":[0.99966294,0.000035250163,0.00002783172,0.00013867328,0.00007494109,0.00006039133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000017826185,0.00007477797,0.00015207703,0.000030000474,0.000042928918,0.0000065792324,0.000015077331,0.000040062034,0.0001312638],"category_scores_gemma":[0.00001930446,0.00005632021,0.00001955671,0.00005551679,0.000044471475,0.000024507322,0.000012188856,0.000056378292,0.000019806961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013934642,0.0009466016,0.95325595,0.0000845392,0.0010169018,0.00060753484,0.0016528191,0.00007275927,0.018356502,0.005043552,0.0041900813,0.013379266],"study_design_scores_gemma":[0.008828843,0.0011685201,0.95777184,0.000010060825,0.0005877693,0.00089567306,0.00033489265,0.00021278036,0.007176471,0.00026300392,0.022596836,0.00015331477],"about_ca_topic_score_codex":0.00002834459,"about_ca_topic_score_gemma":0.000076916964,"teacher_disagreement_score":0.018406756,"about_ca_system_score_codex":0.00001944915,"about_ca_system_score_gemma":0.000072466,"threshold_uncertainty_score":0.22966716},"labels":[],"label_agreement":null},{"id":"W4200222393","doi":"10.5489/cuaj.7733","title":"Practice-changing publications: Muscle-invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Bladder cancer; Medicine; Cancer; General surgery; Internal medicine","score_opus":0.025115540719733237,"score_gpt":0.2901529169606054,"score_spread":0.2650373762408722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200222393","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17575034,0.007637465,0.00033061428,0.73662215,0.0019217818,0.00056935684,0.00023190181,0.00013830143,0.076798104],"genre_scores_gemma":[0.937245,0.0015522466,0.0007870852,0.049910404,0.0014563296,0.00006072045,0.00006444074,0.000024610716,0.008899173],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841136,0.00016199565,0.00027073178,0.00022858307,0.00038181903,0.0005455082],"domain_scores_gemma":[0.9974823,0.0002441516,0.00022175476,0.00013772784,0.0011391208,0.00077492365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037628616,0.00012869184,0.00021671847,0.0002084546,0.00039094163,0.00015937738,0.00007603806,0.00020370375,0.004539339],"category_scores_gemma":[0.0030552817,0.00011129376,0.0001432871,0.0005297914,0.000019171635,0.00023966415,0.000016443402,0.0005079036,0.00011765806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009449861,0.0004969139,0.7777852,0.00002001244,0.0023121675,0.0016989501,0.0016397875,0.000075431635,0.0009085979,0.0024546927,0.16957915,0.04293461],"study_design_scores_gemma":[0.0014098671,0.00014310156,0.32336983,0.000026709415,0.0004181852,0.00079098134,0.0007644529,0.000024009072,0.00018866577,0.00067433337,0.6720233,0.00016654545],"about_ca_topic_score_codex":0.0011246192,"about_ca_topic_score_gemma":0.0021275342,"teacher_disagreement_score":0.76149464,"about_ca_system_score_codex":0.001781772,"about_ca_system_score_gemma":0.003330284,"threshold_uncertainty_score":0.9963707},"labels":[],"label_agreement":null},{"id":"W4200263554","doi":"10.1016/j.xcrm.2021.100472","title":"Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight","year":2021,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"Ferring Pharmaceuticals; Cancer Research UK; Yorkshire Cancer Research; Roche","keywords":"Bladder cancer; Disease; Immunotherapy; Biology; Stage (stratigraphy); Gene expression profiling; Bioinformatics; Computational biology; Immune system; Cancer; Oncology; Gene; Medicine; Gene expression; Internal medicine; Immunology; Genetics","score_opus":0.05384090645608921,"score_gpt":0.3557010919683834,"score_spread":0.3018601855122942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200263554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618101,0.025190758,0.00028135107,0.00081471814,0.0005870157,0.00061511825,0.000007947516,0.000033978675,0.010658985],"genre_scores_gemma":[0.98602456,0.009935788,0.00063562486,0.0015419772,0.00028124056,0.0000633639,0.00004610497,0.000028916327,0.0014424108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976671,0.00009133755,0.00096530165,0.0006448454,0.00036547348,0.00026598887],"domain_scores_gemma":[0.9982765,0.00017857431,0.00042482698,0.00052012864,0.00035951467,0.00024049936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033747527,0.00026165333,0.0008373643,0.000053802767,0.00006161802,0.000008620313,0.000052906656,0.00018230634,0.0007573236],"category_scores_gemma":[0.0002589362,0.00017064293,0.00012467273,0.0002521281,0.00055804255,0.00003395392,0.000045350793,0.00025483352,0.000001927932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011405986,0.00040519272,0.07885811,0.00037494593,0.00041467126,0.0036666365,0.00059734954,0.0000036438478,0.9054915,0.000021726624,0.00022431237,0.00982789],"study_design_scores_gemma":[0.0024710333,0.0013401172,0.041560024,0.000528102,0.0006507355,0.0001463776,0.0010325139,0.000017099424,0.94832134,0.0002130768,0.0035137977,0.00020577078],"about_ca_topic_score_codex":0.00013330733,"about_ca_topic_score_gemma":0.000021231164,"teacher_disagreement_score":0.042829886,"about_ca_system_score_codex":0.000025466567,"about_ca_system_score_gemma":0.00076290255,"threshold_uncertainty_score":0.82921624},"labels":[],"label_agreement":null},{"id":"W4200263878","doi":"10.1111/bju.15677","title":"Nomograms including the UBC <sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre dataset","year":2021,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Receiver operating characteristic; Confidence interval; Medicine; Bladder cancer; Logistic regression; Area under the curve; Internal medicine; Cancer","score_opus":0.022900373566455082,"score_gpt":0.28900008593518295,"score_spread":0.26609971236872787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200263878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8168094,0.060966946,0.0023392406,0.10005052,0.0025148431,0.0028303992,0.008649493,0.00011871038,0.005720448],"genre_scores_gemma":[0.9526456,0.0016366476,0.001298411,0.043043405,0.00091395446,0.000034084227,0.0002268828,0.000048900747,0.00015212408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983142,0.00019463508,0.00043965285,0.0002815581,0.00037736006,0.00039258233],"domain_scores_gemma":[0.9986034,0.00041861425,0.00016873436,0.00029311067,0.00024439945,0.0002717664],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029889442,0.00018128272,0.0004540759,0.00009624144,0.00016605297,0.00005693207,0.00020841246,0.00011080007,0.0012217677],"category_scores_gemma":[0.0004992587,0.00015040563,0.00016767709,0.00025717952,0.00008261252,0.000071967406,0.00008313673,0.0005571996,0.000030070474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003045192,0.0016914088,0.021808436,0.00011275542,0.001123964,0.023576314,0.0005291678,0.004304332,0.0026153442,0.0000020758055,0.19739594,0.7437951],"study_design_scores_gemma":[0.027347423,0.007415403,0.13081105,0.0009679355,0.0027098476,0.0330676,0.00044798947,0.0028908253,0.0032903207,0.0000708602,0.7903165,0.0006642266],"about_ca_topic_score_codex":0.00025088305,"about_ca_topic_score_gemma":0.00025956723,"teacher_disagreement_score":0.74313086,"about_ca_system_score_codex":0.0001484174,"about_ca_system_score_gemma":0.00058536296,"threshold_uncertainty_score":0.99969125},"labels":[],"label_agreement":null},{"id":"W4200305543","doi":"10.1016/j.euo.2021.11.002","title":"Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy","year":2021,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Krebsliga Schweiz","keywords":"Medicine; Bladder cancer; Immunotherapy; Somatic cell; Bacillus (shape); Oncology; Cancer immunotherapy; Complete response; Internal medicine; Urology; Cancer; Chemotherapy; Microbiology","score_opus":0.013395024961628378,"score_gpt":0.28206992650191864,"score_spread":0.2686749015402903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200305543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828192,0.003949593,0.000014701091,0.0039801444,0.00010862476,0.0004064797,0.00002836803,0.00003423827,0.008658668],"genre_scores_gemma":[0.99301064,0.00096616865,0.00042552323,0.0031970798,0.0000705566,0.000048585167,0.000020958887,0.000065457854,0.0021950344],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974249,0.0012403673,0.00037621328,0.0004749029,0.00012832775,0.00035527188],"domain_scores_gemma":[0.9987676,0.00043943257,0.00015605811,0.0003893746,0.00013027966,0.000117254465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003365349,0.00025707204,0.00068344123,0.00019861729,0.000052825897,0.0000059969775,0.00009394844,0.0001592718,0.0003330309],"category_scores_gemma":[0.000137925,0.00019986457,0.00006723195,0.0003021955,0.00036709302,0.000041167932,0.00006221053,0.00036936515,0.000020801943],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054411013,0.0027742293,0.37253568,0.00023637546,0.0027005146,0.03690494,0.009998826,0.000113538736,0.40732747,0.00005705101,0.0026299541,0.110310405],"study_design_scores_gemma":[0.015616876,0.0064880927,0.96211773,0.000072029776,0.0003032978,0.0012195054,0.00026817745,0.000007780517,0.00782085,0.000018013034,0.0058853226,0.00018233365],"about_ca_topic_score_codex":0.00031547042,"about_ca_topic_score_gemma":0.0010547399,"teacher_disagreement_score":0.589582,"about_ca_system_score_codex":0.0001407367,"about_ca_system_score_gemma":0.0006042148,"threshold_uncertainty_score":0.8150241},"labels":[],"label_agreement":null},{"id":"W4200331030","doi":"10.5489/cuaj.7277","title":"Radical cystectomy for clinical T4b urothelial carcinoma: An Ontario, single-center experience","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; NOSM University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Dysuria; Surgery; Cancer; Internal medicine; Urinary system","score_opus":0.06208397806694998,"score_gpt":0.3183011231352604,"score_spread":0.2562171450683104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200331030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863233,0.00019455067,0.0002389782,0.008835097,0.0012822994,0.00037933074,0.000098253295,0.00002910858,0.002619077],"genre_scores_gemma":[0.9843652,0.000019584522,0.0009989128,0.010668397,0.0016852356,0.000042676886,0.0000736743,0.000022378614,0.0021239321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977195,0.00026884975,0.00057864346,0.0004039181,0.00038720548,0.00064186886],"domain_scores_gemma":[0.99751455,0.00016759777,0.00019292027,0.00019170226,0.00045077255,0.0014824634],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005011503,0.0001877567,0.00044716618,0.00008149624,0.0003259282,0.0001283956,0.00013822934,0.00038894513,0.0021099497],"category_scores_gemma":[0.00079235365,0.00015653687,0.00034515758,0.00013010722,0.00006910925,0.00014093163,0.000016794902,0.00067023776,0.00003288813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028755332,0.0004505928,0.9888953,0.00000348513,0.00012083716,0.0004840078,0.0004310153,9.3408494e-7,0.00014037703,0.00004980719,0.006479856,0.002656242],"study_design_scores_gemma":[0.006979845,0.0016215546,0.63075566,0.000012617006,0.0001468089,0.0011914681,0.00012351433,0.000030343583,0.00013083548,0.00023789455,0.35858712,0.00018236203],"about_ca_topic_score_codex":0.0058490117,"about_ca_topic_score_gemma":0.037805725,"teacher_disagreement_score":0.35813966,"about_ca_system_score_codex":0.0023355621,"about_ca_system_score_gemma":0.0030021095,"threshold_uncertainty_score":0.99880224},"labels":[],"label_agreement":null},{"id":"W4200466039","doi":"10.1097/spc.0000000000000587","title":"Emerging treatment options for bacillus Calmette–Guérin-unresponsive non-muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Université de Montréal","funders":"","keywords":"Pembrolizumab; Bladder cancer; Bacillus (shape); MEDLINE; Adverse effect","score_opus":0.09949416389873933,"score_gpt":0.41488955714339515,"score_spread":0.3153953932446558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200466039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86533475,0.1125808,0.0017042784,0.0031166982,0.005980661,0.0046757055,0.0055375556,0.00007722775,0.0009923233],"genre_scores_gemma":[0.95156854,0.040988773,0.00051281165,0.00033337972,0.00088125543,0.002675474,0.002250689,0.00006421979,0.00072487193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983327,0.00008082512,0.0003674181,0.00062394165,0.00020159726,0.00039354435],"domain_scores_gemma":[0.9985187,0.0001929911,0.00012942789,0.00021776046,0.0007228812,0.00021822452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004904226,0.0003302038,0.00050107256,0.00014610635,0.00016263186,0.000027121996,0.000047539852,0.000095834126,0.0003956416],"category_scores_gemma":[0.00011509972,0.00028452752,0.00020926405,0.00028860362,0.000091987626,0.00010086387,0.000049772996,0.00015947685,0.000011029108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014165991,0.0014479576,0.70623404,0.0023302867,0.0014739942,0.000104849016,0.06178357,0.000088545756,0.0023093806,0.0008023849,0.006724183,0.21528423],"study_design_scores_gemma":[0.017822184,0.0026283073,0.7090907,0.0025851864,0.0006717123,0.000011908053,0.030739306,0.00011456363,0.016607318,0.00032258747,0.21854071,0.0008654766],"about_ca_topic_score_codex":0.00009649832,"about_ca_topic_score_gemma":0.00020157105,"teacher_disagreement_score":0.21441875,"about_ca_system_score_codex":0.00053069444,"about_ca_system_score_gemma":0.0009954221,"threshold_uncertainty_score":0.99996066},"labels":[],"label_agreement":null},{"id":"W4200537709","doi":"10.3390/curroncol28060428","title":"Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Genitourinary system; Oncology; Internal medicine; Prostatectomy; Pathological; Cancer; Intensive care medicine; Prostate cancer","score_opus":0.14558180732197082,"score_gpt":0.4624579660321555,"score_spread":0.3168761587101847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200537709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009812991,0.988294,0.000099532685,0.00024564998,0.0053455997,0.0031244336,0.00052314065,0.00003634622,0.0013500144],"genre_scores_gemma":[0.001757681,0.9947908,0.00045112742,0.000024872763,0.0010911574,0.0011316092,0.00057246245,0.00009581453,0.000084465566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99559695,0.00097019365,0.0013044119,0.0010542909,0.00054589706,0.00052827713],"domain_scores_gemma":[0.99674624,0.00041518506,0.0013930991,0.00086797035,0.00038497994,0.00019252203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002117502,0.0007245275,0.0034405037,0.00023434701,0.00014190534,0.000010018982,0.0004833475,0.0005422555,0.00053595373],"category_scores_gemma":[0.000034366618,0.0005196433,0.0014230907,0.00066058536,0.0004305248,0.000049161663,0.00082788465,0.0010903286,0.000013972451],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002475707,0.0042416938,0.00047721446,0.013177266,0.003100342,0.00034596803,0.00096911273,0.0000018244142,0.00000933533,0.00022322434,0.00083384174,0.9763726],"study_design_scores_gemma":[0.0045527816,0.0012250405,0.0016846289,0.0646058,0.01654567,0.00011171489,0.0015366381,0.00000741376,0.000022334541,0.00022097207,0.90903616,0.0004508387],"about_ca_topic_score_codex":0.0003414693,"about_ca_topic_score_gemma":0.00020844056,"teacher_disagreement_score":0.97592175,"about_ca_system_score_codex":0.0035318122,"about_ca_system_score_gemma":0.0026425058,"threshold_uncertainty_score":0.9997255},"labels":[],"label_agreement":null},{"id":"W4200542267","doi":"10.1139/bcb-2021-0277","title":"Synergistic inhibitory effects of 5-aza-2′-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways","year":2021,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"TGFBI; MAPK/ERK pathway; Signal transduction; Cancer research; Carcinogenesis; Biology; Cisplatin; Cell biology; Chemistry; Transforming growth factor; Gene; Genetics","score_opus":0.007786036988436594,"score_gpt":0.22066378826295918,"score_spread":0.21287775127452258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200542267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468935,0.0036745728,0.000047051148,0.000030895222,0.000119807206,0.00013212944,0.000058875627,0.000010554541,0.0012367738],"genre_scores_gemma":[0.99923605,0.00019002787,0.00011494242,0.00006292295,0.00015693471,0.000011189249,0.00008237159,0.000012892596,0.00013269662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916106,0.000050346753,0.00023218451,0.00031897824,0.00007981374,0.00015760977],"domain_scores_gemma":[0.9993776,0.000171919,0.00010387922,0.00016929193,0.00007344695,0.00010387762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051778603,0.00016838973,0.00036241623,0.000030112069,0.00003908717,0.000002649346,0.00003579866,0.00020378371,0.000038153437],"category_scores_gemma":[0.00007164597,0.00013702965,0.00006009835,0.00006281223,0.0001596588,0.000010388218,0.00005110052,0.00011186175,8.350443e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042506456,0.00020801587,0.007452606,0.001509705,0.000042379877,0.00006893413,0.00008191255,2.7349492e-7,0.9890463,0.000035092417,0.000041491614,0.0010882554],"study_design_scores_gemma":[0.0024733432,0.00083572185,0.0020885088,0.000265434,0.00014283437,0.000025203186,0.000043080396,0.000015325555,0.99383026,0.00013019769,0.000040971372,0.00010911423],"about_ca_topic_score_codex":0.00003267318,"about_ca_topic_score_gemma":3.0104565e-7,"teacher_disagreement_score":0.0053640977,"about_ca_system_score_codex":0.000017326429,"about_ca_system_score_gemma":0.00010685753,"threshold_uncertainty_score":0.5587907},"labels":[],"label_agreement":null},{"id":"W4200581117","doi":"10.1016/j.vetimm.2021.110367","title":"Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines","year":2021,"lang":"en","type":"article","venue":"Veterinary Immunology and Immunopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust","keywords":"Flow cytometry; Cell culture; Biology; PD-L1; Immunotherapy; Monoclonal antibody; Cancer research; Molecular biology; Western blot; Urothelial Cell; Messenger RNA; Cell; Antibody; Immunology; Immune system; Urothelium; Urinary system; Gene","score_opus":0.03639980746552644,"score_gpt":0.3044709612541177,"score_spread":0.26807115378859125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200581117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599943,0.038180996,0.000009593871,0.00022216828,0.00031249042,0.00027720872,0.000019717856,0.000013406787,0.0009700795],"genre_scores_gemma":[0.9970703,0.0020912776,0.00036034844,0.00010302608,0.000039923383,0.000062934756,0.0000405854,0.000017702656,0.00021389952],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849993,0.00048051143,0.00032532675,0.0003403636,0.00013044287,0.0002234461],"domain_scores_gemma":[0.9993316,0.000054071348,0.000090974405,0.0002936616,0.00019614182,0.000033538214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037935475,0.0001751558,0.00042776446,0.00014810525,0.000063247506,0.0000047296253,0.00005151143,0.00021873822,0.00016282509],"category_scores_gemma":[0.00008405034,0.00015903257,0.000039960385,0.000117307005,0.00024710226,0.00007181397,0.000139321,0.00020503509,0.000004247657],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014769023,0.00028300376,0.030041587,0.00007043659,0.000040447718,0.00047187018,0.000863238,0.00000115883,0.95562583,0.00001122913,0.000008368104,0.011105926],"study_design_scores_gemma":[0.008165322,0.003747151,0.74946696,0.00010353627,0.0002398904,0.00457103,0.0005133297,0.000053782747,0.23244697,0.00019644955,0.00035361075,0.00014194976],"about_ca_topic_score_codex":0.00011707891,"about_ca_topic_score_gemma":0.000011738629,"teacher_disagreement_score":0.72317886,"about_ca_system_score_codex":0.000048689617,"about_ca_system_score_gemma":0.0002589285,"threshold_uncertainty_score":0.648516},"labels":[],"label_agreement":null},{"id":"W4200626914","doi":"10.1016/j.euros.2021.11.010","title":"Functional and Oncological Outcomes of Female Pelvic Organ–preserving Robot-assisted Radical Cystectomy","year":2021,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Sexual function; Urinary continence; Retrospective cohort study; Bladder cancer; Surgery; Urinary system; Quality of life (healthcare); Robotic surgery; Urology; Cancer; Internal medicine","score_opus":0.061800447476419725,"score_gpt":0.33373241576743573,"score_spread":0.271931968291016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200626914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9198402,0.00037945437,0.00019099153,0.004620859,0.00024912858,0.00028041966,0.00000611109,0.000029641378,0.07440315],"genre_scores_gemma":[0.99297136,0.000016783482,0.0021118962,0.0027316005,0.000047999525,0.0000059628483,0.000006444929,0.000012657987,0.002095316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983255,0.00025335935,0.00025908762,0.00055675674,0.00033225233,0.0002730306],"domain_scores_gemma":[0.9990142,0.00014032944,0.00008015196,0.00038410685,0.00017302205,0.00020817766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076153775,0.00012672493,0.00035725482,0.00007731291,0.00021361459,0.000057672692,0.00047232772,0.000041526277,0.0010534085],"category_scores_gemma":[0.00058865803,0.000093039984,0.000046808662,0.0004642795,0.0009627309,0.00016615383,0.0011019491,0.00018135206,0.0000690133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053245254,0.000789145,0.9026885,0.00003215166,0.00015141032,0.0017438469,0.000503569,0.000020330079,0.076722555,0.00097186817,0.00085907447,0.01498508],"study_design_scores_gemma":[0.0026414576,0.00052016374,0.99019825,0.0000125708675,0.000075424316,0.0006002105,0.00007949622,0.00003675974,0.0020211863,0.000027220916,0.0037036843,0.000083547115],"about_ca_topic_score_codex":0.000028343451,"about_ca_topic_score_gemma":0.0000142877825,"teacher_disagreement_score":0.08750976,"about_ca_system_score_codex":0.000042045896,"about_ca_system_score_gemma":0.0004951318,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W4205090700","doi":"10.1016/j.jval.2021.11.1253","title":"POSB390 Characterisation of the Management Pathway for Muscle-Invasive Urothelial Carcinoma (MIUC) from Physician Perspectives in France, Germany, Italy, Spain, UK (EU5), US, Canada, China, and Japan","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neoadjuvant therapy; Adjuvant therapy; Adjuvant; Workload; Family medicine; Demographics; China; Adjuvant chemotherapy; Disease; Internal medicine; General surgery; Chemotherapy; Cancer; Demography","score_opus":0.014646910119070398,"score_gpt":0.24073067759258132,"score_spread":0.22608376747351092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205090700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281484,0.0010286951,0.000005260855,0.0027908282,0.00026780376,0.0019418945,0.00088204024,0.000007667328,0.00026095228],"genre_scores_gemma":[0.99765384,0.00012939869,0.00008154002,0.0014955142,0.00014462226,0.0002775188,0.000056848403,0.000025081086,0.00013562362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985609,0.00016990835,0.00033894854,0.00033862426,0.0003158587,0.00027577984],"domain_scores_gemma":[0.9993839,0.000067887195,0.00018142027,0.00026785082,0.000027239366,0.00007165213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021149345,0.00015611795,0.0003382846,0.000105056104,0.00015244394,0.000006406181,0.00011040911,0.000027304146,0.000032158463],"category_scores_gemma":[0.000011895488,0.00013386323,0.000060742153,0.00021838598,0.00003950886,0.000037535414,0.0000705366,0.00018270536,2.8883096e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008905123,0.0011882312,0.91639125,0.0014644283,0.00032152166,0.00006991976,0.05196542,0.00068408553,0.0027125382,0.0017709342,0.00039646882,0.022144686],"study_design_scores_gemma":[0.0028532378,0.00039349587,0.99054235,0.00016139391,0.000032162705,0.000002572886,0.0040256875,0.00035687667,0.00032944846,0.00035433925,0.0008435886,0.0001048292],"about_ca_topic_score_codex":0.69765717,"about_ca_topic_score_gemma":0.08345249,"teacher_disagreement_score":0.61420465,"about_ca_system_score_codex":0.0008367762,"about_ca_system_score_gemma":0.0009079246,"threshold_uncertainty_score":0.9332721},"labels":[],"label_agreement":null},{"id":"W4205247861","doi":"10.1158/1940-6207.capr-21-0490","title":"Family History and Risk of Bladder Cancer: An Analysis Accounting for First- and Second-degree Relatives","year":2022,"lang":"en","type":"article","venue":"Cancer Prevention Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"Fundamental Research Funds for the Central Universities; World Cancer Research Fund; FP7 People: Marie-Curie Actions; European Commission; World Cancer Research Fund International","keywords":"Family history; Bladder cancer; Smoking history; Association (psychology); Cancer; Medical history; Urinary bladder","score_opus":0.12544387484947678,"score_gpt":0.40949443246433914,"score_spread":0.28405055761486236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205247861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96696544,0.030367713,0.00013993759,0.00021396703,0.00010426116,0.0008825574,0.00034814666,0.000017083203,0.00096090056],"genre_scores_gemma":[0.9836887,0.004980518,0.00023655857,0.000047003574,0.00010272627,0.0013890734,0.00004259915,0.000025234503,0.009487567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983909,0.0002599172,0.00023815085,0.0004110811,0.00044354738,0.00025639372],"domain_scores_gemma":[0.9990955,0.00015553433,0.00013453538,0.00023676002,0.0002594037,0.00011828466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010202582,0.000110919194,0.00032313578,0.00040153167,0.0003722187,0.000013056578,0.00008659148,0.00004963285,0.0031104272],"category_scores_gemma":[0.00004770644,0.00010625491,0.000115952476,0.00041198434,0.00017580915,0.00014657233,0.00011073928,0.00031035376,4.808134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013713841,0.0003687639,0.9125328,0.00055927417,0.0043005436,0.0000054862035,0.004070213,0.00020626468,0.0023580533,0.00017877218,0.006035165,0.06801325],"study_design_scores_gemma":[0.0034624645,0.0011762566,0.9501577,0.00006578417,0.0018711067,0.0000026646007,0.002022554,0.0021512238,0.00035205134,0.00066891947,0.037911788,0.00015750718],"about_ca_topic_score_codex":0.0038777802,"about_ca_topic_score_gemma":0.0027138202,"teacher_disagreement_score":0.067855746,"about_ca_system_score_codex":0.0005952043,"about_ca_system_score_gemma":0.00045550137,"threshold_uncertainty_score":0.9978009},"labels":[],"label_agreement":null},{"id":"W4205365572","doi":"10.1158/2326-6074.tumimm21-p008","title":"Abstract P008: Effect of route of Bacillus Calmette Guérin administration on the tumor immune microenvironment in a mouse model of non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Immunotherapy; Immune system; Urology; Tumor microenvironment; Cancer; Flow cytometry; Saline; Internal medicine; Immunology","score_opus":0.049497589969809325,"score_gpt":0.3508672274035879,"score_spread":0.30136963743377854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205365572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926773,0.00350114,0.0000025433299,0.0011686402,0.00008844073,0.0014518521,0.0005579338,0.000005436953,0.00054672593],"genre_scores_gemma":[0.9960987,0.0012759579,0.000014049826,0.000087011686,0.000022894097,0.0017028971,0.000025278556,0.000033200828,0.0007400204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976624,0.00038284727,0.00055007637,0.00035247498,0.00062393106,0.0004282596],"domain_scores_gemma":[0.9985542,0.0004234843,0.00023246474,0.000624169,0.00011798067,0.000047689424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009046421,0.00019655222,0.00059426314,0.00027881147,0.00012016973,0.000003790468,0.00034662714,0.00008080232,0.0011428156],"category_scores_gemma":[0.00009116238,0.00014584465,0.00014615989,0.0003637473,0.0005606772,0.000043039578,0.00022759463,0.0008079714,0.000005259853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005854991,0.00062010536,0.009958456,0.00024435922,0.0005422003,0.000027842843,0.0011495689,0.0023347442,0.9732683,0.000021347032,0.00019630104,0.0057818415],"study_design_scores_gemma":[0.004145235,0.004029166,0.08506699,0.00017494986,0.00007144233,0.0000052867717,0.0005489808,0.000294538,0.9054594,0.000023195393,0.000079366015,0.00010145354],"about_ca_topic_score_codex":0.0053737476,"about_ca_topic_score_gemma":0.00035567864,"teacher_disagreement_score":0.07510853,"about_ca_system_score_codex":0.00078089494,"about_ca_system_score_gemma":0.001155215,"threshold_uncertainty_score":0.9997703},"labels":[],"label_agreement":null},{"id":"W4205450298","doi":"10.1371/journal.pone.0261124","title":"Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years","year":2022,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Päivikki ja Sakari Sohlbergin Säätiö; European Commission; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Relative survival; Medicine; Bladder cancer; Incidence (geometry); Demography; Cancer; Health care; Survival rate; Young adult; Gerontology; Cancer registry; Internal medicine","score_opus":0.05248387438351888,"score_gpt":0.2794013187216374,"score_spread":0.22691744433811856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205450298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262154,0.0026126734,3.0702336e-7,0.0007308255,0.000035952547,0.00032538475,0.000039096973,0.000010646608,0.0036235717],"genre_scores_gemma":[0.9975733,0.000729096,0.00017160327,0.0003480875,0.000052291,0.00008965787,0.000011812514,0.000018056991,0.0010060832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921966,0.00004625836,0.00012303247,0.0002192777,0.00021707767,0.00017468761],"domain_scores_gemma":[0.9997747,0.00003847666,0.000020729007,0.000107378524,0.0000069375797,0.00005180881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008297243,0.000093737035,0.00024601037,0.00006976243,0.00003607377,0.000007602795,0.000032522064,0.00003278964,0.00048234616],"category_scores_gemma":[0.000009902676,0.00009250906,0.000016024553,0.000117751995,0.000036553356,0.000063303756,0.000054914308,0.00020447533,0.0000044203457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046205625,0.0016975479,0.99297523,0.00006594385,0.00014156109,0.00031336845,0.0027033638,0.000004883519,0.00083193654,0.000013484847,0.00011544361,0.00067520153],"study_design_scores_gemma":[0.0040654107,0.0007644314,0.9929968,0.00007731508,0.00010142514,0.000039596016,0.0006277401,0.000038166385,0.00020991304,0.00015708887,0.0008118543,0.000110225046],"about_ca_topic_score_codex":0.002330166,"about_ca_topic_score_gemma":0.0002038221,"teacher_disagreement_score":0.00495177,"about_ca_system_score_codex":0.00015155303,"about_ca_system_score_gemma":0.00009006184,"threshold_uncertainty_score":0.52813524},"labels":[],"label_agreement":null},{"id":"W4205789864","doi":"10.5489/cuaj.1416","title":"Podium Session 3: Oncology (Bladder)","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Medical physics; Internal medicine; Oncology; Computer science; World Wide Web","score_opus":0.015715679767105663,"score_gpt":0.2639485197285243,"score_spread":0.24823283996141862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205789864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7284915,0.00041583978,0.00007532488,0.19251348,0.0012387538,0.0005482927,0.000025687128,0.00006964221,0.07662151],"genre_scores_gemma":[0.97334474,0.000076688804,0.00029925047,0.021894734,0.00078721746,0.000022109498,0.0000162569,0.000012109281,0.0035469034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869657,0.0001287618,0.00026132583,0.00015670003,0.00026613974,0.00049053103],"domain_scores_gemma":[0.9983408,0.00007675986,0.00015510518,0.000088011366,0.0002998901,0.0010394736],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023954529,0.000121153396,0.00025043575,0.0001312263,0.00024299156,0.00007051524,0.00008210327,0.00045416577,0.008475359],"category_scores_gemma":[0.000288026,0.00008738453,0.00011982398,0.00013577721,0.000023552124,0.00011956191,0.000010450108,0.00076794735,0.0010338209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052716052,0.00015098361,0.67534494,0.0000030929236,0.00024623843,0.00021694359,0.00016180864,0.000004720505,0.0005222699,0.00011794487,0.274191,0.048987355],"study_design_scores_gemma":[0.0014218219,0.00069688325,0.71050185,0.0000065931763,0.00008221817,0.00043670365,0.000081708444,0.00003744965,0.000048615264,0.0015573689,0.28503045,0.00009832359],"about_ca_topic_score_codex":0.0033103223,"about_ca_topic_score_gemma":0.00043476833,"teacher_disagreement_score":0.24485326,"about_ca_system_score_codex":0.0018940795,"about_ca_system_score_gemma":0.0010174131,"threshold_uncertainty_score":0.999744},"labels":[],"label_agreement":null},{"id":"W4205946049","doi":"10.2147/ceor.s341896","title":"Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Bladder cancer; Systematic review; Discontinuation; Generalization; MEDLINE; Cancer survival; Patient data; Overall survival","score_opus":0.15233066222282354,"score_gpt":0.48595328997153875,"score_spread":0.3336226277487152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205946049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8078379,0.18200137,3.4060056e-7,0.0051501743,0.00042861933,0.0039037666,0.0003080023,0.000018097113,0.00035172573],"genre_scores_gemma":[0.50089014,0.4930914,0.000052537744,0.0007839909,0.000050548028,0.0014313114,0.000016000226,0.000032657947,0.0036514285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618316,0.0006686183,0.0014058971,0.0007390774,0.00046766573,0.00053561054],"domain_scores_gemma":[0.99416983,0.003971741,0.00043598242,0.0009058208,0.0002967878,0.0002198114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021248297,0.00036476555,0.0023790214,0.000520517,0.00025742684,0.00004261401,0.0002961678,0.00008217588,0.000269056],"category_scores_gemma":[0.0009704503,0.00025469885,0.0003517848,0.00061231613,0.00019996792,0.0001540532,0.0003997906,0.0006532504,0.000019499766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025323828,0.0005902568,0.95358926,0.032827094,0.0019478021,0.0001497113,0.002744921,0.000032613247,0.000008277046,0.00014624161,0.0012217046,0.0064889085],"study_design_scores_gemma":[0.0073599447,0.0031959482,0.9450021,0.03816104,0.0012685849,0.000019052211,0.0029705775,0.00009827698,0.00007911291,0.00056288985,0.0008297462,0.00045274425],"about_ca_topic_score_codex":0.004396156,"about_ca_topic_score_gemma":0.0044732587,"teacher_disagreement_score":0.31109005,"about_ca_system_score_codex":0.0013164195,"about_ca_system_score_gemma":0.00077580765,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W4206062027","doi":"10.1016/j.ejca.2021.12.012","title":"Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Kingston Health Sciences Centre; Queen's University","funders":"Genentech; Servier; Cilag; Astellas Pharma; Incyte; Ipsen; Clovis Oncology; Strong; Sanofi; Exelixis; Eisai; Pfizer; Les Laboratories Pierre Fabre; Symphogen; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Clinical endpoint; Internal medicine; Adverse effect; Population; Urology; Tolerability; Phases of clinical research; Oncology; Surgery; Chemotherapy; Clinical trial; Cancer; Immunotherapy; Nivolumab","score_opus":0.04576036169986496,"score_gpt":0.3418975716791859,"score_spread":0.2961372099793209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206062027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573076,0.0013730463,0.000002035177,0.000056731784,0.00011872868,0.0015066162,0.00020284315,0.0000064615124,0.0010028055],"genre_scores_gemma":[0.99923146,0.00012226198,0.00013940595,0.00009388568,0.00006603643,0.0000244467,0.000032030446,0.00006973513,0.00022072539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699736,0.0008435242,0.0009963901,0.0002740678,0.0006671658,0.00022147976],"domain_scores_gemma":[0.9981697,0.000030278636,0.0009654948,0.0003744674,0.00029365695,0.00016639874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005820452,0.00022480302,0.00066494336,0.00022574277,0.00006437041,0.00001405846,0.00039794564,0.00001364647,0.00013726701],"category_scores_gemma":[0.000015012217,0.00016894592,0.00005212866,0.00027839403,0.000046863053,0.0002626737,0.00009307571,0.0003264925,4.5389714e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18038142,0.0876236,0.6601731,0.0000775736,0.00063447485,0.0017758217,0.008574901,0.00026487478,0.0013404534,2.5237435e-7,0.00025375857,0.058899734],"study_design_scores_gemma":[0.19518933,0.11908987,0.6834398,0.00019369295,0.0003262263,0.000039733437,0.00077848975,0.000023700466,0.000308378,2.7965126e-7,0.0004888721,0.00012161364],"about_ca_topic_score_codex":0.00052649796,"about_ca_topic_score_gemma":0.00003859306,"teacher_disagreement_score":0.058778122,"about_ca_system_score_codex":0.00032999474,"about_ca_system_score_gemma":0.00034571794,"threshold_uncertainty_score":0.6889415},"labels":[],"label_agreement":null},{"id":"W4206400562","doi":"10.1080/01635581.2021.2004172","title":"Association of Recommended and Non-Recommended Food Score and Risk of Bladder Cancer: A Case-Control Study","year":2022,"lang":"en","type":"article","venue":"Nutrition and Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Association (psychology); Risk assessment; Framingham Risk Score; MEDLINE; Epidemiology","score_opus":0.020891369385419745,"score_gpt":0.29170592581061683,"score_spread":0.2708145564251971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206400562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895001,0.005710252,0.0000055966807,0.001807639,0.000121568584,0.001074824,0.0016551793,0.000011830275,0.00011301801],"genre_scores_gemma":[0.9914526,0.007264174,0.000030162393,0.0003089135,0.0000712981,0.0006909953,0.000010206936,0.000013684091,0.00015797776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911684,0.0001199349,0.00023334303,0.00021303554,0.0001904842,0.00012634523],"domain_scores_gemma":[0.99945647,0.00007062918,0.00021191216,0.000094038696,0.00009247915,0.00007446283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020114463,0.00011603028,0.0003508902,0.00008594313,0.0001425655,0.000007981184,0.000020727282,0.000045400084,0.0005532103],"category_scores_gemma":[0.000012733358,0.00009945429,0.00004075279,0.00012557968,0.000020523534,0.00004885816,0.000029151137,0.00015293747,9.145016e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010825926,0.0011488117,0.93554705,0.00024278878,0.0015931048,0.000019947222,0.0017158086,0.0000019518002,0.0004125206,0.000004399703,0.0032200054,0.055011045],"study_design_scores_gemma":[0.06627221,0.006831412,0.9049639,0.00022091137,0.004217486,0.00016246707,0.008390743,0.00026007608,0.0018216735,0.00032641308,0.006221676,0.00031105027],"about_ca_topic_score_codex":0.0020125618,"about_ca_topic_score_gemma":0.0014672801,"teacher_disagreement_score":0.065189615,"about_ca_system_score_codex":0.00015009253,"about_ca_system_score_gemma":0.00006230309,"threshold_uncertainty_score":0.60572654},"labels":[],"label_agreement":null},{"id":"W4206566901","doi":"10.1038/s41598-021-04678-7","title":"Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma","year":2022,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Toronto General Hospital; University of Toronto; University Health Network; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Immune system; Chemokine; Downregulation and upregulation; Inflammation; Immunotherapy; Transcriptome; Immunology; Tumor microenvironment; Biology; Cancer research; Gene expression; Gene","score_opus":0.014393332710976592,"score_gpt":0.24527209553925888,"score_spread":0.2308787628282823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206566901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334306,0.0007625537,0.000012757693,0.00039150918,0.0033243042,0.000818564,0.000055663542,0.000025143398,0.0012664335],"genre_scores_gemma":[0.9969683,0.0000059914387,0.000035755467,0.000030238636,0.000053983098,0.00009214172,0.00015475001,0.000020210264,0.0026385777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978457,0.000076117874,0.00066004554,0.00040114188,0.00080837286,0.00020864037],"domain_scores_gemma":[0.9984426,0.00005380442,0.00044590907,0.0007781152,0.00021731941,0.00006226616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080223405,0.0001389825,0.00034125493,0.00016427573,0.0002589535,0.000015893102,0.00012993118,0.000036047895,0.0006833246],"category_scores_gemma":[0.00009527575,0.00009888377,0.00022473361,0.00065247074,0.0003484126,0.000067316214,0.000062762054,0.000118974625,0.0000021845947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000266708,0.0003367209,0.017849194,0.00013459506,0.000105540676,0.00019088591,0.0033040838,0.0000696816,0.9745658,0.000034008128,0.0008397383,0.0023030576],"study_design_scores_gemma":[0.0018998754,0.0003738935,0.1846712,0.000054600947,0.00030737842,0.000364377,0.0008325716,0.00008084903,0.8028745,0.0009348569,0.0074678576,0.00013803894],"about_ca_topic_score_codex":0.0003102224,"about_ca_topic_score_gemma":0.00001254257,"teacher_disagreement_score":0.17169128,"about_ca_system_score_codex":0.00007515379,"about_ca_system_score_gemma":0.0004446286,"threshold_uncertainty_score":0.7481925},"labels":[],"label_agreement":null},{"id":"W4206793550","doi":"10.1016/j.clgc.2022.01.004","title":"Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Gemcitabine; Internal medicine; Chemotherapy; Oncology; Cisplatin; Vinblastine; Hazard ratio; Proportional hazards model; Cancer; Cohort; Urology; Confidence interval","score_opus":0.04488737502863818,"score_gpt":0.3753688852645977,"score_spread":0.3304815102359595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206793550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919394,0.0008280305,0.0000020904258,0.0020157713,0.0014411514,0.0028425269,0.0005230069,0.00007672935,0.0003312542],"genre_scores_gemma":[0.99041533,0.00038173655,0.00016912262,0.0052004065,0.0006394336,0.002030212,0.000071726245,0.000088092405,0.0010039393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996663,0.00036710894,0.00086067675,0.0008869166,0.0007035061,0.0005188048],"domain_scores_gemma":[0.9985893,0.00026138156,0.0002487554,0.0005393707,0.00009971214,0.00026149186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024508184,0.00041501378,0.0010116855,0.00012072572,0.00018303555,0.000021727388,0.0002900723,0.000118759315,0.0052155987],"category_scores_gemma":[0.00003140204,0.00029700887,0.00028919656,0.00027386853,0.00010509809,0.00010389512,0.00014205372,0.00088565703,0.000021565684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009995496,0.016290225,0.89950913,0.000010760097,0.0005408672,0.00043620548,0.0008321743,0.00007007172,0.00001315811,1.5055089e-7,0.0007605606,0.07154121],"study_design_scores_gemma":[0.045847777,0.01163672,0.93004006,0.000049158894,0.00035132768,0.0000019568402,0.00060913595,0.00003452125,0.000018954539,0.000010915773,0.011075151,0.0003243002],"about_ca_topic_score_codex":0.0036387194,"about_ca_topic_score_gemma":0.0005100077,"teacher_disagreement_score":0.07121691,"about_ca_system_score_codex":0.00068001787,"about_ca_system_score_gemma":0.0005993104,"threshold_uncertainty_score":0.9999482},"labels":[],"label_agreement":null},{"id":"W4206810602","doi":"10.1186/s12889-022-12516-2","title":"Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"BMC Public Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Odds ratio; Relative risk; Cohort study; Meta-analysis; Cochrane Library; Confidence interval; Internal medicine; Epidemiology; Demography; Cohort; Incidence (geometry)","score_opus":0.22392796848485427,"score_gpt":0.42105112357694957,"score_spread":0.1971231550920953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206810602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012997191,0.9911163,0.000024645968,0.00079014414,0.00003445205,0.0050113355,0.0029048517,0.000028128285,0.000088846224],"genre_scores_gemma":[0.000011568491,0.9946558,0.00009325889,0.0014438563,0.000032189237,0.0027310136,0.00035643994,0.000053545147,0.0006223266],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950544,0.0017907844,0.0016134325,0.0006446114,0.00050528144,0.00039146704],"domain_scores_gemma":[0.99663377,0.00036506713,0.0015475436,0.0008832646,0.00007032305,0.0005000085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019275618,0.00050391495,0.012936778,0.00042715896,0.00012668101,0.000026239108,0.00015789327,0.00010749802,0.0028385792],"category_scores_gemma":[0.00019677333,0.00030144578,0.0019206925,0.0009595136,0.000049825314,0.00006165448,0.00013097617,0.0003995754,0.0000034428642],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012536342,0.00007280814,0.00034026158,0.78926784,0.1904015,0.0000032314415,0.000059393635,1.8142634e-8,1.2822052e-10,0.0000030045333,0.00027201785,0.019578673],"study_design_scores_gemma":[0.00019940856,0.00018096164,0.00013592937,0.0142573975,0.8295345,0.000053847623,0.00003100844,0.0000015055539,1.9928137e-9,0.0000015361134,0.15543811,0.00016583697],"about_ca_topic_score_codex":0.006078481,"about_ca_topic_score_gemma":0.0009502064,"teacher_disagreement_score":0.77501047,"about_ca_system_score_codex":0.00028689805,"about_ca_system_score_gemma":0.0021710668,"threshold_uncertainty_score":0.9999438},"labels":[],"label_agreement":null},{"id":"W4206898879","doi":"10.1016/j.pathol.2021.10.005","title":"The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes","year":2022,"lang":"en","type":"article","venue":"Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; University Health Network; Mount Sinai Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Concordance; Bladder cancer; Grading (engineering); Cohort; Pathological; Retrospective cohort study; Oncology; Internal medicine; Tumor grade; Urology; Cancer; Biology","score_opus":0.024333530539119987,"score_gpt":0.3432937106662726,"score_spread":0.31896018012715266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206898879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645257,0.0012816929,0.000032337066,0.00032066077,0.0003113815,0.00048106431,0.00013118968,0.000019025303,0.0009700785],"genre_scores_gemma":[0.99921894,0.0001596763,0.00014838371,0.000076347795,0.00010024613,0.00018304883,0.000021025673,0.000022010085,0.00007032605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870294,0.00012996177,0.00029657877,0.00028212264,0.0002897542,0.00029864468],"domain_scores_gemma":[0.9991724,0.000095970485,0.00021761918,0.00035266808,0.00008446068,0.00007690148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025733677,0.00016133713,0.00036928704,0.000083364466,0.00025772036,0.000004768637,0.00014993463,0.000034504457,0.00059364666],"category_scores_gemma":[0.00007750446,0.00010496591,0.00023183951,0.00018172935,0.00021798644,0.000032948054,0.00013122486,0.00026746863,0.0000023593095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041095107,0.0022119416,0.53333074,0.00024280374,0.0015178958,0.001165863,0.0022195315,0.00013032682,0.36352858,0.00025459784,0.0055869315,0.08570124],"study_design_scores_gemma":[0.0073327827,0.0070620677,0.66708946,0.00023645723,0.00049367547,0.0007095347,0.001114245,0.0015717533,0.3117626,0.0013792966,0.00086287904,0.00038522354],"about_ca_topic_score_codex":0.00019589126,"about_ca_topic_score_gemma":0.0000057161237,"teacher_disagreement_score":0.13375871,"about_ca_system_score_codex":0.00011430383,"about_ca_system_score_gemma":0.00037561517,"threshold_uncertainty_score":0.65000147},"labels":[],"label_agreement":null},{"id":"W4206946822","doi":"10.1371/journal.pone.0259992","title":"Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Faculty of Health Sciences, Queen's University; Queen's University","keywords":"Bladder cancer; Mutation; Gene; Biology; Genetics; Cancer; Bioinformatics; Computational biology","score_opus":0.04406808012286811,"score_gpt":0.25694459120199725,"score_spread":0.21287651107912914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206946822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911085,0.002251701,0.0000034347395,0.0021983753,0.00011635802,0.0009771581,0.00012650015,0.00007598882,0.0031420297],"genre_scores_gemma":[0.9916407,0.00035445008,0.0004727102,0.0010787958,0.00013698229,0.0013696515,0.00035610248,0.000043803055,0.0045467974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985583,0.00007593899,0.00027843422,0.00033110517,0.00052868767,0.00022757714],"domain_scores_gemma":[0.99946666,0.0000674377,0.00009853957,0.00017675785,0.00011125122,0.0000793295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000078034725,0.00015536058,0.00027632198,0.0001762552,0.00015471713,0.000009256066,0.00006930368,0.000055476296,0.0048254654],"category_scores_gemma":[0.000051751882,0.0001528413,0.00005732577,0.0003960181,0.000038053215,0.00008786891,0.000078482015,0.0002478687,0.000047133082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034854275,0.017575495,0.40628573,0.00078292086,0.0058757733,0.0016059708,0.013626179,0.0023061843,0.52474546,0.00083735934,0.002548159,0.02032533],"study_design_scores_gemma":[0.016836781,0.0034011123,0.86958885,0.0006013998,0.002100572,0.00010134246,0.0035810012,0.000865636,0.0991316,0.0021237286,0.00090031145,0.00076765596],"about_ca_topic_score_codex":0.0004109461,"about_ca_topic_score_gemma":0.00030453684,"teacher_disagreement_score":0.46330312,"about_ca_system_score_codex":0.00031085502,"about_ca_system_score_gemma":0.0004923471,"threshold_uncertainty_score":0.9960843},"labels":[],"label_agreement":null},{"id":"W4206991343","doi":"10.1016/s0302-2838(21)01139-8","title":"Oncological long-term benefit of re--resection in T1 bladder cancer: A population-based cohort study from Ontario","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cohort; Population; Term (time); Cohort study; Resection; Surgery; Oncology; Cancer; General surgery; Internal medicine; Environmental health","score_opus":0.028064904573314627,"score_gpt":0.3041125760296459,"score_spread":0.2760476714563313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206991343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915066,0.0002335268,0.000019996898,0.00038101876,0.00032291256,0.0005540608,0.000022198878,0.000030537045,0.006929178],"genre_scores_gemma":[0.99762046,0.000019282981,0.0000600715,0.0008826886,0.00016696003,0.000041068193,0.00019931396,0.00002700941,0.0009831623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984366,0.00033287902,0.0003737498,0.00045956916,0.00019636595,0.00020083498],"domain_scores_gemma":[0.99928755,0.00009695545,0.000102258775,0.00034487722,0.0000885514,0.00007984082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017455337,0.00015188979,0.0004166136,0.00008849039,0.00003784259,0.000007386639,0.00007891545,0.00007348818,0.0045852927],"category_scores_gemma":[0.000054705008,0.00013524349,0.00007704843,0.00016684174,0.00003447835,0.000027520213,0.000049941107,0.00025967357,0.00004739322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009508428,0.0012636945,0.99372643,0.0000072505622,0.00022795144,0.0011417989,0.00046551658,0.00022894138,0.0002511248,0.0000035719327,0.00008232235,0.0016505572],"study_design_scores_gemma":[0.0043966593,0.0014036534,0.9932542,0.000019402063,0.00032503868,0.0000109086795,0.000029841118,0.000023975217,0.00017740719,0.000021734848,0.00024171725,0.00009548504],"about_ca_topic_score_codex":0.057687897,"about_ca_topic_score_gemma":0.38944054,"teacher_disagreement_score":0.33175263,"about_ca_system_score_codex":0.0003137587,"about_ca_system_score_gemma":0.00025579345,"threshold_uncertainty_score":0.99632466},"labels":[],"label_agreement":null},{"id":"W4210324162","doi":"10.3390/curroncol29020060","title":"Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Immunotherapy; Malignancy; Immune checkpoint; Disease; Oncology; Metastatic Urothelial Carcinoma; Cancer research; Bioinformatics; Urothelial carcinoma; Internal medicine; Cancer; Bladder cancer; Biology","score_opus":0.1312594613536084,"score_gpt":0.45286424931664493,"score_spread":0.32160478796303654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210324162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015552933,0.9787975,0.0000026272119,0.0000784781,0.002888645,0.002125932,0.00020912482,0.000008758728,0.00033597936],"genre_scores_gemma":[0.0022896363,0.99680525,0.000014927812,0.000018128783,0.00023848086,0.00036471334,0.00020116744,0.000040154035,0.000027554437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965973,0.0006852168,0.0016498817,0.0005240653,0.00022191089,0.00032162174],"domain_scores_gemma":[0.99859715,0.00028238364,0.00064799696,0.0003513199,0.000030975403,0.000090177025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000698103,0.00036098092,0.0021204525,0.00025451952,0.000039298073,0.000005351792,0.00015237725,0.000171066,0.00013040494],"category_scores_gemma":[0.00011315006,0.0002481425,0.0005477643,0.00030813052,0.00023687074,0.000059512506,0.0002161117,0.0015026431,0.0000097074],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015582886,0.0018559612,0.012337272,0.0043424475,0.000034017816,0.00002722644,0.00018017813,5.515191e-7,7.861184e-7,0.00000912635,0.00004076826,0.98101586],"study_design_scores_gemma":[0.0035193297,0.00077266054,0.014200739,0.0032084158,0.00056481664,0.00009342206,0.000025708961,0.00000565424,0.000003994216,0.000093406976,0.9773304,0.00018146235],"about_ca_topic_score_codex":0.000025266456,"about_ca_topic_score_gemma":0.000106474894,"teacher_disagreement_score":0.98083436,"about_ca_system_score_codex":0.0010710025,"about_ca_system_score_gemma":0.0017213004,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W4210591696","doi":"10.1007/s00345-022-03940-5","title":"Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients","year":2022,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Chemotherapy; Cystectomy; Bladder cancer; Internal medicine; Interquartile range; Hazard ratio; Urology; Oncology; Proportional hazards model; Metastatic Urothelial Carcinoma; Metastasis; Gastroenterology; Cancer; Confidence interval; Urothelial carcinoma","score_opus":0.006241251561987509,"score_gpt":0.24488075274548568,"score_spread":0.23863950118349816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210591696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701726,0.0011608991,0.000020015472,0.00095811416,0.00020000777,0.0004924937,0.000029959552,0.0000015391591,0.00011971699],"genre_scores_gemma":[0.9991767,0.00008038616,0.00015863495,0.00047674988,0.00002978482,0.000014684032,0.0000013714107,0.00001829359,0.000043386644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835443,0.00045641809,0.00054927636,0.00014041866,0.0003227502,0.00017667354],"domain_scores_gemma":[0.99898666,0.00033486105,0.00040287848,0.00014479454,0.00004773847,0.00008307356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049959845,0.00014858956,0.0006884614,0.0002993844,0.000050189166,0.0000031704553,0.000119467535,0.000020534651,0.00014199645],"category_scores_gemma":[0.00006721522,0.00009361713,0.00011284554,0.0002697359,0.00021323776,0.00003311695,0.000070621965,0.00036089472,2.2454299e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015232429,0.0011525955,0.95596635,0.00033146102,0.0010405954,0.0005065858,0.0020456237,0.000093306495,0.004262793,0.000068013316,0.0003637498,0.01893651],"study_design_scores_gemma":[0.06591367,0.020811751,0.9002469,0.000084368454,0.0014998062,0.0029998093,0.000112973736,0.00043500672,0.0045711673,0.00039140543,0.0027552536,0.00017785523],"about_ca_topic_score_codex":0.00007859581,"about_ca_topic_score_gemma":0.000025291612,"teacher_disagreement_score":0.05571941,"about_ca_system_score_codex":0.00004678397,"about_ca_system_score_gemma":0.00014404005,"threshold_uncertainty_score":0.38175955},"labels":[],"label_agreement":null},{"id":"W4210644826","doi":"10.5489/cuaj.7430","title":"Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Canadian cost-effectiveness analysis","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Cost effectiveness; Cost-effectiveness analysis; Quality-adjusted life year; Quality of life (healthcare); Surgery; Oncology; Urology; Internal medicine; Cancer","score_opus":0.026175488820557237,"score_gpt":0.2903852196312787,"score_spread":0.26420973081072147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210644826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9365017,0.0025021317,0.00027325292,0.049706213,0.0014508199,0.0037347297,0.00342421,0.00007544841,0.002331498],"genre_scores_gemma":[0.9854326,0.00022739003,0.000057700578,0.011807151,0.0005937938,0.0010817486,0.00025079632,0.0000324937,0.00051630836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970929,0.000568397,0.0003892267,0.00041924402,0.0005652561,0.00096496026],"domain_scores_gemma":[0.99695385,0.00043302184,0.0002544768,0.00017382845,0.00037143633,0.0018134111],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001034563,0.00025519924,0.0006580083,0.0007803695,0.0012631065,0.000094736526,0.00021878773,0.00023662002,0.005864023],"category_scores_gemma":[0.00036593963,0.00022247597,0.000610146,0.0010205851,0.000046266334,0.00007938669,0.000016110767,0.00079644035,0.000014046896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012288118,0.0002114032,0.95167536,0.000010773468,0.0063306647,0.0004398238,0.00037897585,0.0012337319,0.00011852315,0.000114497205,0.022042198,0.016215267],"study_design_scores_gemma":[0.0067312946,0.0013133786,0.5839195,0.000005888412,0.001232983,0.00011512528,0.000101541686,0.00029252976,0.00004614485,0.00023025194,0.4057591,0.00025224496],"about_ca_topic_score_codex":0.27162218,"about_ca_topic_score_gemma":0.24516422,"teacher_disagreement_score":0.38371688,"about_ca_system_score_codex":0.0092669455,"about_ca_system_score_gemma":0.0074950587,"threshold_uncertainty_score":0.9981315},"labels":[],"label_agreement":null},{"id":"W4210680716","doi":"10.3390/curroncol29020052","title":"Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Proportional hazards model; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Multivariate analysis; Retrospective cohort study; Hazard ratio; Survival analysis; Epidemiology; Log-rank test; Surveillance, Epidemiology, and End Results; Cancer registry","score_opus":0.12406958932015336,"score_gpt":0.46737685952759805,"score_spread":0.34330727020744467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210680716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995205,0.0018516725,0.0000055555806,0.00059982034,0.0011166123,0.00040271643,0.00020572938,0.000016531856,0.0005963567],"genre_scores_gemma":[0.998294,0.00054122275,0.000045090153,0.0004499174,0.000059487516,0.0002957429,0.000103446066,0.000010663352,0.00020043053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987887,0.00013730463,0.0004006639,0.00027644253,0.0002326134,0.00016427484],"domain_scores_gemma":[0.9993781,0.00010982308,0.00016282342,0.00013822866,0.000105750005,0.00010529811],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015804508,0.00011031354,0.0006543494,0.00025683286,0.00006625159,0.0000024545675,0.00006263576,0.000048507987,0.0013509201],"category_scores_gemma":[0.000041438496,0.0000868129,0.0002371415,0.0004909215,0.00010565599,0.000027795753,0.00011978046,0.00020233769,0.0000022842366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018772169,0.002394302,0.90106076,0.000018463663,0.0026730543,0.0000031427935,0.00025188472,0.000002135275,0.000003078098,0.000029512106,0.0018185029,0.091557465],"study_design_scores_gemma":[0.002933067,0.0012781381,0.92797357,0.000004865308,0.005552802,9.081374e-7,0.000068260364,0.000066708344,0.000007416086,0.00001101966,0.062033948,0.000069307614],"about_ca_topic_score_codex":0.000115369185,"about_ca_topic_score_gemma":0.00004862677,"teacher_disagreement_score":0.09148816,"about_ca_system_score_codex":0.00014955498,"about_ca_system_score_gemma":0.00018592046,"threshold_uncertainty_score":0.99956197},"labels":[],"label_agreement":null},{"id":"W4210695409","doi":"10.1016/j.clgc.2022.01.011","title":"Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; Cystectomy; Proportional hazards model; Perioperative; Bladder cancer; Urothelial carcinoma; Urology; Oncology; Carcinoma; Cancer; Database; Internal medicine; Surgery","score_opus":0.07033369076109303,"score_gpt":0.4018111346463198,"score_spread":0.33147744388522676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210695409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352986,0.00055887416,0.000029364668,0.0028505346,0.00040488155,0.0008016313,0.0014619919,0.000012177336,0.0003507009],"genre_scores_gemma":[0.99579537,0.0004673601,0.00013621668,0.0008976747,0.0011508565,0.0004991556,0.00020459275,0.000025720323,0.0008230603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977323,0.00047214385,0.00052956486,0.00043561836,0.00061270426,0.00021771072],"domain_scores_gemma":[0.9987758,0.00055408024,0.0002334695,0.00017314943,0.00016035627,0.00010316482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006022,0.00015014461,0.00055144535,0.00014356572,0.00024054368,0.000012344262,0.00012736047,0.00010467931,0.00030746788],"category_scores_gemma":[0.00014749657,0.00012116482,0.00023775369,0.00052488927,0.00010699854,0.000109424196,0.00009974022,0.00039862725,1.5342971e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028930514,0.0003794485,0.9913164,0.00004555769,0.0014844951,0.0000026475452,0.00044397605,0.0003681291,0.00067111343,0.000012510291,0.0004959664,0.0018867259],"study_design_scores_gemma":[0.006781512,0.0010797482,0.9870578,0.000021854032,0.0013992431,0.0000012285199,0.00026603334,0.0015062899,0.00033384276,0.000038719783,0.0013865094,0.00012718579],"about_ca_topic_score_codex":0.0010654597,"about_ca_topic_score_gemma":0.0010513763,"teacher_disagreement_score":0.0042585456,"about_ca_system_score_codex":0.0012666764,"about_ca_system_score_gemma":0.0011590105,"threshold_uncertainty_score":0.4940958},"labels":[],"label_agreement":null},{"id":"W4210741025","doi":"10.1016/j.urolonc.2021.12.006","title":"Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeons","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Institute for Work & Health; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interrupted Time Series Analysis; Resection; Guideline; Bladder cancer; Poisson regression; Population; Autoregressive integrated moving average; Interrupted time series; Cohort; Surgery; Cancer; General surgery; Psychological intervention; Internal medicine; Time series; Pathology; Nursing","score_opus":0.024068480904417638,"score_gpt":0.31044619646088084,"score_spread":0.2863777155564632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210741025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977077,0.00025387417,0.000024219618,0.0011566133,0.00009864006,0.00032653107,0.00016301543,0.000025728903,0.00024367543],"genre_scores_gemma":[0.9975549,0.00006477594,0.0011729476,0.00023408831,0.00002239228,0.00021749127,0.00048837205,0.0000103983075,0.0002346373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986373,0.00023211406,0.00046578277,0.00029320514,0.00019083529,0.0001807185],"domain_scores_gemma":[0.99923766,0.00011739234,0.00026164856,0.00019793207,0.00006262611,0.00012275383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022891353,0.0001542283,0.00055358035,0.0005081293,0.0001504443,0.000004949675,0.00007567305,0.000107407664,0.000989605],"category_scores_gemma":[0.000047110632,0.00013470819,0.0001051153,0.00082924333,0.0002950542,0.000089993606,0.000036822657,0.0002365359,4.0175382e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050355494,0.00051133544,0.99256164,0.000023235913,0.00032816516,0.000018732206,0.00056325214,0.0039986637,0.0005827244,0.00023986207,0.00012477952,0.00054404075],"study_design_scores_gemma":[0.0012615233,0.0041833627,0.9803744,0.00002532217,0.0014803725,0.000013464508,0.00055502844,0.0074102026,0.0006777283,0.0009187834,0.0029724792,0.00012731785],"about_ca_topic_score_codex":0.004691663,"about_ca_topic_score_gemma":0.0064732525,"teacher_disagreement_score":0.012187239,"about_ca_system_score_codex":0.00022185818,"about_ca_system_score_gemma":0.00023545508,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W4211000488","doi":"10.1007/s00345-022-03948-x","title":"Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer","year":2022,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Cystectomy; Hazard ratio; Proportional hazards model; Internal medicine; Urology; Propensity score matching; Bladder cancer; Retrospective cohort study; Oncology; Lymph node; Confidence interval; Surgery; Chemotherapy; Cancer; Cisplatin","score_opus":0.012015857197243959,"score_gpt":0.2555887172330001,"score_spread":0.24357286003575612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211000488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307525,0.0011484347,0.00003780472,0.004068817,0.0009130748,0.00040362886,0.000030935847,0.000011350114,0.0003106932],"genre_scores_gemma":[0.99482185,0.000021499935,0.00026748574,0.00421788,0.00024743102,0.00008767773,0.000011814357,0.000037776383,0.00028656592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844986,0.00014648892,0.00042009781,0.00019625555,0.00051037094,0.0002768959],"domain_scores_gemma":[0.99926007,0.00007870516,0.00025946862,0.00016081678,0.00012202222,0.00011890253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016290457,0.00017824434,0.0004338299,0.0003426754,0.000049544044,0.0000067387778,0.00011028233,0.000048872505,0.0016973414],"category_scores_gemma":[0.000015578196,0.00013700177,0.00010316556,0.00037750552,0.00008160912,0.000058414582,0.000020040143,0.00053408754,0.0000024116134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.083642475,0.0008952983,0.8974229,0.000014481158,0.0003724159,0.0003551086,0.00038568777,0.0013312537,0.00013774965,0.000007677779,0.00075212406,0.014682793],"study_design_scores_gemma":[0.0594961,0.0061753397,0.895187,0.000029997636,0.0003030106,0.000031323638,0.000020407499,0.00019287175,0.00008005413,0.000020792204,0.038304977,0.00015808143],"about_ca_topic_score_codex":0.00012108293,"about_ca_topic_score_gemma":0.00030639037,"teacher_disagreement_score":0.037552856,"about_ca_system_score_codex":0.00044708105,"about_ca_system_score_gemma":0.0006712297,"threshold_uncertainty_score":0.99921525},"labels":[],"label_agreement":null},{"id":"W4211115520","doi":"10.1016/s0140-6736(16)30512-8","title":"Bladder cancer","year":2016,"lang":"en","type":"review","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1453,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Medicine; Bladder cancer; Cystectomy; Chemotherapy; Immunotherapy; Cisplatin; Disease; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.11013775783147689,"score_gpt":0.4052873629048735,"score_spread":0.2951496050733966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211115520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.7951823e-7,0.9684138,0.000003996654,0.0019386864,0.00044310413,0.0006912703,0.00030757076,0.000072123556,0.028129008],"genre_scores_gemma":[0.0000026227187,0.9747666,0.000020913978,0.0011409748,0.0060278377,0.00037717354,0.000026180605,0.00006178633,0.017575882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895775,0.00006715971,0.00022091273,0.00024768524,0.00018722368,0.00031924233],"domain_scores_gemma":[0.9988886,0.0000759802,0.00011597455,0.000815888,0.000028683753,0.00007488883],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000101351696,0.0002821697,0.0017482562,0.000036519916,0.00005626242,0.000016412261,0.00026866718,0.00014281043,0.0021261133],"category_scores_gemma":[0.000015867627,0.00010880925,0.0003355042,0.00011628651,0.00007053307,0.000019006866,0.00005045941,0.00025869644,0.001186564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020817755,0.000016111719,0.000012136701,0.0025767598,0.0006249089,0.000014882303,0.000018425993,3.2802532e-9,1.3022344e-7,0.00008641038,0.10468242,0.891947],"study_design_scores_gemma":[0.0007799747,0.000040952476,0.00002471958,0.012485417,0.0018883321,0.00006303424,0.0000013249265,5.211799e-8,0.0000012621217,0.000081218306,0.98450047,0.00013325225],"about_ca_topic_score_codex":0.000049963674,"about_ca_topic_score_gemma":0.000008393344,"teacher_disagreement_score":0.89181376,"about_ca_system_score_codex":0.00013046962,"about_ca_system_score_gemma":0.00039073845,"threshold_uncertainty_score":0.9995911},"labels":[],"label_agreement":null},{"id":"W4211150554","doi":"10.3390/curroncol29020080","title":"Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Nausea; Metastatic Urothelial Carcinoma; Adverse effect; Tolerability; Retrospective cohort study; Clinical endpoint; Cohort; Clinical trial; Surgery; Oncology; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","score_opus":0.08305809235798994,"score_gpt":0.4483409670874947,"score_spread":0.36528287472950477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211150554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956787,0.0009475053,9.654727e-7,0.00015722628,0.00095718016,0.0018640115,0.00012855152,0.000018889325,0.00024696082],"genre_scores_gemma":[0.99791443,0.0014437614,0.000023982026,0.00011826576,0.00011205408,0.00027727956,0.00006599409,0.000023642366,0.000020616113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767447,0.00040169279,0.00083748886,0.0004976411,0.0002741405,0.00031454637],"domain_scores_gemma":[0.99910986,0.00016876754,0.0002262167,0.00023445317,0.000072073904,0.00018862526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038945678,0.00017909287,0.00070386066,0.00022875155,0.00006407267,0.000002877623,0.00012530942,0.00007025003,0.00017116153],"category_scores_gemma":[0.00011870165,0.00016941389,0.000056313784,0.00034612167,0.000065861495,0.000054712535,0.00016751814,0.00047221186,0.0000013807066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070565874,0.012478468,0.8014012,0.00003102686,0.00003916235,0.00002183922,0.0015183621,0.0001327315,0.000007649727,0.000012811415,0.00003917255,0.17726101],"study_design_scores_gemma":[0.049661614,0.008923318,0.9375772,0.000038648453,0.000107974134,0.0000028304044,0.00055801636,0.00019011437,0.0000055125865,0.000017797984,0.002795988,0.000121028344],"about_ca_topic_score_codex":0.0006117562,"about_ca_topic_score_gemma":0.0007806298,"teacher_disagreement_score":0.17713998,"about_ca_system_score_codex":0.0006026982,"about_ca_system_score_gemma":0.0005668096,"threshold_uncertainty_score":0.6908498},"labels":[],"label_agreement":null},{"id":"W4212767446","doi":"10.1016/j.euf.2022.01.009","title":"Corrigendum to “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” [Eur Urol Focus 2021;7:1347–54]","year":2022,"lang":"en","type":"erratum","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Nomogram; Cystectomy; Medicine; Bladder cancer; Chemotherapy; Oncology; Cancer; Neoadjuvant therapy; Urology; Internal medicine; General surgery; Breast cancer","score_opus":0.025508313751692428,"score_gpt":0.30044375835053316,"score_spread":0.27493544459884073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212767446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58153903,0.076937236,0.0010683875,0.021873586,0.14357147,0.020897187,0.064863235,0.0010830739,0.08816682],"genre_scores_gemma":[0.9263447,0.01137311,0.0005635524,0.004836762,0.013781658,0.0028513423,0.0026596158,0.00085201464,0.03673728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937143,0.0007041523,0.0015112538,0.00214145,0.00090409623,0.0010247794],"domain_scores_gemma":[0.99651533,0.00018444244,0.000899448,0.0012548678,0.0004504599,0.00069545733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000742129,0.0010090903,0.0015574109,0.0005031664,0.00027838198,0.00007310713,0.0007376275,0.000495875,0.0028751371],"category_scores_gemma":[0.00022563347,0.0009525117,0.00047387704,0.00036290492,0.00058103446,0.0001545915,0.00038208454,0.0015583928,0.000019211733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029900389,0.0023050264,0.029065628,0.00046702745,0.01043419,0.004582461,0.0068967557,0.00009506646,0.001334559,0.000057670186,0.6403996,0.27446166],"study_design_scores_gemma":[0.016021827,0.005545863,0.12047272,0.00021733709,0.0017502926,0.00021243864,0.00016592332,0.00015361079,0.00047632685,0.00006107005,0.8540306,0.0008919905],"about_ca_topic_score_codex":0.0021625017,"about_ca_topic_score_gemma":0.0016278396,"teacher_disagreement_score":0.34480566,"about_ca_system_score_codex":0.00039993963,"about_ca_system_score_gemma":0.0009951972,"threshold_uncertainty_score":0.99929255},"labels":[],"label_agreement":null},{"id":"W4212793994","doi":"10.1016/j.urology.2020.04.134","title":"EDITORIAL COMMENT","year":2020,"lang":"es","type":"editorial","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Spina bifida; Surgery; Urinary diversion; Retrospective cohort study; General surgery; Internal medicine","score_opus":0.012544067721134524,"score_gpt":0.2869811005285457,"score_spread":0.27443703280741116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212793994","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010462592,0.0015540547,0.000046538833,0.019768972,0.96823245,0.0007777596,0.00072952185,0.00013707546,0.00874314],"genre_scores_gemma":[0.0023168284,0.0010220602,0.000021371528,0.0070067616,0.9870399,0.00013421212,0.001391263,0.00014014707,0.0009274503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962109,0.00026736667,0.00064135063,0.0010009735,0.0010749926,0.00080443214],"domain_scores_gemma":[0.9975874,0.0006852883,0.00028353403,0.0006394441,0.0002677075,0.00053663034],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017166854,0.000728401,0.0013976472,0.00013013186,0.00015205251,0.00004928829,0.0004316194,0.0022922123,0.0018293164],"category_scores_gemma":[0.00065229554,0.00066095614,0.00036260157,0.00016796775,0.0002413548,0.00004557423,0.00025259165,0.002080854,0.003780103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036412585,0.00035881446,0.00024789482,0.00018040629,0.0010565207,0.00020030062,0.00027873393,0.000002090306,0.000053333224,0.00012084796,0.99265325,0.00120654],"study_design_scores_gemma":[0.008306466,0.0068572927,0.00003792939,0.000044260858,0.0020709666,0.0000088848965,0.000021872827,0.00001309483,0.000047160578,0.00017860261,0.98200667,0.00040682027],"about_ca_topic_score_codex":0.00034882044,"about_ca_topic_score_gemma":0.000013494975,"teacher_disagreement_score":0.018807432,"about_ca_system_score_codex":0.00030665498,"about_ca_system_score_gemma":0.0013557121,"threshold_uncertainty_score":0.99958414},"labels":[],"label_agreement":null},{"id":"W4212853005","doi":"10.22374/jeleu.v5i1.136","title":"Bladder Melanosis","year":2022,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Melanosis; Dermatology; Biopsy; Urinary system; Urinary bladder; Differential diagnosis; Lower urinary tract symptoms; Pathology; Urology; Internal medicine; Cancer; Melanoma","score_opus":0.018294495607439894,"score_gpt":0.2794358224040536,"score_spread":0.2611413267966137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212853005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741208,0.0026121351,0.00017700953,0.0067588454,0.0015295398,0.00021200588,0.00002434756,0.000022597313,0.0145427035],"genre_scores_gemma":[0.9951541,0.00007677738,0.0006217984,0.002480782,0.0005055792,0.000016012344,0.000003666447,0.000021147413,0.0011201688],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986888,0.00013716321,0.00038829338,0.00012730621,0.0004090983,0.00024931305],"domain_scores_gemma":[0.9992255,0.000085232045,0.000271206,0.00014879351,0.00011240621,0.00015687438],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027414382,0.00011671039,0.0003948704,0.00022489144,0.00012416636,0.000006081978,0.00014585043,0.000039174607,0.0036954223],"category_scores_gemma":[0.000059165606,0.00009833638,0.0002481605,0.0001559769,0.00006201238,0.000053420008,0.000072745854,0.00054265297,0.000018072205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048202198,0.00984679,0.3774222,0.00020025329,0.009491491,0.050579634,0.0051069697,0.0010717023,0.10339327,0.0041793874,0.28189382,0.10861227],"study_design_scores_gemma":[0.02051209,0.029407674,0.07839106,0.000019625348,0.0021184941,0.107887596,0.0011955696,0.000069038535,0.0076727537,0.001265406,0.75111574,0.00034493912],"about_ca_topic_score_codex":0.000028400245,"about_ca_topic_score_gemma":0.0000023877622,"teacher_disagreement_score":0.46922192,"about_ca_system_score_codex":0.000116643896,"about_ca_system_score_gemma":0.00027214817,"threshold_uncertainty_score":0.99721533},"labels":[],"label_agreement":null},{"id":"W4212908656","doi":"10.1200/jco.2022.40.6_suppl.454","title":"Effect of neoadjuvant chemotherapy (NAC) on patient preferences for adjuvant treatment in muscle-invasive urothelial carcinoma (MIUC): A multi-country discrete choice experiment (DCE).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Regimen; Interim analysis; Adjuvant; Oncology; Adjuvant therapy; Cancer; Randomized controlled trial","score_opus":0.07644560047612209,"score_gpt":0.44121323392000267,"score_spread":0.3647676334438806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212908656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937705,0.0012441507,0.00002125019,0.0010403541,0.0014344532,0.0020138253,0.00014317913,0.000008431735,0.00032386064],"genre_scores_gemma":[0.99667305,0.00044855403,0.0005763904,0.0011497174,0.00056492136,0.00042163618,0.000017027663,0.000039169277,0.000109562425],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.995655,0.0009135116,0.0021235782,0.00038443282,0.00056531857,0.00035814074],"domain_scores_gemma":[0.9942468,0.0034878673,0.0015437655,0.000286366,0.00014900826,0.00028619345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012185103,0.0003235996,0.0021753763,0.00019480388,0.000079935395,0.00000626486,0.00020600857,0.00019957586,0.00019936601],"category_scores_gemma":[0.0007337082,0.00020431678,0.00076973304,0.00013525673,0.00013523645,0.000057967172,0.00005622455,0.0005569974,0.0000023075531],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10283704,0.018538816,0.15792385,0.00019447907,0.0014421094,0.0007864121,0.0036827414,0.0004251807,0.004232833,0.000018679924,0.00070296775,0.70921487],"study_design_scores_gemma":[0.12152934,0.58280563,0.22222991,0.00028934696,0.00093879824,0.00012310586,0.0009803132,0.00025434344,0.0347761,0.00005083331,0.035705127,0.0003171749],"about_ca_topic_score_codex":0.0005305312,"about_ca_topic_score_gemma":0.00019838118,"teacher_disagreement_score":0.7088977,"about_ca_system_score_codex":0.0010035865,"about_ca_system_score_gemma":0.0020316085,"threshold_uncertainty_score":0.83317965},"labels":[],"label_agreement":null},{"id":"W4212922210","doi":"10.1200/jco.2022.40.6_suppl.tps587","title":"Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Oncology; Internal medicine; Cohort; Cancer; Durvalumab; Lymph node; Cisplatin; Perioperative; Urology; Chemotherapy; Surgery; Pembrolizumab; Immunotherapy","score_opus":0.2125772542963511,"score_gpt":0.542032694900749,"score_spread":0.3294554406043979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212922210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989147,0.0012466777,0.0000029897515,0.0030320953,0.00176933,0.0027269751,0.000010019224,0.000010278543,0.0013101528],"genre_scores_gemma":[0.9947034,0.00062007114,0.0005077839,0.0019824188,0.0011527052,0.00070171437,0.0000042594247,0.000039573944,0.00028809087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935489,0.0017117276,0.0030113414,0.00042028213,0.0009120862,0.00039560965],"domain_scores_gemma":[0.9966406,0.0011775396,0.0013463866,0.00024489776,0.00035091102,0.00023966917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005662004,0.00024570807,0.0019240744,0.00032992256,0.000110253524,0.000018602754,0.00026025902,0.00019300543,0.0013972087],"category_scores_gemma":[0.0013043195,0.00019036148,0.000350946,0.00047703067,0.000147003,0.00015429204,0.00010011803,0.001773524,0.0000060348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09442851,0.011506382,0.80519104,0.00001215617,0.000848132,0.0020164945,0.004850422,0.00079531595,0.00008995085,0.000008878506,0.000588031,0.07966471],"study_design_scores_gemma":[0.25320467,0.09439513,0.6404054,0.00009772166,0.0005045323,0.00011034022,0.0058285818,0.0002461986,0.000065356944,0.00010204213,0.004816878,0.00022313422],"about_ca_topic_score_codex":0.0008553047,"about_ca_topic_score_gemma":0.0020847516,"teacher_disagreement_score":0.16478561,"about_ca_system_score_codex":0.0011348759,"about_ca_system_score_gemma":0.008642611,"threshold_uncertainty_score":0.99951565},"labels":[],"label_agreement":null},{"id":"W4212936557","doi":"10.1200/jco.2022.40.6_suppl.521","title":"First-line pembrolizumab in advanced urothelial carcinoma: Clinical parameters associated with efficacy in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-361 trials.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Urothelial carcinoma; Pembrolizumab; Population; Clinical trial; Multivariate analysis; Logistic regression; Univariate analysis; Cisplatin; Proportional hazards model; Exploratory analysis; Cancer; Chemotherapy; Bladder cancer; Immunotherapy","score_opus":0.21384800772911303,"score_gpt":0.5081010446714576,"score_spread":0.2942530369423445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212936557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868402,0.00078714977,0.00006148798,0.009569261,0.0011347283,0.001235807,0.00006779421,0.000012595009,0.00029101595],"genre_scores_gemma":[0.99353296,0.00070524524,0.00051165547,0.0043400335,0.0007183294,0.00006210885,0.000020901043,0.000039554205,0.00006922995],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98835576,0.0050053834,0.0048836353,0.00048080902,0.00078792055,0.0004864685],"domain_scores_gemma":[0.979926,0.016371166,0.0026968692,0.00037460218,0.00019678306,0.0004345937],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0151571715,0.00032334542,0.0034480062,0.0002835602,0.00013846146,0.000021057815,0.00036661947,0.0003772688,0.00018982147],"category_scores_gemma":[0.016044231,0.00019488775,0.0007220377,0.000509451,0.00041022227,0.00012863062,0.000099665245,0.0030783468,0.0000031588584],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38120043,0.07386334,0.18597531,0.00004052852,0.0012944086,0.012083099,0.001543235,0.0009354881,0.000049195918,0.000036784222,0.0015361533,0.341442],"study_design_scores_gemma":[0.49522611,0.15549454,0.32704398,0.00015677209,0.0015351039,0.0008110449,0.0005342043,0.00081215554,0.000023164148,0.00031401918,0.017762108,0.00028677873],"about_ca_topic_score_codex":0.0001207609,"about_ca_topic_score_gemma":0.0003436992,"teacher_disagreement_score":0.34115523,"about_ca_system_score_codex":0.00043831213,"about_ca_system_score_gemma":0.0024396414,"threshold_uncertainty_score":0.99922156},"labels":[],"label_agreement":null},{"id":"W4212984292","doi":"10.1200/jco.2022.40.6_suppl.528","title":"Biomarker analysis and updated clinical follow-up from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Oncology; Nivolumab; Internal medicine; Biomarker; Clinical endpoint; Cisplatin; Cancer; Urology; Clinical trial; Chemotherapy; Immunotherapy","score_opus":0.060952022965494866,"score_gpt":0.39643526319870204,"score_spread":0.3354832402332072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212984292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551016,0.0010435139,0.00011290168,0.0011277379,0.0011165793,0.0007033908,0.00016886675,0.000010007097,0.00020684136],"genre_scores_gemma":[0.9962437,0.0012256954,0.0007117741,0.0011033347,0.00042353995,0.000049179216,0.000038365455,0.000043619482,0.00016079747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99349535,0.0012861671,0.003415958,0.00059609115,0.00082319946,0.00038323956],"domain_scores_gemma":[0.9922501,0.0037067318,0.002818517,0.00027841312,0.00052062963,0.00042560036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021844048,0.00032480233,0.002909498,0.0005159186,0.00011978566,0.00001893366,0.00018615933,0.0003720386,0.0012098302],"category_scores_gemma":[0.0008202392,0.00024184152,0.0005854858,0.00092082034,0.00035824344,0.00018115461,0.00019011025,0.0012133555,7.5227337e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093118526,0.0019844044,0.8461787,0.00002520212,0.009278913,0.00020956344,0.00025438474,0.00008734572,0.00006392421,0.0000019684,0.00055564346,0.048241407],"study_design_scores_gemma":[0.18290864,0.014490883,0.79319936,0.00012700712,0.007290167,0.0000098461,0.00033466876,0.0003855838,0.000016324137,0.00005304095,0.0009820567,0.00020243815],"about_ca_topic_score_codex":0.0028501484,"about_ca_topic_score_gemma":0.011342368,"teacher_disagreement_score":0.08979011,"about_ca_system_score_codex":0.0003358214,"about_ca_system_score_gemma":0.0029402075,"threshold_uncertainty_score":0.9997032},"labels":[],"label_agreement":null},{"id":"W4213036174","doi":"10.5489/cuaj.7810","title":"Building the Canadian Bladder Cancer Research Network (CBCRN): Progress During a Pandemic","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McGill University Health Centre; University of Calgary; Atlantic Cancer Research Institute; University of British Columbia","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Pandemic; Bladder cancer; Cancer; Coronavirus disease 2019 (COVID-19); Medicine; Political science; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.04416034716089389,"score_gpt":0.33291003740504865,"score_spread":0.28874969024415476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213036174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90652704,0.003286281,0.0000021511796,0.08614156,0.00087429944,0.000626664,0.00010131774,0.00003503081,0.0024056453],"genre_scores_gemma":[0.99073935,0.000115571784,0.00005389912,0.0058152024,0.0017421637,0.0002393842,0.000008029607,0.000025624493,0.0012607813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637026,0.00064345135,0.00028905482,0.00026381615,0.00093981443,0.0014936008],"domain_scores_gemma":[0.9979892,0.00013665477,0.00014332621,0.00016392475,0.00033344555,0.0012334576],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023106972,0.00014831412,0.00023139159,0.00026797818,0.0052110236,0.00018457767,0.0002978055,0.00016134181,0.0033327613],"category_scores_gemma":[0.00022040184,0.00010726378,0.00013108592,0.00075539306,0.00008807325,0.000063674604,0.00006237615,0.0022820104,0.00002272821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008393218,0.000023968982,0.9631071,0.0000027648887,0.00028854344,0.0003195899,0.00028153046,0.0006012204,0.000022691433,0.00025398572,0.031626705,0.0033879483],"study_design_scores_gemma":[0.0010138664,0.00022853854,0.74897194,0.000011871403,0.00009331566,0.00052715966,0.0001566609,0.000065494474,0.0000057375123,0.0012449045,0.24755314,0.00012734531],"about_ca_topic_score_codex":0.29397303,"about_ca_topic_score_gemma":0.5369332,"teacher_disagreement_score":0.24296016,"about_ca_system_score_codex":0.010717012,"about_ca_system_score_gemma":0.0050772596,"threshold_uncertainty_score":0.9975783},"labels":[],"label_agreement":null},{"id":"W4213040106","doi":"10.1200/jco.2022.40.6_suppl.493","title":"Atezolizumab (atezo) with or without Bacille Calmette-Guérin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Cohort; Bladder cancer; Atezolizumab; Urology; Cystectomy; Internal medicine; Carcinoma in situ; Cancer; Oncology; Surgery; Immunotherapy; Pembrolizumab","score_opus":0.07484964919512821,"score_gpt":0.4236228981067292,"score_spread":0.348773248911601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213040106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938804,0.00015588892,0.000017013823,0.0021730498,0.0010013384,0.0014400522,0.0006833445,0.000022175087,0.00062675064],"genre_scores_gemma":[0.99506986,0.0003136149,0.0010239193,0.0018449845,0.0008037142,0.00015533493,0.000055590324,0.00007656672,0.0006564027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99337244,0.0012245649,0.0028550527,0.0007183921,0.0012821585,0.0005474168],"domain_scores_gemma":[0.99403346,0.0015403023,0.0027204219,0.0005263519,0.00058797887,0.0005914638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015755779,0.00043337978,0.0026368455,0.00028014247,0.00025833258,0.000017285838,0.0003685492,0.00024616942,0.0013234211],"category_scores_gemma":[0.0009909885,0.00025253656,0.00027273523,0.0005495764,0.0002394929,0.00019685342,0.0002220102,0.0021817966,0.000012051621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26874232,0.027190553,0.6167679,0.000012339862,0.0027926445,0.0040610856,0.0023406153,0.00038469385,0.000008820594,0.0000013480909,0.002664911,0.07503279],"study_design_scores_gemma":[0.26540282,0.27020973,0.450021,0.00016501891,0.0021570916,0.00010677619,0.0019342507,0.000048417653,0.000052354808,0.000030061166,0.009561091,0.00031138846],"about_ca_topic_score_codex":0.0091076,"about_ca_topic_score_gemma":0.01467236,"teacher_disagreement_score":0.24301918,"about_ca_system_score_codex":0.0010162127,"about_ca_system_score_gemma":0.0052112653,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W4213046634","doi":"10.1200/jco.2022.40.6_suppl.tps600","title":"A prospective, single-center, phase II randomized controlled trial to evaluate the safety, feasibility, and preliminary efficacy of exercise during intravesical therapy for nonmuscle invasive bladder cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Randomized controlled trial; Quality of life (healthcare); Adverse effect; Cancer; Internal medicine; Urology; Surgery; Urinary system","score_opus":0.11565192505267594,"score_gpt":0.46069845958973743,"score_spread":0.34504653453706147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213046634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732544,0.0020864569,0.0000451752,0.0079651475,0.0013199657,0.015103473,0.000045917,0.000007471729,0.00017201446],"genre_scores_gemma":[0.99446845,0.0020484198,0.00033206868,0.0008248803,0.00085439376,0.0012806992,0.0000029919713,0.00002640916,0.0001616937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99453795,0.0014488315,0.002871776,0.00031749866,0.00056036905,0.0002635699],"domain_scores_gemma":[0.9896779,0.007789757,0.0014584962,0.0002383096,0.0005314658,0.00030406337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061777714,0.00021800383,0.0039273812,0.00011556301,0.00025618591,0.00000994286,0.00021471047,0.00013590335,0.00027240335],"category_scores_gemma":[0.005657587,0.00011915393,0.0012628881,0.00014467527,0.00035743602,0.00006109295,0.00017897652,0.0006256331,3.88185e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93664527,0.021405982,0.0009931225,0.000030507634,0.0020821926,0.000048959664,0.0010908626,0.000030103078,0.0007024622,0.000014384897,0.00034090702,0.03661524],"study_design_scores_gemma":[0.85856825,0.13128923,0.0064925626,0.00010302707,0.0020768472,0.00009839817,0.0001580414,0.000060952334,0.0003629799,0.00032215833,0.00037758634,0.000089970876],"about_ca_topic_score_codex":0.00002545402,"about_ca_topic_score_gemma":0.000014692562,"teacher_disagreement_score":0.109883256,"about_ca_system_score_codex":0.00034846543,"about_ca_system_score_gemma":0.0021086822,"threshold_uncertainty_score":0.6773069},"labels":[],"label_agreement":null},{"id":"W4213072175","doi":"10.1200/jco.2022.40.6_suppl.487","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up results from the JAVELIN Bladder 100 trial.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Randomization; Clinical endpoint; Urology; Randomized controlled trial; Progression-free survival; Oncology; Carboplatin; Gemcitabine; Chemotherapy; Surgery; Bladder cancer; Urothelial carcinoma; Cisplatin; Nivolumab; Immunotherapy; Cancer","score_opus":0.13200194208637328,"score_gpt":0.42959722158729624,"score_spread":0.29759527950092296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213072175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414519,0.0011367048,0.00095258775,0.04025677,0.012006713,0.0022675921,0.0007619316,0.00002591966,0.0011398996],"genre_scores_gemma":[0.9781856,0.00069410045,0.0014949904,0.008362228,0.006434861,0.00017779767,0.00007982918,0.00006545343,0.0045051277],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99395645,0.000676673,0.0035337682,0.000523175,0.0007498309,0.0005600956],"domain_scores_gemma":[0.9893405,0.0066382103,0.0024415688,0.00060395605,0.00056804,0.00040775858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038258093,0.00031614158,0.0019331134,0.00009214859,0.00037127867,0.000020269104,0.0005927302,0.0003094093,0.00069713395],"category_scores_gemma":[0.0063137906,0.00019857715,0.0013663059,0.00020333908,0.000239706,0.00010887555,0.000200023,0.0015136217,0.00002303092],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78347784,0.0038984728,0.011391873,0.000021901265,0.0014025129,0.0010629167,0.0006205441,0.000106142106,0.00009711079,0.000047065987,0.041897304,0.15597633],"study_design_scores_gemma":[0.581315,0.066577524,0.089432135,0.00011264727,0.0019270205,0.00034646224,0.00031013635,0.0001448038,0.00015243293,0.0010438483,0.25833666,0.00030130724],"about_ca_topic_score_codex":0.00016976781,"about_ca_topic_score_gemma":0.00040648677,"teacher_disagreement_score":0.21643937,"about_ca_system_score_codex":0.00048589325,"about_ca_system_score_gemma":0.0031389575,"threshold_uncertainty_score":0.80977416},"labels":[],"label_agreement":null},{"id":"W4213073484","doi":"10.1200/jco.2022.40.6_suppl.516","title":"Impact of primary tumor location on efficacy and safety of pembrolizumab (pembro) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) enrolled in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-045 trials.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Docetaxel; Pembrolizumab; Metastatic Urothelial Carcinoma; Phases of clinical research; Primary tumor; Internal medicine; Oncology; Clinical trial; Urology; Surgery; Chemotherapy; Cancer; Urothelial carcinoma; Metastasis; Bladder cancer; Immunotherapy","score_opus":0.09334664641587365,"score_gpt":0.4576947460580274,"score_spread":0.36434809964215376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213073484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968281,0.00038585835,0.0000882697,0.0005305886,0.0001715568,0.0017262462,0.00008790479,0.0000029649038,0.00017855495],"genre_scores_gemma":[0.9983725,0.0002130201,0.00047620133,0.0007381509,0.00010842678,0.00003409342,0.000017048946,0.000024116183,0.000016461254],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99332535,0.0023334576,0.003138389,0.00028393703,0.00065503235,0.00026383038],"domain_scores_gemma":[0.9921151,0.0047244728,0.0024191139,0.0002483867,0.000285296,0.00020762185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004705564,0.00024673188,0.0026926342,0.00032540594,0.000056324563,0.00000622485,0.00017919831,0.00009702726,0.00011989421],"category_scores_gemma":[0.0032978463,0.00013043133,0.00027895655,0.00041003566,0.0002559482,0.000110459376,0.00005750928,0.0008643803,4.006487e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73625743,0.023779687,0.050189093,0.000116413656,0.00052607065,0.0005183547,0.000816218,0.0004921284,0.0002772314,0.000009515308,0.00007159522,0.18694629],"study_design_scores_gemma":[0.3469357,0.18293107,0.4684477,0.00015104267,0.0006349301,0.00017366308,0.0001879287,0.00014522861,0.00006109089,0.000040782466,0.00019595328,0.00009495713],"about_ca_topic_score_codex":0.00012291511,"about_ca_topic_score_gemma":0.000045385023,"teacher_disagreement_score":0.41825858,"about_ca_system_score_codex":0.00042815015,"about_ca_system_score_gemma":0.003565136,"threshold_uncertainty_score":0.63243985},"labels":[],"label_agreement":null},{"id":"W4213073706","doi":"10.1200/jco.2022.40.6_suppl.437","title":"BAYOU: A phase II, randomized, multicenter, double-blind, study of durvalumab (D) in combination with olaparib (O) for the first-line treatment of platinum-ineligible patients with unresectable, stage IV urothelial carcinoma (UC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Population; Olaparib; Oncology; PARP inhibitor; Phases of clinical research; Gastroenterology; Chemotherapy; Surgery; Urology; Randomized controlled trial; Poly ADP ribose polymerase","score_opus":0.10989278370184659,"score_gpt":0.43211884893655506,"score_spread":0.3222260652347085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213073706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189585,0.00033017097,0.00018427125,0.00066284527,0.00043924636,0.0062204544,0.00009854795,0.000004854086,0.00016373693],"genre_scores_gemma":[0.99842334,0.00013857847,0.0003177492,0.00015117099,0.00015586868,0.0004789142,0.000026232306,0.000032292453,0.00027587533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956304,0.0005370895,0.002500856,0.00026819643,0.0007880656,0.00027539764],"domain_scores_gemma":[0.99366826,0.0027539378,0.0024889724,0.00029804633,0.0006506342,0.00014013993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002250953,0.0002448922,0.0024275521,0.00024769953,0.00016606697,0.000006743582,0.00021632019,0.00010579176,0.00013353603],"category_scores_gemma":[0.00033307116,0.000125354,0.0003706919,0.00030704582,0.00019823013,0.00010083392,0.000071566894,0.00040986403,2.6877157e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71406627,0.07278608,0.20075057,0.0000420753,0.0014179376,0.00007998071,0.0016587623,0.0007945747,0.0000064480973,0.00001502908,0.00003616774,0.008346098],"study_design_scores_gemma":[0.7258765,0.23965546,0.029169245,0.000044579672,0.0016952415,0.000014928658,0.0008091889,0.00083148724,0.000079034064,0.000013951766,0.0017280998,0.0000822832],"about_ca_topic_score_codex":0.0013058698,"about_ca_topic_score_gemma":0.0014965917,"teacher_disagreement_score":0.17158133,"about_ca_system_score_codex":0.00036415877,"about_ca_system_score_gemma":0.0011752999,"threshold_uncertainty_score":0.5111788},"labels":[],"label_agreement":null},{"id":"W4213139730","doi":"10.1200/jco.2022.40.6_suppl.505","title":"Association of time to second-line (2L) immune-checkpoint inhibitors (ICI) and outcomes with ICIs in patients (pts) with advanced urothelial carcinoma (aUC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Cisplatin; Cohort; Proportional hazards model; Progression-free survival; Cancer; Retrospective cohort study; Carboplatin; Logistic regression; Hazard ratio; Confidence interval","score_opus":0.025143724840372726,"score_gpt":0.35011932856241934,"score_spread":0.3249756037220466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213139730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946024,0.00008915337,0.0000070858514,0.0036942335,0.00030965407,0.00047556835,0.00003527039,0.0000048722604,0.00078176084],"genre_scores_gemma":[0.9963754,0.000019960542,0.0008345859,0.001276521,0.00014591505,0.000017100661,0.000006673805,0.000023569437,0.0013003147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690056,0.00031051598,0.0018063578,0.00019937126,0.000569588,0.00021359192],"domain_scores_gemma":[0.99704677,0.000637451,0.001628279,0.00014354028,0.00033476902,0.00020916256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001447647,0.00015790628,0.0014323212,0.0001856397,0.000041739986,0.0000040982786,0.00009770888,0.00012741426,0.000595367],"category_scores_gemma":[0.0006581974,0.000103134706,0.00018746847,0.00020148832,0.000060900722,0.00008764276,0.00007391155,0.0006721838,0.0000059098134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018595828,0.0021539703,0.9579097,0.000020541702,0.00039898895,0.00010899286,0.00031818709,0.000084806394,0.00022685259,0.0000015089737,0.0004120747,0.019768529],"study_design_scores_gemma":[0.032667384,0.06288477,0.89684135,0.000057125653,0.00031587857,0.000036430298,0.00013931672,0.0000110306955,0.00039189233,0.000021510232,0.006531158,0.00010213887],"about_ca_topic_score_codex":0.00008160166,"about_ca_topic_score_gemma":0.00013920236,"teacher_disagreement_score":0.061068356,"about_ca_system_score_codex":0.00054013985,"about_ca_system_score_gemma":0.000893969,"threshold_uncertainty_score":0.6518851},"labels":[],"label_agreement":null},{"id":"W4213155579","doi":"10.1200/jco.2022.40.6_suppl.540","title":"Association of TMB and PD-L1 with efficacy of first-line pembrolizumab (pembro) or pembro + chemotherapy (chemo) versus chemo in patients (pts) with advanced urothelial carcinoma (UC) from KEYNOTE-361.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Logistic regression; Oncology; Pembrolizumab; Cancer; Immunotherapy","score_opus":0.045399942099561205,"score_gpt":0.37121616113505207,"score_spread":0.32581621903549085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213155579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960678,0.00018588256,0.000025922978,0.0019685365,0.0005713644,0.0005964962,0.00007717364,0.000007777498,0.0004990458],"genre_scores_gemma":[0.9968868,0.00033372885,0.0015553472,0.0005229043,0.0003980021,0.000017900868,0.000022451464,0.000044837147,0.00021805242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963452,0.00031486183,0.001842733,0.0003356147,0.00084828,0.00031330177],"domain_scores_gemma":[0.9942981,0.0021152983,0.0026131915,0.00026235756,0.00048365394,0.00022740403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008672452,0.00025648504,0.0019266066,0.00016492454,0.00006284087,0.0000051687425,0.00019772102,0.0002568024,0.00042483263],"category_scores_gemma":[0.0009839572,0.00017236799,0.00024234806,0.0003052678,0.00016409432,0.000113529444,0.00007403526,0.00086807087,0.0000010820637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39633045,0.005427668,0.5631383,0.000055833683,0.00092371873,0.000092090806,0.0005284115,0.00013256932,0.00012330341,0.000002098942,0.00031537635,0.032930218],"study_design_scores_gemma":[0.21720515,0.069638506,0.70750964,0.000116782016,0.00070453255,0.000027748083,0.00023712467,0.00006908593,0.0007986529,0.00002140543,0.003521008,0.00015038466],"about_ca_topic_score_codex":0.000361617,"about_ca_topic_score_gemma":0.00043501423,"teacher_disagreement_score":0.17912528,"about_ca_system_score_codex":0.000733755,"about_ca_system_score_gemma":0.0015126168,"threshold_uncertainty_score":0.70289624},"labels":[],"label_agreement":null},{"id":"W4213178610","doi":"10.1200/jco.2022.40.6_suppl.467","title":"Use of perioperative treatment (tx) among patients (pts) undergoing radical resection (RR) for muscle-invasive urothelial cancer (MIUC) in France, Germany, Italy, Spain, the United Kingdom, the United States, Canada, China, and Japan.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perioperative; Internal medicine; Cancer; Cisplatin; Disease; Chemotherapy; Surgery","score_opus":0.08708786525005241,"score_gpt":0.38404967564862247,"score_spread":0.29696181039857006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213178610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996735,0.0001844432,0.000025259347,0.0075866664,0.00088908104,0.0010950604,0.00019425571,0.000004143229,0.000053723983],"genre_scores_gemma":[0.99478364,0.0012246742,0.000069953094,0.0030543613,0.00036316636,0.00013513619,0.000051115545,0.000028136052,0.00028983335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996414,0.0011393228,0.0014184616,0.00024189675,0.0004931304,0.0002932002],"domain_scores_gemma":[0.993888,0.0042501786,0.0010793126,0.00019684626,0.00038882167,0.00019681283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010599649,0.0002093629,0.0008978357,0.00021064392,0.0003110865,0.0000169286,0.00016421768,0.00013769059,0.00010359588],"category_scores_gemma":[0.0012052116,0.00011468662,0.00022998905,0.00042210665,0.00038933533,0.00009741283,0.00007579795,0.0008194694,1.5987182e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015910914,0.0042068255,0.9310762,0.0000959584,0.002723867,0.00031061075,0.0065082344,0.011868407,0.000090330395,0.00020684046,0.0037069719,0.023294797],"study_design_scores_gemma":[0.020387322,0.019280048,0.84466654,0.0001351734,0.00067180797,0.000042085678,0.0013466123,0.0018249542,0.00006194878,0.00004346841,0.11140836,0.00013168051],"about_ca_topic_score_codex":0.35837853,"about_ca_topic_score_gemma":0.36014658,"teacher_disagreement_score":0.10770139,"about_ca_system_score_codex":0.0011703518,"about_ca_system_score_gemma":0.004291471,"threshold_uncertainty_score":0.7612886},"labels":[],"label_agreement":null},{"id":"W4213258321","doi":"10.3390/curroncol29030114","title":"Methods of Sentinel Lymph Node Detection and Management in Urinary Bladder Cancer—A Narrative Review","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Positron emission tomography; Lymph node; Radiology; Bladder cancer; Magnetic resonance imaging; Sentinel lymph node; Urinary system; Sentinel node; Cancer; Pathology; Internal medicine; Breast cancer","score_opus":0.2086248246010019,"score_gpt":0.5274564463661121,"score_spread":0.3188316217651102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213258321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016787773,0.99381065,0.000042536012,0.00010748985,0.0010783897,0.002034081,0.000033468124,0.000019881543,0.0028566942],"genre_scores_gemma":[0.0000034165555,0.99624217,0.00042453196,0.00015257382,0.00012228817,0.002717237,0.000086816326,0.000038788377,0.0002121762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973656,0.00087761646,0.0007729078,0.00053686614,0.00019163066,0.00025536615],"domain_scores_gemma":[0.99893963,0.00015236788,0.00047190915,0.00030439376,0.00003997578,0.000091733746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004912759,0.00036983087,0.002328137,0.00031416054,0.000054073476,0.000002820686,0.00011519379,0.0001503897,0.0006904008],"category_scores_gemma":[0.000037485745,0.00030086897,0.00030093288,0.00050932675,0.00008787199,0.0000289874,0.00021568479,0.0004295835,0.0000040697746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043597873,0.0005416779,0.00012091129,0.098205425,0.0005660215,0.00006605132,0.00014295077,7.057037e-8,3.0660314e-7,0.000007772415,0.00033878064,0.8999664],"study_design_scores_gemma":[0.0013970723,0.00020333129,0.00047425073,0.025648585,0.004955646,0.00021575333,0.000084857624,0.0000045854963,9.123776e-7,0.000015613996,0.96680796,0.00019146013],"about_ca_topic_score_codex":0.000048148642,"about_ca_topic_score_gemma":0.0000056824724,"teacher_disagreement_score":0.96646917,"about_ca_system_score_codex":0.0009989237,"about_ca_system_score_gemma":0.00047331396,"threshold_uncertainty_score":0.9999443},"labels":[],"label_agreement":null},{"id":"W4213275011","doi":"10.1200/jco.2022.40.6_suppl.433","title":"Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Sinai Health System; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Clinical endpoint; Oncology; Urology; Stage (stratigraphy); Randomized controlled trial; Internal medicine; Surgery; Cancer","score_opus":0.22967271024806532,"score_gpt":0.5197063525925104,"score_spread":0.29003364234444506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213275011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98045605,0.0012444075,0.003195186,0.0113801565,0.0022640426,0.0010329372,0.00014240418,0.000011070716,0.00027373922],"genre_scores_gemma":[0.9858325,0.00022702436,0.008687509,0.0040174844,0.0009561722,0.0001243555,0.00000891469,0.00001747133,0.00012852815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996415,0.00043294657,0.0021531752,0.00022981767,0.0005381525,0.0002308928],"domain_scores_gemma":[0.99601084,0.001691385,0.0012618846,0.0001742113,0.0004702364,0.00039144247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001845262,0.00015686965,0.0018616489,0.00011527326,0.00012352296,0.0000037770028,0.00022409312,0.00018761533,0.0005982365],"category_scores_gemma":[0.0012284531,0.000109894674,0.00076212035,0.0001783788,0.0002165189,0.000048144062,0.000062830375,0.00070747506,0.0000029091836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10171262,0.037422664,0.332769,0.00018937839,0.006211329,0.00049339136,0.002754322,0.0020417098,0.016030565,0.00051493646,0.033093624,0.46676645],"study_design_scores_gemma":[0.09058528,0.06644213,0.5443193,0.000110259454,0.0010610302,0.00022981546,0.0010000321,0.00045308168,0.004036983,0.000334269,0.2911653,0.00026259563],"about_ca_topic_score_codex":0.0001485502,"about_ca_topic_score_gemma":0.00008016873,"teacher_disagreement_score":0.46650386,"about_ca_system_score_codex":0.00043202523,"about_ca_system_score_gemma":0.0061819195,"threshold_uncertainty_score":0.9994521},"labels":[],"label_agreement":null},{"id":"W4213307792","doi":"10.1200/jco.2022.40.6_suppl.tps582","title":"TROPiCS-04: Study of sacituzumab govitecan (SG) in patients (pts) with locally advanced (LA) unresectable or metastatic urothelial cancer (mUC) that has progressed after prior platinum (PLT) and checkpoint inhibitor (CPI) therapy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Gilead Sciences","keywords":"Medicine; Internal medicine; Cancer; Chemotherapy; Phases of clinical research; Oncology; Gastroenterology; Surgery","score_opus":0.0877426200166195,"score_gpt":0.4071169907731531,"score_spread":0.31937437075653363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213307792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603236,0.0006718019,0.000018393075,0.0008657529,0.00044634927,0.0018070007,0.000043383865,0.000008629723,0.00010631382],"genre_scores_gemma":[0.99756753,0.00022559772,0.00090119534,0.00050848245,0.00019438424,0.0004048419,0.0000023619796,0.000046534253,0.00014906385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568313,0.0009019939,0.0018526084,0.00036262284,0.00086536165,0.00033425834],"domain_scores_gemma":[0.9968038,0.00086270116,0.001515926,0.00023481711,0.0003122132,0.0002705386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011833378,0.0002735477,0.0018112672,0.00020282356,0.00008652563,0.000019686568,0.00017683541,0.00012404687,0.00048125966],"category_scores_gemma":[0.0004131505,0.00016561101,0.00018224503,0.0002911748,0.0002506739,0.00016042792,0.00010926276,0.0010305877,6.3672303e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17020704,0.015373678,0.6375373,0.00007966572,0.0010253052,0.00095925404,0.0018581685,0.0001427832,0.00006948425,0.000001550153,0.00008854303,0.1726572],"study_design_scores_gemma":[0.119274884,0.15816677,0.7130606,0.00026383775,0.00064333726,0.00009318105,0.0016534103,0.000056545356,0.00033128186,0.000037357764,0.0062086107,0.00021016998],"about_ca_topic_score_codex":0.00022238605,"about_ca_topic_score_gemma":0.0012397498,"teacher_disagreement_score":0.17244703,"about_ca_system_score_codex":0.00042620944,"about_ca_system_score_gemma":0.0034283344,"threshold_uncertainty_score":0.67534214},"labels":[],"label_agreement":null},{"id":"W4213309199","doi":"10.1200/jco.2022.40.6_suppl.519","title":"Post hoc pooled analysis of first-line (1L) pembrolizumab (pembro) for advanced urothelial carcinoma (UC): Outcomes by response at week nine in KEYNOTE-052 and KEYNOTE-361.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Gemcitabine; Carboplatin; Cisplatin; Internal medicine; Exploratory analysis; Oncology; Cancer; Chemotherapy","score_opus":0.05767378072511174,"score_gpt":0.41509262318174606,"score_spread":0.3574188424566343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213309199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776281,0.0018062677,0.000093849994,0.018433437,0.00066478836,0.0006538104,0.0005686622,0.000010244961,0.00014080653],"genre_scores_gemma":[0.9931795,0.00046604848,0.0010082882,0.0030751335,0.00018283472,0.000051542123,0.00005237574,0.000043284497,0.0019409959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945609,0.0008963061,0.0030599262,0.00043419155,0.0006052163,0.0004434471],"domain_scores_gemma":[0.99135095,0.0055914936,0.0018548442,0.00035650746,0.00043627614,0.0004099153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032564518,0.00029997912,0.0032289291,0.0006703148,0.00014670471,0.0000068240606,0.00026708946,0.00028661214,0.0006156313],"category_scores_gemma":[0.0036326498,0.00023389368,0.001114733,0.00056373846,0.0002303314,0.00010002704,0.00021118941,0.0007986558,0.0000019746806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45653135,0.0048501333,0.5049937,0.00006778005,0.004188369,0.00061556825,0.00047693058,0.00041910142,0.0040717474,0.000012681313,0.0020290962,0.02174356],"study_design_scores_gemma":[0.089653656,0.07683849,0.7881667,0.000037727703,0.0067669842,0.00021769902,0.00027867212,0.0006284821,0.0005229582,0.00009021722,0.036544707,0.00025369896],"about_ca_topic_score_codex":0.00018549322,"about_ca_topic_score_gemma":0.00064260967,"teacher_disagreement_score":0.36687768,"about_ca_system_score_codex":0.00065629213,"about_ca_system_score_gemma":0.0012515029,"threshold_uncertainty_score":0.9537907},"labels":[],"label_agreement":null},{"id":"W4213331669","doi":"10.1200/jco.2022.40.6_suppl.470","title":"Real-world treatment patterns, survival outcomes, and health care resource utilization among individuals with nonmuscle-invasive bladder cancer in Canada.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Population; Oncology; Disease; Internal medicine; Retrospective cohort study; Cohort; Receipt; Radiation therapy; Cancer registry; Cancer; Environmental health","score_opus":0.1290476684208425,"score_gpt":0.44996257573215875,"score_spread":0.3209149073113162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213331669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854078,0.0009025012,0.0000040914792,0.011519098,0.0005241774,0.00048514866,0.00016178403,0.0000054097277,0.0009899581],"genre_scores_gemma":[0.9935956,0.002206697,0.00011635672,0.0034290436,0.00025318304,0.000044840952,0.000029815401,0.00002605845,0.00029839206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968859,0.0006263498,0.0013850295,0.00025603417,0.0005599432,0.000286749],"domain_scores_gemma":[0.997522,0.0006449319,0.0011597708,0.00016217327,0.00012322032,0.00038788584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008355795,0.00018323437,0.0014581628,0.00016254398,0.000099983015,0.000006633816,0.00009572945,0.000070864335,0.0002663289],"category_scores_gemma":[0.00007703712,0.00012360569,0.0001180032,0.00020186948,0.00006314712,0.00005301144,0.000054849294,0.00056337984,2.1754073e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00089976226,0.00045133175,0.9279996,0.000027274891,0.00051126804,0.00058588915,0.0008472908,0.00014105349,2.1562752e-7,0.000005430727,0.0010021736,0.06752872],"study_design_scores_gemma":[0.0123684965,0.008777561,0.95680404,0.000086197484,0.00029462474,0.000042217143,0.0034270524,0.000006526924,0.0000066813577,0.000004994513,0.018085212,0.00009638628],"about_ca_topic_score_codex":0.77191925,"about_ca_topic_score_gemma":0.98660076,"teacher_disagreement_score":0.2146815,"about_ca_system_score_codex":0.004069553,"about_ca_system_score_gemma":0.019288572,"threshold_uncertainty_score":0.99975365},"labels":[],"label_agreement":null},{"id":"W4213335399","doi":"10.1200/jco.2022.40.6_suppl.485","title":"Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Cystectomy; Gemcitabine; Bladder cancer; Internal medicine; Oncology; Cancer; Urology","score_opus":0.11419018168274969,"score_gpt":0.4498631705032262,"score_spread":0.3356729888204765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213335399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819196,0.0005458059,0.00006807337,0.009451643,0.00084154826,0.0006459564,0.00011441889,0.000012649705,0.00012791647],"genre_scores_gemma":[0.99128956,0.0002637707,0.0013516869,0.0059693605,0.00088204554,0.000037904465,0.0000060265047,0.000047165096,0.00015246564],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963168,0.00074528676,0.001766294,0.0003193079,0.00048780223,0.00036454623],"domain_scores_gemma":[0.9933014,0.0033580062,0.0022059407,0.00026809733,0.0005603351,0.00030622055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025721441,0.0002499333,0.0017843125,0.00019935601,0.000117863136,0.0000055675146,0.00017688767,0.00020979752,0.0005084839],"category_scores_gemma":[0.001267935,0.0001550512,0.0010472656,0.00021014396,0.00023588198,0.00006148589,0.000049649105,0.0008863553,0.0000022185973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55954444,0.008527523,0.13599484,0.000072010305,0.0055051195,0.0040909806,0.0022515159,0.0018996538,0.037447292,0.000021264668,0.027785046,0.2168603],"study_design_scores_gemma":[0.044655062,0.22898819,0.694678,0.00024671713,0.0010332187,0.0009908073,0.0005574787,0.0001356995,0.0027784342,0.00014484584,0.025515651,0.0002759003],"about_ca_topic_score_codex":0.000100656216,"about_ca_topic_score_gemma":0.000033580287,"teacher_disagreement_score":0.55868316,"about_ca_system_score_codex":0.00067944394,"about_ca_system_score_gemma":0.004330751,"threshold_uncertainty_score":0.7682566},"labels":[],"label_agreement":null},{"id":"W4213347865","doi":"10.1200/jco.2022.40.6_suppl.tps580","title":"Adjuvant infigratinib as targeted therapy for patients with muscle-invasive urothelial carcinoma harboring susceptible<i> FGFR3 </i>genetic alterations: A randomized, double-blind, placebo-controlled, phase 3 trial (PROOF 302).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Cisplatin; Tolerability; Chemotherapy; Urology; Internal medicine; Oncology; Bladder cancer; Placebo; Cancer; Gastroenterology; Adverse effect; Pathology","score_opus":0.07437173397062297,"score_gpt":0.4142051565024548,"score_spread":0.33983342253183185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213347865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799719,0.0011418639,0.0005100334,0.0017605164,0.0029947695,0.013000371,0.00010179741,0.000021167161,0.0004975658],"genre_scores_gemma":[0.9888307,0.00037129648,0.00214428,0.0025012116,0.002920674,0.0028034265,0.00006622219,0.00007391337,0.00028827766],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99289656,0.0014536686,0.0037524172,0.00047431258,0.0009470417,0.00047599504],"domain_scores_gemma":[0.99037087,0.0046551498,0.0030670944,0.00034122032,0.0010537639,0.00051192124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032504562,0.00040991744,0.003851575,0.00032088882,0.00032274355,0.000041947904,0.0002922753,0.00025515238,0.00081144186],"category_scores_gemma":[0.0022803068,0.00026236023,0.0014970151,0.0002494007,0.00023149101,0.00017207125,0.000056299676,0.0010586323,0.0000062787485],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95959866,0.010475509,0.0029731137,0.00002338184,0.0021164138,0.00022783155,0.00045890332,0.00014375555,0.00013478019,0.00003200103,0.00070160115,0.023114074],"study_design_scores_gemma":[0.8264627,0.16225375,0.0006217424,0.00004035945,0.001959044,0.0000665489,0.000152325,0.00012272585,0.00023829048,0.00016631423,0.007704078,0.00021211992],"about_ca_topic_score_codex":0.000083700055,"about_ca_topic_score_gemma":0.000068229856,"teacher_disagreement_score":0.15177824,"about_ca_system_score_codex":0.00031288547,"about_ca_system_score_gemma":0.006412044,"threshold_uncertainty_score":0.99998283},"labels":[],"label_agreement":null},{"id":"W4213390394","doi":"10.1200/jco.2022.40.6_suppl.562","title":"Genomic characterization and identification of actionable variants in patients with locally advanced or metastatic urothelial carcinoma (mUC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Government of Ontario","keywords":"Medicine; Oncology; Amplicon; Internal medicine; Cancer; Disease; Bioinformatics; Gene; Biology; Genetics; Polymerase chain reaction","score_opus":0.04726898439369516,"score_gpt":0.37408223804212215,"score_spread":0.326813253648427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213390394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817675,0.0000338178,0.0004451824,0.00045384504,0.00041009218,0.00038035365,0.00003809361,0.0000022970944,0.000059556765],"genre_scores_gemma":[0.99853665,0.00006620167,0.00073462847,0.00032344286,0.00008196923,0.000022451715,0.000016814627,0.000012762949,0.00020505377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787205,0.00027718072,0.0013248796,0.00013782851,0.00028358313,0.00010445724],"domain_scores_gemma":[0.9980106,0.00027242932,0.0013045666,0.000097605225,0.0002183516,0.000096463584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008523504,0.00007953822,0.0006723557,0.00013579153,0.00003868809,0.0000038299554,0.00006774596,0.000049236034,0.00020726115],"category_scores_gemma":[0.0003597018,0.000055173252,0.000065033026,0.00014701587,0.00006245934,0.00012825929,0.000030708143,0.0003012902,0.0000012213867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0527241,0.0032328076,0.8308374,0.00005133114,0.00027014737,0.00012996701,0.00019187992,0.000090907735,0.0038338783,0.00002274988,0.000026149983,0.10858864],"study_design_scores_gemma":[0.016941544,0.015452588,0.96565104,0.000021962143,0.00026080132,0.00007235157,0.00008234936,0.00008835304,0.00015160607,0.000033188306,0.0011963064,0.000047902537],"about_ca_topic_score_codex":0.00001906954,"about_ca_topic_score_gemma":0.000010894702,"teacher_disagreement_score":0.1348136,"about_ca_system_score_codex":0.00017923837,"about_ca_system_score_gemma":0.0014737743,"threshold_uncertainty_score":0.26144123},"labels":[],"label_agreement":null},{"id":"W4213428886","doi":"10.3390/curroncol29030117","title":"Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Oncology; Immune checkpoint; Cancer research; Metastatic Urothelial Carcinoma; Cancer; Mutation; Microsatellite instability; Internal medicine; Gene; Urothelial carcinoma; Biology; Allele; Genetics","score_opus":0.023529009297822593,"score_gpt":0.30128447330045527,"score_spread":0.2777554640026327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213428886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888137,0.00671541,0.000115699855,0.0018300922,0.0003996513,0.0012141885,0.00006934788,0.000058164187,0.0007837197],"genre_scores_gemma":[0.9966393,0.000047706013,0.00065217604,0.00093423546,0.00022757277,0.0011417932,0.00011952718,0.00005141034,0.00018627904],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985767,0.00015214947,0.00021287001,0.0004130507,0.00030289267,0.0003423369],"domain_scores_gemma":[0.9994563,0.00004358894,0.00011167968,0.0001936477,0.00008505307,0.0001097156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010599874,0.00023184596,0.00039505382,0.00013583129,0.0002126392,0.000021255615,0.00008037045,0.000047606438,0.00059980806],"category_scores_gemma":[0.000010274469,0.00019051024,0.00007051921,0.00013850933,0.00013739045,0.00006528961,0.00008391061,0.0003161263,0.000009512631],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009008984,0.0048687104,0.7326377,0.0006956681,0.003252202,0.004034456,0.02062257,0.00026093549,0.052198943,0.0009690572,0.006147534,0.1653032],"study_design_scores_gemma":[0.07348902,0.044730775,0.2495599,0.00023121346,0.0055328063,0.004537572,0.0062223147,0.0007707708,0.06631585,0.00431439,0.5421317,0.002163674],"about_ca_topic_score_codex":0.0002766183,"about_ca_topic_score_gemma":0.000027918275,"teacher_disagreement_score":0.53598416,"about_ca_system_score_codex":0.00027913536,"about_ca_system_score_gemma":0.0003385865,"threshold_uncertainty_score":0.77687824},"labels":[],"label_agreement":null},{"id":"W4214546616","doi":"10.1007/978-3-030-39903-0_1330","title":"Cancer, Bladder","year":2020,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Medicine; Cancer; Internal medicine","score_opus":0.037528104015590896,"score_gpt":0.29136626722821696,"score_spread":0.2538381632126261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214546616","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002508724,0.0036204176,0.000021321302,0.0040052827,0.00030733235,0.00040699527,0.0000978139,0.00014797905,0.99139035],"genre_scores_gemma":[0.001301799,0.0018063863,0.00017881359,0.007530698,0.0010711312,0.000027303277,0.000079231664,0.000098082484,0.9879066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906343,0.000001936287,0.00017946714,0.00035289268,0.00026050964,0.00014176189],"domain_scores_gemma":[0.99940157,0.000009286855,0.000054102395,0.00025351555,0.00005864663,0.00022286084],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010559412,0.00028790135,0.00045539383,0.000047323203,0.000027194761,0.000009573145,0.000060958737,0.00022452947,0.031688973],"category_scores_gemma":[0.0000030568235,0.00022060305,0.00020269354,0.000014593223,0.00004342153,0.000017945202,0.00003492656,0.00027405407,0.0016555062],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005607705,0.00008442985,0.00027025136,0.0003512642,0.0042763823,0.000900457,0.00015798352,4.3483084e-7,0.00014779001,0.13558258,0.75575984,0.10190783],"study_design_scores_gemma":[0.0011455377,0.000278457,0.00007717488,0.00015639322,0.0008892242,0.000026203124,0.0000035744918,0.0000032745484,0.00025413503,0.0030219273,0.9939181,0.00022600534],"about_ca_topic_score_codex":0.00011436285,"about_ca_topic_score_gemma":0.000037449143,"teacher_disagreement_score":0.23815826,"about_ca_system_score_codex":0.00010846314,"about_ca_system_score_gemma":0.00033060083,"threshold_uncertainty_score":0.99912184},"labels":[],"label_agreement":null},{"id":"W4214612687","doi":"10.3390/cancers14051222","title":"Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Poisson regression; Logistic regression; Odds ratio; Context (archaeology); Lymph node; Internal medicine; Cancer; Surgery; Complication; Genitourinary system; Urology; Population","score_opus":0.007451570679498822,"score_gpt":0.2870362865448312,"score_spread":0.2795847158653324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214612687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673194,0.00085267535,0.0000018058478,0.00025614264,0.0002483467,0.0012001924,0.0001761657,0.000012362677,0.0005203593],"genre_scores_gemma":[0.99914306,0.0002546869,0.000014155151,0.00013854203,0.000028455366,0.0003339065,0.00003808261,0.00002755109,0.000021577282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871075,0.0000925603,0.0003301103,0.00031414433,0.00033256557,0.00021988587],"domain_scores_gemma":[0.9994186,0.00011406142,0.00014320646,0.00020573716,0.000035202465,0.000083156265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013014398,0.00017693943,0.0004468143,0.0001406383,0.00004236866,0.0000040032983,0.00008063042,0.000047205787,0.00010758785],"category_scores_gemma":[0.000024730687,0.00016053316,0.00007004966,0.00026532944,0.00013170346,0.000047907095,0.000048458696,0.0002107154,5.2006646e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096900883,0.0005678289,0.9802554,0.00018613534,0.00025004873,0.000014994304,0.0013456215,0.00038481297,0.00023360184,0.000053065247,0.00023803748,0.015501402],"study_design_scores_gemma":[0.021031436,0.011574563,0.9607554,0.00034440545,0.00010750607,0.0000028890258,0.0003497189,0.0002926738,0.0051409476,0.000023739212,0.00015490345,0.00022183449],"about_ca_topic_score_codex":0.0035447236,"about_ca_topic_score_gemma":0.00028142647,"teacher_disagreement_score":0.020062428,"about_ca_system_score_codex":0.0019374765,"about_ca_system_score_gemma":0.0004181711,"threshold_uncertainty_score":0.65463525},"labels":[],"label_agreement":null},{"id":"W4214670479","doi":"10.5489/cuaj.7612","title":"Outcomes of patients undergoing concurrent radical cystectomy and nephroureterectomy: A single-institution series","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Interquartile range; Nephrectomy; Bladder cancer; Surgery; Occult; Urology; Upper urinary tract; Urinary diversion; Urinary system; Cancer; Internal medicine; Kidney","score_opus":0.015120731812339751,"score_gpt":0.23506920371236617,"score_spread":0.21994847190002642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214670479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215055,0.00022708728,0.00003087336,0.00616134,0.0004628738,0.00020661722,0.000105662984,0.000014962592,0.0006400143],"genre_scores_gemma":[0.998011,0.000026506677,0.000062709354,0.0016568374,0.00007957754,0.000012575888,0.000027653565,0.0000073082997,0.000115833405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879897,0.000162871,0.00027738555,0.00013410613,0.0003681052,0.00025856178],"domain_scores_gemma":[0.9991888,0.00008236213,0.0002142729,0.000052987314,0.00011150122,0.00035011672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021453711,0.00010651606,0.0002762292,0.00012918256,0.0003543541,0.000027888093,0.00005422154,0.00007572283,0.00041249293],"category_scores_gemma":[0.0003070903,0.00008714344,0.00009059307,0.00012809249,0.000051031107,0.00008748223,0.00002634382,0.00035047968,0.0000021518101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009314657,0.00010776461,0.9959635,0.000006996648,0.00015649779,0.000030748575,0.00015136068,0.000008720193,0.000022429454,0.00023278693,0.0007047437,0.0025212776],"study_design_scores_gemma":[0.003581316,0.0016339823,0.9652806,0.000008390303,0.00012436116,0.00013995892,0.00009689652,0.000014062168,0.000023121951,0.00031236018,0.028696038,0.0000888983],"about_ca_topic_score_codex":0.0002909973,"about_ca_topic_score_gemma":0.0003761747,"teacher_disagreement_score":0.030682912,"about_ca_system_score_codex":0.0014260141,"about_ca_system_score_gemma":0.00055938057,"threshold_uncertainty_score":0.45165083},"labels":[],"label_agreement":null},{"id":"W4214671552","doi":"10.5489/cuaj.7698","title":"Case – Gigantic obstructive calculi in continent urinary diversion","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Urinary system; Urinary diversion; Complication; Surgery; Incidence (geometry); Foreign body; Internal medicine; Cancer","score_opus":0.01566065860752604,"score_gpt":0.23692414126711034,"score_spread":0.2212634826595843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214671552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853663,0.00021044174,0.000004886454,0.012096089,0.00042695188,0.0001978479,0.00007090373,0.000011603176,0.0016150157],"genre_scores_gemma":[0.9963131,0.00002069455,0.00003650016,0.0028628185,0.00015158017,0.000016058977,0.000016766146,0.0000075515636,0.0005749448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988005,0.00018665532,0.00021049671,0.00015728954,0.0002951489,0.0003498719],"domain_scores_gemma":[0.9992515,0.000055422795,0.0001189941,0.00006367618,0.000078463185,0.00043193868],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030232946,0.00009516824,0.00019746975,0.00018873668,0.00045124022,0.000022626526,0.000062759194,0.00007737337,0.0019990064],"category_scores_gemma":[0.00013527031,0.00008422115,0.000096238706,0.00022197264,0.000017018716,0.00005655098,0.00003210656,0.0006395847,0.000019959254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015165724,0.00014073405,0.95927113,0.0000021740614,0.000082383835,0.03475668,0.0004144383,0.0000645705,0.000025899975,0.000059228725,0.0033158117,0.0017152887],"study_design_scores_gemma":[0.0033422487,0.0011291689,0.9246813,0.0000057070565,0.00010893053,0.028982157,0.00093522854,0.000117021445,0.0000098899145,0.00045098306,0.04010023,0.00013714626],"about_ca_topic_score_codex":0.004633006,"about_ca_topic_score_gemma":0.0005619702,"teacher_disagreement_score":0.03678442,"about_ca_system_score_codex":0.003063357,"about_ca_system_score_gemma":0.0004263824,"threshold_uncertainty_score":0.9989133},"labels":[],"label_agreement":null},{"id":"W4214711830","doi":"10.1016/j.euo.2021.11.005","title":"TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells","year":2022,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Council for Science, Technology and Innovation; A.P. Giannini Foundation; Svenska Läkaresällskapet; National Cancer Institute; National Institutes of Health; Vetenskapsrådet; National Institute of General Medical Sciences; Giannini Foundation of Agricultural Economics","keywords":"Medicine; Gene knockdown; Bladder cancer; Cancer research; Cancer; Oncology; Internal medicine; Gene; Biology; Genetics","score_opus":0.01368146384953848,"score_gpt":0.27848123575721934,"score_spread":0.26479977190768084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214711830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97423637,0.0009596302,0.00006344692,0.00052966457,0.0003436585,0.0003994229,0.000119480705,0.00004148643,0.023306845],"genre_scores_gemma":[0.9964673,0.000031974483,0.00035014906,0.0025514518,0.00012034418,0.000035919627,0.00004042573,0.000049559934,0.00035285516],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764395,0.00093768944,0.00036657488,0.00042950493,0.0002360656,0.00038621295],"domain_scores_gemma":[0.9991979,0.00009790442,0.00017363094,0.0003599483,0.00004682337,0.0001237682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045381134,0.00020200205,0.00046372367,0.0000962686,0.00018859147,0.000005601736,0.00020312793,0.00007175251,0.00039652834],"category_scores_gemma":[0.000030709612,0.0001830444,0.000108762426,0.00011360764,0.00025859562,0.000026277981,0.00026412492,0.00035439385,0.000026017882],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008504,0.0014236409,0.016890401,0.000090825735,0.00017004783,0.0080073085,0.005852395,0.000043708995,0.947861,0.0004228427,0.0024930816,0.0082407575],"study_design_scores_gemma":[0.032346405,0.05975579,0.253912,0.000020090332,0.0009809519,0.0034730653,0.0028430363,0.00006328474,0.14024854,0.00028557892,0.5053294,0.0007418783],"about_ca_topic_score_codex":0.000053567677,"about_ca_topic_score_gemma":0.0000052123314,"teacher_disagreement_score":0.8076125,"about_ca_system_score_codex":0.000075147276,"about_ca_system_score_gemma":0.00019715185,"threshold_uncertainty_score":0.7464334},"labels":[],"label_agreement":null},{"id":"W4214946710","doi":"10.1097/ju.0000000000001946.03","title":"Reply by Authors","year":2021,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of British Columbia, Okanagan Campus; University of British Columbia; Queen's University; Université Laval","funders":"","keywords":"Queen (butterfly); Library science; Medicine; Radiation oncology; Radiation therapy; Surgery; Biology","score_opus":0.02222824589783744,"score_gpt":0.28392527271981277,"score_spread":0.2616970268219753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214946710","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012059087,0.011880988,0.00007006554,0.9827894,0.0012967865,0.00010532235,0.000019447549,0.0000074606605,0.0026246242],"genre_scores_gemma":[0.003944785,0.0012425367,0.000051252144,0.9760327,0.0052071586,0.0000018263571,0.000031420823,0.000041407395,0.013446923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857295,0.000336722,0.0004121344,0.00011528311,0.00032007392,0.0002428672],"domain_scores_gemma":[0.99880224,0.00018829755,0.00041830904,0.00034797488,0.00017703573,0.000066124085],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00035336366,0.00017700561,0.0005695222,0.00008288847,0.000044065644,0.000007862613,0.00021188796,0.00040064202,0.0007925064],"category_scores_gemma":[0.000084481326,0.00009844105,0.00022448064,0.00008039011,0.00010594315,0.000021078993,0.000033971955,0.0024538923,0.0000311323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002921539,0.00003482916,0.00010579036,0.000023014636,0.0005917455,0.0023873595,0.00012395762,5.7244335e-7,0.00022564115,9.222775e-7,0.9953885,0.0008254849],"study_design_scores_gemma":[0.0009979155,0.0013372612,0.00015527174,0.00002980686,0.0015680558,0.010235515,0.000015172915,7.9440923e-7,0.000194889,0.00018303453,0.985214,0.00006828661],"about_ca_topic_score_codex":0.000039816056,"about_ca_topic_score_gemma":9.3140585e-7,"teacher_disagreement_score":0.0108223,"about_ca_system_score_codex":0.00005989027,"about_ca_system_score_gemma":0.00033796055,"threshold_uncertainty_score":0.9998475},"labels":[],"label_agreement":null},{"id":"W4220701375","doi":"10.5489/cuaj.7875","title":"2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlights","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University Health Network; Health Sciences Centre; University of Calgary; Princess Margaret Cancer Centre; University of Toronto; Dalhousie University; University of British Columbia; McGill University; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Clinical Oncology; Medicine; Genitourinary system; Oncology; Internal medicine; Library science; Cancer; Computer science","score_opus":0.03328807615958547,"score_gpt":0.3232978010745436,"score_spread":0.29000972491495813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220701375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982196,0.0005710064,0.000012622848,0.08362722,0.0014300874,0.00031962074,0.00017539908,0.000025728492,0.015618734],"genre_scores_gemma":[0.9861006,0.00076029485,0.0006155232,0.010082785,0.0011231671,0.000031157135,0.000029239207,0.0000186382,0.001238605],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715894,0.0006550831,0.00077919516,0.00027736134,0.0006081925,0.0005211997],"domain_scores_gemma":[0.99766886,0.0002968381,0.00088024844,0.00013219105,0.00022465839,0.00079719035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001558609,0.00015118916,0.0006561625,0.00011570646,0.0005691478,0.000016061591,0.0001816498,0.00015762549,0.001764823],"category_scores_gemma":[0.0001701818,0.00013100891,0.0004957178,0.00037372732,0.000109909146,0.000050393937,0.00005538245,0.0011736028,0.000011215602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004967658,0.00031078092,0.8918728,0.000007537248,0.0009944731,0.00032424973,0.00053100963,0.0003515547,0.00040381582,0.000051847972,0.08191306,0.022742085],"study_design_scores_gemma":[0.002740814,0.004753031,0.3176483,0.000007658486,0.00032310488,0.00037268928,0.00083221577,0.00025003927,0.000040867504,0.00010988639,0.6727502,0.00017126328],"about_ca_topic_score_codex":0.010213992,"about_ca_topic_score_gemma":0.0011710995,"teacher_disagreement_score":0.59083706,"about_ca_system_score_codex":0.0050376514,"about_ca_system_score_gemma":0.004278984,"threshold_uncertainty_score":0.9991477},"labels":[],"label_agreement":null},{"id":"W4220707959","doi":"10.1097/ju.0000000000002649","title":"Does Smoking Cessation Reduce Bladder Cancer Recurrence?","year":2022,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Smoking cessation; Bladder cancer; MEDLINE; Cancer; Cigarette smoking","score_opus":0.026736174984828075,"score_gpt":0.31557592213392927,"score_spread":0.2888397471491012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220707959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663868,0.004528799,0.00008320973,0.025234342,0.0022939532,0.00014839429,0.000014036369,0.000009183894,0.0013012892],"genre_scores_gemma":[0.9959801,0.00088223873,0.00002155806,0.0021177568,0.0005007872,0.000010836198,0.0000014665005,0.00000977621,0.00047551063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991255,0.00020240746,0.0002209061,0.00006563989,0.00025104574,0.00013451633],"domain_scores_gemma":[0.9994385,0.00007623078,0.00023536569,0.00011944216,0.000085159,0.00004529041],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004351019,0.00006845308,0.00016611064,0.00007304767,0.00015721316,0.000003887852,0.00013402785,0.00002576308,0.001841894],"category_scores_gemma":[0.00002907061,0.000032064265,0.00005968689,0.00011987944,0.000054955515,0.000042990483,0.000042080406,0.0003952936,0.0000018504458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027898569,0.0023527998,0.3556728,0.0001632266,0.0066778027,0.001025327,0.03930018,0.00855532,0.044047464,0.00097088784,0.15554082,0.3577948],"study_design_scores_gemma":[0.023793682,0.017920129,0.34695908,0.00013579692,0.008985108,0.016395167,0.0068126037,0.00057482155,0.017910916,0.020746913,0.53902864,0.0007371105],"about_ca_topic_score_codex":0.00012982979,"about_ca_topic_score_gemma":0.000016024544,"teacher_disagreement_score":0.38348785,"about_ca_system_score_codex":0.0000977151,"about_ca_system_score_gemma":0.00021551567,"threshold_uncertainty_score":0.9990706},"labels":[],"label_agreement":null},{"id":"W4220746096","doi":"10.1111/bju.15723","title":"Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review","year":2022,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Hazard ratio; Bladder cancer; Confidence interval; Randomized controlled trial; White light; Urology; Internal medicine; Surgery; Cancer","score_opus":0.04151623738452765,"score_gpt":0.3605396198355116,"score_spread":0.31902338245098394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220746096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011083595,0.9948054,0.000089451445,0.00081026397,0.0012689327,0.0019408364,0.00077148335,0.000013248901,0.00018956645],"genre_scores_gemma":[0.00013910345,0.99660975,0.00013047777,0.0010026975,0.0011716366,0.00033533367,0.00022730876,0.0001221327,0.00026156337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961777,0.00059615093,0.0017866505,0.00045445506,0.0005543353,0.00043070942],"domain_scores_gemma":[0.99698013,0.00025728648,0.0015869957,0.00033329427,0.0005633006,0.00027900463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000981871,0.0004209541,0.004115657,0.0002975417,0.00013430258,0.000016792053,0.00035668575,0.00038711843,0.001720314],"category_scores_gemma":[0.00021856456,0.0004081559,0.0015064788,0.00037046298,0.00011379195,0.00012698493,0.00003105828,0.0011648687,0.0000021955216],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008443465,0.0004477898,0.00001389359,0.055444267,0.002533393,0.0011330358,0.00012371087,0.000004286017,0.000014146142,0.0000018774773,0.013791405,0.92564785],"study_design_scores_gemma":[0.003763438,0.009342325,0.00016802805,0.042573467,0.01683086,0.020925153,0.000016332307,0.000001143683,0.000012731705,0.00001382185,0.9060743,0.0002784191],"about_ca_topic_score_codex":0.0001777671,"about_ca_topic_score_gemma":0.00036755516,"teacher_disagreement_score":0.92536944,"about_ca_system_score_codex":0.0002313598,"about_ca_system_score_gemma":0.0020074288,"threshold_uncertainty_score":0.99983704},"labels":[],"label_agreement":null},{"id":"W4220756410","doi":"10.1016/j.euf.2022.02.007","title":"Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology; Uehara Memorial Foundation","keywords":"Carboplatin; Medicine; Metastatic Urothelial Carcinoma; Hazard ratio; Internal medicine; Oncology; Cisplatin; Confidence interval; Meta-analysis; Chemotherapy; Odds ratio; Urology; Bladder cancer; Urothelial carcinoma; Cancer","score_opus":0.08312111110216207,"score_gpt":0.3544624212125123,"score_spread":0.27134131011035023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220756410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051928087,0.99116415,0.000016261676,0.000291613,0.0000343945,0.0073943483,0.00045245516,0.0000047436556,0.000590093],"genre_scores_gemma":[0.021190738,0.9772026,0.000077620905,0.00043706436,0.000014932425,0.00087614864,0.000039474147,0.000071338225,0.00009010957],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99259156,0.0047001285,0.0017732246,0.00037942152,0.00036201338,0.00019367125],"domain_scores_gemma":[0.99555033,0.001443003,0.0016479937,0.0012620715,0.000065212276,0.000031368316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022606535,0.00040219878,0.006885285,0.00019815404,0.000046227215,0.000004358282,0.0005396971,0.00004733885,0.00020750995],"category_scores_gemma":[0.00026798723,0.0001832143,0.0028996724,0.00079226366,0.00016734553,0.000013271775,0.00010968079,0.00039906686,9.0692333e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018851107,0.0007246668,0.000034318564,0.7295586,0.24406281,0.000053000058,0.0010425107,0.0000031093846,0.0000019198392,0.00023511481,0.000062439685,0.024033017],"study_design_scores_gemma":[0.0013607782,0.0008760999,0.00038287006,0.0036279021,0.98176354,0.00010474728,0.000031970667,0.0000012999207,0.0000017342428,0.000015775026,0.01169974,0.00013357033],"about_ca_topic_score_codex":0.00014975696,"about_ca_topic_score_gemma":0.000016509148,"teacher_disagreement_score":0.7377007,"about_ca_system_score_codex":0.000041047475,"about_ca_system_score_gemma":0.0002700703,"threshold_uncertainty_score":0.7471262},"labels":[],"label_agreement":null},{"id":"W4220776275","doi":"10.1016/j.euo.2022.03.001","title":"Establishing a Foundation for Studying the Immune Contexture Across the Spectrum of Bladder Cancer","year":2022,"lang":"en","type":"letter","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Immune system; Cancer; Medicine; Broad spectrum; Cancer therapy; Foundation (evidence); Bioinformatics; Immunology; Cancer research; Internal medicine; Biology","score_opus":0.04373693572779449,"score_gpt":0.3407628625726476,"score_spread":0.2970259268448531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220776275","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004840879,0.0057735606,0.0002296929,0.96925217,0.0043301373,0.0029899734,0.00044120802,0.00007744478,0.012064953],"genre_scores_gemma":[0.12836191,0.00046275262,0.000054202617,0.8508889,0.009427024,0.00093201286,0.00092311815,0.0002503283,0.008699746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962678,0.001504105,0.00064994954,0.000595071,0.00030204677,0.0006810582],"domain_scores_gemma":[0.996849,0.0014677069,0.0006955462,0.0008049572,0.00014459048,0.000038171886],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013265118,0.00038895427,0.0008473383,0.000083235005,0.00068306964,0.00003932054,0.0007262847,0.0003451623,0.0017586922],"category_scores_gemma":[0.00020640592,0.00022812284,0.00034773423,0.00020507889,0.00060848094,0.000055538363,0.00038637928,0.0027052555,0.000035832218],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018534975,0.0002269143,0.00097648526,0.00012968102,0.0024851211,0.00072749023,0.006575521,0.00004895555,0.00018680777,0.00007988213,0.9652629,0.021446776],"study_design_scores_gemma":[0.003573671,0.0031520217,0.004419438,0.000015924039,0.001296779,0.00029910041,0.00061669975,0.000020175954,0.000034683417,0.000115721,0.9862805,0.0001752819],"about_ca_topic_score_codex":0.00041515048,"about_ca_topic_score_gemma":0.00023005587,"teacher_disagreement_score":0.12352103,"about_ca_system_score_codex":0.00032504855,"about_ca_system_score_gemma":0.00053088507,"threshold_uncertainty_score":0.9995955},"labels":[],"label_agreement":null},{"id":"W4220783948","doi":"10.1158/1078-0432.ccr-21-3089","title":"Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Pembrolizumab; Clinical trial; Tumor microenvironment; Urothelial cancer; Biomarker; Immunotherapy","score_opus":0.31333517696105834,"score_gpt":0.554651027683863,"score_spread":0.24131585072280465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220783948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776546,0.005522825,0.000010914621,0.008459273,0.0006329064,0.0025302079,0.004065483,0.000030470439,0.0010933147],"genre_scores_gemma":[0.98932546,0.006928472,0.00020349356,0.00080360315,0.0008966378,0.0010387696,0.00011722087,0.00006781003,0.0006185195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900837,0.003740251,0.002613589,0.0012506704,0.0015761484,0.0007356511],"domain_scores_gemma":[0.9821307,0.015477717,0.000641456,0.0008578802,0.00046783686,0.00042438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012991195,0.00032467677,0.0018641601,0.00018518184,0.00033432397,0.000036593665,0.0005097459,0.00021853296,0.0008000374],"category_scores_gemma":[0.0054929303,0.00020201881,0.00037027127,0.0009801371,0.0012196931,0.00009868771,0.00045008765,0.002108569,0.000007200068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27329102,0.0010821067,0.51386553,0.000065062,0.0013382224,0.0001837414,0.001356681,0.00025843031,0.00015543065,0.00006077211,0.0027381221,0.20560485],"study_design_scores_gemma":[0.08885782,0.008286047,0.8819689,0.00049140415,0.00047284004,0.000011711626,0.0017655515,0.00039512076,0.0005752849,0.0016022002,0.0151969725,0.00037610694],"about_ca_topic_score_codex":0.025257293,"about_ca_topic_score_gemma":0.0048191976,"teacher_disagreement_score":0.36810338,"about_ca_system_score_codex":0.00038241103,"about_ca_system_score_gemma":0.0026044045,"threshold_uncertainty_score":0.9812336},"labels":[],"label_agreement":null},{"id":"W4220836777","doi":"10.4081/aiua.2022.1.41","title":"Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario","year":2022,"lang":"en","type":"article","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Pathological; Lymph node; Urology; Population; Epidemiology; Prostate cancer; Cancer; Gynecology; Internal medicine; Oncology","score_opus":0.012394200597438199,"score_gpt":0.2391386282546345,"score_spread":0.2267444276571963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220836777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672097,0.0000686231,0.000011653889,0.00038044876,0.00011402235,0.00080589775,0.0003015781,0.000050119528,0.0015466716],"genre_scores_gemma":[0.9973036,0.000014085383,0.0001733145,0.001509994,0.000016584161,0.0004113931,0.00012571918,0.00003162478,0.00041366593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790925,0.0001786177,0.00038997154,0.000527749,0.00040494947,0.0005894442],"domain_scores_gemma":[0.99908733,0.00013528635,0.00017511104,0.0003930448,0.000067316774,0.00014191121],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001668313,0.00031046857,0.0006097678,0.00017399518,0.00012487004,0.0000055585265,0.0002451144,0.00009905563,0.00093013915],"category_scores_gemma":[0.00006028708,0.00022088186,0.00015996526,0.00025474923,0.00024416504,0.00007583811,0.00023194816,0.00054734596,0.000010131406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018623035,0.0014692119,0.9922109,0.000016608588,0.00023083942,0.0006052064,0.0015352154,0.0006945755,0.00013489218,0.000018256205,0.00005042849,0.0011715466],"study_design_scores_gemma":[0.0055584414,0.0043079536,0.989034,0.000011157512,0.00020237012,0.000028572074,0.00014678917,0.000006159687,0.00007561379,0.00018528568,0.00022453928,0.00021910164],"about_ca_topic_score_codex":0.0058253985,"about_ca_topic_score_gemma":0.11024361,"teacher_disagreement_score":0.10441821,"about_ca_system_score_codex":0.0003448753,"about_ca_system_score_gemma":0.0006441784,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W4220909779","doi":"10.3390/cancers14071781","title":"Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lions Gate Hospital","funders":"European Association of Urology","keywords":"Standardization; Urothelial carcinoma; Medicine; Urology; Quality (philosophy); Oncology; General surgery; Internal medicine; Computer science; Cancer; Bladder cancer","score_opus":0.01410284855680468,"score_gpt":0.2874084299405914,"score_spread":0.27330558138378674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220909779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831075,0.00027362144,0.0027921973,0.00010817646,0.00028508055,0.0036734473,0.0044738585,0.000019485928,0.00006337812],"genre_scores_gemma":[0.99549973,0.0000076069855,0.00261108,0.000122664,0.00009122608,0.0009565179,0.0006403796,0.000041682626,0.00002914176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861497,0.00009319712,0.00029301032,0.00031069858,0.0004461727,0.00024194035],"domain_scores_gemma":[0.9992505,0.000088784094,0.0001749111,0.0001872689,0.00021613903,0.000082452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017930772,0.00015575204,0.0003981592,0.0001577478,0.000124838,0.000007556636,0.00007965227,0.00004893719,0.00007244836],"category_scores_gemma":[0.00008230785,0.00012842062,0.00012147081,0.00033691138,0.000059925445,0.00005765642,0.000020149268,0.00014036632,1.3088813e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017167117,0.00024844878,0.9719494,0.00040869426,0.00015835342,0.0000027947365,0.0020407578,0.0006698689,0.000066335684,0.00014422229,0.0004727958,0.0066712354],"study_design_scores_gemma":[0.086784385,0.018402006,0.8746668,0.00008191261,0.0010543609,0.0000037326338,0.002229544,0.0002465752,0.005507478,0.00023100962,0.010317664,0.0004745426],"about_ca_topic_score_codex":0.0019511213,"about_ca_topic_score_gemma":0.00017921267,"teacher_disagreement_score":0.09728259,"about_ca_system_score_codex":0.002705326,"about_ca_system_score_gemma":0.0022503464,"threshold_uncertainty_score":0.70743334},"labels":[],"label_agreement":null},{"id":"W4220965877","doi":"10.52733/kcj20n1-gu2","title":"ASCO GU22 – Kidney Cancer Highlights","year":2022,"lang":"en","type":"article","venue":"Kidney Cancer Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Kidney cancer; Cancer; Prostate cancer; Medicine; Genitourinary system; Renal cell carcinoma; Bladder cancer; Kidney; Oncology; Internal medicine; Gynecology","score_opus":0.02028934703914708,"score_gpt":0.3071120769885514,"score_spread":0.28682272994940433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220965877","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20906164,0.054133724,0.0004405609,0.5631772,0.04967294,0.0034917572,0.0066498187,0.00077675126,0.1125956],"genre_scores_gemma":[0.8009039,0.011086633,0.00068150315,0.11672831,0.009528727,0.0013065668,0.0001617401,0.00026279394,0.059339825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973163,0.00013070377,0.0004610124,0.00041628408,0.0010225824,0.0006531398],"domain_scores_gemma":[0.99737865,0.000018885243,0.0002463202,0.00035264879,0.00017900454,0.0018244913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025650603,0.00032483067,0.00050131965,0.00022847038,0.0009172831,0.00007598964,0.00030252853,0.00007383998,0.04247131],"category_scores_gemma":[0.000067978246,0.0002683831,0.00030093497,0.00043408488,0.00007049117,0.00018443706,0.00013103454,0.00095268217,0.000060480575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007189355,0.00034360882,0.028189942,0.000063781845,0.0008803623,0.0005438877,0.0010079903,0.000068336165,0.0037517897,0.00015843373,0.95442617,0.009846764],"study_design_scores_gemma":[0.0064889393,0.0005076224,0.007081742,0.00021073935,0.00058652356,0.0011917115,0.00013088687,0.00003847006,0.0038473767,0.0003156259,0.97927946,0.00032092482],"about_ca_topic_score_codex":0.0012817023,"about_ca_topic_score_gemma":0.00003445677,"teacher_disagreement_score":0.59184223,"about_ca_system_score_codex":0.0016744481,"about_ca_system_score_gemma":0.005376547,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4221015882","doi":"10.23736/s2724-6051.20.04127-2","title":"A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis","year":2022,"lang":"en","type":"article","venue":"Minerva Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Propensity score matching; Perioperative; Cuff; Dissection (medical); Laparoscopy; Concomitant; Ureter; Logistic regression; Body mass index","score_opus":0.08116872516120682,"score_gpt":0.3596397103804979,"score_spread":0.2784709852192911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221015882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595934,0.00057332386,0.00009479537,0.0013821708,0.0002067071,0.0012186356,0.00018990983,0.000011330593,0.00036380842],"genre_scores_gemma":[0.9975565,0.0000073051237,0.00043995495,0.0012855496,0.000045635177,0.00031960243,0.000098476135,0.0000179642,0.00022901678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852407,0.00024677525,0.0004281671,0.00040180844,0.0001256731,0.00027348375],"domain_scores_gemma":[0.99908644,0.000257379,0.00022320848,0.00027029662,0.00009077993,0.00007187268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021972996,0.00020756667,0.0013951882,0.00021467013,0.00020110322,0.0000072995886,0.00020180628,0.000120880744,0.00036725288],"category_scores_gemma":[0.000036138907,0.00016757337,0.00021385048,0.00024222101,0.00025048037,0.00006333393,0.00025458756,0.00023631191,5.728526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014944409,0.0007298319,0.9694916,0.000047738016,0.0021705134,0.000018774816,0.003058869,0.00008990364,0.0086511485,0.00025027385,0.00011849749,0.00042843338],"study_design_scores_gemma":[0.016108777,0.010343388,0.96361554,0.0000027425074,0.00415185,0.000057986465,0.00042910592,0.000446205,0.0018469557,0.000054984303,0.0027900995,0.00015236442],"about_ca_topic_score_codex":0.0010386204,"about_ca_topic_score_gemma":0.00039181462,"teacher_disagreement_score":0.009613556,"about_ca_system_score_codex":0.000033878096,"about_ca_system_score_gemma":0.00017774642,"threshold_uncertainty_score":0.68334436},"labels":[],"label_agreement":null},{"id":"W4221078002","doi":"10.1038/s41585-022-00578-1","title":"Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Field cancerization; Stage (stratigraphy); Resection; Metastasis; Carcinoma in situ; Urology; Cancer; Surgery; Internal medicine; Urinary system","score_opus":0.08878212474515171,"score_gpt":0.4579824468593565,"score_spread":0.36920032211420484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221078002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.1628714e-7,0.98789334,0.000062605526,0.0003465129,0.0024929564,0.0044061383,0.00035729952,0.000032645905,0.0044078655],"genre_scores_gemma":[0.000017088989,0.99375665,0.00051822327,0.0023096015,0.0008061667,0.0018960831,0.00017280187,0.00011407364,0.0004093348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99457884,0.0012982944,0.0018028575,0.0013312477,0.0004614238,0.00052731525],"domain_scores_gemma":[0.99600285,0.00083345035,0.0015449575,0.0011090224,0.00025329302,0.00025640265],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010178892,0.00082549953,0.0065883626,0.00031230156,0.000091399525,0.0000068035297,0.0005538086,0.0017458651,0.0042302897],"category_scores_gemma":[0.0012621367,0.0005747192,0.0024620793,0.00085013616,0.00022048113,0.000043334923,0.00025550177,0.0044520567,0.00011890752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007454455,0.00036492667,0.00001281067,0.010320763,0.0012841276,0.00012727063,0.00008140173,4.1486693e-8,5.1133867e-7,0.00071820617,0.006303402,0.980712],"study_design_scores_gemma":[0.0008220245,0.0016844133,0.000029762725,0.0050106593,0.01030395,0.00027147125,0.000022654904,5.0960034e-7,0.0000012129151,0.00045307406,0.9810326,0.00036763854],"about_ca_topic_score_codex":0.000081646576,"about_ca_topic_score_gemma":0.000051953197,"teacher_disagreement_score":0.98034436,"about_ca_system_score_codex":0.00049295725,"about_ca_system_score_gemma":0.0027367184,"threshold_uncertainty_score":0.99967045},"labels":[],"label_agreement":null},{"id":"W4221115485","doi":"10.1038/s41379-022-01062-2","title":"p53 null phenotype is a “positive result” in urothelial carcinoma in situ","year":2022,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pathology; Carcinoma in situ; Biology; Phenotype; H&E stain; Frameshift mutation; Carcinoma; Immunostaining; Urothelial Cell; Staining; Immunohistochemistry; Cancer; Bladder cancer; Medicine; Genetics; Gene","score_opus":0.019328944973250415,"score_gpt":0.2739760683217456,"score_spread":0.25464712334849515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221115485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807685,0.00062837434,0.00009449517,0.0017280248,0.00020099137,0.0005540435,0.00016312729,0.000029825223,0.0158326],"genre_scores_gemma":[0.99482447,0.000015351317,0.00013835638,0.0035362535,0.00008337659,0.0002268823,0.000053401916,0.000034003868,0.0010879202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984901,0.00019732334,0.0002680318,0.00047298268,0.00020171414,0.00036987395],"domain_scores_gemma":[0.9995136,0.000035156325,0.000048737948,0.0003075893,0.00002708484,0.00006782961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017377533,0.00016699256,0.00036320754,0.00022959465,0.000067220324,0.0000047458007,0.00010936133,0.000088894434,0.00034920636],"category_scores_gemma":[0.000021385531,0.00016718253,0.00006815952,0.00023362825,0.000057975652,0.000034695502,0.00012461877,0.00040220807,0.000048793412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018020721,0.0048009697,0.6067921,0.0001299122,0.00016822793,0.036813878,0.10983672,0.00060868263,0.150458,0.0009551993,0.0026853946,0.06873021],"study_design_scores_gemma":[0.025353987,0.0036549214,0.94153184,0.000050473114,0.00014943481,0.0010701307,0.0010092305,0.0021946402,0.012884978,0.007667435,0.0038682462,0.00056467135],"about_ca_topic_score_codex":0.00072703796,"about_ca_topic_score_gemma":0.00044983817,"teacher_disagreement_score":0.33473977,"about_ca_system_score_codex":0.00034359132,"about_ca_system_score_gemma":0.00020053561,"threshold_uncertainty_score":0.68175054},"labels":[],"label_agreement":null},{"id":"W4223611009","doi":"10.21203/rs.3.rs-1504156/v1","title":"Lifestyle and occupational risk assessment using machine learning methods and development a web-based nomogram for prediction of bladder cancer Short title: Risk assessment and nomogram to predict bladder cancer","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Nomogram; Medicine; Logistic regression; Bladder cancer; Receiver operating characteristic; Risk assessment; Population; Machine learning; Area under the curve; Cancer; Oncology; Statistics; Internal medicine; Environmental health; Computer science; Mathematics","score_opus":0.10962885810409621,"score_gpt":0.5078302410366136,"score_spread":0.39820138293251733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223611009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91601866,0.012682984,0.04246491,0.0006375583,0.0008049005,0.010940256,0.014893982,0.00019173321,0.0013650095],"genre_scores_gemma":[0.8090233,0.0062779407,0.17567617,0.000080663594,0.00046455185,0.006272694,0.0014407068,0.00014865931,0.00061531726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967821,0.000602586,0.00044345524,0.000782961,0.0009578742,0.00043098087],"domain_scores_gemma":[0.99830043,0.0003807644,0.00016973601,0.0002892387,0.000529514,0.00033034166],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019705335,0.00032272856,0.00053376704,0.00046415295,0.00047132754,0.0000893879,0.00009799863,0.00020285914,0.0010630433],"category_scores_gemma":[0.00014794688,0.00028925383,0.00008656416,0.0002576269,0.0001367906,0.000053891676,0.0004736728,0.0011854739,5.5217674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004257081,0.00026778723,0.8962196,0.00088478375,0.001036283,0.000005286962,0.00028075188,0.0014498989,0.0002502525,0.000004854516,0.00062437274,0.098550424],"study_design_scores_gemma":[0.0028285198,0.0011423248,0.84723735,0.0006210458,0.0007293394,0.000005593141,0.00021663662,0.11170162,0.0002717295,0.000038203565,0.034916844,0.0002907834],"about_ca_topic_score_codex":0.0027725426,"about_ca_topic_score_gemma":0.00035786818,"teacher_disagreement_score":0.13321127,"about_ca_system_score_codex":0.00086225814,"about_ca_system_score_gemma":0.003434142,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W4224067951","doi":"10.1016/j.urolonc.2022.03.014","title":"Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemotherapy; Race (biology); Medicine; Oncology; Ethnic group; Bladder cancer; Internal medicine; Overall survival; Cancer; Biology","score_opus":0.03306754418097076,"score_gpt":0.3492049090228632,"score_spread":0.3161373648418925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224067951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930718,0.0013676303,0.000005829604,0.004389687,0.00017229244,0.0005591067,0.00011583086,0.00003837886,0.00027945035],"genre_scores_gemma":[0.99145544,0.0014872528,0.0008399225,0.0043749125,0.00005723679,0.0004995433,0.00011952308,0.000029113626,0.0011370381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982573,0.0003436038,0.000292672,0.00051281916,0.00021286368,0.00038077208],"domain_scores_gemma":[0.9992201,0.00025646345,0.00012611451,0.00014411418,0.000022615724,0.00023060146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003363758,0.00030012074,0.00065477943,0.00014877687,0.0003584803,0.000024667554,0.000070914415,0.0001095544,0.00029395206],"category_scores_gemma":[0.000026284899,0.00023419582,0.000053716503,0.0002912574,0.00053474656,0.00006807881,0.000081201906,0.00042318788,6.0062814e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007061708,0.00061443425,0.95156467,0.00003197877,0.00020044537,0.00008714613,0.0032099306,0.000011368966,0.0004890847,0.000061271276,0.00068066776,0.042342834],"study_design_scores_gemma":[0.017963622,0.011514328,0.8569775,0.000028479804,0.0004292983,0.00012322224,0.0006153555,0.00044577918,0.0011109196,0.0011023061,0.10927317,0.00041602226],"about_ca_topic_score_codex":0.000342594,"about_ca_topic_score_gemma":0.0002827092,"teacher_disagreement_score":0.10859251,"about_ca_system_score_codex":0.00020310962,"about_ca_system_score_gemma":0.000086320935,"threshold_uncertainty_score":0.9550228},"labels":[],"label_agreement":null},{"id":"W4224281565","doi":"10.1369/00221554221095530","title":"Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers","year":2022,"lang":"en","type":"article","venue":"Journal of Histochemistry & Cytochemistry","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Cancerfonden; Ontario Institute for Cancer Research; Bladder Cancer Canada; Cancer Research Society","keywords":"Subtyping; Immunohistochemistry; Bladder cancer; Taxonomy (biology); Pathology; Biology; Computational biology; Computer science; Cancer; Medicine; Zoology; Genetics; Programming language","score_opus":0.023942765356281506,"score_gpt":0.2732489403492909,"score_spread":0.24930617499300942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224281565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985119,0.009836897,0.00053557707,0.0003675538,0.00016288839,0.00047816776,0.00009812896,0.00001751984,0.0033843091],"genre_scores_gemma":[0.9930649,0.00021016094,0.0047780056,0.0001712625,0.0002287616,0.00033009643,0.000037717346,0.00005339015,0.0011257184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789464,0.000019772098,0.000818581,0.0003547101,0.0005471983,0.0003651151],"domain_scores_gemma":[0.99809074,0.00006938121,0.0008429898,0.00035471312,0.00036828223,0.00027389452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027388445,0.0003208761,0.00072418706,0.00007885924,0.00020424562,0.000014617777,0.00028406928,0.00015942956,0.0002579825],"category_scores_gemma":[0.00006967564,0.0003284559,0.0003833745,0.00016333138,0.0002507032,0.000086231885,0.00011995765,0.0006707904,2.2151319e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027848624,0.0002817979,0.0028704104,0.0007549552,0.0006041326,0.000059523256,0.000117542244,0.00016229718,0.9870003,0.0000045539523,0.0040263627,0.0013332698],"study_design_scores_gemma":[0.004897986,0.0007732382,0.0001460021,0.0002704601,0.00093125884,0.001161442,0.00069094077,0.00038863855,0.97683483,0.000023648157,0.013534299,0.00034726068],"about_ca_topic_score_codex":0.000010713333,"about_ca_topic_score_gemma":6.816103e-8,"teacher_disagreement_score":0.010165467,"about_ca_system_score_codex":0.00093146355,"about_ca_system_score_gemma":0.00097581255,"threshold_uncertainty_score":0.99991673},"labels":[],"label_agreement":null},{"id":"W4224316186","doi":"10.1177/10668969221095173","title":"The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis","year":2022,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"KWF Kankerbestrijding; University of Toronto; Bladder Cancer Advocacy Network","keywords":"Immunohistochemistry; Bladder cancer; Medicine; Cystectomy; Cut-off; Interquartile range; Internal medicine; Stage (stratigraphy); Cancer; Pathological; Oncology; Pathology; Gastroenterology; Biology","score_opus":0.03078932063284484,"score_gpt":0.3586667574228317,"score_spread":0.3278774367899869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224316186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859329,0.0046831854,0.0016138138,0.0051716794,0.00089813204,0.0005529841,0.0010896706,0.000005936117,0.000051740095],"genre_scores_gemma":[0.99675184,0.0012664534,0.0011684812,0.00022076967,0.00018295176,0.00018303224,0.00002290716,0.000016073578,0.00018746142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980569,0.00017409952,0.0006854997,0.00018124362,0.0007074284,0.00019483389],"domain_scores_gemma":[0.9973648,0.0006313823,0.0004392587,0.00018763638,0.0012790513,0.00009783969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006894805,0.00013203378,0.0004322329,0.00019360399,0.00012948038,0.0000108518025,0.0005486104,0.000056732326,0.00014550671],"category_scores_gemma":[0.00014691763,0.00008057632,0.00046475846,0.0003183809,0.00023912059,0.000039261493,0.00018339186,0.0003386537,5.784358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046717886,0.017705232,0.62351274,0.0002356076,0.06385079,0.0037748953,0.010532353,0.050756056,0.1337226,0.000492797,0.00872484,0.03997418],"study_design_scores_gemma":[0.15291476,0.019416286,0.3537149,0.0009193579,0.02002715,0.0075134225,0.015733745,0.027296431,0.30181482,0.00011618559,0.09906913,0.0014637924],"about_ca_topic_score_codex":0.00007474044,"about_ca_topic_score_gemma":0.00001229448,"teacher_disagreement_score":0.26979786,"about_ca_system_score_codex":0.0002486407,"about_ca_system_score_gemma":0.0005795226,"threshold_uncertainty_score":0.32858068},"labels":[],"label_agreement":null},{"id":"W4224512027","doi":"10.1016/j.euros.2022.02.011","title":"Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study","year":2022,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology","keywords":"Cystectomy; Medicine; Bladder cancer; Retrospective cohort study; Proportional hazards model; Urology; Internal medicine; Carcinoma in situ; Clinical endpoint; Oncology; Carcinoma; Cancer; Clinical trial","score_opus":0.034113312885951465,"score_gpt":0.31443322682576935,"score_spread":0.28031991393981787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224512027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98125845,0.00066944654,0.00000464052,0.0006518738,0.0020262727,0.002753054,0.00210774,0.000042752577,0.01048574],"genre_scores_gemma":[0.99749845,0.00014595565,0.00044365536,0.0011731758,0.000140689,0.00029817995,0.000086317035,0.000050039842,0.00016355189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476314,0.001133083,0.00074700324,0.0017426088,0.0009962822,0.0006179113],"domain_scores_gemma":[0.99688315,0.000946676,0.0005595218,0.000966625,0.00028932543,0.0003546857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012508911,0.0004708522,0.0011601527,0.00026898974,0.0006288237,0.000085905405,0.0011748096,0.000054645214,0.00052267115],"category_scores_gemma":[0.00043102042,0.00039627886,0.00012902179,0.0006355776,0.0015864521,0.0004243063,0.0028748035,0.0009324279,0.000037983584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19347416,0.00773435,0.665784,0.00009157756,0.0052010887,0.0037988764,0.092479736,0.000116548654,0.007807603,0.00002203645,0.0034058704,0.020084176],"study_design_scores_gemma":[0.047396637,0.009608833,0.93818617,0.000033336684,0.0008218965,0.000006430712,0.002490046,0.000022331898,0.00034352904,0.000009975884,0.00074672594,0.00033410554],"about_ca_topic_score_codex":0.002593631,"about_ca_topic_score_gemma":0.0010811867,"teacher_disagreement_score":0.27240217,"about_ca_system_score_codex":0.0007973921,"about_ca_system_score_gemma":0.0015223451,"threshold_uncertainty_score":0.9998489},"labels":[],"label_agreement":null},{"id":"W4224998175","doi":"10.1016/j.humpath.2022.04.013","title":"Morphologic alterations post trimodal therapy in muscle-invasive urothelial carcinoma: understanding the impact of post-treatment changes on the pathological interpretation and their potential clinical correlates","year":2022,"lang":"en","type":"article","venue":"Human Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Pathological; Cancer; Pathology; Fibrosis; Stage (stratigraphy); Carcinoma; Carcinoma in situ; Retrospective cohort study; Internal medicine; Oncology; Biology","score_opus":0.08572796945552806,"score_gpt":0.3445784314609898,"score_spread":0.25885046200546175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224998175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535,0.00040074968,0.0000706108,0.0023661517,0.00018782687,0.0011416178,0.0002444823,0.000022068794,0.00021649098],"genre_scores_gemma":[0.9981441,0.00019023307,0.0000070235274,0.0011322544,0.00010794549,0.00025728202,0.00011020156,0.000020163932,0.000030827432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794674,0.0009650677,0.00035076556,0.00036472123,0.00012583165,0.0002468986],"domain_scores_gemma":[0.9988746,0.00054584176,0.00017136509,0.00030383878,0.000054088847,0.000050250084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043728086,0.00023413335,0.00041243996,0.00013689944,0.00041054425,0.000017109054,0.00012967628,0.00010401256,0.00030331354],"category_scores_gemma":[0.00007193211,0.000108331275,0.00023118562,0.00011632142,0.00039510676,0.000022612725,0.00008151672,0.00038101827,0.000002607727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018920958,0.009602152,0.54634273,0.00003579527,0.001205502,0.004101499,0.09967289,0.0011487931,0.27519622,0.008129569,0.00022001332,0.035423856],"study_design_scores_gemma":[0.0062884586,0.04186715,0.9372998,0.000019281251,0.00010507915,0.000771649,0.00954578,0.00034393667,0.0006523875,0.0029358885,0.000008511745,0.0001620671],"about_ca_topic_score_codex":0.00024707665,"about_ca_topic_score_gemma":0.00018039368,"teacher_disagreement_score":0.3909571,"about_ca_system_score_codex":0.00028406776,"about_ca_system_score_gemma":0.00014723385,"threshold_uncertainty_score":0.44176212},"labels":[],"label_agreement":null},{"id":"W4225249822","doi":"10.1097/ju.0000000000002608.02","title":"MP42-02 URINARY HUMAN PAPILLOMA VIRUS INFECTION AND BLADDER CANCER RISK: A SYSTEMATIC REVIEW AND A PRISMA-COMPLIANT META-ANALYSIS","year":2022,"lang":"en","type":"review","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Garcia; Medicine; Human papilloma virus; Meta-analysis; Cancer; Humanities; Art; Pathology; Internal medicine; Cervical cancer","score_opus":0.1112172071721895,"score_gpt":0.3855041877770571,"score_spread":0.27428698060486756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225249822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096591735,0.9975118,0.000017232178,0.00037393777,0.000086675405,0.0017212906,0.00006922037,0.000009890523,0.00011334553],"genre_scores_gemma":[0.0003753205,0.99799186,0.000010828496,0.0008682303,0.00010702473,0.00027932817,0.00000971084,0.00004266487,0.00031502714],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954509,0.0022847801,0.0014253756,0.0002643639,0.00033884635,0.00023573282],"domain_scores_gemma":[0.9963801,0.00042906558,0.002448459,0.00049357343,0.00009713432,0.00015165584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018481067,0.00044596664,0.007160711,0.0004104016,0.000246092,0.000016257849,0.00018247397,0.0001507902,0.001707246],"category_scores_gemma":[0.00010497092,0.00021509442,0.0017649647,0.00047717008,0.0001241936,0.000051477447,0.00012229329,0.0009900307,0.000005438937],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010162035,0.00029352342,0.000094483985,0.41898516,0.5717921,0.00030247355,0.0002718646,0.0000027623655,6.956659e-7,0.000010155089,0.0005611464,0.0075839977],"study_design_scores_gemma":[0.00038650984,0.0013905638,0.00011564849,0.004323653,0.89617544,0.007213817,0.000009112995,0.0000015156942,1.12206635e-7,0.000036798578,0.090202,0.00014483668],"about_ca_topic_score_codex":0.00047265572,"about_ca_topic_score_gemma":0.00008857091,"teacher_disagreement_score":0.41466153,"about_ca_system_score_codex":0.00012800575,"about_ca_system_score_gemma":0.00019115089,"threshold_uncertainty_score":0.99920535},"labels":[],"label_agreement":null},{"id":"W4225260127","doi":"10.1097/ju.0000000000002613.01","title":"PD45-01 SHORT-TERM POSTOPERATIVE FUNCTIONAL OUTCOMES OF REZŪM VS. GREENLIGHT PVP 180W XPS: A PROPENSITY MATCH SCORE STUDY","year":2022,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Propensity score matching; Urology; Surgery; Internal medicine; Prostate","score_opus":0.04969098774715229,"score_gpt":0.30104222616890386,"score_spread":0.25135123842175155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225260127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934585,0.00041626176,0.000033896384,0.008591352,0.0005309917,0.0005792191,0.00002255447,0.000008069752,0.00047182283],"genre_scores_gemma":[0.99680954,0.000034488774,0.000025348512,0.0021310737,0.00014538335,0.000014890974,0.000004566391,0.000018111443,0.0008166179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818814,0.00046633297,0.000496599,0.00013677806,0.00052220444,0.00018993566],"domain_scores_gemma":[0.9990344,0.00011615978,0.0002639279,0.00026276713,0.00024109612,0.0000816386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006920226,0.00015896541,0.00061437784,0.00012630541,0.0002081815,0.000005032391,0.00021087872,0.000039737915,0.0010566049],"category_scores_gemma":[0.00004096359,0.00008876205,0.00014575124,0.00014798778,0.00012360273,0.00006311989,0.00015690699,0.0005434067,0.0000069955327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011500504,0.0018195488,0.9748545,0.00001113465,0.0013648379,0.000440557,0.00401735,0.000067758185,0.0022969344,0.000044802327,0.0026161599,0.00096585916],"study_design_scores_gemma":[0.0036908768,0.011638353,0.9789654,0.000006385667,0.00095891574,0.0025010912,0.0009988556,0.000007930629,0.00028928608,0.00012537606,0.0007413552,0.000076173776],"about_ca_topic_score_codex":0.00009717194,"about_ca_topic_score_gemma":0.000066655586,"teacher_disagreement_score":0.009818804,"about_ca_system_score_codex":0.00010571686,"about_ca_system_score_gemma":0.00030219814,"threshold_uncertainty_score":0.9998566},"labels":[],"label_agreement":null},{"id":"W4225329268","doi":"10.1186/s13293-022-00428-0","title":"Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"article","venue":"Biology of Sex Differences","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Queen's University; Bladder Cancer Canada","keywords":"Immune system; Bladder cancer; Tumor microenvironment; Medicine; Immunotherapy; Immune checkpoint; Immunology; Myeloid; Cancer; Cancer research; Internal medicine","score_opus":0.041026180601639206,"score_gpt":0.27258926181476195,"score_spread":0.23156308121312275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225329268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951285,0.0029214525,0.000002192982,0.0010717008,0.000044314722,0.000529538,0.00012552565,0.0000057106195,0.00017106225],"genre_scores_gemma":[0.99867976,0.0005746322,0.000021967724,0.00035868058,0.000021024958,0.00022409987,0.0000069171497,0.000009981184,0.00010296255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985263,0.0002471711,0.00042370896,0.00030970867,0.00025596007,0.00023717713],"domain_scores_gemma":[0.9991128,0.00024374029,0.00025119612,0.0003346228,0.00002402278,0.000033617816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023762924,0.00021492029,0.00056063855,0.000106106876,0.00011390699,0.0000035819885,0.00032371422,0.000048238868,0.00019386588],"category_scores_gemma":[0.000016695734,0.00011426806,0.00007642022,0.00013311327,0.0005173499,0.000023902063,0.00017987557,0.00024913927,3.9548283e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002846633,0.00066477834,0.8343275,0.000078680656,0.00028202738,0.000007793329,0.006267944,0.000044842687,0.15622379,0.000117592426,0.000011795733,0.0016885895],"study_design_scores_gemma":[0.0012104661,0.001986409,0.9474268,0.000084196836,0.0001413014,0.000019943258,0.005183487,0.00042323038,0.042862084,0.0005238914,0.000012047318,0.00012614191],"about_ca_topic_score_codex":0.001991934,"about_ca_topic_score_gemma":0.000036365553,"teacher_disagreement_score":0.11336171,"about_ca_system_score_codex":0.000036404963,"about_ca_system_score_gemma":0.00010709263,"threshold_uncertainty_score":0.46597165},"labels":[],"label_agreement":null},{"id":"W4225499003","doi":"10.1016/j.eururo.2022.03.027","title":"Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; McMaster University; Impact; McMaster University Medical Centre","funders":"","keywords":"Medicine; Incidence (geometry); Renal cell carcinoma; Bladder cancer; Cochrane Library; Population; Confidence interval; Meta-analysis; Internal medicine; Urology; Gynecology; Cancer","score_opus":0.01854652745967333,"score_gpt":0.2589730960350942,"score_spread":0.24042656857542088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225499003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013736481,0.9805051,0.0000031123743,0.0000056220406,0.00011625528,0.004548728,0.0005626268,0.0000074630275,0.00051461416],"genre_scores_gemma":[0.015880916,0.9836051,0.000022095886,0.00009085154,0.000031681946,0.00013796307,0.000055012482,0.000072080766,0.00010431297],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975037,0.0009884108,0.00072912953,0.00036366103,0.00023644172,0.00017866134],"domain_scores_gemma":[0.9977109,0.00039461988,0.0012598402,0.00048391894,0.00007282443,0.00007788654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037318908,0.00032666782,0.0020564238,0.00007660757,0.00007894336,0.0000039684746,0.0002054558,0.000059266964,0.000034563735],"category_scores_gemma":[0.00028992418,0.00016899515,0.00023932272,0.00014141647,0.00024430235,0.00002266146,0.00015029043,0.00028135916,5.9502804e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102719,0.00005444413,0.012016381,0.9835252,0.00047883348,0.000011645455,0.00025127642,2.988304e-7,1.8642022e-7,0.0000043803257,0.00012013158,0.0034345079],"study_design_scores_gemma":[0.008099345,0.011352123,0.061696276,0.6871429,0.09741765,0.00020784499,0.0000872063,0.0000053799336,0.000017667684,0.000012880322,0.1328857,0.0010750422],"about_ca_topic_score_codex":0.00016035332,"about_ca_topic_score_gemma":0.000013341876,"teacher_disagreement_score":0.2963823,"about_ca_system_score_codex":0.000066909575,"about_ca_system_score_gemma":0.00024720782,"threshold_uncertainty_score":0.6891422},"labels":[],"label_agreement":null},{"id":"W4225678575","doi":"10.1097/ju.0000000000002574.05","title":"PD26-05 HOW LONG SHOULD WE FOLLOW LOW GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)? A LARGE RETROSPECTIVE SINGLE INSTITUTION ANALYSIS","year":2022,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Medicine; Bladder cancer; General surgery; Classics; Cancer; Internal medicine; History","score_opus":0.031409507139890006,"score_gpt":0.2900274581099525,"score_spread":0.2586179509700625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225678575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549552,0.005024527,0.002389246,0.0354513,0.0010504951,0.00046126265,0.00011784019,0.000022036405,0.00052809255],"genre_scores_gemma":[0.9947831,0.0010682165,0.00003522133,0.00298288,0.00047385233,0.000030892985,0.000013840934,0.00002691871,0.0005850541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981367,0.00031311734,0.00035334015,0.00022196313,0.00057776924,0.00039711955],"domain_scores_gemma":[0.9987165,0.000115319344,0.00047919503,0.0003256348,0.00021809379,0.00014525752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005502108,0.00021501479,0.0006463215,0.00038521388,0.00036787693,0.000019210147,0.00027223886,0.000098645665,0.0008719155],"category_scores_gemma":[0.000093794886,0.00014667177,0.0003996683,0.0009016264,0.00013830319,0.00014727203,0.00012614248,0.0007996255,0.0000050565845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015327262,0.009045101,0.70747,0.00020722795,0.051145416,0.0060468097,0.03036602,0.020408647,0.07955758,0.00048845116,0.06918363,0.010753832],"study_design_scores_gemma":[0.02369269,0.019651175,0.87053335,0.000107496286,0.03680201,0.0030769445,0.00425275,0.0015312678,0.008335902,0.0016928056,0.029536875,0.000786714],"about_ca_topic_score_codex":0.00021644855,"about_ca_topic_score_gemma":0.0012504136,"teacher_disagreement_score":0.16306335,"about_ca_system_score_codex":0.00059311686,"about_ca_system_score_gemma":0.00046863998,"threshold_uncertainty_score":0.95468634},"labels":[],"label_agreement":null},{"id":"W4225729140","doi":"10.23736/s2724-6051.22.04659-6","title":"Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis","year":2022,"lang":"en","type":"article","venue":"Minerva Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multidisciplinary approach; Systemic therapy; MEDLINE; Stage (stratigraphy); Adjuvant; Disease; Clinical endpoint","score_opus":0.016093427060224545,"score_gpt":0.3014694526800163,"score_spread":0.28537602561979175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225729140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8937934,0.096845,0.00006996279,0.006098202,0.00017581104,0.0028324046,0.00013226758,0.00003106923,0.000021868274],"genre_scores_gemma":[0.9808006,0.005967305,0.00007789788,0.01048388,0.00006113544,0.0024552555,0.00005401924,0.000025665946,0.00007422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803746,0.00044615797,0.00050230406,0.0005069678,0.00012260617,0.00038451172],"domain_scores_gemma":[0.9989483,0.00051201857,0.00012275593,0.00024204614,0.0000674521,0.00010742758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003322185,0.00024146235,0.0012805412,0.0002720414,0.00021002098,0.00000687092,0.0000895159,0.00012386385,0.00009796787],"category_scores_gemma":[0.00010090528,0.00019500044,0.00014225935,0.00031220086,0.00014805581,0.000046198642,0.000112476955,0.00023687689,0.000001068356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087751495,0.0013181695,0.90321666,0.07588072,0.005396491,0.00020778751,0.0017761912,0.00006188334,0.00088100124,0.0003293465,0.0007328033,0.0014237835],"study_design_scores_gemma":[0.07695444,0.052493934,0.7799535,0.0067049605,0.06747246,0.0030484663,0.0007304706,0.008005864,0.000045696223,0.0013778383,0.0013315806,0.0018808059],"about_ca_topic_score_codex":0.00013185432,"about_ca_topic_score_gemma":0.00017043126,"teacher_disagreement_score":0.12326319,"about_ca_system_score_codex":0.000078326884,"about_ca_system_score_gemma":0.00010442162,"threshold_uncertainty_score":0.79518867},"labels":[],"label_agreement":null},{"id":"W4226302670","doi":"10.1016/j.urolonc.2022.02.021","title":"The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cytology; Medicine; Cystoscopy; Bladder cancer; Urine cytology; Urinary system; Internal medicine; Cancer; Urology; Pathology","score_opus":0.030104106422192228,"score_gpt":0.3265574076720914,"score_spread":0.29645330124989916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226302670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720499,0.011012009,0.000031761032,0.014452408,0.00037945452,0.0013731596,0.0001533813,0.00003286352,0.0005150879],"genre_scores_gemma":[0.98159885,0.0027496873,0.004629791,0.004777733,0.00019380279,0.0050836797,0.000055712448,0.000024942774,0.0008857712],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986407,0.00021159522,0.000309984,0.00034290686,0.00015976079,0.00033503518],"domain_scores_gemma":[0.99845463,0.0009317993,0.0001764283,0.00020859623,0.000091066926,0.00013747405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027436795,0.00018850453,0.0003595853,0.000088192,0.0006092611,0.000008738797,0.00013032019,0.00012277772,0.00020811865],"category_scores_gemma":[0.00012510945,0.00012888695,0.0001129111,0.00020020816,0.0008046769,0.000041974596,0.000074144584,0.00029236893,0.0000018790423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034081412,0.0014546275,0.95582384,0.00006959485,0.000796181,0.0002613815,0.0021744808,0.00024344344,0.0015435724,0.010060523,0.008835409,0.015328817],"study_design_scores_gemma":[0.0038036269,0.017425045,0.06654323,0.000020740203,0.000646285,0.000482838,0.00065338815,0.0002884325,0.0006320769,0.01185885,0.89745724,0.0001882587],"about_ca_topic_score_codex":0.00011039305,"about_ca_topic_score_gemma":0.000035290654,"teacher_disagreement_score":0.8892806,"about_ca_system_score_codex":0.00014020763,"about_ca_system_score_gemma":0.0011030639,"threshold_uncertainty_score":0.5255858},"labels":[],"label_agreement":null},{"id":"W4226306406","doi":"10.1097/ju.0000000000002562.04","title":"MP23-04 BENEFIT OF NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADIATION-BASED THERAPY: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS","year":2022,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Chemotherapy; Cancer; Psychoanalysis; Radiology; Surgery; Internal medicine; Psychology","score_opus":0.019825560966072856,"score_gpt":0.27316703166901635,"score_spread":0.2533414707029435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226306406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960816,0.00063219963,0.00008183948,0.0018550273,0.000061533436,0.0010618308,0.00019124468,0.000008974495,0.000025758804],"genre_scores_gemma":[0.9975431,0.0004343212,0.00018791205,0.0014545046,0.00006807348,0.0001429247,0.00008713596,0.000026567663,0.000055441607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861187,0.00024493408,0.0004468679,0.00018035763,0.0003070907,0.00020890374],"domain_scores_gemma":[0.9983492,0.00020604508,0.00062414334,0.0003035808,0.0004078196,0.00010919703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002478369,0.0002020464,0.00063629856,0.00024476225,0.00014399138,0.0000043350965,0.00015368515,0.00005377483,0.0006397277],"category_scores_gemma":[0.000011945061,0.00010905366,0.0002546041,0.00047347642,0.00011200267,0.000053844054,0.000008905512,0.00013208277,2.804569e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046079785,0.0049682558,0.8949276,0.00001861906,0.011288682,0.000014118593,0.0034990176,0.014946151,0.0014664998,0.000011182715,0.00017613004,0.022603925],"study_design_scores_gemma":[0.079281755,0.11552837,0.75349396,0.000016616887,0.016394492,0.000050042374,0.00040307658,0.0051881378,0.02580904,0.00061631546,0.0028438626,0.00037430922],"about_ca_topic_score_codex":0.00086736516,"about_ca_topic_score_gemma":0.00058167713,"teacher_disagreement_score":0.14143364,"about_ca_system_score_codex":0.0003578468,"about_ca_system_score_gemma":0.00058006006,"threshold_uncertainty_score":0.7004569},"labels":[],"label_agreement":null},{"id":"W4226415896","doi":"","title":"Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)","year":2022,"lang":"en","type":"review","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Systematic review; MEDLINE; Internal medicine; Population; Oncology; Cancer","score_opus":0.40814354940022013,"score_gpt":0.6052500228315891,"score_spread":0.197106473431369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226415896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007552727,0.9861859,0.0000010779006,0.00016083603,0.0010950046,0.010394539,0.0007596095,0.000033810695,0.0006139651],"genre_scores_gemma":[0.0008927306,0.9906442,0.00005872157,0.00039550572,0.00024229048,0.0054157777,0.000097502365,0.00020794559,0.0020453164],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98999697,0.001973192,0.0043335753,0.0012908881,0.0017046808,0.0007007036],"domain_scores_gemma":[0.98790723,0.0034713265,0.00569547,0.001859301,0.0006516603,0.00041503503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019225904,0.0015283122,0.013707228,0.0020462184,0.00024106365,0.0003091252,0.002448218,0.0002783056,0.007052542],"category_scores_gemma":[0.0015946076,0.000982128,0.0018702161,0.004002984,0.00017913853,0.0011784763,0.0010708123,0.0012325034,0.000018828916],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016245095,0.0011456669,0.041251782,0.7563581,0.013294447,0.000953688,0.00086847384,0.000008867877,0.000008317934,0.0000075042567,0.01174457,0.17419615],"study_design_scores_gemma":[0.0015615987,0.0001987367,0.023685854,0.89583546,0.02235591,0.000068532485,0.00011873606,5.757155e-7,0.000031869506,0.00010289634,0.05521858,0.00082127244],"about_ca_topic_score_codex":0.012386413,"about_ca_topic_score_gemma":0.0023660732,"teacher_disagreement_score":0.17337488,"about_ca_system_score_codex":0.002911567,"about_ca_system_score_gemma":0.0023774807,"threshold_uncertainty_score":0.99974656},"labels":[],"label_agreement":null},{"id":"W4229025450","doi":"10.1007/s11255-022-03221-5","title":"Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity","year":2022,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Poisson regression; Bladder cancer; Ethnic group; Demography; Life expectancy; Internal medicine; Epidemiology; Cancer; Mortality rate; Surveillance, Epidemiology, and End Results; Gerontology; Cancer registry; Population; Environmental health","score_opus":0.02013407828501834,"score_gpt":0.3112342255180455,"score_spread":0.2911001472330272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229025450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98103565,0.0005040257,0.00007356211,0.01581775,0.0009383536,0.0004299963,0.00009706605,0.00002583913,0.0010777292],"genre_scores_gemma":[0.9620297,0.00007357465,0.000091972186,0.036835536,0.00016809249,0.00051058806,0.000030677766,0.000018655763,0.00024122947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872875,0.0001428739,0.00027214046,0.00037706245,0.00020565868,0.0002735305],"domain_scores_gemma":[0.99949265,0.00010506642,0.00006998718,0.00011217317,0.00006240289,0.00015770001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012054834,0.00014872945,0.0003075804,0.00028289508,0.00010483457,0.0000061682163,0.00013759945,0.000057661902,0.0020993173],"category_scores_gemma":[0.00013230731,0.00014384632,0.000052036747,0.00014969803,0.00006775928,0.000058402475,0.00019854594,0.00031102358,0.000022866478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008974505,0.0014611002,0.9702485,0.000011526642,0.0009178766,0.00025824743,0.002004088,0.00049795647,0.0026157096,0.0016306598,0.0053021354,0.006077669],"study_design_scores_gemma":[0.017812517,0.0056455163,0.8714635,0.000010119713,0.00037524122,0.00027030948,0.00053240755,0.00091273355,0.00036443712,0.0026566687,0.09949638,0.00046021675],"about_ca_topic_score_codex":0.0003943558,"about_ca_topic_score_gemma":0.00016524119,"teacher_disagreement_score":0.09878507,"about_ca_system_score_codex":0.000120386765,"about_ca_system_score_gemma":0.00017933953,"threshold_uncertainty_score":0.9988129},"labels":[],"label_agreement":null},{"id":"W4229059608","doi":"10.1016/j.euo.2021.07.001","title":"Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder Cancer","year":2021,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"FP7 Health; University of Sheffield; University of Birmingham; Instituto de Salud Carlos III; National Institute for Health and Care Research; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Cancer Research UK","keywords":"Single-nucleotide polymorphism; Hazard ratio; Genome-wide association study; Bladder cancer; Oncology; SNP; Medicine; Candidate gene; Locus (genetics); Proportional hazards model; Expression quantitative trait loci; 1000 Genomes Project; Genetic association; Genetics; Gene; Internal medicine; Confidence interval; Genotype; Biology; Cancer","score_opus":0.1060085893577181,"score_gpt":0.38479782066120766,"score_spread":0.27878923130348954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229059608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009461503,0.99453855,0.000045568522,0.00045852773,0.00021475219,0.0013702858,0.00020801628,0.000047251146,0.0021709125],"genre_scores_gemma":[0.0022533142,0.9938131,0.00019788127,0.0008793281,0.0001583635,0.00057351287,0.000717875,0.00012814815,0.0012784812],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949155,0.001829503,0.0009740668,0.0013735318,0.0002860922,0.0006213155],"domain_scores_gemma":[0.9972097,0.0008333475,0.0008662758,0.0006089965,0.00026240686,0.00021926941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007727946,0.0007583497,0.005835886,0.00069814286,0.000117901334,0.000034978715,0.00027713482,0.0004776163,0.000629527],"category_scores_gemma":[0.00029339993,0.0005075913,0.0010376959,0.0012346496,0.00043962343,0.00006538921,0.00027962145,0.00089198165,0.00003590008],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022132962,0.0020555342,0.006292281,0.0026875355,0.47178835,0.0099679865,0.0011019423,0.00003644426,0.000026100006,0.0000074854056,0.00047554992,0.50533944],"study_design_scores_gemma":[0.0018867922,0.001407294,0.020870287,0.0005955002,0.51521766,0.00022229037,0.000040239247,0.0000024665421,0.0000023593411,0.0000022686913,0.45925504,0.0004977941],"about_ca_topic_score_codex":0.00008462114,"about_ca_topic_score_gemma":0.0020151678,"teacher_disagreement_score":0.5048417,"about_ca_system_score_codex":0.00032359618,"about_ca_system_score_gemma":0.0012537434,"threshold_uncertainty_score":0.99973756},"labels":[],"label_agreement":null},{"id":"W4229364556","doi":"10.1245/s10434-022-11742-7","title":"ASO Visual Abstract: Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; Urothelial carcinoma; Urology; Carcinoma; Oncology; Pathology; Internal medicine; Bladder cancer; Cancer","score_opus":0.02890507165532032,"score_gpt":0.30698696877399195,"score_spread":0.27808189711867165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229364556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186724,0.0005228491,0.0000010314722,0.0006030108,0.00003524145,0.0010622377,0.000105489504,0.0000094786765,0.005793402],"genre_scores_gemma":[0.9994436,0.0000765261,0.000037361686,0.00010522051,0.000033509914,0.00013959142,0.000017943024,0.000025700945,0.00012053544],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789053,0.00036653006,0.00058043003,0.00031418304,0.0005512906,0.00029704903],"domain_scores_gemma":[0.99889976,0.00029844797,0.0002744159,0.00023353183,0.00018217755,0.00011168849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026613675,0.00020689372,0.0007873032,0.00013150097,0.000058109905,0.000002247962,0.00017054657,0.00014410535,0.0006533606],"category_scores_gemma":[0.000024313014,0.0001311074,0.00023065257,0.00040122634,0.00033395848,0.00003937585,0.00011095644,0.00035684605,0.0000024583726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024646778,0.019815043,0.79829985,0.0005101005,0.0014279196,0.0021904905,0.00452933,0.0009999644,0.13684611,0.00030953292,0.00040316043,0.010021744],"study_design_scores_gemma":[0.015919644,0.016321197,0.45027804,0.00011800516,0.0003421341,0.00018667839,0.000669578,0.00023558315,0.5102575,0.00003709521,0.0054353136,0.0001992594],"about_ca_topic_score_codex":0.0005594235,"about_ca_topic_score_gemma":0.000029345503,"teacher_disagreement_score":0.37341136,"about_ca_system_score_codex":0.00007210293,"about_ca_system_score_gemma":0.0006365302,"threshold_uncertainty_score":0.71538407},"labels":[],"label_agreement":null},{"id":"W4229892500","doi":"10.1016/j.urology.2009.10.065","title":"Reply","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Traditional medicine; Gynecology; Family medicine","score_opus":0.012044468788864369,"score_gpt":0.28125054245806275,"score_spread":0.26920607366919835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229892500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8229429,0.00011235735,0.000100273945,0.014537234,0.0009592533,0.00016149408,0.000003456061,0.00009808091,0.16108492],"genre_scores_gemma":[0.983873,0.0000043545824,0.00020466984,0.013244443,0.00024162066,0.00000930122,0.000004135287,0.0000072502407,0.002411229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997019,0.000005377705,0.00005127048,0.00010252744,0.000037857404,0.00010106093],"domain_scores_gemma":[0.9997311,0.0000121948715,0.000010223021,0.00017667495,0.000016491276,0.0000532635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025696032,0.00004009151,0.00007780599,0.000022950171,0.000017117234,0.0000015667326,0.000024908522,0.000047894657,0.0013193269],"category_scores_gemma":[0.000026640935,0.00003100248,0.000025712741,0.00002849706,0.000038400784,0.000009600376,0.000008817398,0.00013253657,0.00034047395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002341289,0.0010954227,0.48227835,0.000046303332,0.00047014546,0.00112319,0.0009049308,0.0000024820245,0.22197227,0.01866208,0.1325588,0.13854477],"study_design_scores_gemma":[0.0015374846,0.00068940636,0.064558536,5.9829597e-7,0.00007614755,0.00045913883,0.0000038598314,0.000023859488,0.0038800118,0.0011616579,0.92755944,0.00004989155],"about_ca_topic_score_codex":0.00004182816,"about_ca_topic_score_gemma":0.00001823761,"teacher_disagreement_score":0.7950006,"about_ca_system_score_codex":0.0000031780976,"about_ca_system_score_gemma":0.00003549333,"threshold_uncertainty_score":0.9995936},"labels":[],"label_agreement":null},{"id":"W4229911199","doi":"10.1016/j.urolonc.2011.11.013","title":"Commentary on “International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial.” Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK, and the International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group. Medical Research Council Clinical Trials Unit, London, United Kingdom","year":2012,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vinblastine; Cisplatin; Methotrexate; Medicine; Bladder cancer; Chemotherapy; Urothelial cancer; Oncology; Internal medicine; Cancer","score_opus":0.5719069345010497,"score_gpt":0.5827083789599501,"score_spread":0.010801444458900411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229911199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90565646,0.011530558,0.000036103724,0.058465365,0.005743277,0.014915177,0.003538209,0.000039353145,0.000075518314],"genre_scores_gemma":[0.8856925,0.09110137,0.00034576433,0.0032464361,0.0069644735,0.011777643,0.0004722071,0.00013527789,0.0002643264],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.96211785,0.02009448,0.006054794,0.002162783,0.007938093,0.0016319737],"domain_scores_gemma":[0.9523869,0.03167309,0.0034835322,0.0007074461,0.0107575385,0.0009914528],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","sts"],"category_scores_codex":[0.09197753,0.0010275266,0.003548142,0.0007329757,0.0021218585,0.00023132247,0.0012849023,0.0010583227,0.0005017343],"category_scores_gemma":[0.027350403,0.00063608907,0.00045962495,0.0023714018,0.008965188,0.00072013686,0.0006331559,0.0027721634,3.0517205e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.34277067,0.02801114,0.45666546,0.00036961059,0.019662773,0.00013530099,0.010082682,0.000899744,0.0009925044,0.0009557293,0.06823847,0.07121595],"study_design_scores_gemma":[0.50241107,0.0335989,0.16488792,0.0019850244,0.006171262,0.00005571013,0.0071422025,0.0019658776,0.0003574456,0.0005638916,0.27968186,0.0011788191],"about_ca_topic_score_codex":0.120720595,"about_ca_topic_score_gemma":0.5466241,"teacher_disagreement_score":0.42590353,"about_ca_system_score_codex":0.006264511,"about_ca_system_score_gemma":0.023224842,"threshold_uncertainty_score":0.99960905},"labels":[],"label_agreement":null},{"id":"W4230099636","doi":"10.1200/jco.2019.37.7_suppl.432","title":"First-line PD1/PD-L1 inhibitors for platinum-ineligible advanced urothelial carcinoma (UC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Durvalumab; Nivolumab; Internal medicine; Cisplatin; Gastroenterology; Urology; Oncology; Surgery; Cancer; Immunotherapy; Chemotherapy","score_opus":0.0845193435001139,"score_gpt":0.4387206548824291,"score_spread":0.3542013113823152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230099636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777428,0.0006623571,0.00042839348,0.0076558627,0.005377238,0.0009929691,0.000031654294,0.00002180496,0.0070869015],"genre_scores_gemma":[0.9833056,0.00035106647,0.0056451233,0.0030607576,0.004372188,0.000022521703,0.000007885145,0.000048292375,0.0031865982],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964063,0.00012126294,0.0023411387,0.0003094441,0.0003993018,0.0004225423],"domain_scores_gemma":[0.9956501,0.0017659058,0.0013423614,0.00028827044,0.00048831844,0.00046501312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013966894,0.00023660278,0.0018097702,0.00014093536,0.00006350473,0.0000104515775,0.0001911744,0.00046048156,0.00045482244],"category_scores_gemma":[0.0014640901,0.0001665406,0.000884011,0.00014330329,0.00010861327,0.00015159557,0.000052715834,0.0007280467,0.000116983654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07526787,0.0055930666,0.61348975,0.00041415734,0.0014482432,0.00069915986,0.00039726758,0.00048192943,0.0023601754,0.00035735915,0.02959525,0.26989576],"study_design_scores_gemma":[0.08626444,0.07280307,0.17217931,0.00033822577,0.0011013275,0.0005694858,0.00015805011,0.00042266757,0.0028110258,0.0018522323,0.66113573,0.00036444722],"about_ca_topic_score_codex":0.000031539734,"about_ca_topic_score_gemma":0.00003835561,"teacher_disagreement_score":0.6315405,"about_ca_system_score_codex":0.00021426486,"about_ca_system_score_gemma":0.0016878074,"threshold_uncertainty_score":0.6791329},"labels":[],"label_agreement":null},{"id":"W4230210632","doi":"10.5489/cuaj.599","title":"The Canadian Bladder Cancer Network: efforts to improve patient care","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Bladder cancer; Medicine; Intensive care medicine; Internal medicine","score_opus":0.007963897132490292,"score_gpt":0.23091626502846216,"score_spread":0.22295236789597186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230210632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7703551,0.00402215,0.000010521944,0.18880884,0.004251117,0.002424246,0.00021760946,0.000053890377,0.029856512],"genre_scores_gemma":[0.96902823,0.00008353979,0.0000652266,0.028174529,0.0011479462,0.00017212256,0.000013870677,0.00001967679,0.0012948283],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979586,0.00008591681,0.00029772354,0.00021120696,0.00037838446,0.0010681477],"domain_scores_gemma":[0.99656445,0.00006475747,0.00013219182,0.00015638502,0.0006234721,0.0024587377],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001931226,0.00017289522,0.00021502504,0.00009488979,0.0012703342,0.00027504403,0.00013553738,0.00023026679,0.0016224948],"category_scores_gemma":[0.00019534517,0.00010973502,0.00012833362,0.00021441579,0.000026730166,0.00007454164,0.000014899776,0.00052093173,0.00027362208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035162535,0.0000152400435,0.5859021,0.000002853577,0.00035974503,0.00008972247,0.00069150777,0.00023830104,0.000014716231,0.00011675339,0.2861481,0.12638578],"study_design_scores_gemma":[0.000510066,0.00052113907,0.4793399,0.000010859214,0.000087095716,0.000037198646,0.000162631,0.000028983019,0.000014016025,0.00033260716,0.5188174,0.00013811108],"about_ca_topic_score_codex":0.5935516,"about_ca_topic_score_gemma":0.8540571,"teacher_disagreement_score":0.26050553,"about_ca_system_score_codex":0.005130169,"about_ca_system_score_gemma":0.0028154908,"threshold_uncertainty_score":0.99929017},"labels":[],"label_agreement":null},{"id":"W4230409425","doi":"10.1200/jco.2019.37.7_suppl.tps499","title":"A phase III, randomized, open-label, multicenter, global study of first-line (1L) durvalumab in combination with standard of care (SoC) chemotherapy and durvalumab in combination with tremelimumab and soc chemotherapy versus soc chemotherapy alone in patients with unresectable locally advanced or metastatic urothelial cancer (UC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Durvalumab; Tremelimumab; Medicine; Oncology; Internal medicine; Gemcitabine; Carboplatin; Chemotherapy; Cetuximab; Response Evaluation Criteria in Solid Tumors; Cisplatin; Immunotherapy; Cancer; Ipilimumab; Phases of clinical research; Nivolumab","score_opus":0.045782223811546334,"score_gpt":0.42176746985698266,"score_spread":0.3759852460454363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230409425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173766,0.0005958096,0.0001379462,0.0010416773,0.00018845561,0.0061636404,0.000049859333,0.000006461697,0.000078485355],"genre_scores_gemma":[0.99518055,0.0021960605,0.0020228317,0.00034075195,0.000031617557,0.00011814622,0.000015829717,0.00005280556,0.00004142432],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99535704,0.00066386035,0.002263533,0.00048772243,0.0008793937,0.0003484302],"domain_scores_gemma":[0.9955942,0.0009606724,0.0020553975,0.00026349054,0.00094304327,0.00018316688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001741802,0.0003983247,0.0037846642,0.00025118556,0.00004086739,0.000024000467,0.00023177154,0.00020347085,0.0000921547],"category_scores_gemma":[0.00024099242,0.00024889992,0.00008720492,0.0005214945,0.0003562907,0.0003720752,0.000044147866,0.0005180869,2.0827841e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70098275,0.026926234,0.19013368,0.00016711578,0.0010695476,0.000060987342,0.0025204227,0.00010547847,0.000021705724,0.00000485762,0.0000059412837,0.078001305],"study_design_scores_gemma":[0.7553938,0.18039736,0.060340133,0.0008389476,0.00044795984,0.000010015465,0.0016537663,0.00046429003,0.00016431931,0.00003228382,0.00006248278,0.00019465387],"about_ca_topic_score_codex":0.0017076567,"about_ca_topic_score_gemma":0.019709967,"teacher_disagreement_score":0.15347113,"about_ca_system_score_codex":0.000872911,"about_ca_system_score_gemma":0.0016873585,"threshold_uncertainty_score":0.9999963},"labels":[],"label_agreement":null},{"id":"W4230555012","doi":"10.1016/j.urology.2011.09.028","title":"Reply","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Gynecology; Family medicine","score_opus":0.02242305622017574,"score_gpt":0.29561411890895717,"score_spread":0.2731910626887814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230555012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6178093,0.0044203787,0.00051001884,0.014689817,0.0013647906,0.0003312622,0.0000058406017,0.00017802388,0.36069053],"genre_scores_gemma":[0.9822029,0.000012897927,0.000106964806,0.015136985,0.00036370114,0.00000978483,0.000004169995,0.000007060211,0.0021555757],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999675,0.000011001124,0.000049607104,0.00006233118,0.00003827645,0.00016382034],"domain_scores_gemma":[0.9997656,0.000011319431,0.000009983124,0.00012481894,0.000009560789,0.000078732504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003426098,0.00003949484,0.00007874565,0.000020678175,0.000014696417,8.0007777e-7,0.000015962001,0.000031938802,0.0008003173],"category_scores_gemma":[0.000014987379,0.000030305036,0.000024995203,0.000029221805,0.000021601696,0.000020945965,0.000008817422,0.000048334172,0.00054313574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007047848,0.0006136725,0.89650947,0.000020525367,0.00021575832,0.00006583876,0.00086396484,9.597467e-7,0.0025667103,0.003949673,0.06624336,0.028245267],"study_design_scores_gemma":[0.0011072255,0.0004812014,0.14559665,9.389449e-7,0.00010438127,0.00029395884,0.000009695213,0.0000052134496,0.0013121463,0.00018774605,0.8508565,0.00004438108],"about_ca_topic_score_codex":0.000024013538,"about_ca_topic_score_gemma":6.900785e-7,"teacher_disagreement_score":0.7846131,"about_ca_system_score_codex":0.000010934716,"about_ca_system_score_gemma":0.000016500573,"threshold_uncertainty_score":0.87629133},"labels":[],"label_agreement":null},{"id":"W4230590552","doi":"10.1097/ju.0000000000001071.03","title":"Reply by Authors","year":2020,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02229703371865503,"score_gpt":0.28036396413140025,"score_spread":0.2580669304127452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230590552","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035035846,0.004135396,0.000087792854,0.9923234,0.00088679214,0.00013530832,0.000023456261,0.000011808622,0.0020456675],"genre_scores_gemma":[0.0063080634,0.00065316184,0.000043030635,0.98317367,0.0058583994,0.0000016142935,0.000018260394,0.00004233982,0.0039014677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869025,0.00025676048,0.00040756812,0.000112282796,0.00031050624,0.00022262706],"domain_scores_gemma":[0.9989543,0.00016140199,0.0004417075,0.00025332862,0.000098984594,0.000090258254],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00020373189,0.00018200895,0.0005578536,0.000069337795,0.00004377658,0.0000060564603,0.00025865057,0.0002898934,0.00042108344],"category_scores_gemma":[0.000084616135,0.000099047626,0.00020098139,0.000075774966,0.000118064534,0.000021229383,0.00003238143,0.0026369735,0.00007830879],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062025123,0.00002084519,0.00007588455,0.000024113067,0.00050429214,0.0018750904,0.00017810967,4.0252615e-7,0.00018056016,8.342297e-7,0.99581206,0.00070755574],"study_design_scores_gemma":[0.0010409725,0.0025284574,0.000077486206,0.00001623105,0.0015468586,0.004473281,0.000009143184,0.0000019474157,0.000107139516,0.00038712646,0.9897434,0.00006792487],"about_ca_topic_score_codex":0.000028779537,"about_ca_topic_score_gemma":3.3458466e-7,"teacher_disagreement_score":0.009149757,"about_ca_system_score_codex":0.000048262482,"about_ca_system_score_gemma":0.0002275197,"threshold_uncertainty_score":0.999664},"labels":[],"label_agreement":null},{"id":"W4230724877","doi":"10.1016/j.urolonc.2019.09.025","title":"Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer","year":2019,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"Biology; Transcriptome; Phenotype; Bladder cancer; Pathology; Cancer research; Sarcoma; Cancer; Genetics; Gene; Gene expression; Medicine","score_opus":0.018139160072410038,"score_gpt":0.29046182176507557,"score_spread":0.2723226616926655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230724877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277,0.0003569889,0.000038673064,0.0052800197,0.00012451637,0.00080390275,0.00008827407,0.000021933136,0.00051565253],"genre_scores_gemma":[0.9901912,0.0011208045,0.003894401,0.004231637,0.000066384186,0.00014543896,0.00007050592,0.000014127078,0.00026547827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990517,0.00007416783,0.0002657194,0.000321898,0.00008801339,0.00019848303],"domain_scores_gemma":[0.99952173,0.00007403117,0.000094312956,0.00012065819,0.000043445958,0.00014581345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012034068,0.0001527971,0.0003570376,0.00018729384,0.000051164046,0.0000073872156,0.000045578123,0.00016921885,0.00020083401],"category_scores_gemma":[0.000024760408,0.00013084048,0.000031786734,0.00020245838,0.0002039116,0.000080272126,0.00002379546,0.00015211155,0.000015835572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003352543,0.0002293043,0.57981676,0.00008270964,0.00005895306,0.00005728206,0.002207516,0.00006499071,0.41130552,0.0007393347,0.000078702185,0.005023696],"study_design_scores_gemma":[0.0055912016,0.007218507,0.89571303,0.00025991307,0.00042994003,0.0003640261,0.00047419322,0.00069443334,0.015405162,0.003024418,0.07040932,0.00041588355],"about_ca_topic_score_codex":0.00018706553,"about_ca_topic_score_gemma":0.00007303187,"teacher_disagreement_score":0.39590034,"about_ca_system_score_codex":0.000095264964,"about_ca_system_score_gemma":0.0002691946,"threshold_uncertainty_score":0.53355193},"labels":[],"label_agreement":null},{"id":"W4230810821","doi":"10.1016/j.urolonc.2021.05.036","title":"A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer","year":2021,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Urothelial cancer; Cystectomy; Medicine; Clinical trial; Cancer; Immunotherapy; Oncology; Internal medicine","score_opus":0.1315954276886505,"score_gpt":0.4401467663277732,"score_spread":0.3085513386391227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230810821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028187,0.9909825,9.2909846e-7,0.002633709,0.00030085622,0.0010592503,0.00016180915,0.000009708728,0.0020325503],"genre_scores_gemma":[0.0012302545,0.9974125,0.0005622313,0.000081790866,0.00022244656,0.0004077237,0.000030436795,0.000015290621,0.000037331643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983398,0.0005689086,0.00036252168,0.00045106784,0.000117132266,0.00016060163],"domain_scores_gemma":[0.99897337,0.00027043372,0.0003193362,0.00022632441,0.00012117785,0.00008933629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023545625,0.00027360098,0.0010892416,0.00020426908,0.00012505752,0.0000053696876,0.0000700038,0.00034852832,0.000051564693],"category_scores_gemma":[0.0000758458,0.00016384717,0.00013356924,0.0003109562,0.0007196223,0.000057387282,0.000026793206,0.0002677664,3.217805e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013772403,0.00094784406,0.020788796,0.0012068418,0.00061320484,0.000013503097,0.003436181,0.000007828864,0.0000054788147,0.17327058,0.000045532783,0.7995265],"study_design_scores_gemma":[0.0011235339,0.0034467524,0.0002655156,0.00178897,0.002280566,0.0000667742,0.0030514724,0.000007328975,0.000007787005,0.0065982663,0.9812328,0.00013020671],"about_ca_topic_score_codex":0.00017978762,"about_ca_topic_score_gemma":0.00081057765,"teacher_disagreement_score":0.9811873,"about_ca_system_score_codex":0.00093970814,"about_ca_system_score_gemma":0.0014896264,"threshold_uncertainty_score":0.6681494},"labels":[],"label_agreement":null},{"id":"W4232131900","doi":"10.1200/jco.2017.35.15_suppl.e16003","title":"A propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Propensity score matching; Radiation therapy; Urology; Cohort; Proportional hazards model; Surgery; Cancer; Internal medicine","score_opus":0.2912530431791022,"score_gpt":0.5083917734414531,"score_spread":0.21713873026235092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232131900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916435,0.0007810199,0.000020828162,0.0043320437,0.0007768227,0.0004719583,0.000012890694,0.000003825356,0.001957116],"genre_scores_gemma":[0.9970157,0.0014345604,0.00052240543,0.0003172824,0.0006299126,0.0000142134495,0.0000023521015,0.00001598641,0.000047598696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953755,0.00064931164,0.0028080859,0.0002784817,0.00060858566,0.00028001048],"domain_scores_gemma":[0.9925598,0.0023245092,0.0038791462,0.0005966798,0.00044617004,0.0001937063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004954684,0.00019568122,0.0026829778,0.00026845466,0.000121073084,0.000013989654,0.0005694768,0.00039618852,0.00019164183],"category_scores_gemma":[0.002226343,0.0001102519,0.0011670287,0.00032948656,0.00060415873,0.00014308587,0.00012970032,0.001157372,0.0000017288482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02924335,0.0025417511,0.896538,0.0000352664,0.006356043,0.00031168977,0.0009441289,0.00006874731,0.00018029942,0.0000075367593,0.00018875,0.06358442],"study_design_scores_gemma":[0.030326152,0.010502259,0.9529526,0.00015963714,0.0045810007,0.000036868412,0.0002768694,0.00039825088,0.0002099365,0.000042194264,0.00042134375,0.000092867835],"about_ca_topic_score_codex":0.0008864479,"about_ca_topic_score_gemma":0.0013800904,"teacher_disagreement_score":0.06349155,"about_ca_system_score_codex":0.00011616388,"about_ca_system_score_gemma":0.0021567703,"threshold_uncertainty_score":0.502827},"labels":[],"label_agreement":null},{"id":"W4232187498","doi":"10.1002/(sici)1097-0215(20000120)89:1<100::aid-ijc16>3.3.co;2-h","title":"Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes","year":2000,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Région Normandie; Ligue Contre le Cancer","keywords":"Phenotype; Mdm2; Cancer research; Stage (stratigraphy); Bladder cancer; Biology; Oncology; Cancer; Medicine; Internal medicine; Pathology; Genetics; Gene","score_opus":0.016613853412482907,"score_gpt":0.31587341945272907,"score_spread":0.29925956604024617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232187498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98620707,0.004168528,0.00003193701,0.0030480865,0.00090369413,0.00018992266,0.00011251218,0.000010243206,0.0053280303],"genre_scores_gemma":[0.99265945,0.0018934581,0.00008246865,0.002984514,0.00083246024,0.000034303433,0.0000042660067,0.000021946656,0.0014871588],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987458,0.00002576128,0.000344902,0.00015734545,0.0005638393,0.00016235257],"domain_scores_gemma":[0.99939847,0.000040408362,0.00013694946,0.00008981094,0.00021538016,0.000118965625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009988864,0.00014454244,0.00024916182,0.0001903954,0.000022285061,0.000028142986,0.00012996489,0.000051573305,0.007233329],"category_scores_gemma":[0.000015126986,0.0001113214,0.00009842841,0.000091452814,0.00004540364,0.00011735055,0.000009133495,0.00022725959,0.00001444662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013969134,0.0015955982,0.29004833,0.000115733244,0.0020415727,0.0022346948,0.0015816004,0.013051947,0.005155123,0.00030171033,0.002720746,0.6671838],"study_design_scores_gemma":[0.036868725,0.0019390692,0.778246,0.004020678,0.0006152953,0.00023107704,0.0002166931,0.005490322,0.023682566,0.0009896572,0.1469678,0.00073213415],"about_ca_topic_score_codex":0.00062338694,"about_ca_topic_score_gemma":0.00035865072,"teacher_disagreement_score":0.6664517,"about_ca_system_score_codex":0.00038163367,"about_ca_system_score_gemma":0.00051728246,"threshold_uncertainty_score":0.9936742},"labels":[],"label_agreement":null},{"id":"W4232444919","doi":"10.1016/j.urology.2011.03.045","title":"Reply by the Authors","year":2011,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.033435552347495325,"score_gpt":0.27612928689701866,"score_spread":0.24269373454952334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232444919","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.290295,0.0033083702,0.00084587117,0.03599361,0.0014082167,0.0007889823,0.000020724834,0.0002399296,0.6670993],"genre_scores_gemma":[0.9746973,0.000017347109,0.000052979736,0.016971288,0.00007289359,0.000021204083,0.000004572476,0.000009308532,0.008153094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961084,0.00002782166,0.00006960268,0.0001146161,0.000048429913,0.00012867159],"domain_scores_gemma":[0.99969536,0.000015151446,0.000017873728,0.0002107558,0.000013937187,0.000046919828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000054075106,0.00005305875,0.000083665436,0.0000131658135,0.00003568104,0.0000013794232,0.000052876534,0.000043635227,0.0009690921],"category_scores_gemma":[0.000018006389,0.000030072275,0.00003182844,0.000038104834,0.00006965715,0.0000102793165,0.000013870084,0.00009081309,0.00017695087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022361055,0.0007831363,0.108089454,0.0000198447,0.0006176391,0.00030430668,0.0069695506,4.786006e-7,0.0027244217,0.0068900944,0.81792116,0.053443786],"study_design_scores_gemma":[0.0014507115,0.0015479154,0.032804657,0.0000015642577,0.00021468056,0.00030266895,0.00005416843,0.000016750646,0.0036636225,0.002144626,0.9577263,0.000072305695],"about_ca_topic_score_codex":0.0002032986,"about_ca_topic_score_gemma":0.0000058548885,"teacher_disagreement_score":0.6844023,"about_ca_system_score_codex":0.0000081243425,"about_ca_system_score_gemma":0.000024807945,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W4232613001","doi":"10.5489/cuaj.16","title":"A smoking cessation program as a resource for bladder cancer patients","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Smoking cessation; Mood; Cystoscopy; Internal medicine; Urinary system; Psychiatry","score_opus":0.020326805075449917,"score_gpt":0.29041680159445427,"score_spread":0.27008999651900434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232613001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768463,0.000622789,0.000039723895,0.01363796,0.00070495124,0.0010655678,0.000109913046,0.0000607884,0.0069120545],"genre_scores_gemma":[0.9906379,0.000028809323,0.00019264304,0.0068235933,0.0012354386,0.00019049153,0.00007025418,0.000018748538,0.00080215215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860483,0.0000718189,0.0002399756,0.0001360837,0.00032683456,0.00062046986],"domain_scores_gemma":[0.99856913,0.000070244685,0.00020479663,0.00006321293,0.00029664132,0.00079597585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035423416,0.00012556999,0.00019087458,0.00011240035,0.0002969747,0.00006523892,0.000061424755,0.00021323614,0.0006819692],"category_scores_gemma":[0.0004326739,0.0000991392,0.00013028084,0.00014593193,0.000015415997,0.0001411819,0.000006746339,0.00028402294,0.000020012309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084405314,0.0001934015,0.9504397,0.0000044755056,0.00021003628,0.0000024806525,0.00026675194,0.00000320454,0.0000057205534,0.000057163215,0.01902523,0.02970745],"study_design_scores_gemma":[0.0020018495,0.0005412868,0.63973105,0.000011154622,0.00020300312,0.000017290116,0.00004043158,0.000019053476,0.000025819309,0.0001922017,0.35712552,0.00009129857],"about_ca_topic_score_codex":0.0012655206,"about_ca_topic_score_gemma":0.0003034108,"teacher_disagreement_score":0.3381003,"about_ca_system_score_codex":0.001626411,"about_ca_system_score_gemma":0.00041227596,"threshold_uncertainty_score":0.7467085},"labels":[],"label_agreement":null},{"id":"W4233065014","doi":"10.1097/ju.0000000000001020.02","title":"Reply by Authors","year":2020,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine","score_opus":0.02229703371865503,"score_gpt":0.28036396413140025,"score_spread":0.2580669304127452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233065014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035035846,0.004135396,0.000087792854,0.9923234,0.00088679214,0.00013530832,0.000023456261,0.000011808622,0.0020456675],"genre_scores_gemma":[0.0063080634,0.00065316184,0.000043030635,0.98317367,0.0058583994,0.0000016142935,0.000018260394,0.00004233982,0.0039014677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869025,0.00025676048,0.00040756812,0.000112282796,0.00031050624,0.00022262706],"domain_scores_gemma":[0.9989543,0.00016140199,0.0004417075,0.00025332862,0.000098984594,0.000090258254],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00020373189,0.00018200895,0.0005578536,0.000069337795,0.00004377658,0.0000060564603,0.00025865057,0.0002898934,0.00042108344],"category_scores_gemma":[0.000084616135,0.000099047626,0.00020098139,0.000075774966,0.000118064534,0.000021229383,0.00003238143,0.0026369735,0.00007830879],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062025123,0.00002084519,0.00007588455,0.000024113067,0.00050429214,0.0018750904,0.00017810967,4.0252615e-7,0.00018056016,8.342297e-7,0.99581206,0.00070755574],"study_design_scores_gemma":[0.0010409725,0.0025284574,0.000077486206,0.00001623105,0.0015468586,0.004473281,0.000009143184,0.0000019474157,0.000107139516,0.00038712646,0.9897434,0.00006792487],"about_ca_topic_score_codex":0.000028779537,"about_ca_topic_score_gemma":3.3458466e-7,"teacher_disagreement_score":0.009149757,"about_ca_system_score_codex":0.000048262482,"about_ca_system_score_gemma":0.0002275197,"threshold_uncertainty_score":0.999664},"labels":[],"label_agreement":null},{"id":"W4233073939","doi":"10.1002/9780471420194.tnmc44.pub3","title":"Urinary Bladder","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Urinary system; Physical examination; Urinary bladder; Urology; Endoscopy; Radiology; Internal medicine","score_opus":0.03336774798644682,"score_gpt":0.340745078164529,"score_spread":0.30737733017808216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233073939","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003895253,0.003948911,0.000006583141,0.00056722545,0.0004549609,0.00040152253,0.0035337454,0.00026412238,0.990784],"genre_scores_gemma":[0.00024846636,0.0010174569,0.0010785722,0.00069542025,0.0028320067,0.000025865947,0.0024172922,0.0004882122,0.9911967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999151,0.00001038772,0.000106482,0.00030782385,0.00020530887,0.00021902299],"domain_scores_gemma":[0.9988848,0.000007708918,0.00012665651,0.0008172676,0.00002127128,0.00014228444],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000018290359,0.00027116513,0.00044819125,0.00012160789,0.000040607014,0.000010809597,0.0001434017,0.00027365246,0.045058917],"category_scores_gemma":[0.000021136413,0.00021255779,0.00013273576,0.000029263207,0.00007784042,0.000014777476,0.000052786843,0.00022181649,0.0010378798],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058939742,0.00049902045,0.00024102225,0.00009375152,0.00038439635,0.00041431386,0.000012194075,6.10788e-9,0.000009057073,0.000006231597,0.98334616,0.014934918],"study_design_scores_gemma":[0.0015816935,0.00034997854,0.0022611534,0.00060529355,0.00037094593,0.00011947822,0.0000041084904,0.0000018963486,0.000014725581,0.000021584627,0.9944858,0.00018335943],"about_ca_topic_score_codex":0.00028049384,"about_ca_topic_score_gemma":0.00011980675,"teacher_disagreement_score":0.044021036,"about_ca_system_score_codex":0.000041621355,"about_ca_system_score_gemma":0.00019648082,"threshold_uncertainty_score":0.99973994},"labels":[],"label_agreement":null},{"id":"W4233365625","doi":"10.3410/f.728887184.793571214","title":"Faculty Opinions recommendation of Current status of urinary biomarkers for detection and surveillance of bladder cancer.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bladder cancer; Cancer detection; Medicine; Urinary system; Cancer; Current (fluid); Data science; Oncology; Internal medicine; Computer science; Engineering","score_opus":0.050640888534461054,"score_gpt":0.39130429747595713,"score_spread":0.34066340894149605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233365625","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000061818487,0.008854763,0.00006576916,0.03503574,0.00075458805,0.0022811668,0.95297325,0.000015431206,0.000013088396],"genre_scores_gemma":[0.000215474,0.0053151175,0.0003078926,0.00056050404,0.00018064874,0.00035756407,0.992973,0.000024303989,0.00006544838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681014,0.00021523038,0.0013702802,0.00050873985,0.000820593,0.00027503606],"domain_scores_gemma":[0.9933117,0.0001409502,0.0016065212,0.00066872954,0.0039823623,0.00028975974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004736526,0.00038342556,0.0011379041,0.0002554266,0.00008648688,0.00001792193,0.00036236082,0.00035048058,0.00012904982],"category_scores_gemma":[0.0024638777,0.0002551409,0.00048852124,0.0011890742,0.00033889725,0.00012977695,0.00018145819,0.00042107387,0.0000022130432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002132069,0.00051294884,0.00013100299,0.025311556,0.0005645312,9.489242e-8,0.000092392525,4.5459792e-8,0.000023211986,0.000014751355,0.95653206,0.016604213],"study_design_scores_gemma":[0.0019501885,0.0007486894,0.01185715,0.008285425,0.0005008643,0.000015322548,0.00002728516,0.000011804978,0.00021731136,0.000009067907,0.9761937,0.0001831806],"about_ca_topic_score_codex":0.000168982,"about_ca_topic_score_gemma":0.000012514229,"teacher_disagreement_score":0.039999772,"about_ca_system_score_codex":0.00012095026,"about_ca_system_score_gemma":0.0008018579,"threshold_uncertainty_score":0.9999901},"labels":[],"label_agreement":null},{"id":"W4233449401","doi":"10.1016/j.juro.2013.02.740","title":"1125 SILENCING NOTCH-1 AND NOTCH-3 PROMOTES EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) AND SELF-RENEWAL POTENTIAL IN HUMAN BLADDER CANCER","year":2013,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epithelial–mesenchymal transition; Medicine; Cancer; Metastasis; Internal medicine","score_opus":0.008823283445695057,"score_gpt":0.261744832103079,"score_spread":0.2529215486573839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233449401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874991,0.0010644359,0.00014243796,0.01059321,0.0001618316,0.00040777115,0.000006123908,0.000010640519,0.00011442422],"genre_scores_gemma":[0.99731016,0.00047975575,0.00020218606,0.0014778832,0.0004374534,0.000013807799,9.81384e-7,0.00001913442,0.00005865876],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99890053,0.00014634567,0.0003553059,0.00014507229,0.00018623829,0.0002665296],"domain_scores_gemma":[0.99942356,0.00006263185,0.00013084733,0.00011145757,0.00011600102,0.00015550022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029166983,0.00015852462,0.00034888025,0.00016525392,0.0000950602,0.000017480914,0.000079404585,0.00010403304,0.00020486087],"category_scores_gemma":[0.000018103263,0.000101289945,0.000050123872,0.0000981715,0.000098252036,0.00011961233,0.000028857025,0.00030121414,0.0000054753573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014939215,0.000577145,0.011781431,0.00009029616,0.0006367025,0.00021481476,0.019019043,0.00034048618,0.9518099,0.000037520997,0.00040266328,0.01359611],"study_design_scores_gemma":[0.027357755,0.017539514,0.8524395,0.00037251652,0.004056656,0.00777377,0.0021402854,0.0022313606,0.077851556,0.0067347814,0.0006744454,0.0008278413],"about_ca_topic_score_codex":0.0018173915,"about_ca_topic_score_gemma":0.00027252914,"teacher_disagreement_score":0.8739583,"about_ca_system_score_codex":0.000047586997,"about_ca_system_score_gemma":0.00010655856,"threshold_uncertainty_score":0.41304842},"labels":[],"label_agreement":null},{"id":"W4233968628","doi":"10.1002/1097-0142(20000701)89:1<142::aid-cncr19>3.3.co;2-w","title":"The management and outcome of bladder carcinoma in Ontario, 1982–1994","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Multivariate analysis; Carcinoma; Transitional cell carcinoma; Urinary bladder; Population; Urology; Surgery; Internal medicine; Cancer","score_opus":0.024337924198221707,"score_gpt":0.2855642519755207,"score_spread":0.261226327777299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233968628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500305,0.00276921,6.565895e-7,0.00037157972,0.00009018443,0.0002970936,0.0000066818207,0.000006795153,0.04642729],"genre_scores_gemma":[0.9635408,0.00050886493,0.00004040298,0.0003608887,0.000031115884,0.00007478063,0.0000020809089,0.000009173732,0.03543187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994457,0.000008269533,0.00015626999,0.00013302223,0.00011188416,0.00014487875],"domain_scores_gemma":[0.99974245,0.000010383002,0.000020479112,0.00017208327,0.000009150355,0.000045470097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000041541272,0.00008129796,0.00014446978,0.000026239843,0.000033493034,0.000005784079,0.000043359578,0.000026766194,0.0021942826],"category_scores_gemma":[6.3364655e-7,0.000051855037,0.000032362746,0.00006076729,0.000056018987,0.000022102193,0.000013566731,0.00007926606,0.000010208416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020983464,0.000041581596,0.95539236,0.000033706376,0.0001044309,0.000027743128,0.00044927964,0.0000067511432,0.0000119760325,0.00008326646,0.00082554045,0.04281352],"study_design_scores_gemma":[0.0017958224,0.000069574664,0.9381268,0.000035554203,0.00010162107,0.000004416276,0.00006765183,0.000009492516,0.00017336101,0.00009011943,0.059475135,0.000050436676],"about_ca_topic_score_codex":0.059398506,"about_ca_topic_score_gemma":0.07981059,"teacher_disagreement_score":0.058649592,"about_ca_system_score_codex":0.00015662391,"about_ca_system_score_gemma":0.00005385463,"threshold_uncertainty_score":0.99871784},"labels":[],"label_agreement":null},{"id":"W4234338658","doi":"10.5489/cuaj.166","title":"Adenocarcinoma following urinary diversion","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adenocarcinoma; Cystoprostatectomy; Urinary diversion; Medicine; Cystectomy; Urinary system; Pouch; Prostatic adenocarcinoma; Urology; Surgery; General surgery; Internal medicine; Cancer; Bladder cancer","score_opus":0.019049682623853707,"score_gpt":0.24604287162916283,"score_spread":0.22699318900530913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234338658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97787917,0.0018207858,0.000020207452,0.009396717,0.0009349555,0.00012214256,0.000011193328,0.000024980933,0.009789871],"genre_scores_gemma":[0.99343383,0.000033752385,0.00012956146,0.004364254,0.0009179587,0.000003279051,0.000010823954,0.000009039447,0.0010974798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988746,0.00007644339,0.0001532444,0.00009496935,0.00028026878,0.0005204399],"domain_scores_gemma":[0.9987136,0.00004165018,0.00008189518,0.00006687551,0.000060527706,0.0010354639],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032435489,0.00009675708,0.00016851485,0.00010683728,0.00029314173,0.000029771896,0.000059107857,0.00016349419,0.00097319257],"category_scores_gemma":[0.00015760343,0.00007614222,0.00018039857,0.00011438078,0.00000909007,0.00016055036,0.000012360589,0.00033743127,0.00022851916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028334029,0.00006145077,0.98939013,0.0000012285432,0.00011147725,0.00014426615,0.00012609227,4.6160457e-7,0.000028643713,0.000033366843,0.009010921,0.0010636292],"study_design_scores_gemma":[0.00095359574,0.0003054431,0.9470328,0.000006691177,0.00015562931,0.00040255548,0.000066576875,0.000004344986,0.000019502211,0.000110652094,0.05086615,0.00007607806],"about_ca_topic_score_codex":0.0005308331,"about_ca_topic_score_gemma":0.000023710627,"teacher_disagreement_score":0.042357348,"about_ca_system_score_codex":0.0013132594,"about_ca_system_score_gemma":0.00024408405,"threshold_uncertainty_score":0.99994004},"labels":[],"label_agreement":null},{"id":"W4234504732","doi":"10.3410/f.732268512.793571222","title":"Faculty Opinions recommendation of Urothelial neoplasms in pediatric and young adult patients: A large single-center series.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Center (category theory); Series (stratigraphy); Single Center; Medicine; Internal medicine; Biology; Chemistry; Paleontology; Crystallography","score_opus":0.021265549293592662,"score_gpt":0.3129467107332068,"score_spread":0.29168116143961414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234504732","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000928555,0.00052050775,0.0000057695856,0.09427365,0.0008591159,0.002131051,0.9020994,0.000026968952,0.000074284115],"genre_scores_gemma":[0.000077868324,0.0012251945,0.00026746115,0.006430679,0.00039651268,0.0002713832,0.9909695,0.00003608948,0.0003253614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960609,0.00027647355,0.0014573657,0.00068536116,0.0011529814,0.00036689293],"domain_scores_gemma":[0.9944647,0.000054446744,0.0009615,0.00074706826,0.003419807,0.0003524809],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037744167,0.0005245025,0.0010687653,0.00035989445,0.00011697877,0.00007291115,0.0005164385,0.000561416,0.00020521476],"category_scores_gemma":[0.003693669,0.00034791353,0.00039424963,0.001690893,0.0001626043,0.0003213452,0.00034770148,0.00089045346,0.000033990014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012322213,0.0014836813,0.0018885008,0.008990658,0.000118433505,9.873947e-7,0.00024036059,5.6617195e-9,4.6032986e-7,0.000036004334,0.9861709,0.00094682624],"study_design_scores_gemma":[0.00451801,0.0006323722,0.016022336,0.0060738656,0.00038481475,0.000047247144,0.000027310627,0.0000017750256,0.0000058856276,0.0000067206256,0.9720169,0.000262814],"about_ca_topic_score_codex":0.000082159626,"about_ca_topic_score_gemma":0.00004294219,"teacher_disagreement_score":0.08887008,"about_ca_system_score_codex":0.00016463989,"about_ca_system_score_gemma":0.00048109738,"threshold_uncertainty_score":0.9998973},"labels":[],"label_agreement":null},{"id":"W4234885285","doi":"10.1200/jco.2020.38.4_suppl.511","title":"Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.","year":2020,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Western University; Ontario Clinical Oncology Group; McMaster University","funders":"","keywords":"Medicine; Neoadjuvant therapy; Meta-analysis; Immunotherapy; Internal medicine; Oncology; Renal cell carcinoma; Randomized controlled trial; Cancer; Surgery; Breast cancer","score_opus":0.10044782707395385,"score_gpt":0.47906806090004056,"score_spread":0.3786202338260867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234885285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009948163,0.99611527,0.0000015543403,0.0004196575,0.00005925852,0.0023405645,0.000019582594,0.0000034063644,0.000045889916],"genre_scores_gemma":[0.003581677,0.99572015,0.000055744058,0.00042637953,0.000076878285,0.00007088341,0.000010235963,0.000028778928,0.000029303132],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99087596,0.0040838844,0.004140191,0.00029997574,0.0004478405,0.00015214935],"domain_scores_gemma":[0.9913758,0.003653196,0.004306027,0.00025015874,0.0002144758,0.00020033619],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004032175,0.00038463253,0.024680763,0.00030257626,0.000018215476,0.000007839937,0.00011409245,0.0003489911,0.00007135587],"category_scores_gemma":[0.0009565577,0.00016268334,0.0024012055,0.0004489401,0.00014053294,0.000047037032,0.000024309036,0.0010079244,0.0000015548649],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010403256,0.001464195,0.0017184025,0.48696852,0.3866016,0.0007310411,0.00006793729,3.346674e-7,3.66383e-8,0.00000491287,0.000058156907,0.1119816],"study_design_scores_gemma":[0.008906308,0.08372608,0.0010507016,0.049797826,0.8407962,0.00021943408,0.000004149288,9.680547e-7,4.1072306e-7,0.000005222398,0.01533983,0.00015290867],"about_ca_topic_score_codex":0.0000120606655,"about_ca_topic_score_gemma":0.0000058028995,"teacher_disagreement_score":0.45419458,"about_ca_system_score_codex":0.00010557343,"about_ca_system_score_gemma":0.00052121683,"threshold_uncertainty_score":0.98979884},"labels":[],"label_agreement":null},{"id":"W4234949875","doi":"10.1016/j.urology.2010.01.043","title":"Reply","year":2010,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Fulguration; Mitomycin C; Bladder cancer; Resection; Urology; Intensive care medicine; Surgery; General surgery; Gynecology; Internal medicine; Cancer","score_opus":0.012044468788864369,"score_gpt":0.28125054245806275,"score_spread":0.26920607366919835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234949875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8229429,0.00011235735,0.000100273945,0.014537234,0.0009592533,0.00016149408,0.000003456061,0.00009808091,0.16108492],"genre_scores_gemma":[0.983873,0.0000043545824,0.00020466984,0.013244443,0.00024162066,0.00000930122,0.000004135287,0.0000072502407,0.002411229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997019,0.000005377705,0.00005127048,0.00010252744,0.000037857404,0.00010106093],"domain_scores_gemma":[0.9997311,0.0000121948715,0.000010223021,0.00017667495,0.000016491276,0.0000532635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025696032,0.00004009151,0.00007780599,0.000022950171,0.000017117234,0.0000015667326,0.000024908522,0.000047894657,0.0013193269],"category_scores_gemma":[0.000026640935,0.00003100248,0.000025712741,0.00002849706,0.000038400784,0.000009600376,0.000008817398,0.00013253657,0.00034047395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002341289,0.0010954227,0.48227835,0.000046303332,0.00047014546,0.00112319,0.0009049308,0.0000024820245,0.22197227,0.01866208,0.1325588,0.13854477],"study_design_scores_gemma":[0.0015374846,0.00068940636,0.064558536,5.9829597e-7,0.00007614755,0.00045913883,0.0000038598314,0.000023859488,0.0038800118,0.0011616579,0.92755944,0.00004989155],"about_ca_topic_score_codex":0.00004182816,"about_ca_topic_score_gemma":0.00001823761,"teacher_disagreement_score":0.7950006,"about_ca_system_score_codex":0.0000031780976,"about_ca_system_score_gemma":0.00003549333,"threshold_uncertainty_score":0.9995936},"labels":[],"label_agreement":null},{"id":"W4235003169","doi":"10.1016/j.urology.2009.07.879","title":"MP-13.10: Achieving Pt0n0 at Radical Cystectomy: Outcomes of 135 Pt0n0 Bladder Cancer Patients Treated with Radical Cystectomy: The Canadian Bladder Cancer Network Experience","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Dalhousie University; Université de Montréal; University of Alberta; Université Laval; McGill University; Western University; University of Manitoba","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Transitional cell carcinoma; Chemotherapy; Cancer; Surgery; Internal medicine","score_opus":0.013303354456249217,"score_gpt":0.2749601824237764,"score_spread":0.2616568279675272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235003169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98271865,0.0028504913,0.000019496942,0.009158186,0.00041506416,0.0013881071,0.000117381824,0.000109288354,0.0032233533],"genre_scores_gemma":[0.986179,0.00016002619,0.000050955805,0.01058603,0.0004484684,0.0003746394,0.000068518915,0.00007714308,0.0020552154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962979,0.00025265812,0.00065299775,0.0008275692,0.0006549702,0.0013139204],"domain_scores_gemma":[0.9978387,0.00018067898,0.00028308912,0.0007532889,0.0002444506,0.0006998104],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015855441,0.0006061332,0.0011059663,0.00019817955,0.00052491797,0.000029631314,0.00041992601,0.0004460456,0.0033603527],"category_scores_gemma":[0.00007905684,0.00037336396,0.0002219592,0.0006064543,0.0008356447,0.00010732495,0.00007084138,0.0005565531,0.000046147572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024471008,0.00037434042,0.97917795,0.000025336582,0.0012238118,0.00022093866,0.0019821853,0.00045653942,0.00017471738,0.000060130427,0.009384806,0.004472114],"study_design_scores_gemma":[0.010836894,0.0032435614,0.92937547,0.00009828839,0.00125687,0.000119481825,0.0000718734,0.000296405,0.00055227714,0.000029871833,0.05355544,0.0005635702],"about_ca_topic_score_codex":0.0935082,"about_ca_topic_score_gemma":0.20142347,"teacher_disagreement_score":0.10791526,"about_ca_system_score_codex":0.0008212925,"about_ca_system_score_gemma":0.0011752167,"threshold_uncertainty_score":0.99987185},"labels":[],"label_agreement":null},{"id":"W4235659586","doi":"10.1016/j.urology.2018.05.062","title":"AUTHOR REPLY","year":2018,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Biopsy; Metastasis; Radiology; General surgery; Internal medicine; Cancer","score_opus":0.030758683190106717,"score_gpt":0.3064732157962738,"score_spread":0.2757145326061671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235659586","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016589093,0.00042021685,0.000049128725,0.95569086,0.0015389533,0.0002895367,0.00004028932,0.00011065882,0.041694466],"genre_scores_gemma":[0.0010413042,0.000010905069,0.00010476103,0.88815546,0.013154842,0.000046022793,0.00027306212,0.000058703634,0.097154915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879223,0.00005606125,0.00018860905,0.00043503323,0.00016932964,0.00035870724],"domain_scores_gemma":[0.999169,0.000044067656,0.000075357035,0.0005805646,0.00007039363,0.000060628863],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005273498,0.00021860628,0.0004222419,0.00011333544,0.000038401333,0.000006473998,0.00010549031,0.0007914695,0.0032560227],"category_scores_gemma":[0.000044737593,0.00017461141,0.00013282229,0.000060389888,0.00014573958,0.000012075141,0.000037591297,0.0009182587,0.0021632488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011425041,0.000021399415,0.0002305826,0.00003975956,0.00019470416,0.0015974402,0.000043080192,2.0141114e-8,0.000010873449,0.000005310047,0.9969353,0.0008072936],"study_design_scores_gemma":[0.00078064343,0.0014769781,0.00029172265,0.000009613362,0.00047191835,0.00057460385,8.9692804e-7,0.0000034332356,0.000049462622,0.00037068166,0.99584806,0.000122004814],"about_ca_topic_score_codex":0.00006389469,"about_ca_topic_score_gemma":0.0000033751073,"teacher_disagreement_score":0.06753537,"about_ca_system_score_codex":0.000049646605,"about_ca_system_score_gemma":0.00017196109,"threshold_uncertainty_score":0.99861366},"labels":[],"label_agreement":null},{"id":"W4236225208","doi":"10.1200/jco.2017.35.15_suppl.4525","title":"Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma (UC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Tolerability; Clinical endpoint; Metastatic Urothelial Carcinoma; Oncology; Progression-free survival; Immunotherapy; Urology; Gastroenterology; Surgery; Adverse effect; Cancer; Chemotherapy; Clinical trial; Bladder cancer; Nivolumab; Urothelial carcinoma","score_opus":0.15351026332621126,"score_gpt":0.49104671437415287,"score_spread":0.3375364510479416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236225208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399334,0.00026887908,0.000051035833,0.0030123163,0.0005939267,0.0003947293,0.000010350909,0.0000037100424,0.0016716897],"genre_scores_gemma":[0.9955849,0.00028016514,0.0031285358,0.00053526997,0.00023544788,0.0000039513525,0.0000012608366,0.000013857468,0.00021661469],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99674875,0.00036931396,0.002175982,0.00021092843,0.00027714812,0.00021787503],"domain_scores_gemma":[0.99626887,0.0010229326,0.001722376,0.00037171738,0.00032498926,0.0002891043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021697083,0.00014285704,0.001884565,0.000085967644,0.00005463508,0.000009837799,0.00020833024,0.00018250628,0.00020885699],"category_scores_gemma":[0.0050918907,0.00008977322,0.00022419973,0.00005736511,0.00045958874,0.00014370427,0.00007489755,0.0005791152,0.000004126324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06804005,0.004861485,0.44829425,0.000110940455,0.0005049809,0.0017296161,0.00022411288,0.00001779626,0.00056740385,0.000049007886,0.0002728894,0.47532746],"study_design_scores_gemma":[0.048423614,0.022154,0.9238525,0.00013041783,0.00046273044,0.0002848073,0.00006646854,0.00006949451,0.00033064254,0.00029713922,0.0038476444,0.0000805266],"about_ca_topic_score_codex":0.0001769577,"about_ca_topic_score_gemma":0.00027841196,"teacher_disagreement_score":0.47555825,"about_ca_system_score_codex":0.00010025924,"about_ca_system_score_gemma":0.0023560869,"threshold_uncertainty_score":0.6095836},"labels":[],"label_agreement":null},{"id":"W4236380262","doi":"10.1111/iju.12688","title":"<scp>IJU</scp> this issue","year":2015,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Lower urinary tract symptoms; Bladder cancer; Urinary system; Urology; Upper urinary tract; Hyperplasia; Prostate cancer; Prostate; Internal medicine; Oncology; Cancer; Pathology","score_opus":0.02843574655040955,"score_gpt":0.32699760693314445,"score_spread":0.2985618603827349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236380262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6969552,0.0065525877,0.0016776304,0.040962294,0.012467934,0.00023437849,0.00003187564,0.00004869331,0.2410694],"genre_scores_gemma":[0.9855394,0.00015338679,0.0006612169,0.005415564,0.0021566967,0.000001977822,0.0000053618764,0.000013843095,0.0060525564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990526,0.000037656475,0.0002797191,0.00008534702,0.00042219146,0.00012247561],"domain_scores_gemma":[0.99878013,0.00008106877,0.00017990124,0.00008078479,0.00069670216,0.00018140297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018374455,0.00008290653,0.00019907173,0.00017126647,0.000010768057,0.000012270442,0.00019033566,0.00007524576,0.00034677188],"category_scores_gemma":[0.00034384895,0.00006333087,0.00010073552,0.000045776247,0.000049381124,0.00009095027,0.00003245071,0.00020275798,0.00027166068],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017339843,0.0012268171,0.12722641,0.000012435178,0.0030565874,0.0055420925,0.0034463124,0.0001191019,0.0029627609,0.0017011982,0.81947577,0.03349652],"study_design_scores_gemma":[0.0046774894,0.0017761034,0.009897547,0.0000146192715,0.0001542921,0.005434554,0.00012028707,0.000042462354,0.0016140554,0.0019954215,0.974246,0.000027124714],"about_ca_topic_score_codex":0.000031570573,"about_ca_topic_score_gemma":0.0000031799023,"teacher_disagreement_score":0.2885842,"about_ca_system_score_codex":0.0000986755,"about_ca_system_score_gemma":0.0002663164,"threshold_uncertainty_score":0.3796909},"labels":[],"label_agreement":null},{"id":"W4237067208","doi":"10.1200/jco.2020.38.6_suppl.tps600","title":"PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring <i>FGFR3</i> alterations.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical endpoint; Tolerability; Cisplatin; Internal medicine; Oncology; Placebo; Adjuvant therapy; Urology; Cancer; Gastroenterology; Clinical trial; Chemotherapy; Surgery; Adverse effect; Pathology","score_opus":0.0960230797781937,"score_gpt":0.4147880113532452,"score_spread":0.31876493157505154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237067208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868725,0.00036154134,0.00010961232,0.0038112544,0.0007352895,0.0065476983,0.000015312204,0.000008267902,0.0015385287],"genre_scores_gemma":[0.9942983,0.0003360171,0.00048825511,0.0030104993,0.0015365804,0.00023735112,0.000011707324,0.00003286742,0.000048435442],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936832,0.0009295469,0.0040950663,0.00031380358,0.00069830864,0.00028005088],"domain_scores_gemma":[0.99326706,0.002407719,0.0028967478,0.0002099377,0.0007488639,0.00046968707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002154669,0.00029829965,0.004458152,0.00019103616,0.000043833148,0.000017964554,0.0001990421,0.00030230748,0.00017876823],"category_scores_gemma":[0.002542126,0.000175607,0.0008317322,0.00024700625,0.00025765994,0.00020930593,0.000032410215,0.00092599646,0.000005905708],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9632524,0.007276377,0.011610942,0.000027287258,0.001300777,0.00023908037,0.0008816812,0.000033639753,0.00007438087,0.000038551643,0.00017618875,0.015088686],"study_design_scores_gemma":[0.89787304,0.098037206,0.00086690974,0.00012707447,0.00090253336,0.000019069395,0.00007045834,0.000056645284,0.0010780089,0.000049426217,0.0007859016,0.00013374063],"about_ca_topic_score_codex":0.00010036095,"about_ca_topic_score_gemma":0.00006585091,"teacher_disagreement_score":0.09076083,"about_ca_system_score_codex":0.00010790119,"about_ca_system_score_gemma":0.0047855526,"threshold_uncertainty_score":0.8489365},"labels":[],"label_agreement":null},{"id":"W4237269764","doi":"10.1002/cncy.22050","title":"Issue Information","year":2018,"lang":"en","type":"paratext","venue":"Cancer Cytopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Citation; Medicine; Information retrieval; World Wide Web; Internet privacy; Library science; Computer science","score_opus":0.018455314032690222,"score_gpt":0.3274241966522796,"score_spread":0.3089688826195894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237269764","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003492047,0.012420567,0.00044116232,0.002628538,0.027002148,0.0012902695,0.0014130238,0.00012092655,0.9511913],"genre_scores_gemma":[0.013342478,0.009491035,0.00053766667,0.019871738,0.013591749,0.0010609628,0.0030864435,0.00012953907,0.9388884],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873775,0.000042729254,0.00034899983,0.00031305337,0.00019201334,0.0003654263],"domain_scores_gemma":[0.99893874,0.000012651889,0.00019333935,0.00046063212,0.00025164624,0.00014298261],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000639343,0.00032427182,0.00065466366,0.00020224844,0.00007280073,0.000021881422,0.0001335092,0.0005706741,0.042475272],"category_scores_gemma":[0.000019960538,0.00027602987,0.00013767157,0.00015034051,0.00017862153,0.00013056598,0.000060143015,0.00034971104,0.077035464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025013657,0.000034685065,0.00036547144,0.00028699404,0.0000946177,0.000033971297,0.0003772941,0.000001208377,0.000104878374,0.0000089769665,0.97822464,0.020217152],"study_design_scores_gemma":[0.0014830349,0.0005948019,0.0012174747,0.00019858674,0.0002946886,0.00020099997,0.00002946461,0.0000027483804,0.0016786603,0.000021795424,0.99405175,0.0002259696],"about_ca_topic_score_codex":0.00017720267,"about_ca_topic_score_gemma":0.000014870733,"teacher_disagreement_score":0.034560196,"about_ca_system_score_codex":0.00033045464,"about_ca_system_score_gemma":0.00077473704,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W4237350017","doi":"10.5489/cuaj.827","title":"Preoperative hydronephrosis and diabetes mellitus predict poor prognosis in upper urinary tract urothelial carcinoma","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hydronephrosis; Renal pelvis; Proportional hazards model; Urology; Stage (stratigraphy); Upper urinary tract; Urinary system; Urothelial carcinoma; Carcinoma; Internal medicine; Bladder cancer; Surgery; Ureter; Cancer","score_opus":0.010059321405792175,"score_gpt":0.2185328124564884,"score_spread":0.2084734910506962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237350017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797116,0.0014238842,0.0000017250079,0.016833128,0.0001295226,0.0006956037,0.000058906637,0.000019595514,0.0011260454],"genre_scores_gemma":[0.99563575,0.00023688206,0.00012862876,0.0031811665,0.00034209635,0.00014487577,0.00001547008,0.000018613713,0.00029653517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830383,0.00019303644,0.00034705404,0.00026727954,0.00028870013,0.0006001131],"domain_scores_gemma":[0.99877614,0.000106741296,0.00012246032,0.00006774783,0.00015271945,0.0007741744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026818062,0.0001997728,0.00034927274,0.00020409975,0.00019555853,0.00012508218,0.00007919237,0.00025446375,0.0011400369],"category_scores_gemma":[0.00020886844,0.00015189777,0.000103158825,0.00016952209,0.000052222145,0.00024528833,0.000014855735,0.0005316547,0.000062114945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034225504,0.0002305568,0.99542797,0.000006981532,0.00009028325,0.000078347,0.00021685413,0.000002588442,0.00018066434,0.000013074451,0.0013335336,0.002384928],"study_design_scores_gemma":[0.001924346,0.0016371078,0.99334335,0.000026354694,0.00010822759,0.00017533619,0.00007979485,0.00027648534,0.0002269253,0.00033979706,0.001718161,0.00014413368],"about_ca_topic_score_codex":0.0031884592,"about_ca_topic_score_gemma":0.00021230654,"teacher_disagreement_score":0.015924143,"about_ca_system_score_codex":0.0008959024,"about_ca_system_score_gemma":0.0004665589,"threshold_uncertainty_score":0.9997731},"labels":[],"label_agreement":null},{"id":"W4237630196","doi":"10.5489/cuaj.1251","title":"Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Indocyanine green; Lymphatic system; Cystectomy; Lymph node; Lymph; Ex vivo; Medicine; Lymphatic vessel; Bladder cancer; Dissection (medical); Anatomy; Radiology; In vivo; Pathology; Cancer; Biology; Metastasis; Internal medicine","score_opus":0.018312829833106687,"score_gpt":0.24883093438521636,"score_spread":0.23051810455210966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237630196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99050987,0.00039450807,0.0000613817,0.008272972,0.000058188147,0.0005779363,0.00006479578,0.0000070184587,0.00005333873],"genre_scores_gemma":[0.9987636,0.000108789645,0.0001087897,0.00075577514,0.000109905624,0.00006330483,0.000034514433,0.000008589779,0.000046729136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981951,0.00033384495,0.00057482184,0.00017791503,0.00047437934,0.00024389902],"domain_scores_gemma":[0.99816924,0.000273286,0.00055176154,0.00014058955,0.0006898935,0.00017521925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000462058,0.00013399775,0.00030271933,0.00013535071,0.00008704778,0.00004538269,0.0001792719,0.00013514355,0.00035918778],"category_scores_gemma":[0.00044911559,0.000082138155,0.00005427403,0.00048306823,0.00007440147,0.000274127,0.0000077725945,0.0002703468,0.000009341464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014781486,0.00010045373,0.9706847,0.000015316196,0.00017420926,0.000019251414,0.0019263675,0.000052269228,0.021024482,0.000037176866,0.00025413925,0.0055638105],"study_design_scores_gemma":[0.0013568901,0.00046351567,0.9911854,0.00017845815,0.00011261336,0.000014483279,0.0004604458,0.0005681769,0.0050359676,0.0005111615,0.000029625426,0.00008321569],"about_ca_topic_score_codex":0.08139904,"about_ca_topic_score_gemma":0.008992967,"teacher_disagreement_score":0.072406076,"about_ca_system_score_codex":0.0006880299,"about_ca_system_score_gemma":0.00097327353,"threshold_uncertainty_score":0.924718},"labels":[],"label_agreement":null},{"id":"W4237776318","doi":"10.1111/iju.12391","title":"<scp>IJU</scp> this issue","year":2014,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Charlson comorbidity index; Index (typography); Cancer; General surgery; Urology; Surgery; Retrospective cohort study; Oncology; Internal medicine; Kidney","score_opus":0.012062348086193896,"score_gpt":0.29869929284743235,"score_spread":0.28663694476123847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237776318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67606765,0.0024715723,0.0060973978,0.03921482,0.01015196,0.00021458675,0.000021342239,0.00005084188,0.26570985],"genre_scores_gemma":[0.9858213,0.00015337259,0.0005864976,0.0069342367,0.0022705086,0.0000017360672,0.000004107593,0.000013183332,0.0042150402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991209,0.000047948877,0.00028297555,0.00009163151,0.00033128992,0.00012527332],"domain_scores_gemma":[0.99906296,0.00016023398,0.00018981929,0.000088797,0.00039357442,0.00010461916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018055347,0.00008473939,0.00020804249,0.0001671827,0.000017058821,0.000012029921,0.00019379111,0.00007554889,0.00065504067],"category_scores_gemma":[0.00032556415,0.00006485596,0.00012065494,0.000038018847,0.00004969252,0.00006929057,0.000027545377,0.00020662197,0.00023681851],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001956399,0.0020458205,0.22221987,0.000043289,0.0055042896,0.0026645325,0.002871913,0.00017707632,0.01827941,0.00968576,0.5431243,0.19142734],"study_design_scores_gemma":[0.0030524617,0.0014516697,0.024882369,0.000016835107,0.0001421267,0.002753865,0.000024900288,0.00009656359,0.0021919275,0.0018958412,0.963466,0.000025457686],"about_ca_topic_score_codex":0.000019486612,"about_ca_topic_score_gemma":0.0000028413194,"teacher_disagreement_score":0.4203417,"about_ca_system_score_codex":0.000051350242,"about_ca_system_score_gemma":0.000087560606,"threshold_uncertainty_score":0.7172236},"labels":[],"label_agreement":null},{"id":"W4237843631","doi":"10.1016/j.urology.2008.08.162","title":"POD-7.09: Combination of Cell Cycle Regulating Bio-markers Improves Prognosis in Patients with Organ Confined Urothelial Cancer at Radical Cystectomy","year":2008,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urothelial carcinoma; Urology; Transitional cell carcinoma; Oncology; Disease; Internal medicine; Point of delivery; Urothelial cancer; Cancer","score_opus":0.006831633270598919,"score_gpt":0.22287652333951324,"score_spread":0.21604489006891434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237843631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969456,0.00009773137,0.000012200094,0.00041581763,0.000110179135,0.000846463,0.000026209538,0.000034123266,0.0015116823],"genre_scores_gemma":[0.99918157,0.000016483078,0.00014116066,0.00023172218,0.000041242747,0.000085223146,0.00004833421,0.00003246623,0.00022178006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988177,0.00007150817,0.00029991192,0.00029885798,0.00023446037,0.00027755444],"domain_scores_gemma":[0.99943626,0.00005130802,0.0001535961,0.00016209864,0.000106718166,0.00009000997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058960133,0.0001682516,0.00036641702,0.00013877197,0.0000663565,0.0000022342233,0.0000660545,0.00013711095,0.00020758309],"category_scores_gemma":[0.000029066661,0.00013326632,0.00004665182,0.00021132009,0.00025312684,0.000042260766,0.00003263215,0.00013178484,0.0000072062217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004615948,0.0008404978,0.97989285,0.000068866844,0.000095413765,0.00002652657,0.00052734034,0.00001367385,0.011188922,0.000014159699,0.00008797207,0.002627799],"study_design_scores_gemma":[0.022923628,0.004203513,0.9383247,0.00003387098,0.00014494806,0.000021845415,0.000019242003,0.0002373173,0.033596892,0.000017043147,0.00032808058,0.0001489028],"about_ca_topic_score_codex":0.00055878534,"about_ca_topic_score_gemma":0.00010974019,"teacher_disagreement_score":0.041568164,"about_ca_system_score_codex":0.00013037557,"about_ca_system_score_gemma":0.00017264023,"threshold_uncertainty_score":0.5434443},"labels":[],"label_agreement":null},{"id":"W4238629480","doi":"10.1200/jco.2020.38.6_suppl.467","title":"Improving quality of health-related quality of life (HRQOL) reporting in phase III randomized controlled trials (RCTs) of metastatic urothelial carcinoma (mUC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Checklist; Randomized controlled trial; Quality of life (healthcare); Clinical trial; Physical therapy; Internal medicine; Nursing","score_opus":0.41663105511740783,"score_gpt":0.5600466688396258,"score_spread":0.143415613722218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238629480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853669,0.0031312443,0.0009787127,0.0069953236,0.00069240533,0.0023737021,0.000041289233,0.000007707463,0.00041275308],"genre_scores_gemma":[0.9959872,0.00028606426,0.0020845756,0.0012224715,0.00033926553,0.000030230518,0.0000046060554,0.000021676111,0.00002396068],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9164406,0.02274226,0.059172977,0.0003461064,0.0009610908,0.00033695984],"domain_scores_gemma":[0.8303115,0.0506351,0.116543375,0.00038653502,0.0013799592,0.00074354257],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.14296465,0.00026441045,0.030507594,0.00021924745,0.000026891028,0.0000038629623,0.00019016204,0.00032320057,0.0002648164],"category_scores_gemma":[0.423262,0.0001633047,0.0039403513,0.00029680738,0.00042969378,0.0000923077,0.000053472326,0.0009344075,8.5018667e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93333375,0.0044497126,0.023438687,0.0007867679,0.0043658717,0.00012862479,0.0011492665,0.00002993179,0.006097784,0.00014109258,0.00008101527,0.025997473],"study_design_scores_gemma":[0.9634284,0.012358457,0.018281879,0.00025551766,0.0027290378,0.000028183049,0.0006613911,0.0004406718,0.0012656222,0.0004024201,0.000029175864,0.0001192505],"about_ca_topic_score_codex":0.0034117985,"about_ca_topic_score_gemma":0.00007529682,"teacher_disagreement_score":0.28029734,"about_ca_system_score_codex":0.00013388753,"about_ca_system_score_gemma":0.009213634,"threshold_uncertainty_score":0.9964032},"labels":[],"label_agreement":null},{"id":"W4238917550","doi":"10.1097/ju.0000000000000953.011","title":"PD51-11 REPORTING RADICAL CYSTECTOMY OUTCOMES FOLLOWING IMPLEMENTATION OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOLS","year":2020,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cystectomy; Odds ratio; Confidence interval; Perioperative; Observational study; MEDLINE; Surgery; Internal medicine; Bladder cancer","score_opus":0.04486533391749314,"score_gpt":0.3640692265176833,"score_spread":0.31920389260019016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238917550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909152,0.00016934781,0.00087485765,0.0058681173,0.00018129346,0.0019000255,0.0000030923477,0.000009282178,0.00007877927],"genre_scores_gemma":[0.9971029,0.000014766716,0.00020455717,0.0022635313,0.0001943476,0.00018452038,0.0000015007357,0.000016504882,0.00001735092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979086,0.00019641113,0.0013226783,0.000099473466,0.00028725964,0.00018560926],"domain_scores_gemma":[0.99788004,0.00029810038,0.0014938379,0.00013682409,0.000092456474,0.00009871299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094328285,0.000115326635,0.0006465257,0.0000746297,0.000034083925,0.000005343655,0.00008029261,0.00006089934,0.00023088822],"category_scores_gemma":[0.0004880039,0.000069120615,0.00034888697,0.00011917453,0.000042293377,0.00009016772,0.000026758564,0.00020214349,0.000003259284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054268986,0.00012767866,0.94206965,0.00012430106,0.0009824715,0.0005430142,0.0017492737,0.000017174409,0.037330486,0.000003414808,0.0006532047,0.010972452],"study_design_scores_gemma":[0.009734122,0.005462551,0.90204173,0.00017997461,0.0016949505,0.0009552678,0.0007464675,0.000010481786,0.07548679,0.0002590523,0.0032228709,0.00020575324],"about_ca_topic_score_codex":0.00003807184,"about_ca_topic_score_gemma":0.000012165296,"teacher_disagreement_score":0.04002791,"about_ca_system_score_codex":0.000036318037,"about_ca_system_score_gemma":0.00028526832,"threshold_uncertainty_score":0.2818657},"labels":[],"label_agreement":null},{"id":"W4239159476","doi":"10.1038/labinvest.2018.10","title":"USCAP 2018 Abstracts: Genitourinary Pathology (894–1126)","year":2018,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Houston Methodist Research Institute; University of Texas MD Anderson Cancer Center; School of Medicine, Stanford University; Universidade de São Paulo; Houston Methodist Hospital; McMaster University; Foundation Medicine; McGill University; University of Pennsylvania; Emory University; Cleveland Clinic; Henry Ford Health System","keywords":"Genitourinary system; Pathology; Medicine; Anatomy","score_opus":0.023336388858834756,"score_gpt":0.27987289970675966,"score_spread":0.2565365108479249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239159476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894198,0.00031226387,0.000033773726,0.0011980352,0.0006879947,0.00029299653,0.00005322741,0.00015005744,0.007851826],"genre_scores_gemma":[0.99093264,0.000028496464,0.0020531004,0.00456619,0.0014744952,0.000043913165,0.00008117745,0.00003351621,0.00078648666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989521,0.000066317756,0.0002615148,0.00029061048,0.00020040876,0.00022905902],"domain_scores_gemma":[0.99904674,0.000019490484,0.00010550192,0.00033840534,0.0002723502,0.00021751499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001407864,0.00016076177,0.00018674952,0.000089403744,0.0001257617,0.000018167342,0.00006485464,0.00015485601,0.00034805245],"category_scores_gemma":[0.00007420028,0.00014580597,0.00003709879,0.00028738068,0.00033838672,0.00018063585,0.000020357953,0.00014302136,0.0008771839],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057765574,0.00051498663,0.26836026,0.00024921854,0.00029957105,0.00070191734,0.0034895388,0.0000050057693,0.61936164,0.0013541421,0.100577444,0.0045086443],"study_design_scores_gemma":[0.0024557486,0.0018017614,0.64665747,0.0001144738,0.00022764997,0.00012836939,0.00019122445,0.000033690318,0.28284553,0.002632766,0.06259341,0.0003179459],"about_ca_topic_score_codex":0.000039723796,"about_ca_topic_score_gemma":0.000029402328,"teacher_disagreement_score":0.37829718,"about_ca_system_score_codex":0.00010316517,"about_ca_system_score_gemma":0.00034927868,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W4239389551","doi":"10.1097/ju.0000000000001696.01","title":"Editorial Comment","year":2021,"lang":"es","type":"editorial","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; Cystectomy; German; Urology; Bladder cancer; Cancer; Internal medicine; History; Archaeology","score_opus":0.012685953789126722,"score_gpt":0.29589704472528106,"score_spread":0.2832110909361543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239389551","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003066953,0.014349483,0.000052509167,0.015669815,0.9682492,0.00024102004,0.00008469593,0.000007353139,0.0010391994],"genre_scores_gemma":[0.0055933776,0.01612106,0.000023442357,0.001975961,0.97558373,0.0000043532027,0.000041883886,0.000065565524,0.0005906318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552387,0.00110379,0.0011271292,0.00021547142,0.0015098276,0.0005199364],"domain_scores_gemma":[0.99442214,0.0021800601,0.0012932265,0.0005713252,0.001265101,0.0002681512],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016700709,0.00045919998,0.0013947428,0.00016098071,0.00017907615,0.00004115571,0.0006798335,0.0010899273,0.00092561025],"category_scores_gemma":[0.0009512654,0.0002720463,0.0005028797,0.00016358704,0.00029337805,0.00006498956,0.0001815714,0.0030889027,0.00010189515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005920355,0.00045229765,0.0000986851,0.00007084128,0.0022267571,0.0002881484,0.00056657015,0.000013817156,0.00022123373,0.000022334892,0.98893404,0.0011849278],"study_design_scores_gemma":[0.0070412923,0.0066848677,0.00007814979,0.00016814197,0.0057235807,0.0004277102,0.00017611768,0.0000018859171,0.00011991183,0.00020375282,0.97919875,0.00017582973],"about_ca_topic_score_codex":0.00014998208,"about_ca_topic_score_gemma":0.000012569982,"teacher_disagreement_score":0.013693854,"about_ca_system_score_codex":0.00031467094,"about_ca_system_score_gemma":0.0025590027,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W4239518261","doi":"10.1097/ju.0000000000000595.02","title":"Reply by Authors","year":2020,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Health Sciences Centre","funders":"","keywords":"Medicine","score_opus":0.02229703371865503,"score_gpt":0.28036396413140025,"score_spread":0.2580669304127452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239518261","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035035846,0.004135396,0.000087792854,0.9923234,0.00088679214,0.00013530832,0.000023456261,0.000011808622,0.0020456675],"genre_scores_gemma":[0.0063080634,0.00065316184,0.000043030635,0.98317367,0.0058583994,0.0000016142935,0.000018260394,0.00004233982,0.0039014677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869025,0.00025676048,0.00040756812,0.000112282796,0.00031050624,0.00022262706],"domain_scores_gemma":[0.9989543,0.00016140199,0.0004417075,0.00025332862,0.000098984594,0.000090258254],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00020373189,0.00018200895,0.0005578536,0.000069337795,0.00004377658,0.0000060564603,0.00025865057,0.0002898934,0.00042108344],"category_scores_gemma":[0.000084616135,0.000099047626,0.00020098139,0.000075774966,0.000118064534,0.000021229383,0.00003238143,0.0026369735,0.00007830879],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062025123,0.00002084519,0.00007588455,0.000024113067,0.00050429214,0.0018750904,0.00017810967,4.0252615e-7,0.00018056016,8.342297e-7,0.99581206,0.00070755574],"study_design_scores_gemma":[0.0010409725,0.0025284574,0.000077486206,0.00001623105,0.0015468586,0.004473281,0.000009143184,0.0000019474157,0.000107139516,0.00038712646,0.9897434,0.00006792487],"about_ca_topic_score_codex":0.000028779537,"about_ca_topic_score_gemma":3.3458466e-7,"teacher_disagreement_score":0.009149757,"about_ca_system_score_codex":0.000048262482,"about_ca_system_score_gemma":0.0002275197,"threshold_uncertainty_score":0.999664},"labels":[],"label_agreement":null},{"id":"W4240488819","doi":"10.1200/jco.2021.39.15_suppl.4541","title":"Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"National Institutes of Health","keywords":"Medicine; Atezolizumab; Bladder cancer; Cystectomy; Clinical endpoint; Internal medicine; Pathological; Urology; Oncology; Surgery; Clinical trial; Cancer; Immunotherapy; Nivolumab","score_opus":0.1279401219600671,"score_gpt":0.499667704120935,"score_spread":0.3717275821608679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240488819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825929,0.001439533,0.00002565089,0.007987728,0.002910618,0.00048823594,0.000037746348,0.0000060058746,0.004511601],"genre_scores_gemma":[0.98884654,0.0044216975,0.00071628037,0.0028072835,0.0021977348,0.0000239491,0.000007434876,0.00003028289,0.0009487918],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948956,0.0007336269,0.0031553651,0.00032748634,0.00052852783,0.0003593989],"domain_scores_gemma":[0.9938237,0.0025575848,0.001836957,0.0003254861,0.0010086,0.00044765323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016348378,0.0002306476,0.0025095502,0.00021849369,0.000051377654,0.000007041895,0.00019863511,0.00052066566,0.001149038],"category_scores_gemma":[0.005302321,0.00017597318,0.0008343274,0.00037462552,0.00025318892,0.00013748588,0.000114925184,0.0011101404,0.000016618256],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45451137,0.043844085,0.008300224,0.00011060506,0.0026489561,0.011857465,0.001661476,0.000040223094,0.0069572567,0.000055210345,0.014811563,0.45520157],"study_design_scores_gemma":[0.7025648,0.17186768,0.048126407,0.0006148184,0.0018409506,0.00054148375,0.0008749842,0.000034700988,0.009930608,0.0007033357,0.06261507,0.00028520037],"about_ca_topic_score_codex":0.00022058316,"about_ca_topic_score_gemma":0.0006508267,"teacher_disagreement_score":0.4549164,"about_ca_system_score_codex":0.00036296193,"about_ca_system_score_gemma":0.013195354,"threshold_uncertainty_score":0.999764},"labels":[],"label_agreement":null},{"id":"W4240730480","doi":"10.14740/jmc3277","title":"Systemic Tumor Seeding Secondary to Peritonitis due to the Immediate Postoperative Intravesical Instillation of Pirarubicin After Intravesical Explosion Induced Bladder Perforation During Bipolar Transurethral Resection of Bladder Tumors","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pirarubicin; Surgery; Perforation; Bladder cancer; Saline; Anesthesia; Chemotherapy; Cancer; Internal medicine","score_opus":0.017199171381885467,"score_gpt":0.2783738547777805,"score_spread":0.261174683395895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240730480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413806,0.0006248492,0.00021039697,0.0035186678,0.00061773177,0.000797185,0.000038157683,0.0000100594025,0.000044891178],"genre_scores_gemma":[0.9983392,0.00006787016,0.000120450066,0.0005019282,0.00088809704,0.000023542565,0.0000072790685,0.000033377542,0.000018290677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965176,0.0002385684,0.0011170144,0.00024869494,0.0016004429,0.00027770596],"domain_scores_gemma":[0.99830294,0.00021146722,0.00033210946,0.00019679447,0.00050718494,0.00044953547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008023441,0.00024134759,0.0007590329,0.0003854813,0.00008061163,0.00002487016,0.00016335423,0.00018791958,0.00069537933],"category_scores_gemma":[0.0006173393,0.00015390369,0.00019822255,0.00039695858,0.00008666658,0.00029146738,0.000049779952,0.00075519,0.000014975081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02225078,0.00088122213,0.03130839,0.0012724499,0.00083582994,0.0028723988,0.030400682,0.0002375068,0.8874249,0.00005123687,0.00037107317,0.02209352],"study_design_scores_gemma":[0.00843216,0.017761216,0.3984968,0.005476326,0.0005981445,0.01741359,0.009679079,0.0005151442,0.5410326,0.000018018805,0.00018155342,0.0003953798],"about_ca_topic_score_codex":0.00012486905,"about_ca_topic_score_gemma":0.00005675962,"teacher_disagreement_score":0.3671884,"about_ca_system_score_codex":0.00020166983,"about_ca_system_score_gemma":0.0006794288,"threshold_uncertainty_score":0.76139164},"labels":[],"label_agreement":null},{"id":"W4240835418","doi":"10.5489/cuaj.770","title":"Ureteral frozen sections at the time of radical cystectomy: reliability and clinical implications","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cystectomy; Medicine; Urology; Frozen section procedure; Urothelial carcinoma; Ureter; Incidence (geometry); Carcinoma in situ; Stage (stratigraphy); Carcinoma; Bladder cancer; Urethra; Surgery; Internal medicine; Cancer","score_opus":0.014937723798686948,"score_gpt":0.2727031939183894,"score_spread":0.2577654701197024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240835418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90793353,0.00013984174,0.000019574902,0.08929013,0.00013815137,0.0003510058,0.00006362144,0.0000142818235,0.0020498754],"genre_scores_gemma":[0.99441373,0.000057430814,0.00011254526,0.003632478,0.00030915687,0.000022410335,0.000014686642,0.0000075201083,0.0014300421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986294,0.00032373858,0.00042434988,0.00017203137,0.00018445485,0.00026604426],"domain_scores_gemma":[0.99837065,0.00041715524,0.00019348408,0.00016422028,0.00025994435,0.0005945713],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065592205,0.00009488924,0.00025732126,0.0000526647,0.0003850194,0.00003735686,0.00008395044,0.00022060788,0.001899133],"category_scores_gemma":[0.0008771102,0.00005777932,0.00016348234,0.0001280596,0.00015841264,0.000064167434,0.000022573056,0.0005494541,0.00013110021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002993382,0.00005480632,0.97042614,0.0000017841435,0.00013572621,0.0000024958626,0.000055405362,0.000002853977,0.00007761201,0.000042449086,0.027527157,0.0016436226],"study_design_scores_gemma":[0.0009601923,0.00034571264,0.9787174,0.000004377254,0.00014061578,0.00019372118,0.000013103547,0.00008354687,0.000011279605,0.0019594133,0.017516011,0.000054667198],"about_ca_topic_score_codex":0.0025241773,"about_ca_topic_score_gemma":0.0005738686,"teacher_disagreement_score":0.08648021,"about_ca_system_score_codex":0.00066284684,"about_ca_system_score_gemma":0.00037096627,"threshold_uncertainty_score":0.99901325},"labels":[],"label_agreement":null},{"id":"W4240990014","doi":"10.5489/cuaj.3979","title":"Podium Session 2: Urologic Malignancies","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Medical physics; General surgery; Computer science; World Wide Web","score_opus":0.015733356155883876,"score_gpt":0.2424546926347016,"score_spread":0.22672133647881773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240990014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84367365,0.00046862412,0.00022602473,0.14211507,0.00081939617,0.0002316873,0.000071007795,0.00007393692,0.012320607],"genre_scores_gemma":[0.98420244,0.00014725784,0.00013876142,0.010207369,0.00056683004,0.000008187356,0.000004381707,0.000010761981,0.0047139963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986798,0.000108627435,0.00023443303,0.00017609548,0.0003002367,0.0005007893],"domain_scores_gemma":[0.9987268,0.0000988207,0.00014524821,0.0000993626,0.00019840815,0.00073138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032532055,0.0001284348,0.00021984293,0.000123765,0.00022819465,0.000040213945,0.00008800866,0.00023700211,0.0025122582],"category_scores_gemma":[0.00051991025,0.00006828924,0.00013179336,0.00012212407,0.000032317766,0.00009831495,0.0000110643305,0.00023686157,0.00033376226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008539348,0.000043617554,0.95997584,0.000001707772,0.00008314871,0.00021536672,0.000032337903,6.8291604e-7,0.0015095908,0.00019415175,0.025261195,0.012596974],"study_design_scores_gemma":[0.0016394489,0.00055465644,0.78660035,0.000021307222,0.00007415129,0.00041382646,0.000016357766,0.0000023639834,0.00024608258,0.0019601583,0.20836332,0.00010798937],"about_ca_topic_score_codex":0.00030350062,"about_ca_topic_score_gemma":0.0001715431,"teacher_disagreement_score":0.18310213,"about_ca_system_score_codex":0.0011115775,"about_ca_system_score_gemma":0.0005657533,"threshold_uncertainty_score":0.99839956},"labels":[],"label_agreement":null},{"id":"W4241001926","doi":"10.1016/j.urology.2009.05.004","title":"Reply","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Grossman; Chemotherapy; Stage (stratigraphy); Oncology; Neoadjuvant therapy; Cancer; Internal medicine; Urology","score_opus":0.015316934189819694,"score_gpt":0.2881623725489049,"score_spread":0.2728454383590852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241001926","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3573767,0.0017783694,0.0006904142,0.0993209,0.00049324194,0.000418759,0.000004944598,0.00028117115,0.5396355],"genre_scores_gemma":[0.94874245,0.000015373253,0.00010937532,0.048936203,0.00013126241,0.000002586848,0.000003874282,0.000003451597,0.0020554233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996932,0.00000779599,0.000054825585,0.00009984222,0.000039344446,0.00010495262],"domain_scores_gemma":[0.99979156,0.000006555872,0.000009817165,0.00013437722,0.000012628379,0.000045045912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001832386,0.000041163614,0.000087421686,0.000023981931,0.000014822606,0.0000013655937,0.000020146028,0.000031453157,0.00035719396],"category_scores_gemma":[0.000012324805,0.00003229041,0.000027201626,0.000035609366,0.000014985346,0.0000100466095,0.0000030958015,0.000050714334,0.00019468078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005031462,0.001931541,0.08733301,0.00002796061,0.00041321586,0.002260512,0.0012441983,0.000021709928,0.021264205,0.017812664,0.26998407,0.59267545],"study_design_scores_gemma":[0.0033846037,0.0052806046,0.21288475,0.0000029624039,0.00015490141,0.00058324,0.000008215968,0.00004763777,0.0024319822,0.005994681,0.7691293,0.00009715376],"about_ca_topic_score_codex":0.000011428361,"about_ca_topic_score_gemma":8.0665285e-7,"teacher_disagreement_score":0.5925783,"about_ca_system_score_codex":0.000009519535,"about_ca_system_score_gemma":0.000024803436,"threshold_uncertainty_score":0.39110234},"labels":[],"label_agreement":null},{"id":"W4242249173","doi":"10.3233/blc-200013","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Blockade; Immune checkpoint; PD-L1; Cancer research; Immune system; Medicine; Immunology; Immunotherapy; Internal medicine; Receptor","score_opus":0.01940299617668309,"score_gpt":0.30818444827895886,"score_spread":0.2887814521022758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242249173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588474,0.012231906,0.00015145713,0.024644665,0.0003844633,0.0016958262,0.00023227949,0.00010863648,0.0017033527],"genre_scores_gemma":[0.99134696,0.0007678561,0.00075564877,0.0053007076,0.00021652858,0.0008234281,0.000018968005,0.00013170556,0.0006381806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675703,0.00014954891,0.0008494579,0.00086516474,0.00065229635,0.00072649005],"domain_scores_gemma":[0.9983079,0.00007148162,0.0002132991,0.0006303097,0.00021179477,0.000565225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023270395,0.0005070843,0.000928156,0.000281409,0.000056713172,0.000019427504,0.00029060311,0.00020247568,0.002088715],"category_scores_gemma":[0.00018643448,0.00046920445,0.0003259064,0.0012132208,0.00013833697,0.00012317003,0.00014625107,0.0003372235,0.000065527405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025268098,0.00039147164,0.012012707,0.00025461183,0.0014466982,0.0003155952,0.0034975288,0.0012021182,0.9394948,0.00001266838,0.0017173958,0.014386303],"study_design_scores_gemma":[0.01336518,0.001400508,0.15026991,0.0006875626,0.00061360927,0.000017165807,0.00085560314,0.0002780087,0.80615723,0.000045575398,0.025554119,0.0007555526],"about_ca_topic_score_codex":0.002604232,"about_ca_topic_score_gemma":0.00031262072,"teacher_disagreement_score":0.1382572,"about_ca_system_score_codex":0.00046865136,"about_ca_system_score_gemma":0.0010383445,"threshold_uncertainty_score":0.99977595},"labels":[],"label_agreement":null},{"id":"W4242305737","doi":"10.1016/j.urology.2013.06.045","title":"Editorial Comment","year":2013,"lang":"es","type":"editorial","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Cystectomy; Interstitial cystitis; Bladder cancer; Disease; Quality of life (healthcare); Intensive care medicine; Clinical trial; Urinary diversion; Surgery; General surgery; Urinary system; Cancer; Internal medicine","score_opus":0.01011580281380561,"score_gpt":0.28125125570866133,"score_spread":0.27113545289485574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242305737","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052842774,0.0017828017,0.00003343514,0.0057611074,0.9790175,0.0011198549,0.0003766738,0.00011264897,0.01174312],"genre_scores_gemma":[0.0016762724,0.0015125712,0.000022873443,0.002887887,0.98749316,0.00034808234,0.0010686598,0.0001418687,0.004848617],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960742,0.0002706031,0.00067804137,0.00092272,0.001061929,0.000992532],"domain_scores_gemma":[0.9971249,0.0007720577,0.0003165845,0.000892718,0.000453973,0.000439774],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022618858,0.000770556,0.0013313617,0.00020280089,0.00017116862,0.000069973525,0.0004380131,0.00287986,0.005595601],"category_scores_gemma":[0.00043063157,0.00066053943,0.00031872388,0.00012599707,0.000296615,0.000074816264,0.00022327491,0.0018263854,0.008697168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012100905,0.0005015219,0.00021228773,0.00013194935,0.0009296142,0.000054760625,0.00015388528,0.0000020891603,0.00004451258,0.0001317661,0.9946303,0.0019972469],"study_design_scores_gemma":[0.0075853453,0.00484391,0.000063328174,0.000053661566,0.0015850022,0.000010607923,0.000019629419,0.000013493534,0.00003585223,0.00029468405,0.9850631,0.00043141644],"about_ca_topic_score_codex":0.0014591037,"about_ca_topic_score_gemma":0.00001954714,"teacher_disagreement_score":0.009567207,"about_ca_system_score_codex":0.0003724177,"about_ca_system_score_gemma":0.0010684303,"threshold_uncertainty_score":0.99958456},"labels":[],"label_agreement":null},{"id":"W4242326889","doi":"10.5489/cuaj.298","title":"Achieving the achievable in muscle-invasive bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Urology; Internal medicine","score_opus":0.015386554907287082,"score_gpt":0.24828003272310104,"score_spread":0.23289347781581396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242326889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88972104,0.0007398068,0.0000061808832,0.10213093,0.0003195795,0.00038699227,0.000015719506,0.000015110914,0.006664637],"genre_scores_gemma":[0.98128283,0.00030426824,0.000043291802,0.016288552,0.0005234236,0.00007279776,0.000004810811,0.000012778597,0.0014672359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986185,0.00014860502,0.0002615275,0.00016030368,0.00027643418,0.000534618],"domain_scores_gemma":[0.9989499,0.0001652677,0.00013664972,0.00010746689,0.00017824942,0.00046249645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033069417,0.00012896738,0.00021212992,0.00011758891,0.00027076862,0.00011027914,0.00012762421,0.00017088649,0.0041674734],"category_scores_gemma":[0.00040887913,0.00007861819,0.00010540606,0.00023461506,0.000029390754,0.00013846954,0.000013105274,0.00067261944,0.00018823548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013909572,0.00004270472,0.9741902,0.0000026790087,0.0001281071,0.00005095269,0.00028527694,0.000051932337,0.00024721728,0.00004332525,0.016735943,0.008207768],"study_design_scores_gemma":[0.0009013865,0.00013232091,0.97129726,0.000018385017,0.00006230149,0.000050128227,0.00016046024,0.000034628196,0.0000148010395,0.00043465968,0.026808184,0.000085479616],"about_ca_topic_score_codex":0.024124807,"about_ca_topic_score_gemma":0.014061479,"teacher_disagreement_score":0.091561794,"about_ca_system_score_codex":0.0014114969,"about_ca_system_score_gemma":0.00085437414,"threshold_uncertainty_score":0.99674284},"labels":[],"label_agreement":null},{"id":"W4242384421","doi":"10.1200/jco.2020.38.6_suppl.474","title":"Resource utilization analysis of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (DD-MVAC) versus gemcitabine-cisplatin (GC) as neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Cisplatin; Vinblastine; Gemcitabine; Chemotherapy; Internal medicine; Bladder cancer; Urology; Methotrexate; Gastroenterology; Oncology; Cancer","score_opus":0.20651688930918477,"score_gpt":0.478744517378408,"score_spread":0.27222762806922324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242384421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98142326,0.0013189611,0.0012097495,0.013231671,0.000533498,0.00068251044,0.000082302926,0.000020686797,0.00149735],"genre_scores_gemma":[0.9843117,0.0025738534,0.0057199225,0.0059711323,0.0010271189,0.000023378236,0.000030170304,0.000056345343,0.00028638047],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959422,0.00038586307,0.0024207,0.0004422538,0.0004922436,0.00031678108],"domain_scores_gemma":[0.99170744,0.0044633043,0.0022241075,0.00023735977,0.0007902461,0.00057755515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012556246,0.00029633296,0.0024763772,0.00028297547,0.00006864333,0.00001467652,0.00017932404,0.00043867232,0.00072151015],"category_scores_gemma":[0.0044737007,0.00022115055,0.00079182955,0.00074362283,0.00023049393,0.00012711494,0.000056723133,0.00056292984,0.0000041159674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17839393,0.0037451496,0.06849634,0.00044467853,0.03272995,0.0006011387,0.0047784196,0.0021119518,0.026804667,0.00022733024,0.022939699,0.65872675],"study_design_scores_gemma":[0.15432276,0.09107356,0.5465918,0.0005230726,0.041976325,0.000112561815,0.0022383472,0.013739487,0.015494838,0.00039510158,0.13263863,0.0008935266],"about_ca_topic_score_codex":0.00015211222,"about_ca_topic_score_gemma":0.0002633507,"teacher_disagreement_score":0.6578332,"about_ca_system_score_codex":0.00013836929,"about_ca_system_score_gemma":0.0014634224,"threshold_uncertainty_score":0.9018257},"labels":[],"label_agreement":null},{"id":"W4242577180","doi":"10.1097/01.ju.0000556458.60096.e3","title":"MP50-17 PROGNOSTIC VALUE OF THE SYSTEMIC INFLAMMATION MODIFIED GLASGOW PROGNOSTIC SCORE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH RADICAL NEPHROURETERECTOMY: RESULTS FROM A LARGE MULTICENTER INTERNATIONAL COLLABORATION","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial carcinoma; Internal medicine; Urology; Oncology; Cancer","score_opus":0.007599969664016908,"score_gpt":0.2262884358809687,"score_spread":0.2186884662169518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242577180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653745,0.00008950331,0.00005812503,0.0011349405,0.00022361327,0.0016914329,0.00013518771,0.000008107323,0.000121614845],"genre_scores_gemma":[0.99943876,0.000009637287,0.00007007983,0.00019232252,0.0001519502,0.000016536853,0.00006541284,0.000025415664,0.000029885874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980396,0.00041020717,0.000640009,0.00017418343,0.0005226633,0.00021335801],"domain_scores_gemma":[0.99823314,0.00029131444,0.00072441786,0.00025793613,0.00043021483,0.00006295789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027989413,0.00019290914,0.00040295706,0.00014354601,0.000041985622,0.000016205573,0.00020976366,0.00011967837,0.000031165837],"category_scores_gemma":[0.0001798849,0.00009121935,0.00006693875,0.00022873403,0.000098404955,0.00015891764,0.000028844019,0.0003535932,0.0000039993847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03724022,0.00048367816,0.95701706,0.000023722765,0.0003141057,0.000030662293,0.0022566426,0.0009458677,0.0014176212,0.000013001378,0.000030222933,0.00022721651],"study_design_scores_gemma":[0.028631885,0.0040308633,0.96286464,0.0003807407,0.00065097096,0.00014956757,0.00017485335,0.0021946202,0.00073353754,0.000014662189,0.00008304449,0.00009062085],"about_ca_topic_score_codex":0.00013476287,"about_ca_topic_score_gemma":0.0000702182,"teacher_disagreement_score":0.008608335,"about_ca_system_score_codex":0.0001567847,"about_ca_system_score_gemma":0.00036304133,"threshold_uncertainty_score":0.37198174},"labels":[],"label_agreement":null},{"id":"W4242864454","doi":"10.3233/blc-219500","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2021,"lang":"en","type":"erratum","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Blockade; Immune checkpoint; PD-L1; Bladder cancer; Medicine; Cancer research; Immune system; Oncology; Cancer; Internal medicine; Immunotherapy; Immunology; Receptor","score_opus":0.014289048765207263,"score_gpt":0.31194671665820956,"score_spread":0.2976576678930023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242864454","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4238751,0.44175947,0.00015535427,0.028432177,0.043965716,0.010255306,0.004294966,0.0004620174,0.046799928],"genre_scores_gemma":[0.39556274,0.054061983,0.0027440523,0.011582828,0.00582117,0.012403631,0.0022119284,0.002171818,0.5134399],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932056,0.00037242868,0.001712294,0.0018682351,0.001448963,0.0013924576],"domain_scores_gemma":[0.99603164,0.000120850884,0.00064442155,0.0018770549,0.00067700923,0.0006490481],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004888209,0.0013257762,0.0025642137,0.0010015197,0.000101047764,0.000053441217,0.00058567396,0.0011413774,0.005223653],"category_scores_gemma":[0.00031819253,0.0012820438,0.00093369634,0.0019012613,0.0002604261,0.00013571887,0.00035867817,0.0014858431,0.000058181846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03955884,0.0022290016,0.0033761696,0.002942052,0.013770023,0.0037822365,0.0040305895,0.000853798,0.46416786,0.000015077945,0.4335121,0.031762265],"study_design_scores_gemma":[0.016598849,0.0014930757,0.064800054,0.009719485,0.0031783993,0.000096516116,0.001099746,0.000084262305,0.2503734,0.00006660856,0.65003294,0.0024566315],"about_ca_topic_score_codex":0.008060333,"about_ca_topic_score_gemma":0.0026427791,"teacher_disagreement_score":0.46663994,"about_ca_system_score_codex":0.0018659527,"about_ca_system_score_gemma":0.0065733,"threshold_uncertainty_score":0.99994934},"labels":[],"label_agreement":null},{"id":"W4242879125","doi":"10.5489/cuaj.2517","title":"University of Ottawa Uro-oncology Program","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncology; Medicine; Medical physics; Internal medicine","score_opus":0.011123885813613048,"score_gpt":0.24401842426268242,"score_spread":0.23289453844906938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242879125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7362457,0.00026013117,0.0004759666,0.06304943,0.0007992994,0.00070179935,0.000056247245,0.000096243406,0.19831517],"genre_scores_gemma":[0.99661314,0.000027374548,0.0007362854,0.0016477077,0.00020975583,7.4000945e-7,0.000007432869,0.0000047375775,0.0007528094],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922365,0.00013987387,0.0001384733,0.00009508633,0.00015622539,0.00024667443],"domain_scores_gemma":[0.99905205,0.000065704604,0.00015770641,0.000061646264,0.0001843589,0.00047855475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033500098,0.00006368065,0.00020639788,0.0000786527,0.00011902775,0.00000923379,0.00006941437,0.00017891118,0.0008220889],"category_scores_gemma":[0.0002392928,0.000054633114,0.00009798675,0.00010757782,0.000034664503,0.000032381344,0.000006057919,0.00022681578,0.00003688211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007131548,0.0001507737,0.9034003,0.0000041096564,0.00014634477,0.000073963674,0.000113246686,0.000006722247,0.00006320395,0.0005622947,0.020004604,0.0754031],"study_design_scores_gemma":[0.0011559734,0.0011658836,0.41971016,0.000003100834,0.00008042483,0.00007431969,0.000033906268,0.000048818452,0.000015009545,0.0003097923,0.5773633,0.000039284067],"about_ca_topic_score_codex":0.0013922079,"about_ca_topic_score_gemma":0.002156024,"teacher_disagreement_score":0.5573587,"about_ca_system_score_codex":0.0007565044,"about_ca_system_score_gemma":0.00055614143,"threshold_uncertainty_score":0.9001297},"labels":[],"label_agreement":null},{"id":"W4243080052","doi":"10.1097/01.ju.0000552987.15285.c7","title":"Editorial Comment","year":2019,"lang":"es","type":"editorial","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine","score_opus":0.011659868930486796,"score_gpt":0.291860842672676,"score_spread":0.28020097374218916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243080052","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043218565,0.005890853,0.000041328287,0.011522242,0.97997487,0.00043659314,0.00009839544,0.000008108042,0.0015954111],"genre_scores_gemma":[0.010797737,0.008486222,0.000012350485,0.0018440053,0.9777361,0.0000035730777,0.000025604657,0.00007353498,0.0010208753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580866,0.0008294797,0.0011053552,0.00020770782,0.0015042635,0.0005445129],"domain_scores_gemma":[0.9940915,0.0026434998,0.0015393668,0.00062566495,0.00087473984,0.00022523136],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018330711,0.0004814836,0.001414126,0.0002029081,0.00013256365,0.000031108404,0.0008543807,0.001165059,0.0006253581],"category_scores_gemma":[0.00065181515,0.00027166808,0.0004614664,0.00012052575,0.00026789578,0.00007862532,0.000157571,0.003072478,0.0005058578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010610403,0.0003427306,0.00019729258,0.000085208354,0.0018362954,0.000059351252,0.0005023676,0.000024807387,0.0001489519,0.000024370858,0.9852886,0.0008796066],"study_design_scores_gemma":[0.008837098,0.011705164,0.00012253737,0.00013465174,0.004989443,0.00024560606,0.00009139228,0.0000035947512,0.000049087164,0.00021383041,0.9734235,0.00018412096],"about_ca_topic_score_codex":0.00015511474,"about_ca_topic_score_gemma":0.0000054274847,"teacher_disagreement_score":0.01186514,"about_ca_system_score_codex":0.00035352906,"about_ca_system_score_gemma":0.0020175055,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W4243237085","doi":"10.1016/j.euf.2021.04.025","title":"Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz’s Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations","year":2021,"lang":"en","type":"letter","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Environmental ethics; Library science; Philosophy","score_opus":0.042877968560876875,"score_gpt":0.2734961648117268,"score_spread":0.2306181962508499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243237085","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027712021,0.0017277726,0.0001867152,0.9426134,0.0025028836,0.0021163707,0.000430501,0.00006604895,0.022644287],"genre_scores_gemma":[0.24080938,0.001222946,0.0014852876,0.70999926,0.023081567,0.00057136605,0.00049637153,0.00041488305,0.021918952],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99470586,0.0013926607,0.00095495046,0.0016282096,0.0006072234,0.0007111251],"domain_scores_gemma":[0.9977881,0.00046715644,0.00042883796,0.0008644411,0.00024071762,0.00021077014],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007126462,0.0007849095,0.0010543135,0.00038103666,0.00020206999,0.000061008574,0.0004972761,0.00053209695,0.00063598296],"category_scores_gemma":[0.00027628976,0.0006146356,0.00041966024,0.00029977135,0.0003514509,0.000100055324,0.00050545624,0.002524351,0.00014658217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016806793,0.00037205574,0.0033059947,0.000035262157,0.00045460433,0.0004782518,0.0020563845,0.000036408535,0.00041294633,0.000019589666,0.98915005,0.0019977686],"study_design_scores_gemma":[0.0032555163,0.0034552328,0.051793177,0.00014073197,0.00020205895,0.00012521571,0.000096810465,0.00008604554,0.00036051535,0.000076691955,0.93994355,0.00046442513],"about_ca_topic_score_codex":0.0002964837,"about_ca_topic_score_gemma":0.000042716947,"teacher_disagreement_score":0.23261414,"about_ca_system_score_codex":0.00017354237,"about_ca_system_score_gemma":0.00019460074,"threshold_uncertainty_score":0.99977684},"labels":[],"label_agreement":null},{"id":"W4243890948","doi":"10.1016/j.juro.2010.02.414","title":"348 ASSOCIATION OF HEMATURIA ON MICROSCOPIC URINALYSIS AND RISK OF URINARY TRACT CANCER DEVELOPMENT","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urinalysis; Medicine; Microscopic hematuria; Urinary system; Epidemiology; Bladder cancer; Lower urinary tract symptoms; Cancer; Urology; Gynecology; General surgery; Internal medicine; Prostate","score_opus":0.009332894834803145,"score_gpt":0.2818845965218718,"score_spread":0.27255170168706866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243890948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974691,0.0011103724,0.000010705518,0.0009916105,0.00018630658,0.00007338416,0.000007823826,0.0000015179077,0.00014914852],"genre_scores_gemma":[0.99812263,0.0012409354,0.0002624428,0.000119229204,0.00009159924,0.0000014754447,5.6231903e-7,0.000006126547,0.00015501698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999293,0.0000903785,0.00031054672,0.000051111187,0.00016300647,0.00009190053],"domain_scores_gemma":[0.9989503,0.0001679281,0.00061772205,0.00009662843,0.00012710753,0.000040309988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000491584,0.000070207614,0.0003045644,0.00008208969,0.00003200388,0.0000013994229,0.00006183498,0.000077721576,0.000107147374],"category_scores_gemma":[0.00007538182,0.000040914994,0.000058485053,0.000056982157,0.000045235167,0.000021298236,0.000012842799,0.00030584543,0.0000012506347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024531016,0.00092816143,0.92075443,0.000059060687,0.0015498522,0.000019017121,0.0019185353,0.000020432279,0.06660328,0.000011799016,0.00032668374,0.0053556184],"study_design_scores_gemma":[0.0020260215,0.0019971414,0.953392,0.000026931233,0.0014118421,0.00024443364,0.000030233039,0.000005167997,0.039181646,0.000099691555,0.0015491467,0.00003574215],"about_ca_topic_score_codex":0.000087733075,"about_ca_topic_score_gemma":0.000047520683,"teacher_disagreement_score":0.032637548,"about_ca_system_score_codex":0.00003933958,"about_ca_system_score_gemma":0.00014631051,"threshold_uncertainty_score":0.1668465},"labels":[],"label_agreement":null},{"id":"W4244327436","doi":"10.5489/cuaj.846","title":"Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia Hospital; University of Alberta; Dalhousie University; University of Toronto; Hôtel-Dieu de Québec; McGill University","funders":"","keywords":"Bladder cancer; Medicine; Focus (optics); Cancer therapy; Cancer; Urology; Internal medicine","score_opus":0.042803553734192874,"score_gpt":0.3058312846889339,"score_spread":0.263027730954741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244327436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82656306,0.0008297231,0.000030284407,0.16782722,0.0004583504,0.0015085012,0.00035783,0.000015400748,0.0024096628],"genre_scores_gemma":[0.9856183,0.0011333235,0.00033076658,0.010871753,0.0009765672,0.00024812316,0.000026351932,0.000023102151,0.00077173696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846035,0.000055212375,0.00041656793,0.0002188719,0.000251048,0.00059795426],"domain_scores_gemma":[0.9972776,0.00016339784,0.00020528505,0.00012764557,0.00095698447,0.0012690495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014284535,0.00020758258,0.00043290437,0.00023127644,0.00021362532,0.00005209481,0.00009664408,0.00025321692,0.0016668632],"category_scores_gemma":[0.00033817516,0.00014196963,0.00023504089,0.00014618917,0.000027811711,0.000066063985,0.0000026098733,0.00013374611,0.00004696362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003733958,0.0005223617,0.41625646,0.000010664459,0.0018184303,0.000104308,0.00093069347,0.00009235449,0.0016496424,0.00019319753,0.17233154,0.40571696],"study_design_scores_gemma":[0.007844521,0.008061984,0.8726045,0.00004401082,0.000243541,0.000052878073,0.00017379333,0.0002246296,0.0020150724,0.0027403294,0.1056906,0.00030416134],"about_ca_topic_score_codex":0.47605106,"about_ca_topic_score_gemma":0.29579502,"teacher_disagreement_score":0.45634803,"about_ca_system_score_codex":0.003399597,"about_ca_system_score_gemma":0.0034454258,"threshold_uncertainty_score":0.99924576},"labels":[],"label_agreement":null},{"id":"W4245040938","doi":"10.13188/2380-0585.1000022","title":"Bid Cleavage and TRAIL Sensitivity in Urothelial Cell Carcinoma of the Bladder","year":2018,"lang":"en","type":"article","venue":"Journal of Urology & Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; Alberta Cancer Foundation","keywords":"Urothelial carcinoma; Cleavage (geology); Urology; Carcinoma; Sensitivity (control systems); Medicine; Internal medicine; Bladder cancer; Biology; Cancer; Engineering","score_opus":0.011648497760864266,"score_gpt":0.24932197153145572,"score_spread":0.23767347377059145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245040938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923185,0.0005539381,0.000036729423,0.0048038606,0.0003896313,0.00017476102,0.0000078236735,0.0000034236166,0.0017113287],"genre_scores_gemma":[0.9936864,0.000059954087,0.000118868775,0.0055398997,0.00048968394,0.0000016152096,3.5062888e-7,0.000015729947,0.00008750168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873066,0.00027358264,0.0004278234,0.00016254233,0.00014517171,0.00026020178],"domain_scores_gemma":[0.99916553,0.00012324897,0.00028794934,0.00020448168,0.00013026143,0.00008850388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038741826,0.00014114402,0.0004906514,0.00016720261,0.000044132765,0.000002788335,0.000091046226,0.00021298818,0.000101173086],"category_scores_gemma":[0.00004695543,0.000091593036,0.00012382453,0.00013951171,0.00069690705,0.000048309346,0.000055153396,0.00040978348,0.0000061165583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007205209,0.0008184295,0.7506956,0.00004172049,0.0002960364,0.0008905083,0.0023815762,0.0000062614695,0.22870743,0.00012084657,0.0041016582,0.004734761],"study_design_scores_gemma":[0.006034457,0.005205039,0.95629734,0.0000073330502,0.00033681915,0.0031882946,0.00006466706,0.000037888774,0.022782687,0.00037117308,0.005602366,0.00007192062],"about_ca_topic_score_codex":0.00009618342,"about_ca_topic_score_gemma":0.00028076512,"teacher_disagreement_score":0.20592475,"about_ca_system_score_codex":0.000028287337,"about_ca_system_score_gemma":0.00023941915,"threshold_uncertainty_score":0.37350556},"labels":[],"label_agreement":null},{"id":"W4245445047","doi":"10.1383/surg.23.3.89.63115","title":"Pathology of tumours of the urinary tract","year":2005,"lang":"en","type":"article","venue":"Surgery (Oxford)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fleming College","funders":"","keywords":"Medicine; Pathology; Grading (engineering); Pathological; Urinary system; Histopathology; Urinary bladder; Renal cell carcinoma; Kidney; Carcinoma; Dysplasia; Carcinoma in situ; Urology; Internal medicine; Biology","score_opus":0.022517806394295414,"score_gpt":0.2727248946953766,"score_spread":0.2502070883010812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245445047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851718,0.00097400724,0.000004261694,0.0012682352,0.0002456177,0.00016036101,0.000026431526,0.000014737614,0.0121345315],"genre_scores_gemma":[0.99797547,0.00020043644,0.00006280662,0.00034973572,0.00012543479,0.000010370564,0.0000047634053,0.000014719119,0.0012562941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992394,0.000044232376,0.00026998404,0.000120518926,0.00016156053,0.0001643172],"domain_scores_gemma":[0.9993812,0.000112077534,0.00011934867,0.00029375503,0.00004571687,0.000047906193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014780952,0.00009471105,0.00032666532,0.000063121246,0.000024273637,0.0000011479914,0.000063004416,0.000057753616,0.00028898224],"category_scores_gemma":[0.000045830144,0.000060358343,0.00023155517,0.00013422516,0.000100607846,0.00003857227,0.000022982247,0.0000905024,0.0000050010963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002315634,0.0009890363,0.97391945,0.00007767017,0.000045641453,0.0000675793,0.00022184644,0.000003597803,0.0016263205,0.0000750776,0.002611516,0.020130705],"study_design_scores_gemma":[0.00057160965,0.00022546198,0.94386196,0.00008808921,0.000116197574,0.00036823744,0.00005989051,0.000003518567,0.027019376,0.00010748156,0.02751197,0.00006621553],"about_ca_topic_score_codex":0.000022986214,"about_ca_topic_score_gemma":0.00000384278,"teacher_disagreement_score":0.030057495,"about_ca_system_score_codex":0.000025809324,"about_ca_system_score_gemma":0.0001655894,"threshold_uncertainty_score":0.31641528},"labels":[],"label_agreement":null},{"id":"W4246016450","doi":"10.1111/iju.13744","title":"Educational Lecture","year":2018,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Library science; Medicine; Citation; Computer science","score_opus":0.013422783651270653,"score_gpt":0.3352413415344345,"score_spread":0.3218185578831639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246016450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79340786,0.0015371088,0.004598196,0.14373425,0.010051746,0.00012820627,0.00001625903,0.000014973552,0.04651141],"genre_scores_gemma":[0.98974156,0.000040306582,0.00081951503,0.005052233,0.0038695813,9.67679e-7,0.000003912723,0.0000061003516,0.00046582785],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994543,0.00001571417,0.0001784116,0.00005961974,0.00022031029,0.000071618626],"domain_scores_gemma":[0.9990595,0.00003621927,0.000109712135,0.000051495575,0.0006828395,0.000060221228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000061081075,0.00005033391,0.00010244778,0.00012679074,0.00001604694,0.0000070454385,0.000116626084,0.000043343993,0.0021990815],"category_scores_gemma":[0.00008624824,0.00003758024,0.00007151311,0.00003713707,0.00007682344,0.00004694988,0.000013596455,0.00010810056,0.00008977346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015633501,0.003165447,0.48368695,0.000020515017,0.006821071,0.0013861255,0.0026509275,0.00004434803,0.05378607,0.017709991,0.1706855,0.24440956],"study_design_scores_gemma":[0.0070075323,0.0052622156,0.34965363,0.000040045947,0.00031537778,0.018733984,0.000027427119,0.0000694883,0.008992354,0.02636182,0.58338666,0.00014945556],"about_ca_topic_score_codex":0.0000071363534,"about_ca_topic_score_gemma":0.0000048325983,"teacher_disagreement_score":0.41270116,"about_ca_system_score_codex":0.00005485123,"about_ca_system_score_gemma":0.00027077072,"threshold_uncertainty_score":0.998713},"labels":[],"label_agreement":null},{"id":"W4246343560","doi":"10.14740/jmc1801w","title":"Cooccurrence of Multilocular Cystic Renal Cell Carcinoma and High-Grade Urothelial Carcinoma in Bladder","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dysuria; Gross hematuria; Urothelial carcinoma; Urology; Renal cell carcinoma; Carcinoma; Pathology; Radiology; Internal medicine; Urinary system; Bladder cancer; Cancer","score_opus":0.02051146215150713,"score_gpt":0.2843670102064861,"score_spread":0.26385554805497896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246343560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544924,0.0026458,0.00034262607,0.0009630114,0.00027621613,0.00015436775,0.00002008804,0.000004773259,0.00014387956],"genre_scores_gemma":[0.99852604,0.0001554581,0.00041113043,0.00034407887,0.0005083786,0.0000036813422,0.00000316343,0.000017171424,0.00003089862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763775,0.00015814866,0.000671011,0.00018081463,0.0011065993,0.00024570586],"domain_scores_gemma":[0.9985296,0.00041648158,0.00026917667,0.00017156823,0.00014162021,0.00047156075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000608396,0.00017975939,0.0006198447,0.00020276225,0.00002949845,0.00000970008,0.0001531055,0.0001569672,0.00028524554],"category_scores_gemma":[0.0008590118,0.00012731052,0.0001229516,0.00014580664,0.00022791438,0.00006806863,0.000045401055,0.00044098042,0.0000033023084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006335863,0.0047726114,0.84937894,0.0018047058,0.00036994345,0.024782436,0.0024356905,0.000057621062,0.021105688,0.0003483977,0.0062830388,0.082325086],"study_design_scores_gemma":[0.047275405,0.012929219,0.8444011,0.0016085315,0.0013536667,0.012676041,0.0005959308,0.0025544814,0.0701294,0.0004100889,0.005521418,0.00054467714],"about_ca_topic_score_codex":0.00069350295,"about_ca_topic_score_gemma":0.000043447475,"teacher_disagreement_score":0.08178041,"about_ca_system_score_codex":0.000055547833,"about_ca_system_score_gemma":0.00046791046,"threshold_uncertainty_score":0.5191572},"labels":[],"label_agreement":null},{"id":"W4246352610","doi":"10.1002/1097-0215(20001115)88:4<682::aid-ijc26>3.3.co;2-5","title":"Human bladder cancer, schistosomiasis, N‐nitroso compounds and their precursors","year":2000,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schistosomiasis; Nitroso Compounds; Bladder cancer; Cancer; Nitroso; Carcinogen; Medicine; Cancer research; Biology; Pathology; Oncology; Helminths; Immunology; Chemistry; Internal medicine; Biochemistry; Medicinal chemistry; Organic chemistry","score_opus":0.016857488210518124,"score_gpt":0.33451936150846207,"score_spread":0.31766187329794393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246352610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96986026,0.016479403,0.000015058075,0.0045301616,0.0008915159,0.00012281757,0.00008339062,0.000014705346,0.008002713],"genre_scores_gemma":[0.98970056,0.0046592327,0.000091743124,0.0014240631,0.0013724546,0.000015531517,0.0000048392726,0.000022428363,0.002709172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989796,0.000022761382,0.00033752044,0.0001364474,0.0003811701,0.00014246072],"domain_scores_gemma":[0.9992381,0.000018147239,0.00017559889,0.00008711531,0.00033752486,0.00014353395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000071453964,0.00015116872,0.00027637868,0.00012310904,0.000060669736,0.0000419574,0.00016459127,0.00005467373,0.0035883093],"category_scores_gemma":[0.000006137865,0.000108723376,0.00013133837,0.000059633345,0.00009845233,0.00016220789,0.000016038668,0.00021649737,0.0000065664403],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047055376,0.0011266676,0.1961943,0.00007196491,0.009944391,0.00029815943,0.0038637642,0.0002580317,0.03692288,0.00039810195,0.045679133,0.7005371],"study_design_scores_gemma":[0.022281451,0.0014352839,0.36942828,0.0015039102,0.0010756872,0.0014929306,0.00032827494,0.00011690257,0.027217241,0.0026986224,0.5718345,0.0005868986],"about_ca_topic_score_codex":0.00060565135,"about_ca_topic_score_gemma":0.00016571287,"teacher_disagreement_score":0.69995016,"about_ca_system_score_codex":0.00028495057,"about_ca_system_score_gemma":0.0002529555,"threshold_uncertainty_score":0.99732256},"labels":[],"label_agreement":null},{"id":"W4246457274","doi":"10.1097/01.ju.0000139588.81672.dc","title":"RE: BLADDER CANCER FACTS: ACCURACY OF INFORMATION ON THE INTERNET","year":2004,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; The Internet; Cancer; German; Library science; World Wide Web; Internal medicine; Computer science; Philosophy","score_opus":0.024580930171630298,"score_gpt":0.30236465884192737,"score_spread":0.27778372867029705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246457274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93750894,0.0010032137,0.00049689005,0.056332838,0.00037341737,0.00022087003,0.000008418335,0.000005448398,0.0040499847],"genre_scores_gemma":[0.9910195,0.00072137016,0.00001977102,0.008043261,0.00012927814,0.000002483552,8.1417954e-7,0.0000049396053,0.000058623293],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993459,0.00006116251,0.00029343303,0.000027190817,0.00017293794,0.00009940366],"domain_scores_gemma":[0.99918133,0.00017596429,0.00034498482,0.00014165715,0.00012190717,0.000034164532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025695952,0.00006980739,0.0001616387,0.00005612751,0.000025148916,0.000004158441,0.00014297756,0.000044071643,0.0003709904],"category_scores_gemma":[0.00014989763,0.000029775852,0.00006341303,0.00007594043,0.000079684636,0.00010087471,0.00001767709,0.00024828297,0.000024430103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09472467,0.0040501873,0.05625376,0.00046363473,0.015946714,0.00031094684,0.18132338,0.024040043,0.019690575,0.024458474,0.23003238,0.34870523],"study_design_scores_gemma":[0.045810916,0.042004008,0.411881,0.0008428401,0.0061339033,0.0027132668,0.008864791,0.00025188524,0.16664436,0.027818788,0.2863767,0.0006575296],"about_ca_topic_score_codex":0.00019963687,"about_ca_topic_score_gemma":0.00003289703,"teacher_disagreement_score":0.35562724,"about_ca_system_score_codex":0.000052783827,"about_ca_system_score_gemma":0.000162067,"threshold_uncertainty_score":0.4062085},"labels":[],"label_agreement":null},{"id":"W4246625087","doi":"10.1200/jco.2016.34.15_suppl.lba4500","title":"Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Atezolizumab; Medicine; Metastatic Urothelial Carcinoma; Oncology; Cohort; Internal medicine; Cisplatin; Clinical Oncology; Urothelial carcinoma; Bladder cancer; Cancer; Chemotherapy; Immunotherapy; Nivolumab","score_opus":0.0732569150031822,"score_gpt":0.43176995279368185,"score_spread":0.35851303779049964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246625087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886862,0.0010790329,0.000828346,0.004069373,0.0006627139,0.00054346153,0.000045711688,0.000012300787,0.0040728836],"genre_scores_gemma":[0.9884313,0.006762967,0.002003993,0.0017249,0.00043170343,0.000028186365,0.000008394385,0.000038901228,0.00056967675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426,0.0004385049,0.0037689975,0.00039435056,0.00072300254,0.0004151029],"domain_scores_gemma":[0.993637,0.0027758519,0.002064533,0.00042722342,0.0006653651,0.0004300221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179047,0.00030488012,0.003434036,0.00064847706,0.000036305017,0.000006556434,0.000294331,0.0003317714,0.00083770073],"category_scores_gemma":[0.0016594689,0.0001765429,0.0010912542,0.0007731916,0.00032280677,0.00018044654,0.00005968664,0.0005914538,0.000032770084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02495585,0.0031616848,0.6990369,0.000045737903,0.004218373,0.0012005515,0.00009314463,0.00017335136,0.0013408085,0.00003796743,0.00040054446,0.26533508],"study_design_scores_gemma":[0.040697675,0.025331365,0.9198405,0.0002706157,0.0037208956,0.00024490204,0.00003204127,0.00012718923,0.0016229716,0.00078456127,0.0071088937,0.00021834759],"about_ca_topic_score_codex":0.0002788009,"about_ca_topic_score_gemma":0.00024942763,"teacher_disagreement_score":0.26511672,"about_ca_system_score_codex":0.00041247156,"about_ca_system_score_gemma":0.0034743438,"threshold_uncertainty_score":0.9172236},"labels":[],"label_agreement":null},{"id":"W4246703286","doi":"10.1007/978-3-030-17542-9_10","title":"BCG for the Treatment of Non-muscle Invasive Bladder Cancer","year":2019,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Adjuvant; Oncology; Cancer; Internalization; Internal medicine; Cancer research","score_opus":0.038838133304402986,"score_gpt":0.3056801998810619,"score_spread":0.2668420665766589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246703286","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048766748,0.011075985,0.00016516645,0.0015847925,0.00097629067,0.0060685016,0.00091495086,0.00003962084,0.97868705],"genre_scores_gemma":[0.009359271,0.0137785645,0.0001646853,0.00077734404,0.0006297896,0.0003756164,0.000091660855,0.00010210972,0.97472095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998931,0.0000030918952,0.00027950198,0.00034654565,0.0002320917,0.00020777248],"domain_scores_gemma":[0.998776,0.00022901145,0.00015937685,0.00057612994,0.00017953494,0.00007991234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000026090054,0.00036706522,0.0006680037,0.00006493764,0.00005018413,0.000007746617,0.000095466574,0.00022483958,0.0046201358],"category_scores_gemma":[0.000004080876,0.00019337314,0.00047647915,0.000017179407,0.00008587174,0.000021337244,0.000015748736,0.00007776176,0.00012573437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036726536,0.0019871888,0.0018505214,0.0018441267,0.03166948,0.00008455351,0.0042026597,0.000041597108,0.0023050457,0.021404264,0.16696802,0.7639699],"study_design_scores_gemma":[0.006975766,0.005162076,0.0015228696,0.00039777398,0.0046565155,0.0000074735854,0.000084212246,0.000027272754,0.005960452,0.00074565073,0.9741306,0.00032933953],"about_ca_topic_score_codex":0.0008095986,"about_ca_topic_score_gemma":0.00065414375,"teacher_disagreement_score":0.8071626,"about_ca_system_score_codex":0.0002561982,"about_ca_system_score_gemma":0.0007809287,"threshold_uncertainty_score":0.9962898},"labels":[],"label_agreement":null},{"id":"W4247523603","doi":"10.1016/j.juro.2011.02.1873","title":"1840 EXTERNAL VALIDATION OF BLADDER CANCER PREDICTIVE NOMOGRAMS FOR RECURRENCE, CANCER-FREE SURVIVAL, AND OVERALL SURVIVAL FOLLOWING RADICAL CYSTECTOMY","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nomogram; Cystectomy; Medicine; Bladder cancer; Lymph node; Transitional cell carcinoma; Cancer; Urology; Oncology; Internal medicine","score_opus":0.042048382031089196,"score_gpt":0.3099629297216564,"score_spread":0.2679145476905672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247523603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525345,0.0055968394,0.005121562,0.00090610253,0.0019542044,0.00048229686,0.00007731971,0.000009599048,0.0005986338],"genre_scores_gemma":[0.9973839,0.0013629517,0.00044749764,0.00014875398,0.0005271529,0.000028956827,0.0000023442226,0.000022323275,0.00007611284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861914,0.0002077761,0.00046204682,0.0001431827,0.0003192893,0.00024856153],"domain_scores_gemma":[0.9987669,0.00025289736,0.00041926323,0.00020284,0.0002305355,0.0001275505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006964158,0.00016195483,0.0005148474,0.00009673615,0.000071676935,0.000005864423,0.00021959686,0.000109671244,0.0001887858],"category_scores_gemma":[0.00011006552,0.00010335005,0.000179035,0.00009192458,0.00019589736,0.00011086914,0.000049228962,0.00026818886,6.497791e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055572893,0.001815559,0.85239166,0.00040379053,0.009990198,0.00021078764,0.012605455,0.00025365135,0.01944456,0.0008788494,0.0040634363,0.042369157],"study_design_scores_gemma":[0.08556755,0.03474561,0.7888221,0.0010740036,0.018559305,0.0013456374,0.0016010768,0.0010980084,0.036732085,0.019761818,0.009721185,0.000971632],"about_ca_topic_score_codex":0.0008852195,"about_ca_topic_score_gemma":0.0001114182,"teacher_disagreement_score":0.06356958,"about_ca_system_score_codex":0.000059316753,"about_ca_system_score_gemma":0.00027373884,"threshold_uncertainty_score":0.42144927},"labels":[],"label_agreement":null},{"id":"W4247641510","doi":"10.1016/s0022-5347(02)80294-4","title":"Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors","year":2002,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder tumor; Queen (butterfly); ThioTEPA; Urology; Bladder cancer; Gynecology; Surgery; Internal medicine; Cancer; Chemotherapy","score_opus":0.02936457401918024,"score_gpt":0.27271735026295907,"score_spread":0.24335277624377882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247641510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841708,0.004912794,0.000019097106,0.009277196,0.0001791365,0.0002151354,0.0000073530377,0.0000029908454,0.0012154899],"genre_scores_gemma":[0.99651045,0.0016717367,0.000044514076,0.0012671504,0.00038427484,0.0000041549683,9.578465e-7,0.000011027912,0.000105709165],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988325,0.00025922793,0.0004164453,0.00007197552,0.00021933352,0.00020047753],"domain_scores_gemma":[0.999323,0.00021848262,0.00014229231,0.00021108497,0.000055001598,0.000050112525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002838088,0.00012644865,0.0003736013,0.000109142806,0.0000376214,0.0000026017103,0.00016286319,0.00006491065,0.0005076046],"category_scores_gemma":[0.000028295513,0.000057340323,0.0001280623,0.00015062667,0.00015452971,0.000034795426,0.000008677138,0.00022098604,0.00001627311],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025957795,0.026569085,0.17382756,0.00013097581,0.005461955,0.010541891,0.14513025,0.0016292554,0.029504446,0.00077753194,0.023619544,0.5568497],"study_design_scores_gemma":[0.047904447,0.12526104,0.6350412,0.00011558946,0.006412341,0.03371375,0.0069642346,0.0009813751,0.012055433,0.0025400203,0.12833625,0.0006743195],"about_ca_topic_score_codex":0.00017726871,"about_ca_topic_score_gemma":0.00006772914,"teacher_disagreement_score":0.5561754,"about_ca_system_score_codex":0.00006201068,"about_ca_system_score_gemma":0.00004996276,"threshold_uncertainty_score":0.55579144},"labels":[],"label_agreement":null},{"id":"W4247666919","doi":"10.1016/j.urology.2009.08.042","title":"Reply","year":2009,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Traditional medicine; Gynecology; Family medicine","score_opus":0.015316934189819694,"score_gpt":0.2881623725489049,"score_spread":0.2728454383590852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247666919","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3573767,0.0017783694,0.0006904142,0.0993209,0.00049324194,0.000418759,0.000004944598,0.00028117115,0.5396355],"genre_scores_gemma":[0.94874245,0.000015373253,0.00010937532,0.048936203,0.00013126241,0.000002586848,0.000003874282,0.000003451597,0.0020554233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996932,0.00000779599,0.000054825585,0.00009984222,0.000039344446,0.00010495262],"domain_scores_gemma":[0.99979156,0.000006555872,0.000009817165,0.00013437722,0.000012628379,0.000045045912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001832386,0.000041163614,0.000087421686,0.000023981931,0.000014822606,0.0000013655937,0.000020146028,0.000031453157,0.00035719396],"category_scores_gemma":[0.000012324805,0.00003229041,0.000027201626,0.000035609366,0.000014985346,0.0000100466095,0.0000030958015,0.000050714334,0.00019468078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005031462,0.001931541,0.08733301,0.00002796061,0.00041321586,0.002260512,0.0012441983,0.000021709928,0.021264205,0.017812664,0.26998407,0.59267545],"study_design_scores_gemma":[0.0033846037,0.0052806046,0.21288475,0.0000029624039,0.00015490141,0.00058324,0.000008215968,0.00004763777,0.0024319822,0.005994681,0.7691293,0.00009715376],"about_ca_topic_score_codex":0.000011428361,"about_ca_topic_score_gemma":8.0665285e-7,"teacher_disagreement_score":0.5925783,"about_ca_system_score_codex":0.000009519535,"about_ca_system_score_gemma":0.000024803436,"threshold_uncertainty_score":0.39110234},"labels":[],"label_agreement":null},{"id":"W4247846085","doi":"10.1097/ju.0000000000001601.02","title":"Reply by Authors","year":2021,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medical school; General hospital; New england; Medicine; Public health; Gerontology; Family medicine; Medical education; Political science; Nursing; Law","score_opus":0.02222824589783744,"score_gpt":0.28392527271981277,"score_spread":0.2616970268219753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247846085","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012059087,0.011880988,0.00007006554,0.9827894,0.0012967865,0.00010532235,0.000019447549,0.0000074606605,0.0026246242],"genre_scores_gemma":[0.003944785,0.0012425367,0.000051252144,0.9760327,0.0052071586,0.0000018263571,0.000031420823,0.000041407395,0.013446923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857295,0.000336722,0.0004121344,0.00011528311,0.00032007392,0.0002428672],"domain_scores_gemma":[0.99880224,0.00018829755,0.00041830904,0.00034797488,0.00017703573,0.000066124085],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00035336366,0.00017700561,0.0005695222,0.00008288847,0.000044065644,0.000007862613,0.00021188796,0.00040064202,0.0007925064],"category_scores_gemma":[0.000084481326,0.00009844105,0.00022448064,0.00008039011,0.00010594315,0.000021078993,0.000033971955,0.0024538923,0.0000311323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002921539,0.00003482916,0.00010579036,0.000023014636,0.0005917455,0.0023873595,0.00012395762,5.7244335e-7,0.00022564115,9.222775e-7,0.9953885,0.0008254849],"study_design_scores_gemma":[0.0009979155,0.0013372612,0.00015527174,0.00002980686,0.0015680558,0.010235515,0.000015172915,7.9440923e-7,0.000194889,0.00018303453,0.985214,0.00006828661],"about_ca_topic_score_codex":0.000039816056,"about_ca_topic_score_gemma":9.3140585e-7,"teacher_disagreement_score":0.0108223,"about_ca_system_score_codex":0.00005989027,"about_ca_system_score_gemma":0.00033796055,"threshold_uncertainty_score":0.9998475},"labels":[],"label_agreement":null},{"id":"W4249179826","doi":"10.1016/j.urology.2009.05.055","title":"Editorial Comment","year":2009,"lang":"es","type":"editorial","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Lymphadenectomy; Cystectomy; Bladder cancer; Lymph node; Urology; Dissection (medical); Upper urinary tract; Transitional cell carcinoma; Lymph; Retrospective cohort study; Ureter; Cancer; Oncology; Surgery; Urinary system; Internal medicine; Pathology","score_opus":0.009661250443266527,"score_gpt":0.28942722775211194,"score_spread":0.2797659773088454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249179826","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021194306,0.0022749663,0.00003711493,0.007837712,0.9738722,0.000773217,0.00037259344,0.00012291227,0.014688077],"genre_scores_gemma":[0.0017655474,0.0018895518,0.000023845338,0.004893919,0.987698,0.00008389901,0.0011201444,0.00009988739,0.0024252117],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960406,0.00026533267,0.00067343184,0.00093597086,0.0011114173,0.00097324996],"domain_scores_gemma":[0.9975386,0.0005871221,0.00030147494,0.0008459478,0.00032901397,0.00039779695],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028279395,0.00077016605,0.0013713869,0.0002203155,0.0001768976,0.000051214985,0.00041784535,0.0028504005,0.0013686334],"category_scores_gemma":[0.0004026017,0.0006887657,0.0003668539,0.00015147729,0.00021839523,0.00005319144,0.00012118956,0.0018971527,0.0019779087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028887119,0.00070215017,0.000109872264,0.0000760629,0.0006478233,0.00014184313,0.0001371306,0.000003880255,0.000032798427,0.00013000627,0.9899177,0.0052120537],"study_design_scores_gemma":[0.008707076,0.0085770665,0.00009256662,0.00006154739,0.0018513993,0.000015112858,0.000011504419,0.0000067799297,0.00003685073,0.0004788044,0.9797262,0.00043507293],"about_ca_topic_score_codex":0.0003846753,"about_ca_topic_score_gemma":0.000021732378,"teacher_disagreement_score":0.013825781,"about_ca_system_score_codex":0.0004110209,"about_ca_system_score_gemma":0.0011874643,"threshold_uncertainty_score":0.99955636},"labels":[],"label_agreement":null},{"id":"W4249275963","doi":"10.3109/9780203091746-19","title":"Partial cystectomy Yair Lotan, David A Swanson, Arthur I Sagalowsky","year":2008,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer","score_opus":0.028383848334165466,"score_gpt":0.26063820646934394,"score_spread":0.23225435813517847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249275963","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034137446,0.003298563,0.00010069684,0.0007059315,0.0005662562,0.001168057,0.00013413565,0.00035850453,0.9933265],"genre_scores_gemma":[0.033913527,0.0016232093,0.00024861828,0.0019619272,0.0016140409,0.000069928734,0.0002036167,0.00020030081,0.96016484],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758404,0.000013340699,0.00054046366,0.0007322608,0.0006670707,0.0004628329],"domain_scores_gemma":[0.99847054,0.00003333895,0.00015422207,0.0007928218,0.00015607924,0.00039301897],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000055647277,0.000673497,0.0009871225,0.00017031148,0.00011390481,0.000021232036,0.00014167215,0.00054688106,0.009376401],"category_scores_gemma":[0.000011310265,0.0005342159,0.000489319,0.000042539425,0.00016547533,0.00006220703,0.000059158443,0.000528204,0.0028038702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049054143,0.0011702441,0.0024286923,0.0011368131,0.0070064296,0.0146350665,0.0017858662,0.0000044032627,0.00054600986,0.025600858,0.84691155,0.093868665],"study_design_scores_gemma":[0.004223792,0.00090405723,0.00034657103,0.00041677922,0.000722363,0.0008242548,0.0000074578406,0.0000060094767,0.0007985556,0.00043997727,0.9907738,0.0005363979],"about_ca_topic_score_codex":0.000117095886,"about_ca_topic_score_gemma":0.000089201814,"teacher_disagreement_score":0.14386225,"about_ca_system_score_codex":0.00022550733,"about_ca_system_score_gemma":0.00052740984,"threshold_uncertainty_score":0.9997109},"labels":[],"label_agreement":null},{"id":"W4249854399","doi":"10.1016/j.urology.2009.08.076","title":"Editorial Comment","year":2010,"lang":"es","type":"editorial","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lymphovascular invasion; Upper urinary tract; Retrospective cohort study; Transitional cell carcinoma; Urology; Cohort; Incidence (geometry); Single Center; Stage (stratigraphy); Urothelial carcinoma; Prospective cohort study; Urinary system; Oncology; Surgery; Internal medicine; Cancer; Metastasis","score_opus":0.00879684044599307,"score_gpt":0.2870504809998927,"score_spread":0.2782536405538997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249854399","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007457709,0.00089675904,0.000029414081,0.0058115553,0.9815824,0.00078703737,0.00060357276,0.000114123315,0.01010058],"genre_scores_gemma":[0.0021582383,0.0009042393,0.000032955904,0.0025011173,0.99057215,0.00016728294,0.0011557325,0.0001445712,0.002363726],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99619776,0.0002056379,0.0006378005,0.0009417547,0.0010722635,0.00094475417],"domain_scores_gemma":[0.99702513,0.0008253435,0.00031456648,0.0010024395,0.00039357864,0.00043891097],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00032879045,0.0007527377,0.0012769826,0.00020947991,0.00020193137,0.000055193745,0.00047811822,0.004576551,0.0031472535],"category_scores_gemma":[0.00063585833,0.0006617896,0.00035098163,0.00012434536,0.00038012874,0.00005196289,0.00021837691,0.0039271847,0.0026533245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022520954,0.00055857544,0.0002569806,0.00010455312,0.00068571395,0.00009441625,0.00015168186,8.646541e-7,0.00023312529,0.0001312247,0.99352753,0.0020032153],"study_design_scores_gemma":[0.008067364,0.004211464,0.00005452255,0.000036564725,0.0017636736,0.0000170923,0.000011390517,0.000005822151,0.000106025625,0.0002803802,0.9850164,0.0004293242],"about_ca_topic_score_codex":0.00073008845,"about_ca_topic_score_gemma":0.00009881891,"teacher_disagreement_score":0.008989755,"about_ca_system_score_codex":0.00022050278,"about_ca_system_score_gemma":0.0014145828,"threshold_uncertainty_score":0.9995833},"labels":[],"label_agreement":null},{"id":"W4250142904","doi":"10.1503/cmaj.191615","title":"Microscopic hematuria","year":2020,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Queen's University","funders":"","keywords":"Urinalysis; Medicine; Menstruation; High-power field; Microscopic hematuria; Pathology; Computer science; Urine; Internal medicine; Kidney","score_opus":0.011717768587334094,"score_gpt":0.25818605150111656,"score_spread":0.24646828291378248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250142904","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29513744,0.0014865639,0.00016403089,0.66199607,0.0016963257,0.0003424431,0.000058136582,0.00007400523,0.039044976],"genre_scores_gemma":[0.85765314,0.00012086691,0.00025043785,0.13747905,0.0034973263,0.000003709831,0.000010072682,0.000018738028,0.00096665585],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863565,0.000039040693,0.00021216492,0.00010468986,0.0007180303,0.0002904401],"domain_scores_gemma":[0.99703944,0.000025623402,0.000067777066,0.00004805814,0.00014819886,0.0026708927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020351731,0.0000793153,0.00018317564,0.000045894772,0.000115652016,0.000040534545,0.00007872288,0.00020165762,0.008913422],"category_scores_gemma":[0.0006348009,0.000066812456,0.00008408326,0.00013995082,0.00001428506,0.00004711072,0.0000058570267,0.000577147,0.0005766871],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049104383,0.000045415385,0.19943789,0.000031447435,0.00035627338,0.0019981638,0.00081300846,3.1576707e-7,0.00026659362,0.000116123556,0.77105635,0.025829297],"study_design_scores_gemma":[0.0029515473,0.00021776925,0.05081134,0.000072059076,0.00008339754,0.0006554451,0.00015520901,0.00004632885,0.00032442703,0.00007129934,0.9445019,0.00010933159],"about_ca_topic_score_codex":0.00063458807,"about_ca_topic_score_gemma":0.0015313715,"teacher_disagreement_score":0.56251574,"about_ca_system_score_codex":0.0005512021,"about_ca_system_score_gemma":0.0031723387,"threshold_uncertainty_score":0.9919926},"labels":[],"label_agreement":null},{"id":"W4250246459","doi":"10.1200/jco.2017.35.15_suppl.tps4591","title":"S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"","keywords":"Medicine; Atezolizumab; Cystectomy; Bladder cancer; Clinical endpoint; Oncology; Internal medicine; Population; Urology; Immunotherapy; Cancer; Pembrolizumab; Randomized controlled trial","score_opus":0.17885300166355622,"score_gpt":0.5346122422509457,"score_spread":0.3557592405873895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250246459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147935,0.0003573986,0.0000129793525,0.008103156,0.00291107,0.000554072,0.000025634356,0.0000036193917,0.0065527405],"genre_scores_gemma":[0.99338657,0.0021678833,0.00039720218,0.001157085,0.0021686067,0.000019641644,0.0000017472496,0.000021516546,0.0006797748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99624056,0.00033895645,0.00247683,0.00023709428,0.00041610462,0.000290476],"domain_scores_gemma":[0.9939349,0.001445695,0.0032078268,0.00045206244,0.00058587256,0.00037362077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018384897,0.00018489503,0.002100644,0.00017166385,0.0001155549,0.000010858718,0.00036144673,0.00044105918,0.00045631407],"category_scores_gemma":[0.006866776,0.000133027,0.0006247384,0.00008189552,0.0004270196,0.00019330431,0.00012595653,0.00088106963,0.000011951911],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50613475,0.016936352,0.017253038,0.000054621363,0.0014094076,0.0030555294,0.000983747,0.000010292702,0.0019201842,0.000038897608,0.0077097598,0.44449344],"study_design_scores_gemma":[0.5865974,0.16209,0.22033489,0.0004598396,0.0011119563,0.00013951067,0.00027649297,0.000026301965,0.0023139499,0.0006285739,0.025833732,0.00018739278],"about_ca_topic_score_codex":0.00051830854,"about_ca_topic_score_gemma":0.0006736097,"teacher_disagreement_score":0.44430605,"about_ca_system_score_codex":0.00024237827,"about_ca_system_score_gemma":0.006426988,"threshold_uncertainty_score":0.99920565},"labels":[],"label_agreement":null},{"id":"W4250318630","doi":"10.5489/cuaj.906","title":"Renal and functional outcomes following cystectomy and neobladder reconstruction","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cystectomy; Medicine; Urology; Renal function; Creatinine; Hydronephrosis; Urinary diversion; Kidney disease; Surgery; Urinary system; Bladder cancer; Internal medicine; Cancer","score_opus":0.012564446491509512,"score_gpt":0.2221150427081773,"score_spread":0.2095505962166678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250318630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98047125,0.00029100376,0.00004944775,0.016421134,0.00035162055,0.00018082875,0.000006588255,0.000018206305,0.0022099407],"genre_scores_gemma":[0.9952825,0.000029990922,0.00031272962,0.0032333145,0.00020957812,0.000014117305,0.0000053699578,0.000007439462,0.00090500904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991479,0.000059010432,0.00019511316,0.00014707129,0.00019040958,0.00026053225],"domain_scores_gemma":[0.99913824,0.00007303463,0.000092368515,0.000044035423,0.000103751234,0.0005485517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018011844,0.00010626523,0.00020257894,0.000114599556,0.0002626948,0.0001067488,0.000019088166,0.0001514667,0.0010040405],"category_scores_gemma":[0.0001916067,0.00007792163,0.00007969034,0.00007107926,0.000025723106,0.00017508843,0.0000074412474,0.00029038778,0.00003436989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010116168,0.000008562927,0.9837726,0.0000015946141,0.00018638156,0.000020138179,0.000036580568,8.561401e-7,0.00009931284,0.00003145182,0.0021722123,0.013660231],"study_design_scores_gemma":[0.0015784511,0.00013290395,0.99220085,0.0000094681045,0.00010347236,0.0006501806,0.000062609484,0.000039112016,0.000007092743,0.001351098,0.0037863734,0.00007837579],"about_ca_topic_score_codex":0.0014431169,"about_ca_topic_score_gemma":0.0002650395,"teacher_disagreement_score":0.014811221,"about_ca_system_score_codex":0.00034098484,"about_ca_system_score_gemma":0.00018441671,"threshold_uncertainty_score":0.99990916},"labels":[],"label_agreement":null},{"id":"W4250972359","doi":"10.1159/000082109","title":"Author Index","year":2004,"lang":"en","type":"paratext","venue":"Current directions in autoimmunity","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.05470069971760348,"score_gpt":0.37254669538979535,"score_spread":0.31784599567219185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250972359","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024525234,0.15082055,0.0005427762,0.0014905668,0.060268417,0.003927294,0.0011718734,0.0006534738,0.75659984],"genre_scores_gemma":[0.4634567,0.015140731,0.00018143997,0.00020786194,0.001559941,0.001172377,0.003042782,0.00024986832,0.5149883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812657,0.00014403605,0.0005155796,0.0004529287,0.00033149048,0.000429418],"domain_scores_gemma":[0.9987084,0.000046524066,0.00015593588,0.0008114597,0.00012944415,0.00014820076],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016962821,0.00045369446,0.0007684412,0.00068386196,0.00023602006,0.00003988613,0.00020185002,0.00042584233,0.0048637064],"category_scores_gemma":[0.00007640682,0.00043216007,0.0002857664,0.000841288,0.00015859965,0.00007678294,0.00010481308,0.0021048598,0.0042048306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051387335,0.009212907,0.013381203,0.0020911295,0.00088067056,0.00006853157,0.0016605842,0.00025469132,0.000057517995,0.00017283259,0.55585307,0.415853],"study_design_scores_gemma":[0.0022720841,0.00014562331,0.057310816,0.0018528346,0.00020692628,0.00004915361,0.000045218763,0.00002075189,0.00011696622,0.00019720536,0.9374137,0.00036872385],"about_ca_topic_score_codex":0.0021522685,"about_ca_topic_score_gemma":0.0001583673,"teacher_disagreement_score":0.43893147,"about_ca_system_score_codex":0.0015929323,"about_ca_system_score_gemma":0.0015619374,"threshold_uncertainty_score":0.999813},"labels":[],"label_agreement":null},{"id":"W4251094097","doi":"10.1016/s1569-9056(18)30941-2","title":"Impact of number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"European Urology Supplements","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; EMD Serono; Astellas Pharma; Eisai; Sanofi; Exelixis; Genentech; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Urothelial carcinoma; Platinum; Oncology; Chemotherapy; Carcinoma; Metastatic Urothelial Carcinoma; Urology; Line (geometry); Internal medicine; General surgery; Cancer; Bladder cancer","score_opus":0.021207911367035058,"score_gpt":0.3381963280215582,"score_spread":0.31698841665452315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251094097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940116,0.000045862613,0.0008955586,0.00019608479,0.00012706121,0.0008349688,0.0010894297,0.000018743984,0.0027807355],"genre_scores_gemma":[0.9963334,0.000012809601,0.0027988115,0.00026961658,0.00018692772,0.000019126359,0.00018390975,0.000068416455,0.00012695932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856883,0.000086473796,0.00057538884,0.0002833247,0.00018728068,0.00029871936],"domain_scores_gemma":[0.9988232,0.00009068356,0.00033959266,0.00041043898,0.00024982318,0.00008622138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001774938,0.00022079475,0.0005190748,0.00009805247,0.00004096308,0.0000016867001,0.00016220841,0.0000534419,0.0020081545],"category_scores_gemma":[0.00005223632,0.00017936448,0.00026819351,0.000119412754,0.00027551904,0.00003513472,0.000034218567,0.00006665468,0.000018633715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010610307,0.0009707296,0.95062983,0.00014613126,0.0005936931,0.000009587253,0.00052089023,0.000032962933,0.02967446,0.000025922334,0.0016000688,0.005185407],"study_design_scores_gemma":[0.043982808,0.017757457,0.76440954,0.000061226325,0.0004189338,0.000019471569,0.000026486043,0.00024164432,0.16764589,0.0001288256,0.005078206,0.00022953204],"about_ca_topic_score_codex":0.00013316459,"about_ca_topic_score_gemma":0.000020765652,"teacher_disagreement_score":0.18622032,"about_ca_system_score_codex":0.000035320478,"about_ca_system_score_gemma":0.00013721653,"threshold_uncertainty_score":0.99890417},"labels":[],"label_agreement":null},{"id":"W4251233440","doi":"10.1200/jco.2004.22.14_suppl.4519","title":"Long-term effects of conservation therapy for muscle invasive bladder carcinoma","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Radiation therapy; Bladder cancer; Cystoscopy; Urology; Surgery; Salvage therapy; Chemotherapy; Oncology; Internal medicine; Cancer; Urinary system","score_opus":0.10765998591047263,"score_gpt":0.44364298719860124,"score_spread":0.33598300128812864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251233440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917737,0.001047072,0.0005785269,0.004716986,0.0010205568,0.0005776818,0.000003468194,0.0000046037067,0.00027736512],"genre_scores_gemma":[0.99250317,0.0009426225,0.0017170327,0.0039014684,0.0008348208,0.0000136791505,0.0000035343573,0.000015308395,0.000068373556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982215,0.000117091855,0.0012011669,0.00012233571,0.00019458606,0.00014330725],"domain_scores_gemma":[0.99611074,0.002032817,0.0010339639,0.0001308803,0.0005124373,0.00017916632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006087794,0.00010441843,0.0009417666,0.000071362054,0.000023928465,0.0000030243723,0.00008744269,0.00024625123,0.000038686507],"category_scores_gemma":[0.0014365822,0.00007094712,0.0004615614,0.00006856583,0.00014114045,0.00007325547,0.000011789802,0.00026448024,0.0000034568814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011732612,0.005386398,0.8027287,0.0002743173,0.0014175356,0.0006656045,0.00045675295,0.000007686623,0.006952574,0.0001741339,0.0017173383,0.16848633],"study_design_scores_gemma":[0.035612367,0.034794796,0.9144496,0.00013737842,0.00041784125,0.000096402146,0.00002145954,0.000001133052,0.012351515,0.00091675133,0.001145648,0.00005512795],"about_ca_topic_score_codex":0.00003940734,"about_ca_topic_score_gemma":0.00004582358,"teacher_disagreement_score":0.1684312,"about_ca_system_score_codex":0.00011039511,"about_ca_system_score_gemma":0.002416717,"threshold_uncertainty_score":0.42871523},"labels":[],"label_agreement":null},{"id":"W4251250940","doi":"10.1016/j.juro.2010.02.1561","title":"1714 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER","year":2010,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Stage (stratigraphy); Cancer; Gerontology; Demography; Library science; Internal medicine; Sociology","score_opus":0.03379172828899351,"score_gpt":0.37391829644127383,"score_spread":0.3401265681522803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251250940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912417,0.0022663884,0.000278121,0.0049728784,0.00052437955,0.0003462819,0.000034508786,0.0000037038483,0.00033202372],"genre_scores_gemma":[0.9976167,0.00078650995,0.00014140786,0.0011582293,0.000200205,0.000004180469,7.019977e-7,0.000016611848,0.000075428514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980841,0.00042755489,0.00091629365,0.00010814174,0.0002861804,0.00017769569],"domain_scores_gemma":[0.9979537,0.0005869681,0.00078102533,0.000337745,0.00020195378,0.0001385701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001744563,0.00013336621,0.0007658497,0.000071911476,0.000044309487,0.0000033059482,0.00023362535,0.00013393736,0.0001657834],"category_scores_gemma":[0.0003946291,0.000064122185,0.00019372633,0.000095651594,0.00061081944,0.000024898853,0.00007094142,0.0008426455,0.0000018060135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011106888,0.0002249455,0.9754483,0.000027010405,0.0009650976,0.000020971307,0.00068009784,0.00008607615,0.005172145,0.000100789504,0.0011572395,0.005010422],"study_design_scores_gemma":[0.010763064,0.00411489,0.97251683,0.000030494915,0.0031532522,0.00021318914,0.0002301999,0.0002557761,0.004768349,0.00035229605,0.0035076302,0.0000940157],"about_ca_topic_score_codex":0.00031291108,"about_ca_topic_score_gemma":0.00023459755,"teacher_disagreement_score":0.006375011,"about_ca_system_score_codex":0.000010361429,"about_ca_system_score_gemma":0.0001430977,"threshold_uncertainty_score":0.36609223},"labels":[],"label_agreement":null},{"id":"W4251675427","doi":"10.5489/cuaj.757","title":"Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Tongji University","keywords":"Bladder cancer; Telomerase reverse transcriptase; Complementary DNA; Suppression subtractive hybridization; Biology; Urine; Microarray; Molecular biology; Urinary system; Gene; cDNA library; Medicine; Cancer; Gene expression; Telomerase; Genetics; Endocrinology","score_opus":0.007800896883842959,"score_gpt":0.19596452533400854,"score_spread":0.1881636284501656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251675427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132353,0.000278021,0.003550964,0.003375234,0.000083412495,0.00061823206,0.0005875896,0.0000064904243,0.0001765328],"genre_scores_gemma":[0.99746937,0.00006787678,0.0014899297,0.00040852916,0.00022871561,0.000030455916,0.00013525569,0.00001564563,0.00015421696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989707,0.00007479722,0.0002909505,0.00022655525,0.00020564062,0.00023134482],"domain_scores_gemma":[0.99882805,0.00015715107,0.00028266522,0.00006260424,0.00033648586,0.00033306805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001560519,0.00013282149,0.00022191621,0.000112936614,0.00017194895,0.00007537689,0.000039863517,0.00012156484,0.00036090106],"category_scores_gemma":[0.000034065702,0.00010752139,0.000056208755,0.00007223521,0.00006008155,0.0001753216,0.000003924999,0.00018523357,0.0000028337538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019424527,0.0002459871,0.76817983,0.000045953886,0.0006300034,0.00004683909,0.0013353775,0.00011188515,0.21343899,0.00005608358,0.007327152,0.006639413],"study_design_scores_gemma":[0.003825804,0.00047942015,0.97267985,0.000014311377,0.00022576135,0.00005367219,0.00027206048,0.00027941653,0.020741379,0.00026862067,0.0010298389,0.0001298491],"about_ca_topic_score_codex":0.0014635978,"about_ca_topic_score_gemma":0.0001289864,"teacher_disagreement_score":0.2045,"about_ca_system_score_codex":0.00014898968,"about_ca_system_score_gemma":0.0001859136,"threshold_uncertainty_score":0.4384595},"labels":[],"label_agreement":null},{"id":"W4252074904","doi":"10.5489/cuaj.583","title":"Highlights from the Canadian Bladder Cancer Network","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Cancer; General surgery; Internal medicine","score_opus":0.014627725547569354,"score_gpt":0.2329004145980615,"score_spread":0.21827268905049213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252074904","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36149517,0.002982468,0.000012059019,0.607844,0.0022121125,0.0007988884,0.00022740808,0.00004771129,0.024380177],"genre_scores_gemma":[0.93937767,0.00019918375,0.00008549815,0.05475927,0.0032388293,0.00005341733,0.000034967343,0.000017170983,0.0022339677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825835,0.0001413787,0.0002593133,0.0001942958,0.0003482866,0.00079839403],"domain_scores_gemma":[0.9976497,0.00013904308,0.00013821991,0.00015109223,0.00031660183,0.0016053407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002313983,0.0001640843,0.00023647443,0.000063276726,0.0008962556,0.00023933801,0.00017716398,0.00028919766,0.014383417],"category_scores_gemma":[0.00014942234,0.00009822222,0.00013228926,0.00021008085,0.000039295817,0.00010617371,0.0000089974055,0.0006328163,0.0006563951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008245452,0.000009447226,0.6124985,3.213078e-7,0.00029222402,0.000044122233,0.00010258256,0.000030880223,0.000005313321,0.0001606081,0.38432172,0.0025259906],"study_design_scores_gemma":[0.0004739937,0.00005821225,0.6459165,0.000007698828,0.00010917614,0.000024276977,0.000018809658,0.00003670441,0.0000033949696,0.0018675533,0.35140187,0.00008183322],"about_ca_topic_score_codex":0.8979134,"about_ca_topic_score_gemma":0.91323113,"teacher_disagreement_score":0.5778825,"about_ca_system_score_codex":0.002765058,"about_ca_system_score_gemma":0.0025606693,"threshold_uncertainty_score":0.98651755},"labels":[],"label_agreement":null},{"id":"W4252677965","doi":"10.1111/j.1442-2042.2012.03075.x","title":"IJU this issue","year":2012,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphadenectomy; Perspective (graphical); Cancer; General surgery; Internal medicine","score_opus":0.01929068144113904,"score_gpt":0.3326354296330624,"score_spread":0.3133447481919234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252677965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7674158,0.009766875,0.0016212902,0.0636775,0.017605124,0.00020140785,0.000021843905,0.000034366967,0.13965575],"genre_scores_gemma":[0.99065906,0.00015935046,0.00048037965,0.004370925,0.0028280646,0.0000010427556,0.0000023098526,0.000007657558,0.0014912082],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938047,0.00002245724,0.00020104423,0.000041118772,0.00023782381,0.00011708992],"domain_scores_gemma":[0.9994556,0.000035027722,0.00011865043,0.000053749824,0.000232304,0.00010468643],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001227026,0.000055705594,0.00013382474,0.00011412143,0.000010342169,0.0000048541597,0.00010681785,0.000048116162,0.0032033618],"category_scores_gemma":[0.000059234117,0.000041134925,0.00008716984,0.000026774294,0.000030001544,0.00010658684,0.000018511377,0.00013750173,0.00022357343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004842004,0.0020374546,0.7013274,0.000015131536,0.0033968822,0.0011415654,0.0024098223,0.000013778521,0.010112789,0.0033568207,0.14178666,0.12955974],"study_design_scores_gemma":[0.0028046204,0.0008267201,0.0831373,0.000012318665,0.00018254014,0.0062126387,0.000030403831,0.000008240996,0.0024462424,0.00037474063,0.90390635,0.000057906476],"about_ca_topic_score_codex":0.000013816023,"about_ca_topic_score_gemma":7.389216e-7,"teacher_disagreement_score":0.76211965,"about_ca_system_score_codex":0.000055771972,"about_ca_system_score_gemma":0.000063872925,"threshold_uncertainty_score":0.99770784},"labels":[],"label_agreement":null},{"id":"W4253231266","doi":"10.5489/cuaj.878","title":"Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Queen's University","funders":"","keywords":"Medicine; Guideline; Referral; Internal medicine; Bladder cancer; Chemotherapy; Cancer; Retrospective cohort study; Oncology; Neoadjuvant therapy; Surgery; Breast cancer; Family medicine; Pathology","score_opus":0.03249020780185179,"score_gpt":0.347674051797779,"score_spread":0.3151838439959272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253231266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9332777,0.0007484612,0.0000044303943,0.06504744,0.00007087557,0.00035756588,0.000041281346,0.0000035897044,0.00044862652],"genre_scores_gemma":[0.99050653,0.0017426811,0.0008622043,0.006442151,0.00019892478,0.00005105215,0.000014381033,0.000009038529,0.00017305804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985872,0.00014054887,0.0007036606,0.00017262342,0.00017977507,0.00021621653],"domain_scores_gemma":[0.99828166,0.00017496478,0.0004565878,0.00008083401,0.00064796634,0.0003579674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000456792,0.000115547,0.00038959217,0.00012359518,0.00003528466,0.000025638263,0.000034737364,0.00019306141,0.0006297137],"category_scores_gemma":[0.0009262519,0.00007945204,0.000069361464,0.00012037655,0.000055927892,0.00017513524,0.0000072566695,0.00019974468,0.0000023409505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018132398,0.0001487443,0.9195563,0.0000045959378,0.00020742552,0.000013258844,0.00040235906,0.0000011091541,0.00005394242,0.000016590544,0.001843389,0.077570945],"study_design_scores_gemma":[0.0032872122,0.0011864308,0.9810084,0.000022354641,0.00011785993,0.000035862922,0.00016512987,0.00007549797,0.00004237804,0.00022980134,0.0137704685,0.00005861445],"about_ca_topic_score_codex":0.014703116,"about_ca_topic_score_gemma":0.010404236,"teacher_disagreement_score":0.07751233,"about_ca_system_score_codex":0.00036590992,"about_ca_system_score_gemma":0.0006414885,"threshold_uncertainty_score":0.99185807},"labels":[],"label_agreement":null},{"id":"W4253516197","doi":"10.3410/f.1092489.546936","title":"Faculty Opinions recommendation of Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy.","year":2007,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Bladder cancer; In situ hybridization; In situ; Fluorescence; Medicine; Cancer therapy; Fluorescence in situ hybridization; Cancer; Carcinoma in situ; Internal medicine; Biology; Chemistry; Gene; Optics; Biochemistry","score_opus":0.06192332602346164,"score_gpt":0.40608595249480123,"score_spread":0.3441626264713396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253516197","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016151258,0.001999841,0.000054697968,0.024921777,0.0004491599,0.004105517,0.96826845,0.000012433249,0.000026614342],"genre_scores_gemma":[0.0028637704,0.002260776,0.000208688,0.0012596019,0.00015570865,0.00034984975,0.9927554,0.000028810733,0.00011739281],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481386,0.00047258133,0.0025058927,0.00059643475,0.0013082131,0.0003030298],"domain_scores_gemma":[0.9887363,0.00043795098,0.0022312673,0.0011423309,0.0072733327,0.00017882546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018961412,0.00045565213,0.0015099219,0.00026182807,0.00008891591,0.000018053282,0.0006526517,0.0005098396,0.0002369415],"category_scores_gemma":[0.0030809797,0.00023259847,0.000600207,0.001731712,0.0005030374,0.00012435614,0.00012268004,0.0006350481,0.0000017641116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064944493,0.0019369022,0.0076402263,0.0044004903,0.0005736443,1.6558013e-7,0.000078334044,2.5209374e-7,0.0000026116866,0.0000069525613,0.9693474,0.015363577],"study_design_scores_gemma":[0.004272903,0.0006642268,0.2184058,0.004767503,0.00028131832,0.0000029759235,0.00001414639,0.000013534887,0.00016930449,0.0000016605734,0.7712506,0.00015603426],"about_ca_topic_score_codex":0.0005706256,"about_ca_topic_score_gemma":0.00014373116,"teacher_disagreement_score":0.21076557,"about_ca_system_score_codex":0.00010606965,"about_ca_system_score_gemma":0.0008503074,"threshold_uncertainty_score":0.94850904},"labels":[],"label_agreement":null},{"id":"W4254035318","doi":"10.1016/j.urology.2011.11.060","title":"Reply","year":2012,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Generalizability theory; Medicine; Standardization; Selection (genetic algorithm); Limit (mathematics); Age limit; Medical physics; Statistics; Artificial intelligence; Computer science","score_opus":0.02242305622017574,"score_gpt":0.29561411890895717,"score_spread":0.2731910626887814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254035318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6178093,0.0044203787,0.00051001884,0.014689817,0.0013647906,0.0003312622,0.0000058406017,0.00017802388,0.36069053],"genre_scores_gemma":[0.9822029,0.000012897927,0.000106964806,0.015136985,0.00036370114,0.00000978483,0.000004169995,0.000007060211,0.0021555757],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999675,0.000011001124,0.000049607104,0.00006233118,0.00003827645,0.00016382034],"domain_scores_gemma":[0.9997656,0.000011319431,0.000009983124,0.00012481894,0.000009560789,0.000078732504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003426098,0.00003949484,0.00007874565,0.000020678175,0.000014696417,8.0007777e-7,0.000015962001,0.000031938802,0.0008003173],"category_scores_gemma":[0.000014987379,0.000030305036,0.000024995203,0.000029221805,0.000021601696,0.000020945965,0.000008817422,0.000048334172,0.00054313574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007047848,0.0006136725,0.89650947,0.000020525367,0.00021575832,0.00006583876,0.00086396484,9.597467e-7,0.0025667103,0.003949673,0.06624336,0.028245267],"study_design_scores_gemma":[0.0011072255,0.0004812014,0.14559665,9.389449e-7,0.00010438127,0.00029395884,0.000009695213,0.0000052134496,0.0013121463,0.00018774605,0.8508565,0.00004438108],"about_ca_topic_score_codex":0.000024013538,"about_ca_topic_score_gemma":6.900785e-7,"teacher_disagreement_score":0.7846131,"about_ca_system_score_codex":0.000010934716,"about_ca_system_score_gemma":0.000016500573,"threshold_uncertainty_score":0.87629133},"labels":[],"label_agreement":null},{"id":"W4254584811","doi":"10.1200/jco.2019.37.7_suppl.358","title":"BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Nausea; Internal medicine; Safety profile; Cancer; Oncology; Cohort; Immunotherapy; Adverse effect","score_opus":0.03992822245600391,"score_gpt":0.42550026727157153,"score_spread":0.3855720448155676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254584811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953949,0.00051679707,0.000011343207,0.002153945,0.000649052,0.000875634,0.00001967259,0.000013652943,0.0003650202],"genre_scores_gemma":[0.99587256,0.00058845535,0.0005388817,0.0022997428,0.00034339557,0.000016673182,0.000028908144,0.00003972442,0.0002716905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631613,0.00040798768,0.0020173818,0.00041803336,0.00041502772,0.00042544954],"domain_scores_gemma":[0.99732655,0.00057809317,0.0010799122,0.00025661304,0.0003370961,0.00042173016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016180389,0.00025989598,0.0017688494,0.00018270794,0.000032039567,0.00001525911,0.0001371607,0.00033200294,0.00020737601],"category_scores_gemma":[0.00037209995,0.00018811377,0.00013527855,0.0003014506,0.00018422407,0.00036050775,0.000054940694,0.0011287176,0.000010309642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06288922,0.011133149,0.7787562,0.000078814024,0.0005758305,0.0023829623,0.00085044216,0.00035146117,0.0017070094,0.000025750369,0.00048834505,0.1407608],"study_design_scores_gemma":[0.08751539,0.021885844,0.8788213,0.0002996921,0.00013272342,0.00032066775,0.00027554482,0.00017377564,0.0006276972,0.00004803846,0.009693186,0.00020613069],"about_ca_topic_score_codex":0.00034666774,"about_ca_topic_score_gemma":0.002780004,"teacher_disagreement_score":0.14055467,"about_ca_system_score_codex":0.00042619221,"about_ca_system_score_gemma":0.0013335467,"threshold_uncertainty_score":0.7671057},"labels":[],"label_agreement":null},{"id":"W4254989908","doi":"10.1200/jco.2017.35.15_suppl.e16020","title":"Real world outcomes in advanced urothelial cancer and the role of neutrophil to lymphocyte ratio.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Neutrophil to lymphocyte ratio; Proportional hazards model; Overall survival; Urothelial cancer; Cancer; Bladder cancer","score_opus":0.06774151739059532,"score_gpt":0.47023568813214683,"score_spread":0.4024941707415515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254989908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97041595,0.0006158059,0.0000042622028,0.019954996,0.0008655946,0.0003243244,0.0000076112497,0.00000242664,0.0078090364],"genre_scores_gemma":[0.9934823,0.002603264,0.0005959257,0.001819976,0.0006316146,0.000015870468,1.7411418e-7,0.000011304246,0.0008395816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980623,0.0001675228,0.0012702759,0.00013164431,0.0002163995,0.00015183506],"domain_scores_gemma":[0.9974339,0.000802207,0.0011329305,0.00026483167,0.00017220135,0.00019392392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011114732,0.00010604158,0.0013502052,0.00008567731,0.000059174494,0.000010599186,0.00020316547,0.000108671324,0.000045104134],"category_scores_gemma":[0.0011949203,0.000056459376,0.00024052423,0.00004768623,0.00031727614,0.00009051308,0.00006732188,0.00033358153,0.0000028020881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023231046,0.00045050375,0.6886228,0.000008992257,0.0002689531,0.00009243171,0.00022061447,0.000020992176,0.00042684554,0.0005458138,0.000085678636,0.28602538],"study_design_scores_gemma":[0.035251502,0.002973369,0.94092304,0.000086342945,0.00024975542,0.000022742955,0.00006430373,0.00003499278,0.00046336322,0.0010760883,0.01879939,0.00005513895],"about_ca_topic_score_codex":0.0013042042,"about_ca_topic_score_gemma":0.002283263,"teacher_disagreement_score":0.28597024,"about_ca_system_score_codex":0.00012908765,"about_ca_system_score_gemma":0.0012738996,"threshold_uncertainty_score":0.23023465},"labels":[],"label_agreement":null},{"id":"W4255320078","doi":"10.5489/cuaj.557","title":"Virtual cystoscopy: the evaluation of bladder lesions with computed tomographic virtual cystoscopy","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Radiology; Biopsy; Urinary bladder; Thickening; Urinary system; Urology; Materials science; Internal medicine","score_opus":0.021773383423224383,"score_gpt":0.2639924742735409,"score_spread":0.2422190908503165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255320078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804842,0.00023151282,0.000340878,0.015691716,0.00036568852,0.0007732429,0.00003968694,0.000024866295,0.002048232],"genre_scores_gemma":[0.9961367,0.000028690982,0.00015375756,0.002989642,0.0003313429,0.000053517997,0.000029406368,0.000017284505,0.0002596102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975263,0.0004342662,0.00038550922,0.00020481038,0.0010171266,0.00043202727],"domain_scores_gemma":[0.997618,0.00018545393,0.00032879345,0.00018470286,0.0011234607,0.00055956916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091327424,0.00018326046,0.00031637572,0.00021064394,0.0003789876,0.00007676988,0.0001605214,0.00021190742,0.0024739127],"category_scores_gemma":[0.00029442902,0.00010590814,0.00013879128,0.00044354305,0.00010721088,0.00013932829,0.000013248258,0.00053926685,0.00008773433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047215412,0.0005917533,0.88167447,0.000008484593,0.002587011,0.000064139465,0.0013844019,0.0020213237,0.0015457033,0.0011045275,0.062338106,0.046207905],"study_design_scores_gemma":[0.00370156,0.002539374,0.9858376,0.000037668506,0.0007710693,0.00016749237,0.00047004025,0.0019078129,0.00011317037,0.00066570385,0.003622229,0.00016630658],"about_ca_topic_score_codex":0.002798277,"about_ca_topic_score_gemma":0.0012259746,"teacher_disagreement_score":0.10416308,"about_ca_system_score_codex":0.00069378916,"about_ca_system_score_gemma":0.0014258914,"threshold_uncertainty_score":0.99843794},"labels":[],"label_agreement":null},{"id":"W4255379407","doi":"10.5858/2003-127-1263-upfteo","title":"Updated Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder, Ureter, and Renal Pelvis","year":2003,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital","funders":"","keywords":"Renal pelvis; Ureter; Medicine; Urology; Urinary bladder; Urinary system; Pelvis; Carcinoma; Urothelial carcinoma; Bladder cancer; Pathology; Radiology; Internal medicine; Cancer","score_opus":0.01516233098885733,"score_gpt":0.2681721246056658,"score_spread":0.2530097936168085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255379407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760924,0.00021974552,0.00011494032,0.0002574526,0.000058792357,0.022160918,0.00025203842,0.0000060598045,0.0008376697],"genre_scores_gemma":[0.9947098,0.000008968347,0.00073502783,0.00014042834,0.000048155864,0.004250469,0.000038463797,0.000018058674,0.000050628278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988721,0.00022363385,0.00034122902,0.00021479583,0.00021304475,0.00013518799],"domain_scores_gemma":[0.9987471,0.00032525297,0.0003091029,0.00038909013,0.00017858211,0.00005083775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016375032,0.00015197459,0.0003778134,0.000073055686,0.00005634931,8.3967706e-7,0.00010347006,0.000051042007,0.00006763657],"category_scores_gemma":[0.00012264994,0.00007267374,0.000040099367,0.00015781292,0.0010675761,0.000029805733,0.000028864255,0.000111061454,1.430987e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038556717,0.0011722974,0.89308685,0.00032349827,0.00054129184,0.00003592089,0.0076836855,0.0000021872845,0.0882319,0.00061135326,0.0005542286,0.0039011408],"study_design_scores_gemma":[0.011770729,0.0042317365,0.9435267,0.00021307747,0.00039683536,0.0000103116345,0.00034253421,0.000010196758,0.038168475,0.00019666221,0.0010731054,0.00005962977],"about_ca_topic_score_codex":0.000023873143,"about_ca_topic_score_gemma":0.000008091502,"teacher_disagreement_score":0.050439883,"about_ca_system_score_codex":0.00000997343,"about_ca_system_score_gemma":0.00015483306,"threshold_uncertainty_score":0.39335287},"labels":[],"label_agreement":null},{"id":"W4255420632","doi":"10.5489/cuaj.1249","title":"Long-term results of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma in China","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Urology; Transitional cell carcinoma; Lymph node; Surgery; Metastasis; Urinary system; Cuff; Distant metastasis; Upper urinary tract; Bladder cancer; Cancer; Internal medicine","score_opus":0.012302580281258376,"score_gpt":0.23853318241480226,"score_spread":0.22623060213354387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255420632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989206,0.00023180411,0.000016988968,0.0070589166,0.00018770687,0.00047409657,0.0004988865,0.0000070089463,0.0023185697],"genre_scores_gemma":[0.99749744,0.000026823107,0.0003438893,0.0009914656,0.00040569188,0.00004707377,0.00017452872,0.000013120802,0.000499948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987101,0.000093604285,0.0004108979,0.00017797989,0.00022179612,0.00038560078],"domain_scores_gemma":[0.99907124,0.00010380765,0.00017482694,0.00008420922,0.00016756325,0.00039832943],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000196294,0.00013216122,0.00029474995,0.00018111308,0.00009211093,0.000029822133,0.00008046523,0.00021382153,0.0021324672],"category_scores_gemma":[0.00012609002,0.00010555997,0.00017240726,0.00012353383,0.000025245861,0.000113465605,0.0000040009904,0.00036041663,0.000017914665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030366326,0.00029672278,0.98980784,0.000020907793,0.00003605037,0.000095424904,0.00021875002,0.00000576808,0.00027223674,0.0000039147094,0.007823971,0.0011147318],"study_design_scores_gemma":[0.004659221,0.0018340593,0.9908405,0.000026917154,0.00005293073,0.00020104421,0.00001871135,0.00003784357,0.00013917415,0.00012186434,0.001974212,0.00009351082],"about_ca_topic_score_codex":0.002173951,"about_ca_topic_score_gemma":0.00022340365,"teacher_disagreement_score":0.008291436,"about_ca_system_score_codex":0.00074325415,"about_ca_system_score_gemma":0.0005197147,"threshold_uncertainty_score":0.9987797},"labels":[],"label_agreement":null},{"id":"W4255593498","doi":"10.5489/cuaj.116","title":"Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Manitoba; University of Alberta; Université Laval; Université de Montréal; McMaster University; Western University; Dalhousie University; McGill University; University of British Columbia","funders":"McGill University","keywords":"Medicine; Lymphadenectomy; Ureter; Proportional hazards model; Pathological; Urology; Urothelial carcinoma; Ureteroscopy; Internal medicine; Oncology; Cancer; Bladder cancer","score_opus":0.028700191989435297,"score_gpt":0.26312552795548083,"score_spread":0.23442533596604553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255593498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97394687,0.00024882675,0.0000041469198,0.024804829,0.00027521834,0.0002819753,0.0001353811,0.000004108545,0.00029866982],"genre_scores_gemma":[0.9911425,0.000065241926,0.000042369025,0.008368272,0.00020391094,0.000030106603,0.000025338853,0.000010583507,0.00011167377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984558,0.0001781264,0.0003209579,0.00014448864,0.00030002097,0.00060059084],"domain_scores_gemma":[0.99854726,0.0005613257,0.00018466622,0.000050097056,0.00010725694,0.0005493994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005136093,0.00014050516,0.0003366973,0.00014418378,0.0000977553,0.000032009357,0.00005830844,0.00015762422,0.00011017468],"category_scores_gemma":[0.0011735782,0.00010885278,0.00006482522,0.000105148254,0.000011459113,0.00017320063,0.0000060095645,0.00041878244,0.0000014037656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006960505,0.00011049252,0.9980083,0.0000027954977,0.00006587869,0.00005290449,0.00022125835,0.0000010102885,0.0000018483795,0.00003455177,0.0007168231,0.00071454374],"study_design_scores_gemma":[0.002550704,0.00015385462,0.9917213,0.0000135947275,0.00007537227,0.0000962008,0.00035613324,0.000037910268,0.0000017627779,0.000066722125,0.0048173666,0.000109120345],"about_ca_topic_score_codex":0.82720256,"about_ca_topic_score_gemma":0.8910377,"teacher_disagreement_score":0.06383517,"about_ca_system_score_codex":0.0038753,"about_ca_system_score_gemma":0.0020574913,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W4255804937","doi":"10.1016/j.juro.2018.04.103","title":"Editorial Comment","year":2018,"lang":"es","type":"editorial","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Observational study; Library science; Urology; Internal medicine","score_opus":0.01280139799278291,"score_gpt":0.29986553597786625,"score_spread":0.28706413798508335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255804937","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047779983,0.0041739168,0.000056570338,0.0107170995,0.9827011,0.00031713516,0.00009065756,0.000009755472,0.0014559611],"genre_scores_gemma":[0.0071541937,0.006816106,0.000023631537,0.0017784998,0.98356205,0.000004207686,0.000020906338,0.00007098917,0.0005694288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957464,0.0008750143,0.0011401864,0.00021183677,0.0014637475,0.00056284515],"domain_scores_gemma":[0.99448705,0.0018114663,0.00153957,0.0005941572,0.0012898139,0.00027795573],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021625687,0.00048006116,0.0012492633,0.00020153345,0.00021687876,0.000032816515,0.0008713729,0.0011580073,0.00095525413],"category_scores_gemma":[0.0008259397,0.0002695906,0.00041097953,0.00013456155,0.0005950865,0.00007374745,0.00016565388,0.0024450442,0.00037479866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011461389,0.00035613324,0.00009922135,0.00004951486,0.0017945775,0.0000678437,0.0006569592,0.0000029991388,0.000113995615,0.00001516231,0.9845796,0.00080260466],"study_design_scores_gemma":[0.0071816742,0.016240992,0.00009263287,0.0001264774,0.005220799,0.00029768524,0.00007881061,0.000002224337,0.00008849542,0.00044195095,0.9700503,0.00017799373],"about_ca_topic_score_codex":0.0001543098,"about_ca_topic_score_gemma":0.000011320969,"teacher_disagreement_score":0.015884858,"about_ca_system_score_codex":0.00030542052,"about_ca_system_score_gemma":0.0016553034,"threshold_uncertainty_score":0.9999756},"labels":[],"label_agreement":null},{"id":"W4255827666","doi":"10.1016/b978-008055232-3.60818-9","title":"Bladder Cancer","year":2007,"lang":"en","type":"book-chapter","venue":"xPharm: The Comprehensive Pharmacology Reference","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Disease; Oncology; Internal medicine; Urology","score_opus":0.15487299702124177,"score_gpt":0.39919300344993286,"score_spread":0.2443200064286911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255827666","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026081963,0.03312638,0.000033397162,0.0045246263,0.0036861529,0.0026258202,0.00046775688,0.0002904123,0.95263726],"genre_scores_gemma":[0.02297426,0.022980426,0.0001309567,0.035926513,0.0028208767,0.0002952675,0.00021330765,0.0002497519,0.9144086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971683,0.000070116024,0.0005906715,0.0008925634,0.00055394444,0.0007244173],"domain_scores_gemma":[0.9975284,0.00030978475,0.00037025393,0.00064158975,0.00078136945,0.0003686492],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011266351,0.0008610144,0.0010816911,0.00022814788,0.00028277378,0.000023365666,0.00052244886,0.0005838861,0.023848781],"category_scores_gemma":[0.000006071375,0.00059371913,0.00034742348,0.000090863774,0.00069535966,0.000061079285,0.00027881027,0.0018387161,0.0016569173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058782883,0.0005325166,0.00043877697,0.0006611351,0.015910475,0.0025352465,0.00070734933,0.000030095194,0.028649045,0.011032333,0.8036285,0.12999624],"study_design_scores_gemma":[0.0034354408,0.00035557814,0.0007799641,0.00018893502,0.0037657847,0.00027818856,0.0000177339,0.000019698633,0.0039412156,0.0011632215,0.985499,0.0005551937],"about_ca_topic_score_codex":0.00010646479,"about_ca_topic_score_gemma":0.00003038141,"teacher_disagreement_score":0.18187055,"about_ca_system_score_codex":0.00035542142,"about_ca_system_score_gemma":0.00063236477,"threshold_uncertainty_score":0.99965143},"labels":[],"label_agreement":null},{"id":"W4256027239","doi":"10.1097/ju.0000000000001412.01","title":"Editorial Comment","year":2021,"lang":"es","type":"editorial","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Library science; Columbia university; Docetaxel; Cancer; Oncology; Family medicine; Internal medicine; Media studies; Sociology","score_opus":0.012685953789126722,"score_gpt":0.29589704472528106,"score_spread":0.2832110909361543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256027239","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003066953,0.014349483,0.000052509167,0.015669815,0.9682492,0.00024102004,0.00008469593,0.000007353139,0.0010391994],"genre_scores_gemma":[0.0055933776,0.01612106,0.000023442357,0.001975961,0.97558373,0.0000043532027,0.000041883886,0.000065565524,0.0005906318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552387,0.00110379,0.0011271292,0.00021547142,0.0015098276,0.0005199364],"domain_scores_gemma":[0.99442214,0.0021800601,0.0012932265,0.0005713252,0.001265101,0.0002681512],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016700709,0.00045919998,0.0013947428,0.00016098071,0.00017907615,0.00004115571,0.0006798335,0.0010899273,0.00092561025],"category_scores_gemma":[0.0009512654,0.0002720463,0.0005028797,0.00016358704,0.00029337805,0.00006498956,0.0001815714,0.0030889027,0.00010189515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005920355,0.00045229765,0.0000986851,0.00007084128,0.0022267571,0.0002881484,0.00056657015,0.000013817156,0.00022123373,0.000022334892,0.98893404,0.0011849278],"study_design_scores_gemma":[0.0070412923,0.0066848677,0.00007814979,0.00016814197,0.0057235807,0.0004277102,0.00017611768,0.0000018859171,0.00011991183,0.00020375282,0.97919875,0.00017582973],"about_ca_topic_score_codex":0.00014998208,"about_ca_topic_score_gemma":0.000012569982,"teacher_disagreement_score":0.013693854,"about_ca_system_score_codex":0.00031467094,"about_ca_system_score_gemma":0.0025590027,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W4256162960","doi":"10.5489/cuaj.587","title":"Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Université de Montréal; Université Laval; University of Alberta; Dalhousie University; McGill University; Western University","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Stage (stratigraphy); Proportional hazards model; Urology; Cancer; Disease; Internal medicine; Oncology; Surgery; Gynecology","score_opus":0.02331203101785269,"score_gpt":0.2797194942309447,"score_spread":0.25640746321309205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256162960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6290097,0.021485727,0.00012818504,0.33728346,0.00331431,0.004889392,0.0005565604,0.000048554182,0.0032841042],"genre_scores_gemma":[0.98283273,0.0017617306,0.00007614228,0.0103212735,0.0021190958,0.0011117469,0.000011892792,0.000024994699,0.0017404205],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785566,0.00013590435,0.00041955785,0.00024676064,0.0004065557,0.000935586],"domain_scores_gemma":[0.9976381,0.00037822148,0.0002692789,0.00022697427,0.00045084543,0.0010365978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027773692,0.00023880333,0.0003896296,0.00008373037,0.0011206168,0.00013031617,0.00025280454,0.00026848415,0.00416206],"category_scores_gemma":[0.00014071987,0.000120709636,0.00028295137,0.0002854371,0.00017261763,0.00008440898,0.0000071370428,0.00033970253,0.000025125226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015603255,0.00014919158,0.7904819,0.000007182989,0.0023060883,0.000038294038,0.0028165889,0.0008817945,0.000043250973,0.0002798676,0.15201294,0.050826848],"study_design_scores_gemma":[0.0021705239,0.0006964238,0.44418028,0.000017033812,0.00049645134,0.00005826735,0.00026447786,0.0005878086,0.000051035368,0.0003765884,0.5509413,0.00015982258],"about_ca_topic_score_codex":0.65298986,"about_ca_topic_score_gemma":0.67893094,"teacher_disagreement_score":0.3989283,"about_ca_system_score_codex":0.0034834882,"about_ca_system_score_gemma":0.0031469837,"threshold_uncertainty_score":0.99674827},"labels":[],"label_agreement":null},{"id":"W4256609411","doi":"10.1117/12.806893","title":"Safety of three sequential whole bladder photodynamic therapy (WBPDT) treatments in the management of resistant bladder cancer","year":2009,"lang":"en","type":"article","venue":"Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Photodynamic therapy; Medicine; Urology; Cancer; Cancer therapy; Oncology; Internal medicine; Chemistry","score_opus":0.015947760055539204,"score_gpt":0.2678735890794503,"score_spread":0.2519258290239111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256609411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912256,0.0005627668,0.000010169214,0.0025185496,0.00010673974,0.0013427392,0.00013170765,0.000024976944,0.004076744],"genre_scores_gemma":[0.987561,0.0009808161,0.010594049,0.00019884478,0.00015525277,0.0002141179,0.000018004332,0.000043836673,0.00023410011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976013,4.992875e-8,0.0008079256,0.0003532443,0.0008867535,0.00035072927],"domain_scores_gemma":[0.9986687,0.000049926475,0.00038991045,0.00010529113,0.00071294984,0.00007324852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004015013,0.00033077595,0.00055898284,0.00010994055,0.00005158015,0.000027071008,0.00059752306,0.00014596681,0.00003606277],"category_scores_gemma":[0.000028425498,0.00021918945,0.00061868055,0.00040248956,0.00020247756,0.00020840479,0.000058854635,0.0002244606,5.621898e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003256605,0.0016142986,0.0021533389,0.0008788743,0.005580093,0.0000018451103,0.0011424704,0.00015239352,0.856398,0.12366172,0.001100215,0.0040601594],"study_design_scores_gemma":[0.03758687,0.0082875965,0.2785073,0.004766523,0.0048277867,0.0000636753,0.008497696,0.010909982,0.63098836,0.00885372,0.0052827983,0.0014277064],"about_ca_topic_score_codex":0.00009175212,"about_ca_topic_score_gemma":0.0000020009822,"teacher_disagreement_score":0.27635396,"about_ca_system_score_codex":0.00024675525,"about_ca_system_score_gemma":0.0000618281,"threshold_uncertainty_score":0.8938286},"labels":[],"label_agreement":null},{"id":"W4256676900","doi":"10.1093/humrep/den1033","title":"Session 34: Male's sexual health","year":2008,"lang":"en","type":"article","venue":"Human Reproduction","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Session (web analytics); Reproductive health; Medicine; Psychology; Gynecology; Computer science; Environmental health; World Wide Web; Population","score_opus":0.07629168347709483,"score_gpt":0.34456932800951484,"score_spread":0.26827764453242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256676900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98946416,0.0007510386,0.000049297723,0.0022028952,0.0004022675,0.00036322584,0.0000033726294,0.00014465048,0.0066191037],"genre_scores_gemma":[0.9616904,0.00009415552,0.00026618698,0.00037003183,0.0012947628,0.000020150284,0.000069696005,0.000019599833,0.036174964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901927,0.000031727854,0.00016884229,0.00042183645,0.00019607997,0.00016224697],"domain_scores_gemma":[0.99934894,0.0000022160186,0.00006327785,0.000442962,0.000050314844,0.0000923084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011714272,0.000095998344,0.00016884715,0.000063477986,0.00030184927,0.0000044869225,0.000024998495,0.00003799488,0.00039947516],"category_scores_gemma":[0.000013923763,0.000081157246,0.00003485933,0.00010106451,0.00004946836,0.00005718639,0.000012718315,0.00011039985,0.00011041241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009445015,0.0026880994,0.46087873,0.0005972281,0.00029973857,0.00038457665,0.006841172,0.000021623167,0.078266285,0.0005734822,0.2527309,0.19577366],"study_design_scores_gemma":[0.0033593148,0.002734535,0.88457954,0.000101300866,0.000078176025,0.005076726,0.0004454114,0.0000061830415,0.017717076,0.00020175803,0.08543452,0.00026548607],"about_ca_topic_score_codex":0.00030542514,"about_ca_topic_score_gemma":0.000013520519,"teacher_disagreement_score":0.42370078,"about_ca_system_score_codex":0.00015507903,"about_ca_system_score_gemma":0.00010524267,"threshold_uncertainty_score":0.4373973},"labels":[],"label_agreement":null},{"id":"W4280503920","doi":"10.1038/s41598-022-12528-3","title":"Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine","year":2022,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Research Promotion Foundation","keywords":"Gemcitabine; DPYD; Bladder cancer; Dihydropyrimidine dehydrogenase; Cancer research; Exome sequencing; Cancer; Biology; Oncology; Internal medicine; Medicine; Gene; Mutation; Genetics; Pharmacogenetics; Thymidylate synthase; Fluorouracil; Genotype","score_opus":0.02390642500420592,"score_gpt":0.3012624190220083,"score_spread":0.27735599401780237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280503920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893229,0.001716498,0.000035468387,0.0009837983,0.004984079,0.0020987242,0.00008143091,0.000112067035,0.000665008],"genre_scores_gemma":[0.99291724,0.000015473133,0.0002486908,0.0003355239,0.00015510738,0.0011857174,0.00010895018,0.00005872511,0.0049745706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959277,0.0001282052,0.0007261941,0.0014588571,0.0010127436,0.0007463114],"domain_scores_gemma":[0.99830204,0.000027370987,0.0002454892,0.0009139455,0.00018287986,0.00032829138],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015859159,0.0003105566,0.0004895961,0.000514417,0.00063532125,0.00012150211,0.00012182088,0.0000554323,0.0012906129],"category_scores_gemma":[0.000101497535,0.00028967427,0.0001603224,0.001554086,0.0001363735,0.00015262855,0.00031395745,0.00031999752,0.00002586826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021651214,0.0007817969,0.14973213,0.000111813875,0.00009969831,0.0045064087,0.0015464374,0.0045778505,0.8326492,0.00001370035,0.0030821734,0.0026823038],"study_design_scores_gemma":[0.0028828157,0.0004954074,0.06517907,0.00025445464,0.00057358836,0.0022511387,0.00077507173,0.0035379815,0.90820473,0.0011459137,0.013507136,0.001192656],"about_ca_topic_score_codex":0.0027320841,"about_ca_topic_score_gemma":0.0018146315,"teacher_disagreement_score":0.084553055,"about_ca_system_score_codex":0.0010044149,"about_ca_system_score_gemma":0.0011784221,"threshold_uncertainty_score":0.99995553},"labels":[],"label_agreement":null},{"id":"W4280524262","doi":"10.3390/curroncol29050283","title":"Genomics and Immunomics in the Treatment of Urothelial Carcinoma","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Immunotherapy; Metastatic Urothelial Carcinoma; Genomics; Urothelial cancer; Targeted therapy; Genomic sequencing; Urothelial carcinoma; Oncology; Cancer; DNA sequencing; Disease; Bioinformatics; Internal medicine; Cancer research; Computational biology; Bladder cancer; Genome; Gene; Biology; Genetics","score_opus":0.23476166775903082,"score_gpt":0.4491060344939717,"score_spread":0.21434436673494087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280524262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030087077,0.99286705,6.940407e-7,0.00004370904,0.0008589663,0.0018711285,0.00019795832,0.0000068190006,0.0011449618],"genre_scores_gemma":[0.00018486302,0.9985208,0.000024545343,0.00002770963,0.00028174024,0.00065880583,0.00020967296,0.000034375218,0.000057477217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985274,0.00028870683,0.00052996725,0.00031385187,0.000120221834,0.00021985626],"domain_scores_gemma":[0.99905074,0.00026810807,0.00024026168,0.00037652097,0.000013700566,0.000050701245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001471626,0.00030731037,0.0016362269,0.00017093762,0.00004962906,0.0000057735365,0.00014291852,0.00014822387,0.00015146013],"category_scores_gemma":[0.000011193604,0.00018774575,0.00033295687,0.00015255416,0.00011442928,0.000011446811,0.000047117584,0.00029095807,0.000007350263],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009544075,0.0013932944,0.00048869115,0.0019916575,0.00014404007,0.000059429003,0.0012514208,5.0265278e-8,2.3659864e-7,0.00004909162,0.000087997076,0.99443865],"study_design_scores_gemma":[0.002349598,0.0035787816,0.00028206228,0.00028879047,0.0018201141,0.0002926578,0.00013666632,0.0000014945175,5.9273947e-7,0.00002035459,0.9911104,0.00011849186],"about_ca_topic_score_codex":0.000098419,"about_ca_topic_score_gemma":0.000025216494,"teacher_disagreement_score":0.99432015,"about_ca_system_score_codex":0.0013104925,"about_ca_system_score_gemma":0.0012858968,"threshold_uncertainty_score":0.765605},"labels":[],"label_agreement":null},{"id":"W4280579488","doi":"10.1016/j.euf.2022.04.014","title":"T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non–muscle-invasive Bladder Cancer Spectrum","year":2022,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Pathological; Stage (stratigraphy); Incidence (geometry); Internal medicine; Proportional hazards model; Cancer; Oncology; Urology; Cumulative incidence; Gastroenterology; Cohort","score_opus":0.02569201008937486,"score_gpt":0.2776672338045842,"score_spread":0.2519752237152093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280579488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8004456,0.022155827,0.00019880777,0.12900038,0.004194098,0.0080075795,0.0024642062,0.0006609301,0.032872528],"genre_scores_gemma":[0.9747575,0.0010078843,0.00013648978,0.013847173,0.0011924625,0.006135997,0.00006715147,0.00017006653,0.0026852791],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965156,0.00070639735,0.00052938005,0.0009952988,0.00044393257,0.00080940267],"domain_scores_gemma":[0.99830097,0.00038656878,0.00029831965,0.0006620334,0.000119091936,0.00023302728],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056374917,0.00049006136,0.0006052074,0.0001321251,0.0009124563,0.000041730764,0.0005466426,0.00011162284,0.005900976],"category_scores_gemma":[0.0001503308,0.00033550628,0.0003857005,0.00039503156,0.00036311182,0.0000713998,0.00041215422,0.0008355635,0.0001263764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005836725,0.004187816,0.43271655,0.00021605652,0.0056954585,0.005801362,0.016250378,0.0012460976,0.0024671035,0.0011555265,0.42702845,0.09739847],"study_design_scores_gemma":[0.0187135,0.01829357,0.39966413,0.00010270132,0.0065234792,0.0008802223,0.0018098797,0.00031044782,0.010909575,0.0016167216,0.5393389,0.0018368483],"about_ca_topic_score_codex":0.00057259423,"about_ca_topic_score_gemma":0.00044651725,"teacher_disagreement_score":0.17431186,"about_ca_system_score_codex":0.00023867172,"about_ca_system_score_gemma":0.00041812495,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W4280605905","doi":"10.1016/j.eururo.2022.04.022","title":"Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Biomarker; Immunotherapy; Urothelial carcinoma; Cancer research; First line; Carcinoma; Oncology; Internal medicine; Cancer; Bladder cancer; Biology","score_opus":0.03441785734394094,"score_gpt":0.32475810357648244,"score_spread":0.2903402462325415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280605905","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05594181,0.014599067,0.00028135147,0.024389673,0.879835,0.0100304615,0.0080147665,0.00022099797,0.0066868663],"genre_scores_gemma":[0.4241447,0.005735525,0.0005660911,0.005418948,0.5413085,0.0011484297,0.004007743,0.0008205488,0.016849512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972618,0.0005849417,0.0006853214,0.00061767973,0.0004091802,0.0004410498],"domain_scores_gemma":[0.99637663,0.002166584,0.00030606732,0.0008921875,0.00017899794,0.00007951334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058893085,0.00039261923,0.0007445142,0.00025907924,0.00022824005,0.000013855004,0.00047031074,0.00019988751,0.00067346107],"category_scores_gemma":[0.00061670266,0.00030935393,0.0003331801,0.0002599132,0.00019324709,0.000029253768,0.00014051553,0.00087097095,0.000015762595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029888794,0.0015077465,0.0006019111,0.00017793056,0.0011086286,0.00038097124,0.0038703354,0.0016306047,0.0033366438,0.00016015733,0.9479483,0.009388017],"study_design_scores_gemma":[0.015420056,0.004421416,0.0026818078,0.000026838656,0.00039327785,0.000014369862,0.000030128254,0.00003955206,0.0002578769,0.00004012406,0.97645235,0.00022219829],"about_ca_topic_score_codex":0.00033732736,"about_ca_topic_score_gemma":0.000583219,"teacher_disagreement_score":0.3682029,"about_ca_system_score_codex":0.00022175377,"about_ca_system_score_gemma":0.001156397,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W4280608253","doi":"10.1002/dmrr.3546","title":"Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria","year":2022,"lang":"en","type":"article","venue":"Diabetes/Metabolism Research and Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Public Health Agency; Queen's University Belfast; Queen's University; Wellcome Trust","keywords":"Medicine; Biomarker; Type 2 diabetes; Diabetes mellitus; Internal medicine; Oncology; Hazard ratio; Kidney disease; Gastroenterology; Confidence interval; Endocrinology; Biology","score_opus":0.04511230266755503,"score_gpt":0.3741303589959384,"score_spread":0.3290180563283833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280608253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90449613,0.09091449,7.816715e-7,0.0003378002,0.00014123929,0.003633815,0.00021607286,0.000013184245,0.00024647612],"genre_scores_gemma":[0.98424894,0.010800316,0.0005707013,0.00042683844,0.00028723004,0.0026539273,0.00018095029,0.00006820916,0.0007629099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733776,0.00045160428,0.0003764557,0.0006047819,0.00054955494,0.00067983824],"domain_scores_gemma":[0.9987575,0.00027772115,0.00011745114,0.00028880467,0.00027764938,0.00028091806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013697417,0.00023967009,0.0008189042,0.00023370793,0.00031773205,0.00005207271,0.0001162725,0.00007289549,0.00012210407],"category_scores_gemma":[0.00022542918,0.00014219541,0.00006671076,0.0006228816,0.00034554297,0.00012285204,0.00017054933,0.00057098904,0.0000014879415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015279715,0.00041964935,0.96778053,0.00046214208,0.0005253441,0.0000043919667,0.00021225045,9.822105e-7,0.00006974831,0.000010519852,0.0056390692,0.02334742],"study_design_scores_gemma":[0.0065260585,0.00260025,0.9688684,0.0003118123,0.00028361724,0.0000011031269,0.00008812284,0.00004741992,0.00016766148,0.00007933078,0.020839594,0.00018662856],"about_ca_topic_score_codex":0.000034048717,"about_ca_topic_score_gemma":0.000020149602,"teacher_disagreement_score":0.08011417,"about_ca_system_score_codex":0.000048405807,"about_ca_system_score_gemma":0.00016398643,"threshold_uncertainty_score":0.57985604},"labels":[],"label_agreement":null},{"id":"W4281396346","doi":"10.2217/fon-2021-1629","title":"Targeting <i>FGFR3</i> Alterations with Adjuvant Infigratinib in Invasive Urothelial Carcinoma: the Phase III PROOF 302 Trial","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Helsinn","keywords":"Medicine; Placebo; Clinical endpoint; Tolerability; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Adjuvant; Bladder cancer; Cisplatin; Urothelial cancer; Urology; Randomized controlled trial; Adverse effect; Urothelial carcinoma; Cancer; Chemotherapy; Pathology","score_opus":0.019136890186583426,"score_gpt":0.3077494896688529,"score_spread":0.28861259948226947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281396346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618933,0.0012186945,0.00007294672,0.017905654,0.002055048,0.0057369433,0.00023566933,0.00006334408,0.010818395],"genre_scores_gemma":[0.9900642,0.0000266739,0.0002550586,0.003969079,0.00252865,0.0022533692,0.00023159015,0.000033876207,0.0006375278],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825317,0.00034247077,0.00039593948,0.00035605778,0.00030656758,0.0003457995],"domain_scores_gemma":[0.999232,0.00015096125,0.00016829166,0.00028099472,0.000070864015,0.00009687667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027232472,0.00021353149,0.00047276777,0.00010523809,0.00040202375,0.000015431347,0.00015676313,0.000088256085,0.00086309673],"category_scores_gemma":[0.00004671785,0.0001329421,0.00008387653,0.0003583565,0.000093703915,0.00006202995,0.00008184727,0.00063801685,0.000008289813],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63624775,0.019505523,0.026024299,0.00022293128,0.0011932258,0.006531858,0.06946618,0.0011060741,0.023763089,0.003250044,0.15901466,0.05367439],"study_design_scores_gemma":[0.47022337,0.036730893,0.0016056669,0.0000323981,0.00052220054,0.0006462404,0.009059312,0.00017124374,0.0027959538,0.00013704418,0.47767833,0.00039734202],"about_ca_topic_score_codex":0.00028798394,"about_ca_topic_score_gemma":0.001521402,"teacher_disagreement_score":0.3186637,"about_ca_system_score_codex":0.0003802401,"about_ca_system_score_gemma":0.0018459278,"threshold_uncertainty_score":0.9450304},"labels":[],"label_agreement":null},{"id":"W4281552585","doi":"10.1200/edbk_350829","title":"Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Oncology; Adjuvant; Nivolumab; Food and drug administration; Adjuvant therapy; Kidney cancer; Internal medicine; Carcinoma; Metastatic Urothelial Carcinoma; Cancer; Urothelial carcinoma; Immunotherapy; Bladder cancer; Pharmacology","score_opus":0.04383669729226688,"score_gpt":0.41812400890761536,"score_spread":0.3742873116153485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281552585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9038249,0.014762151,0.00012990586,0.06931034,0.0011665407,0.0026990308,0.0006914751,0.00003534831,0.0073802737],"genre_scores_gemma":[0.9676404,0.0018827001,0.005108307,0.021731373,0.0004757568,0.0005018647,0.00005405462,0.000021773334,0.0025837666],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861264,0.00012206166,0.0006383357,0.00025819597,0.000218764,0.00014997342],"domain_scores_gemma":[0.9977081,0.0012106006,0.0005535422,0.00015472953,0.00019816273,0.0001748981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046781523,0.00010371902,0.0007188862,0.000023006181,0.00010204666,0.0000015476915,0.00009450932,0.00005339951,0.0006346551],"category_scores_gemma":[0.00019272843,0.00009279634,0.00036537944,0.000094605246,0.00070312875,0.00003132975,0.000038927912,0.00018683997,9.0207067e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004473693,0.0031219705,0.4259453,0.00022429414,0.0020670288,8.1895354e-7,0.0059874305,0.00003807367,0.0070497673,0.001019003,0.18018304,0.3698896],"study_design_scores_gemma":[0.011352053,0.015175925,0.21477376,0.00008703911,0.00047176014,0.000057604448,0.010662776,0.0004991379,0.00056286535,0.0011838102,0.7449312,0.00024205961],"about_ca_topic_score_codex":0.0005821849,"about_ca_topic_score_gemma":0.0000021109886,"teacher_disagreement_score":0.56474817,"about_ca_system_score_codex":0.0003092471,"about_ca_system_score_gemma":0.0067372606,"threshold_uncertainty_score":0.9988936},"labels":[],"label_agreement":null},{"id":"W4281555918","doi":"10.1007/s00428-022-03346-z","title":"Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma","year":2022,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Basal (medicine); Pathology; Immunohistochemistry; Biology; Carcinoma; GATA3; Stain; Cancer; Internal medicine; Oncology; Staining; Medicine","score_opus":0.03719691927045543,"score_gpt":0.34273698869268227,"score_spread":0.30554006942222683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281555918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98118883,0.0023538077,0.00021105779,0.0020480594,0.0011496678,0.0021079886,0.0003395495,0.00016172483,0.010439284],"genre_scores_gemma":[0.9914405,0.00015451961,0.0023957458,0.0035168892,0.0005185308,0.0008580059,0.00054766587,0.00012188819,0.00044625046],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952183,0.00069708517,0.00083319395,0.0013440137,0.00072035234,0.0011871008],"domain_scores_gemma":[0.9970417,0.0012289768,0.00030914563,0.0009340804,0.000116418225,0.00036968774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008607363,0.00069519615,0.001118955,0.00046119155,0.00059280224,0.000026890903,0.0006490366,0.00024085371,0.000399415],"category_scores_gemma":[0.001361755,0.0005956798,0.00048518757,0.0006234857,0.0007174601,0.00012184642,0.0007528362,0.0011554367,0.000045067147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064202316,0.008705718,0.046969514,0.00064805034,0.002185707,0.010726898,0.008874919,0.00089593633,0.81453794,0.0066116676,0.007414353,0.028226992],"study_design_scores_gemma":[0.1355104,0.11348233,0.33652124,0.00066788384,0.005774977,0.0005007364,0.016683836,0.0024858085,0.2412945,0.035315543,0.10672779,0.005034939],"about_ca_topic_score_codex":0.0006817077,"about_ca_topic_score_gemma":0.00013336798,"teacher_disagreement_score":0.57324344,"about_ca_system_score_codex":0.00030926062,"about_ca_system_score_gemma":0.0012448307,"threshold_uncertainty_score":0.99964947},"labels":[],"label_agreement":null},{"id":"W4281609415","doi":"10.1200/jco.2022.40.16_suppl.tps4619","title":"CCTG BL13 a randomized phase II trial assessing trimodality therapy with or without adjuvant durvalumab to treat patients with muscle-invasive bladder cancer (NCT03768570).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Jewish General Hospital; University of British Columbia; McGill University; Princess Margaret Cancer Centre; Ottawa Hospital; Queen's University; Juravinski Cancer Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Durvalumab; Bladder cancer; Cystectomy; Oncology; Radiation therapy; Internal medicine; Clinical endpoint; Cancer; Immunotherapy; Population; Chemotherapy; Urology; Randomized controlled trial; Nivolumab","score_opus":0.13287692024443595,"score_gpt":0.4888937680684552,"score_spread":0.3560168478240192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281609415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949754,0.000342172,0.00025304809,0.004100014,0.001408394,0.0034762712,0.00006345068,0.000026419,0.0008326969],"genre_scores_gemma":[0.9901638,0.00041369526,0.0014069102,0.005255571,0.0014616254,0.00045453478,0.000017092389,0.0000721836,0.0007545884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992779,0.0022824558,0.002647248,0.00052668614,0.0012854604,0.0004791068],"domain_scores_gemma":[0.9927591,0.0026499147,0.0025857445,0.0003883631,0.00086812174,0.00074871915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033807897,0.0004205511,0.00453548,0.00021938216,0.00035063594,0.00003275311,0.00027069112,0.00022020735,0.0018083097],"category_scores_gemma":[0.0014754932,0.00020955272,0.0007426921,0.00041048773,0.00033847004,0.00023347465,0.00009926676,0.0010264915,0.000003327691],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.860185,0.018776547,0.011399114,0.000014730065,0.0021477176,0.0005697411,0.00076848926,0.000042514872,0.000048838112,0.0000034616796,0.0010579077,0.10498589],"study_design_scores_gemma":[0.7914919,0.18595694,0.011848221,0.00011246841,0.0027497832,0.00010888072,0.00034154416,0.000024078981,0.00007882614,0.000030215544,0.0070265434,0.000230591],"about_ca_topic_score_codex":0.0003268857,"about_ca_topic_score_gemma":0.00018574909,"teacher_disagreement_score":0.16718039,"about_ca_system_score_codex":0.0006796344,"about_ca_system_score_gemma":0.010979846,"threshold_uncertainty_score":0.9991042},"labels":[],"label_agreement":null},{"id":"W4281623486","doi":"10.1002/jso.26973","title":"Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients","year":2022,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Koç Üniversitesi","keywords":"Medicine; Cystectomy; Bladder cancer; Poisson regression; Perioperative; Logistic regression; Cohort; Odds ratio; Urology; Surgery; Internal medicine; Cancer; Population; Environmental health","score_opus":0.04643897100902241,"score_gpt":0.3652354817761625,"score_spread":0.3187965107671401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281623486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816569,0.00090350304,0.0000051121274,0.0020929386,0.0009894925,0.0006808825,0.00008273946,0.0000041859153,0.013584262],"genre_scores_gemma":[0.99894214,0.00018851856,0.0001913068,0.00024888365,0.0000641553,0.000048699505,0.000014999404,0.000018036588,0.00028323702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973997,0.00038204447,0.0011845231,0.00017817115,0.00061884156,0.00023674294],"domain_scores_gemma":[0.998216,0.00039618844,0.00080025854,0.00015257407,0.0002440545,0.00019096394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065053423,0.00015313472,0.0015279631,0.00022864802,0.000041987692,0.0000039697074,0.0002901569,0.00012287719,0.0022487848],"category_scores_gemma":[0.000053655647,0.00011244589,0.00027678604,0.00033033264,0.0001377371,0.00009450229,0.00023665444,0.0005119383,0.0000014441141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018171677,0.0056882584,0.9684847,0.00003746248,0.0011364284,0.0011824993,0.00034164425,0.000060287868,0.00006556688,0.000025387235,0.0026932147,0.0021128599],"study_design_scores_gemma":[0.066021495,0.008847687,0.8644764,0.000071285234,0.0004162542,0.00019112603,0.0004012926,0.000023450752,0.00012800038,0.000019385468,0.05929366,0.000110000496],"about_ca_topic_score_codex":0.0003773599,"about_ca_topic_score_gemma":0.0000857565,"teacher_disagreement_score":0.104008354,"about_ca_system_score_codex":0.0005577982,"about_ca_system_score_gemma":0.0013262163,"threshold_uncertainty_score":0.9986633},"labels":[],"label_agreement":null},{"id":"W4281630379","doi":"10.1016/s0302-2838(22)00327-x","title":"Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Bladder cancer; Urinary system; DNA sequencing; DNA; Urology; Cancer; Oncology; Internal medicine; Genetics","score_opus":0.014950454072681212,"score_gpt":0.23554432693440144,"score_spread":0.22059387286172022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281630379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895915,0.0016026966,0.0003404472,0.00021119945,0.0003012603,0.00024196212,0.000049497932,0.000034457236,0.0076269982],"genre_scores_gemma":[0.99896747,0.00015650978,0.00005769736,0.00042734962,0.0001268972,0.000009832968,0.000015696896,0.000035812598,0.00020272963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988592,0.00032918176,0.00023962793,0.0002601221,0.00014217464,0.00016964674],"domain_scores_gemma":[0.9995206,0.000046677895,0.00013258887,0.00017501558,0.00006503499,0.000060067905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015107352,0.00012240064,0.00026313262,0.00011862797,0.00007839931,0.0000015631673,0.00004698542,0.00002522395,0.00031495007],"category_scores_gemma":[0.000011221117,0.0001177056,0.0000552082,0.0001529038,0.00012942367,0.000026601016,0.000054563618,0.00018881455,0.000008383236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011988358,0.00013791186,0.0021790394,0.000035930843,0.0002518172,0.00044258527,0.0018088345,0.00015438002,0.9858979,0.000016044629,0.000099638404,0.0077770753],"study_design_scores_gemma":[0.0061614583,0.010218885,0.32223147,0.000021568361,0.0006546387,0.0020497174,0.0010978743,0.0004326134,0.6429503,0.000082731094,0.013743871,0.00035486402],"about_ca_topic_score_codex":0.00014238356,"about_ca_topic_score_gemma":0.000008183181,"teacher_disagreement_score":0.3429476,"about_ca_system_score_codex":0.00007877608,"about_ca_system_score_gemma":0.000046261186,"threshold_uncertainty_score":0.4799895},"labels":[],"label_agreement":null},{"id":"W4281631860","doi":"10.5489/cuaj.7933","title":"Poster Session 11: EDI, COVID, Patient Relations","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Computer science; Medicine; Virology; World Wide Web; Internal medicine","score_opus":0.01445316945031644,"score_gpt":0.24414976855389575,"score_spread":0.2296965991035793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281631860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8724566,0.00035357554,0.00004616407,0.11091455,0.0013290707,0.0003948804,0.00024355434,0.000048293892,0.014213279],"genre_scores_gemma":[0.97634375,0.000010318326,0.000054525102,0.020855438,0.0002882897,0.000028536333,0.00006449281,0.000010894231,0.002343729],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856293,0.00020648491,0.00024966136,0.0001500919,0.00045391504,0.0003769281],"domain_scores_gemma":[0.99883586,0.0000704226,0.00016849271,0.00008541431,0.00012284708,0.0007169686],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030766084,0.00009577527,0.00015897007,0.00015116711,0.00096797367,0.000039262355,0.00006872926,0.00009552282,0.009395547],"category_scores_gemma":[0.00024131889,0.00007876996,0.000118231306,0.00020026523,0.0000126261,0.00006522138,0.000029632476,0.00057244714,0.00007743657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006505665,0.00008954469,0.8999147,0.0000010403822,0.00006983943,0.00019426321,0.00033226702,0.00009725537,0.000029560219,0.00008168447,0.096596815,0.0025279683],"study_design_scores_gemma":[0.00129609,0.0007620292,0.40112573,0.0000035648825,0.00009322585,0.00051795534,0.00020111646,0.000043349697,0.000007986355,0.00059140107,0.59525853,0.00009902047],"about_ca_topic_score_codex":0.0012983338,"about_ca_topic_score_gemma":0.00049549044,"teacher_disagreement_score":0.49878898,"about_ca_system_score_codex":0.0031025887,"about_ca_system_score_gemma":0.0010031542,"threshold_uncertainty_score":0.99151},"labels":[],"label_agreement":null},{"id":"W4281641699","doi":"10.5489/cuaj.7922","title":"Podium Session 4: Pediatrics, Pelvic Pain, Sexual Dysfunction, Oncology","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Pelvic pain; Physical therapy; Pediatric oncology; Pediatrics; Internal medicine; Surgery; Cancer","score_opus":0.014644438682616785,"score_gpt":0.25197023127223517,"score_spread":0.2373257925896184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281641699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7786768,0.0017421754,0.0004199798,0.19138956,0.0054125004,0.00081948837,0.00030133213,0.00016612258,0.021072041],"genre_scores_gemma":[0.9677049,0.0000532418,0.000091659414,0.024859348,0.0015619086,0.000035384157,0.000089384186,0.000018286084,0.0055859024],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977123,0.0006664336,0.0003311213,0.00023172364,0.0005404827,0.0005178951],"domain_scores_gemma":[0.9984011,0.00018659138,0.00025564534,0.00010402513,0.0002525506,0.0008000892],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014569359,0.00014483991,0.0002776909,0.0002448971,0.0009181515,0.000041578172,0.00011340376,0.00018900847,0.0064006997],"category_scores_gemma":[0.0006638458,0.000119961565,0.00011424441,0.00033175288,0.000019184967,0.000066953784,0.000032232143,0.0010416774,0.00007937222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016733642,0.00017594933,0.7202717,0.0000043284394,0.00009543775,0.00037745692,0.00020583066,0.00007958408,0.000044979013,0.000037414764,0.2600279,0.01851211],"study_design_scores_gemma":[0.0020616767,0.0027435783,0.32030436,0.0000013083024,0.00016803361,0.000651644,0.00061467633,0.00008439468,0.000002549213,0.00041581958,0.672819,0.00013295596],"about_ca_topic_score_codex":0.0017174856,"about_ca_topic_score_gemma":0.0005398111,"teacher_disagreement_score":0.4127911,"about_ca_system_score_codex":0.0052403538,"about_ca_system_score_gemma":0.0021706002,"threshold_uncertainty_score":0.99857837},"labels":[],"label_agreement":null},{"id":"W4281654376","doi":"10.1200/jco.2022.40.16_suppl.e16538","title":"Real-world, population-based study of treatments, survival and healthcare use in advanced urothelial carcinoma of the bladder.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Bladder cancer; Proportional hazards model; Cohort; Population; Internal medicine; Comorbidity; Cancer registry; Health care; Cancer; Oncology","score_opus":0.1295840010116572,"score_gpt":0.4545162052505024,"score_spread":0.32493220423884517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281654376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964191,0.00014309426,9.739474e-7,0.0017993621,0.0007548542,0.000670176,0.000038797243,0.0000025484296,0.00017109462],"genre_scores_gemma":[0.99909914,0.00005996738,0.00021028289,0.00031547906,0.0001257559,0.00001706554,0.0000036533515,0.000015495714,0.00015316706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960787,0.0012258055,0.00189056,0.00017628071,0.00048079924,0.00014784184],"domain_scores_gemma":[0.9966937,0.0012904053,0.0014512085,0.00024629707,0.00018254692,0.00013588439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010585038,0.000121091005,0.0012441719,0.00016224322,0.000061199324,0.0000022082515,0.00012821541,0.00007743745,0.000070807066],"category_scores_gemma":[0.00045563348,0.00007857836,0.0002415157,0.00028264822,0.000069496724,0.000052576997,0.00006579093,0.0005296127,1.4317085e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00786712,0.0050123446,0.97538173,0.00002204468,0.00022664558,0.00011571037,0.0002604304,0.00019113127,0.000038160215,0.000035078563,0.000026534615,0.01082305],"study_design_scores_gemma":[0.023746558,0.023863142,0.95065933,0.000032101234,0.0003657516,0.000016607079,0.000845968,0.00003125197,0.00003339068,0.00006970447,0.00028818127,0.000048019006],"about_ca_topic_score_codex":0.006916579,"about_ca_topic_score_gemma":0.0075870072,"teacher_disagreement_score":0.024722425,"about_ca_system_score_codex":0.00029503892,"about_ca_system_score_gemma":0.001542303,"threshold_uncertainty_score":0.99969643},"labels":[],"label_agreement":null},{"id":"W4281683309","doi":"10.4178/epih.e2022050","title":"The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies","year":2022,"lang":"en","type":"review","venue":"Epidemiology and Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Meta-analysis; Metabolic syndrome; Internal medicine; Cohort study; Observational study; Cancer; Relative risk; Overweight; Publication bias; Obesity; Oncology; Confidence interval","score_opus":0.5527458453847008,"score_gpt":0.5183854508848341,"score_spread":0.03436039449986672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281683309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005700472,0.990787,0.000001831629,0.0045397677,0.000022900445,0.0042167976,0.00035269605,0.0000095180585,0.000012483823],"genre_scores_gemma":[0.0006253742,0.9954149,0.000032712655,0.0013799465,0.000014208463,0.0020372828,0.00014689701,0.000022749258,0.00032588863],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99409974,0.0032409655,0.0016683034,0.00051573466,0.00016451141,0.00031072297],"domain_scores_gemma":[0.98998666,0.007821813,0.0015245393,0.00040873568,0.000058789592,0.00019947122],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0057919906,0.00040147413,0.016895121,0.00020504421,0.0004657763,0.0000032415785,0.00008959723,0.00012396055,0.000055793716],"category_scores_gemma":[0.00087373407,0.00018284221,0.0005417643,0.00051957206,0.00023421813,0.000027427428,0.0000864274,0.0004693878,0.000001068603],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005751401,0.000015635916,0.024851732,0.5054736,0.46801087,0.000004203765,0.00007445244,1.1868567e-7,1.4192961e-10,0.00067768246,0.00009894355,0.0007869817],"study_design_scores_gemma":[0.00017776247,0.00024000103,0.04075345,0.013270834,0.9313218,0.00015641887,0.000024515204,7.0332135e-7,9.684326e-10,0.000072060866,0.013858464,0.00012400263],"about_ca_topic_score_codex":0.0003774559,"about_ca_topic_score_gemma":0.00009967806,"teacher_disagreement_score":0.4922028,"about_ca_system_score_codex":0.00008164454,"about_ca_system_score_gemma":0.00028317032,"threshold_uncertainty_score":0.9977001},"labels":[],"label_agreement":null},{"id":"W4281711802","doi":"10.3390/curroncol29060312","title":"Trop-2 in Upper Tract Urothelial Carcinoma","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphovascular invasion; Immunohistochemistry; Urothelial carcinoma; Oncology; Overall survival; Internal medicine; Cancer; Cancer research; Metastasis; Bladder cancer","score_opus":0.0884586427932337,"score_gpt":0.39234987196734755,"score_spread":0.3038912291741138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281711802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800158,0.0025064487,0.000011816386,0.0017379889,0.0020151988,0.0005507718,0.00005631784,0.00003866129,0.013066991],"genre_scores_gemma":[0.9982086,0.000068375804,0.000045098783,0.00040824054,0.00033256947,0.0003352706,0.000062856474,0.000021046033,0.0005179724],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887896,0.00013782176,0.00022419285,0.0002706208,0.00019720255,0.00029122326],"domain_scores_gemma":[0.9996058,0.00004075885,0.000047891273,0.0001832436,0.00002162301,0.00010070911],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000121830875,0.0001262829,0.00031164577,0.0001566584,0.00008138953,0.0000035841385,0.00008474651,0.000045848024,0.0024816715],"category_scores_gemma":[0.00001861026,0.000115334646,0.00010307001,0.0001828881,0.000044345248,0.000028619506,0.00007057379,0.00043507808,0.00005753645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010130805,0.0038542063,0.7824285,0.000041606043,0.000031065294,0.00045646305,0.001268335,0.00000815414,0.00061614526,0.0003008636,0.005958185,0.20402342],"study_design_scores_gemma":[0.007256602,0.0030013132,0.2900111,0.000008835245,0.000077822086,0.00028261324,0.00030326945,0.00006589955,0.00018022211,0.00014755854,0.6985468,0.00011791874],"about_ca_topic_score_codex":0.00008219036,"about_ca_topic_score_gemma":0.000019088713,"teacher_disagreement_score":0.6925886,"about_ca_system_score_codex":0.0007467488,"about_ca_system_score_gemma":0.00050522794,"threshold_uncertainty_score":0.9984302},"labels":[],"label_agreement":null},{"id":"W4281780880","doi":"10.5489/cuaj.7859","title":"Comparison of the effectiveness of two combinations of antibiotic used for perioperative prophylactic therapy during radical cystectomy: A retrospective cohort study","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metronidazole; Piperacillin; Cystectomy; Retrospective cohort study; Piperacillin/tazobactam; Perioperative; Tazobactam; Surgery; Ceftriaxone; Bladder cancer; Antibiotics; Internal medicine; Cancer","score_opus":0.01722921311391358,"score_gpt":0.30504501486280455,"score_spread":0.287815801748891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281780880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968752,0.00010389835,0.000018573224,0.00046544848,0.00017979184,0.0021073448,0.000104879255,0.000004589285,0.000140223],"genre_scores_gemma":[0.9997826,0.0000025868198,0.000017616321,0.00003938079,0.000032301847,0.00007363986,0.0000056339363,0.000010144982,0.000036076308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977924,0.0010027122,0.00037567853,0.00014946597,0.00049599045,0.0001837477],"domain_scores_gemma":[0.998598,0.0002871622,0.00045966337,0.000116001866,0.00042771196,0.00011150922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010838753,0.000101195,0.00055525306,0.00011824681,0.00039067917,0.000009733492,0.0001226868,0.00005089101,0.00008875497],"category_scores_gemma":[0.00044127082,0.00006905682,0.0001776818,0.00033677332,0.00007325206,0.00003388236,0.000019275272,0.00037926322,1.7462676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005851204,0.0013127364,0.9924431,0.00001942026,0.0004975896,0.000003880342,0.0009930152,0.00014059589,0.0037942838,0.000167514,0.000007795154,0.0000349424],"study_design_scores_gemma":[0.009954347,0.0040850597,0.9802405,0.00001454497,0.00020539964,0.00001909672,0.0004894577,0.000079620164,0.0046837204,0.00015097421,0.00002165891,0.000055623488],"about_ca_topic_score_codex":0.001133083,"about_ca_topic_score_gemma":0.0002431694,"teacher_disagreement_score":0.01220261,"about_ca_system_score_codex":0.001553026,"about_ca_system_score_gemma":0.000728815,"threshold_uncertainty_score":0.4061109},"labels":[],"label_agreement":null},{"id":"W4281986020","doi":"10.1016/j.urolonc.2022.05.011","title":"Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy","year":2022,"lang":"en","type":"erratum","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein expression; Cystectomy; Cancer research; Tumor microenvironment; Expression (computer science); Medicine; Pathology; Biology; Internal medicine; Cell biology; Tumor cells; Bladder cancer; Computer science; Signal transduction; Cancer; Genetics; Gene","score_opus":0.017948223881097597,"score_gpt":0.2705275158684314,"score_spread":0.25257929198733375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281986020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96605736,0.019389432,0.000027603957,0.00571017,0.0023153094,0.004108849,0.00063411583,0.000038322083,0.001718835],"genre_scores_gemma":[0.6216679,0.011986116,0.06429283,0.031948667,0.0017806909,0.02000096,0.006324752,0.00051226333,0.24148577],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978052,0.00038830258,0.00042918735,0.0006795597,0.00030999535,0.00038776858],"domain_scores_gemma":[0.998741,0.00013384444,0.0005605257,0.00031253454,0.000041508458,0.00021062544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028503532,0.00042121686,0.000808252,0.00023583331,0.0003198545,0.000010112578,0.00019144957,0.00037731297,0.00035712903],"category_scores_gemma":[0.00013473144,0.0002694728,0.000056656503,0.00024406139,0.0005670634,0.0000375439,0.00020306704,0.0010166712,0.0000066948046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008245953,0.003567756,0.23478507,0.0021409404,0.00084122206,0.03333197,0.02429286,0.00021231633,0.06402011,0.0018711224,0.62564266,0.0010480144],"study_design_scores_gemma":[0.0029542362,0.015292033,0.004107874,0.0008513299,0.00082783296,0.0049931244,0.0014765896,0.00013638055,0.0035668297,0.0011689306,0.964176,0.00044884605],"about_ca_topic_score_codex":0.00003734265,"about_ca_topic_score_gemma":0.00004938622,"teacher_disagreement_score":0.3443894,"about_ca_system_score_codex":0.0003138675,"about_ca_system_score_gemma":0.0005032837,"threshold_uncertainty_score":0.99997574},"labels":[],"label_agreement":null},{"id":"W4282821641","doi":"10.1007/s10552-022-01593-8","title":"Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review","year":2022,"lang":"en","type":"review","venue":"Cancer Causes & Control","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK; U.S. Department of Defense","keywords":"Medicine; Race (biology); Bladder cancer; Clinical trial; Epidemiology; Public health; Meta-analysis; Systematic review; MEDLINE; Cancer; Family medicine; Internal medicine; Pathology","score_opus":0.3046902238785381,"score_gpt":0.5211848870248224,"score_spread":0.21649466314628424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282821641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063797847,0.9856105,0.000010060602,0.0006608303,0.001189369,0.011786254,0.00040151327,0.00008412644,0.00025101032],"genre_scores_gemma":[0.00009788297,0.9751835,0.000013419776,0.0029368792,0.00088194036,0.01942437,0.00005826133,0.0001474519,0.0012563164],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98488456,0.003891134,0.008907289,0.0010920386,0.0006152962,0.0006096914],"domain_scores_gemma":[0.98652,0.0043161544,0.007793355,0.00092462695,0.00012414494,0.0003217285],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0115028685,0.00081723125,0.01906112,0.00025011765,0.00015034262,0.0000795031,0.00023117765,0.000336391,0.000817825],"category_scores_gemma":[0.017237809,0.0005659015,0.0019691107,0.00046467874,0.00012142976,0.00011421805,0.00011628694,0.0011895039,0.000006901376],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099419165,0.000075049924,0.0011620262,0.8220338,0.0039375965,0.00041765955,0.000040816878,3.735969e-7,1.110833e-7,0.000015102441,0.002494773,0.16972323],"study_design_scores_gemma":[0.0026975512,0.00011505993,0.000028733864,0.55106264,0.043257,0.00021279602,0.000031085423,0.0000050742883,1.1614271e-7,0.0000063561415,0.40221,0.00037356213],"about_ca_topic_score_codex":0.001031789,"about_ca_topic_score_gemma":0.00029027485,"teacher_disagreement_score":0.39971524,"about_ca_system_score_codex":0.0010464366,"about_ca_system_score_gemma":0.00249751,"threshold_uncertainty_score":0.99967927},"labels":[],"label_agreement":null},{"id":"W4282828336","doi":"10.1111/bju.15825","title":"Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy","year":2022,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SaskWater; University of Saskatchewan","funders":"National Cancer Institute; Sidney Kimmel Center for Prostate and Urologic Cancers; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Cystectomy; Surgery; Extracorporeal; Urinary diversion; Perioperative; Anastomosis; Confidence interval; Bladder cancer; Internal medicine; Cancer","score_opus":0.033494932218555165,"score_gpt":0.3135455561474645,"score_spread":0.28005062392890934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282828336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891295,0.0036124995,0.00044065097,0.0006472059,0.0015637567,0.0022824863,0.000089557,0.000014164088,0.0022201904],"genre_scores_gemma":[0.99863,0.00007563972,0.00022739162,0.0006318525,0.00013398941,0.00011862742,0.000048000536,0.000021258487,0.00011324883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969983,0.00075779605,0.0012314501,0.00023812025,0.0005052656,0.00026903496],"domain_scores_gemma":[0.998049,0.0004460334,0.00095016044,0.0001995799,0.00016155835,0.00019362544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007488717,0.00018361476,0.002662378,0.0004918258,0.00014956256,0.00004430751,0.00043187133,0.00009953296,0.0021533694],"category_scores_gemma":[0.00028579167,0.00016680062,0.0010857306,0.00057461974,0.00009476315,0.00008822635,0.00014380261,0.0007112054,7.4164547e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96268624,0.0011407374,0.006929977,0.000016234968,0.01999889,0.0021422245,0.00013684777,0.0006484889,0.00019218473,0.000003474599,0.00091991073,0.0051847664],"study_design_scores_gemma":[0.91258574,0.0061369087,0.06495233,0.000015536098,0.012023802,0.0024148119,0.00011425334,0.00029636084,0.000007675257,0.000007064285,0.0013358796,0.00010963835],"about_ca_topic_score_codex":0.0002327838,"about_ca_topic_score_gemma":0.000079171754,"teacher_disagreement_score":0.058022354,"about_ca_system_score_codex":0.00015617268,"about_ca_system_score_gemma":0.0005151278,"threshold_uncertainty_score":0.9987588},"labels":[],"label_agreement":null},{"id":"W4282913754","doi":"10.1158/1538-7445.am2022-2058","title":"Abstract 2058: Effect of route of Bacillus-Calmette Guerin administration on systemic immune responses in a murine model of non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Ex vivo; Immune system; Systemic administration; Lymph; Bone marrow; Cancer; Spleen; Cystectomy; Lipopolysaccharide; Immunology; In vivo; Pathology; Cancer research; Internal medicine; Biology","score_opus":0.06863559493204169,"score_gpt":0.4017403420890373,"score_spread":0.3331047471569956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282913754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416524,0.0021834543,0.0000044217772,0.00029831182,0.00010298909,0.0015169036,0.0008089476,0.000009027571,0.00091068144],"genre_scores_gemma":[0.9968212,0.000738459,0.00001938381,0.000027790787,0.000054945293,0.0013817183,0.000031556112,0.000039692066,0.0008852559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713075,0.0003551123,0.00063600537,0.0003780762,0.001119902,0.0003801444],"domain_scores_gemma":[0.99838656,0.0004847058,0.00022309467,0.0005136845,0.00029174276,0.000100186575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001261647,0.00019389454,0.00069286715,0.0005103212,0.000074381045,0.000005440478,0.0002376221,0.00007976826,0.00075234607],"category_scores_gemma":[0.00018095913,0.00016704093,0.00014784755,0.00069599587,0.00018369449,0.00006757238,0.00013671984,0.0005381696,0.0000033195133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01864332,0.0005236981,0.013925576,0.0021582954,0.00029946154,0.0000757733,0.0010937934,0.006687463,0.9486724,0.000019016052,0.00035060127,0.0075505753],"study_design_scores_gemma":[0.007125882,0.0062206853,0.088234834,0.0015975815,0.0001099838,0.000010883835,0.0004337602,0.0007667842,0.89523834,0.000026890224,0.00006783945,0.00016652382],"about_ca_topic_score_codex":0.0077207694,"about_ca_topic_score_gemma":0.0007089146,"teacher_disagreement_score":0.07430926,"about_ca_system_score_codex":0.0007922164,"about_ca_system_score_gemma":0.0021031166,"threshold_uncertainty_score":0.9988869},"labels":[],"label_agreement":null},{"id":"W4282926990","doi":"10.1016/j.euo.2022.04.001","title":"Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Propensity score matching; Lymph node; Cisplatin; Oncology; Internal medicine; Proportional hazards model; Cohort; Urology; Clinical endpoint; Lymph; Stage (stratigraphy); Cancer; Chemotherapy; Randomized controlled trial; Pathology","score_opus":0.009836005636316718,"score_gpt":0.266905499013577,"score_spread":0.2570694933772603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282926990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971826,0.0005325039,0.00020607625,0.004131153,0.00041927976,0.0016205666,0.00015959659,0.000073410614,0.00313918],"genre_scores_gemma":[0.98171026,0.000010440114,0.00025113975,0.01560349,0.00032746315,0.001061495,0.00010317146,0.00010881011,0.0008237475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978357,0.0005750705,0.00031305358,0.0005068217,0.00023560994,0.0005337466],"domain_scores_gemma":[0.9989451,0.00030079586,0.00019246199,0.0003139121,0.00011403127,0.00013366253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003451814,0.000270952,0.00043649628,0.00010048171,0.00043079117,0.0000115292305,0.00020501555,0.00007208888,0.0012249108],"category_scores_gemma":[0.00003820418,0.00017662247,0.000108789245,0.0002073314,0.00036343923,0.000029944194,0.000074838434,0.00052127184,0.000022744602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01330209,0.0011845515,0.95548004,0.000029949639,0.0007564371,0.00032156034,0.0013375625,0.00034019956,0.00013741686,0.0000066278894,0.005662627,0.02144093],"study_design_scores_gemma":[0.035618905,0.019596893,0.6588288,0.000020596624,0.0011775994,0.00012972116,0.0001852426,0.0008506353,0.00025577526,0.000017897419,0.2829104,0.00040755162],"about_ca_topic_score_codex":0.0002169903,"about_ca_topic_score_gemma":0.00030408258,"teacher_disagreement_score":0.29665127,"about_ca_system_score_codex":0.00028081104,"about_ca_system_score_gemma":0.00044085857,"threshold_uncertainty_score":0.9996881},"labels":[],"label_agreement":null},{"id":"W4282928857","doi":"10.36255/exon-publications-urologic-cancers-papillary-urothelial-neoplasms","title":"Papillary Urothelial Neoplasms: Clinical, Histologic, and Prognostic Features","year":2022,"lang":"en","type":"book-chapter","venue":"Exon Publications eBooks","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Papillary carcinoma; Medicine; Pathology; Papillary tumor; Papilloma; Urothelial carcinoma; Etiology; Internal medicine; Cancer; Bladder cancer","score_opus":0.05061585026193081,"score_gpt":0.3120663160800776,"score_spread":0.2614504658181468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282928857","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024042545,0.004111279,0.0000131716415,0.0030415843,0.00050598994,0.0018368298,0.00031794622,0.00032624547,0.9896065],"genre_scores_gemma":[0.006072564,0.0012395564,0.000692105,0.0024813614,0.00062705524,0.0006432656,0.00061798544,0.00012993992,0.98749614],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787253,0.000056598445,0.00060663885,0.0007760984,0.00040779734,0.00028032294],"domain_scores_gemma":[0.99811727,0.00023106276,0.00031230983,0.0008550981,0.00017562832,0.00030862703],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021641546,0.00041946565,0.0006523424,0.00030175626,0.00034523546,0.000072241135,0.00021180243,0.00042540143,0.003177254],"category_scores_gemma":[0.00015524088,0.0003700002,0.00027224608,0.000032798485,0.00037042703,0.00005527562,0.00018995229,0.0008955415,0.000101005535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050755695,0.00043588574,0.0057461737,0.00028166466,0.0015742873,0.00019823958,0.00041056986,2.2733236e-7,0.000034204582,0.4807875,0.28937858,0.2206451],"study_design_scores_gemma":[0.0011978112,0.0007561916,0.0055890433,0.000065848966,0.00066222064,0.0003445064,0.000015324324,0.0000010899888,0.0000073227575,0.004928245,0.98612005,0.0003123438],"about_ca_topic_score_codex":0.00004151358,"about_ca_topic_score_gemma":0.00003230639,"teacher_disagreement_score":0.69674146,"about_ca_system_score_codex":0.00017743991,"about_ca_system_score_gemma":0.0008121416,"threshold_uncertainty_score":0.9998752},"labels":[],"label_agreement":null},{"id":"W4282937006","doi":"10.1158/1538-7445.am2022-3540","title":"Abstract 3540: Effect of route of Bacillus Calmette Guerin administration on the immune microenvironment and growth of bladder tumors","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Immunotherapy; Tumor microenvironment; Urology; Immune system; CD8; Cancer; BCG vaccine; Internal medicine; Oncology; Cancer research; Immunology; Vaccination","score_opus":0.03728540451036644,"score_gpt":0.3463954640408511,"score_spread":0.30911005953048465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948365,0.0017084386,0.000001077464,0.001035914,0.000042143845,0.0007839487,0.00019829081,0.0000031531188,0.0013905171],"genre_scores_gemma":[0.9989319,0.00029035727,0.000006583746,0.000032028955,0.00003140756,0.00026108423,0.000014882688,0.000016155727,0.00041561152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984148,0.00020598671,0.00027397115,0.00019765372,0.00070662133,0.00020094261],"domain_scores_gemma":[0.9992446,0.00024318964,0.000102828286,0.00029228834,0.00005804944,0.000059088954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007711572,0.00010581104,0.0002967586,0.0001017558,0.000095408795,0.000003871095,0.00012458618,0.000027147467,0.0013748422],"category_scores_gemma":[0.000049924518,0.00007078499,0.00007654592,0.00020252734,0.00028386537,0.00002156267,0.00010038815,0.00030740758,0.0000031158195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008288477,0.0006421053,0.048391983,0.0010803585,0.00064215984,0.00006794195,0.0009889749,0.000041572166,0.9260689,0.00031717028,0.001145092,0.0123252785],"study_design_scores_gemma":[0.0016327171,0.003928694,0.19363417,0.00010893036,0.000056247096,0.000008725776,0.00015585087,0.000005672048,0.8000791,0.000031132553,0.00030988373,0.000048900565],"about_ca_topic_score_codex":0.0013826636,"about_ca_topic_score_gemma":0.000015737742,"teacher_disagreement_score":0.14524218,"about_ca_system_score_codex":0.00019084384,"about_ca_system_score_gemma":0.0002090112,"threshold_uncertainty_score":0.99953806},"labels":[],"label_agreement":null},{"id":"W4282939729","doi":"10.1158/1538-7445.am2022-2060","title":"Abstract 2060: Treatment combination strategies to improve radiation efficacy in immunologically cold tumors <i>in vivo</i>","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Sting; Bladder cancer; In vivo; Radiation therapy; Immunotherapy; Cancer research; Immune system; Cancer; Internal medicine; Immunology; Biology","score_opus":0.05512858140882753,"score_gpt":0.3949893531006022,"score_spread":0.33986077169177464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940307,0.0011956093,0.0000012729199,0.0021477947,0.00014242326,0.0020233048,0.00008123125,0.00002948178,0.00497579],"genre_scores_gemma":[0.99504745,0.00042587964,0.000013710009,0.00016247606,0.00006259756,0.0028165295,0.000025355133,0.000022220504,0.0014237883],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99813783,0.00015606656,0.00026855213,0.0003950814,0.00057262485,0.00046984828],"domain_scores_gemma":[0.9993884,0.0001257402,0.000038134873,0.00025073905,0.0000864005,0.000110603905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047495,0.00013925882,0.00026266152,0.00041488,0.00014875586,0.00004424751,0.00013985309,0.000050032773,0.0011169377],"category_scores_gemma":[0.000040361665,0.00012265945,0.00005142525,0.0008277451,0.000051061572,0.00009802503,0.00007191029,0.00040693217,0.000026992942],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006295129,0.007260414,0.030594297,0.00012922425,0.00018018948,0.00076674577,0.004777124,0.0030115105,0.8433292,0.0021136238,0.0029434087,0.09859913],"study_design_scores_gemma":[0.02068672,0.0103057455,0.7707234,0.00017713237,0.00003186442,0.000010251662,0.003761362,0.00008621817,0.16568524,0.0005073378,0.027634807,0.00038989523],"about_ca_topic_score_codex":0.0076414957,"about_ca_topic_score_gemma":0.00065575365,"teacher_disagreement_score":0.7401291,"about_ca_system_score_codex":0.0032650253,"about_ca_system_score_gemma":0.0010024025,"threshold_uncertainty_score":0.99979615},"labels":[],"label_agreement":null},{"id":"W4282939846","doi":"10.5858/arpa.2021-0409-oa","title":"Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Gynecology; Cervical cancer; Uterus; Urology; Vagina; Context (archaeology); Cervix; Proportional hazards model; Bladder cancer; Cancer; Internal medicine; Surgery","score_opus":0.012422306646235953,"score_gpt":0.2712699248526337,"score_spread":0.25884761820639773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282939846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938006,0.003527311,0.000017127933,0.0010618382,0.00017298291,0.0005478392,0.00009538068,0.000027158803,0.00074979034],"genre_scores_gemma":[0.99737394,0.0009815379,0.00034832163,0.0009312528,0.000046717865,0.00014832725,0.00001839427,0.00001984453,0.00013168668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805,0.00040116083,0.00055972167,0.00034981087,0.00034100903,0.00029832593],"domain_scores_gemma":[0.9987939,0.00049117644,0.00021999849,0.00030747824,0.00003440899,0.00015306263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004989119,0.00019115034,0.0007699144,0.00039024852,0.00006604453,8.951632e-7,0.00014847753,0.00005432054,0.00035854912],"category_scores_gemma":[0.00019777403,0.00014671653,0.000038877442,0.00034962187,0.0009510769,0.000035611396,0.0001456629,0.0003085496,5.722719e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069895794,0.0005572536,0.959327,0.0006482783,0.00016483189,0.00049398525,0.014614678,0.000005149229,0.022215355,0.00020977783,0.0000922182,0.0009725121],"study_design_scores_gemma":[0.010938019,0.0067575257,0.97419804,0.00025916658,0.00017600897,0.0000809031,0.0052554593,0.000011685251,0.0009497359,0.0006479357,0.0006116461,0.00011389063],"about_ca_topic_score_codex":0.000034184162,"about_ca_topic_score_gemma":0.000024759243,"teacher_disagreement_score":0.021265619,"about_ca_system_score_codex":0.0001341372,"about_ca_system_score_gemma":0.00047583404,"threshold_uncertainty_score":0.59829265},"labels":[],"label_agreement":null},{"id":"W4282970409","doi":"10.2217/fon-2022-0380","title":"A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an <i>in situ</i> vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trial","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Pfizer","keywords":"Medicine; Oncology; Cystectomy; Bladder cancer; Internal medicine; Radiation therapy; Clinical trial; Cisplatin; Neoadjuvant therapy; Immune checkpoint; Chemotherapy; Cancer; Immunotherapy; Breast cancer","score_opus":0.04402021379365379,"score_gpt":0.4166381891270673,"score_spread":0.3726179753334135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282970409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97818524,0.0021605873,0.000011141384,0.010599181,0.0028841256,0.0055400003,0.000074949574,0.000029189463,0.00051557814],"genre_scores_gemma":[0.98986435,0.0012669379,0.0001303595,0.0029090557,0.004456752,0.0008890537,0.00023542908,0.000042029074,0.00020601359],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973736,0.0006167334,0.00093135954,0.00048389754,0.0002681704,0.00032628136],"domain_scores_gemma":[0.9983121,0.0006032025,0.00043321613,0.00043204194,0.00007599318,0.00014342251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001151831,0.0002515893,0.0009839727,0.00014848361,0.00025212814,0.000011225048,0.00016891344,0.00020818443,0.00022546233],"category_scores_gemma":[0.00013302149,0.00017022828,0.00022095614,0.00026173345,0.00003158071,0.00008774545,0.000073047144,0.000469211,0.0000016071575],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81762147,0.012394495,0.0007249918,0.00002152614,0.00029404805,0.00005405147,0.0010919432,0.0000010394763,0.0023894492,0.00010595441,0.004485502,0.16081554],"study_design_scores_gemma":[0.6868937,0.15083925,0.0014563671,0.000007308576,0.0003436689,0.00009508879,0.00031215537,0.00007478007,0.00040886906,0.00018948894,0.15925917,0.00012018166],"about_ca_topic_score_codex":0.0001249967,"about_ca_topic_score_gemma":0.00016436586,"teacher_disagreement_score":0.16069536,"about_ca_system_score_codex":0.0001786526,"about_ca_system_score_gemma":0.0006578189,"threshold_uncertainty_score":0.6941708},"labels":[],"label_agreement":null},{"id":"W4283311019","doi":"10.1200/jco.22.00205","title":"Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Medicine; Durvalumab; Metastatic Urothelial Carcinoma; Olaparib; Urothelial cancer; Oncology; Urothelial carcinoma; Internal medicine; Multicenter trial; Multicenter study; Urology; Gynecology; Randomized controlled trial; Bladder cancer; Cancer; Immunotherapy; Nivolumab","score_opus":0.07433443946184327,"score_gpt":0.4213825141518132,"score_spread":0.34704807468996995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283311019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204385,0.0005551688,0.000078324796,0.0010568397,0.0017691961,0.0033857939,0.00006444165,0.000015611095,0.0010307904],"genre_scores_gemma":[0.99584,0.00013540531,0.0013686575,0.001267949,0.0006376074,0.00021502223,0.000038663118,0.00004750845,0.000449158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9923843,0.0021522858,0.003661177,0.00038580672,0.0009438921,0.00047253098],"domain_scores_gemma":[0.994478,0.0020831004,0.0023172365,0.00029188386,0.0003745191,0.0004552564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039878804,0.00032386833,0.003787873,0.00032667606,0.00016252273,0.000014605629,0.00025932657,0.00015638678,0.0007407921],"category_scores_gemma":[0.0023363247,0.00020929896,0.00081240945,0.00033179673,0.0002508481,0.00015421052,0.00014593551,0.0014175577,0.000009511712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93843627,0.021794703,0.022147056,0.000033752658,0.0011351941,0.00148949,0.0007581304,0.00014911061,0.00000407682,0.000015301652,0.000821285,0.013215615],"study_design_scores_gemma":[0.8917668,0.09674093,0.003150742,0.00006877373,0.0024580653,0.00018764369,0.00016293272,0.00048403876,0.000012407115,0.00007921591,0.0047214986,0.00016697508],"about_ca_topic_score_codex":0.00044271504,"about_ca_topic_score_gemma":0.00012104814,"teacher_disagreement_score":0.074946225,"about_ca_system_score_codex":0.0007843397,"about_ca_system_score_gemma":0.004306323,"threshold_uncertainty_score":0.8534964},"labels":[],"label_agreement":null},{"id":"W4283456141","doi":"10.1016/j.euf.2022.06.001","title":"Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study","year":2022,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"Rosetrees Trust; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Cancer; Dysuria; Bladder cancer; Urinary system; Malignancy; Logistic regression; Confidence interval; Internal medicine; Cystoscopy; Urology; Oncology","score_opus":0.03189758182309779,"score_gpt":0.2978459033742915,"score_spread":0.26594832155119374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283456141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896785,0.0004957039,0.0006801222,0.0015518118,0.0004368478,0.0033171868,0.0030265017,0.00006589065,0.0007474087],"genre_scores_gemma":[0.99774545,0.00002459904,0.00030047476,0.00041342215,0.00011782737,0.00087126915,0.00026974984,0.000055644312,0.00020153493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802274,0.00057025865,0.00037558773,0.00051391317,0.00024962908,0.00026785713],"domain_scores_gemma":[0.99872106,0.00061633455,0.000169521,0.00031629455,0.0001246265,0.00005216749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000392753,0.00019660055,0.00028550896,0.000073413554,0.00031473482,0.00001623598,0.0001616817,0.000032746433,0.000025854208],"category_scores_gemma":[0.00034272668,0.00013690846,0.000034183468,0.00029208246,0.000045239303,0.00008046876,0.00012408347,0.0003379199,0.000004830649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052782282,0.009145522,0.8626469,0.00002538969,0.0013062328,0.0011678879,0.03988107,0.022291904,0.000051415747,0.000041800587,0.006011833,0.0046477816],"study_design_scores_gemma":[0.025987297,0.006036219,0.9617921,0.000036658064,0.00043751625,0.000013282218,0.0008912559,0.0034343184,0.00001702429,0.000085279695,0.0011153423,0.00015370583],"about_ca_topic_score_codex":0.00040727406,"about_ca_topic_score_gemma":0.00020225282,"teacher_disagreement_score":0.09914522,"about_ca_system_score_codex":0.00026062343,"about_ca_system_score_gemma":0.00028997398,"threshold_uncertainty_score":0.5582965},"labels":[],"label_agreement":null},{"id":"W4283762101","doi":"10.3389/fonc.2022.907975","title":"A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery","year":2022,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Nomogram; Medicine; Meta-analysis; Confidence interval; Oncology; MEDLINE; Internal medicine; Systematic review","score_opus":0.0910238672182798,"score_gpt":0.37497675392547963,"score_spread":0.2839528867071998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283762101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.7397506e-7,0.9944585,0.000025957386,0.000102569495,0.00025366616,0.0046365764,0.00021131473,0.000014291759,0.0002965424],"genre_scores_gemma":[0.0000065385366,0.98962706,0.0004944052,0.0006346727,0.000016291038,0.008325011,0.00024398151,0.000042855954,0.0006091648],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962499,0.001085089,0.0016141816,0.00050963566,0.000264179,0.0002770204],"domain_scores_gemma":[0.99764246,0.00079451595,0.0008276685,0.00058283925,0.00004171535,0.00011079955],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009540916,0.0004231368,0.019790003,0.0010475358,0.000021349815,0.0000052889077,0.00013840703,0.0002511161,0.0013351383],"category_scores_gemma":[0.0003880203,0.00027657434,0.003342388,0.0015722857,0.00010714552,0.000024808418,0.00008813525,0.00036146323,0.0000038041928],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016990598,0.00020849866,0.00030636485,0.70910937,0.2672722,0.00027772988,0.000039033843,3.357769e-8,3.891072e-10,9.1799234e-7,0.0015483047,0.021220546],"study_design_scores_gemma":[0.0001084068,0.00016057209,0.000013526591,0.0145434085,0.7157201,0.00007906013,0.000017322745,7.722073e-7,3.7423793e-9,0.000004005873,0.26922253,0.00013029312],"about_ca_topic_score_codex":0.00004419203,"about_ca_topic_score_gemma":0.000025796307,"teacher_disagreement_score":0.69456595,"about_ca_system_score_codex":0.00045867864,"about_ca_system_score_gemma":0.0006617179,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4283823779","doi":"10.1002/pds.5508","title":"Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study","year":2022,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"Canadian Institutes of Health Research; National Health and Medical Research Council; University of South Australia; Medical Research Council; Australian Government","keywords":"Pioglitazone; Medicine; Demography; Medical prescription; Population; Interrupted Time Series Analysis; Interrupted time series; Diabetes mellitus; Environmental health; Type 2 diabetes; Psychological intervention; Endocrinology","score_opus":0.05851604948178138,"score_gpt":0.3759155644625878,"score_spread":0.31739951498080643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283823779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912483,0.0006587615,0.00001621961,0.0057145697,0.0005013875,0.0013944493,0.00027529467,0.000082810395,0.000108181666],"genre_scores_gemma":[0.99386877,0.00061342126,0.0000818469,0.0030154216,0.00014253361,0.00034256725,0.0001453953,0.00003648912,0.0017535394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934994,0.004464393,0.0006916144,0.00065481523,0.00021188427,0.0004778945],"domain_scores_gemma":[0.997237,0.0019811876,0.00020794345,0.00033722058,0.00004316693,0.00019347084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00363431,0.00038435814,0.0009172678,0.00022032933,0.00076082913,0.00001900952,0.0001574928,0.000064557215,0.0006653752],"category_scores_gemma":[0.0004231107,0.0002634432,0.0001267314,0.00040370692,0.00038720985,0.00026028004,0.0002292883,0.0009815713,0.000006254067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029521199,0.00074581394,0.95035166,0.000026537009,0.001311868,0.00013526989,0.012465272,0.001013208,0.0000766536,0.00054948643,0.0024219304,0.0013811168],"study_design_scores_gemma":[0.041845445,0.0012670909,0.9162752,0.0000990819,0.0021118561,0.0000810342,0.005499589,0.0025462252,0.00011238363,0.00080254866,0.028724073,0.0006354611],"about_ca_topic_score_codex":0.032634325,"about_ca_topic_score_gemma":0.0016038461,"teacher_disagreement_score":0.034076434,"about_ca_system_score_codex":0.00017812528,"about_ca_system_score_gemma":0.00007412041,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W4283835062","doi":"10.21873/anticanres.15843","title":"Can We Predict a Higher Risk of Urothelial Bladder Cancer With a Simple Blood Test?","year":2022,"lang":"en","type":"article","venue":"Anticancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Bladder cancer; Stage (stratigraphy); Logistic regression; Internal medicine; Multivariate analysis; Cancer; Urology; Cystoscopy; Oncology; Pathology; Urinary system","score_opus":0.04973368135687112,"score_gpt":0.368199827364299,"score_spread":0.3184661460074279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283835062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97480214,0.003469446,0.000008427271,0.008148416,0.00018496042,0.001981528,0.0022643888,0.00009380603,0.009046874],"genre_scores_gemma":[0.99011445,0.0019248558,0.00010138796,0.0002872847,0.00038251135,0.0011481636,0.000024478404,0.0000816483,0.0059352424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630433,0.00025855418,0.0002984053,0.000550833,0.001829488,0.00075839664],"domain_scores_gemma":[0.9983734,0.00028936556,0.00010000576,0.0006280676,0.0003479804,0.00026121415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005176908,0.00021973028,0.00045121554,0.00026577633,0.00041854865,0.000021988122,0.00028058654,0.00005676535,0.008036305],"category_scores_gemma":[0.00007544697,0.00016558381,0.00011331673,0.0010833959,0.0004246541,0.000053524498,0.00022400275,0.00086323614,0.000013223913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004069257,0.0027291276,0.9516655,0.0003132338,0.0024571766,0.000437756,0.0018237891,0.00010283794,0.008832192,0.00032464875,0.0145408325,0.012703613],"study_design_scores_gemma":[0.052530847,0.040556435,0.5528632,0.0008318399,0.0053792465,0.00034111214,0.0031020564,0.00065786234,0.084335595,0.005175629,0.25270316,0.0015230614],"about_ca_topic_score_codex":0.017927313,"about_ca_topic_score_gemma":0.0008981204,"teacher_disagreement_score":0.39880237,"about_ca_system_score_codex":0.00027636235,"about_ca_system_score_gemma":0.0018710294,"threshold_uncertainty_score":0.9928705},"labels":[],"label_agreement":null},{"id":"W4285270205","doi":"10.1177/17588359221094879","title":"The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Metastatic Urothelial Carcinoma; Medicine; Chemotherapy; Urothelial carcinoma; Oncology; Metastasis; Bone metastasis; Internal medicine; First line; Carcinoma; Cancer research; Cancer; Bladder cancer","score_opus":0.01586903876166198,"score_gpt":0.32684249620395206,"score_spread":0.3109734574422901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285270205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280125,0.0031237348,0.00039631585,0.0014052774,0.00006374551,0.0018433898,0.00006597486,0.000026839502,0.00027349818],"genre_scores_gemma":[0.9975829,0.0002902582,0.0005183535,0.0008121274,0.000028808556,0.0006288258,0.00005992549,0.000051148,0.000027637632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971331,0.00042455556,0.00061544793,0.00037177614,0.0009518234,0.00050331326],"domain_scores_gemma":[0.99799013,0.0011321475,0.00028751482,0.00033541265,0.00008979612,0.00016497652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005455213,0.00031213035,0.000913205,0.00020406414,0.00013241138,0.000004911982,0.00021493521,0.00006835027,0.0007824505],"category_scores_gemma":[0.00009494144,0.00016286947,0.00011213901,0.0007789157,0.0005111903,0.00006722774,0.000034978893,0.0005136602,0.000001583841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027988778,0.003306807,0.8084892,0.00006601062,0.0003850538,0.00029324755,0.0003623108,0.0013929042,0.000008929956,0.000027248867,0.0000076013275,0.15767193],"study_design_scores_gemma":[0.084734514,0.058056943,0.84798175,0.00020912432,0.0006207875,0.000111062705,0.0003184608,0.0018565311,0.00019473002,0.00035874578,0.0051878565,0.00036946413],"about_ca_topic_score_codex":0.0003229951,"about_ca_topic_score_gemma":0.0009605931,"teacher_disagreement_score":0.15730247,"about_ca_system_score_codex":0.0007013738,"about_ca_system_score_gemma":0.0015823637,"threshold_uncertainty_score":0.85672843},"labels":[],"label_agreement":null},{"id":"W4285384608","doi":"10.1016/j.euros.2022.06.009","title":"Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy","year":2022,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bladder cancer; Internal medicine; Oncology; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Cancer; Immune system; PD-L1; Retrospective cohort study; Logistic regression; Chemotherapy; Immunotherapy; Immunology; Biology","score_opus":0.0311077769242563,"score_gpt":0.3329999919422229,"score_spread":0.3018922150179666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285384608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557096,0.0000327546,0.0000040524606,0.0003184406,0.000037110898,0.00172688,0.000046119207,0.000022327114,0.0022413319],"genre_scores_gemma":[0.9984202,0.000007676697,0.00013090663,0.0010970961,0.000010444311,0.00020575804,0.000029377883,0.000025112742,0.00007345672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803644,0.00031988745,0.00021838468,0.0005573522,0.0005180692,0.00034987222],"domain_scores_gemma":[0.9990675,0.00011379116,0.00018357068,0.00036623937,0.00012554799,0.00014338153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003841453,0.00020334791,0.00036347195,0.00020012628,0.00022903405,0.000029967632,0.0005403402,0.000023057171,0.0002922884],"category_scores_gemma":[0.000056832636,0.00010880502,0.000047280326,0.0006514655,0.00036692442,0.0001216391,0.0001377843,0.00020562507,0.0000042010342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058170245,0.0018087087,0.9828218,0.0000017817744,0.00005842387,0.00008409709,0.0003060232,0.0013049722,0.00089414406,0.0000027993285,0.000036605452,0.006863596],"study_design_scores_gemma":[0.01403487,0.023495762,0.96049553,0.00001641685,0.00003794548,0.0000026331838,0.000027036629,0.000028179798,0.0016086736,0.0000016272118,0.00012926086,0.000122058744],"about_ca_topic_score_codex":0.0004793535,"about_ca_topic_score_gemma":0.000032792028,"teacher_disagreement_score":0.022326289,"about_ca_system_score_codex":0.00027362327,"about_ca_system_score_gemma":0.00091297366,"threshold_uncertainty_score":0.443694},"labels":[],"label_agreement":null},{"id":"W4285492644","doi":"10.1097/mou.0000000000001013","title":"Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Biomarker; Context (archaeology); Oncology; Neoadjuvant therapy; Liquid biopsy; Bladder cancer; Immunotherapy; Precision medicine; Personalized medicine; Urothelial carcinoma; Biopsy; Internal medicine; Carcinoma; Molecular biomarkers; Bioinformatics; Cancer; Pathology","score_opus":0.09049822532303331,"score_gpt":0.38688062474840174,"score_spread":0.2963823994253684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285492644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003033582,0.98408496,0.00009788819,0.00026743163,0.007936491,0.006795822,0.0004104984,0.000023873763,0.0000796528],"genre_scores_gemma":[0.0018561513,0.9937022,0.00001934669,0.00020635757,0.000455797,0.0033683043,0.00025777982,0.00010901899,0.000025088435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711865,0.000524498,0.0008676623,0.0006833845,0.00033101244,0.00047479826],"domain_scores_gemma":[0.9985097,0.00022159505,0.0003675759,0.0007113798,0.00007056417,0.00011917961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002958723,0.0004949003,0.0017012844,0.00040555757,0.00007246302,0.000007462698,0.00046317367,0.00025441244,0.0001641681],"category_scores_gemma":[0.00009151268,0.0003317986,0.00082595105,0.00065861194,0.00008538569,0.00001583503,0.00015190664,0.00046978518,0.000010418288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007072331,0.00046559933,0.00061237573,0.013190603,0.0007319002,0.000005750597,0.0002210009,0.000010237713,0.000023735915,0.00015531018,0.0046328837,0.9792434],"study_design_scores_gemma":[0.00261919,0.0015270157,0.00011331312,0.0020839737,0.00049306,0.00019461219,0.0000151458,0.000011441377,0.000018228695,0.000027456343,0.99264723,0.00024930883],"about_ca_topic_score_codex":0.000048166563,"about_ca_topic_score_gemma":0.0000016939155,"teacher_disagreement_score":0.9880144,"about_ca_system_score_codex":0.00029135263,"about_ca_system_score_gemma":0.0011907348,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4285606368","doi":"10.1016/j.urolonc.2022.06.008","title":"Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Bladder cancer; Concordance; Cohort; Oncology; Internal medicine; Retrospective cohort study; Area under the curve; Risk stratification; Risk assessment; Cancer","score_opus":0.02816320204084686,"score_gpt":0.3112616326000677,"score_spread":0.2830984305592208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285606368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941344,0.0016765385,0.000055748038,0.0070796143,0.00020556984,0.00093844073,0.0003695633,0.0000122752845,0.00024878085],"genre_scores_gemma":[0.990112,0.0043115118,0.0034910764,0.00097214256,0.00007866908,0.0006085783,0.000024142026,0.000014888178,0.00038695938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986857,0.00017076626,0.0003267846,0.00039627636,0.00018728866,0.00023317392],"domain_scores_gemma":[0.99900097,0.0003610775,0.00021162047,0.00021819878,0.000047383663,0.00016078076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002480567,0.00018588637,0.00037262344,0.00013564264,0.0003573324,0.000016583299,0.000102989434,0.00009926475,0.00009351101],"category_scores_gemma":[0.00014984206,0.00013292658,0.00003774281,0.00027096362,0.00038548515,0.00013195278,0.00013326119,0.00033369972,6.959187e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012658861,0.00022553334,0.9854366,0.000032282253,0.00012706517,0.000016464805,0.0017959137,0.0025670321,0.0021870143,0.0012742837,0.0007188141,0.0054923743],"study_design_scores_gemma":[0.007068526,0.00543451,0.8938901,0.00028082923,0.0017591916,0.00016337019,0.0030267024,0.0059570735,0.0034945563,0.031791404,0.046556156,0.00057761034],"about_ca_topic_score_codex":0.004005858,"about_ca_topic_score_gemma":0.0011134187,"teacher_disagreement_score":0.091546565,"about_ca_system_score_codex":0.00012830638,"about_ca_system_score_gemma":0.00069731567,"threshold_uncertainty_score":0.6055686},"labels":[],"label_agreement":null},{"id":"W4286295522","doi":"10.1200/jco.2022.40.16_suppl.4559","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1L chemotherapy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Chemotherapy; Carboplatin; Gemcitabine; Oncology; Progressive disease; Chemotherapy regimen; Neutropenia; Bladder cancer; Gastroenterology; Cisplatin; Urothelial carcinoma; Pembrolizumab; Cancer; Immunotherapy","score_opus":0.08168948695276965,"score_gpt":0.41989050533008004,"score_spread":0.3382010183773104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286295522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493114,0.00067954755,0.0009979083,0.04541693,0.0019438134,0.0011664997,0.0003390147,0.000019197741,0.00012573536],"genre_scores_gemma":[0.9746945,0.0002907402,0.0045844563,0.017320849,0.00076818775,0.00018517087,0.000037074813,0.00008114683,0.0020378705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948894,0.000638493,0.0027738905,0.00053429493,0.0005930388,0.0005708952],"domain_scores_gemma":[0.9931162,0.004456658,0.0011645178,0.00042397567,0.00031085074,0.00052778795],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002739735,0.00035161548,0.0022506323,0.00024533147,0.00012843864,0.000014013786,0.00043189703,0.0003099511,0.0011792091],"category_scores_gemma":[0.003182833,0.00027600638,0.00078416336,0.00027041635,0.00012783744,0.000103579274,0.00012809299,0.0010881085,0.000020993453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29998228,0.008068592,0.54008436,0.000038501163,0.0009997148,0.0016207789,0.00081361295,0.00012942459,0.00302289,0.000015138211,0.016732559,0.12849213],"study_design_scores_gemma":[0.08190148,0.03556336,0.8032546,0.000081724014,0.00037392526,0.00017266271,0.00015863405,0.00006368115,0.0006071073,0.0003635695,0.07714102,0.0003182587],"about_ca_topic_score_codex":0.00017374301,"about_ca_topic_score_gemma":0.00040542183,"teacher_disagreement_score":0.2631702,"about_ca_system_score_codex":0.0008848465,"about_ca_system_score_gemma":0.0018850621,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W4286296447","doi":"10.1200/jco.2022.40.16_suppl.4561","title":"Health-related quality of life (HRQoL) for patients with advanced/metastatic urothelial carcinoma (UC) enrolled in KEYNOTE-052 who are potentially platinum ineligible.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Discontinuation; Quality of life (healthcare); Pembrolizumab; Cisplatin; Nausea; Internal medicine; Performance status; Oncology; Clinical trial; Tolerability; Visual analogue scale; Carboplatin; Chemotherapy; Cancer; Surgery; Adverse effect; Nursing","score_opus":0.09338075154397162,"score_gpt":0.4274998481295275,"score_spread":0.3341190965855559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286296447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915846,0.0008509004,0.0002685589,0.0045815255,0.00095170125,0.0013264524,0.000171032,0.000008879601,0.00025632762],"genre_scores_gemma":[0.9931755,0.00011946831,0.0036851475,0.0024925487,0.0001990529,0.00005092093,0.000026130729,0.000039280432,0.00021194757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926418,0.0011836404,0.004680159,0.0003121982,0.0007720175,0.00041019393],"domain_scores_gemma":[0.99197716,0.0017958478,0.004946454,0.00024994244,0.0005937821,0.0004367944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033329872,0.00022934708,0.0033401777,0.00027040095,0.00010537564,0.000005006372,0.00021996298,0.00015448748,0.0001856969],"category_scores_gemma":[0.0027236142,0.00016809377,0.00054335775,0.00034012232,0.00014360613,0.00010481065,0.00008576718,0.0009969291,0.0000017489649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114697,0.007316931,0.8395232,0.0002538579,0.0007828602,0.00014765024,0.00044151326,0.0008156339,0.000023304854,0.000044331136,0.0014924039,0.034461338],"study_design_scores_gemma":[0.10034258,0.050292645,0.8454304,0.00016158533,0.0002779181,0.00003786935,0.00035462712,0.00007766421,0.000010217567,0.000519678,0.0023434677,0.00015140166],"about_ca_topic_score_codex":0.0002654753,"about_ca_topic_score_gemma":0.0001880372,"teacher_disagreement_score":0.042975713,"about_ca_system_score_codex":0.00039048394,"about_ca_system_score_gemma":0.0048961663,"threshold_uncertainty_score":0.8685589},"labels":[],"label_agreement":null},{"id":"W4286297236","doi":"10.1200/jco.2022.40.16_suppl.tps4607","title":"MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Cabozantinib; Oncology; Internal medicine; Chemotherapy; Avelumab; Maintenance therapy; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.05547294590462917,"score_gpt":0.41005076293859727,"score_spread":0.35457781703396807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286297236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918498,0.00039661632,0.00022472448,0.0027972518,0.0015531695,0.0027367165,0.00016594613,0.00000736369,0.00026840626],"genre_scores_gemma":[0.9944634,0.0006821927,0.001899314,0.0017565198,0.00043013872,0.00047923738,0.000010584707,0.000047321617,0.00023131687],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99459517,0.00082987297,0.0030138344,0.00037233796,0.0007997832,0.00038897886],"domain_scores_gemma":[0.9938825,0.0027216894,0.0025070228,0.00026372523,0.00034371164,0.00028136343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027380597,0.00030974878,0.0033875527,0.00016629152,0.00007018982,0.000008911379,0.00018993179,0.0001535571,0.0012381369],"category_scores_gemma":[0.0011899382,0.00021033865,0.0005090909,0.00026493307,0.00045941235,0.0000993053,0.000047928646,0.0009614021,0.0000014150605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96075916,0.009776956,0.0061410433,0.00005064966,0.0009175147,0.00038098724,0.00022786547,0.0001341303,0.0000033715448,0.000010236111,0.0002691729,0.021328893],"study_design_scores_gemma":[0.92638487,0.06018504,0.0073752915,0.00017960819,0.0010276599,0.000018903047,0.00005465335,0.00030624363,0.00003575168,0.00005144944,0.00420184,0.00017867633],"about_ca_topic_score_codex":0.00017121182,"about_ca_topic_score_gemma":0.00028824943,"teacher_disagreement_score":0.050408084,"about_ca_system_score_codex":0.000342597,"about_ca_system_score_gemma":0.0028802364,"threshold_uncertainty_score":0.99967486},"labels":[],"label_agreement":null},{"id":"W4286298149","doi":"10.1200/jco.2022.40.16_suppl.4564","title":"Prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma (mUC) treated with durvalumab (D) with or without tremelimumab (T) in the DANUBE study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Internal medicine; Metastatic Urothelial Carcinoma; Oncology; Post-hoc analysis; Chemotherapy; Gastroenterology; Cisplatin; Proportional hazards model; Cancer; Immunotherapy; Urothelial carcinoma; Bladder cancer; Nivolumab","score_opus":0.09915499778419397,"score_gpt":0.4290532779881926,"score_spread":0.32989828020399864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286298149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969409,0.000099454315,0.000009256658,0.00035975414,0.000063300286,0.0022166166,0.000053317497,0.0000061689457,0.00025123823],"genre_scores_gemma":[0.9987128,0.000012219164,0.0006855894,0.0002470543,0.00007175639,0.00016876179,0.000009289964,0.000046861005,0.000045679684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99365777,0.002226851,0.002151069,0.00033890887,0.001239957,0.00038542436],"domain_scores_gemma":[0.9956689,0.0015946428,0.0017463829,0.00037506915,0.00040030247,0.00021470884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028359785,0.0003282125,0.0026264659,0.00041182333,0.000071779854,0.000011645672,0.00026768012,0.00007099275,0.00025648184],"category_scores_gemma":[0.0006340569,0.0001348257,0.00027907774,0.0009482968,0.0002534523,0.00013337912,0.000051649775,0.0011482442,0.0000011519899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15319595,0.018706508,0.8155888,0.000025554908,0.0015377041,0.0030033884,0.0012185349,0.00022179558,0.000002390372,0.0000012171618,0.000046604167,0.0064515867],"study_design_scores_gemma":[0.069273464,0.22208937,0.7034818,0.00007836022,0.0024117918,0.00053341984,0.0019232803,0.000032014006,0.000005281272,0.000005302655,0.000053532585,0.000112404785],"about_ca_topic_score_codex":0.0012294885,"about_ca_topic_score_gemma":0.0019560624,"teacher_disagreement_score":0.20338285,"about_ca_system_score_codex":0.0005125173,"about_ca_system_score_gemma":0.00462485,"threshold_uncertainty_score":0.82042855},"labels":[],"label_agreement":null},{"id":"W4286298185","doi":"10.1200/jco.2022.40.16_suppl.tps4614","title":"A phase 3 study of the subcutaneous programmed cell death protein 1 inhibitor sasanlimab as single agent for patients with bacillus Calmette-Guérin, unresponsiv,e high-risk, non-muscle invasive bladder cancer: CREST Study Cohort B.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Bladder cancer; Pembrolizumab; Cystectomy; Internal medicine; Cohort; Carcinoma in situ; Oncology; Urology; Concomitant; Cancer; Surgery; Gastroenterology; Immunotherapy","score_opus":0.05761441077137525,"score_gpt":0.3880984322002823,"score_spread":0.33048402142890704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286298185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98700756,0.000097959484,0.000009806783,0.0006060997,0.001119547,0.010878535,0.00017953636,0.0000124112985,0.00008857178],"genre_scores_gemma":[0.9971253,0.000024383417,0.00037116595,0.0005466632,0.00044642316,0.0011179928,0.000010823134,0.000063550506,0.00029366597],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99393106,0.0015575278,0.0022967763,0.0004947811,0.0012814733,0.00043836498],"domain_scores_gemma":[0.9935543,0.0015726866,0.00295192,0.0005011723,0.0010652606,0.0003546777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017965,0.00033734366,0.0018302592,0.00015223808,0.00031123424,0.000017230728,0.0003980114,0.00015799928,0.00015043684],"category_scores_gemma":[0.0014982676,0.00020229332,0.00045036295,0.0003725266,0.00017497035,0.000072159164,0.00022896142,0.001181865,0.0000021695305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07867917,0.22281948,0.64927757,0.000052939846,0.0027887202,0.001371076,0.0018146426,0.00008234821,0.00034710488,6.9589885e-7,0.000837063,0.04192921],"study_design_scores_gemma":[0.13023297,0.5525438,0.30481815,0.00007022778,0.0040296544,0.00007603701,0.0038278068,0.0000105796535,0.0004948216,0.000019457888,0.0036675273,0.0002089803],"about_ca_topic_score_codex":0.0017071313,"about_ca_topic_score_gemma":0.0014444311,"teacher_disagreement_score":0.3444594,"about_ca_system_score_codex":0.0007622591,"about_ca_system_score_gemma":0.0041355113,"threshold_uncertainty_score":0.82492816},"labels":[],"label_agreement":null},{"id":"W4286298696","doi":"10.1200/jco.2022.40.16_suppl.4560","title":"Long-term outcomes in patients with advanced urothelial carcinoma (UC) who received avelumab first-line (1L) maintenance with or without second-line (2L) treatment: Exploratory analyses from JAVELIN Bladder 100.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Avelumab; Medicine; Internal medicine; Metastatic Urothelial Carcinoma; Discontinuation; Maintenance therapy; Randomization; Gemcitabine; Oncology; Bladder cancer; Surgery; Gastroenterology; Chemotherapy; Urology; Nivolumab; Randomized controlled trial; Urothelial carcinoma; Cancer; Immunotherapy","score_opus":0.1344244734599757,"score_gpt":0.4257519701847146,"score_spread":0.2913274967247389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286298696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541354,0.00040794304,0.0001685147,0.0015998587,0.00075360964,0.0010999014,0.00027094877,0.000025072752,0.00026058042],"genre_scores_gemma":[0.9923361,0.00041904495,0.001997313,0.002337619,0.0005606557,0.00013643995,0.0000856025,0.00009719404,0.0020300199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99457103,0.0006636553,0.0026066583,0.0006762804,0.00087009865,0.00061228883],"domain_scores_gemma":[0.99500734,0.001182063,0.0021281815,0.00055671786,0.0005823217,0.0005433681],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007034164,0.0005580435,0.003460245,0.00032642667,0.00017761218,0.000019373923,0.0003385177,0.00025939418,0.0020824107],"category_scores_gemma":[0.00044645282,0.00031026418,0.00047774953,0.00040379365,0.00029525196,0.00028853107,0.000111917674,0.0011995302,0.000013991475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096419126,0.0071906354,0.8658486,0.000022502776,0.0020024243,0.0021465078,0.00060257793,0.00028099882,0.000019768253,9.3396096e-7,0.00015974038,0.025306191],"study_design_scores_gemma":[0.09575445,0.08901289,0.8097873,0.00017700586,0.0013474543,0.00009726583,0.0003438921,0.00006458422,0.00013553894,0.000024707375,0.002937256,0.00031767014],"about_ca_topic_score_codex":0.00022752001,"about_ca_topic_score_gemma":0.0052109044,"teacher_disagreement_score":0.081822254,"about_ca_system_score_codex":0.0011024734,"about_ca_system_score_gemma":0.003128018,"threshold_uncertainty_score":0.999935},"labels":[],"label_agreement":null},{"id":"W4286696812","doi":"10.1097/mou.0000000000001028","title":"Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?","year":2022,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Carcinoma in situ; Inclusion and exclusion criteria; Cancer; Urology; Urinary system; Oncology; Internal medicine; Pathology; Alternative medicine","score_opus":0.20887857711291133,"score_gpt":0.44947626835735477,"score_spread":0.24059769124444344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286696812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007526678,0.9801297,0.00003792066,0.00037589335,0.012465573,0.0044089938,0.002038068,0.000058617432,0.0004776601],"genre_scores_gemma":[0.00003604141,0.98712784,0.0000220225,0.0002172767,0.0015858264,0.0077035283,0.0028818664,0.00012976454,0.0002958054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677694,0.00034455105,0.0008701804,0.0010159467,0.00029834267,0.0006940532],"domain_scores_gemma":[0.9973447,0.001101696,0.0005452699,0.0005976537,0.00010948353,0.00030124336],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025033252,0.00068473007,0.0024910357,0.00046526254,0.00013371665,0.00001436713,0.0003576225,0.00038643598,0.0028551607],"category_scores_gemma":[0.0003838519,0.00053963106,0.0006021242,0.0005171466,0.0001200528,0.00006395416,0.00019577365,0.0009909994,0.00002991642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052442314,0.00045633648,0.00015951092,0.016318802,0.0004866038,0.000018790543,0.000154985,0.000001311134,8.3868166e-8,0.00003165207,0.012984007,0.9688635],"study_design_scores_gemma":[0.0028663243,0.0013223784,0.00025134807,0.0022589907,0.0005931318,0.00007911414,0.00003917134,0.000007680996,2.717131e-7,0.000049101818,0.9920953,0.0004371904],"about_ca_topic_score_codex":0.00010995347,"about_ca_topic_score_gemma":0.00011145402,"teacher_disagreement_score":0.9791113,"about_ca_system_score_codex":0.0007099499,"about_ca_system_score_gemma":0.0048726397,"threshold_uncertainty_score":0.9997055},"labels":[],"label_agreement":null},{"id":"W4287462321","doi":"","title":"Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.","year":2021,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Cystoscopy; Gold standard (test); Resection; Radiology; Surgery; Cancer; Urinary system; Internal medicine","score_opus":0.036066552984958755,"score_gpt":0.39413035995244516,"score_spread":0.3580638069674864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287462321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7285824,0.0064101764,0.22579522,0.02223155,0.0016285607,0.011799884,0.00025617695,0.00032314096,0.0029728939],"genre_scores_gemma":[0.98573554,0.0011705117,0.0056655626,0.00028538503,0.00013287389,0.006554555,0.00011527062,0.000051198138,0.0002891198],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980408,0.00015937042,0.00055230036,0.0004978049,0.0002163311,0.00053341995],"domain_scores_gemma":[0.9988032,0.00016437341,0.00021659986,0.00026604554,0.00041583,0.000133952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004388614,0.00021211436,0.00063354196,0.00036927575,0.00009162961,0.000013088222,0.00008076435,0.00020269844,0.0001126811],"category_scores_gemma":[0.00024907422,0.00020709842,0.0001319237,0.0012224077,0.00007179869,0.00009547964,0.000022941182,0.00020854786,5.8221957e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030370355,0.0038060325,0.046893626,0.0031759045,0.002570263,0.00006616653,0.004329118,0.00019980357,0.18752412,0.0017969267,0.0018435334,0.7447575],"study_design_scores_gemma":[0.0104594845,0.0007966294,0.43027574,0.0002252436,0.00027599322,0.000017569346,0.0010363789,0.0003462578,0.55480385,0.0007408866,0.00077807467,0.00024390161],"about_ca_topic_score_codex":0.00044886646,"about_ca_topic_score_gemma":0.0046287775,"teacher_disagreement_score":0.7445136,"about_ca_system_score_codex":0.0005545895,"about_ca_system_score_gemma":0.0009831118,"threshold_uncertainty_score":0.84452283},"labels":[],"label_agreement":null},{"id":"W4287837534","doi":"10.3390/diagnostics12081801","title":"A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome","year":2022,"lang":"en","type":"article","venue":"Diagnostics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bladder cancer; Oncology; Multiplex; Medicine; Gene signature; Internal medicine; Cancer; Gene expression; Gene expression profiling; Survival analysis; Biomarker; Disease; Bioinformatics; Gene; Biology; Genetics","score_opus":0.021716441570962742,"score_gpt":0.307460816346516,"score_spread":0.28574437477555326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287837534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697595,0.021976171,0.00046711523,0.0020461073,0.0005733841,0.0022962892,0.0026916757,0.00009937026,0.00009035552],"genre_scores_gemma":[0.99290705,0.001006593,0.001089077,0.0017506592,0.00022948823,0.0021631857,0.00047571852,0.000067495064,0.00031072437],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984968,0.00006259364,0.00028354456,0.00044970636,0.00037448644,0.00033290588],"domain_scores_gemma":[0.99814165,0.0011234883,0.000089043846,0.00030795738,0.00011149848,0.00022636651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084778534,0.00026638294,0.00036003967,0.00008335658,0.00027627492,0.000031588545,0.00010251365,0.00010145662,0.00031534123],"category_scores_gemma":[0.0011847707,0.00023334782,0.00009734286,0.00013588138,0.00007410607,0.00004524547,0.00012652685,0.00027286567,0.0000013316167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014781939,0.0017122864,0.87932014,0.0009092337,0.0010230981,0.0035104111,0.0032917801,0.001511603,0.044494852,0.000298746,0.05022754,0.01222213],"study_design_scores_gemma":[0.032065358,0.013977669,0.31996077,0.00098796,0.008547698,0.0008391933,0.0029290374,0.001069709,0.554139,0.003916414,0.058759805,0.0028073825],"about_ca_topic_score_codex":0.00070129463,"about_ca_topic_score_gemma":0.00023912347,"teacher_disagreement_score":0.5593594,"about_ca_system_score_codex":0.00014943986,"about_ca_system_score_gemma":0.00025908873,"threshold_uncertainty_score":0.9515648},"labels":[],"label_agreement":null},{"id":"W4287844217","doi":"10.1016/j.urolonc.2022.06.009","title":"Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Renal pelvis; Medicine; Urology; Proportional hazards model; Odds ratio; Internal medicine; Lung; Logistic regression; Urothelial carcinoma; Ureter; Oncology; Gastroenterology; Cancer; Bladder cancer","score_opus":0.021627920050810556,"score_gpt":0.2944742899734875,"score_spread":0.27284636992267697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287844217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973493,0.00024569218,9.580749e-7,0.00051023747,0.000044223067,0.0006283339,0.00017752666,0.000009010824,0.0010347135],"genre_scores_gemma":[0.9974802,0.000011405134,0.0006512048,0.0015547121,0.000016276002,0.000098209144,0.0001029727,0.000009760084,0.00007526364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902326,0.00017853326,0.00021067266,0.00024468524,0.00018542945,0.00015740785],"domain_scores_gemma":[0.99945074,0.000114637434,0.00014010239,0.00016722441,0.000039735423,0.00008755044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015783081,0.00014439275,0.0002947148,0.00009492204,0.00016756922,0.0000062519052,0.000058810107,0.000035170586,0.00011040417],"category_scores_gemma":[0.00003675649,0.00008836371,0.000045587138,0.00019755562,0.00033384404,0.000067253095,0.000042799107,0.00029930982,5.6820875e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053817104,0.0008016201,0.99720114,0.000029864723,0.000070198774,0.000023563947,0.00037636657,0.00018674418,0.000076637465,0.00019393445,0.00018417447,0.000317595],"study_design_scores_gemma":[0.002952232,0.008005954,0.9855757,0.000016011687,0.00024347781,0.00006197485,0.000053761614,0.00007564917,0.000043977547,0.0006691492,0.0022208553,0.000081295526],"about_ca_topic_score_codex":0.00031501317,"about_ca_topic_score_gemma":0.000027183798,"teacher_disagreement_score":0.011625468,"about_ca_system_score_codex":0.00024666477,"about_ca_system_score_gemma":0.000711885,"threshold_uncertainty_score":0.36033675},"labels":[],"label_agreement":null},{"id":"W4287881306","doi":"10.1016/j.prro.2022.06.001","title":"The Rate of Prostatic Involvement in Men Treated With Radical Cystectomy for Muscle Invasive Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"Practical Radiation Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cystectomy; Urology; Lymph node; Bladder cancer; Trigone of urinary bladder; Stage (stratigraphy); Prostate; Prostate cancer; Cystoprostatectomy; Carcinoma in situ; Cancer; Radiation therapy; Carcinoma; Internal medicine; Urinary bladder","score_opus":0.03391197701353759,"score_gpt":0.3662230439552891,"score_spread":0.3323110669417515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287881306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91414213,0.0010805995,0.00043521592,0.07228222,0.00026821505,0.0071660415,0.00015424663,0.00004903156,0.004422301],"genre_scores_gemma":[0.99322647,0.0002841826,0.000486047,0.0014851395,0.0000621606,0.0040114396,0.00005619066,0.000020270982,0.0003680767],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987107,0.00033938178,0.00030765668,0.00021454901,0.00019529606,0.00023241345],"domain_scores_gemma":[0.9978919,0.0015933001,0.00019877027,0.00013990096,0.00009058577,0.00008551789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047790026,0.00010397219,0.0002756168,0.00007384591,0.00015118801,0.0000073473457,0.00005371632,0.000048647482,0.00028277107],"category_scores_gemma":[0.00040063236,0.00006801188,0.000042577165,0.00025290827,0.00011559953,0.00006632728,0.000029055347,0.00021196745,0.000002461629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11116195,0.019247323,0.35824308,0.0009946872,0.006732453,0.0012017012,0.022887325,0.0030139673,0.03221414,0.022643225,0.067273475,0.3543867],"study_design_scores_gemma":[0.08039519,0.03444534,0.23619123,0.00009160601,0.001978458,0.00017996515,0.008470297,0.0079254955,0.017818658,0.0022933085,0.60965395,0.0005564969],"about_ca_topic_score_codex":0.00060977135,"about_ca_topic_score_gemma":0.00049544265,"teacher_disagreement_score":0.54238045,"about_ca_system_score_codex":0.0008201237,"about_ca_system_score_gemma":0.0016086339,"threshold_uncertainty_score":0.30961448},"labels":[],"label_agreement":null},{"id":"W4287958183","doi":"10.1016/j.euros.2022.06.007","title":"Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment","year":2022,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Janssen Pharmaceuticals; Fonds de Recherche du Québec - Santé; Ferring Pharmaceuticals; Astellas Pharma Canada; Canadian Cancer Society Research Institute; Bayer; Cancer Research Society; AbbVie; Merck; Sanofi; Bristol-Myers Squibb; Amgen","keywords":"Enzalutamide; Immunotherapy; Medicine; Immune system; Bladder cancer; Prostate cancer; Cancer research; Cancer; Androgen receptor; Oncology; Antiandrogens; In vivo; Durvalumab; Internal medicine; Immunology; Biology; Pembrolizumab","score_opus":0.04154729608095371,"score_gpt":0.33844678900992853,"score_spread":0.29689949292897483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287958183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9177434,0.0012206681,0.00031134006,0.0060063265,0.0005403624,0.0027063945,0.00012937501,0.00008528331,0.07125689],"genre_scores_gemma":[0.9904522,0.00006349325,0.0008475653,0.004596596,0.000055133787,0.00036432318,0.000013707583,0.000041446692,0.003565568],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985408,0.00010966297,0.00015331765,0.0005528793,0.00024776135,0.00039553508],"domain_scores_gemma":[0.99927425,0.000034875007,0.000081815844,0.00041598754,0.00007379961,0.0001192706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005185021,0.00015659932,0.0002448732,0.00009937718,0.00094448024,0.00006743825,0.000671383,0.000009945415,0.0007328547],"category_scores_gemma":[0.000008903316,0.00011243635,0.000049336115,0.00038681415,0.00040146124,0.0001228267,0.00027911915,0.00009672708,0.000020832038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029096171,0.008135662,0.42899418,0.00004482834,0.0037153799,0.0025838932,0.02608232,0.003374443,0.13023327,0.006477129,0.011066339,0.3501964],"study_design_scores_gemma":[0.03505265,0.03476954,0.16428643,0.000019217556,0.0005651679,0.0012290764,0.0009214286,0.0006250567,0.009669017,0.000116682226,0.75206906,0.00067666185],"about_ca_topic_score_codex":0.00021535308,"about_ca_topic_score_gemma":0.000022774359,"teacher_disagreement_score":0.74100274,"about_ca_system_score_codex":0.0001748328,"about_ca_system_score_gemma":0.0006393368,"threshold_uncertainty_score":0.8024245},"labels":[],"label_agreement":null},{"id":"W4288010068","doi":"10.2217/cer-2022-0041","title":"A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladder","year":2022,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Alberta","funders":"","keywords":"Overactive bladder; Medicine; Urination; Accidental; Intensive care medicine; Urology; Alternative medicine; Urinary system; Internal medicine; Pathology","score_opus":0.0675549787563054,"score_gpt":0.4167074654336932,"score_spread":0.3491524866773878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288010068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95044243,0.0043312837,0.0010829542,0.021396508,0.0018691897,0.015596861,0.0034285153,0.000014442038,0.0018378107],"genre_scores_gemma":[0.993774,0.0000672365,0.0002972713,0.002661887,0.0016163064,0.0007643833,0.00021718729,0.00010589145,0.00049585593],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9944313,0.0019786377,0.000835623,0.0003652203,0.0018626951,0.0005265295],"domain_scores_gemma":[0.9875705,0.007356707,0.001544052,0.00043307204,0.0030073542,0.000088281755],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002113318,0.00035756727,0.0016617774,0.0006276603,0.00024303724,0.000022334734,0.0005225624,0.0002794287,0.00011389481],"category_scores_gemma":[0.0008033642,0.00023478136,0.0008699782,0.00052023807,0.00027283057,0.00013482998,0.00019898136,0.0023047614,7.5169845e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09222543,0.006384834,0.029348549,0.011162103,0.014620975,0.000221861,0.012548197,0.00017116465,0.02110054,0.00008782406,0.8070715,0.005057034],"study_design_scores_gemma":[0.07587979,0.092430666,0.29816198,0.01610601,0.0042250077,0.0001878684,0.0036381315,0.00028603812,0.23124734,0.00288179,0.27363676,0.0013186187],"about_ca_topic_score_codex":0.00011914264,"about_ca_topic_score_gemma":0.000007664637,"teacher_disagreement_score":0.53343475,"about_ca_system_score_codex":0.0008434035,"about_ca_system_score_gemma":0.0012207358,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4288056712","doi":"10.1016/j.mlwa.2022.100387","title":"ABC: Artificial Intelligence for Bladder Cancer grading system","year":2022,"lang":"en","type":"article","venue":"Machine Learning with Applications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Toronto General Hospital; Toronto Metropolitan University; University of Toronto","funders":"","keywords":"Grading (engineering); Computer science; Bladder cancer; Artificial intelligence; Deep learning; Residual neural network; Artificial neural network; Medical physics; Cancer; Medicine; Engineering","score_opus":0.02822631841757555,"score_gpt":0.31156437446018503,"score_spread":0.2833380560426095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288056712","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036722403,0.003227309,0.9316488,0.008390412,0.00032208362,0.008174506,0.0005573807,0.0011652785,0.009791857],"genre_scores_gemma":[0.98414975,0.000012336293,0.0032504706,0.00021831424,0.00022455433,0.010501821,0.0001667608,0.000047287627,0.0014287141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990357,0.000032354244,0.00019172776,0.0003113147,0.00021217993,0.0002167302],"domain_scores_gemma":[0.99947435,0.00006289426,0.0000944125,0.00021179291,0.00006595996,0.000090613095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012583731,0.00013263937,0.00018745434,0.000086400825,0.0008312684,0.000021799557,0.000099469245,0.000022717306,0.00028865115],"category_scores_gemma":[0.000008407008,0.00011210007,0.000062815394,0.0003423863,0.000036859194,0.0000253778,0.00003684285,0.00029019458,0.000018076784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032721264,0.0017667958,0.14612176,0.0011548409,0.0018932297,0.000045329583,0.00413682,0.07969062,0.005690899,0.17425632,0.0018200575,0.5801512],"study_design_scores_gemma":[0.0035441034,0.0041790986,0.006852668,0.00021752276,0.0024866231,0.00058923877,0.006718321,0.17034736,0.0060829185,0.0031453725,0.79453826,0.0012984965],"about_ca_topic_score_codex":0.00038671182,"about_ca_topic_score_gemma":0.000042698455,"teacher_disagreement_score":0.94742733,"about_ca_system_score_codex":0.00023050296,"about_ca_system_score_gemma":0.00012632745,"threshold_uncertainty_score":0.6393528},"labels":[],"label_agreement":null},{"id":"W4289109729","doi":"10.3390/curroncol29080430","title":"Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities; Southeast University; Natural Science Foundation of Jiangsu Province; Government of Jiangsu Province","keywords":"Metabolome; Omics; Bladder cancer; Proteome; Medicine; Metabolomics; Urine; Biomarker; Extracellular vesicles; Biomarker discovery; Internal medicine; Bioinformatics; Oncology; Cancer; Biology; Proteomics; Genetics; Gene","score_opus":0.1313193660399825,"score_gpt":0.41811570416061516,"score_spread":0.28679633812063265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289109729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983704,0.00154215,0.0064203884,0.00098052,0.0014483611,0.0050563207,0.00066379405,0.000029880901,0.00015462768],"genre_scores_gemma":[0.9943312,0.0004675125,0.000355422,0.00028012882,0.00014219036,0.0041132187,0.00012618254,0.000025015426,0.00015917061],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984266,0.0002178915,0.00041777935,0.0004122928,0.0002678165,0.00025763267],"domain_scores_gemma":[0.9980414,0.000811251,0.00034755984,0.00034043656,0.0003773753,0.00008196912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029364036,0.0002171562,0.0006542689,0.0002676164,0.00028283367,0.000008884484,0.0002346221,0.000037615846,0.00030778177],"category_scores_gemma":[0.00021493784,0.00015344785,0.00022987793,0.00066938985,0.0001318069,0.000055202272,0.00016732326,0.00030158213,0.0000028433114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053113797,0.032311104,0.4025956,0.00029906761,0.0088537475,0.0000631215,0.07013907,0.00084876857,0.0075292042,0.000052784635,0.0038120486,0.46818408],"study_design_scores_gemma":[0.027567895,0.05645679,0.8167059,0.00007327378,0.017906908,0.0000126045425,0.05119614,0.011292184,0.0043125954,0.0001326199,0.013820847,0.00052223995],"about_ca_topic_score_codex":0.0010385045,"about_ca_topic_score_gemma":0.008853673,"teacher_disagreement_score":0.46766183,"about_ca_system_score_codex":0.00078166893,"about_ca_system_score_gemma":0.0010060156,"threshold_uncertainty_score":0.62574214},"labels":[],"label_agreement":null},{"id":"W4289516878","doi":"10.3389/fonc.2022.964256","title":"Robot-assisted vs. laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysis based on comparative studies","year":2022,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Perioperative; Odds ratio; Cochrane Library; Urothelial carcinoma; Nephrectomy; Subgroup analysis; Urology; Upper urinary tract; Internal medicine; Bladder cancer; Surgery; Urinary system; Cancer; Kidney","score_opus":0.21215861985215625,"score_gpt":0.441188972184241,"score_spread":0.22903035233208477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289516878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002771336,0.98618525,0.000117666656,0.00054744084,0.0005572893,0.011709561,0.000540193,0.000033722252,0.0003060975],"genre_scores_gemma":[0.00017135509,0.9747623,0.0029584472,0.0026331758,0.000082061764,0.017944748,0.00039137772,0.000071594666,0.0009849477],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99493206,0.0019106552,0.0014342342,0.00094702997,0.0003315187,0.00044452172],"domain_scores_gemma":[0.9969931,0.0012197902,0.000854452,0.0007047349,0.00007970891,0.00014816098],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00073692686,0.0008326806,0.020048914,0.0009008931,0.00014966662,0.000015871075,0.0002554176,0.00031730466,0.00030273557],"category_scores_gemma":[0.00019872743,0.00054702535,0.0029997255,0.0008863865,0.00016762971,0.000042466556,0.00007464015,0.0006123246,0.0000047326644],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039109314,0.001415425,0.00012225202,0.7902204,0.19556485,0.00030212785,0.00030368255,0.0000040668288,1.6900962e-8,0.000004364622,0.00934197,0.0023297765],"study_design_scores_gemma":[0.0021101413,0.0037198202,0.00005136381,0.0073242593,0.73398525,0.00011602929,0.0001385474,0.000026162306,1.4136424e-7,0.00000603105,0.2522059,0.00031636946],"about_ca_topic_score_codex":0.000028689092,"about_ca_topic_score_gemma":0.000012867763,"teacher_disagreement_score":0.7828961,"about_ca_system_score_codex":0.0016568587,"about_ca_system_score_gemma":0.0008863978,"threshold_uncertainty_score":0.9996981},"labels":[],"label_agreement":null},{"id":"W4290744603","doi":"10.1111/his.14764","title":"What's new in <scp>WHO</scp> fifth edition – urinary tract","year":2022,"lang":"en","type":"review","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Cancer Research UK; Francis Crick Institute; World Health Organization","keywords":"Grading (engineering); Urinary system; Medicine; Pathology; Urinary bladder; Neuroendocrine tumors; Urology; Internal medicine; Biology","score_opus":0.06406333481412589,"score_gpt":0.34248032842415577,"score_spread":0.27841699361002986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290744603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006992454,0.9872773,0.000007004081,0.0001287864,0.0038655542,0.0010030521,0.000055156135,0.000065592685,0.007527607],"genre_scores_gemma":[0.000010279967,0.9771887,0.00007908325,0.00048836105,0.0013636928,0.00042794598,0.0006863546,0.000100608086,0.019654986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768066,0.0003106234,0.0006015833,0.00070505653,0.00026182825,0.00044025766],"domain_scores_gemma":[0.9986922,0.00025680265,0.00027713992,0.0005645539,0.000017159824,0.00019212413],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021045825,0.00046726907,0.0019733352,0.0005033341,0.00008087497,0.000018867002,0.00020090146,0.0004459486,0.0013311398],"category_scores_gemma":[0.00013315683,0.00042657103,0.00047954047,0.00036379835,0.00007959517,0.00012682851,0.000093121555,0.00093546713,0.00026334022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000195587,0.00096445903,0.000065497945,0.0044647544,0.000024963663,0.010723029,0.0010356175,1.9494132e-7,8.9794446e-7,0.00005971712,0.022843536,0.9597978],"study_design_scores_gemma":[0.0009996677,0.0013063247,0.0009155301,0.0025516616,0.0009489786,0.0075935,0.000098892386,2.2886121e-7,2.0039018e-7,0.000112321875,0.98535573,0.00011694003],"about_ca_topic_score_codex":0.00007524601,"about_ca_topic_score_gemma":0.000011394923,"teacher_disagreement_score":0.9625122,"about_ca_system_score_codex":0.0009872703,"about_ca_system_score_gemma":0.0011899372,"threshold_uncertainty_score":0.9998186},"labels":[],"label_agreement":null},{"id":"W4290805456","doi":"10.1016/j.eururo.2022.07.002","title":"The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; World Health Organization","keywords":"Medicine; Genitourinary system; Urinary system; Prostate cancer; Prostate; Epidemiology; Pathology; Terminology; Histopathology; Gynecology; Sex organ; Cancer; Urology; Internal medicine","score_opus":0.032578417910256084,"score_gpt":0.2827874383631029,"score_spread":0.2502090204528468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290805456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005836007,0.98640966,0.0000019428628,0.00047346586,0.00026824832,0.0017850983,0.00017316238,0.000035934307,0.005016453],"genre_scores_gemma":[0.08481273,0.910656,0.000009376697,0.00013589209,0.00014236655,0.000046036468,0.00019439649,0.00012633952,0.0038768705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971005,0.0013558237,0.0007394861,0.00037846612,0.00020924737,0.00021651619],"domain_scores_gemma":[0.99838364,0.00019118642,0.00080453604,0.00048133128,0.00005483155,0.00008446834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005878714,0.00025742414,0.00083494204,0.0001275495,0.0002777996,0.0000102877375,0.00019944395,0.000039448707,0.00013652291],"category_scores_gemma":[0.00006934788,0.00015664208,0.00009726161,0.0005147072,0.00024484663,0.00002960253,0.00022311042,0.00039533578,0.000006188907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012208414,0.003454789,0.051023077,0.08165904,0.0019963873,0.0020065717,0.004753037,0.0000045410543,0.00006175547,0.0025467223,0.013818939,0.8374543],"study_design_scores_gemma":[0.00078837544,0.0025981306,0.053187963,0.0011689349,0.0009324922,0.008522299,0.00029836508,0.0000045912716,0.0000022413437,0.000003768173,0.93231916,0.00017370516],"about_ca_topic_score_codex":0.000013017471,"about_ca_topic_score_gemma":0.000002570506,"teacher_disagreement_score":0.9185002,"about_ca_system_score_codex":0.0001163317,"about_ca_system_score_gemma":0.00042652042,"threshold_uncertainty_score":0.6387679},"labels":[],"label_agreement":null},{"id":"W4290805642","doi":"10.1016/j.eururo.2022.07.023","title":"Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Astellas Pharma; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Medicine; Cisplatin; Bladder cancer; Chemotherapy; Oncology; Internal medicine; Urothelial cancer; Neoadjuvant therapy; Cancer; Breast cancer","score_opus":0.017363295465902664,"score_gpt":0.31745346749032044,"score_spread":0.3000901720244178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290805642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876677,0.00023848536,0.0014004515,0.0052611167,0.00027731762,0.0014208391,0.00033342285,0.000033588996,0.003367107],"genre_scores_gemma":[0.99217474,0.0000094157895,0.0010564766,0.0059321295,0.00006660147,0.00033667436,0.00003178976,0.0000610202,0.00033115942],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984262,0.0004951601,0.00029860216,0.00035369358,0.000160623,0.00026575188],"domain_scores_gemma":[0.99930453,0.00018995734,0.00009999476,0.00026636198,0.000046845154,0.00009230297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006357732,0.00014734147,0.00030058296,0.00024830847,0.000062640785,0.000002963601,0.00013024373,0.000024683055,0.0006595353],"category_scores_gemma":[0.000039822524,0.00014111781,0.000089832116,0.00020919075,0.00005296016,0.000011859878,0.000059951908,0.00014283622,0.000004635992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15713546,0.0023659712,0.3312453,0.00010712518,0.0016540454,0.00055829476,0.0037765708,0.02656818,0.4339327,0.00007936313,0.0093030855,0.03327394],"study_design_scores_gemma":[0.0117912935,0.0077658608,0.9391755,0.000010667087,0.00012699173,0.000014211056,0.0001073043,0.0025206292,0.0011845693,0.000014458169,0.037153244,0.00013527749],"about_ca_topic_score_codex":0.00008170356,"about_ca_topic_score_gemma":0.000015264695,"teacher_disagreement_score":0.6079302,"about_ca_system_score_codex":0.00027585123,"about_ca_system_score_gemma":0.00041592366,"threshold_uncertainty_score":0.72214484},"labels":[],"label_agreement":null},{"id":"W4291202004","doi":"10.1007/s11864-022-01009-4","title":"Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now","year":2022,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; University Health Network","funders":"","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Urothelial cancer; Targeted therapy; Precision medicine; Fibroblast growth factor receptor; Oncology; Dosing; Immunotherapy; Cancer research; Internal medicine; Cancer; Chemotherapy; Bladder cancer; Fibroblast growth factor; Pathology","score_opus":0.09544036010765244,"score_gpt":0.401192488017979,"score_spread":0.3057521279103266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291202004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001776761,0.9879074,0.0000024515834,0.0019190288,0.0034880242,0.0043389522,0.00043777266,0.000039620845,0.0016890791],"genre_scores_gemma":[0.00022414507,0.98898095,0.00004333459,0.0001775068,0.0015681188,0.007399412,0.0006719737,0.00007698753,0.00085756613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99652946,0.0009281895,0.00088843337,0.0007444311,0.00031347905,0.0005960081],"domain_scores_gemma":[0.9981973,0.0005484368,0.00031359072,0.00081002456,0.000032376964,0.000098281096],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003877924,0.0006780272,0.0017568374,0.000349755,0.00036638742,0.000027126649,0.00041580488,0.00031936684,0.0014576374],"category_scores_gemma":[0.000030637824,0.0003393879,0.00069924287,0.000847511,0.00017485971,0.000043285894,0.00017354802,0.0012703111,0.00015414547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000580638,0.0020291803,0.0007630961,0.0006189827,0.00023297989,0.00017418808,0.0010305038,0.0000053576828,1.3077812e-7,0.0002232379,0.0024149197,0.99244934],"study_design_scores_gemma":[0.0027779373,0.0010536959,0.00021588057,0.0006396774,0.0010995596,0.0001886701,0.0004255996,0.000011063749,4.696248e-7,0.000045057044,0.9932951,0.00024733687],"about_ca_topic_score_codex":0.0001336554,"about_ca_topic_score_gemma":0.00033634307,"teacher_disagreement_score":0.99220204,"about_ca_system_score_codex":0.004718902,"about_ca_system_score_gemma":0.0025948796,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W4292081379","doi":"","title":"Abstracts of the Northeastern Section of the American Urological Association annual meeting, September 7-9, 2006, Ottawa, Canada.","year":2006,"lang":"en","type":"other","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Section (typography); Library science","score_opus":0.00684062072540379,"score_gpt":0.20807801553539876,"score_spread":0.20123739480999497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292081379","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1034857,0.00034402992,9.86126e-7,0.0013138195,0.0012824406,0.0016812917,0.001037359,0.000039125724,0.89081526],"genre_scores_gemma":[0.59988344,0.00000665531,0.000003842967,0.00032605237,0.00043723863,0.0001331203,0.00001569824,0.00007011176,0.39912382],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9984958,0.00011094225,0.00031395847,0.00019830381,0.00061497936,0.00026598948],"domain_scores_gemma":[0.99841696,0.000042756947,0.0010889951,0.00030624785,0.0000882953,0.00005675912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016122717,0.00018093293,0.0004015974,0.000041744974,0.000032334396,0.000003740148,0.00013938785,0.00015610967,0.000064428335],"category_scores_gemma":[0.000085539206,0.0000995375,0.00015533569,0.00020449131,0.00008748008,0.000010641652,0.00003290392,0.00023259762,0.0000014506614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003694215,0.000100476405,0.44417065,0.00004317117,0.00024537946,0.0000015614827,0.00001565192,0.000019159885,0.000004257412,7.707106e-7,0.55229104,0.003070924],"study_design_scores_gemma":[0.00035252594,0.000017339375,0.6653473,0.00002913528,0.00021577069,0.000003073574,0.000010596594,5.720531e-7,0.00012820937,0.0000019232355,0.33383805,0.00005553209],"about_ca_topic_score_codex":0.6000781,"about_ca_topic_score_gemma":0.8096326,"teacher_disagreement_score":0.49639776,"about_ca_system_score_codex":0.00031367422,"about_ca_system_score_gemma":0.00029225976,"threshold_uncertainty_score":0.40590215},"labels":[],"label_agreement":null},{"id":"W4292362048","doi":"10.4103/iju.iju_69_22","title":"Tailoring the dose of Moscow strain of intravesical bacillus Calmette-Guérin for Indian patients","year":2022,"lang":"en","type":"editorial","venue":"Indian Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urology; Bacillus (shape); Strain (injury); Microbiology; Internal medicine","score_opus":0.014407855525351978,"score_gpt":0.28039848793127387,"score_spread":0.2659906324059219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292362048","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4065689,0.0013288092,0.000054263735,0.0016035209,0.5835388,0.0016014364,0.004950184,0.000010240699,0.00034387264],"genre_scores_gemma":[0.7680327,0.00020834012,0.00022156858,0.00024492206,0.23071544,0.00005102629,0.00028721787,0.00009346051,0.00014530963],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702454,0.00023901036,0.0011812423,0.00025186816,0.0008948074,0.0004085114],"domain_scores_gemma":[0.99655235,0.00089648383,0.0014661081,0.00034868866,0.0005201145,0.00021627986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070803246,0.00031056665,0.0011834148,0.0004368983,0.00008504329,0.000009019629,0.00050563156,0.0005492255,0.00036995503],"category_scores_gemma":[0.0010098435,0.00021875193,0.00046204936,0.00020036746,0.00027872954,0.000059652364,0.000086640815,0.0015822022,0.000001721747],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02550961,0.0036063923,0.029460914,0.002116707,0.008141315,0.0028936747,0.016192652,0.000113504124,0.0008084405,0.00008834776,0.78945214,0.12161633],"study_design_scores_gemma":[0.029925525,0.0479538,0.017341511,0.0002976111,0.002832702,0.00046550806,0.0008772236,0.0000035991304,0.0007847945,0.00093207986,0.89807314,0.00051250873],"about_ca_topic_score_codex":0.00006464479,"about_ca_topic_score_gemma":0.000028300226,"teacher_disagreement_score":0.3614638,"about_ca_system_score_codex":0.00020035208,"about_ca_system_score_gemma":0.0015755824,"threshold_uncertainty_score":0.8920445},"labels":[],"label_agreement":null},{"id":"W4292670267","doi":"10.47102/annals-acadmedsg.v44n10p415","title":"Singapore Cancer Network (SCAN) Guidelines for Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer","year":2015,"lang":"en","type":"article","venue":"Annals of the Academy of Medicine Singapore","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National University Health System; National Cancer Centre of Singapore","keywords":"Medicine; Workgroup; Bladder cancer; Oncology; Cancer; Adjuvant; Neoadjuvant therapy; Chemotherapy; Internal medicine; Breast cancer","score_opus":0.2703151703745216,"score_gpt":0.455706171166357,"score_spread":0.1853910007918354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292670267","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26212415,0.10929646,0.00030074024,0.62159663,0.0012681169,0.0043702777,0.00048462898,0.000068894435,0.0004901255],"genre_scores_gemma":[0.8894967,0.020583708,0.0038235295,0.07553153,0.0071814405,0.0006225202,0.00006523417,0.00019541432,0.0024999706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974149,0.000051706877,0.00092718424,0.0004644522,0.0005958686,0.0005458753],"domain_scores_gemma":[0.9971538,0.0002784379,0.00074252253,0.00030944907,0.0011916208,0.0003241522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009277312,0.0003946029,0.0011456927,0.000099202094,0.00013519936,0.0000058478013,0.00030212762,0.00025317603,0.000057361452],"category_scores_gemma":[0.0008884491,0.00023574062,0.0002867934,0.00028758732,0.0006438894,0.00009819588,0.00007316704,0.00023812488,2.7213116e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024871898,0.00015488548,0.008662808,0.00073893846,0.0012311194,0.0000019334293,0.0023753894,0.00034530915,0.0060513653,0.00030171094,0.81096625,0.16668311],"study_design_scores_gemma":[0.0502294,0.00652562,0.058067992,0.01595685,0.004707757,0.00009365511,0.00341395,0.0018503555,0.16004473,0.03488253,0.6629989,0.001228211],"about_ca_topic_score_codex":0.00073634344,"about_ca_topic_score_gemma":0.00008873529,"teacher_disagreement_score":0.6273725,"about_ca_system_score_codex":0.000055798122,"about_ca_system_score_gemma":0.0005745557,"threshold_uncertainty_score":0.96132237},"labels":[],"label_agreement":null},{"id":"W4292737523","doi":"10.2196/37518","title":"Perceived Unmet Needs in Patients Living With Advanced Bladder Cancer and Their Caregivers: Infodemiology Study Using Data From Social Media in the United States","year":2022,"lang":"en","type":"article","venue":"JMIR Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Merck KGaA; Pfizer","keywords":"Social media; Medicine; Content analysis; Family medicine; Social support; Psychology; Psychotherapist","score_opus":0.054126474813610145,"score_gpt":0.3359725983212922,"score_spread":0.28184612350768207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292737523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966282,0.0006714528,0.0000017117986,0.00036471037,0.00014296419,0.0011505723,0.0009876599,0.000018184666,0.00003450119],"genre_scores_gemma":[0.99739647,0.00022017526,0.000016510949,0.0010899509,0.000119329176,0.00065727945,0.00045449502,0.00003234327,0.000013473508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844974,0.0003044366,0.00024004371,0.00039804165,0.00029483106,0.0003129143],"domain_scores_gemma":[0.99918675,0.00024152418,0.00011081101,0.0003492235,0.00005942958,0.000052286334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016638785,0.00022777659,0.00040635906,0.0002446986,0.000180851,0.000017157508,0.000268143,0.000049896687,0.00035372272],"category_scores_gemma":[0.000025904536,0.00014910863,0.000021775357,0.0007283362,0.00009966481,0.00014939504,0.00026039203,0.0003927516,3.7339137e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006045438,0.0004376264,0.8161755,0.00001128036,0.00018207094,0.000014195085,0.1792106,0.0005096404,0.000031871205,7.3878624e-7,0.00032765043,0.002494247],"study_design_scores_gemma":[0.006064508,0.00039675017,0.84774476,0.000066703986,0.00012629508,0.0000012193678,0.14395605,0.00071960106,0.0000018496177,0.0000118253865,0.0007494531,0.00016098676],"about_ca_topic_score_codex":0.026549991,"about_ca_topic_score_gemma":0.021523751,"teacher_disagreement_score":0.03525455,"about_ca_system_score_codex":0.0005087495,"about_ca_system_score_gemma":0.00026228864,"threshold_uncertainty_score":0.9963309},"labels":[],"label_agreement":null},{"id":"W4293053632","doi":"10.1002/btm2.10353","title":"(Nano)platforms in bladder cancer therapy: Challenges and opportunities","year":2022,"lang":"en","type":"review","venue":"Bioengineering & Translational Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Science Foundation of Hubei Province","keywords":"Nanocarriers; Bladder cancer; Nanomedicine; Photothermal therapy; Medicine; Cancer research; Immunotherapy; Tumor microenvironment; Cancer; Cancer cell; Microvesicles; Immune system; microRNA; Internal medicine; Nanotechnology; Immunology; Tumor cells; Pharmacology; Biology; Materials science; Nanoparticle; Drug","score_opus":0.2309023687872812,"score_gpt":0.3596162214632514,"score_spread":0.1287138526759702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293053632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002547029,0.99552286,0.000014390898,0.0015447215,0.00040176057,0.0008881802,0.00011327434,0.00007275476,0.0014165771],"genre_scores_gemma":[0.00029063178,0.99747723,0.000051474282,0.00016901219,0.00044590104,0.0006392872,0.00041981932,0.000097561555,0.0004090659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982341,0.000023770683,0.00055472687,0.0004190743,0.00047124483,0.00029708556],"domain_scores_gemma":[0.9993719,0.00015817814,0.000092635244,0.00021216499,0.000024880712,0.00014026975],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020371839,0.00049525127,0.0014485698,0.0005287888,0.00004847819,0.0000053200556,0.00009931679,0.00018670654,0.0016659709],"category_scores_gemma":[0.00001119044,0.00034945525,0.00015933638,0.0001834395,0.00010093836,0.000072277544,0.000017120143,0.00041335923,0.0000021267049],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004134253,0.00005776458,0.000009331842,0.0051267077,0.00046218128,0.0000598228,0.0006361999,0.000005163004,0.0000017958355,0.0005687946,0.000053902255,0.992977],"study_design_scores_gemma":[0.0019325052,0.00032186136,0.00032056976,0.006847101,0.0006001922,0.00014874933,0.00007925983,0.000021810656,6.572412e-7,0.000071928494,0.98936504,0.00029029802],"about_ca_topic_score_codex":0.00008529129,"about_ca_topic_score_gemma":0.000017162101,"teacher_disagreement_score":0.9926867,"about_ca_system_score_codex":0.00013072626,"about_ca_system_score_gemma":0.00037372575,"threshold_uncertainty_score":0.99989575},"labels":[],"label_agreement":null},{"id":"W4293115705","doi":"10.22374/jeleu.v5i1.142","title":"Urethral Surveillance after Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Urology; Medicine; General surgery; Internal medicine; Bladder cancer","score_opus":0.011175754680613539,"score_gpt":0.26832603638933356,"score_spread":0.25715028170872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293115705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98700005,0.0036896756,0.00017835498,0.0047724214,0.0013020223,0.00020036749,0.000030864994,0.000019030605,0.00280719],"genre_scores_gemma":[0.99619174,0.00004341967,0.0004822815,0.0019122337,0.0007581093,0.000032423603,0.000004067993,0.000024666675,0.00055106106],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982672,0.00026827859,0.00046486015,0.00017073489,0.0004992674,0.00032968182],"domain_scores_gemma":[0.99914664,0.00010048893,0.00026044392,0.00017768558,0.00010676535,0.00020798943],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043939345,0.00014933849,0.00051897595,0.00019744858,0.000096853684,0.000007794458,0.00015985071,0.000058639656,0.0027439795],"category_scores_gemma":[0.00008496089,0.00012479864,0.00028432463,0.00016625639,0.0001309273,0.00005637104,0.00008222584,0.00080431066,0.000015436473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07579501,0.0032565356,0.7969159,0.00019019708,0.0022577601,0.05989331,0.001984957,0.00040494086,0.010625418,0.0005285763,0.03003333,0.018114068],"study_design_scores_gemma":[0.027049033,0.021879962,0.28902754,0.00003221855,0.00062291214,0.13922855,0.0003946969,0.00011003139,0.0009976482,0.0005679816,0.5196985,0.00039092512],"about_ca_topic_score_codex":0.000022439508,"about_ca_topic_score_gemma":0.000006447668,"teacher_disagreement_score":0.5078883,"about_ca_system_score_codex":0.00015181841,"about_ca_system_score_gemma":0.00032170684,"threshold_uncertainty_score":0.99816763},"labels":[],"label_agreement":null},{"id":"W4293225666","doi":"10.21203/rs.3.rs-1322840/v1","title":"Cancer Genomic Profiling Identified Dihydropyrimidine Dehydrogenase Deficiency in Bladder Cancer Promotes Vulnerability to Gemcitabine","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Research Promotion Foundation","keywords":"Gemcitabine; DPYD; Bladder cancer; Dihydropyrimidine dehydrogenase; Cancer research; Biology; Oncology; Exome sequencing; Cancer; Internal medicine; Medicine; Gene; Pharmacogenetics; Genetics; Thymidylate synthase; Fluorouracil; Mutation","score_opus":0.10115704034716382,"score_gpt":0.4478474838909288,"score_spread":0.346690443543765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293225666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707235,0.0134704895,0.000022095826,0.0031043119,0.0006430039,0.00908665,0.0013148226,0.0001474099,0.0014877032],"genre_scores_gemma":[0.97955936,0.0014442138,0.00030051658,0.00020115923,0.0005948759,0.014859392,0.00044875845,0.00018060334,0.0024111453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99231064,0.0007790333,0.00092572987,0.0021120796,0.002229517,0.0016430103],"domain_scores_gemma":[0.9966351,0.00020553784,0.00015368129,0.001626314,0.0006887478,0.00069061614],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002292977,0.00065420684,0.0010978938,0.0011713316,0.00047094378,0.00015029564,0.00073121,0.00035868853,0.006096924],"category_scores_gemma":[0.0005075504,0.00059680286,0.00034228584,0.0016091809,0.00021230475,0.00010532703,0.0022878787,0.0032178238,0.00008381543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066888956,0.006413605,0.7815106,0.014658572,0.0013195933,0.0016831887,0.0087360535,0.021030208,0.13483293,0.0001891825,0.0037528093,0.019184384],"study_design_scores_gemma":[0.019690916,0.0051316856,0.6759022,0.008396913,0.0013798379,0.00007853694,0.004083752,0.0091889165,0.25607035,0.005366161,0.010205021,0.0045057195],"about_ca_topic_score_codex":0.022122368,"about_ca_topic_score_gemma":0.005067152,"teacher_disagreement_score":0.12123741,"about_ca_system_score_codex":0.0049329293,"about_ca_system_score_gemma":0.004134742,"threshold_uncertainty_score":0.99964833},"labels":[],"label_agreement":null},{"id":"W4293741182","doi":"10.5489/cuaj.8008","title":"Impact of exercise on physical health status in bladder cancer patients","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Odds ratio; Confidence interval; Logistic regression; Behavioral Risk Factor Surveillance System; Cancer; Physical therapy; Physical exercise; Cross-sectional study; Internal medicine; Public health; Pathology","score_opus":0.014933386991181819,"score_gpt":0.29833972300231615,"score_spread":0.28340633601113435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293741182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951341,0.0002057051,3.5205798e-7,0.0033016629,0.0001773087,0.00025686363,0.00040426684,0.000005901979,0.0005138441],"genre_scores_gemma":[0.9979121,0.000110194225,0.0000059100075,0.00165008,0.00010179207,0.000033268072,0.00003784336,0.000010983019,0.00013784396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998498,0.00016145007,0.00025690973,0.00014452999,0.0004487386,0.0004903417],"domain_scores_gemma":[0.99894536,0.00004399133,0.0002359053,0.00006884425,0.00010532752,0.0006005731],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019975519,0.00010885987,0.00032835535,0.00020635285,0.00016718182,0.000011055378,0.0000642564,0.00004915417,0.0013926065],"category_scores_gemma":[0.00007986098,0.00008458104,0.00016567577,0.00027332615,0.000013136947,0.00003620055,0.000012655577,0.0005365526,0.0000066769644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025365723,0.0005705372,0.98435223,0.0000025702032,0.00009417482,0.000014516797,0.00047432302,0.0005131733,0.000004915054,0.000009054933,0.007832152,0.0058787013],"study_design_scores_gemma":[0.0025583447,0.0030636373,0.9921356,0.000011778095,0.000034083612,0.000003380369,0.00004171256,0.000057748697,0.0000029919795,0.00015093153,0.0018740743,0.000065759],"about_ca_topic_score_codex":0.023571651,"about_ca_topic_score_gemma":0.0009556634,"teacher_disagreement_score":0.022615988,"about_ca_system_score_codex":0.006361855,"about_ca_system_score_gemma":0.0020240166,"threshold_uncertainty_score":0.99952024},"labels":[],"label_agreement":null},{"id":"W4293792795","doi":"10.1097/cu9.0000000000000113","title":"Comparison of survival outcomes between laparoscopic versus open radical nephroureterectomy in upper tract urothelial cancer patients: Experiences of a tertiary care single center","year":2022,"lang":"en","type":"article","venue":"Current Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Single Center; Laparoscopy; Surgery; Retrospective cohort study; Nephrectomy; Urology; Internal medicine; Kidney","score_opus":0.06889796755908692,"score_gpt":0.396696907955546,"score_spread":0.32779894039645907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293792795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948058,0.0015383288,0.0000031254633,0.00018650977,0.0021707555,0.00072471093,0.0002802632,0.00001118791,0.00027929616],"genre_scores_gemma":[0.99923563,0.000016034528,0.000018504708,0.0000910311,0.00007925086,0.00033159376,0.0001996251,0.000018991163,0.00000932121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982966,0.00024201226,0.00051859545,0.00032512366,0.00033051698,0.000287136],"domain_scores_gemma":[0.99934566,0.00011732619,0.00019044243,0.00020937838,0.000053615437,0.00008359579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000691836,0.00018360454,0.0008130304,0.00013378721,0.000057376714,0.0000064957276,0.00031893063,0.00006412935,0.00083652977],"category_scores_gemma":[0.000031930707,0.00015562076,0.000117148,0.00014720748,0.00017030176,0.00006903652,0.00025449414,0.00028485872,0.0000014328388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013047337,0.0020579959,0.9726365,0.000062053725,0.00009284013,0.0000029889711,0.016735502,0.000004954777,0.000071382114,0.000004786617,0.00015089272,0.006875343],"study_design_scores_gemma":[0.02102762,0.0038047258,0.9589421,0.00003968359,0.00021777747,0.0000012317453,0.0042789313,0.000009986633,0.0017322012,0.0000068239005,0.009768431,0.00017049882],"about_ca_topic_score_codex":0.00034388324,"about_ca_topic_score_gemma":0.00006318087,"teacher_disagreement_score":0.019722886,"about_ca_system_score_codex":0.00016664606,"about_ca_system_score_gemma":0.00019162903,"threshold_uncertainty_score":0.9159414},"labels":[],"label_agreement":null},{"id":"W4294266603","doi":"10.1056/evidoa2200092","title":"A Randomized Trial of PHOTOdynamic Surgery in Non–Muscle-Invasive Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"NEJM Evidence","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Medicine; Bladder cancer; Hazard ratio; Confidence interval; Randomized controlled trial; Cystectomy; Adverse effect; Surgery; Cancer; Urology; Internal medicine","score_opus":0.043052766407140786,"score_gpt":0.3312416262031483,"score_spread":0.2881888597960075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294266603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257576,0.0026839732,0.000013882695,0.0010280686,0.00071408274,0.0022961523,0.000027183269,0.000023685949,0.00063721027],"genre_scores_gemma":[0.9944565,0.0018802899,0.000029274232,0.0006771298,0.0001396164,0.0021410133,0.000008774582,0.000024892142,0.00064250384],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980122,0.00031082536,0.000540773,0.00033245297,0.0005410857,0.0002627011],"domain_scores_gemma":[0.9978001,0.0015117064,0.00020899398,0.0003248568,0.00007287276,0.000081478705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008525919,0.00016955988,0.00094791513,0.00021826098,0.000060906794,0.000005231895,0.00012447948,0.000047453465,0.0015255818],"category_scores_gemma":[0.00062533794,0.00014464474,0.00033502103,0.0004670244,0.000108837274,0.00010696455,0.00007934834,0.00023844764,0.000008546623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9807885,0.00049335463,0.005461612,0.00017557407,0.00025008142,0.00013821575,0.0011439661,0.00010625783,0.005697243,0.000011613643,0.0012111306,0.0045224354],"study_design_scores_gemma":[0.9839396,0.000644478,0.009118811,0.00081717945,0.00046932776,0.00002183419,0.00025244066,0.00031860895,0.0038090267,0.00015091494,0.00023687174,0.00022092898],"about_ca_topic_score_codex":0.0048722923,"about_ca_topic_score_gemma":0.00037774222,"teacher_disagreement_score":0.00449455,"about_ca_system_score_codex":0.00028446683,"about_ca_system_score_gemma":0.0010065405,"threshold_uncertainty_score":0.99938715},"labels":[],"label_agreement":null},{"id":"W4295253878","doi":"10.1007/bf03262051","title":"Allelic Deletion Fingerprinting of Urine Cell Sediments in Bladder Cancer","year":2001,"lang":"en","type":"article","venue":"Molecular Diagnosis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Bladder cancer; Urine cytology; Urine; Biology; Allele; Microsatellite; Cancer; Genotype; Cytology; Pathology; Medicine; Genetics; Gene","score_opus":0.014142908494452369,"score_gpt":0.2840923585427628,"score_spread":0.26994945004831045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295253878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930289,0.0022216837,0.00026790614,0.0010024583,0.00007523975,0.00035434403,0.000007788654,0.000022150478,0.0030195746],"genre_scores_gemma":[0.9966617,0.001301283,0.000366069,0.0011510823,0.000046142308,0.0002698862,0.000011492241,0.000027937007,0.00016441228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902356,0.000031787342,0.00024057773,0.00024039236,0.00023287763,0.00023082565],"domain_scores_gemma":[0.99957395,0.000024511546,0.00006879807,0.00020313088,0.00005464394,0.000074993004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006941865,0.00013749082,0.00023917187,0.00012835705,0.000019839577,0.0000055810274,0.00006134685,0.0000684295,0.00057794404],"category_scores_gemma":[0.000020968726,0.00013254011,0.00009416724,0.00025948934,0.000022701986,0.00003595261,0.000028016073,0.00009785665,0.000019595822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112000154,0.00089725276,0.95435375,0.00008115859,0.00015307151,0.0002738932,0.000223323,0.00026775146,0.030161187,0.000008680605,0.00056318205,0.012904722],"study_design_scores_gemma":[0.006207596,0.0003727463,0.5616323,0.0003250557,0.00035295493,0.000014729118,0.000045415727,0.00017296398,0.42353207,0.000055341243,0.007036849,0.00025203844],"about_ca_topic_score_codex":0.0014609126,"about_ca_topic_score_gemma":0.000083040366,"teacher_disagreement_score":0.39337087,"about_ca_system_score_codex":0.00009970129,"about_ca_system_score_gemma":0.000057843008,"threshold_uncertainty_score":0.6328082},"labels":[],"label_agreement":null},{"id":"W4295745238","doi":"10.3389/fonc.2022.973402","title":"Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Terry Fox Research Institute; Surrey Place Centre","funders":"","keywords":"Immune system; CXCR4; Mass cytometry; Nivolumab; Immune checkpoint; Chemokine; Immunology; Cancer research; Medicine; Chemokine receptor; Flow cytometry; Immunotherapy; Pembrolizumab; CCR4; Internal medicine; Biology","score_opus":0.011916782714233942,"score_gpt":0.25911451839009547,"score_spread":0.24719773567586154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295745238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348027,0.0014891624,0.00027947497,0.00015938518,0.0011365757,0.0013898371,0.000083284656,0.000028993682,0.0019530425],"genre_scores_gemma":[0.97677916,0.00007973927,0.021978796,0.00012617582,0.000067336856,0.00029564212,0.00011571067,0.00005092505,0.0005065339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980896,0.00019071283,0.0005905305,0.00038959214,0.000336888,0.0004026533],"domain_scores_gemma":[0.9990811,0.00007651593,0.00031860764,0.00033381555,0.00010559202,0.000084383544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013909258,0.00023466082,0.0008117422,0.00023957084,0.00012680054,0.0000032733471,0.00018139428,0.00009792183,0.0002856966],"category_scores_gemma":[0.00003605268,0.00019041293,0.00010975767,0.00036587814,0.00014294557,0.00005417584,0.00015097497,0.00048503675,0.0000018516643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061365984,0.004562342,0.79604036,0.00046531757,0.00044774736,0.0006106827,0.0047278632,0.00090690487,0.07497789,0.0000053649514,0.0005096189,0.055379916],"study_design_scores_gemma":[0.064523056,0.029886173,0.6324064,0.00014329575,0.00048757842,0.00008792845,0.0068991655,0.00036212045,0.2300236,0.000088325716,0.034432434,0.00065994175],"about_ca_topic_score_codex":0.00014700949,"about_ca_topic_score_gemma":0.000010100054,"teacher_disagreement_score":0.16363397,"about_ca_system_score_codex":0.0008381314,"about_ca_system_score_gemma":0.0006985635,"threshold_uncertainty_score":0.7764814},"labels":[],"label_agreement":null},{"id":"W4295797277","doi":"10.1016/j.clon.2022.08.026","title":"Bladder Cancer: New Insights Into Dose, Volume and Prognostic Biomarkers","year":2022,"lang":"en","type":"editorial","venue":"Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bladder cancer; Radiation therapy; Cancer; Oncology; Internal medicine; Urology","score_opus":0.04717104169531845,"score_gpt":0.4151838043681179,"score_spread":0.3680127626727995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295797277","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044296486,0.01973775,0.000008181307,0.0048144194,0.9626772,0.001533391,0.0001021853,0.0001417703,0.0065554613],"genre_scores_gemma":[0.002143223,0.02018192,0.000586418,0.001997082,0.9498934,0.00052495307,0.00082503736,0.0001526181,0.023695316],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960876,0.0004327175,0.0011895427,0.0011750377,0.0006445156,0.00047055018],"domain_scores_gemma":[0.99500966,0.0029311483,0.00048774848,0.0005440353,0.0002048076,0.0008225867],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045803853,0.0004887985,0.0018631995,0.00017151763,0.00017178737,0.000025841166,0.00027740616,0.0020054956,0.0032807658],"category_scores_gemma":[0.0026615225,0.0004053726,0.00036338577,0.00026393082,0.00053397473,0.000058503683,0.00037671987,0.0021378496,0.00011936031],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018060348,0.0006368556,0.009706276,0.00011910375,0.0016873672,0.0004773149,0.0001997024,2.1411753e-7,0.0000028565426,0.000005365903,0.8555566,0.12980227],"study_design_scores_gemma":[0.009473158,0.009178701,0.010936094,0.00011140133,0.002502601,0.000013743267,0.000054819535,0.000012081596,0.000001306244,0.00037371606,0.96699625,0.00034610913],"about_ca_topic_score_codex":0.0029754736,"about_ca_topic_score_gemma":0.0010866097,"teacher_disagreement_score":0.12945616,"about_ca_system_score_codex":0.00080610445,"about_ca_system_score_gemma":0.010927248,"threshold_uncertainty_score":0.99983984},"labels":[],"label_agreement":null},{"id":"W4295836740","doi":"10.1016/j.annonc.2022.07.1838","title":"1760P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Results from patients with ≥12 mo of treatment in JAVELIN Bladder 100","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Bavarian Nordic; Astellas Pharma; Genentech; UroGen Pharma; Foundation Medicine; Silverback Therapeutics; Mirati Therapeutics; Regeneron Pharmaceuticals; Gilead Sciences; Exelixis; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Javelin; Internal medicine; Chemotherapy; Maintenance therapy; Oncology; Urology; Gastroenterology; Bladder cancer; Urothelial carcinoma; Immunotherapy; Cancer; Nivolumab","score_opus":0.05196338569092701,"score_gpt":0.32916951755272655,"score_spread":0.27720613186179954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891016,0.00029504398,0.00006688518,0.0023322466,0.00020986059,0.0020202235,0.0042358604,0.000017068409,0.0017211934],"genre_scores_gemma":[0.9956649,0.00017409143,0.0012993343,0.00074042444,0.000094471296,0.000598816,0.0005504524,0.000043546694,0.000833979],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979674,0.000095418174,0.0007173106,0.00049443304,0.00027681162,0.00044862196],"domain_scores_gemma":[0.9985145,0.00030409495,0.00041282098,0.00037221063,0.00028349907,0.00011291874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001792049,0.00026287,0.0008622709,0.00017222307,0.00008300752,0.0000022414783,0.00015048565,0.00010315037,0.00016990372],"category_scores_gemma":[0.000109385306,0.00020635057,0.00016913512,0.00019196444,0.000120581746,0.000055107757,0.00007108416,0.00014154262,0.0000034178433],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32966712,0.02855353,0.22302419,0.00029613188,0.0027743194,0.00036464678,0.014214084,0.005425385,0.003079269,0.0002581291,0.009435917,0.38290727],"study_design_scores_gemma":[0.24806602,0.21478459,0.34400418,0.00028687777,0.0008142837,0.000027762266,0.0015746274,0.0008535309,0.030601824,0.0012673984,0.15691808,0.00080081896],"about_ca_topic_score_codex":0.0030192966,"about_ca_topic_score_gemma":0.0014561302,"teacher_disagreement_score":0.38210645,"about_ca_system_score_codex":0.00039407,"about_ca_system_score_gemma":0.00066168624,"threshold_uncertainty_score":0.8414732},"labels":[],"label_agreement":null},{"id":"W4295836765","doi":"10.1016/j.annonc.2022.07.1832","title":"1754P Association between body mass index (BMI) and anti-PD1/L1 immune checkpoint inhibitor (ICI) outcomes in patients with metastatic urothelial carcinoma (mUC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto East General Hospital; University Health Network; Princess Margaret Cancer Centre; St Mary's Hospital Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Body mass index; Proportional hazards model; Cancer; Oncology; Cohort; Multivariate analysis; Retrospective cohort study","score_opus":0.03412157097411946,"score_gpt":0.31900852576909955,"score_spread":0.2848869547949801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952948,0.00012600327,0.0000070909305,0.0024372684,0.0001680606,0.00075588445,0.0002653109,0.000017512337,0.0009280844],"genre_scores_gemma":[0.9987623,0.00002300013,0.000106637985,0.00046799044,0.00006454462,0.00013404171,0.00009116033,0.000030398522,0.00031990258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980999,0.00024589078,0.00054885825,0.00029052168,0.0004627106,0.0003520959],"domain_scores_gemma":[0.99896556,0.00019327621,0.00039008903,0.00019743112,0.0001535521,0.00010011031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046432743,0.0002008328,0.00090003054,0.00023194228,0.00008338042,0.000006987215,0.00009228795,0.000089833615,0.00016489526],"category_scores_gemma":[0.00011426006,0.00016625978,0.000099226025,0.00022976696,0.00007508865,0.000085807515,0.00009284163,0.0003034356,0.0000044236194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008697809,0.0009198789,0.99424493,0.000047714922,0.0005268379,0.000039327457,0.00031907644,0.0000059684644,0.00035639125,0.0000100549605,0.00017740505,0.0024826345],"study_design_scores_gemma":[0.011119942,0.0056232037,0.97845685,0.000020780024,0.00027964002,0.0000035878336,0.00022860745,0.000009096571,0.0027218729,0.00009192555,0.0013035742,0.00014093671],"about_ca_topic_score_codex":0.00082737673,"about_ca_topic_score_gemma":0.000037851234,"teacher_disagreement_score":0.015788097,"about_ca_system_score_codex":0.00030111117,"about_ca_system_score_gemma":0.00035403643,"threshold_uncertainty_score":0.6779877},"labels":[],"label_agreement":null},{"id":"W4295836972","doi":"10.1016/j.annonc.2022.07.1813","title":"1735O PD-L1 expression on immune cells by SP142 co-localises with dendritic cells and is associated with improved overall survival (OS) with atezolizumab in patients with untreated metastatic urothelial cancer (mUC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Immune system; Urothelial cancer; Dendritic cell; Cancer research; Cancer; Pathology; Oncology; Immunotherapy; Immunology; Internal medicine; Bladder cancer; Nivolumab","score_opus":0.023912725500981502,"score_gpt":0.304654174116137,"score_spread":0.2807414486151555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947996,0.0002764342,0.000009648912,0.0004741377,0.00007571713,0.0013809828,0.0019517392,0.000033887216,0.000997843],"genre_scores_gemma":[0.9971324,0.00016840626,0.00009514534,0.0012252277,0.000018365441,0.00036435892,0.00028565028,0.000086556975,0.00062385877],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974185,0.00035397816,0.0004258,0.0005869453,0.00064088264,0.0005738902],"domain_scores_gemma":[0.998579,0.00022928076,0.00041058796,0.00031219926,0.00027459985,0.00019429196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017756292,0.00043370927,0.0010878997,0.00018584094,0.00014989726,0.000016504922,0.00013521881,0.00010120892,0.0005071469],"category_scores_gemma":[0.000015162211,0.00027741064,0.000052519208,0.0003344942,0.00027129936,0.00009757045,0.00005178948,0.0003717014,0.000002476098],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40137935,0.027256055,0.4325084,0.0007590881,0.009258747,0.002339335,0.007224882,0.0016701714,0.08338412,0.000034106597,0.017361112,0.016824616],"study_design_scores_gemma":[0.1284683,0.15647227,0.16341497,0.0016618058,0.0021121595,0.000060690178,0.0011001386,0.00018349898,0.5405314,0.000035738114,0.0045828214,0.001376183],"about_ca_topic_score_codex":0.003910431,"about_ca_topic_score_gemma":0.0006729813,"teacher_disagreement_score":0.4571473,"about_ca_system_score_codex":0.0002917766,"about_ca_system_score_gemma":0.00068428105,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W4295837070","doi":"10.1016/j.annonc.2022.07.1826","title":"1748P 4-factor model to predict response and survival benefit with durvalumab (D) in previously treated metastatic urinary tract carcinoma (mUTC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Durvalumab; Oncology; Internal medicine; Urinary system; Carcinoma; Urology; Cancer; Immunotherapy","score_opus":0.09783277607515922,"score_gpt":0.36873355237687655,"score_spread":0.2709007763017173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939991,0.0006860525,0.000011117062,0.0028057115,0.000042907413,0.00097332086,0.00027367813,0.000025096899,0.0011830156],"genre_scores_gemma":[0.9973742,0.000082782964,0.00027872925,0.0008373086,0.00001851458,0.00025743362,0.000028647324,0.000033834975,0.0010885658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982981,0.00033107094,0.00035257754,0.0003651449,0.00030028826,0.00035281913],"domain_scores_gemma":[0.99908453,0.0002261254,0.000110553054,0.000273841,0.00009288744,0.00021208328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004687198,0.00019977005,0.00067840394,0.00027578013,0.0000678235,0.0000043483633,0.00010082091,0.00005367108,0.00018038467],"category_scores_gemma":[0.000060836443,0.00016530084,0.000068979825,0.00029114334,0.000069191665,0.000063538966,0.0000829611,0.00020620097,0.000002215429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17404838,0.012466046,0.742927,0.00031890013,0.0009869633,0.006346095,0.014153568,0.0037586123,0.0030755182,0.00009266395,0.0013730025,0.040453233],"study_design_scores_gemma":[0.011544573,0.07934428,0.90209925,0.00005420938,0.0003064266,0.00094897964,0.0006816305,0.0011629784,0.0011274177,0.00014290238,0.0023498104,0.00023751521],"about_ca_topic_score_codex":0.0007763959,"about_ca_topic_score_gemma":0.00015743081,"teacher_disagreement_score":0.16250381,"about_ca_system_score_codex":0.00016506089,"about_ca_system_score_gemma":0.0006392347,"threshold_uncertainty_score":0.6740773},"labels":[],"label_agreement":null},{"id":"W4295837313","doi":"10.1016/j.annonc.2022.07.1825","title":"1747P Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Foundation Medicine; Merck Sharp and Dohme; EMD Serono; Genentech; Ipsen; Astellas Pharma; Calithera Biosciences; Sanofi Genzyme; Incyte; Exelixis; Merck KGaA; Merck; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Docetaxel; Cisplatin; Medicine; Exploratory analysis; Urothelial cancer; Pembrolizumab; Oncology; Cancer; Chemotherapy; Internal medicine","score_opus":0.08060300676111953,"score_gpt":0.44906555892392047,"score_spread":0.36846255216280094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959751,0.00041927732,0.0000025880324,0.0013873033,0.0001365129,0.0012007869,0.00038341718,0.000011166034,0.00048386568],"genre_scores_gemma":[0.9981699,0.00016969304,0.00001085062,0.0010514904,0.000046934667,0.00027427953,0.00001011264,0.00003239771,0.00023435905],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99718916,0.00086495304,0.0007499081,0.00035762557,0.0005297406,0.00030863017],"domain_scores_gemma":[0.99816316,0.0002968369,0.0005627877,0.00067777483,0.00020779538,0.000091669135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092334463,0.0002371944,0.0012752808,0.00065155467,0.000074177326,0.0000022740014,0.0003072642,0.00009636729,0.0014374673],"category_scores_gemma":[0.00010705129,0.00016970064,0.00061328954,0.0014876247,0.00017369175,0.00004444484,0.00010233319,0.0003036391,0.0000010888882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5647185,0.040969644,0.19179587,0.000084181236,0.013961521,0.00016527281,0.0326391,0.004443084,0.092641525,0.000020773294,0.0023718204,0.0561887],"study_design_scores_gemma":[0.0764859,0.0701146,0.79590046,0.00006266592,0.002203078,0.000010933208,0.0030810123,0.00030637888,0.049727377,0.0000469234,0.0017904929,0.0002701655],"about_ca_topic_score_codex":0.002806848,"about_ca_topic_score_gemma":0.0003909151,"teacher_disagreement_score":0.6041046,"about_ca_system_score_codex":0.00043253673,"about_ca_system_score_gemma":0.0018488629,"threshold_uncertainty_score":0.99947536},"labels":[],"label_agreement":null},{"id":"W4295942277","doi":"10.1016/j.clgc.2022.09.004","title":"Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Bladder cancer; Urology; Bacillus (shape); Oncology; Internal medicine; Cancer; Microbiology","score_opus":0.08438223880145321,"score_gpt":0.38274343369118446,"score_spread":0.29836119488973123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952102,0.0016039376,0.000018257704,0.00039014927,0.0004089445,0.0018722543,0.00033804958,0.00000635106,0.0001519],"genre_scores_gemma":[0.9964607,0.0016280814,0.00022250073,0.00021221866,0.0002683608,0.0010498915,0.000076843084,0.000021088346,0.000060337177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756587,0.00035946694,0.0006412733,0.0004214141,0.0007750905,0.00023686564],"domain_scores_gemma":[0.9988793,0.00014965989,0.00026101695,0.0003190476,0.0002864014,0.000104566374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043131455,0.00022454369,0.000537787,0.00010002481,0.000107976164,0.000006139687,0.00011106638,0.000082780454,0.00044602837],"category_scores_gemma":[0.00005163649,0.00014594683,0.00014000239,0.00029913895,0.0003073704,0.00007830108,0.000056975394,0.0002321783,0.000001388552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050814026,0.010773097,0.72995913,0.00013366362,0.0009982858,0.00009523138,0.0032464152,0.0021008393,0.0014454139,0.0000058519836,0.00020155769,0.24595909],"study_design_scores_gemma":[0.024496587,0.007744027,0.96306807,0.000077627614,0.0012447509,0.00000850693,0.00041195878,0.0009181342,0.00096431514,0.000014527126,0.0008822331,0.00016925832],"about_ca_topic_score_codex":0.0016008046,"about_ca_topic_score_gemma":0.00065099564,"teacher_disagreement_score":0.24578984,"about_ca_system_score_codex":0.0005064834,"about_ca_system_score_gemma":0.00093519496,"threshold_uncertainty_score":0.5951539},"labels":[],"label_agreement":null},{"id":"W4296354727","doi":"10.3390/curroncol29090526","title":"Immunogenic Cell Death Role in Urothelial Cancer Therapy","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Immunogenic cell death; Oncolytic virus; Bladder cancer; Clinical trial; Cancer; Radiation therapy; Oncology; Cancer cell; Internal medicine; Cancer research; Immunology","score_opus":0.2213152741321105,"score_gpt":0.4714488376768136,"score_spread":0.2501335635447031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296354727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015631143,0.9868598,9.3902344e-7,0.000037828813,0.0029366035,0.0021233219,0.00021941184,0.000048479385,0.007617277],"genre_scores_gemma":[0.00003264488,0.99437124,0.000017768605,0.00012085701,0.0007734968,0.003292745,0.00031942345,0.00010542157,0.0009664129],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975665,0.00037718847,0.0006540837,0.00062189787,0.00027074467,0.00050958357],"domain_scores_gemma":[0.99894434,0.00013555013,0.00028779273,0.00046524324,0.000029173076,0.0001378714],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018254334,0.00051588233,0.002188384,0.0003086539,0.000077084056,0.0000099018,0.00030469286,0.00031471474,0.0064618257],"category_scores_gemma":[0.000012305831,0.0004015755,0.0006529642,0.000359189,0.00005122123,0.000028558608,0.00012550972,0.0011290542,0.0001484502],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016314515,0.0013122419,0.00047844584,0.0021779698,0.00020423009,0.00007938931,0.0001820977,2.0315532e-7,0.000002385678,0.000009654905,0.0007383255,0.9946519],"study_design_scores_gemma":[0.0036769416,0.0009927205,0.00007300549,0.0012994031,0.0009043417,0.00007839117,0.00002423307,0.0000013100795,0.0000050177564,0.000027579832,0.99262,0.00029709312],"about_ca_topic_score_codex":0.0003310529,"about_ca_topic_score_gemma":0.000050462182,"teacher_disagreement_score":0.99435484,"about_ca_system_score_codex":0.0022070494,"about_ca_system_score_gemma":0.003679579,"threshold_uncertainty_score":0.9998436},"labels":[],"label_agreement":null},{"id":"W4296364403","doi":"10.3390/ph15091154","title":"Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the ‘Real-Life’ Setting","year":2022,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Urothelial cancer; Medicine; Antibody; Cancer; Oncology; Bladder cancer; Internal medicine; Immunology","score_opus":0.049362290622709054,"score_gpt":0.4183144258799173,"score_spread":0.36895213525720827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296364403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676572,0.0011595162,0.00000779314,0.027336758,0.0003041696,0.0013238746,0.00018691683,0.000047079964,0.001976657],"genre_scores_gemma":[0.98243225,0.00043959267,0.00009492241,0.015768757,0.0001283352,0.00076048996,0.0000069317457,0.000034270015,0.00033447373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976316,0.00060784543,0.00036388036,0.00038254817,0.00049094873,0.00052319065],"domain_scores_gemma":[0.9991038,0.00036652398,0.000047448255,0.00027475573,0.000030527695,0.00017694445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011639763,0.00020130635,0.00036024486,0.00021362459,0.00016277617,0.000020759191,0.00022075843,0.000032655145,0.0011276827],"category_scores_gemma":[0.00020713083,0.00015450132,0.00007855414,0.00064842973,0.00005174575,0.00006743168,0.0001309588,0.0004483981,0.000036726233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028195463,0.0019573097,0.6426929,0.00018661127,0.00023212002,0.0015430785,0.018851541,0.004126463,0.25143132,0.00024216816,0.0032317264,0.04730931],"study_design_scores_gemma":[0.017237114,0.00082248816,0.8002813,0.00021206353,0.00023927412,0.00008148735,0.0042095566,0.0011113115,0.023207128,0.00013456504,0.15187097,0.00059275556],"about_ca_topic_score_codex":0.0003254177,"about_ca_topic_score_gemma":0.00005896896,"teacher_disagreement_score":0.22822419,"about_ca_system_score_codex":0.00029153022,"about_ca_system_score_gemma":0.0003317625,"threshold_uncertainty_score":0.9997854},"labels":[],"label_agreement":null},{"id":"W4296669640","doi":"10.1111/bju.15898","title":"Oncological and safety profiles in patients undergoing simultaneous <scp>transurethral resection (TUR) of bladder tumour</scp> and <scp>TUR of the prostate</scp>","year":2022,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Transurethral resection of the prostate; Propensity score matching; Urology; Prostate; Bladder cancer; Complication; Resection; Prostate cancer; Prostatectomy; Hyperplasia; Surgery; Cancer; Internal medicine","score_opus":0.008946689728737427,"score_gpt":0.23870631728622085,"score_spread":0.22975962755748341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296669640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947146,0.0037265574,0.000010534458,0.00024473527,0.00022684441,0.0005356658,0.00008012124,0.000005885779,0.00045503702],"genre_scores_gemma":[0.99830604,0.0011014644,0.00009433327,0.00025806567,0.00006939192,0.000011088853,0.0000089436535,0.000019091927,0.00013160032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980653,0.00042448717,0.0006348056,0.0002104348,0.00039480563,0.0002701685],"domain_scores_gemma":[0.9984226,0.0007581818,0.00043365444,0.00008890025,0.00019846261,0.00009819965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004500519,0.00013839782,0.0005086987,0.000119136865,0.0001483546,0.000011180948,0.00011273063,0.00012691601,0.000028059838],"category_scores_gemma":[0.00091778,0.00011542988,0.00009740749,0.00020451404,0.00026355777,0.0000732763,0.00009965099,0.00067970646,1.932363e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023769257,0.001988691,0.9655192,0.00030760586,0.00052053505,0.0013954577,0.0032302896,0.001935103,0.004120383,0.00003685649,0.0018027956,0.01676615],"study_design_scores_gemma":[0.0123855155,0.011307974,0.9655644,0.00013538757,0.00026844064,0.005668144,0.0010813916,0.00010823075,0.0011942603,0.000631209,0.001614925,0.00004010489],"about_ca_topic_score_codex":0.00012262279,"about_ca_topic_score_gemma":0.00018209535,"teacher_disagreement_score":0.016726045,"about_ca_system_score_codex":0.000091556154,"about_ca_system_score_gemma":0.0002345535,"threshold_uncertainty_score":0.4707094},"labels":[],"label_agreement":null},{"id":"W4296905415","doi":"10.1016/j.eururo.2022.09.003","title":"Predictive Biomarkers in Muscle Invasive Bladder Cancer: Are We There Yet?","year":2022,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Alberta Cancer Foundation; Princess Margaret Cancer Centre","funders":"EMD Serono; Eisai Canada; Astellas Pharma Canada; Janssen Pharmaceuticals; Bayer; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Bladder cancer; Cancer; Risk assessment; Prostate; Internal medicine","score_opus":0.027835450834602243,"score_gpt":0.26499452533724266,"score_spread":0.23715907450264043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296905415","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0079268655,0.014710392,0.0000059171157,0.8575687,0.0024775474,0.001654701,0.001261007,0.00023434483,0.114160545],"genre_scores_gemma":[0.06985342,0.005627272,0.000024179995,0.91064847,0.0037909208,0.0004022992,0.0008840007,0.00042893807,0.0083404975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647164,0.0010627279,0.0004340527,0.0009736517,0.0003814527,0.00067645236],"domain_scores_gemma":[0.9986079,0.00023606609,0.00029863152,0.0006794309,0.00006561422,0.00011238893],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018675001,0.00052556104,0.00074468635,0.00038411393,0.00010354507,0.000016613758,0.00037964233,0.00035189372,0.0073641133],"category_scores_gemma":[0.000074959484,0.00047549928,0.00022446853,0.00031838653,0.00022123223,0.000047337173,0.0002751523,0.0023474598,0.00026433595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000583916,0.00012620384,0.0077235815,0.00013204188,0.0013354836,0.020460792,0.00076843693,0.000019656598,0.0000366383,0.0000015521834,0.96616644,0.0026452718],"study_design_scores_gemma":[0.0028729148,0.0014573158,0.040655423,0.00011612413,0.00060698605,0.00014153327,0.00020657688,0.0000068940963,0.000014694177,0.00005095985,0.9535264,0.00034417826],"about_ca_topic_score_codex":0.0004452762,"about_ca_topic_score_gemma":0.00021644525,"teacher_disagreement_score":0.10582005,"about_ca_system_score_codex":0.0003767502,"about_ca_system_score_gemma":0.0004119134,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W4297002799","doi":"10.3390/curroncol29100539","title":"A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Planning Project of Guangdong Province; National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Nomogram; Medicine; Cystectomy; Bladder cancer; Oncology; Proportional hazards model; Urology; Receiver operating characteristic; Lymph node; Multivariate analysis; Internal medicine; Area under the curve; Univariate; Multivariate statistics; Cancer; Surgery; Statistics","score_opus":0.03839665279731075,"score_gpt":0.3634175893307453,"score_spread":0.32502093653343456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297002799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755544,0.00033104408,0.0017847527,0.00074803416,0.0022337465,0.004159706,0.002641059,0.000041790157,0.0005044472],"genre_scores_gemma":[0.99213266,0.000010743595,0.00033348394,0.0009717095,0.00019064725,0.005859407,0.0003837272,0.00004595552,0.00007167186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798447,0.00019465527,0.00040665694,0.0004798211,0.00048872916,0.00044565834],"domain_scores_gemma":[0.99877185,0.00038762935,0.00014696283,0.0002282306,0.00021922273,0.00024611922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017072805,0.00026700835,0.00063423644,0.00021818065,0.00009730905,0.0000071051163,0.00013504624,0.00006164783,0.0005687864],"category_scores_gemma":[0.0001226885,0.00022814865,0.00021046831,0.00023211433,0.00010854654,0.000030238516,0.00009079091,0.00021058499,0.000008694886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019043593,0.018897265,0.8932794,0.000695312,0.00078138616,0.00009332557,0.0012926692,0.00048177154,0.00012862257,0.000033931938,0.0032420312,0.06203069],"study_design_scores_gemma":[0.039638005,0.026524018,0.9069653,0.00047698425,0.0017553471,0.000011566843,0.00011894386,0.0055521186,0.0003965802,0.00006510936,0.018037288,0.00045875195],"about_ca_topic_score_codex":0.00009706566,"about_ca_topic_score_gemma":0.000019819603,"teacher_disagreement_score":0.061571937,"about_ca_system_score_codex":0.0008134675,"about_ca_system_score_gemma":0.0008598419,"threshold_uncertainty_score":0.9303632},"labels":[],"label_agreement":null},{"id":"W4297141334","doi":"10.1089/end.2022.0248","title":"Detailed Description of the Karolinska Technique for Intracorporeal Studer Neobladder Reconstruction","year":2022,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Surgical procedures; Urinary diversion; Surgery; Medical physics; General surgery; Cystectomy; Bladder cancer","score_opus":0.026174602674751378,"score_gpt":0.2768744108536359,"score_spread":0.25069980817888454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297141334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882657,0.00033505936,0.005759149,0.0022036321,0.00145475,0.00091405195,0.00002490656,0.000008621027,0.0010341412],"genre_scores_gemma":[0.9968173,0.000025223486,0.0021587056,0.0005150108,0.00025919863,0.00008146362,0.0000019559911,0.000013570431,0.00012755954],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99903965,0.00012947411,0.0004227115,0.000086863176,0.0001939987,0.00012729414],"domain_scores_gemma":[0.9990804,0.000059991075,0.00050847064,0.00013081556,0.00017679296,0.000043505388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003682712,0.00008130499,0.00028716528,0.00012709392,0.00009385268,0.0000028750392,0.000112389695,0.00005604402,0.00023913929],"category_scores_gemma":[0.000052488565,0.000053541622,0.00021290858,0.00011265668,0.00006729535,0.000051401297,0.000036653848,0.0003232683,3.086429e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015995432,0.0016861692,0.42503718,0.00013779254,0.0018719449,0.00013232965,0.0010873275,0.0006157424,0.49692544,0.00077709276,0.011276896,0.044456642],"study_design_scores_gemma":[0.052495357,0.045377336,0.48311663,0.0001905404,0.0054873265,0.08522161,0.0022157454,0.00040399094,0.23103254,0.046978086,0.046863906,0.0006169443],"about_ca_topic_score_codex":0.000010925598,"about_ca_topic_score_gemma":0.000016854561,"teacher_disagreement_score":0.26589292,"about_ca_system_score_codex":0.00009802488,"about_ca_system_score_gemma":0.00023048812,"threshold_uncertainty_score":0.26184076},"labels":[],"label_agreement":null},{"id":"W4297174440","doi":"10.1002/bco2.186","title":"Female sexual function in bladder cancer: A review of the evidence","year":2022,"lang":"en","type":"review","venue":"BJUI Compass","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research; Royal Marsden Cancer Charity","keywords":"Sexual function; Bladder cancer; Function (biology); Medicine; Cancer; Biology; Internal medicine; Evolutionary biology","score_opus":0.16478284072889893,"score_gpt":0.40486365499372295,"score_spread":0.24008081426482403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297174440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000106022635,0.9954435,0.0000024784554,0.00027533172,0.0006677325,0.0021833582,0.000080724254,0.000020606596,0.0013156701],"genre_scores_gemma":[0.000044404685,0.99590087,0.000008803845,0.0008424331,0.00019201689,0.0012566857,0.000040967996,0.000042740572,0.0016710765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978295,0.00034844657,0.0006764475,0.00040194142,0.0005235649,0.0002200856],"domain_scores_gemma":[0.998571,0.0001859484,0.0004008131,0.00072932185,0.000050501687,0.00006240751],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032733352,0.00031348842,0.0017568612,0.000095963514,0.00005840246,0.0000059877066,0.00029126895,0.000095379946,0.0032086798],"category_scores_gemma":[0.000095409465,0.00019250222,0.0004238288,0.0007738835,0.000054224813,0.00004358148,0.00016268462,0.00051822985,0.000025471676],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031545896,0.00013519623,0.00044052725,0.15253934,0.0002883403,0.000012813102,0.00004220062,4.6869582e-7,2.6968186e-7,0.00001293569,0.009914735,0.83658165],"study_design_scores_gemma":[0.00028895546,0.00016177449,0.00036203972,0.17030284,0.0025692324,0.000040242492,0.000018743774,0.000001010326,5.261704e-7,0.0000026382916,0.82612544,0.00012654944],"about_ca_topic_score_codex":0.0006877924,"about_ca_topic_score_gemma":0.00010217206,"teacher_disagreement_score":0.8364551,"about_ca_system_score_codex":0.00048576054,"about_ca_system_score_gemma":0.0013174554,"threshold_uncertainty_score":0.99770254},"labels":[],"label_agreement":null},{"id":"W4297179869","doi":"10.1016/j.ejso.2022.09.013","title":"Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer","year":2022,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Cystectomy; Medicine; Hazard ratio; Urology; Internal medicine; Propensity score matching; Oncology; Urothelial cancer; Cancer; Incidence (geometry); Proportional hazards model; Confidence interval","score_opus":0.02879277915582563,"score_gpt":0.33883305568858413,"score_spread":0.3100402765327585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297179869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90806365,0.010455083,0.00008406497,0.013172382,0.0026183422,0.0010128083,0.00016149791,0.000061328974,0.06437085],"genre_scores_gemma":[0.994065,0.0020153713,0.0003813674,0.0015401467,0.0009404166,0.00007154667,0.000009545476,0.00009284438,0.000883782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948343,0.0019481652,0.0013909072,0.00039769078,0.00081515627,0.0006137885],"domain_scores_gemma":[0.9981404,0.00034342345,0.0006387667,0.00024699257,0.00014483929,0.00048560038],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014533679,0.0003481818,0.0014914715,0.00040780142,0.00017800658,0.000023168079,0.00038378523,0.000054775883,0.0061922143],"category_scores_gemma":[0.000038692826,0.00027565032,0.00040001085,0.00055724697,0.00024809866,0.00009755192,0.00019418789,0.0014347752,0.000053809083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056843687,0.01602066,0.17567149,0.00033637744,0.0060015805,0.2083781,0.009374478,0.0068463413,0.0050923596,0.00012432827,0.104643546,0.41066706],"study_design_scores_gemma":[0.03041042,0.007989286,0.023019562,0.00017186832,0.0006172653,0.0053985915,0.0004526379,0.00034337665,0.00033289776,0.000017916242,0.9309018,0.0003443569],"about_ca_topic_score_codex":0.00034259295,"about_ca_topic_score_gemma":0.00008173156,"teacher_disagreement_score":0.8262583,"about_ca_system_score_codex":0.0010022752,"about_ca_system_score_gemma":0.0011838303,"threshold_uncertainty_score":0.99996954},"labels":[],"label_agreement":null},{"id":"W4297239756","doi":"10.4081/aiua.2022.3.291","title":"Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology","year":2022,"lang":"en","type":"article","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Perioperative; Carcinoma; Surgery; Urology; Cancer; Internal medicine","score_opus":0.014859626795620874,"score_gpt":0.24906763746077523,"score_spread":0.23420801066515437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297239756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98258615,0.00086271216,0.0023288163,0.0038626513,0.000630068,0.0025986787,0.0007459314,0.0002689497,0.0061160387],"genre_scores_gemma":[0.9898701,0.000017009637,0.001492745,0.0043053124,0.00026112227,0.0019232893,0.00031099733,0.000086399334,0.001733083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969123,0.0002787177,0.0004382813,0.0009602912,0.00045118955,0.00095924723],"domain_scores_gemma":[0.9983903,0.00028561422,0.0002957089,0.00065320986,0.00008043608,0.0002947121],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000256803,0.00047115804,0.000783644,0.00024089548,0.00059046247,0.000023367793,0.0003859832,0.00015995426,0.0007885742],"category_scores_gemma":[0.00011327163,0.0003551621,0.00029054596,0.00027054315,0.0005725048,0.00007253256,0.00024020298,0.00063246064,0.00003616894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09079831,0.006079986,0.7664005,0.00041069352,0.0047567477,0.032946236,0.0035866033,0.000679085,0.008288196,0.009414455,0.053235814,0.02340336],"study_design_scores_gemma":[0.08925739,0.13170932,0.48047462,0.000081659666,0.005456511,0.050278157,0.0007497669,0.003353778,0.0035332039,0.007854042,0.22404082,0.0032107257],"about_ca_topic_score_codex":0.00016017834,"about_ca_topic_score_gemma":0.00002532934,"teacher_disagreement_score":0.2859259,"about_ca_system_score_codex":0.00017121591,"about_ca_system_score_gemma":0.0005696433,"threshold_uncertainty_score":0.99989},"labels":[],"label_agreement":null},{"id":"W4297457477","doi":"10.1007/s00345-022-04160-7","title":"Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Gemcitabine; Cystectomy; Bladder cancer; Carboplatin; Cisplatin; Urology; Regimen; Internal medicine; Chemotherapy; Neoadjuvant therapy; Nephrology; Oncology; Gastroenterology; Cancer","score_opus":0.033675628097653745,"score_gpt":0.32541311833858305,"score_spread":0.2917374902409293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297457477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983487,0.008648579,0.00015210162,0.0041146665,0.0021574944,0.00096937036,0.00010471467,0.000010109205,0.00035594578],"genre_scores_gemma":[0.99816257,0.0001576993,0.00042773192,0.00042181424,0.00032775273,0.00015356221,0.000029082823,0.000031255615,0.000288536],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979896,0.00027379786,0.00061779615,0.00023748321,0.0006270094,0.00025429975],"domain_scores_gemma":[0.99843776,0.00031823787,0.00055676815,0.0001459919,0.00040570484,0.00013552204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007653882,0.00018133358,0.0005120259,0.00032072916,0.000103706865,0.0000071057575,0.000092408474,0.00007206304,0.0006885623],"category_scores_gemma":[0.00023927585,0.00015715195,0.0001698262,0.00022699751,0.00010841521,0.0000959409,0.000048030146,0.00038043543,6.7110216e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09933748,0.0035863088,0.06495979,0.00043763156,0.008237539,0.00026018446,0.007797251,0.005132058,0.34231374,0.00023723794,0.08292948,0.38477132],"study_design_scores_gemma":[0.4948303,0.044816773,0.19002324,0.00037766944,0.028902218,0.0016230862,0.0033744338,0.020859666,0.015538622,0.0012687696,0.19682041,0.0015648047],"about_ca_topic_score_codex":0.00009147821,"about_ca_topic_score_gemma":0.00014769385,"teacher_disagreement_score":0.39549282,"about_ca_system_score_codex":0.0003399141,"about_ca_system_score_gemma":0.0005172626,"threshold_uncertainty_score":0.7539274},"labels":[],"label_agreement":null},{"id":"W4297855384","doi":"10.1007/s00345-022-04152-7","title":"Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities","year":2022,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"KARL STORZ","keywords":"Medicine; Charlson comorbidity index; Grading (engineering); Proportional hazards model; Multivariate analysis; Comorbidity; Internal medicine; Nephrology; Urothelial carcinoma; American society of anesthesiologists; Urology; Surgery; Cancer; Bladder cancer","score_opus":0.038560680005491725,"score_gpt":0.3007140368616828,"score_spread":0.26215335685619107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297855384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97251505,0.012245159,0.00025673083,0.00879877,0.001971744,0.000557635,0.00018783945,0.000014258615,0.0034528004],"genre_scores_gemma":[0.99807256,0.00017975103,0.00029746574,0.00069778424,0.0003381248,0.00001400489,0.000006403285,0.000015177101,0.00037873426],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909556,0.00011982128,0.00031624222,0.00010731016,0.00020230871,0.0001587829],"domain_scores_gemma":[0.99923855,0.00026050396,0.00022235351,0.00008366561,0.00010060252,0.000094334515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024907832,0.00009840125,0.0004766393,0.00021401898,0.000077335186,0.0000043584973,0.000079060184,0.000029295146,0.0003523918],"category_scores_gemma":[0.000044888307,0.00008334129,0.00012490366,0.00009805784,0.00016460811,0.00003113024,0.000045985373,0.0002636266,3.0695065e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18186294,0.006276993,0.37098068,0.0009175468,0.013886851,0.009089752,0.018698446,0.0007591746,0.019742185,0.09167708,0.10463657,0.1814718],"study_design_scores_gemma":[0.034768537,0.02105122,0.44516155,0.000053556683,0.0016578732,0.004841156,0.0011543075,0.000097079326,0.0012224328,0.0068278983,0.4828468,0.00031759616],"about_ca_topic_score_codex":0.000037810874,"about_ca_topic_score_gemma":0.00006181686,"teacher_disagreement_score":0.37821022,"about_ca_system_score_codex":0.000052233827,"about_ca_system_score_gemma":0.0001502649,"threshold_uncertainty_score":0.3858443},"labels":[],"label_agreement":null},{"id":"W4297981942","doi":"10.1016/j.annonc.2022.08.080","title":"LBA74 Genomic biomarkers in peripheral blood (PB) from patients (pts) enrolled in the JAVELIN Bladder 100 trial of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (aUC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Javelin; Avelumab; Urothelial carcinoma; Peripheral blood; Merkel cell carcinoma; Internal medicine; Oncology; Bladder cancer; Urology; Carcinoma; Immunotherapy; Cancer; Pembrolizumab","score_opus":0.039116989860089754,"score_gpt":0.32086810898857887,"score_spread":0.2817511191284891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297981942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923566,0.0006436812,0.0000033115903,0.002579817,0.00045069808,0.0021706,0.00033779256,0.000008437721,0.0014490364],"genre_scores_gemma":[0.99717647,0.00032625554,0.00018200737,0.0014212558,0.00012287882,0.00052960956,0.0001120787,0.00003553225,0.000093928196],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969363,0.00056403264,0.0011019383,0.0004852881,0.0004119142,0.0005004842],"domain_scores_gemma":[0.9986669,0.00033287605,0.0003835885,0.00043511513,0.00010868061,0.0000728712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006739815,0.00027478702,0.0010069417,0.0003532135,0.000057317186,0.00000430109,0.0003700202,0.00015905945,0.0006174076],"category_scores_gemma":[0.0001985356,0.00022377426,0.00021652985,0.0005150356,0.00015857513,0.00006367266,0.00013836658,0.00041925162,0.0000042885276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4944173,0.02909702,0.3760599,0.00013736261,0.0012311457,0.0011083059,0.018082432,0.0011364871,0.0095805805,0.00007887912,0.0019147398,0.06715586],"study_design_scores_gemma":[0.4931593,0.03498643,0.45634136,0.00011453137,0.0002298697,0.000025583897,0.0020706577,0.00032837974,0.0028299328,0.00072861457,0.008764423,0.00042092183],"about_ca_topic_score_codex":0.0060496232,"about_ca_topic_score_gemma":0.003866699,"teacher_disagreement_score":0.08028149,"about_ca_system_score_codex":0.00029290383,"about_ca_system_score_gemma":0.0006753019,"threshold_uncertainty_score":0.9145261},"labels":[],"label_agreement":null},{"id":"W4297981952","doi":"10.1016/j.annonc.2022.08.079","title":"LBA73 Study EV-103 Cohort K: Antitumor activity of enfortumab vedotin (EV) monotherapy or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Cohort; Adverse effect; Clinical endpoint; Pembrolizumab; Cisplatin; Gastroenterology; Oncology; Urology; Cancer; Randomized controlled trial; Chemotherapy; Immunotherapy","score_opus":0.043784395096860544,"score_gpt":0.3740006686367162,"score_spread":0.33021627353985566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297981952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424034,0.000118923184,0.00003880872,0.00026878342,0.00006763881,0.004428788,0.00011647548,0.000024662324,0.000695568],"genre_scores_gemma":[0.99710304,0.0002973008,0.00018501842,0.0002502037,0.000011766124,0.0017591624,0.00004134521,0.000056344623,0.00029580086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730444,0.0005053281,0.00068853307,0.00048872666,0.0005927056,0.0004202646],"domain_scores_gemma":[0.99838924,0.00027824103,0.0005728177,0.0003288392,0.0003314554,0.00009937491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004545175,0.00032652257,0.0012374164,0.0004201432,0.000065967084,0.0000067997703,0.00017371672,0.00006672125,0.0004076722],"category_scores_gemma":[0.00008113432,0.00022149688,0.00006304437,0.00090847077,0.00014187004,0.00016829789,0.00003996644,0.00031156128,0.000001142724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14467725,0.017995339,0.76874566,0.00020888986,0.0007858043,0.00052870874,0.0024022132,0.0017880189,0.0005521962,0.000018849094,0.000079111545,0.06221796],"study_design_scores_gemma":[0.11327593,0.11487964,0.7591805,0.00033655818,0.0005115103,0.00007487439,0.00084293657,0.00041382873,0.009500648,0.000038694765,0.0005641579,0.00038072746],"about_ca_topic_score_codex":0.0065631187,"about_ca_topic_score_gemma":0.010493089,"teacher_disagreement_score":0.0968843,"about_ca_system_score_codex":0.000406198,"about_ca_system_score_gemma":0.0025914859,"threshold_uncertainty_score":0.9921516},"labels":[],"label_agreement":null},{"id":"W4301656187","doi":"10.5489/cuaj.1194","title":"The optimal management of T1 high-grade bladder cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Disease; Cancer; Stage (stratigraphy); Oncology; Resection; Urology; Internal medicine; Surgery; Biology","score_opus":0.01328694555095602,"score_gpt":0.24825535866671805,"score_spread":0.23496841311576203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301656187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8932941,0.0016406307,0.000051027586,0.09648889,0.00076432066,0.000591272,0.00004468235,0.000021861519,0.0071032387],"genre_scores_gemma":[0.99251044,0.000815103,0.00028390478,0.0024231412,0.00029616893,0.00005340658,0.0000048767474,0.000010134601,0.0036028132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881846,0.000067696754,0.00026484585,0.000117388,0.0003292896,0.00040230382],"domain_scores_gemma":[0.9990228,0.000060638373,0.00017601157,0.000104308885,0.0002099141,0.00042635325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021531395,0.000104481886,0.00017923929,0.00005384969,0.0002681847,0.000062490115,0.0001203489,0.000112348476,0.0020429],"category_scores_gemma":[0.000036798207,0.0000623459,0.000106137886,0.0001338572,0.00004073958,0.00006253582,0.000012973747,0.00028540706,0.00007703066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013848918,0.00022950786,0.71248233,0.000022287044,0.0035506287,0.00017898272,0.00027177556,0.0002518471,0.00020835872,0.0030315225,0.20193258,0.07770172],"study_design_scores_gemma":[0.0013347417,0.00023225478,0.9341738,0.000015656613,0.0002211942,0.00003599363,0.00014564184,0.000056314628,0.000078578,0.0010423668,0.06257964,0.00008378027],"about_ca_topic_score_codex":0.006888527,"about_ca_topic_score_gemma":0.00056679983,"teacher_disagreement_score":0.22169153,"about_ca_system_score_codex":0.00069640245,"about_ca_system_score_gemma":0.0002508654,"threshold_uncertainty_score":0.9997247},"labels":[],"label_agreement":null},{"id":"W4303684736","doi":"10.1016/j.euf.2022.09.013","title":"Radical Transurethral Resection of Bladder Tumor in Seemingly Organ-confined Muscle-invasive Bladder Cancer: Con","year":2022,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AbbVie; UroGen Pharma; Astellas Pharma; Roche; Deutsche Forschungsgemeinschaft; AstraZeneca","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Resection; Bladder tumor; Treatment modality; Surgery; Cancer; Internal medicine","score_opus":0.016286583388275443,"score_gpt":0.2612532505415669,"score_spread":0.24496666715329146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303684736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694573,0.0021306083,0.000038190756,0.0031737082,0.0005905758,0.0006394772,0.00011323447,0.000088089015,0.023768758],"genre_scores_gemma":[0.9971987,0.000089299676,0.00004297143,0.0015001848,0.0002574564,0.00007725197,0.00003643399,0.00008224803,0.0007154724],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975046,0.00070563616,0.00049620133,0.00051976397,0.00034135702,0.00043245323],"domain_scores_gemma":[0.9991603,0.00012661239,0.00015469601,0.00034230328,0.000072419294,0.00014369078],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042983124,0.00024608674,0.00048605292,0.0002589699,0.00013129592,0.000005908012,0.00019282824,0.0000624551,0.004663952],"category_scores_gemma":[0.00008705942,0.00023760587,0.0001434953,0.00041571,0.00025194325,0.000045269793,0.00008619354,0.0006673703,0.000045253295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043550037,0.007448139,0.27901193,0.00057957426,0.004499538,0.025345813,0.034506492,0.0018336856,0.47184154,0.0012813221,0.041445382,0.08865652],"study_design_scores_gemma":[0.06262797,0.027207362,0.6965582,0.00013601703,0.002188211,0.0022643122,0.0022149477,0.0002626017,0.07075174,0.00062488276,0.13376346,0.0014002834],"about_ca_topic_score_codex":0.00064717676,"about_ca_topic_score_gemma":0.0004025841,"teacher_disagreement_score":0.41754624,"about_ca_system_score_codex":0.00014637271,"about_ca_system_score_gemma":0.0003648668,"threshold_uncertainty_score":0.9962459},"labels":[],"label_agreement":null},{"id":"W4303700015","doi":"10.3390/cancers14194911","title":"Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"McMaster University","keywords":"Concordance; Immunohistochemistry; Bladder cancer; Gene expression; Classifier (UML); Molecular diagnostics; Oncology; Internal medicine; Medicine; Gene; Pathology; Bioinformatics; Biology; Cancer; Computer science; Artificial intelligence","score_opus":0.04339852554200791,"score_gpt":0.3263791572930009,"score_spread":0.282980631750993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303700015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97172296,0.0010728504,0.021773303,0.00050226937,0.00048642617,0.0028404205,0.00036436858,0.00007476384,0.0011626568],"genre_scores_gemma":[0.97232574,0.00003109687,0.02187308,0.0009138597,0.000073063915,0.004227061,0.00018130128,0.000040954877,0.00033383892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985048,0.000029809536,0.00048016888,0.00039602703,0.0003497824,0.00023937302],"domain_scores_gemma":[0.99913293,0.00005681261,0.00024308181,0.00030424257,0.00014092271,0.00012201467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001567643,0.00015772501,0.00028441945,0.00006840764,0.0001833821,0.000006978833,0.000121595534,0.000063312335,0.0004191903],"category_scores_gemma":[0.000021975444,0.00014951991,0.00012492335,0.00018093832,0.000050718376,0.000028153681,0.00003485377,0.0001241416,0.0000018250073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011064323,0.00012415498,0.0011669502,0.0001794764,0.00020701527,0.00000712366,0.0005379972,0.005096816,0.97218066,0.00004119553,0.001566736,0.017785467],"study_design_scores_gemma":[0.0042189495,0.0004996284,0.0009352835,0.00009627116,0.00019212205,0.0000016687811,0.00061733037,0.00057738076,0.9637626,0.000041251267,0.028856562,0.0002009691],"about_ca_topic_score_codex":0.00009446705,"about_ca_topic_score_gemma":0.00003215405,"teacher_disagreement_score":0.027289826,"about_ca_system_score_codex":0.001254376,"about_ca_system_score_gemma":0.004807182,"threshold_uncertainty_score":0.8527735},"labels":[],"label_agreement":null},{"id":"W4304588345","doi":"10.1097/ju.0000000000003015","title":"Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic","year":2022,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphovascular invasion; Urology; Cancer; Surgery; Internal medicine; Metastasis","score_opus":0.029387552997861256,"score_gpt":0.30596460995797703,"score_spread":0.27657705696011575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304588345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750578,0.003051782,0.00020827336,0.020398024,0.0005294789,0.0005478368,0.000033169363,0.000009799362,0.00016383805],"genre_scores_gemma":[0.99345803,0.00033537694,0.000047181264,0.0055306316,0.00029855894,0.00004107756,0.0000010790496,0.000025334351,0.00026273812],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824834,0.00042622577,0.0004503112,0.00014151896,0.00049025705,0.00024336076],"domain_scores_gemma":[0.9989301,0.00029511328,0.00025672303,0.00022298729,0.00017693482,0.00011815502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005516324,0.00013584238,0.00040629573,0.0001603614,0.00014207106,0.0000035783225,0.00020239316,0.00006703596,0.0010438825],"category_scores_gemma":[0.00007532365,0.00008659931,0.00017322927,0.00023613525,0.00012788756,0.000035217967,0.000039537135,0.0005570589,0.000003868228],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11566366,0.0027521318,0.052002776,0.0004024381,0.008079225,0.0011788724,0.053716015,0.0026597602,0.667348,0.00013354025,0.009047147,0.087016396],"study_design_scores_gemma":[0.044400893,0.1168782,0.534304,0.0002815576,0.0142071685,0.018143896,0.0046629026,0.0002797203,0.21000955,0.001620827,0.054392487,0.00081879116],"about_ca_topic_score_codex":0.00020299068,"about_ca_topic_score_gemma":0.000056002897,"teacher_disagreement_score":0.48230124,"about_ca_system_score_codex":0.00012768968,"about_ca_system_score_gemma":0.0004781407,"threshold_uncertainty_score":0.9998693},"labels":[],"label_agreement":null},{"id":"W4304761967","doi":"10.3390/curroncol29100599","title":"Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Seagen (Canada); University of Calgary","funders":"Astellas Foundation for Research on Metabolic Disorders; Seagen","keywords":"Urothelial cancer; Medicine; Cancer; Oncology; Population; Retrospective cohort study; Internal medicine; Bladder cancer; Environmental health","score_opus":0.09322747572980705,"score_gpt":0.35368284304963804,"score_spread":0.260455367319831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304761967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482054,0.0001336664,0.0011342833,0.00027147343,0.00038938932,0.0009152602,0.0022277052,0.000017862752,0.00008984362],"genre_scores_gemma":[0.9979643,0.00008174969,0.00016654356,0.00018020312,0.000039748676,0.00057098654,0.0006151748,0.00003033461,0.00035094912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983391,0.00013709502,0.0002825365,0.00047044063,0.0003948976,0.00037588918],"domain_scores_gemma":[0.99911475,0.00021573003,0.00018337044,0.00020986827,0.00006775778,0.00020853203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000049553713,0.000267507,0.0007484196,0.0001601796,0.0002760791,0.000015048063,0.00007426597,0.000031579937,0.0010411461],"category_scores_gemma":[0.000031614676,0.00018780764,0.00008459958,0.0003892321,0.00004722989,0.00006833239,0.000053929893,0.00017807003,3.825708e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001512735,0.0006504595,0.98890334,0.000018282422,0.002725318,0.00006841024,0.0006708742,0.00059125235,0.0000010627974,0.000015095726,0.000049111826,0.0047940244],"study_design_scores_gemma":[0.01172327,0.0021136482,0.98092234,0.000029417843,0.0033041397,0.000004755099,0.0006832644,0.00042610042,0.000009318802,0.00005523784,0.00053414016,0.00019434009],"about_ca_topic_score_codex":0.83705115,"about_ca_topic_score_gemma":0.9797423,"teacher_disagreement_score":0.14269114,"about_ca_system_score_codex":0.009499295,"about_ca_system_score_gemma":0.001572875,"threshold_uncertainty_score":0.999872},"labels":[],"label_agreement":null},{"id":"W4304892112","doi":"10.1016/j.clgc.2022.10.002","title":"Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Clinical trial; Expanded access; Intensive care medicine; Cabozantinib; Cancer; Urothelial carcinoma; Disease; Clinical Practice; Oncology; Bladder cancer; Internal medicine; Family medicine","score_opus":0.05980277892417523,"score_gpt":0.38068527785311157,"score_spread":0.32088249892893633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304892112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166965,0.0035486058,0.0000015999449,0.0023988509,0.00029617694,0.0015463632,0.00023703177,0.00004569684,0.00025604828],"genre_scores_gemma":[0.99433565,0.001385728,0.00006132966,0.0020573724,0.00032517305,0.0014870835,0.000021316124,0.00005566241,0.000270685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766487,0.0001477984,0.0006952636,0.0005719863,0.00044897522,0.00047112288],"domain_scores_gemma":[0.9990685,0.00016122976,0.00019616143,0.00029323302,0.000078033445,0.0002028357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028383225,0.00029425896,0.0006774182,0.00026391656,0.00020253586,0.000088538814,0.00035505666,0.00008123879,0.00013792279],"category_scores_gemma":[0.00003624323,0.00022971466,0.000072584124,0.0005861701,0.00014750884,0.0003984485,0.0005013695,0.00058355456,0.0000011535318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00370943,0.0021655497,0.98527104,0.00024221641,0.000100002035,0.00010059965,0.0011128187,0.00036259147,0.000020827336,0.000003246422,0.00020338489,0.006708312],"study_design_scores_gemma":[0.0071741324,0.0028179807,0.98642194,0.0006033831,0.00007802571,0.000034800007,0.0006526989,0.000027101876,0.00001542298,0.00001810995,0.001876678,0.00027973854],"about_ca_topic_score_codex":0.0070186006,"about_ca_topic_score_gemma":0.00047882838,"teacher_disagreement_score":0.0065397723,"about_ca_system_score_codex":0.00044560258,"about_ca_system_score_gemma":0.00040193793,"threshold_uncertainty_score":0.99959373},"labels":[],"label_agreement":null},{"id":"W4306683141","doi":"10.1016/j.urolonc.2022.09.012","title":"Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Deutsche Forschungsgemeinschaft; Merck","keywords":"Medicine; Bladder cancer; Context (archaeology); Urothelial cancer; Cancer; Oncology; Internal medicine; Intensive care medicine; Immunology","score_opus":0.06396467059731958,"score_gpt":0.380894958434083,"score_spread":0.3169302878367634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306683141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016790599,0.97779715,0.0000025439074,0.0014306436,0.00050782703,0.0013025638,0.000563384,0.000022827728,0.0015824399],"genre_scores_gemma":[0.00021909305,0.99380463,0.0016365948,0.0009519916,0.00019260267,0.0014813762,0.00065690157,0.00003928476,0.001017503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705523,0.00074186135,0.0008702085,0.0007246309,0.0001543298,0.00045376152],"domain_scores_gemma":[0.99738026,0.0013750378,0.0005469762,0.00039342183,0.000057040797,0.0002472635],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061053404,0.0004745595,0.0020810608,0.00049193285,0.00017816797,0.0000094905945,0.00021729786,0.00064100063,0.0031189441],"category_scores_gemma":[0.00032758823,0.00037633517,0.0002463302,0.0007210597,0.00091971346,0.0000638139,0.00017314099,0.00087134674,0.000021130512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016666772,0.0016249195,0.0336094,0.0038101547,0.0018632507,0.0013506078,0.0017406082,0.000021494845,0.00009042007,0.0013935213,0.022405472,0.9304235],"study_design_scores_gemma":[0.0011998072,0.0036273692,0.00020191714,0.0011990407,0.0019395776,0.00019842685,0.0001557641,0.0000060405887,0.000015795857,0.0006886879,0.9904892,0.00027837776],"about_ca_topic_score_codex":0.0004908412,"about_ca_topic_score_gemma":0.00016228312,"teacher_disagreement_score":0.96808374,"about_ca_system_score_codex":0.00044890167,"about_ca_system_score_gemma":0.0035681056,"threshold_uncertainty_score":0.99986887},"labels":[],"label_agreement":null},{"id":"W4306790782","doi":"10.1016/j.eururo.2022.10.002","title":"Re: Management, Surveillance Patterns, and Costs Associated with Low-grade Papillary Stage Ta Non–muscle-invasive Bladder Cancer Among Older Adults, 2004–2013","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Bladder cancer; Urology; Gynecology; Oncology; General surgery; Cancer; Internal medicine","score_opus":0.0076183080132090995,"score_gpt":0.227865805683776,"score_spread":0.22024749767056692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306790782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864409,0.0018780105,0.000026888254,0.0014843906,0.00031276562,0.0011070438,0.000520637,0.00013565183,0.00809371],"genre_scores_gemma":[0.98866564,0.0015887503,0.000015314112,0.0051844264,0.00014576633,0.00015636721,0.00033907633,0.00013521548,0.0037694508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974195,0.0005910464,0.00030478413,0.0007528338,0.00036122854,0.0005706599],"domain_scores_gemma":[0.9989126,0.00010193133,0.00022035601,0.00048209625,0.00007521838,0.00020784243],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028106317,0.00035099415,0.0004251374,0.00013090203,0.00025170186,0.000024991483,0.00019904767,0.00005630581,0.0015339919],"category_scores_gemma":[0.000023259161,0.0003065613,0.0000677529,0.00025442158,0.00015489802,0.00007096657,0.00028131297,0.00043257984,0.000029834675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067859585,0.0004784276,0.96845657,0.0001410693,0.0011928913,0.0045349253,0.0016244866,0.000097672055,0.000060406197,0.0000061685687,0.017509207,0.005219568],"study_design_scores_gemma":[0.007564622,0.001144963,0.9827929,0.00011913924,0.00023801521,0.000029011955,0.00081855315,0.00005843174,0.000030162993,0.0000011906313,0.0068782168,0.00032476347],"about_ca_topic_score_codex":0.0007815046,"about_ca_topic_score_gemma":0.0028886634,"teacher_disagreement_score":0.014336348,"about_ca_system_score_codex":0.00018820025,"about_ca_system_score_gemma":0.00006545764,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W4306934086","doi":"10.48083/ckyl2827","title":"Systematic Review and Meta-Analysis of Response Rates in BCG-unresponsive Non–Muscle-Invasive Bladder Cancer: a Consensus Statement From the International Bladder Cancer Group","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Disease; Meta-analysis; Oncology; Randomized controlled trial; Clinical trial; Cancer; Urology","score_opus":0.0730828713907388,"score_gpt":0.381806470139206,"score_spread":0.3087235987484672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306934086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7077576,0.18760203,0.00006371123,0.09601154,0.0007998604,0.002661499,0.0048348038,0.000027475075,0.0002414727],"genre_scores_gemma":[0.95529103,0.021324152,0.00014547622,0.01929876,0.00011295585,0.0017889338,0.00014286416,0.00003097555,0.0018648704],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99570477,0.0012050399,0.001285059,0.00042150664,0.0011024316,0.00028120825],"domain_scores_gemma":[0.9949998,0.0028620411,0.0011175976,0.0003297139,0.00057912164,0.000111700676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002099638,0.00030920314,0.0016232583,0.00039989996,0.0002118127,0.000057152614,0.000498022,0.00006308961,0.0095689995],"category_scores_gemma":[0.0010587656,0.00020102868,0.0008756794,0.0005035239,0.00016117081,0.00009464357,0.00026891255,0.0006274181,0.0000025298043],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007959188,0.0012429794,0.04386672,0.0029524139,0.90647197,0.0008829769,0.0072502326,0.003126091,0.0028094542,0.00015045606,0.022997273,0.00029025078],"study_design_scores_gemma":[0.008960688,0.0013844453,0.18152098,0.0016522692,0.7876023,0.00031331315,0.01242423,0.0012663729,0.0005407974,0.0011024931,0.0025141758,0.0007179273],"about_ca_topic_score_codex":0.0015323038,"about_ca_topic_score_gemma":0.00089791045,"teacher_disagreement_score":0.24753341,"about_ca_system_score_codex":0.0007909713,"about_ca_system_score_gemma":0.0008102407,"threshold_uncertainty_score":0.9913364},"labels":[],"label_agreement":null},{"id":"W4306955464","doi":"10.1016/j.urolonc.2022.09.024","title":"Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Bladder cancer; Tolerability; Carcinoma in situ; Internal medicine; Medical record; Retrospective cohort study; Cystectomy; Urology; Incidence (geometry); Cancer; Stage (stratigraphy); Oncology; Gynecology; Adverse effect","score_opus":0.0404708845401386,"score_gpt":0.3321718331945408,"score_spread":0.2917009486544022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306955464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98885113,0.00036146396,0.00033052557,0.008232838,0.00015042146,0.00080864393,0.0006646846,0.0000249298,0.00057538523],"genre_scores_gemma":[0.9780994,0.000072849194,0.01106325,0.007986827,0.00006614139,0.001688687,0.00016259425,0.000013364118,0.0008468875],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987693,0.0000918174,0.00029045736,0.00039445632,0.00019054927,0.0002634128],"domain_scores_gemma":[0.9989081,0.00043374146,0.00014055142,0.00019601079,0.000088148634,0.00023345795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019324686,0.00017368929,0.00057681714,0.00038385653,0.00031606198,0.00000799541,0.00011481887,0.000091885435,0.00063422916],"category_scores_gemma":[0.00008976498,0.00014604599,0.0001432331,0.0008330846,0.00027722248,0.000030670108,0.000058888305,0.0001766712,0.0000017991342],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003601159,0.0005274999,0.9784313,0.000050683087,0.0014265823,0.00004008833,0.0015989044,0.0034097647,0.0026672727,0.00030441568,0.004361288,0.006822088],"study_design_scores_gemma":[0.005987334,0.024959685,0.21776193,0.000048426497,0.014056538,0.000037359438,0.002699829,0.012661306,0.0050184065,0.001753176,0.71437734,0.00063867436],"about_ca_topic_score_codex":0.00062493124,"about_ca_topic_score_gemma":0.0004764215,"teacher_disagreement_score":0.76066935,"about_ca_system_score_codex":0.00018656462,"about_ca_system_score_gemma":0.0007880307,"threshold_uncertainty_score":0.6944365},"labels":[],"label_agreement":null},{"id":"W4307256987","doi":"10.5489/cuaj.8096","title":"Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer: A pairwise meta-analysis of outcomes and a network meta-analysis of complications by urinary diversion approach","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Urinary diversion; Bladder cancer; Extracorporeal; Meta-analysis; Hazard ratio; Confidence interval; Randomized controlled trial; Urology; Odds ratio; Perioperative; Surgery; Internal medicine; Cancer","score_opus":0.10368991399963003,"score_gpt":0.3112437397360937,"score_spread":0.2075538257364637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307256987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76371527,0.019692792,0.014684753,0.12598373,0.00043891542,0.014624805,0.05650703,0.00019169872,0.004160994],"genre_scores_gemma":[0.9930128,0.00008132102,0.0027710546,0.0019104255,0.000030700514,0.00046068113,0.001032257,0.000019517618,0.00068125874],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99686044,0.00058921805,0.00079505076,0.00052822503,0.00077261834,0.00045442808],"domain_scores_gemma":[0.9969178,0.0005166734,0.0012489003,0.0002995888,0.0003694401,0.0006475974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010975774,0.00030590195,0.002910561,0.0006601333,0.00075276784,0.000047255595,0.00041601597,0.00017059881,0.002635275],"category_scores_gemma":[0.000060586106,0.00019133155,0.0020168081,0.0019586876,0.00012775118,0.00014354821,0.00017966903,0.00043822516,2.9146696e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015371453,0.00079329644,0.35953945,0.00001225647,0.62728,0.000049635975,0.00016007762,0.0050178124,0.000007687432,0.000040091247,0.0053224456,0.00024007185],"study_design_scores_gemma":[0.0017260311,0.0014988078,0.4025963,7.5899504e-7,0.59027994,0.00006071463,0.00011815783,0.0020203148,0.000001251587,0.0000384794,0.0015229123,0.0001363112],"about_ca_topic_score_codex":0.012742353,"about_ca_topic_score_gemma":0.0020818515,"teacher_disagreement_score":0.2292975,"about_ca_system_score_codex":0.0007705051,"about_ca_system_score_gemma":0.0006259446,"threshold_uncertainty_score":0.9982765},"labels":[],"label_agreement":null},{"id":"W4307291950","doi":"10.1016/j.ijrobp.2022.07.472","title":"Multi-Institutional Matched Comparison of Radical Cystectomy to Trimodality Therapy for Muscle Invasive Bladder Cancer (MIBC)","year":2022,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Cancer; Oncology; Internal medicine","score_opus":0.0575191553862062,"score_gpt":0.3981840223299831,"score_spread":0.3406648669437769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307291950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.956175,0.0010925493,0.032136727,0.005588393,0.0030468593,0.0010061156,0.0007926773,0.000027353817,0.00013430449],"genre_scores_gemma":[0.9907956,0.00020641678,0.0051823715,0.0020815209,0.0013052344,0.000204002,0.00015305831,0.00002411044,0.000047688092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981186,0.00020802482,0.00080626504,0.00024350444,0.00041872097,0.00020489318],"domain_scores_gemma":[0.9977463,0.00037263404,0.0008349378,0.00013196286,0.000762833,0.0001513445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004301645,0.00019136963,0.0006678895,0.00016773515,0.00014632312,0.000010305823,0.00034227263,0.00012451134,0.00029127902],"category_scores_gemma":[0.00019771632,0.00016062282,0.00033997552,0.00018737465,0.00016424104,0.00011816934,0.00006926102,0.00036520787,0.0000047085314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010512722,0.0074250023,0.57080895,0.000041511314,0.004986342,0.00004841034,0.0050749453,0.010946355,0.10404568,0.006350349,0.0067173126,0.2730424],"study_design_scores_gemma":[0.12822495,0.021010652,0.40181586,0.00019950795,0.0011529899,0.0004085172,0.0017439045,0.008735037,0.10929707,0.008507366,0.31792298,0.0009811479],"about_ca_topic_score_codex":0.00013162945,"about_ca_topic_score_gemma":0.00001876861,"teacher_disagreement_score":0.3112057,"about_ca_system_score_codex":0.0012539676,"about_ca_system_score_gemma":0.0021140974,"threshold_uncertainty_score":0.65500087},"labels":[],"label_agreement":null},{"id":"W4307724604","doi":"10.1016/j.measurement.2022.112079","title":"Robot based Transurethral Bladder Tumor Resection with automatic detection of tumor cells","year":2022,"lang":"en","type":"article","venue":"Measurement","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Robot; Artificial intelligence; Computer science; Computer vision","score_opus":0.03251547336544692,"score_gpt":0.2451420635699526,"score_spread":0.2126265902045057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307724604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98622906,0.00047821013,0.008369764,0.0005031549,0.0006309903,0.0020572655,0.000045845813,0.00018587445,0.0014998594],"genre_scores_gemma":[0.99872535,9.370404e-7,0.0005245575,0.00026738158,0.00005162341,0.0003162613,0.0000068577515,0.000031258918,0.000075761534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979434,0.00012913822,0.0002532977,0.00024217139,0.001228868,0.00020311729],"domain_scores_gemma":[0.9994075,0.000011145182,0.00010623815,0.00024994995,0.0001423353,0.00008287627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045448,0.0001524823,0.00025731986,0.00012619188,0.0001527251,0.000007026548,0.00005790749,0.00001640805,0.0006973177],"category_scores_gemma":[0.000010066603,0.00012359786,0.00009560061,0.00027665723,0.000034184537,0.000034710018,0.000009455197,0.00017589917,0.0000055491237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003290982,0.0013992945,0.003117193,0.000432838,0.00045151773,0.00008424098,0.0005240504,0.002679405,0.9806445,0.0000026313262,0.0003154563,0.007057873],"study_design_scores_gemma":[0.00671788,0.00572799,0.027553583,0.00011241986,0.0005406787,0.00006889513,0.00028026762,0.0026218065,0.9550042,0.000012813652,0.0011869222,0.00017250737],"about_ca_topic_score_codex":0.00026615913,"about_ca_topic_score_gemma":0.00017158076,"teacher_disagreement_score":0.025640283,"about_ca_system_score_codex":0.000513126,"about_ca_system_score_gemma":0.0003024881,"threshold_uncertainty_score":0.763514},"labels":[],"label_agreement":null},{"id":"W4307810833","doi":"10.1016/j.urolonc.2022.09.004","title":"5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dutasteride; Bladder cancer; Hazard ratio; Population; Confidence interval; Internal medicine; Gynecology; Demography; Cancer; Prostate cancer","score_opus":0.01339895178721554,"score_gpt":0.3009816262695392,"score_spread":0.28758267448232366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307810833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782045,0.0029059406,0.000006833867,0.007737961,0.00014665716,0.0006396204,0.00023414298,0.000016002152,0.0004923928],"genre_scores_gemma":[0.9951568,0.0005400054,0.0013332047,0.0021263238,0.00005666526,0.0005131168,0.00007081724,0.000009269368,0.00019375897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885863,0.0002919248,0.00027226922,0.00024435698,0.00015258977,0.00018020644],"domain_scores_gemma":[0.99928874,0.00028394433,0.0001640954,0.00013774252,0.000030202378,0.00009527683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005055133,0.00012390173,0.0003240566,0.00012646322,0.0003097438,0.000005687374,0.00005213471,0.000074127434,0.00036190907],"category_scores_gemma":[0.00010900097,0.00008526719,0.000047187074,0.00029150088,0.0004676669,0.000033601078,0.0000473117,0.00034147545,8.114477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038092188,0.00019348213,0.9951838,0.000012405808,0.00009177829,0.000023411749,0.0004332701,0.00057476736,0.000030389516,0.0014979835,0.0009803743,0.0005973995],"study_design_scores_gemma":[0.010756745,0.0020034693,0.821724,0.00003852127,0.0014290868,0.00013359125,0.0008763492,0.0044870437,0.00021324147,0.008920744,0.14920303,0.0002142055],"about_ca_topic_score_codex":0.0027958832,"about_ca_topic_score_gemma":0.00045159637,"teacher_disagreement_score":0.17345984,"about_ca_system_score_codex":0.00012565224,"about_ca_system_score_gemma":0.00038699963,"threshold_uncertainty_score":0.42265576},"labels":[],"label_agreement":null},{"id":"W4307925719","doi":"10.21203/rs.3.rs-2207998/v1","title":"Urinary Eubacterium sp. CAG:581 promotes non-muscle-invasive bladder cancer (NMIBC) development through ECM1/MMP9 pathway","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Peking University; Peking University First Hospital; National Natural Science Foundation of China; McGill University","keywords":"Eubacterium; Biology; Urinary system; Bladder cancer; Cohort; Internal medicine; Cancer; Medicine; Endocrinology; Genetics; Bacteria","score_opus":0.09128219574213459,"score_gpt":0.4037672862846455,"score_spread":0.3124850905425109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307925719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92554045,0.0113797635,0.00007630491,0.006797754,0.002184017,0.012322835,0.002221604,0.00046045572,0.03901684],"genre_scores_gemma":[0.96109754,0.005260306,0.0016746315,0.00052947516,0.001827011,0.011309808,0.002188409,0.00037975315,0.015733097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9916872,0.00057238963,0.00084505783,0.0019833469,0.0030920948,0.0018199352],"domain_scores_gemma":[0.99595875,0.00030381908,0.00025060252,0.0017610219,0.0010763628,0.00064944796],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092980167,0.00092778576,0.0012158703,0.000526101,0.00086864154,0.00019105145,0.00083848776,0.000601734,0.013760278],"category_scores_gemma":[0.0002212639,0.000819428,0.0004648715,0.00074064045,0.00027523693,0.00018900551,0.003291172,0.003581739,0.00034306655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012722197,0.029102242,0.24561228,0.07905671,0.021455543,0.036702886,0.1502451,0.0004993012,0.02100471,0.0003653445,0.15320762,0.25002608],"study_design_scores_gemma":[0.008377281,0.005954128,0.5129081,0.0074150776,0.0005498746,0.00019602841,0.0063539175,0.000056656318,0.044497065,0.0011932396,0.41003612,0.0024625284],"about_ca_topic_score_codex":0.0035385746,"about_ca_topic_score_gemma":0.0004615136,"teacher_disagreement_score":0.2672958,"about_ca_system_score_codex":0.0032934288,"about_ca_system_score_gemma":0.012233691,"threshold_uncertainty_score":0.99942565},"labels":[],"label_agreement":null},{"id":"W4308173050","doi":"10.5489/cuaj.7952","title":"Complications after neoadjuvant chemotherapy and radical cystectomy for patients with bladder cancer: A propensity score matched analysis","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Propensity score matching; Perioperative; Complication; Surgery; Sepsis; Urinary system; Urinary diversion; Blood transfusion; Cancer; Chemotherapy; Internal medicine","score_opus":0.015158887488941147,"score_gpt":0.23664923987876663,"score_spread":0.22149035238982548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308173050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766166,0.00022382698,0.00018883792,0.02147806,0.00007175001,0.0008022186,0.00047150272,0.000017550412,0.00012960487],"genre_scores_gemma":[0.99110556,0.000028112692,0.00026534667,0.0077852476,0.000099157376,0.0003728463,0.00012538256,0.00001503853,0.00020333423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987669,0.0000907136,0.00021966966,0.00024275857,0.0003404358,0.0003394957],"domain_scores_gemma":[0.99890786,0.00005101101,0.00017763331,0.000106346226,0.00026089948,0.0004962723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019742564,0.00013405553,0.00035258132,0.00017849612,0.00051480735,0.000052740743,0.00007309006,0.00007596765,0.0007310109],"category_scores_gemma":[0.000038607875,0.000097638294,0.0001275451,0.0003696713,0.000041438278,0.00004977219,0.000015146711,0.00032565513,0.000001479592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057761994,0.00014449126,0.9943503,0.0000038653234,0.0011774569,0.000014478419,0.0001571716,0.000035874476,0.000004727602,0.000010513524,0.0012682129,0.0022552458],"study_design_scores_gemma":[0.0042852983,0.00075884216,0.9713939,0.000004557976,0.0009072292,0.00003148107,0.000025113053,0.00014599935,0.0000019602019,0.00009604315,0.022234717,0.000114893555],"about_ca_topic_score_codex":0.0012910814,"about_ca_topic_score_gemma":0.0013612735,"teacher_disagreement_score":0.022956477,"about_ca_system_score_codex":0.0011173427,"about_ca_system_score_gemma":0.0004915994,"threshold_uncertainty_score":0.8004057},"labels":[],"label_agreement":null},{"id":"W4308173054","doi":"10.5489/cuaj.8006","title":"Case – Late abdominal wall recurrence following open nephroureterectomy for urothelial carcinoma","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Urothelial carcinoma; Urothelial cancer; Urology; Surgery; Cancer recurrence; Carcinoma; Cancer; Internal medicine; Bladder cancer","score_opus":0.033849415760100435,"score_gpt":0.28446053367056795,"score_spread":0.25061111791046753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308173054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792964,0.00020452666,0.00007150655,0.015742937,0.0013590218,0.001030297,0.00031172537,0.000020451296,0.001963171],"genre_scores_gemma":[0.9889012,0.0000049308674,0.00058481557,0.0080463905,0.0005834284,0.00019869789,0.000041619074,0.000022948983,0.0016159436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819577,0.00024812188,0.00033671214,0.0002836032,0.00033812184,0.0005976831],"domain_scores_gemma":[0.99866295,0.00015301145,0.00022042393,0.00012656255,0.00013440037,0.00070263725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009241845,0.00016912814,0.0003485771,0.00014142306,0.0012091316,0.00017193556,0.0002650753,0.00011241731,0.0013898138],"category_scores_gemma":[0.0002839813,0.00015089367,0.0002842191,0.00019687548,0.0000149757,0.00013577231,0.0000665994,0.0006240973,0.000015323038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016696565,0.00023649666,0.90902317,0.000012968666,0.00070532697,0.014690349,0.0010365067,0.00010756449,0.00015708937,0.0001506629,0.054098886,0.01811134],"study_design_scores_gemma":[0.0202934,0.005658215,0.1987791,0.000022256683,0.0010506166,0.022573324,0.0004711115,0.0014574542,0.00006756952,0.0026053244,0.7463157,0.00070589816],"about_ca_topic_score_codex":0.005638506,"about_ca_topic_score_gemma":0.0011280876,"teacher_disagreement_score":0.71024406,"about_ca_system_score_codex":0.0022598198,"about_ca_system_score_gemma":0.0014175113,"threshold_uncertainty_score":0.99952304},"labels":[],"label_agreement":null},{"id":"W4308173056","doi":"10.5489/cuaj.8056","title":"The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Bladder cancer; Chemotherapy; Medicine; Urology; Oncology; Cancer; Internal medicine; Surgery","score_opus":0.0047402840175364055,"score_gpt":0.22482257031827038,"score_spread":0.22008228630073398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308173056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919368,0.0004045885,8.1286487e-7,0.0064597134,0.00010105658,0.00039761726,0.000047550264,0.000008842132,0.0006430303],"genre_scores_gemma":[0.99824053,0.00006801111,0.0000052452706,0.0012483376,0.00007365564,0.00009158288,0.000013333403,0.000013828295,0.00024548662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841905,0.00036428636,0.0002592961,0.00013402101,0.00046105593,0.00036227974],"domain_scores_gemma":[0.9991906,0.00018097348,0.00019692122,0.00008167385,0.00008382551,0.00026598948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044232229,0.0001224164,0.000281065,0.00011111698,0.00034106878,0.00002105513,0.00011256881,0.0000756697,0.0007107992],"category_scores_gemma":[0.00009171022,0.00006802874,0.00008769513,0.00031659415,0.00004487837,0.00003012264,0.000010171799,0.0005134168,0.0000024602632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091093825,0.00006704489,0.99275345,0.0000024003837,0.00020491573,0.000046791687,0.00007404103,0.000030361323,0.000020777374,0.0000049642476,0.0019007836,0.0039835502],"study_design_scores_gemma":[0.008771707,0.00339607,0.9601528,0.000009294414,0.000078919,0.000061132996,0.000023267326,0.000037110694,0.00016146408,0.000020806332,0.0272092,0.00007824683],"about_ca_topic_score_codex":0.0035983515,"about_ca_topic_score_gemma":0.0013815431,"teacher_disagreement_score":0.03260065,"about_ca_system_score_codex":0.0017036331,"about_ca_system_score_gemma":0.00041980017,"threshold_uncertainty_score":0.7782753},"labels":[],"label_agreement":null},{"id":"W4308502409","doi":"10.1016/j.fpurol.2022.07.124","title":"Résultats oncologiques des patients présentant une atteinte ganglionnaire à la suite d’une chimiothérapie néoadjuvante et d’une cystectomie totale pour un cancer de la vessie infiltrant le muscle : une étude observationnelle multicentrique du groupe de travail sur le carcinome urothélial de l’eau young academic urologists (YAU)","year":2022,"lang":"fr","type":"article","venue":"Progrès en Urologie - FMC","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gynecology","score_opus":0.020909689968664148,"score_gpt":0.28888405785729365,"score_spread":0.2679743678886295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308502409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534264,0.01697352,0.0009330182,0.02223921,0.0012278679,0.0031237348,0.000726091,0.0005935528,0.0007566147],"genre_scores_gemma":[0.98071617,0.010251376,0.0018565375,0.002659916,0.0008801966,0.0024705906,0.00029211547,0.00027867014,0.0005944527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98970443,0.0040069935,0.0013843871,0.0014794114,0.000892867,0.002531901],"domain_scores_gemma":[0.9957982,0.0016109685,0.00077196845,0.0007016759,0.000409002,0.0007082014],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028080456,0.0011514709,0.0013619349,0.00030548763,0.0010887939,0.00015326653,0.0010381433,0.0010531951,0.0002028328],"category_scores_gemma":[0.0013953474,0.0011565264,0.0005085195,0.0015264149,0.001359002,0.0006165811,0.00062561425,0.00290638,0.000021642592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046865437,0.007127764,0.8510774,0.00070198684,0.0012058624,0.0034791292,0.04759041,0.00786386,0.016963476,0.00032140146,0.0015015285,0.05748069],"study_design_scores_gemma":[0.021901932,0.003495836,0.94465536,0.0003399562,0.0010569799,0.00076125615,0.0034607067,0.01081193,0.0053011165,0.0012166459,0.0059184376,0.0010798678],"about_ca_topic_score_codex":0.107758306,"about_ca_topic_score_gemma":0.009567055,"teacher_disagreement_score":0.098191254,"about_ca_system_score_codex":0.0032093045,"about_ca_system_score_gemma":0.0042332574,"threshold_uncertainty_score":0.99939394},"labels":[],"label_agreement":null},{"id":"W4308606502","doi":"10.1111/iju.15061","title":"Biological and prognostic implications of biopsy upgrading for high‐grade upper tract urothelial carcinoma at nephroureterectomy","year":2022,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Biopsy; Hazard ratio; Lymphovascular invasion; Urology; Confidence interval; Proportional hazards model; Cancer; Internal medicine; Gastroenterology; Metastasis","score_opus":0.03328066689091266,"score_gpt":0.3132992528872201,"score_spread":0.28001858599630747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308606502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888791,0.00051386276,0.00041822784,0.009126615,0.0005117436,0.00025341476,0.00019660013,0.000004813051,0.00009565934],"genre_scores_gemma":[0.9980571,0.00004527551,0.000806989,0.0006267963,0.00032455428,0.00004442243,0.000032876713,0.000011625232,0.000050345974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991384,0.000059897327,0.00035714734,0.00013394142,0.00018240623,0.00012816666],"domain_scores_gemma":[0.9991618,0.00023800091,0.00026954192,0.00006963679,0.00019011334,0.00007091072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014338469,0.00009160358,0.00024234383,0.00019090445,0.00006936171,0.0000058716623,0.00015372795,0.000047832506,0.00032356894],"category_scores_gemma":[0.00009366265,0.00007177723,0.00012967741,0.000054825483,0.0000867119,0.00003728472,0.000068143076,0.00015145622,8.541051e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028964826,0.00051862554,0.9412096,0.00000972682,0.00050740765,0.0001198653,0.00028743048,0.00002050582,0.04806675,0.0016925775,0.00048119394,0.004189834],"study_design_scores_gemma":[0.0053693433,0.0041230307,0.96415424,0.0000074975133,0.00024399752,0.01072876,0.000048245303,0.00004991634,0.0016878438,0.0036767747,0.009826062,0.00008430522],"about_ca_topic_score_codex":0.000016335613,"about_ca_topic_score_gemma":0.0000010724883,"teacher_disagreement_score":0.046378907,"about_ca_system_score_codex":0.00011823022,"about_ca_system_score_gemma":0.00010870191,"threshold_uncertainty_score":0.3542853},"labels":[],"label_agreement":null},{"id":"W4309001467","doi":"10.3390/curroncol29110681","title":"Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer research; HIF1A; Hypoxia-inducible factors; Angiogenesis; Hypoxia (environmental); Biology; Metastasis; Gene expression; Medicine; Gene; Pathology; Internal medicine; Cancer; Genetics","score_opus":0.16510704779952634,"score_gpt":0.4304675529981596,"score_spread":0.26536050519863325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309001467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420304,0.0065281414,0.0000137526595,0.0011264153,0.0044843997,0.000631419,0.00016377242,0.00005751921,0.0027915377],"genre_scores_gemma":[0.99681365,0.00026638864,0.00011657781,0.00062301656,0.0012345106,0.00014173127,0.000053751704,0.000030455552,0.0007198926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983988,0.000244408,0.00034589056,0.00049111486,0.00019516886,0.0003246275],"domain_scores_gemma":[0.99922425,0.00010456795,0.000099087716,0.0002969229,0.000038739276,0.00023646145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018905076,0.00018798505,0.0004965903,0.000104225284,0.00020974378,0.000011260119,0.00012243252,0.00009675298,0.0009433146],"category_scores_gemma":[0.000041733125,0.00016545299,0.00014259128,0.000099820914,0.00015917627,0.000031250358,0.00022994516,0.0006676016,0.00003563402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015392884,0.0017282373,0.7293614,0.00006877404,0.00018158933,0.00013428395,0.00085008075,0.0000014464158,0.0020645787,0.00023674322,0.018875554,0.24495801],"study_design_scores_gemma":[0.006706747,0.0026958473,0.6273651,0.0000061346173,0.00017758721,0.0003216056,0.00014599602,0.000016942371,0.00018403088,0.00018107022,0.36205596,0.00014300887],"about_ca_topic_score_codex":0.00006175761,"about_ca_topic_score_gemma":0.000012150028,"teacher_disagreement_score":0.3431804,"about_ca_system_score_codex":0.0002679258,"about_ca_system_score_gemma":0.00059245096,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null},{"id":"W4309164709","doi":"10.1159/000524578","title":"Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series","year":2022,"lang":"en","type":"review","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Mortality rate; Population; Cohort study; Demography; Systematic review; Epidemiology; MEDLINE; Surgery; Environmental health; Internal medicine; Bladder cancer","score_opus":0.07524328788364719,"score_gpt":0.3846242382359612,"score_spread":0.309380950352314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309164709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020128813,0.99311423,0.000016678752,0.00046201702,0.00033365822,0.0036138918,0.00094563037,0.00005723602,0.0014365339],"genre_scores_gemma":[0.000103128696,0.98937106,0.00007524096,0.004139759,0.00008772042,0.0041290675,0.0010005807,0.000042924545,0.0010505276],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953743,0.0016996637,0.0016488389,0.0005491506,0.0004939643,0.00023405712],"domain_scores_gemma":[0.99743444,0.0007170991,0.0009359408,0.0006301938,0.0001806061,0.000101725964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013724873,0.00049720396,0.004264993,0.00017600677,0.000045948,0.000010995538,0.0003662774,0.00022190322,0.005818694],"category_scores_gemma":[0.0026206877,0.00030976156,0.001108266,0.00028385504,0.00018565425,0.00007660597,0.00018800522,0.00053417264,0.00006873468],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007520702,0.00015611801,0.00012796403,0.9929524,0.002683505,0.00033237896,0.000035776273,1.4648107e-7,1.1672923e-7,0.0005626969,0.0009170127,0.002156645],"study_design_scores_gemma":[0.00041513093,0.0008357323,0.00010975578,0.44120994,0.010008698,0.0006703074,0.000008287149,0.000001917892,0.0000014147279,0.00011866262,0.5463206,0.00029951238],"about_ca_topic_score_codex":0.00008183021,"about_ca_topic_score_gemma":0.000005591234,"teacher_disagreement_score":0.5517425,"about_ca_system_score_codex":0.0003925229,"about_ca_system_score_gemma":0.00048364705,"threshold_uncertainty_score":0.99993545},"labels":[],"label_agreement":null},{"id":"W4309349096","doi":"10.1001/jamanetworkopen.2022.42378","title":"Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy","year":2022,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"National Institutes of Health; National Cancer Institute; NRG Oncology","keywords":"Bladder cancer; Medicine; Biomarker; Oncology; Cystectomy; Radiation therapy; Internal medicine; Prospective cohort study; Cancer; Urology; Biology","score_opus":0.024011389635230817,"score_gpt":0.2955461880956183,"score_spread":0.27153479846038747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309349096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932268,0.0008451146,0.000038396167,0.00047858257,0.00004084815,0.0017191647,0.00015524909,0.000023274137,0.0034725682],"genre_scores_gemma":[0.99686337,0.0005697038,0.00014033561,0.0009848711,0.00010759278,0.0006794489,0.00012940672,0.000032415683,0.0004928471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982872,0.00022525968,0.0002456773,0.0005039637,0.00045120664,0.00028671866],"domain_scores_gemma":[0.9988696,0.000081664206,0.000253093,0.00053664506,0.0001150776,0.00014392979],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004107747,0.00022132808,0.0007229577,0.00008852438,0.00022466436,0.00005116176,0.00023415693,0.000048663504,0.0011164072],"category_scores_gemma":[0.0000059006456,0.00015012236,0.00009744604,0.0012331886,0.00014277632,0.00016729665,0.0001851984,0.00023448898,3.6287526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062176865,0.00025431675,0.9724327,0.000031585714,0.009456748,0.00008491437,0.0012781608,0.0028916355,0.0000076058077,0.000033277345,0.0005896479,0.0067217755],"study_design_scores_gemma":[0.00834809,0.0011465697,0.9845558,0.00010789099,0.003764794,0.0000040614127,0.0008552005,0.00051684945,0.00007044471,0.000027521552,0.00041642628,0.00018636105],"about_ca_topic_score_codex":0.016433446,"about_ca_topic_score_gemma":0.011411186,"teacher_disagreement_score":0.012123144,"about_ca_system_score_codex":0.000098996636,"about_ca_system_score_gemma":0.0002598561,"threshold_uncertainty_score":0.9997967},"labels":[],"label_agreement":null},{"id":"W4309536047","doi":"10.1016/j.ucl.2022.09.007","title":"Biological Stratification of Invasive and Advanced Urothelial Carcinoma","year":2022,"lang":"en","type":"review","venue":"Urologic Clinics of North America","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Risk stratification; Malignancy; Urothelial carcinoma; Stratification (seeds); Metastatic Urothelial Carcinoma; Carcinoma; Oncology; Pathology; Cancer research; Internal medicine; Bladder cancer; Cancer; Biology","score_opus":0.09608925452941446,"score_gpt":0.3614752357617229,"score_spread":0.26538598123230844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309536047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011632,0.98522514,0.0000118237,0.000037092916,0.00015991591,0.0014859635,0.00068242487,0.000027919019,0.0007377058],"genre_scores_gemma":[0.01515237,0.9829848,0.00060860807,0.00019479105,0.000069376656,0.00019146528,0.00072501553,0.000027862017,0.000045715908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770164,0.00022759692,0.0010612453,0.0005530679,0.00024315993,0.00021326487],"domain_scores_gemma":[0.9971901,0.00092151033,0.0011803393,0.00051438593,0.00007679429,0.00011688142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013663349,0.00034638122,0.0021812844,0.00013963778,0.00005179781,0.0000032774717,0.00021863046,0.00019465077,0.00036148835],"category_scores_gemma":[0.00054282125,0.00024619605,0.00046146204,0.00033548722,0.00042222143,0.000023533263,0.00013386585,0.00043821032,0.000007005844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002521556,0.00034582725,0.012055123,0.0020722244,0.00020503414,0.000025705389,0.00004106428,0.0000012949736,8.129594e-7,0.0000113813,0.000035223813,0.9849542],"study_design_scores_gemma":[0.0011203967,0.008041038,0.006657175,0.0002858049,0.0015923233,0.000051150568,0.000041202748,0.0000032896423,0.0000018902731,0.00007721241,0.9818811,0.0002474587],"about_ca_topic_score_codex":0.000039705974,"about_ca_topic_score_gemma":0.0000069464595,"teacher_disagreement_score":0.9847067,"about_ca_system_score_codex":0.000039837127,"about_ca_system_score_gemma":0.0006724292,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W4309574459","doi":"10.1016/j.urolonc.2022.10.027","title":"Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Urology; Basal cell; Medicine; Urinary bladder; Oncology; Population; Internal medicine; Bladder cancer; Cancer","score_opus":0.019735400549731642,"score_gpt":0.2885209937949807,"score_spread":0.26878559324524903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309574459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418116,0.00038058296,0.00031618055,0.0029166548,0.00016804761,0.00091029,0.0008161795,0.000017864593,0.00029306562],"genre_scores_gemma":[0.9890812,0.00000491119,0.007012904,0.0020034676,0.000064814616,0.0009892343,0.00057115796,0.000014788552,0.00025752408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985117,0.0002464471,0.00035943103,0.00035520416,0.0002837223,0.00024352179],"domain_scores_gemma":[0.9985122,0.00078612036,0.00022310286,0.00024313375,0.000077361605,0.00015805259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002323914,0.00018685868,0.0004586558,0.0002282885,0.00044472318,0.000007742094,0.00011965515,0.00008479863,0.0004676001],"category_scores_gemma":[0.0000954197,0.00014236713,0.0002672742,0.0005804293,0.00043161924,0.000038240545,0.00006085192,0.0002563843,0.000001517511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048425727,0.0008304716,0.99509954,0.000089171226,0.00024850998,0.000108942375,0.00029387744,0.0015719552,0.00020697301,0.00040397182,0.00059040036,0.00007191626],"study_design_scores_gemma":[0.0064924667,0.008014699,0.93040085,0.000012495024,0.0069326456,0.00018688019,0.0005495725,0.0048165815,0.00052376423,0.003971917,0.037824888,0.0002732383],"about_ca_topic_score_codex":0.00024266413,"about_ca_topic_score_gemma":0.000078238714,"teacher_disagreement_score":0.0646987,"about_ca_system_score_codex":0.0001933254,"about_ca_system_score_gemma":0.0008843827,"threshold_uncertainty_score":0.58055633},"labels":[],"label_agreement":null},{"id":"W4309721833","doi":"10.3390/cancers14235740","title":"Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Retrospective cohort study; Stage (stratigraphy); Urology; Surgery; Hazard ratio; Perioperative; Clinical endpoint; Internal medicine; Cohort; Cancer; Oncology; Randomized controlled trial; Confidence interval","score_opus":0.020850929367811775,"score_gpt":0.30988772851376023,"score_spread":0.28903679914594843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309721833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987356,0.00015080099,0.00003020969,0.0004106339,0.0017837059,0.008429306,0.0015178126,0.00004364299,0.00027787074],"genre_scores_gemma":[0.99317217,0.000017407785,0.00010090217,0.0004249363,0.00026849634,0.00572147,0.000039194798,0.00006297049,0.00019248112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974283,0.00017782825,0.0004408803,0.0006530534,0.00077486946,0.00052508526],"domain_scores_gemma":[0.99848485,0.0006133393,0.0002461988,0.00032881874,0.00015951674,0.00016728259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022737286,0.00033282288,0.0007768091,0.000115760784,0.0005375391,0.000015179706,0.00025888742,0.000089746565,0.00010457625],"category_scores_gemma":[0.00024214684,0.00023313673,0.0007067357,0.0003604133,0.000116014904,0.000057581663,0.00013467907,0.00034959224,8.8210527e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084162215,0.0033038347,0.976052,0.00009549295,0.002561816,0.00011888209,0.0040109665,0.00027596045,0.00042702295,0.00021771075,0.0005829085,0.0039371974],"study_design_scores_gemma":[0.050455086,0.015540592,0.92507356,0.00013575207,0.0018238474,0.0000045462966,0.0027025796,0.00012150953,0.00094320346,0.00004692162,0.0027734232,0.0003789781],"about_ca_topic_score_codex":0.0010027527,"about_ca_topic_score_gemma":0.00016417874,"teacher_disagreement_score":0.050978422,"about_ca_system_score_codex":0.0058957567,"about_ca_system_score_gemma":0.000908946,"threshold_uncertainty_score":0.99792045},"labels":[],"label_agreement":null},{"id":"W4309848179","doi":"10.3390/cancers14235766","title":"Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Internal medicine; Pathology","score_opus":0.09252597735960273,"score_gpt":0.35185613012458083,"score_spread":0.2593301527649781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309848179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98157084,0.012881095,0.000058079426,0.001493174,0.0013909901,0.0015682016,0.00039787358,0.000057358677,0.0005824004],"genre_scores_gemma":[0.9844808,0.0015953854,0.00007252279,0.0030907218,0.00041802553,0.009557235,0.000021084483,0.000041127478,0.0007231001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981452,0.00006369279,0.00030748916,0.00061361876,0.0003578811,0.00051211135],"domain_scores_gemma":[0.9993092,0.000056504552,0.00008675828,0.00028616682,0.00006537392,0.00019602945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014094113,0.0002627671,0.00054012175,0.00014575158,0.0001699233,0.000019957464,0.00018760387,0.0000727399,0.0029691912],"category_scores_gemma":[0.000013167099,0.00021925244,0.00016272075,0.0004242647,0.000075101394,0.00006069816,0.000049073402,0.00026263105,0.0000042782685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007832288,0.00019140796,0.93477905,0.000046912293,0.0003437682,0.00007367776,0.0015946787,0.00035699512,0.0016213857,0.00006164694,0.0062045837,0.04689363],"study_design_scores_gemma":[0.007950748,0.00182767,0.89227015,0.00007660888,0.00015991148,0.000008342463,0.0014357441,0.00015016696,0.0017807764,0.00019537676,0.093585715,0.0005587623],"about_ca_topic_score_codex":0.008092674,"about_ca_topic_score_gemma":0.0015623885,"teacher_disagreement_score":0.08738113,"about_ca_system_score_codex":0.0044900514,"about_ca_system_score_gemma":0.0013824825,"threshold_uncertainty_score":0.99933153},"labels":[],"label_agreement":null},{"id":"W4309947504","doi":"10.1016/j.urolonc.2022.10.031","title":"25 years International Bladder Cancer Network (IBCN): The past, the present, and the future","year":2022,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multidisciplinary approach; Bladder cancer; Pandemic; Coronavirus disease 2019 (COVID-19); Work (physics); Cancer; Medical education; Family medicine; Pathology; Disease; Internal medicine; Social science; Sociology; Engineering","score_opus":0.045583978504341864,"score_gpt":0.3597876445404012,"score_spread":0.3142036660360593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309947504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013187538,0.93802005,0.0000027560527,0.054855987,0.0014286079,0.0014054272,0.00010585994,0.000030470133,0.0040189778],"genre_scores_gemma":[0.00001527041,0.9831429,0.00038052603,0.006273267,0.0047154315,0.0017245988,0.00013007542,0.000029127412,0.0035888015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979649,0.0006185808,0.0003883549,0.00043158274,0.00027460066,0.00032194605],"domain_scores_gemma":[0.99803257,0.0010876445,0.00033080392,0.00038643365,0.000035527017,0.00012700433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060667045,0.00033988728,0.00078374485,0.000059713275,0.0007945686,0.00006661687,0.000407843,0.00026966282,0.0007623451],"category_scores_gemma":[0.000041619267,0.0001449317,0.0002216162,0.00033238056,0.0017233598,0.000045596957,0.00027362432,0.0011829456,0.000009957105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014036552,0.00009479032,0.003942512,0.00024640444,0.00167158,0.000109199216,0.0008181382,0.000024174828,2.5777348e-8,0.0118473265,0.26384884,0.71725667],"study_design_scores_gemma":[0.0008642248,0.0002859103,0.00023179516,0.00017544389,0.0030341062,0.00070432125,0.00020952059,0.000039238093,1.8525975e-8,0.0023463732,0.99197173,0.0001373225],"about_ca_topic_score_codex":0.00016200094,"about_ca_topic_score_gemma":0.00006820178,"teacher_disagreement_score":0.7281229,"about_ca_system_score_codex":0.00015440032,"about_ca_system_score_gemma":0.00069851405,"threshold_uncertainty_score":0.8347144},"labels":[],"label_agreement":null},{"id":"W4310032409","doi":"10.1080/14656566.2022.2150966","title":"Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Chemotherapy; Oncology; Intensive care medicine; Clinical trial; Quality of life (healthcare); Internal medicine; Cancer","score_opus":0.06604193749230337,"score_gpt":0.38864061052098337,"score_spread":0.32259867302868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310032409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010371502,0.98901314,0.0000017192477,0.0030922503,0.0014027669,0.002837292,0.00019768954,0.000070440685,0.0032809868],"genre_scores_gemma":[0.000111335496,0.9876846,0.0000428837,0.0076004304,0.0029292686,0.00092151697,0.000067021116,0.00022921266,0.0004137369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972063,0.00042514355,0.00052473997,0.00080802036,0.00068434095,0.00035146336],"domain_scores_gemma":[0.9983885,0.00031733024,0.0003559185,0.0007294983,0.000049158447,0.0001595621],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023609046,0.0008058198,0.0015863341,0.00027970408,0.00025536877,0.0000312947,0.00035925597,0.00021965898,0.0067744516],"category_scores_gemma":[0.0000056651725,0.00046021427,0.0007558669,0.0003564031,0.00019046554,0.000045853543,0.000032529588,0.00075948774,0.00001648542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015360025,0.00088378054,0.0000061694354,0.0003585376,0.0009722913,0.000009957944,0.0047930228,5.7052045e-8,0.00007455513,0.0010568821,0.011630995,0.97867775],"study_design_scores_gemma":[0.0047760094,0.0024734745,0.000010046713,0.00065536663,0.000050677223,0.000055674496,0.0011274428,0.0000016516288,0.00051694515,0.00003561948,0.98991716,0.00037991995],"about_ca_topic_score_codex":0.000027341886,"about_ca_topic_score_gemma":1.8762383e-7,"teacher_disagreement_score":0.9782978,"about_ca_system_score_codex":0.0002492566,"about_ca_system_score_gemma":0.00040796978,"threshold_uncertainty_score":0.99978495},"labels":[],"label_agreement":null},{"id":"W4310143449","doi":"10.3390/curroncol29120727","title":"Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Concomitant; Medicine; Hazard ratio; Bladder cancer; Urology; Proportional hazards model; Confidence interval; Risk factor; Internal medicine; Cancer","score_opus":0.09988489705996992,"score_gpt":0.39126003769197687,"score_spread":0.291375140632007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310143449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571829,0.0068854964,0.0006529389,0.004652043,0.008470115,0.004074609,0.014569979,0.00021804366,0.0032938798],"genre_scores_gemma":[0.99309385,0.00043462784,0.00044491043,0.0025937168,0.000698579,0.0013834672,0.00012810367,0.000067195855,0.0011555293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749774,0.00020769698,0.00051885174,0.0007115124,0.00042067605,0.0006435484],"domain_scores_gemma":[0.99840933,0.00037749682,0.00029384065,0.0004472029,0.00017598637,0.00029613834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002519042,0.00035590152,0.0007186291,0.0001581322,0.00039206017,0.000018690069,0.0002445687,0.0000993233,0.008070307],"category_scores_gemma":[0.00017459023,0.00030924662,0.00038064184,0.0002055774,0.00014588253,0.000079077145,0.00013969156,0.0007659489,0.00010056637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005243956,0.007440979,0.06697158,0.00025256467,0.0012135932,0.00022631841,0.006995863,0.0000070880883,0.002015522,0.0002820876,0.09956067,0.8097898],"study_design_scores_gemma":[0.010710466,0.005706598,0.040254135,0.00003313109,0.0008502533,0.00029449284,0.00084247626,0.00040086656,0.0028827505,0.000289163,0.9373039,0.00043176516],"about_ca_topic_score_codex":0.00004689384,"about_ca_topic_score_gemma":0.000010523389,"teacher_disagreement_score":0.8377432,"about_ca_system_score_codex":0.0007217841,"about_ca_system_score_gemma":0.0009804575,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W4310951544","doi":"10.1111/bju.15944","title":"Oncological impact of cystoscopic findings in <scp>non‐muscle</scp> ‐invasive bladder cancer: a meta‐analysis","year":2022,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Internal medicine; Confidence interval; Meta-analysis; Oncology; Cystoscopy; Urology; Cancer; Urinary system","score_opus":0.07514506466472629,"score_gpt":0.3776504581658532,"score_spread":0.30250539350112693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310951544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064118337,0.9915559,0.000012699884,0.000051981315,0.00026443688,0.00068223645,0.0004823864,0.000008589735,0.0005299318],"genre_scores_gemma":[0.008100077,0.99078465,0.00010694274,0.00023579232,0.00024692828,0.00016998977,0.00008062234,0.000060879476,0.00021415121],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99587655,0.0007363325,0.0017691553,0.00048489054,0.0005617425,0.0005713526],"domain_scores_gemma":[0.9963763,0.00132723,0.0015163491,0.00028384652,0.00019400282,0.00030230955],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070469745,0.00050099276,0.007625252,0.0012054576,0.000069760375,0.000023854833,0.00045827168,0.0005445025,0.0037267902],"category_scores_gemma":[0.00049301167,0.00040802034,0.0059950734,0.0014616614,0.00017782609,0.000083471736,0.00013436128,0.0017004316,0.000005640226],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001499754,0.0019016049,0.0024525777,0.004253701,0.52822876,0.023351172,0.00042944372,0.00020265367,0.0000066731664,0.0000040242694,0.0042695305,0.4347499],"study_design_scores_gemma":[0.0030684292,0.0064123524,0.00950587,0.0010964322,0.5898477,0.013990811,0.00006727707,0.000002439195,0.0000015491446,0.000048704904,0.37577558,0.0001828721],"about_ca_topic_score_codex":0.0019083488,"about_ca_topic_score_gemma":0.0007281425,"teacher_disagreement_score":0.43456703,"about_ca_system_score_codex":0.00071053195,"about_ca_system_score_gemma":0.0032878248,"threshold_uncertainty_score":0.99983716},"labels":[],"label_agreement":null},{"id":"W4310982511","doi":"10.22374/jeleu.v5i3.147","title":"Diode Laser for the Management of Upper Tract Urothelial Cancer (UTUC) – Case Series.","year":2022,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelial cancer; Series (stratigraphy); Urology; Medicine; Upper urinary tract; Geology; Cancer; Bladder cancer; Internal medicine; Urinary system; Paleontology","score_opus":0.025521402325420935,"score_gpt":0.30917138105124636,"score_spread":0.2836499787258254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310982511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752397,0.0057288846,0.00073378434,0.011647881,0.0027677238,0.0013925264,0.00045622198,0.00001734924,0.002015922],"genre_scores_gemma":[0.99467903,0.00060296676,0.00089449895,0.0009366932,0.00059464655,0.0002059473,0.0000045663805,0.00003357381,0.0020480948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985876,0.00009494191,0.00051052304,0.00015970181,0.00035154613,0.00029568392],"domain_scores_gemma":[0.9989705,0.00016594681,0.00039831377,0.00021502323,0.00014650673,0.00010370117],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004070372,0.00016062791,0.00044828677,0.00012271524,0.00020983614,0.000007170886,0.00019036622,0.000042605025,0.0011461404],"category_scores_gemma":[0.000017969112,0.00010919521,0.00036092038,0.00013275402,0.0001142469,0.00007373869,0.000073539966,0.0003720558,0.0000013720365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19320552,0.013255963,0.10637164,0.0028183816,0.032398954,0.20062748,0.00998984,0.011966016,0.018871801,0.006693736,0.062785774,0.3410149],"study_design_scores_gemma":[0.03002001,0.01786033,0.0141504025,0.00008904402,0.0074082813,0.304206,0.004613215,0.00022399855,0.008545764,0.00057164003,0.61194277,0.00036853427],"about_ca_topic_score_codex":0.00013775853,"about_ca_topic_score_gemma":0.00002017648,"teacher_disagreement_score":0.549157,"about_ca_system_score_codex":0.00012322086,"about_ca_system_score_gemma":0.00020991941,"threshold_uncertainty_score":0.99976695},"labels":[],"label_agreement":null},{"id":"W4310988827","doi":"10.3390/curroncol29120728","title":"Efficacy and Safety of the “Trisection Method” Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Institution; Training (meteorology); Robot; Medical education; Artificial intelligence; Computer science; Bladder cancer; Internal medicine; Cancer","score_opus":0.14225189432447244,"score_gpt":0.39979228709495324,"score_spread":0.2575403927704808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310988827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074054,0.0011560798,0.0030572896,0.00047718704,0.0018151639,0.0017731423,0.00004267843,0.000034561694,0.0009033378],"genre_scores_gemma":[0.9990294,0.000010197945,0.00047340247,0.000027312622,0.00009240156,0.000291911,0.000024649395,0.00000912413,0.000041625073],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989336,0.00028626368,0.00028704063,0.00020732281,0.0001344106,0.00015132209],"domain_scores_gemma":[0.99949706,0.00017939047,0.0001282199,0.000117368545,0.000028233984,0.0000497046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036962947,0.000089486115,0.00033136376,0.0000916383,0.00018377352,0.0000022206489,0.000052139403,0.000059276637,0.000020467643],"category_scores_gemma":[0.00007837674,0.00006723156,0.000073986244,0.00022239235,0.00007802619,0.000018725395,0.00007153038,0.00018005141,3.5888746e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010286581,0.0021267436,0.03526546,0.0008344961,0.00019656861,0.000012701705,0.006565976,0.00042493863,0.023567049,0.0007515828,0.00024958892,0.9197183],"study_design_scores_gemma":[0.08637172,0.009286147,0.64850813,0.0008214415,0.0012252822,0.0019948971,0.0049186554,0.004055589,0.0056347153,0.00006180254,0.23675746,0.0003641675],"about_ca_topic_score_codex":0.000037606183,"about_ca_topic_score_gemma":0.00005733696,"teacher_disagreement_score":0.91935414,"about_ca_system_score_codex":0.0014499677,"about_ca_system_score_gemma":0.0002443431,"threshold_uncertainty_score":0.3791615},"labels":[],"label_agreement":null},{"id":"W4311025044","doi":"10.1016/j.annonc.2022.11.012","title":"Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Pharmacyclics; Merck Sharp and Dohme; EMD Serono; Genentech; Ipsen; Universidad de Navarra; Basilea Pharmaceutica; Astellas Pharma; Eisai; Seagen; Foundation Medicine; Flatiron Health; G1 Therapeutics; GlaxoSmithKline; UroGen Pharma; Bavarian Nordic; Silverback Therapeutics; Pfizer; Innovent Biologics; Incyte; BeiGene; Mirati Therapeutics; Clovis Oncology; Les Laboratories Pierre Fabre; Celldex Therapeutics; Advanced Accelerator Applications; National Institutes of Health; Natera; Regeneron Pharmaceuticals; Merck KGaA; Endocyte; Gilead Sciences; Exelixis; Sanofi; Amgen; Allergan; AstraZeneca; Ignyta; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Oncology; Internal medicine; Expanded access; Cancer; Immunotherapy; Bladder cancer","score_opus":0.05259067387769641,"score_gpt":0.3455086135433258,"score_spread":0.2929179396656294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311025044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994575,0.0010820493,0.000006880392,0.0017883922,0.00019775094,0.0006320717,0.001060144,0.00000616192,0.0006515254],"genre_scores_gemma":[0.9982985,0.00019196211,0.00028273548,0.00083180174,0.000037961167,0.000049895472,0.00003909822,0.00002088159,0.0002471484],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983596,0.00020448877,0.0006174839,0.00033299933,0.0002547467,0.00023064378],"domain_scores_gemma":[0.998932,0.00038099068,0.00019693631,0.00027784772,0.00008551821,0.00012669932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031961137,0.00014823559,0.0007830549,0.00022011447,0.000024934228,0.0000021075903,0.00009415959,0.00006851227,0.00015497711],"category_scores_gemma":[0.00020230204,0.00014532763,0.000085662585,0.00021048136,0.00013857897,0.000036181857,0.00016485598,0.00016301512,0.0000020580082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5760968,0.003520304,0.073246144,0.0004833569,0.0017169904,0.001124916,0.055055458,0.00014503878,0.021980356,0.00020351665,0.0064277663,0.25999936],"study_design_scores_gemma":[0.061179284,0.013139572,0.9024272,0.0000989462,0.0003971838,0.000045063356,0.001078499,0.000027053215,0.008194535,0.00038573172,0.01282762,0.00019929408],"about_ca_topic_score_codex":0.004059969,"about_ca_topic_score_gemma":0.00029523985,"teacher_disagreement_score":0.8291811,"about_ca_system_score_codex":0.000051173716,"about_ca_system_score_gemma":0.00031572368,"threshold_uncertainty_score":0.61374855},"labels":[],"label_agreement":null},{"id":"W4311190457","doi":"10.22374/jeleu.v5i3.155","title":"Check Cystoscopy Follow-up Practice for Low-Risk (pTa) Non-muscle Invasive Bladder Cancer in the United Kingdom","year":2022,"lang":"en","type":"article","venue":"Journal of Endoluminal Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Edinburgh","keywords":"Cystoscopy; Medicine; Bladder cancer; Urology; Cystectomy; Fulguration; Stage (stratigraphy); Surgery; Cancer; Internal medicine; Urinary system","score_opus":0.03489864332333768,"score_gpt":0.33694238741072835,"score_spread":0.30204374408739065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311190457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98626393,0.00084591424,0.0003557878,0.00905958,0.0016776173,0.000908728,0.00012175502,0.000010569757,0.00075609947],"genre_scores_gemma":[0.9910853,0.00038118148,0.00068641634,0.0064379214,0.00081487786,0.0003004351,0.000018507351,0.00004543386,0.00022992054],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974192,0.00055674516,0.000674086,0.0002699886,0.00058637984,0.0004935986],"domain_scores_gemma":[0.9968995,0.0014140093,0.0008810837,0.0002858875,0.00037837637,0.00014112995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012319521,0.0002403552,0.00059074006,0.00043898696,0.00028111885,0.000023947105,0.00037884552,0.00009682171,0.00045776466],"category_scores_gemma":[0.0010722413,0.0001773158,0.00032599826,0.0005492472,0.00010724161,0.00016910443,0.000079809084,0.0011873111,0.0000049245427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24864502,0.022777002,0.21986306,0.0011543196,0.01612297,0.033227492,0.072370455,0.020791864,0.12192885,0.0023741045,0.19979456,0.04095031],"study_design_scores_gemma":[0.10893522,0.05472698,0.09015994,0.00029893825,0.008895045,0.021517258,0.023687817,0.0012812534,0.0077816956,0.0011401733,0.6805672,0.0010084821],"about_ca_topic_score_codex":0.0017257183,"about_ca_topic_score_gemma":0.00032546528,"teacher_disagreement_score":0.48077264,"about_ca_system_score_codex":0.00029026327,"about_ca_system_score_gemma":0.0009512898,"threshold_uncertainty_score":0.7230729},"labels":[],"label_agreement":null},{"id":"W4311229846","doi":"10.1016/j.semradonc.2022.10.006","title":"The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer","year":2022,"lang":"en","type":"review","venue":"Seminars in Radiation Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Chemotherapy; Oncology; Radiation therapy; Randomized controlled trial; Urology; Standard of care; Disease; Internal medicine; Cancer; Surgery","score_opus":0.06832841409171829,"score_gpt":0.3730635528173802,"score_spread":0.3047351387256619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311229846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012061818,0.9912579,9.809453e-7,0.00059828686,0.00032133132,0.002546394,0.00005555778,0.000013260572,0.0040000738],"genre_scores_gemma":[0.0011361567,0.99472064,0.000072054056,0.00017901466,0.00016258568,0.0030013458,0.00024137206,0.000063197964,0.000423661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972194,0.00056022574,0.0010235526,0.0004960111,0.00031494218,0.00038587063],"domain_scores_gemma":[0.9979496,0.00095868757,0.00059655536,0.00040590914,0.000031876472,0.000057385223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006747993,0.00034389884,0.0014441231,0.0005171737,0.000053935953,0.000008710036,0.00026889925,0.0004542509,0.0004488946],"category_scores_gemma":[0.00018553429,0.00026558613,0.0002068826,0.0009381867,0.00011266143,0.00009290193,0.00006769052,0.0007161508,0.0000039919155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014807109,0.0004741695,0.0030907893,0.0007366823,0.00017275367,0.000030134826,0.0023170114,0.000079579506,0.0000030476926,0.000086678745,0.00033843896,0.99252266],"study_design_scores_gemma":[0.0026365644,0.0005011746,0.003446412,0.0016821106,0.0002439562,0.000016966776,0.0009975933,0.00016718538,0.000021239213,0.0002999727,0.9897806,0.00020622688],"about_ca_topic_score_codex":0.0011751158,"about_ca_topic_score_gemma":0.0029681912,"teacher_disagreement_score":0.9923164,"about_ca_system_score_codex":0.0023224829,"about_ca_system_score_gemma":0.002364057,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W4311423887","doi":"10.1016/j.euf.2022.12.003","title":"A Systematic Review and Meta-analysis of Chemoablation for Non–muscle-invasive Bladder Cancer","year":2022,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Bladder cancer; Odds ratio; Internal medicine; Meta-analysis; Gemcitabine; Regimen; Carcinoma in situ; Mitomycin C; Adverse effect; Confidence interval; Urology; Epirubicin; Cystectomy; Oncology; Surgery; Cancer; Breast cancer","score_opus":0.09415758227427964,"score_gpt":0.36051385228027377,"score_spread":0.26635627000599416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311423887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.5284932e-7,0.99113786,0.000045403183,0.0002835377,0.00005645919,0.0053310925,0.0007807537,0.000026513942,0.0023379428],"genre_scores_gemma":[0.000049889946,0.9944166,0.00005506373,0.0013048308,0.000052873675,0.0021875065,0.00031284432,0.00010957274,0.0015107997],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968541,0.0008300204,0.0011987538,0.00064083457,0.00022395965,0.0002522798],"domain_scores_gemma":[0.9973751,0.0005686371,0.0011081521,0.00072921795,0.00011086208,0.0001080707],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007438424,0.00049185025,0.0084786,0.00038991336,0.00007673248,0.000008217556,0.00020116923,0.0001032524,0.0020055408],"category_scores_gemma":[0.00026600837,0.00032578578,0.0029369895,0.0006818807,0.000076990225,0.000029029694,0.000109872555,0.00026139186,0.0000175947],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012939151,0.00007022542,8.119882e-7,0.59303474,0.3969079,0.00003808661,0.000072891926,7.210923e-7,2.0401704e-7,0.000013821116,0.00058929494,0.009258397],"study_design_scores_gemma":[0.00030811795,0.0003182263,0.0000067940314,0.0034144085,0.834096,0.000038377762,0.0000043371056,0.0000018621471,3.962486e-7,0.0000037646594,0.16163205,0.00017568078],"about_ca_topic_score_codex":0.000033824992,"about_ca_topic_score_gemma":0.00002028176,"teacher_disagreement_score":0.5896203,"about_ca_system_score_codex":0.00008125291,"about_ca_system_score_gemma":0.00023126593,"threshold_uncertainty_score":0.9999194},"labels":[],"label_agreement":null},{"id":"W4312071191","doi":"10.3390/curroncol30010002","title":"Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Oncology; Internal medicine; Meta-analysis; Radiation therapy; Clinical endpoint; Randomized controlled trial; Adjuvant therapy; Subgroup analysis; Cancer","score_opus":0.3074163672074743,"score_gpt":0.4839237022761,"score_spread":0.1765073350686257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312071191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.035517e-7,0.9849639,0.00009817421,0.00032574183,0.0004605447,0.012695552,0.0012367571,0.00004091637,0.00017824303],"genre_scores_gemma":[0.0000029332134,0.9823497,0.00015687225,0.00073072605,0.00021202,0.014537769,0.0009008503,0.000098371675,0.0010107595],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961378,0.0008617375,0.0014078445,0.0008538538,0.0003241525,0.00041460033],"domain_scores_gemma":[0.997346,0.00070404744,0.0008374666,0.00079452456,0.00008353281,0.00023444873],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007428155,0.0007382471,0.016397262,0.00043333563,0.00012949877,0.000018031502,0.00025489062,0.00024029572,0.0033998063],"category_scores_gemma":[0.0001358149,0.00044920066,0.0061780578,0.0005433336,0.000077714045,0.000036383513,0.000059837275,0.00052321417,0.000013699727],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020635538,0.0005224742,0.0000053765,0.7966963,0.13680719,0.00002776147,0.000057243953,2.9058162e-8,1.2874127e-8,0.000021940725,0.001427904,0.06441313],"study_design_scores_gemma":[0.00055171305,0.0005177345,8.3305605e-7,0.0028388044,0.49740615,0.00019520194,0.000004942401,0.0000014962834,2.2143228e-8,0.0000030311428,0.4983078,0.00017227439],"about_ca_topic_score_codex":0.000014261091,"about_ca_topic_score_gemma":0.000004136576,"teacher_disagreement_score":0.7938575,"about_ca_system_score_codex":0.00078026624,"about_ca_system_score_gemma":0.00092442933,"threshold_uncertainty_score":0.999796},"labels":[],"label_agreement":null},{"id":"W4312140743","doi":"10.1016/j.urolonc.2022.10.033","title":"Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design","year":2022,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Concordance; Medicine; Cystectomy; Cystoscopy; Carcinoma in situ; Urology; Biopsy; Carcinoma; Radiology; Internal medicine; Cancer; Urinary system","score_opus":0.12152041395633523,"score_gpt":0.3948277263792842,"score_spread":0.273307312422949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312140743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940401,0.00055393367,0.0002465999,0.0034719447,0.00020076922,0.0012088591,0.000025807512,0.0000072150037,0.00024478135],"genre_scores_gemma":[0.99523205,0.00017485936,0.0036483782,0.00032442136,0.000058825906,0.00047659592,0.0000075139315,0.000005388597,0.00007196737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990301,0.00026790207,0.00034376932,0.00019059278,0.00006713099,0.00010050318],"domain_scores_gemma":[0.9991152,0.00046823747,0.00018028714,0.00013873287,0.00004480742,0.000052730073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000576524,0.00006983473,0.00023464774,0.0000870826,0.00019606175,0.0000022439417,0.000051776828,0.0000919916,0.000009482375],"category_scores_gemma":[0.00021855773,0.000053013955,0.000057092533,0.00022241003,0.0003828996,0.000026808772,0.000042525342,0.00019512272,8.614769e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023182014,0.0010448472,0.94693166,0.000052464125,0.0001227066,0.0000034864,0.0006941515,0.00014265749,0.010440751,0.003922169,0.0011589108,0.012304186],"study_design_scores_gemma":[0.0706156,0.09438403,0.6132469,0.00003735252,0.0015589771,0.0004889892,0.0010854766,0.0012841607,0.012189524,0.056757096,0.14807925,0.00027260167],"about_ca_topic_score_codex":0.00007673784,"about_ca_topic_score_gemma":0.00010122551,"teacher_disagreement_score":0.3336847,"about_ca_system_score_codex":0.0000689641,"about_ca_system_score_gemma":0.0003261406,"threshold_uncertainty_score":0.21618463},"labels":[],"label_agreement":null},{"id":"W4312155777","doi":"10.1038/s41467-022-35644-0","title":"Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation","year":2022,"lang":"en","type":"erratum","venue":"Nature Communications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute","keywords":"Psychological repression; Lineage (genetic); Immune system; FOXA1; Biology; Cancer research; Immune surveillance; Medicine; Immunology; Genetics; Gene; Gene expression","score_opus":0.020398838660281186,"score_gpt":0.31681103708076125,"score_spread":0.29641219842048006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312155777","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2317979,0.47607723,0.0009297826,0.030019151,0.10299954,0.017026482,0.0036889233,0.0019256712,0.1355353],"genre_scores_gemma":[0.96111405,0.004185961,0.00049345713,0.0002962746,0.00034006548,0.0005480675,0.0034377119,0.00008245377,0.029501967],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9980829,0.0002777098,0.00041777157,0.00053923705,0.00042805602,0.00025435555],"domain_scores_gemma":[0.9975337,0.0002608865,0.00032445605,0.0015969855,0.00015851732,0.00012546145],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00012165899,0.00037456106,0.0005933633,0.00027924543,0.0005132965,0.000044072036,0.00042178592,0.0007434905,0.00020063373],"category_scores_gemma":[0.00019492186,0.0003130126,0.00011262934,0.00043815002,0.00018460417,0.00009629898,0.00043153152,0.0041378937,0.0000022557813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027951137,0.0028863132,0.07789885,0.0005982023,0.0019110807,0.00012832214,0.004713812,0.00027104333,0.0007815089,0.0002308437,0.9003004,0.0074845334],"study_design_scores_gemma":[0.0048135803,0.0011070091,0.6752709,0.0011035077,0.0016414601,0.00022918335,0.0005973778,0.0050592055,0.0007803709,0.000029122948,0.30855533,0.0008129311],"about_ca_topic_score_codex":0.0009986823,"about_ca_topic_score_gemma":0.010198975,"teacher_disagreement_score":0.7293161,"about_ca_system_score_codex":0.00071940647,"about_ca_system_score_gemma":0.00059024786,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W4312290542","doi":"10.48083/dfbq7749","title":"The CABEM Initiative: Saving Patients With Muscle-invasive Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Multidisciplinary approach; Disease; Cancer; Internal medicine; Political science","score_opus":0.03220035539108795,"score_gpt":0.31171165428208514,"score_spread":0.2795112988909972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312290542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929454,0.001307887,0.00006887098,0.008821518,0.0015633819,0.00045040154,0.00017325315,0.000046439185,0.008273714],"genre_scores_gemma":[0.9919748,0.0005022181,0.00009643765,0.0044683083,0.0004892336,0.00020742067,0.00004988691,0.000026725782,0.0021850124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981297,0.00014729064,0.00029216122,0.0002198811,0.0008879907,0.0003229464],"domain_scores_gemma":[0.99861294,0.00036327995,0.00030046047,0.0001577777,0.00045242877,0.00011312285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024574267,0.00017753239,0.0001980395,0.000084128784,0.00107528,0.000073647134,0.00028515063,0.00004031628,0.0024748214],"category_scores_gemma":[0.00016822468,0.0001108699,0.00015046088,0.00014210146,0.0001192843,0.00014564938,0.00014657188,0.00076719414,0.000007946892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015512771,0.000679894,0.9281367,0.000011456852,0.002286678,0.0002305908,0.0017962517,0.0005159504,0.00011217312,0.00024203406,0.022125734,0.042311236],"study_design_scores_gemma":[0.006372109,0.0014596696,0.93111414,0.000031001786,0.00029004694,0.0001598317,0.002164307,0.000039655057,0.00011173845,0.0010294089,0.057030253,0.00019786254],"about_ca_topic_score_codex":0.00004711776,"about_ca_topic_score_gemma":0.000064275235,"teacher_disagreement_score":0.042113375,"about_ca_system_score_codex":0.0007266149,"about_ca_system_score_gemma":0.00071478885,"threshold_uncertainty_score":0.99843705},"labels":[],"label_agreement":null},{"id":"W4312784136","doi":"10.48083/gbma2534","title":"A Systematic Review of Plant-Based Diets and Bladder Cancer: A Call for Further Research","year":2022,"lang":"en","type":"review","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Prostate Cancer Foundation","keywords":"Bladder cancer; Medicine; Cancer; Systematic review; Oncology; Internal medicine; MEDLINE; Biology","score_opus":0.21740065180606624,"score_gpt":0.484234478213389,"score_spread":0.2668338264073228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312784136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000041823546,0.9927474,0.00003603322,0.0012097274,0.0004902808,0.0036493465,0.0012349117,0.000017588683,0.0006105008],"genre_scores_gemma":[0.000014028732,0.9944474,0.00013818307,0.0010314853,0.00037643293,0.0021772557,0.00029631355,0.00005501887,0.0014638676],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963866,0.00064312137,0.0012008686,0.00035999,0.0010511093,0.0003583415],"domain_scores_gemma":[0.9960897,0.0019816866,0.0009670123,0.00029467512,0.0005141936,0.00015273725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020675012,0.00033699904,0.0024041743,0.00036000146,0.00017151362,0.000034259043,0.00039836863,0.00019296489,0.0015246198],"category_scores_gemma":[0.0013450525,0.00022844347,0.0009362218,0.00020594809,0.00012883871,0.00004741024,0.000113159185,0.0010637993,0.0000039601073],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015351086,0.0002233618,0.000026685319,0.9296308,0.0035320614,0.000088962894,0.00010312801,4.3292806e-7,2.7836364e-7,0.000036742225,0.011463231,0.054740798],"study_design_scores_gemma":[0.0014297602,0.00081013405,0.000005898897,0.3950057,0.0052942983,0.000645451,0.00008055376,0.000016448337,7.6376574e-7,0.00012148025,0.5964112,0.00017830936],"about_ca_topic_score_codex":0.000031085918,"about_ca_topic_score_gemma":0.000006867282,"teacher_disagreement_score":0.58494794,"about_ca_system_score_codex":0.00067693193,"about_ca_system_score_gemma":0.0019633041,"threshold_uncertainty_score":0.9993881},"labels":[],"label_agreement":null},{"id":"W4312927265","doi":"10.48083/rvzv1144","title":"Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape","year":2022,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Biomarker; Medicine; Bladder cancer; Predictive value; Biomarker discovery; Disease; Cancer; Oncology; Internal medicine; Biology; Proteomics","score_opus":0.04729027409747367,"score_gpt":0.35771180517007495,"score_spread":0.3104215310726013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312927265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97605366,0.007327661,0.000066507826,0.004049183,0.00035936062,0.00045261264,0.00004537459,0.00001362138,0.011632027],"genre_scores_gemma":[0.9978573,0.0010146564,0.00009594102,0.00057197054,0.00010878587,0.00016375753,0.000012249583,0.00000984935,0.00016552766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863744,0.00021261198,0.00026898316,0.0001819774,0.000516584,0.00018240276],"domain_scores_gemma":[0.99951047,0.00008559159,0.00014485362,0.00012531741,0.00010135528,0.000032402146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051742455,0.00010825628,0.0001721419,0.00021768031,0.000106358115,0.000022222708,0.00028566972,0.00003092724,0.0020029182],"category_scores_gemma":[0.000012564845,0.000078023295,0.00010263146,0.00023350188,0.00005966298,0.00013176927,0.00006636995,0.00043415662,7.434905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017308039,0.0013707316,0.9646377,0.0000240275,0.0021424822,0.00035981147,0.013946704,0.0014336171,0.00016974164,0.0004573685,0.00079320464,0.012933793],"study_design_scores_gemma":[0.0037091966,0.0008846431,0.91679615,0.00003822946,0.00014817815,0.00013316811,0.07459445,0.0013739043,0.000023975274,0.0017841086,0.00043402353,0.00007996158],"about_ca_topic_score_codex":0.00007973785,"about_ca_topic_score_gemma":0.00004063558,"teacher_disagreement_score":0.06064775,"about_ca_system_score_codex":0.00043496367,"about_ca_system_score_gemma":0.00014265245,"threshold_uncertainty_score":0.9989094},"labels":[],"label_agreement":null},{"id":"W4313035208","doi":"10.2139/ssrn.4252418","title":"Differences in Overall Survival of T2N0M0 Bladder Cancer Patients vs. Population-Based Controls According to Treatment Modalities","year":2022,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Medicine; Internal medicine; Oncology; Population; Modalities; Cancer; Environmental health","score_opus":0.017884052675231424,"score_gpt":0.2802735808975213,"score_spread":0.2623895282222899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313035208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970886,0.0008890507,0.00006941267,0.00091200764,0.00027987114,0.000516746,0.0000782867,0.000013224808,0.00015276276],"genre_scores_gemma":[0.99843776,0.00031477644,0.000014516756,0.00027049493,0.00012276853,0.00016726802,0.000033897413,0.000025888383,0.0006126181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977413,0.00013693482,0.00038978085,0.00021312528,0.00049787865,0.0010209751],"domain_scores_gemma":[0.9994673,0.00006727229,0.00016149979,0.00012706182,0.00007627101,0.00010060407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002725989,0.00019433798,0.00048749874,0.0002280954,0.00015973115,0.0000162474,0.00011219946,0.00003375754,0.00023235915],"category_scores_gemma":[0.000023355613,0.00015537172,0.00014669044,0.0001822325,0.000014279985,0.00006786506,0.000024733205,0.00046344937,0.0000013598932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016563607,0.0006152986,0.9902358,0.000008382509,0.000373509,0.000004018873,0.00032677548,0.0005563461,0.00009862032,0.0010910089,0.000006777216,0.0050270716],"study_design_scores_gemma":[0.016537711,0.0074198437,0.96701676,0.00007012213,0.00028975922,0.000015239102,0.0021882153,0.00027806434,0.00023496877,0.005508039,0.00017441077,0.00026688052],"about_ca_topic_score_codex":0.008679858,"about_ca_topic_score_gemma":0.0033870125,"teacher_disagreement_score":0.023219084,"about_ca_system_score_codex":0.0037085053,"about_ca_system_score_gemma":0.0021195365,"threshold_uncertainty_score":0.9979214},"labels":[],"label_agreement":null},{"id":"W4313198740","doi":"10.14740/wjon1536","title":"Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Lymph node metastasis; Metastasis; Oncology; Association (psychology); Lymph node; Cancer; Internal medicine","score_opus":0.03410703386892047,"score_gpt":0.33606068086659996,"score_spread":0.30195364699767946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313198740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092704,0.00087998126,0.000009378511,0.0053081512,0.0005485667,0.0001474287,0.000079169426,0.000004365144,0.0020959405],"genre_scores_gemma":[0.996792,0.000088718676,0.00021978664,0.0013372438,0.00020714993,0.000020090763,0.0000056994945,0.000013648562,0.001315628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987699,0.00019094216,0.00043001494,0.000113816015,0.00030857982,0.0001867757],"domain_scores_gemma":[0.9991715,0.0001434835,0.00041391855,0.000058413105,0.0001191042,0.00009359297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041656435,0.000095982454,0.0004531409,0.00033906786,0.00006074198,0.000006744862,0.00007098074,0.000038958893,0.0009790222],"category_scores_gemma":[0.000051352203,0.00008269096,0.00007716492,0.0002483621,0.000020507037,0.000070480615,0.00006344593,0.00032851507,0.0000021796022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029290965,0.0003298095,0.9483658,0.000009491482,0.0006624062,0.0000671592,0.00056339067,0.00001784376,0.000076132026,0.000004684916,0.0029753817,0.04663499],"study_design_scores_gemma":[0.007927575,0.001020708,0.9225237,0.00003143043,0.000612398,0.00003637621,0.00013274171,0.0000036501108,0.00018111174,0.000111515445,0.067347445,0.00007136276],"about_ca_topic_score_codex":0.0001938192,"about_ca_topic_score_gemma":0.00024808105,"teacher_disagreement_score":0.06437206,"about_ca_system_score_codex":0.0022749393,"about_ca_system_score_gemma":0.00039247985,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W4313202305","doi":"10.51731/cjht.2022.531","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Drug; Adjuvant; Oncology; Internal medicine; Cancer; Pharmacology; Immunotherapy; Political science","score_opus":0.030712421897495686,"score_gpt":0.29070101617694755,"score_spread":0.25998859427945187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313202305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41696537,0.30435625,0.00019945436,0.26845706,0.0024877053,0.0009871019,0.0001786458,0.00034166235,0.006026773],"genre_scores_gemma":[0.9975039,0.0001796858,0.00030212582,0.0016343893,0.000012434746,0.0000117305335,0.00000250443,0.000012721181,0.00034050763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990362,0.000037781203,0.0003214699,0.00008994967,0.00018478573,0.0003298064],"domain_scores_gemma":[0.9994307,0.000012598808,0.00019650537,0.00018705524,0.00007016363,0.00010293622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002964033,0.00008046446,0.00028443174,0.00047261748,0.0003967653,0.000009613187,0.00019308268,0.00004067784,0.0003304747],"category_scores_gemma":[0.00008767348,0.00007047202,0.000078080855,0.00028543477,0.000088527944,0.00004049541,0.000023250377,0.000463977,0.000006448027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078003424,0.00006401161,0.025736496,0.0000721192,0.00012167135,0.001065802,0.00054665946,0.000015937314,0.000030722334,0.0008157444,0.048252314,0.92320055],"study_design_scores_gemma":[0.0017630672,0.0030584435,0.014370776,0.00006967522,0.00003862698,0.0031545819,0.006776036,0.000004048174,0.00027091758,0.0028303734,0.9675561,0.00010734232],"about_ca_topic_score_codex":0.0062060338,"about_ca_topic_score_gemma":0.001057111,"teacher_disagreement_score":0.9230932,"about_ca_system_score_codex":0.00094992673,"about_ca_system_score_gemma":0.005222593,"threshold_uncertainty_score":0.93817085},"labels":[],"label_agreement":null},{"id":"W4313231353","doi":"10.3389/fonc.2022.1126494","title":"Editorial: Therapies and influences in urothelial carcinoma","year":2022,"lang":"en","type":"editorial","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Urothelial carcinoma; Genitourinary system; Medicine; Oncology; Urology; Internal medicine; General surgery; Gynecology; Bladder cancer; Cancer","score_opus":0.010276872172217908,"score_gpt":0.3007808507740994,"score_spread":0.2905039786018815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313231353","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048983237,0.007926651,0.0000035568676,0.00044418452,0.98347163,0.0007489066,0.00017670938,0.000033105764,0.002296948],"genre_scores_gemma":[0.0020525227,0.0034637994,0.00069643004,0.00019216412,0.99194664,0.00049994414,0.00017658113,0.00006732905,0.0009045941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997525,0.0002922238,0.0004863567,0.00063792296,0.00061156484,0.0004469748],"domain_scores_gemma":[0.9990236,0.00034366772,0.00016502793,0.0002875275,0.00007027731,0.00010991298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043813078,0.00035933248,0.0011717967,0.0005627715,0.00006782721,0.000019465537,0.0002262414,0.0011450619,0.00019303826],"category_scores_gemma":[0.00033550203,0.00033294837,0.000090443784,0.0002706166,0.00024782866,0.000072588184,0.00013616859,0.0015806523,0.0000038101132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016884626,0.00021683509,0.08164191,0.00008625693,0.000111081354,0.0002509537,0.0014548008,0.0000013279092,0.0000092135815,0.0000035511616,0.9073752,0.0071604094],"study_design_scores_gemma":[0.0073144776,0.0021097104,0.0050056786,0.00005825787,0.0001253054,0.000007693269,0.0008103138,0.000004017923,0.000005071484,0.00053427386,0.98377657,0.00024862727],"about_ca_topic_score_codex":0.0022320966,"about_ca_topic_score_gemma":0.00048699678,"teacher_disagreement_score":0.07663623,"about_ca_system_score_codex":0.0014570846,"about_ca_system_score_gemma":0.0023842487,"threshold_uncertainty_score":0.99991226},"labels":[],"label_agreement":null},{"id":"W4313312265","doi":"10.1097/ju.0000000000003126","title":"Urinary Analysis of <i>FGFR3</i> and <i>TERT</i> Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification","year":2022,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Risk stratification; Stratification (seeds); Urinary system; Gene; Oncology; Internal medicine; Genetics; Biology","score_opus":0.009182315181748517,"score_gpt":0.25280044194980866,"score_spread":0.24361812676806013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313312265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585825,0.0034223278,0.00005194945,0.0003869784,0.00004838502,0.00011279466,0.000036815498,0.0000017578126,0.00008071332],"genre_scores_gemma":[0.9979727,0.0016617079,0.00016261575,0.00015077899,0.000018902341,0.000005586994,0.000005656949,0.0000047212598,0.000017331087],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99921495,0.00013596698,0.0003454902,0.000070320544,0.00015890988,0.00007437125],"domain_scores_gemma":[0.9991012,0.00013400805,0.000509703,0.00011874361,0.00010067458,0.00003566216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024032676,0.00006566405,0.00026304263,0.0001544381,0.00009199167,0.0000019830684,0.000056446203,0.00001989411,0.000041114974],"category_scores_gemma":[0.000018427567,0.000042867938,0.000051906747,0.00021922805,0.00013684269,0.00004868649,0.000032049615,0.00013860108,1.0019961e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005578373,0.0014339711,0.3934903,0.00011084284,0.005223326,0.000025106758,0.012327464,0.0032654784,0.53069687,0.00003664428,0.0001623604,0.04764923],"study_design_scores_gemma":[0.0016404529,0.014704511,0.93858784,0.0000074758254,0.0078316135,0.0006420959,0.0008695336,0.001791915,0.033437073,0.00022087955,0.000191792,0.00007482223],"about_ca_topic_score_codex":0.00004374551,"about_ca_topic_score_gemma":0.000007733308,"teacher_disagreement_score":0.54509753,"about_ca_system_score_codex":0.000011591854,"about_ca_system_score_gemma":0.00006411072,"threshold_uncertainty_score":0.17481038},"labels":[],"label_agreement":null},{"id":"W4313369199","doi":"10.4049/jimmunol.204.supp.241.22","title":"BCG immunotherapy response associated immune transcriptomic and spatial immune profiles of non-muscle invasive bladder tumors","year":2020,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; The King's University; Queen's University","funders":"","keywords":"Immune system; FOXP3; Immunotherapy; Bladder cancer; Medicine; Immunology; Adjuvant; CD8; Immune checkpoint; Transcriptome; Cancer immunotherapy; Tumor microenvironment; Cancer research; Cancer; Biology; Internal medicine; Gene expression; Gene","score_opus":0.014831354412497166,"score_gpt":0.25426842813874684,"score_spread":0.23943707372624967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313369199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97939384,0.013465735,0.00017490363,0.006199717,0.00021092276,0.00042345288,0.00002527807,0.000013595526,0.00009254277],"genre_scores_gemma":[0.996292,0.0028422135,0.00008923585,0.00054149696,0.00008767476,0.000006010237,0.000005150803,0.000040793846,0.00009541857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979449,0.0005262726,0.0008759485,0.00013268154,0.00024536886,0.00027482514],"domain_scores_gemma":[0.998329,0.00035556854,0.00071220123,0.00025512493,0.00027107596,0.00007702874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070703076,0.00023166169,0.00085452845,0.00013061927,0.00010135725,0.000009524834,0.00028173748,0.00014402084,0.00023579325],"category_scores_gemma":[0.00030117296,0.00015119782,0.00023605599,0.00021274683,0.00038081943,0.000098003475,0.000047349648,0.0005355449,0.000008259374],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02609764,0.00023710122,0.001252045,0.00002692576,0.0018489633,0.000063144354,0.0074896677,0.000004414065,0.95758903,0.0000037097132,0.00009338441,0.0052939816],"study_design_scores_gemma":[0.011960576,0.008471779,0.59301823,0.0002513641,0.0005291775,0.00047925222,0.0020561968,0.000030227637,0.3827587,0.000074299904,0.00021784665,0.0001523665],"about_ca_topic_score_codex":0.00046365295,"about_ca_topic_score_gemma":0.000013921778,"teacher_disagreement_score":0.5917662,"about_ca_system_score_codex":0.00008513223,"about_ca_system_score_gemma":0.0005135988,"threshold_uncertainty_score":0.61656684},"labels":[],"label_agreement":null},{"id":"W4313510862","doi":"10.1101/2022.12.30.522127","title":"Atypical B cells mediate poor response to Bacillus Calmette Guérin immunotherapy in non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen's University","funders":"","keywords":"Immune system; Bladder cancer; Immunotherapy; Inflammation; Immunology; Cancer research; Tumor microenvironment; Cancer; Cell; Biology; Cancer immunotherapy; Medicine; Internal medicine","score_opus":0.015074340875078703,"score_gpt":0.26089520049912884,"score_spread":0.24582085962405015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313510862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856056,0.0021567477,0.00008420887,0.0027566976,0.0021940588,0.0028799113,0.0011282235,0.00021639433,0.00002317591],"genre_scores_gemma":[0.9890122,0.0011867551,0.0015461884,0.004498496,0.0006132529,0.0027162295,0.0000016165942,0.00030973478,0.00011556559],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9951898,0.00044140944,0.0008692191,0.0016010322,0.000889015,0.0010095637],"domain_scores_gemma":[0.9968071,0.00022776042,0.0003079817,0.0016660009,0.00033175605,0.000659429],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000871036,0.0008927002,0.0012661277,0.0007311583,0.0001736882,0.00010144836,0.00064696034,0.0005800469,0.002107234],"category_scores_gemma":[0.00022660177,0.0009123067,0.00032832197,0.0010556419,0.00012501595,0.00010281824,0.00071123504,0.0015364216,0.00021648873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062816134,0.0006376091,0.012896351,0.00027748186,0.00068331254,0.0010478799,0.00019095777,0.00026052914,0.9753657,0.0000063236653,0.002313668,0.000038602157],"study_design_scores_gemma":[0.006170914,0.0007757305,0.6503389,0.0007106257,0.00031009977,8.111028e-8,0.00002321327,0.00005386927,0.3108527,0.0000012734226,0.029584339,0.0011782461],"about_ca_topic_score_codex":0.0013745322,"about_ca_topic_score_gemma":0.00011800325,"teacher_disagreement_score":0.664513,"about_ca_system_score_codex":0.0020917817,"about_ca_system_score_gemma":0.0030830994,"threshold_uncertainty_score":0.9993327},"labels":[],"label_agreement":null},{"id":"W4313530283","doi":"10.1016/j.eururo.2022.12.018","title":"Re: A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Randomized controlled trial; Cancer; Surgery; Photodynamic therapy; Urology; Internal medicine","score_opus":0.02375014100645199,"score_gpt":0.29255128553373805,"score_spread":0.26880114452728604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313530283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758118,0.00028645052,0.000010679637,0.001712305,0.00087776606,0.0012625058,0.000027740545,0.00008445154,0.01992634],"genre_scores_gemma":[0.9958458,0.0011241299,0.000011979361,0.0012927825,0.00030623333,0.00015200116,0.00004774566,0.00005993832,0.0011593692],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99789566,0.00068369857,0.00055785,0.00034017474,0.00017693467,0.0003456714],"domain_scores_gemma":[0.99843806,0.00094574015,0.00016257081,0.0003143038,0.00005368588,0.00008564398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095944566,0.00018264908,0.00092767476,0.0003619863,0.000024781042,0.0000043098185,0.000094391515,0.00007037432,0.0004772489],"category_scores_gemma":[0.00055647554,0.00014819065,0.00028141923,0.00046021017,0.00017705641,0.000029430326,0.00005874505,0.00018983276,0.00022851648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9703418,0.0004567019,0.0037353465,0.00010976602,0.000662562,0.0017858689,0.0015160928,0.000080888,0.0038790775,0.000022398366,0.009825484,0.007584033],"study_design_scores_gemma":[0.9573707,0.00072830566,0.03828908,0.000072419796,0.000412408,0.000012755816,0.00008472112,0.00020825827,0.00060263544,0.000097866694,0.0019330595,0.00018777653],"about_ca_topic_score_codex":0.00040697804,"about_ca_topic_score_gemma":0.00025959394,"teacher_disagreement_score":0.034553733,"about_ca_system_score_codex":0.000041173706,"about_ca_system_score_gemma":0.00022339047,"threshold_uncertainty_score":0.60430396},"labels":[],"label_agreement":null},{"id":"W4315697801","doi":"10.4103/jcrt.jcrt_2187_21","title":"Efficacy and adverse reactions of intra-arterial chemotherapy in patients with bladder cancer: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Journal of Cancer Research and Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Bladder cancer; Medicine; Oncology; Chemotherapy; Adverse effect; Internal medicine; Urology; Cancer","score_opus":0.15174550650411656,"score_gpt":0.45017147212605646,"score_spread":0.2984259656219399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315697801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006365553,0.99640965,0.0000014605341,0.00044111648,0.0000298672,0.0023051896,0.00015207723,0.000002306924,0.000021776772],"genre_scores_gemma":[0.0008529148,0.99835384,0.000029343442,0.00024957958,0.000046540896,0.00029398527,0.000009982746,0.000038332015,0.00012547652],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99712765,0.00048069045,0.0010439609,0.00026025198,0.000834692,0.00025274407],"domain_scores_gemma":[0.99804807,0.00029023533,0.0008385851,0.00028249715,0.0003608774,0.00017973682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086376374,0.00030175038,0.004715098,0.0006336498,0.00007834205,0.00002497338,0.00012507077,0.00009675636,0.0005302108],"category_scores_gemma":[0.00002685352,0.00016671361,0.0004390748,0.0009486293,0.0001862185,0.000082854785,0.000038538074,0.0007083305,1.5538367e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001839321,0.0009004732,0.0004803524,0.50849164,0.4369075,0.00003476822,0.0004570594,9.155447e-7,0.0000011845664,0.000011543495,0.000056672932,0.050818555],"study_design_scores_gemma":[0.0054330793,0.0024698137,0.0004940334,0.030604064,0.85110277,0.00005304817,0.000071537645,7.789262e-7,0.0000020861337,0.000020025826,0.1095227,0.00022608471],"about_ca_topic_score_codex":0.00021292103,"about_ca_topic_score_gemma":0.00008930536,"teacher_disagreement_score":0.4778876,"about_ca_system_score_codex":0.00022691772,"about_ca_system_score_gemma":0.0006945105,"threshold_uncertainty_score":0.67983836},"labels":[],"label_agreement":null},{"id":"W4315710014","doi":"10.1158/1055-9965.epi-22-1109","title":"5α-Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Medicine; Hyperplasia; Cohort; Urology; Oncology; Internal medicine; Population; Gynecology","score_opus":0.021572242104732343,"score_gpt":0.33320985648904655,"score_spread":0.3116376143843142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315710014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943026,0.0014847203,0.00002910693,0.0012166029,0.000121453195,0.0026256307,0.000091425616,0.00004647429,0.00008201217],"genre_scores_gemma":[0.99711025,0.00095696846,0.00045426132,0.00016475219,0.000044413107,0.00086913374,0.00022688012,0.000029524776,0.0001438274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978251,0.0005773604,0.00056518195,0.00056846323,0.00015138989,0.00031251687],"domain_scores_gemma":[0.99885327,0.00029790986,0.00032048594,0.00022817166,0.000060965325,0.00023917416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012401114,0.00023444736,0.0006800044,0.00029889084,0.0000820961,0.000004311647,0.000040544463,0.00012517886,0.00003698305],"category_scores_gemma":[0.00046969726,0.00018490071,0.000058962436,0.00045494817,0.00019497819,0.000082283594,0.000024400148,0.00014801485,0.0000012647392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012466457,0.00014707023,0.9912712,0.00014531055,0.0012125421,0.000015750638,0.00031462128,0.00011916003,0.00013362014,0.0000071805766,0.0018745473,0.0035123355],"study_design_scores_gemma":[0.005739674,0.0010094324,0.9892312,0.00040176886,0.0011254507,0.000008353512,0.0005953952,0.0011939808,0.00011926244,0.0003746141,0.000047388832,0.00015346317],"about_ca_topic_score_codex":0.016435748,"about_ca_topic_score_gemma":0.0031085203,"teacher_disagreement_score":0.013327228,"about_ca_system_score_codex":0.00028765053,"about_ca_system_score_gemma":0.0005359122,"threshold_uncertainty_score":0.9901139},"labels":[],"label_agreement":null},{"id":"W4316038182","doi":"10.1016/j.urolonc.2022.12.013","title":"Editorial: Cutting edge basic and clinical bladder cancer research – the IBCN updates","year":2023,"lang":"en","type":"editorial","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Library science; General surgery; Internal medicine","score_opus":0.08336077993712795,"score_gpt":0.4499190736971997,"score_spread":0.36655829376007176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316038182","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0128222285,0.0051508597,0.0000015363712,0.01630626,0.96278185,0.00092766987,0.00040157235,0.00015300895,0.0014550211],"genre_scores_gemma":[0.00014456057,0.026668396,0.0010659073,0.000824377,0.9653367,0.0005336656,0.00043006398,0.00008300279,0.0049133245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584424,0.000811773,0.0007132752,0.0010148265,0.0008543066,0.00076157873],"domain_scores_gemma":[0.9892261,0.008915781,0.0002940009,0.00049370894,0.00056542055,0.000505003],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0031173704,0.00044393726,0.0009096906,0.00024335965,0.00097061956,0.0001132659,0.0002960218,0.0019660825,0.000112343565],"category_scores_gemma":[0.0044594496,0.00029270884,0.000145025,0.0005481927,0.0030168528,0.00009768392,0.00030951746,0.00368225,0.00009094315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020839367,0.00013610166,0.021587621,0.00007063131,0.0004375436,0.000085458756,0.00026536305,0.000001071337,0.000009174309,0.00022550677,0.973786,0.0031871102],"study_design_scores_gemma":[0.0014614097,0.0026783173,0.00042932873,0.00019150822,0.001291009,0.000024595587,0.00025646048,0.00003591196,0.000010500745,0.0033884286,0.98998815,0.00024437916],"about_ca_topic_score_codex":0.0013191798,"about_ca_topic_score_gemma":0.00045518077,"teacher_disagreement_score":0.021517538,"about_ca_system_score_codex":0.0002742804,"about_ca_system_score_gemma":0.0032892236,"threshold_uncertainty_score":0.9999525},"labels":[],"label_agreement":null},{"id":"W4317690982","doi":"10.1016/j.euo.2023.01.004","title":"Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non–muscle-invasive Spectrum","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Sorbonne Université; Universitat Autònoma de Barcelona; Karl-Franzens-Universität Graz; European Association of Urology; Radboud Universiteit; Radboud Universitair Medisch Centrum; Royal Free London NHS Foundation Trust; Medizinische Universität Graz; Univerzita Karlova v Praze","keywords":"Medicine; Bladder cancer; Confidence interval; Concomitant; Internal medicine; Risk stratification; Urology; Incidence (geometry); Proportional hazards model; Cumulative incidence; Oncology; Gastroenterology; Cancer; Cohort","score_opus":0.03348403002527243,"score_gpt":0.3052974684279435,"score_spread":0.271813438402671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317690982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8857755,0.0011704931,0.0000065151066,0.030344892,0.0006042261,0.001069266,0.000052328218,0.00010803932,0.08086872],"genre_scores_gemma":[0.9874499,0.0018933117,0.00004694756,0.009377706,0.00043981653,0.00013228605,0.000054205128,0.000057354355,0.0005484822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976915,0.0007471928,0.00041930718,0.00042882818,0.00020420305,0.00050897175],"domain_scores_gemma":[0.9989475,0.0003683296,0.0001586428,0.00039708443,0.000043721277,0.00008472061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005849018,0.00022099643,0.0005325611,0.00024556526,0.000068968395,0.0000047524277,0.00029724944,0.00013421016,0.00030706762],"category_scores_gemma":[0.00007300004,0.0001554891,0.0001312226,0.00060124265,0.00034809846,0.00003724402,0.00013804216,0.00042677895,0.0002913291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023187199,0.004059039,0.70627034,0.0004914896,0.0017887001,0.019182308,0.018204972,0.00022375917,0.035957817,0.00046646057,0.114099346,0.09693703],"study_design_scores_gemma":[0.003523059,0.003106088,0.9458527,0.000025309848,0.00031064218,0.00017935372,0.00027632678,0.000016726037,0.00058961223,0.00017143437,0.04581217,0.0001365649],"about_ca_topic_score_codex":0.00016123509,"about_ca_topic_score_gemma":0.00033333167,"teacher_disagreement_score":0.23958236,"about_ca_system_score_codex":0.00012397236,"about_ca_system_score_gemma":0.00046056416,"threshold_uncertainty_score":0.63406616},"labels":[],"label_agreement":null},{"id":"W4317936583","doi":"10.1016/j.urolonc.2023.01.001","title":"Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1","year":2023,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Neoadjuvant therapy; Cisplatin; Oncology; Clinical trial; Stage (stratigraphy); Urology; Internal medicine; Chemotherapy; Cancer","score_opus":0.10551008056200276,"score_gpt":0.3862761928058856,"score_spread":0.2807661122438828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317936583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066630193,0.9923185,0.000008712565,0.0025722287,0.00057128596,0.0015609812,0.00026869454,0.00013142127,0.0019018383],"genre_scores_gemma":[0.00000471148,0.9834773,0.003372683,0.0017220298,0.00074904395,0.0016640784,0.0012833764,0.000072644674,0.007654132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758863,0.0002698846,0.00068538386,0.0007489027,0.00023663652,0.000470576],"domain_scores_gemma":[0.99841905,0.00037303727,0.00032958845,0.00044846314,0.00009175677,0.00033812525],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030827496,0.0005568673,0.001579716,0.00027011748,0.000214782,0.00004892873,0.00015995256,0.00077798247,0.0009554871],"category_scores_gemma":[0.00011698286,0.0003906928,0.000295554,0.00054571655,0.0005262829,0.00015018949,0.00009146458,0.0006669157,0.0004216331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022715206,0.00044475432,0.0060153655,0.0018618453,0.001437586,0.00080353895,0.00029616273,0.0000020755813,0.0000011017198,0.0007866168,0.063049935,0.92507386],"study_design_scores_gemma":[0.000719631,0.0016260539,0.000104381885,0.0017135399,0.0021506543,0.00029159622,0.00002603495,0.000021024964,0.0000021386593,0.0019360966,0.9910917,0.00031712884],"about_ca_topic_score_codex":0.00005468959,"about_ca_topic_score_gemma":0.000024950486,"teacher_disagreement_score":0.9280418,"about_ca_system_score_codex":0.0001772595,"about_ca_system_score_gemma":0.0011638707,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W4318293180","doi":"10.1016/j.euf.2023.01.012","title":"Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Perioperative; Antibiotic prophylaxis; Antibiotics; Stent; Cochrane Library; Bacteremia; Surgery; Urinary system; Internal medicine; Meta-analysis; Bladder cancer","score_opus":0.05762866142663193,"score_gpt":0.3381672854139014,"score_spread":0.2805386239872695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318293180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029690063,0.9904471,0.000018632094,0.0002910546,0.00018310621,0.006595952,0.00011001689,0.00028819992,0.0020362549],"genre_scores_gemma":[0.00026024814,0.99542797,0.000036392456,0.00022368968,0.000325618,0.00018727187,0.00026204056,0.00016100067,0.003115768],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99594903,0.0015888072,0.0011752764,0.0006382397,0.00030521772,0.00034342322],"domain_scores_gemma":[0.99774706,0.00031211323,0.0009939907,0.00065537303,0.00013920627,0.00015223754],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001037317,0.00048534584,0.0029206446,0.00027618982,0.0001382653,0.000032927393,0.00014970294,0.00025693997,0.00001973135],"category_scores_gemma":[0.0008096246,0.00031355338,0.00040284413,0.0006092469,0.00005730679,0.000045072444,0.00012452719,0.00055453,0.001272993],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010943474,0.000063202315,0.000502228,0.85589206,0.0024527574,0.00030505736,0.000035137462,1.4062349e-8,5.6632807e-8,0.000009949205,0.00048720508,0.14024138],"study_design_scores_gemma":[0.0013544308,0.0030922412,0.0044481596,0.5754246,0.055304002,0.0025484972,0.000003734399,0.0000011088686,1.7020864e-7,0.000022503757,0.35730278,0.0004977443],"about_ca_topic_score_codex":0.000039353785,"about_ca_topic_score_gemma":0.00002166716,"teacher_disagreement_score":0.3568156,"about_ca_system_score_codex":0.00037806795,"about_ca_system_score_gemma":0.00018927919,"threshold_uncertainty_score":0.99993163},"labels":[],"label_agreement":null},{"id":"W4318677405","doi":"10.1016/j.euros.2022.12.016","title":"Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ferring Pharmaceuticals; National Institute for Health and Care Research","keywords":"Bladder cancer; Cystectomy; Medicine; Mixed logit; Disease; Receipt; Internal medicine; Cancer; Oncology; Logistic regression; Surgery","score_opus":0.05742964250734963,"score_gpt":0.37879371071197687,"score_spread":0.32136406820462726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318677405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98275584,0.000534232,0.00002327359,0.00071601715,0.0006837455,0.0024243582,0.00030516592,0.00006287426,0.012494479],"genre_scores_gemma":[0.9954559,0.0002982769,0.00029549128,0.001120058,0.00015324834,0.000873022,0.00003593228,0.000042915228,0.00172514],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972201,0.00014512001,0.0004706395,0.0009917974,0.00047930612,0.00069303816],"domain_scores_gemma":[0.998039,0.0003368478,0.00024019359,0.0006948543,0.0004044739,0.0002846481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004979872,0.00031832504,0.00054477307,0.00025527063,0.00040162334,0.000106996085,0.0007918929,0.000056934176,0.00025572334],"category_scores_gemma":[0.0003181259,0.00023781399,0.000118350006,0.0008494479,0.0010828284,0.00026791822,0.00046837458,0.00007291774,0.00013504081],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011743019,0.005053284,0.22813934,0.0003119541,0.0020640001,0.0014264961,0.05360349,0.001990066,0.35186985,0.00046045223,0.014327688,0.32901037],"study_design_scores_gemma":[0.011909702,0.020941146,0.7508865,0.00010127578,0.0003958362,0.0000499738,0.0012870029,0.00027589937,0.1344322,0.0000661983,0.07908875,0.0005655387],"about_ca_topic_score_codex":0.0010198238,"about_ca_topic_score_gemma":0.00014081612,"teacher_disagreement_score":0.52274716,"about_ca_system_score_codex":0.00024702147,"about_ca_system_score_gemma":0.0012089832,"threshold_uncertainty_score":0.96977735},"labels":[],"label_agreement":null},{"id":"W4318978961","doi":"10.1016/j.ab.2023.115074","title":"Proteomics strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources","year":2023,"lang":"en","type":"review","venue":"Analytical Biochemistry","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Proteomics; Biomarker; Biomarker discovery; Proteome; Bladder cancer; Cancer; Medicine; Computational biology; Bioinformatics; Biology; Internal medicine","score_opus":0.10749740216599896,"score_gpt":0.4037465421689406,"score_spread":0.29624914000294167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318978961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005623843,0.9879489,0.000034371078,0.00046314773,0.000121350495,0.0038166498,0.0065262574,0.00015981452,0.00036712628],"genre_scores_gemma":[0.00021533009,0.95951056,0.00043713232,0.0000953146,0.0010466275,0.031205438,0.0012373858,0.0001996443,0.0060525853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974076,0.000023440565,0.00069171627,0.0010283369,0.00022301532,0.00062586274],"domain_scores_gemma":[0.99852747,0.00036378286,0.00025291086,0.0003827548,0.00012237119,0.00035070218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010693994,0.0008120402,0.0021056468,0.00018638157,0.00015360292,0.00014444173,0.00015528216,0.0004941749,0.00015335639],"category_scores_gemma":[0.00009591027,0.00056655414,0.0011568536,0.00038086253,0.00024898053,0.00004915696,0.000050944913,0.00016501363,0.000009648829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047181858,0.0007581164,0.00035848498,0.036285862,0.008322069,0.00004494697,0.000055854503,1.2121282e-7,0.000042841988,0.00008061369,0.0101876715,0.9433916],"study_design_scores_gemma":[0.0036216876,0.001010449,0.000022414948,0.0068369126,0.021690508,0.000053006603,0.000095370924,0.00010739256,0.0020000474,0.00012083542,0.96362877,0.00081262045],"about_ca_topic_score_codex":0.00012378005,"about_ca_topic_score_gemma":0.00002278755,"teacher_disagreement_score":0.9534411,"about_ca_system_score_codex":0.00031931262,"about_ca_system_score_gemma":0.0012474332,"threshold_uncertainty_score":0.9996786},"labels":[],"label_agreement":null},{"id":"W4319215982","doi":"10.1016/j.eururo.2023.01.009","title":"Re: IL-15 Superagonist NAI in BCG-Unresponsive Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Urology; Oncology; Internal medicine; Cancer","score_opus":0.027076175852111986,"score_gpt":0.2999252089570175,"score_spread":0.27284903310490555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319215982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9188667,0.000620952,0.000012437326,0.011926877,0.0009252964,0.0006257578,0.00012691674,0.0002460714,0.06664903],"genre_scores_gemma":[0.98092437,0.0006875122,0.000034736724,0.010075313,0.00057791354,0.000076277014,0.000088226516,0.00011444011,0.007421241],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99777263,0.00041074815,0.0003536558,0.00061101123,0.00021821998,0.0006337476],"domain_scores_gemma":[0.9989186,0.00022969318,0.00006663801,0.00048556348,0.000098073964,0.00020144352],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031150575,0.00028619097,0.00042110556,0.00031963168,0.000107844826,0.000019769563,0.00019280167,0.000102405174,0.0011420597],"category_scores_gemma":[0.00024473737,0.00025702646,0.00012058034,0.0005995069,0.00017738831,0.00006257405,0.00014532047,0.00039409407,0.0029957897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008970323,0.0016798127,0.294133,0.00039200415,0.002089467,0.06398748,0.03213154,0.0008013887,0.08276627,0.00048680505,0.44731343,0.065248474],"study_design_scores_gemma":[0.006612842,0.0017597252,0.84133613,0.00006499991,0.00024413576,0.000098496545,0.00072624465,0.00008197699,0.002116089,0.00011851429,0.14643851,0.00040233808],"about_ca_topic_score_codex":0.00040037185,"about_ca_topic_score_gemma":0.0007623009,"teacher_disagreement_score":0.5472031,"about_ca_system_score_codex":0.00010882883,"about_ca_system_score_gemma":0.00031527464,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W4319297284","doi":"10.3390/curroncol30020154","title":"Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; EMD Serono; Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; National Comprehensive Cancer Network; Sanofi; Exelixis; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Dana-Farber/Harvard Cancer Center; GlaxoSmithKline; Pfizer; Dana-Farber Cancer Institute","keywords":"Medicine; Bladder cancer; Incidence (geometry); Lung cancer; Epidemiology; Cancer; Demography; Internal medicine","score_opus":0.07447101230694989,"score_gpt":0.40934217167453574,"score_spread":0.3348711593675858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319297284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966235,0.0006990716,0.000003384765,0.0081463605,0.0005994385,0.0006041776,0.000044121367,0.000018157285,0.00022294697],"genre_scores_gemma":[0.9966445,0.0021121483,0.000004365899,0.00072025374,0.00024656634,0.00017246122,0.00005932223,0.00000802518,0.00003238271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852896,0.00043447304,0.00026520714,0.00018674893,0.0003362919,0.00024832351],"domain_scores_gemma":[0.99865514,0.0008383683,0.00019358264,0.00019464099,0.00008464062,0.000033608674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066880684,0.000120290664,0.0002549029,0.00007150696,0.00012074406,0.000015396983,0.00017364544,0.00011716756,0.00007159766],"category_scores_gemma":[0.00010916849,0.00005469763,0.000059620004,0.0005677358,0.00010659448,0.00003537808,0.000121730525,0.00042235787,0.0000016862215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015596303,0.00016532063,0.98577046,0.00002054433,0.000116450974,0.0000046043824,0.0013475375,0.000031270945,0.000016399576,0.000074013704,0.0024719418,0.009965831],"study_design_scores_gemma":[0.0013103391,0.00026793062,0.9682837,0.00005943774,0.00025092592,0.0000022508636,0.0009667818,0.00011535486,0.000010681437,0.00014680665,0.028532097,0.000053663338],"about_ca_topic_score_codex":0.00041135115,"about_ca_topic_score_gemma":0.0005066027,"teacher_disagreement_score":0.026060157,"about_ca_system_score_codex":0.00049185293,"about_ca_system_score_gemma":0.00021562092,"threshold_uncertainty_score":0.22305046},"labels":[],"label_agreement":null},{"id":"W4319333335","doi":"10.1111/bju.15984","title":"Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy","year":2023,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"European Association of Urology; Bladder Cancer Advocacy Network","keywords":"Cystectomy; Medicine; Cohort; Bladder cancer; Internal medicine; Proportional hazards model; Oncology; Stage (stratigraphy); Urology; T-stage; Cancer; Biology","score_opus":0.017767125024580083,"score_gpt":0.29490142641793754,"score_spread":0.2771343013933575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319333335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953657,0.0032080794,0.00004205016,0.00055703707,0.000120316996,0.0002976844,0.000054053802,0.00002708884,0.00032802747],"genre_scores_gemma":[0.9983726,0.0011089739,0.00009931657,0.00010411301,0.0001402709,0.000023819232,0.0000068831414,0.000027275692,0.000116733165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986607,0.00012511133,0.00047529626,0.00016762388,0.00024102844,0.00033023304],"domain_scores_gemma":[0.99923605,0.00012239798,0.00023910997,0.00010146529,0.00017241885,0.00012856926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019377032,0.0001438352,0.0006367149,0.00029843423,0.000027361855,0.000009157269,0.00010997463,0.0001334813,0.000315056],"category_scores_gemma":[0.00017159872,0.00011089459,0.00016293114,0.00042247606,0.00022330794,0.000064811145,0.000019972907,0.00034049214,0.0000058479877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00846331,0.00096836203,0.89122605,0.00009738392,0.0018423469,0.05439748,0.00037611782,0.0008601276,0.0031059762,0.000015188105,0.0042661764,0.034381464],"study_design_scores_gemma":[0.0108564235,0.006532961,0.95009756,0.00025339177,0.0004957109,0.030748045,0.00003617222,0.00010605208,0.00021814484,0.00008700394,0.00045251276,0.0001160256],"about_ca_topic_score_codex":0.0024485013,"about_ca_topic_score_gemma":0.0003278764,"teacher_disagreement_score":0.058871485,"about_ca_system_score_codex":0.00014649483,"about_ca_system_score_gemma":0.00071859616,"threshold_uncertainty_score":0.452215},"labels":[],"label_agreement":null},{"id":"W4319456243","doi":"10.1016/j.acuro.2022.12.009","title":"Cistectomía radical asistida por robot vs. cistectomía radical abierta: revisión sistemática y metaanálisis de ensayos controlados aleatorizados","year":2023,"lang":"es","type":"article","venue":"Actas Urológicas Españolas","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Groin; Humanities; Anatomy; Art","score_opus":0.02050979723528091,"score_gpt":0.2976177627767655,"score_spread":0.2771079655414846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319456243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6710347,0.09126804,0.005541083,0.120944925,0.01387394,0.023867695,0.005654576,0.0094977,0.05831737],"genre_scores_gemma":[0.9775887,0.0062982948,0.0010340246,0.005143017,0.0031910571,0.0007423957,0.00046941746,0.0006061999,0.004926861],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9860549,0.0016194447,0.0026584684,0.002986384,0.0029124038,0.00376839],"domain_scores_gemma":[0.9900511,0.0025859326,0.00088608975,0.0029404042,0.00047979632,0.003056657],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0021393257,0.0022466986,0.004102889,0.0011186405,0.0010148354,0.0006896145,0.0015141974,0.0017164018,0.003978512],"category_scores_gemma":[0.0034080802,0.002002421,0.0021065257,0.003116438,0.0012623589,0.00045302883,0.0005419538,0.002560514,0.0050602886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061042365,0.014347187,0.31372136,0.015544239,0.049897917,0.058988057,0.0054411623,0.00039575604,0.07893267,0.018282648,0.20105404,0.18235259],"study_design_scores_gemma":[0.047657855,0.0075608823,0.15825245,0.0037944568,0.021004276,0.0029033194,0.00040083934,0.0051119043,0.012832312,0.0007453552,0.73525083,0.004485501],"about_ca_topic_score_codex":0.00054010487,"about_ca_topic_score_gemma":0.000019649344,"teacher_disagreement_score":0.5341968,"about_ca_system_score_codex":0.0013767352,"about_ca_system_score_gemma":0.0019388356,"threshold_uncertainty_score":0.9997406},"labels":[],"label_agreement":null},{"id":"W4319662054","doi":"10.1016/j.euf.2023.01.019","title":"Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Meta-analysis; Internal medicine; Hazard ratio; Oncology; Confidence interval; Performance status; Randomized controlled trial; Cancer","score_opus":0.042235915404493826,"score_gpt":0.3198001414093053,"score_spread":0.27756422600481145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319662054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020641478,0.9719221,8.603925e-7,0.000024462142,0.000017612203,0.0062528523,0.00041743316,0.00006663967,0.0006565774],"genre_scores_gemma":[0.16721489,0.83142525,0.000026362119,0.000084705214,0.000012413041,0.00049848604,0.00021197296,0.00017930032,0.0003466294],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955226,0.0011863699,0.0015735163,0.00079658005,0.00038703787,0.00053390407],"domain_scores_gemma":[0.9972087,0.00021393318,0.001246142,0.0009980231,0.00015049062,0.00018271337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047839433,0.00093441573,0.010913705,0.00072044256,0.000048024496,0.000011293824,0.00020360017,0.0001389614,0.000076738615],"category_scores_gemma":[0.00010638966,0.0004282726,0.001584941,0.0011770043,0.00016094577,0.000057378275,0.00008575917,0.0005142043,0.00006247881],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023564366,0.001698383,0.07410049,0.5294,0.3843908,0.00072562846,0.00016865836,0.000023598834,2.2953542e-7,0.000002594819,0.000009062341,0.0071241464],"study_design_scores_gemma":[0.004839077,0.019481823,0.10805259,0.013103415,0.8537515,0.000037711005,0.000003930189,8.318801e-7,8.0752784e-7,2.9347757e-7,0.0002738523,0.0004541888],"about_ca_topic_score_codex":0.000115040435,"about_ca_topic_score_gemma":0.000027328619,"teacher_disagreement_score":0.51629657,"about_ca_system_score_codex":0.00029265042,"about_ca_system_score_gemma":0.00027300368,"threshold_uncertainty_score":0.9998169},"labels":[],"label_agreement":null},{"id":"W4320040300","doi":"10.1245/s10434-022-12692-w","title":"Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses","year":2023,"lang":"en","type":"review","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; MEDLINE; Checklist; Perioperative; Cochrane Library; Systematic review; Meta-analysis; Confounding; Surgery; Intensive care medicine; Cancer; Internal medicine","score_opus":0.8957397616601107,"score_gpt":0.6413350502319424,"score_spread":0.25440471142816834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320040300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.0575662e-7,0.9860482,0.000014164169,0.00220408,0.0005353363,0.009378947,0.0013238471,0.000021617863,0.00047337206],"genre_scores_gemma":[0.0000056328427,0.99345315,0.00011882688,0.00015287794,0.00036798912,0.004951452,0.000492248,0.00006867885,0.00038917467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504155,0.0015183465,0.0019031412,0.0008411617,0.0003106739,0.00038511495],"domain_scores_gemma":[0.9865533,0.010184678,0.0014292496,0.0014726865,0.00017105472,0.0001889949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022332456,0.00056992174,0.011087085,0.00012089849,0.0001078366,0.00005292436,0.0011928155,0.00028822842,0.0003599052],"category_scores_gemma":[0.0006324471,0.00025607419,0.0013618845,0.00034754563,0.00016884766,0.000101471785,0.00080500194,0.00035539735,0.000061674655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005086264,0.00036385903,6.65058e-7,0.29226232,0.08174609,0.00012381775,0.000059548478,0.0000013707182,1.3627783e-7,0.00009148842,0.032570697,0.5922714],"study_design_scores_gemma":[0.0010152133,0.00034279766,3.328316e-7,0.019017879,0.1936061,0.000026739484,0.000020012052,0.000013808296,8.156081e-7,0.000036779013,0.7857501,0.00016945542],"about_ca_topic_score_codex":0.00077033555,"about_ca_topic_score_gemma":0.00020861649,"teacher_disagreement_score":0.7531794,"about_ca_system_score_codex":0.00008388863,"about_ca_system_score_gemma":0.0008088062,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W4320061532","doi":"10.4049/jimmunol.206.supp.55.07","title":"Investigating the age and sex associated mucosal immune landscape of urinary bladder","year":2021,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Immune system; Biology; Immunology; Immunotherapy; Sexual dimorphism; CD8; Bladder cancer; Cancer; Endocrinology","score_opus":0.01882484304289848,"score_gpt":0.2681753739132579,"score_spread":0.24935053087035944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320061532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97483987,0.020487212,0.000008955358,0.003470392,0.00015211156,0.000069808084,0.0000035779162,0.000004702512,0.0009633759],"genre_scores_gemma":[0.997382,0.001456765,0.000077899174,0.00040501356,0.00007566551,0.0000010007992,0.000003225306,0.000011196319,0.0005872426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999038,0.00028589243,0.00034399706,0.000054977038,0.00013867725,0.00013847822],"domain_scores_gemma":[0.99910843,0.00024693302,0.00029837879,0.00018756681,0.00013291444,0.000025794783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043638362,0.000089083725,0.00032087244,0.000038262246,0.00008956132,0.0000065535883,0.00011266086,0.00006846344,0.000099998775],"category_scores_gemma":[0.00021975412,0.000045102122,0.00007885749,0.00012910335,0.00023294696,0.00003596134,0.000078753896,0.00036562816,0.000001732777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010448885,0.0011583781,0.13128687,0.000075641205,0.009341518,0.0015180387,0.01695501,0.000020209282,0.8157631,0.00020736993,0.002548028,0.020080946],"study_design_scores_gemma":[0.005540308,0.0021285892,0.9178434,0.00021519215,0.0010909421,0.007638585,0.0046056593,0.000030430308,0.05911739,0.0008535085,0.00083569996,0.00010026915],"about_ca_topic_score_codex":0.000044412496,"about_ca_topic_score_gemma":0.0000057928632,"teacher_disagreement_score":0.78655654,"about_ca_system_score_codex":0.000022846847,"about_ca_system_score_gemma":0.00019583582,"threshold_uncertainty_score":0.18392113},"labels":[],"label_agreement":null},{"id":"W4320061630","doi":"10.4049/jimmunol.206.supp.56.10","title":"M2 macrophages, B cells, and PD-L1 immune checkpoint protein exhibit sexual dimorphism in the outcomes of non-muscle invasive bladder cancer","year":2021,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"FOXP3; Immune system; Bladder cancer; GATA3; CD163; Immune checkpoint; Sexual dimorphism; CD8; Biology; Tumor microenvironment; Cancer research; Cancer; Medicine; Internal medicine; Immunology; Oncology; Immunotherapy; Gene; Phenotype; Transcription factor","score_opus":0.016261973554040018,"score_gpt":0.27079499545986613,"score_spread":0.2545330219058261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320061630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97155386,0.021444893,0.000012640052,0.0061636143,0.00022999986,0.00036201038,0.000015320757,0.0000030513606,0.00021458992],"genre_scores_gemma":[0.995406,0.0030913407,0.00012878826,0.0005091349,0.000088127235,0.000018885203,0.0000021605945,0.000019882558,0.00073573337],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985113,0.00027958944,0.0006036358,0.00012376798,0.00023692893,0.00024475576],"domain_scores_gemma":[0.99883467,0.00018565051,0.00039374732,0.00035555763,0.00019318124,0.000037214828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004953136,0.0001783812,0.00057247403,0.00009109297,0.00006917455,0.000010219943,0.0002291616,0.00010013557,0.00026880924],"category_scores_gemma":[0.0000888729,0.00009239988,0.00011017785,0.00019000248,0.00025767292,0.00006881423,0.00010352637,0.0005338755,0.0000054919665],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070739863,0.00040626593,0.0039843568,0.000051866395,0.0009903599,0.0003591189,0.0050479304,0.000006996108,0.98308015,0.000014808498,0.00016106761,0.0051896954],"study_design_scores_gemma":[0.004992682,0.0011980024,0.5193517,0.00017056227,0.0004278652,0.00082093186,0.0049788514,0.000002748111,0.46731424,0.00019630262,0.00044192045,0.000104166334],"about_ca_topic_score_codex":0.0011556498,"about_ca_topic_score_gemma":0.00022790763,"teacher_disagreement_score":0.5157659,"about_ca_system_score_codex":0.00007974249,"about_ca_system_score_gemma":0.00043280073,"threshold_uncertainty_score":0.3767958},"labels":[],"label_agreement":null},{"id":"W4320555941","doi":"10.17615/wt4h-9567","title":"A healthy bladder: a consensus statement: Consensus statement - a healthy bladder","year":2020,"lang":"en","type":"article","venue":"UNC Libraries","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; Allergan; Astellas Pharma; University of Pennsylvania; York University; Horizon Pharma; Pfizer; U.S. Department of Veterans Affairs","keywords":"Statement (logic); Consensus conference; Medicine; Internal medicine; Political science; Law","score_opus":0.054809234446247905,"score_gpt":0.3049390928017412,"score_spread":0.2501298583554933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320555941","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30820146,0.018886056,0.0008417556,0.6237185,0.0015958732,0.007250171,0.0020326702,0.0019260426,0.035547502],"genre_scores_gemma":[0.84424454,0.0004238208,0.020749109,0.12943244,0.0010589933,0.00033992503,0.00049281237,0.00023764581,0.0030207257],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627036,0.00020154165,0.001076132,0.0008114976,0.00069813605,0.00094231794],"domain_scores_gemma":[0.99768907,0.00023390436,0.0002983336,0.00052001164,0.00015012217,0.0011085826],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018438374,0.00053193345,0.00084711984,0.00013918402,0.0003212592,0.0001474896,0.00016898403,0.00015248146,0.001928976],"category_scores_gemma":[0.00014328911,0.0004525291,0.00019006208,0.00046761055,0.00040143044,0.00014995232,0.00014350149,0.00040256715,0.0003946268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025575599,0.0018016224,0.013991573,0.0016266386,0.0033543208,0.0018139273,0.018448,0.000033739296,0.0006594734,0.043340415,0.88045734,0.00889732],"study_design_scores_gemma":[0.03567915,0.016657995,0.003502919,0.00026281894,0.0011130116,0.00022620898,0.00884081,0.0006961684,0.0061475188,0.0131745655,0.91232324,0.0013756161],"about_ca_topic_score_codex":0.00047045774,"about_ca_topic_score_gemma":0.000054569853,"teacher_disagreement_score":0.53604305,"about_ca_system_score_codex":0.00019497651,"about_ca_system_score_gemma":0.0023220058,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W4321017836","doi":"10.1097/ju.0000000000003193","title":"Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta","funders":"","keywords":"Medicine; Cystectomy; Cohort; Resection; Pathological; Urology; Oncology; General surgery; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.04186149568498535,"score_gpt":0.3565649033576583,"score_spread":0.3147034076726729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321017836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980013,0.00015617082,0.00011648839,0.001078181,0.00018657363,0.0001914347,0.000027494254,0.0000101261085,0.00023227686],"genre_scores_gemma":[0.9994868,0.00012795646,0.000030965246,0.00017000284,0.00006654928,0.000004278077,0.0000052933806,0.0000074389313,0.00010074054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893755,0.00020795723,0.0003346882,0.00008193706,0.00023588512,0.00020199596],"domain_scores_gemma":[0.99946475,0.00015619317,0.00012919038,0.00010931787,0.000084151754,0.000056370955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073685823,0.000105677165,0.00038604112,0.00019913795,0.000049058846,0.000001408798,0.00008074595,0.00010498123,0.00013133534],"category_scores_gemma":[0.00013534045,0.000050162973,0.00019754826,0.00022741918,0.00010868521,0.000029586074,0.000018609602,0.00032974116,0.000018118597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008992652,0.00041587374,0.9848575,0.000008512889,0.0002598128,0.00046956696,0.0003295667,0.00076594634,0.0034605258,0.000023705214,0.00014100429,0.0002753268],"study_design_scores_gemma":[0.0068398598,0.004727645,0.98646396,0.000013828538,0.00013976291,0.0012574121,0.00001916571,0.000157586,0.0002040989,0.00007610871,0.000064509164,0.000036088677],"about_ca_topic_score_codex":0.000055320765,"about_ca_topic_score_gemma":0.00007281288,"teacher_disagreement_score":0.004311771,"about_ca_system_score_codex":0.00013994571,"about_ca_system_score_gemma":0.00013438071,"threshold_uncertainty_score":0.20455867},"labels":[],"label_agreement":null},{"id":"W4321381316","doi":"10.1016/j.euros.2023.01.009","title":"Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional Series","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Bladder cancer; Logistic regression; Urology; Surgery; Odds ratio; Internal medicine; Cancer","score_opus":0.08566026362049094,"score_gpt":0.3396807571842613,"score_spread":0.2540204935637703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321381316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625992,0.00007778359,0.000041636522,0.0029821142,0.0010116819,0.00069660397,0.000104865125,0.00013575818,0.03235033],"genre_scores_gemma":[0.9957389,0.000032981377,0.001253449,0.0007273314,0.000102836864,0.000017395058,0.00013741097,0.000017019134,0.0019726276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997685,0.00026287662,0.00034109174,0.00084811443,0.00040081676,0.00046206874],"domain_scores_gemma":[0.99899185,0.00013176573,0.00008423562,0.00048531542,0.00007224809,0.00023461152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084479287,0.00019715512,0.00030750173,0.00025416206,0.00041804803,0.000077745455,0.00086113974,0.00006471754,0.00020380293],"category_scores_gemma":[0.00037407334,0.00015817811,0.000055320816,0.0010002501,0.0012613137,0.0004514208,0.001083827,0.00029131433,0.0009286515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16664426,0.008231581,0.336207,0.00017448128,0.0013187244,0.15456463,0.03441,0.0035990456,0.13495417,0.0044674478,0.021754816,0.13367385],"study_design_scores_gemma":[0.021121502,0.0013317215,0.95639116,0.000045793426,0.00005734267,0.00018962989,0.0002170123,0.000667495,0.00033284273,0.000016398966,0.019438673,0.00019046155],"about_ca_topic_score_codex":0.0008997287,"about_ca_topic_score_gemma":0.00018461543,"teacher_disagreement_score":0.6201841,"about_ca_system_score_codex":0.00013913227,"about_ca_system_score_gemma":0.00060857565,"threshold_uncertainty_score":0.99984926},"labels":[],"label_agreement":null},{"id":"W4321482893","doi":"10.1007/s11255-023-03517-0","title":"Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities","year":2023,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Population; Internal medicine; Cystectomy; Urology; Surveillance, Epidemiology, and End Results; Nephrology; Epidemiology; Incidence (geometry); Oncology; Surgery; Cancer; Cancer registry","score_opus":0.02694686710274634,"score_gpt":0.30781461585165754,"score_spread":0.2808677487489112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321482893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928905,0.0000741729,0.000029662366,0.0057559344,0.0004905608,0.00029942082,0.000121014324,0.000025881176,0.0003128866],"genre_scores_gemma":[0.99688774,0.000082409395,0.000028220751,0.002436338,0.000099556106,0.00016145958,0.00010489207,0.000010294796,0.00018907191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991186,0.00006394797,0.00024788274,0.00023888642,0.00013377592,0.00019687285],"domain_scores_gemma":[0.9994895,0.00023243048,0.00006547034,0.00007976899,0.00007500574,0.000057838715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005902538,0.00013122255,0.00035999058,0.00028286933,0.000029801258,0.000005129124,0.000064309155,0.00010740437,0.00020453856],"category_scores_gemma":[0.000037476904,0.000106759704,0.000049606737,0.00009098194,0.000048084516,0.00003916322,0.000027919858,0.00006482031,0.00000894622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002339821,0.00016213224,0.99399334,0.000006231551,0.00026581693,0.000013343305,0.00018390022,0.00013863233,0.00026125787,0.0010208784,0.0000505176,0.0015641521],"study_design_scores_gemma":[0.004867425,0.0012857799,0.9914071,0.000009208581,0.00006457291,0.000002022401,0.00002490961,0.0008811679,0.00011186972,0.0007620047,0.0005126029,0.00007133699],"about_ca_topic_score_codex":0.0025866851,"about_ca_topic_score_gemma":0.000849961,"teacher_disagreement_score":0.0039972905,"about_ca_system_score_codex":0.000076003605,"about_ca_system_score_gemma":0.000066792294,"threshold_uncertainty_score":0.43535343},"labels":[],"label_agreement":null},{"id":"W4321598603","doi":"10.3390/cancers15051409","title":"Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lions Gate Hospital","funders":"European Association of Urology","keywords":"Medicine; Propensity score matching; Urothelial carcinoma; Perioperative; Urology; Laparoscopy; Surgery; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.1572841695027481,"score_gpt":0.383391358959247,"score_spread":0.22610718945649888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321598603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628526,0.00029693727,0.0000535306,0.00040724277,0.0004133139,0.0022865823,0.000097668395,0.000019220328,0.00014027313],"genre_scores_gemma":[0.9985512,0.00020192025,0.00045824595,0.000047448953,0.00006833483,0.0004251234,0.00007051771,0.000015216757,0.00016197293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988861,0.000065600565,0.00029772404,0.0003184843,0.00021196502,0.00022010076],"domain_scores_gemma":[0.99884623,0.00058354443,0.00012887003,0.0002232955,0.00011964176,0.000098412434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001081463,0.00019715072,0.0008934778,0.00010128335,0.00013550541,0.000029045968,0.00014610142,0.00006404874,0.000056192563],"category_scores_gemma":[0.00009040966,0.000116651965,0.00023753647,0.00032797194,0.00027232015,0.00007422833,0.000054932098,0.00006656366,0.0000012749279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0149915,0.00045440005,0.9729068,0.00007363381,0.0041167983,0.000011174805,0.003242122,0.0022507682,0.00067083625,0.000055909943,0.000053682674,0.0011723677],"study_design_scores_gemma":[0.042051047,0.0033002677,0.93387216,0.000029426998,0.0035090668,0.0000010658877,0.0008077983,0.013841693,0.002086466,0.0000017626262,0.00038468075,0.00011454682],"about_ca_topic_score_codex":0.003148968,"about_ca_topic_score_gemma":0.0006948856,"teacher_disagreement_score":0.03903463,"about_ca_system_score_codex":0.0008099641,"about_ca_system_score_gemma":0.00047634743,"threshold_uncertainty_score":0.47603187},"labels":[],"label_agreement":null},{"id":"W4321598714","doi":"10.3390/jcm12051776","title":"The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial cancer; Histology; Stage (stratigraphy); Bladder cancer; Disease; Oncology; Cancer; Urology; Internal medicine; Pathology","score_opus":0.030082461952519488,"score_gpt":0.40483814840645166,"score_spread":0.37475568645393215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321598714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98260707,0.0016965084,0.000029503966,0.01240075,0.0019820372,0.00046725816,0.000022963446,0.0000101387795,0.000783746],"genre_scores_gemma":[0.99446326,0.0021637066,0.000011167179,0.0007132239,0.0017030459,0.000030130743,0.0000019162817,0.000025908406,0.0008876072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969705,0.0005193791,0.0013506704,0.00022881797,0.000646065,0.000284595],"domain_scores_gemma":[0.995354,0.003432481,0.00040925242,0.00025905174,0.00009040184,0.00045483798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002793403,0.0001995302,0.0012190107,0.00018401901,0.000042591117,0.0000047498297,0.00013593695,0.00014159325,0.0002260301],"category_scores_gemma":[0.0021588583,0.000096597556,0.00021135065,0.00025830252,0.0006469122,0.000036025733,0.000039784907,0.0007014769,0.000007997371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061056077,0.00033861064,0.8665903,0.00038252198,0.00083220605,0.005991553,0.0004051813,0.000016206734,0.0002033884,0.000037690486,0.002796982,0.061349273],"study_design_scores_gemma":[0.02998553,0.011941524,0.94462943,0.0010646401,0.0007214304,0.00007587115,0.0000864875,0.00016813964,0.000119591044,0.00010986097,0.010989611,0.00010790643],"about_ca_topic_score_codex":0.000110051216,"about_ca_topic_score_gemma":0.000041670995,"teacher_disagreement_score":0.078039095,"about_ca_system_score_codex":0.00005074039,"about_ca_system_score_gemma":0.00029110064,"threshold_uncertainty_score":0.39391342},"labels":[],"label_agreement":null},{"id":"W4321764397","doi":"10.1016/j.acuroe.2022.12.006","title":"Robot-assisted vs open radical cystectomy: Systematic review and meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"letter","venue":"Actas Urológicas Españolas (English Edition)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Randomized controlled trial; Meta-analysis; Medicine; Urology; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.08015889372713453,"score_gpt":0.3493546634399213,"score_spread":0.26919576971278675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321764397","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026156846,0.1490734,0.00022854765,0.74423,0.0027166319,0.08922842,0.0067955027,0.0007359086,0.0069654686],"genre_scores_gemma":[0.01047412,0.02757304,0.0009782941,0.85266817,0.008933237,0.05666855,0.016563568,0.0007035365,0.025437467],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9786134,0.01019646,0.00700701,0.0014487943,0.0020340846,0.0007002458],"domain_scores_gemma":[0.97113824,0.019501677,0.005534014,0.0019254185,0.0015190279,0.00038160253],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.014479305,0.0014251756,0.06979357,0.0015009763,0.00018751182,0.00035445916,0.00085692096,0.0012512038,0.00517654],"category_scores_gemma":[0.03615424,0.0008117282,0.015161512,0.0019909055,0.00044601946,0.00033135436,0.00029759086,0.0016666872,0.000077488854],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017545568,0.00016293833,0.0000010820238,0.060406573,0.5426244,0.00042822878,0.00007472098,0.000001386134,0.0000017181902,0.000032032076,0.37871715,0.000004165586],"study_design_scores_gemma":[0.18308955,0.0003352713,0.000016191876,0.0045532067,0.80139256,0.000065261695,0.000015413058,0.000022006743,0.000009177743,0.00008790329,0.009914137,0.00049931643],"about_ca_topic_score_codex":0.0001742019,"about_ca_topic_score_gemma":0.00001640038,"teacher_disagreement_score":0.368803,"about_ca_system_score_codex":0.00019722096,"about_ca_system_score_gemma":0.0005259309,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W4321793069","doi":"10.1016/j.eururo.2023.02.007","title":"Erratum to “European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel” [Eur. Urol. 79(4) (2021) 480–488]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Urology; Risk factor; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.05933211470376304,"score_gpt":0.30794320282977533,"score_spread":0.2486110881260123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321793069","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22333996,0.09256744,0.033261374,0.20374355,0.22397892,0.09175368,0.107053265,0.0026500048,0.021651816],"genre_scores_gemma":[0.79163563,0.02334873,0.0009730466,0.021118471,0.054862443,0.0052030026,0.018759914,0.00270666,0.08139211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919614,0.002858372,0.0018117344,0.0017245602,0.00062332384,0.001020602],"domain_scores_gemma":[0.99187255,0.0023591744,0.0026077842,0.0013894862,0.0014333007,0.00033768118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022286435,0.000992769,0.0015272017,0.00028556748,0.00067144464,0.00018219565,0.0009316924,0.00060566526,0.000037727565],"category_scores_gemma":[0.004384469,0.00066622125,0.00037703544,0.00046107874,0.0002923662,0.00016734193,0.00032603214,0.0013142419,0.000099664605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007647023,0.0001788079,0.013335996,0.00028266633,0.001917508,0.00004906679,0.0020031754,0.00020333775,0.0005761538,0.00007517387,0.97183293,0.008780458],"study_design_scores_gemma":[0.0059433426,0.0058441944,0.34100962,0.0006181149,0.006213872,0.00003161671,0.00080644485,0.0070274603,0.000024030975,0.0005707333,0.63077384,0.0011367189],"about_ca_topic_score_codex":0.0015588346,"about_ca_topic_score_gemma":0.0019108104,"teacher_disagreement_score":0.56829566,"about_ca_system_score_codex":0.0002451501,"about_ca_system_score_gemma":0.00074691884,"threshold_uncertainty_score":0.9995789},"labels":[],"label_agreement":null},{"id":"W4323032055","doi":"10.1016/j.euo.2023.02.003","title":"Where To Draw the Line: Stratifying Risk for High-grade Ta Bladder Cancer","year":2023,"lang":"en","type":"letter","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Line (geometry); Internal medicine; Cancer","score_opus":0.04740955244551244,"score_gpt":0.3424454065617327,"score_spread":0.2950358541162203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323032055","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026095072,0.0022771829,0.00040359984,0.97724587,0.005130665,0.002836157,0.0010204915,0.00036326353,0.008113245],"genre_scores_gemma":[0.008676494,0.0018111508,0.00056064076,0.93040156,0.025693845,0.0010390326,0.00063824275,0.0005368259,0.030642191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955832,0.0012132998,0.0006774944,0.0011505631,0.00029603756,0.001079457],"domain_scores_gemma":[0.9971489,0.0010786374,0.00040665705,0.0009822283,0.00019163678,0.00019199275],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062246807,0.00065853057,0.0010963285,0.00024489392,0.00038567706,0.000039141698,0.00063098903,0.00091844564,0.0007000056],"category_scores_gemma":[0.00023005264,0.00045931566,0.00033046716,0.00029582385,0.00035018483,0.00003260347,0.00024077242,0.0029463812,0.0014402323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046320911,0.00010127424,0.0005152615,0.00012228805,0.0013861562,0.0022022976,0.0005353581,0.000060125956,0.000100696445,0.000027748707,0.98211825,0.012367337],"study_design_scores_gemma":[0.003592436,0.004822737,0.0042752433,0.000049444654,0.002372648,0.0001633172,0.000046813628,0.000016030672,0.000036099937,0.00021154902,0.98403525,0.00037841892],"about_ca_topic_score_codex":0.0006793138,"about_ca_topic_score_gemma":0.001286078,"teacher_disagreement_score":0.04684431,"about_ca_system_score_codex":0.00029196026,"about_ca_system_score_gemma":0.00074045843,"threshold_uncertainty_score":0.99978584},"labels":[],"label_agreement":null},{"id":"W4323267818","doi":"10.1016/j.urolonc.2023.01.015","title":"Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Bladder cancer; Urothelial cancer; Urology; Medicine; Oncology; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.03327128359324958,"score_gpt":0.34343645907069204,"score_spread":0.31016517547744243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323267818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934144,0.0006634256,0.000037926537,0.003519659,0.000100868034,0.0005942472,0.00012164001,0.000043061686,0.0015047935],"genre_scores_gemma":[0.99613875,0.00026733265,0.0025634482,0.00036698012,0.000050079307,0.000110782465,0.00003603174,0.00001907883,0.00044749232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986354,0.00018162624,0.00031048054,0.00030650338,0.00030704765,0.00025895415],"domain_scores_gemma":[0.99897337,0.00030931257,0.00026715972,0.0001935472,0.00009991866,0.00015666331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023936425,0.00020009094,0.0005777549,0.00010356805,0.00016651815,0.000007786361,0.000093177856,0.00016360058,0.00006003498],"category_scores_gemma":[0.00005666491,0.000114123126,0.00004518481,0.00048187491,0.0015361438,0.000049633843,0.00005517946,0.00031297747,7.511897e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002711007,0.00023059374,0.99568707,0.000043370375,0.0004311929,0.000047900903,0.0004988741,0.00007859986,0.0007558494,0.00104663,0.0005202397,0.0003886013],"study_design_scores_gemma":[0.006375235,0.007712591,0.9565492,0.00024660816,0.0018108475,0.0001644682,0.0010433615,0.001608587,0.001572425,0.00044279432,0.022253355,0.0002205224],"about_ca_topic_score_codex":0.00020855946,"about_ca_topic_score_gemma":0.0003452488,"teacher_disagreement_score":0.039137844,"about_ca_system_score_codex":0.00008310984,"about_ca_system_score_gemma":0.00081450335,"threshold_uncertainty_score":0.5659986},"labels":[],"label_agreement":null},{"id":"W4323355305","doi":"10.3233/blc-220076","title":"An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Radboud Institute for Health Sciences; Radboud Universitair Medisch Centrum; Radboud Universiteit","keywords":"Bladder cancer; Germline; Cancer; Medicine; Gene; Oncology; Internal medicine; Biology; Genetics","score_opus":0.021976307643931308,"score_gpt":0.3163861492073973,"score_spread":0.294409841563466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323355305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912587,0.0020117713,0.000005170982,0.002350737,0.00042734735,0.0030532714,0.00034371237,0.00012248117,0.00042680049],"genre_scores_gemma":[0.9922885,0.0028335494,0.000046887242,0.0004172372,0.00032965743,0.0027223027,0.00005178822,0.00012356679,0.0011865178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640775,0.00021999802,0.00082571065,0.00076968654,0.0010737,0.0007031364],"domain_scores_gemma":[0.9976036,0.000192718,0.0006878656,0.000667264,0.00066634244,0.00018220974],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043657978,0.00048318456,0.0009556526,0.00036018057,0.00014649318,0.00003042423,0.0003345846,0.0002599461,0.0010757988],"category_scores_gemma":[0.000041712028,0.00033175386,0.00014785015,0.0021067662,0.0001196808,0.00026308678,0.00008401776,0.00038797862,0.000014347289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000745496,0.0033291108,0.9328531,0.0002489287,0.0054843873,0.00007875192,0.020693665,0.003018966,0.015271319,0.0000056757867,0.005317079,0.012953511],"study_design_scores_gemma":[0.010029336,0.0018193861,0.9681223,0.00044934987,0.0020805139,0.0000027458768,0.004895707,0.00074994157,0.010999221,0.000020022375,0.00042537323,0.0004060945],"about_ca_topic_score_codex":0.030001147,"about_ca_topic_score_gemma":0.046359614,"teacher_disagreement_score":0.0352692,"about_ca_system_score_codex":0.0006039565,"about_ca_system_score_gemma":0.0015226275,"threshold_uncertainty_score":0.99991345},"labels":[],"label_agreement":null},{"id":"W4323664790","doi":"10.1016/j.suronc.2023.101924","title":"Regional differences in total hospital costs for radical cystectomy in the United States","year":2023,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Cohort; Bladder cancer; Urology; Linear regression; Demography; Surgery; Animal science; Internal medicine; Statistics; Cancer; Mathematics; Biology","score_opus":0.041047796157247976,"score_gpt":0.3423964095773005,"score_spread":0.30134861342005254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323664790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98022777,0.0001130222,0.000004322013,0.01640698,0.00018023784,0.000690628,0.000025134796,0.000037296624,0.002314584],"genre_scores_gemma":[0.99794346,0.00025999162,0.000031282845,0.00067101204,0.00015992022,0.00034075486,0.00025554182,0.000009685919,0.00032836333],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892664,0.0001685819,0.0002236604,0.00020976098,0.0001569358,0.00031440842],"domain_scores_gemma":[0.998705,0.0010605727,0.000031539217,0.00009984354,0.000028099766,0.000074899144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028709043,0.00010869471,0.00033097304,0.00017657447,0.000034659075,0.0000071038694,0.000087914064,0.00013682002,0.00007144406],"category_scores_gemma":[0.000048627327,0.00006440912,0.000078225654,0.00056365324,0.00016186177,0.00002274663,0.000023489922,0.00021080983,0.00002850862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016772034,0.008992156,0.67660546,0.00026603666,0.00053049135,0.021217732,0.0136074545,0.00007111207,0.00009595773,0.01578911,0.043092065,0.20296039],"study_design_scores_gemma":[0.020035038,0.0066105863,0.44477096,0.000096854856,0.00006113421,0.00036422667,0.0022599895,0.0012132486,0.000021729164,0.0021216834,0.5222274,0.00021711666],"about_ca_topic_score_codex":0.0005319203,"about_ca_topic_score_gemma":0.0001812963,"teacher_disagreement_score":0.47913536,"about_ca_system_score_codex":0.00018416361,"about_ca_system_score_gemma":0.00015353682,"threshold_uncertainty_score":0.26265275},"labels":[],"label_agreement":null},{"id":"W4323823236","doi":"10.1016/j.eururo.2023.03.002","title":"Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cisplatin; Chemotherapy; Oncology; Internal medicine; Neoadjuvant therapy; Urology; Cancer","score_opus":0.029312087197528817,"score_gpt":0.32794164049409424,"score_spread":0.29862955329656543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323823236","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21515895,0.010702544,0.02239324,0.11264758,0.2529823,0.07160884,0.04350172,0.002247811,0.26875702],"genre_scores_gemma":[0.27952397,0.0010773722,0.0036375888,0.05482914,0.007038008,0.0043780734,0.0037714627,0.0025541962,0.6431902],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954043,0.00076301995,0.0010353178,0.0013720026,0.0004718736,0.0009534865],"domain_scores_gemma":[0.99756277,0.0003195148,0.00041719858,0.00096175686,0.0002654141,0.00047336376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010028279,0.00075823563,0.0014056936,0.0011640843,0.00008856639,0.00002018307,0.0005221471,0.00038900707,0.00064402475],"category_scores_gemma":[0.00027518987,0.00073091587,0.0003534133,0.00076383946,0.00013814028,0.000026059015,0.00016339094,0.0007442543,0.00015888725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0358908,0.00042099803,0.0027009202,0.00019570244,0.0012879573,0.00060102163,0.0007318668,0.0010540417,0.007139056,0.0000032295668,0.9448725,0.005101921],"study_design_scores_gemma":[0.011142363,0.012198755,0.31290314,0.00033565378,0.0006903899,0.000021118432,0.00008168984,0.0019958403,0.00021358242,0.000011196898,0.65977335,0.0006328891],"about_ca_topic_score_codex":0.000459439,"about_ca_topic_score_gemma":0.0004070598,"teacher_disagreement_score":0.37443316,"about_ca_system_score_codex":0.0006730209,"about_ca_system_score_gemma":0.0021694412,"threshold_uncertainty_score":0.99951416},"labels":[],"label_agreement":null},{"id":"W4323845192","doi":"10.3390/curroncol30030245","title":"Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Proportional hazards model; Urology; Population; Chemotherapy; Hazard ratio; Cancer; Surgery; Internal medicine; Oncology; Confidence interval","score_opus":0.07234482423475894,"score_gpt":0.40760010669310315,"score_spread":0.33525528245834424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323845192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915642,0.0031772126,0.00029510687,0.0021246257,0.0009747288,0.0013385436,0.000120496996,0.000061545936,0.0003435453],"genre_scores_gemma":[0.9978507,0.0007022937,0.00023025228,0.000089768706,0.00041723473,0.0003269043,0.0001398904,0.00005045307,0.00019251238],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99833345,0.00008456512,0.00035722088,0.00044734898,0.00031231288,0.00046511544],"domain_scores_gemma":[0.9991497,0.00030013334,0.00009018517,0.00017867953,0.00010987005,0.00017145125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022937894,0.00023227977,0.00082236127,0.00017984888,0.000048986116,0.000004803583,0.00008495579,0.00017960832,0.000111716814],"category_scores_gemma":[0.00003253278,0.00017220923,0.00015204515,0.00038386963,0.00015789499,0.000044730416,0.000032792985,0.0002372549,0.000011046793],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013987658,0.0036699404,0.12406804,0.00043025764,0.000889891,0.001100567,0.0027372558,0.00012575599,0.005747665,0.0007334099,0.0024154282,0.84409416],"study_design_scores_gemma":[0.06492529,0.0077122054,0.8287454,0.0013768693,0.00079082104,0.00022345019,0.0004652631,0.001168563,0.012073407,0.00019466113,0.08170359,0.000620444],"about_ca_topic_score_codex":0.00011335055,"about_ca_topic_score_gemma":0.00018791629,"teacher_disagreement_score":0.8434737,"about_ca_system_score_codex":0.0002595494,"about_ca_system_score_gemma":0.00044343018,"threshold_uncertainty_score":0.7022489},"labels":[],"label_agreement":null},{"id":"W4324136255","doi":"10.1200/jco.2023.41.6_suppl.460","title":"FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; McMaster University; London Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Gemcitabine; Cisplatin; Neoadjuvant therapy; Chemotherapy; Vinblastine; Chemoradiotherapy; Radiology; Positron emission tomography; Prospective cohort study; Internal medicine; Oncology; Nuclear medicine; Cancer; Urology; Breast cancer","score_opus":0.10934851904634206,"score_gpt":0.5055802606982742,"score_spread":0.39623174165193215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98093975,0.00013164725,0.000029646442,0.016494771,0.00089831627,0.0009461972,0.0000056757985,0.000022440607,0.0005315439],"genre_scores_gemma":[0.99288887,0.000101555175,0.00070673745,0.0055895788,0.0004271635,0.000080204816,0.0000012412735,0.000044698147,0.00015995359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957258,0.0009695572,0.0020394304,0.0004022225,0.00044474064,0.00041823942],"domain_scores_gemma":[0.99544173,0.0029293823,0.0007781456,0.00023304082,0.00029634312,0.00032133603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043222834,0.00023344679,0.001519685,0.0006545504,0.000042108833,0.0000285322,0.00019298516,0.00006929062,0.00021226592],"category_scores_gemma":[0.0034406155,0.00017973401,0.00028402187,0.0007992222,0.00010914914,0.0001659099,0.00006515406,0.0010341618,0.000024893936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02237134,0.0036420696,0.82389843,0.000018470375,0.00021525062,0.018181486,0.0018706275,0.00024014624,0.0021076861,0.0000010005598,0.000857132,0.12659638],"study_design_scores_gemma":[0.028739749,0.009863107,0.95524335,0.0005456346,0.00013432287,0.00015254281,0.0028910337,0.0003025401,0.00039536934,0.000092543996,0.0014848013,0.00015501853],"about_ca_topic_score_codex":0.00056087587,"about_ca_topic_score_gemma":0.002118806,"teacher_disagreement_score":0.13134491,"about_ca_system_score_codex":0.001086671,"about_ca_system_score_gemma":0.0049584378,"threshold_uncertainty_score":0.8796056},"labels":[],"label_agreement":null},{"id":"W4324136387","doi":"10.1200/jco.2023.41.6_suppl.449","title":"Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment-weighted analysis.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Dalhousie University; Queen's University; McMaster University; University of British Columbia; McGill University Health Centre; McGill University; University of Ottawa; University of Calgary; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital; Université de Sherbrooke; Western University; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Radiation therapy; Urology; Pelvis; Lymph node; Confounding; Internal medicine; Oncology; Randomized controlled trial; Cancer; Surgery","score_opus":0.09554304253305543,"score_gpt":0.42880769995618473,"score_spread":0.3332646574231293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673647,0.00007906271,0.000047580404,0.001615641,0.00038800464,0.000787181,0.00018987797,0.000016299178,0.00013991016],"genre_scores_gemma":[0.99602747,0.00059822644,0.0019724995,0.00044911102,0.000501618,0.000056532783,0.0001601105,0.000022746975,0.0002116871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735945,0.00019503878,0.001571454,0.00028252302,0.0003535649,0.00023798404],"domain_scores_gemma":[0.9956515,0.001099782,0.0015935479,0.00026259653,0.0010309762,0.00036161617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007175437,0.0001791886,0.0016535642,0.00029089648,0.000048081238,0.0000059377835,0.00010634391,0.00026065428,0.00011887136],"category_scores_gemma":[0.000563634,0.00011107945,0.0006627274,0.0006394157,0.00015089718,0.0001672285,0.000014286672,0.00019598003,0.0000048096954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006055786,0.0042485194,0.8117891,0.00003935386,0.0055471165,0.000031235515,0.00034593945,0.00025861646,0.00003169292,0.000013590447,0.00064589083,0.17099316],"study_design_scores_gemma":[0.023274617,0.042950667,0.9177215,0.00003663647,0.00835838,0.0000023805858,0.00009851165,0.00039698617,0.00014615175,0.00044624228,0.0064684665,0.00009944843],"about_ca_topic_score_codex":0.00023366074,"about_ca_topic_score_gemma":0.0015460287,"teacher_disagreement_score":0.17089371,"about_ca_system_score_codex":0.00038206,"about_ca_system_score_gemma":0.0018523147,"threshold_uncertainty_score":0.45296884},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4324136522","doi":"10.1200/jco.2023.41.6_suppl.517","title":"Preliminary clinical outcomes of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced urothelial cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD8; Leukapheresis; Internal medicine; Oncology; Cohort; Cancer; Adverse effect; Immunotherapy; Clinical trial; Antigen; Immunology; CD34; Stem cell","score_opus":0.13308871601389985,"score_gpt":0.4393163791348133,"score_spread":0.30622766312091343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935196,0.00047863752,0.000015429152,0.0021208832,0.0024207283,0.0007492821,0.000031063897,0.000023163988,0.00064118503],"genre_scores_gemma":[0.99085855,0.004266646,0.0019389885,0.0014647616,0.0008028946,0.000034378143,0.00002228894,0.00004487303,0.00056661357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948931,0.0006617279,0.0031877114,0.0003541348,0.000558219,0.00034516107],"domain_scores_gemma":[0.99532235,0.0014513566,0.0020760887,0.00028804934,0.0005427193,0.00031944233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001759571,0.00025362291,0.00214176,0.0002253161,0.00003847176,0.0000072439652,0.0002235601,0.0005098294,0.00018909913],"category_scores_gemma":[0.00082528614,0.00016188216,0.0005523986,0.00034028495,0.00023921914,0.00017257612,0.000050728955,0.0009319192,0.00003077241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023965927,0.005807933,0.7732674,0.000030458885,0.00031112446,0.000108349974,0.00014473026,0.00009401343,0.0004228255,0.000002155859,0.0030908436,0.19275425],"study_design_scores_gemma":[0.045078047,0.076117665,0.8711341,0.000095221265,0.00027559104,0.000006540736,0.00007384991,0.0000778833,0.00055458467,0.000024616957,0.0064145946,0.00014731081],"about_ca_topic_score_codex":0.000077400284,"about_ca_topic_score_gemma":0.00006527965,"teacher_disagreement_score":0.19260694,"about_ca_system_score_codex":0.00016423623,"about_ca_system_score_gemma":0.0024196594,"threshold_uncertainty_score":0.6601363},"labels":[],"label_agreement":null},{"id":"W4324136559","doi":"10.1200/jco.2023.41.6_suppl.489","title":"Quality of life after radical treatment for muscle invasive bladder cancer: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urinary diversion; Systematic review; Quality of life (healthcare); Meta-analysis; Surgery; MEDLINE; Intensive care medicine; Cancer; Internal medicine","score_opus":0.5681781195811048,"score_gpt":0.5940124811918732,"score_spread":0.025834361610768464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016786058,0.99304885,0.000022094217,0.0021456743,0.00023723514,0.004029793,0.00043771474,0.0000075553066,0.000054279208],"genre_scores_gemma":[0.00006607582,0.99408174,0.00045053856,0.002749867,0.0004198768,0.0013856704,0.00002126009,0.00004990286,0.0007750995],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98722774,0.0024121902,0.009168391,0.0004319001,0.0004962582,0.00026350736],"domain_scores_gemma":[0.9791869,0.01057661,0.008487395,0.0005114939,0.0005955471,0.00064207305],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0053115324,0.0004891873,0.040361185,0.00028857664,0.000026962065,0.0000082011,0.00020628245,0.00069752795,0.00043780546],"category_scores_gemma":[0.0074500507,0.00023928814,0.013906832,0.0004518116,0.00023516116,0.000047004985,0.00005511781,0.00056546205,0.000010581582],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003146638,0.0008212276,0.000030001775,0.49413007,0.4861083,0.00009604795,0.000023188191,1.4020331e-7,1.1858061e-8,0.000007767731,0.0007854042,0.017683163],"study_design_scores_gemma":[0.0026232211,0.004974344,0.00013657004,0.02070151,0.86345226,0.000045479796,0.00001205849,3.1232068e-7,5.6794363e-8,0.000030890475,0.10787811,0.00014521764],"about_ca_topic_score_codex":0.0001139024,"about_ca_topic_score_gemma":0.00030468556,"teacher_disagreement_score":0.47342858,"about_ca_system_score_codex":0.00033830773,"about_ca_system_score_gemma":0.006880812,"threshold_uncertainty_score":0.99874926},"labels":[],"label_agreement":null},{"id":"W4324136609","doi":"10.1200/jco.2023.41.6_suppl.506","title":"A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Cohort; Cancer; Immunotherapy","score_opus":0.16250859558715813,"score_gpt":0.4724198347077909,"score_spread":0.3099112391206328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600625,0.00031246812,0.000005151871,0.0010915569,0.00078412413,0.0004661068,0.0000066753405,0.000009406888,0.0013182473],"genre_scores_gemma":[0.99819875,0.00044854853,0.0002611814,0.00037912797,0.00039491244,0.00001081269,0.0000011034409,0.000019907371,0.00028563774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690735,0.00037722843,0.0019266153,0.00020506853,0.00035366093,0.0002300924],"domain_scores_gemma":[0.9974178,0.0011414108,0.00079243566,0.00017522475,0.00022191403,0.00025123177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014640986,0.00013712588,0.0014823219,0.00028407702,0.000022563063,0.0000037081193,0.00011302882,0.00009784519,0.000072901516],"category_scores_gemma":[0.0013875975,0.00009854954,0.00014831299,0.00032310514,0.00012571372,0.0000796075,0.00006447901,0.0005844101,0.000011137277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033672284,0.008229133,0.8472629,0.000055201574,0.00033987666,0.0021194092,0.0008534845,0.000018903202,0.00081832317,0.000020114221,0.0007448352,0.105865486],"study_design_scores_gemma":[0.04566516,0.13937424,0.8110412,0.00006046816,0.00026276583,0.00016020678,0.00082099304,0.00002962134,0.000066444154,0.00018958776,0.002264294,0.00006504598],"about_ca_topic_score_codex":0.00023776562,"about_ca_topic_score_gemma":0.000431132,"teacher_disagreement_score":0.1311451,"about_ca_system_score_codex":0.00009076174,"about_ca_system_score_gemma":0.0010990073,"threshold_uncertainty_score":0.40187338},"labels":[],"label_agreement":null},{"id":"W4324136624","doi":"10.1200/jco.2023.41.6_suppl.477","title":"Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Immunotherapy; Bladder cancer; Cohort; Cancer; Logistic regression","score_opus":0.1806858237803709,"score_gpt":0.48682957261763793,"score_spread":0.306143748837267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821532,0.00023107808,0.00026539585,0.013329082,0.001649506,0.001325779,0.000070995564,0.000020790385,0.00095419324],"genre_scores_gemma":[0.9898915,0.0025704158,0.00078388443,0.0015215662,0.000638501,0.000094961986,0.000008051972,0.00003957216,0.0044515324],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99697506,0.00025152316,0.0018989275,0.00020303104,0.00037732988,0.00029411472],"domain_scores_gemma":[0.99603194,0.0017547394,0.0013792752,0.00031528453,0.00036021598,0.00015853508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012634186,0.00019881631,0.0014075261,0.00016675159,0.00010465046,0.000007766465,0.00021904158,0.0001459898,0.00035832025],"category_scores_gemma":[0.0005598017,0.0001007311,0.0008881754,0.00041589994,0.00018574808,0.00007185332,0.000029348266,0.00023772297,0.0000072756293],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10016024,0.028818484,0.3481378,0.0002952191,0.007711852,0.0005873797,0.009653893,0.000060735812,0.0018583585,0.0014528767,0.01587072,0.48539245],"study_design_scores_gemma":[0.12105046,0.07679575,0.52927965,0.00019794173,0.0015663076,0.00018004279,0.0008904016,0.00074145844,0.005847166,0.002104951,0.26109666,0.00024921345],"about_ca_topic_score_codex":0.0001737816,"about_ca_topic_score_gemma":0.00058551575,"teacher_disagreement_score":0.48514324,"about_ca_system_score_codex":0.00026599958,"about_ca_system_score_gemma":0.0018235209,"threshold_uncertainty_score":0.4107695},"labels":[],"label_agreement":null},{"id":"W4324136686","doi":"10.1200/jco.2023.41.6_suppl.570","title":"Comprehensive gene sequencing to identify progression predictors to muscle-invasive bladder cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu Grace Healthcare; Windsor Regional Hospital; Western University; University of Windsor","funders":"","keywords":"Bladder cancer; Medicine; Oncology; Cancer; Internal medicine; Transitional cell carcinoma","score_opus":0.2163602581421605,"score_gpt":0.5354659678048062,"score_spread":0.3191057096626456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794657,0.0003714636,0.00009849559,0.014835174,0.0036085711,0.00065535214,0.00002409803,0.00004890541,0.0008921908],"genre_scores_gemma":[0.9815333,0.001105925,0.0031418025,0.010243473,0.0032538068,0.00005113024,0.0000067382366,0.000042429678,0.00062142656],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966314,0.00027726224,0.0017370759,0.00032231607,0.00062964123,0.00040231794],"domain_scores_gemma":[0.99606,0.001089266,0.0007195091,0.00023447524,0.0008488042,0.0010479273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009973908,0.00019530045,0.0013056484,0.0002923428,0.00007606088,0.000015130151,0.00020974241,0.00030901082,0.00022159156],"category_scores_gemma":[0.0018081618,0.00013812019,0.00042760244,0.0005611087,0.00008965575,0.00009750255,0.00013777649,0.0006360461,0.00022745755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085119875,0.0014636863,0.16622773,0.00019823574,0.003107226,0.008906398,0.0031646062,0.0009988204,0.06967228,0.000018483253,0.1318836,0.60584694],"study_design_scores_gemma":[0.0068397103,0.020348066,0.8523492,0.0006069118,0.00075276854,0.00024043627,0.0006835924,0.000027033757,0.0052047796,0.00013951161,0.11261665,0.00019132647],"about_ca_topic_score_codex":0.00008715323,"about_ca_topic_score_gemma":0.00008045159,"teacher_disagreement_score":0.68612146,"about_ca_system_score_codex":0.0005113293,"about_ca_system_score_gemma":0.0033367288,"threshold_uncertainty_score":0.5919213},"labels":[],"label_agreement":null},{"id":"W4324136701","doi":"10.1200/jco.2023.41.6_suppl.508","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up from the JAVELIN Bladder 100 trial in subgroups defined by 1L chemotherapy regimen and analysis of overall survival (OS) from start of 1L chemotherapy.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Gemcitabine; Carboplatin; Avelumab; Randomization; Regimen; Internal medicine; Metastatic Urothelial Carcinoma; Clinical endpoint; Chemotherapy; Oncology; Maintenance therapy; Chemotherapy regimen; Cisplatin; Urology; Surgery; Bladder cancer; Randomized controlled trial; Cancer; Nivolumab; Urothelial carcinoma; Immunotherapy","score_opus":0.07867984464162421,"score_gpt":0.3967172159134745,"score_spread":0.3180373712718503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865708,0.0009381661,0.0007017294,0.008529544,0.0012556941,0.0011264276,0.0007909455,0.000013593679,0.00007311293],"genre_scores_gemma":[0.9906604,0.004486816,0.0011859213,0.001770234,0.0010917218,0.000043154414,0.00019430174,0.000064249165,0.00050317467],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99480504,0.00043666858,0.003151736,0.0005253188,0.00060461136,0.00047663916],"domain_scores_gemma":[0.9908389,0.00577461,0.0021923913,0.0005075988,0.00042635223,0.00026018618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002346272,0.00036232086,0.003353361,0.00024865087,0.0000609546,0.000013618912,0.0003813904,0.00050481857,0.00038691462],"category_scores_gemma":[0.0013759944,0.0002429547,0.001185312,0.00055392104,0.0003323478,0.00011511765,0.00006603225,0.0006117715,0.0000027809076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45711926,0.0036254067,0.45578954,0.000055673154,0.010512378,0.00014144194,0.0013485779,0.000050022674,0.0030998026,0.000027833408,0.0056386874,0.06259137],"study_design_scores_gemma":[0.2928242,0.013684083,0.6838836,0.00015129385,0.0030676753,0.0000056404965,0.00016140443,0.0006069147,0.001111668,0.00083264394,0.0034341353,0.00023674448],"about_ca_topic_score_codex":0.0012585112,"about_ca_topic_score_gemma":0.0024499893,"teacher_disagreement_score":0.22809404,"about_ca_system_score_codex":0.00019424061,"about_ca_system_score_gemma":0.0009261501,"threshold_uncertainty_score":0.9907405},"labels":[],"label_agreement":null},{"id":"W4324136745","doi":"10.1200/jco.2023.41.6_suppl.528","title":"A phase II clinical study of intravesical photo dynamic therapy in patients with BCG-unresponsive NMIBC (interim analysis).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; University Health Network; University of Toronto; Dalhousie University; Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Interim analysis; Cystoscopy; Bladder cancer; Carcinoma in situ; Clinical endpoint; Interim; Adverse effect; Urology; Clinical trial; Surgery; Photodynamic therapy; Internal medicine; Carcinoma; Cancer; Urinary system","score_opus":0.1173005526692258,"score_gpt":0.5202315740592199,"score_spread":0.40293102138999415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766296,0.000049369442,0.00002664107,0.00069244666,0.000547064,0.0008055135,0.000015061884,0.000011963075,0.00018900252],"genre_scores_gemma":[0.9982883,0.00031948677,0.0002206813,0.0007794344,0.00021779655,0.000011886999,0.0000112672815,0.000023454593,0.00012771794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99387026,0.0011759992,0.0036975353,0.00034048228,0.0006243557,0.00029134692],"domain_scores_gemma":[0.99498284,0.0019410482,0.001726773,0.0003387239,0.000630374,0.0003802328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031960807,0.00021103559,0.0029721898,0.0005838442,0.00003679547,0.0000055984992,0.00022875109,0.0003201443,0.00020095386],"category_scores_gemma":[0.0014980978,0.00012930356,0.0006612708,0.0011527272,0.00025693473,0.00008508277,0.000077588105,0.0010709419,0.000010470106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09812674,0.0733761,0.7343011,0.000006870076,0.0049752486,0.00090564846,0.0007207338,0.000017802047,0.00002862099,0.0000017123426,0.0003240298,0.08721539],"study_design_scores_gemma":[0.086865835,0.2767843,0.6339769,0.000038363,0.0012633839,0.000009075704,0.0004063258,0.00012829741,0.0000089594505,0.000022867596,0.000423433,0.000072277806],"about_ca_topic_score_codex":0.00004978886,"about_ca_topic_score_gemma":0.00023752567,"teacher_disagreement_score":0.2034082,"about_ca_system_score_codex":0.00014897806,"about_ca_system_score_gemma":0.0013441142,"threshold_uncertainty_score":0.5272846},"labels":[],"label_agreement":null},{"id":"W4324136749","doi":"10.1200/jco.2023.41.6_suppl.549","title":"Distinct gene expression patterns identify patients who relapse after neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Pembrolizumab; Oncology; Internal medicine; Neoadjuvant therapy; Gene expression profiling; Gene expression; Immunotherapy; Cancer; Gene; Biology; Breast cancer","score_opus":0.06726500618780332,"score_gpt":0.4353241490489515,"score_spread":0.36805914286114816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563813,0.00026665517,0.000015206627,0.00248886,0.0007743377,0.0005613215,0.000014686385,0.000010171356,0.00023061069],"genre_scores_gemma":[0.9976583,0.00030045942,0.00005367023,0.0011436583,0.0006436713,0.000037674065,0.000005984368,0.000019964089,0.00013662428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963777,0.00088876433,0.0016494575,0.00025766587,0.00055776327,0.0002686306],"domain_scores_gemma":[0.9977775,0.0009960474,0.0005892366,0.000247173,0.00012457544,0.0002654567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00199983,0.0001675018,0.0011076507,0.00015165126,0.00005335599,0.000020334592,0.00019048864,0.0002538482,0.00011224707],"category_scores_gemma":[0.0010025669,0.000089848916,0.00024519782,0.00019042907,0.00012533237,0.00010379283,0.000116250696,0.0009648693,0.000022583861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054225405,0.002737647,0.96977884,0.000025241892,0.00014569527,0.0034114085,0.0008964621,5.6147593e-7,0.000020771195,9.110768e-7,0.0019663665,0.01559354],"study_design_scores_gemma":[0.024105338,0.011233398,0.9605658,0.00011773758,0.00045224844,0.00020205165,0.00033106213,0.0000077660525,0.0000146456605,0.00010026849,0.0027905798,0.00007908574],"about_ca_topic_score_codex":0.000039858613,"about_ca_topic_score_gemma":0.00010168718,"teacher_disagreement_score":0.018682798,"about_ca_system_score_codex":0.00009723786,"about_ca_system_score_gemma":0.00030575736,"threshold_uncertainty_score":0.41919306},"labels":[],"label_agreement":null},{"id":"W4324136849","doi":"10.1200/jco.2023.41.6_suppl.tps582","title":"Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)—Trial in progress.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Astellas Pharma; Seagen","keywords":"Medicine; Bladder cancer; Cystectomy; Tolerability; Pembrolizumab; Oncology; Internal medicine; Chemotherapy; Carcinoma in situ; Urology; Cancer; Adverse effect; Immunotherapy","score_opus":0.1589544761568458,"score_gpt":0.5099200195524446,"score_spread":0.3509655433955988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937224,0.00006500491,0.000003710922,0.00048159313,0.00076458853,0.004840911,0.000049459733,0.000006740529,0.000065624394],"genre_scores_gemma":[0.9986211,0.00011373566,0.000182277,0.000066609835,0.0006057495,0.00031859093,0.000011579453,0.000029762825,0.000050612678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958311,0.00029404133,0.0026919271,0.0002940908,0.0005882463,0.00030064106],"domain_scores_gemma":[0.9956742,0.0013956352,0.0017843536,0.00024270006,0.00065022113,0.00025288897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009453162,0.00022875755,0.0023332918,0.00026855213,0.000030219608,0.000004770705,0.00014883644,0.0001955589,0.0000642062],"category_scores_gemma":[0.00060427556,0.0001381972,0.00032767648,0.00036000746,0.00018084446,0.00008356969,0.000030661577,0.00024963642,0.0000017202814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18350424,0.117882736,0.5798951,0.000037995127,0.0020212901,0.00038566336,0.0030129983,0.00001930184,0.000009952143,0.0000014428574,0.00027056743,0.1129587],"study_design_scores_gemma":[0.2700709,0.2973015,0.42959315,0.000051088227,0.0010401479,0.000002262163,0.0015345669,0.000009281644,0.00008137633,0.000012955685,0.00024379457,0.000058979327],"about_ca_topic_score_codex":0.00019505923,"about_ca_topic_score_gemma":0.00093024527,"teacher_disagreement_score":0.17941877,"about_ca_system_score_codex":0.0002758919,"about_ca_system_score_gemma":0.0030187895,"threshold_uncertainty_score":0.5635518},"labels":[],"label_agreement":null},{"id":"W4324136914","doi":"10.1200/jco.2023.41.6_suppl.tps591","title":"Phase 2 KEYNOTE-057 cohort C: Pembrolizumab (pembro) with vibostolimab or favezelimab for patients (pts) with high-risk (HR) bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer (NMIBC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Bladder cancer; Oncology; Internal medicine; Cancer; Urology; Immunotherapy","score_opus":0.06530937548472666,"score_gpt":0.4273297818045215,"score_spread":0.3620204063197949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989838,0.00017045708,0.00081266556,0.0035111948,0.001750546,0.002428603,0.00065683236,0.000070082744,0.0007616088],"genre_scores_gemma":[0.98598003,0.0031611645,0.0034279572,0.0035297237,0.0019496458,0.00036533433,0.000109302455,0.0001740765,0.0013027414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934909,0.00061998813,0.00277969,0.000855497,0.0012344124,0.0010195494],"domain_scores_gemma":[0.98780274,0.0051960982,0.002860706,0.0006046777,0.0024726011,0.0010631644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016273216,0.0006715395,0.0033401803,0.0005184591,0.00025870078,0.000038377246,0.00040674134,0.0006999907,0.00048489735],"category_scores_gemma":[0.0034834794,0.0003913928,0.0007354839,0.0008208669,0.00055392645,0.00029937766,0.00011194137,0.0015133884,0.00008631397],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38162997,0.014822576,0.16695963,0.00026077364,0.00966046,0.0059542716,0.0008571207,0.0002887712,0.0001614743,0.000021910913,0.024313774,0.39506924],"study_design_scores_gemma":[0.2574298,0.27497727,0.40932268,0.000600953,0.007651118,0.00052905147,0.0005069209,0.00018863298,0.0005722888,0.000109814035,0.047418844,0.00069262384],"about_ca_topic_score_codex":0.0006823004,"about_ca_topic_score_gemma":0.0013373904,"teacher_disagreement_score":0.39437664,"about_ca_system_score_codex":0.0008306696,"about_ca_system_score_gemma":0.008743779,"threshold_uncertainty_score":0.9998538},"labels":[],"label_agreement":null},{"id":"W4324136925","doi":"10.1200/jco.2023.41.6_suppl.488","title":"Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Proportional hazards model; Internal medicine; Interquartile range; Oncology; Hazard ratio; Comorbidity; Cancer registry; Cancer; Urology; Confidence interval","score_opus":0.1614066650767347,"score_gpt":0.47534668525430473,"score_spread":0.31394002017757006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800818,0.0002882407,0.000020144354,0.0096331155,0.0014354374,0.0005043984,0.00012913735,0.000040811294,0.007866926],"genre_scores_gemma":[0.99306214,0.0017921504,0.00024156495,0.0010477331,0.0008868468,0.000023041692,0.00003750491,0.000037090955,0.0028719106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958565,0.00043804012,0.0022991977,0.0003278823,0.00070253067,0.00037582905],"domain_scores_gemma":[0.99309444,0.002867212,0.002219105,0.000263873,0.0010740487,0.00048130215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009987612,0.00031087323,0.003190123,0.0003163089,0.00006092623,0.000011308287,0.0002019636,0.00025917654,0.0004500342],"category_scores_gemma":[0.00056290237,0.00019628256,0.00058187806,0.0006811582,0.00043594168,0.00014133725,0.000046464724,0.0007469723,0.00005483992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042350106,0.0021235459,0.9353838,0.00006333223,0.0053407685,0.0006045242,0.00073017506,0.00011604511,0.00017544157,0.0001015158,0.0192782,0.03184765],"study_design_scores_gemma":[0.018847818,0.010445976,0.9483618,0.00016737841,0.0019129189,0.00003648828,0.0005116913,0.00006329179,0.0006524628,0.000045857538,0.018773496,0.00018083416],"about_ca_topic_score_codex":0.0007047924,"about_ca_topic_score_gemma":0.0029515547,"teacher_disagreement_score":0.03166681,"about_ca_system_score_codex":0.00030222922,"about_ca_system_score_gemma":0.0044218595,"threshold_uncertainty_score":0.80041707},"labels":[],"label_agreement":null},{"id":"W4324136935","doi":"10.1200/jco.2023.41.6_suppl.lba441","title":"Final overall survival (OS) analysis of atezolizumab (atezo) monotherapy vs chemotherapy (chemo) in untreated locally advanced or metastatic urothelial carcinoma (mUC) from the Phase 3 IMvigor130 study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Metastatic Urothelial Carcinoma; Atezolizumab; Interim analysis; Gemcitabine; Oncology; Population; Phases of clinical research; Urology; Clinical trial; Chemotherapy; Cancer; Pembrolizumab; Bladder cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.17186929022796524,"score_gpt":0.48820594336400025,"score_spread":0.316336653136035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411434,0.00027607763,0.00017679222,0.0036258183,0.00059907057,0.00085898646,0.00013161254,0.0000234106,0.00019391773],"genre_scores_gemma":[0.99553245,0.0012300551,0.00060856075,0.0016998921,0.00045159066,0.000038660743,0.000032175187,0.000051474817,0.00035511047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99386716,0.0011930409,0.0032857202,0.00044411563,0.0007709733,0.00043898923],"domain_scores_gemma":[0.99258214,0.0044531636,0.0017302097,0.00050768116,0.00043261884,0.00029419892],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024923761,0.00035982116,0.0035557775,0.0004594357,0.000058103135,0.000016912245,0.0004356162,0.00025394233,0.0012314259],"category_scores_gemma":[0.0011644441,0.00020408745,0.0010284042,0.001535107,0.00024734755,0.00012561798,0.000052725358,0.00083712867,0.0000193307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24676473,0.014430006,0.51644385,0.000025234342,0.016873019,0.0037118301,0.0021268586,0.000787931,0.0009408314,0.000013230215,0.0009349447,0.19694754],"study_design_scores_gemma":[0.12572438,0.030789353,0.8311994,0.000075768556,0.005681554,0.000034084176,0.0009064376,0.0023387792,0.0005164988,0.00019217364,0.00233292,0.00020866877],"about_ca_topic_score_codex":0.0017931731,"about_ca_topic_score_gemma":0.0017951463,"teacher_disagreement_score":0.31475556,"about_ca_system_score_codex":0.00028354098,"about_ca_system_score_gemma":0.002545107,"threshold_uncertainty_score":0.9996816},"labels":[],"label_agreement":null},{"id":"W4324136951","doi":"10.1200/jco.2023.41.6_suppl.lba442","title":"Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette–Guérin (BCG): Results from cohort B of the phase 2 KEYNOTE-057 trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cohort; Bladder cancer; Cystectomy; Pembrolizumab; Internal medicine; Oncology; Cancer; Metastasis; Urology; Surgery; Immunotherapy","score_opus":0.07345774090978048,"score_gpt":0.43161687563576606,"score_spread":0.3581591347259856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845811,0.000113497714,0.00022366298,0.0068888883,0.0030970823,0.0031007791,0.0016919703,0.000021507403,0.00028151812],"genre_scores_gemma":[0.9903817,0.0014336515,0.0013863735,0.0035730596,0.0021295147,0.00020497416,0.000054284592,0.000081230326,0.00075518177],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99403244,0.00084318995,0.003116636,0.0005869808,0.0009100761,0.00051067624],"domain_scores_gemma":[0.9867183,0.0074753747,0.003079431,0.0006522567,0.0014979928,0.0005766381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019652313,0.00038581868,0.0024279132,0.0002493196,0.00013660413,0.00001574704,0.00044759727,0.0005051275,0.00015472437],"category_scores_gemma":[0.0068754293,0.00022146551,0.00088317884,0.00058205565,0.00029282089,0.000112457536,0.00009210043,0.0008886566,0.000023621451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7402162,0.0050375615,0.030593188,0.000027681832,0.004260093,0.00019693695,0.00091201573,0.0003339873,0.000309706,0.000007653994,0.02450579,0.1935992],"study_design_scores_gemma":[0.46748668,0.10747745,0.3910487,0.00031258253,0.0026253022,0.000010689421,0.00018185144,0.000055740085,0.001419411,0.0002807128,0.028841441,0.000259465],"about_ca_topic_score_codex":0.0021609792,"about_ca_topic_score_gemma":0.0011504695,"teacher_disagreement_score":0.36045548,"about_ca_system_score_codex":0.0004563806,"about_ca_system_score_gemma":0.004315968,"threshold_uncertainty_score":0.90311015},"labels":[],"label_agreement":null},{"id":"W4324136966","doi":"10.1200/jco.2023.41.6_suppl.lba440","title":"Atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem for first-line (1L) treatment (tx) of locally advanced or metastatic urothelial carcinoma (mUC): Final OS from the randomized Phase 3 IMvigor130 study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Atezolizumab; Internal medicine; Clinical endpoint; Placebo; Gemcitabine; Metastatic Urothelial Carcinoma; Urology; Oncology; Gastroenterology; Randomized controlled trial; Chemotherapy; Cancer; Pembrolizumab; Urothelial carcinoma; Bladder cancer; Immunotherapy; Pathology","score_opus":0.20118079705618278,"score_gpt":0.48444036288816095,"score_spread":0.2832595658319782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324136966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808897,0.0007231509,0.0016046229,0.0076236636,0.0020504629,0.006173908,0.00060885353,0.000053938602,0.00027171563],"genre_scores_gemma":[0.9905446,0.001212088,0.0033241927,0.00087993173,0.0018974545,0.0007183886,0.00008046331,0.00010027101,0.0012426218],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99133724,0.0014485433,0.005061574,0.0006103562,0.0008801526,0.00066211756],"domain_scores_gemma":[0.97093487,0.024124447,0.0029842139,0.0006163732,0.00080888113,0.00053119473],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004083594,0.0006103588,0.0055316077,0.00023876365,0.00019699842,0.000024626928,0.00048412674,0.000329891,0.0007483453],"category_scores_gemma":[0.008733754,0.00031546463,0.0017220493,0.00045895085,0.00052102894,0.00016108023,0.00011369882,0.0007496341,0.00004801847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8618201,0.010560381,0.0037990615,0.00008160376,0.00582256,0.001821278,0.001251469,0.00036837955,0.00013729703,0.000028560376,0.0024651827,0.11184414],"study_design_scores_gemma":[0.8501127,0.11498415,0.008514798,0.00025807146,0.008888788,0.00020831531,0.0010327643,0.0025642253,0.0007172628,0.0007462228,0.011663993,0.00030872377],"about_ca_topic_score_codex":0.00040666186,"about_ca_topic_score_gemma":0.00080682925,"teacher_disagreement_score":0.111535415,"about_ca_system_score_codex":0.0004269444,"about_ca_system_score_gemma":0.003942101,"threshold_uncertainty_score":0.9999297},"labels":[],"label_agreement":null},{"id":"W4324355354","doi":"10.3390/curroncol30030259","title":"Real-Time Urethral and Ureteral Assessment during Radical Cystectomy Using Ex-Vivo Optical Imaging: A Novel Technique for the Evaluation of Fresh Unfixed Surgical Margins","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Urology; Gold standard (test); Frozen section procedure; Predictive value; Reproducibility; Surgical margin; Bladder cancer; Nuclear medicine; Radiology; Surgery; Cancer; Internal medicine; Resection","score_opus":0.13998676455037654,"score_gpt":0.46515579715755795,"score_spread":0.32516903260718144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324355354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910828,0.0004552338,0.0027193616,0.0013689769,0.00053655996,0.0027431694,0.000080629645,0.00007812912,0.0009351508],"genre_scores_gemma":[0.9952553,0.00012595166,0.0035743641,0.000014729554,0.000389816,0.00052120787,0.00005301132,0.000030175615,0.000035450685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998383,0.00014309592,0.000358464,0.0003332792,0.0004417808,0.00034040536],"domain_scores_gemma":[0.99898076,0.00036681083,0.00010777133,0.00021655919,0.00020025145,0.00012784603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010009327,0.0001784065,0.00043949333,0.00013707596,0.000115486415,0.000012767428,0.00008707503,0.0001238091,0.00014702258],"category_scores_gemma":[0.00009613419,0.00012647257,0.0001296198,0.00020708505,0.00026087125,0.00004801539,0.00009087452,0.00023894502,0.0000021075552],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027783029,0.0019766726,0.050207045,0.0007807424,0.00065365084,0.00013029709,0.00093551003,0.00012822042,0.9113539,0.001576488,0.0014199405,0.028059257],"study_design_scores_gemma":[0.084056996,0.0035144978,0.47115928,0.0011436943,0.0063625467,0.0029884756,0.0006487422,0.34659317,0.06780082,0.0012422112,0.013527925,0.0009616421],"about_ca_topic_score_codex":0.000042054722,"about_ca_topic_score_gemma":0.000004110014,"teacher_disagreement_score":0.84355307,"about_ca_system_score_codex":0.0004720524,"about_ca_system_score_gemma":0.0006061959,"threshold_uncertainty_score":0.51574016},"labels":[],"label_agreement":null},{"id":"W4327857170","doi":"","title":"Complete Remission of BCG-Refractory High-grade Bladder CIS with Pharmacologic Ascorbate and Mistletoe.","year":2023,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Refractory (planetary science); Carcinoma in situ; Disease; Cancer; Cystectomy; Carcinogen; Internal medicine; Oncology","score_opus":0.0498204556649973,"score_gpt":0.27803369416034535,"score_spread":0.22821323849534805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327857170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992314,0.0005787482,0.000014806951,0.0017906793,0.00017799828,0.00096250593,0.00007104513,0.00014115307,0.0039490825],"genre_scores_gemma":[0.99553245,0.0003445796,0.00010642621,0.00036439384,0.00010999845,0.00038104344,0.00004868883,0.000026374062,0.0030860687],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99897504,0.00003584887,0.00017234331,0.0002587029,0.00024890952,0.0003091391],"domain_scores_gemma":[0.9994267,0.00006153046,0.000079812664,0.00017798594,0.000047443762,0.00020650584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012306741,0.00014875246,0.0002971531,0.00010213712,0.000052320887,0.0000081088765,0.000057367535,0.000058725895,0.000114925206],"category_scores_gemma":[0.000022054961,0.00010066394,0.000041715575,0.00025731474,0.000109169116,0.000048667363,0.000035862715,0.00011691883,0.00001536662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010399576,0.0025728934,0.17818591,0.0019075287,0.004531077,0.001533273,0.0018317985,0.0000453133,0.19045536,0.0002879845,0.10100983,0.50723946],"study_design_scores_gemma":[0.005793718,0.00040754295,0.9598772,0.00004399539,0.0003896229,0.000038942544,0.000072709976,0.000021904474,0.015178643,0.00014124968,0.017877135,0.00015733475],"about_ca_topic_score_codex":0.000095827374,"about_ca_topic_score_gemma":0.0000044547287,"teacher_disagreement_score":0.7816913,"about_ca_system_score_codex":0.00004771649,"about_ca_system_score_gemma":0.0000430307,"threshold_uncertainty_score":0.41049567},"labels":[],"label_agreement":null},{"id":"W4328107718","doi":"10.5489/cuaj.8167","title":"Examining the impact of postoperative opioid use on length of hospital stay following radical cystectomy","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cystectomy; Medicine; Perioperative; Opioid; Morphine; Ileus; Anesthesia; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.02748898851426973,"score_gpt":0.2804258998376101,"score_spread":0.2529369113233404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328107718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533457,0.000057810623,0.0000056350427,0.0034417494,0.0002533928,0.00022618464,0.00009150769,0.000014326674,0.00057482417],"genre_scores_gemma":[0.99900824,0.000031100553,0.000028961598,0.0005503851,0.00013357421,0.0000062670347,0.000016876793,0.00001171039,0.00021285866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986576,0.00018696739,0.0003042386,0.0001303683,0.00038327873,0.00033755958],"domain_scores_gemma":[0.9987952,0.0003991394,0.00021015824,0.00010604761,0.00016029793,0.00032913944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050303864,0.00012340046,0.00031582327,0.0001593909,0.00016574032,0.00003253348,0.00009841938,0.00014063633,0.00017850724],"category_scores_gemma":[0.00111044,0.00007019606,0.00027197532,0.00033143623,0.000042706833,0.00008478277,0.00001157336,0.00041602418,0.00001522979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001055593,0.00007138531,0.9920305,0.0000016704654,0.0006664293,0.000140442,0.0010099595,0.000109838315,0.0002771044,0.000043744858,0.004295354,0.0012479917],"study_design_scores_gemma":[0.0015926702,0.0033529422,0.9933955,0.000028354767,0.00009371059,0.000020892405,0.00026249833,0.00008849151,0.00013273366,0.00009875805,0.0008628779,0.000070549104],"about_ca_topic_score_codex":0.0030953416,"about_ca_topic_score_gemma":0.00011765233,"teacher_disagreement_score":0.0036736967,"about_ca_system_score_codex":0.0007941942,"about_ca_system_score_gemma":0.0006919057,"threshold_uncertainty_score":0.46792513},"labels":[],"label_agreement":null},{"id":"W4353086468","doi":"10.54097/hset.v36i.5700","title":"The usage of Pembrolizumab in Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Metastatic Urothelial Carcinoma; Medicine; Oncology; Chemotherapy; Bladder cancer; Internal medicine; Cancer; Immunotherapy; Cisplatin; Carcinoma; Adverse effect; Immune checkpoint; Urothelial carcinoma","score_opus":0.012497955255559117,"score_gpt":0.2631294578952759,"score_spread":0.2506315026397168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353086468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972159,0.00035716465,0.000015512593,0.0017500292,0.00014348244,0.00016827024,0.0000027803255,0.00007724717,0.00026961553],"genre_scores_gemma":[0.99936926,0.00025239354,0.00021633987,0.0000070053616,0.000010996211,0.00003654972,3.7783693e-7,0.000007002959,0.00010007486],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99919343,0.0000058035807,0.00016769809,0.00019214382,0.00015867184,0.0002822752],"domain_scores_gemma":[0.9996568,0.00005916751,0.000021120002,0.00020329157,0.00002480721,0.000034789453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026889675,0.00008120754,0.00017047803,0.000790035,0.000053686523,0.0000084209405,0.00014783104,0.000040869043,0.0000015021749],"category_scores_gemma":[0.0001111241,0.000052120304,0.00001374887,0.0021696915,0.0003539792,0.00004438889,0.000060393682,0.00011192308,0.0000122416495],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038844248,0.00038302006,0.18753482,0.0003828583,0.00009022039,0.0014315154,0.0028776838,0.0013756477,0.37121585,0.39508834,0.00024560004,0.03898599],"study_design_scores_gemma":[0.009839409,0.0012874164,0.6596657,0.00039970042,0.0000719709,0.0003586299,0.00084868015,0.028635439,0.2748394,0.005155774,0.018403199,0.0004946579],"about_ca_topic_score_codex":0.000054137097,"about_ca_topic_score_gemma":0.00002601934,"teacher_disagreement_score":0.4721309,"about_ca_system_score_codex":0.000049034083,"about_ca_system_score_gemma":0.00011208017,"threshold_uncertainty_score":0.21254043},"labels":[],"label_agreement":null},{"id":"W4353088123","doi":"10.54097/hset.v36i.5576","title":"Single Drug Therapy of PD-1/PD-L1 Checkpoint Inhibitors for Advanced Urothelial Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TD Bank Group","funders":"","keywords":"Pembrolizumab; Atezolizumab; Durvalumab; Medicine; Avelumab; Bladder cancer; Oncology; Immunotherapy; Internal medicine; Chemotherapy; Cancer; Lung cancer; Urothelial cancer","score_opus":0.014442873635525636,"score_gpt":0.27584007118144366,"score_spread":0.261397197545918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353088123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942764,0.0009778446,0.00008079132,0.0032238374,0.0005398906,0.00049300725,0.000018236633,0.0002676883,0.00012228632],"genre_scores_gemma":[0.9969817,0.0011328472,0.0013102818,0.000028143166,0.00008292597,0.00021825923,0.0000021423898,0.000023148801,0.0002205611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880064,0.0000034878915,0.00024498443,0.0003688542,0.00019405657,0.00038795703],"domain_scores_gemma":[0.9995206,0.000040949508,0.00005106751,0.00022872123,0.00009011869,0.00006851458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019268488,0.00015694606,0.0002875511,0.00082708086,0.00006929804,0.000009945265,0.00014689351,0.00009954721,0.0000068132567],"category_scores_gemma":[0.00007650597,0.0001220674,0.00004072363,0.0016401778,0.00033206365,0.00009141001,0.000051230152,0.000110242574,0.0000062677273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001458655,0.00013972312,0.001807874,0.000065975946,0.000039712348,0.000016209133,0.0006277259,0.0004071941,0.9723452,0.004594258,0.00017126188,0.019639],"study_design_scores_gemma":[0.0027010057,0.0004345703,0.0027180521,0.00016267072,0.000014017328,0.000010831679,0.00014041679,0.0011267498,0.9715495,0.00048777575,0.02048498,0.00016939819],"about_ca_topic_score_codex":0.00004802741,"about_ca_topic_score_gemma":0.000015106242,"teacher_disagreement_score":0.02031372,"about_ca_system_score_codex":0.00008917773,"about_ca_system_score_gemma":0.00013499442,"threshold_uncertainty_score":0.49777642},"labels":[],"label_agreement":null},{"id":"W4360596216","doi":"10.2196/42254","title":"Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial","year":2023,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Medac; Urology Foundation; Rosetrees Trust; National Institute for Health and Care Research","keywords":"Medicine; Bladder cancer; Observational study; Perioperative; Audit; Randomized controlled trial; Randomization; Cancer; Surgery; Internal medicine","score_opus":0.307164644251158,"score_gpt":0.5764017589264874,"score_spread":0.26923711467532935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360596216","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41588265,3.9782938e-7,0.000066784785,0.0020135979,0.000013973037,0.58193743,0.000049466675,0.000019745776,0.000015952344],"genre_scores_gemma":[0.07482677,0.0000010566736,0.0010007488,0.00015846429,0.0002894557,0.92325926,0.000059442355,0.00003546455,0.00036934004],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977985,0.0003792813,0.0004631265,0.0005870594,0.0004595814,0.00031242616],"domain_scores_gemma":[0.9983073,0.0007600381,0.00010710337,0.00017556145,0.0004695442,0.00018048029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012576475,0.00021819108,0.0005191585,0.000304733,0.00015018214,0.0001435314,0.00006013421,0.00010509595,0.000020527461],"category_scores_gemma":[0.00035739772,0.00014885381,0.00005797657,0.00022675355,0.00013116967,0.00029996163,0.000026321255,0.00013573178,5.2328573e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9219409,0.0037594577,0.037057087,0.00038252253,0.00025581612,0.0000011080577,0.0044055595,0.0000038811936,0.0016954954,0.000027252821,0.0000970786,0.030373802],"study_design_scores_gemma":[0.7921114,0.020088961,0.18362914,0.00040927195,0.000025630665,0.0000013634548,0.000653815,0.0008032543,0.001122505,0.00036897906,0.00062632473,0.000159347],"about_ca_topic_score_codex":0.00039094887,"about_ca_topic_score_gemma":0.0018457251,"teacher_disagreement_score":0.34132183,"about_ca_system_score_codex":0.00028879553,"about_ca_system_score_gemma":0.00048342958,"threshold_uncertainty_score":0.6070082},"labels":[],"label_agreement":null},{"id":"W4360605945","doi":"10.1097/ju.0000000000003309.01","title":"MP56-01 THE EFFECT OF DIFFERENT CONCURRENT CHEMOTHERAPY REGIMENS ON OUTCOMES IN PATIENTS TREATED WITH RADIATION FOR MUSCLE INVASIVE BLADDER CANCER","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Cancer; Chemotherapy; Psychoanalysis; Psychology; Internal medicine","score_opus":0.01397870496131285,"score_gpt":0.29216089973598464,"score_spread":0.27818219477467176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360605945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469775,0.00018242083,0.0000064560745,0.004063371,0.00017975918,0.0008115343,0.000018139202,0.0000058747155,0.000034688066],"genre_scores_gemma":[0.99872607,0.00044198227,9.660431e-7,0.0006151347,0.000068891575,0.000043085813,0.0000074659424,0.000017616303,0.000078773184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999126,0.00018651516,0.000253607,0.00007975159,0.00019009881,0.00016402526],"domain_scores_gemma":[0.9987661,0.00070284825,0.00028281138,0.00013901076,0.000072041024,0.0000371416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002202142,0.00013161414,0.00039755282,0.000104878665,0.00003717337,0.0000025290044,0.000093959796,0.00004774381,0.000031201726],"category_scores_gemma":[0.000056151766,0.00005077918,0.00009129548,0.00012847436,0.000072039504,0.000020399097,0.000008498555,0.00015078761,0.0000018179752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011566145,0.0003331997,0.9622448,0.00003782609,0.0010066364,0.0000068880236,0.0014737152,0.00022612537,0.0007113168,0.000010691785,0.0015751644,0.020807479],"study_design_scores_gemma":[0.01729536,0.017281419,0.95701486,0.00004291027,0.00049701915,0.0000053575163,0.000037093163,0.000043389948,0.007466334,0.00002971921,0.00023849512,0.000048071477],"about_ca_topic_score_codex":0.000057379457,"about_ca_topic_score_gemma":0.000057745838,"teacher_disagreement_score":0.020759407,"about_ca_system_score_codex":0.00007749569,"about_ca_system_score_gemma":0.000054510434,"threshold_uncertainty_score":0.2070715},"labels":[],"label_agreement":null},{"id":"W4360605996","doi":"10.1097/ju.0000000000003354.08","title":"PD44-08 BENEFIT OF WHOLE-PELVIS RADIATION FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: AN INVERSE PROBABILITY TREATMENT WEIGHTED ANALYSIS","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Art history; History","score_opus":0.020772063222682904,"score_gpt":0.2821370107107835,"score_spread":0.26136494748810063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360605996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696517,0.000199024,0.00009050474,0.0017338841,0.00011585722,0.0006751184,0.00017497793,0.000013180937,0.000032295182],"genre_scores_gemma":[0.99870247,0.00047282258,0.00020125555,0.00024106522,0.00013509412,0.000039017676,0.000091791124,0.000018575713,0.000097940996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988519,0.0001224033,0.00040651066,0.00015541833,0.00024639038,0.00021739397],"domain_scores_gemma":[0.998447,0.00021068129,0.00046833025,0.00028074568,0.00047246175,0.00012080035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000239935,0.00015847084,0.0005277409,0.0002795286,0.000074064366,0.000004425006,0.00010951589,0.00007843518,0.00010066233],"category_scores_gemma":[0.000040177376,0.00008569751,0.00020031538,0.00057035295,0.00010410972,0.00009328336,0.000012387174,0.00009227662,0.000003785381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012109113,0.0022390124,0.9124694,0.00007965517,0.012492612,0.000024086754,0.0057734353,0.0062122256,0.0010166243,0.000034080236,0.00078006095,0.046769727],"study_design_scores_gemma":[0.012121313,0.017448207,0.9513675,0.000016642267,0.014388696,0.000011830161,0.00021050188,0.001036551,0.0011351984,0.00079064444,0.0013541009,0.00011884236],"about_ca_topic_score_codex":0.00033535645,"about_ca_topic_score_gemma":0.0009571493,"teacher_disagreement_score":0.046650883,"about_ca_system_score_codex":0.00017952402,"about_ca_system_score_gemma":0.00027443175,"threshold_uncertainty_score":0.3494643},"labels":[],"label_agreement":null},{"id":"W4360606119","doi":"10.1097/ju.0000000000003292.12","title":"MP46-12 TWENTY YEAR TEMPORAL TRENDS IN SHORT AND LONG-TERM OUTCOMES AFTER RADICAL CYSTECTOMY","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Retrospective cohort study; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.02956404629528846,"score_gpt":0.3233369769417289,"score_spread":0.29377293064644044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360606119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311966,0.0007696425,0.000009310485,0.0055503338,0.00020838581,0.00007433746,0.000003957268,0.0000109305965,0.00025341607],"genre_scores_gemma":[0.99822307,0.00019099405,0.000015952306,0.0008880568,0.00015951619,0.0000036332706,0.0000027561762,0.000013226475,0.00050281954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917704,0.0001063316,0.0002709296,0.00008106917,0.00016953037,0.00019510632],"domain_scores_gemma":[0.9996453,0.00007057788,0.000043711716,0.00012720191,0.000019320358,0.00009388382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034550234,0.00009932169,0.00032434647,0.0002441614,0.000021025084,0.0000048927645,0.0000797057,0.00007521628,0.0002958782],"category_scores_gemma":[0.000017353483,0.000054884902,0.00008017647,0.00014509307,0.000114718874,0.000040243798,0.00003868902,0.00027822267,0.000015409893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015188649,0.00007009634,0.9922906,0.000008194006,0.00012894963,0.00083861203,0.0003185914,0.000001616815,0.000095218544,0.0000030578926,0.00061489915,0.0041112606],"study_design_scores_gemma":[0.0028419246,0.00074838457,0.9941225,0.000012912385,0.00020205324,0.00092124945,0.000022494025,0.00000852983,0.000024803252,0.00005087301,0.0010001735,0.000044091114],"about_ca_topic_score_codex":0.00001585627,"about_ca_topic_score_gemma":0.00007050449,"teacher_disagreement_score":0.005103359,"about_ca_system_score_codex":0.000028913093,"about_ca_system_score_gemma":0.000040396048,"threshold_uncertainty_score":0.32396588},"labels":[],"label_agreement":null},{"id":"W4360606221","doi":"10.1097/ju.0000000000003292.03","title":"MP46-03 GENDER DIFFERENCES OF UNMET SUPPORTIVE CARE NEEDS IN RADICAL CYSTECTOMY PATIENTS ALONG THE SURVIVORSHIP CONTINUUM","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Survivorship curve; Quality of life (healthcare); Bladder cancer; Family medicine; Cancer; Nursing; Internal medicine","score_opus":0.028937726646815914,"score_gpt":0.2848436589356171,"score_spread":0.25590593228880115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360606221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961168,0.0009446077,0.000011443496,0.0015930734,0.0003910491,0.00023866627,0.00001516764,0.0000071479994,0.0006820221],"genre_scores_gemma":[0.99918467,0.00017961612,0.0000052047108,0.00039864305,0.00012945238,0.0000045883517,0.000005807241,0.000013010285,0.000079012396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998361,0.0005083502,0.00047868548,0.00007563722,0.00032658872,0.00024976634],"domain_scores_gemma":[0.9987789,0.0004991966,0.00029902815,0.00017345353,0.00017868142,0.00007076039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060803595,0.00012183574,0.0004256117,0.00020952568,0.000046454737,0.000003995683,0.00022825255,0.00009113982,0.00010669422],"category_scores_gemma":[0.00014678086,0.000057515153,0.00011320256,0.00036991204,0.00024337914,0.0000350743,0.00004856054,0.00037557728,0.00001161758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014276009,0.000114377464,0.9842228,0.000032072647,0.00024521459,0.00006825192,0.012116084,0.0000064379997,0.00019182419,0.000028557377,0.0007225027,0.0008242302],"study_design_scores_gemma":[0.0034625411,0.0016718069,0.9896543,0.00002514526,0.00032052805,0.00010562631,0.003607151,0.000007873466,0.00044932406,0.0003402428,0.00030425852,0.00005120194],"about_ca_topic_score_codex":0.00036964973,"about_ca_topic_score_gemma":0.00043758727,"teacher_disagreement_score":0.008508933,"about_ca_system_score_codex":0.000038980917,"about_ca_system_score_gemma":0.00014431034,"threshold_uncertainty_score":0.23453999},"labels":[],"label_agreement":null},{"id":"W4360606555","doi":"10.1097/ju.0000000000003240.02","title":"PD09-02 THE IMPACT OF VARIANT HISTOLOGY ON CLINICAL OUTCOMES AFTER RADIATION-BASED THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Psychoanalysis; Radiation therapy; Cancer; Psychology; Surgery; Internal medicine","score_opus":0.05420490474968192,"score_gpt":0.40172480137618416,"score_spread":0.34751989662650223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360606555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193134,0.001474904,0.00015823047,0.024974031,0.0007901952,0.00051941065,0.000056797584,0.000010115594,0.0000849912],"genre_scores_gemma":[0.99162835,0.0015452049,0.00002107124,0.006172187,0.00043183344,0.000044076554,0.0000033928109,0.000023474058,0.00013044068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856466,0.00036574467,0.00054846966,0.00011063632,0.00017315727,0.00023732295],"domain_scores_gemma":[0.99622995,0.0027713676,0.0004478149,0.00028307672,0.00019111457,0.00007668156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008516453,0.00014771678,0.00052320876,0.00012591097,0.0000621432,0.0000031626566,0.0001876218,0.00012254057,0.0003736795],"category_scores_gemma":[0.00028757958,0.00006164198,0.00051655225,0.0001329783,0.00020368487,0.00002203418,0.000012133748,0.00029050437,0.000012040803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058609843,0.0017864956,0.80839115,0.000036747642,0.009544616,0.00032079412,0.003544301,0.005758624,0.001371877,0.00012605808,0.05012286,0.060386654],"study_design_scores_gemma":[0.007901448,0.00956093,0.9782094,0.00001161303,0.0006607098,0.00007047372,0.000045462773,0.00020280459,0.00016121197,0.0006235974,0.0024874816,0.000064876265],"about_ca_topic_score_codex":0.00020294132,"about_ca_topic_score_gemma":0.0000508546,"teacher_disagreement_score":0.16981827,"about_ca_system_score_codex":0.00007710911,"about_ca_system_score_gemma":0.00072890596,"threshold_uncertainty_score":0.40915287},"labels":[],"label_agreement":null},{"id":"W4360606840","doi":"10.1097/ju.0000000000003240.03","title":"PD09-03 INVERSE PROBABILITY TREATMENT WEIGHTING COMPARISON OF RADICAL CYSTECTOMY TO TRIMODALITY THERAPY FOR CT2-CT4 MUSCLE INVASIVE BLADDER CANCER","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Art history; Art","score_opus":0.08264044296958524,"score_gpt":0.3708376891399702,"score_spread":0.28819724617038495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360606840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886463,0.00081049337,0.00017208255,0.008587485,0.00032695095,0.001242456,0.000040494873,0.000020280842,0.00015345639],"genre_scores_gemma":[0.9977528,0.0004911395,0.00026926585,0.00092826487,0.00034975263,0.00008361736,0.000004733321,0.000022487187,0.00009797807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983024,0.00030868466,0.00063741667,0.00017539076,0.00026095295,0.0003151673],"domain_scores_gemma":[0.99824476,0.0006555635,0.00038712588,0.0002836991,0.00025602072,0.00017281715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007322405,0.00018490483,0.000727556,0.00013370348,0.00009944058,0.000004904025,0.00017501437,0.00011079767,0.0001395244],"category_scores_gemma":[0.00018328478,0.00010350663,0.00024851674,0.00028462184,0.00017174172,0.000044118035,0.000032358184,0.0001955436,0.000011522447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08066093,0.008131008,0.48755237,0.0004887504,0.009496844,0.0001806097,0.05652669,0.004610678,0.16271946,0.00041535197,0.031205544,0.15801175],"study_design_scores_gemma":[0.08084165,0.07550286,0.57240146,0.00026815615,0.005121224,0.0004321644,0.0035040153,0.0018150421,0.18429762,0.008340941,0.06672132,0.00075351866],"about_ca_topic_score_codex":0.0003955393,"about_ca_topic_score_gemma":0.0002913549,"teacher_disagreement_score":0.15725823,"about_ca_system_score_codex":0.0002108719,"about_ca_system_score_gemma":0.0006318549,"threshold_uncertainty_score":0.42208782},"labels":[],"label_agreement":null},{"id":"W4360607310","doi":"10.1097/ju.0000000000003265.11","title":"MP32-11 FACTORS THAT PREDICT EARLY SALVAGE CYSTECTOMY POST-TRIMODAL THERAPY: RESULTS OF A MULTI-INSTITUTIONAL CANADIAN COHORT","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychoanalysis; Classics; History; Art history; Psychology","score_opus":0.03323356460883823,"score_gpt":0.2785727679014572,"score_spread":0.24533920329261896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360607310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397886,0.00061879697,0.000027779024,0.0036651292,0.0005005916,0.00036493165,0.0002548037,0.000020776813,0.0005683295],"genre_scores_gemma":[0.99846494,0.0003482162,0.000026393796,0.00070539175,0.00017308957,0.000003691427,0.00002730255,0.00001926569,0.00023168368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986069,0.00017375992,0.0004168066,0.000120245175,0.0003625091,0.00031975898],"domain_scores_gemma":[0.99882084,0.0002058247,0.00026926564,0.00023281101,0.00022805517,0.00024319487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006063902,0.00016584406,0.00041428526,0.00034749383,0.00011453293,0.000006132423,0.00022171356,0.00013343786,0.00006967296],"category_scores_gemma":[0.00014447913,0.00009068801,0.00017075433,0.00024087814,0.00021328207,0.000075600175,0.000022767314,0.00032056338,0.000018015335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007173109,0.0002534291,0.9755073,0.000020112127,0.0016074162,0.00068566744,0.0040478767,0.00018965473,0.006252262,0.000045326415,0.0026641807,0.0015536268],"study_design_scores_gemma":[0.007032645,0.0021883992,0.98203903,0.00002166688,0.0002953349,0.0005492174,0.00017009432,0.000047379897,0.0014194257,0.000030872456,0.0061349245,0.00007099689],"about_ca_topic_score_codex":0.05625915,"about_ca_topic_score_gemma":0.013261435,"teacher_disagreement_score":0.042997718,"about_ca_system_score_codex":0.0001145602,"about_ca_system_score_gemma":0.0010714638,"threshold_uncertainty_score":0.9500253},"labels":[],"label_agreement":null},{"id":"W4360607630","doi":"10.1097/ju.0000000000003303.07","title":"PD25-07 PROTEOMIC PROFILING OF MUSCLE INVASIVE BLADDER CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY REVEALS UNIQUE BIOLOGIC CLUSTERS WITH CLINICAL RELEVANCE","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Context (archaeology); Oncology; Cancer; Internal medicine; History; Archaeology","score_opus":0.03689670054639865,"score_gpt":0.32875859049140277,"score_spread":0.2918618899450041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360607630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265414,0.00081005355,0.00014708511,0.0052568885,0.00008927251,0.0008707936,0.000012609716,0.00002784186,0.00013131628],"genre_scores_gemma":[0.9916356,0.0053014383,0.0007095038,0.0018595803,0.0002041846,0.000032648775,0.0000042020547,0.00003854801,0.00021425672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829555,0.0003773787,0.0006154356,0.00019542506,0.00021266154,0.00030354664],"domain_scores_gemma":[0.9981482,0.00042264652,0.00071866455,0.00029158822,0.00031146663,0.000107434105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008408315,0.00020037282,0.0006925662,0.00012211583,0.000057465117,0.000003806947,0.00019371018,0.0001458768,0.000062620486],"category_scores_gemma":[0.00011362386,0.0000929133,0.00010502298,0.00033982052,0.00039537417,0.000055082535,0.000025543868,0.0004755307,0.000008732425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068603106,0.00091550726,0.75460756,0.0002566181,0.0054109218,0.00094710145,0.0025992934,0.0024867698,0.1408788,0.00004893684,0.002404607,0.020840762],"study_design_scores_gemma":[0.029624423,0.049220826,0.8240344,0.00081835606,0.00290199,0.001777793,0.0008461848,0.00028975823,0.088393755,0.0006784783,0.0009446877,0.0004693419],"about_ca_topic_score_codex":0.00011301969,"about_ca_topic_score_gemma":0.00005485012,"teacher_disagreement_score":0.06942683,"about_ca_system_score_codex":0.00006016507,"about_ca_system_score_gemma":0.000523978,"threshold_uncertainty_score":0.37888944},"labels":[],"label_agreement":null},{"id":"W4360608188","doi":"10.1097/ju.0000000000003315.02","title":"PD29-02 BENCHMARKING BLADDER CANCER CARE: A REAL-LIFE POPULATION-BASED STUDY","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Benchmarking; Medicine; Bladder cancer; Population; Cystectomy; Health care; Excellence; Benchmark (surveying); Cohort; Cancer registry; Cancer; Medical physics; Pathology; Internal medicine; Management; Cartography","score_opus":0.029312921366581864,"score_gpt":0.3345921539816755,"score_spread":0.30527923261509365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360608188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931232,0.0009980623,0.00003800933,0.004386442,0.000641986,0.00031462472,0.0000071100344,0.000026856354,0.00046375467],"genre_scores_gemma":[0.9971889,0.00025353802,0.000019443594,0.0016462349,0.00073414796,0.000012883285,0.0000063833872,0.000022860195,0.000115583236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878633,0.00020870153,0.00035738182,0.000105100466,0.00031475295,0.00022770706],"domain_scores_gemma":[0.9990891,0.00018977711,0.00022800342,0.00021113781,0.00016686175,0.000115079354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039074605,0.0001230236,0.00032340758,0.00017161659,0.00011686692,0.000007194783,0.00013143146,0.000061990875,0.0003644289],"category_scores_gemma":[0.000059557948,0.000074172676,0.0000987947,0.00028535552,0.000030620864,0.00003559882,0.000024822539,0.00026085498,0.00002048076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021094955,0.00025561024,0.9804023,0.000025493182,0.0007982105,0.00023240909,0.0041179527,0.0033606766,0.0003168774,0.00001557443,0.0031121785,0.005253223],"study_design_scores_gemma":[0.0036593962,0.002714787,0.9901244,0.000017813649,0.0011093697,0.00005520438,0.0010005423,0.00027406303,0.000038869053,0.000065888235,0.0008660872,0.00007359123],"about_ca_topic_score_codex":0.0013499444,"about_ca_topic_score_gemma":0.00041725748,"teacher_disagreement_score":0.009722088,"about_ca_system_score_codex":0.00010104411,"about_ca_system_score_gemma":0.000368481,"threshold_uncertainty_score":0.3990241},"labels":[],"label_agreement":null},{"id":"W4360746820","doi":"10.1097/ju.0000000000003260.05","title":"PD13-05 LONG-TERM ONCOLOGICAL OUTCOMES OF OFFICE-BASED FULGURATION OF TA LOW-GRADE NON MUSCLE INVASIVE BLADDER CANCER: A LARGE SINGLE CENTER SERIES","year":2023,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulguration; Medicine; Bladder cancer; Cancer; Surgery; Internal medicine","score_opus":0.033213330732462375,"score_gpt":0.3114594404439251,"score_spread":0.27824610971146274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360746820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922357,0.0002894454,0.00011972218,0.006506554,0.00038210404,0.00027138708,0.00005810877,0.0000122822485,0.00012469167],"genre_scores_gemma":[0.9981023,0.00036686822,0.000047752328,0.0011390297,0.00015026494,0.0000073436777,0.000015438609,0.000016831487,0.0001541521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866647,0.00017710864,0.00052853656,0.00010493765,0.00027810066,0.0002448533],"domain_scores_gemma":[0.99869853,0.00028315457,0.00052877556,0.00019120258,0.00022228096,0.000076055105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031099297,0.00014543033,0.00055845286,0.00015246597,0.000049803075,0.000003990638,0.00015921949,0.00012072432,0.00028954897],"category_scores_gemma":[0.00010837621,0.000084823085,0.00018167007,0.00019996346,0.00017862428,0.00007702463,0.00004271461,0.00022163715,0.000008276512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0115111265,0.0039764885,0.7852568,0.0003555924,0.0018294865,0.0005598475,0.0033281425,0.0006921087,0.18316986,0.000040587332,0.004360649,0.0049193357],"study_design_scores_gemma":[0.0074527473,0.007265996,0.95846087,0.000094981704,0.00077408744,0.00020415019,0.00023225586,0.000038967897,0.024721252,0.00005991655,0.00060193846,0.00009281692],"about_ca_topic_score_codex":0.00004754594,"about_ca_topic_score_gemma":0.0003457491,"teacher_disagreement_score":0.17320411,"about_ca_system_score_codex":0.00006907244,"about_ca_system_score_gemma":0.00030235923,"threshold_uncertainty_score":0.3458985},"labels":[],"label_agreement":null},{"id":"W4360966436","doi":"10.1016/j.euros.2023.02.014","title":"Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"Janssen Pharmaceuticals; Astellas Pharma US","keywords":"Carboplatin; Gemcitabine; Medicine; Internal medicine; Oncology; Cystectomy; Cisplatin; Bladder cancer; Regimen; Urology; Chemotherapy; Cancer","score_opus":0.044645930535459136,"score_gpt":0.3710824266276976,"score_spread":0.32643649609223846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360966436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8942191,0.000058323105,0.000018329745,0.008707113,0.000432806,0.0005954508,0.00001090398,0.000077543475,0.095880404],"genre_scores_gemma":[0.9884873,0.00015159961,0.00024812855,0.0083930185,0.00016981087,0.0000403566,0.0000083684645,0.000032612847,0.0024688188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998037,0.00018940702,0.00034711004,0.00069352414,0.00029137108,0.00044162525],"domain_scores_gemma":[0.9991975,0.000053254655,0.000098703094,0.0003908567,0.00010216706,0.00015755332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015701464,0.00015385194,0.00027093964,0.00024064351,0.00016552239,0.00006567042,0.0006842817,0.000051733765,0.00027723896],"category_scores_gemma":[0.00015282466,0.00012899318,0.000040665767,0.0013992874,0.00059241056,0.00024683395,0.00036516335,0.00021784642,0.00053870835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003219333,0.0008274473,0.77584016,0.000028338081,0.0002586394,0.0015002958,0.008008514,0.00052599935,0.06232341,0.0005302813,0.004776158,0.1421614],"study_design_scores_gemma":[0.0033119014,0.00034867183,0.9928426,0.000030293111,0.0000310821,0.000041404557,0.00010278606,0.00036455467,0.0010306294,0.00008097102,0.0016760193,0.00013905314],"about_ca_topic_score_codex":0.00057375326,"about_ca_topic_score_gemma":0.00003439127,"teacher_disagreement_score":0.21700245,"about_ca_system_score_codex":0.00012068494,"about_ca_system_score_gemma":0.0005590743,"threshold_uncertainty_score":0.6924186},"labels":[],"label_agreement":null},{"id":"W4361004745","doi":"10.3390/curroncol30040277","title":"Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Seagen","keywords":"Medicine; Internal medicine; Oncology; Hazard ratio; Metastatic Urothelial Carcinoma; Gemcitabine; Meta-analysis; Odds ratio; Carboplatin; Confidence interval; Urothelial carcinoma; Bladder cancer; Cisplatin; Cancer; Chemotherapy","score_opus":0.24687725787491918,"score_gpt":0.4661487155370378,"score_spread":0.2192714576621186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361004745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.520911e-7,0.9883561,0.00069265906,0.00027745916,0.00063627557,0.008888933,0.0010072376,0.00005617314,0.00008422537],"genre_scores_gemma":[0.000013990992,0.9895035,0.0006490735,0.00015059765,0.0003736473,0.007969915,0.00065172405,0.0001239782,0.0005635647],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949445,0.0011002722,0.0021870034,0.00085188256,0.0004026442,0.00051368336],"domain_scores_gemma":[0.99424124,0.0027370597,0.0015162028,0.00085548416,0.0004300639,0.000219951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001268663,0.00089634466,0.014344186,0.00043295426,0.00010023558,0.00002952572,0.00030250702,0.00034065303,0.00011937529],"category_scores_gemma":[0.00053073885,0.00054075976,0.004320225,0.0015706122,0.00017654544,0.00005768402,0.000108471395,0.0005334275,0.000016292533],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007469787,0.0002640258,0.0000115805005,0.76620346,0.11158057,0.00005898745,0.00010836034,0.000003342764,1.957827e-8,0.00009701026,0.0012616238,0.1203363],"study_design_scores_gemma":[0.00085685996,0.000726474,0.0000021930027,0.13601726,0.47687674,0.000104617386,0.0000096003705,0.00001875486,9.5402115e-8,0.0001104754,0.3850474,0.00022953052],"about_ca_topic_score_codex":0.000004563619,"about_ca_topic_score_gemma":0.000044887962,"teacher_disagreement_score":0.6301862,"about_ca_system_score_codex":0.00020090964,"about_ca_system_score_gemma":0.00067659485,"threshold_uncertainty_score":0.9997044},"labels":[],"label_agreement":null},{"id":"W4361817867","doi":"10.1158/1078-0432.c.6519384.v1","title":"Data from &lt;i&gt;Fibroblast Growth Factor Receptor 3&lt;/i&gt; Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Concomitant; Urine; Bladder cancer; Medicine; Urology; Cystoscopy; Gastroenterology; Internal medicine; Cancer; Urinary system","score_opus":0.03226522560164661,"score_gpt":0.29040499771059536,"score_spread":0.25813977210894873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361817867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8968319,0.00019491307,0.0037880626,0.0006629808,0.00071099686,0.0038821283,0.09348595,0.00020308448,0.00023993183],"genre_scores_gemma":[0.93213856,0.00053470687,0.0023769534,0.00019813224,0.00049812545,0.0006916311,0.06172662,0.00020650723,0.0016287658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527276,0.00011182858,0.00097495154,0.0019432298,0.0011247959,0.00057245186],"domain_scores_gemma":[0.9951579,0.0005568627,0.00086898974,0.0020823535,0.0010201412,0.00031378452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015650447,0.000861636,0.0018057511,0.00059464993,0.0001066623,0.000059018326,0.0006588634,0.0004236883,0.0011930842],"category_scores_gemma":[0.0002744157,0.00065523834,0.0004597298,0.0008323739,0.00014050593,0.00016481093,0.00047696105,0.0003698065,0.00005752581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019013748,0.009237192,0.7017807,0.0074819694,0.12075223,0.00010174335,0.004018771,0.0064835763,0.031842142,0.0000767553,0.09139195,0.007819226],"study_design_scores_gemma":[0.008727739,0.0012190671,0.9732547,0.0010881845,0.003990969,2.1806328e-7,0.000051337076,0.0012102536,0.009048786,0.00010240149,0.0004911666,0.0008151911],"about_ca_topic_score_codex":0.0033230393,"about_ca_topic_score_gemma":0.019437619,"teacher_disagreement_score":0.271474,"about_ca_system_score_codex":0.0004283428,"about_ca_system_score_gemma":0.0007960549,"threshold_uncertainty_score":0.99972},"labels":[],"label_agreement":null},{"id":"W4361901878","doi":"10.1158/1078-0432.22442183.v1","title":"Supplementary Data from &lt;i&gt;In vivo&lt;/i&gt; Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Docetaxel; In vivo; Bladder cancer; Medicine; Urology; Internal medicine; Cancer; Biology","score_opus":0.11362417139301324,"score_gpt":0.37863252896603206,"score_spread":0.2650083575730188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361901878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9297061,0.0019678257,0.0002704063,0.0015827101,0.0010260374,0.008660805,0.056270357,0.000047414265,0.00046837702],"genre_scores_gemma":[0.971898,0.0032464513,0.0029860022,0.00014311876,0.00059694244,0.003066707,0.017004086,0.00013203445,0.0009266526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953377,0.00017984274,0.0013238086,0.0014127727,0.001193265,0.0005525607],"domain_scores_gemma":[0.9962367,0.00045362208,0.0005757431,0.0018618993,0.000648466,0.00022356278],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000522011,0.0006696964,0.0016084984,0.00031154073,0.000049709186,0.000020276542,0.0004328478,0.0003760681,0.005677158],"category_scores_gemma":[0.00014119428,0.0005398633,0.00038645192,0.00022494415,0.00015588463,0.000096789016,0.00046576728,0.00016215128,0.000015012455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063655525,0.010656868,0.021224067,0.0029112971,0.024043212,0.00020816512,0.009584011,0.0039617345,0.8212012,0.00019724938,0.05367996,0.045966677],"study_design_scores_gemma":[0.0439527,0.0038606257,0.11982618,0.0024637661,0.02540866,0.000005919264,0.00072451466,0.035792187,0.7587545,0.0034614494,0.004529215,0.0012203158],"about_ca_topic_score_codex":0.011841463,"about_ca_topic_score_gemma":0.03019355,"teacher_disagreement_score":0.09860212,"about_ca_system_score_codex":0.00097498344,"about_ca_system_score_gemma":0.0024981843,"threshold_uncertainty_score":0.9997053},"labels":[],"label_agreement":null},{"id":"W4361943958","doi":"10.1158/1078-0432.c.6519384","title":"Data from &lt;i&gt;Fibroblast Growth Factor Receptor 3&lt;/i&gt; Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Concomitant; Bladder cancer; Urine; Medicine; Internal medicine; Gastroenterology; Urology; Cancer","score_opus":0.03226522560164661,"score_gpt":0.29040499771059536,"score_spread":0.25813977210894873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361943958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8968319,0.00019491307,0.0037880626,0.0006629808,0.00071099686,0.0038821283,0.09348595,0.00020308448,0.00023993183],"genre_scores_gemma":[0.93213856,0.00053470687,0.0023769534,0.00019813224,0.00049812545,0.0006916311,0.06172662,0.00020650723,0.0016287658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527276,0.00011182858,0.00097495154,0.0019432298,0.0011247959,0.00057245186],"domain_scores_gemma":[0.9951579,0.0005568627,0.00086898974,0.0020823535,0.0010201412,0.00031378452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015650447,0.000861636,0.0018057511,0.00059464993,0.0001066623,0.000059018326,0.0006588634,0.0004236883,0.0011930842],"category_scores_gemma":[0.0002744157,0.00065523834,0.0004597298,0.0008323739,0.00014050593,0.00016481093,0.00047696105,0.0003698065,0.00005752581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019013748,0.009237192,0.7017807,0.0074819694,0.12075223,0.00010174335,0.004018771,0.0064835763,0.031842142,0.0000767553,0.09139195,0.007819226],"study_design_scores_gemma":[0.008727739,0.0012190671,0.9732547,0.0010881845,0.003990969,2.1806328e-7,0.000051337076,0.0012102536,0.009048786,0.00010240149,0.0004911666,0.0008151911],"about_ca_topic_score_codex":0.0033230393,"about_ca_topic_score_gemma":0.019437619,"teacher_disagreement_score":0.271474,"about_ca_system_score_codex":0.0004283428,"about_ca_system_score_gemma":0.0007960549,"threshold_uncertainty_score":0.99972},"labels":[],"label_agreement":null},{"id":"W4361947188","doi":"10.1158/1078-0432.c.6530205","title":"Data from &lt;i&gt;Kdm6a&lt;/i&gt; Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with &lt;i&gt;p53&lt;/i&gt; Dysfunction","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"RIKEN; Chugai Pharmaceutical; Japan Society for the Promotion of Science; Princess Takamatsu Cancer Research Fund; Kao Foundation for Arts and Sciences","keywords":"Bladder cancer; Cancer research; Cancer; Cytokine; Carcinogenesis; Chemistry; Medicine; Immunology; Internal medicine","score_opus":0.035754216102513614,"score_gpt":0.27469272968112496,"score_spread":0.23893851357861134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361947188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661227,0.012968041,0.0031498084,0.0012551683,0.0017021188,0.005235721,0.006514966,0.00095500733,0.0020965044],"genre_scores_gemma":[0.9742906,0.0049908226,0.0011733029,0.00040181933,0.0009763044,0.0010125523,0.010703277,0.0003912458,0.0060600685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99337775,0.0003317183,0.0013397693,0.002717325,0.0012396054,0.0009938458],"domain_scores_gemma":[0.995653,0.00027171528,0.00062181364,0.002273966,0.0007145901,0.00046493407],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005704402,0.0013350549,0.0014310093,0.000715721,0.00046111015,0.00039679327,0.00066096516,0.0010019242,0.0013026365],"category_scores_gemma":[0.00034417448,0.00109224,0.00013545746,0.00089834013,0.0003941631,0.00094374054,0.0011131563,0.00093793543,0.00013084649],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024075084,0.0019016501,0.07849925,0.0018292033,0.0027074672,0.0006057739,0.0039950386,0.0015536083,0.88561696,0.001593481,0.010925222,0.008364848],"study_design_scores_gemma":[0.022628881,0.0025451,0.8241521,0.006083096,0.00551589,0.00017376171,0.0005328402,0.011996214,0.08398186,0.001843898,0.035223655,0.0053226757],"about_ca_topic_score_codex":0.001679451,"about_ca_topic_score_gemma":0.028684068,"teacher_disagreement_score":0.8016351,"about_ca_system_score_codex":0.00077965093,"about_ca_system_score_gemma":0.0025554486,"threshold_uncertainty_score":0.99994004},"labels":[],"label_agreement":null},{"id":"W4361947414","doi":"10.1158/1078-0432.c.6530730","title":"Data from Heterogeneity in &lt;i&gt;NECTIN4&lt;/i&gt; Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"Council for Science, Technology and Innovation; A.P. Giannini Foundation; Svenska Läkaresällskapet; National Institutes of Health; Vetenskapsrådet; Giannini Foundation of Agricultural Economics","keywords":"Bladder cancer; Cancer research; Cancer; Biology; Medicine; Molecular biology; Internal medicine","score_opus":0.06401550406487819,"score_gpt":0.36152916368350146,"score_spread":0.2975136596186233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361947414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97729236,0.0015465604,0.0009291659,0.00053378346,0.0013509669,0.001847889,0.01579422,0.00022185373,0.00048320973],"genre_scores_gemma":[0.9930377,0.00073107675,0.0015853858,0.00040941694,0.00055902667,0.0002937161,0.002683987,0.0001612669,0.00053841824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995406,0.0002694713,0.0008971244,0.0017521933,0.00094824506,0.000727014],"domain_scores_gemma":[0.99626577,0.0002976326,0.0003221632,0.0025062151,0.00021600224,0.00039221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006915104,0.000709029,0.0014568412,0.00022145883,0.00007645744,0.00005152723,0.0006190421,0.0005944559,0.00034693014],"category_scores_gemma":[0.00039544553,0.000613157,0.0002679896,0.0003038107,0.00012915049,0.00011665687,0.0029683704,0.0006092229,0.00010708654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024429352,0.00081336073,0.05476818,0.00064239337,0.0009666109,0.0008295825,0.0015877085,0.0015130463,0.928248,0.000013443384,0.0034309444,0.004743791],"study_design_scores_gemma":[0.0042119115,0.00026745777,0.16069715,0.002064638,0.000484117,0.000010349146,0.00008945635,0.0011641209,0.8272106,0.00025222576,0.0027287933,0.00081919535],"about_ca_topic_score_codex":0.01394745,"about_ca_topic_score_gemma":0.048287746,"teacher_disagreement_score":0.105928965,"about_ca_system_score_codex":0.00030987104,"about_ca_system_score_gemma":0.00090548984,"threshold_uncertainty_score":0.999632},"labels":[],"label_agreement":null},{"id":"W4361954214","doi":"10.1158/1078-0432.c.6532491.v1","title":"Data from Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Pembrolizumab; Medicine; Docetaxel; Oncology; Internal medicine; Stromal cell; Clinical trial; Chemotherapy; Progression-free survival; Cancer; Immunotherapy","score_opus":0.25737149254736225,"score_gpt":0.45464965426621934,"score_spread":0.1972781617188571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8707855,0.0030751813,0.0003302735,0.0044069095,0.0013550867,0.0036830727,0.1150208,0.00013373491,0.0012094977],"genre_scores_gemma":[0.97303253,0.008930378,0.0036136217,0.0005802636,0.0012848754,0.00029449989,0.011320288,0.00015547522,0.0007880545],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9934489,0.0007344509,0.0025715476,0.0020510724,0.00074226834,0.0004517219],"domain_scores_gemma":[0.98896444,0.0068470165,0.0012894614,0.0024289882,0.00020580793,0.00026428472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002288449,0.00069245195,0.0029564973,0.00014933663,0.000073679075,0.00006154679,0.00083188986,0.0005905963,0.00024457966],"category_scores_gemma":[0.002680429,0.00039704956,0.00028379107,0.00029386938,0.00039971434,0.00012447563,0.0012043135,0.0010403459,0.00001875843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41308916,0.0013256536,0.40736702,0.00037550365,0.01703537,0.0005314861,0.0045265667,0.001004922,0.00035703296,0.000042407213,0.009352475,0.1449924],"study_design_scores_gemma":[0.08966934,0.0012829282,0.890271,0.0032128335,0.0036940316,0.000005336889,0.0011712356,0.0022706608,0.000922767,0.0049212333,0.001768657,0.00080998475],"about_ca_topic_score_codex":0.12532593,"about_ca_topic_score_gemma":0.03711885,"teacher_disagreement_score":0.48290396,"about_ca_system_score_codex":0.00015100738,"about_ca_system_score_gemma":0.0014569294,"threshold_uncertainty_score":0.9998481},"labels":[],"label_agreement":null},{"id":"W4361957672","doi":"10.1158/1078-0432.c.6530730.v1","title":"Data from Heterogeneity in &lt;i&gt;NECTIN4&lt;/i&gt; Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"Council for Science, Technology and Innovation; A.P. Giannini Foundation; Svenska Läkaresällskapet; National Institutes of Health; Vetenskapsrådet; Giannini Foundation of Agricultural Economics","keywords":"Bladder cancer; Cancer research; Cancer; Biology; Medicine; Molecular biology; Internal medicine","score_opus":0.06401550406487819,"score_gpt":0.36152916368350146,"score_spread":0.2975136596186233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361957672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97729236,0.0015465604,0.0009291659,0.00053378346,0.0013509669,0.001847889,0.01579422,0.00022185373,0.00048320973],"genre_scores_gemma":[0.9930377,0.00073107675,0.0015853858,0.00040941694,0.00055902667,0.0002937161,0.002683987,0.0001612669,0.00053841824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995406,0.0002694713,0.0008971244,0.0017521933,0.00094824506,0.000727014],"domain_scores_gemma":[0.99626577,0.0002976326,0.0003221632,0.0025062151,0.00021600224,0.00039221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006915104,0.000709029,0.0014568412,0.00022145883,0.00007645744,0.00005152723,0.0006190421,0.0005944559,0.00034693014],"category_scores_gemma":[0.00039544553,0.000613157,0.0002679896,0.0003038107,0.00012915049,0.00011665687,0.0029683704,0.0006092229,0.00010708654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024429352,0.00081336073,0.05476818,0.00064239337,0.0009666109,0.0008295825,0.0015877085,0.0015130463,0.928248,0.000013443384,0.0034309444,0.004743791],"study_design_scores_gemma":[0.0042119115,0.00026745777,0.16069715,0.002064638,0.000484117,0.000010349146,0.00008945635,0.0011641209,0.8272106,0.00025222576,0.0027287933,0.00081919535],"about_ca_topic_score_codex":0.01394745,"about_ca_topic_score_gemma":0.048287746,"teacher_disagreement_score":0.105928965,"about_ca_system_score_codex":0.00030987104,"about_ca_system_score_gemma":0.00090548984,"threshold_uncertainty_score":0.999632},"labels":[],"label_agreement":null},{"id":"W4362393118","doi":"10.1158/1078-0432.22442183","title":"Supplementary Data from &lt;i&gt;In vivo&lt;/i&gt; Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Docetaxel; Bladder cancer; In vivo; Urology; Cancer research; Medicine; Cancer; Internal medicine; Biology","score_opus":0.11362417139301324,"score_gpt":0.37863252896603206,"score_spread":0.2650083575730188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362393118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9297061,0.0019678257,0.0002704063,0.0015827101,0.0010260374,0.008660805,0.056270357,0.000047414265,0.00046837702],"genre_scores_gemma":[0.971898,0.0032464513,0.0029860022,0.00014311876,0.00059694244,0.003066707,0.017004086,0.00013203445,0.0009266526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953377,0.00017984274,0.0013238086,0.0014127727,0.001193265,0.0005525607],"domain_scores_gemma":[0.9962367,0.00045362208,0.0005757431,0.0018618993,0.000648466,0.00022356278],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000522011,0.0006696964,0.0016084984,0.00031154073,0.000049709186,0.000020276542,0.0004328478,0.0003760681,0.005677158],"category_scores_gemma":[0.00014119428,0.0005398633,0.00038645192,0.00022494415,0.00015588463,0.000096789016,0.00046576728,0.00016215128,0.000015012455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063655525,0.010656868,0.021224067,0.0029112971,0.024043212,0.00020816512,0.009584011,0.0039617345,0.8212012,0.00019724938,0.05367996,0.045966677],"study_design_scores_gemma":[0.0439527,0.0038606257,0.11982618,0.0024637661,0.02540866,0.000005919264,0.00072451466,0.035792187,0.7587545,0.0034614494,0.004529215,0.0012203158],"about_ca_topic_score_codex":0.011841463,"about_ca_topic_score_gemma":0.03019355,"teacher_disagreement_score":0.09860212,"about_ca_system_score_codex":0.00097498344,"about_ca_system_score_gemma":0.0024981843,"threshold_uncertainty_score":0.9997053},"labels":[],"label_agreement":null},{"id":"W4362469300","doi":"10.1016/j.euo.2023.03.004","title":"Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Université de Sherbrooke; University of Toronto; Western University; University of Calgary; McGill University Health Centre; University of Ottawa; McGill University; Queen's University; McMaster University; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Confidence interval; Internal medicine; Odds ratio; Urology; Stage (stratigraphy); Hazard ratio; Radiation therapy; Chemotherapy; Retrospective cohort study; Neoadjuvant therapy; Oncology; Cancer; Gastroenterology; Breast cancer","score_opus":0.04950774386209853,"score_gpt":0.3620813512570833,"score_spread":0.31257360739498474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362469300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9399649,0.0019289256,0.00022468498,0.04446716,0.0023887928,0.0022013069,0.0005139844,0.0005971069,0.007713142],"genre_scores_gemma":[0.95182943,0.0004853466,0.00008746092,0.045083363,0.00045563705,0.00035411434,0.0003854067,0.00010560644,0.0012136283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979099,0.0004093061,0.00040599843,0.00054556906,0.00013445919,0.00059473905],"domain_scores_gemma":[0.99847007,0.0006968027,0.00017657601,0.00036350667,0.000104216764,0.00018881257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039185796,0.00028811407,0.0005476838,0.0001537584,0.00019730511,0.000011922618,0.00019447805,0.00015422166,0.00018476378],"category_scores_gemma":[0.00012953467,0.00023614826,0.00025710685,0.0001943228,0.00025280597,0.000055283068,0.000051830313,0.00021754432,0.0002908691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028906818,0.00079226855,0.7739477,0.000056134726,0.0013351727,0.0011674204,0.0021222578,0.00013622889,0.0030388646,0.000025761232,0.09720256,0.117284924],"study_design_scores_gemma":[0.01610052,0.002733334,0.7184606,0.000008956192,0.00010636304,0.000015889167,0.00013877638,0.00011462653,0.00058268505,0.000029772247,0.26152152,0.0001869491],"about_ca_topic_score_codex":0.00013397122,"about_ca_topic_score_gemma":0.00006637701,"teacher_disagreement_score":0.16431896,"about_ca_system_score_codex":0.00014382809,"about_ca_system_score_gemma":0.00068376696,"threshold_uncertainty_score":0.9629847},"labels":[],"label_agreement":null},{"id":"W4362593107","doi":"10.1158/1538-7445.am2023-5915","title":"Abstract 5915: Exploring the impact of microbiome in the response of combined radiation with immune checkpoint blockade in muscle invasive bladder cancer (MIBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; McGill University Health Centre","funders":"","keywords":"Microbiome; Medicine; Immune checkpoint; Akkermansia muciniphila; Immune system; Radiation therapy; Cancer; Immunology; Akkermansia; Blockade; Immunotherapy; Immunity; Bladder cancer; Gut flora; Cancer research; Internal medicine; Bioinformatics; Lactobacillus; Biology","score_opus":0.12049045173666441,"score_gpt":0.41143941378249904,"score_spread":0.29094896204583465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945833,0.0013298943,2.1056806e-7,0.0025484194,0.000054970726,0.0012405599,0.00008762031,0.000012063998,0.00014292933],"genre_scores_gemma":[0.9965414,0.0021058104,0.000003309461,0.000024076511,0.000067679655,0.0010484768,0.000016164182,0.00003191991,0.00016116329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979407,0.00035248292,0.00039870257,0.00025662224,0.0005732699,0.0004782219],"domain_scores_gemma":[0.9984322,0.00070495554,0.00010780201,0.00048291116,0.00021089368,0.000061247185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001997658,0.00015463507,0.00034057107,0.00053202244,0.00007392043,0.0000170902,0.0002839991,0.00005903821,0.00021328357],"category_scores_gemma":[0.00019726696,0.000082584294,0.00010902891,0.002261304,0.00027172305,0.00010677385,0.000063751424,0.0004912675,0.000009262162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010187868,0.00034421385,0.050118223,0.00019376454,0.00027650673,0.00009599082,0.016999843,0.0009544158,0.91614467,0.0000043960977,0.00041551286,0.0042646225],"study_design_scores_gemma":[0.003376149,0.0006634543,0.7736763,0.00046090168,0.000020589197,0.0000029665616,0.00238538,0.000018231724,0.21924882,0.000027284557,0.000054288772,0.000065672684],"about_ca_topic_score_codex":0.037799183,"about_ca_topic_score_gemma":0.002262061,"teacher_disagreement_score":0.72355807,"about_ca_system_score_codex":0.0006438813,"about_ca_system_score_gemma":0.001562476,"threshold_uncertainty_score":0.9686082},"labels":[],"label_agreement":null},{"id":"W4362593182","doi":"10.1158/1538-7445.am2023-609","title":"Abstract 609: The predictive power of tertiary lymphoid structures in assessing response to trimodal therapy in muscle invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Bladder cancer; Germinal center; Tumor microenvironment; Medicine; Cystectomy; FOXP3; Immune system; Pathology; H&E stain; Tissue microarray; CD20; CD68; Cancer; Immunohistochemistry; Internal medicine; Immunology; B cell; Antibody","score_opus":0.07675676988286696,"score_gpt":0.43098091567197466,"score_spread":0.3542241457891077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991164,0.0019264377,0.0000013039852,0.004409062,0.00019142435,0.0014928858,0.00012377473,0.000029852154,0.00066124776],"genre_scores_gemma":[0.99658483,0.0013196599,0.000011000141,0.0005495988,0.00014710712,0.0010210309,0.000007954659,0.00004901318,0.00030981898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972283,0.000416568,0.0003566545,0.0004649988,0.00087491446,0.00065851666],"domain_scores_gemma":[0.9982786,0.00079818483,0.00005754423,0.0004417605,0.00026428257,0.00015963354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013576176,0.00019149247,0.00034575106,0.00073699944,0.00010636147,0.000041956988,0.00028437687,0.00012781828,0.00080603565],"category_scores_gemma":[0.00035782883,0.00012848643,0.00008000555,0.0018108301,0.00022834523,0.00014923124,0.000113416194,0.00053578854,0.000016436645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018538238,0.00042629265,0.31786242,0.00013619696,0.00033681834,0.00044828706,0.022451874,0.0011153275,0.57337934,0.000012503247,0.006603224,0.05868947],"study_design_scores_gemma":[0.003577376,0.0004048781,0.9264209,0.00038428514,0.000009887019,0.0000031543516,0.0027128248,0.000018478966,0.0654872,0.00024268747,0.00063013047,0.000108161345],"about_ca_topic_score_codex":0.011360358,"about_ca_topic_score_gemma":0.0022697418,"teacher_disagreement_score":0.60855854,"about_ca_system_score_codex":0.0008789008,"about_ca_system_score_gemma":0.002818515,"threshold_uncertainty_score":0.9952231},"labels":[],"label_agreement":null},{"id":"W4365811168","doi":"10.1016/j.labinv.2023.100155","title":"Quantitative Nuclear Grading: An Objective, Artificial Intelligence–Facilitated Foundation for Grading Noninvasive Papillary Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Grading (engineering); Medicine; Bladder cancer; Radiology; Pathology; Artificial intelligence; Medical physics; Cancer; Computer science; Biology; Internal medicine","score_opus":0.08457506710775253,"score_gpt":0.3320611813160966,"score_spread":0.24748611420834404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365811168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953584,0.00004033266,0.0010555671,0.0009073744,0.00054164673,0.0013136117,0.00024638063,0.00038149115,0.00015519364],"genre_scores_gemma":[0.994787,0.000020682648,0.0029521603,0.0007036627,0.00031371583,0.00020517893,0.0008848204,0.00007076421,0.00006202135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983022,0.00015520121,0.0003991773,0.00050228054,0.00031050385,0.00033058666],"domain_scores_gemma":[0.9986455,0.0001566326,0.00015009573,0.00025657474,0.0005483223,0.00024286487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003385402,0.00024745084,0.00029661477,0.00030289261,0.00037725465,0.000077358294,0.00008919151,0.00014282251,0.000055748118],"category_scores_gemma":[0.00039169748,0.00024850987,0.00008598197,0.0011361418,0.00021893713,0.0005027561,0.00001754969,0.00015802849,0.00021906562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031880627,0.00045233197,0.048601642,0.0006983111,0.0006386794,0.00015558282,0.0442808,0.00044325108,0.7634144,0.12199897,0.002517128,0.013610845],"study_design_scores_gemma":[0.0038165427,0.011409808,0.06967343,0.00047459354,0.00096771156,0.00003407595,0.034799665,0.058778554,0.6688581,0.14648731,0.0031254361,0.0015747512],"about_ca_topic_score_codex":0.00014515495,"about_ca_topic_score_gemma":0.00006484994,"teacher_disagreement_score":0.094556265,"about_ca_system_score_codex":0.000268935,"about_ca_system_score_gemma":0.0005090811,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W4366257170","doi":"10.1177/15385744231171754","title":"Mycotic Abdominal Aortic Aneurysm Secondary to BCG Therapy for Non-muscle Invasive Urothelial Carcinoma of the Bladder","year":2023,"lang":"en","type":"article","venue":"Vascular and Endovascular Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Surgery; Back pain; Malignancy; Abdominal pain; Constipation; Bladder cancer; Mycotic aneurysm; Abdominal aortic aneurysm; Radiology; Aneurysm; Cancer; Internal medicine; Pathology","score_opus":0.021825623314292542,"score_gpt":0.24971215043533548,"score_spread":0.22788652712104293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366257170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491596,0.0018836887,0.0001961275,0.00048856594,0.0005156021,0.0017139819,0.00006711441,0.00005536737,0.00016360704],"genre_scores_gemma":[0.9966026,0.0015490969,0.00012042542,0.00085190585,0.00024017652,0.00033393368,0.000039112198,0.00007813038,0.00018462577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801517,0.00010184746,0.00040865922,0.00050048326,0.00047453452,0.00049929286],"domain_scores_gemma":[0.9984824,0.00034879812,0.00008200142,0.0007385154,0.00012444414,0.00022381151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005371001,0.00030179237,0.0006974759,0.00025564356,0.00018351372,0.00002642328,0.00013886206,0.00011585971,0.00010331777],"category_scores_gemma":[0.00019742583,0.00021130343,0.0011490261,0.00059709087,0.000110962515,0.000075821605,0.00008500288,0.00015460108,0.000030420548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032200378,0.0017719152,0.37961468,0.0048114285,0.011529667,0.0010256974,0.007880517,0.0002460252,0.18717267,0.00010248298,0.030896666,0.3717282],"study_design_scores_gemma":[0.005904007,0.0004132152,0.9252246,0.00026167175,0.00081876136,0.00014858498,0.00030530864,0.00017609331,0.05858926,0.00021002998,0.007535768,0.00041271534],"about_ca_topic_score_codex":0.00036515694,"about_ca_topic_score_gemma":0.000026582922,"teacher_disagreement_score":0.5456099,"about_ca_system_score_codex":0.000040725416,"about_ca_system_score_gemma":0.00046188087,"threshold_uncertainty_score":0.8616704},"labels":[],"label_agreement":null},{"id":"W4366339435","doi":"10.1200/jco.22.01792","title":"Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cilag; Foundation Medicine; Genentech; Eisai; Astellas Pharma; Eli Lilly and Company; Ono Pharmaceutical; G1 Therapeutics; GlaxoSmithKline; UroGen Pharma; Bavarian Nordic; Silverback Therapeutics; Ipsen; Mirati Therapeutics; Clovis Oncology; Janssen Biotech; Les Laboratories Pierre Fabre; Pfizer; Incyte; Merck KGaA; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Gilead Sciences; Exelixis; Sanofi; Amgen; EUSA Pharma; AstraZeneca; Bristol-Myers Squibb","keywords":"Avelumab; Medicine; Clinical endpoint; Metastatic Urothelial Carcinoma; Hazard ratio; Internal medicine; Bladder cancer; Clinical trial; Progression-free survival; Oncology; Urothelial carcinoma; Chemotherapy; Cancer; Immunotherapy; Confidence interval; Nivolumab","score_opus":0.1206717529403053,"score_gpt":0.42870129326904377,"score_spread":0.30802954032873847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366339435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97697544,0.00037195368,0.00021925684,0.014585818,0.00583259,0.0010928491,0.00047518773,0.000017162878,0.00042976983],"genre_scores_gemma":[0.98890626,0.00077732996,0.0015417789,0.0020204387,0.004639117,0.00006154245,0.000027711214,0.000040638988,0.0019851923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99579155,0.00026035352,0.0028140503,0.00031636519,0.0004643901,0.00035327132],"domain_scores_gemma":[0.99114233,0.0061953543,0.0015062244,0.0003958628,0.000516953,0.00024325309],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024496072,0.00019092733,0.001530716,0.00009010969,0.000050259194,0.000008023585,0.00028541216,0.0003767373,0.00013220837],"category_scores_gemma":[0.008368188,0.000119011005,0.0010427525,0.00022255899,0.00024101185,0.000075654636,0.00007087217,0.0006315042,0.000043372434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.801528,0.0012921335,0.0041123666,0.00002396038,0.0010514773,0.00057255186,0.00075500907,0.00004072047,0.00010343014,0.000022089138,0.0353446,0.1551537],"study_design_scores_gemma":[0.5368831,0.035904743,0.1979698,0.00023580613,0.0014673818,0.000050423576,0.0002812745,0.00017176142,0.0002621177,0.0016747181,0.22489823,0.00020061716],"about_ca_topic_score_codex":0.00015173227,"about_ca_topic_score_gemma":0.00028710373,"teacher_disagreement_score":0.26464483,"about_ca_system_score_codex":0.000117128984,"about_ca_system_score_gemma":0.0017144922,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W4366597564","doi":"10.3390/cancers15082381","title":"Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer","year":2023,"lang":"en","type":"review","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Modalities; Magnetic resonance imaging; Positron emission tomography; Bladder cancer; Bioluminescence imaging; Cancer; Medical imaging; Ultrasound; Radiology; Medical physics; Internal medicine; Biology","score_opus":0.07896200909404114,"score_gpt":0.3702294292701845,"score_spread":0.2912674201761434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366597564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001399339,0.9937425,0.00001880239,0.000070117465,0.0004994075,0.0013145589,0.00042368265,0.000056309604,0.003734683],"genre_scores_gemma":[0.0009486251,0.99504846,0.00004529945,0.00014075032,0.0004661157,0.0009548899,0.000106775326,0.0001457335,0.0021433632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978183,0.000040799456,0.0007547158,0.00055007666,0.00035045706,0.00048563437],"domain_scores_gemma":[0.9989224,0.00010856229,0.0002614415,0.0004354843,0.00009872429,0.00017337117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001005034,0.00050071644,0.0022907758,0.00040841824,0.000028841961,0.000012196949,0.0001947531,0.00020006402,0.00025425776],"category_scores_gemma":[0.00002366052,0.00040529793,0.00046204685,0.0005803312,0.00018679524,0.000095347845,0.00007818653,0.00043938885,0.00003403626],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020873107,0.00010336533,0.00026000928,0.09769747,0.0030003747,0.000690981,0.0021381672,0.001147681,0.0000061301744,0.00028501192,0.006834997,0.88762707],"study_design_scores_gemma":[0.0123356,0.0007657998,0.00033548524,0.35198733,0.01626263,0.00023436133,0.0021226306,0.003752921,0.0003971782,0.0032247824,0.60521454,0.0033667672],"about_ca_topic_score_codex":0.006679203,"about_ca_topic_score_gemma":0.00061644166,"teacher_disagreement_score":0.8842603,"about_ca_system_score_codex":0.0029550954,"about_ca_system_score_gemma":0.0064321253,"threshold_uncertainty_score":0.9999354},"labels":[],"label_agreement":null},{"id":"W4367052024","doi":"10.5489/cuaj.8374","title":"2023 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; University of Toronto; University of British Columbia; BC Cancer Agency; Jewish General Hospital; University of Ottawa; Université de Montréal; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Clinical Oncology; Medicine; Genitourinary system; Internal medicine; Oncology; Cancer","score_opus":0.05336428151783961,"score_gpt":0.359135901585275,"score_spread":0.30577162006743536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367052024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9011117,0.00019565043,0.000017466307,0.08474943,0.0014007649,0.0002997805,0.00016621518,0.000067339,0.011991646],"genre_scores_gemma":[0.9831998,0.0017124827,0.00033583582,0.009340125,0.0017311224,0.000017487835,0.00004202426,0.000020944319,0.0036001822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775594,0.00028148617,0.00070056564,0.0002480318,0.0004179935,0.00059599424],"domain_scores_gemma":[0.99769646,0.00032777045,0.00056146603,0.0001352299,0.00029114733,0.0009879151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011873515,0.00015049134,0.0006602056,0.0001452405,0.0001984268,0.000019125253,0.00013987406,0.0003166152,0.00052976457],"category_scores_gemma":[0.00032420023,0.00012313489,0.00050264027,0.00059806963,0.00014947182,0.00005729495,0.000025264177,0.0007862994,0.00014652635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001681068,0.000080688136,0.7528209,0.000007654498,0.0005738065,0.00019972793,0.00015175881,0.00006123981,0.0001345586,0.000013189357,0.2295559,0.016232483],"study_design_scores_gemma":[0.0017703862,0.0020450132,0.7393611,0.00001092078,0.00018652526,0.00010325285,0.00031021936,0.00022511488,0.000021377587,0.00013462857,0.2557219,0.00010956812],"about_ca_topic_score_codex":0.009726709,"about_ca_topic_score_gemma":0.0016757947,"teacher_disagreement_score":0.08208809,"about_ca_system_score_codex":0.002137706,"about_ca_system_score_gemma":0.0036886493,"threshold_uncertainty_score":0.9968676},"labels":[],"label_agreement":null},{"id":"W4367296748","doi":"10.1016/j.eururo.2023.03.030","title":"Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Javelin; Avelumab; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Oncology; Internal medicine; Carcinoma; Chemotherapy; Clinical trial; Bladder cancer; Urology; Immunotherapy; Pembrolizumab; Cancer","score_opus":0.1709709398084595,"score_gpt":0.4281932307307954,"score_spread":0.2572222909223359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367296748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819213,0.0015312587,0.0015959684,0.0077626687,0.002155025,0.0028492857,0.00062786206,0.00026558895,0.0012910211],"genre_scores_gemma":[0.982082,0.0012690651,0.00029909099,0.010209461,0.00390608,0.00017485353,0.0005373294,0.0001404024,0.0013816884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966676,0.00073611736,0.00085524464,0.000845513,0.00026146698,0.0006340539],"domain_scores_gemma":[0.99683756,0.0016584365,0.00025222698,0.0008203179,0.00022827205,0.00020321835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005252848,0.00040129025,0.0008053001,0.0000992303,0.00027436388,0.00002656309,0.0003824878,0.00013113406,0.00036596667],"category_scores_gemma":[0.0004489944,0.00026010058,0.00054213457,0.00032342644,0.0003587718,0.0000546385,0.00011401255,0.00042443527,0.00059317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68646127,0.004390487,0.007825945,0.000041381438,0.0037500863,0.0018519232,0.0022393505,0.0002788991,0.008493399,0.00017011854,0.11095878,0.17353837],"study_design_scores_gemma":[0.454731,0.02033081,0.0685979,0.000024127527,0.00088504946,0.000044905046,0.0002075015,0.0011884084,0.00078961754,0.0004012525,0.45232284,0.00047659752],"about_ca_topic_score_codex":0.00013333856,"about_ca_topic_score_gemma":0.000052354117,"teacher_disagreement_score":0.3413641,"about_ca_system_score_codex":0.000038566257,"about_ca_system_score_gemma":0.00017187555,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W4367299365","doi":"10.1016/j.suronc.2023.101947","title":"Conditional survival for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder after radical cystectomy","year":2023,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hazard ratio; Medicine; Cystectomy; Stage (stratigraphy); Proportional hazards model; Oncology; Bladder cancer; Internal medicine; Urology; Overall survival; Confidence interval; Survival analysis; Cancer; Surgery; Biology","score_opus":0.03193510363593594,"score_gpt":0.331387836764919,"score_spread":0.2994527331289831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367299365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219377,0.0003090871,0.0000755279,0.0041492106,0.00088970247,0.0014980687,0.00046403133,0.00006105597,0.01035953],"genre_scores_gemma":[0.9969588,0.000048350117,0.00015318426,0.00046955107,0.0003478888,0.0005126069,0.00012168354,0.000027173903,0.0013607743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855155,0.00015306131,0.00034313693,0.00029417442,0.0003105311,0.00034752974],"domain_scores_gemma":[0.9983375,0.0010703364,0.00009072814,0.0002399238,0.00010702368,0.00015447152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022044781,0.000164711,0.000525565,0.00008839844,0.00007303708,0.00000384611,0.00011806412,0.00014064503,0.00091629656],"category_scores_gemma":[0.00008029869,0.00010545137,0.00034031094,0.00029328183,0.0003886023,0.000030741423,0.00008504537,0.00018707885,0.000100102945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072318144,0.02998583,0.55551773,0.006355115,0.015174548,0.06273801,0.00831623,0.00022356342,0.010958579,0.01546929,0.09478911,0.12815385],"study_design_scores_gemma":[0.01805619,0.005424576,0.74330425,0.00011007331,0.00079642254,0.0009637451,0.00032799787,0.00011455474,0.0012899368,0.0026117503,0.2267553,0.00024519349],"about_ca_topic_score_codex":0.000023483708,"about_ca_topic_score_gemma":0.000016514334,"teacher_disagreement_score":0.1877865,"about_ca_system_score_codex":0.00011985398,"about_ca_system_score_gemma":0.00066994503,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W4367600716","doi":"10.1002/jso.27255","title":"Age represents the main driver of surgical decision making in patients candidate to radical cystectomy","year":2023,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Perioperative; Propensity score matching; Urinary diversion; Dissection (medical); Bladder cancer; Logistic regression; Odds ratio; Surgery; Lymph node; Urology; Internal medicine; Cancer","score_opus":0.023481140348389093,"score_gpt":0.35374004505671014,"score_spread":0.33025890470832103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367600716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929943,0.00008943035,0.000017801947,0.0029984068,0.00048484604,0.0003381481,0.000011317739,0.00000883032,0.003056938],"genre_scores_gemma":[0.9986689,0.00037200618,0.00025034382,0.0002175317,0.00024961503,0.0000076014585,0.0000041816425,0.00001637472,0.00021343231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976375,0.00028533678,0.00086773606,0.00019322244,0.0006812119,0.00033496178],"domain_scores_gemma":[0.9982765,0.0008863068,0.0002671072,0.00020651726,0.00012945825,0.00023416543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009116466,0.00013964865,0.00075213274,0.00033534737,0.000043112017,0.00000846401,0.00020688043,0.0001733859,0.00027353314],"category_scores_gemma":[0.0001290155,0.000080059835,0.00023546394,0.0006543611,0.0001277402,0.000054914362,0.00013566422,0.0004418371,0.000039205603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034868363,0.0025446527,0.67567164,0.00006470619,0.000482523,0.07493768,0.0016497413,0.00030386623,0.00022150396,0.00016871397,0.025258478,0.18382813],"study_design_scores_gemma":[0.02531532,0.004485466,0.6108193,0.00051693065,0.0001481896,0.0015331036,0.00011963195,0.00004839131,0.00012900495,0.0004703769,0.35627759,0.00013672234],"about_ca_topic_score_codex":0.000047313402,"about_ca_topic_score_gemma":0.000033399472,"teacher_disagreement_score":0.3310191,"about_ca_system_score_codex":0.0003435103,"about_ca_system_score_gemma":0.00025263007,"threshold_uncertainty_score":0.32647452},"labels":[],"label_agreement":null},{"id":"W4367852910","doi":"10.3390/curroncol30050350","title":"Intravesical Contrast-Enhanced MRI: A Potential Tool for Bladder Cancer Surveillance and Staging","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Radiology; Gadobutrol; Magnetic resonance imaging; Dynamic contrast-enhanced MRI; Cancer; Nuclear medicine; Internal medicine","score_opus":0.14328059069165422,"score_gpt":0.4702550750036901,"score_spread":0.3269744843120359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367852910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013743296,0.9897375,0.0016887314,0.00030237608,0.0034828861,0.003553766,0.0008518485,0.00012925688,0.00011618763],"genre_scores_gemma":[0.00023908766,0.9939611,0.00013127715,0.00008668148,0.0020151208,0.0024901952,0.00041520793,0.00011590895,0.000545425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751765,0.00015408001,0.00070277083,0.00078167603,0.0002162965,0.00062751997],"domain_scores_gemma":[0.99863464,0.00039085778,0.00030613493,0.00028592924,0.00016357277,0.00021885769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024696582,0.00052828365,0.0025995495,0.00017388837,0.00008993163,0.00003156852,0.00013518125,0.00040556857,0.00014022659],"category_scores_gemma":[0.0001118842,0.00040868996,0.0004295764,0.00021326474,0.0001701441,0.00004121384,0.000093260176,0.00053979346,0.0000420228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016892856,0.0002127607,0.000064501524,0.012772889,0.0008725128,0.000035406785,0.00008869467,2.9057654e-7,0.000004201709,0.000043554708,0.003824007,0.98191226],"study_design_scores_gemma":[0.0035704684,0.0006278904,0.00018927346,0.0043109017,0.0025909804,0.00006321303,0.000017907863,0.00003812255,0.000004139268,0.000067868656,0.9881419,0.00037732214],"about_ca_topic_score_codex":0.000024058194,"about_ca_topic_score_gemma":0.00004378169,"teacher_disagreement_score":0.9843179,"about_ca_system_score_codex":0.00050429296,"about_ca_system_score_gemma":0.0015257128,"threshold_uncertainty_score":0.9998365},"labels":[],"label_agreement":null},{"id":"W4375945020","doi":"10.1002/ijc.34560","title":"Bladder cancer risk in relation to occupations held in a nationwide case‐control study in Iran","year":2023,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Veterans Affairs Canada","funders":"National Institute for Medical Research Development; World Health Organization","keywords":"Bladder cancer; Odds ratio; Medicine; Epidemiology; Case-control study; Cancer; Logistic regression; Confidence interval; Environmental health; Demography; Internal medicine","score_opus":0.03351726760322202,"score_gpt":0.3937273335330296,"score_spread":0.36021006592980753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375945020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993449,0.00047877262,0.00011222027,0.0040613064,0.0008670098,0.0005917414,0.00012367412,0.000010715436,0.00030558973],"genre_scores_gemma":[0.9982367,0.00036357675,0.000047975056,0.0005707618,0.0003839673,0.00018118965,0.000003494525,0.000017752689,0.00019459288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832803,0.000099023215,0.00065638236,0.0001728798,0.00057002227,0.00017364102],"domain_scores_gemma":[0.99919015,0.00013106267,0.00021684563,0.00008939454,0.00028880106,0.00008374283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004688096,0.00011971244,0.00026994274,0.0013050047,0.00002280765,0.000023644194,0.00011934559,0.000055551234,0.00034159372],"category_scores_gemma":[0.0001652791,0.00010643334,0.000072353425,0.0007578619,0.000012437403,0.0002163144,0.000020159381,0.0003186579,0.000016193206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010392161,0.00033039012,0.95484185,0.00000417943,0.00030793026,0.00234763,0.00319551,0.021640344,0.000115844465,0.000011739681,0.00025667774,0.015908703],"study_design_scores_gemma":[0.009725876,0.00022897345,0.98714954,0.00025515555,0.00009843461,0.000099646284,0.00074969337,0.001038444,0.0000649754,0.00016442934,0.0003374109,0.00008743093],"about_ca_topic_score_codex":0.0093273055,"about_ca_topic_score_gemma":0.082416564,"teacher_disagreement_score":0.07308926,"about_ca_system_score_codex":0.0008619623,"about_ca_system_score_gemma":0.00032816172,"threshold_uncertainty_score":0.9972697},"labels":[],"label_agreement":null},{"id":"W4376111513","doi":"10.1016/j.euros.2023.03.019","title":"International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; University of British Columbia; Kingston Health Sciences Centre; Queen's University","funders":"European Association of Urology","keywords":"Urothelial carcinoma; Grading (engineering); Medicine; Carcinoma; Urology; Pathology; Internal medicine; Bladder cancer; Biology; Cancer","score_opus":0.056048512825134,"score_gpt":0.33284405820982366,"score_spread":0.27679554538468965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376111513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479468,0.00001376787,0.00004411248,0.0024025573,0.00067889784,0.00029625662,0.00018325487,0.000024689249,0.04840967],"genre_scores_gemma":[0.99834293,0.00010414737,0.00021802155,0.0006298201,0.00007939734,0.000005331096,0.00008254028,0.0000191307,0.000518657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976688,0.0006626068,0.00048979477,0.0005197228,0.0003781462,0.00028090592],"domain_scores_gemma":[0.99855673,0.00036753563,0.000427046,0.0002768014,0.00027072988,0.00010117007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039707604,0.00014526145,0.00036001278,0.0002565126,0.00009664883,0.000019865765,0.00092745747,0.00006506881,0.00007756506],"category_scores_gemma":[0.00085540465,0.00012616815,0.00009241648,0.0004243703,0.0011291807,0.00015287912,0.00084432284,0.00022279352,0.000019766949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060532533,0.0002449587,0.98368776,0.0000108829845,0.00015033402,0.00005399803,0.0010019529,0.00009279186,0.009398071,0.00064012397,0.001994151,0.0021196767],"study_design_scores_gemma":[0.00217213,0.0011211807,0.99282455,0.000008150551,0.00004659041,0.00003794919,0.000058930687,0.000577256,0.0005963424,0.00005743655,0.0024183467,0.00008111499],"about_ca_topic_score_codex":0.00014540783,"about_ca_topic_score_gemma":0.000013797437,"teacher_disagreement_score":0.050396163,"about_ca_system_score_codex":0.000059607424,"about_ca_system_score_gemma":0.00013928355,"threshold_uncertainty_score":0.5144988},"labels":[],"label_agreement":null},{"id":"W4376272229","doi":"10.1016/s1470-2045(23)00170-5","title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","year":2023,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Cystectomy; Medicine; Propensity score matching; Bladder cancer; Urology; Retrospective cohort study; Stage (stratigraphy); Clinical endpoint; Surgery; Cancer; Internal medicine; Randomized controlled trial","score_opus":0.1688769722248086,"score_gpt":0.3886908834160771,"score_spread":0.2198139111912685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376272229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449093,0.00064356194,0.00051980925,0.011558703,0.000380658,0.0016448209,0.00024241315,0.00015526058,0.00036384314],"genre_scores_gemma":[0.9944121,0.0017020189,0.0005991618,0.0014437754,0.000677242,0.00072711776,0.00015954352,0.000018879029,0.00026013504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861413,0.00017918648,0.00022926442,0.00039096098,0.0001948016,0.000391645],"domain_scores_gemma":[0.99889296,0.00042001164,0.00010183235,0.00033106608,0.00012938159,0.00012471912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045272164,0.00020128723,0.00087336573,0.00011286932,0.00025790255,0.000015363621,0.00013988942,0.00015966548,0.0001177384],"category_scores_gemma":[0.00008957649,0.00011511937,0.00019459543,0.00062396243,0.00037626614,0.000042963708,0.000055349323,0.00020341494,0.000016335984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13312998,0.0038972066,0.54545724,0.0009314583,0.051440086,0.001077462,0.010721112,0.0002830504,0.025466539,0.0061273193,0.023712285,0.19775628],"study_design_scores_gemma":[0.06456873,0.0019162431,0.89874864,0.000042049418,0.003785895,0.000035863253,0.00019281793,0.002043011,0.0022983851,0.0004312765,0.025657097,0.00027997422],"about_ca_topic_score_codex":0.0007839921,"about_ca_topic_score_gemma":0.00149303,"teacher_disagreement_score":0.35329142,"about_ca_system_score_codex":0.00025437446,"about_ca_system_score_gemma":0.00089072535,"threshold_uncertainty_score":0.46944317},"labels":[],"label_agreement":null},{"id":"W4376645144","doi":"10.1016/j.eururo.2023.03.029","title":"Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":481,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"National Institute for Health and Care Research; World Health Organization","keywords":"Medicine; Epidemiology; Environmental health; Bladder cancer; Risk factor; Cancer; Pathology; Internal medicine","score_opus":0.10784192216771732,"score_gpt":0.39832168376729765,"score_spread":0.29047976159958033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376645144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015255421,0.9947226,0.000004386349,0.000041356092,0.00035009335,0.0022759382,0.0005824801,0.00003354287,0.0019743473],"genre_scores_gemma":[0.000074281066,0.99846715,0.000014024027,0.0003177714,0.00010561814,0.00015540804,0.00013103202,0.00012946768,0.0006052289],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917127,0.0046409857,0.0025804758,0.0005234346,0.00015837372,0.00038405182],"domain_scores_gemma":[0.9950667,0.0020200245,0.0019128666,0.0007998333,0.00009154371,0.00010900177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017902153,0.00047262665,0.007534608,0.0004089188,0.000014934102,4.7446727e-7,0.00031600363,0.000216146,0.00054550177],"category_scores_gemma":[0.0034868382,0.00030691887,0.0008417039,0.00061188603,0.00016437542,0.0000144029,0.0001303617,0.00057666836,0.000346065],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015780934,0.00008050251,0.0015801339,0.99007064,0.0014239765,0.00010270105,0.0000638906,9.2029427e-7,3.8683766e-8,0.000024794219,0.00055903,0.0060775974],"study_design_scores_gemma":[0.00071520684,0.00050572626,0.003230279,0.92331547,0.021099186,0.000080512655,0.000013953165,0.0000017273208,2.1373872e-7,0.000026477966,0.050719347,0.00029192618],"about_ca_topic_score_codex":0.00042701926,"about_ca_topic_score_gemma":0.000042440926,"teacher_disagreement_score":0.06675519,"about_ca_system_score_codex":0.000087542794,"about_ca_system_score_gemma":0.00031342354,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W4377011135","doi":"10.1097/pas.0000000000002053","title":"International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4","year":2023,"lang":"en","type":"review","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of British Columbia; Queen's University","funders":"","keywords":"Subtyping; Bladder cancer; Medicine; Molecular pathology; Cancer; Pathology; Oncology; Internal medicine; Biology; Gene; Computer science; Genetics","score_opus":0.13608997853246121,"score_gpt":0.42300919645478957,"score_spread":0.28691921792232833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377011135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010573564,0.98252326,0.000013719348,0.0045526647,0.0011857989,0.00045894948,0.000086600856,0.000021762105,0.0005837066],"genre_scores_gemma":[0.0076074935,0.9910888,0.00015967764,0.000232611,0.0007381586,0.00004354904,0.000017085295,0.00003937533,0.00007325538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966736,0.000831859,0.0013091313,0.0003706811,0.0004249673,0.00038975495],"domain_scores_gemma":[0.9967544,0.00096266373,0.0016964838,0.00028579644,0.00017126712,0.000129395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090562215,0.0003906845,0.0030997,0.00024548924,0.000038393446,0.00000983566,0.00046011593,0.00019887026,0.00013930122],"category_scores_gemma":[0.00007438762,0.00021537306,0.0009375558,0.00048631273,0.0013454505,0.00001441018,0.00013897898,0.0015464388,0.000018650442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00101547,0.00046235078,0.0007633481,0.00044266143,0.00061644224,0.0039807744,0.00028195104,0.000005853121,0.0000069927078,0.0002837324,0.0010728128,0.9910676],"study_design_scores_gemma":[0.002717298,0.0039620884,0.0015486843,0.008320095,0.0014524305,0.009286273,0.00029176942,0.000015344289,0.0000019423444,0.00050000113,0.9715779,0.00032621657],"about_ca_topic_score_codex":0.000033960503,"about_ca_topic_score_gemma":0.0000036516892,"teacher_disagreement_score":0.9907414,"about_ca_system_score_codex":0.00019084997,"about_ca_system_score_gemma":0.00042524454,"threshold_uncertainty_score":0.87826586},"labels":[],"label_agreement":null},{"id":"W4377103375","doi":"10.3390/curroncol30050385","title":"One-Step Robot-Assisted Complete Urinary Tract Extirpation in Man with End-Stage Renal Disease on Dialysis: The First Case Report","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Tungs' Taichung MetroHarbor Hospital","keywords":"Medicine; Urothelium; Urinary system; Upper urinary tract; Stage (stratigraphy); Perioperative; Urology; Dialysis; End stage renal disease; Urothelial cancer; Bladder cancer; Surgery; Disease; Cancer; Internal medicine","score_opus":0.1561720402749988,"score_gpt":0.3955838805847184,"score_spread":0.23941184030971957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377103375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904252,0.00039785117,0.00009086048,0.005675887,0.00053794193,0.0011104014,0.00010341198,0.0001228789,0.001535562],"genre_scores_gemma":[0.99797904,0.00010357294,0.00003588712,0.00024791347,0.00025199514,0.00044538395,0.00049993413,0.000027072248,0.0004092071],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99846035,0.00013675302,0.00036998038,0.00042619093,0.00029270962,0.00031402125],"domain_scores_gemma":[0.9989384,0.00017137977,0.00018217719,0.0004735609,0.000057874007,0.00017663481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023254496,0.0001952728,0.00037871176,0.00019182393,0.00016615739,0.000013711275,0.00008378428,0.000057219688,0.00019440542],"category_scores_gemma":[0.000058839752,0.00013306871,0.00010494312,0.00042901808,0.00010068903,0.000053455657,0.000041447613,0.00030641668,0.00008033093],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006423741,0.01182385,0.3359253,0.0004088981,0.00043481155,0.46774167,0.0015623089,0.0005516377,0.0000540424,0.00011940568,0.0036455938,0.17130876],"study_design_scores_gemma":[0.004402836,0.002290589,0.92033917,0.00021450009,0.0005135747,0.005451054,0.00019645662,0.0008619574,0.000012365007,0.000019697276,0.065529376,0.00016840595],"about_ca_topic_score_codex":0.00018292754,"about_ca_topic_score_gemma":0.0007245962,"teacher_disagreement_score":0.5844139,"about_ca_system_score_codex":0.00041831957,"about_ca_system_score_gemma":0.00030307533,"threshold_uncertainty_score":0.5426385},"labels":[],"label_agreement":null},{"id":"W4377157534","doi":"10.1007/s00345-023-04412-0","title":"Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medizinische Universität Wien; European Association of Urology; Universität Wien","keywords":"Medicine; Internal medicine; Oncology; Hazard ratio; Atezolizumab; Pembrolizumab; Renal cell carcinoma; Kidney cancer; Meta-analysis; Metastatic Urothelial Carcinoma; Adjuvant; Cancer; Immunotherapy; Confidence interval; Bladder cancer; Urothelial carcinoma","score_opus":0.07171578300373124,"score_gpt":0.3769055583161595,"score_spread":0.3051897753124283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377157534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007001025,0.99704903,9.357734e-7,0.0009198979,0.000050791685,0.0017212285,0.00009843298,0.0000031363988,0.000086514796],"genre_scores_gemma":[0.0041098692,0.9951336,0.000009329468,0.00034092672,0.00005955989,0.000066525776,0.000005673988,0.00003756321,0.00023698491],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99576825,0.00085549586,0.0026170907,0.00023310244,0.0003173777,0.00020866461],"domain_scores_gemma":[0.9956904,0.0009165701,0.0026671896,0.00044335535,0.00012368718,0.0001587984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017467922,0.00039736766,0.010072835,0.0010509138,0.000021041273,0.0000070111982,0.00019004867,0.00012192233,0.00020938112],"category_scores_gemma":[0.00072067033,0.00018031869,0.0033771666,0.0012243781,0.00015885822,0.000025870644,0.00005603401,0.00058727677,0.0000023726107],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029642344,0.0002770145,0.000106200496,0.59202987,0.40257815,0.0001490345,0.00030441387,0.000008437399,0.0000036985623,0.000022709997,0.00032405058,0.0038999692],"study_design_scores_gemma":[0.0011949285,0.0014462427,0.00015722809,0.0520294,0.94148374,0.00033262637,0.0000120881905,0.0000015172816,0.0000024838844,0.000020133653,0.003182648,0.00013695148],"about_ca_topic_score_codex":0.00031283806,"about_ca_topic_score_gemma":0.00005636672,"teacher_disagreement_score":0.5400005,"about_ca_system_score_codex":0.00016745554,"about_ca_system_score_gemma":0.0007611944,"threshold_uncertainty_score":0.7353183},"labels":[],"label_agreement":null},{"id":"W4377968527","doi":"10.1016/j.eururo.2023.04.034","title":"Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Urological Association; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Family medicine; Urothelial cancer; Gynecology; General surgery; Urology; Internal medicine","score_opus":0.026576535730920017,"score_gpt":0.26940271920859377,"score_spread":0.24282618347767376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377968527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8221016,0.0037715118,0.0000033948759,0.15967685,0.0012620204,0.000753035,0.005839483,0.00015605446,0.006436042],"genre_scores_gemma":[0.6211299,0.00061805506,0.00002333048,0.37360114,0.0015851293,0.00011689568,0.0018496271,0.00012490686,0.0009510582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973075,0.00065005425,0.0003991224,0.00084964576,0.00032453303,0.0004691707],"domain_scores_gemma":[0.99899447,0.00024409842,0.00016361247,0.00041215657,0.00009196942,0.000093685456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001685896,0.00038565916,0.0005939878,0.00009414781,0.000055317374,0.000034214416,0.00013428986,0.00025053823,0.00013945883],"category_scores_gemma":[0.000089816705,0.00028403636,0.000041152325,0.00020927718,0.0003285654,0.000035631572,0.0001124232,0.0006595548,0.00011034675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034220738,0.000048470934,0.14437574,0.000036637128,0.00048092526,0.012609421,0.013245367,0.0000053045856,8.8013314e-7,8.749493e-7,0.82401705,0.0017572682],"study_design_scores_gemma":[0.004996044,0.0019528753,0.44363928,0.00012704331,0.00026258416,0.00008941327,0.0006052105,0.0000038850076,0.0000075523008,0.000010925593,0.54789215,0.00041303172],"about_ca_topic_score_codex":0.017666625,"about_ca_topic_score_gemma":0.0065826382,"teacher_disagreement_score":0.29926354,"about_ca_system_score_codex":0.00011695721,"about_ca_system_score_gemma":0.0002516908,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4377989666","doi":"10.1038/s41585-023-00773-8","title":"Urine biomarkers in bladder cancer — current status and future perspectives","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Bladder cancer; Multiplex; Medicine; Urine; Cancer; Urinary system; Computational biology; Bioinformatics; Biology; Internal medicine","score_opus":0.04815836214438567,"score_gpt":0.4169660643715184,"score_spread":0.3688077022271327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377989666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004816164,0.9935599,4.837885e-7,0.00092658604,0.001525564,0.0032353415,0.00017407963,0.00006977285,0.00050345465],"genre_scores_gemma":[0.000002658191,0.9960564,0.000049601236,0.0003340949,0.001956826,0.0010587854,0.00020086435,0.00012040183,0.0002203655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678755,0.00044678536,0.00082710915,0.0010492259,0.00022460982,0.0006647341],"domain_scores_gemma":[0.998639,0.00012559479,0.00036902475,0.00053361873,0.00007354465,0.00025922622],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032817537,0.0007676033,0.0036742126,0.0005855292,0.000048888483,0.000015457372,0.00016081436,0.001211549,0.00037475367],"category_scores_gemma":[0.00012221663,0.0004995226,0.00057301606,0.0010060424,0.00014073637,0.000046112084,0.00011582162,0.0024697809,0.000111302266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004618912,0.00011898973,0.00023897902,0.020236121,0.00090429647,0.000087723034,0.00015452573,1.3265624e-8,4.9526903e-8,0.0001235982,0.0045373407,0.97355217],"study_design_scores_gemma":[0.00094980415,0.00016754407,0.0005469842,0.006031825,0.0035710728,0.00014061425,0.000029103665,4.4939853e-7,3.430945e-8,0.000034459877,0.9881871,0.00034104445],"about_ca_topic_score_codex":0.00006794033,"about_ca_topic_score_gemma":0.00019171483,"teacher_disagreement_score":0.98364973,"about_ca_system_score_codex":0.00038133565,"about_ca_system_score_gemma":0.00066566025,"threshold_uncertainty_score":0.99983156},"labels":[],"label_agreement":null},{"id":"W4378348371","doi":"10.1159/000530576","title":"Letter to the Editor regarding the Article “Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series”","year":2023,"lang":"en","type":"review","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Series (stratigraphy); General surgery; Urology; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.06591592027976365,"score_gpt":0.37530094902290423,"score_spread":0.30938502874314056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378348371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003169503,0.9752076,0.00006750223,0.01751291,0.001663172,0.004907785,0.0003158279,0.00005998016,0.00023349944],"genre_scores_gemma":[0.00021234853,0.96019703,0.000032662352,0.030803218,0.0027562736,0.0045705447,0.00009804149,0.000045255994,0.0012846383],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959684,0.0016193868,0.0012459211,0.00043279192,0.0004738289,0.0002596462],"domain_scores_gemma":[0.99706775,0.0012831448,0.0005156269,0.0007907642,0.00025933128,0.000083355015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025743751,0.0003721616,0.0021526017,0.000081507074,0.000074619464,0.000027745928,0.000501445,0.00018928056,0.00024078121],"category_scores_gemma":[0.0044532176,0.0001508078,0.0007243072,0.00038868835,0.00016414812,0.000059521888,0.00019419669,0.00050785136,0.00037441618],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012231056,0.000094070194,0.0001284784,0.7651542,0.004460629,0.00018994864,0.00024325417,0.0000028794552,9.42013e-7,0.0005166155,0.22754365,0.0015430474],"study_design_scores_gemma":[0.00021126182,0.00022642974,0.00011125056,0.26822138,0.004302306,0.00009152204,0.000009859681,0.0000070402807,0.0000036598767,0.000056266585,0.7266007,0.00015832414],"about_ca_topic_score_codex":0.000073335876,"about_ca_topic_score_gemma":0.000023405979,"teacher_disagreement_score":0.49905705,"about_ca_system_score_codex":0.00020365544,"about_ca_system_score_gemma":0.00018024126,"threshold_uncertainty_score":0.6149764},"labels":[],"label_agreement":null},{"id":"W4378619903","doi":"10.1186/s12957-023-03046-1","title":"Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes","year":2023,"lang":"en","type":"review","venue":"World Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perioperative; Meta-analysis; Urology; Odds ratio; Observational study; Confidence interval; Urothelial carcinoma; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.09832683596214341,"score_gpt":0.4250351814372282,"score_spread":0.32670834547508476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378619903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009725252,0.98499364,0.0000026327043,0.00061526586,0.00040067956,0.0034653381,0.00043568216,0.000012038024,0.00034945126],"genre_scores_gemma":[0.023103368,0.97546256,0.0003416721,0.00011305203,0.00012825947,0.00025836195,0.00004671026,0.000048324877,0.00049770257],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.994908,0.0009744389,0.0029217345,0.00042643078,0.0004195881,0.00034980392],"domain_scores_gemma":[0.9938981,0.0031124782,0.0020329296,0.0002803989,0.000392466,0.000283662],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00081754284,0.00064514775,0.016647521,0.0009622385,0.00007706801,0.000014940022,0.00022351524,0.00033523623,0.00010885082],"category_scores_gemma":[0.00011380625,0.000370825,0.00221407,0.0009222742,0.0004552497,0.000088724184,0.000058862242,0.00063925626,0.0000015583284],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061548245,0.0035605382,0.009164553,0.88444954,0.08351912,0.0022551294,0.0018654636,0.0000021799162,0.000006810638,0.00023911273,0.00015717083,0.00862553],"study_design_scores_gemma":[0.033027355,0.03361488,0.010456214,0.122044265,0.65973747,0.002664428,0.00064479973,0.000017824104,0.000008859644,0.000009360839,0.13683932,0.00093521335],"about_ca_topic_score_codex":0.000039591305,"about_ca_topic_score_gemma":0.000048904276,"teacher_disagreement_score":0.7624053,"about_ca_system_score_codex":0.000391594,"about_ca_system_score_gemma":0.00093052746,"threshold_uncertainty_score":0.99987435},"labels":[],"label_agreement":null},{"id":"W4378640363","doi":"10.1097/pas.0000000000002059","title":"International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Grading (engineering); Medicine; Bladder cancer; Urothelial carcinoma; Urine cytology; Consensus conference; Gynecology; Urology; Cancer; Internal medicine","score_opus":0.06552173909723191,"score_gpt":0.36864303779267826,"score_spread":0.30312129869544635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378640363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97411394,0.0008789716,0.000025867239,0.023438789,0.0005522728,0.00012989815,0.000019071564,0.000017590224,0.00082357245],"genre_scores_gemma":[0.98808855,0.010610623,0.00021195025,0.00062587246,0.0003743101,0.000013401017,0.000005812829,0.0000130512335,0.00005644285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982568,0.00033345437,0.0005685362,0.00021571958,0.0003200535,0.0003054282],"domain_scores_gemma":[0.99867684,0.00042857954,0.00048803588,0.0001679481,0.00014307414,0.00009551203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006545281,0.00016527498,0.0007354916,0.00014464917,0.000037550373,0.00000629856,0.00023598968,0.00006799322,0.00017072207],"category_scores_gemma":[0.00005044895,0.00009865061,0.00025430977,0.00039309813,0.0010161423,0.00001725358,0.00007937214,0.0006209516,0.000013245856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017900208,0.002426516,0.42031765,0.000060591577,0.00091786805,0.015458471,0.0056159263,0.0005086033,0.014849399,0.003150278,0.011340729,0.50745374],"study_design_scores_gemma":[0.016965467,0.015022505,0.8663655,0.0007550541,0.0005225324,0.012018746,0.004299566,0.0010572175,0.0009466639,0.0053637,0.0760802,0.0006028504],"about_ca_topic_score_codex":0.000035169127,"about_ca_topic_score_gemma":0.0000035651776,"teacher_disagreement_score":0.5068509,"about_ca_system_score_codex":0.000075565586,"about_ca_system_score_gemma":0.000117585085,"threshold_uncertainty_score":0.40228552},"labels":[],"label_agreement":null},{"id":"W4378650540","doi":"10.1016/j.eururo.2023.05.011","title":"Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; Metastatic Urothelial Carcinoma; Nivolumab; Cystectomy; Oncology; Internal medicine; Pembrolizumab; Bladder cancer; Clinical endpoint; Clinical trial; Cancer; Immunotherapy; Urothelial carcinoma","score_opus":0.04715193843860762,"score_gpt":0.3220179099081214,"score_spread":0.2748659714695138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378650540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034150959,0.98733133,0.0000028460277,0.0002835484,0.001224103,0.0009818402,0.000046759524,0.00019807671,0.009589979],"genre_scores_gemma":[0.00070471066,0.9949835,0.000023356475,0.00017975624,0.0017158444,0.00008782354,0.00010312133,0.00019177671,0.0020101094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976878,0.00060486124,0.000576449,0.00064388936,0.00012500778,0.000361953],"domain_scores_gemma":[0.99933636,0.00007515541,0.00015561879,0.00025457807,0.000032495238,0.00014577614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031083974,0.00041805246,0.0010819874,0.0005823057,0.000081238686,0.000018556648,0.00008392441,0.00025642608,0.000084028914],"category_scores_gemma":[0.000064270134,0.00033568733,0.0002719381,0.0006466196,0.000092826784,0.000031917603,0.00009773731,0.00061530893,0.0004683888],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009829965,0.00013154789,0.001275796,0.0028021073,0.0003244991,0.0006614899,0.00020200398,1.15395096e-7,0.000006732306,0.000016282407,0.0022703852,0.99221075],"study_design_scores_gemma":[0.0009628057,0.00037333902,0.008995311,0.00062494166,0.0009306304,0.0007940284,0.000010273286,0.0000023619211,0.000001140313,0.0000077850445,0.9870754,0.00022199386],"about_ca_topic_score_codex":0.00011676665,"about_ca_topic_score_gemma":0.00011997324,"teacher_disagreement_score":0.9919887,"about_ca_system_score_codex":0.00014569159,"about_ca_system_score_gemma":0.00021818143,"threshold_uncertainty_score":0.9999095},"labels":[],"label_agreement":null},{"id":"W4378906038","doi":"10.5489/cuaj.8231","title":"Real-life benchmarking bladder cancer care","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Institute for Clinical Evaluative Sciences","keywords":"Benchmarking; Benchmark (surveying); Bladder cancer; Population; Medicine; Cystectomy; Cohort; Health care; Medical physics; Cancer; Emergency medicine; Internal medicine; Business","score_opus":0.021849799791003075,"score_gpt":0.2823876694832682,"score_spread":0.2605378696922651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378906038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9425437,0.00079730706,0.000009347264,0.0341843,0.0013483112,0.0002787582,0.00014202553,0.0001293469,0.020566916],"genre_scores_gemma":[0.98986375,0.0010298286,0.000042258514,0.0058422033,0.0016394112,0.000026400769,0.000059414135,0.000019050833,0.0014776915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853027,0.00007961644,0.000242206,0.00019326874,0.00037828888,0.0005763574],"domain_scores_gemma":[0.99844533,0.00006445283,0.00012925336,0.000092612376,0.00026814162,0.0010002063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023713356,0.00013330698,0.00023934989,0.00020702877,0.0003493055,0.00006697084,0.00008346593,0.00022131241,0.002430649],"category_scores_gemma":[0.00022084922,0.000107410444,0.00014268489,0.00039897638,0.000018761539,0.00006516649,0.000012544386,0.0004243893,0.00022045974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003462773,0.000012456659,0.9301298,0.0000064989595,0.0002552805,0.00022335995,0.000520023,0.000070247144,0.00005023291,0.00006907916,0.06078727,0.007841119],"study_design_scores_gemma":[0.0010254699,0.00019844313,0.9163118,0.00001598604,0.00014511912,0.00003683302,0.00030777042,0.00009287734,0.000013804479,0.0001383339,0.08159646,0.000117094634],"about_ca_topic_score_codex":0.00798474,"about_ca_topic_score_gemma":0.0035032218,"teacher_disagreement_score":0.047320053,"about_ca_system_score_codex":0.001768071,"about_ca_system_score_gemma":0.0015101478,"threshold_uncertainty_score":0.99862117},"labels":[],"label_agreement":null},{"id":"W4378908108","doi":"10.4081/aiua.2023.11380","title":"History of infantile BCG immunization did not predict lamina propria invasion and/or high-grade in patients with non-muscle invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern Ontario Academic Medicine Association; Lakehead University; NOSM University","funders":"","keywords":"Medicine; Bladder cancer; Vaccination; Stage (stratigraphy); Lamina propria; Demographics; Internal medicine; Medical history; BCG vaccine; Cancer; Pathology","score_opus":0.01453788238458293,"score_gpt":0.23365903787539669,"score_spread":0.21912115549081376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378908108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971735,0.00014735149,0.000013802898,0.00037319912,0.00024853405,0.0012586412,0.00015415954,0.000110297515,0.0005205557],"genre_scores_gemma":[0.99715984,0.000555056,0.00013562152,0.00053460756,0.00004415447,0.00024759024,0.00037661727,0.000050565875,0.00089591986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802953,0.000115337774,0.0004408695,0.0005596139,0.00037487398,0.00047980418],"domain_scores_gemma":[0.99895066,0.00016510804,0.00021831854,0.00043415694,0.000104986735,0.00012675821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016979592,0.00032631753,0.00058179203,0.0003575278,0.000062057785,0.000010263059,0.00017695643,0.00018485113,0.0001119661],"category_scores_gemma":[0.00013760377,0.00022378025,0.00006468411,0.00046476396,0.00036791866,0.0001941903,0.0001766955,0.00029496572,0.000017307942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032964614,0.00055539294,0.98612094,0.00016877275,0.00016703607,0.000100419544,0.0013143041,0.00006089539,0.003285225,0.000022133876,0.0015715428,0.003336891],"study_design_scores_gemma":[0.006626525,0.0048627723,0.98558027,0.00016937342,0.00020200582,0.0000061731853,0.00004955815,0.00016147901,0.0018076812,0.00006549571,0.00024021826,0.00022844518],"about_ca_topic_score_codex":0.0010118017,"about_ca_topic_score_gemma":0.00042900816,"teacher_disagreement_score":0.0043073795,"about_ca_system_score_codex":0.00016029227,"about_ca_system_score_gemma":0.00048434798,"threshold_uncertainty_score":0.9125494},"labels":[],"label_agreement":null},{"id":"W4379012313","doi":"10.1158/1538-7755.asgcr23-abstract-96","title":"Abstract 96: When Canada is a Under-Resourced Country: Patient-Oriented Research on Optimizing Rational Decision-Making for Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Psychological intervention; Medicine; Bladder cancer; Citation; Quality (philosophy); Cancer; Family medicine; Intensive care medicine; Nursing; Political science; Internal medicine","score_opus":0.1273503175271964,"score_gpt":0.4480561198583872,"score_spread":0.32070580233119084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379012313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8907827,0.014131925,0.009447462,0.06671946,0.006441563,0.007846182,0.0023955044,0.00043598478,0.0017991854],"genre_scores_gemma":[0.97338635,0.0012479329,0.0059724813,0.011609154,0.0008280697,0.0036573634,0.0011307361,0.00014178154,0.0020261533],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99642736,0.00034335526,0.00079951296,0.00089586055,0.0006008519,0.0009330636],"domain_scores_gemma":[0.9958219,0.0027565204,0.00032147337,0.00042460268,0.00043269934,0.00024280777],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016447204,0.00032550632,0.0006103112,0.00036530694,0.0005039778,0.000017439634,0.00016465389,0.00029341015,0.0011333762],"category_scores_gemma":[0.00075470627,0.000288031,0.00022366585,0.00060925254,0.00017410242,0.000105512765,0.00007181976,0.00035836454,0.00002309408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063167117,0.00020609707,0.03362436,0.00020047656,0.0024925533,0.00003511993,0.0004758495,0.0030759687,0.0006656434,0.00042488388,0.84613985,0.10634248],"study_design_scores_gemma":[0.0183642,0.0028263193,0.51426643,0.009136459,0.0014463788,0.000035061043,0.003895681,0.0206795,0.0022549753,0.040954255,0.3844136,0.0017271201],"about_ca_topic_score_codex":0.09126719,"about_ca_topic_score_gemma":0.10428262,"teacher_disagreement_score":0.48064208,"about_ca_system_score_codex":0.0018545269,"about_ca_system_score_gemma":0.0022459335,"threshold_uncertainty_score":0.9999572},"labels":[],"label_agreement":null},{"id":"W4379179328","doi":"10.1016/j.euros.2023.05.006","title":"Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science for Life Laboratory; University Hospital Foundation; Vetenskapsrådet; Gunnar Nilssons Cancerstiftelse; Kungliga Fysiografiska Sällskapet i Lund; Lunds Universitet; Cancerfonden; Skåne County Council's Research and Development Foundation","keywords":"Cystoscopy; Medicine; Biopsy; Bladder cancer; Radiology; Magnetic resonance imaging; Cancer; Pathology; Urinary system; Internal medicine","score_opus":0.053687596495965086,"score_gpt":0.35509103217189897,"score_spread":0.30140343567593386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379179328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715237,0.000081729784,0.0059328554,0.00958236,0.00039482475,0.0021564863,0.000052515843,0.00015288584,0.010122641],"genre_scores_gemma":[0.9938091,0.00005390448,0.003603244,0.0014961517,0.00018742755,0.00022032303,0.00000601237,0.000045327677,0.0005784911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781173,0.00019089645,0.00027445788,0.0008134104,0.00041268553,0.00049680704],"domain_scores_gemma":[0.9989224,0.00013728348,0.00009814445,0.0004726306,0.00016066708,0.00020886351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011474383,0.00020616976,0.00023824885,0.00026619204,0.00074196147,0.00016542303,0.0006311111,0.00004981018,0.00010321628],"category_scores_gemma":[0.00044488275,0.00015210139,0.000042591506,0.0012266546,0.0005021443,0.0003565393,0.00046532648,0.00032896327,0.00005521284],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036166832,0.00007198777,0.020730857,0.000024987614,0.00009181703,0.00017237086,0.002446352,0.00017685477,0.973953,0.0001852902,0.00024722997,0.0015375629],"study_design_scores_gemma":[0.0029180408,0.0009067922,0.94472,0.00009037914,0.000126232,0.00043019417,0.00033860814,0.00022460688,0.046084534,0.000114390714,0.0037845243,0.00026171136],"about_ca_topic_score_codex":0.0010043525,"about_ca_topic_score_gemma":0.00017254101,"teacher_disagreement_score":0.9278685,"about_ca_system_score_codex":0.00011745888,"about_ca_system_score_gemma":0.00033499912,"threshold_uncertainty_score":0.6202514},"labels":[],"label_agreement":null},{"id":"W4379282903","doi":"10.1200/jco.2023.41.16_suppl.4516","title":"Long-term safety of avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC) in the JAVELIN Bladder 100 trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Avelumab; Medicine; Discontinuation; Internal medicine; Metastatic Urothelial Carcinoma; Adverse effect; Oncology; Surgery; Bladder cancer; Urothelial carcinoma; Immunotherapy; Nivolumab; Cancer","score_opus":0.14046921801371734,"score_gpt":0.4619004423937132,"score_spread":0.32143122437999583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379282903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97356194,0.000430634,0.00066011626,0.019455057,0.0027442588,0.0018738982,0.00006658898,0.000014767635,0.001192757],"genre_scores_gemma":[0.9917666,0.0018500732,0.00084451155,0.0022278985,0.0022338647,0.000068749156,0.000014300848,0.000035448393,0.0009585591],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9952475,0.00039785393,0.003182294,0.0002816651,0.00047505606,0.00041566906],"domain_scores_gemma":[0.9932518,0.0042110435,0.001506871,0.00035586464,0.0004704388,0.00020397117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041784393,0.00021706558,0.0018096867,0.0001927674,0.00006185331,0.0000069594234,0.00036759328,0.00037236954,0.0001501251],"category_scores_gemma":[0.0040566367,0.00012861355,0.00085676863,0.00036447385,0.00024475498,0.00008965,0.000052696407,0.00077406864,0.000022479991],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5809984,0.006824144,0.08632373,0.0002702241,0.0010759424,0.0018748353,0.0010363404,0.00018496478,0.00022917085,0.00026784927,0.010746233,0.31016815],"study_design_scores_gemma":[0.34143135,0.051548757,0.5640695,0.0003445772,0.000847176,0.00028633693,0.0002748076,0.0001769239,0.00024882975,0.0010859886,0.039477646,0.00020811094],"about_ca_topic_score_codex":0.000036219044,"about_ca_topic_score_gemma":0.00026357043,"teacher_disagreement_score":0.47774577,"about_ca_system_score_codex":0.00018069557,"about_ca_system_score_gemma":0.0018136818,"threshold_uncertainty_score":0.5244708},"labels":[],"label_agreement":null},{"id":"W4379330364","doi":"10.1200/jco.2023.41.16_suppl.e16566","title":"AI-based pathologic biomarker for pathologic downstaging in patients with muscle-invasive bladder cancer undergoing cystectomy after neoadjuvant nivolumab, gemcitabine, and cisplatin: BLAAST-1 Trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Gemcitabine; Cystectomy; Bladder cancer; Biomarker; Nivolumab; Neoadjuvant therapy; Cisplatin; Cancer; Oncology; Urology; Internal medicine; Radiology; Pathology; Chemotherapy; Immunotherapy; Breast cancer","score_opus":0.07790973581627869,"score_gpt":0.4174531822234907,"score_spread":0.339543446407212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379330364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202657,0.00040430663,0.0002853102,0.0045783627,0.0010013704,0.0014340279,0.000052420895,0.000031195075,0.000186463],"genre_scores_gemma":[0.99291694,0.0003265238,0.0018033214,0.004200238,0.00040417266,0.00019470092,0.000016650822,0.000043557524,0.00009386432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963836,0.0004187056,0.0018429058,0.00045532477,0.0004008815,0.00049856375],"domain_scores_gemma":[0.99508584,0.0027915377,0.0011073552,0.00022288902,0.0004908466,0.0003015196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018020095,0.0002973172,0.0016128046,0.00038527424,0.00007038201,0.000022420036,0.00012104409,0.00042111054,0.00009635908],"category_scores_gemma":[0.001734477,0.00018820124,0.0003539942,0.0003973992,0.00024973226,0.0001586245,0.00005857553,0.0006501305,0.000006634409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13917032,0.0019237567,0.75846046,0.00017428384,0.00045152556,0.003634579,0.00020242689,0.000094729425,0.00005905992,0.0000045356855,0.0010455345,0.09477879],"study_design_scores_gemma":[0.20295489,0.025603512,0.76842123,0.0004117346,0.00061874755,0.000046410936,0.000168652,0.00018260504,0.000016534508,0.0001795582,0.001196177,0.0001999419],"about_ca_topic_score_codex":0.000025358147,"about_ca_topic_score_gemma":0.00032553833,"teacher_disagreement_score":0.09457885,"about_ca_system_score_codex":0.00024225657,"about_ca_system_score_gemma":0.0019447397,"threshold_uncertainty_score":0.7674624},"labels":[],"label_agreement":null},{"id":"W4379333019","doi":"10.1200/jco.2023.41.16_suppl.4568","title":"Enfortumab vedotin (EV) with or without pembrolizumab (P) in patients (pts) who are cisplatin-ineligible with previously untreated locally advanced or metastatic urothelial cancer (la/mUC): Additional 3-month follow-up on cohort K data.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Seagen","keywords":"Medicine; Internal medicine; Clinical endpoint; Cohort; Pembrolizumab; Oncology; Cancer; Cisplatin; Urology; Progression-free survival; Chemotherapy; Randomized controlled trial; Immunotherapy","score_opus":0.10170508381080158,"score_gpt":0.4359688664735234,"score_spread":0.33426378266272183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379333019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165183,0.00009834052,0.00010693207,0.001310226,0.00073697703,0.0022094408,0.0015839328,0.00007058528,0.0022317225],"genre_scores_gemma":[0.9894386,0.0010538124,0.0020781723,0.0019120419,0.00061701244,0.00032558283,0.00059348234,0.00012743085,0.0038538906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946553,0.0005461263,0.0022928258,0.0006711492,0.0012172859,0.00061731046],"domain_scores_gemma":[0.9933861,0.0027338576,0.0019808593,0.0005728024,0.0007508244,0.0005755645],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012871573,0.00047462535,0.0027995394,0.00035312423,0.00009187222,0.000030224115,0.00042113467,0.00028902898,0.001872589],"category_scores_gemma":[0.0025170078,0.00025031433,0.00021299049,0.00075899414,0.00029178333,0.00034566416,0.00008061461,0.0011211812,0.00005096149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3260014,0.0034628026,0.5742044,0.00015212833,0.002277914,0.003957394,0.00015525974,0.0005902223,0.0000027232236,0.000014131309,0.023012504,0.0661691],"study_design_scores_gemma":[0.16992892,0.0773772,0.7108776,0.003953288,0.0028424596,0.00048296788,0.00021883889,0.0008464629,0.000046003275,0.000050970702,0.032860022,0.0005152425],"about_ca_topic_score_codex":0.00024463038,"about_ca_topic_score_gemma":0.0053235744,"teacher_disagreement_score":0.15607248,"about_ca_system_score_codex":0.00052759075,"about_ca_system_score_gemma":0.0093204705,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W4379333379","doi":"10.1200/jco.2023.41.16_suppl.4523","title":"Prognostic significance of pretreatment immune cell infiltration in muscle invasive bladder cancer treated with definitive chemoradiation: Analysis of NRG RTOG 0524 and 0712.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Immune system; Bladder cancer; Medicine; Tumor microenvironment; CD8; Cancer research; Oncology; Cancer; Internal medicine; Immunology","score_opus":0.08197830074176479,"score_gpt":0.4020741608459205,"score_spread":0.3200958601041557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379333379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969026,0.0008991129,0.000026029089,0.0006559741,0.000077978024,0.00044508756,0.000040628383,0.0000057280413,0.00094688585],"genre_scores_gemma":[0.9960627,0.0031514608,0.00042713818,0.00011824616,0.00008254964,0.0000382273,0.00002153045,0.0000121395215,0.00008603352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976367,0.0002251248,0.0015112311,0.00019055855,0.0002830556,0.0001533285],"domain_scores_gemma":[0.9960681,0.0016777576,0.0015029237,0.00012852374,0.00049066776,0.00013202924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006299723,0.00013731724,0.0014575045,0.0003790713,0.000017477447,0.0000036404615,0.000058156056,0.00017923566,0.00008898112],"category_scores_gemma":[0.00059804576,0.00009372037,0.00022711608,0.0010758339,0.0001958168,0.00008711624,0.000015413092,0.00025028418,0.0000014973932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035828475,0.0017035126,0.9709723,0.00008745988,0.0032274802,0.00022581662,0.00082176155,0.0007308684,0.002006741,0.000007833984,0.000055144163,0.01657826],"study_design_scores_gemma":[0.0094716,0.011325827,0.9656761,0.00017907553,0.0052517885,0.000009424843,0.00042419008,0.00024825567,0.007251187,0.000037380687,0.000052615196,0.00007254158],"about_ca_topic_score_codex":0.0005537677,"about_ca_topic_score_gemma":0.0007723244,"teacher_disagreement_score":0.01650572,"about_ca_system_score_codex":0.00015081126,"about_ca_system_score_gemma":0.0015781799,"threshold_uncertainty_score":0.38218057},"labels":[],"label_agreement":null},{"id":"W4379335699","doi":"10.1200/jco.2023.41.16_suppl.tps4609","title":"MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Avelumab; Chemotherapy; Internal medicine; Oncology; Maintenance therapy; Cabozantinib; Cancer; Surgery; Immunotherapy; Pembrolizumab","score_opus":0.07253974970556581,"score_gpt":0.43133282188382527,"score_spread":0.35879307217825945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379335699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917005,0.00022913195,0.0002023807,0.0034192926,0.0014792666,0.0025666538,0.000101663594,0.000014625079,0.00028648728],"genre_scores_gemma":[0.9935957,0.002274979,0.0015345735,0.0012709148,0.00060240825,0.00030460957,0.000011462423,0.00005411328,0.0003512049],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99478585,0.000557129,0.0031273228,0.00039147478,0.0006792377,0.00045901485],"domain_scores_gemma":[0.9933767,0.0034329079,0.0021498203,0.0002725948,0.00043715537,0.00033085514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027268017,0.00033834262,0.0035654027,0.00020859209,0.000041548596,0.000011611937,0.00017046912,0.00026203346,0.00040359484],"category_scores_gemma":[0.001978907,0.00021848001,0.00052411074,0.0003832621,0.0005356029,0.000115701936,0.000031251337,0.00070997805,0.0000075148605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95407325,0.0055560316,0.0043322155,0.000081825325,0.0009489878,0.00050845597,0.00022003801,0.00006665964,0.0000058496175,0.000007779718,0.0005042996,0.033694636],"study_design_scores_gemma":[0.9428878,0.042670965,0.009124953,0.0004669133,0.0010010053,0.000013250968,0.000042566557,0.00056732324,0.000084296385,0.000066675675,0.0028873298,0.00018695873],"about_ca_topic_score_codex":0.0001647633,"about_ca_topic_score_gemma":0.00053048634,"teacher_disagreement_score":0.037114933,"about_ca_system_score_codex":0.00021885161,"about_ca_system_score_gemma":0.0023582254,"threshold_uncertainty_score":0.8909356},"labels":[],"label_agreement":null},{"id":"W4379336470","doi":"10.1200/jco.2023.41.16_suppl.4511","title":"Fibroblast growth factor receptor 3 (<i>FGFR3</i>) alterations in PROOF 302: A phase III trial of infigratinib (BGJ398) as adjuvant therapy in patients (pts) with invasive urothelial carcinoma (UC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical endpoint; Tolerability; Internal medicine; Placebo; Oncology; Metastatic Urothelial Carcinoma; Adjuvant therapy; Cancer; Randomized controlled trial; Surgery; Adverse effect; Bladder cancer; Urothelial carcinoma; Pathology","score_opus":0.08624236105440229,"score_gpt":0.4171832021538532,"score_spread":0.3309408410994509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379336470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995073,0.000048179223,0.000011918553,0.0017027648,0.0006561473,0.0017789467,0.000086399625,0.00001086605,0.0006317641],"genre_scores_gemma":[0.9975482,0.0003139703,0.000304874,0.0007616592,0.0007755805,0.00007467957,0.00003503895,0.000034988458,0.00015098738],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99521613,0.00060782244,0.0028963077,0.00030830252,0.00059945765,0.00037199986],"domain_scores_gemma":[0.99615794,0.0011749212,0.0015438374,0.00022190866,0.0005849419,0.00031642962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009820366,0.00025848363,0.0018667356,0.00045266474,0.00003940476,0.0000114936565,0.0001930117,0.000338297,0.00030021946],"category_scores_gemma":[0.0020029647,0.00017047898,0.00035431664,0.0005905024,0.00019548507,0.00020758311,0.00004135097,0.0008413619,0.000021266676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5996459,0.019783791,0.31232977,0.00007774058,0.0005656256,0.00054797373,0.0031449827,0.00002307655,0.0015759616,0.000038534905,0.0021533456,0.060113266],"study_design_scores_gemma":[0.5572351,0.19243667,0.24401557,0.00048649308,0.00011108198,0.000026312202,0.00025885116,0.000020292653,0.0039072377,0.0001628079,0.0011548074,0.00018474847],"about_ca_topic_score_codex":0.0003050907,"about_ca_topic_score_gemma":0.00067136355,"teacher_disagreement_score":0.17265287,"about_ca_system_score_codex":0.00022332695,"about_ca_system_score_gemma":0.004215425,"threshold_uncertainty_score":0.74779826},"labels":[],"label_agreement":null},{"id":"W4379336690","doi":"10.1200/jco.2023.41.16_suppl.4596","title":"A first-in-human trial of intravesical enfortumab vedotin (EV), an antibody-drug conjugate (ADC), in patients with non-muscle invasive bladder cancer (NMIBC): Interim results of a phase 1 study (EV-104).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Urology; Tolerability; Internal medicine; Interim analysis; Oncology; Adverse effect; Cancer; Clinical trial","score_opus":0.0865494763517485,"score_gpt":0.4815242672372223,"score_spread":0.3949747908854738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379336690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645513,0.00002473908,0.000003931203,0.0006918311,0.0008255057,0.0016178197,0.000078364035,0.000008921702,0.00029372994],"genre_scores_gemma":[0.9988325,0.00020292336,0.00009801498,0.00020858434,0.00051266566,0.00003130903,0.00003312876,0.000034626642,0.000046211964],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9938413,0.00057680305,0.0041378373,0.00039381126,0.000666859,0.00038341805],"domain_scores_gemma":[0.99521583,0.0011763811,0.0023800617,0.0003546561,0.00052093755,0.00035214168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026144374,0.0002693433,0.002511943,0.0004593681,0.000033666955,0.000008185891,0.00028074702,0.0002713078,0.00008930587],"category_scores_gemma":[0.0014021691,0.00018759527,0.00030393084,0.00049791654,0.00032604,0.00020790058,0.00006439883,0.00095341966,0.0000037404154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49545783,0.05559169,0.42159444,0.0001216638,0.0010560303,0.0013997214,0.005228096,0.00011171312,0.00058240874,0.0000061177466,0.00069593854,0.018154372],"study_design_scores_gemma":[0.33643243,0.12741674,0.53392434,0.00045711754,0.00038545186,0.0000055936957,0.0007036357,0.00006366622,0.0003063678,0.000038942057,0.00015306128,0.00011264643],"about_ca_topic_score_codex":0.0013184515,"about_ca_topic_score_gemma":0.0048068915,"teacher_disagreement_score":0.15902539,"about_ca_system_score_codex":0.00024706085,"about_ca_system_score_gemma":0.0025224085,"threshold_uncertainty_score":0.76499134},"labels":[],"label_agreement":null},{"id":"W4379337291","doi":"10.1200/jco.2023.41.16_suppl.4508","title":"SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"National Institutes of Health","keywords":"Medicine; Cystectomy; Bladder cancer; Lymphadenectomy; Surgery; Randomized controlled trial; Hazard ratio; Urothelial cancer; Urology; Cancer; Internal medicine; Confidence interval","score_opus":0.16550752834126867,"score_gpt":0.5093724658990231,"score_spread":0.3438649375577544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379337291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162996,0.00027193874,0.00002668551,0.0034960583,0.001962379,0.0019264979,0.00024201762,0.000018229273,0.00042623893],"genre_scores_gemma":[0.99523395,0.00055208703,0.00037997554,0.0004140686,0.002745615,0.00016336709,0.000017995626,0.000044065473,0.0004488631],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947937,0.00055564527,0.002848372,0.0003473139,0.0010102415,0.000444724],"domain_scores_gemma":[0.9912324,0.005566376,0.0012824836,0.00035825607,0.00090327486,0.0006572079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042564343,0.0002535903,0.0025300193,0.00020932317,0.00010662623,0.0000080679365,0.000370158,0.00039938444,0.00087309413],"category_scores_gemma":[0.0032358065,0.00015265345,0.0010713328,0.00038764282,0.00041524446,0.00009683135,0.00011057297,0.000407392,0.000017851235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9000761,0.0025410715,0.00039316915,0.000066881126,0.001490547,0.00032905763,0.0006591506,0.000058304875,0.0025903867,0.000037002337,0.0030830011,0.08867532],"study_design_scores_gemma":[0.75641334,0.18905985,0.005326085,0.00022400482,0.0026576878,0.00016354007,0.0002505212,0.0004179053,0.005820293,0.00020021184,0.03927012,0.0001964323],"about_ca_topic_score_codex":0.00009920283,"about_ca_topic_score_gemma":0.00017985865,"teacher_disagreement_score":0.18651879,"about_ca_system_score_codex":0.00051601045,"about_ca_system_score_gemma":0.005728958,"threshold_uncertainty_score":0.9999076},"labels":[],"label_agreement":null},{"id":"W4379337628","doi":"10.1200/jco.2023.41.16_suppl.4569","title":"Final results from SAUL, a single-arm international real-world study of atezolizumab (atezo) in 1004 patients (pts) with pretreated locally advanced/metastatic urinary tract carcinoma (UTC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Atezolizumab; Discontinuation; Clinical endpoint; Internal medicine; Metastatic Urothelial Carcinoma; Adverse effect; Urology; Population; Oncology; Clinical trial; Surgery; Immunotherapy; Gastroenterology; Cancer; Urothelial carcinoma; Bladder cancer; Nivolumab","score_opus":0.1421393444483367,"score_gpt":0.43814280452401,"score_spread":0.2960034600756733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379337628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932397,0.000049900023,0.0000068250356,0.00083806267,0.0007552455,0.00063426065,0.00012267029,0.00001945738,0.0043339],"genre_scores_gemma":[0.9981303,0.000243933,0.0006772652,0.00016625808,0.00023595312,0.000015548929,0.000089566296,0.00003399941,0.0004071549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950001,0.00047390704,0.0030436164,0.0003914056,0.0007889554,0.00030201316],"domain_scores_gemma":[0.9951395,0.0017629833,0.0019195133,0.00027789525,0.0006187202,0.00028141864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000933443,0.00024774674,0.0016121014,0.00048452147,0.000030293242,0.000009263936,0.00025820074,0.00015358161,0.00011000775],"category_scores_gemma":[0.0011406317,0.0001727245,0.00024434275,0.00057410996,0.00014163087,0.00018755667,0.00007275893,0.00077374687,0.000020206642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07850079,0.04895038,0.76662517,0.000025497717,0.000833402,0.007077291,0.0009271834,0.00031073444,0.000020345811,0.0000018446983,0.00047965502,0.096247725],"study_design_scores_gemma":[0.074213974,0.12018426,0.8030378,0.00032212818,0.0004900979,0.00008318351,0.00043582523,0.000121740006,0.000038409813,0.00009763422,0.0008613682,0.000113544105],"about_ca_topic_score_codex":0.0010471242,"about_ca_topic_score_gemma":0.0012811464,"teacher_disagreement_score":0.096134186,"about_ca_system_score_codex":0.00049312494,"about_ca_system_score_gemma":0.0013706313,"threshold_uncertainty_score":0.70435005},"labels":[],"label_agreement":null},{"id":"W4379768908","doi":"10.1097/pas.0000000000002066","title":"International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Consensus conference; Pathology; Bladder cancer; Anatomical pathology; Urology; Cancer; Internal medicine","score_opus":0.05694653366573402,"score_gpt":0.3778311581451081,"score_spread":0.32088462447937405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96300876,0.00065990794,0.000013870811,0.034867153,0.00045344824,0.000119136916,0.00003439153,0.000014221701,0.0008291008],"genre_scores_gemma":[0.9883586,0.010330445,0.00014139866,0.0007331287,0.00029881165,0.000012312129,0.0000048953775,0.000011445953,0.00010895733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841946,0.00029128086,0.0005247448,0.00019164526,0.00030210573,0.00027078827],"domain_scores_gemma":[0.9987733,0.00034600674,0.00042110312,0.00016460322,0.0002023958,0.00009260215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005383533,0.0001507265,0.00069449784,0.0001344231,0.000028698661,0.000004583677,0.0002113023,0.00006212426,0.00025957217],"category_scores_gemma":[0.000054169373,0.000086842054,0.00024210344,0.0003303379,0.0010531459,0.000017173916,0.00006674835,0.00053836073,0.000020605077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026333425,0.0038346278,0.4191153,0.000099537436,0.0013991366,0.022497945,0.008678719,0.0008598462,0.024721745,0.003495191,0.03774899,0.45121554],"study_design_scores_gemma":[0.016910689,0.015450937,0.8620731,0.00043216115,0.0005088737,0.012603975,0.0036852374,0.0009123967,0.0020588073,0.0051775957,0.07964422,0.00054197834],"about_ca_topic_score_codex":0.00003506843,"about_ca_topic_score_gemma":0.0000022897768,"teacher_disagreement_score":0.45067355,"about_ca_system_score_codex":0.00006233223,"about_ca_system_score_gemma":0.00016593197,"threshold_uncertainty_score":0.38803598},"labels":[],"label_agreement":null},{"id":"W4380433888","doi":"10.3390/cancers15123167","title":"Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; University of Alberta; University of Calgary","funders":"Cumming School of Medicine, University of Calgary","keywords":"Missense mutation; Fibroblast growth factor receptor; Cancer research; Mutation; Exome sequencing; Biology; Fibroblast growth factor receptor 3; Molecular biology; Fibroblast growth factor receptor 1; Gene; Genetics; Fibroblast growth factor; Receptor","score_opus":0.019256258658494514,"score_gpt":0.26924086242707795,"score_spread":0.24998460376858345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380433888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582016,0.00004892571,0.00035743203,0.00023634825,0.0001099712,0.0006840135,0.00041949793,0.000089592075,0.002234037],"genre_scores_gemma":[0.9976508,0.000011448865,0.00046346695,0.00017483944,0.0000907757,0.0001949312,0.00011818287,0.0000594264,0.0012361498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987337,0.000042923835,0.00028576094,0.00030959462,0.00026337002,0.00036462917],"domain_scores_gemma":[0.99933183,0.00007086143,0.0001355147,0.00020239929,0.00013994912,0.00011943061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006758055,0.0001923413,0.00032490186,0.00025174976,0.00009346428,0.00001428525,0.00007605755,0.000082784434,0.0007443469],"category_scores_gemma":[0.0000596094,0.00016239,0.00006893257,0.0011373416,0.000091393325,0.00016598431,0.000017885854,0.00015564755,0.000028818014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007638075,0.00020335618,0.9135958,0.0004627026,0.0005723444,0.0001085239,0.0296882,0.0019070352,0.049921617,0.00030841702,0.0017793376,0.0006888909],"study_design_scores_gemma":[0.010315815,0.0007384405,0.9252255,0.00045191517,0.00017891322,0.000011946465,0.0056917802,0.002650212,0.05319699,0.00017075399,0.000929716,0.0004380064],"about_ca_topic_score_codex":0.0046795793,"about_ca_topic_score_gemma":0.0006241255,"teacher_disagreement_score":0.02399642,"about_ca_system_score_codex":0.0005716171,"about_ca_system_score_gemma":0.0009922414,"threshold_uncertainty_score":0.8150076},"labels":[],"label_agreement":null},{"id":"W4380538775","doi":"10.23736/s2724-6051.23.05289-8","title":"Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy","year":2023,"lang":"en","type":"article","venue":"Minerva Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Chemotherapy; Stage (stratigraphy); Medicine; Oncology; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.011399056079646419,"score_gpt":0.24803015521398408,"score_spread":0.23663109913433766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380538775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957503,0.00033244037,0.0000064356423,0.002910593,0.000060013073,0.0004059312,0.000017220587,0.00007483824,0.00044222723],"genre_scores_gemma":[0.9957752,0.00027844982,0.000028218963,0.002903759,0.000053160504,0.000051050854,0.000052651565,0.000026245349,0.00083122595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878705,0.00011019274,0.0001900264,0.00042121013,0.00011139709,0.00038012277],"domain_scores_gemma":[0.9995502,0.000083379586,0.000042237327,0.0001672436,0.000028852324,0.00012808313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013013401,0.00019815477,0.00044463098,0.00014773567,0.00005288095,0.0000053383396,0.00004370508,0.00022879199,0.00010136663],"category_scores_gemma":[0.000012980784,0.00014292431,0.0000234505,0.000198714,0.0002857177,0.00003589874,0.000037546968,0.00020631241,0.000016882774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005785841,0.0002204479,0.98487175,0.000021963855,0.00016333506,0.00043861906,0.00022413672,0.0000030516524,0.0007017561,0.000038945684,0.00021284659,0.0073173395],"study_design_scores_gemma":[0.019405534,0.0044617285,0.9699292,0.00000697417,0.000092306065,0.00012207657,0.00002642921,0.00016333436,0.00013388257,0.000034892124,0.0055000815,0.00012353627],"about_ca_topic_score_codex":0.0002792169,"about_ca_topic_score_gemma":0.00031485234,"teacher_disagreement_score":0.014942493,"about_ca_system_score_codex":0.00001990196,"about_ca_system_score_gemma":0.00004110838,"threshold_uncertainty_score":0.58282846},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4380577672","doi":"10.22551/2023.39.1002.10249","title":"Rapid metachronous bladder metastasis of type 2 papillary renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Archive of Clinical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Trigone of urinary bladder; Cystoscopy; Nephrectomy; Metastasis; Renal cell carcinoma; Radiology; Urology; Bladder cancer; Lymph; Papillary tumor; Urinary bladder; Pathology; Cancer; Kidney; Urinary system; Internal medicine","score_opus":0.11343493557176411,"score_gpt":0.38500061022883475,"score_spread":0.27156567465707065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380577672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850736,0.0018576503,0.000015320547,0.0001909712,0.00023208969,0.00029229833,0.00029552783,0.000040081686,0.012002463],"genre_scores_gemma":[0.99637496,0.0012360452,0.0012649182,0.00021470089,0.00019633885,0.000009876404,0.00013058791,0.000027982516,0.00054456224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998178,0.00019405513,0.0007955745,0.00029725934,0.00030461408,0.00023050875],"domain_scores_gemma":[0.99757975,0.0014653921,0.00022752368,0.00041537354,0.00012397338,0.00018798356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034590586,0.00015984921,0.00079810753,0.00012538506,0.000032717155,0.000002804896,0.00010759317,0.00006618587,0.000632057],"category_scores_gemma":[0.0005305029,0.00012008568,0.0004466681,0.00029736504,0.00028228504,0.000035088255,0.00008945267,0.00016973111,0.00009479141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015231287,0.0058591114,0.44084764,0.0018792541,0.0054702223,0.0053966045,0.0012949564,0.00005328983,0.026366651,0.000662732,0.082281426,0.41465685],"study_design_scores_gemma":[0.009706769,0.019466985,0.811846,0.00016901964,0.00392094,0.00016143103,0.00042129093,0.00014436318,0.121886164,0.0015474887,0.03031027,0.00041927083],"about_ca_topic_score_codex":0.0002754484,"about_ca_topic_score_gemma":0.000017026721,"teacher_disagreement_score":0.41423756,"about_ca_system_score_codex":0.000007645653,"about_ca_system_score_gemma":0.00032549398,"threshold_uncertainty_score":0.6920581},"labels":[],"label_agreement":null},{"id":"W4380730350","doi":"10.5489/cuaj.8415","title":"Poster Session 7: Oncology - Bladder","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Temerty Faculty of Medicine, University of Toronto; University of California, Davis; Bladder Cancer Canada; University of Texas MD Anderson Cancer Center; Fondation CHU de Québec; Québec Consortium for Drug Discovery; Canadian Urological Association; McGill University Health Centre; University of Toronto; University Health Network; Centre Hospitalier Universitaire de Québec; Dartmouth College","keywords":"Session (web analytics); Medicine; Medical physics; Internal medicine; Oncology; Computer science; World Wide Web","score_opus":0.02471142945841216,"score_gpt":0.29354529672420077,"score_spread":0.2688338672657886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380730350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7746464,0.0001712651,0.000013056828,0.16876186,0.001382635,0.00028254895,0.000053154556,0.00013093017,0.05455812],"genre_scores_gemma":[0.9762544,0.00010174464,0.000041074607,0.017115971,0.0007456825,0.000009192028,0.000038892733,0.000013265258,0.005679754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987679,0.00012083087,0.00021789504,0.00014780166,0.00027152,0.00047406458],"domain_scores_gemma":[0.9988271,0.00009241977,0.00010908354,0.00007702463,0.00016705728,0.000727332],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039754194,0.00010149416,0.00021295113,0.0002077258,0.00023715595,0.000041438438,0.000067136025,0.00040109694,0.002233892],"category_scores_gemma":[0.0002846489,0.00007448385,0.000114803486,0.0002936857,0.000018272232,0.00006517731,0.000013477266,0.0006286174,0.001074101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010401187,0.00006313879,0.72865677,0.0000028815314,0.00023428835,0.0009288847,0.00023502967,0.000007169193,0.00025490235,0.000060053517,0.25108513,0.018367726],"study_design_scores_gemma":[0.001205848,0.0004953469,0.64534634,0.0000060246475,0.00007535666,0.00032176622,0.000052201827,0.000024903391,0.000031774307,0.000660749,0.35170728,0.00007237435],"about_ca_topic_score_codex":0.00053714646,"about_ca_topic_score_gemma":0.00039990508,"teacher_disagreement_score":0.20160799,"about_ca_system_score_codex":0.0014078737,"about_ca_system_score_gemma":0.0008969482,"threshold_uncertainty_score":0.9997037},"labels":[],"label_agreement":null},{"id":"W4381598842","doi":"10.1007/s00345-023-04478-w","title":"Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes","year":2023,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Cisplatin; Internal medicine; Oncology; Bladder cancer; Gemcitabine; Regimen; Methotrexate; Vinblastine; Chemotherapy; Cancer","score_opus":0.19567917583481026,"score_gpt":0.4421262332987352,"score_spread":0.24644705746392492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381598842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018044464,0.9938839,0.0002469624,0.0025173938,0.000118074706,0.0030691465,0.00012175684,0.000012350046,0.000012385329],"genre_scores_gemma":[0.0008597934,0.9962396,0.00012243273,0.0016909201,0.00016351337,0.00036717523,0.000034687993,0.00006548339,0.0004563918],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957783,0.0006248543,0.002537094,0.00037736024,0.000320364,0.00036199167],"domain_scores_gemma":[0.994504,0.0015935827,0.003099216,0.0003948423,0.00020320591,0.00020518216],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009977939,0.00060549605,0.023485418,0.0006110182,0.000058464935,0.000012594654,0.0002091502,0.0002311717,0.00012703301],"category_scores_gemma":[0.00005391422,0.00030684288,0.003011653,0.00072283944,0.00018087964,0.000025561698,0.00004525857,0.00047522306,9.1634297e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001800057,0.00021304433,0.0014385248,0.2204292,0.7073568,0.000032683747,0.00008067958,0.000009741921,8.263766e-8,0.000021644484,0.0018297585,0.068407804],"study_design_scores_gemma":[0.001916422,0.0016454443,0.0006402134,0.013002447,0.9286635,0.00007697304,0.000008625375,0.000011007859,2.2169552e-7,0.00006045719,0.05376144,0.00021322425],"about_ca_topic_score_codex":0.00003079753,"about_ca_topic_score_gemma":0.00013749469,"teacher_disagreement_score":0.22130668,"about_ca_system_score_codex":0.00012541743,"about_ca_system_score_gemma":0.0001991467,"threshold_uncertainty_score":0.99993837},"labels":[],"label_agreement":null},{"id":"W4382198144","doi":"10.1200/jco.22.02887","title":"Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Regeneron Pharmaceuticals; National Institutes of Health; Astellas Pharma; G1 Therapeutics; Pharmacyclics; Genentech; UroGen Pharma; Pfizer; Incyte; Ipsen; Mirati Therapeutics; Clovis Oncology; Sanofi; Exelixis; Advanced Accelerator Applications; Endocyte; National Cancer Institute; Gilead Sciences; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Seagen; Astellas Pharma US","keywords":"Medicine; Pembrolizumab; Neutropenia; Internal medicine; Rash; Oncology; Urothelial cancer; Adverse effect; Metastatic Urothelial Carcinoma; Cisplatin; Cancer; Nausea; Chemotherapy; Bladder cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.09489864755430755,"score_gpt":0.45565051426684977,"score_spread":0.3607518667125422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382198144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579805,0.00013098541,0.000103237595,0.0010966287,0.00044884044,0.0012948981,0.000029540948,0.000045063618,0.0010527415],"genre_scores_gemma":[0.99171233,0.00088117894,0.003097324,0.0013459483,0.00032902742,0.00009554383,0.000018344239,0.00007747998,0.0024428004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582803,0.0003059835,0.002173977,0.00038185925,0.00074593804,0.00056417997],"domain_scores_gemma":[0.99613893,0.001002141,0.0014266474,0.00027328642,0.00066103996,0.00049795356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088439585,0.000346871,0.002311931,0.00031442213,0.000054174852,0.000016609809,0.00020538103,0.00021240089,0.0005113484],"category_scores_gemma":[0.00093212834,0.00016563092,0.00020198648,0.0008383399,0.00021441792,0.00021409412,0.000042933327,0.0008244307,0.000036429687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24707918,0.002292501,0.6341034,0.0001370633,0.0010662586,0.003149974,0.00033565832,0.0006044622,0.000012342539,0.0000062554072,0.0007657427,0.110447146],"study_design_scores_gemma":[0.21976879,0.13162018,0.62975913,0.0019609635,0.002362977,0.0006151086,0.000304311,0.0006018493,0.00013395373,0.000064399195,0.012351135,0.0004572029],"about_ca_topic_score_codex":0.00029898266,"about_ca_topic_score_gemma":0.0032976593,"teacher_disagreement_score":0.12932768,"about_ca_system_score_codex":0.00038126344,"about_ca_system_score_gemma":0.0086098695,"threshold_uncertainty_score":0.9970104},"labels":[],"label_agreement":null},{"id":"W4382502215","doi":"10.1097/pas.0000000000002077","title":"International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Grading (engineering); Urothelial carcinoma; Medicine; Bladder cancer; Consensus conference; Cystectomy; Lymphovascular invasion; Carcinoma; Lamina propria; Hematopathology; Pathology; Biopsy; Cystoscopy; Oncology; Cancer; Urinary system; Internal medicine; Biology; Metastasis; Epithelium","score_opus":0.06360197385914394,"score_gpt":0.3680506495701205,"score_spread":0.30444867571097656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382502215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741754,0.0008905566,0.000025422143,0.023348596,0.0005550191,0.00012974296,0.00001873104,0.000017591155,0.0008389477],"genre_scores_gemma":[0.9878652,0.0108334,0.00020814165,0.000625825,0.00037875277,0.000013190672,0.000005832127,0.00001303486,0.000056587036],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998257,0.00033336296,0.0005687432,0.0002155886,0.00031998882,0.00030533716],"domain_scores_gemma":[0.9986817,0.0004236636,0.00048859074,0.00016768703,0.00014281648,0.000095500945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006516306,0.00016523237,0.0007356375,0.00014457238,0.000037552607,0.000006309644,0.00023588317,0.00006799354,0.00016810907],"category_scores_gemma":[0.00004995459,0.000098624456,0.00025426986,0.00039285037,0.0010161309,0.000017263168,0.00007936309,0.0006208357,0.000013131135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017817305,0.0024253302,0.4098931,0.000061022845,0.00091766904,0.015796544,0.005618507,0.00051047,0.014428489,0.0031944283,0.011184776,0.51815236],"study_design_scores_gemma":[0.017192319,0.015141597,0.86287314,0.0007533164,0.00052505767,0.012134139,0.0042971885,0.001059678,0.00094922667,0.005440345,0.079027504,0.0006065142],"about_ca_topic_score_codex":0.00003545626,"about_ca_topic_score_gemma":0.00000358228,"teacher_disagreement_score":0.5175458,"about_ca_system_score_codex":0.000075583135,"about_ca_system_score_gemma":0.000117160576,"threshold_uncertainty_score":0.40217885},"labels":[],"label_agreement":null},{"id":"W4382798047","doi":"10.1016/j.eururo.2023.06.017","title":"A Step Closer to Predicting Progression After Bacillus Calmette-Guérin Immunotherapy in High-risk Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Foundation for Innovation; Canadian Institutes of Health Research; Bladder Cancer Canada; Cancer Research Society","keywords":"Medicine; Immunotherapy; Bladder cancer; Internal medicine; Tumor progression; Oncology; Bacillus (shape); Cancer immunotherapy; Carcinoma in situ; Cancer; Urology; Immunology; Microbiology","score_opus":0.014753036736855601,"score_gpt":0.28106344253483256,"score_spread":0.26631040579797693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382798047","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60417444,0.003732597,0.00014449697,0.3736553,0.0052060154,0.0053674686,0.0013097748,0.00072053843,0.005689398],"genre_scores_gemma":[0.2289102,0.0014607789,0.00058746856,0.7434934,0.012195124,0.0016445686,0.00057318143,0.001049979,0.010085344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947908,0.0010219772,0.00085789687,0.0014758052,0.00060777477,0.0012457684],"domain_scores_gemma":[0.99793667,0.00028976036,0.00034713268,0.0010540362,0.00015013483,0.00022224977],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00046015135,0.0008591411,0.0011364063,0.00068633555,0.000116103394,0.00004798792,0.00042461514,0.0006886583,0.00094007887],"category_scores_gemma":[0.00014202313,0.00071508175,0.00029394156,0.0005692319,0.00015126298,0.00007173644,0.00031586073,0.002906566,0.0016591792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002638726,0.0002725758,0.12673004,0.00033568975,0.0015076618,0.030530186,0.0022440203,0.000060975068,0.00047684181,6.276629e-7,0.74813324,0.0870694],"study_design_scores_gemma":[0.006682612,0.0031374346,0.39606228,0.000582701,0.0006002163,0.000082470186,0.000029838406,0.000024727193,0.00009801166,0.000012700664,0.59196806,0.00071895955],"about_ca_topic_score_codex":0.0021401786,"about_ca_topic_score_gemma":0.0009146377,"teacher_disagreement_score":0.37526423,"about_ca_system_score_codex":0.00033729913,"about_ca_system_score_gemma":0.00033711913,"threshold_uncertainty_score":0.9999732},"labels":[],"label_agreement":null},{"id":"W4383302884","doi":"10.1007/978-1-0716-3291-8_14","title":"Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Methods in molecular biology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Oncology; Neoadjuvant therapy; Clinical trial; Internal medicine; Cisplatin; Cancer; Breast cancer","score_opus":0.04120421579983263,"score_gpt":0.43201583858881426,"score_spread":0.3908116227889816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383302884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974382,0.0012885386,0.020660944,0.0018679634,0.00026258806,0.0010141076,0.00006211782,0.00003925233,0.00042250103],"genre_scores_gemma":[0.8035875,0.0015828357,0.19014923,0.0031601412,0.00006161744,0.0010744497,0.00004197558,0.00008216866,0.0002600847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756587,0.0013001086,0.0003175275,0.00039141462,0.000096724034,0.00032837005],"domain_scores_gemma":[0.9990533,0.00043410808,0.000058872512,0.00030355656,0.000063633284,0.00008651537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011363103,0.00016389614,0.000439136,0.0005958804,0.000013927592,0.0000022032175,0.00011655512,0.00016674754,0.00009282658],"category_scores_gemma":[0.0006377996,0.00013545461,0.00008864717,0.0011099982,0.000111373985,0.000014305148,0.00007025495,0.00014006573,0.000007976331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038677992,0.00010351384,0.030946242,0.000012981603,0.00019848188,0.0001631798,0.0011928556,0.00007878839,0.89409536,0.00002155242,0.000081137274,0.0692381],"study_design_scores_gemma":[0.004963804,0.0025017795,0.36443865,0.0001345518,0.0000403182,0.000006696651,0.00045211552,0.00010388329,0.6238025,0.0015136675,0.0018630414,0.00017903392],"about_ca_topic_score_codex":0.0009570454,"about_ca_topic_score_gemma":0.00012436612,"teacher_disagreement_score":0.3334924,"about_ca_system_score_codex":0.0001300952,"about_ca_system_score_gemma":0.000285343,"threshold_uncertainty_score":0.55236787},"labels":[],"label_agreement":null},{"id":"W4383816411","doi":"10.1097/01.cot.0000945292.17603.e3","title":"An Oncogenic Route to Targeted Therapy for Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Oncology Times","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Targeted therapy; Bladder cancer; Cancer; Medicine; Cancer therapy; Oncology; Cancer research; Internal medicine","score_opus":0.03949173425088929,"score_gpt":0.3893663700872787,"score_spread":0.3498746358363894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383816411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9358274,0.0023460493,0.00024255022,0.029260565,0.001760912,0.003716877,0.00046881006,0.00080994406,0.02556693],"genre_scores_gemma":[0.90197563,0.00088257354,0.003001311,0.015105505,0.0013651383,0.0025137851,0.00034943028,0.00011049772,0.0746961],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990225,0.00003686633,0.00015606105,0.0003200253,0.00011322254,0.0003513413],"domain_scores_gemma":[0.999351,0.00006849202,0.000036198493,0.00024770765,0.00009136996,0.0002051795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000117689095,0.0001485702,0.00032273072,0.00011717588,0.000098492616,0.000008701786,0.00009723161,0.0001391634,0.0015426541],"category_scores_gemma":[0.000018101295,0.00011640771,0.00010240856,0.00027301422,0.00003998183,0.000048075097,0.000016505948,0.00007728356,0.00039864608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036433465,0.0008586992,0.022428723,0.000027539112,0.0013481817,0.0001085035,0.0026582377,0.000083949715,0.06384955,0.00017795054,0.517198,0.38761726],"study_design_scores_gemma":[0.007129727,0.0068958723,0.06525268,0.00001895334,0.00023968425,0.000016118376,0.00022922723,0.0002683851,0.024566015,0.00045873423,0.89469254,0.00023207703],"about_ca_topic_score_codex":0.000234481,"about_ca_topic_score_gemma":0.00012567859,"teacher_disagreement_score":0.3873852,"about_ca_system_score_codex":0.00019464499,"about_ca_system_score_gemma":0.0005745446,"threshold_uncertainty_score":0.9993701},"labels":[],"label_agreement":null},{"id":"W4383874363","doi":"10.1016/j.euf.2023.06.012","title":"Long-term Recurrence Rates of Low-risk Non–muscle-invasive Bladder Cancer—How Long Is Cystoscopic Surveillance Necessary?","year":2023,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Interquartile range; Bladder cancer; Confidence interval; Retrospective cohort study; Urology; Clinical endpoint; Logistic regression; Internal medicine; Univariate analysis; Surrogate endpoint; Surgery; Cancer; Multivariate analysis; Randomized controlled trial","score_opus":0.021759716398126343,"score_gpt":0.2946873835046523,"score_spread":0.27292766710652594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858286,0.004513901,0.0001456466,0.0033289497,0.0008965461,0.0006232475,0.00029095626,0.00017190701,0.0042002476],"genre_scores_gemma":[0.9916566,0.0047170985,0.000022454871,0.00069221674,0.00042622254,0.000043976557,0.00007738302,0.00010139794,0.0022626205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745595,0.00042127672,0.00042345413,0.00074891956,0.00031175415,0.00063864834],"domain_scores_gemma":[0.99827397,0.00024846746,0.00033185616,0.0007148475,0.00021096537,0.00021992427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035323517,0.0003878459,0.0006432137,0.00022030002,0.00014207095,0.000025625297,0.00034575985,0.00012004574,0.0004331616],"category_scores_gemma":[0.00018315378,0.0003379444,0.00018207215,0.0006478168,0.00031967775,0.0001058461,0.00017145555,0.0004101446,0.00054733834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032506944,0.00015697576,0.9611544,0.0002285477,0.00049496675,0.0012200621,0.0010569281,0.00002190804,0.0015399113,0.000004061327,0.009338204,0.024458986],"study_design_scores_gemma":[0.002936126,0.0010710616,0.9866573,0.00016712652,0.00023652498,0.000044929024,0.000046734098,0.00003309497,0.007918217,0.00002816743,0.00059144176,0.0002692728],"about_ca_topic_score_codex":0.00021501174,"about_ca_topic_score_gemma":0.0003893904,"teacher_disagreement_score":0.025502924,"about_ca_system_score_codex":0.000054680993,"about_ca_system_score_gemma":0.00024559346,"threshold_uncertainty_score":0.99990726},"labels":[],"label_agreement":null},{"id":"W4383874542","doi":"10.1016/j.euo.2023.05.013","title":"Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; NRG Oncology","keywords":"Medicine; Cystectomy; Internal medicine; Oncology; Clinical endpoint; Radiation therapy; Trastuzumab; Bladder cancer; Toxicity; Paclitaxel; Chemotherapy; Urology; Randomized controlled trial; Cancer; Breast cancer","score_opus":0.050891716655193604,"score_gpt":0.3631017691669565,"score_spread":0.3122100525117629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916383,0.00028880205,0.00020195691,0.0020691017,0.00043320368,0.0030136472,0.00096615404,0.00005983203,0.0013290016],"genre_scores_gemma":[0.9969083,0.00049789733,0.00038597683,0.00035377164,0.00027458867,0.0003762353,0.0007182014,0.00008876191,0.00039625147],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9962798,0.0007243338,0.0013937888,0.0006979902,0.0003434104,0.0005607216],"domain_scores_gemma":[0.9963521,0.0012166589,0.0014127996,0.00047915376,0.0003784903,0.00016081562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009785995,0.00040329434,0.001596182,0.0006674956,0.00006564219,0.00000511995,0.00021110685,0.00029954244,0.00008061225],"category_scores_gemma":[0.0005584615,0.00029747986,0.00015662068,0.00076395186,0.000462352,0.00014349836,0.00004495868,0.00030523265,0.000010035122],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7193693,0.006444022,0.12657061,0.0006078171,0.002373277,0.0010661436,0.009036885,0.00083054166,0.007953371,0.000031601106,0.0016300832,0.124086365],"study_design_scores_gemma":[0.35801053,0.06741992,0.56956124,0.000089571055,0.0011457899,0.00007152083,0.00028991693,0.00019477923,0.0019138309,0.000013386697,0.0010370674,0.00025242154],"about_ca_topic_score_codex":0.0006076083,"about_ca_topic_score_gemma":0.004362128,"teacher_disagreement_score":0.44299063,"about_ca_system_score_codex":0.00050468085,"about_ca_system_score_gemma":0.002279754,"threshold_uncertainty_score":0.9999477},"labels":[],"label_agreement":null},{"id":"W4384068667","doi":"10.5489/cuaj.8279","title":"Minimizing the learning curve for robotic-assisted radical cystectomy","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; McMaster University","funders":"","keywords":"Cystectomy; Medicine; Lymph node; Lymph; Urology; Surgery; Prostatectomy; Retrospective cohort study; Bladder cancer; General surgery; Internal medicine; Cancer; Prostate","score_opus":0.03444994177272926,"score_gpt":0.28303504771470556,"score_spread":0.2485851059419763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384068667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65311396,0.0009695468,0.0022843538,0.32964095,0.0026344701,0.0019052698,0.00006639117,0.00039753504,0.008987518],"genre_scores_gemma":[0.99245703,0.000048633912,0.00014822853,0.0036121323,0.00080041855,0.000042468535,0.000038309983,0.000018444653,0.0028343182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854445,0.00018762921,0.0002611668,0.00016333033,0.0002971285,0.00054628414],"domain_scores_gemma":[0.9986385,0.00046146862,0.0001525754,0.000078512836,0.00017360605,0.0004952989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008117717,0.00011709565,0.00024087088,0.00013535557,0.00067104073,0.000092786555,0.00010594424,0.00018886875,0.00023497229],"category_scores_gemma":[0.0014918083,0.00007492023,0.0002023117,0.00034369208,0.00003355292,0.00004652584,0.0000106843645,0.0005833728,0.00009911776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028075025,0.00007369283,0.88142407,0.00001904574,0.0007727178,0.00032754362,0.000666499,0.0012466295,0.00026369086,0.00034830504,0.09695089,0.01762614],"study_design_scores_gemma":[0.0028372924,0.00055895094,0.73396015,0.000020796646,0.00023544,0.00031538514,0.00024860693,0.002315469,0.000019997155,0.00050610513,0.25885132,0.00013049494],"about_ca_topic_score_codex":0.00036127598,"about_ca_topic_score_gemma":0.00029812916,"teacher_disagreement_score":0.3393431,"about_ca_system_score_codex":0.00078624045,"about_ca_system_score_gemma":0.0005164752,"threshold_uncertainty_score":0.5161171},"labels":[],"label_agreement":null},{"id":"W4384627400","doi":"10.34067/kid.0000000000000214","title":"Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Kidney360","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"American Society of Nephrology","keywords":"Gemcitabine; Carboplatin; Medicine; Regimen; Cisplatin; Oncology; Internal medicine; Chemotherapy; Metastatic Urothelial Carcinoma; Interquartile range; Renal function; Urology; Cancer; Bladder cancer; Urothelial carcinoma","score_opus":0.05333528822668144,"score_gpt":0.34814666541493877,"score_spread":0.29481137718825734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384627400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768066,0.00062298495,0.00035019687,0.013869359,0.0005142203,0.0026133943,0.0044113044,0.000118599666,0.0006933736],"genre_scores_gemma":[0.989392,0.001890227,0.0017350538,0.0009351587,0.00024364119,0.0008627898,0.00019878523,0.0000985909,0.004643784],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988464,0.000017403894,0.00022247295,0.00034164483,0.00027612053,0.000295957],"domain_scores_gemma":[0.9990582,0.00013369576,0.00010735009,0.00025817257,0.0001270428,0.00031557563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058486556,0.0002718356,0.0006140034,0.000120890516,0.00008086977,0.000011661006,0.000052379222,0.00004043941,0.0001275192],"category_scores_gemma":[0.00005210039,0.00017531183,0.0001240207,0.00018879311,0.00010675264,0.00004837488,0.00001154696,0.00004038831,0.0000050168683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14357866,0.0030106104,0.6365747,0.0023839285,0.022738675,0.0005745894,0.033526637,0.00019262783,0.003835173,0.001149274,0.040134236,0.11230088],"study_design_scores_gemma":[0.3659909,0.06353461,0.083089955,0.0007580234,0.0066775824,0.00005567456,0.0013946978,0.0014130849,0.17186004,0.0011612969,0.3027741,0.0012900105],"about_ca_topic_score_codex":0.0010157673,"about_ca_topic_score_gemma":0.00014139003,"teacher_disagreement_score":0.55348474,"about_ca_system_score_codex":0.00027097153,"about_ca_system_score_gemma":0.00049581565,"threshold_uncertainty_score":0.71490085},"labels":[],"label_agreement":null},{"id":"W4385066959","doi":"10.21886/2308-6424-2023-11-2-203-214","title":"Robot-assisted cystectomy in treatment of patients with bladder urothelial carcinoma","year":2023,"lang":"en","type":"article","venue":"Urology Herald","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Cystectomy; Medicine; Blood loss; Urology; Urothelial carcinoma; Blood transfusion; Bladder cancer; Robotic surgery; Surgery; Internal medicine; Cancer","score_opus":0.018287096682861305,"score_gpt":0.26341103491026596,"score_spread":0.24512393822740466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385066959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969421,0.00013233745,0.0000075678586,0.00091253396,0.00012249946,0.0007591762,0.000048760154,0.00007766593,0.0009973289],"genre_scores_gemma":[0.9983162,0.00002438896,0.00009486131,0.00038561237,0.00006512726,0.00013863914,0.00011305342,0.000037441765,0.0008246181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884486,0.00006340084,0.00025584488,0.00031405498,0.00018197187,0.00033986825],"domain_scores_gemma":[0.9994273,0.000047112895,0.000067646084,0.00030116417,0.00006458464,0.000092160444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003675728,0.00020397746,0.00044140161,0.00023704566,0.000031254654,0.0000034324075,0.000057070818,0.00012714417,0.0002280252],"category_scores_gemma":[0.00000895045,0.00014247638,0.00007994372,0.00040270633,0.00007721495,0.000035062563,0.00001553595,0.000081984,0.00007157268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025858071,0.00095731503,0.98868513,0.000023983095,0.00023266404,0.0002332956,0.00047209914,0.00004671237,0.00044827472,0.000015569105,0.00017364121,0.0061254865],"study_design_scores_gemma":[0.016469365,0.005353254,0.97444385,0.000009915958,0.00017308851,0.000014613765,0.000020202939,0.000057409754,0.000837498,0.000024835053,0.002487468,0.0001084746],"about_ca_topic_score_codex":0.00062071125,"about_ca_topic_score_gemma":0.00031992357,"teacher_disagreement_score":0.014241277,"about_ca_system_score_codex":0.00010960316,"about_ca_system_score_gemma":0.00014011194,"threshold_uncertainty_score":0.58100176},"labels":[],"label_agreement":null},{"id":"W4385192323","doi":"10.1016/j.euf.2023.07.002","title":"Repeat Transurethral Resection for Non–muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era","year":2023,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Bladder cancer; Context (archaeology); Meta-analysis; Confounding; Confidence interval; Guideline; Resection; Oncology; Internal medicine; Urology; Cancer; Surgery; Pathology","score_opus":0.14450360812563617,"score_gpt":0.38184931380822934,"score_spread":0.23734570568259317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385192323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056964127,0.98713344,0.000024556892,0.001601055,0.000091525464,0.009195927,0.0006239724,0.0000837251,0.0012400904],"genre_scores_gemma":[0.00139201,0.9915447,0.000017785524,0.0023416597,0.00014338976,0.002469483,0.00091831357,0.00016726715,0.00100536],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929617,0.003919054,0.0014616031,0.0009877554,0.00027899278,0.00039089323],"domain_scores_gemma":[0.9974498,0.000496512,0.00064070674,0.001136627,0.00013572803,0.00014062878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023587798,0.0006734519,0.0068891067,0.00047547332,0.00013001933,0.00003990136,0.000380151,0.0002260402,0.00013366045],"category_scores_gemma":[0.00014904384,0.00036830257,0.0020783287,0.0011667111,0.00012257897,0.000085823616,0.00004375691,0.0006804881,0.00004462009],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020961302,0.00023858504,0.000008609625,0.6568169,0.329757,0.0011226496,0.0008159456,0.0000014546565,5.2918057e-7,0.000026198086,0.006322263,0.004680269],"study_design_scores_gemma":[0.00093896204,0.0012385276,0.0000428324,0.0063121133,0.94914967,0.00015743158,0.00003974739,0.000002889912,3.763515e-7,0.000017063072,0.04177864,0.00032175696],"about_ca_topic_score_codex":0.00023595101,"about_ca_topic_score_gemma":0.00079927675,"teacher_disagreement_score":0.65050477,"about_ca_system_score_codex":0.000070682734,"about_ca_system_score_gemma":0.0003197157,"threshold_uncertainty_score":0.9998769},"labels":[],"label_agreement":null},{"id":"W4385471203","doi":"10.1016/s1470-2045(23)00322-4","title":"Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed – Authors' reply","year":2023,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Urology; Oncology; General surgery; Cancer; Internal medicine","score_opus":0.12795852453085177,"score_gpt":0.4080312789043165,"score_spread":0.28007275437346474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385471203","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012225298,0.0018798131,0.000112908725,0.9721819,0.0037368012,0.007319127,0.00068190484,0.00032426725,0.0015379468],"genre_scores_gemma":[0.012301678,0.002853637,0.0002875951,0.9326754,0.037177023,0.007822983,0.001195705,0.00027428294,0.005411697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947624,0.0017331339,0.00066900667,0.0010070212,0.00084609754,0.0009823384],"domain_scores_gemma":[0.99504596,0.0023006557,0.00052994664,0.00126644,0.0007241694,0.00013283978],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021872972,0.00062578375,0.0019804665,0.00017880545,0.00022383285,0.000036563066,0.0004930987,0.0014204768,0.00077167444],"category_scores_gemma":[0.00074282085,0.00040323095,0.0005324582,0.00034486657,0.0003645859,0.000052460262,0.00008068703,0.0019777955,0.00013550783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039364574,0.00012780908,0.00012753313,0.00020316649,0.0018201651,0.00026731676,0.0024647443,0.0000075353614,0.0003677343,0.000018466902,0.9652558,0.025403265],"study_design_scores_gemma":[0.021119492,0.0028474224,0.0046190773,0.00021372442,0.0021678405,0.00011674216,0.00040198193,0.00015630503,0.00041928366,0.002167228,0.96533877,0.00043211202],"about_ca_topic_score_codex":0.00176974,"about_ca_topic_score_gemma":0.00026942592,"teacher_disagreement_score":0.039506536,"about_ca_system_score_codex":0.0013540634,"about_ca_system_score_gemma":0.003410342,"threshold_uncertainty_score":0.9998759},"labels":[],"label_agreement":null},{"id":"W4385514721","doi":"10.1002/1878-0261.13504","title":"Pharmacological <scp>NF‐κB</scp> inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.","year":2023,"lang":"en","type":"article","venue":"Molecular Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"National Institutes of Health; Universidade de Trás-os-Montes e Alto Douro; National Cancer Institute; Fundação para a Ciência e a Tecnologia; Ministério da Ciência, Tecnologia e Ensino Superior","keywords":"Cisplatin; Bladder cancer; Chemotherapy; Cancer research; Cancer; NF-κB; In vivo; Pharmacology; Biology; Signal transduction; Medicine; Oncology; Internal medicine; Cell biology","score_opus":0.03409050186829557,"score_gpt":0.34047675245907877,"score_spread":0.30638625059078317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018824,0.0013127333,0.000017211021,0.001658813,0.00024049461,0.00080818986,0.000041545765,0.00013766067,0.005595138],"genre_scores_gemma":[0.9944393,0.001145317,0.0002361621,0.002661638,0.00018609349,0.0005777085,0.00009900373,0.000048149468,0.0006066528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795616,0.00015141093,0.00040087587,0.0006182223,0.0002998631,0.0005734635],"domain_scores_gemma":[0.9989368,0.00039116782,0.00013824127,0.00017698044,0.00009972205,0.0002571331],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001914701,0.0003118606,0.000582884,0.00026056182,0.00010267529,0.00002164349,0.00008270586,0.00031665372,0.00017573881],"category_scores_gemma":[0.00035217355,0.00028528427,0.000104479164,0.00057788735,0.0001938339,0.000082800754,0.00009639967,0.00033312902,0.0000408351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020562235,0.0003566536,0.0029264768,0.000078554236,0.00022573512,0.003485364,0.00094419107,0.0000324475,0.97366726,0.000099599536,0.0044214055,0.013556663],"study_design_scores_gemma":[0.008194935,0.0013857969,0.08467727,0.00022316174,0.0004563807,0.00012968064,0.0011351643,0.00017294253,0.9005093,0.00070700044,0.002204562,0.00020382534],"about_ca_topic_score_codex":0.00029656393,"about_ca_topic_score_gemma":0.00035195285,"teacher_disagreement_score":0.081750795,"about_ca_system_score_codex":0.00037123795,"about_ca_system_score_gemma":0.00056424015,"threshold_uncertainty_score":0.99995995},"labels":[],"label_agreement":null},{"id":"W4385575883","doi":"10.3390/curroncol30080536","title":"Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Oncology; Atezolizumab; Immunotherapy; Chemotherapy; Internal medicine; Regimen; Cancer; Targeted therapy; Malignancy; Pembrolizumab; Bladder cancer; Intensive care medicine; Urothelial carcinoma","score_opus":0.16512950330442275,"score_gpt":0.5086184551702758,"score_spread":0.34348895186585304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385575883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015208178,0.980781,0.000011437,0.000032735647,0.00048257675,0.0030153384,0.00028314645,0.000011568292,0.0001740181],"genre_scores_gemma":[0.002855405,0.9954365,0.00043879286,0.000027893066,0.00009170193,0.0010129854,0.000042172305,0.00005868354,0.000035863704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815285,0.0002070793,0.0006270448,0.00046813203,0.00023520822,0.0003096737],"domain_scores_gemma":[0.9988904,0.0003138571,0.00029346827,0.00039694083,0.000036024685,0.00006932497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021391561,0.0004543663,0.0017279407,0.000257738,0.0000473895,0.000016448701,0.00013245884,0.00012191005,0.00005315771],"category_scores_gemma":[0.0000058132414,0.00024919852,0.00026479343,0.00031392107,0.00012388712,0.00002176339,0.00007221955,0.00020840847,0.0000048958805],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030133975,0.00042216416,0.0010640858,0.0051295874,0.00093545933,0.00012774343,0.00065620185,0.0000013880656,4.1318032e-7,0.000026705098,0.000054391287,0.9912805],"study_design_scores_gemma":[0.009468663,0.0045495257,0.011355324,0.01201361,0.006776926,0.0002268494,0.00039368463,0.000014871977,0.0000014308139,0.00044369072,0.95440096,0.0003544458],"about_ca_topic_score_codex":0.000057712376,"about_ca_topic_score_gemma":0.00006092742,"teacher_disagreement_score":0.9909261,"about_ca_system_score_codex":0.0006429432,"about_ca_system_score_gemma":0.0004494543,"threshold_uncertainty_score":0.999996},"labels":[],"label_agreement":null},{"id":"W4385649872","doi":"10.1016/j.euo.2023.07.011","title":"Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Else Kröner-Fresenius-Stiftung","keywords":"Medicine; Bladder cancer; Oncology; Cystectomy; Grading (engineering); Immune checkpoint; Immune system; Internal medicine; Adjuvant; Extracellular matrix; Pathology; Cancer; Immunotherapy; Immunology; Biology","score_opus":0.029991755215776218,"score_gpt":0.2978869095146267,"score_spread":0.26789515429885047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385649872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644121,0.00095133187,0.021378111,0.0038914953,0.0013669818,0.00545979,0.00033848837,0.0004800553,0.001721662],"genre_scores_gemma":[0.9913984,0.000031830874,0.0050852634,0.0012356616,0.00036335518,0.0014465502,0.00010714302,0.00011258376,0.00021919247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977894,0.00022364354,0.00039500534,0.0007925134,0.00017828982,0.0006211751],"domain_scores_gemma":[0.99866617,0.00035611365,0.0002920165,0.00022594305,0.00015855009,0.00030120095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024567568,0.0003429976,0.0006657629,0.00017335465,0.0003647636,0.0000197168,0.00012238177,0.00013296245,0.000010245081],"category_scores_gemma":[0.00027366896,0.00024704234,0.00015717301,0.0001432132,0.00030742362,0.000057224504,0.00012097403,0.00023002992,0.000010291455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10803791,0.008040509,0.46518284,0.0063997125,0.010945468,0.022130672,0.02003805,0.016670922,0.033147644,0.018870492,0.0051234453,0.2854123],"study_design_scores_gemma":[0.13249843,0.06460638,0.69471335,0.001092802,0.013616744,0.005620019,0.007802762,0.047011144,0.00064728764,0.00062486465,0.028596684,0.0031695038],"about_ca_topic_score_codex":0.000041168554,"about_ca_topic_score_gemma":0.000014265742,"teacher_disagreement_score":0.28224283,"about_ca_system_score_codex":0.0002258424,"about_ca_system_score_gemma":0.00074410404,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W4385680796","doi":"10.5489/cuaj.8322","title":"Existing trends and applications of artificial intelligence in urothelial cancer","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vector Institute; Western University; The Wilson Centre; Public Health Ontario; University of Toronto","funders":"University of Toronto","keywords":"Computer science; Scopus; Artificial intelligence; Feature selection; MEDLINE; Machine learning","score_opus":0.04398561447352891,"score_gpt":0.3196470909801658,"score_spread":0.2756614765066369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385680796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93472624,0.0011241852,0.0016757526,0.046083875,0.00058535027,0.0006973586,0.00037554197,0.000095317875,0.014636367],"genre_scores_gemma":[0.9983629,0.0001965045,0.00009214863,0.0005047211,0.00028012122,0.000039137438,0.000009281702,0.0000068753925,0.0005082937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991454,0.000044031058,0.00027309178,0.00012108435,0.00016430244,0.00025207296],"domain_scores_gemma":[0.9994242,0.00007499854,0.00011472536,0.000048281563,0.00008867165,0.00024910312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030666206,0.00006989297,0.00017260166,0.0003560771,0.000094233656,0.000019253675,0.000047419777,0.000105229774,0.00029845562],"category_scores_gemma":[0.0001465445,0.000059882434,0.00004548643,0.0006317953,0.000029987956,0.000034084216,0.000008150855,0.00023169088,0.000014196292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046776127,0.0000373492,0.57371974,0.0000070830956,0.00004802067,0.000035062523,0.0002383042,0.00008965595,0.00016339766,0.0011751628,0.00055215316,0.42388728],"study_design_scores_gemma":[0.0004284035,0.00020838386,0.97366816,0.00002537135,0.00006738059,0.00004290418,0.00014005716,0.00078099535,0.000110127075,0.009237859,0.0151826935,0.00010768562],"about_ca_topic_score_codex":0.003002106,"about_ca_topic_score_gemma":0.0031216086,"teacher_disagreement_score":0.42377958,"about_ca_system_score_codex":0.000368246,"about_ca_system_score_gemma":0.00029615633,"threshold_uncertainty_score":0.4538306},"labels":[],"label_agreement":null},{"id":"W4385685902","doi":"10.4049/jimmunol.210.supp.172.12","title":"Biodegradable Nanoparticles Immunotherapy for the Treatment of Carcinogen-Induced Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Immunotherapy; Cancer research; Bladder cancer; CD8; Chemistry; Cytokine; Immune system; Hyperplasia; Tumor microenvironment; Cancer; Medicine; Internal medicine; Immunology","score_opus":0.05340909354186815,"score_gpt":0.32811237770172114,"score_spread":0.274703284159853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385685902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558224,0.037568107,0.000035549725,0.005483406,0.00055887265,0.00045764132,0.000019702164,0.000011974648,0.00004232667],"genre_scores_gemma":[0.9715002,0.027240671,0.00004701576,0.00017663313,0.00017881773,0.00005205969,0.0000015918812,0.000022914284,0.0007801007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910235,0.00007824779,0.00036090045,0.00007105879,0.00014264141,0.0002447719],"domain_scores_gemma":[0.99889046,0.0003516013,0.000248506,0.00029595385,0.00018520118,0.000028251381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025021788,0.00013012651,0.0003648053,0.00008911392,0.00013699444,0.000005256423,0.00017583587,0.000057705754,0.00010391055],"category_scores_gemma":[0.00001709303,0.000055668734,0.00021595844,0.00022932055,0.00013477216,0.00003301383,0.000011042861,0.00008445128,0.000008969438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043718847,0.0003723764,0.002961114,0.000011741048,0.003924149,0.000010679179,0.003900993,0.00003735389,0.902505,0.00005076378,0.0011306093,0.08072333],"study_design_scores_gemma":[0.008743559,0.008357393,0.060854413,0.000048186543,0.0011673577,0.00021728319,0.0016566981,0.00006635042,0.89726824,0.00036935194,0.021160232,0.00009094374],"about_ca_topic_score_codex":0.00068684196,"about_ca_topic_score_gemma":0.0000487155,"teacher_disagreement_score":0.08063239,"about_ca_system_score_codex":0.00010585427,"about_ca_system_score_gemma":0.0002411275,"threshold_uncertainty_score":0.2270105},"labels":[],"label_agreement":null},{"id":"W4385857188","doi":"10.1016/j.eururo.2023.08.004","title":"Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; University of British Columbia Hospital","funders":"National Cancer Institute, Cairo University; AstraZeneca; Genentech; American College of Radiology Imaging Network; Astellas Pharma; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Atezolizumab; Bladder cancer; Oncology; Internal medicine; Bacillus (shape); Urology; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.024811328048888005,"score_gpt":0.3123821855103267,"score_spread":0.2875708574614387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385857188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784035,0.00036494932,0.000026595062,0.0015843308,0.001118832,0.0011280897,0.0003591996,0.00013431879,0.0074433303],"genre_scores_gemma":[0.9949433,0.0012895938,0.000047575333,0.0011408867,0.0007308329,0.00009702833,0.000112540096,0.0001087773,0.0015294657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99686426,0.00083477894,0.000675819,0.00065927295,0.0003212052,0.00064467924],"domain_scores_gemma":[0.99833536,0.00042055015,0.00027091612,0.00061369425,0.00013939683,0.00022006097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005001667,0.0003513489,0.0007784855,0.00050706166,0.00007931838,0.000009584241,0.00024131795,0.00013530141,0.00060391857],"category_scores_gemma":[0.00049972936,0.00031110624,0.00020537441,0.0007375236,0.00023270078,0.00006245306,0.00016208178,0.00046028473,0.0008044676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45952168,0.008179943,0.019536378,0.0003754104,0.003664221,0.026155014,0.011358269,0.0012803099,0.035298947,0.00034033624,0.050640296,0.3836492],"study_design_scores_gemma":[0.66367364,0.04140805,0.23090437,0.00013681065,0.0016626713,0.0001364049,0.00043907153,0.00031409806,0.008756852,0.00028886774,0.051381085,0.0008980625],"about_ca_topic_score_codex":0.0014675604,"about_ca_topic_score_gemma":0.00038871745,"teacher_disagreement_score":0.38275114,"about_ca_system_score_codex":0.000121687386,"about_ca_system_score_gemma":0.0004086617,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W4386026568","doi":"10.1038/s41585-023-00806-2","title":"The sex gap in bladder cancer survival — a missing link in bladder cancer care?","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bladder cancer; Medicine; Disease; Cancer; Referral; Health care; Cystectomy; Oncology; Internal medicine; Family medicine","score_opus":0.11598030012632245,"score_gpt":0.44635769827384303,"score_spread":0.3303773981475206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386026568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003781526,0.9855297,0.00000140267,0.00429147,0.002709026,0.004540645,0.00013902229,0.00007622,0.0027087063],"genre_scores_gemma":[0.000020710704,0.9891458,0.000031559663,0.0025465756,0.0021335317,0.0033462083,0.00017126856,0.00024373051,0.0023606094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99368614,0.0015171069,0.0018037524,0.0013097926,0.0004931756,0.0011900304],"domain_scores_gemma":[0.99708396,0.0007486713,0.0006710339,0.0011197061,0.00014038496,0.00023626095],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0011913943,0.0011014387,0.005104748,0.0005074641,0.0001530605,0.000047971156,0.00060829846,0.0023961666,0.00036552604],"category_scores_gemma":[0.00043394975,0.0006537688,0.0009797805,0.0017116091,0.00019950305,0.000057108482,0.00018735162,0.0049282066,0.00019904783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006061862,0.000054678705,0.00045066915,0.01176357,0.0005933829,0.0002813046,0.0002731993,0.0000013744153,3.369281e-7,0.000040428942,0.0039757043,0.9825047],"study_design_scores_gemma":[0.0012149207,0.000118206444,0.00023805292,0.012374217,0.002721175,0.00008114077,0.000024656052,0.000004444104,4.671472e-7,0.000073741234,0.98265696,0.0004919945],"about_ca_topic_score_codex":0.0012706366,"about_ca_topic_score_gemma":0.011286944,"teacher_disagreement_score":0.98201275,"about_ca_system_score_codex":0.0010025459,"about_ca_system_score_gemma":0.002337277,"threshold_uncertainty_score":0.99959135},"labels":[],"label_agreement":null},{"id":"W4386136664","doi":"10.1016/j.euf.2023.08.002","title":"The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office","year":2023,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"","keywords":"Medicine; Cystoscopy; Systematic review; Bladder cancer; MEDLINE; Checklist; Urine cytology; Meta-analysis; Urology; Internal medicine; Cancer; Urinary system","score_opus":0.046040701547324016,"score_gpt":0.35203773144445527,"score_spread":0.30599702989713123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386136664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013329744,0.9904641,0.000035873258,0.0010141395,0.00037486956,0.0068650893,0.00030542866,0.000057422316,0.00074977527],"genre_scores_gemma":[0.002532342,0.9952896,0.00005564583,0.0003162911,0.00055317546,0.0007409347,0.00007087251,0.00022219757,0.0002189122],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9914889,0.0046357587,0.0023915123,0.0006074423,0.00037453073,0.0005018873],"domain_scores_gemma":[0.97749186,0.01754726,0.0034641826,0.0009216605,0.00051196,0.00006307224],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039371224,0.0005219214,0.0028336917,0.00011740162,0.00015310769,0.000019406118,0.00065885496,0.00015224492,0.00001373696],"category_scores_gemma":[0.02550977,0.0002607842,0.0004941232,0.0005335476,0.00012448979,0.000042901636,0.0002072037,0.00062536326,0.00004519476],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006889626,0.00022023256,0.00084362424,0.8547321,0.008826667,0.00053655443,0.0010911167,0.000027826023,0.000002871982,0.000025243497,0.0045857257,0.12841909],"study_design_scores_gemma":[0.005471287,0.0015682053,0.00233879,0.8172591,0.056888543,0.00028819634,0.00014772938,0.00004892515,0.000006484075,0.000052401992,0.11515952,0.0007708677],"about_ca_topic_score_codex":0.0003688232,"about_ca_topic_score_gemma":0.0006670598,"teacher_disagreement_score":0.12764822,"about_ca_system_score_codex":0.000107916334,"about_ca_system_score_gemma":0.0003167241,"threshold_uncertainty_score":0.99998444},"labels":[],"label_agreement":null},{"id":"W4386170080","doi":"10.1016/j.isci.2023.107722","title":"A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer","year":2023,"lang":"en","type":"article","venue":"iScience","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immunotherapy; Bladder cancer; Nomogram; Medicine; Cancer research; Oncology; Tumor microenvironment; Cancer-Associated Fibroblasts; Cancer; Internal medicine","score_opus":0.0422418927006566,"score_gpt":0.35264292538128156,"score_spread":0.31040103268062497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386170080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051064,0.00454162,0.000002098861,0.004027176,0.00006877543,0.0006884552,0.00004719163,0.000028040131,0.000085997126],"genre_scores_gemma":[0.99869597,0.00032136904,0.000015751764,0.00028816794,0.000018031073,0.000354519,0.0000044260505,0.0000107835995,0.0002910011],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986848,0.00018700708,0.00014990315,0.00022557647,0.0005451673,0.00020751255],"domain_scores_gemma":[0.9993918,0.00017202517,0.00007904886,0.00014227403,0.00017992653,0.000034959885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011856693,0.00009857177,0.00015462255,0.00012501169,0.00008660937,0.000016300364,0.00009554484,0.000059113896,0.00013365239],"category_scores_gemma":[0.00016390384,0.00006226883,0.000034065157,0.0011047721,0.00016859423,0.000064357206,0.000016603946,0.000097247255,0.0000021778665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00414185,0.00043885436,0.42749557,0.00008567129,0.00020596445,0.000024968724,0.007148905,0.0042489613,0.45384032,0.000012879288,0.002238693,0.100117385],"study_design_scores_gemma":[0.0028646148,0.00034560316,0.9336848,0.0004486639,0.00008268224,0.0000014947007,0.00022982695,0.009232465,0.052690428,0.00008155715,0.00024923726,0.00008860835],"about_ca_topic_score_codex":0.0012548972,"about_ca_topic_score_gemma":0.0013176315,"teacher_disagreement_score":0.5061893,"about_ca_system_score_codex":0.00017374296,"about_ca_system_score_gemma":0.00089620147,"threshold_uncertainty_score":0.2539249},"labels":[],"label_agreement":null},{"id":"W4386200358","doi":"10.1186/s13059-023-03026-4","title":"Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Genome biology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Fundação para a Ciência e a Tecnologia; Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Cancer Research UK; Wellcome Trust; National Human Genome Research Institute; University of Huddersfield","keywords":"Biology; Bladder cancer; Cancer research; Fern; Gene; Genetics; Bracken; Cancer","score_opus":0.05117128957418678,"score_gpt":0.34818890241911155,"score_spread":0.2970176128449248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386200358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579097,0.0015623554,0.000011930575,0.00091961195,0.00065760623,0.00042560583,0.0001774619,0.00018492063,0.010269529],"genre_scores_gemma":[0.98588544,0.0017622557,0.00006445204,0.0014039074,0.0009169071,0.00015534619,0.0004658736,0.000050602775,0.009295203],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986123,0.000043383705,0.00028707765,0.0004778697,0.00010375035,0.00047565837],"domain_scores_gemma":[0.9992172,0.000053747528,0.00007883746,0.00036512435,0.0001162374,0.00016883212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008665081,0.00024091049,0.00041008653,0.00020761992,0.0002262774,0.000021361575,0.00016464473,0.00021583575,0.0017984521],"category_scores_gemma":[0.0000291021,0.00019792383,0.00014175326,0.00032003535,0.00031761613,0.000041886422,0.00012373949,0.00016364142,0.00060987135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020744566,0.00013805424,0.17545657,0.00010591193,0.0008885187,0.0001582825,0.005458698,0.000023867351,0.80833805,0.00085504353,0.0011554252,0.007214113],"study_design_scores_gemma":[0.0023402506,0.000747751,0.6696476,0.000019009867,0.0001398147,0.0000130107555,0.00021779141,0.0000025143238,0.01031155,0.0007229837,0.31555516,0.00028260247],"about_ca_topic_score_codex":0.0008114774,"about_ca_topic_score_gemma":0.00059203757,"teacher_disagreement_score":0.7980265,"about_ca_system_score_codex":0.00032363116,"about_ca_system_score_gemma":0.0002980194,"threshold_uncertainty_score":0.99911404},"labels":[],"label_agreement":null},{"id":"W4386201115","doi":"","title":"How I Do It: Maintenance avelumab for advanced urothelial carcinoma","year":2023,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Avelumab; Medicine; Oncology; Maintenance therapy; Bladder cancer; Chemotherapy; Internal medicine; Merkel cell carcinoma; Metastatic Urothelial Carcinoma; Disease; Immunotherapy; Carcinoma; Pembrolizumab; Urothelial carcinoma; Cancer","score_opus":0.03561058926921728,"score_gpt":0.26510030741189156,"score_spread":0.22948971814267427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386201115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85905176,0.0012432913,0.0014055431,0.06630276,0.0039194915,0.016000932,0.0008394106,0.0012105334,0.05002628],"genre_scores_gemma":[0.93257564,0.000063291125,0.00022635338,0.0008716852,0.0004481418,0.007954746,0.000039361807,0.000051825602,0.057768926],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986093,0.000014736713,0.00015168542,0.0003626222,0.00022443452,0.0006371896],"domain_scores_gemma":[0.9992749,0.00005650137,0.000050950064,0.00031228413,0.00009667849,0.00020869983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012394538,0.00017719297,0.00028053793,0.000098060766,0.00009488751,0.000046892856,0.00010617255,0.00007184003,0.000015897054],"category_scores_gemma":[0.00015482206,0.0001431361,0.00015942553,0.00026574472,0.00005214201,0.0000950279,0.000030892195,0.00008765645,0.000038216454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003181852,0.00025855916,0.023533551,0.0003872413,0.00032586843,0.0002470857,0.0006491163,0.0000066639864,0.0011704756,0.0010224874,0.07940368,0.8898134],"study_design_scores_gemma":[0.020617496,0.00045313302,0.59582347,0.00005793487,0.000273773,0.00007939446,0.0005905061,0.000108001324,0.016401779,0.0013495993,0.363803,0.00044192246],"about_ca_topic_score_codex":0.000018746856,"about_ca_topic_score_gemma":0.000008392401,"teacher_disagreement_score":0.8893715,"about_ca_system_score_codex":0.00012980175,"about_ca_system_score_gemma":0.00008240868,"threshold_uncertainty_score":0.5836921},"labels":[],"label_agreement":null},{"id":"W4386291372","doi":"10.5489/cuaj.8442","title":"Regional differences in metastatic urothelial carcinoma of the urinary bladder patients across the United States SEER registries","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Proportional hazards model; Epidemiology; Stage (stratigraphy); Internal medicine; Oncology; Hazard ratio; Bladder cancer; Cancer registry; Surveillance, Epidemiology, and End Results; Population; Cancer; Urology; Confidence interval; Environmental health","score_opus":0.033930177418801805,"score_gpt":0.2654936098825496,"score_spread":0.2315634324637478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386291372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970438,0.00007876527,0.0000017431636,0.02863687,0.00023089904,0.00026580697,0.00020944522,0.000010388315,0.00012809646],"genre_scores_gemma":[0.99556214,0.00009076519,0.0000058538335,0.0032989122,0.00010974651,0.000018162464,0.000064429245,0.000010083463,0.0008398904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826235,0.00031323268,0.00034526424,0.00014351476,0.000498703,0.0004369147],"domain_scores_gemma":[0.9988998,0.00027755913,0.00024890763,0.00013852128,0.00023235765,0.00020282003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004531979,0.00013234116,0.00024211228,0.00012969387,0.000321636,0.000043728265,0.0002045867,0.00009580293,0.00013087748],"category_scores_gemma":[0.0004657648,0.000067566456,0.00013063622,0.0007253132,0.0001372811,0.0000507124,0.000031436037,0.00043980728,0.000014317194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009175964,0.000071040304,0.98961985,0.000004292108,0.00011417661,0.000037189813,0.0011078449,0.00003564953,0.0000029948746,0.000038252092,0.0086537115,0.00022321289],"study_design_scores_gemma":[0.0015134262,0.00031513357,0.9861308,0.00001572165,0.00006603758,0.000034676505,0.0006664237,0.00012554356,0.000010562636,0.0009180087,0.010136633,0.00006705338],"about_ca_topic_score_codex":0.006092846,"about_ca_topic_score_gemma":0.0017600629,"teacher_disagreement_score":0.025337959,"about_ca_system_score_codex":0.00042721242,"about_ca_system_score_gemma":0.0005123961,"threshold_uncertainty_score":0.9210601},"labels":[],"label_agreement":null},{"id":"W4386348958","doi":"10.1016/j.eururo.2023.08.011","title":"Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard’s Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669–81","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Internal medicine; Cancer","score_opus":0.06849769614712614,"score_gpt":0.31392869894434705,"score_spread":0.2454310027972209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386348958","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033109184,0.001919856,0.0007696273,0.94963783,0.004861761,0.0060938434,0.0028122042,0.00029015195,0.0005055456],"genre_scores_gemma":[0.012795884,0.0014218311,0.00064106425,0.9525188,0.026308589,0.0008626347,0.0016391743,0.0002703588,0.0035416246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942719,0.0011616438,0.00079286995,0.0020494661,0.0007062481,0.00101789],"domain_scores_gemma":[0.9969154,0.00068672333,0.0003561847,0.001228577,0.0003439394,0.00046915142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010341782,0.0009809047,0.0019873064,0.000412301,0.0004473433,0.00013941061,0.00051228853,0.00050815975,0.00015583876],"category_scores_gemma":[0.00035416457,0.00067311246,0.0004114948,0.000732906,0.0004637644,0.000100393874,0.00037206282,0.0018018396,0.00008540192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051935352,0.00013759482,0.003507148,0.00013199833,0.0040187608,0.0014543666,0.0006214383,0.000017898798,0.00035203632,0.0000044028434,0.9836023,0.00095853553],"study_design_scores_gemma":[0.01452046,0.0016961417,0.052286107,0.00010109113,0.0023572755,0.00007923309,0.000027456925,0.000079257836,0.00007717794,0.000004672714,0.9281501,0.0006209845],"about_ca_topic_score_codex":0.0006932567,"about_ca_topic_score_gemma":0.0012448719,"teacher_disagreement_score":0.055452142,"about_ca_system_score_codex":0.00030903122,"about_ca_system_score_gemma":0.0008079194,"threshold_uncertainty_score":0.999572},"labels":[],"label_agreement":null},{"id":"W4386545802","doi":"10.2147/ppa.s411751","title":"Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice Experiment","year":2023,"lang":"en","type":"article","venue":"Patient Preference and Adherence","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bristol-Myers Squibb","keywords":"Medicine; Regimen; Urothelial carcinoma; Internal medicine; Oncology; Logistic regression; Observational study; Cancer; Bladder cancer","score_opus":0.07498117337947481,"score_gpt":0.3194310012710001,"score_spread":0.2444498278915253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386545802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940694,0.0012427157,0.00004068487,0.00008415813,0.00029477346,0.003168587,0.00043031093,0.00011089135,0.0005584741],"genre_scores_gemma":[0.9944963,0.00076642056,0.00044784797,0.0001584658,0.0000771726,0.0034288345,0.00021976666,0.000036605037,0.0003686301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976237,0.000068918045,0.00051092607,0.0008190485,0.0003505636,0.00062686583],"domain_scores_gemma":[0.99888885,0.00020571827,0.00015633079,0.00037597577,0.00010561293,0.00026753958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006180786,0.00044296312,0.0005554583,0.00018422084,0.00015268743,0.0000512553,0.00011326294,0.00012736168,0.000074232885],"category_scores_gemma":[0.00009574927,0.00032653962,0.00011429032,0.00031491826,0.00010846333,0.00018512066,0.00009645842,0.00013409398,0.000040614887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002157609,0.0029951958,0.59025013,0.000733877,0.00030314407,0.0001606165,0.032330524,0.000063938096,0.018277073,0.00012543221,0.00045067712,0.35215175],"study_design_scores_gemma":[0.021402638,0.024941932,0.8639641,0.0015027417,0.0003873639,0.000021117497,0.0082944045,0.0016128889,0.069964916,0.00046613792,0.0061799693,0.001261802],"about_ca_topic_score_codex":0.0022763496,"about_ca_topic_score_gemma":0.0011104522,"teacher_disagreement_score":0.35088995,"about_ca_system_score_codex":0.00021504606,"about_ca_system_score_gemma":0.0003734282,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W4386634361","doi":"10.3233/blc-230056","title":"Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"EMD Serono; National Cancer Institute; Natera; Medac; Astellas Pharma; Eisai; Genentech; UroGen Pharma; National Institutes of Health; Incyte; Bristol-Myers Squibb; AstraZeneca; University of Texas MD Anderson Cancer Center; Pfizer; Patient-Centered Outcomes Research Institute","keywords":"Bladder cancer; Medicine; Food and drug administration; Clinical trial; Drug; Intensive care medicine; Oncology; Clinical research; Cancer; Internal medicine; Pharmacology","score_opus":0.11651621659017142,"score_gpt":0.41965319554556235,"score_spread":0.30313697895539093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386634361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90209085,0.007671253,0.012324014,0.02005276,0.021694362,0.02507317,0.0014441548,0.0017474686,0.007901952],"genre_scores_gemma":[0.9035039,0.012219199,0.006320772,0.01414878,0.017226469,0.019412976,0.00026662846,0.00059689255,0.026304381],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99665046,0.00011004874,0.00081072806,0.0009296883,0.0005100403,0.000989058],"domain_scores_gemma":[0.9976908,0.0007224074,0.00023452686,0.0005823119,0.00031118505,0.00045875914],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000628396,0.00044579958,0.0008772585,0.0002000967,0.00024524174,0.000049399565,0.00022338607,0.00030797452,0.0015604034],"category_scores_gemma":[0.0003723881,0.00037911182,0.000525059,0.00062911195,0.00014489138,0.0001918187,0.00006802739,0.000340813,0.00024485224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060748532,0.0010969595,0.011052188,0.00044727259,0.0037285083,0.0001951646,0.0016274855,0.0008183431,0.0049027493,0.00004569736,0.758916,0.15642107],"study_design_scores_gemma":[0.4545351,0.015249015,0.0902105,0.0019006637,0.0063450877,0.000033066706,0.0020330995,0.004645126,0.031438157,0.001720132,0.38904807,0.0028419674],"about_ca_topic_score_codex":0.0006553889,"about_ca_topic_score_gemma":0.0006308647,"teacher_disagreement_score":0.39378658,"about_ca_system_score_codex":0.00033622104,"about_ca_system_score_gemma":0.0023890296,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W4386753453","doi":"10.1016/j.eururo.2023.08.001","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Hazard ratio; Metastatic Urothelial Carcinoma; Avelumab; Internal medicine; Urology; Maintenance therapy; Confidence interval; Progression-free survival; Surgery; Oncology; Bladder cancer; Urothelial carcinoma; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.014595719975332423,"score_gpt":0.26321057400650966,"score_spread":0.24861485403117722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386753453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97033453,0.00060698885,0.016763132,0.0088469,0.00031472094,0.0010572849,0.0012285807,0.00015378933,0.00069405895],"genre_scores_gemma":[0.99290246,0.00056819915,0.0007776586,0.001626203,0.00036219743,0.00007212501,0.0008577295,0.00010599782,0.0027274361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977811,0.000110705645,0.00068924914,0.0007260874,0.00019924012,0.0004936063],"domain_scores_gemma":[0.9986855,0.00016694883,0.00028908224,0.0004956508,0.00020793425,0.00015492478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002961504,0.00035325662,0.00076717633,0.00024052055,0.00012324013,0.000015140412,0.00019317713,0.000112998096,0.00023737362],"category_scores_gemma":[0.00019561958,0.0002962484,0.00027855858,0.00052502134,0.00021161021,0.0000804177,0.00008547298,0.00019121543,0.00004885276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067992374,0.004169072,0.46327928,0.0012571409,0.020104062,0.0017083591,0.01959877,0.0030816575,0.04145017,0.0006331939,0.08683124,0.28989467],"study_design_scores_gemma":[0.07181703,0.016003087,0.6875114,0.00020636663,0.0056706704,0.00013117444,0.00047228372,0.049087252,0.011125451,0.0017864095,0.15481958,0.0013693229],"about_ca_topic_score_codex":0.00020795227,"about_ca_topic_score_gemma":0.00055610796,"teacher_disagreement_score":0.28852537,"about_ca_system_score_codex":0.00006496701,"about_ca_system_score_gemma":0.000046621462,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W4386759743","doi":"10.1016/j.modpat.2023.100333","title":"Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study","year":2023,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"School of Medicine, University of Alabama at Birmingham","keywords":"Bladder cancer; Exome sequencing; Urothelial carcinoma; Carcinoma; Medicine; Microsatellite instability; Pathology; Urinary system; Biology; Oncology; Cancer; Internal medicine; Gene; Mutation; Genetics; Microsatellite","score_opus":0.033140170152398084,"score_gpt":0.29817565388666045,"score_spread":0.2650354837342624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386759743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981387,0.0003058902,0.00013881594,0.00022966902,0.0001691103,0.0006906259,0.0001296822,0.000033009648,0.00016449607],"genre_scores_gemma":[0.9992091,0.000013860021,0.00006433218,0.00010449948,0.000042253945,0.000048458747,0.000016565897,0.000017155082,0.00048375668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999059,0.000103558494,0.00023423052,0.00024395491,0.00016979885,0.00018945117],"domain_scores_gemma":[0.99947983,0.00004025456,0.00007372714,0.00028846183,0.000071001086,0.000046740868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014386934,0.00013370466,0.00033023805,0.00009904636,0.00007762932,0.0000022125673,0.000080900114,0.00008864633,0.00002698553],"category_scores_gemma":[0.000044098302,0.00008489616,0.000081756654,0.00018193168,0.0001638451,0.000032075157,0.0000857775,0.00011257857,0.0000073760452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030650786,0.0020474142,0.98337156,0.000058095535,0.000053549204,0.00039342692,0.0034877027,0.000010095692,0.009370405,0.00006359219,0.0000142952595,0.0008233736],"study_design_scores_gemma":[0.005306295,0.00095769565,0.9902669,0.000022593485,0.00016634657,0.00047955956,0.00030854697,0.0009084402,0.0013698841,0.00008372153,0.000065824104,0.00006417629],"about_ca_topic_score_codex":0.00009727655,"about_ca_topic_score_gemma":0.00003016813,"teacher_disagreement_score":0.008000521,"about_ca_system_score_codex":0.000018910518,"about_ca_system_score_gemma":0.00014965679,"threshold_uncertainty_score":0.34619647},"labels":[],"label_agreement":null},{"id":"W4386824625","doi":"10.1101/2023.09.17.23295670","title":"A systematic review of genome-wide association studies on bladder cancer","year":2023,"lang":"en","type":"review","venue":"medRxiv","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Genome-wide association study; Medicine; Genetic association; Genetic predisposition; Oncology; Cancer; Biology; Genetics; Internal medicine; Disease; Single-nucleotide polymorphism; Genotype; Gene","score_opus":0.09820199284935083,"score_gpt":0.4026814688817549,"score_spread":0.30447947603240405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386824625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000060566617,0.99443567,4.437563e-7,0.0003406727,0.0005127723,0.003973268,0.00013765082,0.000073285104,0.0005202063],"genre_scores_gemma":[0.000001949263,0.987146,0.0000061489236,0.0012466194,0.00020971132,0.0022454741,0.000063140214,0.00009715898,0.008983769],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969714,0.00031694706,0.0013952525,0.00038037673,0.00068009045,0.00025589677],"domain_scores_gemma":[0.9964236,0.0013025388,0.0013388587,0.0005623435,0.00028570896,0.000086947686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009004021,0.00042732875,0.005155782,0.00019110461,0.00003898889,0.0000062889303,0.00015565369,0.00018225303,0.00011091287],"category_scores_gemma":[0.0040463763,0.00026242502,0.0008178349,0.0005913384,0.000025093685,0.00002087319,0.00004665415,0.00026631306,0.00047178465],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032694259,0.000054334825,0.00013719816,0.98783857,0.007654779,0.000027926753,0.00007483215,7.0179695e-8,4.4707136e-8,0.000005392664,0.002527114,0.0016764653],"study_design_scores_gemma":[0.00021289027,0.00012303535,0.000039241404,0.88246965,0.025023818,0.0000038924327,0.00001707539,1.0334466e-7,0.000001166976,0.000007797572,0.09193833,0.00016301502],"about_ca_topic_score_codex":0.000017783912,"about_ca_topic_score_gemma":0.000011030929,"teacher_disagreement_score":0.10536894,"about_ca_system_score_codex":0.000965569,"about_ca_system_score_gemma":0.00044974734,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W4386864758","doi":"10.1007/s00345-023-04597-4","title":"Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods—what’s around the corner?","year":2023,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Coloplast; National Cancer Institute; Karolinska Institutet; Boston Scientific Corporation","keywords":"Medicine; Nephrology; Internal medicine; General surgery","score_opus":0.08144014905510906,"score_gpt":0.40852435572864026,"score_spread":0.3270842066735312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386864758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007523881,0.99439794,0.00006802671,0.0021128724,0.0018347893,0.0012208328,0.00001677636,0.000019900659,0.00025360566],"genre_scores_gemma":[0.000321949,0.9954697,0.0002098359,0.0010644571,0.0008812454,0.00011316416,0.000022019405,0.00007164147,0.0018459787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973715,0.0008191844,0.0009076507,0.00029818626,0.00029758338,0.000305871],"domain_scores_gemma":[0.989587,0.008870098,0.00091572985,0.00027430564,0.00017626974,0.00017658585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009679032,0.00037771853,0.0017057599,0.00052153156,0.00017526392,0.000051370498,0.00019063709,0.00019351166,0.000087895205],"category_scores_gemma":[0.002348115,0.00021198942,0.00034868848,0.00053957367,0.00021591064,0.000079619625,0.000076344164,0.0011423968,0.00005135047],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018120049,0.00014767896,0.00009297393,0.0014305507,0.0011726727,0.00057095307,0.0001842839,0.0000031862435,5.608474e-7,0.00023040485,0.0027570287,0.9932285],"study_design_scores_gemma":[0.0016611586,0.0028272034,0.00055947667,0.0059446143,0.008318084,0.002868391,0.000078490964,0.0000053958966,5.4284965e-7,0.0006042476,0.9769611,0.00017133866],"about_ca_topic_score_codex":0.000008668092,"about_ca_topic_score_gemma":0.000028033319,"teacher_disagreement_score":0.9930572,"about_ca_system_score_codex":0.000113564296,"about_ca_system_score_gemma":0.0005648532,"threshold_uncertainty_score":0.86446774},"labels":[],"label_agreement":null},{"id":"W4386887795","doi":"10.1186/s13014-023-02338-w","title":"Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Radiation Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Radiation therapy; External beam radiotherapy; Hazard ratio; Cumulative incidence; Concomitant; Lipiodol; Retrospective cohort study; Proportional hazards model; Urology; Radiology; Cohort; Nuclear medicine; Cancer; Surgery; Internal medicine; Brachytherapy; Confidence interval; Embolization","score_opus":0.05310517150073083,"score_gpt":0.42725328069126334,"score_spread":0.3741481091905325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386887795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921331,0.0012231605,0.000023143179,0.0046618762,0.00041734692,0.000545561,0.000027038644,0.00005378665,0.0009150223],"genre_scores_gemma":[0.98776114,0.008847307,0.0004873549,0.0019617602,0.00018271849,0.000093583476,0.00003033399,0.000024402347,0.0006114086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880064,0.00016463586,0.00046420336,0.00024528324,0.00013290656,0.00019232891],"domain_scores_gemma":[0.9989245,0.0006160597,0.00013769392,0.00015322329,0.000071120805,0.0000974193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037641928,0.000113332746,0.00051625894,0.00042474215,0.0000234906,0.000004455226,0.00005019915,0.00016527621,0.00032281614],"category_scores_gemma":[0.0003633725,0.00009462414,0.00008265036,0.00071728457,0.00013116171,0.000057756723,0.000018051609,0.00014001952,0.000022848651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015278182,0.00022255183,0.8974185,0.000029253262,0.00023264771,0.000042268548,0.00051781815,0.000010384709,0.0010543907,0.00003406431,0.005450883,0.09483445],"study_design_scores_gemma":[0.008926584,0.0006497137,0.9816655,0.000016839935,0.00008487118,0.0000069319985,0.00008155397,0.00035307938,0.00033624776,0.000069523005,0.0077332626,0.00007589344],"about_ca_topic_score_codex":0.0007944074,"about_ca_topic_score_gemma":0.0002582193,"teacher_disagreement_score":0.094758555,"about_ca_system_score_codex":0.00021426006,"about_ca_system_score_gemma":0.00046580145,"threshold_uncertainty_score":0.38586605},"labels":[],"label_agreement":null},{"id":"W4386905518","doi":"10.14740/wjon1676","title":"Tumor Markers as Predictors of Acute Kidney Injury Incidence and Staging of the Muscle-Invasive Bladder Cancer Receiving Chemoradiation Therapy","year":2023,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fakultas Kedokteran, Universitas Indonesia; Universitas Indonesia; University College London","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine; Exact test; Oncology; Cystectomy; Urology","score_opus":0.015584628536161192,"score_gpt":0.3203378405043753,"score_spread":0.3047532119682141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386905518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923989,0.0004142696,0.0000027075512,0.0053191795,0.0007434785,0.0002490987,0.000041363324,0.0000081409735,0.0008228235],"genre_scores_gemma":[0.99403465,0.003881319,0.00010909657,0.001284764,0.00022416424,0.000010369298,0.000001901967,0.000017293645,0.00043644253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988648,0.0001117559,0.00045018122,0.00011697471,0.00029084878,0.00016538746],"domain_scores_gemma":[0.99868035,0.00016406026,0.0006702355,0.00013468793,0.00021946701,0.00013117479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003872818,0.00011299537,0.0004185644,0.00024975196,0.00004963176,0.000004654803,0.000120702825,0.000046054454,0.00017645772],"category_scores_gemma":[0.00018619237,0.00007458902,0.000112488044,0.0005028701,0.00015579328,0.00009991118,0.000044399265,0.00023224794,0.0000010032015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025499896,0.00018632539,0.82911015,0.00012126127,0.0018917897,0.00014880321,0.0037900447,0.000019444373,0.07897068,0.00001631444,0.019495998,0.063699186],"study_design_scores_gemma":[0.003611081,0.0016786647,0.9492989,0.00054673204,0.00054238434,0.00010980683,0.00033786605,0.000021150907,0.036777724,0.00016358792,0.006832259,0.000079820325],"about_ca_topic_score_codex":0.00018790875,"about_ca_topic_score_gemma":0.00005083779,"teacher_disagreement_score":0.12018876,"about_ca_system_score_codex":0.00021135065,"about_ca_system_score_gemma":0.0015159303,"threshold_uncertainty_score":0.30416518},"labels":[],"label_agreement":null},{"id":"W4386905519","doi":"10.14740/wjon1639","title":"Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Family history; Family aggregation; Hazard ratio; Absolute risk reduction; Cohort study; Population; Confidence interval; Offspring; Cohort; Bladder cancer; Demography; Internal medicine; Cancer; Disease; Environmental health; Genetics; Pregnancy","score_opus":0.03474410963843988,"score_gpt":0.3654487123716521,"score_spread":0.3307046027332122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386905519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985203,0.00023001435,0.000014068753,0.00044958663,0.00024231133,0.00039673687,0.000004364589,0.000010226077,0.00013240005],"genre_scores_gemma":[0.9991072,0.00042850498,0.000080064696,0.00015049809,0.000121207864,0.000026522746,0.0000039645943,0.000010510517,0.00007157361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992202,0.00011068543,0.00027361547,0.000126396,0.00015758447,0.00011152158],"domain_scores_gemma":[0.9994596,0.00013739597,0.00022256158,0.00005414063,0.000057385365,0.00006888426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033183998,0.00008660508,0.0003118383,0.00040208493,0.000049300845,0.000009638121,0.000019385974,0.000037237052,0.00005857366],"category_scores_gemma":[0.000026132158,0.00006429966,0.000021597863,0.00020785352,0.000033932716,0.000072893105,0.000009653945,0.00025987756,0.0000010058912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015297557,0.00019149449,0.96897435,0.000013064673,0.00023294479,0.00021010447,0.000398605,0.00018801555,0.00004839449,0.0000013351902,0.000091932525,0.028119992],"study_design_scores_gemma":[0.008587791,0.0018018491,0.98766506,0.0001091059,0.00051253487,0.00011603398,0.0003280495,0.00028508832,0.00002021287,0.000017241076,0.0005032482,0.000053805717],"about_ca_topic_score_codex":0.001918525,"about_ca_topic_score_gemma":0.01016967,"teacher_disagreement_score":0.028066186,"about_ca_system_score_codex":0.0002716516,"about_ca_system_score_gemma":0.00013463959,"threshold_uncertainty_score":0.5674914},"labels":[],"label_agreement":null},{"id":"W4386945370","doi":"10.1097/pas.0000000000002121","title":"International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Subcategorization; Medicine; Bladder cancer; Pathology; Cancer; Internal medicine; Computer science; Verb; Artificial intelligence","score_opus":0.05694653366573402,"score_gpt":0.3778311581451081,"score_spread":0.32088462447937405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96300876,0.00065990794,0.000013870811,0.034867153,0.00045344824,0.000119136916,0.00003439153,0.000014221701,0.0008291008],"genre_scores_gemma":[0.9883586,0.010330445,0.00014139866,0.0007331287,0.00029881165,0.000012312129,0.0000048953775,0.000011445953,0.00010895733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841946,0.00029128086,0.0005247448,0.00019164526,0.00030210573,0.00027078827],"domain_scores_gemma":[0.9987733,0.00034600674,0.00042110312,0.00016460322,0.0002023958,0.00009260215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005383533,0.0001507265,0.00069449784,0.0001344231,0.000028698661,0.000004583677,0.0002113023,0.00006212426,0.00025957217],"category_scores_gemma":[0.000054169373,0.000086842054,0.00024210344,0.0003303379,0.0010531459,0.000017173916,0.00006674835,0.00053836073,0.000020605077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026333425,0.0038346278,0.4191153,0.000099537436,0.0013991366,0.022497945,0.008678719,0.0008598462,0.024721745,0.003495191,0.03774899,0.45121554],"study_design_scores_gemma":[0.016910689,0.015450937,0.8620731,0.00043216115,0.0005088737,0.012603975,0.0036852374,0.0009123967,0.0020588073,0.0051775957,0.07964422,0.00054197834],"about_ca_topic_score_codex":0.00003506843,"about_ca_topic_score_gemma":0.0000022897768,"teacher_disagreement_score":0.45067355,"about_ca_system_score_codex":0.00006233223,"about_ca_system_score_gemma":0.00016593197,"threshold_uncertainty_score":0.38803598},"labels":[],"label_agreement":null},{"id":"W4387043588","doi":"10.1016/j.euros.2023.09.003","title":"Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy","year":2023,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"McGill University","keywords":"Subtyping; Immunohistochemistry; Bladder cancer; Medicine; Oncology; Internal medicine; Interquartile range; Radiation therapy; Cystectomy; Tissue microarray; Pathology; Cancer","score_opus":0.028530817350268495,"score_gpt":0.34179190873720106,"score_spread":0.3132610913869326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387043588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997497,0.00017536929,0.000041634787,0.0002006062,0.000023815954,0.0013617683,0.0000785996,0.000022139595,0.00059904915],"genre_scores_gemma":[0.99930936,0.000021422275,0.00011837529,0.0003842434,0.000007693672,0.00006961555,0.00004503492,0.000023438046,0.000020836456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873596,0.00009551952,0.00020404388,0.0004908294,0.00018467977,0.00028895843],"domain_scores_gemma":[0.9991133,0.000094365925,0.00012277205,0.00035425744,0.00021225987,0.00010302575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050900003,0.00015311762,0.00025288598,0.0001598515,0.00010366673,0.00002678601,0.0003164955,0.000029121979,0.00004162812],"category_scores_gemma":[0.00015371836,0.00011243699,0.00005029712,0.00072200765,0.0004734866,0.00009339447,0.000053299056,0.00007635781,0.0000025028096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023273767,0.00022224644,0.9385748,0.000020008392,0.00004928958,0.000020377767,0.00017571365,0.0010106339,0.052374505,0.0000020094021,0.000027154663,0.0051958924],"study_design_scores_gemma":[0.010433024,0.0018741766,0.96897113,0.000032440024,0.00003712032,7.504187e-7,0.0000103813345,0.00082273374,0.0176907,0.0000051321445,0.000015984082,0.00010642134],"about_ca_topic_score_codex":0.00044078895,"about_ca_topic_score_gemma":0.0000137130155,"teacher_disagreement_score":0.034683805,"about_ca_system_score_codex":0.00017523658,"about_ca_system_score_gemma":0.00100162,"threshold_uncertainty_score":0.45850474},"labels":[],"label_agreement":null},{"id":"W4387052886","doi":"10.1249/01.mss.0000988856.08161.c1","title":"Feasibility Of High-intensity Interval Training For Non-muscle Invasive Bladder Cancer During Or After Intravesical Therapy","year":2023,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bladder cancer; Randomized controlled trial; High-intensity interval training; Urology; Interval training; Quality of life (healthcare); Physical therapy; Internal medicine; Cancer; Nursing","score_opus":0.05724609950722388,"score_gpt":0.34366537954945053,"score_spread":0.28641928004222666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387052886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590844,0.00006557686,0.00002052786,0.0013752957,0.0008553731,0.0015932284,0.000022262819,0.00006148007,0.00009783625],"genre_scores_gemma":[0.99748355,0.00068175123,0.00020918845,0.00043307274,0.00030506685,0.00039009703,0.000010500356,0.00002970254,0.00045708992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971847,0.000013817632,0.0006088032,0.0007232483,0.00082064513,0.00064879976],"domain_scores_gemma":[0.99864775,0.000094223986,0.00014720224,0.0004850619,0.00033292797,0.00029283942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009508417,0.0002710741,0.0009600894,0.00043349294,0.00011499695,0.000011191451,0.0002436048,0.00008343801,0.0006824061],"category_scores_gemma":[0.0003025852,0.00017561509,0.00011056864,0.0014085192,0.0011189018,0.00022471037,0.00008210866,0.00021096716,0.000004283005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068849246,0.0003447788,0.87299794,0.00025479583,0.000008696765,0.0005691947,0.019831378,0.000014551412,0.00852331,0.0000013216911,0.00036418045,0.09020495],"study_design_scores_gemma":[0.004647096,0.0006595124,0.9863501,0.0013757953,0.00009020389,0.000023873452,0.0029093963,0.00010930178,0.0033992124,0.00023345723,0.000034227567,0.00016780567],"about_ca_topic_score_codex":0.0011039713,"about_ca_topic_score_gemma":0.00034981561,"teacher_disagreement_score":0.113352194,"about_ca_system_score_codex":0.0002505319,"about_ca_system_score_gemma":0.0008609486,"threshold_uncertainty_score":0.74718684},"labels":[],"label_agreement":null},{"id":"W4387058602","doi":"10.3389/fonc.2023.1233125","title":"Simultaneous radical cystectomy and nephroureterectomy in the treatment of panurothelial carcinoma: a systematic review and single-arm meta-analysis","year":2023,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Cochrane Library; Urology; Meta-analysis; Internal medicine; Incidence (geometry); Bladder cancer; Oncology; Surgery; Cancer","score_opus":0.10374131262697328,"score_gpt":0.37547730709169536,"score_spread":0.2717359944647221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387058602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045830093,0.992005,0.000021565304,0.00023621815,0.00013655664,0.0072445897,0.00014661414,0.00001819242,0.00014543234],"genre_scores_gemma":[0.00066620007,0.9958467,0.00046623457,0.0002928123,0.000055182285,0.002265739,0.000067176785,0.00005116875,0.000288809],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956179,0.0016520685,0.0014654652,0.000629275,0.00027571892,0.00035952916],"domain_scores_gemma":[0.99731934,0.0013622801,0.00056055404,0.00060611253,0.00003980329,0.00011189041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006284933,0.00058711023,0.01249448,0.0007411023,0.000033957316,0.000014184913,0.00019777687,0.00041410196,0.000031169333],"category_scores_gemma":[0.00021414043,0.0003054749,0.001430354,0.0011956678,0.00025218082,0.000021508957,0.000036288475,0.00030094644,0.0000037834106],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013889304,0.0018973383,0.00022717282,0.8242861,0.11906756,0.0026484898,0.0014775383,8.1470813e-7,8.525144e-8,0.0000065516433,0.0003473375,0.04990212],"study_design_scores_gemma":[0.0022016212,0.0039736195,0.000008706894,0.013991104,0.861942,0.00055752584,0.00017433598,0.00002397284,1.8639201e-7,0.000024367113,0.11685176,0.00025080942],"about_ca_topic_score_codex":0.000324948,"about_ca_topic_score_gemma":0.0002507277,"teacher_disagreement_score":0.810295,"about_ca_system_score_codex":0.0007492355,"about_ca_system_score_gemma":0.00035810014,"threshold_uncertainty_score":0.99993974},"labels":[],"label_agreement":null},{"id":"W4387132496","doi":"10.3390/curroncol30100638","title":"The Impact of Variant Histology in Patients with Urothelial Carcinoma Treated with Radical Cystectomy: Can We Predict the Presence of Variant Histology?","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Histology; Medicine; Lymphovascular invasion; Bladder cancer; Carcinoma; Pathology; Stage (stratigraphy); Cancer; Urology; Oncology; Internal medicine; Metastasis; Biology","score_opus":0.03402520572820875,"score_gpt":0.3259678959402353,"score_spread":0.2919426902120265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387132496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949878,0.00092662167,0.000034203924,0.001345177,0.0004280313,0.0015461923,0.0001901736,0.000040581017,0.00050122134],"genre_scores_gemma":[0.9992925,0.00016257458,0.000022994684,0.00002003717,0.00007736432,0.00021329614,0.00006730044,0.00003151629,0.00011243848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977415,0.00046509405,0.00052672526,0.00039604603,0.0003356741,0.000534968],"domain_scores_gemma":[0.99824196,0.00051774824,0.00033533422,0.0005604348,0.00020152295,0.00014299808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002834047,0.00028343592,0.00079193414,0.00020120919,0.00010954709,0.0000041743383,0.00031048365,0.00016915596,0.000056975772],"category_scores_gemma":[0.00013320446,0.0001271747,0.00012161281,0.0006180459,0.0010832723,0.00003134295,0.00007710511,0.00041450144,0.0000051045986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011185809,0.0015493768,0.9701781,0.00009820816,0.0004862461,0.0003549169,0.0018716053,0.000054721222,0.000115058145,0.00019628817,0.0019019769,0.012007654],"study_design_scores_gemma":[0.017733397,0.015571832,0.9607116,0.00017268803,0.00048283584,0.0002491675,0.00014399203,0.0005170368,0.0001632126,0.00009818568,0.0039945613,0.0001614658],"about_ca_topic_score_codex":0.0023604946,"about_ca_topic_score_gemma":0.0007906693,"teacher_disagreement_score":0.014022456,"about_ca_system_score_codex":0.00068980147,"about_ca_system_score_gemma":0.0017580802,"threshold_uncertainty_score":0.5186034},"labels":[],"label_agreement":null},{"id":"W4387157256","doi":"10.1186/s12885-023-11380-6","title":"Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma","year":2023,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"AstraZeneca","keywords":"Durvalumab; Medicine; Tremelimumab; Internal medicine; Oncology; Proportional hazards model; Surgical oncology; Absolute neutrophil count; Retrospective cohort study; Lymph node; Cancer; Immunotherapy; Chemotherapy; Nivolumab; Neutropenia","score_opus":0.05369343096997605,"score_gpt":0.332128305429331,"score_spread":0.278434874459355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661976,0.00020964297,0.0005801522,0.00005905641,0.00035940402,0.0011459221,0.00081484654,0.00004897219,0.00016227085],"genre_scores_gemma":[0.99749416,0.00024482064,0.00007058518,0.000019858457,0.00014335218,0.00032818457,0.00011465542,0.000056135472,0.0015282555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979464,0.0001065876,0.00068679673,0.00037530626,0.00058954966,0.00029535906],"domain_scores_gemma":[0.9987866,0.00010776279,0.00035773977,0.00040426877,0.00025129216,0.00009231217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024926008,0.00023155997,0.0007115237,0.00027501592,0.000034793902,0.000010256719,0.00012759826,0.0000664091,0.00025942794],"category_scores_gemma":[0.000084096304,0.00017368558,0.00010426484,0.00070855446,0.0001538081,0.000099334284,0.0000361443,0.00012333498,0.000015259322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016081607,0.00045049872,0.96567833,0.0015364628,0.00043871574,0.00015991017,0.0022008521,0.00017310028,0.008644812,0.000025742736,0.000055215452,0.0045547243],"study_design_scores_gemma":[0.010198499,0.00090862863,0.97161305,0.00039818053,0.00062157016,0.000019814823,0.00030550084,0.00094265246,0.014814982,0.00001150921,0.000009903118,0.00015571987],"about_ca_topic_score_codex":0.0011074054,"about_ca_topic_score_gemma":0.0022135582,"teacher_disagreement_score":0.006170171,"about_ca_system_score_codex":0.00035736067,"about_ca_system_score_gemma":0.0015173565,"threshold_uncertainty_score":0.70826924},"labels":[],"label_agreement":null},{"id":"W4387208016","doi":"10.1016/j.ijrobp.2023.06.278","title":"Prognostic Significance of Pretreatment Immune Cell Infiltration in Muscle Invasive Bladder Cancer Treated with Definitive Chemoradiation: Analysis of NRG RTOG 0524 and 0712","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Infiltration (HVAC); Internal medicine; Oncology; Cancer research; Medicine; Chemistry; Cancer; Materials science","score_opus":0.023151359953600605,"score_gpt":0.31492133698214914,"score_spread":0.2917699770285485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387208016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969349,0.0008218528,0.0005124321,0.00052191137,0.0001672809,0.00044708647,0.00022024546,0.000014684725,0.00035961036],"genre_scores_gemma":[0.9966448,0.0022506479,0.00047728088,0.00009738924,0.0001715863,0.000064641055,0.0002450207,0.000017770286,0.000030852752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985156,0.00013488131,0.0007105735,0.00021506315,0.00026719688,0.00015666646],"domain_scores_gemma":[0.99747247,0.00047675523,0.0010969938,0.00011062382,0.0007719509,0.00007118216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021826064,0.00017818937,0.0006568803,0.0004896464,0.000027733016,0.00000860761,0.000112146256,0.00013490966,0.00005259711],"category_scores_gemma":[0.0001279746,0.00014412637,0.0001485786,0.0009361352,0.00017232551,0.0001752795,0.000020748099,0.00017234264,0.000002368797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008779982,0.00065502815,0.9547134,0.00003097374,0.0033485084,0.000038597555,0.0015507374,0.0042582024,0.014417039,0.00020397938,0.00003009221,0.019875433],"study_design_scores_gemma":[0.008009906,0.0023721142,0.9353547,0.00013514448,0.0020727955,0.000013585218,0.0003478024,0.0019489451,0.049121115,0.0004199615,0.00007432858,0.0001295992],"about_ca_topic_score_codex":0.00037032925,"about_ca_topic_score_gemma":0.0001204067,"teacher_disagreement_score":0.034704078,"about_ca_system_score_codex":0.0004650236,"about_ca_system_score_gemma":0.000766828,"threshold_uncertainty_score":0.5877303},"labels":[],"label_agreement":null},{"id":"W4387221743","doi":"10.5489/cuaj.8438","title":"Impact of adjuvant chemotherapy for patients with locally advanced upper tract urothelial carcinoma in real-world clinical practice","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Internal medicine; Urothelial carcinoma; Cisplatin; Chemotherapy; Oncology; Lymph node; Urothelial cancer; Adjuvant; Urology; Cancer; Bladder cancer","score_opus":0.021148427075771102,"score_gpt":0.33666034928775956,"score_spread":0.3155119222119885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387221743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927892,0.000037347156,0.000018907447,0.0048251664,0.0002002076,0.000782103,0.00018520163,0.000020921445,0.0011409399],"genre_scores_gemma":[0.9969871,0.00014791645,0.00048627253,0.0016860426,0.00028860933,0.000031881587,0.00008045904,0.000029279072,0.00026244775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804044,0.0001665961,0.0006154968,0.0002458772,0.00039560575,0.0005359847],"domain_scores_gemma":[0.99778706,0.0005418453,0.0004320647,0.00012647068,0.0005605364,0.0005520302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007747948,0.00017714652,0.0005087083,0.0002976261,0.00009023287,0.000024569397,0.00009887863,0.00019417089,0.00017389432],"category_scores_gemma":[0.0010920891,0.00012096462,0.00027849435,0.00047326292,0.000037182403,0.00015282223,0.0000059008685,0.0004552336,0.000012375006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00265694,0.00044035414,0.98040587,0.0000049270384,0.00019904795,0.00006206988,0.000105446554,0.000076758864,0.00000640526,0.0000131646975,0.0020981298,0.013930896],"study_design_scores_gemma":[0.012166931,0.004836447,0.9755805,0.000025275132,0.0001103475,0.000015862475,0.00003436538,0.000106775995,0.0000043398836,0.00010539107,0.0068944218,0.000119354336],"about_ca_topic_score_codex":0.0029082515,"about_ca_topic_score_gemma":0.0014897067,"teacher_disagreement_score":0.013811542,"about_ca_system_score_codex":0.0013364138,"about_ca_system_score_gemma":0.0017197776,"threshold_uncertainty_score":0.4932794},"labels":[],"label_agreement":null},{"id":"W4387247501","doi":"10.48083/ltml9783","title":"The End of Photodynamic Surgery for Bladder Cancer Has Arrived","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Photodynamic therapy; Cancer; General surgery; Surgery; Oncology; Internal medicine; Chemistry","score_opus":0.0858243611220835,"score_gpt":0.3681653252043632,"score_spread":0.2823409640822797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387247501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96667284,0.0017701542,0.0004076281,0.0247991,0.00326321,0.000536175,0.00023378726,0.000078577345,0.0022385372],"genre_scores_gemma":[0.9905817,0.0027949368,0.00007761892,0.00070849195,0.00067766686,0.00015051488,0.000051320727,0.000021257498,0.004936491],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99874115,0.000045212793,0.00038847423,0.00015143074,0.00038888195,0.00028487042],"domain_scores_gemma":[0.99807316,0.0010924906,0.00026390713,0.0001353841,0.00035654972,0.00007852433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004967498,0.00012789854,0.0002615845,0.00012977514,0.00027892797,0.00004594398,0.00017577616,0.0000786525,0.0005382002],"category_scores_gemma":[0.0004072323,0.00008291237,0.00038085476,0.00013882238,0.00020963587,0.00006840973,0.00003711615,0.00022759188,0.000011761867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061129793,0.00073017227,0.3017792,0.00019042275,0.01029963,0.00026580069,0.0018671555,0.00071060506,0.023195565,0.0013701456,0.4015707,0.25190762],"study_design_scores_gemma":[0.0108126085,0.0011589499,0.6621941,0.00027388567,0.001017341,0.00050492375,0.0020437879,0.005115346,0.016913239,0.027815156,0.27160925,0.0005414281],"about_ca_topic_score_codex":0.00005277244,"about_ca_topic_score_gemma":0.000054150863,"teacher_disagreement_score":0.36041486,"about_ca_system_score_codex":0.00016417066,"about_ca_system_score_gemma":0.0006299359,"threshold_uncertainty_score":0.58929145},"labels":[],"label_agreement":null},{"id":"W4387264288","doi":"10.3390/cancers15194801","title":"Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prostate Cancer Canada; University of Alberta; University of Calgary","funders":"National Cancer Institute","keywords":"Biomarker discovery; Bladder cancer; Biomarker; Disease; Computational biology; Cancer; Medicine; Cancer therapy; Bioinformatics; Oncology; Internal medicine; Biology; Genetics; Gene; Proteomics","score_opus":0.03936141403687536,"score_gpt":0.34424276986460367,"score_spread":0.3048813558277283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387264288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97974,0.018453563,0.0000016755197,0.00090976234,0.0001425931,0.00050556206,0.000031870357,0.000059809296,0.00015516464],"genre_scores_gemma":[0.98732555,0.011172229,0.00001298782,0.0003099411,0.000048726863,0.00025868168,0.000027319331,0.00003842516,0.00080616784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891055,0.00010942636,0.00017538593,0.0003403276,0.00015368966,0.00031063406],"domain_scores_gemma":[0.99960166,0.00006346436,0.00004172469,0.00014320941,0.00001264674,0.00013726749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002291542,0.00016062077,0.00021945075,0.0002663869,0.000055854143,0.000024238125,0.00004512122,0.000050325336,0.000078664365],"category_scores_gemma":[0.000043297343,0.00012880113,0.000042407268,0.00046197712,0.0000731992,0.00011664468,0.000037582693,0.00017735396,0.0000066502776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017615044,0.000033188157,0.8984594,0.000058669953,0.00006449241,0.00035070378,0.0014304591,0.00044729616,0.013391501,0.0000031178654,0.000120508186,0.06802564],"study_design_scores_gemma":[0.004823124,0.00017824993,0.98423046,0.0003980354,0.000025472345,0.0000029784462,0.000288979,0.004025727,0.00037464275,0.000027197095,0.0054735807,0.00015155978],"about_ca_topic_score_codex":0.001585989,"about_ca_topic_score_gemma":0.00033590288,"teacher_disagreement_score":0.08577108,"about_ca_system_score_codex":0.00082741486,"about_ca_system_score_gemma":0.00071506674,"threshold_uncertainty_score":0.5252358},"labels":[],"label_agreement":null},{"id":"W4387293751","doi":"10.56746/exercer.2023.196.366","title":"Facteurs de risque modifiables de cystite récidivante chez la femme non ménopausée","year":2023,"lang":"fr","type":"article","venue":"EXERCER","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine; Humanities; Philosophy","score_opus":0.024420133693982493,"score_gpt":0.3051443725081229,"score_spread":0.2807242388141404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387293751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8299859,0.016380517,0.001913835,0.010663987,0.0044670436,0.0013491126,0.00069972576,0.00067284954,0.13386701],"genre_scores_gemma":[0.8652305,0.005287203,0.00049534417,0.00089557376,0.0016053858,0.00011772352,0.00009028601,0.00013156889,0.12614642],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973773,0.000209499,0.00032757697,0.00050437794,0.00034138793,0.0012398921],"domain_scores_gemma":[0.9986848,0.00019102654,0.00008025403,0.00045793052,0.00006587749,0.0005200698],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00056436716,0.0004167913,0.0005250653,0.0001889405,0.00016281128,0.00008084344,0.00021315452,0.00039289278,0.0016928614],"category_scores_gemma":[0.000104595536,0.00040141732,0.00019366045,0.000518154,0.00020368451,0.00016629709,0.000104230916,0.00047620357,0.004289718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021799277,0.0021191728,0.22174884,0.0034132346,0.0025212804,0.010910843,0.040531594,0.0043596663,0.13877474,0.0028205053,0.4391258,0.13149439],"study_design_scores_gemma":[0.008791037,0.00089621113,0.40203238,0.0031640786,0.0018710694,0.0005101715,0.0015698954,0.00899752,0.054972023,0.002562419,0.5134721,0.0011610988],"about_ca_topic_score_codex":0.004808171,"about_ca_topic_score_gemma":0.00008506509,"teacher_disagreement_score":0.18028353,"about_ca_system_score_codex":0.0006666331,"about_ca_system_score_gemma":0.0006215181,"threshold_uncertainty_score":0.9998438},"labels":[],"label_agreement":null},{"id":"W4387293934","doi":"10.48083/nqef6409","title":"A Prospective Evaluation of Different Frailty Indices in Patients Undergoing Transurethral Resection of Bladder Tumor","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cohort; Frailty Index; Prospective cohort study; Cancer; Odds ratio; Mortality rate; Cohort study; Surgery; Internal medicine; Urology","score_opus":0.07310096081461115,"score_gpt":0.373121352262511,"score_spread":0.3000203914478998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387293934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597687,0.00011997182,0.000032161788,0.00030197803,0.0004751533,0.0004852188,0.000029281238,0.000018676492,0.002560718],"genre_scores_gemma":[0.9994813,0.000097666256,0.00003711933,0.0000532084,0.00011709296,0.000041050178,0.000042353142,0.000011529992,0.00011866507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979571,0.0001621674,0.0004769206,0.00017010013,0.0010632658,0.0001704136],"domain_scores_gemma":[0.99872875,0.00016980401,0.00033873878,0.00009056562,0.0006247998,0.0000473475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006378973,0.0001205199,0.00027790308,0.00037112233,0.000047393558,0.000010238099,0.000101172525,0.00007754552,0.00042429913],"category_scores_gemma":[0.00045463222,0.00009587958,0.00015266705,0.0002579848,0.000066677036,0.00013571868,0.000025878127,0.00030697408,0.0000037824711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011493519,0.00056670426,0.9917508,0.000039377024,0.00042193153,0.0000062486206,0.0010387846,0.00023833815,0.00059735763,0.000053139767,0.00015164122,0.003986324],"study_design_scores_gemma":[0.0097676,0.0016548957,0.97667456,0.00012730491,0.00017689934,0.000010637038,0.00054986787,0.00064807676,0.0038425496,0.006473543,0.000008658503,0.00006538968],"about_ca_topic_score_codex":0.00003002696,"about_ca_topic_score_gemma":0.0001015674,"teacher_disagreement_score":0.015076224,"about_ca_system_score_codex":0.00039487038,"about_ca_system_score_gemma":0.00030995155,"threshold_uncertainty_score":0.46457776},"labels":[],"label_agreement":null},{"id":"W4387329458","doi":"10.1200/jco.23.00307","title":"Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of British Columbia","funders":"Society for Immunotherapy of Cancer","keywords":"Bladder cancer; Medicine; Clinical trial; Cancer; Cystectomy; Multidisciplinary approach; Immunotherapy; Disease; Clinical study design; Oncology; Family medicine; Internal medicine; Medical physics","score_opus":0.3129307591216636,"score_gpt":0.5244787903783332,"score_spread":0.2115480312566696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387329458","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53866893,0.015111618,0.0017147653,0.4291021,0.009894913,0.0031562045,0.002108838,0.000023400175,0.00021920251],"genre_scores_gemma":[0.2942658,0.6287984,0.016089873,0.042960722,0.015232459,0.0017537758,0.00016212533,0.00010110669,0.00063571305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699897,0.00030998714,0.0019844503,0.000246674,0.00025601182,0.00020390526],"domain_scores_gemma":[0.9821215,0.015780887,0.0013500866,0.00016464389,0.00045300863,0.0001298533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003981862,0.00015591415,0.0010599499,0.000040653988,0.000176884,0.000024048244,0.00021713233,0.0002862559,0.00039674088],"category_scores_gemma":[0.0013764361,0.0000829755,0.0011157583,0.00010878826,0.0006612176,0.000088665765,0.00005562819,0.000526122,8.353025e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14899199,0.0014070453,0.03921775,0.000026377393,0.017706651,0.0000045520273,0.0009906992,0.0000057601546,0.00007943541,0.002022461,0.19341694,0.5961303],"study_design_scores_gemma":[0.38234994,0.009682923,0.11812413,0.00025491675,0.0061261756,0.000019523219,0.0013225735,0.0008620476,0.000057048124,0.020864276,0.46011358,0.00022287056],"about_ca_topic_score_codex":0.0009370757,"about_ca_topic_score_gemma":0.0014579552,"teacher_disagreement_score":0.6136868,"about_ca_system_score_codex":0.00010930179,"about_ca_system_score_gemma":0.0015537539,"threshold_uncertainty_score":0.43440345},"labels":[],"label_agreement":null},{"id":"W4387329471","doi":"10.1016/j.eururo.2023.09.013","title":"SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Bacillus (shape); Immune system; Cancer; Oncology; Internal medicine; Immunotherapy; Urology; Immunology; Microbiology","score_opus":0.013740912748887302,"score_gpt":0.2787620343642913,"score_spread":0.26502112161540403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387329471","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0810293,0.011518247,0.000045889814,0.0015770298,0.8940357,0.0027439056,0.0012613217,0.0005114242,0.007277176],"genre_scores_gemma":[0.15110351,0.010267121,0.000089823494,0.0019850594,0.8166347,0.0008008177,0.0012492364,0.001450696,0.016418992],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99301237,0.0012445474,0.0016138136,0.0018014858,0.0009534612,0.0013742999],"domain_scores_gemma":[0.9953758,0.0017189513,0.00072260475,0.0013011561,0.0004891705,0.00039229513],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001097351,0.0012063783,0.0020878033,0.00093189336,0.00017256674,0.00006776257,0.0006457199,0.001079089,0.0004771037],"category_scores_gemma":[0.0015241087,0.0011204303,0.0005793914,0.0006982951,0.00029561043,0.00011486239,0.00041453735,0.0025478827,0.0016034925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005717252,0.0004459964,0.00068981916,0.00093499594,0.0023486405,0.012625236,0.004834953,0.00022317389,0.024240723,0.0000055455052,0.93909556,0.008838085],"study_design_scores_gemma":[0.030361172,0.0056861443,0.015737751,0.0023327267,0.0019131062,0.000205817,0.0006758803,0.0000827191,0.00243792,0.0000523027,0.93815845,0.0023559825],"about_ca_topic_score_codex":0.002036041,"about_ca_topic_score_gemma":0.0006946166,"teacher_disagreement_score":0.07740096,"about_ca_system_score_codex":0.0010241688,"about_ca_system_score_gemma":0.0018797461,"threshold_uncertainty_score":0.9997533},"labels":[],"label_agreement":null},{"id":"W4387330498","doi":"10.1101/2023.10.03.23296504","title":"Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Toronto East General Hospital; McGill University; St Mary's Hospital Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Metastatic Urothelial Carcinoma; Oncology; Proportional hazards model; Cohort; Cancer; Bladder cancer; Metastasis; Retrospective cohort study; Urothelial carcinoma","score_opus":0.04197801078495516,"score_gpt":0.3099687286496847,"score_spread":0.26799071786472956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387330498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527663,0.00010419621,0.00005128991,0.00045680717,0.00091016997,0.0023041926,0.0003817125,0.00019570197,0.00031932342],"genre_scores_gemma":[0.99607456,0.000028121549,0.0007834179,0.00018306314,0.00015892276,0.00038786078,0.0005784247,0.00019707346,0.0016085589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594235,0.0003253732,0.0012261382,0.0009938333,0.00091708795,0.0005952246],"domain_scores_gemma":[0.9977042,0.0003141416,0.00052821403,0.0009168264,0.0002828119,0.00025380898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008358949,0.00067186746,0.0019258335,0.00029987717,0.0000639783,0.000047438778,0.0002665823,0.00033396317,0.00010783018],"category_scores_gemma":[0.00053971034,0.0004297479,0.00031683242,0.00037702543,0.00018718623,0.00006341867,0.0002960446,0.0011902716,0.00006603614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016606491,0.0018813781,0.99371856,0.00020660493,0.0016557797,0.0003125964,0.00022482417,0.000025679263,0.000010143743,0.0000050550702,0.000044592012,0.00025413383],"study_design_scores_gemma":[0.017795792,0.0018967636,0.97700906,0.001220344,0.0012077,0.0000024246235,0.000039901646,0.00004091845,0.00018642441,0.00012675901,0.00004319094,0.00043071373],"about_ca_topic_score_codex":0.0010439238,"about_ca_topic_score_gemma":0.0004248843,"teacher_disagreement_score":0.016709497,"about_ca_system_score_codex":0.00035461588,"about_ca_system_score_gemma":0.00093254744,"threshold_uncertainty_score":0.9998154},"labels":[],"label_agreement":null},{"id":"W4387340957","doi":"10.5489/cuaj.8577","title":"NS-AUA 2023 Annual Meeting Abstracts – Oncology – Bladder, Renal, Testes","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Medac","keywords":"Medicine; Urology; Internal medicine; Oncology","score_opus":0.023081281469294605,"score_gpt":0.2829900468822963,"score_spread":0.2599087654130017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387340957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81617665,0.0006339741,0.0000056373583,0.093730025,0.0013854097,0.00043537994,0.0003139505,0.00021121853,0.08710776],"genre_scores_gemma":[0.9840969,0.00028002818,0.00015362332,0.006980088,0.0014624584,0.000019678106,0.000077377284,0.000025810252,0.0069040433],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978837,0.00016469907,0.0004606721,0.00025401983,0.00043553163,0.0008013971],"domain_scores_gemma":[0.99784666,0.00036471913,0.00029730593,0.00011268295,0.00033346738,0.0010451729],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009586146,0.00017914643,0.00035973627,0.00030542084,0.00039553776,0.00007276518,0.00012978235,0.00039433813,0.0009098495],"category_scores_gemma":[0.0015366575,0.00014675265,0.00016638862,0.00051107677,0.000039696828,0.0001145732,0.000021366188,0.00072677707,0.0009330002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015627731,0.00016442499,0.42882767,0.000009900395,0.0007019642,0.0027281959,0.00059639086,0.00035097825,0.00082852645,0.000058323065,0.5475641,0.01801327],"study_design_scores_gemma":[0.0015450555,0.00081366213,0.64155537,0.000021052187,0.00014962288,0.00036531995,0.00030464755,0.000052859647,0.000069916445,0.00074353383,0.35422525,0.00015371731],"about_ca_topic_score_codex":0.0027634918,"about_ca_topic_score_gemma":0.0027425596,"teacher_disagreement_score":0.2127277,"about_ca_system_score_codex":0.0015213118,"about_ca_system_score_gemma":0.001378237,"threshold_uncertainty_score":0.9998449},"labels":[],"label_agreement":null},{"id":"W4387341599","doi":"10.5489/cuaj.8570","title":"The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Renal function; Cohort; Bladder cancer; Cisplatin; Urology; Kidney disease; Retrospective cohort study; Internal medicine; Context (archaeology); Chemotherapy; Oncology; Surgery; Cancer","score_opus":0.009001995877740048,"score_gpt":0.22865029542368492,"score_spread":0.21964829954594486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387341599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98531157,0.00004995342,0.000031355667,0.013214417,0.00026973072,0.00033701697,0.00002601973,0.000015104615,0.0007448264],"genre_scores_gemma":[0.9982162,0.000026757842,0.000005194531,0.0014218003,0.00015099521,0.0000132482855,0.000016258944,0.000010732718,0.0001388073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984827,0.00032412473,0.00030790071,0.00010863553,0.00048960524,0.00028701496],"domain_scores_gemma":[0.99777746,0.0014825121,0.00030029094,0.00011544576,0.00013208935,0.000192217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091430184,0.000111023415,0.00022913792,0.00010057484,0.0003086834,0.000021402575,0.00009887678,0.0001287708,0.00017015864],"category_scores_gemma":[0.00092445826,0.00005307445,0.00017256952,0.00030301727,0.000058112615,0.000019554906,0.000005080017,0.00034598898,0.00001852692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015254461,0.000044601522,0.972984,0.00001157838,0.00032474156,0.000012218874,0.000054361026,0.00020363803,0.00018554085,0.00011041956,0.00971004,0.014833382],"study_design_scores_gemma":[0.0050174627,0.0046772826,0.9800976,0.000045197747,0.00012585084,0.0000036343959,0.000016170838,0.000328954,0.0008967613,0.00023311476,0.008498808,0.000059170063],"about_ca_topic_score_codex":0.00014656832,"about_ca_topic_score_gemma":0.0001568417,"teacher_disagreement_score":0.014774213,"about_ca_system_score_codex":0.00043295993,"about_ca_system_score_gemma":0.00035550384,"threshold_uncertainty_score":0.23741744},"labels":[],"label_agreement":null},{"id":"W4387422001","doi":"10.1016/j.euo.2023.09.023","title":"Corrigendum to “Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes” [European Urology Oncology (2023)]","year":2023,"lang":"en","type":"erratum","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Urothelial cancer; Stromal cell; Disease; Regret; Pathology; Cancer; Oncology; Urology; Internal medicine","score_opus":0.03803041929556203,"score_gpt":0.30375274419700765,"score_spread":0.26572232490144565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387422001","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08645685,0.026587155,0.18577217,0.055795815,0.37441233,0.08569699,0.017685136,0.00595312,0.16164045],"genre_scores_gemma":[0.7937412,0.0012379733,0.029516779,0.043740854,0.020513477,0.017889714,0.007925936,0.004339965,0.081094086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912873,0.0016751314,0.001511804,0.0030022848,0.00051706046,0.0020064344],"domain_scores_gemma":[0.9949668,0.0007697271,0.0014923111,0.00089527824,0.00061701506,0.0012588657],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009408831,0.00147206,0.0029447633,0.00078230916,0.0008394801,0.00006341149,0.0006774177,0.001031228,0.000059126207],"category_scores_gemma":[0.0011615169,0.001199903,0.00060828833,0.00037599716,0.0008658514,0.000088906905,0.0007429834,0.0018876883,0.000112270274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09732677,0.008437669,0.010364444,0.0062484746,0.016030034,0.060578242,0.010323409,0.0041937334,0.003150689,0.0035561505,0.63461775,0.14517264],"study_design_scores_gemma":[0.040254157,0.068627566,0.034873094,0.0008444,0.014618781,0.00545551,0.0020123234,0.0041574147,0.0000170799,0.00011124304,0.8260009,0.0030275036],"about_ca_topic_score_codex":0.00020077467,"about_ca_topic_score_gemma":0.00021746007,"teacher_disagreement_score":0.7072844,"about_ca_system_score_codex":0.0014695164,"about_ca_system_score_gemma":0.0044885143,"threshold_uncertainty_score":0.9998029},"labels":[],"label_agreement":null},{"id":"W4387450677","doi":"10.1097/ju9.0000000000000046","title":"Oncological Surveillance After Radical Cystectomy: a Narrative Review of the Enhanced Recovery After Surgery Cystectomy Committee","year":2023,"lang":"en","type":"review","venue":"JU Open Plus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Lymphovascular invasion; General surgery; Retrospective cohort study; Cohort; Cancer; Internal medicine; Metastasis","score_opus":0.07225748113410223,"score_gpt":0.3834063167348232,"score_spread":0.311148835600721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387450677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014757412,0.98521274,0.0000047616268,0.00067052036,0.0010806215,0.0078916885,0.00050504005,0.000069056965,0.004417996],"genre_scores_gemma":[0.00065372477,0.98387086,0.000055052176,0.0020384374,0.0003722828,0.005954155,0.00016276192,0.00012762203,0.0067650788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946253,0.0014786931,0.00167878,0.00091567304,0.000740581,0.00056101],"domain_scores_gemma":[0.9958852,0.0013394889,0.0008918232,0.0014459888,0.00020943212,0.00022807985],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012924366,0.0007919382,0.0062271263,0.00013971173,0.000103194456,0.000059757986,0.0008372579,0.0005564765,0.0015362393],"category_scores_gemma":[0.0007300114,0.00043122895,0.0018927183,0.0011673698,0.0002924927,0.0001143687,0.00082438876,0.0009218931,0.00037517355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033484525,0.0005633455,0.00027683334,0.37993348,0.0035462598,0.0015476265,0.00047095906,1.3943958e-7,8.922752e-7,0.000006000983,0.088786215,0.5215198],"study_design_scores_gemma":[0.0011717398,0.00030988877,0.00065481145,0.24609824,0.0012893726,0.00017312901,0.000019702167,1.889347e-7,0.000004112604,0.000013157117,0.7498694,0.00039623491],"about_ca_topic_score_codex":0.00018730458,"about_ca_topic_score_gemma":0.00017936638,"teacher_disagreement_score":0.6610832,"about_ca_system_score_codex":0.0009102633,"about_ca_system_score_gemma":0.0033076147,"threshold_uncertainty_score":0.999814},"labels":[],"label_agreement":null},{"id":"W4387532894","doi":"10.3390/curroncol30100656","title":"Do Histology and Primary Tumor Location Influence Metastatic Patterns in Bladder Cancer?","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastasis; Bladder cancer; Histology; Carcinoma; Metastatic Urothelial Carcinoma; Lung; Renal pelvis; Cancer; Internal medicine; Oncology; Pathology; Lymph node; Urology; Ureter; Urothelial carcinoma","score_opus":0.10135715839531313,"score_gpt":0.420827653283596,"score_spread":0.3194704948882829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387532894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920902,0.0050901603,0.000037925336,0.001324284,0.0005646959,0.0004402186,0.000024535102,0.000055818462,0.00037214186],"genre_scores_gemma":[0.9969914,0.0017348785,0.00004577434,0.0006309166,0.00008271996,0.0003409486,0.000056351317,0.000015413603,0.0001016285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901557,0.000080542224,0.00023835705,0.00029459727,0.00011079834,0.00026016406],"domain_scores_gemma":[0.99953175,0.00008800351,0.00007238996,0.00014650276,0.00006883888,0.00009254444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012212731,0.00012633528,0.00034389365,0.00020319362,0.00003136769,0.000005148403,0.000054153155,0.000045350895,0.00010349285],"category_scores_gemma":[0.000050615577,0.00011069714,0.00002518153,0.00030941592,0.000092939066,0.000055965575,0.00004883282,0.00018226799,0.000057198067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019019759,0.0003697492,0.8250443,0.00045379164,0.00007262087,0.00022807473,0.0011267671,0.000027892767,0.00047850265,0.00008570726,0.0017059358,0.17021649],"study_design_scores_gemma":[0.003219187,0.00046902327,0.97183657,0.00014886603,0.00015975111,0.00009386201,0.00016174272,0.00013521154,0.00009748291,0.0002676693,0.023296436,0.00011421104],"about_ca_topic_score_codex":0.0002783428,"about_ca_topic_score_gemma":0.00033200462,"teacher_disagreement_score":0.17010228,"about_ca_system_score_codex":0.0004384921,"about_ca_system_score_gemma":0.00044087417,"threshold_uncertainty_score":0.45140982},"labels":[],"label_agreement":null},{"id":"W4387798496","doi":"10.1158/1078-0432.ccr-22-3627","title":"Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; McMaster University; BC Cancer Agency","funders":"EMD Serono; Genentech; Servier; Loxo Oncology; Astellas Pharma; Daiichi-Sankyo; Natera; National Center for Advancing Translational Sciences; Seagen; G1 Therapeutics; Sanofi; Exelixis; Jazz Pharmaceuticals; Advanced Accelerator Applications; Regeneron Pharmaceuticals; Helsinn; CTI Biopharma; Gilead Sciences; Bristol-Myers Squibb; Myriad Genetics; AstraZeneca; Mereo BioPharma; Pfizer","keywords":"Medicine; Pharmacokinetics; Adverse effect; Nausea; Internal medicine; Tolerability; Oncology; Population; Cancer; Urology; Pharmacology; Gastroenterology","score_opus":0.17311337001717203,"score_gpt":0.5108023116460696,"score_spread":0.33768894162889757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387798496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970907,0.00014005728,0.0000032161888,0.00036389002,0.00009301007,0.0021103201,0.00008483426,0.00000857023,0.00010541517],"genre_scores_gemma":[0.9992575,0.00034138907,0.000016452821,0.00005509172,0.0000602241,0.00009093721,0.000007839765,0.000024306808,0.00014626497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976287,0.00047653282,0.0005851284,0.00028725222,0.0007841868,0.00023818969],"domain_scores_gemma":[0.9987756,0.00040338482,0.00011134554,0.0003205156,0.00028913957,0.00009998614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001004287,0.00010847437,0.0004148338,0.00015504709,0.000054581542,0.0000058068663,0.00012911546,0.00004276334,0.000080877035],"category_scores_gemma":[0.00012358432,0.00006426857,0.000055941353,0.00090143265,0.00029793128,0.000036669826,0.0000756843,0.00035583548,0.0000021077226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015874384,0.004137441,0.9437573,0.0000850249,0.000166675,0.000007174889,0.000913011,0.000029557166,0.00016546078,0.000004503654,0.00009400436,0.034765452],"study_design_scores_gemma":[0.055746473,0.0077868174,0.9349209,0.0000836128,0.00010771202,2.2634185e-7,0.00024764473,0.00027821003,0.00058488245,0.000031057643,0.00015866903,0.000053797932],"about_ca_topic_score_codex":0.000910465,"about_ca_topic_score_gemma":0.0002086697,"teacher_disagreement_score":0.039872088,"about_ca_system_score_codex":0.00006721104,"about_ca_system_score_gemma":0.00030513885,"threshold_uncertainty_score":0.26207963},"labels":[],"label_agreement":null},{"id":"W4387807073","doi":"10.1016/j.annonc.2023.09.1014","title":"2365MO Study EV-103 cohort L: Perioperative treatment w/ enfortumab vedotin (EV) monotherapy in cisplatin (cis)-ineligible patients (pts) w/ muscle invasive bladder cancer (MIBC)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Seagen","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Internal medicine; Clinical endpoint; Cohort; Tolerability; Perioperative; Neoadjuvant therapy; Oncology; Gastroenterology; Cancer; Surgery; Adverse effect; Clinical trial","score_opus":0.09810588048068886,"score_gpt":0.4205012147464612,"score_spread":0.3223953342657723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387807073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875151,0.0004187997,0.0000019944014,0.0014927271,0.0003511923,0.0030778707,0.00014314397,0.000073712654,0.006925482],"genre_scores_gemma":[0.9909276,0.0035151776,0.0000492107,0.0013489148,0.00015734718,0.0014567232,0.00014285972,0.00006719502,0.0023349829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735814,0.00022008107,0.00076738774,0.00064766704,0.00039095455,0.0006157565],"domain_scores_gemma":[0.9985855,0.00022228045,0.0002551991,0.00044157662,0.00029394426,0.00020148171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024228895,0.00041541824,0.0011177927,0.00041323368,0.000106150124,0.000015421954,0.00016025592,0.00020993053,0.0007256435],"category_scores_gemma":[0.0000690839,0.00033299386,0.00019413269,0.0006857319,0.00012769543,0.00013983432,0.000043617823,0.00020003565,0.000105708554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026706376,0.006742041,0.8800551,0.000040332998,0.0014660391,0.00030031148,0.0148559455,0.00021803849,0.0017066037,0.000025923882,0.0034672567,0.08845174],"study_design_scores_gemma":[0.023925405,0.029582113,0.9190105,0.00010780787,0.00029720477,0.0000052180867,0.0029542686,0.000091166294,0.012133526,0.00007183524,0.011470114,0.00035083925],"about_ca_topic_score_codex":0.00582849,"about_ca_topic_score_gemma":0.0044133924,"teacher_disagreement_score":0.0881009,"about_ca_system_score_codex":0.0003764643,"about_ca_system_score_gemma":0.0011868017,"threshold_uncertainty_score":0.9999122},"labels":[],"label_agreement":null},{"id":"W4387807077","doi":"10.1016/j.annonc.2023.09.1023","title":"2374P A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Surrogate endpoint; Phases of clinical research; Progression-free survival; Oncology; Refractory (planetary science); Chemotherapy regimen; Gastroenterology; Cancer; Urology; Clinical trial; Surgery; Chemotherapy","score_opus":0.1815938663050468,"score_gpt":0.4683965966881169,"score_spread":0.2868027303830701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387807077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96743965,0.002833556,0.0009910312,0.0067431564,0.002150153,0.008323588,0.0024554038,0.00023889523,0.008824552],"genre_scores_gemma":[0.9831113,0.0041513722,0.0030976965,0.001409222,0.0005277965,0.0017221585,0.00019305937,0.00013158214,0.0056558014],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99740773,0.00012344275,0.0008604682,0.0005137774,0.00038904324,0.0007055306],"domain_scores_gemma":[0.9977003,0.0006311913,0.00045101225,0.0004183617,0.00056414324,0.00023500291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039811066,0.00033515148,0.0013306784,0.00031764948,0.0000748485,0.000007825728,0.00020393549,0.00017878175,0.000588474],"category_scores_gemma":[0.00057638495,0.00025863893,0.00034291568,0.00069759926,0.00024715837,0.00015244428,0.000054790093,0.00016586733,0.000020664125],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40832204,0.010472453,0.000104314255,0.00077846134,0.0015431358,0.00022510307,0.00057099573,0.00036786246,0.04599229,0.00016111867,0.009466092,0.52199614],"study_design_scores_gemma":[0.32973117,0.19746321,0.000099392906,0.00051341066,0.0011754887,0.000047120186,0.00035901606,0.00045067776,0.28471497,0.0012923079,0.1837275,0.00042573427],"about_ca_topic_score_codex":0.0002827727,"about_ca_topic_score_gemma":0.00033400816,"teacher_disagreement_score":0.5215704,"about_ca_system_score_codex":0.00012407426,"about_ca_system_score_gemma":0.0014689183,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W4387807145","doi":"10.1016/j.annonc.2023.09.1020","title":"2371P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Gilead Sciences; Pfizer","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Clinical endpoint; Progression-free survival; Adverse effect; Maintenance therapy; Chemotherapy; Oncology; Surgery; Urology; Randomized controlled trial; Urothelial carcinoma; Bladder cancer; Cancer; Immunotherapy; Nivolumab","score_opus":0.10137632114983085,"score_gpt":0.39086171173493095,"score_spread":0.2894853905851001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387807145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810166,0.00024896086,0.00007066043,0.012934217,0.001297844,0.0032174105,0.00063104206,0.000051994084,0.00053129235],"genre_scores_gemma":[0.9925144,0.0004277845,0.00013816147,0.0039656344,0.00049766485,0.00067514717,0.00035849932,0.000060373473,0.0013623658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997616,0.000117953896,0.00078482577,0.00051978335,0.00032997236,0.0006314527],"domain_scores_gemma":[0.9978622,0.00089813536,0.00028761968,0.00050796365,0.00031274345,0.00013130374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033625515,0.00031814227,0.0009321832,0.00015655474,0.000099641984,0.000010332939,0.00028642153,0.00025447112,0.00032392397],"category_scores_gemma":[0.00053538807,0.00021565724,0.0003415705,0.00030380097,0.00016425975,0.00008914721,0.00010145953,0.00023449004,0.00008169727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088388465,0.004124542,0.68352723,0.00013670004,0.0008219995,0.0001855178,0.0025634326,0.000045642137,0.00018765901,0.00007107234,0.026888574,0.19305916],"study_design_scores_gemma":[0.1551811,0.007223844,0.8268426,0.00011706963,0.00017790198,0.0000029894325,0.000108457934,0.00005829066,0.0010954062,0.00045296882,0.008517901,0.00022146548],"about_ca_topic_score_codex":0.000596617,"about_ca_topic_score_gemma":0.0011945772,"teacher_disagreement_score":0.1928377,"about_ca_system_score_codex":0.000120522156,"about_ca_system_score_gemma":0.0003925947,"threshold_uncertainty_score":0.8794247},"labels":[],"label_agreement":null},{"id":"W4387807199","doi":"10.1016/j.annonc.2023.09.1010","title":"2361MO Impact of positron emission tomography (PET) imaging on staging of muscle-invasive bladder cancer (MIBC) [PET-MUSE]","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of Ottawa; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"Astellas Pharma Canada; AstraZeneca","keywords":"Medicine; Positron emission tomography; Bladder cancer; Pet imaging; Nuclear medicine; Radiology; Preclinical imaging; Cancer; Internal medicine; In vivo","score_opus":0.055383504919857426,"score_gpt":0.4118716535591241,"score_spread":0.35648814863926664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387807199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892894,0.0006917917,0.000004646472,0.0021938174,0.00019929973,0.00037628782,0.00017222387,0.00004658643,0.00702596],"genre_scores_gemma":[0.9969974,0.0019477225,0.00007658705,0.00058233045,0.000108020606,0.000030798787,0.00004261412,0.000038349048,0.00017617669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833304,0.00009982411,0.00050490926,0.00031524216,0.00032834688,0.0004186413],"domain_scores_gemma":[0.99848485,0.0002546474,0.00037931124,0.00034750302,0.00036342943,0.00017028865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002456873,0.00022897836,0.0007456341,0.0005930853,0.000043765765,0.000003694939,0.00014221361,0.00006729192,0.00026214198],"category_scores_gemma":[0.00008816416,0.00018024795,0.00043277693,0.0006681435,0.00016611499,0.00008703192,0.0000654144,0.00017724604,0.0000072358516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033669353,0.001864393,0.45441052,0.00063419493,0.0024866124,0.00066655193,0.0029831047,0.00026637208,0.35352963,0.00006694371,0.04275342,0.1369713],"study_design_scores_gemma":[0.0057214717,0.010333107,0.6906152,0.001126358,0.00053774164,0.000049577517,0.00083139265,0.00011700356,0.28774613,0.00054169714,0.0020795302,0.00030082575],"about_ca_topic_score_codex":0.0028522615,"about_ca_topic_score_gemma":0.00005992073,"teacher_disagreement_score":0.23620464,"about_ca_system_score_codex":0.000100419835,"about_ca_system_score_gemma":0.000727814,"threshold_uncertainty_score":0.7350298},"labels":[],"label_agreement":null},{"id":"W4387807384","doi":"10.1101/2023.10.19.562817","title":"Increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages associate with poor clinical outcomes in BCG treated non-muscle invasive bladder cancer","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Queen's University","funders":"","keywords":"Stromal cell; Tumor microenvironment; CD163; Bladder cancer; Immune system; CD68; Tissue microarray; Cancer research; Cytotoxic T cell; CD8; Immunotherapy; Biology; Pathology; Medicine; Immunohistochemistry; Immunology; Cancer; Macrophage; Internal medicine; In vitro","score_opus":0.02292352715706039,"score_gpt":0.2704444510171391,"score_spread":0.2475209238600787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387807384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945041,0.00071831665,0.000009165309,0.0002193816,0.0007709463,0.0015405474,0.0020128181,0.00021670428,0.000007999862],"genre_scores_gemma":[0.9956652,0.0020519337,0.000934295,0.00039559693,0.00025727894,0.00035186272,0.0000037241384,0.00024516106,0.00009494707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606234,0.0002591347,0.0010521939,0.0012754368,0.00061759166,0.0007333218],"domain_scores_gemma":[0.9971356,0.0003266766,0.00069962605,0.0008518545,0.0005456019,0.00044066893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005090986,0.00085397,0.0019634464,0.0004203221,0.00010252108,0.00008825767,0.0002790586,0.00073962245,0.000060566796],"category_scores_gemma":[0.00011881156,0.00073171064,0.0002805467,0.00050288485,0.00035593915,0.00011209106,0.00036134454,0.00094502495,0.000023963914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006002683,0.00072943437,0.8095914,0.0008026175,0.0021800578,0.00088285,0.00006150013,0.000026067715,0.18460903,0.0000026380565,0.00050840626,0.0000056933004],"study_design_scores_gemma":[0.004692174,0.00046857755,0.76658404,0.0009956062,0.0011159389,4.7544717e-8,0.000032397053,0.000047985366,0.2254886,6.475939e-7,0.000049726907,0.0005242645],"about_ca_topic_score_codex":0.009116523,"about_ca_topic_score_gemma":0.00074697,"teacher_disagreement_score":0.043007404,"about_ca_system_score_codex":0.00044333897,"about_ca_system_score_gemma":0.0018517276,"threshold_uncertainty_score":0.9995134},"labels":[],"label_agreement":null},{"id":"W4387810206","doi":"10.1016/j.annonc.2023.09.2827","title":"2409TiP A global, multicentre, open-label, randomised phase II trial of tobemstomig (tobe) with or without tiragolumab (tira) vs atezolizumab (atezo) in patients (pts) with untreated metastatic urothelial cancer (mUC) ineligible for platinum-based chemotherapy (chemo)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation Medicine; Genentech; Loxo Oncology; Astellas Pharma; Seagen; Bayer Canada; G1 Therapeutics; Sanofi; Exelixis; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Merck KGaA; Gilead Sciences; Mirati Therapeutics; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Atezolizumab; Medicine; TIGIT; Internal medicine; Oncology; Clinical trial; Phases of clinical research; Cancer; Nivolumab; Immunotherapy","score_opus":0.11881336517725506,"score_gpt":0.4432796996802627,"score_spread":0.32446633450300766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387810206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863952,0.00008044787,0.000074679825,0.0012953734,0.00016145408,0.010173415,0.00092344027,0.00007324263,0.00082279154],"genre_scores_gemma":[0.9932882,0.00019986677,0.0017536186,0.0012591012,0.00008120297,0.0024139464,0.0003481282,0.000100574005,0.0005553354],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99682,0.00020762572,0.0010556949,0.0006685962,0.000510449,0.00073764427],"domain_scores_gemma":[0.997475,0.00038220506,0.0007851286,0.0004752696,0.0006466705,0.00023572159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044296487,0.0005201403,0.0022099498,0.00030861533,0.00010734543,0.00002121485,0.0003405861,0.00020588402,0.00026350326],"category_scores_gemma":[0.00022760553,0.00034743204,0.00013824973,0.0011256862,0.00026001272,0.00016316847,0.00006946873,0.00016783336,0.00000638699],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9176721,0.01562615,0.009500107,0.0003104106,0.0013973257,0.000078782905,0.00070243474,0.00011969061,0.00042292502,0.0000075537137,0.00230979,0.051852718],"study_design_scores_gemma":[0.8759342,0.09805393,0.0009499258,0.00050557125,0.00081769907,0.0000082635415,0.00013199438,0.0018808478,0.01822705,0.000029693461,0.00310897,0.00035186164],"about_ca_topic_score_codex":0.003459754,"about_ca_topic_score_gemma":0.0023633002,"teacher_disagreement_score":0.082427785,"about_ca_system_score_codex":0.0003102652,"about_ca_system_score_gemma":0.0025100529,"threshold_uncertainty_score":0.9998978},"labels":[],"label_agreement":null},{"id":"W4387826920","doi":"10.1016/j.annonc.2023.09.1175","title":"1946P Bladder primary sarcomas (BSar): A genomic landscape and clinical outcomes study","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Germline; Oncology; Germline mutation; Internal medicine; Bladder cancer; Genetics; Cancer; Mutation; Biology; Gene","score_opus":0.1362513437820243,"score_gpt":0.45334160226715636,"score_spread":0.31709025848513206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387826920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826656,0.00055269484,0.0000011900265,0.004645889,0.00024418012,0.0005616928,0.000020843909,0.00006193158,0.011245952],"genre_scores_gemma":[0.99357986,0.0009656071,0.00009652646,0.003512573,0.00015752295,0.00003115473,0.000023927922,0.00002232302,0.0016104933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987134,0.00013462029,0.0004467823,0.00028841262,0.00015693517,0.00025988717],"domain_scores_gemma":[0.99906266,0.00034136252,0.00010814297,0.00026476718,0.00007786535,0.00014520595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004893022,0.00013928438,0.0007106957,0.00013313485,0.000045936227,0.000004798826,0.00008074064,0.000129732,0.00013836185],"category_scores_gemma":[0.000083719795,0.00010499993,0.00014679175,0.00015446839,0.0001304169,0.000033163135,0.00011519087,0.0001590285,0.00010913713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004890373,0.001385661,0.92785704,0.00002352201,0.0008931861,0.00022375274,0.0004398739,2.9754864e-7,0.00007212261,0.0000131269235,0.01446928,0.05413312],"study_design_scores_gemma":[0.005477795,0.007826464,0.9679037,0.000008329103,0.00025592223,0.000027503138,0.00043943748,0.000006580918,0.00002598724,0.00013917508,0.017806238,0.00008292281],"about_ca_topic_score_codex":0.00009253686,"about_ca_topic_score_gemma":0.00007146225,"teacher_disagreement_score":0.054050196,"about_ca_system_score_codex":0.00001655382,"about_ca_system_score_gemma":0.00024750695,"threshold_uncertainty_score":0.42817727},"labels":[],"label_agreement":null},{"id":"W4387826951","doi":"10.1016/j.annonc.2023.09.1027","title":"2378P Efficacy and safety outcomes with pembrolizumab (pembro) rechallenge for patients (pts) with advanced/metastatic urothelial cancer (UC) who responded to first-course treatment","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Urothelial cancer; Pembrolizumab; Cancer; Internal medicine","score_opus":0.08085293338280829,"score_gpt":0.4097118803035344,"score_spread":0.3288589469207261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387826951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911066,0.00046258824,0.000038962775,0.014678133,0.00015361526,0.0035755422,0.00055687706,0.000083156185,0.0013404865],"genre_scores_gemma":[0.9870817,0.0034140274,0.0019794179,0.0018429116,0.000097549164,0.0015998564,0.000092729126,0.000102762904,0.0037890498],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99816394,0.00008239791,0.00039137353,0.0005355202,0.00029190435,0.0005348699],"domain_scores_gemma":[0.9983088,0.00050500303,0.00019001866,0.0003692075,0.00033673848,0.00029025372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015711124,0.0003571825,0.0010044753,0.00021067214,0.00013164156,0.000008146473,0.00010014674,0.00010987261,0.00006224435],"category_scores_gemma":[0.00009377916,0.00022892076,0.0001051187,0.00031732445,0.00012644642,0.00008287361,0.000037050308,0.000098561984,0.000015725951],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20828305,0.006985403,0.095066026,0.00062996685,0.0042283623,0.00027764373,0.007212352,0.0005003239,0.00019728167,0.00025452903,0.0053869192,0.6709781],"study_design_scores_gemma":[0.10648794,0.15920068,0.58408064,0.0006392472,0.0013739706,0.000035199973,0.00056611776,0.000041721196,0.0016589223,0.00016153554,0.14519216,0.0005618514],"about_ca_topic_score_codex":0.00022718983,"about_ca_topic_score_gemma":0.0011683078,"teacher_disagreement_score":0.6704163,"about_ca_system_score_codex":0.00019918391,"about_ca_system_score_gemma":0.0006352551,"threshold_uncertainty_score":0.93351173},"labels":[],"label_agreement":null},{"id":"W4387906361","doi":"10.5489/cuaj.8341","title":"Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBC","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Gemcitabine; Docetaxel; Interquartile range; Salvage therapy; Surgery; Adverse effect; Progression-free survival; Urology; Internal medicine; Oncology; Cancer; Overall survival; Chemotherapy","score_opus":0.011893414368432985,"score_gpt":0.23612719624438147,"score_spread":0.22423378187594847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387906361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866307,0.00006741494,0.00003668305,0.0123599265,0.00009496065,0.00057072064,0.000091433314,0.000021982665,0.00012619207],"genre_scores_gemma":[0.997749,0.00006467573,0.0002287944,0.0014466045,0.0002295726,0.000039328876,0.000096959106,0.000017479957,0.00012761987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879503,0.00006460314,0.00019959363,0.00020724279,0.00029061493,0.0004428888],"domain_scores_gemma":[0.999136,0.00006759803,0.00010900366,0.00006537426,0.000175686,0.00044634062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024773565,0.00014558122,0.0002596298,0.00018191843,0.00014243166,0.000060829138,0.00005215904,0.00013924198,0.00012295037],"category_scores_gemma":[0.000097458236,0.00009063989,0.000045599565,0.00026804494,0.000034449145,0.00008297723,0.0000059983763,0.00034412259,0.000009062244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001049689,0.000096943215,0.9863601,0.000005561041,0.00015300426,0.000056801015,0.00015050292,0.000007855388,0.000010859014,0.000047431204,0.00341553,0.008645746],"study_design_scores_gemma":[0.00950425,0.0028026623,0.97709674,0.000021832046,0.000056710767,0.000024201001,0.00003627603,0.00003993049,0.0000074362115,0.00023301713,0.0100628445,0.000114095885],"about_ca_topic_score_codex":0.00024194113,"about_ca_topic_score_gemma":0.0017899312,"teacher_disagreement_score":0.011118279,"about_ca_system_score_codex":0.0005165804,"about_ca_system_score_gemma":0.00036107452,"threshold_uncertainty_score":0.36961874},"labels":[],"label_agreement":null},{"id":"W4387906569","doi":"10.5489/cuaj.8386","title":"Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Bladder cancer; Interquartile range; Proportional hazards model; Urology; Confidence interval; Population; Internal medicine; Oncology; Cancer registry; Cystectomy; Cancer","score_opus":0.03689247387476914,"score_gpt":0.30513868250740417,"score_spread":0.26824620863263504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387906569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97691596,0.00012907996,0.000009613743,0.01654258,0.0004306425,0.00051392015,0.00057996594,0.000079684956,0.0047985706],"genre_scores_gemma":[0.99460936,0.0003103584,0.00002673967,0.0013023581,0.00034232542,0.000044104352,0.00022828918,0.00002764285,0.0031088425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762535,0.00021652412,0.0005279567,0.00032519375,0.0006691092,0.00063588674],"domain_scores_gemma":[0.99757296,0.00033253097,0.0005447744,0.0001523979,0.0006558516,0.0007414788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003367037,0.00029851365,0.0008658037,0.0004217577,0.00024515137,0.000059554724,0.00013203865,0.00019559386,0.00084018894],"category_scores_gemma":[0.0001848561,0.0002149013,0.00020233932,0.00090729556,0.00009034536,0.00013486542,0.000014545125,0.00048668552,0.00008589112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014008043,0.00010127135,0.98355454,0.000010192765,0.0012051435,0.000104376806,0.0005379475,0.00013502086,0.000119975666,0.00007883129,0.0121315345,0.0018811072],"study_design_scores_gemma":[0.0038033337,0.0007224499,0.98511356,0.000036874575,0.0005324932,0.000017072713,0.00029538458,0.00011930869,0.0002684112,0.000057888145,0.008820024,0.0002131985],"about_ca_topic_score_codex":0.013102079,"about_ca_topic_score_gemma":0.044281427,"teacher_disagreement_score":0.031179346,"about_ca_system_score_codex":0.0016000652,"about_ca_system_score_gemma":0.0019047107,"threshold_uncertainty_score":0.9934698},"labels":[],"label_agreement":null},{"id":"W4388034857","doi":"10.1111/bju.16210","title":"Impact of the extent of lymph node dissection on survival outcomes in clinically lymph <scp>node‐positive</scp> bladder cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Interquartile range; Lymph node; Cystectomy; Dissection (medical); Bladder cancer; Hazard ratio; Proportional hazards model; Propensity score matching; Confidence interval; Lymph; Urology; Retrospective cohort study; Clinical endpoint; Surgery; Cancer; Internal medicine; Pathology; Randomized controlled trial","score_opus":0.023447219379213236,"score_gpt":0.3383968113395317,"score_spread":0.31494959196031846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388034857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967821,0.00074491714,0.00002196341,0.0006452107,0.0007338507,0.00018755892,0.00012807967,0.000009343646,0.0007469454],"genre_scores_gemma":[0.99728304,0.0017897354,0.000018328266,0.00040235897,0.0001801746,0.000008693065,0.0000046780783,0.00002758198,0.00028540991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979754,0.00026153008,0.0008830598,0.0001853039,0.00039746176,0.0002972156],"domain_scores_gemma":[0.9984342,0.0004767491,0.0005419406,0.00018023171,0.0002542211,0.00011267477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000489876,0.00015476896,0.0007550892,0.00018070325,0.000041610143,0.000008659815,0.00017591975,0.00015655915,0.000076259894],"category_scores_gemma":[0.0005474273,0.00011357545,0.00050555106,0.00032253435,0.00015570602,0.0000593755,0.000048824404,0.0002853109,0.0000048298084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005967402,0.0007511374,0.9868203,0.000028588485,0.00081041415,0.00039749497,0.00019190965,0.0008945417,0.0011726458,0.000008219936,0.00043384542,0.007894185],"study_design_scores_gemma":[0.00538752,0.0011714653,0.9914117,0.0002456481,0.00026741452,0.00088749995,0.00008115142,0.00005300309,0.00028491448,0.00014461923,0.000024910414,0.000040187977],"about_ca_topic_score_codex":0.0020156808,"about_ca_topic_score_gemma":0.00018082137,"teacher_disagreement_score":0.007853997,"about_ca_system_score_codex":0.00016977148,"about_ca_system_score_gemma":0.0004700153,"threshold_uncertainty_score":0.46314725},"labels":[],"label_agreement":null},{"id":"W4388048545","doi":"10.1136/jitc-2023-sitc2023.0897-d","title":"897-D Combinational treatment of reovirus and NK cells against bladder cancer cells using an intravesical therapy mimicking in vitro assay","year":2023,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cytotoxicity; Oncolytic virus; Bladder cancer; Combination therapy; Cancer research; In vitro; Immunotherapy; K562 cells; Cancer; Immunology; Medicine; Pharmacology; Internal medicine; Biology; Leukemia; Biochemistry","score_opus":0.06188461784131613,"score_gpt":0.3372488614413883,"score_spread":0.27536424360007217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388048545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977063,0.00038295047,0.00003594797,0.000242336,0.00016327074,0.0004956227,0.00005980312,0.00004444777,0.00086930307],"genre_scores_gemma":[0.99624586,0.0021935836,0.0005158642,0.00037523167,0.000104126986,0.000037371483,0.00004921955,0.000031137024,0.00044760652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988649,0.00006892268,0.00026574472,0.00029895536,0.00024178333,0.0002597134],"domain_scores_gemma":[0.9995142,0.00008115214,0.000059489324,0.00016836569,0.000055024855,0.000121759585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011505979,0.00019053108,0.0003568083,0.00019126339,0.00005050098,0.00001592643,0.00004239485,0.00008831949,0.0001560691],"category_scores_gemma":[0.0000032855423,0.00014384587,0.00006181338,0.00026350838,0.00007563996,0.000084284315,0.000014497018,0.0000688458,0.000006634409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035548626,0.0009878078,0.0046961894,0.000024258672,0.00018627083,0.000057184658,0.0011894512,0.00012748472,0.9326682,0.000024096682,0.00007175772,0.059611805],"study_design_scores_gemma":[0.0068189153,0.00063073164,0.018412078,0.000048962513,0.00007411791,0.0000049055748,0.0002630702,0.0062036766,0.9668843,0.00008133804,0.00041676988,0.00016111742],"about_ca_topic_score_codex":0.0014240965,"about_ca_topic_score_gemma":0.00008126981,"teacher_disagreement_score":0.059450686,"about_ca_system_score_codex":0.00022697053,"about_ca_system_score_gemma":0.00019358644,"threshold_uncertainty_score":0.5865864},"labels":[],"label_agreement":null},{"id":"W4388215338","doi":"10.1097/upj.0000000000000481.02","title":"Reply by Authors","year":2023,"lang":"en","type":"article","venue":"Urology Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Bladder cancer; Gemcitabine; Docetaxel; Library science; Family medicine; Urology; General surgery; Internal medicine; Cancer","score_opus":0.02457187011876625,"score_gpt":0.3413789004039344,"score_spread":0.31680703028516816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388215338","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.121744506,0.0017468195,0.0002960401,0.5188627,0.0018865512,0.00082506594,0.000050001297,0.0012462103,0.35334212],"genre_scores_gemma":[0.8529634,0.00050876127,0.0006788088,0.09350628,0.00034762503,0.000081161445,0.00011765146,0.000053060263,0.05174325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992025,0.00009317134,0.000116571275,0.00023182688,0.00013306121,0.00022286792],"domain_scores_gemma":[0.9992458,0.0002939471,0.000054011605,0.00025361337,0.0000517466,0.000100830075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026782116,0.00008311267,0.00013276408,0.00006159358,0.00006349178,0.00000727187,0.00004839553,0.000086709486,0.0003251549],"category_scores_gemma":[0.0008522373,0.00007221448,0.000037756472,0.00024062447,0.00004534524,0.00011226698,0.000028629122,0.00021078573,0.0023722767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010367108,0.0002133285,0.00487049,0.000011714038,0.0002621396,0.00067515613,0.0003550303,0.0000021617439,0.0016901947,0.00037483327,0.9835589,0.0069493446],"study_design_scores_gemma":[0.0010494224,0.0005809671,0.0039794855,0.0000016202447,0.0002861306,0.00034544824,0.00009553438,0.00003896179,0.00046288822,0.00016510706,0.9929363,0.00005812646],"about_ca_topic_score_codex":0.0001330842,"about_ca_topic_score_gemma":0.0000012459022,"teacher_disagreement_score":0.7312189,"about_ca_system_score_codex":0.000022532337,"about_ca_system_score_gemma":0.00007125297,"threshold_uncertainty_score":0.9984045},"labels":[],"label_agreement":null},{"id":"W4388221480","doi":"10.1186/s12894-023-01349-9","title":"Effect of the TERT mutation on the prognosis of patients with urothelial carcinoma: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"BMC Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Meta-analysis; Confidence interval; Cochrane Library; Oncology; Mutation; Relative risk; Urothelial carcinoma; Gastroenterology; Cancer; Bladder cancer; Genetics; Gene","score_opus":0.06010628402728015,"score_gpt":0.33160684116434674,"score_spread":0.2715005571370666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388221480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038653417,0.98900723,0.000004159777,0.00010555729,0.000027002483,0.010189168,0.0002232287,0.000010884773,0.00004621335],"genre_scores_gemma":[0.17758566,0.80880463,0.000026754687,0.00095773395,0.000047985443,0.011597931,0.00021745494,0.00017056178,0.0005912856],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99670243,0.0017772182,0.0007266778,0.00031881372,0.00033264278,0.00014224106],"domain_scores_gemma":[0.99713093,0.0011862518,0.0008734093,0.0006756592,0.00009946598,0.000034289646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060051715,0.00034620907,0.005328423,0.00015198343,0.000037640955,0.000003963942,0.00018033174,0.00012568141,0.000050974293],"category_scores_gemma":[0.00031662296,0.00011274829,0.0015032701,0.00068606174,0.00012348944,0.0000103894545,0.00004816073,0.00016648705,0.000008830797],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090547066,0.00009102854,0.0016903797,0.9489277,0.048925687,0.0000025435645,0.00003325704,3.346801e-7,1.3049222e-8,0.000013721854,0.000022434982,0.0002023479],"study_design_scores_gemma":[0.00046005583,0.0018551036,0.0007785079,0.0034183676,0.9930424,0.000010523878,0.0000012413965,0.000001093743,0.0000021232943,0.0000018791371,0.00035101062,0.00007767756],"about_ca_topic_score_codex":0.000043468117,"about_ca_topic_score_gemma":0.000024492365,"teacher_disagreement_score":0.9455093,"about_ca_system_score_codex":0.000027005002,"about_ca_system_score_gemma":0.00012952731,"threshold_uncertainty_score":0.4597742},"labels":[],"label_agreement":null},{"id":"W4388494977","doi":"10.1136/ijgc-2023-igcs.334","title":"EP262/#530  Is there a role for intraperitoneal chemotherapy in early stage pelvic high-grade serous carcinoma?","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Serous fluid; Stage (stratigraphy); Proportional hazards model; Serous carcinoma; Retrospective cohort study; Population; Cancer; Ovarian cancer","score_opus":0.030596037256476177,"score_gpt":0.33838296012120417,"score_spread":0.307786922864728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388494977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861974,0.00078815984,0.000036435624,0.0112164505,0.0009283685,0.000352972,0.00014540814,0.000025755213,0.00030900925],"genre_scores_gemma":[0.9941106,0.0008958465,0.00029015666,0.002599404,0.00079543685,0.000094350406,0.000012230246,0.000027252021,0.0011747347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851036,0.000034861016,0.00045155728,0.0002126847,0.00050427223,0.00028627564],"domain_scores_gemma":[0.9990503,0.0001787873,0.00020664411,0.00009691569,0.00033411937,0.00013320967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019101564,0.00017166967,0.00039164085,0.00021032245,0.000035298643,0.000037889873,0.00026996358,0.00013739585,0.0016030385],"category_scores_gemma":[0.0000654702,0.00012385452,0.00022140294,0.00019660976,0.00005721721,0.000118448785,0.00003323975,0.00027972477,0.000020395843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057894965,0.0011169454,0.9182728,0.00006141938,0.0011415218,0.0015310546,0.0027499646,0.00021000156,0.007343472,0.00045202594,0.004694753,0.056636535],"study_design_scores_gemma":[0.008704209,0.0015638059,0.9663321,0.00007313137,0.00005933566,0.000056719928,0.00021087295,0.0002186936,0.0047617285,0.0018577849,0.016023017,0.00013861357],"about_ca_topic_score_codex":0.00062968594,"about_ca_topic_score_gemma":0.00018299822,"teacher_disagreement_score":0.05649792,"about_ca_system_score_codex":0.00050930306,"about_ca_system_score_gemma":0.00028805173,"threshold_uncertainty_score":0.99930966},"labels":[],"label_agreement":null},{"id":"W4388500626","doi":"10.1111/his.15091","title":"Head‐to‐head: how many categories for grading urothelial carcinoma?","year":2023,"lang":"en","type":"review","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Grading (engineering); Urothelial carcinoma; Medicine; Carcinoma; Urothelial cancer; Bladder cancer; Oncology; Pathology; Radiology; Internal medicine; Cancer; Biology","score_opus":0.13730023812297723,"score_gpt":0.39881414358615397,"score_spread":0.26151390546317677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388500626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006337647,0.99001163,0.00055855105,0.0007516511,0.0030073272,0.0036431279,0.00058745756,0.0002837198,0.0010931825],"genre_scores_gemma":[0.00020501987,0.9550639,0.0009236886,0.00056075206,0.0020819919,0.003262034,0.00056986074,0.00036590136,0.036966864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738055,0.00013535761,0.0005549187,0.0009527576,0.00022496024,0.00075144443],"domain_scores_gemma":[0.9984615,0.00017060491,0.00022525195,0.00072694576,0.00010760474,0.0003081267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024497102,0.00067325926,0.0028149816,0.0005779909,0.00020193105,0.000027859212,0.00026745032,0.00053808256,0.00005265849],"category_scores_gemma":[0.0001644921,0.00056064146,0.00080584444,0.0003897216,0.000147624,0.00003865822,0.00009655348,0.00040761393,0.0005285933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047432576,0.00032625115,0.00044164815,0.064407036,0.00026199428,0.0035249062,0.0014797552,2.0282583e-7,0.000054985358,0.004267139,0.05009536,0.8746664],"study_design_scores_gemma":[0.0011994134,0.0010443847,0.0002946852,0.002122095,0.0024391233,0.0010885675,0.000027705466,7.998224e-7,0.00000435236,0.00023041424,0.9911232,0.00042523604],"about_ca_topic_score_codex":0.00014718548,"about_ca_topic_score_gemma":0.00010215532,"teacher_disagreement_score":0.9410279,"about_ca_system_score_codex":0.0007488136,"about_ca_system_score_gemma":0.00086378306,"threshold_uncertainty_score":0.9996845},"labels":[],"label_agreement":null},{"id":"W4388657135","doi":"10.1016/j.urolonc.2023.10.004","title":"Optimizing outcomes for high-risk, non-muscle-invasive bladder cancer: The evolving role of PD-(L)1 inhibition","year":2023,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pfizer","keywords":"Medicine; Bladder cancer; Immunotherapy; Clinical trial; Adverse effect; Oncology; Internal medicine; Cancer","score_opus":0.053086448714973825,"score_gpt":0.3638037370371719,"score_spread":0.3107172883221981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388657135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059549413,0.98752576,0.000058536698,0.001679295,0.00047574806,0.0029825973,0.0008169301,0.00009235953,0.0004138131],"genre_scores_gemma":[0.00040735037,0.9841655,0.011241242,0.0005383059,0.0003509954,0.002283225,0.0003388845,0.000068655034,0.00060586515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789727,0.00019612386,0.0007405903,0.00056112756,0.00019586636,0.0004090461],"domain_scores_gemma":[0.9966346,0.0018683324,0.00079980557,0.00034716006,0.00016427187,0.00018580015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004176395,0.00047127326,0.0017484705,0.00025128448,0.00044846899,0.000026099204,0.00015771216,0.0005624339,0.000060966526],"category_scores_gemma":[0.0004437634,0.0002923772,0.00038927782,0.00042205042,0.0006114825,0.000085261556,0.000092138056,0.0006119273,0.000015351163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017444769,0.0007656435,0.031075574,0.014246169,0.00629529,0.00017069116,0.0036149998,0.00015542726,0.00005657761,0.00500513,0.018899068,0.919541],"study_design_scores_gemma":[0.0011374141,0.001938585,0.00045294414,0.003626497,0.010246787,0.0000713894,0.00040209235,0.00008349326,0.000041983774,0.0052543185,0.97643214,0.0003123331],"about_ca_topic_score_codex":0.00077608245,"about_ca_topic_score_gemma":0.00027558635,"teacher_disagreement_score":0.9575331,"about_ca_system_score_codex":0.00027199328,"about_ca_system_score_gemma":0.0016086658,"threshold_uncertainty_score":0.99995285},"labels":[],"label_agreement":null},{"id":"W4388667733","doi":"10.21203/rs.3.rs-3575709/v1","title":"Robot-assisted laparoscopic continent cutaneous urinary diversion in a single- center study; surgical technique and outcomes","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Surgery; Perioperative; Urinary continence; Urinary diversion; Complication; Urinary system; Cystectomy; Concomitant; Single Center; Urethra; Spinal cord injury; Urinary incontinence; Cystostomy; Spinal cord; Bladder cancer; Internal medicine; Prostate","score_opus":0.11173814235415086,"score_gpt":0.421640660441635,"score_spread":0.30990251808748415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388667733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905287,0.00043275848,0.000006086001,0.0020690311,0.00019392665,0.005634734,0.00013496258,0.00017314687,0.00082663295],"genre_scores_gemma":[0.9950388,0.0004856607,0.000100722515,0.000020932901,0.00009302938,0.0008782655,0.00016657975,0.000064086096,0.0031518997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965297,0.0004992873,0.00039353105,0.00085523166,0.0010991998,0.00062307494],"domain_scores_gemma":[0.99851686,0.00030447054,0.00006180426,0.00062440924,0.0002217464,0.00027068658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005598641,0.00033659977,0.00082877703,0.0006728537,0.00012923063,0.000080716854,0.00020123072,0.00033813182,0.00010270119],"category_scores_gemma":[0.00014426796,0.0002643567,0.00014840401,0.00034733667,0.00014659709,0.00003449832,0.0015618952,0.0014051924,0.00004397597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00139739,0.004508405,0.97307825,0.0010598999,0.00021615329,0.016580034,0.00061565475,0.00000345934,0.0001960004,0.0000034128113,0.00040893647,0.001932375],"study_design_scores_gemma":[0.008707365,0.00429689,0.9803834,0.0030176183,0.00009284146,0.0004763358,0.0010751905,0.000021780392,0.00028022655,0.00011893716,0.0012437882,0.00028560747],"about_ca_topic_score_codex":0.00174568,"about_ca_topic_score_gemma":0.00024532658,"teacher_disagreement_score":0.0161037,"about_ca_system_score_codex":0.00062711554,"about_ca_system_score_gemma":0.00023846015,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W4388763584","doi":"10.3390/curroncol30110722","title":"Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation","keywords":"Medicine; Hazard ratio; Internal medicine; Meta-analysis; Subgroup analysis; Oncology; Cochrane Library; Adverse effect; Chemotherapy; Confidence interval","score_opus":0.3473234569335263,"score_gpt":0.4831304058342315,"score_spread":0.13580694890070522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388763584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022183553,0.9721914,0.00012490476,0.00018559949,0.00021213556,0.026175724,0.0009888917,0.00007467766,0.000024500026],"genre_scores_gemma":[0.0001572738,0.98483676,0.00072638865,0.00007506657,0.000121757526,0.012957264,0.00074656366,0.00012172034,0.00025722722],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946588,0.0007553602,0.0025274989,0.0010381846,0.0004050037,0.00061515433],"domain_scores_gemma":[0.9956999,0.0013892944,0.0014238041,0.00075415394,0.0003244367,0.00040839915],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001300884,0.00093180663,0.01684927,0.00055684516,0.00010724372,0.00003257319,0.00021774785,0.0003054637,0.000034989513],"category_scores_gemma":[0.00072662096,0.0005763351,0.0030259874,0.000990893,0.00018814218,0.000043772747,0.00015163231,0.00040799507,0.000011201198],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012524572,0.00064231904,0.000020181595,0.8153406,0.13187599,0.000032058473,0.00008071804,2.1033848e-8,9.1387165e-8,0.00006814815,0.000102942955,0.051711682],"study_design_scores_gemma":[0.0034025998,0.0013508318,0.000010829616,0.021552458,0.8378512,0.00015679924,0.0000166514,0.0000036142017,0.0000010960418,0.000024338065,0.13529485,0.0003347091],"about_ca_topic_score_codex":0.000042614865,"about_ca_topic_score_gemma":0.000037600224,"teacher_disagreement_score":0.79378814,"about_ca_system_score_codex":0.0002798949,"about_ca_system_score_gemma":0.0008856223,"threshold_uncertainty_score":0.99966884},"labels":[],"label_agreement":null},{"id":"W4388783891","doi":"10.1016/j.euo.2023.11.001","title":"Metastatic Organotropism Differential Treatment Response in Urothelial Carcinoma: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials","year":2023,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Oncology; Internal medicine; Hazard ratio; Metastasectomy; Durvalumab; Metastasis; Atezolizumab; Meta-analysis; Clinical endpoint; Randomized controlled trial; Confidence interval; Cancer; Pembrolizumab; Immunotherapy; Bladder cancer","score_opus":0.1729184333299326,"score_gpt":0.41188422629875726,"score_spread":0.23896579296882467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388783891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004543596,0.97291744,0.00004959958,0.0004975046,0.00026491773,0.025547897,0.0003011981,0.00006280595,0.00031318478],"genre_scores_gemma":[0.00090527174,0.99033403,0.00007848225,0.0006902461,0.00015581724,0.005988038,0.00024310875,0.00017515525,0.0014298691],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8923974,0.098014385,0.007678519,0.0009848144,0.00032941168,0.00059548725],"domain_scores_gemma":[0.96526545,0.028521148,0.004807602,0.0010291339,0.00014965388,0.00022699797],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.021012165,0.0012111551,0.118075386,0.0015713566,0.0000649427,0.00001731786,0.00029972903,0.00033361453,0.00090274675],"category_scores_gemma":[0.010370947,0.0006030532,0.015454683,0.0013185353,0.00042096368,0.000022810225,0.00015094772,0.0004834431,0.00010442475],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09123528,0.0005086458,0.0000016812857,0.17349477,0.73197055,0.0015811416,0.00015265492,0.0000038536273,5.011965e-7,0.000055792098,0.00007361652,0.0009215263],"study_design_scores_gemma":[0.15384074,0.0023588298,0.0000088173265,0.004352789,0.83459496,0.00019658572,0.000005304753,0.0000189536,6.0601955e-8,0.000012939484,0.0043564355,0.00025359998],"about_ca_topic_score_codex":0.000074811294,"about_ca_topic_score_gemma":0.00005140292,"teacher_disagreement_score":0.16914198,"about_ca_system_score_codex":0.00034216556,"about_ca_system_score_gemma":0.00095089705,"threshold_uncertainty_score":0.9996421},"labels":[],"label_agreement":null},{"id":"W4388811354","doi":"10.1007/s11255-023-03867-9","title":"Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?","year":2023,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Resection; Proportional hazards model; Cancer; Urology; Internal medicine; Surgery","score_opus":0.018885761329590824,"score_gpt":0.31649922095716465,"score_spread":0.29761345962757385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388811354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98126286,0.00036142484,0.0000034259228,0.011935787,0.0006171541,0.00047477506,0.00010232765,0.00007674982,0.005165505],"genre_scores_gemma":[0.9798876,0.00073315087,0.0000296061,0.016914075,0.00042219105,0.00024550702,0.00014493849,0.000032513522,0.0015904041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839455,0.00009174236,0.00032563545,0.00056195474,0.00018608132,0.0004400476],"domain_scores_gemma":[0.999091,0.00039515656,0.00010441227,0.00020093122,0.00008321924,0.00012524209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017578325,0.00025948623,0.00042802622,0.00044451616,0.000071744245,0.000016091863,0.00015451429,0.00027292344,0.0015239378],"category_scores_gemma":[0.00007962469,0.00019202079,0.00009425438,0.00023875805,0.00022992918,0.00011113878,0.000110216904,0.0004388568,0.00009203251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017544266,0.00079971005,0.9016788,0.00011278026,0.002143632,0.004424837,0.002443428,0.0003037639,0.013619661,0.00033898323,0.03962899,0.016961139],"study_design_scores_gemma":[0.0043933224,0.0018234601,0.98167455,0.00004104527,0.000100786725,0.0003135353,0.000043078948,0.00028052507,0.0008672252,0.0007114244,0.009578901,0.0001721652],"about_ca_topic_score_codex":0.00024600673,"about_ca_topic_score_gemma":0.0006528401,"teacher_disagreement_score":0.07999572,"about_ca_system_score_codex":0.00018064423,"about_ca_system_score_gemma":0.00034177254,"threshold_uncertainty_score":0.9993888},"labels":[],"label_agreement":null},{"id":"W4388863987","doi":"10.5489/cuaj.8525","title":"A multidisciplinary discussion of BladderPath","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Mount Sinai Hospital; McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; University of British Columbia","funders":"Astellas Pharma; EMD Serono; UroGen Pharma; Pfizer; Veracyte; Syndax Pharmaceuticals; Sanofi; Genentech; AstraZeneca","keywords":"Multidisciplinary approach; Sociology; Social science","score_opus":0.018940582289425058,"score_gpt":0.2738170712216295,"score_spread":0.25487648893220444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388863987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9105297,0.00012799946,0.0000422165,0.051501144,0.0004513637,0.0003212213,0.00007469818,0.000102468126,0.0368492],"genre_scores_gemma":[0.9880796,0.000048062095,0.000097392745,0.00039082573,0.00018523628,0.0000049809078,0.00001879537,0.000014364217,0.01116071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915946,0.00005355799,0.00018727871,0.00010114086,0.00022738923,0.00027115713],"domain_scores_gemma":[0.99926883,0.000034701246,0.00011725917,0.00006874006,0.00007865853,0.00043182485],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023851804,0.000073187206,0.00017450136,0.0001925441,0.000110960114,0.000011179433,0.000051070445,0.00011956267,0.0010555815],"category_scores_gemma":[0.0002024975,0.00004250044,0.00010456406,0.0002867104,0.000018191444,0.000033128636,0.000012551764,0.00018878584,0.00018253409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050747807,0.00005242995,0.96931505,0.0000049118216,0.000103704646,0.00016968463,0.00021821058,0.000013632838,0.00054390746,0.00007211188,0.023272445,0.006183167],"study_design_scores_gemma":[0.0010491185,0.00033817955,0.97417444,0.00001792497,0.000059625097,0.000070436945,0.00012637541,0.00014437671,0.00008025155,0.00082734146,0.023051849,0.00006006317],"about_ca_topic_score_codex":0.00030021093,"about_ca_topic_score_gemma":0.00019656592,"teacher_disagreement_score":0.07754994,"about_ca_system_score_codex":0.00029684845,"about_ca_system_score_gemma":0.0003163612,"threshold_uncertainty_score":0.9998576},"labels":[],"label_agreement":null},{"id":"W4388977599","doi":"10.5489/cuaj.8393","title":"Prognostic model using postoperative normalization of C-reactive protein levels in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pathological; Perioperative; Proportional hazards model; Hazard ratio; Stage (stratigraphy); Internal medicine; Oncology; Multivariate analysis; T-stage; C-reactive protein; Univariate analysis; Adjuvant; Urology; Surgery; Overall survival; Inflammation","score_opus":0.019399056352063574,"score_gpt":0.23812869378985926,"score_spread":0.2187296374377957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388977599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975216,0.00000919122,0.00016213,0.00094416086,0.000024693094,0.000959986,0.0001453316,0.000020022713,0.00021291035],"genre_scores_gemma":[0.9990186,7.6253036e-7,0.00033565896,0.0003545853,0.000057842426,0.00003144726,0.00008475173,0.000025995196,0.000090354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836546,0.00017254803,0.00031831086,0.00022202355,0.00047992222,0.0004417116],"domain_scores_gemma":[0.9988507,0.00005129048,0.00023592032,0.00007819283,0.0004299708,0.0003539337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002019051,0.0001946355,0.00036673786,0.00033143375,0.00013702323,0.00003371436,0.00006444046,0.00019151432,0.00008144326],"category_scores_gemma":[0.00017215312,0.00012927814,0.00006109904,0.0005658218,0.000053883636,0.00019177003,0.000006666141,0.00039354002,0.0000043106647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008289736,0.00017567704,0.99639875,0.0000057889583,0.000117004165,0.000101197205,0.0004049753,0.0014954683,0.00026168526,0.000014823997,0.000022840472,0.00017284103],"study_design_scores_gemma":[0.0062260223,0.0019191678,0.9867521,0.00006861809,0.00014584299,0.000035310724,0.000059406164,0.004302182,0.00026182504,0.00004429706,0.00003999558,0.00014526481],"about_ca_topic_score_codex":0.0015085737,"about_ca_topic_score_gemma":0.0004355067,"teacher_disagreement_score":0.009646657,"about_ca_system_score_codex":0.0012322384,"about_ca_system_score_gemma":0.0012834598,"threshold_uncertainty_score":0.52718097},"labels":[],"label_agreement":null},{"id":"W4389143002","doi":"10.3390/curroncol30120740","title":"Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Nomogram; Medicine; Bladder cancer; Receiver operating characteristic; Propensity score matching; Area under the curve; Confounding; Logistic regression; Internal medicine; Cystectomy; Urology; Oncology; Cancer","score_opus":0.14480976560437445,"score_gpt":0.43890111842872315,"score_spread":0.29409135282434873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389143002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337566,0.00114927,0.00030192593,0.00034157367,0.0022993174,0.0018204664,0.00037722144,0.00012377943,0.00021080203],"genre_scores_gemma":[0.99459857,0.0021269154,0.00015682868,0.00021654723,0.0003962994,0.0015054301,0.00058875955,0.000049636794,0.0003609916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983358,0.00008788577,0.00036429384,0.00045502477,0.00024586666,0.0005111718],"domain_scores_gemma":[0.9989541,0.00025005516,0.00016683032,0.00022000536,0.0002170558,0.00019191961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018289225,0.00024276928,0.0005052707,0.00016637357,0.0001546739,0.00002209916,0.000117807016,0.00010673044,0.0002961915],"category_scores_gemma":[0.000107350636,0.00019753735,0.00019964128,0.00030871297,0.00012816403,0.000109676424,0.00005188945,0.00017851633,0.0000723359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011492082,0.0019877118,0.7189047,0.00036542915,0.00091813627,0.000032943746,0.0036717898,0.000025013343,0.0008521681,0.00004648508,0.023880787,0.24816564],"study_design_scores_gemma":[0.019997803,0.0025195517,0.93084437,0.00020337975,0.00066375174,0.000003102819,0.0005080357,0.00051743374,0.004094804,0.00039403656,0.03986904,0.0003846916],"about_ca_topic_score_codex":0.00023032112,"about_ca_topic_score_gemma":0.00021336692,"teacher_disagreement_score":0.24778095,"about_ca_system_score_codex":0.0003664079,"about_ca_system_score_gemma":0.00055418344,"threshold_uncertainty_score":0.80553395},"labels":[],"label_agreement":null},{"id":"W4389161512","doi":"10.1371/journal.pone.0294809","title":"Transperitoneal vs extraperitoneal radical cystectomy: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Ileus; Bladder cancer; Perioperative; Complication; Cochrane Library; Surgery; Urinary diversion; Meta-analysis; Laparoscopy; Incidence (geometry); Blood loss; Cancer; Randomized controlled trial; Internal medicine","score_opus":0.26749680490096134,"score_gpt":0.3654160588865522,"score_spread":0.09791925398559087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389161512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010848094,0.99057096,0.000005635483,0.0005135031,0.000017659213,0.00782904,0.000605374,0.00021869411,0.00023802112],"genre_scores_gemma":[0.000005406404,0.98963565,0.0003886779,0.0006021694,0.00011908215,0.0045485753,0.00033900203,0.00015894805,0.004202505],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995617,0.0005054523,0.001607519,0.000882603,0.00094378775,0.00044366214],"domain_scores_gemma":[0.99778324,0.00026344758,0.00040036638,0.0010332993,0.000098726734,0.00042094014],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047803312,0.00083102187,0.02164784,0.00043873137,0.000090856025,0.000047990343,0.00023918405,0.00037759278,0.0009344545],"category_scores_gemma":[0.000110075314,0.00052025355,0.004375608,0.0014916871,0.00012540248,0.000053222517,0.000046546727,0.00056625635,0.00029778923],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000073018987,0.00037710878,3.2094545e-7,0.5892749,0.40996975,0.00013041635,0.000021890499,2.0287236e-9,1.9055308e-7,0.000004675062,0.000031002484,0.00018246137],"study_design_scores_gemma":[0.00031718248,0.00020539839,5.5336926e-7,0.15964627,0.8351244,0.000101980295,0.0000030761319,0.0000017585086,0.0000014050826,0.0000025042852,0.00427057,0.0003249187],"about_ca_topic_score_codex":0.000060153627,"about_ca_topic_score_gemma":0.000020990432,"teacher_disagreement_score":0.4296286,"about_ca_system_score_codex":0.00014779082,"about_ca_system_score_gemma":0.00029804013,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W4389162882","doi":"10.1016/j.radonc.2023.110038","title":"Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Organisation for Research and Treatment of Cancer","keywords":"Cystectomy; Medicine; Bladder cancer; Quality of life (healthcare); Urinary diversion; Meta-analysis; Systematic review; Physical therapy; Oncology; Internal medicine; Surgery; MEDLINE; Cancer","score_opus":0.24700509892578856,"score_gpt":0.4796728860373032,"score_spread":0.23266778711151462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389162882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000026619819,0.99109495,0.000058560774,0.00048723948,0.000042067924,0.00669121,0.001539786,0.000022881015,0.000060624974],"genre_scores_gemma":[0.0000069778175,0.9837191,0.00029552035,0.0017523634,0.00006990064,0.01256869,0.00008340446,0.000057117548,0.0014469313],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99725914,0.00062810804,0.0012208836,0.00052270654,0.00013804174,0.00023109236],"domain_scores_gemma":[0.9974857,0.0011057314,0.0007516312,0.0003844875,0.00009749385,0.00017496315],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005072862,0.0004931475,0.015206804,0.0002277509,0.000043174783,0.0000084354715,0.000060934373,0.00033215023,0.0003417891],"category_scores_gemma":[0.000071455645,0.00027324003,0.002566092,0.0003739538,0.000120788536,0.000021326025,0.000013682429,0.00010612217,0.000002338717],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012017156,0.00013674404,0.000009197093,0.5552295,0.4297794,0.000008614481,0.00015091719,3.21985e-8,3.525304e-8,0.000036415713,0.00008524605,0.014443722],"study_design_scores_gemma":[0.0013469086,0.0013275748,0.000012954074,0.008075456,0.88159,0.000022438126,0.000016873451,8.402196e-7,1.3829933e-7,0.000015548538,0.10739585,0.00019538314],"about_ca_topic_score_codex":0.0003404849,"about_ca_topic_score_gemma":0.00046920904,"teacher_disagreement_score":0.54715407,"about_ca_system_score_codex":0.0004783678,"about_ca_system_score_gemma":0.00071164506,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W4389240156","doi":"10.1158/2326-6074.tumimm23-b051","title":"Abstract B051: GSTT2 modulates the bladder tumor environment and response to BCG Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Bladder cancer; Cancer research; Immunology; Gene expression; Gene; Immune system; Cancer; Biology; Internal medicine","score_opus":0.06729804768618665,"score_gpt":0.3874945738633544,"score_spread":0.32019652617716776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639478,0.011299912,0.000003199459,0.02284002,0.0001854641,0.0010289205,0.000040493676,0.00008152404,0.00057267945],"genre_scores_gemma":[0.9834399,0.006405976,0.000030996103,0.00087600393,0.00014584386,0.00096002576,0.000010314133,0.000058185204,0.00807272],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778086,0.00028958693,0.00023568842,0.0004793693,0.00045046068,0.00076403795],"domain_scores_gemma":[0.9985368,0.00048397886,0.000033247143,0.0007115951,0.000095534626,0.00013884596],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012506478,0.0001987876,0.00029274297,0.00031474855,0.00041405336,0.000043541768,0.0002651738,0.000112270805,0.0013480134],"category_scores_gemma":[0.00011141006,0.00013389163,0.000070643946,0.0005232709,0.0005970301,0.000054816952,0.00021396385,0.0006016472,0.0010042307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018532388,0.00024615094,0.016629923,0.00004887163,0.0015444746,0.00038408578,0.0060512726,0.00006133384,0.83820015,0.00007341213,0.01650719,0.10172075],"study_design_scores_gemma":[0.002672274,0.0010156531,0.8757237,0.00007135206,0.000030890067,0.000058464455,0.0009266207,0.000027520411,0.021605836,0.00031997618,0.0973811,0.00016661329],"about_ca_topic_score_codex":0.00079443824,"about_ca_topic_score_gemma":0.000020658717,"teacher_disagreement_score":0.8590938,"about_ca_system_score_codex":0.00033481288,"about_ca_system_score_gemma":0.00034624393,"threshold_uncertainty_score":0.9997736},"labels":[],"label_agreement":null},{"id":"W4389606368","doi":"10.1016/s1470-2045(23)00540-5","title":"Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Health and Medical Research Council; F. Hoffmann-La Roche; Roche","keywords":"Metastatic Urothelial Carcinoma; Atezolizumab; Medicine; Chemotherapy; Placebo; Oncology; Internal medicine; Urothelial carcinoma; Carcinoma; Urology; Cancer; Bladder cancer; Immunotherapy; Pathology; Pembrolizumab","score_opus":0.0867280660593854,"score_gpt":0.389108017368519,"score_spread":0.30237995130913364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389606368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838437,0.00026027366,0.00018330524,0.004830424,0.00061308185,0.0074742516,0.00057536876,0.00024933455,0.0019702914],"genre_scores_gemma":[0.9929017,0.00068047596,0.00027419717,0.0013875839,0.0006840527,0.0013390157,0.00047338157,0.0000958177,0.0021638167],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949269,0.0012822447,0.0011717905,0.0009813645,0.0006458019,0.0009918943],"domain_scores_gemma":[0.9952033,0.0028830296,0.0004496861,0.0010825126,0.00015457995,0.00022688601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014928804,0.0006465925,0.003713324,0.00044122984,0.00017379528,0.000048416885,0.0004996244,0.00020223322,0.0007194129],"category_scores_gemma":[0.00042711504,0.00039892056,0.000496647,0.0015978478,0.00020907176,0.000094641335,0.00007554353,0.0005377504,0.000112976304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96799755,0.0017649994,0.0011977593,0.000020781725,0.007942615,0.0018496494,0.006042912,0.0021943124,0.00039604807,0.000013603222,0.00076903054,0.009810716],"study_design_scores_gemma":[0.95526874,0.009568133,0.012250451,0.00003456294,0.0038245902,0.000018730025,0.0017722398,0.0145480875,0.00023404561,0.00007476622,0.0020191462,0.00038649977],"about_ca_topic_score_codex":0.0050176675,"about_ca_topic_score_gemma":0.0064219893,"teacher_disagreement_score":0.012728826,"about_ca_system_score_codex":0.001199103,"about_ca_system_score_gemma":0.0015821931,"threshold_uncertainty_score":0.9998463},"labels":[],"label_agreement":null},{"id":"W4389608093","doi":"10.1016/s1470-2045(23)00539-9","title":"Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Health and Medical Research Council; F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Metastatic Urothelial Carcinoma; Medicine; Placebo; Internal medicine; Oncology; Chemotherapy; Cancer; Bladder cancer; Pembrolizumab; Immunotherapy; Urothelial carcinoma; Pathology","score_opus":0.09030359634918199,"score_gpt":0.3988979223683898,"score_spread":0.3085943260192078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389608093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896032,0.00036538494,0.00020346134,0.0030720152,0.00046880063,0.0048414255,0.00019830723,0.00018039308,0.0010669978],"genre_scores_gemma":[0.9946878,0.00069908483,0.00022083326,0.0012622835,0.000495458,0.0012974301,0.00018402084,0.00006883615,0.0010842662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99633527,0.0010568867,0.00076466455,0.0006563675,0.00044867178,0.0007381411],"domain_scores_gemma":[0.99706024,0.0016464238,0.00026364837,0.00076557044,0.00010651271,0.0001575981],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008615688,0.00046623312,0.00285071,0.00037648904,0.00012629692,0.000033848683,0.00035843335,0.00013123835,0.0012151148],"category_scores_gemma":[0.00015611213,0.00027526455,0.00042195758,0.0013823413,0.00014257163,0.000074126896,0.000046492747,0.00037326096,0.00010149904],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9473216,0.002941849,0.013359741,0.000014772418,0.009385383,0.001624234,0.0033288344,0.0005975327,0.0008201215,0.000021414071,0.0003609393,0.020223605],"study_design_scores_gemma":[0.93759865,0.010989079,0.038524766,0.000018426397,0.004002979,0.0000113019205,0.0011864805,0.0051267794,0.00022136646,0.00016148425,0.0018668864,0.00029178054],"about_ca_topic_score_codex":0.00358926,"about_ca_topic_score_gemma":0.0046790717,"teacher_disagreement_score":0.025165023,"about_ca_system_score_codex":0.00046211298,"about_ca_system_score_gemma":0.0006945936,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null},{"id":"W4389719567","doi":"10.1016/j.urolonc.2023.10.013","title":"Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients","year":2023,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Marital status; Hazard ratio; Proportional hazards model; Cohort; Internal medicine; Epidemiology; Cancer; Gynecology; Demography; Oncology; Confidence interval; Population","score_opus":0.03739399016885166,"score_gpt":0.30028848708957606,"score_spread":0.2628944969207244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389719567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946399,0.0008672391,0.000002085574,0.00085631176,0.00012034228,0.00043781506,0.0003602989,0.00001885711,0.0026971532],"genre_scores_gemma":[0.99792427,0.00061333505,0.0004523606,0.00026775626,0.000026385092,0.00007392638,0.00029192556,0.000008611564,0.0003414569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986685,0.00016039218,0.00038252492,0.00027295403,0.00028705425,0.00022861167],"domain_scores_gemma":[0.9990687,0.00019607728,0.0003168093,0.00020832433,0.00011515448,0.000094976895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026106366,0.00013965888,0.0005334587,0.00025695795,0.00007803711,0.0000054236234,0.00007474047,0.00015979531,0.000035806177],"category_scores_gemma":[0.00003053952,0.00009462911,0.000089534675,0.0014243454,0.0003917248,0.00006707074,0.000041624873,0.00021780675,9.368188e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019400341,0.0002459392,0.9951624,0.000029365256,0.00043551554,0.000017126531,0.0007742403,0.000096214266,0.00016055394,0.00017620703,0.0021059832,0.0006024259],"study_design_scores_gemma":[0.0017188339,0.00085733173,0.9653075,0.000025962756,0.00062856113,0.0000015495013,0.00019695939,0.00009911448,0.00020433255,0.0001909529,0.030691156,0.000077777506],"about_ca_topic_score_codex":0.00083407987,"about_ca_topic_score_gemma":0.0003346061,"teacher_disagreement_score":0.029854959,"about_ca_system_score_codex":0.00038221566,"about_ca_system_score_gemma":0.0005433807,"threshold_uncertainty_score":0.3858863},"labels":[],"label_agreement":null},{"id":"W4389741583","doi":"10.1111/bph.16300","title":"Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer","year":2023,"lang":"en","type":"review","venue":"British Journal of Pharmacology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Immunotherapy; Cystectomy; Immune checkpoint; Cancer; Adjuvant; Immune system; Malignancy; Oncology; Immunology; Internal medicine","score_opus":0.21436761626524836,"score_gpt":0.43387356202545674,"score_spread":0.21950594576020838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389741583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014789228,0.9964944,0.00016997912,0.00032143047,0.0012454622,0.0013530744,0.00014661351,0.00002352028,0.00009761404],"genre_scores_gemma":[0.00020450423,0.99583185,0.0008825649,0.0004620585,0.0014328916,0.0004348031,0.000024623916,0.00015869962,0.0005679998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774563,0.00016607306,0.0011528381,0.00029092777,0.00021523709,0.0004292762],"domain_scores_gemma":[0.99847907,0.00040541048,0.00074915757,0.00008371113,0.00019148261,0.00009114529],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005714835,0.00035027997,0.002122826,0.00038314358,0.00008041156,0.00005018967,0.00033559167,0.00029392092,0.00042819418],"category_scores_gemma":[0.000066019784,0.00030835715,0.00064108695,0.00040434225,0.00008241546,0.00010858156,0.000059003065,0.00095021725,0.0000047624985],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014208574,0.00034067268,0.000019117535,0.0072816345,0.004252785,0.00034843586,0.00029862014,0.0000032922826,0.00026508796,0.000007029453,0.0024369606,0.9846043],"study_design_scores_gemma":[0.009213097,0.00061318616,0.00008432538,0.03617968,0.0077290647,0.006047055,0.00031391563,0.000050344825,0.00013515937,0.000105126615,0.9390668,0.00046222407],"about_ca_topic_score_codex":0.0002910866,"about_ca_topic_score_gemma":0.000212883,"teacher_disagreement_score":0.98414207,"about_ca_system_score_codex":0.00039286164,"about_ca_system_score_gemma":0.0012120972,"threshold_uncertainty_score":0.9999369},"labels":[],"label_agreement":null},{"id":"W4389751876","doi":"10.1016/j.clgc.2023.12.004","title":"Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Guérin","year":2023,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval","funders":"Fonds de Recherche du Québec - Santé; University of British Columbia; Centre Hospitalier Universitaire de Québec","keywords":"Medicine; Internal medicine; Bacillus (shape); Oncology; Immunology; Microbiology","score_opus":0.1080198090621359,"score_gpt":0.44221844007046646,"score_spread":0.3341986310083306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389751876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349243,0.000453972,0.000080184785,0.010630206,0.0013148001,0.0022991071,0.00016336207,0.0002699909,0.001295923],"genre_scores_gemma":[0.976723,0.00016125114,0.0010619634,0.005268736,0.0023725631,0.001792435,0.000046098336,0.000104771876,0.012469196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973241,0.00021633305,0.0007074549,0.00074037776,0.00036885703,0.00064286625],"domain_scores_gemma":[0.99700457,0.0015685273,0.00010294987,0.0005185869,0.00019966638,0.00060567964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010333896,0.00028511696,0.00058890757,0.0001761893,0.00016756913,0.000027046326,0.00016208779,0.00020518247,0.0005002039],"category_scores_gemma":[0.002254563,0.00024875262,0.00041801162,0.0006289665,0.00008596577,0.00005974532,0.0001331427,0.00028681688,0.00075901195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059862986,0.0013819103,0.5303009,0.0006489923,0.001559887,0.0054283333,0.0006965608,0.00031371054,0.010620563,0.000021834468,0.086421676,0.30274266],"study_design_scores_gemma":[0.008365972,0.0060149445,0.8331525,0.00044082216,0.00054072455,0.00013633978,0.0001401892,0.0005811749,0.0005162531,0.00040046373,0.14920102,0.00050959183],"about_ca_topic_score_codex":0.000069523354,"about_ca_topic_score_gemma":0.000009449365,"teacher_disagreement_score":0.30285162,"about_ca_system_score_codex":0.00019826443,"about_ca_system_score_gemma":0.0007049663,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W4389794919","doi":"10.3390/ijms242417535","title":"OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway","year":2023,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Bladder cancer; Crosstalk; Immune system; Toll-like receptor; Cancer research; Receptor; Medicine; Biology; Immunology; Cancer; Innate immune system; Internal medicine","score_opus":0.016612355741571553,"score_gpt":0.2973582223808079,"score_spread":0.28074586663923634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389794919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904992,0.0032305475,0.00040821984,0.003740766,0.0007508137,0.0005684721,0.00004248752,0.000022797996,0.00073671486],"genre_scores_gemma":[0.99609244,0.0007369737,0.0005838933,0.001145,0.00025613612,0.000046701476,0.0000048636325,0.00003520741,0.0010987798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723554,0.00017418149,0.0006373614,0.0003814314,0.0012024867,0.00036898238],"domain_scores_gemma":[0.9983182,0.00030288065,0.00043107657,0.0001907891,0.0005671255,0.0001899419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010150529,0.0002843173,0.00046744963,0.00039461098,0.0002762852,0.00031145714,0.0005649626,0.00008274999,0.00019237923],"category_scores_gemma":[0.00015388904,0.00018184549,0.00028589234,0.00053544866,0.0005924674,0.00027751582,0.00010209822,0.0002623903,0.000017324155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022130124,0.00016301412,0.0011651169,0.000022951019,0.0006566977,0.00076941826,0.0055292565,0.0016976115,0.95747674,0.000049317412,0.00031209478,0.0299448],"study_design_scores_gemma":[0.017588057,0.0032616705,0.010708069,0.001422114,0.00027718223,0.00047339863,0.00600847,0.00046829652,0.95685047,0.0005264854,0.0018704126,0.0005453652],"about_ca_topic_score_codex":0.00075052603,"about_ca_topic_score_gemma":0.00005128204,"teacher_disagreement_score":0.029399434,"about_ca_system_score_codex":0.00024624454,"about_ca_system_score_gemma":0.0010444405,"threshold_uncertainty_score":0.74154437},"labels":[],"label_agreement":null},{"id":"W4389797723","doi":"10.5114/polp.2023.133531","title":"Fosfomycin prophylaxis can reduce the risk of severe recurrent urinary tract infections requiring hospitalisation in children with complex urinary tract malformations","year":2023,"lang":"en","type":"article","venue":"Pediatria Polska","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urinary system; Medicine; Fosfomycin; Pediatrics; Internal medicine; Antibiotics; Microbiology","score_opus":0.02719409096024787,"score_gpt":0.2907952980107203,"score_spread":0.2636012070504724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389797723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952242,0.0002895845,0.000008500412,0.0011405045,0.00014565232,0.0015769685,0.00038505247,0.00011162169,0.001117953],"genre_scores_gemma":[0.9982052,0.0005786033,0.00009615766,0.00003068006,0.00040939995,0.00019930574,0.00031824666,0.000033365843,0.00012903719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985615,0.00013120155,0.00041774608,0.00026370704,0.000321315,0.0003045209],"domain_scores_gemma":[0.9991097,0.0001046269,0.00023863222,0.0003717532,0.0000755613,0.000099715464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027086402,0.00021148928,0.00029068172,0.0002952805,0.00021231323,0.000020250156,0.00011126258,0.00008318193,0.00008718121],"category_scores_gemma":[0.00008908782,0.00014617108,0.00012849671,0.00088736706,0.00007797348,0.00020186864,0.00004048111,0.00036677904,0.000023723693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002036758,0.0022353416,0.9915791,0.00006555278,0.00014015555,0.000017522885,0.0022728133,0.00025470933,0.000026022566,0.00002638225,0.0006472921,0.0025314167],"study_design_scores_gemma":[0.0024974025,0.0044742767,0.9911512,0.00006559598,0.00032415576,0.00043993315,0.0004667143,0.00008249166,0.000058907837,0.0001242682,0.00015534932,0.00015971968],"about_ca_topic_score_codex":0.0014960152,"about_ca_topic_score_gemma":0.00007716472,"teacher_disagreement_score":0.002981041,"about_ca_system_score_codex":0.00017821054,"about_ca_system_score_gemma":0.0002765543,"threshold_uncertainty_score":0.5960684},"labels":[],"label_agreement":null},{"id":"W4389861904","doi":"10.1111/bju.16269","title":"Long‐term outcomes and cost savings of office fulguration of papillary Ta low‐grade bladder cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Sinai Health System; Mount Sinai Hospital","funders":"","keywords":"Fulguration; Medicine; Bladder cancer; Interquartile range; Confidence interval; Incidence (geometry); Cumulative incidence; Pathological; Retrospective cohort study; Surgery; Urology; Cancer; Internal medicine","score_opus":0.024081503995585698,"score_gpt":0.30645997527452773,"score_spread":0.28237847127894206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389861904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917932,0.006110917,0.000042941825,0.0013456926,0.00028553797,0.00018157208,0.00006061496,0.0000094956295,0.00017000352],"genre_scores_gemma":[0.9920981,0.006943955,0.000042969656,0.00053148356,0.00013130366,0.000005304641,0.00001149436,0.0000175817,0.00021780419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989474,0.000055528682,0.00048173298,0.00011924407,0.00022405983,0.0001720313],"domain_scores_gemma":[0.9991571,0.00009264232,0.00034852017,0.00008949843,0.00021379646,0.00009849205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016863254,0.00009761795,0.0004802132,0.00013656169,0.000031695512,0.000008012455,0.000071659975,0.00010055052,0.00017959415],"category_scores_gemma":[0.000089268826,0.000093449285,0.00010595795,0.0001484459,0.00013974097,0.00008657851,0.000029165461,0.00017696535,0.0000023828593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092130626,0.00035985457,0.8743345,0.00026752095,0.00095932087,0.0015807316,0.0004331453,0.000037705668,0.010845629,0.000014977033,0.0055248444,0.10472044],"study_design_scores_gemma":[0.0034973954,0.000758762,0.9908927,0.00016013306,0.00036307581,0.0025207545,0.0000403102,0.000013154373,0.0011900946,0.000050146376,0.00044814567,0.00006529544],"about_ca_topic_score_codex":0.00033150753,"about_ca_topic_score_gemma":0.00021598572,"teacher_disagreement_score":0.11655821,"about_ca_system_score_codex":0.00002512793,"about_ca_system_score_gemma":0.00015472595,"threshold_uncertainty_score":0.3810751},"labels":[],"label_agreement":null},{"id":"W4389917570","doi":"10.3390/curroncol30120770","title":"The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with Radical Chemo-Radiotherapy","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Radiation therapy; Concomitant; Internal medicine; Biomarker; Oncology; Group B; Cancer; Group A; Retrospective cohort study; Surgery","score_opus":0.032717559348998865,"score_gpt":0.3628979976408307,"score_spread":0.33018043829183186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389917570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452364,0.0024006544,0.000002325475,0.0005432368,0.00015192975,0.0007275924,0.000029324488,0.000042109445,0.0015791993],"genre_scores_gemma":[0.9983814,0.00085344864,0.000035563997,0.00009462604,0.00005575688,0.00026773132,0.00006305369,0.000031909716,0.00021654664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988895,0.0000720242,0.00021216106,0.00025097473,0.00025798377,0.0003173428],"domain_scores_gemma":[0.99940354,0.0000875267,0.000092643975,0.00021807791,0.00009589762,0.00010233492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009215937,0.00016730804,0.0003658163,0.00012134709,0.00005081746,0.0000055503024,0.000090739304,0.000084128194,0.00023420909],"category_scores_gemma":[0.000014285322,0.00008643558,0.000045772038,0.0005640451,0.00025247957,0.000029677227,0.000017647668,0.00015792607,0.000016115819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044198493,0.00079680246,0.7809437,0.00001748044,0.00034676638,0.000015682035,0.00035471676,0.0000016437452,0.00018767056,0.000022784112,0.0012059357,0.21168695],"study_design_scores_gemma":[0.015243947,0.0039750678,0.864674,0.00012137415,0.00017647877,0.000008063145,0.00015588531,0.000115696916,0.000731649,0.000040949457,0.114632875,0.00012407303],"about_ca_topic_score_codex":0.00028232706,"about_ca_topic_score_gemma":0.00019116262,"teacher_disagreement_score":0.21156287,"about_ca_system_score_codex":0.00027076792,"about_ca_system_score_gemma":0.00042061764,"threshold_uncertainty_score":0.35247406},"labels":[],"label_agreement":null},{"id":"W4390046835","doi":"10.1159/000534858","title":"Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies","year":2023,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Oncology; Urinary bladder; Urology; Internal medicine; Carcinoma; Cancer","score_opus":0.03975964232458783,"score_gpt":0.29895790249064746,"score_spread":0.2591982601660596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390046835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503983,0.0008383023,0.0003154778,0.008774315,0.0006010831,0.0008557243,0.00021308145,0.00006807673,0.003294106],"genre_scores_gemma":[0.98861736,0.000020734135,0.0003148685,0.0013438488,0.0001350964,0.000096798576,0.00006985198,0.000020382253,0.009381046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991507,0.000030448093,0.00021412269,0.00018187934,0.0002607136,0.00016215074],"domain_scores_gemma":[0.99933153,0.00017935509,0.00009368711,0.00022363281,0.00010007916,0.00007171007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009596024,0.00011904515,0.00017553658,0.000085218,0.000048525853,0.0000075251214,0.00017884171,0.00003865111,0.00039974536],"category_scores_gemma":[0.00011593734,0.00007516201,0.00019562615,0.00014709731,0.000059046266,0.000029852808,0.000057946916,0.000071825634,0.000029150198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024394179,0.001976387,0.64308584,0.00041721237,0.0015282424,0.00016728268,0.0057758135,0.00043134982,0.0094646085,0.0060316105,0.32192326,0.006758993],"study_design_scores_gemma":[0.009441188,0.0035350274,0.85630363,0.000030375704,0.00087554276,0.000109723325,0.00028653195,0.0015495376,0.042221814,0.007052541,0.07829289,0.00030117563],"about_ca_topic_score_codex":0.00038091314,"about_ca_topic_score_gemma":0.000017590786,"teacher_disagreement_score":0.24363036,"about_ca_system_score_codex":0.00004416139,"about_ca_system_score_gemma":0.0001895229,"threshold_uncertainty_score":0.43769312},"labels":[],"label_agreement":null},{"id":"W4390058162","doi":"10.3390/cancers16010044","title":"Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease","year":2023,"lang":"en","type":"review","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal pelvis; Pelvis; Asymptomatic; Abdomen; Upper urinary tract; Ureter; Urinary system; Urothelial carcinoma; Disease; Urology; Radiology; Surgery; Cancer; Internal medicine; Bladder cancer","score_opus":0.09608852255845432,"score_gpt":0.41574833208006606,"score_spread":0.31965980952161177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390058162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015947446,0.98864424,0.00006100808,0.000054638207,0.000957088,0.0059615765,0.003960572,0.00004846985,0.00029647158],"genre_scores_gemma":[0.00019466056,0.99427557,0.00004595949,0.00012892556,0.00043480482,0.0033158576,0.0010209607,0.00013351224,0.00044973366],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975605,0.00012602677,0.00089114526,0.0006197937,0.00038515782,0.00041738062],"domain_scores_gemma":[0.99810874,0.00023270994,0.0005620893,0.00054999936,0.0002419413,0.0003045452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024121693,0.0006052256,0.0029853196,0.0001609805,0.00006879015,0.000018288174,0.00020674439,0.0000684272,0.00012547549],"category_scores_gemma":[0.00015208073,0.0004408485,0.0012480057,0.00046919295,0.00014112031,0.000076823744,0.000028796041,0.00028336834,0.000028310495],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015876966,0.00008467279,0.000044660806,0.7327651,0.00070413796,0.000056928548,0.00029751757,0.0000015853377,1.7848058e-7,0.000051318053,0.011656761,0.25417838],"study_design_scores_gemma":[0.001331957,0.00037508126,0.00007073513,0.21707776,0.004211951,0.000014586546,0.00016523364,0.000008262771,5.922823e-7,0.00006621848,0.7762985,0.0003790996],"about_ca_topic_score_codex":0.000107698586,"about_ca_topic_score_gemma":0.000018095123,"teacher_disagreement_score":0.76464176,"about_ca_system_score_codex":0.0012328117,"about_ca_system_score_gemma":0.014821637,"threshold_uncertainty_score":0.9998043},"labels":[],"label_agreement":null},{"id":"W4390146929","doi":"10.1016/j.eururo.2023.12.003","title":"Predicting Response in TIME and Space: Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Chemoimmunotherapy; Bladder cancer; Neoadjuvant therapy; Urology; Complete response; Cancer; Oncology; Internal medicine; Chemotherapy; Immunotherapy; Breast cancer","score_opus":0.01178047399079701,"score_gpt":0.2804734317108769,"score_spread":0.2686929577200799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390146929","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5499887,0.0059202006,0.0000010318117,0.0028751553,0.43634284,0.001203279,0.00044624816,0.00027213147,0.0029504457],"genre_scores_gemma":[0.097774625,0.020199878,0.000095524476,0.002569587,0.8494785,0.00036337637,0.00089150737,0.0013653093,0.027261697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666643,0.00090295915,0.00054283213,0.0008504216,0.00041244033,0.00062489265],"domain_scores_gemma":[0.99744076,0.0016848703,0.00019341259,0.00046362204,0.00008205284,0.00013527354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011071922,0.00046680038,0.0008437182,0.0005004055,0.000049365764,0.00002913604,0.0002299187,0.0004987741,0.0002484255],"category_scores_gemma":[0.0014640803,0.00043798704,0.00009390887,0.00033635387,0.00016190736,0.000047688543,0.0001829136,0.0013233228,0.00029626614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024032569,0.00040955824,0.01733269,0.00020177415,0.0006516771,0.009903585,0.005173782,0.00006921928,0.0057168,0.0000010994934,0.92908204,0.0074252053],"study_design_scores_gemma":[0.014788592,0.0027942788,0.23008175,0.00063650834,0.00027278365,0.00003180626,0.00006894117,0.00007229547,0.0000831429,0.000016123546,0.7505925,0.0005612359],"about_ca_topic_score_codex":0.0010158776,"about_ca_topic_score_gemma":0.0005949415,"teacher_disagreement_score":0.45221406,"about_ca_system_score_codex":0.00026311545,"about_ca_system_score_gemma":0.00065989094,"threshold_uncertainty_score":0.9998072},"labels":[],"label_agreement":null},{"id":"W4390599409","doi":"10.1200/edbk_430336","title":"Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Genitourinary system; Prostate cancer; Oncology; Radiation therapy; Prostate; Bladder cancer; Internal medicine; Cancer; Urology","score_opus":0.1391443420681022,"score_gpt":0.4639796543301897,"score_spread":0.3248353122620875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390599409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011297997,0.97361046,0.000007897641,0.010843443,0.0009723675,0.0012905356,0.0001775785,0.000009570975,0.0017901757],"genre_scores_gemma":[0.012744478,0.9754228,0.0022050305,0.0049937107,0.001127372,0.0006571305,0.00007916147,0.00006288839,0.002707424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969846,0.00026930732,0.0016701578,0.0005782284,0.00026404017,0.0002336373],"domain_scores_gemma":[0.9945307,0.0037405146,0.00090966304,0.0004935929,0.00013081187,0.00019472757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027537276,0.00034959204,0.0027062704,0.00008496559,0.00004493142,0.0000042135944,0.00037241593,0.00034990447,0.0002762768],"category_scores_gemma":[0.000118389,0.0002274337,0.0019865006,0.00055416103,0.00067567674,0.000026145754,0.00014067945,0.00094075757,0.000044279033],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005813019,0.0063811056,0.0140662845,0.0018148471,0.0009766166,0.0000050433173,0.001591898,5.976475e-7,0.000004487826,0.00007479796,0.008849043,0.96617717],"study_design_scores_gemma":[0.00082960783,0.0013970294,0.03939048,0.0019345,0.0038547344,0.000008678777,0.00042362843,0.00000198808,0.0000066625553,0.00014027327,0.95182806,0.00018433538],"about_ca_topic_score_codex":0.0010725539,"about_ca_topic_score_gemma":0.000047705515,"teacher_disagreement_score":0.9659928,"about_ca_system_score_codex":0.00043075538,"about_ca_system_score_gemma":0.008864841,"threshold_uncertainty_score":0.996754},"labels":[],"label_agreement":null},{"id":"W4390613493","doi":"10.3390/cancers16020245","title":"Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A Comprehensive Review of the Literature","year":2024,"lang":"en","type":"review","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Carcinoma in situ; Concomitant; Oncology; Internal medicine; Randomized controlled trial; Clinical trial; Immunotherapy; Bladder cancer; Cancer","score_opus":0.058529661970799014,"score_gpt":0.3572772979163093,"score_spread":0.2987476359455103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390613493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010154184,0.9937626,2.1922662e-7,0.00021244753,0.00027119057,0.0028193165,0.0006412595,0.000017706154,0.0012598459],"genre_scores_gemma":[0.0130204195,0.9851925,0.000007861,0.0007211376,0.00018769028,0.00024741446,0.00011920576,0.000068032816,0.000435763],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977666,0.00020051294,0.0007638905,0.0005913174,0.00034179402,0.00033587922],"domain_scores_gemma":[0.99871004,0.00010384099,0.00026030425,0.00073919236,0.00008079492,0.00010582679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008752531,0.0005576163,0.0026317267,0.00019186556,0.000021963833,0.000020451385,0.0003620284,0.00032098024,0.00007174537],"category_scores_gemma":[0.00002982794,0.0003146935,0.00069859193,0.0013202095,0.00011216098,0.000025435618,0.00010553571,0.0011213978,0.000016596665],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025262214,0.00004116951,0.00037873312,0.37717733,0.00052595383,0.00032695997,0.0016912177,2.4434937e-7,0.0000012062936,0.000013111395,0.0016776164,0.6181412],"study_design_scores_gemma":[0.00097167067,0.00018792466,0.005364929,0.6113986,0.0033291953,0.000050541534,0.00003186915,5.332867e-7,0.0000035397504,0.000033481232,0.3783631,0.00026462664],"about_ca_topic_score_codex":0.00054013607,"about_ca_topic_score_gemma":0.00011221786,"teacher_disagreement_score":0.6178766,"about_ca_system_score_codex":0.0016732363,"about_ca_system_score_gemma":0.0027819534,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W4390687486","doi":"10.48083/eabm2528","title":"Urinary Tumor DNA-Based Diagnosis and Surveillance for Nonmuscle-Invasive Bladder Cancer—Current Landscape and Future Directions","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urinary system; Intensive care medicine; Biomarker; Cancer; Oncology; Urinary bladder; Urology; Internal medicine; Biology","score_opus":0.04228683112681412,"score_gpt":0.348422865858522,"score_spread":0.30613603473170786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390687486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631482,0.013571541,0.00006396679,0.019455364,0.0022427987,0.0005316868,0.0004913741,0.000111082525,0.0003840204],"genre_scores_gemma":[0.9570576,0.037425224,0.00019924453,0.0012703905,0.0028572006,0.000605025,0.00012113965,0.00003181724,0.0004323806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989102,0.00004934332,0.00024072028,0.00027799382,0.00025333287,0.00026839267],"domain_scores_gemma":[0.9988532,0.0004971589,0.00014848888,0.000097005664,0.00024380098,0.00016035014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020077881,0.00018183715,0.00026720832,0.00017669653,0.0002724564,0.000059889157,0.00008535939,0.00007091755,0.00029590132],"category_scores_gemma":[0.00016369366,0.00014791757,0.00014354213,0.00014982707,0.00007744367,0.00009476257,0.000044238277,0.00026949108,0.0000043098808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004179366,0.00026128537,0.91361153,0.00010298197,0.00049015705,0.00009840786,0.00025378074,0.000022374463,0.00006899941,0.000040195122,0.020558273,0.06407405],"study_design_scores_gemma":[0.0043739574,0.00066014833,0.88075113,0.000078303936,0.00014793359,0.00024238465,0.00035760828,0.000456913,0.00018315965,0.0006095938,0.11196049,0.00017835012],"about_ca_topic_score_codex":0.000013794343,"about_ca_topic_score_gemma":0.000053853397,"teacher_disagreement_score":0.091402225,"about_ca_system_score_codex":0.00010586084,"about_ca_system_score_gemma":0.0002859829,"threshold_uncertainty_score":0.60319036},"labels":[],"label_agreement":null},{"id":"W4390687491","doi":"10.48083/wjmb7232","title":"Utilizing Cell-Free Urinary and Plasma Tumor DNA to Predict Pathologic Stage at Radical Cystectomy","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urine; Cystectomy; Bladder cancer; Medicine; Urinary system; Urology; Internal medicine; Cancer; Gastroenterology","score_opus":0.04391097493006629,"score_gpt":0.3203780589520813,"score_spread":0.27646708402201503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390687491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98173004,0.00045621372,0.000054852855,0.0045261737,0.00080465566,0.00037913397,0.00014892309,0.00019050733,0.011709513],"genre_scores_gemma":[0.98688674,0.00037591462,0.0006271107,0.0018675814,0.0005861722,0.00005906145,0.000041815452,0.000030095604,0.009525492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980888,0.000101212325,0.00039330183,0.00036720894,0.00061170384,0.0004378101],"domain_scores_gemma":[0.99888486,0.00025290018,0.00015569989,0.00024670883,0.00011632043,0.00034349808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043484033,0.00023104172,0.0003346059,0.00026633014,0.00026684176,0.000056451412,0.00030712644,0.00012020081,0.00086443947],"category_scores_gemma":[0.00042053103,0.00018449947,0.000176405,0.00018932793,0.00012506607,0.00011664941,0.00043590745,0.0004984842,0.00012733188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069105616,0.0014658854,0.7728779,0.00032802558,0.0013520331,0.03817348,0.0026802393,0.00023447826,0.026768798,0.00044348242,0.13383168,0.0149334585],"study_design_scores_gemma":[0.02804792,0.008317763,0.8129521,0.0002783756,0.00054136734,0.020004166,0.0026986816,0.0018428988,0.0097716525,0.0032165432,0.111519985,0.0008085542],"about_ca_topic_score_codex":0.000007863607,"about_ca_topic_score_gemma":0.0000036735676,"teacher_disagreement_score":0.040074214,"about_ca_system_score_codex":0.00030963233,"about_ca_system_score_gemma":0.00017875357,"threshold_uncertainty_score":0.9465006},"labels":[],"label_agreement":null},{"id":"W4390687496","doi":"10.48083/znki7577","title":"Public Policies and Type of Insurance Are Associated With the Burden of Bladder Cancer–Related Inpatient Health Care in Chile: A Two-Decade Analysis","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Agencia Nacional de Investigación y Desarrollo","keywords":"Medicine; Psychological intervention; Bladder cancer; Public health; Public health insurance; Medical insurance; Health care; Emergency medicine; Environmental health; Health insurance; Cancer; Actuarial science; Internal medicine; Psychiatry; Business; Nursing","score_opus":0.05695607654258443,"score_gpt":0.3634125636227811,"score_spread":0.3064564870801967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390687496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816028,0.0029079115,0.0000029533544,0.014420384,0.000111534246,0.00022343824,0.00014189054,0.000025198695,0.0005639041],"genre_scores_gemma":[0.9976742,0.0015777652,0.000015087154,0.00039725046,0.000071239,0.000018827152,0.00005928975,0.000011290031,0.00017503093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986409,0.00013503044,0.00040212597,0.00015052484,0.000450583,0.00022086778],"domain_scores_gemma":[0.99854,0.00015524671,0.0005926182,0.000115996234,0.00052547344,0.000070683374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002828743,0.00012514504,0.0004210782,0.00041736042,0.000084756706,0.000016979613,0.00014714015,0.00006721739,0.00010222381],"category_scores_gemma":[0.0001732199,0.00007945926,0.000108981134,0.0012557897,0.0001242772,0.000070882736,0.00004959896,0.00033138946,7.5190883e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022435679,0.00011796019,0.9822026,0.00002380768,0.0033580249,0.0000151651975,0.009002772,0.002245977,0.00003781977,0.000038157217,0.0005776279,0.0021557226],"study_design_scores_gemma":[0.0028220566,0.0006119637,0.991166,0.000102762875,0.00027376658,0.000014859955,0.004150659,0.0004310481,0.000050759136,0.000095866984,0.00021362677,0.00006666147],"about_ca_topic_score_codex":0.0008780896,"about_ca_topic_score_gemma":0.0008483339,"teacher_disagreement_score":0.016071435,"about_ca_system_score_codex":0.00028796925,"about_ca_system_score_gemma":0.0004887867,"threshold_uncertainty_score":0.32402548},"labels":[],"label_agreement":null},{"id":"W4390687518","doi":"10.48083/sblr8004","title":"Urine-Based Cell-Free DNA Tests in Urothelial Cancer: Additional Value for Clinical Decision-Making?","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelial cancer; Urine; Cell-free fetal DNA; Clinical decision making; Urothelial Cell; DNA; Cancer; Value (mathematics); Oncology; Medicine; Computer science; Bladder cancer; Internal medicine; Biology; Intensive care medicine; Genetics; Machine learning","score_opus":0.06926934973124427,"score_gpt":0.4319261510990717,"score_spread":0.3626568013678274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390687518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520517,0.0007988757,0.0028762997,0.017006014,0.0075986004,0.0018799677,0.008140116,0.00036200188,0.009286437],"genre_scores_gemma":[0.98003817,0.0008425012,0.006043518,0.0063111875,0.0038931002,0.00054251606,0.0004861928,0.000065666856,0.0017771712],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9973986,0.000109502806,0.0008517434,0.0004152511,0.0007637981,0.00046107714],"domain_scores_gemma":[0.9955236,0.0033044552,0.0003196958,0.00027600033,0.00039050617,0.00018576687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008034203,0.0002484128,0.00044290966,0.00039221617,0.00017417106,0.0000603779,0.00046872013,0.00022559824,0.005014542],"category_scores_gemma":[0.0026281986,0.00021243255,0.000536299,0.0002844501,0.000120738776,0.00012913249,0.00010577601,0.000630535,0.00009992152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055715316,0.0015831325,0.30477563,0.00006795962,0.0005166865,0.0006895258,0.00010972692,0.0018848721,0.00017421378,0.00042223168,0.6202925,0.063912034],"study_design_scores_gemma":[0.03243624,0.0022343108,0.72130895,0.00065220136,0.0002814691,0.00024211952,0.00013806613,0.0064412886,0.00037434284,0.04198389,0.19339721,0.00050990074],"about_ca_topic_score_codex":0.00001656778,"about_ca_topic_score_gemma":0.000044028344,"teacher_disagreement_score":0.42689526,"about_ca_system_score_codex":0.000445066,"about_ca_system_score_gemma":0.0013249608,"threshold_uncertainty_score":0.995895},"labels":[],"label_agreement":null},{"id":"W4390692472","doi":"10.1200/edbk_430428","title":"Immuno-Oncology Advances in Genitourinary Cancers","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Genitourinary system; Oncology; Standard of care; Prostate cancer; Renal cell carcinoma; Germ cell tumors; Prostate carcinoma; Internal medicine; Cancer; Chemotherapy","score_opus":0.05426018189409378,"score_gpt":0.48883817498398463,"score_spread":0.43457799308989087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390692472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4149361,0.11437759,0.00014519262,0.25546268,0.005142358,0.0013837758,0.00008141234,0.00013750026,0.2083334],"genre_scores_gemma":[0.88494045,0.049602013,0.015284362,0.027822854,0.0024291363,0.000331117,0.00007452871,0.000046188725,0.019469356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981621,0.00015084137,0.00085347466,0.00038712643,0.0002022982,0.0002441533],"domain_scores_gemma":[0.9971282,0.0021777148,0.00023025558,0.00018849861,0.000113986316,0.00016136773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004667341,0.00014631213,0.0008120342,0.000055240085,0.000037248916,0.0000037682291,0.00011659004,0.00016558688,0.0011560974],"category_scores_gemma":[0.00012695472,0.00012612867,0.0004754549,0.000295544,0.0013547185,0.00013525998,0.00003768123,0.00045223627,0.000057442332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074239564,0.0016015819,0.076987535,0.0001299539,0.0005071949,0.000032229218,0.0014289105,0.000019067626,0.0001760789,0.00068366237,0.055977706,0.8617137],"study_design_scores_gemma":[0.0012971117,0.0034116309,0.10795596,0.00008854283,0.00014683767,0.00004702619,0.0012761392,0.000077467164,0.00003421184,0.00062232953,0.884936,0.00010677058],"about_ca_topic_score_codex":0.00050594285,"about_ca_topic_score_gemma":0.000057119283,"teacher_disagreement_score":0.8616069,"about_ca_system_score_codex":0.0010215148,"about_ca_system_score_gemma":0.010530467,"threshold_uncertainty_score":0.999757},"labels":[],"label_agreement":null},{"id":"W4390711087","doi":"10.48083/fyed2556","title":"Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting: Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Triad (sociology); Medicine; Urothelial cancer; Oncology; Cancer; Internal medicine; Psychology; Psychoanalysis","score_opus":0.0654016331186275,"score_gpt":0.3745130392702401,"score_spread":0.3091114061516126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390711087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91357523,0.0015999818,0.000038784565,0.054916326,0.004161915,0.0005974724,0.00022966006,0.00023994477,0.024640655],"genre_scores_gemma":[0.97239256,0.0039812597,0.00015335651,0.009976629,0.0051325853,0.00023121554,0.00008309107,0.00005242267,0.007996855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762934,0.000082152794,0.0005435964,0.00039708198,0.0008327332,0.00051509845],"domain_scores_gemma":[0.9981471,0.00059467537,0.00040075392,0.00016124648,0.00048648368,0.00020978937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063951995,0.00028673682,0.000430227,0.00014482488,0.0003994762,0.00011873387,0.00048803914,0.00022558309,0.0023178514],"category_scores_gemma":[0.0006399414,0.00018964463,0.00034091956,0.0003419413,0.0002108092,0.00020339333,0.00014659183,0.0008428616,0.00011255527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031015538,0.00032184893,0.26035222,0.000016749304,0.00471332,0.00040112945,0.005685028,0.00050689466,0.0064229383,0.0005071143,0.648225,0.06974618],"study_design_scores_gemma":[0.018598577,0.0025806162,0.23085627,0.0002794763,0.0015462195,0.00048561866,0.01245815,0.0018689805,0.0036061204,0.006752305,0.7202731,0.0006946123],"about_ca_topic_score_codex":0.00063316786,"about_ca_topic_score_gemma":0.00015884946,"teacher_disagreement_score":0.072048046,"about_ca_system_score_codex":0.0011976794,"about_ca_system_score_gemma":0.001281399,"threshold_uncertainty_score":0.99859416},"labels":[],"label_agreement":null},{"id":"W4390875529","doi":"10.1172/jci169241","title":"FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Gillings School of Public Health; York University; National Cancer Institute; University of North Carolina at Chapel Hill; National Institutes of Health; Uehara Memorial Foundation","keywords":"Fibroblast growth factor receptor; Cancer research; Fibroblast growth factor; In vivo; Immunosuppression; Biology; Receptor; Immunology","score_opus":0.061160462635822935,"score_gpt":0.41870732933391624,"score_spread":0.3575468666980933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390875529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012285,0.0033579103,0.00009141178,0.0044833263,0.0013351246,0.0003013342,0.000019553645,0.000033205706,0.0002552946],"genre_scores_gemma":[0.9952831,0.0018367019,0.00059195387,0.00097398006,0.00094192394,0.000011372243,0.00004178938,0.000034035438,0.00028511853],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970198,0.00020113638,0.0017314787,0.00026806485,0.00055945315,0.00022005376],"domain_scores_gemma":[0.9985828,0.00032059965,0.00049991487,0.0001471377,0.0001821966,0.0002673432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010183837,0.00018995698,0.00055515906,0.00018531123,0.00005292133,0.000067635425,0.00007336999,0.00020163026,0.00030261392],"category_scores_gemma":[0.00055764674,0.00014048231,0.00024107167,0.0003553137,0.000121296165,0.00045405477,0.000032166656,0.0007987261,0.00002111628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002298751,0.0031449033,0.31109765,0.0011933127,0.0013270471,0.0015486801,0.0018111691,0.00044846404,0.4913831,0.00017771246,0.0482949,0.1372743],"study_design_scores_gemma":[0.03014388,0.0039084675,0.67985255,0.021392277,0.0015095634,0.00050063257,0.00026400137,0.0049636276,0.23517174,0.001812695,0.019814702,0.00066590373],"about_ca_topic_score_codex":0.00013906445,"about_ca_topic_score_gemma":0.0000075524604,"teacher_disagreement_score":0.3687549,"about_ca_system_score_codex":0.00019063403,"about_ca_system_score_gemma":0.0005226948,"threshold_uncertainty_score":0.57287025},"labels":[],"label_agreement":null},{"id":"W4390971156","doi":"10.1109/bibm58861.2023.10385895","title":"Establishing a Correlation of Clinical Characteristics with the Level of Tumor Mutation Burden in Urothelial Bladder Carcinoma","year":2023,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Immunotherapy; Bladder cancer; Correlation; Oncology; Medicine; Cancer; Internal medicine; Immune checkpoint; Mutation; Biomarker; Biology; Gene; Mathematics; Genetics","score_opus":0.08956793566183102,"score_gpt":0.3478687296280058,"score_spread":0.2583007939661748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390971156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637437,0.000010619971,0.00073338015,0.0006934677,0.00012045934,0.00044877906,0.00005682813,0.000021087664,0.0015409893],"genre_scores_gemma":[0.99825,0.0000069454977,0.00026841322,0.00009983827,0.00015791165,0.000020367313,0.000050784995,0.000016279186,0.0011294781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989559,0.000060372484,0.00044992464,0.0001478295,0.00026521354,0.00012072678],"domain_scores_gemma":[0.9992192,0.00025772693,0.0001834643,0.00017426824,0.00012666328,0.000038682985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036616434,0.00008746015,0.00029229818,0.00009754243,0.000020808146,0.0000070700926,0.000059149006,0.00004923311,0.00008369985],"category_scores_gemma":[0.00019389689,0.00005152631,0.000055196124,0.0003347034,0.00008124272,0.00007473651,0.000019482019,0.00013585191,0.000010817806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015965344,0.00019383755,0.97688,0.00011160943,0.0001274118,0.000106460706,0.0035538143,0.0001057049,0.0011198124,0.00021671654,0.00069012627,0.0152979465],"study_design_scores_gemma":[0.0029411472,0.00056478754,0.9899694,0.000073910865,0.0001233648,0.000015699403,0.0010238242,0.0040466012,0.0010459359,0.00003297116,0.000108075,0.000054286458],"about_ca_topic_score_codex":0.0014156402,"about_ca_topic_score_gemma":0.00016432021,"teacher_disagreement_score":0.01524366,"about_ca_system_score_codex":0.000021977567,"about_ca_system_score_gemma":0.0002429784,"threshold_uncertainty_score":0.2140034},"labels":[],"label_agreement":null},{"id":"W4391029857","doi":"10.3390/cancers16020429","title":"The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Pouch; Urinary diversion; Hazard ratio; Urology; Electrical conduit; Surgery; Proportional hazards model; Bladder cancer; Internal medicine; Cancer; Confidence interval","score_opus":0.028974243906844877,"score_gpt":0.3120026567771963,"score_spread":0.2830284128703514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391029857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956884,0.0015714312,0.0000017039588,0.00023110819,0.00036674915,0.00024025181,0.00003711901,0.000030753054,0.0018325065],"genre_scores_gemma":[0.99888575,0.00032027563,0.000004703177,0.00015483185,0.00013578562,0.000012282582,0.000013252743,0.00001013188,0.00046296933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940264,0.00003276186,0.00009886794,0.00014869944,0.00018323012,0.00013382598],"domain_scores_gemma":[0.9997303,0.0000721133,0.000021925536,0.00008859801,0.000027190965,0.000059911963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111328896,0.00006920412,0.000106561645,0.00003085685,0.000060726554,0.000020460333,0.00003167362,0.00005869044,0.000025507165],"category_scores_gemma":[0.000036150977,0.000046602894,0.000023374394,0.00017350123,0.000036138026,0.00004352421,0.000020714071,0.000119288874,0.00001689329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076352815,0.000010512439,0.9933651,0.000036260382,0.00021085372,0.000016256556,0.00025458378,8.848843e-7,0.000009428454,0.000018506782,0.0014140457,0.0045872335],"study_design_scores_gemma":[0.0013066358,0.0002920865,0.9506235,0.00012193835,0.00023406463,0.0000011981775,0.000047658214,0.00005162525,0.00008360153,0.00007219107,0.047105588,0.000059879487],"about_ca_topic_score_codex":0.0007431281,"about_ca_topic_score_gemma":0.00006552625,"teacher_disagreement_score":0.045691542,"about_ca_system_score_codex":0.0015586583,"about_ca_system_score_gemma":0.00022541411,"threshold_uncertainty_score":0.40758374},"labels":[],"label_agreement":null},{"id":"W4391219018","doi":"10.3390/curroncol31020052","title":"A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Centre Hospitalier Universitaire de Sherbrooke; McGill University Health Centre","funders":"Gilead Sciences; EMD Serono; Pfizer","keywords":"Medicine; Immunotherapy; Intensive care medicine; Internal medicine; Oncology; Disease; Medical record; Cancer","score_opus":0.03704448094075645,"score_gpt":0.3640781217968725,"score_spread":0.327033640856116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391219018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829188,0.0013147994,0.0000065519357,0.0003566413,0.0011079349,0.000474465,0.0001180976,0.00000819295,0.013694541],"genre_scores_gemma":[0.9991659,0.0003431202,0.00004481832,0.000024379511,0.000036492078,0.00005463813,0.000009300721,0.000009173511,0.00031219245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990382,0.000048585207,0.0003052961,0.00022492828,0.00022405165,0.00015893127],"domain_scores_gemma":[0.9995419,0.00003703843,0.00007595043,0.00025180122,0.00005150267,0.00004183714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007440167,0.00010201131,0.0004566759,0.00023725169,0.000013076047,0.0000014975666,0.00009686086,0.000023900264,0.0001493628],"category_scores_gemma":[0.000004953481,0.00006982956,0.00014634745,0.0013915724,0.000055172884,0.000016462907,0.000051769053,0.00014479576,9.969672e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025370214,0.00025990055,0.95428973,0.00040120416,0.0017318403,0.00010019188,0.00047637074,0.00009831956,0.00021471907,0.0018273875,0.00035413948,0.039992485],"study_design_scores_gemma":[0.0011834053,0.0001715203,0.98869973,0.00018790246,0.002159268,0.0000015948094,0.00023293032,0.00045862843,0.0005982612,0.000092623195,0.0061606513,0.00005347599],"about_ca_topic_score_codex":0.3087872,"about_ca_topic_score_gemma":0.7902319,"teacher_disagreement_score":0.4814447,"about_ca_system_score_codex":0.0019874126,"about_ca_system_score_gemma":0.0013128438,"threshold_uncertainty_score":0.6958157},"labels":[],"label_agreement":null},{"id":"W4391248735","doi":"10.1038/s41571-024-00861-7","title":"Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Urothelial carcinoma; Context (archaeology); Metastatic Urothelial Carcinoma; Stage (stratigraphy); Medicine; Oncology; Paradigm shift; First line; Chemotherapy; Internal medicine; Bladder cancer; Cancer; Cyclophosphamide","score_opus":0.1680158617999199,"score_gpt":0.528506426900634,"score_spread":0.3604905651007141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391248735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018372143,0.9774552,0.00013120404,0.0013609106,0.005059264,0.010267941,0.0004695082,0.00013309106,0.0051210322],"genre_scores_gemma":[0.000062331375,0.98771274,0.0010062467,0.0018238698,0.002746555,0.003151761,0.0008206986,0.00017665901,0.002499148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99369407,0.0008886445,0.0031340064,0.0013672414,0.00031828694,0.0005977256],"domain_scores_gemma":[0.995876,0.0016054828,0.0011659072,0.00087506836,0.00009458135,0.00038293964],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018641462,0.00096112373,0.0083366325,0.0002379954,0.0000926298,0.00005838805,0.00040631753,0.0037341116,0.00015861775],"category_scores_gemma":[0.000829729,0.0005959118,0.0038662262,0.00047018554,0.00023116455,0.00011892626,0.00010881921,0.004020441,0.0005826508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021426188,0.0006703614,0.000006964631,0.050018158,0.00055370404,0.00016036749,0.000025632633,2.2740586e-8,3.5663234e-8,0.016625362,0.013031671,0.9186935],"study_design_scores_gemma":[0.003355966,0.0044742594,0.000014979953,0.0124996845,0.013341077,0.00009967141,0.000007359024,0.0000021177452,8.737132e-8,0.0033892568,0.96237206,0.00044348318],"about_ca_topic_score_codex":0.000009823745,"about_ca_topic_score_gemma":0.000047336736,"teacher_disagreement_score":0.9493404,"about_ca_system_score_codex":0.000713409,"about_ca_system_score_gemma":0.005692896,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W4391252891","doi":"10.1016/j.xcrm.2024.101393","title":"Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer","year":2024,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Atezolizumab; Carboplatin; Cisplatin; Urothelial cancer; Medicine; Oncology; Chemotherapy; Internal medicine; Bladder cancer; Urology; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.010721143452019747,"score_gpt":0.2850166243809098,"score_spread":0.27429548092889006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391252891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768802,0.013315117,0.00009880551,0.0014292675,0.0017081526,0.0014218246,0.0000060250736,0.00016586593,0.0049747787],"genre_scores_gemma":[0.9964794,0.00027207707,0.00015817673,0.0006795575,0.00031745527,0.00020499784,0.000026954549,0.00009563224,0.0017657294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805284,0.000030364594,0.00048754833,0.00063889014,0.0004127838,0.0003775843],"domain_scores_gemma":[0.99893326,0.00020834045,0.00012779789,0.00045577282,0.00006049615,0.0002143487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019750079,0.000399813,0.00076260616,0.00023531652,0.00005276993,0.000020196157,0.00004798882,0.00013335653,0.00020956878],"category_scores_gemma":[0.000049000344,0.00025339774,0.00007644491,0.00028754922,0.00020391306,0.00006320569,0.0000164496,0.00032014796,0.0000030722122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02626284,0.0010285191,0.518016,0.00985548,0.00289549,0.047997445,0.010356757,0.0002806846,0.19500706,0.000058223544,0.00234349,0.18589802],"study_design_scores_gemma":[0.15721354,0.015574254,0.67917156,0.009105701,0.003659765,0.0012664293,0.00060070044,0.011642771,0.102259085,0.0001643107,0.017378017,0.0019638992],"about_ca_topic_score_codex":0.0025537717,"about_ca_topic_score_gemma":0.00018430792,"teacher_disagreement_score":0.18393412,"about_ca_system_score_codex":0.00041519845,"about_ca_system_score_gemma":0.0008386088,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W4391302039","doi":"10.1200/jco.2024.42.4_suppl.589","title":"Clinical outcomes with split-dose cisplatin-based regimens in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a systematic literature review (SLR) and network meta-analysis (NMA).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Metastatic Urothelial Carcinoma; Oncology; Cisplatin; Internal medicine; Urothelial carcinoma; Urology; Chemotherapy; Cancer; Bladder cancer","score_opus":0.12442925419844507,"score_gpt":0.4530283069035779,"score_spread":0.32859905270513284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391302039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69151235,0.2694449,0.0018893989,0.020996341,0.0015976555,0.01215279,0.0005459376,0.00008631511,0.0017743113],"genre_scores_gemma":[0.9738861,0.0063675544,0.015744017,0.0033040107,0.00017520065,0.00009871217,0.000019236508,0.00005233231,0.0003528775],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98963106,0.0026838232,0.005956608,0.00055013044,0.00084569835,0.00033271097],"domain_scores_gemma":[0.9839777,0.011439865,0.0028804543,0.00055903825,0.0007038676,0.00043910727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007303763,0.00041934772,0.008785317,0.00032272603,0.000030197985,0.00003107228,0.00020565647,0.000292184,0.000062711886],"category_scores_gemma":[0.004345035,0.00018566196,0.0018769001,0.0012176745,0.00031652977,0.00014783267,0.000038996204,0.0012281624,0.0000028530183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13202967,0.007808999,0.4905934,0.06811,0.26826057,0.014381686,0.00039569568,0.0007872636,7.366939e-7,0.00013717687,0.0018962808,0.015598535],"study_design_scores_gemma":[0.051525846,0.06189723,0.31073874,0.040320676,0.5326604,0.00043763642,0.00005788449,0.0005162069,0.0000020355321,0.000065123364,0.0013885034,0.00038969514],"about_ca_topic_score_codex":0.000021687452,"about_ca_topic_score_gemma":0.00024484342,"teacher_disagreement_score":0.28237373,"about_ca_system_score_codex":0.00010933976,"about_ca_system_score_gemma":0.0024688193,"threshold_uncertainty_score":0.7571075},"labels":[],"label_agreement":null},{"id":"W4391302332","doi":"10.1200/jco.2024.42.4_suppl.581","title":"Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term patient-reported outcomes (PROs) in the phase 3 JAVELIN Bladder 100 trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Javelin; Urothelial carcinoma; Avelumab; Metastatic Urothelial Carcinoma; Oncology; Internal medicine; Urology; Carcinoma; Bladder cancer; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.13518270733900614,"score_gpt":0.48475030112486694,"score_spread":0.3495675937858608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391302332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682185,0.0016206212,0.0010377512,0.020356916,0.0055789812,0.002531067,0.000062288804,0.000026600435,0.0005672394],"genre_scores_gemma":[0.99054825,0.00065898034,0.000912148,0.0046384535,0.002126156,0.00017985319,0.000017992286,0.000053559936,0.0008646092],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99435973,0.00034708442,0.003788554,0.0004464372,0.0005730974,0.0004851089],"domain_scores_gemma":[0.9942607,0.0033633234,0.0012375473,0.00040906938,0.0004325889,0.0002967564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026532218,0.00032688837,0.0019084761,0.00021534276,0.00007808851,0.000037478127,0.00029777948,0.00041122586,0.00022933343],"category_scores_gemma":[0.0037031423,0.00018021256,0.0011621609,0.00026822364,0.00020896186,0.00017357216,0.000044925288,0.0011366814,0.000022051523],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25562313,0.013113927,0.05135579,0.00022748527,0.0019203502,0.009736097,0.0010951442,0.000023060722,0.000118520926,0.000116188516,0.008647592,0.6580227],"study_design_scores_gemma":[0.603428,0.12460978,0.13620085,0.0007009946,0.0030341097,0.0018371034,0.0003404576,0.00041895595,0.00030501565,0.0014083778,0.12722825,0.0004881098],"about_ca_topic_score_codex":0.000035101562,"about_ca_topic_score_gemma":0.000155824,"teacher_disagreement_score":0.6575346,"about_ca_system_score_codex":0.00029862483,"about_ca_system_score_gemma":0.0024676998,"threshold_uncertainty_score":0.7348855},"labels":[],"label_agreement":null},{"id":"W4391303315","doi":"10.1200/jco.2024.42.4_suppl.674","title":"Application of artificial intelligence (AI) features of nuclear morphology from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Gemcitabine; Cystectomy; Bladder cancer; Nivolumab; Cisplatin; Oncology; Internal medicine; Clinical endpoint; Biomarker; Chemotherapy; Urology; Cancer; Immunotherapy; Clinical trial","score_opus":0.04359644702124354,"score_gpt":0.39548858770279194,"score_spread":0.3518921406815484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958009,0.0007456282,0.0016418938,0.00077230285,0.00041364893,0.00041368938,0.000030690928,0.000005012365,0.00017620111],"genre_scores_gemma":[0.9973817,0.0002601172,0.0018247069,0.00018704603,0.00030360755,0.000006481315,0.0000044865756,0.000020919018,0.0000109343555],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997141,0.0002170439,0.00193843,0.00022736612,0.00033157232,0.00014457568],"domain_scores_gemma":[0.9967709,0.0014837359,0.0011825219,0.0001371699,0.0003241308,0.00010150628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068869704,0.00013605246,0.0012445772,0.0002079987,0.000014949097,0.000005198459,0.000103186256,0.00029088507,0.00010070286],"category_scores_gemma":[0.00034119037,0.00009653323,0.0001764296,0.00023178369,0.00027816134,0.00008980774,0.000037035734,0.0005687026,0.0000010131927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18019901,0.003909242,0.29209578,0.00037428323,0.0018585266,0.00013983426,0.00096485676,0.0002847556,0.0054899524,0.0005426162,0.00028495202,0.5138562],"study_design_scores_gemma":[0.06073707,0.05079271,0.8754547,0.0016793024,0.0019965663,0.000050763567,0.00053019956,0.0024759136,0.0022392438,0.0030958564,0.0006949274,0.00025271604],"about_ca_topic_score_codex":0.00066872046,"about_ca_topic_score_gemma":0.00058901764,"teacher_disagreement_score":0.58335894,"about_ca_system_score_codex":0.00009733246,"about_ca_system_score_gemma":0.00089361425,"threshold_uncertainty_score":0.39365107},"labels":[],"label_agreement":null},{"id":"W4391303377","doi":"10.1200/jco.2024.42.4_suppl.600","title":"Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in patients (pts) with high body mass index (BMI).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Javelin; Urothelial carcinoma; Body mass index; Avelumab; Internal medicine; Oncology; Urology; Bladder cancer; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.07156124318769336,"score_gpt":0.4065718662245334,"score_spread":0.33501062303684004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798133,0.0004112206,0.0012481775,0.011228801,0.005056739,0.0018608356,0.00016619473,0.000022114726,0.00019266928],"genre_scores_gemma":[0.992132,0.00030828934,0.0011817968,0.0025256437,0.0029894814,0.00009782307,0.000036761016,0.00006980459,0.0006583767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552524,0.00030060852,0.0025681711,0.00048968074,0.0006303206,0.0004860046],"domain_scores_gemma":[0.9940065,0.0039123595,0.00094056356,0.00038426006,0.00044398682,0.0003123162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012624573,0.00036337564,0.0019472485,0.00014469573,0.00007643205,0.000038318638,0.00035590693,0.00046173937,0.00031685625],"category_scores_gemma":[0.0016057071,0.0001897181,0.00068469916,0.00020297099,0.000246092,0.00018616264,0.000058625214,0.0012573864,0.000025483552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2221624,0.0025790276,0.70542544,0.0000480553,0.0012192914,0.00076980446,0.000112677044,0.00003470866,0.000009563884,0.000037796348,0.0017915842,0.06580969],"study_design_scores_gemma":[0.218188,0.029606156,0.7437297,0.00031917368,0.0008257958,0.000026863825,0.00003751431,0.00010832109,0.000033904285,0.0005119458,0.0064325174,0.0001800965],"about_ca_topic_score_codex":0.00019789262,"about_ca_topic_score_gemma":0.0005891941,"teacher_disagreement_score":0.065629594,"about_ca_system_score_codex":0.00045625903,"about_ca_system_score_gemma":0.0021288118,"threshold_uncertainty_score":0.773648},"labels":[],"label_agreement":null},{"id":"W4391303451","doi":"10.1200/jco.2024.42.4_suppl.701","title":"Reasons for refusal of or ineligibility for radical cystectomy (RC) in patients (Pts) with bacillus Calmette-Guérin (BCG)–unresponsive high-risk non–muscle-invasive bladder cancer (HR NMIBC) from the SunRISe-1 study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Janssen Research and Development","keywords":"Medicine; Bladder cancer; Cystectomy; Gemcitabine; Cohort; tar (computing); Carcinoma in situ; Internal medicine; Urology; Cancer; Oncology; Surgery","score_opus":0.08216404500659064,"score_gpt":0.44272863594382383,"score_spread":0.3605645909372332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877263,0.0006518974,0.0003954503,0.004452929,0.0016327812,0.0031045293,0.0009042772,0.000014889091,0.0000706143],"genre_scores_gemma":[0.9944876,0.00046937124,0.0018963924,0.0011277412,0.0014965214,0.0002954538,0.000023063692,0.000058040674,0.0001458056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477506,0.00093709794,0.0026245792,0.0005885006,0.00064457505,0.00043021498],"domain_scores_gemma":[0.97987163,0.017007856,0.0012764923,0.00045458076,0.0010183573,0.00037111167],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030253867,0.00033913428,0.0022472974,0.00017126932,0.00008408867,0.000019779394,0.00033031884,0.00045360916,0.00016844412],"category_scores_gemma":[0.008356826,0.00017073737,0.00062857126,0.0003835403,0.00044920275,0.00013081527,0.00007971431,0.0011942051,0.000004177809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13359863,0.008196819,0.711267,0.00017769396,0.0051012044,0.0006112663,0.0015614408,0.000054557782,0.000040654177,0.000029714223,0.010616231,0.12874478],"study_design_scores_gemma":[0.0551818,0.081783965,0.8433683,0.0005611907,0.003501867,0.000024882052,0.0007687479,0.000087780805,0.000111305024,0.00040585978,0.01400312,0.00020119683],"about_ca_topic_score_codex":0.0029466958,"about_ca_topic_score_gemma":0.010660558,"teacher_disagreement_score":0.13210127,"about_ca_system_score_codex":0.00056036207,"about_ca_system_score_gemma":0.0061324774,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W4391303459","doi":"10.1200/jco.2024.42.4_suppl.529","title":"Correlation of urinary comprehensive genomic profile with risk of recurrence of BCG-unresponsive non-muscle invasive bladder cancer treated with atezolizumab in SWOG S1605.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Atezolizumab; Oncology; Internal medicine; Proportional hazards model; Urinary system; Urology; Cancer; Immunotherapy","score_opus":0.06428930445296924,"score_gpt":0.4078801022914252,"score_spread":0.3435907978384559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522084,0.002504813,0.00009943596,0.00034206646,0.00030922098,0.00058560615,0.00009891564,0.000005095995,0.00083400443],"genre_scores_gemma":[0.99521875,0.0032457593,0.001113466,0.00008374042,0.00015432602,0.000017615097,0.000007971073,0.000024926056,0.00013345675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699074,0.00043202055,0.0018013718,0.00024609533,0.0003442259,0.00018553958],"domain_scores_gemma":[0.99480194,0.001952379,0.0019313889,0.0001925757,0.00097015913,0.00015156393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306386,0.00018977924,0.001608788,0.00028394695,0.000017254373,0.000002825503,0.00011810448,0.00025300236,0.00017798154],"category_scores_gemma":[0.0003758646,0.00011776552,0.0002383489,0.0003965424,0.000435567,0.0001014687,0.000034686716,0.00074134534,0.00000441255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08529037,0.0036368533,0.80542374,0.0006912392,0.004041427,0.0022226488,0.0027838165,0.00216177,0.004522901,0.000032595726,0.000982975,0.08820966],"study_design_scores_gemma":[0.012430501,0.049324244,0.92939407,0.0023404954,0.0016584304,0.00028802833,0.00058020937,0.0005366659,0.0028485209,0.00008403177,0.00039703594,0.000117767275],"about_ca_topic_score_codex":0.00059241324,"about_ca_topic_score_gemma":0.00021420198,"teacher_disagreement_score":0.12397033,"about_ca_system_score_codex":0.00023097846,"about_ca_system_score_gemma":0.004643818,"threshold_uncertainty_score":0.82379335},"labels":[],"label_agreement":null},{"id":"W4391303528","doi":"10.1200/jco.2024.42.4_suppl.tps714","title":"MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab (Av) vs Av after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cabozantinib; Medicine; Urothelial cancer; Chemotherapy; Metastatic Urothelial Carcinoma; Avelumab; Oncology; Cancer; Internal medicine; Urothelial carcinoma; Bladder cancer; Immunotherapy","score_opus":0.0465595784971834,"score_gpt":0.41487149972707943,"score_spread":0.36831192122989603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876595,0.0012572221,0.00062568305,0.005628707,0.0016230794,0.0027599137,0.00012894592,0.000014217041,0.0003027261],"genre_scores_gemma":[0.99020666,0.003029818,0.0024371936,0.0025731085,0.0009097209,0.00028846375,0.000007437543,0.00006104845,0.00048655577],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946003,0.0005685586,0.0033424231,0.00043879138,0.0006349638,0.00041499257],"domain_scores_gemma":[0.99472564,0.0028130687,0.0014876586,0.00025322166,0.0003853015,0.00033511655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002703415,0.0003654202,0.0036678165,0.00019370193,0.00003316897,0.000021988288,0.00015999856,0.0002751303,0.0006807232],"category_scores_gemma":[0.0011540838,0.00022273246,0.00059623626,0.00028229633,0.00055030105,0.00015025564,0.000024922405,0.00089654175,0.000005273486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9436985,0.006145613,0.0041314205,0.00019137983,0.0010826405,0.0007696874,0.00025168931,0.000035057426,0.00001090669,0.000016593009,0.0006320115,0.04303449],"study_design_scores_gemma":[0.9475146,0.03630811,0.00393223,0.0012395072,0.0013235759,0.00004186668,0.000021706137,0.000772733,0.00013671222,0.00012268788,0.008387585,0.00019866525],"about_ca_topic_score_codex":0.00018006343,"about_ca_topic_score_gemma":0.00044773516,"teacher_disagreement_score":0.042835824,"about_ca_system_score_codex":0.00022815198,"about_ca_system_score_gemma":0.0029085223,"threshold_uncertainty_score":0.9082766},"labels":[],"label_agreement":null},{"id":"W4391303586","doi":"10.1200/jco.2024.42.4_suppl.tps719","title":"Pembrolizumab with favezelimab or vibostolimab for patients with bacillus Calmette-Guérin (BCG)–unresponsive high-risk (HR) non–muscle-invasive bladder cancer (NMIBC): Phase 2 KEYNOTE-057 cohort C.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Cohort; Bacillus (shape); Oncology; Internal medicine; Urology; Cancer; Immunotherapy; Microbiology","score_opus":0.049694772448061,"score_gpt":0.426308802879533,"score_spread":0.376614030431472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391303586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868783,0.0008507188,0.0022239094,0.0038226866,0.0024531386,0.002223048,0.0007404507,0.000053839114,0.00075391424],"genre_scores_gemma":[0.9863877,0.002516281,0.004400331,0.0029860195,0.002296403,0.00024338358,0.000063968546,0.00015420152,0.0009516875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945554,0.00044871308,0.0024091392,0.0007946168,0.0010293252,0.0007627803],"domain_scores_gemma":[0.9905536,0.0046409606,0.0015884929,0.00047172516,0.0018591307,0.00088605663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012086527,0.0005974932,0.002800344,0.0003973124,0.00016799134,0.00005775676,0.00030323552,0.00061041943,0.0006901148],"category_scores_gemma":[0.0019543406,0.00032818518,0.00070618844,0.0004969759,0.0004884807,0.0003263544,0.000071037626,0.0015978009,0.000043588832],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2973897,0.010099054,0.12176123,0.00038923064,0.012718891,0.007156838,0.0006690913,0.00011898926,0.00007533628,0.000043919998,0.016353799,0.5332239],"study_design_scores_gemma":[0.1744562,0.2945626,0.39991465,0.0013706397,0.013962609,0.00089593173,0.0002905723,0.0002446791,0.00041501233,0.00016225466,0.112950034,0.000774802],"about_ca_topic_score_codex":0.00044923235,"about_ca_topic_score_gemma":0.0008539402,"teacher_disagreement_score":0.5324491,"about_ca_system_score_codex":0.0008618985,"about_ca_system_score_gemma":0.010508571,"threshold_uncertainty_score":0.99991703},"labels":[],"label_agreement":null},{"id":"W4391333733","doi":"10.1200/jco.2024.42.4_suppl.617","title":"Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohort.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Cohort; Oncology; Solid tumor; Internal medicine; Targeted therapy; Carcinoma; Urothelial cancer; Cancer; Bladder cancer","score_opus":0.061673013247210036,"score_gpt":0.40888773095158637,"score_spread":0.34721471770437634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391333733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020064,0.00036813656,0.000020488003,0.0072303344,0.00043907078,0.0011467017,0.000026479544,0.000011052277,0.0005570942],"genre_scores_gemma":[0.9962755,0.00044424637,0.0004035093,0.0022734022,0.00045218293,0.000039041468,0.000020128004,0.00003095166,0.00006103857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651384,0.0006739293,0.0015782099,0.00031534678,0.0006719758,0.00024670898],"domain_scores_gemma":[0.9962342,0.002427175,0.00065880443,0.00031451604,0.00025733263,0.000107983156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019507933,0.00021258269,0.0010429773,0.00010543937,0.000051069717,0.00003339327,0.00024317195,0.00018206179,0.000028452],"category_scores_gemma":[0.00051638455,0.00007864459,0.00014312645,0.00034092186,0.00020049285,0.00019054282,0.000023295572,0.0011036693,0.0000061419605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11610721,0.0033199717,0.8032315,0.000009982268,0.00025215323,0.00087479554,0.0021930854,0.000033638975,0.000017383054,0.000015425669,0.00026433915,0.07368054],"study_design_scores_gemma":[0.05559227,0.04312542,0.8981054,0.000555273,0.00019849338,0.00006788095,0.00043668682,0.00012465012,0.00004179261,0.00014297907,0.0015112666,0.00009791428],"about_ca_topic_score_codex":0.00035014906,"about_ca_topic_score_gemma":0.0006671235,"teacher_disagreement_score":0.094873905,"about_ca_system_score_codex":0.0002218686,"about_ca_system_score_gemma":0.0019673542,"threshold_uncertainty_score":0.47949556},"labels":[],"label_agreement":null},{"id":"W4391333747","doi":"10.1200/jco.2024.42.4_suppl.625","title":"Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR2/3 genetic alterations (GAs).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rash; Tolerability; Cisplatin; Internal medicine; Oncology; Nausea; Chemotherapy; Adverse effect; Carboplatin; Pharmacology","score_opus":0.08707493923184538,"score_gpt":0.4415278125938331,"score_spread":0.3544528733619877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391333747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258053,0.00050106,0.0016383054,0.0020143667,0.001400594,0.0013469442,0.00006279506,0.000015826035,0.00043958487],"genre_scores_gemma":[0.9873032,0.00006789225,0.010657236,0.00032589768,0.001348149,0.00008104196,0.000012438688,0.000045697805,0.00015842528],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967098,0.00023499878,0.0020795069,0.0002814337,0.00042800762,0.0002662509],"domain_scores_gemma":[0.9959262,0.0024652905,0.0008365805,0.00016750411,0.00026034168,0.000344058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011647643,0.00023831261,0.0016349547,0.00018443845,0.00007381006,0.000030788706,0.00009178826,0.00015897286,0.000057670142],"category_scores_gemma":[0.00074908877,0.00014473528,0.0004719338,0.00017374367,0.00021722664,0.00013992071,0.000017801498,0.0005124489,0.0000017506349],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7564685,0.011550236,0.015231469,0.0006850614,0.0076026004,0.0046562073,0.001668827,0.00007502618,0.0015578247,0.00046991787,0.0027825367,0.19725184],"study_design_scores_gemma":[0.5893654,0.3798134,0.0050185756,0.0008893754,0.009025913,0.0012240275,0.0004092319,0.0012796303,0.0026453002,0.00061698107,0.00939462,0.0003175247],"about_ca_topic_score_codex":0.000035877776,"about_ca_topic_score_gemma":0.000066313,"teacher_disagreement_score":0.36826316,"about_ca_system_score_codex":0.00009021942,"about_ca_system_score_gemma":0.004019758,"threshold_uncertainty_score":0.71308786},"labels":[],"label_agreement":null},{"id":"W4391383908","doi":"10.3390/curroncol31020056","title":"Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Adverse effect; Internal medicine; Oncology; Lymph node; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Urothelial cancer; Lung cancer; Cancer; Bladder cancer; Progressive disease; Urothelial carcinoma","score_opus":0.03181102947675118,"score_gpt":0.3424868844457932,"score_spread":0.31067585496904204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391383908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98972386,0.0072580366,0.0000032818355,0.00053569063,0.00061843026,0.0008060288,0.00003780734,0.000030721636,0.0009861357],"genre_scores_gemma":[0.99754304,0.0018616557,0.00020974352,0.00003353534,0.0001398859,0.00006783976,0.00007044545,0.000017961172,0.000055921264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990343,0.00008270142,0.0003098494,0.00029308637,0.00013041713,0.00014964638],"domain_scores_gemma":[0.99943835,0.00022051392,0.000047640737,0.00011924924,0.00007069714,0.00010357766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007070638,0.00016451716,0.00039427422,0.00029859506,0.00007662736,0.00001443365,0.0000220891,0.00005107182,0.00006303995],"category_scores_gemma":[0.000032810072,0.0001185307,0.000028550348,0.00025925526,0.00015481435,0.0000808856,0.000028309802,0.00021499505,0.0000025709323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033260868,0.0031273467,0.78287476,0.0016707809,0.0005805583,0.00024024709,0.04273776,0.000003342668,0.00022431691,0.0057096486,0.0010978722,0.15840729],"study_design_scores_gemma":[0.012118775,0.0019633356,0.9151912,0.00034690351,0.00059249694,0.000048431095,0.0005011998,0.00008492215,0.00014404816,0.0003519296,0.06846828,0.0001884849],"about_ca_topic_score_codex":0.00044029407,"about_ca_topic_score_gemma":0.0016518278,"teacher_disagreement_score":0.1582188,"about_ca_system_score_codex":0.00020168924,"about_ca_system_score_gemma":0.0004175272,"threshold_uncertainty_score":0.48335418},"labels":[],"label_agreement":null},{"id":"W4391430000","doi":"10.3390/curroncol31020060","title":"Diagnostic Accuracy of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Muscle-Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Bladder cancer; Receiver operating characteristic; Contrast-enhanced ultrasound; Likelihood ratios in diagnostic testing; Diagnostic accuracy; Ultrasound; Radiology; Confidence interval; Systematic review; Diagnostic odds ratio; Area under the curve; Cancer; MEDLINE; Internal medicine","score_opus":0.1573345218242572,"score_gpt":0.45204718355439577,"score_spread":0.29471266173013855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391430000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044176846,0.9902796,0.00006205669,0.00012667013,0.00036584737,0.008519933,0.00052092545,0.000016339922,0.00006444572],"genre_scores_gemma":[0.020095533,0.97160375,0.000005029628,0.00012368713,0.00008687903,0.007916097,0.0001069157,0.000041135572,0.000020979181],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954089,0.0013186802,0.001966934,0.00061868434,0.00038069245,0.0003061407],"domain_scores_gemma":[0.9769432,0.020619148,0.0014211565,0.00067820965,0.00023834982,0.00009991984],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078254216,0.0006023423,0.010244928,0.0004851191,0.000034790883,0.000015068693,0.00027632684,0.00026128048,0.0001861342],"category_scores_gemma":[0.009144212,0.00031630037,0.0022753472,0.0015087152,0.00019942338,0.00005081671,0.000058842757,0.00061411335,0.00001547966],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075406115,0.00044803298,0.000013511946,0.8607206,0.0839723,0.000036199315,0.00036169458,4.5673025e-7,0.0000029656567,0.000011109619,0.000101856785,0.054323737],"study_design_scores_gemma":[0.0004540951,0.00044541963,0.00006160561,0.13006209,0.85771865,0.000086676024,0.00008070795,7.4166513e-7,0.000009292868,0.00002535795,0.010860812,0.00019458945],"about_ca_topic_score_codex":0.00021593332,"about_ca_topic_score_gemma":0.00095696317,"teacher_disagreement_score":0.7737463,"about_ca_system_score_codex":0.0003306196,"about_ca_system_score_gemma":0.00081890216,"threshold_uncertainty_score":0.9999289},"labels":[],"label_agreement":null},{"id":"W4391482304","doi":"10.1007/s12325-023-02763-z","title":"The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Oncology; Urology; Urothelial cancer; Cancer; Rheumatology","score_opus":0.010520303571385316,"score_gpt":0.31308453496181465,"score_spread":0.3025642313904293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391482304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86896366,0.12612486,0.0006697066,0.0011237911,0.00072567293,0.0015139369,0.000117354946,0.000051962114,0.0007090228],"genre_scores_gemma":[0.94405353,0.053454574,0.001330872,0.0002124123,0.00015424642,0.000639717,0.000011739459,0.000042094096,0.000100816615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988104,0.00003913281,0.00035446574,0.00030711017,0.00019052152,0.00029834357],"domain_scores_gemma":[0.9990868,0.00049463037,0.00009495509,0.00021268107,0.000071221846,0.00003968939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019691058,0.00019512672,0.00033962965,0.00014479447,0.00007738673,0.000028842187,0.00007206964,0.00006907412,0.000046142846],"category_scores_gemma":[0.000050342955,0.0001260473,0.00011832528,0.0003024881,0.00007949637,0.00030799746,0.000017648399,0.00018705358,0.000002540948],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013417018,0.0003865859,0.11589731,0.00027633956,0.0004968078,0.000056407294,0.0068119434,0.0021106417,0.0139574325,0.0009731105,0.00015278788,0.85753894],"study_design_scores_gemma":[0.045406953,0.006371129,0.4682901,0.008583079,0.00067620253,0.000045102992,0.01391194,0.009637942,0.30568504,0.10184943,0.037698068,0.0018450157],"about_ca_topic_score_codex":0.00089016435,"about_ca_topic_score_gemma":0.0018570671,"teacher_disagreement_score":0.85569394,"about_ca_system_score_codex":0.00019114497,"about_ca_system_score_gemma":0.00017241013,"threshold_uncertainty_score":0.51400596},"labels":[],"label_agreement":null},{"id":"W4391541159","doi":"10.1016/j.urolonc.2024.01.022","title":"Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cohort; Logistic regression; Stage (stratigraphy); Epidemiology; Internal medicine; Odds ratio; Marital status; Presentation (obstetrics); Cancer; Cohort study; Oncology; Gynecology; Surgery; Population","score_opus":0.022504163406704,"score_gpt":0.3154587156865671,"score_spread":0.29295455227986306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391541159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940335,0.0011491018,0.0000028228055,0.001194407,0.00020991353,0.0008285269,0.0001605056,0.000051868,0.0023693275],"genre_scores_gemma":[0.995689,0.00063036184,0.00056310464,0.0008856769,0.000072991585,0.00023336012,0.00040692513,0.000017719593,0.0015008843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988053,0.00014507001,0.00020759068,0.00042459634,0.00013410619,0.00028333176],"domain_scores_gemma":[0.9992943,0.00029300622,0.00004490593,0.00012470564,0.000017017834,0.00022605945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009742493,0.00021833275,0.00031355713,0.0001747745,0.00011585407,0.000024314995,0.000026143096,0.00015772627,0.0000771395],"category_scores_gemma":[0.000030226856,0.00015720517,0.00004148313,0.0001378109,0.00021243854,0.000082959734,0.000031044667,0.00018218224,0.000013374006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054907915,0.00021539995,0.98352605,0.00009453772,0.000062459505,0.00028400536,0.0009492751,0.000007845132,0.00015475943,0.00028137444,0.00035488166,0.013520327],"study_design_scores_gemma":[0.0042641475,0.018909095,0.837582,0.00009510599,0.00030992384,0.00005175387,0.00006471103,0.0002786377,0.00080357515,0.00026591934,0.1372173,0.00015783205],"about_ca_topic_score_codex":0.00044555916,"about_ca_topic_score_gemma":0.00021176487,"teacher_disagreement_score":0.14594406,"about_ca_system_score_codex":0.0007640081,"about_ca_system_score_gemma":0.00022379347,"threshold_uncertainty_score":0.6410641},"labels":[],"label_agreement":null},{"id":"W4391579712","doi":"10.1016/j.euo.2024.01.014","title":"Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis","year":2024,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Université de Sherbrooke; University of Toronto; Western University; Princess Margaret Cancer Centre; University of Calgary; Queen's University; McMaster University; University of British Columbia; McGill University Health Centre; University of Ottawa; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Lymphovascular invasion; Cystectomy; Cohort; Hazard ratio; Oncology; Internal medicine; Chemotherapy; Cisplatin; Gemcitabine; Radiation therapy; Neoadjuvant therapy; Cancer; Stage (stratigraphy); Subgroup analysis; Urology; Confidence interval; Breast cancer","score_opus":0.02563735697349227,"score_gpt":0.31314711485307073,"score_spread":0.28750975787957844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391579712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993529,0.00023323004,0.00009578495,0.0017668,0.0000966866,0.0024239,0.00028307736,0.00012154396,0.001449985],"genre_scores_gemma":[0.99472106,0.00017104628,0.0010880659,0.0021208643,0.000101722944,0.0005229266,0.0009760143,0.00009040286,0.00020789435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745494,0.0005084627,0.0006168754,0.00082066224,0.00017448825,0.0004245891],"domain_scores_gemma":[0.99835014,0.0005259378,0.00025708933,0.00044959062,0.00024304302,0.00017419197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029168132,0.00040178403,0.0009100796,0.0007824088,0.00006750856,0.000012775672,0.00012476831,0.00014310659,0.0003671332],"category_scores_gemma":[0.000024180823,0.00028591,0.00025147008,0.0011060371,0.00022718248,0.000060544782,0.000008967954,0.0001682758,0.000006343317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010330611,0.003636226,0.91004837,0.000066870365,0.0029013597,0.00015840877,0.0013334855,0.0028560334,0.0005592722,0.000028550387,0.00014358977,0.067937255],"study_design_scores_gemma":[0.03782251,0.036908112,0.8909825,0.000055274075,0.0031021596,0.0000029216046,0.000029652083,0.020276679,0.00560004,0.00006648969,0.004787575,0.00036609347],"about_ca_topic_score_codex":0.001904116,"about_ca_topic_score_gemma":0.012606982,"teacher_disagreement_score":0.067571156,"about_ca_system_score_codex":0.0007812171,"about_ca_system_score_gemma":0.001173696,"threshold_uncertainty_score":0.9999593},"labels":[],"label_agreement":null},{"id":"W4391600406","doi":"10.3390/curroncol31020064","title":"Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Chemotherapy; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Bladder cancer; Cancer; Carcinoma","score_opus":0.03978871772304254,"score_gpt":0.34554349527812106,"score_spread":0.3057547775550785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391600406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666744,0.00069524866,0.000026732348,0.000016424641,0.00017726462,0.0022426588,0.00007228937,0.000030203508,0.000071760434],"genre_scores_gemma":[0.9996355,0.000021845804,0.000028816505,0.0000042273996,0.000023743962,0.00015655204,0.00008881188,0.000022101693,0.000018366485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988095,0.00011004575,0.00027207338,0.0003637317,0.00022182161,0.00022281529],"domain_scores_gemma":[0.99947554,0.00004680337,0.00011037437,0.00013833391,0.00013853365,0.00009044533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006236616,0.00022414935,0.0005063513,0.0002088556,0.000029041192,0.000010266455,0.000040737763,0.000039827584,0.00007406533],"category_scores_gemma":[0.000033395645,0.00012785918,0.00005749059,0.00023819892,0.00009290954,0.000066659246,0.000027854287,0.00018168535,0.0000035213245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042205895,0.0045231944,0.9844866,0.00014494901,0.00048570352,0.000094729716,0.0018403677,0.000002502924,0.000015322208,0.000008127545,0.000015189559,0.004162737],"study_design_scores_gemma":[0.013357561,0.02580107,0.95900625,0.00015653949,0.0010993433,0.000010061985,0.00012754217,0.00028630666,0.000021748458,0.000008025531,0.000014028707,0.00011153495],"about_ca_topic_score_codex":0.00041431765,"about_ca_topic_score_gemma":0.00021021109,"teacher_disagreement_score":0.025480349,"about_ca_system_score_codex":0.0007953329,"about_ca_system_score_gemma":0.00031774913,"threshold_uncertainty_score":0.5213946},"labels":[],"label_agreement":null},{"id":"W4391671329","doi":"10.1016/j.urolonc.2024.01.019","title":"Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"CAPS Research","keywords":"Medicine; Clinical trial; Cystoscopy; Bladder cancer; Context (archaeology); Guideline; Intensive care medicine; Clinical study design; Medical physics; Cancer; Internal medicine; Pathology; Urinary system","score_opus":0.13509189851081152,"score_gpt":0.46451999889989753,"score_spread":0.329428100389086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391671329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071455345,0.92177504,0.00003427628,0.00094350264,0.0006182721,0.0036504013,0.0013865049,0.000015713711,0.00012094263],"genre_scores_gemma":[0.010084294,0.9873614,0.0013308638,0.00023868322,0.00015259934,0.00038960206,0.0002964053,0.000030556515,0.000115641255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99619323,0.001673079,0.0011037912,0.00047494558,0.0003843907,0.00017057986],"domain_scores_gemma":[0.99624705,0.0017486562,0.0011449021,0.00028251563,0.00044307543,0.00013379735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020655983,0.00031996585,0.002035274,0.00015884166,0.000103525075,0.000012493698,0.00009924793,0.00044251024,0.000056994228],"category_scores_gemma":[0.0015880257,0.00016745599,0.00021955326,0.00046301153,0.0010429225,0.000051159102,0.0000696217,0.00042358678,0.0000013447029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009437274,0.0009071603,0.27511826,0.008514983,0.0043853284,0.00002802959,0.0008179798,0.000076116725,0.00000785989,0.0009606278,0.0074811312,0.7007588],"study_design_scores_gemma":[0.0032145602,0.004262871,0.025912443,0.0045421612,0.017397825,0.00002577217,0.000058801405,0.000033652785,0.000016952847,0.0014357322,0.9428447,0.000254534],"about_ca_topic_score_codex":0.00008677683,"about_ca_topic_score_gemma":0.00012831764,"teacher_disagreement_score":0.9353636,"about_ca_system_score_codex":0.00017451463,"about_ca_system_score_gemma":0.0035711408,"threshold_uncertainty_score":0.68286574},"labels":[],"label_agreement":null},{"id":"W4391691849","doi":"10.1016/j.urolonc.2024.01.034","title":"Regional differences in upper tract urothelial carcinoma patients across the United States","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal pelvis; Hazard ratio; Proportional hazards model; Internal medicine; Epidemiology; Stage (stratigraphy); Urology; Ethnic group; Pelvis; Oncology; Surgery; Urinary system; Confidence interval; Biology","score_opus":0.040543153344487055,"score_gpt":0.3270166415059276,"score_spread":0.2864734881614405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391691849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98112553,0.0014976491,0.00000939315,0.01603581,0.00025545908,0.00038223504,0.00008930171,0.00005355538,0.00055108266],"genre_scores_gemma":[0.9925012,0.0007605469,0.0007495333,0.0047234553,0.00014529921,0.00013168626,0.000259337,0.000014058385,0.0007148866],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884784,0.00011876944,0.00024215464,0.00032544124,0.00015957798,0.00030619852],"domain_scores_gemma":[0.9992853,0.00035158757,0.00004415237,0.00013367724,0.00004486435,0.00014044189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017801208,0.00018201974,0.00024588523,0.00013275277,0.00021396311,0.00004707668,0.00009162171,0.00015860348,0.00008379721],"category_scores_gemma":[0.000050831364,0.00010758914,0.0000572774,0.00038585495,0.0006955106,0.00008278626,0.000032232143,0.00039249676,0.00002068662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001144041,0.00025429844,0.9894232,0.000025530904,0.000042816315,0.00013240651,0.0028991774,0.000008711792,0.00001755267,0.0016619826,0.003341639,0.002078274],"study_design_scores_gemma":[0.0010812932,0.0018218019,0.38253275,0.00006429632,0.00013319739,0.00016057749,0.0006173182,0.0011874207,0.0000370846,0.0045625228,0.60768014,0.00012160348],"about_ca_topic_score_codex":0.00063216424,"about_ca_topic_score_gemma":0.00008374304,"teacher_disagreement_score":0.60689044,"about_ca_system_score_codex":0.000117281044,"about_ca_system_score_gemma":0.00028469885,"threshold_uncertainty_score":0.43873578},"labels":[],"label_agreement":null},{"id":"W4391693415","doi":"10.1016/j.isci.2024.109179","title":"Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics","year":2024,"lang":"en","type":"article","venue":"iScience","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Urothelium; Biology; Phenotype; Cancer research; ARID1A; Gene; Pathology; Gene expression; Gene expression profiling; Molecular biology; Mutation; Medicine; Genetics; Urinary system; Endocrinology","score_opus":0.020598260387602003,"score_gpt":0.2779682793214238,"score_spread":0.25737001893382183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391693415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892882,0.008903315,0.00023280062,0.00019120536,0.00032624893,0.00035240344,0.00006169396,0.000023443936,0.0006206895],"genre_scores_gemma":[0.9976599,0.00033967113,0.0015942751,0.000064238935,0.000118733704,0.000013558409,0.000009752273,0.00001317738,0.00018666853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907655,0.000016933416,0.00024382869,0.00029000232,0.00019122317,0.00018148568],"domain_scores_gemma":[0.99964255,0.000040175197,0.000038179747,0.00017315996,0.000043716384,0.00006221197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017817724,0.00010940148,0.00022549815,0.00012311834,0.000033776054,0.000027762708,0.00008035763,0.00006512325,0.000015571277],"category_scores_gemma":[0.00002885974,0.00008719601,0.000038199636,0.0003052959,0.00012916452,0.00008753895,0.000038992,0.00015591702,0.000006687675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009500769,0.000053621843,0.013902127,0.00013563076,0.000008112466,0.00015775552,0.0009417487,0.0000013717754,0.97247124,0.00026042986,0.000016868082,0.011956081],"study_design_scores_gemma":[0.0012632629,0.00036434777,0.3413515,0.00040772095,0.00004759669,0.00014686951,0.00013526957,0.0010942346,0.6541947,0.00030505887,0.00051109825,0.00017832886],"about_ca_topic_score_codex":0.000033378867,"about_ca_topic_score_gemma":0.0000032551795,"teacher_disagreement_score":0.32744938,"about_ca_system_score_codex":0.000070749236,"about_ca_system_score_gemma":0.00013308448,"threshold_uncertainty_score":0.355575},"labels":[],"label_agreement":null},{"id":"W4391810422","doi":"10.3390/siuj5010008","title":"Transfusion in Radical Cystectomy Increases Overall Morbidity and Mortality: A Retrospective Study Using Data from the American College of Surgeons—National Surgical Quality Improvement Program","year":2024,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Perioperative; Blood transfusion; Surgery; Retrospective cohort study; Pulmonary embolism; Septic shock; Odds ratio; Intubation; Thrombosis; Sepsis; Internal medicine","score_opus":0.12373332095350605,"score_gpt":0.4395538170284216,"score_spread":0.3158204960749156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391810422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951126,0.00064971176,0.000055662375,0.0011997893,0.00024857864,0.00085078727,0.0016916881,0.00003522489,0.00015596532],"genre_scores_gemma":[0.99862427,0.0004749961,0.00020572756,0.00016279022,0.00035246048,0.000037107115,0.00010569568,0.000012523487,0.000024462866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974208,0.00036240683,0.00060280995,0.0004097482,0.0010132911,0.0001909659],"domain_scores_gemma":[0.99867994,0.0005920137,0.00020612306,0.00022834926,0.00019875057,0.000094824725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014062754,0.00017336475,0.0004587604,0.00010891347,0.00009992565,0.000053240226,0.000243731,0.000056234534,0.00017423343],"category_scores_gemma":[0.00031463214,0.00011615948,0.00013408998,0.00021792571,0.00027514537,0.00018390374,0.00016403222,0.000536538,5.256316e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009092952,0.0016946134,0.99103886,0.000015795,0.0010186243,0.0004672954,0.0002469649,0.00000644314,0.00026933683,0.00014947224,0.00026660884,0.003916665],"study_design_scores_gemma":[0.0037676413,0.00094236626,0.9890755,0.00007836991,0.00024222766,0.0002086852,0.0008562153,0.0020804987,0.000038307517,0.002106843,0.00050138286,0.000101982],"about_ca_topic_score_codex":0.010693058,"about_ca_topic_score_gemma":0.0013747689,"teacher_disagreement_score":0.009318289,"about_ca_system_score_codex":0.00045393442,"about_ca_system_score_gemma":0.00057631923,"threshold_uncertainty_score":0.99589485},"labels":[],"label_agreement":null},{"id":"W4391817418","doi":"10.1007/s00345-024-04786-9","title":"Experts’ recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group","year":2024,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Laser; Medicine; Holmium; Yttrium aluminium garnet; Thulium; Surgery; Medical physics; Optics","score_opus":0.09672541189337226,"score_gpt":0.37310467014873366,"score_spread":0.2763792582553614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391817418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9048291,0.040763926,0.000044178283,0.05365836,0.00017679551,0.00042392995,0.000022599908,0.000009051388,0.000072053204],"genre_scores_gemma":[0.97796255,0.021447657,0.00014193388,0.00020066336,0.00007933873,0.000057765155,0.0000025840384,0.000014829257,0.00009266949],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987396,0.0002978731,0.00046931798,0.00019042783,0.00009045247,0.00021230125],"domain_scores_gemma":[0.99785703,0.0017432007,0.00011986911,0.000121875615,0.00012057595,0.000037419068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063235406,0.00011302666,0.0004063325,0.000924926,0.00006535956,0.000011347546,0.00006012216,0.000096938245,0.00001692744],"category_scores_gemma":[0.00009471721,0.0000636271,0.00004567224,0.00060791714,0.000584603,0.000050180814,0.00003756837,0.0003226334,9.332564e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019243746,0.0006813294,0.25356275,0.000081935395,0.00086846383,0.00030340627,0.003982684,0.000026345751,0.010597357,0.0006574937,0.0076706447,0.71964324],"study_design_scores_gemma":[0.009961763,0.011606628,0.1286675,0.00038197511,0.0007141682,0.002998392,0.0067491946,0.00094976823,0.0022007362,0.003856313,0.83167034,0.00024319274],"about_ca_topic_score_codex":0.00018758704,"about_ca_topic_score_gemma":0.000781154,"teacher_disagreement_score":0.8239997,"about_ca_system_score_codex":0.000060073424,"about_ca_system_score_gemma":0.00009095652,"threshold_uncertainty_score":0.2594638},"labels":[],"label_agreement":null},{"id":"W4391879700","doi":"10.3390/curroncol31020079","title":"BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Pembrolizumab; Disease; Docetaxel; Immunotherapy; Gemcitabine; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.11856287300900478,"score_gpt":0.45126285469139893,"score_spread":0.3326999816823941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391879700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90561694,0.067358665,0.0013216584,0.014341176,0.005837183,0.003035518,0.00030119251,0.00013084043,0.0020568452],"genre_scores_gemma":[0.9686918,0.02440773,0.00037965277,0.002096293,0.0017439588,0.0018066883,0.00003299792,0.000056332665,0.00078452576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989695,0.00003177387,0.00017295337,0.00041758444,0.00012333856,0.00028486273],"domain_scores_gemma":[0.9993252,0.00022151538,0.000033158936,0.00014180604,0.000119184326,0.00015911412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084623156,0.00020289695,0.0003433707,0.00012170756,0.00006693462,0.000028311057,0.00007118769,0.00008158162,0.0002798278],"category_scores_gemma":[0.000022698401,0.00014566642,0.000099855664,0.00012637497,0.000082584214,0.000058852438,0.000031963114,0.0001503796,0.00003516968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005992718,0.00037720078,0.0042273616,0.00018454915,0.00079263287,0.000036131976,0.009783117,0.0000018260137,0.0032404056,0.00036361947,0.022039669,0.95835423],"study_design_scores_gemma":[0.0054280823,0.0048372117,0.020191096,0.00040988586,0.00030357178,0.000028523624,0.0006209472,0.00018789875,0.0061024036,0.0020626679,0.95955294,0.00027475605],"about_ca_topic_score_codex":0.00009541798,"about_ca_topic_score_gemma":0.00012052534,"teacher_disagreement_score":0.95807946,"about_ca_system_score_codex":0.00022820353,"about_ca_system_score_gemma":0.00045703433,"threshold_uncertainty_score":0.5940104},"labels":[],"label_agreement":null},{"id":"W4392170991","doi":"10.1016/j.eururo.2024.02.009","title":"International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer: Main Conclusions and Recommendations","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Consensus conference; Bladder cancer; Pathology; Gynecology; General surgery; Oncology; Internal medicine; Cancer","score_opus":0.03483546923461492,"score_gpt":0.35888786346175716,"score_spread":0.32405239422714227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392170991","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068954523,0.012235251,0.00003523936,0.08767236,0.8482669,0.001048374,0.00525886,0.00015368391,0.038433906],"genre_scores_gemma":[0.16877323,0.14585283,0.0011324985,0.0056766137,0.66396296,0.00028093116,0.0046124132,0.000341432,0.009367101],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791944,0.0004086381,0.00049831736,0.0006511827,0.00024704315,0.00027537983],"domain_scores_gemma":[0.998817,0.00051469577,0.00016428014,0.00024826534,0.0001558488,0.000099864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003503839,0.00030704064,0.0006107494,0.00016410241,0.000047877737,0.00001551881,0.00017658307,0.00034218375,0.0005929906],"category_scores_gemma":[0.000246616,0.00025492578,0.00013436688,0.00009761868,0.00041629502,0.00001289057,0.00029712828,0.0012995029,0.00006371708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037660738,0.00025281034,0.0003754071,0.00007054619,0.00021580167,0.00030558274,0.00060327345,0.0000025914424,0.00013949563,0.00041615422,0.98953736,0.0077043767],"study_design_scores_gemma":[0.0019940247,0.0010991083,0.0009842984,0.00015793444,0.00027003902,0.00004877934,0.000057975732,0.00009306182,0.00000937738,0.00035580585,0.99476224,0.00016734086],"about_ca_topic_score_codex":0.000070353635,"about_ca_topic_score_gemma":0.00003703266,"teacher_disagreement_score":0.18430392,"about_ca_system_score_codex":0.0001072494,"about_ca_system_score_gemma":0.00038401896,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W4392346771","doi":"10.5489/cuaj.8552","title":"Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Bladder cancer; Cystectomy; Adverse effect; Carcinoma in situ; Internal medicine; Population; Urology; Cancer; Oncology; Surgery","score_opus":0.023823557022401784,"score_gpt":0.29125604809456657,"score_spread":0.26743249107216477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392346771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97130275,0.004877789,0.00012908035,0.021320863,0.00038333485,0.00079240865,0.000888728,0.000010317175,0.00029470757],"genre_scores_gemma":[0.997606,0.0010965032,0.0000905092,0.00051998894,0.00034746187,0.00005572003,0.000011862904,0.000010905013,0.000261074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989623,0.000060665938,0.00033227992,0.00017868748,0.00019567028,0.00027041553],"domain_scores_gemma":[0.9986897,0.00063076545,0.00013099682,0.000099421704,0.0001567263,0.00029236093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026760335,0.0001327883,0.0003390532,0.00007935795,0.00012202134,0.000031115764,0.000056766625,0.0001384327,0.00036876777],"category_scores_gemma":[0.00018411617,0.00007583353,0.00017989032,0.0001347365,0.000071500035,0.00003710895,0.0000042749266,0.0001549713,0.0000017651513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008220279,0.0007949643,0.3947134,0.00018763631,0.00482818,0.00013163088,0.004704705,0.00028177162,0.0036679874,0.00037076528,0.0069568963,0.58254004],"study_design_scores_gemma":[0.0032107695,0.0027461748,0.9595777,0.00005089227,0.00078167074,0.000031162337,0.00013873017,0.00039541058,0.0004351239,0.00037826283,0.032155298,0.00009881294],"about_ca_topic_score_codex":0.003345972,"about_ca_topic_score_gemma":0.0027003034,"teacher_disagreement_score":0.5824412,"about_ca_system_score_codex":0.00085388054,"about_ca_system_score_gemma":0.0009786186,"threshold_uncertainty_score":0.50581306},"labels":[],"label_agreement":null},{"id":"W4392347942","doi":"10.5489/cuaj.8611","title":"Identifying patients at risk for depression after radical cystectomy","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Depression (economics); Beck Depression Inventory; Bladder cancer; Surgery; Internal medicine; Cancer; Anxiety; Psychiatry","score_opus":0.01217261179970478,"score_gpt":0.2587643041239357,"score_spread":0.24659169232423092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392347942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055946,0.0022347737,0.00050675106,0.0035498329,0.001327524,0.00048010863,0.00028499827,0.00005673145,0.0009998302],"genre_scores_gemma":[0.9960216,0.00008971024,0.00023766814,0.0015770522,0.0006948905,0.00006142255,0.00004500286,0.00002005342,0.0012525489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870175,0.00008834186,0.00025558955,0.00022550036,0.0003186924,0.0004101218],"domain_scores_gemma":[0.99892664,0.00013616773,0.000089963796,0.000072643146,0.00013445957,0.00064015185],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031468357,0.00012515919,0.00019415392,0.00014953454,0.0002926079,0.00012138738,0.00005840102,0.00022607403,0.0009538515],"category_scores_gemma":[0.0003481622,0.0000902806,0.0002169327,0.000120428784,0.000014842521,0.000096731295,0.0000144874275,0.00040216657,0.00012772286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022022043,0.000032443724,0.9744624,0.000016617196,0.00017794252,0.00011210253,0.000108946006,0.0000015239971,0.000018246532,0.000011099605,0.016484475,0.008353988],"study_design_scores_gemma":[0.001965116,0.00027587346,0.8205416,0.000054884626,0.0002775092,0.000085383515,0.000007412278,0.00013937314,0.00004253685,0.0006625935,0.1758469,0.00010081818],"about_ca_topic_score_codex":0.00034350445,"about_ca_topic_score_gemma":0.00042277822,"teacher_disagreement_score":0.15936244,"about_ca_system_score_codex":0.0020545123,"about_ca_system_score_gemma":0.00029374534,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W4392599278","doi":"10.3233/blc-230082","title":"Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Clinical trial; Bladder cancer; Biomarker; Medicine; Prioritization; Biomarker discovery; Translational research; Cancer; Intensive care medicine; Oncology; Internal medicine; Pathology; Proteomics; Biology; Business","score_opus":0.39942668439411855,"score_gpt":0.5273932410810593,"score_spread":0.1279665566869408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392599278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8593504,0.104747325,0.00054859614,0.012962967,0.00990675,0.008071548,0.0010677731,0.0004417337,0.002902951],"genre_scores_gemma":[0.9544129,0.025074283,0.0004283788,0.0027073792,0.003832715,0.006640648,0.00010796165,0.00022086735,0.006574876],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99503046,0.0003815679,0.0018350442,0.00128973,0.0006139663,0.0008492008],"domain_scores_gemma":[0.9960817,0.002211079,0.00031448418,0.00058641925,0.00051398366,0.0002923229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002352829,0.0006158742,0.0016569995,0.00042775628,0.00016144718,0.00013334914,0.00024388131,0.0004039089,0.0013982884],"category_scores_gemma":[0.0013799344,0.00047911197,0.0007050429,0.000805017,0.00028202854,0.0005990722,0.00014069071,0.000488345,0.000055443787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053271693,0.0017564093,0.19325174,0.0057666707,0.02713272,0.0006125223,0.010478547,0.000351451,0.013902392,0.00027645033,0.39721432,0.3439296],"study_design_scores_gemma":[0.04614606,0.002530938,0.57292706,0.013786932,0.011993703,0.00006453663,0.005672975,0.008789027,0.029177465,0.0041447566,0.30131716,0.003449407],"about_ca_topic_score_codex":0.001973979,"about_ca_topic_score_gemma":0.0042653163,"teacher_disagreement_score":0.3796753,"about_ca_system_score_codex":0.00062377204,"about_ca_system_score_gemma":0.0017232399,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W4392660400","doi":"10.3390/cancers16061115","title":"Upper Tract Urothelial Cancer: Guideline of Guidelines","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Bladder cancer; MEDLINE; Urothelial cancer; Cancer; Incidence (geometry); Urothelial carcinoma; Family medicine; Urology; Internal medicine; Gynecology; Pathology","score_opus":0.04523905847903937,"score_gpt":0.3748628677841043,"score_spread":0.32962380930506496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392660400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58862823,0.26657578,0.0030382494,0.03989875,0.0148833385,0.003350274,0.0025748394,0.0013254374,0.07972511],"genre_scores_gemma":[0.97682834,0.005502803,0.002282834,0.0034498693,0.002383283,0.00015760055,0.00006833782,0.00009566929,0.009231282],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986047,0.000013391832,0.0005079191,0.00032419933,0.0003013734,0.0002484041],"domain_scores_gemma":[0.9992767,0.000025097304,0.00005309633,0.0002646875,0.0002411295,0.00013930781],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012236493,0.00019376501,0.00035478675,0.00012550536,0.000031365726,0.000016014892,0.000091500864,0.00008468949,0.0020693296],"category_scores_gemma":[0.00004202859,0.00014785475,0.00021777293,0.00028034372,0.00008489307,0.00008205666,0.000017404502,0.00013573293,0.000043032873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008071558,0.00009994236,0.010766328,0.0009662093,0.0011699923,0.00028242834,0.0012533568,0.0011398755,0.028456943,0.00073992845,0.57514447,0.37917337],"study_design_scores_gemma":[0.0018504829,0.00043830127,0.0011773537,0.0009127296,0.000607294,0.000075779535,0.00017232593,0.002766213,0.031225638,0.00022033785,0.9603066,0.00024698226],"about_ca_topic_score_codex":0.0029426897,"about_ca_topic_score_gemma":0.000056341734,"teacher_disagreement_score":0.3882001,"about_ca_system_score_codex":0.0007856939,"about_ca_system_score_gemma":0.0023877977,"threshold_uncertainty_score":0.9988429},"labels":[],"label_agreement":null},{"id":"W4392703546","doi":"10.1016/j.urolonc.2024.01.027","title":"Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"René Vogels Stichting; Deutsche Forschungsgemeinschaft","keywords":"Subtyping; Bladder cancer; Medicine; Cystectomy; Oncology; Internal medicine; Concordance; Cancer","score_opus":0.034280975956934974,"score_gpt":0.3505061778678021,"score_spread":0.3162252019108671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392703546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768052,0.013320105,0.00020599236,0.0067872526,0.00038310888,0.00034017194,0.000086850065,0.00008009288,0.0019911928],"genre_scores_gemma":[0.98750556,0.0015843647,0.007812953,0.0018068395,0.000112910806,0.00014765898,0.00003800172,0.000020957408,0.00097075984],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988991,0.00005478325,0.00025809914,0.00035288077,0.00014587081,0.00028928078],"domain_scores_gemma":[0.9993941,0.00014891868,0.00006440197,0.00015326391,0.000051083716,0.00018823237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016433433,0.00017446285,0.0003128338,0.000083745574,0.00012076557,0.000019967352,0.00006171291,0.00019145462,0.00014746393],"category_scores_gemma":[0.00005296825,0.00013787382,0.000082565755,0.00023679736,0.0005810191,0.00007196499,0.000038507045,0.00022689425,0.00001335494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043420822,0.0004606698,0.89071524,0.00040805584,0.0012517298,0.00088922086,0.0041100974,0.00025709247,0.04859754,0.01241286,0.009189166,0.03127413],"study_design_scores_gemma":[0.001575641,0.0021608241,0.008380973,0.00026517696,0.0009167877,0.00027794295,0.0007651125,0.0019651307,0.030533997,0.004584672,0.9483046,0.0002691205],"about_ca_topic_score_codex":0.00025147622,"about_ca_topic_score_gemma":0.00007237223,"teacher_disagreement_score":0.93911546,"about_ca_system_score_codex":0.000144301,"about_ca_system_score_gemma":0.00044736988,"threshold_uncertainty_score":0.56223315},"labels":[],"label_agreement":null},{"id":"W4392704508","doi":"10.1111/bju.16319","title":"The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemcitabine; Medicine; Bladder cancer; Internal medicine; Cystectomy; Proportional hazards model; Lymph node; Oncology; Chemotherapy; Urology; Vinblastine; Induction chemotherapy; Hazard ratio; Cancer; Confidence interval; Gastroenterology","score_opus":0.01544719037458169,"score_gpt":0.3332293809045745,"score_spread":0.3177821905299928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392704508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97846365,0.013174174,0.00013844266,0.0059048026,0.00068386894,0.00013385189,0.000020585772,0.0000085923,0.0014720483],"genre_scores_gemma":[0.98521185,0.01264393,0.0002998865,0.00096716755,0.00054320606,0.000007244647,0.0000016378926,0.000022296641,0.0003027572],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998844,0.000096343996,0.0005660189,0.00013357091,0.00018192212,0.00017813392],"domain_scores_gemma":[0.9994129,0.00013537853,0.00015707703,0.00007329345,0.0001582167,0.00006312926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035545608,0.00008836096,0.0003111303,0.000057740075,0.000034685974,0.00002515823,0.00008812617,0.00012630191,0.0002883442],"category_scores_gemma":[0.00005456053,0.00006962717,0.00014855932,0.00013820242,0.00017502508,0.00008281787,0.000014454705,0.0003537776,0.0000072567163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060475427,0.0009205552,0.14746757,0.00010476464,0.0028374859,0.0037854228,0.0012768189,0.00024681087,0.0020988488,0.00023472428,0.006792889,0.8281866],"study_design_scores_gemma":[0.008208715,0.0013082606,0.9495803,0.0008602977,0.0005966879,0.027443865,0.0002771509,0.00027103702,0.0011735468,0.0015448583,0.008544476,0.00019080055],"about_ca_topic_score_codex":0.00042372628,"about_ca_topic_score_gemma":0.000054411143,"teacher_disagreement_score":0.8279958,"about_ca_system_score_codex":0.00007542182,"about_ca_system_score_gemma":0.00036714005,"threshold_uncertainty_score":0.31571668},"labels":[],"label_agreement":null},{"id":"W4392718644","doi":"10.1016/j.eururo.2024.01.007","title":"Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Astellas Pharma; Astellas Pharma US; Seagen; Pfizer","keywords":"Medicine; Discontinuation; Chemotherapy; Quality of life (healthcare); Internal medicine; Confidence interval; Chemotherapy regimen; Surgery","score_opus":0.027733290074382112,"score_gpt":0.31330524712796365,"score_spread":0.2855719570535815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392718644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939723,0.0013093702,0.000020197846,0.00037723748,0.0004379988,0.0015683192,0.00022715697,0.00007700731,0.0020104232],"genre_scores_gemma":[0.99902606,0.00006561576,0.00007273646,0.00029090853,0.00010745575,0.000021565667,0.00024897617,0.0000784172,0.000088284854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972325,0.0006327386,0.001055286,0.0004735697,0.0002760665,0.00032983726],"domain_scores_gemma":[0.99881583,0.0001845351,0.00033328397,0.00041687078,0.0000796308,0.00016984089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034777008,0.00026426365,0.00094791595,0.00017663004,0.000023354005,0.000005647713,0.00012633874,0.000080564445,0.00023789171],"category_scores_gemma":[0.00013209892,0.00020718414,0.00013889643,0.00030448707,0.00014302396,0.00005642563,0.000022140248,0.00025166525,0.000024365012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84681773,0.0034104588,0.090954594,0.00020774464,0.00083974627,0.00010976693,0.002912055,0.000016975282,0.00070718315,0.000050415867,0.00017563399,0.053797707],"study_design_scores_gemma":[0.5844399,0.041152958,0.37210003,0.00013398904,0.00022753538,0.0000023846724,0.000032699234,0.000045374967,0.0005621186,0.000022715767,0.0010582338,0.00022205691],"about_ca_topic_score_codex":0.0017157848,"about_ca_topic_score_gemma":0.00009549755,"teacher_disagreement_score":0.28114542,"about_ca_system_score_codex":0.000103424965,"about_ca_system_score_gemma":0.0004887959,"threshold_uncertainty_score":0.8448724},"labels":[],"label_agreement":null},{"id":"W4392807855","doi":"10.1016/j.urolonc.2024.01.099","title":"REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Avelumab; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Oncology; Medicine; Internal medicine; Immunotherapy; Bladder cancer; Cancer; Nivolumab","score_opus":0.03236979243773534,"score_gpt":0.3382561816656844,"score_spread":0.30588638922794903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545723,0.0005738755,0.00009897332,0.00088615017,0.00008189407,0.0007737212,0.000071732014,0.000036550373,0.0020198673],"genre_scores_gemma":[0.9848653,0.0003673686,0.013580285,0.00038582145,0.000020385778,0.00008888966,0.000049605118,0.0000150370115,0.0006272763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887025,0.00008106623,0.00031506442,0.0003879337,0.00013874828,0.00020694148],"domain_scores_gemma":[0.9993771,0.0001804624,0.00007972424,0.00014856386,0.00008118763,0.00013301813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017079705,0.00017229335,0.00038697667,0.00018771063,0.00005996622,0.000012171346,0.000042023796,0.00007345811,0.000049436854],"category_scores_gemma":[0.00008465585,0.00011200455,0.000025005842,0.00042496424,0.000546847,0.00011556653,0.000024069905,0.00017564968,0.0000021389465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018276061,0.00030515177,0.986339,0.00021158936,0.00006447519,0.00012952575,0.00051813346,0.000026146367,0.00006646508,0.003100346,0.00019785693,0.00721375],"study_design_scores_gemma":[0.010810716,0.017433012,0.89157116,0.00071422814,0.00090845395,0.00012627513,0.00030640155,0.0025247317,0.0008270212,0.00853715,0.06585905,0.0003817782],"about_ca_topic_score_codex":0.00027857305,"about_ca_topic_score_gemma":0.0006275905,"teacher_disagreement_score":0.09476777,"about_ca_system_score_codex":0.00014097909,"about_ca_system_score_gemma":0.0006469729,"threshold_uncertainty_score":0.4567413},"labels":[],"label_agreement":null},{"id":"W4392807872","doi":"10.1016/j.urolonc.2024.01.162","title":"DEVELOPMENT AND EXTERNAL VALIDATION OF NIMBLE, AN ARTIFICIAL INTELLIGENCE-BASED TOOL TO PREDICT PROGRESSION IN NON-MUSCLE INVASIVE BLADDER CANCER: A RETROSPECTIVE MULTI-INSTITUTIONAL COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Sinai Health System; Mount Sinai Hospital; University of Toronto; University Health Network; Trillium Health Centre","funders":"","keywords":"Bladder cancer; Retrospective cohort study; Cancer; Medicine; Cohort; Artificial intelligence; Computer science; Internal medicine","score_opus":0.046616179545419495,"score_gpt":0.3640919495551017,"score_spread":0.3174757700096822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955208,0.00036137988,0.0015386973,0.000633496,0.00020155057,0.0016063905,0.000026415988,0.00003720784,0.00007411282],"genre_scores_gemma":[0.94761276,0.00007426627,0.05116213,0.00024962652,0.00008058164,0.000736595,0.000041170053,0.000009975655,0.0000329086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986484,0.00007524655,0.00038719265,0.0004736204,0.00022712398,0.00018842892],"domain_scores_gemma":[0.99947506,0.000077410856,0.000074215575,0.00010909305,0.00009394895,0.00017024178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037110195,0.00018189666,0.00031821112,0.00025405464,0.00014948369,0.000029540355,0.000055911798,0.0001253932,0.00004896417],"category_scores_gemma":[0.00008854105,0.00014013017,0.000025597206,0.00034375864,0.00028961932,0.00013326122,0.000035797075,0.00021330292,0.0000041429507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002523572,0.0010338465,0.970229,0.00005270292,0.0000961606,0.00016277433,0.0033387698,0.0004669025,0.0022592284,0.0005927708,0.000031710682,0.021483766],"study_design_scores_gemma":[0.0012561737,0.008092319,0.95437723,0.00065592304,0.0004815069,0.000069144146,0.0010727514,0.0064267097,0.02172271,0.0017905063,0.003761007,0.00029401688],"about_ca_topic_score_codex":0.00021807844,"about_ca_topic_score_gemma":0.000547767,"teacher_disagreement_score":0.049623437,"about_ca_system_score_codex":0.00033670707,"about_ca_system_score_gemma":0.0013003284,"threshold_uncertainty_score":0.57143426},"labels":[],"label_agreement":null},{"id":"W4392807873","doi":"10.1016/j.urolonc.2024.01.160","title":"ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Gemcitabine; Medicine; Bladder cancer; Docetaxel; Urology; Oncology; Internal medicine; Cancer","score_opus":0.03656695570836435,"score_gpt":0.3458443997824544,"score_spread":0.3092774440740901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97696096,0.002539559,0.00013090801,0.017121064,0.00044345704,0.0013112951,0.00005690247,0.00008293656,0.0013529365],"genre_scores_gemma":[0.98664427,0.0010369719,0.007206069,0.0039186897,0.00012606791,0.00053936266,0.00005060598,0.00002968121,0.0004482921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782854,0.00020942088,0.0006027531,0.0006202848,0.0002866295,0.000452384],"domain_scores_gemma":[0.9983458,0.00080776954,0.00012953574,0.0002355624,0.00013097358,0.0003503458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037610292,0.00034973535,0.00086506596,0.00047972568,0.00013138863,0.000035038545,0.00015534948,0.00033249322,0.0002668157],"category_scores_gemma":[0.00026780236,0.00026677674,0.00012031713,0.0006337318,0.00066250615,0.00014765887,0.000079546415,0.0005391531,0.000028555243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001579038,0.0021519456,0.93118584,0.00020113277,0.0011660535,0.0012092533,0.008440397,0.0006114415,0.019913306,0.0049332934,0.009121048,0.019487258],"study_design_scores_gemma":[0.011101624,0.011371558,0.75901395,0.00055727706,0.00095184747,0.00032406137,0.0015291312,0.0037852451,0.008687947,0.007928749,0.1939841,0.00076452596],"about_ca_topic_score_codex":0.00065208797,"about_ca_topic_score_gemma":0.00045952876,"teacher_disagreement_score":0.18486306,"about_ca_system_score_codex":0.00045926406,"about_ca_system_score_gemma":0.0012123658,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W4392807963","doi":"10.1016/j.urolonc.2024.01.165","title":"US CLINICAL PRACTICE PATTERNS OF INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER AMONG CARCINOMA IN SITU AND PAPILLARY-ONLY TUMORS","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Cancer; Chemotherapy; Bladder cancer; Carcinoma in situ; Oncology; Urology; Internal medicine","score_opus":0.029253706451418535,"score_gpt":0.36721322682754515,"score_spread":0.3379595203761266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392807963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855315,0.00266059,0.000078285935,0.009853303,0.00022671548,0.00089707796,0.00009119593,0.000026089847,0.0006352534],"genre_scores_gemma":[0.983568,0.003355384,0.0076711043,0.004638745,0.00025730167,0.000230798,0.000037244554,0.000024849072,0.00021656294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843913,0.00015542323,0.000495734,0.0004934873,0.00013053442,0.00028569906],"domain_scores_gemma":[0.9976611,0.0016816595,0.0001439123,0.00015328139,0.00011605981,0.00024394794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043053518,0.0002181273,0.0005360226,0.00016165493,0.000084131265,0.000022167707,0.00006663106,0.00029387677,0.000047878402],"category_scores_gemma":[0.0004628078,0.00017495632,0.0000847635,0.00020097329,0.00068709155,0.0001543723,0.00003745974,0.00040293406,0.0000021039104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071632676,0.00031871293,0.97885936,0.00017572546,0.00023032686,0.00045648857,0.0023807562,0.00000806696,0.0010807301,0.00080827426,0.0013292509,0.013635979],"study_design_scores_gemma":[0.003407192,0.0074504702,0.86367345,0.00033321415,0.00081291626,0.0004591072,0.0010639143,0.0006066281,0.0018572962,0.0015369244,0.11855024,0.000248648],"about_ca_topic_score_codex":0.0006419853,"about_ca_topic_score_gemma":0.0006503309,"teacher_disagreement_score":0.11722098,"about_ca_system_score_codex":0.000111492045,"about_ca_system_score_gemma":0.001278495,"threshold_uncertainty_score":0.71345115},"labels":[],"label_agreement":null},{"id":"W4392818236","doi":"10.1007/s00345-024-04798-5","title":"Predicting individual outcomes after radical cystectomy in urothelial variants with Cancer of the Bladder Risk Assessment (COBRA) score","year":2024,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Urothelial carcinoma; Urology; Nephrology; Internal medicine; Urothelial cancer; Oncology; Cancer","score_opus":0.015316638783397039,"score_gpt":0.2988578712682599,"score_spread":0.28354123248486285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392818236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634,0.0042143506,0.0002022238,0.006682749,0.00114787,0.0004081084,0.00009396812,0.000014878873,0.0008958393],"genre_scores_gemma":[0.9979141,0.00018411943,0.0003077592,0.0008976245,0.0003709948,0.00003252387,9.355054e-7,0.000031989166,0.0002600023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820685,0.00021614891,0.0005699828,0.00020363113,0.0005245346,0.0002788645],"domain_scores_gemma":[0.99917674,0.00017834609,0.000267887,0.00018470865,0.000086174194,0.000106151645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042816412,0.00018938529,0.00052268547,0.00034739976,0.000040604325,0.000021484258,0.00018028091,0.000087125605,0.000532579],"category_scores_gemma":[0.000040128914,0.0000990993,0.00018052723,0.00041127796,0.00023772634,0.00010367716,0.00006035532,0.0009134969,0.0000020159612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011566646,0.00019618352,0.9907526,0.000053626998,0.0011410484,0.0006107068,0.00057929865,0.0000961005,0.00010471149,0.00009716383,0.00022315259,0.00498876],"study_design_scores_gemma":[0.0047383644,0.0008248211,0.989458,0.00035937573,0.0012294766,0.0005187994,0.000039614657,0.0001355231,0.000096905336,0.0002158627,0.002297917,0.00008531701],"about_ca_topic_score_codex":0.00023210635,"about_ca_topic_score_gemma":0.0010078348,"teacher_disagreement_score":0.011574039,"about_ca_system_score_codex":0.00011783231,"about_ca_system_score_gemma":0.00088905444,"threshold_uncertainty_score":0.5831367},"labels":[],"label_agreement":null},{"id":"W4392821330","doi":"10.1016/j.urolonc.2024.01.253","title":"IMPACT OF BLADDER CUFF MANAGEMENT ON ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Urothelial carcinoma; Medicine; Meta-analysis; Cuff; Urology; Carcinoma; Oncology; General surgery; Bladder cancer; Surgery; Internal medicine; Cancer","score_opus":0.0983059789797866,"score_gpt":0.42606808411091734,"score_spread":0.32776210513113074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392821330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062277477,0.9899633,0.000021002117,0.0010502839,0.00013556243,0.0070196893,0.00057060696,0.000056450262,0.0005603466],"genre_scores_gemma":[0.00055403396,0.9843293,0.006415159,0.002113729,0.000068545,0.004244354,0.0003199073,0.00006543361,0.0018895756],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964529,0.0005235787,0.0013491348,0.00092464994,0.00030336244,0.00044636076],"domain_scores_gemma":[0.9974039,0.001003807,0.00064535235,0.00053981727,0.000060259685,0.00034681457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007668362,0.000875183,0.009246355,0.000704649,0.00015925536,0.000039845792,0.00020203371,0.00056311424,0.00018945764],"category_scores_gemma":[0.0001919952,0.00045856732,0.0051474185,0.00073095964,0.00038855115,0.00006283448,0.00008196937,0.0005729373,0.000017966286],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067930814,0.0009399411,0.0030330291,0.52515006,0.46160778,0.0006995076,0.00015102107,0.0000021403398,1.615853e-7,0.0015173783,0.004883753,0.0019472757],"study_design_scores_gemma":[0.00062732893,0.003407252,0.00006668311,0.0045795725,0.7854152,0.00024414397,0.000014610081,0.000007456935,1.3682495e-7,0.00038375187,0.20497246,0.00028144225],"about_ca_topic_score_codex":0.00004470996,"about_ca_topic_score_gemma":0.000005111562,"teacher_disagreement_score":0.5205705,"about_ca_system_score_codex":0.00038597526,"about_ca_system_score_gemma":0.0006459148,"threshold_uncertainty_score":0.9997866},"labels":[],"label_agreement":null},{"id":"W4392919076","doi":"10.1111/bju.16333","title":"Trimodal therapy effect on survival in urothelial vs non‐urothelial bladder cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Bladder cancer; Stage (stratigraphy); Hazard ratio; Proportional hazards model; Urothelial cancer; Internal medicine; Urothelial carcinoma; Radiation therapy; Urinary bladder; Cancer; Chemotherapy; Oncology; Gastroenterology; Confidence interval","score_opus":0.014839986380774174,"score_gpt":0.30214790559118815,"score_spread":0.287307919210414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392919076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97279274,0.016183684,0.00007152594,0.0024782263,0.0036962943,0.0005791983,0.00008552046,0.000038935304,0.0040738853],"genre_scores_gemma":[0.9890719,0.0057065296,0.000028915047,0.0018829743,0.002412378,0.00004359362,0.00000460157,0.00007443364,0.0007746541],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99794394,0.00027735913,0.0005622426,0.00034237513,0.00043470948,0.00043938268],"domain_scores_gemma":[0.9992032,0.00024964748,0.00011052609,0.00015063745,0.00009845274,0.0001875149],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058942894,0.00025583652,0.0007537682,0.00032867308,0.000052307798,0.000067322515,0.00017056997,0.00022540627,0.0014907363],"category_scores_gemma":[0.000077355064,0.00022231128,0.000337466,0.00025834146,0.00011617161,0.00011343058,0.000020631782,0.0009072857,0.00009743108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0353046,0.0015421374,0.037055824,0.0001914738,0.0020862555,0.037369538,0.0006200177,0.00017622847,0.013375172,0.000107014996,0.017325547,0.8548462],"study_design_scores_gemma":[0.10142261,0.08748378,0.43675706,0.0026175804,0.001628324,0.041934855,0.00006688472,0.00068272237,0.018423388,0.00121882,0.30633318,0.0014307867],"about_ca_topic_score_codex":0.00088165305,"about_ca_topic_score_gemma":0.00020016044,"teacher_disagreement_score":0.8534154,"about_ca_system_score_codex":0.0001552191,"about_ca_system_score_gemma":0.0006739195,"threshold_uncertainty_score":0.999422},"labels":[],"label_agreement":null},{"id":"W4392949914","doi":"10.1007/s00261-024-04245-4","title":"Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis","year":2024,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Confidence interval; Retrospective cohort study; Predictive value of tests; Hepatology; Internal medicine; Urology; Radiology; Cancer","score_opus":0.013968673355303208,"score_gpt":0.28353713937509073,"score_spread":0.2695684660197875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392949914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933092,0.0034173517,0.000072958035,0.00046173597,0.00045464106,0.0003015555,0.00006913877,0.000038516733,0.0018749143],"genre_scores_gemma":[0.9983211,0.00057778,0.000115996925,0.00013782992,0.00038025476,0.00017052537,0.000017034,0.00002638138,0.00025310504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851114,0.00009104247,0.0003863854,0.0004683448,0.00020017246,0.0003429004],"domain_scores_gemma":[0.99947196,0.00008352278,0.000058770755,0.00021223584,0.00009118416,0.000082341525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017742066,0.00020022536,0.0005998205,0.00045074307,0.000034454206,0.0000093099325,0.00006840654,0.00016697803,0.0006770905],"category_scores_gemma":[0.000032694647,0.00016523835,0.00026486794,0.0008719945,0.00017583024,0.00011125322,0.000017537732,0.00032000858,0.0000071700492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002688517,0.00019306478,0.97970074,0.00023750492,0.0020956693,0.00028648294,0.0032605545,0.00009797442,0.0063949195,0.000008902967,0.0000811202,0.0049545546],"study_design_scores_gemma":[0.0022464287,0.0023112155,0.98453546,0.00043295577,0.0018158066,0.00023887583,0.00021827235,0.0026241592,0.0052355514,0.000028998022,0.00015226679,0.00016003753],"about_ca_topic_score_codex":0.0005316021,"about_ca_topic_score_gemma":0.0016489673,"teacher_disagreement_score":0.005011905,"about_ca_system_score_codex":0.00040468937,"about_ca_system_score_gemma":0.00018238495,"threshold_uncertainty_score":0.74136657},"labels":[],"label_agreement":null},{"id":"W4392973340","doi":"10.1007/s40615-024-01973-7","title":"The effect of race/ethnicity on cancer-specific mortality after trimodal therapy","year":2024,"lang":"en","type":"article","venue":"Journal of Racial and Ethnic Health Disparities","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Pacific islanders; Medicine; Ethnic group; Demography; Epidemiology; Proportional hazards model; Gerontology; Internal medicine; Population; Environmental health","score_opus":0.04813264693407349,"score_gpt":0.39956829926823006,"score_spread":0.3514356523341566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392973340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7495608,0.24213463,0.00001594434,0.006930697,0.00090148934,0.00026416933,0.000035862704,0.000009279419,0.00014717654],"genre_scores_gemma":[0.8907183,0.10760026,0.000006195612,0.00063950056,0.00074954785,0.000026986207,0.0000010304024,0.0000136553235,0.00024455812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99848944,0.00021962149,0.00051501626,0.0001308856,0.00039628355,0.00024877215],"domain_scores_gemma":[0.9990741,0.00038342713,0.00016483909,0.00012599654,0.000067697234,0.00018391901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010391405,0.00015565603,0.00053757674,0.0000704524,0.00012823987,0.00003177256,0.00006385736,0.000074004456,0.000050324255],"category_scores_gemma":[0.000033424094,0.0000782881,0.0002051966,0.00013180393,0.00018891912,0.00008918156,0.00001260467,0.00044013571,0.0000014958346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017398903,0.00020713476,0.06447931,0.0018042444,0.0008081094,0.00013249673,0.004300062,0.0000060891903,0.00019766175,0.0003681497,0.008321915,0.9019759],"study_design_scores_gemma":[0.0037853348,0.00850683,0.93653977,0.0016034251,0.00016737079,0.00008239417,0.00019010692,0.000020901569,0.0024985005,0.0005787681,0.045888852,0.00013776765],"about_ca_topic_score_codex":0.0006173037,"about_ca_topic_score_gemma":0.00017261133,"teacher_disagreement_score":0.9018382,"about_ca_system_score_codex":0.00012586372,"about_ca_system_score_gemma":0.00043868538,"threshold_uncertainty_score":0.31924963},"labels":[],"label_agreement":null},{"id":"W4393043563","doi":"10.1186/s12874-024-02199-1","title":"Development of the multivariate administrative data cystectomy model and its impact on misclassification bias","year":2024,"lang":"en","type":"article","venue":"BMC Medical Research Methodology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Logistic regression; Multivariate analysis; Multivariate statistics; Covariate; Statistics; Urinary diversion; Urology; Internal medicine; Mathematics; Cancer","score_opus":0.837076198824331,"score_gpt":0.637161082707123,"score_spread":0.19991511611720802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393043563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92434937,0.0033522143,0.059960064,0.005833237,0.00035318063,0.0018911834,0.00020619125,0.00006771635,0.0039868173],"genre_scores_gemma":[0.95510536,0.00014897335,0.043591402,0.000083699655,0.00009953739,0.00007833442,0.000037399288,0.00001841588,0.0008368736],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99494684,0.0027400164,0.00034791947,0.00048495343,0.0011575522,0.0003227115],"domain_scores_gemma":[0.98944896,0.009429357,0.00004536526,0.0005771189,0.00015769147,0.00034147486],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009371131,0.00013179946,0.0003381117,0.00015602598,0.000100950325,0.000014390215,0.00036332468,0.00018554358,0.00023941873],"category_scores_gemma":[0.01771842,0.00006560307,0.000055957593,0.0003313861,0.00029374514,0.00004439965,0.00031893537,0.0006164536,0.000023756535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013388937,0.0022381651,0.0055363644,0.005442748,0.0032075862,0.00035957625,0.02061649,0.00006809069,0.1295994,0.039376136,0.008679149,0.77148736],"study_design_scores_gemma":[0.009927363,0.0034841462,0.19133453,0.0049814293,0.0004791623,0.00048351887,0.0021920216,0.65280735,0.112331875,0.007341324,0.014055295,0.0005819758],"about_ca_topic_score_codex":0.00008158127,"about_ca_topic_score_gemma":0.00014289263,"teacher_disagreement_score":0.7709054,"about_ca_system_score_codex":0.00013271751,"about_ca_system_score_gemma":0.006603432,"threshold_uncertainty_score":0.9990282},"labels":[],"label_agreement":null},{"id":"W4393050140","doi":"10.21037/tau-23-620","title":"Biomarker challenges in the pursuit of personalized neoadjuvant chemotherapy for muscle-invasive bladder cancer: conclusions from SWOG S1314","year":2024,"lang":"en","type":"editorial","venue":"Translational Andrology and Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Bladder cancer; Medicine; Biomarker; Chemotherapy; Oncology; Neoadjuvant therapy; Internal medicine; Cancer; Biology","score_opus":0.040692513048562876,"score_gpt":0.32885045597338913,"score_spread":0.28815794292482627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393050140","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032042723,0.4821851,0.0001963806,0.2102634,0.2558621,0.004046236,0.013111483,0.0000907765,0.0022018056],"genre_scores_gemma":[0.45319963,0.18941174,0.00041376307,0.009177525,0.3362823,0.0026295942,0.007462167,0.000247679,0.0011755718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981779,0.00016435824,0.0004072363,0.0005932371,0.0003562306,0.00030105803],"domain_scores_gemma":[0.9970195,0.0025021308,0.00011805237,0.000189571,0.00010864915,0.000062075575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003270486,0.00033271554,0.0008204436,0.00016406759,0.000090591835,0.000009145547,0.0001950986,0.0010489516,0.00048565122],"category_scores_gemma":[0.000049365797,0.00022652835,0.00022808708,0.00009015906,0.00047348507,0.000029465378,0.000022497376,0.00054225477,0.0000034446828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028351363,0.001492759,0.0027294408,0.0015184598,0.008701986,0.00034732904,0.02480795,0.00002162992,0.002041501,0.0048250537,0.83109605,0.0940665],"study_design_scores_gemma":[0.011127603,0.001482505,0.010376628,0.00009930573,0.0016315262,0.00003062463,0.00013225444,0.00012033945,0.000024381286,0.015076126,0.95966583,0.00023286096],"about_ca_topic_score_codex":0.00037678098,"about_ca_topic_score_gemma":0.0013177993,"teacher_disagreement_score":0.4211569,"about_ca_system_score_codex":0.000020226886,"about_ca_system_score_gemma":0.0006122378,"threshold_uncertainty_score":0.9237558},"labels":[],"label_agreement":null},{"id":"W4393071362","doi":"10.1158/1538-7445.am2024-6694","title":"Abstract 6694: Gut microbial drivers of response to bladder-sparing therapy in human muscle-invasive bladder cancer enhance immunotherapy efficacy and limit immunosuppression following fecal microbiome transplantation <i>in vivo</i>","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); Centre Hospitalier de l’Université de Montréal; Institute of Infection and Immunity; McGill University Health Centre","funders":"","keywords":"Immunosuppression; Microbiome; Immunotherapy; Transplantation; Bladder cancer; Medicine; Cancer; In vivo; Ex vivo; Immunology; Immune system; Biology; Internal medicine; Bioinformatics","score_opus":0.04121302489874531,"score_gpt":0.3974398220793401,"score_spread":0.3562267971805948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849008,0.011648175,0.0000110268,0.0011307942,0.00031616836,0.001624859,0.000125297,0.000041449664,0.00020145184],"genre_scores_gemma":[0.98560345,0.013000404,0.00005805341,0.00016398467,0.00013423397,0.0004054921,0.00001875995,0.00008465912,0.0005309757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972256,0.00026336536,0.0005239435,0.0007584366,0.00052767707,0.00070096576],"domain_scores_gemma":[0.9988544,0.00046764823,0.000053090247,0.00034745716,0.00011906729,0.00015833773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085226895,0.0003117771,0.00051050767,0.00079505105,0.00022365064,0.00013747747,0.00022864927,0.00020145226,0.00038726194],"category_scores_gemma":[0.000031976855,0.00028231472,0.00014885305,0.00094993383,0.00017881334,0.00022312235,0.00005252898,0.0006595728,0.000008934841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008200741,0.0002563035,0.0025192758,0.0003021353,0.00028618932,0.00033177235,0.009127254,0.00008305463,0.960198,0.0000024569724,0.0004372794,0.018255562],"study_design_scores_gemma":[0.007698751,0.0007159218,0.10602495,0.004281611,0.000044805936,0.000009872859,0.0003595718,0.000008078317,0.87855566,0.000015878597,0.00200991,0.00027498158],"about_ca_topic_score_codex":0.007783302,"about_ca_topic_score_gemma":0.0021163544,"teacher_disagreement_score":0.10350568,"about_ca_system_score_codex":0.0006926276,"about_ca_system_score_gemma":0.0007821134,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W4393075940","doi":"10.1158/1538-7445.am2024-6641","title":"Abstract 6641: Improving response to bladder-sparing therapies by combining radiotherapy to immuno-potentiating agents in immunologically cold models of bladder cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Radiation therapy; Oncology; Urology; Internal medicine","score_opus":0.09754294860238281,"score_gpt":0.41478729054625263,"score_spread":0.3172443419438698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393075940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547409,0.039164953,0.00032464907,0.0029945683,0.00032237402,0.0016639807,0.00012169713,0.00009862096,0.00056829624],"genre_scores_gemma":[0.99285156,0.0027129317,0.00046802746,0.0005494328,0.0001358669,0.0012211915,0.00000800427,0.00011401047,0.001938962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99636835,0.00025522453,0.0006202374,0.00079017226,0.000969307,0.0009967342],"domain_scores_gemma":[0.99842477,0.00039100234,0.00006848652,0.00052369904,0.0003164493,0.0002755814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001656119,0.00032611963,0.0005972309,0.0007096575,0.00020331766,0.00016603958,0.0004105785,0.0001863666,0.0011395245],"category_scores_gemma":[0.00012647445,0.00027958272,0.00014247913,0.0013117497,0.00013818823,0.0002423608,0.00019488992,0.0008564819,0.000029677463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004584164,0.00021531482,0.0015979212,0.0002334683,0.00071120774,0.0001288477,0.0064256154,0.0013820406,0.9432191,0.0000419129,0.0029069,0.038553488],"study_design_scores_gemma":[0.014887772,0.006747231,0.14053027,0.011828685,0.00030917756,0.00003359985,0.007020629,0.008382313,0.77795553,0.00056775735,0.029658893,0.0020781292],"about_ca_topic_score_codex":0.011489915,"about_ca_topic_score_gemma":0.00029913103,"teacher_disagreement_score":0.16526358,"about_ca_system_score_codex":0.0013626309,"about_ca_system_score_gemma":0.0010274538,"threshold_uncertainty_score":0.9999656},"labels":[],"label_agreement":null},{"id":"W4393093787","doi":"10.1158/1538-7445.am2024-883","title":"Abstract 883: Genetic characteristics between males and females with urothelial bladder cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Urothelial cancer; Cancer; Bladder cancer; Medicine; Urology; Oncology; Internal medicine","score_opus":0.11232281895213285,"score_gpt":0.42028536970988223,"score_spread":0.30796255075774936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393093787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768827,0.017010314,0.000022510385,0.0027072427,0.00020161748,0.00071645255,0.00044184196,0.0000917979,0.0019255136],"genre_scores_gemma":[0.98718834,0.00608182,0.00012012693,0.00014678655,0.0019365846,0.00048420017,0.000025486772,0.00009112278,0.003925554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788386,0.00004910056,0.0002255382,0.0005593364,0.0006907311,0.0005914257],"domain_scores_gemma":[0.9990126,0.00014428374,0.00002594406,0.0002879541,0.00020581065,0.00032340572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002100605,0.00023283406,0.00034762113,0.00022499701,0.0001681146,0.00016815924,0.00012072223,0.00011761312,0.0017327698],"category_scores_gemma":[0.000020135767,0.00016496182,0.000055026372,0.0003583719,0.0003902298,0.00009589421,0.00006529105,0.000568471,0.000099079596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010007975,0.00013108688,0.71089375,0.002152648,0.001475748,0.0011698777,0.0011289257,0.0000032950209,0.02049981,0.00013757752,0.006409211,0.25499725],"study_design_scores_gemma":[0.0011282051,0.00049894536,0.9451551,0.0011236959,0.00027742423,0.000047870297,0.00009519585,0.000018882922,0.00697447,0.0001013608,0.04433704,0.00024181136],"about_ca_topic_score_codex":0.0013495623,"about_ca_topic_score_gemma":0.0002480543,"teacher_disagreement_score":0.25475544,"about_ca_system_score_codex":0.00025633434,"about_ca_system_score_gemma":0.0011028145,"threshold_uncertainty_score":0.9991798},"labels":[],"label_agreement":null},{"id":"W4393234755","doi":"10.3390/cancers16071292","title":"Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based Analysis","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Multimodal therapy; Bladder cancer; Chemotherapy; Radiation therapy; Urothelial carcinoma; Proportional hazards model; Radiology; Bladder tumor; Urology; Resection; Urinary bladder; Surgery; Cancer; Internal medicine","score_opus":0.012772135421516425,"score_gpt":0.27608925409594615,"score_spread":0.2633171186744297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393234755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111116,0.00072841777,0.00012607397,0.0005064497,0.00039621463,0.0008244923,0.000054007756,0.000053787662,0.006199378],"genre_scores_gemma":[0.9983869,0.00003743307,0.00017581214,0.00018303131,0.00015235934,0.00012486457,0.00004302519,0.00003601685,0.0008605397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984597,0.000038677103,0.00038032694,0.000443872,0.00037781737,0.00029960487],"domain_scores_gemma":[0.9993061,0.000047143032,0.0000632755,0.0004441511,0.000037014666,0.00010231576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010620846,0.00022678555,0.00042849936,0.00037651876,0.00006200467,0.000022904327,0.00015748826,0.00009010743,0.00056513783],"category_scores_gemma":[0.000006800497,0.0001661419,0.00034627723,0.0013822473,0.000073191346,0.000048475038,0.000050057868,0.00020040784,0.00001176363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011535779,0.00024369123,0.9609662,0.00058285927,0.004039246,0.0010626161,0.0010400611,0.019661432,0.00045591098,0.00023985251,0.00036558261,0.010188943],"study_design_scores_gemma":[0.005029806,0.00025321846,0.9251129,0.00027260487,0.0028368433,0.000017812243,0.0002065817,0.061842255,0.0030065237,0.000040102514,0.0011313449,0.00025000592],"about_ca_topic_score_codex":0.0060920874,"about_ca_topic_score_gemma":0.0004541844,"teacher_disagreement_score":0.042180825,"about_ca_system_score_codex":0.001053021,"about_ca_system_score_gemma":0.00057464774,"threshold_uncertainty_score":0.92094547},"labels":[],"label_agreement":null},{"id":"W4393282675","doi":"10.1016/j.ejso.2024.108297","title":"Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement","year":2024,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Perioperative; Cystectomy; Odds ratio; Heart valve; Bladder cancer; Confidence interval; Valve replacement; Surgery; Blood transfusion; Heart failure; Aortic valve replacement; Comorbidity; Cardiology; Internal medicine; Cancer; Stenosis","score_opus":0.018300326102627527,"score_gpt":0.3146011647645203,"score_spread":0.2963008386618928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393282675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98074675,0.00067846826,0.00002333836,0.0037422979,0.00013687785,0.0002776928,0.000007306867,0.000008548276,0.014378704],"genre_scores_gemma":[0.99913144,0.00016186833,0.0003521746,0.00020362907,0.00008420737,0.0000050200706,0.000005362946,0.000015593268,0.00004072703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986846,0.00034284557,0.00044475327,0.00018565753,0.00019247037,0.00014967413],"domain_scores_gemma":[0.99951124,0.00009603007,0.000067077926,0.000089161505,0.000078257435,0.0001582148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043441134,0.00010949844,0.0003515674,0.00012705583,0.000024688035,0.000017690329,0.00004657726,0.000028348617,0.00007882297],"category_scores_gemma":[0.000015177324,0.000070449096,0.00006961323,0.00015744365,0.00015603445,0.000077451994,0.00002873396,0.00037744173,0.000013215343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019367434,0.001996047,0.9804449,0.00004563239,0.00023635528,0.0047614467,0.0014829326,0.0000140226075,0.000030321204,0.00016561072,0.00038726436,0.008498741],"study_design_scores_gemma":[0.007972544,0.006278838,0.8540675,0.00022780334,0.00006225189,0.00047487413,0.00009330441,0.000019462852,0.0000088949655,0.000006617918,0.13072093,0.0000670005],"about_ca_topic_score_codex":0.000012766409,"about_ca_topic_score_gemma":0.000013131225,"teacher_disagreement_score":0.13033366,"about_ca_system_score_codex":0.00022536237,"about_ca_system_score_gemma":0.0002027078,"threshold_uncertainty_score":0.28728306},"labels":[],"label_agreement":null},{"id":"W4393346005","doi":"10.1136/bmjopen-2023-081480","title":"Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Toronto East General Hospital; McGill University; St Mary's Hospital Centre; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Fondation de l'Hôpital général juif; Department of Medicine, University of Toronto; Jewish General Hospital; University of Toronto","keywords":"Medicine; Internal medicine; Metastatic Urothelial Carcinoma; Retrospective cohort study; Cohort; Multivariate analysis; Cancer; Proportional hazards model; Body mass index; Oncology; Gastroenterology; Bladder cancer; Urothelial carcinoma","score_opus":0.03841767118140881,"score_gpt":0.3728942548209746,"score_spread":0.3344765836395658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393346005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736447,0.000038582562,0.000010036931,0.00019527656,0.00027519793,0.024075972,0.00014213662,0.000063580934,0.0015545302],"genre_scores_gemma":[0.99582595,0.0000017599583,0.00040411224,0.00011556094,0.000066256034,0.0018273377,0.00009365723,0.00007327732,0.0015921042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972069,0.0002949822,0.00074640574,0.00068631244,0.0007129476,0.00035240166],"domain_scores_gemma":[0.9988204,0.000169707,0.00016926453,0.00049675995,0.00019913081,0.00014471695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011342597,0.00032915178,0.0011804531,0.00011469615,0.000068775495,0.00014045463,0.00020010248,0.00007113304,0.00019406174],"category_scores_gemma":[0.00033460927,0.00019641039,0.00010595522,0.00042983275,0.00007602863,0.00023095298,0.00017924931,0.00036698126,0.000039391412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004252085,0.004945633,0.9865465,0.000052251744,0.002367984,0.0004977254,0.0010460746,0.0000021332219,0.0000029157986,0.000009019005,0.00007579286,0.00020185838],"study_design_scores_gemma":[0.030476766,0.005161745,0.96147877,0.00066058745,0.0013169175,0.0000044881385,0.0005082064,0.00007340165,0.0000308164,0.000017963022,0.000018433244,0.00025189907],"about_ca_topic_score_codex":0.0026080462,"about_ca_topic_score_gemma":0.0012629795,"teacher_disagreement_score":0.02622468,"about_ca_system_score_codex":0.0005316935,"about_ca_system_score_gemma":0.0007071935,"threshold_uncertainty_score":0.8009383},"labels":[],"label_agreement":null},{"id":"W4393356996","doi":"10.3390/cancers16071356","title":"PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette–Guérin (BCG) Therapy","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Internal medicine; Proportional hazards model; Oncology; Hazard ratio; Multivariate analysis; PD-L1; Immunotherapy; Stage (stratigraphy); Urology; Cancer; Biology","score_opus":0.012625347678333204,"score_gpt":0.288487388188065,"score_spread":0.27586204050973184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393356996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98146826,0.012918594,0.00011821547,0.0015028784,0.0010642818,0.00090728654,0.0005622328,0.00013067301,0.001327584],"genre_scores_gemma":[0.9762456,0.017454602,0.00013136311,0.003640569,0.0005694153,0.00056566694,0.00004800063,0.000090125985,0.0012546761],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976308,0.0000668952,0.00041122024,0.00080465426,0.00048322493,0.0006032046],"domain_scores_gemma":[0.9989595,0.00011776563,0.00008084162,0.0004409116,0.00008091622,0.0003200712],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113400245,0.00042278087,0.0005414818,0.00019616721,0.00009677245,0.00006075384,0.00018296948,0.00025184584,0.0021304511],"category_scores_gemma":[0.000032591943,0.00032789423,0.00017098091,0.00055636145,0.00017646156,0.00020816263,0.00004517316,0.0005987577,0.000106775784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027464589,0.0003136389,0.034956455,0.0006489378,0.001626477,0.0009489646,0.015779665,0.00077387155,0.28705156,0.00006187812,0.23931955,0.41577256],"study_design_scores_gemma":[0.019900983,0.0027205632,0.11999755,0.0035399622,0.00060798123,0.00003733186,0.0013403419,0.0013280172,0.6914881,0.00094718026,0.15640424,0.0016877898],"about_ca_topic_score_codex":0.011976476,"about_ca_topic_score_gemma":0.00053119357,"teacher_disagreement_score":0.41408476,"about_ca_system_score_codex":0.0022275303,"about_ca_system_score_gemma":0.0017600851,"threshold_uncertainty_score":0.9999173},"labels":[],"label_agreement":null},{"id":"W4393436440","doi":"10.1007/s11255-024-04035-3","title":"Editorial comment to the paper: RE: low cubilin/myeloperoxidase’s ratio as a promising biomarker for prognosis of high grade T1 bladder cancer","year":2024,"lang":"en","type":"editorial","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Fundação para a Ciência e a Tecnologia","keywords":"Medicine; Biomarker; Internal medicine; Bladder cancer; Nephrology; Cancer; Oncology; Myeloperoxidase; Urology; Inflammation","score_opus":0.014937681294238595,"score_gpt":0.3205807805247134,"score_spread":0.3056430992304748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393436440","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004298736,0.0013830786,0.000066690285,0.11022176,0.880702,0.0018834008,0.0012257604,0.000041597144,0.00017695781],"genre_scores_gemma":[0.053506166,0.00079754496,0.00012189764,0.012697775,0.9291186,0.0020084395,0.0007475866,0.0000780831,0.0009239168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767536,0.00012964611,0.00057231635,0.00073266623,0.00052363495,0.00036637686],"domain_scores_gemma":[0.9978811,0.0009625107,0.00020713366,0.00028601312,0.0005390927,0.00012412992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036207927,0.00039182545,0.00068609195,0.0002112051,0.000111375695,0.000036766414,0.00030607387,0.0010377828,0.00042413903],"category_scores_gemma":[0.00041171617,0.00027141426,0.00019876563,0.00011653284,0.00028446573,0.000060918508,0.00018121966,0.00065186026,0.00003162573],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006238714,0.00028782783,0.00011898804,0.000121127305,0.0028349273,0.000020678563,0.0003482442,0.000007328185,0.0009016781,0.00040584765,0.9867598,0.0019548503],"study_design_scores_gemma":[0.0036354917,0.0020635813,0.00027471734,0.00009136691,0.0012027909,0.000018411136,0.000016575983,0.00006652937,0.0005347328,0.0015516015,0.99034446,0.00019970816],"about_ca_topic_score_codex":0.0009821985,"about_ca_topic_score_gemma":0.00060510566,"teacher_disagreement_score":0.09752399,"about_ca_system_score_codex":0.00015167792,"about_ca_system_score_gemma":0.00077166624,"threshold_uncertainty_score":0.99997383},"labels":[],"label_agreement":null},{"id":"W4393952355","doi":"10.1016/j.eururo.2024.03.023","title":"Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Urothelial cancer; Placebo; Oncology; Cancer; Internal medicine; Urothelial carcinoma; Bladder cancer; Urology; Surgery; Pathology","score_opus":0.03506205683462299,"score_gpt":0.3012544102331573,"score_spread":0.2661923533985343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393952355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7562061,0.0008438091,0.00012125213,0.18285888,0.011979384,0.014536262,0.029611044,0.00051645935,0.0033267897],"genre_scores_gemma":[0.4362138,0.0002653272,0.0011617328,0.36087006,0.13072437,0.0028617687,0.0592345,0.0015245358,0.0071439096],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99596924,0.000987526,0.00074114976,0.0012602605,0.0004405387,0.0006013079],"domain_scores_gemma":[0.99741906,0.0007743174,0.0004404251,0.0010071546,0.00022479698,0.00013424421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003400003,0.000627446,0.00068088336,0.00013955533,0.000294899,0.00015015967,0.00040618412,0.00036173707,0.00021999869],"category_scores_gemma":[0.0003126888,0.00040027432,0.00018318,0.00015689335,0.00017757452,0.00008976085,0.000107228465,0.0018264723,0.00015033635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52336407,0.00033133387,0.00018677082,0.000043009957,0.0015063065,0.00038882322,0.0011876543,0.00003062824,0.00004453786,0.00000397643,0.4675796,0.0053332844],"study_design_scores_gemma":[0.30546534,0.02284104,0.0013744202,0.00007519406,0.0025535221,0.0000052522737,0.000008934585,0.000083531995,0.00004593926,0.000023281362,0.6671363,0.0003872016],"about_ca_topic_score_codex":0.0011866589,"about_ca_topic_score_gemma":0.0004924208,"teacher_disagreement_score":0.3199923,"about_ca_system_score_codex":0.00017828411,"about_ca_system_score_gemma":0.00049684104,"threshold_uncertainty_score":0.9998449},"labels":[],"label_agreement":null},{"id":"W4394008881","doi":"10.1016/j.clgc.2024.102087","title":"Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer","year":2024,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Honing; Oncology; Cancer; Neoadjuvant therapy; Internal medicine; Breast cancer","score_opus":0.13661444070638556,"score_gpt":0.46326579593080336,"score_spread":0.3266513552244178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394008881","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000887459,0.9866072,8.05336e-7,0.0016988897,0.00252331,0.006369858,0.0007764812,0.00008040732,0.0010555735],"genre_scores_gemma":[0.00007698937,0.9853424,0.000092382186,0.0066717607,0.003167701,0.0029395611,0.00007272201,0.00023638865,0.0014001137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937773,0.00065891363,0.0027535025,0.0013151648,0.0007682941,0.00072685716],"domain_scores_gemma":[0.99575895,0.00092111353,0.00073409884,0.0018492105,0.00028715405,0.0004494438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006118911,0.001019051,0.004829008,0.00025879336,0.000084186475,0.000030082414,0.0010066937,0.000396115,0.0009065635],"category_scores_gemma":[0.00020312834,0.000582033,0.0020764102,0.0012396872,0.00028843057,0.000053604246,0.0005452572,0.0018797135,0.0001645685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003796948,0.00096201827,0.00013493006,0.087632984,0.0017071129,0.0006289002,0.00014334076,0.0000031211596,0.000004066621,0.0000015728153,0.07627746,0.83212477],"study_design_scores_gemma":[0.002353043,0.0011128159,0.00059763284,0.20395027,0.0048247147,0.000057863665,0.00002144015,0.0000022124202,0.000011226144,0.000007777228,0.7866345,0.00042649152],"about_ca_topic_score_codex":0.00038839536,"about_ca_topic_score_gemma":0.00004167865,"teacher_disagreement_score":0.8316983,"about_ca_system_score_codex":0.0004602936,"about_ca_system_score_gemma":0.0033735267,"threshold_uncertainty_score":0.9996631},"labels":[],"label_agreement":null},{"id":"W4394065598","doi":"10.6084/m9.figshare.24040675","title":"Additional file 4 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Computer science; Cancer; Biology; Computational biology; Medicine; Internal medicine","score_opus":0.06482944254052064,"score_gpt":0.33441363197207474,"score_spread":0.2695841894315541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394065598","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002962677,0.00020626199,2.478635e-9,0.000025413508,0.00014789142,0.00054518494,0.9972763,0.00006265094,0.0017333243],"genre_scores_gemma":[0.0000024042024,0.0000914548,0.000014225596,0.00045668756,0.0012429191,0.0037145826,0.9862042,0.00008535442,0.008188155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998123,0.000026698472,0.00043883038,0.0005481533,0.0005318048,0.00033150203],"domain_scores_gemma":[0.9976197,0.000763318,0.00036826558,0.0006005175,0.0004564857,0.00019173285],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00001188626,0.00044042713,0.00066441984,0.00023233514,0.0001646701,0.00004923474,0.0003200973,0.00045025826,0.9967587],"category_scores_gemma":[0.001299337,0.00040583545,0.0003284629,0.00026960828,0.00007190853,0.000087415065,0.00022527669,0.00043501589,0.015261142],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003747435,0.00011719971,0.0000014895094,0.0011610147,0.0005590771,0.00016240255,0.00007921712,0.0000013635248,0.000009795748,2.1760074e-7,0.99771816,0.00015259527],"study_design_scores_gemma":[0.00072470383,0.00024001842,0.0045599244,0.007946063,0.00016981945,0.000007205954,0.000029364302,4.2976367e-7,0.00013266665,0.000010272555,0.9858507,0.00032881112],"about_ca_topic_score_codex":0.00065646914,"about_ca_topic_score_gemma":0.002543405,"teacher_disagreement_score":0.9814976,"about_ca_system_score_codex":0.00041555078,"about_ca_system_score_gemma":0.0015066621,"threshold_uncertainty_score":0.99983937},"labels":[],"label_agreement":null},{"id":"W4394171326","doi":"10.6084/m9.figshare.24040672","title":"Additional file 3 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Computer science; Cancer; Computational biology; Biology; Medicine; Human–computer interaction; Internal medicine","score_opus":0.06436345712801297,"score_gpt":0.3339670397819381,"score_spread":0.26960358265392514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394171326","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029777354,0.0002054418,2.4616413e-9,0.000025464067,0.00014934439,0.0005446728,0.9972713,0.00006255866,0.0017382351],"genre_scores_gemma":[0.0000023380012,0.000091400994,0.000014200514,0.0004558784,0.0012558815,0.0037120944,0.98588234,0.0000853272,0.008500561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981232,0.000026702273,0.00043865913,0.00054809335,0.00053184107,0.0003314609],"domain_scores_gemma":[0.9976123,0.0007617229,0.00036819963,0.0006001749,0.0004659102,0.00019172292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011875862,0.00044039375,0.00066424895,0.00023221737,0.00016458081,0.00004920619,0.0003198408,0.00045021676,0.99681765],"category_scores_gemma":[0.0013194082,0.00040575143,0.00032843518,0.00026964583,0.00007189444,0.00008740114,0.00022518309,0.00043503058,0.015602808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037021062,0.00011703128,0.0000014845693,0.0011699639,0.0005585699,0.00016164541,0.00007905975,0.0000013833346,0.000009953216,2.090896e-7,0.99771106,0.00015258903],"study_design_scores_gemma":[0.0007279652,0.00023567642,0.004537124,0.007926906,0.00016846534,0.0000071264585,0.000029272187,4.2821537e-7,0.0001357267,0.000010161745,0.98589236,0.00032878798],"about_ca_topic_score_codex":0.0006628785,"about_ca_topic_score_gemma":0.0025321064,"teacher_disagreement_score":0.9812148,"about_ca_system_score_codex":0.00041730035,"about_ca_system_score_gemma":0.0015128332,"threshold_uncertainty_score":0.9998394},"labels":[],"label_agreement":null},{"id":"W4394175604","doi":"10.6084/m9.figshare.20001023","title":"Additional file 18 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Computational biology; Biology; Cancer research; Oncology; Medicine; Bladder cancer; Internal medicine; Cancer","score_opus":0.02739451353445433,"score_gpt":0.2476486194321379,"score_spread":0.22025410589768357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394175604","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006303203,0.000028580347,2.233027e-8,0.0000109720695,0.000067998786,0.0011312423,0.9985021,0.0000067293417,0.00018934203],"genre_scores_gemma":[0.00013404424,0.0000031018724,0.000007487194,0.0000838652,0.00012741105,0.0017216613,0.9971962,0.000027808564,0.0006984],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875885,0.000068145186,0.00041022498,0.00022696979,0.00041000888,0.00012577896],"domain_scores_gemma":[0.9984696,0.00010566959,0.00064958824,0.0004959572,0.00023741586,0.000041757907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000016189375,0.00021009697,0.00045242102,0.00011213427,0.00004133998,0.0000035804546,0.00027404606,0.00015685623,0.998839],"category_scores_gemma":[0.0004849718,0.00015351748,0.00023150085,0.00024357623,0.000029890878,0.000029125364,0.00014811754,0.00027118312,0.000106036416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001577343,0.00019520862,0.0000044584754,0.0007544804,0.00017192548,0.000005420154,0.0000191867,2.574824e-7,0.00048564357,9.250603e-8,0.9980355,0.0001701187],"study_design_scores_gemma":[0.00061100675,0.0003110383,0.005731813,0.0020282685,0.00014436296,0.000016776134,0.000011276933,0.0000029342084,0.0034794647,0.0000014494519,0.98755723,0.0001043794],"about_ca_topic_score_codex":0.00013048649,"about_ca_topic_score_gemma":0.000011656162,"teacher_disagreement_score":0.998733,"about_ca_system_score_codex":0.00009647927,"about_ca_system_score_gemma":0.0013114971,"threshold_uncertainty_score":0.62602615},"labels":[],"label_agreement":null},{"id":"W4394182843","doi":"10.6084/m9.figshare.24040663","title":"Additional file 1 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; Computer science; Biology; Medicine; Computational biology; Internal medicine","score_opus":0.06547143806311778,"score_gpt":0.33442847465021436,"score_spread":0.2689570365870966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394182843","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029538403,0.00020426938,2.4462925e-9,0.000025592633,0.00014779232,0.00054463116,0.9972851,0.00006263964,0.0017269641],"genre_scores_gemma":[0.0000023115706,0.00009004738,0.000014392045,0.0004565161,0.0012410344,0.0037906747,0.9859905,0.000085380954,0.008329142],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981232,0.000026730282,0.000438447,0.0005483536,0.0005317235,0.00033148876],"domain_scores_gemma":[0.99760836,0.0007691218,0.00036813697,0.000601156,0.00046148256,0.00019174091],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011881719,0.00044046115,0.00066417514,0.00023230173,0.0001645962,0.000049096456,0.00032005974,0.0004502584,0.99690247],"category_scores_gemma":[0.0013197933,0.00040586392,0.00032845797,0.00026975467,0.000071888884,0.00008732803,0.00022536026,0.0004351273,0.015422114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036810692,0.00011718753,0.0000014835867,0.0011495854,0.0005595299,0.00015968124,0.000079119774,0.0000013839842,0.000009934283,2.106932e-7,0.9977348,0.00015030471],"study_design_scores_gemma":[0.00071733363,0.00023609336,0.0045680706,0.007947021,0.00017016997,0.000007201307,0.00002943125,4.2757816e-7,0.00013262547,0.000010132003,0.98585266,0.00032882916],"about_ca_topic_score_codex":0.000654794,"about_ca_topic_score_gemma":0.0025135658,"teacher_disagreement_score":0.98148036,"about_ca_system_score_codex":0.00041550733,"about_ca_system_score_gemma":0.001511925,"threshold_uncertainty_score":0.9998393},"labels":[],"label_agreement":null},{"id":"W4394217959","doi":"10.6084/m9.figshare.24040744","title":"Additional file 22 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; Computer science; Computational biology; Biology; Medicine; Internal medicine","score_opus":0.0634964606059911,"score_gpt":0.3358501851421952,"score_spread":0.2723537245362041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394217959","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000065845757,0.00028191056,3.8926857e-9,0.00002808145,0.00018174916,0.00058940623,0.99693763,0.00006502502,0.0019096141],"genre_scores_gemma":[0.000005402881,0.00012253592,0.000013148621,0.00048685286,0.0012968773,0.003010975,0.9873542,0.00008948362,0.007620523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802446,0.000029366998,0.00046083814,0.0005735046,0.0005651503,0.000346656],"domain_scores_gemma":[0.9977372,0.0005901848,0.00037538618,0.0006270245,0.00047081144,0.00019934688],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000014705616,0.00045879517,0.00069161074,0.00024308587,0.00017487346,0.000052017214,0.0003381504,0.0004584017,0.9923219],"category_scores_gemma":[0.0010209613,0.0004242164,0.00033823636,0.0002772529,0.00007504686,0.00009352133,0.00023895313,0.00045683817,0.011949329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004278022,0.00012811887,0.00000256874,0.0012225892,0.0005925966,0.0001724427,0.000085876025,0.0000019751753,0.000014534472,3.5338542e-7,0.99757767,0.0001585053],"study_design_scores_gemma":[0.0008643438,0.00025467304,0.005338703,0.0067299143,0.00019434522,0.000007727164,0.000033202934,4.9496435e-7,0.0001848825,0.000012998353,0.986034,0.00034474433],"about_ca_topic_score_codex":0.0008089226,"about_ca_topic_score_gemma":0.0024490843,"teacher_disagreement_score":0.9803726,"about_ca_system_score_codex":0.00044923637,"about_ca_system_score_gemma":0.0014755604,"threshold_uncertainty_score":0.99982095},"labels":[],"label_agreement":null},{"id":"W4394243216","doi":"10.6084/m9.figshare.20001011","title":"Additional file 14 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Proteogenomics; Computational biology; Computer science; Biology; Medicine; Bladder cancer; Internal medicine; Cancer; Genetics","score_opus":0.021207816054632258,"score_gpt":0.2377703371504131,"score_spread":0.21656252109578084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394243216","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005758747,0.000028934483,2.0882489e-8,0.000013162836,0.000073195246,0.001136027,0.99853516,0.0000067590295,0.0001491597],"genre_scores_gemma":[0.00010474589,0.0000031785776,0.0000074321265,0.00008622885,0.00012637845,0.0017234427,0.99721384,0.000027874266,0.0007068728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874187,0.0000693859,0.00041333577,0.00022594605,0.00042282097,0.00012665056],"domain_scores_gemma":[0.99844235,0.00010768513,0.00065374223,0.00049415295,0.0002600312,0.0000420095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000017036218,0.00021165052,0.00044862865,0.00011176595,0.000041294268,0.0000035338992,0.0002743454,0.00016286047,0.9981818],"category_scores_gemma":[0.0005326433,0.00015406091,0.00023318168,0.0002421302,0.00002919137,0.000029223354,0.00014621812,0.00028119344,0.00010486054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015148979,0.00019460898,0.000004767059,0.00077248836,0.00017063155,0.0000053279778,0.000021794971,2.4418307e-7,0.0006054395,9.8310714e-8,0.9979128,0.0001602624],"study_design_scores_gemma":[0.0006144751,0.00031192024,0.005262763,0.0020345023,0.000144613,0.00001495065,0.000010539477,0.000002884575,0.0037103181,0.0000012126956,0.98778707,0.00010474009],"about_ca_topic_score_codex":0.000099079334,"about_ca_topic_score_gemma":0.000011969729,"teacher_disagreement_score":0.9980769,"about_ca_system_score_codex":0.000095553165,"about_ca_system_score_gemma":0.0012746791,"threshold_uncertainty_score":0.62824214},"labels":[],"label_agreement":null},{"id":"W4394249484","doi":"10.6084/m9.figshare.20001014","title":"Additional file 15 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Proteogenomics; Computer science; Computational biology; Cancer research; Biology; Medicine; Internal medicine; Bladder cancer; Cancer; Genetics","score_opus":0.021458506030903334,"score_gpt":0.2381083357636132,"score_spread":0.21664982973270988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394249484","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006518893,0.000032484597,1.9594497e-8,0.000012641287,0.000067540284,0.001139881,0.9985315,0.0000067387496,0.00014396655],"genre_scores_gemma":[0.000112166206,0.0000030146343,0.0000074547634,0.00008882299,0.00013431747,0.0016938148,0.9973061,0.00002777218,0.00062651205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987501,0.00006887472,0.0004124972,0.00022540092,0.00041684252,0.00012626495],"domain_scores_gemma":[0.9984655,0.00010545547,0.00065318553,0.00049351924,0.00023992623,0.000042422816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000016541813,0.00021138892,0.00044792265,0.00011206268,0.00004047121,0.0000035297346,0.00027497765,0.00016712809,0.9983961],"category_scores_gemma":[0.0004880339,0.00015384034,0.00023114687,0.00024441,0.000029098479,0.000029518122,0.0001472776,0.00028888322,0.000112128415],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001497554,0.00019615298,0.0000051211728,0.00076012546,0.00017099552,0.0000054586885,0.000022263597,2.4469605e-7,0.00064454856,9.281686e-8,0.9978861,0.00015913446],"study_design_scores_gemma":[0.000595673,0.0003149102,0.0056898324,0.0020199178,0.0001448329,0.000015191677,0.000012495377,0.0000030584579,0.003724259,0.000001214846,0.98737395,0.000104676554],"about_ca_topic_score_codex":0.0001097221,"about_ca_topic_score_gemma":0.000013156958,"teacher_disagreement_score":0.998284,"about_ca_system_score_codex":0.00009445749,"about_ca_system_score_gemma":0.0013120291,"threshold_uncertainty_score":0.6273427},"labels":[],"label_agreement":null},{"id":"W4394279405","doi":"10.6084/m9.figshare.19785682","title":"Additional file 2 of MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder","year":2022,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune system; Urothelial carcinoma; Cancer research; Association (psychology); Medicine; Oncology; Internal medicine; Immunology; Bladder cancer; Cancer; Psychology","score_opus":0.05176497891659811,"score_gpt":0.3004848220515828,"score_spread":0.24871984313498466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394279405","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004634671,0.00010270306,7.7601237e-7,0.00006918154,0.000042434916,0.0017740007,0.99326634,4.752937e-7,0.00010942525],"genre_scores_gemma":[0.0050097397,0.000024957373,0.0013697873,0.000020316476,0.00006997349,0.0010504422,0.9909194,0.000023242152,0.0015121268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998445,0.00005046449,0.00054163596,0.0003307759,0.0004463659,0.00018575648],"domain_scores_gemma":[0.9985077,0.00027468152,0.0007457066,0.00017955013,0.00024246106,0.000049907576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012752773,0.00022072002,0.0007423178,0.0001670335,0.000040060448,0.0000144155,0.00018340838,0.00017080535,0.76026857],"category_scores_gemma":[0.00013239004,0.0001939403,0.0001032132,0.00016730232,0.00005611204,0.00008994579,0.00012337179,0.000164799,0.000005145607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014438374,0.0006262638,0.00024139704,0.000214471,0.0008373109,0.000009856658,0.00007654725,0.0000024777617,0.000535532,1.9913597e-7,0.99437773,0.0016343758],"study_design_scores_gemma":[0.009255544,0.0042523583,0.014519766,0.000864433,0.0016187807,0.000024599889,0.00028270954,0.000014489625,0.035977185,0.0000054209354,0.9328617,0.00032300834],"about_ca_topic_score_codex":0.0016798056,"about_ca_topic_score_gemma":0.0004012772,"teacher_disagreement_score":0.76026344,"about_ca_system_score_codex":0.00013037545,"about_ca_system_score_gemma":0.0009785215,"threshold_uncertainty_score":0.7908656},"labels":[],"label_agreement":null},{"id":"W4394307604","doi":"10.6084/m9.figshare.24040681","title":"Additional file 5 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; Biology; Computer science; Computational biology; Medicine; Internal medicine","score_opus":0.06436555745472812,"score_gpt":0.33411607078228467,"score_spread":0.26975051332755656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394307604","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002978161,0.00020598288,2.4701758e-9,0.000025561525,0.00014789631,0.00054504053,0.9972799,0.00006265414,0.0017300021],"genre_scores_gemma":[0.0000023783214,0.00009143834,0.000014223171,0.00045694772,0.0012429374,0.0037139086,0.9861394,0.000085357904,0.008253368],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981229,0.000026722995,0.00043881498,0.0005482296,0.00053183903,0.00033149295],"domain_scores_gemma":[0.9976168,0.0007622604,0.00036824564,0.0006003971,0.0004605243,0.00019175332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000118927865,0.00044047466,0.0006645442,0.00023232495,0.00016467838,0.00004921103,0.00031996603,0.00045028204,0.99675775],"category_scores_gemma":[0.00130503,0.00040584366,0.00032851123,0.0002697031,0.00007190891,0.00008741492,0.00022528913,0.00043507165,0.0151509745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003684279,0.000117218675,0.0000014840242,0.001161462,0.00055912515,0.00016240696,0.00007917717,0.0000013820926,0.000009876587,2.1774461e-7,0.9977179,0.00015286653],"study_design_scores_gemma":[0.00072413177,0.00023650123,0.0046410826,0.007951218,0.00016986257,0.000007205726,0.000029376346,4.2639505e-7,0.00013376918,0.000010211661,0.9857674,0.0003288137],"about_ca_topic_score_codex":0.0006629699,"about_ca_topic_score_gemma":0.002553346,"teacher_disagreement_score":0.9816068,"about_ca_system_score_codex":0.00041564985,"about_ca_system_score_gemma":0.0015085062,"threshold_uncertainty_score":0.99983937},"labels":[],"label_agreement":null},{"id":"W4394310102","doi":"10.6084/m9.figshare.19704012","title":"Additional file 4 of Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Carcinogen; Immune system; Bladder cancer; Tumor microenvironment; Cancer; Urinary Bladder Cancer; Cancer research; Urinary bladder; Urinary system; Medicine; Biology; Internal medicine; Immunology; Genetics","score_opus":0.045172570239375064,"score_gpt":0.2890898871434938,"score_spread":0.24391731690411875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394310102","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18330881,0.00024285355,2.4837979e-8,0.00014274142,0.000014626076,0.00084694667,0.81523126,2.8122673e-7,0.00021248225],"genre_scores_gemma":[0.072047696,0.00023846547,0.00008157611,0.00027274858,0.000034391927,0.0013600765,0.9253973,0.00001961298,0.0005481797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983553,0.00012902428,0.00047002916,0.00036087606,0.0004977716,0.00018695938],"domain_scores_gemma":[0.9983876,0.00054164394,0.0004052706,0.0005953918,0.00003116455,0.000038934875],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014722302,0.00026595674,0.0005918233,0.00010190572,0.00007569452,0.000013452162,0.00055885705,0.00006359269,0.70343757],"category_scores_gemma":[0.00005114769,0.00015908405,0.00008726015,0.00013353991,0.0002128568,0.000049617804,0.00040386786,0.00037168167,0.0000071584304],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029946436,0.0008379451,0.0002029798,0.0001107763,0.00037025407,0.00004251723,0.00076095207,0.00004528555,0.0009411035,2.6848576e-7,0.9954681,0.00092036603],"study_design_scores_gemma":[0.0055781067,0.0041443976,0.12628083,0.0039581605,0.0016401309,0.00017703137,0.005262777,0.00027382097,0.011807124,0.000055613196,0.8399446,0.0008774036],"about_ca_topic_score_codex":0.002212918,"about_ca_topic_score_gemma":0.0001470987,"teacher_disagreement_score":0.7034304,"about_ca_system_score_codex":0.00006989337,"about_ca_system_score_gemma":0.00039788376,"threshold_uncertainty_score":0.6487259},"labels":[],"label_agreement":null},{"id":"W4394329788","doi":"10.6084/m9.figshare.19785679","title":"Additional file 1 of MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Urothelial carcinoma; Immune system; Cancer research; Urothelial cancer; Medicine; Oncology; Immunology; Bladder cancer; Internal medicine; Cancer","score_opus":0.05040227472529942,"score_gpt":0.2730768105417348,"score_spread":0.2226745358164354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394329788","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106663516,0.00023355224,8.303578e-8,0.00003267148,0.000024433853,0.0011890406,0.9983803,0.0000049953233,0.000028236635],"genre_scores_gemma":[0.0015497972,0.000010894269,0.00012802011,0.000039897976,0.00010972151,0.0032342956,0.9944565,0.00003062025,0.0004402169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849135,0.000037775306,0.00047643078,0.000292016,0.00050342764,0.00019899396],"domain_scores_gemma":[0.9982798,0.0003900516,0.0007403496,0.00016668403,0.00037209567,0.000051032177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000035902976,0.00023786938,0.0006497548,0.00019048233,0.00003607962,0.00000675195,0.00011624586,0.00020813385,0.97532815],"category_scores_gemma":[0.000549499,0.00021420234,0.00014511896,0.000181199,0.000015176914,0.00006114947,0.00007516371,0.00019519027,0.000011451068],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054653565,0.00034660974,0.000048902588,0.0013803779,0.0005881841,0.00000947426,0.00003239895,0.0000022894715,0.00009724854,1.2537096e-7,0.9967911,0.00015672242],"study_design_scores_gemma":[0.0048610657,0.0025693334,0.01694898,0.0041751713,0.0006579626,0.000018434685,0.000083303974,0.00002132103,0.009561109,0.0000031529928,0.9608161,0.00028405193],"about_ca_topic_score_codex":0.00037670697,"about_ca_topic_score_gemma":0.00011171161,"teacher_disagreement_score":0.9753167,"about_ca_system_score_codex":0.00013910505,"about_ca_system_score_gemma":0.0007864454,"threshold_uncertainty_score":0.8734918},"labels":[],"label_agreement":null},{"id":"W4394333321","doi":"10.6084/m9.figshare.20001008","title":"Additional file 13 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Carcinoma; Medicine; Computational biology; Biology; Pathology; Internal medicine; Bladder cancer; Cancer","score_opus":0.0210100341212118,"score_gpt":0.23675319465927422,"score_spread":0.21574316053806242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394333321","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008627529,0.000028865557,1.8961027e-8,0.000012887182,0.00006808894,0.0011495467,0.99849916,0.0000067564374,0.0001484166],"genre_scores_gemma":[0.00013672467,0.0000032412509,0.0000063139246,0.00008559471,0.0001273546,0.001764162,0.99721116,0.00002787933,0.0006375912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875385,0.00006826845,0.00041296563,0.00022560415,0.00041282593,0.00012651853],"domain_scores_gemma":[0.9984677,0.00010673448,0.00065231195,0.00049370335,0.00023754197,0.000042047654],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00001625528,0.00021179643,0.00044723827,0.00011185273,0.0000411117,0.0000035761248,0.0002753444,0.0001593005,0.99824643],"category_scores_gemma":[0.00047828772,0.0001540296,0.00023265263,0.00024246289,0.000029199118,0.000029766883,0.00014699489,0.00027508326,0.000107880405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014658889,0.00019380853,0.0000061772616,0.0007666452,0.00017118179,0.000005324456,0.0000229588,2.9722034e-7,0.00059928745,8.1911246e-8,0.99792737,0.00016029744],"study_design_scores_gemma":[0.00060222537,0.00031092824,0.007361925,0.0020309174,0.00014407822,0.000014959543,0.000012397232,0.0000035039443,0.0033872211,0.0000012049366,0.9860256,0.000105083396],"about_ca_topic_score_codex":0.00014962412,"about_ca_topic_score_gemma":0.000017487127,"teacher_disagreement_score":0.99813855,"about_ca_system_score_codex":0.00009397388,"about_ca_system_score_gemma":0.0012812619,"threshold_uncertainty_score":0.6281145},"labels":[],"label_agreement":null},{"id":"W4394353882","doi":"10.6084/m9.figshare.20001017","title":"Additional file 16 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Computational biology; Computer science; Biology; Medicine; Bladder cancer; Internal medicine; Cancer","score_opus":0.02122952827873775,"score_gpt":0.2378018763871889,"score_spread":0.21657234810845113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394353882","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043375574,0.00003120236,2.6784456e-8,0.000012805923,0.00006758217,0.001134415,0.99851453,0.000006700716,0.00018933791],"genre_scores_gemma":[0.000106174935,0.0000032955613,0.000005747759,0.00008989349,0.00012839198,0.0017292766,0.99717647,0.000027806458,0.00073293544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987495,0.00006874135,0.00042159442,0.00022465264,0.0004093811,0.0001261438],"domain_scores_gemma":[0.9984562,0.000106373736,0.000669352,0.0004915214,0.00023476264,0.000041806034],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000016764156,0.000210879,0.0004445723,0.0001116012,0.000040996732,0.0000034818834,0.00027173705,0.00015840725,0.9988716],"category_scores_gemma":[0.00048725252,0.0001525267,0.00024128698,0.0002394605,0.000029156374,0.000029253762,0.00014561377,0.00027010485,0.000102028636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015315536,0.00019438438,0.0000041762382,0.00076752465,0.00017125923,0.000004314112,0.00001812529,1.723503e-7,0.0004114187,1.1222176e-7,0.99808407,0.00019130322],"study_design_scores_gemma":[0.00060079066,0.00031012407,0.0034424711,0.002081482,0.00014298092,0.00001490272,0.000012959357,0.0000019381655,0.0032975348,0.0000015116842,0.9899892,0.00010407564],"about_ca_topic_score_codex":0.00014129041,"about_ca_topic_score_gemma":0.000021900323,"teacher_disagreement_score":0.9987696,"about_ca_system_score_codex":0.00013502482,"about_ca_system_score_gemma":0.001303562,"threshold_uncertainty_score":0.6219858},"labels":[],"label_agreement":null},{"id":"W4394362623","doi":"10.6084/m9.figshare.20001032","title":"Additional file 20 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Computational biology; Biology; Cancer research; Oncology; Medicine; Computer science; Bladder cancer; Internal medicine; Cancer","score_opus":0.02122716950220736,"score_gpt":0.2376591610218971,"score_spread":0.21643199151968975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394362623","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005025383,0.000031104522,1.8812107e-8,0.000015179311,0.00006712484,0.0011381286,0.9985389,0.000006526662,0.00015275422],"genre_scores_gemma":[0.00007172242,0.0000029609803,0.000007346259,0.000085560474,0.0001313974,0.0016984427,0.9971663,0.000027409546,0.0008088949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987624,0.00006742757,0.0004099234,0.00022441198,0.0004098017,0.00012600399],"domain_scores_gemma":[0.99848163,0.00010372741,0.0006502242,0.00048660554,0.00023536725,0.000042417985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000015853539,0.00021042988,0.00044524294,0.00011002462,0.00004063081,0.0000034635684,0.00027371515,0.00015840071,0.99830806],"category_scores_gemma":[0.00043472924,0.00015325476,0.00023038026,0.00024098733,0.000028802202,0.000029642235,0.00014474255,0.00027479106,0.000106489635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015134369,0.0001933714,0.0000053008757,0.0007414753,0.00017104461,0.0000054015195,0.000020259171,2.9335354e-7,0.0008219642,8.153496e-8,0.997755,0.00013446536],"study_design_scores_gemma":[0.0005919852,0.00030960148,0.0041257176,0.0019768341,0.00014388056,0.0000145532,0.000011004543,0.0000033679137,0.0039614206,0.0000011421755,0.98875654,0.000103961844],"about_ca_topic_score_codex":0.000096557,"about_ca_topic_score_gemma":0.000015070868,"teacher_disagreement_score":0.9982016,"about_ca_system_score_codex":0.00009383979,"about_ca_system_score_gemma":0.0013169944,"threshold_uncertainty_score":0.6249548},"labels":[],"label_agreement":null},{"id":"W4394434081","doi":"10.6084/m9.figshare.20001020","title":"Additional file 17 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Computer science; Computational biology; Biology; Bladder cancer; Cancer; Genetics","score_opus":0.021844829076784856,"score_gpt":0.2395066881457784,"score_spread":0.21766185906899355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394434081","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000062818726,0.000028977352,1.7518918e-8,0.000013520855,0.000060820767,0.0011321146,0.99850816,0.000006664408,0.00018688815],"genre_scores_gemma":[0.0000798647,0.0000029663986,0.0000071879545,0.000092585884,0.00012767426,0.0017203641,0.9969587,0.000026776339,0.0009838876],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987669,0.000063737025,0.00040841714,0.0002248663,0.00040993583,0.00012612378],"domain_scores_gemma":[0.99846005,0.00010495273,0.0006592355,0.0005005261,0.00023344989,0.000041799267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000016283991,0.00021094257,0.0004464206,0.0001101694,0.000042184427,0.0000035761268,0.00027750444,0.00015880856,0.9984307],"category_scores_gemma":[0.00044545543,0.00015353784,0.00023305157,0.00023365382,0.000029303055,0.000029360444,0.00014678945,0.0002741429,0.0000881767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014925482,0.00019451977,0.0000046762675,0.00068064366,0.00017168111,0.0000055087785,0.00002162116,3.3085075e-7,0.0005580504,8.148766e-8,0.99809015,0.00012348873],"study_design_scores_gemma":[0.0005871622,0.00030955192,0.0058538206,0.002033513,0.0001444262,0.000015074183,0.000011365298,0.0000030583194,0.0030651207,0.0000010859528,0.9878717,0.00010411422],"about_ca_topic_score_codex":0.00010381002,"about_ca_topic_score_gemma":0.000012690129,"teacher_disagreement_score":0.9983426,"about_ca_system_score_codex":0.000094774776,"about_ca_system_score_gemma":0.0012772502,"threshold_uncertainty_score":0.6261091},"labels":[],"label_agreement":null},{"id":"W4394443765","doi":"10.6084/m9.figshare.19704015","title":"Additional file 5 of Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Carcinogen; Tumor microenvironment; Cancer research; Immune system; Urinary bladder; Cancer; Urinary Bladder Cancer; Medicine; Oncology; Biology; Internal medicine; Immunology; Genetics","score_opus":0.04242319256101147,"score_gpt":0.2611346198849323,"score_spread":0.21871142732392085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394443765","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0081217615,0.00063437014,2.8289913e-9,0.000083448045,0.000010200589,0.0006829709,0.99039364,0.0000031940917,0.00007038335],"genre_scores_gemma":[0.019469762,0.00007879743,0.000005194712,0.00038699096,0.00003969378,0.0029084412,0.9769698,0.000018529128,0.00012279506],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984352,0.00009690225,0.0004074713,0.00031284068,0.0005520071,0.00019559395],"domain_scores_gemma":[0.99823374,0.0007422047,0.00039533596,0.00054350606,0.00004647219,0.00003873209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000042706448,0.0002799644,0.00051023025,0.000112875445,0.00006775726,0.0000063937955,0.00035330706,0.000075373064,0.9632436],"category_scores_gemma":[0.00019886157,0.00017097038,0.000119006654,0.00014160007,0.000059192,0.000033542252,0.00024378419,0.00043041894,0.000014984131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008633329,0.0003730961,0.00003396921,0.00051077135,0.00020311325,0.000031902684,0.0002588625,0.00003207614,0.000119382086,1.463824e-7,0.9982755,0.00007482797],"study_design_scores_gemma":[0.0024984602,0.002151018,0.12939264,0.014938327,0.0005783761,0.000110962785,0.0013661843,0.00029095492,0.0027416786,0.000027735034,0.84525836,0.0006453166],"about_ca_topic_score_codex":0.00053146423,"about_ca_topic_score_gemma":0.000043142325,"teacher_disagreement_score":0.96322864,"about_ca_system_score_codex":0.000072482566,"about_ca_system_score_gemma":0.0003167823,"threshold_uncertainty_score":0.69719696},"labels":[],"label_agreement":null},{"id":"W4394468839","doi":"10.6084/m9.figshare.21564108","title":"Supplementary Material for: Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series","year":2022,"lang":"en","type":"review","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Series (stratigraphy); Medicine; Geology; Internal medicine; Bladder cancer; Paleontology; Cancer","score_opus":0.11883605963756595,"score_gpt":0.3918302587816238,"score_spread":0.27299419914405787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394468839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.564172e-7,0.51662517,7.445249e-8,0.000034436758,0.00007760349,0.0060471864,0.4771488,0.000016419437,0.00005002815],"genre_scores_gemma":[0.0000012672094,0.57916164,0.000024866615,0.00077344675,0.000096028845,0.021428095,0.39834017,0.000041209463,0.00013330729],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964581,0.0009856723,0.0014617833,0.0005063199,0.00027535378,0.00031273314],"domain_scores_gemma":[0.99798256,0.00043091862,0.0007110867,0.0006509314,0.00010048707,0.00012401505],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043212512,0.00053845305,0.0050569572,0.000077693956,0.00006838252,0.00001317097,0.00023492068,0.00018048119,0.5200517],"category_scores_gemma":[0.0016531931,0.00034519777,0.0011055036,0.00018015021,0.000021960379,0.000054764252,0.00017526321,0.00025212497,0.00006891434],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065686836,0.000054476153,9.963318e-7,0.9395719,0.00094484823,0.00010242745,0.000021260817,4.8071462e-9,4.906291e-8,0.0000031793645,0.05822929,0.0010058632],"study_design_scores_gemma":[0.0002515102,0.00036325818,0.0000020363448,0.49238977,0.0041467757,0.000099282894,0.000007046541,1.0806985e-7,0.0000028264246,0.0000034261664,0.5025866,0.00014739006],"about_ca_topic_score_codex":0.000021908469,"about_ca_topic_score_gemma":0.0000066433054,"teacher_disagreement_score":0.5199828,"about_ca_system_score_codex":0.00032326978,"about_ca_system_score_gemma":0.00064751616,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W4394481661","doi":"10.6084/m9.figshare.19704009","title":"Additional file 3 of Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Carcinogen; Tumor microenvironment; Immune system; Urinary bladder; Cancer research; Urinary Bladder Cancer; Urinary system; Medicine; Cancer; Biology; Oncology; Urology; Internal medicine; Immunology; Genetics","score_opus":0.04241237159353707,"score_gpt":0.261002573065081,"score_spread":0.21859020147154395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394481661","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008120867,0.0006329714,2.8207747e-9,0.00008318051,0.000010284843,0.0006825889,0.99039626,0.0000031900172,0.00007066681],"genre_scores_gemma":[0.019205613,0.00007880786,0.000005190208,0.00038641144,0.00004006157,0.0029086294,0.9772308,0.000018532344,0.0001259755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843544,0.00009683889,0.00040734926,0.00031277508,0.00055200886,0.000195578],"domain_scores_gemma":[0.998234,0.0007417577,0.00039529125,0.00054333225,0.00004692985,0.000038726615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000426552,0.00027992105,0.0005100391,0.00011283137,0.000067723406,0.0000063932653,0.00035319044,0.000075363845,0.9637977],"category_scores_gemma":[0.00020070933,0.00017093761,0.00011898342,0.00014157471,0.000059181963,0.000033537795,0.00024368745,0.00043038468,0.000015365964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008668411,0.00037258788,0.000033979235,0.0005139165,0.00020294018,0.00003177603,0.0002585351,0.000032099975,0.00012016075,1.41459e-7,0.9982725,0.000074712334],"study_design_scores_gemma":[0.0024339836,0.002080063,0.123170696,0.014450616,0.0005570539,0.00010661994,0.0013210538,0.00028320245,0.0026918158,0.000026788344,0.8522523,0.000625829],"about_ca_topic_score_codex":0.0005314025,"about_ca_topic_score_gemma":0.000042838787,"teacher_disagreement_score":0.96378237,"about_ca_system_score_codex":0.00007272525,"about_ca_system_score_gemma":0.0003175492,"threshold_uncertainty_score":0.6970633},"labels":[],"label_agreement":null},{"id":"W4394490509","doi":"10.6084/m9.figshare.24040750","title":"Additional file 23 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Biology; Medicine; Cancer; Internal medicine","score_opus":0.06657919865235669,"score_gpt":0.3367486236709497,"score_spread":0.27016942501859303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394490509","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063320285,0.0002803356,3.9556842e-9,0.00003142695,0.00018420084,0.0005969925,0.9972771,0.0000666468,0.0015569758],"genre_scores_gemma":[0.0000050980366,0.00012500375,0.000013090756,0.00048249023,0.0013136271,0.0029680305,0.9862451,0.00009083725,0.008756716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980149,0.000029112034,0.0004652526,0.00057669217,0.000562783,0.00035124464],"domain_scores_gemma":[0.9977145,0.0006025579,0.00037612746,0.00062822446,0.00047683722,0.00020170721],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000014796512,0.00046275373,0.00069696695,0.00024407347,0.00017487894,0.00005273439,0.00033811657,0.00046970547,0.9883706],"category_scores_gemma":[0.0010498248,0.00042687345,0.0003403702,0.00028089466,0.00007586175,0.00009398414,0.00023550562,0.00045271066,0.015888002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000423974,0.00012607397,0.0000025728425,0.0012489976,0.0005978523,0.00017357836,0.00009529943,0.0000019736663,0.000014871556,3.3518006e-7,0.99756384,0.00013223004],"study_design_scores_gemma":[0.0008635973,0.00025323936,0.005468249,0.007070347,0.0001943079,0.0000075890043,0.000033577075,5.0404e-7,0.0001897067,0.00001262692,0.9855592,0.0003470101],"about_ca_topic_score_codex":0.00068282423,"about_ca_topic_score_gemma":0.0031485334,"teacher_disagreement_score":0.9724826,"about_ca_system_score_codex":0.0004418319,"about_ca_system_score_gemma":0.0014733506,"threshold_uncertainty_score":0.9998183},"labels":[],"label_agreement":null},{"id":"W4394491179","doi":"10.6084/m9.figshare.20001026","title":"Additional file 19 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Proteogenomics; Computer science; Medicine; Computational biology; Internal medicine; Biology; Bladder cancer; Cancer","score_opus":0.02307134409647735,"score_gpt":0.24262191055641757,"score_spread":0.21955056645994023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394491179","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055524328,0.000033517867,2.1965839e-8,0.000014921552,0.00006610326,0.0011751968,0.9985108,0.000006953931,0.00013700349],"genre_scores_gemma":[0.00009351837,0.0000034883462,0.000007629856,0.00010987731,0.00012487256,0.0017651194,0.9972005,0.00002698297,0.00066800206],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875194,0.00007126276,0.00041027993,0.00022731286,0.00041366302,0.00012555697],"domain_scores_gemma":[0.9984683,0.00011629794,0.0006555322,0.0004954608,0.0002143362,0.00005008483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00001723809,0.00021013927,0.00044271036,0.000115309085,0.00004357286,0.0000034887055,0.0002757301,0.0001573002,0.9981746],"category_scores_gemma":[0.000596343,0.0001529778,0.00023208743,0.00024736166,0.000029562632,0.000028075949,0.00014764187,0.00027176028,0.00009835948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001564914,0.00019163288,0.000005961181,0.00085017766,0.00016980704,0.0000059310896,0.000024053761,2.8997667e-7,0.00054888567,1.1047426e-7,0.9979117,0.00013494257],"study_design_scores_gemma":[0.00061842636,0.00029889937,0.0052665807,0.001763014,0.00014194014,0.00001714021,0.000012828293,0.0000028472505,0.0026296282,0.0000013195742,0.9891433,0.00010404587],"about_ca_topic_score_codex":0.0001556627,"about_ca_topic_score_gemma":0.000012969282,"teacher_disagreement_score":0.99807626,"about_ca_system_score_codex":0.00010911139,"about_ca_system_score_gemma":0.0015470232,"threshold_uncertainty_score":0.6238254},"labels":[],"label_agreement":null},{"id":"W4394509765","doi":"10.6084/m9.figshare.24040741","title":"Additional file 21 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; Computer science; Biology; Computational biology; Genetics","score_opus":0.06504367646673144,"score_gpt":0.33555410166043176,"score_spread":0.27051042519370033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394509765","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000674139,0.00029066755,3.99786e-9,0.000033162945,0.0001814914,0.00058293465,0.99725354,0.0000633395,0.0015881376],"genre_scores_gemma":[0.0000055156497,0.00012702314,0.000013645112,0.00048645053,0.0013186529,0.0029055842,0.9875606,0.0000890378,0.0074935243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980251,0.00002926789,0.0004621182,0.0005756216,0.0005600031,0.00034788827],"domain_scores_gemma":[0.99772364,0.0005907578,0.00037398623,0.0006288499,0.0004813364,0.00020145885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000014554921,0.00046027033,0.0006961484,0.00023953704,0.00017343108,0.000052990657,0.00033454542,0.0004685796,0.9899517],"category_scores_gemma":[0.0010443653,0.0004246849,0.0003394641,0.00027696489,0.00007538565,0.00009318466,0.00023532349,0.00045523228,0.01209194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042988882,0.00012762877,0.0000025776894,0.0012374368,0.0005967943,0.00017583043,0.000097367934,0.0000019130716,0.0000150580845,3.2457163e-7,0.99754,0.00016207578],"study_design_scores_gemma":[0.00086086633,0.00024923566,0.0056153564,0.007092706,0.00019484341,0.000007785308,0.00003454261,4.818639e-7,0.00019723835,0.0000121958965,0.98538965,0.00034512614],"about_ca_topic_score_codex":0.00080447824,"about_ca_topic_score_gemma":0.0029323401,"teacher_disagreement_score":0.9778598,"about_ca_system_score_codex":0.00044134652,"about_ca_system_score_gemma":0.0014985912,"threshold_uncertainty_score":0.9998205},"labels":[],"label_agreement":null},{"id":"W4394544083","doi":"10.6084/m9.figshare.19785685","title":"Additional file 3 of MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune system; Urothelial carcinoma; Association (psychology); Cancer research; Medicine; Oncology; Internal medicine; Bladder cancer; Immunology; Cancer; Psychology","score_opus":0.04963276850743812,"score_gpt":0.2727228174283619,"score_spread":0.2230900489209238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394544083","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010742166,0.000234731,8.349383e-8,0.000032527667,0.000024659255,0.0011891322,0.99837804,0.0000049897026,0.00002839892],"genre_scores_gemma":[0.0015655289,0.000011039403,0.00012654028,0.000039854363,0.000110889305,0.0031757501,0.9944915,0.000030607425,0.00044828682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984912,0.000037740556,0.00047663314,0.00029189428,0.00050352537,0.0001989793],"domain_scores_gemma":[0.9982801,0.00038675405,0.0007404599,0.00016644501,0.00037522824,0.00005102795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003588744,0.0002378374,0.0006498181,0.0001904216,0.000036076653,0.0000067651977,0.00011617602,0.00020811694,0.97474897],"category_scores_gemma":[0.00054935814,0.0002141502,0.00014511011,0.0001811348,0.000015177945,0.00006119441,0.00007511182,0.00019515217,0.000011570636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005493016,0.00034622062,0.000048933358,0.0014018994,0.0005873262,0.000009576969,0.000032378914,0.0000022886372,0.000097415876,1.2453879e-7,0.99676573,0.00015881915],"study_design_scores_gemma":[0.004883497,0.0025441837,0.016709577,0.0041314596,0.00064679177,0.000018115621,0.00008222439,0.00002117274,0.009675564,0.00000313503,0.9610026,0.00028167682],"about_ca_topic_score_codex":0.0003807884,"about_ca_topic_score_gemma":0.000112436464,"teacher_disagreement_score":0.9747374,"about_ca_system_score_codex":0.00013963206,"about_ca_system_score_gemma":0.0007868605,"threshold_uncertainty_score":0.8732792},"labels":[],"label_agreement":null},{"id":"W4394595366","doi":"10.1016/j.eururo.2024.03.029","title":"Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial cancer; Oncology; Internal medicine; Bladder cancer; Urology; Gynecology; Cancer; Immunotherapy","score_opus":0.01013489064885537,"score_gpt":0.2911570393851965,"score_spread":0.2810221487363411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394595366","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013507267,0.022278283,0.0000053701456,0.002037496,0.8617376,0.0015114042,0.0011359651,0.00045943173,0.09732719],"genre_scores_gemma":[0.16257869,0.009558952,0.00008528161,0.0015718273,0.7973751,0.00022965403,0.0010889673,0.00069866143,0.026812896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969642,0.00031418208,0.0005867581,0.00108932,0.00041050094,0.0006350371],"domain_scores_gemma":[0.9987555,0.0002465853,0.00014938577,0.00051616965,0.00010837438,0.00022396959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024646235,0.00061959785,0.00093825755,0.00037866877,0.000057921294,0.00004440428,0.00020778732,0.0005187386,0.0005123959],"category_scores_gemma":[0.00029977597,0.0005370908,0.00014439525,0.0002621137,0.0001913846,0.000055898825,0.0001970047,0.001539133,0.00044584804],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004735367,0.00016198287,0.0006884439,0.00043360202,0.00042338023,0.004902485,0.00066375197,0.000012358674,0.00013758455,0.00003346465,0.96806747,0.019740127],"study_design_scores_gemma":[0.009218981,0.0015748735,0.001669239,0.00029016912,0.0007032055,0.000049424936,0.000023818842,0.000025521449,0.0000414761,0.00006672473,0.98594177,0.00039480018],"about_ca_topic_score_codex":0.0006292021,"about_ca_topic_score_gemma":0.00068997586,"teacher_disagreement_score":0.14907141,"about_ca_system_score_codex":0.00027343244,"about_ca_system_score_gemma":0.0008051297,"threshold_uncertainty_score":0.99970806},"labels":[],"label_agreement":null},{"id":"W4394747651","doi":"10.3390/curroncol31040163","title":"Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Intensive care medicine; Cancer; Mortality rate; Gold standard (test); Surgery; Internal medicine","score_opus":0.07323122168078067,"score_gpt":0.42834158885776147,"score_spread":0.3551103671769808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394747651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001221025,0.990091,0.0000017219825,0.00022807483,0.0015892459,0.006979984,0.00036995896,0.000022279964,0.00070550974],"genre_scores_gemma":[0.00021720922,0.995566,0.000005282493,0.00009611902,0.00028819835,0.0035388316,0.00014431546,0.000061951236,0.000082065526],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996835,0.00068787363,0.0012286879,0.0005618993,0.00032069406,0.00036583893],"domain_scores_gemma":[0.99800426,0.00037005698,0.00075098954,0.0006080196,0.0001626686,0.00010398286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047112067,0.0005191634,0.004414415,0.00023580718,0.000033894627,0.000010658787,0.0003450247,0.0002828887,0.00014923823],"category_scores_gemma":[0.00022112584,0.00028261993,0.0008243225,0.0007505358,0.00016000937,0.000035958063,0.0001537609,0.0006815086,0.00010890502],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002000703,0.00022655538,0.00000625183,0.60564727,0.0012914491,0.00004539028,0.00012484286,3.8539785e-8,9.51016e-7,0.0000040868727,0.0017117152,0.39092147],"study_design_scores_gemma":[0.00065090036,0.00030684544,0.00004040962,0.70051885,0.015238166,0.0001244521,0.00013314982,0.000004923786,0.0000016355522,0.00003277732,0.2827262,0.00022170182],"about_ca_topic_score_codex":0.00019567531,"about_ca_topic_score_gemma":0.000327515,"teacher_disagreement_score":0.39069977,"about_ca_system_score_codex":0.00093268655,"about_ca_system_score_gemma":0.0025189428,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W4394760373","doi":"10.1159/000538545","title":"Adjuvant Chemotherapy after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma with Variant Histology: A Systematic Review and Meta-Analysis of Survival Outcomes","year":2024,"lang":"en","type":"review","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial carcinoma; Meta-analysis; Chemotherapy; Adjuvant chemotherapy; Urology; Adjuvant; Histology; Oncology; Urothelial cancer; Carcinoma; Cystectomy; Internal medicine; Surgery; Cancer; Bladder cancer","score_opus":0.06462003366508956,"score_gpt":0.3642623001530647,"score_spread":0.29964226648797515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394760373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024587285,0.99082595,0.0002558267,0.0015692315,0.00016557117,0.004411007,0.0026057162,0.000038693997,0.000103411316],"genre_scores_gemma":[0.0012692757,0.9873231,0.0006142936,0.0032732768,0.00009160001,0.004832786,0.000633925,0.000110319765,0.0018514002],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99705595,0.00027808335,0.0012230377,0.0007180456,0.00047425,0.00025065598],"domain_scores_gemma":[0.9980317,0.00052188186,0.000588444,0.00054297707,0.00020031433,0.00011469054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047814628,0.0006781732,0.009799969,0.00055377284,0.000024317553,0.000028566541,0.00025027935,0.0002861123,0.0009059226],"category_scores_gemma":[0.00014506158,0.00033397283,0.0036028877,0.00035779714,0.00016035025,0.000045894332,0.000045670407,0.00030659774,0.00000940909],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021725504,0.00025304436,0.000394408,0.49186733,0.50548,0.00023952847,0.00009612134,1.0256373e-7,7.295841e-8,0.00031117583,0.0004967594,0.00064424594],"study_design_scores_gemma":[0.0007825177,0.0004975842,0.00023543794,0.006563018,0.9258257,0.00038775263,0.0000024207084,0.000010430253,2.7183626e-7,0.000019720497,0.06540974,0.00026538884],"about_ca_topic_score_codex":0.000111445974,"about_ca_topic_score_gemma":0.00002587587,"teacher_disagreement_score":0.4853043,"about_ca_system_score_codex":0.00016512777,"about_ca_system_score_gemma":0.00029077963,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W4394770710","doi":"10.1016/j.eururo.2024.03.031","title":"Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunosuppression; Mutant; Cancer research; Bladder cancer; Fibroblast growth factor receptor; Urothelial cancer; Fibroblast growth factor; Cancer; Internal medicine; Receptor; Gene","score_opus":0.017818109956835138,"score_gpt":0.2905615366447539,"score_spread":0.2727434266879188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394770710","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22868939,0.019171583,0.00002690544,0.69943726,0.004897741,0.0024913724,0.00094082626,0.00066043355,0.043684512],"genre_scores_gemma":[0.38951373,0.0021365548,0.00007297222,0.5862477,0.005874719,0.00014434928,0.0034611193,0.0006060896,0.01194279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959041,0.00066013605,0.0008591934,0.0012139169,0.0004947409,0.00086791354],"domain_scores_gemma":[0.9987046,0.0001284921,0.00028206708,0.0006860124,0.00007222821,0.00012656678],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028715463,0.00071767956,0.00087290636,0.00037949905,0.0001075277,0.00006576673,0.00023729158,0.0005579782,0.0021283356],"category_scores_gemma":[0.00007513946,0.00061326724,0.00023290065,0.00033924275,0.00015788701,0.00009468521,0.0002999416,0.0029425796,0.00089915853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027502133,0.00030427304,0.00072959985,0.00045530833,0.0003991906,0.013362056,0.00039825254,0.000011775484,0.009584327,0.0000015778018,0.97161365,0.0028649569],"study_design_scores_gemma":[0.0067826766,0.0008633239,0.0047416473,0.0011474022,0.0008160374,0.00025042862,0.00002299375,0.00003828711,0.0023835301,0.000014883784,0.9823642,0.0005746049],"about_ca_topic_score_codex":0.00038226042,"about_ca_topic_score_gemma":0.000017443223,"teacher_disagreement_score":0.16082436,"about_ca_system_score_codex":0.0003127912,"about_ca_system_score_gemma":0.00016891498,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W4394800829","doi":"10.1097/01.ju.0001009424.64728.0c.10","title":"PD38-10 STENTING VERSUS NEPHROSTOMY TUBES FOR BLADDER CANCER ASSOCIATED WITH HYDRONEPHROSIS: DOES STENTING INCREASE THE INCIDENCE OF UPPER TRACT UROTHELIAL CARCINOMA BY RETROGRADE TUMOR CELL SEEDING?","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydronephrosis; Medicine; Urology; Urothelial carcinoma; Urothelial cancer; Bladder cancer; Incidence (geometry); Upper urinary tract; Ureter; Cancer; Urinary system; Internal medicine","score_opus":0.013483019532867903,"score_gpt":0.2684109740366628,"score_spread":0.2549279545037949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394800829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872192,0.0088065155,0.00005541292,0.0024320495,0.0005734175,0.0005609353,0.00012233239,0.000025664687,0.00020448136],"genre_scores_gemma":[0.9979694,0.00024121058,0.000088822046,0.00066687376,0.0005437698,0.00003867779,0.000007996476,0.000060648283,0.00038258772],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998013,0.00023582832,0.0006060721,0.00022014452,0.00047076802,0.000454143],"domain_scores_gemma":[0.9978864,0.0010624317,0.00041715507,0.00022457358,0.00029156072,0.00011786146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009956233,0.00026862792,0.0005296054,0.00012731848,0.00020288344,0.00004266604,0.0003051729,0.00010567862,0.00013274448],"category_scores_gemma":[0.00020182518,0.00012377459,0.0002628162,0.00027063777,0.00029298593,0.00017907745,0.00005482104,0.0005577903,0.0000021933695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06657499,0.0022577122,0.37640184,0.0008568713,0.010375716,0.0005056137,0.011676421,0.0003485008,0.49865615,0.000057678797,0.025295155,0.0069933473],"study_design_scores_gemma":[0.09303849,0.076644406,0.40949497,0.0037959982,0.06839338,0.005214649,0.014809981,0.010342372,0.27054092,0.0006333178,0.044724047,0.0023674557],"about_ca_topic_score_codex":0.000529897,"about_ca_topic_score_gemma":0.000052723273,"teacher_disagreement_score":0.22811523,"about_ca_system_score_codex":0.00014402771,"about_ca_system_score_gemma":0.00045744833,"threshold_uncertainty_score":0.50473815},"labels":[],"label_agreement":null},{"id":"W4394801414","doi":"10.1097/01.ju.0001008816.80828.35.05","title":"MP32-05 ESTIMATING THE REAL-WORLD INCIDENCE OF URETHRAL COMPLICATIONS AFTER PROSTATE CANCER TREATMENT: A POPULATION-BASED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Incidence (geometry); Medicine; Population; Oncology; Urology; Gynecology; Internal medicine; Cancer; Mathematics; Environmental health","score_opus":0.02286810840180868,"score_gpt":0.3487800929869396,"score_spread":0.32591198458513093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394801414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721624,0.0043698614,0.0014017065,0.02122343,0.00021476799,0.00032703936,0.00005599721,0.000016178055,0.00022857131],"genre_scores_gemma":[0.9981645,0.0001909207,0.00061097456,0.00062884076,0.00015043812,0.00003525188,0.0000080121745,0.000012156397,0.00019894016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905777,0.00014448375,0.0003927898,0.00009352067,0.0001793083,0.00013210194],"domain_scores_gemma":[0.9989896,0.0003561046,0.00023196093,0.0002344665,0.0001426881,0.000045201617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026177443,0.00010737626,0.00030467767,0.00021225639,0.000076881784,0.000011421437,0.000105848514,0.000030416193,0.00013981963],"category_scores_gemma":[0.00002649131,0.0000499961,0.00017355163,0.0006231746,0.00010069134,0.000047338257,0.000012047961,0.00016418115,0.0000032845621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001827194,0.0002257031,0.9412626,0.00008989724,0.0040822956,0.00007961327,0.0037560211,0.035069186,0.0006932791,0.00020410081,0.00027077558,0.012439326],"study_design_scores_gemma":[0.00083037023,0.00078456,0.9582241,0.00008766106,0.008192839,0.00008648527,0.00003563147,0.030364536,0.00019255959,0.00065956067,0.00048267544,0.00005900179],"about_ca_topic_score_codex":0.0034290336,"about_ca_topic_score_gemma":0.001705557,"teacher_disagreement_score":0.026002018,"about_ca_system_score_codex":0.00013125347,"about_ca_system_score_gemma":0.00028241656,"threshold_uncertainty_score":0.5183696},"labels":[],"label_agreement":null},{"id":"W4394801754","doi":"10.1097/01.ju.0001009404.49693.12.13","title":"MP77-13 DOWNSTAGING OF PRIMARY VS. SECONDARY MUSCLE INVASIVE BLADDER CANCER AFTER CYSTECTOMY AND ITS ASSOCIATION WITH SURVIVAL","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Cystectomy; Retrospective cohort study; Medicine; Cohort; Internal medicine; Cancer; Oncology","score_opus":0.010483979467628309,"score_gpt":0.24922127923262768,"score_spread":0.23873729976499938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394801754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97573286,0.017497648,0.000028254122,0.004884715,0.00035319425,0.00015634381,0.000026827975,0.000008651146,0.0013114954],"genre_scores_gemma":[0.99659127,0.0015957115,0.000021764401,0.0011679335,0.00027820285,0.0000066543143,0.0000014356207,0.000018115546,0.0003189372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913293,0.0001298258,0.0002477429,0.000092936694,0.0002399426,0.0001566243],"domain_scores_gemma":[0.99923664,0.000272585,0.00018228582,0.000081438295,0.00016767143,0.000059395436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040396396,0.00010647131,0.0003274446,0.000100975194,0.000029253993,0.00000936562,0.000057495417,0.000070732654,0.0002782611],"category_scores_gemma":[0.000027970873,0.00005938626,0.000055355835,0.000109708126,0.000050622974,0.00010986327,0.000027116355,0.0003495762,0.0000034661907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037767928,0.00083758467,0.6719797,0.0032127318,0.019255243,0.0035637494,0.037488542,0.00034008382,0.13554819,0.00018732992,0.0109015545,0.0789173],"study_design_scores_gemma":[0.0069105206,0.00393748,0.9673448,0.0003943843,0.0035695476,0.0013824849,0.00036729954,0.000062572864,0.007266802,0.00027312074,0.008296889,0.00019406514],"about_ca_topic_score_codex":0.00008606184,"about_ca_topic_score_gemma":0.00013462752,"teacher_disagreement_score":0.2953651,"about_ca_system_score_codex":0.00012403913,"about_ca_system_score_gemma":0.00049277704,"threshold_uncertainty_score":0.3046764},"labels":[],"label_agreement":null},{"id":"W4394802129","doi":"10.1097/01.ju.0001008784.37684.bd.03","title":"MP53-03 REAL-WORLD RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastatic Urothelial Carcinoma; Chemotherapy; Medicine; Oncology; Immunotherapy; Cancer; Internal medicine; Urothelial carcinoma; Bladder cancer","score_opus":0.025564943135018933,"score_gpt":0.32713315687416533,"score_spread":0.3015682137391464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394802129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485929,0.0012291224,0.0016514984,0.046809494,0.00048378765,0.0006786468,0.000024294337,0.00003106475,0.00049916137],"genre_scores_gemma":[0.99108505,0.00024265968,0.00097629137,0.006022475,0.00028294296,0.000018154926,0.0000017862727,0.000051564373,0.0013190476],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982899,0.0003350942,0.0005924657,0.0001793206,0.00028676752,0.0003164419],"domain_scores_gemma":[0.9982782,0.0010472443,0.00012996852,0.00027743226,0.000099833545,0.00016729362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010352735,0.00021183616,0.0005230126,0.00047369467,0.0000490856,0.000014607965,0.00019995519,0.000057950943,0.00052840076],"category_scores_gemma":[0.00019222016,0.000118092954,0.00013003232,0.0005530875,0.00008636577,0.000058515197,0.000021171443,0.0004414831,0.000056040677],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83239615,0.0014680977,0.010471869,0.0003686535,0.0011967662,0.010777089,0.007830137,0.014163655,0.047865964,0.00012683595,0.005951462,0.06738332],"study_design_scores_gemma":[0.12947063,0.12605532,0.332825,0.0020776005,0.0043292427,0.00916882,0.00077307964,0.013888859,0.04592656,0.0031127173,0.33086523,0.0015069053],"about_ca_topic_score_codex":0.00015383831,"about_ca_topic_score_gemma":0.00094969524,"teacher_disagreement_score":0.7029255,"about_ca_system_score_codex":0.00019365507,"about_ca_system_score_gemma":0.00092608517,"threshold_uncertainty_score":0.5785618},"labels":[],"label_agreement":null},{"id":"W4394802212","doi":"10.1097/01.ju.0001008712.53259.7d.07","title":"PD48-07 PIVOTAL STUDY EVALUATING PERFORMANCE OF BLADDER EPICHECK, AN FDA CLEARED TEST, IN NON-MUSCLE INVASIVE BLADDER CANCER","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Cystoscopy; Grossman; Cystectomy; Cancer; Urine cytology; Cytology; Urology; Internal medicine; Pathology; Urinary system","score_opus":0.036719619777131375,"score_gpt":0.354167431646218,"score_spread":0.3174478118690866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394802212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948619,0.0025807456,0.000008791012,0.0010459634,0.0003984484,0.00047390684,0.000009201218,0.000011153569,0.0006099136],"genre_scores_gemma":[0.99830335,0.0004690111,0.000066060325,0.00047558922,0.0004156166,0.000017686716,0.000001311778,0.000035487108,0.00021590246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982211,0.00026071884,0.0006346241,0.00018220351,0.0004080935,0.00029326318],"domain_scores_gemma":[0.99874854,0.00041574988,0.0002377223,0.00026472958,0.00023037332,0.000102855294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011240623,0.00018567318,0.00048056064,0.00021692003,0.000059411126,0.00001233644,0.00022035975,0.0000907901,0.0006989203],"category_scores_gemma":[0.00015806475,0.00011632377,0.00009774856,0.00029820035,0.00012693388,0.00018467581,0.000057415797,0.0006064636,0.000029063183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008503584,0.0051067946,0.720239,0.00041558454,0.0034499061,0.0011630896,0.05259226,0.004732664,0.12105697,0.000011761327,0.0022740688,0.080454364],"study_design_scores_gemma":[0.006266609,0.03270357,0.9459644,0.00022995762,0.0018129157,0.00063752814,0.003288684,0.0059919083,0.0026612713,0.00011761191,0.00014176287,0.00018376934],"about_ca_topic_score_codex":0.00034107213,"about_ca_topic_score_gemma":0.00034068074,"teacher_disagreement_score":0.22572546,"about_ca_system_score_codex":0.00010372061,"about_ca_system_score_gemma":0.0006262408,"threshold_uncertainty_score":0.7652687},"labels":[],"label_agreement":null},{"id":"W4394802334","doi":"10.1097/01.ju.0001008848.77629.6f.05","title":"PD30-05 DEVELOPMENT AND EXTERNAL VALIDATION OF AN ARTIFICIAL INTELLIGENCE-BASED TOOL FOR PROGRESSION RISK ASSESSMENT IN NON-MUSCLE INVASIVE BLADDER CANCER (PROGRXN-BCA)","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Artificial intelligence; Cancer; Medicine; Gynecology; Philosophy; Internal medicine; Computer science","score_opus":0.034964288189790894,"score_gpt":0.36422146760019397,"score_spread":0.32925717941040306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394802334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817955,0.0011281956,0.014960461,0.001247527,0.00030376963,0.00053242745,0.00001039505,0.0000056022027,0.000016125454],"genre_scores_gemma":[0.9944341,0.00024423582,0.00488911,0.00015178684,0.00020349241,0.000050744027,0.0000043676505,0.000014894649,0.0000072553235],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887514,0.00013029465,0.00048887206,0.00012632721,0.0002209296,0.00015844627],"domain_scores_gemma":[0.99924034,0.00021645312,0.0002387879,0.0000948872,0.00015083999,0.00005868629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008169591,0.00011324294,0.00025036267,0.00015961008,0.00005181426,0.000017875012,0.00008257393,0.00007216072,0.000055186196],"category_scores_gemma":[0.000043828266,0.00006866644,0.000053415744,0.00011153908,0.00007741268,0.000097051314,0.000018445053,0.00025064443,8.468682e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038874033,0.0007448014,0.024281684,0.0002275078,0.000374222,0.00010419172,0.0041913344,0.0014245231,0.027773598,0.000086538275,0.0000705829,0.9368336],"study_design_scores_gemma":[0.004959742,0.017672196,0.28660786,0.0013205918,0.0021809204,0.00039767416,0.00119877,0.016183611,0.6590067,0.008805852,0.0012759297,0.0003901217],"about_ca_topic_score_codex":0.000042242544,"about_ca_topic_score_gemma":0.00007672849,"teacher_disagreement_score":0.9364435,"about_ca_system_score_codex":0.000099838384,"about_ca_system_score_gemma":0.0007732164,"threshold_uncertainty_score":0.28001362},"labels":[],"label_agreement":null},{"id":"W4394802645","doi":"10.1097/01.ju.0001008612.93052.9d.13","title":"MP36-13 ASSOCIATION BETWEEN THE SARCOMATOID STATUS AND PERCENTAGE OF SARCOMATOID ON THE CLINICAL OUTCOMES OF LOCALIZED RENAL CELL CARCINOMA POST NEPHRECTOMY","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nephrectomy; Renal cell carcinoma; Sarcomatoid carcinoma; Medicine; Carcinoma; Pathology; Internal medicine; Kidney","score_opus":0.02405556786299095,"score_gpt":0.31406089046511587,"score_spread":0.2900053226021249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394802645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352736,0.0027509162,0.00002383838,0.012608965,0.00026116223,0.0002658168,0.000049389055,0.0000068985573,0.0005056451],"genre_scores_gemma":[0.9972502,0.00090032554,0.000025439427,0.0014803341,0.00020873462,0.0000018031423,0.0000032023077,0.000018795912,0.00011116795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977183,0.00081376825,0.00074909476,0.00010485829,0.0003851703,0.00022884554],"domain_scores_gemma":[0.99607474,0.0029975947,0.00047363294,0.0002499792,0.00012130616,0.00008275862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00162436,0.0001467286,0.00058658567,0.00008695814,0.00007284791,0.000010991,0.00019840324,0.000118242606,0.00010009173],"category_scores_gemma":[0.00018153523,0.000059886574,0.00025747088,0.0001005192,0.00023459598,0.000038683767,0.000057793273,0.00060782675,0.0000067679234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013278687,0.0001558089,0.99181306,0.00003519884,0.00087055436,0.000025393123,0.0011772178,0.0000029111486,0.0010866781,0.00008421365,0.0014736032,0.0019475009],"study_design_scores_gemma":[0.0028331887,0.002658744,0.9847078,0.000032560136,0.0013532531,0.00012898425,0.00034064762,0.00003198266,0.0015703031,0.00045950295,0.005827647,0.00005540803],"about_ca_topic_score_codex":0.00020594946,"about_ca_topic_score_gemma":0.000020899644,"teacher_disagreement_score":0.013722829,"about_ca_system_score_codex":0.00006684226,"about_ca_system_score_gemma":0.00022071038,"threshold_uncertainty_score":0.26407385},"labels":[],"label_agreement":null},{"id":"W4394803181","doi":"10.1097/01.ju.0001009420.83948.eb.10","title":"MP57-10 BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF LOW-GRADE (LG) NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Bladder cancer; Excellence; Medicine; Cohort; Townsend; Cancer; Cumulative incidence; Incidence (geometry); Health care; Internal medicine; Oncology; Urology; Political science; Computer science","score_opus":0.05117346270870049,"score_gpt":0.35264893743316,"score_spread":0.3014754747244595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394803181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500188,0.038167182,0.0002797215,0.010228317,0.0005901718,0.0003574448,0.00018217802,0.0000053216227,0.0001708312],"genre_scores_gemma":[0.9885686,0.009820255,0.00016552537,0.00080018997,0.00047209053,0.000009604496,0.0000027882002,0.000021609587,0.00013931144],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989636,0.00006885311,0.0005016222,0.000115891984,0.00018703028,0.00016302992],"domain_scores_gemma":[0.9981392,0.0005930985,0.0003060153,0.00013434018,0.0007576456,0.00006972618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041830057,0.00013182516,0.00045722863,0.00011061724,0.000027022716,0.000004550938,0.00012852838,0.00006948727,0.00009210854],"category_scores_gemma":[0.00022056625,0.00007779369,0.000113435875,0.00011155561,0.00015813811,0.000053196705,0.00003437482,0.00014773781,0.0000013284556],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027608119,0.0018131975,0.06917623,0.00291827,0.01893369,0.00043817537,0.017675014,0.0088508865,0.2808996,0.0018748849,0.13305041,0.43676153],"study_design_scores_gemma":[0.053959418,0.05510918,0.41888082,0.0071206843,0.010711312,0.0047484897,0.0026678352,0.011215347,0.3875173,0.01063179,0.03589053,0.0015472935],"about_ca_topic_score_codex":0.000270121,"about_ca_topic_score_gemma":0.0002509812,"teacher_disagreement_score":0.43521422,"about_ca_system_score_codex":0.000040457846,"about_ca_system_score_gemma":0.0002850146,"threshold_uncertainty_score":0.31723344},"labels":[],"label_agreement":null},{"id":"W4394809050","doi":"10.1097/01.ju.0001008608.50694.4b.05","title":"MP22-05 SEX DIFFERENCES IN MUSCLE-INVASIVE BLADDER CANCER WITH RADICAL CYSTECTOMY","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Proportional hazards model; Cancer; Retrospective cohort study; Cancer registry; Cohort; Gynecology; Internal medicine; Oncology","score_opus":0.02019306203659762,"score_gpt":0.2861071112683363,"score_spread":0.2659140492317387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394809050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97379494,0.010665473,0.00012128768,0.014019484,0.0003956163,0.00017008554,0.0000058413207,0.0000142687095,0.00081302895],"genre_scores_gemma":[0.9960707,0.0015489827,0.00003672657,0.0013846322,0.00046244395,0.000008906795,5.274028e-7,0.000018063636,0.00046900925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902177,0.00014734083,0.0002633054,0.00011303493,0.000236505,0.00021806831],"domain_scores_gemma":[0.99936754,0.00028398933,0.000081076265,0.000122243,0.000052133957,0.00009300457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023380907,0.00013113659,0.00035020904,0.00014730697,0.00003227989,0.000011347148,0.0001297215,0.00007896978,0.0004112237],"category_scores_gemma":[0.000024712595,0.00006095789,0.00006829846,0.00018298367,0.00019075036,0.000053790707,0.000019341735,0.0004969756,0.000011506977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027271304,0.0025305892,0.61022264,0.0010413987,0.013397257,0.034491327,0.050777365,0.0005950465,0.033559516,0.0010100463,0.039922457,0.18518105],"study_design_scores_gemma":[0.025864573,0.027297286,0.8309632,0.0015604945,0.0065469528,0.031476233,0.0027855695,0.0008122558,0.0058843126,0.0035513416,0.062514655,0.00074315106],"about_ca_topic_score_codex":0.00020448561,"about_ca_topic_score_gemma":0.0002914596,"teacher_disagreement_score":0.22074053,"about_ca_system_score_codex":0.000070669936,"about_ca_system_score_gemma":0.000494153,"threshold_uncertainty_score":0.45026115},"labels":[],"label_agreement":null},{"id":"W4394834817","doi":"10.1097/01.ju.0001009548.76580.ba.20","title":"MP71-20 BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Risk analysis (engineering); Oncology; Cancer; Internal medicine","score_opus":0.038378990428406506,"score_gpt":0.3335764283558818,"score_spread":0.2951974379274753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394834817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642837,0.027720988,0.0005003894,0.0061959955,0.0006048878,0.00029491418,0.00030964473,0.0000044714257,0.000085010324],"genre_scores_gemma":[0.9826318,0.01597057,0.00027782118,0.0005449295,0.00047650575,0.000008588316,0.0000029434714,0.000020477908,0.0000663373],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898404,0.00008629331,0.0004903297,0.000113086775,0.00017787276,0.000148374],"domain_scores_gemma":[0.9979633,0.0006778857,0.0003787646,0.00013435577,0.0007822242,0.00006346568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047870027,0.00012509854,0.00046338164,0.000106671716,0.000030511554,0.000004086031,0.00011811751,0.00006575994,0.00004832397],"category_scores_gemma":[0.00024792997,0.000072745155,0.000100761994,0.00010473022,0.00014568027,0.000051453753,0.00003433352,0.00016709467,9.171619e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023436049,0.0010129157,0.16467908,0.0012952534,0.017977482,0.00026076694,0.013404644,0.014317247,0.08136049,0.002281797,0.0619377,0.61803657],"study_design_scores_gemma":[0.043851707,0.05065728,0.66623104,0.0033960291,0.012760215,0.0027692395,0.0018983743,0.0070394874,0.17543782,0.017363397,0.017517416,0.0010779997],"about_ca_topic_score_codex":0.001160004,"about_ca_topic_score_gemma":0.0006883738,"teacher_disagreement_score":0.61695856,"about_ca_system_score_codex":0.000038469614,"about_ca_system_score_gemma":0.00025547322,"threshold_uncertainty_score":0.29664615},"labels":[],"label_agreement":null},{"id":"W4394837754","doi":"10.3390/siuj5020022","title":"Systematic Review: Seventy-Seven Cases of Signet Ring Cell Adenocarcinoma of the Bladder","year":2024,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Signet ring cell carcinoma; Radiation therapy; Adenocarcinoma; Cancer; Oncology; Urology; Internal medicine","score_opus":0.02835814563275254,"score_gpt":0.3170601885170388,"score_spread":0.2887020428842863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394837754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50941473,0.46030587,0.0004879223,0.0072018695,0.0031422444,0.0023219998,0.00022625114,0.00008338264,0.016815705],"genre_scores_gemma":[0.99068624,0.004167408,0.000090493086,0.0007502187,0.00021187965,0.000028803197,0.000006712587,0.00001686935,0.0040413714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99830204,0.00014669857,0.0006882456,0.00015008236,0.0005584418,0.00015446708],"domain_scores_gemma":[0.9987774,0.00035198906,0.0003528206,0.00022174187,0.00023750118,0.000058542653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042822395,0.0001454319,0.00047666987,0.000093041446,0.000052903906,0.000019500516,0.0002715546,0.00006554365,0.0006054716],"category_scores_gemma":[0.0003570631,0.000085610765,0.00046664203,0.00014745742,0.00007695692,0.00008554685,0.00007451104,0.0003369524,0.000011760083],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011291304,0.0030500523,0.14156757,0.6988534,0.021382894,0.003491914,0.0075429925,0.0003868301,0.017440524,0.002556769,0.09793824,0.0046597198],"study_design_scores_gemma":[0.01807743,0.008955629,0.16222599,0.59228486,0.03922578,0.0415985,0.008034582,0.003325515,0.10199889,0.0135620115,0.008610824,0.0020999934],"about_ca_topic_score_codex":0.00001919007,"about_ca_topic_score_gemma":0.0000023672653,"teacher_disagreement_score":0.4812715,"about_ca_system_score_codex":0.00013847352,"about_ca_system_score_gemma":0.0003028738,"threshold_uncertainty_score":0.6629489},"labels":[],"label_agreement":null},{"id":"W4394877070","doi":"10.3390/cancers16081532","title":"Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Forschungsgemeinschaft; Deutschen Konsortium für Translationale Krebsforschung; Albert-Ludwigs-Universität Freiburg; Government of Ontario; University of Pittsburgh","keywords":"Cancer research; PTEN; Cell growth; Biology; Cell cycle; Cancer; Cell migration; Bladder cancer; Cell; Cell biology; Genetics; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.030395989177994024,"score_gpt":0.32606089793637355,"score_spread":0.29566490875837953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394877070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954419,0.021521427,0.0007232781,0.0071867453,0.0023529148,0.0011583986,0.0005925335,0.00035099348,0.011694669],"genre_scores_gemma":[0.9875296,0.0032071213,0.00029132277,0.003161266,0.00062895566,0.00035763142,0.00007461867,0.00007003552,0.0046794703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985093,0.00004068405,0.00022987952,0.00054045126,0.0002808175,0.00039886372],"domain_scores_gemma":[0.99937016,0.000045001332,0.000020046948,0.00024713305,0.000074182164,0.00024347272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010720299,0.00024122324,0.0003298235,0.00021563124,0.00005950974,0.000041393796,0.000077268814,0.00011360933,0.005885708],"category_scores_gemma":[0.000013414719,0.00020953115,0.00012846745,0.00056891685,0.00007262645,0.00028552496,0.000010582827,0.0002668196,0.000078827936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028539773,0.0010470861,0.059101246,0.0038666853,0.0070928135,0.004926756,0.0399907,0.0088483235,0.21997824,0.0010763597,0.170664,0.48055384],"study_design_scores_gemma":[0.01361449,0.0022772313,0.052179713,0.0024482384,0.002257886,0.00012478452,0.0045929444,0.008285265,0.38129064,0.0030625847,0.5279217,0.0019445169],"about_ca_topic_score_codex":0.008267902,"about_ca_topic_score_gemma":0.001722042,"teacher_disagreement_score":0.47860932,"about_ca_system_score_codex":0.0022456318,"about_ca_system_score_gemma":0.0025579822,"threshold_uncertainty_score":0.99833614},"labels":[],"label_agreement":null},{"id":"W4394911989","doi":"10.1038/s41746-024-01088-7","title":"Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI","year":2024,"lang":"en","type":"review","venue":"npj Digital Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Wilson Centre; Sinai Health System; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Western University; Public Health Ontario","funders":"University of Toronto","keywords":"Medicine; MEDLINE; Systematic review; Bladder cancer; Scopus; Meta-analysis; Artificial intelligence; Medical physics; Machine learning; Internal medicine; Computer science; Cancer","score_opus":0.1434620547778596,"score_gpt":0.43946352798282284,"score_spread":0.2960014732049633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394911989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031539003,0.98800135,0.00034018504,0.00045987018,0.0018945064,0.0071341987,0.00035707137,0.00019380951,0.0015874632],"genre_scores_gemma":[0.0008904678,0.9941218,0.0000806743,0.0013576087,0.0018008868,0.0006897151,0.00023548653,0.00030187756,0.0005215023],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99380994,0.00012221899,0.0028623447,0.0011522851,0.0012785619,0.0007746211],"domain_scores_gemma":[0.99677145,0.000473343,0.00094274315,0.0009789456,0.00032769213,0.0005058143],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00046969415,0.0013533849,0.0075203246,0.0005695682,0.00015350047,0.00016211357,0.00038616313,0.00044606868,0.00030862846],"category_scores_gemma":[0.0015487772,0.0008027632,0.0011700377,0.001369683,0.00030152095,0.0003442415,0.00022025901,0.00106769,0.00020515546],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009204778,0.00012839533,0.00002998826,0.8980127,0.0028696652,0.00040246785,0.00023355916,0.0000013353317,0.0000016728502,0.000038205293,0.00036740437,0.09790542],"study_design_scores_gemma":[0.0002303363,0.00032592393,0.0000014925964,0.92876136,0.059051357,0.0006334412,0.00025731703,0.0002149544,0.0000022225422,0.00014486225,0.009778092,0.0005986604],"about_ca_topic_score_codex":0.00029829127,"about_ca_topic_score_gemma":0.000021750946,"teacher_disagreement_score":0.09730676,"about_ca_system_score_codex":0.00095980935,"about_ca_system_score_gemma":0.00213226,"threshold_uncertainty_score":0.9999217},"labels":[],"label_agreement":null},{"id":"W4394936185","doi":"10.1016/j.euo.2024.03.015","title":"Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712","year":2024,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; NRG Oncology","keywords":"Medicine; Bladder cancer; Oncology; Internal medicine; Infiltration (HVAC); Cancer","score_opus":0.0150333448679207,"score_gpt":0.2704961794348791,"score_spread":0.2554628345669584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394936185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97122514,0.005722759,0.00010087179,0.0005775732,0.00007900851,0.0006006814,0.00012478148,0.00003739449,0.021531802],"genre_scores_gemma":[0.9982484,0.0007549255,0.00017833547,0.00035938277,0.00005830945,0.00008003154,0.00011926597,0.000034934143,0.00016641342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983662,0.0003696407,0.0004991669,0.00042786723,0.00011346684,0.00022367106],"domain_scores_gemma":[0.99895626,0.00043304847,0.00021105072,0.00018861219,0.00013891635,0.00007209203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002260845,0.00020172971,0.000689023,0.00050920085,0.000026800995,0.000006036067,0.000066150074,0.000111925634,0.00031647817],"category_scores_gemma":[0.00005885391,0.00016610051,0.000092708295,0.00093388814,0.00034908231,0.00006902214,0.000028313745,0.00026719397,0.000008773225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005107662,0.0021320551,0.80369675,0.0010728647,0.009633397,0.003398081,0.015226828,0.0013761764,0.09616384,0.00028042795,0.00032822078,0.06158368],"study_design_scores_gemma":[0.0045571057,0.0052325474,0.97349125,0.0000849925,0.005387294,0.000054856493,0.00032172995,0.00046407487,0.009476611,0.000023389755,0.00073623826,0.00016990695],"about_ca_topic_score_codex":0.00045229928,"about_ca_topic_score_gemma":0.00074933714,"teacher_disagreement_score":0.16979448,"about_ca_system_score_codex":0.000101146135,"about_ca_system_score_gemma":0.00066638313,"threshold_uncertainty_score":0.6773382},"labels":[],"label_agreement":null},{"id":"W4394953855","doi":"10.3390/curroncol31040172","title":"Antibody–Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Genitourinary system; Clinical trial; Cancer; Prostate cancer; Bladder cancer; Oncology; Drug; Internal medicine; Antibody-drug conjugate; Antibody; Immunology; Pharmacology; Monoclonal antibody","score_opus":0.18571112887616267,"score_gpt":0.49722457957754673,"score_spread":0.31151345070138403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394953855","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26744846,0.72552526,0.000015254798,0.0022925076,0.00097026856,0.0012936558,0.00061850913,0.000028520097,0.001807602],"genre_scores_gemma":[0.63110733,0.36416373,0.00012760167,0.00027899802,0.00036187898,0.000077760385,0.0037949136,0.000018725437,0.00006908223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891436,0.0001694712,0.0003523295,0.00027361434,0.00014405636,0.00014615298],"domain_scores_gemma":[0.99918026,0.0000792976,0.00007251111,0.0005669421,0.000053719512,0.00004728816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021931235,0.00012890834,0.00047203293,0.00007896693,0.000014146287,0.0000034965371,0.0002108854,0.000036005455,0.00032598636],"category_scores_gemma":[0.000008881111,0.00007449784,0.0000666706,0.00024686282,0.00010520863,0.000087826236,0.0000312379,0.0000961236,0.000009932044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007413496,0.008626827,0.04373066,0.0120169725,0.00074431347,0.000618447,0.0064620012,0.0000010476737,0.0015473848,0.00018425855,0.024493515,0.90083325],"study_design_scores_gemma":[0.002681112,0.005623376,0.007755891,0.0055243336,0.0012332082,0.00014012236,0.0005101098,0.00031902562,0.0006855116,0.000076136654,0.97532815,0.00012305123],"about_ca_topic_score_codex":0.00043751724,"about_ca_topic_score_gemma":0.00014277284,"teacher_disagreement_score":0.95083463,"about_ca_system_score_codex":0.00021251828,"about_ca_system_score_gemma":0.00065754226,"threshold_uncertainty_score":0.3569322},"labels":[],"label_agreement":null},{"id":"W4395070926","doi":"10.1016/j.clgc.2024.102105","title":"Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma Patients","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Urothelial carcinoma; Oncology; Urothelial cancer; Presentation (obstetrics); Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Bladder cancer; Surgery","score_opus":0.04021238607358731,"score_gpt":0.38709177310232806,"score_spread":0.34687938702874077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395070926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441135,0.00099612,0.0000034496381,0.00023458323,0.0011314868,0.0017869791,0.00068261195,0.00005137657,0.00070202263],"genre_scores_gemma":[0.9934743,0.0014982146,0.000027724293,0.00035158283,0.00056368497,0.00051728275,0.0002084185,0.00006952621,0.0032892518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774075,0.00022317399,0.0005625159,0.0007080203,0.00032332726,0.00044221195],"domain_scores_gemma":[0.9987498,0.00050350063,0.0000723434,0.00029770224,0.000034799046,0.0003418736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015083812,0.0003547685,0.00056903943,0.00016246461,0.000067948145,0.000038853967,0.00005428381,0.000118224416,0.0005111061],"category_scores_gemma":[0.00004273287,0.00025457825,0.00022847879,0.00015252712,0.00008016176,0.00010510441,0.000047474987,0.00027772124,0.00007232874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033479203,0.0010744892,0.88400704,0.0002578555,0.00021281352,0.00077268766,0.00041895075,0.00001321477,0.00009947887,0.0000010671029,0.00029628832,0.10949818],"study_design_scores_gemma":[0.011647999,0.013018128,0.96791345,0.00028853476,0.00038368462,0.000008927136,0.000041615855,0.0003032166,0.0011266937,0.0000071411177,0.0050402414,0.0002203586],"about_ca_topic_score_codex":0.0011108267,"about_ca_topic_score_gemma":0.00018517025,"teacher_disagreement_score":0.10927782,"about_ca_system_score_codex":0.0007664321,"about_ca_system_score_gemma":0.000250474,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W4395083112","doi":"10.1200/jco.23.01983","title":"<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Else Kröner-Fresenius-Stiftung; Rheinische Friedrich-Wilhelms-Universität Bonn; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft","keywords":"Gene duplication; Bladder cancer; Medicine; Copy-number variation; Cancer; Oncology; Fluorescence in situ hybridization; Internal medicine; Metastatic breast cancer; Cancer research; Breast cancer; Chromosome; Biology; Genome; Gene; Genetics","score_opus":0.1263294054098523,"score_gpt":0.49340585196090614,"score_spread":0.36707644655105387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395083112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819893,0.003236664,0.000075109434,0.012654257,0.001082596,0.00035783483,0.000024364703,0.000011269435,0.00056857266],"genre_scores_gemma":[0.99386734,0.0020540203,0.0005508666,0.0027289274,0.00050152786,0.000029481487,0.0000015373232,0.000021564523,0.0002447633],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967495,0.00050898944,0.0019700336,0.00024902463,0.0002938048,0.00022859788],"domain_scores_gemma":[0.99744445,0.001630312,0.00044322,0.00012843759,0.00011104645,0.00024252708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003356324,0.00014287456,0.0010428107,0.00029655892,0.000017415901,0.000017423654,0.000084747575,0.00016887416,0.00016753438],"category_scores_gemma":[0.0014918866,0.000103457336,0.00018668661,0.00024654783,0.00012497594,0.00012787688,0.000024655877,0.0008670129,0.000011493394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089858174,0.0044751475,0.3451035,0.000517037,0.0013157864,0.011315002,0.0056621647,0.00017364387,0.0043256963,0.00029456653,0.0068535605,0.5301057],"study_design_scores_gemma":[0.020354342,0.020193955,0.9017489,0.0016118478,0.000719219,0.0011233758,0.00039476258,0.0010678775,0.00117478,0.0021585324,0.049236313,0.00021611726],"about_ca_topic_score_codex":0.00037577652,"about_ca_topic_score_gemma":0.00030708246,"teacher_disagreement_score":0.5566454,"about_ca_system_score_codex":0.00040005642,"about_ca_system_score_gemma":0.0041011325,"threshold_uncertainty_score":0.7275233},"labels":[],"label_agreement":null},{"id":"W4395462513","doi":"10.1111/bju.16368","title":"Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review","year":2024,"lang":"en","type":"review","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Immunotherapy; Hazard ratio; Confidence interval; Internal medicine; Oncology; Adverse effect; Grading (engineering); Meta-analysis; Chemotherapy; Cancer","score_opus":0.05676177179654551,"score_gpt":0.40241018492014413,"score_spread":0.3456484131235986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395462513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016524853,0.994757,0.00020043174,0.00033934534,0.0013615171,0.0026268016,0.00056922593,0.000030050074,0.00009910217],"genre_scores_gemma":[0.000027843247,0.99397117,0.0012558978,0.0019308665,0.0010321412,0.00028481684,0.00015225378,0.00020630995,0.0011386904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965316,0.00039325157,0.0017812259,0.00045876345,0.00037651646,0.00045860725],"domain_scores_gemma":[0.9978138,0.0002526735,0.0009004078,0.00036323408,0.00039442605,0.00027542253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078278984,0.0005279383,0.0047553102,0.00025714922,0.00007890414,0.00005020418,0.00035554174,0.00023648508,0.0005118657],"category_scores_gemma":[0.0002240866,0.00039233064,0.001592649,0.00028031264,0.000113962946,0.00012441813,0.000028068753,0.000903526,0.0000355092],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009098554,0.00028849253,4.6065315e-7,0.060864225,0.002102168,0.005797099,0.00001960571,1.4782927e-7,0.0000029444639,0.000008534389,0.006229793,0.9237767],"study_design_scores_gemma":[0.0044038785,0.005796361,0.0000051931547,0.05246087,0.021898922,0.10980084,0.0000045898587,0.0000010644936,0.0000010876819,0.000069656526,0.8053024,0.00025514912],"about_ca_topic_score_codex":0.000034129607,"about_ca_topic_score_gemma":0.000023143832,"teacher_disagreement_score":0.9235215,"about_ca_system_score_codex":0.00016488704,"about_ca_system_score_gemma":0.0021311522,"threshold_uncertainty_score":0.99985284},"labels":[],"label_agreement":null},{"id":"W4396579060","doi":"10.21203/rs.3.rs-4271858/v1","title":"Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; Canada's Michael Smith Genome Sciences Centre; Queen's University; Bristol-Myers Squibb (Canada); AstraZeneca (Canada); Bayer (Canada); University of British Columbia","funders":"","keywords":"Bladder cancer; Proteome; Cystectomy; Biology; Cancer research; Chemotherapy; Proteomics; Extracellular matrix; Cisplatin; Transcriptome; Immunohistochemistry; Cancer; Pathology; Oncology; Bioinformatics; Medicine; Immunology; Cell biology; Gene expression; Gene; Biochemistry","score_opus":0.05469231271848567,"score_gpt":0.4090601279218014,"score_spread":0.35436781520331573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396579060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853307,0.0022683071,0.00008074254,0.0040848227,0.0001564744,0.0063254307,0.0007008964,0.00015868651,0.0008939118],"genre_scores_gemma":[0.99242765,0.0002770324,0.0013734197,0.00021116358,0.00044669208,0.0030741063,0.00022407253,0.00013492629,0.0018309205],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967261,0.0003232752,0.000314987,0.0011946937,0.000719352,0.0007216245],"domain_scores_gemma":[0.9979651,0.0003827439,0.00007183402,0.00070819026,0.0005044956,0.00036762288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006565409,0.0004382295,0.00061927916,0.00068054005,0.00020574572,0.00018449787,0.00020445319,0.00031961352,0.00016568833],"category_scores_gemma":[0.0003876531,0.00031443173,0.00012133875,0.00045202184,0.00042300017,0.000028782877,0.0004429782,0.001373074,0.000055872628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08619622,0.001407382,0.5648579,0.055958115,0.009671384,0.0044813138,0.01868637,0.00047965863,0.1609366,0.000605613,0.01148777,0.08523168],"study_design_scores_gemma":[0.019956166,0.01889826,0.40711215,0.036538452,0.0013647127,0.00011425655,0.0037148332,0.0009962989,0.49191713,0.010863849,0.0057217353,0.002802166],"about_ca_topic_score_codex":0.0022060077,"about_ca_topic_score_gemma":0.0005686968,"teacher_disagreement_score":0.33098054,"about_ca_system_score_codex":0.0008178768,"about_ca_system_score_gemma":0.0045924746,"threshold_uncertainty_score":0.9999308},"labels":[],"label_agreement":null},{"id":"W4396581101","doi":"10.1016/j.urolonc.2024.03.017","title":"Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; General surgery; Database; Surgery; Cancer; Internal medicine","score_opus":0.12929032777667246,"score_gpt":0.45187719873509286,"score_spread":0.3225868709584204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396581101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916924,0.0022352787,0.000031436863,0.0019778535,0.00019160009,0.0021611827,0.001160895,0.000040992054,0.0005083591],"genre_scores_gemma":[0.9941918,0.00015016794,0.0038973188,0.00027697216,0.00007725779,0.00087520084,0.0004105766,0.000010975034,0.00010972753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984194,0.00016991717,0.00048521318,0.00047676236,0.0002655747,0.00018311919],"domain_scores_gemma":[0.9988377,0.00033352655,0.00022517469,0.00021677841,0.00021498966,0.00017183833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006577738,0.00018731509,0.0006086823,0.00014097622,0.00014908343,0.00003360085,0.00016467409,0.00015258002,0.00004945567],"category_scores_gemma":[0.00013965399,0.00012395013,0.00012726293,0.0006257593,0.0007010818,0.00018944753,0.000116794385,0.0001927931,1.829522e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026775182,0.0018883432,0.96927917,0.0011018366,0.006939576,0.000046078687,0.0009178526,0.0004327908,0.0029971695,0.0077920193,0.0026003574,0.0033272982],"study_design_scores_gemma":[0.026316172,0.030630382,0.59005004,0.00062586536,0.02988572,0.00015967542,0.0016892351,0.06568187,0.009922488,0.00592638,0.23800819,0.0011040039],"about_ca_topic_score_codex":0.0018875422,"about_ca_topic_score_gemma":0.0007587498,"teacher_disagreement_score":0.37922913,"about_ca_system_score_codex":0.00012952795,"about_ca_system_score_gemma":0.001438053,"threshold_uncertainty_score":0.50545394},"labels":[],"label_agreement":null},{"id":"W4396610032","doi":"10.1097/ju.0000000000003991","title":"A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Vanderbilt University Medical Center; Pennsylvania State University; University of Pennsylvania; Vanderbilt University; University of Minnesota; University of Southern California","keywords":"Microhematuria; Cystoscopy; Medicine; Randomized controlled trial; Overdiagnosis; Triage; Gynecology; Surgery; Internal medicine; Urinary system; Emergency medicine; Proteinuria","score_opus":0.011471057748088714,"score_gpt":0.2792450341089788,"score_spread":0.26777397636089006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396610032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812422,0.0010139972,0.00075504795,0.0006088251,0.0010995109,0.015103824,0.000017450238,0.000011945892,0.00014722139],"genre_scores_gemma":[0.99744177,0.000019518398,0.001435755,0.00018675097,0.000511367,0.00033043095,0.000002213126,0.00003538435,0.000036788097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996868,0.0009150926,0.0014141307,0.00018202994,0.00032509642,0.00029561497],"domain_scores_gemma":[0.9916254,0.0068464526,0.000889998,0.00023617924,0.000326382,0.00007557154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032155118,0.0002532218,0.0021574919,0.00024832433,0.00008170651,0.000029019615,0.00021259203,0.00010123317,0.000023393544],"category_scores_gemma":[0.0026414776,0.00010385255,0.00043865506,0.0002499804,0.00015486691,0.0000631551,0.00003693417,0.0005041329,0.0000034015923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9910066,0.0006797907,0.0024421385,0.000062253384,0.0021944235,0.000010599147,0.0029021136,0.00006055478,0.00034167265,0.000017455844,0.00013494902,0.00014745776],"study_design_scores_gemma":[0.98238695,0.007795908,0.0038238228,0.00027877692,0.0042203898,0.000046150824,0.000099074765,0.00050661317,0.00037302045,0.00035367647,0.000025879222,0.00008971852],"about_ca_topic_score_codex":0.00003659013,"about_ca_topic_score_gemma":0.000021031045,"teacher_disagreement_score":0.016199615,"about_ca_system_score_codex":0.00010390118,"about_ca_system_score_gemma":0.00025035458,"threshold_uncertainty_score":0.4234984},"labels":[],"label_agreement":null},{"id":"W4396616752","doi":"10.3390/curroncol31050192","title":"Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Oncology; Cohort; Gemcitabine; Internal medicine; Dissection (medical); Chemotherapy; Cancer; Urology; Surgery","score_opus":0.06247506646845135,"score_gpt":0.39667247049084237,"score_spread":0.334197404022391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396616752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97094494,0.024779879,0.00011252268,0.0016701638,0.0015824686,0.00051974395,0.00009442866,0.00002759058,0.00026828487],"genre_scores_gemma":[0.9864718,0.012746154,0.00007203613,0.00006202378,0.00025230154,0.0002277797,0.000025570007,0.00002286304,0.0001194702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999203,0.000036559333,0.00021709634,0.0002737074,0.00008397573,0.0001856331],"domain_scores_gemma":[0.99955153,0.00019929024,0.000041695686,0.000085929016,0.000051354866,0.00007021384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010457654,0.00013796585,0.00037240132,0.00012387772,0.000029387942,0.000011004316,0.000028135273,0.00009354129,0.000050407925],"category_scores_gemma":[0.000029461895,0.00011178294,0.00004793268,0.00011223007,0.00012332777,0.00005778818,0.000021850929,0.00010589116,7.6951324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007644596,0.00038671214,0.56410515,0.0018150606,0.00021250888,0.000018852254,0.0018641251,0.0000022261206,0.0020606013,0.00045350462,0.000293631,0.4280232],"study_design_scores_gemma":[0.0067185587,0.0008493511,0.9774306,0.0008175633,0.00025102182,0.000038482784,0.00043475913,0.00047947906,0.0012435839,0.0010303577,0.01053695,0.00016929665],"about_ca_topic_score_codex":0.00041298766,"about_ca_topic_score_gemma":0.0006893024,"teacher_disagreement_score":0.42785388,"about_ca_system_score_codex":0.00020411487,"about_ca_system_score_gemma":0.00026713306,"threshold_uncertainty_score":0.45583758},"labels":[],"label_agreement":null},{"id":"W4396624125","doi":"10.1097/01.ju.0001015816.87470.c9.03","title":"P2-03 SWOG S1011–SUBGROUP ANALYSIS OF THE PHASE III SURGICAL TRIAL TO EVALUATE THE BENEFIT OF A STANDARD VERSUS AN EXTENDED LYMPHADENECTOMY PERFORMED AT TIME OF RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Subgroup analysis; Lymphadenectomy; Oncology; Internal medicine; Urology; Surgery; Bladder cancer; Meta-analysis; Cancer","score_opus":0.03236496684259647,"score_gpt":0.3606040452234137,"score_spread":0.32823907838081723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396624125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928148,0.0022868563,0.000086171014,0.0023496614,0.00069255364,0.0012634138,0.0003654919,0.000007704587,0.00013337877],"genre_scores_gemma":[0.99871355,0.00030175762,0.000032117354,0.00019442312,0.00051639695,0.00005593135,0.000007739502,0.000030199393,0.00014788455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99719787,0.00048709253,0.0009787155,0.0002195636,0.000799824,0.0003169418],"domain_scores_gemma":[0.99709415,0.0013872245,0.00045453256,0.00047209815,0.00042784575,0.00016414905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016347837,0.00023097005,0.0011492937,0.00029462914,0.00011897676,0.000008969361,0.00047424572,0.00014048762,0.0009982288],"category_scores_gemma":[0.00023230961,0.00010501008,0.0008095504,0.0006974991,0.00041557156,0.00006637131,0.000096702446,0.0002508243,0.0000025723475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9152039,0.00095437665,0.0003439727,0.00012432651,0.013579989,0.000069324145,0.00627567,0.0015644743,0.05010503,0.00015319542,0.0007158916,0.010909827],"study_design_scores_gemma":[0.6697502,0.09233536,0.010496244,0.00039615063,0.09634847,0.00080113846,0.0009176706,0.009195662,0.10533361,0.000707829,0.013183167,0.00053451606],"about_ca_topic_score_codex":0.00021780629,"about_ca_topic_score_gemma":0.00027791166,"teacher_disagreement_score":0.24545373,"about_ca_system_score_codex":0.0002466362,"about_ca_system_score_gemma":0.0010413298,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W4396677006","doi":"10.1080/14796694.2024.2342227","title":"Management of urothelial cancer in patients with chronic kidney disease receiving platinum-based chemotherapy","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Université Laval; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cisplatin; Kidney disease; Urothelial cancer; Chemotherapy; Intensive care medicine; Internal medicine; Oncology; Cancer; Disease; Renal function; Bladder cancer; Urology","score_opus":0.015251667884815143,"score_gpt":0.3354459150738934,"score_spread":0.32019424718907824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396677006","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007958714,0.9923922,0.0000051479265,0.0006277143,0.001190342,0.0030362485,0.00073752226,0.00004822423,0.0018830404],"genre_scores_gemma":[0.00024278092,0.99555475,0.00024548365,0.0004202896,0.0010573482,0.0009342169,0.00045389595,0.00014218816,0.0009490457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809176,0.00009829413,0.000538897,0.0005914525,0.00032102226,0.00035857005],"domain_scores_gemma":[0.99896216,0.000028656232,0.00026904416,0.0004286544,0.000053690743,0.00025777877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008298388,0.000509892,0.001733541,0.0002737942,0.000024991854,0.00000814636,0.00016502537,0.00032622894,0.0008995046],"category_scores_gemma":[0.00000431172,0.00032637254,0.0003067616,0.00045800157,0.00007540265,0.00002576847,0.00003998542,0.00047115597,0.000033630127],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011356493,0.0006126395,0.0016380395,0.04677472,0.0011792504,0.0002997713,0.000051576622,0.0000018555094,7.338989e-8,0.000030562394,0.0023500645,0.9459258],"study_design_scores_gemma":[0.007887296,0.0012654266,0.003660807,0.040208288,0.0047048614,0.0000024298342,0.0000053505883,0.000003067694,7.2108935e-7,0.0000066597536,0.94199175,0.00026331918],"about_ca_topic_score_codex":0.000053226682,"about_ca_topic_score_gemma":0.00007420995,"teacher_disagreement_score":0.9456625,"about_ca_system_score_codex":0.001862302,"about_ca_system_score_gemma":0.0038051086,"threshold_uncertainty_score":0.9999188},"labels":[],"label_agreement":null},{"id":"W4396793480","doi":"10.3233/blc-230086","title":"Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Bladder Cancer Advocacy Network","keywords":"Cystectomy; Bladder cancer; Lymph node; Stage (stratigraphy); Medicine; Oncology; Center (category theory); Urology; Disease; Cancer; Internal medicine; Chemistry; Biology","score_opus":0.018474022223185543,"score_gpt":0.2928376693453191,"score_spread":0.2743636471221335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396793480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98954827,0.0041818772,0.00033753912,0.0007408644,0.00043675822,0.0015344822,0.0028441919,0.000104835795,0.00027117183],"genre_scores_gemma":[0.99613196,0.00073442736,0.0003078358,0.00046738272,0.00015533253,0.00049296825,0.00020554393,0.00010469497,0.0013998618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973016,0.000091672344,0.0004515433,0.0008828954,0.00073758897,0.0005346945],"domain_scores_gemma":[0.99876916,0.00004889226,0.00007714154,0.0004144897,0.00015663603,0.00053366646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010608139,0.00045246715,0.0006610187,0.0002229808,0.000065170854,0.000054686312,0.00011718095,0.0001277287,0.0007067816],"category_scores_gemma":[0.000009075722,0.00033737594,0.000109160304,0.00047520385,0.00017656738,0.00015172022,0.000080006714,0.00024473717,0.000008048644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016960812,0.0013606217,0.9885531,0.00032978528,0.00077583414,0.00012089501,0.00029348442,0.000036542788,0.00055041804,0.000008249478,0.0036948516,0.0025801158],"study_design_scores_gemma":[0.016130524,0.00031283236,0.9725801,0.0009476415,0.0004017573,0.0000026141674,0.000047341804,0.0007001275,0.00048658476,0.0000014738717,0.0080389045,0.00035010566],"about_ca_topic_score_codex":0.0020745106,"about_ca_topic_score_gemma":0.00060140324,"teacher_disagreement_score":0.015973028,"about_ca_system_score_codex":0.00068467075,"about_ca_system_score_gemma":0.0005829264,"threshold_uncertainty_score":0.99990785},"labels":[],"label_agreement":null},{"id":"W4396809848","doi":"10.1016/j.clgc.2024.102119","title":"Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Urothelial carcinoma; Urology; Urothelial cancer; Metastatic Urothelial Carcinoma; Cancer; Oncology; Urinary bladder; Internal medicine","score_opus":0.07550536402370836,"score_gpt":0.37294869773629125,"score_spread":0.2974433337125829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396809848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731046,0.022948332,0.0000034386806,0.0013440213,0.00058954506,0.0007934913,0.00034706225,0.00005020607,0.0008193289],"genre_scores_gemma":[0.9874397,0.009587486,0.000070681504,0.0003459844,0.00077642855,0.00034155225,0.000020820073,0.000073932366,0.0013434382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973882,0.00025957372,0.0007829573,0.0007561989,0.00041868503,0.00039440795],"domain_scores_gemma":[0.9987508,0.00024588837,0.00015479099,0.0005500632,0.00008291134,0.00021556758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024845428,0.00039303914,0.00078976445,0.00018339409,0.000078878686,0.000028101775,0.00018212204,0.00017454947,0.0005555031],"category_scores_gemma":[0.000013713938,0.00023188964,0.0003236287,0.0007625449,0.00055303704,0.000117763535,0.000075502816,0.0005908092,0.0000042097367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00262126,0.0009686284,0.8891478,0.00017231646,0.00066881464,0.0008725886,0.00039006426,0.000015970803,0.00062247575,0.00000803388,0.0007243273,0.103787675],"study_design_scores_gemma":[0.0068421806,0.0028248068,0.9825792,0.0004317637,0.00042712165,0.00006937085,0.00010864482,0.00009193547,0.0015605266,0.00004800787,0.0047586565,0.00025782775],"about_ca_topic_score_codex":0.0025695725,"about_ca_topic_score_gemma":0.00040727702,"teacher_disagreement_score":0.10352985,"about_ca_system_score_codex":0.00018010593,"about_ca_system_score_gemma":0.0010947172,"threshold_uncertainty_score":0.9456185},"labels":[],"label_agreement":null},{"id":"W4396827653","doi":"10.1016/s1470-2045(24)00178-5","title":"Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Foundation Medicine; Sanofi Genzyme; Chugai Pharmaceutical; University of Texas MD Anderson Cancer Center; EMD Serono; Silverback Therapeutics; Bavarian Nordic; Eli Lilly and Company; Ono Pharmaceutical; Astellas Pharma; Seagen; G1 Therapeutics; Genentech; UroGen Pharma; Pfizer; Incyte; Ipsen; Mirati Therapeutics; Amgen; Bladder Cancer Canada; Sanofi; Exelixis; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Invitae; National Cancer Institute; Gilead Sciences; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Carcinoma in situ; Cystectomy; Bladder cancer; Cohort; Internal medicine; Oncology; Carcinoma; Cancer; Urology; Immunotherapy","score_opus":0.05105573192091713,"score_gpt":0.3836772905862923,"score_spread":0.3326215586653752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396827653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98055637,0.0023413983,0.0003200414,0.010279416,0.0011164628,0.004273192,0.00031887845,0.00008207218,0.00071214756],"genre_scores_gemma":[0.99010277,0.0010077338,0.00082736695,0.0038390635,0.0021729502,0.0014462412,0.000028017415,0.00007567831,0.00050017727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99793595,0.0002695615,0.00038114094,0.0006054268,0.00018862795,0.0006192727],"domain_scores_gemma":[0.99815655,0.0010384045,0.00010787442,0.00039885152,0.000106177635,0.00019214257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036405586,0.00033201027,0.00093890436,0.00019889664,0.000111234775,0.00004572853,0.00016667583,0.00020447117,0.000105716084],"category_scores_gemma":[0.00019002213,0.00022601218,0.00011975832,0.0002830061,0.00013700462,0.000072712966,0.000056154,0.00036072807,0.0000248222],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6197512,0.0029459486,0.003329514,0.00034072806,0.0013783849,0.00086473714,0.023252511,0.000085393986,0.03175519,0.00028425027,0.009063076,0.30694908],"study_design_scores_gemma":[0.79526204,0.061800834,0.027816713,0.0006539145,0.002770047,0.00019453141,0.0019040562,0.0013076223,0.027074907,0.0021002104,0.07815681,0.0009582977],"about_ca_topic_score_codex":0.0021362235,"about_ca_topic_score_gemma":0.0054527437,"teacher_disagreement_score":0.3059908,"about_ca_system_score_codex":0.0006129021,"about_ca_system_score_gemma":0.00087205257,"threshold_uncertainty_score":0.92165095},"labels":[],"label_agreement":null},{"id":"W4396886342","doi":"10.21203/rs.3.rs-4345624/v1","title":"A Novel Approach to Engineering Three-dimensional Bladder Tumor Models for Drug Testing.","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Drug; Computer science; Medicine; Pharmacology","score_opus":0.12886465657673615,"score_gpt":0.37712905939822955,"score_spread":0.2482644028214934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396886342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44315368,0.042209044,0.24334502,0.02417119,0.006395543,0.10862021,0.017165111,0.005142613,0.10979757],"genre_scores_gemma":[0.8611815,0.000008932674,0.1235813,0.0002901551,0.0019752083,0.007790551,0.0004819136,0.00037520812,0.004315251],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960787,0.00003054506,0.0003651458,0.0011787062,0.0014073867,0.00093945715],"domain_scores_gemma":[0.9972956,0.00040498524,0.00003598388,0.000777393,0.00092751055,0.00055848033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008406369,0.00044505918,0.0006119494,0.00065833924,0.00013784577,0.00014313354,0.00030850302,0.00020953758,0.00003314618],"category_scores_gemma":[0.0004642703,0.00037171415,0.0002984851,0.00059763907,0.000057173973,0.0000402732,0.0013307022,0.0016950215,0.000094919495],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062306593,0.008670618,0.0010350645,0.0773905,0.0070952233,0.00087465986,0.006249815,0.65331054,0.018439597,0.01399165,0.1824338,0.0242779],"study_design_scores_gemma":[0.0032508082,0.0008629094,0.0012276458,0.006231362,0.00040017508,0.00015708739,0.00013421905,0.9713822,0.0012973141,0.0113404095,0.0029354107,0.00078044966],"about_ca_topic_score_codex":0.00095871434,"about_ca_topic_score_gemma":0.00003022117,"teacher_disagreement_score":0.4180278,"about_ca_system_score_codex":0.0005521402,"about_ca_system_score_gemma":0.00158996,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W4397012901","doi":"10.1158/1557-3265.bladder24-a007","title":"Abstract A007: Circulating tumor DNA and tissue staining analyses reveal heterogeneous <i>ERBB2</i>/HER2 status in urothelial cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Urothelial cancer; Cancer; Staining; Pathology; DNA; Cancer research; Medicine; Biology; Bladder cancer; Internal medicine; Genetics","score_opus":0.2944178235038861,"score_gpt":0.5736665748808023,"score_spread":0.2792487513769162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96002257,0.034426995,0.000006821771,0.0013970388,0.000660061,0.00095970184,0.00019897023,0.00009875803,0.0022291108],"genre_scores_gemma":[0.9902825,0.0059627234,0.00009741463,0.0005501468,0.0017946357,0.000392569,0.000017603375,0.000096434575,0.0008060256],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956055,0.0003495626,0.00094787567,0.0010361656,0.00095507276,0.0011058185],"domain_scores_gemma":[0.9976173,0.0010597125,0.000077083176,0.00041151908,0.00023241257,0.0006019425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018320103,0.0002963272,0.0007471618,0.00035455817,0.00016708809,0.00017941394,0.00016757337,0.00019242785,0.0012332572],"category_scores_gemma":[0.0005190175,0.0002439509,0.0001784642,0.00079956866,0.0004169954,0.00014783777,0.00016292467,0.0014506856,0.00005884063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031020571,0.0006272158,0.29959932,0.002025307,0.0010441282,0.007189168,0.0020205472,0.00027049542,0.028945472,0.000039835304,0.0034515099,0.65168494],"study_design_scores_gemma":[0.019277554,0.0055859108,0.75095874,0.010276528,0.0010257845,0.0003409527,0.0014274354,0.0032733185,0.038138345,0.0020744742,0.16570133,0.0019196344],"about_ca_topic_score_codex":0.015311378,"about_ca_topic_score_gemma":0.002287074,"teacher_disagreement_score":0.6497653,"about_ca_system_score_codex":0.0005891764,"about_ca_system_score_gemma":0.0019263397,"threshold_uncertainty_score":0.99967974},"labels":[],"label_agreement":null},{"id":"W4397012914","doi":"10.1158/1557-3265.bladder24-pr003","title":"Abstract PR003: T cell receptor repertoire and diversity are prognostic markers in bladder cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Bladder cancer; Cancer; Receptor; Repertoire; Biology; Medicine; Cancer research; Pathology; Internal medicine","score_opus":0.17832695203342278,"score_gpt":0.480906556418253,"score_spread":0.3025796043848302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623533,0.0235958,9.539543e-7,0.007431,0.0007162073,0.0011326651,0.00013993577,0.00007753385,0.004552623],"genre_scores_gemma":[0.977938,0.015236742,0.00004019232,0.0004044154,0.0006471898,0.00030454388,0.000011615822,0.000044136887,0.0053731953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971521,0.000205094,0.00044942254,0.0008470447,0.0007400471,0.00060627644],"domain_scores_gemma":[0.99816555,0.00082546513,0.000045288012,0.00032721725,0.00021569038,0.00042077372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00139822,0.00019750487,0.00043560512,0.00020951744,0.00020688397,0.000076240925,0.0001680137,0.00024676323,0.0027539437],"category_scores_gemma":[0.00038763843,0.00015577115,0.00013840267,0.000587923,0.00046420208,0.00013028964,0.0003512248,0.0013681508,0.00012349422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015460991,0.00041873087,0.8725291,0.00089972117,0.00021264859,0.00054928457,0.00038841565,0.0000017700801,0.00026276396,0.000008207497,0.050086137,0.07309715],"study_design_scores_gemma":[0.00279748,0.00061333406,0.95645756,0.001773977,0.00013331723,0.0000055406113,0.00042731198,0.000102406986,0.00040955897,0.00013392804,0.036917042,0.00022852248],"about_ca_topic_score_codex":0.0049025775,"about_ca_topic_score_gemma":0.0014644822,"teacher_disagreement_score":0.08392851,"about_ca_system_score_codex":0.0004642664,"about_ca_system_score_gemma":0.0010000487,"threshold_uncertainty_score":0.9981577},"labels":[],"label_agreement":null},{"id":"W4397012996","doi":"10.1158/1557-3265.bladder24-a021","title":"Abstract A021: The role of MGAT5 in sex-dependent regulation of CD8+ T cells in muscle-invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Cytotoxic T cell; Cancer research; CD8; Medicine; Biology; Pathology; Immunology; Internal medicine; Immune system; In vitro; Genetics","score_opus":0.12674183756787558,"score_gpt":0.4799487102532005,"score_spread":0.3532068726853249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795981,0.0122494325,0.0000013657982,0.001915521,0.00035344405,0.0010121001,0.00013920758,0.000014953242,0.004715867],"genre_scores_gemma":[0.99142367,0.0064262617,0.000015787205,0.00009134725,0.00038150835,0.0002701172,0.000007077247,0.000034290857,0.0013499407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996997,0.00029031295,0.0008929785,0.00048243013,0.00092259987,0.00041465877],"domain_scores_gemma":[0.99771947,0.0013676467,0.00009016349,0.00045160722,0.00024484497,0.00012627552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021593892,0.00014703671,0.00048143847,0.00027198705,0.00003337975,0.000019285142,0.00023087666,0.00020368023,0.0015570741],"category_scores_gemma":[0.00021104336,0.00010022483,0.0001714005,0.0006997287,0.0003927274,0.00008391553,0.00010369304,0.0010067943,0.000028769322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028690659,0.0018039898,0.3970076,0.0015644724,0.0006597999,0.00021259543,0.0046779783,0.000645438,0.20189366,0.00043791288,0.002869027,0.38535845],"study_design_scores_gemma":[0.0033418715,0.0006673636,0.81255615,0.0019128345,0.00010081771,0.0000021556798,0.0013633022,0.0004731125,0.17137204,0.0028355424,0.005205952,0.00016888244],"about_ca_topic_score_codex":0.015367216,"about_ca_topic_score_gemma":0.00872224,"teacher_disagreement_score":0.41554853,"about_ca_system_score_codex":0.0003542216,"about_ca_system_score_gemma":0.0017529213,"threshold_uncertainty_score":0.9993556},"labels":[],"label_agreement":null},{"id":"W4397013178","doi":"10.1158/1557-3265.bladder24-a004","title":"Abstract A004: Clinical test design affects tumor tissue and ctDNA FGFR gene status in metastatic urothelial cancer: a prospective study","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Jewish General Hospital; University of Calgary; University of Alberta; Baker Hughes (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Urothelial cancer; Cancer; Medicine; Oncology; Circulating tumor DNA; Prospective cohort study; Internal medicine; Cancer research; Bladder cancer","score_opus":0.25675409485827455,"score_gpt":0.5592329056097901,"score_spread":0.30247881075151556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397013178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96568906,0.02261106,0.000045206187,0.0017185737,0.0010552626,0.007507325,0.00031743763,0.00014465647,0.00091142085],"genre_scores_gemma":[0.98675793,0.007354069,0.0004161472,0.00030438305,0.0014469668,0.0025090033,0.000008603594,0.00012062785,0.0010822444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935991,0.0012143921,0.0012262238,0.0015719015,0.0012169803,0.0011713817],"domain_scores_gemma":[0.99206156,0.006071196,0.00010214437,0.00058513583,0.00031929996,0.00086064474],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0060698735,0.00040318517,0.001214178,0.0003760291,0.00016738514,0.00018671787,0.00025034547,0.00017888373,0.0008426123],"category_scores_gemma":[0.0024693166,0.00030954927,0.00019567795,0.0010669392,0.000756928,0.0001816192,0.0002096327,0.0023705508,0.00016873566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044697616,0.004575185,0.8244949,0.00050880655,0.0008187543,0.0042511355,0.0008798391,0.000012405472,0.0006084778,0.000026870479,0.0032204334,0.15613346],"study_design_scores_gemma":[0.012711423,0.012688069,0.962966,0.00088758004,0.00048344958,0.000035536337,0.00046823666,0.00030637352,0.0014749698,0.00056668743,0.007018757,0.00039289385],"about_ca_topic_score_codex":0.0066603357,"about_ca_topic_score_gemma":0.002814562,"teacher_disagreement_score":0.15574056,"about_ca_system_score_codex":0.0007314054,"about_ca_system_score_gemma":0.0043028314,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W4397023538","doi":"10.1007/s00261-024-04382-w","title":"Is the excretory phase necessary to identify upper tract urothelial neoplasms at CT urography? A 10-year population-based study","year":2024,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Hepatology; Pyelogram; Upper urinary tract; Excretory system; Radiology; Urology; Urothelial carcinoma; Population; Internal medicine; Urinary system; Cancer; Bladder cancer","score_opus":0.023785506823773436,"score_gpt":0.35841571292246627,"score_spread":0.3346302060986928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397023538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921915,0.0011947582,0.00009731157,0.0029161132,0.0008883416,0.0014893141,0.0001173851,0.00012411203,0.0009811752],"genre_scores_gemma":[0.99414486,0.000018390694,0.00014437125,0.0027057638,0.00064854306,0.00029872463,0.000089794354,0.00006244361,0.0018871238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980024,0.00021781171,0.00039101747,0.00063413975,0.00033201356,0.0004226042],"domain_scores_gemma":[0.99880683,0.00034790105,0.00005494802,0.00051995687,0.000046675206,0.00022368412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003175071,0.0003119685,0.0004724514,0.00027276383,0.00020909809,0.00004999853,0.00020316527,0.00008756565,0.0039576716],"category_scores_gemma":[0.000059990827,0.0002088511,0.00034296897,0.00036598256,0.00009048611,0.00007578927,0.000043255022,0.0002688085,0.0006432448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017403252,0.004527551,0.798641,0.00027243875,0.002797817,0.005033627,0.0064842994,0.00008421246,0.010381427,0.00016632947,0.09763639,0.056571655],"study_design_scores_gemma":[0.018148085,0.012618003,0.86179906,0.0001989291,0.0027057684,0.0016120018,0.0013636677,0.0007521242,0.0026454036,0.0002559407,0.097178355,0.0007226618],"about_ca_topic_score_codex":0.00049770233,"about_ca_topic_score_gemma":0.000054571403,"teacher_disagreement_score":0.06315805,"about_ca_system_score_codex":0.00019726952,"about_ca_system_score_gemma":0.00019703236,"threshold_uncertainty_score":0.99695283},"labels":[],"label_agreement":null},{"id":"W4397025221","doi":"10.1681/asn.20203110s110d","title":"Kidney and Cancer Outcomes with Standard vs. Kidney Protective Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma","year":2020,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; Urothelial cancer; Urothelial carcinoma; Cancer; Kidney; Oncology; Urology; Metastatic Urothelial Carcinoma; Kidney cancer; Carcinoma; Internal medicine; Bladder cancer","score_opus":0.028252382547351382,"score_gpt":0.3076691684358499,"score_spread":0.2794167858884985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397025221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86184126,0.0003911858,0.0014143002,0.13478747,0.000043620264,0.0010882863,0.00041723502,0.0000061359847,0.000010500486],"genre_scores_gemma":[0.95332265,0.0012811526,0.010140429,0.03482986,0.00023893717,0.000067699744,0.000002393229,0.000041266776,0.00007562879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894404,0.000059601618,0.00038232346,0.00016905268,0.00025214363,0.00019280966],"domain_scores_gemma":[0.9982768,0.00009939112,0.00094712427,0.00016405081,0.0002639847,0.00024864016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000863274,0.00020505286,0.0011255407,0.000027437558,0.00006255478,0.0000037333589,0.00010657028,0.00003474928,0.000027749002],"category_scores_gemma":[0.00004405709,0.00010822161,0.0004615687,0.0001691018,0.00061067566,0.000036466416,0.000017495015,0.00011312462,9.799108e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16100734,0.0026925115,0.5044772,0.0016452484,0.035663035,0.000050801227,0.057937857,0.00022151972,0.115346335,0.00004350082,0.079067424,0.041847225],"study_design_scores_gemma":[0.119446754,0.2111236,0.33805817,0.00048423742,0.010244004,0.0005635049,0.0045950767,0.0006810305,0.1064673,0.0006094155,0.20705985,0.0006670659],"about_ca_topic_score_codex":0.0004936849,"about_ca_topic_score_gemma":0.000013252583,"teacher_disagreement_score":0.20843108,"about_ca_system_score_codex":0.00018564108,"about_ca_system_score_gemma":0.0008566256,"threshold_uncertainty_score":0.44131494},"labels":[],"label_agreement":null},{"id":"W4397293643","doi":"10.1016/j.urolonc.2024.04.006","title":"Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Immunotherapy; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Medicine; Chemotherapy; Oncology; Carcinoma; Internal medicine; Line (geometry); Urology; Bladder cancer; Cancer","score_opus":0.05282015430096166,"score_gpt":0.36443208262366944,"score_spread":0.3116119283227078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397293643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97823054,0.0024554955,0.00053700525,0.0146169895,0.00047292552,0.001994265,0.00025058197,0.00008221668,0.0013599783],"genre_scores_gemma":[0.9791831,0.0022857795,0.008571367,0.0018440682,0.0001523218,0.00095538376,0.00006043398,0.00003595482,0.0069116177],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987902,0.00007816595,0.00035540943,0.00035683505,0.00014632488,0.00027304908],"domain_scores_gemma":[0.9990758,0.0003754795,0.00011722287,0.00025809926,0.000067300476,0.00010610195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017176433,0.00023511938,0.00041121573,0.00013641182,0.00027446132,0.000024194513,0.00010558465,0.00009875117,0.00022194414],"category_scores_gemma":[0.00004487043,0.00013319643,0.00015370923,0.00038437947,0.0004511108,0.00008019416,0.000022581477,0.0001268916,0.0000038473095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008809537,0.008444151,0.70650846,0.0011035802,0.0034959281,0.00043058145,0.039104663,0.00010095553,0.008775709,0.12013849,0.013512704,0.08957523],"study_design_scores_gemma":[0.0070751365,0.010697664,0.007766608,0.00013248555,0.00083647255,0.00020885674,0.00039176125,0.0028277158,0.0075359466,0.007960048,0.95436007,0.00020722096],"about_ca_topic_score_codex":0.00035887104,"about_ca_topic_score_gemma":0.0005586714,"teacher_disagreement_score":0.9408474,"about_ca_system_score_codex":0.0002393262,"about_ca_system_score_gemma":0.0006997255,"threshold_uncertainty_score":0.5431593},"labels":[],"label_agreement":null},{"id":"W4398208538","doi":"10.1007/s00345-024-05057-3","title":"Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients","year":2024,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrology; Urothelial carcinoma; Urology; Internal medicine; Urinary system; Upper urinary tract; Oncology; Carcinoma; Cancer; Bladder cancer","score_opus":0.02595139427739147,"score_gpt":0.2847721486597401,"score_spread":0.25882075438234864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398208538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837394,0.013475932,0.000024423476,0.0005756412,0.0010980554,0.00034680596,0.000026907483,0.000011688701,0.00070117036],"genre_scores_gemma":[0.998521,0.00049701857,0.00011810285,0.0003005514,0.00026057268,0.000009999202,0.000007096347,0.000039561706,0.0002461441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825287,0.00018498357,0.00077153987,0.00019299684,0.00032884028,0.00026878636],"domain_scores_gemma":[0.99915326,0.0002006727,0.0002221476,0.00017170234,0.0001386102,0.00011359631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003079649,0.00020495486,0.000709022,0.0006895708,0.00001921133,0.000011568457,0.000135488,0.00006329751,0.00030569243],"category_scores_gemma":[0.000021880129,0.00014811342,0.00027056222,0.00033131993,0.00006362451,0.00011169957,0.00001805673,0.00039589996,0.000009328462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009364581,0.002313511,0.92662215,0.0003765325,0.0010894984,0.003297004,0.0022565306,0.000051113806,0.00927321,0.00024233844,0.0003830006,0.04473054],"study_design_scores_gemma":[0.018380199,0.011919575,0.95383525,0.00042518394,0.0006601492,0.003079917,0.00013330198,0.00009752183,0.001739746,0.0006313771,0.0088502215,0.00024757962],"about_ca_topic_score_codex":0.000053423384,"about_ca_topic_score_gemma":0.000017610992,"teacher_disagreement_score":0.04448296,"about_ca_system_score_codex":0.000113195674,"about_ca_system_score_gemma":0.00026710873,"threshold_uncertainty_score":0.603989},"labels":[],"label_agreement":null},{"id":"W4398210594","doi":"10.1186/s12894-024-01457-0","title":"Clinical characteristics and molecular mechanisms underlying bladder cancer in individuals with spinal cord injury: a systematic review","year":2024,"lang":"en","type":"review","venue":"BMC Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"State Administration of Traditional Chinese Medicine of the People's Republic of China; National Natural Science Foundation of China; Jiangsu Commission of Health","keywords":"Medicine; Spinal cord injury; Bladder cancer; Urinary system; Incidence (geometry); Cancer; Population; Urinary bladder; Oncology; Internal medicine; Spinal cord","score_opus":0.1034593465534482,"score_gpt":0.4443076891301981,"score_spread":0.3408483425767499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398210594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003137304,0.99445117,0.00027698834,0.00018224418,0.00032208857,0.004445687,0.00017090343,0.000049989423,0.000069540736],"genre_scores_gemma":[0.00079242507,0.99457747,0.0004307707,0.0020731245,0.000079876736,0.0017106583,0.00007529528,0.00012168419,0.00013872117],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964454,0.00063422194,0.0014276817,0.000805022,0.00028519295,0.00040246567],"domain_scores_gemma":[0.99856305,0.00013988878,0.0005201425,0.0005326939,0.00005637914,0.0001878664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068015524,0.0006098568,0.0048536374,0.0002587106,0.000028596607,0.000030147463,0.00016859664,0.0005005008,0.00008262163],"category_scores_gemma":[0.00014335077,0.0003830654,0.0003392938,0.00036681836,0.00011936708,0.000027950888,0.00011787479,0.00084312103,0.00007216879],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012228367,0.00010882761,0.00014865835,0.9406529,0.0008989941,0.00042286466,0.000009901111,6.1882526e-9,1.2040533e-7,0.00034661783,0.000087561464,0.05720127],"study_design_scores_gemma":[0.0012648436,0.007390209,0.0002602094,0.8069915,0.10316758,0.0016475362,0.000014092853,0.0000058954324,1.1289959e-7,0.00025706697,0.07827277,0.0007281896],"about_ca_topic_score_codex":0.000022960921,"about_ca_topic_score_gemma":0.000028510547,"teacher_disagreement_score":0.1336614,"about_ca_system_score_codex":0.00013115416,"about_ca_system_score_gemma":0.0010487506,"threshold_uncertainty_score":0.99986213},"labels":[],"label_agreement":null},{"id":"W4398210958","doi":"10.5489/cuaj.8681","title":"Artificial intelligence for predicting response to neoadjuvant chemotherapy for bladder cancer","year":2024,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bladder cancer; Medicine; Meta-analysis; Cystectomy; Cisplatin; Confidence interval; Oncology; Machine learning; Chemotherapy; Internal medicine; Cancer; Computer science","score_opus":0.07199280068240758,"score_gpt":0.3750549734262557,"score_spread":0.3030621727438481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398210958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007625522,0.9632781,0.001477129,0.027713768,0.0020138302,0.0033654745,0.0019255785,0.000056506604,0.00009335046],"genre_scores_gemma":[0.0003900072,0.9826001,0.0009454666,0.006338905,0.005195415,0.0015175773,0.0001090069,0.00013112622,0.0027723839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974333,0.00015613277,0.0008586296,0.00047259827,0.0003120452,0.00076727086],"domain_scores_gemma":[0.9975176,0.00063257053,0.00035920602,0.00014781284,0.0003674192,0.0009754257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012901342,0.0003952214,0.0012154784,0.0004124661,0.00029834875,0.00018739767,0.00019268412,0.0006381193,0.0003527252],"category_scores_gemma":[0.0013800764,0.00028061206,0.00086819415,0.00035854854,0.000020245006,0.000042395848,0.0000140722905,0.00071724155,0.00006795661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061150506,0.00003886953,0.00010910146,0.00056457665,0.0011256617,0.00003531393,0.00016485082,0.0000058703895,0.0000015837041,0.000056073164,0.027497346,0.96978927],"study_design_scores_gemma":[0.0002566787,0.0010462671,0.00008163513,0.0013979265,0.002604668,0.00010414443,0.000026792475,0.00006370181,0.000003443608,0.0009935767,0.99316627,0.0002548875],"about_ca_topic_score_codex":0.00035075215,"about_ca_topic_score_gemma":0.00064916257,"teacher_disagreement_score":0.96953434,"about_ca_system_score_codex":0.0037683754,"about_ca_system_score_gemma":0.0041605732,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W4398764308","doi":"10.1016/j.eururo.2024.04.039","title":"Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.11.012","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Port (circuit theory); Urology; Gynecology; General surgery; Internal medicine; Prostate cancer","score_opus":0.049735138834754195,"score_gpt":0.3308478608407517,"score_spread":0.28111272200599746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398764308","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008095801,0.004136487,0.00018508839,0.88294286,0.0012964946,0.0057716095,0.0004308334,0.0012836753,0.09585715],"genre_scores_gemma":[0.11245153,0.0013559253,0.00072409026,0.69933945,0.0050892327,0.0007357934,0.005025721,0.0018135906,0.17346467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884948,0.0036159644,0.0024695068,0.0028458433,0.0008965523,0.0016773113],"domain_scores_gemma":[0.99631417,0.000919078,0.00048762653,0.0014946171,0.00019847292,0.000586035],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0021194995,0.0015664306,0.0028297147,0.0005813995,0.00012251038,0.00014810289,0.00067126745,0.0016817008,0.0032513642],"category_scores_gemma":[0.00043493553,0.0013062741,0.0008898544,0.00058106903,0.0006828971,0.00014541704,0.00049840455,0.009300466,0.0021332446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016998674,0.0010433672,0.010092393,0.0004342218,0.00086839794,0.06686793,0.00015387424,0.0000028945094,0.00009379894,0.000012043834,0.91495323,0.0037779917],"study_design_scores_gemma":[0.006805204,0.0035200852,0.046867423,0.00017708717,0.0013241557,0.0007894068,0.000008692493,0.000020240366,0.000060353712,0.000059409376,0.93939865,0.00096931466],"about_ca_topic_score_codex":0.0003767171,"about_ca_topic_score_gemma":0.000131256,"teacher_disagreement_score":0.1836034,"about_ca_system_score_codex":0.00032063734,"about_ca_system_score_gemma":0.00047995176,"threshold_uncertainty_score":0.9997084},"labels":[],"label_agreement":null},{"id":"W4399037362","doi":"10.1016/j.euros.2024.05.005","title":"Re: Simone Buchardt Brandt, Stefanie Korsgaard Körner, Rikke Vilsbøll Milling, et al. DaBlaCa-16: Retrosigmoid Versus Conventional Ileal Conduit in Robot-assisted Radical Cystectomy, the MOSAIC Randomized Controlled Trial—Feasibility and 90-day Postoperative Complications. Eur Urol Open Sci 2024;60:8–14","year":2024,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Randomized controlled trial; Medicine; Psychotherapist; Psychology; Surgery; Internal medicine","score_opus":0.06344733808697689,"score_gpt":0.3683740103140483,"score_spread":0.3049266722270714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399037362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47403553,0.017469807,0.0022878912,0.20271021,0.007646996,0.07354575,0.00068384584,0.0004596098,0.22116038],"genre_scores_gemma":[0.98097277,0.00038173277,0.00029547678,0.014275755,0.0000960979,0.0007770643,0.00011223164,0.00006061872,0.0030282773],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9899837,0.0052973134,0.0013213789,0.0018714207,0.00085312425,0.0006731022],"domain_scores_gemma":[0.99530774,0.0025371432,0.0003424154,0.0010600247,0.00036578422,0.00038687122],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.016776552,0.00050876423,0.0018414496,0.00030124435,0.0007340094,0.0010104381,0.0020435841,0.00011773923,0.00068900216],"category_scores_gemma":[0.0024856708,0.00032671334,0.0002851084,0.0011405929,0.003613291,0.0006957301,0.0013299267,0.0010122086,0.00016333135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96353775,0.00093039125,0.00075680495,0.000029770421,0.0007444391,0.00040746972,0.0014758572,0.00009534689,0.0046220478,0.0031118598,0.023041096,0.0012471636],"study_design_scores_gemma":[0.94409853,0.0026564929,0.008384043,0.00013584665,0.00058279536,0.00012355667,0.00018111283,0.0037250908,0.00014545942,0.00022759632,0.039326854,0.00041263696],"about_ca_topic_score_codex":0.00056374253,"about_ca_topic_score_gemma":0.00033849408,"teacher_disagreement_score":0.5069372,"about_ca_system_score_codex":0.00030532453,"about_ca_system_score_gemma":0.0014027485,"threshold_uncertainty_score":0.9999185},"labels":[],"label_agreement":null},{"id":"W4399117164","doi":"10.1007/978-3-031-49428-4_22","title":"Robot-Assisted Female Organ Sparing Cystectomy","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cystectomy; Robot; Computer science; Medicine; Urology; Artificial intelligence; Internal medicine; Bladder cancer; Cancer","score_opus":0.038346785729566235,"score_gpt":0.28331289977716434,"score_spread":0.2449661140475981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399117164","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000770285,0.0025197181,0.000068006906,0.00043816637,0.00062060467,0.00054738316,0.000030778283,0.0003967744,0.99530154],"genre_scores_gemma":[0.057892878,0.00015414118,0.00038440758,0.00042355503,0.00066496554,0.00002100373,0.000096279444,0.0001747038,0.94018805],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985989,0.0000030402514,0.00029930382,0.0005272407,0.00032709676,0.0002444634],"domain_scores_gemma":[0.9991823,0.000018526927,0.00005919126,0.00047886267,0.00006975377,0.00019139753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000403046,0.0004169828,0.00060671597,0.00018442897,0.00004754346,0.000043621323,0.000086686625,0.0003406186,0.008016537],"category_scores_gemma":[0.000004285835,0.00031591082,0.00027096132,0.000043431904,0.00004671532,0.000029115403,0.000085923326,0.0004292661,0.003974871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022116627,0.00096981117,0.004426428,0.013508245,0.026918981,0.025206786,0.001796738,0.0000068715485,0.009943496,0.55748457,0.09482575,0.26270068],"study_design_scores_gemma":[0.0035524308,0.0007671805,0.0024555377,0.0033200877,0.0038109177,0.0010099481,0.000046506888,0.000019840616,0.0020048104,0.005087834,0.9769896,0.00093529595],"about_ca_topic_score_codex":0.00012071252,"about_ca_topic_score_gemma":0.000095066025,"teacher_disagreement_score":0.8821639,"about_ca_system_score_codex":0.0002492521,"about_ca_system_score_gemma":0.00020227623,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W4399240896","doi":"10.1016/j.clgc.2024.102132","title":"Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Stage (stratigraphy); Incidence (geometry); Cumulative incidence; Internal medicine; Adjuvant; Chemotherapy; Overall survival; Urology; Oncology; Gastroenterology; Surgery; Bladder cancer; Cohort; Cancer","score_opus":0.04327223786571829,"score_gpt":0.4050090018454212,"score_spread":0.36173676397970295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399240896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968336,0.02058256,0.00019122295,0.0027699242,0.0037125512,0.0013507114,0.00016784572,0.00021413574,0.0026750818],"genre_scores_gemma":[0.9829928,0.008131769,0.00096453435,0.001461423,0.0012672314,0.00039572082,0.00005717244,0.000118631535,0.0046107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969134,0.0001239018,0.0009616724,0.0008983856,0.00045031053,0.00065234373],"domain_scores_gemma":[0.99840236,0.0004546727,0.0000924441,0.0005199976,0.00006730038,0.00046322987],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036364957,0.00042619545,0.0009516615,0.00019298447,0.000064682456,0.000045132434,0.00020950711,0.00019778467,0.0014139586],"category_scores_gemma":[0.00008020359,0.0003361986,0.000387094,0.00052244746,0.00034246995,0.0001591232,0.00007707259,0.00084227446,0.00025517636],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030882956,0.0026009753,0.043793622,0.001346862,0.0019221846,0.015122342,0.0008931884,0.00030270993,0.0023500242,0.000043628883,0.013207666,0.88753384],"study_design_scores_gemma":[0.14554729,0.020478174,0.19836932,0.006292955,0.0018275827,0.00032990327,0.0011539563,0.01679058,0.006847109,0.00042434217,0.59934,0.0025987609],"about_ca_topic_score_codex":0.00037547795,"about_ca_topic_score_gemma":0.00017772752,"teacher_disagreement_score":0.8849351,"about_ca_system_score_codex":0.00045894255,"about_ca_system_score_gemma":0.0010432057,"threshold_uncertainty_score":0.999909},"labels":[],"label_agreement":null},{"id":"W4399296589","doi":"10.1101/2024.05.30.596555","title":"Low T cell diversity is associated with poor outcome in bladder cancer: a comprehensive longitudinal analysis of the T cell receptor repertoire","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Repertoire; Receptor; Bladder cancer; Cancer research; Characterization (materials science); Biology; Computational biology; Chemistry; Urology; Cancer; Internal medicine; Medicine; Physics; Materials science; Nanotechnology","score_opus":0.022529800033190904,"score_gpt":0.24792095011014584,"score_spread":0.22539115007695493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399296589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992903,0.002344703,0.000008971575,0.0006408975,0.000653762,0.0011171778,0.002171707,0.0001202441,0.00003952922],"genre_scores_gemma":[0.99858296,0.00026489422,0.00014227035,0.00053647003,0.00010313688,0.0001236404,0.0000022013758,0.000100234305,0.00014417543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967328,0.0001471844,0.0006519576,0.001166975,0.0007905612,0.00051055045],"domain_scores_gemma":[0.9972023,0.00007578411,0.0005740569,0.0012165908,0.0007113288,0.00021993267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020388428,0.00065027294,0.0014874546,0.0005558778,0.00017190483,0.000056842313,0.00046026017,0.0004981459,0.0002974522],"category_scores_gemma":[0.00004076627,0.0004783174,0.0006033294,0.0023788747,0.0002091861,0.000052428135,0.0011641291,0.0011175161,0.000019075305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028442105,0.0007869471,0.93990815,0.0010174956,0.0060323304,0.00018248499,0.0001705797,0.00021850794,0.050561603,0.000003861498,0.00083205133,0.0000015565543],"study_design_scores_gemma":[0.0021606702,0.00015439196,0.80563694,0.0012590421,0.011314169,1.3160111e-8,0.000022199085,0.00036595858,0.17832762,5.4865484e-7,0.00020104859,0.00055737933],"about_ca_topic_score_codex":0.002278812,"about_ca_topic_score_gemma":0.000208681,"teacher_disagreement_score":0.13427119,"about_ca_system_score_codex":0.0011262925,"about_ca_system_score_gemma":0.0010670763,"threshold_uncertainty_score":0.9997668},"labels":[],"label_agreement":null},{"id":"W4399320810","doi":"10.1016/j.euf.2024.05.007","title":"Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma","year":2024,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Atezolizumab; Urinary system; Oncology; Urology; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.02015626680701948,"score_gpt":0.2558305766856306,"score_spread":0.2356743098786111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399320810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911108,0.00063186523,0.000033379707,0.00015643975,0.00020001523,0.0007360611,0.00026818828,0.00009008368,0.006773136],"genre_scores_gemma":[0.99901944,0.0000094356055,0.00014843595,0.00006795202,0.000055892742,0.000017454471,0.0003846631,0.000063294574,0.00023345034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980738,0.0002986733,0.00050173915,0.0005698768,0.0002976501,0.00025826454],"domain_scores_gemma":[0.9992472,0.00013433195,0.00011279734,0.00029398475,0.00012484426,0.000086843866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009777374,0.000249454,0.0003539998,0.00027571924,0.000026951893,0.000015596997,0.00015304894,0.000037680424,0.000094969866],"category_scores_gemma":[0.00006690853,0.00019288098,0.000051460156,0.0003559208,0.00007764778,0.000095544456,0.000047987684,0.00030217422,0.000043816388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069430046,0.045614477,0.76434046,0.00008068855,0.0017594513,0.027717287,0.00939826,0.0003497098,0.0005066735,0.000011010641,0.00036553826,0.08042639],"study_design_scores_gemma":[0.025364649,0.038391646,0.9345467,0.00013117993,0.00037256122,0.00011587791,0.00010970455,0.00019021658,0.00016223053,0.00003282011,0.00042002785,0.00016236473],"about_ca_topic_score_codex":0.0003019526,"about_ca_topic_score_gemma":0.00009863309,"teacher_disagreement_score":0.17020625,"about_ca_system_score_codex":0.0001133581,"about_ca_system_score_gemma":0.00011696315,"threshold_uncertainty_score":0.7865458},"labels":[],"label_agreement":null},{"id":"W4399332736","doi":"10.21203/rs.3.rs-4437602/v1","title":"Access to trimodal therapy in muscle-invasive bladder cancer is lower in unmarried females","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Logistic regression; Demography; Context (archaeology); Marital status; Epidemiology; Ethnic group; Bladder cancer; Internal medicine; Cancer; Population; Biology","score_opus":0.17452328323360794,"score_gpt":0.4883426758296185,"score_spread":0.31381939259601055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399332736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600568,0.010908875,0.0000020017612,0.016227901,0.00062840345,0.0052144076,0.00056705007,0.000072717885,0.0063218493],"genre_scores_gemma":[0.9821025,0.009164186,0.00003480245,0.0012438514,0.00068444153,0.0038308501,0.00008250077,0.00013802286,0.0027188535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953275,0.00032953135,0.00051555416,0.001334209,0.0014525796,0.0010406411],"domain_scores_gemma":[0.9978643,0.00027327624,0.0000502319,0.00093972014,0.00044500534,0.00042744036],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073803606,0.00048227113,0.00082886365,0.0016481489,0.00006724521,0.00026250054,0.00059955224,0.00053024123,0.002688915],"category_scores_gemma":[0.00020525503,0.000391842,0.00026541518,0.0015213809,0.00013164245,0.000086224325,0.0013763494,0.0026180854,0.00025483087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017987272,0.0050180415,0.56742483,0.012486764,0.0026090085,0.010877219,0.039216097,0.00078673527,0.003928061,0.00020201194,0.083774544,0.2556894],"study_design_scores_gemma":[0.011110249,0.0025491568,0.9244576,0.017444914,0.00011856942,0.000010259483,0.001787213,0.0001432558,0.015172241,0.007489972,0.01856407,0.0011524973],"about_ca_topic_score_codex":0.019139305,"about_ca_topic_score_gemma":0.0112776905,"teacher_disagreement_score":0.35703278,"about_ca_system_score_codex":0.0015704001,"about_ca_system_score_gemma":0.004243736,"threshold_uncertainty_score":0.9998534},"labels":[],"label_agreement":null},{"id":"W4399359124","doi":"10.5489/cuaj.8828","title":"Poster Session 3: Oncology – Bladder","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Proportional hazards model; Retrospective cohort study; Internal medicine; Oncology; Comorbidity; Cancer","score_opus":0.01807592613590434,"score_gpt":0.2891249215707427,"score_spread":0.27104899543483835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399359124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45375347,0.004754125,0.00014427461,0.36363116,0.005072673,0.00051703746,0.000110445064,0.00021408404,0.17180274],"genre_scores_gemma":[0.97837317,0.00012123674,0.00007637523,0.015185038,0.0011050956,0.000007111232,0.000017301787,0.0000143244715,0.005100341],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890643,0.00010096555,0.00021068315,0.00016753463,0.00023892996,0.00037544707],"domain_scores_gemma":[0.9990014,0.00009248584,0.00005238961,0.00006412681,0.00012711757,0.0006625208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003128808,0.00010686495,0.00019180383,0.00016842772,0.00015205688,0.000104852625,0.0000552712,0.0004034091,0.0037403093],"category_scores_gemma":[0.000143294,0.00007391089,0.00013618049,0.00016653568,0.000018046854,0.00009112263,0.00000854236,0.00083041855,0.00052490004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019487408,0.00016235042,0.42654318,0.000020700283,0.0010002888,0.0041950624,0.0006868236,0.0000061837754,0.00065909285,0.00061594846,0.44759122,0.11832429],"study_design_scores_gemma":[0.00074191915,0.0006792456,0.20077693,0.000025218756,0.00017715443,0.0012593875,0.000034409946,0.00005224898,0.000047822887,0.0010929296,0.7950184,0.00009434325],"about_ca_topic_score_codex":0.00046751645,"about_ca_topic_score_gemma":0.00032500227,"teacher_disagreement_score":0.5246197,"about_ca_system_score_codex":0.0020049505,"about_ca_system_score_gemma":0.0013591397,"threshold_uncertainty_score":0.9971704},"labels":[],"label_agreement":null},{"id":"W4399359308","doi":"10.5489/cuaj.8827","title":"Poster Session 2: Endourology, BPH (Part 1)","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Supine position; Medicine; Body mass index; Percutaneous nephrolithotomy; Repeated measures design; Prone position; Prospective cohort study; Population; Positive airway pressure; Analysis of variance; Urology; Surgery; Internal medicine; Percutaneous; Obstructive sleep apnea; Mathematics","score_opus":0.018201034939839957,"score_gpt":0.26361931357590596,"score_spread":0.245418278636066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399359308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6128001,0.005967276,0.00010353953,0.29859057,0.0059723207,0.0005361078,0.00020580798,0.00025941402,0.07556481],"genre_scores_gemma":[0.9805063,0.00013895263,0.000043413824,0.013300823,0.0014333939,0.000008243409,0.000024774354,0.000016121483,0.0045279684],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987697,0.00010511469,0.00023670746,0.0001956818,0.00025654052,0.00043624235],"domain_scores_gemma":[0.9989861,0.00009099571,0.000058209513,0.00007979158,0.00011134952,0.0006735459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003460083,0.00012513116,0.00019824866,0.00017805937,0.00017922168,0.00012688558,0.00006646551,0.00025339582,0.0034704262],"category_scores_gemma":[0.00017903092,0.00008839457,0.00015419493,0.00016817379,0.000022135731,0.00010030763,0.000010056767,0.00063276215,0.0005184037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014123389,0.00007478,0.67901796,0.000015790543,0.00048733683,0.002156774,0.00021755864,0.0000046802597,0.00029552367,0.00044418735,0.29547495,0.021669205],"study_design_scores_gemma":[0.00077162974,0.0005109282,0.23265782,0.000036092773,0.00017318885,0.0014158905,0.000016872515,0.00004414742,0.00006210098,0.0010231822,0.76318085,0.000107276705],"about_ca_topic_score_codex":0.00043109874,"about_ca_topic_score_gemma":0.00024022603,"teacher_disagreement_score":0.4677059,"about_ca_system_score_codex":0.0009405969,"about_ca_system_score_gemma":0.0007532866,"threshold_uncertainty_score":0.9974405},"labels":[],"label_agreement":null},{"id":"W4399359318","doi":"10.5489/cuaj.8822","title":"Podium Session 3: Oncology – Bladder, Kidney, Testes","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"University of Toronto; Bladder Cancer Canada; Canadian Urological Association Scholarship Fund","keywords":"Medicine; Bladder cancer; Audit; Urothelial cancer; Internal medicine; Oncology; Nephrology; Proportional hazards model; Progression-free survival; Urology; Cancer; Overall survival","score_opus":0.016655805705102947,"score_gpt":0.2839638066030826,"score_spread":0.2673080008979797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399359318","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2202496,0.007308595,0.00025025575,0.6065276,0.007504666,0.00081413914,0.00033690466,0.000423823,0.15658441],"genre_scores_gemma":[0.9714541,0.00026943788,0.0002247642,0.020301633,0.0015373447,0.00001253931,0.000040560768,0.0000208395,0.0061387797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998622,0.00012377878,0.00026863607,0.00021547452,0.0002948057,0.00047533063],"domain_scores_gemma":[0.9982179,0.00015518395,0.00007833368,0.00008255434,0.0001542413,0.0013118034],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039019002,0.00014245667,0.00025240245,0.00020914014,0.00021814319,0.00013360179,0.00008129178,0.0003340571,0.0030240577],"category_scores_gemma":[0.0005567358,0.000101935424,0.00015937451,0.00024417078,0.000028107286,0.000106495645,0.000011832215,0.0007057903,0.00042693657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010776045,0.00017087642,0.3112627,0.000026030437,0.00068715547,0.0025576048,0.00036360172,0.000005782501,0.0007854102,0.00068945653,0.61664057,0.06670308],"study_design_scores_gemma":[0.0009104793,0.0008228473,0.10530883,0.000046239198,0.00022307031,0.001072267,0.000053252585,0.0001253995,0.0000736783,0.0016668679,0.88957685,0.00012019182],"about_ca_topic_score_codex":0.00082226476,"about_ca_topic_score_gemma":0.00025094568,"teacher_disagreement_score":0.7512045,"about_ca_system_score_codex":0.0023041032,"about_ca_system_score_gemma":0.0030082879,"threshold_uncertainty_score":0.9978873},"labels":[],"label_agreement":null},{"id":"W4399361696","doi":"10.1016/j.clgc.2024.102133","title":"Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Urothelial carcinoma; Medicine; Urology; Insulin-like growth factor; Insulin-like growth factor-binding protein; Internal medicine; Oncology; Risk stratification; Insulin; Growth factor; Endocrinology; Cancer; Receptor; Bladder cancer","score_opus":0.040373999970872654,"score_gpt":0.3333764279400442,"score_spread":0.29300242796917153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399361696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298817,0.0011229739,0.00011540446,0.00023081759,0.00039117486,0.0032265526,0.0017521457,0.00008063279,0.000092107504],"genre_scores_gemma":[0.99677545,0.0003551739,0.0007660434,0.00010948166,0.0006460792,0.0007890066,0.00022811754,0.00007538814,0.0002552481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978218,0.00018637726,0.0006660447,0.00069461385,0.0003230003,0.00030812997],"domain_scores_gemma":[0.99860895,0.0004244177,0.00018870269,0.00021503938,0.00029570045,0.00026720844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593583,0.00034287566,0.0005806969,0.00014128424,0.00012399183,0.00004239149,0.00009433872,0.0002440642,0.00012114613],"category_scores_gemma":[0.00011534805,0.00023838025,0.00022208266,0.00023783308,0.00018680055,0.00017217577,0.000020151565,0.00040908816,0.000006072395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01068175,0.0014426816,0.9670487,0.0007246918,0.00065397366,0.000058679074,0.0003839351,0.000007832302,0.00147948,0.00001530056,0.0003004865,0.017202461],"study_design_scores_gemma":[0.016572228,0.014279468,0.9265975,0.0006120302,0.0012469532,0.0000133306585,0.000044906657,0.0032582588,0.035186548,0.000018388237,0.001723659,0.00044674295],"about_ca_topic_score_codex":0.000101911864,"about_ca_topic_score_gemma":0.000012774601,"teacher_disagreement_score":0.040451244,"about_ca_system_score_codex":0.00015480752,"about_ca_system_score_gemma":0.00076959096,"threshold_uncertainty_score":0.9720865},"labels":[],"label_agreement":null},{"id":"W4399381307","doi":"10.1200/jco.2024.42.16_suppl.tps4616","title":"Phase 3 study of disitamab vedotin with pembrolizumab vs chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Internal medicine; Urothelial cancer; Urothelial carcinoma; Cancer research; Cancer; Immunotherapy; Bladder cancer","score_opus":0.05838603961958719,"score_gpt":0.41928429454730964,"score_spread":0.36089825492772243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399381307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675083,0.0005000691,0.00008587778,0.00050957635,0.00030800625,0.0015943117,0.000022951319,0.000020169617,0.00020820735],"genre_scores_gemma":[0.9980196,0.00019043392,0.00088728534,0.00040469907,0.00018638874,0.00003857465,0.000009595766,0.00006552772,0.00019789794],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9962832,0.00046541914,0.0018241964,0.00038908367,0.00069680816,0.00034129174],"domain_scores_gemma":[0.99709725,0.00096330274,0.0009269596,0.00030164781,0.00039809494,0.00031275974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006463114,0.00032721861,0.0021527298,0.00022862262,0.000028840816,0.000022809963,0.00020039664,0.00014736198,0.00028640922],"category_scores_gemma":[0.0002448864,0.0001680739,0.00019520069,0.00035251086,0.0001912594,0.0002617738,0.000028271863,0.00068379974,0.00000517943],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39889354,0.052752525,0.4119465,0.00027256893,0.0023862363,0.0041865627,0.0017462394,0.00006642269,0.000030905103,0.0000033375936,0.00021905218,0.12749611],"study_design_scores_gemma":[0.2770494,0.36467943,0.35258967,0.0008455548,0.0018687268,0.0001989404,0.000904849,0.00006314111,0.00027679827,0.000018718947,0.001300501,0.00020428249],"about_ca_topic_score_codex":0.00015897727,"about_ca_topic_score_gemma":0.00034925374,"teacher_disagreement_score":0.3119269,"about_ca_system_score_codex":0.0002252886,"about_ca_system_score_gemma":0.0026002284,"threshold_uncertainty_score":0.6853854},"labels":[],"label_agreement":null},{"id":"W4399393520","doi":"10.1016/j.cpsurg.2024.101526","title":"Critical care therapy use after radical cystectomy in patients with non-metastatic bladder cancer","year":2024,"lang":"en","type":"review","venue":"Current Problems in Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urinary diversion; Odds ratio; Percutaneous endoscopic gastrostomy; Cancer; Internal medicine; Surgery","score_opus":0.08528130473162544,"score_gpt":0.38452868789003725,"score_spread":0.2992473831584118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399393520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032312959,0.9912985,0.000005761831,0.000028387762,0.0017721029,0.0031384917,0.00043308688,0.00005145105,0.00004090556],"genre_scores_gemma":[0.011624277,0.9826772,0.00003720613,0.000068416455,0.00022655056,0.0046267756,0.0004936152,0.00019372304,0.000052185493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962751,0.00023267238,0.0011165395,0.0009773559,0.00066538114,0.00073294016],"domain_scores_gemma":[0.9984771,0.0004581719,0.00013594239,0.000519542,0.00015945043,0.0002498112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020257197,0.000833465,0.00268561,0.0008612657,0.000027436654,0.00010095098,0.00012631931,0.00025229686,0.00032919575],"category_scores_gemma":[0.0000833056,0.0005207529,0.00055377756,0.0009795353,0.00019432999,0.00021768475,0.00006782974,0.0012096154,0.00008326463],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021013594,0.001033061,0.10876753,0.0668125,0.00038818474,0.00032309708,0.00041507935,7.4973696e-7,1.016961e-8,0.0000017754777,0.0011033466,0.82094455],"study_design_scores_gemma":[0.002818266,0.0002571117,0.010835001,0.17065439,0.0022581576,0.000020842006,0.000015961814,0.0000019143297,2.8504283e-7,0.00001621162,0.81231767,0.0008041976],"about_ca_topic_score_codex":0.00016011574,"about_ca_topic_score_gemma":0.000091108326,"teacher_disagreement_score":0.8201403,"about_ca_system_score_codex":0.0007333816,"about_ca_system_score_gemma":0.0016618697,"threshold_uncertainty_score":0.9997244},"labels":[],"label_agreement":null},{"id":"W4399394081","doi":"10.1200/jco.2024.42.16_suppl.e16566","title":"Real-world evidence for enfortumab vedotin (EV) in metastatic urothelial carcinoma (mUC): a multi-centred observational study in a publicly funded Canadian system.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Observational study; Urothelial carcinoma; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.594388247313195,"score_gpt":0.5451450472887684,"score_spread":0.0492432000244265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877721,0.00091250415,0.00004905376,0.006475572,0.0020948597,0.001959844,0.00005044834,0.00001733615,0.00066826533],"genre_scores_gemma":[0.9954706,0.00007686151,0.0023373098,0.00067643693,0.00071440876,0.00017460111,0.000007457996,0.000032452197,0.00050991296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951835,0.00063325,0.0029240435,0.00037058865,0.00043396675,0.00045461633],"domain_scores_gemma":[0.994216,0.0040770443,0.0005517543,0.0002080343,0.0003609993,0.0005861305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036981155,0.00021079832,0.001542658,0.0007937082,0.000039875144,0.000044152577,0.00022521801,0.00016997544,0.000102276346],"category_scores_gemma":[0.0040841633,0.00016053584,0.00039668145,0.0005987966,0.000074591655,0.00027843873,0.00002397095,0.0007996439,0.000014071174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005034964,0.0023010634,0.9737516,0.0002564611,0.00048640405,0.004665963,0.000703801,0.000035612353,0.000012906445,0.00044265657,0.0011409357,0.011167632],"study_design_scores_gemma":[0.02123003,0.0072498047,0.95993316,0.0008671712,0.0006605458,0.00017692058,0.0012884275,0.003381518,0.000012173262,0.00009117713,0.0049711773,0.00013789377],"about_ca_topic_score_codex":0.19322914,"about_ca_topic_score_gemma":0.7344382,"teacher_disagreement_score":0.54120904,"about_ca_system_score_codex":0.0022583713,"about_ca_system_score_gemma":0.022895306,"threshold_uncertainty_score":0.98264396},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":true,"about_ca_topic":true,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4399394132","doi":"10.1200/jco.2024.42.16_suppl.4502","title":"Patient-reported outcomes (PROs) from a randomized, phase 3 trial of enfortumab vedotin plus pembrolizumab (EV+P) versus platinum-based chemotherapy (PBC) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma US","keywords":"Medicine; Internal medicine; Gemcitabine; Progression-free survival; Brief Pain Inventory; Quality of life (healthcare); Cancer; Carboplatin; Hazard ratio; Chemotherapy; Gastroenterology; Randomized controlled trial; Cisplatin; Oncology; Urology; Confidence interval; Physical therapy; Chronic pain","score_opus":0.09391004980722414,"score_gpt":0.47658217233799316,"score_spread":0.382672122530769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846185,0.0016736476,0.0005594056,0.001902887,0.0034530843,0.0031337242,0.000118156444,0.00004408671,0.00065314973],"genre_scores_gemma":[0.9944336,0.0014456848,0.0021379837,0.0008523663,0.0005472594,0.00028796936,0.00002547263,0.00007613538,0.00019353675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99148124,0.0012380658,0.005568841,0.00047522888,0.0008113334,0.00042526913],"domain_scores_gemma":[0.98389465,0.012324096,0.0026303004,0.00034340424,0.00040889616,0.0003986416],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023290785,0.00044724345,0.005143073,0.0003443613,0.000031008236,0.000026484933,0.00020149846,0.0004224664,0.0011681974],"category_scores_gemma":[0.0069281324,0.00026901645,0.0013911105,0.00040076385,0.0003985025,0.00016756986,0.000025523655,0.0010565193,0.000008757247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7670813,0.0039716293,0.0007817007,0.00009622849,0.0038967454,0.0026912282,0.00048438346,0.00019787137,0.00010190684,0.000012785313,0.0001893101,0.22049487],"study_design_scores_gemma":[0.9479489,0.038498204,0.0007232493,0.00074936886,0.0039913286,0.00007300542,0.00010040463,0.0025714242,0.0008144197,0.00017129889,0.0041336245,0.00022480421],"about_ca_topic_score_codex":0.00080411276,"about_ca_topic_score_gemma":0.00050945673,"teacher_disagreement_score":0.22027007,"about_ca_system_score_codex":0.00063889497,"about_ca_system_score_gemma":0.014752995,"threshold_uncertainty_score":0.9999762},"labels":[],"label_agreement":null},{"id":"W4399394205","doi":"10.1200/jco.2024.42.16_suppl.e16555","title":"Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohort.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Urothelial carcinoma; Oncology; Urothelial cancer; Internal medicine; Solid tumor; Bladder cancer; Cancer","score_opus":0.061673013247210036,"score_gpt":0.40888773095158637,"score_spread":0.34721471770437634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020064,0.00036813656,0.000020488003,0.0072303344,0.00043907078,0.0011467017,0.000026479544,0.000011052277,0.0005570942],"genre_scores_gemma":[0.9962755,0.00044424637,0.0004035093,0.0022734022,0.00045218293,0.000039041468,0.000020128004,0.00003095166,0.00006103857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651384,0.0006739293,0.0015782099,0.00031534678,0.0006719758,0.00024670898],"domain_scores_gemma":[0.9962342,0.002427175,0.00065880443,0.00031451604,0.00025733263,0.000107983156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019507933,0.00021258269,0.0010429773,0.00010543937,0.000051069717,0.00003339327,0.00024317195,0.00018206179,0.000028452],"category_scores_gemma":[0.00051638455,0.00007864459,0.00014312645,0.00034092186,0.00020049285,0.00019054282,0.000023295572,0.0011036693,0.0000061419605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11610721,0.0033199717,0.8032315,0.000009982268,0.00025215323,0.00087479554,0.0021930854,0.000033638975,0.000017383054,0.000015425669,0.00026433915,0.07368054],"study_design_scores_gemma":[0.05559227,0.04312542,0.8981054,0.000555273,0.00019849338,0.00006788095,0.00043668682,0.00012465012,0.00004179261,0.00014297907,0.0015112666,0.00009791428],"about_ca_topic_score_codex":0.00035014906,"about_ca_topic_score_gemma":0.0006671235,"teacher_disagreement_score":0.094873905,"about_ca_system_score_codex":0.0002218686,"about_ca_system_score_gemma":0.0019673542,"threshold_uncertainty_score":0.47949556},"labels":[],"label_agreement":null},{"id":"W4399394238","doi":"10.1200/jco.2024.42.16_suppl.e16588","title":"Retrospective analysis of outcomes of patients with bladder cancer when neoadjuvant chemotherapy is delayed.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health Authority; Saskatchewan Health; University of Saskatchewan","funders":"","keywords":"Medicine; Chemotherapy; Bladder cancer; Oncology; Retrospective cohort study; Neoadjuvant therapy; Internal medicine; Urothelial cancer; Cancer; Breast cancer","score_opus":0.0503117136924127,"score_gpt":0.4411368286301796,"score_spread":0.3908251149377669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181587,0.0011239211,0.00020190745,0.004791531,0.00060949754,0.00019253786,0.00013060152,0.000006635074,0.0011275306],"genre_scores_gemma":[0.9950302,0.0009911715,0.0012525894,0.0020263453,0.00021507911,0.000003901575,0.000004784206,0.000020782434,0.00045510172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731565,0.00010019609,0.0016987787,0.00020096137,0.00052992464,0.00015447065],"domain_scores_gemma":[0.9972797,0.00043499234,0.001116958,0.00019521844,0.0007976085,0.00017551062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058377744,0.0001506875,0.0022399926,0.00029777316,0.000013097602,0.000004459967,0.000113650574,0.00021730826,0.0015078149],"category_scores_gemma":[0.00018158166,0.000083523526,0.00087340316,0.0004264755,0.00018975421,0.00008170378,0.000018371355,0.00044090988,0.0000023712448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038445112,0.0014513211,0.9125495,0.00002407677,0.030030182,0.000059495942,0.00064224843,0.000011207176,0.00001562164,0.000025204201,0.002963168,0.04838349],"study_design_scores_gemma":[0.0069780657,0.012227948,0.9633999,0.000089614,0.010851208,0.000004236591,0.000051055635,0.00008126326,0.00015008691,0.00019508171,0.005899827,0.00007169663],"about_ca_topic_score_codex":0.00021183312,"about_ca_topic_score_gemma":0.00013551317,"teacher_disagreement_score":0.050850444,"about_ca_system_score_codex":0.00020042657,"about_ca_system_score_gemma":0.0012184577,"threshold_uncertainty_score":0.99940497},"labels":[],"label_agreement":null},{"id":"W4399394263","doi":"10.1200/jco.2024.42.16_suppl.e16608","title":"Bladder preservation in muscle invasive bladder cancer (MIBC): A population based analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Medicine; Urology; Population; Cystectomy; Oncology; Cancer; Internal medicine","score_opus":0.1381305796862013,"score_gpt":0.4917405913472761,"score_spread":0.3536100116610748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023754,0.0019295169,0.00052196585,0.013966592,0.0013199548,0.0002900127,0.000013139736,0.000019555193,0.0017017187],"genre_scores_gemma":[0.99367,0.0005827413,0.0009594116,0.0032156135,0.0010835036,0.00001909003,0.000021543849,0.000018575693,0.00042950478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970991,0.0003295775,0.0017449866,0.00024426114,0.0003887587,0.00019331591],"domain_scores_gemma":[0.9974865,0.0013146902,0.0005437416,0.00016535676,0.0002799121,0.00020983229],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001452094,0.00013430353,0.0011186744,0.00049575215,0.000021898737,0.00002011914,0.000096497984,0.0003276491,0.0010330015],"category_scores_gemma":[0.0011644413,0.00009554533,0.000619547,0.0008103222,0.00004937406,0.00026779468,0.000019935338,0.0006821073,0.000014595341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017778067,0.0014078802,0.8642235,0.000084672545,0.0039437246,0.0009075847,0.00024034224,0.0019609686,0.00017042083,0.000087347486,0.0047474876,0.120448284],"study_design_scores_gemma":[0.004255695,0.0025002668,0.9687278,0.00015858722,0.0032939045,0.000014438645,0.000041820353,0.004113483,0.0000514227,0.0005042263,0.016251326,0.000087022694],"about_ca_topic_score_codex":0.0010079984,"about_ca_topic_score_gemma":0.003465012,"teacher_disagreement_score":0.12036126,"about_ca_system_score_codex":0.00037371818,"about_ca_system_score_gemma":0.0026530465,"threshold_uncertainty_score":0.9998802},"labels":[],"label_agreement":null},{"id":"W4399394383","doi":"10.1200/jco.2024.42.16_suppl.e16594","title":"Practice patterns of high-risk non-muscle invasive bladder cancer (HR-NMIBC) in real-world Canadian practice.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; Dalhousie University; University Health Network; Juravinski Cancer Centre; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Janssen Biotech","keywords":"Medicine; Bladder cancer; Clinical Practice; Urothelial cancer; Oncology; Cancer; Internal medicine; Urology; Family medicine","score_opus":0.08410808203693014,"score_gpt":0.47728455489016003,"score_spread":0.3931764728532299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8708755,0.0029457107,0.00005607972,0.08168261,0.005988542,0.00066738547,0.00015310821,0.000016902723,0.037614167],"genre_scores_gemma":[0.96972257,0.019221855,0.0014842212,0.0067163375,0.0019552694,0.000017752915,0.000005024599,0.000038652775,0.0008383006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99591756,0.0006941953,0.0022482052,0.00030318787,0.00046609505,0.00037077095],"domain_scores_gemma":[0.9896127,0.0072058984,0.001513023,0.00025850872,0.0007397414,0.0006701541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002931699,0.0001956531,0.0013752559,0.00047940906,0.000035348625,0.000020248037,0.00017945838,0.0003665844,0.00076873123],"category_scores_gemma":[0.0069464096,0.00014590038,0.00036450554,0.00041115624,0.00011321045,0.0004519396,0.000039920375,0.0017875214,0.00004084949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00741835,0.0041065374,0.42301184,0.000307776,0.005855487,0.022203982,0.0021974149,0.00014095324,0.0001060422,0.0005224848,0.03792919,0.49619994],"study_design_scores_gemma":[0.006754984,0.008755736,0.663514,0.0007808163,0.0032377308,0.00034058635,0.00090988976,0.00003642428,0.00014031357,0.00030849074,0.31506106,0.00015995305],"about_ca_topic_score_codex":0.48575655,"about_ca_topic_score_gemma":0.6101228,"teacher_disagreement_score":0.49604,"about_ca_system_score_codex":0.00085634517,"about_ca_system_score_gemma":0.015292389,"threshold_uncertainty_score":0.99029},"labels":[],"label_agreement":null},{"id":"W4399394385","doi":"10.1200/jco.2024.42.16_suppl.e16596","title":"Real-world treatment practices in patients with muscle invasive bladder cancer (MIBC) treated in Alberta, Canada.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; Dalhousie University; University Health Network; Juravinski Cancer Centre; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Janssen Biotech","keywords":"Medicine; Bladder cancer; Oncology; Cancer; Internal medicine","score_opus":0.08483007707924406,"score_gpt":0.4404339630763551,"score_spread":0.355603885997111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399394385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98070824,0.00045750538,2.7356964e-7,0.00932362,0.00078980933,0.00042230875,0.00001734468,0.0000058084465,0.00827506],"genre_scores_gemma":[0.994251,0.0018178872,0.00012779648,0.0010760998,0.00043436402,0.000032164095,0.000009987569,0.000028201352,0.0022225124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730295,0.000292535,0.0014618465,0.00028897074,0.0003648039,0.00028891562],"domain_scores_gemma":[0.996029,0.0023725287,0.00094017526,0.00015677698,0.00020559989,0.00029589902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004372045,0.00020497908,0.0012060262,0.00025442915,0.00001903418,0.000013678152,0.00009027024,0.00017659996,0.00035291587],"category_scores_gemma":[0.0006253838,0.00012132798,0.00015039906,0.00042798874,0.00007495123,0.0001822228,0.000016226444,0.0006079974,0.000006887193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047320933,0.0023591155,0.92426145,0.00003010749,0.00081371405,0.0025297434,0.00024663148,0.000029381854,0.0000030303304,0.0000131839215,0.0024499772,0.06253155],"study_design_scores_gemma":[0.013912218,0.010589268,0.9221917,0.00035719803,0.00069778675,0.000018277766,0.0000778208,0.000020777818,0.0000439314,0.000025230776,0.051958837,0.00010697234],"about_ca_topic_score_codex":0.85539675,"about_ca_topic_score_gemma":0.9929741,"teacher_disagreement_score":0.13757735,"about_ca_system_score_codex":0.0021839761,"about_ca_system_score_gemma":0.013103319,"threshold_uncertainty_score":0.9924915},"labels":[],"label_agreement":null},{"id":"W4399533312","doi":"10.1080/15384047.2024.2365452","title":"Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model","year":2024,"lang":"en","type":"article","venue":"Cancer Biology & Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"McGill University Health Centre; Bladder Cancer Canada; McGill University; Institut de recherche, Centre universitaire de santé McGill","keywords":"Radiation therapy; Cancer research; Immunotherapy; Immune checkpoint; Bladder cancer; Population; Tumor microenvironment; Medicine; Cancer; Immune system; Memory T cell; T cell; Blockade; Immunology; Internal medicine; Receptor","score_opus":0.016953088264287985,"score_gpt":0.3019605964181636,"score_spread":0.2850075081538756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399533312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86457723,0.13139972,0.0000756553,0.0019069558,0.0006211368,0.0010636586,0.000035917375,0.00010384853,0.00021588028],"genre_scores_gemma":[0.94918793,0.047273684,0.00015708322,0.0011649773,0.00026710573,0.00084825367,0.000027005197,0.00007487775,0.0009991014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826396,0.000105671585,0.00040316948,0.00060456723,0.00016229282,0.0004603425],"domain_scores_gemma":[0.9992319,0.00011751362,0.00010139058,0.00038453852,0.00007442622,0.00009027161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013158134,0.0004127546,0.0008396123,0.00022492919,0.000045036944,0.000010009532,0.00017877274,0.00027816568,0.00044337893],"category_scores_gemma":[0.000005651798,0.00026108627,0.0001878224,0.0003868557,0.00037961546,0.000044495333,0.000021901647,0.00044857935,0.0000070904202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017497243,0.0011048575,0.010079357,0.000278809,0.0027225865,0.0001785612,0.0015641213,0.00041478273,0.91241014,0.00013403053,0.00017708783,0.05343845],"study_design_scores_gemma":[0.028520918,0.012512847,0.074819714,0.0014854766,0.0004020539,0.00005052122,0.00008671853,0.001848557,0.8742153,0.00050178135,0.0048426534,0.0007134657],"about_ca_topic_score_codex":0.0013344615,"about_ca_topic_score_gemma":0.00008392341,"teacher_disagreement_score":0.084610686,"about_ca_system_score_codex":0.00036474294,"about_ca_system_score_gemma":0.0005244773,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W4399605698","doi":"10.1016/j.clgc.2024.102139","title":"Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Urinary bladder; Metastatic Urothelial Carcinoma; Urinary system; Carcinoma; Urothelial cancer; Bladder cancer; Oncology; Internal medicine; Cancer","score_opus":0.07465514347380514,"score_gpt":0.41600303817888884,"score_spread":0.3413478947050837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399605698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916854,0.005386918,0.00021553776,0.00037162728,0.0008081702,0.00055133284,0.00024379577,0.000024108582,0.00071313523],"genre_scores_gemma":[0.9970658,0.0005585575,0.0011937836,0.000128189,0.0004650752,0.000060666513,0.000015440699,0.000043137603,0.0004693879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979744,0.00015496524,0.00090956886,0.00040701427,0.00033868678,0.00021534912],"domain_scores_gemma":[0.9986228,0.0003782844,0.00015525387,0.00031219784,0.0003331331,0.0001983667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037705855,0.00021310899,0.000814437,0.00012935683,0.000026037547,0.000008194575,0.00010227646,0.00007754901,0.0003317005],"category_scores_gemma":[0.0001518988,0.00017338678,0.00020954976,0.0005400199,0.00022273861,0.00009827413,0.000109182394,0.00018362474,0.0000118742255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006732747,0.0026080224,0.88885635,0.0052016443,0.0034868396,0.00045629864,0.0009558383,0.00014269193,0.013488695,0.0003495383,0.0024356532,0.0752857],"study_design_scores_gemma":[0.009361646,0.011619559,0.906694,0.002606989,0.006067865,0.00029923778,0.0015990733,0.0007809873,0.055341024,0.0004931372,0.0043973755,0.0007391295],"about_ca_topic_score_codex":0.00044981425,"about_ca_topic_score_gemma":0.000010354518,"teacher_disagreement_score":0.07454657,"about_ca_system_score_codex":0.000046753292,"about_ca_system_score_gemma":0.00067358464,"threshold_uncertainty_score":0.7070508},"labels":[],"label_agreement":null},{"id":"W4399668223","doi":"10.3390/siuj5030031","title":"Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Perioperative; Blood transfusion; Adverse effect; Proportional hazards model; Anemia; Chemotherapy; Stage (stratigraphy); Cancer; Surgery; Retrospective cohort study; Internal medicine; Urology","score_opus":0.019979974869506267,"score_gpt":0.30495145878902763,"score_spread":0.2849714839195214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399668223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037063,0.0013364855,0.00044235497,0.005182722,0.00091846834,0.0008429565,0.00020633297,0.000058501704,0.0006415651],"genre_scores_gemma":[0.9942558,0.0013824358,0.00021160753,0.0019560114,0.00048058448,0.00027403454,0.00006879349,0.00005386259,0.00131691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980865,0.000097726224,0.00041943163,0.0004101823,0.0005998916,0.0003862391],"domain_scores_gemma":[0.9988876,0.00040098146,0.00011117901,0.00010462061,0.00035886595,0.00013673308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024404195,0.00029142384,0.00041808534,0.00020799547,0.00012568559,0.00011427741,0.00013175816,0.000186186,0.0014424517],"category_scores_gemma":[0.0001386814,0.00020816945,0.00026781776,0.00020147866,0.00010435666,0.00023018471,0.00002046336,0.00058432046,0.000004486253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008767964,0.0026091053,0.93194145,0.00018022172,0.007508617,0.0011538466,0.012643799,0.00015322678,0.0010537107,0.00009340682,0.0015683395,0.03232633],"study_design_scores_gemma":[0.066350594,0.0065694507,0.9122217,0.0024358465,0.0012730623,0.0001708026,0.0015520124,0.00091264665,0.0027908129,0.00069758104,0.0042880443,0.0007374102],"about_ca_topic_score_codex":0.000050490504,"about_ca_topic_score_gemma":0.00048506988,"teacher_disagreement_score":0.057582628,"about_ca_system_score_codex":0.00061377685,"about_ca_system_score_gemma":0.00088459137,"threshold_uncertainty_score":0.99947035},"labels":[],"label_agreement":null},{"id":"W4399882072","doi":"10.3390/siuj5030038","title":"Blood Transfusion, Radical Cystectomy, and Cancer Recurrence: A New Look at an Old Story. Comment on Ladner et al. Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Soc. Int. Urol. J. 2024, 5, 202–213","year":2024,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Perioperative; Medicine; Blood transfusion; Urology; Bladder cancer; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.021563776275278685,"score_gpt":0.31405179033473346,"score_spread":0.2924880140594548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399882072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93816,0.0047827996,0.00018526256,0.053078007,0.0013508778,0.0016431112,0.0005570043,0.00007013049,0.00017280484],"genre_scores_gemma":[0.9400655,0.02894102,0.0001842079,0.027249314,0.0005928583,0.000696163,0.00018714106,0.00012131757,0.0019624971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636835,0.00040885384,0.0006439706,0.00088620157,0.0010943024,0.0005983221],"domain_scores_gemma":[0.998171,0.00064448704,0.00020340762,0.00020448245,0.0003465789,0.000430072],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058972545,0.00057314767,0.0007468507,0.00030242623,0.00030578926,0.00016399636,0.00022636578,0.00031792378,0.00239207],"category_scores_gemma":[0.0001348431,0.00042821013,0.0002982566,0.00027131362,0.00024015532,0.00033483776,0.000048287515,0.0014365669,0.000003031658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042680904,0.011652768,0.68124163,0.0005373291,0.017845687,0.0023777774,0.05763901,0.00052380067,0.0031927645,0.00022492238,0.09871546,0.08336795],"study_design_scores_gemma":[0.31131873,0.046148434,0.47246647,0.013445274,0.006813947,0.00090589235,0.0048762364,0.0027431957,0.0069957697,0.00096573326,0.12958595,0.0037343558],"about_ca_topic_score_codex":0.0005406412,"about_ca_topic_score_gemma":0.0032435886,"teacher_disagreement_score":0.26863784,"about_ca_system_score_codex":0.0010634647,"about_ca_system_score_gemma":0.0015504062,"threshold_uncertainty_score":0.99981695},"labels":[],"label_agreement":null},{"id":"W4400002746","doi":"10.1158/2326-6066.cir-23-1114","title":"Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; Queen's University","funders":"Canada Foundation for Innovation; Bladder Cancer Canada; Cancer Research Society","keywords":"Bladder cancer; Immune system; Immunotherapy; Cancer; Medicine; Tumor microenvironment; Inflammation; Immunology; Cancer research; Cancer immunotherapy; Internal medicine","score_opus":0.05586856429779632,"score_gpt":0.4219470691131157,"score_spread":0.3660785048153194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400002746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9255578,0.04771117,0.000006820473,0.023105215,0.00077491935,0.0022839392,0.00016986621,0.000079583486,0.00031068482],"genre_scores_gemma":[0.9783573,0.00886961,0.0001258954,0.00073796575,0.00037418172,0.004482488,0.000010644332,0.000095726165,0.0069461614],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99627817,0.0004865482,0.0004025963,0.0010618021,0.0006107763,0.001160129],"domain_scores_gemma":[0.9984182,0.00037687918,0.00003578612,0.0004789294,0.00033416785,0.00035601904],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009158436,0.0003443511,0.0005748648,0.0007691885,0.00020001616,0.00008666855,0.00026543715,0.000374397,0.0015105002],"category_scores_gemma":[0.00018255586,0.00027361626,0.00008997704,0.0013538682,0.0005638746,0.00014817118,0.0003737946,0.0013356891,0.00018132817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01435418,0.00028377262,0.009183605,0.00043072633,0.0006020513,0.0011306762,0.0039932136,0.000015006179,0.67675567,0.00001851341,0.0100874975,0.2831451],"study_design_scores_gemma":[0.009180065,0.0050010122,0.4357409,0.0054204324,0.0002662281,0.00011070425,0.000922686,0.00036625733,0.3877034,0.00017462959,0.15427105,0.00084265636],"about_ca_topic_score_codex":0.004739685,"about_ca_topic_score_gemma":0.0027465594,"teacher_disagreement_score":0.42655727,"about_ca_system_score_codex":0.0014428485,"about_ca_system_score_gemma":0.002743492,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W4400037517","doi":"10.3390/cancers16132348","title":"Deep Learning Algorithms for Bladder Cancer Segmentation on Multi-Parametric MRI","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; HEC Montréal","funders":"Informatics Institute, University of Florida","keywords":"Segmentation; Artificial intelligence; Bladder cancer; Computer science; Parametric statistics; Deep learning; Algorithm; Medicine; Cancer; Internal medicine; Mathematics","score_opus":0.04348221479612095,"score_gpt":0.35941158169649595,"score_spread":0.315929366900375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400037517","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26512316,0.15724297,0.49419716,0.011203394,0.026713615,0.016772153,0.00082022033,0.0034037884,0.024523536],"genre_scores_gemma":[0.9662922,0.0035448777,0.009172229,0.001842806,0.0013550723,0.0019573972,0.00016132482,0.00014243081,0.0155316815],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99897486,0.00001673477,0.00015607386,0.00037731894,0.00020122186,0.0002737916],"domain_scores_gemma":[0.9995808,0.00008196786,0.000033844375,0.00011955605,0.000063183,0.00012066621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006789482,0.00017253139,0.00020099885,0.0001940781,0.000096458396,0.000042847078,0.00004559006,0.00007579477,0.00038827778],"category_scores_gemma":[0.000027490076,0.0001442969,0.00012667813,0.00040066376,0.000035789602,0.000076739845,0.000008036638,0.00018403477,0.0000672898],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006665732,0.000089261055,0.0028900388,0.00056506053,0.0013877732,0.00007066882,0.002194704,0.026563952,0.001921911,0.00012658922,0.012195413,0.95132804],"study_design_scores_gemma":[0.015207223,0.0040730326,0.0080021685,0.0012256015,0.002261739,0.000041411047,0.002086488,0.64971685,0.048053667,0.00016285096,0.268127,0.0010419878],"about_ca_topic_score_codex":0.00054017466,"about_ca_topic_score_gemma":0.00006311142,"teacher_disagreement_score":0.9502861,"about_ca_system_score_codex":0.0019946224,"about_ca_system_score_gemma":0.0004754607,"threshold_uncertainty_score":0.58842564},"labels":[],"label_agreement":null},{"id":"W4400187099","doi":"10.1200/jco.2024.42.16_suppl.4574","title":"A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial carcinoma; Oncology; Internal medicine; Cancer; Cancer research; Bladder cancer; Immunotherapy","score_opus":0.12785480290398576,"score_gpt":0.46836267043816465,"score_spread":0.3405078675341789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400187099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925286,0.0026142437,0.000019194893,0.0011526918,0.0012624151,0.0004323423,0.0000071136724,0.000007971029,0.001975408],"genre_scores_gemma":[0.9978387,0.00051511335,0.00043829388,0.00035590475,0.00055994425,0.000008845556,6.024137e-7,0.000021475993,0.0002611187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705607,0.00032702557,0.00188287,0.00022580722,0.00031883057,0.00018938443],"domain_scores_gemma":[0.9978809,0.0011241556,0.00043873853,0.0001509139,0.00017268638,0.00023264083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012106679,0.000142818,0.0013583396,0.00024063465,0.000015991482,0.000007859745,0.00009664326,0.00009812683,0.000113655835],"category_scores_gemma":[0.0007825302,0.00009772272,0.00016832446,0.00020287267,0.00012568546,0.00010492981,0.00004634276,0.0007393707,0.0000063099988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04639094,0.014676552,0.58056015,0.00022437645,0.00090233085,0.005969286,0.0016659856,0.00001335018,0.0013789103,0.00010976904,0.00095334416,0.347155],"study_design_scores_gemma":[0.03807833,0.21656737,0.7339051,0.00023117286,0.00064746925,0.0005917787,0.0006933897,0.0000672558,0.00010735273,0.0003633269,0.008650238,0.00009725265],"about_ca_topic_score_codex":0.00022285948,"about_ca_topic_score_gemma":0.00035584008,"teacher_disagreement_score":0.34705776,"about_ca_system_score_codex":0.00012387955,"about_ca_system_score_gemma":0.0015628631,"threshold_uncertainty_score":0.39850166},"labels":[],"label_agreement":null},{"id":"W4400202520","doi":"10.3390/cancers16132404","title":"Incidence, Characteristics and Survival Rates of Bladder Cancer after Rectosigmoid Cancer Radiation","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cancer; Incidence (geometry); Medicine; Bladder cancer; Cancer incidence; Oncology; Internal medicine","score_opus":0.01965902279837792,"score_gpt":0.32261766590205126,"score_spread":0.3029586431036733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400202520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475796,0.047793712,0.000042124113,0.0007023271,0.0018076204,0.00037900973,0.0003752575,0.00006179904,0.0012585178],"genre_scores_gemma":[0.98090374,0.016138848,0.00003797808,0.0004207323,0.00058497896,0.00031736487,0.000020687097,0.00003697256,0.0015386863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990234,0.000024014842,0.00023022764,0.00030427202,0.00021025931,0.00020787025],"domain_scores_gemma":[0.99953467,0.000048664835,0.000056595803,0.00014800428,0.00009145398,0.00012059594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007629173,0.00017260753,0.0003166193,0.00010459443,0.000032794826,0.000028721905,0.000041346313,0.00008281412,0.0013293364],"category_scores_gemma":[0.000018020683,0.0001426008,0.000065000175,0.00024947413,0.00011582256,0.00012335605,0.000019524266,0.00013694925,0.00001064707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015011202,0.000040051007,0.72024673,0.0015701358,0.0014560481,0.00014399968,0.003202298,0.000042967004,0.013295872,0.00014183721,0.008432034,0.2499269],"study_design_scores_gemma":[0.0021164967,0.0004158997,0.90295565,0.0018151484,0.0012497327,0.000023052513,0.0002077205,0.001494927,0.031064464,0.000111730806,0.058074247,0.00047092058],"about_ca_topic_score_codex":0.00322106,"about_ca_topic_score_gemma":0.00041130002,"teacher_disagreement_score":0.24945597,"about_ca_system_score_codex":0.00072877156,"about_ca_system_score_gemma":0.0012001678,"threshold_uncertainty_score":0.9995836},"labels":[],"label_agreement":null},{"id":"W4400240704","doi":"10.4103/iju.iju_62_24","title":"Combination therapy for advanced urothelial cancer: LEAP-011 trial","year":2024,"lang":"en","type":"article","venue":"Indian Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Lenvatinib; Internal medicine; Hazard ratio; Placebo; Adverse effect; Oncology; Randomized controlled trial; Confidence interval; Cancer; Sorafenib; Immunotherapy; Pathology; Hepatocellular carcinoma","score_opus":0.024514636449482388,"score_gpt":0.3369613821673754,"score_spread":0.31244674571789305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400240704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662541,0.012185114,0.0008029691,0.013492312,0.0055341166,0.0011224276,0.000057062894,0.000034215696,0.0005176531],"genre_scores_gemma":[0.99482787,0.0014724527,0.00019031254,0.0012861073,0.0016456702,0.00006944078,0.000006374281,0.00003244112,0.0004693587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908066,0.00005047635,0.00035473565,0.00014387157,0.0001645545,0.00020569334],"domain_scores_gemma":[0.99940014,0.00011789754,0.00013226135,0.00009227552,0.00014462047,0.00011283382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020508732,0.00012360874,0.00032976185,0.00022664726,0.00004636061,0.000020082698,0.00008808422,0.000113942704,0.0002533393],"category_scores_gemma":[0.000045935354,0.000091839145,0.00022109062,0.00011350947,0.000055370452,0.000104359315,0.0000053127637,0.00024102708,0.000011475503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26247063,0.0010114306,0.0023252065,0.00015320732,0.0017677636,0.0014466973,0.002963253,0.00005030895,0.01025095,0.0012413362,0.008181241,0.708138],"study_design_scores_gemma":[0.38248894,0.07340913,0.0043151383,0.00023411227,0.0008974544,0.00272092,0.00014142618,0.00012387193,0.010868685,0.011160292,0.5132544,0.00038565957],"about_ca_topic_score_codex":0.0000124832995,"about_ca_topic_score_gemma":0.0000080055015,"teacher_disagreement_score":0.70775235,"about_ca_system_score_codex":0.000088492714,"about_ca_system_score_gemma":0.0006274871,"threshold_uncertainty_score":0.37450916},"labels":[],"label_agreement":null},{"id":"W4400272792","doi":"10.1200/jco.2024.42.16_suppl.4563","title":"Enfortumab vedotin (EV) with pembrolizumab (P) versus chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Analysis of the cisplatin (cis)-ineligible population from EV-302/KEYNOTE-A39.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Pembrolizumab; Oncology; Cisplatin; Chemotherapy; Internal medicine; Urothelial carcinoma; Urothelial cancer; Cancer research; Cancer; Immunotherapy; Bladder cancer","score_opus":0.07223645194329825,"score_gpt":0.4361281868087091,"score_spread":0.3638917348654108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400272792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949237,0.0008944407,0.0005011029,0.0014093055,0.00069272454,0.00065866025,0.000051712777,0.000021334185,0.0008469838],"genre_scores_gemma":[0.99619037,0.0005387242,0.002187972,0.00043888527,0.00029797052,0.000025218314,0.000029234643,0.00005004011,0.00024156828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99541444,0.0005945369,0.0025827684,0.00040286517,0.00067385286,0.0003315496],"domain_scores_gemma":[0.9946419,0.0031317263,0.0012784811,0.00040745636,0.00030135558,0.00023909834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011579109,0.00032095186,0.002338046,0.00042083344,0.000040740455,0.000025541098,0.00027414216,0.00030906286,0.0005192439],"category_scores_gemma":[0.0011103626,0.00017239548,0.00081518665,0.0013071775,0.00019875896,0.00017123795,0.000028594335,0.0008765982,0.0000059691765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3065037,0.0031631705,0.38814014,0.0002309834,0.014827865,0.0020638441,0.0012660907,0.0036113267,0.00078978145,0.00013770263,0.00037067357,0.27889472],"study_design_scores_gemma":[0.07676368,0.022021292,0.8708969,0.00080354465,0.016982883,0.00019801606,0.00023698874,0.0075270464,0.0016048701,0.00034704982,0.002288312,0.00032942244],"about_ca_topic_score_codex":0.0016959892,"about_ca_topic_score_gemma":0.0027434693,"teacher_disagreement_score":0.48275676,"about_ca_system_score_codex":0.00050504657,"about_ca_system_score_gemma":0.0037226225,"threshold_uncertainty_score":0.70300835},"labels":[],"label_agreement":null},{"id":"W4400272952","doi":"10.1200/jco.2024.42.16_suppl.4566","title":"Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Medicine; Metastatic Urothelial Carcinoma; Avelumab; Internal medicine; Clinical endpoint; Randomization; Oncology; Bladder cancer; Urology; Surgery; Randomized controlled trial; Urothelial carcinoma; Immunotherapy; Nivolumab; Cancer","score_opus":0.060258553354855554,"score_gpt":0.402080230916988,"score_spread":0.34182167756213244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400272952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871299,0.00077318423,0.00096283626,0.0067680744,0.0028176352,0.0010482235,0.00015643623,0.000026355436,0.00031733437],"genre_scores_gemma":[0.9915815,0.00027423762,0.002846309,0.0023234088,0.0019306146,0.000058589438,0.000032737025,0.00007809308,0.0008744987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582815,0.00015994266,0.0024626276,0.00051851623,0.000529235,0.00050155213],"domain_scores_gemma":[0.9959287,0.0019936848,0.00082527054,0.0003186098,0.0005118451,0.0004218779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080253545,0.0003642417,0.002067799,0.00021661435,0.000051647137,0.000028648032,0.00026460996,0.00032867643,0.00039242295],"category_scores_gemma":[0.0012578819,0.00022766126,0.0006567085,0.00019549484,0.00020750597,0.00020554438,0.00005666563,0.0010054819,0.000048725786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029984292,0.0031788694,0.7904103,0.00018089505,0.001122002,0.002873294,0.0003000108,0.000072894305,0.000028330618,0.000019894502,0.0016889636,0.17014027],"study_design_scores_gemma":[0.059201837,0.027122675,0.9016194,0.0009580346,0.0008551907,0.0001088422,0.000055414715,0.00027118518,0.00012710744,0.0002994435,0.009108675,0.00027220257],"about_ca_topic_score_codex":0.00012460585,"about_ca_topic_score_gemma":0.00045498993,"teacher_disagreement_score":0.16986807,"about_ca_system_score_codex":0.0005011728,"about_ca_system_score_gemma":0.002055192,"threshold_uncertainty_score":0.9283757},"labels":[],"label_agreement":null},{"id":"W4400289859","doi":"10.1002/ijc.35077","title":"Contemporary survival in metastatic bladder cancer patients: A population‐based study","year":2024,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Medicine; Oncology; Population; Cancer; Metastasis; Internal medicine; Environmental health","score_opus":0.04265871964585419,"score_gpt":0.3893986208432788,"score_spread":0.3467399011974246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400289859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849116,0.0068984567,0.00009540397,0.0027250433,0.004131678,0.0003907436,0.00012263311,0.000017778435,0.0007066341],"genre_scores_gemma":[0.99832374,0.00010251773,0.000059468886,0.00060076755,0.00054576993,0.00005391342,0.000018361381,0.000026062333,0.00026940406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982677,0.00006222763,0.0005494245,0.00015850237,0.0008453347,0.00011677775],"domain_scores_gemma":[0.9991304,0.00007204164,0.00015623675,0.00007378702,0.00048335022,0.000084148895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018044443,0.00013769418,0.000301581,0.00041265608,0.000014573961,0.000055723878,0.00013709636,0.00002744178,0.0009134844],"category_scores_gemma":[0.00003741211,0.00010254927,0.00014143756,0.00020281637,0.000014413864,0.00024857675,0.000017272785,0.00021427099,0.0000066626635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009369869,0.0009677899,0.98308253,0.00003030107,0.0017887084,0.00050503376,0.00043572442,0.00028507723,0.000042855794,0.000019730895,0.0016578769,0.010247397],"study_design_scores_gemma":[0.008473382,0.00060215575,0.98384404,0.0007237691,0.00036902216,0.000010327198,0.00019229008,0.00033737655,0.0001401928,0.00014622135,0.0050354684,0.00012572373],"about_ca_topic_score_codex":0.0024352467,"about_ca_topic_score_gemma":0.0006571062,"teacher_disagreement_score":0.013412106,"about_ca_system_score_codex":0.0006251143,"about_ca_system_score_gemma":0.00086485903,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W4400327380","doi":"10.1007/s11523-024-01074-9","title":"A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Carboplatin; Metastatic Urothelial Carcinoma; Pembrolizumab; Oncology; Internal medicine; Cisplatin; Chemotherapy; Nivolumab; Avelumab; Atezolizumab; Urothelial carcinoma; Immunotherapy; Cancer; Bladder cancer","score_opus":0.029661348170795524,"score_gpt":0.32597582500551686,"score_spread":0.29631447683472134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400327380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942355,0.00049755606,0.000066037006,0.0002606698,0.00021040913,0.001850697,0.00016355787,0.00011466688,0.0026009043],"genre_scores_gemma":[0.99597615,0.000056605793,0.0025285752,0.00043841527,0.00007868801,0.00027549083,0.00010435298,0.000055192293,0.0004865448],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806875,0.00011391587,0.00041803555,0.0006784235,0.00025708007,0.000463812],"domain_scores_gemma":[0.9991016,0.00027978868,0.00007100544,0.00027591398,0.000071287344,0.00020040342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001202761,0.0003666337,0.00069009897,0.0002486366,0.00006763618,0.000023594983,0.000055986944,0.000121347155,0.00023068319],"category_scores_gemma":[0.000059481263,0.00022663696,0.00006469822,0.00035380985,0.00011362887,0.0001061372,0.000026820764,0.00024864255,0.00004272036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08318335,0.0043560727,0.42687407,0.0011205806,0.0020293512,0.011129858,0.01665256,0.0014135826,0.0087806955,0.0005932934,0.00061400223,0.44325256],"study_design_scores_gemma":[0.16265318,0.22986309,0.53624403,0.0025064533,0.0027777413,0.001031009,0.00313424,0.010925766,0.023775555,0.0018947434,0.022796022,0.002398186],"about_ca_topic_score_codex":0.0009693079,"about_ca_topic_score_gemma":0.0014926615,"teacher_disagreement_score":0.44085437,"about_ca_system_score_codex":0.002772538,"about_ca_system_score_gemma":0.002186014,"threshold_uncertainty_score":0.9241987},"labels":[],"label_agreement":null},{"id":"W4400674417","doi":"10.3390/curroncol31070298","title":"Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Osimertinib; Urothelial carcinoma; Cancer research; Oncology; Internal medicine; Pathology; Epidermal growth factor receptor; Cancer; Bladder cancer","score_opus":0.10920276587568019,"score_gpt":0.4408981484434388,"score_spread":0.3316953825677586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400674417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881468,0.0030588203,0.00010867045,0.0041043693,0.0019220229,0.0016837321,0.00006175722,0.00014363308,0.00077023904],"genre_scores_gemma":[0.99764305,0.000017893826,0.00027496374,0.00033008252,0.00022440756,0.0006166597,0.000042999578,0.000045405835,0.0008045385],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787,0.00034861328,0.00055337953,0.00058554026,0.00021200108,0.00043045904],"domain_scores_gemma":[0.99898213,0.00024763995,0.0000571979,0.00034180147,0.000087561086,0.00028364992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007060936,0.00023896928,0.0005198133,0.00043176292,0.000046611094,0.000022176122,0.00007201115,0.000089040026,0.00025724864],"category_scores_gemma":[0.00041153704,0.00019446854,0.00012177163,0.000587021,0.00006895831,0.000057157307,0.000055861256,0.00038895707,0.0002778549],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014788206,0.0016425515,0.018262202,0.00039046947,0.0002739776,0.8393301,0.006329665,0.000009529879,0.005904092,0.000044989614,0.006194991,0.10682923],"study_design_scores_gemma":[0.018015394,0.011626459,0.047646426,0.0007804646,0.001750437,0.3226967,0.00095639756,0.0018412792,0.0059859897,0.000305993,0.5875757,0.00081880187],"about_ca_topic_score_codex":0.00026496898,"about_ca_topic_score_gemma":0.0002249333,"teacher_disagreement_score":0.58138067,"about_ca_system_score_codex":0.0007001035,"about_ca_system_score_gemma":0.0015460808,"threshold_uncertainty_score":0.79301965},"labels":[],"label_agreement":null},{"id":"W4400691142","doi":"10.5489/cuaj.8817","title":"Radiographic predictors of muscle-invasive upper tract urothelial cancer","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Hydronephrosis; Lymphovascular invasion; Univariate analysis; Odds ratio; Renal pelvis; Confidence interval; Radiology; Ureter; Urology; Logistic regression; Cancer; Multivariate analysis; Internal medicine; Urinary system; Metastasis","score_opus":0.012813982459903877,"score_gpt":0.25251741143703516,"score_spread":0.2397034289771313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400691142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701218,0.005281668,0.00002513552,0.018080672,0.0020265514,0.00032597917,0.0004113471,0.00006179851,0.003665069],"genre_scores_gemma":[0.99473226,0.0013167682,0.00003781629,0.0018176618,0.0013452524,0.000021611648,0.000018570943,0.000022451066,0.00068761845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985221,0.00009898033,0.0003466557,0.00021046882,0.00040434996,0.00041745038],"domain_scores_gemma":[0.99880433,0.00015027043,0.000121393656,0.00009028964,0.00018757393,0.0006461575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030343293,0.00015716738,0.0003052166,0.00037474008,0.00012205517,0.00006337646,0.00009370563,0.0002488995,0.0019002057],"category_scores_gemma":[0.00023005535,0.0001167089,0.00033753508,0.0003942875,0.000048570946,0.00010755471,0.000005940467,0.0005478288,0.000027535336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005002813,0.0000751091,0.97708446,0.000028883673,0.000635988,0.00028795574,0.00035095605,0.000018281518,0.00054903515,0.00012504768,0.0142560955,0.006538144],"study_design_scores_gemma":[0.0009681963,0.0005500189,0.8740379,0.00009902792,0.00045955786,0.00019858973,0.000046062032,0.000040114915,0.00020346441,0.0004604821,0.122810535,0.00012600633],"about_ca_topic_score_codex":0.002584288,"about_ca_topic_score_gemma":0.0007825119,"teacher_disagreement_score":0.10855444,"about_ca_system_score_codex":0.0009059882,"about_ca_system_score_gemma":0.0017843882,"threshold_uncertainty_score":0.9990122},"labels":[],"label_agreement":null},{"id":"W4400782032","doi":"10.1007/s00345-024-05147-2","title":"Adjuvant immune checkpoint inhibitors for urothelial carcinoma: systematic review and Meta-analysis","year":2024,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adjuvant; Urothelial carcinoma; Meta-analysis; Oncology; Nephrology; Internal medicine; Carcinoma; Cancer research; Bladder cancer; Cancer","score_opus":0.06556057877513792,"score_gpt":0.35893120214905727,"score_spread":0.29337062337391934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400782032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.6115575e-7,0.9941218,0.000041151063,0.0019609781,0.00036940307,0.003189431,0.00016764355,0.000013262787,0.00013607937],"genre_scores_gemma":[0.00023764701,0.99449307,0.00015661247,0.00085778325,0.00035476906,0.0004130867,0.000029093491,0.000088958026,0.0033689828],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954387,0.0004198909,0.0030653093,0.00041677966,0.00032778515,0.0003315601],"domain_scores_gemma":[0.9968329,0.0002917674,0.0018760959,0.0005082491,0.00025921315,0.00023173982],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0013544925,0.00064582814,0.015869442,0.0012362526,0.000050126542,0.000029393786,0.00022841501,0.00020284826,0.0002844541],"category_scores_gemma":[0.00018585668,0.00033852065,0.008996286,0.00086143956,0.0000924105,0.00004638746,0.00007496725,0.00074787496,0.000028186678],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004348995,0.00007257072,8.055675e-7,0.73272556,0.2637783,0.00026992775,0.000026703357,1.2135342e-7,3.0633004e-7,0.000035068297,0.0009565142,0.0020906602],"study_design_scores_gemma":[0.0004389855,0.000555594,7.527952e-7,0.01257451,0.7544064,0.0019512571,0.0000028688235,7.513117e-7,5.767735e-7,0.000042171123,0.22986594,0.00016018635],"about_ca_topic_score_codex":0.000014653581,"about_ca_topic_score_gemma":0.000018163773,"teacher_disagreement_score":0.720151,"about_ca_system_score_codex":0.0001495105,"about_ca_system_score_gemma":0.00052392686,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W4400798284","doi":"10.1016/j.clgc.2024.102166","title":"Rates of Systemic Therapy for Metastatic Bladder Cancer Are Lower in Unmarried Males and Females","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Systemic therapy; Bladder cancer; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.14799061125416446,"score_gpt":0.4574729877468923,"score_spread":0.30948237649272786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400798284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85867286,0.13745092,0.000020368841,0.0013647805,0.0010472683,0.0010301425,0.00026365597,0.000036704932,0.00011329625],"genre_scores_gemma":[0.9563523,0.039683305,0.00023254514,0.00058468885,0.0006988935,0.0007979107,0.000012041131,0.000055210803,0.00158313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827576,0.000092770315,0.0006960232,0.0004893067,0.00017093225,0.0002752145],"domain_scores_gemma":[0.9988899,0.000498686,0.000124011,0.0002288217,0.000114101946,0.00014445177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028762157,0.00023997275,0.00072544784,0.00011702783,0.00003532774,0.000021319553,0.00008303786,0.00012055433,0.0002890888],"category_scores_gemma":[0.00005523931,0.00017409891,0.00023729363,0.00021030384,0.00019191079,0.000080073696,0.00003199388,0.00021259226,0.0000054480906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067195334,0.0010982021,0.8749905,0.0036041124,0.0025923094,0.0005902733,0.00067459425,0.000062580075,0.0029866714,0.00006585539,0.0070184744,0.09959686],"study_design_scores_gemma":[0.02021417,0.005518959,0.9218535,0.009376562,0.0019563136,0.00016691128,0.001447145,0.0012062995,0.006704819,0.001015495,0.029599592,0.0009402792],"about_ca_topic_score_codex":0.00017711312,"about_ca_topic_score_gemma":0.00012355468,"teacher_disagreement_score":0.09865657,"about_ca_system_score_codex":0.00008810557,"about_ca_system_score_gemma":0.00050064945,"threshold_uncertainty_score":0.70995474},"labels":[],"label_agreement":null},{"id":"W4400853717","doi":"10.1245/s10434-024-15814-8","title":"Adjuvant Systemic Therapy Improved Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Urothelial carcinoma; Urology; Ureteral neoplasm; Adjuvant; Oncology; Adjuvant therapy; Internal medicine; Carcinoma; Chemotherapy; Cancer; Transitional cell carcinoma; Bladder cancer","score_opus":0.06138071952757434,"score_gpt":0.37235667348348533,"score_spread":0.310975953955911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400853717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566546,0.020765144,0.000113873524,0.014101512,0.0018995423,0.0016674335,0.00030444458,0.000118563585,0.0043748803],"genre_scores_gemma":[0.9918027,0.004180336,0.00014794063,0.0010875554,0.0015156015,0.00039879035,0.00004729591,0.00005806727,0.0007617017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981178,0.00015606165,0.0005419257,0.0004581189,0.00024245147,0.00048365505],"domain_scores_gemma":[0.99872404,0.0005410176,0.000073053096,0.00024551403,0.00016049022,0.0002558984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039847454,0.0002713473,0.000920093,0.00013680861,0.000036622925,0.000018829587,0.00011160672,0.00034089372,0.0006547129],"category_scores_gemma":[0.000015446325,0.0001855942,0.000628834,0.00014829997,0.00019118447,0.00007875015,0.000025809828,0.00026795632,0.00003175068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08181629,0.0049860566,0.033684697,0.0021391357,0.003503487,0.008231957,0.0023906555,0.0000021912483,0.031204425,0.0020398537,0.020778378,0.8092229],"study_design_scores_gemma":[0.008808151,0.008135011,0.00856026,0.00021196382,0.00022780911,0.0011006806,0.000058971735,0.00016121296,0.007367599,0.00020304872,0.9649179,0.00024739935],"about_ca_topic_score_codex":0.00010687755,"about_ca_topic_score_gemma":0.000005016123,"teacher_disagreement_score":0.94413954,"about_ca_system_score_codex":0.0000791139,"about_ca_system_score_gemma":0.0006340315,"threshold_uncertainty_score":0.7568311},"labels":[],"label_agreement":null},{"id":"W4401002134","doi":"10.1016/j.clgc.2024.102176","title":"Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck KGaA","keywords":"Medicine; Cisplatin; Gemcitabine; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Oncology; Regimen; Meta-analysis; Internal medicine; Urothelial cancer; Chemotherapy; Cancer; Bladder cancer","score_opus":0.11901612622383809,"score_gpt":0.4274046873142976,"score_spread":0.30838856109045953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401002134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004712932,0.9882849,0.000006745026,0.00015259277,0.00032048646,0.0101693515,0.00087464525,0.000056378758,0.00008778621],"genre_scores_gemma":[0.00013886362,0.9891528,0.0009295245,0.001290356,0.0004475734,0.004629548,0.00039954632,0.00019158015,0.0028202005],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99263835,0.001195459,0.0031980998,0.0016155856,0.00069092005,0.00066161284],"domain_scores_gemma":[0.9963342,0.0007251327,0.00096430746,0.0012390884,0.00024517483,0.00049210986],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00094539096,0.0012953328,0.015299457,0.00040120303,0.000073031304,0.000089252426,0.0003110834,0.00040428503,0.0004329413],"category_scores_gemma":[0.00019022025,0.0006335199,0.0035848494,0.0030508544,0.0001568344,0.00012687738,0.00019420158,0.0014741848,0.000051877436],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094870065,0.0005696798,0.0006068814,0.8008379,0.15881278,0.0020021286,0.000034115692,0.000007909709,1.3390984e-9,0.0000034244842,0.0011894911,0.034987003],"study_design_scores_gemma":[0.002446915,0.0016144766,0.00036968014,0.17761464,0.78268725,0.00008286338,0.0000036029267,0.0000077419,6.1649432e-9,0.000007683633,0.03461049,0.000554672],"about_ca_topic_score_codex":0.000027948608,"about_ca_topic_score_gemma":0.00010110879,"teacher_disagreement_score":0.6238744,"about_ca_system_score_codex":0.00028512403,"about_ca_system_score_gemma":0.0013204316,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4401153897","doi":"10.1111/his.15287","title":"Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature","year":2024,"lang":"en","type":"review","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; University Health Network","funders":"","keywords":"Urothelial carcinoma; Histology; Medicine; Carcinoma; Pathology; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.03904888561231959,"score_gpt":0.31785114034442463,"score_spread":0.27880225473210507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401153897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08349694,0.91417617,0.000021558837,0.000024897083,0.00027782016,0.0010362503,0.0008921713,0.000009039804,0.000065127504],"genre_scores_gemma":[0.08993317,0.9092691,0.00009530022,0.0001341534,0.000017267766,0.00008289471,0.00041873814,0.00002666088,0.000022694225],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99735314,0.001032242,0.00079587725,0.00051766576,0.00014116622,0.00015994172],"domain_scores_gemma":[0.99835056,0.000156652,0.0007809606,0.00031484285,0.00033602037,0.0000609892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034992667,0.0003411211,0.0019503498,0.00017749473,0.00003260035,0.0000035743826,0.00009627274,0.00036355594,0.000014175539],"category_scores_gemma":[0.00023983372,0.0002291331,0.00027169313,0.00022616671,0.0014424053,0.00003996178,0.00014226168,0.0003583811,8.539317e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057053706,0.00029335247,0.13512948,0.5501349,0.00029838644,0.0008047688,0.0007496874,1.3276164e-7,0.00026760946,0.00011024485,0.00024307937,0.31139782],"study_design_scores_gemma":[0.0033450082,0.003976292,0.7271339,0.18026258,0.016338669,0.009717925,0.000029156716,0.0000115919,0.00013269519,0.0013774806,0.056796066,0.0008786233],"about_ca_topic_score_codex":0.00007179476,"about_ca_topic_score_gemma":0.000043637367,"teacher_disagreement_score":0.5920044,"about_ca_system_score_codex":0.000054193537,"about_ca_system_score_gemma":0.00017462064,"threshold_uncertainty_score":0.9343777},"labels":[],"label_agreement":null},{"id":"W4401332617","doi":"10.1177/15533506241273378","title":"Laparoscopic Versus Open Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Propensity-Score Matched Studies","year":2024,"lang":"en","type":"review","venue":"Surgical Innovation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Meta-analysis; Cochrane Library; Propensity score matching; Confidence interval; Urology; Urothelial carcinoma; Internal medicine; Surgery; Cancer; Bladder cancer","score_opus":0.4007370305242536,"score_gpt":0.4671862041511133,"score_spread":0.0664491736268597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401332617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012433548,0.98679876,0.0000035538262,0.00029838146,0.00017529409,0.011879038,0.0005006434,0.000027167724,0.00019281474],"genre_scores_gemma":[0.00056456844,0.99225384,0.00011217477,0.00022507623,0.00008616674,0.004157617,0.0007979774,0.00006247594,0.0017400768],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969124,0.00024469965,0.0016971171,0.00061371335,0.00032077043,0.00021130171],"domain_scores_gemma":[0.99775374,0.0003606161,0.00074316683,0.0005143559,0.00057443563,0.00005367166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089132105,0.0005358999,0.012334702,0.00054387405,0.000054885288,0.00006815738,0.00019127202,0.00020735004,0.0001224369],"category_scores_gemma":[0.0002483222,0.00028516387,0.0015682958,0.0025726303,0.00007875713,0.00010320458,0.00014593701,0.00025350394,0.000008443825],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010791177,0.000091441485,0.000005087325,0.79556036,0.20258984,0.00002906691,0.00004915109,1.7553884e-8,1.9904907e-7,0.0005102987,0.00036382474,0.0006928315],"study_design_scores_gemma":[0.0012739368,0.00036474894,0.000004253233,0.030843563,0.9289865,0.000040682426,0.000014403503,0.0000010233417,0.0000031866227,0.00002711361,0.0382219,0.0002187289],"about_ca_topic_score_codex":0.00003659238,"about_ca_topic_score_gemma":0.000006565139,"teacher_disagreement_score":0.76471674,"about_ca_system_score_codex":0.00015817348,"about_ca_system_score_gemma":0.00032150056,"threshold_uncertainty_score":0.99996006},"labels":[],"label_agreement":null},{"id":"W4401421211","doi":"10.1245/s10434-024-16018-w","title":"ASO Author Reflections: Survival Benefit of Adjuvant Systemic Therapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Urothelial carcinoma; Urology; Adjuvant; Adjuvant therapy; Oncology; Ureteral neoplasm; Internal medicine; General surgery; Chemotherapy; Cancer; Transitional cell carcinoma","score_opus":0.10706520887595433,"score_gpt":0.42026263143361,"score_spread":0.31319742255765565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401421211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585631,0.019946473,0.000118871125,0.01332759,0.0016508659,0.0013383887,0.0003974433,0.0000832556,0.004574028],"genre_scores_gemma":[0.9931402,0.0037174986,0.00027459973,0.00042525938,0.0009544481,0.00031969883,0.00004103595,0.0000482517,0.0010789995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981118,0.00014360243,0.00066816696,0.00039965275,0.00029733992,0.0003794593],"domain_scores_gemma":[0.9985938,0.0006181791,0.00011040943,0.00024418684,0.00023751942,0.0001958979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004560862,0.00023764133,0.0009641072,0.00020226814,0.000039293947,0.000010978484,0.00010397862,0.00034590653,0.0005610105],"category_scores_gemma":[0.000021908707,0.0001694398,0.0006159934,0.00023180677,0.00020446542,0.00007496434,0.000022743516,0.00024687356,0.000015734842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10813965,0.009750967,0.064743966,0.0042254953,0.006273471,0.0051070726,0.005525626,0.000021157246,0.040825922,0.011937341,0.027833935,0.7156154],"study_design_scores_gemma":[0.00662285,0.01005171,0.01595404,0.0004402845,0.00033405682,0.0010656768,0.00011121218,0.000073003124,0.0132440915,0.0007444112,0.951123,0.00023565305],"about_ca_topic_score_codex":0.00015331872,"about_ca_topic_score_gemma":0.000012585678,"teacher_disagreement_score":0.92328906,"about_ca_system_score_codex":0.00008172509,"about_ca_system_score_gemma":0.0005243152,"threshold_uncertainty_score":0.6909554},"labels":[],"label_agreement":null},{"id":"W4401514694","doi":"10.1200/jco.2024.42.23_suppl.108","title":"Patient-reported outcomes (PROs) from a randomized, phase 3 trial of enfortumab vedotin plus pembrolizumab (EV+P) versus platinum-based chemotherapy (PBC) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Metastatic Urothelial Carcinoma; Randomized controlled trial; Immunotherapy; Urothelial carcinoma; Bladder cancer","score_opus":0.09391004980722414,"score_gpt":0.47658217233799316,"score_spread":0.382672122530769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401514694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846185,0.0016736476,0.0005594056,0.001902887,0.0034530843,0.0031337242,0.000118156444,0.00004408671,0.00065314973],"genre_scores_gemma":[0.9944336,0.0014456848,0.0021379837,0.0008523663,0.0005472594,0.00028796936,0.00002547263,0.00007613538,0.00019353675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99148124,0.0012380658,0.005568841,0.00047522888,0.0008113334,0.00042526913],"domain_scores_gemma":[0.98389465,0.012324096,0.0026303004,0.00034340424,0.00040889616,0.0003986416],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023290785,0.00044724345,0.005143073,0.0003443613,0.000031008236,0.000026484933,0.00020149846,0.0004224664,0.0011681974],"category_scores_gemma":[0.0069281324,0.00026901645,0.0013911105,0.00040076385,0.0003985025,0.00016756986,0.000025523655,0.0010565193,0.000008757247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7670813,0.0039716293,0.0007817007,0.00009622849,0.0038967454,0.0026912282,0.00048438346,0.00019787137,0.00010190684,0.000012785313,0.0001893101,0.22049487],"study_design_scores_gemma":[0.9479489,0.038498204,0.0007232493,0.00074936886,0.0039913286,0.00007300542,0.00010040463,0.0025714242,0.0008144197,0.00017129889,0.0041336245,0.00022480421],"about_ca_topic_score_codex":0.00080411276,"about_ca_topic_score_gemma":0.00050945673,"teacher_disagreement_score":0.22027007,"about_ca_system_score_codex":0.00063889497,"about_ca_system_score_gemma":0.014752995,"threshold_uncertainty_score":0.9999762},"labels":[],"label_agreement":null},{"id":"W4401539212","doi":"10.1016/j.ijrobp.2024.08.007","title":"Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer—Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; NRG Oncology","keywords":"Gemcitabine; Cisplatin; Randomized controlled trial; Medicine; Radiation therapy; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.03744472699372702,"score_gpt":0.37963319898596176,"score_spread":0.34218847199223473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401539212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92261803,0.0024910048,0.058383685,0.0048785596,0.004757128,0.004728547,0.0016238957,0.00010448835,0.00041466803],"genre_scores_gemma":[0.9877583,0.0017428057,0.0021462878,0.00034309842,0.0038900517,0.00035496912,0.0031699387,0.000087589906,0.0005069972],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950784,0.00046769087,0.0027201578,0.00057703455,0.00080044824,0.00035627594],"domain_scores_gemma":[0.99125266,0.0019653775,0.0038193956,0.0003399414,0.0024314492,0.00019117008],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016042615,0.00045723876,0.0016303434,0.00053226046,0.000091761,0.000058931702,0.0003553757,0.00043292376,0.0002028585],"category_scores_gemma":[0.0018085756,0.00033895983,0.00058263534,0.0005382676,0.0003144604,0.0009181232,0.000047421192,0.00047385282,0.000005474924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8291995,0.0014990763,0.003284752,0.00020753038,0.009254897,0.00034717616,0.0030100064,0.0037957006,0.00798695,0.0007194552,0.0046509863,0.13604397],"study_design_scores_gemma":[0.93249965,0.011829721,0.004886712,0.00064088206,0.0041197534,0.0004725384,0.00014874815,0.019762928,0.01844378,0.0012268344,0.005491463,0.00047696684],"about_ca_topic_score_codex":0.00026765146,"about_ca_topic_score_gemma":0.00008581537,"teacher_disagreement_score":0.135567,"about_ca_system_score_codex":0.0015633564,"about_ca_system_score_gemma":0.004878182,"threshold_uncertainty_score":0.99990624},"labels":[],"label_agreement":null},{"id":"W4401627835","doi":"10.5152/tud.2024.23215","title":"Role of Chemoablation Using UGN-101 in Upper Tract Urothelial Carcinoma: A Systematic Review and MetaAnalysis of Available Evidence","year":2024,"lang":"en","type":"review","venue":"Urology Research and Practice","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Internal medicine; Disease; Population; Surgery","score_opus":0.23692220317746862,"score_gpt":0.47621644651068445,"score_spread":0.23929424333321583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401627835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009718881,0.9957553,0.0000019640274,0.00034673265,0.000018273067,0.0025775228,0.000033871744,0.0000056265435,0.0011635222],"genre_scores_gemma":[0.0036212273,0.99534583,0.00016661751,0.000073569885,0.000041182346,0.00018673055,0.000015477553,0.000033599088,0.00051577593],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956447,0.0020807693,0.0009638679,0.0005098978,0.0004846243,0.00031613442],"domain_scores_gemma":[0.9951094,0.0034847083,0.0004471111,0.00046461372,0.00036986725,0.00012433827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048257424,0.00026715983,0.0029016675,0.0006602515,0.000045696997,0.000022541351,0.00012495049,0.0002629554,0.00014513437],"category_scores_gemma":[0.0053130877,0.00018190943,0.00020517217,0.0009889001,0.00022276326,0.00025138626,0.00011572517,0.0008253843,0.000028440576],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002469427,0.0002239388,0.00017248548,0.9936748,0.001219117,0.00009186912,0.00016135577,7.688182e-8,0.00004622978,0.000032636395,0.00008719433,0.00404333],"study_design_scores_gemma":[0.0015477117,0.0037594545,0.00006682768,0.6156058,0.24680191,0.006629577,0.00034461802,0.00026951265,0.000045931807,0.00024827674,0.12411583,0.00056458276],"about_ca_topic_score_codex":0.00088164076,"about_ca_topic_score_gemma":0.000014413585,"teacher_disagreement_score":0.37806904,"about_ca_system_score_codex":0.00009734152,"about_ca_system_score_gemma":0.00093757827,"threshold_uncertainty_score":0.74180514},"labels":[],"label_agreement":null},{"id":"W4401688197","doi":"10.1007/s40615-024-02131-9","title":"Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma Patients","year":2024,"lang":"en","type":"article","venue":"Journal of Racial and Ethnic Health Disparities","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Urothelial carcinoma; Medicine; Oncology; Chemotherapy; Adjuvant chemotherapy; Internal medicine; Ethnic group; Urology; Carcinoma; Adjuvant; Quality of Life Research; Race (biology); Epidemiology; Bladder cancer; Cancer; Pathology; Public health; Biology","score_opus":0.040366777631281624,"score_gpt":0.3556219609240219,"score_spread":0.31525518329274027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401688197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594312,0.0335237,0.000025223062,0.0055118175,0.00087997154,0.00047440067,0.00006202135,0.000018223702,0.000073471725],"genre_scores_gemma":[0.98595923,0.011553002,0.000038774473,0.0015282051,0.0005528979,0.000026806754,0.000004650746,0.000028113189,0.00030830642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979713,0.00021203245,0.00060348184,0.0002851476,0.0004890937,0.00043895637],"domain_scores_gemma":[0.99899405,0.0002381867,0.00015983781,0.00010269647,0.00006536613,0.00043983333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004912093,0.00026725515,0.00090556074,0.00021796492,0.00010959632,0.00008240264,0.000095482224,0.00014705972,0.00012847631],"category_scores_gemma":[0.000071557275,0.00016575238,0.000114794086,0.00019577588,0.00023415138,0.0003001308,0.000079815196,0.00049977715,0.0000017376666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009983662,0.00038396477,0.865643,0.0022371009,0.00013992481,0.00057014613,0.0059787757,3.6144482e-7,0.000038535203,0.00003082476,0.0008860017,0.11410765],"study_design_scores_gemma":[0.006038493,0.0020977843,0.9878677,0.001251534,0.00007675403,0.00019749097,0.00014678804,0.00005378446,0.0000850696,0.00015847382,0.0018612867,0.00016481311],"about_ca_topic_score_codex":0.00076975353,"about_ca_topic_score_gemma":0.001562431,"teacher_disagreement_score":0.12222468,"about_ca_system_score_codex":0.0002522685,"about_ca_system_score_gemma":0.00064145704,"threshold_uncertainty_score":0.67591864},"labels":[],"label_agreement":null},{"id":"W4401792490","doi":"10.1093/oncolo/oyae215","title":"Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma","year":2024,"lang":"en","type":"review","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Foundation Medicine; EMD Serono; Eisai; National Cancer Institute; Aptitude Health; Natera; Seagen; Loxo Oncology; Astellas Pharma; Calithera Biosciences; Mirati Therapeutics; bluebird bio; Sanofi; Exelixis; Genentech; MEI Pharma; Regeneron Pharmaceuticals; Gilead Sciences; Merck KGaA; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Gemcitabine; Pembrolizumab; Avelumab; Carboplatin; Medicine; Chemotherapy; Cisplatin; Oncology; Nivolumab; Metastatic Urothelial Carcinoma; Regimen; Internal medicine; Urothelial carcinoma; Bladder cancer; Cancer; Immunotherapy","score_opus":0.041673547470804276,"score_gpt":0.360458438488445,"score_spread":0.31878489101764074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401792490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002200871,0.9851386,0.0000070700685,0.0003648256,0.00014619682,0.008419878,0.00028284403,0.000032509994,0.0034071892],"genre_scores_gemma":[0.14073104,0.8485085,0.0007415425,0.00051701244,0.0007719092,0.007559012,0.00041080936,0.00023641801,0.0005237584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811846,0.00027586514,0.0005253513,0.0003745018,0.00038936015,0.00031643815],"domain_scores_gemma":[0.9977937,0.001010695,0.00037767921,0.00069075613,0.0000940348,0.00003318698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005214799,0.00045733625,0.0011665042,0.00007730877,0.00015372377,0.000034160847,0.00037371714,0.00014697587,0.000042078966],"category_scores_gemma":[0.00008573876,0.0001494144,0.00041893998,0.00033275137,0.00017412343,0.000023016844,0.000026200805,0.0002936936,0.000008118352],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092160096,0.0006281675,0.0021141572,0.0020615184,0.0004297732,0.000008549466,0.00111426,0.000010583806,0.0000012749593,0.00003715796,0.00023324632,0.9924397],"study_design_scores_gemma":[0.015724111,0.014142,0.0029828409,0.009130603,0.009393337,0.000025773286,0.00085515075,0.0004445481,0.000031412223,0.00019600193,0.9466196,0.00045462136],"about_ca_topic_score_codex":0.00014245936,"about_ca_topic_score_gemma":0.00013850804,"teacher_disagreement_score":0.9919851,"about_ca_system_score_codex":0.00045445075,"about_ca_system_score_gemma":0.0010168551,"threshold_uncertainty_score":0.60929424},"labels":[],"label_agreement":null},{"id":"W4401818806","doi":"10.1016/j.eururo.2024.07.015","title":"Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Urothelial cancer; Pembrolizumab; Chemotherapy; Oncology; Internal medicine; Bladder cancer; Cancer; Urothelial carcinoma; Urology; Immunotherapy","score_opus":0.02997830348744784,"score_gpt":0.3658515437235423,"score_spread":0.33587324023609444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401818806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545556,0.0004762407,0.00002598248,0.0012769201,0.00039615732,0.00080441614,0.00036300722,0.00003455465,0.0011671429],"genre_scores_gemma":[0.99769276,0.00006045721,0.000011001442,0.0012010557,0.0002710106,0.000034445864,0.000010099379,0.000059104073,0.00066008244],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978398,0.00077386195,0.00050923123,0.00039505397,0.00022424258,0.0002577759],"domain_scores_gemma":[0.99894947,0.00021079995,0.0001119708,0.000557228,0.000059285296,0.000111223824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005648284,0.00022049395,0.00062909577,0.00065247173,0.000025272502,0.000008047122,0.00020478685,0.000063893,0.0013107066],"category_scores_gemma":[0.00013891776,0.00014208506,0.00048032735,0.0011413051,0.00010251537,0.000031765303,0.000046076722,0.00025035575,0.000033000935],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8629025,0.0018233004,0.004359054,0.00005564843,0.0038161573,0.0002909337,0.005238472,0.00109756,0.09303042,0.00002491831,0.0014468466,0.025914142],"study_design_scores_gemma":[0.2928749,0.06625577,0.57080835,0.00023693615,0.004731091,0.00003612174,0.00009074153,0.0013590355,0.030003926,0.000039134717,0.032971982,0.0005920134],"about_ca_topic_score_codex":0.00011748196,"about_ca_topic_score_gemma":0.00009236759,"teacher_disagreement_score":0.57002765,"about_ca_system_score_codex":0.0001678488,"about_ca_system_score_gemma":0.00051826256,"threshold_uncertainty_score":0.99960226},"labels":[],"label_agreement":null},{"id":"W4401836302","doi":"10.1016/j.ijrobp.2024.08.036","title":"Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University; University of Calgary; Princess Margaret Cancer Centre; Ottawa Hospital; University of British Columbia; Université de Sherbrooke; Queen's University; McMaster University; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Resection; Radiation therapy; Urology; Cancer; Surgery; Internal medicine","score_opus":0.031871343504352216,"score_gpt":0.3841043752292309,"score_spread":0.3522330317248787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401836302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807808,0.0034857,0.0031129865,0.004938089,0.0058693504,0.0010009697,0.00046784725,0.000050540555,0.00029372683],"genre_scores_gemma":[0.99318576,0.0026147738,0.0002622136,0.0011353487,0.0024003629,0.00018251385,0.00010975554,0.000039704202,0.000069583075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99823666,0.0003148555,0.0006507174,0.0002716728,0.00031851666,0.00020758432],"domain_scores_gemma":[0.99735975,0.0014607474,0.00047699845,0.0001206811,0.0004934913,0.000088333276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006052401,0.00025043968,0.0006383906,0.0002501607,0.00005064241,0.000023456745,0.00017410805,0.00026324703,0.00014755607],"category_scores_gemma":[0.00018113533,0.00017615191,0.000529197,0.00015768287,0.0001284592,0.00019667839,0.000011624568,0.0003617814,0.000010990236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0123663675,0.00065751205,0.2039976,0.00011269668,0.003915573,0.000058162965,0.0011722193,0.000528451,0.011346307,0.0012890794,0.001538642,0.7630174],"study_design_scores_gemma":[0.07605137,0.08984288,0.57960063,0.0010399383,0.0027268128,0.00023776486,0.000119905664,0.0038075848,0.1163015,0.0135911815,0.11576013,0.0009203069],"about_ca_topic_score_codex":0.00004162398,"about_ca_topic_score_gemma":0.000015542772,"teacher_disagreement_score":0.76209706,"about_ca_system_score_codex":0.00088697026,"about_ca_system_score_gemma":0.000639557,"threshold_uncertainty_score":0.7183266},"labels":[],"label_agreement":null},{"id":"W4401837633","doi":"10.1016/j.eururo.2024.08.001","title":"Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Randomized controlled trial; Urology; Cancer; Oncology; Internal medicine","score_opus":0.07455506336566566,"score_gpt":0.36816012635853634,"score_spread":0.2936050629928707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401837633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008149122,0.981159,0.0019484916,0.0031390758,0.0037685041,0.005488011,0.0022880249,0.00019600903,0.0011979975],"genre_scores_gemma":[0.0015648715,0.9856172,0.0016215193,0.0029357255,0.0020998174,0.0035948742,0.000963791,0.00037073044,0.0012314743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963871,0.00036496384,0.0009390553,0.0013507261,0.00025292562,0.00070520566],"domain_scores_gemma":[0.9979531,0.0005750459,0.00048705837,0.00034857393,0.00039011193,0.00024610898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032756812,0.00084086234,0.0014055413,0.0005389823,0.00031220698,0.00010833753,0.0002600949,0.0003098114,0.0003613789],"category_scores_gemma":[0.00014913622,0.0006942083,0.00061754964,0.00030884458,0.00014387784,0.00013662282,0.00018219501,0.00069293845,0.000041670915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005795285,0.00013190677,0.00002406388,0.0013156505,0.0052536293,0.00007515427,0.0012140698,0.000053390704,0.00009259138,0.000055123233,0.022560714,0.9686442],"study_design_scores_gemma":[0.0027603225,0.0024425862,0.00007163073,0.0014139588,0.0045457794,0.00023356588,0.0001374182,0.00027904537,0.000040851726,0.000025464213,0.9874702,0.0005791966],"about_ca_topic_score_codex":0.00023644608,"about_ca_topic_score_gemma":0.00023154843,"teacher_disagreement_score":0.96806496,"about_ca_system_score_codex":0.0008147486,"about_ca_system_score_gemma":0.0010552846,"threshold_uncertainty_score":0.9995509},"labels":[],"label_agreement":null},{"id":"W4401868380","doi":"10.1111/bju.16509","title":"Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Medac; Fidia Farmaceutici; Astellas Pharma; Eisai; Seagen; UroGen Pharma; Progenics Pharmaceuticals; Incyte; University of Texas MD Anderson Cancer Center; Pfizer; Intuitive Surgical; Gilead Sciences; Sanofi; Les Laboratories Pierre Fabre; Bristol-Myers Squibb; AstraZeneca; Veracyte","keywords":"Medicine; Cystectomy; Bladder cancer; Interquartile range; Urology; Immunotherapy; Retrospective cohort study; Cohort; Oncology; Internal medicine; Surgery; Cancer","score_opus":0.023011544791111647,"score_gpt":0.3124748079495783,"score_spread":0.28946326315846665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401868380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95588905,0.03978378,0.0001439309,0.0023790256,0.00091167446,0.00036802073,0.00004494301,0.00002068134,0.0004589026],"genre_scores_gemma":[0.9853798,0.012155688,0.00010328025,0.0015462051,0.00042443394,0.000028753966,0.00000482337,0.000053704138,0.00030330848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978728,0.00018178727,0.00080961076,0.00031181428,0.00039990293,0.00042407424],"domain_scores_gemma":[0.99878025,0.0003752677,0.00023515172,0.00017618391,0.00022615276,0.00020702103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033918227,0.00023959861,0.00095003285,0.00042585432,0.000043427302,0.000039552997,0.00020458152,0.00023176552,0.0009640707],"category_scores_gemma":[0.00016159142,0.00021721117,0.00034910007,0.00029227207,0.00024286525,0.00015997379,0.000047178328,0.0007355375,0.000013391575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061176694,0.0013116525,0.6635551,0.00036055784,0.0054953163,0.0555533,0.0026214595,0.00013721386,0.012167911,0.000036260277,0.0052874275,0.24735618],"study_design_scores_gemma":[0.008173687,0.0021842036,0.97505105,0.0006488384,0.00041501984,0.009325292,0.00007082263,0.00002579672,0.0020889416,0.00013779517,0.0016968986,0.00018167835],"about_ca_topic_score_codex":0.0006373538,"about_ca_topic_score_gemma":0.0006477251,"teacher_disagreement_score":0.31149596,"about_ca_system_score_codex":0.00014555814,"about_ca_system_score_gemma":0.00093184796,"threshold_uncertainty_score":0.99994916},"labels":[],"label_agreement":null},{"id":"W4401975188","doi":"10.3390/curroncol31080352","title":"Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Meta-analysis; Internal medicine; Immunotherapy; Clinical trial; Oncology; Chemotherapy; Population; Cancer","score_opus":0.43338570285426914,"score_gpt":0.506577732026333,"score_spread":0.07319202917206391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401975188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.9190685e-7,0.9849818,0.000029583227,0.0011296043,0.0005172273,0.007213416,0.006017819,0.0000489669,0.00006093787],"genre_scores_gemma":[0.00002916908,0.98860675,0.000051712832,0.0006147918,0.00007672952,0.006562359,0.0038842587,0.00007324646,0.00010096184],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955968,0.000785094,0.0018155699,0.0010003935,0.0004462486,0.00035584494],"domain_scores_gemma":[0.99713886,0.00038452778,0.0007337631,0.0014675134,0.00011799178,0.00015732594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007639165,0.00070998515,0.010167733,0.0008360717,0.0000701722,0.000043377564,0.0005185324,0.00028326674,0.0005444753],"category_scores_gemma":[0.00013910272,0.00043922392,0.0016097089,0.001472027,0.00010842482,0.000058975096,0.0002673902,0.00073932274,0.000056115234],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011995576,0.0011033302,0.000008442303,0.75173324,0.1310939,0.00005079319,0.00010528042,6.6877055e-7,4.1130255e-9,0.000020327303,0.0015935131,0.11427851],"study_design_scores_gemma":[0.00071241456,0.00028288885,0.000001027225,0.056236543,0.5506102,0.000024431283,0.000004291448,0.00002721317,2.3325786e-8,0.000009627825,0.39190134,0.00019001689],"about_ca_topic_score_codex":0.00015961823,"about_ca_topic_score_gemma":0.00058290316,"teacher_disagreement_score":0.6954967,"about_ca_system_score_codex":0.0006101458,"about_ca_system_score_gemma":0.0016258073,"threshold_uncertainty_score":0.9998059},"labels":[],"label_agreement":null},{"id":"W4401992127","doi":"10.32948/auo.2024.08.25","title":"Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"annals of urologic oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Bladder cancer; Medicine; Cancer; Urology; Internal medicine","score_opus":0.107690695551462,"score_gpt":0.42595397920090244,"score_spread":0.31826328364944045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401992127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9234666,0.014718861,0.00028247494,0.03696225,0.0010331105,0.0019893465,0.0004338597,0.00014161297,0.02097187],"genre_scores_gemma":[0.9887522,0.0041493354,0.00039211477,0.003889299,0.00035497802,0.0007706841,0.000039642626,0.000028648454,0.0016230852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998735,0.000069282614,0.00029741754,0.00040067654,0.0001184324,0.00037915277],"domain_scores_gemma":[0.99875414,0.00060060783,0.0000848992,0.00021814581,0.0002225361,0.000119646036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001197386,0.00023102881,0.0005690864,0.00015074342,0.00005524366,0.000016972259,0.000086302534,0.00023258598,0.0004532925],"category_scores_gemma":[0.00006402288,0.00015855928,0.00026260654,0.00016413577,0.00018088815,0.000090171685,0.00002646584,0.00010832356,0.00004026356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018199034,0.0053269477,0.0073269224,0.0013067056,0.011450539,0.0035688756,0.015052057,0.0005297854,0.07961561,0.014309011,0.11900988,0.7243046],"study_design_scores_gemma":[0.0068132314,0.080126435,0.017688923,0.00015678913,0.0018206896,0.00018545054,0.002756163,0.00031527647,0.05423918,0.01992822,0.81550884,0.0004607736],"about_ca_topic_score_codex":0.00041848872,"about_ca_topic_score_gemma":0.00023529153,"teacher_disagreement_score":0.7238439,"about_ca_system_score_codex":0.00011533381,"about_ca_system_score_gemma":0.0022489068,"threshold_uncertainty_score":0.646586},"labels":[],"label_agreement":null},{"id":"W4402023125","doi":"10.1016/j.eururo.2024.08.013","title":"The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non–muscle-invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Sahlgrenska Akademin; Universitat Autònoma de Barcelona; Skånes universitetssjukhus; Medizinische Universität Graz; Karl-Franzens-Universität Graz; Sahlgrenska Universitetssjukhuset; Universität Regensburg; Umeå Universitet; Linköpings Universitet; King's College London; Lunds Universitet; Sorbonne Université; Radboud Universitair Medisch Centrum; University of Glasgow; European Association of Urology; Bladder Cancer Canada; Radboud Universiteit; Göteborgs Universitet; Univerzita Karlova v Praze; Amsterdam University Medical Centers; Karolinska Institutet; Swedish Council of America; Uppsala Universitet; Cancerfonden; Faculty of Medicine and Health, University of Sydney; Scottish Government; Swedish Movement Disorder Society; Vetenskapsrådet","keywords":"Medicine; Bladder cancer; Cohort; Proportional hazards model; Hazard ratio; Internal medicine; Grading (engineering); Cumulative incidence; Cystectomy; Urology; Oncology; Cancer; Confidence interval","score_opus":0.030796902561310412,"score_gpt":0.2912844273959489,"score_spread":0.2604875248346385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402023125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454654,0.01099807,0.012233846,0.011416141,0.0022784267,0.006142123,0.00043924002,0.00024246592,0.010784304],"genre_scores_gemma":[0.9973663,0.00018282175,0.00019124222,0.0006206081,0.00046801244,0.0006149033,0.00006745159,0.00008542557,0.00040322624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985209,0.00013036841,0.00044624147,0.00042664554,0.00013085332,0.00034500376],"domain_scores_gemma":[0.998994,0.00041082207,0.00012773786,0.00032639026,0.0000776953,0.00006334654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005224217,0.00018437413,0.00032143816,0.000103138016,0.00009299341,0.000019105883,0.00015253475,0.00004675457,0.000007016496],"category_scores_gemma":[0.000063007654,0.0001307557,0.00015907406,0.00014733766,0.00011232978,0.000051231968,0.00003413141,0.00016263536,0.000008796075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008269809,0.0020214603,0.34392697,0.017598752,0.007276146,0.0019145843,0.013142363,0.0003575867,0.17352812,0.045563895,0.058909234,0.32749107],"study_design_scores_gemma":[0.01343859,0.003954889,0.8634254,0.0010169919,0.0021954891,0.00028996615,0.0008613497,0.009822797,0.007902703,0.0028238574,0.09352123,0.00074675615],"about_ca_topic_score_codex":0.000030748004,"about_ca_topic_score_gemma":0.00020494018,"teacher_disagreement_score":0.5194984,"about_ca_system_score_codex":0.00017521618,"about_ca_system_score_gemma":0.00025933608,"threshold_uncertainty_score":0.5332062},"labels":[],"label_agreement":null},{"id":"W4402087631","doi":"10.1016/j.euo.2024.08.001","title":"Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)","year":2024,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; European Association of Urology","keywords":"Medicine; Bladder cancer; Urology; Cancer; Oncology; Internal medicine","score_opus":0.06929239183369176,"score_gpt":0.4047866575280217,"score_spread":0.33549426569432994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402087631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070613864,0.978792,0.000039949147,0.007439524,0.0013186595,0.0045893085,0.0014390291,0.000069907874,0.0063045425],"genre_scores_gemma":[0.00007466937,0.985429,0.00011662386,0.005549657,0.00088939106,0.002382215,0.0015044898,0.0001731107,0.0038808507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964157,0.0009000368,0.0011872911,0.0008819679,0.00020593517,0.00040910108],"domain_scores_gemma":[0.9976009,0.00046449137,0.00079699815,0.0006171568,0.00038795418,0.00013248112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005266741,0.00066537777,0.0024073154,0.00018493828,0.00008692465,0.000016858688,0.0004610598,0.0002703519,0.00039698565],"category_scores_gemma":[0.00016421579,0.00038006445,0.0007552306,0.0003923,0.00041820234,0.000036992406,0.00011973227,0.0004689228,0.00024452206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027141528,0.00075682456,0.000004965442,0.007641717,0.007044032,0.00013680877,0.0003628787,4.1958162e-7,0.000029420287,0.0002610672,0.29694083,0.6865496],"study_design_scores_gemma":[0.0016978423,0.003663119,0.000006639394,0.0051616756,0.016051827,0.00042267103,0.000041084233,0.000008116121,0.000007924237,0.00002430606,0.9726741,0.00024071746],"about_ca_topic_score_codex":0.000060152863,"about_ca_topic_score_gemma":0.000053504198,"teacher_disagreement_score":0.6863089,"about_ca_system_score_codex":0.00092742615,"about_ca_system_score_gemma":0.001634003,"threshold_uncertainty_score":0.9998651},"labels":[],"label_agreement":null},{"id":"W4402093057","doi":"10.5489/cuaj.8815","title":"Images in urology – Novel reconstruction using a cutaneous transureterostomy diversion during robot-assisted radical cystectomy in a patient with crossed fused renal ectopia","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Cystectomy; Urology; Medicine; Urinary diversion; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.011949060107874488,"score_gpt":0.22707722912802844,"score_spread":0.21512816902015394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402093057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571437,0.00023918539,0.00021602986,0.0029513314,0.00032717717,0.00030974875,0.000039645915,0.00003286841,0.0001696433],"genre_scores_gemma":[0.9988528,0.000024063376,0.00050616305,0.00040287816,0.00013282683,0.000011216047,0.0000112619555,0.000018094637,0.000040727627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829865,0.00015725422,0.00040376405,0.00032140434,0.00030069522,0.00051825424],"domain_scores_gemma":[0.9992747,0.000083835635,0.00011535845,0.00007390509,0.0000829156,0.0003693225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020154082,0.00018454394,0.00034370832,0.0005103613,0.00016546516,0.000101602185,0.00006115294,0.0002964643,0.00020257723],"category_scores_gemma":[0.00009030656,0.00014471881,0.00010390935,0.00045312705,0.00006265926,0.00013552647,0.000008073673,0.0008206598,0.0000049622085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002238553,0.00022110296,0.9252039,0.00005040652,0.0002886905,0.017080853,0.0009668745,0.0018199772,0.040741503,0.000008615907,0.00007131196,0.011308222],"study_design_scores_gemma":[0.009456269,0.0015192452,0.94687885,0.0002900461,0.00022170856,0.03677567,0.00012238666,0.0025101902,0.0006222789,0.000062460276,0.0012304566,0.00031041133],"about_ca_topic_score_codex":0.0026386003,"about_ca_topic_score_gemma":0.0031452833,"teacher_disagreement_score":0.040119223,"about_ca_system_score_codex":0.0027574154,"about_ca_system_score_gemma":0.00073272985,"threshold_uncertainty_score":0.7210545},"labels":[],"label_agreement":null},{"id":"W4402164056","doi":"10.1101/2024.09.02.610816","title":"HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Immunotherapy; CD8; Immunology; Cancer research; Immune system; Medicine; PD-L1; Cytotoxic T cell; Cancer; Biology; Internal medicine","score_opus":0.012349966585222787,"score_gpt":0.2590506906706833,"score_spread":0.24670072408546054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402164056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96733576,0.024628583,0.00004471696,0.003024348,0.0017502347,0.0021720263,0.0006433943,0.0002646344,0.0001363274],"genre_scores_gemma":[0.98600036,0.0075801956,0.0019489647,0.001813074,0.000812587,0.0014269567,6.3517456e-7,0.00027149153,0.00014576226],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966328,0.000075255404,0.00062583014,0.001446641,0.0005067275,0.00071274914],"domain_scores_gemma":[0.9978278,0.000078756806,0.00018346113,0.0011435944,0.00030495596,0.00046140267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033486093,0.0007609712,0.0010028268,0.00052436854,0.00008687815,0.00015823665,0.0002969603,0.00053246587,0.00014821583],"category_scores_gemma":[0.000093657625,0.0007285142,0.00017034038,0.0007260853,0.00012102714,0.000077449135,0.00041458078,0.0010342282,0.000113715934],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011552533,0.0005730328,0.036238305,0.0043000267,0.002222871,0.001770624,0.0006965985,0.00004906424,0.9461824,0.00018460704,0.006445983,0.00018120722],"study_design_scores_gemma":[0.0045910613,0.0003121842,0.73801196,0.008451949,0.00078346615,9.0429516e-8,0.000027337695,0.000052941123,0.22120723,0.000034418183,0.024854414,0.0016729438],"about_ca_topic_score_codex":0.0005931755,"about_ca_topic_score_gemma":0.00027477613,"teacher_disagreement_score":0.72497517,"about_ca_system_score_codex":0.00077292306,"about_ca_system_score_gemma":0.0015778797,"threshold_uncertainty_score":0.9995166},"labels":[],"label_agreement":null},{"id":"W4402183327","doi":"10.1200/jco.23.02510","title":"Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; NRG Oncology","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Radiation therapy; Metastasis; Neutropenia; Surgery; Incidence (geometry); Oncology; Internal medicine; Chemotherapy; Cancer","score_opus":0.24440074460822267,"score_gpt":0.5543201257197373,"score_spread":0.3099193811115146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402183327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69925135,0.0034600291,0.0015917306,0.16566214,0.015083055,0.09712221,0.0043411893,0.00033715361,0.013151129],"genre_scores_gemma":[0.9348406,0.0016364374,0.009974559,0.004723202,0.01740156,0.02633994,0.00016615381,0.00015661943,0.0047609312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930154,0.0007201131,0.004263371,0.00078642083,0.0005917938,0.0006229159],"domain_scores_gemma":[0.99115527,0.005163011,0.0017076273,0.0005665916,0.0005615023,0.0008459789],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026877155,0.0004765228,0.0028903019,0.00021044422,0.00019541966,0.000045341985,0.00037663683,0.00097079185,0.00092636206],"category_scores_gemma":[0.0020403082,0.00031111043,0.0013299969,0.00026717145,0.0002948032,0.0002588597,0.00012688151,0.0012053405,0.000029422637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09256429,0.02271246,0.0012379427,0.00013567731,0.008508727,0.002428251,0.0011319608,0.000031149466,0.0011628382,0.00023472458,0.089590825,0.78026116],"study_design_scores_gemma":[0.12560831,0.10949359,0.004343527,0.00039689877,0.003657428,0.00013141338,0.00015619698,0.0005171287,0.002498477,0.004370332,0.7485486,0.0002780682],"about_ca_topic_score_codex":0.001995207,"about_ca_topic_score_gemma":0.0007500482,"teacher_disagreement_score":0.7799831,"about_ca_system_score_codex":0.0016665688,"about_ca_system_score_gemma":0.01019864,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W4402317647","doi":"10.5489/cuaj.8975","title":"NS-AUA 2024 Annual Meeting Abstracts – Oncology – Bladder, Renal, Testes","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Urology; Medicine; Internal medicine; Medical physics; Oncology","score_opus":0.01709935671549198,"score_gpt":0.2795711502492932,"score_spread":0.26247179353380123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402317647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52135605,0.0120020965,0.00003335471,0.23101617,0.005788024,0.00073468854,0.00054434856,0.0003209267,0.22820435],"genre_scores_gemma":[0.98190117,0.00031501203,0.0004027721,0.0066779936,0.002182221,0.00001508038,0.000029876343,0.00002844774,0.008447452],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810416,0.0001348567,0.00044637045,0.00028686313,0.00038931725,0.0006384231],"domain_scores_gemma":[0.99809575,0.0004196341,0.0001483757,0.00012714358,0.00024744836,0.0009616645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000759693,0.00018879295,0.00032426216,0.00025945978,0.00026035568,0.00017166902,0.00014173466,0.00039073653,0.0018943169],"category_scores_gemma":[0.0013664521,0.00014534971,0.0001922138,0.00030156196,0.000039516493,0.00015205824,0.000021459642,0.0010002569,0.0004403917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015632513,0.00022265204,0.18260452,0.000035534053,0.0015034787,0.0061309594,0.0010653331,0.00013897044,0.0008812,0.00022447185,0.7514236,0.055612933],"study_design_scores_gemma":[0.0009286547,0.0010334287,0.17796302,0.00007374149,0.0003446912,0.0012951702,0.00021163019,0.00007327912,0.00008821822,0.0019272811,0.8158754,0.00018547701],"about_ca_topic_score_codex":0.0020001642,"about_ca_topic_score_gemma":0.0017592736,"teacher_disagreement_score":0.46054512,"about_ca_system_score_codex":0.0021494748,"about_ca_system_score_gemma":0.0020558436,"threshold_uncertainty_score":0.9990181},"labels":[],"label_agreement":null},{"id":"W4402327929","doi":"10.1016/j.clgc.2024.102215","title":"Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE Study","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Tremelimumab; Metastatic Urothelial Carcinoma; Bone metastasis; Oncology; Urothelial carcinoma; Metastasis; Internal medicine; Carcinoma; Cancer; Immunotherapy; Bladder cancer","score_opus":0.061469192054745055,"score_gpt":0.3951481070672198,"score_spread":0.33367891501247476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402327929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382186,0.0009006052,0.0000073082833,0.00012772436,0.000071887625,0.0046302443,0.00020074999,0.000048121172,0.00019150818],"genre_scores_gemma":[0.99821234,0.000065574364,0.00023483824,0.00009871769,0.00014212266,0.0008772341,0.00004205417,0.00010432427,0.00022282441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963337,0.0005684915,0.0009529148,0.0007913599,0.0008366802,0.00051685027],"domain_scores_gemma":[0.99832606,0.00044850202,0.00019298629,0.0006499128,0.00019300531,0.00018951239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005504794,0.0005196158,0.0013127263,0.0003182152,0.000055515422,0.00004411376,0.00019824615,0.00007728739,0.00019234311],"category_scores_gemma":[0.000063264284,0.00021859763,0.00020427028,0.001354819,0.0002839949,0.0001725388,0.00004086055,0.0005846873,0.000007450103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04873643,0.006994253,0.9313157,0.00020202497,0.0016143583,0.00271001,0.0013281077,0.000089899746,0.00000486893,5.5795033e-7,0.000068756206,0.0069350046],"study_design_scores_gemma":[0.029537229,0.056897268,0.90875715,0.00068827445,0.002741625,0.0000842496,0.0008190559,0.00013666644,0.000022966564,0.0000034643583,0.00003373174,0.00027832369],"about_ca_topic_score_codex":0.0031805634,"about_ca_topic_score_gemma":0.002604367,"teacher_disagreement_score":0.049903013,"about_ca_system_score_codex":0.0003232578,"about_ca_system_score_gemma":0.0016734762,"threshold_uncertainty_score":0.8914153},"labels":[],"label_agreement":null},{"id":"W4402476564","doi":"10.1089/end.2024.0335","title":"Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Journal of Endourology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Urothelial carcinoma; Grading (engineering); Carcinoma; Upper urinary tract; Clinical significance; Ureteroscopy; Ureteral neoplasm; Urology; Radiology; Internal medicine; Ureter; Transitional cell carcinoma; Bladder cancer; Urinary system; Cancer","score_opus":0.040633935818061725,"score_gpt":0.3615031563020292,"score_spread":0.3208692204839675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402476564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936384,0.002286389,0.0011445218,0.0009862996,0.0013463055,0.00041083692,0.000017416338,0.000008794674,0.0001610679],"genre_scores_gemma":[0.99748397,0.000041571926,0.0010091759,0.00052131497,0.0008307591,0.000021289203,0.0000025650859,0.000024893645,0.00006444364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851567,0.0000996589,0.00084115873,0.00017999261,0.0001561292,0.00020737817],"domain_scores_gemma":[0.9990249,0.00037802383,0.00024482468,0.000117191536,0.00013858844,0.00009643242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005303,0.00012154569,0.00054647966,0.00024784092,0.000016179247,0.000008915506,0.00009385846,0.00007222038,0.000057347937],"category_scores_gemma":[0.00023278923,0.000092875736,0.0002369772,0.00015017686,0.000081668724,0.00008499501,0.000008746128,0.0003491481,0.0000035486264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004800552,0.0009204418,0.9489426,0.0007250017,0.00031861634,0.0014541422,0.0006009328,0.00005828602,0.031383827,0.00055982487,0.0014199419,0.008815828],"study_design_scores_gemma":[0.018297933,0.020107513,0.9097393,0.00081482576,0.0010605016,0.004033863,0.00017655137,0.0016298612,0.028846525,0.0023947607,0.0126180975,0.00028024905],"about_ca_topic_score_codex":0.000026944455,"about_ca_topic_score_gemma":0.000007829382,"teacher_disagreement_score":0.039203286,"about_ca_system_score_codex":0.00007795802,"about_ca_system_score_gemma":0.00054690806,"threshold_uncertainty_score":0.37873626},"labels":[],"label_agreement":null},{"id":"W4402558709","doi":"10.1016/j.annonc.2024.08.2094","title":"2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial carcinoma; Oncology; Multicenter study; Carcinoma; Internal medicine; Cancer; Bladder cancer; Immunotherapy","score_opus":0.05517249742119814,"score_gpt":0.3924936933833818,"score_spread":0.3373211959621837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402558709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651015,0.001225923,0.0001699228,0.0008726824,0.00014927943,0.00036668553,0.00021018817,0.000015762682,0.00047941876],"genre_scores_gemma":[0.9988462,0.0001564135,0.00064185396,0.00013843246,0.000044947235,0.000046505666,0.000010925078,0.0000187386,0.000096005984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986195,0.00031790332,0.0004327823,0.00029333492,0.0001426173,0.00019383803],"domain_scores_gemma":[0.99910814,0.00038379346,0.0001016889,0.00019098521,0.00014409424,0.00007131979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062798976,0.00013569053,0.00045962166,0.00017961132,0.000016409653,0.000007712268,0.00003977874,0.00012554754,0.0001078899],"category_scores_gemma":[0.00024148262,0.00011528024,0.000091586895,0.00013492529,0.00012220035,0.00015647255,0.0000360074,0.00018089234,0.000002275555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17394151,0.0037198642,0.60467356,0.0019777757,0.0005244526,0.0006601981,0.013896058,0.0009753266,0.09982073,0.00007515513,0.00018827607,0.09954709],"study_design_scores_gemma":[0.011885449,0.0033643718,0.91725224,0.00027272178,0.00023949043,0.000040564384,0.00029866557,0.011155634,0.053927526,0.000821596,0.00055966043,0.0001820895],"about_ca_topic_score_codex":0.00019620934,"about_ca_topic_score_gemma":0.0001853098,"teacher_disagreement_score":0.31257865,"about_ca_system_score_codex":0.00007573725,"about_ca_system_score_gemma":0.00049919897,"threshold_uncertainty_score":0.47009918},"labels":[],"label_agreement":null},{"id":"W4402565813","doi":"10.1016/j.annonc.2024.08.2052","title":"1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Metastatic Urothelial Carcinoma; Oncology; Internal medicine; Cohort; Urothelial carcinoma; Expanded access; Safety profile; Adverse effect; Immunotherapy; Cancer; Bladder cancer","score_opus":0.03841236257424397,"score_gpt":0.3611249404934512,"score_spread":0.3227125779192072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402565813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98392123,0.007100493,0.00013770832,0.0014042066,0.00011196455,0.0018349679,0.00014664562,0.000042766394,0.0052999924],"genre_scores_gemma":[0.99604756,0.0018560458,0.00095629116,0.0001638564,0.00005951313,0.00025388814,0.000035223544,0.000054926506,0.0005727087],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979323,0.0002566607,0.00063009973,0.0005259758,0.0002711208,0.00038379882],"domain_scores_gemma":[0.99847114,0.00071305106,0.00017893895,0.00032640982,0.00013488418,0.0001755671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024684554,0.0003461847,0.0011519452,0.00022794634,0.000040773466,0.000011359096,0.000099132914,0.00013591765,0.00018812313],"category_scores_gemma":[0.00009196598,0.00022542084,0.0001242455,0.00025759923,0.00037873525,0.00010550362,0.000054325606,0.00018297973,0.0000073293386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17505446,0.0094650015,0.08870501,0.002035249,0.0040605213,0.007980058,0.008706572,0.00037579375,0.0038811797,0.0007915022,0.0010744998,0.69787014],"study_design_scores_gemma":[0.07201074,0.17466988,0.6769867,0.0040020673,0.0039599165,0.0022620203,0.0013698718,0.0007345974,0.03505437,0.00028884134,0.027814396,0.0008466419],"about_ca_topic_score_codex":0.00059651537,"about_ca_topic_score_gemma":0.00015178038,"teacher_disagreement_score":0.6970235,"about_ca_system_score_codex":0.00016948486,"about_ca_system_score_gemma":0.0014052775,"threshold_uncertainty_score":0.9192395},"labels":[],"label_agreement":null},{"id":"W4402565894","doi":"10.1016/j.annonc.2024.08.2067","title":"1982P Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Janssen Research and Development","keywords":"Atezolizumab; Medicine; Oncology; Post-hoc analysis; Cisplatin; Internal medicine; Post hoc; Platinum; Chemotherapy; Cancer; Immunotherapy; Nivolumab","score_opus":0.08971721828821749,"score_gpt":0.43127055176608836,"score_spread":0.34155333347787087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402565894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905212,0.00052165793,0.000008572849,0.007687363,0.00009968755,0.0008472281,0.000124915,0.0000063142347,0.00018305362],"genre_scores_gemma":[0.9988613,0.00008089999,0.00009009348,0.000736128,0.000028551487,0.00007532375,0.000015041708,0.000012572673,0.00010009759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989055,0.000109819164,0.00043036183,0.00021662994,0.00020135919,0.00013636965],"domain_scores_gemma":[0.9988249,0.0007046371,0.000117285555,0.00018695225,0.00012629104,0.000039939918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058224925,0.00011832565,0.0005904225,0.0005301443,0.000019405546,0.000006352702,0.00013622954,0.00004291983,0.000044417902],"category_scores_gemma":[0.00010800322,0.0000795653,0.00017254344,0.0003573146,0.000038895138,0.000043289238,0.00003612438,0.00007477292,5.6254873e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03322376,0.0060537537,0.837549,0.00015865939,0.0049552447,0.00043084836,0.022832979,0.000051849613,0.005497649,0.000052389747,0.0005361582,0.08865772],"study_design_scores_gemma":[0.003930685,0.022573618,0.9643564,0.0000406277,0.00065693085,0.00003932891,0.0052610226,0.00013498831,0.0013666637,0.00002935732,0.0015462486,0.00006413311],"about_ca_topic_score_codex":0.0006473808,"about_ca_topic_score_gemma":0.00019983744,"teacher_disagreement_score":0.1268074,"about_ca_system_score_codex":0.000060714014,"about_ca_system_score_gemma":0.00018526833,"threshold_uncertainty_score":0.3244579},"labels":[],"label_agreement":null},{"id":"W4402620682","doi":"10.1016/j.urolonc.2024.08.003","title":"Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials","year":2024,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Juravinski Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Meta-analysis; Internal medicine; Randomized controlled trial; Oncology; Systematic review; Cochrane Library; Placebo; Adverse effect; MEDLINE; Lymph node; Guideline; Pathology","score_opus":0.169781366701937,"score_gpt":0.45434342431627,"score_spread":0.284562057614333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402620682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037143132,0.98876464,0.0000123654045,0.0010898077,0.00015111546,0.008665578,0.0008090737,0.000030087018,0.000105887586],"genre_scores_gemma":[0.00018830391,0.99189687,0.002168297,0.0015228811,0.00006880873,0.0034779075,0.0002256635,0.000042038955,0.00040922753],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98323673,0.010700413,0.004638447,0.0008660259,0.0002605996,0.00029776365],"domain_scores_gemma":[0.98608154,0.01037797,0.0025664645,0.0005953274,0.0001174752,0.0002612246],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.013240764,0.00070282177,0.031121006,0.00087442284,0.000082749975,0.00002730133,0.00018675101,0.00072188524,0.0002238305],"category_scores_gemma":[0.0058420147,0.00037260674,0.004414793,0.0011579483,0.0011056942,0.00005442406,0.00008099012,0.00095321937,0.000014396619],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015728177,0.0006368821,0.0006614631,0.5440244,0.4409577,0.00043799324,0.00042451412,0.0000014619758,3.9680015e-7,0.0019091171,0.00086700375,0.008506272],"study_design_scores_gemma":[0.0108382655,0.0009785872,0.0000102631875,0.010158643,0.9042106,0.00011825037,0.000023799279,0.00001589304,2.2324141e-7,0.00091635424,0.0724877,0.0002413889],"about_ca_topic_score_codex":0.0005350793,"about_ca_topic_score_gemma":0.00012459542,"teacher_disagreement_score":0.53386575,"about_ca_system_score_codex":0.00014009397,"about_ca_system_score_gemma":0.0014386955,"threshold_uncertainty_score":0.99987257},"labels":[],"label_agreement":null},{"id":"W4402640769","doi":"10.1007/s00345-024-05196-7","title":"Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review","year":2024,"lang":"en","type":"review","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Nephrology; Carcinoma in situ; Cancer; Urology; Internal medicine; Prospective cohort study; Oncology; Surgery","score_opus":0.05184877624788207,"score_gpt":0.37739804441091246,"score_spread":0.32554926816303037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402640769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019970985,0.99140036,0.000023477922,0.0010950384,0.0020112016,0.0048103523,0.00023932004,0.000025336287,0.0003929116],"genre_scores_gemma":[0.00014208324,0.98917896,0.000077898396,0.0010772254,0.0011809246,0.0027259018,0.00003429208,0.0001353758,0.005447319],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963955,0.00032341704,0.0020196906,0.0004466092,0.0003391065,0.00047564125],"domain_scores_gemma":[0.9972499,0.0004483408,0.0012732944,0.00046379157,0.00030238216,0.00026230997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036055714,0.0007899506,0.0068481294,0.00065053056,0.00004861322,0.000050587838,0.00024025924,0.0002562657,0.00035277137],"category_scores_gemma":[0.000104011095,0.00043559025,0.0030286114,0.00041816322,0.00008077869,0.00009058105,0.000034649664,0.0005335051,0.00006908812],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035039912,0.00018549213,0.0000013408726,0.86695755,0.010432224,0.0011995634,0.0001270394,2.700237e-7,2.6292733e-7,0.000068181325,0.006280863,0.114396796],"study_design_scores_gemma":[0.0017512441,0.002058675,9.182631e-7,0.32780296,0.116625935,0.0013824365,0.000019888814,3.349334e-7,2.42037e-7,0.00010936029,0.55004746,0.00020053408],"about_ca_topic_score_codex":0.000029631037,"about_ca_topic_score_gemma":0.00029590813,"teacher_disagreement_score":0.5437666,"about_ca_system_score_codex":0.00070635346,"about_ca_system_score_gemma":0.0040211133,"threshold_uncertainty_score":0.99980956},"labels":[],"label_agreement":null},{"id":"W4402667368","doi":"10.1016/j.clgc.2024.102214","title":"Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Associazione Italiana per la Ricerca sul Cancro; Deutsche Forschungsgemeinschaft; Merck","keywords":"Medicine; Cystectomy; Pembrolizumab; Oncology; Internal medicine; Neoadjuvant therapy; Bladder cancer; Cancer; Immunotherapy","score_opus":0.03257032447753763,"score_gpt":0.3766893100353639,"score_spread":0.3441189855578263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402667368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936224,0.0067393095,0.000014613556,0.000785674,0.0010927317,0.0015571499,0.00014332737,0.00006138728,0.00024354232],"genre_scores_gemma":[0.995718,0.0008291,0.00002432818,0.0007655492,0.001164436,0.0007834447,0.00003243538,0.00005654634,0.0006261643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971443,0.0004038101,0.0007592784,0.0007919603,0.000512741,0.00038795045],"domain_scores_gemma":[0.9988406,0.0002568524,0.00007325717,0.0005331056,0.000050535065,0.00024566436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040342344,0.00032131633,0.0005753881,0.00010562729,0.00009646162,0.000090857684,0.00019977185,0.00018756474,0.0003851249],"category_scores_gemma":[0.00006787824,0.00019494498,0.00020724154,0.00022277203,0.00014735309,0.00013900174,0.00019367643,0.0007757815,0.000040441406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020281416,0.0018986509,0.97620904,0.00017402475,0.00017371462,0.0027230193,0.0011592295,5.633518e-7,0.000035631463,6.4005116e-7,0.0023840128,0.013213302],"study_design_scores_gemma":[0.007503896,0.0021737306,0.9853757,0.00043096236,0.00057777815,0.00006181373,0.00019934688,0.00002679317,0.000051461677,0.000043451055,0.003339966,0.00021511882],"about_ca_topic_score_codex":0.00017738239,"about_ca_topic_score_gemma":0.00010901907,"teacher_disagreement_score":0.012998183,"about_ca_system_score_codex":0.00013748741,"about_ca_system_score_gemma":0.0001620212,"threshold_uncertainty_score":0.7949626},"labels":[],"label_agreement":null},{"id":"W4402883766","doi":"10.1016/j.euo.2024.09.010","title":"Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical Overview","year":2024,"lang":"en","type":"editorial","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"European Association of Urology","keywords":"Medicine; Bacillus (shape); BCG vaccine; Tuberculosis; Microbiology; Pathology; Biology","score_opus":0.061467679491246124,"score_gpt":0.3512845803886108,"score_spread":0.28981690089736467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402883766","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018235032,0.0957301,0.00006193058,0.019255776,0.70588136,0.003333303,0.0023491115,0.00042640854,0.15472697],"genre_scores_gemma":[0.07238994,0.08915226,0.0036013098,0.01188316,0.8123178,0.0004261503,0.002084388,0.00092617184,0.007218833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956238,0.0016597665,0.00079563196,0.001045773,0.000372791,0.0005022166],"domain_scores_gemma":[0.995244,0.003282826,0.0003456647,0.0005101703,0.0002857476,0.00033155803],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007773127,0.0005648068,0.0014907791,0.00039685427,0.00010472552,0.000025659869,0.00014708111,0.0010127343,0.00027907686],"category_scores_gemma":[0.002214528,0.00047161532,0.00018488825,0.0001989867,0.0008461674,0.00006299566,0.00039149186,0.0017252389,0.00034399508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035059168,0.0006195717,0.00011678171,0.00078148866,0.001355688,0.008995745,0.0008984226,2.760703e-7,0.00025495442,0.0014565134,0.9747195,0.0072951056],"study_design_scores_gemma":[0.005409266,0.011574055,0.0008818184,0.0001874846,0.0028359252,0.0016537736,0.000059705548,0.0000073311353,0.00002828646,0.0008413826,0.97620595,0.00031502856],"about_ca_topic_score_codex":0.000066557404,"about_ca_topic_score_gemma":0.00009291313,"teacher_disagreement_score":0.14750813,"about_ca_system_score_codex":0.00017701638,"about_ca_system_score_gemma":0.0014812353,"threshold_uncertainty_score":0.99977356},"labels":[],"label_agreement":null},{"id":"W4402907216","doi":"10.1016/j.ijrobp.2024.07.1291","title":"Comparison of Urethra Morphology on CT with Urinary Catheter and MRI without Urinary Catheter after Low Dose Rate Prostate Cancer Brachytherapy","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"Boston Scientific Corporation","keywords":"Brachytherapy; Prostate cancer; Medicine; Urology; Catheter; Urethra; Prostate; Radiology; Urinary system; Prostatic urethra; Urinary catheter; Nuclear medicine; Cancer; Internal medicine; Radiation therapy","score_opus":0.02012159443356523,"score_gpt":0.36419855809928764,"score_spread":0.34407696366572244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402907216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902225,0.004583602,0.00051175186,0.003806687,0.0013011334,0.00037142457,0.00014388583,0.000029845029,0.00022941486],"genre_scores_gemma":[0.9951272,0.0017620979,0.00057785196,0.0011422049,0.0010160533,0.00006590911,0.000042088115,0.000049336046,0.00021727993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843436,0.00019838175,0.00058694725,0.00032163368,0.00023420945,0.00022443903],"domain_scores_gemma":[0.99869925,0.00019875859,0.00048627684,0.0001577829,0.00033661682,0.00012132576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002512157,0.0002700202,0.0006271201,0.00020473677,0.000041150415,0.000024761062,0.0001546189,0.00013659026,0.00012039217],"category_scores_gemma":[0.000016152575,0.00018874742,0.00017367759,0.00011746842,0.00030395074,0.0002085865,0.00003611614,0.0005196343,0.0000139813765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010065895,0.002672889,0.9081726,0.00008122558,0.0022854337,0.00085367344,0.0032099322,0.00039708588,0.003828302,0.00040801824,0.0006411046,0.0673838],"study_design_scores_gemma":[0.04308517,0.08924608,0.73365426,0.002510033,0.002275318,0.009049852,0.00045116505,0.0061616516,0.0375371,0.0084037315,0.06632273,0.0013029114],"about_ca_topic_score_codex":0.000040259565,"about_ca_topic_score_gemma":0.000005168206,"teacher_disagreement_score":0.17451838,"about_ca_system_score_codex":0.0003968524,"about_ca_system_score_gemma":0.0005300807,"threshold_uncertainty_score":0.7696896},"labels":[],"label_agreement":null},{"id":"W4402909672","doi":"10.1016/j.ijrobp.2024.07.1161","title":"Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine for Muscle Invasive Bladder Cancer. Long-Term Results","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Gemcitabine; Bladder cancer; Medicine; Radiation therapy; Intensity (physics); Term (time); Oncology; Urology; Cancer; Radiology; Internal medicine; Physics; Optics","score_opus":0.038387513247771066,"score_gpt":0.35401664649617287,"score_spread":0.3156291332484018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402909672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970993,0.0055840444,0.0037059844,0.013856965,0.0045477,0.0006471343,0.00042856022,0.00008338904,0.00015324111],"genre_scores_gemma":[0.98464817,0.009489641,0.0005303174,0.0015823186,0.0030225178,0.000045518907,0.00045934864,0.000041148098,0.00018101912],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984737,0.000091323316,0.0006629873,0.0003300725,0.0002335733,0.00020834882],"domain_scores_gemma":[0.9976263,0.00047121788,0.00052191486,0.0001189783,0.001125608,0.00013600067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033077048,0.00022664398,0.00044417244,0.00022397973,0.000087184446,0.00005533008,0.00014857088,0.00024674332,0.0000612595],"category_scores_gemma":[0.00026050402,0.0001881606,0.00020871572,0.00018954676,0.00012964914,0.00047098668,0.000028312392,0.00036320067,0.000010152935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004510317,0.00061031454,0.08844774,0.00003814315,0.0036871047,0.000104267034,0.0008778445,0.00028538256,0.022185832,0.00080296554,0.005100852,0.87334925],"study_design_scores_gemma":[0.030347573,0.0054096654,0.8771022,0.00035316334,0.00082619727,0.00059674185,0.00009557709,0.00820252,0.019540265,0.0086305,0.04841312,0.00048247908],"about_ca_topic_score_codex":0.00008476781,"about_ca_topic_score_gemma":0.000014812368,"teacher_disagreement_score":0.87286675,"about_ca_system_score_codex":0.0008216164,"about_ca_system_score_gemma":0.0008345259,"threshold_uncertainty_score":0.7672967},"labels":[],"label_agreement":null},{"id":"W4402922390","doi":"10.3390/curroncol31090420","title":"Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Cohort; Clinical trial; Urothelial carcinoma; Bladder cancer; Cancer; Immunotherapy; Nivolumab","score_opus":0.06333125813587427,"score_gpt":0.3673839919854534,"score_spread":0.30405273384957915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402922390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571365,0.00046149633,0.00009928374,0.0014072151,0.0003504532,0.0016515877,0.00015141578,0.00004306986,0.0001218368],"genre_scores_gemma":[0.99665326,0.0018346044,0.00018540033,0.0002983284,0.00004625588,0.00041189825,0.00023976614,0.00003733937,0.00029316475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831945,0.00017474868,0.00041850054,0.00045070495,0.00022438394,0.00041223993],"domain_scores_gemma":[0.9991252,0.00038905724,0.00008049826,0.00024609148,0.00006608887,0.00009308521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017142652,0.00031318635,0.000577473,0.000367195,0.000052865023,0.000028319882,0.00009584805,0.0000438163,0.00006211196],"category_scores_gemma":[0.00004557558,0.00015799372,0.0000510841,0.00049521134,0.00009465701,0.00008452613,0.000031449308,0.00026639196,0.0000064750316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001828124,0.0009549335,0.9219552,0.00027902666,0.000118742624,0.0005397678,0.0039352584,0.000081984756,0.0000013540536,0.00003551702,0.00006555588,0.070204526],"study_design_scores_gemma":[0.018041179,0.007508178,0.9599901,0.001053232,0.00030239302,0.000034057437,0.0008503997,0.0013629163,0.000025668316,0.00009278718,0.010501939,0.00023714593],"about_ca_topic_score_codex":0.0034783294,"about_ca_topic_score_gemma":0.029911619,"teacher_disagreement_score":0.06996738,"about_ca_system_score_codex":0.0014497432,"about_ca_system_score_gemma":0.0004901257,"threshold_uncertainty_score":0.98779},"labels":[],"label_agreement":null},{"id":"W4402930329","doi":"10.1007/s00345-024-05218-4","title":"Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Bladder cancer; Proportional hazards model; Confidence interval; Oncology; Subgroup analysis; BCG vaccine; Confounding; Survival analysis; Cancer; Urology; Immunology; Vaccination","score_opus":0.028781565467476417,"score_gpt":0.31742092480966366,"score_spread":0.28863935934218726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402930329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755606,0.017722877,0.00012111875,0.004013213,0.0013689082,0.0005644192,0.000059360118,0.000018217916,0.00057128357],"genre_scores_gemma":[0.99365264,0.0020139783,0.00020410944,0.00037055617,0.00051380164,0.00005121797,0.000007857007,0.000041810898,0.0031440232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876887,0.000046101406,0.00041542618,0.000268707,0.0001481759,0.00035272705],"domain_scores_gemma":[0.99913985,0.00032311195,0.00015007572,0.0001233952,0.000072144205,0.0001914401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001057245,0.00024563982,0.0005811566,0.00042597504,0.000041710904,0.000030234834,0.00007005881,0.000092749484,0.00018974101],"category_scores_gemma":[0.000038827202,0.00017018776,0.00020696895,0.0001970959,0.00008533149,0.00009308979,0.000019900139,0.00026616233,0.000005440283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015795473,0.0053613167,0.42828235,0.0009670851,0.014629413,0.046603683,0.06370067,0.002472312,0.01254018,0.00056347303,0.021959689,0.38712436],"study_design_scores_gemma":[0.02059268,0.009783712,0.9038274,0.0006691437,0.0031727701,0.0009478754,0.0010726282,0.0003859759,0.0011780678,0.0002493271,0.057635814,0.0004845686],"about_ca_topic_score_codex":0.00022316014,"about_ca_topic_score_gemma":0.001425032,"teacher_disagreement_score":0.47554508,"about_ca_system_score_codex":0.0003202592,"about_ca_system_score_gemma":0.00033290664,"threshold_uncertainty_score":0.69400555},"labels":[],"label_agreement":null},{"id":"W4402932186","doi":"10.1111/his.15324","title":"MTAP protein status is highly concordant with <i>CDKN2A</i> fluorescent <i>in situ</i> hybridization and allows stratification of the luminal subtype in muscle‐invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"CDKN2A; Fluorescence in situ hybridization; Immunohistochemistry; In situ hybridization; Loss of heterozygosity; Bladder cancer; Biopsy; Biology; Pathology; Biomarker; Cancer; Cancer research; Carcinoma in situ; Internal medicine; Carcinoma; Medicine; Oncology; Gene; Gene expression; Chromosome; Allele; Genetics","score_opus":0.010593407858907982,"score_gpt":0.25071355072230705,"score_spread":0.24012014286339908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402932186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279124,0.0037914913,0.000041971492,0.0014929035,0.00019711627,0.0009275965,0.000053014704,0.00001985366,0.00068479136],"genre_scores_gemma":[0.99830455,0.00043436265,0.00015584589,0.00039791965,0.000055104978,0.00019186425,0.000022943834,0.000022470911,0.0004149129],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99891526,0.00008473073,0.0002692517,0.00034986084,0.0001671737,0.00021370738],"domain_scores_gemma":[0.99955875,0.000023710601,0.00008012163,0.0002180211,0.00006765264,0.000051733783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009701854,0.00014635688,0.0002474066,0.00010805044,0.000029445013,0.00000876035,0.000050803814,0.000068096415,0.000035095243],"category_scores_gemma":[0.000017811319,0.000100464655,0.00003212723,0.00026143048,0.00019634704,0.000059922502,0.000019366857,0.00017622867,0.0000033670249],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005610243,0.00026740815,0.13663988,0.00043192974,0.000020669278,0.0004277704,0.004902141,0.000013045044,0.85130495,0.00045830078,0.00066397944,0.0043089204],"study_design_scores_gemma":[0.0029512187,0.000897223,0.836027,0.00084121036,0.00022224238,0.00013723031,0.00038375758,0.00008986185,0.15315486,0.00017190854,0.0049048755,0.00021857106],"about_ca_topic_score_codex":0.0013051336,"about_ca_topic_score_gemma":0.005648287,"teacher_disagreement_score":0.69938713,"about_ca_system_score_codex":0.00024931558,"about_ca_system_score_gemma":0.0006295996,"threshold_uncertainty_score":0.40968296},"labels":[],"label_agreement":null},{"id":"W4402945487","doi":"10.1016/j.ijrobp.2024.07.526","title":"Stereotactic Body Radiation Therapy vs. Palliative Radiotherapy, with or without Immunotherapy, in Metastatic Bladder Cancer: A Canadian Population Analysis","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University Health Centre; University of Calgary; University of British Columbia, Okanagan Campus; University of British Columbia; Princess Margaret Cancer Centre; University of Manitoba; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Immunotherapy; Cancer; Palliative care; Oncology; Population; Internal medicine; Radiology; Nursing","score_opus":0.027017898397801846,"score_gpt":0.37322695887343454,"score_spread":0.3462090604756327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402945487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97248316,0.010529414,0.006386809,0.007040331,0.001937231,0.0010379005,0.00023876362,0.000071040406,0.00027537],"genre_scores_gemma":[0.9865318,0.009153606,0.0010489098,0.001739194,0.0010277171,0.00007738014,0.00022359176,0.00006081018,0.00013702335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783504,0.0003012799,0.0007929546,0.0003556847,0.0003933316,0.00032168964],"domain_scores_gemma":[0.99832606,0.0002709291,0.0006045815,0.0001782809,0.00042748285,0.000192642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004158143,0.0003172409,0.0008265794,0.0009952625,0.00007206143,0.00009334415,0.00023618105,0.00017407682,0.0005036526],"category_scores_gemma":[0.000042216892,0.00022291226,0.0002881748,0.00096572784,0.00009382096,0.00047231285,0.000008989745,0.00047194542,0.000008394188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030667158,0.00030431047,0.80105066,0.000011927246,0.012337445,0.00016537748,0.0018637883,0.00085738365,0.0003302358,0.00042577725,0.00014330832,0.17944306],"study_design_scores_gemma":[0.019625898,0.005059885,0.9164942,0.00024038905,0.0022180085,0.00025486213,0.00016540992,0.02317998,0.00056310784,0.0014455379,0.030235806,0.000516903],"about_ca_topic_score_codex":0.022998506,"about_ca_topic_score_gemma":0.0128847435,"teacher_disagreement_score":0.17892615,"about_ca_system_score_codex":0.0032602765,"about_ca_system_score_gemma":0.002445398,"threshold_uncertainty_score":0.98350745},"labels":[],"label_agreement":null},{"id":"W4403053961","doi":"10.1056/nejmoa2401497","title":"Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society","keywords":"Bladder cancer; Lymphadenectomy; Medicine; Urology; Cancer; Internal medicine","score_opus":0.036115441484633255,"score_gpt":0.35534595381583006,"score_spread":0.3192305123311968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403053961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5051067,0.22439249,0.02521905,0.20796679,0.021608679,0.0036629315,0.0004145674,0.0003466202,0.011282172],"genre_scores_gemma":[0.9590183,0.0076762172,0.0015871726,0.0023705948,0.021092126,0.00002979173,0.000013676736,0.00007751576,0.00813464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839145,0.000036266512,0.0005183402,0.00020806037,0.00057180994,0.00027408265],"domain_scores_gemma":[0.99852353,0.00043297381,0.00013849289,0.00014994478,0.00032966727,0.00042539928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041498206,0.00022054791,0.0006533252,0.0002483597,0.00005179097,0.000021879137,0.00010102218,0.000081597565,0.0017445534],"category_scores_gemma":[0.00034037532,0.000115196846,0.00017139173,0.00023791866,0.00008276011,0.0001173848,0.000011492231,0.0002166695,0.0000051429984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009620263,0.000092339316,0.00088702346,0.0004938607,0.0016928959,0.002153424,0.0026275232,0.000010018628,0.0050854166,0.00018614405,0.15170565,0.8254454],"study_design_scores_gemma":[0.12771957,0.011743804,0.003697106,0.0043540397,0.0031219232,0.0035568222,0.0005144734,0.00005346958,0.0053897616,0.00218589,0.8374343,0.00022885845],"about_ca_topic_score_codex":0.00016248543,"about_ca_topic_score_gemma":0.00016696099,"teacher_disagreement_score":0.8252166,"about_ca_system_score_codex":0.00023048058,"about_ca_system_score_gemma":0.0020847262,"threshold_uncertainty_score":0.999168},"labels":[],"label_agreement":null},{"id":"W4403089337","doi":"10.1200/jco.23.02718","title":"Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Université de Sherbrooke; University of Toronto; Western University; Princess Margaret Cancer Centre; University of Calgary; Queen's University; McMaster University; University of British Columbia; McGill University Health Centre; University of Ottawa; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Pelvis; Radiation therapy; Radiology; Cancer; Internal medicine","score_opus":0.07479623176472212,"score_gpt":0.42429282721793193,"score_spread":0.3494965954532098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403089337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956612,0.0005004945,0.00017797254,0.0019582747,0.0005743755,0.00074172893,0.00020195551,0.000012822973,0.00017116033],"genre_scores_gemma":[0.9946375,0.00072666636,0.0033452727,0.00035451603,0.0006157441,0.000050705552,0.00007783587,0.000021555077,0.0001701861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754256,0.0001612407,0.0014872525,0.0002968448,0.00032476088,0.00018734376],"domain_scores_gemma":[0.99676436,0.0010070466,0.0008805141,0.00022318892,0.0007988983,0.00032598493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005823257,0.00017767187,0.0014629198,0.00024460652,0.00003381419,0.000010610983,0.00008500492,0.00024062618,0.000179195],"category_scores_gemma":[0.00028018042,0.00010443202,0.00073976,0.00040676017,0.00013431894,0.00018090369,0.00001036515,0.00022019476,0.0000025839395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060819164,0.005653726,0.56853485,0.00010395458,0.010815308,0.0000570618,0.00052334554,0.00017735375,0.000031385473,0.000040290397,0.00051238964,0.40746844],"study_design_scores_gemma":[0.018893639,0.06948196,0.8669255,0.00013003225,0.020828148,0.0000070006417,0.00009489454,0.0010035129,0.00024184652,0.00073012954,0.021519996,0.00014334869],"about_ca_topic_score_codex":0.00024391864,"about_ca_topic_score_gemma":0.001367543,"teacher_disagreement_score":0.4073251,"about_ca_system_score_codex":0.0005763422,"about_ca_system_score_gemma":0.002409529,"threshold_uncertainty_score":0.4274401},"labels":[],"label_agreement":null},{"id":"W4403129728","doi":"10.1200/jco.2024.42.16_suppl.4597","title":"Outcomes of patients with bacillus Calmette-Guérin–unresponsive high-risk non–muscle-invasive bladder cancer who demonstrated nonresponse to pembrolizumab in KEYNOTE-057: A post hoc analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Bacillus (shape); Post-hoc analysis; Oncology; Post hoc; Internal medicine; Cancer; Immunotherapy; Microbiology","score_opus":0.03588075244463282,"score_gpt":0.40457235748121484,"score_spread":0.36869160503658205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403129728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991775,0.0005764036,0.0002275193,0.0053118216,0.0008210392,0.0006764021,0.00038985081,0.000015506628,0.0002065046],"genre_scores_gemma":[0.9946131,0.0006583829,0.001299966,0.0026936752,0.00027794193,0.000030561456,0.000017845334,0.000048100137,0.00036042294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943311,0.0010490357,0.0028037103,0.00052214536,0.00081734476,0.00047664365],"domain_scores_gemma":[0.9911377,0.0050920853,0.0012475457,0.00038493462,0.0014648681,0.0006728692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017203853,0.0003896166,0.0033118566,0.0011850742,0.000046289813,0.000022984324,0.00026214603,0.00048403675,0.0004418662],"category_scores_gemma":[0.0033795787,0.0002462753,0.0009160274,0.0015513869,0.00027506222,0.00017787909,0.000080449194,0.0012679799,0.00002637776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0866749,0.0022446082,0.830999,0.000059821286,0.010841027,0.0025932272,0.00074728054,0.0006246169,0.00008593707,0.000009804223,0.0008908817,0.064228855],"study_design_scores_gemma":[0.019613849,0.03511133,0.9358932,0.0002989835,0.006679105,0.000029226832,0.00019857989,0.00007604737,0.0001065495,0.000027910544,0.0017452786,0.00021995045],"about_ca_topic_score_codex":0.0014954199,"about_ca_topic_score_gemma":0.005315382,"teacher_disagreement_score":0.10489415,"about_ca_system_score_codex":0.00055656815,"about_ca_system_score_gemma":0.0063556847,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W4403143673","doi":"10.1016/j.euf.2024.09.013","title":"Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary Bladder","year":2024,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiation therapy; Urothelial carcinoma; Urology; Urinary bladder; Carcinoma; Urinary system; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.03257518189447241,"score_gpt":0.3066635815962522,"score_spread":0.2740883997017798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403143673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503133,0.019901464,0.0000287335,0.0012899438,0.0009830729,0.00046306918,0.000022803979,0.00006829916,0.026929297],"genre_scores_gemma":[0.99782497,0.0009288436,0.00006478755,0.00023822467,0.00042236634,0.000018931305,0.00001087733,0.00008782445,0.00040317202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981214,0.00048551022,0.00040234774,0.0004524067,0.00017247765,0.00036587872],"domain_scores_gemma":[0.99935466,0.00018697228,0.00004312833,0.00030962718,0.000023628014,0.00008199608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038094085,0.00025021384,0.00044878657,0.0003782732,0.000020543433,0.000012452844,0.00015374321,0.00009339848,0.00040081635],"category_scores_gemma":[0.000024147666,0.00020772358,0.00013877123,0.00037278375,0.00015810782,0.000064516484,0.000033521595,0.00036327896,0.00007489696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073750556,0.003946858,0.66110206,0.00019163694,0.001628722,0.02424313,0.008834778,0.00013598162,0.030342964,0.0020574185,0.0017868845,0.19197904],"study_design_scores_gemma":[0.037075028,0.010763142,0.9225928,0.000057818703,0.00010487886,0.00021578542,0.00011800362,0.00033721662,0.0043876567,0.00018537694,0.023789827,0.00037247202],"about_ca_topic_score_codex":0.0003053182,"about_ca_topic_score_gemma":0.00004829833,"teacher_disagreement_score":0.26149076,"about_ca_system_score_codex":0.00008567075,"about_ca_system_score_gemma":0.00021179747,"threshold_uncertainty_score":0.8470722},"labels":[],"label_agreement":null},{"id":"W4403161572","doi":"10.2196/63289","title":"Survival After Radical Cystectomy for Bladder Cancer: Development of a Fair Machine Learning Model","year":2024,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Preprint; Cystectomy; Bladder cancer; Medicine; Urology; Computer science; Cancer; Internal medicine; World Wide Web","score_opus":0.02368896548600963,"score_gpt":0.3287843290220482,"score_spread":0.30509536353603856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403161572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76188475,0.006052018,0.21322864,0.0029958708,0.0013123499,0.0038243146,0.00033115596,0.0007083163,0.009662579],"genre_scores_gemma":[0.97783107,0.00018266139,0.018278478,0.00075684267,0.00024234093,0.0010609765,0.00011573029,0.000048158206,0.0014837442],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979198,0.000015146011,0.0007410294,0.00013290938,0.0008672883,0.00032385867],"domain_scores_gemma":[0.99926025,0.000094910436,0.00007119102,0.00014491766,0.000085038206,0.00034370346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029520152,0.00020586062,0.00042872402,0.00012876438,0.000057184112,0.000021881555,0.00011180339,0.00020155932,0.0006102065],"category_scores_gemma":[0.00005698078,0.00014515588,0.00015114214,0.00017984281,0.00011552194,0.00012018814,0.00006757362,0.0004008634,0.000030500974],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038365026,0.0013959439,0.009597024,0.022515116,0.0044997055,0.00022432151,0.09517109,0.00042519032,0.00031878194,0.0015036016,0.010829568,0.84968317],"study_design_scores_gemma":[0.00742416,0.0006254873,0.0007573339,0.0023946748,0.00045899116,0.000086103086,0.0009255068,0.7852803,0.0019279495,0.00018318192,0.19947498,0.0004613296],"about_ca_topic_score_codex":0.000016268008,"about_ca_topic_score_gemma":0.00002633497,"teacher_disagreement_score":0.8492218,"about_ca_system_score_codex":0.00014049646,"about_ca_system_score_gemma":0.0014280389,"threshold_uncertainty_score":0.6681334},"labels":[],"label_agreement":null},{"id":"W4403204362","doi":"10.1245/s10434-024-16332-3","title":"Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Università degli Studi di Napoli Federico II","keywords":"Medicine; Paraplegia; Perioperative; Cystectomy; Blood transfusion; Comorbidity; Bladder cancer; Odds ratio; Surgery; Mortality rate; Internal medicine; Anesthesia; Cancer","score_opus":0.056671984048462076,"score_gpt":0.3968377237812199,"score_spread":0.3401657397327578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403204362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674192,0.0014331951,0.000001926246,0.010503982,0.00008228227,0.0003860155,0.00003203569,0.000014990546,0.020126387],"genre_scores_gemma":[0.997931,0.001522933,0.00003549462,0.00031694322,0.000031113213,0.000073178904,0.000028793282,0.000007538003,0.000053030384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990794,0.00008228569,0.00030630763,0.00024109891,0.00011876515,0.00017211873],"domain_scores_gemma":[0.9995737,0.00014400388,0.000026628326,0.00009912924,0.000056008616,0.00010052789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001283583,0.00009711799,0.00036721336,0.00010866569,0.000015910804,0.000006150983,0.000037540056,0.00010797436,0.0000807674],"category_scores_gemma":[0.000012023846,0.00007493411,0.000060372895,0.00022881018,0.00021705794,0.000057260568,0.000028255852,0.00017799936,0.000011755306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006625797,0.00423671,0.9460739,0.00016980636,0.00021729956,0.001347049,0.0018532366,0.0000047015224,0.00006958789,0.0051730396,0.0010050883,0.039186995],"study_design_scores_gemma":[0.003075702,0.0017888253,0.8550328,0.00011076742,0.000025179812,0.00002880228,0.00006281743,0.00010314432,0.00012387279,0.00032896895,0.13923857,0.00008055899],"about_ca_topic_score_codex":0.00021439668,"about_ca_topic_score_gemma":0.000085224645,"teacher_disagreement_score":0.13823348,"about_ca_system_score_codex":0.00005068847,"about_ca_system_score_gemma":0.00015337147,"threshold_uncertainty_score":0.30557245},"labels":[],"label_agreement":null},{"id":"W4403309741","doi":"10.14740/jmc4323","title":"Epididymo-Orchitis Mimicking Malignancy Resulting From Intravesical Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer: An Attempt to Understand Pathophysiology, Diagnostic Challenges, Patients’ Implications and Future Directions","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Pathophysiology; Bladder cancer; Immunotherapy; Orchitis; Cancer; Pathology; Internal medicine","score_opus":0.04385463877975324,"score_gpt":0.33955394431315,"score_spread":0.29569930553339674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403309741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8621413,0.077845655,0.0010716602,0.056158897,0.0013503123,0.0006009865,0.00074824924,0.000043801974,0.000039128492],"genre_scores_gemma":[0.9104806,0.081336625,0.0015829864,0.0021136724,0.0042426647,0.00009737344,0.000067944115,0.00005944007,0.000018703045],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99828184,0.00010770599,0.000554328,0.00033919647,0.00043245652,0.00028448456],"domain_scores_gemma":[0.9975565,0.0014418795,0.00012239249,0.00018697929,0.00017062767,0.0005216065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026918642,0.00021190777,0.00047502958,0.00015239354,0.00016610832,0.00004507788,0.000120831115,0.00018990494,0.00018951476],"category_scores_gemma":[0.00063002977,0.00015496864,0.00015391593,0.00015284299,0.0001052039,0.00012231553,0.000032438264,0.0003858081,0.0000018405673],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006423695,0.00050509634,0.0022357206,0.00015921862,0.00070127344,0.0005254648,0.003566079,0.000002516089,0.00091666623,0.00034081188,0.0035670102,0.98683774],"study_design_scores_gemma":[0.020653853,0.01793686,0.62911487,0.0072970027,0.0027710425,0.003039859,0.009607649,0.00039000085,0.0012076708,0.006886253,0.29979205,0.0013029019],"about_ca_topic_score_codex":0.00041557138,"about_ca_topic_score_gemma":0.00027555108,"teacher_disagreement_score":0.98553485,"about_ca_system_score_codex":0.00019385944,"about_ca_system_score_gemma":0.00036072594,"threshold_uncertainty_score":0.63194376},"labels":[],"label_agreement":null},{"id":"W4403339997","doi":"10.3390/cancers16203445","title":"Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"editorial","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Bladder cancer; Medicine; Urology; Internal medicine; Cancer","score_opus":0.028384820743348818,"score_gpt":0.3544318685167544,"score_spread":0.3260470477734056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403339997","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08238563,0.03144603,0.000017923874,0.0013088317,0.866638,0.0030886172,0.0075805797,0.00023224886,0.0073021236],"genre_scores_gemma":[0.16872491,0.008692945,0.000115645635,0.00071859686,0.80920994,0.0013589448,0.0013622593,0.00041775728,0.009399017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957948,0.00011198872,0.0008092081,0.0013879801,0.001021422,0.00087463553],"domain_scores_gemma":[0.99728817,0.0010289018,0.0002654611,0.0005857797,0.00032437855,0.0005073254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024345164,0.0008924046,0.0019260094,0.0005270315,0.000109016866,0.000097516415,0.00025597625,0.0011938071,0.0004269233],"category_scores_gemma":[0.00036525278,0.00081112015,0.00027951106,0.0005707731,0.00032336387,0.00010874863,0.00017481406,0.0020566299,0.0001273019],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00060605706,0.000030854393,0.004785823,0.0010745726,0.001173336,0.0005612128,0.0018981638,0.000039827733,0.000088011446,0.0000022026084,0.97664785,0.013092098],"study_design_scores_gemma":[0.0062215296,0.0010539283,0.0069121243,0.0036131837,0.0023816095,0.000006794972,0.0007511359,0.000046275545,0.0007204214,0.000067435045,0.97727656,0.0009489702],"about_ca_topic_score_codex":0.011234602,"about_ca_topic_score_gemma":0.0048357532,"teacher_disagreement_score":0.08633928,"about_ca_system_score_codex":0.0056337374,"about_ca_system_score_gemma":0.009336773,"threshold_uncertainty_score":0.999434},"labels":[],"label_agreement":null},{"id":"W4403361035","doi":"10.1016/j.urolonc.2024.09.035","title":"Critical care therapy and in-hospital mortality after radical nephroureterectomy for nonmetastatic upper urinary tract carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Upper urinary tract; Urothelial carcinoma; Urinary system; General surgery; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.036588351008754315,"score_gpt":0.3547519681422988,"score_spread":0.3181636171335445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403361035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97080916,0.02000667,0.00003577819,0.007385772,0.0003178611,0.00068579975,0.00011074342,0.00004490453,0.00060333684],"genre_scores_gemma":[0.9834526,0.00052236265,0.013455643,0.0016812036,0.00021997002,0.00051717967,0.00005070275,0.000019135658,0.00008116205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988496,0.00008213244,0.00023189587,0.00044315375,0.0001035678,0.00028966006],"domain_scores_gemma":[0.9992023,0.00038249345,0.000021259975,0.0001260302,0.00003661321,0.00023131857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013484844,0.00020135596,0.00034329016,0.000121150944,0.00010033554,0.00003935943,0.000040583323,0.0001944191,0.0000964427],"category_scores_gemma":[0.00007189571,0.00015331633,0.00007769259,0.00012629965,0.00074177503,0.00013358949,0.000021498061,0.00028462938,0.0000045934994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042623992,0.0005832632,0.98927855,0.00026387422,0.00008328659,0.0014264412,0.0022508723,8.835222e-7,0.0000619541,0.0013186258,0.0006737782,0.0036322144],"study_design_scores_gemma":[0.002744069,0.015680596,0.53694344,0.0001301708,0.00071501476,0.0012460769,0.0006917815,0.0006106946,0.00014422389,0.0064036413,0.43438137,0.0003089305],"about_ca_topic_score_codex":0.00004953855,"about_ca_topic_score_gemma":0.000009049046,"teacher_disagreement_score":0.45233515,"about_ca_system_score_codex":0.000103759034,"about_ca_system_score_gemma":0.00032885312,"threshold_uncertainty_score":0.6252059},"labels":[],"label_agreement":null},{"id":"W4403483790","doi":"10.3390/siuj5050052","title":"Genitourinary Cancer Care in Low- and Middle-Income Countries: Disparities in Incidence and Access to Care","year":2024,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Low and middle income countries; Incidence (geometry); Genitourinary system; Medicine; Low income; Cancer; Cancer incidence; Demography; Demographic economics; Environmental health; Economic growth; Developing country; Economics; Sociology; Internal medicine","score_opus":0.03318850353438242,"score_gpt":0.3713362879262871,"score_spread":0.3381477843919047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403483790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94602853,0.04636891,0.000013305955,0.005636298,0.0007249187,0.00028476116,0.00009171592,0.00002348106,0.0008280782],"genre_scores_gemma":[0.9904706,0.0074058296,0.00006949174,0.0012660667,0.00038970148,0.000091411486,0.000009573772,0.000014777138,0.00028258277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989175,0.000039133123,0.00027640985,0.00025302108,0.0002871369,0.00022676079],"domain_scores_gemma":[0.9994748,0.00013830792,0.000042847376,0.00007422584,0.0001521469,0.00011767291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011015939,0.00015221769,0.00023337496,0.0003010469,0.000070651266,0.00020009311,0.00014358874,0.00008985139,0.00020922672],"category_scores_gemma":[0.00006987688,0.00012777155,0.00004738302,0.00013505138,0.000076683384,0.00033748368,0.00014556735,0.0004177498,0.0000037908176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039504183,0.000022824332,0.9879789,0.00065365416,0.00008087338,0.0010094964,0.005290761,0.000058716723,0.0000107340275,0.00006995812,0.00014749952,0.0042815707],"study_design_scores_gemma":[0.0017302905,0.0003806247,0.98775226,0.0028726968,0.00005703743,0.0004072839,0.0032838113,0.000106152715,0.00014383475,0.00067358714,0.0024288788,0.00016352243],"about_ca_topic_score_codex":0.00070868316,"about_ca_topic_score_gemma":0.0017331666,"teacher_disagreement_score":0.044442035,"about_ca_system_score_codex":0.00064099504,"about_ca_system_score_gemma":0.0003662019,"threshold_uncertainty_score":0.5210372},"labels":[],"label_agreement":null},{"id":"W4403539272","doi":"10.1016/j.urolonc.2024.09.015","title":"Neoadjuvant chemotherapy before radical cystectomy in patients with organ-confined and non-organ-confined urothelial carcinoma","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Chemotherapy; Urothelial cancer; Urology; Bladder cancer; Oncology; Internal medicine; General surgery; Cancer","score_opus":0.008901065744970394,"score_gpt":0.2608157947104071,"score_spread":0.2519147289654367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403539272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986977,0.0008618921,0.000031567397,0.008228592,0.00016800588,0.00092233805,0.000058439804,0.000091970884,0.0026602384],"genre_scores_gemma":[0.9917606,0.00011551796,0.0044157747,0.002528631,0.0001648828,0.000115911316,0.00009946703,0.00004049494,0.00075871183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984269,0.000066870096,0.0003333626,0.0005874473,0.00019735949,0.00038802487],"domain_scores_gemma":[0.9992571,0.000096409276,0.00006793722,0.00020329843,0.000057344514,0.00031792262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015772929,0.00032352892,0.0005445127,0.00024568647,0.00014505658,0.00004388905,0.0000812516,0.00029310738,0.00022975466],"category_scores_gemma":[0.000040105562,0.00022754412,0.000045753623,0.0003910981,0.00076513167,0.00010738363,0.000031465,0.00042972583,0.000017905406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008636487,0.0003163982,0.9879777,0.00009497194,0.00013449129,0.00046785266,0.0013846144,0.0000022839997,0.00039612534,0.0007994904,0.00091296394,0.0066494485],"study_design_scores_gemma":[0.017992174,0.016717536,0.6139056,0.00032271032,0.00066250033,0.00052795926,0.00021542712,0.00069348735,0.0012822143,0.0016461933,0.345538,0.0004962286],"about_ca_topic_score_codex":0.00023219618,"about_ca_topic_score_gemma":0.000121656754,"teacher_disagreement_score":0.37407213,"about_ca_system_score_codex":0.00015603812,"about_ca_system_score_gemma":0.0006859854,"threshold_uncertainty_score":0.927898},"labels":[],"label_agreement":null},{"id":"W4403629137","doi":"10.1016/j.eururo.2024.10.014","title":"Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pirkanmaan Sairaanhoitopiiri; Orionin Tutkimussäätiö; Jane ja Aatos Erkon Säätiö; Tays; Suomen Lääketieteen Säätiö; Suomen Kulttuurirahasto; Academy of Finland","keywords":"Medicine; Urothelial cancer; Urine; Cancer; DNA; Volume (thermodynamics); Urology; Cancer detection; Bladder cancer; Oncology; Internal medicine; Genetics","score_opus":0.010653066025021165,"score_gpt":0.24905752418019983,"score_spread":0.23840445815517866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403629137","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076973066,0.0051403884,0.007231749,0.85053706,0.00918059,0.0025055355,0.0031765425,0.0009256449,0.044329416],"genre_scores_gemma":[0.7074563,0.00019373941,0.000048797843,0.26591915,0.008027657,0.000034034194,0.0005323331,0.00022457066,0.017563438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737394,0.00050381734,0.00052544416,0.0008147619,0.00034227688,0.00043975137],"domain_scores_gemma":[0.99882877,0.00006372242,0.00024688034,0.0005914193,0.00017726966,0.000091948496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016629345,0.0004640017,0.001052772,0.0007303686,0.00004921741,0.000014670402,0.00014562803,0.00038887278,0.0008353798],"category_scores_gemma":[0.0000263899,0.00040036102,0.00055622996,0.00062852254,0.00019891377,0.000028860606,0.0001107857,0.0013513515,0.0008730279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025489265,0.00036352896,0.0024356989,0.0011748922,0.042988602,0.030517375,0.0010318393,0.00016891891,0.03357138,0.000011493339,0.853945,0.031242346],"study_design_scores_gemma":[0.001695284,0.0017917064,0.018839398,0.000054162047,0.025134977,0.00030132843,0.000005471396,0.00020678208,0.006708717,0.000044997458,0.944768,0.00044916497],"about_ca_topic_score_codex":0.0011308399,"about_ca_topic_score_gemma":0.0001209175,"teacher_disagreement_score":0.6304832,"about_ca_system_score_codex":0.00014811513,"about_ca_system_score_gemma":0.0001219006,"threshold_uncertainty_score":0.99990493},"labels":[],"label_agreement":null},{"id":"W4403647853","doi":"10.3390/siuj5050058","title":"Abstracts of the 44th Congress of the Société Internationale d’Urologie","year":2024,"lang":"fr","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Political science; Library science; Computer science","score_opus":0.04774934844992324,"score_gpt":0.34991276049625136,"score_spread":0.30216341204632813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403647853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69703084,0.073869675,0.00023247895,0.07902438,0.08264509,0.0011566523,0.0011759117,0.00008468465,0.06478026],"genre_scores_gemma":[0.9406809,0.0039640004,0.00011280601,0.0017354127,0.0028248075,0.000027966222,0.000017781234,0.000048377056,0.05058793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957629,0.000348563,0.0013637355,0.0004262987,0.0015208012,0.00057769666],"domain_scores_gemma":[0.9964256,0.0010643277,0.0010056254,0.00052105036,0.0008270663,0.00015631384],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010986108,0.00042283715,0.0006048815,0.00018689584,0.00025000685,0.00012876645,0.0014887556,0.0004080872,0.0038869795],"category_scores_gemma":[0.001141988,0.00025472822,0.0012427396,0.00036536957,0.0011477858,0.000340497,0.00047898112,0.0018026119,0.00006614088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017749998,0.0042936355,0.41240087,0.0019776,0.020569203,0.0009031482,0.0067193867,0.006437079,0.010167895,0.056775153,0.2917498,0.18623124],"study_design_scores_gemma":[0.0068306783,0.0013538423,0.59704435,0.0037905225,0.0026676238,0.0024637522,0.002550473,0.0023355114,0.027979434,0.04106903,0.31125996,0.00065480825],"about_ca_topic_score_codex":0.00018391582,"about_ca_topic_score_gemma":0.00006276493,"teacher_disagreement_score":0.24365005,"about_ca_system_score_codex":0.00077130535,"about_ca_system_score_gemma":0.001847279,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W4403807187","doi":"10.1111/bju.16571","title":"Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Bladder cancer; Medicine; Cystectomy; Prostate cancer; Urology; Brachytherapy; Hazard ratio; Internal medicine; Radiation therapy; Cancer; Proportional hazards model; Oncology; Cohort; Cumulative incidence; Incidence (geometry); Surgery; Gastroenterology; Confidence interval","score_opus":0.011142947861298125,"score_gpt":0.300418629498503,"score_spread":0.2892756816372049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403807187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94322586,0.054191977,0.00005651557,0.0012251352,0.0004648678,0.00063916325,0.00015427655,0.000011238928,0.00003096423],"genre_scores_gemma":[0.9912774,0.0068144267,0.000056006764,0.0010733268,0.00037042177,0.00027358835,0.000015577354,0.000031117426,0.00008816716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989842,0.000059552203,0.00033549647,0.00018855339,0.00019968959,0.00023251891],"domain_scores_gemma":[0.9995298,0.000045854573,0.000095349205,0.000060697665,0.00017347078,0.000094878116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014881935,0.000118727665,0.0003200675,0.00011187352,0.00002575576,0.000035523182,0.000047814578,0.000087409324,0.00030678502],"category_scores_gemma":[0.00001742803,0.0000943224,0.00008928883,0.00014097197,0.0000769046,0.00013929521,0.000005902424,0.0002451199,0.0000012502499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042900443,0.00029629914,0.8007948,0.00007777751,0.0006517226,0.0007714837,0.00029220962,0.000038211638,0.00003870501,0.0000027988076,0.001437647,0.1913083],"study_design_scores_gemma":[0.010653107,0.0017245762,0.9713479,0.00024355944,0.00024392852,0.00032477707,0.000007828176,0.00007298639,0.00014219704,0.00012446266,0.01501352,0.00010114557],"about_ca_topic_score_codex":0.00084294745,"about_ca_topic_score_gemma":0.0008146287,"teacher_disagreement_score":0.19120716,"about_ca_system_score_codex":0.00012362404,"about_ca_system_score_gemma":0.00043823032,"threshold_uncertainty_score":0.3846356},"labels":[],"label_agreement":null},{"id":"W4403810575","doi":"10.36469/001c.124208","title":"Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Bladder cancer; Context (archaeology); Maintenance therapy; Carcinoma in situ; Internal medicine; Guideline; Oncology; Cancer; Urology; Surgery; Chemotherapy; Pathology","score_opus":0.09136423934102175,"score_gpt":0.4284052855017772,"score_spread":0.3370410461607555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403810575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93844956,0.0011993664,0.000115750154,0.058536626,0.00019726653,0.0011915771,0.000290585,0.000001685036,0.000017602717],"genre_scores_gemma":[0.97835445,0.01711872,0.0008930445,0.0033271906,0.00013575402,0.000084682215,0.000016543248,0.000018951678,0.000050663442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838746,0.00010844633,0.0008369012,0.00017970202,0.00019948989,0.00028800353],"domain_scores_gemma":[0.998265,0.00081796973,0.00019060225,0.00015647053,0.00040060762,0.00016930874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015867732,0.00011873652,0.0004917074,0.00027475634,0.000116634794,0.000040563467,0.00013457044,0.000046304365,0.00006763862],"category_scores_gemma":[0.00013313284,0.00006557935,0.00007642958,0.00018413227,0.000062204505,0.00008942358,0.000027933807,0.00036784465,0.0000018253386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016809836,0.00056633074,0.28574714,0.00025104062,0.0005041671,0.000009080251,0.005522291,0.0001424286,0.0000064966084,0.00017307462,0.01144691,0.69395006],"study_design_scores_gemma":[0.016986744,0.026245244,0.871608,0.0007363821,0.00008387084,0.000016499474,0.002755115,0.0006735733,0.00022175859,0.00073991815,0.079722576,0.00021030242],"about_ca_topic_score_codex":0.004067158,"about_ca_topic_score_gemma":0.0050357953,"teacher_disagreement_score":0.6937398,"about_ca_system_score_codex":0.00027866074,"about_ca_system_score_gemma":0.0011674603,"threshold_uncertainty_score":0.6148353},"labels":[],"label_agreement":null},{"id":"W4403833889","doi":"10.3390/curroncol31110493","title":"The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Population; Bioinformatics; Internal medicine; Environmental health; Biology","score_opus":0.1257454982064799,"score_gpt":0.4852051036495654,"score_spread":0.3594596054430855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403833889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016725756,0.9944014,0.0000017056201,0.0009000303,0.002016632,0.001620436,0.00011973233,0.000011948686,0.00076088717],"genre_scores_gemma":[0.00034162623,0.99780613,0.00008419848,0.000025508853,0.00017216851,0.0011196517,0.00016674797,0.000029369732,0.0002545805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862164,0.000109276676,0.00059281243,0.00033937462,0.0001369881,0.00019992903],"domain_scores_gemma":[0.99933684,0.00010705477,0.00020397919,0.00024188931,0.000046627523,0.000063617714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101505066,0.00025853704,0.0009157445,0.00015453235,0.000057373803,0.000014531504,0.000083463296,0.00012696719,0.00010650852],"category_scores_gemma":[0.0000067921405,0.00015663811,0.00017389683,0.0002477594,0.000063867126,0.000024391362,0.000110161454,0.00030353398,0.000017644856],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015349218,0.00018832777,0.000102292186,0.009913132,0.00058352406,0.000028228858,0.000368503,8.0974495e-8,4.4790287e-8,0.00007300627,0.0030157596,0.98571175],"study_design_scores_gemma":[0.0005484211,0.00039805498,0.00044945357,0.022820447,0.0030717514,0.000016240298,0.00014144043,0.0000043033247,3.1038346e-7,0.00007572784,0.9723559,0.000117976444],"about_ca_topic_score_codex":0.00014594496,"about_ca_topic_score_gemma":0.0002573071,"teacher_disagreement_score":0.9855938,"about_ca_system_score_codex":0.00043919028,"about_ca_system_score_gemma":0.00024188047,"threshold_uncertainty_score":0.6387516},"labels":[],"label_agreement":null},{"id":"W4403860183","doi":"10.1016/j.urolonc.2024.09.030","title":"Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10)","year":2024,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Nivolumab; Urothelial carcinoma; First line; Oncology; Internal medicine; Urology; Cancer; Bladder cancer; Immunotherapy","score_opus":0.05315875934705231,"score_gpt":0.34628738907932416,"score_spread":0.29312862973227183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403860183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842581,0.003779298,0.00005192012,0.006832865,0.00048337862,0.0013969288,0.0006555729,0.00016205804,0.0023798633],"genre_scores_gemma":[0.9863773,0.00024013022,0.008366177,0.0009706871,0.00030618548,0.00034970246,0.0003586081,0.000041065043,0.0029901587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974604,0.0001794568,0.00071174855,0.00090845936,0.00026675648,0.00047316455],"domain_scores_gemma":[0.99857336,0.0005351027,0.00012993373,0.00036518363,0.000065173816,0.00033121702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034065364,0.00039427358,0.00070516847,0.00034682165,0.00031967484,0.000053271695,0.00014239128,0.00019628371,0.00035578426],"category_scores_gemma":[0.000275635,0.00032932436,0.00009970781,0.00059998775,0.0004737306,0.00019468987,0.00009822232,0.00055440876,0.000057068497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073774904,0.13026045,0.24161613,0.00116931,0.004339232,0.0740449,0.10907087,0.0045233364,0.009969086,0.0046508317,0.08240501,0.26417595],"study_design_scores_gemma":[0.04930814,0.09520805,0.0027841807,0.00038930905,0.0018961777,0.0005306571,0.0016140522,0.007253598,0.0006693544,0.008079516,0.8316234,0.0006435662],"about_ca_topic_score_codex":0.0012747509,"about_ca_topic_score_gemma":0.0013027084,"teacher_disagreement_score":0.7492184,"about_ca_system_score_codex":0.00057169504,"about_ca_system_score_gemma":0.0009641645,"threshold_uncertainty_score":0.9999159},"labels":[],"label_agreement":null},{"id":"W4403870497","doi":"10.1097/ju.0000000000004305","title":"Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of British Columbia; University Health Network; Sinai Health System; Mount Sinai Hospital","funders":"","keywords":"Medicine; Bladder cancer; Term (time); Cancer; Cystoscopy; Urology; Oncology; Radiology; Internal medicine; Urinary system","score_opus":0.018178469730381692,"score_gpt":0.30605073944831024,"score_spread":0.28787226971792856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403870497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501099,0.04722355,0.0005792512,0.0012335619,0.0005467154,0.00018954258,0.00006655314,0.0000054588054,0.000045458728],"genre_scores_gemma":[0.9761893,0.023377778,0.00009636839,0.00012236804,0.00013991994,0.0000033783938,0.0000016004537,0.000016603559,0.000052667634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987199,0.00027468192,0.00047219844,0.0001238039,0.00023262153,0.0001767977],"domain_scores_gemma":[0.9988024,0.00038606636,0.00039021252,0.00018217142,0.00016109912,0.0000780134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045587006,0.00013902447,0.0005036111,0.00013169437,0.000034337372,0.0000057065363,0.00013286927,0.00005241625,0.00014571242],"category_scores_gemma":[0.00009145683,0.0000828505,0.00011132512,0.00015760615,0.0002761436,0.000062305066,0.000033527627,0.0003389852,0.0000023998227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01016727,0.0020088456,0.6934514,0.0059971074,0.018545017,0.002429599,0.01573267,0.0011749655,0.13094676,0.00020528841,0.0033536945,0.11598741],"study_design_scores_gemma":[0.006095519,0.007057327,0.95535195,0.0010054859,0.0052797482,0.0033059581,0.00028448214,0.0003025546,0.019939553,0.00093029236,0.00020779112,0.00023933737],"about_ca_topic_score_codex":0.00017592825,"about_ca_topic_score_gemma":0.00014268442,"teacher_disagreement_score":0.26190057,"about_ca_system_score_codex":0.000026670703,"about_ca_system_score_gemma":0.00032305415,"threshold_uncertainty_score":0.33785453},"labels":[],"label_agreement":null},{"id":"W4403890847","doi":"10.1158/1078-0432.ccr-23-3518","title":"Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Progression-free survival; Cancer; Immunotherapy","score_opus":0.08274151803402123,"score_gpt":0.46282926744188796,"score_spread":0.3800877494078667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403890847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864055,0.001076122,0.000012649532,0.008278505,0.000097052565,0.0011991729,0.000043874825,0.00001924267,0.00063282234],"genre_scores_gemma":[0.99675363,0.0006008706,0.00018912842,0.00017029734,0.00044633582,0.00019355741,0.0000072382472,0.000049850965,0.0015890637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976721,0.0002110033,0.00042024543,0.0004245556,0.0009465653,0.00032555743],"domain_scores_gemma":[0.99739176,0.0017462166,0.000118062315,0.00026695593,0.0003654484,0.00011154763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792036,0.00016536858,0.00051387306,0.00013731235,0.00005481454,0.000025087389,0.00014061882,0.00009570697,0.00031190764],"category_scores_gemma":[0.00019284655,0.00008724743,0.000078076264,0.000619809,0.0004611459,0.000073482806,0.000026300371,0.00056027225,0.0000034245832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3668826,0.0007444616,0.5246577,0.0007684314,0.0015802166,0.00015711153,0.0038941693,0.000072786745,0.0017304863,0.00012677704,0.0011705533,0.098214716],"study_design_scores_gemma":[0.090421595,0.014128581,0.877113,0.0010901927,0.0002857869,0.000031383992,0.0009263069,0.000833358,0.0060976404,0.00007867747,0.008732642,0.00026084823],"about_ca_topic_score_codex":0.00080876134,"about_ca_topic_score_gemma":0.0006152942,"teacher_disagreement_score":0.3524553,"about_ca_system_score_codex":0.00029571864,"about_ca_system_score_gemma":0.001748455,"threshold_uncertainty_score":0.35578468},"labels":[],"label_agreement":null},{"id":"W4403914498","doi":"10.1016/j.clgc.2024.102249","title":"Reevaluating the Role of Extended Pelvic Lymphadenectomy in Muscle-Invasive Bladder Cancer: Insights From SWOG S1011 and LEA AB 25-02 Trials","year":2024,"lang":"en","type":"editorial","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Lymphadenectomy; Oncology; Internal medicine; Urology; Cancer","score_opus":0.0636659490453141,"score_gpt":0.41644178006503174,"score_spread":0.35277583101971766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403914498","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25568262,0.29021633,0.000001179022,0.00079307426,0.44612333,0.002775764,0.002118059,0.0001087675,0.0021808709],"genre_scores_gemma":[0.2201386,0.100285344,0.00011245576,0.0004074937,0.675186,0.0014696926,0.00035780543,0.00025797446,0.0017846467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99189365,0.0013640256,0.0029358866,0.0016995558,0.001470735,0.000636141],"domain_scores_gemma":[0.98826575,0.008686685,0.0011647295,0.0010729402,0.00042950918,0.0003803562],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015100224,0.00090455485,0.003276259,0.00028613763,0.00014790187,0.00007992792,0.000535319,0.0016134718,0.0008220332],"category_scores_gemma":[0.0029035693,0.0006060955,0.000944109,0.00049671356,0.0005182894,0.00013111392,0.0004164572,0.002093857,0.00004092446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057897344,0.0013609609,0.008037492,0.001192641,0.006603094,0.0010226682,0.0025778809,0.00002807452,0.001568935,0.00001266079,0.72865576,0.24315009],"study_design_scores_gemma":[0.026654782,0.0036402,0.03566396,0.008885187,0.013315114,0.0000151203885,0.001650464,0.00025179586,0.002175418,0.0054378714,0.9007038,0.001606279],"about_ca_topic_score_codex":0.009511716,"about_ca_topic_score_gemma":0.0026820817,"teacher_disagreement_score":0.24154381,"about_ca_system_score_codex":0.0006276363,"about_ca_system_score_gemma":0.0057171504,"threshold_uncertainty_score":0.99991953},"labels":[],"label_agreement":null},{"id":"W4403956069","doi":"10.1002/bco2.449","title":"Robot‐assisted laparoscopic continent cutaneous urinary diversion in adults: A single‐centre study","year":2024,"lang":"en","type":"article","venue":"BJUI Compass","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Surgery; Perioperative; Urinary continence; Urinary diversion; Complication; Cystectomy; Urinary system; Concomitant; Cystostomy; Urethra; Spinal cord injury; Urinary incontinence; Spinal cord; Bladder cancer; Prostate; Internal medicine","score_opus":0.021862296345073667,"score_gpt":0.2814684981523762,"score_spread":0.25960620180730254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403956069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923255,0.001550805,0.000014940342,0.0015170549,0.0006147545,0.0010038976,0.000024432766,0.00019468709,0.0027539246],"genre_scores_gemma":[0.9973816,0.000027002163,0.00008055796,0.00015213847,0.00013280487,0.00003338938,0.000036739155,0.000028025543,0.0021277373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987095,0.000062889034,0.0002588205,0.000403674,0.0002899794,0.000275142],"domain_scores_gemma":[0.9994965,0.000052224634,0.000030103416,0.0002546687,0.00004373915,0.0001227249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044135937,0.00020293062,0.000368289,0.00013746784,0.000051310126,0.00004151516,0.000087937624,0.000058673955,0.00030468134],"category_scores_gemma":[0.000012705654,0.00016713192,0.00008712515,0.00024906502,0.000030312727,0.000058202655,0.00007793118,0.00018409062,0.0001986738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005306219,0.021306684,0.8781895,0.0012846636,0.0009321409,0.03139085,0.010900357,0.00004665362,0.0044586486,0.000070198854,0.017626356,0.028487748],"study_design_scores_gemma":[0.025784168,0.007878145,0.9201469,0.005696747,0.00096354104,0.0010863256,0.0070543652,0.0018235402,0.0017686979,0.00005453224,0.027006654,0.0007363784],"about_ca_topic_score_codex":0.00036882106,"about_ca_topic_score_gemma":0.00016995308,"teacher_disagreement_score":0.041957427,"about_ca_system_score_codex":0.00030215035,"about_ca_system_score_gemma":0.0000769754,"threshold_uncertainty_score":0.6815442},"labels":[],"label_agreement":null},{"id":"W4403961830","doi":"10.58931/cot.2024.1329","title":"Antibody-drug Conjugates in The Management of Advanced Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Urothelial carcinoma; Antibody; Drug; Antibody-drug conjugate; Medicine; Conjugate; Carcinoma; Cancer research; Internal medicine; Pharmacology; Immunology; Monoclonal antibody; Cancer; Bladder cancer","score_opus":0.014360824321639591,"score_gpt":0.31596838758125917,"score_spread":0.30160756325961957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403961830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78113055,0.0072846925,0.000009533332,0.013235041,0.000918451,0.0012176693,0.00013201566,0.000036801073,0.19603527],"genre_scores_gemma":[0.995291,0.00031445822,0.00018722111,0.0020208168,0.00010793195,0.000082594255,0.000051715033,0.000019634357,0.001924631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906063,0.000056078283,0.00021011167,0.00023671988,0.000119738426,0.00031671175],"domain_scores_gemma":[0.9994892,0.00005898025,0.000022289178,0.00024468658,0.00002602657,0.00015884245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017550534,0.00012809648,0.00024807322,0.00019990225,0.000042508942,0.000010811086,0.00014113326,0.000076264885,0.00033331788],"category_scores_gemma":[0.0000053375743,0.00009155638,0.00007305276,0.00028041043,0.00010972982,0.000041358675,0.000013804819,0.00017802812,0.00007539504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001687536,0.0011086551,0.19194709,0.003772584,0.002453358,0.062222376,0.031456817,0.000065246655,0.009273951,0.06290098,0.054390058,0.57872134],"study_design_scores_gemma":[0.0048630578,0.0011585773,0.2205006,0.0006899194,0.0005289402,0.00034959707,0.004367403,0.00010128461,0.0014609686,0.0011804736,0.764527,0.00027215312],"about_ca_topic_score_codex":0.027423816,"about_ca_topic_score_gemma":0.05376488,"teacher_disagreement_score":0.71013695,"about_ca_system_score_codex":0.00044855886,"about_ca_system_score_gemma":0.0010316917,"threshold_uncertainty_score":0.97905266},"labels":[],"label_agreement":null},{"id":"W4403978554","doi":"10.1016/j.clgc.2024.102261","title":"Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 Study","year":2024,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Wilfrid Laurier University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Merck Sharp and Dohme; Merck","keywords":"Carboplatin; Pembrolizumab; Medicine; Cisplatin; Gemcitabine; Chemotherapy; Regimen; Internal medicine; Oncology; Chemotherapy regimen; Phases of clinical research; Progression-free survival; Urology; Cancer; Immunotherapy","score_opus":0.08280996112484124,"score_gpt":0.4458786824423694,"score_spread":0.36306872131752815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403978554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98167366,0.01052265,0.00012928025,0.0023970627,0.0018687047,0.0021865985,0.0007127114,0.00021244565,0.00029689886],"genre_scores_gemma":[0.9886061,0.0022815317,0.00016525702,0.0031766554,0.002815229,0.00163045,0.00008699516,0.00013018423,0.0011075839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957414,0.00042992955,0.0012699546,0.0012706748,0.0006958015,0.0005921844],"domain_scores_gemma":[0.9971538,0.0011490142,0.00019701646,0.001023528,0.00013273083,0.00034391458],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047969297,0.0005727151,0.0013357308,0.0002635623,0.00016328844,0.00008657446,0.00039223136,0.00025158437,0.0030343616],"category_scores_gemma":[0.0001066074,0.0003653739,0.00070717745,0.0017384504,0.00021713307,0.00015174018,0.00008017248,0.00095968216,0.00005263812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07746508,0.007121908,0.4842012,0.00019194307,0.010385833,0.004588512,0.0051712366,0.005554036,0.00093035545,0.0000029934588,0.0047280183,0.3996589],"study_design_scores_gemma":[0.20445503,0.0170175,0.6395741,0.0016702994,0.018995762,0.000019206418,0.0039580157,0.05617773,0.0026205622,0.0001471746,0.053008087,0.002356543],"about_ca_topic_score_codex":0.0031496645,"about_ca_topic_score_gemma":0.0042844433,"teacher_disagreement_score":0.39730236,"about_ca_system_score_codex":0.0007690001,"about_ca_system_score_gemma":0.0030284126,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W4403981414","doi":"10.1111/bju.16572","title":"A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Veracyte; Wilson Foundation","keywords":"Cystectomy; Bladder cancer; Medicine; Hazard ratio; Odds ratio; Internal medicine; Oncology; Cohort; Urology; Carcinoma; Confidence interval; Cancer","score_opus":0.013420187104363147,"score_gpt":0.272115857147814,"score_spread":0.25869567004345084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403981414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956258,0.00096036587,0.000348338,0.0015803579,0.00030985766,0.00048620967,0.000051595158,0.000032430085,0.00060503493],"genre_scores_gemma":[0.99739236,0.00014566227,0.0003634662,0.001327836,0.00022348313,0.000028658642,0.00001746747,0.000069373564,0.0004317238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781895,0.000120787685,0.00081227534,0.0003755826,0.00040520704,0.00046722442],"domain_scores_gemma":[0.9988778,0.00016681533,0.00025339946,0.00015573122,0.00026955295,0.00027670624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025992387,0.00027308566,0.000943346,0.00028590797,0.00006456257,0.000075126554,0.00015014179,0.00021148298,0.00076652505],"category_scores_gemma":[0.000053898573,0.00020049007,0.0001563577,0.00029537323,0.00025472185,0.00012451052,0.000018030738,0.00082552544,0.000013037259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01024957,0.0009330984,0.96202546,0.000095178664,0.0015703299,0.010857858,0.00012194994,0.00007965448,0.000487974,0.0000049959895,0.0009399786,0.012633935],"study_design_scores_gemma":[0.03359438,0.009124395,0.9502359,0.00079015596,0.0011996629,0.002283813,0.000041077652,0.00031155383,0.0001978753,0.0000118573935,0.0019268632,0.0002824435],"about_ca_topic_score_codex":0.0005537623,"about_ca_topic_score_gemma":0.00026085813,"teacher_disagreement_score":0.023344811,"about_ca_system_score_codex":0.00020539206,"about_ca_system_score_gemma":0.0011068973,"threshold_uncertainty_score":0.8392912},"labels":[],"label_agreement":null},{"id":"W4404090161","doi":"10.3390/curroncol31110511","title":"The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; PTEN; Prostate cancer; Bladder cancer; Bioinformatics; Targeted therapy; Cancer; Oncology; Internal medicine; Biology; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.10402238634228893,"score_gpt":0.44645034990794535,"score_spread":0.3424279635656564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404090161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003358096,0.99336904,0.000009185943,0.0003092134,0.0015058089,0.0007414396,0.000024527886,0.000027620192,0.003979557],"genre_scores_gemma":[0.00018874575,0.99835885,0.000024028732,0.000055298853,0.00025597253,0.0005916988,0.00007493862,0.000024129937,0.00042632414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896926,0.00011645934,0.00031498232,0.00027162372,0.000095650044,0.00023201658],"domain_scores_gemma":[0.9995039,0.00013286878,0.00008425878,0.00017642944,0.00003123704,0.000071312345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013788267,0.00021386358,0.00069510157,0.00013525704,0.00008504689,0.000033796317,0.0000717718,0.00017024408,0.00006505023],"category_scores_gemma":[0.000041029165,0.00012192497,0.00013997077,0.00022035859,0.000067035005,0.000023754379,0.000056515877,0.0005464172,0.000048307254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015294332,0.00005799219,0.000116035706,0.002834331,0.00017120538,0.0000735685,0.00007858902,9.035104e-7,2.0278291e-7,0.00018625091,0.0058150874,0.99065053],"study_design_scores_gemma":[0.00037062998,0.00022553215,0.000019351852,0.0019506151,0.0013918248,0.00014536393,0.000034693127,0.000052169587,1.6396204e-7,0.00013416323,0.9955829,0.00009258562],"about_ca_topic_score_codex":0.000030920095,"about_ca_topic_score_gemma":0.000098094875,"teacher_disagreement_score":0.99055797,"about_ca_system_score_codex":0.0006274364,"about_ca_system_score_gemma":0.0012498093,"threshold_uncertainty_score":0.4971956},"labels":[],"label_agreement":null},{"id":"W4404102408","doi":"10.5194/egusphere-2024-1864-ac1","title":"Reply on CEC1","year":2024,"lang":"en","type":"peer-review","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Computer science","score_opus":0.04820807403544519,"score_gpt":0.36264138628818887,"score_spread":0.3144333122527437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404102408","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.7808486e-7,0.0912836,0.0000016082912,0.27492344,0.003313212,0.0006037331,0.00022560135,0.00015415394,0.62949395],"genre_scores_gemma":[0.000026434873,0.013149074,0.00006637344,0.14679725,0.0012856979,0.00009748195,0.0007633409,0.00006271201,0.8377516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986107,0.000014856104,0.0002473003,0.00049254147,0.00044023478,0.00019440072],"domain_scores_gemma":[0.999089,0.000025413266,0.000039260252,0.0006382568,0.00007629383,0.00013176342],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008569711,0.00029653928,0.000641808,0.00009098826,0.000018984625,0.000015421012,0.000078313155,0.00014420158,0.013108553],"category_scores_gemma":[0.000040818235,0.00018504301,0.00031385742,0.0001354388,0.000019555479,0.000009447703,0.000035222052,0.00045218848,0.007629792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028473236,0.00006803011,0.0000026211603,0.005416359,0.0002869056,0.00023326314,0.0000064663955,8.313555e-9,7.503828e-7,0.000101450954,0.97517526,0.018680437],"study_design_scores_gemma":[0.000364444,0.0004987127,0.000020230063,0.014041812,0.0014840745,0.00006417606,0.0000013331639,4.2789708e-7,0.000060013554,0.00015452488,0.98315686,0.00015337914],"about_ca_topic_score_codex":0.00042372945,"about_ca_topic_score_gemma":0.000021891126,"teacher_disagreement_score":0.20825768,"about_ca_system_score_codex":0.00015288864,"about_ca_system_score_gemma":0.00034727258,"threshold_uncertainty_score":0.9931429},"labels":[],"label_agreement":null},{"id":"W4404119982","doi":"10.1038/s41598-024-78440-0","title":"A novel approach to engineering three-dimensional bladder tumor models for drug testing","year":2024,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Computer science; Drug; Computational biology; Medicine; Biology; Pharmacology","score_opus":0.043824571018946594,"score_gpt":0.27144822137484004,"score_spread":0.22762365035589344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404119982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5410997,0.0031775518,0.3999098,0.0013147597,0.026148632,0.0072490936,0.000120546014,0.0016291733,0.01935074],"genre_scores_gemma":[0.89478415,9.425978e-8,0.098656416,0.00014626149,0.00032803367,0.00034331504,0.00006514442,0.000060413946,0.005616147],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99800104,0.0000027404483,0.00033440217,0.0008456963,0.00046371663,0.00035239937],"domain_scores_gemma":[0.9990604,0.000056405395,0.0000412554,0.00043821518,0.00017953644,0.00022419824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005635444,0.00017746947,0.00021955825,0.00021308781,0.00014392419,0.00019259562,0.000055620112,0.00003159397,0.00001929785],"category_scores_gemma":[0.00013144306,0.0001414846,0.00012400145,0.0005765098,0.000038650276,0.00014017907,0.00005154704,0.000102120975,0.00001528771],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028422693,0.0023146453,0.0019743291,0.0029666063,0.0013572411,0.0033529287,0.0039916546,0.22469802,0.509608,0.0031580054,0.22378,0.022514371],"study_design_scores_gemma":[0.0008124653,0.00014880793,0.0005996627,0.000770334,0.00038195183,0.004546564,0.00004788872,0.94466627,0.016672406,0.005509793,0.02534253,0.00050130824],"about_ca_topic_score_codex":0.0000717302,"about_ca_topic_score_gemma":0.000006002451,"teacher_disagreement_score":0.71996826,"about_ca_system_score_codex":0.00009699976,"about_ca_system_score_gemma":0.00040655377,"threshold_uncertainty_score":0.5769575},"labels":[],"label_agreement":null},{"id":"W4404195234","doi":"10.1016/j.clgc.2024.102259","title":"Robot-Assisted Cystectomy in Patients With Previous Pelvic Irradiation: A Comprehensive Systematic Review and Single-Arm Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Cystectomy; Meta-analysis; Bladder cancer; Urology; Surgery; General surgery; Oncology; Internal medicine; Cancer","score_opus":0.1854983916649068,"score_gpt":0.4282979106529379,"score_spread":0.24279951898803107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404195234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051865965,0.9902678,0.00000214026,0.00019468606,0.00023745485,0.008708217,0.0003247313,0.00007561828,0.0001374599],"genre_scores_gemma":[0.00053688115,0.9929915,0.00013190601,0.0010031994,0.00021656735,0.0033818437,0.000354037,0.00013520283,0.0012488511],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99377316,0.0010310909,0.0028357957,0.0013320209,0.0006073035,0.00042064703],"domain_scores_gemma":[0.9965802,0.0005257956,0.0010796634,0.0011115379,0.00033076433,0.00037206543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037574657,0.0009985253,0.014289754,0.00048433643,0.000059549173,0.000063801046,0.00024292043,0.00042284984,0.00034158357],"category_scores_gemma":[0.00009932066,0.0005628816,0.0036513759,0.0019102668,0.00014461234,0.000082317805,0.0001428888,0.0009302748,0.000083406114],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076321194,0.0010855965,0.0003502364,0.76643705,0.21384951,0.00028965605,0.000018439398,0.0000011117475,3.3874936e-9,4.577576e-7,0.00034581052,0.017545803],"study_design_scores_gemma":[0.0013676728,0.0014790825,0.0020843763,0.14021395,0.83080906,0.00005847501,0.0000044586777,0.000001836456,8.717972e-9,0.0000017228701,0.023520011,0.0004593388],"about_ca_topic_score_codex":0.00005635623,"about_ca_topic_score_gemma":0.000047397578,"teacher_disagreement_score":0.6262231,"about_ca_system_score_codex":0.0005099701,"about_ca_system_score_gemma":0.0006288494,"threshold_uncertainty_score":0.99968225},"labels":[],"label_agreement":null},{"id":"W4404673689","doi":"10.17650/1726-9776-2024-20-3-104-116","title":"Ureteroileal anastomosis-associated complications of radical cystectomy with ileal conduit in bladder cancer treatment","year":2024,"lang":"en","type":"article","venue":"Cancer Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Cystectomy; Anastomosis; Electrical conduit; Bladder cancer; Medicine; Urology; Surgery; Urinary diversion; Cancer; Internal medicine","score_opus":0.029044409696966637,"score_gpt":0.32728550313827,"score_spread":0.29824109344130334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404673689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268044,0.009919586,0.00005083086,0.0040487805,0.00028116966,0.0007381033,0.00038684535,0.00010237338,0.0017918821],"genre_scores_gemma":[0.99676466,0.0006842083,0.00003469397,0.00085411523,0.0001249709,0.00094907416,0.00007878336,0.000042436328,0.00046707282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986732,0.00007054133,0.0002981931,0.00043245885,0.00017137524,0.000354258],"domain_scores_gemma":[0.99938774,0.00008246115,0.000066213506,0.00025062152,0.0000760505,0.00013692775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004256082,0.00022518574,0.0005084269,0.00018050919,0.000037629325,0.000009002413,0.0000844451,0.0001454939,0.0006511447],"category_scores_gemma":[0.000005301228,0.00016460149,0.000089728936,0.00043642902,0.00025486582,0.00004567698,0.00001687535,0.00021560874,0.000014695932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033104392,0.001905822,0.9164295,0.00036364238,0.0054179374,0.0006989192,0.0051795067,0.00075517455,0.0048087053,0.0008625695,0.005549095,0.054718673],"study_design_scores_gemma":[0.017026769,0.0070257257,0.9045257,0.00043421442,0.0022990617,0.00017433833,0.00013726023,0.002022339,0.0031159502,0.00011374258,0.0626347,0.0004901992],"about_ca_topic_score_codex":0.005990583,"about_ca_topic_score_gemma":0.010751148,"teacher_disagreement_score":0.057085603,"about_ca_system_score_codex":0.0006258099,"about_ca_system_score_gemma":0.0007979067,"threshold_uncertainty_score":0.90560097},"labels":[],"label_agreement":null},{"id":"W4404763381","doi":"10.1139/bcb-2024-0083","title":"E2F8 facilitates malignant phenotypes of muscle-invasive bladder cancer via increasing MCM7 expression","year":2024,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Gene knockdown; Downregulation and upregulation; Cancer research; E2F; Cancer; Cancer cell; Transcription factor; Cell cycle; Cisplatin; Biology; Cyclin D1; Apoptosis","score_opus":0.013094595539070707,"score_gpt":0.268114693308802,"score_spread":0.2550200977697313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404763381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550355,0.041410886,0.000034682427,0.0001937936,0.0001348628,0.00011596982,0.0001380382,0.000036640813,0.0028996412],"genre_scores_gemma":[0.9967024,0.0018989062,0.00017405901,0.00008604054,0.00015822073,0.000026949981,0.0000764914,0.000011880406,0.00086507486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992527,0.00002801146,0.00016790058,0.00032130035,0.000056060435,0.0001740669],"domain_scores_gemma":[0.99960667,0.00008977257,0.0000365346,0.0001398428,0.000039847346,0.00008732125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059622907,0.00014999625,0.00022158383,0.000028631417,0.00003881747,0.000006938972,0.00004305498,0.00016316058,0.00035716713],"category_scores_gemma":[0.000019451125,0.00010709105,0.00006375429,0.000064734806,0.00019584238,0.000020609194,0.000039976327,0.000089734946,0.000007166581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015162778,0.000060310227,0.004014238,0.0006562174,0.00008352627,0.000018041925,0.00023307,2.972468e-7,0.98344433,0.000010752499,0.00016232181,0.011165261],"study_design_scores_gemma":[0.00048619788,0.00017288714,0.0011954766,0.00029442908,0.00013258366,0.00002075463,0.00020549398,0.000014827644,0.9937404,0.00014675282,0.003480928,0.000109281755],"about_ca_topic_score_codex":0.00041225026,"about_ca_topic_score_gemma":0.0000037638363,"teacher_disagreement_score":0.04166689,"about_ca_system_score_codex":0.000027826538,"about_ca_system_score_gemma":0.00013309364,"threshold_uncertainty_score":0.43670464},"labels":[],"label_agreement":null},{"id":"W4404764977","doi":"10.3390/children11121442","title":"Mitrofanoff Appendicovesicostomy in Robotic Paediatric Surgery—A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Children","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Surgery; Appendix; Stoma (medicine); General surgery","score_opus":0.03188142156538742,"score_gpt":0.3279918597033184,"score_spread":0.296110438137931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404764977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012326541,0.9906279,0.0000018645969,0.0000987285,0.0004666595,0.007852227,0.00008699313,0.00012699897,0.0007374389],"genre_scores_gemma":[0.000010549162,0.99532074,0.00001968315,0.00049536815,0.00042644519,0.0010678897,0.00090765813,0.0001769571,0.0015747211],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964399,0.00030078477,0.0015643234,0.00075694383,0.00045192702,0.00048615327],"domain_scores_gemma":[0.99821293,0.00024176112,0.00038841413,0.0009068032,0.000030777635,0.00021929608],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048966747,0.000783455,0.007038645,0.0010153612,0.000031207648,0.00004437324,0.0002516889,0.00031505816,0.00016022549],"category_scores_gemma":[0.00021133992,0.0004994635,0.0017636024,0.0018032264,0.00003233461,0.000055166973,0.00009060448,0.0006934052,0.0032111881],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001983002,0.000104852785,0.00014954146,0.946338,0.00095537264,0.00020216915,0.0000075090848,1.5106533e-8,2.034557e-9,0.000011548255,0.010399595,0.04182944],"study_design_scores_gemma":[0.00023841993,0.000043244523,0.0000661455,0.9075775,0.045803215,0.0010024756,8.9975964e-7,1.9373462e-7,5.7839465e-8,0.000012799259,0.044867903,0.00038711366],"about_ca_topic_score_codex":0.000035763805,"about_ca_topic_score_gemma":0.0000029215928,"teacher_disagreement_score":0.044847842,"about_ca_system_score_codex":0.0004572079,"about_ca_system_score_gemma":0.0009406769,"threshold_uncertainty_score":0.9997457},"labels":[],"label_agreement":null},{"id":"W4404860781","doi":"10.5489/cuaj.8946","title":"2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary; Ottawa Hospital; Foothills Medical Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Urothelial carcinoma; Metastatic Urothelial Carcinoma; Medicine; Oncology; Internal medicine; Cancer; Bladder cancer","score_opus":0.015244889376461311,"score_gpt":0.2718468733718702,"score_spread":0.2566019839954089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404860781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8895039,0.025987037,0.0011509102,0.034312274,0.00299463,0.0013895235,0.00023360967,0.00010488738,0.04432325],"genre_scores_gemma":[0.9902502,0.0006077411,0.00086419296,0.0010486931,0.00023150248,0.000024471523,0.000014091811,0.000019200115,0.0069399085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852455,0.0000747668,0.00039714552,0.0002529824,0.0003764262,0.00037412412],"domain_scores_gemma":[0.9990514,0.00006888128,0.000117976466,0.00011522773,0.00013523149,0.00051126216],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004011079,0.00014962179,0.00030183382,0.00017697278,0.000112109046,0.00007565564,0.00006681764,0.000093471026,0.00095971103],"category_scores_gemma":[0.00009325684,0.00011405296,0.00011936684,0.00023202125,0.000036767822,0.0000985704,0.000017786655,0.0003210866,0.000022712069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001538099,0.00058320543,0.5655685,0.000871756,0.007273627,0.07302825,0.0022550842,0.00017829724,0.0026684175,0.005627086,0.102420054,0.23798761],"study_design_scores_gemma":[0.007754171,0.0029117458,0.49362406,0.000592219,0.0016223199,0.008761374,0.0009869961,0.0009909847,0.00081422273,0.006336301,0.47496,0.0006455937],"about_ca_topic_score_codex":0.0011898219,"about_ca_topic_score_gemma":0.00023140702,"teacher_disagreement_score":0.37253997,"about_ca_system_score_codex":0.0006553351,"about_ca_system_score_gemma":0.0005697285,"threshold_uncertainty_score":0.99995357},"labels":[],"label_agreement":null},{"id":"W4404875027","doi":"10.1016/j.eururo.2024.11.016","title":"Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Risk stratification; Classifier (UML); Clinical decision making; Stratification (seeds); Oncology; Internal medicine; Intensive care medicine; Artificial intelligence; Bladder cancer; Cancer","score_opus":0.02752166542806099,"score_gpt":0.34310388633437333,"score_spread":0.3155822209063123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404875027","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23967181,0.0061166007,0.0003498793,0.0016182974,0.69125724,0.0018357197,0.0014657745,0.00026472614,0.05741992],"genre_scores_gemma":[0.8276386,0.00041807507,0.00040200425,0.0005404191,0.17023595,0.00001866889,0.0002947781,0.00011263789,0.00033884292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967999,0.00039350853,0.0011045145,0.0008573381,0.00047702278,0.00036772492],"domain_scores_gemma":[0.9975196,0.0011419655,0.00029303727,0.0006150546,0.00022056229,0.00020979335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007083948,0.00043948035,0.000931425,0.0002280842,0.000055237037,0.000040200855,0.0002613851,0.00078616635,0.00017637933],"category_scores_gemma":[0.0014117284,0.0003272336,0.00033867368,0.00014657724,0.00045225344,0.000031560437,0.00018093108,0.0013888456,0.00010889793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044204216,0.000984822,0.02937284,0.00042421854,0.0012877099,0.004512833,0.00077914033,0.000002731253,0.00049266696,0.001040612,0.84548223,0.11119975],"study_design_scores_gemma":[0.003088423,0.0049512517,0.064968035,0.0002134519,0.0011206991,0.00019250852,0.00004153153,0.00003302008,0.000026792673,0.0010799874,0.92385286,0.00043146455],"about_ca_topic_score_codex":0.00002611501,"about_ca_topic_score_gemma":0.000008166519,"teacher_disagreement_score":0.5879668,"about_ca_system_score_codex":0.000057230067,"about_ca_system_score_gemma":0.0007592729,"threshold_uncertainty_score":0.999918},"labels":[],"label_agreement":null},{"id":"W4404958575","doi":"10.1245/s10434-024-16639-1","title":"Perioperative Complications and In-Hospital Mortality in Radical Nephroureterectomy Patients with Heart Valve Replacement","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Perioperative; Propensity score matching; Aortic valve replacement; Poisson regression; Myocardial infarction; Odds ratio; Surgery; Internal medicine; Heart valve; Heart failure; Cardiology; Population","score_opus":0.04107962729256308,"score_gpt":0.37572948681190677,"score_spread":0.3346498595193437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404958575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794021,0.0005567509,0.0000033233462,0.013583607,0.0000516373,0.0005139808,0.000025798467,0.000013428205,0.005849352],"genre_scores_gemma":[0.9986425,0.00042432858,0.00013357963,0.0006211298,0.000024059798,0.000079550206,0.00003225357,0.000008770907,0.00003382887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906373,0.00008122787,0.0002687014,0.00026712051,0.00014691289,0.00017229964],"domain_scores_gemma":[0.9995725,0.0001181913,0.000026882011,0.00011584824,0.00006572608,0.000100825084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013901862,0.00010476727,0.00036050697,0.0000858402,0.000017442897,0.00000739682,0.000028673589,0.00008108476,0.000097047465],"category_scores_gemma":[0.000007413589,0.000073720235,0.00005901718,0.00016816166,0.00020245524,0.00005943296,0.000026305599,0.00017317636,0.0000056545678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00100624,0.0017326926,0.9911684,0.00005338699,0.00015855179,0.00011786819,0.00072261126,0.0000024691196,0.000014395119,0.0004592961,0.000723086,0.0038410146],"study_design_scores_gemma":[0.003167469,0.0037160204,0.8798664,0.00012313527,0.000032246462,0.000019265466,0.00005416903,0.00003615813,0.00008271718,0.00006778411,0.11276317,0.00007143272],"about_ca_topic_score_codex":0.00024010096,"about_ca_topic_score_gemma":0.000106218744,"teacher_disagreement_score":0.11204008,"about_ca_system_score_codex":0.00006651921,"about_ca_system_score_gemma":0.00017689868,"threshold_uncertainty_score":0.3006224},"labels":[],"label_agreement":null},{"id":"W4405050504","doi":"10.1016/j.esmoop.2024.103972","title":"Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Foundation Medicine; XBiotech; EMD Serono; Genentech; National Institutes of Health; HCA Healthcare; Pfizer; Incyte; Moderna; Revolution Medicines; Gilead Sciences; National Cancer Institute; Vertex Pharmaceuticals; F. Hoffmann-La Roche; Eli Lilly and Company; AstraZeneca; Jounce Therapeutics; Celgene; Array BioPharma; Astellas Pharma; TG Therapeutics; Seagen; Agios Pharmaceuticals","keywords":"Atezolizumab; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Oncology; Medicine; Urothelial cancer; Internal medicine; Urology; Phase (matter); Bladder cancer; Cancer; Chemistry; Immunotherapy; Nivolumab","score_opus":0.0958352596985449,"score_gpt":0.4042303405836028,"score_spread":0.3083950808850579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701455,0.0024310523,0.0047543775,0.008820093,0.0012210553,0.0070270924,0.0023103447,0.00011460114,0.0031758358],"genre_scores_gemma":[0.98877937,0.000059438677,0.0012640613,0.0012605042,0.0009768591,0.0010414955,0.0004918468,0.00005495344,0.0060714926],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985353,0.00008751323,0.00034345163,0.0004942166,0.00025650687,0.0002830182],"domain_scores_gemma":[0.9990082,0.00025370752,0.00005875839,0.0005140607,0.000051531824,0.00011375271],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027217687,0.00024227533,0.0005815718,0.00010288425,0.00026404808,0.00023081928,0.00038357993,0.000057099787,0.0022938203],"category_scores_gemma":[0.000034917102,0.00014588455,0.000483405,0.00046993888,0.00005916221,0.0001504156,0.00009200665,0.00015701719,0.00006660426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48564342,0.0064057484,0.003031535,0.00015479597,0.048878934,0.0008303361,0.013846547,0.000055540422,0.0011625456,0.0033197678,0.106512025,0.33015883],"study_design_scores_gemma":[0.4822514,0.015098516,0.005552967,0.00013349389,0.028750861,0.00003299289,0.00045910617,0.0074272975,0.0065657184,0.005602032,0.44742814,0.0006974765],"about_ca_topic_score_codex":0.010063307,"about_ca_topic_score_gemma":0.00065870024,"teacher_disagreement_score":0.3409161,"about_ca_system_score_codex":0.00010439914,"about_ca_system_score_gemma":0.00048768576,"threshold_uncertainty_score":0.99861825},"labels":[],"label_agreement":null},{"id":"W4405070154","doi":"10.3390/curroncol31120573","title":"Planned Abscopal Effect with Concurrent Pembrolizumab and Ablative Radiotherapy to Pulmonary Metastasis: A Case Report and Review of the Literature","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ditmanson Medical Foundation Chia-Yi Christian Hospital","keywords":"Abscopal effect; Medicine; Pembrolizumab; Radiation therapy; Ablative case; Lung cancer; Oncology; Immunotherapy; Chemotherapy; Internal medicine; Radiology; Cancer","score_opus":0.06592912289952853,"score_gpt":0.4427797619957307,"score_spread":0.3768506390962022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405070154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014832291,0.9932828,0.0000035083447,0.0002956795,0.0009252268,0.00458363,0.00042086685,0.000024459207,0.00031551512],"genre_scores_gemma":[0.00014996312,0.9982548,0.000041813433,0.00014601267,0.00027194712,0.00076394185,0.00016519183,0.00005754071,0.00014881224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976621,0.0004902801,0.0006690682,0.00068208296,0.00024048578,0.00025598126],"domain_scores_gemma":[0.99861014,0.00020814981,0.00039736828,0.00045279626,0.000110952795,0.00022061006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036088013,0.00058753026,0.0029320652,0.00016680325,0.000058652025,0.000019811052,0.000097517295,0.00019921604,0.000028265578],"category_scores_gemma":[0.00007410948,0.00027062304,0.00034315168,0.00049138605,0.00018411521,0.00003269982,0.00010745355,0.00071499596,0.0000031392262],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023284263,0.00014233137,0.000053480722,0.20061149,0.0011868373,0.02237281,0.0002809519,7.521647e-9,1.4861136e-7,0.0000123186355,0.0023516936,0.7727551],"study_design_scores_gemma":[0.0008167175,0.0022315476,0.000011196088,0.19526571,0.008562862,0.19354331,0.0000067836845,6.3971197e-7,8.671075e-7,0.0000024257051,0.59941095,0.00014700225],"about_ca_topic_score_codex":0.000011035409,"about_ca_topic_score_gemma":0.000008989613,"teacher_disagreement_score":0.7726081,"about_ca_system_score_codex":0.0003063851,"about_ca_system_score_gemma":0.0008538395,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W4405181517","doi":"10.1158/1538-8514.cancerchem24-a002","title":"Abstract A002: Computational identification for missense mutations of bladder cancer candidate genes using TCGA datasets","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Missense mutation; Genetics; Biology; Gene; Bladder cancer; Cancer; Mutation; Genome; Cancer research","score_opus":0.05754441736755274,"score_gpt":0.38405656591091075,"score_spread":0.326512148543358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405181517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.838026,0.0646744,0.07703799,0.0034352278,0.0014186237,0.0021637913,0.012978041,0.0001468412,0.00011912636],"genre_scores_gemma":[0.99493605,0.0006526173,0.0019471669,0.00077170756,0.00014223429,0.0001748694,0.0012106005,0.000062042,0.000102727645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988511,0.000019823208,0.0003344094,0.00031473077,0.0002785016,0.00020139366],"domain_scores_gemma":[0.9993319,0.00004762337,0.00009734607,0.00022974882,0.00022189268,0.00007147367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007127698,0.00017954307,0.0002206654,0.0001210791,0.00008289713,0.000048273603,0.0000743085,0.000075796925,0.00021859292],"category_scores_gemma":[0.0000043055697,0.00016582047,0.00013461019,0.00022520317,0.00008089954,0.00008107823,0.000012590052,0.000087640736,0.000005610113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004522907,0.0003294146,0.001649004,0.0013780486,0.0043864925,0.00012516236,0.0010153943,0.028074274,0.885729,0.0005344456,0.00091525784,0.0754112],"study_design_scores_gemma":[0.005643387,0.00031441535,0.022483012,0.0013633925,0.0080970805,0.00011211747,0.00029710485,0.1121259,0.7898617,0.0044109225,0.054350223,0.000940747],"about_ca_topic_score_codex":0.0008698946,"about_ca_topic_score_gemma":0.00006839213,"teacher_disagreement_score":0.15691008,"about_ca_system_score_codex":0.00019768783,"about_ca_system_score_gemma":0.0005169876,"threshold_uncertainty_score":0.6761963},"labels":[],"label_agreement":null},{"id":"W4405232167","doi":"10.1245/s10434-024-16644-4","title":"Urinary Diversion Versus Adverse In-Hospital Outcomes After Radical Cystectomy","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Urinary diversion; Cohort; Urology; Logistic regression; Odds ratio; Urinary system; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.04079826410407405,"score_gpt":0.3719927427956867,"score_spread":0.33119447869161267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405232167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95338786,0.0024571957,0.0000013605942,0.02126602,0.001022774,0.00027749815,0.000025038724,0.00005169387,0.021510536],"genre_scores_gemma":[0.9970462,0.0017705655,0.000054898992,0.0003172717,0.0001363578,0.000034525005,0.000012164257,0.000013977846,0.0006140636],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890554,0.00006142377,0.00027761608,0.00026890045,0.00022050658,0.0002660171],"domain_scores_gemma":[0.9993449,0.00028141626,0.000029549,0.00014231756,0.000042446594,0.00015941249],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013060472,0.0001413563,0.00046744416,0.00015359209,0.000015980404,0.0000031464272,0.00006429344,0.00019084009,0.0011140894],"category_scores_gemma":[0.000013608865,0.0001028085,0.00025708912,0.00018673463,0.0001672119,0.00008392471,0.00007769817,0.0002253993,0.00017826895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08033819,0.016216174,0.42719236,0.0011616152,0.002836767,0.22420157,0.0034751657,0.000010236443,0.00013021068,0.0027652916,0.04162746,0.20004496],"study_design_scores_gemma":[0.011243357,0.009981528,0.08655555,0.00021319382,0.00016642526,0.00017056271,0.00014986968,0.000023650644,0.00026521526,0.00014887203,0.89090544,0.00017636262],"about_ca_topic_score_codex":0.00007451084,"about_ca_topic_score_gemma":0.0000055421033,"teacher_disagreement_score":0.849278,"about_ca_system_score_codex":0.000087978464,"about_ca_system_score_gemma":0.00018550368,"threshold_uncertainty_score":0.999799},"labels":[],"label_agreement":null},{"id":"W4405265943","doi":"10.32604/or.2024.055155","title":"Biomarkers for predicting bladder cancer therapy response","year":2024,"lang":"en","type":"review","venue":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bladder cancer; Cancer therapy; Medicine; Oncology; Cancer; Internal medicine","score_opus":0.5279350147086131,"score_gpt":0.6319476790168104,"score_spread":0.10401266430819722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405265943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006539993,0.9825537,0.0000042509064,0.0076929806,0.002659711,0.005070936,0.0006237628,0.00019433857,0.0005462705],"genre_scores_gemma":[0.00011295794,0.98154336,0.0003977949,0.0014330626,0.0038457396,0.004319231,0.000068006455,0.0002905028,0.007989359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99056894,0.0029897348,0.0022299269,0.0020314932,0.00080606603,0.0013738407],"domain_scores_gemma":[0.98162144,0.015551837,0.00044007722,0.00088182546,0.0006946952,0.0008101391],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008848933,0.00088007096,0.00396153,0.00041818156,0.000443833,0.0001546686,0.0005578901,0.0026358413,0.0001921614],"category_scores_gemma":[0.0010523581,0.0005702676,0.0017285545,0.00087054766,0.0015929102,0.000077536635,0.00042867838,0.004861719,0.000051255418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012607678,0.00087867293,0.0010019222,0.005682375,0.012500653,0.00008819428,0.0001255067,7.7829256e-8,0.0000023837415,0.000014246807,0.0057483003,0.96134996],"study_design_scores_gemma":[0.0047616055,0.0072245672,0.000625638,0.011181464,0.009187144,0.00006916222,0.000053331696,0.000026242165,0.000005668796,0.00029769595,0.9660689,0.00049857964],"about_ca_topic_score_codex":0.00015989716,"about_ca_topic_score_gemma":0.00012916094,"teacher_disagreement_score":0.96085143,"about_ca_system_score_codex":0.00091805,"about_ca_system_score_gemma":0.008190857,"threshold_uncertainty_score":0.99967486},"labels":[],"label_agreement":null},{"id":"W4405310825","doi":"10.1111/bju.16622","title":"Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Urothelial cancer; Bladder cancer; Urothelial carcinoma; Medicine; Urology; Urinary Bladder Cancer; Cancer; Urinary bladder; Urinary system; Internal medicine","score_opus":0.014421627801781649,"score_gpt":0.2748748845428685,"score_spread":0.2604532567410869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405310825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606271,0.031773467,0.0002419677,0.004717957,0.0010660876,0.00030625708,0.000067028464,0.000028955606,0.001171227],"genre_scores_gemma":[0.9918846,0.0046738596,0.00009495519,0.0016436139,0.0009924131,0.00003187675,0.0000033804022,0.00005512723,0.0006201821],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986429,0.000110777124,0.00040771323,0.00023738465,0.0002772832,0.00032389682],"domain_scores_gemma":[0.999471,0.000059926177,0.00007632922,0.000105216044,0.00014352625,0.00014400916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021352316,0.0001732536,0.00047892088,0.00020131671,0.000028024418,0.000054140197,0.0001000386,0.00014154971,0.0024361024],"category_scores_gemma":[0.000020984926,0.00014102503,0.00013458243,0.00025219595,0.00011244246,0.00010979771,0.000012827681,0.00051716884,0.000015022308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042933542,0.0020591521,0.22138749,0.00018099727,0.0051433574,0.14826304,0.0027417347,0.00014772073,0.008242584,0.00015939387,0.005751327,0.56298965],"study_design_scores_gemma":[0.04614842,0.015884165,0.72352344,0.0009832998,0.0013189823,0.07656064,0.0002382418,0.00010935159,0.0022941637,0.00076031097,0.13140763,0.0007713662],"about_ca_topic_score_codex":0.0008778441,"about_ca_topic_score_gemma":0.0012762526,"teacher_disagreement_score":0.5622183,"about_ca_system_score_codex":0.00008280195,"about_ca_system_score_gemma":0.00087681744,"threshold_uncertainty_score":0.9984758},"labels":[],"label_agreement":null},{"id":"W4405465549","doi":"10.1016/j.euo.2024.12.005","title":"Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Bladder cancer; Bacillus (shape); Urology; Oncology; Internal medicine; Cancer; Microbiology","score_opus":0.01886197048488084,"score_gpt":0.2837807346246937,"score_spread":0.26491876413981286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405465549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870751,0.00067063636,0.00012597827,0.003650177,0.00049963436,0.0014087381,0.00021774242,0.000100252706,0.0062517407],"genre_scores_gemma":[0.99495775,0.00015133628,0.00059774634,0.003243877,0.00019239378,0.00011703384,0.00010494692,0.000112014735,0.0005229039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960895,0.00088173937,0.00077019696,0.0010555739,0.00040310386,0.0007998552],"domain_scores_gemma":[0.9980244,0.0006514397,0.00024254838,0.00046852563,0.0002739158,0.00033918532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004177957,0.0006078048,0.0014859607,0.00050425617,0.00009854408,0.000025100662,0.00024914017,0.0002710856,0.000457656],"category_scores_gemma":[0.00015431776,0.00041381558,0.00012451061,0.00052524864,0.001163356,0.00014106685,0.0002418256,0.0008758176,0.00008207692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021774083,0.0033766737,0.89803433,0.0003956873,0.004095047,0.013539728,0.00536331,0.0004771213,0.002681592,0.00020474273,0.002801533,0.047256142],"study_design_scores_gemma":[0.02235229,0.018314632,0.9482923,0.000094957104,0.0010786622,0.00023831653,0.00019987531,0.00011249358,0.0002497707,0.000025882771,0.008604335,0.00043647052],"about_ca_topic_score_codex":0.0005129074,"about_ca_topic_score_gemma":0.0016535756,"teacher_disagreement_score":0.050257973,"about_ca_system_score_codex":0.00046850226,"about_ca_system_score_gemma":0.001024194,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W4405788039","doi":"10.1093/ajcp/aqae167","title":"Urothelial carcinoma in situ with “early papillary formation” vs “lateral spread/shoulder lesion” of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Genitourinary system; Carcinoma in situ; Carcinoma; Concomitant; Pathology; Urology; Internal medicine","score_opus":0.04312118069971228,"score_gpt":0.3530515567810391,"score_spread":0.30993037608132684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405788039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955018,0.0011622203,0.0008490367,0.0012667323,0.00038724992,0.00046153244,0.00021618402,0.000017527018,0.00013772068],"genre_scores_gemma":[0.99686843,0.0005965389,0.0015991858,0.00063473854,0.00018677147,0.000015870719,0.00002800706,0.00004620392,0.000024231429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955884,0.0011538848,0.0020860338,0.00042902664,0.0003873666,0.0003552398],"domain_scores_gemma":[0.9964996,0.0014236874,0.0010538688,0.00034188267,0.00044172254,0.00023924222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001361392,0.0003220843,0.0017373597,0.00040508923,0.00004606152,0.000020411522,0.00021479938,0.00021661677,0.000028716979],"category_scores_gemma":[0.0006786173,0.0002229687,0.00028704136,0.00044805848,0.0019154443,0.00020961039,0.00008868073,0.00081663445,0.0000036074375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075783175,0.0005820624,0.9685318,0.00017364317,0.00023988781,0.0044515063,0.0020647855,0.000025915271,0.00253443,0.00005337679,0.00009261008,0.013671673],"study_design_scores_gemma":[0.004873224,0.019836811,0.96957177,0.00028762332,0.00043593827,0.0028265126,0.00028707934,0.00006232791,0.0014322386,0.00015971555,0.000039676324,0.00018711298],"about_ca_topic_score_codex":0.0013544571,"about_ca_topic_score_gemma":0.00040720575,"teacher_disagreement_score":0.019254748,"about_ca_system_score_codex":0.000061046914,"about_ca_system_score_gemma":0.000839579,"threshold_uncertainty_score":0.90923995},"labels":[],"label_agreement":null},{"id":"W4405805273","doi":"10.1016/j.eururo.2024.12.002","title":"The Financial Burden of Localized and Metastatic Bladder Cancer","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Internal medicine; Cancer; Intensive care medicine","score_opus":0.04615506967158384,"score_gpt":0.3562117116536257,"score_spread":0.31005664198204186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405805273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006920653,0.9913411,0.00001547636,0.00037632024,0.0005393417,0.00059278624,0.00007512844,0.00003114088,0.0070217988],"genre_scores_gemma":[0.0001123739,0.9955712,0.0000300297,0.0002754395,0.00051720376,0.000059605674,0.000023706327,0.00009213485,0.0033183137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835616,0.00043530675,0.00047285456,0.0003569111,0.00013199857,0.00024676364],"domain_scores_gemma":[0.9992185,0.00016399563,0.00016129107,0.0003309361,0.00004011263,0.000085139334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024958813,0.000310026,0.0011568565,0.00008914544,0.000058477122,0.000015576394,0.00014622037,0.00007309371,0.00013960393],"category_scores_gemma":[0.00009075106,0.00016128941,0.00027336786,0.00016247781,0.0002703349,0.000010702115,0.00012690792,0.00038015674,0.00019270252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063399944,0.000019893689,0.0000012808215,0.0040303227,0.0010471923,0.00033824478,0.0001520797,3.3131593e-7,3.6101574e-7,0.00022370834,0.005590806,0.98853236],"study_design_scores_gemma":[0.00054018764,0.0003464497,0.000009654327,0.00089001557,0.010012344,0.00023385206,0.0000064977967,0.000006805428,2.6088804e-7,0.00006583388,0.98777664,0.00011144177],"about_ca_topic_score_codex":0.00006639008,"about_ca_topic_score_gemma":0.000016230606,"teacher_disagreement_score":0.98842096,"about_ca_system_score_codex":0.000029653374,"about_ca_system_score_gemma":0.00035902593,"threshold_uncertainty_score":0.65771914},"labels":[],"label_agreement":null},{"id":"W4405839392","doi":"10.1245/s10434-024-16766-9","title":"ASO Author Reflections: Urinary Diversion and Adverse in-Hospital Outcomes After Radical Cystectomy: Contemporary Versus Historical Cohorts","year":2024,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; Urinary diversion; General surgery; Urology; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.08298144408122074,"score_gpt":0.3988475446733033,"score_spread":0.31586610059208253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405839392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9024191,0.015877679,0.000004910804,0.059741195,0.0022986832,0.00058717746,0.000032062406,0.00010602321,0.01893316],"genre_scores_gemma":[0.99598336,0.0018937449,0.000087239416,0.00026687796,0.00014556125,0.000058849135,0.00001292499,0.000016761438,0.0015346943],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998691,0.000112269285,0.0003744777,0.0003604792,0.00022685158,0.00023489087],"domain_scores_gemma":[0.99914783,0.0003833717,0.00004833175,0.0001406312,0.000055393906,0.0002244328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002066119,0.0001691419,0.00062522,0.00021212104,0.0000354428,0.0000050033905,0.00004693247,0.00026170808,0.00023014784],"category_scores_gemma":[0.000031763502,0.00012944477,0.00019567128,0.00021489359,0.00018425881,0.00011914893,0.00008015628,0.0003037835,0.00002788118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071720816,0.012044675,0.5629236,0.0010027158,0.0025832735,0.13086618,0.00360656,0.0000022785614,0.00014040731,0.0015974068,0.14913791,0.06437418],"study_design_scores_gemma":[0.0059317835,0.008284853,0.06130412,0.00015992303,0.00013139751,0.00023596587,0.000103132355,0.0000126614395,0.00005453072,0.00015434499,0.9234766,0.00015073945],"about_ca_topic_score_codex":0.00025651808,"about_ca_topic_score_gemma":0.000011889234,"teacher_disagreement_score":0.77433866,"about_ca_system_score_codex":0.0003398924,"about_ca_system_score_gemma":0.0003148625,"threshold_uncertainty_score":0.52786046},"labels":[],"label_agreement":null},{"id":"W4405944604","doi":"10.3390/curroncol32010018","title":"Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Adverse effect; Retrospective cohort study; Observational study; Internal medicine; Stage (stratigraphy); Cancer; Urology","score_opus":0.024792052133342502,"score_gpt":0.34748079916654784,"score_spread":0.3226887470332053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405944604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957288,0.00021613747,0.000030275762,0.00025584182,0.0010109245,0.0023687147,0.00018064289,0.000013923222,0.00019474879],"genre_scores_gemma":[0.99913573,0.00013191556,0.000015418924,0.00003605714,0.00008690503,0.000526472,0.00003165747,0.000025841204,0.000010007352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981358,0.00025951077,0.00040222055,0.0006028064,0.00031765303,0.0002819849],"domain_scores_gemma":[0.99906534,0.00041336348,0.00009434932,0.0002381489,0.000096781594,0.0000920158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018901638,0.00026458417,0.0005588722,0.00019400106,0.000039158906,0.000014490712,0.00012002504,0.00006620677,0.00010938243],"category_scores_gemma":[0.00006016021,0.00017220849,0.000082278624,0.0003460936,0.00023186572,0.00009193705,0.00009340028,0.0004261681,0.0000048155284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033721921,0.004831049,0.9744608,0.00010826845,0.00025414844,0.00008770557,0.005140021,0.000004923148,0.00007100488,0.00002060083,0.000051808016,0.011597523],"study_design_scores_gemma":[0.0108318105,0.005537082,0.9803516,0.0015931346,0.00012688925,4.4922214e-7,0.0008869697,0.00009554652,0.00027475198,0.00001672209,0.00013297677,0.00015206779],"about_ca_topic_score_codex":0.0022866926,"about_ca_topic_score_gemma":0.0041780653,"teacher_disagreement_score":0.011445455,"about_ca_system_score_codex":0.0010491288,"about_ca_system_score_gemma":0.00016824731,"threshold_uncertainty_score":0.70224583},"labels":[],"label_agreement":null},{"id":"W4405956361","doi":"10.5194/egusphere-2024-3787-cc2","title":"Reply on CEC2","year":2025,"lang":"en","type":"peer-review","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Geological Survey of Canada","funders":"Japan Society for the Promotion of Science; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Computer science","score_opus":0.04055595280947484,"score_gpt":0.3613032272099114,"score_spread":0.3207472744004366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405956361","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.8408733e-7,0.038392857,0.0000068070512,0.21237525,0.001845126,0.0007798963,0.00018519629,0.00009903629,0.74631524],"genre_scores_gemma":[0.000012481765,0.017438699,0.000103526865,0.2006182,0.000496772,0.000091091286,0.00073438376,0.000022590792,0.7804823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998743,0.000021863096,0.00025634578,0.0004252242,0.00036552016,0.00018806942],"domain_scores_gemma":[0.9989343,0.000042579064,0.00005922484,0.00073850655,0.0001229159,0.00010243828],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000078259814,0.00027579934,0.00072301197,0.00009744737,0.000028751225,0.000007894521,0.00009666141,0.00015051519,0.008216928],"category_scores_gemma":[0.0000921861,0.00018527763,0.00027014886,0.00014368798,0.000017992157,0.000009217773,0.000034605386,0.0003413002,0.00078116136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044249395,0.00010527838,0.000013744283,0.003479344,0.00022777665,0.000054681674,0.0000028095299,1.2661184e-8,4.1260537e-7,0.00008745406,0.9646028,0.031381436],"study_design_scores_gemma":[0.0007494143,0.0003718827,0.00008343763,0.012357589,0.0009830388,0.00001376747,0.0000013682723,2.1874366e-7,0.000081284,0.0000459979,0.9851799,0.00013209927],"about_ca_topic_score_codex":0.00057769415,"about_ca_topic_score_gemma":0.000021998147,"teacher_disagreement_score":0.03416702,"about_ca_system_score_codex":0.00014764794,"about_ca_system_score_gemma":0.00057676464,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W4406072618","doi":"10.5489/cuaj.9096","title":"2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université Laval; McGill University; University of Calgary; Princess Margaret Cancer Centre; McMaster University; Dalhousie University; University Health Network; University of Toronto; University of British Columbia","funders":"EMD Serono; Genentech; Astellas Pharma; Eisai; Seagen; Boston Scientific Corporation; Gilead Sciences; Progenics Pharmaceuticals; Exelixis; Sanofi; AstraZeneca; Veracyte; Amgen; Pfizer; Ipsen; Varian Medical Systems; GlaxoSmithKline","keywords":"Bladder cancer; Medicine; Association (psychology); Cancer; Urology; Internal medicine; Psychology","score_opus":0.017291651910384995,"score_gpt":0.2802770995261158,"score_spread":0.2629854476157308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406072618","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39155596,0.004692064,0.00010269671,0.5090485,0.0055645043,0.0013478849,0.00045377534,0.00017856255,0.08705602],"genre_scores_gemma":[0.92490244,0.0008256467,0.000110928304,0.054877184,0.001281835,0.00010244972,0.0000956352,0.000025204537,0.017778656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965529,0.00029994026,0.000712096,0.0005197062,0.0006581635,0.0012572309],"domain_scores_gemma":[0.9963529,0.00032234515,0.00046895657,0.0002515521,0.0008469041,0.0017573414],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089045096,0.00033263728,0.000593403,0.0005269358,0.00072659075,0.00019120674,0.0002245464,0.0009139074,0.004521631],"category_scores_gemma":[0.0030159045,0.0002803602,0.00034041703,0.00061229954,0.00004377474,0.00015581863,0.000025068113,0.0011589234,0.00014155556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004828809,0.00006840495,0.77159244,0.0000046430464,0.00070176885,0.0009820139,0.00014284113,0.000024000254,0.00008129651,0.00013811952,0.22185256,0.004363614],"study_design_scores_gemma":[0.0012765443,0.00016961114,0.61851645,0.00002938873,0.00026214292,0.00012876403,0.000076242715,0.000026204067,0.000045562116,0.00073353713,0.3785437,0.00019185295],"about_ca_topic_score_codex":0.23150301,"about_ca_topic_score_gemma":0.26885754,"teacher_disagreement_score":0.5333465,"about_ca_system_score_codex":0.01248258,"about_ca_system_score_gemma":0.008328028,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W4406132942","doi":"10.1002/bco2.475","title":"The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY study","year":2025,"lang":"en","type":"article","venue":"BJUI Compass","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Urology Foundation; Rosetrees Trust","keywords":"Urinary system; Medicine; Bladder cancer; Cancer; Urology; Clinical significance; Internal medicine","score_opus":0.023640362727252322,"score_gpt":0.30962237629634404,"score_spread":0.2859820135690917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406132942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212015,0.00045043466,0.000010169456,0.004127998,0.0001460778,0.0020471336,0.00013973996,0.000024431018,0.0009338663],"genre_scores_gemma":[0.999045,0.00006977262,0.00001319123,0.00026311315,0.000043461438,0.00031336537,0.00004716256,0.000017030294,0.00018790775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799216,0.00045749833,0.0005243328,0.0003435311,0.0003836252,0.00029883778],"domain_scores_gemma":[0.9981293,0.0008331517,0.000172448,0.0007011337,0.00012947971,0.0000344938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000413467,0.00020568933,0.00035745677,0.000066733235,0.00013884221,0.0000372971,0.00040752094,0.000063139734,0.000014601635],"category_scores_gemma":[0.00011366825,0.00009693827,0.000053398635,0.00076045864,0.000113465685,0.00005252353,0.000048269474,0.00037800666,0.0000017160194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010582086,0.0036226185,0.97467273,0.000013126047,0.00035541487,0.00009329724,0.0069824676,0.000041352043,0.00016077467,0.000010181068,0.00224603,0.0012199258],"study_design_scores_gemma":[0.012664581,0.0010156587,0.9806333,0.0002197354,0.00019611619,0.0000023973575,0.0042524775,0.00013601732,0.00022361655,0.000112859474,0.00044805827,0.00009517726],"about_ca_topic_score_codex":0.014190565,"about_ca_topic_score_gemma":0.01158255,"teacher_disagreement_score":0.006924846,"about_ca_system_score_codex":0.00021182794,"about_ca_system_score_gemma":0.0003260944,"threshold_uncertainty_score":0.992374},"labels":[],"label_agreement":null},{"id":"W4406136944","doi":"10.1016/j.euo.2024.12.009","title":"Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines","year":2025,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Urothelial carcinoma; Lymph node metastasis; Multimodal therapy; Lymph node; Metastasis; Oncology; General surgery; Urology; Internal medicine; Cancer; Bladder cancer","score_opus":0.16649947699337558,"score_gpt":0.42395589411950907,"score_spread":0.2574564171261335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406136944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014052461,0.99213815,0.000071955175,0.0009951215,0.0000538642,0.0043011033,0.0007688181,0.000010544149,0.00025517496],"genre_scores_gemma":[0.022067994,0.975266,0.0005495524,0.0010483142,0.000084095416,0.00035586837,0.00023740732,0.00006961281,0.00032115972],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9875845,0.007450021,0.003486822,0.0007807587,0.00034463932,0.00035327865],"domain_scores_gemma":[0.98985547,0.0043278574,0.0042767213,0.0006616123,0.00075299066,0.00012532297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036762548,0.0005839379,0.008856187,0.00026946454,0.000061457926,0.0000063779084,0.00033265635,0.00027069583,0.00004283524],"category_scores_gemma":[0.0017065258,0.00031426107,0.0019180003,0.00034003626,0.00055386417,0.00004894934,0.00014082492,0.00027258988,0.0000012534434],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026902077,0.004244066,0.01894242,0.436046,0.47591522,0.00011106746,0.0004723361,0.00002388664,0.000004772292,0.000067277775,0.001477734,0.060005005],"study_design_scores_gemma":[0.0045606545,0.0076639336,0.0025059409,0.0040943213,0.95906156,0.0001529877,0.000017380382,0.000019341864,0.0000027429328,0.0000074320747,0.021683166,0.00023056396],"about_ca_topic_score_codex":0.00014476111,"about_ca_topic_score_gemma":0.000016179216,"teacher_disagreement_score":0.4831463,"about_ca_system_score_codex":0.000092794646,"about_ca_system_score_gemma":0.0006175095,"threshold_uncertainty_score":0.9999309},"labels":[],"label_agreement":null},{"id":"W4406206742","doi":"10.1016/j.anicom.2024.12.002","title":"Bandelette urinaire : les protéines virent au vert ! Je fais quoi ?","year":2025,"lang":"fr","type":"article","venue":"Revue Vétérinaire Clinique","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.027431763187860187,"score_gpt":0.3296531644178808,"score_spread":0.3022214012300206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406206742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32186088,0.14735039,0.0061141783,0.31911173,0.029722828,0.011728622,0.00044918005,0.0012730947,0.16238911],"genre_scores_gemma":[0.85640615,0.0098263705,0.0007655015,0.0032948845,0.004990413,0.0009361517,0.00007187992,0.00014831305,0.12356032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563545,0.00036039448,0.0012289232,0.0011865825,0.0003455097,0.001243126],"domain_scores_gemma":[0.9973358,0.00038534234,0.00028202805,0.0012052241,0.00031093656,0.00048070148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005489787,0.00083055353,0.0012923108,0.00032412648,0.00044315867,0.0000761335,0.00043711512,0.0007837559,0.00071408175],"category_scores_gemma":[0.00046616574,0.00080908457,0.0006998156,0.0007568789,0.0004622306,0.00030656307,0.00025227838,0.0009777138,0.000555066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011119121,0.002502173,0.25270864,0.0093014045,0.0014214417,0.0014641371,0.0012761994,0.000034396053,0.00038185538,0.012003131,0.046619218,0.6711755],"study_design_scores_gemma":[0.0055915066,0.0020869893,0.18048489,0.017268263,0.0016324223,0.00028636187,0.0003275951,0.00031456945,0.0059973253,0.0023137627,0.78275514,0.0009411901],"about_ca_topic_score_codex":0.0047512804,"about_ca_topic_score_gemma":0.0016963474,"teacher_disagreement_score":0.7361359,"about_ca_system_score_codex":0.0014300237,"about_ca_system_score_gemma":0.002455022,"threshold_uncertainty_score":0.999436},"labels":[],"label_agreement":null},{"id":"W4406209263","doi":"10.1007/s40615-025-02285-0","title":"Non-Caucasian Race/Ethnicity Predisposes to Unfavorable Stage and Grade at Upper Tract Urothelial Carcinoma Diagnosis","year":2025,"lang":"en","type":"article","venue":"Journal of Racial and Ethnic Health Disparities","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Università degli Studi di Napoli Federico II","keywords":"Medicine; Renal pelvis; Stage (stratigraphy); Pacific islanders; Confidence interval; Internal medicine; Hazard ratio; Epidemiology; Logistic regression; T-stage; Urology; Gastroenterology; Oncology; Cancer; Kidney; Population; Biology","score_opus":0.035390138461818016,"score_gpt":0.3561791849066887,"score_spread":0.3207890464448707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406209263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486392,0.020393621,0.00008054648,0.028982332,0.0005665625,0.00061991595,0.00012470217,0.000014924171,0.00057816494],"genre_scores_gemma":[0.9792207,0.009988251,0.00022283007,0.006279368,0.00043827284,0.000041780557,0.0000058345163,0.000021544287,0.003781423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981951,0.00010187931,0.00065055944,0.00025467286,0.0003344622,0.0004632864],"domain_scores_gemma":[0.998734,0.00016504563,0.00021315068,0.00015705904,0.00011608612,0.0006146657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049708877,0.00024457072,0.00079135754,0.00024313426,0.00032946587,0.000044616696,0.00008676837,0.00013103966,0.000076395816],"category_scores_gemma":[0.00011859342,0.00018940591,0.00013881795,0.00021810354,0.0001456048,0.00020484583,0.00007641655,0.0003975587,0.0000025228605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023912038,0.00068000256,0.94222474,0.0017691425,0.00021345314,0.00013450038,0.007828531,0.0000057559123,0.00020811064,0.00020972303,0.013596697,0.03073816],"study_design_scores_gemma":[0.0032826015,0.001784581,0.9659361,0.0007203111,0.00019591203,0.0001405066,0.0010479876,0.000014650302,0.0010112213,0.00022179607,0.025483998,0.00016029555],"about_ca_topic_score_codex":0.0019390633,"about_ca_topic_score_gemma":0.0008168869,"teacher_disagreement_score":0.030581463,"about_ca_system_score_codex":0.00027379894,"about_ca_system_score_gemma":0.000775423,"threshold_uncertainty_score":0.7723749},"labels":[],"label_agreement":null},{"id":"W4406239303","doi":"10.1007/978-3-031-68505-7_20","title":"Mechanisms and Biomarkers of Response to BCG and Chemotherapy in Bladder Cancer","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Oncology; Chemotherapy; Cancer research; Internal medicine; Cancer","score_opus":0.01646202853063005,"score_gpt":0.29130542304857215,"score_spread":0.2748433945179421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406239303","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039013814,0.02307508,0.00011821438,0.022186926,0.0006248791,0.0038043323,0.0005291574,0.0001485097,0.9104991],"genre_scores_gemma":[0.04814585,0.0040453025,0.0010887133,0.0028172566,0.000060328126,0.000063442,0.000008674887,0.00012403021,0.94364643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907935,0.0000075596668,0.00022261358,0.00037884567,0.00017340384,0.0001382042],"domain_scores_gemma":[0.99956834,0.000041761054,0.000035945774,0.00018487385,0.000033828306,0.00013527465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001228313,0.0002532963,0.00045043282,0.00030699914,0.00001092349,0.000010212547,0.000032801898,0.000201733,0.0013743272],"category_scores_gemma":[0.0000051962534,0.00019458204,0.000055494183,0.000045464567,0.00006243401,0.000017608008,0.000039512797,0.00012337977,0.000013667643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.118899494,0.0005976969,0.0030314603,0.0050652493,0.018779872,0.0022724434,0.011467588,0.0000021497153,0.15135123,0.18004644,0.055367425,0.45311895],"study_design_scores_gemma":[0.030629529,0.00978885,0.034195635,0.01115955,0.0037161398,0.00041771584,0.0007273602,0.00008733965,0.033712067,0.12505117,0.74776125,0.0027533814],"about_ca_topic_score_codex":0.00044806392,"about_ca_topic_score_gemma":0.0002557429,"teacher_disagreement_score":0.69239384,"about_ca_system_score_codex":0.00008780894,"about_ca_system_score_gemma":0.00014347394,"threshold_uncertainty_score":0.99953854},"labels":[],"label_agreement":null},{"id":"W4406314794","doi":"10.1111/bju.16643","title":"Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Innovációs és Technológiai Minisztérium; Universität Duisburg-Essen","keywords":"Bladder cancer; Immunohistochemistry; Cystectomy; Tissue microarray; Urothelial cancer; Pathology; Medicine; Lymph node; Nectin; Cancer; Oncology; Internal medicine; Cancer research; Cell; Biology; Cell adhesion","score_opus":0.011487031936126373,"score_gpt":0.26784499338688855,"score_spread":0.2563579614507622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406314794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888302,0.008662142,0.0010547271,0.000691142,0.00036501864,0.0001300817,0.00007925565,0.0000034839888,0.00018396552],"genre_scores_gemma":[0.9925707,0.0069568697,0.000028391438,0.00022275942,0.00014199747,0.0000058351156,0.000012169725,0.000006915168,0.00005434898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992046,0.00007354223,0.000342614,0.00012584821,0.00011402436,0.00013936585],"domain_scores_gemma":[0.99949855,0.000068803274,0.00016790329,0.00006556595,0.0001432182,0.00005595741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010724448,0.00007650009,0.00030800118,0.00009155406,0.000027621274,0.000008007045,0.000048531012,0.000098663644,0.00017019719],"category_scores_gemma":[0.00007170284,0.00007652604,0.000059079513,0.00008596227,0.000053347812,0.000052192845,0.000026121916,0.00022977592,4.1599986e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015475665,0.0005253055,0.7327861,0.00013701411,0.00019786446,0.0013602793,0.00027349795,0.000023791385,0.017331367,0.000046413355,0.0033919201,0.24237888],"study_design_scores_gemma":[0.0040533347,0.00051194365,0.98625195,0.00044187636,0.00010783316,0.0007207802,0.00007464526,0.0000058297396,0.0052410094,0.00021124854,0.0023282052,0.000051350224],"about_ca_topic_score_codex":0.0014332902,"about_ca_topic_score_gemma":0.0009282667,"teacher_disagreement_score":0.25346583,"about_ca_system_score_codex":0.00005799598,"about_ca_system_score_gemma":0.00017066929,"threshold_uncertainty_score":0.31206414},"labels":[],"label_agreement":null},{"id":"W4406378277","doi":"10.14740/wjon1966","title":"Prevalence and Clinical Outcomes of Human Epidermal Growth Factor Receptor 2 Expression in Patients With Advanced Urothelial Carcinoma","year":2025,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial carcinoma; Epidermal growth factor receptor; Oncology; Human Epidermal Growth Factor Receptor 2; Carcinoma; Internal medicine; Cancer research; Receptor; Cancer; Bladder cancer","score_opus":0.021278229730735097,"score_gpt":0.35354944882475775,"score_spread":0.33227121909402263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406378277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756265,0.0002800954,0.0000148925155,0.0005302918,0.0003249473,0.00031527271,0.000013077382,0.0000036327633,0.0009551542],"genre_scores_gemma":[0.9978543,0.00011017495,0.0012076106,0.00029844255,0.000060002498,0.0000046040113,0.0000014946611,0.000009613911,0.00045377453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860704,0.00016440057,0.0007307738,0.00015650426,0.00018692012,0.00015436392],"domain_scores_gemma":[0.9989375,0.0002391124,0.00040447462,0.00011644413,0.00019928119,0.00010321078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018589037,0.00012666099,0.00068641774,0.0002621124,0.000030052483,0.000002942241,0.00009018575,0.00007655771,0.00013173503],"category_scores_gemma":[0.00013358897,0.00008189497,0.00009590858,0.00013272448,0.00013967975,0.00009142651,0.000038552673,0.00030573146,6.787349e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032757905,0.0008705653,0.9802179,0.000081367856,0.000105239735,0.000025432906,0.00011308411,3.2525836e-7,0.0004298392,0.000019617062,0.00018957425,0.014671289],"study_design_scores_gemma":[0.016268337,0.0055463235,0.9756878,0.00028308659,0.00014277364,0.000005279376,0.000021095251,3.4906776e-7,0.0014624454,0.000047144826,0.0004765566,0.000058792226],"about_ca_topic_score_codex":0.000017488132,"about_ca_topic_score_gemma":0.000045448152,"teacher_disagreement_score":0.014612497,"about_ca_system_score_codex":0.00013202631,"about_ca_system_score_gemma":0.0003018843,"threshold_uncertainty_score":0.333958},"labels":[],"label_agreement":null},{"id":"W4406382295","doi":"10.5489/cuaj.8989","title":"Readmission and unplanned healthcare use after radical cystectomy are independent of discharge destination","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Quartile; Hospital discharge; Incidence (geometry); Bladder cancer; Socioeconomic status; Emergency department; Patient discharge; Emergency medicine; Internal medicine; Cancer; MEDLINE; Nursing; Environmental health; Confidence interval","score_opus":0.014637456146452014,"score_gpt":0.26451938287753274,"score_spread":0.24988192673108073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406382295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96107936,0.0005853509,0.00008182828,0.037443712,0.00018537935,0.0002516849,0.000076089025,0.000013517327,0.00028307666],"genre_scores_gemma":[0.9959171,0.0000888823,0.00012557689,0.0031679356,0.0000844261,0.000011404836,0.000016013732,0.000005764101,0.0005829234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893034,0.00014597643,0.00027595606,0.00015103153,0.00025053375,0.00024616643],"domain_scores_gemma":[0.9989178,0.00009291513,0.00017852604,0.00007028342,0.00021973735,0.0005207485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002680006,0.00009967088,0.00024094805,0.00019344373,0.00013153654,0.000039512906,0.00004041393,0.00021896348,0.00013066104],"category_scores_gemma":[0.00061897875,0.00007517612,0.00006154286,0.00015854131,0.000026148016,0.00008572531,0.000011732642,0.00035433855,0.0000030363167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000209605,0.000042560943,0.9969184,0.000021957512,0.000066250715,0.00005701629,0.00006333034,8.390118e-7,0.000059887643,0.00011807793,0.0011335177,0.0013085932],"study_design_scores_gemma":[0.0015812067,0.00023880697,0.99117345,0.000115669114,0.00008532973,0.0000897378,0.0000450191,0.000022628048,0.00007090937,0.0004840891,0.0060357195,0.000057452224],"about_ca_topic_score_codex":0.0012476578,"about_ca_topic_score_gemma":0.0010244356,"teacher_disagreement_score":0.03483771,"about_ca_system_score_codex":0.0007244622,"about_ca_system_score_gemma":0.0005491999,"threshold_uncertainty_score":0.30655932},"labels":[],"label_agreement":null},{"id":"W4406390326","doi":"10.1016/s1283-0879(20)78073-x","title":"10.1016/s1283-0879(20)78073-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.009256940693220842,"score_gpt":0.21715070753348123,"score_spread":0.2078937668402604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406390326","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008906917,0.00019688533,5.3231304e-7,0.00097407243,0.0000024494555,0.00034700753,0.000031837735,0.00014028217,0.99741626],"genre_scores_gemma":[0.0007410845,9.655994e-7,0.00011562819,0.00031388723,0.00028921635,0.00004038691,0.000038315025,0.0000357245,0.99842477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909586,0.00001861965,0.00015330654,0.00024425067,0.00021309746,0.00027484613],"domain_scores_gemma":[0.9993508,0.000017896666,0.000016372114,0.0003260715,0.000038852377,0.00025001],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000524778,0.00015745847,0.00023561649,0.000060209662,0.00005583939,0.000015384481,0.000087411645,0.00006420831,0.998345],"category_scores_gemma":[0.000011931853,0.00013218915,0.000081164755,0.00016793357,0.000026779193,0.000048629983,0.00001706322,0.00009346114,0.99496037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047208832,0.00014207256,0.0000021797327,0.0000109029515,0.00007084746,0.000038943057,0.00002825283,0.0000045294505,0.0001021854,2.9499134e-7,0.38586026,0.6132674],"study_design_scores_gemma":[0.0013879649,0.0006358539,0.00026672214,0.00003947896,0.00011417288,0.00004599983,0.0000010852328,0.000018420109,0.0004474191,0.0000074211553,0.9969026,0.00013288033],"about_ca_topic_score_codex":0.00005570373,"about_ca_topic_score_gemma":3.8310282e-7,"teacher_disagreement_score":0.61313456,"about_ca_system_score_codex":0.00006795525,"about_ca_system_score_gemma":0.00007028001,"threshold_uncertainty_score":0.5390517},"labels":[],"label_agreement":null},{"id":"W4406400675","doi":"10.1177/23523735241304348","title":"North American study and meta-analysis evaluating performance of Bladder EpiCheck <sup>®</sup> , a FDA cleared test, in non-muscle invasive bladder cancer recurrence","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Cytology; Urine cytology; Internal medicine; Meta-analysis; Urine; Urology; Prospective cohort study; Cancer; Gastroenterology; Urinary system; Pathology","score_opus":0.06489310274473702,"score_gpt":0.36296035896314255,"score_spread":0.2980672562184055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406400675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831534,0.012762862,0.000016084146,0.0007735971,0.0001098047,0.0020628506,0.00048269238,0.0000878426,0.0005508867],"genre_scores_gemma":[0.992968,0.0024053864,0.00035016012,0.00070239627,0.00021487343,0.0019135593,0.000038515333,0.00010937604,0.0012977382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955048,0.00020729958,0.0010438814,0.0013955188,0.0010652436,0.00078324135],"domain_scores_gemma":[0.9977154,0.0004221938,0.00032394435,0.0008184492,0.00040485023,0.00031517036],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005003731,0.0007032344,0.002145252,0.0007354576,0.00014633752,0.00009593366,0.00028516428,0.000113145026,0.0026117095],"category_scores_gemma":[0.00014799199,0.0005551412,0.0006293032,0.003673119,0.0003572073,0.00036576408,0.0001765883,0.0006183164,0.000033136417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043947148,0.0011964515,0.8355917,0.00057135645,0.1047531,0.00013902536,0.014486386,0.0049689147,0.00029571017,0.000001467344,0.0015903735,0.03596609],"study_design_scores_gemma":[0.0027255353,0.002533734,0.7909964,0.00013415731,0.1742386,0.000013542018,0.0030934154,0.024619417,0.0006950493,0.000008958342,0.00023262069,0.0007085681],"about_ca_topic_score_codex":0.014871093,"about_ca_topic_score_gemma":0.022966312,"teacher_disagreement_score":0.0694855,"about_ca_system_score_codex":0.0003522886,"about_ca_system_score_gemma":0.0011064885,"threshold_uncertainty_score":0.99969},"labels":[],"label_agreement":null},{"id":"W4406450389","doi":"10.1016/s1283-0879(15)53436-7","title":"10.1016/s1283-0879(15)53436-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.009350479154879162,"score_gpt":0.21737979520239162,"score_spread":0.20802931604751246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406450389","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010720639,0.00020649657,5.2873105e-7,0.00075260294,0.0000024613314,0.0003476034,0.0000276702,0.00013966083,0.9974509],"genre_scores_gemma":[0.0010167384,0.0000010093438,0.00012610981,0.0003153703,0.0002801764,0.000040756455,0.000030996034,0.0000353565,0.9981535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991081,0.000018361503,0.00015065793,0.00024219706,0.00020858907,0.00027213592],"domain_scores_gemma":[0.99936134,0.000017873057,0.00001608494,0.00032250953,0.000037650323,0.00024456443],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050450915,0.00015579395,0.0002308936,0.000058622296,0.00005563984,0.00001627135,0.00008587994,0.000063434956,0.9985602],"category_scores_gemma":[0.000012330801,0.00013155375,0.00008305578,0.00016501079,0.0000265009,0.000047551403,0.000017223114,0.00009570592,0.9953886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004595608,0.00014665048,0.000002114282,0.000011034592,0.00007164559,0.000038265738,0.000028529863,0.000003746916,0.00009148937,3.135378e-7,0.41411465,0.585032],"study_design_scores_gemma":[0.0013252781,0.00061591837,0.00036272345,0.000037726426,0.00011387049,0.00004687215,0.000001087603,0.000017322169,0.0004741046,0.000006986781,0.9968656,0.00013256575],"about_ca_topic_score_codex":0.00007124157,"about_ca_topic_score_gemma":3.0861239e-7,"teacher_disagreement_score":0.5848994,"about_ca_system_score_codex":0.00006561565,"about_ca_system_score_gemma":0.00006701671,"threshold_uncertainty_score":0.53646064},"labels":[],"label_agreement":null},{"id":"W4406482305","doi":"10.1080/14796694.2024.2435208","title":"Avelumab maintenance treatment for advanced urothelial cancer: plain language summary of long-term results from the JAVELIN Bladder 100 study","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Javelin; Medicine; Urothelial cancer; Avelumab; Bladder cancer; Term (time); Oncology; Internal medicine; Urology; Intensive care medicine; Cancer; Immunotherapy; Pembrolizumab; Astronomy","score_opus":0.019722409884365175,"score_gpt":0.35553043528897854,"score_spread":0.33580802540461335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406482305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522623,0.0082248375,0.00030628138,0.016268836,0.0031281693,0.0070088906,0.004464431,0.00010324519,0.008233002],"genre_scores_gemma":[0.97952455,0.0010691284,0.00064252614,0.0022152083,0.001928003,0.0013637585,0.00044307308,0.000048342245,0.012765387],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99821144,0.00015271117,0.0005273441,0.0005504188,0.00018122641,0.00037686995],"domain_scores_gemma":[0.99841523,0.00051814993,0.00021216195,0.0006302203,0.00014075825,0.00008350763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017539533,0.00031119192,0.0007423966,0.000075989694,0.00013276807,0.000009298872,0.00022449448,0.00020444275,0.00015106266],"category_scores_gemma":[0.0000827959,0.00018897204,0.00020919541,0.00019755222,0.00011255804,0.00003638723,0.00005627464,0.00019031338,0.0000082712495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.078610264,0.008240918,0.07292565,0.00015713452,0.0058331355,0.00072547497,0.02400986,0.0000416216,0.0070668473,0.0002833125,0.046741314,0.7553645],"study_design_scores_gemma":[0.21110712,0.025685586,0.47727942,0.000926166,0.0053271553,0.000044324446,0.021067804,0.000075827455,0.02365037,0.00026444634,0.2337681,0.0008036575],"about_ca_topic_score_codex":0.002354002,"about_ca_topic_score_gemma":0.010443287,"teacher_disagreement_score":0.7545608,"about_ca_system_score_codex":0.0006413746,"about_ca_system_score_gemma":0.0009944516,"threshold_uncertainty_score":0.7706056},"labels":[],"label_agreement":null},{"id":"W4406489208","doi":"10.1016/j.yonc.2013.05.010","title":"10.1016/j.yonc.2013.05.010","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Chemotherapy; Urology; Oncology; Internal medicine; Cancer","score_opus":0.008803399806709548,"score_gpt":0.2156131792811443,"score_spread":0.20680977947443474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406489208","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011339099,0.00020026199,4.0440423e-7,0.0012088841,0.0000029941639,0.00032520285,0.000023796372,0.00012953294,0.996975],"genre_scores_gemma":[0.0006674955,0.0000015405229,0.00012299692,0.0003270084,0.00028308647,0.00003558676,0.000027355021,0.000033602122,0.9985013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999189,0.000015806918,0.00013702289,0.0002195831,0.00018975674,0.00024882844],"domain_scores_gemma":[0.99939954,0.000015628262,0.00001493746,0.0003020106,0.000036009984,0.00023187813],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00004514664,0.00014308559,0.00021301274,0.000052356983,0.000049434642,0.000014710319,0.000079436046,0.00006152967,0.99803877],"category_scores_gemma":[0.000009327775,0.000119493605,0.000074180476,0.00013670097,0.000025487328,0.00004610663,0.000015629465,0.00009366398,0.9942683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003017976,0.00010614614,0.0000011364681,0.000007456691,0.00005106087,0.0000298845,0.000021540636,0.0000024849253,0.00006515046,2.3032828e-7,0.4631637,0.5362494],"study_design_scores_gemma":[0.0012598259,0.0006554242,0.00024055259,0.000033234664,0.00009958148,0.000048107653,8.9190473e-7,0.000018015762,0.0004272889,0.0000057057637,0.9970906,0.00012076897],"about_ca_topic_score_codex":0.00013646529,"about_ca_topic_score_gemma":5.000811e-7,"teacher_disagreement_score":0.53612864,"about_ca_system_score_codex":0.000056371413,"about_ca_system_score_gemma":0.00005869193,"threshold_uncertainty_score":0.4872808},"labels":[],"label_agreement":null},{"id":"W4406501282","doi":"10.1016/j.ysur.2013.02.045","title":"10.1016/j.ysur.2013.02.045","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Parenteral nutrition; Surgery; General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.008900320160759811,"score_gpt":0.2128742406801716,"score_spread":0.2039739205194118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406501282","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015014193,0.00021183307,3.777198e-7,0.0009762686,0.0000023403898,0.00032136304,0.00002350958,0.00012538927,0.9968375],"genre_scores_gemma":[0.0013511963,0.0000015481369,0.00009889544,0.00029139433,0.00025597605,0.00003347605,0.000026939219,0.000032894794,0.9979077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991805,0.000017985698,0.0001384184,0.00022034392,0.00019324226,0.00024948583],"domain_scores_gemma":[0.999403,0.000017798397,0.000014994785,0.00029948432,0.000037103917,0.00022762359],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000049505812,0.00014317929,0.00021617187,0.000051657233,0.00004934526,0.000014626305,0.00007720346,0.000058310008,0.99843],"category_scores_gemma":[0.000010125421,0.00011990675,0.00007544251,0.00014228122,0.000024266667,0.000046202174,0.000015161861,0.00008491221,0.9950831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033304156,0.00012546669,0.0000021736057,0.000008577342,0.000060268427,0.000026147616,0.000022706408,0.000004169799,0.00006157475,2.1031475e-7,0.39975363,0.59960204],"study_design_scores_gemma":[0.0011668197,0.0005951167,0.0003288525,0.00003337139,0.00009800286,0.00003296956,9.0929115e-7,0.000019143828,0.00044455452,0.0000056363265,0.997153,0.00012165544],"about_ca_topic_score_codex":0.000121636534,"about_ca_topic_score_gemma":4.2662344e-7,"teacher_disagreement_score":0.5994804,"about_ca_system_score_codex":0.00005595681,"about_ca_system_score_gemma":0.000057729187,"threshold_uncertainty_score":0.4889655},"labels":[],"label_agreement":null},{"id":"W4406528122","doi":"10.1016/0967-0653(96)85063-0","title":"10.1016/0967-0653(96)85063-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nodule (geology); Resource (disambiguation); Business; Computer science; Biology; Paleontology","score_opus":0.009522129002154604,"score_gpt":0.21152588479022172,"score_spread":0.20200375578806712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406528122","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079437764,0.00013464496,4.657686e-7,0.00072857214,0.0000024776343,0.00033256348,0.000027648368,0.00013604075,0.9978432],"genre_scores_gemma":[0.0007635298,9.1237104e-7,0.000103883984,0.00028783266,0.00028556338,0.000039536048,0.000037538284,0.00003355636,0.99844766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991316,0.000018366594,0.0001468603,0.00023562791,0.00020385568,0.000263643],"domain_scores_gemma":[0.9993801,0.000017048718,0.000015411686,0.0003109406,0.000036194437,0.00024031058],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050401693,0.00015145229,0.00022368177,0.00005418279,0.00005420078,0.000016271442,0.00008442744,0.00006257062,0.9991187],"category_scores_gemma":[0.000012530212,0.00012739477,0.00008086182,0.00015896316,0.000025879752,0.00004918404,0.000016048309,0.00009398784,0.9973689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041438083,0.0001430942,0.0000019822096,0.000010533193,0.000069732065,0.000035203422,0.000031972417,0.0000031980835,0.000041045452,4.0990622e-7,0.25348654,0.74576193],"study_design_scores_gemma":[0.0012562362,0.0005885582,0.00020386452,0.00003033757,0.0001096193,0.00003955386,0.0000011753516,0.000015080941,0.0005319325,0.0000068392164,0.99708766,0.00012913243],"about_ca_topic_score_codex":0.00007259564,"about_ca_topic_score_gemma":2.7474974e-7,"teacher_disagreement_score":0.74563277,"about_ca_system_score_codex":0.0000659808,"about_ca_system_score_gemma":0.00006347999,"threshold_uncertainty_score":0.5195008},"labels":[],"label_agreement":null},{"id":"W4406554711","doi":"10.1016/s1634-6939(14)65935-4","title":"10.1016/s1634-6939(14)65935-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.008552132542448482,"score_gpt":0.21353904075739086,"score_spread":0.20498690821494236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554711","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009283795,0.00019032879,5.152107e-7,0.00072142825,0.000002683068,0.00034498787,0.000026143878,0.0001400402,0.9976455],"genre_scores_gemma":[0.0009600988,0.0000010818572,0.00012226542,0.00030224092,0.00029195703,0.00003951752,0.000029758887,0.000035949575,0.9982171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991014,0.000018307446,0.0001509553,0.00024287893,0.0002150882,0.00027134203],"domain_scores_gemma":[0.9993574,0.00001750527,0.000016052261,0.0003229131,0.00004083386,0.00024528426],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000052151794,0.00015617262,0.00023170354,0.000058542824,0.000055381603,0.000016472188,0.00008588187,0.000065304,0.9983255],"category_scores_gemma":[0.00001366493,0.0001319115,0.000083186336,0.00016447842,0.00002706494,0.000049027,0.000017118151,0.00009826271,0.99476534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042837465,0.00014076369,0.0000018880323,0.00001034652,0.00006862104,0.00003503257,0.000027028509,0.0000033283297,0.000067991255,2.9908705e-7,0.40571597,0.5935003],"study_design_scores_gemma":[0.0013925266,0.0006099405,0.00030006623,0.000038831757,0.00011477097,0.00004183601,9.547863e-7,0.000015036534,0.00050803425,0.0000070903143,0.99683815,0.00013274718],"about_ca_topic_score_codex":0.000064543805,"about_ca_topic_score_gemma":2.70622e-7,"teacher_disagreement_score":0.5933676,"about_ca_system_score_codex":0.00006772902,"about_ca_system_score_gemma":0.00006808813,"threshold_uncertainty_score":0.53791946},"labels":[],"label_agreement":null},{"id":"W4406563263","doi":"10.1016/j.bjorlp.2017.03.009","title":"10.1016/j.bjorlp.2017.03.009","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Bacillus (shape); Urology; Cancer; Pathology; Internal medicine; Biology; Microbiology","score_opus":0.010928955765436227,"score_gpt":0.22349182546337878,"score_spread":0.21256286969794255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406563263","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011018615,0.00018430309,2.7685326e-7,0.00074289646,0.000002424645,0.00031939737,0.000024332992,0.00012558134,0.9974989],"genre_scores_gemma":[0.0010654879,0.0000011492874,0.00010334765,0.00029293852,0.00027989436,0.000014703078,0.000027970935,0.000030080566,0.99818444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916065,0.000016871625,0.00014011776,0.00023120784,0.0001949708,0.00025618827],"domain_scores_gemma":[0.9993704,0.000015514339,0.000016060309,0.00032560635,0.00003777949,0.00023466312],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00004890168,0.00014769,0.00022063173,0.00005875605,0.00005017711,0.000015965956,0.000085667416,0.00005955579,0.99774224],"category_scores_gemma":[0.000012315865,0.00012366915,0.00007733655,0.00014474057,0.000025169666,0.00004722454,0.000015183535,0.00009009331,0.9967409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041584895,0.00014400372,0.000001522863,0.000009027568,0.00006551765,0.00004176331,0.000026790207,0.000003888962,0.00007593166,3.3908287e-7,0.4363969,0.56281847],"study_design_scores_gemma":[0.0012913779,0.00061707303,0.00030821582,0.00003867827,0.00010654295,0.000051830244,9.3884444e-7,0.000018509903,0.00041560605,0.0000068986465,0.9970189,0.00012545787],"about_ca_topic_score_codex":0.00006552206,"about_ca_topic_score_gemma":2.121301e-7,"teacher_disagreement_score":0.562693,"about_ca_system_score_codex":0.00006049386,"about_ca_system_score_gemma":0.00006379768,"threshold_uncertainty_score":0.50430816},"labels":[],"label_agreement":null},{"id":"W4406664825","doi":"10.1016/b978-0-323-39242-6.00041-5","title":"10.1016/b978-0-323-39242-6.00041-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Urinary diversion; Medicine; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.012577229649439501,"score_gpt":0.21084829614387776,"score_spread":0.19827106649443826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406664825","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.337161e-7,0.0010832903,3.3242094e-7,0.00038048715,0.000008470076,0.0008718338,0.0002720007,0.00021787136,0.99716496],"genre_scores_gemma":[0.0000031911866,0.0000051331326,0.00007056172,0.00030139604,0.00093030446,0.0000376512,0.0002944561,0.00020506751,0.99815226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813455,0.000011757578,0.00037365445,0.00059820164,0.00048514322,0.00039668835],"domain_scores_gemma":[0.99860734,0.000033873734,0.000090651796,0.0007435059,0.00009448157,0.00043015336],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000059817437,0.0005660789,0.000789779,0.00023529101,0.000067093126,0.000029909983,0.00019125854,0.00041154018,0.99874055],"category_scores_gemma":[0.0000100266625,0.00051036244,0.0003196846,0.000049377275,0.000072296076,0.000044172928,0.000063156665,0.00040133126,0.99711806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064384093,0.00007308018,5.6649977e-8,0.000046093486,0.00040563373,0.00018489621,0.0000152825,0.0000010469066,0.000006300365,0.00002274715,0.28890097,0.70970005],"study_design_scores_gemma":[0.0013097315,0.0009787583,0.000005339084,0.0003827212,0.0007122107,0.000103164995,2.3172193e-7,0.0000018249033,0.000044753317,0.00021883672,0.99579626,0.00044619027],"about_ca_topic_score_codex":0.000046586843,"about_ca_topic_score_gemma":5.375327e-7,"teacher_disagreement_score":0.70925385,"about_ca_system_score_codex":0.0002179596,"about_ca_system_score_gemma":0.00024577582,"threshold_uncertainty_score":0.9997348},"labels":[],"label_agreement":null},{"id":"W4406664912","doi":"10.1016/b978-0-323-39242-6.00047-6","title":"10.1016/b978-0-323-39242-6.00047-6","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.012576929208375632,"score_gpt":0.2108393469017345,"score_spread":0.19826241769335887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406664912","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.4470145e-7,0.0010462743,3.596685e-7,0.0003563822,0.000008256017,0.0008963913,0.00029425666,0.00022098901,0.99717623],"genre_scores_gemma":[0.0000037504158,0.000004998033,0.000069156275,0.00028488497,0.00089806766,0.00004860261,0.00029620188,0.00020507888,0.9981893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812806,0.000012137365,0.00037268735,0.00059640023,0.00049558695,0.00039513482],"domain_scores_gemma":[0.99860865,0.000034546676,0.00009086812,0.0007405915,0.0000960265,0.00042933112],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006092939,0.00056350115,0.0007905199,0.000234458,0.00007264314,0.000030334355,0.00019069076,0.00040212716,0.9987145],"category_scores_gemma":[0.000009697082,0.0005076451,0.00030924415,0.00004924512,0.00007029223,0.000044914585,0.00006361859,0.00040269093,0.9962536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006628789,0.00007350137,5.6770443e-8,0.000045612756,0.00041146672,0.00017956957,0.000016371167,0.0000011638147,0.000005777204,0.000022368862,0.2651678,0.7334134],"study_design_scores_gemma":[0.0013254519,0.0010255491,0.0000053806443,0.00037681533,0.0006831904,0.00008926752,2.7396575e-7,0.0000019059628,0.00004026497,0.00020994582,0.9957986,0.0004433632],"about_ca_topic_score_codex":0.000045549383,"about_ca_topic_score_gemma":5.5575845e-7,"teacher_disagreement_score":0.73297006,"about_ca_system_score_codex":0.00022080439,"about_ca_system_score_gemma":0.00025287733,"threshold_uncertainty_score":0.9997375},"labels":[],"label_agreement":null},{"id":"W4406725618","doi":"10.1016/j.euf.2024.12.003","title":"Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Meta-analysis; Bladder cancer; Radiation therapy; Oncology; Incidence (geometry); Cancer; Prostate; Internal medicine; Urology; Gynecology","score_opus":0.04003204275226144,"score_gpt":0.362867200916147,"score_spread":0.3228351581638855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406725618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000106138095,0.9920966,0.000021374783,0.0007471783,0.00008030682,0.0061201947,0.00061736006,0.00002698277,0.00027937972],"genre_scores_gemma":[0.00035437738,0.9936688,0.000044446257,0.0019295475,0.000025589334,0.0021179542,0.000060704366,0.000058657562,0.0017399543],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971685,0.0007786428,0.0010412543,0.000612214,0.00016033318,0.00023908397],"domain_scores_gemma":[0.99809974,0.00046299252,0.0007618105,0.00048582512,0.00009714558,0.00009249915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007054577,0.0005008202,0.0076943226,0.0003147814,0.00007371829,0.000016822325,0.00014555008,0.00010749825,0.00010960907],"category_scores_gemma":[0.00014853086,0.0003023226,0.0018032821,0.00042302438,0.00007353013,0.00005569374,0.00006651817,0.00021892974,0.0000020579541],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028989502,0.000040483992,0.00031783702,0.5320381,0.3440165,0.000030401978,0.00014247643,2.6819671e-7,1.3460621e-7,0.000008705724,0.00023491778,0.12314121],"study_design_scores_gemma":[0.00088610133,0.00025136524,0.00027195006,0.007914195,0.96056753,0.000015383364,0.0000034387213,8.5036544e-7,6.938633e-7,0.000011287192,0.029862395,0.00021480383],"about_ca_topic_score_codex":0.00015709823,"about_ca_topic_score_gemma":0.00005868362,"teacher_disagreement_score":0.61655104,"about_ca_system_score_codex":0.000051032144,"about_ca_system_score_gemma":0.00038558597,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W4406732473","doi":"10.1001/jamanetworkopen.2024.55630","title":"Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring","year":2025,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Censoring (clinical trials); Medicine; Oncology; Clinical trial; Survival analysis; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.044372446639796836,"score_gpt":0.37287228196156125,"score_spread":0.3284998353217644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406732473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.909176,0.005115019,0.002548291,0.005594672,0.0008879582,0.0038925586,0.00011738121,0.00008365623,0.072584465],"genre_scores_gemma":[0.9827982,0.0012698343,0.0010198092,0.00093589566,0.0007727298,0.00026299886,0.000030114164,0.000034852244,0.012875532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984752,0.0001688287,0.0005228579,0.00031085973,0.00024863819,0.00027362123],"domain_scores_gemma":[0.9989471,0.00014339488,0.00024377236,0.0004744908,0.00012600987,0.0000652676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052331924,0.00020397863,0.0011117911,0.0000786545,0.00009409272,0.000083745595,0.00028697652,0.00010100327,0.0014787752],"category_scores_gemma":[0.00004328899,0.00013499845,0.00019914033,0.0004984962,0.000058390186,0.00009734073,0.00009783506,0.00015445754,0.0000043455684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06964131,0.001181167,0.49971497,0.00035910684,0.02072925,0.000058430673,0.00088951684,0.0012292082,0.018706642,0.0023929116,0.02041692,0.36468056],"study_design_scores_gemma":[0.077823974,0.0017391718,0.7066104,0.0060454505,0.010257503,0.000014217154,0.000275807,0.0008251917,0.10064855,0.0011656147,0.093699865,0.000894291],"about_ca_topic_score_codex":0.0023341097,"about_ca_topic_score_gemma":0.00015815803,"teacher_disagreement_score":0.36378625,"about_ca_system_score_codex":0.000099264566,"about_ca_system_score_gemma":0.00033275934,"threshold_uncertainty_score":0.999434},"labels":[],"label_agreement":null},{"id":"W4406771426","doi":"10.1016/j.clgc.2025.102306","title":"Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Meta-analysis; Urology; Oncology; Cancer; Internal medicine","score_opus":0.14743990973766827,"score_gpt":0.4676024706977903,"score_spread":0.3201625609601221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406771426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035615147,0.98473734,0.000088271634,0.0003267858,0.00019866266,0.0130421,0.0014667896,0.000032676046,0.00007174011],"genre_scores_gemma":[0.00007724786,0.9843071,0.00052021595,0.00072290126,0.00020456346,0.011707144,0.00033419495,0.00007363566,0.0020529935],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99363226,0.00075608614,0.0032063988,0.0013931424,0.0004341488,0.0005779773],"domain_scores_gemma":[0.995359,0.0017312396,0.0012593326,0.0008825622,0.00040223158,0.00036562406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008182475,0.0008879729,0.013289855,0.00044697543,0.00010217887,0.0000477121,0.00035958178,0.0004460277,0.0004126536],"category_scores_gemma":[0.0007470643,0.0005537173,0.0059027784,0.0012955074,0.00020957695,0.00010489189,0.00019261004,0.000935569,0.000007689419],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010738046,0.0009812632,0.00054567755,0.8086404,0.16185626,0.000027811813,0.00001605949,6.7671465e-7,1.7344808e-9,0.000004416507,0.0003984169,0.027421618],"study_design_scores_gemma":[0.0013096242,0.0008134807,0.0006281895,0.24983054,0.7445562,0.000005065454,0.000005007527,0.0000022110867,9.802014e-8,0.000008117535,0.0024403832,0.00040108955],"about_ca_topic_score_codex":0.000060045313,"about_ca_topic_score_gemma":0.00020456777,"teacher_disagreement_score":0.58269995,"about_ca_system_score_codex":0.00033166466,"about_ca_system_score_gemma":0.0015805016,"threshold_uncertainty_score":0.9996914},"labels":[],"label_agreement":null},{"id":"W4406853762","doi":"10.1016/j.euros.2024.12.009","title":"Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy","year":2025,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Erasmus Medisch Centrum; Wilson Foundation","keywords":"Cystectomy; Subtyping; Bladder cancer; Pathological; Medicine; Oncology; Urology; Cancer; Internal medicine","score_opus":0.024887374722433114,"score_gpt":0.34653066722644094,"score_spread":0.3216432925040078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406853762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97961575,0.00014291231,0.0011499256,0.0028959108,0.00042599326,0.0011386756,0.000011749493,0.000048512193,0.014570578],"genre_scores_gemma":[0.9942546,0.0000313811,0.0010641682,0.0043449686,0.00003093007,0.000051120765,0.0000053871195,0.000023119515,0.00019431896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757004,0.00029216346,0.00052985776,0.0008491543,0.00023951137,0.0005192829],"domain_scores_gemma":[0.99881303,0.00046651732,0.00012351979,0.00030415927,0.00013652188,0.00015625627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019154588,0.0002058441,0.00048681005,0.0002000231,0.00028043048,0.00011204954,0.0006329542,0.000067369474,0.000030197745],"category_scores_gemma":[0.0019024168,0.00016239635,0.000056295667,0.0004663434,0.0006669971,0.00017032624,0.0007414199,0.0002803071,0.000005082887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041270797,0.00018643883,0.9924378,0.000024069333,0.000052206713,0.00009619269,0.00026044247,0.000020704818,0.0015889725,0.0004285663,0.00001981036,0.0044721155],"study_design_scores_gemma":[0.009501043,0.0008510126,0.98759204,0.00010184481,0.000117342126,0.0000104401115,0.000113425485,0.0005562799,0.00040350456,0.00019856567,0.00037878138,0.00017571058],"about_ca_topic_score_codex":0.00006341919,"about_ca_topic_score_gemma":0.00003455597,"teacher_disagreement_score":0.0146388635,"about_ca_system_score_codex":0.00008633145,"about_ca_system_score_gemma":0.00052752346,"threshold_uncertainty_score":0.6622331},"labels":[],"label_agreement":null},{"id":"W4406858482","doi":"10.57598/r247c","title":"Bladder cancer","year":2015,"lang":"en","type":"book","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Internal medicine","score_opus":0.04311568537214053,"score_gpt":0.32598746673488194,"score_spread":0.2828717813627414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406858482","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000079087995,0.0061242934,0.000007432159,0.00066580536,0.0004832418,0.0004210541,0.0000912143,0.00011451793,0.9920845],"genre_scores_gemma":[0.000096477066,0.0005460372,0.00011835282,0.0025658142,0.0014009961,0.000066457615,0.00016588131,0.00007665999,0.99496335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990025,0.000005592208,0.00015609822,0.00028098922,0.0003643178,0.00019049065],"domain_scores_gemma":[0.9992109,0.000008560482,0.00004894888,0.0003235201,0.0001716745,0.000236392],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00003544767,0.00024993598,0.00042905018,0.000069516034,0.000018921135,0.000009663747,0.000061003102,0.00027549374,0.013373035],"category_scores_gemma":[0.0000052880705,0.00017819894,0.00013140793,0.00003051832,0.000044635442,0.000022353028,0.000029525845,0.00023134277,0.0012410572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006736742,0.000037760896,0.00009170717,0.000053878724,0.0005085843,0.00006701108,0.00004433643,1.3990618e-7,0.0000034531142,0.00038051963,0.9887184,0.010026851],"study_design_scores_gemma":[0.0014396795,0.00020490208,0.000090694884,0.00015102362,0.00077434356,0.00003055568,0.0000055184237,0.0000016663677,0.000060446597,0.0019676934,0.9950937,0.00017979935],"about_ca_topic_score_codex":0.00019486914,"about_ca_topic_score_gemma":0.00008500483,"teacher_disagreement_score":0.012131978,"about_ca_system_score_codex":0.0005306281,"about_ca_system_score_gemma":0.0028916132,"threshold_uncertainty_score":0.9995366},"labels":[],"label_agreement":null},{"id":"W4406885123","doi":"10.1016/j.euo.2024.12.013","title":"A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Bladder cancer; Adjuvant; Meta-analysis; Bacillus (shape); Oncology; Urology; Cancer; Internal medicine; Surgery; Microbiology","score_opus":0.11001338861337835,"score_gpt":0.43894441216388796,"score_spread":0.3289310235505096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406885123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016168377,0.9901053,0.00003896713,0.0004578115,0.00011821541,0.007938989,0.0005823152,0.000014011734,0.0005827504],"genre_scores_gemma":[0.0066349437,0.99063,0.00009610375,0.0010812802,0.0000560335,0.0008877682,0.00007454275,0.000060408598,0.00047892597],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936468,0.0030754409,0.0020926,0.0006920011,0.00019434055,0.00029880716],"domain_scores_gemma":[0.9941061,0.0018937745,0.0025198306,0.0009478032,0.0004230452,0.00010940806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011139073,0.00056379347,0.012072109,0.00038962436,0.000060105962,0.0000043856335,0.00030371954,0.00030541726,0.000116095456],"category_scores_gemma":[0.0009929934,0.0002556457,0.0036138357,0.0008991797,0.00049951905,0.000028187796,0.00014943934,0.00044817093,0.0000040959208],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021916463,0.00032727973,0.00019356546,0.5753916,0.40412265,0.000051126022,0.000099757664,0.000011661836,6.4624385e-7,0.000007963976,0.000199116,0.019375505],"study_design_scores_gemma":[0.0012408108,0.004775392,0.0017131009,0.00968827,0.976414,0.000100643054,0.0000061590636,0.0000049365162,3.349188e-7,0.0000020660334,0.0058723926,0.0001818447],"about_ca_topic_score_codex":0.00010614846,"about_ca_topic_score_gemma":0.00023919965,"teacher_disagreement_score":0.57229143,"about_ca_system_score_codex":0.000174367,"about_ca_system_score_gemma":0.002381155,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W4407021913","doi":"10.1038/s41467-024-55665-1","title":"Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Queen's University; University of British Columbia","funders":"Deutsche Forschungsgemeinschaft; Cancer Research Society","keywords":"Chemotherapy; Bladder cancer; Cisplatin; Biology; Cancer research; Medicine; Computational biology; Bioinformatics; Internal medicine; Cancer","score_opus":0.019434022195714603,"score_gpt":0.34593899558266167,"score_spread":0.32650497338694706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407021913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96617746,0.004658893,0.00039578855,0.02303875,0.000086103755,0.002046372,0.00012652454,0.0001167718,0.0033533182],"genre_scores_gemma":[0.98435515,0.00021788898,0.011235857,0.0029614754,0.000027252658,0.0005004996,0.000096427386,0.00001851924,0.00058695703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927205,0.000087797926,0.00015447306,0.00024659975,0.00008185278,0.0001572424],"domain_scores_gemma":[0.9984967,0.00027687085,0.00005543758,0.00093742897,0.0001644208,0.00006915096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093835464,0.00014930604,0.00021299173,0.00016176148,0.0002485611,0.000026218759,0.00023798636,0.00015329686,0.000015393287],"category_scores_gemma":[0.00019343576,0.000113486334,0.000035968475,0.00034533508,0.00020686508,0.000035532546,0.000075193486,0.0004054097,0.000003046506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004717265,0.00055554183,0.8707924,0.00029054747,0.0014963286,0.00001241494,0.0019096029,0.00001882152,0.09014226,0.004610492,0.0041904123,0.021263955],"study_design_scores_gemma":[0.0072291433,0.00088723935,0.8519514,0.00086063717,0.00058245653,0.000011539494,0.0004861156,0.00018053858,0.11295146,0.0006634685,0.023775415,0.000420548],"about_ca_topic_score_codex":0.00020013505,"about_ca_topic_score_gemma":0.0011872966,"teacher_disagreement_score":0.0228092,"about_ca_system_score_codex":0.0001560461,"about_ca_system_score_gemma":0.00073430716,"threshold_uncertainty_score":0.46278384},"labels":[],"label_agreement":null},{"id":"W4407100878","doi":"10.3390/cancers17030509","title":"Split-Dose Cisplatin Use, Eligibility Criteria, and Drivers for Treatment Choice in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: Results of a Large International Physician Survey","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cisplatin; Medicine; Gemcitabine; Demographics; Creatinine; Oncology; Urology; Internal medicine; Chemotherapy; Renal function; Demography","score_opus":0.02830510392594019,"score_gpt":0.35213082768433834,"score_spread":0.32382572375839813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407100878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940709,0.000062871135,0.00016334339,0.000090304464,0.00018718744,0.0017755966,0.0034029358,0.0000120681325,0.0002348321],"genre_scores_gemma":[0.99766123,0.00002738538,0.0009807774,0.00030647207,0.000023003562,0.0001847171,0.00036689796,0.000017338658,0.00043218906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988026,0.000057418067,0.0003287028,0.0004085042,0.00017505497,0.00022771696],"domain_scores_gemma":[0.9991084,0.00025251234,0.00011801109,0.00023802232,0.00020864708,0.00007442348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011867954,0.00019965152,0.00044369153,0.00011708137,0.00003856084,0.000014351888,0.00006590268,0.000037045298,0.000011781095],"category_scores_gemma":[0.00018018717,0.00014463576,0.00005358245,0.00021952699,0.000082452374,0.00013146833,0.000021626123,0.0000460926,3.7353064e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0517066,0.0005804719,0.9314917,0.00018475474,0.0004601369,0.000009013478,0.0005779822,0.00010210378,0.00014977703,0.000026846501,0.00029590863,0.014414748],"study_design_scores_gemma":[0.053924054,0.002135365,0.94067764,0.00022442975,0.000191738,2.7872284e-7,0.00009291887,0.00041745146,0.00091307156,0.00001697998,0.0012854522,0.00012060486],"about_ca_topic_score_codex":0.0069177793,"about_ca_topic_score_gemma":0.011897138,"teacher_disagreement_score":0.014294143,"about_ca_system_score_codex":0.001191619,"about_ca_system_score_gemma":0.0009438139,"threshold_uncertainty_score":0.99969524},"labels":[],"label_agreement":null},{"id":"W4407113054","doi":"10.7759/cureus.78406","title":"Intracorporeal Versus Extracorporeal Urinary Diversion Following Robotic-Assisted Radical Cystectomy for Bladder Cancer in Patients ≥ 65 Years of Age: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Cureus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Extracorporeal; Bladder cancer; Meta-analysis; Urinary system; Urology; Urothelial cancer; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.07928002069276757,"score_gpt":0.37558965011611317,"score_spread":0.2963096294233456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407113054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018653362,0.9921336,0.000029538394,0.000029303364,0.00023339127,0.006758902,0.0006210994,0.00002419866,0.00015127934],"genre_scores_gemma":[0.00078956824,0.99575067,0.00034190164,0.0000747583,0.00003237617,0.0018110374,0.00073997065,0.00004975786,0.0004099426],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968089,0.0003020349,0.0013946712,0.0006836409,0.00048086882,0.000329916],"domain_scores_gemma":[0.99780905,0.00048728086,0.0007702211,0.0006470753,0.00010959998,0.00017677933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035764294,0.0005559812,0.008947503,0.00042322243,0.00004807708,0.000017215518,0.00023901665,0.0003440673,0.000121833415],"category_scores_gemma":[0.00021230403,0.00040395852,0.0032958633,0.0009903003,0.00007224955,0.00007673737,0.0001205241,0.0002894047,0.0000019721867],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016133097,0.0005568262,0.00007967105,0.7589652,0.22416681,0.00019201271,0.000043697077,9.223066e-7,3.952048e-8,0.000008303814,0.0002749273,0.015550247],"study_design_scores_gemma":[0.002867109,0.0004953224,0.0003233319,0.05863072,0.9355237,0.000007749184,0.000007765823,0.0000029532853,1.2091716e-7,0.0000052719474,0.0018562162,0.00027975536],"about_ca_topic_score_codex":0.0002796101,"about_ca_topic_score_gemma":0.00008472835,"teacher_disagreement_score":0.7113569,"about_ca_system_score_codex":0.00041920514,"about_ca_system_score_gemma":0.0004167295,"threshold_uncertainty_score":0.9998412},"labels":[],"label_agreement":null},{"id":"W4407122004","doi":"10.1016/j.clgc.2025.102313","title":"Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review","year":2025,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Santé et de Services Sociaux de Chicoutimi; Cégep de Chicoutimi; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck Sharp and Dohme; EMD Serono; Astellas Pharma; Natera; Bladder Cancer Advocacy Network; American Association for Cancer Research; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Bladder cancer; Urothelial cancer; Chart; Oncology; Cancer; Internal medicine; Bacillus (shape); Urology","score_opus":0.021617643058209353,"score_gpt":0.3654198877687889,"score_spread":0.3438022447105796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407122004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200434,0.006311336,0.000006589609,0.006848192,0.0009301981,0.002658131,0.00076819124,0.000064757434,0.0004082777],"genre_scores_gemma":[0.79018456,0.1955076,0.00012382702,0.008922354,0.00046898666,0.0014417119,0.00010409781,0.000070440066,0.0031764056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594134,0.0003656922,0.0011969773,0.0011105572,0.0007262149,0.0006592197],"domain_scores_gemma":[0.99711275,0.0009322265,0.00032162212,0.00074747385,0.00028463016,0.0006013086],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034440224,0.0006380078,0.0017996132,0.0002525321,0.00014367848,0.000022348506,0.00021129935,0.00029012328,0.0009897714],"category_scores_gemma":[0.00032460337,0.00042941383,0.00029761967,0.00047943302,0.00029982027,0.00011148438,0.00016684427,0.00068561756,0.000024636605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020296534,0.0017298482,0.8892106,0.00058730115,0.0013341765,0.00046824518,0.000086339205,0.000003641947,0.0000011588285,0.0000024630458,0.0020417862,0.10250481],"study_design_scores_gemma":[0.020916343,0.0026464073,0.9643412,0.0049648494,0.0018023675,0.0000032780135,0.000043009015,0.000020233207,0.000041065723,0.000010439542,0.0048198644,0.00039093033],"about_ca_topic_score_codex":0.02066974,"about_ca_topic_score_gemma":0.019021895,"teacher_disagreement_score":0.19181974,"about_ca_system_score_codex":0.00082924496,"about_ca_system_score_gemma":0.0019416357,"threshold_uncertainty_score":0.99992347},"labels":[],"label_agreement":null},{"id":"W4407167288","doi":"10.14440/bladder.2024.0021","title":"Predictive value of mitotic figure counts in tumor progression of non-invasive high-grade papillary urothelial carcinoma of the urinary bladder: A retrospective study from a single cancer center","year":2025,"lang":"en","type":"article","venue":"Bladder","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tumor progression; Bladder cancer; Malignancy; Lamina propria; Cancer; Pathology; Carcinoma; Internal medicine; Oncology; Epithelium","score_opus":0.010622906894181737,"score_gpt":0.2765020697146869,"score_spread":0.26587916282050517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407167288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934051,0.0010160353,0.000008175075,0.00019344129,0.00043248959,0.0018844436,0.00059741724,0.000012350979,0.0024505197],"genre_scores_gemma":[0.99911845,0.00003961684,0.00007898534,0.000121848716,0.00011238131,0.00014562371,0.000015130333,0.000026249287,0.0003417255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998461,0.00011571825,0.00042522777,0.0003508646,0.00044345122,0.00020373284],"domain_scores_gemma":[0.9990387,0.00006495075,0.00023726639,0.00042878414,0.00018421694,0.000046106852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006551038,0.00021688447,0.0005546982,0.00012962561,0.0000366306,0.0000039775014,0.00016848493,0.000095042305,0.0002019055],"category_scores_gemma":[0.000056473473,0.00014825059,0.00014392404,0.00038364696,0.00017848732,0.000045769295,0.00010781255,0.00020293107,0.0000024933706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011581962,0.00427906,0.9795084,0.0001659214,0.0007970292,0.00006082596,0.0025480187,0.000011399287,0.009878688,0.000016891332,0.0012337938,0.00034178968],"study_design_scores_gemma":[0.005897071,0.001806372,0.9322901,0.0010995843,0.0005258677,0.0000036913982,0.0008229286,0.000059150734,0.057158306,0.00019757378,0.00004113512,0.00009821589],"about_ca_topic_score_codex":0.0018457873,"about_ca_topic_score_gemma":0.00014591283,"teacher_disagreement_score":0.04727962,"about_ca_system_score_codex":0.00021408916,"about_ca_system_score_gemma":0.000577827,"threshold_uncertainty_score":0.60454834},"labels":[],"label_agreement":null},{"id":"W4407236407","doi":"10.1590/s1677-5538.ibju.2024.0615","title":"Multicenter Retrospective Registry Study on BCG Use in Non-Muscle Invasive Bladder Cancer in Latin America: BLATAM (Bladder Cancer in Latin America) Group","year":2025,"lang":"en","type":"article","venue":"International braz j urol","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Latin Americans; Retrospective cohort study; Cancer; Clinical trial; Epidemiology; Internal medicine; Oncology","score_opus":0.01924973704241141,"score_gpt":0.32479322159455937,"score_spread":0.30554348455214797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407236407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778385,0.0001682551,0.000055646695,0.0029277303,0.0008060823,0.0017438395,0.000391419,0.000043860524,0.0060793366],"genre_scores_gemma":[0.9916093,0.00023776223,0.0001198277,0.0033636666,0.00021070025,0.0010142623,0.00005936047,0.00005278882,0.0033323613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723375,0.00012195371,0.0006751291,0.00088900066,0.00063360535,0.00044657022],"domain_scores_gemma":[0.9987596,0.0002871565,0.00022505726,0.0004409284,0.00018312955,0.0001040977],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000111550406,0.0003975471,0.00059942657,0.000687754,0.000045117875,0.00006519587,0.00030796241,0.00013820257,0.0009749941],"category_scores_gemma":[0.00031561154,0.00037623374,0.000116942014,0.0008849404,0.00012814575,0.0002871046,0.00014555173,0.00072452833,0.0000487111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011804134,0.0026420297,0.9816416,0.000019914412,0.0005063717,0.00031388737,0.002280964,0.0008252389,0.0016213901,0.00002718306,0.001667068,0.007273978],"study_design_scores_gemma":[0.009701279,0.00044588643,0.98434854,0.00055546605,0.00008875789,0.0000012602677,0.0014349736,0.0015090284,0.00045401955,0.00006002973,0.0011220186,0.00027874793],"about_ca_topic_score_codex":0.028552921,"about_ca_topic_score_gemma":0.03238254,"teacher_disagreement_score":0.008520866,"about_ca_system_score_codex":0.0016157568,"about_ca_system_score_gemma":0.00030074586,"threshold_uncertainty_score":0.99993825},"labels":[],"label_agreement":null},{"id":"W4407242731","doi":"10.1016/j.euf.2025.01.001","title":"Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non–muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies","year":2025,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Stage (stratigraphy); Urology; Oncology; Internal medicine; Cancer","score_opus":0.025137385275600825,"score_gpt":0.318956506789732,"score_spread":0.29381912151413114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407242731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98079884,0.0015082635,0.00016683109,0.0017243656,0.00041415665,0.000748187,0.000191532,0.00008392362,0.014363877],"genre_scores_gemma":[0.99568325,0.00034259315,0.0001580728,0.001631519,0.00009869928,0.000039950803,0.000013069811,0.000075943644,0.0019569271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972313,0.00059744227,0.0006730092,0.00062723435,0.00030075017,0.00057023834],"domain_scores_gemma":[0.9974528,0.0011066054,0.00041343868,0.00068703026,0.00019163497,0.00014848528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000313693,0.0004916036,0.0011035268,0.00047116601,0.000118840304,0.000013012453,0.00030854702,0.00012375359,0.00047876357],"category_scores_gemma":[0.0003793773,0.00035884342,0.0004322399,0.00041362626,0.00038623414,0.00006677088,0.00017605045,0.00044683655,0.000044139277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010205589,0.0035611526,0.8534466,0.00044959626,0.018791365,0.0031100672,0.0053229784,0.0047682077,0.059013188,0.0019938513,0.0041993507,0.03513807],"study_design_scores_gemma":[0.008234066,0.0063266363,0.9704954,0.00013320684,0.0008053313,0.000016938877,0.00033006672,0.0000171536,0.0126371905,0.00022942637,0.00049990613,0.00027465887],"about_ca_topic_score_codex":0.0017345395,"about_ca_topic_score_gemma":0.00055925234,"teacher_disagreement_score":0.11704883,"about_ca_system_score_codex":0.00029272633,"about_ca_system_score_gemma":0.0008522064,"threshold_uncertainty_score":0.99988633},"labels":[],"label_agreement":null},{"id":"W4407313079","doi":"10.1016/j.acuroe.2025.501701","title":"Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group","year":2025,"lang":"en","type":"article","venue":"Actas Urológicas Españolas (English Edition)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Chemotherapy; Oncology; Urothelial carcinoma; Urology; Internal medicine; Observational study; Neoadjuvant therapy; Cancer","score_opus":0.022923562183718504,"score_gpt":0.29478224521426494,"score_spread":0.27185868303054644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407313079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925418,0.00019439563,0.00012391004,0.0014399543,0.000994388,0.0040507675,0.00050027267,0.000049005164,0.00010551319],"genre_scores_gemma":[0.9964692,0.0000380258,0.00031634342,0.0017385992,0.00038145197,0.00083937985,0.00014024015,0.000042668526,0.00003407794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741286,0.00018555106,0.0006476056,0.0006389943,0.0007177999,0.00039718085],"domain_scores_gemma":[0.9978257,0.0007898525,0.00037804194,0.000367488,0.0004503072,0.00018861542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018580831,0.00040296116,0.0007634149,0.00013933827,0.00024946366,0.000025449855,0.0002536101,0.00020318002,0.00003744379],"category_scores_gemma":[0.0005558922,0.00025828835,0.0002902515,0.00034800853,0.00028863212,0.00020194806,0.00011803681,0.0004311396,2.95195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054740356,0.0020611465,0.98816293,0.00007631205,0.0010518584,0.000022312746,0.001835334,0.000026369466,0.00013079356,0.00008312206,0.00018807735,0.00088768447],"study_design_scores_gemma":[0.02630328,0.0017464928,0.9686135,0.00027534788,0.0016045069,0.0000011742022,0.0004618973,0.00009947273,0.00027134473,0.00007831189,0.00033062889,0.0002140149],"about_ca_topic_score_codex":0.00017255604,"about_ca_topic_score_gemma":0.00010512299,"teacher_disagreement_score":0.020829244,"about_ca_system_score_codex":0.00020919387,"about_ca_system_score_gemma":0.00037403335,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W4407393511","doi":"10.3390/siuj6010008","title":"Hyaluronic Acid Rectal Spacer for Rectal Protection in Salvage Cystoprostatectomy","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hyaluronic acid; Cystoprostatectomy; Salvage therapy; Medicine; Urology; Surgery; Internal medicine; Prostatectomy; Anatomy; Prostate; Chemotherapy","score_opus":0.0337693463208641,"score_gpt":0.34794768223664224,"score_spread":0.31417833591577815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407393511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954022,0.0014260743,0.0072215567,0.012883083,0.0026255269,0.001786242,0.00005358288,0.00011395472,0.019867972],"genre_scores_gemma":[0.9900073,0.0001715098,0.0009035505,0.0010467861,0.0004460774,0.00030602198,0.000031189014,0.000019569328,0.0070679914],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986548,0.0000733563,0.00038920887,0.00028143908,0.00027576447,0.00032547396],"domain_scores_gemma":[0.99931085,0.00009635695,0.00015662996,0.00012978383,0.00023594165,0.000070448856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004024796,0.00018389006,0.0002862126,0.0003311056,0.00013894883,0.000056281388,0.00012723646,0.00015837785,0.00027630446],"category_scores_gemma":[0.0004032569,0.00015702035,0.00024575487,0.00020505437,0.000059274706,0.00015880495,0.00004434788,0.0006077527,0.000011860645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027516609,0.0033275648,0.3008457,0.0005858284,0.00407067,0.0009944907,0.002511491,0.00037787543,0.091624714,0.0033151004,0.030886635,0.5339433],"study_design_scores_gemma":[0.06478372,0.008963198,0.604511,0.00114451,0.00085847656,0.003142914,0.001981642,0.004005962,0.07589683,0.052912436,0.18062456,0.001174726],"about_ca_topic_score_codex":0.000049284383,"about_ca_topic_score_gemma":0.00006200256,"teacher_disagreement_score":0.53276855,"about_ca_system_score_codex":0.0008234019,"about_ca_system_score_gemma":0.00048279375,"threshold_uncertainty_score":0.64031035},"labels":[],"label_agreement":null},{"id":"W4407416005","doi":"10.1007/s11912-025-01648-4","title":"Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder","year":2025,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Université Laval","funders":"","keywords":"Medicine; Urothelial carcinoma; Oncology; Cell-free fetal DNA; Cancer research; Internal medicine; Bladder cancer; Cancer","score_opus":0.048099055463530306,"score_gpt":0.3868624913836161,"score_spread":0.3387634359200858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407416005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006017486,0.9859198,0.000020120613,0.00020414406,0.0019036325,0.005536735,0.00009454974,0.000028038688,0.00027552785],"genre_scores_gemma":[0.011778409,0.9848654,0.00016403482,0.00005506565,0.00015921348,0.002758833,0.000028764416,0.00005309974,0.00013713847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729806,0.00016488727,0.0012017079,0.00075062347,0.00021392676,0.00037077293],"domain_scores_gemma":[0.9971877,0.00069706014,0.0008875943,0.0010129785,0.00014607247,0.000068595844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045027892,0.00044481998,0.0023184097,0.0004124536,0.0000805759,0.000008798149,0.0002515119,0.00045276457,0.000013382374],"category_scores_gemma":[0.00060253544,0.00028083328,0.00042277292,0.000573203,0.00026029578,0.000017728897,0.00027611002,0.00051040686,5.9490844e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074110416,0.0006818912,0.062196333,0.01243419,0.00013911615,0.00018339041,0.000048350626,1.0127017e-7,0.0000022122383,0.000017357199,0.0012847498,0.92293817],"study_design_scores_gemma":[0.0028695979,0.0006858474,0.004306672,0.014894001,0.0018295826,0.0012328756,0.000017474102,0.0000017488944,0.00009742517,0.0011541265,0.97266704,0.00024360977],"about_ca_topic_score_codex":0.000018202658,"about_ca_topic_score_gemma":0.000057585334,"teacher_disagreement_score":0.97138226,"about_ca_system_score_codex":0.00037230432,"about_ca_system_score_gemma":0.0031443895,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W4407655199","doi":"10.3390/siuj6010018","title":"B2B: Bladder Cancer Summary","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"Johnson and Johnson; Merck Sharp and Dohme; Bristol-Myers Squibb","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.03391210409341515,"score_gpt":0.3744070476203938,"score_spread":0.3404949435269786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407655199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45485482,0.017030496,0.002367424,0.07003192,0.008866564,0.00072391523,0.00012722159,0.00024922626,0.44574842],"genre_scores_gemma":[0.9025659,0.0034717715,0.0005138365,0.014696533,0.0012156008,0.000070511654,0.000033066724,0.000019351126,0.077413425],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987862,0.00004796851,0.00032361614,0.00021424156,0.00036003257,0.0002679331],"domain_scores_gemma":[0.9991906,0.000113142116,0.000121426725,0.00015412184,0.00031152947,0.00010915088],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017681107,0.00016530839,0.00025563,0.00018920116,0.00015993214,0.000056635363,0.00020580718,0.00012288512,0.0029334633],"category_scores_gemma":[0.00013237773,0.00013125657,0.0002456017,0.00014750742,0.00008435267,0.0001277323,0.00006942331,0.00051051285,0.000032743348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012255879,0.00069060863,0.5005127,0.00005197638,0.0038082076,0.0003727493,0.000281887,0.000091790884,0.0016703985,0.0025205354,0.36899677,0.1197768],"study_design_scores_gemma":[0.009805513,0.000564334,0.44351926,0.00031681714,0.0008490484,0.0005133674,0.0005022545,0.0002955927,0.0035156766,0.016986337,0.522777,0.00035474089],"about_ca_topic_score_codex":0.00005928238,"about_ca_topic_score_gemma":0.000019384963,"teacher_disagreement_score":0.44771108,"about_ca_system_score_codex":0.00038873538,"about_ca_system_score_gemma":0.00065708684,"threshold_uncertainty_score":0.997978},"labels":[],"label_agreement":null},{"id":"W4407678360","doi":"10.1200/jco.2025.43.5_suppl.687","title":"Detection of early-stage urothelial cancers using methylation patterns in urine cell-free DNA.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Grail","keywords":"Medicine; Stage (stratigraphy); Urine; DNA methylation; Urothelial cancer; Cell-free fetal DNA; DNA; Cancer research; Methylation; Bladder cancer; Cancer; Pathology; Internal medicine; Gene; Biology; Genetics; Gene expression","score_opus":0.09353962825535082,"score_gpt":0.4518999914947042,"score_spread":0.3583603632393534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407678360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993058,0.00023821743,0.0025362687,0.00068064674,0.0014130365,0.00020805387,0.0000103519005,0.0000043665077,0.0018510169],"genre_scores_gemma":[0.9975977,0.00033470723,0.000829581,0.0004463938,0.00045355567,0.0000027303033,6.7286635e-7,0.000010397727,0.00032424397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975809,0.0002760943,0.0016297854,0.00013675625,0.00022856976,0.00014788615],"domain_scores_gemma":[0.9980486,0.00048789446,0.0009632918,0.00017601716,0.0002168895,0.00010728422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011515552,0.00010200017,0.0009042454,0.0002564667,0.000019622412,0.0000035306352,0.0001150119,0.0002580483,0.0000810461],"category_scores_gemma":[0.0006750823,0.00008056997,0.0002797898,0.00020651115,0.00007019581,0.00008351125,0.000038554997,0.00053298427,0.0000012198302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014340484,0.0018334892,0.79858255,0.00026409756,0.0005548445,0.0003387444,0.0002876535,0.0004849916,0.042627186,0.00003401071,0.000103305065,0.14054866],"study_design_scores_gemma":[0.025222247,0.010447615,0.91097414,0.00032372764,0.0006887915,0.000031028216,0.000153002,0.000476433,0.046593,0.0004493869,0.0045382017,0.00010243039],"about_ca_topic_score_codex":0.0015422672,"about_ca_topic_score_gemma":0.00082795473,"teacher_disagreement_score":0.14044625,"about_ca_system_score_codex":0.00047225758,"about_ca_system_score_gemma":0.0018887764,"threshold_uncertainty_score":0.33506083},"labels":[],"label_agreement":null},{"id":"W4407698114","doi":"10.1200/jco.2025.43.5_suppl.699","title":"Patterns of split-dose gemcitabine and cisplatin (GC) use in patients with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a 10-country physician survey.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Gemcitabine; Urothelial carcinoma; Cisplatin; Urothelial cancer; Oncology; Internal medicine; Chemotherapy; Cancer; Bladder cancer","score_opus":0.06019323005253112,"score_gpt":0.40073797644489895,"score_spread":0.3405447463923678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407698114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821484,0.00008818628,0.00009319835,0.00028786456,0.00020702592,0.00047780023,0.00026624714,0.0000028722986,0.00036194612],"genre_scores_gemma":[0.99726266,0.00010434083,0.0017433736,0.0005426071,0.0000658767,0.0000073681554,0.000017966322,0.000018146042,0.00023769028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960213,0.0007037215,0.002437161,0.00024386395,0.00038434227,0.00020962494],"domain_scores_gemma":[0.9932984,0.0041300855,0.0015726672,0.0002381329,0.0005977296,0.00016296937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016462693,0.00019429805,0.0018504816,0.00020270722,0.000016057229,0.0000062466793,0.00012358603,0.00016783767,0.000030118474],"category_scores_gemma":[0.0035726116,0.00012045242,0.00015147241,0.00028769142,0.00019738254,0.00014766362,0.000051634048,0.00046885203,6.5332557e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12898934,0.003300011,0.8101337,0.00015556323,0.00047007136,0.0001988124,0.00008555303,0.000018158922,0.000031620606,0.000021817594,0.00014580958,0.05644955],"study_design_scores_gemma":[0.061841607,0.018787995,0.9172464,0.0005458023,0.00053729216,0.000011558114,0.000057389578,0.000038842933,0.000118153956,0.000040547293,0.0006906329,0.00008378534],"about_ca_topic_score_codex":0.00060359744,"about_ca_topic_score_gemma":0.0017763753,"teacher_disagreement_score":0.1071127,"about_ca_system_score_codex":0.00009226794,"about_ca_system_score_gemma":0.0019232753,"threshold_uncertainty_score":0.49119073},"labels":[],"label_agreement":null},{"id":"W4407699408","doi":"10.1200/jco.2025.43.5_suppl.tps890","title":"NEO-BLAST: Neoadjuvant therapy for bladder cancer followed by active surveillance vs treatment.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bladder cancer; Oncology; Neoadjuvant therapy; Cancer; Urothelial cancer; Internal medicine; Surgery; Breast cancer","score_opus":0.09079120429685564,"score_gpt":0.4945529439766049,"score_spread":0.40376173967974927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.895052,0.013495048,0.0010922605,0.066855386,0.0075827325,0.0020338278,0.00028562086,0.00004253388,0.013560581],"genre_scores_gemma":[0.95698,0.017471338,0.0012666942,0.011991357,0.0017433825,0.00013924863,0.000018184488,0.000040430743,0.010349382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974702,0.00025110366,0.0014568616,0.00028386392,0.00021849861,0.0003194438],"domain_scores_gemma":[0.99611306,0.0020000015,0.00091398583,0.00020956779,0.0004886912,0.00027469912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006854636,0.00023299002,0.0018412836,0.000098713754,0.000071402006,0.000011076249,0.00014813006,0.00037863394,0.00027900923],"category_scores_gemma":[0.00056139147,0.00014648709,0.0008486089,0.00015984497,0.0001459631,0.000081072256,0.000017711964,0.0003876646,0.000005637283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05052296,0.004057064,0.085819796,0.000018091241,0.004695335,0.00011834905,0.00014045724,0.000006494458,0.00089052983,0.000047648326,0.11945151,0.73423177],"study_design_scores_gemma":[0.049296364,0.03361465,0.110198915,0.00008031568,0.00064771535,0.00003526779,0.00008057423,0.00003340753,0.0023911186,0.0003114277,0.8031761,0.00013414756],"about_ca_topic_score_codex":0.00017027391,"about_ca_topic_score_gemma":0.00019828185,"teacher_disagreement_score":0.7340976,"about_ca_system_score_codex":0.00046790208,"about_ca_system_score_gemma":0.003510493,"threshold_uncertainty_score":0.6227464},"labels":[],"label_agreement":null},{"id":"W4407699454","doi":"10.1200/jco.2025.43.5_suppl.765","title":"Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Internal medicine; Intensive care medicine","score_opus":0.09811926584908452,"score_gpt":0.47016135365676626,"score_spread":0.3720420878076817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672228,0.0025369984,0.00030189627,0.020919297,0.002946609,0.0009436155,0.000084542124,0.00001281624,0.00503143],"genre_scores_gemma":[0.97809136,0.006042737,0.0005298911,0.012156467,0.0016607459,0.00016102944,0.0000051642846,0.000020565214,0.0013320262],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997739,0.0002225274,0.0013727726,0.00021196213,0.00019442721,0.00025930433],"domain_scores_gemma":[0.99582523,0.0025699916,0.00069351605,0.00024147105,0.0004542036,0.00021561577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048266497,0.00019135303,0.001014793,0.00009383504,0.0001393064,0.000013977792,0.00013209807,0.0002834066,0.00045803317],"category_scores_gemma":[0.0006606657,0.00009246119,0.00091043307,0.00013449742,0.00020954596,0.00006074409,0.000034639437,0.00042541084,0.000009412795],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033015085,0.0037219452,0.076562054,0.000032386437,0.0034440549,0.00007434425,0.0014849962,0.000046537945,0.00023198049,0.00021412369,0.04477531,0.86611074],"study_design_scores_gemma":[0.010839023,0.012387237,0.54236984,0.0001627638,0.0015346258,0.000036300884,0.00092203234,0.000025081026,0.00019631765,0.00052380626,0.43092352,0.00007945277],"about_ca_topic_score_codex":0.0001076178,"about_ca_topic_score_gemma":0.00087523257,"teacher_disagreement_score":0.8660313,"about_ca_system_score_codex":0.0005165849,"about_ca_system_score_gemma":0.0034956997,"threshold_uncertainty_score":0.62012213},"labels":[],"label_agreement":null},{"id":"W4407699871","doi":"10.1200/jco.2025.43.5_suppl.819","title":"Long-term outcomes of neoadjuvant chemotherapy (NAC) before bladder-sparing chemoradiotherapy (CRT) for patients with nonmetastatic muscle-invasive bladder cancer (MIBC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University Health Network; Lakeridge Health; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Oncology; Neoadjuvant therapy; Urology; Internal medicine; Cystectomy; Chemoradiotherapy; Cancer; Breast cancer","score_opus":0.057723729309533844,"score_gpt":0.4357738761988746,"score_spread":0.37805014688934074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958194,0.0007659076,0.0012457622,0.0052988706,0.0014763548,0.0011412407,0.000047421603,0.000013798584,0.0004287302],"genre_scores_gemma":[0.9845825,0.0014421135,0.005970483,0.006505016,0.0005679584,0.00006359423,0.000014166861,0.00006215011,0.00079201313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964365,0.00012964748,0.0022288074,0.00034641393,0.0004661701,0.00039245805],"domain_scores_gemma":[0.9952184,0.0013441662,0.0019143319,0.00034026158,0.00089188473,0.00029097567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006668189,0.0003356565,0.002776889,0.00021811301,0.00006402166,0.000012780837,0.0002624562,0.00032460125,0.0002636709],"category_scores_gemma":[0.00053898,0.00020939861,0.00075787876,0.0002192091,0.00029884087,0.00013814856,0.00003179971,0.0005367637,0.0000019523166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006386957,0.0033484916,0.75279653,0.00016472908,0.0048597315,0.000053900836,0.00027287533,0.0000143598645,0.000059642818,0.000019033247,0.000944786,0.23107894],"study_design_scores_gemma":[0.04527806,0.018327922,0.93066955,0.00043021975,0.0018392124,0.000014298329,0.00006390279,0.000019124536,0.00066145346,0.00019975405,0.0023385403,0.00015794463],"about_ca_topic_score_codex":0.00006291596,"about_ca_topic_score_gemma":0.00032083996,"teacher_disagreement_score":0.230921,"about_ca_system_score_codex":0.00032217082,"about_ca_system_score_gemma":0.0028339701,"threshold_uncertainty_score":0.85390276},"labels":[],"label_agreement":null},{"id":"W4407700595","doi":"10.1200/jco.2025.43.5_suppl.717","title":"Global real-world patients characteristics, treatment patterns, and impact of BCG shortage in patients with high-risk non-muscle invasive bladder cancer.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Bladder cancer; Economic shortage; Cancer; Oncology; Internal medicine; Intensive care medicine","score_opus":0.029333133924035762,"score_gpt":0.40970377722594165,"score_spread":0.3803706433019059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758446,0.000067430694,0.000008650885,0.00025673292,0.000586804,0.0005228361,0.00041726028,0.000003816256,0.00055198726],"genre_scores_gemma":[0.9965505,0.0026265618,0.00015620382,0.0003236509,0.00019762707,0.000012695398,0.000033300454,0.000014077953,0.000085371335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726653,0.00021325781,0.0017162318,0.00025834396,0.00028949778,0.00025614866],"domain_scores_gemma":[0.99707305,0.00049586955,0.0014588065,0.00020438404,0.00048749897,0.0002803966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003250847,0.000237851,0.0017188647,0.0001707418,0.000029707819,0.000008028299,0.00009993591,0.00020656269,0.00009788842],"category_scores_gemma":[0.00031830708,0.00014374973,0.00028049797,0.00022728022,0.00014060193,0.00009555492,0.000044478275,0.00032535498,0.00000112856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007128219,0.0042304667,0.84687877,0.000033098608,0.0013675513,0.000084216124,0.0000666227,0.0000063472125,0.0000010151679,0.0000034806753,0.00030810773,0.13989212],"study_design_scores_gemma":[0.027314734,0.033481825,0.937414,0.0003566526,0.0010958626,0.0000014487298,0.000023660232,0.0000047239796,0.000014468519,0.000041949505,0.00015554484,0.00009516674],"about_ca_topic_score_codex":0.011058713,"about_ca_topic_score_gemma":0.009489752,"teacher_disagreement_score":0.13979694,"about_ca_system_score_codex":0.0010450684,"about_ca_system_score_gemma":0.0023681174,"threshold_uncertainty_score":0.99552673},"labels":[],"label_agreement":null},{"id":"W4407700917","doi":"10.1200/jco.2025.43.5_suppl.669","title":"Understanding diversity and disparities in a real-world locally advanced/metastatic urothelial carcinoma (la/mUC): Clinical characteristics, genomic landscape, and self-reported social determinants of health (SDOH).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta; University of Calgary; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Diversity (politics); Internal medicine; Oncology; Anthropology; Sociology","score_opus":0.21774744144758554,"score_gpt":0.4700278986500869,"score_spread":0.25228045720250136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961351,0.00041108145,0.0001954893,0.0016353631,0.0005997597,0.00029571494,0.00002079968,0.000007721576,0.0006989436],"genre_scores_gemma":[0.9939018,0.0043733404,0.0006536859,0.00077171385,0.00019881126,0.0000028876577,0.0000018030198,0.000011467615,0.00008450139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563986,0.00077864144,0.0028781744,0.000246928,0.00021120459,0.0002452064],"domain_scores_gemma":[0.9957217,0.002051776,0.0017581152,0.000108002256,0.00014018932,0.00022023518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034557434,0.00016073155,0.0021596206,0.00023491986,0.00015777323,0.000009028211,0.00009279522,0.00019752908,0.000011583859],"category_scores_gemma":[0.00090143475,0.00013010454,0.00021435879,0.00013893214,0.0004157247,0.000082132254,0.00021659156,0.0006426138,3.015247e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042932937,0.0011248714,0.95888484,0.00022476312,0.00042218188,0.0004917623,0.00029315328,2.707436e-7,0.000003064405,0.00018330266,0.0001850958,0.03389342],"study_design_scores_gemma":[0.013495955,0.003669856,0.97994745,0.00023087046,0.00069934723,0.000101597005,0.0002525294,0.00010577248,0.0000027051756,0.001038516,0.00037207713,0.000083311024],"about_ca_topic_score_codex":0.00030051568,"about_ca_topic_score_gemma":0.0007187095,"teacher_disagreement_score":0.03381011,"about_ca_system_score_codex":0.00026950167,"about_ca_system_score_gemma":0.0025034402,"threshold_uncertainty_score":0.5305509},"labels":[],"label_agreement":null},{"id":"W4407701540","doi":"10.1200/jco.2025.43.5_suppl.tps889","title":"A phase 2/3 multicenter trial evaluating safety and efficacy of a new mucoadhesive gemcitabine suspension for ablation of upper tract urothelial carcinoma.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gemcitabine; Urothelial carcinoma; Multicenter study; Oncology; Carcinoma; Urology; Internal medicine; Chemotherapy; Bladder cancer; Cancer; Randomized controlled trial","score_opus":0.1555843798926918,"score_gpt":0.521490643124918,"score_spread":0.3659062632322262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407701540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933103,0.0004344313,0.0009739799,0.0025532555,0.0010291775,0.0012736372,0.000016659546,0.00000308019,0.0004054871],"genre_scores_gemma":[0.9926281,0.00016355104,0.005487492,0.0004679318,0.000903244,0.000004374766,0.0000067009637,0.000011675671,0.00032691998],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966375,0.0002904023,0.0024902984,0.00017533917,0.0002592763,0.00014713446],"domain_scores_gemma":[0.99388146,0.0035915503,0.001607554,0.00013476907,0.0006087685,0.00017589278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019307719,0.00012672588,0.0014592771,0.00015115365,0.000030959913,0.0000033312426,0.000070479306,0.00024582827,0.00006575694],"category_scores_gemma":[0.006495418,0.000089176174,0.0005123209,0.000098595294,0.00011306107,0.00007474536,0.000026161553,0.0003080653,5.134249e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67894745,0.006795394,0.016717453,0.00010372763,0.000559838,0.000023469505,0.00041049585,0.000009062384,0.004611614,0.00005744084,0.00064770295,0.29111633],"study_design_scores_gemma":[0.72360516,0.10160298,0.16055225,0.0003553593,0.0028372218,0.00003707513,0.00014421696,0.0010396788,0.0034244992,0.00027832968,0.006040299,0.00008295968],"about_ca_topic_score_codex":0.00006563388,"about_ca_topic_score_gemma":0.000007361242,"teacher_disagreement_score":0.2910334,"about_ca_system_score_codex":0.00010070565,"about_ca_system_score_gemma":0.0024150917,"threshold_uncertainty_score":0.7776091},"labels":[],"label_agreement":null},{"id":"W4407701764","doi":"10.1200/jco.2025.43.5_suppl.808","title":"ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Urothelial cancer; Oncology; Internal medicine; Cancer research; Cancer; Bladder cancer","score_opus":0.07342563517190712,"score_gpt":0.44259894561825625,"score_spread":0.36917331044634916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407701764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912556,0.00025409018,0.0022764793,0.002520471,0.0011046267,0.0016421195,0.00004570177,0.000010812508,0.00089013006],"genre_scores_gemma":[0.98529744,0.00005430599,0.012829556,0.0007299465,0.0006915695,0.000096159376,0.000011692441,0.000030897674,0.0002584023],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963506,0.00030852627,0.0023694094,0.00028516146,0.00039681222,0.00028948166],"domain_scores_gemma":[0.9951073,0.002624161,0.0013496439,0.00021707709,0.00040029746,0.0003014989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011899814,0.000256378,0.0019636871,0.0002171089,0.000105860534,0.000020234414,0.00012062119,0.00018899569,0.000045101624],"category_scores_gemma":[0.0013085334,0.00016383578,0.00046725452,0.0002083661,0.00025501903,0.00011442291,0.000025028285,0.0004990046,8.429019e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8089148,0.010388097,0.04701981,0.00036938084,0.005783174,0.0012248157,0.0007766304,0.00007817174,0.0010003073,0.00044368283,0.0022249187,0.12177621],"study_design_scores_gemma":[0.731679,0.22920112,0.018123122,0.00066383986,0.008437281,0.00035847045,0.00046247197,0.0004933287,0.0033087241,0.0007025322,0.0062858406,0.0002842473],"about_ca_topic_score_codex":0.00005173896,"about_ca_topic_score_gemma":0.00011251761,"teacher_disagreement_score":0.21881302,"about_ca_system_score_codex":0.00010102804,"about_ca_system_score_gemma":0.004750973,"threshold_uncertainty_score":0.8428022},"labels":[],"label_agreement":null},{"id":"W4407702330","doi":"10.1200/jco.2025.43.5_suppl.826","title":"Mechanism of action and translation to the clinic of detalimogene voraplasmid (EG-70): A novel, investigational, non-viral immunotherapy for non-muscle-invasive bladder cancer (NMIBC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Cancer; Mechanism (biology); Investigational Drugs; Cancer immunotherapy; Mechanism of action; Oncology; Internal medicine; Clinical trial","score_opus":0.13907920804179502,"score_gpt":0.4697884836353675,"score_spread":0.3307092755935725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407702330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96054935,0.0008947202,0.016921751,0.018435309,0.0016742412,0.0010669497,0.00007209309,0.000004071237,0.0003814998],"genre_scores_gemma":[0.9843506,0.0024328642,0.008174589,0.00417438,0.00053161377,0.00005358686,0.0000050073895,0.000017339227,0.00025996863],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974503,0.00012610108,0.0018302504,0.00018577989,0.0002594791,0.00014809844],"domain_scores_gemma":[0.9959632,0.0018954225,0.0012307949,0.0001619828,0.00061885966,0.0001297235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014299109,0.00014330966,0.0010294924,0.00015598879,0.00005339422,0.000005324191,0.00012768923,0.00029038987,0.00007537689],"category_scores_gemma":[0.00054978154,0.00009443856,0.00041330408,0.0001867797,0.00018423672,0.000092627124,0.000017904025,0.0003137651,0.0000011724695],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03402518,0.0043083457,0.024086127,0.0005782502,0.0077743516,0.000015691776,0.0020798708,0.0002699605,0.2984038,0.0007984643,0.0077878865,0.6198721],"study_design_scores_gemma":[0.08715339,0.0708077,0.5597694,0.0017690535,0.006417321,0.000102160455,0.0010659503,0.0017466492,0.20625712,0.013936907,0.050472107,0.0005022573],"about_ca_topic_score_codex":0.000092547605,"about_ca_topic_score_gemma":0.0002526891,"teacher_disagreement_score":0.6193698,"about_ca_system_score_codex":0.00008247285,"about_ca_system_score_gemma":0.00276024,"threshold_uncertainty_score":0.48965475},"labels":[],"label_agreement":null},{"id":"W4407702530","doi":"10.1200/jco.2025.43.5_suppl.853","title":"DNA damage repair alterations as predictive biomarker for platinum-based chemotherapy in metastatic urothelial cancer.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Urothelial cancer; Biomarker; Chemotherapy; DNA damage; Oncology; Cancer; Cancer research; DNA; Bladder cancer; Internal medicine; Pathology; Genetics; Biology","score_opus":0.10767130414792704,"score_gpt":0.5015680105756978,"score_spread":0.39389670642777075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407702530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93618864,0.00079688267,0.0077212825,0.040914055,0.002898147,0.0020300725,0.00013499285,0.000043332017,0.009272616],"genre_scores_gemma":[0.97327656,0.00026656163,0.00949247,0.014817731,0.00063969335,0.00014229905,0.0000106862735,0.000025329995,0.0013286726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735606,0.00029332846,0.0017197577,0.0002160373,0.00020739804,0.00020741875],"domain_scores_gemma":[0.9965266,0.002141091,0.0006701059,0.00017083672,0.00032148464,0.00016987676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001456823,0.00014896641,0.0011348036,0.00022405732,0.000047554688,0.000008456977,0.00010767698,0.00019819112,0.0002580594],"category_scores_gemma":[0.0017811195,0.00010871317,0.0005722217,0.00023098598,0.00014306356,0.000082239654,0.000012673073,0.00041481122,0.0000035678559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19208291,0.017170409,0.3706488,0.0004784645,0.009104567,0.0012100752,0.0008214454,0.0006859768,0.0038216205,0.0012454161,0.068568595,0.33416173],"study_design_scores_gemma":[0.12171779,0.042008165,0.6296994,0.00086152996,0.0026493003,0.000067353045,0.0002632363,0.010780902,0.0031143487,0.004808358,0.18375808,0.0002715099],"about_ca_topic_score_codex":0.000104298546,"about_ca_topic_score_gemma":0.000219104,"teacher_disagreement_score":0.3338902,"about_ca_system_score_codex":0.0003070727,"about_ca_system_score_gemma":0.0053608455,"threshold_uncertainty_score":0.950991},"labels":[],"label_agreement":null},{"id":"W4407702756","doi":"10.1200/jco.2025.43.5_suppl.tps886","title":"A phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer (NMIBC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Urothelial cancer; Oncology; Urology; Internal medicine; Cancer","score_opus":0.04831964550911251,"score_gpt":0.4395237639829985,"score_spread":0.39120411847388603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407702756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951756,0.0002263393,0.00066490186,0.0011364726,0.0010905361,0.001458279,0.00007835866,0.0000068580302,0.00016265603],"genre_scores_gemma":[0.99500865,0.00076509203,0.0019068572,0.001485624,0.0005750884,0.00008212854,0.000006481951,0.000029964014,0.00014013099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966656,0.0002781303,0.0020672432,0.00030685196,0.00040975673,0.00027243828],"domain_scores_gemma":[0.9949166,0.0017426829,0.0017154736,0.0002687262,0.0010712977,0.00028522444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007800996,0.00023604711,0.0018985649,0.00019151549,0.00006401287,0.000008188744,0.00019589489,0.00029040067,0.00011494478],"category_scores_gemma":[0.0007620545,0.00014919361,0.00037519165,0.00024632565,0.00019547541,0.00009653645,0.000034355257,0.0005656075,0.0000019510212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06343824,0.061616138,0.52802813,0.00007575571,0.0073246793,0.000114486036,0.0006511323,0.00005282797,0.00026317083,0.000016757745,0.0031225746,0.3352961],"study_design_scores_gemma":[0.17709798,0.21812381,0.59470356,0.00019390827,0.0039066556,0.0000067091105,0.0003594007,0.00004563281,0.0017021237,0.00030406466,0.0033956699,0.00016048354],"about_ca_topic_score_codex":0.00028604598,"about_ca_topic_score_gemma":0.0004544947,"teacher_disagreement_score":0.3351356,"about_ca_system_score_codex":0.00017253344,"about_ca_system_score_gemma":0.002861804,"threshold_uncertainty_score":0.6083939},"labels":[],"label_agreement":null},{"id":"W4407763627","doi":"10.1016/j.urolonc.2024.11.001","title":"Change of the guards—Looking back at Michael Droller: Visionary and supporter—The perspective of the International Bladder Cancer Network","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Supporter; Medicine; Perspective (graphical); Cancer; Bladder cancer; Internal medicine; Archaeology; Visual arts","score_opus":0.02592953384629358,"score_gpt":0.32497997666076645,"score_spread":0.29905044281447285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407763627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.891014,0.006719786,0.0000060924126,0.09122925,0.00080294424,0.0007012397,0.00006874531,0.000008922712,0.009449045],"genre_scores_gemma":[0.97639465,0.0020128505,0.001022453,0.014007342,0.00028969007,0.00016135006,0.000009014082,0.000010643822,0.006091996],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916434,0.00009675116,0.00022034156,0.00021876585,0.00014771415,0.00015207619],"domain_scores_gemma":[0.9992716,0.0001918794,0.00017387093,0.00020703868,0.00010971605,0.000045919915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017376032,0.0001241653,0.00023313145,0.000041570842,0.0002772802,0.000005902267,0.0001724683,0.000115200055,0.00020394674],"category_scores_gemma":[0.000056927856,0.00006238196,0.000080063124,0.00023223554,0.001075794,0.000039251616,0.00022170183,0.00020522,0.0000011450376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019428346,0.00010808452,0.9643943,0.000024326051,0.00037607702,0.000005083976,0.0020379892,0.000037658865,0.00045060017,0.00825848,0.02272726,0.0013859042],"study_design_scores_gemma":[0.0020807255,0.0007310288,0.3380527,0.00032483932,0.0010762059,0.00013967064,0.0012776853,0.00065497693,0.0011825674,0.021668417,0.63267875,0.00013245628],"about_ca_topic_score_codex":0.00045958738,"about_ca_topic_score_gemma":0.00036495028,"teacher_disagreement_score":0.6263416,"about_ca_system_score_codex":0.00014345696,"about_ca_system_score_gemma":0.00034485708,"threshold_uncertainty_score":0.39638078},"labels":[],"label_agreement":null},{"id":"W4407838464","doi":"10.1038/s41467-025-57187-w","title":"Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy","year":2025,"lang":"en","type":"erratum","venue":"Nature Communications","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Queen's University; University of British Columbia","funders":"","keywords":"Profiling (computer programming); Computational biology; Chemotherapy; Biology; Bioinformatics; Cancer research; Medicine; Internal medicine; Computer science","score_opus":0.02341961153719929,"score_gpt":0.3485381221266047,"score_spread":0.3251185105894054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407838464","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10039796,0.2285254,0.0031318087,0.32556063,0.07801279,0.05415229,0.010617104,0.0033358631,0.19626616],"genre_scores_gemma":[0.51819384,0.0036885883,0.020823028,0.0083290115,0.001522754,0.0052695465,0.007141112,0.00026496316,0.4347672],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833596,0.00022102288,0.00034072486,0.00058996293,0.00021994847,0.00029236992],"domain_scores_gemma":[0.9967887,0.0004954798,0.000226513,0.0018820061,0.00045390896,0.00015341684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016373183,0.00043253187,0.0006132246,0.0003911025,0.0004947189,0.00006686746,0.0005013819,0.000907336,0.000049419366],"category_scores_gemma":[0.0005307664,0.00034733242,0.00010849632,0.0005723043,0.00033753988,0.000048520218,0.00015892007,0.0022537438,0.0000060086295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025538325,0.0003089676,0.018485455,0.0004976879,0.0015960286,0.000016399777,0.0009692876,0.0000061555597,0.0011450517,0.00017889727,0.9653543,0.008887905],"study_design_scores_gemma":[0.0049061845,0.0016895474,0.08603355,0.004379269,0.001967636,0.00004686602,0.00053963036,0.00030023052,0.0063314387,0.00014402921,0.8926353,0.0010263489],"about_ca_topic_score_codex":0.00048545055,"about_ca_topic_score_gemma":0.00459528,"teacher_disagreement_score":0.41779587,"about_ca_system_score_codex":0.00051442184,"about_ca_system_score_gemma":0.0035787488,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W4407857554","doi":"10.1016/j.urolonc.2025.01.002","title":"Sex-related differences in response to neoadjuvant and adjuvant chemotherapy in urothelial carcinoma of urinary bladder treated with radical cystectomy","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Urology; Chemotherapy; Adjuvant chemotherapy; Adjuvant; Urinary bladder; Oncology; Bladder cancer; Internal medicine; Carcinoma; Cancer","score_opus":0.015456757536302806,"score_gpt":0.28890780753686457,"score_spread":0.27345105000056175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407857554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887225,0.0012640562,0.0000114805325,0.008316651,0.000036411475,0.0007933981,0.000017276903,0.000025254185,0.000812958],"genre_scores_gemma":[0.99455005,0.00021205725,0.002851975,0.0013585602,0.000013617112,0.00013946943,0.000010013637,0.000011214318,0.0008530284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985603,0.0002557557,0.00038314212,0.00041302433,0.00011689714,0.00027089796],"domain_scores_gemma":[0.99923855,0.00030904677,0.00007674712,0.00016661135,0.000032549015,0.00017646997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028328988,0.00022199748,0.0006338958,0.0004642571,0.000066392895,0.000008148429,0.00007347067,0.00023168634,0.00004107073],"category_scores_gemma":[0.00007537095,0.00015997847,0.00002934457,0.0005856136,0.00067794323,0.000046324112,0.000035109497,0.00029145597,0.0000015237251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058897175,0.00053443946,0.98607403,0.000028205235,0.000080314436,0.00050396606,0.0014304997,0.000010320524,0.002369251,0.00033393706,0.000106258754,0.0026390746],"study_design_scores_gemma":[0.011351276,0.011733082,0.9592787,0.0002718065,0.0001906901,0.00041778234,0.0005512667,0.00040138018,0.0016795433,0.0009010322,0.013034307,0.00018914303],"about_ca_topic_score_codex":0.00045341323,"about_ca_topic_score_gemma":0.00010588964,"teacher_disagreement_score":0.026795326,"about_ca_system_score_codex":0.00012684107,"about_ca_system_score_gemma":0.0005508147,"threshold_uncertainty_score":0.6523733},"labels":[],"label_agreement":null},{"id":"W4407878127","doi":"10.3390/curroncol32030125","title":"Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Urology; Renal function; Hazard ratio; Dialysis; Kidney disease; Propensity score matching; Retrospective cohort study; Incidence (geometry); Cohort; Urothelial carcinoma; Internal medicine; Surgery; Confidence interval; Cancer; Bladder cancer","score_opus":0.0902602606865169,"score_gpt":0.43331243916614726,"score_spread":0.3430521784796304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407878127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309844,0.0008715061,0.0015197606,0.000403737,0.00088277756,0.0004762401,0.000043961925,0.000018975788,0.0026846193],"genre_scores_gemma":[0.99940646,0.000042097778,0.00007387847,0.000077102304,0.0000722981,0.00005598435,0.00017431054,0.0000061163432,0.00009174354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986242,0.0001672597,0.00046136454,0.0003103669,0.0001949593,0.00024184394],"domain_scores_gemma":[0.9992294,0.0002789066,0.00011622706,0.00020657545,0.000082120954,0.000086789885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115078605,0.00018666773,0.0010097332,0.00060938153,0.000032258467,0.000005406169,0.000092580914,0.00015031957,0.00029183223],"category_scores_gemma":[0.000033178636,0.00015166214,0.0002816151,0.00068530947,0.00022558904,0.000051251467,0.00003353377,0.00028631414,0.0000081126855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003064292,0.0016562275,0.96614546,0.000043893902,0.0013023202,0.000047462338,0.0006340361,0.00004431674,0.00014028471,0.00011568572,0.000174569,0.026631432],"study_design_scores_gemma":[0.0122340135,0.00094078167,0.98028725,0.000047746944,0.0028880606,0.000004244117,0.00008177302,0.00095797004,0.0008044644,0.000016412774,0.0016371433,0.000100149],"about_ca_topic_score_codex":0.00012608501,"about_ca_topic_score_gemma":0.00042064532,"teacher_disagreement_score":0.026531283,"about_ca_system_score_codex":0.0005614429,"about_ca_system_score_gemma":0.00049640395,"threshold_uncertainty_score":0.6184603},"labels":[],"label_agreement":null},{"id":"W4407930482","doi":"10.1177/23523735251319185","title":"Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer <sup/>","year":2025,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Clinical trial; Bladder cancer; Medicine; Prioritization; Multidisciplinary approach; Task force; Genitourinary system; Cancer; Medical physics; Intensive care medicine; Internal medicine; Management science; Engineering","score_opus":0.5750571568378412,"score_gpt":0.5616935397453389,"score_spread":0.013363617092502333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407930482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013987678,0.982034,0.000026217493,0.00078369136,0.0048868824,0.0064244266,0.0021220304,0.00005270547,0.0022712254],"genre_scores_gemma":[0.0007209451,0.97743,0.00017994283,0.0034108586,0.013548672,0.0026880598,0.00077489234,0.00015942908,0.0010872193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9739099,0.012159601,0.010421345,0.0017465757,0.0010301579,0.00073242956],"domain_scores_gemma":[0.95440406,0.038732436,0.0047547575,0.0014125933,0.00033935354,0.000356824],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021762524,0.0011273545,0.012720856,0.00037017534,0.00017547335,0.000108932305,0.00065003324,0.0016449208,0.0013865671],"category_scores_gemma":[0.022096619,0.0006903817,0.003950625,0.0008118849,0.00027129898,0.00015990315,0.00022919648,0.0021788047,0.000039916686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008239477,0.0005001048,0.0031032017,0.0027214722,0.0054122824,0.00006335479,0.0003550773,0.000072803385,0.000015177234,0.0000068906265,0.0876458,0.8992799],"study_design_scores_gemma":[0.01444745,0.0008716155,0.0031095995,0.15501767,0.024965921,0.0000039882893,0.00039155866,0.00022845714,0.00009984972,0.00006155612,0.79966456,0.0011377604],"about_ca_topic_score_codex":0.0058428193,"about_ca_topic_score_gemma":0.0019823061,"teacher_disagreement_score":0.8981421,"about_ca_system_score_codex":0.0004989466,"about_ca_system_score_gemma":0.008996632,"threshold_uncertainty_score":0.99965113},"labels":[],"label_agreement":null},{"id":"W4407957443","doi":"10.1007/s00428-025-04057-x","title":"Clinicopathological characteristics and prognostic significance of HER2 status evaluation in patients with urothelial carcinoma: a retrospective single-center experience in China","year":2025,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Urothelial carcinoma; Single Center; Retrospective cohort study; Medicine; Oncology; China; Carcinoma; Internal medicine; Center (category theory); Cancer; Bladder cancer","score_opus":0.03139020139103618,"score_gpt":0.3516966169273228,"score_spread":0.3203064155362866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407957443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393064,0.00068643695,0.00018526825,0.00019094895,0.00020394307,0.002730214,0.000145045,0.00004744525,0.0018800341],"genre_scores_gemma":[0.9973579,0.0002251771,0.0013700185,0.00039155522,0.00006263526,0.00033881684,0.00020084015,0.000029568888,0.000023494356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961263,0.0006516498,0.00096687925,0.0010230155,0.0005383779,0.0006938098],"domain_scores_gemma":[0.9982264,0.00047880676,0.000362553,0.0005527602,0.00021147686,0.00016801726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007600932,0.0004700292,0.001162385,0.00038148175,0.00008315912,0.000017904464,0.00023118588,0.00025059193,0.000029485354],"category_scores_gemma":[0.0018230986,0.000328308,0.00009945669,0.00066434836,0.0011484121,0.00012512822,0.00018091695,0.00077366584,0.0000028613554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036299522,0.0024904823,0.97899544,0.00013504992,0.00006728601,0.0001163864,0.0020000201,0.000009608066,0.0028769262,0.00015958493,0.000011326738,0.00950794],"study_design_scores_gemma":[0.012723393,0.0045687137,0.97866875,0.00053384353,0.0002751389,0.0000041671346,0.00045494808,0.0003234796,0.0010957234,0.001039653,0.000036400448,0.00027581665],"about_ca_topic_score_codex":0.00026155938,"about_ca_topic_score_gemma":0.00007559156,"teacher_disagreement_score":0.009232123,"about_ca_system_score_codex":0.00023663638,"about_ca_system_score_gemma":0.0005609078,"threshold_uncertainty_score":0.9999169},"labels":[],"label_agreement":null},{"id":"W4407995237","doi":"10.1097/ju.0000000000004490","title":"Updates to Microhematuria: AUA/SUFU Guideline (2025)","year":2025,"lang":"es","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Medicine; Microhematuria; Guideline; Intensive care medicine; Internal medicine; Pathology","score_opus":0.011992384205804524,"score_gpt":0.3206144273842732,"score_spread":0.3086220431784687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407995237","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36305356,0.11952192,0.004925704,0.47977495,0.008975429,0.0012374574,0.00008545843,0.000046069905,0.022379423],"genre_scores_gemma":[0.9528696,0.0041669896,0.00070578477,0.03547164,0.0015829045,0.00000374612,0.0000044906724,0.000031900505,0.0051629273],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787575,0.00030404574,0.0009923977,0.00016528305,0.00024253188,0.00041998157],"domain_scores_gemma":[0.9982281,0.00033225247,0.0003725827,0.0004353157,0.0004544089,0.00017734687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010193499,0.00026012983,0.00071662315,0.0003179582,0.00012320797,0.000025459402,0.0004928074,0.00019602156,0.00086450577],"category_scores_gemma":[0.00029527396,0.00015428054,0.00019996839,0.00035028232,0.00014111704,0.000050032177,0.0001518434,0.0006062023,0.00027362438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010688931,0.0007406099,0.006288307,0.0001414798,0.0034603185,0.0004486943,0.0011876212,0.00023159372,0.028544517,0.0018782523,0.9260577,0.020331992],"study_design_scores_gemma":[0.0056930855,0.004316692,0.011395487,0.0002853581,0.0048769796,0.0011968433,0.0003314337,0.000040097537,0.010162775,0.0035769567,0.9579276,0.00019668207],"about_ca_topic_score_codex":0.00008380916,"about_ca_topic_score_gemma":0.00001390757,"teacher_disagreement_score":0.58981603,"about_ca_system_score_codex":0.00010848138,"about_ca_system_score_gemma":0.0006078203,"threshold_uncertainty_score":0.9465732},"labels":[],"label_agreement":null},{"id":"W4408052326","doi":"10.3390/uro5010004","title":"Patient-Reported Urinary Symptom Progression After Bacillus Calmette–Guerin Therapy for Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Uro","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Urology; Urinary system; Urinary bladder; Bacillus (shape); Urinary Bladder Cancer; Cancer; Oncology; Internal medicine; Microbiology; Biology","score_opus":0.01746103369688195,"score_gpt":0.32909582007715565,"score_spread":0.3116347863802737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408052326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795932,0.009380346,0.00022487638,0.0024605342,0.0008675187,0.0022483438,0.00007810054,0.00013683079,0.0050102468],"genre_scores_gemma":[0.987977,0.00031232394,0.0004603991,0.0035275873,0.00017920943,0.0020281947,0.000041458654,0.00003596186,0.005437818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998879,0.000022687325,0.00025435595,0.0003570363,0.00019955183,0.0002873609],"domain_scores_gemma":[0.99935675,0.00003408773,0.00006411591,0.00032649824,0.000120165685,0.00009839943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004391761,0.0002012528,0.0002620362,0.00009495924,0.000077429904,0.000016321635,0.000050219052,0.00010077917,0.00059416634],"category_scores_gemma":[0.000019216774,0.00014496552,0.00013821447,0.00017224195,0.00004827048,0.000051706396,0.00003289914,0.00010139175,0.000011849339],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00871292,0.0019722062,0.1937521,0.00024588752,0.0017660992,0.00039660744,0.0011365815,0.000003879359,0.004199486,0.000047420024,0.032771964,0.75499487],"study_design_scores_gemma":[0.016265154,0.0040158425,0.31238443,0.00071985344,0.000783019,0.00006679077,0.00012528924,0.00012869555,0.037727114,0.00036762084,0.62691134,0.0005048539],"about_ca_topic_score_codex":0.000091424656,"about_ca_topic_score_gemma":0.0000079632655,"teacher_disagreement_score":0.75449,"about_ca_system_score_codex":0.00011228767,"about_ca_system_score_gemma":0.00024585382,"threshold_uncertainty_score":0.65057045},"labels":[],"label_agreement":null},{"id":"W4408151637","doi":"10.1007/s40615-025-02343-7","title":"Effect of Race/Ethnicity on In-hospital Outcomes After Radical Cystectomy","year":2025,"lang":"en","type":"article","venue":"Journal of Racial and Ethnic Health Disparities","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Ethnic group; Race (biology); Cystectomy; Quality of Life Research; Epidemiology; Medicine; Gerontology; Psychology; Public health; Sociology; Gender studies; Anthropology; Internal medicine; Bladder cancer; Pathology; Cancer","score_opus":0.011714613564006316,"score_gpt":0.35948548769774896,"score_spread":0.34777087413374264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408151637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97278494,0.012062448,0.000023132772,0.013802111,0.00054952444,0.00033693606,0.000012121523,0.0000061367246,0.00042264228],"genre_scores_gemma":[0.9960277,0.0016616553,0.000038709153,0.0018189936,0.00011976894,0.000014679654,9.616092e-7,0.000007800018,0.00030974948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985506,0.0001991513,0.0006105071,0.000118386684,0.0002826698,0.00023871906],"domain_scores_gemma":[0.9991533,0.00033415479,0.00019112395,0.00009948521,0.000055691027,0.00016622065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072127295,0.00015042443,0.00086476136,0.00021436962,0.000042321215,0.000007153676,0.00005485868,0.00010312496,0.000025842832],"category_scores_gemma":[0.00021434414,0.00009680675,0.00016685746,0.00015365476,0.0001444229,0.00007725181,0.000023519246,0.00042016804,0.000001106794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012630055,0.001044376,0.86590004,0.0038122595,0.00033609464,0.0002086877,0.0030104648,0.0000033453548,0.00002742397,0.00040517052,0.0020725594,0.11054953],"study_design_scores_gemma":[0.0066127293,0.005886583,0.9837762,0.0015329492,0.0001070899,0.000024192741,0.000112704656,0.000004602125,0.00041339884,0.00022071146,0.0012339554,0.0000748522],"about_ca_topic_score_codex":0.00033137834,"about_ca_topic_score_gemma":0.00010206849,"teacher_disagreement_score":0.1178762,"about_ca_system_score_codex":0.00013240549,"about_ca_system_score_gemma":0.00036678757,"threshold_uncertainty_score":0.39476648},"labels":[],"label_agreement":null},{"id":"W4408200720","doi":"10.1016/j.urology.2025.02.051","title":"Survival Outcomes and Temporal Trends of Non-Surgical Management Vs Radical Cystectomy in Non-Organ-Confined Urothelial Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial cancer; Bladder cancer; Urology; Urothelial carcinoma; Cancer; General surgery; Internal medicine","score_opus":0.009664492240888414,"score_gpt":0.3018662507904051,"score_spread":0.2922017585495167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408200720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93818456,0.00052571064,0.0001900678,0.008418029,0.0006490463,0.0006111886,0.000047299527,0.000041796276,0.051332306],"genre_scores_gemma":[0.9926817,0.00012802734,0.00010739268,0.0009643887,0.00007876252,0.00011175593,0.00001775912,0.000020572586,0.0058896495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985759,0.0000699057,0.00041157435,0.00040722688,0.00019176342,0.00034360614],"domain_scores_gemma":[0.9994583,0.00007878485,0.00006482928,0.0002643016,0.000031234453,0.00010255392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014345486,0.0002325005,0.0007524394,0.00040447162,0.000033226668,0.000006228311,0.00010832942,0.00019176309,0.0007112931],"category_scores_gemma":[0.000010260706,0.00018398078,0.00010525369,0.0003531595,0.00022630488,0.000027169212,0.00008984775,0.00021616802,0.000007920743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040122312,0.0005788491,0.97136456,0.00017977951,0.0008915914,0.00069536327,0.000246185,0.000010714216,0.00029391644,0.00075207005,0.0009467872,0.020027937],"study_design_scores_gemma":[0.02640842,0.00093895907,0.9484631,0.00004889468,0.00049894635,0.000036568912,0.000055066852,0.00026000768,0.0006024464,0.00011500552,0.022383796,0.00018882276],"about_ca_topic_score_codex":0.0010030783,"about_ca_topic_score_gemma":0.00039800082,"teacher_disagreement_score":0.054497138,"about_ca_system_score_codex":0.000055550005,"about_ca_system_score_gemma":0.00011299029,"threshold_uncertainty_score":0.77881604},"labels":[],"label_agreement":null},{"id":"W4408245008","doi":"10.1007/s00345-025-05496-6","title":"The effect of chronic kidney disease on adverse in-hospital outcomes after radical cystectomy with ileal conduit urinary diversion","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Kidney disease; Nephrology; Adverse effect; Internal medicine; Cystectomy; Dialysis; Renal function; Renal replacement therapy; Propensity score matching; Urology; Surgery; Bladder cancer; Cancer","score_opus":0.0034194254669934862,"score_gpt":0.2520401576267778,"score_spread":0.2486207321597843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408245008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585,0.002294092,0.000007952414,0.009998901,0.00053694425,0.0003615604,0.000008185764,0.000005745022,0.00093665736],"genre_scores_gemma":[0.99817526,0.00010295662,0.000007479309,0.0009021129,0.00008091373,0.000013482235,0.0000014273654,0.000008931563,0.00070745917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999037,0.00014904607,0.0002772448,0.00012615781,0.00021550013,0.00019502455],"domain_scores_gemma":[0.9991891,0.00027783425,0.00013805943,0.00017557835,0.000040792715,0.00017868009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016653317,0.00013900148,0.000395288,0.00023640502,0.000045519704,0.0000030667115,0.00011194329,0.000036811736,0.00012044323],"category_scores_gemma":[0.00006597446,0.00007029195,0.00015872551,0.00016445598,0.00021952738,0.000040629464,0.000040375726,0.00034208092,0.000006361713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03576016,0.00042809584,0.95550364,0.000096567725,0.00042601462,0.0029652,0.000058349597,0.000025161378,0.000023335675,0.000073344905,0.001727596,0.0029125516],"study_design_scores_gemma":[0.020635705,0.019171828,0.9303181,0.00035084464,0.0007838114,0.000099464756,0.0000126312025,0.000017767277,0.00013317453,0.000052307376,0.028343884,0.000080471014],"about_ca_topic_score_codex":0.000016898628,"about_ca_topic_score_gemma":0.000019369973,"teacher_disagreement_score":0.026616288,"about_ca_system_score_codex":0.0001526459,"about_ca_system_score_gemma":0.0003371979,"threshold_uncertainty_score":0.28664225},"labels":[],"label_agreement":null},{"id":"W4408245429","doi":"10.1111/bju.16695","title":"Understanding patient perspectives in the management of their muscle‐invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cohort; Medicine; Bladder cancer; Radiation oncologist; Cancer; Internal medicine; Family medicine; Radiation therapy","score_opus":0.04477173562625952,"score_gpt":0.2934308188158507,"score_spread":0.24865908318959118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408245429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427139,0.033827297,0.0006527247,0.006155211,0.00039989926,0.00044086756,0.000022525772,0.0000053683893,0.015782174],"genre_scores_gemma":[0.99021757,0.008606316,0.000073901196,0.0009805674,0.00004664443,0.000011232943,6.722933e-7,0.000006371112,0.00005674764],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992075,0.00009330045,0.00029650657,0.00010611159,0.00015040804,0.00014618781],"domain_scores_gemma":[0.9995708,0.00007843692,0.0001413369,0.00008811548,0.000094277,0.00002704627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016139397,0.00007650979,0.00024584695,0.00012690686,0.000040570223,0.000009754167,0.00010467263,0.00004628491,0.00010381036],"category_scores_gemma":[0.000014703767,0.00005791957,0.000104992454,0.00018717602,0.00010082383,0.00003885063,0.000024849734,0.00020874508,3.689073e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067384574,0.0087301275,0.10922174,0.0014649273,0.018930191,0.026698042,0.08043943,0.0012293892,0.0022842104,0.036703758,0.037362054,0.67019767],"study_design_scores_gemma":[0.013354216,0.0033992992,0.8298163,0.0020635042,0.0016785284,0.003441012,0.12180455,0.000026078926,0.00065048755,0.01727261,0.0062609017,0.00023256012],"about_ca_topic_score_codex":0.00015551227,"about_ca_topic_score_gemma":0.00021076019,"teacher_disagreement_score":0.7205945,"about_ca_system_score_codex":0.0001611978,"about_ca_system_score_gemma":0.0001350147,"threshold_uncertainty_score":0.23618916},"labels":[],"label_agreement":null},{"id":"W4408301663","doi":"10.1111/his.15438","title":"Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Concordance; Kappa; Reproducibility; Grading (engineering); Medicine; Bladder cancer; Nuclear medicine; Internal medicine; Cancer; Biology; Mathematics; Statistics","score_opus":0.028307033759629802,"score_gpt":0.2941451156711584,"score_spread":0.26583808191152863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408301663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926514,0.00037307947,0.00079816283,0.00012201343,0.0016332942,0.0009229123,0.00007525902,0.000051980165,0.0033718783],"genre_scores_gemma":[0.99894434,0.000010006359,0.00034978313,0.00012225994,0.00011611992,0.00008020191,0.000030435254,0.000023753853,0.00032309568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972824,0.00055560423,0.00071646116,0.0010245092,0.00020122377,0.000219823],"domain_scores_gemma":[0.9976947,0.00007038038,0.0002571273,0.0015904823,0.0003183933,0.000068939975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014020264,0.00021091265,0.00075156207,0.00029631663,0.000055149907,0.0000037825525,0.0002794101,0.000080293285,0.000057402704],"category_scores_gemma":[0.00039406115,0.00019197575,0.00015732458,0.00017549781,0.00027842834,0.00008939456,0.00017453355,0.00018837037,0.0000059762087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078359677,0.001472935,0.9567419,0.00031857958,0.000065208624,0.00089517894,0.0014045405,0.0000044293324,0.03614429,0.00038655053,0.00006538875,0.0017173723],"study_design_scores_gemma":[0.0034374145,0.002189099,0.9791083,0.00011251538,0.00036850147,0.0004672153,0.000720867,0.000049572376,0.013161514,0.00015867257,0.00011038169,0.00011594486],"about_ca_topic_score_codex":0.00048248968,"about_ca_topic_score_gemma":0.00015381079,"teacher_disagreement_score":0.022982776,"about_ca_system_score_codex":0.0003024626,"about_ca_system_score_gemma":0.00031103208,"threshold_uncertainty_score":0.78285444},"labels":[],"label_agreement":null},{"id":"W4408339655","doi":"10.1097/ju.0000000000004495","title":"Letter: Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes","year":2025,"lang":"en","type":"letter","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Tranexamic acid; Cystectomy; Surgery; General surgery; Blood loss; Bladder cancer; Internal medicine; Cancer","score_opus":0.017875648599578835,"score_gpt":0.30955907111302006,"score_spread":0.2916834225134412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408339655","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24114121,0.0018731675,0.000028958644,0.7543157,0.0010335337,0.00040294044,0.000039374252,0.000011469472,0.0011536333],"genre_scores_gemma":[0.538264,0.00071130623,0.000012394827,0.45884883,0.0018852014,0.0000045257034,0.000009391618,0.000030676074,0.00023371693],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99782306,0.0006035537,0.0005858405,0.00020962337,0.00037437322,0.0004035213],"domain_scores_gemma":[0.9986905,0.0006296982,0.00027555524,0.00024854433,0.000074706615,0.00008100591],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005497868,0.00040383395,0.0015740936,0.0004233389,0.000055598757,0.000017762179,0.00025852906,0.00057258044,0.00017140001],"category_scores_gemma":[0.00007743254,0.00020260824,0.0002501032,0.00013769847,0.00028561038,0.00005202404,0.000036882248,0.0034511506,0.0000065858535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007001849,0.0004313522,0.032422386,0.00026887012,0.005765133,0.006761708,0.0035164875,0.000043314947,0.0012209158,0.00003965501,0.93882346,0.0037048757],"study_design_scores_gemma":[0.04204541,0.025663452,0.53816044,0.0010378949,0.009127454,0.0110673765,0.00019463272,0.00006715007,0.0013005045,0.0014410687,0.36880335,0.0010912752],"about_ca_topic_score_codex":0.00015015814,"about_ca_topic_score_gemma":0.000026132575,"teacher_disagreement_score":0.5700201,"about_ca_system_score_codex":0.00019579494,"about_ca_system_score_gemma":0.0003890902,"threshold_uncertainty_score":0.9988479},"labels":[],"label_agreement":null},{"id":"W4408341294","doi":"10.1097/mou.0000000000001276","title":"The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Current Opinion in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Hazard ratio; Primary tumor; Cochrane Library; Meta-analysis; Oncology; Lymph node; Confidence interval; Subgroup analysis; Systematic review; Internal medicine; Stage (stratigraphy); Metastasis; Cancer; Database; Surgery; MEDLINE","score_opus":0.07393983176617225,"score_gpt":0.38813681555264207,"score_spread":0.3141969837864698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408341294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008659342,0.9950081,0.0000017698479,0.00025286662,0.0003551292,0.004083477,0.00015233057,0.0000038130818,0.0001338682],"genre_scores_gemma":[0.0011260872,0.9974102,0.0000038962576,0.000033706172,0.00002771149,0.0012633152,0.00006154766,0.000015010716,0.0000585176],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99543566,0.0020323563,0.001648853,0.00038136056,0.0002906916,0.00021111044],"domain_scores_gemma":[0.9974243,0.0010344037,0.000777678,0.000645836,0.00007669202,0.000041079762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010432535,0.0003267965,0.0059196088,0.00041086096,0.000034938505,0.000005544839,0.00024496706,0.00010181549,0.000041308667],"category_scores_gemma":[0.00023136358,0.00014811858,0.0016965241,0.0011523571,0.00015166905,0.000022988257,0.00010120404,0.00048747295,0.0000011898245],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069012174,0.00034796272,0.00048326666,0.9809218,0.014605903,0.0000032942696,0.000046043366,7.812067e-7,4.8764367e-8,0.0002459327,0.00004439776,0.0032315776],"study_design_scores_gemma":[0.0011137672,0.00034915758,0.00037531494,0.034588225,0.860077,0.00019017757,0.000017680632,0.000010263309,6.735157e-7,0.0001327164,0.1029671,0.00017789754],"about_ca_topic_score_codex":0.000067338486,"about_ca_topic_score_gemma":0.00001560567,"teacher_disagreement_score":0.9463335,"about_ca_system_score_codex":0.000094137016,"about_ca_system_score_gemma":0.0005189787,"threshold_uncertainty_score":0.60401005},"labels":[],"label_agreement":null},{"id":"W4408563004","doi":"10.1016/j.esmoop.2025.104506","title":"Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Merck; Pfizer","keywords":"Javelin; Urothelial carcinoma; Avelumab; Medicine; Oncology; Carcinoma; Term (time); Urology; Internal medicine; Bladder cancer; Immunotherapy; Cancer; Pembrolizumab","score_opus":0.03674774194139571,"score_gpt":0.33897801224876994,"score_spread":0.30223027030737426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408563004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753013,0.00019087002,0.000577331,0.007664442,0.0017620724,0.010967659,0.00049861585,0.00003833462,0.002999379],"genre_scores_gemma":[0.9835594,0.00005552323,0.00040626005,0.0038672534,0.0002519193,0.0014958802,0.00031154117,0.000046282417,0.010005931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813265,0.000066894245,0.00054318336,0.00057672645,0.00024938615,0.00043117037],"domain_scores_gemma":[0.9986605,0.00034049095,0.0001248978,0.00065026135,0.00013622385,0.00008762358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019633594,0.0003168473,0.00064947293,0.00007479985,0.0001750531,0.000080124344,0.00056318,0.00013370876,0.0005462045],"category_scores_gemma":[0.00027153693,0.00018595319,0.00019898973,0.000207665,0.00007334236,0.00016083643,0.00025127636,0.00022128578,0.000043510187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049498454,0.0016194653,0.90432847,0.000049971335,0.00039564847,0.000031755953,0.0007435931,0.000008389957,0.000006733916,0.00008259099,0.0079158945,0.035319027],"study_design_scores_gemma":[0.20046286,0.000590755,0.7925533,0.00022147305,0.00021148418,6.3284483e-7,0.00004990665,0.000026944444,0.00036415845,0.00034007634,0.0049962397,0.00018214974],"about_ca_topic_score_codex":0.0036918474,"about_ca_topic_score_gemma":0.004269718,"teacher_disagreement_score":0.15096441,"about_ca_system_score_codex":0.00022568824,"about_ca_system_score_gemma":0.00035549566,"threshold_uncertainty_score":0.7582951},"labels":[],"label_agreement":null},{"id":"W4408576730","doi":"10.5489/cuaj.9039","title":"Open, laparoscopic, and robotic radical nephroureterectomy for upper tract urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Medicine; Urology; Upper urinary tract; Open surgery; Surgery; Internal medicine; Cancer; Urinary system; Bladder cancer","score_opus":0.018591204126100328,"score_gpt":0.28206467966883514,"score_spread":0.2634734755427348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408576730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86784375,0.0012895036,0.0007236838,0.11466823,0.0016719537,0.0017904445,0.00016783431,0.000039428654,0.011805172],"genre_scores_gemma":[0.9799023,0.000056959663,0.0006959358,0.015818188,0.00054698245,0.000050386163,0.000024783027,0.00001274955,0.002891716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877113,0.00010190554,0.0002795513,0.00023995587,0.0001599723,0.0004474847],"domain_scores_gemma":[0.99890625,0.0001747228,0.00010161898,0.00009543146,0.00014035583,0.0005816297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003459132,0.00015036608,0.00039257834,0.00015170882,0.0003471118,0.00021260185,0.0001597205,0.0002491301,0.0003607722],"category_scores_gemma":[0.00044219094,0.00011841784,0.00012448108,0.00013018832,0.000043406424,0.00010669873,0.000025880134,0.00038142424,0.0000071993873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002904081,0.000094690084,0.9586885,0.000014319416,0.00020348448,0.000055395834,0.000073656935,0.0000035841745,0.00008729966,0.0008986529,0.035088383,0.0045016133],"study_design_scores_gemma":[0.0064750393,0.0006637843,0.786829,0.000027526909,0.00029519046,0.0001787956,0.000030698702,0.0001095229,0.00008618328,0.0022150367,0.2029652,0.00012402826],"about_ca_topic_score_codex":0.0015057281,"about_ca_topic_score_gemma":0.00046469545,"teacher_disagreement_score":0.17185952,"about_ca_system_score_codex":0.00079938176,"about_ca_system_score_gemma":0.0012323156,"threshold_uncertainty_score":0.4828939},"labels":[],"label_agreement":null},{"id":"W4408621175","doi":"10.3389/fonc.2025.1546447","title":"Assessing the clinical, humanistic, and economic impact of early cancer diagnosis: a systematic literature review","year":2025,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Cancer; Checklist; MEDLINE; Observational study; Systematic review; Breast cancer; Health care; Stage (stratigraphy); Family medicine; Intensive care medicine; Internal medicine","score_opus":0.07132795586177057,"score_gpt":0.49749506036668123,"score_spread":0.4261671045049107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408621175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014517252,0.99399143,0.000010067107,0.00013667338,0.0014569494,0.0035429483,0.00015782188,0.000010215231,0.000679386],"genre_scores_gemma":[0.000023781076,0.9960445,0.00026526555,0.00031898014,0.00022199324,0.002796622,0.00003564014,0.000028928056,0.00026426642],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99687177,0.0009833579,0.00142586,0.00040392054,0.00008696563,0.00022814059],"domain_scores_gemma":[0.997685,0.0008720372,0.00082798535,0.00047974926,0.00005404601,0.0000811585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007982849,0.00035944185,0.0052674003,0.00020583264,0.000045389606,0.00003975758,0.00021650983,0.00046046465,0.0000528886],"category_scores_gemma":[0.0003027971,0.00019320745,0.00074544514,0.00024070188,0.00017600598,0.00006254105,0.000070763526,0.0006340566,0.0000030240355],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014336664,0.000080555204,0.0058020013,0.60345256,0.0014030221,0.00006140824,0.000062706895,7.513881e-8,1.3761305e-9,0.0000071779227,0.038645193,0.35047096],"study_design_scores_gemma":[0.000641848,0.000575989,0.0007474164,0.77711165,0.009641323,0.000057832007,0.000017802295,0.0000021394105,1.0824058e-8,0.000028546618,0.21104626,0.0001291792],"about_ca_topic_score_codex":0.0001682913,"about_ca_topic_score_gemma":0.000037045924,"teacher_disagreement_score":0.35034177,"about_ca_system_score_codex":0.0014773371,"about_ca_system_score_gemma":0.003922422,"threshold_uncertainty_score":0.78787714},"labels":[],"label_agreement":null},{"id":"W4408656210","doi":"10.1016/j.urolonc.2025.02.014","title":"Bladder cuff excision at radical nephroureterectomy improved survival in upper tract urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cuff; Urothelial carcinoma; Urology; Upper urinary tract; Carcinoma; Urothelium; Urothelial cancer; Bladder cancer; Surgery; Internal medicine; Urinary bladder; Cancer; Urinary system","score_opus":0.023155762000314162,"score_gpt":0.31734632134100776,"score_spread":0.2941905593406936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408656210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712005,0.0013574613,0.00004889971,0.0086536,0.00047407122,0.00066513056,0.000033501332,0.00006379506,0.017502991],"genre_scores_gemma":[0.97963965,0.0004101385,0.008365066,0.005991319,0.00022764961,0.0001905815,0.00009057911,0.000022750519,0.005062271],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982505,0.0002002519,0.00041003706,0.00055251014,0.00015806835,0.00042865143],"domain_scores_gemma":[0.999013,0.00033015865,0.00008827417,0.0002611276,0.0000483798,0.00025905395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029335957,0.00027962637,0.00054825295,0.00027543338,0.00022889698,0.000021318887,0.00011325397,0.000410624,0.00031071133],"category_scores_gemma":[0.00015238266,0.00022470827,0.000105600964,0.0003647653,0.00064670003,0.0000941086,0.000085762964,0.00047215802,0.000024082881],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093579077,0.00053589616,0.98433375,0.00003363016,0.00009287698,0.0003117538,0.00039986614,0.0000061239934,0.002654214,0.002123536,0.0046342476,0.003938339],"study_design_scores_gemma":[0.006255516,0.002622485,0.15821761,0.00006542015,0.00042676582,0.00031261632,0.0001578731,0.0008007401,0.0016379588,0.004622549,0.8246244,0.00025605704],"about_ca_topic_score_codex":0.00028764652,"about_ca_topic_score_gemma":0.00015319296,"teacher_disagreement_score":0.82611614,"about_ca_system_score_codex":0.00037282688,"about_ca_system_score_gemma":0.0007293892,"threshold_uncertainty_score":0.91633373},"labels":[],"label_agreement":null},{"id":"W4408662609","doi":"10.1016/j.eururo.2025.02.019","title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital","funders":"Sanofi Pasteur; Genentech; Medac; Astellas Pharma; Eisai; European Association of Urology; Incyte; Ipsen; Mirati Therapeutics; Clovis Oncology; Seagen; Gilead Sciences; Sanofi; G1 Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Bladder cancer; Urology; General surgery; Cancer; Gynecology; Internal medicine","score_opus":0.04959131884894241,"score_gpt":0.33942095235536296,"score_spread":0.28982963350642055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408662609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6959957,0.016188774,0.00024933493,0.09258662,0.0024391075,0.0014658828,0.0003234363,0.000121871104,0.19062926],"genre_scores_gemma":[0.96639574,0.0024657724,0.00032449298,0.021636568,0.00026198657,0.000011640066,0.000019922627,0.00004920133,0.008834703],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975456,0.0009080694,0.00074875244,0.0003503626,0.00020541437,0.00024178094],"domain_scores_gemma":[0.99821734,0.0003339071,0.00039776778,0.00042928802,0.0005672677,0.000054432752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073568785,0.00021136522,0.00047008056,0.00015664083,0.000068211746,0.000005316543,0.00020480844,0.00005207089,0.000094734874],"category_scores_gemma":[0.001592342,0.00014594765,0.00013865532,0.0002536636,0.00016114539,0.00002711932,0.00017524092,0.00020128216,0.000018075396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023410136,0.001039165,0.28878865,0.00067103567,0.0055279043,0.00028915083,0.001447773,0.0010948564,0.033804804,0.0033127873,0.4964125,0.16527037],"study_design_scores_gemma":[0.008179186,0.0022454162,0.6434977,0.00030669972,0.0035496752,0.000032815882,0.0001561753,0.0002138052,0.0042487034,0.000768585,0.33648363,0.00031761586],"about_ca_topic_score_codex":0.00014601265,"about_ca_topic_score_gemma":0.000106268984,"teacher_disagreement_score":0.35470903,"about_ca_system_score_codex":0.000045409783,"about_ca_system_score_gemma":0.0002044244,"threshold_uncertainty_score":0.59515727},"labels":[],"label_agreement":null},{"id":"W4408776919","doi":"10.1016/j.labinv.2024.103126","title":"893 Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinomas Among Genitourinary Pathologists","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Calgary; McGill University","funders":"","keywords":"Genitourinary system; Reproducibility; Pathology; Medicine; Cytological Techniques; Urology; Gynecology; Internal medicine; Chemistry","score_opus":0.024001364309004597,"score_gpt":0.27305766193002845,"score_spread":0.24905629762102385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408776919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745566,0.00037381068,0.000018676621,0.00040022927,0.00017332862,0.0004593592,0.000022527158,0.000039995743,0.0010563988],"genre_scores_gemma":[0.99845684,0.00001581803,0.0006706391,0.00042594137,0.000055730496,0.000040021616,0.000056262485,0.000010856972,0.00026789142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840426,0.0001995784,0.00043563265,0.0006371484,0.00017219437,0.0001511814],"domain_scores_gemma":[0.9987061,0.000038222486,0.00012388456,0.00084624236,0.00019929583,0.00008623808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005777011,0.00014052015,0.0002822933,0.00015764649,0.000033234603,0.0000074443174,0.00008020659,0.00013994722,0.000032994652],"category_scores_gemma":[0.00032998866,0.00012678216,0.000052251853,0.00061672,0.00023431121,0.00013733396,0.000057884234,0.00021357201,0.000005804008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018597404,0.00018194117,0.8954932,0.00023718711,0.000014318782,0.00004554341,0.0006055542,0.000012033605,0.102468625,0.00004094553,0.00047789776,0.0002367595],"study_design_scores_gemma":[0.000993065,0.0001908098,0.7119241,0.00017437972,0.000049332568,0.0000010430975,0.0000741221,0.000029368744,0.28590295,0.0005425272,0.000058332,0.000059963415],"about_ca_topic_score_codex":0.00043188213,"about_ca_topic_score_gemma":0.00019710539,"teacher_disagreement_score":0.18356912,"about_ca_system_score_codex":0.00018368583,"about_ca_system_score_gemma":0.00043016995,"threshold_uncertainty_score":0.51700264},"labels":[],"label_agreement":null},{"id":"W4408780248","doi":"10.3390/curroncol32040187","title":"Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Discontinuation; Metastatic Urothelial Carcinoma; Carboplatin; Internal medicine; Oncology; Bladder cancer; Population; Cisplatin; Nivolumab; Chemotherapy; Cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.06938084763196287,"score_gpt":0.4064602409107799,"score_spread":0.3370793932788171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408780248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217874,0.00046020336,0.000084928215,0.00082587556,0.0005776053,0.005116172,0.000057168487,0.00004119281,0.0006581271],"genre_scores_gemma":[0.99648523,0.00051652663,0.00020521898,0.00022507775,0.00006890467,0.0007801556,0.000027210526,0.00003468388,0.0016570173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757415,0.00030816795,0.00074574834,0.0006702335,0.00025286287,0.00044882757],"domain_scores_gemma":[0.9983594,0.000537613,0.00022745396,0.00051884033,0.00020869369,0.00014799832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025131085,0.0004177964,0.0011744046,0.00018204706,0.00017377952,0.000015878724,0.00015045925,0.00006011318,0.00003420126],"category_scores_gemma":[0.000110059045,0.00018867372,0.00008196324,0.00047373492,0.00027884298,0.000058735386,0.00009466244,0.00031168413,0.0000071060435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010886114,0.007221809,0.9511865,0.00013414196,0.0006900016,0.00019472868,0.0008837919,0.000024244398,3.7194758e-7,0.00003252066,0.00010917301,0.02863665],"study_design_scores_gemma":[0.063003354,0.028916722,0.9015481,0.00051601295,0.0013599398,0.000029403445,0.000732177,0.00006780171,0.000003999259,0.000016818498,0.0036124976,0.00019319425],"about_ca_topic_score_codex":0.00092442456,"about_ca_topic_score_gemma":0.032057405,"teacher_disagreement_score":0.05211724,"about_ca_system_score_codex":0.0007624593,"about_ca_system_score_gemma":0.0013549837,"threshold_uncertainty_score":0.985605},"labels":[],"label_agreement":null},{"id":"W4408796647","doi":"10.1016/j.labinv.2024.103020","title":"787 Fibroblast Growth Factor Receptor (FGFR) Testing in Urothelial Carcinoma (UC): A Single Institution Experience Incorporating Pathologist-driven Reflex Testing","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibroblast growth factor receptor; Urothelial carcinoma; Fibroblast growth factor; Medicine; Pathology; Reflex; Fibroblast growth factor receptor 3; Carcinoma; Receptor; Oncology; Cancer research; Internal medicine; Cancer; Bladder cancer","score_opus":0.05708627751679056,"score_gpt":0.2920661846183361,"score_spread":0.23497990710154554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408796647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956558,0.00009654355,0.00030919968,0.00035633883,0.0003169217,0.0007751835,0.00008530717,0.00025538544,0.0021493712],"genre_scores_gemma":[0.97857547,0.0000019694696,0.019906463,0.00093503646,0.00021529899,0.00019527513,0.00006631643,0.000031816362,0.00007235562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791604,0.00018393433,0.0006163946,0.00059429416,0.00030108186,0.0003882669],"domain_scores_gemma":[0.99855244,0.00014559145,0.0002856957,0.00031243995,0.00053733034,0.00016652723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019811388,0.00031563785,0.000364388,0.000305932,0.00027591203,0.000078141326,0.00013728686,0.00021133595,0.00001773864],"category_scores_gemma":[0.0026224684,0.00031036985,0.000040498402,0.0020918588,0.00034426645,0.0004996443,0.00007794814,0.00034367578,0.000025491281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051445437,0.00008274029,0.4998265,0.0001372937,0.000009126405,0.000034768364,0.0010953535,0.0000375272,0.49705735,0.00029937478,0.000056981746,0.0013115446],"study_design_scores_gemma":[0.003067896,0.00092943583,0.6461287,0.00211461,0.000062096035,0.000016670581,0.0008641268,0.0014337929,0.34370098,0.0010356746,0.00016446438,0.00048151822],"about_ca_topic_score_codex":0.0005743961,"about_ca_topic_score_gemma":0.000082868944,"teacher_disagreement_score":0.15335637,"about_ca_system_score_codex":0.00073966186,"about_ca_system_score_gemma":0.0015131066,"threshold_uncertainty_score":0.99993485},"labels":[],"label_agreement":null},{"id":"W4408797502","doi":"10.1016/j.labinv.2024.103033","title":"800 The Percentage of the High-Grade Component in Non-Invasive Papillary Urothelial Carcinoma: Does it Impact Clinical Outcome?","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Urothelial carcinoma; Papillary carcinoma; Medicine; Carcinoma; Oncology; Component (thermodynamics); Pathology; Internal medicine; Urology; Cancer; Thyroid carcinoma; Bladder cancer","score_opus":0.024927999908177182,"score_gpt":0.3318418354920363,"score_spread":0.3069138355838591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408797502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873085,0.00017557915,0.0000057401357,0.008897498,0.00079623586,0.00098163,0.00015890265,0.000019494953,0.00023408713],"genre_scores_gemma":[0.9939863,0.00006607078,0.000059656424,0.0054318276,0.00018022438,0.000054301952,0.000031009546,0.000017250819,0.00017336017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.00035529304,0.0006440495,0.0002690922,0.00030713473,0.00020048469],"domain_scores_gemma":[0.99882317,0.0002264434,0.0001880517,0.00054633996,0.00011904529,0.000096972566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040686683,0.00019835366,0.00038843983,0.0000827461,0.000112394,0.000017282204,0.00019980187,0.0001395408,0.00004683037],"category_scores_gemma":[0.00019773393,0.00009543946,0.00016660335,0.00045604122,0.00041315748,0.000080143436,0.00006553477,0.00035424522,0.000009699598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011294601,0.000152011,0.98137885,0.00009588202,0.00009444397,0.0000098609635,0.0008652651,0.00001648225,0.015403921,0.00023506403,0.0015293605,0.00010589581],"study_design_scores_gemma":[0.002671639,0.00014338476,0.9642133,0.00018839918,0.00018797095,0.0000014136748,0.00060113287,0.000047270405,0.03094893,0.00047249193,0.00043571528,0.00008834233],"about_ca_topic_score_codex":0.0011012933,"about_ca_topic_score_gemma":0.0005165163,"teacher_disagreement_score":0.017165557,"about_ca_system_score_codex":0.0002313661,"about_ca_system_score_gemma":0.0009340063,"threshold_uncertainty_score":0.38919082},"labels":[],"label_agreement":null},{"id":"W4408814667","doi":"10.1097/ju.0000000000004542","title":"Hybrid 3-Tier Bladder Cancer Grade: The Mutually Beneficial Marriage of 2 Grading Systems","year":2025,"lang":"en","type":"editorial","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Grading (engineering); Gynecology; Oncology; Urology; Cancer; Internal medicine","score_opus":0.013556631830528978,"score_gpt":0.29631962338461587,"score_spread":0.2827629915540869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408814667","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011226495,0.03903774,0.0001434396,0.004072948,0.9427667,0.00076088065,0.00046579525,0.000016204169,0.0015097919],"genre_scores_gemma":[0.20389616,0.010330162,0.000015657393,0.00059943215,0.7816232,0.000030659496,0.000033346507,0.000083181825,0.0033881976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968525,0.00055634655,0.001043559,0.00020259747,0.0009539923,0.00039096252],"domain_scores_gemma":[0.99594456,0.0014817718,0.0012693674,0.00050879765,0.000692278,0.00010322071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012211519,0.00037257766,0.0012566994,0.00024432305,0.00015460918,0.00002092392,0.00069657096,0.00045880766,0.00016153867],"category_scores_gemma":[0.00039813787,0.00018727429,0.00039350055,0.00017116948,0.0002718586,0.00004795514,0.00010585859,0.0017901857,0.000004248776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023716718,0.00013242186,0.000108810425,0.00023630583,0.0022988773,0.0001305372,0.0004671237,0.00021617103,0.00021218794,0.00008265551,0.9926685,0.0010747453],"study_design_scores_gemma":[0.0044475906,0.00244644,0.00027930705,0.0004391693,0.009644922,0.00056561973,0.0002016089,0.000046371286,0.00027343738,0.0006609654,0.98076844,0.00022610577],"about_ca_topic_score_codex":0.00085146393,"about_ca_topic_score_gemma":0.000058658094,"teacher_disagreement_score":0.19266967,"about_ca_system_score_codex":0.00019483927,"about_ca_system_score_gemma":0.001853339,"threshold_uncertainty_score":0.7777566},"labels":[],"label_agreement":null},{"id":"W4408842288","doi":"10.5489/cuaj.9142","title":"Advocating female genital-sparing cystectomy as the standard of care for women with bladder cancer","year":2025,"lang":"en","type":"letter","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Northwestern Polytechnic","funders":"","keywords":"Cystectomy; Medicine; Bladder cancer; Standard of care; Sex organ; Urology; Gynecology; Cancer; Surgery; Internal medicine; Biology","score_opus":0.012001248551164611,"score_gpt":0.2601802058820823,"score_spread":0.2481789573309177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408842288","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055426046,0.003117431,0.00008734776,0.9267946,0.00078624306,0.0018709131,0.0015055191,0.000036168396,0.010375718],"genre_scores_gemma":[0.5330741,0.00015664528,0.00019582263,0.4517225,0.004034708,0.0005435758,0.00013369753,0.000059690807,0.010079278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792594,0.00012386612,0.00040423067,0.00028084192,0.00055120216,0.00071392785],"domain_scores_gemma":[0.99783224,0.00028486128,0.0005115527,0.00018648249,0.00091307116,0.00027179916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029914762,0.00027392828,0.0006722185,0.00018090947,0.00041490656,0.00008529552,0.0002076823,0.0005984632,0.0004936049],"category_scores_gemma":[0.0003079905,0.00016684033,0.00018578088,0.00021510193,0.000052781314,0.0000449577,0.000017694958,0.0015187131,0.000003572205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020672483,0.000038893657,0.22445942,0.0008408041,0.005919494,0.00062873313,0.0057949163,0.00011241461,0.00001957913,0.000034262743,0.74507767,0.015006574],"study_design_scores_gemma":[0.0027011815,0.0020018679,0.015209873,0.00023233292,0.00082272664,0.00010406677,0.0011010518,0.0000065570275,0.00003803795,0.00019073529,0.9773626,0.0002289751],"about_ca_topic_score_codex":0.0029050233,"about_ca_topic_score_gemma":0.0037545445,"teacher_disagreement_score":0.47764805,"about_ca_system_score_codex":0.003843864,"about_ca_system_score_gemma":0.004631515,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W4408885212","doi":"10.1111/bju.16714","title":"The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidates","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Concordance; Cystectomy; Medicine; Bladder cancer; Hazard ratio; Urology; Proportional hazards model; Oncology; Internal medicine; Confidence interval; Cancer","score_opus":0.020990972821197582,"score_gpt":0.3315227762587705,"score_spread":0.3105318034375729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408885212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924455,0.00474845,0.00003496256,0.00063976605,0.00028585203,0.00022730292,0.00001549322,0.000002780437,0.0015998846],"genre_scores_gemma":[0.9991979,0.00057420734,0.000014778092,0.0000460757,0.00006848179,0.0000062978193,0.0000044199237,0.000006265929,0.00008156536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833894,0.00052587735,0.0005348719,0.0001169104,0.0003196616,0.00016373997],"domain_scores_gemma":[0.99916226,0.00023987741,0.00021845743,0.00008948299,0.00023951055,0.00005041816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011877408,0.000085766515,0.00041332343,0.00014771447,0.000049988488,0.000004786759,0.00008877789,0.00012620391,0.00016073043],"category_scores_gemma":[0.00040552748,0.000060787002,0.00020292062,0.00016911837,0.00020592236,0.000029834824,0.000012448486,0.00033379704,7.6687724e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06517988,0.002699228,0.7435193,0.00012745797,0.0013939345,0.00222393,0.0006100618,0.0017939928,0.05703717,0.00017983076,0.0061064074,0.1191288],"study_design_scores_gemma":[0.00851268,0.005854263,0.97959614,0.00012601913,0.0002470179,0.002540479,0.000029559213,0.00020171492,0.0020454668,0.0006497346,0.00015232008,0.00004463396],"about_ca_topic_score_codex":0.0006518226,"about_ca_topic_score_gemma":0.00074982486,"teacher_disagreement_score":0.2360768,"about_ca_system_score_codex":0.00026891983,"about_ca_system_score_gemma":0.00038290911,"threshold_uncertainty_score":0.2478822},"labels":[],"label_agreement":null},{"id":"W4408892086","doi":"10.1186/s41687-025-00864-7","title":"Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI","year":2025,"lang":"en","type":"article","venue":"Journal of Patient-Reported Outcomes","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cancer Council NSW; Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Fiona Stanley Hospital; Cancer Australia","keywords":"Medicine; Cystoscopy; Bladder cancer; Context (archaeology); Reliability (semiconductor); Internal medicine; Cancer; Urinary system","score_opus":0.024767438997038514,"score_gpt":0.3166368038945946,"score_spread":0.29186936489755605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408892086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951655,0.00074284716,0.00017534634,0.0003963711,0.0007689745,0.002369605,0.000017450247,0.00001213888,0.0003517542],"genre_scores_gemma":[0.99796736,0.00007698699,0.0010254435,0.000523088,0.00003628429,0.00021618197,0.00002494079,0.000033052795,0.00009666562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602425,0.00007572852,0.001711119,0.00032711693,0.0015511265,0.00031066954],"domain_scores_gemma":[0.9939065,0.00024085616,0.002344516,0.0003838977,0.0029579417,0.00016628305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005121017,0.0003362402,0.0008051819,0.0007431424,0.0001663208,0.000031427262,0.0001257158,0.00012137868,0.00004776188],"category_scores_gemma":[0.0006857682,0.00019257613,0.00021714566,0.00090566947,0.0000972509,0.00019296708,0.00005000357,0.00022323118,4.3749642e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009059326,0.00091571733,0.89030343,0.00010430457,0.0035125352,0.000010557916,0.0019092051,0.000055253196,0.000077013894,0.000004094428,0.00047967467,0.101722255],"study_design_scores_gemma":[0.015866492,0.0015735942,0.9739117,0.00054207153,0.0030487643,0.000028530061,0.0009589433,0.00006211325,0.002134232,0.00008207217,0.0015985998,0.0001928803],"about_ca_topic_score_codex":0.00012068877,"about_ca_topic_score_gemma":0.0000849919,"teacher_disagreement_score":0.101529375,"about_ca_system_score_codex":0.00040221636,"about_ca_system_score_gemma":0.0020412481,"threshold_uncertainty_score":0.78530264},"labels":[],"label_agreement":null},{"id":"W4408957067","doi":"10.1002/jso.28108","title":"Robot‐Assisted Versus Open Radical Cystectomy: Comparison of Adverse In‐Hospital Outcomes","year":2025,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Adverse effect; General surgery; Surgery; Urinary diversion; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.051061763336422,"score_gpt":0.4207009937339884,"score_spread":0.3696392303975664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408957067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272786,0.00089522544,0.000047103258,0.015968705,0.002250128,0.00054399256,0.0000069800903,0.000010165449,0.05299912],"genre_scores_gemma":[0.99819034,0.00013959075,0.00096479314,0.00015102662,0.00008241017,0.0000070336077,0.0000026474909,0.00000820557,0.0004539336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827594,0.0001536146,0.00095948303,0.00014275161,0.00026181963,0.00020639299],"domain_scores_gemma":[0.99859804,0.0005411821,0.00039699793,0.00014581719,0.00015929824,0.00015868874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003358244,0.00013786605,0.0013696972,0.00023705859,0.000026666336,0.0000049593255,0.00025391852,0.00020941583,0.00030727935],"category_scores_gemma":[0.000108500266,0.00009543578,0.00027432124,0.00030349204,0.00015744951,0.0000929916,0.00011321155,0.00044822143,0.000006567481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038519826,0.012484955,0.8451988,0.00012787222,0.0020162354,0.0059030554,0.0006262406,0.00007697945,0.00038971676,0.0010968229,0.006016787,0.08754269],"study_design_scores_gemma":[0.084854424,0.013585793,0.65553445,0.00034631806,0.0007265424,0.00027511912,0.0007350053,0.000040934723,0.0007388337,0.00012385861,0.24288999,0.00014873283],"about_ca_topic_score_codex":0.00010377457,"about_ca_topic_score_gemma":0.00005254528,"teacher_disagreement_score":0.2368732,"about_ca_system_score_codex":0.0004917396,"about_ca_system_score_gemma":0.0009756703,"threshold_uncertainty_score":0.38917583},"labels":[],"label_agreement":null},{"id":"W4409148188","doi":"10.1016/j.euf.2025.03.011","title":"Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"MSD Australia; Meso Scale Diagnostics; Agencja Badań Medycznych; Narodowa Agencja Wymiany Akademickiej; Bayer","keywords":"Medicine; Metastasectomy; Meta-analysis; Confidence interval; Internal medicine; Oncology; Metastasis; Lung cancer; Cancer; Surgery","score_opus":0.07160996512780192,"score_gpt":0.34200837293814146,"score_spread":0.2703984078103395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409148188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.779858e-7,0.9829683,0.000011234672,0.00038961176,0.00002887234,0.0059425794,0.0001605454,0.00003484211,0.010463075],"genre_scores_gemma":[0.00054096605,0.99611336,0.000075413904,0.001287527,0.00001705911,0.0007663709,0.000055292672,0.000048004134,0.0010960272],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935581,0.00399688,0.0012831739,0.0006112918,0.00027883818,0.00027170035],"domain_scores_gemma":[0.99782073,0.0002952673,0.00054888235,0.001214894,0.00006235999,0.000057866662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014980132,0.00057220325,0.007887239,0.0005048708,0.00004340102,0.000014027155,0.00045150606,0.0000897173,0.0001809076],"category_scores_gemma":[0.00003866158,0.00027997245,0.0023339037,0.0014411223,0.000099245844,0.000018707457,0.00011298012,0.00034881977,0.00002832224],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028231008,0.0001943099,0.0000037641212,0.6968626,0.28843293,0.0005896405,0.00007856194,7.395747e-8,1.3051773e-8,0.00010004957,0.00018539144,0.013524451],"study_design_scores_gemma":[0.0006320289,0.00027435858,0.000053795156,0.006797914,0.95534855,0.00010411283,0.000009292613,1.7483727e-7,1.365143e-7,0.000008861992,0.036611315,0.00015947923],"about_ca_topic_score_codex":0.00004707657,"about_ca_topic_score_gemma":0.000010798594,"teacher_disagreement_score":0.69006467,"about_ca_system_score_codex":0.000031671145,"about_ca_system_score_gemma":0.00008783494,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W4409243650","doi":"10.1097/01.ju.0001109864.72014.8e.39","title":"IP09-39 “ATYPICAL” PRESENTATION OF LOWER URINARY TRACT OBSTRUCTION: A CASE FOR HEIGHTENED LEVEL OF SUSPICION AND USE OF THE TORONTO NOMOGRAM","year":2025,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nomogram; Presentation (obstetrics); Urinary system; Urinary tract obstruction; General surgery; Pediatrics; Surgery; Internal medicine","score_opus":0.05761527045429007,"score_gpt":0.33349740317831644,"score_spread":0.2758821327240264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409243650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568385,0.0013358148,0.0006706119,0.0016016426,0.0003009964,0.00031623855,0.000021999855,0.0000013528443,0.00006747761],"genre_scores_gemma":[0.99909097,0.00020190077,0.0003360502,0.00012840163,0.000060149105,0.000003092418,6.959807e-7,0.0000050636595,0.000173702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932575,0.00009860391,0.00035331675,0.000053091473,0.00009562803,0.000073583666],"domain_scores_gemma":[0.99904466,0.00026063403,0.00031032437,0.00014821182,0.00021074613,0.000025429586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015978234,0.000065759756,0.00025342894,0.000037271773,0.000034519144,0.0000015929842,0.000058781676,0.000062791245,0.000028625242],"category_scores_gemma":[0.00007749254,0.00003452703,0.00010444776,0.000056007186,0.00013532411,0.00007186189,0.000021636295,0.00008496664,3.560814e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28354165,0.014176373,0.31423554,0.0022846074,0.008238995,0.001259965,0.013858081,0.00089483446,0.19820431,0.004498211,0.005237137,0.15357031],"study_design_scores_gemma":[0.010653721,0.015412562,0.9259369,0.00013947977,0.0031923994,0.016744306,0.0008464422,0.00028247345,0.021744246,0.0027039843,0.0022541017,0.00008939967],"about_ca_topic_score_codex":0.00033187095,"about_ca_topic_score_gemma":0.00010357001,"teacher_disagreement_score":0.61170137,"about_ca_system_score_codex":0.00002644993,"about_ca_system_score_gemma":0.00008376916,"threshold_uncertainty_score":0.14079715},"labels":[],"label_agreement":null},{"id":"W4409310212","doi":"10.1038/s41585-025-01029-3","title":"Knockout of extended pelvic lymph node dissection during radical cystectomy","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Dissection (medical); Lymph node; General surgery; Urology; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.018614517902769363,"score_gpt":0.3594654131503409,"score_spread":0.34085089524757156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409310212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012260713,0.99149567,0.000017622464,0.00012969377,0.0010319698,0.0025218416,0.000056182056,0.00007025156,0.004664518],"genre_scores_gemma":[0.0001891042,0.9962686,0.00015699842,0.0003301866,0.00057054707,0.00046372265,0.00021127322,0.00006644332,0.0017431773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965803,0.0006089725,0.0012924469,0.00080629863,0.00027732432,0.0004346623],"domain_scores_gemma":[0.9980052,0.0002042217,0.00063789,0.00089358387,0.0000949705,0.00016411323],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00030307943,0.00068945944,0.005028857,0.00049106556,0.00007132107,0.000007138629,0.00028451037,0.0019444771,0.00030919266],"category_scores_gemma":[0.00044806345,0.0004656151,0.0014999832,0.0007560664,0.00012206657,0.000034634155,0.00010421431,0.0018576696,0.00009712185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012544428,0.00020180615,0.000047814356,0.1165142,0.0005384894,0.000120402,0.000012779388,3.9097998e-8,0.000005887129,0.00008441445,0.0004997978,0.88184893],"study_design_scores_gemma":[0.0014271664,0.00016252429,0.00032839846,0.020952538,0.0069717956,0.0016370893,9.4458323e-7,3.312091e-7,0.000007281442,0.00002376868,0.9682387,0.0002494235],"about_ca_topic_score_codex":0.0000110514175,"about_ca_topic_score_gemma":0.0000047363546,"teacher_disagreement_score":0.9677389,"about_ca_system_score_codex":0.00028881157,"about_ca_system_score_gemma":0.00081115885,"threshold_uncertainty_score":0.9997796},"labels":[],"label_agreement":null},{"id":"W4409374630","doi":"10.1016/j.jval.2025.03.010","title":"Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Pembrolizumab; Urothelial cancer; Oncology; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","score_opus":0.0888941128100231,"score_gpt":0.40198297474328815,"score_spread":0.313088861933265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409374630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864439,0.0033317397,0.0009385025,0.003695071,0.00017083515,0.0049530016,0.00035189712,0.000014391984,0.000100693454],"genre_scores_gemma":[0.9958851,0.0020561935,0.00014364392,0.00090492517,0.000022933347,0.0008682154,0.00006497548,0.0000139325,0.000040080482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874604,0.000297579,0.00037240976,0.00019704476,0.00013522232,0.000251692],"domain_scores_gemma":[0.9986999,0.0009534014,0.00008291785,0.00015697935,0.00005831286,0.00004847498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083923695,0.00012966564,0.0004123326,0.00026467963,0.000053276664,0.0000069961643,0.00006958649,0.000033788285,0.000010379376],"category_scores_gemma":[0.00011356526,0.00008941838,0.000042009768,0.0004962421,0.000058413076,0.000027600236,0.000015025378,0.00012874232,3.084095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049070194,0.006131859,0.510269,0.06777154,0.0013749021,0.00012308941,0.034890156,0.15582152,0.00040080486,0.028662719,0.0010373429,0.14444688],"study_design_scores_gemma":[0.112624705,0.009063341,0.6932807,0.013977225,0.00072739035,0.00005526858,0.003395336,0.11505697,0.0054717446,0.026626062,0.019091196,0.00063008815],"about_ca_topic_score_codex":0.041588884,"about_ca_topic_score_gemma":0.0014657604,"teacher_disagreement_score":0.18301168,"about_ca_system_score_codex":0.00025722853,"about_ca_system_score_gemma":0.0007291536,"threshold_uncertainty_score":0.96479326},"labels":[],"label_agreement":null},{"id":"W4409415629","doi":"10.1007/s12672-025-02165-3","title":"Microbiome landscapes of the bladder, intestine, and vagina in bladder cancer: a systematic review","year":2025,"lang":"en","type":"review","venue":"Discover Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vagina; Bladder cancer; Medicine; Microbiome; Urology; Large intestine; Cancer; Biology; Anatomy; Internal medicine; Bioinformatics","score_opus":0.021886010832823627,"score_gpt":0.3766925366837446,"score_spread":0.354806525850921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409415629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013349145,0.99193186,0.000001905029,0.00060206925,0.0003179945,0.0044756243,0.0002562395,0.000013430497,0.0023875409],"genre_scores_gemma":[0.00005290369,0.995501,0.000023595696,0.00094842835,0.000054301294,0.0011736649,0.000059158916,0.00003317239,0.0021538076],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977073,0.0004041673,0.0010245993,0.00043472025,0.00015633187,0.00027289017],"domain_scores_gemma":[0.9983373,0.00040229884,0.00055405626,0.0005734979,0.0000699665,0.000062847204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002459136,0.00043345548,0.004380928,0.0002089884,0.000030608575,0.000009458454,0.0002736433,0.0002660106,0.000090913636],"category_scores_gemma":[0.00023823782,0.0002318482,0.0004303466,0.0006676845,0.00012932898,0.00003716355,0.00019350294,0.00039202988,0.00000860137],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014984332,0.00019942784,0.00015741849,0.9588387,0.0008573428,0.000034433073,0.00008465771,4.765693e-8,0.0000012557988,0.000045202087,0.002462036,0.037304465],"study_design_scores_gemma":[0.0009794066,0.00019385754,0.00005043862,0.77889276,0.014461371,0.00024855958,0.00002457524,6.300275e-7,0.0000025619183,0.000019871632,0.20494157,0.00018440951],"about_ca_topic_score_codex":0.0003790529,"about_ca_topic_score_gemma":0.00047298195,"teacher_disagreement_score":0.20247954,"about_ca_system_score_codex":0.00033878197,"about_ca_system_score_gemma":0.0024186682,"threshold_uncertainty_score":0.94544953},"labels":[],"label_agreement":null},{"id":"W4409450767","doi":"10.1016/j.urology.2025.04.020","title":"Reply to Editorial Comment on “Survival Outcomes and Temporal Trends of Nonsurgical Management vs Radical Cystectomy in Nonorgan-Confined Urothelial Bladder Cancer”","year":2025,"lang":"en","type":"letter","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial cancer; Bladder cancer; Urology; General surgery; Cancer; Oncology; Internal medicine","score_opus":0.014323276612887719,"score_gpt":0.2947009228239522,"score_spread":0.2803776462110645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409450767","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023667319,0.00010972305,0.000028377768,0.9667242,0.021482855,0.0012613928,0.00043161065,0.000063582826,0.0075314813],"genre_scores_gemma":[0.02296453,0.000099142344,0.00012412705,0.9423391,0.02621384,0.0006103993,0.00034975813,0.00009035705,0.0072087073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967031,0.0002580946,0.00080011575,0.0009443291,0.00067110045,0.00062327954],"domain_scores_gemma":[0.9986154,0.00031092123,0.00017873246,0.0006531554,0.00007150679,0.00017028044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023471854,0.0005883029,0.0017006028,0.00088915916,0.000050151644,0.000016089356,0.0002601987,0.00088003825,0.0006258212],"category_scores_gemma":[0.000047260506,0.0004818798,0.00023141217,0.0003483707,0.00020058722,0.000019287147,0.0001907136,0.0013520516,0.000019251356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005593274,0.0003710132,0.011431895,0.00022686427,0.000994491,0.0011967332,0.00012658027,0.0000054068323,0.0000069981065,0.00006588089,0.9772468,0.0027340383],"study_design_scores_gemma":[0.013660498,0.00265874,0.007652097,0.00011685576,0.0007024997,0.000017707465,0.000009508664,0.000007228479,0.00004815438,0.00003263688,0.97478706,0.00030704337],"about_ca_topic_score_codex":0.0023114055,"about_ca_topic_score_gemma":0.00013551867,"teacher_disagreement_score":0.024385106,"about_ca_system_score_codex":0.0002415771,"about_ca_system_score_gemma":0.00026213637,"threshold_uncertainty_score":0.9997633},"labels":[],"label_agreement":null},{"id":"W4409496667","doi":"10.5194/gmd-2024-215-ac1","title":"Reply on CEC1","year":2025,"lang":"en","type":"peer-review","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Environmental science","score_opus":0.04055595280947484,"score_gpt":0.3613032272099114,"score_spread":0.3207472744004366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409496667","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.1291204e-7,0.037112296,0.000006889777,0.20598383,0.0018491935,0.00076509046,0.00018458352,0.00009357188,0.7540041],"genre_scores_gemma":[0.000011791256,0.01733262,0.00010504569,0.2002387,0.00050002005,0.00009113444,0.00074706733,0.000022012844,0.7809516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987437,0.000021837997,0.00025611953,0.0004252169,0.000365099,0.0001880265],"domain_scores_gemma":[0.9989348,0.000042645534,0.000059203634,0.000738233,0.00012273132,0.000102385995],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000078157434,0.00027576007,0.00072253955,0.00009698253,0.000029268778,0.000007886555,0.00009666244,0.00015052795,0.008580392],"category_scores_gemma":[0.00009203716,0.00018527525,0.00026993503,0.00014375609,0.000017938173,0.0000092028,0.00003460461,0.00033803837,0.0008026974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044224722,0.000104489605,0.00001303684,0.0034908336,0.0002281615,0.00005463744,0.0000027258031,1.2602019e-8,4.0053038e-7,0.00010162378,0.9643104,0.031649463],"study_design_scores_gemma":[0.0007477098,0.0003617805,0.0000776798,0.012397267,0.0009824275,0.000013204984,0.0000010732077,2.2036755e-7,0.00008015182,0.00006129273,0.9851451,0.00013212088],"about_ca_topic_score_codex":0.00053085526,"about_ca_topic_score_gemma":0.000020621039,"teacher_disagreement_score":0.031517345,"about_ca_system_score_codex":0.00014767724,"about_ca_system_score_gemma":0.0005726617,"threshold_uncertainty_score":0.99997526},"labels":[],"label_agreement":null},{"id":"W4409574526","doi":"10.1016/j.eururo.2025.02.010","title":"A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Rutgers Cancer Institute of New Jersey","keywords":"Medicine; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.05422407078785609,"score_gpt":0.3137210043075716,"score_spread":0.25949693351971553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409574526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006697354,0.98747486,0.0002967728,0.00010542472,0.00014284064,0.01006555,0.0006449674,0.000012443384,0.0012504515],"genre_scores_gemma":[0.000096769945,0.99684954,0.0001273794,0.00040067776,0.0001247322,0.0016104673,0.00023098405,0.00007888101,0.0004805836],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977778,0.0003083076,0.0010124502,0.00043668275,0.00021129196,0.00025346968],"domain_scores_gemma":[0.9972281,0.00091872097,0.00082074315,0.0007592631,0.00020253382,0.00007064971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019314485,0.0004830115,0.003427874,0.00011167608,0.000041264393,0.000004024046,0.00025149202,0.00009973937,0.000036712194],"category_scores_gemma":[0.00017225789,0.00021977456,0.0006761331,0.00023598316,0.00017589031,0.000013692217,0.000039436152,0.00012984959,0.000005603541],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001102308,0.0011569464,0.000013284914,0.8892026,0.0044841836,0.0000067985475,0.00013681024,6.785418e-7,5.7502447e-8,0.000037057627,0.0001903498,0.10466099],"study_design_scores_gemma":[0.005590035,0.007545438,0.0003647696,0.71303535,0.09739722,0.000022211894,0.000019249714,0.000006388105,0.0000025474972,0.000001455626,0.17567821,0.00033710996],"about_ca_topic_score_codex":0.000015203089,"about_ca_topic_score_gemma":0.0000067084056,"teacher_disagreement_score":0.17616725,"about_ca_system_score_codex":0.00010684704,"about_ca_system_score_gemma":0.0006240311,"threshold_uncertainty_score":0.89621466},"labels":[],"label_agreement":null},{"id":"W4409588505","doi":"10.3390/curroncol32040236","title":"Crizotinib Inhibits Viability, Migration, and Invasion by Suppressing the c-Met/PI3K/Akt Pathway in the Three-Dimensional Bladder Cancer Spheroid Model","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and ICT, South Korea; National IT Industry Promotion Agency","keywords":"Crizotinib; Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Cisplatin; Medicine; Vimentin; C-Met; Chemistry; Biology; Signal transduction; Pathology; Cell biology; Internal medicine; Lung cancer; Hepatocyte growth factor; Receptor","score_opus":0.07058005262654199,"score_gpt":0.3784841833704924,"score_spread":0.3079041307439504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409588505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97179925,0.011332609,0.00028495796,0.013902611,0.000606164,0.0010428336,0.00006240149,0.000025181804,0.0009439925],"genre_scores_gemma":[0.9966132,0.00023086651,0.00014784388,0.0023340348,0.00012391308,0.00029603622,0.00005763337,0.000013342233,0.000183135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856186,0.00020867148,0.00033198297,0.00038458448,0.00024182453,0.00027109738],"domain_scores_gemma":[0.99916947,0.0002867261,0.00007921475,0.0002949642,0.00011080516,0.00005882965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037868886,0.00019804918,0.00030653825,0.000057820256,0.00019375587,0.000027991931,0.00013623424,0.00012680034,0.0000944471],"category_scores_gemma":[0.00008719885,0.00010910019,0.00006397131,0.00023538466,0.00023124037,0.000078416044,0.00010891756,0.0004013682,0.0000048146503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012895922,0.004166527,0.41653,0.00040202332,0.00029314446,0.000022916885,0.006555685,0.0006539204,0.028743716,0.0011126023,0.12088383,0.419346],"study_design_scores_gemma":[0.048431367,0.0051295436,0.22130114,0.0029291916,0.0024013016,0.00025311424,0.003556133,0.09285318,0.10340731,0.043117028,0.47472864,0.0018920299],"about_ca_topic_score_codex":0.0003202314,"about_ca_topic_score_gemma":0.0033257105,"teacher_disagreement_score":0.41745397,"about_ca_system_score_codex":0.00018966061,"about_ca_system_score_gemma":0.00068726996,"threshold_uncertainty_score":0.44489765},"labels":[],"label_agreement":null},{"id":"W4409618482","doi":"10.3390/siuj6020034","title":"ChatGPT vs. Gemini: Which Provides Better Information on Bladder Cancer?","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Computer science; Urology; Medicine; Cancer; Internal medicine","score_opus":0.022728546962426203,"score_gpt":0.33876624865561056,"score_spread":0.31603770169318435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409618482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.719991,0.00091483456,0.0012858871,0.1210844,0.004671191,0.0008878968,0.00011757263,0.00018123178,0.15086597],"genre_scores_gemma":[0.96194524,0.0007131693,0.00032367467,0.030127369,0.00081836124,0.00011731235,0.000066557324,0.000012358523,0.0058759414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985581,0.00004729293,0.0004415224,0.0001798067,0.00049349427,0.0002797939],"domain_scores_gemma":[0.9988398,0.00013057697,0.00021895942,0.0001737299,0.0005389212,0.00009803321],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021963016,0.00020076736,0.00026566925,0.00029699673,0.00018176419,0.00011907411,0.00021394397,0.0001531094,0.0012756237],"category_scores_gemma":[0.00028239517,0.00015605752,0.00016924416,0.00019532621,0.000055291297,0.00041569065,0.000056977715,0.00059166097,0.0000791919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036926845,0.0007526863,0.35869512,0.00015145539,0.0033801242,0.00008698975,0.0015992605,0.0003276236,0.00045582847,0.002824401,0.26568723,0.36234662],"study_design_scores_gemma":[0.010582066,0.0015858979,0.50432384,0.00047377282,0.0005628161,0.00023810752,0.00060702104,0.000959475,0.00423117,0.007736278,0.46828344,0.0004160947],"about_ca_topic_score_codex":0.00004626377,"about_ca_topic_score_gemma":0.0000188962,"teacher_disagreement_score":0.36193052,"about_ca_system_score_codex":0.00046907045,"about_ca_system_score_gemma":0.0005943847,"threshold_uncertainty_score":0.99963737},"labels":[],"label_agreement":null},{"id":"W4409628978","doi":"10.1158/1538-7445.am2025-6262","title":"Abstract 6262: Changes in the spatial architecture of the tumor microenvironment associated with treatment resistance in muscle invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Tumor microenvironment; Cancer; Medicine; Pathology; Cancer research; Internal medicine; Oncology","score_opus":0.0389716449890969,"score_gpt":0.34232908957000874,"score_spread":0.30335744458091185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779445,0.004305378,9.1004244e-7,0.01289094,0.00007071877,0.0018409402,0.0001564542,0.00000659531,0.0027835998],"genre_scores_gemma":[0.9946434,0.0011775914,0.000010439223,0.0006496567,0.00007252457,0.0015870339,0.000009320472,0.000020644946,0.0018294215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980557,0.0002594514,0.00021724965,0.00036673868,0.00062572013,0.00047514366],"domain_scores_gemma":[0.99902517,0.00029781114,0.00007752707,0.00047048886,0.0000798564,0.000049154958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035921758,0.0001888533,0.00031919839,0.00019194328,0.00011257795,0.000017672493,0.0002769702,0.00006823523,0.00028326552],"category_scores_gemma":[0.0000779553,0.000095599215,0.00006372677,0.0007973973,0.0003335795,0.000022232867,0.000059072252,0.00048214293,0.000001804356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070706643,0.0042786193,0.7713204,0.00095160917,0.0015820144,0.0006490922,0.02841207,0.00062792574,0.12426123,0.0001228648,0.0063714786,0.054352008],"study_design_scores_gemma":[0.0038999028,0.00030485075,0.9368464,0.0016076564,0.00007354979,0.0000010313763,0.00074900914,0.0000016173502,0.051999733,0.00014259276,0.0042835544,0.00009010103],"about_ca_topic_score_codex":0.017879693,"about_ca_topic_score_gemma":0.4638772,"teacher_disagreement_score":0.4459975,"about_ca_system_score_codex":0.0015117739,"about_ca_system_score_gemma":0.0011421267,"threshold_uncertainty_score":0.98866034},"labels":[],"label_agreement":null},{"id":"W4409631375","doi":"10.1158/1538-7445.am2025-6475","title":"Abstract 6475: Characterizing peri-tumoral tertiary lymphoid structures in non-muscle invasive bladder cancer using a spatial whole transcriptomics approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Peri; Medicine; Lymphatic system; Pathology; Transcriptome; Cancer; Internal medicine; Biology; Gene; Gene expression","score_opus":0.06672396543935512,"score_gpt":0.3857057745671302,"score_spread":0.3189818091277751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992039,0.0027624625,0.00009790602,0.0012630075,0.0004747401,0.0014055327,0.00020271107,0.00003923569,0.0017153708],"genre_scores_gemma":[0.99628204,0.0007089099,0.00021569066,0.00096600654,0.00055483956,0.00065250194,0.000064006985,0.00006964104,0.00048634608],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970788,0.0001129539,0.0004544209,0.00074876164,0.0006630526,0.000942059],"domain_scores_gemma":[0.99893427,0.000067459456,0.00006956614,0.00044721577,0.00025381582,0.0002276488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003508388,0.0003343586,0.0005674847,0.0005837135,0.00025887115,0.0001152519,0.00029881584,0.00021502891,0.00048830645],"category_scores_gemma":[0.000044583478,0.00029939413,0.000148761,0.00076040893,0.00027528105,0.00024134947,0.00010829326,0.0008193082,0.000008241425],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011188671,0.00036537438,0.1199578,0.00090411835,0.00034490088,0.00015830198,0.0029321017,0.00018254759,0.84013444,0.000019376712,0.0007311358,0.033151045],"study_design_scores_gemma":[0.006907227,0.00014809392,0.8442613,0.0012682388,0.00016665617,0.000024113548,0.0013844712,0.0011888044,0.1420393,0.00019496583,0.0019879097,0.00042893342],"about_ca_topic_score_codex":0.029846186,"about_ca_topic_score_gemma":0.0021312104,"teacher_disagreement_score":0.7243035,"about_ca_system_score_codex":0.0016203707,"about_ca_system_score_gemma":0.0031151967,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W4409632787","doi":"10.1158/1538-7445.am2025-6522","title":"Abstract 6522: Sex differences in gut microbial composition during pelvic radiation therapy in experimental models of muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Radiation therapy; Bladder cancer; Cancer; Medicine; Anal cancer; Urology; Internal medicine; Physiology; Biology","score_opus":0.07603751464444992,"score_gpt":0.3998424462951537,"score_spread":0.3238049316507038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409632787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894381,0.007797931,0.0000026454568,0.00057053275,0.00013501947,0.0009540181,0.000044984223,0.000013354915,0.0010433967],"genre_scores_gemma":[0.9943314,0.0045990213,0.000010422955,0.00009376612,0.00010190022,0.0005565823,0.00001926195,0.000018581035,0.00026902478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984499,0.00011274361,0.00031435178,0.0003575735,0.00038692955,0.00037847593],"domain_scores_gemma":[0.9994842,0.00008662117,0.00005092622,0.00019250829,0.0001196443,0.000066103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017826825,0.00015209329,0.0003338854,0.00051412906,0.00007384295,0.000022065444,0.00012705814,0.00010631732,0.00047287607],"category_scores_gemma":[0.000008074849,0.00013657872,0.00006192411,0.0005206861,0.000112262096,0.00014480198,0.00004176863,0.00034018586,0.000002811332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012516348,0.0005681564,0.06407887,0.00018364961,0.000110185916,0.000027695474,0.0035362863,0.00028109053,0.921637,0.000027367609,0.00016392446,0.008134161],"study_design_scores_gemma":[0.0051010735,0.00014174839,0.44195107,0.0006079094,0.000008299416,7.927031e-7,0.0006013402,0.00011859944,0.55125594,0.00010836333,0.000016547852,0.00008832667],"about_ca_topic_score_codex":0.012855536,"about_ca_topic_score_gemma":0.0020052106,"teacher_disagreement_score":0.3778722,"about_ca_system_score_codex":0.0009955629,"about_ca_system_score_gemma":0.0007639216,"threshold_uncertainty_score":0.99371797},"labels":[],"label_agreement":null},{"id":"W4409655242","doi":"10.1007/s00345-025-05626-0","title":"Endoscopic ablation versus nephroureterectomy in localized low-grade upper tract urothelial carcinoma: a comparison in terms of cancer-specific and other-cause mortality","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Propensity score matching; Urology; Hazard ratio; Ablation; Nephrology; Proportional hazards model; Surgery; Internal medicine; Confidence interval","score_opus":0.0410090868462035,"score_gpt":0.3542053203631919,"score_spread":0.3131962335169884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409655242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243426,0.004993914,0.000058278758,0.00078357966,0.00051841326,0.00030586668,0.000012456413,0.000004846443,0.0008883847],"genre_scores_gemma":[0.9989298,0.00042000896,0.00010927355,0.00035416192,0.0001118409,0.000013117542,0.0000020513785,0.000012847647,0.00004691118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985488,0.00016769354,0.0007175582,0.00018122653,0.00016459734,0.0002200968],"domain_scores_gemma":[0.9993143,0.00015269741,0.00027571994,0.00015030189,0.000037613234,0.00006933709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020448666,0.00015810104,0.0006780382,0.00057922216,0.000018938286,0.000007759613,0.00008621937,0.00009506601,0.00012901054],"category_scores_gemma":[0.000023661723,0.00013216311,0.00008875428,0.00035430593,0.00012340865,0.000062903375,0.000018205892,0.0003882528,6.5178494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045787184,0.00047393425,0.9877711,0.00006186761,0.00020018166,0.00011918075,0.00045922614,0.00008237389,0.002270932,0.00013064717,0.00009823196,0.0037536118],"study_design_scores_gemma":[0.022487728,0.000740847,0.9683604,0.00015186385,0.00028777515,0.000022774464,0.00004250362,0.00018852804,0.0018123981,0.0002759608,0.005559096,0.00007010981],"about_ca_topic_score_codex":0.0009228954,"about_ca_topic_score_gemma":0.0034128716,"teacher_disagreement_score":0.01941068,"about_ca_system_score_codex":0.00016867754,"about_ca_system_score_gemma":0.00017391238,"threshold_uncertainty_score":0.5389455},"labels":[],"label_agreement":null},{"id":"W4409656120","doi":"10.1016/j.eururo.2025.03.017","title":"Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group","year":2025,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Princess Margaret Cancer Centre; McGill University","funders":"Merck; AstraZeneca","keywords":"Medicine; Bladder cancer; Urology; Cancer; Urinary bladder; Oncology; Internal medicine","score_opus":0.05681618418317142,"score_gpt":0.36254200085038235,"score_spread":0.30572581666721094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409656120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009072271,0.9506809,0.00008577668,0.010398824,0.002705293,0.0017126307,0.001471061,0.00011341485,0.03274139],"genre_scores_gemma":[0.00048984005,0.9849973,0.00010325066,0.0055546346,0.0018610077,0.0008609899,0.0025642237,0.0001298195,0.003438983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961988,0.0010021187,0.00097626273,0.0009853531,0.0003415213,0.00049595226],"domain_scores_gemma":[0.99743974,0.0010167917,0.00046629406,0.0007823514,0.00018217835,0.00011266205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032904337,0.00065281574,0.0012074264,0.00031701275,0.00015684516,0.00011943517,0.00082330464,0.0002871476,0.004514362],"category_scores_gemma":[0.00021918728,0.00046639267,0.00039839064,0.00051288545,0.00017241637,0.0002534097,0.00036056057,0.0010447066,0.00018154534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001200951,0.00035554825,0.0006884542,0.0008668734,0.0037390876,0.00018550947,0.00092599954,0.000035175955,0.0000071645745,0.00057915045,0.09050461,0.9019923],"study_design_scores_gemma":[0.0014607504,0.0001448378,0.0044131638,0.002561696,0.0025793435,0.000013155515,0.00017631444,0.000013694758,0.0000010165143,0.00020694555,0.98809004,0.00033906172],"about_ca_topic_score_codex":0.003559104,"about_ca_topic_score_gemma":0.007777944,"teacher_disagreement_score":0.9016533,"about_ca_system_score_codex":0.0003690904,"about_ca_system_score_gemma":0.0016139614,"threshold_uncertainty_score":0.9997788},"labels":[],"label_agreement":null},{"id":"W4409822224","doi":"10.1158/1538-7445.am2025-ct128","title":"Abstract CT128: RADIANT: A window of opportunity trial exploring preoperative immunomodulatory radiotherapy and durvalumab prior to radical cystectomy in patients with cisplatin-ineligible muscle-invasive bladder carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Alberta Cancer Foundation; Juravinski Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cystectomy; Durvalumab; Medicine; Cisplatin; Urology; Bladder cancer; Radiation therapy; Carcinoma; Surgery; Chemotherapy; Internal medicine; Cancer; Immunotherapy","score_opus":0.0753871562874924,"score_gpt":0.3679530494545817,"score_spread":0.29256589316708925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928908,0.0016626599,0.0000083025925,0.00041392713,0.00014120845,0.0041259695,0.000071334995,0.000020024603,0.00066579506],"genre_scores_gemma":[0.997686,0.00038259185,0.0001410294,0.0001380003,0.00013036132,0.0012167075,0.00001631534,0.000043582022,0.00024538944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974192,0.00020612654,0.0004640086,0.00058825174,0.00075320475,0.0005692106],"domain_scores_gemma":[0.99834895,0.00029624472,0.000072557246,0.00047633823,0.00042607283,0.00037981302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537735,0.00026501232,0.0006347046,0.00068555574,0.00016495564,0.000039279344,0.00017887581,0.00011930232,0.00024311441],"category_scores_gemma":[0.00023780261,0.00021095487,0.00007228266,0.0008193807,0.00029238657,0.00020384294,0.000081685794,0.0005602611,0.0000028208844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.144923,0.0016741006,0.79134774,0.000901145,0.001015181,0.00019129591,0.008375993,0.000058004814,0.012918754,0.00007791129,0.0005891468,0.037927732],"study_design_scores_gemma":[0.088263474,0.0024935047,0.89710957,0.00084221014,0.000056809713,0.0000017697564,0.00040075387,0.0000073688775,0.010352524,0.000015198544,0.0002794812,0.0001773323],"about_ca_topic_score_codex":0.002606046,"about_ca_topic_score_gemma":0.00031585954,"teacher_disagreement_score":0.10576183,"about_ca_system_score_codex":0.00084053614,"about_ca_system_score_gemma":0.0028738617,"threshold_uncertainty_score":0.860249},"labels":[],"label_agreement":null},{"id":"W4409870580","doi":"10.1186/s12894-025-01754-2","title":"Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"BMC Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Agencja Badań Medycznych; Narodowa Agencja Wymiany Akademickiej; European Association of Urology","keywords":"Medicine; Concomitant; Meta-analysis; Metastatic Urothelial Carcinoma; Systemic therapy; Urothelial carcinoma; Oncology; Internal medicine; Urology; Cancer; Bladder cancer","score_opus":0.08222964927709163,"score_gpt":0.387266042580237,"score_spread":0.30503639330314536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409870580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011146696,0.9862645,0.000020137271,0.00006314158,0.00001814754,0.012018774,0.00043694128,0.000009358891,0.000054295724],"genre_scores_gemma":[0.19153185,0.80560046,0.000058999918,0.0002495109,0.0000049166842,0.002365854,0.00008213698,0.000027189579,0.000079099],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99567676,0.0017882648,0.0015344338,0.00045720505,0.00031805673,0.00022529818],"domain_scores_gemma":[0.9940046,0.0033299075,0.0014185983,0.0009763267,0.00019670029,0.00007386647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006052657,0.0005022336,0.009957879,0.00047293009,0.000029608644,0.0000035848789,0.0002731097,0.00014543379,0.00020492652],"category_scores_gemma":[0.0006277484,0.00018353989,0.0015787161,0.0011850797,0.0001758746,0.000017922463,0.000035742436,0.00025790188,0.0000028345626],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012530091,0.0013761807,0.0020647957,0.84843475,0.14558506,0.000016432708,0.00013828266,0.000009933053,1.10392385e-7,0.000069712405,0.000021159174,0.0010305973],"study_design_scores_gemma":[0.003617217,0.0060725315,0.002544519,0.009914016,0.9775874,0.000029520692,0.000013560052,0.0000017857002,1.3360048e-7,0.0000037182347,0.00006254968,0.0001530485],"about_ca_topic_score_codex":0.00007684953,"about_ca_topic_score_gemma":0.00004900517,"teacher_disagreement_score":0.8385207,"about_ca_system_score_codex":0.00016026392,"about_ca_system_score_gemma":0.0015642522,"threshold_uncertainty_score":0.7484539},"labels":[],"label_agreement":null},{"id":"W4409962909","doi":"10.2139/ssrn.5233279","title":"Quantitative FGFR3-Act Signature Predicts Immune Evasion and Differential Therapeutic Response in Luminal Papillary Bladder Cancer","year":2025,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Canada; Health Canada; University of Guelph","funders":"","keywords":"Evasion (ethics); Signature (topology); Immune system; Bladder cancer; Differential (mechanical device); Cancer; Medicine; Biology; Oncology; Pathology; Internal medicine; Immunology; Mathematics; Physics","score_opus":0.01700129965061761,"score_gpt":0.3169088173150208,"score_spread":0.2999075176644032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409962909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83766985,0.15716034,0.00052120275,0.0023976536,0.0009800093,0.00092505943,0.00008090844,0.000040712363,0.00022427214],"genre_scores_gemma":[0.91958106,0.07693225,0.00004219652,0.00022310707,0.0004463822,0.000093849805,0.00004847242,0.00005198645,0.002580676],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99597424,0.00054746226,0.0005953201,0.000625369,0.00054142554,0.0017162076],"domain_scores_gemma":[0.9988488,0.00016666991,0.00029912588,0.00035398992,0.0001750969,0.00015630868],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009756152,0.00056531024,0.00086812576,0.00045750907,0.00017693194,0.000069487985,0.00024161156,0.00058364024,0.00013719659],"category_scores_gemma":[0.0000770805,0.0004464741,0.00028665547,0.00022758437,0.00012614318,0.000093943745,0.00021812714,0.006479911,0.0000026885489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39738753,0.005326678,0.14155644,0.003063866,0.036725953,0.0015519339,0.017847065,0.0008284552,0.09036344,0.0075456025,0.00085902895,0.29694402],"study_design_scores_gemma":[0.032111127,0.016377972,0.83476895,0.009433366,0.0064486857,0.0018931426,0.0048000915,0.001526751,0.004452674,0.08412937,0.0019532214,0.0021046558],"about_ca_topic_score_codex":0.0006345286,"about_ca_topic_score_gemma":0.001012636,"teacher_disagreement_score":0.6932125,"about_ca_system_score_codex":0.0018710706,"about_ca_system_score_gemma":0.010601966,"threshold_uncertainty_score":0.9997987},"labels":[],"label_agreement":null},{"id":"W4410038451","doi":"10.1016/j.euo.2025.04.004","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck; Pfizer; Merck Healthcare KGaA","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Avelumab; Javelin; Oncology; Toxicity; Internal medicine; Urology; Bladder cancer; Immunotherapy; Cancer; Pembrolizumab","score_opus":0.06087568181395224,"score_gpt":0.3749091265974353,"score_spread":0.31403344478348305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410038451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98946387,0.0005996622,0.0010478935,0.0035172086,0.00072964706,0.002512754,0.00024198774,0.00008242296,0.0018045661],"genre_scores_gemma":[0.99098885,0.000083207546,0.00054617337,0.0048622605,0.0002613715,0.00014226454,0.00014488446,0.000057198875,0.002913771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964854,0.00089054275,0.0012086969,0.00074344577,0.00019786888,0.00047402692],"domain_scores_gemma":[0.99672496,0.0015557505,0.0006194406,0.0006984384,0.0002705405,0.00013085066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051733945,0.0004057667,0.0013353272,0.00014524539,0.00019028076,0.000012495639,0.00026248122,0.00021595511,0.00025871227],"category_scores_gemma":[0.0011987764,0.00024895958,0.0002695687,0.00022740338,0.0005709808,0.000053162043,0.00018547586,0.00031684223,0.00001939989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37527218,0.0033501931,0.54754806,0.00016631575,0.0061210045,0.00059151,0.0018627541,0.000050108585,0.0080934195,0.00014524904,0.0017463929,0.055052817],"study_design_scores_gemma":[0.19369902,0.014304576,0.7801109,0.0000659869,0.0034669118,0.000080082216,0.000109104774,0.00013996151,0.002541747,0.00012006726,0.005000776,0.000360892],"about_ca_topic_score_codex":0.0002846208,"about_ca_topic_score_gemma":0.0005149625,"teacher_disagreement_score":0.23256283,"about_ca_system_score_codex":0.00011929886,"about_ca_system_score_gemma":0.0004911564,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W4410161697","doi":"10.1007/s11255-025-04566-3","title":"Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancer","year":2025,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Urothelial cancer; Nephrology; Bladder cancer; Urology; General surgery; Urothelial carcinoma; Internal medicine; Oncology; Surgical oncology; Cancer","score_opus":0.00927737997970095,"score_gpt":0.31389983064650556,"score_spread":0.3046224506668046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410161697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9368229,0.00032824988,0.00019611263,0.025492918,0.0017638531,0.00070040463,0.000030708467,0.000036891714,0.034627967],"genre_scores_gemma":[0.98309225,0.00033273327,0.00016854455,0.013155141,0.00025917386,0.00058942114,0.000022143047,0.000016074322,0.0023645293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983566,0.000073147196,0.00040405281,0.0005695275,0.00018928546,0.00040740866],"domain_scores_gemma":[0.9993415,0.0002324272,0.000060637358,0.00019490339,0.000058936483,0.00011160223],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001399043,0.00027555684,0.00056084455,0.0003412237,0.00005591789,0.000012711046,0.00018958468,0.00042497058,0.0018725363],"category_scores_gemma":[0.000022572833,0.0002191626,0.00012351877,0.00015593194,0.00038479752,0.000051315063,0.00017752181,0.00043438104,0.00006983802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.075336404,0.0018597896,0.8828614,0.00008537328,0.0048665158,0.008362311,0.0003684633,0.00004485639,0.00063418853,0.0055467444,0.004746141,0.015287864],"study_design_scores_gemma":[0.031107325,0.0010055648,0.8946483,0.000025685538,0.0003700383,0.00011594327,0.00002555324,0.00039480528,0.00013447007,0.0005623565,0.07141908,0.00019084028],"about_ca_topic_score_codex":0.00019891649,"about_ca_topic_score_gemma":0.00029326614,"teacher_disagreement_score":0.06667294,"about_ca_system_score_codex":0.00013969015,"about_ca_system_score_gemma":0.00012737929,"threshold_uncertainty_score":0.9990399},"labels":[],"label_agreement":null},{"id":"W4410368075","doi":"10.3390/curroncol32050278","title":"Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo &amp; Anne Albert Institute for Bladder Cancer Care and Research Symposium","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Pembrolizumab; Clinical trial; Oncology; Internal medicine; Disease; Cancer; Urothelial cancer; Urothelial carcinoma; Immunotherapy","score_opus":0.1172378783594064,"score_gpt":0.4553304150399648,"score_spread":0.3380925366805584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410368075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036612275,0.9794629,0.000048979313,0.0014832,0.0052918294,0.007061017,0.0058114813,0.000031759424,0.0004426698],"genre_scores_gemma":[0.00031652322,0.9853507,0.00016768552,0.0000848409,0.0038419901,0.0073381746,0.0020910304,0.0000616307,0.0007473887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728316,0.00031230695,0.00060944114,0.0009640744,0.0002532625,0.0005777802],"domain_scores_gemma":[0.99742717,0.001293159,0.00017658931,0.00044237784,0.00045948944,0.0002012342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021589526,0.0005493274,0.001745981,0.00039833752,0.0004860486,0.000043738484,0.00023035685,0.0005931125,0.000025788591],"category_scores_gemma":[0.00013771416,0.00035421213,0.00027244468,0.00041335804,0.00029218092,0.00008420976,0.00016114356,0.0007750612,0.000003164849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005790399,0.00038635722,0.00012936872,0.013588766,0.00055260817,0.00001689668,0.005163555,2.085815e-7,0.0000020086532,0.0017474531,0.010855134,0.9669786],"study_design_scores_gemma":[0.0040211314,0.0008908318,0.00013271136,0.00402284,0.0027616853,0.00002501886,0.0003494972,0.0000046238442,0.0000041544577,0.00026039078,0.9872379,0.000289251],"about_ca_topic_score_codex":0.002119198,"about_ca_topic_score_gemma":0.019870775,"teacher_disagreement_score":0.97638273,"about_ca_system_score_codex":0.0009693279,"about_ca_system_score_gemma":0.0040183803,"threshold_uncertainty_score":0.999891},"labels":[],"label_agreement":null},{"id":"W4410464455","doi":"10.5489/cuaj.9070","title":"Comparative effectiveness of en-bloc resection techniques vs. conventional transurethral resection for non-muscle-invasive bladder cancer","year":2025,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Resection; Medicine; Bladder cancer; Urology; Cancer; Surgery; Internal medicine","score_opus":0.03703157769122861,"score_gpt":0.3596157336378073,"score_spread":0.3225841559465787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410464455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086414395,0.9831283,0.0009818563,0.0014864465,0.002144439,0.0062128915,0.0029927744,0.00006400901,0.0021251582],"genre_scores_gemma":[0.015087923,0.9805695,0.00022075427,0.0002664597,0.0011743275,0.0012657569,0.00055819633,0.0000402802,0.00081679446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968399,0.0010198847,0.0007910039,0.000425297,0.0004446058,0.00047931855],"domain_scores_gemma":[0.9959714,0.0017623067,0.0007328142,0.00013885059,0.0010257753,0.00036884885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013478977,0.00039736417,0.0019788826,0.00061407156,0.0003017413,0.0000470464,0.00016111197,0.0010144945,0.00028860194],"category_scores_gemma":[0.00059349404,0.00031674711,0.0010051985,0.0004978557,0.000068380854,0.000097524426,0.000012216577,0.0010609886,0.0000043197083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011190386,0.001667852,0.022043847,0.07140606,0.027219221,0.00020673944,0.000934454,0.00006216261,0.000205893,0.00069750956,0.060711376,0.8036545],"study_design_scores_gemma":[0.004460622,0.0055569443,0.021429546,0.020238176,0.0067622284,0.000159866,0.000053790383,0.000012429683,0.00053748174,0.0011195401,0.93906564,0.0006037323],"about_ca_topic_score_codex":0.0014050902,"about_ca_topic_score_gemma":0.0030145922,"teacher_disagreement_score":0.87835425,"about_ca_system_score_codex":0.004094204,"about_ca_system_score_gemma":0.005721561,"threshold_uncertainty_score":0.9999285},"labels":[],"label_agreement":null},{"id":"W4410543590","doi":"10.3390/cancers17101714","title":"Active Surveillance in Non-Muscle Invasive Bladder Cancer: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Systematic review; Psychological intervention; Population; Cancer; Gold standard (test); MEDLINE; Intensive care medicine; Oncology; Internal medicine","score_opus":0.029504069683918343,"score_gpt":0.35235430341577145,"score_spread":0.3228502337318531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410543590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014484395,0.9837309,0.0000023445778,0.000113437665,0.0006017834,0.009380357,0.0005088581,0.000049634848,0.005611198],"genre_scores_gemma":[0.000023475333,0.98607486,0.000012096211,0.0015770281,0.00017304398,0.008864466,0.0001715779,0.000082620354,0.0030208228],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99693114,0.00027026344,0.0010804014,0.000816179,0.00037876848,0.0005232455],"domain_scores_gemma":[0.9977627,0.0004081182,0.00058310706,0.00088700635,0.0001637498,0.00019534532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023274145,0.00073501654,0.006144438,0.00031556594,0.000053949945,0.000019006613,0.00033071093,0.00031293987,0.00030185492],"category_scores_gemma":[0.00036575468,0.0005516226,0.00077743,0.001270693,0.00007828321,0.00007057912,0.00007714473,0.0005838512,0.0000820979],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000014846922,0.000020660136,0.000007958749,0.8822564,0.00095986854,0.000096828626,0.00007043347,9.352025e-7,9.310871e-8,0.0000024096016,0.00407563,0.11249397],"study_design_scores_gemma":[0.00074004964,0.000083599276,0.000020694535,0.879374,0.006065848,0.000021511281,0.00003708021,0.0000010166516,0.0000015035155,0.0000037546024,0.11326507,0.00038584086],"about_ca_topic_score_codex":0.0018341257,"about_ca_topic_score_gemma":0.0015680789,"teacher_disagreement_score":0.112108134,"about_ca_system_score_codex":0.007826987,"about_ca_system_score_gemma":0.012071539,"threshold_uncertainty_score":0.9996935},"labels":[],"label_agreement":null},{"id":"W4410555626","doi":"10.1016/j.eururo.2025.03.023","title":"Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; McGill University Health Centre; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Atezolizumab; Bladder cancer; Urology; Urine; Bladder tumor; Cancer; Oncology; Internal medicine; Surgery; Immunotherapy; Pembrolizumab","score_opus":0.011856070442732526,"score_gpt":0.2697056526208086,"score_spread":0.2578495821780761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410555626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134284,0.00021693921,0.0001222798,0.0011947944,0.00016838794,0.0018980769,0.0003687892,0.000025743086,0.0046621226],"genre_scores_gemma":[0.9965036,0.000070700546,0.00011535145,0.0022394757,0.00006669816,0.00019341148,0.000039162307,0.00004098517,0.0007306179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818295,0.0003813761,0.00039455833,0.00048801696,0.00016461236,0.00038845683],"domain_scores_gemma":[0.99863434,0.00032846996,0.00016894509,0.0004611124,0.00030152252,0.000105607476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019924736,0.0002719204,0.00045271282,0.00020974132,0.000084786494,0.00000898331,0.00021188562,0.000046322304,0.0000800814],"category_scores_gemma":[0.00033432172,0.00017225252,0.00008796582,0.00047156887,0.00015767301,0.000029543842,0.00007972038,0.00023719003,0.000024590161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029196817,0.0012098511,0.8871924,0.00021263231,0.001592927,0.0003680512,0.0028684612,0.0005565825,0.0015691373,0.0001380041,0.0075765895,0.067518525],"study_design_scores_gemma":[0.009697943,0.005587243,0.9773748,0.0001266487,0.0005217742,0.000005814583,0.00008054956,0.00003340731,0.0030976462,0.000027805685,0.0032841743,0.00016217756],"about_ca_topic_score_codex":0.00050806935,"about_ca_topic_score_gemma":0.00062407827,"teacher_disagreement_score":0.090182394,"about_ca_system_score_codex":0.00010163447,"about_ca_system_score_gemma":0.0003399521,"threshold_uncertainty_score":0.70242536},"labels":[],"label_agreement":null},{"id":"W4410573706","doi":"10.1016/j.euo.2025.04.010","title":"Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"European Association of Urology","keywords":"Medicine; Bladder cancer; Oncology; Cancer; Internal medicine; Intensive care medicine","score_opus":0.011843675398855743,"score_gpt":0.28240497704873446,"score_spread":0.27056130164987874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410573706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8673228,0.00075801427,0.0017836884,0.0013085688,0.0020967792,0.0014079771,0.00022133655,0.00014631412,0.12495451],"genre_scores_gemma":[0.98772806,0.0002952697,0.0010128657,0.008789071,0.0002486605,0.00029490027,0.00023119034,0.000081450584,0.0013185198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997943,0.000297813,0.00040907235,0.0006352235,0.00014636971,0.0005685376],"domain_scores_gemma":[0.998661,0.00031409835,0.00022859068,0.0003603618,0.00029405413,0.00014188475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023366003,0.000348291,0.000668929,0.00021307432,0.00018231118,0.000021835276,0.00022011093,0.00018015468,0.00014959452],"category_scores_gemma":[0.00014112765,0.00026959184,0.00015162084,0.00019339914,0.00033594595,0.00010084714,0.00013776874,0.00040591735,0.00006852059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017187025,0.0020283842,0.5607606,0.00039678102,0.0042908504,0.00050994835,0.004565086,0.00009849506,0.0004213873,0.0009986648,0.038824484,0.3699183],"study_design_scores_gemma":[0.025030192,0.01171865,0.89985,0.000078368685,0.0018098501,0.000012793194,0.00037158115,0.000017823142,0.00007944016,0.0003943774,0.06034473,0.00029218898],"about_ca_topic_score_codex":0.00013045575,"about_ca_topic_score_gemma":0.00042040888,"teacher_disagreement_score":0.3696261,"about_ca_system_score_codex":0.0002703705,"about_ca_system_score_gemma":0.0020366148,"threshold_uncertainty_score":0.9999756},"labels":[],"label_agreement":null},{"id":"W4410597775","doi":"10.1245/s10434-025-17456-w","title":"Perioperative Complications and In-hospital Mortality After Cystectomy for Nonbladder Cancer Conditions Versus Radical Cystectomy for Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; Bladder cancer; Cancer; Urology; Perioperative; General surgery; Surgery; Internal medicine","score_opus":0.06850703507124006,"score_gpt":0.45108426701544097,"score_spread":0.3825772319442009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410597775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90450954,0.0051986533,0.00024808405,0.0724797,0.0007197093,0.0039989743,0.00230309,0.000042141623,0.010500108],"genre_scores_gemma":[0.98828334,0.0018255119,0.0002543099,0.001632632,0.00014205596,0.007269436,0.00009425366,0.000018760962,0.00047972734],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986059,0.000061560684,0.00044484437,0.0004179907,0.00012166603,0.00034805364],"domain_scores_gemma":[0.9985644,0.00058793125,0.000096716496,0.00019348107,0.0004086721,0.0001487881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013579358,0.00020207606,0.0006699089,0.00013204473,0.00010138968,0.000010481569,0.000076095115,0.00022179024,0.00029056834],"category_scores_gemma":[0.000035489495,0.00016891031,0.00019824464,0.00020859482,0.0004546466,0.000076385055,0.00003991011,0.00015717493,0.0000017839184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13707481,0.028929861,0.4272705,0.0048428797,0.028775623,0.00086186145,0.010136746,0.00035290886,0.0050598485,0.055201594,0.1354717,0.16602167],"study_design_scores_gemma":[0.035297878,0.0033830411,0.21146536,0.0002924266,0.0008173343,0.000014024501,0.00032354784,0.00034201064,0.0021632232,0.0006596044,0.7449086,0.00033299028],"about_ca_topic_score_codex":0.000566544,"about_ca_topic_score_gemma":0.0010577812,"teacher_disagreement_score":0.60943687,"about_ca_system_score_codex":0.00013146487,"about_ca_system_score_gemma":0.00072315097,"threshold_uncertainty_score":0.6887962},"labels":[],"label_agreement":null},{"id":"W4410607441","doi":"10.1111/bju.16780","title":"Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Interquartile range; Urology; Mitomycin C; Cohort; Cystectomy; Cumulative incidence; Internal medicine; Incidence (geometry); Cancer; Surgery","score_opus":0.016425537050333013,"score_gpt":0.30039976531338947,"score_spread":0.28397422826305646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410607441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980809,0.008048694,0.000043145323,0.0025350426,0.00064111693,0.0006235089,0.00004405702,0.000014226665,0.007241252],"genre_scores_gemma":[0.99494666,0.0008108728,0.000038500042,0.003142264,0.00013396303,0.000012918618,0.0000034991026,0.000023135577,0.000888184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984015,0.0003005935,0.0006097421,0.00021311507,0.00018735154,0.00028765568],"domain_scores_gemma":[0.9992264,0.00011321279,0.00020953956,0.00014329122,0.00018866458,0.0001188756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000315456,0.00015204497,0.0006257259,0.00022765415,0.000057715893,0.000022580858,0.0001569599,0.00006693861,0.00016558645],"category_scores_gemma":[0.00018551393,0.00014716058,0.00015153245,0.00018125378,0.000049365197,0.00009234355,0.00006514228,0.00044804532,0.000010662759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005817892,0.0028295096,0.9453535,0.000032195854,0.00089494186,0.021962019,0.0009001187,0.000008991663,0.00011959279,0.000002671577,0.008057613,0.019257078],"study_design_scores_gemma":[0.019883195,0.0011763519,0.97219115,0.0001861495,0.00032455253,0.0007244906,0.0011236006,0.000009094762,0.000024866738,0.000021558693,0.0042401277,0.00009483078],"about_ca_topic_score_codex":0.0008374906,"about_ca_topic_score_gemma":0.0019251177,"teacher_disagreement_score":0.026837703,"about_ca_system_score_codex":0.00008617434,"about_ca_system_score_gemma":0.00045241092,"threshold_uncertainty_score":0.60010344},"labels":[],"label_agreement":null},{"id":"W4410755415","doi":"10.1111/bju.16793","title":"Impact of concomitant carcinoma in situ distribution on non‐muscle‐invasive bladder cancer progression risk","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Mount Sinai Hospital; Trillium Health Centre; University of Toronto; University Health Network","funders":"","keywords":"Concomitant; Carcinoma in situ; Medicine; Bladder cancer; Interquartile range; Hazard ratio; Internal medicine; Retrospective cohort study; Oncology; Urology; Cancer; Confidence interval; Pathology","score_opus":0.0107293972093264,"score_gpt":0.31398747866254784,"score_spread":0.3032580814532214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410755415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927646,0.005346443,0.00007308855,0.0004217208,0.00026581722,0.00026406537,0.00017614428,0.000004123678,0.0006840027],"genre_scores_gemma":[0.9972733,0.0023404981,0.0000236911,0.00017425849,0.000117702446,0.000011664573,0.000017135471,0.000010164126,0.000031541345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885106,0.0001259394,0.00047140254,0.00015293485,0.0001754393,0.00022321918],"domain_scores_gemma":[0.999096,0.000107542466,0.00034515644,0.000106705615,0.00025032082,0.00009429928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018584289,0.00012097234,0.00048384813,0.00013710024,0.000038890474,0.000008420241,0.000082931445,0.00013658576,0.00008830362],"category_scores_gemma":[0.00018834573,0.00010451048,0.00021249408,0.0001942744,0.00009824154,0.00005403421,0.000021902879,0.0004122588,0.0000014517001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029364685,0.00087726576,0.85951024,0.000047877267,0.0005010444,0.0018146463,0.00013515141,0.00016005503,0.0049489993,0.000011183173,0.0042842044,0.12477283],"study_design_scores_gemma":[0.0067428313,0.0038188503,0.98490894,0.00047419168,0.00032281267,0.0006466062,0.000029861096,0.000027665023,0.0026267604,0.0001460923,0.00019121874,0.00006416421],"about_ca_topic_score_codex":0.0014125688,"about_ca_topic_score_gemma":0.0005455805,"teacher_disagreement_score":0.12539868,"about_ca_system_score_codex":0.0002961038,"about_ca_system_score_gemma":0.0007811217,"threshold_uncertainty_score":0.42618138},"labels":[],"label_agreement":null},{"id":"W4410772533","doi":"10.1245/s10434-025-17488-2","title":"Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; Bladder cancer; Urothelial cancer; Urology; Oncology; Cancer; Internal medicine","score_opus":0.10441979674830532,"score_gpt":0.43513924529605735,"score_spread":0.33071944854775204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410772533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9470953,0.0076210215,0.000016987093,0.010923054,0.0013417642,0.0008270486,0.00018989085,0.00004059698,0.031944342],"genre_scores_gemma":[0.9866022,0.011793434,0.00004331615,0.00047156474,0.0003647626,0.0002632899,0.0000151372,0.000021480007,0.00042484736],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742305,0.00024414912,0.00092318613,0.00048247198,0.00040745497,0.0005196707],"domain_scores_gemma":[0.99857163,0.00037758585,0.00023119214,0.00037191826,0.00024896328,0.00019870806],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037670846,0.00026900313,0.0012683704,0.00024898848,0.000038638707,0.0000050109174,0.00019562396,0.00037938636,0.0016475815],"category_scores_gemma":[0.00003087449,0.00022427725,0.0003253229,0.00063108373,0.00055028585,0.00006324051,0.00008369127,0.00037644643,0.000010177674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1330489,0.013488318,0.4288541,0.0020610925,0.0085913595,0.0045302426,0.0018453381,0.00044924548,0.012008113,0.013977874,0.04103479,0.34011063],"study_design_scores_gemma":[0.038120512,0.0028693778,0.07110721,0.00048317868,0.00055865047,0.00002645705,0.00011968323,0.00007249333,0.05208571,0.0002984695,0.83393204,0.0003262204],"about_ca_topic_score_codex":0.0042759697,"about_ca_topic_score_gemma":0.00070469326,"teacher_disagreement_score":0.7928972,"about_ca_system_score_codex":0.00020307573,"about_ca_system_score_gemma":0.0013587106,"threshold_uncertainty_score":0.9992651},"labels":[],"label_agreement":null},{"id":"W4410799942","doi":"10.1016/s1470-2045(25)00158-5","title":"Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Astellas Pharma; Seagen; Pfizer","keywords":"Pembrolizumab; Urothelial cancer; Medicine; Open label; Oncology; Internal medicine; Chemotherapy; Phases of clinical research; Cancer; Clinical trial; Immunotherapy; Bladder cancer","score_opus":0.054222734857564785,"score_gpt":0.40464735792672296,"score_spread":0.35042462306915817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410799942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783451,0.00035261142,0.00004951025,0.0014239694,0.0006180142,0.017286593,0.00017737086,0.00010868285,0.0016381278],"genre_scores_gemma":[0.9903501,0.00018242546,0.00039219702,0.0037792344,0.00009950718,0.0042868555,0.00018848879,0.00007543109,0.00064571755],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962102,0.00077325106,0.0010606758,0.0007724031,0.00046315952,0.00072029396],"domain_scores_gemma":[0.9972438,0.00073795684,0.00056114676,0.000991861,0.00028075982,0.00018445445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044885365,0.0005801446,0.0028947028,0.00016485545,0.00017567637,0.000066497516,0.00058171863,0.00013077247,0.00063349766],"category_scores_gemma":[0.0002570797,0.00030813573,0.00008624191,0.00048438628,0.00017701008,0.0002120503,0.000100629746,0.00040937334,0.0000094826755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8686654,0.01165278,0.048958134,0.000030676994,0.004466264,0.0003739566,0.0023296976,0.00009375755,0.000057421665,0.000010820792,0.00022679594,0.063134275],"study_design_scores_gemma":[0.9253067,0.03337808,0.036206126,0.00015097069,0.0024773541,0.000005920589,0.00063604285,0.00025754498,0.00012200344,0.00003891686,0.0011133585,0.0003070303],"about_ca_topic_score_codex":0.00503469,"about_ca_topic_score_gemma":0.007007504,"teacher_disagreement_score":0.062827244,"about_ca_system_score_codex":0.0010239085,"about_ca_system_score_gemma":0.0028178145,"threshold_uncertainty_score":0.99993706},"labels":[],"label_agreement":null},{"id":"W4410808221","doi":"10.1007/s00345-025-05716-z","title":"Critical appraisal of “Impact of prior endoscopic management of upper tract urothelial carcinoma on nephroureterectomy complexity.”","year":2025,"lang":"en","type":"letter","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Continental (Canada)","funders":"","keywords":"Medicine; Urothelial carcinoma; Nephrology; Urology; Carcinoma; Internal medicine; General surgery; Cancer; Bladder cancer","score_opus":0.032986867168826095,"score_gpt":0.35262872723023886,"score_spread":0.31964186006141276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410808221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46512392,0.008903883,0.00063744665,0.45740625,0.00895852,0.0031194983,0.0017031943,0.000049508653,0.05409778],"genre_scores_gemma":[0.97111404,0.00014970846,0.0011601757,0.025473714,0.0013565916,0.000009211061,0.000033638342,0.000051065555,0.0006518829],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9969066,0.00031371613,0.0013717109,0.0003017369,0.00066664146,0.0004396165],"domain_scores_gemma":[0.9972504,0.00090089557,0.0008932749,0.00047272677,0.0003627094,0.000120006705],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022511077,0.0004289034,0.0019231384,0.0010267916,0.000028120092,0.0000065596782,0.00036514062,0.00036866698,0.0010235731],"category_scores_gemma":[0.00011356076,0.00032423076,0.001006581,0.00027498262,0.0004956697,0.000049959915,0.000068686786,0.0015920149,0.0000037354177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027478326,0.0059316587,0.18429613,0.01057823,0.016880563,0.0114355385,0.0011212665,0.000045555993,0.002329329,0.0020027582,0.71766853,0.020232102],"study_design_scores_gemma":[0.029577585,0.036234394,0.63695663,0.003508839,0.012264997,0.0017192846,0.00007714476,0.000029876242,0.0029819352,0.0014167142,0.27456188,0.0006707153],"about_ca_topic_score_codex":0.00011452498,"about_ca_topic_score_gemma":0.000003906071,"teacher_disagreement_score":0.5059901,"about_ca_system_score_codex":0.00014702212,"about_ca_system_score_gemma":0.0005882596,"threshold_uncertainty_score":0.99992096},"labels":[],"label_agreement":null},{"id":"W4410816943","doi":"10.1200/jco.2025.43.16_suppl.4610","title":"Sasanlimab in combination with bacillus Calmette-Guérin (BCG) in BCG-naive in BCG-naive, high-risk non–muscle-invasive bladder cancer (NMIBC): Patient-reported outcomes (PROs) from CREST.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Bacillus (shape); Internal medicine; Oncology; Gynecology","score_opus":0.04503844893980579,"score_gpt":0.400640073618219,"score_spread":0.3556016246784132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410816943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869979,0.0006682278,0.000081018865,0.007919554,0.0017753394,0.0010406002,0.000061834464,0.000014921849,0.0014405816],"genre_scores_gemma":[0.9929302,0.0015494003,0.0010336826,0.0038506482,0.00024032862,0.000103664126,0.000027137708,0.00003823189,0.00022672446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936321,0.00082419073,0.0037428841,0.0006064061,0.0006621131,0.00053231133],"domain_scores_gemma":[0.99347717,0.0030490167,0.0022089414,0.00039431165,0.0005594352,0.00031111707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012965931,0.00040837622,0.0027218221,0.0007304672,0.000052549276,0.000020479072,0.00025354317,0.0006932494,0.00025426265],"category_scores_gemma":[0.0027557348,0.00029368736,0.0003643695,0.00078135484,0.0002698747,0.00025758264,0.0001055525,0.0020825737,0.000012315156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006528442,0.005129592,0.8916725,0.00003380124,0.0009598851,0.0033225338,0.00065353647,0.00020899341,0.00006368451,0.000026405025,0.00082857534,0.09057205],"study_design_scores_gemma":[0.0599442,0.00978685,0.924891,0.00074431644,0.0007573537,0.000027729315,0.0006582204,0.00010129539,0.00021653569,0.0012556079,0.001380606,0.00023629256],"about_ca_topic_score_codex":0.017262543,"about_ca_topic_score_gemma":0.033577356,"teacher_disagreement_score":0.090335764,"about_ca_system_score_codex":0.0013146261,"about_ca_system_score_gemma":0.004480404,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W4410816990","doi":"10.1200/jco.2025.43.16_suppl.tps4627","title":"Intravesical sacituzumab tirumotecan in participants with intermediate-risk non–muscle-invasive bladder cancer: The phase 1/2 TroFuse-027 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Oncology; Urology; Internal medicine","score_opus":0.09020439217103945,"score_gpt":0.4854147767435448,"score_spread":0.39521038457250535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410816990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886693,0.00033734186,0.00014683694,0.007718985,0.001254182,0.0008376149,0.000014546968,0.000010711818,0.0010105309],"genre_scores_gemma":[0.9939563,0.0010838783,0.00012732482,0.0036413723,0.0008663431,0.00006208208,0.0000012711114,0.000022815553,0.00023859792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957695,0.00075663684,0.0022340007,0.00032527157,0.00044040685,0.00047416947],"domain_scores_gemma":[0.99557877,0.0022354766,0.0011212067,0.00036271178,0.00032311922,0.0003787077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021358812,0.00025283408,0.0017619662,0.00020362774,0.00008005728,0.000019684865,0.00033029806,0.00027446426,0.00018812662],"category_scores_gemma":[0.002005222,0.00013112724,0.0003218892,0.00039201137,0.000440045,0.00010360212,0.0000792075,0.0018333249,0.000012657608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023714924,0.013889514,0.55311626,0.00003466976,0.0029615501,0.002639538,0.002025367,0.000044511344,0.000087358494,0.000022537502,0.003696383,0.3977674],"study_design_scores_gemma":[0.058940925,0.047577072,0.8824336,0.0003378612,0.0026696587,0.00006237972,0.0023143333,0.00013175227,0.000250432,0.00025104464,0.0048878845,0.00014304277],"about_ca_topic_score_codex":0.000458205,"about_ca_topic_score_gemma":0.005140281,"teacher_disagreement_score":0.39762434,"about_ca_system_score_codex":0.00041230654,"about_ca_system_score_gemma":0.0058587766,"threshold_uncertainty_score":0.9997771},"labels":[],"label_agreement":null},{"id":"W4410818285","doi":"10.1200/jco.2025.43.16_suppl.e16602","title":"Non-muscle invasive bladder cancer burden: The impact of BCG shortage and its interaction with epidemiological patient profile—A population cohort study in Brazil.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Epidemiology; Economic shortage; Cohort; Cancer; Population; Cohort study; Oncology; Internal medicine; Environmental health","score_opus":0.08393674413643219,"score_gpt":0.5021151829109328,"score_spread":0.4181784387745006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410818285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954475,0.00030523373,0.000008901906,0.0018844532,0.00034222752,0.0010961324,0.000004894569,0.000002788771,0.0009078689],"genre_scores_gemma":[0.9985921,0.00048667294,0.000060537277,0.0005406008,0.00021543555,0.000042599215,0.0000026640998,0.000007029027,0.00005238631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742323,0.0004964081,0.0015400548,0.00019044692,0.00020408105,0.00014577623],"domain_scores_gemma":[0.9968933,0.0015474154,0.0010217989,0.00012454632,0.000304208,0.000108773165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014898814,0.00013405332,0.0011936895,0.000112348374,0.000031393265,0.0000048461893,0.00007449144,0.00018429733,0.00012409162],"category_scores_gemma":[0.0014051178,0.000061834806,0.00019689926,0.00017659915,0.0000802566,0.000098180724,0.000040475865,0.00067075813,8.5454957e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004526547,0.0014757446,0.95987135,0.000014448417,0.00090275303,0.00009894871,0.00030681508,0.0003020352,0.00007377709,0.0000043797845,0.0004824766,0.031940714],"study_design_scores_gemma":[0.004719973,0.02148549,0.97205013,0.00018394657,0.0004915031,0.00003545986,0.0005556559,0.00026284723,0.000038094408,0.000059995746,0.000067731715,0.000049191534],"about_ca_topic_score_codex":0.0018383138,"about_ca_topic_score_gemma":0.0009655732,"teacher_disagreement_score":0.03189152,"about_ca_system_score_codex":0.0002799384,"about_ca_system_score_gemma":0.0009602087,"threshold_uncertainty_score":0.29141477},"labels":[],"label_agreement":null},{"id":"W4410818946","doi":"10.1200/jco.2025.43.16_suppl.tps4631","title":"LEGEND: A phase 1/2 study of detalimogene voraplasmid (EG-70), an intravesical monotherapy for patients with high-risk non–muscle-invasive bladder cancer (NMIBC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Urology; Cancer; Urothelial cancer; Oncology; Internal medicine","score_opus":0.055545716074392626,"score_gpt":0.45342300534315355,"score_spread":0.3978772892687609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410818946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511683,0.00023282127,0.00080250064,0.00087587896,0.0012020787,0.0015075214,0.00011691141,0.000009547287,0.0001358845],"genre_scores_gemma":[0.9948119,0.00070613,0.0020310131,0.0014167961,0.00078627357,0.00008276335,0.0000120297345,0.00003815456,0.00011496488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962317,0.0003939138,0.0022162185,0.00037912314,0.00046262224,0.0003164242],"domain_scores_gemma":[0.9950481,0.001312349,0.0017907465,0.000339767,0.0011156513,0.00039340393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000897598,0.00027863745,0.002039925,0.00021933338,0.0000772029,0.000010531663,0.00023606035,0.00033188108,0.00012579122],"category_scores_gemma":[0.00039972927,0.00017873448,0.0003862533,0.00023989174,0.00020594886,0.0001502285,0.00003139635,0.0006162477,0.0000015984645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071615234,0.059529714,0.47410074,0.00007230417,0.0072087706,0.00015487922,0.0008624607,0.00010016901,0.0003078603,0.00002867026,0.0014085217,0.38461065],"study_design_scores_gemma":[0.14589837,0.24724956,0.59605193,0.00015686009,0.0044725523,0.000010399093,0.00054165017,0.00006978778,0.0021238937,0.00021961436,0.0030095724,0.0001958246],"about_ca_topic_score_codex":0.0003717994,"about_ca_topic_score_gemma":0.00085220835,"teacher_disagreement_score":0.38441485,"about_ca_system_score_codex":0.00018236629,"about_ca_system_score_gemma":0.003038533,"threshold_uncertainty_score":0.72885805},"labels":[],"label_agreement":null},{"id":"W4410821448","doi":"10.1200/jco.2025.43.16_suppl.4500","title":"Nivolumab plus ipilimumab (NIVO+IPI) vs gemcitabine-carboplatin (gem-carbo) chemotherapy for previously untreated unresectable or metastatic urothelial carcinoma (mUC): Final results for cisplatin-ineligible patients from the CheckMate 901 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Gemcitabine; Nivolumab; Ipilimumab; Carboplatin; Metastatic Urothelial Carcinoma; Cisplatin; Chemotherapy; Internal medicine; Oncology; Urology; Urothelial carcinoma; Bladder cancer; Cancer; Immunotherapy","score_opus":0.14105371689962076,"score_gpt":0.4486486768325521,"score_spread":0.30759495993293134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410821448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97497237,0.0007472338,0.0012328121,0.009759227,0.0035999222,0.006443457,0.00075666595,0.00004556473,0.0024427378],"genre_scores_gemma":[0.9778513,0.00057044503,0.007291599,0.004597922,0.002609244,0.0005366712,0.00015819912,0.00009648382,0.0062881866],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931092,0.00065979245,0.0042263204,0.0006562703,0.00060538057,0.0007429956],"domain_scores_gemma":[0.9843004,0.011014139,0.0024478969,0.000623833,0.0012400777,0.00037368137],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031306436,0.0005107882,0.0030713824,0.00020416548,0.00024480885,0.0000628504,0.0005515625,0.00050533836,0.00017895467],"category_scores_gemma":[0.009477652,0.00029891936,0.0012093397,0.00043499397,0.00023694882,0.0001711562,0.00008486118,0.0008211399,0.000009806012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90603477,0.0032447907,0.0099821165,0.00016775982,0.002660358,0.00008083225,0.00035970518,0.000056495806,0.000068891386,0.00005462135,0.03850714,0.038782537],"study_design_scores_gemma":[0.838654,0.05412582,0.037659217,0.0005268678,0.0049153734,0.00002850021,0.00015295057,0.002672545,0.0009304799,0.0014826667,0.05848235,0.00036922132],"about_ca_topic_score_codex":0.0005617962,"about_ca_topic_score_gemma":0.00039305325,"teacher_disagreement_score":0.06738074,"about_ca_system_score_codex":0.0006411681,"about_ca_system_score_gemma":0.0071484693,"threshold_uncertainty_score":0.9999463},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4410821794","doi":"10.1200/jco.2025.43.16_suppl.4517","title":"Sasanlimab in combination with bacillus Calmette-Guérin (BCG) in BCG-naive, high-risk non–muscle-invasive bladder cancer (NMIBC): Event-free survival (EFS) subgroup analyses based on disease stage from the CREST study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Stage (stratigraphy); Bacillus (shape); Disease; Internal medicine; Cancer; Microbiology","score_opus":0.08760939791952503,"score_gpt":0.44937335501430903,"score_spread":0.361763957094784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410821794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410916,0.00046344328,0.00031821823,0.012154283,0.0011677102,0.001052277,0.00020916712,0.000010592799,0.00051517057],"genre_scores_gemma":[0.9949212,0.000527645,0.00019263875,0.0035686253,0.00046061815,0.000080180085,0.000026085012,0.000029937106,0.00019306938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942736,0.0019362489,0.0020691815,0.00050015573,0.00084601756,0.00037478408],"domain_scores_gemma":[0.9908114,0.0065486785,0.0012378927,0.0006607779,0.00040122538,0.00033998975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021676014,0.00033783965,0.0017644662,0.00036364814,0.00009332877,0.00002808217,0.00046871454,0.00026161646,0.00027841338],"category_scores_gemma":[0.0034960925,0.00020066647,0.00037511744,0.00069098896,0.0002465546,0.00014139105,0.000102670434,0.0015465068,0.000006486878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022392655,0.012094973,0.9410686,0.000026619557,0.0010387029,0.0020588618,0.00021023586,0.002357716,0.000020452624,0.000026698817,0.0009677941,0.017736727],"study_design_scores_gemma":[0.06192248,0.013780435,0.91956145,0.00041918035,0.0016454583,0.0000012893056,0.0008879522,0.000647982,0.000035699108,0.0003442624,0.0005907081,0.00016313007],"about_ca_topic_score_codex":0.013353916,"about_ca_topic_score_gemma":0.056448936,"teacher_disagreement_score":0.043095022,"about_ca_system_score_codex":0.000743712,"about_ca_system_score_gemma":0.0045835623,"threshold_uncertainty_score":0.9932162},"labels":[],"label_agreement":null},{"id":"W4410821849","doi":"10.1200/jco.2025.43.16_suppl.4571","title":"EV-302: Long-term subgroup analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial cancer; Oncology; Chemotherapy; Internal medicine; Subgroup analysis; Phases of clinical research; Cancer; Immunotherapy; Bladder cancer; Meta-analysis","score_opus":0.04983913750394723,"score_gpt":0.44657523319513354,"score_spread":0.3967360956911863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410821849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956844,0.000402936,0.0005435218,0.0014393614,0.00018742247,0.001392286,0.000025443638,0.000009075909,0.0003155457],"genre_scores_gemma":[0.9982739,0.00027838498,0.0003709566,0.00082125765,0.00008218807,0.000051053514,0.000017565624,0.000018955578,0.00008574917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99486774,0.001172524,0.0027644176,0.00036739756,0.0005257631,0.0003021264],"domain_scores_gemma":[0.9951613,0.0023807324,0.0015010718,0.00038319183,0.00040724158,0.00016644382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015757604,0.00029207303,0.0025542527,0.00029517745,0.000036026926,0.000017240403,0.00032785416,0.00021899598,0.00017955371],"category_scores_gemma":[0.00097106973,0.00016542834,0.00038412964,0.0013822886,0.00022299794,0.00012820652,0.000030470661,0.0006936811,0.0000014482202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11852607,0.017615305,0.77164286,0.00003892485,0.003229181,0.001243723,0.00061653473,0.00011804952,0.000034896046,0.000016571066,0.000030635736,0.08688727],"study_design_scores_gemma":[0.15037514,0.02929699,0.8145382,0.00021209684,0.0043334933,0.00005247346,0.00046677428,0.00029423376,0.0001543039,0.00010893086,0.000058277237,0.00010907448],"about_ca_topic_score_codex":0.0015088092,"about_ca_topic_score_gemma":0.014401941,"teacher_disagreement_score":0.0867782,"about_ca_system_score_codex":0.0006172094,"about_ca_system_score_gemma":0.0036008416,"threshold_uncertainty_score":0.80366206},"labels":[],"label_agreement":null},{"id":"W4410822662","doi":"10.1200/jco.2025.43.16_suppl.4501","title":"Avelumab + sacituzumab govitecan (SG) vs avelumab monotherapy as first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC): Interim analysis from the JAVELIN Bladder Medley phase 2 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Javelin; Avelumab; Medicine; Urothelial carcinoma; Interim analysis; Metastatic Urothelial Carcinoma; Interim; Internal medicine; Urology; Oncology; Bladder cancer; Clinical trial; Immunotherapy; Cancer; Nivolumab","score_opus":0.05185089913416787,"score_gpt":0.4237002166275673,"score_spread":0.37184931749339944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836771,0.00063088036,0.0013711149,0.009866742,0.0013728659,0.0018160419,0.00014942366,0.000020544725,0.0010953025],"genre_scores_gemma":[0.9898635,0.0015343853,0.0009988127,0.0055103796,0.0008396838,0.0001285256,0.000056035595,0.000050524915,0.0010181104],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938843,0.00075994234,0.003448835,0.0006890417,0.0006637189,0.0005541615],"domain_scores_gemma":[0.994126,0.0021958349,0.0019023253,0.00075599505,0.0006167109,0.00040311067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011342759,0.00054416107,0.0033264211,0.0004231172,0.0001289327,0.00003776639,0.00047546125,0.000472614,0.00057691487],"category_scores_gemma":[0.00116514,0.0003017153,0.0012035092,0.0008863276,0.00036894204,0.00016526703,0.00006753332,0.0010231233,0.000022934648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5895854,0.01833761,0.10833174,0.000014270872,0.008996558,0.0006366495,0.0008517101,0.00017987439,0.000027077944,0.000035830813,0.000983323,0.27201992],"study_design_scores_gemma":[0.62340665,0.13176109,0.19378096,0.00031424308,0.00653899,0.000027492048,0.0003451409,0.0004630317,0.0003793385,0.0004838749,0.042141825,0.00035737018],"about_ca_topic_score_codex":0.0020034497,"about_ca_topic_score_gemma":0.0042571872,"teacher_disagreement_score":0.27166256,"about_ca_system_score_codex":0.0016367047,"about_ca_system_score_gemma":0.0036034023,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W4410879240","doi":"10.1016/j.euo.2025.05.008","title":"The Burden of Genitourinary Malignancies in Southeast Asia from 1990 to 2021","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Prostate Cancer Foundation","keywords":"Medicine; Genitourinary system; Southeast asia; Oncology; Intensive care medicine; Internal medicine; Ancient history","score_opus":0.01420437330433892,"score_gpt":0.2891482787989355,"score_spread":0.2749439054945966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410879240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6539982,0.0023467408,0.00009156352,0.028067691,0.0007906211,0.00051908987,0.000038167902,0.000028174187,0.31411976],"genre_scores_gemma":[0.99453896,0.000096692864,0.00025773485,0.0010641409,0.00039466535,0.000025732792,0.000012584529,0.000019915677,0.0035895526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984596,0.0005275186,0.00034687444,0.00029284772,0.00008179269,0.000291376],"domain_scores_gemma":[0.9991607,0.00026395384,0.00006891055,0.0003789764,0.00005450033,0.000072949944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029138473,0.00013900975,0.00035877683,0.00013902177,0.000071764,0.000004580598,0.00022180597,0.00008550498,0.00017991672],"category_scores_gemma":[0.00011870675,0.000100628706,0.000072345705,0.00022237436,0.00020595305,0.000013570188,0.00017823657,0.00022576866,0.00028823563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027947113,0.0033430955,0.22109252,0.00013471814,0.0029006933,0.012698,0.018958159,0.0006689676,0.09227831,0.010937353,0.12174215,0.48729894],"study_design_scores_gemma":[0.004564488,0.0030207187,0.35630468,0.000048251954,0.00025537284,0.00007749128,0.0024383867,0.000030290383,0.0008406078,0.00063689804,0.63165087,0.00013195514],"about_ca_topic_score_codex":0.00051601406,"about_ca_topic_score_gemma":0.0001498967,"teacher_disagreement_score":0.5099087,"about_ca_system_score_codex":0.000071428716,"about_ca_system_score_gemma":0.00024492238,"threshold_uncertainty_score":0.41035193},"labels":[],"label_agreement":null},{"id":"W4410916531","doi":"10.1038/s41591-025-03738-z","title":"Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Core Research for Evolutional Science and Technology; Pfizer","keywords":"Bladder cancer; Medicine; Crest; Randomized controlled trial; Cancer; Urothelial cancer; Oncology; Internal medicine; Urology","score_opus":0.010660452206690534,"score_gpt":0.33509794586690667,"score_spread":0.3244374936602161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410916531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86662376,0.04045498,0.00024427183,0.05260246,0.0071395827,0.009720898,0.00017730899,0.00014918402,0.02288754],"genre_scores_gemma":[0.9775457,0.006202286,0.0000927825,0.00954315,0.0022982885,0.00093205617,0.00013085114,0.000046521855,0.003208356],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99692124,0.0003706674,0.00079731015,0.00064518227,0.0007348637,0.0005307444],"domain_scores_gemma":[0.9970513,0.001500645,0.0002762785,0.00072587695,0.00024992292,0.00019598487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001004707,0.00048145582,0.0017538783,0.0004071447,0.00019795692,0.00002079587,0.00033277654,0.0005217598,0.0009039901],"category_scores_gemma":[0.0021376328,0.0002596725,0.0002735424,0.0010525718,0.00056322885,0.00008459328,0.00008153848,0.0018558567,0.000021153422],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88364357,0.0013526878,0.0011065422,0.00021564667,0.0019875385,0.00040510084,0.0029549208,0.000018980052,0.0012407792,0.0007423013,0.07439627,0.03193567],"study_design_scores_gemma":[0.9732974,0.00135984,0.0038951815,0.001041441,0.0026372985,0.000010579055,0.0005586111,0.00016161232,0.0017703293,0.0010252547,0.014016411,0.00022600089],"about_ca_topic_score_codex":0.008084915,"about_ca_topic_score_gemma":0.0021791595,"teacher_disagreement_score":0.11092193,"about_ca_system_score_codex":0.0004560186,"about_ca_system_score_gemma":0.0012697023,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W4410935761","doi":"10.1016/j.annonc.2025.05.010","title":"Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"EMD Serono; Genentech; Foundation Medicine; LEO Pharma; Medac; Ipsen; Ono Pharmaceutical; Genesis Pharma; Cilag; Astellas Pharma; Seagen; Teva Pharmaceutical Industries; Gilead Sciences; Daiichi Sankyo Europe; Exelixis; Sanofi; Merck; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Merck Healthcare KGaA","keywords":"Javelin; Avelumab; Medicine; Urothelial carcinoma; Interim analysis; Interim; Oncology; Internal medicine; Urology; First line treatment; Metastatic Urothelial Carcinoma; Urothelial cancer; Bladder cancer; Chemotherapy; Immunotherapy; Cancer; Clinical trial; Pembrolizumab","score_opus":0.03714372364506753,"score_gpt":0.35750115043469394,"score_spread":0.3203574267896264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410935761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868722,0.0005830202,0.0005060784,0.0032264935,0.000356178,0.0015427482,0.00016362626,0.00006563991,0.0066840374],"genre_scores_gemma":[0.9956829,0.00068134966,0.00044041287,0.0014105813,0.000065004424,0.0003004559,0.00013945298,0.000057779103,0.0012220478],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99741817,0.00012426708,0.00076889404,0.0007258924,0.0003391384,0.0006236713],"domain_scores_gemma":[0.99823064,0.00019109988,0.0003116552,0.0006618455,0.0004221456,0.00018259788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014193844,0.00048176706,0.0014946364,0.0007053873,0.000070456554,0.00001248816,0.00021865153,0.00025376515,0.00027222416],"category_scores_gemma":[0.00008183254,0.00036908113,0.00035869374,0.0010646785,0.00023373502,0.000105716455,0.00005685355,0.00022385869,0.00001686621],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27401105,0.014268206,0.2774421,0.000234204,0.01936527,0.00058941613,0.0057073263,0.0026720173,0.00025319617,0.0007030316,0.0014039825,0.4033502],"study_design_scores_gemma":[0.254522,0.104489885,0.58011556,0.00042910335,0.0043689376,0.000014616963,0.0008969969,0.0009904602,0.011724006,0.0004887478,0.040928226,0.0010314808],"about_ca_topic_score_codex":0.003415432,"about_ca_topic_score_gemma":0.0057235635,"teacher_disagreement_score":0.40231872,"about_ca_system_score_codex":0.0012296836,"about_ca_system_score_gemma":0.0013848412,"threshold_uncertainty_score":0.99987614},"labels":[],"label_agreement":null},{"id":"W4410983248","doi":"10.1016/j.eururo.2025.05.017","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node–only Disease","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Merck","keywords":"Medicine; Metastatic Urothelial Carcinoma; Avelumab; Hazard ratio; Internal medicine; Oncology; Lymph node; Clinical endpoint; Regimen; Carcinoma; Bladder cancer; Confidence interval; Randomized controlled trial; Urothelial carcinoma; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.019226915041649754,"score_gpt":0.27508665559570633,"score_spread":0.2558597405540566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410983248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873146,0.0002324981,0.0011381587,0.005640577,0.00091736176,0.002974616,0.0005356839,0.00006896104,0.0011775867],"genre_scores_gemma":[0.9865164,0.000026653624,0.0002154045,0.008780253,0.00041535439,0.00018283396,0.00030470354,0.000091152906,0.0034672227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976966,0.0002460703,0.0005405891,0.0007167345,0.00023531058,0.0005647233],"domain_scores_gemma":[0.9984552,0.00039065516,0.00014905495,0.00070533005,0.00013236921,0.0001673863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016671246,0.0004092401,0.00059957715,0.00011079023,0.00015981641,0.0000284463,0.0003336796,0.00007317485,0.00025505718],"category_scores_gemma":[0.0003402786,0.00023249268,0.00018150413,0.00019160501,0.00019080787,0.0000718733,0.00012430178,0.00023289047,0.00006136271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2203743,0.0009030858,0.77001643,0.00003216096,0.00024786522,0.00022999759,0.00016331543,0.00004075859,0.0000026927733,0.000031271364,0.00054548844,0.0074126446],"study_design_scores_gemma":[0.18441485,0.0016045937,0.81140196,0.00005865762,0.000419934,0.0000026713271,0.000009247477,0.000052275005,0.000005775781,0.000035708945,0.0018014282,0.00019290629],"about_ca_topic_score_codex":0.000112043126,"about_ca_topic_score_gemma":0.0002782848,"teacher_disagreement_score":0.041385535,"about_ca_system_score_codex":0.00013626844,"about_ca_system_score_gemma":0.0004683092,"threshold_uncertainty_score":0.9480776},"labels":[],"label_agreement":null},{"id":"W4411029735","doi":"10.1245/s10434-025-17637-7","title":"ASO Visual Abstract: Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; Bladder cancer; Urothelial cancer; Urology; Cancer; Oncology; General surgery; Internal medicine","score_opus":0.09932412367996077,"score_gpt":0.45022777382980067,"score_spread":0.35090365014983993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411029735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959439,0.005078741,0.000008708405,0.006538754,0.0012393506,0.0007640731,0.00017425646,0.000040601124,0.026716562],"genre_scores_gemma":[0.99006325,0.008464449,0.000028615606,0.00039380344,0.00044610622,0.00023579727,0.000021464277,0.000025413921,0.00032107468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714035,0.00017624881,0.0010710428,0.00053857366,0.00048816818,0.0005856419],"domain_scores_gemma":[0.9984121,0.00046233193,0.00029114427,0.00032939977,0.00027042488,0.0002346298],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043952587,0.00031198998,0.0013466222,0.0002681502,0.000046139798,0.0000072666116,0.0001988054,0.0004553318,0.0023240768],"category_scores_gemma":[0.00003577188,0.00026459983,0.00035588798,0.0005876746,0.0005783717,0.00008259944,0.00008500284,0.0004696592,0.000014737051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13347958,0.019103047,0.3489411,0.0023085454,0.008306422,0.005698536,0.0016682592,0.00045467098,0.018898787,0.006603506,0.028424906,0.42611268],"study_design_scores_gemma":[0.043990087,0.0038355037,0.22272797,0.00062879384,0.00066316413,0.00003413987,0.00017423676,0.000089343936,0.07161509,0.00023398246,0.6555475,0.00046019157],"about_ca_topic_score_codex":0.0048492104,"about_ca_topic_score_gemma":0.00074879226,"teacher_disagreement_score":0.6271226,"about_ca_system_score_codex":0.00022629449,"about_ca_system_score_gemma":0.0015228754,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W4411037154","doi":"10.1016/j.euros.2025.05.002","title":"Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational Study","year":2025,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Hochschule Luzern","keywords":"Cystectomy; Observational study; Medicine; Anemia; Retrospective cohort study; Multicenter study; General surgery; Surgery; Internal medicine; Bladder cancer; Randomized controlled trial; Cancer","score_opus":0.032373601946858975,"score_gpt":0.33028452978174055,"score_spread":0.2979109278348816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411037154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870389,0.000088078465,0.0000328313,0.0003402267,0.00008543693,0.0028671864,0.000014515207,0.000010626032,0.009522205],"genre_scores_gemma":[0.9985171,0.000008352204,0.000456104,0.0005635098,0.000010175935,0.0000830128,0.0000023470145,0.000007257901,0.00035212634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982701,0.00031581675,0.00031095193,0.00061405584,0.00027577014,0.00021332742],"domain_scores_gemma":[0.9991987,0.00011235004,0.00008732845,0.0002676001,0.00026157295,0.00007246898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008101566,0.00012467633,0.0002526666,0.000142079,0.00010950829,0.000037686896,0.0004953897,0.000020779476,0.000037934464],"category_scores_gemma":[0.00088067766,0.00009965225,0.000015289093,0.0006324557,0.0008820073,0.00026568776,0.00045185292,0.00017280734,0.0000062845734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045498484,0.00091873726,0.9961746,0.000034222063,0.000017835797,0.00003092554,0.0014033332,0.000004121592,0.0005298648,0.0001073107,0.00003004287,0.000294071],"study_design_scores_gemma":[0.004872287,0.0017945949,0.9925474,0.00007752773,0.00005947662,0.0000029883845,0.00011285025,0.000097025426,0.0003043185,0.000026726239,0.00003512198,0.000069669026],"about_ca_topic_score_codex":0.00008254396,"about_ca_topic_score_gemma":0.000024937888,"teacher_disagreement_score":0.01147822,"about_ca_system_score_codex":0.00009794651,"about_ca_system_score_gemma":0.0003586961,"threshold_uncertainty_score":0.4063701},"labels":[],"label_agreement":null},{"id":"W4411098218","doi":"10.5489/cuaj.9251","title":"Podium Session 4: Oncology-Bladder, Kidney, Other","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Alberta; McGill University Health Centre; McGill University; Dalhousie University; University of Ottawa","keywords":"Session (web analytics); Medicine; Urology; Internal medicine; Oncology; Computer science; World Wide Web","score_opus":0.014187432142092726,"score_gpt":0.2860576951268028,"score_spread":0.27187026298471006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411098218","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14820972,0.0012439055,0.00040550178,0.44910285,0.0035183525,0.00071150647,0.0001682365,0.00013714177,0.3965028],"genre_scores_gemma":[0.88287246,0.00009937768,0.00029924518,0.09869778,0.0006425802,0.00001543474,0.000020174319,0.000013502134,0.017339453],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871755,0.0001461393,0.00027768934,0.00018445727,0.00023070056,0.00044347194],"domain_scores_gemma":[0.99858814,0.00007656671,0.00013730238,0.00010701861,0.00020534807,0.0008856214],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037566456,0.00013416325,0.00027735272,0.00021452099,0.00029556482,0.000055222677,0.00009972277,0.0003646207,0.0025169603],"category_scores_gemma":[0.0005534864,0.00010054865,0.00014553673,0.00024577786,0.000028938479,0.000062388775,0.0000136624,0.0005789657,0.00015280358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015122749,0.00015394298,0.5784749,0.0000060222505,0.00039272054,0.00015406901,0.00009557953,0.0000030019758,0.00025502418,0.00049932866,0.4009194,0.018894803],"study_design_scores_gemma":[0.0019735273,0.00030771445,0.2243848,0.000024914927,0.0001580684,0.000091152935,0.000049468417,0.000020155336,0.00008215221,0.0015195921,0.77130824,0.00008021315],"about_ca_topic_score_codex":0.0014565255,"about_ca_topic_score_gemma":0.00048952183,"teacher_disagreement_score":0.7346627,"about_ca_system_score_codex":0.0023102234,"about_ca_system_score_gemma":0.002852401,"threshold_uncertainty_score":0.99839485},"labels":[],"label_agreement":null},{"id":"W4411098537","doi":"10.5489/cuaj.9260","title":"Poster Session 3: Oncology - Bladder","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Temerty Faculty of Medicine, University of Toronto; University of Toronto; Dalhousie University; Canadian Institutes of Health Research; McGill University Health Centre; Ottawa Hospital Research Institute; Cumming School of Medicine, University of Calgary; McGill University","keywords":"Session (web analytics); Medicine; Internal medicine; Medical physics; Oncology; Urology; Computer science; World Wide Web","score_opus":0.014296825200135158,"score_gpt":0.2882822547260339,"score_spread":0.27398542952589877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411098537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3967052,0.0009216697,0.00014341195,0.2994336,0.002218675,0.0004377057,0.00004081334,0.00006571032,0.3000332],"genre_scores_gemma":[0.9481465,0.00006509399,0.00009360206,0.042637993,0.0003417877,0.000007688417,0.000012314475,0.000006337478,0.008688639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896526,0.00012159473,0.00023105447,0.00014373768,0.0001777713,0.00036058287],"domain_scores_gemma":[0.9990684,0.00008267247,0.00009880893,0.00008046635,0.00020902083,0.00046063965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027653546,0.00010064424,0.00022596707,0.00018602198,0.00022457857,0.00004444942,0.000069964175,0.0004282496,0.0017651526],"category_scores_gemma":[0.00027492427,0.00007399813,0.000112589914,0.00018763557,0.000020469306,0.000056168516,0.000011947096,0.00068016525,0.0001212332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015085867,0.00011121894,0.8175354,0.000003810833,0.00034143796,0.00024315016,0.00009560214,0.0000025697266,0.00017635054,0.00028532045,0.1556782,0.02537609],"study_design_scores_gemma":[0.001537775,0.00035166225,0.546978,0.000013119455,0.00013824731,0.00014876571,0.00003363594,0.000009366816,0.000062726336,0.0012518392,0.4494141,0.000060766717],"about_ca_topic_score_codex":0.00066575635,"about_ca_topic_score_gemma":0.0005504299,"teacher_disagreement_score":0.5514413,"about_ca_system_score_codex":0.002023994,"about_ca_system_score_gemma":0.001547094,"threshold_uncertainty_score":0.99914736},"labels":[],"label_agreement":null},{"id":"W4411134039","doi":"10.3390/siuj6030037","title":"Extended vs. Standard Pelvic Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Lymph node; Dissection (medical); Medicine; Bladder cancer; Meta-analysis; Urology; General surgery; Cancer; Surgery; Internal medicine","score_opus":0.03111732590054896,"score_gpt":0.3550886963695304,"score_spread":0.32397137046898145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411134039","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45280832,0.4572154,0.006441987,0.062920414,0.002200222,0.00664448,0.0005611644,0.00026624615,0.01094179],"genre_scores_gemma":[0.9807297,0.010498109,0.00015812255,0.0060143783,0.00005668507,0.00026136407,0.000036434743,0.000015670232,0.0022295183],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977095,0.00028230913,0.0008310742,0.00034105993,0.00057684194,0.00025920168],"domain_scores_gemma":[0.99868166,0.00028353595,0.00036235928,0.000196595,0.0003632399,0.00011259316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005461619,0.0002537286,0.0015788327,0.00044997188,0.00013423518,0.00007329994,0.00016102004,0.00011596555,0.0010765704],"category_scores_gemma":[0.00054486294,0.00017630772,0.0007252327,0.0004978369,0.00007113975,0.00016217692,0.000061848434,0.0003722951,0.0000034504087],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015596851,0.0013376476,0.47760278,0.04746875,0.46712542,0.00025450127,0.00051707285,0.00022483035,0.00003061312,0.00051048567,0.0027523956,0.0006158372],"study_design_scores_gemma":[0.01050118,0.000498011,0.26941308,0.004137474,0.7117881,0.00018229565,0.00029391836,0.00036536512,0.00008946027,0.0021226448,0.00018497453,0.00042347793],"about_ca_topic_score_codex":0.000062375555,"about_ca_topic_score_gemma":0.00010902958,"teacher_disagreement_score":0.52792144,"about_ca_system_score_codex":0.00083267014,"about_ca_system_score_gemma":0.00040671253,"threshold_uncertainty_score":0.99983656},"labels":[],"label_agreement":null},{"id":"W4411135866","doi":"10.1016/j.euf.2025.05.024","title":"A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer","year":2025,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Perioperative; Bladder cancer; Meta-analysis; Surgery; Cochrane Library; Systematic review; Stent; Anastomosis; MEDLINE; Randomized controlled trial; Cancer; Internal medicine","score_opus":0.02900287729906161,"score_gpt":0.3189671333558785,"score_spread":0.2899642560568169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411135866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023858735,0.9923181,0.0000047738513,0.00060777145,0.00003321343,0.0056442735,0.00036226516,0.000022583308,0.0007684222],"genre_scores_gemma":[0.001136002,0.99252164,0.00004860071,0.0018167025,0.000014761738,0.0004335296,0.00010465832,0.000056256667,0.0038678218],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99645555,0.001432155,0.00078940444,0.0008634439,0.00017480936,0.00028462915],"domain_scores_gemma":[0.9983885,0.00071498496,0.00033110194,0.00033777513,0.00009316474,0.00013442434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042832768,0.0006155022,0.0058985436,0.0004278489,0.00015662509,0.000034979086,0.0001094093,0.000141993,0.00010175039],"category_scores_gemma":[0.00026084756,0.00037151534,0.00072016905,0.0002946499,0.00014397639,0.000058254125,0.00020802562,0.00033327544,0.000015097367],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037670668,0.00075287546,0.0014217204,0.66337746,0.3238146,0.00038714355,0.0008164779,0.0000012076168,1.4580893e-7,0.000051641775,0.0002856437,0.008714364],"study_design_scores_gemma":[0.0036072233,0.0024988386,0.00064936094,0.01888897,0.9685633,0.000047342022,0.00001888956,0.0000072792623,1.5760932e-7,0.0000021726462,0.0052986997,0.00041772675],"about_ca_topic_score_codex":0.000023366598,"about_ca_topic_score_gemma":0.000016161937,"teacher_disagreement_score":0.64474875,"about_ca_system_score_codex":0.00009551601,"about_ca_system_score_gemma":0.00012515108,"threshold_uncertainty_score":0.9998737},"labels":[],"label_agreement":null},{"id":"W4411282591","doi":"10.1002/jso.70014","title":"Cancer‐Specific Survival of Trimodal Therapy Versus Radical Cystectomy in T2N0M0 Non‐Urothelial Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial cancer; Bladder cancer; Cancer; Urology; Bladder Neoplasm; Oncology; Internal medicine","score_opus":0.04119683191526006,"score_gpt":0.37619251042219287,"score_spread":0.3349956785069328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411282591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540591,0.013160396,0.000054471668,0.0082295835,0.004490361,0.0005254888,0.00003642569,0.000012656118,0.019431517],"genre_scores_gemma":[0.96301484,0.03476677,0.00014023404,0.00029256818,0.0011344864,0.000042739564,0.0000022226684,0.00002472125,0.0005814047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758554,0.00024388652,0.0010452693,0.00025339614,0.00048609727,0.00038583652],"domain_scores_gemma":[0.9983706,0.0005466488,0.00039396653,0.00018510243,0.00029165728,0.00021206278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051939115,0.00024117711,0.0013555934,0.00040145245,0.000039749113,0.00000866666,0.00021865148,0.0003348847,0.0014119814],"category_scores_gemma":[0.000027805201,0.00017237716,0.00039322986,0.0005511561,0.00028573244,0.00007843357,0.000038261132,0.00070983457,0.00000498604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26072976,0.007926014,0.15101694,0.0002684162,0.004838066,0.007680523,0.0012074093,0.00031293972,0.017498363,0.001324034,0.012365516,0.534832],"study_design_scores_gemma":[0.1273235,0.007240127,0.052791905,0.0005034414,0.00039763743,0.00025858436,0.00024323167,0.000043314933,0.0073349425,0.00017385377,0.8034302,0.00025927994],"about_ca_topic_score_codex":0.00055149576,"about_ca_topic_score_gemma":0.00020477953,"teacher_disagreement_score":0.7910647,"about_ca_system_score_codex":0.00081686355,"about_ca_system_score_gemma":0.0028144908,"threshold_uncertainty_score":0.9995009},"labels":[],"label_agreement":null},{"id":"W4411301071","doi":"10.1245/s10434-025-17629-7","title":"ASO Visual Abstract: Perioperative Complications and In-Hospital Mortality after Cystectomy for Non-Bladder Cancer Conditions versus Radical Cystectomy for Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; Bladder cancer; Perioperative; Urology; General surgery; Cancer; Surgery; Internal medicine","score_opus":0.05645719979729757,"score_gpt":0.45520057782394735,"score_spread":0.3987433780266498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411301071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95497054,0.0020528522,0.00010839537,0.029758023,0.0005836239,0.003052176,0.0015682833,0.000031650805,0.007874474],"genre_scores_gemma":[0.9905303,0.0012955281,0.00015240646,0.0013064741,0.00018837559,0.0059826793,0.00012947209,0.000023266906,0.0003915149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834675,0.00004392603,0.0005485182,0.00048702786,0.00015797131,0.0004157994],"domain_scores_gemma":[0.9983605,0.00068460166,0.0001312014,0.00018893117,0.00044712028,0.00018762003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016510996,0.00024919675,0.00076218916,0.00014935835,0.00012439092,0.00001551566,0.00008661984,0.00028333536,0.00043199502],"category_scores_gemma":[0.000037968897,0.00021160845,0.00022951471,0.00021287453,0.00049349613,0.00010277954,0.00004459154,0.00021459686,0.000003161947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14252132,0.0437189,0.43657553,0.0055526644,0.03505025,0.0013537182,0.011541154,0.00044422506,0.010662463,0.018589182,0.12632667,0.16766393],"study_design_scores_gemma":[0.03444193,0.0039744535,0.59535795,0.00033185465,0.0008574451,0.000014834648,0.00043450718,0.00042148336,0.0030469429,0.00036209283,0.3603465,0.0004099959],"about_ca_topic_score_codex":0.0007656047,"about_ca_topic_score_gemma":0.0010961847,"teacher_disagreement_score":0.23401985,"about_ca_system_score_codex":0.0001583843,"about_ca_system_score_gemma":0.0008860512,"threshold_uncertainty_score":0.8629142},"labels":[],"label_agreement":null},{"id":"W4411306911","doi":"10.14740/wjon2515","title":"Assessing the Impact of <i>VEGF</i> -2578C&gt;A (rs699947) and -7C&gt;T (rs2010963) Polymorphisms on Bladder Cancer Susceptibility: A Pilot Study","year":2025,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; VEGF receptors; Cancer research; Oncology; Internal medicine","score_opus":0.04833521330003921,"score_gpt":0.41463680871767605,"score_spread":0.36630159541763685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411306911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792064,0.003738595,0.000026816888,0.0047983583,0.00071018934,0.00065331056,0.000012778424,0.0000117372865,0.010841824],"genre_scores_gemma":[0.9961114,0.00033266202,0.000109003784,0.0012372975,0.0003672185,0.000020169247,0.0000010195539,0.000024077093,0.0017971706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979069,0.0003557748,0.00078193547,0.00026456863,0.00036036037,0.00033045403],"domain_scores_gemma":[0.99815583,0.0004438487,0.0005659068,0.00036091942,0.00030386826,0.00016960212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082701334,0.00026808318,0.000945163,0.00042019153,0.000145864,0.00003777943,0.00019997665,0.00006752187,0.00041248844],"category_scores_gemma":[0.0000982319,0.00015225142,0.0002241829,0.0005129617,0.00025948175,0.00013809017,0.00007531081,0.00058985996,0.0000030475765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00791369,0.010826069,0.80779284,0.00008455431,0.004937779,0.0004925582,0.0020528708,0.000097093565,0.037891425,0.00016470929,0.02061002,0.10713637],"study_design_scores_gemma":[0.0139115555,0.0318745,0.94349825,0.0004665919,0.0017647652,0.0002876679,0.00095591415,0.000026510692,0.0014192367,0.00044602487,0.00516396,0.0001850082],"about_ca_topic_score_codex":0.0010109725,"about_ca_topic_score_gemma":0.001382232,"teacher_disagreement_score":0.1357054,"about_ca_system_score_codex":0.000674862,"about_ca_system_score_gemma":0.0018313557,"threshold_uncertainty_score":0.62086326},"labels":[],"label_agreement":null},{"id":"W4411347849","doi":"10.1007/s00345-025-05495-7","title":"Effect of sex on adverse in-hospital outcomes after radical cystectomy according to urinary diversion type","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrology; Cystectomy; Urinary diversion; Adverse effect; Urinary system; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.005402441295979848,"score_gpt":0.28994039366365815,"score_spread":0.2845379523676783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411347849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938398,0.0004459801,0.000011044973,0.0027677896,0.0007608647,0.00021475347,0.000001682005,0.0000050395015,0.0019530453],"genre_scores_gemma":[0.99817526,0.000028729666,0.00005893801,0.0011048611,0.00006863768,0.0000037803823,5.395221e-7,0.000007604164,0.00055163575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991902,0.00010961095,0.00027932067,0.00011526194,0.00015165184,0.00015391702],"domain_scores_gemma":[0.9994565,0.00021340251,0.00008499432,0.0001183474,0.00004354068,0.000083188956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002059739,0.0001124578,0.00046345213,0.0005481029,0.000016761116,0.0000016742636,0.00008368416,0.000056010238,0.00011448907],"category_scores_gemma":[0.00008856318,0.00007755235,0.00013342251,0.0002755958,0.000039646504,0.00003494403,0.00005424128,0.00025625742,0.000015941729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013896275,0.00037636867,0.9735766,0.00005528036,0.00019876916,0.001226555,0.00016125994,0.000025315207,0.00024586983,0.000014691101,0.00062744954,0.009595546],"study_design_scores_gemma":[0.014794243,0.030944118,0.9362428,0.0003674869,0.00056205,0.00015565069,0.0000852964,0.000009350444,0.0018466236,0.000060401904,0.014804986,0.00012699209],"about_ca_topic_score_codex":0.000012377436,"about_ca_topic_score_gemma":0.000004032702,"teacher_disagreement_score":0.03733382,"about_ca_system_score_codex":0.00009507976,"about_ca_system_score_gemma":0.00007051619,"threshold_uncertainty_score":0.3162493},"labels":[],"label_agreement":null},{"id":"W4411489613","doi":"10.1158/1078-0432.ccr-24-3912","title":"<i>ERBB2</i> /HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Abbotsford Veterinary Clinic; Spinal Cord Injury BC; BC Cancer Agency; Kelowna General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Bladder Cancer Advocacy Network","keywords":"Genotype; Immunohistochemistry; Biology; Cancer; DNA sequencing; Tumour heterogeneity; Cancer research; Biomarker; Fluorescence in situ hybridization; Pathology; DNA; Medicine; Gene; Genetics; Immunology","score_opus":0.1118459611401712,"score_gpt":0.5057213308847733,"score_spread":0.39387536974460213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411489613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871096,0.00589232,0.000052291845,0.0024196976,0.00020000324,0.0015107127,0.00021567677,0.000017392942,0.0025823007],"genre_scores_gemma":[0.99404377,0.002267465,0.00035477255,0.00049714244,0.00010966005,0.00053707795,0.000024611727,0.000023744753,0.0021417795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781644,0.00030721276,0.00055632374,0.00044041872,0.00051983347,0.00035974692],"domain_scores_gemma":[0.9985478,0.00047005017,0.00006785665,0.00031908558,0.00043729637,0.00015793237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066826586,0.00015055026,0.0005817807,0.00023079144,0.00008573469,0.000024468467,0.00012143923,0.00007377341,0.0003692718],"category_scores_gemma":[0.00020626653,0.0001073672,0.00006815272,0.0006238072,0.00048042418,0.000086955326,0.00008182664,0.00047592536,0.0000053992467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038068593,0.0013795439,0.92923623,0.00037423612,0.00054304174,0.000021382722,0.0003209959,0.000016269316,0.00009058417,0.00024895268,0.0017532187,0.062208667],"study_design_scores_gemma":[0.017235087,0.0025508208,0.9561388,0.000984975,0.0004915182,9.2867356e-7,0.00015577185,0.00010084462,0.0026802765,0.00066977774,0.018785253,0.00020597204],"about_ca_topic_score_codex":0.0056641377,"about_ca_topic_score_gemma":0.0034503036,"teacher_disagreement_score":0.062002696,"about_ca_system_score_codex":0.00017353444,"about_ca_system_score_gemma":0.0012397808,"threshold_uncertainty_score":0.85625196},"labels":[],"label_agreement":null},{"id":"W4411540675","doi":"10.1016/j.urology.2025.06.041","title":"Cystectomy and Ileal Conduit for Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review of Outcomes for Different Surgical Approaches","year":2025,"lang":"en","type":"review","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Cystectomy; Electrical conduit; Urinary system; Urinary diversion; Urology; Intensive care medicine; Internal medicine; Bladder cancer","score_opus":0.07648452583275493,"score_gpt":0.3491127451566107,"score_spread":0.2726282193238558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411540675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016542976,0.9875297,0.00010775393,0.00023042726,0.00039699613,0.011226952,0.000247877,0.000030224868,0.00021355838],"genre_scores_gemma":[0.00030855212,0.9914147,0.000023028475,0.0003955085,0.000104920626,0.0059757316,0.00023587255,0.00004645467,0.0014951794],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978573,0.00023161717,0.0009938678,0.0005143105,0.00013522974,0.00026772462],"domain_scores_gemma":[0.99749476,0.0014714563,0.00041406025,0.0004516574,0.000071359056,0.00009670875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022067489,0.00046306927,0.005085105,0.00014658071,0.000042897467,0.000005610225,0.000115265495,0.0003304086,0.00004608632],"category_scores_gemma":[0.00018598342,0.0002772906,0.0011989163,0.00009957907,0.00007803951,0.000017197972,0.000048876056,0.00019971305,0.0000027409087],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017962875,0.00049155945,0.000017316215,0.9873328,0.0014091146,0.000055487973,0.0000072143694,1.6146515e-8,1.8145133e-8,0.00019680345,0.0001586735,0.010151346],"study_design_scores_gemma":[0.0069356128,0.008278318,0.00002334939,0.38440418,0.07640654,0.005093367,0.0000068454215,0.000010654949,4.8610565e-7,0.00006171963,0.5183512,0.0004277269],"about_ca_topic_score_codex":0.0000027756723,"about_ca_topic_score_gemma":6.355879e-7,"teacher_disagreement_score":0.60292864,"about_ca_system_score_codex":0.000051571624,"about_ca_system_score_gemma":0.00024529514,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W4411569967","doi":"10.1097/pas.0000000000002430","title":"International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1","year":2025,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; EMD Serono; Astellas Pharma; Eisai; Gilead Sciences; Exelixis; Genentech; AstraZeneca; Eli Lilly and Company","keywords":"Consensus conference; Medicine; Pathology; Anatomical pathology; Cancer; Internal medicine","score_opus":0.031192016653096184,"score_gpt":0.3320643304242959,"score_spread":0.3008723137711997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411569967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652196,0.0010178024,0.00015971398,0.027805194,0.0006055778,0.00014125364,0.000015283029,0.000011835308,0.005023745],"genre_scores_gemma":[0.9926112,0.0025886134,0.0009953814,0.0032662877,0.0002658453,0.0000111916,0.0000021399521,0.000009485547,0.00024985158],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856496,0.00029295264,0.0005034848,0.00018647761,0.00022941825,0.00022271625],"domain_scores_gemma":[0.9984359,0.00063469005,0.00050535524,0.00018528078,0.00015970877,0.00007906569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048086554,0.00014723792,0.0006657969,0.000103374136,0.000060328744,0.0000048182155,0.0002260753,0.00008061891,0.0001253846],"category_scores_gemma":[0.00006173087,0.000082818944,0.00035518312,0.0002536108,0.0010834122,0.000012045766,0.000068279536,0.00051034434,0.0000039088386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035945456,0.0029234157,0.22773881,0.000055064036,0.0026147105,0.0065698484,0.0014866252,0.00027659163,0.018185617,0.004884678,0.021833736,0.67748547],"study_design_scores_gemma":[0.022360004,0.020493964,0.6523888,0.0009878547,0.0018768886,0.019843519,0.0021705069,0.00023120352,0.0033374717,0.0050800256,0.27067596,0.00055381295],"about_ca_topic_score_codex":0.000015207858,"about_ca_topic_score_gemma":8.650672e-7,"teacher_disagreement_score":0.6769316,"about_ca_system_score_codex":0.00008617611,"about_ca_system_score_gemma":0.00015944432,"threshold_uncertainty_score":0.39918774},"labels":[],"label_agreement":null},{"id":"W4411632146","doi":"10.1016/j.omton.2025.201016","title":"Intravesical VSVd51-GM-CSF virotherapy is superior to BCG in treating bladder cancer in preclinical and translational models","year":2025,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Virotherapy; Bladder cancer; Medicine; Cancer research; Cancer; Urology; Oncology; Oncolytic virus; Internal medicine","score_opus":0.03738937015852793,"score_gpt":0.3985951182135021,"score_spread":0.36120574805497413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411632146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695381,0.004083991,0.0027538275,0.0189978,0.00010291409,0.0011801043,0.000022604989,0.000024191113,0.0032964807],"genre_scores_gemma":[0.97821146,0.0014795614,0.002014774,0.01738823,0.000061830026,0.0004537692,0.000008161188,0.000031394928,0.00035080206],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99845105,0.0001604218,0.00042543747,0.00048414615,0.0001594826,0.0003194668],"domain_scores_gemma":[0.99951077,0.00011338381,0.00003024233,0.00018788924,0.000042655152,0.00011509267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018387476,0.0002148349,0.00054453046,0.00025303097,0.000035697296,0.0000144429805,0.00008376416,0.00025697268,0.00043898114],"category_scores_gemma":[0.0000141650835,0.00018862737,0.00008725438,0.00033682794,0.000092090835,0.00005670264,0.000016654556,0.0002742428,0.000004274628],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006118165,0.0014402831,0.07889246,0.000034748682,0.00050873234,0.000277727,0.0070491256,0.00059681234,0.060143214,0.0010575571,0.0001596055,0.84372157],"study_design_scores_gemma":[0.115457326,0.011391166,0.6748108,0.0009790241,0.0004269461,0.00014501356,0.0008912083,0.018659431,0.09516582,0.025597429,0.054827694,0.0016481074],"about_ca_topic_score_codex":0.00067636435,"about_ca_topic_score_gemma":0.0007488292,"teacher_disagreement_score":0.84207344,"about_ca_system_score_codex":0.00014505936,"about_ca_system_score_gemma":0.0005232905,"threshold_uncertainty_score":0.7692001},"labels":[],"label_agreement":null},{"id":"W4411638092","doi":"10.1016/j.euo.2025.05.028","title":"Radiation Therapy in the Management of Muscle-invasive Bladder Cancer with Carcinoma in Situ: Still a No Go?","year":2025,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Medicine; Bladder cancer; Radiation therapy; Carcinoma in situ; Cancer therapy; Cancer; Oncology; General surgery; Internal medicine","score_opus":0.035201486465901315,"score_gpt":0.3372665991929558,"score_spread":0.3020651127270545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411638092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002031491,0.9021303,0.000002797654,0.00060281897,0.00033370598,0.0026233932,0.000036222107,0.000018132238,0.09222112],"genre_scores_gemma":[0.015518229,0.9805947,0.000055327637,0.0021545135,0.00019531907,0.0005113747,0.00009792507,0.00005776099,0.00081483845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965639,0.0016446905,0.00065970473,0.00058004365,0.00016946976,0.00038215428],"domain_scores_gemma":[0.99860054,0.00038929543,0.00035893908,0.00053397357,0.00006780607,0.000049467042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004723056,0.0004154725,0.0015392216,0.00041642206,0.000026026602,0.0000048334805,0.0003570041,0.0002301738,0.0001662322],"category_scores_gemma":[0.0000209917,0.00025147488,0.00018775692,0.00056062645,0.0001829201,0.000025399895,0.00008071108,0.00060372456,0.00006675801],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005279027,0.0006220275,0.0012160953,0.003744292,0.0008706443,0.0030686324,0.0010066241,0.00000625488,0.0000012819081,0.000069786634,0.0007830758,0.98808336],"study_design_scores_gemma":[0.00595673,0.0036123407,0.038396973,0.0018448301,0.0017519167,0.0000994917,0.00007378399,7.962905e-7,0.0000010729253,0.00000725937,0.94806,0.00019485588],"about_ca_topic_score_codex":0.00015570033,"about_ca_topic_score_gemma":0.0005060153,"teacher_disagreement_score":0.9878885,"about_ca_system_score_codex":0.0003311002,"about_ca_system_score_gemma":0.0009376423,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W4411681345","doi":"10.18203/2349-3933.ijam20251942","title":"Long-term indwelling urinary catheterization and bladder cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Advances in Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urinary catheterization; Urinary system; Urinary Bladder Cancer; Term (time); Cancer; Urology; Bladder cancer; Internal medicine","score_opus":0.014889235946118691,"score_gpt":0.3798289260280285,"score_spread":0.3649396900819098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411681345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91178256,0.06702345,0.004723413,0.01033927,0.0027936778,0.00018553913,0.00000526203,0.000009713824,0.003137123],"genre_scores_gemma":[0.9716442,0.025619432,0.00029849797,0.001487399,0.00058354856,0.0000060464126,0.000005571003,0.0000075899025,0.00034770925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990695,0.000019210464,0.0003908345,0.000111658956,0.00031811968,0.00009065883],"domain_scores_gemma":[0.999326,0.000056374847,0.00016798307,0.00006154922,0.00033456474,0.0000535502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013631105,0.00009656125,0.00024847212,0.00036382864,0.000017694716,0.0000075342596,0.000108838,0.00003807943,0.00014436916],"category_scores_gemma":[0.00008574145,0.00006968716,0.000034696335,0.00013166807,0.000099429344,0.00022632035,0.000024693709,0.00016880035,5.930713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011176069,0.00019679806,0.8287581,0.00008405202,0.00037684667,0.00052639743,0.00068308297,0.00010184444,0.0023488945,0.0001792238,0.00014086558,0.16548629],"study_design_scores_gemma":[0.013205034,0.001358011,0.96012276,0.006456486,0.00043173437,0.000879988,0.0003636454,0.00012818586,0.004084534,0.002736078,0.010066952,0.00016660614],"about_ca_topic_score_codex":0.000020721185,"about_ca_topic_score_gemma":0.000013025111,"teacher_disagreement_score":0.1653197,"about_ca_system_score_codex":0.0001371276,"about_ca_system_score_gemma":0.0001082586,"threshold_uncertainty_score":0.28417596},"labels":[],"label_agreement":null},{"id":"W4411705141","doi":"10.1177/03915603251347444","title":"Comparison of long-term survival for muscle-invasive bladder cancer patients who underwent bladder preservation therapy and radical cystectomy: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Urologia Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jadad scale; Medicine; Bladder cancer; Randomized controlled trial; Meta-analysis; Internal medicine; Cystectomy; Cochrane Library; Observational study; Subgroup analysis; MEDLINE; Oncology; Surgery; Cancer","score_opus":0.15268886820161903,"score_gpt":0.42164936625909777,"score_spread":0.26896049805747874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411705141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017542843,0.9920597,0.00042719056,0.00036636868,0.00012061852,0.0064741117,0.0003330287,0.000014680463,0.000028894718],"genre_scores_gemma":[0.00091083173,0.99667764,0.00008413566,0.00062677247,0.00007374839,0.0010742665,0.00015027478,0.000043804233,0.00035853387],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957864,0.0008456063,0.00187428,0.0005650722,0.00057978806,0.00034883246],"domain_scores_gemma":[0.99607,0.00091278105,0.0018033552,0.0004467609,0.0005397923,0.00022731282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072168274,0.0006508797,0.00981909,0.0004373445,0.00015011981,0.000068356014,0.00024019225,0.0003588332,0.00029365614],"category_scores_gemma":[0.00037575464,0.00037217262,0.0021394237,0.0005316419,0.00013329273,0.000112777896,0.0000813699,0.00053487613,7.9922404e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094659714,0.000537494,0.0038481262,0.6566866,0.3293461,0.000013168963,0.000119090284,0.0000015784951,1.368481e-7,0.000007799577,0.0004307311,0.008914499],"study_design_scores_gemma":[0.0020664686,0.0010631823,0.0024124773,0.030167986,0.96216214,0.000036855403,0.000010347889,0.000006765558,0.0000014163012,0.000016847282,0.0017580697,0.00029744377],"about_ca_topic_score_codex":0.000027192016,"about_ca_topic_score_gemma":0.000051615538,"teacher_disagreement_score":0.6328161,"about_ca_system_score_codex":0.0001467451,"about_ca_system_score_gemma":0.00064662995,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W4411715921","doi":"10.1097/01.cot.0000000000000083","title":"Bladder-Sparing Therapy vs. Radical Cystectomy in BCG-Unresponsive NMIBC","year":2025,"lang":"en","type":"article","venue":"Oncology Times","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Urology; Medicine; Internal medicine; Bladder cancer","score_opus":0.01948410455560918,"score_gpt":0.33617530440799565,"score_spread":0.3166911998523865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411715921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61912787,0.0048387744,0.00006657897,0.015437872,0.0005679643,0.0009977247,0.000007705427,0.00014138808,0.3588141],"genre_scores_gemma":[0.96616566,0.00040882814,0.00059468305,0.0054976097,0.00013738227,0.00016210212,0.000010783459,0.00002065731,0.02700228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988281,0.00015021428,0.00025516137,0.00032164756,0.0001262569,0.00031857728],"domain_scores_gemma":[0.9993005,0.00026667467,0.000045507648,0.00025116742,0.000046750683,0.00008944251],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018018951,0.0001739169,0.0004904747,0.00025444786,0.00006436496,0.000009111526,0.0001081072,0.00023774446,0.0009959547],"category_scores_gemma":[0.0000858702,0.00014148754,0.00009313789,0.00030475733,0.00016015832,0.000030837004,0.00004670548,0.00029585013,0.00014002834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024492227,0.0041586035,0.34258148,0.00015419243,0.0024435257,0.0033677025,0.0036190297,0.00003606472,0.014100554,0.0048075705,0.14496917,0.45526987],"study_design_scores_gemma":[0.026809389,0.0033993484,0.2736096,0.000254491,0.0002378949,0.00018342915,0.00037307988,0.0001665901,0.018031245,0.0016718673,0.67495394,0.00030910416],"about_ca_topic_score_codex":0.0002153116,"about_ca_topic_score_gemma":0.0000838949,"teacher_disagreement_score":0.5299848,"about_ca_system_score_codex":0.00032031108,"about_ca_system_score_gemma":0.00080350455,"threshold_uncertainty_score":0.99991727},"labels":[],"label_agreement":null},{"id":"W4411758919","doi":"10.7759/cureus.86938","title":"Survival Outcomes in Bladder Cancer: An Ambispective Study of Patients Undergoing Radical Cystectomy","year":2025,"lang":"en","type":"article","venue":"Cureus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Cancer; Oncology; Internal medicine","score_opus":0.020911772512164906,"score_gpt":0.3407910924107748,"score_spread":0.3198793198986099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411758919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994274,0.0002933702,0.000015107786,0.00013274512,0.00046071445,0.0008560131,0.000022728871,0.000032337655,0.0039129504],"genre_scores_gemma":[0.9992691,0.000038688013,0.000030359586,0.00012675887,0.000035681103,0.00008792013,0.000009389117,0.000015597529,0.00038648205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988772,0.00008763633,0.00028385327,0.0002906284,0.00026437006,0.00019630579],"domain_scores_gemma":[0.9994174,0.00007313938,0.000057882655,0.00028901154,0.00008929005,0.00007325491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007353174,0.0001543734,0.00046512965,0.00011556791,0.00003939785,0.000007414851,0.0000984508,0.00006590475,0.00011310516],"category_scores_gemma":[0.00006193885,0.00012440527,0.000056016404,0.00026420076,0.000044170552,0.000078848534,0.000045276443,0.00013764261,0.0000025006461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033415327,0.004148565,0.9918747,0.00003528328,0.00046266883,0.000016933216,0.0014895758,0.000007278058,0.000028454877,0.00008955201,0.00007206622,0.0014407974],"study_design_scores_gemma":[0.012943857,0.0015261527,0.9825825,0.00007111228,0.00021738771,2.925664e-7,0.002057687,0.00001455668,0.00026889882,0.00013747164,0.0000882306,0.00009183727],"about_ca_topic_score_codex":0.0046967887,"about_ca_topic_score_gemma":0.013626168,"teacher_disagreement_score":0.012609704,"about_ca_system_score_codex":0.00030797292,"about_ca_system_score_gemma":0.0002516243,"threshold_uncertainty_score":0.76037216},"labels":[],"label_agreement":null},{"id":"W4411831069","doi":"10.1007/s00345-025-05767-2","title":"The effect of race/ethnicity on systemic chemotherapy in urothelial carcinoma patients exposed to radiotherapy","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrology; Internal medicine; Chemotherapy; Oncology; Radiation therapy; Urothelial carcinoma; Race (biology); Ethnic group; Urology; Cancer; Bladder cancer","score_opus":0.00710438534448216,"score_gpt":0.27841161309135154,"score_spread":0.2713072277468694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411831069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119365,0.0026843895,0.00007665281,0.0036822888,0.0007393865,0.0007296269,0.0000039170795,0.0000056727586,0.00088439137],"genre_scores_gemma":[0.99671155,0.00028986973,0.00003617795,0.0021563072,0.00014473447,0.000017314667,6.066969e-7,0.000018332397,0.0006250772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984442,0.00034945094,0.00057998224,0.00015197368,0.00023655295,0.0002378317],"domain_scores_gemma":[0.9988447,0.00046673918,0.00024687417,0.00025260288,0.000105899424,0.00008317687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052198,0.00017063048,0.0006396895,0.00043080322,0.000046139936,0.0000064711876,0.00019751542,0.00007232457,0.00003406412],"category_scores_gemma":[0.00009777418,0.0001005215,0.00017684541,0.00038508352,0.00007019725,0.000023117444,0.000014407846,0.0003125931,0.0000032670212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048576374,0.0004265546,0.8516658,0.000092005605,0.00046084187,0.00007091132,0.00060329755,0.00012737114,0.014469078,0.000102899096,0.0028404798,0.080564395],"study_design_scores_gemma":[0.048927937,0.028110823,0.85888267,0.00042467087,0.00028117263,0.00010163014,0.000032132488,0.000048697817,0.038404442,0.000104299244,0.024501452,0.0001800807],"about_ca_topic_score_codex":0.000031765227,"about_ca_topic_score_gemma":0.000043918237,"teacher_disagreement_score":0.080384314,"about_ca_system_score_codex":0.0002082574,"about_ca_system_score_gemma":0.00014613275,"threshold_uncertainty_score":0.4099148},"labels":[],"label_agreement":null},{"id":"W4411846294","doi":"10.1097/pas.0000000000002440","title":"International Society of Urological Pathology Consensus Meeting 2024","year":2025,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"European Association of Urology","keywords":"Terminology; Medicine; Consensus conference; Pathology; MEDLINE; Family medicine; Internal medicine; Political science","score_opus":0.018332472916728865,"score_gpt":0.3155808175949123,"score_spread":0.29724834467818345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411846294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566391,0.0007004099,0.00018131557,0.026066156,0.00054691266,0.000091265414,0.000011033242,0.000009132843,0.015754636],"genre_scores_gemma":[0.9942678,0.0009816708,0.0018335157,0.0021569207,0.000223551,0.0000031495945,0.0000014882852,0.0000072471084,0.0005246608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865896,0.0002517174,0.00054759206,0.0001471284,0.00019686954,0.00019774352],"domain_scores_gemma":[0.99852204,0.0005294967,0.00047470693,0.00016563252,0.00023891166,0.000069207024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006548417,0.00012116274,0.0006418929,0.00008702858,0.00004527921,0.0000042777333,0.00020308512,0.000065870874,0.00013537698],"category_scores_gemma":[0.000097917036,0.00006854748,0.00036492205,0.00024022744,0.001214478,0.000013091353,0.00008343924,0.00042636436,0.0000048738693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03302397,0.0033112552,0.46982136,0.00014461334,0.005417148,0.023144905,0.003081797,0.00030238967,0.07339835,0.0049363924,0.062430046,0.32098776],"study_design_scores_gemma":[0.031070368,0.022640772,0.4514835,0.0006585408,0.0032372884,0.11827283,0.0076585757,0.000536732,0.008516135,0.011655928,0.3435234,0.0007459141],"about_ca_topic_score_codex":0.000011114901,"about_ca_topic_score_gemma":2.6929445e-7,"teacher_disagreement_score":0.32024187,"about_ca_system_score_codex":0.000048469363,"about_ca_system_score_gemma":0.00017023228,"threshold_uncertainty_score":0.4474795},"labels":[],"label_agreement":null},{"id":"W4411853332","doi":"10.14740/jocmr6263","title":"Survival After Partial Cystectomy Versus Radical Cystectomy for Non-Urothelial Carcinoma of the Bladder: A Population-Based Study","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; Urothelial carcinoma; Urology; Bladder cancer; Internal medicine; Cancer","score_opus":0.14910523070732049,"score_gpt":0.5102302147037557,"score_spread":0.3611249839964352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411853332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98260075,0.00038704928,0.00033947502,0.010242865,0.0031103133,0.0023893723,0.00001974213,0.000008054014,0.00090239116],"genre_scores_gemma":[0.9961753,0.000020071473,0.00016605532,0.0002647675,0.0028529305,0.000114109,0.0000031003426,0.000030008474,0.00037365523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99354,0.0011937966,0.002267602,0.00035620073,0.002164238,0.00047816837],"domain_scores_gemma":[0.99110365,0.0059263576,0.00048741186,0.00063934736,0.0014698207,0.00037343163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006890618,0.00022796342,0.001423072,0.00043818023,0.00015443469,0.0000152366765,0.00047043976,0.00022574967,0.000207226],"category_scores_gemma":[0.008045776,0.00012434948,0.00066884025,0.00081675616,0.00053582276,0.00005659151,0.00010228347,0.0013045415,0.000003421013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05081458,0.0020163166,0.9376529,0.00029062055,0.0009031075,0.0001288033,0.00018251376,0.0000055749315,0.00012613648,0.000037155693,0.001592298,0.0062500066],"study_design_scores_gemma":[0.076120876,0.018105045,0.89825726,0.00094350666,0.0012892531,0.000012700992,0.00056673656,0.00022732721,0.0007646815,0.00014669956,0.0034620978,0.00010383115],"about_ca_topic_score_codex":0.00047748812,"about_ca_topic_score_gemma":0.00014735178,"teacher_disagreement_score":0.039395645,"about_ca_system_score_codex":0.00017878736,"about_ca_system_score_gemma":0.0022852959,"threshold_uncertainty_score":0.9632126},"labels":[],"label_agreement":null},{"id":"W4411871351","doi":"10.1016/j.urology.2025.06.057","title":"Effect of Sex Differences on Cancer Outcomes After Chemo-Radiation for Muscle-Invasive Bladder Cancer: A Retrospective Multicenter Cohort Study","year":2025,"lang":"en","type":"article","venue":"Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Dalhousie University; University of Ottawa; University of British Columbia; McMaster University Medical Centre; Ottawa Hospital; Queen's University; University of Calgary","funders":"Centre National de la Recherche Scientifique; Institute Pasteur De Lille; Université de Sherbrooke; Queen's University; Institut National de la Santé et de la Recherche Médicale; Université de Lille","keywords":"Medicine; Retrospective cohort study; Bladder cancer; Cancer; Radiation therapy; Cohort; Cohort study; Multicenter study; Oncology; Internal medicine; Randomized controlled trial","score_opus":0.008261293471492218,"score_gpt":0.32240893779800256,"score_spread":0.3141476443265103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411871351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382204,0.00046683295,0.000032664822,0.0009873816,0.0006321061,0.0032991248,0.00013865631,0.000031840405,0.0005893801],"genre_scores_gemma":[0.9936542,0.00012343349,0.0000060277926,0.0014366796,0.00011223315,0.003783533,0.000012166459,0.000019597503,0.0008521655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998794,0.00011073982,0.00024398601,0.00043382723,0.00016977818,0.00024767307],"domain_scores_gemma":[0.99910307,0.00038384512,0.00010125965,0.00025507493,0.00010573226,0.000051046452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012317783,0.00022808067,0.0006838248,0.00013503723,0.000048048572,0.000005873917,0.00007403659,0.00011692333,0.00024369],"category_scores_gemma":[0.00012248101,0.00015825823,0.00014144428,0.000115444534,0.00007277605,0.000028458788,0.000026686255,0.00013115785,0.0000041387575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003161523,0.0004777412,0.9850646,0.00009846289,0.0015335709,0.000008202193,0.00077491935,0.000007179427,0.00014634228,0.000006935104,0.00020715599,0.008513342],"study_design_scores_gemma":[0.008475927,0.004890617,0.980298,0.000033987017,0.0015453504,3.9445027e-7,0.00006171324,0.00008531845,0.004294301,0.00003439912,0.00018205571,0.00009796362],"about_ca_topic_score_codex":0.0010586614,"about_ca_topic_score_gemma":0.0008970374,"teacher_disagreement_score":0.008415378,"about_ca_system_score_codex":0.0002190205,"about_ca_system_score_gemma":0.00012935049,"threshold_uncertainty_score":0.6453583},"labels":[],"label_agreement":null},{"id":"W4411925715","doi":"10.1038/s41585-025-01064-0","title":"Promise without practice — charting the path forward for bladder cancer biomarkers","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Internal medicine; Intensive care medicine","score_opus":0.0386491265143727,"score_gpt":0.4263064777783826,"score_spread":0.3876573512640099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411925715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.70828e-8,0.9759243,0.000097614546,0.005179873,0.001329166,0.013048662,0.00020160945,0.00006209573,0.004156573],"genre_scores_gemma":[0.0000017044979,0.97577417,0.00094135327,0.0105724465,0.001141176,0.00900201,0.00021016864,0.00010052788,0.0022564658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633425,0.00076201017,0.0010975025,0.00091964414,0.00025867025,0.0006279023],"domain_scores_gemma":[0.99637026,0.0011461509,0.0011006845,0.00095942896,0.00027231502,0.00015115974],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00130737,0.0007795823,0.0035949643,0.00017672953,0.00020225726,0.000030301835,0.0004032699,0.0013867303,0.0001399596],"category_scores_gemma":[0.0027981878,0.00039871508,0.0014082417,0.000581361,0.00011362628,0.000074089745,0.000104316445,0.0018002423,0.0000526243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020806336,0.00009244893,0.000011008942,0.035398204,0.0019827618,0.000016553417,0.00004138892,2.2583894e-8,2.8783344e-7,0.000097428594,0.03274461,0.92940724],"study_design_scores_gemma":[0.0010463385,0.00029490612,0.000002149382,0.0105936965,0.024765696,0.0002583993,0.000006381909,0.000003360355,6.9325336e-7,0.000029971014,0.9627127,0.00028573032],"about_ca_topic_score_codex":0.000024840747,"about_ca_topic_score_gemma":0.000020236712,"teacher_disagreement_score":0.92996806,"about_ca_system_score_codex":0.00022947339,"about_ca_system_score_gemma":0.0014991161,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W4411974173","doi":"10.3390/curroncol32070384","title":"Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Merck KGaA; Johns Hopkins University","keywords":"Medicine; Metastatic Urothelial Carcinoma; Urothelial carcinoma; Urothelial cancer; Oncology; Systemic therapy; Cancer; Internal medicine; Retrospective cohort study; Bladder cancer","score_opus":0.07389743370804301,"score_gpt":0.4253334390539458,"score_spread":0.3514360053459028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411974173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267685,0.00019288929,0.0000071425693,0.00019963134,0.00018533974,0.0060634147,0.00059802405,0.00002502851,0.000051703442],"genre_scores_gemma":[0.99863523,0.00052099593,0.000009887273,0.00006640148,0.000046826794,0.00051674177,0.000118065065,0.00002757201,0.000058277565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700063,0.0008466611,0.0010266528,0.000591235,0.00025283365,0.00028195832],"domain_scores_gemma":[0.99728894,0.0013357685,0.0005202103,0.00056250574,0.00021934447,0.00007324898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050341303,0.00037600865,0.0013780465,0.00021685853,0.000119688666,0.000022524013,0.00022759842,0.000052973646,0.000023542301],"category_scores_gemma":[0.00008927941,0.00015029212,0.00007680332,0.00054473936,0.00034050917,0.000075374875,0.00005747543,0.00038490215,8.903254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029730402,0.0067808214,0.9478999,0.0000343608,0.0020049014,0.00003590365,0.011301037,0.00047330977,4.1872374e-7,0.0000020899063,0.00005995107,0.0016769129],"study_design_scores_gemma":[0.07650377,0.016562006,0.89161247,0.00033433342,0.0011713406,0.0000011793053,0.013382198,0.00026124986,0.0000024291057,0.000008562633,0.000028687271,0.00013178961],"about_ca_topic_score_codex":0.046538074,"about_ca_topic_score_gemma":0.1127316,"teacher_disagreement_score":0.06619352,"about_ca_system_score_codex":0.00041929082,"about_ca_system_score_gemma":0.000637794,"threshold_uncertainty_score":0.9598111},"labels":[],"label_agreement":null},{"id":"W4412044663","doi":"10.1007/s11701-025-02512-0","title":"Extracorporeal vs. intracorporeal urinary diversion at robot-assisted radical cystectomy: adverse in-hospital outcomes","year":2025,"lang":"en","type":"article","venue":"Journal of Robotic Surgery","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Extracorporeal; Adverse effect; Surgery; Urinary system; General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.016492730891948564,"score_gpt":0.27245452019385125,"score_spread":0.25596178930190266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412044663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856944,0.0008062994,0.000341749,0.0048088296,0.0034541707,0.00032716955,0.00000639649,0.00003693904,0.0016490328],"genre_scores_gemma":[0.99689704,0.00027768477,0.0008228805,0.00048399018,0.00020688829,0.0000065358518,0.000016667778,0.000026132517,0.0012622043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756485,0.00012225605,0.0010542943,0.00027418995,0.0005814436,0.00040298424],"domain_scores_gemma":[0.99815786,0.0006080301,0.0005021081,0.00027561432,0.00015585234,0.00030052816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049399585,0.00029399758,0.0011641976,0.0007607518,0.00009415705,0.00001450829,0.00014454173,0.00020174499,0.00023319827],"category_scores_gemma":[0.000212908,0.00022352852,0.00067510456,0.000474416,0.0001424518,0.00021514404,0.00010337675,0.00047148124,0.000021417276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025053949,0.0019457695,0.9612326,0.00012738575,0.0005026828,0.008485007,0.00010352917,0.00021312558,0.00019254892,0.00001747663,0.011442169,0.013232294],"study_design_scores_gemma":[0.0044080955,0.00072453835,0.9906509,0.0007710859,0.0005236653,0.0012303606,0.00009334387,0.000060737922,0.00021471473,0.00009800562,0.0010426209,0.0001819311],"about_ca_topic_score_codex":0.00009942485,"about_ca_topic_score_gemma":0.000013975646,"teacher_disagreement_score":0.029418282,"about_ca_system_score_codex":0.000851889,"about_ca_system_score_gemma":0.00073154544,"threshold_uncertainty_score":0.91152287},"labels":[],"label_agreement":null},{"id":"W4412075413","doi":"10.1136/bcr-2025-267448","title":"From immunotherapy to autoimmunity: reactive arthritis following intravesical BCG","year":2025,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Oligoarthritis; Immunotherapy; Malignancy; Reactive arthritis; Arthritis; Discontinuation; Autoimmunity; Bladder cancer; Immunology; Cancer; Dermatology; Internal medicine; Polyarthritis; Immune system","score_opus":0.016925893681472872,"score_gpt":0.33797016291366794,"score_spread":0.3210442692321951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412075413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794994,0.0012445312,0.00058661075,0.001636074,0.00094935263,0.0011358261,0.00001378636,0.00013000106,0.0148044415],"genre_scores_gemma":[0.9946388,0.00004369269,0.0011817035,0.0016595043,0.00022685507,0.00019001412,0.000043018033,0.000028533776,0.0019878808],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985911,0.000053147276,0.0004793293,0.0003839418,0.00024047056,0.00025198088],"domain_scores_gemma":[0.9988888,0.000083036226,0.00009194868,0.00072250207,0.000068705725,0.0001449897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021636672,0.00019653172,0.00046700027,0.0001270982,0.0001339327,0.000036482812,0.000029525962,0.00011176371,0.0002255652],"category_scores_gemma":[0.0001557084,0.00017822423,0.00021666469,0.0002587849,0.000030348832,0.00007477526,0.000047369056,0.00020734496,0.000035432524],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037883862,0.00028010664,0.003337546,0.000012313794,0.00085283443,0.7919259,0.0012077279,8.562754e-7,0.010075053,0.000028973825,0.0022321835,0.18966767],"study_design_scores_gemma":[0.00976211,0.0013804015,0.08602007,0.0029808532,0.0011558175,0.65878856,0.0027397738,0.00003666109,0.08714991,0.006519632,0.14239891,0.001067311],"about_ca_topic_score_codex":0.0055701095,"about_ca_topic_score_gemma":0.00010025758,"teacher_disagreement_score":0.18860036,"about_ca_system_score_codex":0.00020790084,"about_ca_system_score_gemma":0.00042789578,"threshold_uncertainty_score":0.8420376},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4412119459","doi":"10.1111/bju.16851","title":"Impact of timing of computed tomography staging and patient factors on the detection of ‘true’ <scp>cN</scp>+ bladder cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Concordance; Lymph node; Bladder cancer; Pathological; Logistic regression; Lymph; Radiology; Pathological staging; Odds ratio; Confidence interval; Lymphovascular invasion; Metastasis; Urology; Internal medicine; Cancer; Pathology","score_opus":0.014150036114835935,"score_gpt":0.27692823130789546,"score_spread":0.2627781951930595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412119459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376494,0.0052445843,0.00026601824,0.00010272091,0.00019749643,0.0001509822,0.000043386,0.0000034508091,0.00022640341],"genre_scores_gemma":[0.9992498,0.000528478,0.000032927404,0.00014038903,0.000028876873,0.0000019757404,0.000001093337,0.000008546235,0.000007889279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991018,0.00008813055,0.0004151157,0.00009513667,0.00016526076,0.00013454485],"domain_scores_gemma":[0.9989695,0.00023958241,0.00040561284,0.00008546871,0.00024799688,0.000051819243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001056416,0.00009551464,0.00039172833,0.00023012112,0.000038889662,0.0000054858338,0.000060348266,0.0000679781,0.000030292815],"category_scores_gemma":[0.00009478929,0.00007124335,0.00018534172,0.00021580987,0.00012946145,0.000037132322,0.000021780084,0.00020948869,4.9624045e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008252563,0.00083492236,0.73934,0.00017476248,0.004099593,0.00010579798,0.0020499392,0.0006012584,0.038383696,0.000023579396,0.0015792036,0.21198201],"study_design_scores_gemma":[0.0018809072,0.0032424775,0.96965194,0.0003123126,0.00040285572,0.000209253,0.00027535507,0.000108725486,0.023626253,0.00011445888,0.00014843284,0.000027045311],"about_ca_topic_score_codex":0.000985512,"about_ca_topic_score_gemma":0.000052080784,"teacher_disagreement_score":0.23031195,"about_ca_system_score_codex":0.000034723915,"about_ca_system_score_gemma":0.00012525193,"threshold_uncertainty_score":0.29052195},"labels":[],"label_agreement":null},{"id":"W4412119987","doi":"10.1111/iju.70176","title":"Efficacy of Metastasectomy for Metastatic Bladder Cancer: A Systematic Review and Meta‐Analysis","year":2025,"lang":"en","type":"review","venue":"International Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Shandong Province","keywords":"Metastasectomy; Medicine; Hazard ratio; Confidence interval; Cochrane Library; Meta-analysis; Bladder cancer; Oncology; Metastasis; Internal medicine; MEDLINE; Cohort; Surgery; General surgery; Cancer","score_opus":0.06909311461656324,"score_gpt":0.4305751784645445,"score_spread":0.36148206384798126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412119987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.0614037e-7,0.99513614,0.00086894556,0.0009967657,0.00020766504,0.0019394918,0.00079439057,0.0000041359026,0.000052079453],"genre_scores_gemma":[0.000052549585,0.99730456,0.0006312655,0.0011306519,0.00007186119,0.00036644505,0.00006985434,0.00002190779,0.00035088928],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99712247,0.00033426864,0.0017705258,0.00023525757,0.00039110333,0.00014640778],"domain_scores_gemma":[0.9954363,0.0012932364,0.0020522734,0.00023156458,0.0008905066,0.000096098884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005959033,0.0003325479,0.008566779,0.00096553494,0.000016128275,0.000012254569,0.00034071534,0.00009589194,0.000360436],"category_scores_gemma":[0.0005190411,0.00019786326,0.0036639317,0.0003734451,0.00006591156,0.00004796537,0.000051245883,0.00023281074,0.0000013419436],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008796897,0.00014192738,8.3839166e-7,0.39020738,0.60487634,0.00005176553,0.000011859205,0.0000022125164,8.0571354e-8,0.000076526325,0.0002604183,0.004282702],"study_design_scores_gemma":[0.0012118086,0.00031777108,0.0000012408635,0.02091744,0.9318337,0.0005706144,0.0000024519143,0.000002073224,9.504587e-7,0.00004806581,0.04499917,0.000094715084],"about_ca_topic_score_codex":0.000027412814,"about_ca_topic_score_gemma":0.000010833987,"teacher_disagreement_score":0.36928993,"about_ca_system_score_codex":0.00008465661,"about_ca_system_score_gemma":0.0007619401,"threshold_uncertainty_score":0.80686295},"labels":[],"label_agreement":null},{"id":"W4412176223","doi":"10.5489/cuaj.9110","title":"A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; McMaster University; Juravinski Cancer Centre; McGill University Health Centre; Dalhousie University; University Health Network; University of Toronto; University of British Columbia; Foothills Medical Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Janssen Canada","keywords":"Bladder cancer; Medicine; Population; Cancer; Oncology; Internal medicine; Environmental health","score_opus":0.003222219888236911,"score_gpt":0.20744145678113524,"score_spread":0.20421923689289834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412176223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964345,0.00008601287,0.000015993948,0.0012575637,0.00011162576,0.00021051358,0.0017576219,0.0000019139538,0.00012425096],"genre_scores_gemma":[0.9980537,0.00001674105,0.000035348323,0.0013594542,0.000029637888,0.000013310016,0.00043884476,0.0000073001515,0.000045635137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869084,0.00010235089,0.00040373736,0.00018312686,0.00037202318,0.00024791042],"domain_scores_gemma":[0.9985099,0.0002613179,0.0004157647,0.00012432372,0.0004639778,0.00022475857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006682683,0.00013239114,0.00053166767,0.0003955832,0.00006920361,0.0000101269125,0.00008207805,0.00013494595,0.00055109174],"category_scores_gemma":[0.00019920568,0.00010212373,0.000115409166,0.0006288756,0.0000102064,0.000033438493,0.0000055571186,0.00024308308,2.6720514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017932245,0.00005805491,0.99391824,0.0000097003995,0.00164683,0.0000082808165,0.00012902741,0.0029226125,0.0000011524668,0.0000033142337,0.00012378597,0.0009997032],"study_design_scores_gemma":[0.0029959183,0.0002605726,0.9941801,0.00006868365,0.0020682306,4.7126576e-8,0.00010061989,0.00008367739,0.00003264586,0.00001619312,0.0001114643,0.00008184719],"about_ca_topic_score_codex":0.9933589,"about_ca_topic_score_gemma":0.99807996,"teacher_disagreement_score":0.004721022,"about_ca_system_score_codex":0.002487936,"about_ca_system_score_gemma":0.003428682,"threshold_uncertainty_score":0.6505866},"labels":[],"label_agreement":null},{"id":"W4412195973","doi":"10.3390/curroncol32070394","title":"Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Bursa Uludağ Üniversitesi","keywords":"Medicine; Internal medicine; Bladder cancer; Oncology; Propensity score matching; Stage (stratigraphy); Proportional hazards model; Hazard ratio; Malignancy; T-stage; Carcinoma; Multivariate analysis; Pathological; Cancer; Confidence interval","score_opus":0.05230929089663148,"score_gpt":0.3297196339396206,"score_spread":0.2774103430429891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412195973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527764,0.00029208497,0.00001955298,0.0003269747,0.0004788761,0.0008666926,0.000027667562,0.00001185567,0.0026986788],"genre_scores_gemma":[0.99948585,0.0000058065016,0.000021038659,0.00009098405,0.0000148126155,0.000044912325,0.000026645019,0.000008385241,0.00030154717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988277,0.00015323678,0.0003018876,0.00027781964,0.00022152433,0.00021783222],"domain_scores_gemma":[0.9991948,0.00007602592,0.00013095056,0.0004039209,0.00014060271,0.000053706648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009861517,0.00016522821,0.0007480786,0.00020838315,0.000043117805,0.0000035732655,0.00014342935,0.00007731555,0.000049182734],"category_scores_gemma":[0.000032627107,0.000093525385,0.00016653269,0.0007510488,0.00012563795,0.000027090928,0.000113204216,0.00020800471,0.000003158746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008530624,0.0043662866,0.9922618,0.000109271015,0.00025787967,0.000010446991,0.0002758768,0.000007878207,0.000008423831,0.0000146996745,0.00009321324,0.001741139],"study_design_scores_gemma":[0.007840478,0.001211978,0.9886078,0.000024946794,0.0015794915,6.4397085e-7,0.00006017426,0.000018279447,0.0002558846,0.000019566358,0.0003030131,0.00007772796],"about_ca_topic_score_codex":0.0002920961,"about_ca_topic_score_gemma":0.000444064,"teacher_disagreement_score":0.0069874157,"about_ca_system_score_codex":0.0002486164,"about_ca_system_score_gemma":0.00046846992,"threshold_uncertainty_score":0.38138545},"labels":[],"label_agreement":null},{"id":"W4412201614","doi":"10.1158/1055-9965.epi-25-0210","title":"Long-term Trends in Bladder Cancer Incidence Using a Harmonized Staging Variable: A SEER-Based Study","year":2025,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Surveillance, Epidemiology, and End Results; Epidemiology; Bladder cancer; Incidence (geometry); AJCC staging system; Cancer registry; Cancer; Demography; Staging system; Internal medicine; Mathematics","score_opus":0.08773693803541169,"score_gpt":0.44083693925201173,"score_spread":0.3531000012166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412201614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96498424,0.016501775,0.0124805765,0.0026609574,0.0012385456,0.001694134,0.000040634157,0.00012356047,0.00027559936],"genre_scores_gemma":[0.9923916,0.00036629647,0.002469822,0.0018684254,0.00013810479,0.0011426567,0.000096497984,0.00004343151,0.0014831838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613965,0.0010169192,0.0009848011,0.00095920905,0.00019236769,0.00070704595],"domain_scores_gemma":[0.99850106,0.00031772244,0.00035393605,0.0005232508,0.00014570048,0.00015835614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015959138,0.0004152647,0.0010413505,0.0008044485,0.00015763893,0.000016375549,0.00019557601,0.00027492424,0.00087853806],"category_scores_gemma":[0.00020573998,0.0003836557,0.00022619538,0.0014173203,0.00014729226,0.00017431115,0.00008567299,0.0003549062,0.0000035595774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017385744,0.0007040558,0.9409314,0.00014160722,0.0014566038,0.00005052366,0.00012654337,0.00033051337,0.0015266053,0.000017412238,0.00056158024,0.052414577],"study_design_scores_gemma":[0.009944426,0.00031951774,0.9812688,0.0015777645,0.0015266729,0.0000038120652,0.000099306526,0.0039406624,0.0004548892,0.00042105382,0.0001431159,0.00029992842],"about_ca_topic_score_codex":0.006140922,"about_ca_topic_score_gemma":0.0025420606,"teacher_disagreement_score":0.05211465,"about_ca_system_score_codex":0.0014573161,"about_ca_system_score_gemma":0.0012065349,"threshold_uncertainty_score":0.99986154},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4412391234","doi":"10.3390/cancers17142332","title":"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Pfizer","keywords":"Javelin; Immune system; Medicine; Immunotherapy; Avelumab; Chromatin; Epigenetics; Immune checkpoint; Cancer research; Biomarker; Immunology; Transcriptome; Oncology; Gene; Biology; Gene expression; Nivolumab; Genetics","score_opus":0.009618753222674975,"score_gpt":0.24232013199182542,"score_spread":0.23270137876915045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412391234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927515,0.00077581475,0.000048716516,0.00019558979,0.00023857194,0.000862787,0.00029776245,0.000041815318,0.004787467],"genre_scores_gemma":[0.9972469,0.000017723884,0.0003796343,0.00095408375,0.00006651503,0.00014646897,0.00017111342,0.000041265746,0.0009762523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986537,0.000043374846,0.00025666525,0.0004090324,0.00029754825,0.00033967657],"domain_scores_gemma":[0.9992441,0.000047570284,0.00009210191,0.00036351438,0.0001542934,0.0000984099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045063254,0.00024662126,0.00036976617,0.00016460377,0.00008869014,0.000023815253,0.00010741455,0.00007605479,0.00032443667],"category_scores_gemma":[0.000022679405,0.00018611691,0.000054224933,0.00051767426,0.00009557445,0.00005973286,0.000023949822,0.0001709709,0.000022353022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019236215,0.00020227204,0.99415,0.000020004458,0.0007698733,0.00003463685,0.00033451148,0.00005850743,0.00029656218,0.00001554351,0.00042086403,0.0017735906],"study_design_scores_gemma":[0.013877739,0.0006371899,0.9819599,0.00018105775,0.00068083097,7.043078e-7,0.000097572294,0.000038425387,0.0015999129,0.00004789433,0.0006770922,0.00020168768],"about_ca_topic_score_codex":0.008997169,"about_ca_topic_score_gemma":0.0014827461,"teacher_disagreement_score":0.012190119,"about_ca_system_score_codex":0.0011549644,"about_ca_system_score_gemma":0.0018952339,"threshold_uncertainty_score":0.997602},"labels":[],"label_agreement":null},{"id":"W4412430993","doi":"10.1158/1078-0432.ccr-24-3726","title":"Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"René Vogels Stichting; Deutsche Forschungsgemeinschaft","keywords":"Bladder cancer; Cystectomy; Medicine; Neoadjuvant therapy; Oncology; Gene expression profiling; Pathology; Internal medicine; Cancer; Gene expression; Biology; Gene; Breast cancer","score_opus":0.08110261616488323,"score_gpt":0.4377643613611631,"score_spread":0.35666174519627986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412430993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867806,0.005271935,0.00005156117,0.003923527,0.000370346,0.0025923157,0.00027861143,0.00005109154,0.0006800219],"genre_scores_gemma":[0.98198354,0.008652049,0.000072537325,0.0010593559,0.00023508274,0.0036465318,0.00007118049,0.00006149957,0.0042182403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652016,0.00041924143,0.0007219726,0.0007799617,0.00094742,0.0006112719],"domain_scores_gemma":[0.9978386,0.00017541517,0.00012953918,0.00055382494,0.001093743,0.00020885783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007673188,0.00027128353,0.00070282124,0.0002983117,0.00013424204,0.0000642134,0.00024956104,0.00023118794,0.0012592154],"category_scores_gemma":[0.00008473275,0.00019797066,0.00021553553,0.0009363357,0.0006532813,0.00016516529,0.00007107061,0.00065639295,0.000015474661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022779653,0.0025909252,0.45510858,0.0014431629,0.0031556927,0.0002680368,0.0015991133,0.000012154372,0.41521072,0.000055515513,0.0048146346,0.092961825],"study_design_scores_gemma":[0.00913011,0.002221597,0.61395395,0.002203074,0.00044293297,0.000002949517,0.00028627933,0.000039206174,0.36607087,0.00009670078,0.005254238,0.0002980869],"about_ca_topic_score_codex":0.0016206013,"about_ca_topic_score_gemma":0.0007832855,"teacher_disagreement_score":0.1588454,"about_ca_system_score_codex":0.00021041239,"about_ca_system_score_gemma":0.0028539216,"threshold_uncertainty_score":0.99965376},"labels":[],"label_agreement":null},{"id":"W4412442827","doi":"10.1016/j.jval.2025.04.424","title":"EE132 Creation of a Novel Canadian Policy Model for Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of British Columbia; University of Waterloo; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Computer science; Business; Cancer; Medicine; Internal medicine","score_opus":0.0708554990239001,"score_gpt":0.3963069757825291,"score_spread":0.325451476758629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51646894,0.014912902,0.07357918,0.3071191,0.0016138903,0.015186525,0.0044679893,0.00017077052,0.06648072],"genre_scores_gemma":[0.98915875,0.00033143393,0.0023231755,0.005103795,0.00008970917,0.00019282664,0.000024463225,0.000013761237,0.0027620988],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992369,0.000013611174,0.00025234642,0.00015301057,0.000083745654,0.0002604236],"domain_scores_gemma":[0.99955744,0.000031927477,0.00004999358,0.00014482325,0.0000695266,0.00014628847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012860638,0.00007929185,0.00022694633,0.00034948712,0.00004393335,0.0000030484787,0.000039832805,0.00005759546,0.000014030585],"category_scores_gemma":[0.000054764663,0.00007360315,0.000043786433,0.00030162826,0.000020525118,0.00002360247,0.000005326994,0.000060884326,5.8311554e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024957831,0.0028822916,0.20322847,0.00875464,0.0010221887,0.000008578996,0.01889161,0.375995,0.0017980798,0.184633,0.029861303,0.17042904],"study_design_scores_gemma":[0.010220362,0.00046378715,0.04239578,0.001341014,0.000106155945,0.0000033391318,0.00016218013,0.93139106,0.0007560942,0.0041373945,0.008854935,0.00016790614],"about_ca_topic_score_codex":0.87543786,"about_ca_topic_score_gemma":0.19572163,"teacher_disagreement_score":0.6797162,"about_ca_system_score_codex":0.00097166863,"about_ca_system_score_gemma":0.009026788,"threshold_uncertainty_score":0.9965911},"labels":[],"label_agreement":null},{"id":"W4412444010","doi":"10.1016/j.jval.2025.04.018","title":"P12 Development and Prospective Evaluation of the Bladder Utility Symptom Scale (Utility): A Novel Tool to Measure Utilities and Quality of LIfe in Bladder Cancer Patients","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University of Waterloo; McGill University Health Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Measure (data warehouse); Quality of life (healthcare); Scale (ratio); Medicine; Quality (philosophy); Intensive care medicine; Cancer; Computer science; Data mining; Internal medicine; Nursing; Geography; Cartography","score_opus":0.09442651486090517,"score_gpt":0.36225017490191336,"score_spread":0.2678236600410082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993424,0.0022498418,0.000029976449,0.00076052913,0.00012426027,0.0028599116,0.00009647127,0.0000073422893,0.00044764884],"genre_scores_gemma":[0.99893314,0.00005560671,0.0002627749,0.00043178527,0.000010391216,0.00024403949,0.000003979171,0.000007852266,0.00005040911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976304,0.00035797484,0.00079326803,0.00036593789,0.0006241091,0.00022828346],"domain_scores_gemma":[0.99898195,0.00011176844,0.00016492292,0.00026100816,0.00038928614,0.000091065915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020094546,0.00015383796,0.0004998521,0.00014139964,0.00006139197,0.000005670238,0.00006237203,0.000078487625,0.000024450464],"category_scores_gemma":[0.0005482445,0.00011574124,0.00003449781,0.00045788678,0.00012035709,0.000053877124,0.00007620093,0.00014593049,1.8073547e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054843165,0.00062367984,0.97078407,0.000739942,0.00008128236,3.0253283e-8,0.007960375,0.000027068447,0.00003584627,0.00010519393,0.00002112449,0.019072948],"study_design_scores_gemma":[0.0048728697,0.0001208447,0.99134636,0.00075394864,0.00004685931,1.3647434e-7,0.0007173786,0.0005732135,0.0011380705,0.00029421487,0.000059822556,0.00007625907],"about_ca_topic_score_codex":0.018166723,"about_ca_topic_score_gemma":0.0055545126,"teacher_disagreement_score":0.020562304,"about_ca_system_score_codex":0.0004900629,"about_ca_system_score_gemma":0.0027364062,"threshold_uncertainty_score":0.9883714},"labels":[],"label_agreement":null},{"id":"W4412530106","doi":"10.1038/s41591-025-03894-2","title":"Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial","year":2025,"lang":"en","type":"erratum","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Crest; Bladder cancer; Medicine; Randomized controlled trial; Internal medicine; Cancer; Oncology; Urology; Physics","score_opus":0.014041024302534993,"score_gpt":0.33804032956082053,"score_spread":0.3239993052582855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412530106","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00832044,0.18151328,0.00025706715,0.0852486,0.5468762,0.028707884,0.0016207554,0.0004961157,0.14695969],"genre_scores_gemma":[0.10003374,0.045381635,0.000104121245,0.013315249,0.054426298,0.004860679,0.004588916,0.00031387576,0.7769755],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935885,0.0008352307,0.0015633362,0.0014094539,0.001716981,0.00088651717],"domain_scores_gemma":[0.99437404,0.002216944,0.0009929714,0.0013759567,0.00064631796,0.0003937816],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001541672,0.0012582127,0.004439618,0.0009119704,0.0003795719,0.00004950716,0.000645381,0.0027706677,0.0023813075],"category_scores_gemma":[0.005115926,0.00072201394,0.00072038453,0.0016201108,0.0008418904,0.00010541787,0.00015734002,0.009183365,0.000035238365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29189414,0.0005312018,0.000022067661,0.00026564364,0.0015372573,0.00034143115,0.0010704783,0.000004485092,0.000014028788,0.000023695035,0.6935565,0.010739055],"study_design_scores_gemma":[0.6544635,0.002037685,0.00036242156,0.0040855757,0.00662999,0.000034303623,0.00044244275,0.00020624748,0.00009128247,0.00018070107,0.33102933,0.0004365125],"about_ca_topic_score_codex":0.01611372,"about_ca_topic_score_gemma":0.006245476,"teacher_disagreement_score":0.6300158,"about_ca_system_score_codex":0.0013704278,"about_ca_system_score_gemma":0.005733039,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W4412606172","doi":"10.1245/s10434-025-17841-5","title":"Adverse In-hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Cystectomy; Dissection (medical); General surgery; Lymph node; Adverse effect; Surgery; Bladder cancer; Internal medicine; Cancer","score_opus":0.03278689098915606,"score_gpt":0.3809048498694131,"score_spread":0.34811795888025704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412606172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496145,0.00014730259,0.000014292196,0.022310147,0.00057574705,0.0003519669,0.000009227108,0.000031080122,0.026945716],"genre_scores_gemma":[0.9968543,0.00023761111,0.000053196905,0.0013032873,0.00008410234,0.00006987748,0.000009652338,0.000010202863,0.0013777391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883306,0.0000646091,0.00037772857,0.0002742719,0.00014970991,0.0003006362],"domain_scores_gemma":[0.99934775,0.00018802455,0.00006696597,0.00017576395,0.00008576745,0.00013572366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001514365,0.00014296401,0.0005879826,0.00019298492,0.00004175557,0.0000027937244,0.000070771755,0.0001517533,0.00019473079],"category_scores_gemma":[0.00004321201,0.000114236565,0.00018535148,0.00031710288,0.00005766201,0.000052775424,0.00009130362,0.000099981975,0.00006344613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030922543,0.001308275,0.97052246,0.00007376381,0.0002331419,0.00071779615,0.00027381934,0.00003711822,0.00043030895,0.00039836997,0.0015279286,0.021384774],"study_design_scores_gemma":[0.01161074,0.0021991539,0.7371193,0.00022183868,0.0001567846,0.00006648562,0.0004925299,0.000036188772,0.00815912,0.00017558731,0.23953417,0.00022806608],"about_ca_topic_score_codex":0.00029371047,"about_ca_topic_score_gemma":0.00005626916,"teacher_disagreement_score":0.23800623,"about_ca_system_score_codex":0.00020608482,"about_ca_system_score_gemma":0.00017332274,"threshold_uncertainty_score":0.4658432},"labels":[],"label_agreement":null},{"id":"W4412616566","doi":"10.1007/s00345-025-05815-x","title":"Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lions Gate Hospital","funders":"","keywords":"Medicine; Urothelial carcinoma; Nephrology; Urology; Urothelial cancer; Internal medicine; Urothelium; Oncology; Surgery; Urinary system; Cancer; Bladder cancer","score_opus":0.03445919398845159,"score_gpt":0.35329254931129345,"score_spread":0.31883335532284185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412616566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96298635,0.0025380212,0.0004464491,0.01779734,0.0023847388,0.0016418792,0.00005018257,0.000013692418,0.012141357],"genre_scores_gemma":[0.99014246,0.0001494303,0.004721273,0.0032906255,0.00020904146,0.00004265299,0.000004532788,0.000019020083,0.0014209773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850327,0.00010875088,0.0007024173,0.00021624223,0.0001817441,0.00028755717],"domain_scores_gemma":[0.9979518,0.0009635057,0.0004054154,0.00020210417,0.00034827326,0.00012891204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026201582,0.00020303704,0.00096936064,0.00032086673,0.00005293352,0.000015956095,0.0003966799,0.00012231516,0.00023358961],"category_scores_gemma":[0.000364858,0.0001444017,0.00036054375,0.00020714366,0.00014481643,0.00011955346,0.000098771256,0.00029489858,0.0000030088624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1781453,0.002899839,0.7097793,0.00023974321,0.0032178897,0.00081997074,0.0004998937,0.000070931885,0.01598713,0.0023826296,0.013625059,0.07233229],"study_design_scores_gemma":[0.0747696,0.025824843,0.72276396,0.00015346332,0.001960321,0.00024684318,0.00017888218,0.000014479681,0.0051721428,0.0012589284,0.16740945,0.0002470724],"about_ca_topic_score_codex":0.000029856139,"about_ca_topic_score_gemma":0.00019670263,"teacher_disagreement_score":0.1537844,"about_ca_system_score_codex":0.00013234644,"about_ca_system_score_gemma":0.0012125841,"threshold_uncertainty_score":0.588853},"labels":[],"label_agreement":null},{"id":"W4412639766","doi":"10.3390/curroncol32080415","title":"Prognostic Utility of Combining VI-RADS Scores and CYFRA 21-1 Levels in Bladder Cancer: A Retrospective Single-Center Study","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science","keywords":"Medicine; Bladder cancer; Proportional hazards model; Retrospective cohort study; Hazard ratio; Single Center; Internal medicine; Cancer; Receiver operating characteristic; Cytokeratin; Oncology; Magnetic resonance imaging; Urology; Multivariate analysis; Biomarker; Gastroenterology; Radiology; Immunohistochemistry; Confidence interval","score_opus":0.11930202583976532,"score_gpt":0.42199134055547766,"score_spread":0.30268931471571237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412639766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129635,0.0034209327,0.00003499338,0.00035915023,0.00085268926,0.0015607603,0.00005055607,0.000026439486,0.0023981112],"genre_scores_gemma":[0.9993908,0.000119899676,0.000028924493,0.00008737696,0.00005301063,0.00024063353,0.000006819347,0.000011012098,0.00006155502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986643,0.00014365702,0.00037806702,0.00040003925,0.0001565694,0.00025733872],"domain_scores_gemma":[0.9993758,0.00010775368,0.00010600562,0.00019712385,0.00014188969,0.00007140188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018081095,0.0001759467,0.0006127626,0.00018382272,0.000043650056,0.000007710358,0.0000730856,0.00008722705,0.000107972024],"category_scores_gemma":[0.00015214985,0.00015100982,0.000050519568,0.00030984156,0.00018779497,0.000044891538,0.00010150988,0.00027850588,0.0000015693499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045956366,0.005949365,0.94927824,0.00015285787,0.00021342208,0.00002338471,0.0020744957,2.4261885e-7,0.00013736298,0.000047564292,0.00030308755,0.041360438],"study_design_scores_gemma":[0.009695483,0.0025813712,0.9847451,0.00047728827,0.00030679526,0.0000074596496,0.00063974544,0.0000815795,0.00022983026,0.00027822243,0.0008648712,0.00009226011],"about_ca_topic_score_codex":0.0002207741,"about_ca_topic_score_gemma":0.0007626935,"teacher_disagreement_score":0.041268177,"about_ca_system_score_codex":0.00035534508,"about_ca_system_score_gemma":0.00042637845,"threshold_uncertainty_score":0.6158002},"labels":[],"label_agreement":null},{"id":"W4412658061","doi":"10.1016/j.ejso.2025.110345","title":"Robot-assisted vs. open radical cystectomy: octogenarians vs. non octogenarians","year":2025,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Adverse effect; Blood transfusion; Surgery; Bladder cancer; Internal medicine; Poisson regression; Propensity score matching; Cancer; Population","score_opus":0.032492819392001424,"score_gpt":0.3385506488633111,"score_spread":0.30605782947130966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412658061","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07909371,0.0015054911,0.0032887356,0.07492138,0.0032696095,0.0012982097,0.000032485073,0.00008949438,0.8365009],"genre_scores_gemma":[0.98337483,0.0007046008,0.0025482744,0.0048936196,0.00094223756,0.0000074443574,0.000014067465,0.00006299008,0.0074519604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963801,0.0011689508,0.0012096547,0.0003812583,0.0003742615,0.0004857799],"domain_scores_gemma":[0.9980489,0.00027936432,0.0004534392,0.00038460764,0.00029155923,0.0005421055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015563918,0.00031760318,0.0013115476,0.00031014107,0.00016675296,0.000079507874,0.00072400755,0.0001610752,0.0008493258],"category_scores_gemma":[0.000092478585,0.00023052657,0.0004445683,0.00049640064,0.00026274414,0.00014871212,0.00030480415,0.00085328845,0.00017346253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053833712,0.006627502,0.014023572,0.00022434203,0.0041827373,0.17061904,0.0010602551,0.00009453359,0.007251178,0.0012620677,0.10787535,0.6329457],"study_design_scores_gemma":[0.0296464,0.007351413,0.05602151,0.00034968436,0.0007007284,0.008107127,0.000082379054,0.00001911672,0.00055215193,0.000045486657,0.89693093,0.000193045],"about_ca_topic_score_codex":0.000042454136,"about_ca_topic_score_gemma":0.000011365605,"teacher_disagreement_score":0.9042811,"about_ca_system_score_codex":0.00049649435,"about_ca_system_score_gemma":0.0014361021,"threshold_uncertainty_score":0.94006},"labels":[],"label_agreement":null},{"id":"W4412724750","doi":"10.1080/14796694.2025.2535280","title":"SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"Seagen; Pfizer","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Antibody-drug conjugate; Chemotherapy; Metastatic Urothelial Carcinoma; Antibody; Immunotherapy; Cancer; Urothelial carcinoma; Monoclonal antibody; Immunology; Bladder cancer","score_opus":0.012634334458240302,"score_gpt":0.3140959120053023,"score_spread":0.301461577547062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412724750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9257101,0.0028907002,0.0008506494,0.009862917,0.0014494288,0.0024450198,0.000068319445,0.0001721851,0.056550693],"genre_scores_gemma":[0.98759353,0.00007661296,0.0044351597,0.002497759,0.00040262908,0.00025243702,0.00004963448,0.000046050987,0.0046462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826217,0.00015777216,0.00037315997,0.00050209515,0.00021843065,0.00048636968],"domain_scores_gemma":[0.99918664,0.00010363524,0.000101741345,0.00037453923,0.00009502425,0.00013841536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010628311,0.00031258113,0.0007475092,0.00022044641,0.0000917405,0.000018708773,0.00015057628,0.00017287597,0.00044240497],"category_scores_gemma":[0.000040857536,0.00020683347,0.000076184675,0.00043681348,0.00012725584,0.00009024121,0.000054154138,0.00040426737,0.000032483927],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15266189,0.008232995,0.10664618,0.0018147908,0.0016463469,0.015011286,0.00499958,0.0002586305,0.012675911,0.0030927202,0.012493292,0.68046635],"study_design_scores_gemma":[0.17936681,0.020782067,0.3336727,0.0016528156,0.0020677757,0.0015716917,0.005134701,0.000379234,0.0064258208,0.00067538343,0.4471184,0.0011525821],"about_ca_topic_score_codex":0.00028061104,"about_ca_topic_score_gemma":0.0017968271,"teacher_disagreement_score":0.6793138,"about_ca_system_score_codex":0.0005394647,"about_ca_system_score_gemma":0.001814924,"threshold_uncertainty_score":0.84344244},"labels":[],"label_agreement":null},{"id":"W4412728021","doi":"10.1111/bju.16867","title":"Response to Hof et al.: spurious associations between <scp>BCG</scp> instillations and outcomes in non‐muscle‐invasive bladder cancer","year":2025,"lang":"en","type":"letter","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Bladder cancer; Spurious relationship; Medicine; Urology; Internal medicine; Cancer; Computer science","score_opus":0.017700447217908612,"score_gpt":0.3078181022736918,"score_spread":0.2901176550557832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412728021","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2794415,0.0025630668,0.000054355394,0.71438414,0.00060549844,0.000598581,0.0016682765,0.000016355945,0.00066821725],"genre_scores_gemma":[0.12080337,0.0031264513,0.0003078099,0.8710418,0.0008903502,0.000061001407,0.0001429075,0.00006806068,0.0035582809],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9973221,0.0004876008,0.0008750107,0.0003911806,0.000442942,0.00048116475],"domain_scores_gemma":[0.9965736,0.0021112482,0.0005132831,0.00020616845,0.00040570792,0.00018998781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005484134,0.0003149898,0.001291782,0.00080638356,0.0001071597,0.000066565335,0.0001906725,0.0006469556,0.000049365433],"category_scores_gemma":[0.0020369168,0.00034331062,0.00024456184,0.00033185328,0.000095674004,0.00010831571,0.00009264782,0.002085769,0.000007844451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007510491,0.000088524204,0.11951451,0.000026777385,0.0010839778,0.0045256037,0.00043139773,0.000027829523,0.00003206191,9.4658645e-7,0.869571,0.00462228],"study_design_scores_gemma":[0.0024874853,0.0005436833,0.5996715,0.00024065864,0.00060085946,0.00057769375,0.000020974338,5.484315e-7,0.0000058815917,0.00011802773,0.39565402,0.000078704266],"about_ca_topic_score_codex":0.0013295687,"about_ca_topic_score_gemma":0.001906603,"teacher_disagreement_score":0.48015696,"about_ca_system_score_codex":0.000341825,"about_ca_system_score_gemma":0.0014823269,"threshold_uncertainty_score":0.9999019},"labels":[],"label_agreement":null},{"id":"W4412840492","doi":"10.5489/cuaj.9166","title":"Frailty and nutritional status predict postoperative complications in radical cystectomy patients","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cystectomy; Medicine; General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.012322891525313762,"score_gpt":0.26005229990159157,"score_spread":0.2477294083762778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412840492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516238,0.0003972859,0.000060801474,0.038433135,0.00015325504,0.00040646084,0.00026700215,0.000015486237,0.008642757],"genre_scores_gemma":[0.99039465,0.0000832023,0.00018257312,0.0088985115,0.00005411594,0.00002885537,0.00009434748,0.0000045699867,0.00025915002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894136,0.00011475204,0.0002560726,0.00016555889,0.00020158522,0.00032064546],"domain_scores_gemma":[0.9990968,0.00011161675,0.000067573266,0.00005750536,0.00021715046,0.00044932537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014224713,0.00009785677,0.000195868,0.00022026699,0.00021026438,0.000045657383,0.00004698618,0.00015983976,0.0002105355],"category_scores_gemma":[0.00036296897,0.0000818255,0.000049102586,0.00022225603,0.00004868004,0.00006845827,0.000010820683,0.00042530737,0.000010131821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063185296,0.00013764322,0.9917658,0.0000028245715,0.00006625982,0.000015001792,0.00006339366,0.000002598405,0.000011063071,0.0005261887,0.005492082,0.0018539532],"study_design_scores_gemma":[0.0038366418,0.00022854008,0.9346369,0.000027578702,0.000035143374,0.000021681,0.00002952404,0.000053426436,0.000005194012,0.0012012838,0.059866715,0.000057404774],"about_ca_topic_score_codex":0.0013029373,"about_ca_topic_score_gemma":0.0012061065,"teacher_disagreement_score":0.05712894,"about_ca_system_score_codex":0.00138958,"about_ca_system_score_gemma":0.00076833076,"threshold_uncertainty_score":0.3633703},"labels":[],"label_agreement":null},{"id":"W4412853562","doi":"10.5489/cuaj.9145","title":"The Impact of bladder cuff management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","year":2025,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University","funders":"","keywords":"Urothelial carcinoma; Cuff; Urology; Medicine; Oncology; Bladder cancer; Internal medicine; Surgery; Cancer","score_opus":0.030215990643838207,"score_gpt":0.34715901926093873,"score_spread":0.3169430286171005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412853562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028346092,0.97506464,0.00003892407,0.003934207,0.002560097,0.0048674303,0.0008425451,0.000046529396,0.009811027],"genre_scores_gemma":[0.023211936,0.966316,0.00022180937,0.002323434,0.0012885708,0.00052258495,0.00020131955,0.000085837186,0.005828505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967519,0.00047137658,0.0009766824,0.00039713638,0.00053726893,0.00086563226],"domain_scores_gemma":[0.99653214,0.0016852877,0.00071880606,0.00029079564,0.00015358481,0.00061940413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009381362,0.00054060033,0.0019475184,0.0004169623,0.0005270411,0.00012167979,0.00038834452,0.0007342275,0.0002733336],"category_scores_gemma":[0.00081627164,0.0002779762,0.0036330838,0.000311267,0.00005499146,0.00004744368,0.000028475051,0.0010591766,0.000023378734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033646185,0.0005282394,0.09777541,0.0009460343,0.01216666,0.00052782777,0.00006099721,0.000007830186,1.5140593e-7,0.00039174707,0.057540353,0.8297183],"study_design_scores_gemma":[0.0030047568,0.0019444837,0.068859875,0.0008600288,0.0044287844,0.00008523563,0.000018230006,0.000003989195,2.4210956e-7,0.00043793724,0.92008096,0.00027548094],"about_ca_topic_score_codex":0.00049545657,"about_ca_topic_score_gemma":0.00007190393,"teacher_disagreement_score":0.8625406,"about_ca_system_score_codex":0.004533832,"about_ca_system_score_gemma":0.0033057267,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W4412910124","doi":"10.1093/mam/ozaf048.446","title":"Improved Prediction of Trimodality Therapy Response in Muscle-Invasive Bladder Cancer Using Deep Learning and Pathology-Optimized Expansion Microscopy","year":2025,"lang":"en","type":"article","venue":"Microscopy and Microanalysis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Microscopy; Cancer therapy; Medicine; Pathology; Cancer; Internal medicine","score_opus":0.015842234496393687,"score_gpt":0.31973196533548986,"score_spread":0.3038897308390962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412910124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809532,0.015784854,0.0023571157,0.00018077214,0.00008570974,0.0005188498,0.00007036005,0.000026020109,0.000023073153],"genre_scores_gemma":[0.98550653,0.010469303,0.0032806892,0.00028497606,0.000022161641,0.000049540384,0.00003193078,0.000022600014,0.00033227023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823636,0.00032651398,0.0005036507,0.0005552791,0.00009169056,0.00028650204],"domain_scores_gemma":[0.99923205,0.00014559359,0.00018037812,0.00022921879,0.00013359546,0.000079140955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000465144,0.00026720355,0.00073575554,0.00044865345,0.00016429812,0.000027709553,0.000053955526,0.00021699621,0.000058810765],"category_scores_gemma":[0.00008119008,0.00023345248,0.00014836031,0.0005429891,0.00022271227,0.00008801319,0.00005559765,0.00025117214,2.9061337e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074196984,0.00018283437,0.080030635,0.00008168544,0.0004538034,0.000012461646,0.0013429044,0.000026766516,0.9042665,6.7617754e-7,0.000008382718,0.0061736708],"study_design_scores_gemma":[0.011566332,0.0005213314,0.12278759,0.0003505653,0.001242617,0.00001822707,0.0011907043,0.0015799945,0.8603597,0.00002688548,0.00016293881,0.00019307918],"about_ca_topic_score_codex":0.0015983599,"about_ca_topic_score_gemma":0.00014925956,"teacher_disagreement_score":0.043906745,"about_ca_system_score_codex":0.00015660589,"about_ca_system_score_gemma":0.00030107083,"threshold_uncertainty_score":0.95199156},"labels":[],"label_agreement":null},{"id":"W4412981359","doi":"10.1016/j.jpurol.2025.07.030","title":"Early outcomes and risk factors for complications following pediatric neurogenic bladder reconstruction: A secondary analysis of the pediatric NSQIP database (2015–2020)","year":2025,"lang":"en","type":"article","venue":"Journal of Pediatric Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; London Health Sciences Centre; Western University","funders":"American College of Surgeons","keywords":"Medicine; MEDLINE; Database; Pediatrics; General surgery","score_opus":0.0154376472613589,"score_gpt":0.29412079233454785,"score_spread":0.278683145073189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412981359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897438,0.0063429284,0.00086229894,0.0009939852,0.0012074198,0.0004336946,0.00030862328,0.000013739846,0.00009350734],"genre_scores_gemma":[0.9940041,0.004330909,0.00057921396,0.0002798502,0.00066812756,0.000017075105,0.00001421059,0.000019881827,0.00008665691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980404,0.0001656201,0.0009425587,0.00030785298,0.00027021082,0.00027335642],"domain_scores_gemma":[0.997264,0.000920991,0.00095660705,0.00041603015,0.00028601877,0.00015633265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035233345,0.00023377058,0.0007936776,0.0011401512,0.0002057481,0.000018663077,0.00023901128,0.00015392735,0.00005740594],"category_scores_gemma":[0.00048205617,0.00015925842,0.00088435237,0.0018957716,0.000062870226,0.0001472552,0.00008831562,0.00048279366,0.0000011925517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014422093,0.00018512529,0.99285764,0.000032708223,0.004897384,0.00000890539,0.0001168953,0.000022264834,0.000013880766,0.000021018981,0.0011686244,0.0005313429],"study_design_scores_gemma":[0.0032655066,0.0003978946,0.9190968,8.223583e-7,0.076604895,0.000065612745,0.000058654103,0.00006443703,0.00000903289,0.000174725,0.00016481586,0.0000967944],"about_ca_topic_score_codex":0.000079070305,"about_ca_topic_score_gemma":0.000022099735,"teacher_disagreement_score":0.073760815,"about_ca_system_score_codex":0.000048893206,"about_ca_system_score_gemma":0.0006519236,"threshold_uncertainty_score":0.64943695},"labels":[],"label_agreement":null},{"id":"W4413013628","doi":"10.1016/j.euros.2025.07.010","title":"Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment—A Systematic Review of Current Evidence","year":2025,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Bladder cancer; Immunotherapy; Medicine; Cancer immunotherapy; Current (fluid); Oncology; Cancer; Internal medicine; Urology","score_opus":0.05932284707882495,"score_gpt":0.3986393449284024,"score_spread":0.33931649784957746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413013628","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2817613,0.692036,0.0001473219,0.0040665767,0.00060400466,0.0065162876,0.000011833981,0.000024384215,0.01483234],"genre_scores_gemma":[0.92602694,0.07185628,0.00018755152,0.0013533154,0.000013909502,0.00007801945,9.836283e-7,0.000013972611,0.00046903608],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99797744,0.00033114763,0.00077173027,0.00043853206,0.0002080742,0.00027310493],"domain_scores_gemma":[0.9988629,0.00011277374,0.00024186297,0.0006185009,0.00009408912,0.00006984846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013280759,0.00017037343,0.00087841006,0.00022060124,0.000033927183,0.000016987568,0.00087606924,0.000019313122,0.000100902675],"category_scores_gemma":[0.00031786002,0.0001238215,0.000069505666,0.0012453069,0.00027492456,0.00021784693,0.00022857486,0.00015643748,0.000010732356],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00257908,0.0028188797,0.47194928,0.20806144,0.0006892391,0.0004312201,0.009611115,0.00024453364,0.04926556,0.0017242569,0.00086317473,0.2517622],"study_design_scores_gemma":[0.011035209,0.003404616,0.32409003,0.65250516,0.00079088996,0.000062638115,0.00015398284,0.00040640304,0.0052748104,0.0001159267,0.0017201243,0.0004401844],"about_ca_topic_score_codex":0.0019295465,"about_ca_topic_score_gemma":0.00018442329,"teacher_disagreement_score":0.64426565,"about_ca_system_score_codex":0.0002721901,"about_ca_system_score_gemma":0.0020575903,"threshold_uncertainty_score":0.5049294},"labels":[],"label_agreement":null},{"id":"W4413052266","doi":"10.1007/s00345-025-05860-6","title":"Contemporary rates and predictors of prolonged hospital stay after radical cystectomy: a population-based analysis","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Percentile; Cystectomy; Logistic regression; Bladder cancer; Population; Surgery; Internal medicine; Cancer","score_opus":0.007160263234330286,"score_gpt":0.26813378997225557,"score_spread":0.2609735267379253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413052266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918074,0.006132223,0.00023304869,0.0036576276,0.00020108005,0.00021599175,0.000015449294,0.000007667206,0.0003561477],"genre_scores_gemma":[0.9988108,0.000026022526,0.0002078536,0.00064632867,0.0000757574,0.000009532202,0.000009084043,0.0000073321644,0.00020725388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901396,0.000111754474,0.00047300084,0.00012711908,0.00015633121,0.0001178231],"domain_scores_gemma":[0.9992808,0.00012922473,0.00024593604,0.00012042099,0.00012943445,0.00009414637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018594421,0.0001098158,0.000570375,0.00073010067,0.000022765167,0.000005736909,0.000052608837,0.0000668039,0.0000984972],"category_scores_gemma":[0.00006589706,0.000080250764,0.00018224285,0.0005062485,0.000113371214,0.000045799836,0.000013887294,0.00018812413,3.5969168e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003123043,0.00022068279,0.9932738,0.00004062591,0.00212067,0.00012642688,0.00009304701,0.000025553803,0.00006381735,0.000014749948,0.00042366894,0.00047390617],"study_design_scores_gemma":[0.0043846313,0.0013647111,0.9897667,0.000042443822,0.0022138476,0.00001406014,0.000014402081,0.00013471124,0.00017867789,0.0000818478,0.0017531739,0.000050802],"about_ca_topic_score_codex":0.00006281511,"about_ca_topic_score_gemma":0.000057597605,"teacher_disagreement_score":0.009630071,"about_ca_system_score_codex":0.000037377264,"about_ca_system_score_gemma":0.00027555658,"threshold_uncertainty_score":0.32725313},"labels":[],"label_agreement":null},{"id":"W4413055622","doi":"10.1245/s10434-025-18065-3","title":"ASO Visual Abstract: Adverse In-Hospital Outcomes After Radical Cystectomy: A Contemporary Versus Historical Population-Based Analysis","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Medicine; Surgical oncology; General surgery; Oncology; Internal medicine; Bladder cancer","score_opus":0.041291133321693194,"score_gpt":0.38515506927512094,"score_spread":0.34386393595342774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413055622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96235824,0.00096933625,0.000015439282,0.022330709,0.00056537596,0.00039790533,0.000026369777,0.00004127099,0.013295347],"genre_scores_gemma":[0.99830085,0.000075769254,0.00007343286,0.0008691355,0.000060864288,0.00007281818,0.00007467495,0.000011045175,0.00046139877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829525,0.000097779804,0.00068405876,0.00035267722,0.00029037066,0.00027985097],"domain_scores_gemma":[0.99868846,0.0006527178,0.00014593464,0.00021448388,0.000117394804,0.0001810106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022200267,0.00020001312,0.0011256061,0.0005281484,0.0000272367,0.0000035587518,0.000083066916,0.00030279506,0.0005332625],"category_scores_gemma":[0.00006905822,0.00016183608,0.0005830383,0.00072028185,0.00009948168,0.000063179556,0.000032079573,0.00025144804,0.000014770545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011346062,0.0031655957,0.9757608,0.00005408565,0.0013728632,0.0017404413,0.000057954618,0.000027433513,0.000004031754,0.000103793485,0.0017784191,0.0045884843],"study_design_scores_gemma":[0.012119675,0.0017839113,0.8918977,0.000044837103,0.0005419515,0.0000018461225,0.000028994387,0.000081191596,0.000052955507,0.000044380617,0.093262345,0.00014021916],"about_ca_topic_score_codex":0.0019730113,"about_ca_topic_score_gemma":0.00019293887,"teacher_disagreement_score":0.09148392,"about_ca_system_score_codex":0.0004804438,"about_ca_system_score_gemma":0.00062382425,"threshold_uncertainty_score":0.6599484},"labels":[],"label_agreement":null},{"id":"W4413111668","doi":"10.1016/j.esmoop.2025.105544","title":"Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Genentech; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Eisai; Daiichi-Sankyo; Arena Pharmaceuticals; G1 Therapeutics; Incyte; Sanofi; Exelixis; Merck KGaA; Gilead Sciences; Ipsen; Mirati Therapeutics; Clovis Oncology; EUSA Pharma; Seagen; Roche; Pfizer; Eli Lilly and Company; AstraZeneca; National Cancer Institute; Accuray","keywords":"Medicine; Pembrolizumab; Internal medicine; Carboplatin; Gemcitabine; Oncology; Metastatic Urothelial Carcinoma; Clinical endpoint; Chemotherapy; Phases of clinical research; Population; Cisplatin; Cancer; Gastroenterology; Bladder cancer; Randomized controlled trial; Urothelial carcinoma; Immunotherapy","score_opus":0.06668643470950594,"score_gpt":0.42626148429913696,"score_spread":0.35957504958963105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990616,0.00013273525,0.00017530247,0.00021852035,0.00009203909,0.0071938587,0.000034083605,0.00002692955,0.0015104929],"genre_scores_gemma":[0.99806124,0.00002438111,0.00040425023,0.00026156503,0.000009715417,0.00081029464,0.00005400724,0.000029172406,0.0003453656],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977903,0.00026374916,0.00064139307,0.0005301793,0.0004303183,0.00034407945],"domain_scores_gemma":[0.9989562,0.000077321594,0.00015987095,0.00047993692,0.00020155207,0.0001251225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040059947,0.00032605365,0.0009334638,0.00030353034,0.000046858935,0.00004026121,0.00032523373,0.000043429136,0.00019767028],"category_scores_gemma":[0.00008749377,0.00024217898,0.000061027065,0.0015007819,0.000056070654,0.00024850568,0.000082650986,0.00012938016,0.0000073775113],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6861902,0.025281202,0.20622477,0.0003240409,0.0024555898,0.0011376619,0.012224059,0.0009218,0.0009498282,0.00016494632,0.00019862615,0.06392731],"study_design_scores_gemma":[0.63953775,0.03746598,0.2988008,0.0010338349,0.0015393974,0.000014278612,0.006724923,0.0009014869,0.013260018,0.00011419814,0.00010823503,0.0004990889],"about_ca_topic_score_codex":0.0122400755,"about_ca_topic_score_gemma":0.024215588,"teacher_disagreement_score":0.09257601,"about_ca_system_score_codex":0.0007203572,"about_ca_system_score_gemma":0.0017166891,"threshold_uncertainty_score":0.9943375},"labels":[],"label_agreement":null},{"id":"W4413126067","doi":"10.5194/egusphere-2025-3396-ac3","title":"Reply on CEC2","year":2025,"lang":"en","type":"peer-review","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Environment and Climate Change Canada","funders":"","keywords":"Geology","score_opus":0.04055595280947484,"score_gpt":0.3613032272099114,"score_spread":0.3207472744004366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413126067","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.8408733e-7,0.038392857,0.0000068070512,0.21237525,0.001845126,0.0007798963,0.00018519629,0.00009903629,0.74631524],"genre_scores_gemma":[0.000012481765,0.017438699,0.000103526865,0.2006182,0.000496772,0.000091091286,0.00073438376,0.000022590792,0.7804823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998743,0.000021863096,0.00025634578,0.0004252242,0.00036552016,0.00018806942],"domain_scores_gemma":[0.9989343,0.000042579064,0.00005922484,0.00073850655,0.0001229159,0.00010243828],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000078259814,0.00027579934,0.00072301197,0.00009744737,0.000028751225,0.000007894521,0.00009666141,0.00015051519,0.008216928],"category_scores_gemma":[0.0000921861,0.00018527763,0.00027014886,0.00014368798,0.000017992157,0.000009217773,0.000034605386,0.0003413002,0.00078116136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044249395,0.00010527838,0.000013744283,0.003479344,0.00022777665,0.000054681674,0.0000028095299,1.2661184e-8,4.1260537e-7,0.00008745406,0.9646028,0.031381436],"study_design_scores_gemma":[0.0007494143,0.0003718827,0.00008343763,0.012357589,0.0009830388,0.00001376747,0.0000013682723,2.1874366e-7,0.000081284,0.0000459979,0.9851799,0.00013209927],"about_ca_topic_score_codex":0.00057769415,"about_ca_topic_score_gemma":0.000021998147,"teacher_disagreement_score":0.03416702,"about_ca_system_score_codex":0.00014764794,"about_ca_system_score_gemma":0.00057676464,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W4413257758","doi":"10.1038/s41585-025-01075-x","title":"HER2 and urothelial carcinoma: current understanding and future directions","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Current (fluid); Oncology; Carcinoma; Internal medicine; Urology; Bladder cancer; Cancer","score_opus":0.05308732763137469,"score_gpt":0.3771578376860292,"score_spread":0.3240705100546545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413257758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.5682955e-7,0.9912455,0.000021934582,0.0009243986,0.00212586,0.0024670786,0.000106874846,0.000050655304,0.003057107],"genre_scores_gemma":[0.000010479388,0.9966215,0.00007320821,0.0006910594,0.001780593,0.00029389406,0.00010753841,0.000046874215,0.00037485635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978096,0.0003686218,0.0005778792,0.0007623131,0.00013909364,0.000342477],"domain_scores_gemma":[0.99892527,0.00018350255,0.00023956633,0.00042124998,0.000038040394,0.0001923434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023321078,0.0006097936,0.0028769453,0.00033741698,0.00016367066,0.000024705945,0.000101810096,0.0011360872,0.00007285182],"category_scores_gemma":[0.00009339274,0.00040845148,0.00044843915,0.00042885478,0.00012585011,0.000036974518,0.00010021379,0.001989743,0.000014164927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022534867,0.000051808533,0.00006677822,0.030298466,0.00017005306,0.000025302883,0.000030872103,5.9968597e-10,2.752785e-8,0.0012156722,0.0032773835,0.9648411],"study_design_scores_gemma":[0.0006518001,0.00019537049,0.000039992083,0.0050289053,0.0059281792,0.0007239599,0.0000057312773,2.4225292e-7,4.278632e-8,0.00016816423,0.98701644,0.00024115822],"about_ca_topic_score_codex":0.000008419818,"about_ca_topic_score_gemma":0.000019611614,"teacher_disagreement_score":0.9837391,"about_ca_system_score_codex":0.0002368057,"about_ca_system_score_gemma":0.0004496526,"threshold_uncertainty_score":0.99983674},"labels":[],"label_agreement":null},{"id":"W4413270555","doi":"10.1245/s10434-025-18072-4","title":"ASO Author Reflections: Adverse In-Hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Surgical oncology; Cystectomy; Dissection (medical); General surgery; Lymph node; Adverse effect; Radiology; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.057659563933416744,"score_gpt":0.430299136690873,"score_spread":0.37263957275745624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9308173,0.0001917995,0.000041794035,0.039643086,0.0009721235,0.00048093768,0.000012183554,0.000055618417,0.027785175],"genre_scores_gemma":[0.9950264,0.00024018982,0.00014307168,0.0011252107,0.000116681185,0.00013444597,0.000011837393,0.000013185252,0.0031889752],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860066,0.00010145582,0.0004603807,0.00033344998,0.0001709694,0.00033307273],"domain_scores_gemma":[0.9992002,0.00023039979,0.000087033884,0.00020570878,0.00012227296,0.00015435297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021684276,0.0001650813,0.000614668,0.00028813066,0.000079449026,0.000004537201,0.00007494243,0.00019886043,0.00018268981],"category_scores_gemma":[0.000084036925,0.00013561122,0.00021350392,0.0005175354,0.00006601218,0.000071890485,0.000088626155,0.00014272516,0.000066834065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006530829,0.003007284,0.9470701,0.00014674534,0.0005940839,0.0009514991,0.0007547499,0.000100496,0.0015974056,0.0011088792,0.0046424493,0.03349545],"study_design_scores_gemma":[0.010368328,0.0030455964,0.48014843,0.0002861505,0.00023949958,0.000116921925,0.00087163196,0.00004276116,0.008720332,0.00036248824,0.49550754,0.0002903192],"about_ca_topic_score_codex":0.00038100732,"about_ca_topic_score_gemma":0.00012990595,"teacher_disagreement_score":0.4908651,"about_ca_system_score_codex":0.00032426757,"about_ca_system_score_gemma":0.00023654231,"threshold_uncertainty_score":0.5530065},"labels":[],"label_agreement":null},{"id":"W4413309124","doi":"10.1136/bmjopen-2025-099524","title":"Ward AdmiSsion of Haematuria: an Observational mUlticentre sTudy (WASHOUT) – study protocol","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Urology Foundation; Rosetrees Trust","keywords":"Medicine; Observational study; Workforce; Emergency medicine; Prospective cohort study; Intensive care medicine; Surgery; Internal medicine","score_opus":0.23100104648737554,"score_gpt":0.5332020112058654,"score_spread":0.3022009647184899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413309124","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36469108,0.0000029799085,0.0000072277667,0.0004536327,0.0000982758,0.627894,0.000012326195,0.000029430006,0.0068110623],"genre_scores_gemma":[0.653617,1.2257165e-7,0.0006403438,0.00031115205,0.00006952205,0.3388447,0.000019613051,0.000016624044,0.006480897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985878,0.00015745459,0.00040681407,0.00032070634,0.00038860814,0.00013862536],"domain_scores_gemma":[0.99899864,0.000030177114,0.00011621294,0.0005685789,0.00018051504,0.000105866115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004088474,0.00014921698,0.00041699884,0.000064523956,0.00008250776,0.00003783545,0.0002801736,0.000046424822,0.0004354793],"category_scores_gemma":[0.0001125445,0.000106139414,0.00004648579,0.00021588009,0.000014367748,0.00017045069,0.00026854206,0.00008256583,0.000012204325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007434033,0.013283492,0.967737,0.00022745419,0.0003852552,0.00006087201,0.0032191346,0.000006507397,0.00018496568,0.000031047195,0.0031088055,0.004321436],"study_design_scores_gemma":[0.026839152,0.0035322458,0.95756274,0.00036206405,0.0003386572,0.0000037560612,0.00694147,0.00010031586,0.00095310534,0.00007453826,0.0031666607,0.0001252786],"about_ca_topic_score_codex":0.00046102572,"about_ca_topic_score_gemma":0.000409532,"teacher_disagreement_score":0.2890493,"about_ca_system_score_codex":0.00006727566,"about_ca_system_score_gemma":0.00065643666,"threshold_uncertainty_score":0.4768193},"labels":[],"label_agreement":null},{"id":"W4413350557","doi":"10.1245/s10434-025-18032-y","title":"The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes After Radical Cystectomy and Ileal Conduit Urinary Diversion","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Urinary diversion; Surgical oncology; Adverse effect; Electrical conduit; Urology; Surgery; General surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.014148786783695022,"score_gpt":0.3330052441108451,"score_spread":0.31885645732715007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413350557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858589,0.0035825658,3.2978085e-7,0.007304092,0.00016158636,0.0004935224,0.000017096834,0.000007904552,0.00257398],"genre_scores_gemma":[0.9962844,0.0029575971,0.000002084763,0.00026405105,0.000033218566,0.00004797923,0.0000043075606,0.0000053943336,0.0004009451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905694,0.00016797268,0.00023438518,0.00019263319,0.00015527093,0.00019277981],"domain_scores_gemma":[0.99879086,0.0008334431,0.00005967377,0.00015930101,0.000035169334,0.0001215768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018648632,0.00012556414,0.00046608853,0.00008045039,0.00003594679,0.0000016287796,0.00006443389,0.00009263418,0.000110472785],"category_scores_gemma":[0.000029954555,0.0000712787,0.00015957942,0.000094486655,0.00039334063,0.000030914907,0.00008971369,0.0001555756,0.000007982667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039852813,0.002325972,0.87821025,0.0005494506,0.0004959985,0.006348718,0.00016737048,0.0000040865953,0.000021974465,0.00058808783,0.0026033625,0.06883193],"study_design_scores_gemma":[0.012961789,0.018656898,0.85347766,0.00031954938,0.00022998397,0.000018496057,0.000023689543,0.000030490737,0.0006442425,0.00006930254,0.11347391,0.00009397484],"about_ca_topic_score_codex":0.00010463167,"about_ca_topic_score_gemma":0.000010514576,"teacher_disagreement_score":0.11087054,"about_ca_system_score_codex":0.00006745391,"about_ca_system_score_gemma":0.00015056599,"threshold_uncertainty_score":0.2906661},"labels":[],"label_agreement":null},{"id":"W4413603149","doi":"10.1016/j.urolonc.2025.07.015","title":"Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Urothelial carcinoma; Cohort; Center (category theory); General surgery; Oncology; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.02579685490237768,"score_gpt":0.34680054229461504,"score_spread":0.3210036873922374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413603149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804693,0.00039829512,0.0029975113,0.0059222872,0.00045381568,0.0011220532,0.00021807295,0.000035918572,0.00838277],"genre_scores_gemma":[0.92102545,0.00023569858,0.07036978,0.002555214,0.00004350314,0.00041202328,0.00022708402,0.000008619072,0.0051226094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902105,0.00003947459,0.0003231601,0.00031904122,0.000112929476,0.00018432699],"domain_scores_gemma":[0.99941856,0.00013227592,0.000105239465,0.00017435613,0.00007923386,0.00009032765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014206648,0.00015846106,0.0004622138,0.00039423967,0.00009813679,0.000010148474,0.0000999477,0.00012190227,0.00008151665],"category_scores_gemma":[0.000049544862,0.00012436694,0.00018455827,0.00027061885,0.00025562628,0.00004738351,0.000039917693,0.00010978281,0.0000024727146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001355998,0.0008980534,0.9909937,0.000042901123,0.0020640027,0.000022748736,0.00013216943,0.000012076708,0.00005048427,0.0036777742,0.0008013747,0.0011691301],"study_design_scores_gemma":[0.0056638434,0.0006690667,0.78225416,0.000023050288,0.004475521,0.000013856987,0.00013717309,0.00074100564,0.0002786637,0.00093629607,0.20471917,0.000088208486],"about_ca_topic_score_codex":0.00007663727,"about_ca_topic_score_gemma":0.000021739643,"teacher_disagreement_score":0.20873955,"about_ca_system_score_codex":0.000113551694,"about_ca_system_score_gemma":0.00015122241,"threshold_uncertainty_score":0.50715363},"labels":[],"label_agreement":null},{"id":"W4413676809","doi":"10.2196/72597","title":"Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma: Protocol for a Pilot Randomized Controlled Trial","year":2025,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Health and Medical Research Fund","keywords":"Medicine; Oncology; Internal medicine; Randomized controlled trial; Personalized medicine; Bioinformatics","score_opus":0.1307576895022469,"score_gpt":0.48948756715070424,"score_spread":0.3587298776484573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413676809","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017985765,0.000011590769,0.00013341007,0.0007527154,0.000023595898,0.98046386,0.000026550775,0.00001998367,0.0005825336],"genre_scores_gemma":[0.19486472,1.858658e-7,0.00029909465,0.000112621274,0.00018217975,0.8040611,0.0000022728877,0.000039765455,0.00043807202],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99571276,0.0012193237,0.0012230453,0.000522285,0.0006419589,0.0006806099],"domain_scores_gemma":[0.9966094,0.0020322306,0.000285411,0.00051726255,0.00048165434,0.00007402466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004547827,0.00027966397,0.0017849286,0.00039185194,0.00013383038,0.00004451863,0.00036060557,0.00013730695,0.000035875142],"category_scores_gemma":[0.002346629,0.00016862754,0.00051687856,0.0007194991,0.00021160323,0.00004581387,0.00007478656,0.00036849844,5.0929856e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9729501,0.0015407831,0.005347356,0.0019241094,0.00009906215,0.0000071500785,0.00022251447,0.000010837754,0.016314534,0.00017970744,0.00041748083,0.0009863492],"study_design_scores_gemma":[0.97504216,0.003162618,0.004041994,0.0030492172,0.0000118069365,0.000002044829,0.00003470485,0.001039698,0.010121979,0.0014955301,0.0018656731,0.0001325501],"about_ca_topic_score_codex":0.00011285807,"about_ca_topic_score_gemma":0.00007673522,"teacher_disagreement_score":0.17687896,"about_ca_system_score_codex":0.00032569488,"about_ca_system_score_gemma":0.0018355569,"threshold_uncertainty_score":0.6876431},"labels":[],"label_agreement":null},{"id":"W4413781546","doi":"10.1245/s10434-025-18218-4","title":"ASO Author Reflections: Chronic Liver Disease and Radical Cystectomy: Uncovering a Hidden Risk Factor","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Surgical oncology; Medicine; Cystectomy; General surgery; Risk factor; Disease; Internal medicine; Bladder cancer; Cancer","score_opus":0.0669568823620164,"score_gpt":0.40657194401933083,"score_spread":0.3396150616573144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413781546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92545515,0.02643129,0.0001337011,0.025099507,0.00049298146,0.0008846978,0.0001994723,0.00011945108,0.021183744],"genre_scores_gemma":[0.98191977,0.015405403,0.00015584209,0.0005436793,0.00020674341,0.000050188843,0.000008130047,0.000012102218,0.0016981619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988693,0.00014379855,0.0002900474,0.0002928632,0.00014884974,0.00025517048],"domain_scores_gemma":[0.9990691,0.00029216244,0.000086594446,0.00018913834,0.00008734933,0.00027563336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014210443,0.00014464027,0.0004752026,0.00013204133,0.000082650375,0.000007784918,0.000058683585,0.00016344416,0.00040029443],"category_scores_gemma":[0.00007366616,0.00011357826,0.00015201258,0.0002174052,0.00021697959,0.00005556341,0.00006845988,0.000244899,0.000016584321],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011478532,0.0021937594,0.055189062,0.0008956944,0.0024096677,0.0029366459,0.0004853669,0.000012035379,0.001205784,0.003319265,0.013010048,0.90686417],"study_design_scores_gemma":[0.004963306,0.0024276897,0.10296064,0.00023267786,0.00045679073,0.000073444826,0.00002551881,0.00007711686,0.0014449707,0.0012157728,0.8859788,0.00014324462],"about_ca_topic_score_codex":0.00029978796,"about_ca_topic_score_gemma":0.00006642296,"teacher_disagreement_score":0.9067209,"about_ca_system_score_codex":0.00014608754,"about_ca_system_score_gemma":0.00072556786,"threshold_uncertainty_score":0.4631587},"labels":[],"label_agreement":null},{"id":"W4413831807","doi":"10.5489/cuaj.9207","title":"Testosterone replacement therapy and bladder cancer","year":2025,"lang":"en","type":"review","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Testosterone (patch); Cancer; Chemotherapy; Prostate cancer; Urology; Malignancy; Clinical trial; Oncology; Internal medicine","score_opus":0.04455863327594491,"score_gpt":0.3229883897514964,"score_spread":0.2784297564755515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413831807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060577357,0.99123305,0.0000022235954,0.004729861,0.0004805265,0.00067421526,0.00016354305,0.000019059178,0.0026369398],"genre_scores_gemma":[0.000076396755,0.98732495,0.00004071038,0.0048833224,0.00061605306,0.00011579076,0.00004804865,0.000022323835,0.0068724123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824166,0.00020491311,0.0004784456,0.00032147925,0.00028724052,0.00046623524],"domain_scores_gemma":[0.9984858,0.00017580886,0.0003625455,0.00014836797,0.00015835883,0.0006691404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033031066,0.00031922254,0.0011310022,0.00027522194,0.00022746099,0.000098375574,0.00010175473,0.0005308052,0.0013214516],"category_scores_gemma":[0.00020080266,0.00021570042,0.00028253597,0.00022940537,0.000027142964,0.000041488725,0.00001890553,0.0008171193,0.000025859203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000322472,0.000040094,0.008254375,0.00036634432,0.0010946502,0.00006311065,0.000026170534,1.06783304e-7,6.533438e-8,0.000015116491,0.025267998,0.9648397],"study_design_scores_gemma":[0.0011267842,0.0003822461,0.0037839136,0.001311016,0.0011179951,0.0001985891,0.0000053532012,5.5201787e-7,1.2841683e-7,0.000053510244,0.9918505,0.00016942636],"about_ca_topic_score_codex":0.0012559665,"about_ca_topic_score_gemma":0.00048350336,"teacher_disagreement_score":0.9665825,"about_ca_system_score_codex":0.0021281668,"about_ca_system_score_gemma":0.003246065,"threshold_uncertainty_score":0.99959147},"labels":[],"label_agreement":null},{"id":"W4413831984","doi":"10.5489/cuaj.9111","title":"A population-based analysis of patterns of care in patients with de novo muscle-invasive bladder cancer from Alberta, Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; McMaster University; Princess Margaret Cancer Centre; Dalhousie University; University Health Network; University of Toronto; University of British Columbia; Juravinski Cancer Centre; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Cohort; Internal medicine; Population; Multivariate analysis; Comorbidity; Chemoradiotherapy; Retrospective cohort study; Oncology; Cancer","score_opus":0.004223437689222437,"score_gpt":0.219344401601425,"score_spread":0.21512096391220256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413831984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967982,0.00010287099,0.000015993672,0.0017873282,0.000064979904,0.00015509056,0.00086912315,0.0000017806545,0.00020463608],"genre_scores_gemma":[0.9972901,0.000008301776,0.000034991925,0.0023138996,0.000022498263,0.000010543377,0.00026620048,0.000005788754,0.000047712954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998912,0.00008704193,0.0003237367,0.00014213735,0.0002938744,0.00024125511],"domain_scores_gemma":[0.99885505,0.00020833786,0.0002526122,0.00009456483,0.00037596578,0.00021347504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060192233,0.00010551732,0.00041269118,0.00033433363,0.000049383598,0.000008362666,0.000069587804,0.000116197414,0.000546129],"category_scores_gemma":[0.00018870829,0.00008338296,0.00009830422,0.00052800844,0.000008598132,0.000026277929,0.000004207447,0.0001825202,1.4643443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001486396,0.000052439857,0.9957583,0.000009902804,0.0011358656,0.000012341848,0.00015522729,0.0019756262,0.0000021993578,0.0000049045316,0.00007044669,0.0006741157],"study_design_scores_gemma":[0.0023064197,0.00016914909,0.9956913,0.00006256772,0.0012905335,1.24796e-7,0.00011050712,0.000067089095,0.000030110932,0.000012724159,0.00019385347,0.00006559614],"about_ca_topic_score_codex":0.9813215,"about_ca_topic_score_gemma":0.9977098,"teacher_disagreement_score":0.016388312,"about_ca_system_score_codex":0.0031533423,"about_ca_system_score_gemma":0.004516288,"threshold_uncertainty_score":0.824588},"labels":[],"label_agreement":null},{"id":"W4413836646","doi":"10.1111/bju.16913","title":"Defining statistical cure in patients with T1 high‐grade non‐muscle‐invasive bladder carcinoma treated with BCG immunotherapy","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Immunotherapy; Medicine; Carcinoma; Oncology; Urology; Internal medicine; Cancer","score_opus":0.005149658023539372,"score_gpt":0.2328476688108495,"score_spread":0.22769801078731014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413836646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576116,0.0021168531,0.0005429274,0.0005774515,0.00010700126,0.0003164853,0.000075467404,0.000010938038,0.0004917441],"genre_scores_gemma":[0.9971495,0.00030292777,0.001218808,0.0010874129,0.00004956192,0.000013536576,0.000047233494,0.000033933557,0.000097042204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860704,0.00011028439,0.0004328855,0.00023948582,0.00026556698,0.00034474663],"domain_scores_gemma":[0.9991485,0.00013352835,0.00019047614,0.00014051204,0.0002693953,0.000117570766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009416833,0.00019558638,0.0005785668,0.00023018043,0.0000659218,0.000026473701,0.00010740744,0.0001320763,0.00015893599],"category_scores_gemma":[0.000039301947,0.00016040674,0.000058286303,0.00026062437,0.00015992754,0.00008963151,0.000015542833,0.0004823274,0.0000037235434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005071005,0.00091648236,0.9642631,0.00003049676,0.0006576154,0.004220274,0.00014168017,0.000034043813,0.000053741984,0.00010103484,0.0012216353,0.023288917],"study_design_scores_gemma":[0.024199871,0.006398934,0.9668719,0.00025857755,0.0003583572,0.0011261716,0.000052251955,0.0000064350916,0.000111480396,0.00012535698,0.00036153657,0.00012911954],"about_ca_topic_score_codex":0.00082810293,"about_ca_topic_score_gemma":0.0003890449,"teacher_disagreement_score":0.023159798,"about_ca_system_score_codex":0.0001145269,"about_ca_system_score_gemma":0.00050298404,"threshold_uncertainty_score":0.6541197},"labels":[],"label_agreement":null},{"id":"W4413838724","doi":"10.24908/iqurcp19874","title":"Tumour–Host Immunodynamics of Bacillus Calmette Guérin (BCG) Refractory Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Inquiry Queen s Undergraduate Research Conference Proceedings","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Refractory (planetary science); Bladder cancer; Host (biology); Bacillus (shape); BCG vaccine; Medicine; Microbiology; Cancer; Cancer research; Biology; Immunology; Internal medicine; Vaccination; Astrobiology","score_opus":0.07089602898392562,"score_gpt":0.39650748059708807,"score_spread":0.32561145161316246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413838724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8507474,0.002663786,0.0009185268,0.051170178,0.000805123,0.0027012795,0.00012929873,0.00028531926,0.09057909],"genre_scores_gemma":[0.9865696,0.004360083,0.00027335025,0.00030766544,0.00020260485,0.00034553712,0.000027562923,0.00006418459,0.00784944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957294,0.00009758747,0.0007595692,0.00087105937,0.001448694,0.0010937236],"domain_scores_gemma":[0.9956105,0.00020333641,0.00020496231,0.00044959222,0.0031941195,0.00033754183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009550052,0.0004455657,0.00082962855,0.0009247103,0.0002986988,0.00015022804,0.00056863955,0.00030529706,0.0002426158],"category_scores_gemma":[0.000436037,0.00039130804,0.00021129455,0.0015880812,0.0012148365,0.00039229856,0.00039294976,0.0012540653,0.000059323946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005483881,0.0032264302,0.084371954,0.00521403,0.0049836608,0.00020121947,0.00886984,0.000008845791,0.59458596,0.17631473,0.04646712,0.070272334],"study_design_scores_gemma":[0.03187247,0.010163079,0.27434942,0.015409831,0.0024274501,0.00019506921,0.026118357,0.0032715574,0.42561415,0.12712824,0.0798135,0.003636861],"about_ca_topic_score_codex":0.0032249216,"about_ca_topic_score_gemma":0.000090277346,"teacher_disagreement_score":0.18997747,"about_ca_system_score_codex":0.00086248957,"about_ca_system_score_gemma":0.0027352101,"threshold_uncertainty_score":0.9998539},"labels":[],"label_agreement":null},{"id":"W4413908688","doi":"10.1007/s11255-025-04734-5","title":"Development of a nomogram for prediction of postoperative bleeding after transurethral resection of bladder tumors","year":2025,"lang":"en","type":"article","venue":"International Urology and Nephrology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nomogram; Nephrology; Resection; Urology; Internal medicine; Bladder tumor; General surgery; Surgery; Bladder cancer; Cancer","score_opus":0.015446710287760537,"score_gpt":0.2958848720198541,"score_spread":0.28043816173209357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413908688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928702,0.00027118207,0.0034588615,0.001692432,0.00024979535,0.00028637302,0.000084379855,0.0000062670224,0.0010805023],"genre_scores_gemma":[0.9977054,0.000021785534,0.0014950754,0.00049865537,0.00002708709,0.000086113854,0.000031364118,0.0000040495556,0.00013049689],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994029,0.000021092006,0.00029768475,0.00013494396,0.00006446808,0.00007892067],"domain_scores_gemma":[0.9995947,0.000066350796,0.00007641933,0.000047109144,0.00019904715,0.000016399428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102295526,0.000067996836,0.00021347518,0.00018212399,0.000020663292,8.009358e-7,0.00003468647,0.00011108247,0.00007475225],"category_scores_gemma":[0.000023208668,0.000059402733,0.000047666734,0.00005729243,0.00015449437,0.000030324794,0.000014351452,0.000065738684,2.2014312e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07744772,0.0015598567,0.40197518,0.00042172012,0.0069895326,0.000014879952,0.008231615,0.00006022262,0.46360013,0.01552395,0.000850806,0.023324398],"study_design_scores_gemma":[0.009305196,0.0050853407,0.84026694,0.00008893525,0.0004932433,0.0000769114,0.0002309534,0.0007752111,0.13201904,0.0025025816,0.009066135,0.00008950267],"about_ca_topic_score_codex":0.000015467594,"about_ca_topic_score_gemma":0.000044415552,"teacher_disagreement_score":0.43829176,"about_ca_system_score_codex":0.0000167954,"about_ca_system_score_gemma":0.000107930246,"threshold_uncertainty_score":0.24223731},"labels":[],"label_agreement":null},{"id":"W4413915752","doi":"10.1159/000548236","title":"Upper Urinary Tract Urothelial Carcinoma Diagnosis Effect on Life Expectancy Relative to Population-Based Controls: A Retrospective Analysis","year":2025,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Life expectancy; Population; Urology; Urinary system; Upper urinary tract; Retrospective cohort study; Epidemiology; Urothelial carcinoma; Internal medicine; Oncology; Cancer; Bladder cancer","score_opus":0.011846303432410487,"score_gpt":0.3021402459431517,"score_spread":0.2902939425107412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413915752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98052835,0.00022427847,0.001381695,0.006618948,0.0003754563,0.0012045435,0.00031483718,0.00012121961,0.009230674],"genre_scores_gemma":[0.99001586,0.000004735511,0.00018772077,0.007375576,0.00020266435,0.0010597454,0.00022704912,0.000025070794,0.00090155273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980382,0.00018630258,0.00038871056,0.0006321104,0.0004917357,0.00026299484],"domain_scores_gemma":[0.9983638,0.00073867646,0.00012579565,0.00038162843,0.000223763,0.0001663188],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001498278,0.0003090265,0.00062315137,0.00088409963,0.00011634732,0.000037453887,0.00017087492,0.00015517908,0.00097244635],"category_scores_gemma":[0.0011788827,0.00025126096,0.00050815864,0.00083551876,0.00003746111,0.0000929679,0.00003363052,0.00026845615,0.00008126805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024344523,0.0008337005,0.9909461,0.0000124853395,0.0020139446,0.00008077004,0.00012891127,0.00036688038,0.000060026458,0.002059716,0.0007143922,0.0003486239],"study_design_scores_gemma":[0.003926019,0.0042852964,0.9872442,0.000058605237,0.0016652207,0.0000036813053,0.00001166446,0.0007568319,0.0009206371,0.00040825192,0.0005432198,0.0001763629],"about_ca_topic_score_codex":0.0009975916,"about_ca_topic_score_gemma":0.000044759156,"teacher_disagreement_score":0.009487538,"about_ca_system_score_codex":0.0006751289,"about_ca_system_score_gemma":0.00015306183,"threshold_uncertainty_score":0.999994},"labels":[],"label_agreement":null},{"id":"W4414010804","doi":"10.1016/j.urolonc.2025.08.006","title":"Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Urothelial cancer; Urothelial carcinoma; Urology; Oncology; Bladder cancer; Carcinoma; Internal medicine","score_opus":0.03370020825334547,"score_gpt":0.34964820926319,"score_spread":0.31594800100984455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414010804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704168,0.010960906,0.000045900157,0.00949498,0.0007518427,0.0011582657,0.00038870686,0.00004702611,0.0067355917],"genre_scores_gemma":[0.9750518,0.0022000505,0.005361304,0.010943004,0.0004987806,0.0032394046,0.00008881026,0.000026962765,0.002589851],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984342,0.000091532645,0.0003840175,0.00055606617,0.00011368176,0.00042053632],"domain_scores_gemma":[0.99922734,0.0001884325,0.00009186075,0.0002304072,0.00007937611,0.00018259778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018630819,0.00027697906,0.000529728,0.00022755585,0.00016130923,0.000025531514,0.00009384944,0.0003148637,0.00061675964],"category_scores_gemma":[0.00003188952,0.00023233797,0.000120505625,0.00030026745,0.00047094395,0.000115464005,0.00003457305,0.00039775769,0.000004387375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006550556,0.00029895894,0.97875243,0.00008384541,0.0001631742,0.00010593479,0.00045736338,0.000011530319,0.00038375315,0.0008731476,0.009019252,0.009195551],"study_design_scores_gemma":[0.002642415,0.00067352294,0.37496227,0.00007004582,0.0003824919,0.000029162007,0.00008850569,0.0000798779,0.0006151284,0.0020378856,0.61826384,0.00015483981],"about_ca_topic_score_codex":0.0009964426,"about_ca_topic_score_gemma":0.00086318486,"teacher_disagreement_score":0.6092446,"about_ca_system_score_codex":0.00034543948,"about_ca_system_score_gemma":0.0013805293,"threshold_uncertainty_score":0.94744676},"labels":[],"label_agreement":null},{"id":"W4414042147","doi":"10.1245/s10434-025-18241-5","title":"ASO Visual Abstract: The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary Diversion","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Urinary diversion; Surgical oncology; Adverse effect; Chronic liver disease; Chronic disease","score_opus":0.015310983341177524,"score_gpt":0.3489335644961113,"score_spread":0.33362258115493376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414042147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922056,0.0019043664,2.630443e-7,0.0054726033,0.00015119501,0.00056230766,0.00002276043,0.0000092651535,0.0026566605],"genre_scores_gemma":[0.99808234,0.001193828,0.0000017033547,0.00038277198,0.00004831551,0.000046364807,0.000007784875,0.000006861928,0.0002300205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989771,0.0001265178,0.00027212562,0.00022659979,0.00019172925,0.00020591915],"domain_scores_gemma":[0.9988462,0.00075992756,0.00007658524,0.0001482264,0.000037278685,0.00013178769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020366927,0.00015256772,0.0005411191,0.00010333552,0.000030324669,0.0000019074532,0.000069114154,0.000119015014,0.00032779563],"category_scores_gemma":[0.000027628266,0.00008877199,0.00018546013,0.00010299003,0.0003921618,0.00004340898,0.00009260834,0.00021335798,0.000012892065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03544305,0.004556292,0.88637406,0.00080476346,0.0005772367,0.008917433,0.00027191394,0.000008000628,0.000056130928,0.00025560736,0.0020460815,0.060689438],"study_design_scores_gemma":[0.009230225,0.01316819,0.94807243,0.00026877227,0.00021049072,0.000017822817,0.00002387019,0.00002396609,0.0006770188,0.000027372544,0.028196704,0.00008312762],"about_ca_topic_score_codex":0.00016487158,"about_ca_topic_score_gemma":0.000009260805,"teacher_disagreement_score":0.06169839,"about_ca_system_score_codex":0.00007060895,"about_ca_system_score_gemma":0.000171696,"threshold_uncertainty_score":0.36200166},"labels":[],"label_agreement":null},{"id":"W4414119284","doi":"10.1200/jco-25-01608","title":"End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bladder cancer; Perioperative; Clinical trial; Urothelial cancer; Cancer; MEDLINE; Cystectomy","score_opus":0.3125837297208131,"score_gpt":0.4929975713143874,"score_spread":0.18041384159357426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414119284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91155475,0.0031495844,0.01598284,0.0522421,0.008121239,0.0066916943,0.00019284917,0.000020890622,0.0020440714],"genre_scores_gemma":[0.9807884,0.0011673545,0.0050228466,0.0083487965,0.0032673336,0.0003760908,0.00002033093,0.000028591416,0.0009802423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969426,0.00036939842,0.0019204713,0.00025316273,0.00026774567,0.0002466274],"domain_scores_gemma":[0.9891208,0.0077594733,0.0013394221,0.00018066599,0.0014388412,0.0001608392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025645576,0.00019234653,0.0015471014,0.00009021424,0.0001936804,0.000036915786,0.00014587541,0.00025866175,0.00016966536],"category_scores_gemma":[0.0071980916,0.00009665479,0.00059600774,0.000114876246,0.00016486969,0.0001605298,0.000026158605,0.0003823872,0.0000016046698],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04135427,0.0044333967,0.07247798,0.00014715541,0.01314268,0.000031061638,0.0011655161,0.00025088488,0.0011710743,0.00092455914,0.036431167,0.82847023],"study_design_scores_gemma":[0.14888173,0.06684588,0.42936584,0.00065712247,0.016715543,0.000024376963,0.0012518609,0.001303478,0.0043020574,0.00088479806,0.32929623,0.00047109436],"about_ca_topic_score_codex":0.000044791825,"about_ca_topic_score_gemma":0.00044648172,"teacher_disagreement_score":0.8279992,"about_ca_system_score_codex":0.00022791598,"about_ca_system_score_gemma":0.0036298756,"threshold_uncertainty_score":0.8617308},"labels":[],"label_agreement":null},{"id":"W4414399086","doi":"10.1016/s0167-8140(25)04793-0","title":"EFFECT OF RADIATION DOSE AND VOLUME ON SURVIVAL AND RECURRENCE OUTCOMES IN BLADDER CANCER PATIENTS TREATED WITH RADIATION THERAPY","year":2025,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Radiation therapy; Bladder cancer; Univariate analysis; Lymph node; Stage (stratigraphy); Proportional hazards model; Retrospective cohort study; Cystoscopy; Cancer","score_opus":0.009995075384940662,"score_gpt":0.3219002634618089,"score_spread":0.31190518807686823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414399086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224865,0.00596314,0.0000075774487,0.00059766136,0.000106813975,0.00074522576,0.00001596266,0.000010890471,0.00030404935],"genre_scores_gemma":[0.9841349,0.015170866,0.000020137792,0.00036532176,0.000025623129,0.00008283002,0.00001355293,0.000010156002,0.00017662927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992365,0.00017302259,0.00015873415,0.00022728844,0.00008089017,0.00012356273],"domain_scores_gemma":[0.99956304,0.00021400038,0.000070850445,0.000082215614,0.000023568235,0.00004634695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013352887,0.00014765222,0.00044844474,0.00014487837,0.000036413316,0.0000067587807,0.00002043835,0.00010837021,0.000024264828],"category_scores_gemma":[0.000014830336,0.00009687501,0.000019623796,0.00013928764,0.000095800766,0.000047991743,0.0000038770704,0.00008716568,1.454835e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003200009,0.0001525911,0.5893913,0.000026657312,0.00013555965,0.000002019001,0.00026135307,0.000001354015,0.00011940153,0.000014925608,0.00002893658,0.4066659],"study_design_scores_gemma":[0.02136991,0.010420634,0.96467537,0.000059074013,0.00007041935,0.000001847015,0.000010132203,0.00011492641,0.0013366686,0.000008700065,0.0018563444,0.00007597835],"about_ca_topic_score_codex":0.00050519657,"about_ca_topic_score_gemma":0.00014214174,"teacher_disagreement_score":0.40658993,"about_ca_system_score_codex":0.00018431932,"about_ca_system_score_gemma":0.00008492132,"threshold_uncertainty_score":0.39504483},"labels":[],"label_agreement":null},{"id":"W4414465159","doi":"10.1158/2326-6074.cimm25-b017","title":"Abstract B017: Impact of gut microbiota on response to Bacillus Calmette-Guérin immunotherapy in bladder cancer: Towards a predictive molecular model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Gut flora; Bladder cancer; Antibiotics; Bacteria; Probiotic; Cancer","score_opus":0.051216184011676304,"score_gpt":0.4408723039258178,"score_spread":0.38965611991414145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762029,0.012781778,0.00008582285,0.0053185043,0.00020640642,0.0018032816,0.0005445937,0.000038505674,0.0030181813],"genre_scores_gemma":[0.99303526,0.002265839,0.00009522948,0.0006765637,0.000039471215,0.0011353334,0.000016947968,0.00006067671,0.0026746746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967922,0.00041928588,0.00054723356,0.0007526788,0.0004930732,0.0009955297],"domain_scores_gemma":[0.9979492,0.00023564481,0.000082839135,0.00096980593,0.00060902536,0.00015351383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009086211,0.00037425003,0.000808573,0.0014037444,0.00011570647,0.000024301624,0.00048552253,0.00037812334,0.00062179525],"category_scores_gemma":[0.00022118409,0.00031506387,0.00028141204,0.001470018,0.0004809056,0.000075781245,0.00018488351,0.0011376882,0.00003175691],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06190057,0.00065625395,0.0068468587,0.00007135693,0.0021076072,0.000122729,0.0011293888,0.003725541,0.89051837,0.000034216853,0.0029596926,0.029927408],"study_design_scores_gemma":[0.012828276,0.0047815153,0.80865103,0.0011656025,0.000096138894,0.0000133959775,0.00024961669,0.00056474167,0.16958311,0.0002681599,0.0014402753,0.00035814976],"about_ca_topic_score_codex":0.017107485,"about_ca_topic_score_gemma":0.00032630903,"teacher_disagreement_score":0.8018041,"about_ca_system_score_codex":0.0031152808,"about_ca_system_score_gemma":0.005686568,"threshold_uncertainty_score":0.9999503},"labels":[],"label_agreement":null},{"id":"W4414490399","doi":"10.5489/cuaj.9204","title":"Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Queen's University; Dalhousie University; Université Laval; Ottawa Hospital; University Health Network; Université de Sherbrooke; University of Toronto; Western University; McMaster University; Alberta Health Services; McGill University Health Centre; University of Ottawa; McGill University; University of Manitoba; Université de Montréal","funders":"Bladder Cancer Canada; EMD Serono; Seagen; Pfizer","keywords":"Cystectomy; Electrical conduit; Perioperative; Odds ratio; Urinary diversion; Odds","score_opus":0.04537400609944766,"score_gpt":0.34583743737478684,"score_spread":0.3004634312753392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960791,0.00066525623,0.0004882977,0.001728673,0.00016023975,0.00025795525,0.0001852566,0.00000883778,0.00042636777],"genre_scores_gemma":[0.9987065,0.000031325435,0.00022870602,0.0007761541,0.000112349604,0.000008469626,0.000057245732,0.0000040946898,0.00007513202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986207,0.00019687974,0.00042132876,0.00020469345,0.00024403616,0.0003123501],"domain_scores_gemma":[0.9991608,0.00016617504,0.000132372,0.000081873266,0.00006796477,0.0003907933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075336715,0.00012888151,0.00048068492,0.00017753695,0.00019049118,0.000029352177,0.000056636087,0.0002042922,0.00009517399],"category_scores_gemma":[0.00045847552,0.000103515034,0.00008370341,0.00018024426,0.00006889289,0.000094858486,0.000027283359,0.00051978824,0.0000013208559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020029156,0.00009337556,0.9980549,0.000017707516,0.00021081092,0.0000930082,0.00013347855,0.0000026459763,0.00005176289,0.00017945368,0.00022064087,0.00092215795],"study_design_scores_gemma":[0.0043099746,0.00009723802,0.9908629,0.000051543462,0.00020891956,0.000016076892,0.000064102715,0.0003505665,0.000044280212,0.00012575541,0.0037921753,0.00007648446],"about_ca_topic_score_codex":0.005303665,"about_ca_topic_score_gemma":0.008058864,"teacher_disagreement_score":0.007192046,"about_ca_system_score_codex":0.0004387683,"about_ca_system_score_gemma":0.00067276234,"threshold_uncertainty_score":0.80175906},"labels":[],"label_agreement":null},{"id":"W4414490560","doi":"10.1158/2326-6074.cimm25-b018","title":"Abstract B018: Gut microbiome influences the antitumor response to BCG immunotherapy in bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Microbiome; Gut flora; ELISPOT; Immunotherapy; Feces; Bladder cancer; Colorectal cancer; Gut microbiome","score_opus":0.058597466461270495,"score_gpt":0.4462746043513444,"score_spread":0.3876771378900739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91635585,0.04212251,0.0000030882413,0.03718841,0.0005683965,0.001396383,0.00006464374,0.000044348046,0.002256394],"genre_scores_gemma":[0.97745985,0.0065834415,0.000033736604,0.0032311336,0.000120742545,0.001695442,0.0000061267456,0.000036969792,0.010832542],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972035,0.0004451583,0.00043861198,0.00059193413,0.00036602915,0.0009547532],"domain_scores_gemma":[0.99813414,0.00048673377,0.00005433595,0.00083255756,0.00040494223,0.00008732286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013721546,0.0002607701,0.00047061316,0.0008831368,0.0003471488,0.00006823044,0.00063672574,0.00021934845,0.0015601619],"category_scores_gemma":[0.00019385357,0.00018106426,0.00010906031,0.00196091,0.0008038913,0.000103952334,0.0001954939,0.0010080917,0.00019224799],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014803314,0.00026974155,0.054841544,0.00005963601,0.0008435238,0.000108671804,0.0015240181,0.000020479407,0.88556886,0.0000806247,0.009617197,0.032262396],"study_design_scores_gemma":[0.0034492852,0.00038213533,0.8477,0.00046947622,0.000030812273,0.0000148555755,0.0006065071,0.0000023894452,0.039806508,0.0001640006,0.10721124,0.00016278506],"about_ca_topic_score_codex":0.010146419,"about_ca_topic_score_gemma":0.0013202067,"teacher_disagreement_score":0.8457624,"about_ca_system_score_codex":0.00091710646,"about_ca_system_score_gemma":0.0025372468,"threshold_uncertainty_score":0.9993526},"labels":[],"label_agreement":null},{"id":"W4414491856","doi":"10.1158/2326-6074.cimm25-pr-08","title":"Abstract PR-08: Impact of gut microbiota on response to Bacillus Calmette-Guérin immunotherapy in bladder cancer: Towards a predictive molecular model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Gut flora; Bladder cancer; Antibiotics; Bacteria; Probiotic; Cancer","score_opus":0.049512098751903516,"score_gpt":0.4361155299961281,"score_spread":0.3866034312442246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97609705,0.013054625,0.00008907865,0.0051088063,0.00020559673,0.0020222815,0.00055973494,0.000040824416,0.002822021],"genre_scores_gemma":[0.99275875,0.002210687,0.000103279184,0.00065238815,0.000040782717,0.0012814224,0.000018286788,0.0000634764,0.0028709297],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966699,0.0004417161,0.000567675,0.0007785432,0.00051165797,0.0010305179],"domain_scores_gemma":[0.99790466,0.00023593532,0.000087517474,0.000980933,0.0006331351,0.00015784522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009339917,0.00038740053,0.00082591746,0.0014051094,0.000117366646,0.000023388966,0.00049263425,0.00038998597,0.00066419673],"category_scores_gemma":[0.00022897946,0.0003254735,0.0002824645,0.0015202393,0.0004896708,0.0000742355,0.00019112055,0.0011681159,0.000036717494],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06343648,0.0007023228,0.0068411045,0.000080981605,0.0021966442,0.0001226011,0.0012409101,0.0036780678,0.88832676,0.00003337909,0.002797703,0.03054304],"study_design_scores_gemma":[0.013688539,0.0051443544,0.7996435,0.0012524761,0.000103600694,0.0000146234115,0.00026838304,0.00057127967,0.17719479,0.00026623558,0.0014726721,0.00037953924],"about_ca_topic_score_codex":0.014111121,"about_ca_topic_score_gemma":0.00030743866,"teacher_disagreement_score":0.7928024,"about_ca_system_score_codex":0.003206398,"about_ca_system_score_gemma":0.005969831,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W4414498519","doi":"10.1016/j.urolonc.2025.08.016","title":"The association between prior pelvic radiotherapy for cancer and surgical outcomes in patients undergoing radical cystectomy for bladder cancer: An analysis of national surgical quality improvement program targeted cystectomy database","year":2025,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cystectomy; Odds; Odds ratio; Bladder cancer; Multicenter study; Radiation therapy; Cancer","score_opus":0.02858455760598524,"score_gpt":0.39471119652205305,"score_spread":0.36612663891606784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414498519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964965,0.0014811682,0.00008319029,0.0055345544,0.00011979502,0.0022133715,0.00084020896,0.000029935387,0.000048144415],"genre_scores_gemma":[0.9845863,0.0013091736,0.0089189075,0.00066479424,0.00013503051,0.003091264,0.0008681138,0.00001683604,0.00040958766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820757,0.00018993477,0.0005897972,0.0004239933,0.0002726121,0.0003160963],"domain_scores_gemma":[0.99696165,0.0021975343,0.00030690085,0.0001380958,0.00025188204,0.00014390536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008824961,0.00019576271,0.0007105713,0.00024499896,0.0003053829,0.000028287921,0.000088752204,0.00022944104,0.000013026159],"category_scores_gemma":[0.00027522337,0.00013627546,0.00013299259,0.00048489808,0.00030887948,0.0000924916,0.000028348368,0.00018282128,5.9527203e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008402787,0.0005103558,0.9789726,0.000072426505,0.0021276532,0.0000020195891,0.0001616438,0.00004438928,0.000024664076,0.0015199166,0.00013084867,0.0155931655],"study_design_scores_gemma":[0.02019256,0.004967057,0.78382486,0.000061341605,0.0032737944,0.0000018106421,0.00014508145,0.0032416647,0.0001584647,0.0010545944,0.18284988,0.00022886942],"about_ca_topic_score_codex":0.0005215829,"about_ca_topic_score_gemma":0.0016943443,"teacher_disagreement_score":0.19514775,"about_ca_system_score_codex":0.0007113133,"about_ca_system_score_gemma":0.00087798946,"threshold_uncertainty_score":0.5557152},"labels":[],"label_agreement":null},{"id":"W4414571077","doi":"10.5489/cuaj.9439","title":"Guideline adherence in treating non-muscle-invasive bladder cancer: Discipline can save lives","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Guideline; MEDLINE; Population; Disease","score_opus":0.014767526452503307,"score_gpt":0.2923355600094106,"score_spread":0.2775680335569073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414571077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8927697,0.0014513307,0.00013930043,0.08863115,0.000813817,0.00063416053,0.00022007477,0.000039772396,0.015300672],"genre_scores_gemma":[0.9869393,0.00043537814,0.0003471344,0.009037472,0.00046830627,0.000049591694,0.000038266673,0.0000132595815,0.0026712948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816656,0.00010803574,0.0005803194,0.0002900527,0.00026987793,0.00058515364],"domain_scores_gemma":[0.9986382,0.00017307841,0.00023279605,0.00012547593,0.00031774628,0.00051269104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003608216,0.00020352358,0.00040957858,0.00031293838,0.00025066084,0.00006886276,0.00013606869,0.00020281691,0.00090282725],"category_scores_gemma":[0.0007087116,0.0001619946,0.00013731913,0.00048045447,0.000036774632,0.00007442336,0.000024070418,0.00059498876,0.000014964653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006540647,0.00008903408,0.9576708,0.0000094556335,0.00023138049,0.00023700189,0.0005363273,0.00013040284,0.00023306588,0.00004325613,0.011624365,0.029129498],"study_design_scores_gemma":[0.0032658621,0.00047231218,0.9797692,0.00017809238,0.00022424645,0.00003900274,0.0005961085,0.00032355855,0.00015291222,0.0010661047,0.013708193,0.00020442305],"about_ca_topic_score_codex":0.025133537,"about_ca_topic_score_gemma":0.10711149,"teacher_disagreement_score":0.09416958,"about_ca_system_score_codex":0.002618103,"about_ca_system_score_gemma":0.0027011023,"threshold_uncertainty_score":0.98853254},"labels":[],"label_agreement":null},{"id":"W4414574552","doi":"10.1016/j.ijrobp.2025.06.2797","title":"Urethra-Sparing Prostate Cancer Radiotherapy: Current Practices and Future Insights from an International Survey","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Prostate cancer; Urethra; Radiation therapy; Genitourinary system; Contouring; Prostate; External beam radiotherapy; Urinary system","score_opus":0.03160774698785568,"score_gpt":0.4010625086154889,"score_spread":0.36945476162763324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414574552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598318,0.014953377,0.002305624,0.010015304,0.0116877835,0.0003290029,0.0002840872,0.000038325215,0.0005547116],"genre_scores_gemma":[0.9613314,0.02845983,0.001451151,0.0017893652,0.006521522,0.000025599895,0.00032880492,0.000025283227,0.000067040535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984294,0.00028997508,0.00055246515,0.00030468573,0.00027126336,0.00015219211],"domain_scores_gemma":[0.9974634,0.00029623063,0.0011486406,0.00014346781,0.00082441425,0.00012383751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029991247,0.00020710385,0.00042249268,0.00019481935,0.0000775244,0.00006926258,0.00030995355,0.00018146481,0.00008062775],"category_scores_gemma":[0.00016687697,0.00016952363,0.00010352512,0.00014606201,0.00011859669,0.00059313513,0.000049914204,0.00050034304,0.00000244724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012178468,0.00039484067,0.65508485,0.0000063403404,0.0012862985,0.000013621238,0.00076734665,0.000057892805,0.001091474,0.0014108893,0.00046108148,0.33820754],"study_design_scores_gemma":[0.008931005,0.0006830166,0.7757016,0.00013571703,0.0002766442,0.000040014434,0.00010175147,0.0018792438,0.0012418653,0.0042461865,0.20657448,0.00018849802],"about_ca_topic_score_codex":0.0004260861,"about_ca_topic_score_gemma":0.00012171725,"teacher_disagreement_score":0.33801904,"about_ca_system_score_codex":0.00070754625,"about_ca_system_score_gemma":0.0008899392,"threshold_uncertainty_score":0.6912973},"labels":[],"label_agreement":null},{"id":"W4414623976","doi":"10.5489/cuaj.9431","title":"Poster Session 7: Oncology – Bladder, Renal, Testes (Part 2)","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Session (web analytics); MEDLINE","score_opus":0.018401972672421735,"score_gpt":0.2854420362698654,"score_spread":0.2670400635974437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414623976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38604352,0.002249916,0.00010948201,0.32349998,0.002941682,0.0007179499,0.00010172453,0.00011891879,0.28421682],"genre_scores_gemma":[0.9501162,0.00018596755,0.00014383969,0.035722304,0.00065568223,0.000015224157,0.000028278386,0.000010862636,0.013121606],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865264,0.00016558295,0.00032208223,0.00019175783,0.00022572202,0.00044219667],"domain_scores_gemma":[0.99876064,0.00016540567,0.00015511778,0.0001083562,0.00026118793,0.00054928544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037446024,0.00013535845,0.0002948007,0.00021517336,0.00029841997,0.00006291388,0.00009447842,0.00033790417,0.0016977094],"category_scores_gemma":[0.00050535274,0.00010033828,0.00013307722,0.00024206453,0.000031005475,0.000074645184,0.000017005157,0.0005495632,0.00011492309],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016965577,0.00015812267,0.69557613,0.0000054856223,0.00040397784,0.00029611797,0.000079777885,0.000004224931,0.000328841,0.0002003739,0.28415877,0.018618502],"study_design_scores_gemma":[0.001771141,0.0005903466,0.32697505,0.000033622837,0.00019811981,0.00018183874,0.000034878085,0.000010717827,0.00014032278,0.0010783827,0.6688986,0.00008701043],"about_ca_topic_score_codex":0.00066929444,"about_ca_topic_score_gemma":0.0008375955,"teacher_disagreement_score":0.5640727,"about_ca_system_score_codex":0.0019359641,"about_ca_system_score_gemma":0.0018064727,"threshold_uncertainty_score":0.9992149},"labels":[],"label_agreement":null},{"id":"W4414710167","doi":"10.1016/j.esmoop.2025.105651","title":"76eP Clinical-grade comprehensive genomic profiling (CGP) of urothelial carcinoma (UC)","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Occupational Cancer Research Centre; University of Calgary","funders":"","keywords":"Urothelial carcinoma; Profiling (computer programming); Urothelial cancer; Gene expression profiling; Bladder cancer; Genomic sequencing","score_opus":0.08534673143963108,"score_gpt":0.4059433389521601,"score_spread":0.32059660751252905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414710167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9430814,0.00051103655,0.00008898156,0.0012275908,0.00066743983,0.0021263731,0.000062699386,0.000034922006,0.0521996],"genre_scores_gemma":[0.9902976,0.000086054766,0.0022737936,0.0017488564,0.00018358813,0.00007803953,0.00004170636,0.000026572601,0.005263776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985796,0.00009916494,0.0005283239,0.00038180585,0.00015289731,0.00025819152],"domain_scores_gemma":[0.9990192,0.000110851506,0.00012327533,0.00051347085,0.00012454284,0.00010867498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018974426,0.00017719432,0.0006244767,0.00008606645,0.00008418381,0.000027242892,0.0003507149,0.00011415477,0.0002576486],"category_scores_gemma":[0.00004440194,0.00014924433,0.00017046508,0.00018221236,0.00012627961,0.00006775834,0.00031822795,0.0002129411,0.000077937395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002379951,0.0010327267,0.9563696,0.00032634856,0.0010264207,0.00014864249,0.00040961133,0.000008375403,0.008388233,0.0026652466,0.006811397,0.02043345],"study_design_scores_gemma":[0.010672722,0.0008246759,0.9074126,0.00022623084,0.000515431,0.000023455475,0.00026483028,0.000084920095,0.04080376,0.00078492425,0.038183242,0.00020320246],"about_ca_topic_score_codex":0.0025257661,"about_ca_topic_score_gemma":0.00006487325,"teacher_disagreement_score":0.04895699,"about_ca_system_score_codex":0.0000766426,"about_ca_system_score_gemma":0.0005947317,"threshold_uncertainty_score":0.6086007},"labels":[],"label_agreement":null},{"id":"W4414806181","doi":"10.1016/j.eururo.2025.09.4137","title":"Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Carcinoma in situ; Carcinoma; Bacillus (shape); Selection (genetic algorithm); In situ","score_opus":0.036703424071056125,"score_gpt":0.32891123115028453,"score_spread":0.2922078070792284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414806181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98471916,0.00041472653,0.00033910258,0.00036104117,0.00016298429,0.0012425487,0.0001109924,0.000009595152,0.0126398485],"genre_scores_gemma":[0.9985599,0.000012728922,0.000038687398,0.0005639639,0.00001716058,0.00007205593,0.000028713986,0.000017346316,0.000689424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984366,0.0006545408,0.00031592711,0.00028877676,0.0001009195,0.00020323138],"domain_scores_gemma":[0.9988383,0.00045442148,0.000113774826,0.00043203167,0.00012368226,0.000037799062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027387374,0.00015281781,0.00056850037,0.00040123434,0.00003326983,0.0000020575108,0.00013828272,0.000053939537,0.000037400525],"category_scores_gemma":[0.0001809127,0.00010536502,0.00029274003,0.00083638733,0.00014565348,0.000016280042,0.00007535191,0.00009327512,0.0000038063688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007249285,0.00097401213,0.9432452,0.00012338546,0.00890242,0.00010972242,0.0010381587,0.0007121013,0.023221055,0.00047632656,0.00027121423,0.013677165],"study_design_scores_gemma":[0.0056603807,0.00081238995,0.9729882,0.00001794897,0.00487406,0.0000040906725,0.000050149923,0.00012024237,0.01408342,0.000039432936,0.0012894521,0.00006026793],"about_ca_topic_score_codex":0.00016831674,"about_ca_topic_score_gemma":0.00013818897,"teacher_disagreement_score":0.02974301,"about_ca_system_score_codex":0.00008567887,"about_ca_system_score_gemma":0.00012838654,"threshold_uncertainty_score":0.4296661},"labels":[],"label_agreement":null},{"id":"W4414810039","doi":"10.1007/s00345-025-05983-w","title":"Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patients","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Nephrology; Chemotherapy; Years of potential life lost; Proportional hazards model; Young adult","score_opus":0.005881255714477819,"score_gpt":0.2842965404165478,"score_spread":0.27841528470206994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414810039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444044,0.0022704813,0.0000052682963,0.001293468,0.00032770642,0.00029730776,0.000011997531,0.000003919676,0.0013494045],"genre_scores_gemma":[0.99785197,0.00041343417,0.000019419116,0.0013042529,0.000075971264,0.0000056422073,0.0000023015377,0.00001615535,0.00031082716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998651,0.00018585625,0.00059485936,0.00013790911,0.00023761924,0.00019273043],"domain_scores_gemma":[0.99907595,0.00024569436,0.00031776878,0.0001496845,0.00011484781,0.000096062045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022394051,0.00014476157,0.0007799691,0.0005744592,0.00000976348,0.0000019143574,0.000110366534,0.00009807133,0.00033218888],"category_scores_gemma":[0.00010543616,0.00010830469,0.00016261166,0.00041136376,0.00012413033,0.000024758352,0.000015916363,0.0003119091,0.0000043228288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022765901,0.0011367456,0.89418244,0.0001354028,0.00096463296,0.00012342715,0.00019908641,0.00008076655,0.0022817564,0.00003084034,0.0025429768,0.07555602],"study_design_scores_gemma":[0.040755536,0.012938981,0.92019075,0.0004949041,0.0005558686,0.00001982588,0.000007470061,0.000034437442,0.016768293,0.000054743854,0.008063743,0.00011546132],"about_ca_topic_score_codex":0.00018556305,"about_ca_topic_score_gemma":0.00009024211,"teacher_disagreement_score":0.07544056,"about_ca_system_score_codex":0.000098071454,"about_ca_system_score_gemma":0.00024019164,"threshold_uncertainty_score":0.4416537},"labels":[],"label_agreement":null},{"id":"W4414847419","doi":"10.1186/s43055-025-01603-0","title":"Machine learning-based radiomics using magnetic resonance images for prediction of clinical complete response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"The Egyptian Journal of Radiology and Nuclear Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Radiomics; Receiver operating characteristic; Bladder cancer; Magnetic resonance imaging; Clinical trial; Feature selection; Chemotherapy","score_opus":0.02448598171557317,"score_gpt":0.31384929854438076,"score_spread":0.2893633168288076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414847419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817513,0.0053514573,0.00039859526,0.011584039,0.00026190534,0.0005651964,0.000057312474,0.0000060789325,0.000024064111],"genre_scores_gemma":[0.9944287,0.0010217935,0.0011279539,0.0031388374,0.0001875839,0.0000049978353,0.000005520827,0.00002385293,0.00006075817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856573,0.00031875732,0.00062231894,0.00017220242,0.00014655221,0.00017442307],"domain_scores_gemma":[0.9987084,0.0005281077,0.0002908177,0.00015228464,0.00021690178,0.00010343243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010139651,0.00014740102,0.000696611,0.00021910097,0.000077551915,0.0000026944201,0.00010333655,0.000090143876,0.00005960107],"category_scores_gemma":[0.00039282424,0.00008409277,0.0000729239,0.00019457247,0.0004397063,0.000030604253,0.0000119364695,0.00033673414,2.0070509e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18402094,0.00047709196,0.75209665,0.00016109174,0.00057379616,0.000062495565,0.0023611602,0.0008128057,0.0057819006,0.00002397644,0.0033364175,0.050291695],"study_design_scores_gemma":[0.030125037,0.0149502475,0.9429385,0.0009434252,0.0004542083,0.00006676086,0.00017411074,0.0015338246,0.00007428376,0.00003408785,0.008637316,0.00006816622],"about_ca_topic_score_codex":0.000044336797,"about_ca_topic_score_gemma":0.000008711025,"teacher_disagreement_score":0.19084191,"about_ca_system_score_codex":0.00006415506,"about_ca_system_score_gemma":0.0002380472,"threshold_uncertainty_score":0.34292036},"labels":[],"label_agreement":null},{"id":"W4414870711","doi":"10.1093/oncolo/oyaf333","title":"Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Comprehensive Cancer Network","keywords":"Identification (biology); Selection (genetic algorithm); Precision medicine; MEDLINE; Data collection; Urothelial cancer","score_opus":0.0884092151270177,"score_gpt":0.38047784830099896,"score_spread":0.29206863317398124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414870711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95064765,0.0016040686,0.0003357282,0.004336826,0.00059497665,0.0013221379,0.00020058353,0.00007560448,0.04088245],"genre_scores_gemma":[0.9953596,0.0005309684,0.00028545375,0.0007598428,0.00008912984,0.00019379568,0.00003748236,0.000011093688,0.0027326483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987422,0.00013970326,0.00032098917,0.00031887577,0.00015629602,0.00032188557],"domain_scores_gemma":[0.99885684,0.0004743514,0.000056863817,0.0004686052,0.000066316345,0.00007703321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003089431,0.00020971648,0.00041156626,0.000061819264,0.0001760533,0.000018389806,0.00017528878,0.00009514972,0.00005942826],"category_scores_gemma":[0.00042568147,0.0001236789,0.000113143455,0.0005313428,0.00013157842,0.000031390708,0.00007579062,0.00008157091,0.00004800387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004079904,0.0015010891,0.8931629,0.000013171241,0.0001787779,0.0002313631,0.00020974803,0.0002490513,0.00015550682,0.00063466793,0.0024144505,0.09716938],"study_design_scores_gemma":[0.010032859,0.0015457025,0.96433467,0.00009500133,0.00017296836,0.000023247401,0.00008675746,0.00010965133,0.0005492428,0.00080052915,0.022129748,0.00011962582],"about_ca_topic_score_codex":0.0075280047,"about_ca_topic_score_gemma":0.025168996,"teacher_disagreement_score":0.09704975,"about_ca_system_score_codex":0.0015731492,"about_ca_system_score_gemma":0.0005979992,"threshold_uncertainty_score":0.99908096},"labels":[],"label_agreement":null},{"id":"W4414889590","doi":"10.1111/bju.70018","title":"Temporal trends and clinical determinants of urinary diversion after radical cystectomy","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Urinary diversion; Ureterosigmoidostomy; Urinary system; Comorbidity","score_opus":0.01518143631971009,"score_gpt":0.3218315943221197,"score_spread":0.30665015800240963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414889590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134,0.0070486804,0.00003237696,0.0006045908,0.0003436443,0.000053776654,0.000011963843,0.000004007078,0.0005609545],"genre_scores_gemma":[0.99764913,0.0010797775,0.0002551835,0.0004958942,0.0001247654,0.0000012555403,0.0000012437948,0.0000059838003,0.00038674433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990135,0.000110813,0.00050357863,0.00012244281,0.00012205193,0.00012760147],"domain_scores_gemma":[0.9995048,0.00006921057,0.00016035039,0.00007405497,0.000079438876,0.00011216867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022898198,0.00007302144,0.00045629844,0.00015608901,0.000027996168,0.000005623477,0.00006272748,0.0001373798,0.00014489061],"category_scores_gemma":[0.00006341331,0.00006825196,0.00015579848,0.00009263717,0.00023092383,0.000051494913,0.000055612534,0.0002541404,0.0000011122092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026170488,0.00041971717,0.77213615,0.000035072233,0.00014076153,0.005970685,0.000016972388,8.252872e-8,0.000016078271,0.0000014276052,0.0012364145,0.21740958],"study_design_scores_gemma":[0.0069966456,0.0037179468,0.96749145,0.00019299531,0.0004304088,0.015449218,0.000011566358,0.00001584008,0.00004376675,0.0000638262,0.0055424045,0.000043918968],"about_ca_topic_score_codex":0.000058835805,"about_ca_topic_score_gemma":0.000019754436,"teacher_disagreement_score":0.21736567,"about_ca_system_score_codex":0.000017097776,"about_ca_system_score_gemma":0.00011824192,"threshold_uncertainty_score":0.27832344},"labels":[],"label_agreement":null},{"id":"W4414905242","doi":"10.1016/j.eururo.2025.09.4145","title":"Development and International Evaluation of an Artificial Intelligence–based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Dalhousie University; Université Laval; Centre Hospitalier de l’Université de Montréal; University Health Network; Ottawa Hospital; University of British Columbia; McGill University Health Centre; Sinai Health System; University of Calgary; Mount Sinai Hospital; University of Alberta; Trillium Health Centre; Université de Sherbrooke; University of Toronto","funders":"Temerty Faculty of Medicine, University of Toronto; University of Toronto; Bladder Cancer Canada","keywords":"Bladder cancer; Risk stratification; Grading (engineering); Cohort; Risk assessment; MEDLINE","score_opus":0.05980056407992791,"score_gpt":0.36768821682397723,"score_spread":0.30788765274404933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414905242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87959117,0.00031063124,0.116042525,0.001324415,0.00032323334,0.0022070855,0.000052011506,0.000034246914,0.000114701026],"genre_scores_gemma":[0.99170345,0.00001422567,0.0075957202,0.0003265559,0.00009908753,0.00011992378,0.00009579195,0.000023113116,0.000022142734],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99872154,0.00021529032,0.00037982833,0.00033551303,0.00020289858,0.00014490986],"domain_scores_gemma":[0.9990884,0.0000610415,0.0002215346,0.00015303226,0.0004054941,0.0000704741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009799823,0.00012276728,0.0001633831,0.00018139617,0.00021573226,0.000027393926,0.00007462995,0.000031586467,0.0000072887624],"category_scores_gemma":[0.0001252046,0.00009557336,0.000017280063,0.00024957347,0.000052842817,0.000058288726,0.00003234646,0.000085101165,4.5921055e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010148389,0.00038371174,0.016157134,0.00036336714,0.0003538873,0.0000023468658,0.0060821404,0.027596945,0.026153147,0.0010207061,0.000106070125,0.9207657],"study_design_scores_gemma":[0.0012509782,0.0005441432,0.028368985,0.00022784946,0.00053364865,0.000004560848,0.0008420698,0.9417984,0.026016507,0.0001600672,0.00011979286,0.0001329871],"about_ca_topic_score_codex":0.000029343611,"about_ca_topic_score_gemma":0.00031561815,"teacher_disagreement_score":0.9206327,"about_ca_system_score_codex":0.00022356045,"about_ca_system_score_gemma":0.00065913924,"threshold_uncertainty_score":0.38973686},"labels":[],"label_agreement":null},{"id":"W4414973786","doi":"10.1080/14737159.2025.2573459","title":"Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlook","year":2025,"lang":"en","type":"review","venue":"Expert Review of Molecular Diagnostics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Immunotherapy; Multiplex; Urinary system; Risk stratification; Biomarker; Standardization","score_opus":0.019889241857227534,"score_gpt":0.3733927665432517,"score_spread":0.3535035246860242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414973786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001574739,0.99161834,0.00009979391,0.00039408047,0.0007526286,0.0064579067,0.0005424744,0.000020424359,0.00009862622],"genre_scores_gemma":[0.0000038220637,0.99538815,0.0010684469,0.0008761477,0.00027839997,0.0018637386,0.00038330798,0.00009958539,0.00003837241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970033,0.0004926704,0.0011103116,0.000628599,0.00032460323,0.00044048537],"domain_scores_gemma":[0.997617,0.00092302926,0.0003574645,0.0007749436,0.00015131765,0.00017626594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042839273,0.00068168115,0.0029701395,0.00036182022,0.00004051367,0.000013131536,0.00020503493,0.00028087338,0.000038988284],"category_scores_gemma":[0.00079935894,0.0005298015,0.0008898225,0.00042216928,0.000105145344,0.00002923347,0.00009369285,0.00031690337,0.0000032629148],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055944815,0.00042657286,0.000042210213,0.18354101,0.0003599041,0.0001361369,0.000066080465,6.6230483e-9,0.000004013062,0.000036556834,0.0027561146,0.8120719],"study_design_scores_gemma":[0.0019606864,0.0008103362,0.00009176935,0.19157499,0.0012492874,0.00004370181,0.000010327966,2.2258048e-7,0.000021262942,0.00001294534,0.8039196,0.0003048511],"about_ca_topic_score_codex":0.000026384336,"about_ca_topic_score_gemma":6.993088e-7,"teacher_disagreement_score":0.8117671,"about_ca_system_score_codex":0.00028201705,"about_ca_system_score_gemma":0.0018147989,"threshold_uncertainty_score":0.9997153},"labels":[],"label_agreement":null},{"id":"W4415017202","doi":"10.1016/s2666-1683(25)01336-9","title":"Association between high-risk human papillomavirus and tumor stage and grade in urothelial bladder cancer","year":2025,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Human papillomavirus; Stage (stratigraphy); Bladder cancer; Urothelial cancer; Bladder tumor; Tumor stage","score_opus":0.023184576918897404,"score_gpt":0.3368911544270232,"score_spread":0.3137065775081258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415017202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097634,0.00035617134,0.0000128910015,0.0024465625,0.00015177808,0.0005843927,0.00006479848,0.000025233423,0.015381832],"genre_scores_gemma":[0.9927258,0.000181549,0.00012341146,0.002181722,0.00008056684,0.0000234082,0.000004021475,0.000015417583,0.004664124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830836,0.0002710886,0.00025121408,0.00059976766,0.00021494163,0.00035460517],"domain_scores_gemma":[0.9993573,0.000085729785,0.00012604185,0.00025045432,0.00005374272,0.00012673813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012882238,0.00015232892,0.00030349955,0.00020170448,0.00033576644,0.00012293378,0.00037797698,0.000038348626,0.00008306475],"category_scores_gemma":[0.00017193305,0.0001302427,0.000017543152,0.00042562102,0.00044367166,0.0002248629,0.0005035451,0.0002649609,0.000016265563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006802238,0.000052563955,0.9897008,0.000009082782,0.00006652664,0.0000577221,0.0003132416,0.0000024025992,0.003480966,0.0004197057,0.00029292473,0.0055360394],"study_design_scores_gemma":[0.0032673427,0.00032100632,0.98769325,0.000022441507,0.00016489846,0.0000037299797,0.000038031438,0.000013442545,0.0011305504,0.00030229724,0.0069327476,0.00011028404],"about_ca_topic_score_codex":0.0033513277,"about_ca_topic_score_gemma":0.00049549947,"teacher_disagreement_score":0.011749438,"about_ca_system_score_codex":0.00013340285,"about_ca_system_score_gemma":0.00021256729,"threshold_uncertainty_score":0.5311143},"labels":[],"label_agreement":null},{"id":"W4415082452","doi":"10.1016/j.euo.2025.08.003","title":"Intermediate-risk Non–muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; North York General Hospital","funders":"","keywords":"Clinical trial; Bladder cancer; Research design; Clinical study design; MEDLINE; Clinical research; Standard of care","score_opus":0.09042560362667153,"score_gpt":0.38350139166491815,"score_spread":0.29307578803824663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415082452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50203145,0.00965118,0.17660676,0.17753582,0.03136511,0.019623436,0.0072203516,0.0005852721,0.07538066],"genre_scores_gemma":[0.91633034,0.053368814,0.00786612,0.015752487,0.0024308811,0.0022572514,0.0011218399,0.00008035651,0.0007919411],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967551,0.0012594663,0.00082053145,0.0007178708,0.00012832104,0.00031869975],"domain_scores_gemma":[0.9965395,0.0022829259,0.00044621804,0.00042714385,0.0001902698,0.00011399495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010276578,0.0002689492,0.0004298683,0.00012692263,0.00038260722,0.00007740264,0.00035572887,0.00018034366,0.0005652801],"category_scores_gemma":[0.0003012334,0.00020860575,0.0001616743,0.00014602033,0.0004253689,0.00011602856,0.00015191452,0.0005543244,0.00003732299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03799913,0.0025919715,0.034725342,0.00003502261,0.011880358,0.00010202904,0.0015024489,0.00012594523,0.00010573744,0.00670712,0.3155899,0.58863497],"study_design_scores_gemma":[0.09956678,0.0071719484,0.48998678,0.000087421075,0.007967545,0.000011758432,0.002820601,0.000643964,0.000032221862,0.011792997,0.37949198,0.00042602004],"about_ca_topic_score_codex":0.00072060677,"about_ca_topic_score_gemma":0.0028894325,"teacher_disagreement_score":0.588209,"about_ca_system_score_codex":0.00018888478,"about_ca_system_score_gemma":0.0007869647,"threshold_uncertainty_score":0.85066956},"labels":[],"label_agreement":null},{"id":"W4415096284","doi":"10.7759/cureus.94420","title":"Comparison of Cold-Cup Biopsy Versus Resection Biopsy in the Early Detection of Detrusor Muscle Invasion in the Case of Bladder Tumor","year":2025,"lang":"en","type":"article","venue":"Cureus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Biopsy; Bladder cancer; Detrusor muscle; Resection; Needle biopsy; Sampling (signal processing); Bladder tumor; Demographics; Prospective cohort study","score_opus":0.04770082517861699,"score_gpt":0.35386401149815416,"score_spread":0.30616318631953715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415096284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659353,0.0007140574,0.000041664993,0.00012327456,0.00026368542,0.0005983083,0.00001414229,0.0000066432485,0.0016447029],"genre_scores_gemma":[0.9997894,0.00002168635,0.00004354516,0.00003287684,0.00003123375,0.000046801128,0.0000033321448,0.0000070910246,0.0000240249],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99900776,0.00015922844,0.00037441807,0.0001548369,0.00017976477,0.00012399173],"domain_scores_gemma":[0.99920857,0.00020720415,0.00014062597,0.0003442333,0.000082013365,0.000017375514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003318183,0.000101576334,0.00026527685,0.00017175057,0.00004051192,0.0000056536933,0.00011598079,0.00007465412,0.000020807807],"category_scores_gemma":[0.00013033608,0.00006314013,0.00007022577,0.0007742863,0.00009206966,0.00005169156,0.000022333554,0.00017247033,0.0000016402864],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010077155,0.004515098,0.24568991,0.0007844431,0.0003816857,0.00062145345,0.019512983,0.000045320754,0.70143616,0.0010504898,0.0004922369,0.015393083],"study_design_scores_gemma":[0.008553321,0.0029485335,0.62679183,0.00033788625,0.00035608764,0.00015106771,0.01410521,0.00028862583,0.34593302,0.00017073315,0.00024927614,0.00011441526],"about_ca_topic_score_codex":0.009183622,"about_ca_topic_score_gemma":0.0052815974,"teacher_disagreement_score":0.3811019,"about_ca_system_score_codex":0.000083305546,"about_ca_system_score_gemma":0.00008052937,"threshold_uncertainty_score":0.9974143},"labels":[],"label_agreement":null},{"id":"W4415246348","doi":"10.1007/s00345-025-05975-w","title":"Gross hematuria in nonagenarians admitted to a urological ward: prevalence, predictors, and outcomes","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medizinische Universität Wien; Universität Wien","keywords":"Risk stratification; Nephrology; Gross hematuria; MEDLINE; Risk assessment","score_opus":0.010547481915029465,"score_gpt":0.2939199891165013,"score_spread":0.28337250720147183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415246348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651682,0.003550369,0.000183179,0.027592,0.00055355,0.0003733657,0.000008567157,0.000017606795,0.0025531915],"genre_scores_gemma":[0.98920316,0.00029104526,0.00040929683,0.00792598,0.00009414082,0.000011569561,9.60239e-7,0.000008634679,0.002055219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888784,0.00009727941,0.00043412347,0.00018447918,0.00015174475,0.00024454718],"domain_scores_gemma":[0.9993794,0.00015094805,0.000097089374,0.00014027744,0.00006917233,0.00016314558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025281485,0.00014221136,0.00051160424,0.0005020076,0.000031164138,0.000009964384,0.000111408415,0.00009524971,0.00010851804],"category_scores_gemma":[0.00013860565,0.00009816036,0.000090648806,0.000341389,0.00007347185,0.00004486561,0.00004571724,0.0003575425,0.000004127977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019130195,0.00027235493,0.9917964,0.000059719147,0.000211934,0.0004919348,0.00027515527,0.000012146356,0.00023410706,0.0003817996,0.002211665,0.002139779],"study_design_scores_gemma":[0.0037182146,0.0012576471,0.9680125,0.00006235838,0.00023347959,0.0003198425,0.000017327111,0.000011426532,0.000044002645,0.0006041416,0.025656344,0.00006271645],"about_ca_topic_score_codex":0.000009015622,"about_ca_topic_score_gemma":0.00006352606,"teacher_disagreement_score":0.024034983,"about_ca_system_score_codex":0.000048135444,"about_ca_system_score_gemma":0.0001223023,"threshold_uncertainty_score":0.40028632},"labels":[],"label_agreement":null},{"id":"W4415269250","doi":"10.1093/ajcp/aqaf108","title":"Reflex somatic testing for the detection of <i>FGFR</i> alterations in urinary tract carcinomas: A dual-institutional experience","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Urinary system; Reflex; Cohort; Somatic cell; Urine","score_opus":0.08368069504643455,"score_gpt":0.432148220460316,"score_spread":0.34846752541388143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415269250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881198,0.00051232416,0.008967841,0.0013190238,0.00041696287,0.0002440903,0.0000060239963,0.0000049179225,0.00040903327],"genre_scores_gemma":[0.9949249,0.00005445516,0.00391837,0.00084458996,0.00018740685,0.000033994016,8.5431464e-7,0.0000052066607,0.000030234585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843055,0.00016983165,0.0010253417,0.00012887489,0.00011795632,0.00012746819],"domain_scores_gemma":[0.99722904,0.0018607253,0.00051064556,0.00014740354,0.00019908689,0.0000530716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063533074,0.00008142295,0.0004981405,0.00011087259,0.00007225965,0.000004184258,0.00008034494,0.000044240704,0.000005293389],"category_scores_gemma":[0.0018062423,0.00005305455,0.00017971548,0.00028861276,0.00052478706,0.00006026626,0.000016640417,0.00026625962,5.94824e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032946286,0.0025580018,0.53891385,0.00008345915,0.00020021935,0.0006350899,0.0014244049,0.00017188063,0.0137281725,0.0001971662,0.00003562376,0.4387575],"study_design_scores_gemma":[0.0031404893,0.008477337,0.98262084,0.00021236898,0.00023606748,0.0019459596,0.0010145423,0.00043104772,0.00091867585,0.0005907793,0.00035340965,0.000058463724],"about_ca_topic_score_codex":0.000048401074,"about_ca_topic_score_gemma":0.000010768223,"teacher_disagreement_score":0.44370702,"about_ca_system_score_codex":0.000043952317,"about_ca_system_score_gemma":0.00048722475,"threshold_uncertainty_score":0.21635018},"labels":[],"label_agreement":null},{"id":"W4415281009","doi":"10.1016/j.annonc.2025.09.017","title":"ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Unicancer; Roche","keywords":"Atezolizumab; Bladder cancer; Bacillus (shape); BCG vaccine; Clinical trial; Phases of clinical research","score_opus":0.06096434800192671,"score_gpt":0.4136386297376899,"score_spread":0.3526742817357632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415281009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768502,0.0013301607,0.00013269654,0.0065572304,0.0018420309,0.003320431,0.00036731854,0.000016845175,0.009583066],"genre_scores_gemma":[0.988169,0.008589638,0.00041530037,0.0011626763,0.00039278175,0.0005826298,0.000093937706,0.000033175354,0.00056086836],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99671715,0.00043153827,0.00128745,0.0006535543,0.00039304924,0.0005172716],"domain_scores_gemma":[0.9969731,0.0013277719,0.0006078987,0.00038867167,0.00048116493,0.00022142434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008014048,0.00040368605,0.0023444938,0.000409312,0.00007695833,0.0000248097,0.0004120312,0.0003944186,0.00048634288],"category_scores_gemma":[0.0007187025,0.00034563284,0.0001967767,0.00038156973,0.00068836863,0.00016974121,0.00029965272,0.0005154549,0.000008429146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76056236,0.006578446,0.00015189678,0.00008649417,0.0032114522,0.00029554043,0.0016131696,0.000013382247,0.001303369,0.0006008981,0.0030190917,0.22256388],"study_design_scores_gemma":[0.96528363,0.017239261,0.0008647331,0.00033161978,0.0011537584,0.000023436536,0.0003917137,0.000188069,0.010751318,0.0010029926,0.002496863,0.0002726071],"about_ca_topic_score_codex":0.017593494,"about_ca_topic_score_gemma":0.0029890947,"teacher_disagreement_score":0.22229128,"about_ca_system_score_codex":0.00029685674,"about_ca_system_score_gemma":0.0018246693,"threshold_uncertainty_score":0.99989957},"labels":[],"label_agreement":null},{"id":"W4415297453","doi":"10.1016/s0140-6736(25)01897-5","title":"Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"AstraZeneca","keywords":"Durvalumab; Bladder cancer; BCG vaccine; Phase (matter); Phases of clinical research","score_opus":0.05291830162122361,"score_gpt":0.37584802076122775,"score_spread":0.3229297191400041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415297453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887546,0.00035016495,0.00081172056,0.0024444272,0.00020931302,0.0053057107,0.0005774578,0.000021748016,0.0015248847],"genre_scores_gemma":[0.9946748,0.00040782307,0.00048262815,0.00076486525,0.00021116309,0.0020464922,0.00015867066,0.000020417812,0.0012331555],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99855644,0.00015599997,0.00041251432,0.00033641452,0.00025078948,0.00028785874],"domain_scores_gemma":[0.9985143,0.000450397,0.00026870077,0.00051677733,0.00019881847,0.00005101777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052299193,0.00020815391,0.0012251864,0.0002635487,0.000113465045,0.00003633001,0.0003206231,0.00007739184,0.00015500581],"category_scores_gemma":[0.00016011304,0.00012985509,0.00012184279,0.0010483518,0.00010039275,0.00009143699,0.000054177228,0.00018072891,0.0000020677378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9341793,0.004106528,0.012612559,0.00024278705,0.010249247,0.00002507956,0.0012523232,0.00026363574,0.0010716591,0.00044240247,0.009773936,0.025780518],"study_design_scores_gemma":[0.9520271,0.0032337164,0.028760875,0.0002910783,0.009182909,9.511656e-7,0.0001374545,0.0019737573,0.003039022,0.0005340619,0.0006567929,0.00016232267],"about_ca_topic_score_codex":0.0052320133,"about_ca_topic_score_gemma":0.0033706005,"teacher_disagreement_score":0.025618196,"about_ca_system_score_codex":0.00014943143,"about_ca_system_score_gemma":0.0005356051,"threshold_uncertainty_score":0.79092735},"labels":[],"label_agreement":null},{"id":"W4415377446","doi":"10.3390/siuj6050067","title":"Abstracts of the 45th Congress of the Société Internationale d’Urologie","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gratitude; Government (linguistics); Latin Americans; Kingdom","score_opus":0.03662945982128457,"score_gpt":0.3466401621090536,"score_spread":0.310010702287769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415377446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107858,0.0010800576,0.000113981754,0.019586654,0.005391574,0.0005132268,0.00010730207,0.000028865894,0.06239253],"genre_scores_gemma":[0.98290235,0.0003061744,0.00012833784,0.002882597,0.00028896137,0.000021525333,0.000008354888,0.000013608697,0.01344811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783474,0.00012701158,0.00077844295,0.00022492399,0.00078043155,0.0002544678],"domain_scores_gemma":[0.9976799,0.00037352953,0.0007823045,0.00038955724,0.0007150503,0.000059653867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004636098,0.00020813807,0.00038853657,0.00013334402,0.00018538821,0.000031337415,0.00091108965,0.00017466873,0.00061381527],"category_scores_gemma":[0.0008694955,0.00011835655,0.0006016771,0.00022856747,0.00043875902,0.00011618343,0.00029723387,0.00073308335,0.0000056168415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010670547,0.0013581892,0.9158192,0.00014565249,0.0035026607,0.00003968928,0.00062630087,0.0008402704,0.006695834,0.0087824715,0.045066036,0.016056582],"study_design_scores_gemma":[0.004259104,0.00025867217,0.93524003,0.00026416755,0.00039792754,0.00016936542,0.0005047116,0.00013079966,0.025663778,0.013010374,0.019969754,0.00013133415],"about_ca_topic_score_codex":0.00005884999,"about_ca_topic_score_gemma":0.00003052069,"teacher_disagreement_score":0.072116524,"about_ca_system_score_codex":0.00026822626,"about_ca_system_score_gemma":0.0008203839,"threshold_uncertainty_score":0.6720847},"labels":[],"label_agreement":null},{"id":"W4415377453","doi":"10.3390/siuj6050061","title":"When Bladder Cancer Treatment Strikes Back: Mycotic Aneurysms After Intravesical BCG Therapy","year":2025,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Adjuvant; Gold standard (test); Bladder tumor; Urinary bladder; Standard of care; Bacillus (shape)","score_opus":0.039702409414364065,"score_gpt":0.3491521670032869,"score_spread":0.3094497575889228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415377453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448904,0.008878551,0.00041636656,0.02474677,0.0023819883,0.0006688258,0.00009955012,0.00007927717,0.01783828],"genre_scores_gemma":[0.96089065,0.008494203,0.00042177594,0.007087837,0.0010762137,0.00016092064,0.000031612286,0.000025996893,0.02181076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829465,0.00009886145,0.00044182283,0.00034866825,0.00042333372,0.000392636],"domain_scores_gemma":[0.99902785,0.0001627974,0.00014461954,0.00023069886,0.00026514306,0.00016887841],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001292172,0.00031092315,0.00042813865,0.00020809165,0.00013129068,0.00010353169,0.00021365691,0.00017192002,0.010635065],"category_scores_gemma":[0.00005417667,0.00021675858,0.00035566796,0.00011867662,0.00013090289,0.00015193927,0.00004584468,0.00034640962,0.00006917389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008823962,0.0036575196,0.6385904,0.000070496026,0.008997517,0.0011237351,0.0022718532,0.00016713381,0.0039460715,0.0009446534,0.054131612,0.27727506],"study_design_scores_gemma":[0.028617322,0.004719972,0.7384818,0.000295453,0.0012272296,0.0011031067,0.0006744356,0.00047555813,0.014985018,0.022725513,0.1859594,0.0007351503],"about_ca_topic_score_codex":0.00009511864,"about_ca_topic_score_gemma":0.00003381201,"teacher_disagreement_score":0.2765399,"about_ca_system_score_codex":0.00077966443,"about_ca_system_score_gemma":0.0006934956,"threshold_uncertainty_score":0.99026936},"labels":[],"label_agreement":null},{"id":"W4415396380","doi":"10.1177/23523735251384859","title":"Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer","year":2025,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; MEDLINE; Bladder tumor; Urinary bladder; Urinary Bladder Cancer","score_opus":0.01755985747081858,"score_gpt":0.37390173788908654,"score_spread":0.356341880418268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415396380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8634322,0.055864237,0.00038917342,0.025362551,0.008476531,0.0028511807,0.0010386909,0.00034013053,0.042245295],"genre_scores_gemma":[0.9664605,0.008407137,0.0002852162,0.0079793,0.0030875865,0.001270259,0.000064519845,0.0001187146,0.0123267155],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552137,0.00019147842,0.0011023533,0.0009992432,0.0010013611,0.0011841943],"domain_scores_gemma":[0.99782157,0.00007979766,0.0003813555,0.0005580633,0.00071095355,0.0004482463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029488344,0.00074652815,0.0010119018,0.0003912051,0.0004142746,0.000256801,0.00035769664,0.00046228134,0.0070132585],"category_scores_gemma":[0.00011475977,0.0006683461,0.00030523643,0.001989436,0.00022128636,0.00046179863,0.00012466974,0.0008279373,0.00007321892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067968997,0.0022331872,0.4465956,0.00044806307,0.008342948,0.00078549347,0.005717186,0.007827242,0.0035644118,0.0025724627,0.27958193,0.23553456],"study_design_scores_gemma":[0.04837049,0.0015452266,0.3079964,0.0052292384,0.006865389,0.00026324886,0.0068254787,0.0029401854,0.021365361,0.004446474,0.5906851,0.0034673912],"about_ca_topic_score_codex":0.011723435,"about_ca_topic_score_gemma":0.029716928,"teacher_disagreement_score":0.3111032,"about_ca_system_score_codex":0.0025958128,"about_ca_system_score_gemma":0.007500093,"threshold_uncertainty_score":0.99957675},"labels":[],"label_agreement":null},{"id":"W4415447492","doi":"10.1016/j.ijrobp.2025.09.056","title":"The Clinical Relevance of Tertiary Lymphoid Structures in Assessing Treatment Response in Muscle-Invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; McGill University Health Centre","funders":"Cancer Research Society","keywords":"Clinical significance; Bladder cancer; Prospective cohort study; Cancer; Clinical trial","score_opus":0.03206025418246451,"score_gpt":0.41440690722394186,"score_spread":0.38234665304147736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415447492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879846,0.0027855628,0.00039645866,0.0061431476,0.002099031,0.00026121395,0.00003192544,0.00000768975,0.0002903487],"genre_scores_gemma":[0.99181986,0.0058639958,0.0005756798,0.0010247417,0.00059309724,0.000026009859,0.000010812553,0.000012772518,0.000073056195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978502,0.0005692042,0.0010193322,0.00019994576,0.00018075261,0.00018056968],"domain_scores_gemma":[0.9964645,0.002233049,0.00072855834,0.00015132365,0.00036908273,0.000053512056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006928432,0.00015874216,0.0004838075,0.00019681768,0.00004582616,0.00001682007,0.00023460426,0.00019082241,0.000019036444],"category_scores_gemma":[0.00079292,0.00010774759,0.00019978973,0.00020346245,0.00022444964,0.00014831827,0.000035829766,0.00030550917,0.0000014499618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028691175,0.0004420669,0.6794672,0.0000050219223,0.00052642316,0.00005539341,0.00030404777,0.0003840781,0.0027669705,0.00062739797,0.00016248651,0.3123898],"study_design_scores_gemma":[0.011632558,0.0011361968,0.9646054,0.00021535951,0.00014496766,0.000040781728,0.00019859574,0.00031991245,0.0052317223,0.008541127,0.007843245,0.00009012808],"about_ca_topic_score_codex":0.00016879215,"about_ca_topic_score_gemma":0.00016146494,"teacher_disagreement_score":0.31229967,"about_ca_system_score_codex":0.0016163952,"about_ca_system_score_gemma":0.0028148468,"threshold_uncertainty_score":0.49934176},"labels":[],"label_agreement":null},{"id":"W4415619512","doi":"10.1007/s00345-025-05992-9","title":"Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Bladder cancer; Chemotherapy; Nephrology; Retrospective cohort study; Overall survival; Urothelial cancer","score_opus":0.027786436870169032,"score_gpt":0.3738947692302779,"score_spread":0.3461083323601089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97483546,0.0009843089,0.00006031325,0.006037449,0.0008885765,0.00065481936,0.000028692528,0.000022090775,0.016488325],"genre_scores_gemma":[0.9943365,0.00023779846,0.000105352054,0.0015094,0.00026275933,0.000012850187,0.000002627479,0.000033088985,0.0034996374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982916,0.00017850187,0.0006647984,0.0002186905,0.00034571817,0.000300689],"domain_scores_gemma":[0.9985768,0.00024082804,0.00043104528,0.00033150506,0.0002766256,0.00014318703],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035540728,0.00024504185,0.0008893836,0.00083069975,0.00004556443,0.000008422628,0.00016878876,0.000064786545,0.0013755229],"category_scores_gemma":[0.000033986766,0.00017042208,0.00036176987,0.00066534994,0.00008996612,0.000033784057,0.000017183585,0.00043245792,0.0000061526384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015352741,0.0025990345,0.9515296,0.000032423028,0.0029606856,0.00022794915,0.00032149968,0.0012327192,0.002176485,0.00011214567,0.010501678,0.012953035],"study_design_scores_gemma":[0.021031987,0.009069734,0.9609845,0.00014970504,0.001015633,0.000015433629,0.00006948194,0.00010365547,0.0009751156,0.00019556783,0.0062381416,0.00015102248],"about_ca_topic_score_codex":0.0012603401,"about_ca_topic_score_gemma":0.002006685,"teacher_disagreement_score":0.01950106,"about_ca_system_score_codex":0.00024794525,"about_ca_system_score_gemma":0.0009234831,"threshold_uncertainty_score":0.99953735},"labels":[],"label_agreement":null},{"id":"W4415711132","doi":"10.1097/ju.0000000000004836","title":"Outcomes Among Rural and Urban Patients With High-Risk Nonmuscle-Invasive Bladder Cancer: Results From the Canadian Bladder Cancer Information System","year":2025,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary; University of Ottawa; Dalhousie University; University Health Network; Université Laval; University of Alberta; McGill University Health Centre; University of Manitoba","funders":"","keywords":"Bladder cancer; Rural area; Bladder tumor; Quality (philosophy); Quality management; MEDLINE; Data quality","score_opus":0.0052114345562486826,"score_gpt":0.22097530819046504,"score_spread":0.21576387363421637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415711132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889376,0.0008563016,0.00002064334,0.007962187,0.0006574221,0.0004636581,0.0005057087,0.000010438454,0.0005860368],"genre_scores_gemma":[0.9957763,0.0004553818,0.000015688927,0.003399137,0.00018962262,0.000018333536,0.000022290013,0.000012149925,0.00011108145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986958,0.00018155474,0.00047508182,0.000096522635,0.00027603016,0.00027501013],"domain_scores_gemma":[0.99837214,0.00033419434,0.0005055984,0.0002658095,0.00036495642,0.00015729251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025687146,0.00018993436,0.0003810148,0.00013486018,0.00031163418,0.000034462213,0.00019017288,0.00011635648,0.000039734816],"category_scores_gemma":[0.000097542,0.00008733961,0.000059543403,0.0001577946,0.00019995664,0.0001971347,0.000032461536,0.00042769007,0.000003981373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019566412,0.000020878106,0.98610926,0.000011966115,0.0015242024,0.000009236417,0.0030026669,0.00019721896,0.0000018518301,0.00003481293,0.0041027647,0.0030284778],"study_design_scores_gemma":[0.0072787073,0.00048262792,0.9877937,0.00012158141,0.0018496853,0.000012429558,0.00089145935,0.000035927584,0.000031391966,0.00004059406,0.0013805644,0.00008136853],"about_ca_topic_score_codex":0.4431038,"about_ca_topic_score_gemma":0.37343544,"teacher_disagreement_score":0.06966835,"about_ca_system_score_codex":0.00031562487,"about_ca_system_score_gemma":0.00092617545,"threshold_uncertainty_score":0.63799775},"labels":[],"label_agreement":null},{"id":"W4415898806","doi":"10.1136/jitc-2025-sitc2025.0441","title":"441 Reimagining bladder cancer immunotherapy: local non-viral gene delivery of DNA-encoded immune checkpoint inhibitors","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent","funders":"","keywords":"Bladder cancer; Immune system; Gene; Immune checkpoint; Gene delivery","score_opus":0.01088837622101589,"score_gpt":0.25748898297937334,"score_spread":0.24660060675835746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415898806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92935586,0.0603856,0.00024688407,0.0027882326,0.0039953147,0.0013598166,0.00014879197,0.00014648969,0.0015730164],"genre_scores_gemma":[0.98516464,0.008645018,0.0007134852,0.0010995057,0.000742584,0.00013831152,0.000069071575,0.00020490345,0.0032224997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99400365,0.00019303113,0.0023466337,0.0012956145,0.00094404205,0.001217045],"domain_scores_gemma":[0.99648476,0.000102119295,0.0008519352,0.0011231285,0.0004959962,0.00094205735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008454777,0.0011363904,0.0018471249,0.00051582535,0.00037024697,0.00014990263,0.0004106386,0.0007339105,0.00014353215],"category_scores_gemma":[0.00014203072,0.0009891969,0.00067518326,0.0007240762,0.0020790382,0.00049615983,0.0002489706,0.0011338589,0.000020590298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001779795,0.00082616584,0.0257994,0.0017663778,0.005397732,0.00037456013,0.0037667067,0.00039072792,0.9206461,0.00011872856,0.003003109,0.036130626],"study_design_scores_gemma":[0.008575318,0.00063313544,0.12995005,0.0038855032,0.0019507855,0.000112114925,0.0010161584,0.00073054765,0.8474251,0.00068431103,0.0041687135,0.00086824293],"about_ca_topic_score_codex":0.010012793,"about_ca_topic_score_gemma":0.00012130326,"teacher_disagreement_score":0.10415064,"about_ca_system_score_codex":0.00064043136,"about_ca_system_score_gemma":0.0049415207,"threshold_uncertainty_score":0.99925584},"labels":[],"label_agreement":null},{"id":"W4415932855","doi":"10.3390/curroncol32110618","title":"A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Merck KGaA; Pfizer","keywords":"Avelumab; Gemcitabine; Retrospective cohort study; Subgroup analysis; Pembrolizumab; Population; Maintenance therapy; Survival analysis; Urothelial carcinoma","score_opus":0.0459240996353212,"score_gpt":0.363908499100913,"score_spread":0.3179843994655918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415932855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98598516,0.0059171994,0.00077710534,0.00052477844,0.0001335023,0.0063266503,0.00029317997,0.000016863538,0.000025573687],"genre_scores_gemma":[0.9962449,0.0020452684,0.00061925413,0.000066650944,0.00002977349,0.0008324775,0.00003010217,0.000032707063,0.0000988618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696016,0.0003605931,0.0010295614,0.00093016104,0.00027021125,0.00044931535],"domain_scores_gemma":[0.997555,0.0010384461,0.0004886413,0.0004056683,0.00038284846,0.00012938277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006895585,0.0005462057,0.0020801788,0.00049355713,0.0001741984,0.000030000732,0.0001121952,0.00009483357,0.000010505467],"category_scores_gemma":[0.0003130995,0.0003576518,0.000111247304,0.0006053243,0.00049612427,0.00009124506,0.00013656609,0.00023986594,9.268628e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013003854,0.006392753,0.91624457,0.00059616857,0.0034962704,0.00009585098,0.029317094,0.000052526793,0.0005432885,0.00010771408,0.000015351123,0.030134572],"study_design_scores_gemma":[0.075851694,0.022122495,0.8706442,0.0003197939,0.0071005104,0.000047600763,0.014762254,0.008442463,0.00015255448,0.00016191945,0.00010702573,0.00028747914],"about_ca_topic_score_codex":0.001235344,"about_ca_topic_score_gemma":0.017953247,"teacher_disagreement_score":0.06284784,"about_ca_system_score_codex":0.00033210832,"about_ca_system_score_gemma":0.00013075532,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W4415939716","doi":"10.1016/j.annonc.2025.08.675","title":"245eP Assessment of the diagnostic accuracy of urine biomarkers for the detection of bladder cancer from an international multicentric study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Cystoscopy; Bladder cancer; Diagnostic accuracy; Gold standard (test); Biomarker; Cancer; Diagnostic test; Urothelial cancer","score_opus":0.06477506658228259,"score_gpt":0.4663409624708745,"score_spread":0.4015658958885919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415939716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300367,0.00075669534,0.00042517466,0.0030534854,0.00071319076,0.0013507752,0.00018783739,0.0000038108776,0.0005053728],"genre_scores_gemma":[0.9986921,0.0006297655,0.0000915964,0.0003035408,0.000058235695,0.00016351619,0.000007769073,0.0000061103465,0.000047385354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991245,0.00009800001,0.000378765,0.00013468921,0.00017290551,0.000091090355],"domain_scores_gemma":[0.99734896,0.0016134954,0.00035301436,0.00025594918,0.00040733593,0.00002122212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020351337,0.00007964864,0.00029648648,0.00008555025,0.000028750092,0.0000017013805,0.0001830767,0.000051739764,0.000112174224],"category_scores_gemma":[0.0005408685,0.00004640962,0.00011232648,0.00017881916,0.000109430664,0.000044091328,0.000055825632,0.000061637744,1.2704464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021046242,0.005811202,0.7204934,0.0001151978,0.005612818,0.0000020002162,0.0009486986,0.00019857299,0.016822556,0.000070433445,0.0005251396,0.24729536],"study_design_scores_gemma":[0.004064214,0.0022383675,0.9421468,0.00006640205,0.0007757715,5.148492e-7,0.0006777874,0.0005726737,0.047819484,0.000105151244,0.001502018,0.00003084696],"about_ca_topic_score_codex":0.0041705985,"about_ca_topic_score_gemma":0.0009937242,"teacher_disagreement_score":0.24726452,"about_ca_system_score_codex":0.000051629915,"about_ca_system_score_gemma":0.00037274612,"threshold_uncertainty_score":0.6304725},"labels":[],"label_agreement":null},{"id":"W4415939879","doi":"10.1016/j.annonc.2025.08.3702","title":"3088P Association of molecular markers with clinical response to TAR-200 in the phase IIb SunRISe-1 trial in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary disease","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Johnson and Johnson; Astellas Pharma; Merck KGaA; Eisai; Else Kröner-Fresenius-Stiftung; AstraZeneca","keywords":"Bladder cancer; Carcinoma in situ; In situ; Carcinoma; Phases of clinical research","score_opus":0.03733582358958509,"score_gpt":0.4027620757087445,"score_spread":0.3654262521191594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415939879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990993,0.00013443567,0.00001567318,0.0042503187,0.00006465297,0.003920205,0.000109374916,0.000007873505,0.0005044702],"genre_scores_gemma":[0.9950123,0.000074367796,0.00016956207,0.0039146217,0.00003454997,0.0005759632,0.00003929739,0.000035050536,0.0001443232],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963529,0.0012780362,0.0007588235,0.00054951775,0.00059841655,0.00046227372],"domain_scores_gemma":[0.99707526,0.001227204,0.0004591128,0.00047509265,0.00057018036,0.00019316554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012234355,0.00032113498,0.0011018553,0.0004825637,0.00003773524,0.000009494952,0.00019844554,0.00019789589,0.000035996738],"category_scores_gemma":[0.00069961883,0.00018112893,0.00008361789,0.0011584975,0.00021807302,0.00011186558,0.000045988923,0.00037245834,0.0000012019889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49882704,0.0022581406,0.49539047,0.000042739746,0.00032708395,0.0005619228,0.0011302414,0.00008797423,0.000059884485,0.0000020984821,0.00025162907,0.0010607635],"study_design_scores_gemma":[0.15282227,0.056305867,0.78809047,0.00058118056,0.00040801681,0.0000021684637,0.0009472594,0.00001180874,0.00040300912,0.000010120813,0.00023705888,0.0001807449],"about_ca_topic_score_codex":0.0013812233,"about_ca_topic_score_gemma":0.015533872,"teacher_disagreement_score":0.34600478,"about_ca_system_score_codex":0.00041610276,"about_ca_system_score_gemma":0.0052622757,"threshold_uncertainty_score":0.9335051},"labels":[],"label_agreement":null},{"id":"W4415940413","doi":"10.1016/j.annonc.2025.08.3697","title":"3083P JAVELIN bladder medley phase II trial of avelumab + sacituzumab govitecan (Ave + SG) vs avelumab monotherapy (Ave mono) as first-line (1L) maintenance treatment for advanced urothelial carcinoma (aUC): Subgroup analyses based on metastatic sites","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merck","keywords":"Javelin; Avelumab; Interim analysis; Bladder cancer; Chemotherapy; Urothelial carcinoma; Subgroup analysis; Merkel cell carcinoma","score_opus":0.12129978985561646,"score_gpt":0.4482988970148013,"score_spread":0.32699910715918484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415940413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97021013,0.001439168,0.006006986,0.010477482,0.00065208547,0.006625803,0.0018317868,0.00008819065,0.0026683782],"genre_scores_gemma":[0.9884474,0.001022565,0.0027372076,0.003603813,0.00025177468,0.0013051686,0.0003932543,0.00009356219,0.002145256],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958677,0.0002748631,0.0015454706,0.00097479805,0.00050990796,0.0008272173],"domain_scores_gemma":[0.9960342,0.0011568161,0.0008349511,0.0009562329,0.00073413673,0.0002836841],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044352404,0.0007676596,0.0024823446,0.0006944934,0.00023408902,0.000016007556,0.00031795085,0.00031170575,0.00040571674],"category_scores_gemma":[0.0005021092,0.00060987996,0.0010085679,0.00058318215,0.0003703319,0.00011699884,0.000051515162,0.00023390696,0.000011484455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74223024,0.03263396,0.00046700545,0.00052626117,0.0058557233,0.00024940757,0.0019970331,0.0015368655,0.0248019,0.00084806053,0.003893646,0.18495989],"study_design_scores_gemma":[0.42724296,0.21511872,0.00046298254,0.00035273164,0.0024527758,0.000021116586,0.0003503175,0.006374986,0.3264444,0.0020100607,0.018596288,0.00057267846],"about_ca_topic_score_codex":0.0012614838,"about_ca_topic_score_gemma":0.0007090788,"teacher_disagreement_score":0.31498727,"about_ca_system_score_codex":0.00059610116,"about_ca_system_score_gemma":0.0020428067,"threshold_uncertainty_score":0.9996353},"labels":[],"label_agreement":null},{"id":"W4415940731","doi":"10.1016/j.annonc.2025.08.3688","title":"3074P EV-103 Cohort K: Efficacy and safety of enfortumab vedotin (EV) with or without pembrolizumab (P) in cisplatin (cis)-ineligible pts with previously untreated locally advanced or metastatic urothelial cancer (la/mUC) with a median (m) follow-up (FU) of ≈3.5 y","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"Astellas Pharma; Pfizer","keywords":"Pembrolizumab; Urothelial cancer; Cohort; Cisplatin; Metastatic Urothelial Carcinoma; Expanded access; Chemotherapy","score_opus":0.0360325907053891,"score_gpt":0.3754102315221576,"score_spread":0.33937764081676847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415940731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888231,0.0011721068,0.0004659047,0.00090635876,0.00006866215,0.0036378077,0.00015143401,0.000039734772,0.0047348887],"genre_scores_gemma":[0.99310094,0.0022607879,0.0023434742,0.00038547485,0.000024478555,0.00048725004,0.000036193655,0.00006453314,0.0012968518],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99713254,0.00022618027,0.001004313,0.0005985886,0.0004820081,0.00055639714],"domain_scores_gemma":[0.9974571,0.0006275274,0.0006297886,0.00047528217,0.0006001668,0.0002101558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039697942,0.00048369757,0.002117202,0.00041746814,0.000051449453,0.000008127411,0.00019157979,0.00018491279,0.00017032192],"category_scores_gemma":[0.00020441679,0.0002783794,0.000084132516,0.0009590035,0.00062452315,0.00013116018,0.000040771327,0.00028079373,0.0000010793361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6026923,0.002880583,0.25763604,0.002614882,0.0048166793,0.0009601508,0.0032722848,0.000613466,0.002032195,0.00023876395,0.0003684932,0.121874146],"study_design_scores_gemma":[0.39204946,0.17327058,0.28464702,0.017230093,0.010164127,0.0014058675,0.0020644928,0.0011087683,0.10992367,0.00018556773,0.006293611,0.0016567574],"about_ca_topic_score_codex":0.004493302,"about_ca_topic_score_gemma":0.026319616,"teacher_disagreement_score":0.21064286,"about_ca_system_score_codex":0.00014719441,"about_ca_system_score_gemma":0.0056643044,"threshold_uncertainty_score":0.99997264},"labels":[],"label_agreement":null},{"id":"W4415942465","doi":"10.1016/j.annonc.2025.08.3732","title":"3119eP Real-world use of Bacillus Calmette Guérin (BCG) in patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"Johnson and Johnson","keywords":"Bladder cancer; Bacillus (shape); Urinary bladder; Cancer; Bladder Neoplasm","score_opus":0.04215214399027526,"score_gpt":0.3440201172759157,"score_spread":0.3018679732856404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895469,0.00017308274,0.000011543392,0.0018675049,0.0002431498,0.00080026337,0.0002533695,0.000015068619,0.0070891506],"genre_scores_gemma":[0.9946399,0.0012170584,0.0003559357,0.0021462385,0.000052260864,0.00010931245,0.000047631067,0.000025792573,0.001405887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830306,0.0001284178,0.0005569179,0.0003740395,0.00026459654,0.00037300008],"domain_scores_gemma":[0.9983573,0.00029162833,0.00032924494,0.0004202102,0.00048868655,0.00011294198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001469027,0.00023284864,0.0008636122,0.0004182791,0.000036515703,0.00000485395,0.00012805924,0.00016603782,0.00025239127],"category_scores_gemma":[0.00011861017,0.00018337251,0.000105045365,0.0006473498,0.00021177037,0.00011902335,0.00007893215,0.00024516397,0.000007873942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002634933,0.0015996197,0.91714376,0.00014255031,0.00082432944,0.000051807263,0.0004249456,0.00011991084,0.00023604861,0.000120818586,0.010649698,0.06605158],"study_design_scores_gemma":[0.00849217,0.00500264,0.9693308,0.00032523056,0.00032942145,5.710491e-7,0.000052347033,0.000007866797,0.007782604,0.00017068128,0.008363685,0.00014198777],"about_ca_topic_score_codex":0.041096326,"about_ca_topic_score_gemma":0.029405788,"teacher_disagreement_score":0.065909594,"about_ca_system_score_codex":0.00017292296,"about_ca_system_score_gemma":0.0009912828,"threshold_uncertainty_score":0.98830503},"labels":[],"label_agreement":null},{"id":"W4415942750","doi":"10.1016/j.annonc.2025.08.3710","title":"3096P Impact of time of infusion of immunotherapy on efficacy in metastatic urothelial cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Urothelial cancer; Immunotherapy; Cancer; Cancer immunotherapy; Bladder cancer; Chemotherapy","score_opus":0.058975160825329186,"score_gpt":0.45157997907242453,"score_spread":0.39260481824709537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920343,0.001422286,0.000006430731,0.0006729293,0.00007048434,0.00043548504,0.00010249939,0.000004074391,0.0052514826],"genre_scores_gemma":[0.9974721,0.0017332569,0.00008008558,0.00035720033,0.000015704823,0.000017310327,0.0000072052526,0.000010493535,0.00030661872],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989377,0.00010549465,0.00053510244,0.00012803743,0.00014464461,0.0001490204],"domain_scores_gemma":[0.99904627,0.000230319,0.00028484515,0.00022379139,0.00018402036,0.000030730407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020822436,0.0001176214,0.0008158825,0.00029849287,0.0000071968384,5.075225e-7,0.00009181567,0.00008305854,0.000574595],"category_scores_gemma":[0.000074798336,0.000087382956,0.00021800226,0.00029697505,0.0001321762,0.00002180158,0.000020105745,0.00008946122,0.0000029469081],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024375562,0.00908439,0.05632639,0.00046685146,0.0025001192,0.000022771957,0.0024807234,0.00058024476,0.56967896,0.00022281245,0.0030901546,0.331171],"study_design_scores_gemma":[0.018088233,0.024688527,0.48362958,0.0010517023,0.00023876657,0.0000036799133,0.00006187075,0.00006338272,0.47001526,0.000488736,0.0015597825,0.000110475106],"about_ca_topic_score_codex":0.0037011264,"about_ca_topic_score_gemma":0.00006244474,"teacher_disagreement_score":0.4273032,"about_ca_system_score_codex":0.0000644864,"about_ca_system_score_gemma":0.00092150713,"threshold_uncertainty_score":0.6291413},"labels":[],"label_agreement":null},{"id":"W4416168727","doi":"10.1016/j.acra.2025.10.021","title":"Incidental Bladder Lesions on Prostate Multiparametric MRI: Prevalence and Factors Associated with Bladder Carcinoma","year":2025,"lang":"en","type":"article","venue":"Academic Radiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; American Roentgen Ray Society","keywords":"Multiparametric MRI; Risk stratification; Prostate; Prostate cancer; Bladder cancer; Carcinoma","score_opus":0.02646581115681537,"score_gpt":0.301250872938658,"score_spread":0.27478506178184264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416168727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993791,0.0026179855,0.000019518859,0.00095850625,0.00018343156,0.0009081685,0.000059268903,0.000086055465,0.0013760749],"genre_scores_gemma":[0.99377954,0.0014285652,0.000042136195,0.0011722376,0.000054200395,0.00008452807,0.000055176122,0.000026378775,0.0033572307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841624,0.00013663968,0.00029672222,0.0005385363,0.00018548532,0.00042636893],"domain_scores_gemma":[0.9989569,0.00046794311,0.000111427464,0.00024361795,0.000059683985,0.00016039578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013917791,0.0002795112,0.00044858424,0.00064740615,0.00013609197,0.000007624614,0.00012527933,0.00039621955,0.000059048947],"category_scores_gemma":[0.0003512583,0.00019563439,0.00005787235,0.00083212816,0.00030032004,0.00007340117,0.00005568399,0.00074495014,0.000010840089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034049197,0.00009824021,0.99299675,0.000034816378,0.00044722206,0.000038920272,0.0005653701,0.000010589962,0.00076936925,0.00012551389,0.0036472955,0.0009253973],"study_design_scores_gemma":[0.0037701644,0.0009848807,0.99115324,0.0001528392,0.00048115908,0.00007047545,0.00016226977,0.000109472465,0.002247846,0.000118298376,0.0005745491,0.00017477547],"about_ca_topic_score_codex":0.00014409599,"about_ca_topic_score_gemma":0.000016132602,"teacher_disagreement_score":0.0034296724,"about_ca_system_score_codex":0.00018918581,"about_ca_system_score_gemma":0.00019601446,"threshold_uncertainty_score":0.7977739},"labels":[],"label_agreement":null},{"id":"W4416237913","doi":"10.1007/978-3-032-08452-1_14","title":"Explainable AI for Clinical Decision-Making: Unlocking the Potential of MSI Thresholds in Bladder Cancer","year":2025,"lang":"en","type":"book-chapter","venue":"Lecture notes in computer science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Interpretability; Random forest; Logistic regression; Bladder cancer; Categorical variable; Hyperparameter optimization; Naive Bayes classifier; Decision tree; Personalized medicine","score_opus":0.031426794872800576,"score_gpt":0.37139232294974683,"score_spread":0.33996552807694624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416237913","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014999406,0.0038792794,0.98492765,0.0025425514,0.0027796305,0.001620828,0.000040057876,0.000029365056,0.0026806947],"genre_scores_gemma":[0.9621537,0.00060345436,0.0294303,0.0057566073,0.0010365442,0.00007963061,0.000005983739,0.000044182056,0.0008896513],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99737823,0.000023450459,0.0007151673,0.00084008137,0.0006099988,0.00043306354],"domain_scores_gemma":[0.99770296,0.001039298,0.00020780807,0.0006839878,0.00029605976,0.00006988824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007580875,0.00033231772,0.0007174961,0.00042406487,0.00014042955,0.000060886614,0.00065426127,0.0003374773,0.0000846194],"category_scores_gemma":[0.00021653358,0.00022229578,0.0002532041,0.00036106224,0.00057349075,0.000093261784,0.00032699152,0.0006713051,0.0000015144554],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051487354,0.0001280632,0.0048236568,0.0001435899,0.000111109526,0.000087679626,0.0003147183,0.010822701,0.000022093325,0.0011240195,0.00060899364,0.9812985],"study_design_scores_gemma":[0.01816704,0.00429741,0.028383376,0.029476073,0.001495995,0.0002491923,0.000013985282,0.33336917,0.0026645486,0.53305155,0.04622556,0.0026061325],"about_ca_topic_score_codex":0.000101695965,"about_ca_topic_score_gemma":0.00035558292,"teacher_disagreement_score":0.97869235,"about_ca_system_score_codex":0.00025703656,"about_ca_system_score_gemma":0.0015338131,"threshold_uncertainty_score":0.90649587},"labels":[],"label_agreement":null},{"id":"W4416262808","doi":"10.1016/j.eclinm.2025.103640","title":"A non-invasive MRI-based multimodal fusion deep learning model (MF-DLM) for predicting overall survival in bladder cancer: a multicentre retrospective study","year":2025,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Foundation (evidence); Retrospective cohort study; China; Overall survival; Deep learning","score_opus":0.02577913385739844,"score_gpt":0.357023787559143,"score_spread":0.33124465370174455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416262808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783938,0.0005711395,0.009281225,0.003521511,0.00093423406,0.0054983194,0.000054291628,0.00017213394,0.0015733395],"genre_scores_gemma":[0.9933403,0.00023213078,0.0019750814,0.0015365735,0.00057330035,0.0007558775,0.00007908281,0.00006570257,0.0014419567],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9965823,0.0001348063,0.0010375272,0.0010120765,0.00058306917,0.00065021653],"domain_scores_gemma":[0.99770486,0.0009192521,0.00026340643,0.00047101863,0.0003787193,0.0002627425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000828525,0.0004427192,0.0012179699,0.0003006838,0.0002178946,0.000019001345,0.00018342574,0.00025511108,0.00013208989],"category_scores_gemma":[0.0018153904,0.00036476585,0.00026120045,0.00045932658,0.00012938207,0.00008689388,0.00010450981,0.00088653987,0.000006577997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005385978,0.0026885285,0.9724028,0.00021326961,0.00056109723,0.00009757515,0.0024865107,0.011457879,0.00042465064,0.000010505172,0.00032160524,0.003949586],"study_design_scores_gemma":[0.054411232,0.0029808052,0.44334134,0.0011207702,0.00095192157,0.000001385707,0.0018633223,0.4946577,0.0002027597,0.00012998402,0.000087211374,0.00025158917],"about_ca_topic_score_codex":0.0016487928,"about_ca_topic_score_gemma":0.0030988725,"teacher_disagreement_score":0.5290615,"about_ca_system_score_codex":0.0006153652,"about_ca_system_score_gemma":0.0008739312,"threshold_uncertainty_score":0.99988043},"labels":[],"label_agreement":null},{"id":"W4416275632","doi":"10.1016/j.euo.2025.09.002","title":"A Systematic Review of Intracavitary Therapies for Upper Tract Urothelial Carcinoma","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Urothelial carcinoma; Urothelial cancer; Disease; Mitomycin C; MEDLINE; Carcinoma","score_opus":0.015169956557332038,"score_gpt":0.31247897854828194,"score_spread":0.2973090219909499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416275632","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13291337,0.535482,0.0025607364,0.049510345,0.0029430469,0.01636229,0.00029132466,0.00034030477,0.25959662],"genre_scores_gemma":[0.9528981,0.00521704,0.0008252101,0.03772749,0.00023307352,0.00033811518,0.000064733955,0.000057837016,0.0026384126],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796134,0.00068046286,0.0006881418,0.00030882884,0.00009168501,0.00026951046],"domain_scores_gemma":[0.9987375,0.00042767497,0.00020676453,0.0004113058,0.00015151702,0.00006523969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006754847,0.00020143154,0.0010940842,0.00015524805,0.000055728095,0.000002700953,0.00018398438,0.000103752354,0.00013853506],"category_scores_gemma":[0.00038894953,0.00015031376,0.00028260774,0.00013832268,0.00018415198,0.000027802516,0.000043697968,0.00018982012,0.000043917415],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005006053,0.0045074876,0.01962678,0.8956399,0.004911831,0.0011117428,0.002570123,0.0000016969558,0.0063333274,0.0067652347,0.035210274,0.018315539],"study_design_scores_gemma":[0.06361389,0.06139904,0.24155179,0.15454273,0.045564454,0.0049342937,0.0010360981,0.00013928814,0.004160917,0.0033486544,0.41786772,0.001841141],"about_ca_topic_score_codex":0.000011053871,"about_ca_topic_score_gemma":0.0000023307891,"teacher_disagreement_score":0.81998473,"about_ca_system_score_codex":0.00007736772,"about_ca_system_score_gemma":0.0003385199,"threshold_uncertainty_score":0.6129617},"labels":[],"label_agreement":null},{"id":"W4416378632","doi":"10.1111/bju.70085","title":"Risk of metachronous upper tract urothelial carcinoma following non‐muscle‐invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Mount Sinai Hospital; University Health Network; Trillium Health Centre; University of Toronto","funders":"","keywords":"Urothelial cancer; Guideline; Incidence (geometry); Urothelial carcinoma; Bladder cancer; Duration (music); Bladder tumor; Gold standard (test)","score_opus":0.009809963727174078,"score_gpt":0.2737953147956144,"score_spread":0.26398535106844034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416378632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727945,0.021947384,0.000453366,0.0007570953,0.0012200255,0.0002965719,0.00009960607,0.000010235183,0.00242123],"genre_scores_gemma":[0.99429816,0.0032849892,0.0003727323,0.0011002475,0.0004137937,0.000016305477,0.0000045851793,0.000030765947,0.00047840097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830025,0.00015864252,0.0006851802,0.00023546742,0.000281999,0.00033843517],"domain_scores_gemma":[0.9988055,0.00017253199,0.00040719667,0.00018346072,0.00028567723,0.00014559684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029064863,0.00018984686,0.0008258681,0.00023673815,0.000095187585,0.000018031273,0.00017928459,0.00017991474,0.00037284358],"category_scores_gemma":[0.00022407874,0.00018653818,0.00062409206,0.00020400391,0.00011897703,0.000117816904,0.000036138663,0.00052236085,0.0000044840235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020457648,0.0019443795,0.7217891,0.00021948882,0.00791767,0.008763823,0.0009354978,0.00024927824,0.015775021,0.000036823756,0.008506819,0.23181632],"study_design_scores_gemma":[0.010506262,0.0020384162,0.967748,0.00026735966,0.0050351243,0.0029982077,0.0001422088,0.000030073734,0.005281013,0.00032529395,0.005451583,0.00017647108],"about_ca_topic_score_codex":0.0019374839,"about_ca_topic_score_gemma":0.00024308,"teacher_disagreement_score":0.24595888,"about_ca_system_score_codex":0.00011354022,"about_ca_system_score_gemma":0.0011521527,"threshold_uncertainty_score":0.7606806},"labels":[],"label_agreement":null},{"id":"W4416387737","doi":"10.1016/j.annonc.2025.09.126","title":"LBA107 ALBAN: A phase III, randomized, open-label, international study of intravenous (iv) atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) vs BCG alone in BCG-naïve high-risk, non-muscle-invasive bladder cancer (NMIBC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Tsukuba; Medizinische Universität Wien; Astellas Pharma; St. Antonius Ziekenhuis; Universität Wien; Russian Academy of Sciences; Cancer Research UK; Queen Mary University of London; Université Laval; Gilead Sciences; Merck KGaA; Sanofi; AstraZeneca; Pfizer","keywords":"Atezolizumab; Bladder cancer; Bacillus (shape); Bladder tumor; Standard of care; Resection","score_opus":0.050700726460933994,"score_gpt":0.40621506218727943,"score_spread":0.35551433572634544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416387737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848356,0.0011285207,0.0000990767,0.0057865065,0.0006473978,0.0035735238,0.0002248409,0.000018885095,0.0036856316],"genre_scores_gemma":[0.9922135,0.00413966,0.00024804642,0.0019890694,0.00018824483,0.00068204984,0.00005830598,0.000035435507,0.00044567455],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99649185,0.0004993374,0.0013553924,0.00071968115,0.00041773304,0.000516006],"domain_scores_gemma":[0.9973352,0.00090298697,0.0005734182,0.00044777602,0.00052590796,0.00021469739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008668518,0.00042204387,0.0025287345,0.0005234185,0.00008576058,0.000026700087,0.00045385756,0.0003107193,0.00041569176],"category_scores_gemma":[0.0004070806,0.00035380374,0.00013064258,0.00046104475,0.00050195534,0.00017151359,0.0003791534,0.0005319749,0.0000067728693],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43094072,0.043458685,0.00936006,0.00031736444,0.010366174,0.0015694211,0.014128265,0.000076804354,0.0040818593,0.0007576547,0.007921778,0.47702122],"study_design_scores_gemma":[0.927118,0.028052324,0.026026713,0.00053390284,0.0018038775,0.00007506724,0.001985713,0.0004018807,0.010392456,0.0013296658,0.0018103386,0.00047008166],"about_ca_topic_score_codex":0.029561829,"about_ca_topic_score_gemma":0.0070924847,"teacher_disagreement_score":0.49617726,"about_ca_system_score_codex":0.0002461076,"about_ca_system_score_gemma":0.0012456155,"threshold_uncertainty_score":0.9998914},"labels":[],"label_agreement":null},{"id":"W4416387766","doi":"10.1016/j.annonc.2025.09.127","title":"LBA108 Durvalumab (D) in combination with Bacillus Calmette-Guérin (BCG) for BCG-naïve, high-risk non-muscle-invasive bladder cancer (NMIBC): Final analysis of the phase III, open-label, randomised POTOMAC trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cilag; Institut National Du Cancer; Sanofi; AstraZeneca; Pfizer","keywords":"Durvalumab; Bladder cancer; Bacillus (shape); Phases of clinical research; Cancer; Clinical trial","score_opus":0.08227437248820987,"score_gpt":0.4244943737016463,"score_spread":0.34222000121343643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416387766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858133,0.00035825395,0.00033669005,0.0046366807,0.00039167193,0.005597367,0.00047436863,0.000011452071,0.0023801841],"genre_scores_gemma":[0.99495804,0.0005181666,0.00025082077,0.0015513458,0.000072216455,0.0014632179,0.00011062068,0.00002211976,0.0010534344],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997612,0.00033846314,0.00088837824,0.00047013955,0.0003203099,0.00037069494],"domain_scores_gemma":[0.9972481,0.000843248,0.00069306564,0.00049029256,0.0006340032,0.00009128651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007436314,0.00027616243,0.0016543732,0.0005206534,0.00011623958,0.000013995314,0.0003632995,0.00022922225,0.00022288345],"category_scores_gemma":[0.00036714083,0.00018795834,0.00028753912,0.0014354469,0.00024919308,0.00010897278,0.00010630207,0.00023400808,9.532861e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74970603,0.014517797,0.007779718,0.00023098936,0.016216928,0.000059182912,0.0011565462,0.0004863866,0.003172447,0.0004196124,0.009643354,0.196611],"study_design_scores_gemma":[0.9225783,0.020981269,0.02772706,0.00022157365,0.008283996,0.0000024675314,0.00021154218,0.0009411854,0.016372332,0.00051770866,0.0019448695,0.00021771216],"about_ca_topic_score_codex":0.00903271,"about_ca_topic_score_gemma":0.008352093,"teacher_disagreement_score":0.1963933,"about_ca_system_score_codex":0.00019495792,"about_ca_system_score_gemma":0.0020558452,"threshold_uncertainty_score":0.9975662},"labels":[],"label_agreement":null},{"id":"W4416391634","doi":"10.1016/j.annonc.2025.09.130","title":"LBA111 Randomized comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers: Final survival analysis from the BladderPath trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Assistance publique-Hôpitaux de Paris; Medac; University College London; Weston Park Cancer Charity; National Institute for Health and Care Research; Cancer Research UK; Seoul National University Hospital; UroGen Pharma; AstraZeneca; Queen Elizabeth Hospital Birmingham Charity; Astellas Pharma; Elekta; Université de Paris; Queen Mary University of London; University of Washington; Gilead Sciences; Seoul National University; Sanofi; Pfizer","keywords":"Cystoscopy; Bladder cancer; Magnetic resonance imaging; Stage (stratigraphy); Clinical trial; Resection","score_opus":0.12984180004286444,"score_gpt":0.43859941479951153,"score_spread":0.3087576147566471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416391634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8306668,0.08093416,0.021315783,0.04379494,0.0052932715,0.0071270624,0.00074764085,0.000089886504,0.0100304475],"genre_scores_gemma":[0.99671304,0.0006637718,0.00088821,0.00062148593,0.00038900232,0.0001596947,0.0000899308,0.000017071865,0.00045777406],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99771845,0.0004350528,0.0008404838,0.00037327604,0.0003060845,0.00032667755],"domain_scores_gemma":[0.99681395,0.0020998435,0.00032952643,0.0003569475,0.00032037287,0.000079383266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008643804,0.00021161047,0.0016431994,0.00020690415,0.00009649318,0.000011657018,0.00018326905,0.00012899232,0.00019955351],"category_scores_gemma":[0.00039177603,0.00015558816,0.0006905575,0.0005320074,0.00028631318,0.00005876371,0.000027220998,0.00021064146,6.865428e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8560533,0.0003676136,0.0072118365,0.000030175908,0.002737629,0.0000033020347,0.001706798,0.00014882532,0.00018211786,0.00015951399,0.00949301,0.12190591],"study_design_scores_gemma":[0.9367276,0.008042512,0.013198092,0.0001419085,0.0099251885,5.5644614e-7,0.0015699201,0.004644911,0.003969275,0.0011821393,0.02039916,0.00019875297],"about_ca_topic_score_codex":0.013020797,"about_ca_topic_score_gemma":0.0056784456,"teacher_disagreement_score":0.16604625,"about_ca_system_score_codex":0.000120926576,"about_ca_system_score_gemma":0.0011088287,"threshold_uncertainty_score":0.9935516},"labels":[],"label_agreement":null},{"id":"W4416398254","doi":"10.1007/s00345-025-06089-z","title":"Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy","year":2025,"lang":"en","type":"article","venue":"World Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Universität Regensburg","keywords":"Cystectomy; Grading (engineering); Bladder cancer; Multicenter study; Proportional hazards model; Nephrology; Clinical significance; Tumor grade; Adjuvant","score_opus":0.03925760891162828,"score_gpt":0.3221806514048012,"score_spread":0.2829230424931729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416398254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98939204,0.001542197,0.00002539845,0.006408503,0.0010076866,0.0011392633,0.00032779144,0.000011072515,0.00014604842],"genre_scores_gemma":[0.9981594,0.00011474421,0.000009170182,0.0011326745,0.00030285562,0.0001167,0.0000042516886,0.00002648139,0.00013370282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966359,0.00091051986,0.0010492384,0.00043923839,0.0005481236,0.00041696578],"domain_scores_gemma":[0.9967661,0.0018083662,0.00046490863,0.0006117936,0.000110817164,0.00023802133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003417773,0.0003797938,0.0010759704,0.00050772476,0.00005429242,0.000022687536,0.0003659059,0.00011511524,0.00016976887],"category_scores_gemma":[0.00055395067,0.00019945789,0.0005016863,0.00025231167,0.00019966507,0.00004121977,0.00008514973,0.0008108204,0.0000040410396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077925056,0.0058000586,0.90525913,0.000037100406,0.0030311497,0.0021116938,0.0023957565,0.00024929392,0.00037720078,0.00005727209,0.0022220255,0.00053427386],"study_design_scores_gemma":[0.021384053,0.00414381,0.9718126,0.00045565263,0.00092811213,0.000011962176,0.00021559671,0.00020495354,0.00007665309,0.00034580642,0.0002757124,0.00014509531],"about_ca_topic_score_codex":0.001474331,"about_ca_topic_score_gemma":0.00084169663,"teacher_disagreement_score":0.06655347,"about_ca_system_score_codex":0.00057522935,"about_ca_system_score_gemma":0.000309065,"threshold_uncertainty_score":0.8133657},"labels":[],"label_agreement":null},{"id":"W4416676951","doi":"10.3389/or.2025.1679974","title":"DNA methylation as prognostic factors in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Oncology Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University Grants Commission; Indian Council of Medical Research","keywords":"DNA methylation; Biomarker; Risk stratification; Methylation; Prospective cohort study; Bladder cancer; Biomarker discovery; Gene","score_opus":0.11288019957345646,"score_gpt":0.4359907627853525,"score_spread":0.323110563211896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416676951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001061244,0.9744517,0.000008742288,0.00040223548,0.00009865291,0.022997966,0.00014195472,0.000027793802,0.0018698485],"genre_scores_gemma":[0.000005323847,0.97630394,0.00010593499,0.001876852,0.000039381714,0.017826764,0.00033274,0.000051091887,0.003457983],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931836,0.002258401,0.0028021068,0.0010491518,0.00028398767,0.00042274818],"domain_scores_gemma":[0.9953689,0.0014785931,0.0017847338,0.0009858247,0.00015766929,0.00022428861],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014202811,0.0010180362,0.028228324,0.00077371637,0.00007124316,0.000023688237,0.00026367122,0.0005868388,0.0012782604],"category_scores_gemma":[0.001802999,0.00057260896,0.004278097,0.0023770179,0.000083520295,0.00007928156,0.00010480458,0.0006093575,0.000120362776],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023294363,0.00013419513,0.00002582996,0.8548325,0.10609662,0.00004897527,0.000073659045,4.4419934e-8,8.521276e-8,0.000004953555,0.0005095575,0.03827131],"study_design_scores_gemma":[0.00020072608,0.00017971158,0.000016854605,0.14282998,0.6567821,0.000024555695,0.000007803969,1.4551514e-7,2.0282911e-7,0.00000599262,0.19970652,0.00024539875],"about_ca_topic_score_codex":0.00023429631,"about_ca_topic_score_gemma":0.0007166085,"teacher_disagreement_score":0.71200246,"about_ca_system_score_codex":0.0007539619,"about_ca_system_score_gemma":0.0017924465,"threshold_uncertainty_score":0.99967253},"labels":[],"label_agreement":null},{"id":"W4416688580","doi":"10.5489/cuaj.9329","title":"Contemporary outcomes and disease burden of high-grade T1 bladder cancer","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Disease burden; Disease; Burden of disease; Cancer","score_opus":0.01805206630553217,"score_gpt":0.2751758515775109,"score_spread":0.2571237852719787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416688580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8442893,0.003905447,0.000026383597,0.14743848,0.00045368148,0.00027716218,0.00020864511,0.000017966775,0.0033829492],"genre_scores_gemma":[0.98880273,0.00020676962,0.00003803803,0.0080340225,0.00015651711,0.000013195145,0.000011126208,0.000006274818,0.0027313526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991155,0.00007243936,0.00025355807,0.00013822073,0.00019589427,0.00022438435],"domain_scores_gemma":[0.9988539,0.00008721014,0.00013592091,0.00007817272,0.00014528335,0.0006995081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014927918,0.00010851167,0.00030209115,0.0001444138,0.00011634848,0.000027474374,0.00005807927,0.00011628653,0.00036785507],"category_scores_gemma":[0.0003563588,0.000079475314,0.000092900766,0.00012732361,0.000041669908,0.000053986492,0.000011582814,0.00023820112,0.000003556523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007800913,0.000034650875,0.96782076,0.00000939523,0.00040986342,0.00005556998,0.000056684665,0.000009122986,0.000020963576,0.0002833167,0.029681794,0.0015398498],"study_design_scores_gemma":[0.002029825,0.00009266156,0.97309214,0.000027480683,0.00022779102,0.000005861013,0.000044805507,0.000021899661,0.00001748631,0.0024943424,0.021879518,0.00006620856],"about_ca_topic_score_codex":0.012457325,"about_ca_topic_score_gemma":0.0004460574,"teacher_disagreement_score":0.14451343,"about_ca_system_score_codex":0.00042979902,"about_ca_system_score_gemma":0.0016071553,"threshold_uncertainty_score":0.9941188},"labels":[],"label_agreement":null},{"id":"W4416854610","doi":"10.1111/bju.70038","title":"Analysis of upper tract urothelial carcinoma in the Asian population","year":2025,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Urothelial carcinoma; Population; Table (database); Carcinoma; Urothelial cancer; Upper urinary tract","score_opus":0.011302231932064664,"score_gpt":0.28471453585310497,"score_spread":0.2734123039210403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416854610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263877,0.0019347038,0.00009581673,0.0021504702,0.00014188018,0.00011400727,0.000015098073,0.000002010786,0.0029072526],"genre_scores_gemma":[0.9986489,0.00012690658,0.000045894423,0.0010226015,0.00007731158,0.0000025044985,0.000010610775,0.000004529193,0.00006077188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990876,0.00014524211,0.0004118759,0.0000843832,0.00015674059,0.00011420532],"domain_scores_gemma":[0.9995834,0.000057689307,0.00014977485,0.00009892483,0.00008200004,0.000028192982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002857974,0.000059804053,0.00038146027,0.00040839292,0.00002510753,0.000009009079,0.00009971207,0.00007383902,0.000114713126],"category_scores_gemma":[0.00007680054,0.000048892223,0.00022267367,0.000507018,0.00003839037,0.000043938737,0.000007332998,0.00021292403,5.385482e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003526944,0.00032578412,0.9551171,0.000011438059,0.00051898666,0.00052260567,0.00023448194,0.000079206424,0.00008036376,0.00008152148,0.0002126427,0.042463154],"study_design_scores_gemma":[0.0018152718,0.00040269527,0.99351025,0.000024596571,0.0018384323,0.0011790231,0.00009855047,0.00007729819,0.000025949485,0.00024099376,0.00075879414,0.000028176208],"about_ca_topic_score_codex":0.00096722716,"about_ca_topic_score_gemma":0.00033886448,"teacher_disagreement_score":0.042434976,"about_ca_system_score_codex":0.000034593104,"about_ca_system_score_gemma":0.00010045361,"threshold_uncertainty_score":0.1993767},"labels":[],"label_agreement":null},{"id":"W4416989256","doi":"10.1016/j.euros.2025.11.005","title":"Neoadjuvant Chemotherapy Prior to Trimodality Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Chemotherapy; Radiation therapy; Neoadjuvant therapy; Clinical trial; MEDLINE; Cancer","score_opus":0.06284371825864796,"score_gpt":0.3880834686278801,"score_spread":0.32523975036923214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416989256","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06778814,0.43444565,0.010874786,0.35411793,0.0006695245,0.08264531,0.0006707882,0.00034029677,0.048447564],"genre_scores_gemma":[0.78917754,0.0065533207,0.001449122,0.19436763,0.000032279244,0.001760814,0.0000076881715,0.000038260667,0.006613378],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975948,0.00035774,0.00051069283,0.00092097605,0.00024631605,0.0003694951],"domain_scores_gemma":[0.9982139,0.0001830259,0.00018340322,0.00090414874,0.00030402074,0.00021151031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024705192,0.00025747836,0.0019124158,0.0002419363,0.00029669632,0.00011803726,0.0009813327,0.000029749333,0.0002593796],"category_scores_gemma":[0.0003836389,0.00016225547,0.00037101703,0.0015149795,0.00030694896,0.00014461394,0.00027089103,0.00009781046,0.000019432586],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005956224,0.004106526,0.006980646,0.10603129,0.77401316,0.00036854783,0.012550976,0.00013180633,0.019665364,0.007510461,0.029910505,0.032774467],"study_design_scores_gemma":[0.0091716,0.0028080184,0.059510596,0.0011236394,0.91295844,0.00004060124,0.00016363083,0.00008999347,0.0028826168,0.0002792369,0.010166242,0.00080540247],"about_ca_topic_score_codex":0.00016545536,"about_ca_topic_score_gemma":0.000059713973,"teacher_disagreement_score":0.72138935,"about_ca_system_score_codex":0.000066322325,"about_ca_system_score_gemma":0.0005722028,"threshold_uncertainty_score":0.6616586},"labels":[],"label_agreement":null},{"id":"W4416998010","doi":"10.1016/j.euros.2025.11.013","title":"Bladder Cancer Burden in the USA: Population Scenarios for 2040","year":2025,"lang":"en","type":"article","venue":"European Urology Open Science","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Division of Cancer Prevention, National Cancer Institute","keywords":"Bladder cancer; Incidence (geometry); Population; Disease; Cancer; Disease burden; Burden of disease","score_opus":0.041849464364634985,"score_gpt":0.3752965577728276,"score_spread":0.3334470934081926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416998010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8129656,0.0004194092,0.00029700174,0.031775616,0.00075178326,0.0027454754,0.000017026021,0.000025208523,0.1510029],"genre_scores_gemma":[0.98545754,0.00002405743,0.0002795692,0.010259177,0.00010621418,0.00009809052,0.000006029335,0.000009028693,0.0037602782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880594,0.0001322874,0.00018597585,0.00041352084,0.00017149364,0.00029080347],"domain_scores_gemma":[0.9993851,0.0000701889,0.000046996312,0.00037730843,0.00007510395,0.000045302568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012141264,0.0001008046,0.00015740063,0.0001338783,0.0002649581,0.000091556525,0.0009526206,0.000024225139,0.00011872616],"category_scores_gemma":[0.00016301147,0.00006542308,0.00003172967,0.0006053648,0.00026744386,0.00017417144,0.00023189947,0.00012648662,0.00005009656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014317783,0.00045395264,0.84935874,0.000051838215,0.00012923215,0.00015323563,0.004349391,0.0012380333,0.0056800186,0.009272083,0.020062722,0.107819006],"study_design_scores_gemma":[0.00198469,0.00025468986,0.95352846,0.000023469443,0.0000745621,0.000014930648,0.00008147835,0.00052682863,0.00009414401,0.00026599658,0.04307189,0.000078868776],"about_ca_topic_score_codex":0.002074352,"about_ca_topic_score_gemma":0.0008285119,"teacher_disagreement_score":0.17249198,"about_ca_system_score_codex":0.00006877512,"about_ca_system_score_gemma":0.0002890026,"threshold_uncertainty_score":0.31358135},"labels":[],"label_agreement":null},{"id":"W4417035351","doi":"10.1245/s10434-025-18821-5","title":"The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria","year":2025,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Surgical oncology; Cystectomy; Dissection (medical); Lymph node; Retrospective cohort study","score_opus":0.05824207290735467,"score_gpt":0.4606032444259093,"score_spread":0.4023611715185546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417035351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848869,0.0006875636,0.000009126344,0.00531129,0.00053127715,0.0005560151,0.000021058648,0.000015104704,0.007981704],"genre_scores_gemma":[0.99818623,0.0012342619,0.0000048459538,0.00023269707,0.000107874555,0.00015645649,0.0000046614873,0.000007200026,0.000065755194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984313,0.0003444755,0.00048624485,0.00029404255,0.00018191292,0.00026201693],"domain_scores_gemma":[0.9986293,0.0007829099,0.000098698496,0.00030431055,0.00010021764,0.00008458812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000758393,0.00014241484,0.0006622998,0.00010062632,0.000054292337,0.0000060072794,0.00009994737,0.00012732856,0.00006557604],"category_scores_gemma":[0.000068957066,0.00009022243,0.00016507469,0.00037491825,0.00012024239,0.000028978766,0.000046140416,0.00013240865,0.0000047767653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020988178,0.0006802497,0.8519986,0.00028086922,0.00027332312,0.00012163203,0.00014434094,0.00006983886,0.0047584865,0.00037598453,0.0010365725,0.1192719],"study_design_scores_gemma":[0.006856604,0.004004058,0.7996255,0.00043492307,0.00012437344,0.000012500431,0.00009830942,0.00005468704,0.13580368,0.0002406169,0.052613,0.00013171599],"about_ca_topic_score_codex":0.0012383066,"about_ca_topic_score_gemma":0.0001625705,"teacher_disagreement_score":0.13104519,"about_ca_system_score_codex":0.00016446794,"about_ca_system_score_gemma":0.00016269312,"threshold_uncertainty_score":0.36791638},"labels":[],"label_agreement":null},{"id":"W4417036026","doi":"10.2196/76736","title":"Protein-Protein Interactions in Papillary and Nonpapillary Urothelial Carcinoma Architectures: Comparative Study","year":2025,"lang":"en","type":"article","venue":"JMIR Bioinformatics and Biotechnology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Urothelial cancer; Papillary carcinoma; Transcriptome; Clinical significance; Carcinoma","score_opus":0.01786620038079396,"score_gpt":0.3086915078598775,"score_spread":0.29082530747908353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417036026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917918,0.00044869233,0.00011311963,0.002089353,0.00004886968,0.0030429214,0.00002263125,0.00007791552,0.002364738],"genre_scores_gemma":[0.9978728,0.00004966929,0.0011187218,0.0002632694,0.00001897002,0.00033335056,0.000008303685,0.0000080060545,0.00032690872],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905354,0.000028777064,0.0003693144,0.0002177981,0.00010017028,0.00023039941],"domain_scores_gemma":[0.9995493,0.000022843959,0.00007449319,0.00026207874,0.000032178497,0.00005906414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007444211,0.00021309563,0.00039692305,0.0005001154,0.00010817449,0.000027513044,0.000078132005,0.00015623098,0.000012343537],"category_scores_gemma":[0.000017835982,0.0001612601,0.00003539889,0.00033765245,0.0002101036,0.000049045026,0.00015226906,0.00040034173,0.0000058782307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006564729,0.0069077704,0.35688886,0.0039116563,0.002000731,0.00061791594,0.03648463,0.000008151941,0.10017197,0.011987032,0.0012276262,0.47322893],"study_design_scores_gemma":[0.04961679,0.019106591,0.6503473,0.003034997,0.00066612667,0.0010274894,0.050650444,0.0091586495,0.17017247,0.009896331,0.034187894,0.002134919],"about_ca_topic_score_codex":0.00017397093,"about_ca_topic_score_gemma":0.00022851679,"teacher_disagreement_score":0.471094,"about_ca_system_score_codex":0.000053778236,"about_ca_system_score_gemma":0.000100260855,"threshold_uncertainty_score":0.6575996},"labels":[],"label_agreement":null},{"id":"W4417076681","doi":"10.2196/75929","title":"Evaluation of the 2020 American Urological Association Microscopic Hematuria Guidelines in Clinical Practice: Retrospective Chart Review Analysis","year":2025,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microscopic hematuria; Referral; Risk stratification; Chart; MEDLINE; Retrospective cohort study","score_opus":0.11505823039838291,"score_gpt":0.5728953303573558,"score_spread":0.4578370999589729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417076681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8372281,0.016724579,0.00006755723,0.10971794,0.000354522,0.006193482,0.00007792636,0.000030746476,0.029605148],"genre_scores_gemma":[0.9916261,0.0055899546,0.00016705123,0.0016405022,0.000074439675,0.00036222176,0.00001866313,0.0000053335293,0.000515748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421394,0.002575402,0.0008197758,0.0002531483,0.0018897123,0.00024802878],"domain_scores_gemma":[0.9943595,0.0006217819,0.0003930723,0.00036286912,0.0042146756,0.000048102018],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013946662,0.00010159342,0.0006060869,0.00021365652,0.00008663603,0.000014467103,0.00015333646,0.000093446506,0.00013226346],"category_scores_gemma":[0.013203184,0.000061581435,0.00024993904,0.003640233,0.00016972155,0.00012801866,0.00011004133,0.0006585882,0.00001907323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000441009,0.0010329941,0.9014653,0.00038381258,0.0024610392,0.0000027907922,0.0008143711,0.000004779329,0.00012620851,0.00018071925,0.0617404,0.031346586],"study_design_scores_gemma":[0.0013684741,0.00045975432,0.9908534,0.0006320429,0.0013679076,9.336235e-7,0.00029694036,0.0005137947,0.00022015187,0.0003598238,0.0038808442,0.000045903173],"about_ca_topic_score_codex":0.00019233544,"about_ca_topic_score_gemma":0.00006943696,"teacher_disagreement_score":0.154398,"about_ca_system_score_codex":0.0010864149,"about_ca_system_score_gemma":0.00073727284,"threshold_uncertainty_score":0.995109},"labels":[],"label_agreement":null},{"id":"W4417154834","doi":"10.1097/ju9.0000000000000389","title":"Identification of a Highly Sensitive Combination of Urinary Protein Biomarkers for the Detection of High-Grade Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé","keywords":"Bladder cancer; Urinary system; Biomarker; Cancer; Urine; Malignancy; Diagnostic biomarker; Cancer biomarkers","score_opus":0.0211840932082635,"score_gpt":0.3222843878663795,"score_spread":0.301100294658116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417154834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847817,0.00054105354,0.00558815,0.0026027274,0.00029970336,0.00544758,0.00017388356,0.000012281508,0.00055295916],"genre_scores_gemma":[0.99764436,0.00004272794,0.000113157126,0.00004580993,0.00001711222,0.00050631544,0.000019581785,0.000009130179,0.0016018202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999274,0.00004261579,0.00031330757,0.00015056277,0.00014278996,0.00007668922],"domain_scores_gemma":[0.99915165,0.00007690918,0.00025375874,0.00021712937,0.00028433625,0.00001621787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019496473,0.00007898585,0.00023863568,0.00009252109,0.000052121155,0.000007700612,0.00009861886,0.000053412194,0.000008722124],"category_scores_gemma":[0.000045143974,0.000057477882,0.00006654159,0.00026626376,0.00008041955,0.00007726721,0.00004217319,0.000040677274,5.601617e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004409447,0.0006612828,0.00041856355,0.0006209559,0.0014712311,0.000001640359,0.0007491545,0.00004060372,0.9585867,0.0016824602,0.0004034737,0.03095449],"study_design_scores_gemma":[0.004296949,0.0004996954,0.059176747,0.00022185617,0.0004899938,0.0000016952016,0.00034637592,0.0009108351,0.933342,0.00048620318,0.00018141641,0.00004624503],"about_ca_topic_score_codex":0.0046917503,"about_ca_topic_score_gemma":0.00015103088,"teacher_disagreement_score":0.058758184,"about_ca_system_score_codex":0.00012578352,"about_ca_system_score_gemma":0.00023579365,"threshold_uncertainty_score":0.70925546},"labels":[],"label_agreement":null},{"id":"W4417232104","doi":"10.3390/curroncol32120699","title":"Bladder Preservation in Muscle-Invasive Bladder Cancer: A Population-Based Analysis from British Columbia","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"","keywords":"Cystectomy; Bladder cancer; Retrospective cohort study; Cohort; Bladder tumor; Radiation therapy; Cohort study; Resection","score_opus":0.04950845875521607,"score_gpt":0.38112642513042505,"score_spread":0.33161796637520896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417232104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913742,0.0033575054,0.000362609,0.0015418412,0.00090595736,0.0007888167,0.00029292158,0.000064077554,0.0013120843],"genre_scores_gemma":[0.9954156,0.00044160595,0.00019660708,0.0011534656,0.00019335488,0.00050149753,0.001220719,0.000016102244,0.00086100894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845546,0.0001316838,0.0004295817,0.0004954923,0.00020552108,0.00028225392],"domain_scores_gemma":[0.9990813,0.00022346247,0.00012559826,0.00029276975,0.00017990511,0.00009694603],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009090984,0.00013953797,0.00057964836,0.00025062938,0.00008383618,0.000059015176,0.00010864104,0.00018004962,0.0023329135],"category_scores_gemma":[0.0001376656,0.00019340024,0.00018538245,0.0011749358,0.00004934542,0.00009363806,0.000036958885,0.00023458936,0.000009163588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008209485,0.0007331167,0.9105664,0.000045631783,0.0007986313,0.000028428201,0.000110783,0.00018887891,0.00004081205,0.000005098026,0.010426985,0.07697314],"study_design_scores_gemma":[0.004528343,0.00014488667,0.96867305,0.00016486237,0.0021591706,5.632683e-7,0.000053373973,0.0015684185,0.000030244628,0.00047893694,0.02206033,0.00013783887],"about_ca_topic_score_codex":0.22434984,"about_ca_topic_score_gemma":0.6621142,"teacher_disagreement_score":0.43776435,"about_ca_system_score_codex":0.00083341566,"about_ca_system_score_gemma":0.0009982868,"threshold_uncertainty_score":0.9985791},"labels":[],"label_agreement":null},{"id":"W4417276352","doi":"10.1111/his.15559","title":"Grading of bladder cancer: updates, controversies and practical solutions","year":2025,"lang":"en","type":"review","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Grading (engineering); Bladder cancer; Risk stratification; Bladder tumor; Classification scheme; Bladder injury","score_opus":0.07335786768315528,"score_gpt":0.4018870277981325,"score_spread":0.32852916011497724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417276352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025076013,0.99255216,0.00006673298,0.00072545983,0.0004896365,0.00054964854,0.00023623898,0.000028936867,0.0053486717],"genre_scores_gemma":[0.00003321363,0.99477816,0.00030011812,0.0003426022,0.00009399482,0.00015111343,0.00007855064,0.000021321017,0.004200915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988268,0.00012120859,0.00037110335,0.0003405099,0.000095877826,0.0002445022],"domain_scores_gemma":[0.99904746,0.00034553782,0.00020728658,0.00026120362,0.00005775203,0.00008073682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010224448,0.00024559608,0.0016309359,0.00021437704,0.000078842524,0.000004070237,0.000043799035,0.00027847677,0.00026268838],"category_scores_gemma":[0.00018804596,0.00019976584,0.00022587697,0.000118710384,0.0002767967,0.00003105109,0.00007403331,0.00028638635,0.00001254569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001069468,0.0003032766,0.00019846341,0.026974443,0.0003937148,0.0006960191,0.00011540306,4.638969e-8,0.000008847352,0.00531666,0.048841935,0.9170442],"study_design_scores_gemma":[0.0006573883,0.00016892779,0.000099487625,0.003384021,0.0058732512,0.00083636673,0.000010402715,5.3742207e-7,0.0000017156448,0.00007416923,0.98877287,0.00012088531],"about_ca_topic_score_codex":0.00011937832,"about_ca_topic_score_gemma":0.00002726471,"teacher_disagreement_score":0.9399309,"about_ca_system_score_codex":0.00022330649,"about_ca_system_score_gemma":0.0011048068,"threshold_uncertainty_score":0.81462145},"labels":[],"label_agreement":null},{"id":"W4417276362","doi":"10.1111/his.15555","title":"Molecular pathology of bladder cancer","year":2025,"lang":"en","type":"review","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Molecular pathology; Bladder cancer; Trastuzumab; Personalized medicine; Targeted therapy; Cancer; Molecular diagnostics; Urothelial cancer; Clinical trial; Molecular oncology","score_opus":0.03235400222110826,"score_gpt":0.3691104928525055,"score_spread":0.33675649063139723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417276362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001797257,0.98042256,0.00007431248,0.000069355505,0.0008978693,0.0008174247,0.00020151235,0.000046083194,0.017452918],"genre_scores_gemma":[0.000023286828,0.99212426,0.00022217644,0.00041615864,0.000110067216,0.0004998494,0.00012366474,0.000055735,0.006424792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813753,0.00020968668,0.00063319603,0.00056209543,0.00014123107,0.00031627688],"domain_scores_gemma":[0.9987469,0.000072070936,0.00030748278,0.0006770167,0.00010982316,0.00008673853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009603852,0.00041505328,0.0028060658,0.0004064759,0.000030262285,0.0000019469592,0.0001805536,0.00061885733,0.0006687182],"category_scores_gemma":[0.00006363635,0.00033509347,0.00067758374,0.00030856446,0.00023670653,0.000012421118,0.000091902606,0.00037848347,0.000071448165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042743843,0.00024277178,0.00006352632,0.031248378,0.00016462826,0.0030796325,0.00006773285,2.3245843e-7,0.000074794414,0.00052488525,0.0030728139,0.96141785],"study_design_scores_gemma":[0.0006004452,0.0002608565,0.00011540585,0.005781183,0.005514582,0.0008477154,0.0000030111378,1.257189e-7,0.000023109664,0.000062002044,0.98659134,0.00020024284],"about_ca_topic_score_codex":0.000044860415,"about_ca_topic_score_gemma":0.0000076728375,"teacher_disagreement_score":0.9835185,"about_ca_system_score_codex":0.0002415531,"about_ca_system_score_gemma":0.0015195595,"threshold_uncertainty_score":0.9999101},"labels":[],"label_agreement":null},{"id":"W4417296326","doi":"10.1038/s41598-025-30020-6","title":"Investigation of image-guided in vivo irradiation on voiding patterns and bladder contractility in female mice","year":2025,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Department for the Economy; Medical Research Council; Friends of the Cancer Centre","keywords":"Contractility; Urination; Urinary bladder; Irradiation; In vivo; Cystometry","score_opus":0.028066639667856677,"score_gpt":0.3042414911964342,"score_spread":0.2761748515285775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417296326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959958,0.00007354848,0.00002065302,0.00034504096,0.000816615,0.0004548002,0.000004476443,0.000011255085,0.0022777724],"genre_scores_gemma":[0.9989685,0.0000071153972,0.000093015056,0.00010078474,0.000012783587,0.000021897475,0.000017298418,0.0000045800352,0.0007740557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988284,0.000045760753,0.00041796008,0.00038470505,0.00019775175,0.00012541196],"domain_scores_gemma":[0.999431,0.000044392145,0.00014027601,0.00026094334,0.00007763956,0.000045707602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007313443,0.00008070848,0.00018674645,0.00029098612,0.000040770014,0.000032236512,0.000021382004,0.000049849594,0.000041659758],"category_scores_gemma":[0.00019990357,0.0000739185,0.000026889531,0.00036844352,0.0000899456,0.00012241458,0.000013927413,0.00008526157,8.759236e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004343985,0.000069525435,0.8884872,0.00010127698,0.000013152954,0.00009261429,0.00070410303,0.0000061401447,0.1092899,0.000015819973,0.00056530203,0.0006115213],"study_design_scores_gemma":[0.0007067248,0.000028816823,0.80034786,0.0002494384,0.000025508118,0.00001787223,0.00016300498,0.00013086767,0.19693685,0.0011981998,0.00014841695,0.00004643641],"about_ca_topic_score_codex":0.00096099416,"about_ca_topic_score_gemma":0.00047191523,"teacher_disagreement_score":0.08813933,"about_ca_system_score_codex":0.00011514833,"about_ca_system_score_gemma":0.00018741105,"threshold_uncertainty_score":0.30143088},"labels":[],"label_agreement":null},{"id":"W4417360948","doi":"10.5489/cuaj.9370","title":"Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features","year":2025,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; Université Laval; University of Ottawa; McGill University Health Centre; Sinai Health System; University of British Columbia; Public Health Ontario; Dalhousie University; University of Toronto; University Health Network","funders":"University of Toronto; Canadian Institutes of Health Research; Bladder Cancer Canada","keywords":"Radiomics; Computed tomography; Segmentation; Medical imaging; Cancer imaging; Urothelial carcinoma; Image segmentation; Carcinoma","score_opus":0.02487647552395568,"score_gpt":0.2794751737810094,"score_spread":0.2545986982570537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417360948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701834,0.0003795333,0.001032841,0.0006002032,0.00020793882,0.00028613303,0.0001955348,0.000008409962,0.00027104755],"genre_scores_gemma":[0.9934151,0.000094048584,0.005799383,0.0005076328,0.000115211245,0.0000044607596,0.000015200803,0.0000073640645,0.00004157298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985136,0.00020974691,0.00063361146,0.00019672721,0.00022039247,0.00022596345],"domain_scores_gemma":[0.99880564,0.0001464532,0.00035619907,0.000077194105,0.00032336984,0.00029111275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005345497,0.00013481926,0.00042247426,0.00029764653,0.00020884651,0.000019090443,0.00006264871,0.00025767615,0.000022412869],"category_scores_gemma":[0.00033089716,0.00010725671,0.00016905174,0.00021201116,0.000083199,0.000060723418,0.0000130278195,0.00044933116,3.004253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019340521,0.00012371378,0.992598,0.000014011449,0.000411719,0.000008376245,0.0007113441,0.00029728722,0.0009817184,0.000045562338,0.00030916827,0.004305701],"study_design_scores_gemma":[0.0026641628,0.00030278368,0.9913534,0.000059748665,0.0003468377,0.000029195917,0.00011948554,0.003950081,0.00063893484,0.00025712693,0.00020550512,0.00007276414],"about_ca_topic_score_codex":0.00061054534,"about_ca_topic_score_gemma":0.00040267323,"teacher_disagreement_score":0.004766542,"about_ca_system_score_codex":0.00040520166,"about_ca_system_score_gemma":0.0021761304,"threshold_uncertainty_score":0.43738016},"labels":[],"label_agreement":null},{"id":"W4417480587","doi":"10.1016/j.jval.2025.09.570","title":"EE186 Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Carcinoma in situ; Food and drug administration; Bladder cancer; Bacillus (shape); Drug; Carcinoma","score_opus":0.029656904322169757,"score_gpt":0.29236009972322824,"score_spread":0.26270319540105846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928371,0.0013165072,0.000057278306,0.0024948216,0.00008631124,0.002722451,0.0003055983,0.000013279346,0.00016668571],"genre_scores_gemma":[0.9939474,0.0010851433,0.00034419537,0.0036411884,0.00003367697,0.00050167105,0.000071822295,0.000045718913,0.00032919683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735653,0.0005678471,0.0006135592,0.0005627006,0.00034527897,0.00055405684],"domain_scores_gemma":[0.9984569,0.00058463437,0.00023237555,0.0004638532,0.0001230716,0.00013917296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053512474,0.0003571789,0.0007166918,0.0007878039,0.00008805928,0.000018537583,0.00014558628,0.00013700401,0.000044487442],"category_scores_gemma":[0.000087860986,0.00023882401,0.00005171401,0.0014177759,0.00020767582,0.00008646446,0.00004855338,0.000393338,0.0000017482254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004433076,0.00095850305,0.96772265,0.00032861548,0.0002769897,0.00011432899,0.01647653,0.0065505435,0.00082489627,0.000040809202,0.00028721144,0.0019858195],"study_design_scores_gemma":[0.01492252,0.0013928023,0.97570574,0.00062988925,0.0001483482,0.000008016419,0.003498941,0.0018938859,0.0010868659,0.00006451676,0.0004512312,0.0001972696],"about_ca_topic_score_codex":0.44691792,"about_ca_topic_score_gemma":0.06604498,"teacher_disagreement_score":0.38087294,"about_ca_system_score_codex":0.00093068084,"about_ca_system_score_gemma":0.0014420621,"threshold_uncertainty_score":0.973896},"labels":[],"label_agreement":null},{"id":"W4417486584","doi":"10.1016/j.euf.2025.12.010","title":"Prognostic Factors of Trimodal Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"review","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Risk stratification; Selection (genetic algorithm); MEDLINE; Bladder cancer; Risk factor","score_opus":0.08328602889193773,"score_gpt":0.3628401935679633,"score_spread":0.27955416467602556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417486584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031627874,0.9874098,0.000058700913,0.00027254617,0.00006719284,0.010310618,0.0010226616,0.000045389417,0.0008099458],"genre_scores_gemma":[0.00038993882,0.995232,0.00004103408,0.0007901691,0.000047507587,0.0018996573,0.00017122773,0.0000933925,0.0013350733],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99602205,0.0013244329,0.0013366312,0.0007747842,0.00020327255,0.00033883873],"domain_scores_gemma":[0.9965096,0.0013587073,0.0009749586,0.00080462097,0.0002104338,0.00014169302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005183672,0.0007280485,0.011189301,0.00046163893,0.000066668676,0.0000131520455,0.00028024972,0.00017464701,0.0002483649],"category_scores_gemma":[0.0005370557,0.0004135546,0.0038991375,0.0007041908,0.00012827161,0.000026943379,0.00007404479,0.00027327758,0.000009261408],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002320071,0.00012824545,0.000016334527,0.65064627,0.3393436,0.000032691692,0.00006216074,1.3847995e-7,8.800634e-8,0.000015556448,0.000271964,0.00945974],"study_design_scores_gemma":[0.0006809245,0.00076757657,0.000039223534,0.013016116,0.95398915,0.0000195484,0.0000053405793,1.8371415e-7,0.0000010150345,0.000008843848,0.0312284,0.00024368735],"about_ca_topic_score_codex":0.00005046357,"about_ca_topic_score_gemma":0.00002104896,"teacher_disagreement_score":0.63763016,"about_ca_system_score_codex":0.00004845593,"about_ca_system_score_gemma":0.00054195203,"threshold_uncertainty_score":0.9998316},"labels":[],"label_agreement":null},{"id":"W4417487997","doi":"10.1002/bco2.70124","title":"Urinary biomarkers in multicentric studies: Shaping the future of bladder cancer diagnosis and follow‐up","year":2025,"lang":"en","type":"article","venue":"BJUI Compass","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Bundesministerium für Bildung und Forschung; Agence Nationale de la Recherche; World Health Organization","keywords":"Bladder cancer; Urinary system; Biomarker; Cancer; MEDLINE; Cancer biomarkers","score_opus":0.04705291178230041,"score_gpt":0.35331673764960486,"score_spread":0.30626382586730444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417487997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80795175,0.17852928,0.000012062795,0.010357577,0.0009812427,0.00092267117,0.000032585318,0.000026742626,0.0011861121],"genre_scores_gemma":[0.9883118,0.009960715,0.000059598835,0.0008767397,0.00010553087,0.0003933388,0.000002752847,0.0000100105735,0.00027945772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991967,0.000052065276,0.00021951892,0.00021052932,0.00013788238,0.00018330317],"domain_scores_gemma":[0.99944514,0.00019178707,0.000054632328,0.00019749053,0.00006959935,0.000041329593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000979729,0.00013819215,0.00033190125,0.00012986724,0.000069693146,0.000007507006,0.00007912941,0.000050027083,0.00007817814],"category_scores_gemma":[0.000029166642,0.000088997745,0.000066315595,0.00042123345,0.000096192314,0.00003591516,0.000076107695,0.000106552274,0.0000020124749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065056083,0.00041784561,0.9254254,0.00045791562,0.0023368958,0.00005023157,0.0020965151,0.0000069042694,0.000105009785,0.00013755767,0.03235613,0.03595903],"study_design_scores_gemma":[0.0094115585,0.00022346688,0.94887555,0.001014846,0.0007814941,0.000009269277,0.0054672835,0.00034207807,0.0010750946,0.00020169484,0.032433506,0.00016418914],"about_ca_topic_score_codex":0.00048672722,"about_ca_topic_score_gemma":0.00031416232,"teacher_disagreement_score":0.18036012,"about_ca_system_score_codex":0.00011771801,"about_ca_system_score_gemma":0.00010239672,"threshold_uncertainty_score":0.36292228},"labels":[],"label_agreement":null},{"id":"W4417535484","doi":"10.1016/j.soncn.2025.152090","title":"Exercise During or After Intravesical Therapy for Bladder Cancer: A Randomized Feasibility Trial","year":2025,"lang":"en","type":"article","venue":"Seminars in Oncology Nursing","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Canada Research Chairs; Alberta Cancer Foundation","keywords":"Randomized controlled trial; Confidence interval; Bladder cancer; MEDLINE; Prehabilitation; Clinical trial","score_opus":0.028374052065801895,"score_gpt":0.40675211407411194,"score_spread":0.37837806200831003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417535484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738023,0.010081832,0.00012869999,0.0047186003,0.0017329801,0.0074456483,0.000018672834,0.000056035533,0.0020151907],"genre_scores_gemma":[0.9847288,0.0048167435,0.001897469,0.00078923645,0.00039965397,0.0043365625,0.000012025468,0.000031964166,0.0029875566],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99831504,0.00018437667,0.0004971335,0.0004583925,0.00012907422,0.00041598963],"domain_scores_gemma":[0.9989325,0.00055854133,0.000082676335,0.00026434733,0.00006977129,0.00009216643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051663665,0.00022755,0.001135473,0.00019633805,0.000087213855,0.000013298453,0.00008688746,0.00028878642,0.0002063885],"category_scores_gemma":[0.00019923043,0.00016419686,0.00024594003,0.00025616406,0.00035849487,0.000054068743,0.000016503298,0.00025594712,0.0000016828747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81263125,0.0013940801,0.0011683684,0.0000619111,0.00015027942,0.00006295234,0.0017746686,0.0000011873509,0.00039448438,0.000018594701,0.0005909588,0.18175127],"study_design_scores_gemma":[0.97969633,0.0017624603,0.0040168664,0.0021424575,0.0006275687,0.000022428358,0.000404104,0.00010438942,0.007888821,0.0019656827,0.001186124,0.00018276167],"about_ca_topic_score_codex":0.000054243057,"about_ca_topic_score_gemma":0.000046244506,"teacher_disagreement_score":0.1815685,"about_ca_system_score_codex":0.0015053655,"about_ca_system_score_gemma":0.0010887608,"threshold_uncertainty_score":0.66957533},"labels":[],"label_agreement":null},{"id":"W53276981","doi":"10.4324/9780429436406-4","title":"The G7/G8 System","year":2019,"lang":"en","type":"book-chapter","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01939269722460827,"score_gpt":0.25176578090874524,"score_spread":0.23237308368413698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W53276981","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005385947,0.0024780983,0.000015617488,0.00047725363,0.00074731215,0.00066335115,0.000023114013,0.000102042235,0.9954878],"genre_scores_gemma":[0.007822416,0.00034545347,0.000024407798,0.00043086443,0.00047614577,0.0000114911345,0.000023418406,0.00006033094,0.99080545],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917716,0.000004370569,0.00018057253,0.00021825907,0.0002660967,0.00015352164],"domain_scores_gemma":[0.99921,0.00004551886,0.0000646864,0.00054120854,0.00006217241,0.000076385884],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000052922227,0.00021462534,0.00032331087,0.000029544273,0.00007155892,0.000020230536,0.000088787056,0.00018820117,0.00094335555],"category_scores_gemma":[0.0000024392327,0.00010835899,0.0001779506,0.0000073318633,0.000039519233,0.000011752237,0.00003105507,0.00019106628,0.0043380526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029621038,0.000021327633,0.00017570345,0.00052244944,0.0013662075,0.00014881755,0.000052477255,1.4426098e-7,0.000012606881,0.85650307,0.114346184,0.02655481],"study_design_scores_gemma":[0.0008004519,0.00021487345,0.00009114547,0.0003846327,0.00039523977,0.0000874386,0.00002919799,0.000004118533,0.000035197194,0.00040406667,0.9974272,0.00012643059],"about_ca_topic_score_codex":0.00004772211,"about_ca_topic_score_gemma":0.000021522597,"teacher_disagreement_score":0.883081,"about_ca_system_score_codex":0.00016538588,"about_ca_system_score_gemma":0.00022691496,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W55318368","doi":"","title":"Management of bacillus Calmette-Guerin (BCG) refractory superficial bladder cancer: results with intravesical BCG and Interferon combination therapy.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital","funders":"","keywords":"Medicine; Refractory (planetary science); Salvage therapy; Cystectomy; Urology; Bladder cancer; Surgery; Immunotherapy; Internal medicine; Oncology; Chemotherapy; Cancer","score_opus":0.02499655862825063,"score_gpt":0.25170137858460007,"score_spread":0.22670481995634945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W55318368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97967905,0.0011604275,0.00006341312,0.0006874167,0.00020700524,0.0013205039,0.000039197756,0.00003405772,0.016808927],"genre_scores_gemma":[0.99641615,0.0011770875,0.00012946212,0.00015690431,0.00005912341,0.00062679,0.000019819874,0.000025444337,0.0013892129],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99880993,0.00006008784,0.00026068653,0.0003038123,0.00028467202,0.00028082443],"domain_scores_gemma":[0.99946666,0.000026707217,0.00007515235,0.00022128616,0.00007197461,0.00013823398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018103156,0.00017653397,0.00028054928,0.000083320454,0.000042120275,0.000013641464,0.00005227786,0.00007155477,0.000049215778],"category_scores_gemma":[0.000013648284,0.00012906129,0.000037067217,0.00015372044,0.00011169174,0.00007603695,0.000017621442,0.0001318703,0.0000018236458],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0088481745,0.001453769,0.0104989335,0.00021839487,0.0014211901,0.00011976147,0.0010302744,0.0000044932876,0.00039342593,0.0023595053,0.00067482603,0.9729773],"study_design_scores_gemma":[0.020657618,0.0020792985,0.94086695,0.00011593583,0.00037621494,0.000039002647,0.00039250657,0.000008448344,0.020776406,0.00016637497,0.0142285675,0.00029265613],"about_ca_topic_score_codex":0.00019465534,"about_ca_topic_score_gemma":0.00004788597,"teacher_disagreement_score":0.9726846,"about_ca_system_score_codex":0.00013466366,"about_ca_system_score_gemma":0.000049187012,"threshold_uncertainty_score":0.5262967},"labels":[],"label_agreement":null},{"id":"W603820443","doi":"10.1200/jco.2004.22.90140.4519","title":"Long-term effects of conservation therapy for muscle invasive bladder carcinoma","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Radiation therapy; Bladder cancer; Cystoscopy; Surgery; Urology; Chemotherapy; Carcinoma; Survival rate; Cancer; Internal medicine; Urinary system","score_opus":0.10765998591047263,"score_gpt":0.44364298719860124,"score_spread":0.33598300128812864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W603820443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917737,0.001047072,0.0005785269,0.004716986,0.0010205568,0.0005776818,0.000003468194,0.0000046037067,0.00027736512],"genre_scores_gemma":[0.99250317,0.0009426225,0.0017170327,0.0039014684,0.0008348208,0.0000136791505,0.0000035343573,0.000015308395,0.000068373556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982215,0.000117091855,0.0012011669,0.00012233571,0.00019458606,0.00014330725],"domain_scores_gemma":[0.99611074,0.002032817,0.0010339639,0.0001308803,0.0005124373,0.00017916632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006087794,0.00010441843,0.0009417666,0.000071362054,0.000023928465,0.0000030243723,0.00008744269,0.00024625123,0.000038686507],"category_scores_gemma":[0.0014365822,0.00007094712,0.0004615614,0.00006856583,0.00014114045,0.00007325547,0.000011789802,0.00026448024,0.0000034568814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011732612,0.005386398,0.8027287,0.0002743173,0.0014175356,0.0006656045,0.00045675295,0.000007686623,0.006952574,0.0001741339,0.0017173383,0.16848633],"study_design_scores_gemma":[0.035612367,0.034794796,0.9144496,0.00013737842,0.00041784125,0.000096402146,0.00002145954,0.000001133052,0.012351515,0.00091675133,0.001145648,0.00005512795],"about_ca_topic_score_codex":0.00003940734,"about_ca_topic_score_gemma":0.00004582358,"teacher_disagreement_score":0.1684312,"about_ca_system_score_codex":0.00011039511,"about_ca_system_score_gemma":0.002416717,"threshold_uncertainty_score":0.42871523},"labels":[],"label_agreement":null},{"id":"W6885876940","doi":"10.1371/journal.pone.0294809.s007","title":"PICO analysis.","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Perioperative; Ileus; Bladder cancer; Blood loss; Complication; Urinary diversion; Incidence (geometry)","score_opus":0.059332427288903,"score_gpt":0.32804152585236435,"score_spread":0.26870909856346137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6885876940","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029447328,0.00092374766,0.000002554734,0.0019411122,0.00018237108,0.0010146378,0.73687184,0.0017847695,0.22783165],"genre_scores_gemma":[0.7878329,0.000004669125,0.000014336042,0.00067462464,0.00015819748,0.00013836812,0.19473651,0.000014676473,0.016425693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957687,0.000005202338,0.000059814352,0.00011941922,0.0001162825,0.00012239815],"domain_scores_gemma":[0.9997037,0.000017863955,0.000013607293,0.00016312776,0.000031699263,0.00006997044],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000009395789,0.00005542448,0.00012358792,0.00012057082,0.00002681532,0.0000081196995,0.000035159017,0.00003113966,0.3307157],"category_scores_gemma":[0.00007969426,0.000044465367,0.00011188991,0.0008375484,0.0000013794063,0.00002086547,0.000021595359,0.000042521213,0.018536003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001391826,0.000025185564,0.0054414156,0.0000572945,0.0004949113,0.00011752743,0.00007485377,0.000006425804,0.000026191832,0.0000045090474,0.99109095,0.0026468246],"study_design_scores_gemma":[0.00066979026,0.00008405809,0.484675,0.00015854448,0.00038457688,0.0000055705877,0.000027169592,0.00032492285,0.00084906846,0.00002460694,0.5127115,0.000085157226],"about_ca_topic_score_codex":0.000007963748,"about_ca_topic_score_gemma":0.000006142642,"teacher_disagreement_score":0.7583856,"about_ca_system_score_codex":0.00001892509,"about_ca_system_score_gemma":0.000037924066,"threshold_uncertainty_score":0.98222816},"labels":[],"label_agreement":null},{"id":"W6885902854","doi":"10.1371/journal.pone.0294809.s004","title":"Literature search strategy.","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Perioperative; Bladder cancer; Ileus; Blood loss; Complication; Urinary diversion; Incidence (geometry)","score_opus":0.09254375937095599,"score_gpt":0.34835841187286026,"score_spread":0.25581465250190427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6885902854","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021541867,0.0032415073,2.1778708e-7,0.0015287895,0.0001627371,0.0012949291,0.72167104,0.0012556298,0.24930325],"genre_scores_gemma":[0.7167428,0.00002282937,0.000011877109,0.00047329624,0.00038829277,0.00015459351,0.25989762,0.000030070565,0.022278618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994564,0.000009090186,0.000056440735,0.00014053978,0.00015952604,0.00017800012],"domain_scores_gemma":[0.9996548,0.000018276758,0.000007628419,0.0001568759,0.00006778236,0.00009458304],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000012937017,0.00007379521,0.00008885173,0.000060307335,0.000037688613,0.00003357221,0.000046332454,0.00006123356,0.14395879],"category_scores_gemma":[0.000051146486,0.000057027763,0.000051841213,0.0004052353,0.000002012445,0.000045654455,0.000026886437,0.0001255983,0.015478705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031668238,0.000027490703,0.00026671277,0.00023948228,0.000037458994,0.00049143384,0.00029306894,0.0000033374122,0.00012932913,0.000012801811,0.99005187,0.008415354],"study_design_scores_gemma":[0.003958232,0.00095227204,0.21705538,0.007884973,0.00006385464,0.00021574888,0.00040043183,0.00051604246,0.011064899,0.00017313777,0.75729287,0.00042217755],"about_ca_topic_score_codex":0.0000025852826,"about_ca_topic_score_gemma":9.831027e-7,"teacher_disagreement_score":0.6952009,"about_ca_system_score_codex":0.000021449881,"about_ca_system_score_gemma":0.00009232942,"threshold_uncertainty_score":0.98528785},"labels":[],"label_agreement":null},{"id":"W6889165868","doi":"10.25402/fon.22006616.v1","title":"French translation of: Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.","year":2023,"lang":"en","type":"article","venue":"Future Science Group","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Javelin; Avelumab; Urothelial cancer; Translation (biology); Plain language","score_opus":0.027502424383626857,"score_gpt":0.3255212212646091,"score_spread":0.2980187968809822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889165868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98723555,0.0012245409,0.00034500798,0.0026372143,0.0011678151,0.0030257425,0.0035948888,0.00007707418,0.0006921565],"genre_scores_gemma":[0.99656725,0.00025702958,0.0011249743,0.00012915046,0.0007086529,0.00028773118,0.00018949251,0.000023355813,0.0007123614],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805623,0.000048875863,0.0004311614,0.00052531087,0.00057317066,0.00036523593],"domain_scores_gemma":[0.9988231,0.00023796121,0.00018782631,0.00051383185,0.0001445884,0.00009268287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048376955,0.00021058366,0.0003790765,0.00011932546,0.00019583353,0.00001493001,0.00028585063,0.0000657552,0.000042679392],"category_scores_gemma":[0.00008910577,0.00012617403,0.00014125822,0.0009320302,0.0002744296,0.00013091444,0.000028020988,0.00009281136,0.0000054517645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010843533,0.0023401645,0.021372272,0.00012946274,0.0007939925,0.00007339482,0.120426536,0.00040533778,0.21211608,0.00026153866,0.00682035,0.62441736],"study_design_scores_gemma":[0.08685767,0.01402504,0.7194741,0.0010011245,0.0015526374,0.00001279202,0.052731197,0.004201235,0.093559876,0.0007997478,0.024771564,0.0010130435],"about_ca_topic_score_codex":0.0044994666,"about_ca_topic_score_gemma":0.002912473,"teacher_disagreement_score":0.6981018,"about_ca_system_score_codex":0.00015544084,"about_ca_system_score_gemma":0.00042917818,"threshold_uncertainty_score":0.68018776},"labels":[],"label_agreement":null},{"id":"W6891785221","doi":"10.48083/vubv4988","title":"Clinical Utility of Bladder Cancer Biomarkers","year":2020,"lang":"en","type":"article","venue":"Société Internationale d’Urologie Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Disease; Biomarker; Cancer; Drug; Food and drug administration; Medical diagnosis; Bladder tumor","score_opus":0.13337931943829137,"score_gpt":0.4268216637221022,"score_spread":0.2934423442838108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6891785221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9309642,0.0024781213,0.0011207638,0.032350034,0.0018447258,0.0003316234,0.00013478198,0.00006546168,0.030710327],"genre_scores_gemma":[0.990805,0.0012310019,0.0006534745,0.005807488,0.0010267078,0.000009679772,0.000013410809,0.000012655117,0.00044063563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984406,0.00010110702,0.0006093373,0.00022414162,0.00043702393,0.00018775358],"domain_scores_gemma":[0.99883854,0.00016318184,0.00029773725,0.00011832089,0.00033672963,0.00024551174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033112025,0.00013450714,0.00036262043,0.000049602208,0.000055672906,0.000015380654,0.0001965034,0.00012726082,0.007463028],"category_scores_gemma":[0.0004437148,0.00010436016,0.000398647,0.00010771387,0.00017804478,0.000091179696,0.000061176645,0.00046693557,0.000025295645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014711674,0.00032557076,0.8982586,0.000026402293,0.002086068,0.00007878842,0.00020055677,0.0000055604864,0.00041591126,0.000039022165,0.042577434,0.054514866],"study_design_scores_gemma":[0.0061985687,0.0011321255,0.9437047,0.000048228492,0.00044705774,0.00012698572,0.00034770984,0.0009759273,0.0013459647,0.0008980962,0.044618793,0.00015584614],"about_ca_topic_score_codex":0.000031074105,"about_ca_topic_score_gemma":0.0000039889205,"teacher_disagreement_score":0.059840783,"about_ca_system_score_codex":0.000059243506,"about_ca_system_score_gemma":0.00044595829,"threshold_uncertainty_score":0.99344426},"labels":[],"label_agreement":null},{"id":"W6901518872","doi":"10.60692/akzkz-xa809","title":"Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Cystectomy; Urinary system; Cancer; PTEN; Urinary bladder; Retrospective cohort study; Carcinoma","score_opus":0.016545439314320586,"score_gpt":0.2068846966616084,"score_spread":0.19033925734728782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901518872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553204,0.000012655624,0.0001695084,0.000016146334,0.00035227358,0.0010443517,0.0001679227,0.00003346466,0.0026716376],"genre_scores_gemma":[0.999539,2.3561034e-7,0.000017001425,0.00004290799,0.000035817786,0.000070079994,0.000041024894,0.000016651338,0.00023727183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854314,0.00009727325,0.00073382515,0.00015638125,0.00033247194,0.00013690353],"domain_scores_gemma":[0.998505,0.0000036863605,0.00054266193,0.00052647095,0.00036542476,0.000056746456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012415157,0.00016916286,0.0003966054,0.00013614907,0.00008236354,0.000014729548,0.00009710244,0.000089281435,0.00003863279],"category_scores_gemma":[0.0000082610695,0.00012330698,0.00013756803,0.00033672625,0.00003640286,0.00022664564,0.00006897821,0.00010882045,0.0000490822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019455096,0.00008200366,0.8700201,0.00041577197,0.00009689317,0.000012234396,0.12681179,0.000004536855,0.0023177369,0.0000036809483,0.0000060902075,0.00003459922],"study_design_scores_gemma":[0.0041378257,0.00048194441,0.9363447,0.000080722006,0.00026145735,0.000053385527,0.02178105,0.00010694092,0.036653526,2.0529512e-7,0.00000604077,0.000092210736],"about_ca_topic_score_codex":0.000012771645,"about_ca_topic_score_gemma":3.27625e-7,"teacher_disagreement_score":0.105030745,"about_ca_system_score_codex":0.00024712065,"about_ca_system_score_gemma":0.0002459564,"threshold_uncertainty_score":0.5028313},"labels":[],"label_agreement":null},{"id":"W6901562887","doi":"10.60692/3dj59-wdx42","title":"Additional file 21 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Germline; Urinary system","score_opus":0.049546789808453534,"score_gpt":0.2749349546073354,"score_spread":0.22538816479888188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901562887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69616175,0.000009211957,0.000060683353,0.000089174704,0.0005024585,0.00096754637,0.26133475,0.00038441314,0.040490028],"genre_scores_gemma":[0.97893786,0.0000014586478,0.000077130804,0.00022687156,0.00024722022,0.0006048163,0.016497893,0.00002213549,0.003384627],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99857354,0.00002399918,0.0006012985,0.0001639947,0.00040533795,0.00023181432],"domain_scores_gemma":[0.998843,0.00004149619,0.00030222317,0.00028960398,0.00040434458,0.00011931238],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000064780616,0.00020004959,0.0003372873,0.0003269386,0.00017925691,0.00006567376,0.00010436671,0.00012516281,0.05754412],"category_scores_gemma":[0.000044784225,0.00016440249,0.00014715602,0.00035347405,0.000104557,0.000397548,0.00005570765,0.000092286595,0.0013943276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046519496,0.0000330036,0.12026335,0.0031269423,0.0014293268,0.000056096567,0.22389615,0.00026611995,0.00018669669,0.00022507831,0.64849025,0.001561761],"study_design_scores_gemma":[0.0036247785,0.00028460263,0.8656821,0.00115258,0.00016237561,0.000031141306,0.010637407,0.00016552545,0.003238458,0.0000053707627,0.1146505,0.00036514516],"about_ca_topic_score_codex":0.00006530096,"about_ca_topic_score_gemma":0.000006862731,"teacher_disagreement_score":0.7454188,"about_ca_system_score_codex":0.0003211517,"about_ca_system_score_gemma":0.0002717511,"threshold_uncertainty_score":0.9993832},"labels":[],"label_agreement":null},{"id":"W6901621209","doi":"10.60692/j2r1h-p0884","title":"Additional file 3 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Urinary system; Somatic cell","score_opus":0.049099445652345385,"score_gpt":0.27338275807373286,"score_spread":0.22428331242138747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901621209","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38886276,0.0000058079927,0.000037846534,0.00006371864,0.00037694388,0.00081077125,0.56871927,0.0003460664,0.040776823],"genre_scores_gemma":[0.9609771,0.0000010918151,0.000087311004,0.00022574943,0.00024658404,0.000789368,0.033666976,0.000022241276,0.0039836215],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986432,0.000022042932,0.0005713677,0.00015610331,0.0003854093,0.00022183043],"domain_scores_gemma":[0.9988721,0.000051351995,0.00029518877,0.0002764756,0.0003909006,0.00011397076],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054264976,0.00019095535,0.00032083242,0.00031904783,0.00017167728,0.000061379,0.00009965601,0.00011906523,0.145261],"category_scores_gemma":[0.000054543907,0.00015670236,0.0001417557,0.00034835964,0.00010121307,0.00037926534,0.000053142678,0.000087580134,0.0017089371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002373747,0.00001710254,0.04659693,0.0016825394,0.0007712786,0.000029926381,0.11282026,0.000117014955,0.00007532431,0.000092289425,0.8366864,0.0008735955],"study_design_scores_gemma":[0.0030845113,0.00026482853,0.7850268,0.0012207908,0.0001383098,0.00002849998,0.009469992,0.00015217482,0.002308754,0.0000044284893,0.19795835,0.0003425775],"about_ca_topic_score_codex":0.000052705254,"about_ca_topic_score_gemma":0.0000056289246,"teacher_disagreement_score":0.73842984,"about_ca_system_score_codex":0.0003040648,"about_ca_system_score_gemma":0.0002707362,"threshold_uncertainty_score":0.9990683},"labels":[],"label_agreement":null},{"id":"W6901624999","doi":"10.60692/x1ptp-4cs30","title":"Additional file 1 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Kidney cancer; Cancer; MEDLINE","score_opus":0.04986049044063756,"score_gpt":0.273731890060865,"score_spread":0.22387139962022745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901624999","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38535643,0.000005759219,0.000037511643,0.00006376966,0.00037226695,0.0008078684,0.57259953,0.00034523293,0.040411636],"genre_scores_gemma":[0.960457,0.0000010787818,0.000088390734,0.00022620022,0.000244272,0.00080436916,0.03423902,0.000022270999,0.003917355],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99864346,0.000022062772,0.0005711306,0.00015616695,0.0003853362,0.00022184644],"domain_scores_gemma":[0.99887455,0.000051780084,0.00029514602,0.0002768638,0.000387711,0.00011398007],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005428794,0.00019098046,0.00032080183,0.00031914728,0.00017169108,0.00006126153,0.00009971456,0.00011907469,0.14817293],"category_scores_gemma":[0.000054557586,0.00015673964,0.00014176415,0.0003484803,0.00010120635,0.00037899322,0.00005317856,0.00008759685,0.0016917035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022992092,0.000016665777,0.045329515,0.0016131682,0.000751829,0.000028824727,0.10988295,0.00011394205,0.000073197,0.00009042047,0.8410302,0.0008393775],"study_design_scores_gemma":[0.0030462218,0.00026526419,0.78826636,0.001223624,0.00013952765,0.000028760287,0.009515168,0.00015199977,0.0022637357,0.0000044179246,0.19475226,0.00034265776],"about_ca_topic_score_codex":0.000052152864,"about_ca_topic_score_gemma":0.00000559345,"teacher_disagreement_score":0.74293685,"about_ca_system_score_codex":0.00030294326,"about_ca_system_score_gemma":0.00027059656,"threshold_uncertainty_score":0.9990856},"labels":[],"label_agreement":null},{"id":"W6901665691","doi":"10.60692/vtx7k-p5r29","title":"Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Cystectomy; Urinary system; Cancer; PTEN; Urinary bladder; Retrospective cohort study; Carcinoma","score_opus":0.016545439314320586,"score_gpt":0.2068846966616084,"score_spread":0.19033925734728782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901665691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553204,0.000012655624,0.0001695084,0.000016146334,0.00035227358,0.0010443517,0.0001679227,0.00003346466,0.0026716376],"genre_scores_gemma":[0.999539,2.3561034e-7,0.000017001425,0.00004290799,0.000035817786,0.000070079994,0.000041024894,0.000016651338,0.00023727183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854314,0.00009727325,0.00073382515,0.00015638125,0.00033247194,0.00013690353],"domain_scores_gemma":[0.998505,0.0000036863605,0.00054266193,0.00052647095,0.00036542476,0.000056746456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012415157,0.00016916286,0.0003966054,0.00013614907,0.00008236354,0.000014729548,0.00009710244,0.000089281435,0.00003863279],"category_scores_gemma":[0.0000082610695,0.00012330698,0.00013756803,0.00033672625,0.00003640286,0.00022664564,0.00006897821,0.00010882045,0.0000490822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019455096,0.00008200366,0.8700201,0.00041577197,0.00009689317,0.000012234396,0.12681179,0.000004536855,0.0023177369,0.0000036809483,0.0000060902075,0.00003459922],"study_design_scores_gemma":[0.0041378257,0.00048194441,0.9363447,0.000080722006,0.00026145735,0.000053385527,0.02178105,0.00010694092,0.036653526,2.0529512e-7,0.00000604077,0.000092210736],"about_ca_topic_score_codex":0.000012771645,"about_ca_topic_score_gemma":3.27625e-7,"teacher_disagreement_score":0.105030745,"about_ca_system_score_codex":0.00024712065,"about_ca_system_score_gemma":0.0002459564,"threshold_uncertainty_score":0.5028313},"labels":[],"label_agreement":null},{"id":"W6901719069","doi":"10.60692/320bx-exk41","title":"Additional file 14 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Somatic cell; Chromosome; Gene; Urothelial carcinoma; Gene duplication; Table (database)","score_opus":0.01761217176436455,"score_gpt":0.1924936927287976,"score_spread":0.17488152096443305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901719069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6697836,8.444488e-7,0.00012824146,0.00002000857,0.00014304284,0.00091579685,0.32730258,0.000018617635,0.0016872663],"genre_scores_gemma":[0.98997676,2.5427186e-8,0.000058350655,0.000056828572,0.000032063774,0.00049334497,0.008940612,0.000008991081,0.0004330224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988311,0.00006615,0.0005695634,0.000075733944,0.00036675326,0.0000907011],"domain_scores_gemma":[0.99888605,0.000009702738,0.00059031026,0.00024350114,0.00024194155,0.00002848952],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007581684,0.00010179907,0.00024020085,0.00013995264,0.0000699456,0.000005058307,0.0001050862,0.00003927249,0.04920382],"category_scores_gemma":[0.000022384274,0.000070205664,0.000114544826,0.00025181836,0.000045494955,0.000110788234,0.000054519372,0.00007816493,0.000025264833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009863229,0.0004171551,0.5815846,0.008967919,0.0028173486,0.000013524604,0.2578894,0.00038118157,0.01831303,0.00044781022,0.11341511,0.0058897515],"study_design_scores_gemma":[0.0047398913,0.0007875072,0.9173972,0.0005746708,0.0002326321,0.00014116218,0.008160398,0.0010211379,0.049540933,0.0000014287215,0.017186172,0.00021688892],"about_ca_topic_score_codex":0.000022026703,"about_ca_topic_score_gemma":9.773768e-8,"teacher_disagreement_score":0.33581263,"about_ca_system_score_codex":0.00012060735,"about_ca_system_score_gemma":0.00029880466,"threshold_uncertainty_score":0.95166534},"labels":[],"label_agreement":null},{"id":"W6901731763","doi":"10.60692/dx9m6-3nc83","title":"Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemotherapy; Regimen; Bladder cancer; Vinblastine; Cisplatin","score_opus":0.1474640356602482,"score_gpt":0.35044805500334636,"score_spread":0.20298401934309815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901731763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8964788,0.043775406,0.024855973,0.0050370344,0.00035942186,0.02582016,0.0025686237,0.00074093323,0.00036364666],"genre_scores_gemma":[0.9972077,0.0003036043,0.00007114914,0.00096287974,0.00002688773,0.0011602822,0.00009661622,0.000015397742,0.00015546761],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9980346,0.000105711784,0.0011200819,0.00019940373,0.00029552396,0.000244696],"domain_scores_gemma":[0.99865544,0.00007238385,0.00064557913,0.00035354868,0.00015901128,0.00011405019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047023926,0.0002868469,0.0038322988,0.00024287877,0.000087059016,0.00003394322,0.00007276162,0.00009999075,0.000026914702],"category_scores_gemma":[0.000010547961,0.00015733544,0.000501935,0.00048831635,0.00005038288,0.00010356715,0.000026333924,0.00006320852,0.000007657604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002519606,0.000019905527,0.6197515,0.11589391,0.24381588,0.0000019659763,0.01886202,0.00014373615,6.18526e-7,0.000030595063,0.00063803216,0.0005898619],"study_design_scores_gemma":[0.0073082275,0.0008253639,0.43098283,0.0044722757,0.5470265,0.0000121993535,0.004275514,0.004458971,0.0001233674,0.000003776923,0.00007645456,0.00043447834],"about_ca_topic_score_codex":0.00003480444,"about_ca_topic_score_gemma":0.000002272742,"teacher_disagreement_score":0.30321065,"about_ca_system_score_codex":0.00009214485,"about_ca_system_score_gemma":0.000028888548,"threshold_uncertainty_score":0.6415953},"labels":[],"label_agreement":null},{"id":"W6901740272","doi":"10.60692/p5agv-wj339","title":"Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Medical Research Council","keywords":"Bracken; Bladder cancer; Fern; Mutation; Cancer; Gene; Animal model; Urinary bladder; Chromatin","score_opus":0.058711113299676196,"score_gpt":0.2889245152361715,"score_spread":0.2302134019364953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901740272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792952,0.000014154191,0.00015059393,0.00013953475,0.000674981,0.00069177884,0.00024086412,0.0004746324,0.018318284],"genre_scores_gemma":[0.9954234,0.000004816241,0.000029403855,0.0005073614,0.00032338372,0.00024562562,0.00016552738,0.000030524552,0.0032699932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984102,0.000029195418,0.00060317514,0.0002151393,0.00040284157,0.00033940608],"domain_scores_gemma":[0.99890864,0.000009090631,0.00021465216,0.00040792002,0.00028305658,0.00017663685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013710906,0.0002597389,0.00036614973,0.0003792852,0.00030144796,0.00017062055,0.00013052332,0.00015285425,0.00025327876],"category_scores_gemma":[0.000014780103,0.00020629374,0.00014704872,0.0004278535,0.0000790254,0.0004883817,0.00007227765,0.00012324355,0.0018992935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001964206,0.000008278073,0.7505836,0.0011714525,0.000540211,0.000049725102,0.24464783,0.00016327358,0.000260704,0.0001555587,0.0010941151,0.001128824],"study_design_scores_gemma":[0.0046536736,0.00021404283,0.963339,0.00038272006,0.00020634542,0.000032584303,0.0125038335,0.00016619677,0.0068269293,0.0000030114845,0.011301522,0.0003701602],"about_ca_topic_score_codex":0.00015819028,"about_ca_topic_score_gemma":0.000009087649,"teacher_disagreement_score":0.232144,"about_ca_system_score_codex":0.00053428364,"about_ca_system_score_gemma":0.00019769465,"threshold_uncertainty_score":0.9988778},"labels":[],"label_agreement":null},{"id":"W6901820804","doi":"10.6084/m9.figshare.13141507","title":"Additional file 2 of Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Value (mathematics); Carcinoma; Biomarker; Scale (ratio); Overall survival","score_opus":0.022646305895735144,"score_gpt":0.23933884694848195,"score_spread":0.21669254105274682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901820804","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009312406,0.0067365956,8.74663e-8,0.000036052596,0.0000016283576,0.0034835197,0.9802771,0.000022914011,0.00012969051],"genre_scores_gemma":[0.5951456,0.000011612362,0.00004426853,0.00023652463,0.000006795462,0.0033896822,0.40108207,0.000027991398,0.00005550533],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99809027,0.0002855973,0.00074644026,0.00034313014,0.00037212914,0.00016244088],"domain_scores_gemma":[0.99839836,0.00056315836,0.000427954,0.00020821794,0.0002432961,0.00015902938],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000037150476,0.00027579162,0.0019417793,0.00015530967,0.000024171986,0.000008156293,0.000089065325,0.00010261086,0.6542216],"category_scores_gemma":[0.0013041472,0.00017559736,0.00041684575,0.0007072308,0.000035055793,0.00008846172,0.000026507407,0.000105416824,0.000047356767],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010600806,0.0008687714,0.02074474,0.5007023,0.21425518,0.00028986298,0.0018452556,0.000017099472,0.000017344022,0.000001944637,0.2601805,0.000016919945],"study_design_scores_gemma":[0.0103015015,0.003595629,0.19603159,0.15271707,0.6337871,0.0002107825,0.00021659976,0.0014509128,0.00033189543,0.0000011495996,0.00054788234,0.0008079212],"about_ca_topic_score_codex":0.000029208766,"about_ca_topic_score_gemma":0.0000038612993,"teacher_disagreement_score":0.6541742,"about_ca_system_score_codex":0.00010415438,"about_ca_system_score_gemma":0.0003933909,"threshold_uncertainty_score":0.7160653},"labels":[],"label_agreement":null},{"id":"W6901848519","doi":"10.60692/kc6kn-pvv45","title":"Additional file 1 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Kidney cancer; Cancer; MEDLINE","score_opus":0.04986049044063756,"score_gpt":0.273731890060865,"score_spread":0.22387139962022745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901848519","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38535643,0.000005759219,0.000037511643,0.00006376966,0.00037226695,0.0008078684,0.57259953,0.00034523293,0.040411636],"genre_scores_gemma":[0.960457,0.0000010787818,0.000088390734,0.00022620022,0.000244272,0.00080436916,0.03423902,0.000022270999,0.003917355],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99864346,0.000022062772,0.0005711306,0.00015616695,0.0003853362,0.00022184644],"domain_scores_gemma":[0.99887455,0.000051780084,0.00029514602,0.0002768638,0.000387711,0.00011398007],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005428794,0.00019098046,0.00032080183,0.00031914728,0.00017169108,0.00006126153,0.00009971456,0.00011907469,0.14817293],"category_scores_gemma":[0.000054557586,0.00015673964,0.00014176415,0.0003484803,0.00010120635,0.00037899322,0.00005317856,0.00008759685,0.0016917035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022992092,0.000016665777,0.045329515,0.0016131682,0.000751829,0.000028824727,0.10988295,0.00011394205,0.000073197,0.00009042047,0.8410302,0.0008393775],"study_design_scores_gemma":[0.0030462218,0.00026526419,0.78826636,0.001223624,0.00013952765,0.000028760287,0.009515168,0.00015199977,0.0022637357,0.0000044179246,0.19475226,0.00034265776],"about_ca_topic_score_codex":0.000052152864,"about_ca_topic_score_gemma":0.00000559345,"teacher_disagreement_score":0.74293685,"about_ca_system_score_codex":0.00030294326,"about_ca_system_score_gemma":0.00027059656,"threshold_uncertainty_score":0.9990856},"labels":[],"label_agreement":null},{"id":"W6901849793","doi":"10.60692/sqtce-sdm95","title":"Additional file 13 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proteogenomics; Gene; Transcriptome; Genome; Bladder cancer; Exome sequencing; DNA sequencing","score_opus":0.017477801892394205,"score_gpt":0.19162258008215038,"score_spread":0.17414477818975618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901849793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6965306,7.7204317e-7,0.000108017455,0.000017989894,0.00012256486,0.00084829744,0.3008152,0.000017068514,0.001539491],"genre_scores_gemma":[0.99004334,2.5800912e-8,0.000049953138,0.00005639517,0.000032275402,0.00050258846,0.008915002,0.000008979802,0.00039146107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884087,0.00006521093,0.0005690644,0.000075626034,0.0003586233,0.00009059579],"domain_scores_gemma":[0.99890715,0.000009626765,0.0005892384,0.00024333246,0.00022212137,0.000028509661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007267058,0.00010185663,0.00023954811,0.00014004766,0.000069659254,0.0000051103893,0.00010543999,0.000038465772,0.05067913],"category_scores_gemma":[0.000020257725,0.00007019109,0.000114318434,0.00025210454,0.000045504883,0.00011254804,0.000054775435,0.00007656636,0.000025884136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008276023,0.0003591481,0.64063895,0.007697289,0.0024405054,0.000011679498,0.23338188,0.0003957379,0.015691018,0.00032592658,0.08568886,0.005092994],"study_design_scores_gemma":[0.003747539,0.000632704,0.9387168,0.0004622644,0.00018680262,0.00011375863,0.007623169,0.0009876769,0.036649283,0.0000011443391,0.010703615,0.00017521919],"about_ca_topic_score_codex":0.000032355416,"about_ca_topic_score_gemma":1.3966407e-7,"teacher_disagreement_score":0.29807788,"about_ca_system_score_codex":0.00011867911,"about_ca_system_score_gemma":0.0003000921,"threshold_uncertainty_score":0.9501887},"labels":[],"label_agreement":null},{"id":"W6901863850","doi":"10.6084/m9.figshare.12715346","title":"Additional file 1 of Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Survivorship curve; Bladder cancer; Plan (archaeology); Cancer; Health care; MEDLINE; Patient care","score_opus":0.1821102988319279,"score_gpt":0.3864732081429659,"score_spread":0.20436290931103798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901863850","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004554672,0.0021527945,0.0000020321327,0.000014346436,0.000014584635,0.00086699513,0.99179476,0.0000124514745,0.00058737624],"genre_scores_gemma":[0.057215482,0.000009119765,0.010001203,0.00012625073,0.00006968642,0.0011771206,0.93134624,0.00002186403,0.000033029188],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987509,0.00014288335,0.0003106871,0.00031664287,0.0003658136,0.000113075],"domain_scores_gemma":[0.9987627,0.00031026485,0.00015736656,0.0000905767,0.0005350746,0.00014399568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000046125006,0.00013741468,0.00028602706,0.000029125555,0.000036117905,0.000008421776,0.000045330125,0.000102548125,0.5596602],"category_scores_gemma":[0.0007758275,0.00011802079,0.00004839573,0.000088756206,0.00002382634,0.000050163,0.00004816051,0.00010722044,0.000013732137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012381391,0.00014582937,0.0041917902,0.00081941497,0.00014172429,6.507706e-7,0.004489825,6.883952e-7,0.0000032655748,4.9717183e-8,0.91322374,0.07685919],"study_design_scores_gemma":[0.009665682,0.00097277283,0.43763205,0.0034100814,0.00033126015,0.00000249192,0.0068110707,0.00082527293,0.0012648915,0.0000012435065,0.5386904,0.00039280517],"about_ca_topic_score_codex":0.000026434542,"about_ca_topic_score_gemma":0.000029244284,"teacher_disagreement_score":0.5596465,"about_ca_system_score_codex":0.00006408737,"about_ca_system_score_gemma":0.00047414802,"threshold_uncertainty_score":0.4812748},"labels":[],"label_agreement":null},{"id":"W6901875787","doi":"10.60692/j19bf-8jw91","title":"Additional file 4 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Urinary system; Somatic cell","score_opus":0.04942577986166618,"score_gpt":0.27374421822568,"score_spread":0.22431843836401383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901875787","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38943455,0.0000058568253,0.000038259644,0.00006392591,0.00037565097,0.00081545446,0.56803626,0.00034822483,0.04088183],"genre_scores_gemma":[0.9612039,0.0000010886216,0.00008714354,0.00022531819,0.00024355833,0.0007871151,0.033585932,0.000022171094,0.003843813],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99864304,0.000022040238,0.00057155907,0.00015611797,0.00038538672,0.00022185403],"domain_scores_gemma":[0.9988786,0.00005144497,0.00029523787,0.00027661456,0.00038411006,0.000113977265],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054305743,0.0001909678,0.0003209033,0.00031918666,0.0001717572,0.000061409555,0.000099724595,0.000119074655,0.14331138],"category_scores_gemma":[0.000053830263,0.00015673021,0.00014176597,0.00034831802,0.00010123008,0.0003793172,0.000053161635,0.000087577595,0.001676331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024122495,0.00001722064,0.046993125,0.0016809478,0.00077625125,0.00003021681,0.11364783,0.00011623021,0.000074721385,0.00009604465,0.8354476,0.0008785739],"study_design_scores_gemma":[0.0030874226,0.0002703032,0.79112697,0.0012292205,0.00013993261,0.000028910843,0.009541093,0.00015338042,0.0022749323,0.0000044913777,0.19179907,0.0003442447],"about_ca_topic_score_codex":0.0000522674,"about_ca_topic_score_gemma":0.000005650525,"teacher_disagreement_score":0.7441339,"about_ca_system_score_codex":0.00030297047,"about_ca_system_score_gemma":0.0002697871,"threshold_uncertainty_score":0.999101},"labels":[],"label_agreement":null},{"id":"W6901909716","doi":"10.6084/m9.figshare.24040765.v1","title":"Additional file 26 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Cancer; Human disease","score_opus":0.0678167115461763,"score_gpt":0.33056138394439954,"score_spread":0.26274467239822324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901909716","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004238606,0.000121362915,2.6420443e-8,0.000086792425,0.000058469854,0.0002947318,0.9778243,0.00013444801,0.017241297],"genre_scores_gemma":[0.046785668,0.000025874933,0.00003772233,0.00047145062,0.0005408122,0.0014444083,0.93831664,0.0000641659,0.0123132365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894994,0.000014363908,0.00022951874,0.00027801585,0.00029164331,0.00023649656],"domain_scores_gemma":[0.99892956,0.00031011555,0.00011093684,0.00024287206,0.00028187936,0.00012460895],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00001101272,0.00017667901,0.00026449305,0.00012288711,0.00013641425,0.000024801639,0.00012170693,0.00011177857,0.9843997],"category_scores_gemma":[0.00048528207,0.00015949312,0.00015604509,0.00029818536,0.000043260166,0.00009856293,0.0000891011,0.00012998532,0.0037502928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027024556,0.00005807328,0.0001382114,0.00020112302,0.00016381814,0.000053324933,0.000621138,0.000007198318,0.0006111929,0.000006431865,0.9973333,0.00077918696],"study_design_scores_gemma":[0.000834848,0.00016889755,0.13414434,0.0015356675,0.00003689595,0.000004160557,0.000104549086,0.000009196576,0.004313674,0.00005147762,0.8586429,0.00015343248],"about_ca_topic_score_codex":0.00007997554,"about_ca_topic_score_gemma":0.0002786908,"teacher_disagreement_score":0.98064935,"about_ca_system_score_codex":0.00017514778,"about_ca_system_score_gemma":0.00048562855,"threshold_uncertainty_score":0.99702543},"labels":[],"label_agreement":null},{"id":"W6901995548","doi":"10.6084/m9.figshare.24040768.v1","title":"Additional file 27 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; Table (database); Gene","score_opus":0.06716418527288916,"score_gpt":0.3301432262449604,"score_spread":0.26297904097207125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901995548","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044168173,0.00012088581,2.5729337e-8,0.00008312587,0.000076727614,0.0002921873,0.9748011,0.00009332988,0.02011576],"genre_scores_gemma":[0.033917878,0.000026036629,0.000035095545,0.00043087438,0.0005076036,0.0010572888,0.94696194,0.000047498288,0.017015783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998952,0.000014358263,0.00022905313,0.00027766477,0.00029090449,0.0002360689],"domain_scores_gemma":[0.99892986,0.00031125685,0.00011088907,0.00024248334,0.00028100313,0.0001245171],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010954078,0.00017660309,0.00026407177,0.00012311971,0.00012436915,0.000024777135,0.00012188987,0.0001116619,0.9859885],"category_scores_gemma":[0.0004865498,0.00015941168,0.00015591847,0.00029689728,0.000043133823,0.00009848887,0.00008933965,0.00012969994,0.0035670982],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002680187,0.00005779603,0.00015330479,0.00019978003,0.00016328497,0.00005275507,0.0006178411,0.0000071411323,0.0007008637,0.0000064921987,0.9974224,0.00059152505],"study_design_scores_gemma":[0.0008231702,0.00016725954,0.110018484,0.0015222639,0.000036672103,0.00000412147,0.000103679966,0.000008233062,0.004421639,0.000051135576,0.8826908,0.00015253761],"about_ca_topic_score_codex":0.00007804571,"about_ca_topic_score_gemma":0.00027817272,"teacher_disagreement_score":0.9824214,"about_ca_system_score_codex":0.00017503931,"about_ca_system_score_gemma":0.0004852234,"threshold_uncertainty_score":0.9972087},"labels":[],"label_agreement":null},{"id":"W6902016756","doi":"10.6084/m9.figshare.24223796","title":"Additional file 1 of Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma","year":2023,"lang":"en","type":"article","venue":"Open MIND","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Toronto","funders":"","keywords":"Durvalumab; Tremelimumab; Table (database); Baseline (sea); Logistic regression; Identification (biology); Metastatic Urothelial Carcinoma","score_opus":0.056478196676771,"score_gpt":0.32287421775356345,"score_spread":0.26639602107679244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902016756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6614871,0.000007767683,0.000021310198,0.000022132379,0.000058604535,0.0010142382,0.3362629,0.0000027145006,0.0011232065],"genre_scores_gemma":[0.96148497,0.000009874454,0.00058760046,0.0000047595504,0.000046248413,0.00031627325,0.034125675,0.000029746116,0.0033948356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99825203,0.00009466701,0.0006768548,0.00030443387,0.0004885166,0.00018346494],"domain_scores_gemma":[0.99845475,0.00043257774,0.00046161562,0.00032334763,0.000259721,0.00006796587],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001840707,0.00016760221,0.0006314004,0.00020534678,0.000028061222,0.000012784063,0.00019651609,0.000053271775,0.2262909],"category_scores_gemma":[0.0002815236,0.00013038097,0.000072685696,0.00049806095,0.00016272352,0.00013535754,0.00007218613,0.00009204578,0.00008258405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17627499,0.015175641,0.28072447,0.0057799458,0.008581577,0.0037665253,0.027955191,0.00027996945,0.03162735,0.000048676986,0.1253057,0.32447997],"study_design_scores_gemma":[0.0072028306,0.0017065422,0.9785159,0.0007742456,0.0003876723,0.000036676898,0.0005412676,0.00039561302,0.009866603,0.000008771336,0.00042340145,0.00014047454],"about_ca_topic_score_codex":0.0001611175,"about_ca_topic_score_gemma":0.00026659959,"teacher_disagreement_score":0.69779146,"about_ca_system_score_codex":0.00010888819,"about_ca_system_score_gemma":0.0011561053,"threshold_uncertainty_score":0.7744164},"labels":[],"label_agreement":null},{"id":"W6902036887","doi":"10.6084/m9.figshare.19704021.v1","title":"Additional file 6 of Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Immune system; Tumor microenvironment; Urinary system; Urinary bladder; Disease","score_opus":0.04124733527612807,"score_gpt":0.24941394704289113,"score_spread":0.20816661176676307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902036887","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38052958,0.00025843666,1.1900695e-8,0.00012809424,0.0000034396664,0.0002844102,0.618511,0.000002446229,0.00028256228],"genre_scores_gemma":[0.956178,0.000008958638,0.000013091257,0.00037843367,0.000018407714,0.0018689359,0.041312356,0.000011529122,0.00021026623],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990458,0.000064836975,0.00023311828,0.00017242346,0.0003508192,0.00013301116],"domain_scores_gemma":[0.9991283,0.00041190782,0.00016159462,0.00024296444,0.000030582618,0.000024676514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003414566,0.00012466728,0.0002307294,0.000054949858,0.000070823284,0.0000031679892,0.00016441598,0.000018938405,0.7769213],"category_scores_gemma":[0.00008878979,0.000076936594,0.00006345973,0.00011778307,0.000034915476,0.000028827364,0.00013882207,0.00018069486,0.000006429346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048779714,0.001822635,0.004330593,0.0006450692,0.0005099563,0.00007767977,0.0073077576,0.0009519373,0.013823496,0.000010347545,0.968707,0.001325731],"study_design_scores_gemma":[0.0022060126,0.0017019926,0.9561383,0.0033442732,0.00013724087,0.00007860019,0.0035530943,0.0027771916,0.020940777,0.00008154553,0.0087551875,0.00028578882],"about_ca_topic_score_codex":0.00015562288,"about_ca_topic_score_gemma":0.000009381294,"teacher_disagreement_score":0.9599518,"about_ca_system_score_codex":0.0000459265,"about_ca_system_score_gemma":0.00014290841,"threshold_uncertainty_score":0.31373832},"labels":[],"label_agreement":null},{"id":"W6902075859","doi":"10.6084/m9.figshare.24040738","title":"Additional file 20 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Context (archaeology); Sequence (biology); Base (topology); Human disease","score_opus":0.06669249215027505,"score_gpt":0.32975875321139875,"score_spread":0.2630662610611237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902075859","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035349408,0.0001284447,2.4882722e-8,0.00009486669,0.000056845784,0.00029021446,0.97361666,0.00009181584,0.02218616],"genre_scores_gemma":[0.028375372,0.000021538392,0.00003395962,0.00043256942,0.00050994847,0.0012991364,0.95272446,0.000045634544,0.016557362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989584,0.0000141178425,0.00022748929,0.00027620498,0.000288765,0.0002350234],"domain_scores_gemma":[0.99894357,0.00030105177,0.00011034228,0.00023893378,0.00028031174,0.00012581747],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010564951,0.00017553403,0.00026270415,0.00012099736,0.00013416365,0.00002428205,0.00012117414,0.00011100455,0.98640835],"category_scores_gemma":[0.00043610815,0.00015857018,0.00015392531,0.00029616218,0.000042580148,0.000099022305,0.00008822902,0.00012959879,0.0030906673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027316082,0.00005686629,0.00014288122,0.00019310162,0.00016268161,0.00005268738,0.0005744217,0.00000875356,0.00076040317,0.0000051058482,0.9973584,0.00065742905],"study_design_scores_gemma":[0.0008337988,0.0001668355,0.09626708,0.0014877635,0.0000366283,0.0000039878355,0.000096089534,0.000010101722,0.0044940696,0.00004821258,0.89640325,0.00015216405],"about_ca_topic_score_codex":0.00007034538,"about_ca_topic_score_gemma":0.00035200058,"teacher_disagreement_score":0.9833177,"about_ca_system_score_codex":0.00017082693,"about_ca_system_score_gemma":0.000492102,"threshold_uncertainty_score":0.99768555},"labels":[],"label_agreement":null},{"id":"W6902083746","doi":"10.6084/m9.figshare.24040699","title":"Additional file 10 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Indel; Bladder cancer; Chromothripsis; Urothelial cancer; Urinary bladder; Urinary system","score_opus":0.06799290781389802,"score_gpt":0.32971126833165176,"score_spread":0.26171836051775377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902083746","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040763416,0.00010973217,1.785941e-8,0.00007306704,0.000048190952,0.00027560804,0.9674189,0.00009300797,0.027905148],"genre_scores_gemma":[0.02903037,0.000017952416,0.000030637864,0.000348532,0.00048140934,0.0012965149,0.9383875,0.00004565226,0.030361423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998965,0.000014076537,0.00022595534,0.00027532192,0.00028766264,0.00023193289],"domain_scores_gemma":[0.9989035,0.00031130057,0.00010988633,0.00024217217,0.00031028694,0.00012282387],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010858881,0.00017494189,0.00026031543,0.00012175174,0.00013300427,0.000024669409,0.00012099053,0.0001121593,0.9936739],"category_scores_gemma":[0.00054020697,0.00015798466,0.00015432911,0.00029487794,0.000042839085,0.00009637579,0.00008884751,0.00011833378,0.0048822244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033517903,0.0000573159,0.00007837118,0.00019215686,0.00015845096,0.00004859328,0.0005185427,0.0000052423884,0.00046663263,0.0000051942784,0.9976327,0.0008033164],"study_design_scores_gemma":[0.0008120402,0.00018095228,0.0927397,0.001378825,0.000035148954,0.0000035369246,0.00008676816,0.000008764482,0.0037592575,0.000048485366,0.90079963,0.00014690937],"about_ca_topic_score_codex":0.00006533833,"about_ca_topic_score_gemma":0.00023451794,"teacher_disagreement_score":0.98879164,"about_ca_system_score_codex":0.00017114799,"about_ca_system_score_gemma":0.00048921624,"threshold_uncertainty_score":0.9958926},"labels":[],"label_agreement":null},{"id":"W6902161280","doi":"10.6084/m9.figshare.24040765","title":"Additional file 26 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Cancer; Human disease","score_opus":0.0678167115461763,"score_gpt":0.33056138394439954,"score_spread":0.26274467239822324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902161280","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004238606,0.000121362915,2.6420443e-8,0.000086792425,0.000058469854,0.0002947318,0.9778243,0.00013444801,0.017241297],"genre_scores_gemma":[0.046785668,0.000025874933,0.00003772233,0.00047145062,0.0005408122,0.0014444083,0.93831664,0.0000641659,0.0123132365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894994,0.000014363908,0.00022951874,0.00027801585,0.00029164331,0.00023649656],"domain_scores_gemma":[0.99892956,0.00031011555,0.00011093684,0.00024287206,0.00028187936,0.00012460895],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00001101272,0.00017667901,0.00026449305,0.00012288711,0.00013641425,0.000024801639,0.00012170693,0.00011177857,0.9843997],"category_scores_gemma":[0.00048528207,0.00015949312,0.00015604509,0.00029818536,0.000043260166,0.00009856293,0.0000891011,0.00012998532,0.0037502928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027024556,0.00005807328,0.0001382114,0.00020112302,0.00016381814,0.000053324933,0.000621138,0.000007198318,0.0006111929,0.000006431865,0.9973333,0.00077918696],"study_design_scores_gemma":[0.000834848,0.00016889755,0.13414434,0.0015356675,0.00003689595,0.000004160557,0.000104549086,0.000009196576,0.004313674,0.00005147762,0.8586429,0.00015343248],"about_ca_topic_score_codex":0.00007997554,"about_ca_topic_score_gemma":0.0002786908,"teacher_disagreement_score":0.98064935,"about_ca_system_score_codex":0.00017514778,"about_ca_system_score_gemma":0.00048562855,"threshold_uncertainty_score":0.99702543},"labels":[],"label_agreement":null},{"id":"W6902245233","doi":"10.6084/m9.figshare.24040702","title":"Additional file 11 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; In vitro; Cancer","score_opus":0.06790424637729232,"score_gpt":0.3297295210749292,"score_spread":0.2618252746976369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902245233","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007258588,0.00009990694,2.5861919e-8,0.0000851672,0.000057703684,0.00029148554,0.97770983,0.00009579666,0.014401512],"genre_scores_gemma":[0.050623752,0.00001907145,0.000034536082,0.00041892708,0.00048887363,0.0013229434,0.93473274,0.00004678414,0.012312396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895406,0.000014314631,0.00022869123,0.00027729664,0.00028932522,0.0002363213],"domain_scores_gemma":[0.9989381,0.0003041823,0.000110715766,0.00024254013,0.00028002734,0.00012444926],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010932834,0.00017642476,0.00026391094,0.00012337077,0.00013542776,0.000024330882,0.00012193982,0.0001103189,0.98464143],"category_scores_gemma":[0.00047435064,0.0001593187,0.00015572131,0.00029858208,0.000043085136,0.00009843193,0.000089465,0.00011406824,0.0025332053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020288564,0.000058248173,0.00027341652,0.0001997614,0.00013252918,0.000053875083,0.0006110677,0.000006863185,0.0005027338,0.000007819755,0.99755996,0.0005734211],"study_design_scores_gemma":[0.0008032045,0.0001374836,0.1579083,0.0014354883,0.000034929235,0.000003954626,0.00010541006,0.000008255498,0.0039348677,0.00004142044,0.8354418,0.00014482676],"about_ca_topic_score_codex":0.00012184818,"about_ca_topic_score_gemma":0.00056610967,"teacher_disagreement_score":0.98210824,"about_ca_system_score_codex":0.0001719623,"about_ca_system_score_gemma":0.00047815946,"threshold_uncertainty_score":0.99824345},"labels":[],"label_agreement":null},{"id":"W6902270072","doi":"10.6084/m9.figshare.24040705","title":"Additional file 12 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Mutation; Base (topology); Cancer","score_opus":0.07212420733341551,"score_gpt":0.32894751311182524,"score_spread":0.2568233057784097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902270072","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032234187,0.00010740459,3.264844e-8,0.00007449027,0.000058432957,0.00029263264,0.97112894,0.000094277144,0.025020342],"genre_scores_gemma":[0.04268171,0.000023678143,0.000031601307,0.00043154383,0.000517861,0.0013433384,0.9403576,0.000047191566,0.014565454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895436,0.000014330059,0.000228084,0.00027495893,0.0002907565,0.0002375439],"domain_scores_gemma":[0.99897146,0.00030803678,0.00011030306,0.00024128886,0.00024359216,0.00012530999],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010960049,0.00017619901,0.00026272496,0.00012157124,0.00013572311,0.000024361483,0.00012047268,0.00011146787,0.98582006],"category_scores_gemma":[0.00046853026,0.00015903471,0.00015544257,0.00024200542,0.000042788542,0.00010022182,0.00008908362,0.00012866477,0.002764756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000285596,0.0000582008,0.00017264509,0.00019981091,0.00016555558,0.00005096648,0.0006600618,0.000008334175,0.00052821037,0.0000059169233,0.99740094,0.0007207948],"study_design_scores_gemma":[0.00082769064,0.00016855309,0.13924728,0.0014888364,0.00003665012,0.0000040477134,0.000100450976,0.000009839554,0.003420035,0.00004694365,0.85449946,0.0001502404],"about_ca_topic_score_codex":0.000085260035,"about_ca_topic_score_gemma":0.0003806224,"teacher_disagreement_score":0.9830553,"about_ca_system_score_codex":0.0001759463,"about_ca_system_score_gemma":0.00047299868,"threshold_uncertainty_score":0.9980117},"labels":[],"label_agreement":null},{"id":"W6902305127","doi":"10.6084/m9.figshare.24040732","title":"Additional file 19 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Indel; Bladder cancer; Urinary bladder; Urinary system; Mutation","score_opus":0.07235850267625167,"score_gpt":0.3363142776486124,"score_spread":0.2639557749723607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902305127","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039348034,0.00013910895,2.9256414e-8,0.00009351198,0.00005619332,0.00030113634,0.9753973,0.00009838599,0.019979563],"genre_scores_gemma":[0.03736467,0.000025700023,0.000035645484,0.0005641254,0.00048882276,0.001364816,0.9463299,0.000045361656,0.01378095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989518,0.000014940245,0.00022769392,0.000279863,0.0002915636,0.00023417262],"domain_scores_gemma":[0.99890316,0.00033846876,0.00011126354,0.0002434145,0.00025464152,0.0001490644],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011509932,0.0001752905,0.00026118543,0.00012696757,0.00014410177,0.000024462806,0.00012208775,0.0001102056,0.985305],"category_scores_gemma":[0.0006022869,0.00015828034,0.0001551099,0.0003041979,0.000043725977,0.00009365198,0.00009004088,0.0001281333,0.0028496878],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002826646,0.000056353143,0.00016114546,0.00022222009,0.0001614971,0.000057970665,0.00068500947,0.000008651943,0.0005034287,0.0000069727325,0.99744827,0.00066023937],"study_design_scores_gemma":[0.00084896496,0.0001566979,0.11740069,0.0012887404,0.000035171302,0.000004591033,0.00010945555,0.000008281219,0.0028780515,0.00005440883,0.8770667,0.00014828006],"about_ca_topic_score_codex":0.000114657174,"about_ca_topic_score_gemma":0.00030187407,"teacher_disagreement_score":0.9824553,"about_ca_system_score_codex":0.00019933784,"about_ca_system_score_gemma":0.00058019307,"threshold_uncertainty_score":0.9979267},"labels":[],"label_agreement":null},{"id":"W6902362162","doi":"10.6084/m9.figshare.24040723","title":"Additional file 16 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Bracken; Table (database); Signature (topology); Cancer; Fern","score_opus":0.06650654841165893,"score_gpt":0.3297488570631881,"score_spread":0.2632423086515292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902362162","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003039989,0.00012856766,3.5659713e-8,0.00007956815,0.00005714679,0.00028876937,0.96886665,0.000094201074,0.027445052],"genre_scores_gemma":[0.04084578,0.000023412787,0.00002575893,0.0004435249,0.00048542416,0.0012902239,0.94223404,0.000045152574,0.014606693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989512,0.000014401018,0.00023412108,0.0002765208,0.00028847528,0.00023530236],"domain_scores_gemma":[0.99893236,0.00030902136,0.000113666305,0.00024143788,0.000279578,0.00012394985],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011187108,0.00017592375,0.00026230456,0.00012279433,0.00013541315,0.00002441414,0.00012028316,0.00011101181,0.9909755],"category_scores_gemma":[0.0004901295,0.00015779393,0.00016139554,0.00029423946,0.000043121418,0.00009769238,0.00008877784,0.00012732035,0.0029577946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002759956,0.00005707099,0.00011171964,0.00019972623,0.00016259716,0.000041798303,0.00051184965,0.000005067942,0.000374227,0.0000070747383,0.99755955,0.0009417128],"study_design_scores_gemma":[0.000841592,0.0001661379,0.0806882,0.00155987,0.000036176552,0.000004062652,0.00011295972,0.000005703868,0.0037046939,0.00006387544,0.9126653,0.00015143721],"about_ca_topic_score_codex":0.00010372776,"about_ca_topic_score_gemma":0.0005154322,"teacher_disagreement_score":0.9880177,"about_ca_system_score_codex":0.00024793422,"about_ca_system_score_gemma":0.00048701,"threshold_uncertainty_score":0.9978185},"labels":[],"label_agreement":null},{"id":"W6904815175","doi":"10.1371/journal.pone.0294809.s003","title":"Funnel plot.","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Perioperative; Ileus; Bladder cancer; Blood loss; Complication; Urinary diversion; Postoperative ileus","score_opus":0.08603617560339406,"score_gpt":0.3234068732725644,"score_spread":0.23737069766917035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6904815175","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025255349,0.0011680109,6.306062e-7,0.00317881,0.00041255698,0.0014534767,0.6577755,0.0028559582,0.30789968],"genre_scores_gemma":[0.790216,0.000011905203,0.000022865854,0.0015825651,0.00052801846,0.00037507506,0.18137251,0.000050156945,0.025840897],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995782,0.000003983757,0.000053937758,0.00011212793,0.00011134721,0.00014043627],"domain_scores_gemma":[0.99972486,0.000018775438,0.000011100069,0.00014071459,0.00002922212,0.000075351454],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000076095957,0.000059989932,0.000083423096,0.000041116426,0.00003069303,0.000007746339,0.000036207548,0.000035284276,0.2315648],"category_scores_gemma":[0.00010153508,0.000048662114,0.000047759335,0.00018972444,0.0000015623781,0.00002602614,0.000026429898,0.00005083187,0.044835664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015993473,0.000018720546,0.00047218183,0.00007067167,0.000025631576,0.00010749115,0.00007033454,5.29119e-7,0.000057775596,0.0000053911413,0.9956632,0.0034920247],"study_design_scores_gemma":[0.0013182984,0.00017342548,0.11888366,0.00080784975,0.000030550043,0.000028634115,0.000070711474,0.00008624589,0.0020795097,0.00007090511,0.8763366,0.00011362997],"about_ca_topic_score_codex":0.0000049442756,"about_ca_topic_score_gemma":0.0000013537408,"teacher_disagreement_score":0.76496065,"about_ca_system_score_codex":0.000020291756,"about_ca_system_score_gemma":0.00005130775,"threshold_uncertainty_score":0.95590806},"labels":[],"label_agreement":null},{"id":"W6920083874","doi":"10.60692/cmh49-dq342","title":"Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Logistic regression; Confidence interval; Biopsy; Stage (stratigraphy); T-stage; Retrospective cohort study; Stepwise regression; Hydronephrosis; Risk stratification; Urothelial carcinoma","score_opus":0.041398835784562896,"score_gpt":0.2781369927777442,"score_spread":0.2367381569931813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920083874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934083,0.000008825108,0.0013905863,0.000072437266,0.0006645204,0.0021263335,0.000814286,0.00007521619,0.001439479],"genre_scores_gemma":[0.997721,0.00000124309,0.000416944,0.000088183166,0.0001623912,0.0009197917,0.00054679246,0.000017343367,0.00012629956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983318,0.00013711852,0.00070185476,0.00027841784,0.00033715868,0.0002136426],"domain_scores_gemma":[0.9987662,0.000026307913,0.0002777022,0.0003610064,0.0004172172,0.00015157256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029162207,0.000212347,0.00037358355,0.00027763753,0.00011084428,0.00015173425,0.000071845665,0.00008639034,0.000045363882],"category_scores_gemma":[0.00008664634,0.00018053513,0.000093552735,0.00026513857,0.000014428125,0.0007767871,0.00001690214,0.0000939843,0.000038490067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037846604,0.00013081402,0.95617026,0.00013262338,0.00015568266,0.000019759065,0.04229779,0.000029314251,0.0000075257117,0.000023321903,0.000025036663,0.0006294004],"study_design_scores_gemma":[0.006746747,0.00038233976,0.95828,0.00014500513,0.00018907775,0.00003025481,0.03001402,0.0009525991,0.0029665718,0.0000013625856,0.00014533312,0.00014667488],"about_ca_topic_score_codex":0.00009051152,"about_ca_topic_score_gemma":0.000007742616,"teacher_disagreement_score":0.012283771,"about_ca_system_score_codex":0.00047244344,"about_ca_system_score_gemma":0.0005974266,"threshold_uncertainty_score":0.7362009},"labels":[],"label_agreement":null},{"id":"W6920225220","doi":"10.6068/dp14ba8d3a42c39","title":"Trend 1981 - 2013. Statistics Canada. CANSIM: Construction - Nonresidential Building Construction | Country: Canada | Table: Flows and stocks of fixed non-residential capital, by sector of North American Industry Classification System (NAICS) and asset | Variable: Straight-line end-year net stock, Software (x 1,000,000), Industrial sector, 2007 constant prices | Units: $CAD, 1981-2013. Data-Planet™ Statistical Ready Reference by Conquest Systems, Inc. Dataset-ID: 075-001-035.","year":2015,"lang":"en","type":"other","venue":"Data Planet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic statistics; Census; Stock (firearms); Official statistics; Publication; Summary statistics; Index (typography); Descriptive statistics; National accounts","score_opus":0.02622844276683422,"score_gpt":0.2534936732107721,"score_spread":0.22726523044393787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920225220","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046156492,0.0008440769,0.00010361448,0.0000032508744,0.0014704783,0.0014465634,0.99535793,0.00006837404,0.0002441594],"genre_scores_gemma":[0.0026975018,0.0005410744,0.0008822423,0.000029964403,0.0007060433,0.000029255263,0.9947562,0.00017371016,0.0001839657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950402,0.00034963465,0.0013874394,0.0011899443,0.0013896623,0.0006431435],"domain_scores_gemma":[0.99530333,0.0004430578,0.0019403576,0.0013802696,0.00025627398,0.0006767275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037098533,0.0008082225,0.0016191315,0.00022262479,0.00016503048,0.00014760066,0.0006089778,0.00074241695,0.0014318647],"category_scores_gemma":[0.000085262145,0.0007804049,8.1395206e-7,0.00044365748,0.0007855423,0.0002909338,0.0002642523,0.001187141,0.0000015365533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007271849,0.00008776419,0.0029301946,0.0010948873,0.0010537958,0.0001194646,0.0000050964104,0.000017291375,0.000045326182,0.00006704996,0.9934485,0.00040347737],"study_design_scores_gemma":[0.0038562776,0.00045860844,0.00020888275,0.00020775624,0.0019476466,0.00045328823,0.0007161157,0.00094459613,0.0000015521864,1.0403132e-7,0.9905374,0.0006677908],"about_ca_topic_score_codex":0.99893504,"about_ca_topic_score_gemma":0.9935706,"teacher_disagreement_score":0.012386037,"about_ca_system_score_codex":0.0004381181,"about_ca_system_score_gemma":0.012824155,"threshold_uncertainty_score":0.99948096},"labels":[],"label_agreement":null},{"id":"W6920430866","doi":"10.60692/ad1hh-f0m82","title":"Comparison Between Urothelial and Non-Urothelial Urethral Cancer","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Histology; Adenocarcinoma; Cancer; Chemotherapy; Clear-cell adenocarcinoma; Proportional hazards model","score_opus":0.049539146188261565,"score_gpt":0.2950704053883475,"score_spread":0.24553125920008595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920430866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871079,0.000047750615,0.0035310062,0.00029724307,0.0005420255,0.00059210934,0.00048825794,0.0001466153,0.007247118],"genre_scores_gemma":[0.99804676,0.0000016299159,0.00023164185,0.00042965627,0.00054355274,0.0001022032,0.000060084556,0.000019945022,0.0005645438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857277,0.00004268637,0.0005515801,0.0002042236,0.00035525163,0.00027346835],"domain_scores_gemma":[0.9991341,0.000007373954,0.00016419558,0.0002874058,0.00020642609,0.00020046784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112726426,0.00022316848,0.00049608696,0.000117396965,0.00013223384,0.000115751,0.00006085431,0.0001459188,0.00012917267],"category_scores_gemma":[0.00001074084,0.00018090302,0.000094275296,0.0001715107,0.000043666918,0.00029755474,0.00005064607,0.00015294651,0.00028914082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015895275,0.0000047886556,0.9782171,0.000410014,0.00017423855,0.000013018871,0.018823458,0.0000060690827,0.000024297637,0.000015916788,0.00023520763,0.0019169172],"study_design_scores_gemma":[0.007528251,0.00022355925,0.9686375,0.0005012151,0.0004677318,0.00013295974,0.0050057205,0.0005118618,0.013137149,0.0000016149227,0.0035217323,0.00033069344],"about_ca_topic_score_codex":0.00006691045,"about_ca_topic_score_gemma":0.000001328192,"teacher_disagreement_score":0.013817738,"about_ca_system_score_codex":0.00014539194,"about_ca_system_score_gemma":0.00022248493,"threshold_uncertainty_score":0.7377011},"labels":[],"label_agreement":null},{"id":"W6920445187","doi":"10.60692/7wwnb-z3s25","title":"Additional file 23 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Germline; Table (database); Urinary system; Urinary bladder","score_opus":0.05060970997108681,"score_gpt":0.27597878546164833,"score_spread":0.2253690754905615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920445187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67958593,0.000009129562,0.000060810373,0.00008654791,0.0005185604,0.001007086,0.27776933,0.00040904575,0.040553574],"genre_scores_gemma":[0.97450787,0.0000014471561,0.00007451793,0.00022619547,0.0002472677,0.0006181835,0.020381015,0.000022592067,0.003920943],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99856794,0.00002385772,0.0006037696,0.00016425272,0.00040662094,0.00023354699],"domain_scores_gemma":[0.9988454,0.000042231382,0.0003032293,0.00028917415,0.00040061574,0.00011932403],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006551797,0.00020085622,0.0003373777,0.0003317477,0.00018036045,0.000065289765,0.000105293526,0.0001253477,0.050956927],"category_scores_gemma":[0.000045030316,0.00016504836,0.00014739859,0.00035737263,0.00010497876,0.0003997231,0.000055738332,0.00009178618,0.0017963415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042431013,0.000030267493,0.11045288,0.0029165684,0.0013253968,0.00005148361,0.20250551,0.00025224168,0.00017110238,0.00021419386,0.68045723,0.0011987807],"study_design_scores_gemma":[0.003702857,0.00029409426,0.86660856,0.0011727157,0.000165105,0.00003100587,0.01054311,0.00017447516,0.0031866096,0.00000564021,0.11374194,0.0003738695],"about_ca_topic_score_codex":0.00005591621,"about_ca_topic_score_gemma":0.000007344011,"teacher_disagreement_score":0.75615567,"about_ca_system_score_codex":0.00032108137,"about_ca_system_score_gemma":0.00026779316,"threshold_uncertainty_score":0.9989809},"labels":[],"label_agreement":null},{"id":"W6920449103","doi":"10.60692/whbf6-v4p67","title":"The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Urothelial carcinoma; Logistic regression; Concordance; Proportional hazards model; VEGF receptors; Lymph node; Carcinoma; Pathological","score_opus":0.022420208307601705,"score_gpt":0.2217265461404965,"score_spread":0.1993063378328948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920449103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949713,0.00001013305,0.000074505486,0.000101986465,0.000119632656,0.0013120284,0.0003147117,0.000023083825,0.0030726392],"genre_scores_gemma":[0.9993071,9.885508e-8,0.000025550975,0.00006707924,0.00002568504,0.00027997218,0.000007930372,0.000012774405,0.0002738381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831325,0.0002156215,0.00059681025,0.00011894574,0.00056491315,0.00019045807],"domain_scores_gemma":[0.9991169,0.000022340058,0.0003009491,0.00038638472,0.00012583779,0.000047616704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002530799,0.00016296569,0.0003214812,0.00011981722,0.00020532068,0.00001899335,0.00018485748,0.000048931593,0.00003944358],"category_scores_gemma":[0.000012635579,0.00007944791,0.000091278256,0.00039939862,0.00012348258,0.00012503877,0.000074609765,0.00017266358,0.000009123161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017192595,0.000021210059,0.9247979,0.00022764942,0.00024187237,0.00000850269,0.071977094,0.00053486763,0.000029384968,0.00023798474,0.00003599215,0.00016828332],"study_design_scores_gemma":[0.011343438,0.0009688571,0.9448712,0.0002244378,0.00019250737,0.0002569329,0.023682667,0.002186327,0.01588571,8.843529e-7,0.00024084937,0.00014620525],"about_ca_topic_score_codex":0.00015143571,"about_ca_topic_score_gemma":0.0000026088667,"teacher_disagreement_score":0.048294425,"about_ca_system_score_codex":0.00022131902,"about_ca_system_score_gemma":0.00029259673,"threshold_uncertainty_score":0.3239792},"labels":[],"label_agreement":null},{"id":"W6920477010","doi":"10.60692/f3966-cxf61","title":"Additional file 13 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proteogenomics; Gene; Transcriptome; Genome; Bladder cancer; Exome sequencing; DNA sequencing","score_opus":0.017477801892394205,"score_gpt":0.19162258008215038,"score_spread":0.17414477818975618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920477010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6965306,7.7204317e-7,0.000108017455,0.000017989894,0.00012256486,0.00084829744,0.3008152,0.000017068514,0.001539491],"genre_scores_gemma":[0.99004334,2.5800912e-8,0.000049953138,0.00005639517,0.000032275402,0.00050258846,0.008915002,0.000008979802,0.00039146107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884087,0.00006521093,0.0005690644,0.000075626034,0.0003586233,0.00009059579],"domain_scores_gemma":[0.99890715,0.000009626765,0.0005892384,0.00024333246,0.00022212137,0.000028509661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007267058,0.00010185663,0.00023954811,0.00014004766,0.000069659254,0.0000051103893,0.00010543999,0.000038465772,0.05067913],"category_scores_gemma":[0.000020257725,0.00007019109,0.000114318434,0.00025210454,0.000045504883,0.00011254804,0.000054775435,0.00007656636,0.000025884136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008276023,0.0003591481,0.64063895,0.007697289,0.0024405054,0.000011679498,0.23338188,0.0003957379,0.015691018,0.00032592658,0.08568886,0.005092994],"study_design_scores_gemma":[0.003747539,0.000632704,0.9387168,0.0004622644,0.00018680262,0.00011375863,0.007623169,0.0009876769,0.036649283,0.0000011443391,0.010703615,0.00017521919],"about_ca_topic_score_codex":0.000032355416,"about_ca_topic_score_gemma":1.3966407e-7,"teacher_disagreement_score":0.29807788,"about_ca_system_score_codex":0.00011867911,"about_ca_system_score_gemma":0.0003000921,"threshold_uncertainty_score":0.9501887},"labels":[],"label_agreement":null},{"id":"W6920503856","doi":"10.60692/knzj8-dez53","title":"Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Endoglin; Cystectomy; Lymph node; Lymphadenectomy; Proportional hazards model; Bladder cancer; Urothelial carcinoma; Carcinoma; Preoperative care","score_opus":0.05643904423599899,"score_gpt":0.2664807193072297,"score_spread":0.21004167507123073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920503856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97454363,0.000018957644,0.012812956,0.00018313916,0.0003526757,0.00329139,0.00851235,0.000024884803,0.00026004482],"genre_scores_gemma":[0.9963399,1.1836711e-7,0.0010101426,0.00023300033,0.0000730218,0.0014225539,0.00006711223,0.000020265681,0.0008338698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984209,0.0000659991,0.000743902,0.00017030485,0.00038952183,0.00020938151],"domain_scores_gemma":[0.9986781,0.000051790852,0.00028203835,0.00039721327,0.0004536928,0.00013715954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012893643,0.00021020234,0.00050020975,0.000093269955,0.000068206624,0.000024646739,0.0001005538,0.00007415675,0.00005639616],"category_scores_gemma":[0.0001280907,0.00012700549,0.00035947468,0.0001220883,0.00007862177,0.00018601233,0.000042210984,0.000059782677,0.000015416119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005519994,0.00006161685,0.94153225,0.0047515975,0.0009922725,0.000010654128,0.046500914,0.000029188534,0.000036938258,0.00019981513,0.00014390372,0.0002208439],"study_design_scores_gemma":[0.030672688,0.00070399727,0.9149201,0.0008581323,0.0019395242,0.00009156145,0.007769585,0.003425965,0.03890057,0.000012881847,0.00040315418,0.00030183172],"about_ca_topic_score_codex":0.000011872722,"about_ca_topic_score_gemma":0.0000010221411,"teacher_disagreement_score":0.038863633,"about_ca_system_score_codex":0.00008923478,"about_ca_system_score_gemma":0.00055756845,"threshold_uncertainty_score":0.51791334},"labels":[],"label_agreement":null},{"id":"W6920551124","doi":"10.6084/m9.figshare.24040687","title":"Additional file 7 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Urinary system; Gene","score_opus":0.0661051645643221,"score_gpt":0.32844936034575745,"score_spread":0.26234419578143536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920551124","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023362935,0.00008646094,1.6443769e-8,0.00006485981,0.00004577563,0.00026454002,0.97448725,0.000091331254,0.022623476],"genre_scores_gemma":[0.020265255,0.000016199609,0.000035716796,0.00038161562,0.00044014925,0.0015864616,0.96290916,0.0000418602,0.014323564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990093,0.000013121294,0.00021541916,0.00026309481,0.00027507267,0.00022396099],"domain_scores_gemma":[0.9988782,0.0003954482,0.00010710061,0.0002301802,0.00027077884,0.00011829735],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008969562,0.00016665399,0.0002494508,0.00011814957,0.00012885887,0.00002300323,0.00011461164,0.00010551721,0.99529225],"category_scores_gemma":[0.0006002603,0.00015032463,0.00014940978,0.0002936336,0.000040794726,0.0000921115,0.000085106796,0.00012215166,0.0036957283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023144194,0.000052154097,0.00008489117,0.00018354726,0.00014993979,0.000049460836,0.00052114855,0.000005175503,0.00042812675,0.000004415398,0.9976928,0.0008051585],"study_design_scores_gemma":[0.00065503194,0.00014629519,0.11233426,0.0016106316,0.00002927822,0.0000036627528,0.000088659704,0.000007736079,0.0029182672,0.00004007429,0.8820307,0.0001354028],"about_ca_topic_score_codex":0.000063856576,"about_ca_topic_score_gemma":0.00022169578,"teacher_disagreement_score":0.9915965,"about_ca_system_score_codex":0.00016338218,"about_ca_system_score_gemma":0.00048895285,"threshold_uncertainty_score":0.99708},"labels":[],"label_agreement":null},{"id":"W6920602578","doi":"10.6084/m9.figshare.12679779.v1","title":"Additional file 7 of Examining the relationship between maternal body size, gestational glucose tolerance status, mode of delivery and ethnicity on human milk microbiota at three months post-partum","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gestational diabetes; Ethnic group; Gestation; Pregnancy; Gestational age; Birth weight; Obesity","score_opus":0.08329967015750807,"score_gpt":0.30048764070272044,"score_spread":0.21718797054521238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920602578","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31261542,0.00007042343,1.6219066e-7,0.00010527238,0.0000043837854,0.00019929222,0.68662506,0.000011243347,0.0003687427],"genre_scores_gemma":[0.6067784,0.0000011545071,0.00011697478,0.0002584411,0.0000789597,0.000091909424,0.3925123,0.000012120809,0.00014978515],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991415,0.0000359546,0.00023224275,0.00020444905,0.00024396359,0.00014187607],"domain_scores_gemma":[0.997528,0.0019284199,0.00016138931,0.00013630714,0.00014732103,0.00009852046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000013328482,0.00012800613,0.00020298752,0.00002407439,0.00011103545,0.000007934171,0.00007690843,0.00006758025,0.63614917],"category_scores_gemma":[0.0008960234,0.000101180514,0.00005427696,0.00007633193,0.000031595402,0.000061990264,0.000062949715,0.00015603953,0.000097456454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002885834,0.000052443145,0.042461943,0.00024018525,0.00008457436,0.000008695719,0.00037239294,0.000017712231,0.0013439882,0.0000072083944,0.9549079,0.00021437946],"study_design_scores_gemma":[0.00080976554,0.00037327505,0.98866075,0.0014338782,0.000039819635,0.000003976414,0.000022997792,0.00009073622,0.0024308525,0.000030856332,0.0060204775,0.00008259003],"about_ca_topic_score_codex":0.00007811455,"about_ca_topic_score_gemma":0.00006187792,"teacher_disagreement_score":0.9488874,"about_ca_system_score_codex":0.0000476966,"about_ca_system_score_gemma":0.00012055831,"threshold_uncertainty_score":0.41260216},"labels":[],"label_agreement":null},{"id":"W6920608696","doi":"10.60692/hmyp0-1ns90","title":"Additional file 1 of MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune system; Urothelial cancer; Human papillomavirus; Oncogene; Bladder cancer","score_opus":0.038840513185525935,"score_gpt":0.22457496287620365,"score_spread":0.1857344496906777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920608696","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46179628,0.000007974413,0.00016178428,0.000039938874,0.00004538788,0.0009938317,0.5366722,0.000011910679,0.00027069403],"genre_scores_gemma":[0.99086845,1.4351458e-7,0.0005512695,0.00002845399,0.00003092792,0.0010230625,0.007192592,0.000010663263,0.00029442576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986842,0.00003613617,0.0006269453,0.0001033667,0.00041310146,0.00013625085],"domain_scores_gemma":[0.99883384,0.000041258074,0.00066619704,0.0000937008,0.00033093503,0.00003410184],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001236257,0.00011975507,0.00035634084,0.00022096549,0.00005262401,0.000008561741,0.000049931445,0.000057610665,0.015005397],"category_scores_gemma":[0.000031382875,0.0001002037,0.000075955904,0.00018091987,0.000022022405,0.0001832507,0.000030119088,0.000061511084,0.0000042308366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01482291,0.00047056453,0.7548234,0.009760064,0.004633053,0.000014559319,0.10206751,0.00091684394,0.0017127565,0.00015249057,0.107853115,0.0027727606],"study_design_scores_gemma":[0.018156096,0.0036253836,0.88730603,0.0010458503,0.00063390145,0.000098950084,0.018641794,0.00265617,0.0658334,0.00000243843,0.0016320806,0.00036791526],"about_ca_topic_score_codex":0.0000838907,"about_ca_topic_score_gemma":0.0000012463098,"teacher_disagreement_score":0.5294796,"about_ca_system_score_codex":0.0001578085,"about_ca_system_score_gemma":0.00021324524,"threshold_uncertainty_score":0.98589504},"labels":[],"label_agreement":null},{"id":"W6920623250","doi":"10.60692/tevty-q4266","title":"Additional file 21 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Germline; Urinary system","score_opus":0.049546789808453534,"score_gpt":0.2749349546073354,"score_spread":0.22538816479888188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920623250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69616175,0.000009211957,0.000060683353,0.000089174704,0.0005024585,0.00096754637,0.26133475,0.00038441314,0.040490028],"genre_scores_gemma":[0.97893786,0.0000014586478,0.000077130804,0.00022687156,0.00024722022,0.0006048163,0.016497893,0.00002213549,0.003384627],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99857354,0.00002399918,0.0006012985,0.0001639947,0.00040533795,0.00023181432],"domain_scores_gemma":[0.998843,0.00004149619,0.00030222317,0.00028960398,0.00040434458,0.00011931238],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000064780616,0.00020004959,0.0003372873,0.0003269386,0.00017925691,0.00006567376,0.00010436671,0.00012516281,0.05754412],"category_scores_gemma":[0.000044784225,0.00016440249,0.00014715602,0.00035347405,0.000104557,0.000397548,0.00005570765,0.000092286595,0.0013943276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046519496,0.0000330036,0.12026335,0.0031269423,0.0014293268,0.000056096567,0.22389615,0.00026611995,0.00018669669,0.00022507831,0.64849025,0.001561761],"study_design_scores_gemma":[0.0036247785,0.00028460263,0.8656821,0.00115258,0.00016237561,0.000031141306,0.010637407,0.00016552545,0.003238458,0.0000053707627,0.1146505,0.00036514516],"about_ca_topic_score_codex":0.00006530096,"about_ca_topic_score_gemma":0.000006862731,"teacher_disagreement_score":0.7454188,"about_ca_system_score_codex":0.0003211517,"about_ca_system_score_gemma":0.0002717511,"threshold_uncertainty_score":0.9993832},"labels":[],"label_agreement":null},{"id":"W6920661369","doi":"10.60692/ve608-k6006","title":"Additional file 5 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Urinary system; Urinary bladder; Somatic cell","score_opus":0.04910807857056008,"score_gpt":0.2735163798097642,"score_spread":0.2244083012392041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920661369","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39157093,0.000005861075,0.000038219645,0.00006436664,0.00037637138,0.00081680925,0.56588554,0.000348898,0.04089299],"genre_scores_gemma":[0.9612204,0.0000010899641,0.00008725172,0.00022574121,0.00024389946,0.0007880845,0.033535767,0.000022202645,0.0038755694],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998643,0.000022057611,0.0005715419,0.00015613665,0.00038540806,0.00022184885],"domain_scores_gemma":[0.9988758,0.000051383933,0.00029522518,0.0002765679,0.00038702576,0.0001139881],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005433133,0.00019098546,0.00032095483,0.00031917467,0.00017176461,0.000061384184,0.0000996895,0.000119080054,0.1432803],"category_scores_gemma":[0.000054032836,0.00015673293,0.00014178388,0.00034842314,0.00010123054,0.00037931665,0.000053164153,0.000087587236,0.0016657995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023665777,0.000017145183,0.046634484,0.0016739035,0.0007727995,0.000030080926,0.11308648,0.0001170555,0.00007491006,0.00009566476,0.8363849,0.00087593653],"study_design_scores_gemma":[0.0030647337,0.0002651184,0.7940029,0.0012216993,0.00013902866,0.000028717046,0.009480715,0.00015133114,0.0022758364,0.000004438689,0.18902354,0.00034194873],"about_ca_topic_score_codex":0.000052711493,"about_ca_topic_score_gemma":0.00000566952,"teacher_disagreement_score":0.7473684,"about_ca_system_score_codex":0.00030303246,"about_ca_system_score_gemma":0.00027007077,"threshold_uncertainty_score":0.99911153},"labels":[],"label_agreement":null},{"id":"W6920691892","doi":"10.60692/bfavk-s4e47","title":"Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Endoglin; Cystectomy; Lymph node; Lymphadenectomy; Proportional hazards model; Bladder cancer; Urothelial carcinoma; Carcinoma; Preoperative care","score_opus":0.05643904423599899,"score_gpt":0.2664807193072297,"score_spread":0.21004167507123073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920691892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97454363,0.000018957644,0.012812956,0.00018313916,0.0003526757,0.00329139,0.00851235,0.000024884803,0.00026004482],"genre_scores_gemma":[0.9963399,1.1836711e-7,0.0010101426,0.00023300033,0.0000730218,0.0014225539,0.00006711223,0.000020265681,0.0008338698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984209,0.0000659991,0.000743902,0.00017030485,0.00038952183,0.00020938151],"domain_scores_gemma":[0.9986781,0.000051790852,0.00028203835,0.00039721327,0.0004536928,0.00013715954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012893643,0.00021020234,0.00050020975,0.000093269955,0.000068206624,0.000024646739,0.0001005538,0.00007415675,0.00005639616],"category_scores_gemma":[0.0001280907,0.00012700549,0.00035947468,0.0001220883,0.00007862177,0.00018601233,0.000042210984,0.000059782677,0.000015416119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005519994,0.00006161685,0.94153225,0.0047515975,0.0009922725,0.000010654128,0.046500914,0.000029188534,0.000036938258,0.00019981513,0.00014390372,0.0002208439],"study_design_scores_gemma":[0.030672688,0.00070399727,0.9149201,0.0008581323,0.0019395242,0.00009156145,0.007769585,0.003425965,0.03890057,0.000012881847,0.00040315418,0.00030183172],"about_ca_topic_score_codex":0.000011872722,"about_ca_topic_score_gemma":0.0000010221411,"teacher_disagreement_score":0.038863633,"about_ca_system_score_codex":0.00008923478,"about_ca_system_score_gemma":0.00055756845,"threshold_uncertainty_score":0.51791334},"labels":[],"label_agreement":null},{"id":"W6920823209","doi":"10.6084/m9.figshare.12715346.v1","title":"Additional file 1 of Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Survivorship curve; Bladder cancer; Plan (archaeology); Cancer; Health care; MEDLINE; Patient care","score_opus":0.1821102988319279,"score_gpt":0.3864732081429659,"score_spread":0.20436290931103798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920823209","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004554672,0.0021527945,0.0000020321327,0.000014346436,0.000014584635,0.00086699513,0.99179476,0.0000124514745,0.00058737624],"genre_scores_gemma":[0.057215482,0.000009119765,0.010001203,0.00012625073,0.00006968642,0.0011771206,0.93134624,0.00002186403,0.000033029188],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987509,0.00014288335,0.0003106871,0.00031664287,0.0003658136,0.000113075],"domain_scores_gemma":[0.9987627,0.00031026485,0.00015736656,0.0000905767,0.0005350746,0.00014399568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000046125006,0.00013741468,0.00028602706,0.000029125555,0.000036117905,0.000008421776,0.000045330125,0.000102548125,0.5596602],"category_scores_gemma":[0.0007758275,0.00011802079,0.00004839573,0.000088756206,0.00002382634,0.000050163,0.00004816051,0.00010722044,0.000013732137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012381391,0.00014582937,0.0041917902,0.00081941497,0.00014172429,6.507706e-7,0.004489825,6.883952e-7,0.0000032655748,4.9717183e-8,0.91322374,0.07685919],"study_design_scores_gemma":[0.009665682,0.00097277283,0.43763205,0.0034100814,0.00033126015,0.00000249192,0.0068110707,0.00082527293,0.0012648915,0.0000012435065,0.5386904,0.00039280517],"about_ca_topic_score_codex":0.000026434542,"about_ca_topic_score_gemma":0.000029244284,"teacher_disagreement_score":0.5596465,"about_ca_system_score_codex":0.00006408737,"about_ca_system_score_gemma":0.00047414802,"threshold_uncertainty_score":0.4812748},"labels":[],"label_agreement":null},{"id":"W6920863306","doi":"10.6084/m9.figshare.23258889.v1","title":"Additional file 1 of Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perioperative; Table (database); Upper urinary tract; Meta-analysis; Operating table; Nephrectomy; Pooled analysis","score_opus":0.061454969228414015,"score_gpt":0.34139262911332685,"score_spread":0.2799376598849128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920863306","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05151348,0.001823519,9.178032e-8,0.00008115274,0.000019316709,0.0017395441,0.9445582,0.000018877303,0.0002457904],"genre_scores_gemma":[0.62514776,0.0000508406,0.00021642946,0.00013200937,0.000025304347,0.0030608564,0.37087485,0.000019815048,0.00047215167],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99873495,0.00009331878,0.0005285059,0.0002588137,0.00022369467,0.00016070898],"domain_scores_gemma":[0.9977143,0.0015405681,0.00026002736,0.00018614181,0.00021984542,0.00007914874],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000040052146,0.00022253185,0.0019978175,0.00018757973,0.000051678475,0.0000066606517,0.00007502447,0.000083219515,0.31301856],"category_scores_gemma":[0.0005772805,0.00015454576,0.000344234,0.00039340544,0.0000610554,0.0000696357,0.00002921235,0.00008350888,0.000011419273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029842341,0.0020013056,0.018454134,0.38001102,0.024799159,0.000102999715,0.0070677805,0.00000737628,0.00032472273,0.000026366437,0.564153,0.00006784793],"study_design_scores_gemma":[0.0094386665,0.0066365027,0.9152391,0.040635083,0.02264263,0.00003171042,0.0013871293,0.00045634096,0.0005833784,0.0000022993806,0.0025365378,0.00041062135],"about_ca_topic_score_codex":0.000021293074,"about_ca_topic_score_gemma":0.000013672638,"teacher_disagreement_score":0.89678496,"about_ca_system_score_codex":0.000042535496,"about_ca_system_score_gemma":0.00015770903,"threshold_uncertainty_score":0.68760943},"labels":[],"label_agreement":null},{"id":"W6920939284","doi":"10.6084/m9.figshare.24040732.v1","title":"Additional file 19 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Indel; Bladder cancer; Urinary bladder; Urinary system; Mutation","score_opus":0.07235850267625167,"score_gpt":0.3363142776486124,"score_spread":0.2639557749723607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920939284","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039348034,0.00013910895,2.9256414e-8,0.00009351198,0.00005619332,0.00030113634,0.9753973,0.00009838599,0.019979563],"genre_scores_gemma":[0.03736467,0.000025700023,0.000035645484,0.0005641254,0.00048882276,0.001364816,0.9463299,0.000045361656,0.01378095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989518,0.000014940245,0.00022769392,0.000279863,0.0002915636,0.00023417262],"domain_scores_gemma":[0.99890316,0.00033846876,0.00011126354,0.0002434145,0.00025464152,0.0001490644],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011509932,0.0001752905,0.00026118543,0.00012696757,0.00014410177,0.000024462806,0.00012208775,0.0001102056,0.985305],"category_scores_gemma":[0.0006022869,0.00015828034,0.0001551099,0.0003041979,0.000043725977,0.00009365198,0.00009004088,0.0001281333,0.0028496878],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002826646,0.000056353143,0.00016114546,0.00022222009,0.0001614971,0.000057970665,0.00068500947,0.000008651943,0.0005034287,0.0000069727325,0.99744827,0.00066023937],"study_design_scores_gemma":[0.00084896496,0.0001566979,0.11740069,0.0012887404,0.000035171302,0.000004591033,0.00010945555,0.000008281219,0.0028780515,0.00005440883,0.8770667,0.00014828006],"about_ca_topic_score_codex":0.000114657174,"about_ca_topic_score_gemma":0.00030187407,"teacher_disagreement_score":0.9824553,"about_ca_system_score_codex":0.00019933784,"about_ca_system_score_gemma":0.00058019307,"threshold_uncertainty_score":0.9979267},"labels":[],"label_agreement":null},{"id":"W6920946513","doi":"10.6084/m9.figshare.24040711","title":"Additional file 13 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Context (archaeology); Sequence (biology); Urinary system; Urinary bladder","score_opus":0.06621057772092111,"score_gpt":0.32896071911908853,"score_spread":0.26275014139816744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920946513","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061478005,0.00011912962,2.5132813e-8,0.00008036575,0.000057790578,0.00029379025,0.971607,0.0000953405,0.021598717],"genre_scores_gemma":[0.054109737,0.000023799388,0.000029328308,0.00043621773,0.00049778144,0.0013620486,0.9303738,0.000046818193,0.01312051],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989518,0.000014299675,0.00022922967,0.00027771736,0.00029096476,0.0002360185],"domain_scores_gemma":[0.9989291,0.00031005364,0.00011070114,0.00024251683,0.0002829662,0.00012467729],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010839364,0.00017670997,0.00026391883,0.00012307825,0.00013580396,0.000025095329,0.000121918005,0.000111655114,0.9858992],"category_scores_gemma":[0.0004808962,0.00015939742,0.00015549325,0.00029804258,0.0000431848,0.00009945102,0.000089640525,0.00012973827,0.0031313899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002653366,0.00005722312,0.00016762527,0.0002006653,0.00016346069,0.00005211582,0.00065580755,0.000008907586,0.00055287406,0.000005156817,0.9973193,0.0007903692],"study_design_scores_gemma":[0.0008512879,0.00016811192,0.16314681,0.0015346424,0.000036797504,0.000004116076,0.00010897659,0.000010554944,0.0038424192,0.000051121464,0.8300908,0.00015434917],"about_ca_topic_score_codex":0.00011002812,"about_ca_topic_score_gemma":0.00040947722,"teacher_disagreement_score":0.9827678,"about_ca_system_score_codex":0.00017112096,"about_ca_system_score_gemma":0.0004784085,"threshold_uncertainty_score":0.9976448},"labels":[],"label_agreement":null},{"id":"W6920954414","doi":"10.6084/m9.figshare.24040768","title":"Additional file 27 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; Table (database); Gene","score_opus":0.06716418527288916,"score_gpt":0.3301432262449604,"score_spread":0.26297904097207125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920954414","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044168173,0.00012088581,2.5729337e-8,0.00008312587,0.000076727614,0.0002921873,0.9748011,0.00009332988,0.02011576],"genre_scores_gemma":[0.033917878,0.000026036629,0.000035095545,0.00043087438,0.0005076036,0.0010572888,0.94696194,0.000047498288,0.017015783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998952,0.000014358263,0.00022905313,0.00027766477,0.00029090449,0.0002360689],"domain_scores_gemma":[0.99892986,0.00031125685,0.00011088907,0.00024248334,0.00028100313,0.0001245171],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010954078,0.00017660309,0.00026407177,0.00012311971,0.00012436915,0.000024777135,0.00012188987,0.0001116619,0.9859885],"category_scores_gemma":[0.0004865498,0.00015941168,0.00015591847,0.00029689728,0.000043133823,0.00009848887,0.00008933965,0.00012969994,0.0035670982],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002680187,0.00005779603,0.00015330479,0.00019978003,0.00016328497,0.00005275507,0.0006178411,0.0000071411323,0.0007008637,0.0000064921987,0.9974224,0.00059152505],"study_design_scores_gemma":[0.0008231702,0.00016725954,0.110018484,0.0015222639,0.000036672103,0.00000412147,0.000103679966,0.000008233062,0.004421639,0.000051135576,0.8826908,0.00015253761],"about_ca_topic_score_codex":0.00007804571,"about_ca_topic_score_gemma":0.00027817272,"teacher_disagreement_score":0.9824214,"about_ca_system_score_codex":0.00017503931,"about_ca_system_score_gemma":0.0004852234,"threshold_uncertainty_score":0.9972087},"labels":[],"label_agreement":null},{"id":"W6921027537","doi":"10.6084/m9.figshare.24040771.v1","title":"Additional file 28 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; MEDLINE; Kidney cancer; Radiation therapy","score_opus":0.06734486274596097,"score_gpt":0.33022782188167876,"score_spread":0.2628829591357178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921027537","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039998647,0.00012181225,2.6122699e-8,0.00008693686,0.000057817524,0.00029120198,0.97137904,0.00009548214,0.023967799],"genre_scores_gemma":[0.04644682,0.000026234638,0.000036428042,0.00045290333,0.00052074355,0.0013861184,0.93890655,0.000048621976,0.012175555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887687,0.000014377021,0.00022936983,0.0002783313,0.00036437425,0.00023666862],"domain_scores_gemma":[0.998822,0.0003114934,0.000110859655,0.00024339104,0.0003875697,0.00012469255],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000013625706,0.00017680682,0.00026447148,0.00012335944,0.00013665597,0.00002485179,0.00012210365,0.000111918336,0.9855723],"category_scores_gemma":[0.00064738386,0.00015953649,0.00015609997,0.00029798472,0.000043193948,0.00009869172,0.0000897722,0.00013013717,0.0030557185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002693636,0.00005793767,0.000116060284,0.00020048235,0.00016348864,0.00005325356,0.0006232994,0.000007156322,0.00060013944,0.0000065387303,0.9973531,0.00079160463],"study_design_scores_gemma":[0.000821941,0.00016637325,0.116964065,0.001511855,0.000036345937,0.0000041231833,0.000102593105,0.000008992585,0.004178196,0.00005052964,0.8760037,0.00015127094],"about_ca_topic_score_codex":0.00008386586,"about_ca_topic_score_gemma":0.00030224447,"teacher_disagreement_score":0.9825166,"about_ca_system_score_codex":0.00022812314,"about_ca_system_score_gemma":0.0005838378,"threshold_uncertainty_score":0.99772054},"labels":[],"label_agreement":null},{"id":"W6921085964","doi":"10.6084/m9.figshare.24040726","title":"Additional file 17 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Bracken; Cancer; Human bladder; Urinary bladder","score_opus":0.0682406956949832,"score_gpt":0.33160742966681117,"score_spread":0.26336673397182797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921085964","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044307597,0.000119066,2.3070777e-8,0.00008401559,0.00005126174,0.0002878683,0.967878,0.00009357209,0.027055442],"genre_scores_gemma":[0.03214553,0.000021907239,0.00003373723,0.00047618093,0.00050295884,0.0013374103,0.9449677,0.000045270226,0.020469315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989591,0.000013329121,0.00022663033,0.0002767883,0.0002888762,0.00023525837],"domain_scores_gemma":[0.99893546,0.00030472074,0.00011192215,0.00024599265,0.00027796553,0.00012392107],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010860333,0.00017597909,0.00026343044,0.000121178644,0.00013947143,0.00002509889,0.00012291687,0.00011130264,0.98738855],"category_scores_gemma":[0.00044727194,0.00015887644,0.00015577186,0.0002868797,0.00004334601,0.000098062876,0.00008951879,0.00012928556,0.0025485535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026848724,0.000057047913,0.00012529912,0.00017645913,0.00016282997,0.00005361058,0.0006124998,0.000009866096,0.00051050005,0.000005092946,0.99765855,0.0006013852],"study_design_scores_gemma":[0.00079847535,0.00016107138,0.1281515,0.0014792315,0.000035507965,0.0000039930655,0.000095942494,0.0000088340985,0.0033396808,0.000044240314,0.86573434,0.00014715812],"about_ca_topic_score_codex":0.000075719625,"about_ca_topic_score_gemma":0.00029513598,"teacher_disagreement_score":0.98484,"about_ca_system_score_codex":0.00017259756,"about_ca_system_score_gemma":0.0004769266,"threshold_uncertainty_score":0.9982281},"labels":[],"label_agreement":null},{"id":"W6921120342","doi":"10.6084/m9.figshare.24040759.v1","title":"Additional file 24 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; Somatic cell; Urothelial cancer","score_opus":0.0740289303604134,"score_gpt":0.3290571810170109,"score_spread":0.2550282506565975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921120342","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042454875,0.00013144544,2.4888976e-8,0.00008814765,0.00007854111,0.0002917962,0.9758306,0.000096222626,0.019237746],"genre_scores_gemma":[0.03475186,0.000024956611,0.000038018108,0.00045126944,0.00052267424,0.0013593192,0.9462114,0.00004787197,0.016592648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989508,0.00001416722,0.00022854662,0.00027835305,0.00029310698,0.00023506788],"domain_scores_gemma":[0.99894756,0.00030496207,0.00010880007,0.0002417633,0.0002727045,0.00012423864],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010676952,0.00017644626,0.0002628143,0.00012403223,0.00013414433,0.000025145471,0.000121133606,0.000111584086,0.9854],"category_scores_gemma":[0.00047879247,0.00015897074,0.00015595421,0.0002998517,0.00004284878,0.00009769592,0.00008997611,0.00013467665,0.0031123308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027195045,0.000057992478,0.00013278157,0.00020661452,0.00016404368,0.000053059437,0.00062831654,0.000006957731,0.000620671,0.000006313502,0.99737865,0.0007173778],"study_design_scores_gemma":[0.00082782394,0.00016913375,0.10592287,0.00156745,0.000037454636,0.000004184029,0.00010678871,0.00000928778,0.0044379164,0.000052284202,0.88671184,0.00015297842],"about_ca_topic_score_codex":0.0000760308,"about_ca_topic_score_gemma":0.00027534648,"teacher_disagreement_score":0.98228765,"about_ca_system_score_codex":0.00017491747,"about_ca_system_score_gemma":0.00048590347,"threshold_uncertainty_score":0.99766386},"labels":[],"label_agreement":null},{"id":"W6921126870","doi":"10.6084/m9.figshare.21069516","title":"Additional file 2 of Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; McGill University; Ottawa Hospital; McGill University Health Centre","funders":"","keywords":"Perception; Health care; Health professionals; Cannabis; Qualitative research; MEDLINE","score_opus":0.05536063764475454,"score_gpt":0.33445649655796544,"score_spread":0.2790958589132109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921126870","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013636662,0.00003228667,3.1535826e-8,0.0016506102,0.000032563923,0.00031992706,0.98762244,0.000045701556,0.010160096],"genre_scores_gemma":[0.07498902,8.406364e-7,0.00011156657,0.0012167935,0.00018867255,0.0032157183,0.9170677,0.00002397593,0.0031857367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990028,0.000075783224,0.00015375677,0.00020788003,0.00038316377,0.0001765723],"domain_scores_gemma":[0.99874073,0.00043591508,0.00033797236,0.00018150535,0.00013802141,0.00016586276],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023294035,0.00010393283,0.00013971065,0.00008640667,0.00038741867,0.000012975052,0.00006127128,0.000035548826,0.9986604],"category_scores_gemma":[0.004627414,0.00010135793,0.000093591,0.000177028,0.0000065622867,0.00015476882,0.00005228898,0.00031153453,0.000437161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097775504,0.00008620182,0.00003445566,0.00008971853,0.00005283631,0.000021778522,0.00037703483,0.000019399133,0.000016048969,0.0000024654728,0.99865454,0.0005477516],"study_design_scores_gemma":[0.00033611868,0.00056978624,0.0062609133,0.0008907429,0.000027240905,0.000095585696,0.0024638171,0.00005012941,0.000051937164,0.000006237894,0.9891571,0.000090389534],"about_ca_topic_score_codex":0.00023904793,"about_ca_topic_score_gemma":0.00004006571,"teacher_disagreement_score":0.99822325,"about_ca_system_score_codex":0.00026375853,"about_ca_system_score_gemma":0.0007868115,"threshold_uncertainty_score":0.5618966},"labels":[],"label_agreement":null},{"id":"W6921164186","doi":"10.6084/m9.figshare.28376261.v1","title":"Role of TERT mutations in bladder cancer prognosis: Protocol for a systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Funnel plot; Checklist; Hazard ratio; Protocol (science); Confidence interval; Meta-analysis; Publication bias","score_opus":0.08005789240609726,"score_gpt":0.403640746364093,"score_spread":0.3235828539579957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921164186","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000106342795,0.045521233,0.000004022659,0.0017228771,0.0000032552946,0.7909023,0.15995473,0.00004490793,0.0018360621],"genre_scores_gemma":[0.005538082,0.00000669984,0.00007936244,0.00077559095,0.000004112521,0.99031967,0.00225581,0.000007753998,0.0010129216],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9993004,0.00003046576,0.0003245045,0.00016447896,0.000089829206,0.000090311376],"domain_scores_gemma":[0.99948984,0.000055206263,0.00010924029,0.00016462743,0.00015126329,0.00002981305],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000042551143,0.00010319395,0.0009768676,0.0001269944,0.000018531253,0.000007720233,0.00004554474,0.000033965265,0.01987836],"category_scores_gemma":[0.00016669718,0.00006638173,0.00030381975,0.00045592288,0.000003932822,0.00003405602,0.000015876498,0.00003623181,0.0000059799095],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033595465,0.00024107893,0.00045254338,0.8891425,0.09668796,0.0000018126655,0.0001990238,0.0000028944116,0.0000104225,0.000011390817,0.013157999,0.000058777503],"study_design_scores_gemma":[0.002239275,0.00016754943,0.0030860656,0.10111051,0.88820684,0.0000024792878,0.00010719386,0.00020788958,0.0013450711,0.00009670899,0.0032580236,0.00017237075],"about_ca_topic_score_codex":0.000045428937,"about_ca_topic_score_gemma":0.00012091482,"teacher_disagreement_score":0.7915189,"about_ca_system_score_codex":0.000028720075,"about_ca_system_score_gemma":0.0001220772,"threshold_uncertainty_score":0.9810176},"labels":[],"label_agreement":null},{"id":"W6923419603","doi":"10.1371/journal.pone.0294809.s001","title":"PRISMA flow diagram.","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Perioperative; Ileus; Bladder cancer; Complication; Blood loss; Incidence (geometry)","score_opus":0.05741645679834311,"score_gpt":0.3103522965363352,"score_spread":0.2529358397379921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6923419603","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017881073,0.0018091486,0.0000044769363,0.004437957,0.000703637,0.0026154174,0.74890244,0.0033146304,0.22033119],"genre_scores_gemma":[0.6013479,0.000028253637,0.00014535336,0.0019606245,0.0009158228,0.0008454192,0.36683354,0.000078828234,0.027844269],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949354,0.000005884783,0.00006758886,0.00013367768,0.000133025,0.00016630949],"domain_scores_gemma":[0.9996708,0.000022192253,0.0000138726255,0.0001679866,0.000033558637,0.00009161104],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010320148,0.00007396568,0.00010124294,0.000044052966,0.000035511803,0.000011195788,0.00004269371,0.0000461792,0.18125336],"category_scores_gemma":[0.00015088901,0.000059429763,0.00006064549,0.0002183937,0.0000019903866,0.00002889205,0.000030842468,0.0000646621,0.030843081],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014452743,0.000024023384,0.000491226,0.00008108831,0.000029397084,0.00014129009,0.00010363517,0.000001483453,0.00002177216,0.0000019307663,0.96983284,0.029256877],"study_design_scores_gemma":[0.0014281292,0.00019563078,0.09581602,0.0008223232,0.000037692924,0.000029148274,0.00002944693,0.00092802785,0.0023220293,0.00006603585,0.8981855,0.00014001234],"about_ca_topic_score_codex":0.000004797637,"about_ca_topic_score_gemma":0.0000021586982,"teacher_disagreement_score":0.5834668,"about_ca_system_score_codex":0.000024785686,"about_ca_system_score_gemma":0.000058778776,"threshold_uncertainty_score":0.9699115},"labels":[],"label_agreement":null},{"id":"W6924949782","doi":"10.15468/dl.su8m52","title":"Occurrence Download","year":2023,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Matching (statistics); Range (aeronautics); Column (typography); Set (abstract data type)","score_opus":0.023598262415263076,"score_gpt":0.25996526935453873,"score_spread":0.23636700693927565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6924949782","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027834254,0.00002307011,8.600949e-7,0.0002791161,0.00068451295,0.0005010864,0.997843,0.00017734425,0.00021263107],"genre_scores_gemma":[0.000008517417,0.00016208163,8.1054804e-7,0.0008428758,0.0000033316144,0.00000788342,0.9989735,2.1874511e-8,9.715823e-7],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986792,0.000025107493,0.00030332102,0.00021210912,0.0005106504,0.00026961643],"domain_scores_gemma":[0.9989494,0.00001191431,0.00015289345,0.00046495217,0.00020841806,0.00021239072],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011191287,0.0002619918,0.00034316463,0.00009501561,0.0001628259,0.000057609588,0.00019179935,0.00031535112,0.0009459273],"category_scores_gemma":[0.000088526795,0.00024278302,0.0001903617,0.00034759406,0.00010914665,0.00035007237,0.00016578504,0.0002446014,0.6122015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018116509,0.000055828514,0.0022960044,0.0002945614,0.000111783826,0.00001446065,0.000022941358,7.738974e-7,2.5281302e-8,1.5460843e-8,0.9956213,0.0014010927],"study_design_scores_gemma":[0.0010888232,0.00012562353,0.0009944576,0.000008252086,0.00025100284,0.000014497792,0.00007348356,3.873851e-8,0.0000030190097,5.368095e-7,0.99725085,0.00018942913],"about_ca_topic_score_codex":0.0016398455,"about_ca_topic_score_gemma":0.00002109697,"teacher_disagreement_score":0.6112556,"about_ca_system_score_codex":0.00043987817,"about_ca_system_score_gemma":0.00030453852,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W6927649760","doi":"10.3205/25nrwgu32","title":"Die Rolle von „UroAmp Minimal Residual Disease“ in der Vorhersage von rezidivfreiem Überleben bei nicht-muskelinvasivem Urothelkarzinom der Blase","year":2025,"lang":"de","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Context (archaeology); Clinical Practice; Congenital disease","score_opus":0.04748528089812002,"score_gpt":0.41455046757221153,"score_spread":0.3670651866740915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6927649760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87706566,0.031930815,0.00040733034,0.059377972,0.004122968,0.0060912273,0.00023702788,0.00026780512,0.020499174],"genre_scores_gemma":[0.9766634,0.004171505,0.00018044426,0.0034165808,0.002292003,0.00052196614,0.0004011114,0.00010696864,0.012246034],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9810609,0.0017318218,0.0017804253,0.0026709838,0.009179082,0.0035767637],"domain_scores_gemma":[0.9912953,0.0016667055,0.00028173294,0.0019854752,0.0012497924,0.0035210296],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["sts","insufficient_payload"],"category_scores_codex":[0.010046459,0.00086863694,0.0011133666,0.0023515401,0.0021125076,0.00085451757,0.0025695292,0.0005856017,0.007183959],"category_scores_gemma":[0.007407974,0.0007753688,0.00033068747,0.0048827776,0.0063921707,0.0013639131,0.0015312391,0.002812912,0.005247318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01397184,0.01360577,0.31298,0.0041964087,0.0042528394,0.019837704,0.01925662,0.00009412263,0.005160813,0.013802031,0.10203393,0.49080795],"study_design_scores_gemma":[0.021896182,0.0021294656,0.58403015,0.006093708,0.00210865,0.000025454363,0.00090903114,0.009079995,0.005297909,0.009713192,0.35647655,0.0022396774],"about_ca_topic_score_codex":0.0016849164,"about_ca_topic_score_gemma":0.0014606506,"teacher_disagreement_score":0.48856828,"about_ca_system_score_codex":0.002585817,"about_ca_system_score_gemma":0.018354982,"threshold_uncertainty_score":0.99948764},"labels":[],"label_agreement":null},{"id":"W6927808783","doi":"10.3205/24urobay85","title":"Die Auswirkungen von T1-Substaging auf das onkologische Überleben bei PatientInnen mit high grade nicht-muskelinvasivem Urothelkarzinom der Harnblase","year":2024,"lang":"de","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Sima; Uterine cervix; MEDLINE","score_opus":0.07342436231806815,"score_gpt":0.4320950672525049,"score_spread":0.35867070493443676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6927808783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79373664,0.08011607,0.0012236823,0.07993849,0.015973842,0.007407182,0.00046398514,0.0011807373,0.019959372],"genre_scores_gemma":[0.981011,0.004095776,0.0002988146,0.0018691251,0.0048731267,0.00045286235,0.0006974205,0.00017724672,0.006524641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98007447,0.0010999416,0.001447052,0.0029294568,0.010588567,0.003860499],"domain_scores_gemma":[0.99129003,0.0019837401,0.00025560177,0.001795067,0.0012487218,0.0034268457],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["sts","insufficient_payload"],"category_scores_codex":[0.009219598,0.00094103056,0.001010856,0.001817243,0.0026435414,0.001857985,0.0025543664,0.00063647615,0.015337527],"category_scores_gemma":[0.0041339127,0.0007719097,0.00041194202,0.004209492,0.006739526,0.0019064957,0.0011644355,0.0035400349,0.019250918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008018429,0.0034469997,0.015333111,0.0026924284,0.0053824983,0.011761377,0.01756785,0.000015655623,0.007819884,0.009899454,0.06756357,0.8577153],"study_design_scores_gemma":[0.0074858293,0.0034842906,0.08573122,0.0068210606,0.0041149044,0.0001615255,0.00085772155,0.011111789,0.018962264,0.008545202,0.84993106,0.0027931102],"about_ca_topic_score_codex":0.0025430222,"about_ca_topic_score_gemma":0.00054077664,"teacher_disagreement_score":0.85492224,"about_ca_system_score_codex":0.0022417465,"about_ca_system_score_gemma":0.009853988,"threshold_uncertainty_score":0.9994732},"labels":[],"label_agreement":null},{"id":"W6931038709","doi":"10.5281/zenodo.4803313","title":"DOWNLOAD ALBUM: Fabregas Le Metis Noir - Cible : Mise à jour - Volume.1 (Zip Mp3)","year":2021,"lang":"fr","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metis; Download; White (mutation); Range (aeronautics)","score_opus":0.03227579479139288,"score_gpt":0.25956111577380697,"score_spread":0.2272853209824141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931038709","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057137344,0.012322731,0.0016347923,0.004236145,0.0010279309,0.0015338508,0.0018784596,0.0007422478,0.97605246],"genre_scores_gemma":[0.019916488,0.0043454748,0.00079049735,0.00090304425,0.002611471,6.1116606e-7,0.01184519,0.0093812775,0.9502059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950341,0.00086943136,0.0006471985,0.0013065118,0.0009542377,0.0011885496],"domain_scores_gemma":[0.99652165,0.000039133363,0.00031683352,0.0013331574,0.0009370424,0.0008521594],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006056364,0.0006809562,0.00087230967,0.0005502392,0.0022676997,0.0010365394,0.0012550632,0.00045584014,0.6008458],"category_scores_gemma":[0.0006602338,0.0007247839,0.0003356625,0.0011175175,0.00045984777,0.00020893246,0.0013865817,0.0009615192,0.086749375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001972588,0.0008909278,0.000035584544,0.0006762554,0.0009285656,0.00048437717,0.0009648532,0.000016429693,0.0032725516,0.0011894875,0.81668836,0.17465533],"study_design_scores_gemma":[0.003404762,0.00079954043,0.0006582473,0.00086728844,0.00042740413,0.00060202606,0.00068044313,0.000104470164,0.0011840747,0.000060480397,0.9905973,0.0006139315],"about_ca_topic_score_codex":0.0008713577,"about_ca_topic_score_gemma":0.000010694886,"teacher_disagreement_score":0.51409644,"about_ca_system_score_codex":0.0009087161,"about_ca_system_score_gemma":0.00011705068,"threshold_uncertainty_score":0.99953735},"labels":[],"label_agreement":null},{"id":"W6931484120","doi":"10.5281/zenodo.4506774","title":"Amblysellus Sleesman","year":2020,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apex (geometry); Aedeagus; Black spot; Atrium (architecture)","score_opus":0.05886653184821075,"score_gpt":0.2730737084374724,"score_spread":0.21420717658926167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931484120","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07777888,0.00041288673,0.004536735,0.019017698,0.00017799194,0.0013313019,0.00029275432,0.0026942196,0.8937575],"genre_scores_gemma":[0.99470156,0.00006387264,0.00022423179,0.0019961908,0.00031137728,2.4774897e-8,0.00070965994,0.0009831568,0.0010099225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989655,0.00008213753,0.00014747061,0.00030217363,0.0002669255,0.00023576638],"domain_scores_gemma":[0.9991778,0.0000058346795,0.00003822404,0.00024203997,0.00021668959,0.00031940686],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010593703,0.000107676715,0.00014519524,0.00006584974,0.0007203954,0.0001630828,0.00027941627,0.000042300962,0.019281141],"category_scores_gemma":[0.00017814517,0.00010230264,0.000057971596,0.000339827,0.00007517148,0.000090981026,0.00029634786,0.00017972785,0.01471657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091739243,0.0004542464,0.00009609394,0.000237303,0.00033057647,0.00022465042,0.004711077,0.000018527116,0.025828566,0.0025120776,0.6619676,0.3027019],"study_design_scores_gemma":[0.0013712707,0.00073334156,0.0013673751,0.000017356086,0.00005095508,0.00011976316,0.00016377415,0.0001562398,0.0021702573,0.000041401338,0.9937046,0.00010365497],"about_ca_topic_score_codex":0.000010202185,"about_ca_topic_score_gemma":5.149071e-8,"teacher_disagreement_score":0.9169227,"about_ca_system_score_codex":0.00007871806,"about_ca_system_score_gemma":0.0000044988606,"threshold_uncertainty_score":0.9860506},"labels":[],"label_agreement":null},{"id":"W6932275076","doi":"10.5683/sp3/skwvez","title":"UNI-CEN Boundaries (CBF-Original Shorelines) - Province/Territory (PR) - 1931 - Esri Shapefile format (NAD83 CSRS / EPSG:3348)","year":2023,"lang":"en","type":"dataset","venue":"Borealis","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Shapefile; File format; North American Datum of 1927; Documentation; Data file; Boundary (topology); Geocoding","score_opus":0.02349547469458063,"score_gpt":0.29667906389615684,"score_spread":0.2731835892015762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6932275076","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054117,0.0012695824,0.000009759175,0.0010463311,0.0018951168,0.0015320505,0.99120814,0.00042412427,0.0025607678],"genre_scores_gemma":[0.000042172185,0.0015904263,0.00016085913,0.001365353,0.0034269483,0.00044607813,0.9898752,0.00018827614,0.0029046906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568635,0.000092249764,0.0009255224,0.001009117,0.0012156209,0.0010711355],"domain_scores_gemma":[0.99708456,0.000099478726,0.00036014672,0.0016551813,0.00021802934,0.0005825785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027650731,0.0010218883,0.0013457257,0.00047032617,0.00062613573,0.00038283892,0.0007026558,0.0007856266,0.00058378774],"category_scores_gemma":[0.000114969764,0.00085823383,0.0004565445,0.00032696707,0.000573751,0.0003057949,0.00027755334,0.00095706433,0.0009803752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006483915,0.00031693515,0.00016369781,0.00093054323,0.0006259805,0.0009955554,0.000115418974,0.000001087119,0.0000030991034,0.000059399852,0.9942194,0.0019204678],"study_design_scores_gemma":[0.0025972317,0.00084313226,0.00080936716,0.0006264336,0.0013825345,0.00019286935,0.00011343442,0.000023373343,0.000046516117,0.00014576517,0.99245936,0.0007599708],"about_ca_topic_score_codex":0.21590063,"about_ca_topic_score_gemma":0.08957086,"teacher_disagreement_score":0.12632978,"about_ca_system_score_codex":0.00073077105,"about_ca_system_score_gemma":0.0030483175,"threshold_uncertainty_score":0.99979746},"labels":[],"label_agreement":null},{"id":"W6938949378","doi":"10.60692/159tj-fhp43","title":"Additional file 15 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Proteogenomics; Gene; Carcinoma; Bladder cancer; Messenger RNA","score_opus":0.017814728249893667,"score_gpt":0.19271148470386495,"score_spread":0.1748967564539713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6938949378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6765957,9.090031e-7,0.000117705604,0.000018691608,0.00012854928,0.0008900569,0.32064918,0.000017993107,0.0015812254],"genre_scores_gemma":[0.9898967,2.4203361e-8,0.000058473615,0.00005843024,0.000033949338,0.00048579197,0.009071371,0.000008956342,0.0003862893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883807,0.00006573067,0.00056855875,0.0000755756,0.0003616467,0.0000904505],"domain_scores_gemma":[0.99890447,0.000009530666,0.0005900064,0.0002432628,0.00022397733,0.000028727478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000073739466,0.00010168896,0.00023987815,0.00014029622,0.00006873856,0.00000505317,0.000105319676,0.00004024781,0.055051517],"category_scores_gemma":[0.00002061905,0.00007011741,0.00011369007,0.00025389314,0.00004536426,0.0001117346,0.00005486991,0.000080188656,0.000026883203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009298709,0.00040048026,0.5934285,0.008434092,0.002691563,0.000013169267,0.25017786,0.00036402786,0.018570557,0.00040583056,0.11062129,0.0055939327],"study_design_scores_gemma":[0.0043568793,0.0007522248,0.9216584,0.00054087763,0.00022059129,0.00013555346,0.009018314,0.0010241523,0.04709587,0.0000013542891,0.014990526,0.00020527407],"about_ca_topic_score_codex":0.000024198158,"about_ca_topic_score_gemma":1.0668149e-7,"teacher_disagreement_score":0.32822987,"about_ca_system_score_codex":0.00011917016,"about_ca_system_score_gemma":0.00030631584,"threshold_uncertainty_score":0.9458123},"labels":[],"label_agreement":null},{"id":"W6938972935","doi":"10.60692/sk6qf-85y33","title":"Additional file 20 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Table (database); Bladder cancer; Proteogenomics","score_opus":0.01761578232235163,"score_gpt":0.19231635431683186,"score_spread":0.17470057199448022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6938972935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62552303,8.7780717e-7,0.000114418464,0.000022303202,0.00012901762,0.00089744333,0.371607,0.00001768189,0.0016882109],"genre_scores_gemma":[0.98790234,2.3621036e-8,0.00005776494,0.000056459998,0.000033235316,0.00048748995,0.010965392,0.000008868009,0.0004884225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988482,0.00006451902,0.0005653867,0.000075275435,0.00035634788,0.0000902902],"domain_scores_gemma":[0.99891376,0.00000939337,0.0005875048,0.00024026472,0.00022032009,0.000028723067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007101538,0.000101286074,0.00023862055,0.00013811848,0.00006896094,0.000004968943,0.00010489646,0.000038277394,0.052077387],"category_scores_gemma":[0.000018540008,0.00006988542,0.00011335784,0.00025083782,0.00004496191,0.00011213211,0.00005402267,0.00007648347,0.000025543499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009224811,0.0003888018,0.6006611,0.008113529,0.002645864,0.000012826341,0.22661196,0.0004244364,0.022968408,0.00035559986,0.12388326,0.004709416],"study_design_scores_gemma":[0.0053718854,0.0009181304,0.89548504,0.0006574794,0.0002717195,0.00016182446,0.009994336,0.0013882205,0.061843295,0.0000015936638,0.023653684,0.00025280387],"about_ca_topic_score_codex":0.00002136636,"about_ca_topic_score_gemma":1.2078303e-7,"teacher_disagreement_score":0.36237928,"about_ca_system_score_codex":0.00011876142,"about_ca_system_score_gemma":0.00030776623,"threshold_uncertainty_score":0.9487891},"labels":[],"label_agreement":null},{"id":"W6939252626","doi":"10.60692/96z80-zzd51","title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Biomarker; Interleukin 6; Lymph node; Bladder cancer; Proportional hazards model; Lymphovascular invasion; Carcinoma; Logistic regression; Interleukin-6 receptor","score_opus":0.03654192086416528,"score_gpt":0.29426182647264365,"score_spread":0.25771990560847835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939252626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551564,0.00002958226,0.000770867,0.000094950876,0.0002592814,0.0009155132,0.0021153644,0.000030393201,0.00026842524],"genre_scores_gemma":[0.9987061,8.407451e-7,0.0002012784,0.000115136965,0.00004853025,0.000391792,0.000041746367,0.000017179294,0.000477383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870133,0.000051070136,0.0006197704,0.00018111306,0.00025332338,0.00019337237],"domain_scores_gemma":[0.998958,0.000025251546,0.00022991492,0.00026706897,0.00034428237,0.00017549674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094944764,0.00022437422,0.00053787226,0.0001613402,0.00003545879,0.00003394742,0.000055385797,0.00008663981,0.0002507665],"category_scores_gemma":[0.000042914926,0.00014931592,0.00023215935,0.000111661866,0.00006396387,0.00026848743,0.000039314902,0.000077418656,0.000018126759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047533517,0.000036287478,0.95862883,0.0014712587,0.0009952631,0.0000072089992,0.03312482,0.000028556233,0.000040652,0.000024592648,0.00018261392,0.0007065331],"study_design_scores_gemma":[0.0093545765,0.0007780227,0.97444403,0.0014169122,0.00034787675,0.000021727248,0.0026094264,0.0006013045,0.010145991,0.0000010234146,0.000083118925,0.00019598087],"about_ca_topic_score_codex":0.00003563783,"about_ca_topic_score_gemma":0.0000020594666,"teacher_disagreement_score":0.030515393,"about_ca_system_score_codex":0.0002370721,"about_ca_system_score_gemma":0.00031636676,"threshold_uncertainty_score":0.6088927},"labels":[],"label_agreement":null},{"id":"W6939285884","doi":"10.6084/m9.figshare.13141507.v1","title":"Additional file 2 of Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Value (mathematics); Carcinoma; Biomarker; Scale (ratio); Overall survival","score_opus":0.022646305895735144,"score_gpt":0.23933884694848195,"score_spread":0.21669254105274682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939285884","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009312406,0.0067365956,8.74663e-8,0.000036052596,0.0000016283576,0.0034835197,0.9802771,0.000022914011,0.00012969051],"genre_scores_gemma":[0.5951456,0.000011612362,0.00004426853,0.00023652463,0.000006795462,0.0033896822,0.40108207,0.000027991398,0.00005550533],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99809027,0.0002855973,0.00074644026,0.00034313014,0.00037212914,0.00016244088],"domain_scores_gemma":[0.99839836,0.00056315836,0.000427954,0.00020821794,0.0002432961,0.00015902938],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000037150476,0.00027579162,0.0019417793,0.00015530967,0.000024171986,0.000008156293,0.000089065325,0.00010261086,0.6542216],"category_scores_gemma":[0.0013041472,0.00017559736,0.00041684575,0.0007072308,0.000035055793,0.00008846172,0.000026507407,0.000105416824,0.000047356767],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010600806,0.0008687714,0.02074474,0.5007023,0.21425518,0.00028986298,0.0018452556,0.000017099472,0.000017344022,0.000001944637,0.2601805,0.000016919945],"study_design_scores_gemma":[0.0103015015,0.003595629,0.19603159,0.15271707,0.6337871,0.0002107825,0.00021659976,0.0014509128,0.00033189543,0.0000011495996,0.00054788234,0.0008079212],"about_ca_topic_score_codex":0.000029208766,"about_ca_topic_score_gemma":0.0000038612993,"teacher_disagreement_score":0.6541742,"about_ca_system_score_codex":0.00010415438,"about_ca_system_score_gemma":0.0003933909,"threshold_uncertainty_score":0.7160653},"labels":[],"label_agreement":null},{"id":"W6939352235","doi":"10.60692/b4j4f-j4z40","title":"Additional file 5 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Urinary system; Urinary bladder; Somatic cell","score_opus":0.04910807857056008,"score_gpt":0.2735163798097642,"score_spread":0.2244083012392041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939352235","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39157093,0.000005861075,0.000038219645,0.00006436664,0.00037637138,0.00081680925,0.56588554,0.000348898,0.04089299],"genre_scores_gemma":[0.9612204,0.0000010899641,0.00008725172,0.00022574121,0.00024389946,0.0007880845,0.033535767,0.000022202645,0.0038755694],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998643,0.000022057611,0.0005715419,0.00015613665,0.00038540806,0.00022184885],"domain_scores_gemma":[0.9988758,0.000051383933,0.00029522518,0.0002765679,0.00038702576,0.0001139881],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005433133,0.00019098546,0.00032095483,0.00031917467,0.00017176461,0.000061384184,0.0000996895,0.000119080054,0.1432803],"category_scores_gemma":[0.000054032836,0.00015673293,0.00014178388,0.00034842314,0.00010123054,0.00037931665,0.000053164153,0.000087587236,0.0016657995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023665777,0.000017145183,0.046634484,0.0016739035,0.0007727995,0.000030080926,0.11308648,0.0001170555,0.00007491006,0.00009566476,0.8363849,0.00087593653],"study_design_scores_gemma":[0.0030647337,0.0002651184,0.7940029,0.0012216993,0.00013902866,0.000028717046,0.009480715,0.00015133114,0.0022758364,0.000004438689,0.18902354,0.00034194873],"about_ca_topic_score_codex":0.000052711493,"about_ca_topic_score_gemma":0.00000566952,"teacher_disagreement_score":0.7473684,"about_ca_system_score_codex":0.00030303246,"about_ca_system_score_gemma":0.00027007077,"threshold_uncertainty_score":0.99911153},"labels":[],"label_agreement":null},{"id":"W6939447393","doi":"10.60692/xb9ep-w0q37","title":"Additional file 3 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Urinary system; Somatic cell","score_opus":0.049099445652345385,"score_gpt":0.27338275807373286,"score_spread":0.22428331242138747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939447393","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38886276,0.0000058079927,0.000037846534,0.00006371864,0.00037694388,0.00081077125,0.56871927,0.0003460664,0.040776823],"genre_scores_gemma":[0.9609771,0.0000010918151,0.000087311004,0.00022574943,0.00024658404,0.000789368,0.033666976,0.000022241276,0.0039836215],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986432,0.000022042932,0.0005713677,0.00015610331,0.0003854093,0.00022183043],"domain_scores_gemma":[0.9988721,0.000051351995,0.00029518877,0.0002764756,0.0003909006,0.00011397076],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054264976,0.00019095535,0.00032083242,0.00031904783,0.00017167728,0.000061379,0.00009965601,0.00011906523,0.145261],"category_scores_gemma":[0.000054543907,0.00015670236,0.0001417557,0.00034835964,0.00010121307,0.00037926534,0.000053142678,0.000087580134,0.0017089371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002373747,0.00001710254,0.04659693,0.0016825394,0.0007712786,0.000029926381,0.11282026,0.000117014955,0.00007532431,0.000092289425,0.8366864,0.0008735955],"study_design_scores_gemma":[0.0030845113,0.00026482853,0.7850268,0.0012207908,0.0001383098,0.00002849998,0.009469992,0.00015217482,0.002308754,0.0000044284893,0.19795835,0.0003425775],"about_ca_topic_score_codex":0.000052705254,"about_ca_topic_score_gemma":0.0000056289246,"teacher_disagreement_score":0.73842984,"about_ca_system_score_codex":0.0003040648,"about_ca_system_score_gemma":0.0002707362,"threshold_uncertainty_score":0.9990683},"labels":[],"label_agreement":null},{"id":"W6939491239","doi":"10.6084/m9.figshare.24040684.v1","title":"Additional file 6 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; Gene; Urothelial cancer","score_opus":0.06604016761152713,"score_gpt":0.3283715155154365,"score_spread":0.26233134790390933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939491239","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002319548,0.000086655535,1.645742e-8,0.000064877575,0.00004575926,0.00026490306,0.974204,0.00009129416,0.022922972],"genre_scores_gemma":[0.020374896,0.000016153032,0.000035740308,0.00038189188,0.00044044293,0.0015912512,0.96268904,0.0000418865,0.014428706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990094,0.000013125282,0.00021542031,0.0002630698,0.00027506985,0.00022394155],"domain_scores_gemma":[0.9988778,0.0003958044,0.00010710759,0.00023017277,0.0002707988,0.00011829173],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008970095,0.0001666431,0.00024944468,0.00011813818,0.00012883151,0.000023002425,0.00011460882,0.00010551436,0.99532187],"category_scores_gemma":[0.0006071523,0.000150316,0.00014940665,0.00029364895,0.0000407908,0.00009210782,0.000085103835,0.00012215026,0.0036961096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023270917,0.000052417432,0.00008474051,0.0001818203,0.00014992438,0.00004943152,0.00052205124,0.000005087769,0.0004262438,0.000004469455,0.99770087,0.00079968554],"study_design_scores_gemma":[0.0006540038,0.00014572593,0.113568984,0.001589482,0.000029215571,0.0000036527067,0.00008868639,0.00000761365,0.002876527,0.000040006296,0.880861,0.0001351079],"about_ca_topic_score_codex":0.00006452915,"about_ca_topic_score_gemma":0.00022577155,"teacher_disagreement_score":0.9916258,"about_ca_system_score_codex":0.00016312436,"about_ca_system_score_gemma":0.0004888711,"threshold_uncertainty_score":0.9970796},"labels":[],"label_agreement":null},{"id":"W6939493870","doi":"10.60692/t0373-14f31","title":"Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Perioperative; Antibiotics; Stent; Antibiotic prophylaxis; Cystectomy; Bacteremia; Urinary system","score_opus":0.04204953155751076,"score_gpt":0.2714273022121077,"score_spread":0.22937777065459694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939493870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98368984,0.00027724326,0.0011141842,0.00070967886,0.0003747406,0.0100475475,0.00033406835,0.0012606072,0.0021920986],"genre_scores_gemma":[0.99825007,0.000026937385,0.0000642567,0.00024001622,0.00007745692,0.0003024649,0.0001508244,0.000017253742,0.00087072735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981162,0.000119201344,0.00087139517,0.00018152401,0.0004789179,0.00023275834],"domain_scores_gemma":[0.9986523,0.00002129038,0.0005423296,0.000365935,0.00030099833,0.00011713922],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006000399,0.00020415624,0.0006605877,0.00030791794,0.0001669684,0.0000924948,0.00005670292,0.00013286926,0.000008394189],"category_scores_gemma":[0.00015024387,0.00013534211,0.000103341874,0.0007130695,0.000015497673,0.0003554211,0.000038222857,0.000110015855,0.00096854684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004311978,0.0000051781535,0.5896109,0.40232682,0.00058787735,0.000011047186,0.0067726024,0.0000012841788,8.2187984e-7,0.000013995967,0.0002220392,0.0004043116],"study_design_scores_gemma":[0.0029409614,0.0006920614,0.8853528,0.105481885,0.0024708065,0.0005260072,0.0016166893,0.000413649,0.000058663794,0.0000015607588,0.0001644153,0.00028053753],"about_ca_topic_score_codex":0.000028360748,"about_ca_topic_score_gemma":9.684721e-7,"teacher_disagreement_score":0.29684493,"about_ca_system_score_codex":0.00049947086,"about_ca_system_score_gemma":0.000071553084,"threshold_uncertainty_score":0.9998093},"labels":[],"label_agreement":null},{"id":"W6939540459","doi":"10.6084/m9.figshare.24040720","title":"Additional file 15 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Bracken; Table (database); Fern; Cancer; Signature (topology)","score_opus":0.06737171160842814,"score_gpt":0.3303498432074862,"score_spread":0.2629781315990581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939540459","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046309987,0.00013471449,2.6040055e-8,0.00007893234,0.000057419842,0.00029177126,0.9737216,0.000095260715,0.020989243],"genre_scores_gemma":[0.044910654,0.000022243874,0.000034994515,0.00045619693,0.0005292828,0.0013150254,0.93970877,0.000046957426,0.012975861],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894977,0.00001443022,0.00022895909,0.00027745578,0.00029388635,0.00023552701],"domain_scores_gemma":[0.9989287,0.00030622166,0.00011085778,0.00024243469,0.00028592322,0.00012583271],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011037284,0.00017635875,0.0002643338,0.00012331422,0.00013361698,0.000024759407,0.00012175024,0.00011726375,0.987109],"category_scores_gemma":[0.0004909963,0.00015919506,0.00015445282,0.0003005065,0.000043031832,0.0000985936,0.000089817724,0.00013639238,0.0032564404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027066866,0.000057809044,0.00013812233,0.0001984555,0.00016290805,0.0000533534,0.00063414464,0.00000728499,0.0005941579,0.0000058441988,0.9973383,0.0007825578],"study_design_scores_gemma":[0.00084339647,0.00017062886,0.12995657,0.0015287565,0.000037061778,0.0000041892595,0.000110067536,0.000009198751,0.0042406903,0.000051648836,0.86289376,0.0001540057],"about_ca_topic_score_codex":0.00008011998,"about_ca_topic_score_gemma":0.00030624916,"teacher_disagreement_score":0.98385257,"about_ca_system_score_codex":0.00017203644,"about_ca_system_score_gemma":0.0004902773,"threshold_uncertainty_score":0.9975196},"labels":[],"label_agreement":null},{"id":"W6939562148","doi":"10.6084/m9.figshare.24040696.v1","title":"Additional file 9 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Gene; Urinary system; Cancer; Urinary bladder","score_opus":0.06606459265921336,"score_gpt":0.32842644634653856,"score_spread":0.26236185368732523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939562148","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002335352,0.00008652532,1.6477244e-8,0.00006494823,0.00004576901,0.0002644882,0.97444135,0.00009132613,0.022670247],"genre_scores_gemma":[0.020330444,0.000016185339,0.000035719688,0.00038197596,0.00044039785,0.0015772195,0.96279263,0.00004186062,0.014383554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990095,0.000013124436,0.00021541349,0.0002630246,0.00027504718,0.00022392675],"domain_scores_gemma":[0.998878,0.00039576736,0.00010709342,0.0002300962,0.0002707848,0.00011827144],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008967906,0.00016662742,0.00024940635,0.00011814291,0.00012885897,0.000022994913,0.000114507304,0.000105496954,0.99534416],"category_scores_gemma":[0.0006071568,0.00015029768,0.00014940456,0.00029361693,0.000040789684,0.00009210773,0.00008505983,0.00012210087,0.003703194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023147048,0.000052149262,0.00008502918,0.00018183138,0.00014991652,0.000049452505,0.00052103715,0.000005176925,0.00042665325,0.0000043335576,0.9977101,0.00079115835],"study_design_scores_gemma":[0.0006540666,0.00014591403,0.11333603,0.0015929217,0.000029248022,0.0000036603979,0.00008862975,0.0000077358745,0.0029039995,0.000040060662,0.8810625,0.00013524723],"about_ca_topic_score_codex":0.00006242629,"about_ca_topic_score_gemma":0.0002210532,"teacher_disagreement_score":0.991641,"about_ca_system_score_codex":0.00016333735,"about_ca_system_score_gemma":0.00048871106,"threshold_uncertainty_score":0.9970725},"labels":[],"label_agreement":null},{"id":"W6939573667","doi":"10.6084/m9.figshare.19704021","title":"Additional file 6 of Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Immune system; Tumor microenvironment; Urinary system; Urinary bladder; Disease","score_opus":0.04124733527612807,"score_gpt":0.24941394704289113,"score_spread":0.20816661176676307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939573667","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38052958,0.00025843666,1.1900695e-8,0.00012809424,0.0000034396664,0.0002844102,0.618511,0.000002446229,0.00028256228],"genre_scores_gemma":[0.956178,0.000008958638,0.000013091257,0.00037843367,0.000018407714,0.0018689359,0.041312356,0.000011529122,0.00021026623],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990458,0.000064836975,0.00023311828,0.00017242346,0.0003508192,0.00013301116],"domain_scores_gemma":[0.9991283,0.00041190782,0.00016159462,0.00024296444,0.000030582618,0.000024676514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003414566,0.00012466728,0.0002307294,0.000054949858,0.000070823284,0.0000031679892,0.00016441598,0.000018938405,0.7769213],"category_scores_gemma":[0.00008878979,0.000076936594,0.00006345973,0.00011778307,0.000034915476,0.000028827364,0.00013882207,0.00018069486,0.000006429346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048779714,0.001822635,0.004330593,0.0006450692,0.0005099563,0.00007767977,0.0073077576,0.0009519373,0.013823496,0.000010347545,0.968707,0.001325731],"study_design_scores_gemma":[0.0022060126,0.0017019926,0.9561383,0.0033442732,0.00013724087,0.00007860019,0.0035530943,0.0027771916,0.020940777,0.00008154553,0.0087551875,0.00028578882],"about_ca_topic_score_codex":0.00015562288,"about_ca_topic_score_gemma":0.000009381294,"teacher_disagreement_score":0.9599518,"about_ca_system_score_codex":0.0000459265,"about_ca_system_score_gemma":0.00014290841,"threshold_uncertainty_score":0.31373832},"labels":[],"label_agreement":null},{"id":"W6939592156","doi":"10.6084/m9.figshare.24040738.v1","title":"Additional file 20 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Context (archaeology); Sequence (biology); Base (topology); Human disease","score_opus":0.06669249215027505,"score_gpt":0.32975875321139875,"score_spread":0.2630662610611237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939592156","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035349408,0.0001284447,2.4882722e-8,0.00009486669,0.000056845784,0.00029021446,0.97361666,0.00009181584,0.02218616],"genre_scores_gemma":[0.028375372,0.000021538392,0.00003395962,0.00043256942,0.00050994847,0.0012991364,0.95272446,0.000045634544,0.016557362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989584,0.0000141178425,0.00022748929,0.00027620498,0.000288765,0.0002350234],"domain_scores_gemma":[0.99894357,0.00030105177,0.00011034228,0.00023893378,0.00028031174,0.00012581747],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010564951,0.00017553403,0.00026270415,0.00012099736,0.00013416365,0.00002428205,0.00012117414,0.00011100455,0.98640835],"category_scores_gemma":[0.00043610815,0.00015857018,0.00015392531,0.00029616218,0.000042580148,0.000099022305,0.00008822902,0.00012959879,0.0030906673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027316082,0.00005686629,0.00014288122,0.00019310162,0.00016268161,0.00005268738,0.0005744217,0.00000875356,0.00076040317,0.0000051058482,0.9973584,0.00065742905],"study_design_scores_gemma":[0.0008337988,0.0001668355,0.09626708,0.0014877635,0.0000366283,0.0000039878355,0.000096089534,0.000010101722,0.0044940696,0.00004821258,0.89640325,0.00015216405],"about_ca_topic_score_codex":0.00007034538,"about_ca_topic_score_gemma":0.00035200058,"teacher_disagreement_score":0.9833177,"about_ca_system_score_codex":0.00017082693,"about_ca_system_score_gemma":0.000492102,"threshold_uncertainty_score":0.99768555},"labels":[],"label_agreement":null},{"id":"W6939612353","doi":"10.6084/m9.figshare.24040771","title":"Additional file 28 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; MEDLINE; Kidney cancer; Radiation therapy","score_opus":0.06734486274596097,"score_gpt":0.33022782188167876,"score_spread":0.2628829591357178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939612353","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039998647,0.00012181225,2.6122699e-8,0.00008693686,0.000057817524,0.00029120198,0.97137904,0.00009548214,0.023967799],"genre_scores_gemma":[0.04644682,0.000026234638,0.000036428042,0.00045290333,0.00052074355,0.0013861184,0.93890655,0.000048621976,0.012175555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887687,0.000014377021,0.00022936983,0.0002783313,0.00036437425,0.00023666862],"domain_scores_gemma":[0.998822,0.0003114934,0.000110859655,0.00024339104,0.0003875697,0.00012469255],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000013625706,0.00017680682,0.00026447148,0.00012335944,0.00013665597,0.00002485179,0.00012210365,0.000111918336,0.9855723],"category_scores_gemma":[0.00064738386,0.00015953649,0.00015609997,0.00029798472,0.000043193948,0.00009869172,0.0000897722,0.00013013717,0.0030557185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002693636,0.00005793767,0.000116060284,0.00020048235,0.00016348864,0.00005325356,0.0006232994,0.000007156322,0.00060013944,0.0000065387303,0.9973531,0.00079160463],"study_design_scores_gemma":[0.000821941,0.00016637325,0.116964065,0.001511855,0.000036345937,0.0000041231833,0.000102593105,0.000008992585,0.004178196,0.00005052964,0.8760037,0.00015127094],"about_ca_topic_score_codex":0.00008386586,"about_ca_topic_score_gemma":0.00030224447,"teacher_disagreement_score":0.9825166,"about_ca_system_score_codex":0.00022812314,"about_ca_system_score_gemma":0.0005838378,"threshold_uncertainty_score":0.99772054},"labels":[],"label_agreement":null},{"id":"W6939617420","doi":"10.6084/m9.figshare.24040717.v1","title":"Additional file 14 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; MEDLINE; Urinary bladder","score_opus":0.06638066329221803,"score_gpt":0.32961892242215934,"score_spread":0.2632382591299413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939617420","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040813503,0.00011964549,2.7814496e-8,0.00008228797,0.000062348656,0.00029079235,0.97351897,0.00009556854,0.021749021],"genre_scores_gemma":[0.04216015,0.00002357548,0.0000350207,0.00044433543,0.0004992975,0.0013440099,0.9407315,0.000047318008,0.014714793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894345,0.000014540844,0.00022943968,0.00027814865,0.00029817258,0.00023626578],"domain_scores_gemma":[0.9988984,0.00031291554,0.00011096003,0.00024276345,0.00031037987,0.00012456742],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011374458,0.00017658366,0.00026476436,0.00012297985,0.00013642148,0.00002478956,0.00012146491,0.000114206785,0.98536915],"category_scores_gemma":[0.00053692574,0.00015943019,0.00015585785,0.00029761868,0.00004317291,0.000097575794,0.000089152956,0.00013268502,0.00304112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027396098,0.00005736134,0.00012844217,0.00020187108,0.00016261445,0.000052055842,0.0006205406,0.0000072717835,0.0005577373,0.000006202958,0.99738973,0.0007888005],"study_design_scores_gemma":[0.00086651783,0.00016818361,0.12054169,0.001533047,0.00003683252,0.0000041016774,0.00009199996,0.000008627074,0.004205109,0.000051312218,0.8723392,0.00015338813],"about_ca_topic_score_codex":0.00007216717,"about_ca_topic_score_gemma":0.00027799027,"teacher_disagreement_score":0.98232806,"about_ca_system_score_codex":0.00017405086,"about_ca_system_score_gemma":0.0004758608,"threshold_uncertainty_score":0.99773514},"labels":[],"label_agreement":null},{"id":"W6939735476","doi":"10.6084/m9.figshare.24040711.v1","title":"Additional file 13 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Context (archaeology); Sequence (biology); Urinary system; Urinary bladder","score_opus":0.06621057772092111,"score_gpt":0.32896071911908853,"score_spread":0.26275014139816744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939735476","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061478005,0.00011912962,2.5132813e-8,0.00008036575,0.000057790578,0.00029379025,0.971607,0.0000953405,0.021598717],"genre_scores_gemma":[0.054109737,0.000023799388,0.000029328308,0.00043621773,0.00049778144,0.0013620486,0.9303738,0.000046818193,0.01312051],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989518,0.000014299675,0.00022922967,0.00027771736,0.00029096476,0.0002360185],"domain_scores_gemma":[0.9989291,0.00031005364,0.00011070114,0.00024251683,0.0002829662,0.00012467729],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010839364,0.00017670997,0.00026391883,0.00012307825,0.00013580396,0.000025095329,0.000121918005,0.000111655114,0.9858992],"category_scores_gemma":[0.0004808962,0.00015939742,0.00015549325,0.00029804258,0.0000431848,0.00009945102,0.000089640525,0.00012973827,0.0031313899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002653366,0.00005722312,0.00016762527,0.0002006653,0.00016346069,0.00005211582,0.00065580755,0.000008907586,0.00055287406,0.000005156817,0.9973193,0.0007903692],"study_design_scores_gemma":[0.0008512879,0.00016811192,0.16314681,0.0015346424,0.000036797504,0.000004116076,0.00010897659,0.000010554944,0.0038424192,0.000051121464,0.8300908,0.00015434917],"about_ca_topic_score_codex":0.00011002812,"about_ca_topic_score_gemma":0.00040947722,"teacher_disagreement_score":0.9827678,"about_ca_system_score_codex":0.00017112096,"about_ca_system_score_gemma":0.0004784085,"threshold_uncertainty_score":0.9976448},"labels":[],"label_agreement":null},{"id":"W6946384986","doi":"10.3205/24urobay84","title":"Lymphovaskuläre Invasion als prognostischer Faktor bei PatientInnen mit high grade T1 nicht-muskelinvasivem Urothelkarzinom der Harnblase","year":2024,"lang":"de","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Uterine cervix; Coronary heart disease; Cancer","score_opus":0.06883851980314334,"score_gpt":0.4123400496345409,"score_spread":0.3435015298313976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946384986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87945235,0.041697297,0.00044774075,0.0493213,0.012393489,0.007853046,0.00040461632,0.0007809238,0.007649262],"genre_scores_gemma":[0.97412014,0.0046505686,0.0004138374,0.0023293293,0.005851502,0.00072507985,0.00090535544,0.00020657665,0.010797626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9787533,0.0011939888,0.0014785222,0.002893346,0.012250919,0.0034299197],"domain_scores_gemma":[0.991145,0.0015854615,0.0002418311,0.0016658864,0.0016046098,0.003757226],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["sts","insufficient_payload"],"category_scores_codex":[0.008613085,0.00091914146,0.0009801234,0.0017749534,0.0023252578,0.001958136,0.002241969,0.0007025428,0.015523901],"category_scores_gemma":[0.0044557424,0.0007434056,0.00042995592,0.005316686,0.00612578,0.0020637193,0.001083113,0.002510913,0.027905457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067845784,0.0040605515,0.017102612,0.0030681666,0.0028277352,0.007878881,0.009686035,0.0000050408544,0.007636805,0.008406119,0.14277576,0.7958738],"study_design_scores_gemma":[0.0077591166,0.0026493077,0.05214567,0.0067295814,0.001809265,0.0001917567,0.00046635835,0.0041368417,0.018115094,0.004128062,0.9000625,0.0018064171],"about_ca_topic_score_codex":0.0014124049,"about_ca_topic_score_gemma":0.00017839673,"teacher_disagreement_score":0.79406744,"about_ca_system_score_codex":0.0020869153,"about_ca_system_score_gemma":0.014451885,"threshold_uncertainty_score":0.9997903},"labels":[],"label_agreement":null},{"id":"W6954732863","doi":"10.57745/xoiqkr","title":"Data_Set_Figure8B_101016jjnoncrysol2025123695_20250711_V0.opju","year":2025,"lang":"en","type":"dataset","venue":"Recherche Data Gouv France","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Set (abstract data type); Data set; Identification (biology); Work (physics)","score_opus":0.2001790692291364,"score_gpt":0.4333833986769702,"score_spread":0.23320432944783379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6954732863","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029990028,0.0097685745,0.00016903508,0.0015412804,0.0014183755,0.0012550658,0.9814017,0.0001654376,0.0042775706],"genre_scores_gemma":[9.834446e-7,0.014289692,0.0043113553,0.0046215067,0.0010122431,0.00014764645,0.9471244,0.000050280127,0.02844186],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514824,0.0004689095,0.00077795354,0.002045529,0.0007871316,0.0007722591],"domain_scores_gemma":[0.98910975,0.0007053903,0.0002836243,0.009356309,0.00020079613,0.0003441284],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001218453,0.000898297,0.0014602906,0.00031234455,0.00015638497,0.00011085779,0.002909908,0.0018806745,0.0023569588],"category_scores_gemma":[0.0019529529,0.0007982034,0.00021799712,0.0010775336,0.00016931341,0.00033573716,0.0016071527,0.0032856048,0.00065064436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021039683,0.00040534764,0.00006302535,0.0014926402,0.00073266204,0.0002396427,0.0000107822,2.6603536e-7,0.000022379989,0.0000049088517,0.98134106,0.015476869],"study_design_scores_gemma":[0.0020676102,0.00017442665,0.00018101795,0.001455421,0.0015815538,0.00006690433,0.0000138059595,0.000026232834,0.000104460785,0.0000715425,0.99365455,0.0006024509],"about_ca_topic_score_codex":0.002196688,"about_ca_topic_score_gemma":0.0002469412,"teacher_disagreement_score":0.034277227,"about_ca_system_score_codex":0.00051944423,"about_ca_system_score_gemma":0.002904545,"threshold_uncertainty_score":0.99944687},"labels":[],"label_agreement":null},{"id":"W6957709825","doi":"10.60692/6bser-9rk74","title":"Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Bladder cancer; Cohort; Perioperative; Poisson regression; Logistic regression; Odds ratio","score_opus":0.047022297902778024,"score_gpt":0.2828588027836274,"score_spread":0.2358365048808494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957709825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722965,0.00001831758,0.00010361896,0.00005589807,0.0005476661,0.0019660867,0.00080247415,0.000035151897,0.009241144],"genre_scores_gemma":[0.9988983,2.3855424e-7,0.00006692525,0.00013988979,0.000012783554,0.00054058357,0.00014771789,0.00001454221,0.00017896679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795157,0.00011486423,0.0009784657,0.00016034546,0.00059264834,0.00020211036],"domain_scores_gemma":[0.9989171,0.000014473582,0.00048601782,0.0003186665,0.0001729389,0.00009077664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028586102,0.00017504864,0.0007136834,0.00028259712,0.0000707014,0.000018698529,0.00021516095,0.00006876816,0.0003054302],"category_scores_gemma":[0.000015837655,0.00014040057,0.000099528006,0.00035779254,0.00003796744,0.0003107313,0.00020902492,0.0001325217,0.000017832373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018474628,0.00007335158,0.9820846,0.00029885137,0.0003926773,0.00000504917,0.0149353845,0.00006114538,0.0000010963906,0.0000086715645,0.0002241218,0.000067642504],"study_design_scores_gemma":[0.022544535,0.00049006054,0.96884674,0.0001425766,0.00014586003,0.0000060882717,0.007109015,0.0002513987,0.00013869829,1.5017645e-7,0.00020528113,0.00011961876],"about_ca_topic_score_codex":0.0004043021,"about_ca_topic_score_gemma":0.0000054703473,"teacher_disagreement_score":0.020697072,"about_ca_system_score_codex":0.00033785377,"about_ca_system_score_gemma":0.0002660401,"threshold_uncertainty_score":0.57253695},"labels":[],"label_agreement":null},{"id":"W6957765077","doi":"10.60692/7fjew-ys615","title":"Additional file 4 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Urinary system; Somatic cell","score_opus":0.04942577986166618,"score_gpt":0.27374421822568,"score_spread":0.22431843836401383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957765077","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38943455,0.0000058568253,0.000038259644,0.00006392591,0.00037565097,0.00081545446,0.56803626,0.00034822483,0.04088183],"genre_scores_gemma":[0.9612039,0.0000010886216,0.00008714354,0.00022531819,0.00024355833,0.0007871151,0.033585932,0.000022171094,0.003843813],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99864304,0.000022040238,0.00057155907,0.00015611797,0.00038538672,0.00022185403],"domain_scores_gemma":[0.9988786,0.00005144497,0.00029523787,0.00027661456,0.00038411006,0.000113977265],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054305743,0.0001909678,0.0003209033,0.00031918666,0.0001717572,0.000061409555,0.000099724595,0.000119074655,0.14331138],"category_scores_gemma":[0.000053830263,0.00015673021,0.00014176597,0.00034831802,0.00010123008,0.0003793172,0.000053161635,0.000087577595,0.001676331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024122495,0.00001722064,0.046993125,0.0016809478,0.00077625125,0.00003021681,0.11364783,0.00011623021,0.000074721385,0.00009604465,0.8354476,0.0008785739],"study_design_scores_gemma":[0.0030874226,0.0002703032,0.79112697,0.0012292205,0.00013993261,0.000028910843,0.009541093,0.00015338042,0.0022749323,0.0000044913777,0.19179907,0.0003442447],"about_ca_topic_score_codex":0.0000522674,"about_ca_topic_score_gemma":0.000005650525,"teacher_disagreement_score":0.7441339,"about_ca_system_score_codex":0.00030297047,"about_ca_system_score_gemma":0.0002697871,"threshold_uncertainty_score":0.999101},"labels":[],"label_agreement":null},{"id":"W6958015683","doi":"10.60692/2jxe7-2vb98","title":"The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Cystectomy; Urothelial carcinoma; Logistic regression; Concordance; Proportional hazards model; VEGF receptors; Lymph node; Carcinoma; Pathological","score_opus":0.022420208307601705,"score_gpt":0.2217265461404965,"score_spread":0.1993063378328948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958015683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949713,0.00001013305,0.000074505486,0.000101986465,0.000119632656,0.0013120284,0.0003147117,0.000023083825,0.0030726392],"genre_scores_gemma":[0.9993071,9.885508e-8,0.000025550975,0.00006707924,0.00002568504,0.00027997218,0.000007930372,0.000012774405,0.0002738381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831325,0.0002156215,0.00059681025,0.00011894574,0.00056491315,0.00019045807],"domain_scores_gemma":[0.9991169,0.000022340058,0.0003009491,0.00038638472,0.00012583779,0.000047616704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002530799,0.00016296569,0.0003214812,0.00011981722,0.00020532068,0.00001899335,0.00018485748,0.000048931593,0.00003944358],"category_scores_gemma":[0.000012635579,0.00007944791,0.000091278256,0.00039939862,0.00012348258,0.00012503877,0.000074609765,0.00017266358,0.000009123161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017192595,0.000021210059,0.9247979,0.00022764942,0.00024187237,0.00000850269,0.071977094,0.00053486763,0.000029384968,0.00023798474,0.00003599215,0.00016828332],"study_design_scores_gemma":[0.011343438,0.0009688571,0.9448712,0.0002244378,0.00019250737,0.0002569329,0.023682667,0.002186327,0.01588571,8.843529e-7,0.00024084937,0.00014620525],"about_ca_topic_score_codex":0.00015143571,"about_ca_topic_score_gemma":0.0000026088667,"teacher_disagreement_score":0.048294425,"about_ca_system_score_codex":0.00022131902,"about_ca_system_score_gemma":0.00029259673,"threshold_uncertainty_score":0.3239792},"labels":[],"label_agreement":null},{"id":"W6958040850","doi":"10.60692/mcmmq-nzw27","title":"Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Medical Research Council","keywords":"Bracken; Bladder cancer; Fern; Mutation; Cancer; Gene; Animal model; Urinary bladder; Chromatin","score_opus":0.058711113299676196,"score_gpt":0.2889245152361715,"score_spread":0.2302134019364953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958040850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792952,0.000014154191,0.00015059393,0.00013953475,0.000674981,0.00069177884,0.00024086412,0.0004746324,0.018318284],"genre_scores_gemma":[0.9954234,0.000004816241,0.000029403855,0.0005073614,0.00032338372,0.00024562562,0.00016552738,0.000030524552,0.0032699932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984102,0.000029195418,0.00060317514,0.0002151393,0.00040284157,0.00033940608],"domain_scores_gemma":[0.99890864,0.000009090631,0.00021465216,0.00040792002,0.00028305658,0.00017663685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013710906,0.0002597389,0.00036614973,0.0003792852,0.00030144796,0.00017062055,0.00013052332,0.00015285425,0.00025327876],"category_scores_gemma":[0.000014780103,0.00020629374,0.00014704872,0.0004278535,0.0000790254,0.0004883817,0.00007227765,0.00012324355,0.0018992935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001964206,0.000008278073,0.7505836,0.0011714525,0.000540211,0.000049725102,0.24464783,0.00016327358,0.000260704,0.0001555587,0.0010941151,0.001128824],"study_design_scores_gemma":[0.0046536736,0.00021404283,0.963339,0.00038272006,0.00020634542,0.000032584303,0.0125038335,0.00016619677,0.0068269293,0.0000030114845,0.011301522,0.0003701602],"about_ca_topic_score_codex":0.00015819028,"about_ca_topic_score_gemma":0.000009087649,"teacher_disagreement_score":0.232144,"about_ca_system_score_codex":0.00053428364,"about_ca_system_score_gemma":0.00019769465,"threshold_uncertainty_score":0.9988778},"labels":[],"label_agreement":null},{"id":"W6958060066","doi":"10.60692/26dac-37x35","title":"Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Logistic regression; Stage (stratigraphy); Predictive value; T-stage; Risk stratification; Urothelial carcinoma; Cancer; Predictive value of tests; Carcinoma","score_opus":0.055577942734148574,"score_gpt":0.2925480091992488,"score_spread":0.23697006646510022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958060066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943001,0.00002125778,0.002946384,0.00005423343,0.000087877524,0.0010793553,0.000972931,0.000042218708,0.00049562997],"genre_scores_gemma":[0.99934596,4.8739935e-7,0.00016407516,0.00024382607,0.000019719624,0.0001512043,0.000034189925,0.000010137604,0.000030421825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839705,0.00015266164,0.000767978,0.0001861496,0.00033071416,0.00016545881],"domain_scores_gemma":[0.99926835,0.000031119805,0.00027395433,0.00023636883,0.00007349306,0.00011670808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048499554,0.00015425775,0.0004248246,0.00018973225,0.000079579855,0.000020459045,0.000057074645,0.00005666091,0.00003954398],"category_scores_gemma":[0.000035575154,0.00012550522,0.00008137806,0.00013313771,0.00007745771,0.00023194792,0.000056302175,0.00019094558,0.00000270332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022524106,0.00003948656,0.9835601,0.000424478,0.00003940413,0.000011213948,0.013063637,0.00017393439,0.0000010853967,0.000010686209,0.000012167838,0.0004113973],"study_design_scores_gemma":[0.012030382,0.00057630433,0.7143678,0.000077990495,0.000112358866,0.000050994466,0.0063480046,0.2661088,0.00015179312,0.0000020173554,0.00006544455,0.00010809001],"about_ca_topic_score_codex":0.00010901896,"about_ca_topic_score_gemma":5.698672e-7,"teacher_disagreement_score":0.2691923,"about_ca_system_score_codex":0.00009910897,"about_ca_system_score_gemma":0.00026726417,"threshold_uncertainty_score":0.51179546},"labels":[],"label_agreement":null},{"id":"W6958072271","doi":"10.6084/m9.figshare.24040723.v1","title":"Additional file 16 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Bracken; Table (database); Signature (topology); Cancer; Fern","score_opus":0.06650654841165893,"score_gpt":0.3297488570631881,"score_spread":0.2632423086515292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958072271","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003039989,0.00012856766,3.5659713e-8,0.00007956815,0.00005714679,0.00028876937,0.96886665,0.000094201074,0.027445052],"genre_scores_gemma":[0.04084578,0.000023412787,0.00002575893,0.0004435249,0.00048542416,0.0012902239,0.94223404,0.000045152574,0.014606693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989512,0.000014401018,0.00023412108,0.0002765208,0.00028847528,0.00023530236],"domain_scores_gemma":[0.99893236,0.00030902136,0.000113666305,0.00024143788,0.000279578,0.00012394985],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011187108,0.00017592375,0.00026230456,0.00012279433,0.00013541315,0.00002441414,0.00012028316,0.00011101181,0.9909755],"category_scores_gemma":[0.0004901295,0.00015779393,0.00016139554,0.00029423946,0.000043121418,0.00009769238,0.00008877784,0.00012732035,0.0029577946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002759956,0.00005707099,0.00011171964,0.00019972623,0.00016259716,0.000041798303,0.00051184965,0.000005067942,0.000374227,0.0000070747383,0.99755955,0.0009417128],"study_design_scores_gemma":[0.000841592,0.0001661379,0.0806882,0.00155987,0.000036176552,0.000004062652,0.00011295972,0.000005703868,0.0037046939,0.00006387544,0.9126653,0.00015143721],"about_ca_topic_score_codex":0.00010372776,"about_ca_topic_score_gemma":0.0005154322,"teacher_disagreement_score":0.9880177,"about_ca_system_score_codex":0.00024793422,"about_ca_system_score_gemma":0.00048701,"threshold_uncertainty_score":0.9978185},"labels":[],"label_agreement":null},{"id":"W6958083669","doi":"10.60692/fs1wj-1b187","title":"Additional file 15 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Urothelial carcinoma; Proteogenomics; Gene; Carcinoma; Bladder cancer; Messenger RNA","score_opus":0.017814728249893667,"score_gpt":0.19271148470386495,"score_spread":0.1748967564539713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958083669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6765957,9.090031e-7,0.000117705604,0.000018691608,0.00012854928,0.0008900569,0.32064918,0.000017993107,0.0015812254],"genre_scores_gemma":[0.9898967,2.4203361e-8,0.000058473615,0.00005843024,0.000033949338,0.00048579197,0.009071371,0.000008956342,0.0003862893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883807,0.00006573067,0.00056855875,0.0000755756,0.0003616467,0.0000904505],"domain_scores_gemma":[0.99890447,0.000009530666,0.0005900064,0.0002432628,0.00022397733,0.000028727478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000073739466,0.00010168896,0.00023987815,0.00014029622,0.00006873856,0.00000505317,0.000105319676,0.00004024781,0.055051517],"category_scores_gemma":[0.00002061905,0.00007011741,0.00011369007,0.00025389314,0.00004536426,0.0001117346,0.00005486991,0.000080188656,0.000026883203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009298709,0.00040048026,0.5934285,0.008434092,0.002691563,0.000013169267,0.25017786,0.00036402786,0.018570557,0.00040583056,0.11062129,0.0055939327],"study_design_scores_gemma":[0.0043568793,0.0007522248,0.9216584,0.00054087763,0.00022059129,0.00013555346,0.009018314,0.0010241523,0.04709587,0.0000013542891,0.014990526,0.00020527407],"about_ca_topic_score_codex":0.000024198158,"about_ca_topic_score_gemma":1.0668149e-7,"teacher_disagreement_score":0.32822987,"about_ca_system_score_codex":0.00011917016,"about_ca_system_score_gemma":0.00030631584,"threshold_uncertainty_score":0.9458123},"labels":[],"label_agreement":null},{"id":"W6958087642","doi":"10.60692/nsw78-4w886","title":"Additional file 22 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Germline; Urinary bladder; Table (database); Urinary system","score_opus":0.04848650025612248,"score_gpt":0.2752981515445095,"score_spread":0.226811651288387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958087642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68435925,0.000008950899,0.00005915841,0.000076217875,0.0005019077,0.0009745265,0.2657638,0.00039230403,0.04786387],"genre_scores_gemma":[0.9787703,0.000001416925,0.00007483586,0.00022723204,0.00024400241,0.0006246542,0.01659196,0.000022267632,0.0034432947],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985732,0.00002406684,0.0005997551,0.00016344292,0.00040853606,0.00023103219],"domain_scores_gemma":[0.99885154,0.000041457457,0.00030314858,0.0002888305,0.0003968311,0.00011818671],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006534652,0.00019946719,0.00033534341,0.0003311491,0.00018037546,0.000064624466,0.0001053103,0.00012278353,0.07277184],"category_scores_gemma":[0.000043919597,0.00016423245,0.00014668611,0.0003537545,0.00010412027,0.000398933,0.00005643657,0.000092521586,0.0013798419],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042294632,0.000030305644,0.10943727,0.0028323622,0.0013002423,0.00005048755,0.18273504,0.00025014536,0.00016578796,0.00022293722,0.70114857,0.0014039173],"study_design_scores_gemma":[0.0037208106,0.00029656367,0.8578813,0.0011265988,0.00016572508,0.000031647054,0.010497094,0.0001731651,0.0031317412,0.000005821582,0.12259641,0.00037308747],"about_ca_topic_score_codex":0.00006559271,"about_ca_topic_score_gemma":0.0000058101054,"teacher_disagreement_score":0.7484441,"about_ca_system_score_codex":0.00032599227,"about_ca_system_score_gemma":0.0002680197,"threshold_uncertainty_score":0.9993977},"labels":[],"label_agreement":null},{"id":"W6958088298","doi":"10.6084/m9.figshare.12715349","title":"Additional file 2 of Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Bladder cancer; Survivorship curve; Health care; Plan (archaeology); Resource (disambiguation); Preventive care; MEDLINE","score_opus":0.17714597754687775,"score_gpt":0.38583175376055057,"score_spread":0.20868577621367282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958088298","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045300387,0.002186485,0.0000019932243,0.000014289455,0.000014675825,0.0008662848,0.9917735,0.0000124590615,0.0006002855],"genre_scores_gemma":[0.056402482,0.000009344556,0.009800154,0.00012627683,0.000070655646,0.0011563418,0.9323798,0.000021839029,0.00003313558],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875116,0.00014283841,0.00031081657,0.00031642258,0.0003657288,0.000113036345],"domain_scores_gemma":[0.99876785,0.00030618955,0.00015757058,0.00009041486,0.00053396815,0.00014397563],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000045891058,0.0001373741,0.00028609208,0.000029107841,0.000036120364,0.000008438754,0.00004530669,0.00010254868,0.5553012],"category_scores_gemma":[0.00076713203,0.00011798496,0.000048387035,0.00008869211,0.000023826035,0.000050194925,0.00004815422,0.00010719751,0.000013595998],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012338656,0.00014602055,0.0040751607,0.00082764094,0.00014195434,6.6837566e-7,0.004500594,6.925842e-7,0.0000031655145,5.0610925e-8,0.9113259,0.0788548],"study_design_scores_gemma":[0.0096276095,0.00096298655,0.42734453,0.00333658,0.0003267736,0.0000024715498,0.0066776555,0.0008117712,0.0012447381,0.0000012399047,0.54927564,0.00038803494],"about_ca_topic_score_codex":0.000026681892,"about_ca_topic_score_gemma":0.000029405019,"teacher_disagreement_score":0.5552876,"about_ca_system_score_codex":0.000064104424,"about_ca_system_score_gemma":0.00047218858,"threshold_uncertainty_score":0.4811287},"labels":[],"label_agreement":null},{"id":"W6958090170","doi":"10.60692/6wk6y-hm975","title":"Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Logistic regression; Stage (stratigraphy); Predictive value; T-stage; Risk stratification; Urothelial carcinoma; Cancer; Predictive value of tests; Carcinoma","score_opus":0.055577942734148574,"score_gpt":0.2925480091992488,"score_spread":0.23697006646510022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958090170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943001,0.00002125778,0.002946384,0.00005423343,0.000087877524,0.0010793553,0.000972931,0.000042218708,0.00049562997],"genre_scores_gemma":[0.99934596,4.8739935e-7,0.00016407516,0.00024382607,0.000019719624,0.0001512043,0.000034189925,0.000010137604,0.000030421825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839705,0.00015266164,0.000767978,0.0001861496,0.00033071416,0.00016545881],"domain_scores_gemma":[0.99926835,0.000031119805,0.00027395433,0.00023636883,0.00007349306,0.00011670808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048499554,0.00015425775,0.0004248246,0.00018973225,0.000079579855,0.000020459045,0.000057074645,0.00005666091,0.00003954398],"category_scores_gemma":[0.000035575154,0.00012550522,0.00008137806,0.00013313771,0.00007745771,0.00023194792,0.000056302175,0.00019094558,0.00000270332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022524106,0.00003948656,0.9835601,0.000424478,0.00003940413,0.000011213948,0.013063637,0.00017393439,0.0000010853967,0.000010686209,0.000012167838,0.0004113973],"study_design_scores_gemma":[0.012030382,0.00057630433,0.7143678,0.000077990495,0.000112358866,0.000050994466,0.0063480046,0.2661088,0.00015179312,0.0000020173554,0.00006544455,0.00010809001],"about_ca_topic_score_codex":0.00010901896,"about_ca_topic_score_gemma":5.698672e-7,"teacher_disagreement_score":0.2691923,"about_ca_system_score_codex":0.00009910897,"about_ca_system_score_gemma":0.00026726417,"threshold_uncertainty_score":0.51179546},"labels":[],"label_agreement":null},{"id":"W6958100578","doi":"10.6084/m9.figshare.24040696","title":"Additional file 9 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Gene; Urinary system; Cancer; Urinary bladder","score_opus":0.06606459265921336,"score_gpt":0.32842644634653856,"score_spread":0.26236185368732523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958100578","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002335352,0.00008652532,1.6477244e-8,0.00006494823,0.00004576901,0.0002644882,0.97444135,0.00009132613,0.022670247],"genre_scores_gemma":[0.020330444,0.000016185339,0.000035719688,0.00038197596,0.00044039785,0.0015772195,0.96279263,0.00004186062,0.014383554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990095,0.000013124436,0.00021541349,0.0002630246,0.00027504718,0.00022392675],"domain_scores_gemma":[0.998878,0.00039576736,0.00010709342,0.0002300962,0.0002707848,0.00011827144],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008967906,0.00016662742,0.00024940635,0.00011814291,0.00012885897,0.000022994913,0.000114507304,0.000105496954,0.99534416],"category_scores_gemma":[0.0006071568,0.00015029768,0.00014940456,0.00029361693,0.000040789684,0.00009210773,0.00008505983,0.00012210087,0.003703194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023147048,0.000052149262,0.00008502918,0.00018183138,0.00014991652,0.000049452505,0.00052103715,0.000005176925,0.00042665325,0.0000043335576,0.9977101,0.00079115835],"study_design_scores_gemma":[0.0006540666,0.00014591403,0.11333603,0.0015929217,0.000029248022,0.0000036603979,0.00008862975,0.0000077358745,0.0029039995,0.000040060662,0.8810625,0.00013524723],"about_ca_topic_score_codex":0.00006242629,"about_ca_topic_score_gemma":0.0002210532,"teacher_disagreement_score":0.991641,"about_ca_system_score_codex":0.00016333735,"about_ca_system_score_gemma":0.00048871106,"threshold_uncertainty_score":0.9970725},"labels":[],"label_agreement":null},{"id":"W6958224606","doi":"10.6084/m9.figshare.19704006.v1","title":"Additional file 2 of Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Multiplex; Immunofluorescence; Tumor microenvironment; Immune system; Antibody; Urinary Bladder Cancer","score_opus":0.04062955985492051,"score_gpt":0.24918210845295377,"score_spread":0.20855254859803327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958224606","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3794461,0.00025965742,1.155088e-8,0.00012755026,0.0000034562277,0.0002834689,0.6195926,0.0000024459541,0.000284692],"genre_scores_gemma":[0.955112,0.000009068326,0.000012963042,0.00037819147,0.000018631734,0.0018665666,0.04237977,0.000011517905,0.00021132854],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99904615,0.000064829284,0.00023304368,0.0001723361,0.00035067403,0.00013295277],"domain_scores_gemma":[0.99913055,0.00040964002,0.00016175475,0.00024279402,0.000030567968,0.000024670482],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000033948792,0.00012462678,0.00023067511,0.000054913606,0.000070809445,0.0000031665963,0.00016436032,0.00001893854,0.78189385],"category_scores_gemma":[0.00008864956,0.000076913835,0.00006344427,0.00011771293,0.00003490493,0.000028818851,0.00013883546,0.00018066396,0.0000064513256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046990273,0.0017651962,0.004101456,0.000627441,0.00049655116,0.00007640391,0.007093459,0.00094366126,0.013112272,0.000009872509,0.9699988,0.0013050322],"study_design_scores_gemma":[0.0022374687,0.00172789,0.9551681,0.0033616787,0.00013926264,0.00008007661,0.0035789036,0.0028282406,0.021152679,0.00008254621,0.0093532,0.0002899419],"about_ca_topic_score_codex":0.00015395564,"about_ca_topic_score_gemma":0.000009161533,"teacher_disagreement_score":0.96064556,"about_ca_system_score_codex":0.000045979228,"about_ca_system_score_gemma":0.00014258125,"threshold_uncertainty_score":0.3136455},"labels":[],"label_agreement":null},{"id":"W6958311027","doi":"10.6084/m9.figshare.28681693.v1","title":"Additional file 1 of Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI","year":2025,"lang":"en","type":"article","venue":"Open MIND","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Index (typography); Computed tomography; MEDLINE; Patient data; Psychometrics","score_opus":0.02955165708298877,"score_gpt":0.3128727865906083,"score_spread":0.2833211295076195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958311027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94527656,0.00008938317,0.000016220667,0.00007440662,0.000061849125,0.003444708,0.043314252,9.681652e-7,0.0077216704],"genre_scores_gemma":[0.9826654,0.000006670875,0.0030653563,0.00010324331,0.000015295453,0.0027813297,0.010518503,0.000012235043,0.00083193684],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989631,0.00002268014,0.00028829926,0.00021801381,0.00040246957,0.000105401115],"domain_scores_gemma":[0.9985293,0.0003180436,0.00024712356,0.00016819965,0.00069836114,0.00003898267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000099495155,0.00010628775,0.00021435812,0.00014035286,0.000068382054,0.0000133906315,0.0000808578,0.00004267276,0.09858068],"category_scores_gemma":[0.0002326638,0.000068024434,0.000028632112,0.00042564693,0.00005708349,0.000068633824,0.00004633318,0.000042360265,0.0000029265952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072977843,0.0007602028,0.041859806,0.0000549299,0.0010289807,4.0470084e-7,0.0011041838,0.0000089990435,0.000018666626,8.0940663e-7,0.17707963,0.7773536],"study_design_scores_gemma":[0.0074684145,0.00069280976,0.89012396,0.0008371081,0.0005690444,9.78e-7,0.0003613952,0.00008423557,0.0020623573,0.000028308179,0.09766529,0.00010608398],"about_ca_topic_score_codex":0.00008732983,"about_ca_topic_score_gemma":0.00017014927,"teacher_disagreement_score":0.84826416,"about_ca_system_score_codex":0.00009141741,"about_ca_system_score_gemma":0.0015993431,"threshold_uncertainty_score":0.9022433},"labels":[],"label_agreement":null},{"id":"W6958322794","doi":"10.6084/m9.figshare.24040684","title":"Additional file 6 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; Gene; Urothelial cancer","score_opus":0.06604016761152713,"score_gpt":0.3283715155154365,"score_spread":0.26233134790390933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958322794","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002319548,0.000086655535,1.645742e-8,0.000064877575,0.00004575926,0.00026490306,0.974204,0.00009129416,0.022922972],"genre_scores_gemma":[0.020374896,0.000016153032,0.000035740308,0.00038189188,0.00044044293,0.0015912512,0.96268904,0.0000418865,0.014428706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990094,0.000013125282,0.00021542031,0.0002630698,0.00027506985,0.00022394155],"domain_scores_gemma":[0.9988778,0.0003958044,0.00010710759,0.00023017277,0.0002707988,0.00011829173],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008970095,0.0001666431,0.00024944468,0.00011813818,0.00012883151,0.000023002425,0.00011460882,0.00010551436,0.99532187],"category_scores_gemma":[0.0006071523,0.000150316,0.00014940665,0.00029364895,0.0000407908,0.00009210782,0.000085103835,0.00012215026,0.0036961096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023270917,0.000052417432,0.00008474051,0.0001818203,0.00014992438,0.00004943152,0.00052205124,0.000005087769,0.0004262438,0.000004469455,0.99770087,0.00079968554],"study_design_scores_gemma":[0.0006540038,0.00014572593,0.113568984,0.001589482,0.000029215571,0.0000036527067,0.00008868639,0.00000761365,0.002876527,0.000040006296,0.880861,0.0001351079],"about_ca_topic_score_codex":0.00006452915,"about_ca_topic_score_gemma":0.00022577155,"teacher_disagreement_score":0.9916258,"about_ca_system_score_codex":0.00016312436,"about_ca_system_score_gemma":0.0004888711,"threshold_uncertainty_score":0.9970796},"labels":[],"label_agreement":null},{"id":"W6958439817","doi":"10.6084/m9.figshare.24040687.v1","title":"Additional file 7 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Table (database); Urinary system; Gene","score_opus":0.0661051645643221,"score_gpt":0.32844936034575745,"score_spread":0.26234419578143536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958439817","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023362935,0.00008646094,1.6443769e-8,0.00006485981,0.00004577563,0.00026454002,0.97448725,0.000091331254,0.022623476],"genre_scores_gemma":[0.020265255,0.000016199609,0.000035716796,0.00038161562,0.00044014925,0.0015864616,0.96290916,0.0000418602,0.014323564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990093,0.000013121294,0.00021541916,0.00026309481,0.00027507267,0.00022396099],"domain_scores_gemma":[0.9988782,0.0003954482,0.00010710061,0.0002301802,0.00027077884,0.00011829735],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008969562,0.00016665399,0.0002494508,0.00011814957,0.00012885887,0.00002300323,0.00011461164,0.00010551721,0.99529225],"category_scores_gemma":[0.0006002603,0.00015032463,0.00014940978,0.0002936336,0.000040794726,0.0000921115,0.000085106796,0.00012215166,0.0036957283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023144194,0.000052154097,0.00008489117,0.00018354726,0.00014993979,0.000049460836,0.00052114855,0.000005175503,0.00042812675,0.000004415398,0.9976928,0.0008051585],"study_design_scores_gemma":[0.00065503194,0.00014629519,0.11233426,0.0016106316,0.00002927822,0.0000036627528,0.000088659704,0.000007736079,0.0029182672,0.00004007429,0.8820307,0.0001354028],"about_ca_topic_score_codex":0.000063856576,"about_ca_topic_score_gemma":0.00022169578,"teacher_disagreement_score":0.9915965,"about_ca_system_score_codex":0.00016338218,"about_ca_system_score_gemma":0.00048895285,"threshold_uncertainty_score":0.99708},"labels":[],"label_agreement":null},{"id":"W6958484234","doi":"10.6084/m9.figshare.24040762.v1","title":"Additional file 25 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Urinary bladder; Urinary system; Urothelial cancer; Ureterostomy","score_opus":0.0670411789865436,"score_gpt":0.33078380775589056,"score_spread":0.26374262876934695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958484234","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004641124,0.000121022946,2.6541416e-8,0.00008157413,0.00005774694,0.00029170266,0.97192013,0.00009477748,0.022791907],"genre_scores_gemma":[0.05010805,0.00002393475,0.00003454719,0.00043905008,0.00049434946,0.0013402521,0.93396163,0.000046080313,0.013552082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989541,0.000014368214,0.00022892977,0.0002776512,0.00028947246,0.00023543947],"domain_scores_gemma":[0.9989288,0.00031003347,0.00011087394,0.00024317874,0.0002837037,0.00012340504],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010980897,0.00017620371,0.00026392902,0.00012541117,0.0001364155,0.000024588135,0.00012271806,0.00011187248,0.98521703],"category_scores_gemma":[0.00049486756,0.00015910111,0.00015557423,0.0003004303,0.000042944746,0.00009809872,0.000090382404,0.00012955077,0.002979548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002315437,0.000058039666,0.00014621291,0.00020335801,0.00016392645,0.00005158701,0.00069248,0.0000060140756,0.0005769274,0.000007847167,0.99727964,0.0007908015],"study_design_scores_gemma":[0.00083412847,0.0001630934,0.14880645,0.0015285468,0.000036261245,0.0000039418187,0.0001160238,0.000008748651,0.0036267105,0.00004922395,0.84467757,0.00014926937],"about_ca_topic_score_codex":0.00008247202,"about_ca_topic_score_gemma":0.0002700327,"teacher_disagreement_score":0.9822375,"about_ca_system_score_codex":0.00017673124,"about_ca_system_score_gemma":0.00048465005,"threshold_uncertainty_score":0.9977968},"labels":[],"label_agreement":null},{"id":"W6958525878","doi":"10.6084/m9.figshare.23258889","title":"Additional file 1 of Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perioperative; Table (database); Upper urinary tract; Meta-analysis; Operating table; Nephrectomy; Pooled analysis","score_opus":0.061454969228414015,"score_gpt":0.34139262911332685,"score_spread":0.2799376598849128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958525878","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05151348,0.001823519,9.178032e-8,0.00008115274,0.000019316709,0.0017395441,0.9445582,0.000018877303,0.0002457904],"genre_scores_gemma":[0.62514776,0.0000508406,0.00021642946,0.00013200937,0.000025304347,0.0030608564,0.37087485,0.000019815048,0.00047215167],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99873495,0.00009331878,0.0005285059,0.0002588137,0.00022369467,0.00016070898],"domain_scores_gemma":[0.9977143,0.0015405681,0.00026002736,0.00018614181,0.00021984542,0.00007914874],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000040052146,0.00022253185,0.0019978175,0.00018757973,0.000051678475,0.0000066606517,0.00007502447,0.000083219515,0.31301856],"category_scores_gemma":[0.0005772805,0.00015454576,0.000344234,0.00039340544,0.0000610554,0.0000696357,0.00002921235,0.00008350888,0.000011419273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029842341,0.0020013056,0.018454134,0.38001102,0.024799159,0.000102999715,0.0070677805,0.00000737628,0.00032472273,0.000026366437,0.564153,0.00006784793],"study_design_scores_gemma":[0.0094386665,0.0066365027,0.9152391,0.040635083,0.02264263,0.00003171042,0.0013871293,0.00045634096,0.0005833784,0.0000022993806,0.0025365378,0.00041062135],"about_ca_topic_score_codex":0.000021293074,"about_ca_topic_score_gemma":0.000013672638,"teacher_disagreement_score":0.89678496,"about_ca_system_score_codex":0.000042535496,"about_ca_system_score_gemma":0.00015770903,"threshold_uncertainty_score":0.68760943},"labels":[],"label_agreement":null},{"id":"W6958571778","doi":"10.6084/m9.figshare.24223796.v1","title":"Additional file 1 of Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Toronto","funders":"","keywords":"Durvalumab; Tremelimumab; Table (database); Baseline (sea); Logistic regression; Identification (biology); Metastatic Urothelial Carcinoma","score_opus":0.05162177268717813,"score_gpt":0.293126333992556,"score_spread":0.24150456130537787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958571778","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055067874,0.000017510843,0.000002014077,0.000010401863,0.000033874792,0.0006832269,0.9438427,0.000028514327,0.00031387617],"genre_scores_gemma":[0.5035791,0.0000027854621,0.000030530853,0.00000577743,0.000045334986,0.0005909457,0.49508587,0.000024425759,0.0006352691],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99829656,0.00007178351,0.00060330424,0.00027027394,0.0005586633,0.00019938753],"domain_scores_gemma":[0.99815285,0.0006168303,0.00046180835,0.00030279186,0.00039537167,0.00007033744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053554537,0.00018244397,0.0005596562,0.00023901455,0.00002555854,0.0000060658704,0.00012537636,0.000065504,0.7716191],"category_scores_gemma":[0.0011362016,0.00014514134,0.00010302577,0.0005535141,0.00004572729,0.000093851355,0.000044028206,0.00010948779,0.00018447412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015400629,0.00197373,0.014047219,0.008271676,0.0013918265,0.000871783,0.0027249695,0.00006029332,0.0011919328,0.000008204135,0.9465808,0.007476904],"study_design_scores_gemma":[0.0042156675,0.0011600567,0.9859201,0.0039725313,0.00017488368,0.000031238105,0.00018050504,0.0005539154,0.0030600177,0.0000056745453,0.0005878231,0.00013764073],"about_ca_topic_score_codex":0.000037843583,"about_ca_topic_score_gemma":0.00007613195,"teacher_disagreement_score":0.9718728,"about_ca_system_score_codex":0.00011556212,"about_ca_system_score_gemma":0.0009455323,"threshold_uncertainty_score":0.5918692},"labels":[],"label_agreement":null},{"id":"W6976411795","doi":"10.60692/gxaka-hca91","title":"Additional file 19 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Downregulation and upregulation; Gene; Urothelial carcinoma; Proteogenomics; Immune system; Gene expression; Table (database)","score_opus":0.018962442921019382,"score_gpt":0.19579512478663635,"score_spread":0.17683268186561696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976411795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6530263,9.569936e-7,0.00013439242,0.000022349215,0.00012848296,0.0009342914,0.3441943,0.000018936595,0.0015400158],"genre_scores_gemma":[0.98915726,2.7720487e-8,0.00005992501,0.00007139522,0.000031715696,0.0005052302,0.009756564,0.00000872722,0.0004091328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884075,0.00006792897,0.0005658232,0.0000761755,0.0003593551,0.00008998797],"domain_scores_gemma":[0.9989174,0.000010440129,0.0005920395,0.00024411622,0.00020235725,0.00003365117],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007678177,0.00010113535,0.00023728092,0.00014410831,0.00007364078,0.0000050018652,0.000105611645,0.000038056038,0.049172923],"category_scores_gemma":[0.000025009907,0.00006975611,0.00011404126,0.00025689672,0.000046106816,0.000106780346,0.00005501632,0.00007571006,0.000023748422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008650746,0.00034989047,0.6069302,0.008351328,0.0023860214,0.000012731387,0.24047084,0.00038107528,0.014236494,0.00042617784,0.11353199,0.004272493],"study_design_scores_gemma":[0.0048114904,0.0007641467,0.92502105,0.00050706003,0.00023076282,0.00016193956,0.0099102985,0.0010224892,0.0363443,0.0000015695479,0.021007314,0.00021757519],"about_ca_topic_score_codex":0.00003338116,"about_ca_topic_score_gemma":1.0500986e-7,"teacher_disagreement_score":0.33613098,"about_ca_system_score_codex":0.00013659257,"about_ca_system_score_gemma":0.0003581788,"threshold_uncertainty_score":0.9516963},"labels":[],"label_agreement":null},{"id":"W6976530085","doi":"10.60692/sjzmh-pv131","title":"Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Bladder cancer; Cohort; Perioperative; Poisson regression; Logistic regression; Odds ratio","score_opus":0.047022297902778024,"score_gpt":0.2828588027836274,"score_spread":0.2358365048808494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976530085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722965,0.00001831758,0.00010361896,0.00005589807,0.0005476661,0.0019660867,0.00080247415,0.000035151897,0.009241144],"genre_scores_gemma":[0.9988983,2.3855424e-7,0.00006692525,0.00013988979,0.000012783554,0.00054058357,0.00014771789,0.00001454221,0.00017896679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795157,0.00011486423,0.0009784657,0.00016034546,0.00059264834,0.00020211036],"domain_scores_gemma":[0.9989171,0.000014473582,0.00048601782,0.0003186665,0.0001729389,0.00009077664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028586102,0.00017504864,0.0007136834,0.00028259712,0.0000707014,0.000018698529,0.00021516095,0.00006876816,0.0003054302],"category_scores_gemma":[0.000015837655,0.00014040057,0.000099528006,0.00035779254,0.00003796744,0.0003107313,0.00020902492,0.0001325217,0.000017832373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018474628,0.00007335158,0.9820846,0.00029885137,0.0003926773,0.00000504917,0.0149353845,0.00006114538,0.0000010963906,0.0000086715645,0.0002241218,0.000067642504],"study_design_scores_gemma":[0.022544535,0.00049006054,0.96884674,0.0001425766,0.00014586003,0.0000060882717,0.007109015,0.0002513987,0.00013869829,1.5017645e-7,0.00020528113,0.00011961876],"about_ca_topic_score_codex":0.0004043021,"about_ca_topic_score_gemma":0.0000054703473,"teacher_disagreement_score":0.020697072,"about_ca_system_score_codex":0.00033785377,"about_ca_system_score_gemma":0.0002660401,"threshold_uncertainty_score":0.57253695},"labels":[],"label_agreement":null},{"id":"W6976578086","doi":"10.60692/ja6ev-rba44","title":"Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Carboplatin; Proportional hazards model; Bladder cancer; Propensity score matching; Regimen; Nomogram; Confidence interval; Chemotherapy; Clinical endpoint","score_opus":0.04191632983397821,"score_gpt":0.28992500454681114,"score_spread":0.24800867471283294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976578086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908777,0.0000054942248,0.00028243646,0.0004939844,0.00045923967,0.00070555275,0.000108489236,0.00028214444,0.0067849546],"genre_scores_gemma":[0.9979296,0.0000033942083,0.00006179544,0.0008898006,0.00020260588,0.00025695373,0.000061114486,0.000020180882,0.0005745639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851644,0.000043331827,0.0006846395,0.00017991246,0.0003126063,0.00026305648],"domain_scores_gemma":[0.99931854,0.0000074762315,0.00019615029,0.00024223568,0.00013734675,0.00009822123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025132173,0.0001813667,0.00032397878,0.000344696,0.00006177549,0.00004569319,0.00006238012,0.00016585407,0.000077909],"category_scores_gemma":[0.0000128977845,0.00014609129,0.000086298074,0.0005668572,0.000026760703,0.00031661967,0.0000213271,0.00011862096,0.00075648923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067052286,0.000009069154,0.942233,0.00028712823,0.00021804593,0.00001742771,0.052716237,0.00014352667,0.00001709373,0.000017060913,0.00025271316,0.003418159],"study_design_scores_gemma":[0.0058828993,0.000087367385,0.9851412,0.00044611833,0.00006533734,0.000031930635,0.0056589562,0.0017156227,0.0006891714,0.0000015601379,0.00010971875,0.00017009854],"about_ca_topic_score_codex":0.00019912049,"about_ca_topic_score_gemma":0.00000117167,"teacher_disagreement_score":0.04705728,"about_ca_system_score_codex":0.0003476486,"about_ca_system_score_gemma":0.00015639156,"threshold_uncertainty_score":0.9723391},"labels":[],"label_agreement":null},{"id":"W6976600823","doi":"10.60692/m9xr0-81r85","title":"Additional file 18 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immune system; Downregulation and upregulation; Urothelial carcinoma; Immune surveillance; Table (database); Proteogenomics","score_opus":0.021961317715046943,"score_gpt":0.19975098476930636,"score_spread":0.17778966705425941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976600823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6729009,8.133717e-7,0.00013397775,0.000016536087,0.00013008308,0.000889182,0.3238609,0.000018075827,0.002049489],"genre_scores_gemma":[0.98999316,2.4839204e-8,0.000058617912,0.000055326756,0.000032245807,0.0004923124,0.008932596,0.000008959725,0.00042674554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884677,0.00006510617,0.0005656069,0.000076056975,0.000356348,0.00009011602],"domain_scores_gemma":[0.9989089,0.000009545352,0.00058691367,0.00024436807,0.00022195009,0.000028332775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007233121,0.00010112506,0.00024222514,0.00014037362,0.00006993609,0.0000051133156,0.00010497404,0.000037948736,0.07296027],"category_scores_gemma":[0.000020512907,0.00006997879,0.0001137993,0.0002531266,0.000046412202,0.00011038127,0.000055165976,0.00007561091,0.000025470723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010602765,0.0004330668,0.5665082,0.009093352,0.0029382142,0.000014217131,0.23737434,0.0004170117,0.015449291,0.00043819344,0.15027066,0.006460732],"study_design_scores_gemma":[0.0044684033,0.0007437556,0.92520094,0.00054290274,0.0002200827,0.00014882768,0.008237521,0.0009875654,0.04422794,0.0000016027825,0.01501556,0.00020487282],"about_ca_topic_score_codex":0.0000285165,"about_ca_topic_score_gemma":9.543907e-8,"teacher_disagreement_score":0.3586928,"about_ca_system_score_codex":0.00012165605,"about_ca_system_score_gemma":0.00030626293,"threshold_uncertainty_score":0.92788714},"labels":[],"label_agreement":null},{"id":"W6976655656","doi":"10.6084/m9.figshare.24040729","title":"Additional file 18 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Base (topology); Mutation; Human disease; Cancer; Human bladder","score_opus":0.08329770016803997,"score_gpt":0.3408259198335968,"score_spread":0.25752821966555683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976655656","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004446633,0.000117377625,2.9567438e-8,0.000067814755,0.000057448844,0.00028763458,0.96750826,0.00009451207,0.027420286],"genre_scores_gemma":[0.053050347,0.000022732616,0.000034893343,0.00042699368,0.0004978405,0.0013274387,0.9302165,0.000046672245,0.014376611],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989551,0.000014273093,0.00022766933,0.00027943504,0.000288932,0.00023460206],"domain_scores_gemma":[0.9989326,0.0003068718,0.000110234396,0.00024366262,0.00028283717,0.00012380126],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010795634,0.00017525245,0.0002670365,0.00012339554,0.00013659638,0.000025128205,0.00012133007,0.00010988998,0.9907101],"category_scores_gemma":[0.00048780022,0.00015885364,0.00015470409,0.0002994515,0.00004424369,0.00009724789,0.00009034099,0.00012784384,0.0030768083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028469716,0.000057376456,0.00011958719,0.00019645368,0.00016339593,0.000052829026,0.00054309395,0.000007649446,0.00044375745,0.0000058113474,0.9975458,0.000835776],"study_design_scores_gemma":[0.0008643893,0.00016827391,0.1306955,0.0015333924,0.000036890637,0.0000046306864,0.00009891775,0.000008803343,0.0039509786,0.00006176995,0.86242306,0.00015335905],"about_ca_topic_score_codex":0.000095634576,"about_ca_topic_score_gemma":0.00027051038,"teacher_disagreement_score":0.9876333,"about_ca_system_score_codex":0.00017578444,"about_ca_system_score_gemma":0.00049006083,"threshold_uncertainty_score":0.99769944},"labels":[],"label_agreement":null},{"id":"W6976659054","doi":"10.60692/zpnw7-tsr19","title":"Additional file 22 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Germline; Urinary bladder; Table (database); Urinary system","score_opus":0.04848650025612248,"score_gpt":0.2752981515445095,"score_spread":0.226811651288387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976659054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68435925,0.000008950899,0.00005915841,0.000076217875,0.0005019077,0.0009745265,0.2657638,0.00039230403,0.04786387],"genre_scores_gemma":[0.9787703,0.000001416925,0.00007483586,0.00022723204,0.00024400241,0.0006246542,0.01659196,0.000022267632,0.0034432947],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985732,0.00002406684,0.0005997551,0.00016344292,0.00040853606,0.00023103219],"domain_scores_gemma":[0.99885154,0.000041457457,0.00030314858,0.0002888305,0.0003968311,0.00011818671],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006534652,0.00019946719,0.00033534341,0.0003311491,0.00018037546,0.000064624466,0.0001053103,0.00012278353,0.07277184],"category_scores_gemma":[0.000043919597,0.00016423245,0.00014668611,0.0003537545,0.00010412027,0.000398933,0.00005643657,0.000092521586,0.0013798419],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042294632,0.000030305644,0.10943727,0.0028323622,0.0013002423,0.00005048755,0.18273504,0.00025014536,0.00016578796,0.00022293722,0.70114857,0.0014039173],"study_design_scores_gemma":[0.0037208106,0.00029656367,0.8578813,0.0011265988,0.00016572508,0.000031647054,0.010497094,0.0001731651,0.0031317412,0.000005821582,0.12259641,0.00037308747],"about_ca_topic_score_codex":0.00006559271,"about_ca_topic_score_gemma":0.0000058101054,"teacher_disagreement_score":0.7484441,"about_ca_system_score_codex":0.00032599227,"about_ca_system_score_gemma":0.0002680197,"threshold_uncertainty_score":0.9993977},"labels":[],"label_agreement":null},{"id":"W6976699250","doi":"10.60692/a6we7-p6450","title":"Additional file 19 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Downregulation and upregulation; Gene; Urothelial carcinoma; Proteogenomics; Immune system; Gene expression; Table (database)","score_opus":0.018962442921019382,"score_gpt":0.19579512478663635,"score_spread":0.17683268186561696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976699250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6530263,9.569936e-7,0.00013439242,0.000022349215,0.00012848296,0.0009342914,0.3441943,0.000018936595,0.0015400158],"genre_scores_gemma":[0.98915726,2.7720487e-8,0.00005992501,0.00007139522,0.000031715696,0.0005052302,0.009756564,0.00000872722,0.0004091328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884075,0.00006792897,0.0005658232,0.0000761755,0.0003593551,0.00008998797],"domain_scores_gemma":[0.9989174,0.000010440129,0.0005920395,0.00024411622,0.00020235725,0.00003365117],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007678177,0.00010113535,0.00023728092,0.00014410831,0.00007364078,0.0000050018652,0.000105611645,0.000038056038,0.049172923],"category_scores_gemma":[0.000025009907,0.00006975611,0.00011404126,0.00025689672,0.000046106816,0.000106780346,0.00005501632,0.00007571006,0.000023748422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008650746,0.00034989047,0.6069302,0.008351328,0.0023860214,0.000012731387,0.24047084,0.00038107528,0.014236494,0.00042617784,0.11353199,0.004272493],"study_design_scores_gemma":[0.0048114904,0.0007641467,0.92502105,0.00050706003,0.00023076282,0.00016193956,0.0099102985,0.0010224892,0.0363443,0.0000015695479,0.021007314,0.00021757519],"about_ca_topic_score_codex":0.00003338116,"about_ca_topic_score_gemma":1.0500986e-7,"teacher_disagreement_score":0.33613098,"about_ca_system_score_codex":0.00013659257,"about_ca_system_score_gemma":0.0003581788,"threshold_uncertainty_score":0.9516963},"labels":[],"label_agreement":null},{"id":"W6976724582","doi":"10.60692/trhtc-rg519","title":"Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cystectomy; Carboplatin; Proportional hazards model; Bladder cancer; Propensity score matching; Regimen; Nomogram; Confidence interval; Chemotherapy; Clinical endpoint","score_opus":0.04191632983397821,"score_gpt":0.28992500454681114,"score_spread":0.24800867471283294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976724582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908777,0.0000054942248,0.00028243646,0.0004939844,0.00045923967,0.00070555275,0.000108489236,0.00028214444,0.0067849546],"genre_scores_gemma":[0.9979296,0.0000033942083,0.00006179544,0.0008898006,0.00020260588,0.00025695373,0.000061114486,0.000020180882,0.0005745639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851644,0.000043331827,0.0006846395,0.00017991246,0.0003126063,0.00026305648],"domain_scores_gemma":[0.99931854,0.0000074762315,0.00019615029,0.00024223568,0.00013734675,0.00009822123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025132173,0.0001813667,0.00032397878,0.000344696,0.00006177549,0.00004569319,0.00006238012,0.00016585407,0.000077909],"category_scores_gemma":[0.0000128977845,0.00014609129,0.000086298074,0.0005668572,0.000026760703,0.00031661967,0.0000213271,0.00011862096,0.00075648923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067052286,0.000009069154,0.942233,0.00028712823,0.00021804593,0.00001742771,0.052716237,0.00014352667,0.00001709373,0.000017060913,0.00025271316,0.003418159],"study_design_scores_gemma":[0.0058828993,0.000087367385,0.9851412,0.00044611833,0.00006533734,0.000031930635,0.0056589562,0.0017156227,0.0006891714,0.0000015601379,0.00010971875,0.00017009854],"about_ca_topic_score_codex":0.00019912049,"about_ca_topic_score_gemma":0.00000117167,"teacher_disagreement_score":0.04705728,"about_ca_system_score_codex":0.0003476486,"about_ca_system_score_gemma":0.00015639156,"threshold_uncertainty_score":0.9723391},"labels":[],"label_agreement":null},{"id":"W6976781745","doi":"10.60692/s5dgt-v6j13","title":"Additional file 18 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder","year":2022,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immune system; Downregulation and upregulation; Urothelial carcinoma; Immune surveillance; Table (database); Proteogenomics","score_opus":0.021961317715046943,"score_gpt":0.19975098476930636,"score_spread":0.17778966705425941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976781745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6729009,8.133717e-7,0.00013397775,0.000016536087,0.00013008308,0.000889182,0.3238609,0.000018075827,0.002049489],"genre_scores_gemma":[0.98999316,2.4839204e-8,0.000058617912,0.000055326756,0.000032245807,0.0004923124,0.008932596,0.000008959725,0.00042674554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884677,0.00006510617,0.0005656069,0.000076056975,0.000356348,0.00009011602],"domain_scores_gemma":[0.9989089,0.000009545352,0.00058691367,0.00024436807,0.00022195009,0.000028332775],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007233121,0.00010112506,0.00024222514,0.00014037362,0.00006993609,0.0000051133156,0.00010497404,0.000037948736,0.07296027],"category_scores_gemma":[0.000020512907,0.00006997879,0.0001137993,0.0002531266,0.000046412202,0.00011038127,0.000055165976,0.00007561091,0.000025470723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010602765,0.0004330668,0.5665082,0.009093352,0.0029382142,0.000014217131,0.23737434,0.0004170117,0.015449291,0.00043819344,0.15027066,0.006460732],"study_design_scores_gemma":[0.0044684033,0.0007437556,0.92520094,0.00054290274,0.0002200827,0.00014882768,0.008237521,0.0009875654,0.04422794,0.0000016027825,0.01501556,0.00020487282],"about_ca_topic_score_codex":0.0000285165,"about_ca_topic_score_gemma":9.543907e-8,"teacher_disagreement_score":0.3586928,"about_ca_system_score_codex":0.00012165605,"about_ca_system_score_gemma":0.00030626293,"threshold_uncertainty_score":0.92788714},"labels":[],"label_agreement":null},{"id":"W6976854463","doi":"10.60692/e80hk-b2h15","title":"Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Logistic regression; Confidence interval; Biopsy; Stage (stratigraphy); T-stage; Retrospective cohort study; Stepwise regression; Hydronephrosis; Risk stratification; Urothelial carcinoma","score_opus":0.041398835784562896,"score_gpt":0.2781369927777442,"score_spread":0.2367381569931813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976854463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934083,0.000008825108,0.0013905863,0.000072437266,0.0006645204,0.0021263335,0.000814286,0.00007521619,0.001439479],"genre_scores_gemma":[0.997721,0.00000124309,0.000416944,0.000088183166,0.0001623912,0.0009197917,0.00054679246,0.000017343367,0.00012629956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983318,0.00013711852,0.00070185476,0.00027841784,0.00033715868,0.0002136426],"domain_scores_gemma":[0.9987662,0.000026307913,0.0002777022,0.0003610064,0.0004172172,0.00015157256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029162207,0.000212347,0.00037358355,0.00027763753,0.00011084428,0.00015173425,0.000071845665,0.00008639034,0.000045363882],"category_scores_gemma":[0.00008664634,0.00018053513,0.000093552735,0.00026513857,0.000014428125,0.0007767871,0.00001690214,0.0000939843,0.000038490067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037846604,0.00013081402,0.95617026,0.00013262338,0.00015568266,0.000019759065,0.04229779,0.000029314251,0.0000075257117,0.000023321903,0.000025036663,0.0006294004],"study_design_scores_gemma":[0.006746747,0.00038233976,0.95828,0.00014500513,0.00018907775,0.00003025481,0.03001402,0.0009525991,0.0029665718,0.0000013625856,0.00014533312,0.00014667488],"about_ca_topic_score_codex":0.00009051152,"about_ca_topic_score_gemma":0.000007742616,"teacher_disagreement_score":0.012283771,"about_ca_system_score_codex":0.00047244344,"about_ca_system_score_gemma":0.0005974266,"threshold_uncertainty_score":0.7362009},"labels":[],"label_agreement":null},{"id":"W6976890685","doi":"10.60692/rvb3n-0zt92","title":"Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pembrolizumab; Atezolizumab; Renal cell carcinoma; Hazard ratio; Kidney cancer; Adjuvant; Metastatic Urothelial Carcinoma; Immunotherapy; Adjuvant therapy","score_opus":0.05416245767672298,"score_gpt":0.29214461075707776,"score_spread":0.23798215308035478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976890685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159235,0.0014579366,0.000037336093,0.00050932216,0.00004523386,0.0048300126,0.0006693013,0.00006499668,0.00079349446],"genre_scores_gemma":[0.99948186,0.000024865434,0.0000051167704,0.00017139086,0.000008001537,0.00021317333,0.000015623138,0.000007736842,0.000072216564],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998232,0.00012669312,0.0011114008,0.000114741946,0.00028247762,0.00013266895],"domain_scores_gemma":[0.9988874,0.00003726466,0.00051898934,0.00038290222,0.000093028604,0.000080376914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075281586,0.00017753096,0.0015118184,0.0003911782,0.000030032908,0.00001871497,0.00006115255,0.000049656508,0.000036950405],"category_scores_gemma":[0.00011305012,0.00008664917,0.00051512173,0.0007928165,0.000040574934,0.00010626348,0.00003000465,0.00006751246,0.00001939504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006576411,0.00003871088,0.12219816,0.5675737,0.16106151,0.0000118336775,0.1479239,0.0002300342,0.00003605406,0.000055490127,0.00016688366,0.000046057692],"study_design_scores_gemma":[0.010070016,0.0015173013,0.32255813,0.03795483,0.60572034,0.00009497875,0.016467245,0.0017817394,0.0032226087,0.000002389466,0.0000066912835,0.00060373207],"about_ca_topic_score_codex":0.0003261369,"about_ca_topic_score_gemma":7.584373e-7,"teacher_disagreement_score":0.5296189,"about_ca_system_score_codex":0.00011698252,"about_ca_system_score_gemma":0.00009501321,"threshold_uncertainty_score":0.35334504},"labels":[],"label_agreement":null},{"id":"W6976935433","doi":"10.60692/qbdcq-67b68","title":"Comparison Between Urothelial and Non-Urothelial Urethral Cancer","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Histology; Adenocarcinoma; Cancer; Chemotherapy; Clear-cell adenocarcinoma; Proportional hazards model","score_opus":0.049539146188261565,"score_gpt":0.2950704053883475,"score_spread":0.24553125920008595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976935433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871079,0.000047750615,0.0035310062,0.00029724307,0.0005420255,0.00059210934,0.00048825794,0.0001466153,0.007247118],"genre_scores_gemma":[0.99804676,0.0000016299159,0.00023164185,0.00042965627,0.00054355274,0.0001022032,0.000060084556,0.000019945022,0.0005645438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857277,0.00004268637,0.0005515801,0.0002042236,0.00035525163,0.00027346835],"domain_scores_gemma":[0.9991341,0.000007373954,0.00016419558,0.0002874058,0.00020642609,0.00020046784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112726426,0.00022316848,0.00049608696,0.000117396965,0.00013223384,0.000115751,0.00006085431,0.0001459188,0.00012917267],"category_scores_gemma":[0.00001074084,0.00018090302,0.000094275296,0.0001715107,0.000043666918,0.00029755474,0.00005064607,0.00015294651,0.00028914082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015895275,0.0000047886556,0.9782171,0.000410014,0.00017423855,0.000013018871,0.018823458,0.0000060690827,0.000024297637,0.000015916788,0.00023520763,0.0019169172],"study_design_scores_gemma":[0.007528251,0.00022355925,0.9686375,0.0005012151,0.0004677318,0.00013295974,0.0050057205,0.0005118618,0.013137149,0.0000016149227,0.0035217323,0.00033069344],"about_ca_topic_score_codex":0.00006691045,"about_ca_topic_score_gemma":0.000001328192,"teacher_disagreement_score":0.013817738,"about_ca_system_score_codex":0.00014539194,"about_ca_system_score_gemma":0.00022248493,"threshold_uncertainty_score":0.7377011},"labels":[],"label_agreement":null},{"id":"W6976979121","doi":"10.6084/m9.figshare.24040717","title":"Additional file 14 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Cancer; MEDLINE; Urinary bladder","score_opus":0.06638066329221803,"score_gpt":0.32961892242215934,"score_spread":0.2632382591299413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976979121","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040813503,0.00011964549,2.7814496e-8,0.00008228797,0.000062348656,0.00029079235,0.97351897,0.00009556854,0.021749021],"genre_scores_gemma":[0.04216015,0.00002357548,0.0000350207,0.00044433543,0.0004992975,0.0013440099,0.9407315,0.000047318008,0.014714793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894345,0.000014540844,0.00022943968,0.00027814865,0.00029817258,0.00023626578],"domain_scores_gemma":[0.9988984,0.00031291554,0.00011096003,0.00024276345,0.00031037987,0.00012456742],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011374458,0.00017658366,0.00026476436,0.00012297985,0.00013642148,0.00002478956,0.00012146491,0.000114206785,0.98536915],"category_scores_gemma":[0.00053692574,0.00015943019,0.00015585785,0.00029761868,0.00004317291,0.000097575794,0.000089152956,0.00013268502,0.00304112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027396098,0.00005736134,0.00012844217,0.00020187108,0.00016261445,0.000052055842,0.0006205406,0.0000072717835,0.0005577373,0.000006202958,0.99738973,0.0007888005],"study_design_scores_gemma":[0.00086651783,0.00016818361,0.12054169,0.001533047,0.00003683252,0.0000041016774,0.00009199996,0.000008627074,0.004205109,0.000051312218,0.8723392,0.00015338813],"about_ca_topic_score_codex":0.00007216717,"about_ca_topic_score_gemma":0.00027799027,"teacher_disagreement_score":0.98232806,"about_ca_system_score_codex":0.00017405086,"about_ca_system_score_gemma":0.0004758608,"threshold_uncertainty_score":0.99773514},"labels":[],"label_agreement":null},{"id":"W6976990237","doi":"10.60692/y502c-7cg35","title":"Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemotherapy; Regimen; Bladder cancer; Vinblastine; Cisplatin","score_opus":0.1474640356602482,"score_gpt":0.35044805500334636,"score_spread":0.20298401934309815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976990237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8964788,0.043775406,0.024855973,0.0050370344,0.00035942186,0.02582016,0.0025686237,0.00074093323,0.00036364666],"genre_scores_gemma":[0.9972077,0.0003036043,0.00007114914,0.00096287974,0.00002688773,0.0011602822,0.00009661622,0.000015397742,0.00015546761],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9980346,0.000105711784,0.0011200819,0.00019940373,0.00029552396,0.000244696],"domain_scores_gemma":[0.99865544,0.00007238385,0.00064557913,0.00035354868,0.00015901128,0.00011405019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047023926,0.0002868469,0.0038322988,0.00024287877,0.000087059016,0.00003394322,0.00007276162,0.00009999075,0.000026914702],"category_scores_gemma":[0.000010547961,0.00015733544,0.000501935,0.00048831635,0.00005038288,0.00010356715,0.000026333924,0.00006320852,0.000007657604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002519606,0.000019905527,0.6197515,0.11589391,0.24381588,0.0000019659763,0.01886202,0.00014373615,6.18526e-7,0.000030595063,0.00063803216,0.0005898619],"study_design_scores_gemma":[0.0073082275,0.0008253639,0.43098283,0.0044722757,0.5470265,0.0000121993535,0.004275514,0.004458971,0.0001233674,0.000003776923,0.00007645456,0.00043447834],"about_ca_topic_score_codex":0.00003480444,"about_ca_topic_score_gemma":0.000002272742,"teacher_disagreement_score":0.30321065,"about_ca_system_score_codex":0.00009214485,"about_ca_system_score_gemma":0.000028888548,"threshold_uncertainty_score":0.6415953},"labels":[],"label_agreement":null},{"id":"W6977017571","doi":"10.6084/m9.figshare.13238627.v1","title":"Additional file 2 of Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urothelial carcinoma; Sarcomatoid carcinoma; Carcinoma; Urothelial cancer; Overall survival; Survival analysis; Scale (ratio)","score_opus":0.07812572819565547,"score_gpt":0.29773356328483674,"score_spread":0.21960783508918127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977017571","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014882551,0.008769367,6.224006e-8,0.00095159194,0.0000060259977,0.0008703804,0.98885906,0.000005693682,0.0003890151],"genre_scores_gemma":[0.74593824,0.00017963276,0.00022460149,0.011321167,0.00007306616,0.0025943052,0.2380516,0.000058072346,0.0015593442],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99869657,0.00024067992,0.00046395123,0.00019089924,0.00032287583,0.00008501582],"domain_scores_gemma":[0.9980451,0.0010340613,0.00040009158,0.00033626062,0.00012505073,0.00005946292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000622661,0.0001465019,0.0016625907,0.000025860483,0.000036302106,0.0000049636433,0.00015664753,0.000059157657,0.7663403],"category_scores_gemma":[0.003489702,0.00006169524,0.0008045109,0.00029741376,0.00004863743,0.000019715917,0.00013799862,0.000109809785,0.000008155447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034479315,0.00012252953,0.0010272651,0.05107685,0.025161708,0.000013476677,0.0001853118,4.4212047e-7,0.000007412218,0.000022305052,0.92234075,0.0000074559207],"study_design_scores_gemma":[0.0010283861,0.00039787183,0.53585285,0.01027166,0.44883525,0.00012044387,0.0001397064,0.000038968177,0.00016994728,0.000022606562,0.0029100615,0.00021225352],"about_ca_topic_score_codex":0.000010775376,"about_ca_topic_score_gemma":0.000010358071,"teacher_disagreement_score":0.9194307,"about_ca_system_score_codex":0.0000064485157,"about_ca_system_score_gemma":0.00009241926,"threshold_uncertainty_score":0.41777512},"labels":[],"label_agreement":null},{"id":"W6977041660","doi":"10.6084/m9.figshare.24040699.v1","title":"Additional file 10 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Indel; Bladder cancer; Chromothripsis; Urothelial cancer; Urinary bladder; Urinary system","score_opus":0.06799290781389802,"score_gpt":0.32971126833165176,"score_spread":0.26171836051775377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977041660","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040763416,0.00010973217,1.785941e-8,0.00007306704,0.000048190952,0.00027560804,0.9674189,0.00009300797,0.027905148],"genre_scores_gemma":[0.02903037,0.000017952416,0.000030637864,0.000348532,0.00048140934,0.0012965149,0.9383875,0.00004565226,0.030361423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998965,0.000014076537,0.00022595534,0.00027532192,0.00028766264,0.00023193289],"domain_scores_gemma":[0.9989035,0.00031130057,0.00010988633,0.00024217217,0.00031028694,0.00012282387],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010858881,0.00017494189,0.00026031543,0.00012175174,0.00013300427,0.000024669409,0.00012099053,0.0001121593,0.9936739],"category_scores_gemma":[0.00054020697,0.00015798466,0.00015432911,0.00029487794,0.000042839085,0.00009637579,0.00008884751,0.00011833378,0.0048822244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033517903,0.0000573159,0.00007837118,0.00019215686,0.00015845096,0.00004859328,0.0005185427,0.0000052423884,0.00046663263,0.0000051942784,0.9976327,0.0008033164],"study_design_scores_gemma":[0.0008120402,0.00018095228,0.0927397,0.001378825,0.000035148954,0.0000035369246,0.00008676816,0.000008764482,0.0037592575,0.000048485366,0.90079963,0.00014690937],"about_ca_topic_score_codex":0.00006533833,"about_ca_topic_score_gemma":0.00023451794,"teacher_disagreement_score":0.98879164,"about_ca_system_score_codex":0.00017114799,"about_ca_system_score_gemma":0.00048921624,"threshold_uncertainty_score":0.9958926},"labels":[],"label_agreement":null},{"id":"W6977110150","doi":"10.6068/dp14ba8bc879e91","title":"Trend 2000 - 2002. Statistics Canada. CANSIM: Business Performance and Ownership - Financial Statements and Performance | Country: Canada | Table: Financial and taxation statistics for enterprises, by North American Industry Classification System (NAICS) | Variable: Total, timing differences, Chemicals, plastic and rubber manufacturing (x 1,000,000) | Units: , 2000-2002. Data-Planet™ Statistical Ready Reference by Conquest Systems, Inc. Dataset-ID: 075-001-022.","year":2015,"lang":"en","type":"other","venue":"Data Planet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic statistics; Descriptive statistics; Income statement; Revenue; Balance sheet; Business statistics; Financial ratio; Census; Year-ending; Debt","score_opus":0.026825968157017314,"score_gpt":0.24708636325550415,"score_spread":0.22026039509848683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977110150","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007932727,0.001319655,0.000075235665,0.0000025174886,0.00034335573,0.00095404807,0.9962343,0.00003747223,0.00024016864],"genre_scores_gemma":[0.0040646736,0.0023461229,0.00026584128,0.000113235656,0.00023394142,0.000070900096,0.9909988,0.0001374312,0.0017690605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966925,0.00009963527,0.00075781514,0.0010481138,0.000711959,0.0006900213],"domain_scores_gemma":[0.9972951,0.00036111067,0.0009115856,0.00076130906,0.00011674486,0.0005541626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000203748,0.0007133696,0.0009801184,0.000098265955,0.00025698115,0.00020248869,0.0003407466,0.00035764466,0.00026080786],"category_scores_gemma":[0.00012842721,0.00064460724,2.0634862e-7,0.00021000736,0.00030969744,0.00031026782,0.00021531408,0.0006524971,0.0000015499761],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044553357,0.00006362132,0.0025008542,0.0029315199,0.00016007034,0.00004429791,0.000009560908,0.0000050473514,0.0000019605895,0.000010131681,0.99144644,0.0023809937],"study_design_scores_gemma":[0.0020293219,0.00026395867,0.004190981,0.0002464269,0.0007629136,0.00014840737,0.00013953238,0.006815853,2.5092487e-7,3.8820925e-8,0.98475105,0.0006512656],"about_ca_topic_score_codex":0.9809473,"about_ca_topic_score_gemma":0.8944523,"teacher_disagreement_score":0.086495005,"about_ca_system_score_codex":0.00045870186,"about_ca_system_score_gemma":0.007151443,"threshold_uncertainty_score":0.9996005},"labels":[],"label_agreement":null},{"id":"W6977123964","doi":"10.6084/m9.figshare.24040666.v1","title":"Additional file 2 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Presentation (obstetrics); Urinary bladder; Urinary system; Pathological","score_opus":0.06500811290110292,"score_gpt":0.32809823662021653,"score_spread":0.2630901237191136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977123964","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002299899,0.00008708503,1.5876527e-8,0.000064510794,0.000045990917,0.00026369878,0.9740392,0.00009122424,0.023108361],"genre_scores_gemma":[0.019435093,0.00001636247,0.00003527299,0.00038102447,0.00044611262,0.0015864562,0.96356606,0.000041774885,0.014491841],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900985,0.00001312344,0.00021533876,0.00026291216,0.00027493518,0.00022382528],"domain_scores_gemma":[0.9988807,0.0003932271,0.00010723314,0.00022998164,0.00027064522,0.00011825747],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008908932,0.00016657906,0.00024937524,0.00011804597,0.00012880172,0.000022990458,0.000114562914,0.000105515246,0.9954786],"category_scores_gemma":[0.00060601847,0.0001502634,0.00014936358,0.00029344208,0.00004077622,0.00009207564,0.00008511355,0.00012212555,0.0037110096],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022974184,0.00005207778,0.000081993676,0.00018156672,0.00014990484,0.000050017916,0.00052005565,0.0000051960524,0.0004131672,0.0000043625187,0.99770874,0.000809956],"study_design_scores_gemma":[0.00065136724,0.00014530045,0.11082884,0.0015663808,0.000029113822,0.0000036571917,0.00008760792,0.0000076194547,0.0028510685,0.000039752635,0.8836547,0.00013460603],"about_ca_topic_score_codex":0.00006371189,"about_ca_topic_score_gemma":0.00021952858,"teacher_disagreement_score":0.9917676,"about_ca_system_score_codex":0.00016334596,"about_ca_system_score_gemma":0.00048754766,"threshold_uncertainty_score":0.9970647},"labels":[],"label_agreement":null},{"id":"W6977176000","doi":"10.6084/m9.figshare.24040720.v1","title":"Additional file 15 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Bracken; Table (database); Fern; Cancer; Signature (topology)","score_opus":0.06737171160842814,"score_gpt":0.3303498432074862,"score_spread":0.2629781315990581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977176000","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046309987,0.00013471449,2.6040055e-8,0.00007893234,0.000057419842,0.00029177126,0.9737216,0.000095260715,0.020989243],"genre_scores_gemma":[0.044910654,0.000022243874,0.000034994515,0.00045619693,0.0005292828,0.0013150254,0.93970877,0.000046957426,0.012975861],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894977,0.00001443022,0.00022895909,0.00027745578,0.00029388635,0.00023552701],"domain_scores_gemma":[0.9989287,0.00030622166,0.00011085778,0.00024243469,0.00028592322,0.00012583271],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011037284,0.00017635875,0.0002643338,0.00012331422,0.00013361698,0.000024759407,0.00012175024,0.00011726375,0.987109],"category_scores_gemma":[0.0004909963,0.00015919506,0.00015445282,0.0003005065,0.000043031832,0.0000985936,0.000089817724,0.00013639238,0.0032564404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027066866,0.000057809044,0.00013812233,0.0001984555,0.00016290805,0.0000533534,0.00063414464,0.00000728499,0.0005941579,0.0000058441988,0.9973383,0.0007825578],"study_design_scores_gemma":[0.00084339647,0.00017062886,0.12995657,0.0015287565,0.000037061778,0.0000041892595,0.000110067536,0.000009198751,0.0042406903,0.000051648836,0.86289376,0.0001540057],"about_ca_topic_score_codex":0.00008011998,"about_ca_topic_score_gemma":0.00030624916,"teacher_disagreement_score":0.98385257,"about_ca_system_score_codex":0.00017203644,"about_ca_system_score_gemma":0.0004902773,"threshold_uncertainty_score":0.9975196},"labels":[],"label_agreement":null},{"id":"W6977377462","doi":"10.6084/m9.figshare.28376261","title":"Role of TERT mutations in bladder cancer prognosis: Protocol for a systematic review and meta-analysis","year":2025,"lang":"en","type":"preprint","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Funnel plot; Checklist; Hazard ratio; Protocol (science); Confidence interval; Meta-analysis; Publication bias","score_opus":0.1130697382369752,"score_gpt":0.4156795687711802,"score_spread":0.302609830534205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977377462","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.86933e-7,0.032771327,0.0000015448794,0.0004646148,0.000003291253,0.52279687,0.443364,0.000027088707,0.0005702808],"genre_scores_gemma":[0.0006637396,0.000028227452,0.00017548405,0.00050722715,0.000012387668,0.97938734,0.017950315,0.000015853584,0.0012594279],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985823,0.00006807599,0.0006391093,0.00039171445,0.0001815873,0.00013722264],"domain_scores_gemma":[0.99876046,0.00008345687,0.00037463175,0.0004020764,0.0003241243,0.000055228225],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007244573,0.0002584318,0.002445037,0.00022868028,0.000020310878,0.000016790464,0.00011567095,0.00013697693,0.028798133],"category_scores_gemma":[0.00025422114,0.00017523865,0.0008433127,0.00034603002,0.0000056868057,0.000026421792,0.00011491071,0.00015191492,0.0000059894096],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018273642,0.00014281327,0.00006743829,0.8880646,0.106283955,0.0000016005782,0.00017012702,0.000011609718,5.6737355e-7,0.0000014595913,0.0052172896,0.000020263531],"study_design_scores_gemma":[0.0008704349,0.00007365595,0.00040916976,0.20287123,0.79410875,0.000001566893,0.000035220168,0.00018511996,0.00020138963,0.00007620294,0.0009781198,0.00018914096],"about_ca_topic_score_codex":0.00014139175,"about_ca_topic_score_gemma":0.00021149722,"teacher_disagreement_score":0.6878248,"about_ca_system_score_codex":0.000070183174,"about_ca_system_score_gemma":0.0004268205,"threshold_uncertainty_score":0.97208965},"labels":[],"label_agreement":null},{"id":"W6977466042","doi":"10.6084/m9.figshare.24040690.v1","title":"Additional file 8 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Table (database); Urinary bladder; Urinary system; Gene","score_opus":0.06605780187142449,"score_gpt":0.32841140475588204,"score_spread":0.2623536028844575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977466042","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023460814,0.000086525855,1.645845e-8,0.00006493726,0.000045760913,0.0002645334,0.97430116,0.00009065674,0.022800347],"genre_scores_gemma":[0.02039391,0.00001597437,0.000035762114,0.00038190276,0.00044022448,0.0015889966,0.96260893,0.00004181857,0.014492493],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900943,0.000013124984,0.00021541481,0.00026305695,0.00027500853,0.00022394759],"domain_scores_gemma":[0.9988778,0.00039583346,0.000107107844,0.00023016878,0.00027080224,0.000118288284],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000008969876,0.00016664872,0.00024944879,0.00011811321,0.00012885132,0.00002299983,0.00011459567,0.000105515515,0.9953666],"category_scores_gemma":[0.0006071899,0.00015031667,0.0001494084,0.00029344586,0.00004079068,0.00009209492,0.00008508458,0.00012214767,0.0037197152],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023143604,0.000052137937,0.00008431362,0.00018181927,0.00014992306,0.000049455313,0.000520968,0.000005176968,0.00042303742,0.0000043978043,0.9976928,0.000812818],"study_design_scores_gemma":[0.0006549492,0.00014634315,0.11260416,0.0015944516,0.000029278524,0.0000036640267,0.00008868918,0.000007742887,0.0029483186,0.000040089035,0.8817469,0.00013539883],"about_ca_topic_score_codex":0.00006372669,"about_ca_topic_score_gemma":0.00022141851,"teacher_disagreement_score":0.9916468,"about_ca_system_score_codex":0.00016337336,"about_ca_system_score_gemma":0.000489009,"threshold_uncertainty_score":0.997056},"labels":[],"label_agreement":null},{"id":"W6977529057","doi":"10.6084/m9.figshare.24040726.v1","title":"Additional file 17 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Bracken; Cancer; Human bladder; Urinary bladder","score_opus":0.0682406956949832,"score_gpt":0.33160742966681117,"score_spread":0.26336673397182797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977529057","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044307597,0.000119066,2.3070777e-8,0.00008401559,0.00005126174,0.0002878683,0.967878,0.00009357209,0.027055442],"genre_scores_gemma":[0.03214553,0.000021907239,0.00003373723,0.00047618093,0.00050295884,0.0013374103,0.9449677,0.000045270226,0.020469315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989591,0.000013329121,0.00022663033,0.0002767883,0.0002888762,0.00023525837],"domain_scores_gemma":[0.99893546,0.00030472074,0.00011192215,0.00024599265,0.00027796553,0.00012392107],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010860333,0.00017597909,0.00026343044,0.000121178644,0.00013947143,0.00002509889,0.00012291687,0.00011130264,0.98738855],"category_scores_gemma":[0.00044727194,0.00015887644,0.00015577186,0.0002868797,0.00004334601,0.000098062876,0.00008951879,0.00012928556,0.0025485535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026848724,0.000057047913,0.00012529912,0.00017645913,0.00016282997,0.00005361058,0.0006124998,0.000009866096,0.00051050005,0.000005092946,0.99765855,0.0006013852],"study_design_scores_gemma":[0.00079847535,0.00016107138,0.1281515,0.0014792315,0.000035507965,0.0000039930655,0.000095942494,0.0000088340985,0.0033396808,0.000044240314,0.86573434,0.00014715812],"about_ca_topic_score_codex":0.000075719625,"about_ca_topic_score_gemma":0.00029513598,"teacher_disagreement_score":0.98484,"about_ca_system_score_codex":0.00017259756,"about_ca_system_score_gemma":0.0004769266,"threshold_uncertainty_score":0.9982281},"labels":[],"label_agreement":null},{"id":"W6977786239","doi":"10.6084/m9.figshare.24040705.v1","title":"Additional file 12 of Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bladder cancer; Mutation; Base (topology); Cancer","score_opus":0.07212420733341551,"score_gpt":0.32894751311182524,"score_spread":0.2568233057784097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977786239","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032234187,0.00010740459,3.264844e-8,0.00007449027,0.000058432957,0.00029263264,0.97112894,0.000094277144,0.025020342],"genre_scores_gemma":[0.04268171,0.000023678143,0.000031601307,0.00043154383,0.000517861,0.0013433384,0.9403576,0.000047191566,0.014565454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895436,0.000014330059,0.000228084,0.00027495893,0.0002907565,0.0002375439],"domain_scores_gemma":[0.99897146,0.00030803678,0.00011030306,0.00024128886,0.00024359216,0.00012530999],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000010960049,0.00017619901,0.00026272496,0.00012157124,0.00013572311,0.000024361483,0.00012047268,0.00011146787,0.98582006],"category_scores_gemma":[0.00046853026,0.00015903471,0.00015544257,0.00024200542,0.000042788542,0.00010022182,0.00008908362,0.00012866477,0.002764756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000285596,0.0000582008,0.00017264509,0.00019981091,0.00016555558,0.00005096648,0.0006600618,0.000008334175,0.00052821037,0.0000059169233,0.99740094,0.0007207948],"study_design_scores_gemma":[0.00082769064,0.00016855309,0.13924728,0.0014888364,0.00003665012,0.0000040477134,0.000100450976,0.000009839554,0.003420035,0.00004694365,0.85449946,0.0001502404],"about_ca_topic_score_codex":0.000085260035,"about_ca_topic_score_gemma":0.0003806224,"teacher_disagreement_score":0.9830553,"about_ca_system_score_codex":0.0001759463,"about_ca_system_score_gemma":0.00047299868,"threshold_uncertainty_score":0.9980117},"labels":[],"label_agreement":null},{"id":"W6982340564","doi":"","title":"Identifying a Genetic Signature that Predicts the Progression of Non-Muscle Invasive Urothelial Carcinoma to Muscle-Invasive Cancer.","year":2025,"lang":"en","type":"article","venue":"Scholarship at UWindsor (University of Windsor)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proteogenomics; TSG101; Nucleofection; Gestational period; Dysgeusia; Fusible alloy","score_opus":0.024837223312832318,"score_gpt":0.28264148940750083,"score_spread":0.2578042660946685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6982340564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920409,0.0014737755,0.00014853195,0.0020913759,0.00040997326,0.0018285958,0.00022036232,0.00004743962,0.0017390846],"genre_scores_gemma":[0.99607116,0.00022320275,0.00087331026,0.0005762029,0.00011713469,0.000014977936,0.000026982752,0.000037204263,0.0020598096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759614,0.00017725077,0.00028698688,0.00065765774,0.0007924878,0.0004894476],"domain_scores_gemma":[0.9980547,0.00019499824,0.00029850178,0.0007677331,0.00039958078,0.00028452717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027672306,0.00035325708,0.0006145952,0.0004108179,0.0005197586,0.000030283943,0.0006926332,0.00032832974,0.0003303279],"category_scores_gemma":[0.00014591108,0.00031154262,0.00035429033,0.0008908454,0.00030152695,0.0002989963,0.00048315764,0.00055790297,0.000029156903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002085478,0.00043256042,0.7561312,0.0010483263,0.00067772175,0.0002632597,0.010753878,0.00005870636,0.21137738,0.00003263267,0.0014900345,0.015648881],"study_design_scores_gemma":[0.004046078,0.0005811533,0.9002931,0.0017272655,0.000774142,0.000010477757,0.0028780277,0.0000131108745,0.08860297,0.00010784036,0.00074448896,0.00022135099],"about_ca_topic_score_codex":0.00087596657,"about_ca_topic_score_gemma":0.0014823587,"teacher_disagreement_score":0.14416195,"about_ca_system_score_codex":0.00028845956,"about_ca_system_score_gemma":0.0010623514,"threshold_uncertainty_score":0.99993366},"labels":[],"label_agreement":null},{"id":"W6989863765","doi":"","title":"Clinical relevance of tertiary lymphoid structures on treatment response in muscle invasive bladder cancer","year":2023,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Clinical significance; Bladder cancer; Cancer; Lymphatic system; Clinical trial; Carcinoma","score_opus":0.036576347343851096,"score_gpt":0.3386978425213364,"score_spread":0.3021214951774853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6989863765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98775756,0.0010406384,7.443215e-9,0.00006633816,0.0018545232,0.001649378,0.002269163,0.00016132247,0.0052010794],"genre_scores_gemma":[0.97874,0.00643346,0.00011662704,0.0005532335,0.00014079892,0.000643982,0.0008179728,0.00031293655,0.012240983],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9947388,0.0006976257,0.0015385693,0.0014308176,0.00088768685,0.00070648274],"domain_scores_gemma":[0.99620235,0.0013562894,0.0006840562,0.0010604096,0.0003079237,0.00038895145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063094683,0.000954707,0.0016332373,0.00066754606,0.000247044,0.000019789963,0.0003343753,0.0010051545,0.00037136316],"category_scores_gemma":[0.0015238898,0.0008005031,0.00069761905,0.00066196325,0.00011255627,0.00018370306,0.000060134113,0.0009985835,0.00016497413],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059949387,0.0035065992,0.013478986,0.0013053011,0.0037438006,0.002333479,0.00024453088,0.00013888188,0.07559468,0.0011135676,0.00008934598,0.83850145],"study_design_scores_gemma":[0.014382851,0.0055915625,0.75723565,0.0036587468,0.0015506829,0.000037902148,0.00072875485,0.000005906017,0.20003943,0.0042192456,0.011339196,0.0012100462],"about_ca_topic_score_codex":0.002925112,"about_ca_topic_score_gemma":0.008063798,"teacher_disagreement_score":0.8372914,"about_ca_system_score_codex":0.0022690108,"about_ca_system_score_gemma":0.00074899977,"threshold_uncertainty_score":0.9994446},"labels":[],"label_agreement":null},{"id":"W6990436284","doi":"","title":"Desarrollo de modelos predictivos en el Carcinoma vesical tratado mediante Cistectomía radical","year":2018,"lang":"es","type":"article","venue":"e_Buah","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Beef Cattle Research Council; National Comprehensive Cancer Network","keywords":"Carcinoma; Cancer; Oral cavity","score_opus":0.016457132949838516,"score_gpt":0.29895270826707393,"score_spread":0.2824955753172354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990436284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707941,0.003941808,0.0030007302,0.0028336192,0.0013209713,0.001208561,0.0003996858,0.00023067962,0.016269838],"genre_scores_gemma":[0.98857635,0.0002822284,0.00071319356,0.0013062382,0.0071957824,0.00012168794,0.000051425326,0.00012946296,0.0016236227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964954,0.0002920837,0.0005555506,0.0008115814,0.0007879845,0.0010573498],"domain_scores_gemma":[0.9978442,0.00021291907,0.00011389406,0.000779914,0.00014103405,0.00090803526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033098416,0.0005559484,0.0007706095,0.00018274882,0.00024544628,0.00007514663,0.00040874307,0.0005411219,0.0010882635],"category_scores_gemma":[0.00022713245,0.00048172323,0.00030152462,0.0003141844,0.0007262802,0.00016218226,0.00011372837,0.00063647894,0.0008373756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015048188,0.0059886975,0.71555114,0.0014993929,0.004148157,0.00516103,0.028423348,0.000020824786,0.059533603,0.0045596715,0.075030446,0.0850355],"study_design_scores_gemma":[0.042320088,0.014058811,0.7344504,0.0019636871,0.005098847,0.0015949345,0.00087067846,0.037382554,0.09371044,0.002801971,0.06357587,0.0021717388],"about_ca_topic_score_codex":0.00055083586,"about_ca_topic_score_gemma":0.000036092522,"teacher_disagreement_score":0.08286376,"about_ca_system_score_codex":0.0005362831,"about_ca_system_score_gemma":0.0010575731,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W6992902607","doi":"","title":"Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TKK in human bladder cancer, screening for mutations and loss of heterozygosity","year":2001,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University; Kræftens Bekæmpelse","keywords":"Loss of heterozygosity; Gene; Mutation; Mitosis; Human genome","score_opus":0.04578678581834557,"score_gpt":0.33972685371383526,"score_spread":0.2939400678954897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6992902607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452305,0.00194476,0.0013634196,0.00070284883,0.000042414365,0.00064963655,0.000035083445,0.000024979425,0.00071382086],"genre_scores_gemma":[0.9955124,0.00048292454,0.0027583754,0.00021626567,0.00008488008,0.00009619394,0.000021788284,0.000020273785,0.00080687535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991226,0.00001703629,0.00026771848,0.00026159227,0.00011742017,0.0002136375],"domain_scores_gemma":[0.99957776,0.000044940687,0.000059599748,0.0001355338,0.00007214206,0.000110043926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008141015,0.00014786577,0.00031114562,0.00011317954,0.00008894033,0.000013501749,0.000034437802,0.000066282366,0.000113788396],"category_scores_gemma":[0.000014102586,0.00012478682,0.000053007036,0.00011799339,0.00011855968,0.00008166114,0.000028686745,0.00006690093,4.7164298e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041615212,0.0003732441,0.95030373,0.000279373,0.00033059798,0.000039697214,0.0010172417,0.00004159223,0.01913179,0.00020045211,0.00013563913,0.027730456],"study_design_scores_gemma":[0.012695363,0.00094649656,0.9536772,0.0002890784,0.0005136704,0.0001252513,0.0006099058,0.0009955288,0.02798465,0.00089682173,0.0009482535,0.0003177988],"about_ca_topic_score_codex":0.0027170428,"about_ca_topic_score_gemma":0.0020070856,"teacher_disagreement_score":0.027412657,"about_ca_system_score_codex":0.000036865677,"about_ca_system_score_gemma":0.000041194737,"threshold_uncertainty_score":0.5088659},"labels":[],"label_agreement":null},{"id":"W6995796718","doi":"","title":"@+1-800-769-2805 =pnk=Norton support phone number","year":2016,"lang":"en","type":"other","venue":"OSF Preprints (OSF Preprints)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phone; Telephone number; Toll; Service (business); The Internet","score_opus":0.014474147321144073,"score_gpt":0.28932166715671676,"score_spread":0.2748475198355727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995796718","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048622742,0.0000093077715,0.00028020045,0.00049709325,0.0012640606,0.0021676105,0.00027494875,0.0006691586,0.9943514],"genre_scores_gemma":[0.0057478454,0.0009720261,0.0007543625,0.0007191421,0.0011390811,0.00056777004,0.00021701107,0.0010013691,0.9888814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935692,0.00030230565,0.0008509531,0.0033434995,0.0009655802,0.0009684941],"domain_scores_gemma":[0.9927207,0.00014964485,0.0005553917,0.005709371,0.00015543094,0.0007094372],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011952845,0.000996385,0.0014279512,0.0003373166,0.00011850299,0.0000733627,0.0009168423,0.0010225525,0.98179424],"category_scores_gemma":[0.00041845764,0.0008717671,0.0006481782,0.00022196051,0.00030688665,0.00013022887,0.0009727313,0.0007830365,0.98037094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004472315,0.00083740405,0.027862465,0.00040134776,0.0014394921,0.0003688162,0.0002818949,4.6514702e-7,0.0007471069,0.000178627,0.9383944,0.029040705],"study_design_scores_gemma":[0.0039975294,0.000004835931,0.0045406083,0.0007655187,0.0007405926,0.00033816192,0.000029502527,0.0000017195147,0.0042405105,0.000557625,0.9839921,0.0007913142],"about_ca_topic_score_codex":0.0011743614,"about_ca_topic_score_gemma":0.00018651168,"teacher_disagreement_score":0.04559764,"about_ca_system_score_codex":0.0006185848,"about_ca_system_score_gemma":0.00076801743,"threshold_uncertainty_score":0.9993733},"labels":[],"label_agreement":null},{"id":"W6995889278","doi":"","title":"Planck 2013 results. XI. All-sky model of thermal dust emission","year":2020,"lang":"en","type":"article","venue":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Planck; Research council; Chinese academy of sciences; Space Science; National laboratory; Space (punctuation); Thermal emission","score_opus":0.04202206667419431,"score_gpt":0.2686982437089167,"score_spread":0.2266761770347224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995889278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41430596,0.0014879982,0.0027923973,0.16659606,0.00097422965,0.00214973,0.00081154844,0.0008941859,0.4099879],"genre_scores_gemma":[0.99464476,0.00016163972,0.002549244,0.0011026502,0.00059780607,0.000081422506,0.0003029722,0.000059341623,0.00050017424],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709755,0.00012827652,0.0007670155,0.00067688787,0.00080267136,0.00052757526],"domain_scores_gemma":[0.9979871,0.00008866151,0.00033245134,0.0005069644,0.00033384646,0.0007510007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023096969,0.0004011725,0.00060216896,0.00017000163,0.0002146938,0.000047834186,0.00033460438,0.00041187147,0.00005562814],"category_scores_gemma":[0.00029253506,0.0003384708,0.0002625577,0.00037160533,0.000024900704,0.0002419954,0.00015056875,0.00052608654,0.000019308376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023442617,0.005208636,0.007230888,0.0014797413,0.002681514,0.0011648942,0.019454634,0.0037159997,0.45052943,0.41256806,0.06276806,0.009755546],"study_design_scores_gemma":[0.008987768,0.00067777245,0.0053487467,0.00033444812,0.00048170364,0.00052397675,0.0003507448,0.011644125,0.026717136,0.00018782596,0.94409287,0.0006528921],"about_ca_topic_score_codex":0.0000034050825,"about_ca_topic_score_gemma":0.000013732145,"teacher_disagreement_score":0.8813248,"about_ca_system_score_codex":0.00027510108,"about_ca_system_score_gemma":0.0007258873,"threshold_uncertainty_score":0.9999067},"labels":[],"label_agreement":null},{"id":"W6999558589","doi":"","title":"Cystoscopic-assisted partial cystectomy: description of technique and results","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Cystoscopy; Bladder cancer; Bladder tumor; Palpation; Ultrasound","score_opus":0.2149247350923091,"score_gpt":0.5183374514789815,"score_spread":0.30341271638667233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6999558589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97974265,0.0047929385,0.0020372958,0.00026809992,0.00039036412,0.0012722429,0.000082233055,0.000056788303,0.011357408],"genre_scores_gemma":[0.9964844,0.001687491,0.00095734344,0.00017198449,0.00017659695,0.00008867737,0.000019312158,0.00003944309,0.00037476205],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976694,0.0002363949,0.0009528854,0.00038329317,0.00049208454,0.00026597065],"domain_scores_gemma":[0.9981264,0.0001366931,0.00072773726,0.00046728985,0.00028642273,0.00025546394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010015717,0.00025776977,0.0008590625,0.00047258977,0.00011605935,0.00019765554,0.000507047,0.00014780478,0.0007016494],"category_scores_gemma":[0.00034030943,0.00021130512,0.00013240753,0.00048336148,0.00015231181,0.0006864799,0.0002482219,0.0002586266,0.0000042217134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028871105,0.0004873356,0.33229488,0.0003519667,0.00032857657,0.000033848057,0.00020229425,0.0000045871325,0.6294744,0.0000501128,0.007336529,0.02654834],"study_design_scores_gemma":[0.0037526202,0.00016179359,0.72505057,0.0011539764,0.0003087701,0.00008112099,0.000027357697,0.000030814066,0.26099145,0.0010021428,0.007225707,0.00021368447],"about_ca_topic_score_codex":0.00132282,"about_ca_topic_score_gemma":0.0000508297,"teacher_disagreement_score":0.3927557,"about_ca_system_score_codex":0.00009278031,"about_ca_system_score_gemma":0.00015480776,"threshold_uncertainty_score":0.8616772},"labels":[],"label_agreement":null},{"id":"W7001601041","doi":"","title":"Landsdelige provincies","year":2002,"lang":"af","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Law Foundation of Nova Scotia","funders":"","keywords":"Process (computing); Identification (biology); Product (mathematics)","score_opus":0.03847945688790673,"score_gpt":0.26435121818643775,"score_spread":0.22587176129853104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001601041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8556734,0.05816744,0.00046025743,0.0016108374,0.0015015354,0.0013577921,0.005406938,0.00041735382,0.07540444],"genre_scores_gemma":[0.97970915,0.007349399,0.00038070287,0.000822739,0.0022001127,0.000024994943,0.0028899831,0.00008771183,0.006535209],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99706304,0.00017394176,0.0004963745,0.0010146428,0.00041888945,0.0008331095],"domain_scores_gemma":[0.9975908,0.00020239198,0.00017435804,0.0016446465,0.000031918746,0.0003558754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030089196,0.0005266895,0.0006124692,0.00010610825,0.00046725807,0.00020506897,0.00090803433,0.00014120081,0.00023511285],"category_scores_gemma":[0.000009153163,0.00042488702,0.00007783762,0.0002613405,0.00018084461,0.00036571597,0.00085497,0.00040303692,0.0001986417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000853006,0.0017006893,0.6121036,0.005294619,0.0019430991,0.0006992508,0.025987512,0.0002378623,0.0009292964,0.0001619095,0.062041916,0.28804722],"study_design_scores_gemma":[0.007181293,0.0012354162,0.22835127,0.004796304,0.0028977266,0.00031863348,0.0035145166,0.50820607,0.0001710407,0.00031403446,0.24138863,0.0016250522],"about_ca_topic_score_codex":0.0051370133,"about_ca_topic_score_gemma":0.0034113608,"teacher_disagreement_score":0.5079682,"about_ca_system_score_codex":0.000046876223,"about_ca_system_score_gemma":0.000047162677,"threshold_uncertainty_score":0.9998203},"labels":[],"label_agreement":null},{"id":"W7028347912","doi":"","title":"Efficacité d'un programme d'éducation et de prévention sur le stress perçu d'une population étudiante au collégial","year":2021,"lang":"fr","type":"other","venue":"Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Stress (linguistics); Actuary","score_opus":0.01923381429076417,"score_gpt":0.24404391581145385,"score_spread":0.22481010152068967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7028347912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7647575,0.024497999,0.023236185,0.0010993368,0.00399791,0.0026663402,0.00020770477,0.00008412788,0.17945287],"genre_scores_gemma":[0.9319029,0.0010593765,0.0027571206,0.00002018252,0.00044358338,0.0000047204567,0.0003860298,0.00005896258,0.06336715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787384,0.00036415065,0.00040226462,0.00047895906,0.00047230412,0.00040850788],"domain_scores_gemma":[0.99867284,0.00007363026,0.00030663286,0.0004271334,0.00032586895,0.00019387538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025881638,0.00038699826,0.00062645145,0.00019230362,0.00047972507,0.000020641632,0.00039279246,0.00043506303,0.00071309763],"category_scores_gemma":[0.00011443361,0.0003886308,0.00056697807,0.0005068427,0.0005489394,0.00015192053,0.00018400144,0.00032688928,0.000030250065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029131032,0.023777273,0.6319137,0.053876087,0.007875901,0.00024914218,0.048570234,0.022043101,0.061688513,0.05134638,0.003919185,0.09182737],"study_design_scores_gemma":[0.005690191,0.00031867044,0.9128574,0.023627212,0.001893424,0.00008335093,0.0006191075,0.0018889138,0.02245874,0.00013692299,0.030001316,0.0004247661],"about_ca_topic_score_codex":0.04467903,"about_ca_topic_score_gemma":0.173079,"teacher_disagreement_score":0.28094366,"about_ca_system_score_codex":0.006130517,"about_ca_system_score_gemma":0.0032510697,"threshold_uncertainty_score":0.99985653},"labels":[],"label_agreement":null},{"id":"W7029627202","doi":"","title":"Komplikasjoner og liggetid etter urologisk kirurgi","year":2016,"lang":"en","type":"dissertation","venue":"Duo Research Archive (University of Oslo)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Limiting; Myoglobinuria; Ureterosigmoidostomy","score_opus":0.03724081894552901,"score_gpt":0.3154579161511607,"score_spread":0.2782170972056317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7029627202","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3737191,0.0012843994,0.00070306455,0.007910142,0.00062163005,0.0025836253,0.0013323583,0.00016721497,0.6116785],"genre_scores_gemma":[0.73682505,0.005941564,0.0032142983,0.0003727915,0.00076405867,0.00001761174,0.0036434492,0.00017843433,0.24904273],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99708277,0.0003043984,0.00018247866,0.00065984833,0.0010902435,0.00068026356],"domain_scores_gemma":[0.9980577,0.00030676712,0.00013878175,0.0006441362,0.00048245283,0.00037016874],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00038964595,0.0002860311,0.00060436345,0.00083946006,0.0003664179,0.0000147936125,0.00048562285,0.00029612982,0.002922416],"category_scores_gemma":[0.000104827,0.0002567035,0.00035044522,0.0002961467,0.000512023,0.000118061056,0.00016736345,0.0009345731,0.00091532647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04266035,0.0029727933,0.03372734,0.0034052345,0.0057070307,0.005820117,0.022550154,0.0000015848494,0.12314427,0.004899176,0.5385128,0.21659909],"study_design_scores_gemma":[0.015081616,0.005759847,0.49121177,0.0026259886,0.0008235352,0.000075676486,0.009231312,0.000044866072,0.007180255,0.022937316,0.44380412,0.0012236795],"about_ca_topic_score_codex":0.0019206688,"about_ca_topic_score_gemma":0.0008820731,"teacher_disagreement_score":0.45748445,"about_ca_system_score_codex":0.00016693075,"about_ca_system_score_gemma":0.00066055654,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W7033739448","doi":"","title":"Quarterly report of Materials Innovation and Recycling Authority operations for the quarter ending 2015: Mar. 31.","year":2015,"lang":"en","type":"article","venue":"State Elections Enforcement Commission (State of Connecticut)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Fiscal year; Annual report; Work (physics)","score_opus":0.04525642840588506,"score_gpt":0.3509381414255469,"score_spread":0.30568171301966185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7033739448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88440955,0.00027456746,0.10115801,0.002721896,0.0013142915,0.0032408575,0.00019504521,0.00009943025,0.0065863756],"genre_scores_gemma":[0.99334306,0.000048135138,0.0019852312,0.000048055987,0.00006956484,0.00016636873,0.000120893725,0.000021952157,0.0041967183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831885,0.000068198235,0.0008751252,0.00023424799,0.0002843598,0.00021921576],"domain_scores_gemma":[0.99824786,0.00017718201,0.00031299808,0.0003229196,0.0008339894,0.00010503916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008960818,0.00017725425,0.00035071184,0.0002366798,0.00027964998,0.0000438446,0.0000662589,0.00004775351,0.00007668824],"category_scores_gemma":[0.00024718142,0.00012766551,0.000057127778,0.00040958708,0.00007775766,0.00018622015,0.000017288443,0.00010847506,0.0000014648826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01436395,0.0028841628,0.010131043,0.0019915455,0.004919645,0.0000937306,0.049477804,0.005305596,0.6574522,0.031555768,0.10257671,0.119247824],"study_design_scores_gemma":[0.018296449,0.015458798,0.006731446,0.00082229957,0.0016988856,0.0008342085,0.01400105,0.009418619,0.8250328,0.01256037,0.0941883,0.00095677964],"about_ca_topic_score_codex":0.0008651129,"about_ca_topic_score_gemma":0.00009157489,"teacher_disagreement_score":0.16758057,"about_ca_system_score_codex":0.00012373691,"about_ca_system_score_gemma":0.00034694528,"threshold_uncertainty_score":0.52060485},"labels":[],"label_agreement":null},{"id":"W7042622820","doi":"","title":"Performance of IHC3-Uro Immunohistochemistry-based Molecular Subtyping in Muscle-Invasive Bladder Cancer","year":2021,"lang":"en","type":"dissertation","venue":"QSpace (Queen's University Library)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vanderbilt University Medical Center; Government of Ontario; Bladder Cancer Canada; Cancer Research Society","keywords":"Subtyping; Bladder cancer; Immunohistochemistry; Clinical Practice; Cancer","score_opus":0.0063074297092509165,"score_gpt":0.22301306272758153,"score_spread":0.21670563301833062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7042622820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977261,0.00074444583,0.00000555712,0.002907012,0.00023052137,0.0005165754,0.00012112754,0.00007937317,0.018134369],"genre_scores_gemma":[0.9171577,0.0019655705,0.0005187463,0.00023218612,0.00005842545,0.000010997709,0.0021138638,0.000097190656,0.07784532],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983415,0.00006493939,0.0002702571,0.0005908816,0.0003720189,0.00036038237],"domain_scores_gemma":[0.9988213,0.000051828534,0.00028414108,0.00052272563,0.00016030343,0.00015969174],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000022992368,0.00042422334,0.00069437973,0.0003754462,0.00008053139,0.000017458802,0.0002585748,0.0004180941,0.0011447574],"category_scores_gemma":[0.000022390825,0.0004989475,0.00029912905,0.0006749636,0.00007775031,0.0002979165,0.00005702417,0.00051479525,0.000008006598],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032274473,0.006124205,0.55065894,0.043413997,0.008902511,0.019930108,0.015688933,0.0028590136,0.2104451,0.00044880292,0.094719395,0.014534491],"study_design_scores_gemma":[0.0065683834,0.00053082494,0.122742794,0.0065583484,0.0013716082,0.0000014589834,0.0044057607,0.000037955666,0.84866595,0.000009979697,0.008016195,0.0010907578],"about_ca_topic_score_codex":0.006413023,"about_ca_topic_score_gemma":0.0001268268,"teacher_disagreement_score":0.63822085,"about_ca_system_score_codex":0.00036277573,"about_ca_system_score_gemma":0.002937517,"threshold_uncertainty_score":0.9997683},"labels":[],"label_agreement":null},{"id":"W7052262329","doi":"","title":"Recent Breeding Success of Richardson's Merlin in Saskatchewan","year":2024,"lang":"en","type":"article","venue":"Digital Commons - University of South Florida (University of South Florida)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Merlin (protein); Interspecific hybridization; Inheritance (genetic algorithm); Government (linguistics)","score_opus":0.02129950335116429,"score_gpt":0.2227148250652577,"score_spread":0.2014153217140934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052262329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380464,0.000585142,0.0008442792,0.00043287902,0.00039462562,0.00042462154,0.0014622485,0.0001152906,0.0119362995],"genre_scores_gemma":[0.9979536,0.00013101817,0.00033711907,0.00001124754,0.000071451315,1.131967e-7,0.00011497093,0.000031371597,0.0013490965],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99807286,0.000041325922,0.0002961277,0.00053702557,0.0006440699,0.00040857156],"domain_scores_gemma":[0.99863625,0.00009598113,0.00022827755,0.00046969595,0.00029571334,0.00027406376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000188859,0.00032231217,0.0008672983,0.00075748883,0.00016117068,0.000026640224,0.00050312123,0.0002209612,0.00030798302],"category_scores_gemma":[0.000026230337,0.0004040693,0.00042978016,0.0012158069,0.00055993703,0.00067509303,0.0003275196,0.0004110231,0.000042873402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008071836,0.0011495878,0.6922972,0.0028938188,0.002956637,0.0022943388,0.22319521,0.00026313533,0.0013525037,0.0012748069,0.00195666,0.062294226],"study_design_scores_gemma":[0.020031694,0.0033271667,0.2541533,0.0044542793,0.0028563642,0.00006629084,0.6835699,0.0019461118,0.0026655553,0.00046617168,0.024582285,0.0018808353],"about_ca_topic_score_codex":0.0013269281,"about_ca_topic_score_gemma":0.00063865114,"teacher_disagreement_score":0.4603747,"about_ca_system_score_codex":0.0002731558,"about_ca_system_score_gemma":0.00045678503,"threshold_uncertainty_score":0.9998411},"labels":[],"label_agreement":null},{"id":"W7052270763","doi":"","title":"RE Royalties COO, Peter Leighton, Wins Canada’s 2020 Clean50 Award for Advancing Sustainability and Clean Capitalism","year":2019,"lang":"en","type":"other","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sustainability; Capitalism; Clean technology; Government (linguistics)","score_opus":0.007172673268747312,"score_gpt":0.25748131185140305,"score_spread":0.25030863858265573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052270763","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021811172,0.0045231963,0.000282666,0.010545508,0.0017440622,0.0067143105,0.0011329651,0.00032689256,0.97254926],"genre_scores_gemma":[0.042458784,0.00023587102,0.0004551737,0.0018243376,0.0007015703,0.00009519926,0.00018117535,0.00044779715,0.9536001],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982658,0.000030880907,0.00027672495,0.0006267518,0.00029420297,0.0005056343],"domain_scores_gemma":[0.9988265,0.000069861344,0.00012380454,0.0005529666,0.00016184353,0.0002650083],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009247853,0.00043480366,0.00076193217,0.00008279213,0.000072532035,0.00002544001,0.000101030004,0.00034491174,0.0013677402],"category_scores_gemma":[0.00007062306,0.00033912284,0.00012656106,0.000050275725,0.000086990694,0.000040696996,0.000062170926,0.00026103095,0.000010651297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021849888,0.000047949212,0.0029155856,0.0015641318,0.0003187748,0.00006694997,0.0002308693,8.8759856e-7,0.000001532794,0.0001336825,0.9920007,0.0025004644],"study_design_scores_gemma":[0.0027009603,0.0004749287,0.0015615945,0.00022710666,0.00041665585,0.000020993595,0.0026426476,0.000017706732,0.0000798265,0.000110766196,0.9913608,0.0003860342],"about_ca_topic_score_codex":0.63658816,"about_ca_topic_score_gemma":0.8737195,"teacher_disagreement_score":0.23713133,"about_ca_system_score_codex":0.0007496188,"about_ca_system_score_gemma":0.0025402964,"threshold_uncertainty_score":0.99990606},"labels":[],"label_agreement":null},{"id":"W7052394795","doi":"","title":"Processos de Recrutamento: O Caso da Empresa Tox’Inn Marketing Promocional","year":2017,"lang":"pt","type":"dissertation","venue":"Repositório Comum (Repositório Científico de Acesso Aberto de Portugal)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Forge; Context (archaeology); Nova scotia; Face (sociological concept)","score_opus":0.023522536289114333,"score_gpt":0.31909524130045197,"score_spread":0.29557270501133764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052394795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8733001,0.035908766,0.0006952863,0.0026577562,0.0051254327,0.0076467893,0.00049436215,0.0008969319,0.07327463],"genre_scores_gemma":[0.8587427,0.003624298,0.0013540232,0.0020961221,0.0014490449,0.002187742,0.0031717075,0.0008437751,0.12653059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98162204,0.0014494421,0.0037812442,0.004386753,0.003856775,0.0049037365],"domain_scores_gemma":[0.98473907,0.00073735,0.0050938604,0.0044184835,0.0019540354,0.0030572293],"candidate_categories":["metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0046287486,0.0032331303,0.0035802908,0.0010823194,0.00382636,0.0023463953,0.0027221295,0.002711706,0.0010369126],"category_scores_gemma":[0.0021042938,0.0033648582,0.0017593063,0.0010529868,0.00049641676,0.0012366344,0.0005729098,0.0037068,0.00025305303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015992079,0.008479204,0.6597035,0.012646156,0.009385675,0.030115623,0.039754357,0.00017228062,0.13537757,0.00018831805,0.029478544,0.058706712],"study_design_scores_gemma":[0.02589459,0.00479643,0.49327976,0.03779296,0.023803113,0.036112428,0.008706627,0.009952338,0.18731442,0.00042641597,0.16032578,0.011595135],"about_ca_topic_score_codex":0.004156675,"about_ca_topic_score_gemma":0.0012077416,"teacher_disagreement_score":0.16642372,"about_ca_system_score_codex":0.0068735983,"about_ca_system_score_gemma":0.01102784,"threshold_uncertainty_score":0.99987626},"labels":[],"label_agreement":null},{"id":"W7052689411","doi":"","title":"The Shipwrecks of the Great Lakes Part 2","year":2019,"lang":"en","type":"other","venue":"Bulletin of Miscellaneous Information (Royal Gardens Kew)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Treasure; Nothing; Carving; CONTEST; Queen (butterfly); Geologist; Legend","score_opus":0.00808449829269507,"score_gpt":0.20356116504147398,"score_spread":0.19547666674877892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052689411","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000511088,0.001044623,3.0144115e-8,0.00055043516,0.00059271394,0.00081831403,0.0001605394,0.000046912493,0.99673533],"genre_scores_gemma":[0.00089950836,0.00063820404,0.000038851438,0.00033418543,0.00018991203,0.000019535248,0.00004118756,0.00008440257,0.9977542],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987021,0.000055566987,0.00045516674,0.00012739115,0.0004518021,0.00020797939],"domain_scores_gemma":[0.9986317,0.00010202576,0.00047249254,0.00061954896,0.000113881935,0.00006036276],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013039916,0.00024229802,0.0003901196,0.000025922216,0.00006620345,0.000018036886,0.00027145783,0.000249807,0.12407052],"category_scores_gemma":[0.00007359107,0.00013304144,0.00024482986,0.000008011896,0.00019685522,8.0415276e-8,0.00006461237,0.00021432474,0.0037930186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001527093,0.000030507745,0.000046447498,0.00038062967,0.00018240951,0.0000027146828,0.00008080709,0.0000061075775,2.3702611e-7,0.000024806192,0.9958457,0.0032469328],"study_design_scores_gemma":[0.0008837254,0.00018743213,0.0000782648,0.0005185479,0.00020988645,0.000047802037,0.000068888934,0.0000014334518,0.0000404411,0.0000057347524,0.9978376,0.00012024864],"about_ca_topic_score_codex":0.0020162538,"about_ca_topic_score_gemma":0.0010793343,"teacher_disagreement_score":0.120277494,"about_ca_system_score_codex":0.000036982976,"about_ca_system_score_gemma":0.00008559383,"threshold_uncertainty_score":0.99698263},"labels":[],"label_agreement":null},{"id":"W7052808479","doi":"","title":"A simulation study of the second-order least squares estimators for nonlinear mixed effects models","year":2006,"lang":"en","type":"dissertation","venue":"Mspace (University of Manitoba)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; National Energy Research Scientific Computing Center","keywords":"Estimator; Least-squares function approximation; Nonlinear system; Non-linear least squares; Linear model; Estimation theory","score_opus":0.017221956766994628,"score_gpt":0.25616729819457246,"score_spread":0.23894534142757784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052808479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952474,0.00010122175,0.00097205484,0.000048572765,0.00030635064,0.0022809936,0.00012999632,0.000026855287,0.0008865247],"genre_scores_gemma":[0.9947848,0.0000026917483,0.0011542258,0.000010758476,0.00005088257,0.0000039691718,0.0003090386,0.00003408419,0.0036495856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908483,0.00005007644,0.00012897681,0.00026481875,0.0003266702,0.00014460692],"domain_scores_gemma":[0.99888813,0.00012038091,0.00029351853,0.0003075123,0.00033843334,0.000052033512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051907264,0.0002107828,0.00047046677,0.00014311673,0.0001534888,0.0000057946695,0.00015416795,0.00017950604,0.0000086169985],"category_scores_gemma":[0.000030101834,0.00019756971,0.00020105358,0.0001965169,0.000038136834,0.00008865271,0.000026319885,0.00013559201,0.0000020833547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02998286,0.027197083,0.46968114,0.03641193,0.0105798235,0.00021773159,0.03236758,0.35242322,0.0042894958,0.00055537216,0.017046329,0.019247439],"study_design_scores_gemma":[0.018188098,0.0034510335,0.8192976,0.0010998291,0.004488722,0.000002112174,0.052078184,0.09724256,0.0024408011,0.00028187872,0.0008995186,0.0005296615],"about_ca_topic_score_codex":0.0024485746,"about_ca_topic_score_gemma":0.23701172,"teacher_disagreement_score":0.34961647,"about_ca_system_score_codex":0.000096016614,"about_ca_system_score_gemma":0.00016231292,"threshold_uncertainty_score":0.80566585},"labels":[],"label_agreement":null},{"id":"W7052826968","doi":"","title":"Swift-BAT GUANO Follow-up of Gravitational-wave Triggers in the Third LIGO–Virgo–KAGRA Observing Run","year":2025,"lang":"en","type":"article","venue":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Social Fund; Japan Society for the Promotion of Science; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Science and Technology Facilities Council; National Science and Technology Council; European Regional Development Fund; Centre National de la Recherche Scientifique; ICTP South American Institute for Fundamental Research; Ministry of Science and ICT, South Korea; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; National Research Foundation; Vlaamse regering; National Astronomical Observatory of Japan; Ministry of Education, Culture, Sports, Science and Technology; Natural Sciences and Engineering Research Council of Canada; Ministry of Education, India; Agencia Estatal de Investigación; Great Southern Development Commission, Government of Western Australia; Israel Science Foundation; Scottish Universities Physics Alliance; National Natural Science Foundation of China; National Research Foundation of Korea; Division of Human Resource Development; Korea Astronomy and Space Science Institute; Nuclear Safety and Security Commission; Hungarian Scientific Research Fund; Generalitat de Catalunya; Generalitat Valenciana; Istituto Nazionale di Fisica Nucleare; U.S. Department of Energy; National Research, Development and Innovation Office; Korea Institute of Science and Technology Information; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Council of Scientific and Industrial Research, India; Fundacja na rzecz Nauki Polskiej; Academia Sinica; Abdus Salam International Centre for Theoretical Physics; Leverhulme Trust; European Commission; Russian Science Foundation; Scottish Funding Council; Narodowa Agencja Wymiany Akademickiej; Centres de Recerca de Catalunya; Institut des Origines de Lyon; Fonds De La Recherche Scientifique - FNRS; Fonds Wetenschappelijk Onderzoek; National Aeronautics and Space Administration; Science and Engineering Research Board; National Science Foundation","keywords":"Sky; Transient (computer programming); Flux (metallurgy); Guano; Electromagnetic interference; False alarm; Telescope; Binary number","score_opus":0.022556914511573038,"score_gpt":0.2305336671350113,"score_spread":0.20797675262343826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052826968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9325862,0.00048410794,0.0008988081,0.0011142559,0.00033720318,0.00086537964,0.00017023234,0.000036999212,0.063506804],"genre_scores_gemma":[0.99544984,0.00026948666,0.0011010183,0.000062389314,0.00004159344,6.3748337e-7,0.000046306184,0.000008987737,0.003019761],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99754316,0.00022684205,0.00048473655,0.00052456826,0.0008753412,0.0003453344],"domain_scores_gemma":[0.9979203,0.00028747952,0.0004474889,0.0006999726,0.0005254419,0.00011935224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050736713,0.00033617523,0.0006442026,0.00032453507,0.00082917634,0.000022243308,0.00088301185,0.00026735943,0.000083262035],"category_scores_gemma":[0.000054893895,0.0003078157,0.000546959,0.00091851846,0.0016724429,0.00043070526,0.00015784158,0.0005455565,0.000007007709],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015110653,0.006639333,0.09704608,0.0028469772,0.0056058886,0.004075376,0.040157206,0.003002989,0.16684799,0.6457237,0.0036221065,0.009321688],"study_design_scores_gemma":[0.015248919,0.0014101765,0.8413914,0.0020805236,0.0020488168,0.0003000496,0.11230058,0.0004170988,0.01229563,0.007872608,0.0039048982,0.00072933186],"about_ca_topic_score_codex":0.004176366,"about_ca_topic_score_gemma":0.0013218994,"teacher_disagreement_score":0.7443453,"about_ca_system_score_codex":0.00033183943,"about_ca_system_score_gemma":0.0020526145,"threshold_uncertainty_score":0.9999374},"labels":[],"label_agreement":null},{"id":"W7052854646","doi":"","title":"Talking to the Chair-elect of the Realtors Association of Edmonton about their 2021 Real Estate forecast","year":2020,"lang":"en","type":"other","venue":"Bulletin of Miscellaneous Information (Royal Gardens Kew)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real estate; Association (psychology); Data association; Association rule learning","score_opus":0.005981941827570185,"score_gpt":0.19910246998888861,"score_spread":0.19312052816131842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7052854646","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053824147,0.00015043268,4.1732883e-7,0.0012457718,0.00027726474,0.0010460992,0.000418599,0.000032435895,0.99629074],"genre_scores_gemma":[0.01429312,0.0015450955,0.00012782736,0.00032274876,0.00028534952,0.000028286431,0.00010763637,0.00009413287,0.9831958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982899,0.00009820766,0.00064456963,0.00016347783,0.000569081,0.00023479482],"domain_scores_gemma":[0.9981675,0.00010464053,0.0010510096,0.0003985637,0.00018883616,0.00008941973],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023966414,0.00027105043,0.0005542654,0.000050174975,0.00005577458,0.000012784628,0.00025650297,0.00024495152,0.031628102],"category_scores_gemma":[0.00016477954,0.00016660074,0.00026464852,0.00003063573,0.00006343167,2.4184013e-7,0.00007939766,0.00024228869,0.00031312142],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024516822,0.000043819793,0.0001330027,0.00043499676,0.00027293141,0.000002471211,0.0014799351,0.000059008984,0.0000055342484,0.000004372448,0.98263747,0.014681297],"study_design_scores_gemma":[0.0007486588,0.00038414926,0.00066781096,0.0005771316,0.0002152726,0.000012538936,0.00022429957,0.000015612579,0.0002737272,0.000002221531,0.9967484,0.0001301813],"about_ca_topic_score_codex":0.018143743,"about_ca_topic_score_gemma":0.006430309,"teacher_disagreement_score":0.03131498,"about_ca_system_score_codex":0.00014257857,"about_ca_system_score_gemma":0.00011583856,"threshold_uncertainty_score":0.9883945},"labels":[],"label_agreement":null},{"id":"W7053076853","doi":"","title":"Vancouver's greenest office building envisions a new kind of office space with TELUS Garden","year":2016,"lang":"en","type":"other","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Space (punctuation); Work (physics); Post office; Office workers","score_opus":0.011920253562766115,"score_gpt":0.2713896543838872,"score_spread":0.2594694008211211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7053076853","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076020755,0.0010887798,0.0036221994,0.00030519927,0.00037366958,0.00084414164,0.000112419744,0.00018460127,0.99339294],"genre_scores_gemma":[0.004111736,0.00031158453,0.008403139,0.00021048145,0.0008621154,0.000014382274,0.000016418477,0.00048843253,0.9855817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837685,0.000024787176,0.00024713806,0.0005092459,0.0005001143,0.0003418779],"domain_scores_gemma":[0.99861085,0.00007292489,0.00025122348,0.0006818112,0.000066261695,0.00031690812],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047215242,0.00044087638,0.000766372,0.000261343,0.00003336888,0.000009169985,0.0001740482,0.00029086767,0.022333086],"category_scores_gemma":[0.000021184522,0.00025965078,0.00014461146,0.0001555836,0.00010013912,0.00003100509,0.000060311886,0.0001736478,0.00037031894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070218806,0.00018428544,0.0007457432,0.00018329838,0.00079115573,0.00009313757,0.000059431288,0.0000010050883,0.00036750553,0.00011008786,0.9888285,0.007933656],"study_design_scores_gemma":[0.0048771217,0.0006913027,0.00085293787,0.0022329672,0.0008180531,0.00005254303,0.00006200875,9.998148e-7,0.0012080568,0.000010353325,0.98884416,0.00034948523],"about_ca_topic_score_codex":0.007512786,"about_ca_topic_score_gemma":0.008236817,"teacher_disagreement_score":0.021962767,"about_ca_system_score_codex":0.00010187005,"about_ca_system_score_gemma":0.0007237123,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W7053245529","doi":"","title":"TVET scoping and advisory mission to Sierra Leone 2012:diagnostic report","year":2020,"lang":"en","type":"article","venue":"Graduate Institute Geneva Institutional Repository (Graduate Institute of International and Development Studies)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Gesellschaft für Internationale Zusammenarbeit; Ministry of Education, Science and Technology; Overseas Development Institute; European Commission; FP7 International Cooperation; African Union; Leukemia and Lymphoma Society of Canada","keywords":"Sierra leone; Context (archaeology); Order (exchange); Section (typography); Government (linguistics)","score_opus":0.13001988999148195,"score_gpt":0.34103276668147,"score_spread":0.21101287668998803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7053245529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96445316,0.004975066,0.0031480575,0.014831625,0.005120447,0.0015813515,0.000050830295,0.00017012413,0.005669361],"genre_scores_gemma":[0.9810551,0.002622255,0.0124422,0.0019534598,0.00076015113,0.00014623876,0.00021552976,0.00003390796,0.00077116623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960918,0.000033219752,0.0012498922,0.0009914844,0.001229474,0.00040415995],"domain_scores_gemma":[0.99777853,0.000076578974,0.00034450178,0.00026365565,0.0008697633,0.000666949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026849617,0.00054449076,0.00079590187,0.0002957315,0.00077649567,0.00006883768,0.00022647357,0.0001263871,0.000016628792],"category_scores_gemma":[0.0008705968,0.00047800655,0.0001249003,0.00030162968,0.0007758804,0.00068011496,0.00045111906,0.00030465843,0.00004807818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01753104,0.006886858,0.21687183,0.017253667,0.033915184,0.06677019,0.04511466,0.0201753,0.10374179,0.023729855,0.07004804,0.37796158],"study_design_scores_gemma":[0.012248535,0.0015432093,0.36933926,0.011138114,0.00092349894,0.010727219,0.001171359,0.0003287171,0.041043263,0.0003742082,0.54870737,0.0024552597],"about_ca_topic_score_codex":0.00015458059,"about_ca_topic_score_gemma":0.000038175618,"teacher_disagreement_score":0.4786593,"about_ca_system_score_codex":0.00033744058,"about_ca_system_score_gemma":0.001370643,"threshold_uncertainty_score":0.9997672},"labels":[],"label_agreement":null},{"id":"W7053354807","doi":"","title":"With a unity of purpose how the First World War changed Newfoundland","year":2024,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dominion; State (computer science); Government (linguistics); Rationing; Liberalism; Duty; First world war; House of Commons","score_opus":0.027744015189027454,"score_gpt":0.2663847138598671,"score_spread":0.23864069867083967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7053354807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58338803,0.011214982,0.0006212508,0.18397334,0.000810374,0.0031787097,0.00008743978,0.0005327215,0.21619317],"genre_scores_gemma":[0.974042,0.00007695714,0.00008662758,0.0006521368,0.00014833163,0.000036261314,0.000006154492,0.000014988234,0.024936538],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995396,0.000010387046,0.000059298472,0.00011995484,0.00015707269,0.00011368275],"domain_scores_gemma":[0.99965495,0.000042952375,0.000013054392,0.00020450525,0.000034587854,0.0000499284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057229136,0.00008897954,0.00013802703,0.000058793197,0.000046482477,0.000017955208,0.000047666803,0.000019225414,0.000364542],"category_scores_gemma":[0.000004996126,0.00003889976,0.000042137213,0.0003143872,0.00006317436,0.000041426618,0.000015141718,0.000096018244,0.000020003767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005706509,0.0020160892,0.5897866,0.0039423243,0.00602014,0.0013926182,0.021936364,0.000012288665,0.0018182585,0.00987705,0.22401148,0.13348027],"study_design_scores_gemma":[0.0045862785,0.0017662199,0.1362434,0.0008542982,0.0011256414,0.00017713034,0.00075783575,0.00030494193,0.005152076,0.0003916643,0.8483822,0.0002583625],"about_ca_topic_score_codex":0.0011113597,"about_ca_topic_score_gemma":0.015179842,"teacher_disagreement_score":0.6243707,"about_ca_system_score_codex":0.000043169228,"about_ca_system_score_gemma":0.00008447467,"threshold_uncertainty_score":0.8470708},"labels":[],"label_agreement":null},{"id":"W7053447463","doi":"","title":"Widely tunable, fast scanning, narrow linewidth, Mid-IR source centred at 2.9 µm","year":2020,"lang":"en","type":"article","venue":"Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Process (computing); Set (abstract data type); Identification (biology); Focus (optics); Work (physics)","score_opus":0.022796858593994426,"score_gpt":0.219623336497202,"score_spread":0.19682647790320756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7053447463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77596134,0.0043704077,0.022977194,0.0334561,0.0004944906,0.0056435205,0.0011294394,0.0022859436,0.15368156],"genre_scores_gemma":[0.9709206,0.000551976,0.009685396,0.0007275329,0.00011647773,5.6308613e-7,0.00010240806,0.00009241683,0.01780259],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521774,0.00023113145,0.00071209646,0.0014451549,0.0013453123,0.0010485392],"domain_scores_gemma":[0.99581593,0.00032822235,0.0006772327,0.001203125,0.0005887142,0.0013867529],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002876587,0.0007670304,0.0017890818,0.00042741594,0.00054594706,0.000021005117,0.0016224114,0.001031505,0.0052508665],"category_scores_gemma":[0.00028765827,0.000917095,0.0011317298,0.0015283203,0.0016654483,0.00039561992,0.0015669189,0.0012013575,0.0005166922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05349039,0.008564164,0.09097064,0.0031350842,0.0039145215,0.009642705,0.0049589234,0.0008226507,0.33923993,0.0016279304,0.4627905,0.02084255],"study_design_scores_gemma":[0.05895505,0.012201331,0.13347219,0.0031395587,0.008997348,0.0013763092,0.011431585,0.0019854316,0.03665003,0.0005386435,0.72587824,0.0053742984],"about_ca_topic_score_codex":0.0012324715,"about_ca_topic_score_gemma":0.0005661222,"teacher_disagreement_score":0.3025899,"about_ca_system_score_codex":0.0010254367,"about_ca_system_score_gemma":0.0006345007,"threshold_uncertainty_score":0.99932796},"labels":[],"label_agreement":null},{"id":"W7053466730","doi":"","title":"Voz y escritura. Revista de estudios literarios.","year":2008,"lang":"es","type":"other","venue":"Actualidad Contable FACES","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ideology; Context (archaeology); Field (mathematics); Higher education","score_opus":0.020027869384490426,"score_gpt":0.2796712553409839,"score_spread":0.2596433859564935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7053466730","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07249871,0.20227253,0.00018764759,0.0016447814,0.0023222768,0.0042643766,0.0013345724,0.0007021534,0.71477294],"genre_scores_gemma":[0.34030178,0.028528325,0.00047535085,0.0030488765,0.0021726692,0.00026472082,0.0003210975,0.0006033843,0.6242838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579585,0.00023806673,0.00076960423,0.0011579862,0.000747253,0.0012912152],"domain_scores_gemma":[0.9973792,0.00023893862,0.00045654766,0.0011861996,0.00018174852,0.00055740995],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021633905,0.0012060093,0.0019491786,0.00032142716,0.0003175088,0.00041122435,0.0005637682,0.0008082891,0.012569934],"category_scores_gemma":[0.00020443357,0.0010161193,0.00043726564,0.0003553008,0.00026954268,0.00023842709,0.00016403203,0.0007630005,0.0035472012],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094273593,0.0013775293,0.054597445,0.001985047,0.0070722457,0.002208721,0.01085405,0.0000028748932,0.0017938735,0.0013583631,0.85661244,0.061194647],"study_design_scores_gemma":[0.00433418,0.000760415,0.0046407855,0.0029639916,0.0014608632,0.0002691377,0.00048004315,0.000008105354,0.0015615245,0.000021940283,0.98254925,0.0009497357],"about_ca_topic_score_codex":0.0038942033,"about_ca_topic_score_gemma":0.00014363627,"teacher_disagreement_score":0.26780307,"about_ca_system_score_codex":0.00057998043,"about_ca_system_score_gemma":0.001152534,"threshold_uncertainty_score":0.9992289},"labels":[],"label_agreement":null},{"id":"W7073860569","doi":"","title":"A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients","year":2010,"lang":"en","type":"other","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotoxin; Bladder cancer; Refractory (planetary science); Adverse effect; Toxicity; Pseudomonas exotoxin; Maximum tolerated dose; Transitional cell carcinoma; Dose-ranging study","score_opus":0.13700097561078703,"score_gpt":0.5321842460916494,"score_spread":0.3951832704808623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7073860569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967815,0.021717675,0.000011696803,0.000040657975,0.0006310196,0.006540522,0.0010391169,0.000017879705,0.0021864567],"genre_scores_gemma":[0.9754055,0.020300273,0.00015748006,0.00008938864,0.00035770217,0.0008827281,0.00008834594,0.00037172265,0.0023468635],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965947,0.00023803036,0.0013835487,0.0006647979,0.0007018594,0.0004170657],"domain_scores_gemma":[0.9962314,0.00043061934,0.0019361753,0.00075974764,0.000373728,0.0002683378],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041530983,0.0006648895,0.0020316248,0.0007954044,0.00011298945,0.00013968891,0.0009416591,0.00030614456,0.005486566],"category_scores_gemma":[0.00013722474,0.0004425417,0.00026869684,0.00035329998,0.00023267664,0.0003376662,0.0001819242,0.00041076663,9.2039727e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017047165,0.091555566,0.3114378,0.0016186078,0.011345945,0.00015633563,0.013222574,0.000020066624,0.1052251,0.0000033457648,0.013284733,0.43508276],"study_design_scores_gemma":[0.080878355,0.0113770105,0.82139885,0.0047544762,0.005119736,0.000013237315,0.0026486882,0.00006555928,0.048914857,0.00010040842,0.02334155,0.0013872654],"about_ca_topic_score_codex":0.00915811,"about_ca_topic_score_gemma":0.0038497478,"teacher_disagreement_score":0.50996107,"about_ca_system_score_codex":0.00018706702,"about_ca_system_score_gemma":0.00056113856,"threshold_uncertainty_score":0.99980265},"labels":[],"label_agreement":null},{"id":"W7084861965","doi":"10.6084/m9.figshare.c.8074030","title":"Machine learning-based radiomics using magnetic resonance images for prediction of clinical complete response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer","year":2025,"lang":"en","type":"other","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Radiomics; Receiver operating characteristic; Bladder cancer; Magnetic resonance imaging; Clinical trial; Feature selection; Chemotherapy; Feature (linguistics)","score_opus":0.04441651390519974,"score_gpt":0.32815902103746875,"score_spread":0.283742507132269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084861965","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025067045,0.006241296,0.000054575085,0.0002568123,0.00021576615,0.0054495162,0.9829786,0.0001202031,0.0021765498],"genre_scores_gemma":[0.06734914,0.001360793,0.017870411,0.010933897,0.0030108034,0.007584703,0.52077645,0.00448837,0.36662543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829537,0.00012797797,0.00048076702,0.0005364871,0.00028711892,0.00027229806],"domain_scores_gemma":[0.9987068,0.00028090415,0.00030750848,0.00035081754,0.00023775666,0.000116201845],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000091503374,0.00033961557,0.0008139661,0.00032148845,0.000033758228,0.000010519294,0.00012679872,0.0002726567,0.022782018],"category_scores_gemma":[0.00062076235,0.0002864504,0.00015367796,0.00026319645,0.00002584131,0.000021205336,0.000028536031,0.00027845099,0.00001338009],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048218276,0.0014155549,0.11228843,0.002884295,0.0005760573,0.000058154234,0.00021787982,0.0005719192,0.00009512131,4.2288892e-7,0.7696513,0.06402257],"study_design_scores_gemma":[0.02381228,0.0037519063,0.40538093,0.018460736,0.00025988455,8.222195e-7,0.000008096719,0.0012831432,0.00016708534,0.0000010939365,0.54657,0.00030403314],"about_ca_topic_score_codex":0.0003834833,"about_ca_topic_score_gemma":0.00018247156,"teacher_disagreement_score":0.46220213,"about_ca_system_score_codex":0.00017751081,"about_ca_system_score_gemma":0.0010566295,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W7085103290","doi":"10.6084/m9.figshare.30291985.v1","title":"Additional file 2 of Machine learning-based radiomics using magnetic resonance images for prediction of clinical complete response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Radiomics; Magnetic resonance imaging; Bladder cancer; Chemotherapy; Complete response; Patient data","score_opus":0.036359453115577506,"score_gpt":0.31292111379906534,"score_spread":0.27656166068348786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7085103290","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014534555,0.00021383406,0.000008530237,0.000098208206,0.000024006085,0.0009564416,0.9841059,0.000013949347,0.000044593635],"genre_scores_gemma":[0.076404564,0.000009266843,0.0040510204,0.0010085162,0.000100636345,0.0017540499,0.91588503,0.00005396293,0.0007329214],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99895924,0.00007099773,0.00037990406,0.00025237488,0.00018859925,0.00014889803],"domain_scores_gemma":[0.99801487,0.001262174,0.0001651806,0.00016082151,0.0003384948,0.000058469763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000482855,0.00013248782,0.0003653318,0.00013783449,0.000033811844,0.000004163,0.00006547599,0.000074392796,0.4627343],"category_scores_gemma":[0.0017101871,0.00011396302,0.000090613976,0.00024871845,0.00002491875,0.000032868862,0.000016814874,0.0001194797,0.0000055693404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015432263,0.00048259023,0.013729125,0.0002976809,0.00007767635,0.000004701447,0.00006155264,0.00041620177,0.00009496864,1.18970206e-7,0.9557986,0.01360449],"study_design_scores_gemma":[0.008873667,0.0020835283,0.7816542,0.0060657524,0.0000468986,4.2346372e-7,0.000009721541,0.003199002,0.00043115142,0.0000018888366,0.19755216,0.00008162228],"about_ca_topic_score_codex":0.000041704905,"about_ca_topic_score_gemma":0.000035029174,"teacher_disagreement_score":0.7679251,"about_ca_system_score_codex":0.00009621235,"about_ca_system_score_gemma":0.00071555056,"threshold_uncertainty_score":0.5377568},"labels":[],"label_agreement":null},{"id":"W7093352706","doi":"10.71892/11143/1151","title":"Place de la virothérapie dans le traitement du cancer de la vessie","year":2023,"lang":"fr","type":"other","venue":"Open MIND","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Cancer; Breast cancer; Lung cancer","score_opus":0.021439825616681483,"score_gpt":0.33236305566821994,"score_spread":0.31092323005153844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7093352706","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024600431,0.005463958,0.00023337165,0.0012729018,0.00086310494,0.0015946529,0.00065238803,0.0000176385,0.9653016],"genre_scores_gemma":[0.038929015,0.003635908,0.0025259112,0.00035362827,0.0019488557,0.0007599674,0.00003714095,0.00070188777,0.9511077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976549,0.0004900641,0.00031314767,0.00060902745,0.00027744423,0.0006553764],"domain_scores_gemma":[0.99863786,0.0004077355,0.0001624323,0.00041266583,0.000022663802,0.0003566592],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007395782,0.0004617116,0.00061703584,0.00009880188,0.00016539918,0.00019755909,0.00050646527,0.00052663015,0.070372015],"category_scores_gemma":[0.00007340897,0.00043001448,0.00015117152,0.00019031443,0.00037184937,0.00008417426,0.00016583664,0.0004284906,0.0016613753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072099926,0.0020693147,0.028052574,0.0003346626,0.0035793346,0.0026792695,0.023483394,0.0003606783,0.0066031837,0.00055459683,0.08190525,0.84965676],"study_design_scores_gemma":[0.006220734,0.00022218052,0.027798451,0.002095631,0.0009975381,0.000079673875,0.0011272532,0.00012874269,0.0047877687,0.000078022436,0.95604426,0.00041975046],"about_ca_topic_score_codex":0.01886856,"about_ca_topic_score_gemma":0.0069682216,"teacher_disagreement_score":0.874139,"about_ca_system_score_codex":0.0012848339,"about_ca_system_score_gemma":0.0026696215,"threshold_uncertainty_score":0.99981517},"labels":[],"label_agreement":null},{"id":"W7095960303","doi":"","title":"© 2014 Canadian Urological Association","year":2014,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transitional cell carcinoma; Upper urinary tract; Ureter; Nephrectomy; Association (psychology); Kidney","score_opus":0.010670671060384062,"score_gpt":0.248398829144121,"score_spread":0.23772815808373696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7095960303","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11052571,0.000045206216,0.00023515157,0.019200874,0.00022344093,0.00017869647,0.00000553548,0.00008073331,0.86950463],"genre_scores_gemma":[0.97790873,0.0000066757493,0.00018276884,0.007418712,0.00015864872,0.000006051358,0.000010098416,0.0000044713197,0.014303817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961066,0.00001642153,0.00005195321,0.000084726096,0.000089903,0.00014636041],"domain_scores_gemma":[0.9996885,0.000020190386,0.000011726347,0.00007820656,0.000028386556,0.00017298563],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000085541324,0.000042211745,0.00008068203,0.0000282404,0.00003134225,0.000006234772,0.00001871089,0.00006353935,0.0022886528],"category_scores_gemma":[0.00005634066,0.000029725568,0.000028611725,0.000029436573,0.0000047915214,0.000014422355,0.00000293481,0.000049367423,0.00094533176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019560664,0.000033336466,0.86738557,0.0000027437789,0.000042988893,0.000003821466,0.000024236017,5.374425e-7,0.00009474604,0.0015311253,0.12351433,0.00734701],"study_design_scores_gemma":[0.00080267806,0.00023822654,0.6170567,0.0000019442323,0.00004683709,0.000005751098,0.0000045537117,0.00008136996,0.00028225165,0.00037224873,0.3810606,0.000046807592],"about_ca_topic_score_codex":0.040533226,"about_ca_topic_score_gemma":0.014015009,"teacher_disagreement_score":0.86738306,"about_ca_system_score_codex":0.0001706158,"about_ca_system_score_gemma":0.000076435295,"threshold_uncertainty_score":0.9998326},"labels":[],"label_agreement":null},{"id":"W7096695286","doi":"","title":"CUAJ • May-June 2013 • Volume 7, Issue 5-6 © 2013 Canadian Urological Association","year":2013,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blood loss; Blood transfusion; Cystectomy; MEDLINE; Clinical trial; Randomized controlled trial","score_opus":0.011353670351293144,"score_gpt":0.24860323450365185,"score_spread":0.2372495641523587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096695286","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22530532,0.00094227307,0.00007330457,0.45164716,0.0016728109,0.002254121,0.000068722286,0.00033829178,0.317698],"genre_scores_gemma":[0.6477472,0.00013825344,0.00038072316,0.0076277456,0.00040313057,0.00009370695,0.000052214436,0.000019770878,0.3435372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874187,0.000037692294,0.00019957585,0.0002632253,0.0002611866,0.0004964806],"domain_scores_gemma":[0.99898785,0.00002616782,0.00005042323,0.00023533992,0.00016654098,0.0005336982],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009370504,0.0001652203,0.00025884114,0.000094431845,0.0000927619,0.000044228782,0.00008097757,0.00022484802,0.0625584],"category_scores_gemma":[0.000044838474,0.00012375144,0.00008414451,0.00013093863,0.000024508356,0.00013440577,0.000017690996,0.00017819983,0.023632528],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000105609615,0.000060800005,0.1867076,0.0000053637723,0.000081130805,0.000010466996,0.000054564112,0.0000012459974,0.000090177135,0.000038280938,0.81052727,0.002412515],"study_design_scores_gemma":[0.0009822386,0.00023272062,0.31689012,0.0000064920146,0.000086243366,0.000013091097,0.000048987906,0.00021847567,0.00012920392,0.00016794782,0.68109107,0.00013338907],"about_ca_topic_score_codex":0.6108893,"about_ca_topic_score_gemma":0.07139943,"teacher_disagreement_score":0.53948987,"about_ca_system_score_codex":0.0004852623,"about_ca_system_score_gemma":0.00021252656,"threshold_uncertainty_score":0.9771277},"labels":[],"label_agreement":null},{"id":"W7099133302","doi":"","title":"DEPARTEMENT DES SOLS ET DE GENIE AGROALIMENTAIRE","year":2015,"lang":"en","type":"article","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Class (philosophy); Work (physics); Process (computing); Context (archaeology)","score_opus":0.08458861499718372,"score_gpt":0.38221737575172654,"score_spread":0.2976287607545428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7099133302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68659246,0.00083631906,0.0031734111,0.0025178194,0.0001338022,0.0005190248,0.000008646446,0.00016326549,0.30605525],"genre_scores_gemma":[0.98405194,0.0000341065,0.004199227,0.0037245168,0.000084463245,0.000044015298,0.000014181933,0.000013595978,0.007833961],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994209,0.00002310514,0.00009380799,0.00011644724,0.00016021745,0.00018551717],"domain_scores_gemma":[0.9995603,0.000007262159,0.000013931389,0.00013520927,0.000038519214,0.0002447761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116153344,0.000083566185,0.0001104003,0.00002090586,0.00002801802,0.0000123422315,0.0000324944,0.000028986044,0.00031081433],"category_scores_gemma":[0.000008999332,0.000060495928,0.000041250692,0.000044341887,0.000029666457,0.000053161395,0.000020253516,0.000038379683,0.00017013798],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089894386,0.0017890503,0.74914783,0.0001093467,0.0010044384,0.00036887566,0.0062932232,0.00001799858,0.011510202,0.0034253297,0.18915135,0.03628339],"study_design_scores_gemma":[0.03201041,0.006245841,0.3105342,0.00024114715,0.001409726,0.0008160249,0.0063286186,0.0002229431,0.4346926,0.013138673,0.19350494,0.0008548691],"about_ca_topic_score_codex":0.0005167944,"about_ca_topic_score_gemma":0.00009584324,"teacher_disagreement_score":0.43861362,"about_ca_system_score_codex":0.00023769327,"about_ca_system_score_gemma":0.00026902385,"threshold_uncertainty_score":0.34031987},"labels":[],"label_agreement":null},{"id":"W7110226906","doi":"10.64898/2025.12.04.25341613","title":"Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner","year":2025,"lang":"","type":"article","venue":"medRxiv","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fondation pour la Recherche Médicale; Cancerfonden; European Commission","keywords":"Bladder cancer; Cohort; Transcriptome; Cystectomy; Gene expression profiling; Cytotoxic T cell; Gene; Immune system; Biomarker","score_opus":0.008039109698682748,"score_gpt":0.284179767976506,"score_spread":0.27614065827782325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7110226906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597033,0.031679172,0.0003441524,0.003753706,0.0006489352,0.0023937237,0.000029602603,0.00005174571,0.0013956572],"genre_scores_gemma":[0.9891915,0.0013264071,0.000099173216,0.002782921,0.00013938808,0.00031618957,0.000022850701,0.0000811288,0.0060404707],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964043,0.00038009422,0.0008927318,0.0010098608,0.00058717263,0.0007258796],"domain_scores_gemma":[0.9984965,0.0001528959,0.00019423208,0.00071017165,0.00022159457,0.00022465074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005552385,0.0006381884,0.00089285255,0.0007101687,0.00018220999,0.0001445909,0.0002732998,0.00040051053,0.0006651678],"category_scores_gemma":[0.00021369016,0.000583094,0.00019500012,0.0008825488,0.00023385092,0.00017949412,0.00013940457,0.00072241836,0.000062107174],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007748534,0.0022415877,0.33910927,0.00096455164,0.0028737183,0.0033983104,0.004573926,0.0002577902,0.6306843,0.0019339807,0.0006164839,0.0055975467],"study_design_scores_gemma":[0.011005652,0.0005996289,0.58737,0.0011340778,0.0005974033,0.000047982394,0.00068624027,0.00043825546,0.39585432,0.0011938141,0.0005150376,0.0005575717],"about_ca_topic_score_codex":0.0002512906,"about_ca_topic_score_gemma":0.00016629309,"teacher_disagreement_score":0.24826074,"about_ca_system_score_codex":0.00026178884,"about_ca_system_score_gemma":0.00077569124,"threshold_uncertainty_score":0.99966204},"labels":[],"label_agreement":null},{"id":"W7116064327","doi":"10.1097/ju9.0000000000000404","title":"Reply to Editorial Comment: Identification of a Highly Sensitive Combination of Urinary Protein Biomarkers for the Detection of High-Grade Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Bladder cancer; Biomarker; Urinary system; Identification (biology); Cancer biomarkers; Cancer","score_opus":0.018848979091477033,"score_gpt":0.3216461870422603,"score_spread":0.30279720795078324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116064327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88102764,0.0005873633,0.014778823,0.053128865,0.021497343,0.026957594,0.00096724916,0.000052404364,0.0010027111],"genre_scores_gemma":[0.997547,0.000016617902,0.0001423829,0.00031649583,0.00051374594,0.00076303503,0.000030911437,0.000010916922,0.000658903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990535,0.00005608257,0.000385548,0.00018937787,0.00022259528,0.00009293816],"domain_scores_gemma":[0.99890375,0.00010923924,0.0002627664,0.00028235256,0.0004142646,0.00002760202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003041344,0.0000927054,0.0002735736,0.00010608596,0.000067532244,0.000011790285,0.00012626639,0.000059529924,0.0000058310025],"category_scores_gemma":[0.000093886076,0.00007044266,0.00006769032,0.00030623606,0.000056996825,0.00007903347,0.00006772626,0.000052262683,7.30635e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019733462,0.001503948,0.00033927907,0.00084125093,0.0025647357,0.0000022503389,0.0021950274,0.00008741855,0.8930667,0.0016862751,0.05226714,0.02571253],"study_design_scores_gemma":[0.0065391595,0.0011230432,0.015559768,0.00029844124,0.00052050065,9.924047e-7,0.00039379954,0.00025699273,0.9652414,0.00032163976,0.009675572,0.00006872639],"about_ca_topic_score_codex":0.010742141,"about_ca_topic_score_gemma":0.00010481526,"teacher_disagreement_score":0.11651935,"about_ca_system_score_codex":0.00019976431,"about_ca_system_score_gemma":0.00024258344,"threshold_uncertainty_score":0.99584544},"labels":[],"label_agreement":null},{"id":"W7117112965","doi":"10.1016/j.eururo.2025.09.4174","title":"RESECT: A Randomised Controlled Trial of Audit and Feedback in Non–muscle-invasive Bladder Cancer Surgery","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"KARL STORZ; Medac; Urology Foundation; Photocure; Rosetrees Trust","keywords":"Audit; Randomized controlled trial; Bladder cancer; Intervention (counseling); Documentation; Adjuvant chemotherapy; Adjuvant; Clinical trial","score_opus":0.015823097151976585,"score_gpt":0.28036949429266467,"score_spread":0.26454639714068806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117112965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943784,0.0017608692,0.000018335417,0.0025156592,0.00065465766,0.0023588075,0.000012247173,0.000023766652,0.04887168],"genre_scores_gemma":[0.99455565,0.0009978978,0.000013804349,0.0018353958,0.0002231146,0.00017731696,0.0000073493893,0.000026536522,0.0021629063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982292,0.000520896,0.000530821,0.0003355828,0.00011645806,0.00026705992],"domain_scores_gemma":[0.99841666,0.0010222056,0.00014626117,0.00025639145,0.00008198192,0.000076495584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586107,0.00017849985,0.00093731546,0.00028594755,0.000032954555,0.000006611721,0.00007219588,0.0000745397,0.0002493672],"category_scores_gemma":[0.000685252,0.00014071501,0.00016937258,0.00022291685,0.0001526742,0.000027983402,0.00005516011,0.00018696404,0.000015789992],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9638608,0.00051590265,0.012713977,0.00011808371,0.00083987485,0.00039700288,0.0004476165,0.000011716963,0.0027731464,0.000032888685,0.008676268,0.009612711],"study_design_scores_gemma":[0.8745532,0.00070705963,0.12125165,0.00009687081,0.00047279545,0.000008438619,0.000032947708,0.000024256544,0.0003654805,0.00005966108,0.0023208198,0.00010684074],"about_ca_topic_score_codex":0.00019602587,"about_ca_topic_score_gemma":0.0001647441,"teacher_disagreement_score":0.108537674,"about_ca_system_score_codex":0.000035672612,"about_ca_system_score_gemma":0.0003559636,"threshold_uncertainty_score":0.57381916},"labels":[],"label_agreement":null},{"id":"W7117456809","doi":"10.1111/his.70086","title":"A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Papillary carcinoma; Urothelial carcinoma; Component (thermodynamics); Urothelial cancer; Minor (academic); Immunohistochemistry","score_opus":0.014554870125107582,"score_gpt":0.2619715636137007,"score_spread":0.24741669348859313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117456809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370205,0.0005057029,0.000028998353,0.0032216373,0.00035512142,0.000870083,0.00014166489,0.00005371247,0.0011210273],"genre_scores_gemma":[0.9908161,0.00004043415,0.0001639107,0.005532681,0.000061296545,0.00024507905,0.00010641106,0.000034741774,0.0029993139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983569,0.000107556414,0.00034800795,0.0005269557,0.00023999637,0.00042060774],"domain_scores_gemma":[0.9992321,0.00006224105,0.000113235976,0.00038746663,0.00009282095,0.00011213321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009907161,0.0002916792,0.0006402879,0.00032509887,0.00008194916,0.0000072913476,0.00012518554,0.00022677664,0.000092578],"category_scores_gemma":[0.000040323284,0.0002469526,0.00010803774,0.00028955052,0.0002020881,0.000031829462,0.00006188727,0.00032604812,0.000023481769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013169949,0.0012604527,0.96811044,0.000086536886,0.000051264422,0.0050843046,0.0034625682,0.0000027441506,0.017834114,0.000067146786,0.002260923,0.00046252186],"study_design_scores_gemma":[0.009421302,0.00097493554,0.97986704,0.00023979334,0.00036957732,0.00016629824,0.00017661204,0.0000124394855,0.008099802,0.000031919888,0.00044156832,0.00019873703],"about_ca_topic_score_codex":0.0017394276,"about_ca_topic_score_gemma":0.00065922836,"teacher_disagreement_score":0.011756587,"about_ca_system_score_codex":0.00069422333,"about_ca_system_score_gemma":0.0004735784,"threshold_uncertainty_score":0.9999983},"labels":[],"label_agreement":null},{"id":"W7133025347","doi":"","title":"Utilization of Re-resection in T1 Bladder Cancer: A Population-based Study","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Uniscientia Foundation; Swiss Cancer Research Foundation; Stiftung Professor Dr. Max Cloëtta","keywords":"Bladder cancer; Logistic regression; Cohort; Proportional hazards model; Population; Cancer registry; Guideline; Bladder tumor","score_opus":0.052862282000872125,"score_gpt":0.4124349489252656,"score_spread":0.3595726669243935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133025347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98591167,0.006335417,0.00007813245,0.000238478,0.0018233448,0.0032373809,0.000050446022,0.000039933966,0.0022852148],"genre_scores_gemma":[0.98784477,0.00065517076,0.000048287642,0.000080369115,0.00030757257,0.00057302846,0.0025065383,0.00011525778,0.007869003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615693,0.00040060945,0.0010708235,0.00093296997,0.0009991237,0.00043952072],"domain_scores_gemma":[0.9976589,0.0001320358,0.0007202249,0.0006722418,0.0006588736,0.00015774212],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002885204,0.0006006497,0.0011717372,0.0006833155,0.00013836328,0.000038045342,0.00014323748,0.00048551476,0.0043636593],"category_scores_gemma":[0.00021059079,0.00063311576,0.00023775062,0.0016335275,0.000026058773,0.0001142239,0.000021092244,0.0005007333,0.000012638968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041848887,0.004843732,0.9314038,0.0015802054,0.0009349215,0.00008225188,0.040777244,0.0029963513,0.0014662534,0.000014862571,0.0001495468,0.011565921],"study_design_scores_gemma":[0.010298809,0.0020604823,0.8877738,0.0027697757,0.001960549,0.0000011593246,0.07747142,0.0023801276,0.014654083,0.00002100249,0.0000841911,0.00052461086],"about_ca_topic_score_codex":0.09103183,"about_ca_topic_score_gemma":0.12066078,"teacher_disagreement_score":0.043630034,"about_ca_system_score_codex":0.0008576337,"about_ca_system_score_gemma":0.0017608849,"threshold_uncertainty_score":0.99961203},"labels":[],"label_agreement":null},{"id":"W7133027731","doi":"","title":"Molecular Subtyping to Stratify the Treatment of Muscle-invasive Bladder Cancer: A Cost-effectiveness Analysis","year":2021,"lang":"","type":"dissertation","venue":"TSpace","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"University of Toronto; Canadian Urological Oncology Group","keywords":"Subtyping; Cystectomy; Bladder cancer; Standard of care; Chemotherapy; Gemcitabine","score_opus":0.03595561867070826,"score_gpt":0.3982988727497323,"score_spread":0.362343254079024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133027731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958166,0.030829573,0.00072269986,0.0007418439,0.0008945628,0.0061363624,0.00029338597,0.000033902536,0.0021816874],"genre_scores_gemma":[0.98001254,0.011280548,0.0000758339,0.00022645676,0.0002847599,0.0033235452,0.0011683991,0.00012947578,0.0034984674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955778,0.0006678467,0.0007642533,0.0013202975,0.0009074745,0.0007623195],"domain_scores_gemma":[0.99598444,0.0006246919,0.00058657356,0.001371741,0.0009979978,0.00043453497],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021644193,0.0010446567,0.0022495326,0.0005179081,0.00029592865,0.00008869938,0.00029396525,0.0004483458,0.0017765728],"category_scores_gemma":[0.00011178716,0.0007768695,0.0014599119,0.0029474744,0.00011728993,0.000057455505,0.000033796598,0.00031571763,0.000030782827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007989296,0.00814252,0.03437546,0.0036280311,0.18259408,0.0017083548,0.26251662,0.030363072,0.26779258,0.00033369806,0.0001313972,0.20042486],"study_design_scores_gemma":[0.0063838023,0.0045325705,0.18425927,0.0023377154,0.07913047,0.0000072733174,0.058971252,0.00029646652,0.66105866,0.000020782849,0.001948071,0.0010536881],"about_ca_topic_score_codex":0.026683468,"about_ca_topic_score_gemma":0.01725007,"teacher_disagreement_score":0.39326605,"about_ca_system_score_codex":0.0013094328,"about_ca_system_score_gemma":0.0026113607,"threshold_uncertainty_score":0.9994682},"labels":[],"label_agreement":null},{"id":"W7149238786","doi":"10.1093/ajcp/aqaf150","title":"Comment on “Reflex somatic testing for the detection of <i>FGFR</i> alterations in urinary tract carcinomas: a dual-institutional experience”","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Urinary system; Somatic cell; Urine; Upper urinary tract","score_opus":0.08790032792485683,"score_gpt":0.42852859269524196,"score_spread":0.3406282647703851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7149238786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853637,0.0002474877,0.005481228,0.0076474417,0.00047355564,0.00032292714,0.000008312276,0.0000048846355,0.0004504558],"genre_scores_gemma":[0.9927534,0.000040681145,0.0020915247,0.004881705,0.00016776133,0.000044225144,0.0000012579567,0.0000053329873,0.000014117171],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99842674,0.00019958099,0.0009834317,0.00012701437,0.00013462473,0.00012861287],"domain_scores_gemma":[0.99690324,0.002261353,0.00048151123,0.00014999372,0.00014834017,0.000055566983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063062354,0.000089525565,0.00050338195,0.0001182212,0.0000801915,0.0000043310574,0.00007687666,0.000041598574,0.0000059516365],"category_scores_gemma":[0.0011303603,0.000057039873,0.00018508003,0.00022533139,0.00042543374,0.000040000552,0.0000154638,0.0002829663,7.6881446e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067766034,0.007151902,0.4663804,0.00010020212,0.00035576735,0.000727257,0.002045122,0.00043757327,0.005318378,0.00063435425,0.00020611804,0.50986636],"study_design_scores_gemma":[0.0055580493,0.021801349,0.96513337,0.00035825043,0.00029489503,0.0011239941,0.0014840765,0.0005820877,0.0012244883,0.0007623593,0.0015936698,0.00008338387],"about_ca_topic_score_codex":0.00004461441,"about_ca_topic_score_gemma":0.00000626177,"teacher_disagreement_score":0.50978297,"about_ca_system_score_codex":0.000062168794,"about_ca_system_score_gemma":0.0003386047,"threshold_uncertainty_score":0.23260185},"labels":[],"label_agreement":null},{"id":"W7150871363","doi":"10.1093/ajcp/aqaf151","title":"Response to <i>Comment on “Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: a dual-institutional experience”</i>","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Urinary system; Somatic cell; Fibroblast growth factor receptor; Upper urinary tract","score_opus":0.08181724891517914,"score_gpt":0.4351960557772738,"score_spread":0.35337880686209466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7150871363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97634745,0.0001055816,0.0065936274,0.016009564,0.00038053855,0.00037205205,0.000008597991,0.0000046288415,0.0001779708],"genre_scores_gemma":[0.9874274,0.000011861649,0.0037145668,0.008621048,0.00012469015,0.00006449722,6.326086e-7,0.000005876427,0.000029431347],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982252,0.00038598038,0.0009633188,0.00014266469,0.00014564344,0.0001372025],"domain_scores_gemma":[0.9954715,0.0037400199,0.00037265645,0.00016999475,0.00016543538,0.00008042095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001177982,0.00009200681,0.00048012848,0.0001806613,0.00007907257,0.000004849849,0.00008406194,0.00004022272,0.000006613689],"category_scores_gemma":[0.0030318447,0.00006010123,0.00016496082,0.00026481645,0.00028513596,0.000036015823,0.000019667306,0.00025093253,0.0000013453077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07010209,0.008141185,0.27049884,0.000076990844,0.00036423065,0.0012986378,0.005859488,0.0010231655,0.033687472,0.0002630805,0.0004317967,0.60825306],"study_design_scores_gemma":[0.0046882913,0.033332236,0.9534461,0.0003390106,0.00018552512,0.00090550416,0.0015324868,0.00020465566,0.0017494746,0.00044264644,0.0030933195,0.000080773374],"about_ca_topic_score_codex":0.000041195457,"about_ca_topic_score_gemma":0.0000060018706,"teacher_disagreement_score":0.6829472,"about_ca_system_score_codex":0.0000846018,"about_ca_system_score_gemma":0.00044123526,"threshold_uncertainty_score":0.36296204},"labels":[],"label_agreement":null},{"id":"W7161967392","doi":"10.82308/8322","title":"PD-L1 immune checkpoint inhibition in combination with radiation across different bladder cancer molecular subtypes and influences on immune memory","year":2021,"lang":"en","type":"dissertation","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Abscopal effect; Immunotherapy; Immune system; Radiation therapy; Immune checkpoint; Antigen; Cancer","score_opus":0.00841940502898848,"score_gpt":0.2892901774799048,"score_spread":0.28087077245091635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161967392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782736,0.00780988,0.000011066285,0.00043152727,0.00029190502,0.0010380743,0.00003134185,0.00004779048,0.0025110692],"genre_scores_gemma":[0.9904654,0.0021802473,0.00002676741,0.0002170635,0.00005963091,0.00042875306,0.0029152296,0.00006266096,0.0036442466],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99807507,0.000071755465,0.0005113378,0.00055652234,0.0004914135,0.00029390084],"domain_scores_gemma":[0.9991453,0.00003212561,0.00025771762,0.00027143027,0.0002063493,0.00008704643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011002733,0.0004307416,0.00064703566,0.00019883177,0.00009822884,0.00007178177,0.00004056114,0.0003049221,0.00027176001],"category_scores_gemma":[0.000027320646,0.00032808597,0.000106786385,0.00026871855,0.00005358657,0.00013685078,0.00001685291,0.00037968162,0.000005908679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023748701,0.0073379967,0.07530752,0.0054097595,0.0046461937,0.0014612176,0.03453068,0.00049653463,0.63272625,0.0010212202,0.00015360731,0.21316034],"study_design_scores_gemma":[0.005267363,0.0006766872,0.5863541,0.0012820443,0.0002539148,0.000012025737,0.0020291612,0.000036861413,0.4036952,0.00008831778,0.000020431595,0.00028388502],"about_ca_topic_score_codex":0.0030801974,"about_ca_topic_score_gemma":0.0032648805,"teacher_disagreement_score":0.5110466,"about_ca_system_score_codex":0.0003305617,"about_ca_system_score_gemma":0.0002375791,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W863345957","doi":"10.1016/j.eururo.2015.06.048","title":"Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399–405","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; General surgery; Cancer; Internal medicine","score_opus":0.0481298095899044,"score_gpt":0.34345811580166524,"score_spread":0.29532830621176087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W863345957","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013524141,0.0060976325,0.00071469415,0.96746165,0.0027154654,0.004077909,0.00242591,0.0002307547,0.014923594],"genre_scores_gemma":[0.02271532,0.00086343405,0.000633161,0.9588459,0.0029142112,0.00088889746,0.0020309575,0.00053798145,0.010570129],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927025,0.0017692207,0.0010524959,0.0023282696,0.000734552,0.0014129585],"domain_scores_gemma":[0.9966525,0.00035617073,0.0005187458,0.0014841156,0.00034547038,0.0006430182],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010771576,0.0012178514,0.0016931038,0.00031238832,0.00018915822,0.00022599135,0.001108102,0.0006594319,0.0012029626],"category_scores_gemma":[0.00025020132,0.0010533028,0.00032797438,0.0002342353,0.00046406293,0.00023987558,0.0008578093,0.002897833,0.00028941946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023033277,0.00021832438,0.0033225091,0.00016215697,0.0008203425,0.0047312165,0.00036905266,0.0000023874072,0.00006728893,0.0000032342232,0.9819916,0.006008556],"study_design_scores_gemma":[0.010784642,0.0028232154,0.014604737,0.00026171407,0.0010957828,0.0007373222,0.000026599377,0.00005635106,0.000018064296,0.000024306788,0.9686443,0.00092293596],"about_ca_topic_score_codex":0.000662138,"about_ca_topic_score_gemma":0.00044408778,"teacher_disagreement_score":0.021362906,"about_ca_system_score_codex":0.00023085797,"about_ca_system_score_gemma":0.0008256597,"threshold_uncertainty_score":0.9997101},"labels":[],"label_agreement":null},{"id":"W87228302","doi":"10.1155/2010/572410","title":"A Case of Pott’s Disease with Epidural Abscess and Probable Cerebral Tuberculoma following Bacillus Calmette‐Guérin Therapy for Superficial Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Infectious Diseases and Medical Microbiology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Tuberculoma; Immunotherapy; Abscess; Surgery; BCG vaccine; Vertebral osteomyelitis; Bladder cancer; Carcinoma in situ; Osteomyelitis; Carcinoma; Tuberculosis; Cancer; Internal medicine; Pathology","score_opus":0.008580102162196734,"score_gpt":0.2578554575785729,"score_spread":0.2492753554163762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W87228302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991859,0.0051864986,0.000033455864,0.0014973881,0.00055651076,0.00044638442,0.00038384454,0.000006477293,0.000030413135],"genre_scores_gemma":[0.99814713,0.00019881355,0.000055768607,0.0011010185,0.0003955698,0.00003187051,0.000018295375,0.00002289057,0.000028656563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990072,0.000041620962,0.00030957823,0.00020760112,0.00007375328,0.00036020903],"domain_scores_gemma":[0.99784017,0.00007135406,0.00011003326,0.00010469776,0.00018012483,0.0016936472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011853001,0.00019005204,0.0004832459,0.00015901291,0.0001553305,0.000018840388,0.000059212252,0.00014393903,0.00030647786],"category_scores_gemma":[0.00016806443,0.0001261832,0.00015716114,0.000088615205,0.0004135097,0.00006928826,0.000010107453,0.00025773718,2.695418e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017179322,0.00030122028,0.94474125,0.00024029455,0.0011422437,0.0068750926,0.0004373969,0.0000032204473,0.0035659745,0.00015074873,0.0011202414,0.039704397],"study_design_scores_gemma":[0.10507186,0.018553928,0.65525603,0.0019253013,0.008205747,0.16882631,0.0012776341,0.00018406041,0.0023929044,0.0015859739,0.03474986,0.0019703945],"about_ca_topic_score_codex":0.010042756,"about_ca_topic_score_gemma":0.05842187,"teacher_disagreement_score":0.2894852,"about_ca_system_score_codex":0.000063133055,"about_ca_system_score_gemma":0.0029187212,"threshold_uncertainty_score":0.9965494},"labels":[],"label_agreement":null},{"id":"W883696639","doi":"","title":"Evidence for b → d γ transitions from a sum of exclusive final states in the hadronic final state mass range 1.0GeV/c2 < M(X d) < 1.8GeV/c2","year":2007,"lang":"en","type":"article","venue":"arXiv (Cornell University)","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Montréal; McGill University; University of British Columbia","funders":"","keywords":"Physics; Hadron; Humanities; Particle physics; Philosophy","score_opus":0.16536869040863733,"score_gpt":0.2649810510154564,"score_spread":0.09961236060681905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W883696639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95109797,0.0005666835,0.046230305,0.0004679138,0.00007513453,0.0008012066,0.00029396464,0.000027527045,0.00043930238],"genre_scores_gemma":[0.99807155,0.0004916622,0.00032822735,0.00028783653,0.000058336846,0.0000047840585,0.000054261833,0.000017504186,0.0006858565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883515,0.00007199378,0.00024497765,0.00037443207,0.00011374142,0.00035972352],"domain_scores_gemma":[0.99878156,0.0005881114,0.0001062546,0.00032776754,0.00009742218,0.000098894074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002748984,0.0001820586,0.00028891867,0.00015571257,0.000103278944,0.000010621815,0.00022008346,0.000071296236,0.00013763065],"category_scores_gemma":[0.00003810311,0.00015459345,0.00017712789,0.00043215737,0.0001549786,0.00019217636,0.000021220218,0.00017875155,0.000013641105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06791127,0.0056776917,0.789499,0.001324237,0.0025986962,0.008648131,0.05191418,0.023564607,0.017661924,0.013959755,0.0033949935,0.013845512],"study_design_scores_gemma":[0.06615825,0.008649278,0.73798877,0.0031419473,0.00477738,0.00009337018,0.02357593,0.026016494,0.016579669,0.10460512,0.006517022,0.0018967673],"about_ca_topic_score_codex":0.00080888387,"about_ca_topic_score_gemma":0.0009034055,"teacher_disagreement_score":0.09064537,"about_ca_system_score_codex":0.00015512184,"about_ca_system_score_gemma":0.000188129,"threshold_uncertainty_score":0.6304138},"labels":[],"label_agreement":null}]}